qiita_sample_name,sample_name,run_prefix,experimental_strategy,base_name,filename,analyte_amount,analyte_A260A280Ratio,aliquot_concentration,id_cgc,filename_cgc,vital_status,gender,race,ethnicity,disease_type,data_subtype,sample_id_tcga,case_uuid_cgc,sample_type,platform_tcga,gdc_uuid,primary_site,age_at_diagnosis,sample_uuid_cgc,aliquot_uuid_cgc,aliquot_id_tcga,reference_genome,case_id_tcga,investigation,days_to_death,knightlabID,data_submitting_center_label,tissue_source_site_label,country_of_sample_procurement,portion_is_ffpe,pathologic_t_label,pathologic_n_label,histological_diagnosis_label,pathologic_stage_label
13722.58cfa830e4b0c9d6adf6bcae,58cfa830e4b0c9d6adf6bcae,TCGA-AZ-4614-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AZ-4614-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-AZ-4614-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,449.02,1.9,0.16,58cfa830e4b0c9d6adf6bcae,TCGA-AZ-4614-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-4614-01A,3334201D-A3C0-45EC-A9ED-CF48CC8C38E8,Primary Tumor,Illumina HiSeq,50679ea1-6443-43b4-ab23-0f7542f4cb98,Colorectal,71,0C4DAF52-CC9F-4099-8825-33C484CED5B1,29DA0D99-6FD9-4CC0-84BE-E1670FC253E7,TCGA-AZ-4614-01A-01D-1405-02,HG18,TCGA-AZ-4614,TCGA-COAD,172,s12888,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N1,Colon Adenocarcinoma,Stage IVA
13722.58cfa82fe4b0c9d6adf6b91e,58cfa82fe4b0c9d6adf6b91e,TCGA-A6-2674-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-2674-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-2674-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,342.56,1.9,0.15,58cfa82fe4b0c9d6adf6b91e,TCGA-A6-2674-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2674-10A,57CDAA1C-4E94-4A28-AB3B-300C0457555F,Blood Derived Normal,Illumina HiSeq,6c0170f4-886c-4c9e-b831-9e7ddbe64526,Colorectal,71,CED59EE0-9A95-4E2D-AC39-22EF6F80EBF7,DD75656D-6DF6-4C53-972D-439791C908AC,TCGA-A6-2674-10A-01D-1167-02,HG18,TCGA-A6-2674,TCGA-COAD,NA,s13350,Harvard Medical School,Christiana Healthcare,None,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage IV
13722.58cfa82fe4b0c9d6adf6b928,58cfa82fe4b0c9d6adf6b928,TCGA-A6-2679-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-2679-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-2679-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,236,1.9,0.15,58cfa82fe4b0c9d6adf6b928,TCGA-A6-2679-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2679-10A,0F74D992-00DA-4728-9564-086CA1B95921,Blood Derived Normal,Illumina HiSeq,ad1b1f81-bc17-4bdc-8bb9-06993af79462,Colorectal,73,2863DE87-C342-45EB-8448-F4ACDEC30A3E,822A50C3-E1D1-4CE4-93C6-E563328852D1,TCGA-A6-2679-10A-01D-1405-02,HG18,TCGA-A6-2679,TCGA-COAD,NA,s13507,Harvard Medical School,Christiana Healthcare,None,NO,T3,N0,Colon Adenocarcinoma,Stage IIB
13722.58cfa82fe4b0c9d6adf6b842,58cfa82fe4b0c9d6adf6b842,TCGA-A6-2674-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-2674-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-2674-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,260.29,1.9,0.14,58cfa82fe4b0c9d6adf6b842,TCGA-A6-2674-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2674-01A,57CDAA1C-4E94-4A28-AB3B-300C0457555F,Primary Tumor,Illumina HiSeq,92b3a16b-1a9e-47a3-9146-1a297c51c5a3,Colorectal,71,8ACA008C-F55A-420A-82C7-ACD2CCA77D85,9FDFC199-B878-4049-994E-B5CA384678FB,TCGA-A6-2674-01A-02D-1167-02,HG18,TCGA-A6-2674,TCGA-COAD,NA,s13013,Harvard Medical School,Christiana Healthcare,None,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage IV
13722.58cfa830e4b0c9d6adf6bc42,58cfa830e4b0c9d6adf6bc42,TCGA-AA-3553-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3553-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3553-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,20.56,1.9,0.14,58cfa830e4b0c9d6adf6bc42,TCGA-AA-3553-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3553-10A,D181C72B-843C-4B2D-B014-2A6DD1C3C1EC,Blood Derived Normal,Illumina HiSeq,6795b83b-1ca7-4060-a078-6649fa9004bb,Colorectal,61,FE42F5D3-CFBB-478F-BB34-6518206A8718,B7B44E75-51E9-4F51-9523-B54C92828A01,TCGA-AA-3553-10A-01D-1167-02,HG18,TCGA-AA-3553,TCGA-COAD,NA,s13023,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa82fe4b0c9d6adf6ba39,58cfa82fe4b0c9d6adf6ba39,TCGA-A6-2684-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-2684-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-2684-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,93.3,1.9,0.14,58cfa82fe4b0c9d6adf6ba39,TCGA-A6-2684-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2684-10A,49929108-023E-4D35-B26D-50AB4D3AE581,Blood Derived Normal,Illumina HiSeq,86cc24c1-f3f5-4564-9c97-63a25b07290c,Colorectal,75,955A8753-B2CC-4378-BBC0-4100F76E3609,A77948EC-84FD-4A3E-9452-29434410D95F,TCGA-A6-2684-10A-01D-1405-02,HG18,TCGA-A6-2684,TCGA-COAD,NA,s13506,Harvard Medical School,Christiana Healthcare,None,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bb5a,58cfa830e4b0c9d6adf6bb5a,TCGA-AA-3553-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3553-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3553-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,1010.56,1.9,0.17,58cfa830e4b0c9d6adf6bb5a,TCGA-AA-3553-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3553-01A,D181C72B-843C-4B2D-B014-2A6DD1C3C1EC,Primary Tumor,Illumina HiSeq,b8e8f766-3a6f-4c2c-aeb0-ba7b926a3b99,Colorectal,61,B1DCD03C-3CDD-4C23-9391-C5ADEEBFF489,2159EE82-6427-4E1F-9C6F-28B48562DF0C,TCGA-AA-3553-01A-01D-1167-02,HG18,TCGA-AA-3553,TCGA-COAD,NA,s13362,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa82fe4b0c9d6adf6b840,58cfa82fe4b0c9d6adf6b840,TCGA-A6-2679-01A-02D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-2679-01A-02D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-2679-01A-02D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,556,1.9,0.17,58cfa82fe4b0c9d6adf6b840,TCGA-A6-2679-01A-02D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2679-01A,0F74D992-00DA-4728-9564-086CA1B95921,Primary Tumor,Illumina HiSeq,6ba315a4-973a-47a1-b157-8f6ab62fdaef,Colorectal,73,1FCB9C83-18CB-42A4-8769-FDDB3541C95D,118D83B1-3464-40E3-8A77-270650CFED42,TCGA-A6-2679-01A-02D-1405-02,HG18,TCGA-A6-2679,TCGA-COAD,NA,s13014,Harvard Medical School,Christiana Healthcare,None,NO,T3,N0,Colon Adenocarcinoma,Stage IIB
13722.58cfa830e4b0c9d6adf6ba7c,58cfa830e4b0c9d6adf6ba7c,TCGA-AA-3509-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3509-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3509-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,496,1.9,0.14,58cfa830e4b0c9d6adf6ba7c,TCGA-AA-3509-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3509-01A,80E677B1-5EBE-4069-A1A5-1538FFEE6642,Primary Tumor,Illumina HiSeq,41b8f6a5-58f8-4e97-bbd3-a2587a70e30d,Colorectal,54,BA6E3333-3651-450E-A6EA-4E47CF0D18BF,ACCC21A8-D026-40E4-AA2C-C0F998A1D370,TCGA-AA-3509-01A-01D-1405-02,HG18,TCGA-AA-3509,TCGA-COAD,NA,s13183,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa82fe4b0c9d6adf6b5e4,58cfa82fe4b0c9d6adf6b5e4,TCGA-44-2661-01A-01D-1103_110913_SN208_0238_BC008YACXX_s_7_rg.sorted.filtered.,WGS,TCGA-44-2661-01A-01D-1103_110913_SN208_0238_BC008YACXX_s_7_rg.sorted,TCGA-44-2661-01A-01D-1103_110913_SN208_0238_BC008YACXX_s_7_rg.sorted.bam,735.66,1.9,0.15,58cfa82fe4b0c9d6adf6b5e4,TCGA-44-2661-01A-01D-1103_110913_SN208_0238_BC008YACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-2661-01A,F3501466-CF32-4866-B5FB-E94DD32341BC,Primary Tumor,Illumina HiSeq,fbe0b7e0-45f4-4c61-9965-be52ae790251,Lung,69,48DD9724-8848-48C3-8628-7E78A24E3F2C,5F5307B5-02FF-4262-BB72-A215897B2EA7,TCGA-44-2661-01A-01D-1103-02,HG19_Broad_variant,TCGA-44-2661,TCGA-LUAD,NA,s10650,Harvard Medical School,Christiana Healthcare,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa830e4b0c9d6adf6bd11,58cfa830e4b0c9d6adf6bd11,TCGA-AA-3688-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AA-3688-01A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AA-3688-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,604.6,1.9,0.15,58cfa830e4b0c9d6adf6bd11,TCGA-AA-3688-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3688-01A,2C9996BB-AF6E-4424-881A-E81B9C9AEB78,Primary Tumor,Illumina GA,f0292645-2a44-4572-a3e7-4187c78f0618,Colorectal,80,9E071449-9392-4384-B38F-26722D2D5C51,C61B5B29-385C-4D49-9C8A-6E701632AEBE,TCGA-AA-3688-01A-01D-0957-02,HG18,TCGA-AA-3688,TCGA-COAD,NA,s13680,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage IV
13722.58cfa830e4b0c9d6adf6bbfe,58cfa830e4b0c9d6adf6bbfe,TCGA-A6-2684-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-2684-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-2684-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,463.6,1.9,0.15,58cfa830e4b0c9d6adf6bbfe,TCGA-A6-2684-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2684-01A,49929108-023E-4D35-B26D-50AB4D3AE581,Primary Tumor,Illumina HiSeq,1d127721-dd08-4127-af3b-0dfd623ea7bf,Colorectal,75,73B6994E-C9BF-41A8-A455-17D7BE309A9F,5A35E547-72DB-4B4E-8459-1264D0845506,TCGA-A6-2684-01A-01D-1405-02,HG18,TCGA-A6-2684,TCGA-COAD,NA,s13174,Harvard Medical School,Christiana Healthcare,None,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa82fe4b0c9d6adf6b77c,58cfa82fe4b0c9d6adf6b77c,TCGA-44-5645-01A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_5_rg.sorted.filtered.,WGS,TCGA-44-5645-01A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_5_rg.sorted,TCGA-44-5645-01A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_5_rg.sorted.bam,466.6,1.9,0.16,58cfa82fe4b0c9d6adf6b77c,TCGA-44-5645-01A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_5_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-5645-01A,DDEACCCF-0953-4952-8A4E-C2617F2E7BCC,Primary Tumor,Illumina HiSeq,e1f13e42-abbc-4a28-91d2-65b2a95b0018,Lung,61,37A8D3A5-BAA0-427C-AB43-48AE4B93633B,A35054A5-9324-47AD-841E-E2ADCD97126D,TCGA-44-5645-01A-01D-1623-02,HG19_Broad_variant,TCGA-44-5645,TCGA-LUAD,NA,s10993,Harvard Medical School,Christiana Healthcare,United States,NO,T1,NX,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa830e4b0c9d6adf6bbf8,58cfa830e4b0c9d6adf6bbf8,TCGA-AA-3688-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AA-3688-10A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AA-3688-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,0,1.9,0.16,58cfa830e4b0c9d6adf6bbf8,TCGA-AA-3688-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3688-10A,2C9996BB-AF6E-4424-881A-E81B9C9AEB78,Blood Derived Normal,Illumina GA,e3f20272-feb4-4134-bc8d-637a5df2af3a,Colorectal,80,9D851BD7-7241-494F-85FF-7A7C6FABA09B,D8BA91DA-67CB-4C7C-8A09-F65834FB2068,TCGA-AA-3688-10A-01D-0957-02,HG18,TCGA-AA-3688,TCGA-COAD,NA,s13368,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage IV
13722.58cfa82fe4b0c9d6adf6b624,58cfa82fe4b0c9d6adf6b624,TCGA-75-5146-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_5_rg.sorted.filtered.,WGS,TCGA-75-5146-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_5_rg.sorted,TCGA-75-5146-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_5_rg.sorted.bam,692.7,1.9,0.15,58cfa82fe4b0c9d6adf6b624,TCGA-75-5146-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_5_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-5146-01A,1D276B62-5E64-48FB-B2CE-5192B511FE37,Primary Tumor,Illumina HiSeq,926ac8ca-ff8f-4822-bf62-819bf5525a5d,Lung,NA,373C5231-B6AE-49DB-AC0D-D674A0C9C100,2578C781-0BDF-4CA2-A8FA-8B624489818B,TCGA-75-5146-01A-01D-1623-02,HG19_Broad_variant,TCGA-75-5146,TCGA-LUAD,NA,s10668,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82fe4b0c9d6adf6b682,58cfa82fe4b0c9d6adf6b682,TCGA-44-5645-10A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_6_rg.sorted.filtered.,WGS,TCGA-44-5645-10A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_6_rg.sorted,TCGA-44-5645-10A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_6_rg.sorted.bam,312.7,2,0.16,58cfa82fe4b0c9d6adf6b682,TCGA-44-5645-10A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_6_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-5645-10A,DDEACCCF-0953-4952-8A4E-C2617F2E7BCC,Blood Derived Normal,Illumina HiSeq,9eac595e-5daf-4448-bb4f-5c16b028bddb,Lung,61,0F56A5D5-274E-4599-9566-3EABA30AF2F9,78734754-0680-489A-886B-2F5FCE472560,TCGA-44-5645-10A-01D-1623-02,HG19_Broad_variant,TCGA-44-5645,TCGA-LUAD,NA,s11549,Harvard Medical School,Christiana Healthcare,United States,NO,T1,NX,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82fe4b0c9d6adf6ba0c,58cfa82fe4b0c9d6adf6ba0c,TCGA-AA-3970-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3970-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3970-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,686.66,1.9,0.15,58cfa82fe4b0c9d6adf6ba0c,TCGA-AA-3970-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3970-01A,733D8B6A-CA9D-4A69-8C9C-1F88733E8B68,Primary Tumor,Illumina HiSeq,9a7a59e0-b435-4e8b-b503-c49ce6f819e4,Colorectal,65,767A5260-34F4-4BED-9CDA-305BC431A402,0F57E6B4-FE51-4ACF-B65B-1FDB2CF9C6CB,TCGA-AA-3970-01A-01D-1109-02,HG18,TCGA-AA-3970,TCGA-COAD,NA,s13190,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6ae62,58cfa82ee4b0c9d6adf6ae62,TCGA-05-4395-01A-01D-1203_110913_SN208_0238_BC008YACXX_s_8_rg.sorted.filtered.,WGS,TCGA-05-4395-01A-01D-1203_110913_SN208_0238_BC008YACXX_s_8_rg.sorted,TCGA-05-4395-01A-01D-1203_110913_SN208_0238_BC008YACXX_s_8_rg.sorted.bam,385.2,1.9,0.14,58cfa82ee4b0c9d6adf6ae62,TCGA-05-4395-01A-01D-1203_110913_SN208_0238_BC008YACXX_s_8_rg.sorted.bam,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4395-01A,762DEA8A-5B41-4058-979A-B7876ED13D7E,Primary Tumor,Illumina HiSeq,dcb07672-8bde-427e-9d94-ac644e457e91,Lung,76,9DED6605-39A3-4C0F-AD2E-7F6863960DBE,5E9E0A0C-75C0-48AA-BD85-A2E102787EF9,TCGA-05-4395-01A-01D-1203-02,HG19_Broad_variant,TCGA-05-4395,TCGA-LUAD,0,s11115,Harvard Medical School,Indivumed,Germany,NO,T4,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIB
13722.58cfa82fe4b0c9d6adf6b726,58cfa82fe4b0c9d6adf6b726,TCGA-75-5147-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_4_rg.sorted.filtered.,WGS,TCGA-75-5147-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_4_rg.sorted,TCGA-75-5147-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_4_rg.sorted.bam,817.7,1.9,0.15,58cfa82fe4b0c9d6adf6b726,TCGA-75-5147-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-5147-01A,D2824E6D-3784-45C2-9B0F-52B17356B5DA,Primary Tumor,Illumina HiSeq,ca549b28-f771-489d-93fe-90211aa22391,Lung,NA,F9F9C1DD-8462-4560-82B8-AEA4309854C9,1291FD50-F1A9-4A2A-A2FD-2320ED01FB4E,TCGA-75-5147-01A-01D-1623-02,HG19_Broad_variant,TCGA-75-5147,TCGA-LUAD,NA,s11466,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c788,58cfa831e4b0c9d6adf6c788,TCGA-CV-7183-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CV-7183-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_1_rg.sorted,TCGA-CV-7183-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_1_rg.sorted.bam,42.03,NA,0.13,58cfa831e4b0c9d6adf6c788,TCGA-CV-7183-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7183-10A,DE206681-3E27-4D4F-8669-AEFB12B5B1E3,Blood Derived Normal,Illumina HiSeq,f7f69891-d84b-4137-92ba-59f738bbc299,Head and Neck,53,E9101C16-E19C-46E7-99F4-2851FF7DA89E,E13D1C47-E67F-403E-984F-19721890E7A8,TCGA-CV-7183-10A-01D-2317-26,HG19_Broad_variant,TCGA-CV-7183,TCGA-HNSC,NA,s15778,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa830e4b0c9d6adf6c070,58cfa830e4b0c9d6adf6c070,TCGA-AY-4070-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AY-4070-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole,TCGA-AY-4070-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,458.59,1.9,0.13,58cfa830e4b0c9d6adf6c070,TCGA-AY-4070-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AY-4070-01A,6BAF61B6-AE5B-42F0-ADC9-0D26FDA231F7,Primary Tumor,Illumina HiSeq,c0679a4e-afc6-4b64-80a5-35bf5e446cb1,Colorectal,50,C35CB7B2-7A85-4320-89AC-3A395EF8C1BE,B9EFEB1A-FA1D-4917-8FC5-149ECAF26989,TCGA-AY-4070-01A-01D-1109-02,HG18,TCGA-AY-4070,TCGA-COAD,496,s13388,Harvard Medical School,UNC,None,NO,T3,N2,Colon Adenocarcinoma,Stage IIIC
13722.58cfa830e4b0c9d6adf6c28a,58cfa830e4b0c9d6adf6c28a,TCGA-AF-3913-01A-02D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AF-3913-01A-02D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AF-3913-01A-02D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,452.29,1.8,0.16,58cfa830e4b0c9d6adf6c28a,TCGA-AF-3913-01A-02D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-AF-3913-01A,03A9DD9D-62AE-4ACD-9272-389274858F3D,Primary Tumor,Illumina HiSeq,6b7624bc-5e74-4fd2-9475-f916cbe9bc5f,Colorectal,60,B01C6CD1-68DA-437F-90E4-9A645E8F3470,44A5F915-BADF-4521-8102-1B353E302E80,TCGA-AF-3913-01A-02D-1115-02,HG18,TCGA-AF-3913,TCGA-READ,316,s2147,Harvard Medical School,Christiana Healthcare,None,NO,T3,N1,Rectal Adenocarcinoma,Stage IV
13722.58cfa830e4b0c9d6adf6beac,58cfa830e4b0c9d6adf6beac,TCGA-AG-3898-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3898-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3898-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,24.59,1.9,0.15,58cfa830e4b0c9d6adf6beac,TCGA-AG-3898-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3898-10A,5A7D19F9-6BE2-45AC-9FFC-11E28594EEEE,Blood Derived Normal,Illumina HiSeq,bb8d9cc7-db6f-4290-b00e-c26297f8be6c,Colorectal,61,4328ABB7-6E1F-4DA9-A6A4-2F8FA32B4C30,B12A19E2-25CF-414F-BA42-396566C2A486,TCGA-AG-3898-10A-01D-1115-02,HG18,TCGA-AG-3898,TCGA-READ,NA,s1997,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6bf36,58cfa830e4b0c9d6adf6bf36,TCGA-AY-4070-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AY-4070-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole,TCGA-AY-4070-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,18.29,1.9,0.16,58cfa830e4b0c9d6adf6bf36,TCGA-AY-4070-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AY-4070-10A,6BAF61B6-AE5B-42F0-ADC9-0D26FDA231F7,Blood Derived Normal,Illumina HiSeq,b2605015-9592-44b0-b1e7-23aa852eff26,Colorectal,50,0D65E88C-0275-4A7D-A116-470897A07F13,46D73EBC-5D30-4452-9EE2-CD16E22B4140,TCGA-AY-4070-10A-01D-1109-02,HG18,TCGA-AY-4070,TCGA-COAD,496,s13844,Harvard Medical School,UNC,None,NO,T3,N2,Colon Adenocarcinoma,Stage IIIC
13722.58cfa830e4b0c9d6adf6bf42,58cfa830e4b0c9d6adf6bf42,TCGA-AY-4071-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AY-4071-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole,TCGA-AY-4071-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,79.29,1.9,0.14,58cfa830e4b0c9d6adf6bf42,TCGA-AY-4071-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AY-4071-10A,315EF7F6-CA21-4D87-8F19-40BD455885EC,Blood Derived Normal,Illumina HiSeq,31d451c9-cf15-4db5-beb0-ed60aa728435,Colorectal,63,FADCFBCB-EB8C-464A-ABDE-C349EFDC2583,B208E815-84DF-439C-8187-CC8994DB7FBF,TCGA-AY-4071-10A-01D-1109-02,HG18,TCGA-AY-4071,TCGA-COAD,29,s13210,Harvard Medical School,UNC,None,NO,T1,N0,Not available,Stage I
13722.58cfa832e4b0c9d6adf6d401,58cfa832e4b0c9d6adf6d401,TCGA-V4-A9EH-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_5_rg.sorted.filtered.,WGS,TCGA-V4-A9EH-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_5_rg.sorted,TCGA-V4-A9EH-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_5_rg.sorted.bam,32.48,NA,0.17,58cfa832e4b0c9d6adf6d401,TCGA-V4-A9EH-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EH-01A,5E54122F-1C4D-45CC-8842-CD1C1DF0EED8,Primary Tumor,Illumina HiSeq,f23ae536-eb5e-4d13-baf2-94a4eb03d083,Eye,53,A320EAC2-C0FB-44D0-9849-DD541C2428E1,AC2BA0CC-C007-44BF-8C99-4C88D55C022E,TCGA-V4-A9EH-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9EH,TCGA-UVM,NA,s222,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4c,N0,Not available,Stage IIIB
13722.58cfa832e4b0c9d6adf6d4e4,58cfa832e4b0c9d6adf6d4e4,TCGA-V4-A9EE-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_3_rg.sorted.filtered.,WGS,TCGA-V4-A9EE-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_3_rg.sorted,TCGA-V4-A9EE-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_3_rg.sorted.bam,37.61,NA,0.17,58cfa832e4b0c9d6adf6d4e4,TCGA-V4-A9EE-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EE-01A,EDBF6720-467E-4928-B1CB-0E7336358D18,Primary Tumor,Illumina HiSeq,88edb951-b2e0-476d-bc63-3f5883671a8f,Eye,86,1C5AB1BD-67EF-43AB-B46B-17E126DF2B82,0E1D56AE-4213-4443-BDD3-A652CFC60104,TCGA-V4-A9EE-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9EE,TCGA-UVM,398,s223,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3a,N0,Not available,Stage IIB
13722.58cfa830e4b0c9d6adf6bbec,58cfa830e4b0c9d6adf6bbec,TCGA-AA-3693-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AA-3693-10A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AA-3693-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,0,1.9,0.15,58cfa830e4b0c9d6adf6bbec,TCGA-AA-3693-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3693-10A,33522271-B2CA-4DA4-A942-501AB9117C51,Blood Derived Normal,Illumina GA,87d9c831-1d20-4971-8c16-6e160def0527,Colorectal,77,52BF3A80-1CC2-4D58-B5C5-D83C98958D62,6D13E1D0-04FC-449E-9C90-72D5C610A7F6,TCGA-AA-3693-10A-01D-0957-02,HG18,TCGA-AA-3693,TCGA-COAD,NA,s13369,Harvard Medical School,Indivumed,Germany,NO,T4,N1,Colon Adenocarcinoma,Stage IV
13722.58cfa831e4b0c9d6adf6cb08,58cfa831e4b0c9d6adf6cb08,TCGA-DU-6542-10A-01D-1891_130912_SN590_0237_AC292LACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DU-6542-10A-01D-1891_130912_SN590_0237_AC292LACXX_s_2_rg.sorted,TCGA-DU-6542-10A-01D-1891_130912_SN590_0237_AC292LACXX_s_2_rg.sorted.bam,143,1.9,0.16,58cfa831e4b0c9d6adf6cb08,TCGA-DU-6542-10A-01D-1891_130912_SN590_0237_AC292LACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6542-10A,CD69D509-A652-4257-A8D3-767296BBB4EC,Blood Derived Normal,Illumina HiSeq,dda7afb5-9e07-42bd-b2e0-7499a263ebb5,Brain,25,28B425E6-57A6-432D-A995-D6B03D2094E4,3CD1E613-829B-40DD-AA6A-3460085EEC07,TCGA-DU-6542-10A-01D-1891-02,HG19_Broad_variant,TCGA-DU-6542,TCGA-LGG,NA,s8360,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa830e4b0c9d6adf6bc6e,58cfa830e4b0c9d6adf6bc6e,TCGA-AF-3913-11A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AF-3913-11A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AF-3913-11A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,448.89,1.9,0.15,58cfa830e4b0c9d6adf6bc6e,TCGA-AF-3913-11A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-AF-3913-11A,03A9DD9D-62AE-4ACD-9272-389274858F3D,Solid Tissue Normal,Illumina HiSeq,af7c14b7-a3d9-4dba-99b0-753ad2c7d90d,Colorectal,60,4A702DED-02FC-40BA-A4F8-A9C4FE7007F9,A5CC1277-D1B0-4662-97FC-84A21AD24CFF,TCGA-AF-3913-11A-01D-1115-02,HG18,TCGA-AF-3913,TCGA-READ,316,s2310,Harvard Medical School,Christiana Healthcare,None,NO,T3,N1,Rectal Adenocarcinoma,Stage IV
13722.58cfa830e4b0c9d6adf6ba62,58cfa830e4b0c9d6adf6ba62,TCGA-AA-A01D-10A-01D-A078_110329_SN208_0198_B702NLABXX_s_8_rg.sorted.filtered.,WGS,TCGA-AA-A01D-10A-01D-A078_110329_SN208_0198_B702NLABXX_s_8_rg.sorted,TCGA-AA-A01D-10A-01D-A078_110329_SN208_0198_B702NLABXX_s_8_rg.sorted.bam,23.49,1.74,0.15,58cfa830e4b0c9d6adf6ba62,TCGA-AA-A01D-10A-01D-A078_110329_SN208_0198_B702NLABXX_s_8_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01D-10A,E2EDBF3F-25D8-49AA-B656-2A59C3B99AEB,Blood Derived Normal,Illumina HiSeq,f2fab628-0348-4344-8274-3e741299a65f,Colorectal,47,A962D396-8357-4093-BCC5-854E59FE7F98,8EFAC126-7B81-4E97-9F8A-C6D3F921E7E6,TCGA-AA-A01D-10A-01D-A078-02,HG18_Broad_variant,TCGA-AA-A01D,TCGA-COAD,NA,s13530,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage IIIC
13722.58cfa830e4b0c9d6adf6bfee,58cfa830e4b0c9d6adf6bfee,TCGA-AG-3882-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AG-3882-10A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AG-3882-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,82,1.9,0.16,58cfa830e4b0c9d6adf6bfee,TCGA-AG-3882-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3882-10A,92C65E5A-3F07-49D9-AB69-46A0EB86AE88,Blood Derived Normal,Illumina GA,a1997fa7-5f47-4ddc-b151-e58709808dbd,Colorectal,66,0FC9AB73-F4D2-4BC6-A824-790C2C904BAC,CBD098BC-110D-41E8-965E-D1E3485BD49A,TCGA-AG-3882-10A-01D-0957-02,HG18,TCGA-AG-3882,TCGA-READ,NA,s1966,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bea4,58cfa830e4b0c9d6adf6bea4,TCGA-AG-3898-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3898-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3898-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,722.89,1.9,0.15,58cfa830e4b0c9d6adf6bea4,TCGA-AG-3898-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3898-01A,5A7D19F9-6BE2-45AC-9FFC-11E28594EEEE,Primary Tumor,Illumina HiSeq,846bcf47-2650-4479-be12-96589e587f3a,Colorectal,61,C782D6BF-AA57-4184-8276-E08D6B64E6B2,AA49029D-0F51-4836-BD7B-74CC0C2F9576,TCGA-AG-3898-01A-01D-1115-02,HG18,TCGA-AG-3898,TCGA-READ,NA,s2314,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6bbee,58cfa830e4b0c9d6adf6bbee,TCGA-AA-3693-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AA-3693-01A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AA-3693-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,667,1.9,0.15,58cfa830e4b0c9d6adf6bbee,TCGA-AA-3693-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3693-01A,33522271-B2CA-4DA4-A942-501AB9117C51,Primary Tumor,Illumina GA,5df0c5c9-a1db-4f57-8057-6c9e4416b84a,Colorectal,77,E2843875-A4DE-4D90-BDA2-0FBBC929757F,232D0A9B-C1E1-435A-BB5F-D346243D420E,TCGA-AA-3693-01A-01D-0957-02,HG18,TCGA-AA-3693,TCGA-COAD,NA,s13375,Harvard Medical School,Indivumed,Germany,NO,T4,N1,Colon Adenocarcinoma,Stage IV
13722.58cfa82fe4b0c9d6adf6b5da,58cfa82fe4b0c9d6adf6b5da,TCGA-35-4123-01A-01D-1103_110913_SN208_0238_BC008YACXX_s_6_rg.sorted.filtered.,WGS,TCGA-35-4123-01A-01D-1103_110913_SN208_0238_BC008YACXX_s_6_rg.sorted,TCGA-35-4123-01A-01D-1103_110913_SN208_0238_BC008YACXX_s_6_rg.sorted.bam,766.93,1.9,0.16,58cfa82fe4b0c9d6adf6b5da,TCGA-35-4123-01A-01D-1103_110913_SN208_0238_BC008YACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-35-4123-01A,6CF49CF0-DE4C-4C90-8358-EAE19C6206B0,Primary Tumor,Illumina HiSeq,c620a587-dd69-4a1c-81c9-5ae742181fbc,Lung,38,3AF63E86-157B-408C-9527-58A45107DDD2,D1765CB9-4A13-425F-8B2D-E632B656058B,TCGA-35-4123-01A-01D-1103-02,HG19_Broad_variant,TCGA-35-4123,TCGA-LUAD,NA,s11335,Harvard Medical School,Cureline,Russia,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82fe4b0c9d6adf6b9c2,58cfa82fe4b0c9d6adf6b9c2,TCGA-AA-3970-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3970-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3970-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,24.22,1.9,0.15,58cfa82fe4b0c9d6adf6b9c2,TCGA-AA-3970-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3970-10A,733D8B6A-CA9D-4A69-8C9C-1F88733E8B68,Blood Derived Normal,Illumina HiSeq,4026ba28-eed0-4ab6-b27f-69b6f55197e1,Colorectal,65,46E88E56-D24F-4E70-B2DD-E87DF153A137,67C863D0-F45C-40F0-9668-B0A92339D290,TCGA-AA-3970-10A-01D-1109-02,HG18,TCGA-AA-3970,TCGA-COAD,NA,s13187,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82fe4b0c9d6adf6b967,58cfa82fe4b0c9d6adf6b967,TCGA-AA-3672-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AA-3672-01A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AA-3672-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,603.66,1.9,0.15,58cfa82fe4b0c9d6adf6b967,TCGA-AA-3672-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3672-01A,C46971A1-CBAC-425D-BAC2-F4142C92522E,Primary Tumor,Illumina GA,5b874cb8-bbea-4250-9119-2cfab36b6b3c,Colorectal,90,496316BA-00B4-49FF-9B67-02273FBFA945,21644D79-AE6D-4900-B2EB-E4E1BF31B0EE,TCGA-AA-3672-01A-01D-0957-02,HG18,TCGA-AA-3672,TCGA-COAD,NA,s13377,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage III
13722.58cfa830e4b0c9d6adf6c292,58cfa830e4b0c9d6adf6c292,TCGA-AY-4071-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AY-4071-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole,TCGA-AY-4071-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,504.59,1.9,0.15,58cfa830e4b0c9d6adf6c292,TCGA-AY-4071-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AY-4071-01A,315EF7F6-CA21-4D87-8F19-40BD455885EC,Primary Tumor,Illumina HiSeq,0335df8b-3dec-4304-95e5-47210ed06ba3,Colorectal,63,7D09112D-53F5-4B72-993A-337C55A0C902,8DE6361C-E9B5-45FF-A328-67B0DED836B9,TCGA-AY-4071-01A-01D-1109-02,HG18,TCGA-AY-4071,TCGA-COAD,29,s12887,Harvard Medical School,UNC,None,NO,T1,N0,Not available,Stage I
13722.58cfa830e4b0c9d6adf6c27e,58cfa830e4b0c9d6adf6c27e,TCGA-AG-3728-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AG-3728-10A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AG-3728-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,6.01,1.9,0.17,58cfa830e4b0c9d6adf6c27e,TCGA-AG-3728-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3728-10A,856A490C-C6DA-48FE-88B5-9FDE0F481365,Blood Derived Normal,Illumina GA,bc948ab6-858f-4be4-8cc6-cd00ca76abd2,Colorectal,73,0BCFA029-86E5-47DE-A315-D9991F67E5CD,FBAAFCF4-5AEE-430B-B1D8-0E6C3D363A5A,TCGA-AG-3728-10A-01D-0957-02,HG18,TCGA-AG-3728,TCGA-READ,NA,s1965,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIB
13722.58cfa830e4b0c9d6adf6beb1,58cfa830e4b0c9d6adf6beb1,TCGA-AG-3890-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3890-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3890-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,8.59,1.9,0.17,58cfa830e4b0c9d6adf6beb1,TCGA-AG-3890-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3890-10A,E2D395F8-BF13-4FE4-8031-683B0EEDD875,Blood Derived Normal,Illumina HiSeq,4dc195af-fda9-4230-ab6a-998f1e36540b,Colorectal,62,C5DC7F19-74F0-4053-A405-42EF3E6049B4,B0DA3675-FA73-4BC9-9E24-63A31968FDCB,TCGA-AG-3890-10A-01D-1115-02,HG18,TCGA-AG-3890,TCGA-READ,NA,s1971,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bc54,58cfa830e4b0c9d6adf6bc54,TCGA-AG-3582-10A-01D-1167_101105_SN208_0168_A80A3BABXX_s_2_rg.sorted.filtered.,WGS,TCGA-AG-3582-10A-01D-1167_101105_SN208_0168_A80A3BABXX_s_2_rg.sorted,TCGA-AG-3582-10A-01D-1167_101105_SN208_0168_A80A3BABXX_s_2_rg.sorted.bam,20,1.9,0.17,58cfa830e4b0c9d6adf6bc54,TCGA-AG-3582-10A-01D-1167_101105_SN208_0168_A80A3BABXX_s_2_rg.sorted.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3582-10A,DB1E3104-8BFD-4353-854A-C478BA1F7D07,Blood Derived Normal,Illumina HiSeq,f5b3fbbc-73ee-4343-9f0d-d1ed07587650,Colorectal,75,E948F2D0-E1BF-46FA-A0E0-A733036D3DA3,1D663F25-1724-47FF-9D68-6842EF17F51A,TCGA-AG-3582-10A-01D-1167-02,HG18_Broad_variant,TCGA-AG-3582,TCGA-READ,NA,s1961,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IV
13722.58cfa830e4b0c9d6adf6c1a1,58cfa830e4b0c9d6adf6c1a1,TCGA-B7-5816-01A-21D-1598_121025_SN590_0187_BC191FACXX_s_1_rg.sorted.filtered.,WGS,TCGA-B7-5816-01A-21D-1598_121025_SN590_0187_BC191FACXX_s_1_rg.sorted,TCGA-B7-5816-01A-21D-1598_121025_SN590_0187_BC191FACXX_s_1_rg.sorted.bam,114,1.9,0.15,58cfa830e4b0c9d6adf6c1a1,TCGA-B7-5816-01A-21D-1598_121025_SN590_0187_BC191FACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-B7-5816-01A,F07070C0-FD0A-4C19-BA1E-5F06B933CD7C,Primary Tumor,Illumina HiSeq,b9711ffa-01b8-4434-ac32-445717298e6c,Stomach,51,1B4B19C1-75A6-4434-831E-ADCE44C54EB5,52F84358-E1B4-4837-8C3D-9B4E8DDB4FAB,TCGA-B7-5816-01A-21D-1598-02,HG19_Broad_variant,TCGA-B7-5816,TCGA-STAD,NA,s14607,Harvard Medical School,Cureline,Russia,NO,T4a,N0,Stomach  Adenocarcinoma  Diffuse Type,Stage IIB
13722.58cfa830e4b0c9d6adf6be18,58cfa830e4b0c9d6adf6be18,TCGA-AZ-4615-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AZ-4615-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-AZ-4615-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,361.02,1.9,0.15,58cfa830e4b0c9d6adf6be18,TCGA-AZ-4615-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-4615-01A,BF69A4CE-EC7E-4752-A86D-DCC80E3C9A57,Primary Tumor,Illumina HiSeq,82dc215a-4234-4f8b-a4c0-50c8103dda6e,Colorectal,84,89811300-8202-4A82-8353-5B2B2B2ECFD4,90D11094-F492-4B05-81AB-E637AEC8F953,TCGA-AZ-4615-01A-01D-1405-02,HG18,TCGA-AZ-4615,TCGA-COAD,NA,s13216,Harvard Medical School,University of Pittsburgh,None,NO,T3,N1,Colon Adenocarcinoma,Stage IIIB
13722.58cfa82fe4b0c9d6adf6ba04,58cfa82fe4b0c9d6adf6ba04,TCGA-AA-3692-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AA-3692-01A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AA-3692-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,538,1.9,0.15,58cfa82fe4b0c9d6adf6ba04,TCGA-AA-3692-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3692-01A,BCE3CE45-4FB3-4D8E-9EC7-D24427C2BA4D,Primary Tumor,Illumina GA,e7e27ca0-3167-4b5f-9acf-83201974668e,Colorectal,47,48CBF5B5-BEA9-4D31-BC93-6122A329F3EA,0ED467FA-5172-4475-9492-DD03798E81AD,TCGA-AA-3692-01A-01D-0957-02,HG18,TCGA-AA-3692,TCGA-COAD,NA,s13678,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage IV
13722.58cfa830e4b0c9d6adf6bc20,58cfa830e4b0c9d6adf6bc20,TCGA-AG-3727-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AG-3727-01A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AG-3727-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,489.31,1.9,0.15,58cfa830e4b0c9d6adf6bc20,TCGA-AG-3727-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3727-01A,E6827400-0D95-46B0-8874-6CE9E9D5011B,Primary Tumor,Illumina GA,9c9444cc-d0f2-48f8-b574-d9266fdedb94,Colorectal,78,DA1CA84F-6C55-4536-9449-3C87E51EF85A,FD6FD5F1-FB42-441A-AC29-0C008CAD2B34,TCGA-AG-3727-01A-01D-0957-02,HG18,TCGA-AG-3727,TCGA-READ,NA,s2144,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage III
13722.58cfa830e4b0c9d6adf6bc06,58cfa830e4b0c9d6adf6bc06,TCGA-AA-3715-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AA-3715-10A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AA-3715-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,24.66,1.9,0.16,58cfa830e4b0c9d6adf6bc06,TCGA-AA-3715-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3715-10A,E394E9EC-7288-4EDE-9EF8-41B631D100DD,Blood Derived Normal,Illumina GA,e53b5033-ceab-474c-ae96-0cac15fd591d,Colorectal,77,90BE4505-6489-43D9-B536-E90418DAE2ED,DA1F731D-DA4F-427B-B7AF-5FD0E3DD9484,TCGA-AA-3715-10A-01D-0957-02,HG18,TCGA-AA-3715,TCGA-COAD,NA,s13371,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa830e4b0c9d6adf6c011,58cfa830e4b0c9d6adf6c011,TCGA-AG-3882-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AG-3882-01A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AG-3882-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,926,1.9,0.15,58cfa830e4b0c9d6adf6c011,TCGA-AG-3882-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3882-01A,92C65E5A-3F07-49D9-AB69-46A0EB86AE88,Primary Tumor,Illumina GA,9f85795f-f9ab-4547-8d13-532176aeef8c,Colorectal,66,012ADC3A-0CEF-48E8-B468-7C816AFE1DE0,AB580F0B-74F6-4511-B62D-FBCD2E2AE01D,TCGA-AG-3882-01A-01D-0957-02,HG18,TCGA-AG-3882,TCGA-READ,NA,s2139,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c512,58cfa831e4b0c9d6adf6c512,TCGA-CM-4744-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-CM-4744-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-CM-4744-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,114.72,1.9,0.13,58cfa831e4b0c9d6adf6c512,TCGA-CM-4744-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-CM-4744-10A,CC15469C-7BAD-4E86-9DA3-AE0C72E9D380,Blood Derived Normal,Illumina HiSeq,e3c7b057-8313-444c-ad60-7fedc6f305a7,Colorectal,69,76B67785-5572-4167-B089-D142BD5A5EA7,253D4412-8761-475D-B845-25C45F12576C,TCGA-CM-4744-10A-01D-1405-02,HG18,TCGA-CM-4744,TCGA-COAD,NA,s13395,Harvard Medical School,MSKCC,None,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa831e4b0c9d6adf6ccae,58cfa831e4b0c9d6adf6ccae,TCGA-EE-A2MT-10A-01D-A190_120718_SN1222_0126_AC117AACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EE-A2MT-10A-01D-A190_120718_SN1222_0126_AC117AACXX_s_6_rg.sorted,TCGA-EE-A2MT-10A-01D-A190_120718_SN1222_0126_AC117AACXX_s_6_rg.sorted.bam,21.98,NA,0.16,58cfa831e4b0c9d6adf6ccae,TCGA-EE-A2MT-10A-01D-A190_120718_SN1222_0126_AC117AACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MT-10A,69A17647-493F-46D2-9CF0-6596E56289A0,Blood Derived Normal,Illumina HiSeq,0484298e-529e-4cc4-bcca-4b0806922cd6,Skin,45,626AC5AE-EBF4-47E3-8019-8192FAA0D4FE,3C5D5E61-64B7-4D2C-B2D9-8F946A7482F3,TCGA-EE-A2MT-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2MT,TCGA-SKCM,NA,s7341,Harvard Medical School,University of Sydney,Australia,NO,T2a,N0,Not available,Stage IB
13722.58cfa830e4b0c9d6adf6bff2,58cfa830e4b0c9d6adf6bff2,TCGA-AG-3881-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AG-3881-01A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AG-3881-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,657.31,1.9,0.15,58cfa830e4b0c9d6adf6bff2,TCGA-AG-3881-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3881-01A,B6BA7313-8E91-4C39-8629-DB3E96F4C556,Primary Tumor,Illumina GA,e5f35b21-8b55-4e46-a53f-8c3be31a48cd,Colorectal,83,3FEE9478-7F68-4407-9EB9-32FB7D853CE7,80238D61-E881-437B-8667-3FFAB1A839CB,TCGA-AG-3881-01A-01D-0957-02,HG18,TCGA-AG-3881,TCGA-READ,NA,s1957,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Not available,Stage IIA
13722.58cfa82fe4b0c9d6adf6b9dc,58cfa82fe4b0c9d6adf6b9dc,TCGA-AA-3994-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3994-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3994-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,9.59,1.9,0.13,58cfa82fe4b0c9d6adf6b9dc,TCGA-AA-3994-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3994-10A,750770DB-53CF-4021-A8C2-5E0DDB97FEF5,Blood Derived Normal,Illumina HiSeq,0bea6476-1972-414f-be09-4c4197784248,Colorectal,69,775698AF-8ABC-408B-A47A-C00430B1224B,A6F4E88E-40A5-4CE3-827D-A4A2C9DC02A8,TCGA-AA-3994-10A-01D-1109-02,HG18,TCGA-AA-3994,TCGA-COAD,NA,s13376,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Colon Mucinous Adenocarcinoma,Stage IIIB
13722.58cfa830e4b0c9d6adf6c05a,58cfa830e4b0c9d6adf6c05a,TCGA-AZ-4313-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AZ-4313-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-AZ-4313-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,91.72,1.9,0.15,58cfa830e4b0c9d6adf6c05a,TCGA-AZ-4313-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-4313-10A,1FD75C4D-E74C-410C-A150-814722C6C1CC,Blood Derived Normal,Illumina HiSeq,4ffaabe7-0883-46bc-82c8-dc80170cd61a,Colorectal,51,0C7A7506-169C-471D-8148-F81D48BA20A7,260C8250-6170-4932-9AD1-6DFFFD711ED0,TCGA-AZ-4313-10A-01D-1405-02,HG18,TCGA-AZ-4313,TCGA-COAD,NA,s13539,Harvard Medical School,University of Pittsburgh,None,NO,T1,N0,Colon Adenocarcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bcc4,58cfa830e4b0c9d6adf6bcc4,TCGA-AZ-4313-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AZ-4313-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-AZ-4313-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,397.02,1.9,0.15,58cfa830e4b0c9d6adf6bcc4,TCGA-AZ-4313-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-4313-01A,1FD75C4D-E74C-410C-A150-814722C6C1CC,Primary Tumor,Illumina HiSeq,b8e9093c-1570-45c6-8278-f686c276ee91,Colorectal,51,475F161C-2F7F-43A2-B187-DE6038752F39,F64D4985-D460-435C-8EC0-477D313A895A,TCGA-AZ-4313-01A-01D-1405-02,HG18,TCGA-AZ-4313,TCGA-COAD,NA,s13212,Harvard Medical School,University of Pittsburgh,None,NO,T1,N0,Colon Adenocarcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bc22,58cfa830e4b0c9d6adf6bc22,TCGA-AG-3727-01A-01D-1167_101105_SN208_0168_A80A3BABXX_s_3.rg.sorted.filtered.,WGS,TCGA-AG-3727-01A-01D-1167_101105_SN208_0168_A80A3BABXX_s_3.rg.sorted,TCGA-AG-3727-01A-01D-1167_101105_SN208_0168_A80A3BABXX_s_3.rg.sorted.bam,489.31,1.9,0.15,58cfa830e4b0c9d6adf6bc22,TCGA-AG-3727-01A-01D-1167_101105_SN208_0168_A80A3BABXX_s_3.rg.sorted.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3727-01A,E6827400-0D95-46B0-8874-6CE9E9D5011B,Primary Tumor,Illumina HiSeq,c29d4836-8104-479e-98ce-a8c435a242d7,Colorectal,78,DA1CA84F-6C55-4536-9449-3C87E51EF85A,D8361FC2-8AB1-4D36-9009-237D905CF899,TCGA-AG-3727-01A-01D-1167-02,HG18_Broad_variant,TCGA-AG-3727,TCGA-READ,NA,s2141,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage III
13722.58cfa830e4b0c9d6adf6ba56,58cfa830e4b0c9d6adf6ba56,TCGA-AA-3966-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3966-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3966-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,526.89,1.9,0.15,58cfa830e4b0c9d6adf6ba56,TCGA-AA-3966-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3966-01A,BC42FE2D-1A33-428D-A601-B1871F4C8D9B,Primary Tumor,Illumina HiSeq,3a88f23b-5740-4937-be5d-a5aed2c4e962,Colorectal,89,8C5799BF-DB65-40F6-9A67-ABD4DA4025F2,F1E05BF6-0B98-45F8-9F97-10ABE5957C99,TCGA-AA-3966-01A-01D-1109-02,HG18,TCGA-AA-3966,TCGA-COAD,NA,s13674,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Mucinous Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6bc03,58cfa830e4b0c9d6adf6bc03,TCGA-AG-3727-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AG-3727-10A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AG-3727-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,55.31,1.9,0.15,58cfa830e4b0c9d6adf6bc03,TCGA-AG-3727-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3727-10A,E6827400-0D95-46B0-8874-6CE9E9D5011B,Blood Derived Normal,Illumina GA,3f42563f-15e7-4d6d-a47b-03d075f3f364,Colorectal,78,A2FEF5A0-A5B1-4835-B92E-6F1E8C88C510,0F5E8079-ED89-4CF3-A882-915C72793B6F,TCGA-AG-3727-10A-01D-0957-02,HG18,TCGA-AG-3727,TCGA-READ,NA,s1968,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage III
13722.58cfa830e4b0c9d6adf6c147,58cfa830e4b0c9d6adf6c147,TCGA-B7-5818-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_2_rg.sorted.filtered.,WGS,TCGA-B7-5818-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_2_rg.sorted,TCGA-B7-5818-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_2_rg.sorted.bam,411,1.9,0.14,58cfa830e4b0c9d6adf6c147,TCGA-B7-5818-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-B7-5818-01A,6E03B415-84A1-4B91-8717-1A41EDD4A255,Primary Tumor,Illumina HiSeq,e2875187-aeca-43f4-85d8-13ecd0452ec3,Stomach,62,FD97CDF5-0F7F-48A2-B5DA-5C5F56A89166,0EBF1A63-C6E4-49FE-B21B-AE46FF14261D,TCGA-B7-5818-01A-11D-1598-02,HG19_Broad_variant,TCGA-B7-5818,TCGA-STAD,NA,s15372,Harvard Medical School,Cureline,Russia,NO,T2,N0,Stomach  Adenocarcinoma  Diffuse Type,Stage IB
13722.58cfa830e4b0c9d6adf6bc02,58cfa830e4b0c9d6adf6bc02,TCGA-AA-3715-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AA-3715-01A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AA-3715-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,791.66,1.9,0.14,58cfa830e4b0c9d6adf6bc02,TCGA-AA-3715-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3715-01A,E394E9EC-7288-4EDE-9EF8-41B631D100DD,Primary Tumor,Illumina GA,24785643-8624-40aa-8fbf-88954d364f7f,Colorectal,77,A172CF89-8820-4A84-97EF-6731E7AE71E2,E6481F25-E9DD-483E-B274-1FC5F1E54DC1,TCGA-AA-3715-01A-01D-0957-02,HG18,TCGA-AA-3715,TCGA-COAD,NA,s13670,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa830e4b0c9d6adf6bffe,58cfa830e4b0c9d6adf6bffe,TCGA-AG-3885-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AG-3885-10A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AG-3885-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,19.31,1.8,0.15,58cfa830e4b0c9d6adf6bffe,TCGA-AG-3885-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3885-10A,E5E4AA9F-6015-4D62-A088-69920D7F2500,Blood Derived Normal,Illumina GA,c335220b-290e-43ec-8441-8cc56f0e165e,Colorectal,71,D7D09FF1-A9F4-4E5B-B1C1-854DF4A856C9,3B4D9A4E-E094-4C6D-B5A1-606CF549443F,TCGA-AG-3885-10A-01D-0957-02,HG18,TCGA-AG-3885,TCGA-READ,NA,s2133,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIB
13722.58cfa831e4b0c9d6adf6c874,58cfa831e4b0c9d6adf6c874,TCGA-CV-6933-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CV-6933-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_1_rg.sorted,TCGA-CV-6933-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_1_rg.sorted.bam,215.7,1.9,0.16,58cfa831e4b0c9d6adf6c874,TCGA-CV-6933-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6933-11A,2A749317-0156-4213-8482-B2C2D6E52E9B,Solid Tissue Normal,Illumina HiSeq,8d4274cf-c829-4e6a-abf1-e3380c63ab8f,Head and Neck,53,EDD36B53-EB43-4ED6-9509-53A56CDCF80D,2E0F5A01-B6BF-4A04-9F70-05CAECA30B83,TCGA-CV-6933-11A-01D-1911-02,HG19_Broad_variant,TCGA-CV-6933,TCGA-HNSC,2741,s16339,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T3,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa832e4b0c9d6adf6d6a6,58cfa832e4b0c9d6adf6d6a6,TCGA-V4-A9E5-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_4_rg.sorted.filtered.,WGS,TCGA-V4-A9E5-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_4_rg.sorted,TCGA-V4-A9E5-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_4_rg.sorted.bam,30.36,NA,0.16,58cfa832e4b0c9d6adf6d6a6,TCGA-V4-A9E5-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9E5-01A,029CC59C-60DF-4411-A044-3A2EEEE7B110,Primary Tumor,Illumina HiSeq,6d4c51c2-0829-4ab2-9c4e-0a4653d8b744,Eye,51,9FD9F385-A009-44AE-836F-F18BAD96628F,CE4927D1-2A65-4BEF-98E5-EDD02A341820,TCGA-V4-A9E5-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9E5,TCGA-UVM,NA,s190,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4b,N0,Not available,Stage IIIB
13722.58cfa830e4b0c9d6adf6c270,58cfa830e4b0c9d6adf6c270,TCGA-AG-3885-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AG-3885-01A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AG-3885-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,688.31,1.9,0.15,58cfa830e4b0c9d6adf6c270,TCGA-AG-3885-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3885-01A,E5E4AA9F-6015-4D62-A088-69920D7F2500,Primary Tumor,Illumina GA,6bd67dc5-0b5c-4bda-8250-2660907732d8,Colorectal,71,7764DB67-5D9E-4421-86C6-7151ACA688D1,E1DD2AF8-4D7F-4D52-A78E-416FDDD793C4,TCGA-AG-3885-01A-01D-0957-02,HG18,TCGA-AG-3885,TCGA-READ,NA,s2143,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIB
13722.58cfa82ee4b0c9d6adf6afb2,58cfa82ee4b0c9d6adf6afb2,TCGA-05-4418-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-05-4418-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-05-4418-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,65.9,1.9,0.13,58cfa82ee4b0c9d6adf6afb2,TCGA-05-4418-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4418-10A,D2C1E896-6886-4122-BB48-5FBCD3F641F4,Blood Derived Normal,Illumina HiSeq,ba806a17-fb08-48cf-8ed8-069510bc4e50,Lung,69,5808A3F7-0876-4816-94D6-4DBE08257955,7D13B485-47B6-4326-BBA6-28C5E5014829,TCGA-05-4418-10A-01D-1203-02,GRCh37,TCGA-05-4418,TCGA-LUAD,274,s11330,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIA
13722.58cfa82fe4b0c9d6adf6b9ee,58cfa82fe4b0c9d6adf6b9ee,TCGA-AA-3672-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AA-3672-10A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AA-3672-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,22.66,1.9,0.16,58cfa82fe4b0c9d6adf6b9ee,TCGA-AA-3672-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3672-10A,C46971A1-CBAC-425D-BAC2-F4142C92522E,Blood Derived Normal,Illumina GA,ff013252-2316-471d-a3fb-fb531fc524f9,Colorectal,90,518D61A9-8B71-498E-99AF-70C477D0BB1E,E2FBE0B6-EEF0-4832-8F55-F5F22DEDC31A,TCGA-AA-3672-10A-01D-0957-02,HG18,TCGA-AA-3672,TCGA-COAD,NA,s13524,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage III
13722.58cfa830e4b0c9d6adf6bbf2,58cfa830e4b0c9d6adf6bbf2,TCGA-AA-3692-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AA-3692-10A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AA-3692-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,7,1.9,0.15,58cfa830e4b0c9d6adf6bbf2,TCGA-AA-3692-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3692-10A,BCE3CE45-4FB3-4D8E-9EC7-D24427C2BA4D,Blood Derived Normal,Illumina GA,d39aa0ba-3fa4-4598-9241-fd36baa2672b,Colorectal,47,FCDFF14B-1413-430E-93DC-B753021DF3F5,E9F2C198-8F5F-4FCD-AAD4-E9A1127B529D,TCGA-AA-3692-10A-01D-0957-02,HG18,TCGA-AA-3692,TCGA-COAD,NA,s13189,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage IV
13722.58cfa831e4b0c9d6adf6c93b,58cfa831e4b0c9d6adf6c93b,TCGA-DK-A2I1-10A-01D-A17R_120927_SN208_0433_BD1D5JACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DK-A2I1-10A-01D-A17R_120927_SN208_0433_BD1D5JACXX_s_2_rg.sorted,TCGA-DK-A2I1-10A-01D-A17R_120927_SN208_0433_BD1D5JACXX_s_2_rg.sorted.bam,9.75,NA,0.2,58cfa831e4b0c9d6adf6c93b,TCGA-DK-A2I1-10A-01D-A17R_120927_SN208_0433_BD1D5JACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A2I1-10A,036B9681-AB58-4734-A8FD-E0D5D078BF5A,Blood Derived Normal,Illumina HiSeq,7f2d5952-2a08-48c4-b4c9-5773f777866e,Bladder,73,829A349C-E8DE-4D77-B7B9-5EA893FC583C,F360737A-DEB2-485E-A1D4-1A9C236B399F,TCGA-DK-A2I1-10A-01D-A17R-02,HG19_Broad_variant,TCGA-DK-A2I1,TCGA-BLCA,NA,s2714,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa832e4b0c9d6adf6d57c,58cfa832e4b0c9d6adf6d57c,TCGA-V4-A9E9-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_7_rg.sorted.filtered.,WGS,TCGA-V4-A9E9-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_7_rg.sorted,TCGA-V4-A9E9-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_7_rg.sorted.bam,12.39,NA,0.16,58cfa832e4b0c9d6adf6d57c,TCGA-V4-A9E9-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9E9-10A,418152BD-7D33-4F0A-B890-2356B30D6F44,Blood Derived Normal,Illumina HiSeq,89c81999-484a-4bcc-a643-eb59e2c6ea8c,Eye,50,798AEB09-7401-4CD1-9CD0-D9DEE19B227A,EB217F26-4D34-4C7E-B6F6-AC30F771CC5B,TCGA-V4-A9E9-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9E9,TCGA-UVM,NA,s185,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa82fe4b0c9d6adf6b889,58cfa82fe4b0c9d6adf6b889,TCGA-A6-2674-10A-01D-1167_101023_SN208_0166_A808PFABXX_s_4_rg.sorted.filtered.,WGS,TCGA-A6-2674-10A-01D-1167_101023_SN208_0166_A808PFABXX_s_4_rg.sorted,TCGA-A6-2674-10A-01D-1167_101023_SN208_0166_A808PFABXX_s_4_rg.sorted.bam,342.56,1.9,0.15,58cfa82fe4b0c9d6adf6b889,TCGA-A6-2674-10A-01D-1167_101023_SN208_0166_A808PFABXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2674-10A,57CDAA1C-4E94-4A28-AB3B-300C0457555F,Blood Derived Normal,Illumina HiSeq,1aeeda77-810f-4e12-bd35-f5a7cf7a31b2,Colorectal,71,CED59EE0-9A95-4E2D-AC39-22EF6F80EBF7,DD75656D-6DF6-4C53-972D-439791C908AC,TCGA-A6-2674-10A-01D-1167-02,HG18_Broad_variant,TCGA-A6-2674,TCGA-COAD,NA,s13021,Harvard Medical School,Christiana Healthcare,None,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage IV
13722.58cfa830e4b0c9d6adf6c018,58cfa830e4b0c9d6adf6c018,TCGA-AG-3881-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AG-3881-10A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AG-3881-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,19.31,1.9,0.15,58cfa830e4b0c9d6adf6c018,TCGA-AG-3881-10A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3881-10A,B6BA7313-8E91-4C39-8629-DB3E96F4C556,Blood Derived Normal,Illumina GA,4cfcc5af-8677-439a-b328-aee2853880e6,Colorectal,83,D9F4E8EB-B620-4728-A2D1-EA3F6AD9309D,0A10AE32-FA2C-45E1-8E02-ED0DACD72ED1,TCGA-AG-3881-10A-01D-0957-02,HG18,TCGA-AG-3881,TCGA-READ,NA,s2132,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Not available,Stage IIA
13722.58cfa830e4b0c9d6adf6bbea,58cfa830e4b0c9d6adf6bbea,TCGA-AG-A008-10A-01D-A078-02_110217_SN208_0190_B81CLKABXX_s_8.rg.sorted.filtered.,WGS,TCGA-AG-A008-10A-01D-A078-02_110217_SN208_0190_B81CLKABXX_s_8.rg.sorted,TCGA-AG-A008-10A-01D-A078-02_110217_SN208_0190_B81CLKABXX_s_8.rg.sorted.bam,47.46,1.73,0.15,58cfa830e4b0c9d6adf6bbea,TCGA-AG-A008-10A-01D-A078-02_110217_SN208_0190_B81CLKABXX_s_8.rg.sorted.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A008-10A,E7503A51-6647-4CC2-80DD-645D0DF4DB43,Blood Derived Normal,Illumina HiSeq,6a8b3387-94d5-401f-ba50-c00e0b2d1c7f,Colorectal,50,5CD9C79F-D0C1-48B0-85AA-5270C0E866B5,2CEB5DAF-1FA5-4163-82EF-8304514D8D9A,TCGA-AG-A008-10A-01D-A078-02,HG18_Broad_variant,TCGA-AG-A008,TCGA-READ,NA,s2311,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Rectal Mucinous Adenocarcinoma,Stage I
13722.58cfa830e4b0c9d6adf6be62,58cfa830e4b0c9d6adf6be62,TCGA-AG-3728-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.filtered.,WGS,TCGA-AG-3728-01A-01D-0957-02_IlluminaGAII-DNASeq_whole,TCGA-AG-3728-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,650.31,1.9,0.14,58cfa830e4b0c9d6adf6be62,TCGA-AG-3728-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3728-01A,856A490C-C6DA-48FE-88B5-9FDE0F481365,Primary Tumor,Illumina GA,9ef45df9-d1c6-4ccd-8789-400bfa2be5fc,Colorectal,73,019EB82B-4A2D-4E67-99A6-FE10B0ABCB70,E6EAE485-CB8C-4119-8E98-45CC8A7B9291,TCGA-AG-3728-01A-01D-0957-02,HG18,TCGA-AG-3728,TCGA-READ,NA,s2146,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIB
13722.58cfa82fe4b0c9d6adf6b974,58cfa82fe4b0c9d6adf6b974,TCGA-AA-3675-01A-02D-1109-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3675-01A-02D-1109-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3675-01A-02D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,570.96,1.9,0.14,58cfa82fe4b0c9d6adf6b974,TCGA-AA-3675-01A-02D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3675-01A,41658CF8-0DE1-4A97-BB60-0F0107C84E00,Primary Tumor,Illumina HiSeq,f57af06a-9d5a-4a69-888a-8d611982b88e,Colorectal,84,A4CE3727-4506-493B-95F4-2F11CEB09CEB,D611373E-EF0A-46E4-8D3E-0722F221E828,TCGA-AA-3675-01A-02D-1109-02,HG18,TCGA-AA-3675,TCGA-COAD,NA,s13672,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa832e4b0c9d6adf6d583,58cfa832e4b0c9d6adf6d583,TCGA-V4-A9E5-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_4_rg.sorted.filtered.,WGS,TCGA-V4-A9E5-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_4_rg.sorted,TCGA-V4-A9E5-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_4_rg.sorted.bam,13.88,NA,0.15,58cfa832e4b0c9d6adf6d583,TCGA-V4-A9E5-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9E5-10A,029CC59C-60DF-4411-A044-3A2EEEE7B110,Blood Derived Normal,Illumina HiSeq,e96caa41-d6d6-4cfd-a3bc-2311f73f30e0,Eye,51,E3ABDA28-EB41-46FA-B79F-EEC951A53715,97DBE95D-0EAF-4FA5-823E-61F999D4BB58,TCGA-V4-A9E5-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9E5,TCGA-UVM,NA,s191,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4b,N0,Not available,Stage IIIB
13722.58cfa830e4b0c9d6adf6bbf6,58cfa830e4b0c9d6adf6bbf6,TCGA-AA-A01C-10A-01D-A078_110329_SN208_0198_B702NLABXX_s_6_rg.sorted.filtered.,WGS,TCGA-AA-A01C-10A-01D-A078_110329_SN208_0198_B702NLABXX_s_6_rg.sorted,TCGA-AA-A01C-10A-01D-A078_110329_SN208_0198_B702NLABXX_s_6_rg.sorted.bam,34.25,1.75,0.15,58cfa830e4b0c9d6adf6bbf6,TCGA-AA-A01C-10A-01D-A078_110329_SN208_0198_B702NLABXX_s_6_rg.sorted.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01C-10A,80809D79-92E1-4D6C-BA2E-0A9589997792,Blood Derived Normal,Illumina HiSeq,5008c942-2f6d-42fb-bac0-f992c3f5f122,Colorectal,75,0D2F53A8-9261-4E57-A0CD-5CD5E6376743,8683DA63-3130-447E-89E9-3137D78E8475,TCGA-AA-A01C-10A-01D-A078-02,HG18_Broad_variant,TCGA-AA-A01C,TCGA-COAD,NA,s13533,Harvard Medical School,Indivumed,Germany,NO,T2,N1,Colon Adenocarcinoma,Stage IIIA
13722.58cfa832e4b0c9d6adf6d47f,58cfa832e4b0c9d6adf6d47f,TCGA-V4-A9EC-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_1_rg.sorted.filtered.,WGS,TCGA-V4-A9EC-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_1_rg.sorted,TCGA-V4-A9EC-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_1_rg.sorted.bam,44.61,NA,0.16,58cfa832e4b0c9d6adf6d47f,TCGA-V4-A9EC-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EC-01A,EEAB0529-31E6-4EDB-BD2C-A21F2A169381,Primary Tumor,Illumina HiSeq,b19262ce-546a-4f20-b2c6-542d12745c33,Eye,75,3234E814-AD34-48F0-AEBD-19E1A694ED8E,3ED594C4-5AF5-4461-838D-367758D3BA55,TCGA-V4-A9EC-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9EC,TCGA-UVM,NA,s232,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3a,N0,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6d3f0,58cfa832e4b0c9d6adf6d3f0,TCGA-V4-A9ED-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_2_rg.sorted.filtered.,WGS,TCGA-V4-A9ED-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_2_rg.sorted,TCGA-V4-A9ED-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_2_rg.sorted.bam,53.75,NA,0.17,58cfa832e4b0c9d6adf6d3f0,TCGA-V4-A9ED-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9ED-01A,367869F9-BBE7-4E57-A16F-F2B63F2DE697,Primary Tumor,Illumina HiSeq,db951476-e1a5-4731-8c40-dbe710922b60,Eye,45,F1A146CE-B2C6-4CD5-9153-F640D38ABAF1,8CDB01C8-C2D9-40DB-84EE-00B50B9EC314,TCGA-V4-A9ED-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9ED,TCGA-UVM,NA,s220,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3b,N0,Not available,Stage IIIA
13722.58cfa831e4b0c9d6adf6c538,58cfa831e4b0c9d6adf6c538,TCGA-CN-4730-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CN-4730-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_6_rg.sorted,TCGA-CN-4730-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_6_rg.sorted.bam,928.4,1.9,0.16,58cfa831e4b0c9d6adf6c538,TCGA-CN-4730-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4730-10A,35C1F2C6-771C-4533-82DF-F8E2EC7107D7,Blood Derived Normal,Illumina HiSeq,2fecd58a-13da-4b74-ae07-237756d10f5c,Head and Neck,62,3D7DC830-42C8-4746-AA06-C5A58E6AD510,D7DBCD9B-1AF6-41AE-8C6F-420E6041E346,TCGA-CN-4730-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4730,TCGA-HNSC,NA,s16174,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N1,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6bea6,58cfa830e4b0c9d6adf6bea6,TCGA-AZ-4615-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AZ-4615-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-AZ-4615-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,170.72,1.9,0.14,58cfa830e4b0c9d6adf6bea6,TCGA-AZ-4615-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-4615-10A,BF69A4CE-EC7E-4752-A86D-DCC80E3C9A57,Blood Derived Normal,Illumina HiSeq,90608783-775c-48d4-a0e7-3b07c961c2e6,Colorectal,84,ADA35D85-5095-452A-B796-8684F1688500,7FE7E146-7FD2-4C9E-A64B-644543E97DE3,TCGA-AZ-4615-10A-01D-1405-02,HG18,TCGA-AZ-4615,TCGA-COAD,NA,s13035,Harvard Medical School,University of Pittsburgh,None,NO,T3,N1,Colon Adenocarcinoma,Stage IIIB
13722.58cfa830e4b0c9d6adf6bd5d,58cfa830e4b0c9d6adf6bd5d,TCGA-AA-3516-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3516-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3516-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,47.29,1.9,0.13,58cfa830e4b0c9d6adf6bd5d,TCGA-AA-3516-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3516-01A,D9D7F0D4-FA64-48F2-8037-52CBF0B34AD8,Primary Tumor,Illumina HiSeq,99b382c5-00ca-4acd-81bc-0c46b9c7ccea,Colorectal,74,4E4F7BEC-56AF-4888-B40B-A33218B010E8,3F9A934E-C9BE-4A5F-A1F5-EB51BED8DCDD,TCGA-AA-3516-01A-02D-1167-02,HG18,TCGA-AA-3516,TCGA-COAD,NA,s13181,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage III
13722.58cfa830e4b0c9d6adf6bde2,58cfa830e4b0c9d6adf6bde2,TCGA-AG-A01N-01A-01D-A077_110406_SN177_0154_B818URABXX_s_3.rg.sorted.filtered.,WGS,TCGA-AG-A01N-01A-01D-A077_110406_SN177_0154_B818URABXX_s_3.rg.sorted,TCGA-AG-A01N-01A-01D-A077_110406_SN177_0154_B818URABXX_s_3.rg.sorted.bam,237.59,1.78,0.15,58cfa830e4b0c9d6adf6bde2,TCGA-AG-A01N-01A-01D-A077_110406_SN177_0154_B818URABXX_s_3.rg.sorted.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A01N-01A,1118490D-75AA-43CC-B2A2-C2AF61829FFC,Primary Tumor,Illumina HiSeq,1e5467f7-e974-4244-b9fb-2afff5ed40b4,Colorectal,68,0350E0DE-7B86-485A-A057-50E77D899ED9,49977602-A81B-4DDD-9354-8949BC3208CF,TCGA-AG-A01N-01A-01D-A077-02,HG18_Broad_variant,TCGA-AG-A01N,TCGA-READ,NA,s2007,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage IV
13722.58cfa831e4b0c9d6adf6c86c,58cfa831e4b0c9d6adf6c86c,TCGA-CV-6952-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CV-6952-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_5_rg.sorted,TCGA-CV-6952-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_5_rg.sorted.bam,203.7,1.9,0.15,58cfa831e4b0c9d6adf6c86c,TCGA-CV-6952-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6952-11A,7ED006E8-461F-4664-BFFF-55FA6812743C,Solid Tissue Normal,Illumina HiSeq,48cd5e34-4d2c-4cb0-802c-1b4c2e7a44e1,Head and Neck,65,FE486AA7-B37A-4016-A71C-56D97BD73208,11CB737F-78D0-42B4-9800-C4D38EADAC88,TCGA-CV-6952-11A-01D-1911-02,HG19_Broad_variant,TCGA-CV-6952,TCGA-HNSC,185,s15780,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6bc2a,58cfa830e4b0c9d6adf6bc2a,TCGA-AA-3994-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3994-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3994-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,631.89,1.9,0.16,58cfa830e4b0c9d6adf6bc2a,TCGA-AA-3994-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3994-01A,750770DB-53CF-4021-A8C2-5E0DDB97FEF5,Primary Tumor,Illumina HiSeq,dadc0f63-410b-4eb6-b287-c05bbc274608,Colorectal,69,41933A62-1325-4089-80B5-06E3EBB238DA,FED1DBB6-D332-4239-A878-8587A7CE4D05,TCGA-AA-3994-01A-01D-1109-02,HG18,TCGA-AA-3994,TCGA-COAD,NA,s13518,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Colon Mucinous Adenocarcinoma,Stage IIIB
13722.58cfa82fe4b0c9d6adf6ba0e,58cfa82fe4b0c9d6adf6ba0e,TCGA-AA-3966-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3966-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3966-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,44.59,1.9,0.14,58cfa82fe4b0c9d6adf6ba0e,TCGA-AA-3966-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3966-10A,BC42FE2D-1A33-428D-A601-B1871F4C8D9B,Blood Derived Normal,Illumina HiSeq,58f3078c-baa2-4a9f-a588-8c6f8a3811e2,Colorectal,89,70893CD9-CCF1-423B-B39F-884974A30EA4,E7FEF3FA-293D-49F6-A3E2-C079E1ABF260,TCGA-AA-3966-10A-01D-1109-02,HG18,TCGA-AA-3966,TCGA-COAD,NA,s13522,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Mucinous Adenocarcinoma,Stage IIA
13722.58cfa82fe4b0c9d6adf6b7ec,58cfa82fe4b0c9d6adf6b7ec,TCGA-35-4122-10A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_4_rg.sorted.filtered.,WGS,TCGA-35-4122-10A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_4_rg.sorted,TCGA-35-4122-10A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_4_rg.sorted.bam,168.63,1.9,0.15,58cfa82fe4b0c9d6adf6b7ec,TCGA-35-4122-10A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-35-4122-10A,44ADF4CB-2829-4153-80FD-A8B7EE0E654A,Blood Derived Normal,Illumina HiSeq,7b36ec07-4c97-4a6e-a53d-7325e0d04974,Lung,69,CA26FD6D-CF60-4EB0-8D86-BCD9067356C7,F68CAE7E-7619-4D5A-81DA-71EA6F05CFEA,TCGA-35-4122-10A-01D-1103-02,HG19_Broad_variant,TCGA-35-4122,TCGA-LUAD,NA,s10988,Harvard Medical School,Cureline,Russia,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa832e4b0c9d6adf6d2a8,58cfa832e4b0c9d6adf6d2a8,TCGA-HT-7604-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_6_rg.sorted.filtered.,WGS,TCGA-HT-7604-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_6_rg.sorted,TCGA-HT-7604-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_6_rg.sorted.bam,175,NA,0.13,58cfa832e4b0c9d6adf6d2a8,TCGA-HT-7604-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_6_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7604-01A,019C5DE9-74FD-48B7-95A3-227532E16C5A,Primary Tumor,Illumina HiSeq,b3d0b563-b12d-4872-9a0c-f795ca13842f,Brain,50,9CA3488A-91F8-4EB2-8B03-24E8629757E1,31412731-7A51-4E73-BFC4-0098275D633B,TCGA-HT-7604-01A-11D-2088-02,HG19_Broad_variant,TCGA-HT-7604,TCGA-LGG,NA,s8575,Harvard Medical School,Case Western - St Joes,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6cc6c,58cfa831e4b0c9d6adf6cc6c,TCGA-ER-A199-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-ER-A199-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_1_rg.sorted,TCGA-ER-A199-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_1_rg.sorted.bam,78.21,NA,0.16,58cfa831e4b0c9d6adf6cc6c,TCGA-ER-A199-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A199-06A,E218FC54-1139-4944-82E2-742839E5553A,Metastatic,Illumina HiSeq,92b8625e-5129-4ea4-b59d-d35fa267eb87,Skin,86,7D2F3D83-95E7-4003-A2C8-3D986BB225EA,2A5E7859-8C9A-45B7-BD81-86DC3B6D5D20,TCGA-ER-A199-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-ER-A199,TCGA-SKCM,279,s8018,Harvard Medical School,University of Pittsburgh,United States,NO,T4b,N3,Not available,Stage IIIC
13722.58cfa831e4b0c9d6adf6c42c,58cfa831e4b0c9d6adf6c42c,TCGA-BT-A2LD-01A-12D-A210_120914_SN590_0180_BC19KDACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BT-A2LD-01A-12D-A210_120914_SN590_0180_BC19KDACXX_s_5_rg.sorted,TCGA-BT-A2LD-01A-12D-A210_120914_SN590_0180_BC19KDACXX_s_5_rg.sorted.bam,16.84,NA,0.18,58cfa831e4b0c9d6adf6c42c,TCGA-BT-A2LD-01A-12D-A210_120914_SN590_0180_BC19KDACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A2LD-01A,9DD97821-7AFD-4982-8B1D-F14F845B79F7,Primary Tumor,Illumina HiSeq,205bfe9f-2bc9-4236-930c-a862874ad8e0,Bladder,78,AEB379D5-B157-4BCE-82C5-0CD0077DB01F,BF6A16B2-9DC9-4E9A-A810-2EBA7E9B56A1,TCGA-BT-A2LD-01A-12D-A210-26,HG19_Broad_variant,TCGA-BT-A2LD,TCGA-BLCA,NA,s3089,MD Anderson - Institute for Applied Cancer Science,University of Pittsburgh,United States,NO,T3a,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa830e4b0c9d6adf6c1f3,58cfa830e4b0c9d6adf6c1f3,TCGA-BG-A0LX-10A-01D-A043_120214_SN590_0138_AC0E8HACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BG-A0LX-10A-01D-A043_120214_SN590_0138_AC0E8HACXX_s_8_rg.sorted,TCGA-BG-A0LX-10A-01D-A043_120214_SN590_0138_AC0E8HACXX_s_8_rg.sorted.bam,21.13,2,0.15,58cfa830e4b0c9d6adf6c1f3,TCGA-BG-A0LX-10A-01D-A043_120214_SN590_0138_AC0E8HACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0LX-10A,AC1D3946-FE6C-4BD8-B02C-638799CB0F67,Blood Derived Normal,Illumina HiSeq,35dff020-7f96-4a7b-bb1e-57225beb9c83,Uterus,57,BB935FAB-8B12-4FDC-8A49-A03FD67CC014,6BD21A7A-30FC-4BD0-8ED7-F4ABE21ECBA8,TCGA-BG-A0LX-10A-01D-A043-02,HG19_Broad_variant,TCGA-BG-A0LX,TCGA-UCEC,NA,s5213,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c3c8,58cfa831e4b0c9d6adf6c3c8,TCGA-CG-4477-10A-01D-1154_130815_VM001_0007_VMR0007CXX_s_3_rg.sorted.filtered.,WGS,TCGA-CG-4477-10A-01D-1154_130815_VM001_0007_VMR0007CXX_s_3_rg.sorted,TCGA-CG-4477-10A-01D-1154_130815_VM001_0007_VMR0007CXX_s_3_rg.sorted.bam,67.9,1.9,0.16,58cfa831e4b0c9d6adf6c3c8,TCGA-CG-4477-10A-01D-1154_130815_VM001_0007_VMR0007CXX_s_3_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4477-10A,18D0AAE7-9694-4252-B8FE-16E62DADAB07,Blood Derived Normal,Illumina HiSeq,c4ccf0ac-fcca-40dd-8c41-080f1d7c3e3f,Stomach,58,02F3A2F6-914C-4201-AB90-A7F2830F5CBA,B851171C-FDED-4A21-8766-A0AFD1B147B2,TCGA-CG-4477-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4477,TCGA-STAD,NA,s15460,Harvard Medical School,Indivumed,Germany,NO,T2a,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa830e4b0c9d6adf6bc1a,58cfa830e4b0c9d6adf6bc1a,TCGA-AG-A01W-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-A01W-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-A01W-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,55.89,1.98,0.16,58cfa830e4b0c9d6adf6bc1a,TCGA-AG-A01W-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A01W-11A,74543FA4-CE73-46E4-9C59-224E8242B4A2,Solid Tissue Normal,Illumina HiSeq,8e0654a7-ab7a-42c0-ba12-438dee1fd119,Colorectal,67,C913E113-9731-488A-AC17-652F5A52F771,7897A8D4-72BE-4C87-BADE-523FCDBBEFBD,TCGA-AG-A01W-11A-11D-A079-02,HG18,TCGA-AG-A01W,TCGA-READ,NA,s2004,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6ae71,58cfa82ee4b0c9d6adf6ae71,TCGA-05-4402-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-05-4402-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-05-4402-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,65.9,1.8,0.14,58cfa82ee4b0c9d6adf6ae71,TCGA-05-4402-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4402-10A,722D6818-F1CB-49F4-B68A-FD0A31304681,Blood Derived Normal,Illumina HiSeq,30d6ff50-187c-495a-8364-d0ae343f89c2,Lung,57,02C4F8D1-061F-4897-AF1F-755345D7D91B,A9423B91-152F-4BD3-97FC-8B715A63136A,TCGA-05-4402-10A-01D-1203-02,GRCh37,TCGA-05-4402,TCGA-LUAD,244,s10983,Harvard Medical School,Indivumed,Germany,NO,T2,NX,Lung Adenocarcinoma Mixed Subtype,Stage IV
13722.58cfa832e4b0c9d6adf6d590,58cfa832e4b0c9d6adf6d590,TCGA-V3-A9ZY-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_3_rg.sorted.filtered.,WGS,TCGA-V3-A9ZY-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_3_rg.sorted,TCGA-V3-A9ZY-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_3_rg.sorted.bam,50.6,NA,0.15,58cfa832e4b0c9d6adf6d590,TCGA-V3-A9ZY-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V3-A9ZY-01A,2112A42A-9B85-475A-A31B-4CE7751CDEB9,Primary Tumor,Illumina HiSeq,00a09c4d-5a88-4562-b9f3-e397798bdc18,Eye,54,E835BB77-E3EE-41B0-B8E0-D39E966F91A7,CD97490D-738A-48A2-B014-F9DB48DE45FA,TCGA-V3-A9ZY-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V3-A9ZY,TCGA-UVM,NA,s192,MD Anderson - Institute for Applied Cancer Science,Cleveland Clinic Foundation,United States,NO,T3a,NX,Not available,Stage IIB
13722.58cfa830e4b0c9d6adf6c1bc,58cfa830e4b0c9d6adf6c1bc,TCGA-AG-A01L-01A-01D-A077_110406_SN177_0154_B818URABXX_s_1_rg.sorted.filtered.,WGS,TCGA-AG-A01L-01A-01D-A077_110406_SN177_0154_B818URABXX_s_1_rg.sorted,TCGA-AG-A01L-01A-01D-A077_110406_SN177_0154_B818URABXX_s_1_rg.sorted.bam,251.75,1.72,0.15,58cfa830e4b0c9d6adf6c1bc,TCGA-AG-A01L-01A-01D-A077_110406_SN177_0154_B818URABXX_s_1_rg.sorted.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A01L-01A,848A5838-8A06-45A9-A3D6-E4ED47B824AB,Primary Tumor,Illumina HiSeq,f1b7cb66-3e14-4411-b17a-0ad856d8c686,Colorectal,58,B034C90B-D0BD-466A-88BA-B61EFD36C6E4,337F94D6-ECFB-4653-A63C-49F0D1893BF0,TCGA-AG-A01L-01A-01D-A077-02,HG18_Broad_variant,TCGA-AG-A01L,TCGA-READ,NA,s2002,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIB
13722.58cfa832e4b0c9d6adf6d5a7,58cfa832e4b0c9d6adf6d5a7,TCGA-V4-A9E7-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_5_rg.sorted.filtered.,WGS,TCGA-V4-A9E7-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_5_rg.sorted,TCGA-V4-A9E7-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_5_rg.sorted.bam,15.6,NA,0.17,58cfa832e4b0c9d6adf6d5a7,TCGA-V4-A9E7-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,Not available,Uveal Melanoma,Aligned reads,TCGA-V4-A9E7-10A,B5C516BA-4785-41DC-BD07-B129D47808DD,Blood Derived Normal,Illumina HiSeq,59abaf30-bfab-44cc-b3a2-99126daaa801,Eye,76,52B162F5-CF88-43CA-AE7A-F1054B5DFDB8,384E9070-8386-46B2-9643-2DB59E8A5A5C,TCGA-V4-A9E7-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9E7,TCGA-UVM,415,s182,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa830e4b0c9d6adf6bc1e,58cfa830e4b0c9d6adf6bc1e,TCGA-AG-A01Y-01A-41D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-A01Y-01A-41D-A079-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-A01Y-01A-41D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,100.13,2.07,0.17,58cfa830e4b0c9d6adf6bc1e,TCGA-AG-A01Y-01A-41D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A01Y-01A,A91F7A8C-E0FE-403A-9EF0-F7679B2761CC,Primary Tumor,Illumina HiSeq,9b6deb45-fcab-4b6f-8c5d-225444c42154,Colorectal,49,28B76ABF-6A5F-4D3B-87FE-18EA7139DEDF,D295156A-3A31-4540-B295-0B620340E4DB,TCGA-AG-A01Y-01A-41D-A079-02,HG18,TCGA-AG-A01Y,TCGA-READ,NA,s2172,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage II
13722.58cfa82fe4b0c9d6adf6b9ca,58cfa82fe4b0c9d6adf6b9ca,TCGA-AA-A00U-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A00U-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A00U-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,232.95,1.72,0.15,58cfa82fe4b0c9d6adf6b9ca,TCGA-AA-A00U-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A00U-01A,091E3084-04EE-4497-893C-D46226DEC78F,Primary Tumor,Illumina HiSeq,95f8b5f7-db6e-4a69-959f-dde28a98d4ed,Colorectal,50,2FC854D7-4F80-4C39-BD92-397E94FEE4A0,6765593B-17DC-4B0F-A20B-7F0FF67DFF64,TCGA-AA-A00U-01A-01D-A077-02,HG18,TCGA-AA-A00U,TCGA-COAD,NA,s13682,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage IIIB
13722.58cfa830e4b0c9d6adf6bdf5,58cfa830e4b0c9d6adf6bdf5,TCGA-AG-A01W-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-A01W-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-A01W-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,140.75,2,0.15,58cfa830e4b0c9d6adf6bdf5,TCGA-AG-A01W-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A01W-01A,74543FA4-CE73-46E4-9C59-224E8242B4A2,Primary Tumor,Illumina HiSeq,66ffc729-68c6-4bd6-b4d2-e68e3989e252,Colorectal,67,C481ABBB-21EB-4393-AB8D-C27E3DA1B8F7,BC3C3340-5E36-4754-AF22-F08EF550BD07,TCGA-AG-A01W-01A-21D-A079-02,HG18,TCGA-AG-A01W,TCGA-READ,NA,s2171,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage II
13722.58cfa830e4b0c9d6adf6baa6,58cfa830e4b0c9d6adf6baa6,TCGA-AA-A03F-01A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A03F-01A-11D-A079-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A03F-01A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,124.44,1.85,0.17,58cfa830e4b0c9d6adf6baa6,TCGA-AA-A03F-01A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A03F-01A,2A971E32-B0E7-4A3F-8C40-62D69C0307D8,Primary Tumor,Illumina HiSeq,93e089c5-c259-445d-9ffa-10073ad2d336,Colorectal,90,8ABA8350-B5EE-4CA2-BC99-5C7922A886C4,F445E8E6-6A82-4400-8307-1DE92AC03539,TCGA-AA-A03F-01A-11D-A079-02,HG18,TCGA-AA-A03F,TCGA-COAD,549,s13207,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage III
13722.58cfa831e4b0c9d6adf6cd4b,58cfa831e4b0c9d6adf6cd4b,TCGA-ER-A197-06A-32D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-ER-A197-06A-32D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_2_rg.sorted,TCGA-ER-A197-06A-32D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_2_rg.sorted.bam,77.22,NA,0.17,58cfa831e4b0c9d6adf6cd4b,TCGA-ER-A197-06A-32D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A197-06A,3EBB2374-4518-4E19-9B65-9C3E66252C4C,Metastatic,Illumina HiSeq,63175366-aa4e-4f4a-99c8-5d6985a153a6,Skin,83,A0B189C0-996A-4A35-B8BF-EC1309B05603,E86E19FF-B225-4C87-9F16-4C931BEADC30,TCGA-ER-A197-06A-32D-A18Y-02,HG19_Broad_variant,TCGA-ER-A197,TCGA-SKCM,424,s7697,Harvard Medical School,University of Pittsburgh,United States,NO,T4b,N1a,Not available,Stage IIIB
13722.58cfa82fe4b0c9d6adf6b617,58cfa82fe4b0c9d6adf6b617,TCGA-35-4122-01A-01D-1103_110804_SN208_0217_BC03EKABXX_s_3_rg.sorted.filtered.,WGS,TCGA-35-4122-01A-01D-1103_110804_SN208_0217_BC03EKABXX_s_3_rg.sorted,TCGA-35-4122-01A-01D-1103_110804_SN208_0217_BC03EKABXX_s_3_rg.sorted.bam,244.93,1.9,0.15,58cfa82fe4b0c9d6adf6b617,TCGA-35-4122-01A-01D-1103_110804_SN208_0217_BC03EKABXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-35-4122-01A,44ADF4CB-2829-4153-80FD-A8B7EE0E654A,Primary Tumor,Illumina HiSeq,3887aeb9-e6df-492e-ad08-f4037acba9aa,Lung,69,587F8383-3A48-49AF-8AC4-D86E6009C96B,DD8A0F54-0311-49FB-B270-ABF1AE9B56A5,TCGA-35-4122-01A-01D-1103-02,HG19_Broad_variant,TCGA-35-4122,TCGA-LUAD,NA,s11445,Harvard Medical School,Cureline,Russia,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa832e4b0c9d6adf6d588,58cfa832e4b0c9d6adf6d588,TCGA-V4-A9EA-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_8_rg.sorted.filtered.,WGS,TCGA-V4-A9EA-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_8_rg.sorted,TCGA-V4-A9EA-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_8_rg.sorted.bam,13.93,NA,0.15,58cfa832e4b0c9d6adf6d588,TCGA-V4-A9EA-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EA-10A,A9FE64A9-6D22-4E9F-96F3-F16AF7D298F8,Blood Derived Normal,Illumina HiSeq,0a3f9188-7162-4f34-88ca-30feeb541794,Eye,66,0CB57231-0EBB-4BC0-A41B-92EFB694B49A,7D1BAF81-479A-4EC1-85C6-38562AD40844,TCGA-V4-A9EA-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9EA,TCGA-UVM,NA,s212,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa830e4b0c9d6adf6bff0,58cfa830e4b0c9d6adf6bff0,TCGA-AG-3878-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3878-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3878-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,68.61,1.9,0.15,58cfa830e4b0c9d6adf6bff0,TCGA-AG-3878-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3878-10A,FDEEFF8E-1328-42A4-ACA0-A03B97421F1E,Blood Derived Normal,Illumina HiSeq,d50f98e5-5a4a-4380-9f43-9add34b2e020,Colorectal,64,33490C7D-BDA5-4F34-9334-41FFEA509F86,3A5CB7A1-AB43-4C31-AFAE-98A3BF30F091,TCGA-AG-3878-10A-01D-1167-02,HG18,TCGA-AG-3878,TCGA-READ,NA,s1970,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa82fe4b0c9d6adf6ba1e,58cfa82fe4b0c9d6adf6ba1e,TCGA-AA-3664-01A-01D-1167_101023_SN208_0166_A808PFABXX_s_5_rg.sorted.filtered.,WGS,TCGA-AA-3664-01A-01D-1167_101023_SN208_0166_A808PFABXX_s_5_rg.sorted,TCGA-AA-3664-01A-01D-1167_101023_SN208_0166_A808PFABXX_s_5_rg.sorted.bam,338.96,1.9,0.16,58cfa82fe4b0c9d6adf6ba1e,TCGA-AA-3664-01A-01D-1167_101023_SN208_0166_A808PFABXX_s_5_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3664-01A,A06C09A8-0951-49F4-A765-5147BBCAE109,Primary Tumor,Illumina HiSeq,1eb3d869-c9bd-4087-80cd-7fb426eb7997,Colorectal,74,D448668C-90F3-40FA-9961-88407090DA31,4B4C0EDF-1012-4A6A-B01E-CDEB130FF2E6,TCGA-AA-3664-01A-01D-1167-02,HG18_Broad_variant,TCGA-AA-3664,TCGA-COAD,NA,s12864,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c722,58cfa831e4b0c9d6adf6c722,TCGA-CV-6938-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CV-6938-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_2_rg.sorted,TCGA-CV-6938-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_2_rg.sorted.bam,127.7,1.9,0.14,58cfa831e4b0c9d6adf6c722,TCGA-CV-6938-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6938-11A,FF9DB03D-F81C-4079-8B05-F5A8C05B8CFE,Solid Tissue Normal,Illumina HiSeq,f15c68cb-d7b4-4f77-9154-f6beb21ff1f1,Head and Neck,87,CF972FFA-A8F4-4DDF-AE83-F80E7C24DE3F,EF1B3760-3B55-4C1B-9952-4AD151738604,TCGA-CV-6938-11A-01D-1911-02,HG19_Broad_variant,TCGA-CV-6938,TCGA-HNSC,144,s15645,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa82fe4b0c9d6adf6b978,58cfa82fe4b0c9d6adf6b978,TCGA-AA-3664-10A-01D-1167_110111_SN208_0178_B818TTABXX_s_6.rg.sorted.filtered.,WGS,TCGA-AA-3664-10A-01D-1167_110111_SN208_0178_B818TTABXX_s_6.rg.sorted,TCGA-AA-3664-10A-01D-1167_110111_SN208_0178_B818TTABXX_s_6.rg.sorted.bam,76.96,1.9,0.15,58cfa82fe4b0c9d6adf6b978,TCGA-AA-3664-10A-01D-1167_110111_SN208_0178_B818TTABXX_s_6.rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3664-10A,A06C09A8-0951-49F4-A765-5147BBCAE109,Blood Derived Normal,Illumina HiSeq,bb549fb1-8744-496c-bf19-13b063fd8edd,Colorectal,74,B4FFAC44-CCEF-458F-80CC-2D230D78012A,44FE059D-488A-4152-ABB9-A305EA066D2D,TCGA-AA-3664-10A-01D-1167-02,HG18_Broad_variant,TCGA-AA-3664,TCGA-COAD,NA,s13175,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa832e4b0c9d6adf6d582,58cfa832e4b0c9d6adf6d582,TCGA-V4-A9EA-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_8_rg.sorted.filtered.,WGS,TCGA-V4-A9EA-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_8_rg.sorted,TCGA-V4-A9EA-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_8_rg.sorted.bam,33.08,NA,0.17,58cfa832e4b0c9d6adf6d582,TCGA-V4-A9EA-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EA-01A,A9FE64A9-6D22-4E9F-96F3-F16AF7D298F8,Primary Tumor,Illumina HiSeq,35b1a08b-2b90-4f04-887c-7e95542f287e,Eye,66,1A18A8C2-C00F-42B2-B5C6-3AAB27BCE06D,10EEDA0C-C4C3-4F47-A3AF-599FDFCD62DF,TCGA-V4-A9EA-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9EA,TCGA-UVM,NA,s188,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa832e4b0c9d6adf6d3b4,58cfa832e4b0c9d6adf6d3b4,TCGA-RZ-AB0B-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_1_rg.sorted.filtered.,WGS,TCGA-RZ-AB0B-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_1_rg.sorted,TCGA-RZ-AB0B-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_1_rg.sorted.bam,44.08,NA,0.16,58cfa832e4b0c9d6adf6d3b4,TCGA-RZ-AB0B-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,Not available,Uveal Melanoma,Aligned reads,TCGA-RZ-AB0B-10A,2BF47A88-DF0A-4102-AF2E-998C3D252B9C,Blood Derived Normal,Illumina HiSeq,1fc76325-1366-4861-a777-3e3353ccdfb1,Eye,47,383155F8-5C76-46C8-A989-BA166FBC3842,4CA8558D-9B6A-4FE0-915B-C4A9ABC927D5,TCGA-RZ-AB0B-10A-01D-A40E-26,HG19_Broad_variant,TCGA-RZ-AB0B,TCGA-UVM,149,s184,MD Anderson - Institute for Applied Cancer Science,Wills Eye Institute,United States,NO,T4b,Not available,Not available,Stage IV
13722.58cfa832e4b0c9d6adf6d58a,58cfa832e4b0c9d6adf6d58a,TCGA-V4-A9E9-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_7_rg.sorted.filtered.,WGS,TCGA-V4-A9E9-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_7_rg.sorted,TCGA-V4-A9E9-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_7_rg.sorted.bam,31.06,NA,0.16,58cfa832e4b0c9d6adf6d58a,TCGA-V4-A9E9-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9E9-01A,418152BD-7D33-4F0A-B890-2356B30D6F44,Primary Tumor,Illumina HiSeq,d8293c54-78cb-49a0-a69f-f36723632ddd,Eye,50,5CB8105A-6D8B-441B-A8F7-89308DD4FC92,3782E96A-456F-4747-B75B-A48597EDFD90,TCGA-V4-A9E9-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9E9,TCGA-UVM,NA,s189,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa832e4b0c9d6adf6d39e,58cfa832e4b0c9d6adf6d39e,TCGA-V3-A9ZX-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_2_rg.sorted.filtered.,WGS,TCGA-V3-A9ZX-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_2_rg.sorted,TCGA-V3-A9ZX-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_2_rg.sorted.bam,16.07,NA,0.14,58cfa832e4b0c9d6adf6d39e,TCGA-V3-A9ZX-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V3-A9ZX-10A,5019E7F1-DB46-4A07-9E7B-B6E5D1481B84,Blood Derived Normal,Illumina HiSeq,4a466349-9f08-41d1-871c-743dd4fee9e8,Eye,56,D6318FE7-F539-45A8-99BA-BF590F8B7082,8211B0F6-A6D4-4EAA-9465-9C35DB27FA3F,TCGA-V3-A9ZX-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V3-A9ZX,TCGA-UVM,NA,s194,MD Anderson - Institute for Applied Cancer Science,Cleveland Clinic Foundation,United States,NO,T2b,NX,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6cf16,58cfa832e4b0c9d6adf6cf16,TCGA-FG-7636-10A-01D-2088_130923_SN1222_0220_BC2DUUACXX_s_7_rg.sorted.filtered.,WGS,TCGA-FG-7636-10A-01D-2088_130923_SN1222_0220_BC2DUUACXX_s_7_rg.sorted,TCGA-FG-7636-10A-01D-2088_130923_SN1222_0220_BC2DUUACXX_s_7_rg.sorted.bam,66.3,NA,0.15,58cfa832e4b0c9d6adf6cf16,TCGA-FG-7636-10A-01D-2088_130923_SN1222_0220_BC2DUUACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-7636-10A,B342E980-8383-4F1B-BF57-4098C37A536C,Blood Derived Normal,Illumina HiSeq,3936d9e1-9fc2-4de3-9c2d-6bb41eecfcf5,Brain,48,3E8DB019-9057-49BD-8B3D-6B51A370C15F,CAB252B2-7534-44B2-894C-673368843642,TCGA-FG-7636-10A-01D-2088-02,HG19_Broad_variant,TCGA-FG-7636,TCGA-LGG,NA,s8150,Harvard Medical School,Case Western,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa832e4b0c9d6adf6d4d7,58cfa832e4b0c9d6adf6d4d7,TCGA-RZ-AB0B-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_1_rg.sorted.filtered.,WGS,TCGA-RZ-AB0B-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_1_rg.sorted,TCGA-RZ-AB0B-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_1_rg.sorted.bam,44.7,NA,0.14,58cfa832e4b0c9d6adf6d4d7,TCGA-RZ-AB0B-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,Not available,Uveal Melanoma,Aligned reads,TCGA-RZ-AB0B-01A,2BF47A88-DF0A-4102-AF2E-998C3D252B9C,Primary Tumor,Illumina HiSeq,e284c77f-87fb-456b-8707-5f7b1219d267,Eye,47,78DA02B6-41D6-4911-8762-A71657F26F3C,B2D03978-B98B-4FB4-BA5C-50CE935C0056,TCGA-RZ-AB0B-01A-11D-A40D-26,HG19_Broad_variant,TCGA-RZ-AB0B,TCGA-UVM,149,s187,MD Anderson - Institute for Applied Cancer Science,Wills Eye Institute,United States,NO,T4b,Not available,Not available,Stage IV
13722.58cfa832e4b0c9d6adf6d58c,58cfa832e4b0c9d6adf6d58c,TCGA-V4-A9E7-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_5_rg.sorted.filtered.,WGS,TCGA-V4-A9E7-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_5_rg.sorted,TCGA-V4-A9E7-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_5_rg.sorted.bam,32.61,NA,0.16,58cfa832e4b0c9d6adf6d58c,TCGA-V4-A9E7-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,Not available,Uveal Melanoma,Aligned reads,TCGA-V4-A9E7-01A,B5C516BA-4785-41DC-BD07-B129D47808DD,Primary Tumor,Illumina HiSeq,18accc0b-97a3-4386-b4c6-9213eeb4da3e,Eye,76,76AF65DC-CCCD-4257-8D05-38334D3110DA,3D700A8D-7760-4095-B537-1171444D1A5D,TCGA-V4-A9E7-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9E7,TCGA-UVM,415,s193,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa830e4b0c9d6adf6bb78,58cfa830e4b0c9d6adf6bb78,TCGA-AA-A00U-10A-01D-A078_110429_SN590_0080_AC02UTABXX_s_1.rg.sorted.filtered.,WGS,TCGA-AA-A00U-10A-01D-A078_110429_SN590_0080_AC02UTABXX_s_1.rg.sorted,TCGA-AA-A00U-10A-01D-A078_110429_SN590_0080_AC02UTABXX_s_1.rg.sorted.bam,49.5,1.73,0.15,58cfa830e4b0c9d6adf6bb78,TCGA-AA-A00U-10A-01D-A078_110429_SN590_0080_AC02UTABXX_s_1.rg.sorted.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A00U-10A,091E3084-04EE-4497-893C-D46226DEC78F,Blood Derived Normal,Illumina HiSeq,40302890-3ffe-40e0-870d-debebe9c5015,Colorectal,50,4F0B6C3E-065D-4C16-93ED-26BFFFB2A79A,E063BC1B-1347-4301-A09D-0FCCC244DB7A,TCGA-AA-A00U-10A-01D-A078-02,HG18_Broad_variant,TCGA-AA-A00U,TCGA-COAD,NA,s13196,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage IIIB
13722.58cfa830e4b0c9d6adf6bca6,58cfa830e4b0c9d6adf6bca6,TCGA-AZ-4315-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AZ-4315-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-AZ-4315-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,524.02,1.9,0.15,58cfa830e4b0c9d6adf6bca6,TCGA-AZ-4315-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-4315-01A,DE287A25-981D-49F8-81AF-FE0300E4CD31,Primary Tumor,Illumina HiSeq,8b6a06d6-c15c-4491-996c-2a012440f8a2,Colorectal,61,BA9E5603-BB1D-4AA8-93E4-40043164F143,FBEA9F07-A969-4396-8A17-A269BF1F8A2A,TCGA-AZ-4315-01A-01D-1405-02,HG18,TCGA-AZ-4315,TCGA-COAD,NA,s13389,Harvard Medical School,University of Pittsburgh,None,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6c6cc,58cfa831e4b0c9d6adf6c6cc,TCGA-CS-4938-10A-01D-1891_130912_SN590_0237_AC292LACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CS-4938-10A-01D-1891_130912_SN590_0237_AC292LACXX_s_1_rg.sorted,TCGA-CS-4938-10A-01D-1891_130912_SN590_0237_AC292LACXX_s_1_rg.sorted.bam,1013,1.9,0.15,58cfa831e4b0c9d6adf6c6cc,TCGA-CS-4938-10A-01D-1891_130912_SN590_0237_AC292LACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-4938-10A,334F715E-08DC-4A29-B8E4-B010B829C478,Blood Derived Normal,Illumina HiSeq,d987c181-1947-486c-957f-c5bd782a1eba,Brain,31,1B19B2AB-F094-4B73-8AB7-E06F91AFE729,DDD29528-58AD-461F-8509-4E42F71B49FB,TCGA-CS-4938-10A-01D-1891-02,HG19_Broad_variant,TCGA-CS-4938,TCGA-LGG,NA,s8125,Harvard Medical School,Thomas Jefferson University,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6c6d8,58cfa831e4b0c9d6adf6c6d8,TCGA-CG-4460-01A-01D-1154_120913_SN208_0429_AC187FACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CG-4460-01A-01D-1154_120913_SN208_0429_AC187FACXX_s_8_rg.sorted,TCGA-CG-4460-01A-01D-1154_120913_SN208_0429_AC187FACXX_s_8_rg.sorted.bam,183.9,1.9,0.15,58cfa831e4b0c9d6adf6c6d8,TCGA-CG-4460-01A-01D-1154_120913_SN208_0429_AC187FACXX_s_8_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4460-01A,3C3D4EF0-019A-423E-89B2-4AC5A7B567AB,Primary Tumor,Illumina HiSeq,1d341d0a-b2f5-4f35-b60d-7c87f2a7dc78,Stomach,66,14FE3057-C82E-4D66-9798-BCD042CF64D6,1AE6944B-600D-40A8-ADD3-16F99982CDFE,TCGA-CG-4460-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4460,TCGA-STAD,669,s15396,Harvard Medical School,Indivumed,Germany,NO,T4,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa82ee4b0c9d6adf6afc4,58cfa82ee4b0c9d6adf6afc4,TCGA-05-4418-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-05-4418-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-05-4418-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,313.3,1.9,0.15,58cfa82ee4b0c9d6adf6afc4,TCGA-05-4418-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4418-01A,D2C1E896-6886-4122-BB48-5FBCD3F641F4,Primary Tumor,Illumina HiSeq,961e7ff2-7efc-46b6-9fe6-3f19366eeab8,Lung,69,C9E092B2-D6C3-4161-BD9E-0FA4015BEBBB,AA7559AC-F8C0-40E5-A313-3914A6E4559A,TCGA-05-4418-01A-01D-1203-02,GRCh37,TCGA-05-4418,TCGA-LUAD,274,s11440,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIA
13722.58cfa831e4b0c9d6adf6cadd,58cfa831e4b0c9d6adf6cadd,TCGA-E1-5305-01A-01D-1891_130919_SN590_0238_AC29TRACXX_s_3_rg.sorted.filtered.,WGS,TCGA-E1-5305-01A-01D-1891_130919_SN590_0238_AC29TRACXX_s_3_rg.sorted,TCGA-E1-5305-01A-01D-1891_130919_SN590_0238_AC29TRACXX_s_3_rg.sorted.bam,57.7,1.9,0.14,58cfa831e4b0c9d6adf6cadd,TCGA-E1-5305-01A-01D-1891_130919_SN590_0238_AC29TRACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-E1-5305-01A,A0BC5147-D9B4-41FD-8DF3-A241D23722E8,Primary Tumor,Illumina HiSeq,0f660d53-1dae-499d-8a76-f591e1110acb,Brain,34,1B3185BF-9DEF-4B13-93F8-02CF3171464A,036EF90A-EACA-4105-9B7B-74C20BFA0BB9,TCGA-E1-5305-01A-01D-1891-02,HG19_Broad_variant,TCGA-E1-5305,TCGA-LGG,2433,s8354,Harvard Medical School,Duke,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa832e4b0c9d6adf6d4f4,58cfa832e4b0c9d6adf6d4f4,TCGA-V3-A9ZX-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_2_rg.sorted.filtered.,WGS,TCGA-V3-A9ZX-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_2_rg.sorted,TCGA-V3-A9ZX-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_2_rg.sorted.bam,47.71,NA,0.15,58cfa832e4b0c9d6adf6d4f4,TCGA-V3-A9ZX-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V3-A9ZX-01A,5019E7F1-DB46-4A07-9E7B-B6E5D1481B84,Primary Tumor,Illumina HiSeq,ad32c24c-f4fa-4356-95a8-15d394368122,Eye,56,A2DFEBBB-9A38-4CC2-A3F3-857C2A70DCF4,314EE286-7E1A-4CF8-A39D-D12E23C6DAAB,TCGA-V3-A9ZX-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V3-A9ZX,TCGA-UVM,NA,s195,MD Anderson - Institute for Applied Cancer Science,Cleveland Clinic Foundation,United States,NO,T2b,NX,Not available,Stage IIB
13722.58cfa82ee4b0c9d6adf6b146,58cfa82ee4b0c9d6adf6b146,TCGA-05-4426-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_7_rg.sorted.filtered.,WGS,TCGA-05-4426-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_7_rg.sorted,TCGA-05-4426-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_7_rg.sorted.bam,65.9,1.9,0.15,58cfa82ee4b0c9d6adf6b146,TCGA-05-4426-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_7_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4426-10A,36BF02F8-C1C8-49F9-A417-ADF88A205C70,Blood Derived Normal,Illumina HiSeq,7e65d1f5-4103-44eb-a39a-9944b9f86be9,Lung,71,7DBB3F0E-B957-4AE1-A1B2-2672DC10FE87,4071BFD9-5804-4F10-899F-5C5DFC27D93B,TCGA-05-4426-10A-01D-1203-02,HG19_Broad_variant,TCGA-05-4426,TCGA-LUAD,NA,s11333,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa832e4b0c9d6adf6d4f6,58cfa832e4b0c9d6adf6d4f6,TCGA-L5-A4OI-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-L5-A4OI-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_1_rg.sorted,TCGA-L5-A4OI-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_1_rg.sorted.bam,40.07,NA,0.16,58cfa832e4b0c9d6adf6d4f6,TCGA-L5-A4OI-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OI-01A,CB2AF13B-CBED-4657-8FD4-FED8DB375CBA,Primary Tumor,Illumina HiSeq,61f0c88a-c61d-400f-b8cf-b9cacd5fcada,Esophagus,79,1B1CBB34-DA71-4441-B1A1-C936E8F04C73,8D5A0D62-D9C1-46D1-9B81-685293B45E6B,TCGA-L5-A4OI-01A-11D-A267-26,HG19_Broad_variant,TCGA-L5-A4OI,TCGA-ESCA,NA,s1924,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T3,N3,Not available,Stage IIIC
13722.58cfa830e4b0c9d6adf6bc68,58cfa830e4b0c9d6adf6bc68,TCGA-AG-A01L-10A-01D-A078_110406_SN177_0154_B818URABXX_s_2_rg.sorted.filtered.,WGS,TCGA-AG-A01L-10A-01D-A078_110406_SN177_0154_B818URABXX_s_2_rg.sorted,TCGA-AG-A01L-10A-01D-A078_110406_SN177_0154_B818URABXX_s_2_rg.sorted.bam,22.13,1.73,0.15,58cfa830e4b0c9d6adf6bc68,TCGA-AG-A01L-10A-01D-A078_110406_SN177_0154_B818URABXX_s_2_rg.sorted.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A01L-10A,848A5838-8A06-45A9-A3D6-E4ED47B824AB,Blood Derived Normal,Illumina HiSeq,8d5db315-7d34-49ae-915e-152128dc9162,Colorectal,58,7F43C713-73CA-4971-A247-E7E2022C2A6B,B4B64FC1-C309-48D2-8B1D-E0F7AA1ED9A4,TCGA-AG-A01L-10A-01D-A078-02,HG18_Broad_variant,TCGA-AG-A01L,TCGA-READ,NA,s2006,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIB
13722.58cfa832e4b0c9d6adf6d11a,58cfa832e4b0c9d6adf6d11a,TCGA-G2-A2EL-10A-01D-A18D_120912_SN1222_0148_AC188PACXX_s_6_rg.sorted.filtered.,WGS,TCGA-G2-A2EL-10A-01D-A18D_120912_SN1222_0148_AC188PACXX_s_6_rg.sorted,TCGA-G2-A2EL-10A-01D-A18D_120912_SN1222_0148_AC188PACXX_s_6_rg.sorted.bam,17.24,NA,0.17,58cfa832e4b0c9d6adf6d11a,TCGA-G2-A2EL-10A-01D-A18D_120912_SN1222_0148_AC188PACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-G2-A2EL-10A,30C7445E-D0C4-4A0F-96A4-27E4259EE10B,Blood Derived Normal,Illumina HiSeq,9b81589b-68e2-4101-b77c-a356f255eb95,Bladder,77,C109058D-19C0-44B5-BFB5-5BD6C9D4E3B8,53F645F9-F8B0-46D6-B1FF-91042F47FA80,TCGA-G2-A2EL-10A-01D-A18D-02,HG19_Broad_variant,TCGA-G2-A2EL,TCGA-BLCA,819,s2915,Harvard Medical School,MD Anderson,United States,NO,Not available,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa832e4b0c9d6adf6d28b,58cfa832e4b0c9d6adf6d28b,TCGA-HT-7601-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_5_rg.sorted.filtered.,WGS,TCGA-HT-7601-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_5_rg.sorted,TCGA-HT-7601-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_5_rg.sorted.bam,56,NA,0.15,58cfa832e4b0c9d6adf6d28b,TCGA-HT-7601-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7601-01A,E7FDF164-A85D-4FF5-9676-D2215CA35403,Primary Tumor,Illumina HiSeq,5faa261d-a169-4ab5-a52b-de3b50c46299,Brain,30,7F6B5679-49E1-498D-BD1F-A757CD7DB4CC,5F766AF5-08F5-4E10-AAED-4B582275CFC1,TCGA-HT-7601-01A-11D-2088-02,HG19_Broad_variant,TCGA-HT-7601,TCGA-LGG,NA,s8153,Harvard Medical School,Case Western - St Joes,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa830e4b0c9d6adf6bbc6,58cfa830e4b0c9d6adf6bbc6,TCGA-AG-A002-10A-01D-A078-02_110217_SN208_0190_B81CLKABXX_s_2.rg.sorted.filtered.,WGS,TCGA-AG-A002-10A-01D-A078-02_110217_SN208_0190_B81CLKABXX_s_2.rg.sorted,TCGA-AG-A002-10A-01D-A078-02_110217_SN208_0190_B81CLKABXX_s_2.rg.sorted.bam,17.06,1.74,0.14,58cfa830e4b0c9d6adf6bbc6,TCGA-AG-A002-10A-01D-A078-02_110217_SN208_0190_B81CLKABXX_s_2.rg.sorted.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A002-10A,CB005C69-7301-41CE-B534-C9751F1436C5,Blood Derived Normal,Illumina HiSeq,ab767da1-ed1c-4246-8d29-4d8f720c4f46,Colorectal,35,E2660CFD-8FEC-437F-8A0E-4869030DE46E,26E7A890-3DE3-486F-91AB-C76F14908F1C,TCGA-AG-A002-10A-01D-A078-02,HG18_Broad_variant,TCGA-AG-A002,TCGA-READ,NA,s1979,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bac2,58cfa830e4b0c9d6adf6bac2,TCGA-49-4501-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-49-4501-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-49-4501-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,133.2,1.9,0.14,58cfa830e4b0c9d6adf6bac2,TCGA-49-4501-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4501-01A,0780EB43-D5B5-4C3D-9825-BEACBA5CC723,Primary Tumor,Illumina HiSeq,2df919ad-215d-40a5-8e9d-e22862898cd7,Lung,67,FC511A67-5383-4877-AEEF-36C0B7934B77,FA521F2B-4BB1-4A15-9101-422B2B65489A,TCGA-49-4501-01A-01D-1203-02,GRCh37,TCGA-49-4501,TCGA-LUAD,1421,s11003,Harvard Medical School,Johns Hopkins,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa830e4b0c9d6adf6ba70,58cfa830e4b0c9d6adf6ba70,TCGA-AA-A00Z-10A-01D-A078-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A00Z-10A-01D-A078-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A00Z-10A-01D-A078-02_IlluminaHiSeq-DNASeq_whole.bam,10.8,1.73,0.15,58cfa830e4b0c9d6adf6ba70,TCGA-AA-A00Z-10A-01D-A078-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A00Z-10A,AF3A0634-4292-45BD-B948-6B6BD2D58090,Blood Derived Normal,Illumina HiSeq,be8d500d-5a28-4752-bb94-e477bd22168e,Colorectal,70,C58C91E2-443F-49D4-A568-9F087F4153F7,2D40907C-B742-4853-9863-70F92CB5D712,TCGA-AA-A00Z-10A-01D-A078-02,HG18,TCGA-AA-A00Z,TCGA-COAD,NA,s12878,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa832e4b0c9d6adf6d3d7,58cfa832e4b0c9d6adf6d3d7,TCGA-V4-A9EJ-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_7_rg.sorted.filtered.,WGS,TCGA-V4-A9EJ-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_7_rg.sorted,TCGA-V4-A9EJ-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_7_rg.sorted.bam,36.7,NA,0.17,58cfa832e4b0c9d6adf6d3d7,TCGA-V4-A9EJ-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EJ-01A,D9CCBA9B-6BF0-44D9-8097-A97AB747F0BD,Primary Tumor,Illumina HiSeq,9a75e8fd-7cbd-4d0f-a91b-22e52e02c00d,Eye,38,6D2FBFD2-E1BF-483E-B0A0-A308F93871D4,42B46C86-61F4-4C2E-9EC3-0ED0113F3EC3,TCGA-V4-A9EJ-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9EJ,TCGA-UVM,NA,s206,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3a,N0,Not available,Stage IIB
13722.58cfa82fe4b0c9d6adf6ba3e,58cfa82fe4b0c9d6adf6ba3e,TCGA-A5-A0GU-10A-01D-A043_120209_SN1120_0114_BC0DFVACXX_s_6_rg.sorted.filtered.,WGS,TCGA-A5-A0GU-10A-01D-A043_120209_SN1120_0114_BC0DFVACXX_s_6_rg.sorted,TCGA-A5-A0GU-10A-01D-A043_120209_SN1120_0114_BC0DFVACXX_s_6_rg.sorted.bam,17.29,2.1,0.13,58cfa82fe4b0c9d6adf6ba3e,TCGA-A5-A0GU-10A-01D-A043_120209_SN1120_0114_BC0DFVACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GU-10A,ADC22472-E31D-419F-AEAE-CB01B9423343,Blood Derived Normal,Illumina HiSeq,91b25823-6457-4f3a-a469-d6a89777c2ec,Uterus,58,14A66466-7AC3-48D7-B39F-5353E27D370F,1D6A08A4-CB4C-499F-A0D2-874DDC00D825,TCGA-A5-A0GU-10A-01D-A043-02,HG19_Broad_variant,TCGA-A5-A0GU,TCGA-UCEC,NA,s4416,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bdde,58cfa830e4b0c9d6adf6bdde,TCGA-AG-A01N-10A-01D-A078_110406_SN177_0154_B818URABXX_s_4.rg.sorted.filtered.,WGS,TCGA-AG-A01N-10A-01D-A078_110406_SN177_0154_B818URABXX_s_4.rg.sorted,TCGA-AG-A01N-10A-01D-A078_110406_SN177_0154_B818URABXX_s_4.rg.sorted.bam,20.24,1.77,0.15,58cfa830e4b0c9d6adf6bdde,TCGA-AG-A01N-10A-01D-A078_110406_SN177_0154_B818URABXX_s_4.rg.sorted.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A01N-10A,1118490D-75AA-43CC-B2A2-C2AF61829FFC,Blood Derived Normal,Illumina HiSeq,3aceb122-1e5e-4a17-b935-f21972323dbe,Colorectal,68,64D63876-3188-4D41-877F-BBA0E771AB03,D585FD9D-B88A-44F3-9672-2E0C067C78BF,TCGA-AG-A01N-10A-01D-A078-02,HG18_Broad_variant,TCGA-AG-A01N,TCGA-READ,NA,s2005,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage IV
13722.58cfa830e4b0c9d6adf6ba7a,58cfa830e4b0c9d6adf6ba7a,TCGA-AA-A02Y-10A-01D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A02Y-10A-01D-A079-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A02Y-10A-01D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,42.84,1.95,0.15,58cfa830e4b0c9d6adf6ba7a,TCGA-AA-A02Y-10A-01D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A02Y-10A,A435FDF4-A89A-499E-9006-CBB5693EAB26,Blood Derived Normal,Illumina HiSeq,2769747d-4ce8-4519-b01e-2cb2d9afd496,Colorectal,73,DDA1BA9D-36A4-45EA-A100-8B9B8204A3EF,129EA15A-A5D4-4971-BDA2-22700248990B,TCGA-AA-A02Y-10A-01D-A079-02,HG18,TCGA-AA-A02Y,TCGA-COAD,NA,s13535,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bb5c,58cfa830e4b0c9d6adf6bb5c,TCGA-AA-3675-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3675-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3675-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,570.96,1.9,0.14,58cfa830e4b0c9d6adf6bb5c,TCGA-AA-3675-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3675-01A,41658CF8-0DE1-4A97-BB60-0F0107C84E00,Primary Tumor,Illumina HiSeq,971987d4-bd49-45d8-949e-4c2108a7cbc7,Colorectal,84,A4CE3727-4506-493B-95F4-2F11CEB09CEB,42AD4E5A-8E58-47EC-9D1F-F65D5C22DA49,TCGA-AA-3675-01A-02D-1167-02,HG18,TCGA-AA-3675,TCGA-COAD,NA,s13372,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa830e4b0c9d6adf6c280,58cfa830e4b0c9d6adf6c280,TCGA-AZ-4682-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AZ-4682-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-AZ-4682-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,332.72,1.9,0.14,58cfa830e4b0c9d6adf6c280,TCGA-AZ-4682-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-4682-10A,E588714A-7753-4C3C-ABB6-EAF1AAB53AB3,Blood Derived Normal,Illumina HiSeq,06999186-ddf0-40ae-b4fb-80e9ffdac6d6,Colorectal,61,03CDE413-3796-4E16-8EF7-6FF0B8629F30,18D2197B-A289-4CD8-B545-FA3F29137DF4,TCGA-AZ-4682-10A-01D-1405-02,HG18,TCGA-AZ-4682,TCGA-COAD,680,s13214,Harvard Medical School,University of Pittsburgh,None,NO,T3,N0,Colon Adenocarcinoma,Stage IVA
13722.58cfa82fe4b0c9d6adf6b797,58cfa82fe4b0c9d6adf6b797,TCGA-49-4494-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-49-4494-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-49-4494-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,228.2,1.9,0.14,58cfa82fe4b0c9d6adf6b797,TCGA-49-4494-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4494-11A,C6D78E27-E510-4F57-ABAE-19EFA6105A8D,Solid Tissue Normal,Illumina HiSeq,56ee8c8c-9b38-4430-97b6-3272b9f84d68,Lung,77,DFD80010-DE16-4E33-B408-71B37AFE3FDF,D3182B5C-BA8F-49F0-967E-A209011B552B,TCGA-49-4494-11A-01D-1203-02,GRCh37,TCGA-49-4494,TCGA-LUAD,1081,s10659,Harvard Medical School,Johns Hopkins,United States,NO,T3,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa830e4b0c9d6adf6bc16,58cfa830e4b0c9d6adf6bc16,TCGA-AA-3516-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3516-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3516-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,88.56,1.9,0.15,58cfa830e4b0c9d6adf6bc16,TCGA-AA-3516-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3516-10A,D9D7F0D4-FA64-48F2-8037-52CBF0B34AD8,Blood Derived Normal,Illumina HiSeq,7b47a89f-cadb-4126-be00-ec268b11a135,Colorectal,74,E0942099-D2A8-4110-99C4-9B968B88C09D,28C399FE-B886-4FBA-976F-F0B03A795CA7,TCGA-AA-3516-10A-01D-1167-02,HG18,TCGA-AA-3516,TCGA-COAD,NA,s13660,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage III
13722.58cfa831e4b0c9d6adf6c64c,58cfa831e4b0c9d6adf6c64c,TCGA-CG-4455-01A-01D-1154_120913_SN208_0429_AC187FACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CG-4455-01A-01D-1154_120913_SN208_0429_AC187FACXX_s_7_rg.sorted,TCGA-CG-4455-01A-01D-1154_120913_SN208_0429_AC187FACXX_s_7_rg.sorted.bam,62.2,1.9,0.14,58cfa831e4b0c9d6adf6c64c,TCGA-CG-4455-01A-01D-1154_120913_SN208_0429_AC187FACXX_s_7_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4455-01A,8A173D98-20A1-4C84-86C1-97818E1C665A,Primary Tumor,Illumina HiSeq,002ff9b2-954c-4a9c-9f81-b5919872e770,Stomach,72,4622DF2E-9B9E-4B17-ADE3-A602B50B1288,AFA14A3A-5E6B-4CBE-B660-65AA53E9D10F,TCGA-CG-4455-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4455,TCGA-STAD,NA,s14978,Harvard Medical School,Indivumed,Germany,NO,T2b,N1,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage II
13722.58cfa831e4b0c9d6adf6cb2a,58cfa831e4b0c9d6adf6cb2a,TCGA-E1-5307-01A-01D-1891_130919_SN590_0238_AC29TRACXX_s_4_rg.sorted.filtered.,WGS,TCGA-E1-5307-01A-01D-1891_130919_SN590_0238_AC29TRACXX_s_4_rg.sorted,TCGA-E1-5307-01A-01D-1891_130919_SN590_0238_AC29TRACXX_s_4_rg.sorted.bam,138.7,1.9,0.14,58cfa831e4b0c9d6adf6cb2a,TCGA-E1-5307-01A-01D-1891_130919_SN590_0238_AC29TRACXX_s_4_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-E1-5307-01A,A6EE311C-0A7B-4F47-86F1-F2164B128F9C,Primary Tumor,Illumina HiSeq,80d2e037-eb0e-4514-bdd4-caa1fc77176d,Brain,62,DED0F767-9CEE-4F1D-8E91-CB242D30B57E,A95622B9-01E0-4625-AAB8-2193C2594976,TCGA-E1-5307-01A-01D-1891-02,HG19_Broad_variant,TCGA-E1-5307,TCGA-LGG,1762,s8363,Harvard Medical School,Duke,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa830e4b0c9d6adf6c02a,58cfa830e4b0c9d6adf6c02a,TCGA-AX-A0IW-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-AX-A0IW-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_3_rg.sorted,TCGA-AX-A0IW-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_3_rg.sorted.bam,112.67,1.79,0.14,58cfa830e4b0c9d6adf6c02a,TCGA-AX-A0IW-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A0IW-01A,DB21FCCF-40CB-4235-A34D-336A03B8C8F4,Primary Tumor,Illumina HiSeq,26dfa889-ba7c-4cc0-8adc-59d5eb4e4026,Uterus,67,874A1C5C-229B-4BCE-B612-55EFF238D533,CFB35E8C-470B-4F9E-B7C1-63FCAA162F3C,TCGA-AX-A0IW-01A-11D-A043-02,HG19_Broad_variant,TCGA-AX-A0IW,TCGA-UCEC,NA,s4422,Harvard Medical School,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aeb4,58cfa82ee4b0c9d6adf6aeb4,TCGA-05-4403-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-05-4403-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-05-4403-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,126.9,1.9,0.14,58cfa82ee4b0c9d6adf6aeb4,TCGA-05-4403-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4403-10A,CE15F31F-2BAD-4485-96FA-495BFA262E66,Blood Derived Normal,Illumina HiSeq,09d1673e-6daf-469e-ae53-19559464d5ed,Lung,76,0C58725D-22C6-4621-B1EA-D8E3E212D366,5E511CAA-31C9-48F7-BCF5-DD3838BD9B30,TCGA-05-4403-10A-01D-1203-02,GRCh37,TCGA-05-4403,TCGA-LUAD,NA,s11219,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa830e4b0c9d6adf6bcb0,58cfa830e4b0c9d6adf6bcb0,TCGA-AZ-4614-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AZ-4614-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-AZ-4614-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,494.72,1.9,0.14,58cfa830e4b0c9d6adf6bcb0,TCGA-AZ-4614-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-4614-10A,3334201D-A3C0-45EC-A9ED-CF48CC8C38E8,Blood Derived Normal,Illumina HiSeq,d265532f-fb66-4ede-9987-db7efa4fb8bb,Colorectal,71,202EF751-89B7-4F0A-B67A-75E08342335D,44D70E0C-69C3-405A-946D-5A48D45D5429,TCGA-AZ-4614-10A-01D-1405-02,HG18,TCGA-AZ-4614,TCGA-COAD,172,s13213,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N1,Colon Adenocarcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c71a,58cfa831e4b0c9d6adf6c71a,TCGA-CV-6954-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CV-6954-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_7_rg.sorted,TCGA-CV-6954-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_7_rg.sorted.bam,99.7,1.9,0.14,58cfa831e4b0c9d6adf6c71a,TCGA-CV-6954-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_7_rg.sorted.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,Not available,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6954-11A,402FD96C-76D3-4AC2-9F64-77BD34BE0ADB,Solid Tissue Normal,Illumina HiSeq,fa689d79-bedd-452e-935f-21bd4866b9d0,Head and Neck,59,9695FCED-AEF4-43ED-B1BE-026072DC4DDD,BDAFAD43-C3AE-4356-8B6F-DB08ACA4EDD1,TCGA-CV-6954-11A-01D-1911-02,HG19_Broad_variant,TCGA-CV-6954,TCGA-HNSC,2002,s15521,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T4a,NX,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6bede,58cfa830e4b0c9d6adf6bede,TCGA-AA-A03F-11A-12D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A03F-11A-12D-A079-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A03F-11A-12D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,80.18,1.92,0.14,58cfa830e4b0c9d6adf6bede,TCGA-AA-A03F-11A-12D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A03F-11A,2A971E32-B0E7-4A3F-8C40-62D69C0307D8,Solid Tissue Normal,Illumina HiSeq,8bc5ee97-80b0-460b-a611-d26490800e55,Colorectal,90,3CED81F6-87AB-49F3-9C9C-0E2A7DA86182,C3ACEE2B-AA06-4400-A29E-9C244DD6EDA8,TCGA-AA-A03F-11A-12D-A079-02,HG18,TCGA-AA-A03F,TCGA-COAD,549,s13385,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6ae68,58cfa82ee4b0c9d6adf6ae68,TCGA-05-4403-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-05-4403-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-05-4403-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,211.2,1.9,0.15,58cfa82ee4b0c9d6adf6ae68,TCGA-05-4403-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4403-01A,CE15F31F-2BAD-4485-96FA-495BFA262E66,Primary Tumor,Illumina HiSeq,80e2118c-7ebf-42fc-8600-573afcbb3fe6,Lung,76,44B1D21C-0794-428C-BA01-82812D74DA2F,48F1FF7F-84F4-4420-96F9-DA1917577B6D,TCGA-05-4403-01A-01D-1203-02,GRCh37,TCGA-05-4403,TCGA-LUAD,NA,s10980,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa831e4b0c9d6adf6c64a,58cfa831e4b0c9d6adf6c64a,TCGA-CG-4466-10A-01D-1154_130815_VM001_0005_VMR0005CXX_s_5_rg.sorted.filtered.,WGS,TCGA-CG-4466-10A-01D-1154_130815_VM001_0005_VMR0005CXX_s_5_rg.sorted,TCGA-CG-4466-10A-01D-1154_130815_VM001_0005_VMR0005CXX_s_5_rg.sorted.bam,67.9,1.9,0.15,58cfa831e4b0c9d6adf6c64a,TCGA-CG-4466-10A-01D-1154_130815_VM001_0005_VMR0005CXX_s_5_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4466-10A,2F1B96B2-7031-4F7D-9490-14728D320F3E,Blood Derived Normal,Illumina HiSeq,f0d50aa8-d8a6-4d7d-bfa9-58c964a75540,Stomach,81,2775F741-265C-4B56-9D75-AF665CCBFC8A,45323803-2E2E-4A6F-B8C7-1D74C29E9C84,TCGA-CG-4466-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4466,TCGA-STAD,NA,s14416,Harvard Medical School,Indivumed,Germany,NO,T2a,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c644,58cfa831e4b0c9d6adf6c644,TCGA-CG-4449-10A-01D-A326_131015_SN1440_0171_AC2DLBACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CG-4449-10A-01D-A326_131015_SN1440_0171_AC2DLBACXX_s_8_rg.sorted,TCGA-CG-4449-10A-01D-A326_131015_SN1440_0171_AC2DLBACXX_s_8_rg.sorted.bam,141.9,1.9,0.14,58cfa831e4b0c9d6adf6c644,TCGA-CG-4449-10A-01D-A326_131015_SN1440_0171_AC2DLBACXX_s_8_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4449-10A,10B5774D-7079-4B4B-B824-F4745F5598C7,Blood Derived Normal,Illumina HiSeq,e078d104-2b36-461b-9e5c-af5b8b2fc89a,Stomach,81,6CE70785-B370-4EE1-813C-9155E0BD7189,B0E0C604-B8BA-4ADD-8540-5081DABB30E3,TCGA-CG-4449-10A-01D-A326-26,HG19_Broad_variant,TCGA-CG-4449,TCGA-STAD,NA,s14485,MD Anderson - Institute for Applied Cancer Science,Indivumed,Germany,NO,T2,N1,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage II
13722.58cfa831e4b0c9d6adf6c5ae,58cfa831e4b0c9d6adf6c5ae,TCGA-CG-4455-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_5_rg.sorted.filtered.,WGS,TCGA-CG-4455-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_5_rg.sorted,TCGA-CG-4455-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_5_rg.sorted.bam,62.2,1.9,0.14,58cfa831e4b0c9d6adf6c5ae,TCGA-CG-4455-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_5_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4455-01A,8A173D98-20A1-4C84-86C1-97818E1C665A,Primary Tumor,Illumina HiSeq,97e101b8-16a4-4357-b26f-0bd6d14f9d6e,Stomach,72,4622DF2E-9B9E-4B17-ADE3-A602B50B1288,AFA14A3A-5E6B-4CBE-B660-65AA53E9D10F,TCGA-CG-4455-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4455,TCGA-STAD,NA,s14979,Harvard Medical School,Indivumed,Germany,NO,T2b,N1,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage II
13722.58cfa830e4b0c9d6adf6bc26,58cfa830e4b0c9d6adf6bc26,TCGA-A6-3810-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-3810-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-3810-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,420.6,1.9,0.16,58cfa830e4b0c9d6adf6bc26,TCGA-A6-3810-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-3810-01A,B728E6E8-A0E4-496B-904C-6F07C12E901F,Primary Tumor,Illumina HiSeq,54687a8d-c693-4ae5-8451-4f4c80adca53,Colorectal,62,F2BD44D3-A53C-4A10-9AE1-A93E762F174C,AD4275F1-789D-471C-88DD-B6E76069D856,TCGA-A6-3810-01A-01D-1167-02,HG18,TCGA-A6-3810,TCGA-COAD,NA,s13016,Harvard Medical School,Christiana Healthcare,None,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6bcda,58cfa830e4b0c9d6adf6bcda,TCGA-AG-3574-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3574-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3574-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,750.21,1.9,0.14,58cfa830e4b0c9d6adf6bcda,TCGA-AG-3574-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3574-01A,0EDA7373-8335-455F-B90A-8C3540F28088,Primary Tumor,Illumina HiSeq,44e4b931-5188-44b9-aea5-fdff70c4c058,Colorectal,89,DA897A5D-B2CC-419F-ACD7-473B4928C5D5,5DAA6B90-B302-4B0E-A44B-0A6D3159DACE,TCGA-AG-3574-01A-01D-1167-02,HG18,TCGA-AG-3574,TCGA-READ,NA,s1955,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage II
13722.58cfa830e4b0c9d6adf6bbda,58cfa830e4b0c9d6adf6bbda,TCGA-AG-4005-10A-01D-1115_101122_SN177_0123_B20APUABXX_s_4_rg.sorted.filtered.,WGS,TCGA-AG-4005-10A-01D-1115_101122_SN177_0123_B20APUABXX_s_4_rg.sorted,TCGA-AG-4005-10A-01D-1115_101122_SN177_0123_B20APUABXX_s_4_rg.sorted.bam,44.59,1.9,0.13,58cfa830e4b0c9d6adf6bbda,TCGA-AG-4005-10A-01D-1115_101122_SN177_0123_B20APUABXX_s_4_rg.sorted.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-4005-10A,866DE12B-E4DF-4F19-B62E-E3FD85D4EC08,Blood Derived Normal,Illumina HiSeq,bdef1f23-55e4-48bd-ad1b-4463e64ebaea,Colorectal,64,0A308492-A312-4FE2-9C7A-BFA189C009A4,703F6CA3-4393-4199-86EE-B3FBFE1FD121,TCGA-AG-4005-10A-01D-1115-02,HG18_Broad_variant,TCGA-AG-4005,TCGA-READ,NA,s1996,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Rectal Adenocarcinoma,Stage IV
13722.58cfa82fe4b0c9d6adf6b9a3,58cfa82fe4b0c9d6adf6b9a3,TCGA-AA-3675-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3675-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3675-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,56.66,1.9,0.15,58cfa82fe4b0c9d6adf6b9a3,TCGA-AA-3675-10A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3675-10A,41658CF8-0DE1-4A97-BB60-0F0107C84E00,Blood Derived Normal,Illumina HiSeq,a1895003-f469-49f2-a729-93d8405faf2c,Colorectal,84,9C0C79F7-1500-452C-904C-35CC9D3C4634,215719E3-587A-4CCC-8A65-B659BD0FA78A,TCGA-AA-3675-10A-01D-1109-02,HG18,TCGA-AA-3675,TCGA-COAD,NA,s13521,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa830e4b0c9d6adf6bbac,58cfa830e4b0c9d6adf6bbac,TCGA-AA-A02O-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A02O-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A02O-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,107.64,2.11,0.16,58cfa830e4b0c9d6adf6bbac,TCGA-AA-A02O-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A02O-01A,6FA41234-9077-4D05-A295-6820F3BEDF5B,Primary Tumor,Illumina HiSeq,e53db54a-bb1b-4c60-8214-aaa269abd153,Colorectal,82,2151DC9E-F76A-4CFF-8A20-B7C107D59C27,519A6BBF-68D8-4275-854A-5216FC4DFD15,TCGA-AA-A02O-01A-21D-A079-02,HG18,TCGA-AA-A02O,TCGA-COAD,NA,s12873,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c5c2,58cfa831e4b0c9d6adf6c5c2,TCGA-CG-4462-01A-01D-1154_121023_SN208_0437_BD1H3FACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CG-4462-01A-01D-1154_121023_SN208_0437_BD1H3FACXX_s_7_rg.sorted,TCGA-CG-4462-01A-01D-1154_121023_SN208_0437_BD1H3FACXX_s_7_rg.sorted.bam,57.2,1.9,0.14,58cfa831e4b0c9d6adf6c5c2,TCGA-CG-4462-01A-01D-1154_121023_SN208_0437_BD1H3FACXX_s_7_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4462-01A,E9EA3687-0DB3-47F3-8099-B4FC054397F1,Primary Tumor,Illumina HiSeq,1bcd6b3d-eeca-4c1e-bf6f-52c0a6b151ca,Stomach,72,D4F28131-D917-449B-95DC-DC6BA2EEE81B,8CB261D0-2AF0-4D1B-895C-9D7F2404DBDC,TCGA-CG-4462-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4462,TCGA-STAD,0,s15124,Harvard Medical School,Indivumed,Germany,NO,T3,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IV
13722.58cfa832e4b0c9d6adf6d598,58cfa832e4b0c9d6adf6d598,TCGA-V3-A9ZY-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_3_rg.sorted.filtered.,WGS,TCGA-V3-A9ZY-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_3_rg.sorted,TCGA-V3-A9ZY-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_3_rg.sorted.bam,20.32,NA,0.14,58cfa832e4b0c9d6adf6d598,TCGA-V3-A9ZY-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V3-A9ZY-10A,2112A42A-9B85-475A-A31B-4CE7751CDEB9,Blood Derived Normal,Illumina HiSeq,655ee601-e167-428b-aff1-3d283d935e6f,Eye,54,85AB834C-34B5-4777-8EA7-6819A13B40BC,8416FCBC-F166-42C4-A25A-DEA20F77E6E7,TCGA-V3-A9ZY-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V3-A9ZY,TCGA-UVM,NA,s186,MD Anderson - Institute for Applied Cancer Science,Cleveland Clinic Foundation,United States,NO,T3a,NX,Not available,Stage IIB
13722.58cfa830e4b0c9d6adf6bc00,58cfa830e4b0c9d6adf6bc00,TCGA-A6-3807-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-3807-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-3807-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,380,1.9,0.15,58cfa830e4b0c9d6adf6bc00,TCGA-A6-3807-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-3807-01A,5116E3B4-2BAC-40F5-8046-B9C1783FAAA5,Primary Tumor,Illumina HiSeq,d5f643a5-b69b-499a-8aab-7fc6520f2e55,Colorectal,53,1EB2A255-6EDD-4ADB-B52D-99DCEC590C5D,3A4293C1-0860-42F9-9D64-26B7298C2CDB,TCGA-A6-3807-01A-01D-1167-02,HG18,TCGA-A6-3807,TCGA-COAD,NA,s13505,Harvard Medical School,Christiana Healthcare,None,NO,T3,N2,Colon Adenocarcinoma,Stage IIIC
13722.58cfa832e4b0c9d6adf6d586,58cfa832e4b0c9d6adf6d586,TCGA-V4-A9E8-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_6_rg.sorted.filtered.,WGS,TCGA-V4-A9E8-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_6_rg.sorted,TCGA-V4-A9E8-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_6_rg.sorted.bam,31.12,NA,0.16,58cfa832e4b0c9d6adf6d586,TCGA-V4-A9E8-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9E8-01A,DF941BC1-6356-4F2E-A3F5-AE190266B441,Primary Tumor,Illumina HiSeq,20fb461e-733f-4247-b4ad-e78418cd1866,Eye,49,7C95738B-C7F2-470F-AB95-88CDABBEEF21,F5FF03D8-69DA-49EC-8BF3-8132071649AC,TCGA-V4-A9E8-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9E8,TCGA-UVM,808,s183,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa830e4b0c9d6adf6ba6e,58cfa830e4b0c9d6adf6ba6e,TCGA-AA-A01D-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A01D-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A01D-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,119.82,1.79,0.15,58cfa830e4b0c9d6adf6ba6e,TCGA-AA-A01D-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01D-01A,E2EDBF3F-25D8-49AA-B656-2A59C3B99AEB,Primary Tumor,Illumina HiSeq,dc156fb1-9b36-4d02-a6f0-54027775ed04,Colorectal,47,082DEF2F-4D99-4270-83E7-5A9A5C049C23,5BF3D0AB-D301-4EE7-84A1-83F596C29E6E,TCGA-AA-A01D-01A-01D-A077-02,HG18,TCGA-AA-A01D,TCGA-COAD,NA,s13525,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage IIIC
13722.58cfa82fe4b0c9d6adf6b7d4,58cfa82fe4b0c9d6adf6b7d4,TCGA-44-3919-01A-02D-1103_110804_SN208_0217_BC03EKABXX_s_7_rg.sorted.filtered.,WGS,TCGA-44-3919-01A-02D-1103_110804_SN208_0217_BC03EKABXX_s_7_rg.sorted,TCGA-44-3919-01A-02D-1103_110804_SN208_0217_BC03EKABXX_s_7_rg.sorted.bam,427.33,1.9,0.15,58cfa82fe4b0c9d6adf6b7d4,TCGA-44-3919-01A-02D-1103_110804_SN208_0217_BC03EKABXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-3919-01A,66ED89F6-8BA2-49D0-AF0F-4B6EBF2381BF,Primary Tumor,Illumina HiSeq,14d2cfc2-f4ac-4ab1-93d3-0e178305e26f,Lung,71,9DE8D353-3442-41D8-8BFE-A08C4975EACA,9C982400-B6C3-4D00-9981-BA06775FEF4F,TCGA-44-3919-01A-02D-1103-02,HG19_Broad_variant,TCGA-44-3919,TCGA-LUAD,NA,s10994,Harvard Medical School,Christiana Healthcare,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa832e4b0c9d6adf6ce15,58cfa832e4b0c9d6adf6ce15,TCGA-FD-A3N5-10A-01D-A21C_120830_SN590_0177_BD141PACXX_s_6_rg.sorted.filtered.,WGS,TCGA-FD-A3N5-10A-01D-A21C_120830_SN590_0177_BD141PACXX_s_6_rg.sorted,TCGA-FD-A3N5-10A-01D-A21C_120830_SN590_0177_BD141PACXX_s_6_rg.sorted.bam,27.72,NA,0.14,58cfa832e4b0c9d6adf6ce15,TCGA-FD-A3N5-10A-01D-A21C_120830_SN590_0177_BD141PACXX_s_6_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3N5-10A,A658BECF-3934-49F2-9E74-291DCA61D4BB,Blood Derived Normal,Illumina HiSeq,2ca8a15e-2f08-4dfa-9203-7f5d50080161,Bladder,69,E5E8BC12-FB3C-4404-AEE2-2B90A11384A0,A9D6A35E-2C5B-4DDC-BE14-122E21B76D7A,TCGA-FD-A3N5-10A-01D-A21C-26,HG19_Broad_variant,TCGA-FD-A3N5,TCGA-BLCA,NA,s3113,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa830e4b0c9d6adf6bb52,58cfa830e4b0c9d6adf6bb52,TCGA-AA-3685-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3685-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3685-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,110.96,1.9,0.15,58cfa830e4b0c9d6adf6bb52,TCGA-AA-3685-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3685-10A,DCA004BF-9C14-45A1-B186-AB3759F6C7FE,Blood Derived Normal,Illumina HiSeq,559d0dc8-235b-43f5-8ee5-0af39884be50,Colorectal,69,EAB2CE78-F983-46D1-BCA1-643049B73934,4AE07847-2759-47E7-B5FE-687C851365EA,TCGA-AA-3685-10A-01D-1167-02,HG18,TCGA-AA-3685,TCGA-COAD,NA,s13675,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c92d,58cfa831e4b0c9d6adf6c92d,TCGA-D9-A1X3-10A-01D-A190_120718_SN208_0415_AC116EACXX_s_5_rg.sorted.filtered.,WGS,TCGA-D9-A1X3-10A-01D-A190_120718_SN208_0415_AC116EACXX_s_5_rg.sorted,TCGA-D9-A1X3-10A-01D-A190_120718_SN208_0415_AC116EACXX_s_5_rg.sorted.bam,69.24,NA,0.18,58cfa831e4b0c9d6adf6c92d,TCGA-D9-A1X3-10A-01D-A190_120718_SN208_0415_AC116EACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D9-A1X3-10A,F0744FA2-DB4A-40DE-9FD2-F61863FD98D4,Blood Derived Normal,Illumina HiSeq,078e58c4-ac54-45b3-8a5e-9908be0db216,Skin,63,0DCEB511-4D42-4BE9-B6DA-F399F8D3C5B0,FAFD47F9-A673-4461-A8B3-B78A3EE989FE,TCGA-D9-A1X3-10A-01D-A190-02,HG19_Broad_variant,TCGA-D9-A1X3,TCGA-SKCM,NA,s7503,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T4b,N2b,Not available,Not available
13722.58cfa830e4b0c9d6adf6bf46,58cfa830e4b0c9d6adf6bf46,TCGA-BR-4188-11A-01D-1128_120805_SN1222_0143_BD172BACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BR-4188-11A-01D-1128_120805_SN1222_0143_BD172BACXX_s_5_rg.sorted,NA,NA,NA,NA,58cfa830e4b0c9d6adf6bf46,TCGA-BR-4188-11A-01D-1128_120805_SN1222_0143_BD172BACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4188-11A,151257D7-BA5B-49A0-94F5-50E28F9F46F1,Solid Tissue Normal,Illumina HiSeq,732653b3-3515-43cf-b1c1-13a96336330f,Stomach,53,0E93D83A-60E7-4F50-8943-8FF42F508009,0702091B-3A66-48BB-AC91-1F4259151191,TCGA-BR-4188-11A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4188,TCGA-STAD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
13722.58cfa82fe4b0c9d6adf6b8f8,58cfa82fe4b0c9d6adf6b8f8,TCGA-A6-2683-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-2683-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-2683-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,790.56,1.9,0.16,58cfa82fe4b0c9d6adf6b8f8,TCGA-A6-2683-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2683-10A,FAFD4576-0709-49E1-926F-AD1EE09907EC,Blood Derived Normal,Illumina HiSeq,98608f88-13ef-4b96-91d0-d6f053a8a8a3,Colorectal,57,D62CA19B-102E-4018-A957-ACFB23055369,98056E22-3F16-4920-94E1-39E334B37D18,TCGA-A6-2683-10A-01D-1167-02,HG18,TCGA-A6-2683,TCGA-COAD,NA,s13504,Harvard Medical School,Christiana Healthcare,None,NO,T4,N0,Colon Adenocarcinoma,Stage IV
13722.58cfa832e4b0c9d6adf6d0b4,58cfa832e4b0c9d6adf6d0b4,TCGA-FN-7833-10A-01D-2088_130923_SN1222_0220_BC2DUUACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FN-7833-10A-01D-2088_130923_SN1222_0220_BC2DUUACXX_s_8_rg.sorted,TCGA-FN-7833-10A-01D-2088_130923_SN1222_0220_BC2DUUACXX_s_8_rg.sorted.bam,1039,NA,0.14,58cfa832e4b0c9d6adf6d0b4,TCGA-FN-7833-10A-01D-2088_130923_SN1222_0220_BC2DUUACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FN-7833-10A,5B9D7565-A933-449D-8FFA-EC5F82DB2E77,Blood Derived Normal,Illumina HiSeq,8a4a2069-1e0c-4d49-a1eb-77f38954eed2,Brain,25,500D7019-6256-4698-BAAC-6F29E0B85AD7,A6D04659-D36D-433C-BFA9-B633C5BB206F,TCGA-FN-7833-10A-01D-2088-02,HG19_Broad_variant,TCGA-FN-7833,TCGA-LGG,NA,s8149,Harvard Medical School,International Genomics Consortium,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa830e4b0c9d6adf6bba5,58cfa830e4b0c9d6adf6bba5,TCGA-AA-A02W-01A-01D-A077_110406_SN177_0153_A818P3ABXX_s_1_rg.sorted.filtered.,WGS,TCGA-AA-A02W-01A-01D-A077_110406_SN177_0153_A818P3ABXX_s_1_rg.sorted,TCGA-AA-A02W-01A-01D-A077_110406_SN177_0153_A818P3ABXX_s_1_rg.sorted.bam,226.38,1.78,0.15,58cfa830e4b0c9d6adf6bba5,TCGA-AA-A02W-01A-01D-A077_110406_SN177_0153_A818P3ABXX_s_1_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A02W-01A,73448B56-A6C6-4C98-A153-AB704261E073,Primary Tumor,Illumina HiSeq,faf93a8d-56fb-4e28-97fa-1fcee234250c,Colorectal,73,B0F0EA02-B1DA-4613-A9B0-D18A07910010,4D2B2573-105C-4770-B8CF-9243B6D709EC,TCGA-AA-A02W-01A-01D-A077-02,HG18_Broad_variant,TCGA-AA-A02W,TCGA-COAD,NA,s13532,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d57e,58cfa832e4b0c9d6adf6d57e,TCGA-V4-A9E8-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_6_rg.sorted.filtered.,WGS,TCGA-V4-A9E8-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_6_rg.sorted,TCGA-V4-A9E8-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_6_rg.sorted.bam,16.01,NA,0.15,58cfa832e4b0c9d6adf6d57e,TCGA-V4-A9E8-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9E8-10A,DF941BC1-6356-4F2E-A3F5-AE190266B441,Blood Derived Normal,Illumina HiSeq,5c511f50-84f8-4407-829b-5ce144a548a7,Eye,49,63440933-4916-4E91-82DD-B36F5DF305DC,8C247885-DC24-4797-A985-434C7BE9458A,TCGA-V4-A9E8-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9E8,TCGA-UVM,808,s196,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa82fe4b0c9d6adf6b89a,58cfa82fe4b0c9d6adf6b89a,TCGA-A6-2683-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-2683-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-2683-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,467.29,1.9,0.16,58cfa82fe4b0c9d6adf6b89a,TCGA-A6-2683-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2683-01A,FAFD4576-0709-49E1-926F-AD1EE09907EC,Primary Tumor,Illumina HiSeq,06c41745-bee7-471d-9c51-8886c6c8dd9c,Colorectal,57,C24759F8-566B-42DA-A26D-BB0BF51EE15F,B22E3766-3FC6-4E77-86D0-0A10A810D313,TCGA-A6-2683-01A-01D-1167-02,HG18,TCGA-A6-2683,TCGA-COAD,NA,s12852,Harvard Medical School,Christiana Healthcare,None,NO,T4,N0,Colon Adenocarcinoma,Stage IV
13722.58cfa82fe4b0c9d6adf6ba20,58cfa82fe4b0c9d6adf6ba20,TCGA-AA-3664-01A-01D-1167_110111_SN208_0178_B818TTABXX_s_5.rg.sorted.filtered.,WGS,TCGA-AA-3664-01A-01D-1167_110111_SN208_0178_B818TTABXX_s_5.rg.sorted,TCGA-AA-3664-01A-01D-1167_110111_SN208_0178_B818TTABXX_s_5.rg.sorted.bam,338.96,1.9,0.16,58cfa82fe4b0c9d6adf6ba20,TCGA-AA-3664-01A-01D-1167_110111_SN208_0178_B818TTABXX_s_5.rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3664-01A,A06C09A8-0951-49F4-A765-5147BBCAE109,Primary Tumor,Illumina HiSeq,9caec406-c1d9-43df-a730-7226fd5880b0,Colorectal,74,D448668C-90F3-40FA-9961-88407090DA31,4B4C0EDF-1012-4A6A-B01E-CDEB130FF2E6,TCGA-AA-3664-01A-01D-1167-02,HG18_Broad_variant,TCGA-AA-3664,TCGA-COAD,NA,s13024,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa832e4b0c9d6adf6d400,58cfa832e4b0c9d6adf6d400,TCGA-V4-A9EK-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_8_rg.sorted.filtered.,WGS,TCGA-V4-A9EK-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_8_rg.sorted,TCGA-V4-A9EK-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_8_rg.sorted.bam,48.23,NA,0.16,58cfa832e4b0c9d6adf6d400,TCGA-V4-A9EK-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EK-01A,4464418C-EC35-4826-B3D5-152AC2A27A04,Primary Tumor,Illumina HiSeq,9f84d9e1-572c-43b9-8fa8-695decf3b44e,Eye,37,9F324851-EAAE-41B8-BB0E-5D5CEB9E5B23,01AA5AFA-5877-45CA-98DB-9547B99B30C5,TCGA-V4-A9EK-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9EK,TCGA-UVM,NA,s234,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3a,N0,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6c5ab,58cfa831e4b0c9d6adf6c5ab,TCGA-CG-4462-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_7_rg.sorted.filtered.,WGS,TCGA-CG-4462-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_7_rg.sorted,TCGA-CG-4462-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_7_rg.sorted.bam,57.2,1.9,0.14,58cfa831e4b0c9d6adf6c5ab,TCGA-CG-4462-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_7_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4462-01A,E9EA3687-0DB3-47F3-8099-B4FC054397F1,Primary Tumor,Illumina HiSeq,bd5f9f37-7032-427b-a031-8789066620ac,Stomach,72,D4F28131-D917-449B-95DC-DC6BA2EEE81B,8CB261D0-2AF0-4D1B-895C-9D7F2404DBDC,TCGA-CG-4462-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4462,TCGA-STAD,0,s14700,Harvard Medical School,Indivumed,Germany,NO,T3,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IV
13722.58cfa832e4b0c9d6adf6ce2a,58cfa832e4b0c9d6adf6ce2a,TCGA-FN-7833-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FN-7833-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_4_rg.sorted,TCGA-FN-7833-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_4_rg.sorted.bam,141.7,NA,0.14,58cfa832e4b0c9d6adf6ce2a,TCGA-FN-7833-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FN-7833-01A,5B9D7565-A933-449D-8FFA-EC5F82DB2E77,Primary Tumor,Illumina HiSeq,91f0d100-c921-4319-9d82-98819189b525,Brain,25,CF2E4A0A-59C5-41DA-9F24-DE83EEB856E5,1C69F8E8-7D70-4BD1-8B42-7E93DC23DA7B,TCGA-FN-7833-01A-11D-2088-02,HG19_Broad_variant,TCGA-FN-7833,TCGA-LGG,NA,s8366,Harvard Medical School,International Genomics Consortium,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa82fe4b0c9d6adf6ba35,58cfa82fe4b0c9d6adf6ba35,TCGA-A6-3810-11A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-3810-11A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-3810-11A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,469.86,1.9,0.15,58cfa82fe4b0c9d6adf6ba35,TCGA-A6-3810-11A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-3810-11A,B728E6E8-A0E4-496B-904C-6F07C12E901F,Solid Tissue Normal,Illumina HiSeq,f725df5d-8fb1-4c7b-b4c6-828a349265d2,Colorectal,62,A692CCDA-F941-46A5-9AC4-28E300686929,F933A74E-5E70-45F7-95A1-CFC3039EE936,TCGA-A6-3810-11A-01D-1167-02,HG18,TCGA-A6-3810,TCGA-COAD,NA,s13653,Harvard Medical School,Christiana Healthcare,None,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82fe4b0c9d6adf6b71c,58cfa82fe4b0c9d6adf6b71c,TCGA-64-5779-10A-01D-1623_110824_SN208_0222_BB0164ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-64-5779-10A-01D-1623_110824_SN208_0222_BB0164ACXX_s_6_rg.sorted,TCGA-64-5779-10A-01D-1623_110824_SN208_0222_BB0164ACXX_s_6_rg.sorted.bam,134.4,1.9,0.14,58cfa82fe4b0c9d6adf6b71c,TCGA-64-5779-10A-01D-1623_110824_SN208_0222_BB0164ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-64-5779-10A,1C58D9B8-17A2-4FC6-9898-FE6F47BD2C2A,Blood Derived Normal,Illumina HiSeq,c02b55b5-b815-4d90-9374-32d338c3a9c3,Lung,61,EF7E3BD2-56CE-478D-BBF8-3A9BFA941F40,8D610E60-A626-458E-B768-D3058F421662,TCGA-64-5779-10A-01D-1623-02,HG19_Broad_variant,TCGA-64-5779,TCGA-LUAD,NA,s11358,Harvard Medical School,Fox Chase,United States,NO,T2,N2,Lung Acinar Adenocarcinoma,Stage IIIA
13722.58cfa830e4b0c9d6adf6bb6e,58cfa830e4b0c9d6adf6bb6e,TCGA-AA-A02O-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A02O-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A02O-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,47.17,1.97,0.13,58cfa830e4b0c9d6adf6bb6e,TCGA-AA-A02O-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A02O-11A,6FA41234-9077-4D05-A295-6820F3BEDF5B,Solid Tissue Normal,Illumina HiSeq,8fc33742-2fc4-4f40-8319-f7aa7d19f507,Colorectal,82,DD519F88-2D62-425B-9553-8BB374CD054B,7C1C19E2-1B4A-4D59-88CA-E111AA111165,TCGA-AA-A02O-11A-11D-A079-02,HG18,TCGA-AA-A02O,TCGA-COAD,NA,s13841,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa830e4b0c9d6adf6ba50,58cfa830e4b0c9d6adf6ba50,TCGA-AA-A02K-01A-21D-A079_110401_SN177_0152_A819RJABXX_s_2.rg.sorted.filtered.,WGS,TCGA-AA-A02K-01A-21D-A079_110401_SN177_0152_A819RJABXX_s_2.rg.sorted,TCGA-AA-A02K-01A-21D-A079_110401_SN177_0152_A819RJABXX_s_2.rg.sorted.bam,28.83,1.9,0.15,58cfa830e4b0c9d6adf6ba50,TCGA-AA-A02K-01A-21D-A079_110401_SN177_0152_A819RJABXX_s_2.rg.sorted.bam,Dead,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A02K-01A,10881458-55B2-41D1-8358-4EE6CCB8EC85,Primary Tumor,Illumina HiSeq,7942eab9-d80a-496e-b3cb-50b42bd23334,Colorectal,50,685DF015-1B7B-4993-BF05-E3206619DFBA,7CC17F3D-27F5-484A-8E22-C9D0B5B27836,TCGA-AA-A02K-01A-21D-A079-02,HG18_Broad_variant,TCGA-AA-A02K,TCGA-COAD,426,s13842,Harvard Medical School,Indivumed,Germany,NO,T4,N2,Colon Adenocarcinoma,Stage IV
13722.58cfa830e4b0c9d6adf6bb70,58cfa830e4b0c9d6adf6bb70,TCGA-AA-3956-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3956-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3956-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,75.56,1.8,0.15,58cfa830e4b0c9d6adf6bb70,TCGA-AA-3956-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3956-10A,7B47489F-C3CC-4388-B5D7-C7C02790A5F6,Blood Derived Normal,Illumina HiSeq,10d20517-4670-47bf-b211-1c3989c3a7e0,Colorectal,65,5C8C7A7D-1677-43B6-9526-52EF9B17D11A,2182EAC8-282F-460D-821B-EAB404F6B01A,TCGA-AA-3956-10A-01D-1167-02,HG18,TCGA-AA-3956,TCGA-COAD,NA,s13676,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82fe4b0c9d6adf6b960,58cfa82fe4b0c9d6adf6b960,TCGA-AA-3558-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3558-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3558-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,969.56,1.9,0.14,58cfa82fe4b0c9d6adf6b960,TCGA-AA-3558-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3558-01A,A56D528B-238A-4556-92C8-7645304A2DA0,Primary Tumor,Illumina HiSeq,803b71f6-51cd-4b3d-86d6-0f321432fe8f,Colorectal,70,B0ACDAFA-A75C-48B9-812D-3FB449157F8B,B1AEDAAD-A964-4D7E-A641-F05AC4F174F2,TCGA-AA-3558-01A-01D-1167-02,HG18,TCGA-AA-3558,TCGA-COAD,NA,s13511,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa830e4b0c9d6adf6ba68,58cfa830e4b0c9d6adf6ba68,TCGA-AA-A02W-10A-01D-A078_110406_SN177_0153_A818P3ABXX_s_2_rg.sorted.filtered.,WGS,TCGA-AA-A02W-10A-01D-A078_110406_SN177_0153_A818P3ABXX_s_2_rg.sorted,TCGA-AA-A02W-10A-01D-A078_110406_SN177_0153_A818P3ABXX_s_2_rg.sorted.bam,15.84,1.72,0.13,58cfa830e4b0c9d6adf6ba68,TCGA-AA-A02W-10A-01D-A078_110406_SN177_0153_A818P3ABXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A02W-10A,73448B56-A6C6-4C98-A153-AB704261E073,Blood Derived Normal,Illumina HiSeq,d8ea3ea4-455e-45dd-829f-b2ba608c4a27,Colorectal,73,0ABE6B1F-88DA-4739-9F30-02D4C28159FD,98C33AB6-987A-4DDA-A0FA-BB6CD04D2B9E,TCGA-AA-A02W-10A-01D-A078-02,HG18_Broad_variant,TCGA-AA-A02W,TCGA-COAD,NA,s12879,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa82fe4b0c9d6adf6b96b,58cfa82fe4b0c9d6adf6b96b,TCGA-AA-3558-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3558-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3558-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,42.56,1.9,0.14,58cfa82fe4b0c9d6adf6b96b,TCGA-AA-3558-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3558-10A,A56D528B-238A-4556-92C8-7645304A2DA0,Blood Derived Normal,Illumina HiSeq,42785715-e63b-4e12-a1e2-9623cb000df0,Colorectal,70,AAA77FAE-A493-42B5-B03D-6488422FA0FA,6A7C5A1E-2A2A-49A9-A113-3DDEEFD16456,TCGA-AA-3558-10A-01D-1167-02,HG18,TCGA-AA-3558,TCGA-COAD,NA,s13178,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bc3c,58cfa830e4b0c9d6adf6bc3c,TCGA-AG-A01Y-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-A01Y-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-A01Y-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,78.77,2.06,0.14,58cfa830e4b0c9d6adf6bc3c,TCGA-AG-A01Y-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A01Y-11A,A91F7A8C-E0FE-403A-9EF0-F7679B2761CC,Solid Tissue Normal,Illumina HiSeq,10fb3294-ad7e-403d-a856-0932f5e15052,Colorectal,49,9E602612-9215-46E5-8058-6FA8FCE6B739,B70F17F6-457E-4FF0-8E50-2A1573BC5EB9,TCGA-AG-A01Y-11A-11D-A079-02,HG18,TCGA-AG-A01Y,TCGA-READ,NA,s2008,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage II
13722.58cfa82fe4b0c9d6adf6b898,58cfa82fe4b0c9d6adf6b898,TCGA-A6-2676-01A-01D-1167-02_101203_SN177_0125_B802RYABXX_s_1.rg.sorted.filtered.,WGS,TCGA-A6-2676-01A-01D-1167-02_101203_SN177_0125_B802RYABXX_s_1.rg.sorted,TCGA-A6-2676-01A-01D-1167-02_101203_SN177_0125_B802RYABXX_s_1.rg.sorted.bam,296.29,1.9,0.17,58cfa82fe4b0c9d6adf6b898,TCGA-A6-2676-01A-01D-1167-02_101203_SN177_0125_B802RYABXX_s_1.rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2676-01A,89A6384E-1CEA-440B-9F17-D57CB0805174,Primary Tumor,Illumina HiSeq,c175a01b-eba5-4c4d-b786-fc9f54a2fa60,Colorectal,75,CBBD1187-E8F7-4E63-A8E2-3C19863E89F5,D02407DB-AECE-475A-AA3F-00653B1E7BEE,TCGA-A6-2676-01A-01D-1167-02,HG18_Broad_variant,TCGA-A6-2676,TCGA-COAD,NA,s13022,Harvard Medical School,Christiana Healthcare,None,NO,T4,N0,Colon Adenocarcinoma,Stage IIB
13722.58cfa82fe4b0c9d6adf6b9ec,58cfa82fe4b0c9d6adf6b9ec,TCGA-A5-A0G9-10A-01D-A043_120318_SN590_0146_AC0KH7ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-A5-A0G9-10A-01D-A043_120318_SN590_0146_AC0KH7ACXX_s_4_rg.sorted,TCGA-A5-A0G9-10A-01D-A043_120318_SN590_0146_AC0KH7ACXX_s_4_rg.sorted.bam,15.75,1.83,0.15,58cfa82fe4b0c9d6adf6b9ec,TCGA-A5-A0G9-10A-01D-A043_120318_SN590_0146_AC0KH7ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0G9-10A,45D58088-D3F4-4EB0-B75C-BCB98C0981DC,Blood Derived Normal,Illumina HiSeq,f3c31c9e-b618-476e-a3aa-2ca4fc7347b1,Uterus,79,824F35BF-457F-4E24-90FB-4F2934263C69,07E576F1-2D19-4850-A0F1-52CE65696BD7,TCGA-A5-A0G9-10A-01D-A043-02,HG19_Broad_variant,TCGA-A5-A0G9,TCGA-UCEC,NA,s4417,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cda9,58cfa831e4b0c9d6adf6cda9,TCGA-FG-7636-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FG-7636-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_3_rg.sorted,TCGA-FG-7636-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_3_rg.sorted.bam,103.7,NA,0.15,58cfa831e4b0c9d6adf6cda9,TCGA-FG-7636-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-7636-01A,B342E980-8383-4F1B-BF57-4098C37A536C,Primary Tumor,Illumina HiSeq,336bd48f-3c20-4a2f-a2ef-38bb94e30e11,Brain,48,BF70C0A6-CA2D-4355-B5BA-738094382E28,CE49A704-BECD-4A35-978B-4E21572CC5B2,TCGA-FG-7636-01A-11D-2088-02,HG19_Broad_variant,TCGA-FG-7636,TCGA-LGG,NA,s8573,Harvard Medical School,Case Western,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa830e4b0c9d6adf6bc3a,58cfa830e4b0c9d6adf6bc3a,TCGA-AA-3968-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3968-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3968-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,259.56,1.9,0.15,58cfa830e4b0c9d6adf6bc3a,TCGA-AA-3968-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3968-10A,CAB7BDBC-0A11-4901-97C3-26B884F79CB5,Blood Derived Normal,Illumina HiSeq,0cd10640-5672-427b-b9a7-d5acdef28f73,Colorectal,55,08FA1A76-022E-49E6-B416-314F7A02E2A4,10BF212B-35D2-453A-87C1-9A7D315DF220,TCGA-AA-3968-10A-01D-1167-02,HG18,TCGA-AA-3968,TCGA-COAD,NA,s13374,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa830e4b0c9d6adf6c170,58cfa830e4b0c9d6adf6c170,TCGA-BS-A0TG-01A-32D-A101_120407_SN590_0152_AC0C7LACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BS-A0TG-01A-32D-A101_120407_SN590_0152_AC0C7LACXX_s_4_rg.sorted,TCGA-BS-A0TG-01A-32D-A101_120407_SN590_0152_AC0C7LACXX_s_4_rg.sorted.bam,31.82,1.93,0.16,58cfa830e4b0c9d6adf6c170,TCGA-BS-A0TG-01A-32D-A101_120407_SN590_0152_AC0C7LACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TG-01A,13F31BCB-BEFD-4ED2-ADC0-DC9E9CE52B75,Primary Tumor,Illumina HiSeq,bbb0de46-a395-47cf-938b-3a6a6c59b9ec,Uterus,60,36E44603-A1EE-4A5B-9506-49A9358BF8D0,FABEC5F4-2EF2-41CB-A728-E21D6C49F3F7,TCGA-BS-A0TG-01A-32D-A101-02,HG19_Broad_variant,TCGA-BS-A0TG,TCGA-UCEC,NA,s4795,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b914,58cfa82fe4b0c9d6adf6b914,TCGA-49-4505-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-49-4505-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-49-4505-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,129.53,1.9,0.14,58cfa82fe4b0c9d6adf6b914,TCGA-49-4505-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4505-01A,088EDF89-D2B5-40C7-B066-DF3BD383F7EA,Primary Tumor,Illumina HiSeq,af550be6-0986-458b-8206-9c7cf928c215,Lung,61,D1FB0862-8D9C-4BC4-AAC6-81DC4EED66C9,30B77A0C-3439-44E2-A586-5DF68C0D0002,TCGA-49-4505-01A-01D-1203-02,GRCh37,TCGA-49-4505,TCGA-LUAD,428,s11125,Harvard Medical School,Johns Hopkins,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa830e4b0c9d6adf6bde4,58cfa830e4b0c9d6adf6bde4,TCGA-AG-A032-10A-01D-A078-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-A032-10A-01D-A078-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-A032-10A-01D-A078-02_IlluminaHiSeq-DNASeq_whole.bam,17.49,1.84,0.15,58cfa830e4b0c9d6adf6bde4,TCGA-AG-A032-10A-01D-A078-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A032-10A,0BB786EE-07CF-4853-9B49-EC95CD14E282,Blood Derived Normal,Illumina HiSeq,8eaed029-ac09-41bb-bb2c-3ac4e7f86390,Colorectal,68,02E756EF-31BD-4E2F-AC81-2476368DBD96,549B9DFE-21E5-4A0B-BEE5-F8C71ADEACA2,TCGA-AG-A032-10A-01D-A078-02,HG18,TCGA-AG-A032,TCGA-READ,NA,s2177,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIB
13722.58cfa82fe4b0c9d6adf6b98e,58cfa82fe4b0c9d6adf6b98e,TCGA-50-5944-01A-11D-1751_111221_SN1120_0106_BD0M7HACXX_s_1_rg.sorted.filtered.,WGS,TCGA-50-5944-01A-11D-1751_111221_SN1120_0106_BD0M7HACXX_s_1_rg.sorted,TCGA-50-5944-01A-11D-1751_111221_SN1120_0106_BD0M7HACXX_s_1_rg.sorted.bam,115.4,1.9,0.14,58cfa82fe4b0c9d6adf6b98e,TCGA-50-5944-01A-11D-1751_111221_SN1120_0106_BD0M7HACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-50-5944-01A,1C339545-C08A-4A77-B8E9-A7E49E53853F,Primary Tumor,Illumina HiSeq,c76f3861-5117-4ed7-9ca6-eecc10e949f3,Lung,69,BF8FDF82-62B4-4B5D-93E7-CE153576FE49,71CD46A8-30B0-4452-860D-3ED173C461A7,TCGA-50-5944-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-5944,TCGA-LUAD,NA,s11348,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N0,Lung Acinar Adenocarcinoma,Stage IA
13722.58cfa82fe4b0c9d6adf6b7b0,58cfa82fe4b0c9d6adf6b7b0,TCGA-49-4494-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-49-4494-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-49-4494-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,245.2,1.9,0.16,58cfa82fe4b0c9d6adf6b7b0,TCGA-49-4494-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4494-01A,C6D78E27-E510-4F57-ABAE-19EFA6105A8D,Primary Tumor,Illumina HiSeq,3cb48d09-95ac-452f-9c92-19d7f966aec0,Lung,77,7CA68089-C61F-4D31-8CC8-FB11AE70910A,8DF0AEB4-1455-4760-A230-54FE1551D08C,TCGA-49-4494-01A-01D-1203-02,GRCh37,TCGA-49-4494,TCGA-LUAD,1081,s10783,Harvard Medical School,Johns Hopkins,United States,NO,T3,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6cd20,58cfa831e4b0c9d6adf6cd20,TCGA-EE-A2MQ-06A-11D-A18Y_120718_SN1222_0126_AC117AACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EE-A2MQ-06A-11D-A18Y_120718_SN1222_0126_AC117AACXX_s_4_rg.sorted,TCGA-EE-A2MQ-06A-11D-A18Y_120718_SN1222_0126_AC117AACXX_s_4_rg.sorted.bam,46.6,NA,0.15,58cfa831e4b0c9d6adf6cd20,TCGA-EE-A2MQ-06A-11D-A18Y_120718_SN1222_0126_AC117AACXX_s_4_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MQ-06A,C127FFB6-2CCF-4E90-B811-0AA40EBFAB17,Metastatic,Illumina HiSeq,55e99af5-5846-42c7-a272-5ff5cf525357,Skin,70,478A0B67-A1CF-456A-8D5F-12A1BF907AFB,80DE212A-5675-41C7-A79E-44E95D0B3C61,TCGA-EE-A2MQ-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2MQ,TCGA-SKCM,1315,s8011,Harvard Medical School,University of Sydney,Australia,NO,T3a,N2a,Not available,Stage IIIA
13722.58cfa82fe4b0c9d6adf6b72e,58cfa82fe4b0c9d6adf6b72e,TCGA-50-5045-10A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_2_rg.sorted.filtered.,WGS,TCGA-50-5045-10A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_2_rg.sorted,TCGA-50-5045-10A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_2_rg.sorted.bam,120.4,1.9,0.14,58cfa82fe4b0c9d6adf6b72e,TCGA-50-5045-10A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_2_rg.sorted.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5045-10A,9EE20C0D-A1C3-47F3-ABDA-131B3F190F52,Blood Derived Normal,Illumina HiSeq,425edc83-a2c5-4ada-be24-0e87cc319fbe,Lung,57,33B96FAD-DAF0-4E90-834C-4BBE9F2FD129,0C850234-0109-4AB4-B0B5-7E7E976BAFFC,TCGA-50-5045-10A-01D-1623-02,HG19_Broad_variant,TCGA-50-5045,TCGA-LUAD,2174,s11123,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82fe4b0c9d6adf6b70c,58cfa82fe4b0c9d6adf6b70c,TCGA-73-4670-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-73-4670-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-73-4670-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,149.9,1.9,0.13,58cfa82fe4b0c9d6adf6b70c,TCGA-73-4670-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4670-11A,1B354837-4925-4480-AC32-6B44D0957314,Solid Tissue Normal,Illumina HiSeq,fb70791d-abaa-4c78-8e45-77605f89d966,Lung,69,D46B3B2F-00FD-4F1F-97A5-BDBE14F5F119,6353F7CF-C3E0-4059-8C7E-92A313474444,TCGA-73-4670-11A-01D-1203-02,GRCh37,TCGA-73-4670,TCGA-LUAD,NA,s11556,Harvard Medical School,Roswell Park,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IV
13722.58cfa82fe4b0c9d6adf6b694,58cfa82fe4b0c9d6adf6b694,TCGA-49-4486-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-49-4486-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-49-4486-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,176.53,1.9,0.16,58cfa82fe4b0c9d6adf6b694,TCGA-49-4486-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4486-11A,61C655EC-52B5-453F-A6CC-B2ABA445B027,Solid Tissue Normal,Illumina HiSeq,20f65a1e-78a9-454e-a05c-5c944d95f215,Lung,72,5AF4A67E-13EF-41DD-945C-18669C7D2701,C0F67DA7-7FC7-4C97-9D1D-EA984206252B,TCGA-49-4486-11A-01D-1203-02,GRCh37,TCGA-49-4486,TCGA-LUAD,2318,s10654,Harvard Medical School,Johns Hopkins,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa830e4b0c9d6adf6bb40,58cfa830e4b0c9d6adf6bb40,TCGA-AA-A02R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A02R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A02R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,146.73,1.77,0.15,58cfa830e4b0c9d6adf6bb40,TCGA-AA-A02R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A02R-01A,764C97C9-01D3-45CB-86BD-F8A52B5468DA,Primary Tumor,Illumina HiSeq,5affe933-9b26-4971-81d9-e380618fbfa0,Colorectal,84,197245F6-A310-4AF4-9231-0AFEFC547ECD,A803F2CD-F90D-4E51-8D90-1E6AF6897413,TCGA-AA-A02R-01A-01D-A077-02,HG18,TCGA-AA-A02R,TCGA-COAD,670,s13204,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82fe4b0c9d6adf6b7da,58cfa82fe4b0c9d6adf6b7da,TCGA-44-3918-11A-01D-1103_110712_SN590_0096_A80WMCABXX_s_8_rg.sorted.filtered.,WGS,TCGA-44-3918-11A-01D-1103_110712_SN590_0096_A80WMCABXX_s_8_rg.sorted,TCGA-44-3918-11A-01D-1103_110712_SN590_0096_A80WMCABXX_s_8_rg.sorted.bam,480.93,1.9,0.17,58cfa82fe4b0c9d6adf6b7da,TCGA-44-3918-11A-01D-1103_110712_SN590_0096_A80WMCABXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-3918-11A,6E3B6B72-142D-4B8D-A462-28A205796E41,Solid Tissue Normal,Illumina HiSeq,297c5d46-e808-423b-9a00-4da7e03a6cc5,Lung,60,E1A3BB46-6508-4DC0-9A81-361C8E1B5A66,46149026-2FAD-4FCD-A4E5-B02224FED763,TCGA-44-3918-11A-01D-1103-02,HG19_Broad_variant,TCGA-44-3918,TCGA-LUAD,NA,s10989,Harvard Medical School,Christiana Healthcare,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa830e4b0c9d6adf6ba83,58cfa830e4b0c9d6adf6ba83,TCGA-AA-3509-11A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3509-11A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3509-11A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,106.02,1.9,0.14,58cfa830e4b0c9d6adf6ba83,TCGA-AA-3509-11A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3509-11A,80E677B1-5EBE-4069-A1A5-1538FFEE6642,Solid Tissue Normal,Illumina HiSeq,4b1f49df-c379-4fdf-8cca-aa65f0a35643,Colorectal,54,2B81FC5F-9198-4D3A-A969-30AFFFF7CF87,E6370F83-5CBA-409A-8EF1-4A5AC69D95BF,TCGA-AA-3509-11A-01D-1405-02,HG18,TCGA-AA-3509,TCGA-COAD,NA,s13661,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa832e4b0c9d6adf6d44c,58cfa832e4b0c9d6adf6d44c,TCGA-VD-A8KB-10C-01D-A40E_140716_SN208_0518_AC59RNACXX_s_8_rg.sorted.filtered.,WGS,TCGA-VD-A8KB-10C-01D-A40E_140716_SN208_0518_AC59RNACXX_s_8_rg.sorted,TCGA-VD-A8KB-10C-01D-A40E_140716_SN208_0518_AC59RNACXX_s_8_rg.sorted.bam,8.76,NA,0.14,58cfa832e4b0c9d6adf6d44c,TCGA-VD-A8KB-10C-01D-A40E_140716_SN208_0518_AC59RNACXX_s_8_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KB-10C,31771082-C094-4749-A9C7-80B67762F4D1,Blood Derived Normal,Illumina HiSeq,e1d788da-5660-4655-9711-9791583e80c7,Eye,66,992D0E43-D833-4A7E-834D-BD8FF0C486A9,0311A38D-86C7-446E-9342-1E3FE02B04B7,TCGA-VD-A8KB-10C-01D-A40E-26,HG19_Broad_variant,TCGA-VD-A8KB,TCGA-UVM,NA,s247,MD Anderson - RPPA Core Facility (Proteomics),University of Liverpool,United Kingdom,NO,T3a,NX,Not available,Stage IIB
13722.58cfa82fe4b0c9d6adf6b9d8,58cfa82fe4b0c9d6adf6b9d8,TCGA-AA-3947-01A-01D-1167-02_101023_SN208_0167_B80L4DABXX_s_1.rg.sorted.filtered.,WGS,TCGA-AA-3947-01A-01D-1167-02_101023_SN208_0167_B80L4DABXX_s_1.rg.sorted,TCGA-AA-3947-01A-01D-1167-02_101023_SN208_0167_B80L4DABXX_s_1.rg.sorted.bam,880.86,1.9,0.14,58cfa82fe4b0c9d6adf6b9d8,TCGA-AA-3947-01A-01D-1167-02_101023_SN208_0167_B80L4DABXX_s_1.rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3947-01A,654C6F5C-3E5C-49F0-B53F-87CD9797D7C9,Primary Tumor,Illumina HiSeq,2d1ad0b4-c460-4a5b-ae6d-2926bfe40052,Colorectal,60,5241539D-65AC-434D-8EAA-AE57F702C8CE,EE2FCBCE-108F-46EC-8C7A-12D34142820A,TCGA-AA-3947-01A-01D-1167-02,HG18_Broad_variant,TCGA-AA-3947,TCGA-COAD,NA,s13679,Harvard Medical School,Indivumed,Germany,NO,T4,N0,Colon Mucinous Adenocarcinoma,Stage IIB
13722.58cfa830e4b0c9d6adf6c1fe,58cfa830e4b0c9d6adf6c1fe,TCGA-AF-2689-10A-01D-1167_101023_SN208_0167_B80L4DABXX_s_4_rg.sorted.filtered.,WGS,TCGA-AF-2689-10A-01D-1167_101023_SN208_0167_B80L4DABXX_s_4_rg.sorted,TCGA-AF-2689-10A-01D-1167_101023_SN208_0167_B80L4DABXX_s_4_rg.sorted.bam,3.21,1.9,0.14,58cfa830e4b0c9d6adf6c1fe,TCGA-AF-2689-10A-01D-1167_101023_SN208_0167_B80L4DABXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-AF-2689-10A,335D0351-3740-4847-9FF4-BE2F078C70F7,Blood Derived Normal,Illumina HiSeq,86649ab3-345e-430f-9b1e-e734f487554a,Colorectal,41,DC4852E8-3E77-4D45-8E7E-F9B6EFFF01E4,6EFA7CE1-E770-4DD6-9E61-E52E87134298,TCGA-AF-2689-10A-01D-1167-02,HG18_Broad_variant,TCGA-AF-2689,TCGA-READ,NA,s1960,Harvard Medical School,Christiana Healthcare,None,NO,T3,N2,Rectal Adenocarcinoma,Stage IV
13722.58cfa830e4b0c9d6adf6c172,58cfa830e4b0c9d6adf6c172,TCGA-BS-A0U7-01A-21D-A101_120407_SN590_0152_AC0C7LACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BS-A0U7-01A-21D-A101_120407_SN590_0152_AC0C7LACXX_s_7_rg.sorted,TCGA-BS-A0U7-01A-21D-A101_120407_SN590_0152_AC0C7LACXX_s_7_rg.sorted.bam,86.95,1.93,0.17,58cfa830e4b0c9d6adf6c172,TCGA-BS-A0U7-01A-21D-A101_120407_SN590_0152_AC0C7LACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0U7-01A,282DDC43-922D-4F1F-80C7-6BA2DE23B7BC,Primary Tumor,Illumina HiSeq,1d76b3a6-ff5e-4092-b273-cc2380e0810c,Uterus,63,803C6D51-0EBA-475A-9C3C-7B3401787907,652088F1-AB84-40C7-8B24-FD92A32DFA44,TCGA-BS-A0U7-01A-21D-A101-02,HG19_Broad_variant,TCGA-BS-A0U7,TCGA-UCEC,935,s4436,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c3ae,58cfa831e4b0c9d6adf6c3ae,TCGA-B6-A0X4-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_8_rg.sorted.filtered.,WGS,TCGA-B6-A0X4-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_8_rg.sorted,TCGA-B6-A0X4-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_8_rg.sorted.bam,56.99,1.97,0.14,58cfa831e4b0c9d6adf6c3ae,TCGA-B6-A0X4-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0X4-10A,4E42FDC5-2A8B-49E9-87EF-6DB7A6692D08,Blood Derived Normal,Illumina HiSeq,b1fb31e5-69fe-4970-b9ab-98311778aa34,Breast,62,C437468C-9912-4AFB-99E6-1C9C7B566857,AB0347C3-AE35-4484-88A5-E545B27F5691,TCGA-B6-A0X4-10A-01D-A106-02,HG19_Broad_variant,TCGA-B6-A0X4,TCGA-BRCA,860,s6123,Harvard Medical School,Duke,United States,NO,T2,N1b,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa832e4b0c9d6adf6d200,58cfa832e4b0c9d6adf6d200,TCGA-FS-A1Z0-06A-11D-A18Y_120718_SN1222_0127_BD147HACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FS-A1Z0-06A-11D-A18Y_120718_SN1222_0127_BD147HACXX_s_1_rg.sorted,TCGA-FS-A1Z0-06A-11D-A18Y_120718_SN1222_0127_BD147HACXX_s_1_rg.sorted.bam,52.88,NA,0.16,58cfa832e4b0c9d6adf6d200,TCGA-FS-A1Z0-06A-11D-A18Y_120718_SN1222_0127_BD147HACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1Z0-06A,6A1966C3-7F01-4304-B4A1-C4EF683B179A,Metastatic,Illumina HiSeq,8f3ae468-0d68-4a91-ba8d-55ed86034e27,Skin,32,5B0F64D4-6052-4465-8AD9-058556EC9AA3,960ADBFE-F551-4DC6-95BA-5C1CE5D253AB,TCGA-FS-A1Z0-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1Z0,TCGA-SKCM,6164,s7866,Harvard Medical School,Essen,Germany,NO,T1a,N0,Not available,Stage IA
13722.58cfa82fe4b0c9d6adf6b8d5,58cfa82fe4b0c9d6adf6b8d5,TCGA-A6-2682-10A-01D-1405_110503_SN177_0159_AB02MCABXX_s_8_rg.sorted.filtered.,WGS,TCGA-A6-2682-10A-01D-1405_110503_SN177_0159_AB02MCABXX_s_8_rg.sorted,TCGA-A6-2682-10A-01D-1405_110503_SN177_0159_AB02MCABXX_s_8_rg.sorted.bam,611,1.9,0.15,58cfa82fe4b0c9d6adf6b8d5,TCGA-A6-2682-10A-01D-1405_110503_SN177_0159_AB02MCABXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2682-10A,77A44132-AF22-4115-9FA2-78F2F74BF687,Blood Derived Normal,Illumina HiSeq,d4197dea-75a2-40e6-9698-efb40827723a,Colorectal,70,CA3662D9-88B8-4E80-8C54-9DC7DF374DE5,0CBA805A-F14E-42A5-B4C7-AA7EE434EED8,TCGA-A6-2682-10A-01D-1405-02,HG18_Broad_variant,TCGA-A6-2682,TCGA-COAD,424,s13020,Harvard Medical School,Christiana Healthcare,United States,NO,T4b,N1,Colon Adenocarcinoma,Stage IV
13722.58cfa830e4b0c9d6adf6bffa,58cfa830e4b0c9d6adf6bffa,TCGA-AG-3878-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3878-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3878-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,360.61,1.9,0.15,58cfa830e4b0c9d6adf6bffa,TCGA-AG-3878-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3878-01A,FDEEFF8E-1328-42A4-ACA0-A03B97421F1E,Primary Tumor,Illumina HiSeq,df3192f9-1041-4ef9-80aa-2f3e263fa968,Colorectal,64,D2F28259-87A7-4BD8-84BC-832E551C1ACE,8F233F73-550A-4708-9C2C-BEA9347969F7,TCGA-AG-3878-01A-02D-1167-02,HG18,TCGA-AG-3878,TCGA-READ,NA,s2127,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d206,58cfa832e4b0c9d6adf6d206,TCGA-G2-A2EF-10A-01D-A18D_120912_SN1222_0148_AC188PACXX_s_8_rg.sorted.filtered.,WGS,TCGA-G2-A2EF-10A-01D-A18D_120912_SN1222_0148_AC188PACXX_s_8_rg.sorted,TCGA-G2-A2EF-10A-01D-A18D_120912_SN1222_0148_AC188PACXX_s_8_rg.sorted.bam,21.13,NA,0.15,58cfa832e4b0c9d6adf6d206,TCGA-G2-A2EF-10A-01D-A18D_120912_SN1222_0148_AC188PACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-G2-A2EF-10A,2A142731-119C-495D-AD30-EB0B48BACB46,Blood Derived Normal,Illumina HiSeq,a641053d-d0ab-4204-a4c7-6fff5ed2ef4e,Bladder,50,7A1B6C6D-2E87-4DD7-B1EC-7871F8D24611,E7B17777-D064-43A5-9AFA-14891917BAC7,TCGA-G2-A2EF-10A-01D-A18D-02,HG19_Broad_variant,TCGA-G2-A2EF,TCGA-BLCA,NA,s3121,Harvard Medical School,MD Anderson,United States,NO,Not available,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa830e4b0c9d6adf6bcc8,58cfa830e4b0c9d6adf6bcc8,TCGA-AG-3582-01A-01D-1167_101105_SN208_0168_A80A3BABXX_s_1_rg.sorted.filtered.,WGS,TCGA-AG-3582-01A-01D-1167_101105_SN208_0168_A80A3BABXX_s_1_rg.sorted,TCGA-AG-3582-01A-01D-1167_101105_SN208_0168_A80A3BABXX_s_1_rg.sorted.bam,747.21,1.9,0.15,58cfa830e4b0c9d6adf6bcc8,TCGA-AG-3582-01A-01D-1167_101105_SN208_0168_A80A3BABXX_s_1_rg.sorted.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3582-01A,DB1E3104-8BFD-4353-854A-C478BA1F7D07,Primary Tumor,Illumina HiSeq,85a5fdbc-5a9a-4ddf-aac9-84a213ee17fd,Colorectal,75,1B1EF856-EA45-4857-8B4B-C4330FA930D8,CA0DD61C-D4F2-4ED9-91EF-11F7B1BE15AF,TCGA-AG-3582-01A-01D-1167-02,HG18_Broad_variant,TCGA-AG-3582,TCGA-READ,NA,s1973,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IV
13722.58cfa830e4b0c9d6adf6baf6,58cfa830e4b0c9d6adf6baf6,TCGA-49-6767-11A-01D-1853_120205_SN590_0136_BD0LRYACXX_s_8_rg.sorted.filtered.,WGS,TCGA-49-6767-11A-01D-1853_120205_SN590_0136_BD0LRYACXX_s_8_rg.sorted,TCGA-49-6767-11A-01D-1853_120205_SN590_0136_BD0LRYACXX_s_8_rg.sorted.bam,32.7,1.9,0.13,58cfa830e4b0c9d6adf6baf6,TCGA-49-6767-11A-01D-1853_120205_SN590_0136_BD0LRYACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-49-6767-11A,6BFFE800-EC2B-4638-9333-97FE85DCD91C,Solid Tissue Normal,Illumina HiSeq,a55991e3-e5fc-4ba4-b7e8-a98bfc625775,Lung,46,3C1E2C11-A721-4AF0-BA91-FD0D77A75E0C,A7E94D11-09B7-41BF-A21E-BC5C7DA0A972,TCGA-49-6767-11A-01D-1853-02,HG19_Broad_variant,TCGA-49-6767,TCGA-LUAD,NA,s11001,Harvard Medical School,Johns Hopkins,United States,NO,T3,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6b030,58cfa82ee4b0c9d6adf6b030,TCGA-05-4432-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_3_rg.sorted.filtered.,WGS,TCGA-05-4432-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_3_rg.sorted,TCGA-05-4432-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_3_rg.sorted.bam,97.23,1.9,0.14,58cfa82ee4b0c9d6adf6b030,TCGA-05-4432-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_3_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4432-10A,E737F650-B72D-44E7-B750-558A56716803,Blood Derived Normal,Illumina HiSeq,10b90006-c305-434b-a1e6-0d2d780fe84f,Lung,66,DF254D50-B666-4512-99E9-F65D94454FDE,92BC38C1-04F3-419F-877A-0D020898851A,TCGA-05-4432-10A-01D-1203-02,HG19_Broad_variant,TCGA-05-4432,TCGA-LUAD,NA,s10647,Harvard Medical School,Indivumed,Germany,NO,T2,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIB
13722.58cfa831e4b0c9d6adf6cc33,58cfa831e4b0c9d6adf6cc33,TCGA-EE-A29N-06A-12D-A18Y_120729_SN1120_0180_BC1176ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EE-A29N-06A-12D-A18Y_120729_SN1120_0180_BC1176ACXX_s_5_rg.sorted,TCGA-EE-A29N-06A-12D-A18Y_120729_SN1120_0180_BC1176ACXX_s_5_rg.sorted.bam,55.63,NA,0.17,58cfa831e4b0c9d6adf6cc33,TCGA-EE-A29N-06A-12D-A18Y_120729_SN1120_0180_BC1176ACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29N-06A,8AAD9690-D1AD-424B-9A80-D7980760D093,Metastatic,Illumina HiSeq,1a8bfce8-1606-45e1-8da4-fbad852ec59c,Skin,78,1B381338-4AB1-4468-8042-2519061691E7,A2EF6B29-26E7-4BE0-A87B-122DC2D217A2,TCGA-EE-A29N-06A-12D-A18Y-02,HG19_Broad_variant,TCGA-EE-A29N,TCGA-SKCM,566,s7337,Harvard Medical School,University of Sydney,Australia,NO,TX,N0,Not available,I or II NOS
13722.58cfa830e4b0c9d6adf6ba52,58cfa830e4b0c9d6adf6ba52,TCGA-AA-A02K-10A-01D-A079_110401_SN177_0152_A819RJABXX_s_3.rg.sorted.filtered.,WGS,TCGA-AA-A02K-10A-01D-A079_110401_SN177_0152_A819RJABXX_s_3.rg.sorted,TCGA-AA-A02K-10A-01D-A079_110401_SN177_0152_A819RJABXX_s_3.rg.sorted.bam,9.16,1.85,0.08,58cfa830e4b0c9d6adf6ba52,TCGA-AA-A02K-10A-01D-A079_110401_SN177_0152_A819RJABXX_s_3.rg.sorted.bam,Dead,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A02K-10A,10881458-55B2-41D1-8358-4EE6CCB8EC85,Blood Derived Normal,Illumina HiSeq,02957b7f-f470-4222-8764-6e333e997592,Colorectal,50,413A3C76-E914-435C-8311-A874004A7B34,44235651-438D-4E5D-90F3-E42E5ED3F236,TCGA-AA-A02K-10A-01D-A079-02,HG18_Broad_variant,TCGA-AA-A02K,TCGA-COAD,426,s13203,Harvard Medical School,Indivumed,Germany,NO,T4,N2,Colon Adenocarcinoma,Stage IV
13722.58cfa82ee4b0c9d6adf6ae74,58cfa82ee4b0c9d6adf6ae74,TCGA-05-4402-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-05-4402-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-05-4402-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,176.2,1.9,0.14,58cfa82ee4b0c9d6adf6ae74,TCGA-05-4402-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4402-01A,722D6818-F1CB-49F4-B68A-FD0A31304681,Primary Tumor,Illumina HiSeq,603e16bf-9b05-49c9-a925-f409626c969a,Lung,57,07C1FCE4-EC48-47A4-8391-E553936B67F2,5E791B10-E5FD-412D-9F42-72CAC197F253,TCGA-05-4402-01A-01D-1203-02,GRCh37,TCGA-05-4402,TCGA-LUAD,244,s10900,Harvard Medical School,Indivumed,Germany,NO,T2,NX,Lung Adenocarcinoma Mixed Subtype,Stage IV
13722.58cfa832e4b0c9d6adf6d234,58cfa832e4b0c9d6adf6d234,TCGA-JX-A3Q8-01A-11D-A245_140206_SN1222_0239_BC2RAKACXX_s_3_rg.sorted.filtered.,WGS,TCGA-JX-A3Q8-01A-11D-A245_140206_SN1222_0239_BC2RAKACXX_s_3_rg.sorted,TCGA-JX-A3Q8-01A-11D-A245_140206_SN1222_0239_BC2RAKACXX_s_3_rg.sorted.bam,63.47,NA,0.14,58cfa832e4b0c9d6adf6d234,TCGA-JX-A3Q8-01A-11D-A245_140206_SN1222_0239_BC2RAKACXX_s_3_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-JX-A3Q8-01A,34629EB8-0C5E-4910-8E13-BF7D6A1E337F,Primary Tumor,Illumina HiSeq,e8f02d77-0077-4817-a34b-ab4ddd64bbd5,Cervix,40,28954012-3732-40B0-8EA7-F48CBEEF4105,52CB86FE-6EFF-4FF4-BC53-FD82E04854FB,TCGA-JX-A3Q8-01A-11D-A245-26,HG19_Broad_variant,TCGA-JX-A3Q8,TCGA-CESC,NA,s1380,MD Anderson - Institute for Applied Cancer Science,Washington University,United States,NO,T1b1,N0,Endocervical Type of Adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b67d,58cfa82fe4b0c9d6adf6b67d,TCGA-49-4486-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-49-4486-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-49-4486-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,142.53,1.9,0.14,58cfa82fe4b0c9d6adf6b67d,TCGA-49-4486-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4486-01A,61C655EC-52B5-453F-A6CC-B2ABA445B027,Primary Tumor,Illumina HiSeq,cb4d8cf1-9903-481c-8ba1-df0586b69916,Lung,72,5AE9B10F-347C-48C3-90CD-9290055CFE4B,EC0EE49C-D1D4-490D-BA82-CFAE6D451B8D,TCGA-49-4486-01A-01D-1203-02,GRCh37,TCGA-49-4486,TCGA-LUAD,2318,s10907,Harvard Medical School,Johns Hopkins,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82fe4b0c9d6adf6b88c,58cfa82fe4b0c9d6adf6b88c,TCGA-A6-2681-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-2681-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-2681-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,466,1.9,0.15,58cfa82fe4b0c9d6adf6b88c,TCGA-A6-2681-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2681-10A,7D8EAB0A-E6C8-4449-9EBF-50C41DB94A06,Blood Derived Normal,Illumina HiSeq,39e367a8-940b-4e1b-aa38-cdb0fdfe9d26,Colorectal,73,EA27374C-3F62-4128-A14A-8418966AFDB3,CCF319C5-BF63-4423-8D31-10013BB84BAA,TCGA-A6-2681-10A-01D-1405-02,HG18,TCGA-A6-2681,TCGA-COAD,NA,s13171,Harvard Medical School,Christiana Healthcare,United States,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa832e4b0c9d6adf6ceae,58cfa832e4b0c9d6adf6ceae,TCGA-EM-A1YD-11A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EM-A1YD-11A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_7_rg.sorted,TCGA-EM-A1YD-11A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_7_rg.sorted.bam,34.99,2.08,0.16,58cfa832e4b0c9d6adf6ceae,TCGA-EM-A1YD-11A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_7_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1YD-11A,8A3659A8-2A85-4BAB-8BF3-55795922474C,Solid Tissue Normal,Illumina HiSeq,6c5fce85-3633-4842-af59-ac8edb797640,Thyroid,53,B5EFE349-B8D1-4B10-95D7-24B2233C1AFB,DCEFBF06-A42B-4AA6-B1C1-A321DE2BBE64,TCGA-EM-A1YD-11A-11D-A14U-02,HG19_Broad_variant,TCGA-EM-A1YD,TCGA-THCA,NA,s12522,Harvard Medical School,University Health Network,Canada,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa82fe4b0c9d6adf6b940,58cfa82fe4b0c9d6adf6b940,TCGA-A6-3808-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-3808-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-3808-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,236,1.9,0.14,58cfa82fe4b0c9d6adf6b940,TCGA-A6-3808-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-3808-01A,4F9775F2-B663-4DAF-AA9E-50915CAE9407,Primary Tumor,Illumina HiSeq,58504a37-4eb0-44ec-bb5d-83e955521de2,Colorectal,73,037BA047-2228-43DE-8DF8-32920A689ECA,2B2625B5-FBDD-41C3-9BB3-71566C5FBBA4,TCGA-A6-3808-01A-01D-1167-02,HG18,TCGA-A6-3808,TCGA-COAD,NA,s13173,Harvard Medical School,Christiana Healthcare,None,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6bc7e,58cfa830e4b0c9d6adf6bc7e,TCGA-AG-A020-11A-11D-A079-02_110409_SN590_0077_BB04EHABXX_s_2.rg.sorted.filtered.,WGS,TCGA-AG-A020-11A-11D-A079-02_110409_SN590_0077_BB04EHABXX_s_2.rg.sorted,TCGA-AG-A020-11A-11D-A079-02_110409_SN590_0077_BB04EHABXX_s_2.rg.sorted.bam,58.34,2.2,0.13,58cfa830e4b0c9d6adf6bc7e,TCGA-AG-A020-11A-11D-A079-02_110409_SN590_0077_BB04EHABXX_s_2.rg.sorted.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A020-11A,19E46A3D-18C5-4927-8501-2265E2D617B8,Solid Tissue Normal,Illumina HiSeq,48f20c48-bd37-4231-9bac-8b276e4a31ea,Colorectal,57,1268F79E-4F75-4363-AFD9-342DD40BACA8,18047D41-47EA-4CC0-9918-19D33D182298,TCGA-AG-A020-11A-11D-A079-02,HG18_Broad_variant,TCGA-AG-A020,TCGA-READ,NA,s2176,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Mucinous Adenocarcinoma,Stage III
13722.58cfa830e4b0c9d6adf6bb0a,58cfa830e4b0c9d6adf6bb0a,TCGA-A5-A0R6-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_2_rg.sorted.filtered.,WGS,TCGA-A5-A0R6-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_2_rg.sorted,TCGA-A5-A0R6-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_2_rg.sorted.bam,55.64,2.08,0.15,58cfa830e4b0c9d6adf6bb0a,TCGA-A5-A0R6-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0R6-01A,39609D3C-F5D3-4BC4-B356-1403C6DD1CB5,Primary Tumor,Illumina HiSeq,7485f99f-a7fe-456f-873d-eb1be9fa04b1,Uterus,64,836BD487-091B-4728-BCD7-8065E5B76465,FBE6A365-A19A-42F1-9198-63549F77CD9B,TCGA-A5-A0R6-01A-11D-A101-02,HG19_Broad_variant,TCGA-A5-A0R6,TCGA-UCEC,NA,s4991,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6ce19,58cfa832e4b0c9d6adf6ce19,TCGA-FD-A3N6-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FD-A3N6-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_3_rg.sorted,TCGA-FD-A3N6-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_3_rg.sorted.bam,47.84,NA,0.16,58cfa832e4b0c9d6adf6ce19,TCGA-FD-A3N6-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_3_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3N6-01A,8C1DD7F7-B74A-4FA2-B6A7-86F0348D2567,Primary Tumor,Illumina HiSeq,2beb0463-75e7-4244-b88e-022e447445f2,Bladder,43,6CD6D1F4-D8E4-47F9-812F-EB7FEC925F8D,C218A6A8-78F5-472B-A1CA-886E2331A688,TCGA-FD-A3N6-01A-11D-A21C-26,HG19_Broad_variant,TCGA-FD-A3N6,TCGA-BLCA,NA,s3292,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa830e4b0c9d6adf6c11a,58cfa830e4b0c9d6adf6c11a,TCGA-BS-A0TE-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BS-A0TE-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_3_rg.sorted,TCGA-BS-A0TE-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_3_rg.sorted.bam,53.44,1.91,0.17,58cfa830e4b0c9d6adf6c11a,TCGA-BS-A0TE-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_3_rg.sorted.bam,Dead,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TE-01A,09066FBF-6A1D-46C9-A4C5-C53340C3D1BA,Primary Tumor,Illumina HiSeq,a687b0ac-0eda-43c1-ab2f-cf8b3d6ffb94,Uterus,35,2D1226A1-1C88-422B-9A8D-316BEBEB65FD,250BF272-4CCD-41DB-ABD1-4FE2E304AB21,TCGA-BS-A0TE-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0TE,TCGA-UCEC,146,s4607,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bf97,58cfa830e4b0c9d6adf6bf97,TCGA-B5-A0JY-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-B5-A0JY-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_5_rg.sorted,TCGA-B5-A0JY-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_5_rg.sorted.bam,7.92,1.89,0.13,58cfa830e4b0c9d6adf6bf97,TCGA-B5-A0JY-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0JY-10A,61935424-44D0-4211-81C1-C925E436EAC5,Blood Derived Normal,Illumina HiSeq,f9b617a6-9bb1-4794-9174-1ee1aa7d653a,Uterus,50,F3FF3E83-7B73-4243-BDAC-837D6AB60BF7,F8D2C20A-39DF-448D-8532-5299988AEB97,TCGA-B5-A0JY-10A-01D-A101-02,HG19_Broad_variant,TCGA-B5-A0JY,TCGA-UCEC,NA,s5207,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6af57,58cfa82ee4b0c9d6adf6af57,TCGA-05-5429-10A-01D-1623_110714_SN590_0097_BD0CMJABXX_s_2_rg.sorted.filtered.,WGS,TCGA-05-5429-10A-01D-1623_110714_SN590_0097_BD0CMJABXX_s_2_rg.sorted,TCGA-05-5429-10A-01D-1623_110714_SN590_0097_BD0CMJABXX_s_2_rg.sorted.bam,136.4,1.9,0.16,58cfa82ee4b0c9d6adf6af57,TCGA-05-5429-10A-01D-1623_110714_SN590_0097_BD0CMJABXX_s_2_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-5429-10A,63BD2175-4B7C-44C9-AEF3-9EFC8F79837B,Blood Derived Normal,Illumina HiSeq,bcdedbe7-cbd5-46a7-b0e3-3586421a59ec,Lung,60,CBFF89AF-5FC7-4C9C-B081-5774657967C2,8637A9F5-39CB-4E47-9029-FB9B2F2BA2C4,TCGA-05-5429-10A-01D-1623-02,HG19_Broad_variant,TCGA-05-5429,TCGA-LUAD,NA,s11442,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82ee4b0c9d6adf6afe6,58cfa82ee4b0c9d6adf6afe6,TCGA-05-4434-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_2_rg.sorted.filtered.,WGS,TCGA-05-4434-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_2_rg.sorted,TCGA-05-4434-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_2_rg.sorted.bam,724.9,1.9,0.15,58cfa82ee4b0c9d6adf6afe6,TCGA-05-4434-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_2_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4434-01A,D94FE32F-BEDD-4F4C-9FEB-FCB60D40F4BB,Primary Tumor,Illumina HiSeq,f43f1ef0-b383-4a17-a3cc-25c353416799,Lung,67,7A03048B-58B6-4CAE-B143-81C0A4977AC6,8A64C790-988A-4B51-8E5F-B4F746F2D9EB,TCGA-05-4434-01A-01D-1203-02,HG19_Broad_variant,TCGA-05-4434,TCGA-LUAD,457,s10644,Harvard Medical School,Indivumed,Germany,NO,T4,N1,Lung Adenocarcinoma Mixed Subtype,Stage IV
13722.58cfa831e4b0c9d6adf6ccac,58cfa831e4b0c9d6adf6ccac,TCGA-EE-A2MT-06A-11D-A18Y_120718_SN1222_0126_AC117AACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EE-A2MT-06A-11D-A18Y_120718_SN1222_0126_AC117AACXX_s_2_rg.sorted,TCGA-EE-A2MT-06A-11D-A18Y_120718_SN1222_0126_AC117AACXX_s_2_rg.sorted.bam,50.87,NA,0.15,58cfa831e4b0c9d6adf6ccac,TCGA-EE-A2MT-06A-11D-A18Y_120718_SN1222_0126_AC117AACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MT-06A,69A17647-493F-46D2-9CF0-6596E56289A0,Metastatic,Illumina HiSeq,5ccfc0fe-3cd9-4899-98f4-e668f12adcb1,Skin,45,9124FB58-5EB0-481C-B5A6-F2ED8114F887,528706E9-22D6-4A37-8E2D-2D945CD36F1F,TCGA-EE-A2MT-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2MT,TCGA-SKCM,NA,s7516,Harvard Medical School,University of Sydney,Australia,NO,T2a,N0,Not available,Stage IB
13722.58cfa830e4b0c9d6adf6c124,58cfa830e4b0c9d6adf6c124,TCGA-BS-A0TC-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BS-A0TC-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_1_rg.sorted,TCGA-BS-A0TC-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_1_rg.sorted.bam,60.12,1.87,0.14,58cfa830e4b0c9d6adf6c124,TCGA-BS-A0TC-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_1_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TC-01A,7B7D2D2B-ABE6-4F32-ADD0-3715096995D1,Primary Tumor,Illumina HiSeq,402004c3-b5d0-41ad-990c-203cbf02ec5d,Uterus,69,C4C99327-B778-4E29-A111-75569AD38696,99E19D8C-EC6E-45D7-89E5-091D101BF466,TCGA-BS-A0TC-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0TC,TCGA-UCEC,NA,s5015,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cd22,58cfa831e4b0c9d6adf6cd22,TCGA-EE-A2MQ-10A-01D-A190_120718_SN1222_0126_AC117AACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EE-A2MQ-10A-01D-A190_120718_SN1222_0126_AC117AACXX_s_8_rg.sorted,TCGA-EE-A2MQ-10A-01D-A190_120718_SN1222_0126_AC117AACXX_s_8_rg.sorted.bam,62.38,NA,0.16,58cfa831e4b0c9d6adf6cd22,TCGA-EE-A2MQ-10A-01D-A190_120718_SN1222_0126_AC117AACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MQ-10A,C127FFB6-2CCF-4E90-B811-0AA40EBFAB17,Blood Derived Normal,Illumina HiSeq,379ff829-20a8-487f-a935-55656f3311b8,Skin,70,C1DCE764-F077-4696-B50A-3D778AE1E11C,3C4E786A-0441-4E99-BE3E-E840A7A5D529,TCGA-EE-A2MQ-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2MQ,TCGA-SKCM,1315,s7343,Harvard Medical School,University of Sydney,Australia,NO,T3a,N2a,Not available,Stage IIIA
13722.58cfa831e4b0c9d6adf6c46c,58cfa831e4b0c9d6adf6c46c,TCGA-CA-5256-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-CA-5256-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-CA-5256-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,178.72,1.9,0.15,58cfa831e4b0c9d6adf6c46c,TCGA-CA-5256-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,ASIAN,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-CA-5256-10A,17633A60-E12B-4A7C-BD8A-C16341DDC606,Blood Derived Normal,Illumina HiSeq,1adb4258-b5bf-4496-a9fa-8f7a1ce8b667,Colorectal,54,8603228A-5F83-4B2E-A57B-DD3133CDE96E,2B29D3EE-2BBD-43FB-8262-86CB5B0CF0FA,TCGA-CA-5256-10A-01D-1405-02,HG18,TCGA-CA-5256,TCGA-COAD,NA,s12890,Harvard Medical School,ILSbio,None,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6be8e,58cfa830e4b0c9d6adf6be8e,TCGA-AZ-4681-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AZ-4681-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-AZ-4681-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,483.72,1.9,0.15,58cfa830e4b0c9d6adf6be8e,TCGA-AZ-4681-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-4681-10A,6FBC2B46-6762-4778-AA7E-782162C5397C,Blood Derived Normal,Illumina HiSeq,dc4796f6-2368-48bd-b430-d1c8295cbd5e,Colorectal,79,CCCCF1C4-7B2D-465A-BF22-9EA9DC2B8545,E84FBE12-AD2B-469B-8883-65CBB46B7A0D,TCGA-AZ-4681-10A-01D-1405-02,HG18,TCGA-AZ-4681,TCGA-COAD,NA,s12889,Harvard Medical School,University of Pittsburgh,None,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6c46a,58cfa831e4b0c9d6adf6c46a,TCGA-CA-5256-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-CA-5256-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-CA-5256-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,806.02,1.9,0.13,58cfa831e4b0c9d6adf6c46a,TCGA-CA-5256-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,ASIAN,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-CA-5256-01A,17633A60-E12B-4A7C-BD8A-C16341DDC606,Primary Tumor,Illumina HiSeq,21c81645-36f0-4e4a-8f23-b589998bcb76,Colorectal,54,D4D5DEB6-6CFB-4E25-9824-8F7DC8D5B451,A8F8AAD6-F8C5-4133-A651-454C047A19D0,TCGA-CA-5256-01A-01D-1405-02,HG18,TCGA-CA-5256,TCGA-COAD,NA,s13544,Harvard Medical School,ILSbio,None,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6bcf5,58cfa830e4b0c9d6adf6bcf5,TCGA-AF-2692-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AF-2692-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AF-2692-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,254.21,1.9,0.14,58cfa830e4b0c9d6adf6bcf5,TCGA-AF-2692-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-AF-2692-10A,71A32FCA-D48F-4EA3-8DF7-69F9DDA8FA91,Blood Derived Normal,Illumina HiSeq,41bfa67f-dcaa-4ae8-8c1d-99652cd97c9a,Colorectal,54,C80E7FB0-4536-404A-BE8B-21A2DAA61D47,D5B76166-4D9A-48AB-93C4-47E3524CD423,TCGA-AF-2692-10A-01D-1167-02,HG18,TCGA-AF-2692,TCGA-READ,NA,s1963,Harvard Medical School,Christiana Healthcare,United States,NO,T3,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6c4a6,58cfa831e4b0c9d6adf6c4a6,TCGA-BJ-A0ZJ-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BJ-A0ZJ-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_2_rg.sorted,TCGA-BJ-A0ZJ-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_2_rg.sorted.bam,59.26,1.9,0.16,58cfa831e4b0c9d6adf6c4a6,TCGA-BJ-A0ZJ-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0ZJ-01A,8877B479-B62A-4794-B71E-418DE96DFF23,Primary Tumor,Illumina HiSeq,649e17cb-1adf-40a9-a837-4980acc1a108,Thyroid,36,C6D64D80-C8AA-494A-8C0E-8640BEEBDFC9,D54FCA2A-0B8E-4A33-8B52-3FBF0E47D799,TCGA-BJ-A0ZJ-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZJ,TCGA-THCA,NA,s12629,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa830e4b0c9d6adf6bbf0,58cfa830e4b0c9d6adf6bbf0,TCGA-A6-3807-11A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-3807-11A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-3807-11A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,203.86,1.9,0.16,58cfa830e4b0c9d6adf6bbf0,TCGA-A6-3807-11A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-3807-11A,5116E3B4-2BAC-40F5-8046-B9C1783FAAA5,Solid Tissue Normal,Illumina HiSeq,e14fd460-b6c8-44b8-81ad-b9ce224af5cb,Colorectal,53,6CC29D0A-19C3-4C7F-AD8D-BF10E1392E09,BADA9982-36A5-48B3-BE62-DFD0D8AC7FC8,TCGA-A6-3807-11A-01D-1167-02,HG18,TCGA-A6-3807,TCGA-COAD,NA,s13352,Harvard Medical School,Christiana Healthcare,None,NO,T3,N2,Colon Adenocarcinoma,Stage IIIC
13722.58cfa830e4b0c9d6adf6bb48,58cfa830e4b0c9d6adf6bb48,TCGA-AA-A02Y-01A-43D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A02Y-01A-43D-A079-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A02Y-01A-43D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,84.8,1.91,0.16,58cfa830e4b0c9d6adf6bb48,TCGA-AA-A02Y-01A-43D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A02Y-01A,A435FDF4-A89A-499E-9006-CBB5693EAB26,Primary Tumor,Illumina HiSeq,faa460a7-9c39-4da6-93c1-22d5d99742f0,Colorectal,73,8537633B-6426-4B66-A2A3-FA942EEDF01B,CD188DB1-ED81-42A6-B550-07D4008143EE,TCGA-AA-A02Y-01A-43D-A079-02,HG18,TCGA-AA-A02Y,TCGA-COAD,NA,s13195,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c970,58cfa831e4b0c9d6adf6c970,TCGA-DB-5280-10A-01D-1465_130808_SN208_0488_BC294YACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DB-5280-10A-01D-1465_130808_SN208_0488_BC294YACXX_s_4_rg.sorted,TCGA-DB-5280-10A-01D-1465_130808_SN208_0488_BC294YACXX_s_4_rg.sorted.bam,79.4,1.9,0.15,58cfa831e4b0c9d6adf6c970,TCGA-DB-5280-10A-01D-1465_130808_SN208_0488_BC294YACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DB-5280-10A,4797C600-F024-42FE-B287-D919B24DCB79,Blood Derived Normal,Illumina HiSeq,c2968c6a-5afe-480e-a036-e3522ae763ec,Brain,43,B21973CB-382F-4B36-BAD8-973286C32FA8,F09CED0A-4EC8-4586-B8EF-B3B65DF18113,TCGA-DB-5280-10A-01D-1465-02,HG19_Broad_variant,TCGA-DB-5280,TCGA-LGG,NA,s8558,Harvard Medical School,Mayo Clinic - Rochester,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa831e4b0c9d6adf6cd42,58cfa831e4b0c9d6adf6cd42,TCGA-ER-A2NC-06A-11D-A18Y_120718_SN208_0415_AC116EACXX_s_2_rg.sorted.filtered.,WGS,TCGA-ER-A2NC-06A-11D-A18Y_120718_SN208_0415_AC116EACXX_s_2_rg.sorted,TCGA-ER-A2NC-06A-11D-A18Y_120718_SN208_0415_AC116EACXX_s_2_rg.sorted.bam,21.95,NA,0.16,58cfa831e4b0c9d6adf6cd42,TCGA-ER-A2NC-06A-11D-A18Y_120718_SN208_0415_AC116EACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A2NC-06A,B9607824-A8D3-4915-AB73-962CDCFD8DC3,Metastatic,Illumina HiSeq,903bc6ae-f6d5-44d0-afdf-0b93235b368b,Skin,50,F4967D10-95FD-4C8D-BCB5-19072D8D8DFA,7D63E49D-B427-499D-834A-D78B54B5713F,TCGA-ER-A2NC-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-ER-A2NC,TCGA-SKCM,1333,s7864,Harvard Medical School,University of Pittsburgh,United States,NO,T2a,N0,Not available,Stage IB
13722.58cfa831e4b0c9d6adf6c51e,58cfa831e4b0c9d6adf6c51e,TCGA-CM-4746-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-CM-4746-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-CM-4746-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,87.72,1.9,0.15,58cfa831e4b0c9d6adf6c51e,TCGA-CM-4746-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-CM-4746-10A,C0B8C55C-B993-481D-AEEA-9EBFA64EE20E,Blood Derived Normal,Illumina HiSeq,454e7afb-d46f-4230-bbf3-ee5844e29cdc,Colorectal,61,3ED6A50C-8AC3-49DB-9DC1-C2F8C49D78A1,850C3F5C-2CB7-465D-9254-BAC172442BAA,TCGA-CM-4746-10A-01D-1405-02,HG18,TCGA-CM-4746,TCGA-COAD,NA,s13846,Harvard Medical School,MSKCC,None,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa82fe4b0c9d6adf6b95a,58cfa82fe4b0c9d6adf6b95a,TCGA-AA-3548-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3548-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3548-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,45.56,1.9,0.14,58cfa82fe4b0c9d6adf6b95a,TCGA-AA-3548-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3548-10A,2DCED66C-1F0D-4039-A5E5-54CCA77C16E9,Blood Derived Normal,Illumina HiSeq,16ab76f5-0b3e-4aad-b31c-125bf8ae94d1,Colorectal,71,F43CBCA2-40EF-493A-8D28-2D58A65C7898,4F954A4C-1E74-445C-A681-9C3B3AF8AC81,TCGA-AA-3548-10A-01D-1167-02,HG18,TCGA-AA-3548,TCGA-COAD,NA,s13357,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Colon Adenocarcinoma,Stage IIIC
13722.58cfa82fe4b0c9d6adf6b83f,58cfa82fe4b0c9d6adf6b83f,TCGA-A6-2676-10A-01D-1167-02_101203_SN177_0125_B802RYABXX_s_2.rg.sorted.filtered.,WGS,TCGA-A6-2676-10A-01D-1167-02_101203_SN177_0125_B802RYABXX_s_2.rg.sorted,TCGA-A6-2676-10A-01D-1167-02_101203_SN177_0125_B802RYABXX_s_2.rg.sorted.bam,362.56,1.9,0.14,58cfa82fe4b0c9d6adf6b83f,TCGA-A6-2676-10A-01D-1167-02_101203_SN177_0125_B802RYABXX_s_2.rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2676-10A,89A6384E-1CEA-440B-9F17-D57CB0805174,Blood Derived Normal,Illumina HiSeq,d6eb31c8-71e8-41a3-9cb0-1dcd5bb091d4,Colorectal,75,74BBC0AF-904E-4F03-B750-7A0585D15215,5A85D32F-EC89-43D1-9B06-2D3EDD680F6D,TCGA-A6-2676-10A-01D-1167-02,HG18_Broad_variant,TCGA-A6-2676,TCGA-COAD,NA,s13655,Harvard Medical School,Christiana Healthcare,None,NO,T4,N0,Colon Adenocarcinoma,Stage IIB
13722.58cfa82fe4b0c9d6adf6b9fe,58cfa82fe4b0c9d6adf6b9fe,TCGA-AA-3968-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3968-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3968-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,756,1.9,0.15,58cfa82fe4b0c9d6adf6b9fe,TCGA-AA-3968-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3968-01A,CAB7BDBC-0A11-4901-97C3-26B884F79CB5,Primary Tumor,Illumina HiSeq,7c5f1648-b5c0-4e96-a5ca-38b2630f40ee,Colorectal,55,E950BC59-116F-4366-8524-F0731B1C9A3D,193F15A1-6BE4-4992-AC6E-EF34CBB3B57A,TCGA-AA-3968-01A-01D-1167-02,HG18,TCGA-AA-3968,TCGA-COAD,NA,s13030,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c524,58cfa831e4b0c9d6adf6c524,TCGA-CM-4744-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-CM-4744-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-CM-4744-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,471,1.9,0.14,58cfa831e4b0c9d6adf6c524,TCGA-CM-4744-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-CM-4744-01A,CC15469C-7BAD-4E86-9DA3-AE0C72E9D380,Primary Tumor,Illumina HiSeq,e1403b52-6792-4d08-acad-95659ceeca82,Colorectal,69,A545FB9A-C386-4A80-9A25-660DC4F62904,6D073A6F-FB7B-4ED2-BD24-5233E019D64A,TCGA-CM-4744-01A-01D-1405-02,HG18,TCGA-CM-4744,TCGA-COAD,NA,s13689,Harvard Medical School,MSKCC,None,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa831e4b0c9d6adf6cd65,58cfa831e4b0c9d6adf6cd65,TCGA-FE-A232-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FE-A232-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_5_rg.sorted,TCGA-FE-A232-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_5_rg.sorted.bam,72.56,2.05,0.18,58cfa831e4b0c9d6adf6cd65,TCGA-FE-A232-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A232-01A,5EB0D577-223B-4409-89D1-5C5D196AFFC3,Primary Tumor,Illumina HiSeq,ca8aaa05-1546-46a2-aee9-1ad97cadf087,Thyroid,44,213BE6EE-1E61-4FA0-9B73-66B696086397,AD42DF5B-2665-4CA1-8049-943F684B6BFD,TCGA-FE-A232-01A-11D-A14U-02,HG19_Broad_variant,TCGA-FE-A232,TCGA-THCA,NA,s12530,Harvard Medical School,Ohio State University,United States,NO,T3,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa830e4b0c9d6adf6bd00,58cfa830e4b0c9d6adf6bd00,TCGA-AF-2692-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AF-2692-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AF-2692-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,2,1.9,0.15,58cfa830e4b0c9d6adf6bd00,TCGA-AF-2692-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-AF-2692-01A,71A32FCA-D48F-4EA3-8DF7-69F9DDA8FA91,Primary Tumor,Illumina HiSeq,f19d4bca-a876-4c65-a830-4d5f12eb5803,Colorectal,54,3CA7589A-E887-4DA2-8D59-19FE5963AC21,CC1B3C2A-43B7-43CB-85F8-383A3C255D4B,TCGA-AF-2692-01A-01D-1167-02,HG18,TCGA-AF-2692,TCGA-READ,NA,s1972,Harvard Medical School,Christiana Healthcare,United States,NO,T3,N0,Not available,Stage IIA
13722.58cfa82fe4b0c9d6adf6b8b8,58cfa82fe4b0c9d6adf6b8b8,TCGA-73-4675-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-73-4675-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-73-4675-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,482.2,1.9,0.16,58cfa82fe4b0c9d6adf6b8b8,TCGA-73-4675-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4675-01A,AE39E358-08D7-4367-AE68-82B469E791E4,Primary Tumor,Illumina HiSeq,14b3ad66-64c9-4b39-a34e-5cb29788735a,Lung,59,1F5FA8FD-1DE8-4456-8935-71B5A8B54BD2,356D01E0-DF80-40C6-BA06-8CD4EDFBD1EC,TCGA-73-4675-01A-01D-1203-02,GRCh37,TCGA-73-4675,TCGA-LUAD,NA,s11013,Harvard Medical School,Roswell Park,United States,NO,T3,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa830e4b0c9d6adf6bc38,58cfa830e4b0c9d6adf6bc38,TCGA-AA-A01C-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A01C-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A01C-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,91.92,1.64,0.15,58cfa830e4b0c9d6adf6bc38,TCGA-AA-A01C-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01C-01A,80809D79-92E1-4D6C-BA2E-0A9589997792,Primary Tumor,Illumina HiSeq,a7b8c819-1f82-43d2-93aa-5c85e2710e7e,Colorectal,75,1E191EED-2238-450E-A384-26DF9C569FD0,77F9EF43-7202-4C9B-9556-F00F0A66D2D4,TCGA-AA-A01C-01A-01D-A077-02,HG18,TCGA-AA-A01C,TCGA-COAD,NA,s13199,Harvard Medical School,Indivumed,Germany,NO,T2,N1,Colon Adenocarcinoma,Stage IIIA
13722.58cfa82fe4b0c9d6adf6b96c,58cfa82fe4b0c9d6adf6b96c,TCGA-AA-3675-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3675-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3675-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,56.66,1.9,0.15,58cfa82fe4b0c9d6adf6b96c,TCGA-AA-3675-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3675-10A,41658CF8-0DE1-4A97-BB60-0F0107C84E00,Blood Derived Normal,Illumina HiSeq,b96e4a5b-ccba-4670-96a2-87b4bde329ea,Colorectal,84,9C0C79F7-1500-452C-904C-35CC9D3C4634,07C43104-A2D5-4F74-B22F-166D8364562E,TCGA-AA-3675-10A-01D-1167-02,HG18,TCGA-AA-3675,TCGA-COAD,NA,s12869,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa82fe4b0c9d6adf6b8e8,58cfa82fe4b0c9d6adf6b8e8,TCGA-AA-3510-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3510-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3510-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,346,1.9,0.13,58cfa82fe4b0c9d6adf6b8e8,TCGA-AA-3510-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3510-01A,35C295C2-37D1-44B2-87A3-1039645E5BAE,Primary Tumor,Illumina HiSeq,0bb810fb-0134-4ea2-a821-41bbbdbd9155,Colorectal,70,C71C031C-3089-44E5-A49F-5284D7D300CE,DA2A173C-BBD3-4A90-8D1D-CD35CBE750F3,TCGA-AA-3510-01A-01D-1405-02,HG18,TCGA-AA-3510,TCGA-COAD,NA,s13666,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa830e4b0c9d6adf6bed1,58cfa830e4b0c9d6adf6bed1,TCGA-AP-A0LT-10A-01D-A043_120327_SN590_0149_AD0U12ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-AP-A0LT-10A-01D-A043_120327_SN590_0149_AD0U12ACXX_s_2_rg.sorted,TCGA-AP-A0LT-10A-01D-A043_120327_SN590_0149_AD0U12ACXX_s_2_rg.sorted.bam,31.35,1.97,0.15,58cfa830e4b0c9d6adf6bed1,TCGA-AP-A0LT-10A-01D-A043_120327_SN590_0149_AD0U12ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LT-10A,43714E9A-E9C4-4206-AF92-1D00D2A8AE35,Blood Derived Normal,Illumina HiSeq,9984e9fd-d5fa-4d3d-928b-43d15de26280,Uterus,57,52D5B5E2-55AA-4622-B266-0DC88D470B5C,C8CC7D82-73D0-4640-938E-773CDE42FF4E,TCGA-AP-A0LT-10A-01D-A043-02,HG19_Broad_variant,TCGA-AP-A0LT,TCGA-UCEC,NA,s4997,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bb88,58cfa830e4b0c9d6adf6bb88,TCGA-AA-3956-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3956-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3956-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,282.86,1.9,0.14,58cfa830e4b0c9d6adf6bb88,TCGA-AA-3956-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3956-01A,7B47489F-C3CC-4388-B5D7-C7C02790A5F6,Primary Tumor,Illumina HiSeq,edcd6fc2-ca83-409b-957a-ff0199cedf0d,Colorectal,65,DC1FFDA5-5B8F-4227-BE04-321643F73731,63EEF7A5-A1CC-4BB6-BA02-464D2DE89E2A,TCGA-AA-3956-01A-02D-1167-02,HG18,TCGA-AA-3956,TCGA-COAD,NA,s13519,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa832e4b0c9d6adf6d61a,58cfa832e4b0c9d6adf6d61a,TCGA-LN-A49X-01A-31D-A267_131018_SN590_0241_BC30HBACXX_s_3_rg.sorted.filtered.,WGS,TCGA-LN-A49X-01A-31D-A267_131018_SN590_0241_BC30HBACXX_s_3_rg.sorted,TCGA-LN-A49X-01A-31D-A267_131018_SN590_0241_BC30HBACXX_s_3_rg.sorted.bam,16.61,NA,0.16,58cfa832e4b0c9d6adf6d61a,TCGA-LN-A49X-01A-31D-A267_131018_SN590_0241_BC30HBACXX_s_3_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49X-01A,B05AEFC4-2D61-44B6-9451-E660D10D8A79,Primary Tumor,Illumina HiSeq,e3d2b395-b1fa-4edd-86a9-72ca75792159,Esophagus,44,F67F4ACC-E1DC-41F5-AF25-F4C03856B1AC,92F976C9-1D13-4347-ADDB-6C8F4C2E078F,TCGA-LN-A49X-01A-31D-A267-26,HG19_Broad_variant,TCGA-LN-A49X,TCGA-ESCA,NA,s1683,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6c42a,58cfa831e4b0c9d6adf6c42a,TCGA-BT-A2LA-01A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BT-A2LA-01A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_3_rg.sorted,TCGA-BT-A2LA-01A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_3_rg.sorted.bam,80.43,NA,0.15,58cfa831e4b0c9d6adf6c42a,TCGA-BT-A2LA-01A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A2LA-01A,797A71EE-372D-41E5-AEEE-5AB3C4661110,Primary Tumor,Illumina HiSeq,587f05f3-8e6a-4a97-b59b-29371f2f8b74,Bladder,54,6ED52558-8039-4658-A245-78A29968CE2F,D08FDC4F-83B0-4885-A8CF-45F72E5E6BD2,TCGA-BT-A2LA-01A-11D-A18D-02,HG19_Broad_variant,TCGA-BT-A2LA,TCGA-BLCA,NA,s2860,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa830e4b0c9d6adf6c204,58cfa830e4b0c9d6adf6c204,TCGA-BG-A0M8-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BG-A0M8-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_6_rg.sorted,TCGA-BG-A0M8-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_6_rg.sorted.bam,11.34,2,0.14,58cfa830e4b0c9d6adf6c204,TCGA-BG-A0M8-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0M8-10A,E055DB71-F3DA-43D3-A9B2-2F65DFB23D3E,Blood Derived Normal,Illumina HiSeq,59c03a66-dea6-47f6-a91b-d3d200938b26,Uterus,50,575EA3DD-0638-4CFE-9FC6-80D1C566D266,4B474E3A-F2D2-40E5-956C-316AD96A9840,TCGA-BG-A0M8-10A-01D-A101-02,HG19_Broad_variant,TCGA-BG-A0M8,TCGA-UCEC,NA,s4430,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b96f,58cfa82fe4b0c9d6adf6b96f,TCGA-AA-3666-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3666-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3666-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,554.96,1.9,0.17,58cfa82fe4b0c9d6adf6b96f,TCGA-AA-3666-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3666-01A,A512701F-88BB-4B05-8C94-FD285B9DD13E,Primary Tumor,Illumina HiSeq,0bc29a5e-10c6-4c45-8cb6-2284ab7be445,Colorectal,68,F1064663-1462-4901-8BF7-9F50DA5EE7B1,CAD86B88-04E5-400F-B3EB-43D31A2D8358,TCGA-AA-3666-01A-02D-1167-02,HG18,TCGA-AA-3666,TCGA-COAD,61,s13363,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage III
13722.58cfa830e4b0c9d6adf6c058,58cfa830e4b0c9d6adf6c058,TCGA-AZ-4308-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AZ-4308-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-AZ-4308-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,123.72,1.9,0.16,58cfa830e4b0c9d6adf6c058,TCGA-AZ-4308-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-4308-10A,3D8FD9B2-9AA2-4C81-8843-535AE66D6140,Blood Derived Normal,Illumina HiSeq,fc1a3245-0316-493f-b46a-f179c1f6a452,Colorectal,47,54F3DCE1-F69B-44BD-BAFB-17A6C937452E,4230CC2F-6B46-4130-A9E8-D7E834E13C4C,TCGA-AZ-4308-10A-01D-1405-02,HG18,TCGA-AZ-4308,TCGA-COAD,NA,s13686,Harvard Medical School,University of Pittsburgh,None,NO,T3,N1,Colon Adenocarcinoma,Stage IIIB
13722.58cfa82fe4b0c9d6adf6b68e,58cfa82fe4b0c9d6adf6b68e,TCGA-38-4628-11A-01D-1203_120305_SN1120_0119_BD0REAACXX_s_7_rg.sorted.filtered.,WGS,TCGA-38-4628-11A-01D-1203_120305_SN1120_0119_BD0REAACXX_s_7_rg.sorted,TCGA-38-4628-11A-01D-1203_120305_SN1120_0119_BD0REAACXX_s_7_rg.sorted.bam,97.53,1.9,0.15,58cfa82fe4b0c9d6adf6b68e,TCGA-38-4628-11A-01D-1203_120305_SN1120_0119_BD0REAACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-38-4628-11A,CC4BD56A-25C5-4C48-B583-AC3AEB778CA6,Solid Tissue Normal,Illumina HiSeq,afa5b5e6-b6c7-42c3-9267-97e6d760c86c,Lung,65,CB638069-0750-4BA1-BB4E-A2EE25DCA5FF,F3E003F8-BD6F-4262-AE8E-BB45F1DABBE6,TCGA-38-4628-11A-01D-1203-02,HG19_Broad_variant,TCGA-38-4628,TCGA-LUAD,1492,s11118,Harvard Medical School,UNC,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa831e4b0c9d6adf6cab2,58cfa831e4b0c9d6adf6cab2,TCGA-D9-A1X3-01A-11D-A18Y_120718_SN208_0415_AC116EACXX_s_1_rg.sorted.filtered.,WGS,TCGA-D9-A1X3-01A-11D-A18Y_120718_SN208_0415_AC116EACXX_s_1_rg.sorted,TCGA-D9-A1X3-01A-11D-A18Y_120718_SN208_0415_AC116EACXX_s_1_rg.sorted.bam,59.17,NA,0.16,58cfa831e4b0c9d6adf6cab2,TCGA-D9-A1X3-01A-11D-A18Y_120718_SN208_0415_AC116EACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D9-A1X3-06A,F0744FA2-DB4A-40DE-9FD2-F61863FD98D4,Metastatic,Illumina HiSeq,7f130a48-c6c4-40f7-b932-8ab8de632835,Skin,63,989C7C90-4017-4395-AD7B-4FB221370028,D9538A0C-8449-4969-8D94-3157029387E6,TCGA-D9-A1X3-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-D9-A1X3,TCGA-SKCM,NA,s7837,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T4b,N2b,Not available,Not available
13722.58cfa831e4b0c9d6adf6c51c,58cfa831e4b0c9d6adf6c51c,TCGA-CM-4752-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-CM-4752-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-CM-4752-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,126.72,1.8,0.14,58cfa831e4b0c9d6adf6c51c,TCGA-CM-4752-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-CM-4752-10A,7EA546CE-F48A-4D9C-96B4-A0124C692870,Blood Derived Normal,Illumina HiSeq,8c9dcc5b-1f5c-4bf0-82e0-ce0697d2e59a,Colorectal,58,F9417E48-23D4-47D4-BF20-A8A4E64EFEA8,FEC9AC5A-D50A-44BD-BF54-0DF36D078227,TCGA-CM-4752-10A-01D-1405-02,HG18,TCGA-CM-4752,TCGA-COAD,NA,s13690,Harvard Medical School,MSKCC,None,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6cc28,58cfa831e4b0c9d6adf6cc28,TCGA-EE-A29R-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EE-A29R-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_6_rg.sorted,TCGA-EE-A29R-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_6_rg.sorted.bam,45.53,NA,0.17,58cfa831e4b0c9d6adf6cc28,TCGA-EE-A29R-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29R-06A,D73D1B38-9AB4-409E-A360-E93F8C54715C,Metastatic,Illumina HiSeq,39cebd09-df59-45a2-bd13-b75055a7a352,Skin,48,9C98FCC2-FD1F-4F19-A550-B0FF0B78CF89,86C0AB31-7A14-40E7-AEA8-2CAD1F90CB27,TCGA-EE-A29R-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A29R,TCGA-SKCM,NA,s7679,Harvard Medical School,University of Sydney,Australia,NO,T3b,N1b,Not available,Stage IIIC
13722.58cfa82fe4b0c9d6adf6ba00,58cfa82fe4b0c9d6adf6ba00,TCGA-AA-3555-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3555-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3555-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole.bam,949.56,1.9,0.13,58cfa82fe4b0c9d6adf6ba00,TCGA-AA-3555-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3555-01A,36EAF209-C332-4321-B6AA-51A3368ECD79,Primary Tumor,Illumina HiSeq,4abf3b47-09b2-46e1-8bca-eb46790b3930,Colorectal,81,9F9961F0-4EE2-4471-AE4A-A0122D630A28,099EA705-3D94-4746-AF72-E21B31D0425A,TCGA-AA-3555-01A-01D-1637-02,HG18,TCGA-AA-3555,TCGA-COAD,NA,s13513,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Mucinous Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6c1b2,58cfa830e4b0c9d6adf6c1b2,TCGA-BG-A0MO-01A-11D-A043_120327_SN590_0148_BC0LM8ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BG-A0MO-01A-11D-A043_120327_SN590_0148_BC0LM8ACXX_s_1_rg.sorted,TCGA-BG-A0MO-01A-11D-A043_120327_SN590_0148_BC0LM8ACXX_s_1_rg.sorted.bam,37.97,2,0.16,58cfa830e4b0c9d6adf6c1b2,TCGA-BG-A0MO-01A-11D-A043_120327_SN590_0148_BC0LM8ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0MO-01A,734EF97F-807C-480E-8DF9-FEAF041032D2,Primary Tumor,Illumina HiSeq,e165d17d-a860-4111-9ae9-3fb19605cd21,Uterus,63,7582CBB9-42D3-496C-991D-D76BEA4C434C,9AD06738-F4A2-47A8-972E-BF8C817326A6,TCGA-BG-A0MO-01A-11D-A043-02,HG19_Broad_variant,TCGA-BG-A0MO,TCGA-UCEC,NA,s5215,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c7ca,58cfa831e4b0c9d6adf6c7ca,TCGA-CX-7085-10A-01D-2317_120730_SN1222_0140_AC11GKACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CX-7085-10A-01D-2317_120730_SN1222_0140_AC11GKACXX_s_3_rg.sorted,TCGA-CX-7085-10A-01D-2317_120730_SN1222_0140_AC11GKACXX_s_3_rg.sorted.bam,8.03,NA,0.14,58cfa831e4b0c9d6adf6c7ca,TCGA-CX-7085-10A-01D-2317_120730_SN1222_0140_AC11GKACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CX-7085-10A,2A7B4613-F908-4E78-98ED-857DCD7ED774,Blood Derived Normal,Illumina HiSeq,2187824f-bc90-441a-8180-5f1524daf954,Head and Neck,77,9B665276-9D15-4B3B-B201-FB0A8C7C54B2,97FE8A31-73BB-4EC1-A07E-C7D8A6B7059F,TCGA-CX-7085-10A-01D-2317-26,HG19_Broad_variant,TCGA-CX-7085,TCGA-HNSC,NA,s15911,MD Anderson - Institute for Applied Cancer Science,Medical College of Georgia,United States,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6cd32,58cfa831e4b0c9d6adf6cd32,TCGA-ER-A1A1-06A-11D-A18Y_120718_SN208_0415_AC116EACXX_s_3_rg.sorted.filtered.,WGS,TCGA-ER-A1A1-06A-11D-A18Y_120718_SN208_0415_AC116EACXX_s_3_rg.sorted,TCGA-ER-A1A1-06A-11D-A18Y_120718_SN208_0415_AC116EACXX_s_3_rg.sorted.bam,80.44,NA,0.17,58cfa831e4b0c9d6adf6cd32,TCGA-ER-A1A1-06A-11D-A18Y_120718_SN208_0415_AC116EACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A1A1-06A,1251ACEE-CEB4-4530-BA5B-4D163FCAB8D2,Metastatic,Illumina HiSeq,a0dd4823-2335-43ba-8e32-a91e08f80afd,Skin,58,B813EC36-059B-4833-9D27-CC72D8FD3A20,8CE5648E-5D8C-4B99-B39D-5F0D47F98209,TCGA-ER-A1A1-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-ER-A1A1,TCGA-SKCM,NA,s7362,Harvard Medical School,University of Pittsburgh,United States,NO,TX,N3,Not available,Stage IIIC
13722.58cfa830e4b0c9d6adf6bcf3,58cfa830e4b0c9d6adf6bcf3,TCGA-AG-3574-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3574-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3574-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,41.21,1.8,0.14,58cfa830e4b0c9d6adf6bcf3,TCGA-AG-3574-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3574-10A,0EDA7373-8335-455F-B90A-8C3540F28088,Blood Derived Normal,Illumina HiSeq,9211afac-c744-41bb-ac38-56805c35f544,Colorectal,89,FC65E77A-760D-49D6-81B3-CD55899C76AB,8BCF4B23-7007-4919-BC51-A71E98E295B4,TCGA-AG-3574-10A-01D-1167-02,HG18,TCGA-AG-3574,TCGA-READ,NA,s1967,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage II
13722.58cfa832e4b0c9d6adf6cf91,58cfa832e4b0c9d6adf6cf91,TCGA-G9-6365-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-G9-6365-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_1_rg.sorted,TCGA-G9-6365-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_1_rg.sorted.bam,59.4,1.9,0.17,58cfa832e4b0c9d6adf6cf91,TCGA-G9-6365-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6365-01A,6845076E-E940-4437-8618-81DB4A447544,Primary Tumor,Illumina HiSeq,9d7979c6-8197-4347-806d-4bb667d5cb2b,Prostate,71,95D6E1D3-91C1-40E5-986D-1C5ABB33A03F,CD30C4FA-8BBF-4A8A-A1F7-4FA0D45CA380,TCGA-G9-6365-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6365,TCGA-PRAD,NA,s3973,Harvard Medical School,Roswell Park,United States,NO,T4,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c588,58cfa831e4b0c9d6adf6c588,TCGA-CM-4748-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-CM-4748-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-CM-4748-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,227.02,1.9,0.13,58cfa831e4b0c9d6adf6c588,TCGA-CM-4748-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-CM-4748-01A,CD845618-4CC4-49C2-9055-C171D4C24EE1,Primary Tumor,Illumina HiSeq,f3119dfa-63bb-4098-9ea9-874f04789d12,Colorectal,53,1A465792-4DA7-4D37-9352-73E76ECFF4D2,3E7170B8-B0ED-4077-A65A-B6E399719A93,TCGA-CM-4748-01A-01D-1405-02,HG18,TCGA-CM-4748,TCGA-COAD,NA,s13392,Harvard Medical School,MSKCC,None,NO,T4a,N1a,Colon Mucinous Adenocarcinoma,Stage IIIB
13722.58cfa82fe4b0c9d6adf6b882,58cfa82fe4b0c9d6adf6b882,TCGA-A6-2678-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-2678-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-2678-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,493.29,1.9,0.15,58cfa82fe4b0c9d6adf6b882,TCGA-A6-2678-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2678-01A,3A785E32-7960-4C72-84C4-FB42C4DD86F1,Primary Tumor,Illumina HiSeq,31675676-aba0-4d34-a2dc-0356129ceaa2,Colorectal,43,20ECCD8A-DFAF-40E4-8128-D77AA41680C4,83E77250-E68B-4ECA-9592-4424151E0D79,TCGA-A6-2678-01A-01D-1167-02,HG18,TCGA-A6-2678,TCGA-COAD,NA,s12856,Harvard Medical School,Christiana Healthcare,None,NO,T3,N1,Colon Adenocarcinoma,Stage IIIB
13722.58cfa830e4b0c9d6adf6bd02,58cfa830e4b0c9d6adf6bd02,TCGA-AF-2691-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AF-2691-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AF-2691-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,372.21,1.9,0.14,58cfa830e4b0c9d6adf6bd02,TCGA-AF-2691-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-AF-2691-10A,830FD359-ABD4-4C99-89E4-2D6BB9CE5637,Blood Derived Normal,Illumina HiSeq,9b916a25-d6ee-4633-9d63-964fb2d45c38,Colorectal,48,2902CDFC-CF54-4459-B018-FE50678C284E,6E66F7DA-5AB7-4769-B367-1CFDFE3D058A,TCGA-AF-2691-10A-01D-1167-02,HG18,TCGA-AF-2691,TCGA-READ,NA,s1974,Harvard Medical School,Christiana Healthcare,None,NO,T1,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa831e4b0c9d6adf6caa0,58cfa831e4b0c9d6adf6caa0,TCGA-DJ-A1QM-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DJ-A1QM-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_3_rg.sorted,TCGA-DJ-A1QM-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_3_rg.sorted.bam,41.49,1.86,0.16,58cfa831e4b0c9d6adf6caa0,TCGA-DJ-A1QM-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QM-01A,3597AF5E-65FF-40A7-95FC-DACC26CBCA14,Primary Tumor,Illumina HiSeq,e98815fd-cd95-4af1-af17-129186e4a00a,Thyroid,42,B4215B1F-3918-43D6-8862-380C35F891EC,A070BCA4-DDFA-4BE7-A635-69A2BA97FFE9,TCGA-DJ-A1QM-01A-11D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QM,TCGA-THCA,NA,s12243,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T1a,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa830e4b0c9d6adf6bc1c,58cfa830e4b0c9d6adf6bc1c,TCGA-AG-A020-01A-21D-A079-02_110409_SN590_0077_BB04EHABXX_s_1.rg.sorted.filtered.,WGS,TCGA-AG-A020-01A-21D-A079-02_110409_SN590_0077_BB04EHABXX_s_1.rg.sorted,TCGA-AG-A020-01A-21D-A079-02_110409_SN590_0077_BB04EHABXX_s_1.rg.sorted.bam,125.63,1.96,0.17,58cfa830e4b0c9d6adf6bc1c,TCGA-AG-A020-01A-21D-A079-02_110409_SN590_0077_BB04EHABXX_s_1.rg.sorted.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A020-01A,19E46A3D-18C5-4927-8501-2265E2D617B8,Primary Tumor,Illumina HiSeq,1aa43549-776a-4daf-b60e-f0b8c3287077,Colorectal,57,EEC9C9E3-6CB3-4589-B3A8-EA2337878599,140B186D-B7EC-4A31-8FE0-A490BBDAE19B,TCGA-AG-A020-01A-21D-A079-02,HG18_Broad_variant,TCGA-AG-A020,TCGA-READ,NA,s2003,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Mucinous Adenocarcinoma,Stage III
13722.58cfa832e4b0c9d6adf6ce20,58cfa832e4b0c9d6adf6ce20,TCGA-FG-6688-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FG-6688-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_5_rg.sorted,TCGA-FG-6688-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_5_rg.sorted.bam,62.7,2,0.17,58cfa832e4b0c9d6adf6ce20,TCGA-FG-6688-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_5_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-6688-01A,DADD7428-9E4D-4652-9469-AB521B88D529,Primary Tumor,Illumina HiSeq,3b45431a-1066-4467-bc8a-f1aa3342c5f0,Brain,59,8594744F-F317-4022-991B-21891DA7F80A,5977877C-7B55-4666-AC08-54FEF233FB2F,TCGA-FG-6688-01A-11D-1891-02,HG19_Broad_variant,TCGA-FG-6688,TCGA-LGG,NA,s8570,Harvard Medical School,Case Western,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa82fe4b0c9d6adf6b982,58cfa82fe4b0c9d6adf6b982,TCGA-AA-3861-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3861-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3861-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,294,1.9,0.15,58cfa82fe4b0c9d6adf6b982,TCGA-AA-3861-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3861-01A,5DA56982-6DE7-4994-AA9E-3B01200B2959,Primary Tumor,Illumina HiSeq,041d683a-798a-4869-a98d-b7abfe977709,Colorectal,72,390070D8-EF9B-46FE-93EE-9CF01A642A92,3FF478FA-97AF-4122-AC93-1BF1DD21BCB3,TCGA-AA-3861-01A-01D-1167-02,HG18,TCGA-AA-3861,TCGA-COAD,NA,s13186,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6af9a,58cfa82ee4b0c9d6adf6af9a,TCGA-05-4396-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_2_rg.sorted.filtered.,WGS,TCGA-05-4396-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_2_rg.sorted,TCGA-05-4396-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_2_rg.sorted.bam,73,1.9,0.14,58cfa82ee4b0c9d6adf6af9a,TCGA-05-4396-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_2_rg.sorted.bam,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4396-10A,9F81C602-8AFA-4588-B0B6-6E5A1A128D5A,Blood Derived Normal,Illumina HiSeq,65a4aa5b-a7ca-4c50-a08f-ef176cfb2ff3,Lung,76,329954AA-6B53-4356-9429-09DD91CEA2C5,21900785-5668-4654-B046-19D1F2FA1674,TCGA-05-4396-10A-01D-1853-02,HG19_Broad_variant,TCGA-05-4396,TCGA-LUAD,303,s10772,Harvard Medical School,Indivumed,Germany,NO,T4,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIIB
13722.58cfa831e4b0c9d6adf6c598,58cfa831e4b0c9d6adf6c598,TCGA-CN-4735-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CN-4735-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_2_rg.sorted,TCGA-CN-4735-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_2_rg.sorted.bam,543.4,1.9,0.16,58cfa831e4b0c9d6adf6c598,TCGA-CN-4735-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4735-10A,FE844945-3EA9-449E-993C-DF392FABCFD0,Blood Derived Normal,Illumina HiSeq,430a1e6e-314d-47f4-82fe-d5976cdc409d,Head and Neck,52,A2CAEAB5-55A4-412F-A647-0112F48BBBE7,9E74974B-EE15-4452-801B-770B4D7F9FD3,TCGA-CN-4735-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4735,TCGA-HNSC,NA,s16029,Harvard Medical School,University of Pittsburgh,None,NO,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82fe4b0c9d6adf6b980,58cfa82fe4b0c9d6adf6b980,TCGA-AA-3681-10A-01D-1638-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3681-10A-01D-1638-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3681-10A-01D-1638-02_IlluminaHiSeq-DNASeq_whole.bam,9.96,1.9,0.15,58cfa82fe4b0c9d6adf6b980,TCGA-AA-3681-10A-01D-1638-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3681-10A,ABB0D53F-F74E-45DC-8FBB-40863016F3C6,Blood Derived Normal,Illumina HiSeq,15b89ab0-b489-477c-8f9d-9ab768e31c22,Colorectal,77,330FD816-5184-41E7-9BAD-F271D7D1D295,F650F791-6E5F-46FC-BD54-1621F8A13514,TCGA-AA-3681-10A-01D-1638-02,HG18,TCGA-AA-3681,TCGA-COAD,NA,s13191,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage III
13722.58cfa831e4b0c9d6adf6c8ac,58cfa831e4b0c9d6adf6c8ac,TCGA-D9-A1JX-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-D9-A1JX-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_7_rg.sorted,TCGA-D9-A1JX-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_7_rg.sorted.bam,53.11,NA,0.17,58cfa831e4b0c9d6adf6c8ac,TCGA-D9-A1JX-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D9-A1JX-10A,F505058F-74F2-4476-887F-06590A605980,Blood Derived Normal,Illumina HiSeq,7a4a6e10-a6a2-4a78-be06-7e650df381ef,Skin,80,6D928F3A-A036-44CD-B714-15E0C19C30CD,6D4599CC-43B3-4AE5-805E-8D23DEF87FAA,TCGA-D9-A1JX-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-D9-A1JX,TCGA-SKCM,NA,s7505,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,TX,NX,Not available,Not available
13722.58cfa82fe4b0c9d6adf6b876,58cfa82fe4b0c9d6adf6b876,TCGA-A6-2678-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-2678-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-2678-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,275.56,1.9,0.14,58cfa82fe4b0c9d6adf6b876,TCGA-A6-2678-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2678-10A,3A785E32-7960-4C72-84C4-FB42C4DD86F1,Blood Derived Normal,Illumina HiSeq,49b530ed-0c02-4603-9fe8-fcca89de8079,Colorectal,43,D010B8B9-6926-4ADB-A0F8-7613A5325C92,1CEE58FF-C097-408F-B6DF-EA79482C80F7,TCGA-A6-2678-10A-01D-1167-02,HG18,TCGA-A6-2678,TCGA-COAD,NA,s13658,Harvard Medical School,Christiana Healthcare,None,NO,T3,N1,Colon Adenocarcinoma,Stage IIIB
13722.58cfa831e4b0c9d6adf6cada,58cfa831e4b0c9d6adf6cada,TCGA-DU-6542-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DU-6542-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_2_rg.sorted,TCGA-DU-6542-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_2_rg.sorted.bam,424.7,1.9,0.14,58cfa831e4b0c9d6adf6cada,TCGA-DU-6542-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6542-01A,CD69D509-A652-4257-A8D3-767296BBB4EC,Primary Tumor,Illumina HiSeq,4b6cb752-5ed6-42e5-aed5-c8bdc6b95945,Brain,25,D00791AB-AA9D-406B-934C-E6946A430BB2,6EF0AE20-9197-4162-9A35-E235071A83B5,TCGA-DU-6542-01A-11D-1891-02,HG19_Broad_variant,TCGA-DU-6542,TCGA-LGG,NA,s8143,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa82fe4b0c9d6adf6b754,58cfa82fe4b0c9d6adf6b754,TCGA-49-4505-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-49-4505-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-49-4505-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,307.53,1.9,0.16,58cfa82fe4b0c9d6adf6b754,TCGA-49-4505-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4505-11A,088EDF89-D2B5-40C7-B066-DF3BD383F7EA,Solid Tissue Normal,Illumina HiSeq,edd13c78-4a11-4932-8158-20f922466310,Lung,61,5812901F-A0CE-4772-862D-FF9AD12B0EE8,2FCDCB12-DC4B-4CCC-8E27-986DB65670A4,TCGA-49-4505-11A-01D-1203-02,GRCh37,TCGA-49-4505,TCGA-LUAD,428,s10779,Harvard Medical School,Johns Hopkins,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa831e4b0c9d6adf6c96e,58cfa831e4b0c9d6adf6c96e,TCGA-DJ-A1QO-10A-01D-A14U_120629_SN1120_0168_BD1454ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DJ-A1QO-10A-01D-A14U_120629_SN1120_0168_BD1454ACXX_s_8_rg.sorted,TCGA-DJ-A1QO-10A-01D-A14U_120629_SN1120_0168_BD1454ACXX_s_8_rg.sorted.bam,38.63,2.12,0.17,58cfa831e4b0c9d6adf6c96e,TCGA-DJ-A1QO-10A-01D-A14U_120629_SN1120_0168_BD1454ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QO-10A,F2AD720E-579F-4E2C-A3F0-17877CA91067,Blood Derived Normal,Illumina HiSeq,622981e6-e448-492c-bef1-f31bd0dea146,Thyroid,69,23A38BFD-4AF5-44A9-B3C4-737D07E4E4F1,2852AA8B-F5D8-423F-BE97-83053C855246,TCGA-DJ-A1QO-10A-01D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QO,TCGA-THCA,NA,s12374,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage III
13722.58cfa830e4b0c9d6adf6c11c,58cfa830e4b0c9d6adf6c11c,TCGA-BS-A0TD-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BS-A0TD-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_2_rg.sorted,TCGA-BS-A0TD-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_2_rg.sorted.bam,96.72,1.83,0.13,58cfa830e4b0c9d6adf6c11c,TCGA-BS-A0TD-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_2_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TD-01A,FFAA98A0-2B69-46DC-AEE5-C5C3F2ABBC38,Primary Tumor,Illumina HiSeq,8f5ee5b5-1b1c-4af7-a179-4b71cc7c9f12,Uterus,65,8BB3A057-8958-4F62-AF81-976DA2E92DF7,3EF9C5ED-860A-4FF2-AA76-C53E9EB2453E,TCGA-BS-A0TD-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0TD,TCGA-UCEC,NA,s5219,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cd5e,58cfa831e4b0c9d6adf6cd5e,TCGA-EE-A2MS-06A-11D-A18Y_120718_SN1222_0126_AC117AACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EE-A2MS-06A-11D-A18Y_120718_SN1222_0126_AC117AACXX_s_3_rg.sorted,TCGA-EE-A2MS-06A-11D-A18Y_120718_SN1222_0126_AC117AACXX_s_3_rg.sorted.bam,64.33,NA,0.16,58cfa831e4b0c9d6adf6cd5e,TCGA-EE-A2MS-06A-11D-A18Y_120718_SN1222_0126_AC117AACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MS-06A,4A4F5EE9-B588-4357-B058-EFFBFB53E2C3,Metastatic,Illumina HiSeq,4cc98a8c-1e89-4a0a-a8c5-4a23e7880ac4,Skin,72,CEFFDD2F-6C8E-43DB-BE2E-D111F892C683,10D894D7-3C7B-4DBB-AD20-8ED6A970572F,TCGA-EE-A2MS-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2MS,TCGA-SKCM,NA,s7346,Harvard Medical School,University of Sydney,Australia,NO,T3a,N0,Not available,Stage II
13722.58cfa830e4b0c9d6adf6c31b,58cfa830e4b0c9d6adf6c31b,TCGA-BS-A0TI-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BS-A0TI-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_5_rg.sorted,TCGA-BS-A0TI-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_5_rg.sorted.bam,82.74,1.89,0.17,58cfa830e4b0c9d6adf6c31b,TCGA-BS-A0TI-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TI-01A,DF857BC6-FD6A-4713-BEF9-6EE1301E5FB1,Primary Tumor,Illumina HiSeq,ea49ec05-391f-4ccc-8dbf-11ec80154839,Uterus,64,2F52C850-8E70-4EAB-88F3-D35DC55E385B,E1707EDD-FAC5-4213-BA50-2538F9F90EE5,TCGA-BS-A0TI-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0TI,TCGA-UCEC,NA,s5010,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d5f6,58cfa832e4b0c9d6adf6d5f6,TCGA-LN-A49V-10A-01D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-LN-A49V-10A-01D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_8_rg.sorted,TCGA-LN-A49V-10A-01D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_8_rg.sorted.bam,40.05,NA,0.17,58cfa832e4b0c9d6adf6d5f6,TCGA-LN-A49V-10A-01D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_8_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49V-10A,0AB29DE2-EB9E-4A25-99DE-5F543CFBDB53,Blood Derived Normal,Illumina HiSeq,693ea7aa-4e14-484b-87a9-564ba5815ad3,Esophagus,49,54100362-D87F-4360-B9C3-8042B2B670EB,94EC2C86-92CE-4560-94F0-E82AE31B9245,TCGA-LN-A49V-10A-01D-A248-26,HG19_Broad_variant,TCGA-LN-A49V,TCGA-ESCA,NA,s1867,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa82fe4b0c9d6adf6ba21,58cfa82fe4b0c9d6adf6ba21,TCGA-AA-3666-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3666-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3666-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,81.96,1.9,0.15,58cfa82fe4b0c9d6adf6ba21,TCGA-AA-3666-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3666-10A,A512701F-88BB-4B05-8C94-FD285B9DD13E,Blood Derived Normal,Illumina HiSeq,58cda208-4b02-4391-9361-09d9fb432ba9,Colorectal,68,F181B2C2-6FB2-4B7D-8C6B-A198EEE941FB,E48DCD11-E4C2-40AA-98C9-5CFE97E37E4F,TCGA-AA-3666-10A-01D-1167-02,HG18,TCGA-AA-3666,TCGA-COAD,61,s13026,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage III
13722.58cfa832e4b0c9d6adf6d5f9,58cfa832e4b0c9d6adf6d5f9,TCGA-LN-A49W-10A-01D-A267_131018_SN590_0240_AC2MW5ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-LN-A49W-10A-01D-A267_131018_SN590_0240_AC2MW5ACXX_s_6_rg.sorted,TCGA-LN-A49W-10A-01D-A267_131018_SN590_0240_AC2MW5ACXX_s_6_rg.sorted.bam,43.58,NA,0.16,58cfa832e4b0c9d6adf6d5f9,TCGA-LN-A49W-10A-01D-A267_131018_SN590_0240_AC2MW5ACXX_s_6_rg.sorted.bam,Alive,MALE,ASIAN,Not available,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49W-10A,DAF211F2-941E-4244-8CF5-D31492269443,Blood Derived Normal,Illumina HiSeq,cfd64f86-5534-4ee7-ae0e-a68a622e0be8,Esophagus,73,67C9543B-3D37-4762-9FFF-602E7E0B7D93,8F89DE2A-8C40-4F93-BD00-3CB47EFC4876,TCGA-LN-A49W-10A-01D-A267-26,HG19_Broad_variant,TCGA-LN-A49W,TCGA-ESCA,NA,s1878,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N1,Not available,Stage III
13722.58cfa830e4b0c9d6adf6bf7a,58cfa830e4b0c9d6adf6bf7a,TCGA-BR-6454-11A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BR-6454-11A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_7_rg.sorted,TCGA-BR-6454-11A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_7_rg.sorted.bam,186.4,1.9,0.15,58cfa830e4b0c9d6adf6bf7a,TCGA-BR-6454-11A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6454-11A,AC2CBCE4-4BA8-42C9-AC61-70F42995588E,Solid Tissue Normal,Illumina HiSeq,e6845469-d068-4e77-bc48-b17e5ad0c4de,Stomach,58,71DFB0A1-8475-4990-82F3-51CD5CE7D230,5AEB6210-8FC6-45B4-8594-777F0A5D7CA7,TCGA-BR-6454-11A-01D-1798-02,HG19_Broad_variant,TCGA-BR-6454,TCGA-STAD,NA,s15180,Harvard Medical School,Asterand,Russia,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA
13722.58cfa82fe4b0c9d6adf6b9cc,58cfa82fe4b0c9d6adf6b9cc,TCGA-AA-A00Z-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A00Z-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A00Z-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,264.6,1.73,0.15,58cfa82fe4b0c9d6adf6b9cc,TCGA-AA-A00Z-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A00Z-01A,AF3A0634-4292-45BD-B948-6B6BD2D58090,Primary Tumor,Illumina HiSeq,9701e2c0-3702-4d55-9816-940f128d19e0,Colorectal,70,75A6A64E-11F0-41C8-9CBA-179AE3333621,DF16D4D9-DD5E-4614-AE58-465EC09F2992,TCGA-AA-A00Z-01A-01D-A077-02,HG18,TCGA-AA-A00Z,TCGA-COAD,NA,s13198,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82fe4b0c9d6adf6b834,58cfa82fe4b0c9d6adf6b834,TCGA-A5-A0RA-01A-21D-A101_120403_SN1222_0093_AC0L7VACXX_s_6_rg.sorted.filtered.,WGS,TCGA-A5-A0RA-01A-21D-A101_120403_SN1222_0093_AC0L7VACXX_s_6_rg.sorted,TCGA-A5-A0RA-01A-21D-A101_120403_SN1222_0093_AC0L7VACXX_s_6_rg.sorted.bam,85.83,2.23,0.16,58cfa82fe4b0c9d6adf6b834,TCGA-A5-A0RA-01A-21D-A101_120403_SN1222_0093_AC0L7VACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0RA-01A,AFD710B8-D172-4AC4-9973-E969DB1ED231,Primary Tumor,Illumina HiSeq,d644ff0f-6dc7-4922-a46d-3223823e8118,Uterus,68,4ED231EE-0E54-4AC5-8278-1061AD3972A2,01EFCC42-CCFA-4D41-87BE-CA8F1C551823,TCGA-A5-A0RA-01A-21D-A101-02,HG19_Broad_variant,TCGA-A5-A0RA,TCGA-UCEC,NA,s5195,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cc54,58cfa831e4b0c9d6adf6cc54,TCGA-ER-A193-06A-12D-A18Y_120718_SN1222_0126_AC117AACXX_s_1_rg.sorted.filtered.,WGS,TCGA-ER-A193-06A-12D-A18Y_120718_SN1222_0126_AC117AACXX_s_1_rg.sorted,TCGA-ER-A193-06A-12D-A18Y_120718_SN1222_0126_AC117AACXX_s_1_rg.sorted.bam,48.72,NA,0.16,58cfa831e4b0c9d6adf6cc54,TCGA-ER-A193-06A-12D-A18Y_120718_SN1222_0126_AC117AACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A193-06A,8AB09143-DAF6-40A9-85D3-0FE9DE7B3E06,Metastatic,Illumina HiSeq,1095eea4-ccec-4aca-9afa-5f2c1ca24703,Skin,62,378B3D8A-ADBB-4912-A0BF-6B74A282113E,8A1BFE0E-C97A-41C4-815F-CF5BB5CFC69F,TCGA-ER-A193-06A-12D-A18Y-02,HG19_Broad_variant,TCGA-ER-A193,TCGA-SKCM,955,s8017,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N0,Not available,Stage IIB
13722.58cfa830e4b0c9d6adf6be44,58cfa830e4b0c9d6adf6be44,TCGA-AF-2691-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AF-2691-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AF-2691-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,406.94,1.9,0.15,58cfa830e4b0c9d6adf6be44,TCGA-AF-2691-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-AF-2691-01A,830FD359-ABD4-4C99-89E4-2D6BB9CE5637,Primary Tumor,Illumina HiSeq,92f1a7a8-08ff-487e-bd7d-8146bc0109c6,Colorectal,48,CE252C3D-5CF3-46BC-A181-3714D1C65E4E,64EDFE90-619C-42A0-BBE1-EB78B4D5C26D,TCGA-AF-2691-01A-01D-1167-02,HG18,TCGA-AF-2691,TCGA-READ,NA,s2131,Harvard Medical School,Christiana Healthcare,None,NO,T1,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa831e4b0c9d6adf6cc11,58cfa831e4b0c9d6adf6cc11,TCGA-EE-A29H-06A-12D-A18Y_120729_SN1120_0180_BC1176ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EE-A29H-06A-12D-A18Y_120729_SN1120_0180_BC1176ACXX_s_6_rg.sorted,TCGA-EE-A29H-06A-12D-A18Y_120729_SN1120_0180_BC1176ACXX_s_6_rg.sorted.bam,57.71,NA,0.17,58cfa831e4b0c9d6adf6cc11,TCGA-EE-A29H-06A-12D-A18Y_120729_SN1120_0180_BC1176ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29H-06A,C8BA1856-D055-4DC6-A184-72763C76AAE4,Metastatic,Illumina HiSeq,21070c2b-7503-4c5c-9a66-5e6564c37d01,Skin,59,92AE970D-75B4-4D9F-B84F-A2070F0CBE90,F32701EE-123A-4D6C-AE5A-06F52AAD063E,TCGA-EE-A29H-06A-12D-A18Y-02,HG19_Broad_variant,TCGA-EE-A29H,TCGA-SKCM,NA,s7840,Harvard Medical School,University of Sydney,Australia,NO,T1a,N0,Not available,Stage IA
13722.58cfa832e4b0c9d6adf6ce97,58cfa832e4b0c9d6adf6ce97,TCGA-G2-A2EF-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_7_rg.sorted.filtered.,WGS,TCGA-G2-A2EF-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_7_rg.sorted,TCGA-G2-A2EF-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_7_rg.sorted.bam,40.86,NA,0.15,58cfa832e4b0c9d6adf6ce97,TCGA-G2-A2EF-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-G2-A2EF-01A,2A142731-119C-495D-AD30-EB0B48BACB46,Primary Tumor,Illumina HiSeq,ac16538b-bd5d-496e-bccc-6f3374d226c6,Bladder,50,981F581E-32AF-486B-9B60-0C8F1047C879,CE2F4DE7-C8AE-4103-8084-5F783B1087A7,TCGA-G2-A2EF-01A-12D-A18D-02,HG19_Broad_variant,TCGA-G2-A2EF,TCGA-BLCA,NA,s3118,Harvard Medical School,MD Anderson,United States,NO,Not available,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa82fe4b0c9d6adf6b8cc,58cfa82fe4b0c9d6adf6b8cc,TCGA-49-4501-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-49-4501-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-49-4501-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,199.2,1.9,0.16,58cfa82fe4b0c9d6adf6b8cc,TCGA-49-4501-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4501-11A,0780EB43-D5B5-4C3D-9825-BEACBA5CC723,Solid Tissue Normal,Illumina HiSeq,2e94d307-de8c-4849-a870-8731a029c297,Lung,67,21AC5886-832B-4352-95D2-0147F90423CC,CE4FA727-5E58-4C07-921C-2C3B9BC509DB,TCGA-49-4501-11A-01D-1203-02,GRCh37,TCGA-49-4501,TCGA-LUAD,1421,s10905,Harvard Medical School,Johns Hopkins,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6cd70,58cfa831e4b0c9d6adf6cd70,TCGA-ET-A25K-10A-01D-A16N_120717_SN1120_0176_BC1178ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-ET-A25K-10A-01D-A16N_120717_SN1120_0176_BC1178ACXX_s_8_rg.sorted,TCGA-ET-A25K-10A-01D-A16N_120717_SN1120_0176_BC1178ACXX_s_8_rg.sorted.bam,18.33,1.84,0.16,58cfa831e4b0c9d6adf6cd70,TCGA-ET-A25K-10A-01D-A16N_120717_SN1120_0176_BC1178ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-ET-A25K-10A,2F9ED09D-2626-4C23-BA47-1850D36F812A,Blood Derived Normal,Illumina HiSeq,6f869861-b0d2-4022-a0ef-d1f46eea9f40,Thyroid,36,38379990-627C-4FAC-A13A-6AFD9D47A448,34182C38-B860-44A4-AA11-6D1DFD5BB267,TCGA-ET-A25K-10A-01D-A16N-02,HG19_Broad_variant,TCGA-ET-A25K,TCGA-THCA,NA,s12526,Harvard Medical School,Johns Hopkins,United States,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6d272,58cfa832e4b0c9d6adf6d272,TCGA-JX-A3PZ-10A-01D-A245_140206_SN1222_0239_BC2RAKACXX_s_1_rg.sorted.filtered.,WGS,TCGA-JX-A3PZ-10A-01D-A245_140206_SN1222_0239_BC2RAKACXX_s_1_rg.sorted,TCGA-JX-A3PZ-10A-01D-A245_140206_SN1222_0239_BC2RAKACXX_s_1_rg.sorted.bam,152.85,NA,0.16,58cfa832e4b0c9d6adf6d272,TCGA-JX-A3PZ-10A-01D-A245_140206_SN1222_0239_BC2RAKACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-JX-A3PZ-10A,3DF6ABE2-2123-4BFA-A4E4-88DF5F940C04,Blood Derived Normal,Illumina HiSeq,1078fe30-c37b-494e-97ca-3359b7d8f630,Cervix,25,BFDA8AD6-DEAE-44DD-BAFE-BA82787B90B2,AB085977-E921-4F4D-A79C-15305114674B,TCGA-JX-A3PZ-10A-01D-A245-26,HG19_Broad_variant,TCGA-JX-A3PZ,TCGA-CESC,642,s1217,MD Anderson - Institute for Applied Cancer Science,Washington University,United States,NO,T1b,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6ba75,58cfa830e4b0c9d6adf6ba75,TCGA-AA-3812-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3812-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3812-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,270.96,1.9,0.15,58cfa830e4b0c9d6adf6ba75,TCGA-AA-3812-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3812-01A,4563E4E0-A661-46DE-AD25-9C86A621E147,Primary Tumor,Illumina HiSeq,92316171-5ae2-4812-b824-183f14adf90a,Colorectal,82,98AD41D5-FD77-4F30-94B5-03BF7B9C69B9,B4AA0837-42E8-41B7-B44B-F84D48155C3E,TCGA-AA-3812-01A-01D-1167-02,HG18,TCGA-AA-3812,TCGA-COAD,NA,s13188,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6c106,58cfa830e4b0c9d6adf6c106,TCGA-BS-A0TJ-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BS-A0TJ-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_6_rg.sorted,TCGA-BS-A0TJ-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_6_rg.sorted.bam,96.9,1.86,0.16,58cfa830e4b0c9d6adf6c106,TCGA-BS-A0TJ-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_6_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TJ-01A,F74DA4C6-4291-46D2-ABD4-7D7F6EF03B00,Primary Tumor,Illumina HiSeq,d9625d1c-df48-4532-994d-9ab3a3c8f8b6,Uterus,59,AC35307B-AC7F-49FC-A237-5E03AB2E2276,C20AA17E-3866-4864-A4AE-44ACFD746221,TCGA-BS-A0TJ-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0TJ,TCGA-UCEC,NA,s5012,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b93e,58cfa82fe4b0c9d6adf6b93e,TCGA-AA-3861-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3861-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3861-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,101.56,1.9,0.15,58cfa82fe4b0c9d6adf6b93e,TCGA-AA-3861-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3861-10A,5DA56982-6DE7-4994-AA9E-3B01200B2959,Blood Derived Normal,Illumina HiSeq,51e1be67-574c-47ee-9d7f-9f7f081cdd0e,Colorectal,72,51992867-495A-41A3-B708-311F08B6981F,479CE743-8C57-4B91-98BA-A36F2B526CAE,TCGA-AA-3861-10A-01D-1167-02,HG18,TCGA-AA-3861,TCGA-COAD,NA,s13520,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6bbc8,58cfa830e4b0c9d6adf6bbc8,TCGA-AG-4015-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-4015-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-4015-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,610.89,1.9,0.14,58cfa830e4b0c9d6adf6bbc8,TCGA-AG-4015-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-4015-01A,1388BBA1-02BA-40DF-93E5-C3D58B7BBAE0,Primary Tumor,Illumina HiSeq,70efc59a-8909-43e4-961b-76a7a3633927,Colorectal,85,3C910093-DF83-485B-86EF-26A0991D9A0B,2E183A8C-5755-4DC7-AEAB-6F7E9A9A5D1A,TCGA-AG-4015-01A-01D-1115-02,HG18,TCGA-AG-4015,TCGA-READ,NA,s1986,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6be2a,58cfa830e4b0c9d6adf6be2a,TCGA-B6-A0X4-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_7_rg.sorted.filtered.,WGS,TCGA-B6-A0X4-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_7_rg.sorted,TCGA-B6-A0X4-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_7_rg.sorted.bam,65.55,2.08,0.15,58cfa830e4b0c9d6adf6be2a,TCGA-B6-A0X4-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0X4-01A,4E42FDC5-2A8B-49E9-87EF-6DB7A6692D08,Primary Tumor,Illumina HiSeq,1973be6c-c5a9-40d1-bdd2-a752dd33d6d1,Breast,62,45C3BD72-D260-4663-9091-5058E58F352D,062A41CC-4B23-49E2-AFF8-3CFE34DE9A36,TCGA-B6-A0X4-01A-11D-A106-02,HG19_Broad_variant,TCGA-B6-A0X4,TCGA-BRCA,860,s6462,Harvard Medical School,Duke,United States,NO,T2,N1b,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa82fe4b0c9d6adf6b87d,58cfa82fe4b0c9d6adf6b87d,TCGA-A6-2680-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-2680-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-2680-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,161,1.9,0.15,58cfa82fe4b0c9d6adf6b87d,TCGA-A6-2680-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2680-10A,FF1407C6-9174-4BAE-A19B-D34CA71B898C,Blood Derived Normal,Illumina HiSeq,516bf47a-48a2-4f0d-af51-c876cfa2f44a,Colorectal,72,9A6C98F6-F3B0-4BB7-9825-ED33C33C33D0,4AB3A66F-319D-435E-84DA-2302950C6A04,TCGA-A6-2680-10A-01D-1405-02,HG18,TCGA-A6-2680,TCGA-COAD,NA,s12859,Harvard Medical School,Christiana Healthcare,None,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c77a,58cfa831e4b0c9d6adf6c77a,TCGA-D3-A3CC-06A-11D-A18Z_120626_SN590_0164_BC0VMVACXX_s_5_rg.sorted.filtered.,WGS,TCGA-D3-A3CC-06A-11D-A18Z_120626_SN590_0164_BC0VMVACXX_s_5_rg.sorted,TCGA-D3-A3CC-06A-11D-A18Z_120626_SN590_0164_BC0VMVACXX_s_5_rg.sorted.bam,27.47,NA,0.16,58cfa831e4b0c9d6adf6c77a,TCGA-D3-A3CC-06A-11D-A18Z_120626_SN590_0164_BC0VMVACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A3CC-06A,2D36CEA4-73E9-493B-8433-0C2B911C0521,Metastatic,Illumina HiSeq,fd606b6a-a303-4b04-be1d-f12779b19969,Skin,69,2B274033-FA42-4A06-AEFE-7013E0E29318,D76073BC-61B7-4D7E-AF06-1C9CED11318B,TCGA-D3-A3CC-06A-11D-A18Z-02,HG19_Broad_variant,TCGA-D3-A3CC,TCGA-SKCM,NA,s7325,Harvard Medical School,MD Anderson,United States,NO,T4b,N0,Not available,Stage IIC
13722.58cfa830e4b0c9d6adf6bd44,58cfa830e4b0c9d6adf6bd44,TCGA-AP-A054-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_1_rg.sorted.filtered.,WGS,TCGA-AP-A054-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_1_rg.sorted,TCGA-AP-A054-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_1_rg.sorted.bam,117.13,2.03,0.16,58cfa830e4b0c9d6adf6bd44,TCGA-AP-A054-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A054-01A,D77E4DBC-B239-4742-8CB7-EFD427010D13,Primary Tumor,Illumina HiSeq,a8fe0928-3d0c-4d16-be11-a5dd077bdb2c,Uterus,64,DDFFB9C7-185F-402F-99B8-8058B40086D9,F5A9F85D-4E8E-4400-A109-C227D6B4C0A4,TCGA-AP-A054-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A054,TCGA-UCEC,709,s4590,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b39c,58cfa82fe4b0c9d6adf6b39c,TCGA-24-0966-01A-01W-0421-09_capture.filtered.,WGS,TCGA-24-0966-01A-01W-0421-09_capture,TCGA-24-0966-01A-01W-0421-09_capture.bam,296,NA,0.5,58cfa82fe4b0c9d6adf6b39c,TCGA-24-0966-01A-01W-0421-09_capture.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-0966-01A,FEF1696C-A8F4-4DB6-8615-E486522BAAAA,Primary Tumor,Illumina GA,7b2caf1d-ed89-4f67-87a4-cfa90da98b48,Ovary,78,67C7B4CB-5FE3-49CF-9AA3-DF23717553BB,21750467-8A05-4EDB-B90D-969D9026BFF9,TCGA-24-0966-01A-01W-0421-09,NCBI36_WUGSC_variant,TCGA-24-0966,TCGA-OV,NA,s17822,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d47c,58cfa832e4b0c9d6adf6d47c,TCGA-VD-A8KA-10A-01D-A40E_140716_SN208_0518_AC59RNACXX_s_7_rg.sorted.filtered.,WGS,TCGA-VD-A8KA-10A-01D-A40E_140716_SN208_0518_AC59RNACXX_s_7_rg.sorted,TCGA-VD-A8KA-10A-01D-A40E_140716_SN208_0518_AC59RNACXX_s_7_rg.sorted.bam,15.8,NA,0.14,58cfa832e4b0c9d6adf6d47c,TCGA-VD-A8KA-10A-01D-A40E_140716_SN208_0518_AC59RNACXX_s_7_rg.sorted.bam,Alive,MALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KA-10A,AF04CA52-8B71-497E-8135-6DDFCA9AB221,Blood Derived Normal,Illumina HiSeq,db421158-8c05-4eb4-a4b9-021a19779fdc,Eye,22,35A80607-31C3-409E-A3A9-B081980A6E5F,2BBA69DF-D77D-443A-A115-894CCEAC2270,TCGA-VD-A8KA-10A-01D-A40E-26,HG19_Broad_variant,TCGA-VD-A8KA,TCGA-UVM,NA,s249,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T3a,NX,Not available,Stage IIB
13722.58cfa82fe4b0c9d6adf6b678,58cfa82fe4b0c9d6adf6b678,TCGA-73-4670-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-73-4670-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-73-4670-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,343.9,1.9,0.16,58cfa82fe4b0c9d6adf6b678,TCGA-73-4670-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4670-01A,1B354837-4925-4480-AC32-6B44D0957314,Primary Tumor,Illumina HiSeq,8e4449ab-641c-44ea-af17-a681182f7299,Lung,69,646402AF-BA5F-438C-AE63-213EBD58B16D,D2FFA731-14A2-4A83-964E-C9969080263C,TCGA-73-4670-01A-01D-1203-02,GRCh37,TCGA-73-4670,TCGA-LUAD,NA,s11356,Harvard Medical School,Roswell Park,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IV
13722.58cfa831e4b0c9d6adf6cdca,58cfa831e4b0c9d6adf6cdca,TCGA-FG-6692-10A-01D-1891_130923_SN1222_0220_BC2DUUACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FG-6692-10A-01D-1891_130923_SN1222_0220_BC2DUUACXX_s_2_rg.sorted,TCGA-FG-6692-10A-01D-1891_130923_SN1222_0220_BC2DUUACXX_s_2_rg.sorted.bam,278.3,1.9,0.14,58cfa831e4b0c9d6adf6cdca,TCGA-FG-6692-10A-01D-1891_130923_SN1222_0220_BC2DUUACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-6692-10A,5F10CD91-1E03-4016-B35A-8629A1A8FCC9,Blood Derived Normal,Illumina HiSeq,08012a5a-0f7a-4f6e-92cf-b1878218e33c,Brain,63,D7EA0C8C-8642-4491-982E-6FC30D6D9237,C8066486-BC5A-4D91-B766-437C0A491304,TCGA-FG-6692-10A-01D-1891-02,HG19_Broad_variant,TCGA-FG-6692,TCGA-LGG,NA,s8369,Harvard Medical School,Case Western,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82fe4b0c9d6adf6b965,58cfa82fe4b0c9d6adf6b965,TCGA-AA-3529-01A-02D-1547-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3529-01A-02D-1547-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3529-01A-02D-1547-02_IlluminaHiSeq-DNASeq_whole.bam,109.29,1.9,0.13,58cfa82fe4b0c9d6adf6b965,TCGA-AA-3529-01A-02D-1547-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3529-01A,BFB07784-693B-4C25-874E-4AD6E04A5D46,Primary Tumor,Illumina HiSeq,8d96c289-9e08-45f8-a5dc-8c089ca7eb93,Colorectal,78,B083E3CB-0AF1-44EA-854D-85FD99B75AD5,B8C9B915-BD7E-41FA-B5E1-4A28478EDC6E,TCGA-AA-3529-01A-02D-1547-02,HG18,TCGA-AA-3529,TCGA-COAD,0,s13364,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Colon Adenocarcinoma,Stage IIIC
13722.58cfa82ee4b0c9d6adf6b034,58cfa82ee4b0c9d6adf6b034,TCGA-05-4426-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_8_rg.sorted.filtered.,WGS,TCGA-05-4426-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_8_rg.sorted,TCGA-05-4426-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_8_rg.sorted.bam,666.2,1.9,0.14,58cfa82ee4b0c9d6adf6b034,TCGA-05-4426-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_8_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4426-01A,36BF02F8-C1C8-49F9-A417-ADF88A205C70,Primary Tumor,Illumina HiSeq,63037227-adb0-4505-bd71-2527743ec736,Lung,71,0C06CF85-61EB-4E6D-AE54-B8F5CBAB9B63,EA6C652F-4896-4D57-978D-7528578BB153,TCGA-05-4426-01A-01D-1203-02,HG19_Broad_variant,TCGA-05-4426,TCGA-LUAD,NA,s10645,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa830e4b0c9d6adf6bfa8,58cfa830e4b0c9d6adf6bfa8,TCGA-BR-6454-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BR-6454-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_6_rg.sorted,TCGA-BR-6454-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_6_rg.sorted.bam,478.4,1.9,0.14,58cfa830e4b0c9d6adf6bfa8,TCGA-BR-6454-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6454-01A,AC2CBCE4-4BA8-42C9-AC61-70F42995588E,Primary Tumor,Illumina HiSeq,e344c34d-da8c-4145-8a02-b9ae248ca3a3,Stomach,58,E7D94421-7A3B-4100-9CBF-1B1F2EC07737,6F5506E4-8375-4F62-8B85-64FD729C6136,TCGA-BR-6454-01A-11D-1798-02,HG19_Broad_variant,TCGA-BR-6454,TCGA-STAD,NA,s14619,Harvard Medical School,Asterand,Russia,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA
13722.58cfa832e4b0c9d6adf6d0a8,58cfa832e4b0c9d6adf6d0a8,TCGA-FS-A1Z0-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FS-A1Z0-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_5_rg.sorted,TCGA-FS-A1Z0-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_5_rg.sorted.bam,37.19,NA,0.16,58cfa832e4b0c9d6adf6d0a8,TCGA-FS-A1Z0-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1Z0-10A,6A1966C3-7F01-4304-B4A1-C4EF683B179A,Blood Derived Normal,Illumina HiSeq,3e0779ab-0f7e-470a-8d69-255e5d4fb90b,Skin,32,56E023E3-67FD-4361-8BA5-79B69EFA4EBC,28CD8467-DF08-4AE9-B50A-F7C7ED3F60F3,TCGA-FS-A1Z0-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1Z0,TCGA-SKCM,6164,s7526,Harvard Medical School,Essen,Germany,NO,T1a,N0,Not available,Stage IA
13722.58cfa82fe4b0c9d6adf6b892,58cfa82fe4b0c9d6adf6b892,TCGA-A6-2681-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-2681-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-2681-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,308,1.9,0.15,58cfa82fe4b0c9d6adf6b892,TCGA-A6-2681-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2681-01A,7D8EAB0A-E6C8-4449-9EBF-50C41DB94A06,Primary Tumor,Illumina HiSeq,eda754a1-3a13-47a5-8e0e-49ef1384646d,Colorectal,73,0537BAD8-0E85-4B05-91B3-FD965E96D0D7,BFF8CDA3-3C4B-416F-AF46-6811B139D670,TCGA-A6-2681-01A-01D-1405-02,HG18,TCGA-A6-2681,TCGA-COAD,NA,s12860,Harvard Medical School,Christiana Healthcare,United States,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6ba5a,58cfa830e4b0c9d6adf6ba5a,TCGA-AA-3947-10A-01D-1167-02_101023_SN208_0167_B80L4DABXX_s_2.rg.sorted.filtered.,WGS,TCGA-AA-3947-10A-01D-1167-02_101023_SN208_0167_B80L4DABXX_s_2.rg.sorted,TCGA-AA-3947-10A-01D-1167-02_101023_SN208_0167_B80L4DABXX_s_2.rg.sorted.bam,111.56,1.9,0.15,58cfa830e4b0c9d6adf6ba5a,TCGA-AA-3947-10A-01D-1167-02_101023_SN208_0167_B80L4DABXX_s_2.rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3947-10A,654C6F5C-3E5C-49F0-B53F-87CD9797D7C9,Blood Derived Normal,Illumina HiSeq,fc7bc9a6-aec3-4170-bcb0-bea7670f93a4,Colorectal,60,9D9915E4-6918-4C69-B5DC-662EF545CA9E,8721FC52-DE61-486D-AFF2-921862F66212,TCGA-AA-3947-10A-01D-1167-02,HG18_Broad_variant,TCGA-AA-3947,TCGA-COAD,NA,s13671,Harvard Medical School,Indivumed,Germany,NO,T4,N0,Colon Mucinous Adenocarcinoma,Stage IIB
13722.58cfa831e4b0c9d6adf6c95a,58cfa831e4b0c9d6adf6c95a,TCGA-DJ-A1QF-01A-12D-A14U_120629_SN1120_0167_AC0WMBACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DJ-A1QF-01A-12D-A14U_120629_SN1120_0167_AC0WMBACXX_s_4_rg.sorted,TCGA-DJ-A1QF-01A-12D-A14U_120629_SN1120_0167_AC0WMBACXX_s_4_rg.sorted.bam,14.32,1.97,0.15,58cfa831e4b0c9d6adf6c95a,TCGA-DJ-A1QF-01A-12D-A14U_120629_SN1120_0167_AC0WMBACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QF-01A,FCA0C7D9-5E6F-4AA7-BA04-5DF2EB8BA398,Primary Tumor,Illumina HiSeq,267d7caa-22fc-41bc-8ea9-ee910a0ac510,Thyroid,61,E4B53CA1-D395-4FEA-A962-DFBD2B373A6B,FA0BE982-CE22-449F-9D2B-E688196BA8AE,TCGA-DJ-A1QF-01A-12D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QF,TCGA-THCA,NA,s11991,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage II
13722.58cfa831e4b0c9d6adf6cdf4,58cfa831e4b0c9d6adf6cdf4,TCGA-FS-A1YW-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FS-A1YW-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_8_rg.sorted,TCGA-FS-A1YW-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_8_rg.sorted.bam,46.15,NA,0.15,58cfa831e4b0c9d6adf6cdf4,TCGA-FS-A1YW-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1YW-10A,57DD4D65-CFAD-4533-92B4-90742289603B,Blood Derived Normal,Illumina HiSeq,fe104857-b150-4f94-8725-1ab7b8430b73,Skin,52,CFFED28D-93D2-4DCA-8B34-4F3B87858133,4577BE4B-3CA2-48A1-82B2-6CB50E1DABA3,TCGA-FS-A1YW-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1YW,TCGA-SKCM,6598,s7363,Harvard Medical School,Essen,Germany,NO,T1b,N0,Not available,Stage IB
13722.58cfa830e4b0c9d6adf6c010,58cfa830e4b0c9d6adf6c010,TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_7_rg.sorted.filtered.,WGS,TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_7_rg.sorted,TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_7_rg.sorted.bam,106.93,1.95,0.16,58cfa830e4b0c9d6adf6c010,TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0K0-01A,29C8F468-5AC1-4D6C-8376-E36E6D246926,Primary Tumor,Illumina HiSeq,e5550bf6-3edf-480e-9dc5-6d590e837e5e,Uterus,48,11C43948-E7C9-4436-A654-82FA8033B625,3296C785-7C20-487D-BAEC-C66022E77E53,TCGA-B5-A0K0-01A-11D-A043-02,HG19_Broad_variant,TCGA-B5-A0K0,TCGA-UCEC,NA,s4598,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6cec8,58cfa832e4b0c9d6adf6cec8,TCGA-EM-A1CW-10A-01D-A13U_120706_SN1222_0122_AC0WPYACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EM-A1CW-10A-01D-A13U_120706_SN1222_0122_AC0WPYACXX_s_8_rg.sorted,TCGA-EM-A1CW-10A-01D-A13U_120706_SN1222_0122_AC0WPYACXX_s_8_rg.sorted.bam,52.41,2,0.16,58cfa832e4b0c9d6adf6cec8,TCGA-EM-A1CW-10A-01D-A13U_120706_SN1222_0122_AC0WPYACXX_s_8_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1CW-10A,22EB9F00-6869-4D8F-B657-DFD64F81E9E9,Blood Derived Normal,Illumina HiSeq,b7ca46ef-71df-40f8-a10f-e27c97112b79,Thyroid,39,F4C14A19-949F-410C-9FC9-D81CBBA2D0B7,40DD4E1B-1BB2-47C1-A3AB-8F6D66FD12FF,TCGA-EM-A1CW-10A-01D-A13U-02,HG19_Broad_variant,TCGA-EM-A1CW,TCGA-THCA,NA,s12756,Harvard Medical School,University Health Network,Canada,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa831e4b0c9d6adf6cca2,58cfa831e4b0c9d6adf6cca2,TCGA-EQ-5647-01A-01D-1598_130110_SN1222_0167_AC1JPDACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EQ-5647-01A-01D-1598_130110_SN1222_0167_AC1JPDACXX_s_7_rg.sorted,TCGA-EQ-5647-01A-01D-1598_130110_SN1222_0167_AC1JPDACXX_s_7_rg.sorted.bam,255.7,1.87,0.15,58cfa831e4b0c9d6adf6cca2,TCGA-EQ-5647-01A-01D-1598_130110_SN1222_0167_AC1JPDACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-EQ-5647-01A,2D291FA3-F0FD-4BC1-91A6-783863714190,Primary Tumor,Illumina HiSeq,913ab9c5-864c-4652-a243-a0dc44a3b28e,Stomach,86,400FED84-FE61-4F7A-9DCC-6C32131106CD,ABD8CB7C-0FEC-4D00-950D-5A190A0D75F4,TCGA-EQ-5647-01A-01D-1598-02,HG19_Broad_variant,TCGA-EQ-5647,TCGA-STAD,19,s15252,Harvard Medical School,Christiana Healthcare,United States,NO,T4,N3,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa82fe4b0c9d6adf6b95e,58cfa82fe4b0c9d6adf6b95e,TCGA-AA-3548-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3548-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3548-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,628.56,1.9,0.16,58cfa82fe4b0c9d6adf6b95e,TCGA-AA-3548-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3548-01A,2DCED66C-1F0D-4039-A5E5-54CCA77C16E9,Primary Tumor,Illumina HiSeq,362e7b19-891a-4eba-9cba-97d157a94152,Colorectal,71,633AFC4C-4A35-420E-9CE6-FF4670E28395,B5E87744-9963-4DBA-84C8-B61048169517,TCGA-AA-3548-01A-01D-1167-02,HG18,TCGA-AA-3548,TCGA-COAD,NA,s13669,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Colon Adenocarcinoma,Stage IIIC
13722.58cfa832e4b0c9d6adf6d52e,58cfa832e4b0c9d6adf6d52e,TCGA-LN-A4A8-01A-32D-A267_131018_SN590_0241_BC30HBACXX_s_5_rg.sorted.filtered.,WGS,TCGA-LN-A4A8-01A-32D-A267_131018_SN590_0241_BC30HBACXX_s_5_rg.sorted,TCGA-LN-A4A8-01A-32D-A267_131018_SN590_0241_BC30HBACXX_s_5_rg.sorted.bam,34.22,NA,0.15,58cfa832e4b0c9d6adf6d52e,TCGA-LN-A4A8-01A-32D-A267_131018_SN590_0241_BC30HBACXX_s_5_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A4A8-01A,AA364B98-0097-43A4-976D-742FAA0276DF,Primary Tumor,Illumina HiSeq,fd30434f-5a9a-4128-99f1-85d8d06ead73,Esophagus,52,0C0582CA-A181-4EFB-8486-C4312B250BA9,E42ECB6E-825E-407C-9CC7-C153C8F40DDC,TCGA-LN-A4A8-01A-32D-A267-26,HG19_Broad_variant,TCGA-LN-A4A8,TCGA-ESCA,NA,s1935,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T2,N0,Not available,Stage IIA
13722.58cfa82fe4b0c9d6adf6b900,58cfa82fe4b0c9d6adf6b900,TCGA-73-4675-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-73-4675-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-73-4675-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,90.2,1.9,0.15,58cfa82fe4b0c9d6adf6b900,TCGA-73-4675-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4675-11A,AE39E358-08D7-4367-AE68-82B469E791E4,Solid Tissue Normal,Illumina HiSeq,5c0c01fd-bde7-41d5-ab01-78909043c0fe,Lung,59,F422BC11-2BEC-4E61-AA7E-384B157A83F7,5BA6E146-2BE0-4F81-B023-7C53B8408113,TCGA-73-4675-11A-01D-1203-02,GRCh37,TCGA-73-4675,TCGA-LUAD,NA,s11012,Harvard Medical School,Roswell Park,United States,NO,T3,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa830e4b0c9d6adf6c1ec,58cfa830e4b0c9d6adf6c1ec,TCGA-BG-A0MT-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BG-A0MT-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_8_rg.sorted,TCGA-BG-A0MT-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_8_rg.sorted.bam,21.55,1.88,0.13,58cfa830e4b0c9d6adf6c1ec,TCGA-BG-A0MT-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0MT-10A,082E32C5-7F82-466A-B52D-A3293A8F8E57,Blood Derived Normal,Illumina HiSeq,7782d010-e2ee-427f-8198-76914b5ce75c,Uterus,64,8D4F3C46-F13A-4CC8-B989-DE6DEE5F5F54,48BC2B88-56C8-442A-B864-39704586ED2C,TCGA-BG-A0MT-10A-01D-A101-02,HG19_Broad_variant,TCGA-BG-A0MT,TCGA-UCEC,NA,s5391,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c5f0,58cfa831e4b0c9d6adf6c5f0,TCGA-CG-4440-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CG-4440-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_5_rg.sorted,TCGA-CG-4440-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_5_rg.sorted.bam,126.2,1.9,0.14,58cfa831e4b0c9d6adf6c5f0,TCGA-CG-4440-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_5_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4440-01A,8CA597DB-AC21-43D1-9329-586B2EAF6982,Primary Tumor,Illumina HiSeq,d72343ff-91f0-4705-a398-914c5d2344d9,Stomach,68,C7B05D36-0386-4B2C-9E8B-2C7502CC4F21,8743D838-FD82-47D4-9BD0-0BAC137FE644,TCGA-CG-4440-01A-01D-A326-26,HG19_Broad_variant,TCGA-CG-4440,TCGA-STAD,122,s15397,MD Anderson - Institute for Applied Cancer Science,Indivumed,Germany,NO,T3,N3,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa830e4b0c9d6adf6bec2,58cfa830e4b0c9d6adf6bec2,TCGA-AR-A0TU-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_6_rg.sorted.filtered.,WGS,TCGA-AR-A0TU-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_6_rg.sorted,TCGA-AR-A0TU-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_6_rg.sorted.bam,28.88,1.95,0.15,58cfa830e4b0c9d6adf6bec2,TCGA-AR-A0TU-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_6_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-AR-A0TU-10A,DFE6DB17-CF45-488E-BD3C-B8433D7343CA,Blood Derived Normal,Illumina HiSeq,79a26532-d93b-48b3-8756-9508d69f56ad,Breast,35,D6BE9B14-E2D3-4CE1-BC6F-3BC967EC4D4C,C5244957-8900-4EAC-B127-01E2EA5663C5,TCGA-AR-A0TU-10A-01D-A106-02,HG19_Broad_variant,TCGA-AR-A0TU,TCGA-BRCA,NA,s6461,Harvard Medical School,Mayo,None,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa832e4b0c9d6adf6cf6a,58cfa832e4b0c9d6adf6cf6a,TCGA-GC-A3OO-01A-11D-A233_120905_SN1120_0187_AD1E4NACXX_s_5_rg.sorted.filtered.,WGS,TCGA-GC-A3OO-01A-11D-A233_120905_SN1120_0187_AD1E4NACXX_s_5_rg.sorted,TCGA-GC-A3OO-01A-11D-A233_120905_SN1120_0187_AD1E4NACXX_s_5_rg.sorted.bam,11.56,NA,0.16,58cfa832e4b0c9d6adf6cf6a,TCGA-GC-A3OO-01A-11D-A233_120905_SN1120_0187_AD1E4NACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GC-A3OO-01A,1FF60FD9-3CA3-43BE-92A8-8DBA2CD4D4DF,Primary Tumor,Illumina HiSeq,8c665767-edb1-4860-b26a-4171237962fa,Bladder,79,91E7F41C-17B3-4724-96EF-D3C207B964E1,67B2932F-8C9D-4D38-8791-D4D8AAB7F3B2,TCGA-GC-A3OO-01A-11D-A233-26,HG19_Broad_variant,TCGA-GC-A3OO,TCGA-BLCA,NA,s3306,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c851,58cfa831e4b0c9d6adf6c851,TCGA-D3-A2J6-06A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D3-A2J6-06A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_4_rg.sorted,TCGA-D3-A2J6-06A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_4_rg.sorted.bam,31.51,NA,0.16,58cfa831e4b0c9d6adf6c851,TCGA-D3-A2J6-06A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A2J6-06A,6F5157B8-D43A-4FBC-B7DA-23629F5B53DA,Metastatic,Illumina HiSeq,27e93d3a-66fc-4038-8b4e-236c996851f2,Skin,65,60BDA95D-1E8B-4232-AFEE-DEB9FB3D5AFF,EF7E375F-A88C-4030-ACFC-D8BAB223820A,TCGA-D3-A2J6-06A-11D-A18Z-02,HG19_Broad_variant,TCGA-D3-A2J6,TCGA-SKCM,1321,s7998,Harvard Medical School,MD Anderson,United States,NO,T3b,N0,Not available,Stage IIB
13722.58cfa82fe4b0c9d6adf6b84e,58cfa82fe4b0c9d6adf6b84e,TCGA-A5-A0R8-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_4_rg.sorted.filtered.,WGS,TCGA-A5-A0R8-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_4_rg.sorted,TCGA-A5-A0R8-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_4_rg.sorted.bam,80.74,2.11,0.16,58cfa82fe4b0c9d6adf6b84e,TCGA-A5-A0R8-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0R8-01A,06D16B6B-9CA6-4CEC-A785-F27AA4323CEC,Primary Tumor,Illumina HiSeq,ed11d53d-5cbb-44e2-b4d2-1603cef4ec13,Uterus,81,5B5CC2BA-6A10-4279-A0AA-8DDAE94D56EA,289CE7E4-AF92-4857-9D07-7CF334C40542,TCGA-A5-A0R8-01A-11D-A101-02,HG19_Broad_variant,TCGA-A5-A0R8,TCGA-UCEC,NA,s4420,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b95c,58cfa82fe4b0c9d6adf6b95c,TCGA-AA-3549-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3549-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3549-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,54.56,1.9,0.14,58cfa82fe4b0c9d6adf6b95c,TCGA-AA-3549-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3549-10A,E6EC5A68-7555-4F26-BD7E-9CDB4C5F7004,Blood Derived Normal,Illumina HiSeq,6ae6ef34-eb3e-417d-8adc-ab3a6979baaa,Colorectal,69,5FCA30B8-1C68-4449-8070-CE5127CB0BFA,D1D611E2-C8EA-4FC5-9B12-6603CB932F3E,TCGA-AA-3549-10A-01D-1167-02,HG18,TCGA-AA-3549,TCGA-COAD,NA,s13184,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d640,58cfa832e4b0c9d6adf6d640,TCGA-LN-A49X-10A-01D-A267_131018_SN590_0241_BC30HBACXX_s_4_rg.sorted.filtered.,WGS,TCGA-LN-A49X-10A-01D-A267_131018_SN590_0241_BC30HBACXX_s_4_rg.sorted,TCGA-LN-A49X-10A-01D-A267_131018_SN590_0241_BC30HBACXX_s_4_rg.sorted.bam,70.22,NA,0.16,58cfa832e4b0c9d6adf6d640,TCGA-LN-A49X-10A-01D-A267_131018_SN590_0241_BC30HBACXX_s_4_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49X-10A,B05AEFC4-2D61-44B6-9451-E660D10D8A79,Blood Derived Normal,Illumina HiSeq,36d33c92-611d-44d0-9a6e-9081dd25e768,Esophagus,44,536B8CCC-B916-4BCA-9D1C-C1DE6809F32F,4E9E93FC-FB95-49E8-93C8-C8F5CB3FB6EB,TCGA-LN-A49X-10A-01D-A267-26,HG19_Broad_variant,TCGA-LN-A49X,TCGA-ESCA,NA,s1874,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa82fe4b0c9d6adf6ba16,58cfa82fe4b0c9d6adf6ba16,TCGA-AA-3549-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3549-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3549-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,431.56,1.9,0.17,58cfa82fe4b0c9d6adf6ba16,TCGA-AA-3549-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3549-01A,E6EC5A68-7555-4F26-BD7E-9CDB4C5F7004,Primary Tumor,Illumina HiSeq,cff80dc2-c080-4905-afce-cfd06a84f6c9,Colorectal,69,86158696-60A3-45B7-8351-D800F57EF23B,C5D50597-F0E1-4C34-AB95-3718566AF540,TCGA-AA-3549-01A-02D-1167-02,HG18,TCGA-AA-3549,TCGA-COAD,NA,s13358,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa831e4b0c9d6adf6cd82,58cfa831e4b0c9d6adf6cd82,TCGA-FE-A230-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FE-A230-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_2_rg.sorted,TCGA-FE-A230-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_2_rg.sorted.bam,73.25,2.05,0.17,58cfa831e4b0c9d6adf6cd82,TCGA-FE-A230-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A230-01A,B1D71782-2443-43F3-BD0E-8B7220515CB6,Primary Tumor,Illumina HiSeq,5aeaadf5-f228-4383-97ce-9048120f8b41,Thyroid,30,12FC3F30-08FB-47C6-92F1-009D961C1E94,001C6478-B20D-40D8-AF62-C45C64269129,TCGA-FE-A230-01A-11D-A14U-02,HG19_Broad_variant,TCGA-FE-A230,TCGA-THCA,NA,s12389,Harvard Medical School,Ohio State University,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c9c9,58cfa831e4b0c9d6adf6c9c9,TCGA-DJ-A1QH-01A-21D-A14U_120629_SN1222_0121_BD143UACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DJ-A1QH-01A-21D-A14U_120629_SN1222_0121_BD143UACXX_s_7_rg.sorted,TCGA-DJ-A1QH-01A-21D-A14U_120629_SN1222_0121_BD143UACXX_s_7_rg.sorted.bam,51.98,1.61,0.16,58cfa831e4b0c9d6adf6c9c9,TCGA-DJ-A1QH-01A-21D-A14U_120629_SN1222_0121_BD143UACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QH-01A,F3C73DC9-6280-4619-A629-B575FDBDB0CA,Primary Tumor,Illumina HiSeq,0e84405e-6687-4f5d-89c9-c507d3c0bba0,Thyroid,58,B1775A45-D30D-42C3-91D8-53C662B4A974,31F3AA22-9E90-4FF7-872C-0EED3DB18545,TCGA-DJ-A1QH-01A-21D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QH,TCGA-THCA,NA,s12376,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage III
13722.58cfa82fe4b0c9d6adf6b7f6,58cfa82fe4b0c9d6adf6b7f6,TCGA-73-4677-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-73-4677-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-73-4677-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,153,1.9,0.15,58cfa82fe4b0c9d6adf6b7f6,TCGA-73-4677-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4677-01A,03C3409A-9D16-41D0-9E26-F9FC2547A4C8,Primary Tumor,Illumina HiSeq,5dd207d7-c666-46ae-8154-cb0c0cd6467f,Lung,74,EF88B85A-61EE-44E1-BB63-1B4CE9154BFB,2E41BAD5-941E-4EE8-A1DC-5BBA14E89141,TCGA-73-4677-01A-01D-1203-02,GRCh37,TCGA-73-4677,TCGA-LUAD,38,s10914,Harvard Medical School,Roswell Park,United States,NO,T2a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6ca4b,58cfa831e4b0c9d6adf6ca4b,TCGA-D7-6820-10A-01D-1880_121220_SN1120_0207_BC1JALACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D7-6820-10A-01D-1880_121220_SN1120_0207_BC1JALACXX_s_4_rg.sorted,TCGA-D7-6820-10A-01D-1880_121220_SN1120_0207_BC1JALACXX_s_4_rg.sorted.bam,520,1.9,0.15,58cfa831e4b0c9d6adf6ca4b,TCGA-D7-6820-10A-01D-1880_121220_SN1120_0207_BC1JALACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6820-10A,1142251C-28EB-48BF-9C54-7126D4557605,Blood Derived Normal,Illumina HiSeq,99cd87aa-0deb-4ace-86d1-adfb8dbee226,Stomach,64,1FFC07AF-EDDD-461E-B600-D4DB171D48DC,E4430C45-E033-4BA6-B72A-999CE7624FE8,TCGA-D7-6820-10A-01D-1880-02,HG19_Broad_variant,TCGA-D7-6820,TCGA-STAD,NA,s14842,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N1,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIB
13722.58cfa832e4b0c9d6adf6d05d,58cfa832e4b0c9d6adf6d05d,TCGA-IG-A4P3-10A-01D-A267_131018_SN590_0240_AC2MW5ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-IG-A4P3-10A-01D-A267_131018_SN590_0240_AC2MW5ACXX_s_4_rg.sorted,TCGA-IG-A4P3-10A-01D-A267_131018_SN590_0240_AC2MW5ACXX_s_4_rg.sorted.bam,57.83,NA,0.16,58cfa832e4b0c9d6adf6d05d,TCGA-IG-A4P3-10A-01D-A267_131018_SN590_0240_AC2MW5ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A4P3-10A,6594ACD5-4D2A-4CC5-8CF8-4064E252C5F6,Blood Derived Normal,Illumina HiSeq,9056b666-ce18-4b5a-94bb-382a902669e1,Esophagus,48,E561AA89-7464-440D-9545-C1FAA51A42BD,F25DEB48-DA51-457E-A2CC-46AC70E073DB,TCGA-IG-A4P3-10A-01D-A267-26,HG19_Broad_variant,TCGA-IG-A4P3,TCGA-ESCA,NA,s1821,MD Anderson - Institute for Applied Cancer Science,Asterand,Ukraine,NO,T2,N1,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6d652,58cfa832e4b0c9d6adf6d652,TCGA-LN-A49U-10A-01D-A267_131001_SN1222_0222_BC2CN2ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-LN-A49U-10A-01D-A267_131001_SN1222_0222_BC2CN2ACXX_s_8_rg.sorted,TCGA-LN-A49U-10A-01D-A267_131001_SN1222_0222_BC2CN2ACXX_s_8_rg.sorted.bam,60.4,NA,0.17,58cfa832e4b0c9d6adf6d652,TCGA-LN-A49U-10A-01D-A267_131001_SN1222_0222_BC2CN2ACXX_s_8_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49U-10A,931A50FF-3149-4C4A-9456-45ED3A9DD457,Blood Derived Normal,Illumina HiSeq,bc23178f-d94d-41be-b8c1-35a1341dbd1b,Esophagus,62,2040DFBB-2F61-4060-9FE6-C22998DF392E,896B7A56-9A8B-4A6B-95DB-BF2D9C98FC95,TCGA-LN-A49U-10A-01D-A267-26,HG19_Broad_variant,TCGA-LN-A49U,TCGA-ESCA,NA,s1866,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6c50a,58cfa831e4b0c9d6adf6c50a,TCGA-CM-4748-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-CM-4748-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-CM-4748-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,126.72,1.9,0.13,58cfa831e4b0c9d6adf6c50a,TCGA-CM-4748-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-CM-4748-10A,CD845618-4CC4-49C2-9055-C171D4C24EE1,Blood Derived Normal,Illumina HiSeq,d5afe3c7-77dc-415d-8178-1fff2cea011d,Colorectal,53,EB335F3B-6294-4C41-93E3-5731044A8DFD,2803D40C-88C2-40B7-85ED-DADDE3910DF5,TCGA-CM-4748-10A-01D-1405-02,HG18,TCGA-CM-4748,TCGA-COAD,NA,s13688,Harvard Medical School,MSKCC,None,NO,T4a,N1a,Colon Mucinous Adenocarcinoma,Stage IIIB
13722.58cfa832e4b0c9d6adf6d554,58cfa832e4b0c9d6adf6d554,TCGA-LN-A4A6-10A-01D-A267_131018_SN590_0240_AC2MW5ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-LN-A4A6-10A-01D-A267_131018_SN590_0240_AC2MW5ACXX_s_8_rg.sorted,TCGA-LN-A4A6-10A-01D-A267_131018_SN590_0240_AC2MW5ACXX_s_8_rg.sorted.bam,40.26,NA,0.16,58cfa832e4b0c9d6adf6d554,TCGA-LN-A4A6-10A-01D-A267_131018_SN590_0240_AC2MW5ACXX_s_8_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A4A6-10A,FFCFA005-A04F-458E-9D1D-86143DD823E5,Blood Derived Normal,Illumina HiSeq,29825da7-28db-4d24-8bcd-58dbd1171bc7,Esophagus,65,2128AB00-CC9C-49BE-A3E0-E73A517640A6,A3E3912C-F921-4008-B272-9004233876F2,TCGA-LN-A4A6-10A-01D-A267-26,HG19_Broad_variant,TCGA-LN-A4A6,TCGA-ESCA,NA,s1873,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T2,N0,Not available,Stage II
13722.58cfa832e4b0c9d6adf6d3bc,58cfa832e4b0c9d6adf6d3bc,TCGA-L5-A43M-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-L5-A43M-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_7_rg.sorted,TCGA-L5-A43M-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_7_rg.sorted.bam,22.55,NA,0.16,58cfa832e4b0c9d6adf6d3bc,TCGA-L5-A43M-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_7_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A43M-01A,29DA08F4-C9E2-4E7A-9733-B4EC5B9C5F13,Primary Tumor,Illumina HiSeq,4e3268fa-d698-4529-abb8-7a235754a070,Esophagus,84,AEEC137A-E929-439C-B7E7-33943CFFB642,97721561-B3CE-4B56-B0D2-B7C70E978526,TCGA-L5-A43M-01A-11D-A248-26,HG19_Broad_variant,TCGA-L5-A43M,TCGA-ESCA,NA,s1745,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T3,N2,Not available,Not available
13722.58cfa830e4b0c9d6adf6bb90,58cfa830e4b0c9d6adf6bb90,TCGA-AA-A02R-10A-01D-A078_110401_SN177_0152_A819RJABXX.sorted.filtered.,WGS,TCGA-AA-A02R-10A-01D-A078_110401_SN177_0152_A819RJABXX.sorted,TCGA-AA-A02R-10A-01D-A078_110401_SN177_0152_A819RJABXX.sorted.bam,22.97,1.74,0.15,58cfa830e4b0c9d6adf6bb90,TCGA-AA-A02R-10A-01D-A078_110401_SN177_0152_A819RJABXX.sorted.bam,Dead,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A02R-10A,764C97C9-01D3-45CB-86BD-F8A52B5468DA,Blood Derived Normal,Illumina HiSeq,504339f4-40ca-46f4-9410-0e1d81df5210,Colorectal,84,B01A9BCF-A155-48B7-A3CC-5A6E3CB2E7AC,AEAF71B1-9EEB-4E7F-B4D8-D138B60D6CF3,TCGA-AA-A02R-10A-01D-A078-02,HG18_Broad_variant,TCGA-AA-A02R,TCGA-COAD,670,s13684,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6bb80,58cfa830e4b0c9d6adf6bb80,TCGA-AA-3812-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3812-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3812-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,50.96,1.9,0.15,58cfa830e4b0c9d6adf6bb80,TCGA-AA-3812-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3812-10A,4563E4E0-A661-46DE-AD25-9C86A621E147,Blood Derived Normal,Illumina HiSeq,c10599a7-29dd-4112-9b47-0d65eac9945f,Colorectal,82,B8FE759F-F298-4AEB-AC2A-689D0586AF55,F85C5073-4043-4E77-A48D-CBA0EC45FE88,TCGA-AA-3812-10A-01D-1167-02,HG18,TCGA-AA-3812,TCGA-COAD,NA,s13378,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6c396,58cfa831e4b0c9d6adf6c396,TCGA-BG-A0MG-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BG-A0MG-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_7_rg.sorted,TCGA-BG-A0MG-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_7_rg.sorted.bam,8.16,2,0.17,58cfa831e4b0c9d6adf6c396,TCGA-BG-A0MG-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0MG-10A,9CDE90C8-2BE0-4328-A032-FF1DC19E66FD,Blood Derived Normal,Illumina HiSeq,9079f7a8-53e7-4675-b3c6-f6c7b3f81eba,Uterus,73,8231519C-3DF2-4C72-A011-AE8DD15C4A93,7720E40E-CFCF-4514-A5B2-DD2643315F90,TCGA-BG-A0MG-10A-01D-A101-02,HG19_Broad_variant,TCGA-BG-A0MG,TCGA-UCEC,NA,s4433,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6afea,58cfa82ee4b0c9d6adf6afea,TCGA-05-4430-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_5_rg.sorted.filtered.,WGS,TCGA-05-4430-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_5_rg.sorted,TCGA-05-4430-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_5_rg.sorted.bam,81.9,1.9,0.14,58cfa82ee4b0c9d6adf6afea,TCGA-05-4430-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_5_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4430-10A,3A23CDB5-2327-45AC-B0B5-D4AFE038C757,Blood Derived Normal,Illumina HiSeq,794fbc75-e590-4df0-9b98-9e113eef5c46,Lung,59,39E4B10A-F05F-4EE7-85FE-700924C5507A,2EB474B5-5E99-4041-BFD3-7A50F1CA9136,TCGA-05-4430-10A-01D-1203-02,HG19_Broad_variant,TCGA-05-4430,TCGA-LUAD,NA,s10774,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa832e4b0c9d6adf6d552,58cfa832e4b0c9d6adf6d552,TCGA-L5-A4OJ-11A-12D-A267_131018_SN590_0241_BC30HBACXX_s_2_rg.sorted.filtered.,WGS,TCGA-L5-A4OJ-11A-12D-A267_131018_SN590_0241_BC30HBACXX_s_2_rg.sorted,TCGA-L5-A4OJ-11A-12D-A267_131018_SN590_0241_BC30HBACXX_s_2_rg.sorted.bam,21.68,NA,0.16,58cfa832e4b0c9d6adf6d552,TCGA-L5-A4OJ-11A-12D-A267_131018_SN590_0241_BC30HBACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OJ-11A,CB419344-6148-43D4-B549-570BD09B3E05,Solid Tissue Normal,Illumina HiSeq,9dcd8ee0-57f8-4c88-85d4-d194b403a41d,Esophagus,70,F73DB16E-FFF9-43A0-A75C-AF0D39812E68,1856316F-0A68-4C23-9F33-4E22C8259AEF,TCGA-L5-A4OJ-11A-12D-A267-26,HG19_Broad_variant,TCGA-L5-A4OJ,TCGA-ESCA,NA,s1839,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T1,N0,Not available,Stage I
13722.58cfa832e4b0c9d6adf6d5e3,58cfa832e4b0c9d6adf6d5e3,TCGA-LN-A49U-01A-31D-A267_131001_SN1222_0222_BC2CN2ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-LN-A49U-01A-31D-A267_131001_SN1222_0222_BC2CN2ACXX_s_7_rg.sorted,TCGA-LN-A49U-01A-31D-A267_131001_SN1222_0222_BC2CN2ACXX_s_7_rg.sorted.bam,24.19,NA,0.15,58cfa832e4b0c9d6adf6d5e3,TCGA-LN-A49U-01A-31D-A267_131001_SN1222_0222_BC2CN2ACXX_s_7_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49U-01A,931A50FF-3149-4C4A-9456-45ED3A9DD457,Primary Tumor,Illumina HiSeq,c075129e-527d-4603-9336-8b26a5ce10d2,Esophagus,62,9B3E9E79-52EB-40F7-87EC-E1CB360004E6,FF6F10D6-874C-4281-AB3B-79FF2440A901,TCGA-LN-A49U-01A-31D-A267-26,HG19_Broad_variant,TCGA-LN-A49U,TCGA-ESCA,NA,s1777,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6c4d6,58cfa831e4b0c9d6adf6c4d6,TCGA-CF-A3MF-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CF-A3MF-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_1_rg.sorted,TCGA-CF-A3MF-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_1_rg.sorted.bam,55.07,NA,0.16,58cfa831e4b0c9d6adf6c4d6,TCGA-CF-A3MF-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_1_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CF-A3MF-01A,1E308B12-0590-4DAE-94D0-A539FCF25DF7,Primary Tumor,Illumina HiSeq,57be2848-15e4-489c-b122-a660f03c68dd,Bladder,34,E9889071-4C6E-4761-9D65-06C6B5989FB7,6646401F-5235-4847-A4E6-006F98CAFE85,TCGA-CF-A3MF-01A-12D-A21C-26,HG19_Broad_variant,TCGA-CF-A3MF,TCGA-BLCA,NA,s3092,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6d4b4,58cfa832e4b0c9d6adf6d4b4,TCGA-V4-A9EV-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_7_rg.sorted.filtered.,WGS,TCGA-V4-A9EV-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_7_rg.sorted,TCGA-V4-A9EV-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_7_rg.sorted.bam,56.76,NA,0.15,58cfa832e4b0c9d6adf6d4b4,TCGA-V4-A9EV-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EV-01A,DA6F0ED2-A6D5-4D87-823E-122EBD59AABA,Primary Tumor,Illumina HiSeq,463c617e-a31f-4ebe-9bb0-bdf35b3823f8,Eye,59,42BBB13B-DA94-44FF-A01C-4776A74AEA6F,A08A9A90-323B-48AB-89C8-4805FE59BC70,TCGA-V4-A9EV-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9EV,TCGA-UVM,NA,s204,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa830e4b0c9d6adf6bc14,58cfa830e4b0c9d6adf6bc14,TCGA-AG-A014-10A-01D-A078_110504_SN590_0081_BB0BM5ABXX_s_7_rg.sorted.filtered.,WGS,TCGA-AG-A014-10A-01D-A078_110504_SN590_0081_BB0BM5ABXX_s_7_rg.sorted,TCGA-AG-A014-10A-01D-A078_110504_SN590_0081_BB0BM5ABXX_s_7_rg.sorted.bam,27.2,1.76,0.15,58cfa830e4b0c9d6adf6bc14,TCGA-AG-A014-10A-01D-A078_110504_SN590_0081_BB0BM5ABXX_s_7_rg.sorted.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A014-10A,51C37449-6A2E-4C3D-A7CC-06F901E1224F,Blood Derived Normal,Illumina HiSeq,a425b9fe-c528-4966-aee2-96c0be7b7839,Colorectal,86,0FA514AA-C0EB-4177-BA65-1B8616232054,36D22107-9741-44B7-9673-D26682C4280A,TCGA-AG-A014-10A-01D-A078-02,HG18_Broad_variant,TCGA-AG-A014,TCGA-READ,NA,s2174,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bf18,58cfa830e4b0c9d6adf6bf18,TCGA-BR-4257-11A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BR-4257-11A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_4_rg.sorted,TCGA-BR-4257-11A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_4_rg.sorted.bam,173.9,1.9,0.14,58cfa830e4b0c9d6adf6bf18,TCGA-BR-4257-11A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4257-11A,DA112431-5579-4FD1-A230-9144B359B0E9,Solid Tissue Normal,Illumina HiSeq,40fc7a6d-ebf3-490f-ab9d-19e641ea0dbb,Stomach,79,52D44B33-2D4C-4DE0-9777-5778536688EE,4822B1AA-E623-4C70-9958-A598E90D3467,TCGA-BR-4257-11A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4257,TCGA-STAD,NA,s15375,Harvard Medical School,Asterand,Russia,NO,TX,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa830e4b0c9d6adf6c1c2,58cfa830e4b0c9d6adf6c1c2,TCGA-BG-A186-10A-01D-A12F_120413_SN1120_0132_AD0T6RACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BG-A186-10A-01D-A12F_120413_SN1120_0132_AD0T6RACXX_s_7_rg.sorted,TCGA-BG-A186-10A-01D-A12F_120413_SN1120_0132_AD0T6RACXX_s_7_rg.sorted.bam,23.56,1.97,0.15,58cfa830e4b0c9d6adf6c1c2,TCGA-BG-A186-10A-01D-A12F_120413_SN1120_0132_AD0T6RACXX_s_7_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A186-10A,FE4DB898-3A9F-4DFF-ADCB-7B8C30137350,Blood Derived Normal,Illumina HiSeq,8129312b-e94b-44d4-a281-81ed98ddc053,Uterus,61,E251DCCF-5BE4-49B3-987F-F12FA0F69A1D,F1D4B342-2032-4053-B725-F19B088FDB42,TCGA-BG-A186-10A-01D-A12F-02,HG19_Broad_variant,TCGA-BG-A186,TCGA-UCEC,NA,s4254,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bc56,58cfa830e4b0c9d6adf6bc56,TCGA-AG-A011-10A-01D-A078-02_110409_SN590_0076_AB04G5ABXX_s_2.rg.sorted.filtered.,WGS,TCGA-AG-A011-10A-01D-A078-02_110409_SN590_0076_AB04G5ABXX_s_2.rg.sorted,TCGA-AG-A011-10A-01D-A078-02_110409_SN590_0076_AB04G5ABXX_s_2.rg.sorted.bam,33.9,1.72,0.15,58cfa830e4b0c9d6adf6bc56,TCGA-AG-A011-10A-01D-A078-02_110409_SN590_0076_AB04G5ABXX_s_2.rg.sorted.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A011-10A,3BE106BC-BA42-4C70-9B50-697D89DB617D,Blood Derived Normal,Illumina HiSeq,04332223-3071-4709-bd66-2081f4982c3c,Colorectal,80,3950AEDB-3B85-496C-9DED-BB55707362AF,81A99699-BB5D-4A80-B132-77EDDB57F984,TCGA-AG-A011-10A-01D-A078-02,HG18_Broad_variant,TCGA-AG-A011,TCGA-READ,NA,s2315,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6cdcc,58cfa831e4b0c9d6adf6cdcc,TCGA-FG-6689-01A-11D-1891_130923_SN1222_0220_BC2DUUACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FG-6689-01A-11D-1891_130923_SN1222_0220_BC2DUUACXX_s_1_rg.sorted,TCGA-FG-6689-01A-11D-1891_130923_SN1222_0220_BC2DUUACXX_s_1_rg.sorted.bam,86.7,1.9,0.16,58cfa831e4b0c9d6adf6cdcc,TCGA-FG-6689-01A-11D-1891_130923_SN1222_0220_BC2DUUACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-6689-01A,8D07B1E8-5D1D-4A43-B616-D29DD58CE5FE,Primary Tumor,Illumina HiSeq,9e07a7ab-1033-43c4-a4f4-49ba35319fea,Brain,30,D81C3F19-BBCF-4071-8BA4-CB8C505307D7,2FD05E93-48E8-460E-80E0-C3262EAEE72B,TCGA-FG-6689-01A-11D-1891-02,HG19_Broad_variant,TCGA-FG-6689,TCGA-LGG,NA,s8144,Harvard Medical School,Case Western,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa830e4b0c9d6adf6bba0,58cfa830e4b0c9d6adf6bba0,TCGA-AA-A01V-11A-11D-A079_110409_SN590_0077_BB04EHABXX_s_7_rg.sorted.filtered.,WGS,TCGA-AA-A01V-11A-11D-A079_110409_SN590_0077_BB04EHABXX_s_7_rg.sorted,TCGA-AA-A01V-11A-11D-A079_110409_SN590_0077_BB04EHABXX_s_7_rg.sorted.bam,40,1.86,0.13,58cfa830e4b0c9d6adf6bba0,TCGA-AA-A01V-11A-11D-A079_110409_SN590_0077_BB04EHABXX_s_7_rg.sorted.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01V-11A,0CB0DAC8-4CE2-444A-B1AE-1550E065B4D9,Solid Tissue Normal,Illumina HiSeq,a0120ca6-fc3e-4ff4-b926-6c38e3180674,Colorectal,59,398A605C-0A45-4757-BC28-996816990576,725B35D1-7AAA-4471-9539-6CC0EA98A6DE,TCGA-AA-A01V-11A-11D-A079-02,HG18_Broad_variant,TCGA-AA-A01V,TCGA-COAD,NA,s13528,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d604,58cfa832e4b0c9d6adf6d604,TCGA-LN-A49W-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-LN-A49W-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_5_rg.sorted,TCGA-LN-A49W-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_5_rg.sorted.bam,22.73,NA,0.15,58cfa832e4b0c9d6adf6d604,TCGA-LN-A49W-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_5_rg.sorted.bam,Alive,MALE,ASIAN,Not available,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49W-01A,DAF211F2-941E-4244-8CF5-D31492269443,Primary Tumor,Illumina HiSeq,30b9eb80-84d4-4582-aa2d-a826faadd2f2,Esophagus,73,25E6A27B-B015-4936-B57E-CF39DD5AF9BA,38678D1B-A9D9-4231-95B8-95D5AB4D64F2,TCGA-LN-A49W-01A-11D-A267-26,HG19_Broad_variant,TCGA-LN-A49W,TCGA-ESCA,NA,s1772,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N1,Not available,Stage III
13722.58cfa831e4b0c9d6adf6cab0,58cfa831e4b0c9d6adf6cab0,TCGA-DJ-A13U-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DJ-A13U-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_3_rg.sorted,TCGA-DJ-A13U-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_3_rg.sorted.bam,76.6,1.95,0.16,58cfa831e4b0c9d6adf6cab0,TCGA-DJ-A13U-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13U-01A,8C5AEF43-341E-4A37-84EB-FD730EB957C7,Primary Tumor,Illumina HiSeq,c717fac6-b3b3-4335-8ee8-5862d742ea16,Thyroid,60,CD19D6BB-21A4-409A-A7BA-A4521A03ABD3,B80A7146-1AB2-49BD-A3B2-7F6650840195,TCGA-DJ-A13U-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13U,TCGA-THCA,NA,s12104,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa831e4b0c9d6adf6c97b,58cfa831e4b0c9d6adf6c97b,TCGA-D9-A1JW-06A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D9-A1JW-06A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_3_rg.sorted,TCGA-D9-A1JW-06A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_3_rg.sorted.bam,55.53,NA,0.16,58cfa831e4b0c9d6adf6c97b,TCGA-D9-A1JW-06A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D9-A1JW-06A,9A903FC2-57D7-4A02-94E7-9B9B7EE99276,Metastatic,Illumina HiSeq,dd38c2b9-2249-41f4-81df-ff133c8dc39d,Skin,82,65549283-35D4-4916-B990-BD714A63BB36,7B532980-AD10-4961-A39D-3B48A518DFD0,TCGA-D9-A1JW-06A-11D-A18Z-02,HG19_Broad_variant,TCGA-D9-A1JW,TCGA-SKCM,NA,s7672,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T1a,N2a,Not available,Not available
13722.58cfa82ee4b0c9d6adf6b001,58cfa82ee4b0c9d6adf6b001,TCGA-05-4430-01A-02D-1203_111013_SN208_0253_B00PJACXX_s_6_rg.sorted.filtered.,WGS,TCGA-05-4430-01A-02D-1203_111013_SN208_0253_B00PJACXX_s_6_rg.sorted,TCGA-05-4430-01A-02D-1203_111013_SN208_0253_B00PJACXX_s_6_rg.sorted.bam,342.2,1.9,0.15,58cfa82ee4b0c9d6adf6b001,TCGA-05-4430-01A-02D-1203_111013_SN208_0253_B00PJACXX_s_6_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4430-01A,3A23CDB5-2327-45AC-B0B5-D4AFE038C757,Primary Tumor,Illumina HiSeq,e4ae6498-889f-4900-a73c-2e61a6e154d1,Lung,59,122AAA4F-8FD5-4C41-BFF8-8A45BDFB3F81,C14A77D1-DB59-434E-BD3C-DBBE647D790C,TCGA-05-4430-01A-02D-1203-02,HG19_Broad_variant,TCGA-05-4430,TCGA-LUAD,NA,s10646,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa830e4b0c9d6adf6bf9c,58cfa830e4b0c9d6adf6bf9c,TCGA-BR-6453-11A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BR-6453-11A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_5_rg.sorted,TCGA-BR-6453-11A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_5_rg.sorted.bam,263.4,1.9,0.14,58cfa830e4b0c9d6adf6bf9c,TCGA-BR-6453-11A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6453-11A,AE633E83-303F-4A90-AC3B-34458FD9BEEF,Solid Tissue Normal,Illumina HiSeq,717f3dd6-5471-4f58-b218-01a2ca71eced,Stomach,54,B6DFCC18-F388-4486-8D3D-611C5E15FB29,C1402501-D8BA-4AF4-A88E-ABB79009DB18,TCGA-BR-6453-11A-01D-1798-02,HG19_Broad_variant,TCGA-BR-6453,TCGA-STAD,NA,s15306,Harvard Medical School,Asterand,Russia,NO,T2,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA
13722.58cfa830e4b0c9d6adf6bc46,58cfa830e4b0c9d6adf6bc46,TCGA-AO-A0JF-01A-11D-A060_130719_SN1120_0270_AC2CVRACXX_s_1_rg.sorted.filtered.,WGS,TCGA-AO-A0JF-01A-11D-A060_130719_SN1120_0270_AC2CVRACXX_s_1_rg.sorted,TCGA-AO-A0JF-01A-11D-A060_130719_SN1120_0270_AC2CVRACXX_s_1_rg.sorted.bam,16.97,1.91,0.13,58cfa830e4b0c9d6adf6bc46,TCGA-AO-A0JF-01A-11D-A060_130719_SN1120_0270_AC2CVRACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A0JF-01A,F357FE19-5359-4662-8CE9-AA996132283B,Primary Tumor,Illumina HiSeq,031ab51d-07d0-4afe-a9dd-222889f5c32b,Breast,68,DDEE0B07-2771-40C7-BDDA-C1100958F0D8,BDAA1600-1B4F-4BBA-B4D6-A4D169B029D6,TCGA-AO-A0JF-01A-11D-A060-02,HG19_Broad_variant,TCGA-AO-A0JF,TCGA-BRCA,NA,s5491,Harvard Medical School,MSKCC,None,NO,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6ba6c,58cfa830e4b0c9d6adf6ba6c,TCGA-AA-A010-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A010-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A010-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,113.85,1.65,0.15,58cfa830e4b0c9d6adf6ba6c,TCGA-AA-A010-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A010-01A,0712566E-3371-4715-95F1-5B792E72D758,Primary Tumor,Illumina HiSeq,ea0e92bb-7617-4183-82be-773e8cc15dca,Colorectal,46,46FB1711-E385-49A4-BF15-7990123CBE6B,30FCD977-8C62-4925-BC84-5894A12BABDB,TCGA-AA-A010-01A-01D-A077-02,HG18,TCGA-AA-A010,TCGA-COAD,NA,s13200,Harvard Medical School,Indivumed,Germany,NO,T4,N0,Colon Adenocarcinoma,Stage IIB
13722.58cfa830e4b0c9d6adf6bf48,58cfa830e4b0c9d6adf6bf48,TCGA-BR-4184-11A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BR-4184-11A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_6_rg.sorted,TCGA-BR-4184-11A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_6_rg.sorted.bam,170.9,1.9,0.16,58cfa830e4b0c9d6adf6bf48,TCGA-BR-4184-11A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4184-11A,0D4D23BA-066B-4244-A3A5-922CDCAAA28F,Solid Tissue Normal,Illumina HiSeq,c3487483-8be4-437d-9ff4-0105653e0870,Stomach,70,67DCA15E-B2EC-4283-8602-3B39ADA18B3E,0B4713D1-6EAE-4D1C-8895-756154563BB3,TCGA-BR-4184-11A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4184,TCGA-STAD,NA,s14530,Harvard Medical School,Asterand,Russia,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6cbe1,58cfa831e4b0c9d6adf6cbe1,TCGA-EE-A29P-06A-11D-A18Y_120729_SN1120_0180_BC1176ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EE-A29P-06A-11D-A18Y_120729_SN1120_0180_BC1176ACXX_s_2_rg.sorted,TCGA-EE-A29P-06A-11D-A18Y_120729_SN1120_0180_BC1176ACXX_s_2_rg.sorted.bam,56.49,NA,0.16,58cfa831e4b0c9d6adf6cbe1,TCGA-EE-A29P-06A-11D-A18Y_120729_SN1120_0180_BC1176ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29P-06A,FD1A49F2-FB3B-481D-888E-F4224D59F6D1,Metastatic,Illumina HiSeq,54534e99-c9b7-483e-aa8e-c9fd9fa41058,Skin,73,EC3CFAD3-2825-4BCC-B524-48282C546D80,27389E3E-4A1A-4628-9AA0-02B5B684DBF7,TCGA-EE-A29P-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A29P,TCGA-SKCM,NA,s7846,Harvard Medical School,University of Sydney,Australia,NO,T4b,N0,Not available,Stage IIC
13722.58cfa832e4b0c9d6adf6cf68,58cfa832e4b0c9d6adf6cf68,TCGA-G9-6384-10A-01D-1784_130301_SN590_0217_BC1UHMACXX_s_6_rg.sorted.filtered.,WGS,TCGA-G9-6384-10A-01D-1784_130301_SN590_0217_BC1UHMACXX_s_6_rg.sorted,TCGA-G9-6384-10A-01D-1784_130301_SN590_0217_BC1UHMACXX_s_6_rg.sorted.bam,43.7,1.9,0.13,58cfa832e4b0c9d6adf6cf68,TCGA-G9-6384-10A-01D-1784_130301_SN590_0217_BC1UHMACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6384-10A,A279D5AA-51F7-4E75-9E14-B206B97EC4BD,Blood Derived Normal,Illumina HiSeq,723bbf9b-83eb-429b-ae56-ab0fce6478b2,Prostate,53,FD710149-273E-455D-BFB6-C5EE4849D370,4A6911E9-EF41-4A88-B0C4-BD34DFB1CEB2,TCGA-G9-6384-10A-01D-1784-02,HG19_Broad_variant,TCGA-G9-6384,TCGA-PRAD,NA,s3458,Harvard Medical School,Roswell Park,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c726,58cfa831e4b0c9d6adf6c726,TCGA-D6-6825-01A-21D-1911_120518_SN1120_0143_BC0VN6ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-D6-6825-01A-21D-1911_120518_SN1120_0143_BC0VN6ACXX_s_2_rg.sorted,TCGA-D6-6825-01A-21D-1911_120518_SN1120_0143_BC0VN6ACXX_s_2_rg.sorted.bam,288.7,1.9,0.14,58cfa831e4b0c9d6adf6c726,TCGA-D6-6825-01A-21D-1911_120518_SN1120_0143_BC0VN6ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-D6-6825-01A,42BC2336-2408-441A-83B9-AADC9700F750,Primary Tumor,Illumina HiSeq,e785062a-dcec-4a1d-aa67-6089980c9e35,Head and Neck,73,D9E2F5AA-A6E2-491A-9DBC-E5D10B4ABA58,8B36C904-50A1-4B17-94A2-F9331A5FED1E,TCGA-D6-6825-01A-21D-1911-02,HG19_Broad_variant,TCGA-D6-6825,TCGA-HNSC,NA,s15529,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6c072,58cfa830e4b0c9d6adf6c072,TCGA-B5-A0K7-10A-02D-A101_120406_SN208_0282_BC0L15ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-B5-A0K7-10A-02D-A101_120406_SN208_0282_BC0L15ACXX_s_7_rg.sorted,TCGA-B5-A0K7-10A-02D-A101_120406_SN208_0282_BC0L15ACXX_s_7_rg.sorted.bam,10.79,1.95,0.13,58cfa830e4b0c9d6adf6c072,TCGA-B5-A0K7-10A-02D-A101_120406_SN208_0282_BC0L15ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0K7-10A,2F0640BC-598C-4714-9E9B-7E0F2CA4567F,Blood Derived Normal,Illumina HiSeq,75f5b2c3-8f25-414e-ba05-28be0f8f09af,Uterus,64,7CC26CBE-ED1E-4AB4-A83A-C776DFCB4FFD,93CE4D46-6D02-4B2D-8D50-E9B82A41E0F6,TCGA-B5-A0K7-10A-02D-A101-02,HG19_Broad_variant,TCGA-B5-A0K7,TCGA-UCEC,NA,s4787,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bc6c,58cfa830e4b0c9d6adf6bc6c,TCGA-AG-4007-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-4007-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-4007-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,915.89,1.9,0.16,58cfa830e4b0c9d6adf6bc6c,TCGA-AG-4007-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-4007-01A,8E00E7E7-FFAF-44F0-91A7-172671F18E08,Primary Tumor,Illumina HiSeq,5f015b15-7286-4700-88d4-e7c460f68336,Colorectal,87,E6FC3F28-1DE1-4587-9E0E-0861323E6772,E9D7A5C4-3E98-4C98-A953-B75EA555DD7D,TCGA-AG-4007-01A-01D-1115-02,HG18,TCGA-AG-4007,TCGA-READ,NA,s1985,Harvard Medical School,Indivumed,Germany,NO,T4,N2,Rectal Adenocarcinoma,Stage IV
13722.58cfa831e4b0c9d6adf6c654,58cfa831e4b0c9d6adf6c654,TCGA-CG-4449-01A-01D-A326_131015_SN1440_0171_AC2DLBACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CG-4449-01A-01D-A326_131015_SN1440_0171_AC2DLBACXX_s_7_rg.sorted,TCGA-CG-4449-01A-01D-A326_131015_SN1440_0171_AC2DLBACXX_s_7_rg.sorted.bam,127.2,1.9,0.14,58cfa831e4b0c9d6adf6c654,TCGA-CG-4449-01A-01D-A326_131015_SN1440_0171_AC2DLBACXX_s_7_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4449-01A,10B5774D-7079-4B4B-B824-F4745F5598C7,Primary Tumor,Illumina HiSeq,c8b033d1-998b-4fee-88e7-33c14e8c3ffc,Stomach,81,E98BD336-1B0D-4655-A537-2A5DAE99114D,9D1B5FD6-77DA-4EB5-B849-BDD7AA698D70,TCGA-CG-4449-01A-01D-A326-26,HG19_Broad_variant,TCGA-CG-4449,TCGA-STAD,NA,s15123,MD Anderson - Institute for Applied Cancer Science,Indivumed,Germany,NO,T2,N1,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage II
13722.58cfa831e4b0c9d6adf6c4c8,58cfa831e4b0c9d6adf6c4c8,TCGA-BR-4256-11A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BR-4256-11A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_2_rg.sorted,TCGA-BR-4256-11A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_2_rg.sorted.bam,7.9,1.9,0.13,58cfa831e4b0c9d6adf6c4c8,TCGA-BR-4256-11A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4256-11A,7B0D69CA-13A6-46E0-839C-E433BBEDE3AD,Solid Tissue Normal,Illumina HiSeq,9e52ce3a-8344-444b-b624-ae3604caa8be,Stomach,80,339C38E9-DA05-4C0C-AD3F-D6013815C00D,D94675A0-ACA4-4E03-8423-54E73EEA68A8,TCGA-BR-4256-11A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4256,TCGA-STAD,NA,s14686,Harvard Medical School,Asterand,Russia,NO,TX,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa831e4b0c9d6adf6cc35,58cfa831e4b0c9d6adf6cc35,TCGA-EE-A29Q-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EE-A29Q-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_3_rg.sorted,TCGA-EE-A29Q-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_3_rg.sorted.bam,30.57,NA,0.18,58cfa831e4b0c9d6adf6cc35,TCGA-EE-A29Q-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29Q-10A,6A1818F9-9303-41B0-B3B7-07FAF5055C86,Blood Derived Normal,Illumina HiSeq,3a35cc5e-4313-46ab-857d-f22cddd7625f,Skin,70,CB5DCB2E-D966-42CA-8DFD-034FFEF5A40A,033506C2-A0D7-4E02-B9F5-F3ADE80F7094,TCGA-EE-A29Q-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A29Q,TCGA-SKCM,NA,s7848,Harvard Medical School,University of Sydney,Australia,NO,T3b,N0,Not available,Stage IIB
13722.58cfa830e4b0c9d6adf6be52,58cfa830e4b0c9d6adf6be52,TCGA-BJ-A0ZJ-10A-01D-A10R_120616_SN1120_0153_AC0WMJACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BJ-A0ZJ-10A-01D-A10R_120616_SN1120_0153_AC0WMJACXX_s_5_rg.sorted,TCGA-BJ-A0ZJ-10A-01D-A10R_120616_SN1120_0153_AC0WMJACXX_s_5_rg.sorted.bam,6.77,1.42,0.16,58cfa830e4b0c9d6adf6be52,TCGA-BJ-A0ZJ-10A-01D-A10R_120616_SN1120_0153_AC0WMJACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0ZJ-10A,8877B479-B62A-4794-B71E-418DE96DFF23,Blood Derived Normal,Illumina HiSeq,110bdb40-c410-4bef-a3c5-b142645edcd4,Thyroid,36,82C99A8E-9640-4F09-94C0-07FB8A7588B7,80EB5F2E-D4BA-41DE-B319-1723C12672F7,TCGA-BJ-A0ZJ-10A-01D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZJ,TCGA-THCA,NA,s12102,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6d41e,58cfa832e4b0c9d6adf6d41e,TCGA-V4-A9F7-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-V4-A9F7-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_6_rg.sorted,TCGA-V4-A9F7-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_6_rg.sorted.bam,12.6,NA,0.17,58cfa832e4b0c9d6adf6d41e,TCGA-V4-A9F7-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9F7-10A,64422CC5-5E5B-4EF9-A9E2-214CEBF8DFBC,Blood Derived Normal,Illumina HiSeq,0ecf7ed8-da8c-4cc5-b32d-57ebd27f429f,Eye,78,19625377-CFA4-4A5F-A271-91A25C8FE0A9,11E5D5DB-7E3D-4B04-992A-E61FF959AA66,TCGA-V4-A9F7-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9F7,TCGA-UVM,NA,s254,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3a,N0,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6cf0c,58cfa832e4b0c9d6adf6cf0c,TCGA-FS-A1ZC-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_7_rg.sorted.filtered.,WGS,TCGA-FS-A1ZC-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_7_rg.sorted,TCGA-FS-A1ZC-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_7_rg.sorted.bam,30.03,NA,0.16,58cfa832e4b0c9d6adf6cf0c,TCGA-FS-A1ZC-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZC-10A,B1739CB5-09BC-414A-8F05-C66D2CB9868D,Blood Derived Normal,Illumina HiSeq,05f8afcc-0825-4cb1-b5fa-c947afc82409,Skin,51,A4CC2293-5B42-469C-960E-4BC3770C9E9C,45B62C9F-DD93-4A8C-BEED-384E3A6A5A58,TCGA-FS-A1ZC-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZC,TCGA-SKCM,10870,s7529,Harvard Medical School,Essen,Germany,NO,TX,N0,Not available,I or II NOS
13722.58cfa831e4b0c9d6adf6c52c,58cfa831e4b0c9d6adf6c52c,TCGA-CK-4951-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-CK-4951-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-CK-4951-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,36.02,1.9,0.17,58cfa831e4b0c9d6adf6c52c,TCGA-CK-4951-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-CK-4951-01A,2DB3C23D-C591-4EA0-B0A8-ED9C4343C80E,Primary Tumor,Illumina HiSeq,7dcee63f-adaa-46d6-a48c-750143760f41,Colorectal,79,EA9E7E8C-4151-4CFC-8631-5880C6F1A21F,C501681C-26B5-4385-AE24-BEC8FB230C51,TCGA-CK-4951-01A-01D-1405-02,HG18,TCGA-CK-4951,TCGA-COAD,NA,s13040,Harvard Medical School,Harvard,None,NO,T3,N0,Colon Mucinous Adenocarcinoma,Stage IIA
13722.58cfa832e4b0c9d6adf6d008,58cfa832e4b0c9d6adf6d008,TCGA-FS-A1YY-06A-11D-A18Y_120718_SN1222_0127_BD147HACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FS-A1YY-06A-11D-A18Y_120718_SN1222_0127_BD147HACXX_s_2_rg.sorted,TCGA-FS-A1YY-06A-11D-A18Y_120718_SN1222_0127_BD147HACXX_s_2_rg.sorted.bam,37.95,NA,0.17,58cfa832e4b0c9d6adf6d008,TCGA-FS-A1YY-06A-11D-A18Y_120718_SN1222_0127_BD147HACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1YY-06A,C3A8881B-70F8-402C-AC75-1CC49FCA4E87,Metastatic,Illumina HiSeq,4c946768-7b87-4e7f-97eb-e35ca0ffdd80,Skin,55,877D00AD-E477-4EF6-9D32-9244EC62F0E5,26E8EBFA-B65D-4860-8B9A-B558ACE4F45B,TCGA-FS-A1YY-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1YY,TCGA-SKCM,6953,s8024,Harvard Medical School,Essen,Germany,NO,T3a,N0,Not available,Stage IIA
13722.58cfa830e4b0c9d6adf6baf9,58cfa830e4b0c9d6adf6baf9,TCGA-AA-3514-11A-01D-1547_110525_SN590_0091_AC02W2ABXX_s_2.rg.sorted.filtered.,WGS,TCGA-AA-3514-11A-01D-1547_110525_SN590_0091_AC02W2ABXX_s_2.rg.sorted,TCGA-AA-3514-11A-01D-1547_110525_SN590_0091_AC02W2ABXX_s_2.rg.sorted.bam,276.73,1.9,0.16,58cfa830e4b0c9d6adf6baf9,TCGA-AA-3514-11A-01D-1547_110525_SN590_0091_AC02W2ABXX_s_2.rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3514-11A,DDF69ED9-4C53-48B8-9F01-495BD60C3425,Solid Tissue Normal,Illumina HiSeq,ae830bae-2a2d-412f-8150-07ddd6a7aef2,Colorectal,81,9681EB58-DE63-473B-85B8-91BDD07D5F45,E3814098-5BA3-4953-A4E3-B9BBB0BDC37C,TCGA-AA-3514-11A-01D-1547-02,HG18_Broad_variant,TCGA-AA-3514,TCGA-COAD,NA,s12866,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa831e4b0c9d6adf6cd74,58cfa831e4b0c9d6adf6cd74,TCGA-ET-A25K-01A-11D-A16N_120717_SN1120_0176_BC1178ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-ET-A25K-01A-11D-A16N_120717_SN1120_0176_BC1178ACXX_s_7_rg.sorted,TCGA-ET-A25K-01A-11D-A16N_120717_SN1120_0176_BC1178ACXX_s_7_rg.sorted.bam,57.24,2,0.17,58cfa831e4b0c9d6adf6cd74,TCGA-ET-A25K-01A-11D-A16N_120717_SN1120_0176_BC1178ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-ET-A25K-01A,2F9ED09D-2626-4C23-BA47-1850D36F812A,Primary Tumor,Illumina HiSeq,81720382-db9a-41e3-814e-ee8ec59ce22d,Thyroid,36,343311B1-D586-4F92-9984-32AF1AFB1F62,663173D3-A9EE-4E73-8444-52F01727BE6D,TCGA-ET-A25K-01A-11D-A16N-02,HG19_Broad_variant,TCGA-ET-A25K,TCGA-THCA,NA,s12115,Harvard Medical School,Johns Hopkins,United States,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6d620,58cfa832e4b0c9d6adf6d620,TCGA-LN-A49L-10A-01D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-LN-A49L-10A-01D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_4_rg.sorted,TCGA-LN-A49L-10A-01D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_4_rg.sorted.bam,100.28,NA,0.15,58cfa832e4b0c9d6adf6d620,TCGA-LN-A49L-10A-01D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_4_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49L-10A,AD29744C-A09D-463A-84B5-63CFEB7FF786,Blood Derived Normal,Illumina HiSeq,99b9e88b-8467-4621-84ff-05a2c953027e,Esophagus,44,DC4443DD-EE35-4D2A-B1BE-8DC494CACA30,E493918A-38F6-4A21-A333-2F73AD73C4D8,TCGA-LN-A49L-10A-01D-A248-26,HG19_Broad_variant,TCGA-LN-A49L,TCGA-ESCA,NA,s1754,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T2,N0,Not available,Stage IIA
13722.58cfa830e4b0c9d6adf6c04c,58cfa830e4b0c9d6adf6c04c,TCGA-B5-A0K6-10A-01D-A043_120327_SN590_0149_AD0U12ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-B5-A0K6-10A-01D-A043_120327_SN590_0149_AD0U12ACXX_s_6_rg.sorted,TCGA-B5-A0K6-10A-01D-A043_120327_SN590_0149_AD0U12ACXX_s_6_rg.sorted.bam,11.2,2,0.16,58cfa830e4b0c9d6adf6c04c,TCGA-B5-A0K6-10A-01D-A043_120327_SN590_0149_AD0U12ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0K6-10A,5CBA9441-6812-49C0-A0F6-7928ED4E5B81,Blood Derived Normal,Illumina HiSeq,d89fc39f-4622-4fd1-a54c-7ceeb21064d3,Uterus,58,8DCB31CF-3146-4698-A71B-BFEF58BE9FDC,EB3CFF8E-79EF-4922-85F9-354E49963B7C,TCGA-B5-A0K6-10A-01D-A043-02,HG19_Broad_variant,TCGA-B5-A0K6,TCGA-UCEC,NA,s4788,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6c200,58cfa830e4b0c9d6adf6c200,TCGA-BG-A0M4-10A-02D-A101_120406_SN1120_0130_AD0UKGACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BG-A0M4-10A-02D-A101_120406_SN1120_0130_AD0UKGACXX_s_4_rg.sorted,TCGA-BG-A0M4-10A-02D-A101_120406_SN1120_0130_AD0UKGACXX_s_4_rg.sorted.bam,37.2,2.03,0.15,58cfa830e4b0c9d6adf6c200,TCGA-BG-A0M4-10A-02D-A101_120406_SN1120_0130_AD0UKGACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0M4-10A,73E5310D-BA8C-4CBC-AA4F-E06206F898F4,Blood Derived Normal,Illumina HiSeq,948469de-ebaf-429d-b96b-b4d48cc57e3f,Uterus,60,D293C52A-3628-45E5-AFFE-F6839F6BB8B8,120F65B5-E0FD-4430-AEBD-78ABBB7832FF,TCGA-BG-A0M4-10A-02D-A101-02,HG19_Broad_variant,TCGA-BG-A0M4,TCGA-UCEC,NA,s5004,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bf80,58cfa830e4b0c9d6adf6bf80,TCGA-BR-6455-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BR-6455-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_8_rg.sorted,TCGA-BR-6455-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_8_rg.sorted.bam,324.7,1.9,0.15,58cfa830e4b0c9d6adf6bf80,TCGA-BR-6455-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6455-01A,75A29059-4705-4A55-BC3D-F5923B24B358,Primary Tumor,Illumina HiSeq,719ee3a5-cfe9-48cb-9e48-e11e49bd217c,Stomach,59,59BD0192-A50B-4672-A17F-4DF138F58988,6C038E7C-8B03-4AB6-A31A-00C3C6CE6204,TCGA-BR-6455-01A-11D-1798-02,HG19_Broad_variant,TCGA-BR-6455,TCGA-STAD,NA,s14470,Harvard Medical School,Asterand,Russia,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB
13722.58cfa831e4b0c9d6adf6c655,58cfa831e4b0c9d6adf6c655,TCGA-CG-4444-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CG-4444-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_7_rg.sorted,TCGA-CG-4444-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_7_rg.sorted.bam,51.2,1.9,0.14,58cfa831e4b0c9d6adf6c655,TCGA-CG-4444-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_7_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4444-01A,5C087D33-0BD3-407D-8350-FABBA6AEC597,Primary Tumor,Illumina HiSeq,37421315-54a7-4a59-9939-4706dcd66019,Stomach,76,8563E95B-8E50-4E23-95D1-25AE8437B1DB,37738374-DDCD-4710-A1CC-BF86868C252A,TCGA-CG-4444-01A-01D-A326-26,HG19_Broad_variant,TCGA-CG-4444,TCGA-STAD,NA,s15192,MD Anderson - Institute for Applied Cancer Science,Indivumed,Germany,NO,T2b,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA
13722.58cfa82ee4b0c9d6adf6b020,58cfa82ee4b0c9d6adf6b020,TCGA-05-4432-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_4_rg.sorted.filtered.,WGS,TCGA-05-4432-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_4_rg.sorted,TCGA-05-4432-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_4_rg.sorted.bam,306.53,1.9,0.14,58cfa82ee4b0c9d6adf6b020,TCGA-05-4432-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_4_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4432-01A,E737F650-B72D-44E7-B750-558A56716803,Primary Tumor,Illumina HiSeq,6110bc85-6f14-48d5-b166-2b3f42776573,Lung,66,2A675528-1ABC-4220-A61A-25109850CE0D,A4E437A5-1603-4AE4-89C2-CD741FDE5015,TCGA-05-4432-01A-01D-1203-02,HG19_Broad_variant,TCGA-05-4432,TCGA-LUAD,NA,s11334,Harvard Medical School,Indivumed,Germany,NO,T2,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIB
13722.58cfa831e4b0c9d6adf6c7ff,58cfa831e4b0c9d6adf6c7ff,TCGA-D1-A16X-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D1-A16X-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_4_rg.sorted,TCGA-D1-A16X-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_4_rg.sorted.bam,91.84,2.11,0.16,58cfa831e4b0c9d6adf6c7ff,TCGA-D1-A16X-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A16X-01A,22618073-4EF0-4C3A-97B9-90BA1CAA1D72,Primary Tumor,Illumina HiSeq,8f166eb0-a44e-4848-ae7a-4e174f470d5b,Uterus,54,6421D807-9BEC-4AD4-8B75-8F9DD594A977,E652FF84-B885-4245-86E5-70ADE972FD67,TCGA-D1-A16X-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A16X,TCGA-UCEC,NA,s5023,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bf72,58cfa830e4b0c9d6adf6bf72,TCGA-BR-4363-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_7_rg.sorted.filtered.,WGS,TCGA-BR-4363-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_7_rg.sorted,TCGA-BR-4363-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_7_rg.sorted.bam,264.2,1.9,0.15,58cfa830e4b0c9d6adf6bf72,TCGA-BR-4363-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4363-01A,66BCA2F8-F269-454D-ABE2-CE51A0704645,Primary Tumor,Illumina HiSeq,ab5af808-6239-48fa-ba17-b80aa3fc5e14,Stomach,60,06EC6231-EE0E-4C15-AF9F-5B9E5BF557B8,D62228AE-B0AB-4C31-9FD7-F9D48B140CDC,TCGA-BR-4363-01A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4363,TCGA-STAD,NA,s14528,Harvard Medical School,Asterand,Russia,NO,T3,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa830e4b0c9d6adf6c05e,58cfa830e4b0c9d6adf6c05e,TCGA-AG-3999-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3999-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3999-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,651.89,1.9,0.14,58cfa830e4b0c9d6adf6c05e,TCGA-AG-3999-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3999-01A,60778DA8-D99E-4E51-96A2-3E900B3978D9,Primary Tumor,Illumina HiSeq,3d30dbe4-9c61-402a-afcd-c869123af4c6,Colorectal,61,022BA0B0-F8CC-474C-9FB9-7928B45FD756,1C65913D-665D-455E-9F40-8464E5EA0D55,TCGA-AG-3999-01A-01D-1115-02,HG18,TCGA-AG-3999,TCGA-READ,NA,s2161,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Rectal Adenocarcinoma,Stage IIIC
13722.58cfa830e4b0c9d6adf6c13a,58cfa830e4b0c9d6adf6c13a,TCGA-BS-A0U8-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BS-A0U8-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_8_rg.sorted,TCGA-BS-A0U8-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_8_rg.sorted.bam,116.56,1.88,0.15,58cfa830e4b0c9d6adf6c13a,TCGA-BS-A0U8-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0U8-01A,FB7475DF-30CC-4316-B9AC-37CBEEB6BA2B,Primary Tumor,Illumina HiSeq,44c78212-4860-4cf3-bd54-0e8e150cd0b1,Uterus,55,E3E23393-8597-4091-A343-CD544111C63B,89AB037F-B001-486F-A7EB-37AF8FBD0677,TCGA-BS-A0U8-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0U8,TCGA-UCEC,NA,s4261,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bfd6,58cfa830e4b0c9d6adf6bfd6,TCGA-AG-3728-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3728-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3728-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,650.31,1.9,0.14,58cfa830e4b0c9d6adf6bfd6,TCGA-AG-3728-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3728-01A,856A490C-C6DA-48FE-88B5-9FDE0F481365,Primary Tumor,Illumina HiSeq,d36f782a-483a-478d-a9a6-22f626b032bb,Colorectal,73,019EB82B-4A2D-4E67-99A6-FE10B0ABCB70,DF699DEA-C800-47D0-A526-A6C7A610041A,TCGA-AG-3728-01A-01D-1115-02,HG18,TCGA-AG-3728,TCGA-READ,NA,s2137,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIB
13722.58cfa831e4b0c9d6adf6c392,58cfa831e4b0c9d6adf6c392,TCGA-CD-5799-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CD-5799-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_4_rg.sorted,TCGA-CD-5799-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_4_rg.sorted.bam,177.7,2,0.17,58cfa831e4b0c9d6adf6c392,TCGA-CD-5799-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_4_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-5799-01A,C991697F-77F9-412A-9BD1-0E47F7387CB2,Primary Tumor,Illumina HiSeq,a59236bd-649f-4f2d-a702-4fb190d7f92c,Stomach,45,A3180E0E-EB99-49DD-8252-5FEA05A9885F,74F06FDA-C4D0-4542-AC92-68677B595800,TCGA-CD-5799-01A-11D-1598-02,HG19_Broad_variant,TCGA-CD-5799,TCGA-STAD,NA,s14633,Harvard Medical School,ILSbio,Vietnam,NO,T2,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa82fe4b0c9d6adf6b8a1,58cfa82fe4b0c9d6adf6b8a1,TCGA-50-5051-10A-01D-1853_120322_SN208_0277_AD0PL1ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-50-5051-10A-01D-1853_120322_SN208_0277_AD0PL1ACXX_s_8_rg.sorted,TCGA-50-5051-10A-01D-1853_120322_SN208_0277_AD0PL1ACXX_s_8_rg.sorted.bam,125,1.9,0.15,58cfa82fe4b0c9d6adf6b8a1,TCGA-50-5051-10A-01D-1853_120322_SN208_0277_AD0PL1ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5051-10A,E1C55BAC-BB41-4964-ADD5-ECD6BA04B58D,Blood Derived Normal,Illumina HiSeq,8d384520-9763-4a0c-ba5d-b99274779d43,Lung,42,1895845D-5A35-42A4-A721-CDF7AF2DE35D,03DB87CD-5705-4F69-AE8A-D3DF5310B8DD,TCGA-50-5051-10A-01D-1853-02,HG19_Broad_variant,TCGA-50-5051,TCGA-LUAD,NA,s11239,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa832e4b0c9d6adf6d346,58cfa832e4b0c9d6adf6d346,TCGA-L5-A4OH-11A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-L5-A4OH-11A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_6_rg.sorted,TCGA-L5-A4OH-11A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_6_rg.sorted.bam,17.09,NA,0.17,58cfa832e4b0c9d6adf6d346,TCGA-L5-A4OH-11A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OH-11A,3FA7FC16-49DA-4BF6-90C4-74DF5CF68B65,Solid Tissue Normal,Illumina HiSeq,418bb01c-56cb-4904-892b-312c5befe22e,Esophagus,71,EB31C2A9-A3F5-41FB-889D-3D6A0C2C33E2,BB7593BD-9F90-4BAD-8A1A-5D4CF3082270,TCGA-L5-A4OH-11A-11D-A267-26,HG19_Broad_variant,TCGA-L5-A4OH,TCGA-ESCA,NA,s1659,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T1,N0,Not available,Stage I
13722.58cfa82fe4b0c9d6adf6b964,58cfa82fe4b0c9d6adf6b964,TCGA-AA-3664-10A-01D-1167_101023_SN208_0166_A808PFABXX_s_6_rg.sorted.filtered.,WGS,TCGA-AA-3664-10A-01D-1167_101023_SN208_0166_A808PFABXX_s_6_rg.sorted,TCGA-AA-3664-10A-01D-1167_101023_SN208_0166_A808PFABXX_s_6_rg.sorted.bam,76.96,1.9,0.15,58cfa82fe4b0c9d6adf6b964,TCGA-AA-3664-10A-01D-1167_101023_SN208_0166_A808PFABXX_s_6_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3664-10A,A06C09A8-0951-49F4-A765-5147BBCAE109,Blood Derived Normal,Illumina HiSeq,803e167a-de07-4fb9-b8df-e555c5687f32,Colorectal,74,B4FFAC44-CCEF-458F-80CC-2D230D78012A,44FE059D-488A-4152-ABB9-A305EA066D2D,TCGA-AA-3664-10A-01D-1167-02,HG18_Broad_variant,TCGA-AA-3664,TCGA-COAD,NA,s13360,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa831e4b0c9d6adf6cbe5,58cfa831e4b0c9d6adf6cbe5,TCGA-EE-A29P-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EE-A29P-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_4_rg.sorted,TCGA-EE-A29P-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_4_rg.sorted.bam,47.99,NA,0.16,58cfa831e4b0c9d6adf6cbe5,TCGA-EE-A29P-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29P-10A,FD1A49F2-FB3B-481D-888E-F4224D59F6D1,Blood Derived Normal,Illumina HiSeq,74fe7aee-fe79-4d9a-bb11-86f865d6a0b2,Skin,73,94437E00-B2E2-462C-AFC7-510FA17E5F3E,F86BBD71-66E1-4FA6-8F1E-A7C065DC3CFD,TCGA-EE-A29P-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A29P,TCGA-SKCM,NA,s8009,Harvard Medical School,University of Sydney,Australia,NO,T4b,N0,Not available,Stage IIC
13722.58cfa830e4b0c9d6adf6bd8e,58cfa830e4b0c9d6adf6bd8e,TCGA-BG-A0M3-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BG-A0M3-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_3_rg.sorted,TCGA-BG-A0M3-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_3_rg.sorted.bam,19.16,1.97,0.13,58cfa830e4b0c9d6adf6bd8e,TCGA-BG-A0M3-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0M3-10A,8BDD4E0E-5BEC-43F2-B9FA-D6E94A72FE05,Blood Derived Normal,Illumina HiSeq,20d6cb0d-6d0f-4683-8837-180c95258795,Uterus,74,0EB45A88-73EA-4282-B0E1-2E2EA1E2D8F1,6A871B0F-421A-47E1-9B5D-150E4C3E0B99,TCGA-BG-A0M3-10A-01D-A101-02,HG19_Broad_variant,TCGA-BG-A0M3,TCGA-UCEC,NA,s4255,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c5be,58cfa831e4b0c9d6adf6c5be,TCGA-CG-4440-10A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CG-4440-10A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_6_rg.sorted,TCGA-CG-4440-10A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_6_rg.sorted.bam,57.9,1.9,0.16,58cfa831e4b0c9d6adf6c5be,TCGA-CG-4440-10A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_6_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4440-10A,8CA597DB-AC21-43D1-9329-586B2EAF6982,Blood Derived Normal,Illumina HiSeq,d6eefe03-313a-4546-8bd5-62d1cb79c1c5,Stomach,68,241B8D60-8B01-4942-A21B-2A457E612418,BF70B61F-0395-42EF-A642-421B7235CB6E,TCGA-CG-4440-10A-01D-A326-26,HG19_Broad_variant,TCGA-CG-4440,TCGA-STAD,122,s14759,MD Anderson - Institute for Applied Cancer Science,Indivumed,Germany,NO,T3,N3,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa832e4b0c9d6adf6d45a,58cfa832e4b0c9d6adf6d45a,TCGA-VD-A8K8-10A-01D-A40E_140716_SN208_0518_AC59RNACXX_s_5_rg.sorted.filtered.,WGS,TCGA-VD-A8K8-10A-01D-A40E_140716_SN208_0518_AC59RNACXX_s_5_rg.sorted,TCGA-VD-A8K8-10A-01D-A40E_140716_SN208_0518_AC59RNACXX_s_5_rg.sorted.bam,7.61,NA,0.16,58cfa832e4b0c9d6adf6d45a,TCGA-VD-A8K8-10A-01D-A40E_140716_SN208_0518_AC59RNACXX_s_5_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8K8-10A,9B1ECFB2-9DFB-4E71-B51A-D2A0C5A7940E,Blood Derived Normal,Illumina HiSeq,ff9baa57-d806-40bf-b1bf-9dc609c28fd9,Eye,56,1F8344DE-A0F5-41C3-BDA1-71E9F6F6E2A2,2A5FC793-ECF4-4C4E-9BDD-8909FDE5DCF1,TCGA-VD-A8K8-10A-01D-A40E-26,HG19_Broad_variant,TCGA-VD-A8K8,TCGA-UVM,NA,s253,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T3a,NX,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6c94b,58cfa831e4b0c9d6adf6c94b,TCGA-DJ-A1QO-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DJ-A1QO-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_6_rg.sorted,TCGA-DJ-A1QO-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_6_rg.sorted.bam,43.74,1.8,0.18,58cfa831e4b0c9d6adf6c94b,TCGA-DJ-A1QO-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QO-01A,F2AD720E-579F-4E2C-A3F0-17877CA91067,Primary Tumor,Illumina HiSeq,1ac10023-1615-4727-ac8d-23b842c19d3c,Thyroid,69,03811796-0ECE-4408-82F7-B449A631D2FB,9E0C97ED-7482-4400-B66A-72AB48BA11A2,TCGA-DJ-A1QO-01A-11D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QO,TCGA-THCA,NA,s12372,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage III
13722.58cfa830e4b0c9d6adf6bea9,58cfa830e4b0c9d6adf6bea9,TCGA-AG-3909-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3909-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3909-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,208.89,1.9,0.14,58cfa830e4b0c9d6adf6bea9,TCGA-AG-3909-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3909-01A,769880AE-34D9-405E-8EA7-33BA47CF2DD2,Primary Tumor,Illumina HiSeq,f11e5abe-82c7-4b53-bc65-7bde2dbc2bb1,Colorectal,69,12A43BEB-EDB6-4ABC-8322-CA8246D64B3F,F168205F-B2ED-4563-A211-DA59223830AB,TCGA-AG-3909-01A-01D-1115-02,HG18,TCGA-AG-3909,TCGA-READ,NA,s1987,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIB
13722.58cfa82fe4b0c9d6adf6b97e,58cfa82fe4b0c9d6adf6b97e,TCGA-AA-3681-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3681-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3681-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole.bam,353.96,1.9,0.15,58cfa82fe4b0c9d6adf6b97e,TCGA-AA-3681-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3681-01A,ABB0D53F-F74E-45DC-8FBB-40863016F3C6,Primary Tumor,Illumina HiSeq,4a7f8872-1280-4a05-8448-a62ee6de1108,Colorectal,77,190FECAB-1EF1-43FA-87A2-104014EB2CE2,85305E56-627C-4471-BD16-6818AD3751C2,TCGA-AA-3681-01A-01D-1637-02,HG18,TCGA-AA-3681,TCGA-COAD,NA,s13029,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage III
13722.58cfa830e4b0c9d6adf6bf6a,58cfa830e4b0c9d6adf6bf6a,TCGA-BR-6452-01A-12D-1798_130115_SN1222_0169_BD1K2PACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BR-6452-01A-12D-1798_130115_SN1222_0169_BD1K2PACXX_s_2_rg.sorted,TCGA-BR-6452-01A-12D-1798_130115_SN1222_0169_BD1K2PACXX_s_2_rg.sorted.bam,409.4,1.9,0.16,58cfa830e4b0c9d6adf6bf6a,TCGA-BR-6452-01A-12D-1798_130115_SN1222_0169_BD1K2PACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6452-01A,27988B3E-CDE1-4F4B-82A1-6D8AD08DB8E9,Primary Tumor,Illumina HiSeq,cfd9aa7a-7f3d-4b70-9359-2c93f0238361,Stomach,78,76144F2F-2498-430D-B33C-F000394C427E,460DE564-5AAB-46B0-8174-36AF18D2DF4C,TCGA-BR-6452-01A-12D-1798-02,HG19_Broad_variant,TCGA-BR-6452,TCGA-STAD,NA,s14744,Harvard Medical School,Asterand,Russia,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA
13722.58cfa830e4b0c9d6adf6bc44,58cfa830e4b0c9d6adf6bc44,TCGA-AO-A0JF-10A-01D-A060_130719_SN1120_0270_AC2CVRACXX_s_2_rg.sorted.filtered.,WGS,TCGA-AO-A0JF-10A-01D-A060_130719_SN1120_0270_AC2CVRACXX_s_2_rg.sorted,TCGA-AO-A0JF-10A-01D-A060_130719_SN1120_0270_AC2CVRACXX_s_2_rg.sorted.bam,33.53,1.83,0.13,58cfa830e4b0c9d6adf6bc44,TCGA-AO-A0JF-10A-01D-A060_130719_SN1120_0270_AC2CVRACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A0JF-10A,F357FE19-5359-4662-8CE9-AA996132283B,Blood Derived Normal,Illumina HiSeq,ecbc57df-ef58-47a5-9ae5-83e394d14191,Breast,68,DA127378-BDD7-4D9E-AD83-D2C223B4A40E,85F3A9D5-E0B8-47B2-B525-5C8177F22C46,TCGA-AO-A0JF-10A-01D-A060-02,HG19_Broad_variant,TCGA-AO-A0JF,TCGA-BRCA,NA,s6629,Harvard Medical School,MSKCC,None,NO,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6bf6c,58cfa830e4b0c9d6adf6bf6c,TCGA-BR-6452-10A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BR-6452-10A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_3_rg.sorted,TCGA-BR-6452-10A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_3_rg.sorted.bam,34.7,1.9,0.15,58cfa830e4b0c9d6adf6bf6c,TCGA-BR-6452-10A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6452-10A,27988B3E-CDE1-4F4B-82A1-6D8AD08DB8E9,Blood Derived Normal,Illumina HiSeq,b5d222fd-498a-40a1-880d-322d0a7a1323,Stomach,78,14F163DB-E740-48B9-8126-AC2A5A691288,617B4921-0897-4062-A233-BDA2F15A1E47,TCGA-BR-6452-10A-01D-1798-02,HG19_Broad_variant,TCGA-BR-6452,TCGA-STAD,NA,s14400,Harvard Medical School,Asterand,Russia,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA
13722.58cfa832e4b0c9d6adf6cf6e,58cfa832e4b0c9d6adf6cf6e,TCGA-G9-6384-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_5_rg.sorted.filtered.,WGS,TCGA-G9-6384-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_5_rg.sorted,TCGA-G9-6384-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_5_rg.sorted.bam,146.4,1.9,0.15,58cfa832e4b0c9d6adf6cf6e,TCGA-G9-6384-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6384-01A,A279D5AA-51F7-4E75-9E14-B206B97EC4BD,Primary Tumor,Illumina HiSeq,75df59ac-7525-45fc-843a-5210bd036dca,Prostate,53,1ABCBE00-5A6F-4E0F-A61C-D158545C2293,1F750885-56C4-4953-8D22-BC7719F57F9F,TCGA-G9-6384-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6384,TCGA-PRAD,NA,s4152,Harvard Medical School,Roswell Park,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d514,58cfa832e4b0c9d6adf6d514,TCGA-V4-A9EU-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_6_rg.sorted.filtered.,WGS,TCGA-V4-A9EU-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_6_rg.sorted,TCGA-V4-A9EU-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_6_rg.sorted.bam,49,NA,0.14,58cfa832e4b0c9d6adf6d514,TCGA-V4-A9EU-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EU-01A,DF685F8C-645A-47AE-A471-63BF1973A0AE,Primary Tumor,Illumina HiSeq,929aff65-5561-439c-9850-a5ce595efc28,Eye,83,2DAC7136-D3A0-4FFD-B22D-7F1F9B8B8E4C,4C43B0FD-D2D3-456F-AFDD-EC90DBBD5FBA,TCGA-V4-A9EU-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9EU,TCGA-UVM,NA,s213,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4d,N0,Not available,Stage IIIC
13722.58cfa832e4b0c9d6adf6d088,58cfa832e4b0c9d6adf6d088,TCGA-IG-A3YC-10A-01D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-IG-A3YC-10A-01D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_6_rg.sorted,TCGA-IG-A3YC-10A-01D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_6_rg.sorted.bam,49.22,NA,0.16,58cfa832e4b0c9d6adf6d088,TCGA-IG-A3YC-10A-01D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A3YC-10A,6A05288E-D051-40A5-9F4E-864AB806A5DC,Blood Derived Normal,Illumina HiSeq,42f724a5-5a65-474e-9415-c6f38bfe7936,Esophagus,62,C3705307-CFE1-4F4A-A190-F2C4B8144B9B,6141E563-12F7-410F-BFA9-906422505D6C,TCGA-IG-A3YC-10A-01D-A248-26,HG19_Broad_variant,TCGA-IG-A3YC,TCGA-ESCA,NA,s1623,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T3,N1,Not available,Stage IIIA
13722.58cfa832e4b0c9d6adf6d160,58cfa832e4b0c9d6adf6d160,TCGA-IG-A4P3-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-IG-A4P3-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_3_rg.sorted,TCGA-IG-A4P3-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_3_rg.sorted.bam,40.74,NA,0.15,58cfa832e4b0c9d6adf6d160,TCGA-IG-A4P3-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A4P3-01A,6594ACD5-4D2A-4CC5-8CF8-4064E252C5F6,Primary Tumor,Illumina HiSeq,a5b7767c-9dba-49bf-8711-9a76a0ab0e4f,Esophagus,48,784021B2-5F94-48F9-9DF7-854B4FBDF802,84882FB6-6ED6-42E8-9179-90CE089C4664,TCGA-IG-A4P3-01A-11D-A267-26,HG19_Broad_variant,TCGA-IG-A4P3,TCGA-ESCA,NA,s1826,MD Anderson - Institute for Applied Cancer Science,Asterand,Ukraine,NO,T2,N1,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6d446,58cfa832e4b0c9d6adf6d446,TCGA-VD-A8K9-10A-01D-A40E_140716_SN208_0518_AC59RNACXX_s_6_rg.sorted.filtered.,WGS,TCGA-VD-A8K9-10A-01D-A40E_140716_SN208_0518_AC59RNACXX_s_6_rg.sorted,TCGA-VD-A8K9-10A-01D-A40E_140716_SN208_0518_AC59RNACXX_s_6_rg.sorted.bam,8.23,NA,0.14,58cfa832e4b0c9d6adf6d446,TCGA-VD-A8K9-10A-01D-A40E_140716_SN208_0518_AC59RNACXX_s_6_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8K9-10A,FA9089FA-9AF9-4932-8AB7-0E7F2FD6B121,Blood Derived Normal,Illumina HiSeq,3eaaa561-96c0-473b-a998-ed4430f251b3,Eye,71,573AF9C2-1EFA-4D41-ADB4-F1EDAD9B42FB,D52917BC-A225-450A-856F-1F2CF40B4C8B,TCGA-VD-A8K9-10A-01D-A40E-26,HG19_Broad_variant,TCGA-VD-A8K9,TCGA-UVM,NA,s276,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T2a,NX,Not available,Stage IIA
13722.58cfa832e4b0c9d6adf6d38c,58cfa832e4b0c9d6adf6d38c,TCGA-L5-A4OI-11A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-L5-A4OI-11A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_2_rg.sorted,TCGA-L5-A4OI-11A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_2_rg.sorted.bam,21.97,NA,0.16,58cfa832e4b0c9d6adf6d38c,TCGA-L5-A4OI-11A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OI-11A,CB2AF13B-CBED-4657-8FD4-FED8DB375CBA,Solid Tissue Normal,Illumina HiSeq,6004ba96-89c1-404c-b70c-9fa87aaa66ba,Esophagus,79,78CC5D13-3605-49A1-8677-27CC819E5E0F,DE7981C4-10C0-4218-889B-AEDCADCB5AFE,TCGA-L5-A4OI-11A-11D-A267-26,HG19_Broad_variant,TCGA-L5-A4OI,TCGA-ESCA,NA,s1657,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T3,N3,Not available,Stage IIIC
13722.58cfa830e4b0c9d6adf6bf3c,58cfa830e4b0c9d6adf6bf3c,TCGA-BR-4256-01A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BR-4256-01A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_1_rg.sorted,TCGA-BR-4256-01A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_1_rg.sorted.bam,67.9,1.9,0.15,58cfa830e4b0c9d6adf6bf3c,TCGA-BR-4256-01A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4256-01A,7B0D69CA-13A6-46E0-839C-E433BBEDE3AD,Primary Tumor,Illumina HiSeq,6e990147-2463-4d38-a785-6c76ae1dbc25,Stomach,80,61C7AAB0-51D9-4706-A37C-D5058007DAF1,30AF7950-11F7-43BF-9A1D-98A57F416397,TCGA-BR-4256-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4256,TCGA-STAD,NA,s14396,Harvard Medical School,Asterand,Russia,NO,TX,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa830e4b0c9d6adf6bbcc,58cfa830e4b0c9d6adf6bbcc,TCGA-AG-4007-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-4007-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-4007-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,3.59,1.9,0.16,58cfa830e4b0c9d6adf6bbcc,TCGA-AG-4007-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-4007-10A,8E00E7E7-FFAF-44F0-91A7-172671F18E08,Blood Derived Normal,Illumina HiSeq,0497e43f-7588-413d-a72a-cf9badca95be,Colorectal,87,EB3A1A59-B2C5-4436-A971-FCFE5C643820,A7A0117E-4BA7-4AB2-B390-F77472D2F2B5,TCGA-AG-4007-10A-01D-1115-02,HG18,TCGA-AG-4007,TCGA-READ,NA,s1982,Harvard Medical School,Indivumed,Germany,NO,T4,N2,Rectal Adenocarcinoma,Stage IV
13722.58cfa832e4b0c9d6adf6d846,58cfa832e4b0c9d6adf6d846,TCGA-LN-A4A3-10A-01D-A267_131001_SN1120_0280_BD2FDEACXX_s_6_rg.sorted.filtered.,WGS,TCGA-LN-A4A3-10A-01D-A267_131001_SN1120_0280_BD2FDEACXX_s_6_rg.sorted,TCGA-LN-A4A3-10A-01D-A267_131001_SN1120_0280_BD2FDEACXX_s_6_rg.sorted.bam,79.42,NA,0.14,58cfa832e4b0c9d6adf6d846,TCGA-LN-A4A3-10A-01D-A267_131001_SN1120_0280_BD2FDEACXX_s_6_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A4A3-10A,3C0BB5E2-AD33-4D91-A31E-2A18F1C94D2D,Blood Derived Normal,Illumina HiSeq,beea86b9-7fea-427d-a4df-81d35845d958,Esophagus,61,24CC2A4A-0D52-49B4-B28B-6550CDCF637F,C4BFAEA6-AF26-419D-9DF8-AC3F4E31C3FA,TCGA-LN-A4A3-10A-01D-A267-26,HG19_Broad_variant,TCGA-LN-A4A3,TCGA-ESCA,NA,s1771,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N1,Not available,Stage III
13722.58cfa831e4b0c9d6adf6c4f9,58cfa831e4b0c9d6adf6c4f9,TCGA-BR-4369-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_7_rg.sorted.filtered.,WGS,TCGA-BR-4369-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_7_rg.sorted,TCGA-BR-4369-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_7_rg.sorted.bam,161.2,1.9,0.14,58cfa831e4b0c9d6adf6c4f9,TCGA-BR-4369-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4369-01A,FE9A5FCF-FF99-4DD1-8CC7-ED9F4B9D952B,Primary Tumor,Illumina HiSeq,cbba5183-9ada-4363-8f98-bf406b64f6d6,Stomach,75,39B440B3-F888-488A-A0CC-D7410DC73093,7220D8C0-DF8F-4A72-8338-795181BD8A47,TCGA-BR-4369-01A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4369,TCGA-STAD,NA,s14966,Harvard Medical School,Asterand,Russia,NO,TX,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa832e4b0c9d6adf6d5d7,58cfa832e4b0c9d6adf6d5d7,TCGA-LN-A49L-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-LN-A49L-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_3_rg.sorted,TCGA-LN-A49L-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_3_rg.sorted.bam,15.51,NA,0.16,58cfa832e4b0c9d6adf6d5d7,TCGA-LN-A49L-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_3_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49L-01A,AD29744C-A09D-463A-84B5-63CFEB7FF786,Primary Tumor,Illumina HiSeq,a9a8bab1-537c-4252-8ec0-8e76946ff9c5,Esophagus,44,D2B00CB1-19A7-4A41-97E1-F2D60108590B,BB9C6E8A-5D74-40DC-A5FF-779E4511B584,TCGA-LN-A49L-01A-11D-A248-26,HG19_Broad_variant,TCGA-LN-A49L,TCGA-ESCA,NA,s1855,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T2,N0,Not available,Stage IIA
13722.58cfa82fe4b0c9d6adf6b86c,58cfa82fe4b0c9d6adf6b86c,TCGA-A5-A0VP-01A-21D-A101_120407_SN590_0151_BC0KKJACXX_s_6_rg.sorted.filtered.,WGS,TCGA-A5-A0VP-01A-21D-A101_120407_SN590_0151_BC0KKJACXX_s_6_rg.sorted,TCGA-A5-A0VP-01A-21D-A101_120407_SN590_0151_BC0KKJACXX_s_6_rg.sorted.bam,77.93,2.03,0.16,58cfa82fe4b0c9d6adf6b86c,TCGA-A5-A0VP-01A-21D-A101_120407_SN590_0151_BC0KKJACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0VP-01A,2DB0FB62-64CE-457C-9E22-DD05EF59F684,Primary Tumor,Illumina HiSeq,26cc510d-e8a9-4782-9488-478373dbc1df,Uterus,74,F1FBE4AC-F3FD-4609-9A2B-507820ABE77E,E23FE404-0449-453D-971C-6E940B546119,TCGA-A5-A0VP-01A-21D-A101-02,HG19_Broad_variant,TCGA-A5-A0VP,TCGA-UCEC,NA,s4992,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bec5,58cfa830e4b0c9d6adf6bec5,TCGA-AG-A032-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-A032-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-A032-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,237.12,1.85,0.15,58cfa830e4b0c9d6adf6bec5,TCGA-AG-A032-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A032-01A,0BB786EE-07CF-4853-9B49-EC95CD14E282,Primary Tumor,Illumina HiSeq,16a2716c-9563-4403-9a4b-8d4856022741,Colorectal,68,AE3C8931-C06F-466A-B6BF-440007E13387,AF7D94D6-C414-4812-A329-8856C086087E,TCGA-AG-A032-01A-01D-A077-02,HG18,TCGA-AG-A032,TCGA-READ,NA,s2175,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIB
13722.58cfa830e4b0c9d6adf6c27a,58cfa830e4b0c9d6adf6c27a,TCGA-AF-2689-01A-01D-1167_101023_SN208_0167_B80L4DABXX_s_3_rg.sorted.filtered.,WGS,TCGA-AF-2689-01A-01D-1167_101023_SN208_0167_B80L4DABXX_s_3_rg.sorted,TCGA-AF-2689-01A-01D-1167_101023_SN208_0167_B80L4DABXX_s_3_rg.sorted.bam,291.94,1.9,0.15,58cfa830e4b0c9d6adf6c27a,TCGA-AF-2689-01A-01D-1167_101023_SN208_0167_B80L4DABXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-AF-2689-01A,335D0351-3740-4847-9FF4-BE2F078C70F7,Primary Tumor,Illumina HiSeq,8f7ba742-44b6-41bd-8b8b-980ea208f9b8,Colorectal,41,8BEE44CB-3FE4-47A8-BD1B-90A59EA606BE,9AB254E9-6A35-46C6-BFB1-36247B20ABD6,TCGA-AF-2689-01A-01D-1167-02,HG18_Broad_variant,TCGA-AF-2689,TCGA-READ,NA,s1952,Harvard Medical School,Christiana Healthcare,None,NO,T3,N2,Rectal Adenocarcinoma,Stage IV
13722.58cfa831e4b0c9d6adf6cc21,58cfa831e4b0c9d6adf6cc21,TCGA-EE-A29Q-06A-11D-A18Y_120729_SN1120_0180_BC1176ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EE-A29Q-06A-11D-A18Y_120729_SN1120_0180_BC1176ACXX_s_1_rg.sorted,TCGA-EE-A29Q-06A-11D-A18Y_120729_SN1120_0180_BC1176ACXX_s_1_rg.sorted.bam,43.29,NA,0.16,58cfa831e4b0c9d6adf6cc21,TCGA-EE-A29Q-06A-11D-A18Y_120729_SN1120_0180_BC1176ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29Q-06A,6A1818F9-9303-41B0-B3B7-07FAF5055C86,Metastatic,Illumina HiSeq,ac015b9b-1772-42b1-a39c-c771b610492d,Skin,70,9B9F0B93-CF1E-4052-8938-2C56AD8A2FD2,E581778B-21C0-4DE9-9D03-B37046313700,TCGA-EE-A29Q-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A29Q,TCGA-SKCM,NA,s7845,Harvard Medical School,University of Sydney,Australia,NO,T3b,N0,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6d5d0,58cfa832e4b0c9d6adf6d5d0,TCGA-L7-A56G-01A-21D-A267_131001_SN1120_0280_BD2FDEACXX_s_3_rg.sorted.filtered.,WGS,TCGA-L7-A56G-01A-21D-A267_131001_SN1120_0280_BD2FDEACXX_s_3_rg.sorted,TCGA-L7-A56G-01A-21D-A267_131001_SN1120_0280_BD2FDEACXX_s_3_rg.sorted.bam,26.05,NA,0.15,58cfa832e4b0c9d6adf6d5d0,TCGA-L7-A56G-01A-21D-A267_131001_SN1120_0280_BD2FDEACXX_s_3_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-L7-A56G-01A,70C5CE85-4022-46C0-8BD0-F5E9009DDF41,Primary Tumor,Illumina HiSeq,8e835c63-a680-469e-82b7-850d8f01da57,Esophagus,65,3DD6751A-6FA6-4365-8E5E-FCB3D17910F6,6AD8F7F3-2EEC-47F7-9176-B10EBEB78F7E,TCGA-L7-A56G-01A-21D-A267-26,HG19_Broad_variant,TCGA-L7-A56G,TCGA-ESCA,NA,s1851,MD Anderson - Institute for Applied Cancer Science,Christiana Care,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6c060,58cfa830e4b0c9d6adf6c060,TCGA-AG-4001-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-4001-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-4001-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,15.59,1.9,0.16,58cfa830e4b0c9d6adf6c060,TCGA-AG-4001-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-4001-10A,D846228F-67AF-4B3B-9796-DBC263C2054C,Blood Derived Normal,Illumina HiSeq,0ada69d2-8f3d-4a5c-b254-7da0555e380f,Colorectal,74,1E7AC47A-A3DA-49BC-9871-6BE154A0014E,D5159D6F-6342-4D19-B7F2-35301995017A,TCGA-AG-4001-10A-01D-1115-02,HG18,TCGA-AG-4001,TCGA-READ,NA,s2162,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa832e4b0c9d6adf6d84d,58cfa832e4b0c9d6adf6d84d,TCGA-LN-A4A6-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-LN-A4A6-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_7_rg.sorted,TCGA-LN-A4A6-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_7_rg.sorted.bam,24.13,NA,0.16,58cfa832e4b0c9d6adf6d84d,TCGA-LN-A4A6-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_7_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A4A6-01A,FFCFA005-A04F-458E-9D1D-86143DD823E5,Primary Tumor,Illumina HiSeq,113e1f46-b529-435b-bb5a-879746bc79bb,Esophagus,65,14A1D0B5-CA52-4E95-B965-66A9E6BEAE43,B0BB8A76-3BF2-44E3-884A-F94A2D687F53,TCGA-LN-A4A6-01A-11D-A267-26,HG19_Broad_variant,TCGA-LN-A4A6,TCGA-ESCA,NA,s1775,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T2,N0,Not available,Stage II
13722.58cfa82fe4b0c9d6adf6b6f6,58cfa82fe4b0c9d6adf6b6f6,TCGA-50-6591-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-50-6591-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_5_rg.sorted,TCGA-50-6591-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_5_rg.sorted.bam,351.4,1.8,0.14,58cfa82fe4b0c9d6adf6b6f6,TCGA-50-6591-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-6591-01A,9B132E4F-7E35-4CC5-8711-43AD62B906D0,Primary Tumor,Illumina HiSeq,c1731efd-11ec-47b9-bb3c-32eab31d3552,Lung,63,0791E7AA-E97C-4DD0-9615-09EC7090F684,C57EF4F0-5BE8-4761-9763-5052EFDFD7D5,TCGA-50-6591-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-6591,TCGA-LUAD,119,s10784,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IV
13722.58cfa832e4b0c9d6adf6d3ba,58cfa832e4b0c9d6adf6d3ba,TCGA-L5-A43C-11A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-L5-A43C-11A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_2_rg.sorted,TCGA-L5-A43C-11A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_2_rg.sorted.bam,24.46,NA,0.15,58cfa832e4b0c9d6adf6d3ba,TCGA-L5-A43C-11A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A43C-11A,A935DAEB-1EFD-4113-A614-A5E4D446C72B,Solid Tissue Normal,Illumina HiSeq,3116c1ad-9e0f-46bb-9270-5f8216e359c7,Esophagus,81,B2C149F0-88E9-41F3-AF2B-198AE343B161,AB540F33-1AB8-45D1-BA4C-E3571C676F78,TCGA-L5-A43C-11A-11D-A248-26,HG19_Broad_variant,TCGA-L5-A43C,TCGA-ESCA,NA,s1833,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6bf8d,58cfa830e4b0c9d6adf6bf8d,TCGA-B5-A0JV-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-B5-A0JV-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_4_rg.sorted,TCGA-B5-A0JV-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_4_rg.sorted.bam,4.9,2.08,0.16,58cfa830e4b0c9d6adf6bf8d,TCGA-B5-A0JV-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_4_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0JV-10A,233E947A-D5E2-48E5-A8CE-5DA1ABB20681,Blood Derived Normal,Illumina HiSeq,2c067c19-fda2-4331-8fc7-1e59ff81b137,Uterus,63,9F2AD0C0-34CC-4100-9788-492988A0283B,1B4100CB-6FD4-4CF8-A6BB-773963BDA7C4,TCGA-B5-A0JV-10A-01D-A101-02,HG19_Broad_variant,TCGA-B5-A0JV,TCGA-UCEC,NA,s5206,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c51f,58cfa831e4b0c9d6adf6c51f,TCGA-CM-4747-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-CM-4747-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-CM-4747-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,64.72,1.9,0.14,58cfa831e4b0c9d6adf6c51f,TCGA-CM-4747-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-CM-4747-10A,56EB96A4-D2C2-42FB-B26C-1A80012BCB8E,Blood Derived Normal,Illumina HiSeq,226c6a2b-0354-4f94-af55-1dc92b881c07,Colorectal,47,9B97D882-564D-4683-AAE3-4AA286113EC5,76C6378E-72C1-40AB-847B-C943D4B38105,TCGA-CM-4747-10A-01D-1405-02,HG18,TCGA-CM-4747,TCGA-COAD,NA,s13394,Harvard Medical School,MSKCC,None,NO,T4a,N1b,Colon Adenocarcinoma,Stage IVA
13722.58cfa82fe4b0c9d6adf6b8bc,58cfa82fe4b0c9d6adf6b8bc,TCGA-73-4668-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-73-4668-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-73-4668-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,311.9,1.9,0.15,58cfa82fe4b0c9d6adf6b8bc,TCGA-73-4668-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4668-01A,B2285924-9813-4F46-BB8F-91A0EFD8A9B6,Primary Tumor,Illumina HiSeq,c3c82aae-4b64-4f65-b4ed-048053aef739,Lung,66,FDBFDF52-C0CD-4FBB-A910-B747516DFEF4,DC227D17-FED3-489A-B5C6-3D4C910310FF,TCGA-73-4668-01A-01D-1203-02,GRCh37,TCGA-73-4668,TCGA-LUAD,NA,s10795,Harvard Medical School,Roswell Park,United States,NO,T2,N1,Lung Micropapillary Adenocarcinoma,Stage IIB
13722.58cfa830e4b0c9d6adf6c024,58cfa830e4b0c9d6adf6c024,TCGA-AX-A0J1-01A-11D-A043_120403_SN1222_0094_BD0UKBACXX_s_4_rg.sorted.filtered.,WGS,TCGA-AX-A0J1-01A-11D-A043_120403_SN1222_0094_BD0UKBACXX_s_4_rg.sorted,TCGA-AX-A0J1-01A-11D-A043_120403_SN1222_0094_BD0UKBACXX_s_4_rg.sorted.bam,87.89,1.88,0.15,58cfa830e4b0c9d6adf6c024,TCGA-AX-A0J1-01A-11D-A043_120403_SN1222_0094_BD0UKBACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A0J1-01A,EC7A9D74-8B3F-4747-8926-1739A016AB2B,Primary Tumor,Illumina HiSeq,7bce686e-1ac7-49b4-9b2f-c76eec80a77c,Uterus,80,AC14E378-2DE1-458A-B8CD-7C60131AA927,3612DB54-D93C-47FB-A5E7-3BA3CE404A3C,TCGA-AX-A0J1-01A-11D-A043-02,HG19_Broad_variant,TCGA-AX-A0J1,TCGA-UCEC,NA,s4594,Harvard Medical School,Gynecologic Oncology Group,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6be86,58cfa830e4b0c9d6adf6be86,TCGA-AG-3892-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3892-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3892-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,8.59,1.9,0.16,58cfa830e4b0c9d6adf6be86,TCGA-AG-3892-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3892-10A,DED3FEB2-1079-4520-A7CA-F5B5FC73D7C5,Blood Derived Normal,Illumina HiSeq,359d1105-6b0b-4505-9c85-3e8b04d67dbb,Colorectal,57,00A6EA95-E9E2-41C5-9B0C-83F51B972B88,13881E1C-77C0-4063-A39D-98036ABA6FE8,TCGA-AG-3892-10A-01D-1115-02,HG18,TCGA-AG-3892,TCGA-READ,NA,s2155,Harvard Medical School,Indivumed,Germany,NO,T1,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa82fe4b0c9d6adf6b714,58cfa82fe4b0c9d6adf6b714,TCGA-73-4666-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-73-4666-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-73-4666-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,160,1.9,0.15,58cfa82fe4b0c9d6adf6b714,TCGA-73-4666-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4666-11A,4C31127E-D095-4978-9DAC-35153C27F6ED,Solid Tissue Normal,Illumina HiSeq,eb82e62e-f7d1-4c52-8b12-2d7dba1bd1b8,Lung,52,D07AC871-EAE1-4892-9E0B-CEEA122D3A64,FC424E08-A5D0-4A6D-AC7A-0EF4826BC886,TCGA-73-4666-11A-01D-1203-02,GRCh37,TCGA-73-4666,TCGA-LUAD,NA,s11357,Harvard Medical School,Roswell Park,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IV
13722.58cfa832e4b0c9d6adf6d366,58cfa832e4b0c9d6adf6d366,TCGA-L5-A4OG-11A-12D-A267_131001_SN1120_0280_BD2FDEACXX_s_8_rg.sorted.filtered.,WGS,TCGA-L5-A4OG-11A-12D-A267_131001_SN1120_0280_BD2FDEACXX_s_8_rg.sorted,TCGA-L5-A4OG-11A-12D-A267_131001_SN1120_0280_BD2FDEACXX_s_8_rg.sorted.bam,12.58,NA,0.14,58cfa832e4b0c9d6adf6d366,TCGA-L5-A4OG-11A-12D-A267_131001_SN1120_0280_BD2FDEACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OG-11A,EB4AD376-4CC1-4D2C-9B93-AD2B082C77C4,Solid Tissue Normal,Illumina HiSeq,963a01ba-f0ef-4d64-8bc1-402cdc062304,Esophagus,79,FB3D273C-B99F-411C-8D1C-A3DE77851316,2E4C3D9F-D7F1-4E3D-9DB6-7EDEAC584599,TCGA-L5-A4OG-11A-12D-A267-26,HG19_Broad_variant,TCGA-L5-A4OG,TCGA-ESCA,NA,s1925,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T1,N0,Not available,Stage I
13722.58cfa830e4b0c9d6adf6c064,58cfa830e4b0c9d6adf6c064,TCGA-AG-4005-01A-01D-1115_101122_SN177_0123_B20APUABXX_s_3_rg.sorted.filtered.,WGS,TCGA-AG-4005-01A-01D-1115_101122_SN177_0123_B20APUABXX_s_3_rg.sorted,TCGA-AG-4005-01A-01D-1115_101122_SN177_0123_B20APUABXX_s_3_rg.sorted.bam,618.89,1.9,0.15,58cfa830e4b0c9d6adf6c064,TCGA-AG-4005-01A-01D-1115_101122_SN177_0123_B20APUABXX_s_3_rg.sorted.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-4005-01A,866DE12B-E4DF-4F19-B62E-E3FD85D4EC08,Primary Tumor,Illumina HiSeq,06bb3e36-d2de-48c4-a23d-89eae00ec7e5,Colorectal,64,5B98C136-7BC3-411C-B07D-F0CF657F834D,284653D0-67A2-4ABF-9F75-1F045D0DAA70,TCGA-AG-4005-01A-01D-1115-02,HG18_Broad_variant,TCGA-AG-4005,TCGA-READ,NA,s1999,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Rectal Adenocarcinoma,Stage IV
13722.58cfa830e4b0c9d6adf6bb07,58cfa830e4b0c9d6adf6bb07,TCGA-73-4677-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-73-4677-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-73-4677-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,63.9,1.9,0.15,58cfa830e4b0c9d6adf6bb07,TCGA-73-4677-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4677-11A,03C3409A-9D16-41D0-9E26-F9FC2547A4C8,Solid Tissue Normal,Illumina HiSeq,12b710fb-7df3-4422-baf3-33178cb5a9fc,Lung,74,4282FBEB-27B9-4BF9-BC76-44DF35D48126,E3737810-1E1A-411C-AB1F-79C490181DF1,TCGA-73-4677-11A-01D-1203-02,GRCh37,TCGA-73-4677,TCGA-LUAD,38,s10800,Harvard Medical School,Roswell Park,United States,NO,T2a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa830e4b0c9d6adf6baf8,58cfa830e4b0c9d6adf6baf8,TCGA-AA-3514-01A-02D-1547_110525_SN590_0091_AC02W2ABXX_s_1.rg.sorted.filtered.,WGS,TCGA-AA-3514-01A-02D-1547_110525_SN590_0091_AC02W2ABXX_s_1.rg.sorted,TCGA-AA-3514-01A-02D-1547_110525_SN590_0091_AC02W2ABXX_s_1.rg.sorted.bam,263.29,1.9,0.15,58cfa830e4b0c9d6adf6baf8,TCGA-AA-3514-01A-02D-1547_110525_SN590_0091_AC02W2ABXX_s_1.rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3514-01A,DDF69ED9-4C53-48B8-9F01-495BD60C3425,Primary Tumor,Illumina HiSeq,3737ce68-bbb0-4ecc-849f-0fd049fe4d85,Colorectal,81,A657AFDB-5322-454F-8DD7-8397291401C5,C0486DD0-5BE4-4B64-8A8F-3CF47BD5A330,TCGA-AA-3514-01A-02D-1547-02,HG18_Broad_variant,TCGA-AA-3514,TCGA-COAD,NA,s13361,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa830e4b0c9d6adf6be28,58cfa830e4b0c9d6adf6be28,TCGA-BH-A0W5-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BH-A0W5-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_4_rg.sorted,TCGA-BH-A0W5-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_4_rg.sorted.bam,17.76,2.22,0.16,58cfa830e4b0c9d6adf6be28,TCGA-BH-A0W5-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0W5-10A,DA9C10EA-C13F-4D88-8B94-A0CBC106D036,Blood Derived Normal,Illumina HiSeq,b768a52b-e629-46df-b042-fa815cb7ce57,Breast,77,B49CDE05-00A3-4B24-A1B9-64E300CF63E0,154C09B7-C645-497A-9B14-655DB46CD990,TCGA-BH-A0W5-10A-01D-A106-02,HG19_Broad_variant,TCGA-BH-A0W5,TCGA-BRCA,NA,s5641,Harvard Medical School,University of Pittsburgh,None,NO,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa832e4b0c9d6adf6d468,58cfa832e4b0c9d6adf6d468,TCGA-V4-A9EX-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_5_rg.sorted.filtered.,WGS,TCGA-V4-A9EX-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_5_rg.sorted,TCGA-V4-A9EX-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_5_rg.sorted.bam,9.97,NA,0.17,58cfa832e4b0c9d6adf6d468,TCGA-V4-A9EX-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EX-10A,892E7630-B11E-47BD-987C-327D33258E11,Blood Derived Normal,Illumina HiSeq,4e8e6d0d-524b-4120-8948-607043612fe3,Eye,55,E633FB19-C417-47AB-9676-73E95DE23B46,DD43FAF9-A6AC-4FF2-8043-09B0A6DECCED,TCGA-V4-A9EX-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9EX,TCGA-UVM,730,s197,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa82fe4b0c9d6adf6b6e2,58cfa82fe4b0c9d6adf6b6e2,TCGA-64-5775-10A-01D-1623_110824_SN208_0222_BB0164ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-64-5775-10A-01D-1623_110824_SN208_0222_BB0164ACXX_s_2_rg.sorted,TCGA-64-5775-10A-01D-1623_110824_SN208_0222_BB0164ACXX_s_2_rg.sorted.bam,85.4,1.9,0.13,58cfa82fe4b0c9d6adf6b6e2,TCGA-64-5775-10A-01D-1623_110824_SN208_0222_BB0164ACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-64-5775-10A,C8544FB3-B26E-4672-BB81-A271DB724B04,Blood Derived Normal,Illumina HiSeq,e35e2779-31f7-418f-8ed1-52c4af96d40c,Lung,71,EB99A1B7-D1A5-4C22-BC7C-C97CC57F664D,0141AC27-5124-4127-9B84-D3B01F37618B,TCGA-64-5775-10A-01D-1623-02,HG19_Broad_variant,TCGA-64-5775,TCGA-LUAD,62,s10797,Harvard Medical School,Fox Chase,United States,NO,T4,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa830e4b0c9d6adf6bcb2,58cfa830e4b0c9d6adf6bcb2,TCGA-AZ-4684-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AZ-4684-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-AZ-4684-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,275.02,1.9,0.15,58cfa830e4b0c9d6adf6bcb2,TCGA-AZ-4684-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-4684-01A,CAC80259-3A26-4A99-B0D3-13454068E6ED,Primary Tumor,Illumina HiSeq,bab439b0-f1d3-41c2-98dd-a660818851fe,Colorectal,49,37AD61EA-96D1-40F1-B77A-56408E4243EA,6731F782-4435-497F-9626-C0199DAE8A8A,TCGA-AZ-4684-01A-01D-1405-02,HG18,TCGA-AZ-4684,TCGA-COAD,NA,s13391,Harvard Medical School,University of Pittsburgh,None,NO,T3,N2,Colon Adenocarcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c882,58cfa831e4b0c9d6adf6c882,TCGA-CV-6939-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CV-6939-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_3_rg.sorted,TCGA-CV-6939-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_3_rg.sorted.bam,16.7,1.9,0.13,58cfa831e4b0c9d6adf6c882,TCGA-CV-6939-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,Not available,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6939-11A,E7D1F0DD-EEC0-4670-A2BA-00FFE38C6382,Solid Tissue Normal,Illumina HiSeq,c0371496-b9f6-4925-bbcf-e8a5de80d00d,Head and Neck,60,B7635DF8-644C-473D-8B07-F586693A1F3E,28B55601-835D-4281-828D-37363F5D7EAF,TCGA-CV-6939-11A-01D-1911-02,HG19_Broad_variant,TCGA-CV-6939,TCGA-HNSC,666,s15781,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6be36,58cfa830e4b0c9d6adf6be36,TCGA-BJ-A18Z-10A-01D-A13U_120712_SN1222_0125_BD13TPACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BJ-A18Z-10A-01D-A13U_120712_SN1222_0125_BD13TPACXX_s_2_rg.sorted,TCGA-BJ-A18Z-10A-01D-A13U_120712_SN1222_0125_BD13TPACXX_s_2_rg.sorted.bam,32.23,1.72,0.17,58cfa830e4b0c9d6adf6be36,TCGA-BJ-A18Z-10A-01D-A13U_120712_SN1222_0125_BD13TPACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A18Z-10A,0D497FAF-2C1C-4173-A5FE-770CCA73323C,Blood Derived Normal,Illumina HiSeq,e2be58e6-cbfb-4ba0-acae-d10c09b96f62,Thyroid,58,FDF1E501-F34F-450C-9A5C-611157079A86,85A7922F-0327-437C-BDF5-1BB67A1E932F,TCGA-BJ-A18Z-10A-01D-A13U-02,HG19_Broad_variant,TCGA-BJ-A18Z,TCGA-THCA,NA,s12356,Harvard Medical School,University of Pittsburgh,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA
13722.58cfa831e4b0c9d6adf6c5fa,58cfa831e4b0c9d6adf6c5fa,TCGA-CG-4444-10A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CG-4444-10A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_8_rg.sorted,TCGA-CG-4444-10A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_8_rg.sorted.bam,31.9,1.9,0.15,58cfa831e4b0c9d6adf6c5fa,TCGA-CG-4444-10A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_8_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4444-10A,5C087D33-0BD3-407D-8350-FABBA6AEC597,Blood Derived Normal,Illumina HiSeq,71fb65dc-8cfc-4004-a794-1a756c04d829,Stomach,76,5DE68F68-D900-44C0-8322-EF593085AA24,2378575A-14F0-4F7C-AB38-A5FBDB689011,TCGA-CG-4444-10A-01D-A326-26,HG19_Broad_variant,TCGA-CG-4444,TCGA-STAD,NA,s14828,MD Anderson - Institute for Applied Cancer Science,Indivumed,Germany,NO,T2b,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA
13722.58cfa82fe4b0c9d6adf6b72a,58cfa82fe4b0c9d6adf6b72a,TCGA-49-6767-01A-11D-1853_120205_SN590_0136_BD0LRYACXX_s_7_rg.sorted.filtered.,WGS,TCGA-49-6767-01A-11D-1853_120205_SN590_0136_BD0LRYACXX_s_7_rg.sorted,TCGA-49-6767-01A-11D-1853_120205_SN590_0136_BD0LRYACXX_s_7_rg.sorted.bam,291.7,1.9,0.14,58cfa82fe4b0c9d6adf6b72a,TCGA-49-6767-01A-11D-1853_120205_SN590_0136_BD0LRYACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-49-6767-01A,6BFFE800-EC2B-4638-9333-97FE85DCD91C,Primary Tumor,Illumina HiSeq,759c1dd3-0f7d-4ba7-8c8e-c276faf0255b,Lung,46,708A8742-F6D6-411D-9340-2C6C25885D22,FBCE84D6-2880-45F5-BD6F-B079C33C353E,TCGA-49-6767-01A-11D-1853-02,HG19_Broad_variant,TCGA-49-6767,TCGA-LUAD,NA,s11233,Harvard Medical School,Johns Hopkins,United States,NO,T3,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa830e4b0c9d6adf6c1ba,58cfa830e4b0c9d6adf6c1ba,TCGA-BS-A0UT-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BS-A0UT-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_4_rg.sorted,TCGA-BS-A0UT-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_4_rg.sorted.bam,65.26,1.97,0.13,58cfa830e4b0c9d6adf6c1ba,TCGA-BS-A0UT-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_4_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0UT-01A,E2B1D0DE-5221-44A1-8FAD-9708A3CADA14,Primary Tumor,Illumina HiSeq,ca5a88b7-6801-435a-aeef-b9ca9d963c17,Uterus,62,824D0DBC-293F-4893-A68C-24DEDD437EA5,12674687-D555-40DB-ACC9-7638F85D0661,TCGA-BS-A0UT-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0UT,TCGA-UCEC,NA,s4608,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d4fe,58cfa832e4b0c9d6adf6d4fe,TCGA-L5-A4OG-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_7_rg.sorted.filtered.,WGS,TCGA-L5-A4OG-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_7_rg.sorted,TCGA-L5-A4OG-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_7_rg.sorted.bam,40.59,NA,0.16,58cfa832e4b0c9d6adf6d4fe,TCGA-L5-A4OG-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OG-01A,EB4AD376-4CC1-4D2C-9B93-AD2B082C77C4,Primary Tumor,Illumina HiSeq,cef87877-7e34-43b9-9599-f98660d7b833,Esophagus,79,E8E44C65-B4E4-4688-A217-206905E68A7F,04C91C91-E55A-4075-B08A-F80568BB4A7B,TCGA-L5-A4OG-01A-11D-A267-26,HG19_Broad_variant,TCGA-L5-A4OG,TCGA-ESCA,NA,s1926,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T1,N0,Not available,Stage I
13722.58cfa831e4b0c9d6adf6cdb8,58cfa831e4b0c9d6adf6cdb8,TCGA-FG-6691-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FG-6691-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_8_rg.sorted,TCGA-FG-6691-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_8_rg.sorted.bam,105.7,1.9,0.16,58cfa831e4b0c9d6adf6cdb8,TCGA-FG-6691-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-6691-01A,E4D9B696-3311-44E7-9191-FDE56C080A00,Primary Tumor,Illumina HiSeq,b404ac67-1c7f-4b01-8038-7432d3d6e489,Brain,23,87800B98-1FD3-4A09-AC98-3125962BFA72,B4968770-4D21-4C51-9ECA-47E23D5C240E,TCGA-FG-6691-01A-11D-1891-02,HG19_Broad_variant,TCGA-FG-6691,TCGA-LGG,NA,s8368,Harvard Medical School,Case Western,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6cd18,58cfa831e4b0c9d6adf6cd18,TCGA-ET-A25N-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-ET-A25N-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_7_rg.sorted,TCGA-ET-A25N-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_7_rg.sorted.bam,26.49,1.71,0.15,58cfa831e4b0c9d6adf6cd18,TCGA-ET-A25N-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-ET-A25N-01A,EBCCFB5F-C0A8-4263-AAFF-B5DD83585191,Primary Tumor,Illumina HiSeq,2e9fb20e-cc3d-4aa3-a188-6695dc2532a3,Thyroid,28,0CD93B1F-1CBB-4C1E-A4F6-940F95C41683,1A00F009-28F5-406B-8F47-4BB9D55D25D6,TCGA-ET-A25N-01A-11D-A16N-02,HG19_Broad_variant,TCGA-ET-A25N,TCGA-THCA,NA,s12525,Harvard Medical School,Johns Hopkins,United States,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c510,58cfa831e4b0c9d6adf6c510,TCGA-CK-4951-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-CK-4951-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-CK-4951-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,543,1.9,0.16,58cfa831e4b0c9d6adf6c510,TCGA-CK-4951-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-CK-4951-10A,2DB3C23D-C591-4EA0-B0A8-ED9C4343C80E,Blood Derived Normal,Illumina HiSeq,53f23902-49e3-4ebb-8694-fcf7b0c3ab7e,Colorectal,79,38BB4C4A-4414-411E-B94B-6A1044286106,0A96870C-4BC0-477C-B3F0-248D15A3D17E,TCGA-CK-4951-10A-01D-1405-02,HG18,TCGA-CK-4951,TCGA-COAD,NA,s13393,Harvard Medical School,Harvard,None,NO,T3,N0,Colon Mucinous Adenocarcinoma,Stage IIA
13722.58cfa832e4b0c9d6adf6d47e,58cfa832e4b0c9d6adf6d47e,TCGA-V4-A9F4-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-V4-A9F4-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_8_rg.sorted,TCGA-V4-A9F4-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_8_rg.sorted.bam,11.51,NA,0.15,58cfa832e4b0c9d6adf6d47e,TCGA-V4-A9F4-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9F4-10A,4B9FD822-17AA-4A22-8E17-175A72931D5D,Blood Derived Normal,Illumina HiSeq,6e4d47f8-ee26-4117-9c28-2815eb3d97f8,Eye,41,C35C6BF5-3F7A-46F6-A9E0-626450A4B645,3263B1FD-DD80-4509-8F1E-02C0543A8030,TCGA-V4-A9F4-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9F4,TCGA-UVM,NA,s237,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa831e4b0c9d6adf6cac5,58cfa831e4b0c9d6adf6cac5,TCGA-DA-A1I8-06A-11D-A18Y_120730_SN208_0419_AC13W9ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DA-A1I8-06A-11D-A18Y_120730_SN208_0419_AC13W9ACXX_s_5_rg.sorted,TCGA-DA-A1I8-06A-11D-A18Y_120730_SN208_0419_AC13W9ACXX_s_5_rg.sorted.bam,29.72,NA,0.16,58cfa831e4b0c9d6adf6cac5,TCGA-DA-A1I8-06A-11D-A18Y_120730_SN208_0419_AC13W9ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1I8-06A,7B92FCD4-F9BE-4B97-94A2-B2E8348AEABA,Metastatic,Illumina HiSeq,0533c67c-0914-42e2-97d4-0f5e0bbacc84,Skin,63,53F3FC7C-3B45-4516-9749-776E039318AA,B33A4712-88D6-40C0-A09C-F837438461D3,TCGA-DA-A1I8-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-DA-A1I8,TCGA-SKCM,NA,s7502,Harvard Medical School,Yale,United States,NO,T4b,N0,Not available,Stage IIC
13722.58cfa82fe4b0c9d6adf6b676,58cfa82fe4b0c9d6adf6b676,TCGA-73-4666-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-73-4666-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-73-4666-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,375.23,1.9,0.16,58cfa82fe4b0c9d6adf6b676,TCGA-73-4666-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4666-01A,4C31127E-D095-4978-9DAC-35153C27F6ED,Primary Tumor,Illumina HiSeq,7af89597-2a6c-4030-acf6-4bd33963a3f3,Lung,52,5BAE2E45-6DBC-458C-A66F-702EB1AF7357,AC0D75F8-B4C5-40A8-9044-0B74722424D8,TCGA-73-4666-01A-01D-1203-02,GRCh37,TCGA-73-4666,TCGA-LUAD,NA,s11461,Harvard Medical School,Roswell Park,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IV
13722.58cfa832e4b0c9d6adf6ce1c,58cfa832e4b0c9d6adf6ce1c,TCGA-FD-A3N6-10A-01D-A21C_120830_SN590_0177_BD141PACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FD-A3N6-10A-01D-A21C_120830_SN590_0177_BD141PACXX_s_4_rg.sorted,TCGA-FD-A3N6-10A-01D-A21C_120830_SN590_0177_BD141PACXX_s_4_rg.sorted.bam,41.98,NA,0.16,58cfa832e4b0c9d6adf6ce1c,TCGA-FD-A3N6-10A-01D-A21C_120830_SN590_0177_BD141PACXX_s_4_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3N6-10A,8C1DD7F7-B74A-4FA2-B6A7-86F0348D2567,Blood Derived Normal,Illumina HiSeq,bd4052fe-7b60-414b-86ef-94a2d4a47891,Bladder,43,B14ED321-47EF-43C9-BA7E-8F36E576FDFB,734A985F-A602-4D40-81E4-452363A5FBBE,TCGA-FD-A3N6-10A-01D-A21C-26,HG19_Broad_variant,TCGA-FD-A3N6,TCGA-BLCA,NA,s2904,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa832e4b0c9d6adf6ceb5,58cfa832e4b0c9d6adf6ceb5,TCGA-EM-A1YA-10A-01D-A14U_120629_SN1222_0121_BD143UACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EM-A1YA-10A-01D-A14U_120629_SN1222_0121_BD143UACXX_s_5_rg.sorted,TCGA-EM-A1YA-10A-01D-A14U_120629_SN1222_0121_BD143UACXX_s_5_rg.sorted.bam,91.22,1.84,0.16,58cfa832e4b0c9d6adf6ceb5,TCGA-EM-A1YA-10A-01D-A14U_120629_SN1222_0121_BD143UACXX_s_5_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1YA-10A,567E4D90-5C5A-44F0-A462-90C831F3C096,Blood Derived Normal,Illumina HiSeq,d9bc79ac-a106-484a-88cf-2401b2a13b25,Thyroid,74,B823CFE2-8FC2-411E-BEED-92165341AC2F,1F7C16DC-32BA-4DBE-A864-AADCE33B9EC4,TCGA-EM-A1YA-10A-01D-A14U-02,HG19_Broad_variant,TCGA-EM-A1YA,TCGA-THCA,NA,s12380,Harvard Medical School,University Health Network,Canada,NO,T2,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa831e4b0c9d6adf6c548,58cfa831e4b0c9d6adf6c548,TCGA-CM-4747-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-CM-4747-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-CM-4747-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,541,1.9,0.15,58cfa831e4b0c9d6adf6c548,TCGA-CM-4747-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-CM-4747-01A,56EB96A4-D2C2-42FB-B26C-1A80012BCB8E,Primary Tumor,Illumina HiSeq,e66cdfc9-e0b0-4ca4-bbcc-9ae23d9d663f,Colorectal,47,D3DAA95A-19B5-4822-BCBE-35CEEC12FDF1,7E2021D4-E528-4EB1-A7A0-71D6BE77A71D,TCGA-CM-4747-01A-01D-1405-02,HG18,TCGA-CM-4747,TCGA-COAD,NA,s13217,Harvard Medical School,MSKCC,None,NO,T4a,N1b,Colon Adenocarcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6bf16,58cfa830e4b0c9d6adf6bf16,TCGA-BR-4257-01A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BR-4257-01A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_3_rg.sorted,TCGA-BR-4257-01A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_3_rg.sorted.bam,106.9,1.9,0.16,58cfa830e4b0c9d6adf6bf16,TCGA-BR-4257-01A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4257-01A,DA112431-5579-4FD1-A230-9144B359B0E9,Primary Tumor,Illumina HiSeq,5e38d8b4-97fb-407a-ab06-2f002456472d,Stomach,79,97B44B05-97EB-486C-94DB-42838831DE0B,465E5E4D-A801-4BBC-9E1C-004C7718571F,TCGA-BR-4257-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4257,TCGA-STAD,NA,s15048,Harvard Medical School,Asterand,Russia,NO,TX,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa830e4b0c9d6adf6bbe2,58cfa830e4b0c9d6adf6bbe2,TCGA-AG-A015-10A-01D-A078_110409_SN590_0076_AB04G5ABXX_s_6_rg.sorted.filtered.,WGS,TCGA-AG-A015-10A-01D-A078_110409_SN590_0076_AB04G5ABXX_s_6_rg.sorted,TCGA-AG-A015-10A-01D-A078_110409_SN590_0076_AB04G5ABXX_s_6_rg.sorted.bam,7.76,1.97,0.15,58cfa830e4b0c9d6adf6bbe2,TCGA-AG-A015-10A-01D-A078_110409_SN590_0076_AB04G5ABXX_s_6_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A015-10A,09DAFF79-6493-45C1-8CBA-9381259E2BEA,Blood Derived Normal,Illumina HiSeq,e61bfaa9-8fd2-4a31-8149-9812aa5a5406,Colorectal,64,BCF9BBF4-758D-4290-855E-5D913C3B53D8,B02FA52E-709A-4709-A4FD-629A7D7E4033,TCGA-AG-A015-10A-01D-A078-02,HG18_Broad_variant,TCGA-AG-A015,TCGA-READ,NA,s2173,Harvard Medical School,Indivumed,Germany,NO,T1,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c526,58cfa831e4b0c9d6adf6c526,TCGA-CM-4746-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-CM-4746-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-CM-4746-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,516,1.9,0.15,58cfa831e4b0c9d6adf6c526,TCGA-CM-4746-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-CM-4746-01A,C0B8C55C-B993-481D-AEEA-9EBFA64EE20E,Primary Tumor,Illumina HiSeq,cba07266-002c-406e-bfb3-5fc3483bb04b,Colorectal,61,85991716-6807-4F31-BE63-BF80CEC40CC2,32AAA8D7-1ABF-4AEF-8067-BE801C95D30B,TCGA-CM-4746-01A-01D-1405-02,HG18,TCGA-CM-4746,TCGA-COAD,NA,s12892,Harvard Medical School,MSKCC,None,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa830e4b0c9d6adf6c167,58cfa830e4b0c9d6adf6c167,TCGA-BJ-A0Z9-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BJ-A0Z9-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_7_rg.sorted,TCGA-BJ-A0Z9-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_7_rg.sorted.bam,75.83,2.17,0.13,58cfa830e4b0c9d6adf6c167,TCGA-BJ-A0Z9-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0Z9-01A,86F9ECA0-D1EA-4375-A6BC-055E44B3198A,Primary Tumor,Illumina HiSeq,2fcaeaf0-3a03-4b60-975a-31ac8afe58aa,Thyroid,57,AA8578FE-EDB2-4137-B363-FEB2C27D475A,B761F912-BDF6-4F1F-8CD0-0AE9DFC57A59,TCGA-BJ-A0Z9-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0Z9,TCGA-THCA,NA,s12099,Harvard Medical School,University of Pittsburgh,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage III
13722.58cfa831e4b0c9d6adf6cb32,58cfa831e4b0c9d6adf6cb32,TCGA-EE-A29C-06A-21D-A18Y_120807_SN590_0173_AC0VN5ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EE-A29C-06A-21D-A18Y_120807_SN590_0173_AC0VN5ACXX_s_2_rg.sorted,TCGA-EE-A29C-06A-21D-A18Y_120807_SN590_0173_AC0VN5ACXX_s_2_rg.sorted.bam,30.14,NA,0.17,58cfa831e4b0c9d6adf6cb32,TCGA-EE-A29C-06A-21D-A18Y_120807_SN590_0173_AC0VN5ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29C-06A,FC5B5D2F-0D03-45C2-B7A0-BA6EC108FE51,Metastatic,Illumina HiSeq,ad8de103-2a4c-4260-a774-90e01027128e,Skin,20,E6B3B5F4-1A6B-40BE-A1DE-1C680855F5D6,02881604-8976-48A4-947A-84391AEC2B24,TCGA-EE-A29C-06A-21D-A18Y-02,HG19_Broad_variant,TCGA-EE-A29C,TCGA-SKCM,NA,s7331,Harvard Medical School,University of Sydney,Australia,NO,T2a,N0,Not available,Stage IB
13722.58cfa831e4b0c9d6adf6cc0c,58cfa831e4b0c9d6adf6cc0c,TCGA-EE-A29E-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EE-A29E-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_4_rg.sorted,TCGA-EE-A29E-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_4_rg.sorted.bam,41.77,NA,0.17,58cfa831e4b0c9d6adf6cc0c,TCGA-EE-A29E-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29E-06A,83D05B9A-F409-4169-BEF9-E772D2CFBFAF,Metastatic,Illumina HiSeq,93b49bcb-3ba4-4360-93e8-7c91eee744ee,Skin,54,ADDBE524-382B-48CA-B4A0-962FAB71E0D0,C1A44D60-23D2-46B9-93E7-7E9DC671902C,TCGA-EE-A29E-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A29E,TCGA-SKCM,NA,s7335,Harvard Medical School,University of Sydney,Australia,NO,T3a,N1b,Not available,Stage IIIB
13722.58cfa831e4b0c9d6adf6c9ed,58cfa831e4b0c9d6adf6c9ed,TCGA-DJ-A13P-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DJ-A13P-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_5_rg.sorted,TCGA-DJ-A13P-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_5_rg.sorted.bam,104.83,1.95,0.16,58cfa831e4b0c9d6adf6c9ed,TCGA-DJ-A13P-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13P-01A,CA95A11C-B54C-409E-B9A0-DA850945033D,Primary Tumor,Illumina HiSeq,5d993dc5-0dfb-4f12-bd8b-c21a2c64577d,Thyroid,52,EFAD8B07-B295-468F-A836-F94029AEC777,528EC19A-8218-4E8F-B1E7-8A149F54A6BE,TCGA-DJ-A13P-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13P,TCGA-THCA,NA,s11995,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage II
13722.58cfa830e4b0c9d6adf6ba58,58cfa830e4b0c9d6adf6ba58,TCGA-AA-A01Q-10A-01D-A078_110409_SN590_0077_BB04EHABXX_s_3_rg.sorted.filtered.,WGS,TCGA-AA-A01Q-10A-01D-A078_110409_SN590_0077_BB04EHABXX_s_3_rg.sorted,TCGA-AA-A01Q-10A-01D-A078_110409_SN590_0077_BB04EHABXX_s_3_rg.sorted.bam,64.8,1.74,0.15,58cfa830e4b0c9d6adf6ba58,TCGA-AA-A01Q-10A-01D-A078_110409_SN590_0077_BB04EHABXX_s_3_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01Q-10A,4BE66108-E72A-406B-BB4B-F58FF2877336,Blood Derived Normal,Illumina HiSeq,d65a9979-1e3f-4a41-92ec-18be75411835,Colorectal,48,AA17437D-52F5-41D6-A4A8-5635B598242A,C641C01D-375D-4CBE-AF9C-1B861B489BCB,TCGA-AA-A01Q-10A-01D-A078-02,HG18_Broad_variant,TCGA-AA-A01Q,TCGA-COAD,NA,s13197,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa830e4b0c9d6adf6c226,58cfa830e4b0c9d6adf6c226,TCGA-BS-A0UV-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BS-A0UV-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_5_rg.sorted,TCGA-BS-A0UV-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_5_rg.sorted.bam,96.07,1.92,0.15,58cfa830e4b0c9d6adf6c226,TCGA-BS-A0UV-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_5_rg.sorted.bam,Alive,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0UV-01A,B19425AB-A82F-4C2A-BF58-D1BD30511D74,Primary Tumor,Illumina HiSeq,91fbcf9b-f514-49ff-925b-08d6244293f7,Uterus,55,30945527-528A-448E-8DB4-2E0C31C9016D,A0F51177-4C00-4F97-8CD4-2E05B63B00DE,TCGA-BS-A0UV-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0UV,TCGA-UCEC,NA,s5222,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6cfde,58cfa832e4b0c9d6adf6cfde,TCGA-GV-A3JZ-10A-01D-A21C_120830_SN590_0178_AD143RACXX_s_8_rg.sorted.filtered.,WGS,TCGA-GV-A3JZ-10A-01D-A21C_120830_SN590_0178_AD143RACXX_s_8_rg.sorted,TCGA-GV-A3JZ-10A-01D-A21C_120830_SN590_0178_AD143RACXX_s_8_rg.sorted.bam,40.03,NA,0.17,58cfa832e4b0c9d6adf6cfde,TCGA-GV-A3JZ-10A-01D-A21C_120830_SN590_0178_AD143RACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GV-A3JZ-10A,9CC92795-7A24-4875-87F0-3EFCCBFCC970,Blood Derived Normal,Illumina HiSeq,4b54f30a-eae2-443c-8c0c-f198b72091d1,Bladder,55,06A54EE0-6B26-49FA-8C3D-38D97027C679,90FA8258-8CF7-4F2D-A075-17706DD69BA8,TCGA-GV-A3JZ-10A-01D-A21C-26,HG19_Broad_variant,TCGA-GV-A3JZ,TCGA-BLCA,NA,s2739,MD Anderson - Institute for Applied Cancer Science,BLN - Cleveland Clinic,United States,NO,T4a,N3,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa830e4b0c9d6adf6c015,58cfa830e4b0c9d6adf6c015,TCGA-AG-3728-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3728-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3728-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,6.01,1.9,0.17,58cfa830e4b0c9d6adf6c015,TCGA-AG-3728-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3728-10A,856A490C-C6DA-48FE-88B5-9FDE0F481365,Blood Derived Normal,Illumina HiSeq,16067ed2-6dd1-4888-9db0-bcc0f3becf40,Colorectal,73,0BCFA029-86E5-47DE-A315-D9991F67E5CD,6A2A30EF-2FCF-485B-9FE3-D32C89393F50,TCGA-AG-3728-10A-01D-1115-02,HG18,TCGA-AG-3728,TCGA-READ,NA,s1962,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIB
13722.58cfa831e4b0c9d6adf6cda0,58cfa831e4b0c9d6adf6cda0,TCGA-FE-A233-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FE-A233-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_3_rg.sorted,TCGA-FE-A233-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_3_rg.sorted.bam,92.7,2.05,0.18,58cfa831e4b0c9d6adf6cda0,TCGA-FE-A233-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A233-01A,E70FEAFD-1390-4F4C-A635-DA65C1A7DAEB,Primary Tumor,Illumina HiSeq,3609a0f8-b027-4392-adea-96eab2e1d78f,Thyroid,18,76A6F76D-F33E-4B4A-B0EE-FB863345F194,4336BC49-7D28-4EB6-8B41-F43127ED8EC1,TCGA-FE-A233-01A-11D-A14U-02,HG19_Broad_variant,TCGA-FE-A233,TCGA-THCA,NA,s12758,Harvard Medical School,Ohio State University,United States,NO,T2,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82fe4b0c9d6adf6b9c8,58cfa82fe4b0c9d6adf6b9c8,TCGA-AA-A00Q-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A00Q-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A00Q-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,212.1,1.72,0.15,58cfa82fe4b0c9d6adf6b9c8,TCGA-AA-A00Q-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A00Q-01A,62D39BE5-F029-4EB8-8B00-46470E06A755,Primary Tumor,Illumina HiSeq,5ccd68f8-a32c-47e2-805b-e3721dbb395d,Colorectal,66,89FC5DB9-EDFF-480F-8FC4-ADDD28C6D615,D458CE34-22B1-41F7-9CE7-659107AD6F77,TCGA-AA-A00Q-01A-01D-A077-02,HG18,TCGA-AA-A00Q,TCGA-COAD,NA,s13523,Harvard Medical School,Indivumed,Germany,NO,T4,N1,Colon Adenocarcinoma,Stage IIIB
13722.58cfa831e4b0c9d6adf6cd5a,58cfa831e4b0c9d6adf6cd5a,TCGA-EE-A2MS-10A-01D-A190_120718_SN1222_0126_AC117AACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EE-A2MS-10A-01D-A190_120718_SN1222_0126_AC117AACXX_s_7_rg.sorted,TCGA-EE-A2MS-10A-01D-A190_120718_SN1222_0126_AC117AACXX_s_7_rg.sorted.bam,41.54,NA,0.16,58cfa831e4b0c9d6adf6cd5a,TCGA-EE-A2MS-10A-01D-A190_120718_SN1222_0126_AC117AACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MS-10A,4A4F5EE9-B588-4357-B058-EFFBFB53E2C3,Blood Derived Normal,Illumina HiSeq,ff803ed6-50bf-4221-a401-0cc77d8299a6,Skin,72,6DC218EC-F0E8-4EEC-B905-0F1B24680088,C47237B8-13E6-4B9A-9A95-8CBA4C66327A,TCGA-EE-A2MS-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2MS,TCGA-SKCM,NA,s7690,Harvard Medical School,University of Sydney,Australia,NO,T3a,N0,Not available,Stage II
13722.58cfa830e4b0c9d6adf6bd98,58cfa830e4b0c9d6adf6bd98,TCGA-BF-A1PV-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BF-A1PV-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_2_rg.sorted,TCGA-BF-A1PV-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_2_rg.sorted.bam,39.59,NA,0.16,58cfa830e4b0c9d6adf6bd98,TCGA-BF-A1PV-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Skin Cutaneous Melanoma,Aligned reads,TCGA-BF-A1PV-10A,EFF78AF6-0F68-49B9-866B-0D511606F2B1,Blood Derived Normal,Illumina HiSeq,be8992e2-ef31-477b-a01b-e8a37a6e135b,Skin,74,0CC75509-DCDA-41FA-A4BB-2BFA77E7E9D4,298F1BB0-CC50-4805-9BDC-2635F16BC5D5,TCGA-BF-A1PV-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-BF-A1PV,TCGA-SKCM,NA,s7826,Harvard Medical School,Cureline,Russia,NO,T4b,N0,Not available,Stage IIC
13722.58cfa831e4b0c9d6adf6c3a8,58cfa831e4b0c9d6adf6c3a8,TCGA-CD-5798-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CD-5798-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_3_rg.sorted,TCGA-CD-5798-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_3_rg.sorted.bam,44,1.9,0.13,58cfa831e4b0c9d6adf6c3a8,TCGA-CD-5798-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_3_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-5798-01A,E42F45C6-FD00-44CF-A210-C8803DA326A1,Primary Tumor,Illumina HiSeq,5b2c6e2f-0b61-49e1-bef5-6d7408918d47,Stomach,82,72855D36-60BE-498F-96E9-0F10DC05B3A0,F9D13E07-70F4-48F3-B49E-06984C9E39EE,TCGA-CD-5798-01A-11D-1598-02,HG19_Broad_variant,TCGA-CD-5798,TCGA-STAD,NA,s15455,Harvard Medical School,ILSbio,Vietnam,NO,T3,N0,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage II
13722.58cfa831e4b0c9d6adf6cc6e,58cfa831e4b0c9d6adf6cc6e,TCGA-ER-A193-10A-01D-A190_120718_SN1222_0126_AC117AACXX_s_5_rg.sorted.filtered.,WGS,TCGA-ER-A193-10A-01D-A190_120718_SN1222_0126_AC117AACXX_s_5_rg.sorted,TCGA-ER-A193-10A-01D-A190_120718_SN1222_0126_AC117AACXX_s_5_rg.sorted.bam,37.78,NA,0.15,58cfa831e4b0c9d6adf6cc6e,TCGA-ER-A193-10A-01D-A190_120718_SN1222_0126_AC117AACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A193-10A,8AB09143-DAF6-40A9-85D3-0FE9DE7B3E06,Blood Derived Normal,Illumina HiSeq,73c549f9-ad97-4f0c-9a29-143ee37774ba,Skin,62,7A384D44-8B05-4197-9921-7D020ADA2437,390B3574-BA23-4ECB-ACF8-F5AD8A958BD2,TCGA-ER-A193-10A-01D-A190-02,HG19_Broad_variant,TCGA-ER-A193,TCGA-SKCM,955,s8023,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N0,Not available,Stage IIB
13722.58cfa82fe4b0c9d6adf6b764,58cfa82fe4b0c9d6adf6b764,TCGA-64-5778-10A-01D-1623_110824_SN208_0222_BB0164ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-64-5778-10A-01D-1623_110824_SN208_0222_BB0164ACXX_s_4_rg.sorted,TCGA-64-5778-10A-01D-1623_110824_SN208_0222_BB0164ACXX_s_4_rg.sorted.bam,181.4,1.9,0.14,58cfa82fe4b0c9d6adf6b764,TCGA-64-5778-10A-01D-1623_110824_SN208_0222_BB0164ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-64-5778-10A,8FDBD88F-19AE-4AB8-BCD7-6BFA1BBDE742,Blood Derived Normal,Illumina HiSeq,daa71055-8f7e-4087-850f-1669fc21e1dd,Lung,60,71FC99BF-0BE2-44E2-B3DD-E000EF28734A,C48A8170-9BD1-4084-836C-933C79ABDDFC,TCGA-64-5778-10A-01D-1623-02,HG19_Broad_variant,TCGA-64-5778,TCGA-LUAD,NA,s11248,Harvard Medical School,Fox Chase,United States,NO,T2,N0,Lung Bronchioloalveolar Carcinoma Nonmucinous,Stage IB
13722.58cfa830e4b0c9d6adf6c20b,58cfa830e4b0c9d6adf6c20b,TCGA-BA-4078-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BA-4078-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_1_rg.sorted,TCGA-BA-4078-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_1_rg.sorted.bam,747.33,1.9,0.16,58cfa830e4b0c9d6adf6c20b,TCGA-BA-4078-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-4078-01A,C7353D6A-82A2-4A0D-8CD4-8C8957943EDB,Primary Tumor,Illumina HiSeq,aaa9123e-a827-4226-9b51-0b04709fadb2,Head and Neck,83,2027EDE3-13F5-40F6-BEF6-16704981D676,66A9CFF2-397E-415E-BF54-9A75CCC80BDE,TCGA-BA-4078-01A-01D-1431-02,HG19_Broad_variant,TCGA-BA-4078,TCGA-HNSC,276,s15493,Harvard Medical School,UNC,None,NO,Not available,Not available,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d608,58cfa832e4b0c9d6adf6d608,TCGA-LN-A5U5-01A-21D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-LN-A5U5-01A-21D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_4_rg.sorted,TCGA-LN-A5U5-01A-21D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_4_rg.sorted.bam,66.44,NA,0.15,58cfa832e4b0c9d6adf6d608,TCGA-LN-A5U5-01A-21D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_4_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A5U5-01A,656E3C14-1FC6-473A-813E-719753E7B408,Primary Tumor,Illumina HiSeq,d3861f7c-bb4e-48be-b15b-0c082a3b6ff5,Esophagus,57,945DA36D-32AD-4996-9D77-BE6D09B858F9,E9CE892D-BF42-4445-B566-A8D7AC73AED0,TCGA-LN-A5U5-01A-21D-A28P-26,HG19_Broad_variant,TCGA-LN-A5U5,TCGA-ESCA,NA,s1682,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N1,Not available,Stage IV
13722.58cfa831e4b0c9d6adf6cb46,58cfa831e4b0c9d6adf6cb46,TCGA-EE-A29S-10A-01D-A190_120729_SN1120_0179_AC11G3ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EE-A29S-10A-01D-A190_120729_SN1120_0179_AC11G3ACXX_s_7_rg.sorted,TCGA-EE-A29S-10A-01D-A190_120729_SN1120_0179_AC11G3ACXX_s_7_rg.sorted.bam,45.66,NA,0.16,58cfa831e4b0c9d6adf6cb46,TCGA-EE-A29S-10A-01D-A190_120729_SN1120_0179_AC11G3ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29S-10A,5DEC1B6A-5D60-463C-9655-FC7ED79CA19D,Blood Derived Normal,Illumina HiSeq,acaa3027-4446-467e-bc84-eaf1b02d992c,Skin,79,FDFC609C-F6A9-4B25-82F5-D9FFFD07A8F8,DBD444A5-622C-4E3C-BFBD-15A7CD824EA8,TCGA-EE-A29S-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A29S,TCGA-SKCM,NA,s7330,Harvard Medical School,University of Sydney,Australia,NO,T3a,N0,Not available,Stage IIA
13722.58cfa830e4b0c9d6adf6bc18,58cfa830e4b0c9d6adf6bc18,TCGA-AG-4008-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-4008-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-4008-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,44.59,1.9,0.17,58cfa830e4b0c9d6adf6bc18,TCGA-AG-4008-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-4008-10A,72802851-9340-4C5F-A90B-23B7AFD7577A,Blood Derived Normal,Illumina HiSeq,fc33b07e-7ad9-4cf9-be0a-b7abc28b8160,Colorectal,63,BA57F55A-1ADE-4C91-9B44-ED9DE039CF29,04D642B5-E53C-43E1-9B48-5A3C55F61950,TCGA-AG-4008-10A-01D-1115-02,HG18,TCGA-AG-4008,TCGA-READ,NA,s1993,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6c107,58cfa830e4b0c9d6adf6c107,TCGA-BS-A0TA-01A-11D-A101_120403_SN1222_0094_BD0UKBACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BS-A0TA-01A-11D-A101_120403_SN1222_0094_BD0UKBACXX_s_1_rg.sorted,TCGA-BS-A0TA-01A-11D-A101_120403_SN1222_0094_BD0UKBACXX_s_1_rg.sorted.bam,95.02,2.03,0.15,58cfa830e4b0c9d6adf6c107,TCGA-BS-A0TA-01A-11D-A101_120403_SN1222_0094_BD0UKBACXX_s_1_rg.sorted.bam,Alive,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TA-01A,AD3D8420-F562-4CBE-AC82-C968BD4F782D,Primary Tumor,Illumina HiSeq,ee69554a-eb4c-482a-b37e-a643758f27e5,Uterus,58,B6A042B6-F94A-4ACC-98CB-A1A2FE72B9AD,896590DE-B00E-40A3-912D-D625F3581AD8,TCGA-BS-A0TA-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0TA,TCGA-UCEC,NA,s4437,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6cfbc,58cfa832e4b0c9d6adf6cfbc,TCGA-G9-6496-10A-01D-1784_130131_SN1120_0234_AD1PVUACXX_s_4_rg.sorted.filtered.,WGS,TCGA-G9-6496-10A-01D-1784_130131_SN1120_0234_AD1PVUACXX_s_4_rg.sorted,TCGA-G9-6496-10A-01D-1784_130131_SN1120_0234_AD1PVUACXX_s_4_rg.sorted.bam,29.7,1.8,0.14,58cfa832e4b0c9d6adf6cfbc,TCGA-G9-6496-10A-01D-1784_130131_SN1120_0234_AD1PVUACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6496-10A,CE2B7E17-424E-4954-8A68-19D7F98D2E7E,Blood Derived Normal,Illumina HiSeq,6bf8c890-7563-4945-80e3-504f41b07661,Prostate,61,EA48E760-6854-4397-9FF3-39740419DEC7,46FECAD7-A6C0-49D5-B8CC-ED2F81C0C16E,TCGA-G9-6496-10A-01D-1784-02,HG19_Broad_variant,TCGA-G9-6496,TCGA-PRAD,NA,s3457,Harvard Medical School,Roswell Park,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c97a,58cfa831e4b0c9d6adf6c97a,TCGA-DJ-A1QN-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DJ-A1QN-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_1_rg.sorted,TCGA-DJ-A1QN-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_1_rg.sorted.bam,94.75,1.91,0.17,58cfa831e4b0c9d6adf6c97a,TCGA-DJ-A1QN-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_1_rg.sorted.bam,Alive,FEMALE,Not available,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QN-01A,2012869D-C169-4CEA-AA09-C892FB79BBAA,Primary Tumor,Illumina HiSeq,5cfa9ea5-2e72-4f40-96be-d6accc8482a8,Thyroid,42,884C1978-00CF-4E48-BEF8-F03CA67D6C02,F5D0FC17-824D-42F7-931B-E23CD68B9E2F,TCGA-DJ-A1QN-01A-11D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QN,TCGA-THCA,NA,s12640,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6cedf,58cfa832e4b0c9d6adf6cedf,TCGA-EM-A1YD-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EM-A1YD-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_5_rg.sorted,TCGA-EM-A1YD-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_5_rg.sorted.bam,41.17,1.98,0.17,58cfa832e4b0c9d6adf6cedf,TCGA-EM-A1YD-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_5_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1YD-01A,8A3659A8-2A85-4BAB-8BF3-55795922474C,Primary Tumor,Illumina HiSeq,76d6fe1c-fb49-412c-bf6f-43229f7b7df6,Thyroid,53,AD5054BB-96D0-47CC-BB8C-F36E58784A31,CD27AF7E-F458-49BA-8C82-D18BDE252DB2,TCGA-EM-A1YD-01A-11D-A14U-02,HG19_Broad_variant,TCGA-EM-A1YD,TCGA-THCA,NA,s12381,Harvard Medical School,University Health Network,Canada,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa82ee4b0c9d6adf6aff0,58cfa82ee4b0c9d6adf6aff0,TCGA-05-4434-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_1_rg.sorted.filtered.,WGS,TCGA-05-4434-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_1_rg.sorted,TCGA-05-4434-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_1_rg.sorted.bam,30,1.9,0.16,58cfa82ee4b0c9d6adf6aff0,TCGA-05-4434-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_1_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4434-10A,D94FE32F-BEDD-4F4C-9FEB-FCB60D40F4BB,Blood Derived Normal,Illumina HiSeq,9a0b4c83-372f-4226-889a-a732c74385ac,Lung,67,FE65992A-E982-44B2-BD53-D714C17A5E4A,8B98B536-3F48-4FA0-8FDB-EC787499CBD5,TCGA-05-4434-10A-01D-1203-02,HG19_Broad_variant,TCGA-05-4434,TCGA-LUAD,457,s11224,Harvard Medical School,Indivumed,Germany,NO,T4,N1,Lung Adenocarcinoma Mixed Subtype,Stage IV
13722.58cfa832e4b0c9d6adf6d1f8,58cfa832e4b0c9d6adf6d1f8,TCGA-G9-6373-10A-01D-1784_130301_SN590_0217_BC1UHMACXX_s_2_rg.sorted.filtered.,WGS,TCGA-G9-6373-10A-01D-1784_130301_SN590_0217_BC1UHMACXX_s_2_rg.sorted,TCGA-G9-6373-10A-01D-1784_130301_SN590_0217_BC1UHMACXX_s_2_rg.sorted.bam,37.7,1.8,0.13,58cfa832e4b0c9d6adf6d1f8,TCGA-G9-6373-10A-01D-1784_130301_SN590_0217_BC1UHMACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6373-10A,C3A509C6-35A6-4D17-A9FD-0AA8884B33A0,Blood Derived Normal,Illumina HiSeq,245d306c-0874-4b09-84db-125f16769148,Prostate,68,F4291A83-98AD-4FDD-91C3-AE2FB206015E,E41F9C47-07AA-4B54-AE7C-8B0F58EAB483,TCGA-G9-6373-10A-01D-1784-02,HG19_Broad_variant,TCGA-G9-6373,TCGA-PRAD,NA,s3802,Harvard Medical School,Roswell Park,United States,NO,T3a,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c4fd,58cfa831e4b0c9d6adf6c4fd,TCGA-CD-5800-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CD-5800-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_5_rg.sorted,TCGA-CD-5800-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_5_rg.sorted.bam,389,2,0.17,58cfa831e4b0c9d6adf6c4fd,TCGA-CD-5800-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_5_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-5800-01A,EEB114EA-ECEE-49EE-A162-B3B7BC0A60CD,Primary Tumor,Illumina HiSeq,e62fc018-7ddb-4d26-b187-0781aa2ba772,Stomach,51,B23E2D58-E61B-4B94-B4D8-407418351167,5EF4C8F7-B17A-48DA-AAF2-EF2FA32619A9,TCGA-CD-5800-01A-11D-1598-02,HG19_Broad_variant,TCGA-CD-5800,TCGA-STAD,NA,s14753,Harvard Medical School,ILSbio,Vietnam,NO,T3,N0,Stomach Intestinal Adenocarcinoma Papillary Type,Stage II
13722.58cfa830e4b0c9d6adf6bbe4,58cfa830e4b0c9d6adf6bbe4,TCGA-AG-A002-01A-01D-A077-02_110217_SN208_0190_B81CLKABXX_s_1.rg.sorted.filtered.,WGS,TCGA-AG-A002-01A-01D-A077-02_110217_SN208_0190_B81CLKABXX_s_1.rg.sorted,TCGA-AG-A002-01A-01D-A077-02_110217_SN208_0190_B81CLKABXX_s_1.rg.sorted.bam,228.5,1.72,0.15,58cfa830e4b0c9d6adf6bbe4,TCGA-AG-A002-01A-01D-A077-02_110217_SN208_0190_B81CLKABXX_s_1.rg.sorted.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A002-01A,CB005C69-7301-41CE-B534-C9751F1436C5,Primary Tumor,Illumina HiSeq,90021059-77d3-4362-9cc9-f14fcfba46c9,Colorectal,35,B918B56C-5C78-4CEE-85A7-7C88501E88AD,901C5D59-CE0A-44AE-91AE-9C253E99B68E,TCGA-AG-A002-01A-01D-A077-02,HG18_Broad_variant,TCGA-AG-A002,TCGA-READ,NA,s1991,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d3ee,58cfa832e4b0c9d6adf6d3ee,TCGA-V4-A9ES-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_4_rg.sorted.filtered.,WGS,TCGA-V4-A9ES-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_4_rg.sorted,TCGA-V4-A9ES-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_4_rg.sorted.bam,57.9,NA,0.15,58cfa832e4b0c9d6adf6d3ee,TCGA-V4-A9ES-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9ES-01A,C510A423-6AB1-431E-9248-D2AC91FDEDBA,Primary Tumor,Illumina HiSeq,0edc5349-7b58-4f3e-ae40-3c517bcc8d47,Eye,54,1BC52C96-A28E-4E9C-AD3F-0797234C5A12,B16AE1A2-403B-4573-A6B0-9CBB05CEA149,TCGA-V4-A9ES-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9ES,TCGA-UVM,NA,s201,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3b,N0,Not available,Stage IIIA
13722.58cfa832e4b0c9d6adf6d5cc,58cfa832e4b0c9d6adf6d5cc,TCGA-LN-A49V-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-LN-A49V-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_7_rg.sorted,TCGA-LN-A49V-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_7_rg.sorted.bam,39.36,NA,0.17,58cfa832e4b0c9d6adf6d5cc,TCGA-LN-A49V-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_7_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49V-01A,0AB29DE2-EB9E-4A25-99DE-5F543CFBDB53,Primary Tumor,Illumina HiSeq,331651f5-689d-41cf-b0d4-379dc314bf42,Esophagus,49,BF039639-98CF-496D-9A11-44DFAFBD7DD7,CF32B517-90B2-400E-B3CE-FD19CC09B10F,TCGA-LN-A49V-01A-11D-A248-26,HG19_Broad_variant,TCGA-LN-A49V,TCGA-ESCA,NA,s1877,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa830e4b0c9d6adf6be13,58cfa830e4b0c9d6adf6be13,TCGA-BH-A0W5-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BH-A0W5-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_3_rg.sorted,TCGA-BH-A0W5-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_3_rg.sorted.bam,55.92,1.91,0.16,58cfa830e4b0c9d6adf6be13,TCGA-BH-A0W5-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0W5-01A,DA9C10EA-C13F-4D88-8B94-A0CBC106D036,Primary Tumor,Illumina HiSeq,eeccc516-2d3d-4f41-a324-c90f92a6f944,Breast,77,050E66BB-438A-49D5-A005-7967A006B3F0,6C8B3A70-CD58-4BFC-9418-54182588CFCB,TCGA-BH-A0W5-01A-11D-A106-02,HG19_Broad_variant,TCGA-BH-A0W5,TCGA-BRCA,NA,s5803,Harvard Medical School,University of Pittsburgh,None,NO,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6c61f,58cfa831e4b0c9d6adf6c61f,TCGA-CG-4436-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_5_rg.sorted.filtered.,WGS,TCGA-CG-4436-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_5_rg.sorted,TCGA-CG-4436-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_5_rg.sorted.bam,336.2,1.9,0.13,58cfa831e4b0c9d6adf6c61f,TCGA-CG-4436-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_5_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4436-01A,7938CA55-766E-4277-9E7E-603FFA02E570,Primary Tumor,Illumina HiSeq,0b869c68-28bb-4675-ba6c-6d20a89a1a49,Stomach,57,21F40CF9-D89F-4FEC-BE65-1740AB39DAE4,9215C180-AC30-4585-9AF3-4EF1D718E187,TCGA-CG-4436-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4436,TCGA-STAD,NA,s14980,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa832e4b0c9d6adf6cf41,58cfa832e4b0c9d6adf6cf41,TCGA-FS-A1ZR-06A-21D-A18Y_120602_SN208_0304_BC0WTWACXX_s_7_rg.sorted.filtered.,WGS,TCGA-FS-A1ZR-06A-21D-A18Y_120602_SN208_0304_BC0WTWACXX_s_7_rg.sorted,TCGA-FS-A1ZR-06A-21D-A18Y_120602_SN208_0304_BC0WTWACXX_s_7_rg.sorted.bam,45.28,NA,0.16,58cfa832e4b0c9d6adf6cf41,TCGA-FS-A1ZR-06A-21D-A18Y_120602_SN208_0304_BC0WTWACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZR-06A,9F4DDE50-FA0C-43BF-8D5D-70B76CC35793,Metastatic,Illumina HiSeq,3dc9427b-527d-465c-bfd9-7593de78af96,Skin,36,4EEC8951-5B1B-4881-BBC9-2B4C2C4FCD16,62E364ED-D71C-41D9-9C7C-04CC844CE8AE,TCGA-FS-A1ZR-06A-21D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZR,TCGA-SKCM,347,s8031,Harvard Medical School,Essen,Germany,NO,T2,N0,Not available,Stage II
13722.58cfa830e4b0c9d6adf6c258,58cfa830e4b0c9d6adf6c258,TCGA-BJ-A0Z5-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BJ-A0Z5-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_1_rg.sorted,TCGA-BJ-A0Z5-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_1_rg.sorted.bam,95.63,2.11,0.16,58cfa830e4b0c9d6adf6c258,TCGA-BJ-A0Z5-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0Z5-01A,0FE3B19A-F5E4-497E-92DA-32FF6C77B066,Primary Tumor,Illumina HiSeq,84ec4e2b-c502-4348-b6ce-ae4a912e603c,Thyroid,58,D17746B4-EDEA-45DB-9AD1-5EE4973F007C,0AB5F114-C3CC-4DB4-87DF-1B339DDC54C2,TCGA-BJ-A0Z5-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0Z5,TCGA-THCA,NA,s12352,Harvard Medical School,University of Pittsburgh,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa832e4b0c9d6adf6d5bc,58cfa832e4b0c9d6adf6d5bc,TCGA-LN-A4A4-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-LN-A4A4-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_3_rg.sorted,TCGA-LN-A4A4-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_3_rg.sorted.bam,24.3,NA,0.16,58cfa832e4b0c9d6adf6d5bc,TCGA-LN-A4A4-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_3_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A4A4-01A,E89D7900-915D-4936-B1B2-CAC3670EA2F4,Primary Tumor,Illumina HiSeq,8f2d7e64-e129-494b-9068-ad15dcb9457e,Esophagus,36,C7A31A25-A496-4D26-A9D2-C42ADB22BB45,655BFF55-E213-442B-8C1F-A1A959E89CDB,TCGA-LN-A4A4-01A-11D-A267-26,HG19_Broad_variant,TCGA-LN-A4A4,TCGA-ESCA,NA,s1778,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N1,Not available,Stage III
13722.58cfa831e4b0c9d6adf6c646,58cfa831e4b0c9d6adf6c646,TCGA-CQ-5327-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CQ-5327-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_2_rg.sorted,TCGA-CQ-5327-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_2_rg.sorted.bam,234,1.9,0.15,58cfa831e4b0c9d6adf6c646,TCGA-CQ-5327-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_2_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-5327-01A,5A03E2B6-4C8B-479A-9036-9859AF031DA4,Primary Tumor,Illumina HiSeq,3482a15d-acdc-4fcf-86a5-b015e57faefd,Head and Neck,61,93D283A7-E866-4F23-81F7-942DEE5009B8,55F0F300-E472-4254-9BDA-76AD94EA8C13,TCGA-CQ-5327-01A-01D-1681-02,HG19_Broad_variant,TCGA-CQ-5327,TCGA-HNSC,NA,s15638,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T3,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6d374,58cfa832e4b0c9d6adf6d374,TCGA-LN-A49M-01A-21D-A267_131001_SN1222_0222_BC2CN2ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-LN-A49M-01A-21D-A267_131001_SN1222_0222_BC2CN2ACXX_s_1_rg.sorted,TCGA-LN-A49M-01A-21D-A267_131001_SN1222_0222_BC2CN2ACXX_s_1_rg.sorted.bam,23.64,NA,0.16,58cfa832e4b0c9d6adf6d374,TCGA-LN-A49M-01A-21D-A267_131001_SN1222_0222_BC2CN2ACXX_s_1_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49M-01A,B3E248B5-5D40-495C-BD10-90ECF0ED6A95,Primary Tumor,Illumina HiSeq,821eaabe-92ee-4e30-9254-77b2ce89ea42,Esophagus,62,E6BEF2C0-1C6A-4137-A099-920F1F811489,9C284314-4356-44EA-8087-E64F5A614179,TCGA-LN-A49M-01A-21D-A267-26,HG19_Broad_variant,TCGA-LN-A49M,TCGA-ESCA,NA,s1862,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T2,N0,Not available,Stage IIA
13722.58cfa832e4b0c9d6adf6d42e,58cfa832e4b0c9d6adf6d42e,TCGA-VD-A8K8-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_1_rg.sorted.filtered.,WGS,TCGA-VD-A8K8-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_1_rg.sorted,TCGA-VD-A8K8-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_1_rg.sorted.bam,51.97,NA,0.15,58cfa832e4b0c9d6adf6d42e,TCGA-VD-A8K8-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_1_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8K8-01A,9B1ECFB2-9DFB-4E71-B51A-D2A0C5A7940E,Primary Tumor,Illumina HiSeq,874e4766-c478-4406-91cf-977d43d9ed07,Eye,56,F23780FD-DFEB-472B-B747-84ECE2A6226D,E0DBB55F-2753-4B23-B621-F8003B05D814,TCGA-VD-A8K8-01A-11D-A40D-26,HG19_Broad_variant,TCGA-VD-A8K8,TCGA-UVM,NA,s283,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T3a,NX,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6d530,58cfa832e4b0c9d6adf6d530,TCGA-LN-A4A8-10A-01D-A267_131018_SN590_0241_BC30HBACXX_s_6_rg.sorted.filtered.,WGS,TCGA-LN-A4A8-10A-01D-A267_131018_SN590_0241_BC30HBACXX_s_6_rg.sorted,TCGA-LN-A4A8-10A-01D-A267_131018_SN590_0241_BC30HBACXX_s_6_rg.sorted.bam,89.73,NA,0.15,58cfa832e4b0c9d6adf6d530,TCGA-LN-A4A8-10A-01D-A267_131018_SN590_0241_BC30HBACXX_s_6_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A4A8-10A,AA364B98-0097-43A4-976D-742FAA0276DF,Blood Derived Normal,Illumina HiSeq,3df71dcd-1124-40ba-a673-8621cba26f0a,Esophagus,52,235C11BC-7C94-44E0-974D-CC03379AD870,20B6F5EE-3F57-4ADE-9A30-04D909225F56,TCGA-LN-A4A8-10A-01D-A267-26,HG19_Broad_variant,TCGA-LN-A4A8,TCGA-ESCA,NA,s1676,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T2,N0,Not available,Stage IIA
13722.58cfa832e4b0c9d6adf6cf1e,58cfa832e4b0c9d6adf6cf1e,TCGA-IG-A5S3-10A-01D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-IG-A5S3-10A-01D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_1_rg.sorted,TCGA-IG-A5S3-10A-01D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_1_rg.sorted.bam,11.17,NA,0.14,58cfa832e4b0c9d6adf6cf1e,TCGA-IG-A5S3-10A-01D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A5S3-10A,DF0125B2-5278-4DED-B3B7-9FC829FE9F63,Blood Derived Normal,Illumina HiSeq,035aec3c-7fd4-4cda-a1f6-75e648183b15,Esophagus,69,B0AE809D-7DFE-426A-ABD7-F985B047EA6E,10871486-28F3-47CD-9B20-150E2B43FC7D,TCGA-IG-A5S3-10A-01D-A28P-26,HG19_Broad_variant,TCGA-IG-A5S3,TCGA-ESCA,NA,s1640,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T3,N0,Not available,Stage IIB
13722.58cfa830e4b0c9d6adf6c2a0,58cfa830e4b0c9d6adf6c2a0,TCGA-CE-A13K-10A-01D-A10R_120616_SN1120_0154_BD142VACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CE-A13K-10A-01D-A10R_120616_SN1120_0154_BD142VACXX_s_3_rg.sorted,TCGA-CE-A13K-10A-01D-A10R_120616_SN1120_0154_BD142VACXX_s_3_rg.sorted.bam,85.39,1.94,0.14,58cfa830e4b0c9d6adf6c2a0,TCGA-CE-A13K-10A-01D-A10R_120616_SN1120_0154_BD142VACXX_s_3_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-CE-A13K-10A,A1227FFA-2733-4A43-BA82-834755453870,Blood Derived Normal,Illumina HiSeq,11f43f2a-bc3e-457f-aa02-8f62d0aa4650,Thyroid,30,E78C8BDF-CE47-4E6D-9839-C48C7A481A10,0FB298DB-426F-488E-A632-EE02CE231F09,TCGA-CE-A13K-10A-01D-A10R-02,HG19_Broad_variant,TCGA-CE-A13K,TCGA-THCA,NA,s12363,Harvard Medical School,ILSbio,Vietnam,NO,T3,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82ee4b0c9d6adf6ae34,58cfa82ee4b0c9d6adf6ae34,TCGA-05-4382-10A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_4_rg.sorted.filtered.,WGS,TCGA-05-4382-10A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_4_rg.sorted,TCGA-05-4382-10A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_4_rg.sorted.bam,14.23,1.8,0.14,58cfa82ee4b0c9d6adf6ae34,TCGA-05-4382-10A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_4_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4382-10A,3434B91A-C05F-460F-A078-7B1BB6E7085D,Blood Derived Normal,Illumina HiSeq,12d07a36-94e0-4d6d-8625-86f383684a7d,Lung,68,ADF04F24-D50F-473D-AA66-AD4778ABAD3B,40ACF290-13FF-44D8-8CC7-9FE9DB183619,TCGA-05-4382-10A-01D-1203-02,HG19_Broad_variant,TCGA-05-4382,TCGA-LUAD,NA,s11436,Harvard Medical School,Indivumed,None,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa831e4b0c9d6adf6cabc,58cfa831e4b0c9d6adf6cabc,TCGA-DA-A1I7-06A-22D-A18Y_120730_SN208_0419_AC13W9ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DA-A1I7-06A-22D-A18Y_120730_SN208_0419_AC13W9ACXX_s_4_rg.sorted,TCGA-DA-A1I7-06A-22D-A18Y_120730_SN208_0419_AC13W9ACXX_s_4_rg.sorted.bam,26.08,NA,0.17,58cfa831e4b0c9d6adf6cabc,TCGA-DA-A1I7-06A-22D-A18Y_120730_SN208_0419_AC13W9ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1I7-06A,DFE8BAA8-1C2C-4C36-92C9-61548CEBEC19,Metastatic,Illumina HiSeq,85c1bc41-87de-4fc0-89c9-aa8f1e56755c,Skin,62,75633AC0-2F77-486E-BA9B-BCEA02CD7DC4,C48121FD-7F92-4206-BE49-41F103CB35C8,TCGA-DA-A1I7-06A-22D-A18Y-02,HG19_Broad_variant,TCGA-DA-A1I7,TCGA-SKCM,NA,s7329,Harvard Medical School,Yale,United States,NO,T0,N2b,Not available,Stage IIIB
13722.58cfa830e4b0c9d6adf6bebe,58cfa830e4b0c9d6adf6bebe,TCGA-AX-A0IU-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-AX-A0IU-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_1_rg.sorted,TCGA-AX-A0IU-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_1_rg.sorted.bam,10.58,2.1,0.17,58cfa830e4b0c9d6adf6bebe,TCGA-AX-A0IU-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_1_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A0IU-10A,7E64EA6C-A3DB-48EB-91BE-131361510A92,Blood Derived Normal,Illumina HiSeq,c794d801-58df-429e-af9f-4c21e2b0add2,Uterus,79,38271B9F-B5F8-4A0D-AE45-2E9E927F9FF7,23D83EA6-61EF-4BA3-AEB7-B12A5C58555B,TCGA-AX-A0IU-10A-01D-A101-02,HG19_Broad_variant,TCGA-AX-A0IU,TCGA-UCEC,NA,s4781,Harvard Medical School,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c605,58cfa831e4b0c9d6adf6c605,TCGA-CQ-5329-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CQ-5329-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_3_rg.sorted,TCGA-CQ-5329-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_3_rg.sorted.bam,687,1.9,0.14,58cfa831e4b0c9d6adf6c605,TCGA-CQ-5329-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-5329-01A,02DCC11F-4F0E-4C9E-8D96-D22D47BEEF5D,Primary Tumor,Illumina HiSeq,b54a3eac-9c58-453d-9db1-395601ae82ea,Head and Neck,46,D22E9B65-495B-4D42-926A-01BF2C436D76,63CE8A9C-2CC5-41D9-B24D-3FB88343B693,TCGA-CQ-5329-01A-01D-1681-02,HG19_Broad_variant,TCGA-CQ-5329,TCGA-HNSC,NA,s15772,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa832e4b0c9d6adf6cef6,58cfa832e4b0c9d6adf6cef6,TCGA-EM-A1YC-11A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EM-A1YC-11A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_8_rg.sorted,TCGA-EM-A1YC-11A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_8_rg.sorted.bam,36.34,1.72,0.16,58cfa832e4b0c9d6adf6cef6,TCGA-EM-A1YC-11A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_8_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1YC-11A,0AD2A2B3-C1BB-4597-B28E-A6385F93D09C,Solid Tissue Normal,Illumina HiSeq,48ec7cab-ce60-4ef3-af40-8674fd036459,Thyroid,71,1780D814-E472-4BD0-98DB-8DBCF68718D7,9B877E88-4F42-4688-9173-F650662BF50A,TCGA-EM-A1YC-11A-11D-A14U-02,HG19_Broad_variant,TCGA-EM-A1YC,TCGA-THCA,NA,s11997,Harvard Medical School,University Health Network,Canada,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III
13722.58cfa831e4b0c9d6adf6c6d2,58cfa831e4b0c9d6adf6c6d2,TCGA-CS-4938-01B-11D-1891_130919_SN590_0238_AC29TRACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CS-4938-01B-11D-1891_130919_SN590_0238_AC29TRACXX_s_1_rg.sorted,TCGA-CS-4938-01B-11D-1891_130919_SN590_0238_AC29TRACXX_s_1_rg.sorted.bam,19.7,1.9,0.15,58cfa831e4b0c9d6adf6c6d2,TCGA-CS-4938-01B-11D-1891_130919_SN590_0238_AC29TRACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-4938-01B,334F715E-08DC-4A29-B8E4-B010B829C478,Primary Tumor,Illumina HiSeq,8b9dc3cd-2c99-405c-8306-3b388ad5bdf6,Brain,31,99104139-6CB5-44F7-8314-A4DDF02DE7D4,7FE72196-9DE8-4A43-87F2-D2E8F74B0007,TCGA-CS-4938-01B-11D-1891-02,HG19_Broad_variant,TCGA-CS-4938,TCGA-LGG,NA,s8553,Harvard Medical School,Thomas Jefferson University,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa830e4b0c9d6adf6bbd2,58cfa830e4b0c9d6adf6bbd2,TCGA-AG-4015-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-4015-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-4015-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,44.59,1.9,0.15,58cfa830e4b0c9d6adf6bbd2,TCGA-AG-4015-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-4015-10A,1388BBA1-02BA-40DF-93E5-C3D58B7BBAE0,Blood Derived Normal,Illumina HiSeq,0fb81d5a-c5b6-4a11-8255-4cd067ce53ea,Colorectal,85,3C5E0211-94A1-4760-AAF4-DE2B80A92DC3,F7C39024-56CA-4778-9225-6E2423426413,TCGA-AG-4015-10A-01D-1115-02,HG18,TCGA-AG-4015,TCGA-READ,NA,s1978,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6c764,58cfa831e4b0c9d6adf6c764,TCGA-D1-A17N-10A-01D-A12F_120413_SN1120_0133_BC0J8UACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D1-A17N-10A-01D-A12F_120413_SN1120_0133_BC0J8UACXX_s_4_rg.sorted,TCGA-D1-A17N-10A-01D-A12F_120413_SN1120_0133_BC0J8UACXX_s_4_rg.sorted.bam,26.01,1.98,0.17,58cfa831e4b0c9d6adf6c764,TCGA-D1-A17N-10A-01D-A12F_120413_SN1120_0133_BC0J8UACXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A17N-10A,001E0309-9C50-42B0-9E38-347883EE2CD3,Blood Derived Normal,Illumina HiSeq,f78748fd-fd4c-4684-9f8e-ad983533175d,Uterus,46,24469145-571C-44CA-AACA-9ACAC7CCF417,0645ECD0-0B4B-4CAF-B5FE-B8BF4BFC74E1,TCGA-D1-A17N-10A-01D-A12F-02,HG19_Broad_variant,TCGA-D1-A17N,TCGA-UCEC,NA,s4798,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6cee1,58cfa832e4b0c9d6adf6cee1,TCGA-EM-A3FR-10A-01D-A221_120610_SN1120_0152_BD13TDACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EM-A3FR-10A-01D-A221_120610_SN1120_0152_BD13TDACXX_s_3_rg.sorted,TCGA-EM-A3FR-10A-01D-A221_120610_SN1120_0152_BD13TDACXX_s_3_rg.sorted.bam,35.15,NA,0.15,58cfa832e4b0c9d6adf6cee1,TCGA-EM-A3FR-10A-01D-A221_120610_SN1120_0152_BD13TDACXX_s_3_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3FR-10A,2B84CFBC-7CF6-4CB1-A1E3-BA85DAFB89F4,Blood Derived Normal,Illumina HiSeq,e514d668-eadd-47c2-8cb2-67681432cc75,Thyroid,55,6B610B46-F51C-47AE-B5D1-CAF366E9B2AC,F23011FD-9279-4C81-91CB-DA059D589AD1,TCGA-EM-A3FR-10A-01D-A221-26,HG19_Broad_variant,TCGA-EM-A3FR,TCGA-THCA,NA,s12523,MD Anderson - Institute for Applied Cancer Science,University Health Network,Canada,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa831e4b0c9d6adf6cdc4,58cfa831e4b0c9d6adf6cdc4,TCGA-FG-6690-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_7_rg.sorted.filtered.,WGS,TCGA-FG-6690-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_7_rg.sorted,TCGA-FG-6690-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_7_rg.sorted.bam,113.7,1.9,0.16,58cfa831e4b0c9d6adf6cdc4,TCGA-FG-6690-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-6690-01A,AD202887-88B3-4E0F-A4C3-7E135D4CB258,Primary Tumor,Illumina HiSeq,e33fa79f-3d33-4f0b-81d9-705ab9c8a19c,Brain,70,F6C7B8C5-02DF-4B89-B527-F647762A98B7,BA96EFD0-90DE-4458-89DE-8B16639760B8,TCGA-FG-6690-01A-11D-1891-02,HG19_Broad_variant,TCGA-FG-6690,TCGA-LGG,NA,s8146,Harvard Medical School,Case Western,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa832e4b0c9d6adf6cf4e,58cfa832e4b0c9d6adf6cf4e,TCGA-G9-6356-01A-11D-1784_130215_SN590_0211_AC1UJWACXX_s_1_rg.sorted.filtered.,WGS,TCGA-G9-6356-01A-11D-1784_130215_SN590_0211_AC1UJWACXX_s_1_rg.sorted,TCGA-G9-6356-01A-11D-1784_130215_SN590_0211_AC1UJWACXX_s_1_rg.sorted.bam,144.4,1.9,0.15,58cfa832e4b0c9d6adf6cf4e,TCGA-G9-6356-01A-11D-1784_130215_SN590_0211_AC1UJWACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6356-01A,1D7FFBE7-6139-412B-8739-8082A63A2B33,Primary Tumor,Illumina HiSeq,4c78b0a9-d4e9-4656-95bf-0306c7bb406e,Prostate,60,C6E0F83F-ABA3-4705-ABAC-C81C885B53BA,E43C07B2-F48D-4780-9766-15CC08CE6FE2,TCGA-G9-6356-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6356,TCGA-PRAD,NA,s4146,Harvard Medical School,Roswell Park,United States,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d3fd,58cfa832e4b0c9d6adf6d3fd,TCGA-V4-A9ET-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_5_rg.sorted.filtered.,WGS,TCGA-V4-A9ET-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_5_rg.sorted,TCGA-V4-A9ET-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_5_rg.sorted.bam,11.73,NA,0.15,58cfa832e4b0c9d6adf6d3fd,TCGA-V4-A9ET-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9ET-10A,5383FB57-69C2-4B34-AF7F-C67208EFB2B5,Blood Derived Normal,Illumina HiSeq,2fd12512-d94f-4122-a28c-d8b12a51b5e3,Eye,57,BAAE2476-4B4C-4CAA-AA88-DD8875B32287,6BC51720-1129-4403-A2BA-3124DCBE629A,TCGA-V4-A9ET-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9ET,TCGA-UVM,NA,s235,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4b,N0,Not available,Stage IIIB
13722.58cfa830e4b0c9d6adf6bf2e,58cfa830e4b0c9d6adf6bf2e,TCGA-BR-4255-01A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BR-4255-01A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_7_rg.sorted,TCGA-BR-4255-01A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_7_rg.sorted.bam,0,1.9,0.13,58cfa830e4b0c9d6adf6bf2e,TCGA-BR-4255-01A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4255-01A,956017BA-5E4B-42C7-B93D-42316874BA93,Primary Tumor,Illumina HiSeq,17f1cd5b-fb98-46b4-bfb0-906c39341a06,Stomach,76,A64A7CB8-BA30-45A3-B1DC-2A62D6B1919F,11EA17E5-60EF-4695-866B-B328A51D15A9,TCGA-BR-4255-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4255,TCGA-STAD,NA,s14741,Harvard Medical School,Asterand,Russia,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa830e4b0c9d6adf6bfa9,58cfa830e4b0c9d6adf6bfa9,TCGA-BR-6456-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BR-6456-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_1_rg.sorted,TCGA-BR-6456-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_1_rg.sorted.bam,282.7,1.9,0.15,58cfa830e4b0c9d6adf6bfa9,TCGA-BR-6456-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6456-01A,1CA3C5E0-32B0-4467-8EC0-CA212E35D2B3,Primary Tumor,Illumina HiSeq,a772744a-8f77-4f03-adaf-cbd5db4ba399,Stomach,74,53369A25-3BC4-48CB-9004-DA3507C4D478,B2D5157F-5D0A-451C-8E78-AFFFC67B2F68,TCGA-BR-6456-01A-11D-1798-02,HG19_Broad_variant,TCGA-BR-6456,TCGA-STAD,NA,s14399,Harvard Medical School,Asterand,Russia,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB
13722.58cfa832e4b0c9d6adf6d440,58cfa832e4b0c9d6adf6d440,TCGA-V4-A9F0-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_8_rg.sorted.filtered.,WGS,TCGA-V4-A9F0-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_8_rg.sorted,TCGA-V4-A9F0-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_8_rg.sorted.bam,14.63,NA,0.14,58cfa832e4b0c9d6adf6d440,TCGA-V4-A9F0-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9F0-10A,92FCA97D-6123-46A7-9C34-7A6F877FE612,Blood Derived Normal,Illumina HiSeq,f1cef754-8998-4ec4-a0df-7dc28a3c599e,Eye,59,0344ECE0-33DF-40B0-B120-F29C8F4290F0,0D77B5D5-25EC-4411-B800-26FBF24A4418,TCGA-V4-A9F0-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9F0,TCGA-UVM,NA,s228,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4b,N0,Not available,Stage IIIB
13722.58cfa830e4b0c9d6adf6bc71,58cfa830e4b0c9d6adf6bc71,TCGA-AP-A0LQ-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-AP-A0LQ-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_8_rg.sorted,TCGA-AP-A0LQ-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_8_rg.sorted.bam,30.08,1.92,0.15,58cfa830e4b0c9d6adf6bc71,TCGA-AP-A0LQ-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LQ-10A,252500D2-86A3-4090-A57F-1E8C3D44C573,Blood Derived Normal,Illumina HiSeq,2883876d-43eb-49aa-8484-a338e112d898,Uterus,59,2B945126-5955-411F-97D5-0B5A956B6991,0ED05C05-F270-48D1-9526-2B5D45710385,TCGA-AP-A0LQ-10A-01D-A101-02,HG19_Broad_variant,TCGA-AP-A0LQ,TCGA-UCEC,NA,s5198,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b657,58cfa82fe4b0c9d6adf6b657,TCGA-64-5778-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-64-5778-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_3_rg.sorted,TCGA-64-5778-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_3_rg.sorted.bam,702.7,1.9,0.15,58cfa82fe4b0c9d6adf6b657,TCGA-64-5778-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-64-5778-01A,8FDBD88F-19AE-4AB8-BCD7-6BFA1BBDE742,Primary Tumor,Illumina HiSeq,bd5570f2-ed45-408a-a615-0a6808c31d84,Lung,60,92514FD2-A178-42E8-8929-0910558E7F87,BC8FFDB4-AB99-44B7-95B0-7BC2F8110B76,TCGA-64-5778-01A-01D-1623-02,HG19_Broad_variant,TCGA-64-5778,TCGA-LUAD,NA,s10796,Harvard Medical School,Fox Chase,United States,NO,T2,N0,Lung Bronchioloalveolar Carcinoma Nonmucinous,Stage IB
13722.58cfa82fe4b0c9d6adf6b9f6,58cfa82fe4b0c9d6adf6b9f6,TCGA-AA-3555-10A-01D-1638-02_110525_SN590_0091_AC02W2ABXX_s_6.rg.sorted.filtered.,WGS,TCGA-AA-3555-10A-01D-1638-02_110525_SN590_0091_AC02W2ABXX_s_6.rg.sorted,TCGA-AA-3555-10A-01D-1638-02_110525_SN590_0091_AC02W2ABXX_s_6.rg.sorted.bam,0,1.9,0.14,58cfa82fe4b0c9d6adf6b9f6,TCGA-AA-3555-10A-01D-1638-02_110525_SN590_0091_AC02W2ABXX_s_6.rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3555-10A,36EAF209-C332-4321-B6AA-51A3368ECD79,Blood Derived Normal,Illumina HiSeq,4ca4d097-aba8-4b2e-80ef-1c1b06463366,Colorectal,81,A08213B9-B852-4C99-9469-8C9DF8A34AD0,631554D6-FDA1-4D51-8FA8-2225A0A0F285,TCGA-AA-3555-10A-01D-1638-02,HG18_Broad_variant,TCGA-AA-3555,TCGA-COAD,NA,s13508,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Mucinous Adenocarcinoma,Stage IIA
13722.58cfa832e4b0c9d6adf6d362,58cfa832e4b0c9d6adf6d362,TCGA-L5-A4OH-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-L5-A4OH-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_5_rg.sorted,TCGA-L5-A4OH-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_5_rg.sorted.bam,43.66,NA,0.17,58cfa832e4b0c9d6adf6d362,TCGA-L5-A4OH-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OH-01A,3FA7FC16-49DA-4BF6-90C4-74DF5CF68B65,Primary Tumor,Illumina HiSeq,ba83865e-0ba3-48ab-841f-de07856ee9bc,Esophagus,71,4029F7BA-1D2D-49B8-A37B-4D4A5D0ACB79,C886B6DD-1595-49DD-B4DA-B69AA9C813E4,TCGA-L5-A4OH-01A-11D-A267-26,HG19_Broad_variant,TCGA-L5-A4OH,TCGA-ESCA,NA,s1747,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T1,N0,Not available,Stage I
13722.58cfa830e4b0c9d6adf6bffc,58cfa830e4b0c9d6adf6bffc,TCGA-AG-3890-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3890-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3890-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,614.89,1.9,0.15,58cfa830e4b0c9d6adf6bffc,TCGA-AG-3890-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3890-01A,E2D395F8-BF13-4FE4-8031-683B0EEDD875,Primary Tumor,Illumina HiSeq,b4bf7544-0816-4940-aa9f-d770f09f35f3,Colorectal,62,DB70A6DD-DE09-4ED7-916C-708B21734500,12064771-AE96-441D-BE8B-EE49B63F1E4E,TCGA-AG-3890-01A-01D-1115-02,HG18,TCGA-AG-3890,TCGA-READ,NA,s2145,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c794,58cfa831e4b0c9d6adf6c794,TCGA-CN-6017-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CN-6017-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_2_rg.sorted,TCGA-CN-6017-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_2_rg.sorted.bam,69,1.9,0.15,58cfa831e4b0c9d6adf6c794,TCGA-CN-6017-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-6017-01A,23C4E2EB-142B-4FCC-A974-9A248AEC3F37,Primary Tumor,Illumina HiSeq,e0dae8a5-f74f-4e25-98c2-238e28c54863,Head and Neck,55,6C07CD48-2269-4D42-9879-309EA4CD3A74,48A22F9A-2A18-4FCA-8271-44B3F7C3A628,TCGA-CN-6017-01A-11D-1681-02,HG19_Broad_variant,TCGA-CN-6017,TCGA-HNSC,NA,s16181,Harvard Medical School,University of Pittsburgh,United States,NO,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82fe4b0c9d6adf6b953,58cfa82fe4b0c9d6adf6b953,TCGA-AA-3529-11A-01D-1548-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3529-11A-01D-1548-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3529-11A-01D-1548-02_IlluminaHiSeq-DNASeq_whole.bam,446.7,1.9,0.16,58cfa82fe4b0c9d6adf6b953,TCGA-AA-3529-11A-01D-1548-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3529-11A,BFB07784-693B-4C25-874E-4AD6E04A5D46,Solid Tissue Normal,Illumina HiSeq,c3a90e62-0feb-4728-99f1-8b461bfa7760,Colorectal,78,B73F0D09-2505-4F94-9E8B-02B6E2B0FB92,43D26085-49A1-4247-B514-6349557FD2F8,TCGA-AA-3529-11A-01D-1548-02,HG18,TCGA-AA-3529,TCGA-COAD,0,s12865,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Colon Adenocarcinoma,Stage IIIC
13722.58cfa831e4b0c9d6adf6c4c6,58cfa831e4b0c9d6adf6c4c6,TCGA-CF-A3MH-10A-01D-A210_120906_SN208_0425_AD1CU2ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CF-A3MH-10A-01D-A210_120906_SN208_0425_AD1CU2ACXX_s_2_rg.sorted,TCGA-CF-A3MH-10A-01D-A210_120906_SN208_0425_AD1CU2ACXX_s_2_rg.sorted.bam,82.68,NA,0.16,58cfa831e4b0c9d6adf6c4c6,TCGA-CF-A3MH-10A-01D-A210_120906_SN208_0425_AD1CU2ACXX_s_2_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CF-A3MH-10A,B8A8D2FC-421B-4393-8D5A-946CF72CB496,Blood Derived Normal,Illumina HiSeq,dd0cfd9f-503f-4f83-9fd9-acd2b40f14f0,Bladder,75,DE21C647-75A9-4ADF-AF5C-C1B3507514A9,9DF2D6FE-5036-4CFB-BCA8-3A80085231BE,TCGA-CF-A3MH-10A-01D-A210-26,HG19_Broad_variant,TCGA-CF-A3MH,TCGA-BLCA,NA,s2700,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T2,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa832e4b0c9d6adf6ce54,58cfa832e4b0c9d6adf6ce54,TCGA-GN-A265-06A-21D-A18Y_120602_SN208_0304_BC0WTWACXX_s_2_rg.sorted.filtered.,WGS,TCGA-GN-A265-06A-21D-A18Y_120602_SN208_0304_BC0WTWACXX_s_2_rg.sorted,TCGA-GN-A265-06A-21D-A18Y_120602_SN208_0304_BC0WTWACXX_s_2_rg.sorted.bam,56.4,NA,0.18,58cfa832e4b0c9d6adf6ce54,TCGA-GN-A265-06A-21D-A18Y_120602_SN208_0304_BC0WTWACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-GN-A265-06A,61B777F6-A59A-4500-AD33-107E2C9254C1,Metastatic,Illumina HiSeq,95729723-84b0-4360-acd5-b7f42668ae18,Skin,53,06B6BF3E-9158-4829-91E7-4A79EC5EFADD,2DA18FF0-EB58-450F-8179-B903BC9C03E6,TCGA-GN-A265-06A-21D-A18Y-02,HG19_Broad_variant,TCGA-GN-A265,TCGA-SKCM,NA,s7875,Harvard Medical School,Roswell,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa832e4b0c9d6adf6d4a6,58cfa832e4b0c9d6adf6d4a6,TCGA-V4-A9EW-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_8_rg.sorted.filtered.,WGS,TCGA-V4-A9EW-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_8_rg.sorted,TCGA-V4-A9EW-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_8_rg.sorted.bam,43.67,NA,0.16,58cfa832e4b0c9d6adf6d4a6,TCGA-V4-A9EW-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EW-01A,6BE5176C-4980-4663-ADFF-D04F05737DA0,Primary Tumor,Illumina HiSeq,3dd4d560-67ce-426b-9eeb-63fec58eaf05,Eye,44,685D5387-B35F-40EE-8F14-491CE212F0DE,6B52C651-649F-41C5-B0DD-197F77F2AA10,TCGA-V4-A9EW-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9EW,TCGA-UVM,NA,s216,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa832e4b0c9d6adf6d426,58cfa832e4b0c9d6adf6d426,TCGA-V4-A9F0-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_4_rg.sorted.filtered.,WGS,TCGA-V4-A9F0-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_4_rg.sorted,TCGA-V4-A9F0-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_4_rg.sorted.bam,54.63,NA,0.15,58cfa832e4b0c9d6adf6d426,TCGA-V4-A9F0-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9F0-01A,92FCA97D-6123-46A7-9C34-7A6F877FE612,Primary Tumor,Illumina HiSeq,96f55937-5d74-4e04-8ab5-f928a9a23da4,Eye,59,62859C7E-4B8D-4122-9365-B1595E944C42,C752F975-1E44-4EDF-87BA-4823698AC3F5,TCGA-V4-A9F0-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9F0,TCGA-UVM,NA,s227,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4b,N0,Not available,Stage IIIB
13722.58cfa830e4b0c9d6adf6bbc2,58cfa830e4b0c9d6adf6bbc2,TCGA-AG-4008-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-4008-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-4008-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,624.89,1.9,0.14,58cfa830e4b0c9d6adf6bbc2,TCGA-AG-4008-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-4008-01A,72802851-9340-4C5F-A90B-23B7AFD7577A,Primary Tumor,Illumina HiSeq,95360a98-f3fd-40d4-b451-5973fe934b51,Colorectal,63,D803F092-3340-485D-9964-D6554D210E2E,CD36B70F-6819-4136-ADB5-8024E27B05A6,TCGA-AG-4008-01A-01D-1115-02,HG18,TCGA-AG-4008,TCGA-READ,NA,s2312,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6be3e,58cfa830e4b0c9d6adf6be3e,TCGA-B5-A0JN-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-B5-A0JN-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_2_rg.sorted,TCGA-B5-A0JN-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_2_rg.sorted.bam,5.6,1.78,0.16,58cfa830e4b0c9d6adf6be3e,TCGA-B5-A0JN-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_2_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0JN-10A,B60F22AC-A659-4F33-B01D-820E86A9A5C9,Blood Derived Normal,Illumina HiSeq,17e54440-953c-4773-a31f-d4aff974f24a,Uterus,84,00FD9A99-8E94-4AEF-94FC-4AABC6381BFC,0FF9F0E9-4672-42A2-BB98-102949DD8304,TCGA-B5-A0JN-10A-01D-A101-02,HG19_Broad_variant,TCGA-B5-A0JN,TCGA-UCEC,NA,s4785,Harvard Medical School,Duke,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bdc0,58cfa830e4b0c9d6adf6bdc0,TCGA-BG-A186-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BG-A186-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_1_rg.sorted,TCGA-BG-A186-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_1_rg.sorted.bam,79.77,1.93,0.17,58cfa830e4b0c9d6adf6bdc0,TCGA-BG-A186-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_1_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A186-01A,FE4DB898-3A9F-4DFF-ADCB-7B8C30137350,Primary Tumor,Illumina HiSeq,f65268ef-b937-4d49-922e-a5e3ebc0eab8,Uterus,61,B1645A83-57B7-4357-B977-63A5B6AEE39E,ECF410AD-B160-4F00-A165-38529FAE974B,TCGA-BG-A186-01A-11D-A12F-02,HG19_Broad_variant,TCGA-BG-A186,TCGA-UCEC,NA,s4792,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bd3c,58cfa830e4b0c9d6adf6bd3c,TCGA-AG-3892-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3892-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3892-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,728.89,1.9,0.15,58cfa830e4b0c9d6adf6bd3c,TCGA-AG-3892-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3892-01A,DED3FEB2-1079-4520-A7CA-F5B5FC73D7C5,Primary Tumor,Illumina HiSeq,adde3886-c16e-4d0c-8186-1a253ffca559,Colorectal,57,D5B6919D-5654-486F-95B0-D89CB1893614,8B81AA70-5B77-4BE9-8438-AE0928339E21,TCGA-AG-3892-01A-01D-1115-02,HG18,TCGA-AG-3892,TCGA-READ,NA,s1998,Harvard Medical School,Indivumed,Germany,NO,T1,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa831e4b0c9d6adf6cb52,58cfa831e4b0c9d6adf6cb52,TCGA-EE-A29B-10A-01D-A190_120807_SN590_0173_AC0VN5ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EE-A29B-10A-01D-A190_120807_SN590_0173_AC0VN5ACXX_s_3_rg.sorted,TCGA-EE-A29B-10A-01D-A190_120807_SN590_0173_AC0VN5ACXX_s_3_rg.sorted.bam,23.54,NA,0.15,58cfa831e4b0c9d6adf6cb52,TCGA-EE-A29B-10A-01D-A190_120807_SN590_0173_AC0VN5ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29B-10A,905EA29F-588A-497B-9F06-2EEF3BDC9442,Blood Derived Normal,Illumina HiSeq,628ddf51-45ee-4b67-891e-132909689e76,Skin,67,CDBC7250-CFDB-485B-BD1F-B3D82DCD168D,352C1BF5-2EA6-4E78-833D-8F16B117A2A8,TCGA-EE-A29B-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A29B,TCGA-SKCM,NA,s7336,Harvard Medical School,University of Sydney,Australia,NO,T3b,N0,Not available,Stage IIB
13722.58cfa830e4b0c9d6adf6be96,58cfa830e4b0c9d6adf6be96,TCGA-AZ-4681-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AZ-4681-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-AZ-4681-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,495.02,1.9,0.14,58cfa830e4b0c9d6adf6be96,TCGA-AZ-4681-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-4681-01A,6FBC2B46-6762-4778-AA7E-782162C5397C,Primary Tumor,Illumina HiSeq,6ba6ed18-e876-4135-beef-7355f9bafa79,Colorectal,79,6171DB74-FE5A-4495-8B6A-724BE0CBA79E,37179766-A54A-4FA0-9E6E-5A33ABF3AC45,TCGA-AZ-4681-01A-01D-1405-02,HG18,TCGA-AZ-4681,TCGA-COAD,NA,s13543,Harvard Medical School,University of Pittsburgh,None,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6c03c,58cfa830e4b0c9d6adf6c03c,TCGA-AG-4001-01A-02D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-4001-01A-02D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-4001-01A-02D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,420.89,1.9,0.15,58cfa830e4b0c9d6adf6c03c,TCGA-AG-4001-01A-02D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-4001-01A,D846228F-67AF-4B3B-9796-DBC263C2054C,Primary Tumor,Illumina HiSeq,53c6af7e-4876-4559-b1b1-d7dc58c2b702,Colorectal,74,6160C363-B050-4B3B-9909-4EBC33ED3A1A,05B6BA78-DDE8-4E68-9622-7B618A083CC8,TCGA-AG-4001-01A-02D-1115-02,HG18,TCGA-AG-4001,TCGA-READ,NA,s2164,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6bec0,58cfa830e4b0c9d6adf6bec0,TCGA-AR-A0TU-01A-31D-A106_130719_SN1120_0270_AC2CVRACXX_s_5_rg.sorted.filtered.,WGS,TCGA-AR-A0TU-01A-31D-A106_130719_SN1120_0270_AC2CVRACXX_s_5_rg.sorted,TCGA-AR-A0TU-01A-31D-A106_130719_SN1120_0270_AC2CVRACXX_s_5_rg.sorted.bam,73.2,1.9,0.15,58cfa830e4b0c9d6adf6bec0,TCGA-AR-A0TU-01A-31D-A106_130719_SN1120_0270_AC2CVRACXX_s_5_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-AR-A0TU-01A,DFE6DB17-CF45-488E-BD3C-B8433D7343CA,Primary Tumor,Illumina HiSeq,fb34c291-904a-4613-80cd-9788ff446157,Breast,35,1E629A73-68CD-449D-A1C0-B856BE4143E6,E00819A1-4A65-4289-9DDE-0800FC6C69F6,TCGA-AR-A0TU-01A-31D-A106-02,HG19_Broad_variant,TCGA-AR-A0TU,TCGA-BRCA,NA,s6630,Harvard Medical School,Mayo,None,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa832e4b0c9d6adf6cfe8,58cfa832e4b0c9d6adf6cfe8,TCGA-GV-A3JX-01A-11D-A210_120912_SN1222_0148_AC188PACXX_s_1_rg.sorted.filtered.,WGS,TCGA-GV-A3JX-01A-11D-A210_120912_SN1222_0148_AC188PACXX_s_1_rg.sorted,TCGA-GV-A3JX-01A-11D-A210_120912_SN1222_0148_AC188PACXX_s_1_rg.sorted.bam,67.04,NA,0.15,58cfa832e4b0c9d6adf6cfe8,TCGA-GV-A3JX-01A-11D-A210_120912_SN1222_0148_AC188PACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GV-A3JX-01A,D9DCBB57-F6C2-4465-8A60-AFE876E113CA,Primary Tumor,Illumina HiSeq,317cc3f0-7a98-402b-bb1f-81a0437fbaf8,Bladder,59,CE32612D-F504-4164-AE50-04C4AC2999FB,A8636E11-C752-46F4-A6A8-42D5B7DCBD02,TCGA-GV-A3JX-01A-11D-A210-26,HG19_Broad_variant,TCGA-GV-A3JX,TCGA-BLCA,NA,s2736,MD Anderson - Institute for Applied Cancer Science,BLN - Cleveland Clinic,United States,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6cb9c,58cfa831e4b0c9d6adf6cb9c,TCGA-EE-A29H-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EE-A29H-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_8_rg.sorted,TCGA-EE-A29H-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_8_rg.sorted.bam,28.94,NA,0.15,58cfa831e4b0c9d6adf6cb9c,TCGA-EE-A29H-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29H-10A,C8BA1856-D055-4DC6-A184-72763C76AAE4,Blood Derived Normal,Illumina HiSeq,66ec2170-64e3-497d-aa60-e0f40b3875a6,Skin,59,D9FB008D-2BD2-4F50-99D3-C4E0863A5AE0,63B79CED-2594-4C16-9788-95BBF1F99D37,TCGA-EE-A29H-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A29H,TCGA-SKCM,NA,s7849,Harvard Medical School,University of Sydney,Australia,NO,T1a,N0,Not available,Stage IA
13722.58cfa831e4b0c9d6adf6c820,58cfa831e4b0c9d6adf6c820,TCGA-D1-A16Q-10A-01D-A12F_120511_SN208_0299_BD12J9ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-D1-A16Q-10A-01D-A12F_120511_SN208_0299_BD12J9ACXX_s_6_rg.sorted,TCGA-D1-A16Q-10A-01D-A12F_120511_SN208_0299_BD12J9ACXX_s_6_rg.sorted.bam,8.1,1.88,0.16,58cfa831e4b0c9d6adf6c820,TCGA-D1-A16Q-10A-01D-A12F_120511_SN208_0299_BD12J9ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A16Q-10A,7F4F3AED-69AF-421E-817B-B258DCC0BAC5,Blood Derived Normal,Illumina HiSeq,5a60f363-a607-4fc0-9cac-d1c33bcacd05,Uterus,54,083F8BFB-D189-4E99-A597-89DD3A7769EB,A0CD8E6F-AEDE-4B7D-A9E1-E38034C51638,TCGA-D1-A16Q-10A-01D-A12F-02,HG19_Broad_variant,TCGA-D1-A16Q,TCGA-UCEC,NA,s5021,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bc92,58cfa830e4b0c9d6adf6bc92,TCGA-AG-3902-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3902-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3902-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,500.89,1.9,0.14,58cfa830e4b0c9d6adf6bc92,TCGA-AG-3902-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3902-01A,BCFE4FE9-D090-49F9-85A7-2B472E0F7453,Primary Tumor,Illumina HiSeq,66b629b3-3801-4c84-966b-4b01243390f0,Colorectal,61,F52423C2-7780-4470-8E27-5982201CCB83,A8A88775-9775-4087-8C03-9B5BC771F983,TCGA-AG-3902-01A-01D-1115-02,HG18,TCGA-AG-3902,TCGA-READ,NA,s2159,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6c662,58cfa831e4b0c9d6adf6c662,TCGA-CM-4750-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-CM-4750-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-CM-4750-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,450.02,1.9,0.14,58cfa831e4b0c9d6adf6c662,TCGA-CM-4750-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-CM-4750-01A,C777A777-373A-4773-9566-6C373261F00A,Primary Tumor,Illumina HiSeq,eae74e76-b630-469d-9ad7-549fbfe64297,Colorectal,34,463D4B1E-2068-45DD-9631-FB9C7268FE6C,EE814BA4-311A-4ABC-B7A6-F32C68C50F2A,TCGA-CM-4750-01A-01D-1405-02,HG18,TCGA-CM-4750,TCGA-COAD,NA,s12891,Harvard Medical School,MSKCC,United States,NO,T1,N1b,Colon Adenocarcinoma,Stage IIIA
13722.58cfa830e4b0c9d6adf6bbb8,58cfa830e4b0c9d6adf6bbb8,TCGA-AA-A01T-11A-11D-A079-02_110409_SN590_0077_BB04EHABXX_s_6.rg.sorted.filtered.,WGS,TCGA-AA-A01T-11A-11D-A079-02_110409_SN590_0077_BB04EHABXX_s_6.rg.sorted,TCGA-AA-A01T-11A-11D-A079-02_110409_SN590_0077_BB04EHABXX_s_6.rg.sorted.bam,40.17,1.97,0.14,58cfa830e4b0c9d6adf6bbb8,TCGA-AA-A01T-11A-11D-A079-02_110409_SN590_0077_BB04EHABXX_s_6.rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01T-11A,F87C6DCC-1A9E-4DF5-962C-1F946E2611F8,Solid Tissue Normal,Illumina HiSeq,bb48e041-be2a-4f2c-83ff-39500c7790bb,Colorectal,63,4B1CA823-0752-4F67-AD05-70BDBCDC73B6,C5BE2240-6C97-4875-A26F-79B7F17D067F,TCGA-AA-A01T-11A-11D-A079-02,HG18_Broad_variant,TCGA-AA-A01T,TCGA-COAD,NA,s13031,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage III
13722.58cfa831e4b0c9d6adf6ca05,58cfa831e4b0c9d6adf6ca05,TCGA-DE-A0Y3-01B-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DE-A0Y3-01B-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_3_rg.sorted,TCGA-DE-A0Y3-01B-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_3_rg.sorted.bam,60.48,2.03,0.14,58cfa831e4b0c9d6adf6ca05,TCGA-DE-A0Y3-01B-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_3_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DE-A0Y3-01B,C31B3ADF-3FC6-4A72-83B0-BBC0F295B5E7,Primary Tumor,Illumina HiSeq,e17f6c8d-d069-4561-8371-8138731e3dd2,Thyroid,60,3AE03B86-1473-409C-8118-A91A73A36F60,F3099D9B-DBBE-46CB-BA22-DAD7F9428C4F,TCGA-DE-A0Y3-01B-11D-A10R-02,HG19_Broad_variant,TCGA-DE-A0Y3,TCGA-THCA,NA,s12848,Harvard Medical School,University of North Carolina,United States,NO,T4a,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVC
13722.58cfa830e4b0c9d6adf6bc80,58cfa830e4b0c9d6adf6bc80,TCGA-AP-A054-10A-01D-A043_120209_SN1120_0114_BC0DFVACXX_s_2_rg.sorted.filtered.,WGS,TCGA-AP-A054-10A-01D-A043_120209_SN1120_0114_BC0DFVACXX_s_2_rg.sorted,TCGA-AP-A054-10A-01D-A043_120209_SN1120_0114_BC0DFVACXX_s_2_rg.sorted.bam,29.88,1.72,0.15,58cfa830e4b0c9d6adf6bc80,TCGA-AP-A054-10A-01D-A043_120209_SN1120_0114_BC0DFVACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A054-10A,D77E4DBC-B239-4742-8CB7-EFD427010D13,Blood Derived Normal,Illumina HiSeq,a6bc8f80-d89a-45e0-8e71-e6f13632dba6,Uterus,64,2A884E50-859A-4269-A604-210562E65E9C,3E58B079-B1CB-4356-842E-F08E2F1EBD65,TCGA-AP-A054-10A-01D-A043-02,HG19_Broad_variant,TCGA-AP-A054,TCGA-UCEC,709,s4591,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d474,58cfa832e4b0c9d6adf6d474,TCGA-V4-A9EI-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_6_rg.sorted.filtered.,WGS,TCGA-V4-A9EI-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_6_rg.sorted,TCGA-V4-A9EI-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_6_rg.sorted.bam,32.62,NA,0.17,58cfa832e4b0c9d6adf6d474,TCGA-V4-A9EI-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EI-01A,B533E555-90CF-4657-80C6-15B67DA8AD26,Primary Tumor,Illumina HiSeq,ffc1ec43-7da7-4a9b-ab87-1ad3a3ba5c42,Eye,78,0077CCB8-615D-4725-95E7-72708732E963,B0CCF5D2-B334-4B7C-858E-53005B6FD0D7,TCGA-V4-A9EI-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9EI,TCGA-UVM,389,s203,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4c,N0,Not available,Stage IIIB
13722.58cfa831e4b0c9d6adf6c9e7,58cfa831e4b0c9d6adf6c9e7,TCGA-DJ-A1QQ-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DJ-A1QQ-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_4_rg.sorted,TCGA-DJ-A1QQ-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_4_rg.sorted.bam,48.48,1.91,0.16,58cfa831e4b0c9d6adf6c9e7,TCGA-DJ-A1QQ-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_4_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QQ-01A,99EF2FEC-5A3C-4E42-8F78-7EAF9877E26D,Primary Tumor,Illumina HiSeq,091bb28f-4fe0-41e6-b7c5-b952dc370506,Thyroid,43,64D1F58A-986F-4D4B-962E-DA59A48C988B,DDE34A05-A208-4F86-9803-0FB1EB858947,TCGA-DJ-A1QQ-01A-11D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QQ,TCGA-THCA,NA,s12639,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6ce11,58cfa832e4b0c9d6adf6ce11,TCGA-EM-A1YE-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EM-A1YE-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_3_rg.sorted,TCGA-EM-A1YE-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_3_rg.sorted.bam,72.49,1.98,0.17,58cfa832e4b0c9d6adf6ce11,TCGA-EM-A1YE-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_3_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1YE-01A,E632B443-CF6A-4592-96C6-C3493EC86FEA,Primary Tumor,Illumina HiSeq,a16ef214-00f5-4385-81e9-e66da356395c,Thyroid,47,A5DE766B-9CCC-4B56-8D9B-25704C1C91D0,4AE46D2E-BA86-426F-A127-4C1AAF92AB5B,TCGA-EM-A1YE-01A-11D-A14U-02,HG19_Broad_variant,TCGA-EM-A1YE,TCGA-THCA,NA,s12519,Harvard Medical School,University Health Network,Canada,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa831e4b0c9d6adf6c958,58cfa831e4b0c9d6adf6c958,TCGA-DK-A3IK-01A-32D-A21C_120914_SN590_0179_AD13PPACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DK-A3IK-01A-32D-A21C_120914_SN590_0179_AD13PPACXX_s_3_rg.sorted,TCGA-DK-A3IK-01A-32D-A21C_120914_SN590_0179_AD13PPACXX_s_3_rg.sorted.bam,35.88,NA,0.16,58cfa831e4b0c9d6adf6c958,TCGA-DK-A3IK-01A-32D-A21C_120914_SN590_0179_AD13PPACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3IK-01A,3F0A0748-9ACC-4D0B-BA18-7C08BD183F86,Primary Tumor,Illumina HiSeq,6c286798-955c-487f-b541-72f253866ada,Bladder,87,4FF20C48-29EE-4101-B409-C4573E38CF92,B13B80DE-1722-44D3-888D-EEE8677F205C,TCGA-DK-A3IK-01A-32D-A21C-26,HG19_Broad_variant,TCGA-DK-A3IK,TCGA-BLCA,NA,s2887,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6cecf,58cfa832e4b0c9d6adf6cecf,TCGA-EM-A3O9-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EM-A3O9-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_6_rg.sorted,TCGA-EM-A3O9-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_6_rg.sorted.bam,16.65,NA,0.16,58cfa832e4b0c9d6adf6cecf,TCGA-EM-A3O9-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_6_rg.sorted.bam,Alive,MALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3O9-01A,34B8D361-9C95-4F28-8E45-669DEFC5C3A7,Primary Tumor,Illumina HiSeq,862b34f6-6d2e-4084-a468-f0bf4a755cc9,Thyroid,40,8CCE6685-0688-4923-97AF-AEF08B17CB58,5D9FCA63-9540-40DB-9841-66A273AF8D35,TCGA-EM-A3O9-01A-11D-A221-26,HG19_Broad_variant,TCGA-EM-A3O9,TCGA-THCA,NA,s12001,MD Anderson - RPPA Core Facility (Proteomics),University Health Network,Canada,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa830e4b0c9d6adf6bff8,58cfa830e4b0c9d6adf6bff8,TCGA-AG-3887-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3887-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3887-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,745.89,1.9,0.15,58cfa830e4b0c9d6adf6bff8,TCGA-AG-3887-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3887-01A,8C7CCDB0-7653-4A8D-86B6-DE39AFC40765,Primary Tumor,Illumina HiSeq,0041b462-7ad7-4a4d-8fea-1942532341ed,Colorectal,68,7F10DD13-E2C3-4F27-8673-FF5CD1632B2B,5986038D-2696-4F89-A5F5-C8173BA7D70F,TCGA-AG-3887-01A-01D-1115-02,HG18,TCGA-AG-3887,TCGA-READ,NA,s2136,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Mucinous Adenocarcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6c993,58cfa831e4b0c9d6adf6c993,TCGA-D9-A1JW-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_6_rg.sorted.filtered.,WGS,TCGA-D9-A1JW-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_6_rg.sorted,TCGA-D9-A1JW-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_6_rg.sorted.bam,44.09,NA,0.18,58cfa831e4b0c9d6adf6c993,TCGA-D9-A1JW-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D9-A1JW-10A,9A903FC2-57D7-4A02-94E7-9B9B7EE99276,Blood Derived Normal,Illumina HiSeq,81b083e1-deb3-4935-b274-bded2a4d47fb,Skin,82,7402F1FA-E9DF-45A3-9DD7-B5F82F427F52,790E7D9B-A1E6-40EF-B46D-22E35DAB4E5D,TCGA-D9-A1JW-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-D9-A1JW,TCGA-SKCM,NA,s7673,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T1a,N2a,Not available,Not available
13722.58cfa830e4b0c9d6adf6bda0,58cfa830e4b0c9d6adf6bda0,TCGA-BG-A0M0-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BG-A0M0-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_1_rg.sorted,TCGA-BG-A0M0-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_1_rg.sorted.bam,8.96,2.22,0.16,58cfa830e4b0c9d6adf6bda0,TCGA-BG-A0M0-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0M0-10A,8BF0B156-6EB4-45E8-9CBB-0979EFBEA898,Blood Derived Normal,Illumina HiSeq,131e2c60-ce89-4bf3-8c00-24e790507005,Uterus,66,6C55929F-1C1E-48C9-873E-7FF6A1433ED3,6D3FBD58-8A84-4355-B4E6-D38E5D099E8A,TCGA-BG-A0M0-10A-01D-A101-02,HG19_Broad_variant,TCGA-BG-A0M0,TCGA-UCEC,NA,s4256,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c876,58cfa831e4b0c9d6adf6c876,TCGA-D6-6826-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D6-6826-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_3_rg.sorted,TCGA-D6-6826-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_3_rg.sorted.bam,275.7,1.9,0.14,58cfa831e4b0c9d6adf6c876,TCGA-D6-6826-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-D6-6826-01A,31243867-8E9F-46E9-A213-B83544EB8028,Primary Tumor,Illumina HiSeq,377f848a-3e59-4eee-bd9d-87fdc1a898bb,Head and Neck,64,1737989D-8463-4761-B111-53E4FD396375,07759CEA-B923-4D20-96DB-7952D50314C7,TCGA-D6-6826-01A-11D-1911-02,HG19_Broad_variant,TCGA-D6-6826,TCGA-HNSC,NA,s15912,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6d2a6,58cfa832e4b0c9d6adf6d2a6,TCGA-IR-A3LL-01A-11D-A20X_140117_SN590_0245_AC371LACXX_s_4_rg.sorted.filtered.,WGS,TCGA-IR-A3LL-01A-11D-A20X_140117_SN590_0245_AC371LACXX_s_4_rg.sorted,TCGA-IR-A3LL-01A-11D-A20X_140117_SN590_0245_AC371LACXX_s_4_rg.sorted.bam,66.26,NA,0.15,58cfa832e4b0c9d6adf6d2a6,TCGA-IR-A3LL-01A-11D-A20X_140117_SN590_0245_AC371LACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-IR-A3LL-01A,7C4AB1CA-4BDD-4EF7-9A42-F6C0C7136D26,Primary Tumor,Illumina HiSeq,817ccf3b-ceaa-45cf-a938-67e531a9f57a,Cervix,60,A0FB972A-CE8F-441F-8707-C3CC1081DEE0,5457562E-E184-4D13-B11C-49728B689275,TCGA-IR-A3LL-01A-11D-A20X-26,HG19_Broad_variant,TCGA-IR-A3LL,TCGA-CESC,NA,s1378,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d844,58cfa832e4b0c9d6adf6d844,TCGA-LN-A4A4-10A-01D-A267_131001_SN1222_0222_BC2CN2ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-LN-A4A4-10A-01D-A267_131001_SN1222_0222_BC2CN2ACXX_s_4_rg.sorted,TCGA-LN-A4A4-10A-01D-A267_131001_SN1222_0222_BC2CN2ACXX_s_4_rg.sorted.bam,59.55,NA,0.15,58cfa832e4b0c9d6adf6d844,TCGA-LN-A4A4-10A-01D-A267_131001_SN1222_0222_BC2CN2ACXX_s_4_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A4A4-10A,E89D7900-915D-4936-B1B2-CAC3670EA2F4,Blood Derived Normal,Illumina HiSeq,2003efcc-7a3a-488c-928b-54ba8035d1cc,Esophagus,36,43AD599A-DF3C-4BBF-9F36-285112CB79F5,E3F623FA-1061-408F-91B4-E35946F09795,TCGA-LN-A4A4-10A-01D-A267-26,HG19_Broad_variant,TCGA-LN-A4A4,TCGA-ESCA,NA,s1937,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N1,Not available,Stage III
13722.58cfa831e4b0c9d6adf6c678,58cfa831e4b0c9d6adf6c678,TCGA-CQ-5325-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CQ-5325-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_1_rg.sorted,TCGA-CQ-5325-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_1_rg.sorted.bam,166,1.9,0.14,58cfa831e4b0c9d6adf6c678,TCGA-CQ-5325-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-5325-01A,408C5D54-7888-4955-8386-BF8819B48A6C,Primary Tumor,Illumina HiSeq,a7440672-d797-4ad6-979a-c0835f0c2768,Head and Neck,65,8394A7F6-1BF6-473E-A155-3DA1A3DE244F,FFB4F8E1-B683-4A35-A5E7-15DBF610AE47,TCGA-CQ-5325-01A-01D-1681-02,HG19_Broad_variant,TCGA-CQ-5325,TCGA-HNSC,654,s16331,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d4b7,58cfa832e4b0c9d6adf6d4b7,TCGA-V4-A9F3-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-V4-A9F3-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_7_rg.sorted,TCGA-V4-A9F3-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_7_rg.sorted.bam,12.02,NA,0.15,58cfa832e4b0c9d6adf6d4b7,TCGA-V4-A9F3-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9F3-10A,E21D8018-8FE9-4C92-8B36-28D7D3F7DF2B,Blood Derived Normal,Illumina HiSeq,40c95883-0b1f-49f7-85e7-f75948cf985f,Eye,49,E5C71F8C-4F74-402A-AC5E-F641892F8BA5,7E133B8C-01B3-4758-96FC-AAD8D49326EA,TCGA-V4-A9F3-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9F3,TCGA-UVM,NA,s219,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa830e4b0c9d6adf6bf83,58cfa830e4b0c9d6adf6bf83,TCGA-BR-6453-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BR-6453-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_4_rg.sorted,TCGA-BR-6453-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_4_rg.sorted.bam,93.7,1.9,0.15,58cfa830e4b0c9d6adf6bf83,TCGA-BR-6453-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6453-01A,AE633E83-303F-4A90-AC3B-34458FD9BEEF,Primary Tumor,Illumina HiSeq,e92977c9-6880-4f84-842a-9152e558d0b1,Stomach,54,A8F3B148-5929-4025-81A1-6595D49F2279,EE3446DC-7278-47AF-8F65-F63A1D423644,TCGA-BR-6453-01A-11D-1798-02,HG19_Broad_variant,TCGA-BR-6453,TCGA-STAD,NA,s15305,Harvard Medical School,Asterand,Russia,NO,T2,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA
13722.58cfa831e4b0c9d6adf6c949,58cfa831e4b0c9d6adf6c949,TCGA-DJ-A13O-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DJ-A13O-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_5_rg.sorted,TCGA-DJ-A13O-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_5_rg.sorted.bam,21.24,1.93,0.16,58cfa831e4b0c9d6adf6c949,TCGA-DJ-A13O-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13O-01A,77D5B246-33BA-4A96-9D73-06ACA797653E,Primary Tumor,Illumina HiSeq,ae4a78d9-4c9a-40f7-9612-17d11799ea67,Thyroid,56,457B11C0-3C36-4907-8C76-60E3861EBABB,EC713290-9998-489B-9D1E-CC9D33CF5428,TCGA-DJ-A13O-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13O,TCGA-THCA,NA,s12241,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6ccf6,58cfa831e4b0c9d6adf6ccf6,TCGA-EM-A1CU-11A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EM-A1CU-11A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_8_rg.sorted,TCGA-EM-A1CU-11A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_8_rg.sorted.bam,35.57,1.9,0.16,58cfa831e4b0c9d6adf6ccf6,TCGA-EM-A1CU-11A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_8_rg.sorted.bam,Alive,MALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1CU-11A,4E80F403-0E10-4725-854D-F023C12EE1E2,Solid Tissue Normal,Illumina HiSeq,6237f724-77de-47ae-bd28-0e479ae2def9,Thyroid,31,9EBED2E5-A61B-4F2A-9B9F-1693B660EA5F,BEC01D9D-E7EA-48F7-9272-7C71AA578CB8,TCGA-EM-A1CU-11A-11D-A13U-02,HG19_Broad_variant,TCGA-EM-A1CU,TCGA-THCA,NA,s12250,Harvard Medical School,University Health Network,Canada,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82fe4b0c9d6adf6b6b7,58cfa82fe4b0c9d6adf6b6b7,TCGA-64-5781-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-64-5781-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_7_rg.sorted,TCGA-64-5781-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_7_rg.sorted.bam,555.7,1.9,0.15,58cfa82fe4b0c9d6adf6b6b7,TCGA-64-5781-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-64-5781-01A,41C4C704-825E-49F5-9D54-DBD7D30725E0,Primary Tumor,Illumina HiSeq,901f4776-2659-4626-abec-5a9323e6f75e,Lung,55,B32F509D-91E5-4601-B8B3-4B0A5212C22B,69DEF564-A4D8-4820-9ED6-F17AF2CAB0A7,TCGA-64-5781-01A-01D-1623-02,HG19_Broad_variant,TCGA-64-5781,TCGA-LUAD,NA,s11352,Harvard Medical School,Fox Chase,United States,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa832e4b0c9d6adf6d54e,58cfa832e4b0c9d6adf6d54e,TCGA-L5-A4OS-01A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-L5-A4OS-01A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_3_rg.sorted,TCGA-L5-A4OS-01A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_3_rg.sorted.bam,26.15,NA,0.16,58cfa832e4b0c9d6adf6d54e,TCGA-L5-A4OS-01A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OS-01A,D5AC647F-0C6D-40D7-87A8-FAA1CC968C82,Primary Tumor,Illumina HiSeq,5c0f7af4-2359-4784-8db9-a4acac6fbb09,Esophagus,86,8734680B-CA7B-49F4-A539-0182B45454F3,C3CAE2EF-E23F-4D72-8B4F-E9F9AF08340D,TCGA-L5-A4OS-01A-11D-A28P-26,HG19_Broad_variant,TCGA-L5-A4OS,TCGA-ESCA,NA,s1849,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T2,N1,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6ca5e,58cfa831e4b0c9d6adf6ca5e,TCGA-DJ-A1QG-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DJ-A1QG-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_1_rg.sorted,TCGA-DJ-A1QG-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_1_rg.sorted.bam,73.27,1.98,0.17,58cfa831e4b0c9d6adf6ca5e,TCGA-DJ-A1QG-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QG-01A,CB29E795-7618-4882-A7E0-69D39787B80C,Primary Tumor,Illumina HiSeq,cd7d52cc-20ac-4fa7-a821-231d15f926fc,Thyroid,62,D0A669AF-1A0A-451D-9D6F-9EEE15F7264C,EF88FE61-36C4-43CF-BD57-D15F7E264DF0,TCGA-DJ-A1QG-01A-11D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QG,TCGA-THCA,NA,s12240,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa831e4b0c9d6adf6cb6e,58cfa831e4b0c9d6adf6cb6e,TCGA-EE-A29N-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EE-A29N-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_7_rg.sorted,TCGA-EE-A29N-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_7_rg.sorted.bam,20.7,NA,0.17,58cfa831e4b0c9d6adf6cb6e,TCGA-EE-A29N-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29N-10A,8AAD9690-D1AD-424B-9A80-D7980760D093,Blood Derived Normal,Illumina HiSeq,a5f48fa3-7af5-4273-be19-0d3562ccb440,Skin,78,5EFDE57D-D614-4DD4-9506-6B2A9BC6ADA3,B9CB409B-AC7F-4C8D-AE93-906AFBF3EC93,TCGA-EE-A29N-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A29N,TCGA-SKCM,566,s7842,Harvard Medical School,University of Sydney,Australia,NO,TX,N0,Not available,I or II NOS
13722.58cfa832e4b0c9d6adf6d4ca,58cfa832e4b0c9d6adf6d4ca,TCGA-V4-A9F5-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-V4-A9F5-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_1_rg.sorted,TCGA-V4-A9F5-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_1_rg.sorted.bam,57.62,NA,0.17,58cfa832e4b0c9d6adf6d4ca,TCGA-V4-A9F5-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9F5-01A,BBF07E1F-8C17-4C2E-89ED-38332D82E455,Primary Tumor,Illumina HiSeq,11ec05e6-4b9a-4abf-8b47-45f259c5eaf3,Eye,85,16FCA21C-963E-4D77-8B5A-3C178DAC6168,38812469-1716-4B6F-8DBE-822654AC13F6,TCGA-V4-A9F5-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9F5,TCGA-UVM,NA,s245,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4e,N0,Not available,Stage IV
13722.58cfa832e4b0c9d6adf6d4fa,58cfa832e4b0c9d6adf6d4fa,TCGA-L5-A4OE-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_1_rg.sorted.filtered.,WGS,TCGA-L5-A4OE-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_1_rg.sorted,TCGA-L5-A4OE-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_1_rg.sorted.bam,43.86,NA,0.16,58cfa832e4b0c9d6adf6d4fa,TCGA-L5-A4OE-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OE-01A,0A466142-C513-4257-85D4-4BD7CFD0EF29,Primary Tumor,Illumina HiSeq,49822c02-a9e7-4e7e-bd12-f1756b639beb,Esophagus,81,BD8CADB2-1382-4BF5-A68F-C5A71837FE95,C5F599A9-1398-4E49-9CC7-77129658E143,TCGA-L5-A4OE-01A-11D-A267-26,HG19_Broad_variant,TCGA-L5-A4OE,TCGA-ESCA,NA,s1838,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T3,N2,Not available,Stage IIIB
13722.58cfa832e4b0c9d6adf6d0e2,58cfa832e4b0c9d6adf6d0e2,TCGA-IG-A3YC-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-IG-A3YC-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_5_rg.sorted,TCGA-IG-A3YC-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_5_rg.sorted.bam,24.61,NA,0.15,58cfa832e4b0c9d6adf6d0e2,TCGA-IG-A3YC-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A3YC-01A,6A05288E-D051-40A5-9F4E-864AB806A5DC,Primary Tumor,Illumina HiSeq,a1261941-39f5-47ec-a6a4-ab07b298fb93,Esophagus,62,C754C363-924A-404A-9D60-4CA2A3930D2A,44EE541C-5657-43A9-9D56-6D88319E4617,TCGA-IG-A3YC-01A-11D-A248-26,HG19_Broad_variant,TCGA-IG-A3YC,TCGA-ESCA,NA,s1622,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T3,N1,Not available,Stage IIIA
13722.58cfa831e4b0c9d6adf6c4e9,58cfa831e4b0c9d6adf6c4e9,TCGA-AZ-4682-01B-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AZ-4682-01B-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-AZ-4682-01B-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,752.02,1.9,0.15,58cfa831e4b0c9d6adf6c4e9,TCGA-AZ-4682-01B-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-4682-01B,E588714A-7753-4C3C-ABB6-EAF1AAB53AB3,Primary Tumor,Illumina HiSeq,fb93cdea-2ff1-454c-9fac-523a4bb11d62,Colorectal,61,A2412F6F-324E-4EF2-BD46-0D33596A033B,2007180A-F4AC-4300-A560-903ACEAC4F71,TCGA-AZ-4682-01B-01D-1405-02,HG18,TCGA-AZ-4682,TCGA-COAD,680,s13390,Harvard Medical School,University of Pittsburgh,None,NO,T3,N0,Colon Adenocarcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6beaa,58cfa830e4b0c9d6adf6beaa,TCGA-AG-3902-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3902-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3902-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,72.59,1.9,0.16,58cfa830e4b0c9d6adf6beaa,TCGA-AG-3902-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3902-10A,BCFE4FE9-D090-49F9-85A7-2B472E0F7453,Blood Derived Normal,Illumina HiSeq,95d95b49-faee-4d63-9800-12a04600f01c,Colorectal,61,52980AB7-69C5-4FA3-83ED-EB21E703C60D,D70EBF7E-FBCE-48D0-A2DC-BAD5CD28928D,TCGA-AG-3902-10A-01D-1115-02,HG18,TCGA-AG-3902,TCGA-READ,NA,s2156,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa82fe4b0c9d6adf6b7e4,58cfa82fe4b0c9d6adf6b7e4,TCGA-44-3396-10A-01D-1203_110729_SN208_0215_BD0CLPABXX_s_5_rg.sorted.filtered.,WGS,TCGA-44-3396-10A-01D-1203_110729_SN208_0215_BD0CLPABXX_s_5_rg.sorted,TCGA-44-3396-10A-01D-1203_110729_SN208_0215_BD0CLPABXX_s_5_rg.sorted.bam,724.3,1.9,0.15,58cfa82fe4b0c9d6adf6b7e4,TCGA-44-3396-10A-01D-1203_110729_SN208_0215_BD0CLPABXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-3396-10A,3BD6BADB-27FF-4D8D-B206-4D28DC264862,Blood Derived Normal,Illumina HiSeq,03abf6dc-ed65-46a4-bca8-920d74f39139,Lung,74,C3FFB1CC-785E-49FE-AC62-1C99554C6001,0F4135A4-53D2-499B-9F1F-12A9317EDE14,TCGA-44-3396-10A-01D-1203-02,HG19_Broad_variant,TCGA-44-3396,TCGA-LUAD,NA,s11336,Harvard Medical School,Christiana Healthcare,United States,NO,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa832e4b0c9d6adf6cf24,58cfa832e4b0c9d6adf6cf24,TCGA-G9-6351-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_3_rg.sorted.filtered.,WGS,TCGA-G9-6351-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_3_rg.sorted,TCGA-G9-6351-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_3_rg.sorted.bam,30,1.8,0.15,58cfa832e4b0c9d6adf6cf24,TCGA-G9-6351-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6351-10A,F59B9C65-46E8-4CC3-AA71-8844F6C2273C,Blood Derived Normal,Illumina HiSeq,8cd65f12-8354-414b-a45b-9cc78613df38,Prostate,51,69DD99BE-72DD-46BC-96FB-97531992367D,F73E670B-2D6D-4E55-AA8E-D99FF270E536,TCGA-G9-6351-10A-01D-1957-02,HG19_Broad_variant,TCGA-G9-6351,TCGA-PRAD,NA,s3616,Harvard Medical School,Roswell Park,United States,NO,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c5d0,58cfa831e4b0c9d6adf6c5d0,TCGA-CF-A3MF-10A-01D-A21C_120914_SN590_0180_BC19KDACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CF-A3MF-10A-01D-A21C_120914_SN590_0180_BC19KDACXX_s_2_rg.sorted,TCGA-CF-A3MF-10A-01D-A21C_120914_SN590_0180_BC19KDACXX_s_2_rg.sorted.bam,37.24,NA,0.15,58cfa831e4b0c9d6adf6c5d0,TCGA-CF-A3MF-10A-01D-A21C_120914_SN590_0180_BC19KDACXX_s_2_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CF-A3MF-10A,1E308B12-0590-4DAE-94D0-A539FCF25DF7,Blood Derived Normal,Illumina HiSeq,9153f608-1d9c-4c91-b21d-2e945c114aa0,Bladder,34,59B99C9A-D1C0-4CC0-953B-4358BCF9F392,DE88D0C8-186A-4D0C-9EDA-963F28666F02,TCGA-CF-A3MF-10A-01D-A21C-26,HG19_Broad_variant,TCGA-CF-A3MF,TCGA-BLCA,NA,s3094,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6d418,58cfa832e4b0c9d6adf6d418,TCGA-V4-A9F2-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-V4-A9F2-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_2_rg.sorted,TCGA-V4-A9F2-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_2_rg.sorted.bam,38.01,NA,0.16,58cfa832e4b0c9d6adf6d418,TCGA-V4-A9F2-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9F2-01A,411DDF79-FE92-44AD-8D10-EEB703F11BE7,Primary Tumor,Illumina HiSeq,c4fcd1a4-5246-4a6b-b5b0-45b8b838edf2,Eye,78,2F2FF6C7-9568-47E4-AB09-6050F84BBF5C,87781EA6-C3E9-476A-B5D2-E58FC557FC7A,TCGA-V4-A9F2-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9F2,TCGA-UVM,NA,s207,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3b,N0,Not available,Stage IIIA
13722.58cfa832e4b0c9d6adf6ce40,58cfa832e4b0c9d6adf6ce40,TCGA-ER-A1A1-10A-01D-A190_120718_SN208_0415_AC116EACXX_s_7_rg.sorted.filtered.,WGS,TCGA-ER-A1A1-10A-01D-A190_120718_SN208_0415_AC116EACXX_s_7_rg.sorted,TCGA-ER-A1A1-10A-01D-A190_120718_SN208_0415_AC116EACXX_s_7_rg.sorted.bam,26.11,NA,0.18,58cfa832e4b0c9d6adf6ce40,TCGA-ER-A1A1-10A-01D-A190_120718_SN208_0415_AC116EACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A1A1-10A,1251ACEE-CEB4-4530-BA5B-4D163FCAB8D2,Blood Derived Normal,Illumina HiSeq,a929309c-6fce-4ba9-ab55-aca676e8c78d,Skin,58,38829905-3718-4085-B50E-ACB5FF37D546,5DC16C47-0D73-491B-B153-7F80E8453720,TCGA-ER-A1A1-10A-01D-A190-02,HG19_Broad_variant,TCGA-ER-A1A1,TCGA-SKCM,NA,s7353,Harvard Medical School,University of Pittsburgh,United States,NO,TX,N3,Not available,Stage IIIC
13722.58cfa830e4b0c9d6adf6babe,58cfa830e4b0c9d6adf6babe,TCGA-AA-A01S-11A-21D-A079_110409_SN590_0077_BB04EHABXX_s_5_rg.sorted.filtered.,WGS,TCGA-AA-A01S-11A-21D-A079_110409_SN590_0077_BB04EHABXX_s_5_rg.sorted,TCGA-AA-A01S-11A-21D-A079_110409_SN590_0077_BB04EHABXX_s_5_rg.sorted.bam,16.83,1.81,0.16,58cfa830e4b0c9d6adf6babe,TCGA-AA-A01S-11A-21D-A079_110409_SN590_0077_BB04EHABXX_s_5_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01S-11A,84E34CF2-B3BB-4A1A-8FB7-6C2C604C4008,Solid Tissue Normal,Illumina HiSeq,272c148a-7ae2-411c-bdcf-153d522ba479,Colorectal,47,1F703295-7062-4692-87CB-1E5204837A60,56C81840-4216-4792-BA0F-8B0973F377E6,TCGA-AA-A01S-11A-21D-A079-02,HG18_Broad_variant,TCGA-AA-A01S,TCGA-COAD,NA,s13382,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage III
13722.58cfa830e4b0c9d6adf6c164,58cfa830e4b0c9d6adf6c164,TCGA-BA-5151-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BA-5151-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_3_rg.sorted,TCGA-BA-5151-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_3_rg.sorted.bam,227.7,1.9,0.15,58cfa830e4b0c9d6adf6c164,TCGA-BA-5151-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5151-01A,A55FB87D-F606-48A5-82F5-09EACBACF41B,Primary Tumor,Illumina HiSeq,d1067ce4-863a-49f4-9061-d2e677695382,Head and Neck,72,63384A6A-9686-44EE-8C8F-22923968C9DE,5B29B8E2-23E6-4E6E-815C-B8D0EF534B14,TCGA-BA-5151-01A-01D-1431-02,HG19_Broad_variant,TCGA-BA-5151,TCGA-HNSC,NA,s15488,Harvard Medical School,UNC,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6c022,58cfa830e4b0c9d6adf6c022,TCGA-BJ-A0ZE-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BJ-A0ZE-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_4_rg.sorted,TCGA-BJ-A0ZE-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_4_rg.sorted.bam,36.9,2.03,0.15,58cfa830e4b0c9d6adf6c022,TCGA-BJ-A0ZE-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0ZE-01A,AB8C9101-ADEB-4C43-A8BB-B089EBD711F6,Primary Tumor,Illumina HiSeq,b215d9c2-6a64-45cf-8e4b-0e2b87207119,Thyroid,63,695C5627-F442-4A86-9702-EF35DEFD8C8C,ED0B1C86-A516-422F-92C4-7C535E709989,TCGA-BJ-A0ZE-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZE,TCGA-THCA,NA,s12231,Harvard Medical School,University of Pittsburgh,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa832e4b0c9d6adf6d14e,58cfa832e4b0c9d6adf6d14e,TCGA-GV-A3JX-10A-01D-A210_120912_SN1222_0148_AC188PACXX_s_2_rg.sorted.filtered.,WGS,TCGA-GV-A3JX-10A-01D-A210_120912_SN1222_0148_AC188PACXX_s_2_rg.sorted,TCGA-GV-A3JX-10A-01D-A210_120912_SN1222_0148_AC188PACXX_s_2_rg.sorted.bam,37.23,NA,0.15,58cfa832e4b0c9d6adf6d14e,TCGA-GV-A3JX-10A-01D-A210_120912_SN1222_0148_AC188PACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GV-A3JX-10A,D9DCBB57-F6C2-4465-8A60-AFE876E113CA,Blood Derived Normal,Illumina HiSeq,4e9101b0-24aa-443e-aabd-2a8d28d2f118,Bladder,59,05D0651A-0DD5-4BD6-A9B3-D0ED340649A4,90D762D5-9001-45D9-9867-E2F0EBBCFB8C,TCGA-GV-A3JX-10A-01D-A210-26,HG19_Broad_variant,TCGA-GV-A3JX,TCGA-BLCA,NA,s2740,MD Anderson - Institute for Applied Cancer Science,BLN - Cleveland Clinic,United States,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6d492,58cfa832e4b0c9d6adf6d492,TCGA-VD-A8K7-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-VD-A8K7-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_8_rg.sorted,TCGA-VD-A8K7-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_8_rg.sorted.bam,11.73,NA,0.14,58cfa832e4b0c9d6adf6d492,TCGA-VD-A8K7-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_8_rg.sorted.bam,Alive,MALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8K7-10A,6103E640-8B62-4E39-908B-B62A0DEBEB0E,Blood Derived Normal,Illumina HiSeq,926668ef-5aff-4e7c-8316-27a0d8271a54,Eye,39,494C0BBB-82D8-4B86-81C5-AAEAC95BFBD7,53880B08-7EBC-4BAA-B92C-D6A42E805908,TCGA-VD-A8K7-10A-01D-A40E-26,HG19_Broad_variant,TCGA-VD-A8K7,TCGA-UVM,NA,s275,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T4a,NX,Not available,Stage IIIA
13722.58cfa832e4b0c9d6adf6d4e2,58cfa832e4b0c9d6adf6d4e2,TCGA-V4-A9EZ-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_7_rg.sorted.filtered.,WGS,TCGA-V4-A9EZ-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_7_rg.sorted,TCGA-V4-A9EZ-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_7_rg.sorted.bam,11.99,NA,0.14,58cfa832e4b0c9d6adf6d4e2,TCGA-V4-A9EZ-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EZ-10A,39E494BC-7710-4F9F-98B0-0F509F7AEF1A,Blood Derived Normal,Illumina HiSeq,49a69d58-72e4-43f1-99cb-1689be923794,Eye,78,825F8A51-66E0-42B7-BE80-4639BC39B365,31310B3F-6936-49C3-A929-3BE145C274D5,TCGA-V4-A9EZ-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9EZ,TCGA-UVM,NA,s200,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3a,N0,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6d352,58cfa832e4b0c9d6adf6d352,TCGA-L5-A43M-11A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-L5-A43M-11A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_8_rg.sorted,TCGA-L5-A43M-11A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_8_rg.sorted.bam,34.97,NA,0.14,58cfa832e4b0c9d6adf6d352,TCGA-L5-A43M-11A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_8_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A43M-11A,29DA08F4-C9E2-4E7A-9733-B4EC5B9C5F13,Solid Tissue Normal,Illumina HiSeq,ec5b6d0d-8ad6-46bd-8732-a65abd993589,Esophagus,84,264FE136-5F49-47FC-8A47-C932B9193E16,C5DDF0EC-CC42-40D1-BFE2-8E50C92D46C6,TCGA-L5-A43M-11A-11D-A248-26,HG19_Broad_variant,TCGA-L5-A43M,TCGA-ESCA,NA,s1650,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T3,N2,Not available,Not available
13722.58cfa830e4b0c9d6adf6bfb4,58cfa830e4b0c9d6adf6bfb4,TCGA-B5-A0JS-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-B5-A0JS-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_3_rg.sorted,TCGA-B5-A0JS-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_3_rg.sorted.bam,8.12,1.94,0.14,58cfa830e4b0c9d6adf6bfb4,TCGA-B5-A0JS-10A-01D-A101_120406_SN208_0282_BC0L15ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0JS-10A,0DA7BBD4-ED8D-474B-B494-CB93C5FA811E,Blood Derived Normal,Illumina HiSeq,c0a0da0a-9cca-4ed6-915b-59f87d57f0b6,Uterus,54,DEAC81F9-E5C9-402A-9B45-121E2C7DCF7A,38161F2E-8148-4B49-A822-CA9F0D0A5CF2,TCGA-B5-A0JS-10A-01D-A101-02,HG19_Broad_variant,TCGA-B5-A0JS,TCGA-UCEC,NA,s5205,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cadc,58cfa831e4b0c9d6adf6cadc,TCGA-DE-A0Y3-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DE-A0Y3-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_6_rg.sorted,TCGA-DE-A0Y3-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_6_rg.sorted.bam,23.61,1.93,0.15,58cfa831e4b0c9d6adf6cadc,TCGA-DE-A0Y3-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_6_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DE-A0Y3-10A,C31B3ADF-3FC6-4A72-83B0-BBC0F295B5E7,Blood Derived Normal,Illumina HiSeq,645c3982-4de8-4fca-b798-0fad3d0c28af,Thyroid,60,2B40DE55-0CBB-44D8-A26F-B48448B32354,7FFF3470-5023-47AE-B166-496D0AB4DE13,TCGA-DE-A0Y3-10A-01D-A10R-02,HG19_Broad_variant,TCGA-DE-A0Y3,TCGA-THCA,NA,s12365,Harvard Medical School,University of North Carolina,United States,NO,T4a,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVC
13722.58cfa830e4b0c9d6adf6c038,58cfa830e4b0c9d6adf6c038,TCGA-AG-3909-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3909-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3909-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,11.59,1.8,0.16,58cfa830e4b0c9d6adf6c038,TCGA-AG-3909-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3909-10A,769880AE-34D9-405E-8EA7-33BA47CF2DD2,Blood Derived Normal,Illumina HiSeq,897a4144-0e3c-4ce6-9031-d32b8f3f18a7,Colorectal,69,1176543D-336D-451F-8A8E-3AC97C76EBEB,FD9134ED-57B7-4220-9F8E-C9AFC2AF6A9E,TCGA-AG-3909-10A-01D-1115-02,HG18,TCGA-AG-3909,TCGA-READ,NA,s2167,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIB
13722.58cfa832e4b0c9d6adf6d65c,58cfa832e4b0c9d6adf6d65c,TCGA-L7-A56G-10A-01D-A267_131001_SN1120_0280_BD2FDEACXX_s_4_rg.sorted.filtered.,WGS,TCGA-L7-A56G-10A-01D-A267_131001_SN1120_0280_BD2FDEACXX_s_4_rg.sorted,TCGA-L7-A56G-10A-01D-A267_131001_SN1120_0280_BD2FDEACXX_s_4_rg.sorted.bam,50.63,NA,0.16,58cfa832e4b0c9d6adf6d65c,TCGA-L7-A56G-10A-01D-A267_131001_SN1120_0280_BD2FDEACXX_s_4_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-L7-A56G-10A,70C5CE85-4022-46C0-8BD0-F5E9009DDF41,Blood Derived Normal,Illumina HiSeq,706e5ae3-7e01-487d-9b3c-a30499801066,Esophagus,65,A113928B-AB74-4561-9143-AAD7CA5BE72B,7F1B3484-A4B4-482F-8852-5AFAA491F8E0,TCGA-L7-A56G-10A-01D-A267-26,HG19_Broad_variant,TCGA-L7-A56G,TCGA-ESCA,NA,s1766,MD Anderson - Institute for Applied Cancer Science,Christiana Care,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa831e4b0c9d6adf6cde0,58cfa831e4b0c9d6adf6cde0,TCGA-EQ-5647-10A-01D-1598_130110_SN1222_0167_AC1JPDACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EQ-5647-10A-01D-1598_130110_SN1222_0167_AC1JPDACXX_s_8_rg.sorted,TCGA-EQ-5647-10A-01D-1598_130110_SN1222_0167_AC1JPDACXX_s_8_rg.sorted.bam,716.4,1.9,0.15,58cfa831e4b0c9d6adf6cde0,TCGA-EQ-5647-10A-01D-1598_130110_SN1222_0167_AC1JPDACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-EQ-5647-10A,2D291FA3-F0FD-4BC1-91A6-783863714190,Blood Derived Normal,Illumina HiSeq,20f56565-871a-4820-bb70-9b7b7e4745e5,Stomach,86,7E8AA1C7-AA0E-4205-914C-A2A48DC11844,D88ABB94-74D3-45D6-BAFB-8158DB1AEA94,TCGA-EQ-5647-10A-01D-1598-02,HG19_Broad_variant,TCGA-EQ-5647,TCGA-STAD,19,s14843,Harvard Medical School,Christiana Healthcare,United States,NO,T4,N3,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa832e4b0c9d6adf6d416,58cfa832e4b0c9d6adf6d416,TCGA-VD-A8K9-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_2_rg.sorted.filtered.,WGS,TCGA-VD-A8K9-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_2_rg.sorted,TCGA-VD-A8K9-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_2_rg.sorted.bam,33.22,NA,0.15,58cfa832e4b0c9d6adf6d416,TCGA-VD-A8K9-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8K9-01A,FA9089FA-9AF9-4932-8AB7-0E7F2FD6B121,Primary Tumor,Illumina HiSeq,bd825a81-851e-4e11-a617-ff32ec721c33,Eye,71,25BDDCB7-2759-42F7-A8EB-D67F0D973802,03211DE4-51EB-4AB9-84CB-30D7A6F12025,TCGA-VD-A8K9-01A-11D-A40D-26,HG19_Broad_variant,TCGA-VD-A8K9,TCGA-UVM,NA,s277,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T2a,NX,Not available,Stage IIA
13722.58cfa832e4b0c9d6adf6d41c,58cfa832e4b0c9d6adf6d41c,TCGA-V4-A9F1-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-V4-A9F1-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_5_rg.sorted,TCGA-V4-A9F1-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_5_rg.sorted.bam,11.73,NA,0.14,58cfa832e4b0c9d6adf6d41c,TCGA-V4-A9F1-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9F1-10A,94F3D9B0-0EE4-4F6A-A8FF-CE7A4D8FAB76,Blood Derived Normal,Illumina HiSeq,dca7eb10-fda3-4ec8-ad7a-f7a42ad867e1,Eye,46,D7AB3182-83ED-4594-9594-B2333C7BF502,A9C18A3D-E88D-4429-8B69-1EAE04C2B305,TCGA-V4-A9F1-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9F1,TCGA-UVM,NA,s243,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3a,N0,Not available,Stage IIB
13722.58cfa830e4b0c9d6adf6be10,58cfa830e4b0c9d6adf6be10,TCGA-BH-A0HX-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BH-A0HX-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_7_rg.sorted,TCGA-BH-A0HX-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_7_rg.sorted.bam,19.84,1.95,0.16,58cfa830e4b0c9d6adf6be10,TCGA-BH-A0HX-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0HX-01A,3B01D064-8C00-4972-9F07-407EAC8E7534,Primary Tumor,Illumina HiSeq,06f7db86-540c-401d-bbd9-0b88698c5f36,Breast,54,989C2DF5-5183-4DAA-A8DA-FC9AB18A437C,11821020-0E93-4479-85F8-306976DE6722,TCGA-BH-A0HX-01A-21D-A060-02,HG19_Broad_variant,TCGA-BH-A0HX,TCGA-BRCA,NA,s6126,Harvard Medical School,University of Pittsburgh,None,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa832e4b0c9d6adf6d4f8,58cfa832e4b0c9d6adf6d4f8,TCGA-L5-A4OT-01A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-L5-A4OT-01A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_7_rg.sorted,TCGA-L5-A4OT-01A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_7_rg.sorted.bam,28.48,NA,0.14,58cfa832e4b0c9d6adf6d4f8,TCGA-L5-A4OT-01A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OT-01A,9559F579-5D9A-4C96-9836-8A039D394795,Primary Tumor,Illumina HiSeq,7d4e10aa-fe0f-4c18-800f-98fde94f819b,Esophagus,77,6671C9B7-5445-40F1-ADB6-FCC8BAD25301,79E420D7-8852-45A0-BBEB-CAEEC5BE685F,TCGA-L5-A4OT-01A-11D-A28P-26,HG19_Broad_variant,TCGA-L5-A4OT,TCGA-ESCA,149,s1927,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T3,N1,Not available,Stage IV
13722.58cfa830e4b0c9d6adf6bff6,58cfa830e4b0c9d6adf6bff6,TCGA-AG-3887-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3887-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3887-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,12.59,1.9,0.17,58cfa830e4b0c9d6adf6bff6,TCGA-AG-3887-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3887-10A,8C7CCDB0-7653-4A8D-86B6-DE39AFC40765,Blood Derived Normal,Illumina HiSeq,aa0d32fd-4a31-43c5-9b23-6a623a285c80,Colorectal,68,52C98B93-E4D6-43AF-A56A-542D7DE940B6,79732BB4-4ACB-47D0-95C0-38D934C99F0D,TCGA-AG-3887-10A-01D-1115-02,HG18,TCGA-AG-3887,TCGA-READ,NA,s1959,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Mucinous Adenocarcinoma,Stage IIA
13722.58cfa82fe4b0c9d6adf6b850,58cfa82fe4b0c9d6adf6b850,TCGA-A6-2671-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-2671-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-2671-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,5,1.9,0.15,58cfa82fe4b0c9d6adf6b850,TCGA-A6-2671-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2671-10A,565E2726-4942-4726-89D3-C5E3797F7204,Blood Derived Normal,Illumina HiSeq,6743db0e-7f17-4758-a3ff-6ca3e2297764,Colorectal,85,BC8A183F-C178-4F6B-AC3F-AEC164B9C0D9,DA65C9D3-62AC-4FB5-B452-1E9C551BA243,TCGA-A6-2671-10A-01D-1405-02,HG18,TCGA-A6-2671,TCGA-COAD,NA,s13501,Harvard Medical School,Christiana Healthcare,None,NO,T3,N2,Colon Adenocarcinoma,Stage IV
13722.58cfa831e4b0c9d6adf6c990,58cfa831e4b0c9d6adf6c990,TCGA-DK-A3IV-10A-01D-A21C_120830_SN590_0177_BD141PACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DK-A3IV-10A-01D-A21C_120830_SN590_0177_BD141PACXX_s_8_rg.sorted,TCGA-DK-A3IV-10A-01D-A21C_120830_SN590_0177_BD141PACXX_s_8_rg.sorted.bam,26.36,NA,0.16,58cfa831e4b0c9d6adf6c990,TCGA-DK-A3IV-10A-01D-A21C_120830_SN590_0177_BD141PACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3IV-10A,F953DC5D-58BF-4936-B9FE-74B45E8C00E5,Blood Derived Normal,Illumina HiSeq,0e2f8cf4-b42d-4b2c-a2f1-68e364dd633d,Bladder,60,D089CB7E-CD56-4438-87F9-281BE9A22A7F,C1FFB644-C8B5-4873-A844-768425004971,TCGA-DK-A3IV-10A-01D-A21C-26,HG19_Broad_variant,TCGA-DK-A3IV,TCGA-BLCA,294,s2717,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa830e4b0c9d6adf6c1c6,58cfa830e4b0c9d6adf6c1c6,TCGA-BG-A0M2-10A-02D-A101_120406_SN1120_0130_AD0UKGACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BG-A0M2-10A-02D-A101_120406_SN1120_0130_AD0UKGACXX_s_2_rg.sorted,TCGA-BG-A0M2-10A-02D-A101_120406_SN1120_0130_AD0UKGACXX_s_2_rg.sorted.bam,8.71,1.91,0.13,58cfa830e4b0c9d6adf6c1c6,TCGA-BG-A0M2-10A-02D-A101_120406_SN1120_0130_AD0UKGACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0M2-10A,9731E0B3-C62D-43CB-8AE7-8F973D69AB19,Blood Derived Normal,Illumina HiSeq,b02fc796-b592-46f5-8222-5a702393c7cb,Uterus,62,56931C60-F82B-4F1F-8C4F-547B7EFCFF0B,115C6BD3-1D4D-481F-A939-2B5D0F89BD7F,TCGA-BG-A0M2-10A-02D-A101-02,HG19_Broad_variant,TCGA-BG-A0M2,TCGA-UCEC,NA,s5214,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6cf06,58cfa832e4b0c9d6adf6cf06,TCGA-H2-A3RI-10A-01D-A221_120610_SN1120_0152_BD13TDACXX_s_5_rg.sorted.filtered.,WGS,TCGA-H2-A3RI-10A-01D-A221_120610_SN1120_0152_BD13TDACXX_s_5_rg.sorted,TCGA-H2-A3RI-10A-01D-A221_120610_SN1120_0152_BD13TDACXX_s_5_rg.sorted.bam,131.92,NA,0.16,58cfa832e4b0c9d6adf6cf06,TCGA-H2-A3RI-10A-01D-A221_120610_SN1120_0152_BD13TDACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-H2-A3RI-10A,BF193C4F-FBAC-41BC-B1AF-19B6CE856F0F,Blood Derived Normal,Illumina HiSeq,20e68fc9-4df9-4048-8ef9-981ac5307c3d,Thyroid,29,4D71C092-3156-4518-A533-78EA2D15C800,2B23C8F1-24F6-44C0-BE5D-403419E75FFA,TCGA-H2-A3RI-10A-01D-A221-26,HG19_Broad_variant,TCGA-H2-A3RI,TCGA-THCA,NA,s12393,MD Anderson - Institute for Applied Cancer Science,Christiana Healthcare,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa830e4b0c9d6adf6bf30,58cfa830e4b0c9d6adf6bf30,TCGA-BR-4191-01A-02D-1128_120805_SN1222_0143_BD172BACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BR-4191-01A-02D-1128_120805_SN1222_0143_BD172BACXX_s_3_rg.sorted,TCGA-BR-4191-01A-02D-1128_120805_SN1222_0143_BD172BACXX_s_3_rg.sorted.bam,266.9,1.9,0.15,58cfa830e4b0c9d6adf6bf30,TCGA-BR-4191-01A-02D-1128_120805_SN1222_0143_BD172BACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4191-01A,74F859CF-6DF5-4E96-AE6B-CFAAB691D5FD,Primary Tumor,Illumina HiSeq,d71fa3ea-a7fb-40af-a7b9-64ceca39e135,Stomach,72,E5A1A598-5896-46F9-8DCA-BA19AC138D14,125C563B-A1CE-4FFC-8D8D-19C7CA2E1049,TCGA-BR-4191-01A-02D-1128-02,HG19_Broad_variant,TCGA-BR-4191,TCGA-STAD,NA,s14608,Harvard Medical School,Asterand,Russia,NO,TX,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa832e4b0c9d6adf6d5a8,58cfa832e4b0c9d6adf6d5a8,TCGA-LN-A49S-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-LN-A49S-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_5_rg.sorted,TCGA-LN-A49S-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_5_rg.sorted.bam,29.69,NA,0.17,58cfa832e4b0c9d6adf6d5a8,TCGA-LN-A49S-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_5_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49S-01A,E9F82800-647A-4D61-BD1F-2C17C4CCAFBA,Primary Tumor,Illumina HiSeq,f173addf-1b74-441d-b167-5eb17cdfe1c3,Esophagus,59,A83FF623-8AF0-44A9-8468-95457A017E5A,151B9A13-9D3D-4AF2-A779-24F62A13975B,TCGA-LN-A49S-01A-11D-A248-26,HG19_Broad_variant,TCGA-LN-A49S,TCGA-ESCA,NA,s1680,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6c5b6,58cfa831e4b0c9d6adf6c5b6,TCGA-CG-4301-10A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CG-4301-10A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_2_rg.sorted,TCGA-CG-4301-10A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_2_rg.sorted.bam,80.6,1.9,0.15,58cfa831e4b0c9d6adf6c5b6,TCGA-CG-4301-10A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4301-10A,7E13FE2A-3D6E-487F-900D-F5891D986AA2,Blood Derived Normal,Illumina HiSeq,d5252a57-94a3-4451-967d-5b96d5c139b4,Stomach,75,7189941F-88C7-4E4A-94E9-D9E9EBEE1CDE,0F357403-8DB7-4D4F-913B-F2D4658224D8,TCGA-CG-4301-10A-01D-A326-26,HG19_Broad_variant,TCGA-CG-4301,TCGA-STAD,NA,s14481,MD Anderson - Institute for Applied Cancer Science,Indivumed,Germany,NO,T4,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa831e4b0c9d6adf6c7ac,58cfa831e4b0c9d6adf6c7ac,TCGA-D6-6827-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D6-6827-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_4_rg.sorted,TCGA-D6-6827-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_4_rg.sorted.bam,262.7,1.9,0.14,58cfa831e4b0c9d6adf6c7ac,TCGA-D6-6827-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-D6-6827-01A,3C5BC678-41E9-46B3-9686-5CD95659AB71,Primary Tumor,Illumina HiSeq,849f41d7-0557-40ce-bca0-8a54c496fef2,Head and Neck,55,C53D6135-C614-45F4-8F41-49B20ED4A549,E2CDC496-8A62-4501-98C0-2AF2CCF48988,TCGA-D6-6827-01A-11D-1911-02,HG19_Broad_variant,TCGA-D6-6827,TCGA-HNSC,NA,s16057,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c485,58cfa831e4b0c9d6adf6c485,TCGA-CM-4752-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-CM-4752-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-CM-4752-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,846.02,1.9,0.15,58cfa831e4b0c9d6adf6c485,TCGA-CM-4752-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-CM-4752-01A,7EA546CE-F48A-4D9C-96B4-A0124C692870,Primary Tumor,Illumina HiSeq,ad469933-d84b-4305-85e2-a7d919298b71,Colorectal,58,5703F0D8-DB96-40CE-8009-51D2EC188ABF,43756C1F-6ED2-468B-B0AD-D44A447C7709,TCGA-CM-4752-01A-01D-1405-02,HG18,TCGA-CM-4752,TCGA-COAD,NA,s13219,Harvard Medical School,MSKCC,None,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6bf0e,58cfa830e4b0c9d6adf6bf0e,TCGA-BR-4183-11A-01D-1128_120807_SN590_0174_BC11N6ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BR-4183-11A-01D-1128_120807_SN590_0174_BC11N6ACXX_s_8_rg.sorted,TCGA-BR-4183-11A-01D-1128_120807_SN590_0174_BC11N6ACXX_s_8_rg.sorted.bam,174.9,1.9,0.16,58cfa830e4b0c9d6adf6bf0e,TCGA-BR-4183-11A-01D-1128_120807_SN590_0174_BC11N6ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4183-11A,33503349-BA7A-43F4-BCB2-AC8D16808432,Solid Tissue Normal,Illumina HiSeq,29ec7ccd-2408-49f4-a189-cc1afd540e0c,Stomach,55,2846005F-B9E8-432F-91F6-2D9DE5D80943,612DD500-0EBB-4FA1-B929-F4B2ABC28B06,TCGA-BR-4183-11A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4183,TCGA-STAD,NA,s14879,Harvard Medical School,Asterand,Russia,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6c604,58cfa831e4b0c9d6adf6c604,TCGA-CQ-5330-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CQ-5330-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_4_rg.sorted,TCGA-CQ-5330-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_4_rg.sorted.bam,258,1.9,0.14,58cfa831e4b0c9d6adf6c604,TCGA-CQ-5330-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-5330-01A,9FFA79FA-D2D8-48E1-8FD6-4B020ECF357C,Primary Tumor,Illumina HiSeq,a37f15ec-e0df-4bcd-8275-88312d0a1566,Head and Neck,69,A70301B0-F66D-49B7-B420-C1F56B90002D,AB6DC814-ECE0-497C-BC58-5FECE5D3DCE6,TCGA-CQ-5330-01A-01D-1681-02,HG19_Broad_variant,TCGA-CQ-5330,TCGA-HNSC,NA,s15640,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6d360,58cfa832e4b0c9d6adf6d360,TCGA-L5-A4OP-11A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_2_rg.sorted.filtered.,WGS,TCGA-L5-A4OP-11A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_2_rg.sorted,TCGA-L5-A4OP-11A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_2_rg.sorted.bam,18.66,NA,0.16,58cfa832e4b0c9d6adf6d360,TCGA-L5-A4OP-11A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OP-11A,97031483-1185-41D6-9722-0A03B63CAA19,Solid Tissue Normal,Illumina HiSeq,6e4456e2-e01b-4589-8383-79dff4c0bf2b,Esophagus,67,81E97DF8-7363-46B0-8150-D1993E54F8CF,EA1709B6-7F44-45CA-AF7D-954C1B181799,TCGA-L5-A4OP-11A-11D-A267-26,HG19_Broad_variant,TCGA-L5-A4OP,TCGA-ESCA,NA,s1920,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T1,N0,Not available,Stage IA
13722.58cfa831e4b0c9d6adf6cba7,58cfa831e4b0c9d6adf6cba7,TCGA-EK-A2RN-10A-01D-A20X_140117_SN590_0246_BC37BDACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EK-A2RN-10A-01D-A20X_140117_SN590_0246_BC37BDACXX_s_5_rg.sorted,TCGA-EK-A2RN-10A-01D-A20X_140117_SN590_0246_BC37BDACXX_s_5_rg.sorted.bam,16.01,NA,0.17,58cfa831e4b0c9d6adf6cba7,TCGA-EK-A2RN-10A-01D-A20X_140117_SN590_0246_BC37BDACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2RN-10A,B610D391-0C9D-4114-94D6-5E4AA4270122,Blood Derived Normal,Illumina HiSeq,2fca04bd-9b4b-4ad4-b36c-b9e0f2a2fcac,Cervix,45,C44B832D-9F76-4EA3-9CB8-9F51465D605A,D36BBDC2-AAB8-4221-A25F-5D2E6F4EA346,TCGA-EK-A2RN-10A-01D-A20X-26,HG19_Broad_variant,TCGA-EK-A2RN,TCGA-CESC,NA,s1188,MD Anderson - Institute for Applied Cancer Science,Gynecologic Oncology Group,United States,NO,T2b,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d388,58cfa832e4b0c9d6adf6d388,TCGA-L5-A4OP-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_1_rg.sorted.filtered.,WGS,TCGA-L5-A4OP-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_1_rg.sorted,TCGA-L5-A4OP-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_1_rg.sorted.bam,41.04,NA,0.17,58cfa832e4b0c9d6adf6d388,TCGA-L5-A4OP-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OP-01A,97031483-1185-41D6-9722-0A03B63CAA19,Primary Tumor,Illumina HiSeq,940f64ee-414a-4190-9fc9-c697ad112dfe,Esophagus,67,BA02D5B4-9CA9-4455-81D4-E5F2C8C0DF74,5D8E8DA5-04FF-4548-96EC-AE1E80C57CD1,TCGA-L5-A4OP-01A-11D-A267-26,HG19_Broad_variant,TCGA-L5-A4OP,TCGA-ESCA,NA,s1923,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T1,N0,Not available,Stage IA
13722.58cfa832e4b0c9d6adf6d5db,58cfa832e4b0c9d6adf6d5db,TCGA-LN-A49S-10A-01D-A248_121207_SN1222_0162_BD1MA7ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-LN-A49S-10A-01D-A248_121207_SN1222_0162_BD1MA7ACXX_s_6_rg.sorted,TCGA-LN-A49S-10A-01D-A248_121207_SN1222_0162_BD1MA7ACXX_s_6_rg.sorted.bam,31.72,NA,0.16,58cfa832e4b0c9d6adf6d5db,TCGA-LN-A49S-10A-01D-A248_121207_SN1222_0162_BD1MA7ACXX_s_6_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49S-10A,E9F82800-647A-4D61-BD1F-2C17C4CCAFBA,Blood Derived Normal,Illumina HiSeq,a7ead9a6-0126-423e-9883-34764ed611ea,Esophagus,59,E4EDE1CD-18C5-49CD-99F2-D36EFA410FA1,3F24214C-86AA-4262-92C4-50717808F783,TCGA-LN-A49S-10A-01D-A248-26,HG19_Broad_variant,TCGA-LN-A49S,TCGA-ESCA,NA,s1675,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa832e4b0c9d6adf6cf59,58cfa832e4b0c9d6adf6cf59,TCGA-GN-A266-06A-11D-A18Y_120602_SN208_0304_BC0WTWACXX_s_1_rg.sorted.filtered.,WGS,TCGA-GN-A266-06A-11D-A18Y_120602_SN208_0304_BC0WTWACXX_s_1_rg.sorted,TCGA-GN-A266-06A-11D-A18Y_120602_SN208_0304_BC0WTWACXX_s_1_rg.sorted.bam,47.6,NA,0.15,58cfa832e4b0c9d6adf6cf59,TCGA-GN-A266-06A-11D-A18Y_120602_SN208_0304_BC0WTWACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-GN-A266-06A,3429967F-4F77-4894-BF27-C4A22698CA92,Metastatic,Illumina HiSeq,faac710c-c974-41c3-ba2d-102952992342,Skin,45,EA59B74A-7456-43DD-B79C-74040176F0CD,E13423F1-89D5-41CC-9E1F-B2E8B1F42F25,TCGA-GN-A266-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-GN-A266,TCGA-SKCM,308,s7376,Harvard Medical School,Roswell,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa831e4b0c9d6adf6c36c,58cfa831e4b0c9d6adf6c36c,TCGA-CD-5803-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CD-5803-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_8_rg.sorted,TCGA-CD-5803-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_8_rg.sorted.bam,193.3,1.9,0.14,58cfa831e4b0c9d6adf6c36c,TCGA-CD-5803-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_8_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-5803-01A,33901C6F-9180-4A19-866C-F4AC6BEC76DA,Primary Tumor,Illumina HiSeq,1002025d-03b9-46ab-988a-576f59957cac,Stomach,78,EB71264D-C896-4910-BF46-D6F129B83941,EABD49CE-0F0C-443D-9BF4-0ADD2C2532B2,TCGA-CD-5803-01A-11D-1598-02,HG19_Broad_variant,TCGA-CD-5803,TCGA-STAD,NA,s15118,Harvard Medical School,ILSbio,Vietnam,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa830e4b0c9d6adf6c2ca,58cfa830e4b0c9d6adf6c2ca,TCGA-BG-A0RY-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BG-A0RY-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_7_rg.sorted,TCGA-BG-A0RY-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_7_rg.sorted.bam,73.32,1.95,0.16,58cfa830e4b0c9d6adf6c2ca,TCGA-BG-A0RY-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0RY-01A,F299AD43-BB16-46CE-9617-48CC6C6F29E7,Primary Tumor,Illumina HiSeq,5464e1b6-9efc-49a0-bd5b-4fcd152a7718,Uterus,68,260692E1-9B2C-4F8B-952D-1B95C042E659,8DB9ED84-C708-4075-B93D-CC58E84E6D99,TCGA-BG-A0RY-01A-11D-A101-02,HG19_Broad_variant,TCGA-BG-A0RY,TCGA-UCEC,NA,s4258,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bd72,58cfa830e4b0c9d6adf6bd72,TCGA-AA-A01K-10A-01D-A078_110409_SN590_0076_AB04G5ABXX_s_8.rg.sorted.filtered.,WGS,TCGA-AA-A01K-10A-01D-A078_110409_SN590_0076_AB04G5ABXX_s_8.rg.sorted,TCGA-AA-A01K-10A-01D-A078_110409_SN590_0076_AB04G5ABXX_s_8.rg.sorted.bam,11.63,1.75,0.15,58cfa830e4b0c9d6adf6bd72,TCGA-AA-A01K-10A-01D-A078_110409_SN590_0076_AB04G5ABXX_s_8.rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01K-10A,A72DD578-3A6F-4807-A843-4A942500944E,Blood Derived Normal,Illumina HiSeq,4d29a7d1-b004-42ad-a291-1eed2ad67b3c,Colorectal,74,A76B2563-5D11-4A5C-846B-6B5A1539FCA9,A99DF831-6313-455E-9180-77C0A9743248,TCGA-AA-A01K-10A-01D-A078-02,HG18_Broad_variant,TCGA-AA-A01K,TCGA-COAD,NA,s12882,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Colon Adenocarcinoma,Stage IIIC
13722.58cfa831e4b0c9d6adf6c36d,58cfa831e4b0c9d6adf6c36d,TCGA-CD-5802-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CD-5802-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_7_rg.sorted,TCGA-CD-5802-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_7_rg.sorted.bam,199,2,0.17,58cfa831e4b0c9d6adf6c36d,TCGA-CD-5802-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_7_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-5802-01A,0AECAC64-5982-4D76-8F31-958F6A00951D,Primary Tumor,Illumina HiSeq,43a17980-59c7-4b7c-a3a6-9ed51fb03889,Stomach,58,93C38FFB-27AC-4C91-939D-7102EE72F404,B0BEA59D-9484-4FF9-BC14-0DD1882EF6BE,TCGA-CD-5802-01A-11D-1598-02,HG19_Broad_variant,TCGA-CD-5802,TCGA-STAD,NA,s14477,Harvard Medical School,ILSbio,Vietnam,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa831e4b0c9d6adf6cdf8,58cfa831e4b0c9d6adf6cdf8,TCGA-FS-A1YX-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_7_rg.sorted.filtered.,WGS,TCGA-FS-A1YX-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_7_rg.sorted,TCGA-FS-A1YX-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_7_rg.sorted.bam,39,NA,0.17,58cfa831e4b0c9d6adf6cdf8,TCGA-FS-A1YX-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1YX-10A,4537C0E1-B2BD-425F-A6F4-27F4733DC25A,Blood Derived Normal,Illumina HiSeq,a2b998a3-6ed9-4244-b31a-5c256868a3d8,Skin,39,7FD6C9CC-CA57-4F01-AE4F-7F097B7017D1,3248BAFD-512C-4096-956F-B4FEFC4C4394,TCGA-FS-A1YX-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1YX,TCGA-SKCM,1478,s7525,Harvard Medical School,Essen,Germany,NO,T2,N0,Not available,Stage I
13722.58cfa832e4b0c9d6adf6d5f8,58cfa832e4b0c9d6adf6d5f8,TCGA-LN-A49K-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-LN-A49K-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_1_rg.sorted,TCGA-LN-A49K-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_1_rg.sorted.bam,28.24,NA,0.15,58cfa832e4b0c9d6adf6d5f8,TCGA-LN-A49K-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_1_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49K-01A,0F06153A-0F28-4A7E-9E81-1E0B3F4412AB,Primary Tumor,Illumina HiSeq,acf1b0d3-d28b-4f31-acbc-52f1f4e5dca1,Esophagus,66,F60AAA21-7D4E-4988-94BD-69F0929560A5,E09E9D66-13C9-481C-BAE1-C5DF26292666,TCGA-LN-A49K-01A-11D-A248-26,HG19_Broad_variant,TCGA-LN-A49K,TCGA-ESCA,NA,s1666,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6cb48,58cfa831e4b0c9d6adf6cb48,TCGA-EE-A29S-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EE-A29S-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_5_rg.sorted,TCGA-EE-A29S-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_5_rg.sorted.bam,34.67,NA,0.17,58cfa831e4b0c9d6adf6cb48,TCGA-EE-A29S-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29S-06A,5DEC1B6A-5D60-463C-9655-FC7ED79CA19D,Metastatic,Illumina HiSeq,b6eef3eb-6a3c-4010-a637-48540f303a1c,Skin,79,4EA37293-D9B4-4231-A283-6839810566D9,512F2D57-71FC-4050-AD4F-FBCC6EA2E687,TCGA-EE-A29S-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A29S,TCGA-SKCM,NA,s7675,Harvard Medical School,University of Sydney,Australia,NO,T3a,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6cc4e,58cfa831e4b0c9d6adf6cc4e,TCGA-DU-7007-01A-11D-2022_130910_SN208_0494_AC2A1DACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DU-7007-01A-11D-2022_130910_SN208_0494_AC2A1DACXX_s_7_rg.sorted,TCGA-DU-7007-01A-11D-2022_130910_SN208_0494_AC2A1DACXX_s_7_rg.sorted.bam,200.7,NA,0.17,58cfa831e4b0c9d6adf6cc4e,TCGA-DU-7007-01A-11D-2022_130910_SN208_0494_AC2A1DACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7007-01A,8E2DCC00-9F7E-4DEE-B24D-43C8B30294C5,Primary Tumor,Illumina HiSeq,84edb90d-0a24-46dd-bed3-126c5fdcda42,Brain,33,E8E363D0-D9EA-478F-880C-7ADED5846237,A15321DD-20AE-4D64-9D89-C64A92468ECA,TCGA-DU-7007-01A-11D-2022-02,HG19_Broad_variant,TCGA-DU-7007,TCGA-LGG,1915,s8352,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa830e4b0c9d6adf6bd7c,58cfa830e4b0c9d6adf6bd7c,TCGA-BF-A1PV-01A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BF-A1PV-01A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_1_rg.sorted,TCGA-BF-A1PV-01A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_1_rg.sorted.bam,78.67,NA,0.17,58cfa830e4b0c9d6adf6bd7c,TCGA-BF-A1PV-01A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Skin Cutaneous Melanoma,Aligned reads,TCGA-BF-A1PV-01A,EFF78AF6-0F68-49B9-866B-0D511606F2B1,Primary Tumor,Illumina HiSeq,a219d21e-e657-407a-8e8f-aba8b0190425,Skin,74,090DEBB2-290D-49DD-B642-7F01C99A795C,BC0B690D-7C05-4B68-B2F2-5D38EA621A02,TCGA-BF-A1PV-01A-11D-A18Z-02,HG19_Broad_variant,TCGA-BF-A1PV,TCGA-SKCM,NA,s7491,Harvard Medical School,Cureline,Russia,NO,T4b,N0,Not available,Stage IIC
13722.58cfa82fe4b0c9d6adf6b70e,58cfa82fe4b0c9d6adf6b70e,TCGA-73-4668-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-73-4668-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-73-4668-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,111.9,1.9,0.15,58cfa82fe4b0c9d6adf6b70e,TCGA-73-4668-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4668-11A,B2285924-9813-4F46-BB8F-91A0EFD8A9B6,Solid Tissue Normal,Illumina HiSeq,c21a88c1-b349-46d8-8008-d9bc9b8cf337,Lung,66,8E273348-F4DA-41D4-8FEA-080222382FFA,79FEE508-0F2C-4825-BD6B-32CB6ACC6F83,TCGA-73-4668-11A-01D-1203-02,GRCh37,TCGA-73-4668,TCGA-LUAD,NA,s11353,Harvard Medical School,Roswell Park,United States,NO,T2,N1,Lung Micropapillary Adenocarcinoma,Stage IIB
13722.58cfa830e4b0c9d6adf6bcd2,58cfa830e4b0c9d6adf6bcd2,TCGA-AZ-4684-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AZ-4684-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-AZ-4684-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,80.72,1.9,0.14,58cfa830e4b0c9d6adf6bcd2,TCGA-AZ-4684-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-4684-10A,CAC80259-3A26-4A99-B0D3-13454068E6ED,Blood Derived Normal,Illumina HiSeq,058fc621-f56b-4373-bed9-e77a7ab13be4,Colorectal,49,8FBA5B6B-6883-4617-B1D9-B1063BCCDC12,B1BFE1F0-9C46-492D-8BA8-3B5451248B77,TCGA-AZ-4684-10A-01D-1405-02,HG18,TCGA-AZ-4684,TCGA-COAD,NA,s13036,Harvard Medical School,University of Pittsburgh,None,NO,T3,N2,Colon Adenocarcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6ca25,58cfa831e4b0c9d6adf6ca25,TCGA-DE-A0Y2-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DE-A0Y2-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_3_rg.sorted,TCGA-DE-A0Y2-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_3_rg.sorted.bam,63,2.03,0.14,58cfa831e4b0c9d6adf6ca25,TCGA-DE-A0Y2-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DE-A0Y2-01A,6AD260AD-769A-4F3C-BD07-927ADF6B2338,Primary Tumor,Illumina HiSeq,eaf940db-08d0-4dc4-b390-0576523fb2f5,Thyroid,30,EB4FEEBB-293E-43E3-A2ED-344B17D180B3,E86091EB-6DCC-479B-BAFD-3DABA65787EC,TCGA-DE-A0Y2-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DE-A0Y2,TCGA-THCA,NA,s12514,Harvard Medical School,University of North Carolina,United States,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa830e4b0c9d6adf6bbc4,58cfa830e4b0c9d6adf6bbc4,TCGA-AG-A008-01A-01D-A077-02_110217_SN208_0190_B81CLKABXX_s_7.rg.sorted.filtered.,WGS,TCGA-AG-A008-01A-01D-A077-02_110217_SN208_0190_B81CLKABXX_s_7.rg.sorted,TCGA-AG-A008-01A-01D-A077-02_110217_SN208_0190_B81CLKABXX_s_7.rg.sorted.bam,174.93,1.72,0.15,58cfa830e4b0c9d6adf6bbc4,TCGA-AG-A008-01A-01D-A077-02_110217_SN208_0190_B81CLKABXX_s_7.rg.sorted.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A008-01A,E7503A51-6647-4CC2-80DD-645D0DF4DB43,Primary Tumor,Illumina HiSeq,e31d4ba3-4d48-4e50-9932-05a2978a90df,Colorectal,50,AC02CD55-BC05-4329-8845-E09D088E3CB4,999D82E8-B92F-4397-A9F9-9AFBFD8A249C,TCGA-AG-A008-01A-01D-A077-02,HG18_Broad_variant,TCGA-AG-A008,TCGA-READ,NA,s1995,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Rectal Mucinous Adenocarcinoma,Stage I
13722.58cfa830e4b0c9d6adf6c12f,58cfa830e4b0c9d6adf6c12f,TCGA-BG-A0MU-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BG-A0MU-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_1_rg.sorted,TCGA-BG-A0MU-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_1_rg.sorted.bam,74.26,2.08,0.16,58cfa830e4b0c9d6adf6c12f,TCGA-BG-A0MU-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0MU-01A,A7329910-B1C7-4A18-B28E-8FAD79121339,Primary Tumor,Illumina HiSeq,c676fa46-db3a-402d-804d-9717141fdae6,Uterus,78,F0AF3F30-3D64-4BD8-9A8F-7FF7AB9BB7B0,0BB10C9F-C337-4E2E-A661-9CE12C8BEB35,TCGA-BG-A0MU-01A-11D-A101-02,HG19_Broad_variant,TCGA-BG-A0MU,TCGA-UCEC,NA,s5393,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aeda,58cfa82ee4b0c9d6adf6aeda,TCGA-05-4397-10A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_8_rg.sorted.filtered.,WGS,TCGA-05-4397-10A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_8_rg.sorted,TCGA-05-4397-10A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_8_rg.sorted.bam,256.93,1.9,0.15,58cfa82ee4b0c9d6adf6aeda,TCGA-05-4397-10A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_8_rg.sorted.bam,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4397-10A,6DFD47D2-831A-4386-9051-F78199A16BB5,Blood Derived Normal,Illumina HiSeq,6be1b088-22a4-428b-be61-923f6c558318,Lung,65,E9F8F56D-E3A6-4F92-807A-99BD857CAD8A,448DEB16-395E-480B-A492-374FFD9579FD,TCGA-05-4397-10A-01D-1203-02,HG19_Broad_variant,TCGA-05-4397,TCGA-LUAD,731,s11434,Harvard Medical School,Indivumed,Germany,NO,T2,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIB
13722.58cfa82fe4b0c9d6adf6b730,58cfa82fe4b0c9d6adf6b730,TCGA-44-3919-11A-01D-1103_110707_SN590_0095_BD0D4KABXX_s_6_rg.sorted.filtered.,WGS,TCGA-44-3919-11A-01D-1103_110707_SN590_0095_BD0D4KABXX_s_6_rg.sorted,TCGA-44-3919-11A-01D-1103_110707_SN590_0095_BD0D4KABXX_s_6_rg.sorted.bam,569.93,1.9,0.14,58cfa82fe4b0c9d6adf6b730,TCGA-44-3919-11A-01D-1103_110707_SN590_0095_BD0D4KABXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-3919-11A,66ED89F6-8BA2-49D0-AF0F-4B6EBF2381BF,Solid Tissue Normal,Illumina HiSeq,0b6ce057-abf2-4149-a103-a243ae3d9354,Lung,71,6C4744D1-7AAF-4A93-8C76-82B253C39EFC,7186DA3A-2D33-4087-9B1F-541223684945,TCGA-44-3919-11A-01D-1103-02,HG19_Broad_variant,TCGA-44-3919,TCGA-LUAD,NA,s11547,Harvard Medical School,Christiana Healthcare,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6c6c3,58cfa831e4b0c9d6adf6c6c3,TCGA-CU-A3QU-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CU-A3QU-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_1_rg.sorted,TCGA-CU-A3QU-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_1_rg.sorted.bam,73.31,NA,0.15,58cfa831e4b0c9d6adf6c6c3,TCGA-CU-A3QU-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CU-A3QU-01A,AE6D853B-A7F0-4465-B7BF-5A45006AB3B3,Primary Tumor,Illumina HiSeq,c4c9ea17-be51-4e92-8cdc-0d5880def11c,Bladder,58,75448068-DED8-42F0-BB99-6D1C4B3FFA4E,98A4CFCF-34FE-433A-A598-4191742DC977,TCGA-CU-A3QU-01A-11D-A233-26,HG19_Broad_variant,TCGA-CU-A3QU,TCGA-BLCA,NA,s3278,MD Anderson - Institute for Applied Cancer Science,UNC,United States,NO,T2b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6d266,58cfa832e4b0c9d6adf6d266,TCGA-HT-7472-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_8_rg.sorted.filtered.,WGS,TCGA-HT-7472-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_8_rg.sorted,TCGA-HT-7472-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_8_rg.sorted.bam,312,NA,0.15,58cfa832e4b0c9d6adf6d266,TCGA-HT-7472-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7472-10A,482D4078-7576-48CF-BF7C-29014935FD47,Blood Derived Normal,Illumina HiSeq,480868bd-a33a-4c42-855e-c6bfafe22ecb,Brain,38,7F8D24AB-5E9D-4AFF-9B0B-EB2BFAD0509E,0FF070CF-955D-40C8-8BD0-1475E3AA49F8,TCGA-HT-7472-10A-01D-2022-02,HG19_Broad_variant,TCGA-HT-7472,TCGA-LGG,NA,s8151,Harvard Medical School,Case Western - St Joes,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa832e4b0c9d6adf6d220,58cfa832e4b0c9d6adf6d220,TCGA-HR-A2OG-01A-21D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_2_rg.sorted.filtered.,WGS,TCGA-HR-A2OG-01A-21D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_2_rg.sorted,TCGA-HR-A2OG-01A-21D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_2_rg.sorted.bam,45,NA,0.15,58cfa832e4b0c9d6adf6d220,TCGA-HR-A2OG-01A-21D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Skin Cutaneous Melanoma,Aligned reads,TCGA-HR-A2OG-06A,021D32B0-A94A-4DAD-95F4-8EB0ABD894BF,Metastatic,Illumina HiSeq,714a155f-a1c4-4187-87f5-bcfe1d63b0dc,Skin,50,4DEB7C12-15A2-456D-B46B-B70B29AE3EEC,7ED57F3A-334B-465C-A179-632F84FCD10E,TCGA-HR-A2OG-06A-21D-A18Y-02,HG19_Broad_variant,TCGA-HR-A2OG,TCGA-SKCM,NA,s8033,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,Not available,Not available,Not available,Not available
13722.58cfa832e4b0c9d6adf6d623,58cfa832e4b0c9d6adf6d623,TCGA-LN-A49K-10A-01D-A248_121207_SN1222_0162_BD1MA7ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-LN-A49K-10A-01D-A248_121207_SN1222_0162_BD1MA7ACXX_s_2_rg.sorted,TCGA-LN-A49K-10A-01D-A248_121207_SN1222_0162_BD1MA7ACXX_s_2_rg.sorted.bam,57.83,NA,0.15,58cfa832e4b0c9d6adf6d623,TCGA-LN-A49K-10A-01D-A248_121207_SN1222_0162_BD1MA7ACXX_s_2_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49K-10A,0F06153A-0F28-4A7E-9E81-1E0B3F4412AB,Blood Derived Normal,Illumina HiSeq,46d097ad-5e48-435e-8808-ee5f3b5cf5d1,Esophagus,66,5D06E974-5364-4B48-8A28-3F7BF18411B6,17AFE08B-44FB-4E24-9463-D864B3A1980F,TCGA-LN-A49K-10A-01D-A248-26,HG19_Broad_variant,TCGA-LN-A49K,TCGA-ESCA,NA,s1758,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6c9ce,58cfa831e4b0c9d6adf6c9ce,TCGA-DK-A3WY-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DK-A3WY-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_7_rg.sorted,TCGA-DK-A3WY-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_7_rg.sorted.bam,13.9,NA,0.15,58cfa831e4b0c9d6adf6c9ce,TCGA-DK-A3WY-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3WY-01A,9BB5D187-033E-4E86-A76E-E1A6D20488F7,Primary Tumor,Illumina HiSeq,ae1b3911-b342-4886-b75a-3e9be21dae41,Bladder,67,33D579B3-198D-46CA-B2CF-574A0673E26F,ABA3AF01-2CBD-4450-9CCB-698DF8982E91,TCGA-DK-A3WY-01A-11D-A233-26,HG19_Broad_variant,TCGA-DK-A3WY,TCGA-BLCA,NA,s2895,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c5e4,58cfa831e4b0c9d6adf6c5e4,TCGA-CG-4437-01A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CG-4437-01A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_4_rg.sorted,TCGA-CG-4437-01A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_4_rg.sorted.bam,215.4,1.9,0.14,58cfa831e4b0c9d6adf6c5e4,TCGA-CG-4437-01A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_4_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4437-01A,6244E506-D163-4D34-8FEC-6158191679CB,Primary Tumor,Illumina HiSeq,ff02c427-3a7b-4e29-9ddc-0b8034807ad6,Stomach,83,A882F6C0-D12D-4D49-9A2A-3850EA736C37,B6D1C576-6AB8-4759-B1B0-6E18DC162962,TCGA-CG-4437-01A-01D-1798-02,HG19_Broad_variant,TCGA-CG-4437,TCGA-STAD,NA,s14553,Harvard Medical School,Indivumed,Germany,NO,T2,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa832e4b0c9d6adf6ce0e,58cfa832e4b0c9d6adf6ce0e,TCGA-FD-A3N5-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FD-A3N5-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_5_rg.sorted,TCGA-FD-A3N5-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_5_rg.sorted.bam,30.45,NA,0.15,58cfa832e4b0c9d6adf6ce0e,TCGA-FD-A3N5-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_5_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3N5-01A,A658BECF-3934-49F2-9E74-291DCA61D4BB,Primary Tumor,Illumina HiSeq,b9214ac8-956d-471d-8cad-a44ddc8825e8,Bladder,69,66559B5F-AB2F-406B-9EDB-0F5085EEC7C5,BA548041-624F-4357-A9F9-3BE29A3FF4FD,TCGA-FD-A3N5-01A-11D-A21C-26,HG19_Broad_variant,TCGA-FD-A3N5,TCGA-BLCA,NA,s2907,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa832e4b0c9d6adf6d386,58cfa832e4b0c9d6adf6d386,TCGA-LN-A4A3-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_5_rg.sorted.filtered.,WGS,TCGA-LN-A4A3-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_5_rg.sorted,TCGA-LN-A4A3-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_5_rg.sorted.bam,20.45,NA,0.16,58cfa832e4b0c9d6adf6d386,TCGA-LN-A4A3-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_5_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A4A3-01A,3C0BB5E2-AD33-4D91-A31E-2A18F1C94D2D,Primary Tumor,Illumina HiSeq,e04a9b3d-9bc4-4857-9030-288efed94e80,Esophagus,61,3C85B0AB-C83E-4371-9F53-6A71D3763F3F,5402975D-7AE7-46FC-847A-4EE7DEBCD553,TCGA-LN-A4A3-01A-11D-A267-26,HG19_Broad_variant,TCGA-LN-A4A3,TCGA-ESCA,NA,s1770,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N1,Not available,Stage III
13722.58cfa832e4b0c9d6adf6d60c,58cfa832e4b0c9d6adf6d60c,TCGA-LN-A5U5-10A-01D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-LN-A5U5-10A-01D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_6_rg.sorted,TCGA-LN-A5U5-10A-01D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_6_rg.sorted.bam,41.87,NA,0.15,58cfa832e4b0c9d6adf6d60c,TCGA-LN-A5U5-10A-01D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_6_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A5U5-10A,656E3C14-1FC6-473A-813E-719753E7B408,Blood Derived Normal,Illumina HiSeq,25ff8945-c42c-4dbc-9cc2-94670f1cc4f1,Esophagus,57,36438768-5E31-4D84-ACE3-067F5F044360,AA54FC2F-753B-458F-BA9A-AEFDE2BAE854,TCGA-LN-A5U5-10A-01D-A28P-26,HG19_Broad_variant,TCGA-LN-A5U5,TCGA-ESCA,NA,s1941,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N1,Not available,Stage IV
13722.58cfa832e4b0c9d6adf6d02e,58cfa832e4b0c9d6adf6d02e,TCGA-G9-6367-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-G9-6367-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_3_rg.sorted,TCGA-G9-6367-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_3_rg.sorted.bam,59.4,1.9,0.14,58cfa832e4b0c9d6adf6d02e,TCGA-G9-6367-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6367-01A,9F751C9D-AD41-4F02-B7F8-12423857D418,Primary Tumor,Illumina HiSeq,d4203e0e-c16e-4638-a239-378ffed98124,Prostate,60,5BC98578-E4C7-4BE8-89DF-F26AA5D545A9,9667EB66-775F-4C37-9309-FF73E55D553B,TCGA-G9-6367-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6367,TCGA-PRAD,NA,s3612,Harvard Medical School,Roswell Park,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6cee6,58cfa832e4b0c9d6adf6cee6,TCGA-FI-A2D0-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FI-A2D0-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_3_rg.sorted,TCGA-FI-A2D0-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_3_rg.sorted.bam,65.38,NA,0.17,58cfa832e4b0c9d6adf6cee6,TCGA-FI-A2D0-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-FI-A2D0-01A,1B35D083-F7C9-47D2-9A9E-718788F9E39A,Primary Tumor,Illumina HiSeq,5d8357bd-6f87-41b8-af0f-a2bdcb483e07,Uterus,55,A2D2A29A-5ABC-48C3-AC17-76B8B9EE1717,9406B9B9-CC2D-470D-BFB6-2118C0B84982,TCGA-FI-A2D0-01A-11D-A17E-02,HG19_Broad_variant,TCGA-FI-A2D0,TCGA-UCEC,NA,s5399,Harvard Medical School,Washington University,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d4c6,58cfa832e4b0c9d6adf6d4c6,TCGA-VD-A8KA-01B-11D-A40D_140716_SN208_0518_AC59RNACXX_s_3_rg.sorted.filtered.,WGS,TCGA-VD-A8KA-01B-11D-A40D_140716_SN208_0518_AC59RNACXX_s_3_rg.sorted,TCGA-VD-A8KA-01B-11D-A40D_140716_SN208_0518_AC59RNACXX_s_3_rg.sorted.bam,26.17,NA,0.16,58cfa832e4b0c9d6adf6d4c6,TCGA-VD-A8KA-01B-11D-A40D_140716_SN208_0518_AC59RNACXX_s_3_rg.sorted.bam,Alive,MALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KA-01B,AF04CA52-8B71-497E-8135-6DDFCA9AB221,Primary Tumor,Illumina HiSeq,c48413ae-339d-4a00-8615-5fbb50dad7b2,Eye,22,F028A8C2-1AD9-4CCD-9EF4-076F90D73806,CE40220B-D109-4A14-9C17-3C7DFD0A737A,TCGA-VD-A8KA-01B-11D-A40D-26,HG19_Broad_variant,TCGA-VD-A8KA,TCGA-UVM,NA,s262,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T3a,NX,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6cf9d,58cfa832e4b0c9d6adf6cf9d,TCGA-FU-A3EO-11A-13D-A20X_140106_SN590_0244_BC384EACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FU-A3EO-11A-13D-A20X_140106_SN590_0244_BC384EACXX_s_5_rg.sorted,TCGA-FU-A3EO-11A-13D-A20X_140106_SN590_0244_BC384EACXX_s_5_rg.sorted.bam,40.25,NA,0.16,58cfa832e4b0c9d6adf6cf9d,TCGA-FU-A3EO-11A-13D-A20X_140106_SN590_0244_BC384EACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-FU-A3EO-11A,B7F2958F-256E-4C30-9C61-11E76DDB36BA,Solid Tissue Normal,Illumina HiSeq,6577de22-c954-4658-98b4-6dad43c6b910,Cervix,55,B4C02B0C-1ABE-4C3F-BE7C-5DE397EFAC95,BA02550F-9784-4C3A-A518-0066AFF7EBD8,TCGA-FU-A3EO-11A-13D-A20X-26,HG19_Broad_variant,TCGA-FU-A3EO,TCGA-CESC,NA,s1198,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T2b,N0,Endocervical Type of Adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6ca60,58cfa831e4b0c9d6adf6ca60,TCGA-CN-6013-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CN-6013-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_1_rg.sorted,TCGA-CN-6013-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_1_rg.sorted.bam,354,1.9,0.15,58cfa831e4b0c9d6adf6ca60,TCGA-CN-6013-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-6013-01A,714496C5-D221-4397-9C5A-CD2D22603E6F,Primary Tumor,Illumina HiSeq,2ca5ef3f-76f6-4db9-85e7-d32249cd642f,Head and Neck,56,D018CD44-6B01-44F2-9181-81153225AAB8,2DE7DBC6-2A3E-4E67-BB96-552E27137618,TCGA-CN-6013-01A-11D-1681-02,HG19_Broad_variant,TCGA-CN-6013,TCGA-HNSC,NA,s15629,Harvard Medical School,University of Pittsburgh,United States,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6ced7,58cfa832e4b0c9d6adf6ced7,TCGA-EM-A1YE-11A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EM-A1YE-11A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_6_rg.sorted,TCGA-EM-A1YE-11A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_6_rg.sorted.bam,43.93,1.89,0.17,58cfa832e4b0c9d6adf6ced7,TCGA-EM-A1YE-11A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_6_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1YE-11A,E632B443-CF6A-4592-96C6-C3493EC86FEA,Solid Tissue Normal,Illumina HiSeq,48d31326-3565-4dff-ae01-be3fd0b5ca6c,Thyroid,47,B3126B21-FD84-4E3D-BB16-B7834044D5BE,57CCBCC4-DF14-48CB-9F31-BF776D712E32,TCGA-EM-A1YE-11A-11D-A14U-02,HG19_Broad_variant,TCGA-EM-A1YE,TCGA-THCA,NA,s12520,Harvard Medical School,University Health Network,Canada,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa830e4b0c9d6adf6bb83,58cfa830e4b0c9d6adf6bb83,TCGA-AA-A01G-10A-01D-A078_110326_SN590_0061_B702DPABXX_s_2_rg.sorted.filtered.,WGS,TCGA-AA-A01G-10A-01D-A078_110326_SN590_0061_B702DPABXX_s_2_rg.sorted,TCGA-AA-A01G-10A-01D-A078_110326_SN590_0061_B702DPABXX_s_2_rg.sorted.bam,16.78,1.71,0.14,58cfa830e4b0c9d6adf6bb83,TCGA-AA-A01G-10A-01D-A078_110326_SN590_0061_B702DPABXX_s_2_rg.sorted.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01G-10A,6F2B5A14-569C-4084-8C67-B1A44D787897,Blood Derived Normal,Illumina HiSeq,032cb2e6-9cac-4851-bf1b-448209aceb57,Colorectal,63,38D09491-9FAE-4B43-BDFA-B262EBD93D02,4D746D14-DF9B-4B7B-87FD-7E6D9ECC76B3,TCGA-AA-A01G-10A-01D-A078-02,HG18_Broad_variant,TCGA-AA-A01G,TCGA-COAD,NA,s13381,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Mucinous Adenocarcinoma,Stage IIA
13722.58cfa832e4b0c9d6adf6d0ae,58cfa832e4b0c9d6adf6d0ae,TCGA-IG-A3YB-10A-01D-A248_121207_SN1222_0162_BD1MA7ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-IG-A3YB-10A-01D-A248_121207_SN1222_0162_BD1MA7ACXX_s_4_rg.sorted,TCGA-IG-A3YB-10A-01D-A248_121207_SN1222_0162_BD1MA7ACXX_s_4_rg.sorted.bam,42.43,NA,0.16,58cfa832e4b0c9d6adf6d0ae,TCGA-IG-A3YB-10A-01D-A248_121207_SN1222_0162_BD1MA7ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A3YB-10A,A1A233EA-5DDA-4EEB-BD92-6667E8B3EF57,Blood Derived Normal,Illumina HiSeq,be80f48c-d89d-4f3e-88e4-9d442481434b,Esophagus,61,4EDC7B38-9477-4E2C-A2E2-064E563FA206,932DA1AE-92B3-496F-B4BA-91329E505479,TCGA-IG-A3YB-10A-01D-A248-26,HG19_Broad_variant,TCGA-IG-A3YB,TCGA-ESCA,NA,s1633,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T3,N1,Not available,Stage IIIA
13722.58cfa831e4b0c9d6adf6c6d4,58cfa831e4b0c9d6adf6c6d4,TCGA-CQ-5327-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CQ-5327-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_6_rg.sorted,TCGA-CQ-5327-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_6_rg.sorted.bam,87.7,1.9,0.14,58cfa831e4b0c9d6adf6c6d4,TCGA-CQ-5327-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_6_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-5327-10A,5A03E2B6-4C8B-479A-9036-9859AF031DA4,Blood Derived Normal,Illumina HiSeq,f13990a7-88ec-44b6-b54c-82cd223ab0e2,Head and Neck,61,1C3A8D45-573F-49F3-AF6C-F5686B6F21C5,B39DC256-152A-4592-B7BC-6859E46D1F8E,TCGA-CQ-5327-10A-01D-1681-02,HG19_Broad_variant,TCGA-CQ-5327,TCGA-HNSC,NA,s16330,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T3,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c346,58cfa831e4b0c9d6adf6c346,TCGA-CG-5717-10A-01D-1598_121029_SN208_0438_AC18NJACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CG-5717-10A-01D-1598_121029_SN208_0438_AC18NJACXX_s_7_rg.sorted,TCGA-CG-5717-10A-01D-1598_121029_SN208_0438_AC18NJACXX_s_7_rg.sorted.bam,27.7,1.9,0.16,58cfa831e4b0c9d6adf6c346,TCGA-CG-5717-10A-01D-1598_121029_SN208_0438_AC18NJACXX_s_7_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5717-10A,BDC3899E-15AE-421F-829B-0E07FBD27C60,Blood Derived Normal,Illumina HiSeq,6aa2ef88-18e7-4056-b37a-72a9acd0fed9,Stomach,58,AB9865D3-94CD-404B-B7A0-3703038C2E32,54637B38-876F-4F77-918F-8AD88539274B,TCGA-CG-5717-10A-01D-1598-02,HG19_Broad_variant,TCGA-CG-5717,TCGA-STAD,212,s14830,Harvard Medical School,Indivumed,Germany,NO,T2b,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa830e4b0c9d6adf6bee6,58cfa830e4b0c9d6adf6bee6,TCGA-AX-A0IU-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_2_rg.sorted.filtered.,WGS,TCGA-AX-A0IU-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_2_rg.sorted,TCGA-AX-A0IU-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_2_rg.sorted.bam,117.75,2.28,0.16,58cfa830e4b0c9d6adf6bee6,TCGA-AX-A0IU-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_2_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A0IU-01A,7E64EA6C-A3DB-48EB-91BE-131361510A92,Primary Tumor,Illumina HiSeq,927c6e80-e2e3-4198-98a4-77a79159fb8a,Uterus,79,DC4B3695-CE62-48D5-9F1D-7DD70D049C97,24746F36-88BC-44B0-955A-55A2CC98E17C,TCGA-AX-A0IU-01A-11D-A101-02,HG19_Broad_variant,TCGA-AX-A0IU,TCGA-UCEC,NA,s4999,Harvard Medical School,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6cf66,58cfa832e4b0c9d6adf6cf66,TCGA-GD-A3OQ-11A-21D-A221_120902_SN1222_0147_AC195DACXX_s_5_rg.sorted.filtered.,WGS,TCGA-GD-A3OQ-11A-21D-A221_120902_SN1222_0147_AC195DACXX_s_5_rg.sorted,TCGA-GD-A3OQ-11A-21D-A221_120902_SN1222_0147_AC195DACXX_s_5_rg.sorted.bam,14.6,NA,0.15,58cfa832e4b0c9d6adf6cf66,TCGA-GD-A3OQ-11A-21D-A221_120902_SN1222_0147_AC195DACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GD-A3OQ-11A,2E85C30C-C4C4-4096-9EEF-4EB2C7D991A3,Solid Tissue Normal,Illumina HiSeq,b206c126-8a3d-4051-89bb-086c3e66ed39,Bladder,48,FA1B5772-8254-49BA-A385-AF8C9AC7FA4F,478C5567-E4F7-4155-A9DC-6B0B135A1758,TCGA-GD-A3OQ-11A-21D-A221-26,HG19_Broad_variant,TCGA-GD-A3OQ,TCGA-BLCA,NA,s2927,MD Anderson - Institute for Applied Cancer Science,ABS - IUPUI,United States,NO,T4a,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6d51e,58cfa832e4b0c9d6adf6d51e,TCGA-L5-A4OS-11A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-L5-A4OS-11A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_5_rg.sorted,TCGA-L5-A4OS-11A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_5_rg.sorted.bam,34.86,NA,0.17,58cfa832e4b0c9d6adf6d51e,TCGA-L5-A4OS-11A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OS-11A,D5AC647F-0C6D-40D7-87A8-FAA1CC968C82,Solid Tissue Normal,Illumina HiSeq,6438914d-a10f-4c4f-85fa-01a639a93627,Esophagus,86,FEEB1DE4-55BA-4A18-A8B8-117063525780,824F0EF5-79A6-43D6-A7E3-781619A16443,TCGA-L5-A4OS-11A-11D-A28P-26,HG19_Broad_variant,TCGA-L5-A4OS,TCGA-ESCA,NA,s1652,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T2,N1,Not available,Stage IIB
13722.58cfa82fe4b0c9d6adf6b664,58cfa82fe4b0c9d6adf6b664,TCGA-50-6594-01A-11D-1751_120105_SN1120_0107_AC054PACXX_s_1_rg.sorted.filtered.,WGS,TCGA-50-6594-01A-11D-1751_120105_SN1120_0107_AC054PACXX_s_1_rg.sorted,TCGA-50-6594-01A-11D-1751_120105_SN1120_0107_AC054PACXX_s_1_rg.sorted.bam,193.4,1.8,0.13,58cfa82fe4b0c9d6adf6b664,TCGA-50-6594-01A-11D-1751_120105_SN1120_0107_AC054PACXX_s_1_rg.sorted.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-6594-01A,8504FD86-A70A-4CBA-9EC8-25C9E60CA549,Primary Tumor,Illumina HiSeq,e9b1ca6e-b0f0-48d8-ba44-ebfcec8cd171,Lung,79,DAB00804-E92F-43F1-9348-16F3015B5DCE,9AED6934-5553-4BAC-AD76-BA2DDAE0DC72,TCGA-50-6594-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-6594,TCGA-LUAD,370,s11350,Harvard Medical School,University of Pittsburgh,United States,NO,T3,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6c4d2,58cfa831e4b0c9d6adf6c4d2,TCGA-CF-A3MG-01A-11D-A210_120914_SN590_0180_BC19KDACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CF-A3MG-01A-11D-A210_120914_SN590_0180_BC19KDACXX_s_7_rg.sorted,TCGA-CF-A3MG-01A-11D-A210_120914_SN590_0180_BC19KDACXX_s_7_rg.sorted.bam,66.73,NA,0.14,58cfa831e4b0c9d6adf6c4d2,TCGA-CF-A3MG-01A-11D-A210_120914_SN590_0180_BC19KDACXX_s_7_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CF-A3MG-01A,39EFA06A-FFE5-40B3-8F8A-A2D7071BC9E3,Primary Tumor,Illumina HiSeq,695ed631-423c-4381-ae8f-4a70fd6266b9,Bladder,48,1ACF91C8-4971-4893-AC27-64EA4A4C3023,99993BCD-8555-407A-A918-3F51D57BA720,TCGA-CF-A3MG-01A-11D-A210-26,HG19_Broad_variant,TCGA-CF-A3MG,TCGA-BLCA,NA,s3095,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T2,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa832e4b0c9d6adf6d5df,58cfa832e4b0c9d6adf6d5df,TCGA-LN-A4MR-10A-01D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-LN-A4MR-10A-01D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_2_rg.sorted,TCGA-LN-A4MR-10A-01D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_2_rg.sorted.bam,64.31,NA,0.17,58cfa832e4b0c9d6adf6d5df,TCGA-LN-A4MR-10A-01D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_2_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A4MR-10A,CC14603B-E32C-43F3-8218-B6ED7EE2EC18,Blood Derived Normal,Illumina HiSeq,a1b4bdbf-37df-4608-9b6c-2135b3819b62,Esophagus,57,6665EBB7-F9B6-407B-9365-F11953BBE24D,F78B0C6D-EDD4-4509-B2C3-5EA27D875735,TCGA-LN-A4MR-10A-01D-A28P-26,HG19_Broad_variant,TCGA-LN-A4MR,TCGA-ESCA,NA,s1780,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T2,N0,Not available,Stage IIA
13722.58cfa82ee4b0c9d6adf6ae58,58cfa82ee4b0c9d6adf6ae58,TCGA-05-4398-10A-01D-1203_120322_SN208_0278_BD0RB0ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-05-4398-10A-01D-1203_120322_SN208_0278_BD0RB0ACXX_s_4_rg.sorted,TCGA-05-4398-10A-01D-1203_120322_SN208_0278_BD0RB0ACXX_s_4_rg.sorted.bam,168.23,1.9,0.14,58cfa82ee4b0c9d6adf6ae58,TCGA-05-4398-10A-01D-1203_120322_SN208_0278_BD0RB0ACXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4398-10A,31C96E35-5E2F-429C-B12A-7BC5A497A300,Blood Derived Normal,Illumina HiSeq,c5182685-5c5b-42dc-9a85-4c0076ee389a,Lung,47,A65C5573-B230-4CA0-8BE3-8BCCE6BE385E,900A4C89-CD98-4F90-AA26-CCC7B285A8CC,TCGA-05-4398-10A-01D-1203-02,HG19_Broad_variant,TCGA-05-4398,TCGA-LUAD,NA,s10770,Harvard Medical School,Indivumed,Germany,NO,T4,N3,Lung Adenocarcinoma Mixed Subtype,Stage IIIB
13722.58cfa831e4b0c9d6adf6cdb1,58cfa831e4b0c9d6adf6cdb1,TCGA-FG-6692-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_6_rg.sorted.filtered.,WGS,TCGA-FG-6692-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_6_rg.sorted,TCGA-FG-6692-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_6_rg.sorted.bam,270.7,1.9,0.15,58cfa831e4b0c9d6adf6cdb1,TCGA-FG-6692-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-6692-01A,5F10CD91-1E03-4016-B35A-8629A1A8FCC9,Primary Tumor,Illumina HiSeq,66eb8fac-6ead-47b2-be40-effbb245f499,Brain,63,FDDB3709-5F1C-40C8-A39A-48329DFE9C97,5BB5BFCC-DB34-474C-95E6-3A84C3A7DBAA,TCGA-FG-6692-01A-11D-1891-02,HG19_Broad_variant,TCGA-FG-6692,TCGA-LGG,NA,s8367,Harvard Medical School,Case Western,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6cc05,58cfa831e4b0c9d6adf6cc05,TCGA-EE-A29D-06A-11D-A18Y_120730_SN208_0419_AC13W9ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EE-A29D-06A-11D-A18Y_120730_SN208_0419_AC13W9ACXX_s_1_rg.sorted,TCGA-EE-A29D-06A-11D-A18Y_120730_SN208_0419_AC13W9ACXX_s_1_rg.sorted.bam,72.15,NA,0.18,58cfa831e4b0c9d6adf6cc05,TCGA-EE-A29D-06A-11D-A18Y_120730_SN208_0419_AC13W9ACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29D-06A,EF608754-3F87-458E-9BCF-4434C54C8C9E,Metastatic,Illumina HiSeq,a8d2aa91-891f-4915-ab15-e620b21c436c,Skin,87,C129BD85-B320-4B3C-9316-CE00F58BA3D0,332D373A-A849-4B7E-854A-38DC56DC627D,TCGA-EE-A29D-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A29D,TCGA-SKCM,425,s7841,Harvard Medical School,University of Sydney,Australia,NO,T3b,N1b,Not available,Stage IIIC
13722.58cfa831e4b0c9d6adf6c8da,58cfa831e4b0c9d6adf6c8da,TCGA-D1-A168-01A-31D-A12F_120413_SN1120_0133_BC0J8UACXX_s_6_rg.sorted.filtered.,WGS,TCGA-D1-A168-01A-31D-A12F_120413_SN1120_0133_BC0J8UACXX_s_6_rg.sorted,TCGA-D1-A168-01A-31D-A12F_120413_SN1120_0133_BC0J8UACXX_s_6_rg.sorted.bam,60.13,1.98,0.15,58cfa831e4b0c9d6adf6c8da,TCGA-D1-A168-01A-31D-A12F_120413_SN1120_0133_BC0J8UACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A168-01A,41893E97-7E90-4B03-B738-260F288ADE4C,Primary Tumor,Illumina HiSeq,f7d0c63d-0a01-4ff3-b721-3c10692581ca,Uterus,67,B44C673E-9560-4B59-9FF3-34CE230CAD1C,4593D11C-3A35-4269-80EC-D282497CF71C,TCGA-D1-A168-01A-31D-A12F-02,HG19_Broad_variant,TCGA-D1-A168,TCGA-UCEC,NA,s4438,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b700,58cfa82fe4b0c9d6adf6b700,TCGA-64-5775-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-64-5775-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_1_rg.sorted,TCGA-64-5775-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_1_rg.sorted.bam,360.7,1.9,0.14,58cfa82fe4b0c9d6adf6b700,TCGA-64-5775-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-64-5775-01A,C8544FB3-B26E-4672-BB81-A271DB724B04,Primary Tumor,Illumina HiSeq,af9f3482-e78b-4fe4-ac01-64f69b84d78d,Lung,71,5449BCED-1356-4DE5-9352-349725656C5C,11AEF70D-D22B-4936-BD8C-863BDBD4940E,TCGA-64-5775-01A-01D-1623-02,HG19_Broad_variant,TCGA-64-5775,TCGA-LUAD,62,s10664,Harvard Medical School,Fox Chase,United States,NO,T4,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6cb78,58cfa831e4b0c9d6adf6cb78,TCGA-DU-7292-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DU-7292-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_2_rg.sorted,TCGA-DU-7292-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_2_rg.sorted.bam,49,NA,0.14,58cfa831e4b0c9d6adf6cb78,TCGA-DU-7292-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7292-10A,145F87A3-5E86-4A87-8E49-B166A2271D02,Blood Derived Normal,Illumina HiSeq,0ac4dae2-d60a-4869-a3a6-c2ecd1c7640f,Brain,69,568D1C55-344D-4294-85C5-1CA8356F23EB,20E6FABE-8B03-4E27-B98A-0501685E1A90,TCGA-DU-7292-10A-01D-2022-02,HG19_Broad_variant,TCGA-DU-7292,TCGA-LGG,242,s8358,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa830e4b0c9d6adf6be60,58cfa830e4b0c9d6adf6be60,TCGA-AP-A0L9-10A-01D-A043_120318_SN590_0147_BD0U3RACXX_s_4_rg.sorted.filtered.,WGS,TCGA-AP-A0L9-10A-01D-A043_120318_SN590_0147_BD0U3RACXX_s_4_rg.sorted,TCGA-AP-A0L9-10A-01D-A043_120318_SN590_0147_BD0U3RACXX_s_4_rg.sorted.bam,35.11,1.93,0.15,58cfa830e4b0c9d6adf6be60,TCGA-AP-A0L9-10A-01D-A043_120318_SN590_0147_BD0U3RACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0L9-10A,7B9947D5-E86B-4006-8890-EA5209584A88,Blood Derived Normal,Illumina HiSeq,da796750-9751-47a4-a977-f1ef14fbfbe5,Uterus,71,60EAC6D9-6404-4C11-A30C-3986D1CACAF2,9BEEC8F7-2E37-425F-8FE7-8E205CABF969,TCGA-AP-A0L9-10A-01D-A043-02,HG19_Broad_variant,TCGA-AP-A0L9,TCGA-UCEC,NA,s4424,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b808,58cfa82fe4b0c9d6adf6b808,TCGA-44-5643-11A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_4_rg.sorted.filtered.,WGS,TCGA-44-5643-11A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_4_rg.sorted,TCGA-44-5643-11A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_4_rg.sorted.bam,105.7,1.9,0.14,58cfa82fe4b0c9d6adf6b808,TCGA-44-5643-11A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_4_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-5643-11A,27FCEEC1-3298-4CDD-A4E6-8F5CF34604F0,Solid Tissue Normal,Illumina HiSeq,7f469523-6155-4b35-86b7-4dd7791a1ea5,Lung,53,57F5E960-B2D3-41ED-A062-DC21ABA0E07B,320B802D-2F12-4C61-A021-E3B66486F1CE,TCGA-44-5643-11A-01D-1623-02,HG19_Broad_variant,TCGA-44-5643,TCGA-LUAD,NA,s11230,Harvard Medical School,Christiana Healthcare,United States,NO,T2b,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82fe4b0c9d6adf6b806,58cfa82fe4b0c9d6adf6b806,TCGA-49-6744-11A-01D-1853_111218_SN208_0258_C054RACXX_s_6_rg.sorted.filtered.,WGS,TCGA-49-6744-11A-01D-1853_111218_SN208_0258_C054RACXX_s_6_rg.sorted,TCGA-49-6744-11A-01D-1853_111218_SN208_0258_C054RACXX_s_6_rg.sorted.bam,191.7,1.9,0.14,58cfa82fe4b0c9d6adf6b806,TCGA-49-6744-11A-01D-1853_111218_SN208_0258_C054RACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-49-6744-11A,15340DD3-84AE-49FB-989A-EB212F3E73DA,Solid Tissue Normal,Illumina HiSeq,f185e615-65c6-4c02-aa8a-77c17e89e5e5,Lung,64,E3962E0E-EAFA-4016-8FA4-1C4BA0D2A9AD,564E82B9-E3C8-4EDE-8E58-BE9D0BA157D5,TCGA-49-6744-11A-01D-1853-02,HG19_Broad_variant,TCGA-49-6744,TCGA-LUAD,NA,s10906,Harvard Medical School,Johns Hopkins,United States,NO,T2a,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIA
13722.58cfa82fe4b0c9d6adf6b866,58cfa82fe4b0c9d6adf6b866,TCGA-A6-2682-01A-01D-1405_110114_SN177_0133_A809KVABXX_s_8_rg.sorted.filtered.,WGS,TCGA-A6-2682-01A-01D-1405_110114_SN177_0133_A809KVABXX_s_8_rg.sorted,TCGA-A6-2682-01A-01D-1405_110114_SN177_0133_A809KVABXX_s_8_rg.sorted.bam,618,1.9,0.16,58cfa82fe4b0c9d6adf6b866,TCGA-A6-2682-01A-01D-1405_110114_SN177_0133_A809KVABXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2682-01A,77A44132-AF22-4115-9FA2-78F2F74BF687,Primary Tumor,Illumina HiSeq,dd9a1c6d-4344-4fed-a29f-b60afcfaa5eb,Colorectal,70,F10F139D-1D7F-4923-8129-F103F5D3163B,F8B17713-D431-4418-A6F7-DC6DE3077212,TCGA-A6-2682-01A-01D-1405-02,HG18_Broad_variant,TCGA-A6-2682,TCGA-COAD,424,s13651,Harvard Medical School,Christiana Healthcare,United States,NO,T4b,N1,Colon Adenocarcinoma,Stage IV
13722.58cfa831e4b0c9d6adf6c704,58cfa831e4b0c9d6adf6c704,TCGA-CU-A3KJ-10A-01D-A21C_120914_SN590_0179_AD13PPACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CU-A3KJ-10A-01D-A21C_120914_SN590_0179_AD13PPACXX_s_8_rg.sorted,TCGA-CU-A3KJ-10A-01D-A21C_120914_SN590_0179_AD13PPACXX_s_8_rg.sorted.bam,11.68,NA,0.15,58cfa831e4b0c9d6adf6c704,TCGA-CU-A3KJ-10A-01D-A21C_120914_SN590_0179_AD13PPACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CU-A3KJ-10A,A75584BC-BEF7-48F6-B4B3-C1472A3AF768,Blood Derived Normal,Illumina HiSeq,a2af4db6-b93c-4e1f-9be7-28fdb75431a6,Bladder,75,76B6E3EC-6F76-43BA-9B90-35B64A47AE41,F5A5ED54-8D76-482B-AEC6-3022C52AFE30,TCGA-CU-A3KJ-10A-01D-A21C-26,HG19_Broad_variant,TCGA-CU-A3KJ,TCGA-BLCA,NA,s2881,MD Anderson - Institute for Applied Cancer Science,UNC,United States,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c7ce,58cfa831e4b0c9d6adf6c7ce,TCGA-CV-7434-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CV-7434-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_3_rg.sorted,TCGA-CV-7434-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_3_rg.sorted.bam,274.73,NA,0.14,58cfa831e4b0c9d6adf6c7ce,TCGA-CV-7434-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7434-01A,63B50E1C-7948-464F-BFF1-8E0E5DAAFCC5,Primary Tumor,Illumina HiSeq,c645c62d-79d3-478c-a9c4-16294daad71c,Head and Neck,64,2CB75C6E-CA4F-4A88-9679-812A51C7B832,4A4BF5E3-272F-492C-9755-BBFE14D3BEE1,TCGA-CV-7434-01A-11D-2317-26,HG19_Broad_variant,TCGA-CV-7434,TCGA-HNSC,218,s15528,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T4a,N1,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c919,58cfa831e4b0c9d6adf6c919,TCGA-DK-A3IU-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DK-A3IU-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_8_rg.sorted,TCGA-DK-A3IU-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_8_rg.sorted.bam,27.55,NA,0.15,58cfa831e4b0c9d6adf6c919,TCGA-DK-A3IU-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3IU-10A,F093F043-EFD4-4CBA-A87F-8CBB5C1ACD9E,Blood Derived Normal,Illumina HiSeq,ef01cea3-48ce-4afb-a6e9-4a52d7c8a07b,Bladder,58,8C6EDADF-707F-4529-8E90-16E5263E389D,1BA781B6-1D14-48EB-9BE2-7D73913397FB,TCGA-DK-A3IU-10A-01D-A210-26,HG19_Broad_variant,TCGA-DK-A3IU,TCGA-BLCA,NA,s2893,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa832e4b0c9d6adf6d1ec,58cfa832e4b0c9d6adf6d1ec,TCGA-HT-7604-10A-01D-2088_130910_SN208_0494_AC2A1DACXX_s_2_rg.sorted.filtered.,WGS,TCGA-HT-7604-10A-01D-2088_130910_SN208_0494_AC2A1DACXX_s_2_rg.sorted,TCGA-HT-7604-10A-01D-2088_130910_SN208_0494_AC2A1DACXX_s_2_rg.sorted.bam,135,NA,0.13,58cfa832e4b0c9d6adf6d1ec,TCGA-HT-7604-10A-01D-2088_130910_SN208_0494_AC2A1DACXX_s_2_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7604-10A,019C5DE9-74FD-48B7-95A3-227532E16C5A,Blood Derived Normal,Illumina HiSeq,b43b5074-d9bd-4d06-b367-bebab284ebfe,Brain,50,2D4653B8-97BC-4074-8BCB-670897CEB16A,17624312-479E-4C9B-9C97-65D8C13B0217,TCGA-HT-7604-10A-01D-2088-02,HG19_Broad_variant,TCGA-HT-7604,TCGA-LGG,NA,s8576,Harvard Medical School,Case Western - St Joes,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa830e4b0c9d6adf6c1cc,58cfa830e4b0c9d6adf6c1cc,TCGA-BF-A1PU-01A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BF-A1PU-01A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_5_rg.sorted,TCGA-BF-A1PU-01A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_5_rg.sorted.bam,55.01,NA,0.18,58cfa830e4b0c9d6adf6c1cc,TCGA-BF-A1PU-01A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Skin Cutaneous Melanoma,Aligned reads,TCGA-BF-A1PU-01A,3DD5A206-D7F3-42F1-B9CC-4B31C76D495D,Primary Tumor,Illumina HiSeq,26c2ab51-9411-4718-8733-1c3c5ba19602,Skin,46,D9C8128A-5990-43C8-AC08-CBDF035213D6,AAC0230D-759F-4B2E-9904-3F7822E6B13C,TCGA-BF-A1PU-01A-11D-A18Z-02,HG19_Broad_variant,TCGA-BF-A1PU,TCGA-SKCM,NA,s7667,Harvard Medical School,Cureline,Russia,NO,T4b,N0,Not available,Stage IIC
13722.58cfa831e4b0c9d6adf6cc4a,58cfa831e4b0c9d6adf6cc4a,TCGA-EB-A24C-01A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EB-A24C-01A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_3_rg.sorted,TCGA-EB-A24C-01A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_3_rg.sorted.bam,54.37,NA,0.17,58cfa831e4b0c9d6adf6cc4a,TCGA-EB-A24C-01A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EB-A24C-01A,2F1BBE96-49D9-417B-BC9C-A09992489340,Primary Tumor,Illumina HiSeq,536296fc-5bec-4776-8ce4-7eee8581fbc3,Skin,56,67D59A46-5944-4B23-AA7B-9561C6F7B956,B48D03D1-E323-4119-B62E-1952163AAB2A,TCGA-EB-A24C-01A-11D-A18Y-02,HG19_Broad_variant,TCGA-EB-A24C,TCGA-SKCM,NA,s7333,Harvard Medical School,Asterand,Ukraine,NO,T4b,NX,Not available,Not available
13722.58cfa82fe4b0c9d6adf6b85e,58cfa82fe4b0c9d6adf6b85e,TCGA-A6-2680-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-2680-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-2680-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,38,1.9,0.16,58cfa82fe4b0c9d6adf6b85e,TCGA-A6-2680-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2680-01A,FF1407C6-9174-4BAE-A19B-D34CA71B898C,Primary Tumor,Illumina HiSeq,b2bf326b-6022-44c8-87fd-c3777c1ab858,Colorectal,72,D664F620-CFEE-4700-B00E-68B65387883C,22A3FC8C-A661-4B3D-A4BA-B35DFDBE24BC,TCGA-A6-2680-01A-01D-1405-02,HG18,TCGA-A6-2680,TCGA-COAD,NA,s13356,Harvard Medical School,Christiana Healthcare,None,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c62c,58cfa831e4b0c9d6adf6c62c,TCGA-CG-4301-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CG-4301-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_1_rg.sorted,TCGA-CG-4301-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_1_rg.sorted.bam,84.9,1.9,0.15,58cfa831e4b0c9d6adf6c62c,TCGA-CG-4301-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_1_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4301-01A,7E13FE2A-3D6E-487F-900D-F5891D986AA2,Primary Tumor,Illumina HiSeq,7d1cd13f-5ac5-457f-8e7b-89cabb2463c6,Stomach,75,F8CCC777-65A2-41FA-95AC-AB33C3E9AD9A,55F814EC-D386-4277-8CF1-245313CF373D,TCGA-CG-4301-01A-01D-A326-26,HG19_Broad_variant,TCGA-CG-4301,TCGA-STAD,NA,s15456,MD Anderson - Institute for Applied Cancer Science,Indivumed,Germany,NO,T4,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa832e4b0c9d6adf6d0c9,58cfa832e4b0c9d6adf6d0c9,TCGA-IG-A3YB-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-IG-A3YB-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_3_rg.sorted,TCGA-IG-A3YB-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_3_rg.sorted.bam,34.41,NA,0.15,58cfa832e4b0c9d6adf6d0c9,TCGA-IG-A3YB-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A3YB-01A,A1A233EA-5DDA-4EEB-BD92-6667E8B3EF57,Primary Tumor,Illumina HiSeq,6b51ea9f-5ca3-4973-bc0f-8df5ae95abbd,Esophagus,61,F936DE42-1441-4C4C-882A-DC67D332C125,335AAD40-B278-4EEC-BEE6-FC4F77C63370,TCGA-IG-A3YB-01A-11D-A248-26,HG19_Broad_variant,TCGA-IG-A3YB,TCGA-ESCA,NA,s1911,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T3,N1,Not available,Stage IIIA
13722.58cfa831e4b0c9d6adf6c75b,58cfa831e4b0c9d6adf6c75b,TCGA-D1-A16D-10A-01D-A12F_120511_SN208_0299_BD12J9ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D1-A16D-10A-01D-A12F_120511_SN208_0299_BD12J9ACXX_s_4_rg.sorted,TCGA-D1-A16D-10A-01D-A12F_120511_SN208_0299_BD12J9ACXX_s_4_rg.sorted.bam,7.4,1.95,0.15,58cfa831e4b0c9d6adf6c75b,TCGA-D1-A16D-10A-01D-A12F_120511_SN208_0299_BD12J9ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A16D-10A,5693302A-4548-4C0B-8725-0CB7C67BC4F8,Blood Derived Normal,Illumina HiSeq,1632a50b-463d-4306-a663-2af6737ce5c8,Uterus,49,9341A9C7-C7D3-4695-A721-2EE86F5F188D,FD5F8332-92E6-4A62-95A5-2A377BFAD623,TCGA-D1-A16D-10A-01D-A12F-02,HG19_Broad_variant,TCGA-D1-A16D,TCGA-UCEC,NA,s5019,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d48e,58cfa832e4b0c9d6adf6d48e,TCGA-VD-A8KL-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-VD-A8KL-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_7_rg.sorted,TCGA-VD-A8KL-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_7_rg.sorted.bam,9.25,NA,0.15,58cfa832e4b0c9d6adf6d48e,TCGA-VD-A8KL-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_7_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KL-10A,A9F956A0-660F-4185-A843-D9911D2484DE,Blood Derived Normal,Illumina HiSeq,d4977491-5388-4d8b-9930-21d022a1a517,Eye,77,5285262F-0786-43A8-A43B-3E21BA157040,85FB40B2-A81F-48BD-99FD-50406C00B57D,TCGA-VD-A8KL-10A-01D-A40E-26,HG19_Broad_variant,TCGA-VD-A8KL,TCGA-UVM,NA,s265,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T3a,NX,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6d528,58cfa832e4b0c9d6adf6d528,TCGA-L5-A4OJ-01A-11D-A267_131018_SN590_0241_BC30HBACXX_s_1_rg.sorted.filtered.,WGS,TCGA-L5-A4OJ-01A-11D-A267_131018_SN590_0241_BC30HBACXX_s_1_rg.sorted,TCGA-L5-A4OJ-01A-11D-A267_131018_SN590_0241_BC30HBACXX_s_1_rg.sorted.bam,44.72,NA,0.17,58cfa832e4b0c9d6adf6d528,TCGA-L5-A4OJ-01A-11D-A267_131018_SN590_0241_BC30HBACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OJ-01A,CB419344-6148-43D4-B549-570BD09B3E05,Primary Tumor,Illumina HiSeq,b8117191-ea00-451f-85ca-53357a42b44f,Esophagus,70,4F03824A-79D6-40E8-A9E0-4079B1209F38,74221A72-4B40-4943-877D-7979EB4BD268,TCGA-L5-A4OJ-01A-11D-A267-26,HG19_Broad_variant,TCGA-L5-A4OJ,TCGA-ESCA,NA,s1651,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T1,N0,Not available,Stage I
13722.58cfa831e4b0c9d6adf6cb5e,58cfa831e4b0c9d6adf6cb5e,TCGA-DU-7018-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DU-7018-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_5_rg.sorted,TCGA-DU-7018-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_5_rg.sorted.bam,193.7,NA,0.15,58cfa831e4b0c9d6adf6cb5e,TCGA-DU-7018-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7018-01A,F18DAB99-26B0-4727-89A9-7F16BD382356,Primary Tumor,Illumina HiSeq,2736e751-ccc3-4721-b516-238f987ad26f,Brain,57,FE98F78B-2C80-4999-B430-E1D95A53F356,02FCFCBB-05D7-4671-BDDF-DED65316FCC6,TCGA-DU-7018-01A-11D-2022-02,HG19_Broad_variant,TCGA-DU-7018,TCGA-LGG,933,s8567,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6cc48,58cfa831e4b0c9d6adf6cc48,TCGA-E1-5307-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-E1-5307-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_2_rg.sorted,TCGA-E1-5307-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_2_rg.sorted.bam,20,1.9,0.15,58cfa831e4b0c9d6adf6cc48,TCGA-E1-5307-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-E1-5307-10A,A6EE311C-0A7B-4F47-86F1-F2164B128F9C,Blood Derived Normal,Illumina HiSeq,39a2e360-0a4c-4285-ace9-946e589970f4,Brain,62,011BB79A-079B-4EDF-A004-B699AB42F04F,B1BA990A-9299-42AB-BA66-CA60073B02F5,TCGA-E1-5307-10A-01D-1891-02,HG19_Broad_variant,TCGA-E1-5307,TCGA-LGG,1762,s8351,Harvard Medical School,Duke,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa830e4b0c9d6adf6be80,58cfa830e4b0c9d6adf6be80,TCGA-BL-A3JM-11A-31D-A21C_120914_SN590_0180_BC19KDACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BL-A3JM-11A-31D-A21C_120914_SN590_0180_BC19KDACXX_s_4_rg.sorted,TCGA-BL-A3JM-11A-31D-A21C_120914_SN590_0180_BC19KDACXX_s_4_rg.sorted.bam,6.95,NA,0.15,58cfa830e4b0c9d6adf6be80,TCGA-BL-A3JM-11A-31D-A21C_120914_SN590_0180_BC19KDACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BL-A3JM-11A,0F4FB205-B13C-4A85-97B3-779429E6CCDD,Solid Tissue Normal,Illumina HiSeq,33f45265-9a07-4291-ad56-6a47f9838213,Bladder,62,4D4A9AB9-0FAE-4393-978D-612C22D5B393,C3DC6688-BCC8-4FF9-B396-778E160F57FD,TCGA-BL-A3JM-11A-31D-A21C-26,HG19_Broad_variant,TCGA-BL-A3JM,TCGA-BLCA,205,s3395,MD Anderson - Institute for Applied Cancer Science,Christiana Healthcare,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6d139,58cfa832e4b0c9d6adf6d139,TCGA-FS-A1ZE-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FS-A1ZE-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_5_rg.sorted,TCGA-FS-A1ZE-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_5_rg.sorted.bam,51.96,NA,0.16,58cfa832e4b0c9d6adf6d139,TCGA-FS-A1ZE-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZE-10A,2C79ADD1-8093-4E81-8F80-069AF7B7C2FA,Blood Derived Normal,Illumina HiSeq,c24d750d-c28d-461b-b1b0-31a50556c535,Skin,40,B3D6F0EE-2E71-4139-A421-044034679F48,D2393DD6-8CE3-42D4-BD36-27FEF8F4F170,TCGA-FS-A1ZE-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZE,TCGA-SKCM,NA,s8030,Harvard Medical School,Essen,Germany,NO,T4b,N0,Not available,Stage IIC
13722.58cfa830e4b0c9d6adf6bfa4,58cfa830e4b0c9d6adf6bfa4,TCGA-BR-6457-01A-21D-1798_130116_SN208_0448_AC1J58ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BR-6457-01A-21D-1798_130116_SN208_0448_AC1J58ACXX_s_3_rg.sorted,TCGA-BR-6457-01A-21D-1798_130116_SN208_0448_AC1J58ACXX_s_3_rg.sorted.bam,77.4,1.9,0.15,58cfa830e4b0c9d6adf6bfa4,TCGA-BR-6457-01A-21D-1798_130116_SN208_0448_AC1J58ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6457-01A,05CE16D4-A999-491A-91AD-9449A57228FF,Primary Tumor,Illumina HiSeq,695f7145-7735-48f7-98e8-99b86bb936f4,Stomach,69,BADB9AE0-9C44-41D4-848B-EE03B6FCA503,85EEEBBE-BDBB-4FE7-8CCD-401E818EEB29,TCGA-BR-6457-01A-21D-1798-02,HG19_Broad_variant,TCGA-BR-6457,TCGA-STAD,NA,s14618,Harvard Medical School,Asterand,Ukraine,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA
13722.58cfa831e4b0c9d6adf6ccdc,58cfa831e4b0c9d6adf6ccdc,TCGA-EM-A1YC-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EM-A1YC-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_7_rg.sorted,TCGA-EM-A1YC-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_7_rg.sorted.bam,43.33,1.93,0.17,58cfa831e4b0c9d6adf6ccdc,TCGA-EM-A1YC-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_7_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1YC-01A,0AD2A2B3-C1BB-4597-B28E-A6385F93D09C,Primary Tumor,Illumina HiSeq,256cee86-6dd3-4d12-bb0b-e3ab680044aa,Thyroid,71,17610B7B-F2EC-4B55-808C-1C2219A0D1BA,3D02FB7F-EB7D-49F9-BD40-20E9BDA1FBAB,TCGA-EM-A1YC-01A-11D-A14U-02,HG19_Broad_variant,TCGA-EM-A1YC,TCGA-THCA,NA,s12752,Harvard Medical School,University Health Network,Canada,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III
13722.58cfa831e4b0c9d6adf6c6c0,58cfa831e4b0c9d6adf6c6c0,TCGA-CU-A3YL-10A-01D-A233_120829_SN1120_0183_AC18U8ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CU-A3YL-10A-01D-A233_120829_SN1120_0183_AC18U8ACXX_s_4_rg.sorted,TCGA-CU-A3YL-10A-01D-A233_120829_SN1120_0183_AC18U8ACXX_s_4_rg.sorted.bam,7.69,NA,0.15,58cfa831e4b0c9d6adf6c6c0,TCGA-CU-A3YL-10A-01D-A233_120829_SN1120_0183_AC18U8ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CU-A3YL-10A,087A7F70-2FA8-4A16-B130-4DF10A70C662,Blood Derived Normal,Illumina HiSeq,69971830-c186-43e1-a945-c5eb5bd2b1e3,Bladder,67,F3592A46-AABB-4F24-9BC4-4471FA33B37A,E6F4BF20-8433-4C74-9565-64141B6145B1,TCGA-CU-A3YL-10A-01D-A233-26,HG19_Broad_variant,TCGA-CU-A3YL,TCGA-BLCA,NA,s3099,MD Anderson - Institute for Applied Cancer Science,UNC,United States,NO,T4a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa830e4b0c9d6adf6bd9e,58cfa830e4b0c9d6adf6bd9e,TCGA-BF-A1PX-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BF-A1PX-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_4_rg.sorted,TCGA-BF-A1PX-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_4_rg.sorted.bam,46.56,NA,0.16,58cfa830e4b0c9d6adf6bd9e,TCGA-BF-A1PX-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-BF-A1PX-10A,197AC33E-D5DF-40DE-92F2-6EF7FE2AD6DD,Blood Derived Normal,Illumina HiSeq,4b89e22d-ca8e-4b65-bc95-a9d403830b04,Skin,56,BC1A2679-829C-4E75-9BD4-26AAA3A9FB65,58BCC596-D401-44A7-85AE-AB47E3C939F9,TCGA-BF-A1PX-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-BF-A1PX,TCGA-SKCM,282,s7828,Harvard Medical School,Cureline,Russia,NO,T4b,N2a,Not available,Stage IIIB
13722.58cfa832e4b0c9d6adf6d00d,58cfa832e4b0c9d6adf6d00d,TCGA-GF-A2C7-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_6_rg.sorted.filtered.,WGS,TCGA-GF-A2C7-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_6_rg.sorted,TCGA-GF-A2C7-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_6_rg.sorted.bam,37.69,NA,0.15,58cfa832e4b0c9d6adf6d00d,TCGA-GF-A2C7-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-GF-A2C7-10A,285D8E2C-F183-49D5-BC1C-FD47C6670ACC,Blood Derived Normal,Illumina HiSeq,eb7c9c39-ce72-4d12-ad47-16a2553d134f,Skin,48,D8D62D62-BF65-4F7D-A2E2-D97A1A0B7F6B,89BB0409-1D64-4FEE-A5CE-39B9AAB6408C,TCGA-GF-A2C7-10A-01D-A190-02,HG19_Broad_variant,TCGA-GF-A2C7,TCGA-SKCM,NA,s7704,Harvard Medical School,ABS - IUPUI,United States,NO,T4b,N0,Not available,Stage IIC
13722.58cfa831e4b0c9d6adf6cd9e,58cfa831e4b0c9d6adf6cd9e,TCGA-FE-A238-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FE-A238-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_5_rg.sorted,TCGA-FE-A238-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_5_rg.sorted.bam,71.81,1.88,0.16,58cfa831e4b0c9d6adf6cd9e,TCGA-FE-A238-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A238-01A,DFFC4F7A-C67A-4AC5-A338-717DFFDE686D,Primary Tumor,Illumina HiSeq,004a2d8a-2dac-4e95-b287-dde59c5f0561,Thyroid,36,D68C3B99-CB82-48BD-A1F8-BEE0A9A9E8C3,BA986EBD-8E2D-4BAF-AC16-FCEB1286F590,TCGA-FE-A238-01A-11D-A16N-02,HG19_Broad_variant,TCGA-FE-A238,TCGA-THCA,NA,s12004,Harvard Medical School,Ohio State University,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c896,58cfa831e4b0c9d6adf6c896,TCGA-DJ-A13V-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DJ-A13V-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_2_rg.sorted,TCGA-DJ-A13V-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_2_rg.sorted.bam,80.38,1.94,0.14,58cfa831e4b0c9d6adf6c896,TCGA-DJ-A13V-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13V-01A,99AC4F2E-2E63-4F1E-AF0F-8F23A2CAF999,Primary Tumor,Illumina HiSeq,a3620988-3968-488b-88e7-9ae555459dc7,Thyroid,21,A870F5CA-F049-48C1-AFAC-B788A3111086,DB0AC00C-ABED-4D02-B05B-A3CD87DCA75F,TCGA-DJ-A13V-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13V,TCGA-THCA,NA,s12634,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa830e4b0c9d6adf6be8d,58cfa830e4b0c9d6adf6be8d,TCGA-BK-A0CB-01A-32D-A101_120330_SN208_0280_AD0UKLACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BK-A0CB-01A-32D-A101_120330_SN208_0280_AD0UKLACXX_s_1_rg.sorted,TCGA-BK-A0CB-01A-32D-A101_120330_SN208_0280_AD0UKLACXX_s_1_rg.sorted.bam,79.7,1.9,0.16,58cfa830e4b0c9d6adf6be8d,TCGA-BK-A0CB-01A-32D-A101_120330_SN208_0280_AD0UKLACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BK-A0CB-01A,59E9029A-8DDD-4447-B35A-72BC39F82A30,Primary Tumor,Illumina HiSeq,2c466122-c49e-4866-b9d4-faf31dde999c,Uterus,60,7678C70D-A298-4472-89A0-427AF1E93D28,F186159C-DCE6-467C-AAAF-BB08FBAE6827,TCGA-BK-A0CB-01A-32D-A101-02,HG19_Broad_variant,TCGA-BK-A0CB,TCGA-UCEC,NA,s5006,Harvard Medical School,Christiana Healthcare,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b6a8,58cfa82fe4b0c9d6adf6b6a8,TCGA-50-5944-10A-01D-1751_111221_SN1120_0106_BD0M7HACXX_s_2_rg.sorted.filtered.,WGS,TCGA-50-5944-10A-01D-1751_111221_SN1120_0106_BD0M7HACXX_s_2_rg.sorted,TCGA-50-5944-10A-01D-1751_111221_SN1120_0106_BD0M7HACXX_s_2_rg.sorted.bam,216.7,1.9,0.16,58cfa82fe4b0c9d6adf6b6a8,TCGA-50-5944-10A-01D-1751_111221_SN1120_0106_BD0M7HACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-50-5944-10A,1C339545-C08A-4A77-B8E9-A7E49E53853F,Blood Derived Normal,Illumina HiSeq,8879c93f-169f-4772-9556-86a9ed97e824,Lung,69,8586678E-D6D9-4B29-BB21-BF7BD0244322,1CB5A4D2-AF01-4F13-921E-068C63417920,TCGA-50-5944-10A-01D-1751-02,HG19_Broad_variant,TCGA-50-5944,TCGA-LUAD,NA,s11241,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N0,Lung Acinar Adenocarcinoma,Stage IA
13722.58cfa831e4b0c9d6adf6c99c,58cfa831e4b0c9d6adf6c99c,TCGA-DK-A3WX-01A-22D-A233_120829_SN1120_0183_AC18U8ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DK-A3WX-01A-22D-A233_120829_SN1120_0183_AC18U8ACXX_s_5_rg.sorted,TCGA-DK-A3WX-01A-22D-A233_120829_SN1120_0183_AC18U8ACXX_s_5_rg.sorted.bam,36.57,NA,0.16,58cfa831e4b0c9d6adf6c99c,TCGA-DK-A3WX-01A-22D-A233_120829_SN1120_0183_AC18U8ACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3WX-01A,D63C186D-ADD6-492E-8250-E83F46D39D00,Primary Tumor,Illumina HiSeq,12365344-0a7a-4ef2-a651-2f1f3a15f6a1,Bladder,67,FED73C89-75F1-45C9-B14B-7840C52C305F,A6D2A8FB-6A01-4625-AEB9-FFA9476B658E,TCGA-DK-A3WX-01A-22D-A233-26,HG19_Broad_variant,TCGA-DK-A3WX,TCGA-BLCA,321,s2899,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82fe4b0c9d6adf6b86e,58cfa82fe4b0c9d6adf6b86e,TCGA-A6-2671-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-A6-2671-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-A6-2671-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,243,1.9,0.15,58cfa82fe4b0c9d6adf6b86e,TCGA-A6-2671-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2671-01A,565E2726-4942-4726-89D3-C5E3797F7204,Primary Tumor,Illumina HiSeq,866dc7b9-86cd-4842-ad2f-1d5e7c714ccb,Colorectal,85,81505915-6C01-4299-AE89-964DC20D93CB,82E23BAF-DA11-4175-BEE0-81C0C0137D72,TCGA-A6-2671-01A-01D-1405-02,HG18,TCGA-A6-2671,TCGA-COAD,NA,s13649,Harvard Medical School,Christiana Healthcare,None,NO,T3,N2,Colon Adenocarcinoma,Stage IV
13722.58cfa832e4b0c9d6adf6d4e0,58cfa832e4b0c9d6adf6d4e0,TCGA-V4-A9F8-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-V4-A9F8-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_7_rg.sorted,TCGA-V4-A9F8-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_7_rg.sorted.bam,11.78,NA,0.14,58cfa832e4b0c9d6adf6d4e0,TCGA-V4-A9F8-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9F8-10A,64BD88BD-1D5A-4569-9F46-F668D448C336,Blood Derived Normal,Illumina HiSeq,f07890a3-2a55-40df-b5d5-c3c2fe47fd3e,Eye,68,1BBE45A1-3D3F-4AD1-986D-3E510F13F1E1,9D61AA78-1EE3-4606-AB37-0B5FF74AA8AF,TCGA-V4-A9F8-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9F8,TCGA-UVM,NA,s264,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa832e4b0c9d6adf6d196,58cfa832e4b0c9d6adf6d196,TCGA-K4-A3WV-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_6_rg.sorted.filtered.,WGS,TCGA-K4-A3WV-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_6_rg.sorted,TCGA-K4-A3WV-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_6_rg.sorted.bam,33.77,NA,0.15,58cfa832e4b0c9d6adf6d196,TCGA-K4-A3WV-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-K4-A3WV-01A,D53EADE8-A845-4252-AECE-92F3573486A7,Primary Tumor,Illumina HiSeq,ca7a6b06-a6fa-4314-80ef-725b81781598,Bladder,77,3ADFA409-A9F8-4EDB-AAF7-C5285AE5F895,9A7CA3A1-631F-41BA-A490-04D470C4AF8E,TCGA-K4-A3WV-01A-11D-A23Q-26,HG19_Broad_variant,TCGA-K4-A3WV,TCGA-BLCA,NA,s2937,MD Anderson - Institute for Applied Cancer Science,ABS - Lahey Clinic,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa830e4b0c9d6adf6bf74,58cfa830e4b0c9d6adf6bf74,TCGA-AP-A0LD-01A-11D-A043_120330_SN1120_0128_AC0L52ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-AP-A0LD-01A-11D-A043_120330_SN1120_0128_AC0L52ACXX_s_6_rg.sorted,TCGA-AP-A0LD-01A-11D-A043_120330_SN1120_0128_AC0L52ACXX_s_6_rg.sorted.bam,84.77,1.86,0.16,58cfa830e4b0c9d6adf6bf74,TCGA-AP-A0LD-01A-11D-A043_120330_SN1120_0128_AC0L52ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LD-01A,1200C8B7-A058-4C01-BBE2-04EC09A65245,Primary Tumor,Illumina HiSeq,aa90984a-1483-43a2-8b20-f1654e3f601e,Uterus,63,649DADDA-5823-4B0D-B5A2-49F501ADC029,3D587F43-D9C5-4E3B-B245-60BB0AE92808,TCGA-AP-A0LD-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A0LD,TCGA-UCEC,NA,s5199,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b938,58cfa82fe4b0c9d6adf6b938,TCGA-64-5779-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-64-5779-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_5_rg.sorted,TCGA-64-5779-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_5_rg.sorted.bam,439.7,1.9,0.15,58cfa82fe4b0c9d6adf6b938,TCGA-64-5779-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-64-5779-01A,1C58D9B8-17A2-4FC6-9898-FE6F47BD2C2A,Primary Tumor,Illumina HiSeq,40156a89-cb76-4ae2-b73d-ec06c1cbd7bb,Lung,61,4131DA8F-3C6C-43E1-A7EB-81CB8988F524,AE15BEF8-478B-432E-B429-643A75BD2EB8,TCGA-64-5779-01A-01D-1623-02,HG19_Broad_variant,TCGA-64-5779,TCGA-LUAD,NA,s11463,Harvard Medical School,Fox Chase,United States,NO,T2,N2,Lung Acinar Adenocarcinoma,Stage IIIA
13722.58cfa831e4b0c9d6adf6c504,58cfa831e4b0c9d6adf6c504,TCGA-CF-A3MG-10A-01D-A210_120914_SN590_0180_BC19KDACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CF-A3MG-10A-01D-A210_120914_SN590_0180_BC19KDACXX_s_8_rg.sorted,TCGA-CF-A3MG-10A-01D-A210_120914_SN590_0180_BC19KDACXX_s_8_rg.sorted.bam,60.19,NA,0.16,58cfa831e4b0c9d6adf6c504,TCGA-CF-A3MG-10A-01D-A210_120914_SN590_0180_BC19KDACXX_s_8_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CF-A3MG-10A,39EFA06A-FFE5-40B3-8F8A-A2D7071BC9E3,Blood Derived Normal,Illumina HiSeq,1385e047-6123-41fc-bd33-96122ff0e918,Bladder,48,97AAAEE6-F7F3-451C-8149-B4A7B783A4FC,640F6D03-1C1B-4B7F-8055-44E1F08FC852,TCGA-CF-A3MG-10A-01D-A210-26,HG19_Broad_variant,TCGA-CF-A3MG,TCGA-BLCA,NA,s3093,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T2,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa82fe4b0c9d6adf6b874,58cfa82fe4b0c9d6adf6b874,TCGA-A5-A0VQ-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_2_rg.sorted.filtered.,WGS,TCGA-A5-A0VQ-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_2_rg.sorted,TCGA-A5-A0VQ-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_2_rg.sorted.bam,105.24,2,0.15,58cfa82fe4b0c9d6adf6b874,TCGA-A5-A0VQ-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0VQ-01A,23489245-48D7-4F19-8A42-E23B1181412B,Primary Tumor,Illumina HiSeq,b4dd6449-2e78-432b-86c6-348339f37763,Uterus,62,952CB6A5-7527-470A-978E-EDD44E3A368F,97FE43D0-30DF-45A1-83F0-B4ED5EDF76AE,TCGA-A5-A0VQ-01A-11D-A101-02,HG19_Broad_variant,TCGA-A5-A0VQ,TCGA-UCEC,NA,s5381,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c866,58cfa831e4b0c9d6adf6c866,TCGA-D6-6823-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-D6-6823-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_1_rg.sorted,TCGA-D6-6823-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_1_rg.sorted.bam,384.7,1.9,0.14,58cfa831e4b0c9d6adf6c866,TCGA-D6-6823-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-D6-6823-01A,FBDAB01C-191C-4AEF-9451-CA3AFEC55FA1,Primary Tumor,Illumina HiSeq,250e5855-f3af-4c16-9efe-918be02bf754,Head and Neck,50,2DA83450-04C2-44D0-AB8A-9CC876242D5A,FE15C318-C3B1-4541-A0DA-4E41D7E99FBB,TCGA-D6-6823-01A-11D-1911-02,HG19_Broad_variant,TCGA-D6-6823,TCGA-HNSC,NA,s15531,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c4b4,58cfa831e4b0c9d6adf6c4b4,TCGA-CE-A13K-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CE-A13K-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_1_rg.sorted,TCGA-CE-A13K-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_1_rg.sorted.bam,88.59,2.02,0.17,58cfa831e4b0c9d6adf6c4b4,TCGA-CE-A13K-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_1_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-CE-A13K-01A,A1227FFA-2733-4A43-BA82-834755453870,Primary Tumor,Illumina HiSeq,7f979498-38e3-4b28-b84a-c3eede43fa06,Thyroid,30,DAF2A444-AB89-48D4-9DA7-888AC3099AB7,7CEF35A1-E530-47C9-9A86-3EA2C970FCD3,TCGA-CE-A13K-01A-11D-A10R-02,HG19_Broad_variant,TCGA-CE-A13K,TCGA-THCA,NA,s12632,Harvard Medical School,ILSbio,Vietnam,NO,T3,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6cb58,58cfa831e4b0c9d6adf6cb58,TCGA-EB-A299-01A-21D-A18Y_120730_SN208_0420_BC12YJACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EB-A299-01A-21D-A18Y_120730_SN208_0420_BC12YJACXX_s_5_rg.sorted,TCGA-EB-A299-01A-21D-A18Y_120730_SN208_0420_BC12YJACXX_s_5_rg.sorted.bam,56.25,NA,0.15,58cfa831e4b0c9d6adf6cb58,TCGA-EB-A299-01A-21D-A18Y_120730_SN208_0420_BC12YJACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EB-A299-01A,90402C32-9548-432E-85B8-A4F80E14401E,Primary Tumor,Illumina HiSeq,8780c547-110c-4e3a-88fa-1feeb9a57ad0,Skin,63,5678AE8F-382C-4167-839E-A160CE6710C7,C164DE0A-E762-48BE-B940-9E5EA31AD026,TCGA-EB-A299-01A-21D-A18Y-02,HG19_Broad_variant,TCGA-EB-A299,TCGA-SKCM,NA,s7844,Harvard Medical School,Asterand,Russia,NO,T2b,N0,Not available,Stage IIA
13722.58cfa830e4b0c9d6adf6c21a,58cfa830e4b0c9d6adf6c21a,TCGA-BA-5153-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BA-5153-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_5_rg.sorted,TCGA-BA-5153-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_5_rg.sorted.bam,422.7,1.9,0.15,58cfa830e4b0c9d6adf6c21a,TCGA-BA-5153-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5153-01A,B3631718-9E0A-454C-BEE1-8F36EBC509D8,Primary Tumor,Illumina HiSeq,3bd56918-8f2b-4486-86ea-e479c2cab413,Head and Neck,51,2DC7070A-9C70-4BB1-9634-8C934BB9C8D1,F14D0AA8-E7BB-4E0E-B887-DA7B6FA0BC86,TCGA-BA-5153-01A-01D-1431-02,HG19_Broad_variant,TCGA-BA-5153,TCGA-HNSC,1762,s16316,Harvard Medical School,UNC,None,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6cfc1,58cfa832e4b0c9d6adf6cfc1,TCGA-FS-A1ZQ-06A-11D-A18Y_120602_SN1120_0147_BD13TBACXX_s_6_rg.sorted.filtered.,WGS,TCGA-FS-A1ZQ-06A-11D-A18Y_120602_SN1120_0147_BD13TBACXX_s_6_rg.sorted,TCGA-FS-A1ZQ-06A-11D-A18Y_120602_SN1120_0147_BD13TBACXX_s_6_rg.sorted.bam,50.02,NA,0.16,58cfa832e4b0c9d6adf6cfc1,TCGA-FS-A1ZQ-06A-11D-A18Y_120602_SN1120_0147_BD13TBACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZQ-06A,B91AF125-A024-4BA3-A5E8-99955FF9EFC5,Metastatic,Illumina HiSeq,62f92046-b8e5-402d-9e66-c3285a06b50f,Skin,31,32C0747F-0DBF-4047-B6D0-AD274724EB93,FA4F4875-8DB0-4CA3-9A4F-72074AE2A7C5,TCGA-FS-A1ZQ-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZQ,TCGA-SKCM,4062,s8026,Harvard Medical School,Essen,Germany,NO,TX,N0,Not available,I or II NOS
13722.58cfa82fe4b0c9d6adf6b994,58cfa82fe4b0c9d6adf6b994,TCGA-50-6591-11A-01D-1751_111111_SN208_0254_B0160ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-50-6591-11A-01D-1751_111111_SN208_0254_B0160ACXX_s_6_rg.sorted,TCGA-50-6591-11A-01D-1751_111111_SN208_0254_B0160ACXX_s_6_rg.sorted.bam,59.4,1.9,0.13,58cfa82fe4b0c9d6adf6b994,TCGA-50-6591-11A-01D-1751_111111_SN208_0254_B0160ACXX_s_6_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-6591-11A,9B132E4F-7E35-4CC5-8711-43AD62B906D0,Solid Tissue Normal,Illumina HiSeq,86f2ae5a-c2aa-41c4-869a-f8ffb3112aa9,Lung,63,76A1F269-62CE-4AE1-A08B-8AF43F853E5A,1BF4CDE2-93BB-4471-B7FD-EBCC768CD8F6,TCGA-50-6591-11A-01D-1751-02,HG19_Broad_variant,TCGA-50-6591,TCGA-LUAD,119,s10786,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IV
13722.58cfa832e4b0c9d6adf6d384,58cfa832e4b0c9d6adf6d384,TCGA-LN-A4A2-10A-01D-A267_131001_SN1120_0279_AC2DKPACXX_s_6_rg.sorted.filtered.,WGS,TCGA-LN-A4A2-10A-01D-A267_131001_SN1120_0279_AC2DKPACXX_s_6_rg.sorted,TCGA-LN-A4A2-10A-01D-A267_131001_SN1120_0279_AC2DKPACXX_s_6_rg.sorted.bam,55.13,NA,0.16,58cfa832e4b0c9d6adf6d384,TCGA-LN-A4A2-10A-01D-A267_131001_SN1120_0279_AC2DKPACXX_s_6_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A4A2-10A,A91C3F09-5F48-4B54-B669-C768F9FE9682,Blood Derived Normal,Illumina HiSeq,851a5275-b983-4599-85c4-1977d891d109,Esophagus,57,837916DC-D5EA-4BA2-99DB-51B8939E11EA,FE78EF12-EB65-4ACC-B5B4-FFADD627B6A0,TCGA-LN-A4A2-10A-01D-A267-26,HG19_Broad_variant,TCGA-LN-A4A2,TCGA-ESCA,NA,s1783,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6c730,58cfa831e4b0c9d6adf6c730,TCGA-D1-A17N-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_6_rg.sorted.filtered.,WGS,TCGA-D1-A17N-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_6_rg.sorted,TCGA-D1-A17N-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_6_rg.sorted.bam,98.78,1.87,0.17,58cfa831e4b0c9d6adf6c730,TCGA-D1-A17N-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_6_rg.sorted.bam,Alive,FEMALE,Not available,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A17N-01A,001E0309-9C50-42B0-9E38-347883EE2CD3,Primary Tumor,Illumina HiSeq,610d595a-df00-4af9-9644-d750501c1737,Uterus,46,F93931BA-8333-4E22-A430-CA02D9DA3FFC,DB0F8EE9-33A0-46CC-8218-59E18B2F824F,TCGA-D1-A17N-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A17N,TCGA-UCEC,NA,s5226,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6baaa,58cfa830e4b0c9d6adf6baaa,TCGA-A5-A0GD-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_3_rg.sorted.filtered.,WGS,TCGA-A5-A0GD-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_3_rg.sorted,TCGA-A5-A0GD-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_3_rg.sorted.bam,96.48,1.95,0.14,58cfa830e4b0c9d6adf6baaa,TCGA-A5-A0GD-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GD-01A,1486A031-B74D-4976-8B0B-4569E6978F49,Primary Tumor,Illumina HiSeq,98b5ea92-9e57-4d1f-937d-8bb0dd2a3cf2,Uterus,75,F449F50A-7664-4DDC-87AA-6A061EE7190C,069406A8-56D7-4E93-8570-7880A99D6C2D,TCGA-A5-A0GD-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0GD,TCGA-UCEC,NA,s4771,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b721,58cfa82fe4b0c9d6adf6b721,TCGA-73-4659-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-73-4659-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-73-4659-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,274.3,1.9,0.16,58cfa82fe4b0c9d6adf6b721,TCGA-73-4659-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4659-11A,CD0DC947-B708-464E-BEB7-954C9D4583E7,Solid Tissue Normal,Illumina HiSeq,b8f31350-d0a7-4223-90f8-280be07f9351,Lung,66,C3A0A2B9-B84B-48DF-BE21-1B2D9EBC7955,F44A21FC-E317-42C7-BAB8-F0E1AC8331EB,TCGA-73-4659-11A-01D-1203-02,GRCh37,TCGA-73-4659,TCGA-LUAD,711,s11354,Harvard Medical School,Roswell Park,United States,NO,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa830e4b0c9d6adf6bfc0,58cfa830e4b0c9d6adf6bfc0,TCGA-B5-A0JS-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_4_rg.sorted.filtered.,WGS,TCGA-B5-A0JS-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_4_rg.sorted,TCGA-B5-A0JS-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_4_rg.sorted.bam,61.49,1.87,0.17,58cfa830e4b0c9d6adf6bfc0,TCGA-B5-A0JS-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0JS-01A,0DA7BBD4-ED8D-474B-B494-CB93C5FA811E,Primary Tumor,Illumina HiSeq,06607d3e-b9f0-4332-aee8-7001d26e7d12,Uterus,54,D0B88B1C-150D-4ABC-9F9E-8C51CB208EFA,D2DD7ED4-03F6-463E-94BD-6CF98D80E8FD,TCGA-B5-A0JS-01A-11D-A101-02,HG19_Broad_variant,TCGA-B5-A0JS,TCGA-UCEC,NA,s5208,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c804,58cfa831e4b0c9d6adf6c804,TCGA-D1-A2G6-01A-11D-A17E_120511_SN208_0299_BD12J9ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-D1-A2G6-01A-11D-A17E_120511_SN208_0299_BD12J9ACXX_s_7_rg.sorted,TCGA-D1-A2G6-01A-11D-A17E_120511_SN208_0299_BD12J9ACXX_s_7_rg.sorted.bam,60.54,NA,0.18,58cfa831e4b0c9d6adf6c804,TCGA-D1-A2G6-01A-11D-A17E_120511_SN208_0299_BD12J9ACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A2G6-01A,46CD8DED-F8A1-4F8C-A4C2-2D5B51C04F18,Primary Tumor,Illumina HiSeq,4ac2b259-f781-4a71-b271-2d326472c965,Uterus,53,2127E58B-BD7B-490E-B34B-4F626B2A4053,079C1D47-95AC-456B-8DD5-C89B4076E578,TCGA-D1-A2G6-01A-11D-A17E-02,HG19_Broad_variant,TCGA-D1-A2G6,TCGA-UCEC,258,s5230,Harvard Medical School,Mayo Clinic,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c394,58cfa831e4b0c9d6adf6c394,TCGA-BJ-A0Z5-10A-01D-A10R_120616_SN1120_0153_AC0WMJACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BJ-A0Z5-10A-01D-A10R_120616_SN1120_0153_AC0WMJACXX_s_4_rg.sorted,TCGA-BJ-A0Z5-10A-01D-A10R_120616_SN1120_0153_AC0WMJACXX_s_4_rg.sorted.bam,16.85,2.05,0.16,58cfa831e4b0c9d6adf6c394,TCGA-BJ-A0Z5-10A-01D-A10R_120616_SN1120_0153_AC0WMJACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0Z5-10A,0FE3B19A-F5E4-497E-92DA-32FF6C77B066,Blood Derived Normal,Illumina HiSeq,db8a561b-7268-464c-851c-223c161825ed,Thyroid,58,8C067558-66E7-43F3-8332-6CB96F657B4C,0707D604-60AA-4399-9703-E9758C0BA08A,TCGA-BJ-A0Z5-10A-01D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0Z5,TCGA-THCA,NA,s12230,Harvard Medical School,University of Pittsburgh,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa830e4b0c9d6adf6c073,58cfa830e4b0c9d6adf6c073,TCGA-BJ-A0ZE-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BJ-A0ZE-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_7_rg.sorted,TCGA-BJ-A0ZE-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_7_rg.sorted.bam,15.88,1.98,0.16,58cfa830e4b0c9d6adf6c073,TCGA-BJ-A0ZE-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0ZE-10A,AB8C9101-ADEB-4C43-A8BB-B089EBD711F6,Blood Derived Normal,Illumina HiSeq,4568433f-6965-4efc-8d70-3369d6a70e72,Thyroid,63,ABE80C37-F3CB-4A56-9C18-9080057AA81D,9A3C6D5A-4AD4-40BC-A4B0-69544AA5A5D0,TCGA-BJ-A0ZE-10A-01D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZE,TCGA-THCA,NA,s12229,Harvard Medical School,University of Pittsburgh,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa831e4b0c9d6adf6ca9e,58cfa831e4b0c9d6adf6ca9e,TCGA-D3-A1QB-06A-11D-A18Z_120626_SN590_0164_BC0VMVACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D3-A1QB-06A-11D-A18Z_120626_SN590_0164_BC0VMVACXX_s_3_rg.sorted,TCGA-D3-A1QB-06A-11D-A18Z_120626_SN590_0164_BC0VMVACXX_s_3_rg.sorted.bam,67.14,NA,0.18,58cfa831e4b0c9d6adf6ca9e,TCGA-D3-A1QB-06A-11D-A18Z_120626_SN590_0164_BC0VMVACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A1QB-06A,C59A5615-2DD1-4902-A62B-0E312EAB5484,Metastatic,Illumina HiSeq,6f1f7dfb-3aa1-435f-a587-d289d5b4872a,Skin,75,52F51508-F3A2-4752-A0E5-8CF0160D5CE1,7D4C74D8-F98C-43B4-AB7F-28E9DCB0D961,TCGA-D3-A1QB-06A-11D-A18Z-02,HG19_Broad_variant,TCGA-D3-A1QB,TCGA-SKCM,NA,s7831,Harvard Medical School,MD Anderson,United States,NO,T0,N2c,Not available,Stage III
13722.58cfa831e4b0c9d6adf6cc9e,58cfa831e4b0c9d6adf6cc9e,TCGA-EE-A2MH-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EE-A2MH-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_5_rg.sorted,TCGA-EE-A2MH-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_5_rg.sorted.bam,35.5,NA,0.18,58cfa831e4b0c9d6adf6cc9e,TCGA-EE-A2MH-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MH-10A,BD2345ED-33B8-4010-8479-4D6C67E29561,Blood Derived Normal,Illumina HiSeq,7ea403bb-8745-4d11-b0a5-e6b28b5c7114,Skin,66,BA0B86CE-0A55-4698-A73D-966F4D2C88B3,595733A4-7B2B-4052-8A2E-66E910D9A28F,TCGA-EE-A2MH-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2MH,TCGA-SKCM,516,s7687,Harvard Medical School,University of Sydney,Australia,NO,T4a,N0,Not available,Stage III
13722.58cfa832e4b0c9d6adf6cfda,58cfa832e4b0c9d6adf6cfda,TCGA-FS-A1ZJ-06A-12D-A18Y_120605_SN1222_0113_BC0WUCACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FS-A1ZJ-06A-12D-A18Y_120605_SN1222_0113_BC0WUCACXX_s_1_rg.sorted,TCGA-FS-A1ZJ-06A-12D-A18Y_120605_SN1222_0113_BC0WUCACXX_s_1_rg.sorted.bam,67.75,NA,0.16,58cfa832e4b0c9d6adf6cfda,TCGA-FS-A1ZJ-06A-12D-A18Y_120605_SN1222_0113_BC0WUCACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZJ-06A,2F0661E5-5006-481E-9B40-7B1EC96EAA3C,Metastatic,Illumina HiSeq,54b65a8a-8a6e-4bb3-96ce-4ae0b250e615,Skin,75,73FDF583-1BDB-41AA-98B9-1E433023A144,16D2CC2B-3D7C-4180-8AE2-B8A977064CE6,TCGA-FS-A1ZJ-06A-12D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZJ,TCGA-SKCM,1441,s7370,Harvard Medical School,Essen,Germany,NO,T2,N0,Not available,Stage I
13722.58cfa832e4b0c9d6adf6d4d0,58cfa832e4b0c9d6adf6d4d0,TCGA-V4-A9F5-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-V4-A9F5-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_5_rg.sorted,TCGA-V4-A9F5-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_5_rg.sorted.bam,11.84,NA,0.16,58cfa832e4b0c9d6adf6d4d0,TCGA-V4-A9F5-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9F5-10A,BBF07E1F-8C17-4C2E-89ED-38332D82E455,Blood Derived Normal,Illumina HiSeq,33f50b70-0a01-4be3-8b48-20c7ba37721e,Eye,85,01218558-DF35-423E-A4A5-9237F6B3BCCE,839EE0D1-59B0-4818-BEE2-43500FF6C271,TCGA-V4-A9F5-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9F5,TCGA-UVM,NA,s278,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4e,N0,Not available,Stage IV
13722.58cfa830e4b0c9d6adf6bdf4,58cfa830e4b0c9d6adf6bdf4,TCGA-AG-A014-01A-02D-A077_110504_SN590_0081_BB0BM5ABXX_s_6_rg.sorted.filtered.,WGS,TCGA-AG-A014-01A-02D-A077_110504_SN590_0081_BB0BM5ABXX_s_6_rg.sorted,TCGA-AG-A014-01A-02D-A077_110504_SN590_0081_BB0BM5ABXX_s_6_rg.sorted.bam,223.31,1.73,0.15,58cfa830e4b0c9d6adf6bdf4,TCGA-AG-A014-01A-02D-A077_110504_SN590_0081_BB0BM5ABXX_s_6_rg.sorted.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A014-01A,51C37449-6A2E-4C3D-A7CC-06F901E1224F,Primary Tumor,Illumina HiSeq,b165eaa6-faee-4f3f-967e-55f2b4b0bba2,Colorectal,86,FBFA61FE-4FB7-4B2A-9BF0-33140FD41873,7771CB7E-1405-4B8E-86B5-0E06A0EB7FD1,TCGA-AG-A014-01A-02D-A077-02,HG18_Broad_variant,TCGA-AG-A014,TCGA-READ,NA,s2000,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa832e4b0c9d6adf6ce24,58cfa832e4b0c9d6adf6ce24,TCGA-FI-A2D0-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FI-A2D0-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_4_rg.sorted,TCGA-FI-A2D0-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_4_rg.sorted.bam,151.56,NA,0.16,58cfa832e4b0c9d6adf6ce24,TCGA-FI-A2D0-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-FI-A2D0-10A,1B35D083-F7C9-47D2-9A9E-718788F9E39A,Blood Derived Normal,Illumina HiSeq,452078a9-1e91-4915-9a31-397391041482,Uterus,55,96923E73-5E5F-4234-BF2E-E34EAE4C0AB5,FB0BFE72-D375-41D6-90F6-DF04FA514215,TCGA-FI-A2D0-10A-01D-A17E-02,HG19_Broad_variant,TCGA-FI-A2D0,TCGA-UCEC,NA,s4806,Harvard Medical School,Washington University,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6be3a,58cfa830e4b0c9d6adf6be3a,TCGA-BJ-A18Z-01A-21D-A13U_120712_SN1222_0125_BD13TPACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BJ-A18Z-01A-21D-A13U_120712_SN1222_0125_BD13TPACXX_s_1_rg.sorted,TCGA-BJ-A18Z-01A-21D-A13U_120712_SN1222_0125_BD13TPACXX_s_1_rg.sorted.bam,45.3,1.98,0.17,58cfa830e4b0c9d6adf6be3a,TCGA-BJ-A18Z-01A-21D-A13U_120712_SN1222_0125_BD13TPACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A18Z-01A,0D497FAF-2C1C-4173-A5FE-770CCA73323C,Primary Tumor,Illumina HiSeq,a740c90f-9cbc-4ff1-8cad-c78d4dbb92cf,Thyroid,58,19DEE039-9C98-4D4A-8BAF-EEA1B6DDA8EB,815C53C3-8ADD-4612-B93C-3ED4BFA530AA,TCGA-BJ-A18Z-01A-21D-A13U-02,HG19_Broad_variant,TCGA-BJ-A18Z,TCGA-THCA,NA,s12354,Harvard Medical School,University of Pittsburgh,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA
13722.58cfa832e4b0c9d6adf6d1a8,58cfa832e4b0c9d6adf6d1a8,TCGA-HT-7472-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_7_rg.sorted.filtered.,WGS,TCGA-HT-7472-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_7_rg.sorted,TCGA-HT-7472-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_7_rg.sorted.bam,62.7,NA,0.17,58cfa832e4b0c9d6adf6d1a8,TCGA-HT-7472-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7472-01A,482D4078-7576-48CF-BF7C-29014935FD47,Primary Tumor,Illumina HiSeq,518f9b23-97da-447f-90e5-a03c5ae09642,Brain,38,F05081A2-2465-4EA4-9EC3-319810FE2D45,A68374D7-4782-4FF5-B921-35D45468A4D1,TCGA-HT-7472-01A-11D-2022-02,HG19_Broad_variant,TCGA-HT-7472,TCGA-LGG,NA,s8574,Harvard Medical School,Case Western - St Joes,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6c6da,58cfa831e4b0c9d6adf6c6da,TCGA-CS-6186-10A-01D-2022_130910_SN208_0494_AC2A1DACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CS-6186-10A-01D-2022_130910_SN208_0494_AC2A1DACXX_s_4_rg.sorted,TCGA-CS-6186-10A-01D-2022_130910_SN208_0494_AC2A1DACXX_s_4_rg.sorted.bam,250,1.9,0.16,58cfa831e4b0c9d6adf6c6da,TCGA-CS-6186-10A-01D-2022_130910_SN208_0494_AC2A1DACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-6186-10A,9EE6E821-3AF2-42D7-9D14-F0CA455F338C,Blood Derived Normal,Illumina HiSeq,e995755c-602f-4204-8174-82c097701e8a,Brain,58,8443AA4F-9650-45F4-921B-927C1F00A31C,1B2818EA-5C5F-4464-9DBF-0FFEDD77A707,TCGA-CS-6186-10A-01D-2022-02,HG19_Broad_variant,TCGA-CS-6186,TCGA-LGG,538,s8128,Harvard Medical School,Thomas Jefferson University,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa831e4b0c9d6adf6cdb4,58cfa831e4b0c9d6adf6cdb4,TCGA-FE-A231-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FE-A231-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_1_rg.sorted,TCGA-FE-A231-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_1_rg.sorted.bam,101.76,2.16,0.16,58cfa831e4b0c9d6adf6cdb4,TCGA-FE-A231-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A231-01A,7044DEE0-FD6C-4E75-B731-DC60A386A1AB,Primary Tumor,Illumina HiSeq,2983a837-7d6a-4e9d-a68a-a3aa674fbb8b,Thyroid,70,96C298EB-0699-42AE-B2EA-63A192353D69,056B3922-279A-4869-A933-0C53C1137450,TCGA-FE-A231-01A-11D-A14U-02,HG19_Broad_variant,TCGA-FE-A231,TCGA-THCA,NA,s12256,Harvard Medical School,Ohio State University,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA
13722.58cfa831e4b0c9d6adf6c8e0,58cfa831e4b0c9d6adf6c8e0,TCGA-DK-A3IV-01A-22D-A21C_120830_SN590_0177_BD141PACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DK-A3IV-01A-22D-A21C_120830_SN590_0177_BD141PACXX_s_7_rg.sorted,TCGA-DK-A3IV-01A-22D-A21C_120830_SN590_0177_BD141PACXX_s_7_rg.sorted.bam,71.23,NA,0.16,58cfa831e4b0c9d6adf6c8e0,TCGA-DK-A3IV-01A-22D-A21C_120830_SN590_0177_BD141PACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3IV-01A,F953DC5D-58BF-4936-B9FE-74B45E8C00E5,Primary Tumor,Illumina HiSeq,5bf5cb9d-7592-4967-8440-fe80dfe9c2a6,Bladder,60,BC065247-1179-4FC2-B45C-8EFB13AADE65,62148C98-8E6F-4CA0-9EC6-C7FD7F96495D,TCGA-DK-A3IV-01A-22D-A21C-26,HG19_Broad_variant,TCGA-DK-A3IV,TCGA-BLCA,294,s3108,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6cc66,58cfa831e4b0c9d6adf6cc66,TCGA-EB-A24D-01A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EB-A24D-01A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_4_rg.sorted,TCGA-EB-A24D-01A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_4_rg.sorted.bam,62.95,NA,0.16,58cfa831e4b0c9d6adf6cc66,TCGA-EB-A24D-01A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EB-A24D-01A,D7EE2693-39A8-4E3A-B6F6-E4729800E34E,Primary Tumor,Illumina HiSeq,44c42419-04e6-439f-aceb-e330fd514f35,Skin,72,A74E2FEC-291C-4967-AFE3-101955578225,0FD8F30A-936E-4A72-AA69-4DAC1E4BCE49,TCGA-EB-A24D-01A-11D-A18Y-02,HG19_Broad_variant,TCGA-EB-A24D,TCGA-SKCM,NA,s7508,Harvard Medical School,Asterand,Ukraine,NO,T4a,N2b,Not available,Stage IIIB
13722.58cfa832e4b0c9d6adf6d182,58cfa832e4b0c9d6adf6d182,TCGA-FI-A2D4-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FI-A2D4-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_8_rg.sorted,TCGA-FI-A2D4-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_8_rg.sorted.bam,114.51,NA,0.17,58cfa832e4b0c9d6adf6d182,TCGA-FI-A2D4-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-FI-A2D4-10A,490AE247-EE67-48D4-94ED-93DF5B9BBEFE,Blood Derived Normal,Illumina HiSeq,5e4179ce-75a2-4122-b1a8-62dda9ba7956,Uterus,44,3BBCA20D-49CD-43EC-A564-7CB92F0B21A0,A5A21FE6-266C-4A55-A57D-CE21AEB1C50A,TCGA-FI-A2D4-10A-01D-A17E-02,HG19_Broad_variant,TCGA-FI-A2D4,TCGA-UCEC,243,s4449,Harvard Medical School,Washington University,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6caa8,58cfa831e4b0c9d6adf6caa8,TCGA-D1-A16X-10A-01D-A12F_120413_SN1120_0133_BC0J8UACXX_s_2_rg.sorted.filtered.,WGS,TCGA-D1-A16X-10A-01D-A12F_120413_SN1120_0133_BC0J8UACXX_s_2_rg.sorted,TCGA-D1-A16X-10A-01D-A12F_120413_SN1120_0133_BC0J8UACXX_s_2_rg.sorted.bam,51.17,2,0.17,58cfa831e4b0c9d6adf6caa8,TCGA-D1-A16X-10A-01D-A12F_120413_SN1120_0133_BC0J8UACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A16X-10A,22618073-4EF0-4C3A-97B9-90BA1CAA1D72,Blood Derived Normal,Illumina HiSeq,39003c18-13a0-4376-81fa-0efb483df6bb,Uterus,54,6E19DB42-C247-4736-9204-E279B2C50B37,A5170FF0-1D2C-48BD-B254-4978E17794EE,TCGA-D1-A16X-10A-01D-A12F-02,HG19_Broad_variant,TCGA-D1-A16X,TCGA-UCEC,NA,s5020,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c7bc,58cfa831e4b0c9d6adf6c7bc,TCGA-CN-6019-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CN-6019-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_4_rg.sorted,TCGA-CN-6019-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_4_rg.sorted.bam,172,1.9,0.15,58cfa831e4b0c9d6adf6c7bc,TCGA-CN-6019-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-6019-01A,EE3061EC-273C-4BEF-A325-35E9C469BF01,Primary Tumor,Illumina HiSeq,e7b9cb7d-0a1a-4461-ab89-108d02821762,Head and Neck,61,AC349695-2219-4A67-ADD5-A94FF85794E1,2C509E96-12D7-4DBB-A02F-DCDCC6F76952,TCGA-CN-6019-01A-11D-1681-02,HG19_Broad_variant,TCGA-CN-6019,TCGA-HNSC,NA,s16178,Harvard Medical School,University of Pittsburgh,United States,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c982,58cfa831e4b0c9d6adf6c982,TCGA-D7-6520-10A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_8_rg.sorted.filtered.,WGS,TCGA-D7-6520-10A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_8_rg.sorted,TCGA-D7-6520-10A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_8_rg.sorted.bam,377.7,1.9,0.15,58cfa831e4b0c9d6adf6c982,TCGA-D7-6520-10A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6520-10A,3C573AF6-6298-49DE-8DE0-6A7F9CE9B000,Blood Derived Normal,Illumina HiSeq,c35f64e9-94a7-4b34-aba4-01aea848176d,Stomach,53,08B577B2-7497-4C99-8963-D8E70CFFA135,24639C02-25A3-48D6-B248-C46DFF509941,TCGA-D7-6520-10A-01D-1798-02,HG19_Broad_variant,TCGA-D7-6520,TCGA-STAD,NA,s14643,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2b,N2,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIIA
13722.58cfa82fe4b0c9d6adf6b852,58cfa82fe4b0c9d6adf6b852,TCGA-A5-A0R9-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_5_rg.sorted.filtered.,WGS,TCGA-A5-A0R9-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_5_rg.sorted,TCGA-A5-A0R9-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_5_rg.sorted.bam,112.95,1.93,0.17,58cfa82fe4b0c9d6adf6b852,TCGA-A5-A0R9-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0R9-01A,284174FD-1320-4617-9E99-75BD75DF9BF3,Primary Tumor,Illumina HiSeq,4139f46d-ae94-47a2-a3ae-0b96262c6a89,Uterus,51,986AC6AC-087F-412B-BB0C-9BE10D104989,6BBEF031-7106-4D36-86A9-F8A2333448BB,TCGA-A5-A0R9-01A-11D-A101-02,HG19_Broad_variant,TCGA-A5-A0R9,TCGA-UCEC,NA,s4419,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d17a,58cfa832e4b0c9d6adf6d17a,TCGA-K4-A3WV-10A-01D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_7_rg.sorted.filtered.,WGS,TCGA-K4-A3WV-10A-01D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_7_rg.sorted,TCGA-K4-A3WV-10A-01D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_7_rg.sorted.bam,24.03,NA,0.17,58cfa832e4b0c9d6adf6d17a,TCGA-K4-A3WV-10A-01D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-K4-A3WV-10A,D53EADE8-A845-4252-AECE-92F3573486A7,Blood Derived Normal,Illumina HiSeq,015c156d-7402-4fca-8adb-dbd88fbd9136,Bladder,77,BB5CD3CB-6946-4178-A1BB-2CD75E5F61BD,019DB289-ECE0-4A5C-8BA9-65BE2BB7635F,TCGA-K4-A3WV-10A-01D-A23Q-26,HG19_Broad_variant,TCGA-K4-A3WV,TCGA-BLCA,NA,s2936,MD Anderson - Institute for Applied Cancer Science,ABS - Lahey Clinic,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c360,58cfa831e4b0c9d6adf6c360,TCGA-CG-5719-10A-01D-1598_121029_SN208_0439_BD1KHKACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CG-5719-10A-01D-1598_121029_SN208_0439_BD1KHKACXX_s_3_rg.sorted,TCGA-CG-5719-10A-01D-1598_121029_SN208_0439_BD1KHKACXX_s_3_rg.sorted.bam,94.7,1.8,0.15,58cfa831e4b0c9d6adf6c360,TCGA-CG-5719-10A-01D-1598_121029_SN208_0439_BD1KHKACXX_s_3_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5719-10A,263F67E0-0A28-42E6-B3F3-1DDD0D397220,Blood Derived Normal,Illumina HiSeq,74d5e460-86bd-441b-9409-00b8f0248eb9,Stomach,54,6CF9DAA3-1ED5-45C2-9A6F-3340D256C9D7,B0A51CDD-A3AC-4497-B9CB-3B766E4A549F,TCGA-CG-5719-10A-01D-1598-02,HG19_Broad_variant,TCGA-CG-5719,TCGA-STAD,NA,s14902,Harvard Medical School,Indivumed,Germany,NO,T4,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa831e4b0c9d6adf6c68a,58cfa831e4b0c9d6adf6c68a,TCGA-CU-A0YR-01A-12D-A10R_120926_SN590_0182_BD1EAGACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CU-A0YR-01A-12D-A10R_120926_SN590_0182_BD1EAGACXX_s_7_rg.sorted,TCGA-CU-A0YR-01A-12D-A10R_120926_SN590_0182_BD1EAGACXX_s_7_rg.sorted.bam,36.74,1.82,0.16,58cfa831e4b0c9d6adf6c68a,TCGA-CU-A0YR-01A-12D-A10R_120926_SN590_0182_BD1EAGACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CU-A0YR-01A,811B3950-36E7-485F-BC48-ACA1EEE2DDEF,Primary Tumor,Illumina HiSeq,197d19a7-07c1-4cd3-b41d-a8233c9d8a42,Bladder,83,B362FCFA-4E31-4321-9E17-11A8BAE839C3,0CB51232-CFEA-4F4F-A26A-173B1094A64B,TCGA-CU-A0YR-01A-12D-A10R-02,HG19_Broad_variant,TCGA-CU-A0YR,TCGA-BLCA,NA,s3096,Harvard Medical School,UNC,United States,NO,T2,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6d1e4,58cfa832e4b0c9d6adf6d1e4,TCGA-FG-6688-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FG-6688-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_3_rg.sorted,TCGA-FG-6688-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_3_rg.sorted.bam,107,1.9,0.15,58cfa832e4b0c9d6adf6d1e4,TCGA-FG-6688-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_3_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-6688-10A,DADD7428-9E4D-4652-9469-AB521B88D529,Blood Derived Normal,Illumina HiSeq,ed5c4e17-1960-4f9e-9152-02db5a6f6ec9,Brain,59,845A2B47-F2B9-431C-8E95-B2DDCB1F6DF0,898DE9F3-554F-4445-B365-D8C2F9B85780,TCGA-FG-6688-10A-01D-1891-02,HG19_Broad_variant,TCGA-FG-6688,TCGA-LGG,NA,s8571,Harvard Medical School,Case Western,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6cc18,58cfa831e4b0c9d6adf6cc18,TCGA-DU-7290-10A-01D-2022_130910_SN208_0495_BD2FGNACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DU-7290-10A-01D-2022_130910_SN208_0495_BD2FGNACXX_s_8_rg.sorted,TCGA-DU-7290-10A-01D-2022_130910_SN208_0495_BD2FGNACXX_s_8_rg.sorted.bam,74,NA,0.13,58cfa831e4b0c9d6adf6cc18,TCGA-DU-7290-10A-01D-2022_130910_SN208_0495_BD2FGNACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7290-10A,E00A9855-C15E-46EF-988F-25CA64EC4717,Blood Derived Normal,Illumina HiSeq,3a7ec773-52e2-4eed-bd70-2dc1f059a2ec,Brain,45,BC285F76-F7AE-4E4A-8D30-3AD400926D14,74D15A12-81B2-407D-A75E-C8C6297FFAB2,TCGA-DU-7290-10A-01D-2022-02,HG19_Broad_variant,TCGA-DU-7290,TCGA-LGG,315,s8356,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa832e4b0c9d6adf6d126,58cfa832e4b0c9d6adf6d126,TCGA-FY-A3ON-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FY-A3ON-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_1_rg.sorted,TCGA-FY-A3ON-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_1_rg.sorted.bam,44.16,NA,0.14,58cfa832e4b0c9d6adf6d126,TCGA-FY-A3ON-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FY-A3ON-01A,4D1AEC67-C345-4721-8EE8-356B0DFF009B,Primary Tumor,Illumina HiSeq,276539e6-e471-4dc2-96e7-0c80fb486af1,Thyroid,20,1392A49C-87BC-45E7-B7D2-ACD53E921467,68FEC551-495D-47E6-BF85-FBD422FC68D6,TCGA-FY-A3ON-01A-11D-A221-26,HG19_Broad_variant,TCGA-FY-A3ON,TCGA-THCA,NA,s12121,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T2,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6cf6c,58cfa832e4b0c9d6adf6cf6c,TCGA-G9-6496-01A-11D-1784_130131_SN1120_0234_AD1PVUACXX_s_3_rg.sorted.filtered.,WGS,TCGA-G9-6496-01A-11D-1784_130131_SN1120_0234_AD1PVUACXX_s_3_rg.sorted,TCGA-G9-6496-01A-11D-1784_130131_SN1120_0234_AD1PVUACXX_s_3_rg.sorted.bam,223.4,1.9,0.14,58cfa832e4b0c9d6adf6cf6c,TCGA-G9-6496-01A-11D-1784_130131_SN1120_0234_AD1PVUACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6496-01A,CE2B7E17-424E-4954-8A68-19D7F98D2E7E,Primary Tumor,Illumina HiSeq,9bf9f3ef-b79e-4a93-8df6-ab2b9a3f24aa,Prostate,61,ECE85143-957D-4AD1-BFCC-B71307EFB911,10BB38BE-9E75-4793-89B5-7BB19D7AA4F8,TCGA-G9-6496-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6496,TCGA-PRAD,NA,s3619,Harvard Medical School,Roswell Park,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cb42,58cfa831e4b0c9d6adf6cb42,TCGA-EE-A29B-06A-11D-A18Y_120807_SN590_0173_AC0VN5ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EE-A29B-06A-11D-A18Y_120807_SN590_0173_AC0VN5ACXX_s_1_rg.sorted,TCGA-EE-A29B-06A-11D-A18Y_120807_SN590_0173_AC0VN5ACXX_s_1_rg.sorted.bam,66.45,NA,0.17,58cfa831e4b0c9d6adf6cb42,TCGA-EE-A29B-06A-11D-A18Y_120807_SN590_0173_AC0VN5ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29B-06A,905EA29F-588A-497B-9F06-2EEF3BDC9442,Metastatic,Illumina HiSeq,0d511b2e-752b-43a4-b27f-81a205cac15e,Skin,67,73ED3AA7-1AAD-42B6-AC8A-1CA284A75A48,4A8251BE-6505-4681-AB78-55086FC7D877,TCGA-EE-A29B-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A29B,TCGA-SKCM,NA,s7677,Harvard Medical School,University of Sydney,Australia,NO,T3b,N0,Not available,Stage IIB
13722.58cfa82fe4b0c9d6adf6b9d4,58cfa82fe4b0c9d6adf6b9d4,TCGA-AA-A01I-10A-01D-A078_110326_SN590_0061_B702DPABXX_s_4_rg.sorted.filtered.,WGS,TCGA-AA-A01I-10A-01D-A078_110326_SN590_0061_B702DPABXX_s_4_rg.sorted,TCGA-AA-A01I-10A-01D-A078_110326_SN590_0061_B702DPABXX_s_4_rg.sorted.bam,25.35,1.75,0.15,58cfa82fe4b0c9d6adf6b9d4,TCGA-AA-A01I-10A-01D-A078_110326_SN590_0061_B702DPABXX_s_4_rg.sorted.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01I-10A,86D18004-9478-4E46-83B4-4FBE445CCB70,Blood Derived Normal,Illumina HiSeq,4c584f48-2e93-4b94-91b6-ee509cff0531,Colorectal,76,65CF8358-D83A-4ED2-98B7-5E75A73D77B9,88062B48-3BB7-4FC4-852E-4E26715F74D3,TCGA-AA-A01I-10A-01D-A078-02,HG18_Broad_variant,TCGA-AA-A01I,TCGA-COAD,NA,s13202,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa82fe4b0c9d6adf6ba02,58cfa82fe4b0c9d6adf6ba02,TCGA-AA-A01I-01A-02D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A01I-01A-02D-A077-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A01I-01A-02D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,237.83,1.78,0.15,58cfa82fe4b0c9d6adf6ba02,TCGA-AA-A01I-01A-02D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01I-01A,86D18004-9478-4E46-83B4-4FBE445CCB70,Primary Tumor,Illumina HiSeq,397e6c0b-1bf2-43ff-b659-15147ee8be30,Colorectal,76,FBA03796-B9C8-4042-9720-F21660CFEC28,DAED1A71-909A-42D8-87B4-6760B54D91AF,TCGA-AA-A01I-01A-02D-A077-02,HG18,TCGA-AA-A01I,TCGA-COAD,NA,s13201,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d0c8,58cfa832e4b0c9d6adf6d0c8,TCGA-FS-A1ZN-01A-11D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FS-A1ZN-01A-11D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_2_rg.sorted,TCGA-FS-A1ZN-01A-11D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_2_rg.sorted.bam,65.89,NA,0.15,58cfa832e4b0c9d6adf6d0c8,TCGA-FS-A1ZN-01A-11D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZN-01A,9D86940D-50FB-4D2F-8B1E-539196885F46,Primary Tumor,Illumina HiSeq,497c930e-47cd-4669-a434-af770d331308,Skin,43,C6C66FAF-676B-4302-B825-143E1E72D04D,507A59F5-70A6-464C-ADA3-3E686414045A,TCGA-FS-A1ZN-01A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZN,TCGA-SKCM,730,s7372,Harvard Medical School,Essen,Germany,NO,T4b,N1a,Not available,Stage IIIA
13722.58cfa830e4b0c9d6adf6be98,58cfa830e4b0c9d6adf6be98,TCGA-AG-3896-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3896-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3896-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,44.59,1.9,0.14,58cfa830e4b0c9d6adf6be98,TCGA-AG-3896-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3896-10A,9AF35239-FFB9-4D4F-889E-F743DA271EEF,Blood Derived Normal,Illumina HiSeq,5936dd60-e257-4b23-9cd8-a67a0afcbb78,Colorectal,85,C8B8CE61-200B-4FD8-B315-CA68823CFBCC,08DEACDA-23DF-416A-8235-E5342322D44F,TCGA-AG-3896-10A-01D-1115-02,HG18,TCGA-AG-3896,TCGA-READ,NA,s2168,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c624,58cfa831e4b0c9d6adf6c624,TCGA-CG-4301-10A-01D-1154_130218_SN208_0453_AC1T26ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CG-4301-10A-01D-1154_130218_SN208_0453_AC1T26ACXX_s_8_rg.sorted,TCGA-CG-4301-10A-01D-1154_130218_SN208_0453_AC1T26ACXX_s_8_rg.sorted.bam,80.6,1.9,0.15,58cfa831e4b0c9d6adf6c624,TCGA-CG-4301-10A-01D-1154_130218_SN208_0453_AC1T26ACXX_s_8_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4301-10A,7E13FE2A-3D6E-487F-900D-F5891D986AA2,Blood Derived Normal,Illumina HiSeq,6015c990-2a38-459d-9d91-64c1561fac75,Stomach,75,7189941F-88C7-4E4A-94E9-D9E9EBEE1CDE,D9A32B4F-0323-45B8-97B8-C88E75E95431,TCGA-CG-4301-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4301,TCGA-STAD,NA,s15190,Harvard Medical School,Indivumed,Germany,NO,T4,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa831e4b0c9d6adf6c8cc,58cfa831e4b0c9d6adf6c8cc,TCGA-D7-5579-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D7-5579-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_3_rg.sorted,TCGA-D7-5579-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_3_rg.sorted.bam,84.7,1.89,0.15,58cfa831e4b0c9d6adf6c8cc,TCGA-D7-5579-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-5579-01A,8B5746F9-DBEE-40BD-9141-1081960CF286,Primary Tumor,Illumina HiSeq,269741db-5bad-48aa-af11-42d222310df9,Stomach,74,633DCE5B-7A88-46DC-AD06-8897A609675B,CFF33A88-0211-46EE-AB5B-78F56C63E2A6,TCGA-D7-5579-01A-01D-1598-02,HG19_Broad_variant,TCGA-D7-5579,TCGA-STAD,NA,s15198,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T3,N2,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage IIIA
13722.58cfa82ee4b0c9d6adf6af63,58cfa82ee4b0c9d6adf6af63,TCGA-05-4433-10A-01D-1853_120312_SN1120_0120_AD0PYGACXX_s_4_rg.sorted.filtered.,WGS,TCGA-05-4433-10A-01D-1853_120312_SN1120_0120_AD0PYGACXX_s_4_rg.sorted,TCGA-05-4433-10A-01D-1853_120312_SN1120_0120_AD0PYGACXX_s_4_rg.sorted.bam,64,1.8,0.13,58cfa82ee4b0c9d6adf6af63,TCGA-05-4433-10A-01D-1853_120312_SN1120_0120_AD0PYGACXX_s_4_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4433-10A,AEA68827-DC0F-484D-A00D-06DEEAA4B3CE,Blood Derived Normal,Illumina HiSeq,5d83cd06-942c-4ea6-827b-4d1fdb9c4cee,Lung,82,971AFEDB-FA6F-4B34-86F7-A8020E0A1448,45479C86-60A4-4BAC-9152-B9D4433841C2,TCGA-05-4433-10A-01D-1853-02,HG19_Broad_variant,TCGA-05-4433,TCGA-LUAD,NA,s10987,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa82fe4b0c9d6adf6ba44,58cfa82fe4b0c9d6adf6ba44,TCGA-AA-A01R-11A-12D-A079-02_110409_SN590_0077_BB04EHABXX_s_4.rg.sorted.filtered.,WGS,TCGA-AA-A01R-11A-12D-A079-02_110409_SN590_0077_BB04EHABXX_s_4.rg.sorted,TCGA-AA-A01R-11A-12D-A079-02_110409_SN590_0077_BB04EHABXX_s_4.rg.sorted.bam,76.75,1.9,0.16,58cfa82fe4b0c9d6adf6ba44,TCGA-AA-A01R-11A-12D-A079-02_110409_SN590_0077_BB04EHABXX_s_4.rg.sorted.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01R-11A,97F6C8D3-09A0-4128-8F10-41E736648A5F,Solid Tissue Normal,Illumina HiSeq,e3101288-fc25-4e13-b4de-7cf4122567d3,Colorectal,47,D19B4EE7-CBA4-491B-8764-99AC49304AD5,23D92BFE-081F-4563-AA86-D0E0786FFD2E,TCGA-AA-A01R-11A-12D-A079-02,HG18_Broad_variant,TCGA-AA-A01R,TCGA-COAD,NA,s12883,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage III
13722.58cfa832e4b0c9d6adf6cfc9,58cfa832e4b0c9d6adf6cfc9,TCGA-FU-A3HZ-01A-11D-A20X_140106_SN590_0243_AC371BACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FU-A3HZ-01A-11D-A20X_140106_SN590_0243_AC371BACXX_s_4_rg.sorted,TCGA-FU-A3HZ-01A-11D-A20X_140106_SN590_0243_AC371BACXX_s_4_rg.sorted.bam,19.8,NA,0.16,58cfa832e4b0c9d6adf6cfc9,TCGA-FU-A3HZ-01A-11D-A20X_140106_SN590_0243_AC371BACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-FU-A3HZ-01A,6FF12A54-10DA-4941-BFEA-7B66E19B4BE9,Primary Tumor,Illumina HiSeq,40af9367-bd77-4c64-98d6-d2e2c6e5c11a,Cervix,64,6408A1F5-F5F7-40C8-A2EE-CB8038C15C95,230B8BFA-EBC7-4058-AA0C-78CA7DD01386,TCGA-FU-A3HZ-01A-11D-A20X-26,HG19_Broad_variant,TCGA-FU-A3HZ,TCGA-CESC,NA,s1202,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T2a2,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6cf3c,58cfa832e4b0c9d6adf6cf3c,TCGA-G9-6373-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_1_rg.sorted.filtered.,WGS,TCGA-G9-6373-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_1_rg.sorted,TCGA-G9-6373-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_1_rg.sorted.bam,59.4,2,0.15,58cfa832e4b0c9d6adf6cf3c,TCGA-G9-6373-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6373-01A,C3A509C6-35A6-4D17-A9FD-0AA8884B33A0,Primary Tumor,Illumina HiSeq,b8d1f15f-e927-4a6e-8154-620ccb08e6f5,Prostate,68,18365C1F-9BC0-4865-B40D-DEF3EE73331C,A0563516-591D-4FC2-AF37-8BA62A071C58,TCGA-G9-6373-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6373,TCGA-PRAD,NA,s3976,Harvard Medical School,Roswell Park,United States,NO,T3a,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cb62,58cfa831e4b0c9d6adf6cb62,TCGA-EE-A2ME-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EE-A2ME-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_3_rg.sorted,TCGA-EE-A2ME-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_3_rg.sorted.bam,55.34,NA,0.16,58cfa831e4b0c9d6adf6cb62,TCGA-EE-A2ME-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2ME-06A,D70E0D27-7F27-4807-A36E-9FB7B00F0A70,Metastatic,Illumina HiSeq,81c3a18a-d39b-4ddf-a120-483e380a99ad,Skin,51,1ED77DED-07C5-4428-9393-56A8585E832E,B4C34C6E-B437-4AE6-B1E1-344C6A9C660A,TCGA-EE-A2ME-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2ME,TCGA-SKCM,3141,s7686,Harvard Medical School,University of Sydney,Australia,NO,T2,N0,Not available,Stage I
13722.58cfa832e4b0c9d6adf6d4aa,58cfa832e4b0c9d6adf6d4aa,TCGA-V4-A9ET-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_5_rg.sorted.filtered.,WGS,TCGA-V4-A9ET-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_5_rg.sorted,TCGA-V4-A9ET-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_5_rg.sorted.bam,57.02,NA,0.17,58cfa832e4b0c9d6adf6d4aa,TCGA-V4-A9ET-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9ET-01A,5383FB57-69C2-4B34-AF7F-C67208EFB2B5,Primary Tumor,Illumina HiSeq,98f43560-a2c1-4edb-a936-9c84114cf0c2,Eye,57,C16B2576-AB56-4BEB-B621-22EA9FC4E898,D544884F-7E0D-4029-B778-55E14B5C2C38,TCGA-V4-A9ET-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9ET,TCGA-UVM,NA,s244,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4b,N0,Not available,Stage IIIB
13722.58cfa831e4b0c9d6adf6ca7e,58cfa831e4b0c9d6adf6ca7e,TCGA-DK-A3IK-10A-01D-A21C_120914_SN590_0179_AD13PPACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DK-A3IK-10A-01D-A21C_120914_SN590_0179_AD13PPACXX_s_4_rg.sorted,TCGA-DK-A3IK-10A-01D-A21C_120914_SN590_0179_AD13PPACXX_s_4_rg.sorted.bam,19.24,NA,0.14,58cfa831e4b0c9d6adf6ca7e,TCGA-DK-A3IK-10A-01D-A21C_120914_SN590_0179_AD13PPACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3IK-10A,3F0A0748-9ACC-4D0B-BA18-7C08BD183F86,Blood Derived Normal,Illumina HiSeq,7044d689-15dd-4f2a-ab94-f0e69c9f157a,Bladder,87,9A2737F8-9E5D-4D4E-AF7E-9F08F8E5752A,41291F30-6EF3-45C4-8D02-4DA497B910A2,TCGA-DK-A3IK-10A-01D-A21C-26,HG19_Broad_variant,TCGA-DK-A3IK,TCGA-BLCA,NA,s3105,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6cf04,58cfa832e4b0c9d6adf6cf04,TCGA-FS-A1ZB-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FS-A1ZB-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_8_rg.sorted,TCGA-FS-A1ZB-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_8_rg.sorted.bam,30.5,NA,0.18,58cfa832e4b0c9d6adf6cf04,TCGA-FS-A1ZB-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZB-10A,6F2EF983-0A22-4A65-9E53-8742AC89A1C4,Blood Derived Normal,Illumina HiSeq,047bc4fc-13cd-4dc5-b9d5-8f46a3cfe2a8,Skin,57,0E2E739B-B421-44B9-8524-1ED5CAA6F13A,D583AB9A-A74E-416E-967D-97AEDEE476AA,TCGA-FS-A1ZB-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZB,TCGA-SKCM,1486,s7531,Harvard Medical School,Essen,Germany,NO,T3a,N0,Not available,Stage II
13722.58cfa832e4b0c9d6adf6cf88,58cfa832e4b0c9d6adf6cf88,TCGA-G9-6494-10A-01D-1784_130131_SN1120_0234_AD1PVUACXX_s_2_rg.sorted.filtered.,WGS,TCGA-G9-6494-10A-01D-1784_130131_SN1120_0234_AD1PVUACXX_s_2_rg.sorted,TCGA-G9-6494-10A-01D-1784_130131_SN1120_0234_AD1PVUACXX_s_2_rg.sorted.bam,227.7,1.9,0.17,58cfa832e4b0c9d6adf6cf88,TCGA-G9-6494-10A-01D-1784_130131_SN1120_0234_AD1PVUACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6494-10A,0C459149-0DFE-4206-B50B-DB79180EBB57,Blood Derived Normal,Illumina HiSeq,b30a02c0-4047-4759-bcc8-ae1a36aec49d,Prostate,66,E9D501EB-D41B-4419-80C8-4941CF3EF3E9,EDDF0801-9067-45FA-AD22-F8B6B5F71945,TCGA-G9-6494-10A-01D-1784-02,HG19_Broad_variant,TCGA-G9-6494,TCGA-PRAD,NA,s3979,Harvard Medical School,Roswell Park,United States,NO,T4,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cc7e,58cfa831e4b0c9d6adf6cc7e,TCGA-ER-A19L-06A-12D-A18Y_120718_SN208_0416_BD140PACXX_s_4_rg.sorted.filtered.,WGS,TCGA-ER-A19L-06A-12D-A18Y_120718_SN208_0416_BD140PACXX_s_4_rg.sorted,TCGA-ER-A19L-06A-12D-A18Y_120718_SN208_0416_BD140PACXX_s_4_rg.sorted.bam,49.69,NA,0.17,58cfa831e4b0c9d6adf6cc7e,TCGA-ER-A19L-06A-12D-A18Y_120718_SN208_0416_BD140PACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19L-06A,5F6DF69C-4EBF-4811-8B28-AD393DFBE1A3,Metastatic,Illumina HiSeq,1db4cf92-091c-4a30-996d-ce04e7c3f2e2,Skin,35,83679B9D-34F4-487B-93E3-08F1B8060120,E77400BE-0BAE-4D18-BA27-3C208A7565EA,TCGA-ER-A19L-06A-12D-A18Y-02,HG19_Broad_variant,TCGA-ER-A19L,TCGA-SKCM,4000,s7521,Harvard Medical School,University of Pittsburgh,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa832e4b0c9d6adf6ce34,58cfa832e4b0c9d6adf6ce34,TCGA-ER-A19T-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_8_rg.sorted.filtered.,WGS,TCGA-ER-A19T-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_8_rg.sorted,TCGA-ER-A19T-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_8_rg.sorted.bam,76.29,NA,0.18,58cfa832e4b0c9d6adf6ce34,TCGA-ER-A19T-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19T-01A,B85B14D7-3B5A-4800-AF12-622EC03B9FE5,Primary Tumor,Illumina HiSeq,f16ac608-e77d-4717-aeea-b71439dc385a,Skin,51,11E2F891-251A-4813-AA90-E944F350C54D,9C1427B0-B112-4BB7-89B3-27934F92E077,TCGA-ER-A19T-01A-11D-A18Z-02,HG19_Broad_variant,TCGA-ER-A19T,TCGA-SKCM,270,s8022,Harvard Medical School,University of Pittsburgh,United States,NO,T4a,N3,Not available,Stage IV
13722.58cfa831e4b0c9d6adf6c9b0,58cfa831e4b0c9d6adf6c9b0,TCGA-DJ-A13M-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DJ-A13M-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_6_rg.sorted,TCGA-DJ-A13M-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_6_rg.sorted.bam,24.89,1.93,0.14,58cfa831e4b0c9d6adf6c9b0,TCGA-DJ-A13M-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13M-01A,BA9DEC81-FFC0-453A-9621-94BEBA45FAB1,Primary Tumor,Illumina HiSeq,6d7b5f3b-5fba-469e-a651-31a4569d7877,Thyroid,28,28913C64-8637-4537-AF8C-7315097A5AD1,8C708D3B-B312-4C27-898B-A0FE87110474,TCGA-DJ-A13M-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13M,TCGA-THCA,NA,s12369,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa831e4b0c9d6adf6c8a4,58cfa831e4b0c9d6adf6c8a4,TCGA-DK-A3WX-10A-01D-A233_120829_SN1120_0183_AC18U8ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DK-A3WX-10A-01D-A233_120829_SN1120_0183_AC18U8ACXX_s_6_rg.sorted,TCGA-DK-A3WX-10A-01D-A233_120829_SN1120_0183_AC18U8ACXX_s_6_rg.sorted.bam,31.04,NA,0.17,58cfa831e4b0c9d6adf6c8a4,TCGA-DK-A3WX-10A-01D-A233_120829_SN1120_0183_AC18U8ACXX_s_6_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3WX-10A,D63C186D-ADD6-492E-8250-E83F46D39D00,Blood Derived Normal,Illumina HiSeq,bed65641-3cb7-440c-a595-ed3f210f52a2,Bladder,67,3681F425-BCA8-40B9-929E-DC5752D38D69,2BB61FC0-9D7A-48E7-AB8A-F531F9E94DFD,TCGA-DK-A3WX-10A-01D-A233-26,HG19_Broad_variant,TCGA-DK-A3WX,TCGA-BLCA,321,s2897,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6d4c8,58cfa832e4b0c9d6adf6d4c8,TCGA-V4-A9F2-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-V4-A9F2-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_6_rg.sorted,TCGA-V4-A9F2-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_6_rg.sorted.bam,10.5,NA,0.14,58cfa832e4b0c9d6adf6d4c8,TCGA-V4-A9F2-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9F2-10A,411DDF79-FE92-44AD-8D10-EEB703F11BE7,Blood Derived Normal,Illumina HiSeq,06d52331-c1e3-4a25-87d6-44b4f0983c53,Eye,78,77979FE6-057B-471D-B693-815A0DF47A5B,9D0B4423-FE74-4D68-859C-DEFA836BE221,TCGA-V4-A9F2-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9F2,TCGA-UVM,NA,s238,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3b,N0,Not available,Stage IIIA
13722.58cfa82fe4b0c9d6adf6b8c4,58cfa82fe4b0c9d6adf6b8c4,TCGA-49-4510-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-49-4510-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-49-4510-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,177.53,1.9,0.14,58cfa82fe4b0c9d6adf6b8c4,TCGA-49-4510-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4510-01A,F77B6930-A1CE-446E-A15D-C018CBBECFEE,Primary Tumor,Illumina HiSeq,abe8920d-80b9-4fc8-a249-5bf0a4a06ac7,Lung,51,9A479D32-13A4-46C2-B26D-34CB6051A891,3324FA3E-B195-4974-A15B-0C8D8AC2EFA9,TCGA-49-4510-01A-01D-1203-02,GRCh37,TCGA-49-4510,TCGA-LUAD,896,s11338,Harvard Medical School,Johns Hopkins,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa831e4b0c9d6adf6c560,58cfa831e4b0c9d6adf6c560,TCGA-CH-5767-01A-11D-1784_130329_SN590_0221_BD1WHDACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CH-5767-01A-11D-1784_130329_SN590_0221_BD1WHDACXX_s_6_rg.sorted,TCGA-CH-5767-01A-11D-1784_130329_SN590_0221_BD1WHDACXX_s_6_rg.sorted.bam,200.4,1.9,0.16,58cfa831e4b0c9d6adf6c560,TCGA-CH-5767-01A-11D-1784_130329_SN590_0221_BD1WHDACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5767-01A,8DC53431-44AB-485E-B4E6-C3D06509506D,Primary Tumor,Illumina HiSeq,4ec6dbff-5194-4938-949c-d5ae0ec6a882,Prostate,66,A87E6352-C469-484D-87FC-FABDBA237D01,02D28407-4AE4-4DA6-ABB5-6D6A4BB3D8D3,TCGA-CH-5767-01A-11D-1784-02,HG19_Broad_variant,TCGA-CH-5767,TCGA-PRAD,NA,s4129,Harvard Medical School,Indivumed,Germany,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bc0f,58cfa830e4b0c9d6adf6bc0f,TCGA-AG-A00Y-10A-01D-A078-02_110405_SN590_0074_AB04EUABXX_s_8.rg.sorted.filtered.,WGS,TCGA-AG-A00Y-10A-01D-A078-02_110405_SN590_0074_AB04EUABXX_s_8.rg.sorted,TCGA-AG-A00Y-10A-01D-A078-02_110405_SN590_0074_AB04EUABXX_s_8.rg.sorted.bam,21.77,1.74,0.15,58cfa830e4b0c9d6adf6bc0f,TCGA-AG-A00Y-10A-01D-A078-02_110405_SN590_0074_AB04EUABXX_s_8.rg.sorted.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A00Y-10A,C7E09161-60D6-4DFF-A840-7CEC3BB7A30A,Blood Derived Normal,Illumina HiSeq,6f10226b-f6f1-4624-8526-bff208e827a0,Colorectal,68,B67C3548-2135-4E0B-8687-624F330FD0AA,49EBF21C-8481-4D18-BF18-81A24A168FCA,TCGA-AG-A00Y-10A-01D-A078-02,HG18_Broad_variant,TCGA-AG-A00Y,TCGA-READ,NA,s1977,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6cb30,58cfa831e4b0c9d6adf6cb30,TCGA-EA-A3HQ-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EA-A3HQ-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_3_rg.sorted,TCGA-EA-A3HQ-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_3_rg.sorted.bam,14.36,NA,0.15,58cfa831e4b0c9d6adf6cb30,TCGA-EA-A3HQ-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EA-A3HQ-01A,6BF00B63-89F8-420C-8D36-F680FB0908B1,Primary Tumor,Illumina HiSeq,33c80031-f923-4aa0-adfa-9e229f413f83,Cervix,60,E4B391D9-2F3E-474C-AFA0-FDF4FD11FDF9,0032959A-5D7B-4D74-927E-25F79EF25D49,TCGA-EA-A3HQ-01A-11D-A20X-26,HG19_Broad_variant,TCGA-EA-A3HQ,TCGA-CESC,NA,s1180,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T2a,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c3d4,58cfa831e4b0c9d6adf6c3d4,TCGA-C5-A3HF-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_1_rg.sorted.filtered.,WGS,TCGA-C5-A3HF-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_1_rg.sorted,TCGA-C5-A3HF-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_1_rg.sorted.bam,62.13,NA,0.16,58cfa831e4b0c9d6adf6c3d4,TCGA-C5-A3HF-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A3HF-01A,085DF27C-9BC2-425A-9A49-547D692EA028,Primary Tumor,Illumina HiSeq,4b4bea19-4db4-4996-8037-4129a4494419,Cervix,24,79C43439-BC01-4033-85FA-3191A79277C6,0C08A31F-1414-42E3-986A-00BAF9C926F8,TCGA-C5-A3HF-01A-11D-A20X-26,HG19_Broad_variant,TCGA-C5-A3HF,TCGA-CESC,543,s1358,MD Anderson - Institute for Applied Cancer Science,Medical College of Wisconsin,United States,NO,Not available,Not available,Mucinous Adenocarcinoma of Endocervical Type,Not available
13722.58cfa831e4b0c9d6adf6cae6,58cfa831e4b0c9d6adf6cae6,TCGA-D9-A1JX-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-D9-A1JX-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_5_rg.sorted,TCGA-D9-A1JX-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_5_rg.sorted.bam,50.25,NA,0.14,58cfa831e4b0c9d6adf6cae6,TCGA-D9-A1JX-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D9-A1JX-06A,F505058F-74F2-4476-887F-06590A605980,Metastatic,Illumina HiSeq,88b1dbb7-2897-4de5-a042-e5a7d53d6389,Skin,80,24A6A89E-4FA9-4245-BB7F-C28C9385AE0F,1A90853A-2BEE-415D-854B-456C8CDABC0C,TCGA-D9-A1JX-06A-11D-A18Z-02,HG19_Broad_variant,TCGA-D9-A1JX,TCGA-SKCM,NA,s8002,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,TX,NX,Not available,Not available
13722.58cfa831e4b0c9d6adf6cc83,58cfa831e4b0c9d6adf6cc83,TCGA-ER-A19O-06A-11D-A18Y_120718_SN208_0416_BD140PACXX_s_2_rg.sorted.filtered.,WGS,TCGA-ER-A19O-06A-11D-A18Y_120718_SN208_0416_BD140PACXX_s_2_rg.sorted,TCGA-ER-A19O-06A-11D-A18Y_120718_SN208_0416_BD140PACXX_s_2_rg.sorted.bam,47.63,NA,0.16,58cfa831e4b0c9d6adf6cc83,TCGA-ER-A19O-06A-11D-A18Y_120718_SN208_0416_BD140PACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19O-06A,69C0EF46-3117-46F3-B36E-581EB03EB829,Metastatic,Illumina HiSeq,906d1045-517c-43da-94cc-b05bd82e61a5,Skin,56,24DDB156-D896-44BB-B0B1-A5191ABCDC3F,40A9B358-E49D-42B6-AEF0-CF04F33F2E14,TCGA-ER-A19O-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-ER-A19O,TCGA-SKCM,NA,s8016,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N1b,Not available,Stage IIIB
13722.58cfa831e4b0c9d6adf6cb86,58cfa831e4b0c9d6adf6cb86,TCGA-DU-7010-10A-01D-2022_130910_SN208_0495_BD2FGNACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DU-7010-10A-01D-2022_130910_SN208_0495_BD2FGNACXX_s_4_rg.sorted,TCGA-DU-7010-10A-01D-2022_130910_SN208_0495_BD2FGNACXX_s_4_rg.sorted.bam,74,NA,0.14,58cfa831e4b0c9d6adf6cb86,TCGA-DU-7010-10A-01D-2022_130910_SN208_0495_BD2FGNACXX_s_4_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7010-10A,834E560A-A506-456D-BAF2-A206CA058153,Blood Derived Normal,Illumina HiSeq,550d6316-2067-4f67-ba64-a8687f3320b1,Brain,58,7820F440-CDBA-4F4C-8B1D-A2E089055BE7,8F524DED-7AE8-44CD-8E62-5DB87178452C,TCGA-DU-7010-10A-01D-2022-02,HG19_Broad_variant,TCGA-DU-7010,TCGA-LGG,456,s8565,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa832e4b0c9d6adf6d138,58cfa832e4b0c9d6adf6d138,TCGA-FS-A1ZG-06A-11D-A18Y_120605_SN1222_0113_BC0WUCACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FS-A1ZG-06A-11D-A18Y_120605_SN1222_0113_BC0WUCACXX_s_3_rg.sorted,TCGA-FS-A1ZG-06A-11D-A18Y_120605_SN1222_0113_BC0WUCACXX_s_3_rg.sorted.bam,69.36,NA,0.17,58cfa832e4b0c9d6adf6d138,TCGA-FS-A1ZG-06A-11D-A18Y_120605_SN1222_0113_BC0WUCACXX_s_3_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZG-06A,F52AE9F4-8A61-4FF2-9C24-23F4048D3DA6,Metastatic,Illumina HiSeq,0cac5d8a-2184-4f80-9dc3-2ad5a8d9f0de,Skin,60,C283D7F9-CC6A-43AE-B5BE-6043FAD85111,60D3B4B4-5B8E-4423-9834-25AE8223B2AB,TCGA-FS-A1ZG-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZG,TCGA-SKCM,295,s7537,Harvard Medical School,Essen,Germany,NO,T4b,N2b,Not available,Stage IIIC
13722.58cfa832e4b0c9d6adf6cffa,58cfa832e4b0c9d6adf6cffa,TCGA-GC-A3WC-10A-01D-A233_120904_SN1120_0186_BC1911ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-GC-A3WC-10A-01D-A233_120904_SN1120_0186_BC1911ACXX_s_3_rg.sorted,TCGA-GC-A3WC-10A-01D-A233_120904_SN1120_0186_BC1911ACXX_s_3_rg.sorted.bam,79.1,NA,0.16,58cfa832e4b0c9d6adf6cffa,TCGA-GC-A3WC-10A-01D-A233_120904_SN1120_0186_BC1911ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GC-A3WC-10A,DB52C68A-ED44-4EC4-9381-D75F9BCBC29A,Blood Derived Normal,Illumina HiSeq,86cc0d9a-1aa0-4d61-9fb9-ea2370c44f9d,Bladder,80,9BCD8C28-B397-41D2-A004-2B093EB9A739,9BB2C8B6-EDF9-4258-8938-7D7CB74DCDBF,TCGA-GC-A3WC-10A-01D-A233-26,HG19_Broad_variant,TCGA-GC-A3WC,TCGA-BLCA,NA,s2730,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa830e4b0c9d6adf6be3c,58cfa830e4b0c9d6adf6be3c,TCGA-BJ-A18Y-01A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BJ-A18Y-01A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_1_rg.sorted,TCGA-BJ-A18Y-01A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_1_rg.sorted.bam,77.56,2,0.18,58cfa830e4b0c9d6adf6be3c,TCGA-BJ-A18Y-01A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A18Y-01A,ACB3B9DB-16E9-40F5-87A9-9DF9D4CEEE54,Primary Tumor,Illumina HiSeq,0074a697-0800-4872-9a48-48945f46d18d,Thyroid,29,5D1D84D0-9A03-4381-9CF1-E460B3617AAA,56D2A069-7969-40F1-A237-E4FE7E62C84C,TCGA-BJ-A18Y-01A-11D-A13U-02,HG19_Broad_variant,TCGA-BJ-A18Y,TCGA-THCA,NA,s12351,Harvard Medical School,University of Pittsburgh,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c8ce,58cfa831e4b0c9d6adf6c8ce,TCGA-D1-A16Q-01A-12D-A12F_120511_SN208_0299_BD12J9ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-D1-A16Q-01A-12D-A12F_120511_SN208_0299_BD12J9ACXX_s_5_rg.sorted,TCGA-D1-A16Q-01A-12D-A12F_120511_SN208_0299_BD12J9ACXX_s_5_rg.sorted.bam,74.24,1.92,0.14,58cfa831e4b0c9d6adf6c8ce,TCGA-D1-A16Q-01A-12D-A12F_120511_SN208_0299_BD12J9ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A16Q-01A,7F4F3AED-69AF-421E-817B-B258DCC0BAC5,Primary Tumor,Illumina HiSeq,c23e5f4d-d7be-44b1-a19e-c949819d58c9,Uterus,54,BFE3DA05-506E-4837-AC72-A285FE079C58,23DF790A-0AB3-4EFB-AD9D-62AF1B79D941,TCGA-D1-A16Q-01A-12D-A12F-02,HG19_Broad_variant,TCGA-D1-A16Q,TCGA-UCEC,NA,s5024,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6ca7c,58cfa831e4b0c9d6adf6ca7c,TCGA-DJ-A13X-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DJ-A13X-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_1_rg.sorted,TCGA-DJ-A13X-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_1_rg.sorted.bam,52.8,1.95,0.16,58cfa831e4b0c9d6adf6ca7c,TCGA-DJ-A13X-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_1_rg.sorted.bam,Alive,FEMALE,Not available,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13X-01A,3B3C99AB-5336-4433-B682-E1A590221611,Primary Tumor,Illumina HiSeq,a3b0754a-92ca-4ef2-b612-4e5bf2f74048,Thyroid,51,AC52BED3-FDD6-4281-89DE-D2F125BA038E,3E92A45C-FFFB-4C07-BD81-DB3EBF41841F,TCGA-DJ-A13X-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13X,TCGA-THCA,NA,s12748,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III
13722.58cfa82fe4b0c9d6adf6b9f8,58cfa82fe4b0c9d6adf6b9f8,TCGA-64-5781-10A-01D-1623_110824_SN208_0222_BB0164ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-64-5781-10A-01D-1623_110824_SN208_0222_BB0164ACXX_s_8_rg.sorted,TCGA-64-5781-10A-01D-1623_110824_SN208_0222_BB0164ACXX_s_8_rg.sorted.bam,142.4,1.9,0.15,58cfa82fe4b0c9d6adf6b9f8,TCGA-64-5781-10A-01D-1623_110824_SN208_0222_BB0164ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-64-5781-10A,41C4C704-825E-49F5-9D54-DBD7D30725E0,Blood Derived Normal,Illumina HiSeq,ef6d1a20-4c6f-43f4-96c3-26a38a678e60,Lung,55,68DD1C45-4DBE-4B8D-B6B6-034EB1AE9DC0,F5139F81-3CCA-4253-BBCD-8C210DEEE920,TCGA-64-5781-10A-01D-1623-02,HG19_Broad_variant,TCGA-64-5781,TCGA-LUAD,NA,s11355,Harvard Medical School,Fox Chase,United States,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa831e4b0c9d6adf6ca1d,58cfa831e4b0c9d6adf6ca1d,TCGA-D1-A2G6-10A-01D-A17E_120511_SN208_0299_BD12J9ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-D1-A2G6-10A-01D-A17E_120511_SN208_0299_BD12J9ACXX_s_8_rg.sorted,TCGA-D1-A2G6-10A-01D-A17E_120511_SN208_0299_BD12J9ACXX_s_8_rg.sorted.bam,12.4,NA,0.16,58cfa831e4b0c9d6adf6ca1d,TCGA-D1-A2G6-10A-01D-A17E_120511_SN208_0299_BD12J9ACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A2G6-10A,46CD8DED-F8A1-4F8C-A4C2-2D5B51C04F18,Blood Derived Normal,Illumina HiSeq,88a27a1c-460f-45a8-8579-5e7a02138395,Uterus,53,397A60A8-E8A7-4FAE-B4AD-27ED69507657,22A38614-AE6F-4E56-8B54-7C09F02695E0,TCGA-D1-A2G6-10A-01D-A17E-02,HG19_Broad_variant,TCGA-D1-A2G6,TCGA-UCEC,258,s5022,Harvard Medical School,Mayo Clinic,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c5b2,58cfa831e4b0c9d6adf6c5b2,TCGA-CG-4304-10A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CG-4304-10A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_4_rg.sorted,TCGA-CG-4304-10A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_4_rg.sorted.bam,56.9,1.9,0.15,58cfa831e4b0c9d6adf6c5b2,TCGA-CG-4304-10A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_4_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4304-10A,8E005891-D6FE-4FEE-A699-971FEE4E70F1,Blood Derived Normal,Illumina HiSeq,2a7989dd-2b9c-48c4-9b6a-ab9a5864b004,Stomach,84,C6B27339-4304-4ADD-8731-575B086BAF65,C85CAB43-38AF-44F9-8D8B-50AB497BF361,TCGA-CG-4304-10A-01D-A326-26,HG19_Broad_variant,TCGA-CG-4304,TCGA-STAD,NA,s14484,MD Anderson - Institute for Applied Cancer Science,Indivumed,Germany,NO,T2a,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa830e4b0c9d6adf6bcac,58cfa830e4b0c9d6adf6bcac,TCGA-AG-3894-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3894-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3894-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,7.59,1.9,0.16,58cfa830e4b0c9d6adf6bcac,TCGA-AG-3894-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3894-10A,065B26FC-6827-44D5-83D8-1100C63FCDA6,Blood Derived Normal,Illumina HiSeq,6a9c36f1-b845-4ba6-abf3-648188c51636,Colorectal,65,5D172F3A-8B5B-4CEB-A5C7-314571E3EB30,6B64DF2F-F727-46E7-BD39-518D8D68F796,TCGA-AG-3894-10A-01D-1115-02,HG18,TCGA-AG-3894,TCGA-READ,NA,s2165,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6c9dc,58cfa831e4b0c9d6adf6c9dc,TCGA-DU-6392-01A-11D-1703_130906_SN1440_0166_BC2A68ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DU-6392-01A-11D-1703_130906_SN1440_0166_BC2A68ACXX_s_6_rg.sorted,TCGA-DU-6392-01A-11D-1703_130906_SN1440_0166_BC2A68ACXX_s_6_rg.sorted.bam,16,2,0.13,58cfa831e4b0c9d6adf6c9dc,TCGA-DU-6392-01A-11D-1703_130906_SN1440_0166_BC2A68ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6392-01A,FCD9E1C4-BDDB-4856-844C-03DF48FBA499,Primary Tumor,Illumina HiSeq,8f4eff17-77e1-4e7d-9fc7-83ae4db50b3a,Brain,35,14780BB2-67A9-4ACA-BCE4-12793FB1808E,E7B36F2D-9AB1-4A46-B669-65367B841752,TCGA-DU-6392-01A-11D-1703-02,HG19_Broad_variant,TCGA-DU-6392,TCGA-LGG,NA,s8561,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6c879,58cfa831e4b0c9d6adf6c879,TCGA-D3-A3CC-10A-01D-A18Z_120626_SN590_0164_BC0VMVACXX_s_6_rg.sorted.filtered.,WGS,TCGA-D3-A3CC-10A-01D-A18Z_120626_SN590_0164_BC0VMVACXX_s_6_rg.sorted,TCGA-D3-A3CC-10A-01D-A18Z_120626_SN590_0164_BC0VMVACXX_s_6_rg.sorted.bam,17.68,NA,0.15,58cfa831e4b0c9d6adf6c879,TCGA-D3-A3CC-10A-01D-A18Z_120626_SN590_0164_BC0VMVACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A3CC-10A,2D36CEA4-73E9-493B-8433-0C2B911C0521,Blood Derived Normal,Illumina HiSeq,59c97e2f-e76c-4017-a55f-31efc29ca6c1,Skin,69,1F41A22B-7415-4DEB-8EF0-78D6FE7E5576,3EFAE3EC-F99E-40C8-8265-0FBA134E19EB,TCGA-D3-A3CC-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-D3-A3CC,TCGA-SKCM,NA,s7324,Harvard Medical School,MD Anderson,United States,NO,T4b,N0,Not available,Stage IIC
13722.58cfa832e4b0c9d6adf6d498,58cfa832e4b0c9d6adf6d498,TCGA-V4-A9EF-01A-21D-A40D_140725_SN590_0251_AC41YJACXX_s_4_rg.sorted.filtered.,WGS,TCGA-V4-A9EF-01A-21D-A40D_140725_SN590_0251_AC41YJACXX_s_4_rg.sorted,TCGA-V4-A9EF-01A-21D-A40D_140725_SN590_0251_AC41YJACXX_s_4_rg.sorted.bam,37.33,NA,0.17,58cfa832e4b0c9d6adf6d498,TCGA-V4-A9EF-01A-21D-A40D_140725_SN590_0251_AC41YJACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EF-01A,A18D3BA3-E2F4-4144-9C25-2019CAD193F4,Primary Tumor,Illumina HiSeq,bf602ec4-fef9-41b6-9f28-a773493f4507,Eye,56,0966DF5C-5838-4E92-ADA6-304241CCAEF1,0CE78DDD-32D4-43DB-B7A4-FE7C3AD9563D,TCGA-V4-A9EF-01A-21D-A40D-26,HG19_Broad_variant,TCGA-V4-A9EF,TCGA-UVM,NA,s215,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4b,N0,Not available,Stage IIIB
13722.58cfa832e4b0c9d6adf6cec9,58cfa832e4b0c9d6adf6cec9,TCGA-FY-A3R6-10A-01D-A221_120622_SN1120_0155_AC0WVLACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FY-A3R6-10A-01D-A221_120622_SN1120_0155_AC0WVLACXX_s_2_rg.sorted,TCGA-FY-A3R6-10A-01D-A221_120622_SN1120_0155_AC0WVLACXX_s_2_rg.sorted.bam,18.59,NA,0.15,58cfa832e4b0c9d6adf6cec9,TCGA-FY-A3R6-10A-01D-A221_120622_SN1120_0155_AC0WVLACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FY-A3R6-10A,905469D2-4C97-4293-A20C-1B1F0462A25D,Blood Derived Normal,Illumina HiSeq,11d932a4-58f5-4d3e-8599-cb0e1ccbb7aa,Thyroid,57,13711D44-7A61-43EF-A89B-A04FB762F9D0,CA288DF5-2624-4061-BA43-8FFD9032FE3F,TCGA-FY-A3R6-10A-01D-A221-26,HG19_Broad_variant,TCGA-FY-A3R6,TCGA-THCA,NA,s12007,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T2,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA
13722.58cfa82fe4b0c9d6adf6b653,58cfa82fe4b0c9d6adf6b653,TCGA-50-6592-11A-01D-1751_111111_SN208_0254_B0160ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-50-6592-11A-01D-1751_111111_SN208_0254_B0160ACXX_s_8_rg.sorted,TCGA-50-6592-11A-01D-1751_111111_SN208_0254_B0160ACXX_s_8_rg.sorted.bam,45.4,1.9,0.14,58cfa82fe4b0c9d6adf6b653,TCGA-50-6592-11A-01D-1751_111111_SN208_0254_B0160ACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-6592-11A,09918B81-4696-4CBA-A45A-5FE7407C2337,Solid Tissue Normal,Illumina HiSeq,e1284c11-5577-48dd-b880-07c391fb1cc6,Lung,71,6C1516A2-6916-4D9B-949D-4F5ABB97B94C,85C013AC-B0E7-4ACD-9031-E8E31E92C5CC,TCGA-50-6592-11A-01D-1751-02,HG19_Broad_variant,TCGA-50-6592,TCGA-LUAD,777,s11459,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa832e4b0c9d6adf6d4a2,58cfa832e4b0c9d6adf6d4a2,TCGA-V4-A9F8-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-V4-A9F8-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_3_rg.sorted,TCGA-V4-A9F8-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_3_rg.sorted.bam,54.24,NA,0.17,58cfa832e4b0c9d6adf6d4a2,TCGA-V4-A9F8-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9F8-01A,64BD88BD-1D5A-4569-9F46-F668D448C336,Primary Tumor,Illumina HiSeq,05bff1f2-adb9-4252-892d-c86207753ca1,Eye,68,6B903079-A499-4AE3-B399-59276DCB9C70,5FABEAFA-9ADE-43AA-B4EB-979826FAE9BF,TCGA-V4-A9F8-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9F8,TCGA-UVM,NA,s252,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa831e4b0c9d6adf6c498,58cfa831e4b0c9d6adf6c498,TCGA-CN-4722-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CN-4722-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_7_rg.sorted,TCGA-CN-4722-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_7_rg.sorted.bam,52.7,1.9,0.16,58cfa831e4b0c9d6adf6c498,TCGA-CN-4722-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4722-01A,B64BFCA1-033C-4501-A900-103AC105C084,Primary Tumor,Illumina HiSeq,3723e20c-1e27-4158-8bc5-1768c49ee5e5,Head and Neck,61,6E767FC9-0F5A-49EC-999A-CDA2DAEBA6FF,0CA196A7-5A71-4E70-8FA6-9506E1883032,TCGA-CN-4722-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4722,TCGA-HNSC,NA,s15758,Harvard Medical School,University of Pittsburgh,None,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6cc86,58cfa831e4b0c9d6adf6cc86,TCGA-ER-A19L-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_8_rg.sorted.filtered.,WGS,TCGA-ER-A19L-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_8_rg.sorted,TCGA-ER-A19L-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_8_rg.sorted.bam,12.67,NA,0.15,58cfa831e4b0c9d6adf6cc86,TCGA-ER-A19L-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19L-10A,5F6DF69C-4EBF-4811-8B28-AD393DFBE1A3,Blood Derived Normal,Illumina HiSeq,656f4bf4-fed8-4e7c-b480-6387636bd29b,Skin,35,A2CADDC2-B60F-42C0-B863-09AE4FC38249,CC6B0115-4DD4-4B35-9AAA-E31125A8D890,TCGA-ER-A19L-10A-01D-A190-02,HG19_Broad_variant,TCGA-ER-A19L,TCGA-SKCM,4000,s7865,Harvard Medical School,University of Pittsburgh,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa831e4b0c9d6adf6cab6,58cfa831e4b0c9d6adf6cab6,TCGA-D9-A148-06A-11D-A18Z_120626_SN590_0164_BC0VMVACXX_s_1_rg.sorted.filtered.,WGS,TCGA-D9-A148-06A-11D-A18Z_120626_SN590_0164_BC0VMVACXX_s_1_rg.sorted,TCGA-D9-A148-06A-11D-A18Z_120626_SN590_0164_BC0VMVACXX_s_1_rg.sorted.bam,54.12,NA,0.15,58cfa831e4b0c9d6adf6cab6,TCGA-D9-A148-06A-11D-A18Z_120626_SN590_0164_BC0VMVACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D9-A148-06A,FED23055-1600-4128-8D73-E1AA902A9D1D,Metastatic,Illumina HiSeq,5581a0f7-47cd-4369-995b-8c74d2e3d62e,Skin,40,8F476CE5-CCCE-4CF6-8374-69F447F17008,63C72F1C-4A39-4E59-B615-1809B196A2C8,TCGA-D9-A148-06A-11D-A18Z-02,HG19_Broad_variant,TCGA-D9-A148,TCGA-SKCM,NA,s7834,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,TX,N3,Not available,Not available
13722.58cfa831e4b0c9d6adf6c750,58cfa831e4b0c9d6adf6c750,TCGA-D3-A3CE-06A-11D-A18Z_120626_SN590_0164_BC0VMVACXX_s_7_rg.sorted.filtered.,WGS,TCGA-D3-A3CE-06A-11D-A18Z_120626_SN590_0164_BC0VMVACXX_s_7_rg.sorted,TCGA-D3-A3CE-06A-11D-A18Z_120626_SN590_0164_BC0VMVACXX_s_7_rg.sorted.bam,57.35,NA,0.17,58cfa831e4b0c9d6adf6c750,TCGA-D3-A3CE-06A-11D-A18Z_120626_SN590_0164_BC0VMVACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A3CE-06A,730F7400-E94A-4F41-B081-5227FA1A9C18,Metastatic,Illumina HiSeq,32fb9058-a555-47ba-8e2e-29360b53085b,Skin,74,8A1C62F5-4F3B-43C8-879D-370EE764B01F,75C4A565-3E22-46BA-B9FE-0A43B9556EBB,TCGA-D3-A3CE-06A-11D-A18Z-02,HG19_Broad_variant,TCGA-D3-A3CE,TCGA-SKCM,1832,s7499,Harvard Medical School,MD Anderson,United States,NO,T0,N1b,Not available,Stage III
13722.58cfa832e4b0c9d6adf6d11f,58cfa832e4b0c9d6adf6d11f,TCGA-IR-A3LK-01A-12D-A20X_140417_SN590_0248_AC3EUFACXX_s_3_rg.sorted.filtered.,WGS,TCGA-IR-A3LK-01A-12D-A20X_140417_SN590_0248_AC3EUFACXX_s_3_rg.sorted,TCGA-IR-A3LK-01A-12D-A20X_140417_SN590_0248_AC3EUFACXX_s_3_rg.sorted.bam,71.39,NA,0.16,58cfa832e4b0c9d6adf6d11f,TCGA-IR-A3LK-01A-12D-A20X_140417_SN590_0248_AC3EUFACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-IR-A3LK-01A,B79558C5-1DB2-4B1E-A7B8-EFBD19AA855E,Primary Tumor,Illumina HiSeq,1c6981be-5fe3-4898-ba63-e0cd0eecc5e5,Cervix,69,DCA9FF1F-DD32-43DD-8FD4-446D014F5DB8,9E7C0BE8-042F-4B5F-BFE9-E993081589AD,TCGA-IR-A3LK-01A-12D-A20X-26,HG19_Broad_variant,TCGA-IR-A3LK,TCGA-CESC,NA,s1376,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T1b2,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d264,58cfa832e4b0c9d6adf6d264,TCGA-IR-A3LI-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_8_rg.sorted.filtered.,WGS,TCGA-IR-A3LI-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_8_rg.sorted,TCGA-IR-A3LI-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_8_rg.sorted.bam,14.76,NA,0.17,58cfa832e4b0c9d6adf6d264,TCGA-IR-A3LI-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-IR-A3LI-10A,75BC22D8-738D-45F8-B6C0-C664F5FEF47C,Blood Derived Normal,Illumina HiSeq,a2fb1563-5e71-4358-b452-ac8ecd9024d6,Cervix,48,CBE595E1-116B-4745-9CCA-56DF1B8806E7,7B435D76-72F8-4815-8740-18BC146ACBF4,TCGA-IR-A3LI-10A-01D-A20X-26,HG19_Broad_variant,TCGA-IR-A3LI,TCGA-CESC,NA,s1214,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T2b,N1,Endocervical Type of Adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d322,58cfa832e4b0c9d6adf6d322,TCGA-L5-A43C-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-L5-A43C-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_1_rg.sorted,TCGA-L5-A43C-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_1_rg.sorted.bam,21.33,NA,0.16,58cfa832e4b0c9d6adf6d322,TCGA-L5-A43C-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A43C-01A,A935DAEB-1EFD-4113-A614-A5E4D446C72B,Primary Tumor,Illumina HiSeq,f5b917a1-f719-4ee6-b994-c4bc7dbbc159,Esophagus,81,2DD3A5ED-42EF-4CA1-AC40-B2F486F0395A,74016C2E-EEC8-4FE9-A297-A4E64D797DEE,TCGA-L5-A43C-01A-11D-A248-26,HG19_Broad_variant,TCGA-L5-A43C,TCGA-ESCA,NA,s1646,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa832e4b0c9d6adf6cfce,58cfa832e4b0c9d6adf6cfce,TCGA-FS-A1ZR-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FS-A1ZR-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_8_rg.sorted,TCGA-FS-A1ZR-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_8_rg.sorted.bam,58,NA,0.17,58cfa832e4b0c9d6adf6cfce,TCGA-FS-A1ZR-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZR-10A,9F4DDE50-FA0C-43BF-8D5D-70B76CC35793,Blood Derived Normal,Illumina HiSeq,474ef1b0-6baa-490c-a7db-37e3d083bc3b,Skin,36,77933881-ACDD-4EB4-BB5C-5E0C3FA29794,03A94509-FF21-40B8-83BE-B24887F8A1A3,TCGA-FS-A1ZR-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZR,TCGA-SKCM,347,s8028,Harvard Medical School,Essen,Germany,NO,T2,N0,Not available,Stage II
13722.58cfa830e4b0c9d6adf6c050,58cfa830e4b0c9d6adf6c050,TCGA-B5-A0K6-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-B5-A0K6-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_5_rg.sorted,TCGA-B5-A0K6-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_5_rg.sorted.bam,110.74,2.06,0.14,58cfa830e4b0c9d6adf6c050,TCGA-B5-A0K6-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0K6-01A,5CBA9441-6812-49C0-A0F6-7928ED4E5B81,Primary Tumor,Illumina HiSeq,06cd1c7f-2531-4a07-bf4f-c086f7a954a0,Uterus,58,69BF0D3A-B7AE-4EE1-B7D1-18A32FCFA67C,A4364F57-81A8-4B96-BA31-1D8B1CC78C5D,TCGA-B5-A0K6-01A-11D-A043-02,HG19_Broad_variant,TCGA-B5-A0K6,TCGA-UCEC,NA,s4247,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c962,58cfa831e4b0c9d6adf6c962,TCGA-DE-A0Y2-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DE-A0Y2-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_6_rg.sorted,TCGA-DE-A0Y2-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_6_rg.sorted.bam,21.64,2,0.14,58cfa831e4b0c9d6adf6c962,TCGA-DE-A0Y2-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DE-A0Y2-10A,6AD260AD-769A-4F3C-BD07-927ADF6B2338,Blood Derived Normal,Illumina HiSeq,49e7891f-4770-48d9-819b-603aec748234,Thyroid,30,8E3AF0FC-266C-47E7-8FD0-25C2DBBFB372,9279B921-3B76-4AD0-88C2-03BB66D1C235,TCGA-DE-A0Y2-10A-01D-A10R-02,HG19_Broad_variant,TCGA-DE-A0Y2,TCGA-THCA,NA,s12633,Harvard Medical School,University of North Carolina,United States,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c8d6,58cfa831e4b0c9d6adf6c8d6,TCGA-D1-A16B-01A-11D-A12F_120511_SN208_0299_BD12J9ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-D1-A16B-01A-11D-A12F_120511_SN208_0299_BD12J9ACXX_s_1_rg.sorted,TCGA-D1-A16B-01A-11D-A12F_120511_SN208_0299_BD12J9ACXX_s_1_rg.sorted.bam,93.6,1.92,0.15,58cfa831e4b0c9d6adf6c8d6,TCGA-D1-A16B-01A-11D-A12F_120511_SN208_0299_BD12J9ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A16B-01A,BCA1057A-1E96-404D-8A37-5A8DC1944EE7,Primary Tumor,Illumina HiSeq,fee88e21-5479-4b67-8933-80c22e6fa222,Uterus,64,6A59FF6E-7CC6-4D46-8983-7D9E6A48CC19,D581BCAA-4EA7-4364-840B-E2D24F1916E4,TCGA-D1-A16B-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A16B,TCGA-UCEC,NA,s5017,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d52a,58cfa832e4b0c9d6adf6d52a,TCGA-L5-A4OT-11A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-L5-A4OT-11A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_8_rg.sorted,TCGA-L5-A4OT-11A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_8_rg.sorted.bam,29.34,NA,0.17,58cfa832e4b0c9d6adf6d52a,TCGA-L5-A4OT-11A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OT-11A,9559F579-5D9A-4C96-9836-8A039D394795,Solid Tissue Normal,Illumina HiSeq,2a181c5e-e4ca-4351-aeec-3b3141bdedd2,Esophagus,77,1ACC1158-82F7-4DFD-8DD3-400C3B050482,F92FA8D1-BF23-47C6-902F-8B68943C40D7,TCGA-L5-A4OT-11A-11D-A28P-26,HG19_Broad_variant,TCGA-L5-A4OT,TCGA-ESCA,149,s1742,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T3,N1,Not available,Stage IV
13722.58cfa82fe4b0c9d6adf6b659,58cfa82fe4b0c9d6adf6b659,TCGA-50-6592-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-50-6592-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_7_rg.sorted,TCGA-50-6592-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_7_rg.sorted.bam,254.4,1.9,0.13,58cfa82fe4b0c9d6adf6b659,TCGA-50-6592-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-6592-01A,09918B81-4696-4CBA-A45A-5FE7407C2337,Primary Tumor,Illumina HiSeq,207da806-7a0b-406f-aaa6-b5bb17f7f28a,Lung,71,01F94091-EB70-40D3-9D56-70C4F847CB4C,F61D3411-6EED-4EDE-8BBA-A40AF0C9DA84,TCGA-50-6592-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-6592,TCGA-LUAD,777,s10793,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c696,58cfa831e4b0c9d6adf6c696,TCGA-CS-6186-01A-12D-2022_130910_SN208_0494_AC2A1DACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CS-6186-01A-12D-2022_130910_SN208_0494_AC2A1DACXX_s_3_rg.sorted,TCGA-CS-6186-01A-12D-2022_130910_SN208_0494_AC2A1DACXX_s_3_rg.sorted.bam,324.7,NA,0.15,58cfa831e4b0c9d6adf6c696,TCGA-CS-6186-01A-12D-2022_130910_SN208_0494_AC2A1DACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-6186-01A,9EE6E821-3AF2-42D7-9D14-F0CA455F338C,Primary Tumor,Illumina HiSeq,5660aee8-60eb-40d1-9083-d4fc781e8ddc,Brain,58,5F73FA4E-FC7D-4FC0-8436-2241E57B9B69,4143FB11-BA46-4129-8543-F72C015AE5C4,TCGA-CS-6186-01A-12D-2022-02,HG19_Broad_variant,TCGA-CS-6186,TCGA-LGG,538,s8556,Harvard Medical School,Thomas Jefferson University,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa831e4b0c9d6adf6c4e4,58cfa831e4b0c9d6adf6c4e4,TCGA-C5-A2LZ-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_2_rg.sorted.filtered.,WGS,TCGA-C5-A2LZ-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_2_rg.sorted,TCGA-C5-A2LZ-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_2_rg.sorted.bam,58.89,NA,0.17,58cfa831e4b0c9d6adf6c4e4,TCGA-C5-A2LZ-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A2LZ-01A,BE8FA67D-C2D3-4FFF-82FE-A46BA1FA8DF0,Primary Tumor,Illumina HiSeq,19f84215-7f5d-4cf8-a6f5-e135327ccd50,Cervix,65,6B9F4254-DBD3-4D82-BAE8-D43A4915A7CD,837B293C-0843-4002-A8AB-3A945E040C75,TCGA-C5-A2LZ-01A-11D-A20X-26,HG19_Broad_variant,TCGA-C5-A2LZ,TCGA-CESC,3046,s1173,MD Anderson - Institute for Applied Cancer Science,Medical College of Wisconsin,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b5f9,58cfa82fe4b0c9d6adf6b5f9,TCGA-75-5125-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_4_rg.sorted.filtered.,WGS,TCGA-75-5125-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_4_rg.sorted,TCGA-75-5125-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_4_rg.sorted.bam,314.7,1.9,0.17,58cfa82fe4b0c9d6adf6b5f9,TCGA-75-5125-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_4_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-5125-10A,205759A6-6391-491B-9857-0080C3A5871E,Blood Derived Normal,Illumina HiSeq,44fab539-38d3-48de-af3c-307ac13fbe93,Lung,NA,1822469A-D526-4A61-B1B3-7F167407448B,66BFF328-E44D-4A86-AE1A-311B5CA4B44C,TCGA-75-5125-10A-01D-1751-02,HG19_Broad_variant,TCGA-75-5125,TCGA-LUAD,NA,s11253,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82fe4b0c9d6adf6b88d,58cfa82fe4b0c9d6adf6b88d,TCGA-49-4510-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-49-4510-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-49-4510-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,247.53,1.9,0.15,58cfa82fe4b0c9d6adf6b88d,TCGA-49-4510-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4510-11A,F77B6930-A1CE-446E-A15D-C018CBBECFEE,Solid Tissue Normal,Illumina HiSeq,b8bf16ce-9774-4ef9-a278-487ae6ec947e,Lung,51,DB4E6EFA-79AA-44D7-AB88-4866B4E94B0D,DA919955-6B7A-4A94-B62F-4A31555A4AA9,TCGA-49-4510-11A-01D-1203-02,GRCh37,TCGA-49-4510,TCGA-LUAD,896,s11002,Harvard Medical School,Johns Hopkins,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa830e4b0c9d6adf6bc52,58cfa830e4b0c9d6adf6bc52,TCGA-AG-A011-01A-01D-A077-02_110409_SN590_0076_AB04G5ABXX_s_1.rg.sorted.filtered.,WGS,TCGA-AG-A011-01A-01D-A077-02_110409_SN590_0076_AB04G5ABXX_s_1.rg.sorted,TCGA-AG-A011-01A-01D-A077-02_110409_SN590_0076_AB04G5ABXX_s_1.rg.sorted.bam,217.29,1.72,0.15,58cfa830e4b0c9d6adf6bc52,TCGA-AG-A011-01A-01D-A077-02_110409_SN590_0076_AB04G5ABXX_s_1.rg.sorted.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A011-01A,3BE106BC-BA42-4C70-9B50-697D89DB617D,Primary Tumor,Illumina HiSeq,af371ab1-77bf-4408-860e-ccc4386c99aa,Colorectal,80,B5DD8F49-26FC-48D9-A964-D8EBDCCA9E19,8C282A6C-3D47-4F9E-96C4-2C0852E7785B,TCGA-AG-A011-01A-01D-A077-02,HG18_Broad_variant,TCGA-AG-A011,TCGA-READ,NA,s2001,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6be7e,58cfa830e4b0c9d6adf6be7e,TCGA-BJ-A192-01A-31D-A13U_120706_SN1120_0170_BD1422ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BJ-A192-01A-31D-A13U_120706_SN1120_0170_BD1422ACXX_s_4_rg.sorted,TCGA-BJ-A192-01A-31D-A13U_120706_SN1120_0170_BD1422ACXX_s_4_rg.sorted.bam,32.81,2.02,0.17,58cfa830e4b0c9d6adf6be7e,TCGA-BJ-A192-01A-31D-A13U_120706_SN1120_0170_BD1422ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A192-01A,B55375C3-9EF2-4D2F-9C29-224E746931C4,Primary Tumor,Illumina HiSeq,9218178e-761c-40ac-b3ca-044bf37f8686,Thyroid,54,582C3030-1F23-4535-9C8B-6B594E656AF4,6D770754-E14D-4E47-AE33-BE0FC9B40CE9,TCGA-BJ-A192-01A-31D-A13U-02,HG19_Broad_variant,TCGA-BJ-A192,TCGA-THCA,NA,s12235,Harvard Medical School,University of Pittsburgh,United States,NO,T3,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa82fe4b0c9d6adf6b64a,58cfa82fe4b0c9d6adf6b64a,TCGA-73-4662-01A-01D-1203_110629_SN208_0211_AB0BP8ABXX_s_5_rg.sorted.filtered.,WGS,TCGA-73-4662-01A-01D-1203_110629_SN208_0211_AB0BP8ABXX_s_5_rg.sorted,TCGA-73-4662-01A-01D-1203_110629_SN208_0211_AB0BP8ABXX_s_5_rg.sorted.bam,337.2,1.9,0.15,58cfa82fe4b0c9d6adf6b64a,TCGA-73-4662-01A-01D-1203_110629_SN208_0211_AB0BP8ABXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4662-01A,294FF941-AEA1-4588-9A0E-E9F5393E2BB6,Primary Tumor,Illumina HiSeq,bb68d6e1-efca-4ccb-bbd6-45c4da207bb7,Lung,65,C7D727B6-47C6-4339-B9DD-5BAF41527BD4,DCC0A32E-EF17-4AA8-8321-A03137A61D72,TCGA-73-4662-01A-01D-1203-02,HG19_Broad_variant,TCGA-73-4662,TCGA-LUAD,NA,s10663,Harvard Medical School,Roswell Park,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa832e4b0c9d6adf6d488,58cfa832e4b0c9d6adf6d488,TCGA-V4-A9EY-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_6_rg.sorted.filtered.,WGS,TCGA-V4-A9EY-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_6_rg.sorted,TCGA-V4-A9EY-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_6_rg.sorted.bam,9.08,NA,0.17,58cfa832e4b0c9d6adf6d488,TCGA-V4-A9EY-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EY-10A,15D19CCC-52B8-41F6-B1C1-2CC55691AED5,Blood Derived Normal,Illumina HiSeq,defbc15e-8345-4c88-a6dd-2ba635ad7715,Eye,66,3D45925C-CB21-458A-975E-5C917757141B,91B9CCDC-9A01-41D2-B641-6A25A1540715,TCGA-V4-A9EY-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9EY,TCGA-UVM,NA,s208,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa830e4b0c9d6adf6bbd8,58cfa830e4b0c9d6adf6bbd8,TCGA-AG-A00H-10A-01D-A078_110405_SN590_0074_AB04EUABXX_s_6_rg.sorted.filtered.,WGS,TCGA-AG-A00H-10A-01D-A078_110405_SN590_0074_AB04EUABXX_s_6_rg.sorted,TCGA-AG-A00H-10A-01D-A078_110405_SN590_0074_AB04EUABXX_s_6_rg.sorted.bam,31.86,1.75,0.15,58cfa830e4b0c9d6adf6bbd8,TCGA-AG-A00H-10A-01D-A078_110405_SN590_0074_AB04EUABXX_s_6_rg.sorted.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A00H-10A,9F4574EC-A58A-4410-8735-C5E5BC4CA7E0,Blood Derived Normal,Illumina HiSeq,b60fa920-96ee-45f5-945a-5efb41023fac,Colorectal,75,A94D44D3-470F-4CA2-B93C-5D5A06340345,59D8A039-76E5-4E7E-B461-6DBDC5BE4398,TCGA-AG-A00H-10A-01D-A078-02,HG18_Broad_variant,TCGA-AG-A00H,TCGA-READ,NA,s2150,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6cc1e,58cfa831e4b0c9d6adf6cc1e,TCGA-EM-A3OB-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EM-A3OB-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_7_rg.sorted,TCGA-EM-A3OB-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_7_rg.sorted.bam,51.44,NA,0.15,58cfa831e4b0c9d6adf6cc1e,TCGA-EM-A3OB-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_7_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3OB-01A,8CFC2589-B0AD-4FE6-8420-8F6FE0178BCC,Primary Tumor,Illumina HiSeq,2d07ef47-3523-49c8-9f8e-64e984c3ceda,Thyroid,33,8133FCFE-ECC4-4503-B81E-00FDF6F87426,F90A631C-4556-43E2-8AA2-1114326B6984,TCGA-EM-A3OB-01A-11D-A221-26,HG19_Broad_variant,TCGA-EM-A3OB,TCGA-THCA,NA,s12384,MD Anderson - Institute for Applied Cancer Science,University Health Network,Canada,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa830e4b0c9d6adf6bc88,58cfa830e4b0c9d6adf6bc88,TCGA-AG-3901-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3901-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3901-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,44.59,1.9,0.16,58cfa830e4b0c9d6adf6bc88,TCGA-AG-3901-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3901-10A,1586CB0A-081A-4364-9470-46F9D0F0167D,Blood Derived Normal,Illumina HiSeq,89a4a4fc-6853-4e6e-ae7c-a413dcd1b0bf,Colorectal,67,339F4C4C-C973-40F0-85EC-C244987AA9C1,D6A98EC3-E843-482D-88AB-484235F648B0,TCGA-AG-3901-10A-01D-1115-02,HG18,TCGA-AG-3901,TCGA-READ,NA,s1994,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Mucinous Adenocarcinoma,Stage IIIB
13722.58cfa831e4b0c9d6adf6ca04,58cfa831e4b0c9d6adf6ca04,TCGA-DB-5273-10A-01D-1465_130808_SN208_0488_BC294YACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DB-5273-10A-01D-1465_130808_SN208_0488_BC294YACXX_s_2_rg.sorted,TCGA-DB-5273-10A-01D-1465_130808_SN208_0488_BC294YACXX_s_2_rg.sorted.bam,51.7,1.9,0.14,58cfa831e4b0c9d6adf6ca04,TCGA-DB-5273-10A-01D-1465_130808_SN208_0488_BC294YACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DB-5273-10A,AE2DB022-EB4F-4B65-89B6-9FD4439DDEEF,Blood Derived Normal,Illumina HiSeq,fe0c497b-caa5-4108-8564-a1507ba99ed4,Brain,33,3C8435A1-E37C-417E-B3D7-27F4E15014ED,A10E85BD-5A8B-4697-87C3-B2F060C02436,TCGA-DB-5273-10A-01D-1465-02,HG19_Broad_variant,TCGA-DB-5273,TCGA-LGG,NA,s8343,Harvard Medical School,Mayo Clinic - Rochester,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa830e4b0c9d6adf6bd9b,58cfa830e4b0c9d6adf6bd9b,TCGA-BG-A0M3-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BG-A0M3-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_8_rg.sorted,TCGA-BG-A0M3-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_8_rg.sorted.bam,101.93,1.88,0.15,58cfa830e4b0c9d6adf6bd9b,TCGA-BG-A0M3-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0M3-01A,8BDD4E0E-5BEC-43F2-B9FA-D6E94A72FE05,Primary Tumor,Illumina HiSeq,d3fa774f-c50e-499c-ad6e-1a5f67dd2be3,Uterus,74,1802CD6B-4D4A-45FA-B839-7450071E41EE,04E49830-378E-4EB2-B77C-70D6955627F7,TCGA-BG-A0M3-01A-11D-A101-02,HG19_Broad_variant,TCGA-BG-A0M3,TCGA-UCEC,NA,s5394,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ae50,58cfa82ee4b0c9d6adf6ae50,TCGA-05-4382-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_3_rg.sorted.filtered.,WGS,TCGA-05-4382-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_3_rg.sorted,TCGA-05-4382-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_3_rg.sorted.bam,445.53,1.9,0.14,58cfa82ee4b0c9d6adf6ae50,TCGA-05-4382-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_3_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4382-01A,3434B91A-C05F-460F-A078-7B1BB6E7085D,Primary Tumor,Illumina HiSeq,42d76c95-55a7-4160-b22f-4338315e6146,Lung,68,CCE6D71F-369E-467F-BD7E-03D20E97B7F3,EE1D241A-B371-433A-9AF7-F1C9074C155F,TCGA-05-4382-01A-01D-1203-02,HG19_Broad_variant,TCGA-05-4382,TCGA-LUAD,NA,s11435,Harvard Medical School,Indivumed,None,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa831e4b0c9d6adf6cc98,58cfa831e4b0c9d6adf6cc98,TCGA-EE-A2MI-06A-11D-A18Y_120724_SN208_0418_BD13N7ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EE-A2MI-06A-11D-A18Y_120724_SN208_0418_BD13N7ACXX_s_7_rg.sorted,TCGA-EE-A2MI-06A-11D-A18Y_120724_SN208_0418_BD13N7ACXX_s_7_rg.sorted.bam,23.06,NA,0.17,58cfa831e4b0c9d6adf6cc98,TCGA-EE-A2MI-06A-11D-A18Y_120724_SN208_0418_BD13N7ACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MI-06A,C061AE6C-7A02-47C3-AECD-A56487C01603,Metastatic,Illumina HiSeq,535ded66-253b-4519-b2d3-4e45793d2ee6,Skin,43,3C7442C7-5655-4D38-AE50-41D4E531CE12,779F841E-DB02-429D-A5A8-39CEFC074719,TCGA-EE-A2MI-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2MI,TCGA-SKCM,6225,s7685,Harvard Medical School,University of Sydney,Australia,NO,T4,N0,Not available,Stage IIB
13722.58cfa830e4b0c9d6adf6c222,58cfa830e4b0c9d6adf6c222,TCGA-BA-4078-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BA-4078-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_2_rg.sorted,TCGA-BA-4078-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_2_rg.sorted.bam,63.03,1.9,0.14,58cfa830e4b0c9d6adf6c222,TCGA-BA-4078-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-4078-10A,C7353D6A-82A2-4A0D-8CD4-8C8957943EDB,Blood Derived Normal,Illumina HiSeq,9f383e84-52bd-4beb-b916-e1c652c45e27,Head and Neck,83,25B0AE1D-2ADD-49B9-A5AE-99702A5C48F4,FA6F21FF-7667-491C-9A99-31B473C9D683,TCGA-BA-4078-10A-01D-1431-02,HG19_Broad_variant,TCGA-BA-4078,TCGA-HNSC,276,s15618,Harvard Medical School,UNC,None,NO,Not available,Not available,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6c1e0,58cfa830e4b0c9d6adf6c1e0,TCGA-BA-5151-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BA-5151-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_4_rg.sorted,TCGA-BA-5151-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_4_rg.sorted.bam,73.4,1.9,0.14,58cfa830e4b0c9d6adf6c1e0,TCGA-BA-5151-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5151-10A,A55FB87D-F606-48A5-82F5-09EACBACF41B,Blood Derived Normal,Illumina HiSeq,fe120e7f-b67b-43e6-9502-3878c982d056,Head and Neck,72,18B31768-284F-4B52-9BED-D0ACE9B8D4FE,5B6DC28D-F368-4A15-8CAE-781081317AB9,TCGA-BA-5151-10A-01D-1431-02,HG19_Broad_variant,TCGA-BA-5151,TCGA-HNSC,NA,s15750,Harvard Medical School,UNC,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6bea2,58cfa830e4b0c9d6adf6bea2,TCGA-BJ-A3PU-11A-11D-A221_120611_SN1222_0115_BD141KACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BJ-A3PU-11A-11D-A221_120611_SN1222_0115_BD141KACXX_s_3_rg.sorted,TCGA-BJ-A3PU-11A-11D-A221_120611_SN1222_0115_BD141KACXX_s_3_rg.sorted.bam,33.42,NA,0.15,58cfa830e4b0c9d6adf6bea2,TCGA-BJ-A3PU-11A-11D-A221_120611_SN1222_0115_BD141KACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A3PU-11A,4CCCC34B-DAF6-41CA-9BF8-F1614525EAC9,Solid Tissue Normal,Illumina HiSeq,7e9a0494-fa34-4859-b282-e797fc03ad17,Thyroid,52,57FA975B-608C-48FD-B515-DFB145B13028,4E857195-62D1-4F2C-BDF5-DC9907C450F6,TCGA-BJ-A3PU-11A-11D-A221-26,HG19_Broad_variant,TCGA-BJ-A3PU,TCGA-THCA,NA,s12359,MD Anderson - Institute for Applied Cancer Science,University of Pittsburgh,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa831e4b0c9d6adf6ca67,58cfa831e4b0c9d6adf6ca67,TCGA-D9-A148-10A-01D-A18Z_120626_SN590_0164_BC0VMVACXX_s_2_rg.sorted.filtered.,WGS,TCGA-D9-A148-10A-01D-A18Z_120626_SN590_0164_BC0VMVACXX_s_2_rg.sorted,TCGA-D9-A148-10A-01D-A18Z_120626_SN590_0164_BC0VMVACXX_s_2_rg.sorted.bam,18.06,NA,0.17,58cfa831e4b0c9d6adf6ca67,TCGA-D9-A148-10A-01D-A18Z_120626_SN590_0164_BC0VMVACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D9-A148-10A,FED23055-1600-4128-8D73-E1AA902A9D1D,Blood Derived Normal,Illumina HiSeq,a0f07bb7-ce52-49fe-83aa-97c4fe2af227,Skin,40,93BEBC8E-9072-407B-AE4F-E763B7193F5C,F7E5B9A6-E556-4DA7-AC55-B0312C05DF0F,TCGA-D9-A148-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-D9-A148,TCGA-SKCM,NA,s7326,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,TX,N3,Not available,Not available
13722.58cfa831e4b0c9d6adf6c73e,58cfa831e4b0c9d6adf6c73e,TCGA-D3-A2JP-10A-01D-A18Z_120612_SN590_0162_BC0VNGACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D3-A2JP-10A-01D-A18Z_120612_SN590_0162_BC0VNGACXX_s_4_rg.sorted,TCGA-D3-A2JP-10A-01D-A18Z_120612_SN590_0162_BC0VNGACXX_s_4_rg.sorted.bam,18.1,NA,0.17,58cfa831e4b0c9d6adf6c73e,TCGA-D3-A2JP-10A-01D-A18Z_120612_SN590_0162_BC0VNGACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A2JP-10A,E9A42A85-9513-41B2-A71D-6D62F70B00E4,Blood Derived Normal,Illumina HiSeq,4b9843ae-869e-4a07-ba84-7e300b9c03cc,Skin,37,071D73D9-5C08-4BE9-8C14-DF3D6EC9BF56,BBB42C52-862D-4BF6-A09F-B65BAEAF3841,TCGA-D3-A2JP-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-D3-A2JP,TCGA-SKCM,NA,s7323,Harvard Medical School,MD Anderson,United States,NO,T0,N3,Not available,Stage IIIC
13722.58cfa82fe4b0c9d6adf6b7c6,58cfa82fe4b0c9d6adf6b7c6,TCGA-49-4507-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-49-4507-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-49-4507-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,258.2,1.9,0.16,58cfa82fe4b0c9d6adf6b7c6,TCGA-49-4507-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4507-11A,50B2C647-AECD-4C81-AF22-0D8116593552,Solid Tissue Normal,Illumina HiSeq,85ba42cf-c97b-4bd6-910f-d3e06fb69a79,Lung,73,8A603532-91DB-487A-A4E2-A8C1F848FA19,6C9A73D4-8E10-4957-9739-603EAF942BBD,TCGA-49-4507-11A-01D-1203-02,GRCh37,TCGA-49-4507,TCGA-LUAD,268,s10781,Harvard Medical School,Johns Hopkins,United States,NO,T3,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82fe4b0c9d6adf6b66c,58cfa82fe4b0c9d6adf6b66c,TCGA-50-5946-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-50-5946-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_3_rg.sorted,TCGA-50-5946-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_3_rg.sorted.bam,242.4,1.9,0.14,58cfa82fe4b0c9d6adf6b66c,TCGA-50-5946-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-50-5946-01A,C95957A7-1A1A-4C8D-BB61-7C99B500F224,Primary Tumor,Illumina HiSeq,b7f024ff-9569-4d31-b652-ffc2ceaa2789,Lung,62,AD9A794F-52DD-4572-BF29-CD3D11BA6C24,F9F38A15-2964-4AE0-90AA-E5F3F7461AB3,TCGA-50-5946-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-5946,TCGA-LUAD,NA,s10790,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N0,Lung Adenocarcinoma Mixed Subtype,Stage IA
13722.58cfa832e4b0c9d6adf6d414,58cfa832e4b0c9d6adf6d414,TCGA-VD-A8KB-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_4_rg.sorted.filtered.,WGS,TCGA-VD-A8KB-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_4_rg.sorted,TCGA-VD-A8KB-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_4_rg.sorted.bam,41.19,NA,0.15,58cfa832e4b0c9d6adf6d414,TCGA-VD-A8KB-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KB-01A,31771082-C094-4749-A9C7-80B67762F4D1,Primary Tumor,Illumina HiSeq,55fb2927-8427-4ec7-a0cd-d9250ff855be,Eye,66,3106274B-1330-4C1D-9D6F-EE36138BC929,DEE2EF23-9722-4006-AC98-0F262EB9ECF7,TCGA-VD-A8KB-01A-11D-A40D-26,HG19_Broad_variant,TCGA-VD-A8KB,TCGA-UVM,NA,s273,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T3a,NX,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6ce8e,58cfa832e4b0c9d6adf6ce8e,TCGA-FY-A3ON-10A-01D-A221_120610_SN1120_0152_BD13TDACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FY-A3ON-10A-01D-A221_120610_SN1120_0152_BD13TDACXX_s_4_rg.sorted,TCGA-FY-A3ON-10A-01D-A221_120610_SN1120_0152_BD13TDACXX_s_4_rg.sorted.bam,38.02,NA,0.16,58cfa832e4b0c9d6adf6ce8e,TCGA-FY-A3ON-10A-01D-A221_120610_SN1120_0152_BD13TDACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FY-A3ON-10A,4D1AEC67-C345-4721-8EE8-356B0DFF009B,Blood Derived Normal,Illumina HiSeq,a641c1e1-a490-4f51-9cdc-7e1b0e7e4cbd,Thyroid,20,EE84B90F-55B5-4837-959C-51F9BA8062F8,3176F5B4-4545-4A94-99B6-73280F2D1A0C,TCGA-FY-A3ON-10A-01D-A221-26,HG19_Broad_variant,TCGA-FY-A3ON,TCGA-THCA,NA,s12391,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T2,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82fe4b0c9d6adf6ba10,58cfa82fe4b0c9d6adf6ba10,TCGA-AA-A01G-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A01G-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A01G-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,233.25,1.69,0.15,58cfa82fe4b0c9d6adf6ba10,TCGA-AA-A01G-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01G-01A,6F2B5A14-569C-4084-8C67-B1A44D787897,Primary Tumor,Illumina HiSeq,efd511ca-ff06-4cbe-afe2-2c025120233e,Colorectal,63,A09ABC20-4F93-4130-A23A-8413E6C32FE5,D7D83B15-9EE5-4206-805D-AC3E5914BCC6,TCGA-AA-A01G-01A-01D-A077-02,HG18,TCGA-AA-A01G,TCGA-COAD,NA,s13205,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Mucinous Adenocarcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6ca37,58cfa831e4b0c9d6adf6ca37,TCGA-DB-5279-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DB-5279-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_7_rg.sorted,TCGA-DB-5279-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_7_rg.sorted.bam,81,1.9,0.14,58cfa831e4b0c9d6adf6ca37,TCGA-DB-5279-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_7_rg.sorted.bam,Alive,MALE,Not available,Not available,Brain Lower Grade Glioma,Aligned reads,TCGA-DB-5279-01A,85F77526-791E-47CD-904D-D1DBB49EAEAB,Primary Tumor,Illumina HiSeq,1c15ff7e-3cbc-41b1-b814-1cf03f1f5a27,Brain,59,0096C7FB-34E3-4D0F-BA81-3559CC00080A,109052DB-CACF-4E14-8258-500E90B6B476,TCGA-DB-5279-01A-01D-1465-02,HG19_Broad_variant,TCGA-DB-5279,TCGA-LGG,NA,s8559,Harvard Medical School,Mayo Clinic - Rochester,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82fe4b0c9d6adf6b7c4,58cfa82fe4b0c9d6adf6b7c4,TCGA-44-4112-11A-01D-1103_120318_SN1120_0124_AC0HNPACXX_s_2_rg.sorted.filtered.,WGS,TCGA-44-4112-11A-01D-1103_120318_SN1120_0124_AC0HNPACXX_s_2_rg.sorted,TCGA-44-4112-11A-01D-1103_120318_SN1120_0124_AC0HNPACXX_s_2_rg.sorted.bam,555.93,1.9,0.17,58cfa82fe4b0c9d6adf6b7c4,TCGA-44-4112-11A-01D-1103_120318_SN1120_0124_AC0HNPACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-4112-11A,68B86559-38B2-41F2-B66E-C3C2B628B14D,Solid Tissue Normal,Illumina HiSeq,e885be2d-89c8-413a-bae1-1458a975bd33,Lung,60,6D41EF8F-9599-40F3-8A7D-32DE1ED0ACC0,161AB88F-51DF-41DF-B38C-C1DC9764DC82,TCGA-44-4112-11A-01D-1103-02,HG19_Broad_variant,TCGA-44-4112,TCGA-LUAD,NA,s10902,Harvard Medical School,Christiana Healthcare,None,NO,T2a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6ccd0,58cfa831e4b0c9d6adf6ccd0,TCGA-EM-A1YA-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EM-A1YA-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_2_rg.sorted,TCGA-EM-A1YA-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_2_rg.sorted.bam,45.94,1.87,0.18,58cfa831e4b0c9d6adf6ccd0,TCGA-EM-A1YA-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1YA-01A,567E4D90-5C5A-44F0-A462-90C831F3C096,Primary Tumor,Illumina HiSeq,69cba75e-7be6-4707-b524-255288547622,Thyroid,74,D0880877-36CF-4DED-87B2-898C3446F90D,D1BD818E-62BF-4375-A171-ED388341014F,TCGA-EM-A1YA-01A-11D-A14U-02,HG19_Broad_variant,TCGA-EM-A1YA,TCGA-THCA,NA,s12754,Harvard Medical School,University Health Network,Canada,NO,T2,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa832e4b0c9d6adf6d1fa,58cfa832e4b0c9d6adf6d1fa,TCGA-GV-A3JW-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-GV-A3JW-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_7_rg.sorted,TCGA-GV-A3JW-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_7_rg.sorted.bam,45.77,NA,0.15,58cfa832e4b0c9d6adf6d1fa,TCGA-GV-A3JW-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GV-A3JW-01A,3D644EAF-82FC-4BC7-93B7-3E600E8C6511,Primary Tumor,Illumina HiSeq,586abfdd-f50a-4834-8143-3bda5638ea60,Bladder,74,B02C03B6-24AA-42D3-9310-741DE1EF0D30,D7EFF32B-E9EB-4891-93D7-4C3D10BE21EA,TCGA-GV-A3JW-01A-11D-A210-26,HG19_Broad_variant,TCGA-GV-A3JW,TCGA-BLCA,NA,s2737,MD Anderson - Institute for Applied Cancer Science,BLN - Cleveland Clinic,United States,NO,T2,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c741,58cfa831e4b0c9d6adf6c741,TCGA-CV-7247-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CV-7247-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_7_rg.sorted,TCGA-CV-7247-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_7_rg.sorted.bam,52.73,NA,0.13,58cfa831e4b0c9d6adf6c741,TCGA-CV-7247-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7247-01A,5E25AB76-A8AB-4779-AA03-8DE658F18DA1,Primary Tumor,Illumina HiSeq,0b4ae8f3-7acd-4d37-a39f-cb4fc2b537b4,Head and Neck,55,F84AE44B-4BB7-4841-AEE0-139CD79B9680,A5BA905A-C959-4118-B1C9-F6466CB5541A,TCGA-CV-7247-01A-11D-2317-26,HG19_Broad_variant,TCGA-CV-7247,TCGA-HNSC,577,s15904,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6caf0,58cfa831e4b0c9d6adf6caf0,TCGA-DU-7006-01A-11D-2022_130910_SN208_0494_AC2A1DACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DU-7006-01A-11D-2022_130910_SN208_0494_AC2A1DACXX_s_5_rg.sorted,TCGA-DU-7006-01A-11D-2022_130910_SN208_0494_AC2A1DACXX_s_5_rg.sorted.bam,301.7,NA,0.16,58cfa831e4b0c9d6adf6caf0,TCGA-DU-7006-01A-11D-2022_130910_SN208_0494_AC2A1DACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7006-01A,215E117C-4D76-463C-8F8A-FD6A28D23929,Primary Tumor,Illumina HiSeq,a423d9b3-2389-45d5-b834-d5cf57e5e647,Brain,60,21E471E0-6B87-4D98-A7E0-DE0F34598460,FDA752F3-371F-460B-8D81-216E0AC53B0E,TCGA-DU-7006-01A-11D-2022-02,HG19_Broad_variant,TCGA-DU-7006,TCGA-LGG,349,s8357,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa830e4b0c9d6adf6c29e,58cfa830e4b0c9d6adf6c29e,TCGA-BR-4366-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_1_rg.sorted.filtered.,WGS,TCGA-BR-4366-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_1_rg.sorted,TCGA-BR-4366-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_1_rg.sorted.bam,194.2,1.9,0.15,58cfa830e4b0c9d6adf6c29e,TCGA-BR-4366-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4366-01A,525A6978-2D7B-4F3A-AC68-13FE8CBBBDCC,Primary Tumor,Illumina HiSeq,c4b9424f-d0da-48ae-8723-69cbccfdefc6,Stomach,87,8C2D2CCE-E071-42E8-89B2-77C56B4F3472,5AF4101A-F7F6-4014-BC9C-02446DA9CBDC,TCGA-BR-4366-01A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4366,TCGA-STAD,NA,s15235,Harvard Medical School,Asterand,Russia,NO,TX,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa82fe4b0c9d6adf6b903,58cfa82fe4b0c9d6adf6b903,TCGA-49-4506-11A-01D-1203_110729_SN208_0215_BD0CLPABXX_s_8_rg.sorted.filtered.,WGS,TCGA-49-4506-11A-01D-1203_110729_SN208_0215_BD0CLPABXX_s_8_rg.sorted,TCGA-49-4506-11A-01D-1203_110729_SN208_0215_BD0CLPABXX_s_8_rg.sorted.bam,147.2,1.9,0.15,58cfa82fe4b0c9d6adf6b903,TCGA-49-4506-11A-01D-1203_110729_SN208_0215_BD0CLPABXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4506-11A,B61ABDFD-B7A0-4E1A-B570-D1EAECAD3A9E,Solid Tissue Normal,Illumina HiSeq,30c3d956-3fe6-4cf5-9829-00573c3a5813,Lung,68,5185FAF2-69D2-40D6-8554-97D5D71AB112,8641683B-986D-4A4F-878E-CE0E3754727F,TCGA-49-4506-11A-01D-1203-02,HG19_Broad_variant,TCGA-49-4506,TCGA-LUAD,999,s11005,Harvard Medical School,Johns Hopkins,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa832e4b0c9d6adf6d638,58cfa832e4b0c9d6adf6d638,TCGA-LN-A49M-10A-01D-A267_131001_SN1222_0222_BC2CN2ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-LN-A49M-10A-01D-A267_131001_SN1222_0222_BC2CN2ACXX_s_2_rg.sorted,TCGA-LN-A49M-10A-01D-A267_131001_SN1222_0222_BC2CN2ACXX_s_2_rg.sorted.bam,100.9,NA,0.17,58cfa832e4b0c9d6adf6d638,TCGA-LN-A49M-10A-01D-A267_131001_SN1222_0222_BC2CN2ACXX_s_2_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49M-10A,B3E248B5-5D40-495C-BD10-90ECF0ED6A95,Blood Derived Normal,Illumina HiSeq,86fd7937-c4db-479b-adbe-410e6559701f,Esophagus,62,A0AE2D0B-40EF-4D6A-8324-D70740FAF2B1,4529BBDC-CC2C-41CA-8690-AB724F408810,TCGA-LN-A49M-10A-01D-A267-26,HG19_Broad_variant,TCGA-LN-A49M,TCGA-ESCA,NA,s1853,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T2,N0,Not available,Stage IIA
13722.58cfa832e4b0c9d6adf6d216,58cfa832e4b0c9d6adf6d216,TCGA-J8-A3YH-10A-01D-A23Q_120927_SN208_0432_AC188LACXX_s_4_rg.sorted.filtered.,WGS,TCGA-J8-A3YH-10A-01D-A23Q_120927_SN208_0432_AC188LACXX_s_4_rg.sorted,TCGA-J8-A3YH-10A-01D-A23Q_120927_SN208_0432_AC188LACXX_s_4_rg.sorted.bam,86.99,NA,0.16,58cfa832e4b0c9d6adf6d216,TCGA-J8-A3YH-10A-01D-A23Q_120927_SN208_0432_AC188LACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,Not available,Thyroid Carcinoma,Aligned reads,TCGA-J8-A3YH-10A,A09B20B5-C187-4632-B996-0D5314A9885C,Blood Derived Normal,Illumina HiSeq,3180bef4-6ed0-4432-af76-0f70becf05c1,Thyroid,39,E5E18EDC-042A-4A3B-BF29-D4560D3E3DC2,3B557C96-DD0A-4695-939A-0874237C4827,TCGA-J8-A3YH-10A-01D-A23Q-26,HG19_Broad_variant,TCGA-J8-A3YH,TCGA-THCA,NA,s12124,MD Anderson - Institute for Applied Cancer Science,Mayo Clinic,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c854,58cfa831e4b0c9d6adf6c854,TCGA-D3-A2JD-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-D3-A2JD-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_1_rg.sorted,TCGA-D3-A2JD-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_1_rg.sorted.bam,57.77,NA,0.15,58cfa831e4b0c9d6adf6c854,TCGA-D3-A2JD-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A2JD-06A,A5F95C6C-E25A-4AD8-BD5D-FCFD8A31933C,Metastatic,Illumina HiSeq,65653c49-be73-44c2-b13c-3aa7f55d5748,Skin,58,5A484E4E-D555-4AC6-9269-6E36FCC955B9,512AF874-0BA3-4BD2-A1FE-361C73F3EADF,TCGA-D3-A2JD-06A-11D-A18Z-02,HG19_Broad_variant,TCGA-D3-A2JD,TCGA-SKCM,361,s7669,Harvard Medical School,MD Anderson,United States,NO,T4b,N1b,Not available,Stage IIIC
13722.58cfa831e4b0c9d6adf6cc1f,58cfa831e4b0c9d6adf6cc1f,TCGA-EE-A29R-10A-01D-A190_120729_SN1120_0179_AC11G3ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EE-A29R-10A-01D-A190_120729_SN1120_0179_AC11G3ACXX_s_8_rg.sorted,TCGA-EE-A29R-10A-01D-A190_120729_SN1120_0179_AC11G3ACXX_s_8_rg.sorted.bam,37,NA,0.17,58cfa831e4b0c9d6adf6cc1f,TCGA-EE-A29R-10A-01D-A190_120729_SN1120_0179_AC11G3ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29R-10A,D73D1B38-9AB4-409E-A360-E93F8C54715C,Blood Derived Normal,Illumina HiSeq,a15d7730-71dc-45c5-b2e1-e431da6b8f38,Skin,48,A16B0EA8-3F15-4F42-A709-06B6BAC4AF91,E54FFA2C-E4BB-4048-AF1A-63CE7BA1F45E,TCGA-EE-A29R-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A29R,TCGA-SKCM,NA,s8010,Harvard Medical School,University of Sydney,Australia,NO,T3b,N1b,Not available,Stage IIIC
13722.58cfa82fe4b0c9d6adf6b666,58cfa82fe4b0c9d6adf6b666,TCGA-50-5946-10A-01D-1751_111111_SN208_0254_B0160ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-50-5946-10A-01D-1751_111111_SN208_0254_B0160ACXX_s_4_rg.sorted,TCGA-50-5946-10A-01D-1751_111111_SN208_0254_B0160ACXX_s_4_rg.sorted.bam,375.7,1.9,0.16,58cfa82fe4b0c9d6adf6b666,TCGA-50-5946-10A-01D-1751_111111_SN208_0254_B0160ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-50-5946-10A,C95957A7-1A1A-4C8D-BB61-7C99B500F224,Blood Derived Normal,Illumina HiSeq,e8b95c33-23ff-4672-86df-5200e75ba0fc,Lung,62,085A5EEE-EB20-4B3D-BBFF-D477971DFD89,59E74FEE-E0A0-4392-A42E-9CB3EAE8E931,TCGA-50-5946-10A-01D-1751-02,HG19_Broad_variant,TCGA-50-5946,TCGA-LUAD,NA,s11010,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N0,Lung Adenocarcinoma Mixed Subtype,Stage IA
13722.58cfa831e4b0c9d6adf6ca2e,58cfa831e4b0c9d6adf6ca2e,TCGA-DA-A1IC-06A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DA-A1IC-06A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_1_rg.sorted,TCGA-DA-A1IC-06A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_1_rg.sorted.bam,43.33,NA,0.16,58cfa831e4b0c9d6adf6ca2e,TCGA-DA-A1IC-06A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1IC-06A,6625CE3F-3A1F-45F9-AA42-AB1931D6DAF4,Metastatic,Illumina HiSeq,805d3497-3d9a-4634-b16a-2e69b7424813,Skin,81,B9FDDA29-EBD4-4B0B-A8DA-555BA05D3567,3D33A1E2-8AC8-4EE2-8659-2B15EB1C3949,TCGA-DA-A1IC-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-DA-A1IC,TCGA-SKCM,NA,s7506,Harvard Medical School,Yale,United States,NO,T3a,N2c,Not available,Stage IIIB
13722.58cfa831e4b0c9d6adf6c76a,58cfa831e4b0c9d6adf6c76a,TCGA-D3-A2JC-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-D3-A2JC-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_6_rg.sorted,TCGA-D3-A2JC-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_6_rg.sorted.bam,52.51,NA,0.15,58cfa831e4b0c9d6adf6c76a,TCGA-D3-A2JC-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A2JC-06A,DB239624-3DBA-48BB-9889-F479DC2BA046,Metastatic,Illumina HiSeq,a7d7b7f7-01dd-4c3f-9406-513601821293,Skin,53,350D1C39-1CE1-4140-ACE9-3FB908D0FF5B,61155BF2-23AB-49CC-BEE7-FE6901B7D1D7,TCGA-D3-A2JC-06A-11D-A18Z-02,HG19_Broad_variant,TCGA-D3-A2JC,TCGA-SKCM,NA,s7493,Harvard Medical School,MD Anderson,United States,NO,T0,N2b,Not available,Stage III
13722.58cfa831e4b0c9d6adf6c63a,58cfa831e4b0c9d6adf6c63a,TCGA-CG-4304-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CG-4304-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_3_rg.sorted,TCGA-CG-4304-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_3_rg.sorted.bam,286.2,1.9,0.16,58cfa831e4b0c9d6adf6c63a,TCGA-CG-4304-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_3_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4304-01A,8E005891-D6FE-4FEE-A699-971FEE4E70F1,Primary Tumor,Illumina HiSeq,4fbdbad3-32cb-45de-990a-1337f32a25fa,Stomach,84,CC852701-8996-4C8B-828D-5C4AC1F4CFD4,46FB2601-D210-4528-B7D9-BE054DD54BFD,TCGA-CG-4304-01A-01D-A326-26,HG19_Broad_variant,TCGA-CG-4304,TCGA-STAD,NA,s14549,MD Anderson - Institute for Applied Cancer Science,Indivumed,Germany,NO,T2a,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa832e4b0c9d6adf6d4a7,58cfa832e4b0c9d6adf6d4a7,TCGA-VD-A8KH-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-VD-A8KH-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_5_rg.sorted,TCGA-VD-A8KH-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_5_rg.sorted.bam,39.6,NA,0.17,58cfa832e4b0c9d6adf6d4a7,TCGA-VD-A8KH-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_5_rg.sorted.bam,Alive,MALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KH-01A,39AF6E0F-908C-4B2B-97B8-A4D1966E47E1,Primary Tumor,Illumina HiSeq,c1aaf5dd-316d-42b5-9471-88f8c886efd8,Eye,69,98A73F7B-83C7-4160-944E-7A19B07AD696,4A25E140-632B-481F-8D50-49433ECEF545,TCGA-VD-A8KH-01A-11D-A40D-26,HG19_Broad_variant,TCGA-VD-A8KH,TCGA-UVM,NA,s251,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T4b,NX,Not available,Stage IIIB
13722.58cfa831e4b0c9d6adf6cb38,58cfa831e4b0c9d6adf6cb38,TCGA-EE-A2GT-06A-12D-A18Y_120724_SN208_0418_BD13N7ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EE-A2GT-06A-12D-A18Y_120724_SN208_0418_BD13N7ACXX_s_2_rg.sorted,TCGA-EE-A2GT-06A-12D-A18Y_120724_SN208_0418_BD13N7ACXX_s_2_rg.sorted.bam,81.94,NA,0.16,58cfa831e4b0c9d6adf6cb38,TCGA-EE-A2GT-06A-12D-A18Y_120724_SN208_0418_BD13N7ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2GT-06A,97D9DFC9-C937-48B4-B453-DF081950419F,Metastatic,Illumina HiSeq,c72f6347-e501-475f-a0b1-44e625169c38,Skin,77,549F66DB-E789-4BBA-897A-297DD6A0EE8E,A3857F08-F577-41B4-A573-71D084FC9CE4,TCGA-EE-A2GT-06A-12D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2GT,TCGA-SKCM,NA,s7856,Harvard Medical School,University of Sydney,Australia,NO,T3a,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6c810,58cfa831e4b0c9d6adf6c810,TCGA-D1-A2G0-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-D1-A2G0-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_5_rg.sorted,TCGA-D1-A2G0-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_5_rg.sorted.bam,59.69,NA,0.17,58cfa831e4b0c9d6adf6c810,TCGA-D1-A2G0-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A2G0-01A,6F661F0D-F08B-486E-8BD7-4306E1593EB9,Primary Tumor,Illumina HiSeq,675cc0ce-f2e1-4e4c-a337-4bc31fcb46c5,Uterus,70,134CD317-CBEB-4633-B540-B639454615F7,DF417E78-8258-40C2-8305-2FE14DCC8035,TCGA-D1-A2G0-01A-11D-A17E-02,HG19_Broad_variant,TCGA-D1-A2G0,TCGA-UCEC,NA,s4803,Harvard Medical School,Mayo Clinic,United States,NO,Not available,Not available,Mixed serous and endometrioid,Not available
13722.58cfa831e4b0c9d6adf6ca39,58cfa831e4b0c9d6adf6ca39,TCGA-DJ-A13M-10A-01D-A10R_120616_SN1120_0154_BD142VACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DJ-A13M-10A-01D-A10R_120616_SN1120_0154_BD142VACXX_s_8_rg.sorted,TCGA-DJ-A13M-10A-01D-A10R_120616_SN1120_0154_BD142VACXX_s_8_rg.sorted.bam,44.61,1.89,0.14,58cfa831e4b0c9d6adf6ca39,TCGA-DJ-A13M-10A-01D-A10R_120616_SN1120_0154_BD142VACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13M-10A,BA9DEC81-FFC0-453A-9621-94BEBA45FAB1,Blood Derived Normal,Illumina HiSeq,88b57bac-8053-4bda-992c-1bcbae291251,Thyroid,28,CA0A1B87-487B-4214-9EFA-E9C6AC46EA9A,A684E286-8E67-4A5A-B295-AAEAA0E8F5CD,TCGA-DJ-A13M-10A-01D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13M,TCGA-THCA,NA,s12637,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa830e4b0c9d6adf6be84,58cfa830e4b0c9d6adf6be84,TCGA-BJ-A191-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BJ-A191-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_1_rg.sorted,TCGA-BJ-A191-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_1_rg.sorted.bam,110.16,1.93,0.17,58cfa830e4b0c9d6adf6be84,TCGA-BJ-A191-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A191-01A,2501EE46-8D38-448B-8765-E9C9706CBBE8,Primary Tumor,Illumina HiSeq,fb73296b-b8ef-4ff9-a954-fab7d29ab101,Thyroid,49,C92FC4E3-7A96-4000-A969-AA894CA58A33,B3EDF2BC-5E8F-435A-ADA1-F292722EDD9C,TCGA-BJ-A191-01A-11D-A13U-02,HG19_Broad_variant,TCGA-BJ-A191,TCGA-THCA,NA,s12237,Harvard Medical School,University of Pittsburgh,United States,NO,T1b,N0,Other  specify,Stage I
13722.58cfa832e4b0c9d6adf6ce3d,58cfa832e4b0c9d6adf6ce3d,TCGA-ER-A19Q-06A-11D-A18Y_120718_SN208_0416_BD140PACXX_s_1_rg.sorted.filtered.,WGS,TCGA-ER-A19Q-06A-11D-A18Y_120718_SN208_0416_BD140PACXX_s_1_rg.sorted,TCGA-ER-A19Q-06A-11D-A18Y_120718_SN208_0416_BD140PACXX_s_1_rg.sorted.bam,51.18,NA,0.17,58cfa832e4b0c9d6adf6ce3d,TCGA-ER-A19Q-06A-11D-A18Y_120718_SN208_0416_BD140PACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19Q-06A,391EAB51-B140-4BC2-BC8C-99400FBA9066,Metastatic,Illumina HiSeq,d8a90220-2acb-4d71-9feb-6febee1f8745,Skin,37,1BBEF533-EB97-492C-A674-AC5C8B8AC7F2,4CDA923B-2193-4654-9525-468CDDD89E62,TCGA-ER-A19Q-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-ER-A19Q,TCGA-SKCM,1548,s7361,Harvard Medical School,University of Pittsburgh,United States,NO,Not available,N0,Not available,Not available
13722.58cfa82fe4b0c9d6adf6b868,58cfa82fe4b0c9d6adf6b868,TCGA-A5-A0R7-01A-31D-A101_120403_SN1222_0093_AC0L7VACXX_s_3_rg.sorted.filtered.,WGS,TCGA-A5-A0R7-01A-31D-A101_120403_SN1222_0093_AC0L7VACXX_s_3_rg.sorted,TCGA-A5-A0R7-01A-31D-A101_120403_SN1222_0093_AC0L7VACXX_s_3_rg.sorted.bam,88.28,1.87,0.17,58cfa82fe4b0c9d6adf6b868,TCGA-A5-A0R7-01A-31D-A101_120403_SN1222_0093_AC0L7VACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0R7-01A,02B25675-094D-4098-96DA-51D121380FEC,Primary Tumor,Illumina HiSeq,daa92f08-7339-46a6-8a74-e6756c170ed5,Uterus,55,550C6341-260A-4156-B00C-0AE9031D647F,4C9B54D0-A58E-44CF-8937-913A34F0788C,TCGA-A5-A0R7-01A-31D-A101-02,HG19_Broad_variant,TCGA-A5-A0R7,TCGA-UCEC,NA,s4777,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c34e,58cfa831e4b0c9d6adf6c34e,TCGA-CG-5718-10A-01D-1598_121029_SN208_0438_AC18NJACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CG-5718-10A-01D-1598_121029_SN208_0438_AC18NJACXX_s_8_rg.sorted,TCGA-CG-5718-10A-01D-1598_121029_SN208_0438_AC18NJACXX_s_8_rg.sorted.bam,305.7,1.9,0.15,58cfa831e4b0c9d6adf6c34e,TCGA-CG-5718-10A-01D-1598_121029_SN208_0438_AC18NJACXX_s_8_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5718-10A,D5C58161-05ED-4472-81ED-176216F49929,Blood Derived Normal,Illumina HiSeq,30044c1d-1cc7-49e5-9bed-dbb5168be8f4,Stomach,78,D44D5BD5-5034-4D33-8554-CD1A8179A711,C1D35FF6-7260-49C2-A7C1-2E22CBB10ED7,TCGA-CG-5718-10A-01D-1598-02,HG19_Broad_variant,TCGA-CG-5718,TCGA-STAD,NA,s15324,Harvard Medical School,Indivumed,Germany,NO,T2b,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa832e4b0c9d6adf6cfea,58cfa832e4b0c9d6adf6cfea,TCGA-G9-6494-01A-11D-1784_130131_SN1120_0234_AD1PVUACXX_s_1_rg.sorted.filtered.,WGS,TCGA-G9-6494-01A-11D-1784_130131_SN1120_0234_AD1PVUACXX_s_1_rg.sorted,TCGA-G9-6494-01A-11D-1784_130131_SN1120_0234_AD1PVUACXX_s_1_rg.sorted.bam,129.4,1.9,0.13,58cfa832e4b0c9d6adf6cfea,TCGA-G9-6494-01A-11D-1784_130131_SN1120_0234_AD1PVUACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6494-01A,0C459149-0DFE-4206-B50B-DB79180EBB57,Primary Tumor,Illumina HiSeq,d55338b0-a49a-4c6e-ba7d-757df0a55dfe,Prostate,66,45DB5303-BBAB-4F8C-A2A2-9A9A9BFA2FD1,5BCBE988-68F6-48D0-8F2A-B34369A5FBB9,TCGA-G9-6494-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6494,TCGA-PRAD,NA,s3620,Harvard Medical School,Roswell Park,United States,NO,T4,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6cfc0,58cfa832e4b0c9d6adf6cfc0,TCGA-GF-A2C7-01A-11D-A18Y_120602_SN208_0304_BC0WTWACXX_s_3_rg.sorted.filtered.,WGS,TCGA-GF-A2C7-01A-11D-A18Y_120602_SN208_0304_BC0WTWACXX_s_3_rg.sorted,TCGA-GF-A2C7-01A-11D-A18Y_120602_SN208_0304_BC0WTWACXX_s_3_rg.sorted.bam,42.41,NA,0.16,58cfa832e4b0c9d6adf6cfc0,TCGA-GF-A2C7-01A-11D-A18Y_120602_SN208_0304_BC0WTWACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-GF-A2C7-01A,285D8E2C-F183-49D5-BC1C-FD47C6670ACC,Primary Tumor,Illumina HiSeq,9e0dd24f-4e97-44c0-916f-03fc02fc29ac,Skin,48,053CAF96-E851-401D-A5CC-214DBA82FE05,12E86E5E-AA64-4E6F-B5BC-846DDCBF4A64,TCGA-GF-A2C7-01A-11D-A18Y-02,HG19_Broad_variant,TCGA-GF-A2C7,TCGA-SKCM,NA,s7374,Harvard Medical School,ABS - IUPUI,United States,NO,T4b,N0,Not available,Stage IIC
13722.58cfa831e4b0c9d6adf6c528,58cfa831e4b0c9d6adf6c528,TCGA-CM-4750-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-CM-4750-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-CM-4750-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,166.72,1.9,0.13,58cfa831e4b0c9d6adf6c528,TCGA-CM-4750-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-CM-4750-10A,C777A777-373A-4773-9566-6C373261F00A,Blood Derived Normal,Illumina HiSeq,ec4b40d2-142c-4754-8825-4cdae52c5b9b,Colorectal,34,0D218B20-9C44-4C04-8BD5-3490D4E67333,5F8BF9A0-0680-44A1-809D-A2CAA776B977,TCGA-CM-4750-10A-01D-1405-02,HG18,TCGA-CM-4750,TCGA-COAD,NA,s13218,Harvard Medical School,MSKCC,United States,NO,T1,N1b,Colon Adenocarcinoma,Stage IIIA
13722.58cfa831e4b0c9d6adf6cb69,58cfa831e4b0c9d6adf6cb69,TCGA-EE-A2MD-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EE-A2MD-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_8_rg.sorted,TCGA-EE-A2MD-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_8_rg.sorted.bam,33.67,NA,0.18,58cfa831e4b0c9d6adf6cb69,TCGA-EE-A2MD-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MD-10A,D28B2D64-2399-4CE1-9C9A-7538DABAB862,Blood Derived Normal,Illumina HiSeq,036982a1-44c4-415d-bccb-fc3d2738a8f4,Skin,52,ECE5B357-8523-4EB7-B583-80A639DC4C72,48E9ED1E-9771-494E-89AC-A8C2BDC0522B,TCGA-EE-A2MD-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2MD,TCGA-SKCM,1438,s7513,Harvard Medical School,University of Sydney,Australia,NO,T3a,N0,Not available,Stage II
13722.58cfa82fe4b0c9d6adf6b8b3,58cfa82fe4b0c9d6adf6b8b3,TCGA-50-5051-01A-21D-1853_120322_SN208_0277_AD0PL1ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-50-5051-01A-21D-1853_120322_SN208_0277_AD0PL1ACXX_s_7_rg.sorted,TCGA-50-5051-01A-21D-1853_120322_SN208_0277_AD0PL1ACXX_s_7_rg.sorted.bam,416.7,1.9,0.15,58cfa82fe4b0c9d6adf6b8b3,TCGA-50-5051-01A-21D-1853_120322_SN208_0277_AD0PL1ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5051-01A,E1C55BAC-BB41-4964-ADD5-ECD6BA04B58D,Primary Tumor,Illumina HiSeq,fd2a1c20-3ed6-4057-8fb5-4027ce0eec74,Lung,42,180EB213-0DDC-4F10-AB0E-B3AF92CDE3C3,80170E98-4886-4A34-BC88-F2B2F84743B2,TCGA-50-5051-01A-21D-1853-02,HG19_Broad_variant,TCGA-50-5051,TCGA-LUAD,NA,s10789,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa830e4b0c9d6adf6ba84,58cfa830e4b0c9d6adf6ba84,TCGA-AA-A03J-11A-11D-A079_110405_SN590_0074_AB04EUABXX_s_2_rg.sorted.filtered.,WGS,TCGA-AA-A03J-11A-11D-A079_110405_SN590_0074_AB04EUABXX_s_2_rg.sorted,TCGA-AA-A03J-11A-11D-A079_110405_SN590_0074_AB04EUABXX_s_2_rg.sorted.bam,66.74,2.13,0.16,58cfa830e4b0c9d6adf6ba84,TCGA-AA-A03J-11A-11D-A079_110405_SN590_0074_AB04EUABXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A03J-11A,E6C8C5FC-158A-4DE4-B3F6-3B645584BBC7,Solid Tissue Normal,Illumina HiSeq,39ecbe8b-f969-4295-91c5-0a82dff4041a,Colorectal,65,F7D192AA-1D64-404A-BC35-A8603E1567E1,E4A72EFE-8456-45A1-A935-1769A2298CEE,TCGA-AA-A03J-11A-11D-A079-02,HG18_Broad_variant,TCGA-AA-A03J,TCGA-COAD,NA,s12885,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa830e4b0c9d6adf6c066,58cfa830e4b0c9d6adf6c066,TCGA-AG-3894-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3894-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3894-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,710.89,1.9,0.15,58cfa830e4b0c9d6adf6c066,TCGA-AG-3894-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3894-01A,065B26FC-6827-44D5-83D8-1100C63FCDA6,Primary Tumor,Illumina HiSeq,8db01c5c-36a6-4060-ada7-3d57682daaf6,Colorectal,65,D6B7E2F3-01AD-4E77-87BB-9CBAEF03A5FB,339E9078-1166-45F6-A6BD-A2818B8918A1,TCGA-AG-3894-01A-01D-1115-02,HG18,TCGA-AG-3894,TCGA-READ,NA,s2163,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa832e4b0c9d6adf6cf10,58cfa832e4b0c9d6adf6cf10,TCGA-FS-A1ZF-06A-12D-A18Y_120605_SN1222_0113_BC0WUCACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FS-A1ZF-06A-12D-A18Y_120605_SN1222_0113_BC0WUCACXX_s_4_rg.sorted,TCGA-FS-A1ZF-06A-12D-A18Y_120605_SN1222_0113_BC0WUCACXX_s_4_rg.sorted.bam,57.08,NA,0.16,58cfa832e4b0c9d6adf6cf10,TCGA-FS-A1ZF-06A-12D-A18Y_120605_SN1222_0113_BC0WUCACXX_s_4_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZF-06A,E0D36CC0-652C-4224-BB10-09D15C7BD8F1,Metastatic,Illumina HiSeq,fc766dcd-902b-4505-bf3f-e747d286eec1,Skin,78,FE7D6D24-E8DA-4703-BC74-2720363B4C01,876B574E-6381-47ED-A60B-0E7216F3D665,TCGA-FS-A1ZF-06A-12D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZF,TCGA-SKCM,470,s7874,Harvard Medical School,Essen,Germany,NO,T4b,N0,Not available,Stage IIC
13722.58cfa830e4b0c9d6adf6bc90,58cfa830e4b0c9d6adf6bc90,TCGA-AZ-4308-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AZ-4308-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-AZ-4308-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,414.02,1.9,0.15,58cfa830e4b0c9d6adf6bc90,TCGA-AZ-4308-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-4308-01A,3D8FD9B2-9AA2-4C81-8843-535AE66D6140,Primary Tumor,Illumina HiSeq,562ea734-bcd1-499a-8054-f710f2de3e41,Colorectal,47,6F0E65B2-7CA0-4F10-8952-B64900009001,1C7E82B6-A8EB-4593-B329-5299BC05140E,TCGA-AZ-4308-01A-01D-1405-02,HG18,TCGA-AZ-4308,TCGA-COAD,NA,s13540,Harvard Medical School,University of Pittsburgh,None,NO,T3,N1,Colon Adenocarcinoma,Stage IIIB
13722.58cfa830e4b0c9d6adf6bfe8,58cfa830e4b0c9d6adf6bfe8,TCGA-BR-6565-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BR-6565-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_7_rg.sorted,TCGA-BR-6565-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_7_rg.sorted.bam,338.7,1.9,0.14,58cfa830e4b0c9d6adf6bfe8,TCGA-BR-6565-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6565-01A,DAECEA36-B379-46CE-8AE9-A38D22556CE2,Primary Tumor,Illumina HiSeq,8cfafa49-f561-4e59-98c5-b9a816534417,Stomach,67,1D7AAE07-2453-4DC3-A26D-D67161172648,E5F188AD-28C2-4AD0-89DD-C13493CE4B03,TCGA-BR-6565-01A-11D-1798-02,HG19_Broad_variant,TCGA-BR-6565,TCGA-STAD,NA,s14881,Harvard Medical School,Asterand,Russia,NO,T4a,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB
13722.58cfa831e4b0c9d6adf6c514,58cfa831e4b0c9d6adf6c514,TCGA-CN-4735-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CN-4735-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_2_rg.sorted,TCGA-CN-4735-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_2_rg.sorted.bam,52.7,1.9,0.13,58cfa831e4b0c9d6adf6c514,TCGA-CN-4735-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4735-01A,FE844945-3EA9-449E-993C-DF392FABCFD0,Primary Tumor,Illumina HiSeq,b8913a67-9dd4-41f9-8888-c998df0a0a23,Head and Neck,52,FBB300FA-8793-42DA-A68E-4570AE2E5186,F759672A-62CA-49DC-BC4F-643E8A885787,TCGA-CN-4735-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4735,TCGA-HNSC,NA,s16032,Harvard Medical School,University of Pittsburgh,None,NO,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6d3ec,58cfa832e4b0c9d6adf6d3ec,TCGA-V4-A9EH-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_5_rg.sorted.filtered.,WGS,TCGA-V4-A9EH-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_5_rg.sorted,TCGA-V4-A9EH-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_5_rg.sorted.bam,15,NA,0.16,58cfa832e4b0c9d6adf6d3ec,TCGA-V4-A9EH-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EH-10A,5E54122F-1C4D-45CC-8842-CD1C1DF0EED8,Blood Derived Normal,Illumina HiSeq,f5db97a6-5c11-4667-98bb-731af29355e3,Eye,53,9256FF7E-5674-4E61-9FDC-947669E525C7,720E6B3C-C272-4D59-B28A-EA878E339A9E,TCGA-V4-A9EH-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9EH,TCGA-UVM,NA,s209,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4c,N0,Not available,Stage IIIB
13722.58cfa831e4b0c9d6adf6ccf4,58cfa831e4b0c9d6adf6ccf4,TCGA-EE-A2MJ-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EE-A2MJ-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_4_rg.sorted,TCGA-EE-A2MJ-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_4_rg.sorted.bam,59.56,NA,0.16,58cfa831e4b0c9d6adf6ccf4,TCGA-EE-A2MJ-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MJ-06A,8509F10A-C454-45A5-9C22-853FDA423B9F,Metastatic,Illumina HiSeq,b16f81f2-a92c-4e0d-8f13-16041c8c6cf5,Skin,60,369D076F-430B-4E9A-8835-07A02B736CBF,1C803F97-8436-4E2A-82CE-58DE4B49DEA3,TCGA-EE-A2MJ-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2MJ,TCGA-SKCM,2927,s7349,Harvard Medical School,University of Sydney,Australia,NO,T4b,N0,Not available,Stage III
13722.58cfa830e4b0c9d6adf6be6a,58cfa830e4b0c9d6adf6be6a,TCGA-BL-A0C8-10A-01D-A10R_120926_SN590_0181_AC19HCACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BL-A0C8-10A-01D-A10R_120926_SN590_0181_AC19HCACXX_s_2_rg.sorted,TCGA-BL-A0C8-10A-01D-A10R_120926_SN590_0181_AC19HCACXX_s_2_rg.sorted.bam,19.58,1.95,0.14,58cfa830e4b0c9d6adf6be6a,TCGA-BL-A0C8-10A-01D-A10R_120926_SN590_0181_AC19HCACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BL-A0C8-10A,A6003B1C-56A9-430A-A5E2-B70AF3F81BDB,Blood Derived Normal,Illumina HiSeq,ccc5396b-d9e0-4f96-85ec-4a894585996f,Bladder,73,4BD51539-3638-4721-B7CA-C9AFC50611B7,61A64D7A-438E-47DE-9521-B5FD28DFBA20,TCGA-BL-A0C8-10A-01D-A10R-02,HG19_Broad_variant,TCGA-BL-A0C8,TCGA-BLCA,NA,s2856,Harvard Medical School,Christiana Healthcare,United States,NO,T1,NX,Not available,Stage I
13722.58cfa82fe4b0c9d6adf6b8fe,58cfa82fe4b0c9d6adf6b8fe,TCGA-49-6744-01A-11D-1853_111218_SN208_0258_C054RACXX_s_5_rg.sorted.filtered.,WGS,TCGA-49-6744-01A-11D-1853_111218_SN208_0258_C054RACXX_s_5_rg.sorted,TCGA-49-6744-01A-11D-1853_111218_SN208_0258_C054RACXX_s_5_rg.sorted.bam,62.7,1.9,0.15,58cfa82fe4b0c9d6adf6b8fe,TCGA-49-6744-01A-11D-1853_111218_SN208_0258_C054RACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-49-6744-01A,15340DD3-84AE-49FB-989A-EB212F3E73DA,Primary Tumor,Illumina HiSeq,8290093a-0193-41fa-8e87-71960e0e640e,Lung,64,A9D69D7E-298C-4AB6-B64F-1EDC58832CCD,7455D0A5-45DB-461F-9026-5A0FE3D55A6A,TCGA-49-6744-01A-11D-1853-02,HG19_Broad_variant,TCGA-49-6744,TCGA-LUAD,NA,s10656,Harvard Medical School,Johns Hopkins,United States,NO,T2a,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIA
13722.58cfa831e4b0c9d6adf6c77e,58cfa831e4b0c9d6adf6c77e,TCGA-CS-5396-01A-02D-1465_130906_SN1440_0166_BC2A68ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CS-5396-01A-02D-1465_130906_SN1440_0166_BC2A68ACXX_s_4_rg.sorted,TCGA-CS-5396-01A-02D-1465_130906_SN1440_0166_BC2A68ACXX_s_4_rg.sorted.bam,152.7,1.9,0.15,58cfa831e4b0c9d6adf6c77e,TCGA-CS-5396-01A-02D-1465_130906_SN1440_0166_BC2A68ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-5396-01A,B6C2C9BD-625B-4A98-830C-49C344F6CB5F,Primary Tumor,Illumina HiSeq,3d26b7bb-4cc9-4d9b-8c42-6fbd2ea9b590,Brain,53,CE1ED4B3-AF89-4BBD-B9A6-EEFA007E4368,F2F5E5EE-B807-4CAF-99B3-68270C1F305E,TCGA-CS-5396-01A-02D-1465-02,HG19_Broad_variant,TCGA-CS-5396,TCGA-LGG,NA,s8342,Harvard Medical School,Thomas Jefferson University,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82fe4b0c9d6adf6b7d8,58cfa82fe4b0c9d6adf6b7d8,TCGA-50-5932-11A-01D-1751_110928_SN590_0108_BB01CWACXX_s_5_rg.sorted.filtered.,WGS,TCGA-50-5932-11A-01D-1751_110928_SN590_0108_BB01CWACXX_s_5_rg.sorted,TCGA-50-5932-11A-01D-1751_110928_SN590_0108_BB01CWACXX_s_5_rg.sorted.bam,147.4,1.9,0.15,58cfa82fe4b0c9d6adf6b7d8,TCGA-50-5932-11A-01D-1751_110928_SN590_0108_BB01CWACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5932-11A,EBCBA7F2-CE13-4BAE-97CD-91A6B1DCD465,Solid Tissue Normal,Illumina HiSeq,f7b98f6e-b7a7-4ed0-91bd-7e0749dbf7a0,Lung,75,0E7847D9-D1D0-4980-8F44-C428F36B83F0,6BF1CE92-0865-4D8B-AB4D-EFC68871FED1,TCGA-50-5932-11A-01D-1751-02,HG19_Broad_variant,TCGA-50-5932,TCGA-LUAD,1235,s11127,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa830e4b0c9d6adf6c1a7,58cfa830e4b0c9d6adf6c1a7,TCGA-BA-5153-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BA-5153-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_6_rg.sorted,TCGA-BA-5153-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_6_rg.sorted.bam,61.4,1.9,0.14,58cfa830e4b0c9d6adf6c1a7,TCGA-BA-5153-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5153-10A,B3631718-9E0A-454C-BEE1-8F36EBC509D8,Blood Derived Normal,Illumina HiSeq,246bc4c7-cd66-439e-b78e-15222d1efba7,Head and Neck,51,F079E825-160A-40D5-97CC-1931F11C4E2E,88631234-EDDF-4B86-BAAD-6450C21ED2CC,TCGA-BA-5153-10A-01D-1431-02,HG19_Broad_variant,TCGA-BA-5153,TCGA-HNSC,1762,s16170,Harvard Medical School,UNC,None,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b6de,58cfa82fe4b0c9d6adf6b6de,TCGA-44-6147-11A-01D-1751_111207_SN590_0112_D09CDACXX_s_2_rg.sorted.filtered.,WGS,TCGA-44-6147-11A-01D-1751_111207_SN590_0112_D09CDACXX_s_2_rg.sorted,TCGA-44-6147-11A-01D-1751_111207_SN590_0112_D09CDACXX_s_2_rg.sorted.bam,59.4,1.9,0.16,58cfa82fe4b0c9d6adf6b6de,TCGA-44-6147-11A-01D-1751_111207_SN590_0112_D09CDACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-6147-11A,889AEC8E-14BA-48D9-8FE1-F2416E82B333,Solid Tissue Normal,Illumina HiSeq,ea7b7b64-8b4e-46fd-91d3-0a22729856f0,Lung,67,D990632B-B55A-4893-9C3D-5AC0FB6BB6F8,503A3086-3453-4AAE-987B-019FBCB13272,TCGA-44-6147-11A-01D-1751-02,HG19_Broad_variant,TCGA-44-6147,TCGA-LUAD,NA,s11342,Harvard Medical School,Christiana Healthcare,United States,NO,T1b,NX,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6cb10,58cfa831e4b0c9d6adf6cb10,TCGA-EA-A3HQ-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EA-A3HQ-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_6_rg.sorted,TCGA-EA-A3HQ-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_6_rg.sorted.bam,30.47,NA,0.15,58cfa831e4b0c9d6adf6cb10,TCGA-EA-A3HQ-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EA-A3HQ-10A,6BF00B63-89F8-420C-8D36-F680FB0908B1,Blood Derived Normal,Illumina HiSeq,15d3baa9-7081-4e33-9ce7-8280513fd8c9,Cervix,60,7423D8CE-ECDC-4A4D-9757-74D543D9EB6B,D2878ABE-E8E9-41BC-B849-4F6F6EDE1FF9,TCGA-EA-A3HQ-10A-01D-A20X-26,HG19_Broad_variant,TCGA-EA-A3HQ,TCGA-CESC,NA,s1360,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T2a,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6c2ec,58cfa830e4b0c9d6adf6c2ec,TCGA-BR-6566-01A-11D-1798_130116_SN208_0449_BD1RNWACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BR-6566-01A-11D-1798_130116_SN208_0449_BD1RNWACXX_s_2_rg.sorted,TCGA-BR-6566-01A-11D-1798_130116_SN208_0449_BD1RNWACXX_s_2_rg.sorted.bam,118.7,1.9,0.15,58cfa830e4b0c9d6adf6c2ec,TCGA-BR-6566-01A-11D-1798_130116_SN208_0449_BD1RNWACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6566-01A,43F0421C-6578-4D77-9314-EF0305C7EFBD,Primary Tumor,Illumina HiSeq,ae711b74-3be9-4959-addd-03427c07f35b,Stomach,64,EEB8703E-5F0A-429D-9A5C-7C5227EB7A01,7BAAEED3-AA68-4825-84F1-0516B543C762,TCGA-BR-6566-01A-11D-1798-02,HG19_Broad_variant,TCGA-BR-6566,TCGA-STAD,NA,s14884,Harvard Medical School,Asterand,Russia,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA
13722.58cfa831e4b0c9d6adf6ca08,58cfa831e4b0c9d6adf6ca08,TCGA-DJ-A13X-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DJ-A13X-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_2_rg.sorted,TCGA-DJ-A13X-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_2_rg.sorted.bam,38.18,1.95,0.15,58cfa831e4b0c9d6adf6ca08,TCGA-DJ-A13X-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13X-10A,3B3C99AB-5336-4433-B682-E1A590221611,Blood Derived Normal,Illumina HiSeq,e05a7c3c-afd8-40a3-a5c3-93f13f5a77e6,Thyroid,51,F42843AA-6AD0-4FBB-BA27-1D821E9C9D17,F4474674-D623-4B24-BF83-420FA71317DC,TCGA-DJ-A13X-10A-01D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13X,TCGA-THCA,NA,s12512,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III
13722.58cfa830e4b0c9d6adf6c026,58cfa830e4b0c9d6adf6c026,TCGA-BJ-A0ZB-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BJ-A0ZB-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_4_rg.sorted,TCGA-BJ-A0ZB-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_4_rg.sorted.bam,79.63,2,0.16,58cfa830e4b0c9d6adf6c026,TCGA-BJ-A0ZB-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0ZB-01A,DC4D8468-6F34-40CB-A826-8D582CD86FDE,Primary Tumor,Illumina HiSeq,72ce31c8-5889-450a-ac21-159c97d9b125,Thyroid,66,145A474E-D262-468A-8DB7-EE9F1B7CE0A7,EBAA6AE4-66C0-49A7-938C-620E24564846,TCGA-BJ-A0ZB-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZB,TCGA-THCA,NA,s12097,Harvard Medical School,University of Pittsburgh,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA
13722.58cfa832e4b0c9d6adf6cf8e,58cfa832e4b0c9d6adf6cf8e,TCGA-G9-6367-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-G9-6367-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_4_rg.sorted,TCGA-G9-6367-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_4_rg.sorted.bam,11.7,1.8,0.17,58cfa832e4b0c9d6adf6cf8e,TCGA-G9-6367-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6367-10A,9F751C9D-AD41-4F02-B7F8-12423857D418,Blood Derived Normal,Illumina HiSeq,0c245fbb-c69b-4134-9b5f-883401c73269,Prostate,60,233F06E4-3E3D-4FC5-BED3-8B543E1ED896,DEEB5EEC-2375-4911-8B02-4E9928860E4D,TCGA-G9-6367-10A-01D-1784-02,HG19_Broad_variant,TCGA-G9-6367,TCGA-PRAD,NA,s3968,Harvard Medical School,Roswell Park,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d55a,58cfa832e4b0c9d6adf6d55a,TCGA-L5-A4OF-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_7_rg.sorted.filtered.,WGS,TCGA-L5-A4OF-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_7_rg.sorted,TCGA-L5-A4OF-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_7_rg.sorted.bam,26.16,NA,0.16,58cfa832e4b0c9d6adf6d55a,TCGA-L5-A4OF-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OF-01A,0C78B1B5-F480-45AD-A253-19297BC886B4,Primary Tumor,Illumina HiSeq,0b3ce949-4295-46f8-8809-392587ea21dc,Esophagus,63,B11F1BF7-3546-4F3C-872F-A4A910D910E7,921BE625-9769-4D00-B2FC-ACAE3ADFCAE7,TCGA-L5-A4OF-01A-11D-A267-26,HG19_Broad_variant,TCGA-L5-A4OF,TCGA-ESCA,NA,s1741,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T1,N1,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6d358,58cfa832e4b0c9d6adf6d358,TCGA-L5-A4OF-11A-12D-A267_131001_SN1120_0279_AC2DKPACXX_s_8_rg.sorted.filtered.,WGS,TCGA-L5-A4OF-11A-12D-A267_131001_SN1120_0279_AC2DKPACXX_s_8_rg.sorted,TCGA-L5-A4OF-11A-12D-A267_131001_SN1120_0279_AC2DKPACXX_s_8_rg.sorted.bam,20.59,NA,0.17,58cfa832e4b0c9d6adf6d358,TCGA-L5-A4OF-11A-12D-A267_131001_SN1120_0279_AC2DKPACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OF-11A,0C78B1B5-F480-45AD-A253-19297BC886B4,Solid Tissue Normal,Illumina HiSeq,9488c508-c33e-4dcf-b824-56abb00ffcc6,Esophagus,63,8941FC42-90AF-46D6-B1EF-E18FCB957BCF,0E4FE666-0D76-4C25-9A8C-5DB4DE5AC8F6,TCGA-L5-A4OF-11A-12D-A267-26,HG19_Broad_variant,TCGA-L5-A4OF,TCGA-ESCA,NA,s1653,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T1,N1,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6cef2,58cfa832e4b0c9d6adf6cef2,TCGA-IG-A51D-10A-01D-A267_131001_SN1120_0279_AC2DKPACXX_s_4_rg.sorted.filtered.,WGS,TCGA-IG-A51D-10A-01D-A267_131001_SN1120_0279_AC2DKPACXX_s_4_rg.sorted,TCGA-IG-A51D-10A-01D-A267_131001_SN1120_0279_AC2DKPACXX_s_4_rg.sorted.bam,27.6,NA,0.14,58cfa832e4b0c9d6adf6cef2,TCGA-IG-A51D-10A-01D-A267_131001_SN1120_0279_AC2DKPACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A51D-10A,F8DBAB24-B9F4-4B8A-BFEA-57856CCF6364,Blood Derived Normal,Illumina HiSeq,78030014-0fb7-46ad-b8fb-ddaacf65aaaa,Esophagus,63,5AA5B69E-CAFA-4929-BC52-C688E270CFD0,8C6FC111-30E3-4D53-8597-377D7DFAA47A,TCGA-IG-A51D-10A-01D-A267-26,HG19_Broad_variant,TCGA-IG-A51D,TCGA-ESCA,NA,s1629,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T1,N1,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6ced9,58cfa832e4b0c9d6adf6ced9,TCGA-EM-A3O8-10A-01D-A221_120530_SN1222_0111_BD12L1ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EM-A3O8-10A-01D-A221_120530_SN1222_0111_BD12L1ACXX_s_4_rg.sorted,TCGA-EM-A3O8-10A-01D-A221_120530_SN1222_0111_BD12L1ACXX_s_4_rg.sorted.bam,47.99,NA,0.16,58cfa832e4b0c9d6adf6ced9,TCGA-EM-A3O8-10A-01D-A221_120530_SN1222_0111_BD12L1ACXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3O8-10A,97B5017C-2066-4472-AB3F-31CFE64A6762,Blood Derived Normal,Illumina HiSeq,a5858580-6e2c-4848-9e14-5af6b816998e,Thyroid,33,63EF63DB-CB13-405C-8742-E74764708CDD,F89319FB-B4ED-4E21-AFF8-A1BBE35A355D,TCGA-EM-A3O8-10A-01D-A221-26,HG19_Broad_variant,TCGA-EM-A3O8,TCGA-THCA,NA,s12644,MD Anderson - Institute for Applied Cancer Science,University Health Network,Canada,NO,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa832e4b0c9d6adf6d4be,58cfa832e4b0c9d6adf6d4be,TCGA-V4-A9F7-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-V4-A9F7-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_2_rg.sorted,TCGA-V4-A9F7-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_2_rg.sorted.bam,49.86,NA,0.16,58cfa832e4b0c9d6adf6d4be,TCGA-V4-A9F7-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9F7-01A,64422CC5-5E5B-4EF9-A9E2-214CEBF8DFBC,Primary Tumor,Illumina HiSeq,8388df36-e4c1-4450-bc87-acc118ce705e,Eye,78,44AD0268-6B48-4264-A1DD-58C2302224D7,07397855-A0D5-4287-A21B-5AB83A4E0DE0,TCGA-V4-A9F7-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9F7,TCGA-UVM,NA,s257,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3a,N0,Not available,Stage IIB
13722.58cfa82fe4b0c9d6adf6b738,58cfa82fe4b0c9d6adf6b738,TCGA-49-4488-11A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_2_rg.sorted.filtered.,WGS,TCGA-49-4488-11A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_2_rg.sorted,TCGA-49-4488-11A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_2_rg.sorted.bam,59.4,1.9,0.13,58cfa82fe4b0c9d6adf6b738,TCGA-49-4488-11A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4488-11A,D721BFE0-90E3-415E-B9F3-1A270EFA5FBB,Solid Tissue Normal,Illumina HiSeq,1a64c497-725c-488a-a6a9-c32abe246dea,Lung,74,B5A8C70C-9BE7-4923-945C-32807605402A,104B5C75-71A5-4757-A244-E393AB14FC0E,TCGA-49-4488-11A-01D-1751-02,HG19_Broad_variant,TCGA-49-4488,TCGA-LUAD,869,s11340,Harvard Medical School,Johns Hopkins,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6cc15,58cfa831e4b0c9d6adf6cc15,TCGA-DU-7290-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DU-7290-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_7_rg.sorted,TCGA-DU-7290-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_7_rg.sorted.bam,157.7,NA,0.14,58cfa831e4b0c9d6adf6cc15,TCGA-DU-7290-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7290-01A,E00A9855-C15E-46EF-988F-25CA64EC4717,Primary Tumor,Illumina HiSeq,827baf09-e242-460a-8d97-75059c6c3a98,Brain,45,942B676C-CCFD-4005-A564-C48F558D5D3B,9A452E24-A4D1-4229-9256-6A30800A5DDF,TCGA-DU-7290-01A-11D-2022-02,HG19_Broad_variant,TCGA-DU-7290,TCGA-LGG,315,s8353,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa832e4b0c9d6adf6d222,58cfa832e4b0c9d6adf6d222,TCGA-IR-A3LI-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_5_rg.sorted.filtered.,WGS,TCGA-IR-A3LI-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_5_rg.sorted,TCGA-IR-A3LI-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_5_rg.sorted.bam,19.9,NA,0.16,58cfa832e4b0c9d6adf6d222,TCGA-IR-A3LI-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-IR-A3LI-01A,75BC22D8-738D-45F8-B6C0-C664F5FEF47C,Primary Tumor,Illumina HiSeq,3a9d3f81-919f-44e3-a9cc-813b4dcaf027,Cervix,48,EBFA4682-49C9-4AC1-8147-E3860D852D28,689630AD-8262-403B-9983-B4BAE99B8A45,TCGA-IR-A3LI-01A-11D-A20X-26,HG19_Broad_variant,TCGA-IR-A3LI,TCGA-CESC,NA,s1210,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T2b,N1,Endocervical Type of Adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6befc,58cfa830e4b0c9d6adf6befc,TCGA-BK-A0CB-11A-33D-A101_120504_SN590_0156_BC0H68ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BK-A0CB-11A-33D-A101_120504_SN590_0156_BC0H68ACXX_s_6_rg.sorted,TCGA-BK-A0CB-11A-33D-A101_120504_SN590_0156_BC0H68ACXX_s_6_rg.sorted.bam,56.21,1.83,0.15,58cfa830e4b0c9d6adf6befc,TCGA-BK-A0CB-11A-33D-A101_120504_SN590_0156_BC0H68ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BK-A0CB-11A,59E9029A-8DDD-4447-B35A-72BC39F82A30,Solid Tissue Normal,Illumina HiSeq,1f202d50-0049-42ea-9454-b7a7487a247c,Uterus,60,F1D2D79C-CE6A-4160-9DE2-C169F0DAB321,827E9BF6-71A0-4329-8CDB-DC588E496AFB,TCGA-BK-A0CB-11A-33D-A101-02,HG19_Broad_variant,TCGA-BK-A0CB,TCGA-UCEC,NA,s5395,Harvard Medical School,Christiana Healthcare,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d103,58cfa832e4b0c9d6adf6d103,TCGA-FS-A1ZH-06A-11D-A18Y_120605_SN1222_0113_BC0WUCACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FS-A1ZH-06A-11D-A18Y_120605_SN1222_0113_BC0WUCACXX_s_2_rg.sorted,TCGA-FS-A1ZH-06A-11D-A18Y_120605_SN1222_0113_BC0WUCACXX_s_2_rg.sorted.bam,60.02,NA,0.17,58cfa832e4b0c9d6adf6d103,TCGA-FS-A1ZH-06A-11D-A18Y_120605_SN1222_0113_BC0WUCACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZH-06A,9F5BD948-DC3D-4B17-A114-D2F5C46FE10C,Metastatic,Illumina HiSeq,a2479881-3488-41b7-be08-204b2027d50f,Skin,71,A3A4EFCC-DFA8-4A69-AEE4-D2A93CD98F30,A6A5CEBF-FBB3-4228-B776-B3B792D0574B,TCGA-FS-A1ZH-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZH,TCGA-SKCM,996,s7700,Harvard Medical School,Essen,Germany,NO,T3b,N2c,Not available,Stage IV
13722.58cfa830e4b0c9d6adf6c15c,58cfa830e4b0c9d6adf6c15c,TCGA-BA-4075-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BA-4075-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_4_rg.sorted,TCGA-BA-4075-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_4_rg.sorted.bam,80.03,1.9,0.14,58cfa830e4b0c9d6adf6c15c,TCGA-BA-4075-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_4_rg.sorted.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-4075-10A,6FA62461-E721-415A-8B0F-363B84292B82,Blood Derived Normal,Illumina HiSeq,5481b0b3-1652-4735-9746-fbf7bfb454a9,Head and Neck,49,4A5BA6E2-C47A-4CF4-A657-5FD0E962E49C,515D017E-D7A6-4CFF-AC82-F58E5A47005D,TCGA-BA-4075-10A-01D-1431-02,HG19_Broad_variant,TCGA-BA-4075,TCGA-HNSC,283,s15487,Harvard Medical School,UNC,None,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6c424,58cfa831e4b0c9d6adf6c424,TCGA-CN-4725-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CN-4725-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_3_rg.sorted,TCGA-CN-4725-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_3_rg.sorted.bam,52.7,1.9,0.17,58cfa831e4b0c9d6adf6c424,TCGA-CN-4725-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4725-01A,3BE2ACE5-1C2A-49E9-8DA9-CEED6119530B,Primary Tumor,Illumina HiSeq,7ddc2537-f164-4a40-befe-6e0a3deed186,Head and Neck,60,DD42AB2F-E936-4ACE-93D8-60375E03F2FE,C8B71532-685F-47AC-B019-B898A8D1670D,TCGA-CN-4725-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4725,TCGA-HNSC,NA,s15755,Harvard Medical School,University of Pittsburgh,None,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa82fe4b0c9d6adf6b912,58cfa82fe4b0c9d6adf6b912,TCGA-49-4506-01A-01D-1203_110729_SN208_0215_BD0CLPABXX_s_7_rg.sorted.filtered.,WGS,TCGA-49-4506-01A-01D-1203_110729_SN208_0215_BD0CLPABXX_s_7_rg.sorted,TCGA-49-4506-01A-01D-1203_110729_SN208_0215_BD0CLPABXX_s_7_rg.sorted.bam,258.2,1.9,0.13,58cfa82fe4b0c9d6adf6b912,TCGA-49-4506-01A-01D-1203_110729_SN208_0215_BD0CLPABXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4506-01A,B61ABDFD-B7A0-4E1A-B570-D1EAECAD3A9E,Primary Tumor,Illumina HiSeq,b07f7ea8-c74b-4559-97d3-987f1985f2e9,Lung,68,9EDEA53D-AD06-4B5D-BFF0-48E834C3684F,2270ABD6-565B-46B6-8154-505C5659A7C3,TCGA-49-4506-01A-01D-1203-02,HG19_Broad_variant,TCGA-49-4506,TCGA-LUAD,999,s11234,Harvard Medical School,Johns Hopkins,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6ae66,58cfa82ee4b0c9d6adf6ae66,TCGA-05-4389-10A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_6_rg.sorted.filtered.,WGS,TCGA-05-4389-10A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_6_rg.sorted,TCGA-05-4389-10A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_6_rg.sorted.bam,61.23,1.8,0.15,58cfa82ee4b0c9d6adf6ae66,TCGA-05-4389-10A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_6_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4389-10A,A3DE401D-91FE-49A2-BB07-81C1A06506E6,Blood Derived Normal,Illumina HiSeq,2952e37a-d8f8-4392-9a0e-7bde008209b0,Lung,70,BDCAC214-BA95-4DDD-8C84-9B60C14109BB,575A85DF-E14B-46E3-ACA2-60F32FABC941,TCGA-05-4389-10A-01D-1203-02,HG19_Broad_variant,TCGA-05-4389,TCGA-LUAD,NA,s11546,Harvard Medical School,Indivumed,Germany,NO,T1,N0,Lung Adenocarcinoma Mixed Subtype,Stage IA
13722.58cfa82fe4b0c9d6adf6b7b6,58cfa82fe4b0c9d6adf6b7b6,TCGA-44-3918-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_6_rg.sorted.filtered.,WGS,TCGA-44-3918-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_6_rg.sorted,TCGA-44-3918-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_6_rg.sorted.bam,467.53,1.9,0.16,58cfa82fe4b0c9d6adf6b7b6,TCGA-44-3918-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-3918-01A,6E3B6B72-142D-4B8D-A462-28A205796E41,Primary Tumor,Illumina HiSeq,96ae9138-6a97-4b93-9d28-35ec09a8d772,Lung,60,2FF8BAFD-2AC5-4BFD-8C60-81519CD44166,81D8D7E2-65FA-4E92-B064-0D7D41C54E7F,TCGA-44-3918-01A-01D-1103-02,HG19_Broad_variant,TCGA-44-3918,TCGA-LUAD,NA,s11122,Harvard Medical School,Christiana Healthcare,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6c384,58cfa831e4b0c9d6adf6c384,TCGA-CD-5801-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CD-5801-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_6_rg.sorted,TCGA-CD-5801-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_6_rg.sorted.bam,374,2,0.17,58cfa831e4b0c9d6adf6c384,TCGA-CD-5801-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_6_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-5801-01A,DF822EA3-E0E6-4AD3-A228-E20E3A737DAC,Primary Tumor,Illumina HiSeq,5196b0dd-1d41-47f4-84a8-999f211443f4,Stomach,69,9D0DF8D7-8D59-4983-9BBF-C6C106BDEFEC,F32CB4AA-D842-427A-8B7E-371764308512,TCGA-CD-5801-01A-11D-1598-02,HG19_Broad_variant,TCGA-CD-5801,TCGA-STAD,NA,s15317,Harvard Medical School,ILSbio,Vietnam,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6caca,58cfa831e4b0c9d6adf6caca,TCGA-DA-A1I5-06A-11D-A18Y_120730_SN208_0419_AC13W9ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DA-A1I5-06A-11D-A18Y_120730_SN208_0419_AC13W9ACXX_s_3_rg.sorted,TCGA-DA-A1I5-06A-11D-A18Y_120730_SN208_0419_AC13W9ACXX_s_3_rg.sorted.bam,27.32,NA,0.16,58cfa831e4b0c9d6adf6caca,TCGA-DA-A1I5-06A-11D-A18Y_120730_SN208_0419_AC13W9ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1I5-06A,E2271488-1A7D-4733-A1EA-38BBAEB97B4C,Metastatic,Illumina HiSeq,8a4bbbcb-4e6d-4d92-b983-e45ad42d97f1,Skin,27,378ABE14-B9FB-4D03-9287-7ECA9C0B8368,F8FA24D5-DB63-4545-BCDD-55B50E01BC3E,TCGA-DA-A1I5-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-DA-A1I5,TCGA-SKCM,NA,s7501,Harvard Medical School,Yale,United States,NO,T1a,N0,Not available,Stage IV
13722.58cfa832e4b0c9d6adf6d14c,58cfa832e4b0c9d6adf6d14c,TCGA-G9-6385-10A-01D-1784_130301_SN590_0217_BC1UHMACXX_s_8_rg.sorted.filtered.,WGS,TCGA-G9-6385-10A-01D-1784_130301_SN590_0217_BC1UHMACXX_s_8_rg.sorted,TCGA-G9-6385-10A-01D-1784_130301_SN590_0217_BC1UHMACXX_s_8_rg.sorted.bam,22.7,1.9,0.14,58cfa832e4b0c9d6adf6d14c,TCGA-G9-6385-10A-01D-1784_130301_SN590_0217_BC1UHMACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6385-10A,E82A04CF-E81E-43C6-9CD9-0E29FA0F00AE,Blood Derived Normal,Illumina HiSeq,40e5463c-dc65-437e-a884-d99c34009f5a,Prostate,66,79E5CAE9-6334-4E3E-9524-5DD7D0A4FFB9,BCC5E846-D84A-469B-ACB6-68EC1BE537D3,TCGA-G9-6385-10A-01D-1784-02,HG19_Broad_variant,TCGA-G9-6385,TCGA-PRAD,NA,s3803,Harvard Medical School,Roswell Park,United States,NO,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bead,58cfa830e4b0c9d6adf6bead,TCGA-AG-3901-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3901-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3901-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,510.89,1.9,0.15,58cfa830e4b0c9d6adf6bead,TCGA-AG-3901-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3901-01A,1586CB0A-081A-4364-9470-46F9D0F0167D,Primary Tumor,Illumina HiSeq,c8ff4c94-25ea-4468-8ae0-06cb92ffa025,Colorectal,67,93B755E6-5D6E-4542-8BAE-2121F44F590C,F5D4395A-5E00-4616-A402-CDCAD8702E1B,TCGA-AG-3901-01A-01D-1115-02,HG18,TCGA-AG-3901,TCGA-READ,NA,s2148,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Mucinous Adenocarcinoma,Stage IIIB
13722.58cfa831e4b0c9d6adf6cb28,58cfa831e4b0c9d6adf6cb28,TCGA-E7-A3Y1-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_7_rg.sorted.filtered.,WGS,TCGA-E7-A3Y1-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_7_rg.sorted,TCGA-E7-A3Y1-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_7_rg.sorted.bam,43.56,NA,0.17,58cfa831e4b0c9d6adf6cb28,TCGA-E7-A3Y1-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-E7-A3Y1-01A,F7C891EB-3B09-4E01-BB8A-53D570518CBE,Primary Tumor,Illumina HiSeq,aaeb4857-84bb-4a72-9e0d-81280de1ca61,Bladder,57,FABE5B98-4586-445D-9513-598BB7FD1909,46542747-5AF3-4F7E-AE97-7E0689976D0A,TCGA-E7-A3Y1-01A-11D-A233-26,HG19_Broad_variant,TCGA-E7-A3Y1,TCGA-BLCA,NA,s3109,MD Anderson - Institute for Applied Cancer Science,Asterand,Ukraine,NO,Not available,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa830e4b0c9d6adf6c2b2,58cfa830e4b0c9d6adf6c2b2,TCGA-CF-A1HR-10A-01D-A13U_121011_SN590_0184_BC192GACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CF-A1HR-10A-01D-A13U_121011_SN590_0184_BC192GACXX_s_4_rg.sorted,TCGA-CF-A1HR-10A-01D-A13U_121011_SN590_0184_BC192GACXX_s_4_rg.sorted.bam,57.84,1.95,0.16,58cfa830e4b0c9d6adf6c2b2,TCGA-CF-A1HR-10A-01D-A13U_121011_SN590_0184_BC192GACXX_s_4_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CF-A1HR-10A,39EA19E1-4959-4F1B-9934-54BDAF766842,Blood Derived Normal,Illumina HiSeq,8f5d258a-5720-4244-a4e2-2288d64a7ef9,Bladder,62,0AE65E89-1DB2-4E20-96D7-D337AACBB040,A854E387-FD99-4C95-9F75-0B359B1592FD,TCGA-CF-A1HR-10A-01D-A13U-02,HG19_Broad_variant,TCGA-CF-A1HR,TCGA-BLCA,NA,s2701,Harvard Medical School,ILSbio,Vietnam,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa830e4b0c9d6adf6bf91,58cfa830e4b0c9d6adf6bf91,TCGA-BJ-A291-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BJ-A291-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_4_rg.sorted,TCGA-BJ-A291-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_4_rg.sorted.bam,64.65,1.83,0.15,58cfa830e4b0c9d6adf6bf91,TCGA-BJ-A291-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A291-10A,D4C68C1C-A3F3-4E0C-B555-D457378A1D24,Blood Derived Normal,Illumina HiSeq,5f3310c7-9ee7-4637-b188-b3dad474042f,Thyroid,56,8051F3C6-7C36-45D1-B403-032983DA863F,4DEB3BDB-15F0-42E8-BBD6-EC9657F55AD1,TCGA-BJ-A291-10A-01D-A16N-02,HG19_Broad_variant,TCGA-BJ-A291,TCGA-THCA,NA,s12360,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6cfb6,58cfa832e4b0c9d6adf6cfb6,TCGA-G9-6342-01A-11D-1957_130222_SN1222_0174_BC1RNEACXX_s_7_rg.sorted.filtered.,WGS,TCGA-G9-6342-01A-11D-1957_130222_SN1222_0174_BC1RNEACXX_s_7_rg.sorted,TCGA-G9-6342-01A-11D-1957_130222_SN1222_0174_BC1RNEACXX_s_7_rg.sorted.bam,201.7,1.9,0.14,58cfa832e4b0c9d6adf6cfb6,TCGA-G9-6342-01A-11D-1957_130222_SN1222_0174_BC1RNEACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6342-01A,00E41E6A-9FE7-44F9-978B-7B05B179506A,Primary Tumor,Illumina HiSeq,2e8198a3-6874-4ea2-9d85-405122d87da4,Prostate,61,2C85548B-D1FD-4FC8-9908-60205A42E080,0C765D21-A6AE-4FE8-9B80-7DEBA8459E76,TCGA-G9-6342-01A-11D-1957-02,HG19_Broad_variant,TCGA-G9-6342,TCGA-PRAD,NA,s3797,Harvard Medical School,Roswell Park,United States,NO,T3a,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c041,58cfa830e4b0c9d6adf6c041,TCGA-AG-3893-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3893-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3893-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,44.59,1.9,0.15,58cfa830e4b0c9d6adf6c041,TCGA-AG-3893-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3893-10A,ADD567B7-29EF-4122-8A54-57D36F735E78,Blood Derived Normal,Illumina HiSeq,089d5f62-916b-4ea2-b8cf-7e0e2540e174,Colorectal,74,E2428535-1739-45BC-8466-FF8BAEB59F57,E815B25F-95E5-4AC6-96D0-CB4BB686E712,TCGA-AG-3893-10A-01D-1115-02,HG18,TCGA-AG-3893,TCGA-READ,NA,s2153,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIB
13722.58cfa830e4b0c9d6adf6c102,58cfa830e4b0c9d6adf6c102,TCGA-B5-A0K9-01A-21D-A101_120330_SN208_0279_BC0L73ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-B5-A0K9-01A-21D-A101_120330_SN208_0279_BC0L73ACXX_s_1_rg.sorted,TCGA-B5-A0K9-01A-21D-A101_120330_SN208_0279_BC0L73ACXX_s_1_rg.sorted.bam,97.15,2.16,0.13,58cfa830e4b0c9d6adf6c102,TCGA-B5-A0K9-01A-21D-A101_120330_SN208_0279_BC0L73ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0K9-01A,4485CC98-5D58-4EB4-8325-7D1A617B6461,Primary Tumor,Illumina HiSeq,71c016d1-ab89-4d8f-acb9-92767959d603,Uterus,88,52A96216-708F-43F2-A923-130A1C35922D,30D94271-91F3-4CF5-83C0-4708662115D0,TCGA-B5-A0K9-01A-21D-A101-02,HG19_Broad_variant,TCGA-B5-A0K9,TCGA-UCEC,NA,s5210,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6cea0,58cfa832e4b0c9d6adf6cea0,TCGA-ER-A2NF-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_7_rg.sorted.filtered.,WGS,TCGA-ER-A2NF-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_7_rg.sorted,TCGA-ER-A2NF-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_7_rg.sorted.bam,52.36,NA,0.16,58cfa832e4b0c9d6adf6cea0,TCGA-ER-A2NF-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A2NF-01A,D32A4219-4CCA-470F-B6B3-11447D9F5E0B,Primary Tumor,Illumina HiSeq,cf624be8-7ec3-4fce-9ab0-1d9ac2fb1edb,Skin,53,52EDD1DB-F1C3-4B87-B959-B5B095E52463,DB2D94A9-5B22-4163-AE7A-1DA11F7037A6,TCGA-ER-A2NF-01A-11D-A18Z-02,HG19_Broad_variant,TCGA-ER-A2NF,TCGA-SKCM,NA,s7861,Harvard Medical School,University of Pittsburgh,None,NO,T4b,N3,Not available,Stage IIIC
13722.58cfa832e4b0c9d6adf6d1f4,58cfa832e4b0c9d6adf6d1f4,TCGA-IG-A51D-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_3_rg.sorted.filtered.,WGS,TCGA-IG-A51D-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_3_rg.sorted,TCGA-IG-A51D-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_3_rg.sorted.bam,23.75,NA,0.16,58cfa832e4b0c9d6adf6d1f4,TCGA-IG-A51D-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A51D-01A,F8DBAB24-B9F4-4B8A-BFEA-57856CCF6364,Primary Tumor,Illumina HiSeq,c422f0b8-8f83-4d33-b800-bab29faa7b7b,Esophagus,63,3889C9FE-3777-4B3D-9CF1-12135D4D7F7D,02AA44BC-DD51-4A76-B94E-FF273011E904,TCGA-IG-A51D-01A-11D-A267-26,HG19_Broad_variant,TCGA-IG-A51D,TCGA-ESCA,NA,s1825,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T1,N1,Not available,Stage IIB
13722.58cfa830e4b0c9d6adf6c2cc,58cfa830e4b0c9d6adf6c2cc,TCGA-CF-A1HS-10A-01D-A13U_121011_SN590_0184_BC192GACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CF-A1HS-10A-01D-A13U_121011_SN590_0184_BC192GACXX_s_6_rg.sorted,TCGA-CF-A1HS-10A-01D-A13U_121011_SN590_0184_BC192GACXX_s_6_rg.sorted.bam,49.47,1.98,0.17,58cfa830e4b0c9d6adf6c2cc,TCGA-CF-A1HS-10A-01D-A13U_121011_SN590_0184_BC192GACXX_s_6_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CF-A1HS-10A,A73C0842-39C5-4C2C-AA6A-F31341A4F36E,Blood Derived Normal,Illumina HiSeq,6774ba08-2ee0-4555-946b-3fcf2996801b,Bladder,75,0157F04D-8289-4163-88AB-1D1AAACFCB7B,CEC780F5-CAB3-4786-8E82-26BB356E4801,TCGA-CF-A1HS-10A-01D-A13U-02,HG19_Broad_variant,TCGA-CF-A1HS,TCGA-BLCA,NA,s2877,Harvard Medical School,ILSbio,Vietnam,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa830e4b0c9d6adf6bec9,58cfa830e4b0c9d6adf6bec9,TCGA-AP-A0LP-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-AP-A0LP-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_4_rg.sorted,TCGA-AP-A0LP-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_4_rg.sorted.bam,109.58,1.91,0.16,58cfa830e4b0c9d6adf6bec9,TCGA-AP-A0LP-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LP-01A,EFAE3940-D3CC-4988-BDB4-FA05D977AFF5,Primary Tumor,Illumina HiSeq,369f32c0-ebb9-490e-baa4-0735e0efa092,Uterus,76,D67450C1-8848-4B28-9C16-83AA7132E8C8,C7A70C11-A05E-473D-929E-59A260FFBD97,TCGA-AP-A0LP-01A-12D-A101-02,HG19_Broad_variant,TCGA-AP-A0LP,TCGA-UCEC,NA,s5202,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b631,58cfa82fe4b0c9d6adf6b631,TCGA-44-6148-11A-01D-1751_110927_SN208_0243_BC00TKACXX_s_8_rg.sorted.filtered.,WGS,TCGA-44-6148-11A-01D-1751_110927_SN208_0243_BC00TKACXX_s_8_rg.sorted,TCGA-44-6148-11A-01D-1751_110927_SN208_0243_BC00TKACXX_s_8_rg.sorted.bam,27.4,1.9,0.15,58cfa82fe4b0c9d6adf6b631,TCGA-44-6148-11A-01D-1751_110927_SN208_0243_BC00TKACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-6148-11A,8994C8C4-9EA0-46CB-B4A5-0055D7DA5BFA,Solid Tissue Normal,Illumina HiSeq,453af1ae-a7ef-4716-8eff-3295325729cd,Lung,60,ACE83CB7-28BC-44BA-A600-8A6155E08A42,967F0F6A-855F-4544-BD9B-E49909EB6ACB,TCGA-44-6148-11A-01D-1751-02,HG19_Broad_variant,TCGA-44-6148,TCGA-LUAD,NA,s10904,Harvard Medical School,Christiana Healthcare,United States,NO,T1b,N0,Lung Mucinous Adenocarcinoma,Stage IA
13722.58cfa832e4b0c9d6adf6cfe5,58cfa832e4b0c9d6adf6cfe5,TCGA-GC-A3BM-11A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_5_rg.sorted.filtered.,WGS,TCGA-GC-A3BM-11A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_5_rg.sorted,TCGA-GC-A3BM-11A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_5_rg.sorted.bam,16.33,NA,0.17,58cfa832e4b0c9d6adf6cfe5,TCGA-GC-A3BM-11A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GC-A3BM-11A,7840AEA9-40C4-473E-BE33-8FA0B9F332C9,Solid Tissue Normal,Illumina HiSeq,33f4607f-b43c-4a61-a3cf-ff21ad2e6d62,Bladder,70,BFBA8167-6ACC-47F8-B7AA-E9AB2B2F1005,93BD7C4E-CBF2-41B4-9B5B-C5426106C182,TCGA-GC-A3BM-11A-11D-A23Q-26,HG19_Broad_variant,TCGA-GC-A3BM,TCGA-BLCA,NA,s3123,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa82fe4b0c9d6adf6b6ba,58cfa82fe4b0c9d6adf6b6ba,TCGA-44-6778-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_5_rg.sorted.filtered.,WGS,TCGA-44-6778-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_5_rg.sorted,TCGA-44-6778-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_5_rg.sorted.bam,227.7,1.9,0.15,58cfa82fe4b0c9d6adf6b6ba,TCGA-44-6778-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_5_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-44-6778-01A,5D5CC436-6E57-4D23-A164-7F5153C2E666,Primary Tumor,Illumina HiSeq,8d0de456-4a8c-48ad-bfc5-fa6e66ba6e0d,Lung,59,15321297-7110-4E79-8D6F-94C95BC83C94,737A7A30-1F60-4D88-B94D-B5FCD996FED2,TCGA-44-6778-01A-11D-1853-02,HG19_Broad_variant,TCGA-44-6778,TCGA-LUAD,NA,s11126,Harvard Medical School,Christiana Healthcare,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa830e4b0c9d6adf6c1b8,58cfa830e4b0c9d6adf6c1b8,TCGA-BF-A1PZ-01A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BF-A1PZ-01A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_5_rg.sorted,TCGA-BF-A1PZ-01A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_5_rg.sorted.bam,64.32,NA,0.18,58cfa830e4b0c9d6adf6c1b8,TCGA-BF-A1PZ-01A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-BF-A1PZ-01A,455F982C-A067-46AC-BF89-3E535D0FFCA0,Primary Tumor,Illumina HiSeq,61217185-aa8a-467c-ba89-48231f6a81cc,Skin,71,2A5EE782-122E-432B-98E0-0849B6F9A3D9,25D65D8B-ED75-47D6-B7F6-95CF26CCBE06,TCGA-BF-A1PZ-01A-11D-A18Z-02,HG19_Broad_variant,TCGA-BF-A1PZ,TCGA-SKCM,NA,s7319,Harvard Medical School,Cureline,Russia,NO,T4a,N0,Not available,Stage IIB
13722.58cfa830e4b0c9d6adf6bf77,58cfa830e4b0c9d6adf6bf77,TCGA-BR-4280-11A-01D-1128_121127_SN208_0440_AC1F4LACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BR-4280-11A-01D-1128_121127_SN208_0440_AC1F4LACXX_s_3_rg.sorted,TCGA-BR-4280-11A-01D-1128_121127_SN208_0440_AC1F4LACXX_s_3_rg.sorted.bam,0,1.9,0.14,58cfa830e4b0c9d6adf6bf77,TCGA-BR-4280-11A-01D-1128_121127_SN208_0440_AC1F4LACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4280-11A,E0916597-E489-45EF-A8F7-653A3C6591EF,Solid Tissue Normal,Illumina HiSeq,c1175b78-f7af-45d0-ba00-7b437cfbda5e,Stomach,78,4DC8B427-EBDF-40E0-922C-FCB5020C94FC,04EFD145-592B-499E-931B-4BF17F9C447D,TCGA-BR-4280-11A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4280,TCGA-STAD,NA,s14813,Harvard Medical School,Asterand,Russia,NO,T2b,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage III
13722.58cfa832e4b0c9d6adf6cf18,58cfa832e4b0c9d6adf6cf18,TCGA-FS-A1ZB-06A-12D-A18Y_120609_SN208_0343_BC0WVWACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FS-A1ZB-06A-12D-A18Y_120609_SN208_0343_BC0WVWACXX_s_4_rg.sorted,TCGA-FS-A1ZB-06A-12D-A18Y_120609_SN208_0343_BC0WVWACXX_s_4_rg.sorted.bam,40.46,NA,0.16,58cfa832e4b0c9d6adf6cf18,TCGA-FS-A1ZB-06A-12D-A18Y_120609_SN208_0343_BC0WVWACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZB-06A,6F2EF983-0A22-4A65-9E53-8742AC89A1C4,Metastatic,Illumina HiSeq,61e179ee-80dc-4bdc-bc49-9e53a7bf0600,Skin,57,323FF6EE-1901-4D6B-8FE5-0C9BB4B246D1,4DB084C7-2C0F-4DFF-995A-A069E011D42C,TCGA-FS-A1ZB-06A-12D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZB,TCGA-SKCM,1486,s7527,Harvard Medical School,Essen,Germany,NO,T3a,N0,Not available,Stage II
13722.58cfa831e4b0c9d6adf6caa2,58cfa831e4b0c9d6adf6caa2,TCGA-D3-A3CE-10A-01D-A18Z_120626_SN590_0164_BC0VMVACXX_s_8_rg.sorted.filtered.,WGS,TCGA-D3-A3CE-10A-01D-A18Z_120626_SN590_0164_BC0VMVACXX_s_8_rg.sorted,TCGA-D3-A3CE-10A-01D-A18Z_120626_SN590_0164_BC0VMVACXX_s_8_rg.sorted.bam,15.52,NA,0.17,58cfa831e4b0c9d6adf6caa2,TCGA-D3-A3CE-10A-01D-A18Z_120626_SN590_0164_BC0VMVACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A3CE-10A,730F7400-E94A-4F41-B081-5227FA1A9C18,Blood Derived Normal,Illumina HiSeq,2562aa30-08b4-450f-b475-0acd4a83cc07,Skin,74,AC3EE2A0-FF6D-47F5-BC29-865DF8B9DEFC,07C8BA8D-7364-44D6-A546-5BFFF1C795BA,TCGA-D3-A3CE-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-D3-A3CE,TCGA-SKCM,1832,s7832,Harvard Medical School,MD Anderson,United States,NO,T0,N1b,Not available,Stage III
13722.58cfa831e4b0c9d6adf6cc9f,58cfa831e4b0c9d6adf6cc9f,TCGA-EE-A2MN-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EE-A2MN-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_2_rg.sorted,TCGA-EE-A2MN-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_2_rg.sorted.bam,76.45,NA,0.16,58cfa831e4b0c9d6adf6cc9f,TCGA-EE-A2MN-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MN-06A,0797CAAF-18AD-41C6-820A-E96554D14B31,Metastatic,Illumina HiSeq,73490ea3-b79d-4ba3-a8ef-250ff13e4c21,Skin,58,6AE1DCF7-E35C-419F-B132-7E5F7BEDE538,7CF2B294-2EE5-4AAC-98CF-30E9FA1C374B,TCGA-EE-A2MN-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2MN,TCGA-SKCM,1446,s7854,Harvard Medical School,University of Sydney,Australia,NO,T2,N0,Not available,Stage I
13722.58cfa832e4b0c9d6adf6d19c,58cfa832e4b0c9d6adf6d19c,TCGA-HG-A2PA-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_4_rg.sorted.filtered.,WGS,TCGA-HG-A2PA-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_4_rg.sorted,TCGA-HG-A2PA-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_4_rg.sorted.bam,61.98,NA,0.15,58cfa832e4b0c9d6adf6d19c,TCGA-HG-A2PA-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-HG-A2PA-01A,E2FF7CFD-A101-45B9-895F-26F403E7BDFB,Primary Tumor,Illumina HiSeq,2c605f98-0c77-45ff-bcea-2fcf6094ca2d,Cervix,38,235DBD13-5052-4E19-9C1C-A72A1A9A79CE,ECE06317-01F9-4EF2-ACE0-E9B18C7F4DE1,TCGA-HG-A2PA-01A-11D-A20X-26,HG19_Broad_variant,TCGA-HG-A2PA,TCGA-CESC,NA,s1534,MD Anderson - Institute for Applied Cancer Science,Roswell Park,United States,NO,T1b2,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c872,58cfa831e4b0c9d6adf6c872,TCGA-D3-A3C3-06A-12D-A18Z_120520_SN590_0158_AC0J99ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D3-A3C3-06A-12D-A18Z_120520_SN590_0158_AC0J99ACXX_s_3_rg.sorted,TCGA-D3-A3C3-06A-12D-A18Z_120520_SN590_0158_AC0J99ACXX_s_3_rg.sorted.bam,63.5,NA,0.16,58cfa831e4b0c9d6adf6c872,TCGA-D3-A3C3-06A-12D-A18Z_120520_SN590_0158_AC0J99ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A3C3-06A,FC59CC57-CA7A-4DE3-BD13-2E283716A243,Metastatic,Illumina HiSeq,fcc6bf30-9ef1-43ac-84e6-68661b4266d8,Skin,30,56E5EA92-2D58-494F-8350-B31E95060314,2FD34FBF-5B0C-4171-BAC1-38FD03A62295,TCGA-D3-A3C3-06A-12D-A18Z-02,HG19_Broad_variant,TCGA-D3-A3C3,TCGA-SKCM,NA,s7833,Harvard Medical School,MD Anderson,United States,NO,TX,N0,Not available,I or II NOS
13722.58cfa82fe4b0c9d6adf6b704,58cfa82fe4b0c9d6adf6b704,TCGA-73-4659-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-73-4659-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-73-4659-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,665.52,1.9,0.15,58cfa82fe4b0c9d6adf6b704,TCGA-73-4659-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4659-01A,CD0DC947-B708-464E-BEB7-954C9D4583E7,Primary Tumor,Illumina HiSeq,37276b21-3a00-4b58-b1df-cc2199584cb0,Lung,66,C35A5ED1-1821-4077-BA1E-B972DFA3233B,277D2F7F-1A7F-4D39-BD15-0334CC02840E,TCGA-73-4659-01A-01D-1203-02,GRCh37,TCGA-73-4659,TCGA-LUAD,711,s11246,Harvard Medical School,Roswell Park,United States,NO,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6ccfc,58cfa831e4b0c9d6adf6ccfc,TCGA-FD-A3SL-10A-01D-A233_120830_SN208_0423_AC190AACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FD-A3SL-10A-01D-A233_120830_SN208_0423_AC190AACXX_s_4_rg.sorted,TCGA-FD-A3SL-10A-01D-A233_120830_SN208_0423_AC190AACXX_s_4_rg.sorted.bam,39.22,NA,0.15,58cfa831e4b0c9d6adf6ccfc,TCGA-FD-A3SL-10A-01D-A233_120830_SN208_0423_AC190AACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3SL-10A,4570B6E2-D430-41CA-AAB1-CE4D14C36463,Blood Derived Normal,Illumina HiSeq,ed617be2-c160-4372-8c95-3b4037dfc801,Bladder,60,347756FB-29DC-4A2A-8FD2-5B9DDADCA907,09B19DDB-F282-4055-A4E6-836C92502071,TCGA-FD-A3SL-10A-01D-A233-26,HG19_Broad_variant,TCGA-FD-A3SL,TCGA-BLCA,NA,s2723,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T4a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6cdc0,58cfa831e4b0c9d6adf6cdc0,TCGA-FI-A2CY-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FI-A2CY-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_1_rg.sorted,TCGA-FI-A2CY-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_1_rg.sorted.bam,72.14,NA,0.16,58cfa831e4b0c9d6adf6cdc0,TCGA-FI-A2CY-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_1_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-FI-A2CY-01A,B9AB4AB9-BA9C-4A01-9F61-55C82B924936,Primary Tumor,Illumina HiSeq,d1004865-f030-4d10-90a0-3d6d105408a0,Uterus,60,047B688C-AA29-4A63-B555-9275AF4B0CEE,4BCC9DA0-4F58-4BB8-B660-D8591AD1CE18,TCGA-FI-A2CY-01A-11D-A17E-02,HG19_Broad_variant,TCGA-FI-A2CY,TCGA-UCEC,NA,s5398,Harvard Medical School,Washington University,United States,NO,Not available,Not available,Mixed serous and endometrioid,Not available
13722.58cfa832e4b0c9d6adf6d20e,58cfa832e4b0c9d6adf6d20e,TCGA-HT-7468-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_5_rg.sorted.filtered.,WGS,TCGA-HT-7468-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_5_rg.sorted,TCGA-HT-7468-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_5_rg.sorted.bam,188,NA,0.13,58cfa832e4b0c9d6adf6d20e,TCGA-HT-7468-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7468-01A,E6C55BA6-4C8A-4EA4-8DDE-74D01915DB02,Primary Tumor,Illumina HiSeq,e1855a2f-1904-41ee-ba33-a27e1c202d99,Brain,30,D2775F99-CC96-4C72-94FF-E3BA985DC151,143CEFE3-F477-4CDE-AEA6-CE0610835570,TCGA-HT-7468-01A-11D-2022-02,HG19_Broad_variant,TCGA-HT-7468,TCGA-LGG,NA,s8759,Harvard Medical School,Case Western - St Joes,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6c651,58cfa831e4b0c9d6adf6c651,TCGA-CN-4736-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CN-4736-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_3_rg.sorted,TCGA-CN-4736-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_3_rg.sorted.bam,52.7,1.9,0.15,58cfa831e4b0c9d6adf6c651,TCGA-CN-4736-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_3_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4736-01A,0FB3E5FF-54F0-43C5-9322-541BB7825E7F,Primary Tumor,Illumina HiSeq,45c5cea2-56a4-43af-9c53-19302867f2d9,Head and Neck,70,6DB0B6EE-23B3-43BF-8AA9-FDF641AFC673,8141905F-DE66-4DB2-A9F9-5819C953A465,TCGA-CN-4736-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4736,TCGA-HNSC,395,s15881,Harvard Medical School,University of Pittsburgh,None,NO,T1,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c9da,58cfa831e4b0c9d6adf6c9da,TCGA-DJ-A13T-01A-11D-A10R_120629_SN1120_0167_AC0WMBACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DJ-A13T-01A-11D-A10R_120629_SN1120_0167_AC0WMBACXX_s_1_rg.sorted,TCGA-DJ-A13T-01A-11D-A10R_120629_SN1120_0167_AC0WMBACXX_s_1_rg.sorted.bam,48.83,2,0.16,58cfa831e4b0c9d6adf6c9da,TCGA-DJ-A13T-01A-11D-A10R_120629_SN1120_0167_AC0WMBACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13T-01A,0B170ED4-D919-466B-B765-47878B865AED,Primary Tumor,Illumina HiSeq,f42aa2a6-4acd-4650-aea7-c83fbddf27d2,Thyroid,37,6883BA87-9184-40D7-840B-603B15D73F7A,76DCBA6C-0992-44BB-9492-3023A2430CC4,TCGA-DJ-A13T-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13T,TCGA-THCA,NA,s12513,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82ee4b0c9d6adf6ae52,58cfa82ee4b0c9d6adf6ae52,TCGA-05-4389-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_5_rg.sorted.filtered.,WGS,TCGA-05-4389-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_5_rg.sorted,TCGA-05-4389-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_5_rg.sorted.bam,372.53,1.9,0.14,58cfa82ee4b0c9d6adf6ae52,TCGA-05-4389-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_5_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4389-01A,A3DE401D-91FE-49A2-BB07-81C1A06506E6,Primary Tumor,Illumina HiSeq,63a06f9b-e1c2-495a-8f7e-88e19c550049,Lung,70,ED61AC6A-F21F-4B88-928A-029340D4AEBD,575D4BEF-5610-41F4-B219-C9BBBA72F047,TCGA-05-4389-01A-01D-1203-02,HG19_Broad_variant,TCGA-05-4389,TCGA-LUAD,NA,s10769,Harvard Medical School,Indivumed,Germany,NO,T1,N0,Lung Adenocarcinoma Mixed Subtype,Stage IA
13722.58cfa831e4b0c9d6adf6caac,58cfa831e4b0c9d6adf6caac,TCGA-DJ-A13P-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DJ-A13P-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_8_rg.sorted,TCGA-DJ-A13P-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_8_rg.sorted.bam,40.13,1.88,0.16,58cfa831e4b0c9d6adf6caac,TCGA-DJ-A13P-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13P-10A,CA95A11C-B54C-409E-B9A0-DA850945033D,Blood Derived Normal,Illumina HiSeq,3ad8b774-daba-42c2-8cab-709a65bf8803,Thyroid,52,74FE8C42-926C-43EB-81D0-CF4E56C9DC12,7AC0BF88-1435-4589-9A2A-318E32C9344B,TCGA-DJ-A13P-10A-01D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13P,TCGA-THCA,NA,s12636,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage II
13722.58cfa831e4b0c9d6adf6cd72,58cfa831e4b0c9d6adf6cd72,TCGA-ET-A25M-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_8_rg.sorted.filtered.,WGS,TCGA-ET-A25M-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_8_rg.sorted,TCGA-ET-A25M-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_8_rg.sorted.bam,26.1,1.88,0.18,58cfa831e4b0c9d6adf6cd72,TCGA-ET-A25M-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-ET-A25M-10A,8023D4C9-B56D-417A-9A52-D45B59C756ED,Blood Derived Normal,Illumina HiSeq,7f27862b-c742-46ca-b311-8c6eb5df24f3,Thyroid,33,5972C59C-3CD2-41D9-AE04-42DEC3ECC565,0B4371FA-86D7-4C34-8E65-3D53CE130BE2,TCGA-ET-A25M-10A-01D-A16N-02,HG19_Broad_variant,TCGA-ET-A25M,TCGA-THCA,NA,s12385,Harvard Medical School,Johns Hopkins,United States,NO,T2,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa830e4b0c9d6adf6c260,58cfa830e4b0c9d6adf6c260,TCGA-C5-A3HL-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_7_rg.sorted.filtered.,WGS,TCGA-C5-A3HL-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_7_rg.sorted,TCGA-C5-A3HL-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_7_rg.sorted.bam,48.29,NA,0.14,58cfa830e4b0c9d6adf6c260,TCGA-C5-A3HL-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A3HL-01A,09329A53-D58D-4480-95D8-32043E40DE6E,Primary Tumor,Illumina HiSeq,84c6e022-f737-4fae-a2c7-812ef4f00adf,Cervix,76,2A3CC87B-B120-49EC-93E6-8BDDBAE5C97C,04FC6219-3EAC-4BB8-82CA-CD0AA6B0ACE3,TCGA-C5-A3HL-01A-11D-A20X-26,HG19_Broad_variant,TCGA-C5-A3HL,TCGA-CESC,NA,s1516,MD Anderson - Institute for Applied Cancer Science,Medical College of Wisconsin,United States,NO,T1b2,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c68f,58cfa831e4b0c9d6adf6c68f,TCGA-CU-A3YL-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CU-A3YL-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_3_rg.sorted,TCGA-CU-A3YL-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_3_rg.sorted.bam,42.41,NA,0.15,58cfa831e4b0c9d6adf6c68f,TCGA-CU-A3YL-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CU-A3YL-01A,087A7F70-2FA8-4A16-B130-4DF10A70C662,Primary Tumor,Illumina HiSeq,8753d7f5-4d92-4781-8d19-d44710fa4f45,Bladder,67,F66AD788-E2D8-4688-820F-49A609701533,CAD008C4-3B53-4E9D-8730-9807E4753DDD,TCGA-CU-A3YL-01A-11D-A233-26,HG19_Broad_variant,TCGA-CU-A3YL,TCGA-BLCA,NA,s3274,MD Anderson - Institute for Applied Cancer Science,UNC,United States,NO,T4a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6cf5b,58cfa832e4b0c9d6adf6cf5b,TCGA-GN-A265-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_5_rg.sorted.filtered.,WGS,TCGA-GN-A265-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_5_rg.sorted,TCGA-GN-A265-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_5_rg.sorted.bam,16.67,NA,0.18,58cfa832e4b0c9d6adf6cf5b,TCGA-GN-A265-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-GN-A265-10A,61B777F6-A59A-4500-AD33-107E2C9254C1,Blood Derived Normal,Illumina HiSeq,8ad44bb1-82fb-42de-8306-68b2e86c747f,Skin,53,5045BC39-C8BA-4AC5-A6F4-F175E41DB27C,7457238B-0093-49A0-8B19-F71894346253,TCGA-GN-A265-10A-01D-A190-02,HG19_Broad_variant,TCGA-GN-A265,TCGA-SKCM,NA,s7541,Harvard Medical School,Roswell,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6bd8c,58cfa830e4b0c9d6adf6bd8c,TCGA-BG-A0M0-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BG-A0M0-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_6_rg.sorted,TCGA-BG-A0M0-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_6_rg.sorted.bam,94.25,2.11,0.15,58cfa830e4b0c9d6adf6bd8c,TCGA-BG-A0M0-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0M0-01A,8BF0B156-6EB4-45E8-9CBB-0979EFBEA898,Primary Tumor,Illumina HiSeq,bedca351-a4f7-4fbd-af8e-d49f3d9b2c37,Uterus,66,E3F599DB-19CF-4086-8E5D-D3527119120F,78D21C64-205B-4C9C-A862-8A70348D2602,TCGA-BG-A0M0-01A-11D-A101-02,HG19_Broad_variant,TCGA-BG-A0M0,TCGA-UCEC,NA,s5216,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6cf52,58cfa832e4b0c9d6adf6cf52,TCGA-FS-A1ZC-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FS-A1ZC-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_3_rg.sorted,TCGA-FS-A1ZC-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_3_rg.sorted.bam,65.24,NA,0.17,58cfa832e4b0c9d6adf6cf52,TCGA-FS-A1ZC-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZC-06A,B1739CB5-09BC-414A-8F05-C66D2CB9868D,Metastatic,Illumina HiSeq,446e73e5-004b-4ac5-9413-27d76ce8fad0,Skin,51,1C388CA4-2E3E-429D-844E-52D6DF03F240,30CED7B6-9CD7-4F9B-96CC-3264EF036734,TCGA-FS-A1ZC-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZC,TCGA-SKCM,10870,s7366,Harvard Medical School,Essen,Germany,NO,TX,N0,Not available,I or II NOS
13722.58cfa831e4b0c9d6adf6cad6,58cfa831e4b0c9d6adf6cad6,TCGA-DU-6408-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DU-6408-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_8_rg.sorted,TCGA-DU-6408-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_8_rg.sorted.bam,157.3,1.9,0.15,58cfa831e4b0c9d6adf6cad6,TCGA-DU-6408-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6408-01A,14375753-A69F-41E0-B910-2BB8E84CC43A,Primary Tumor,Illumina HiSeq,f441e949-5e27-4235-a0db-39c77aacdb5c,Brain,23,F68159AD-A0E9-4F9F-AD68-A29D53772982,57952871-E6FE-4C1F-87FE-404FADFC67C1,TCGA-DU-6408-01A-11D-1703-02,HG19_Broad_variant,TCGA-DU-6408,TCGA-LGG,3470,s8757,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6c770,58cfa831e4b0c9d6adf6c770,TCGA-D3-A3C3-10A-01D-A18Z_120520_SN590_0158_AC0J99ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D3-A3C3-10A-01D-A18Z_120520_SN590_0158_AC0J99ACXX_s_4_rg.sorted,TCGA-D3-A3C3-10A-01D-A18Z_120520_SN590_0158_AC0J99ACXX_s_4_rg.sorted.bam,24.92,NA,0.16,58cfa831e4b0c9d6adf6c770,TCGA-D3-A3C3-10A-01D-A18Z_120520_SN590_0158_AC0J99ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A3C3-10A,FC59CC57-CA7A-4DE3-BD13-2E283716A243,Blood Derived Normal,Illumina HiSeq,c29f3065-3e54-48d6-bbed-7aac0fbd2f92,Skin,30,4396781F-3443-4AB0-82DA-0151CEE7085F,B3AF114B-4AF4-46EB-8545-916D55C38FC1,TCGA-D3-A3C3-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-D3-A3C3,TCGA-SKCM,NA,s7671,Harvard Medical School,MD Anderson,United States,NO,TX,N0,Not available,I or II NOS
13722.58cfa830e4b0c9d6adf6bf9f,58cfa830e4b0c9d6adf6bf9f,TCGA-BR-6458-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BR-6458-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_5_rg.sorted,TCGA-BR-6458-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_5_rg.sorted.bam,306.4,1.9,0.15,58cfa830e4b0c9d6adf6bf9f,TCGA-BR-6458-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6458-01A,E516880B-C4E5-43CD-A358-BE0DB88564D7,Primary Tumor,Illumina HiSeq,545acf44-8e16-46b9-b35a-c860c08b416b,Stomach,57,A30B45F5-C6E4-4975-A912-8313D93DFD27,2DD3E59B-4DBB-49B4-9DC4-A949FE48AA17,TCGA-BR-6458-01A-11D-1798-02,HG19_Broad_variant,TCGA-BR-6458,TCGA-STAD,NA,s14613,Harvard Medical School,Asterand,Ukraine,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB
13722.58cfa832e4b0c9d6adf6d136,58cfa832e4b0c9d6adf6d136,TCGA-FS-A1ZK-06A-11D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FS-A1ZK-06A-11D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_4_rg.sorted,TCGA-FS-A1ZK-06A-11D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_4_rg.sorted.bam,33.04,NA,0.16,58cfa832e4b0c9d6adf6d136,TCGA-FS-A1ZK-06A-11D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZK-06A,1404791B-86BF-4DFD-85B4-C8FF356F109C,Metastatic,Illumina HiSeq,e43f4ad5-e270-438e-b3c0-0449ebdb43b1,Skin,68,07E2FEA3-4BA5-49B3-AE9B-61FF8492026C,25F7EF72-9CE1-4BFB-BEBE-3815E34FFCB8,TCGA-FS-A1ZK-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZK,TCGA-SKCM,728,s7368,Harvard Medical School,Essen,Germany,NO,T4,N0,Not available,Stage II
13722.58cfa830e4b0c9d6adf6bd64,58cfa830e4b0c9d6adf6bd64,TCGA-AA-A00R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A00R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A00R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,205.35,1.73,0.15,58cfa830e4b0c9d6adf6bd64,TCGA-AA-A00R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A00R-01A,CA22EDD4-EB7C-4677-84AA-6F0354459A19,Primary Tumor,Illumina HiSeq,f8afa471-fd74-43ef-8cc5-58a4f3788e31,Colorectal,64,F72EEAE9-F7F5-4576-A072-5021119117D6,AC9F45EC-C004-475F-8537-8977F20B0DE8,TCGA-AA-A00R-01A-01D-A077-02,HG18,TCGA-AA-A00R,TCGA-COAD,NA,s13517,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d3ea,58cfa832e4b0c9d6adf6d3ea,TCGA-V4-A9EO-01A-12D-A40D_140808_SN590_0253_AC499NACXX_s_3_rg.sorted.filtered.,WGS,TCGA-V4-A9EO-01A-12D-A40D_140808_SN590_0253_AC499NACXX_s_3_rg.sorted,TCGA-V4-A9EO-01A-12D-A40D_140808_SN590_0253_AC499NACXX_s_3_rg.sorted.bam,16.22,NA,0.17,58cfa832e4b0c9d6adf6d3ea,TCGA-V4-A9EO-01A-12D-A40D_140808_SN590_0253_AC499NACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EO-01A,BCB87378-9F43-45E4-BDF2-F6DFA6AC5B8C,Primary Tumor,Illumina HiSeq,e433357d-cafe-49f8-b481-e9b804bd4a06,Eye,74,C46DB8A8-DAF3-4E99-9307-E6C6CD8F79D5,B0A67E95-2ED2-43EB-9490-5F94BB8E21F4,TCGA-V4-A9EO-01A-12D-A40D-26,HG19_Broad_variant,TCGA-V4-A9EO,TCGA-UVM,NA,s240,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa831e4b0c9d6adf6caaa,58cfa831e4b0c9d6adf6caaa,TCGA-D1-A16D-01A-11D-A12F_120511_SN208_0299_BD12J9ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D1-A16D-01A-11D-A12F_120511_SN208_0299_BD12J9ACXX_s_3_rg.sorted,TCGA-D1-A16D-01A-11D-A12F_120511_SN208_0299_BD12J9ACXX_s_3_rg.sorted.bam,64.8,1.88,0.16,58cfa831e4b0c9d6adf6caaa,TCGA-D1-A16D-01A-11D-A12F_120511_SN208_0299_BD12J9ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A16D-01A,5693302A-4548-4C0B-8725-0CB7C67BC4F8,Primary Tumor,Illumina HiSeq,c72febd1-cbf3-4ba1-9e3e-35d65e99aa5e,Uterus,49,007BDFD3-81B6-42C3-A4A6-C4DDAF1BE0AE,DCA0D1DE-E9A0-45CF-B709-A492D513C1C4,TCGA-D1-A16D-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A16D,TCGA-UCEC,NA,s4613,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b90e,58cfa82fe4b0c9d6adf6b90e,TCGA-49-4507-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-49-4507-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole,TCGA-49-4507-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,289.2,1.9,0.14,58cfa82fe4b0c9d6adf6b90e,TCGA-49-4507-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4507-01A,50B2C647-AECD-4C81-AF22-0D8116593552,Primary Tumor,Illumina HiSeq,557606c6-d245-45ba-b9f0-adc05c6a5f4f,Lung,73,962F85FF-1F27-49E4-8C3D-798FACEA122F,EF299B98-6A9F-4022-8683-A9C830E7263C,TCGA-49-4507-01A-01D-1203-02,GRCh37,TCGA-49-4507,TCGA-LUAD,268,s11453,Harvard Medical School,Johns Hopkins,United States,NO,T3,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa832e4b0c9d6adf6cf57,58cfa832e4b0c9d6adf6cf57,TCGA-FS-A1ZP-06A-11D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FS-A1ZP-06A-11D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_1_rg.sorted,TCGA-FS-A1ZP-06A-11D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_1_rg.sorted.bam,66.69,NA,0.15,58cfa832e4b0c9d6adf6cf57,TCGA-FS-A1ZP-06A-11D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZP-06A,4CDB18F5-47BF-475F-B34C-FA4912515268,Metastatic,Illumina HiSeq,f5d63bd9-91dc-447c-a780-e7203db239c7,Skin,52,3FC2F92E-E55E-4484-B306-4303A9A0CBF5,B5D10C46-EDAB-475F-830A-D3DE0D187046,TCGA-FS-A1ZP-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZP,TCGA-SKCM,2273,s7701,Harvard Medical School,Essen,Germany,NO,T3,N0,Not available,Stage II
13722.58cfa832e4b0c9d6adf6d4af,58cfa832e4b0c9d6adf6d4af,TCGA-V4-A9ED-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_2_rg.sorted.filtered.,WGS,TCGA-V4-A9ED-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_2_rg.sorted,TCGA-V4-A9ED-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_2_rg.sorted.bam,16.02,NA,0.17,58cfa832e4b0c9d6adf6d4af,TCGA-V4-A9ED-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9ED-10A,367869F9-BBE7-4E57-A16F-F2B63F2DE697,Blood Derived Normal,Illumina HiSeq,ede3cdcb-2e06-48da-8e58-ec6f411f9456,Eye,45,9C706079-3704-4DB8-BE79-43AF1EDEF68D,BD061E25-B202-4D5B-A321-9E5311A6C868,TCGA-V4-A9ED-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9ED,TCGA-UVM,NA,s239,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3b,N0,Not available,Stage IIIA
13722.58cfa830e4b0c9d6adf6bc9e,58cfa830e4b0c9d6adf6bc9e,TCGA-AZ-4315-10A-01D-1405_110225_SN177_0142_B81JPFABXX_s_4.rg.sorted.filtered.,WGS,TCGA-AZ-4315-10A-01D-1405_110225_SN177_0142_B81JPFABXX_s_4.rg.sorted,TCGA-AZ-4315-10A-01D-1405_110225_SN177_0142_B81JPFABXX_s_4.rg.sorted.bam,287.72,1.9,0.15,58cfa830e4b0c9d6adf6bc9e,TCGA-AZ-4315-10A-01D-1405_110225_SN177_0142_B81JPFABXX_s_4.rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-4315-10A,DE287A25-981D-49F8-81AF-FE0300E4CD31,Blood Derived Normal,Illumina HiSeq,9a6322eb-3fac-4d37-bbec-89355ddc9dbb,Colorectal,61,8D10297B-DEF9-4F00-B231-B1448967FA7A,59F67AA1-B650-40DD-A6F8-D2BC53380B6C,TCGA-AZ-4315-10A-01D-1405-02,HG18_Broad_variant,TCGA-AZ-4315,TCGA-COAD,NA,s13541,Harvard Medical School,University of Pittsburgh,None,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa832e4b0c9d6adf6d18e,58cfa832e4b0c9d6adf6d18e,TCGA-FI-A2D4-01A-12D-A17E_120511_SN1120_0140_AD12J0ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-FI-A2D4-01A-12D-A17E_120511_SN1120_0140_AD12J0ACXX_s_7_rg.sorted,TCGA-FI-A2D4-01A-12D-A17E_120511_SN1120_0140_AD12J0ACXX_s_7_rg.sorted.bam,28.14,NA,0.16,58cfa832e4b0c9d6adf6d18e,TCGA-FI-A2D4-01A-12D-A17E_120511_SN1120_0140_AD12J0ACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-FI-A2D4-01A,490AE247-EE67-48D4-94ED-93DF5B9BBEFE,Primary Tumor,Illumina HiSeq,8f265179-0deb-4bbd-bd06-f6a211fae179,Uterus,44,A8393121-29DF-4525-BF4F-FCE0DEAF25F5,6DA2AADF-7B34-4F4F-93E4-0963248B3DEB,TCGA-FI-A2D4-01A-12D-A17E-02,HG19_Broad_variant,TCGA-FI-A2D4,TCGA-UCEC,243,s5232,Harvard Medical School,Washington University,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6ca54,58cfa831e4b0c9d6adf6ca54,TCGA-DB-5280-01A-01D-1465_130906_SN1440_0166_BC2A68ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DB-5280-01A-01D-1465_130906_SN1440_0166_BC2A68ACXX_s_5_rg.sorted,TCGA-DB-5280-01A-01D-1465_130906_SN1440_0166_BC2A68ACXX_s_5_rg.sorted.bam,325.7,1.9,0.15,58cfa831e4b0c9d6adf6ca54,TCGA-DB-5280-01A-01D-1465_130906_SN1440_0166_BC2A68ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DB-5280-01A,4797C600-F024-42FE-B287-D919B24DCB79,Primary Tumor,Illumina HiSeq,47363648-94bb-4221-a905-4832396ef90e,Brain,43,D9B929FD-335C-46B1-B60D-B846C372AA6A,677B8F71-325E-49F9-B3D7-B6ADB6831ED5,TCGA-DB-5280-01A-01D-1465-02,HG19_Broad_variant,TCGA-DB-5280,TCGA-LGG,NA,s8130,Harvard Medical School,Mayo Clinic - Rochester,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa830e4b0c9d6adf6bded,58cfa830e4b0c9d6adf6bded,TCGA-BH-A0DK-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BH-A0DK-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_5_rg.sorted,TCGA-BH-A0DK-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_5_rg.sorted.bam,43.73,2.05,0.16,58cfa830e4b0c9d6adf6bded,TCGA-BH-A0DK-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0DK-01A,F2BBFA9D-9A9D-4F46-9FDE-378E4C44E2AD,Primary Tumor,Illumina HiSeq,71acb20b-f186-44d4-a92e-a2751f845fe3,Breast,49,1ACAE6E0-3100-4DE8-A436-E15CDBE1322B,92245807-8B1B-4E96-8567-6CFE5E70ADE4,TCGA-BH-A0DK-01A-21D-A060-02,HG19_Broad_variant,TCGA-BH-A0DK,TCGA-BRCA,NA,s5493,Harvard Medical School,University of Pittsburgh,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6cc70,58cfa831e4b0c9d6adf6cc70,TCGA-DU-7294-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DU-7294-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_4_rg.sorted,TCGA-DU-7294-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_4_rg.sorted.bam,41,NA,0.15,58cfa831e4b0c9d6adf6cc70,TCGA-DU-7294-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7294-10A,3F6FFB08-32A9-4555-BFD1-243B7F526105,Blood Derived Normal,Illumina HiSeq,fb816713-22f8-4650-a51e-d1dc31150849,Brain,53,8B4922DC-8990-4A9A-892F-CA57EBD6D987,E6951FEB-A4F1-42ED-BC55-E6BC8DFBC1AD,TCGA-DU-7294-10A-01D-2022-02,HG19_Broad_variant,TCGA-DU-7294,TCGA-LGG,NA,s8568,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6c999,58cfa831e4b0c9d6adf6c999,TCGA-DJ-A13T-10A-01D-A10R_120629_SN1120_0167_AC0WMBACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DJ-A13T-10A-01D-A10R_120629_SN1120_0167_AC0WMBACXX_s_2_rg.sorted,TCGA-DJ-A13T-10A-01D-A10R_120629_SN1120_0167_AC0WMBACXX_s_2_rg.sorted.bam,30.25,1.92,0.14,58cfa831e4b0c9d6adf6c999,TCGA-DJ-A13T-10A-01D-A10R_120629_SN1120_0167_AC0WMBACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13T-10A,0B170ED4-D919-466B-B765-47878B865AED,Blood Derived Normal,Illumina HiSeq,b76e1212-5c0d-4aa2-8571-b51b3b490d27,Thyroid,37,ABFEC4E3-79D8-4263-B6F7-F98FDFEB1877,70AE0C44-BF61-4871-88A2-C7F5EE11296C,TCGA-DJ-A13T-10A-01D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13T,TCGA-THCA,NA,s11993,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c8ba,58cfa831e4b0c9d6adf6c8ba,TCGA-DK-A3IM-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DK-A3IM-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_7_rg.sorted,TCGA-DK-A3IM-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_7_rg.sorted.bam,26.41,NA,0.15,58cfa831e4b0c9d6adf6c8ba,TCGA-DK-A3IM-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3IM-01A,41B59716-116F-4942-8B63-409870A87E26,Primary Tumor,Illumina HiSeq,27ca0d22-3ef8-4c3c-814a-94dfb76c3289,Bladder,76,7A37AE7C-6B46-410D-AE2B-12FD868C25B3,CDAC6FE7-FB06-4F9A-86D0-DF0DF26FD558,TCGA-DK-A3IM-01A-11D-A210-26,HG19_Broad_variant,TCGA-DK-A3IM,TCGA-BLCA,NA,s2882,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6cd02,58cfa831e4b0c9d6adf6cd02,TCGA-FD-A3SJ-10A-01D-A233_120830_SN208_0423_AC190AACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FD-A3SJ-10A-01D-A233_120830_SN208_0423_AC190AACXX_s_2_rg.sorted,TCGA-FD-A3SJ-10A-01D-A233_120830_SN208_0423_AC190AACXX_s_2_rg.sorted.bam,77.54,NA,0.16,58cfa831e4b0c9d6adf6cd02,TCGA-FD-A3SJ-10A-01D-A233_120830_SN208_0423_AC190AACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3SJ-10A,6D8D8169-0C1A-4CDB-BE6F-9761C981A369,Blood Derived Normal,Illumina HiSeq,42daaedd-31f4-4764-92e7-8eeccec3ee06,Bladder,59,3032F083-B2A7-4B52-87E6-B8C68B3281C9,013D4863-EEC6-4563-ABB8-28C82991A7C5,TCGA-FD-A3SJ-10A-01D-A233-26,HG19_Broad_variant,TCGA-FD-A3SJ,TCGA-BLCA,739,s3115,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T2b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6d42a,58cfa832e4b0c9d6adf6d42a,TCGA-VD-AA8O-01A-11D-A40D_140807_SN1440_0194_AC5B5RACXX_s_3_rg.sorted.filtered.,WGS,TCGA-VD-AA8O-01A-11D-A40D_140807_SN1440_0194_AC5B5RACXX_s_3_rg.sorted,TCGA-VD-AA8O-01A-11D-A40D_140807_SN1440_0194_AC5B5RACXX_s_3_rg.sorted.bam,48.76,NA,0.16,58cfa832e4b0c9d6adf6d42a,TCGA-VD-AA8O-01A-11D-A40D_140807_SN1440_0194_AC5B5RACXX_s_3_rg.sorted.bam,Alive,MALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-AA8O-01A,99D1BFCC-1989-4DD2-A5E9-78E08F6CE7CF,Primary Tumor,Illumina HiSeq,cfc969dd-923b-4187-808c-584f86e0c276,Eye,77,9C21476F-E62A-4259-BD84-52E539EB5806,9E3B6CA4-5102-4C1E-99FD-3E149D0E4B6D,TCGA-VD-AA8O-01A-11D-A40D-26,HG19_Broad_variant,TCGA-VD-AA8O,TCGA-UVM,NA,s269,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T3a,N0,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6d15a,58cfa832e4b0c9d6adf6d15a,TCGA-IR-A3LH-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_2_rg.sorted.filtered.,WGS,TCGA-IR-A3LH-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_2_rg.sorted,TCGA-IR-A3LH-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_2_rg.sorted.bam,13.44,NA,0.16,58cfa832e4b0c9d6adf6d15a,TCGA-IR-A3LH-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_2_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-IR-A3LH-10A,F24ED9C0-92BB-4003-86D2-42AB26617A05,Blood Derived Normal,Illumina HiSeq,4b14cf40-d107-436f-878b-51206195206b,Cervix,49,603DD19A-BBC4-4442-879C-F012C469F83B,15118B5A-8494-454E-84DC-1142C32AE6FA,TCGA-IR-A3LH-10A-01D-A20X-26,HG19_Broad_variant,TCGA-IR-A3LH,TCGA-CESC,NA,s1537,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T2a1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6cbed,58cfa831e4b0c9d6adf6cbed,TCGA-EM-A3O6-10A-01D-A221_120524_SN1120_0144_AC0VNCACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EM-A3O6-10A-01D-A221_120524_SN1120_0144_AC0VNCACXX_s_4_rg.sorted,TCGA-EM-A3O6-10A-01D-A221_120524_SN1120_0144_AC0VNCACXX_s_4_rg.sorted.bam,47.4,NA,0.15,58cfa831e4b0c9d6adf6cbed,TCGA-EM-A3O6-10A-01D-A221_120524_SN1120_0144_AC0VNCACXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3O6-10A,398D5C2E-F877-4BBF-A10C-486B8523C9CE,Blood Derived Normal,Illumina HiSeq,b9dd8c1b-73aa-4893-983e-650726517b6c,Thyroid,54,D9F42748-4A69-45AA-90B3-EFDF0B98A1C1,00A504CB-DF5E-4F7F-B213-E6A946141919,TCGA-EM-A3O6-10A-01D-A221-26,HG19_Broad_variant,TCGA-EM-A3O6,TCGA-THCA,NA,s12248,MD Anderson - Institute for Applied Cancer Science,University Health Network,Canada,NO,T2,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa830e4b0c9d6adf6c01c,58cfa830e4b0c9d6adf6c01c,TCGA-B5-A0K7-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_8_rg.sorted.filtered.,WGS,TCGA-B5-A0K7-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_8_rg.sorted,TCGA-B5-A0K7-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_8_rg.sorted.bam,106.4,2,0.15,58cfa830e4b0c9d6adf6c01c,TCGA-B5-A0K7-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0K7-01A,2F0640BC-598C-4714-9E9B-7E0F2CA4567F,Primary Tumor,Illumina HiSeq,b1ac8e27-775c-4d91-8a4d-9d096cde589d,Uterus,64,51E8577D-6849-422E-8F37-2EA8C400BBE5,ED30E619-1EBE-4CCE-B7FD-93B552953B65,TCGA-B5-A0K7-01A-11D-A101-02,HG19_Broad_variant,TCGA-B5-A0K7,TCGA-UCEC,NA,s5390,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6ccd8,58cfa831e4b0c9d6adf6ccd8,TCGA-EM-A1CU-10A-02D-A13U_120706_SN1120_0170_BD1422ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EM-A1CU-10A-02D-A13U_120706_SN1120_0170_BD1422ACXX_s_5_rg.sorted,TCGA-EM-A1CU-10A-02D-A13U_120706_SN1120_0170_BD1422ACXX_s_5_rg.sorted.bam,7.14,1.98,0.17,58cfa831e4b0c9d6adf6ccd8,TCGA-EM-A1CU-10A-02D-A13U_120706_SN1120_0170_BD1422ACXX_s_5_rg.sorted.bam,Alive,MALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1CU-10A,4E80F403-0E10-4725-854D-F023C12EE1E2,Blood Derived Normal,Illumina HiSeq,e983d945-1e86-4d1a-ba00-131dea102879,Thyroid,31,457E4448-24E8-412C-A7DA-77CA0582A32A,918729C5-0155-4161-8C98-2F473CF87907,TCGA-EM-A1CU-10A-02D-A13U-02,HG19_Broad_variant,TCGA-EM-A1CU,TCGA-THCA,NA,s11996,Harvard Medical School,University Health Network,Canada,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6d19a,58cfa832e4b0c9d6adf6d19a,TCGA-IR-A3LC-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_3_rg.sorted.filtered.,WGS,TCGA-IR-A3LC-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_3_rg.sorted,TCGA-IR-A3LC-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_3_rg.sorted.bam,81.15,NA,0.15,58cfa832e4b0c9d6adf6d19a,TCGA-IR-A3LC-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-IR-A3LC-01A,58BDCACE-0047-456E-A225-68953EDAFE5E,Primary Tumor,Illumina HiSeq,8b84ea0a-0512-427e-8456-2facdcd978b9,Cervix,40,AC6D15A0-67CF-42AA-97DC-BA50D0E9F409,47A900B4-52E8-448E-B092-EEE4E394A309,TCGA-IR-A3LC-01A-11D-A20X-26,HG19_Broad_variant,TCGA-IR-A3LC,TCGA-CESC,NA,s1375,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6cc63,58cfa831e4b0c9d6adf6cc63,TCGA-EA-A3HU-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EA-A3HU-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_3_rg.sorted,TCGA-EA-A3HU-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_3_rg.sorted.bam,40.2,NA,0.16,58cfa831e4b0c9d6adf6cc63,TCGA-EA-A3HU-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EA-A3HU-01A,9912432E-74BC-4846-93B4-FA2BF8070BD1,Primary Tumor,Illumina HiSeq,4f5312e3-89a9-41d7-a296-8b90e22cb408,Cervix,43,05409DA8-60DC-4073-91F0-F91832F3A607,B66F8B97-9149-4C12-A66E-4BC7D1352269,TCGA-EA-A3HU-01A-11D-A20X-26,HG19_Broad_variant,TCGA-EA-A3HU,TCGA-CESC,NA,s1520,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T2a2,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b64b,58cfa82fe4b0c9d6adf6b64b,TCGA-75-5126-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_5_rg.sorted.filtered.,WGS,TCGA-75-5126-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_5_rg.sorted,TCGA-75-5126-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_5_rg.sorted.bam,392.4,1.9,0.15,58cfa82fe4b0c9d6adf6b64b,TCGA-75-5126-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_5_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-5126-01A,93766482-2F20-4C8F-BBD8-BDD203C37D5A,Primary Tumor,Illumina HiSeq,8c670948-9cf1-4db3-82d5-39ed824c61ff,Lung,NA,39509EA1-E728-4350-B444-798C72ADE33A,7BCB1D5A-871F-472E-A964-9B68259D9716,TCGA-75-5126-01A-01D-1751-02,HG19_Broad_variant,TCGA-75-5126,TCGA-LUAD,NA,s11251,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,T3,N2,Lung Papillary Adenocarcinoma,Stage IIIA
13722.58cfa831e4b0c9d6adf6cbe8,58cfa831e4b0c9d6adf6cbe8,TCGA-DU-7018-10A-01D-2022_130910_SN208_0495_BD2FGNACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DU-7018-10A-01D-2022_130910_SN208_0495_BD2FGNACXX_s_6_rg.sorted,TCGA-DU-7018-10A-01D-2022_130910_SN208_0495_BD2FGNACXX_s_6_rg.sorted.bam,88.3,NA,0.14,58cfa831e4b0c9d6adf6cbe8,TCGA-DU-7018-10A-01D-2022_130910_SN208_0495_BD2FGNACXX_s_6_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7018-10A,F18DAB99-26B0-4727-89A9-7F16BD382356,Blood Derived Normal,Illumina HiSeq,7ee7f69e-1fcd-495d-bbfa-f262e711b4a6,Brain,57,DE3EF329-B9B1-4CE3-BC89-9D0CA332B620,AD54AA45-1111-4E52-8971-C86ED709F3FB,TCGA-DU-7018-10A-01D-2022-02,HG19_Broad_variant,TCGA-DU-7018,TCGA-LGG,933,s8564,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa832e4b0c9d6adf6d190,58cfa832e4b0c9d6adf6d190,TCGA-IR-A3LH-01A-21D-A20X_140117_SN590_0246_BC37BDACXX_s_8_rg.sorted.filtered.,WGS,TCGA-IR-A3LH-01A-21D-A20X_140117_SN590_0246_BC37BDACXX_s_8_rg.sorted,TCGA-IR-A3LH-01A-21D-A20X_140117_SN590_0246_BC37BDACXX_s_8_rg.sorted.bam,62.48,NA,0.15,58cfa832e4b0c9d6adf6d190,TCGA-IR-A3LH-01A-21D-A20X_140117_SN590_0246_BC37BDACXX_s_8_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-IR-A3LH-01A,F24ED9C0-92BB-4003-86D2-42AB26617A05,Primary Tumor,Illumina HiSeq,159f94e1-d4e4-45d7-9220-90578144802f,Cervix,49,D95E5389-DD55-4D55-AB01-6A770C66502F,7BDB76AA-01BA-48A8-A58A-29B118B8118A,TCGA-IR-A3LH-01A-21D-A20X-26,HG19_Broad_variant,TCGA-IR-A3LH,TCGA-CESC,NA,s1535,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T2a1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6cd04,58cfa831e4b0c9d6adf6cd04,TCGA-EE-A2MN-10A-01D-A190_120724_SN1222_0138_AC1168ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EE-A2MN-10A-01D-A190_120724_SN1222_0138_AC1168ACXX_s_6_rg.sorted,TCGA-EE-A2MN-10A-01D-A190_120724_SN1222_0138_AC1168ACXX_s_6_rg.sorted.bam,18.48,NA,0.16,58cfa831e4b0c9d6adf6cd04,TCGA-EE-A2MN-10A-01D-A190_120724_SN1222_0138_AC1168ACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MN-10A,0797CAAF-18AD-41C6-820A-E96554D14B31,Blood Derived Normal,Illumina HiSeq,4dd5f91c-db26-4412-82e2-69e29de55207,Skin,58,32AF5A86-4721-4842-B88A-821506D7DDFB,8A8CC4E3-C877-43A1-BD00-9FAA04CA6E66,TCGA-EE-A2MN-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2MN,TCGA-SKCM,1446,s7692,Harvard Medical School,University of Sydney,Australia,NO,T2,N0,Not available,Stage I
13722.58cfa831e4b0c9d6adf6c9e6,58cfa831e4b0c9d6adf6c9e6,TCGA-DK-A3X1-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DK-A3X1-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_1_rg.sorted,TCGA-DK-A3X1-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_1_rg.sorted.bam,47.57,NA,0.16,58cfa831e4b0c9d6adf6c9e6,TCGA-DK-A3X1-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3X1-01A,6BDDAFDE-7004-49B6-80CF-8081CD4B7D44,Primary Tumor,Illumina HiSeq,4c8de054-fd6d-4ebd-8a6e-b5061ef5913b,Bladder,78,3D440A83-214E-432F-89D2-B523BFE7C6EF,4A8B5117-AF70-40AB-9698-B736EF20F3DE,TCGA-DK-A3X1-01A-12D-A233-26,HG19_Broad_variant,TCGA-DK-A3X1,TCGA-BLCA,NA,s3286,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6d37a,58cfa832e4b0c9d6adf6d37a,TCGA-LN-A4A2-01A-31D-A267_131001_SN1120_0279_AC2DKPACXX_s_5_rg.sorted.filtered.,WGS,TCGA-LN-A4A2-01A-31D-A267_131001_SN1120_0279_AC2DKPACXX_s_5_rg.sorted,TCGA-LN-A4A2-01A-31D-A267_131001_SN1120_0279_AC2DKPACXX_s_5_rg.sorted.bam,18.85,NA,0.15,58cfa832e4b0c9d6adf6d37a,TCGA-LN-A4A2-01A-31D-A267_131001_SN1120_0279_AC2DKPACXX_s_5_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A4A2-01A,A91C3F09-5F48-4B54-B669-C768F9FE9682,Primary Tumor,Illumina HiSeq,2f75f56a-b508-4f23-97ee-ccf05449e360,Esophagus,57,9FA38DD4-123F-4A89-9124-372E03184A9C,F64DF8A5-1964-46A4-829C-6B0B8CD97516,TCGA-LN-A4A2-01A-31D-A267-26,HG19_Broad_variant,TCGA-LN-A4A2,TCGA-ESCA,NA,s1684,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa832e4b0c9d6adf6cf61,58cfa832e4b0c9d6adf6cf61,TCGA-G9-6378-10A-01D-1784_130301_SN590_0217_BC1UHMACXX_s_4_rg.sorted.filtered.,WGS,TCGA-G9-6378-10A-01D-1784_130301_SN590_0217_BC1UHMACXX_s_4_rg.sorted,TCGA-G9-6378-10A-01D-1784_130301_SN590_0217_BC1UHMACXX_s_4_rg.sorted.bam,16.7,1.9,0.13,58cfa832e4b0c9d6adf6cf61,TCGA-G9-6378-10A-01D-1784_130301_SN590_0217_BC1UHMACXX_s_4_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6378-10A,12F225D0-CBFF-44EB-9183-BACC7F33B090,Blood Derived Normal,Illumina HiSeq,0d86bec5-370a-4a3d-a9e9-120faf1ed159,Prostate,54,71A35F86-610E-433B-80CF-0B496F3A604C,39E1FE96-A986-4FCE-B017-B5FC5B49068E,TCGA-G9-6378-10A-01D-1784-02,HG19_Broad_variant,TCGA-G9-6378,TCGA-PRAD,NA,s3455,Harvard Medical School,Roswell Park,United States,NO,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6be74,58cfa830e4b0c9d6adf6be74,TCGA-BJ-A191-10A-01D-A13U_120706_SN1120_0170_BD1422ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BJ-A191-10A-01D-A13U_120706_SN1120_0170_BD1422ACXX_s_2_rg.sorted,TCGA-BJ-A191-10A-01D-A13U_120706_SN1120_0170_BD1422ACXX_s_2_rg.sorted.bam,61.82,1.95,0.17,58cfa830e4b0c9d6adf6be74,TCGA-BJ-A191-10A-01D-A13U_120706_SN1120_0170_BD1422ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A191-10A,2501EE46-8D38-448B-8765-E9C9706CBBE8,Blood Derived Normal,Illumina HiSeq,71641a64-f2ef-4736-9e22-5982cfc1280f,Thyroid,49,88A3A560-FB2D-4E5E-B7B5-831CF7F9671C,C49240A9-A6FB-4612-A5F9-F855585E12EA,TCGA-BJ-A191-10A-01D-A13U-02,HG19_Broad_variant,TCGA-BJ-A191,TCGA-THCA,NA,s12509,Harvard Medical School,University of Pittsburgh,United States,NO,T1b,N0,Other  specify,Stage I
13722.58cfa831e4b0c9d6adf6ccd2,58cfa831e4b0c9d6adf6ccd2,TCGA-EM-A3OA-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EM-A3OA-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_6_rg.sorted,TCGA-EM-A3OA-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_6_rg.sorted.bam,47.85,NA,0.16,58cfa831e4b0c9d6adf6ccd2,TCGA-EM-A3OA-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_6_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3OA-01A,24CF6397-60EF-4635-81F0-78A67157AAC0,Primary Tumor,Illumina HiSeq,ddf917ff-6b4d-45ca-a503-8d6449f76e72,Thyroid,55,8B048263-6C2F-4BF6-8F37-C69DA9F3839F,2604E6C9-A117-49DC-A06E-082E63859DCA,TCGA-EM-A3OA-01A-11D-A221-26,HG19_Broad_variant,TCGA-EM-A3OA,TCGA-THCA,NA,s12249,MD Anderson - Institute for Applied Cancer Science,University Health Network,Canada,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa830e4b0c9d6adf6c272,58cfa830e4b0c9d6adf6c272,TCGA-BJ-A0ZA-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BJ-A0ZA-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_5_rg.sorted,TCGA-BJ-A0ZA-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_5_rg.sorted.bam,34.66,1.95,0.15,58cfa830e4b0c9d6adf6c272,TCGA-BJ-A0ZA-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0ZA-01A,4C513413-263E-4C7B-B997-7B688C47B698,Primary Tumor,Illumina HiSeq,787aed3e-08d4-4fa8-93e1-c04216a9875f,Thyroid,67,A61A9EC7-B893-44A5-AB6F-A390C168BE88,F3A353BB-07C3-49D1-BED2-2F8F5A328E1C,TCGA-BJ-A0ZA-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZA,TCGA-THCA,NA,s12744,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage II
13722.58cfa831e4b0c9d6adf6cd68,58cfa831e4b0c9d6adf6cd68,TCGA-FE-A232-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FE-A232-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_8_rg.sorted,TCGA-FE-A232-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_8_rg.sorted.bam,19.22,1.85,0.18,58cfa831e4b0c9d6adf6cd68,TCGA-FE-A232-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A232-10A,5EB0D577-223B-4409-89D1-5C5D196AFFC3,Blood Derived Normal,Illumina HiSeq,b0870db2-3e35-4d95-926d-744f50c9ad56,Thyroid,44,305278F6-641B-45C8-A758-5148346161C8,8DC86F0D-2853-49B9-89D3-046871A44F42,TCGA-FE-A232-10A-01D-A14U-02,HG19_Broad_variant,TCGA-FE-A232,TCGA-THCA,NA,s12005,Harvard Medical School,Ohio State University,United States,NO,T3,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa830e4b0c9d6adf6bc62,58cfa830e4b0c9d6adf6bc62,TCGA-AG-A00Y-01A-02D-A077-02_110405_SN590_0074_AB04EUABXX_s_7.rg.sorted.filtered.,WGS,TCGA-AG-A00Y-01A-02D-A077-02_110405_SN590_0074_AB04EUABXX_s_7.rg.sorted,TCGA-AG-A00Y-01A-02D-A077-02_110405_SN590_0074_AB04EUABXX_s_7.rg.sorted.bam,150.39,1.72,0.15,58cfa830e4b0c9d6adf6bc62,TCGA-AG-A00Y-01A-02D-A077-02_110405_SN590_0074_AB04EUABXX_s_7.rg.sorted.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A00Y-01A,C7E09161-60D6-4DFF-A840-7CEC3BB7A30A,Primary Tumor,Illumina HiSeq,2c284389-2d4d-4e3b-9b5b-a37212874f6e,Colorectal,68,8EC6ADED-026E-47F5-91F1-2A75F07BD8D0,27B036A3-5277-4C0F-93EE-593FDA1441DC,TCGA-AG-A00Y-01A-02D-A077-02,HG18_Broad_variant,TCGA-AG-A00Y,TCGA-READ,NA,s1983,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6c830,58cfa831e4b0c9d6adf6c830,TCGA-CV-7407-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CV-7407-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_8_rg.sorted,TCGA-CV-7407-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_8_rg.sorted.bam,131.73,NA,0.16,58cfa831e4b0c9d6adf6c830,TCGA-CV-7407-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7407-01A,8B63BE59-9CE6-45A0-80D9-4D20F4918CB9,Primary Tumor,Illumina HiSeq,e5709830-4141-4354-94f0-94f576fe84c9,Head and Neck,67,6ABAF81A-B228-4AFE-B931-BC1FC39CD265,4CC9AD85-2F84-4657-8F3E-6C5DD69F1B30,TCGA-CV-7407-01A-11D-2317-26,HG19_Broad_variant,TCGA-CV-7407,TCGA-HNSC,1081,s15909,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6b02c,58cfa82ee4b0c9d6adf6b02c,TCGA-05-4420-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-05-4420-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_3_rg.sorted,TCGA-05-4420-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_3_rg.sorted.bam,651.3,1.9,0.16,58cfa82ee4b0c9d6adf6b02c,TCGA-05-4420-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_3_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4420-01A,3D2AA654-1B5F-4EB4-A1C2-AF31F5760069,Primary Tumor,Illumina HiSeq,067a9600-61b8-4de1-ac32-914605c3033e,Lung,41,4B202550-9744-4C6C-AD17-97F764EA3F18,A50583F2-BB90-4848-9A5F-EAF4656A1866,TCGA-05-4420-01A-01D-1203-02,HG19_Broad_variant,TCGA-05-4420,TCGA-LUAD,NA,s11332,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa832e4b0c9d6adf6ce30,58cfa832e4b0c9d6adf6ce30,TCGA-ER-A19N-06A-11D-A18Y_120718_SN208_0416_BD140PACXX_s_3_rg.sorted.filtered.,WGS,TCGA-ER-A19N-06A-11D-A18Y_120718_SN208_0416_BD140PACXX_s_3_rg.sorted,TCGA-ER-A19N-06A-11D-A18Y_120718_SN208_0416_BD140PACXX_s_3_rg.sorted.bam,58.25,NA,0.16,58cfa832e4b0c9d6adf6ce30,TCGA-ER-A19N-06A-11D-A18Y_120718_SN208_0416_BD140PACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19N-06A,9EE83669-D7A4-476E-8857-304600B4917A,Metastatic,Illumina HiSeq,82cbbead-49f8-4968-aece-ebb693a35c8f,Skin,47,69508F90-DC5F-4B36-AC71-566B29496868,6EE8D916-F53C-4604-8801-029DA7809D11,TCGA-ER-A19N-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-ER-A19N,TCGA-SKCM,NA,s7863,Harvard Medical School,University of Pittsburgh,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6ae6a,58cfa82ee4b0c9d6adf6ae6a,TCGA-05-4398-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-05-4398-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_1_rg.sorted,TCGA-05-4398-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_1_rg.sorted.bam,403.53,1.9,0.15,58cfa82ee4b0c9d6adf6ae6a,TCGA-05-4398-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_1_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4398-01A,31C96E35-5E2F-429C-B12A-7BC5A497A300,Primary Tumor,Illumina HiSeq,af507e03-fa73-4b22-88ae-8d5d9cee85dc,Lung,47,DA010683-C537-478F-8F95-E606B05DBC5C,CC8C5E2D-1878-49EC-9D63-D65EB4FE8256,TCGA-05-4398-01A-01D-1203-02,HG19_Broad_variant,TCGA-05-4398,TCGA-LUAD,NA,s10981,Harvard Medical School,Indivumed,Germany,NO,T4,N3,Lung Adenocarcinoma Mixed Subtype,Stage IIIB
13722.58cfa830e4b0c9d6adf6ba91,58cfa830e4b0c9d6adf6ba91,TCGA-AA-3510-11A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-3510-11A-01D-1405-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-3510-11A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,507.02,1.9,0.14,58cfa830e4b0c9d6adf6ba91,TCGA-AA-3510-11A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3510-11A,35C295C2-37D1-44B2-87A3-1039645E5BAE,Solid Tissue Normal,Illumina HiSeq,0032406a-20bf-4092-832e-d73a3da4c00d,Colorectal,70,3EA9A3FD-16A0-4ED0-A9C8-45CB3972FE2B,EEC8BD6A-B080-43D6-971B-3E2E56DCA0AF,TCGA-AA-3510-11A-01D-1405-02,HG18,TCGA-AA-3510,TCGA-COAD,NA,s13510,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa831e4b0c9d6adf6caf8,58cfa831e4b0c9d6adf6caf8,TCGA-EA-A3HR-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EA-A3HR-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_1_rg.sorted,TCGA-EA-A3HR-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_1_rg.sorted.bam,47.83,NA,0.16,58cfa831e4b0c9d6adf6caf8,TCGA-EA-A3HR-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EA-A3HR-01A,638035F6-2909-4A44-980F-468AC5D74E18,Primary Tumor,Illumina HiSeq,a2c5a51a-5933-4597-b207-2c761c54f7c2,Cervix,57,1FBFA952-F272-4531-9F9D-1B8BD1DD0845,2B1D8BBD-0F37-40D4-AF38-C78C4BB556BB,TCGA-EA-A3HR-01A-11D-A20X-26,HG19_Broad_variant,TCGA-EA-A3HR,TCGA-CESC,NA,s1179,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T2a,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6ceec,58cfa832e4b0c9d6adf6ceec,TCGA-FS-A1ZD-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_6_rg.sorted.filtered.,WGS,TCGA-FS-A1ZD-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_6_rg.sorted,TCGA-FS-A1ZD-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_6_rg.sorted.bam,45.56,NA,0.16,58cfa832e4b0c9d6adf6ceec,TCGA-FS-A1ZD-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZD-10A,C2948FE9-5798-43BC-A743-511E94E417F8,Blood Derived Normal,Illumina HiSeq,701956ba-1fb7-423e-a1b1-a5d7bf040bdf,Skin,63,D502A3A3-2BD2-49FE-92B7-5DF2826B53E9,6D0B52E3-2420-42A8-A655-B60579DB056D,TCGA-FS-A1ZD-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZD,TCGA-SKCM,1628,s8027,Harvard Medical School,Essen,Germany,NO,T2b,N0,Not available,Stage IIA
13722.58cfa832e4b0c9d6adf6d281,58cfa832e4b0c9d6adf6d281,TCGA-HT-7601-10A-01D-2088_130910_SN208_0494_AC2A1DACXX_s_1_rg.sorted.filtered.,WGS,TCGA-HT-7601-10A-01D-2088_130910_SN208_0494_AC2A1DACXX_s_1_rg.sorted,TCGA-HT-7601-10A-01D-2088_130910_SN208_0494_AC2A1DACXX_s_1_rg.sorted.bam,67.3,NA,0.14,58cfa832e4b0c9d6adf6d281,TCGA-HT-7601-10A-01D-2088_130910_SN208_0494_AC2A1DACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7601-10A,E7FDF164-A85D-4FF5-9676-D2215CA35403,Blood Derived Normal,Illumina HiSeq,94873a5a-9d98-4c3a-8ea2-528afa271e07,Brain,30,6D717D58-096B-4E45-B0B0-A0069B72028D,7E20EB67-B215-4519-96A6-6233B9E5AE9F,TCGA-HT-7601-10A-01D-2088-02,HG19_Broad_variant,TCGA-HT-7601,TCGA-LGG,NA,s8371,Harvard Medical School,Case Western - St Joes,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa832e4b0c9d6adf6d56c,58cfa832e4b0c9d6adf6d56c,TCGA-V4-A9EY-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_2_rg.sorted.filtered.,WGS,TCGA-V4-A9EY-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_2_rg.sorted,TCGA-V4-A9EY-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_2_rg.sorted.bam,24.77,NA,0.16,58cfa832e4b0c9d6adf6d56c,TCGA-V4-A9EY-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EY-01A,15D19CCC-52B8-41F6-B1C1-2CC55691AED5,Primary Tumor,Illumina HiSeq,27c8b2d4-9133-49cb-a86b-84553dcf1c8e,Eye,66,E8C4DEFB-7781-4B3D-B209-7D444A1A1BB5,FDFEA8DC-451B-4493-B7ED-DBF97D7C1D78,TCGA-V4-A9EY-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9EY,TCGA-UVM,NA,s218,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa830e4b0c9d6adf6be7c,58cfa830e4b0c9d6adf6be7c,TCGA-BJ-A3PU-10A-01D-A221_120530_SN1222_0111_BD12L1ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BJ-A3PU-10A-01D-A221_120530_SN1222_0111_BD12L1ACXX_s_7_rg.sorted,TCGA-BJ-A3PU-10A-01D-A221_120530_SN1222_0111_BD12L1ACXX_s_7_rg.sorted.bam,25.77,NA,0.14,58cfa830e4b0c9d6adf6be7c,TCGA-BJ-A3PU-10A-01D-A221_120530_SN1222_0111_BD12L1ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A3PU-10A,4CCCC34B-DAF6-41CA-9BF8-F1614525EAC9,Blood Derived Normal,Illumina HiSeq,f697a039-96a4-4336-a1d2-ea747b114ada,Thyroid,52,0F717E35-9DD7-4F18-9061-0984256642EC,33745454-C21E-44D6-B119-87B31BFB1977,TCGA-BJ-A3PU-10A-01D-A221-26,HG19_Broad_variant,TCGA-BJ-A3PU,TCGA-THCA,NA,s11989,MD Anderson - Institute for Applied Cancer Science,University of Pittsburgh,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa831e4b0c9d6adf6cb34,58cfa831e4b0c9d6adf6cb34,TCGA-EE-A29D-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EE-A29D-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_2_rg.sorted,TCGA-EE-A29D-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_2_rg.sorted.bam,48.84,NA,0.18,58cfa831e4b0c9d6adf6cb34,TCGA-EE-A29D-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29D-10A,EF608754-3F87-458E-9BCF-4434C54C8C9E,Blood Derived Normal,Illumina HiSeq,1b436706-8b80-4fb0-bf1c-1375bfc4d0f1,Skin,87,66039C7A-457B-4BB7-96BB-36B094817E77,CCB9460E-97C4-481F-AD9F-103BDF67F2AF,TCGA-EE-A29D-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A29D,TCGA-SKCM,425,s7334,Harvard Medical School,University of Sydney,Australia,NO,T3b,N1b,Not available,Stage IIIC
13722.58cfa830e4b0c9d6adf6c23c,58cfa830e4b0c9d6adf6c23c,TCGA-BT-A2LB-01A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BT-A2LB-01A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_6_rg.sorted,TCGA-BT-A2LB-01A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_6_rg.sorted.bam,51.24,NA,0.18,58cfa830e4b0c9d6adf6c23c,TCGA-BT-A2LB-01A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A2LB-01A,D17A5AB1-3789-4652-AFF5-D8F4F2291F9C,Primary Tumor,Illumina HiSeq,de67212f-594e-409c-bd19-3d40f013b89a,Bladder,73,7C6178A6-6D4C-4DEF-B4AC-A064AB4A6C8A,FAD087E0-3752-4144-960B-659B59312C92,TCGA-BT-A2LB-01A-11D-A18D-02,HG19_Broad_variant,TCGA-BT-A2LB,TCGA-BLCA,NA,s3087,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c83a,58cfa831e4b0c9d6adf6c83a,TCGA-D3-A3C8-06A-12D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-D3-A3C8-06A-12D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_5_rg.sorted,TCGA-D3-A3C8-06A-12D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_5_rg.sorted.bam,72.53,NA,0.15,58cfa831e4b0c9d6adf6c83a,TCGA-D3-A3C8-06A-12D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A3C8-06A,16182443-12A1-4B0F-A6AB-33C2942E2991,Metastatic,Illumina HiSeq,21d12df1-c29f-4e93-86da-c2c511ada473,Skin,58,D0ECA475-4A80-42EB-BC91-4159699CDFBA,F088E04C-D72E-43E4-ACBF-BBF455866244,TCGA-D3-A3C8-06A-12D-A18Z-02,HG19_Broad_variant,TCGA-D3-A3C8,TCGA-SKCM,NA,s7498,Harvard Medical School,MD Anderson,United States,NO,TX,N3,Not available,Stage IIIC
13722.58cfa832e4b0c9d6adf6ce90,58cfa832e4b0c9d6adf6ce90,TCGA-FY-A3RA-10A-01D-A221_120611_SN1222_0114_AC0WL3ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FY-A3RA-10A-01D-A221_120611_SN1222_0114_AC0WL3ACXX_s_5_rg.sorted,TCGA-FY-A3RA-10A-01D-A221_120611_SN1222_0114_AC0WL3ACXX_s_5_rg.sorted.bam,64.67,NA,0.15,58cfa832e4b0c9d6adf6ce90,TCGA-FY-A3RA-10A-01D-A221_120611_SN1222_0114_AC0WL3ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FY-A3RA-10A,58FF4366-20A3-40A2-A87A-551E17CDB5D3,Blood Derived Normal,Illumina HiSeq,bea33252-fb79-434d-bb8a-9f82457e5ea9,Thyroid,21,C40FB837-4CF9-4AAC-9AD5-24CFFA1B0428,1425910E-CA62-469A-88A9-DCB1214073FF,TCGA-FY-A3RA-10A-01D-A221-26,HG19_Broad_variant,TCGA-FY-A3RA,TCGA-THCA,NA,s12120,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T2,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6cf9c,58cfa832e4b0c9d6adf6cf9c,TCGA-GC-A3RD-10B-01D-A233_120905_SN1120_0187_AD1E4NACXX_s_8_rg.sorted.filtered.,WGS,TCGA-GC-A3RD-10B-01D-A233_120905_SN1120_0187_AD1E4NACXX_s_8_rg.sorted,TCGA-GC-A3RD-10B-01D-A233_120905_SN1120_0187_AD1E4NACXX_s_8_rg.sorted.bam,64.89,NA,0.15,58cfa832e4b0c9d6adf6cf9c,TCGA-GC-A3RD-10B-01D-A233_120905_SN1120_0187_AD1E4NACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GC-A3RD-10B,6A2155B3-915C-41B1-B730-32E55E0C1FBD,Blood Derived Normal,Illumina HiSeq,b81dceea-a960-49fc-9cfc-00d61570a8b0,Bladder,83,623992FA-E316-4AEF-9B0E-6C7EAA5121A5,E5267C53-6EEA-47F5-A7E2-EC228507E6E1,TCGA-GC-A3RD-10B-01D-A233-26,HG19_Broad_variant,TCGA-GC-A3RD,TCGA-BLCA,NA,s2728,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa830e4b0c9d6adf6c248,58cfa830e4b0c9d6adf6c248,TCGA-BT-A2LA-11A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BT-A2LA-11A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_4_rg.sorted,TCGA-BT-A2LA-11A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_4_rg.sorted.bam,9.14,NA,0.16,58cfa830e4b0c9d6adf6c248,TCGA-BT-A2LA-11A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A2LA-11A,797A71EE-372D-41E5-AEEE-5AB3C4661110,Solid Tissue Normal,Illumina HiSeq,ee7f989e-a375-4956-a120-aab1394e350f,Bladder,54,F12723EF-51A8-4071-B612-B47A14C2B459,BA6BC788-FE48-412B-B303-B45370501109,TCGA-BT-A2LA-11A-11D-A18D-02,HG19_Broad_variant,TCGA-BT-A2LA,TCGA-BLCA,NA,s2866,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c5fe,58cfa831e4b0c9d6adf6c5fe,TCGA-CQ-5330-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CQ-5330-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_8_rg.sorted,TCGA-CQ-5330-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_8_rg.sorted.bam,55.7,1.9,0.14,58cfa831e4b0c9d6adf6c5fe,TCGA-CQ-5330-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-5330-10A,9FFA79FA-D2D8-48E1-8FD6-4B020ECF357C,Blood Derived Normal,Illumina HiSeq,583ffff7-e647-470a-ac1d-3d6bab206e8a,Head and Neck,69,B3D8B1A6-DCC5-434F-B17A-BCC2D1D9CA2D,3BF2FBFA-2B1F-423B-9FB5-84C16EF882DE,TCGA-CQ-5330-10A-01D-1681-02,HG19_Broad_variant,TCGA-CQ-5330,TCGA-HNSC,NA,s15773,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6cf3d,58cfa832e4b0c9d6adf6cf3d,TCGA-G9-6378-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_3_rg.sorted.filtered.,WGS,TCGA-G9-6378-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_3_rg.sorted,TCGA-G9-6378-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_3_rg.sorted.bam,245.4,1.9,0.13,58cfa832e4b0c9d6adf6cf3d,TCGA-G9-6378-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_3_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6378-01A,12F225D0-CBFF-44EB-9183-BACC7F33B090,Primary Tumor,Illumina HiSeq,cc75d8b4-ea9f-4b89-9c12-d370ba7a227f,Prostate,54,940BBB5C-7280-41ED-9332-47C2072AE072,CA3B6408-29B5-4DB1-A56D-7B47F966177D,TCGA-G9-6378-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6378,TCGA-PRAD,NA,s3801,Harvard Medical School,Roswell Park,United States,NO,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6caa6,58cfa831e4b0c9d6adf6caa6,TCGA-D3-A1Q9-06A-11D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D3-A1Q9-06A-11D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_3_rg.sorted,TCGA-D3-A1Q9-06A-11D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_3_rg.sorted.bam,41.58,NA,0.17,58cfa831e4b0c9d6adf6caa6,TCGA-D3-A1Q9-06A-11D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A1Q9-06A,798074D3-0B84-4DD5-AA88-91FEDA9AC8C6,Metastatic,Illumina HiSeq,08f6a8cd-257b-49ce-8dcb-a0c8de2d345c,Skin,72,F5AA07C1-3302-4B54-A791-007714139901,7EF9AAEF-51C2-424E-A14C-C2C35942EE22,TCGA-D3-A1Q9-06A-11D-A18Z-02,HG19_Broad_variant,TCGA-D3-A1Q9,TCGA-SKCM,961,s7322,Harvard Medical School,MD Anderson,United States,NO,T4b,N2a,Not available,Stage IIIB
13722.58cfa830e4b0c9d6adf6bf1f,58cfa830e4b0c9d6adf6bf1f,TCGA-BR-4191-11A-01D-1128_120805_SN1222_0143_BD172BACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BR-4191-11A-01D-1128_120805_SN1222_0143_BD172BACXX_s_6_rg.sorted,TCGA-BR-4191-11A-01D-1128_120805_SN1222_0143_BD172BACXX_s_6_rg.sorted.bam,193.3,1.9,0.14,58cfa830e4b0c9d6adf6bf1f,TCGA-BR-4191-11A-01D-1128_120805_SN1222_0143_BD172BACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4191-11A,74F859CF-6DF5-4E96-AE6B-CFAAB691D5FD,Solid Tissue Normal,Illumina HiSeq,78b2b7ff-d302-4923-bfa4-f8d169667d90,Stomach,72,B69926B2-1C04-4F98-935E-2F9F9849504B,6E50ABE2-9B55-471A-A75E-62B119882476,TCGA-BR-4191-11A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4191,TCGA-STAD,NA,s14687,Harvard Medical School,Asterand,Russia,NO,TX,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa832e4b0c9d6adf6ce2c,58cfa832e4b0c9d6adf6ce2c,TCGA-ER-A19T-10A-01D-A18Z_120520_SN590_0158_AC0J99ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-ER-A19T-10A-01D-A18Z_120520_SN590_0158_AC0J99ACXX_s_8_rg.sorted,TCGA-ER-A19T-10A-01D-A18Z_120520_SN590_0158_AC0J99ACXX_s_8_rg.sorted.bam,23.88,NA,0.18,58cfa832e4b0c9d6adf6ce2c,TCGA-ER-A19T-10A-01D-A18Z_120520_SN590_0158_AC0J99ACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19T-10A,B85B14D7-3B5A-4800-AF12-622EC03B9FE5,Blood Derived Normal,Illumina HiSeq,40fd8b7e-4227-45f0-8438-9eeb0c2ba2b2,Skin,51,C070D019-1F19-43D0-8B34-A46DC4C8790E,69B15A85-AF40-4FDA-AF0A-E71FBBDFA7B6,TCGA-ER-A19T-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-ER-A19T,TCGA-SKCM,270,s7359,Harvard Medical School,University of Pittsburgh,United States,NO,T4a,N3,Not available,Stage IV
13722.58cfa830e4b0c9d6adf6bda8,58cfa830e4b0c9d6adf6bda8,TCGA-BF-A1Q0-01A-21D-A18Z_120520_SN590_0158_AC0J99ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BF-A1Q0-01A-21D-A18Z_120520_SN590_0158_AC0J99ACXX_s_5_rg.sorted,TCGA-BF-A1Q0-01A-21D-A18Z_120520_SN590_0158_AC0J99ACXX_s_5_rg.sorted.bam,66.95,NA,0.16,58cfa830e4b0c9d6adf6bda8,TCGA-BF-A1Q0-01A-21D-A18Z_120520_SN590_0158_AC0J99ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-BF-A1Q0-01A,633DDC04-C424-42C8-8E54-673968B130A7,Primary Tumor,Illumina HiSeq,44801af7-d042-441d-afc9-4c0d7b493b01,Skin,80,B68CFB6B-4249-4855-8278-B18C0F561EFD,C94F7E24-8073-4786-BFC0-C45A37D85B2F,TCGA-BF-A1Q0-01A-21D-A18Z-02,HG19_Broad_variant,TCGA-BF-A1Q0,TCGA-SKCM,NA,s7320,Harvard Medical School,Cureline,Russia,NO,T4b,N0,Not available,Stage IIC
13722.58cfa832e4b0c9d6adf6cfaf,58cfa832e4b0c9d6adf6cfaf,TCGA-GC-A3BM-10A-01D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_4_rg.sorted.filtered.,WGS,TCGA-GC-A3BM-10A-01D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_4_rg.sorted,TCGA-GC-A3BM-10A-01D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_4_rg.sorted.bam,29.57,NA,0.16,58cfa832e4b0c9d6adf6cfaf,TCGA-GC-A3BM-10A-01D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GC-A3BM-10A,7840AEA9-40C4-473E-BE33-8FA0B9F332C9,Blood Derived Normal,Illumina HiSeq,1701d500-8ca9-4b1b-87a0-fccb8808328e,Bladder,70,9090938A-4845-482F-8CD3-C74B9DEE11D1,6CF9CAE6-FB82-4A94-B37C-B03F213D509D,TCGA-GC-A3BM-10A-01D-A23Q-26,HG19_Broad_variant,TCGA-GC-A3BM,TCGA-BLCA,NA,s3127,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c96a,58cfa831e4b0c9d6adf6c96a,TCGA-DJ-A1QI-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DJ-A1QI-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_5_rg.sorted,TCGA-DJ-A1QI-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_5_rg.sorted.bam,97.61,1.98,0.17,58cfa831e4b0c9d6adf6c96a,TCGA-DJ-A1QI-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QI-01A,3B1E2BD6-3D32-40F7-9B32-0DF32DFCBC72,Primary Tumor,Illumina HiSeq,e0052e53-2d8c-45ba-8d2c-db4eab61a141,Thyroid,63,C58506A1-8C6B-4CE8-99E0-F2D1234F95F5,3C049586-BD3C-490D-93DB-E344BD6A1AE8,TCGA-DJ-A1QI-01A-11D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QI,TCGA-THCA,NA,s12641,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage II
13722.58cfa831e4b0c9d6adf6c4a4,58cfa831e4b0c9d6adf6c4a4,TCGA-CF-A1HR-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CF-A1HR-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_3_rg.sorted,TCGA-CF-A1HR-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_3_rg.sorted.bam,37.6,2,0.16,58cfa831e4b0c9d6adf6c4a4,TCGA-CF-A1HR-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_3_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CF-A1HR-01A,39EA19E1-4959-4F1B-9934-54BDAF766842,Primary Tumor,Illumina HiSeq,65dee943-f41b-4f59-a5bb-2477053d1079,Bladder,62,6E77AB45-9C53-4A74-9581-043005C3E685,B048E28D-38FC-4E37-9C54-9C56526AD0E3,TCGA-CF-A1HR-01A-11D-A13U-02,HG19_Broad_variant,TCGA-CF-A1HR,TCGA-BLCA,NA,s2872,Harvard Medical School,ILSbio,Vietnam,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6d1b0,58cfa832e4b0c9d6adf6d1b0,TCGA-FG-6689-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FG-6689-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_4_rg.sorted,TCGA-FG-6689-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_4_rg.sorted.bam,111,1.9,0.15,58cfa832e4b0c9d6adf6d1b0,TCGA-FG-6689-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-6689-10A,8D07B1E8-5D1D-4A43-B616-D29DD58CE5FE,Blood Derived Normal,Illumina HiSeq,08b74256-79b2-4fe1-81c5-28cc122988ca,Brain,30,BAD0094C-DE01-4419-9ADB-5E8EF0A4D397,983E8501-88CE-42E5-8C99-752182F14D81,TCGA-FG-6689-10A-01D-1891-02,HG19_Broad_variant,TCGA-FG-6689,TCGA-LGG,NA,s8147,Harvard Medical School,Case Western,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa82ee4b0c9d6adf6af8c,58cfa82ee4b0c9d6adf6af8c,TCGA-05-4249-10A-01D-1103_110804_SN208_0217_BC03EKABXX_s_1_rg.sorted.filtered.,WGS,TCGA-05-4249-10A-01D-1103_110804_SN208_0217_BC03EKABXX_s_1_rg.sorted,TCGA-05-4249-10A-01D-1103_110804_SN208_0217_BC03EKABXX_s_1_rg.sorted.bam,36.63,1.9,0.16,58cfa82ee4b0c9d6adf6af8c,TCGA-05-4249-10A-01D-1103_110804_SN208_0217_BC03EKABXX_s_1_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4249-10A,4ADDF05F-3668-4B3F-A17F-C0227329CA52,Blood Derived Normal,Illumina HiSeq,61a4cbac-f493-484b-bbd9-4a2745d89f22,Lung,67,6E8AF3CE-3987-44F1-BF4C-E52F68039567,E6DEFCC8-1E9D-46ED-B8BA-B8C62B21A5B5,TCGA-05-4249-10A-01D-1103-02,HG19_Broad_variant,TCGA-05-4249,TCGA-LUAD,NA,s11439,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa830e4b0c9d6adf6c1fc,58cfa830e4b0c9d6adf6c1fc,TCGA-BG-A0M2-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BG-A0M2-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_7_rg.sorted,TCGA-BG-A0M2-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_7_rg.sorted.bam,63.57,1.97,0.15,58cfa830e4b0c9d6adf6c1fc,TCGA-BG-A0M2-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0M2-01A,9731E0B3-C62D-43CB-8AE7-8F973D69AB19,Primary Tumor,Illumina HiSeq,9dcd7360-a8dc-49cb-bf13-8fb36c436e30,Uterus,62,2AF18345-2A71-4574-AC8E-83DDEED3AD57,E59EB8B5-DA68-44B3-BB18-8C42F583B2BA,TCGA-BG-A0M2-01A-11D-A101-02,HG19_Broad_variant,TCGA-BG-A0M2,TCGA-UCEC,NA,s4604,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cc7c,58cfa831e4b0c9d6adf6cc7c,TCGA-EM-A1CU-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EM-A1CU-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_3_rg.sorted,TCGA-EM-A1CU-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_3_rg.sorted.bam,50.69,1.91,0.18,58cfa831e4b0c9d6adf6cc7c,TCGA-EM-A1CU-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_3_rg.sorted.bam,Alive,MALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1CU-01A,4E80F403-0E10-4725-854D-F023C12EE1E2,Primary Tumor,Illumina HiSeq,a03be55f-c2fb-41d6-88ae-f1063ed587f6,Thyroid,31,C285C3AC-26D7-4481-BAAF-769F49AED55A,A9886789-6859-4FC9-812A-D9813FD1C20D,TCGA-EM-A1CU-01A-11D-A13U-02,HG19_Broad_variant,TCGA-EM-A1CU,TCGA-THCA,NA,s12379,Harvard Medical School,University Health Network,Canada,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6cf8a,58cfa832e4b0c9d6adf6cf8a,TCGA-FS-A1ZY-06A-11D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_6_rg.sorted.filtered.,WGS,TCGA-FS-A1ZY-06A-11D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_6_rg.sorted,TCGA-FS-A1ZY-06A-11D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_6_rg.sorted.bam,53.49,NA,0.15,58cfa832e4b0c9d6adf6cf8a,TCGA-FS-A1ZY-06A-11D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZY-06A,A3DF4BA6-538E-4B53-A356-EB1EF743B2AB,Metastatic,Illumina HiSeq,aa1f701f-1d30-46f6-a60c-0d519147d690,Skin,71,483D87A4-7427-4BE0-83C2-32807C2D3A59,AB390594-05F0-4B2F-AD4D-CD680F6CB7FB,TCGA-FS-A1ZY-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZY,TCGA-SKCM,824,s7702,Harvard Medical School,Essen,Germany,NO,T3b,N0,Not available,Stage IIB
13722.58cfa82fe4b0c9d6adf6b5f4,58cfa82fe4b0c9d6adf6b5f4,TCGA-44-6146-11A-01D-1751_110927_SN208_0243_BC00TKACXX_s_5_rg.sorted.filtered.,WGS,TCGA-44-6146-11A-01D-1751_110927_SN208_0243_BC00TKACXX_s_5_rg.sorted,TCGA-44-6146-11A-01D-1751_110927_SN208_0243_BC00TKACXX_s_5_rg.sorted.bam,59.4,1.9,0.16,58cfa82fe4b0c9d6adf6b5f4,TCGA-44-6146-11A-01D-1751_110927_SN208_0243_BC00TKACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-6146-11A,0C0B610E-FE4C-406D-A5ED-5CC3B11DABF5,Solid Tissue Normal,Illumina HiSeq,f7ee8faa-879c-4d5c-ac00-24452fb7fe3f,Lung,64,DED52BAC-FEDF-43E0-BE97-E261A84383AD,03A2138C-B699-47D1-A5EB-161399020946,TCGA-44-6146-11A-01D-1751-02,HG19_Broad_variant,TCGA-44-6146,TCGA-LUAD,NA,s11228,Harvard Medical School,Christiana Healthcare,United States,NO,T3,N0,Lung Mucinous Adenocarcinoma,Stage IIB
13722.58cfa831e4b0c9d6adf6c4ce,58cfa831e4b0c9d6adf6c4ce,TCGA-BR-4363-11A-01D-1154_130815_VM001_0001_VMR0001CXX_s_8_rg.sorted.filtered.,WGS,TCGA-BR-4363-11A-01D-1154_130815_VM001_0001_VMR0001CXX_s_8_rg.sorted,TCGA-BR-4363-11A-01D-1154_130815_VM001_0001_VMR0001CXX_s_8_rg.sorted.bam,193.3,1.9,0.14,58cfa831e4b0c9d6adf6c4ce,TCGA-BR-4363-11A-01D-1154_130815_VM001_0001_VMR0001CXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4363-11A,66BCA2F8-F269-454D-ABE2-CE51A0704645,Solid Tissue Normal,Illumina HiSeq,06da121c-66ee-44be-8a1c-58e736f82e55,Stomach,60,12B616D2-B101-4B61-9285-121AA7D6C11F,3A3723C2-50D2-4F01-95C8-6298E1FD303E,TCGA-BR-4363-11A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4363,TCGA-STAD,NA,s14815,Harvard Medical School,Asterand,Russia,NO,T3,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa82fe4b0c9d6adf6b955,58cfa82fe4b0c9d6adf6b955,TCGA-A5-A0GN-10A-01D-A043_120324_SN1120_0127_BC0L80ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-A5-A0GN-10A-01D-A043_120324_SN1120_0127_BC0L80ACXX_s_4_rg.sorted,TCGA-A5-A0GN-10A-01D-A043_120324_SN1120_0127_BC0L80ACXX_s_4_rg.sorted.bam,19.14,1.86,0.16,58cfa82fe4b0c9d6adf6b955,TCGA-A5-A0GN-10A-01D-A043_120324_SN1120_0127_BC0L80ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GN-10A,A2A2DBDA-D10C-49C4-86A8-61BAF6160CDA,Blood Derived Normal,Illumina HiSeq,1c07f20d-3b72-45ca-8708-cd4d625736d2,Uterus,65,31CA1860-C5E6-43CB-AB4D-E9A0F5A6D605,97FEC691-A406-45EC-BC0F-61D1F1439D74,TCGA-A5-A0GN-10A-01D-A043-02,HG19_Broad_variant,TCGA-A5-A0GN,TCGA-UCEC,NA,s4772,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cc31,58cfa831e4b0c9d6adf6cc31,TCGA-DU-7008-10A-01D-2022_130910_SN208_0495_BD2FGNACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DU-7008-10A-01D-2022_130910_SN208_0495_BD2FGNACXX_s_2_rg.sorted,TCGA-DU-7008-10A-01D-2022_130910_SN208_0495_BD2FGNACXX_s_2_rg.sorted.bam,61,NA,0.15,58cfa831e4b0c9d6adf6cc31,TCGA-DU-7008-10A-01D-2022_130910_SN208_0495_BD2FGNACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7008-10A,427C40F6-D1BD-49F2-B303-A975793B937E,Blood Derived Normal,Illumina HiSeq,259728ba-b3fd-4001-a0d5-cef1d22b2ff2,Brain,41,64EA52EB-A005-4D05-BBA1-536F0D76A890,580B19BF-F779-4B08-A79B-21367B9E0F4B,TCGA-DU-7008-10A-01D-2022-02,HG19_Broad_variant,TCGA-DU-7008,TCGA-LGG,NA,s8364,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6cd3c,58cfa831e4b0c9d6adf6cd3c,TCGA-ET-A25M-01A-11D-A16N_120718_SN590_0170_BD141RACXX_s_6_rg.sorted.filtered.,WGS,TCGA-ET-A25M-01A-11D-A16N_120718_SN590_0170_BD141RACXX_s_6_rg.sorted,TCGA-ET-A25M-01A-11D-A16N_120718_SN590_0170_BD141RACXX_s_6_rg.sorted.bam,54.33,1.96,0.17,58cfa831e4b0c9d6adf6cd3c,TCGA-ET-A25M-01A-11D-A16N_120718_SN590_0170_BD141RACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-ET-A25M-01A,8023D4C9-B56D-417A-9A52-D45B59C756ED,Primary Tumor,Illumina HiSeq,893b646b-2fc5-4163-905e-37bfeb036280,Thyroid,33,0C601625-ED21-47E5-BC3D-A0057D6A148F,7DE80DCB-BBFD-4D87-AD80-EE29258EFFD1,TCGA-ET-A25M-01A-11D-A16N-02,HG19_Broad_variant,TCGA-ET-A25M,TCGA-THCA,NA,s12002,Harvard Medical School,Johns Hopkins,United States,NO,T2,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6cdab,58cfa831e4b0c9d6adf6cdab,TCGA-FE-A234-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FE-A234-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_2_rg.sorted,TCGA-FE-A234-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_2_rg.sorted.bam,101.34,2.14,0.18,58cfa831e4b0c9d6adf6cdab,TCGA-FE-A234-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A234-01A,E4C85BDD-7B7C-414F-9503-647D9B825915,Primary Tumor,Illumina HiSeq,f1eeb2ea-cc97-40b1-ac5b-fa027012fff2,Thyroid,26,8765B072-83E1-40B2-B1C9-15F38D799FC3,D4A41A96-02D5-455E-BB12-7225EBEA15A5,TCGA-FE-A234-01A-11D-A14U-02,HG19_Broad_variant,TCGA-FE-A234,TCGA-THCA,NA,s12388,Harvard Medical School,Ohio State University,United States,NO,T2,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6cf2e,58cfa832e4b0c9d6adf6cf2e,TCGA-G9-6362-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_4_rg.sorted.filtered.,WGS,TCGA-G9-6362-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_4_rg.sorted,TCGA-G9-6362-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_4_rg.sorted.bam,23.7,1.8,0.14,58cfa832e4b0c9d6adf6cf2e,TCGA-G9-6362-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6362-10A,F228EF91-ECFB-4D1E-8E6A-B43D2185270E,Blood Derived Normal,Illumina HiSeq,a86b9f92-8f31-484f-9706-b320c5f42cfd,Prostate,57,1A7B59F4-CD3A-4FAD-BACA-A948676498CC,4F214276-0F7B-4ED4-B0EB-FC69C1A89514,TCGA-G9-6362-10A-01D-1784-02,HG19_Broad_variant,TCGA-G9-6362,TCGA-PRAD,NA,s3617,Harvard Medical School,Roswell Park,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c7d2,58cfa831e4b0c9d6adf6c7d2,TCGA-CV-6951-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CV-6951-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_4_rg.sorted,TCGA-CV-6951-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_4_rg.sorted.bam,99.7,1.9,0.14,58cfa831e4b0c9d6adf6c7d2,TCGA-CV-6951-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6951-11A,91728CD6-ED91-49DC-9279-FAEDBE211A9D,Solid Tissue Normal,Illumina HiSeq,a087903d-fb41-4d87-9500-6b62de815139,Head and Neck,57,E5D22220-4951-42F5-80E5-4510AC3E99C2,73E856AD-F850-4433-AF90-1D7EF628FBB8,TCGA-CV-6951-11A-01D-1911-02,HG19_Broad_variant,TCGA-CV-6951,TCGA-HNSC,915,s15907,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T4a,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c753,58cfa831e4b0c9d6adf6c753,TCGA-D3-A2JC-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-D3-A2JC-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_8_rg.sorted,TCGA-D3-A2JC-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_8_rg.sorted.bam,25.03,NA,0.15,58cfa831e4b0c9d6adf6c753,TCGA-D3-A2JC-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A2JC-10A,DB239624-3DBA-48BB-9889-F479DC2BA046,Blood Derived Normal,Illumina HiSeq,cfb3a5aa-61a3-4974-b482-8860495c3f56,Skin,53,02B48BFC-E122-4E01-8DB6-B979C5A21AB6,E21E67AD-2A45-4833-8DA8-C2D467D5412A,TCGA-D3-A2JC-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-D3-A2JC,TCGA-SKCM,NA,s7495,Harvard Medical School,MD Anderson,United States,NO,T0,N2b,Not available,Stage III
13722.58cfa82fe4b0c9d6adf6b6aa,58cfa82fe4b0c9d6adf6b6aa,TCGA-44-6774-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-44-6774-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_7_rg.sorted,TCGA-44-6774-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_7_rg.sorted.bam,62.7,1.9,0.17,58cfa82fe4b0c9d6adf6b6aa,TCGA-44-6774-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-6774-01A,33C71EAD-4C2A-476D-85EF-885DBBFC2CBD,Primary Tumor,Illumina HiSeq,5ff8e7e5-3b91-49af-b384-9d870bd9e425,Lung,56,79CF84B5-84FF-42E5-B438-697B35D272FC,6B977266-994D-4440-BC09-59FD8737F2D0,TCGA-44-6774-01A-21D-1853-02,HG19_Broad_variant,TCGA-44-6774,TCGA-LUAD,NA,s10996,Harvard Medical School,Christiana Healthcare,United States,NO,T1,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6cc9c,58cfa831e4b0c9d6adf6cc9c,TCGA-FD-A3SM-01A-11D-A233_120830_SN208_0423_AC190AACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FD-A3SM-01A-11D-A233_120830_SN208_0423_AC190AACXX_s_5_rg.sorted,TCGA-FD-A3SM-01A-11D-A233_120830_SN208_0423_AC190AACXX_s_5_rg.sorted.bam,22.6,NA,0.16,58cfa831e4b0c9d6adf6cc9c,TCGA-FD-A3SM-01A-11D-A233_120830_SN208_0423_AC190AACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3SM-01A,474582F2-8DEC-4FBC-803F-4FD9BA2E0957,Primary Tumor,Illumina HiSeq,bacf3136-6605-4a66-a869-8d91e4003a0d,Bladder,70,5F7DE481-C011-43A8-844B-F47569499F0D,AF7DFCCA-999E-4EA2-A14B-1E923C2ECE38,TCGA-FD-A3SM-01A-11D-A233-26,HG19_Broad_variant,TCGA-FD-A3SM,TCGA-BLCA,NA,s3299,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T3a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa830e4b0c9d6adf6c2da,58cfa830e4b0c9d6adf6c2da,TCGA-BR-4370-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_1_rg.sorted.filtered.,WGS,TCGA-BR-4370-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_1_rg.sorted,TCGA-BR-4370-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_1_rg.sorted.bam,179.2,1.9,0.15,58cfa830e4b0c9d6adf6c2da,TCGA-BR-4370-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4370-01A,A2A71CB0-9DBD-45CC-8867-DA84500515E7,Primary Tumor,Illumina HiSeq,a1feb789-c851-4608-a5c1-382bb432c4c7,Stomach,74,CFB7901B-E4E1-42FE-802D-DCD34F8C4912,B27FAC46-97C3-4262-B8CB-6E15AA75483A,TCGA-BR-4370-01A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4370,TCGA-STAD,NA,s14883,Harvard Medical School,Asterand,Russia,NO,TX,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa830e4b0c9d6adf6bf85,58cfa830e4b0c9d6adf6bf85,TCGA-BR-6456-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BR-6456-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_2_rg.sorted,TCGA-BR-6456-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_2_rg.sorted.bam,66,1.9,0.14,58cfa830e4b0c9d6adf6bf85,TCGA-BR-6456-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6456-10A,1CA3C5E0-32B0-4467-8EC0-CA212E35D2B3,Blood Derived Normal,Illumina HiSeq,4fcd3184-8cb8-4097-8550-b9905d13adb4,Stomach,74,3A8917B9-B3FC-4221-AB95-84927E1DEC28,602267D7-4BCC-4F1A-9F65-6102235DAEB0,TCGA-BR-6456-10A-01D-1798-02,HG19_Broad_variant,TCGA-BR-6456,TCGA-STAD,NA,s15379,Harvard Medical School,Asterand,Russia,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB
13722.58cfa830e4b0c9d6adf6c044,58cfa830e4b0c9d6adf6c044,TCGA-AG-3893-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3893-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3893-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,551.89,1.9,0.15,58cfa830e4b0c9d6adf6c044,TCGA-AG-3893-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3893-01A,ADD567B7-29EF-4122-8A54-57D36F735E78,Primary Tumor,Illumina HiSeq,d98305fc-80c0-4336-b35c-0c47d8c297b8,Colorectal,74,7E16AFE9-DA05-451B-BD8C-86D75C8E475C,5815181B-A53B-4AAF-9817-168AC41DAD2A,TCGA-AG-3893-01A-01D-1115-02,HG18,TCGA-AG-3893,TCGA-READ,NA,s2152,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIB
13722.58cfa831e4b0c9d6adf6c929,58cfa831e4b0c9d6adf6c929,TCGA-DK-A3X1-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DK-A3X1-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_2_rg.sorted,TCGA-DK-A3X1-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_2_rg.sorted.bam,24.19,NA,0.14,58cfa831e4b0c9d6adf6c929,TCGA-DK-A3X1-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3X1-10A,6BDDAFDE-7004-49B6-80CF-8081CD4B7D44,Blood Derived Normal,Illumina HiSeq,a711317a-7fc9-4637-968e-842d8b6afc22,Bladder,78,C261CDF0-D8C6-49A6-948D-54621ACEB07E,DC958F8E-1A58-4C77-B54A-7A89B2BFE6C4,TCGA-DK-A3X1-10A-01D-A233-26,HG19_Broad_variant,TCGA-DK-A3X1,TCGA-BLCA,NA,s3284,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa830e4b0c9d6adf6bdc2,58cfa830e4b0c9d6adf6bdc2,TCGA-BG-A0RY-10A-02D-A101_120409_SN1222_0096_BD0VA2ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BG-A0RY-10A-02D-A101_120409_SN1222_0096_BD0VA2ACXX_s_8_rg.sorted,TCGA-BG-A0RY-10A-02D-A101_120409_SN1222_0096_BD0VA2ACXX_s_8_rg.sorted.bam,8.16,2.15,0.17,58cfa830e4b0c9d6adf6bdc2,TCGA-BG-A0RY-10A-02D-A101_120409_SN1222_0096_BD0VA2ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0RY-10A,F299AD43-BB16-46CE-9617-48CC6C6F29E7,Blood Derived Normal,Illumina HiSeq,b0821143-56d7-444a-af2f-dafc2980c4d6,Uterus,68,6F9655B3-797D-4CD0-9E22-99C1D20C7938,BBD003F7-A80A-4F04-AC85-B023C527922C,TCGA-BG-A0RY-10A-02D-A101-02,HG19_Broad_variant,TCGA-BG-A0RY,TCGA-UCEC,NA,s5212,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bf21,58cfa830e4b0c9d6adf6bf21,TCGA-BR-4279-01A-01D-1128_121127_SN208_0441_BC1F8CACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BR-4279-01A-01D-1128_121127_SN208_0441_BC1F8CACXX_s_1_rg.sorted,TCGA-BR-4279-01A-01D-1128_121127_SN208_0441_BC1F8CACXX_s_1_rg.sorted.bam,7.9,1.9,0.16,58cfa830e4b0c9d6adf6bf21,TCGA-BR-4279-01A-01D-1128_121127_SN208_0441_BC1F8CACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4279-01A,117EB38B-0C62-4336-A866-FA5BD013256A,Primary Tumor,Illumina HiSeq,0fa8a7d6-6636-4135-82f6-21c9df279b16,Stomach,43,84AD647D-76B8-4EDA-8603-40220089BE34,01DC88B7-45FC-464C-A613-9793CD0C068B,TCGA-BR-4279-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4279,TCGA-STAD,NA,s14814,Harvard Medical School,Asterand,Russia,NO,T2a,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa831e4b0c9d6adf6ca0f,58cfa831e4b0c9d6adf6ca0f,TCGA-DK-A3X2-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DK-A3X2-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_3_rg.sorted,TCGA-DK-A3X2-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_3_rg.sorted.bam,51.32,NA,0.15,58cfa831e4b0c9d6adf6ca0f,TCGA-DK-A3X2-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3X2-01A,40551D53-388B-4067-9341-76E94D023703,Primary Tumor,Illumina HiSeq,a8b7a158-32d0-421e-82bd-edb6a44d69e0,Bladder,85,3B816277-91CB-413E-BC7C-BA33CD72B67D,5D13DEBC-82D6-45EA-A9EA-A85B85CF659F,TCGA-DK-A3X2-01A-11D-A233-26,HG19_Broad_variant,TCGA-DK-A3X2,TCGA-BLCA,547,s2716,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6cb1b,58cfa831e4b0c9d6adf6cb1b,TCGA-DU-7006-10A-01D-2022_130910_SN208_0494_AC2A1DACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DU-7006-10A-01D-2022_130910_SN208_0494_AC2A1DACXX_s_6_rg.sorted,TCGA-DU-7006-10A-01D-2022_130910_SN208_0494_AC2A1DACXX_s_6_rg.sorted.bam,73,NA,0.16,58cfa831e4b0c9d6adf6cb1b,TCGA-DU-7006-10A-01D-2022_130910_SN208_0494_AC2A1DACXX_s_6_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7006-10A,215E117C-4D76-463C-8F8A-FD6A28D23929,Blood Derived Normal,Illumina HiSeq,7d7ca01f-5584-4e12-a544-5ffb6d2cdc3f,Brain,60,24717D65-D851-4101-A942-18C112C35A7A,E4871FA8-7D51-4AEF-8027-B0F212931DFA,TCGA-DU-7006-10A-01D-2022-02,HG19_Broad_variant,TCGA-DU-7006,TCGA-LGG,349,s8756,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa82fe4b0c9d6adf6b790,58cfa82fe4b0c9d6adf6b790,TCGA-44-6146-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_3_rg.sorted.filtered.,WGS,TCGA-44-6146-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_3_rg.sorted,TCGA-44-6146-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_3_rg.sorted.bam,72,1.9,0.16,58cfa82fe4b0c9d6adf6b790,TCGA-44-6146-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-6146-01A,0C0B610E-FE4C-406D-A5ED-5CC3B11DABF5,Primary Tumor,Illumina HiSeq,99148000-be38-4da1-aeaa-4b0271725662,Lung,64,AD66185F-983D-4416-B705-25D3D4D8B5A5,2D5C6425-E3F4-4389-9DDF-FDE694B4227E,TCGA-44-6146-01A-11D-1751-02,HG19_Broad_variant,TCGA-44-6146,TCGA-LUAD,NA,s11337,Harvard Medical School,Christiana Healthcare,United States,NO,T3,N0,Lung Mucinous Adenocarcinoma,Stage IIB
13722.58cfa832e4b0c9d6adf6d4dc,58cfa832e4b0c9d6adf6d4dc,TCGA-VD-A8KN-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-VD-A8KN-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_8_rg.sorted,TCGA-VD-A8KN-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_8_rg.sorted.bam,23.55,NA,0.15,58cfa832e4b0c9d6adf6d4dc,TCGA-VD-A8KN-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_8_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KN-01A,B26CB5F2-4FF0-4476-8D02-7256ACE7D8A3,Primary Tumor,Illumina HiSeq,48635af7-70bf-40ad-8bc3-2acb2a60ab81,Eye,60,3DD23C74-0B1D-40F4-8E8E-A5032CC7C87D,CBCBD0D3-2964-4D54-9872-0442D37D9D04,TCGA-VD-A8KN-01A-11D-A40D-26,HG19_Broad_variant,TCGA-VD-A8KN,TCGA-UVM,NA,s258,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T2a,NX,Not available,Stage IIA
13722.58cfa830e4b0c9d6adf6bc8c,58cfa830e4b0c9d6adf6bc8c,TCGA-AG-3896-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3896-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3896-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,913.89,1.9,0.15,58cfa830e4b0c9d6adf6bc8c,TCGA-AG-3896-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3896-01A,9AF35239-FFB9-4D4F-889E-F743DA271EEF,Primary Tumor,Illumina HiSeq,5666993b-483e-4cb2-ac08-c5f26b31b9cd,Colorectal,85,03B40342-3CCE-4A45-B2EC-8855AEB85100,D33D46C5-F3FD-4FD5-9CE2-06839BF33A37,TCGA-AG-3896-01A-01D-1115-02,HG18,TCGA-AG-3896,TCGA-READ,NA,s1988,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa832e4b0c9d6adf6cf90,58cfa832e4b0c9d6adf6cf90,TCGA-G9-6348-10A-01D-1784_130115_SN590_0208_BD1TAGACXX_s_8_rg.sorted.filtered.,WGS,TCGA-G9-6348-10A-01D-1784_130115_SN590_0208_BD1TAGACXX_s_8_rg.sorted,TCGA-G9-6348-10A-01D-1784_130115_SN590_0208_BD1TAGACXX_s_8_rg.sorted.bam,33.7,1.8,0.13,58cfa832e4b0c9d6adf6cf90,TCGA-G9-6348-10A-01D-1784_130115_SN590_0208_BD1TAGACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6348-10A,8AD78C4F-C84C-4F9E-88C9-42A05EB65498,Blood Derived Normal,Illumina HiSeq,4c26631b-a745-412f-890f-793dd4b04e14,Prostate,68,0E5F2922-DEE4-4048-ADFA-E9BAEB9120E4,B79A7DF4-6CB9-4885-8CA8-7341500BDC76,TCGA-G9-6348-10A-01D-1784-02,HG19_Broad_variant,TCGA-G9-6348,TCGA-PRAD,NA,s3610,Harvard Medical School,Roswell Park,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82fe4b0c9d6adf6b635,58cfa82fe4b0c9d6adf6b635,TCGA-44-2661-10A-01D-1103_110804_SN208_0217_BC03EKABXX_s_6_rg.sorted.filtered.,WGS,TCGA-44-2661-10A-01D-1103_110804_SN208_0217_BC03EKABXX_s_6_rg.sorted,TCGA-44-2661-10A-01D-1103_110804_SN208_0217_BC03EKABXX_s_6_rg.sorted.bam,454.63,1.9,0.14,58cfa82fe4b0c9d6adf6b635,TCGA-44-2661-10A-01D-1103_110804_SN208_0217_BC03EKABXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-2661-10A,F3501466-CF32-4866-B5FB-E94DD32341BC,Blood Derived Normal,Illumina HiSeq,d921a1d0-fc6b-4140-adea-0274147e2026,Lung,69,5464840F-763F-45AC-892C-C7A11E7969EB,7EC94B2F-ECF5-407A-9D70-6C158288F30A,TCGA-44-2661-10A-01D-1103-02,HG19_Broad_variant,TCGA-44-2661,TCGA-LUAD,NA,s11117,Harvard Medical School,Christiana Healthcare,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa830e4b0c9d6adf6c01e,58cfa830e4b0c9d6adf6c01e,TCGA-BJ-A0Z2-01A-11D-A10R_120711_SN208_0414_BD13L5ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BJ-A0Z2-01A-11D-A10R_120711_SN208_0414_BD13L5ACXX_s_1_rg.sorted,TCGA-BJ-A0Z2-01A-11D-A10R_120711_SN208_0414_BD13L5ACXX_s_1_rg.sorted.bam,89.84,1.92,0.14,58cfa830e4b0c9d6adf6c01e,TCGA-BJ-A0Z2-01A-11D-A10R_120711_SN208_0414_BD13L5ACXX_s_1_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0Z2-01A,F9CEFFC0-D544-418D-B4A9-BD3C84E37026,Primary Tumor,Illumina HiSeq,9493c81d-440a-4066-975b-c6265b7641a6,Thyroid,57,B06B7493-F38A-493F-8B47-61E0FA4D111F,D8B6F131-76CA-45D3-8934-A6CDEA8153AD,TCGA-BJ-A0Z2-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0Z2,TCGA-THCA,NA,s12353,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage IVC
13722.58cfa82fe4b0c9d6adf6b98a,58cfa82fe4b0c9d6adf6b98a,TCGA-A5-A0GW-10A-01D-A043_120301_SN590_0142_AD0LPVACXX_s_6_rg.sorted.filtered.,WGS,TCGA-A5-A0GW-10A-01D-A043_120301_SN590_0142_AD0LPVACXX_s_6_rg.sorted,TCGA-A5-A0GW-10A-01D-A043_120301_SN590_0142_AD0LPVACXX_s_6_rg.sorted.bam,18.14,2.16,0.13,58cfa82fe4b0c9d6adf6b98a,TCGA-A5-A0GW-10A-01D-A043_120301_SN590_0142_AD0LPVACXX_s_6_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GW-10A,5B6B9D0F-787C-4AE9-AFD4-DE7CE6C57A42,Blood Derived Normal,Illumina HiSeq,3077e8e1-511d-46c3-8240-c6c80f64d770,Uterus,46,7AE1717D-A559-42CB-8197-47F279B612F1,843EA109-EF2F-48C5-A955-2420D9B7F00E,TCGA-A5-A0GW-10A-01D-A043-02,HG19_Broad_variant,TCGA-A5-A0GW,TCGA-UCEC,NA,s4775,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c5ea,58cfa831e4b0c9d6adf6c5ea,TCGA-CG-4437-10A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CG-4437-10A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_5_rg.sorted,TCGA-CG-4437-10A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_5_rg.sorted.bam,9,1.9,0.14,58cfa831e4b0c9d6adf6c5ea,TCGA-CG-4437-10A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_5_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4437-10A,6244E506-D163-4D34-8FEC-6158191679CB,Blood Derived Normal,Illumina HiSeq,a6985d3e-05da-443e-9b5e-7098618981c5,Stomach,83,A03A5DAB-F43F-4A95-8560-FA1D2A613D92,C49F85DE-B830-44D8-A89A-8857899F0CD3,TCGA-CG-4437-10A-01D-1798-02,HG19_Broad_variant,TCGA-CG-4437,TCGA-STAD,NA,s14410,Harvard Medical School,Indivumed,Germany,NO,T2,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa832e4b0c9d6adf6cfb2,58cfa832e4b0c9d6adf6cfb2,TCGA-FS-A1ZW-06A-12D-A18Y_120602_SN1120_0147_BD13TBACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FS-A1ZW-06A-12D-A18Y_120602_SN1120_0147_BD13TBACXX_s_1_rg.sorted,TCGA-FS-A1ZW-06A-12D-A18Y_120602_SN1120_0147_BD13TBACXX_s_1_rg.sorted.bam,58.48,NA,0.16,58cfa832e4b0c9d6adf6cfb2,TCGA-FS-A1ZW-06A-12D-A18Y_120602_SN1120_0147_BD13TBACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZW-06A,49A6F6A6-BF6F-45CF-93DC-B006B4A0637D,Metastatic,Illumina HiSeq,5e95e70e-4afd-41fb-87d9-eaf4198223e9,Skin,65,7E7CA145-7979-4105-AEAC-0417C6052AAF,F96DD387-37CA-4EDE-9851-4EB769271D76,TCGA-FS-A1ZW-06A-12D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZW,TCGA-SKCM,NA,s8029,Harvard Medical School,Essen,Germany,NO,T2b,N1a,Not available,Stage IIIB
13722.58cfa82fe4b0c9d6adf6b716,58cfa82fe4b0c9d6adf6b716,TCGA-73-4662-11A-01D-1203_110629_SN208_0211_AB0BP8ABXX_s_6_rg.sorted.filtered.,WGS,TCGA-73-4662-11A-01D-1203_110629_SN208_0211_AB0BP8ABXX_s_6_rg.sorted,TCGA-73-4662-11A-01D-1203_110629_SN208_0211_AB0BP8ABXX_s_6_rg.sorted.bam,648.3,1.9,0.15,58cfa82fe4b0c9d6adf6b716,TCGA-73-4662-11A-01D-1203_110629_SN208_0211_AB0BP8ABXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4662-11A,294FF941-AEA1-4588-9A0E-E9F5393E2BB6,Solid Tissue Normal,Illumina HiSeq,2018de7f-d9e8-4e7f-8459-9794814494b5,Lung,65,D4E6A949-F60C-4B76-8810-A778180F9139,998F30CD-957A-4E93-87A8-BED043774480,TCGA-73-4662-11A-01D-1203-02,HG19_Broad_variant,TCGA-73-4662,TCGA-LUAD,NA,s11245,Harvard Medical School,Roswell Park,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6c57e,58cfa831e4b0c9d6adf6c57e,TCGA-CN-4729-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CN-4729-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_3_rg.sorted,TCGA-CN-4729-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_3_rg.sorted.bam,99.7,1.9,0.15,58cfa831e4b0c9d6adf6c57e,TCGA-CN-4729-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4729-01A,2FC960BD-01B0-422D-AD33-34520FA3DF0E,Primary Tumor,Illumina HiSeq,8b48a937-18eb-4e54-95d1-680ce9284b60,Head and Neck,73,1DA8FE25-AEE2-45FD-A1F3-3239A42E54B2,A49670C2-95A6-4DEB-BFC5-59B0FF37389E,TCGA-CN-4729-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4729,TCGA-HNSC,NA,s15620,Harvard Medical School,University of Pittsburgh,None,NO,T2,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6cc3e,58cfa831e4b0c9d6adf6cc3e,TCGA-EM-A3FR-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EM-A3FR-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_6_rg.sorted,TCGA-EM-A3FR-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_6_rg.sorted.bam,45.93,NA,0.15,58cfa831e4b0c9d6adf6cc3e,TCGA-EM-A3FR-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_6_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3FR-01A,2B84CFBC-7CF6-4CB1-A1E3-BA85DAFB89F4,Primary Tumor,Illumina HiSeq,0430ed44-5b5d-4b22-b78a-9b9ecd259736,Thyroid,55,319E3498-D5FB-4142-A09F-ABA779DBC094,FEA6D565-EDBC-4FB7-ADB8-090914F4259E,TCGA-EM-A3FR-01A-11D-A221-26,HG19_Broad_variant,TCGA-EM-A3FR,TCGA-THCA,NA,s12247,MD Anderson - Institute for Applied Cancer Science,University Health Network,Canada,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa832e4b0c9d6adf6d1de,58cfa832e4b0c9d6adf6d1de,TCGA-HR-A2OG-10A-01D-A190_120602_SN1120_0146_AC0WLVACXX_s_4_rg.sorted.filtered.,WGS,TCGA-HR-A2OG-10A-01D-A190_120602_SN1120_0146_AC0WLVACXX_s_4_rg.sorted,TCGA-HR-A2OG-10A-01D-A190_120602_SN1120_0146_AC0WLVACXX_s_4_rg.sorted.bam,52.33,NA,0.18,58cfa832e4b0c9d6adf6d1de,TCGA-HR-A2OG-10A-01D-A190_120602_SN1120_0146_AC0WLVACXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Skin Cutaneous Melanoma,Aligned reads,TCGA-HR-A2OG-10A,021D32B0-A94A-4DAD-95F4-8EB0ABD894BF,Blood Derived Normal,Illumina HiSeq,e5c8850f-c39d-4383-8ab4-a1c8872882da,Skin,50,A06A0BBF-D4D2-4705-828D-100ED335E812,65C5FDD8-86E3-4ACA-9DFB-46CDF39E49BC,TCGA-HR-A2OG-10A-01D-A190-02,HG19_Broad_variant,TCGA-HR-A2OG,TCGA-SKCM,NA,s7542,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,Not available,Not available,Not available,Not available
13722.58cfa831e4b0c9d6adf6c4f6,58cfa831e4b0c9d6adf6c4f6,TCGA-CG-5730-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CG-5730-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_1_rg.sorted,TCGA-CG-5730-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_1_rg.sorted.bam,326.3,1.9,0.15,58cfa831e4b0c9d6adf6c4f6,TCGA-CG-5730-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_1_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5730-01A,09587F1C-5C99-4102-BC49-84D50FA8D0CE,Primary Tumor,Illumina HiSeq,61f3e14a-530d-43c8-a795-a6aef7d031e4,Stomach,80,2986F11F-3C18-4621-8406-D46614537ED4,9E9AC3CA-F6EC-497E-938D-F6FEA03CC75C,TCGA-CG-5730-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5730,TCGA-STAD,NA,s14765,Harvard Medical School,Indivumed,Germany,NO,T2,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa832e4b0c9d6adf6ce38,58cfa832e4b0c9d6adf6ce38,TCGA-ER-A2NC-10A-01D-A190_120718_SN208_0415_AC116EACXX_s_6_rg.sorted.filtered.,WGS,TCGA-ER-A2NC-10A-01D-A190_120718_SN208_0415_AC116EACXX_s_6_rg.sorted,TCGA-ER-A2NC-10A-01D-A190_120718_SN208_0415_AC116EACXX_s_6_rg.sorted.bam,18.45,NA,0.18,58cfa832e4b0c9d6adf6ce38,TCGA-ER-A2NC-10A-01D-A190_120718_SN208_0415_AC116EACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A2NC-10A,B9607824-A8D3-4915-AB73-962CDCFD8DC3,Blood Derived Normal,Illumina HiSeq,d8753ce7-f69f-4ba8-8838-f059baaaf786,Skin,50,C1263982-3881-4D2D-AF77-D238E78A1417,238F6B9D-5469-4510-8FAD-6C83D7652DFE,TCGA-ER-A2NC-10A-01D-A190-02,HG19_Broad_variant,TCGA-ER-A2NC,TCGA-SKCM,1333,s7357,Harvard Medical School,University of Pittsburgh,United States,NO,T2a,N0,Not available,Stage IB
13722.58cfa832e4b0c9d6adf6d3f8,58cfa832e4b0c9d6adf6d3f8,TCGA-V4-A9EK-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_8_rg.sorted.filtered.,WGS,TCGA-V4-A9EK-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_8_rg.sorted,TCGA-V4-A9EK-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_8_rg.sorted.bam,14.71,NA,0.15,58cfa832e4b0c9d6adf6d3f8,TCGA-V4-A9EK-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EK-10A,4464418C-EC35-4826-B3D5-152AC2A27A04,Blood Derived Normal,Illumina HiSeq,15b18072-acb9-4966-8fe3-4443bb420700,Eye,37,08A866B3-FA9C-47B1-AD86-276BEA2B63FD,50AE90FA-2A06-4F7A-952D-631A766060E1,TCGA-V4-A9EK-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9EK,TCGA-UVM,NA,s242,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3a,N0,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6cc8a,58cfa831e4b0c9d6adf6cc8a,TCGA-EM-A3OA-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EM-A3OA-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_8_rg.sorted,TCGA-EM-A3OA-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_8_rg.sorted.bam,45.54,NA,0.16,58cfa831e4b0c9d6adf6cc8a,TCGA-EM-A3OA-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_8_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3OA-10A,24CF6397-60EF-4635-81F0-78A67157AAC0,Blood Derived Normal,Illumina HiSeq,3c187948-81e7-47b3-9daa-642120425827,Thyroid,55,CC8519D3-1D5A-4895-A850-E6C7662EDA6D,94813927-BC9D-4638-9424-BCB3053A87B8,TCGA-EM-A3OA-10A-01D-A221-26,HG19_Broad_variant,TCGA-EM-A3OA,TCGA-THCA,NA,s12755,MD Anderson - Institute for Applied Cancer Science,University Health Network,Canada,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa831e4b0c9d6adf6cce4,58cfa831e4b0c9d6adf6cce4,TCGA-EL-A3T6-11A-11D-A221_120523_SN1222_0108_AC0VL4ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EL-A3T6-11A-11D-A221_120523_SN1222_0108_AC0VL4ACXX_s_8_rg.sorted,TCGA-EL-A3T6-11A-11D-A221_120523_SN1222_0108_AC0VL4ACXX_s_8_rg.sorted.bam,38.3,NA,0.15,58cfa831e4b0c9d6adf6cce4,TCGA-EL-A3T6-11A-11D-A221_120523_SN1222_0108_AC0VL4ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EL-A3T6-11A,90507BAA-B716-4BCF-A18E-9D8AE97D809A,Solid Tissue Normal,Illumina HiSeq,6ede869a-f207-46f9-9580-687f5e7cf183,Thyroid,34,77038D13-DE93-4357-9DDA-AF1A3E2C02A9,0577F77E-6C99-4AA4-B037-08722EB22BFA,TCGA-EL-A3T6-11A-11D-A221-26,HG19_Broad_variant,TCGA-EL-A3T6,TCGA-THCA,NA,s12246,MD Anderson - Institute for Applied Cancer Science,MD Anderson,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6cdce,58cfa831e4b0c9d6adf6cdce,TCGA-FI-A2CY-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FI-A2CY-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_2_rg.sorted,TCGA-FI-A2CY-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_2_rg.sorted.bam,82.11,NA,0.16,58cfa831e4b0c9d6adf6cdce,TCGA-FI-A2CY-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_2_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-FI-A2CY-10A,B9AB4AB9-BA9C-4A01-9F61-55C82B924936,Blood Derived Normal,Illumina HiSeq,77b11597-ba2d-483b-b654-69ed9c5924d2,Uterus,60,B09A76E3-73B7-4192-B3DD-E37C42C8D271,A1CABC1F-6CD8-48F6-80FC-0D153932CF6E,TCGA-FI-A2CY-10A-01D-A17E-02,HG19_Broad_variant,TCGA-FI-A2CY,TCGA-UCEC,NA,s5231,Harvard Medical School,Washington University,United States,NO,Not available,Not available,Mixed serous and endometrioid,Not available
13722.58cfa82fe4b0c9d6adf6b70a,58cfa82fe4b0c9d6adf6b70a,TCGA-67-6216-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_1.rg.sorted.filtered.,WGS,TCGA-67-6216-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_1.rg.sorted,TCGA-67-6216-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_1.rg.sorted.bam,355.4,1.9,0.14,58cfa82fe4b0c9d6adf6b70a,TCGA-67-6216-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_1.rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-67-6216-01A,CCECCE70-DD54-4C5B-BF9F-CA87D290CB00,Primary Tumor,Illumina HiSeq,ae4aaef1-8b47-476b-933a-ff69761aa0a9,Lung,57,4EAA4B4A-E9DB-4E65-97D6-7FA1A205DA95,1003F495-01FE-47ED-A717-B8769F0FA3A3,TCGA-67-6216-01A-11D-1751-02,HG19_Broad_variant,TCGA-67-6216,TCGA-LUAD,NA,s11242,Harvard Medical School,St Joseph's Medical Center (MD),United States,NO,T1a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82fe4b0c9d6adf6b7ac,58cfa82fe4b0c9d6adf6b7ac,TCGA-35-4123-10A-01D-1103_110804_SN208_0217_BC03EKABXX_s_4_rg.sorted.filtered.,WGS,TCGA-35-4123-10A-01D-1103_110804_SN208_0217_BC03EKABXX_s_4_rg.sorted,TCGA-35-4123-10A-01D-1103_110804_SN208_0217_BC03EKABXX_s_4_rg.sorted.bam,256.63,1.9,0.16,58cfa82fe4b0c9d6adf6b7ac,TCGA-35-4123-10A-01D-1103_110804_SN208_0217_BC03EKABXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-35-4123-10A,6CF49CF0-DE4C-4C90-8358-EAE19C6206B0,Blood Derived Normal,Illumina HiSeq,49076069-b689-4bbd-984c-7718df09a20e,Lung,38,1BBB46B1-7CEA-49F8-AAA9-C7E7994BB9F3,0F2760D3-4015-4E5E-AFD8-0325AE5A7D9A,TCGA-35-4123-10A-01D-1103-02,HG19_Broad_variant,TCGA-35-4123,TCGA-LUAD,NA,s10648,Harvard Medical School,Cureline,Russia,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6c3f4,58cfa831e4b0c9d6adf6c3f4,TCGA-C5-A3HF-10A-01D-A20X_140117_SN590_0246_BC37BDACXX_s_4_rg.sorted.filtered.,WGS,TCGA-C5-A3HF-10A-01D-A20X_140117_SN590_0246_BC37BDACXX_s_4_rg.sorted,TCGA-C5-A3HF-10A-01D-A20X_140117_SN590_0246_BC37BDACXX_s_4_rg.sorted.bam,14.16,NA,0.15,58cfa831e4b0c9d6adf6c3f4,TCGA-C5-A3HF-10A-01D-A20X_140117_SN590_0246_BC37BDACXX_s_4_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A3HF-10A,085DF27C-9BC2-425A-9A49-547D692EA028,Blood Derived Normal,Illumina HiSeq,19a65231-8bdc-43c7-81ed-e92f884b6c03,Cervix,24,8EF5E6DB-2FBD-4D96-846E-7708C085E72C,04632A90-4508-464B-8BE3-DB0E1646F3F8,TCGA-C5-A3HF-10A-01D-A20X-26,HG19_Broad_variant,TCGA-C5-A3HF,TCGA-CESC,543,s1178,MD Anderson - Institute for Applied Cancer Science,Medical College of Wisconsin,United States,NO,Not available,Not available,Mucinous Adenocarcinoma of Endocervical Type,Not available
13722.58cfa832e4b0c9d6adf6d0da,58cfa832e4b0c9d6adf6d0da,TCGA-FS-A1ZE-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FS-A1ZE-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_1_rg.sorted,TCGA-FS-A1ZE-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_1_rg.sorted.bam,65.82,NA,0.17,58cfa832e4b0c9d6adf6d0da,TCGA-FS-A1ZE-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZE-06A,2C79ADD1-8093-4E81-8F80-069AF7B7C2FA,Metastatic,Illumina HiSeq,7e15422f-a494-44e1-a671-0b2ec886c3e2,Skin,40,A6FF4B8A-BCD0-4925-9638-AA4DA7388BED,387CCD51-0985-414E-B10B-ABAA3FB068D6,TCGA-FS-A1ZE-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZE,TCGA-SKCM,NA,s7532,Harvard Medical School,Essen,Germany,NO,T4b,N0,Not available,Stage IIC
13722.58cfa831e4b0c9d6adf6c64e,58cfa831e4b0c9d6adf6c64e,TCGA-CN-4741-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CN-4741-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_6_rg.sorted,TCGA-CN-4741-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_6_rg.sorted.bam,215.7,1.9,0.14,58cfa831e4b0c9d6adf6c64e,TCGA-CN-4741-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4741-01A,277B02E9-DED5-4980-845D-AF53690000AC,Primary Tumor,Illumina HiSeq,cd19ee2f-be9d-446a-9045-e7bfcafb49aa,Head and Neck,75,03C9108A-5139-4BAC-9641-C7DBBEDEF420,FAA30C0B-E008-4313-A2AB-1D641F98E2B9,TCGA-CN-4741-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4741,TCGA-HNSC,NA,s15760,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82fe4b0c9d6adf6b5e6,58cfa82fe4b0c9d6adf6b5e6,TCGA-50-5935-11A-01D-1751_110928_SN590_0108_BB01CWACXX_s_1_rg.sorted.filtered.,WGS,TCGA-50-5935-11A-01D-1751_110928_SN590_0108_BB01CWACXX_s_1_rg.sorted,TCGA-50-5935-11A-01D-1751_110928_SN590_0108_BB01CWACXX_s_1_rg.sorted.bam,32.4,2.1,0.13,58cfa82fe4b0c9d6adf6b5e6,TCGA-50-5935-11A-01D-1751_110928_SN590_0108_BB01CWACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5935-11A,100430C8-1446-45C8-AF36-B6DBB3DDD0C1,Solid Tissue Normal,Illumina HiSeq,32fab0c6-8503-4996-a31a-4968a251eaa8,Lung,86,7D689C5F-365D-4E69-8AE6-971D96D56DF1,AD1E6112-B2F8-4871-BE0E-D073956C4A21,TCGA-50-5935-11A-01D-1751-02,HG19_Broad_variant,TCGA-50-5935,TCGA-LUAD,653,s11238,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa832e4b0c9d6adf6d16a,58cfa832e4b0c9d6adf6d16a,TCGA-K4-A3WS-10A-01D-A23Q_120927_SN208_0432_AC188LACXX_s_2_rg.sorted.filtered.,WGS,TCGA-K4-A3WS-10A-01D-A23Q_120927_SN208_0432_AC188LACXX_s_2_rg.sorted,TCGA-K4-A3WS-10A-01D-A23Q_120927_SN208_0432_AC188LACXX_s_2_rg.sorted.bam,52.54,NA,0.16,58cfa832e4b0c9d6adf6d16a,TCGA-K4-A3WS-10A-01D-A23Q_120927_SN208_0432_AC188LACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-K4-A3WS-10A,68ADACD1-A16E-4489-9E68-792A6BD8811C,Blood Derived Normal,Illumina HiSeq,c3da67a4-50f4-4eb4-999c-b861247e86ee,Bladder,66,ED18EE2C-9A9A-4C03-9A0A-03EDA70A233F,BB450A24-0C76-442C-B06D-3D1A54405B2A,TCGA-K4-A3WS-10A-01D-A23Q-26,HG19_Broad_variant,TCGA-K4-A3WS,TCGA-BLCA,NA,s3130,MD Anderson - Institute for Applied Cancer Science,ABS - Lahey Clinic,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82fe4b0c9d6adf6b760,58cfa82fe4b0c9d6adf6b760,TCGA-75-5122-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_1_rg.sorted.filtered.,WGS,TCGA-75-5122-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_1_rg.sorted,TCGA-75-5122-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_1_rg.sorted.bam,466.4,1.9,0.15,58cfa82fe4b0c9d6adf6b760,TCGA-75-5122-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_1_rg.sorted.bam,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-5122-01A,78AE716B-0CA5-4C01-A053-D41288385FCD,Primary Tumor,Illumina HiSeq,611aeb0f-3dbe-41c6-8b8e-b4a7c827ac1d,Lung,NA,DD9C2F71-145A-4F7F-8B64-095B1FC75C3D,4ADD8465-F06A-4752-8B9F-A6F790F727B1,TCGA-75-5122-01A-01D-1751-02,HG19_Broad_variant,TCGA-75-5122,TCGA-LUAD,NA,s11249,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c83e,58cfa831e4b0c9d6adf6c83e,TCGA-D3-A1Q9-10A-01D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D3-A1Q9-10A-01D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_4_rg.sorted,TCGA-D3-A1Q9-10A-01D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_4_rg.sorted.bam,16.46,NA,0.16,58cfa831e4b0c9d6adf6c83e,TCGA-D3-A1Q9-10A-01D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A1Q9-10A,798074D3-0B84-4DD5-AA88-91FEDA9AC8C6,Blood Derived Normal,Illumina HiSeq,9bdfcf04-e0e9-42e7-b757-5b5e6020d85a,Skin,72,8AAB08F4-76AD-4862-B09D-BAF412BBBB6A,9F418C93-5A97-41D5-B69F-EB581C967390,TCGA-D3-A1Q9-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-D3-A1Q9,TCGA-SKCM,961,s7494,Harvard Medical School,MD Anderson,United States,NO,T4b,N2a,Not available,Stage IIIB
13722.58cfa832e4b0c9d6adf6d1b7,58cfa832e4b0c9d6adf6d1b7,TCGA-HI-7169-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-HI-7169-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_4_rg.sorted,TCGA-HI-7169-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_4_rg.sorted.bam,162,NA,0.14,58cfa832e4b0c9d6adf6d1b7,TCGA-HI-7169-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HI-7169-10A,11FB5853-8EEB-4AD8-825D-3EAAF3FA08D6,Blood Derived Normal,Illumina HiSeq,a13e9b9b-1033-4ccd-8d15-9040610834b3,Prostate,55,BC487EB7-6A06-467B-9D26-DE09895879D8,3884E13B-ACA5-4878-84F6-7C19DF94BA80,TCGA-HI-7169-10A-01D-2111-02,HG19_Broad_variant,TCGA-HI-7169,TCGA-PRAD,NA,s3462,Harvard Medical School,Fox Chase,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bada,58cfa830e4b0c9d6adf6bada,TCGA-49-6745-01A-11D-1853_111218_SN208_0258_C054RACXX_s_7_rg.sorted.filtered.,WGS,TCGA-49-6745-01A-11D-1853_111218_SN208_0258_C054RACXX_s_7_rg.sorted,TCGA-49-6745-01A-11D-1853_111218_SN208_0258_C054RACXX_s_7_rg.sorted.bam,88.7,1.9,0.15,58cfa830e4b0c9d6adf6bada,TCGA-49-6745-01A-11D-1853_111218_SN208_0258_C054RACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-49-6745-01A,9C7875AD-AB71-4D48-B2E3-E4C7A46393E9,Primary Tumor,Illumina HiSeq,b4eee7d7-a56c-4927-929e-ac66abe41408,Lung,82,357F3EFE-E2C9-432A-A2B6-75A5FDBAE3BE,A88D69EF-BE3C-4341-AD6C-0F035685862F,TCGA-49-6745-01A-11D-1853-02,HG19_Broad_variant,TCGA-49-6745,TCGA-LUAD,NA,s11451,Harvard Medical School,Johns Hopkins,United States,NO,T2a,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82fe4b0c9d6adf6b6a6,58cfa82fe4b0c9d6adf6b6a6,TCGA-44-6145-10A-01D-1751_110927_SN208_0243_BC00TKACXX_s_1_rg.sorted.filtered.,WGS,TCGA-44-6145-10A-01D-1751_110927_SN208_0243_BC00TKACXX_s_1_rg.sorted,TCGA-44-6145-10A-01D-1751_110927_SN208_0243_BC00TKACXX_s_1_rg.sorted.bam,305.7,1.8,0.16,58cfa82fe4b0c9d6adf6b6a6,TCGA-44-6145-10A-01D-1751_110927_SN208_0243_BC00TKACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-6145-10A,6144D666-8F77-4EFE-95F1-F9E5C4E5E056,Blood Derived Normal,Illumina HiSeq,b21d12d5-2762-46b6-bd9c-d2f3579c9779,Lung,62,FDD20655-0DB6-4ABB-BEC4-451BD3E5389E,04AD8606-F9CC-4067-821C-BB964D10F1B3,TCGA-44-6145-10A-01D-1751-02,HG19_Broad_variant,TCGA-44-6145,TCGA-LUAD,NA,s10649,Harvard Medical School,Christiana Healthcare,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa830e4b0c9d6adf6c29a,58cfa830e4b0c9d6adf6c29a,TCGA-B5-A0JR-01A-13D-A043_120403_SN1222_0094_BD0UKBACXX_s_6_rg.sorted.filtered.,WGS,TCGA-B5-A0JR-01A-13D-A043_120403_SN1222_0094_BD0UKBACXX_s_6_rg.sorted,TCGA-B5-A0JR-01A-13D-A043_120403_SN1222_0094_BD0UKBACXX_s_6_rg.sorted.bam,91.47,2.12,0.14,58cfa830e4b0c9d6adf6c29a,TCGA-B5-A0JR-01A-13D-A043_120403_SN1222_0094_BD0UKBACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0JR-01A,A766D113-BC3F-4448-A4E5-F391FB0C0E22,Primary Tumor,Illumina HiSeq,1e3ae5a0-6439-4dba-a151-f107d43c65cf,Uterus,73,07381A09-5CBD-4744-86EC-41A81E470204,E4F782AB-1668-4730-95D9-CB28E3CF61FD,TCGA-B5-A0JR-01A-13D-A043-02,HG19_Broad_variant,TCGA-B5-A0JR,TCGA-UCEC,NA,s4786,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d21a,58cfa832e4b0c9d6adf6d21a,TCGA-IR-A3LC-10A-01D-A20X_140117_SN590_0246_BC37BDACXX_s_6_rg.sorted.filtered.,WGS,TCGA-IR-A3LC-10A-01D-A20X_140117_SN590_0246_BC37BDACXX_s_6_rg.sorted,TCGA-IR-A3LC-10A-01D-A20X_140117_SN590_0246_BC37BDACXX_s_6_rg.sorted.bam,18.54,NA,0.16,58cfa832e4b0c9d6adf6d21a,TCGA-IR-A3LC-10A-01D-A20X_140117_SN590_0246_BC37BDACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-IR-A3LC-10A,58BDCACE-0047-456E-A225-68953EDAFE5E,Blood Derived Normal,Illumina HiSeq,52127837-efa1-4fef-8096-506ecc100e1b,Cervix,40,CA909A69-58FA-4EB0-A013-FC6EB99ED794,D09FD998-7F1A-48DA-9C6D-6666714FC7E9,TCGA-IR-A3LC-10A-01D-A20X-26,HG19_Broad_variant,TCGA-IR-A3LC,TCGA-CESC,NA,s1536,MD Anderson - RPPA Core Facility (Proteomics),Memorial Sloan Kettering,United States,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6ca77,58cfa831e4b0c9d6adf6ca77,TCGA-DJ-A13U-10A-01D-A10R_120616_SN1120_0153_AC0WMJACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DJ-A13U-10A-01D-A10R_120616_SN1120_0153_AC0WMJACXX_s_6_rg.sorted,TCGA-DJ-A13U-10A-01D-A10R_120616_SN1120_0153_AC0WMJACXX_s_6_rg.sorted.bam,33.29,1.92,0.15,58cfa831e4b0c9d6adf6ca77,TCGA-DJ-A13U-10A-01D-A10R_120616_SN1120_0153_AC0WMJACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13U-10A,8C5AEF43-341E-4A37-84EB-FD730EB957C7,Blood Derived Normal,Illumina HiSeq,6b567a7f-04e1-4dfb-97cc-0c569f787f04,Thyroid,60,544D494E-88F5-4B2E-8170-CD4595ACD592,D40518AF-D226-45D0-8FD0-56ADB4A4AF25,TCGA-DJ-A13U-10A-01D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13U,TCGA-THCA,NA,s12106,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa82fe4b0c9d6adf6b6af,58cfa82fe4b0c9d6adf6b6af,TCGA-44-6146-10A-01D-1751_110927_SN208_0243_BC00TKACXX_s_4_rg.sorted.filtered.,WGS,TCGA-44-6146-10A-01D-1751_110927_SN208_0243_BC00TKACXX_s_4_rg.sorted,TCGA-44-6146-10A-01D-1751_110927_SN208_0243_BC00TKACXX_s_4_rg.sorted.bam,191,1.9,0.15,58cfa82fe4b0c9d6adf6b6af,TCGA-44-6146-10A-01D-1751_110927_SN208_0243_BC00TKACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-6146-10A,0C0B610E-FE4C-406D-A5ED-5CC3B11DABF5,Blood Derived Normal,Illumina HiSeq,66abe87b-119e-4f15-822b-795e8ec2e60f,Lung,64,2640D6DC-15C7-405F-A348-6751393DEE6D,8D8C3FBF-204B-4A7A-942A-6A6CE2E0470C,TCGA-44-6146-10A-01D-1751-02,HG19_Broad_variant,TCGA-44-6146,TCGA-LUAD,NA,s10992,Harvard Medical School,Christiana Healthcare,United States,NO,T3,N0,Lung Mucinous Adenocarcinoma,Stage IIB
13722.58cfa831e4b0c9d6adf6cab8,58cfa831e4b0c9d6adf6cab8,TCGA-DA-A1HY-06A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DA-A1HY-06A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_1_rg.sorted,TCGA-DA-A1HY-06A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_1_rg.sorted.bam,38.32,NA,0.17,58cfa831e4b0c9d6adf6cab8,TCGA-DA-A1HY-06A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1HY-06A,40E17BF8-6C19-4E5E-B60D-AD54F504A970,Metastatic,Illumina HiSeq,8aae7183-1c94-4dda-a586-c65451a782cb,Skin,42,12590302-AB64-4652-88DD-CBBF5091E1C1,538AFAF8-22F1-4E4D-A83D-5DE08B257EDC,TCGA-DA-A1HY-06A-11D-A18Z-02,HG19_Broad_variant,TCGA-DA-A1HY,TCGA-SKCM,NA,s7674,Harvard Medical School,Yale,United States,NO,T2b,N1,Not available,Stage III
13722.58cfa831e4b0c9d6adf6cc13,58cfa831e4b0c9d6adf6cc13,TCGA-DU-6402-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DU-6402-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_4_rg.sorted,TCGA-DU-6402-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_4_rg.sorted.bam,234.3,1.9,0.15,58cfa831e4b0c9d6adf6cc13,TCGA-DU-6402-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6402-01A,152F028E-EE29-40E0-8E75-5CAFFFACBD45,Primary Tumor,Illumina HiSeq,d556f16a-ad20-42eb-8e92-57114d46e174,Brain,52,0E594B0A-05E4-40C8-80BA-0D4BB08E437D,A60A9995-6A02-4035-9C3E-2FEE0E6E87C5,TCGA-DU-6402-01A-11D-1703-02,HG19_Broad_variant,TCGA-DU-6402,TCGA-LGG,214,s8563,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa832e4b0c9d6adf6d03e,58cfa832e4b0c9d6adf6d03e,TCGA-FS-A1ZT-06A-11D-A18Y_120602_SN1120_0147_BD13TBACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FS-A1ZT-06A-11D-A18Y_120602_SN1120_0147_BD13TBACXX_s_2_rg.sorted,TCGA-FS-A1ZT-06A-11D-A18Y_120602_SN1120_0147_BD13TBACXX_s_2_rg.sorted.bam,56.66,NA,0.15,58cfa832e4b0c9d6adf6d03e,TCGA-FS-A1ZT-06A-11D-A18Y_120602_SN1120_0147_BD13TBACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZT-06A,57882F61-4A32-49F1-AFD4-61C70B184D8B,Metastatic,Illumina HiSeq,0a573a63-c701-4756-9f53-242b32237d44,Skin,55,2812580B-D88A-4141-BC61-92A08C292C5F,89EAE08E-6977-4C47-95DE-354EB7F787E9,TCGA-FS-A1ZT-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZT,TCGA-SKCM,NA,s7533,Harvard Medical School,Essen,Germany,NO,T2,N1b,Not available,Stage III
13722.58cfa832e4b0c9d6adf6d1b4,58cfa832e4b0c9d6adf6d1b4,TCGA-HT-7468-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_6_rg.sorted.filtered.,WGS,TCGA-HT-7468-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_6_rg.sorted,TCGA-HT-7468-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_6_rg.sorted.bam,141,NA,0.13,58cfa832e4b0c9d6adf6d1b4,TCGA-HT-7468-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7468-10A,E6C55BA6-4C8A-4EA4-8DDE-74D01915DB02,Blood Derived Normal,Illumina HiSeq,dd94727e-cce1-407e-99ce-89064229b3e8,Brain,30,F5491D55-E07E-45FE-B0BA-85DCAC4E3BE3,47B970F3-550E-4358-9099-1F74287DC96B,TCGA-HT-7468-10A-01D-2022-02,HG19_Broad_variant,TCGA-HT-7468,TCGA-LGG,NA,s8758,Harvard Medical School,Case Western - St Joes,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6cd52,58cfa831e4b0c9d6adf6cd52,TCGA-ER-A19O-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_6_rg.sorted.filtered.,WGS,TCGA-ER-A19O-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_6_rg.sorted,TCGA-ER-A19O-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_6_rg.sorted.bam,45.99,NA,0.17,58cfa831e4b0c9d6adf6cd52,TCGA-ER-A19O-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19O-10A,69C0EF46-3117-46F3-B36E-581EB03EB829,Blood Derived Normal,Illumina HiSeq,e63520a0-e72d-453b-ac6c-6a1a491fac19,Skin,56,AD02F0ED-FBB4-49AE-9315-7D42D2C5F628,8AC49AAE-2C7C-4426-9FAA-B4652A8D51A8,TCGA-ER-A19O-10A-01D-A190-02,HG19_Broad_variant,TCGA-ER-A19O,TCGA-SKCM,NA,s7695,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N1b,Not available,Stage IIIB
13722.58cfa82fe4b0c9d6adf6b864,58cfa82fe4b0c9d6adf6b864,TCGA-A5-A0GU-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_5_rg.sorted.filtered.,WGS,TCGA-A5-A0GU-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_5_rg.sorted,TCGA-A5-A0GU-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_5_rg.sorted.bam,101.03,2.18,0.17,58cfa82fe4b0c9d6adf6b864,TCGA-A5-A0GU-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GU-01A,ADC22472-E31D-419F-AEAE-CB01B9423343,Primary Tumor,Illumina HiSeq,7666f932-cff3-4ea2-8650-8d4bdae72cac,Uterus,58,074D4466-E072-42CD-9A6C-A595DC9363E7,BB726D7A-6861-48AA-9BFD-5DF8DAAA1538,TCGA-A5-A0GU-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0GU,TCGA-UCEC,NA,s4241,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6cf9f,58cfa832e4b0c9d6adf6cf9f,TCGA-H2-A3RH-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-H2-A3RH-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_2_rg.sorted,TCGA-H2-A3RH-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_2_rg.sorted.bam,62.17,NA,0.15,58cfa832e4b0c9d6adf6cf9f,TCGA-H2-A3RH-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-H2-A3RH-01A,0314B145-2F3A-4A90-A580-375B5F0A63A4,Primary Tumor,Illumina HiSeq,dddfb702-cb09-4a5f-b023-b31d89ec07a8,Thyroid,41,1A9E811D-1C60-409C-A7D2-1D58AFA473E9,8358E269-BD6E-4189-86AB-520C84405DAA,TCGA-H2-A3RH-01A-11D-A221-26,HG19_Broad_variant,TCGA-H2-A3RH,TCGA-THCA,NA,s12532,MD Anderson - Institute for Applied Cancer Science,Christiana Healthcare,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa831e4b0c9d6adf6c640,58cfa831e4b0c9d6adf6c640,TCGA-CG-4466-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CG-4466-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_1_rg.sorted,TCGA-CG-4466-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_1_rg.sorted.bam,143.3,1.9,0.14,58cfa831e4b0c9d6adf6c640,TCGA-CG-4466-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_1_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4466-01A,2F1B96B2-7031-4F7D-9490-14728D320F3E,Primary Tumor,Illumina HiSeq,a8cb52d3-64c6-4fca-a59c-b177968a7489,Stomach,81,0BC4ABB4-047B-4C8D-9F79-5B9EB32969E9,623D5E6A-A5D3-4580-BEF7-04673D42A1D0,TCGA-CG-4466-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4466,TCGA-STAD,NA,s14987,Harvard Medical School,Indivumed,Germany,NO,T2a,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa830e4b0c9d6adf6bf87,58cfa830e4b0c9d6adf6bf87,TCGA-BJ-A3PR-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BJ-A3PR-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_7_rg.sorted,TCGA-BJ-A3PR-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_7_rg.sorted.bam,45.84,NA,0.15,58cfa830e4b0c9d6adf6bf87,TCGA-BJ-A3PR-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A3PR-01A,FD036EC5-3FFB-40B1-8002-943BE0E2532E,Primary Tumor,Illumina HiSeq,c8c8646f-54e4-4440-bf91-d2cd90083c44,Thyroid,69,E058A8E1-ED00-48A5-A46B-77538D7B73F1,57FD6BDA-C7B4-4B74-B21A-B7FF5D1C87EE,TCGA-BJ-A3PR-01A-11D-A221-26,HG19_Broad_variant,TCGA-BJ-A3PR,TCGA-THCA,NA,s12358,MD Anderson - Institute for Applied Cancer Science,University of Pittsburgh,United States,NO,T1a,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6ca13,58cfa831e4b0c9d6adf6ca13,TCGA-DK-A3WY-10A-01D-A233_120829_SN1120_0183_AC18U8ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DK-A3WY-10A-01D-A233_120829_SN1120_0183_AC18U8ACXX_s_8_rg.sorted,TCGA-DK-A3WY-10A-01D-A233_120829_SN1120_0183_AC18U8ACXX_s_8_rg.sorted.bam,22.12,NA,0.17,58cfa831e4b0c9d6adf6ca13,TCGA-DK-A3WY-10A-01D-A233_120829_SN1120_0183_AC18U8ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3WY-10A,9BB5D187-033E-4E86-A76E-E1A6D20488F7,Blood Derived Normal,Illumina HiSeq,0d07635d-ca76-4aca-986a-7167437f8520,Bladder,67,95115280-63B5-4C4C-B240-E53ABCB87160,7B2D53E0-51E6-4308-8EF8-99BDDF56276F,TCGA-DK-A3WY-10A-01D-A233-26,HG19_Broad_variant,TCGA-DK-A3WY,TCGA-BLCA,NA,s2898,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6d3e3,58cfa832e4b0c9d6adf6d3e3,TCGA-V4-A9EL-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_1_rg.sorted.filtered.,WGS,TCGA-V4-A9EL-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_1_rg.sorted,TCGA-V4-A9EL-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_1_rg.sorted.bam,36.66,NA,0.17,58cfa832e4b0c9d6adf6d3e3,TCGA-V4-A9EL-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EL-01A,8DE236F1-C029-44DF-A2A9-319145488BAA,Primary Tumor,Illumina HiSeq,37f105ff-ac0b-4651-9c5f-008d937dc883,Eye,60,DB91E719-82B1-4E9A-AB28-AC67B726340B,50022AEA-CB52-4402-9FC2-C8A4EC1600FF,TCGA-V4-A9EL-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9EL,TCGA-UVM,NA,s199,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa831e4b0c9d6adf6ccec,58cfa831e4b0c9d6adf6ccec,TCGA-EK-A3GM-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EK-A3GM-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_7_rg.sorted,TCGA-EK-A3GM-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_7_rg.sorted.bam,64.38,NA,0.16,58cfa831e4b0c9d6adf6ccec,TCGA-EK-A3GM-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A3GM-10A,CB780C10-8810-4384-B829-954AAB1C16C8,Blood Derived Normal,Illumina HiSeq,5eb98be0-3349-4f64-acb4-1eebb375d826,Cervix,65,1CFB672B-EB3D-44D6-AC76-BF3993632CAA,FCCA67BE-B1FF-4247-9970-FFE404BD2A33,TCGA-EK-A3GM-10A-01D-A20X-26,HG19_Broad_variant,TCGA-EK-A3GM,TCGA-CESC,NA,s1367,MD Anderson - Institute for Applied Cancer Science,Gynecologic Oncology Group,United States,NO,Not available,Not available,Endocervical Type of Adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bf7e,58cfa830e4b0c9d6adf6bf7e,TCGA-B5-A0JV-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_5_rg.sorted.filtered.,WGS,TCGA-B5-A0JV-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_5_rg.sorted,TCGA-B5-A0JV-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_5_rg.sorted.bam,90.33,1.92,0.15,58cfa830e4b0c9d6adf6bf7e,TCGA-B5-A0JV-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_5_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0JV-01A,233E947A-D5E2-48E5-A8CE-5DA1ABB20681,Primary Tumor,Illumina HiSeq,2c99d5d5-1f92-452e-9370-59486a6d7bce,Uterus,63,42199E5A-9F4F-4445-9E6E-114D47BA67FA,7132C5C6-9DC5-42A8-863F-D82280266427,TCGA-B5-A0JV-01A-11D-A101-02,HG19_Broad_variant,TCGA-B5-A0JV,TCGA-UCEC,NA,s4783,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6c1b6,58cfa830e4b0c9d6adf6c1b6,TCGA-BA-4076-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BA-4076-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_5_rg.sorted,TCGA-BA-4076-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_5_rg.sorted.bam,333.33,1.9,0.15,58cfa830e4b0c9d6adf6c1b6,TCGA-BA-4076-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-4076-01A,7DE19081-D5FD-468C-AD0D-F6E3E8B2AD70,Primary Tumor,Illumina HiSeq,f67d413c-c33d-4d97-9853-0b00f93f2304,Head and Neck,39,FD99FD83-4040-4738-8A5A-E42D36ECFE0E,54F77A3E-290A-4073-8012-4873579E95E9,TCGA-BA-4076-01A-01D-1431-02,HG19_Broad_variant,TCGA-BA-4076,TCGA-HNSC,415,s15749,Harvard Medical School,UNC,None,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c580,58cfa831e4b0c9d6adf6c580,TCGA-BR-4368-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_5_rg.sorted.filtered.,WGS,TCGA-BR-4368-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_5_rg.sorted,TCGA-BR-4368-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_5_rg.sorted.bam,215.2,1.9,0.15,58cfa831e4b0c9d6adf6c580,TCGA-BR-4368-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4368-01A,449BF2BE-B20E-4AD0-9FFB-910D83114018,Primary Tumor,Illumina HiSeq,138fe28f-1055-4872-99b0-71ca92e3494a,Stomach,78,87239062-9EA0-4987-AD13-5A2DDED4FF82,1AED45C5-BB15-43D4-9C04-291B7C5B4428,TCGA-BR-4368-01A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4368,TCGA-STAD,NA,s14469,Harvard Medical School,Asterand,Russia,NO,T4,N2,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa832e4b0c9d6adf6cfbe,58cfa832e4b0c9d6adf6cfbe,TCGA-G9-6385-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_7_rg.sorted.filtered.,WGS,TCGA-G9-6385-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_7_rg.sorted,TCGA-G9-6385-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_7_rg.sorted.bam,249.4,1.9,0.14,58cfa832e4b0c9d6adf6cfbe,TCGA-G9-6385-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6385-01A,E82A04CF-E81E-43C6-9CD9-0E29FA0F00AE,Primary Tumor,Illumina HiSeq,53da3cf6-b29e-4b1f-9d51-c1f9648b6634,Prostate,66,CFE4B1FA-B658-49D3-87AD-6DF7D75A58DF,00D3CD80-E6C2-4408-8F10-3656BD371157,TCGA-G9-6385-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6385,TCGA-PRAD,NA,s3456,Harvard Medical School,Roswell Park,United States,NO,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c368,58cfa831e4b0c9d6adf6c368,TCGA-CD-5802-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CD-5802-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_7_rg.sorted,TCGA-CD-5802-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_7_rg.sorted.bam,617.7,1.9,0.15,58cfa831e4b0c9d6adf6c368,TCGA-CD-5802-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_7_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-5802-10A,0AECAC64-5982-4D76-8F31-958F6A00951D,Blood Derived Normal,Illumina HiSeq,7f21b1e4-76db-4eac-a757-f5497d930e2e,Stomach,58,602943B6-8FFC-4667-BE39-2E6A9FB3661A,82931E93-6809-4AF5-AEF9-6FAC2C21630D,TCGA-CD-5802-10A-01D-1598-02,HG19_Broad_variant,TCGA-CD-5802,TCGA-STAD,NA,s15391,Harvard Medical School,ILSbio,Vietnam,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa831e4b0c9d6adf6caf4,58cfa831e4b0c9d6adf6caf4,TCGA-EA-A3HU-10B-01D-A20X_140106_SN590_0244_BC384EACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EA-A3HU-10B-01D-A20X_140106_SN590_0244_BC384EACXX_s_7_rg.sorted,TCGA-EA-A3HU-10B-01D-A20X_140106_SN590_0244_BC384EACXX_s_7_rg.sorted.bam,19.75,NA,0.14,58cfa831e4b0c9d6adf6caf4,TCGA-EA-A3HU-10B-01D-A20X_140106_SN590_0244_BC384EACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EA-A3HU-10B,9912432E-74BC-4846-93B4-FA2BF8070BD1,Blood Derived Normal,Illumina HiSeq,512fb31d-ffcf-410b-bb95-1e25ac434187,Cervix,43,AAAB0578-2C13-4ECA-BFD1-06FB6840756E,4B33B319-40C6-4C3C-B259-5518A1B55410,TCGA-EA-A3HU-10B-01D-A20X-26,HG19_Broad_variant,TCGA-EA-A3HU,TCGA-CESC,NA,s1525,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T2a2,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c985,58cfa831e4b0c9d6adf6c985,TCGA-DJ-A13W-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DJ-A13W-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_1_rg.sorted,TCGA-DJ-A13W-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_1_rg.sorted.bam,50.62,1.95,0.15,58cfa831e4b0c9d6adf6c985,TCGA-DJ-A13W-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13W-01A,3B48CC5E-3396-4DD5-893D-54B75B98B016,Primary Tumor,Illumina HiSeq,ab5fa454-36a6-4d10-bfda-443dd6709cd8,Thyroid,45,4DCA97A5-B0E5-4383-8CC5-B6FF07741647,8A15A4FE-F286-422D-9D50-33ABBD885250,TCGA-DJ-A13W-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13W,TCGA-THCA,NA,s11992,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa831e4b0c9d6adf6cc0b,58cfa831e4b0c9d6adf6cc0b,TCGA-DU-6403-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DU-6403-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_5_rg.sorted,TCGA-DU-6403-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_5_rg.sorted.bam,180.3,1.9,0.14,58cfa831e4b0c9d6adf6cc0b,TCGA-DU-6403-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6403-01A,8DAA29C0-F652-4130-A004-5183BBE30C63,Primary Tumor,Illumina HiSeq,d17b6f47-d1c9-4916-8722-8b6908f8552a,Brain,60,664226B3-6C8B-4E0A-A75B-955D65E62DA9,97CFB7E8-82E2-43BD-A458-376AD3CD7CFE,TCGA-DU-6403-01A-11D-1703-02,HG19_Broad_variant,TCGA-DU-6403,TCGA-LGG,354,s8135,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa831e4b0c9d6adf6cb80,58cfa831e4b0c9d6adf6cb80,TCGA-EE-A2ME-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EE-A2ME-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_7_rg.sorted,TCGA-EE-A2ME-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_7_rg.sorted.bam,18.96,NA,0.16,58cfa831e4b0c9d6adf6cb80,TCGA-EE-A2ME-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2ME-10A,D70E0D27-7F27-4807-A36E-9FB7B00F0A70,Blood Derived Normal,Illumina HiSeq,18ac5a1c-5e50-4962-ab78-94e561021d0c,Skin,51,C51882CD-DAC8-4FB1-973A-1287195E7CBF,F92F171E-3442-4EF7-B30A-B4A11C86AA47,TCGA-EE-A2ME-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2ME,TCGA-SKCM,3141,s8012,Harvard Medical School,University of Sydney,Australia,NO,T2,N0,Not available,Stage I
13722.58cfa831e4b0c9d6adf6cb76,58cfa831e4b0c9d6adf6cb76,TCGA-EE-A2MC-10A-01D-A190_120724_SN208_0417_AC117BACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EE-A2MC-10A-01D-A190_120724_SN208_0417_AC117BACXX_s_6_rg.sorted,TCGA-EE-A2MC-10A-01D-A190_120724_SN208_0417_AC117BACXX_s_6_rg.sorted.bam,53.6,NA,0.18,58cfa831e4b0c9d6adf6cb76,TCGA-EE-A2MC-10A-01D-A190_120724_SN208_0417_AC117BACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MC-10A,3791BD88-C61E-46C3-AAA4-942C2169887C,Blood Derived Normal,Illumina HiSeq,a6801df2-863b-49c3-8b02-52bbb3536e41,Skin,73,7243ECA7-7101-4963-821E-0F2676CD42E9,CDD2EA14-07C6-40F9-846A-B28DAF3762E3,TCGA-EE-A2MC-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2MC,TCGA-SKCM,1871,s7342,Harvard Medical School,University of Sydney,Australia,NO,T2,N0,Not available,Stage I
13722.58cfa82fe4b0c9d6adf6b78c,58cfa82fe4b0c9d6adf6b78c,TCGA-49-6745-11A-01D-1853_111218_SN208_0258_C054RACXX_s_8_rg.sorted.filtered.,WGS,TCGA-49-6745-11A-01D-1853_111218_SN208_0258_C054RACXX_s_8_rg.sorted,TCGA-49-6745-11A-01D-1853_111218_SN208_0258_C054RACXX_s_8_rg.sorted.bam,117.7,1.9,0.14,58cfa82fe4b0c9d6adf6b78c,TCGA-49-6745-11A-01D-1853_111218_SN208_0258_C054RACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-49-6745-11A,9C7875AD-AB71-4D48-B2E3-E4C7A46393E9,Solid Tissue Normal,Illumina HiSeq,d9c97389-6652-4cde-82d7-7b8704ed1f0d,Lung,82,36BE2A07-E71C-4B12-83D8-506376DA8F5E,198687D4-99FD-4CA3-9BAE-603FAB00A5B4,TCGA-49-6745-11A-01D-1853-02,HG19_Broad_variant,TCGA-49-6745,TCGA-LUAD,NA,s11231,Harvard Medical School,Johns Hopkins,United States,NO,T2a,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa832e4b0c9d6adf6cfa6,58cfa832e4b0c9d6adf6cfa6,TCGA-FS-A1ZZ-06A-11D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FS-A1ZZ-06A-11D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_5_rg.sorted,TCGA-FS-A1ZZ-06A-11D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_5_rg.sorted.bam,76.94,NA,0.18,58cfa832e4b0c9d6adf6cfa6,TCGA-FS-A1ZZ-06A-11D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZZ-06A,F6FF5E77-60D8-4987-9A92-654FD4DB81F1,Metastatic,Illumina HiSeq,a063d15d-a203-4c9c-ba64-60b38c6876fa,Skin,54,6FCB5378-D9E3-460E-9409-4298EA610BB6,45F0846F-66B7-49B9-A950-CBCD1D5ABA94,TCGA-FS-A1ZZ-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZZ,TCGA-SKCM,822,s7538,Harvard Medical School,Essen,Germany,NO,T3b,N0,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6ca40,58cfa831e4b0c9d6adf6ca40,TCGA-DK-A3X2-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DK-A3X2-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_4_rg.sorted,TCGA-DK-A3X2-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_4_rg.sorted.bam,48.49,NA,0.15,58cfa831e4b0c9d6adf6ca40,TCGA-DK-A3X2-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3X2-10A,40551D53-388B-4067-9341-76E94D023703,Blood Derived Normal,Illumina HiSeq,dc4b6741-a258-4b67-9da6-c236d90bddf7,Bladder,85,9DBF916D-61DC-4447-A805-0419A35DB9A0,4F911767-EC32-4E3E-98C7-3F0BEAB7BA3A,TCGA-DK-A3X2-10A-01D-A233-26,HG19_Broad_variant,TCGA-DK-A3X2,TCGA-BLCA,547,s3287,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6cc52,58cfa831e4b0c9d6adf6cc52,TCGA-EJ-5499-10A-01D-1573_130223_SN590_0214_BC1UJ3ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EJ-5499-10A-01D-1573_130223_SN590_0214_BC1UJ3ACXX_s_2_rg.sorted,TCGA-EJ-5499-10A-01D-1573_130223_SN590_0214_BC1UJ3ACXX_s_2_rg.sorted.bam,289.4,1.9,0.16,58cfa831e4b0c9d6adf6cc52,TCGA-EJ-5499-10A-01D-1573_130223_SN590_0214_BC1UJ3ACXX_s_2_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5499-10A,FD1AA612-DF86-4D48-892D-2ACEBD76EA96,Blood Derived Normal,Illumina HiSeq,3635d2b0-fde1-42b9-8831-c429d8b8e864,Prostate,61,CF9C48D8-C21F-408D-8E2C-4F93DA7ADA73,FF5F777F-4C0B-4A02-8E24-2748D02154CB,TCGA-EJ-5499-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5499,TCGA-PRAD,NA,s3950,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bbaa,58cfa830e4b0c9d6adf6bbaa,TCGA-AA-A01X-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A01X-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A01X-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,47.22,2.09,0.14,58cfa830e4b0c9d6adf6bbaa,TCGA-AA-A01X-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01X-11A,2E386E48-B99B-4806-A3E3-081D72A606E7,Solid Tissue Normal,Illumina HiSeq,95a2f5a6-e084-4235-87c5-5b3a0605dcba,Colorectal,80,E3A8174D-358B-4367-BE5D-95FB8A2CE86F,CD4E760E-84CB-460F-9000-B3AF56756CCE,TCGA-AA-A01X-11A-11D-A079-02,HG18,TCGA-AA-A01X,TCGA-COAD,NA,s13380,Harvard Medical School,Indivumed,Germany,NO,T2,N1,Colon Adenocarcinoma,Stage III
13722.58cfa830e4b0c9d6adf6c036,58cfa830e4b0c9d6adf6c036,TCGA-AG-3999-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AG-3999-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole,TCGA-AG-3999-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,13.59,1.9,0.15,58cfa830e4b0c9d6adf6c036,TCGA-AG-3999-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3999-10A,60778DA8-D99E-4E51-96A2-3E900B3978D9,Blood Derived Normal,Illumina HiSeq,f639d084-d99e-4579-aeae-2edb77da3a8e,Colorectal,61,18262C9A-5015-4179-A10C-39149B47B13F,49016CD5-C461-45B4-8016-DDE0CD096173,TCGA-AG-3999-10A-01D-1115-02,HG18,TCGA-AG-3999,TCGA-READ,NA,s1980,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Rectal Adenocarcinoma,Stage IIIC
13722.58cfa82fe4b0c9d6adf6b8a7,58cfa82fe4b0c9d6adf6b8a7,TCGA-44-6145-11A-01D-1751_110927_SN208_0243_BC00TKACXX_s_2_rg.sorted.filtered.,WGS,TCGA-44-6145-11A-01D-1751_110927_SN208_0243_BC00TKACXX_s_2_rg.sorted,TCGA-44-6145-11A-01D-1751_110927_SN208_0243_BC00TKACXX_s_2_rg.sorted.bam,59.4,1.9,0.14,58cfa82fe4b0c9d6adf6b8a7,TCGA-44-6145-11A-01D-1751_110927_SN208_0243_BC00TKACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-6145-11A,6144D666-8F77-4EFE-95F1-F9E5C4E5E056,Solid Tissue Normal,Illumina HiSeq,6aee5e9f-1c40-44eb-a1a8-7ee785f62ee5,Lung,62,420FD4EB-E667-4F53-811C-B128D261ACF8,5856EED8-2D53-48F8-B43D-A5523422B632,TCGA-44-6145-11A-01D-1751-02,HG19_Broad_variant,TCGA-44-6145,TCGA-LUAD,NA,s10903,Harvard Medical School,Christiana Healthcare,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6cafa,58cfa831e4b0c9d6adf6cafa,TCGA-EA-A3HS-10B-01D-A20X_140106_SN590_0243_AC371BACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EA-A3HS-10B-01D-A20X_140106_SN590_0243_AC371BACXX_s_7_rg.sorted,TCGA-EA-A3HS-10B-01D-A20X_140106_SN590_0243_AC371BACXX_s_7_rg.sorted.bam,13.46,NA,0.17,58cfa831e4b0c9d6adf6cafa,TCGA-EA-A3HS-10B-01D-A20X_140106_SN590_0243_AC371BACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EA-A3HS-10B,753EE373-FBCF-4349-B9B2-5A41936E27E9,Blood Derived Normal,Illumina HiSeq,66d157df-3130-4d6f-b945-b2b660c92060,Cervix,35,241D9F57-D791-41B8-8450-62543149792B,B53FE367-BD69-4183-BDC7-DF720E7858D2,TCGA-EA-A3HS-10B-01D-A20X-26,HG19_Broad_variant,TCGA-EA-A3HS,TCGA-CESC,NA,s1519,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T1b,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c619,58cfa831e4b0c9d6adf6c619,TCGA-CN-5356-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CN-5356-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_8_rg.sorted,TCGA-CN-5356-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_8_rg.sorted.bam,301.7,1.9,0.15,58cfa831e4b0c9d6adf6c619,TCGA-CN-5356-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5356-01A,E1FED7AA-2BCE-45AE-B0C6-7F50EF97E425,Primary Tumor,Illumina HiSeq,c8e59618-fd16-4e8e-abe2-e3d5d674390c,Head and Neck,56,BCB5DA85-78D6-4519-9740-378587B1BD37,199B42E1-301A-49AD-A364-BBF4FAD8B049,TCGA-CN-5356-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5356,TCGA-HNSC,NA,s15885,Harvard Medical School,University of Pittsburgh,None,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6cc2f,58cfa831e4b0c9d6adf6cc2f,TCGA-DU-7008-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DU-7008-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_1_rg.sorted,TCGA-DU-7008-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_1_rg.sorted.bam,111,NA,0.15,58cfa831e4b0c9d6adf6cc2f,TCGA-DU-7008-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7008-01A,427C40F6-D1BD-49F2-B303-A975793B937E,Primary Tumor,Illumina HiSeq,3a51e8e7-621e-4d62-bb3d-cb6700af6a43,Brain,41,7A0C3571-4265-4D36-AFBC-FA234970F94B,7602BA72-B5E0-49C7-940A-6E9EFBDB5C58,TCGA-DU-7008-01A-11D-2022-02,HG19_Broad_variant,TCGA-DU-7008,TCGA-LGG,NA,s8566,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82fe4b0c9d6adf6b7d5,58cfa82fe4b0c9d6adf6b7d5,TCGA-50-5931-11A-01D-1751_110928_SN590_0108_BB01CWACXX_s_3_rg.sorted.filtered.,WGS,TCGA-50-5931-11A-01D-1751_110928_SN590_0108_BB01CWACXX_s_3_rg.sorted,TCGA-50-5931-11A-01D-1751_110928_SN590_0108_BB01CWACXX_s_3_rg.sorted.bam,12.4,1.9,0.14,58cfa82fe4b0c9d6adf6b7d5,TCGA-50-5931-11A-01D-1751_110928_SN590_0108_BB01CWACXX_s_3_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5931-11A,12CCD581-A921-41BC-BCEE-4E9BE54532CC,Solid Tissue Normal,Illumina HiSeq,638da55f-beb6-4757-bcc1-bf1427cde1b8,Lung,75,0EBE60D2-3A5B-41A5-A3F2-8E50A72DC2D1,5C292720-2298-4865-B541-A4A822B0B768,TCGA-50-5931-11A-01D-1751-02,HG19_Broad_variant,TCGA-50-5931,TCGA-LUAD,434,s11237,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa830e4b0c9d6adf6be38,58cfa830e4b0c9d6adf6be38,TCGA-B5-A0JY-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_6_rg.sorted.filtered.,WGS,TCGA-B5-A0JY-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_6_rg.sorted,TCGA-B5-A0JY-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_6_rg.sorted.bam,80.24,1.95,0.16,58cfa830e4b0c9d6adf6be38,TCGA-B5-A0JY-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0JY-01A,61935424-44D0-4211-81C1-C925E436EAC5,Primary Tumor,Illumina HiSeq,e463dbb2-091a-4183-98b6-a90c2e55ffae,Uterus,50,95F418CE-FCD9-4402-BC24-1520F45CB6B7,88CE0037-F3F9-4F45-BF14-36A58FF61A3D,TCGA-B5-A0JY-01A-11D-A101-02,HG19_Broad_variant,TCGA-B5-A0JY,TCGA-UCEC,NA,s4784,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d4cc,58cfa832e4b0c9d6adf6d4cc,TCGA-VD-A8KL-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-VD-A8KL-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_7_rg.sorted,TCGA-VD-A8KL-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_7_rg.sorted.bam,30.16,NA,0.15,58cfa832e4b0c9d6adf6d4cc,TCGA-VD-A8KL-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_7_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KL-01A,A9F956A0-660F-4185-A843-D9911D2484DE,Primary Tumor,Illumina HiSeq,e7c1dbaa-f0ee-479a-b2ad-cbbb8555e36e,Eye,77,86E0C8DD-546C-4B53-A56B-2C985E58CE68,4D1068DC-E769-4374-B895-4430A9B03322,TCGA-VD-A8KL-01A-11D-A40D-26,HG19_Broad_variant,TCGA-VD-A8KL,TCGA-UVM,NA,s263,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T3a,NX,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6caf5,58cfa831e4b0c9d6adf6caf5,TCGA-EA-A3HR-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EA-A3HR-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_4_rg.sorted,TCGA-EA-A3HR-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_4_rg.sorted.bam,23.52,NA,0.14,58cfa831e4b0c9d6adf6caf5,TCGA-EA-A3HR-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EA-A3HR-10A,638035F6-2909-4A44-980F-468AC5D74E18,Blood Derived Normal,Illumina HiSeq,f3670983-2ab7-4d5f-ba0a-78f0cba773a0,Cervix,57,066A7341-746F-4602-9C74-C42683B1ECC0,7B31AC99-E2BE-4715-B60E-4737C96BB145,TCGA-EA-A3HR-10A-01D-A20X-26,HG19_Broad_variant,TCGA-EA-A3HR,TCGA-CESC,NA,s1181,MD Anderson - RPPA Core Facility (Proteomics),Asterand,Russia,NO,T2a,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6bbd4,58cfa830e4b0c9d6adf6bbd4,TCGA-AG-A00C-10A-01D-A078_110405_SN590_0074_AB04EUABXX_s_4_rg.sorted.filtered.,WGS,TCGA-AG-A00C-10A-01D-A078_110405_SN590_0074_AB04EUABXX_s_4_rg.sorted,TCGA-AG-A00C-10A-01D-A078_110405_SN590_0074_AB04EUABXX_s_4_rg.sorted.bam,12.8,1.94,0.15,58cfa830e4b0c9d6adf6bbd4,TCGA-AG-A00C-10A-01D-A078_110405_SN590_0074_AB04EUABXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A00C-10A,FF004403-8CC5-43E6-BD1C-DDE4EB1E6193,Blood Derived Normal,Illumina HiSeq,364f941f-a9dd-4021-8c6d-fcdc069f3379,Colorectal,49,BB4FB9DC-E786-4FCF-8A1C-F5791BC900C3,096C7C19-C359-4B0D-859C-FB8A74921594,TCGA-AG-A00C-10A-01D-A078-02,HG18_Broad_variant,TCGA-AG-A00C,TCGA-READ,NA,s2166,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIB
13722.58cfa831e4b0c9d6adf6cc78,58cfa831e4b0c9d6adf6cc78,TCGA-EM-A1CV-10A-01D-A13U_120706_SN1222_0122_AC0WPYACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EM-A1CV-10A-01D-A13U_120706_SN1222_0122_AC0WPYACXX_s_5_rg.sorted,TCGA-EM-A1CV-10A-01D-A13U_120706_SN1222_0122_AC0WPYACXX_s_5_rg.sorted.bam,54.35,1.98,0.16,58cfa831e4b0c9d6adf6cc78,TCGA-EM-A1CV-10A-01D-A13U_120706_SN1222_0122_AC0WPYACXX_s_5_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1CV-10A,762EDDB5-1B47-4B79-B20A-1EDFB07C0705,Blood Derived Normal,Illumina HiSeq,c32dd2f8-7551-4307-aa32-932cfa20250a,Thyroid,32,449B0789-B12B-43EB-AB63-960CA4B24122,04EBB1B4-E7FC-4A7F-8159-0B763306E991,TCGA-EM-A1CV-10A-01D-A13U-02,HG19_Broad_variant,TCGA-EM-A1CV,TCGA-THCA,NA,s12113,Harvard Medical School,University Health Network,Canada,NO,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c700,58cfa831e4b0c9d6adf6c700,TCGA-CU-A3QU-10B-01D-A233_120829_SN1120_0183_AC18U8ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CU-A3QU-10B-01D-A233_120829_SN1120_0183_AC18U8ACXX_s_2_rg.sorted,TCGA-CU-A3QU-10B-01D-A233_120829_SN1120_0183_AC18U8ACXX_s_2_rg.sorted.bam,14.24,NA,0.15,58cfa831e4b0c9d6adf6c700,TCGA-CU-A3QU-10B-01D-A233_120829_SN1120_0183_AC18U8ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CU-A3QU-10B,AE6D853B-A7F0-4465-B7BF-5A45006AB3B3,Blood Derived Normal,Illumina HiSeq,2cb07ca9-b658-4d19-ac30-c9da9c4550d8,Bladder,58,B69B6173-4486-441B-A064-11221248C33E,33A6CF93-649E-47FA-B281-ADBAA0E440B5,TCGA-CU-A3QU-10B-01D-A233-26,HG19_Broad_variant,TCGA-CU-A3QU,TCGA-BLCA,NA,s3100,MD Anderson - Institute for Applied Cancer Science,UNC,United States,NO,T2b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6d026,58cfa832e4b0c9d6adf6d026,TCGA-GD-A3OQ-01A-32D-A221_120902_SN1222_0147_AC195DACXX_s_4_rg.sorted.filtered.,WGS,TCGA-GD-A3OQ-01A-32D-A221_120902_SN1222_0147_AC195DACXX_s_4_rg.sorted,TCGA-GD-A3OQ-01A-32D-A221_120902_SN1222_0147_AC195DACXX_s_4_rg.sorted.bam,40.42,NA,0.15,58cfa832e4b0c9d6adf6d026,TCGA-GD-A3OQ-01A-32D-A221_120902_SN1222_0147_AC195DACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GD-A3OQ-01A,2E85C30C-C4C4-4096-9EEF-4EB2C7D991A3,Primary Tumor,Illumina HiSeq,a07d0456-032d-409c-af8d-c4d6349ef4db,Bladder,48,E3D22638-C0AE-48AA-A523-8C9A6CFBF063,F77305E9-430E-4E7D-97A6-C97FFDDC3B65,TCGA-GD-A3OQ-01A-32D-A221-26,HG19_Broad_variant,TCGA-GD-A3OQ,TCGA-BLCA,NA,s2923,MD Anderson - Institute for Applied Cancer Science,ABS - IUPUI,United States,NO,T4a,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82fe4b0c9d6adf6b728,58cfa82fe4b0c9d6adf6b728,TCGA-44-6147-01A-11D-1751_111207_SN590_0112_D09CDACXX_s_1_rg.sorted.filtered.,WGS,TCGA-44-6147-01A-11D-1751_111207_SN590_0112_D09CDACXX_s_1_rg.sorted,TCGA-44-6147-01A-11D-1751_111207_SN590_0112_D09CDACXX_s_1_rg.sorted.bam,219,1.9,0.17,58cfa82fe4b0c9d6adf6b728,TCGA-44-6147-01A-11D-1751_111207_SN590_0112_D09CDACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-6147-01A,889AEC8E-14BA-48D9-8FE1-F2416E82B333,Primary Tumor,Illumina HiSeq,a9e60432-a9de-4497-b94d-5ead787d2de3,Lung,67,43F5270A-F2F2-4DD9-83B5-486B805E35B8,E9CE62EF-711E-4252-AC93-97B69C39041A,TCGA-44-6147-01A-11D-1751-02,HG19_Broad_variant,TCGA-44-6147,TCGA-LUAD,NA,s11447,Harvard Medical School,Christiana Healthcare,United States,NO,T1b,NX,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6cdd6,58cfa831e4b0c9d6adf6cdd6,TCGA-FE-A3PC-10A-01D-A221_120524_SN1120_0145_BD12MWACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FE-A3PC-10A-01D-A221_120524_SN1120_0145_BD12MWACXX_s_4_rg.sorted,TCGA-FE-A3PC-10A-01D-A221_120524_SN1120_0145_BD12MWACXX_s_4_rg.sorted.bam,19.97,NA,0.16,58cfa831e4b0c9d6adf6cdd6,TCGA-FE-A3PC-10A-01D-A221_120524_SN1120_0145_BD12MWACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A3PC-10A,A86AC3B5-B5E9-4420-8DE0-A358FCAD85B6,Blood Derived Normal,Illumina HiSeq,513f4605-231a-4f82-97b1-cba55b6f3445,Thyroid,37,CD642D87-A56C-4537-A0D2-BD29FC7AA3A2,1A12B15A-00A3-4156-B3E8-65A3B9C5DA1E,TCGA-FE-A3PC-10A-01D-A221-26,HG19_Broad_variant,TCGA-FE-A3PC,TCGA-THCA,NA,s12116,MD Anderson - Institute for Applied Cancer Science,Ohio State University,United States,NO,T3,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82fe4b0c9d6adf6b5f0,58cfa82fe4b0c9d6adf6b5f0,TCGA-50-5933-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_6_rg.sorted.filtered.,WGS,TCGA-50-5933-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_6_rg.sorted,TCGA-50-5933-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_6_rg.sorted.bam,168.4,2,0.15,58cfa82fe4b0c9d6adf6b5f0,TCGA-50-5933-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5933-01A,7A0EA814-F0DE-4BC4-A81A-DAA000559369,Primary Tumor,Illumina HiSeq,ca97b42b-d723-4c0a-8f71-819eca1bb805,Lung,72,D2355F3A-E2CE-4791-B1FB-B570850681DF,1D83B47D-66A8-4AE9-81BB-BDC03FA64AC6,TCGA-50-5933-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-5933,TCGA-LUAD,2393,s11009,Harvard Medical School,University of Pittsburgh,United States,NO,T4,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIB
13722.58cfa831e4b0c9d6adf6c85c,58cfa831e4b0c9d6adf6c85c,TCGA-D3-A1Q8-06A-11D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-D3-A1Q8-06A-11D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_1_rg.sorted,TCGA-D3-A1Q8-06A-11D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_1_rg.sorted.bam,45.79,NA,0.17,58cfa831e4b0c9d6adf6c85c,TCGA-D3-A1Q8-06A-11D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A1Q8-06A,7B7A49B5-5BE8-4966-8F3A-E6E01E694F86,Metastatic,Illumina HiSeq,0f0ce208-c694-4ce1-9864-0eef3d792bb5,Skin,33,5AA5BBF1-9369-42CE-AB77-4FB0CDC57F39,CE0BE99D-0C07-4338-96A6-799D8F5A6C38,TCGA-D3-A1Q8-06A-11D-A18Z-02,HG19_Broad_variant,TCGA-D3-A1Q8,TCGA-SKCM,854,s7829,Harvard Medical School,MD Anderson,United States,NO,T0,N3,Not available,Stage IV
13722.58cfa831e4b0c9d6adf6c8f8,58cfa831e4b0c9d6adf6c8f8,TCGA-CN-5373-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CN-5373-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_8_rg.sorted,TCGA-CN-5373-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_8_rg.sorted.bam,50.4,1.9,0.15,58cfa831e4b0c9d6adf6c8f8,TCGA-CN-5373-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5373-10A,546F01D5-AED5-4FB8-91C0-0FD5E0FDE935,Blood Derived Normal,Illumina HiSeq,166276f6-82c3-4536-bce5-6e520be8554c,Head and Neck,55,629A4D66-6FD4-4619-B949-362860B276CB,08C37803-59E9-44B8-BC72-C4D512312537,TCGA-CN-5373-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5373,TCGA-HNSC,NA,s15765,Harvard Medical School,University of Pittsburgh,None,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6cf64,58cfa832e4b0c9d6adf6cf64,TCGA-FS-A1ZW-10A-01D-A190_120602_SN1120_0147_BD13TBACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FS-A1ZW-10A-01D-A190_120602_SN1120_0147_BD13TBACXX_s_3_rg.sorted,TCGA-FS-A1ZW-10A-01D-A190_120602_SN1120_0147_BD13TBACXX_s_3_rg.sorted.bam,66.18,NA,0.16,58cfa832e4b0c9d6adf6cf64,TCGA-FS-A1ZW-10A-01D-A190_120602_SN1120_0147_BD13TBACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZW-10A,49A6F6A6-BF6F-45CF-93DC-B006B4A0637D,Blood Derived Normal,Illumina HiSeq,7453f952-2bcf-495f-a111-5064baf2d40a,Skin,65,B7772DDC-6155-409A-B672-F61861CB4268,42C7AAC2-EA71-4E4C-81CD-1BEAD1D3DA9D,TCGA-FS-A1ZW-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZW,TCGA-SKCM,NA,s7869,Harvard Medical School,Essen,Germany,NO,T2b,N1a,Not available,Stage IIIB
13722.58cfa831e4b0c9d6adf6ca8c,58cfa831e4b0c9d6adf6ca8c,TCGA-DJ-A1QF-10A-01D-A14U_120629_SN1120_0167_AC0WMBACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DJ-A1QF-10A-01D-A14U_120629_SN1120_0167_AC0WMBACXX_s_6_rg.sorted,TCGA-DJ-A1QF-10A-01D-A14U_120629_SN1120_0167_AC0WMBACXX_s_6_rg.sorted.bam,45.48,1.84,0.17,58cfa831e4b0c9d6adf6ca8c,TCGA-DJ-A1QF-10A-01D-A14U_120629_SN1120_0167_AC0WMBACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QF-10A,FCA0C7D9-5E6F-4AA7-BA04-5DF2EB8BA398,Blood Derived Normal,Illumina HiSeq,f9c3adcc-b52e-4ce1-bede-54362599ed2f,Thyroid,61,11ECEDEE-9701-4923-B899-EC553D73B7B0,165ED3A5-FE7D-473C-9877-AC901C36D97E,TCGA-DJ-A1QF-10A-01D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QF,TCGA-THCA,NA,s12371,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage II
13722.58cfa830e4b0c9d6adf6c184,58cfa830e4b0c9d6adf6c184,TCGA-BA-4075-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BA-4075-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_3_rg.sorted,TCGA-BA-4075-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_3_rg.sorted.bam,430.33,1.9,0.16,58cfa830e4b0c9d6adf6c184,TCGA-BA-4075-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_3_rg.sorted.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-4075-01A,6FA62461-E721-415A-8B0F-363B84292B82,Primary Tumor,Illumina HiSeq,85bcc36c-7376-4108-ac13-c495a75d3e00,Head and Neck,49,4DC36C31-35D8-4263-B141-C734545540A9,4B0B38F4-AC21-4F3E-8A8E-A69FBA619629,TCGA-BA-4075-01A-01D-1431-02,HG19_Broad_variant,TCGA-BA-4075,TCGA-HNSC,283,s16169,Harvard Medical School,UNC,None,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6ae5c,58cfa82ee4b0c9d6adf6ae5c,TCGA-05-4397-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_7_rg.sorted.filtered.,WGS,TCGA-05-4397-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_7_rg.sorted,TCGA-05-4397-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_7_rg.sorted.bam,573.23,1.9,0.14,58cfa82ee4b0c9d6adf6ae5c,TCGA-05-4397-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_7_rg.sorted.bam,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4397-01A,6DFD47D2-831A-4386-9051-F78199A16BB5,Primary Tumor,Illumina HiSeq,09ccfcd9-4865-439b-9162-cf783f33f44d,Lung,65,C4C061CD-E926-400B-B18C-B47C234337CA,5D48DDB3-ED53-49CB-99B9-B75FCECCA1B4,TCGA-05-4397-01A-01D-1203-02,HG19_Broad_variant,TCGA-05-4397,TCGA-LUAD,731,s10643,Harvard Medical School,Indivumed,Germany,NO,T2,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIB
13722.58cfa831e4b0c9d6adf6cbaf,58cfa831e4b0c9d6adf6cbaf,TCGA-EK-A3GN-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EK-A3GN-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_2_rg.sorted,TCGA-EK-A3GN-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_2_rg.sorted.bam,50.85,NA,0.14,58cfa831e4b0c9d6adf6cbaf,TCGA-EK-A3GN-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A3GN-01A,F727FCB9-E457-4643-9468-F739133B7E9C,Primary Tumor,Illumina HiSeq,b9e845ee-3e61-4ccf-b14e-f8a6b8481bd3,Cervix,47,EB5034E2-D4A7-48E0-9524-31DDD63C9D94,49F2E671-D283-4B5C-B8A3-490C0A383FC1,TCGA-EK-A3GN-01A-11D-A20X-26,HG19_Broad_variant,TCGA-EK-A3GN,TCGA-CESC,NA,s1364,MD Anderson - Institute for Applied Cancer Science,Gynecologic Oncology Group,United States,NO,TX,NX,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6cd24,58cfa831e4b0c9d6adf6cd24,TCGA-EE-A2ML-10A-01D-A190_120724_SN1222_0138_AC1168ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EE-A2ML-10A-01D-A190_120724_SN1222_0138_AC1168ACXX_s_7_rg.sorted,TCGA-EE-A2ML-10A-01D-A190_120724_SN1222_0138_AC1168ACXX_s_7_rg.sorted.bam,23.1,NA,0.16,58cfa831e4b0c9d6adf6cd24,TCGA-EE-A2ML-10A-01D-A190_120724_SN1222_0138_AC1168ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2ML-10A,01CFBFAE-F344-439D-AEAB-A9E15D636325,Blood Derived Normal,Illumina HiSeq,2eb86a50-3721-4e6d-9fac-46ce15804128,Skin,35,9F14A724-08E5-4861-8F83-DFDD5832387D,B84CE7BC-4FA4-40E5-A103-B6957623CC2C,TCGA-EE-A2ML-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2ML,TCGA-SKCM,NA,s7512,Harvard Medical School,University of Sydney,Australia,NO,T3a,N0,Not available,Stage II
13722.58cfa831e4b0c9d6adf6c5e7,58cfa831e4b0c9d6adf6c5e7,TCGA-CN-5367-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CN-5367-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_2_rg.sorted,TCGA-CN-5367-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_2_rg.sorted.bam,214.7,1.9,0.15,58cfa831e4b0c9d6adf6c5e7,TCGA-CN-5367-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5367-01A,61D0709C-D148-413B-A7B5-C0C82ED2F32F,Primary Tumor,Illumina HiSeq,9ab4b634-5191-4a97-b9df-f75528b90bae,Head and Neck,60,379F9E65-54F3-4566-B018-3F3EEE6A4DF4,1380173D-316F-4821-8B98-654AD1050A38,TCGA-CN-5367-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5367,TCGA-HNSC,352,s15762,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6ca0d,58cfa831e4b0c9d6adf6ca0d,TCGA-DK-A1AD-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DK-A1AD-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_5_rg.sorted,TCGA-DK-A1AD-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_5_rg.sorted.bam,55.51,1.93,0.17,58cfa831e4b0c9d6adf6ca0d,TCGA-DK-A1AD-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,Not available,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AD-01A,88A521CE-A5E9-4C6F-83D4-EC36A62FEDB6,Primary Tumor,Illumina HiSeq,26694fc3-c6e4-45f9-82f0-57b6f4955b4b,Bladder,69,C79F4327-675D-4651-994D-E683096DF9C3,86DF29FD-B5F6-4316-BC89-DC9386D177C6,TCGA-DK-A1AD-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DK-A1AD,TCGA-BLCA,NA,s2711,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c772,58cfa831e4b0c9d6adf6c772,TCGA-CQ-7068-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CQ-7068-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_6_rg.sorted,TCGA-CQ-7068-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_6_rg.sorted.bam,637.73,NA,0.15,58cfa831e4b0c9d6adf6c772,TCGA-CQ-7068-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-7068-01A,8EBE8C25-5EF9-42D4-9414-8313227B673F,Primary Tumor,Illumina HiSeq,77b40e7d-41a7-4e5d-a3e9-ce1e2d077c98,Head and Neck,80,1C86E4AF-03CE-477C-BE08-0CFA565861B7,F0B87929-92F5-4AB9-849F-00F970E56577,TCGA-CQ-7068-01A-11D-2317-26,HG19_Broad_variant,TCGA-CQ-7068,TCGA-HNSC,NA,s15506,MD Anderson - Institute for Applied Cancer Science,"University Health Network, Toronto",Canada,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa82fe4b0c9d6adf6b8ea,58cfa82fe4b0c9d6adf6b8ea,TCGA-49-6743-11A-01D-1853_111218_SN208_0258_C054RACXX_s_4_rg.sorted.filtered.,WGS,TCGA-49-6743-11A-01D-1853_111218_SN208_0258_C054RACXX_s_4_rg.sorted,TCGA-49-6743-11A-01D-1853_111218_SN208_0258_C054RACXX_s_4_rg.sorted.bam,16.7,1.9,0.13,58cfa82fe4b0c9d6adf6b8ea,TCGA-49-6743-11A-01D-1853_111218_SN208_0258_C054RACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-49-6743-11A,A391D49F-A822-460B-981C-6FBE1868EE38,Solid Tissue Normal,Illumina HiSeq,b26d0042-8fd0-41ca-8236-a6509446e036,Lung,81,4DA6A729-3CAE-47F9-8739-D4B614B8561D,2E932287-E4F8-444F-A78B-BD537EB8787B,TCGA-49-6743-11A-01D-1853-02,HG19_Broad_variant,TCGA-49-6743,TCGA-LUAD,NA,s10999,Harvard Medical School,Johns Hopkins,United States,NO,T1,N2,Lung Clear Cell Adenocarcinoma,Stage IIIA
13722.58cfa831e4b0c9d6adf6cb8c,58cfa831e4b0c9d6adf6cb8c,TCGA-EE-A2M6-06A-12D-A18Y_120724_SN208_0417_AC117BACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EE-A2M6-06A-12D-A18Y_120724_SN208_0417_AC117BACXX_s_5_rg.sorted,TCGA-EE-A2M6-06A-12D-A18Y_120724_SN208_0417_AC117BACXX_s_5_rg.sorted.bam,43.63,NA,0.16,58cfa831e4b0c9d6adf6cb8c,TCGA-EE-A2M6-06A-12D-A18Y_120724_SN208_0417_AC117BACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2M6-06A,58F0AE89-E277-4DFF-BB73-777CDF602DC7,Metastatic,Illumina HiSeq,73c366ca-675a-4a91-b0e1-63b111e2cfd6,Skin,61,7381FB99-0C06-416B-A503-F2570172B894,F5E09CF4-DC1D-49AF-AD66-DCC9BE52FB34,TCGA-EE-A2M6-06A-12D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2M6,TCGA-SKCM,NA,s7851,Harvard Medical School,University of Sydney,Australia,NO,T1,N0,Not available,Stage I
13722.58cfa831e4b0c9d6adf6c8e6,58cfa831e4b0c9d6adf6c8e6,TCGA-CV-6960-01A-41D-2317_120623_SN1222_0118_AD13T1ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CV-6960-01A-41D-2317_120623_SN1222_0118_AD13T1ACXX_s_6_rg.sorted,TCGA-CV-6960-01A-41D-2317_120623_SN1222_0118_AD13T1ACXX_s_6_rg.sorted.bam,52.73,NA,0.13,58cfa831e4b0c9d6adf6c8e6,TCGA-CV-6960-01A-41D-2317_120623_SN1222_0118_AD13T1ACXX_s_6_rg.sorted.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,Not available,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6960-01A,2C985B30-0F8F-4C8F-A924-CC6AAD7EBF0D,Primary Tumor,Illumina HiSeq,5fdfb781-64fd-48dd-9d26-3de7bfdf5908,Head and Neck,49,967F6CC9-95D2-4666-A20A-717D768613A4,F41864FE-49FA-4037-AF02-E3F8E2515614,TCGA-CV-6960-01A-41D-2317-26,HG19_Broad_variant,TCGA-CV-6960,TCGA-HNSC,862,s15902,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa832e4b0c9d6adf6d248,58cfa832e4b0c9d6adf6d248,TCGA-J8-A3YH-06A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_5_rg.sorted.filtered.,WGS,TCGA-J8-A3YH-06A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_5_rg.sorted,TCGA-J8-A3YH-06A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_5_rg.sorted.bam,30.87,NA,0.16,58cfa832e4b0c9d6adf6d248,TCGA-J8-A3YH-06A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,Not available,Thyroid Carcinoma,Aligned reads,TCGA-J8-A3YH-06A,A09B20B5-C187-4632-B996-0D5314A9885C,Metastatic,Illumina HiSeq,7d3cd3ed-cad7-46bd-848b-34f3904aa818,Thyroid,39,AF889679-331B-479F-899A-25A7FB219AA8,CF393DD3-98A4-4CD5-AD50-33697BD70065,TCGA-J8-A3YH-06A-11D-A23Q-26,HG19_Broad_variant,TCGA-J8-A3YH,TCGA-THCA,NA,s12260,MD Anderson - Institute for Applied Cancer Science,Mayo Clinic,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6d1c5,58cfa832e4b0c9d6adf6d1c5,TCGA-HI-7171-01A-12D-2111_130607_SN590_0232_BD26R5ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-HI-7171-01A-12D-2111_130607_SN590_0232_BD26R5ACXX_s_7_rg.sorted,TCGA-HI-7171-01A-12D-2111_130607_SN590_0232_BD26R5ACXX_s_7_rg.sorted.bam,127.3,NA,0.14,58cfa832e4b0c9d6adf6d1c5,TCGA-HI-7171-01A-12D-2111_130607_SN590_0232_BD26R5ACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HI-7171-01A,931FEB14-3F69-41C1-8435-5FD4FB775BDF,Primary Tumor,Illumina HiSeq,0dc8ef7a-58a8-4b25-ad57-4c31592151e2,Prostate,56,B9D6C505-4D71-4189-925F-36914241B831,5A0710CB-B515-48F7-94B1-5DCD72B30F3F,TCGA-HI-7171-01A-12D-2111-02,HG19_Broad_variant,TCGA-HI-7171,TCGA-PRAD,1329,s3814,Harvard Medical School,Fox Chase,United States,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cb5c,58cfa831e4b0c9d6adf6cb5c,TCGA-EE-A2MD-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EE-A2MD-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_4_rg.sorted,TCGA-EE-A2MD-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_4_rg.sorted.bam,46.36,NA,0.16,58cfa831e4b0c9d6adf6cb5c,TCGA-EE-A2MD-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MD-06A,D28B2D64-2399-4CE1-9C9A-7538DABAB862,Metastatic,Illumina HiSeq,d129b319-ccf2-4715-9abd-3890ff13945f,Skin,52,FE5CCE9F-6DBD-4532-8926-BBF6BD850E71,5A62986F-DA0F-41F6-A848-4AD44A3E7885,TCGA-EE-A2MD-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2MD,TCGA-SKCM,1438,s7517,Harvard Medical School,University of Sydney,Australia,NO,T3a,N0,Not available,Stage II
13722.58cfa831e4b0c9d6adf6cbb4,58cfa831e4b0c9d6adf6cbb4,TCGA-EK-A2RN-01A-12D-A20X_140117_SN590_0246_BC37BDACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EK-A2RN-01A-12D-A20X_140117_SN590_0246_BC37BDACXX_s_2_rg.sorted,TCGA-EK-A2RN-01A-12D-A20X_140117_SN590_0246_BC37BDACXX_s_2_rg.sorted.bam,17.97,NA,0.17,58cfa831e4b0c9d6adf6cbb4,TCGA-EK-A2RN-01A-12D-A20X_140117_SN590_0246_BC37BDACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2RN-01A,B610D391-0C9D-4114-94D6-5E4AA4270122,Primary Tumor,Illumina HiSeq,def278f8-93eb-4373-a525-98b2cf12af7a,Cervix,45,24BACABF-8C6F-416A-B1F3-B0BAAA2F0AD9,3B5905A9-4B73-4946-A10B-D3E7ECAFFC7C,TCGA-EK-A2RN-01A-12D-A20X-26,HG19_Broad_variant,TCGA-EK-A2RN,TCGA-CESC,NA,s1368,MD Anderson - Institute for Applied Cancer Science,Gynecologic Oncology Group,United States,NO,T2b,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c600,58cfa831e4b0c9d6adf6c600,TCGA-CG-4466-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_4_rg.sorted.filtered.,WGS,TCGA-CG-4466-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_4_rg.sorted,TCGA-CG-4466-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_4_rg.sorted.bam,143.3,1.9,0.14,58cfa831e4b0c9d6adf6c600,TCGA-CG-4466-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4466-01A,2F1B96B2-7031-4F7D-9490-14728D320F3E,Primary Tumor,Illumina HiSeq,ca26b1dd-13f3-4f26-9cb8-922cb4b53a59,Stomach,81,0BC4ABB4-047B-4C8D-9F79-5B9EB32969E9,623D5E6A-A5D3-4580-BEF7-04673D42A1D0,TCGA-CG-4466-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4466,TCGA-STAD,NA,s14760,Harvard Medical School,Indivumed,Germany,NO,T2a,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa832e4b0c9d6adf6d024,58cfa832e4b0c9d6adf6d024,TCGA-GC-A3BM-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_3_rg.sorted.filtered.,WGS,TCGA-GC-A3BM-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_3_rg.sorted,TCGA-GC-A3BM-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_3_rg.sorted.bam,51.48,NA,0.15,58cfa832e4b0c9d6adf6d024,TCGA-GC-A3BM-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GC-A3BM-01A,7840AEA9-40C4-473E-BE33-8FA0B9F332C9,Primary Tumor,Illumina HiSeq,1901f2a9-837a-482c-8073-472f3c4d9ba1,Bladder,70,5C631CE8-F96A-4C35-A459-556FC4AB21E1,5FE3FF9D-CCF4-4C76-820D-26FD5D1FCD15,TCGA-GC-A3BM-01A-11D-A23Q-26,HG19_Broad_variant,TCGA-GC-A3BM,TCGA-BLCA,NA,s2924,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa832e4b0c9d6adf6d4a4,58cfa832e4b0c9d6adf6d4a4,TCGA-V4-A9EE-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_3_rg.sorted.filtered.,WGS,TCGA-V4-A9EE-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_3_rg.sorted,TCGA-V4-A9EE-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_3_rg.sorted.bam,13.28,NA,0.15,58cfa832e4b0c9d6adf6d4a4,TCGA-V4-A9EE-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EE-10A,EDBF6720-467E-4928-B1CB-0E7336358D18,Blood Derived Normal,Illumina HiSeq,13176c9c-7e2e-4835-9a15-75896c085c18,Eye,86,0E3BE5E7-04CC-4E29-ACE9-DF3E22701A1A,9B0E05B2-A98F-4BC4-8878-5280F78A1DC5,TCGA-V4-A9EE-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9EE,TCGA-UVM,398,s211,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3a,N0,Not available,Stage IIB
13722.58cfa830e4b0c9d6adf6c1f6,58cfa830e4b0c9d6adf6c1f6,TCGA-BG-A0M4-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BG-A0M4-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_1_rg.sorted,TCGA-BG-A0M4-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_1_rg.sorted.bam,66.56,2.03,0.15,58cfa830e4b0c9d6adf6c1f6,TCGA-BG-A0M4-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0M4-01A,73E5310D-BA8C-4CBC-AA4F-E06206F898F4,Primary Tumor,Illumina HiSeq,6f34976e-c9a0-4b3f-afb6-d476e4d9f22d,Uterus,60,E6E7E411-45CF-47A1-BCF0-7AE800A61A8D,238A1E43-B716-479B-82C8-0E62A30F9BE9,TCGA-BG-A0M4-01A-11D-A101-02,HG19_Broad_variant,TCGA-BG-A0M4,TCGA-UCEC,NA,s4429,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b7f2,58cfa82fe4b0c9d6adf6b7f2,TCGA-50-5055-10A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_6_rg.sorted.filtered.,WGS,TCGA-50-5055-10A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_6_rg.sorted,TCGA-50-5055-10A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_6_rg.sorted.bam,8.4,1.9,0.14,58cfa82fe4b0c9d6adf6b7f2,TCGA-50-5055-10A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5055-10A,CC3D9750-7CE0-489F-86D4-8017B7EBED29,Blood Derived Normal,Illumina HiSeq,d1b8082f-27b0-4a78-990a-3de7ee79daa3,Lung,79,7CF34EAB-C975-4CF2-ADA2-0AA156B533EA,C02CF895-93BD-4553-AD4D-9AC9D02A06C0,TCGA-50-5055-10A-01D-1623-02,HG19_Broad_variant,TCGA-50-5055,TCGA-LUAD,NA,s11346,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIA
13722.58cfa82fe4b0c9d6adf6b762,58cfa82fe4b0c9d6adf6b762,TCGA-75-5125-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_3_rg.sorted.filtered.,WGS,TCGA-75-5125-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_3_rg.sorted,TCGA-75-5125-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_3_rg.sorted.bam,628.4,1.9,0.15,58cfa82fe4b0c9d6adf6b762,TCGA-75-5125-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_3_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-5125-01A,205759A6-6391-491B-9857-0080C3A5871E,Primary Tumor,Illumina HiSeq,0a5ee83a-046b-41b4-9551-40372fa70b7d,Lung,NA,73A77977-FAB0-486F-8D15-BE8B30C8808A,02DE68CC-AD50-45FD-BB4D-819D6E0F55F5,TCGA-75-5125-01A-01D-1751-02,HG19_Broad_variant,TCGA-75-5125,TCGA-LUAD,NA,s11362,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa830e4b0c9d6adf6bd93,58cfa830e4b0c9d6adf6bd93,TCGA-BG-A0M6-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BG-A0M6-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_5_rg.sorted,TCGA-BG-A0M6-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_5_rg.sorted.bam,20.25,2.19,0.16,58cfa830e4b0c9d6adf6bd93,TCGA-BG-A0M6-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0M6-10A,002724FA-7051-49FA-9C58-4BCB7EBA4AC6,Blood Derived Normal,Illumina HiSeq,5884b987-20f3-49d4-adaa-3cde9f57adb8,Uterus,73,302D4FE2-E8F2-4C69-B767-6F01B4F42261,6D389072-9861-4CD5-BF7E-A389380F9FDF,TCGA-BG-A0M6-10A-01D-A101-02,HG19_Broad_variant,TCGA-BG-A0M6,TCGA-UCEC,NA,s4257,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c82a,58cfa831e4b0c9d6adf6c82a,TCGA-D3-A1Q8-10A-01D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-D3-A1Q8-10A-01D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_2_rg.sorted,TCGA-D3-A1Q8-10A-01D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_2_rg.sorted.bam,16.71,NA,0.17,58cfa831e4b0c9d6adf6c82a,TCGA-D3-A1Q8-10A-01D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A1Q8-10A,7B7A49B5-5BE8-4966-8F3A-E6E01E694F86,Blood Derived Normal,Illumina HiSeq,9944e3cf-cf47-4a95-bb4f-b82804de4674,Skin,33,FBB400A5-4F92-4C9E-B44C-89110811E667,B69AFD53-07D1-49E8-9049-06D83D6458FF,TCGA-D3-A1Q8-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-D3-A1Q8,TCGA-SKCM,854,s7830,Harvard Medical School,MD Anderson,United States,NO,T0,N3,Not available,Stage IV
13722.58cfa831e4b0c9d6adf6cbfe,58cfa831e4b0c9d6adf6cbfe,TCGA-DU-6405-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DU-6405-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_6_rg.sorted,TCGA-DU-6405-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_6_rg.sorted.bam,241.3,1.9,0.14,58cfa831e4b0c9d6adf6cbfe,TCGA-DU-6405-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_6_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6405-01A,9239A22E-80B1-49A2-B0D5-CBAB7E415254,Primary Tumor,Illumina HiSeq,2d1d4000-347f-44e4-8ff3-b61fea3daeb3,Brain,51,54BFF4F3-312D-4E1A-8327-F08F5A270EAC,9593D4DE-0DAB-4D1E-B86C-AF91CAC938E6,TCGA-DU-6405-01A-11D-1703-02,HG19_Broad_variant,TCGA-DU-6405,TCGA-LGG,605,s8359,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6c642,58cfa831e4b0c9d6adf6c642,TCGA-CN-4734-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CN-4734-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_1_rg.sorted,TCGA-CN-4734-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_1_rg.sorted.bam,72.7,1.9,0.15,58cfa831e4b0c9d6adf6c642,TCGA-CN-4734-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4734-01A,B80FDC9A-341D-4277-9664-8E8F770D9DDD,Primary Tumor,Illumina HiSeq,4b3be461-622d-492e-8465-1d0d1167701c,Head and Neck,70,20614787-1E55-40F0-88DE-080640EB8A03,EA9125C8-3F3B-47CE-AD79-802692B1FB4A,TCGA-CN-4734-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4734,TCGA-HNSC,NA,s15759,Harvard Medical School,University of Pittsburgh,None,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c900,58cfa831e4b0c9d6adf6c900,TCGA-DU-6399-01A-12D-1703_130813_SN1440_0160_AD2B87ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DU-6399-01A-12D-1703_130813_SN1440_0160_AD2B87ACXX_s_3_rg.sorted,TCGA-DU-6399-01A-12D-1703_130813_SN1440_0160_AD2B87ACXX_s_3_rg.sorted.bam,39.3,1.9,0.17,58cfa831e4b0c9d6adf6c900,TCGA-DU-6399-01A-12D-1703_130813_SN1440_0160_AD2B87ACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6399-01A,4EF429BE-C345-4258-9B42-B56E215E1A2C,Primary Tumor,Illumina HiSeq,bcd63f96-cd75-4e38-826d-5304bd0d18db,Brain,54,41555F97-0269-4F3D-AB13-6B0AE08D1FF5,329097BC-E434-4EA7-B0AC-EFF202C58C6F,TCGA-DU-6399-01A-12D-1703-02,HG19_Broad_variant,TCGA-DU-6399,TCGA-LGG,2000,s8754,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa832e4b0c9d6adf6cebc,58cfa832e4b0c9d6adf6cebc,TCGA-FE-A233-10A-01D-A14U_120629_SN1222_0121_BD143UACXX_s_6_rg.sorted.filtered.,WGS,TCGA-FE-A233-10A-01D-A14U_120629_SN1222_0121_BD143UACXX_s_6_rg.sorted,TCGA-FE-A233-10A-01D-A14U_120629_SN1222_0121_BD143UACXX_s_6_rg.sorted.bam,21.67,2,0.18,58cfa832e4b0c9d6adf6cebc,TCGA-FE-A233-10A-01D-A14U_120629_SN1222_0121_BD143UACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A233-10A,E70FEAFD-1390-4F4C-A635-DA65C1A7DAEB,Blood Derived Normal,Illumina HiSeq,42951f67-0d38-478d-8f8d-86556244b29d,Thyroid,18,B9FD4BE0-F412-494D-8837-BEB45B0A3B03,CFCCBE24-737D-4CDE-B74F-D319C3723974,TCGA-FE-A233-10A-01D-A14U-02,HG19_Broad_variant,TCGA-FE-A233,TCGA-THCA,NA,s12117,Harvard Medical School,Ohio State University,United States,NO,T2,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa830e4b0c9d6adf6bc7c,58cfa830e4b0c9d6adf6bc7c,TCGA-AP-A0LQ-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-AP-A0LQ-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_5_rg.sorted,TCGA-AP-A0LQ-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_5_rg.sorted.bam,63.33,2.03,0.16,58cfa830e4b0c9d6adf6bc7c,TCGA-AP-A0LQ-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LQ-01A,252500D2-86A3-4090-A57F-1E8C3D44C573,Primary Tumor,Illumina HiSeq,cf355e19-2857-4830-9be8-5053dc9c4d0a,Uterus,59,B75648DC-B25B-4EE6-850A-7D1F3A353E83,F8D9DE13-1935-483C-B2F4-B1CD8D61613F,TCGA-AP-A0LQ-01A-12D-A101-02,HG19_Broad_variant,TCGA-AP-A0LQ,TCGA-UCEC,NA,s5000,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c6bc,58cfa831e4b0c9d6adf6c6bc,TCGA-CQ-7065-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CQ-7065-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_4_rg.sorted,TCGA-CQ-7065-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_4_rg.sorted.bam,9.83,NA,0.14,58cfa831e4b0c9d6adf6c6bc,TCGA-CQ-7065-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_4_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-7065-10A,20ECE2CA-8601-4CCA-AEC5-0A5C0B92594D,Blood Derived Normal,Illumina HiSeq,2b184042-0329-4d3e-866c-14da9baa50d2,Head and Neck,40,DF6098B9-A45D-4EF8-A29B-B4B3F271D335,378F921F-A78B-4094-A8C4-D41ECCDB94F9,TCGA-CQ-7065-10A-01D-2317-26,HG19_Broad_variant,TCGA-CQ-7065,TCGA-HNSC,NA,s16036,MD Anderson - Institute for Applied Cancer Science,"University Health Network, Toronto",Canada,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6cda5,58cfa831e4b0c9d6adf6cda5,TCGA-FE-A3PB-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FE-A3PB-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_2_rg.sorted,TCGA-FE-A3PB-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_2_rg.sorted.bam,45.08,NA,0.15,58cfa831e4b0c9d6adf6cda5,TCGA-FE-A3PB-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A3PB-01A,05A8268A-6B33-429B-8638-8C9BB366EF28,Primary Tumor,Illumina HiSeq,cc57e94a-0d41-4543-a4d8-3b42fc1afd8c,Thyroid,33,955243D6-118F-41B7-BC8A-D3DDF7AD00B6,F89BA6FD-2785-49F3-8611-5147D09C6AC0,TCGA-FE-A3PB-01A-11D-A221-26,HG19_Broad_variant,TCGA-FE-A3PB,TCGA-THCA,NA,s12650,MD Anderson - RPPA Core Facility (Proteomics),Ohio State University,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6cb66,58cfa831e4b0c9d6adf6cb66,TCGA-EE-A2GS-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EE-A2GS-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_6_rg.sorted,TCGA-EE-A2GS-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_6_rg.sorted.bam,19.44,NA,0.15,58cfa831e4b0c9d6adf6cb66,TCGA-EE-A2GS-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2GS-10A,880BB701-F1D3-4BF2-BFC8-143AD8D07B6A,Blood Derived Normal,Illumina HiSeq,49f9daa4-da67-4d32-9183-82c94e8344b4,Skin,28,DA45B6F7-4C97-4614-BE20-3BD10F785476,C21B6ECB-F70F-4E2E-964B-CBA7E8EBAEE9,TCGA-EE-A2GS-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2GS,TCGA-SKCM,NA,s7350,Harvard Medical School,University of Sydney,Australia,NO,T2a,N0,Not available,Stage IB
13722.58cfa82ee4b0c9d6adf6b038,58cfa82ee4b0c9d6adf6b038,TCGA-05-4424-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_1_rg.sorted.filtered.,WGS,TCGA-05-4424-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_1_rg.sorted,TCGA-05-4424-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_1_rg.sorted.bam,16.7,1.9,0.14,58cfa82ee4b0c9d6adf6b038,TCGA-05-4424-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_1_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4424-01A,66763A0C-6CDA-4832-A0CC-E7B496D78EAA,Primary Tumor,Illumina HiSeq,1e635509-6178-417e-9452-bc77482ee8ed,Lung,70,A4D06D63-8DA9-4C3C-A75D-4079C2238AA8,D1052F23-44EC-4C05-A164-6FBD72DFC9E2,TCGA-05-4424-01A-22D-1853-02,HG19_Broad_variant,TCGA-05-4424,TCGA-LUAD,NA,s11438,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Lung Adenocarcinoma Mixed Subtype,Stage IIB
13722.58cfa830e4b0c9d6adf6c027,58cfa830e4b0c9d6adf6c027,TCGA-BJ-A0ZA-10A-02D-A10R_120616_SN1120_0154_BD142VACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BJ-A0ZA-10A-02D-A10R_120616_SN1120_0154_BD142VACXX_s_7_rg.sorted,TCGA-BJ-A0ZA-10A-02D-A10R_120616_SN1120_0154_BD142VACXX_s_7_rg.sorted.bam,7.91,1.97,0.13,58cfa830e4b0c9d6adf6c027,TCGA-BJ-A0ZA-10A-02D-A10R_120616_SN1120_0154_BD142VACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0ZA-10A,4C513413-263E-4C7B-B997-7B688C47B698,Blood Derived Normal,Illumina HiSeq,b6543b80-1693-4e71-b213-e80b5a7c7e81,Thyroid,67,EAD7A19A-AF58-4B53-8091-A52C2221A4A9,6F261862-34AD-4C24-B71F-934B0762F5D8,TCGA-BJ-A0ZA-10A-02D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZA,TCGA-THCA,NA,s12626,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage II
13722.58cfa832e4b0c9d6adf6cfd0,58cfa832e4b0c9d6adf6cfd0,TCGA-FU-A3HZ-10A-01D-A20X_140106_SN590_0243_AC371BACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FU-A3HZ-10A-01D-A20X_140106_SN590_0243_AC371BACXX_s_8_rg.sorted,TCGA-FU-A3HZ-10A-01D-A20X_140106_SN590_0243_AC371BACXX_s_8_rg.sorted.bam,21.79,NA,0.14,58cfa832e4b0c9d6adf6cfd0,TCGA-FU-A3HZ-10A-01D-A20X_140106_SN590_0243_AC371BACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-FU-A3HZ-10A,6FF12A54-10DA-4941-BFEA-7B66E19B4BE9,Blood Derived Normal,Illumina HiSeq,d2ffd1d9-03a6-48ce-9dcc-4302224492ec,Cervix,64,11958C14-EAF7-49CF-97CE-686341DD94C0,36FB3357-BC39-4A59-ABAD-C6D0C1C4F2E5,TCGA-FU-A3HZ-10A-01D-A20X-26,HG19_Broad_variant,TCGA-FU-A3HZ,TCGA-CESC,NA,s1533,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T2a2,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6cc2b,58cfa831e4b0c9d6adf6cc2b,TCGA-DU-7007-10A-01D-2022_130910_SN208_0494_AC2A1DACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DU-7007-10A-01D-2022_130910_SN208_0494_AC2A1DACXX_s_8_rg.sorted,TCGA-DU-7007-10A-01D-2022_130910_SN208_0494_AC2A1DACXX_s_8_rg.sorted.bam,81,NA,0.15,58cfa831e4b0c9d6adf6cc2b,TCGA-DU-7007-10A-01D-2022_130910_SN208_0494_AC2A1DACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7007-10A,8E2DCC00-9F7E-4DEE-B24D-43C8B30294C5,Blood Derived Normal,Illumina HiSeq,df044351-b6ec-40c5-befc-9a76d30cd84c,Brain,33,D801113A-0DB4-4C93-960F-6870AB10435F,5424DC10-3749-49F8-8972-69C24AF94AA4,TCGA-DU-7007-10A-01D-2022-02,HG19_Broad_variant,TCGA-DU-7007,TCGA-LGG,1915,s8141,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa82fe4b0c9d6adf6b6be,58cfa82fe4b0c9d6adf6b6be,TCGA-55-6543-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_8.rg.sorted.filtered.,WGS,TCGA-55-6543-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_8.rg.sorted,TCGA-55-6543-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_8.rg.sorted.bam,127.4,1.9,0.15,58cfa82fe4b0c9d6adf6b6be,TCGA-55-6543-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_8.rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-55-6543-01A,E68219B0-A9C2-49DF-8F0D-DB5EA97FD2DC,Primary Tumor,Illumina HiSeq,0715b83e-fcd8-41e9-88ac-cfeb5fabd3de,Lung,60,8D9491E7-9B14-4988-8FA7-E6AF041120BD,1D88DA12-E71A-4F44-8D71-DA8957BDFCD4,TCGA-55-6543-01A-11D-1751-02,HG19_Broad_variant,TCGA-55-6543,TCGA-LUAD,NA,s10791,Harvard Medical School,International Genomics Consortium,United States,NO,T1b,N0,Lung Bronchioloalveolar Carcinoma Mucinous,Stage IA
13722.58cfa832e4b0c9d6adf6d49c,58cfa832e4b0c9d6adf6d49c,TCGA-V4-A9F4-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-V4-A9F4-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_4_rg.sorted,TCGA-V4-A9F4-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_4_rg.sorted.bam,55.04,NA,0.16,58cfa832e4b0c9d6adf6d49c,TCGA-V4-A9F4-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9F4-01A,4B9FD822-17AA-4A22-8E17-175A72931D5D,Primary Tumor,Illumina HiSeq,1f82d81a-7827-4bb8-89b2-fc4bd009cdde,Eye,41,AD550F5E-1469-4A09-9CDA-3F069B1AE258,1837571E-8D54-4BA2-A9FB-B7160BFD38BB,TCGA-V4-A9F4-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9F4,TCGA-UVM,NA,s236,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa832e4b0c9d6adf6ce94,58cfa832e4b0c9d6adf6ce94,TCGA-G2-A3IE-10A-01D-A210_120912_SN1222_0149_BD1CW3ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-G2-A3IE-10A-01D-A210_120912_SN1222_0149_BD1CW3ACXX_s_4_rg.sorted,TCGA-G2-A3IE-10A-01D-A210_120912_SN1222_0149_BD1CW3ACXX_s_4_rg.sorted.bam,15.12,NA,0.16,58cfa832e4b0c9d6adf6ce94,TCGA-G2-A3IE-10A-01D-A210_120912_SN1222_0149_BD1CW3ACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-G2-A3IE-10A,C65BA2B8-E867-42E8-BBD0-C2CDF5130CFB,Blood Derived Normal,Illumina HiSeq,4630216d-d5a0-4073-a48f-8326641af6de,Bladder,51,9DF84D8A-DBDE-4C67-B662-78F5E63FB43A,33EF5F61-EF32-44C0-A963-A266DA07BABB,TCGA-G2-A3IE-10A-01D-A210-26,HG19_Broad_variant,TCGA-G2-A3IE,TCGA-BLCA,612,s3117,MD Anderson - Institute for Applied Cancer Science,MD Anderson,United States,NO,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa832e4b0c9d6adf6d191,58cfa832e4b0c9d6adf6d191,TCGA-FE-A3PC-01A-11D-A221_120524_SN1120_0145_BD12MWACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FE-A3PC-01A-11D-A221_120524_SN1120_0145_BD12MWACXX_s_2_rg.sorted,TCGA-FE-A3PC-01A-11D-A221_120524_SN1120_0145_BD12MWACXX_s_2_rg.sorted.bam,48.5,NA,0.15,58cfa832e4b0c9d6adf6d191,TCGA-FE-A3PC-01A-11D-A221_120524_SN1120_0145_BD12MWACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A3PC-01A,A86AC3B5-B5E9-4420-8DE0-A358FCAD85B6,Primary Tumor,Illumina HiSeq,7072b927-397f-4821-a834-0b1e21ec3434,Thyroid,37,7A5628FF-C5C2-4F25-809B-640415323477,8B0BF4B5-9846-473B-A2DB-8390B0DB90A7,TCGA-FE-A3PC-01A-11D-A221-26,HG19_Broad_variant,TCGA-FE-A3PC,TCGA-THCA,NA,s12647,MD Anderson - Institute for Applied Cancer Science,Ohio State University,United States,NO,T3,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82ee4b0c9d6adf6b014,58cfa82ee4b0c9d6adf6b014,TCGA-05-4433-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_3_rg.sorted.filtered.,WGS,TCGA-05-4433-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_3_rg.sorted,TCGA-05-4433-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_3_rg.sorted.bam,199.7,1.9,0.16,58cfa82ee4b0c9d6adf6b014,TCGA-05-4433-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_3_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4433-01A,AEA68827-DC0F-484D-A00D-06DEEAA4B3CE,Primary Tumor,Illumina HiSeq,d1b6064d-6736-4aad-8ad3-70ab64c92e3d,Lung,82,1E9DAC94-1A10-47D0-AE92-81D38A264376,61B1812A-9455-437F-ACF7-D1AC3FA9F215,TCGA-05-4433-01A-22D-1853-02,HG19_Broad_variant,TCGA-05-4433,TCGA-LUAD,NA,s10986,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa831e4b0c9d6adf6cacc,58cfa831e4b0c9d6adf6cacc,TCGA-DA-A1I2-10A-01D-A18Z_120520_SN590_0158_AC0J99ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DA-A1I2-10A-01D-A18Z_120520_SN590_0158_AC0J99ACXX_s_2_rg.sorted,TCGA-DA-A1I2-10A-01D-A18Z_120520_SN590_0158_AC0J99ACXX_s_2_rg.sorted.bam,37.33,NA,0.16,58cfa831e4b0c9d6adf6cacc,TCGA-DA-A1I2-10A-01D-A18Z_120520_SN590_0158_AC0J99ACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1I2-10A,01AD975D-C2ED-4E4D-BD3B-C9512FC9073C,Blood Derived Normal,Illumina HiSeq,e0b5bd2d-5be5-428e-8560-0623991eaa7c,Skin,45,346BA3E2-73E0-4ACC-961E-13D258A286DA,E498CB49-0DF9-4FB6-A426-4B09202C16D6,TCGA-DA-A1I2-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-DA-A1I2,TCGA-SKCM,NA,s8001,Harvard Medical School,Yale,United States,NO,T4b,N2b,Not available,Stage III
13722.58cfa832e4b0c9d6adf6d132,58cfa832e4b0c9d6adf6d132,TCGA-FY-A3R6-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FY-A3R6-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_1_rg.sorted,TCGA-FY-A3R6-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_1_rg.sorted.bam,10.85,NA,0.16,58cfa832e4b0c9d6adf6d132,TCGA-FY-A3R6-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FY-A3R6-01A,905469D2-4C97-4293-A20C-1B1F0462A25D,Primary Tumor,Illumina HiSeq,bd320251-720a-4498-a699-419a2544fe75,Thyroid,57,65414BA0-8800-4626-9488-10D79274CF32,EFF7FEA8-DF07-4DAD-BD26-7384906844E9,TCGA-FY-A3R6-01A-11D-A221-26,HG19_Broad_variant,TCGA-FY-A3R6,TCGA-THCA,NA,s12258,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T2,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA
13722.58cfa82ee4b0c9d6adf6af8a,58cfa82ee4b0c9d6adf6af8a,TCGA-05-4390-10A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_2_rg.sorted.filtered.,WGS,TCGA-05-4390-10A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_2_rg.sorted,TCGA-05-4390-10A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_2_rg.sorted.bam,27,1.9,0.15,58cfa82ee4b0c9d6adf6af8a,TCGA-05-4390-10A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4390-10A,B8475929-2D9D-4909-BD62-59684A140BD7,Blood Derived Normal,Illumina HiSeq,ad4b348b-351c-4edf-b95d-e49dfe7c5de7,Lung,58,B038C472-1AF2-45E1-81D8-B66FAE6FD66F,D3C7ABBD-591E-4F80-9A1C-046C2C4C1028,TCGA-05-4390-10A-01D-1751-02,HG19_Broad_variant,TCGA-05-4390,TCGA-LUAD,NA,s10899,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa831e4b0c9d6adf6caf2,58cfa831e4b0c9d6adf6caf2,TCGA-E1-5305-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-E1-5305-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_1_rg.sorted,TCGA-E1-5305-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_1_rg.sorted.bam,19,1.9,0.16,58cfa831e4b0c9d6adf6caf2,TCGA-E1-5305-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-E1-5305-10A,A0BC5147-D9B4-41FD-8DF3-A241D23722E8,Blood Derived Normal,Illumina HiSeq,69689ca9-e4c2-440e-9e41-961f4b548891,Brain,34,CA30BB7E-5171-4C32-9D2E-BBB8DBA00832,18C43302-644E-4786-8BB6-0FE155B00DC2,TCGA-E1-5305-10A-01D-1891-02,HG19_Broad_variant,TCGA-E1-5305,TCGA-LGG,2433,s8569,Harvard Medical School,Duke,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6c8b3,58cfa831e4b0c9d6adf6c8b3,TCGA-CV-7411-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CV-7411-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_1_rg.sorted,TCGA-CV-7411-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_1_rg.sorted.bam,10.03,NA,0.14,58cfa831e4b0c9d6adf6c8b3,TCGA-CV-7411-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7411-10A,600FC87B-A177-4BF9-9084-457F7E7E102C,Blood Derived Normal,Illumina HiSeq,9ad035d2-035c-4447-a744-24409cfeb23e,Head and Neck,64,3F69EF25-0751-46B5-934D-9501DA864535,2A1972F4-F2EE-40C5-BF2F-22F4C26237D7,TCGA-CV-7411-10A-01D-2317-26,HG19_Broad_variant,TCGA-CV-7411,TCGA-HNSC,2717,s16207,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6d3f1,58cfa832e4b0c9d6adf6d3f1,TCGA-V4-A9EF-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_4_rg.sorted.filtered.,WGS,TCGA-V4-A9EF-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_4_rg.sorted,TCGA-V4-A9EF-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_4_rg.sorted.bam,14.01,NA,0.16,58cfa832e4b0c9d6adf6d3f1,TCGA-V4-A9EF-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EF-10A,A18D3BA3-E2F4-4144-9C25-2019CAD193F4,Blood Derived Normal,Illumina HiSeq,78a187f9-d569-4fc7-9d0f-cbcf6ff44771,Eye,56,D1BBFD38-9E8A-43CB-8380-2ACB524088D1,88B85F89-CF62-4BEB-8C1C-042D1B199427,TCGA-V4-A9EF-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9EF,TCGA-UVM,NA,s205,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4b,N0,Not available,Stage IIIB
13722.58cfa830e4b0c9d6adf6c197,58cfa830e4b0c9d6adf6c197,TCGA-BH-A0H7-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BH-A0H7-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_8_rg.sorted,TCGA-BH-A0H7-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_8_rg.sorted.bam,6.8,1.96,0.17,58cfa830e4b0c9d6adf6c197,TCGA-BH-A0H7-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0H7-10A,2021ED1F-DC75-4701-B8B8-1386466E4802,Blood Derived Normal,Illumina HiSeq,a267b823-747c-4258-b5e8-9cb33834ff6a,Breast,65,F104689E-1DC6-412D-BFAA-D3203EAF095C,AA3E5150-7EFF-4837-9946-EFECBEE42E92,TCGA-BH-A0H7-10A-01D-A060-02,HG19_Broad_variant,TCGA-BH-A0H7,TCGA-BRCA,NA,s6773,Harvard Medical School,University of Pittsburgh,None,NO,T1c,N2a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa831e4b0c9d6adf6cca7,58cfa831e4b0c9d6adf6cca7,TCGA-EE-A2MJ-10A-01D-A190_120729_SN1120_0179_AC11G3ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EE-A2MJ-10A-01D-A190_120729_SN1120_0179_AC11G3ACXX_s_3_rg.sorted,TCGA-EE-A2MJ-10A-01D-A190_120729_SN1120_0179_AC11G3ACXX_s_3_rg.sorted.bam,76.88,NA,0.17,58cfa831e4b0c9d6adf6cca7,TCGA-EE-A2MJ-10A-01D-A190_120729_SN1120_0179_AC11G3ACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MJ-10A,8509F10A-C454-45A5-9C22-853FDA423B9F,Blood Derived Normal,Illumina HiSeq,ef89481c-65ce-4d5e-8f55-3544d9b1be29,Skin,60,A76B218B-2CE8-43D9-8E5E-9BF7561F6AF9,53494B17-8D69-4F26-B944-7FFEB5B95524,TCGA-EE-A2MJ-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2MJ,TCGA-SKCM,2927,s7518,Harvard Medical School,University of Sydney,Australia,NO,T4b,N0,Not available,Stage III
13722.58cfa831e4b0c9d6adf6c855,58cfa831e4b0c9d6adf6c855,TCGA-D7-5577-10A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D7-5577-10A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_4_rg.sorted,TCGA-D7-5577-10A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_4_rg.sorted.bam,72.7,1.9,0.17,58cfa831e4b0c9d6adf6c855,TCGA-D7-5577-10A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-5577-10A,2DC154AA-C478-404B-A92E-86ABCC8DBDB7,Blood Derived Normal,Illumina HiSeq,9f188367-53c1-43c9-a6bb-c59e0546fb91,Stomach,53,52FE54DA-9C54-49F6-89D3-7039B86A7D7D,EB4BEB73-DFEC-4A76-A41C-3266B9DBB17C,TCGA-D7-5577-10A-01D-1598-02,HG19_Broad_variant,TCGA-D7-5577,TCGA-STAD,NA,s14709,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N3,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIIA
13722.58cfa831e4b0c9d6adf6c8de,58cfa831e4b0c9d6adf6c8de,TCGA-CV-7429-01A-11D-2317_120710_SN590_0165_BC0VU7ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CV-7429-01A-11D-2317_120710_SN590_0165_BC0VU7ACXX_s_4_rg.sorted,TCGA-CV-7429-01A-11D-2317_120710_SN590_0165_BC0VU7ACXX_s_4_rg.sorted.bam,262.73,NA,0.15,58cfa831e4b0c9d6adf6c8de,TCGA-CV-7429-01A-11D-2317_120710_SN590_0165_BC0VU7ACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7429-01A,44D99F11-EF5B-45D7-B7DF-B5C5893D878F,Primary Tumor,Illumina HiSeq,4860e1b8-251e-4894-91f2-c9416a9b7f28,Head and Neck,55,A8A03639-FAD0-4B1B-9802-E3882BBFC7B8,18E1FCE0-D678-48D9-AD23-432E23C9077D,TCGA-CV-7429-01A-11D-2317-26,HG19_Broad_variant,TCGA-CV-7429,TCGA-HNSC,107,s15908,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6bf89,58cfa830e4b0c9d6adf6bf89,TCGA-BJ-A3PT-10A-01D-A221_120530_SN1222_0111_BD12L1ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BJ-A3PT-10A-01D-A221_120530_SN1222_0111_BD12L1ACXX_s_3_rg.sorted,TCGA-BJ-A3PT-10A-01D-A221_120530_SN1222_0111_BD12L1ACXX_s_3_rg.sorted.bam,14.3,NA,0.15,58cfa830e4b0c9d6adf6bf89,TCGA-BJ-A3PT-10A-01D-A221_120530_SN1222_0111_BD12L1ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A3PT-10A,29C4319C-3EAD-42B1-810D-418DA8D515C4,Blood Derived Normal,Illumina HiSeq,e321cd7c-76e9-42a9-8b95-147d6044e88d,Thyroid,51,FF8056D1-C634-4B2F-8454-767C32568F1E,6FA57A46-E968-4539-BDC5-C785DCA718FE,TCGA-BJ-A3PT-10A-01D-A221-26,HG19_Broad_variant,TCGA-BJ-A3PT,TCGA-THCA,NA,s12357,MD Anderson - Institute for Applied Cancer Science,University of Pittsburgh,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa831e4b0c9d6adf6ca21,58cfa831e4b0c9d6adf6ca21,TCGA-DJ-A1QD-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DJ-A1QD-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_6_rg.sorted,TCGA-DJ-A1QD-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_6_rg.sorted.bam,61.38,2,0.18,58cfa831e4b0c9d6adf6ca21,TCGA-DJ-A1QD-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QD-01A,DA201150-748E-4B74-BB35-10C995E26079,Primary Tumor,Illumina HiSeq,df7bafb3-c992-479d-be29-dae220124025,Thyroid,20,A8307181-67CE-4A79-8D23-76CEEE1D2761,781162AA-AAFA-4C44-B9AF-727917E8C9F4,TCGA-DJ-A1QD-01A-11D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QD,TCGA-THCA,NA,s12367,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c693,58cfa831e4b0c9d6adf6c693,TCGA-CU-A0YR-10A-01D-A10R_120926_SN590_0182_BD1EAGACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CU-A0YR-10A-01D-A10R_120926_SN590_0182_BD1EAGACXX_s_8_rg.sorted,TCGA-CU-A0YR-10A-01D-A10R_120926_SN590_0182_BD1EAGACXX_s_8_rg.sorted.bam,27.06,2.08,0.17,58cfa831e4b0c9d6adf6c693,TCGA-CU-A0YR-10A-01D-A10R_120926_SN590_0182_BD1EAGACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CU-A0YR-10A,811B3950-36E7-485F-BC48-ACA1EEE2DDEF,Blood Derived Normal,Illumina HiSeq,d19696d2-2d27-4f0f-acfa-a934b3336215,Bladder,83,0810DD0F-204F-415E-B849-79C0AA43A030,34E801D2-2A81-4F1A-A0E3-799A7CD4EEB5,TCGA-CU-A0YR-10A-01D-A10R-02,HG19_Broad_variant,TCGA-CU-A0YR,TCGA-BLCA,NA,s2879,Harvard Medical School,UNC,United States,NO,T2,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6d1ba,58cfa832e4b0c9d6adf6d1ba,TCGA-HR-A2OH-01A-11D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_1_rg.sorted.filtered.,WGS,TCGA-HR-A2OH-01A-11D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_1_rg.sorted,TCGA-HR-A2OH-01A-11D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_1_rg.sorted.bam,42.28,NA,0.15,58cfa832e4b0c9d6adf6d1ba,TCGA-HR-A2OH-01A-11D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_1_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Skin Cutaneous Melanoma,Aligned reads,TCGA-HR-A2OH-06A,6668ACFE-1594-42C0-B839-8A592702675F,Metastatic,Illumina HiSeq,e5833102-da03-41b2-8042-99e9d2c36758,Skin,46,0E839C8C-39B3-4DFB-8798-4AAAB5F20460,CC15F1D0-36E1-44E6-8FEE-0A6DEB3FA407,TCGA-HR-A2OH-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-HR-A2OH,TCGA-SKCM,2004,s7705,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,T3b,N2a,Not available,Stage IIIB
13722.58cfa830e4b0c9d6adf6c262,58cfa830e4b0c9d6adf6c262,TCGA-C5-A1BQ-10A-01D-A20X_140106_SN590_0243_AC371BACXX_s_6_rg.sorted.filtered.,WGS,TCGA-C5-A1BQ-10A-01D-A20X_140106_SN590_0243_AC371BACXX_s_6_rg.sorted,TCGA-C5-A1BQ-10A-01D-A20X_140106_SN590_0243_AC371BACXX_s_6_rg.sorted.bam,16.26,NA,0.15,58cfa830e4b0c9d6adf6c262,TCGA-C5-A1BQ-10A-01D-A20X_140106_SN590_0243_AC371BACXX_s_6_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A1BQ-10A,E77C3F70-08D1-40D3-B038-F09A519423CC,Blood Derived Normal,Illumina HiSeq,16a3e11d-b1b5-40a1-adc4-2985ddceef19,Cervix,65,5E2F8194-F97F-4AFE-B68D-6AF81A516288,ADB4CC51-9343-4879-9C4F-2F64FA812D4D,TCGA-C5-A1BQ-10A-01D-A20X-26,HG19_Broad_variant,TCGA-C5-A1BQ,TCGA-CESC,604,s1177,MD Anderson - Institute for Applied Cancer Science,Medical College of Wisconsin,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c7c0,58cfa831e4b0c9d6adf6c7c0,TCGA-CN-5369-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CN-5369-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_7_rg.sorted,TCGA-CN-5369-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_7_rg.sorted.bam,64.4,1.9,0.16,58cfa831e4b0c9d6adf6c7c0,TCGA-CN-5369-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5369-10A,B98867D7-7D5A-4C58-8878-37BEE6F2F4FA,Blood Derived Normal,Illumina HiSeq,054b3120-d8ab-44a6-93c2-a8a5ae1f7855,Head and Neck,90,8D31F35C-9178-447D-9A2B-ACC305FAB407,A8FA8446-39EF-4B2C-B42B-A6FFD39139E1,TCGA-CN-5369-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5369,TCGA-HNSC,380,s15502,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6ce44,58cfa832e4b0c9d6adf6ce44,TCGA-EM-A3O9-10A-01D-A221_120530_SN1222_0111_BD12L1ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EM-A3O9-10A-01D-A221_120530_SN1222_0111_BD12L1ACXX_s_8_rg.sorted,TCGA-EM-A3O9-10A-01D-A221_120530_SN1222_0111_BD12L1ACXX_s_8_rg.sorted.bam,60.45,NA,0.16,58cfa832e4b0c9d6adf6ce44,TCGA-EM-A3O9-10A-01D-A221_120530_SN1222_0111_BD12L1ACXX_s_8_rg.sorted.bam,Alive,MALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3O9-10A,34B8D361-9C95-4F28-8E45-669DEFC5C3A7,Blood Derived Normal,Illumina HiSeq,2eb46d1f-f0f0-4fca-a0e7-fe43854a78da,Thyroid,40,EE680E2F-6164-4446-ADBC-6E6F9088B5B3,810506C0-04AB-4AE4-9444-E8CCF430ED4C,TCGA-EM-A3O9-10A-01D-A221-26,HG19_Broad_variant,TCGA-EM-A3O9,TCGA-THCA,NA,s12000,MD Anderson - Institute for Applied Cancer Science,University Health Network,Canada,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa832e4b0c9d6adf6d042,58cfa832e4b0c9d6adf6d042,TCGA-FU-A3EO-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FU-A3EO-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_1_rg.sorted,TCGA-FU-A3EO-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_1_rg.sorted.bam,43.71,NA,0.16,58cfa832e4b0c9d6adf6d042,TCGA-FU-A3EO-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-FU-A3EO-01A,B7F2958F-256E-4C30-9C61-11E76DDB36BA,Primary Tumor,Illumina HiSeq,31874bb0-fa47-43d4-8135-1be05e8163eb,Cervix,55,59F1684E-5631-4E1E-A1DC-91739F7C159C,50DBFC58-57DC-4878-8506-7B6B21899DF5,TCGA-FU-A3EO-01A-11D-A20X-26,HG19_Broad_variant,TCGA-FU-A3EO,TCGA-CESC,NA,s1201,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T2b,N0,Endocervical Type of Adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6c2ce,58cfa830e4b0c9d6adf6c2ce,TCGA-B5-A0JN-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_3_rg.sorted.filtered.,WGS,TCGA-B5-A0JN-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_3_rg.sorted,TCGA-B5-A0JN-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_3_rg.sorted.bam,73.22,2.09,0.15,58cfa830e4b0c9d6adf6c2ce,TCGA-B5-A0JN-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_3_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0JN-01A,B60F22AC-A659-4F33-B01D-820E86A9A5C9,Primary Tumor,Illumina HiSeq,19c2a28e-bdeb-46af-b33e-e9849fc553ed,Uterus,84,684C6894-FD49-4934-8962-9628ECE734FB,EB2131FF-4AE0-4814-81F3-A480A0DEBB2E,TCGA-B5-A0JN-01A-11D-A101-02,HG19_Broad_variant,TCGA-B5-A0JN,TCGA-UCEC,NA,s4245,Harvard Medical School,Duke,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c36a,58cfa831e4b0c9d6adf6c36a,TCGA-CG-5720-11A-01D-1598_121029_SN208_0439_BD1KHKACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CG-5720-11A-01D-1598_121029_SN208_0439_BD1KHKACXX_s_4_rg.sorted,TCGA-CG-5720-11A-01D-1598_121029_SN208_0439_BD1KHKACXX_s_4_rg.sorted.bam,326,1.9,0.15,58cfa831e4b0c9d6adf6c36a,TCGA-CG-5720-11A-01D-1598_121029_SN208_0439_BD1KHKACXX_s_4_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5720-11A,7C9EA4FA-4CBC-4941-945A-E531E1D48304,Solid Tissue Normal,Illumina HiSeq,75fe7913-8432-492a-a33c-286c06164f35,Stomach,71,4D91E3D9-C9AC-487D-B617-295AF67176B0,EA5CD178-A2D6-4F23-8164-E5963541B835,TCGA-CG-5720-11A-01D-1598-02,HG19_Broad_variant,TCGA-CG-5720,TCGA-STAD,30,s15458,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa832e4b0c9d6adf6cdfc,58cfa832e4b0c9d6adf6cdfc,TCGA-FD-A3SN-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_7_rg.sorted.filtered.,WGS,TCGA-FD-A3SN-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_7_rg.sorted,TCGA-FD-A3SN-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_7_rg.sorted.bam,33.16,NA,0.15,58cfa832e4b0c9d6adf6cdfc,TCGA-FD-A3SN-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3SN-01A,0FB043D3-D86B-4CD8-8C01-9E2B3E965BB0,Primary Tumor,Illumina HiSeq,2281a267-dad6-42d6-9df2-8d37a696c507,Bladder,79,127892ED-8A7A-41CB-8ABE-353E09E6D327,B0AD1373-0C51-41A3-9F8B-BDE28C67CFB8,TCGA-FD-A3SN-01A-12D-A233-26,HG19_Broad_variant,TCGA-FD-A3SN,TCGA-BLCA,NA,s2719,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c84d,58cfa831e4b0c9d6adf6c84d,TCGA-D3-A2JP-06A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D3-A2JP-06A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_3_rg.sorted,TCGA-D3-A2JP-06A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_3_rg.sorted.bam,52.77,NA,0.16,58cfa831e4b0c9d6adf6c84d,TCGA-D3-A2JP-06A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A2JP-06A,E9A42A85-9513-41B2-A71D-6D62F70B00E4,Metastatic,Illumina HiSeq,ed56a64c-9f71-4163-bdda-c3d36448943e,Skin,37,922EA7D7-2F0F-47B3-BC8C-6A55203EBECB,D3A9DE23-92A7-401A-B49B-5CA3B97F8F9D,TCGA-D3-A2JP-06A-11D-A18Z-02,HG19_Broad_variant,TCGA-D3-A2JP,TCGA-SKCM,NA,s7670,Harvard Medical School,MD Anderson,United States,NO,T0,N3,Not available,Stage IIIC
13722.58cfa830e4b0c9d6adf6c1c0,58cfa830e4b0c9d6adf6c1c0,TCGA-BB-4225-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BB-4225-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_3_rg.sorted,TCGA-BB-4225-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_3_rg.sorted.bam,56.7,1.9,0.15,58cfa830e4b0c9d6adf6c1c0,TCGA-BB-4225-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BB-4225-01A,C1F50A22-38DF-41CC-A1F4-F7985504A7AC,Primary Tumor,Illumina HiSeq,4903ac5e-6fa0-41de-b272-c4139a3c0632,Head and Neck,73,AC42070B-F4D6-47BE-96AA-A713D66A0072,F7E6BD4D-3E7C-427E-8618-FAFB3731E597,TCGA-BB-4225-01A-01D-1431-02,HG19_Broad_variant,TCGA-BB-4225,TCGA-HNSC,NA,s16024,Harvard Medical School,Johns Hopkins,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d364,58cfa832e4b0c9d6adf6d364,TCGA-L5-A4OE-11A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_2_rg.sorted.filtered.,WGS,TCGA-L5-A4OE-11A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_2_rg.sorted,TCGA-L5-A4OE-11A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_2_rg.sorted.bam,20.71,NA,0.17,58cfa832e4b0c9d6adf6d364,TCGA-L5-A4OE-11A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OE-11A,0A466142-C513-4257-85D4-4BD7CFD0EF29,Solid Tissue Normal,Illumina HiSeq,a69b345d-d7ec-4a0c-8798-6f086e030da6,Esophagus,81,AB5FB3E7-5ECE-4713-93BD-589B873E7C07,9CC4E7DB-B881-406F-9E7D-B4E09D0FA644,TCGA-L5-A4OE-11A-11D-A267-26,HG19_Broad_variant,TCGA-L5-A4OE,TCGA-ESCA,NA,s1649,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T3,N2,Not available,Stage IIIB
13722.58cfa832e4b0c9d6adf6cee4,58cfa832e4b0c9d6adf6cee4,TCGA-EM-A3O8-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EM-A3O8-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_2_rg.sorted,TCGA-EM-A3O8-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_2_rg.sorted.bam,55.95,NA,0.15,58cfa832e4b0c9d6adf6cee4,TCGA-EM-A3O8-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3O8-01A,97B5017C-2066-4472-AB3F-31CFE64A6762,Primary Tumor,Illumina HiSeq,63701f3e-e258-497f-a7b6-1dddce3369f2,Thyroid,33,7F540311-430C-46B2-98C8-F314B27ECB0E,F125CCA1-271D-4716-9746-9AB9DD2A1C43,TCGA-EM-A3O8-01A-11D-A221-26,HG19_Broad_variant,TCGA-EM-A3O8,TCGA-THCA,NA,s12252,MD Anderson - Institute for Applied Cancer Science,University Health Network,Canada,NO,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa831e4b0c9d6adf6caba,58cfa831e4b0c9d6adf6caba,TCGA-DA-A1HW-06A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DA-A1HW-06A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_7_rg.sorted,TCGA-DA-A1HW-06A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_7_rg.sorted.bam,44.61,NA,0.16,58cfa831e4b0c9d6adf6caba,TCGA-DA-A1HW-06A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1HW-06A,800D3A17-269F-4D97-94FF-8585F20038D8,Metastatic,Illumina HiSeq,fc79df1a-6c0c-45d1-96da-6463d1b33fe9,Skin,37,0CB9BC8F-475B-4FED-9CC0-D1B29E9F178B,BA059B4A-D1BF-4DBD-87DD-B0F7DD234917,TCGA-DA-A1HW-06A-11D-A18Z-02,HG19_Broad_variant,TCGA-DA-A1HW,TCGA-SKCM,NA,s7504,Harvard Medical School,Yale,United States,NO,T1a,N1b,Not available,Stage IIIB
13722.58cfa830e4b0c9d6adf6bd82,58cfa830e4b0c9d6adf6bd82,TCGA-BF-A1Q0-10A-01D-A18Z_120520_SN590_0158_AC0J99ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BF-A1Q0-10A-01D-A18Z_120520_SN590_0158_AC0J99ACXX_s_6_rg.sorted,TCGA-BF-A1Q0-10A-01D-A18Z_120520_SN590_0158_AC0J99ACXX_s_6_rg.sorted.bam,56.81,NA,0.17,58cfa830e4b0c9d6adf6bd82,TCGA-BF-A1Q0-10A-01D-A18Z_120520_SN590_0158_AC0J99ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-BF-A1Q0-10A,633DDC04-C424-42C8-8E54-673968B130A7,Blood Derived Normal,Illumina HiSeq,6c5142a8-af0f-42a2-9924-fb42c095c0d9,Skin,80,5060B0AD-E07A-443E-8582-382C61AF81AC,F0A92AEC-2C16-4B97-85B4-019D30C9EFC9,TCGA-BF-A1Q0-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-BF-A1Q0,TCGA-SKCM,NA,s7492,Harvard Medical School,Cureline,Russia,NO,T4b,N0,Not available,Stage IIC
13722.58cfa831e4b0c9d6adf6c708,58cfa831e4b0c9d6adf6c708,TCGA-CU-A0YN-11A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CU-A0YN-11A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_4_rg.sorted,TCGA-CU-A0YN-11A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_4_rg.sorted.bam,8.8,2.09,0.14,58cfa831e4b0c9d6adf6c708,TCGA-CU-A0YN-11A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CU-A0YN-11A,679A6869-2CE9-4472-8DB1-8869E2C1A440,Solid Tissue Normal,Illumina HiSeq,4f24b2d4-a63d-40e7-82c7-bc6e188fbb4a,Bladder,60,CAAC9355-9BAC-41D8-B7A7-8EEB775179FA,25F4133F-37D6-46DA-9405-03D506557044,TCGA-CU-A0YN-11A-11D-A10R-02,HG19_Broad_variant,TCGA-CU-A0YN,TCGA-BLCA,393,s3277,Harvard Medical School,UNC,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6d4ba,58cfa832e4b0c9d6adf6d4ba,TCGA-VD-A8K7-01B-11D-A40D_140716_SN208_0519_BC5946ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-VD-A8K7-01B-11D-A40D_140716_SN208_0519_BC5946ACXX_s_4_rg.sorted,TCGA-VD-A8K7-01B-11D-A40D_140716_SN208_0519_BC5946ACXX_s_4_rg.sorted.bam,27.7,NA,0.16,58cfa832e4b0c9d6adf6d4ba,TCGA-VD-A8K7-01B-11D-A40D_140716_SN208_0519_BC5946ACXX_s_4_rg.sorted.bam,Alive,MALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8K7-01B,6103E640-8B62-4E39-908B-B62A0DEBEB0E,Primary Tumor,Illumina HiSeq,649c4e6f-5b69-4d14-b5cc-99938c78d650,Eye,39,1B626599-EC44-409D-8123-ED69D8442C19,4208E47B-01BB-4C91-9411-F214F46F656C,TCGA-VD-A8K7-01B-11D-A40D-26,HG19_Broad_variant,TCGA-VD-A8K7,TCGA-UVM,NA,s260,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T4a,NX,Not available,Stage IIIA
13722.58cfa831e4b0c9d6adf6ccf2,58cfa831e4b0c9d6adf6ccf2,TCGA-EK-A3GJ-11A-11D-A20X_140106_SN590_0243_AC371BACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EK-A3GJ-11A-11D-A20X_140106_SN590_0243_AC371BACXX_s_5_rg.sorted,TCGA-EK-A3GJ-11A-11D-A20X_140106_SN590_0243_AC371BACXX_s_5_rg.sorted.bam,8.43,NA,0.15,58cfa831e4b0c9d6adf6ccf2,TCGA-EK-A3GJ-11A-11D-A20X_140106_SN590_0243_AC371BACXX_s_5_rg.sorted.bam,Alive,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A3GJ-11A,DEDA68DD-E9AD-45CC-9DBB-1C5836EF6519,Solid Tissue Normal,Illumina HiSeq,5b9221da-4fdc-484f-867a-280b02e25e7e,Cervix,51,D21C9094-664F-49DC-8768-178D56256B45,60DDA853-569C-44A8-BA84-A7DA6FD85407,TCGA-EK-A3GJ-11A-11D-A20X-26,HG19_Broad_variant,TCGA-EK-A3GJ,TCGA-CESC,NA,s1193,MD Anderson - Institute for Applied Cancer Science,Gynecologic Oncology Group,United States,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6ce8b,58cfa832e4b0c9d6adf6ce8b,TCGA-FY-A3RA-01A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-FY-A3RA-01A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_6_rg.sorted,TCGA-FY-A3RA-01A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_6_rg.sorted.bam,38.77,NA,0.17,58cfa832e4b0c9d6adf6ce8b,TCGA-FY-A3RA-01A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FY-A3RA-01A,58FF4366-20A3-40A2-A87A-551E17CDB5D3,Primary Tumor,Illumina HiSeq,a7a005ec-f27f-4c17-8bb6-879c800bb0ae,Thyroid,21,E67E2BBE-8C3F-41B1-BE3C-C89555A10AEE,40CA310C-DB41-44D5-A76C-72938CF4AED0,TCGA-FY-A3RA-01A-11D-A221-26,HG19_Broad_variant,TCGA-FY-A3RA,TCGA-THCA,NA,s12651,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T2,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82fe4b0c9d6adf6b6e4,58cfa82fe4b0c9d6adf6b6e4,TCGA-50-6593-11A-01D-1751_120105_SN1120_0107_AC054PACXX_s_4_rg.sorted.filtered.,WGS,TCGA-50-6593-11A-01D-1751_120105_SN1120_0107_AC054PACXX_s_4_rg.sorted,TCGA-50-6593-11A-01D-1751_120105_SN1120_0107_AC054PACXX_s_4_rg.sorted.bam,37.4,1.9,0.14,58cfa82fe4b0c9d6adf6b6e4,TCGA-50-6593-11A-01D-1751_120105_SN1120_0107_AC054PACXX_s_4_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-6593-11A,E10568FE-0436-43F2-9F0F-48F9903868C4,Solid Tissue Normal,Illumina HiSeq,d6164f86-2486-463f-897c-fa4c2934fd35,Lung,49,2EE7CF16-ECAC-4175-A280-C7C8C38CDCC9,9A45C8BD-B122-4E13-AD72-E9CE655FE37F,TCGA-50-6593-11A-01D-1751-02,HG19_Broad_variant,TCGA-50-6593,TCGA-LUAD,336,s10787,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIA
13722.58cfa832e4b0c9d6adf6cfb9,58cfa832e4b0c9d6adf6cfb9,TCGA-G9-6365-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-G9-6365-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_2_rg.sorted,TCGA-G9-6365-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_2_rg.sorted.bam,27.7,1.8,0.14,58cfa832e4b0c9d6adf6cfb9,TCGA-G9-6365-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6365-10A,6845076E-E940-4437-8618-81DB4A447544,Blood Derived Normal,Illumina HiSeq,cc8dcea7-b44b-4a7d-a9ef-f98a23c37e9a,Prostate,71,1668E387-F9EB-4301-9E72-9FDBDC521D45,CE08011F-F42E-46C6-8565-B825EB960B1D,TCGA-G9-6365-10A-01D-1784-02,HG19_Broad_variant,TCGA-G9-6365,TCGA-PRAD,NA,s3614,Harvard Medical School,Roswell Park,United States,NO,T4,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c9af,58cfa831e4b0c9d6adf6c9af,TCGA-DJ-A13W-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DJ-A13W-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_2_rg.sorted,TCGA-DJ-A13W-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_2_rg.sorted.bam,38.59,1.95,0.14,58cfa831e4b0c9d6adf6c9af,TCGA-DJ-A13W-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13W-10A,3B48CC5E-3396-4DD5-893D-54B75B98B016,Blood Derived Normal,Illumina HiSeq,8ac86520-440a-4302-b185-5f222e1f75ef,Thyroid,45,C6EAF3F8-DD7D-4B38-BF42-8A53AAFAB259,BCB946CF-8A80-41B4-BD03-3A3255FA1C83,TCGA-DJ-A13W-10A-01D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13W,TCGA-THCA,NA,s12107,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa832e4b0c9d6adf6d122,58cfa832e4b0c9d6adf6d122,TCGA-JX-A3Q0-10A-01D-A245_140206_SN1222_0239_BC2RAKACXX_s_2_rg.sorted.filtered.,WGS,TCGA-JX-A3Q0-10A-01D-A245_140206_SN1222_0239_BC2RAKACXX_s_2_rg.sorted,TCGA-JX-A3Q0-10A-01D-A245_140206_SN1222_0239_BC2RAKACXX_s_2_rg.sorted.bam,32.99,NA,0.14,58cfa832e4b0c9d6adf6d122,TCGA-JX-A3Q0-10A-01D-A245_140206_SN1222_0239_BC2RAKACXX_s_2_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-JX-A3Q0-10A,20280122-A66A-4C83-8F25-0B9D97558DC2,Blood Derived Normal,Illumina HiSeq,fbcd3e16-2a1f-44e8-a46e-d05f1c5d52d1,Cervix,63,3E3551F6-66DC-4F55-97C4-A7741E412CEA,3494D848-1830-49A0-B144-22550B8A0428,TCGA-JX-A3Q0-10A-01D-A245-26,HG19_Broad_variant,TCGA-JX-A3Q0,TCGA-CESC,NA,s1379,MD Anderson - Institute for Applied Cancer Science,Washington University,United States,NO,T3,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6cb88,58cfa831e4b0c9d6adf6cb88,TCGA-EE-A2M5-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EE-A2M5-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_4_rg.sorted,TCGA-EE-A2M5-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_4_rg.sorted.bam,52.28,NA,0.18,58cfa831e4b0c9d6adf6cb88,TCGA-EE-A2M5-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2M5-10A,B5E37B9B-6264-4CC8-9B44-1D8AC0692D6C,Blood Derived Normal,Illumina HiSeq,711839e5-5f9c-40f0-9927-79435679cb77,Skin,49,0F5E478D-C3FA-44B6-8A17-BA0991516D60,CE036245-08C0-4D4E-B64A-810A1B7ACF40,TCGA-EE-A2M5-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2M5,TCGA-SKCM,659,s7340,Harvard Medical School,University of Sydney,Australia,NO,T2,N0,Not available,Stage I
13722.58cfa832e4b0c9d6adf6ce3c,58cfa832e4b0c9d6adf6ce3c,TCGA-ER-A19T-06A-11D-A18Z_120520_SN590_0158_AC0J99ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-ER-A19T-06A-11D-A18Z_120520_SN590_0158_AC0J99ACXX_s_7_rg.sorted,TCGA-ER-A19T-06A-11D-A18Z_120520_SN590_0158_AC0J99ACXX_s_7_rg.sorted.bam,21.29,NA,0.16,58cfa832e4b0c9d6adf6ce3c,TCGA-ER-A19T-06A-11D-A18Z_120520_SN590_0158_AC0J99ACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19T-06A,B85B14D7-3B5A-4800-AF12-622EC03B9FE5,Metastatic,Illumina HiSeq,0a570c18-b47d-4029-b8d7-68764071be02,Skin,51,D3EBC18D-E94B-4991-ABB0-5324B67CD8CE,E3E60482-506A-4226-A44D-DD0062514CD1,TCGA-ER-A19T-06A-11D-A18Z-02,HG19_Broad_variant,TCGA-ER-A19T,TCGA-SKCM,270,s7355,Harvard Medical School,University of Pittsburgh,United States,NO,T4a,N3,Not available,Stage IV
13722.58cfa831e4b0c9d6adf6cb20,58cfa831e4b0c9d6adf6cb20,TCGA-E7-A3Y1-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_8_rg.sorted.filtered.,WGS,TCGA-E7-A3Y1-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_8_rg.sorted,TCGA-E7-A3Y1-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_8_rg.sorted.bam,30.66,NA,0.15,58cfa831e4b0c9d6adf6cb20,TCGA-E7-A3Y1-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-E7-A3Y1-10A,F7C891EB-3B09-4E01-BB8A-53D570518CBE,Blood Derived Normal,Illumina HiSeq,57523af1-f9b2-4f88-abec-4cf325040361,Bladder,57,C731473C-DAFC-4F28-9683-7FCF109D79D8,42EB6C1F-26F0-4D41-9184-8614DD9EE356,TCGA-E7-A3Y1-10A-01D-A233-26,HG19_Broad_variant,TCGA-E7-A3Y1,TCGA-BLCA,NA,s3396,MD Anderson - Institute for Applied Cancer Science,Asterand,Ukraine,NO,Not available,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c8fc,58cfa831e4b0c9d6adf6c8fc,TCGA-CN-6018-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CN-6018-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_7_rg.sorted,TCGA-CN-6018-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_7_rg.sorted.bam,523.7,1.9,0.16,58cfa831e4b0c9d6adf6c8fc,TCGA-CN-6018-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-6018-10A,55838E1F-07E8-49CA-89D6-46216BABC6F7,Blood Derived Normal,Illumina HiSeq,c73af9fc-fb38-4307-955a-8e275bdab29f,Head and Neck,85,DD41FBB4-0AB7-469D-BF71-44017FEB05E1,CEB9ED62-B029-4AFD-8D10-EA5EA35F24F5,TCGA-CN-6018-10A-01D-1681-02,HG19_Broad_variant,TCGA-CN-6018,TCGA-HNSC,NA,s15625,Harvard Medical School,University of Pittsburgh,United States,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6ce5e,58cfa832e4b0c9d6adf6ce5e,TCGA-GV-A3QG-10A-01D-A221_120830_SN590_0178_AD143RACXX_s_4_rg.sorted.filtered.,WGS,TCGA-GV-A3QG-10A-01D-A221_120830_SN590_0178_AD143RACXX_s_4_rg.sorted,TCGA-GV-A3QG-10A-01D-A221_120830_SN590_0178_AD143RACXX_s_4_rg.sorted.bam,31,NA,0.16,58cfa832e4b0c9d6adf6ce5e,TCGA-GV-A3QG-10A-01D-A221_120830_SN590_0178_AD143RACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GV-A3QG-10A,79F23A0E-5AAE-4618-8191-7DD7C0552408,Blood Derived Normal,Illumina HiSeq,ee01ec50-47b1-43fa-96a1-b63ae8f92127,Bladder,65,2F30FC3B-B3CC-402A-9596-9A052C0D918E,DEFBEB50-9488-44C5-9115-2356095A1CEB,TCGA-GV-A3QG-10A-01D-A221-26,HG19_Broad_variant,TCGA-GV-A3QG,TCGA-BLCA,NA,s3128,MD Anderson - Institute for Applied Cancer Science,BLN - Cleveland Clinic,United States,NO,T3a,N3,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6cebb,58cfa832e4b0c9d6adf6cebb,TCGA-EM-A1YB-10A-01D-A14U_120717_SN1120_0175_AC1179ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EM-A1YB-10A-01D-A14U_120717_SN1120_0175_AC1179ACXX_s_3_rg.sorted,TCGA-EM-A1YB-10A-01D-A14U_120717_SN1120_0175_AC1179ACXX_s_3_rg.sorted.bam,54.54,1.7,0.18,58cfa832e4b0c9d6adf6cebb,TCGA-EM-A1YB-10A-01D-A14U_120717_SN1120_0175_AC1179ACXX_s_3_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1YB-10A,B43A4F92-7A13-4558-A97E-7B3FEB2D70C9,Blood Derived Normal,Illumina HiSeq,ebadd853-06ca-4a12-b3b8-43a03254305a,Thyroid,73,D4C2816C-B09F-49A4-9FB8-0CABFA72553E,B5299B6D-EF3E-487F-8115-F46E0DBA1E4D,TCGA-EM-A1YB-10A-01D-A14U-02,HG19_Broad_variant,TCGA-EM-A1YB,TCGA-THCA,NA,s12643,Harvard Medical School,University Health Network,Canada,NO,T2,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa830e4b0c9d6adf6bda9,58cfa830e4b0c9d6adf6bda9,TCGA-BF-A1PU-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BF-A1PU-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_8_rg.sorted,TCGA-BF-A1PU-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_8_rg.sorted.bam,38.15,NA,0.15,58cfa830e4b0c9d6adf6bda9,TCGA-BF-A1PU-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Skin Cutaneous Melanoma,Aligned reads,TCGA-BF-A1PU-10A,3DD5A206-D7F3-42F1-B9CC-4B31C76D495D,Blood Derived Normal,Illumina HiSeq,b11bd287-6ec9-4e17-97a9-0d9e09163409,Skin,46,A4D739D2-63A1-41FC-82C1-F1D027DB756D,04FD07BE-1E5D-48D0-8AE5-E21FDDCF797C,TCGA-BF-A1PU-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-BF-A1PU,TCGA-SKCM,NA,s7668,Harvard Medical School,Cureline,Russia,NO,T4b,N0,Not available,Stage IIC
13722.58cfa831e4b0c9d6adf6ccce,58cfa831e4b0c9d6adf6ccce,TCGA-EE-A2M7-10A-01D-A190_120724_SN208_0417_AC117BACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EE-A2M7-10A-01D-A190_120724_SN208_0417_AC117BACXX_s_7_rg.sorted,TCGA-EE-A2M7-10A-01D-A190_120724_SN208_0417_AC117BACXX_s_7_rg.sorted.bam,24.33,NA,0.17,58cfa831e4b0c9d6adf6ccce,TCGA-EE-A2M7-10A-01D-A190_120724_SN208_0417_AC117BACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2M7-10A,7B4BCF0E-EC55-489B-870F-A4360A6BEA2F,Blood Derived Normal,Illumina HiSeq,42bab265-08ca-4684-a949-bfbfe42eedc1,Skin,66,9D059E5A-B61B-40B9-B66F-0733A0DE6208,C3FF18F0-682B-426E-9885-7DD12B1AA703,TCGA-EE-A2M7-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2M7,TCGA-SKCM,877,s7344,Harvard Medical School,University of Sydney,Australia,NO,T3a,N0,Not available,Stage II
13722.58cfa832e4b0c9d6adf6d40c,58cfa832e4b0c9d6adf6d40c,TCGA-VD-AA8O-10A-01D-A40E_140807_SN1440_0194_AC5B5RACXX_s_4_rg.sorted.filtered.,WGS,TCGA-VD-AA8O-10A-01D-A40E_140807_SN1440_0194_AC5B5RACXX_s_4_rg.sorted,TCGA-VD-AA8O-10A-01D-A40E_140807_SN1440_0194_AC5B5RACXX_s_4_rg.sorted.bam,9.27,NA,0.15,58cfa832e4b0c9d6adf6d40c,TCGA-VD-AA8O-10A-01D-A40E_140807_SN1440_0194_AC5B5RACXX_s_4_rg.sorted.bam,Alive,MALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-AA8O-10A,99D1BFCC-1989-4DD2-A5E9-78E08F6CE7CF,Blood Derived Normal,Illumina HiSeq,9b42d7d1-b15e-4989-b862-5312e7eadbcf,Eye,77,1C4D043F-1BE0-4C47-9D0D-F5C551CE15FB,BF083593-194A-4549-AFF8-7A5188EF4082,TCGA-VD-AA8O-10A-01D-A40E-26,HG19_Broad_variant,TCGA-VD-AA8O,TCGA-UVM,NA,s250,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T3a,N0,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6ccde,58cfa831e4b0c9d6adf6ccde,TCGA-EM-A1CV-01A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EM-A1CV-01A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_4_rg.sorted,TCGA-EM-A1CV-01A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_4_rg.sorted.bam,104.75,1.89,0.17,58cfa831e4b0c9d6adf6ccde,TCGA-EM-A1CV-01A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1CV-01A,762EDDB5-1B47-4B79-B20A-1EDFB07C0705,Primary Tumor,Illumina HiSeq,54060b82-ddf3-4449-aa9c-baaa4d66f1b7,Thyroid,32,95D077B1-E4F3-48EA-84BC-F663FD438693,DEC98438-085F-40C3-8751-D50BA12C8584,TCGA-EM-A1CV-01A-11D-A13U-02,HG19_Broad_variant,TCGA-EM-A1CV,TCGA-THCA,NA,s12521,Harvard Medical School,University Health Network,Canada,NO,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa830e4b0c9d6adf6bc8a,58cfa830e4b0c9d6adf6bc8a,TCGA-AP-A0L8-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-AP-A0L8-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_5_rg.sorted,TCGA-AP-A0L8-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_5_rg.sorted.bam,128.45,2.03,0.16,58cfa830e4b0c9d6adf6bc8a,TCGA-AP-A0L8-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_5_rg.sorted.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0L8-01A,9AA8C2B4-DB32-4899-BF0C-D578CB175E90,Primary Tumor,Illumina HiSeq,41360e8e-e9e9-402a-bd9e-a987e56c920e,Uterus,70,D1A7A58F-7A35-4A94-A337-051AE56DED00,2BE44D5B-CCD6-4DD5-B0C7-C7813B526B94,TCGA-AP-A0L8-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A0L8,TCGA-UCEC,1484,s4244,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bc82,58cfa830e4b0c9d6adf6bc82,TCGA-AP-A0LI-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_7_rg.sorted.filtered.,WGS,TCGA-AP-A0LI-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_7_rg.sorted,TCGA-AP-A0LI-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_7_rg.sorted.bam,85.32,1.85,0.15,58cfa830e4b0c9d6adf6bc82,TCGA-AP-A0LI-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_7_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LI-01A,E1E8DC66-467C-48A5-BE56-3DB4F665B9F1,Primary Tumor,Illumina HiSeq,9fe530df-5c54-45fa-a25d-65e1a7d0110b,Uterus,67,981D9E3B-63C5-41E9-827F-7F1D268D62F4,D80E9147-7A64-4AB0-891A-2D97D0634EAB,TCGA-AP-A0LI-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A0LI,TCGA-UCEC,NA,s5387,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bdca,58cfa830e4b0c9d6adf6bdca,TCGA-BH-A0DK-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BH-A0DK-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_6_rg.sorted,TCGA-BH-A0DK-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_6_rg.sorted.bam,14.3,1.95,0.15,58cfa830e4b0c9d6adf6bdca,TCGA-BH-A0DK-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0DK-10A,F2BBFA9D-9A9D-4F46-9FDE-378E4C44E2AD,Blood Derived Normal,Illumina HiSeq,70caaa1c-198e-4a38-9d77-d97bb89f7c65,Breast,49,0FBA2EFB-9EDE-4FD2-ABED-F18275A076DD,1CC19E5F-922B-4878-A0E9-546A8C3FC949,TCGA-BH-A0DK-10A-01D-A060-02,HG19_Broad_variant,TCGA-BH-A0DK,TCGA-BRCA,NA,s6465,Harvard Medical School,University of Pittsburgh,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6cd2d,58cfa831e4b0c9d6adf6cd2d,TCGA-ER-A19Q-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_5_rg.sorted.filtered.,WGS,TCGA-ER-A19Q-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_5_rg.sorted,TCGA-ER-A19Q-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_5_rg.sorted.bam,35.12,NA,0.15,58cfa831e4b0c9d6adf6cd2d,TCGA-ER-A19Q-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19Q-10A,391EAB51-B140-4BC2-BC8C-99400FBA9066,Blood Derived Normal,Illumina HiSeq,34899f85-566b-41ea-a927-a0707757d97f,Skin,37,9A2863AB-9C6C-4A1C-9405-D18063553DD6,97955976-6F7E-4890-A478-C205EEEA7277,TCGA-ER-A19Q-10A-01D-A190-02,HG19_Broad_variant,TCGA-ER-A19Q,TCGA-SKCM,1548,s7520,Harvard Medical School,University of Pittsburgh,United States,NO,Not available,N0,Not available,Not available
13722.58cfa831e4b0c9d6adf6cc00,58cfa831e4b0c9d6adf6cc00,TCGA-EE-A29C-10A-01D-A190_120807_SN590_0173_AC0VN5ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EE-A29C-10A-01D-A190_120807_SN590_0173_AC0VN5ACXX_s_4_rg.sorted,TCGA-EE-A29C-10A-01D-A190_120807_SN590_0173_AC0VN5ACXX_s_4_rg.sorted.bam,28.26,NA,0.18,58cfa831e4b0c9d6adf6cc00,TCGA-EE-A29C-10A-01D-A190_120807_SN590_0173_AC0VN5ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29C-10A,FC5B5D2F-0D03-45C2-B7A0-BA6EC108FE51,Blood Derived Normal,Illumina HiSeq,dc2f1c6e-824c-4c84-8733-8ec69a47d878,Skin,20,27C69419-2272-46E8-AE91-5A441A29BDB1,FA3B6B80-3EAC-4AFB-865C-DA8B0CB10C9B,TCGA-EE-A29C-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A29C,TCGA-SKCM,NA,s7681,Harvard Medical School,University of Sydney,Australia,NO,T2a,N0,Not available,Stage IB
13722.58cfa832e4b0c9d6adf6cec4,58cfa832e4b0c9d6adf6cec4,TCGA-EM-A1YB-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EM-A1YB-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_1_rg.sorted,TCGA-EM-A1YB-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_1_rg.sorted.bam,31.49,1.93,0.17,58cfa832e4b0c9d6adf6cec4,TCGA-EM-A1YB-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_1_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1YB-01A,B43A4F92-7A13-4558-A97E-7B3FEB2D70C9,Primary Tumor,Illumina HiSeq,13add68c-df0c-4f19-8032-d084a8cedcab,Thyroid,73,13C7182D-EF93-48A7-9569-EED7714CEC40,59B09269-9CB6-4AD9-874D-5237896747A1,TCGA-EM-A1YB-01A-11D-A14U-02,HG19_Broad_variant,TCGA-EM-A1YB,TCGA-THCA,NA,s12751,Harvard Medical School,University Health Network,Canada,NO,T2,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa830e4b0c9d6adf6c266,58cfa830e4b0c9d6adf6c266,TCGA-C5-A1BQ-01C-11D-A20X_140106_SN590_0243_AC371BACXX_s_2_rg.sorted.filtered.,WGS,TCGA-C5-A1BQ-01C-11D-A20X_140106_SN590_0243_AC371BACXX_s_2_rg.sorted,TCGA-C5-A1BQ-01C-11D-A20X_140106_SN590_0243_AC371BACXX_s_2_rg.sorted.bam,43.3,NA,0.15,58cfa830e4b0c9d6adf6c266,TCGA-C5-A1BQ-01C-11D-A20X_140106_SN590_0243_AC371BACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A1BQ-01C,E77C3F70-08D1-40D3-B038-F09A519423CC,Primary Tumor,Illumina HiSeq,58d97d84-99da-4b08-ae63-7e49f4b861b7,Cervix,65,6EF38E19-07AC-4032-8FB4-59129A126D3F,359691B6-9EB5-40F2-8F9E-16AA5A1D32F4,TCGA-C5-A1BQ-01C-11D-A20X-26,HG19_Broad_variant,TCGA-C5-A1BQ,TCGA-CESC,604,s1170,MD Anderson - Institute for Applied Cancer Science,Medical College of Wisconsin,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6c1aa,58cfa830e4b0c9d6adf6c1aa,TCGA-BA-5555-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BA-5555-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_2_rg.sorted,TCGA-BA-5555-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_2_rg.sorted.bam,213.7,1.9,0.16,58cfa830e4b0c9d6adf6c1aa,TCGA-BA-5555-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_2_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5555-01A,8970F713-4A7A-4125-892C-6A34139371D8,Primary Tumor,Illumina HiSeq,cd7725ec-bc8e-4c93-aba5-19dbdeb78b0d,Head and Neck,54,2920CA1C-6035-4350-ADA4-C60D485DBFFF,4AB42DF9-A215-4965-A125-CC0C4122FF06,TCGA-BA-5555-01A-01D-1509-02,HG19_Broad_variant,TCGA-BA-5555,TCGA-HNSC,NA,s15609,Harvard Medical School,UNC,None,NO,T3,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6cbbe,58cfa831e4b0c9d6adf6cbbe,TCGA-EK-A3GM-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EK-A3GM-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_4_rg.sorted,TCGA-EK-A3GM-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_4_rg.sorted.bam,59.88,NA,0.15,58cfa831e4b0c9d6adf6cbbe,TCGA-EK-A3GM-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A3GM-01A,CB780C10-8810-4384-B829-954AAB1C16C8,Primary Tumor,Illumina HiSeq,2ec77e09-5fb7-4247-9027-1db441eab2b8,Cervix,65,A4B92B76-FF87-475E-924B-840F652FC019,4981CFD4-2A8C-4CF8-8AC2-31BDF9DC02CD,TCGA-EK-A3GM-01A-11D-A20X-26,HG19_Broad_variant,TCGA-EK-A3GM,TCGA-CESC,NA,s1186,MD Anderson - Institute for Applied Cancer Science,Gynecologic Oncology Group,United States,NO,Not available,Not available,Endocervical Type of Adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6ce99,58cfa832e4b0c9d6adf6ce99,TCGA-FY-A3R8-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FY-A3R8-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_3_rg.sorted,TCGA-FY-A3R8-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_3_rg.sorted.bam,51.96,NA,0.15,58cfa832e4b0c9d6adf6ce99,TCGA-FY-A3R8-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FY-A3R8-01A,C77976B6-35EA-4623-A92A-6D9440A978E6,Primary Tumor,Illumina HiSeq,7d0e9d6d-fb33-481e-93f7-84ae9641ce75,Thyroid,62,BAA64E5A-237E-44AC-8B22-2D86E710F7DB,3D9D0EC4-8C81-40D9-886F-8813570E732D,TCGA-FY-A3R8-01A-11D-A221-26,HG19_Broad_variant,TCGA-FY-A3R8,TCGA-THCA,NA,s12392,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T3,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa830e4b0c9d6adf6c2c6,58cfa830e4b0c9d6adf6c2c6,TCGA-CF-A1HS-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CF-A1HS-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_5_rg.sorted,TCGA-CF-A1HS-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_5_rg.sorted.bam,42.45,1.95,0.16,58cfa830e4b0c9d6adf6c2c6,TCGA-CF-A1HS-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_5_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CF-A1HS-01A,A73C0842-39C5-4C2C-AA6A-F31341A4F36E,Primary Tumor,Illumina HiSeq,ed90abf4-1d04-41ce-9de3-9dcf24c1e375,Bladder,75,0A01E5BA-5549-4027-9E84-1BBB163A8F07,B8F18CDA-053F-4E40-8978-7524A4C0B49A,TCGA-CF-A1HS-01A-11D-A13U-02,HG19_Broad_variant,TCGA-CF-A1HS,TCGA-BLCA,NA,s2875,Harvard Medical School,ILSbio,Vietnam,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6d412,58cfa832e4b0c9d6adf6d412,TCGA-V4-A9EX-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_1_rg.sorted.filtered.,WGS,TCGA-V4-A9EX-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_1_rg.sorted,TCGA-V4-A9EX-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_1_rg.sorted.bam,48.32,NA,0.15,58cfa832e4b0c9d6adf6d412,TCGA-V4-A9EX-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EX-01A,892E7630-B11E-47BD-987C-327D33258E11,Primary Tumor,Illumina HiSeq,9f56ee51-fd1c-43d8-9e64-faacd67069e0,Eye,55,69F3ECE7-394D-4FA7-93E7-B6DCD538831A,9A4969D9-222E-4BA3-B0F4-34F42C0D1A19,TCGA-V4-A9EX-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9EX,TCGA-UVM,730,s210,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa82fe4b0c9d6adf6b6d2,58cfa82fe4b0c9d6adf6b6d2,TCGA-44-3396-01A-01D-1203_110804_SN208_0216_AD0CLLABXX_s_7_rg.sorted.filtered.,WGS,TCGA-44-3396-01A-01D-1203_110804_SN208_0216_AD0CLLABXX_s_7_rg.sorted,TCGA-44-3396-01A-01D-1203_110804_SN208_0216_AD0CLLABXX_s_7_rg.sorted.bam,472.3,1.9,0.15,58cfa82fe4b0c9d6adf6b6d2,TCGA-44-3396-01A-01D-1203_110804_SN208_0216_AD0CLLABXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-3396-01A,3BD6BADB-27FF-4D8D-B206-4D28DC264862,Primary Tumor,Illumina HiSeq,bf55243b-c7c6-46fc-9d54-e1916b0d7ea2,Lung,74,B560DF97-986B-4A88-A0F1-C38A30080EDB,ECCC6A5C-BB25-4591-996A-EE2A7507F771,TCGA-44-3396-01A-01D-1203-02,HG19_Broad_variant,TCGA-44-3396,TCGA-LUAD,NA,s10653,Harvard Medical School,Christiana Healthcare,United States,NO,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82fe4b0c9d6adf6b9a2,58cfa82fe4b0c9d6adf6b9a2,TCGA-44-6148-10A-01D-1751_110927_SN208_0243_BC00TKACXX_s_7_rg.sorted.filtered.,WGS,TCGA-44-6148-10A-01D-1751_110927_SN208_0243_BC00TKACXX_s_7_rg.sorted,TCGA-44-6148-10A-01D-1751_110927_SN208_0243_BC00TKACXX_s_7_rg.sorted.bam,315.7,1.9,0.15,58cfa82fe4b0c9d6adf6b9a2,TCGA-44-6148-10A-01D-1751_110927_SN208_0243_BC00TKACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-6148-10A,8994C8C4-9EA0-46CB-B4A5-0055D7DA5BFA,Blood Derived Normal,Illumina HiSeq,14543816-c21e-496a-932b-67a41ac47e99,Lung,60,E221C1C3-71D5-424D-8D88-AC09C3140220,D46F0B7B-7D07-42BE-8C8B-7B74E46B4179,TCGA-44-6148-10A-01D-1751-02,HG19_Broad_variant,TCGA-44-6148,TCGA-LUAD,NA,s11235,Harvard Medical School,Christiana Healthcare,United States,NO,T1b,N0,Lung Mucinous Adenocarcinoma,Stage IA
13722.58cfa831e4b0c9d6adf6c54a,58cfa831e4b0c9d6adf6c54a,TCGA-CN-4730-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CN-4730-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_5_rg.sorted,TCGA-CN-4730-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_5_rg.sorted.bam,23.7,1.9,0.14,58cfa831e4b0c9d6adf6c54a,TCGA-CN-4730-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4730-01A,35C1F2C6-771C-4533-82DF-F8E2EC7107D7,Primary Tumor,Illumina HiSeq,56942e06-fb67-4bf4-993e-16cb67f52239,Head and Neck,62,8270C53E-F2CF-4F57-A1AC-A8BA978CC1C8,094C2014-ABA2-4C11-B076-27EA61C7A48E,TCGA-CN-4730-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4730,TCGA-HNSC,NA,s15496,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N1,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c801,58cfa831e4b0c9d6adf6c801,TCGA-CN-6018-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CN-6018-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_3_rg.sorted,TCGA-CN-6018-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_3_rg.sorted.bam,96,1.9,0.14,58cfa831e4b0c9d6adf6c801,TCGA-CN-6018-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-6018-01A,55838E1F-07E8-49CA-89D6-46216BABC6F7,Primary Tumor,Illumina HiSeq,ce9ca233-92c4-44b8-b97f-b56f1f73cb5a,Head and Neck,85,1A3E8C8B-9E99-499A-9BA7-4CDFC11B106D,7F0998E4-AF05-42C5-962C-5EA4D8993EB0,TCGA-CN-6018-01A-11D-1681-02,HG19_Broad_variant,TCGA-CN-6018,TCGA-HNSC,NA,s15498,Harvard Medical School,University of Pittsburgh,United States,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6be9b,58cfa830e4b0c9d6adf6be9b,TCGA-BJ-A3PR-10A-01D-A221_120524_SN1120_0144_AC0VNCACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BJ-A3PR-10A-01D-A221_120524_SN1120_0144_AC0VNCACXX_s_8_rg.sorted,TCGA-BJ-A3PR-10A-01D-A221_120524_SN1120_0144_AC0VNCACXX_s_8_rg.sorted.bam,26.01,NA,0.14,58cfa830e4b0c9d6adf6be9b,TCGA-BJ-A3PR-10A-01D-A221_120524_SN1120_0144_AC0VNCACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A3PR-10A,FD036EC5-3FFB-40B1-8002-943BE0E2532E,Blood Derived Normal,Illumina HiSeq,b0be97a7-0687-4388-a8eb-f3c845aae414,Thyroid,69,FD054193-A342-4FAF-8AF5-69AB1ABD5BAC,939A4C11-7D05-4CEB-82B0-ED59048E9393,TCGA-BJ-A3PR-10A-01D-A221-26,HG19_Broad_variant,TCGA-BJ-A3PR,TCGA-THCA,NA,s12630,MD Anderson - Institute for Applied Cancer Science,University of Pittsburgh,United States,NO,T1a,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6cf4a,58cfa832e4b0c9d6adf6cf4a,TCGA-FS-A1ZT-10A-01D-A190_120602_SN1120_0147_BD13TBACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FS-A1ZT-10A-01D-A190_120602_SN1120_0147_BD13TBACXX_s_4_rg.sorted,TCGA-FS-A1ZT-10A-01D-A190_120602_SN1120_0147_BD13TBACXX_s_4_rg.sorted.bam,57.99,NA,0.17,58cfa832e4b0c9d6adf6cf4a,TCGA-FS-A1ZT-10A-01D-A190_120602_SN1120_0147_BD13TBACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZT-10A,57882F61-4A32-49F1-AFD4-61C70B184D8B,Blood Derived Normal,Illumina HiSeq,174a6efc-f288-454f-97ae-e05d238bb3d9,Skin,55,138B9456-4B6D-43BA-AB95-F0E1408A5C15,09813947-8BFD-48A8-B0C9-E2FD7699BEBA,TCGA-FS-A1ZT-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZT,TCGA-SKCM,NA,s7703,Harvard Medical School,Essen,Germany,NO,T2,N1b,Not available,Stage III
13722.58cfa831e4b0c9d6adf6c5d4,58cfa831e4b0c9d6adf6c5d4,TCGA-CN-5367-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CN-5367-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_6_rg.sorted,TCGA-CN-5367-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_6_rg.sorted.bam,28.4,1.9,0.15,58cfa831e4b0c9d6adf6c5d4,TCGA-CN-5367-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_6_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5367-10A,61D0709C-D148-413B-A7B5-C0C82ED2F32F,Blood Derived Normal,Illumina HiSeq,b73d2b70-fbf3-440b-bf21-7a3ea5ebcdbd,Head and Neck,60,DA2FE372-D082-40B6-81AF-F895050AF58D,BA3EF724-B5F4-4DDF-BFD9-8928FB36BE7F,TCGA-CN-5367-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5367,TCGA-HNSC,352,s15887,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c94c,58cfa831e4b0c9d6adf6c94c,TCGA-DU-6392-10A-01D-1703_130813_SN1440_0160_AD2B87ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DU-6392-10A-01D-1703_130813_SN1440_0160_AD2B87ACXX_s_2_rg.sorted,TCGA-DU-6392-10A-01D-1703_130813_SN1440_0160_AD2B87ACXX_s_2_rg.sorted.bam,65.7,1.9,0.15,58cfa831e4b0c9d6adf6c94c,TCGA-DU-6392-10A-01D-1703_130813_SN1440_0160_AD2B87ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6392-10A,FCD9E1C4-BDDB-4856-844C-03DF48FBA499,Blood Derived Normal,Illumina HiSeq,743888e9-97f5-42de-bb8b-acf4ade0af5e,Brain,35,24654746-1EA4-4FDB-83B8-5096F86C5509,C0870844-1918-4DCF-BE7C-010C6BEFF20C,TCGA-DU-6392-10A-01D-1703-02,HG19_Broad_variant,TCGA-DU-6392,TCGA-LGG,NA,s8134,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa82fe4b0c9d6adf6b84c,58cfa82fe4b0c9d6adf6b84c,TCGA-73-4676-11A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_8_rg.sorted.filtered.,WGS,TCGA-73-4676-11A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_8_rg.sorted,TCGA-73-4676-11A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_8_rg.sorted.bam,168.4,1.9,0.16,58cfa82fe4b0c9d6adf6b84c,TCGA-73-4676-11A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4676-11A,195A5AFB-B79F-44D2-9D12-884487630C2B,Solid Tissue Normal,Illumina HiSeq,a85b7af6-36cb-40db-9085-3d24b08100ea,Lung,45,D68673CD-08CA-404C-AD04-0774C51A6BFB,B3359F92-6D7F-4BF0-A8BF-4B17A50AF3BC,TCGA-73-4676-11A-01D-1751-02,HG19_Broad_variant,TCGA-73-4676,TCGA-LUAD,NA,s11557,Harvard Medical School,Roswell Park,United States,NO,T2a,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa830e4b0c9d6adf6bec3,58cfa830e4b0c9d6adf6bec3,TCGA-AP-A0LI-10A-01D-A043_120301_SN590_0142_AD0LPVACXX_s_8_rg.sorted.filtered.,WGS,TCGA-AP-A0LI-10A-01D-A043_120301_SN590_0142_AD0LPVACXX_s_8_rg.sorted,TCGA-AP-A0LI-10A-01D-A043_120301_SN590_0142_AD0LPVACXX_s_8_rg.sorted.bam,29.22,1.75,0.14,58cfa830e4b0c9d6adf6bec3,TCGA-AP-A0LI-10A-01D-A043_120301_SN590_0142_AD0LPVACXX_s_8_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LI-10A,E1E8DC66-467C-48A5-BE56-3DB4F665B9F1,Blood Derived Normal,Illumina HiSeq,8775e935-a82a-4dc0-9613-f331b1008811,Uterus,67,4B47A13D-1E13-47F0-AD67-6CB0AD02E3B1,A9E3D1B6-CC95-4AAC-B068-764F0814C9FF,TCGA-AP-A0LI-10A-01D-A043-02,HG19_Broad_variant,TCGA-AP-A0LI,TCGA-UCEC,NA,s4596,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c43c,58cfa831e4b0c9d6adf6c43c,TCGA-CG-5732-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CG-5732-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_5_rg.sorted,TCGA-CG-5732-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_5_rg.sorted.bam,46,1.9,0.17,58cfa831e4b0c9d6adf6c43c,TCGA-CG-5732-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_5_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5732-11A,E62D5F3C-0A99-4932-A589-BFF4FA02B1D3,Solid Tissue Normal,Illumina HiSeq,c4e25e33-1ac2-427d-adeb-7d6cfc0269a6,Stomach,66,A3B99090-FED5-4A73-A2E8-12A4B51A4879,3F2916B7-2093-4A7B-8495-46C9EDEDA78D,TCGA-CG-5732-11A-01D-1598-02,HG19_Broad_variant,TCGA-CG-5732,TCGA-STAD,NA,s14835,Harvard Medical School,Indivumed,Germany,NO,T2,N3,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa830e4b0c9d6adf6c12c,58cfa830e4b0c9d6adf6c12c,TCGA-B6-A0RE-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_8_rg.sorted.filtered.,WGS,TCGA-B6-A0RE-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_8_rg.sorted,TCGA-B6-A0RE-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_8_rg.sorted.bam,18.08,1.86,0.16,58cfa830e4b0c9d6adf6c12c,TCGA-B6-A0RE-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_8_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0RE-10A,08DA7C4C-3067-4BCF-9D7A-78566DF72E69,Blood Derived Normal,Illumina HiSeq,67bd449b-7035-4a63-8e7e-e32f1f49e4f0,Breast,61,B515904E-B78D-41BB-A960-D8B26A384B16,F2DEE42D-9E1D-471D-BF3E-F1A0A27E16DF,TCGA-B6-A0RE-10A-01D-A060-02,HG19_Broad_variant,TCGA-B6-A0RE,TCGA-BRCA,NA,s6272,Harvard Medical School,Duke,United States,NO,TX,N0 (i-),Infiltrating Ductal Carcinoma,Stage X
13722.58cfa831e4b0c9d6adf6cc62,58cfa831e4b0c9d6adf6cc62,TCGA-EM-A3O7-10A-01D-A221_120524_SN1120_0145_BD12MWACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EM-A3O7-10A-01D-A221_120524_SN1120_0145_BD12MWACXX_s_3_rg.sorted,TCGA-EM-A3O7-10A-01D-A221_120524_SN1120_0145_BD12MWACXX_s_3_rg.sorted.bam,135.98,NA,0.14,58cfa831e4b0c9d6adf6cc62,TCGA-EM-A3O7-10A-01D-A221_120524_SN1120_0145_BD12MWACXX_s_3_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3O7-10A,3A211D5A-085F-4902-86B6-50E4EB36B897,Blood Derived Normal,Illumina HiSeq,e978af87-12e7-4f69-a1e9-28702ab63dc0,Thyroid,46,D66318BA-D9A0-4825-86FA-6AC403212254,EE07CE20-D823-4A80-83FD-43E2B9BA9475,TCGA-EM-A3O7-10A-01D-A221-26,HG19_Broad_variant,TCGA-EM-A3O7,TCGA-THCA,NA,s12382,MD Anderson - Institute for Applied Cancer Science,University Health Network,Canada,NO,T3,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa831e4b0c9d6adf6cad4,58cfa831e4b0c9d6adf6cad4,TCGA-DA-A1I2-06A-21D-A18Z_120520_SN590_0158_AC0J99ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DA-A1I2-06A-21D-A18Z_120520_SN590_0158_AC0J99ACXX_s_1_rg.sorted,TCGA-DA-A1I2-06A-21D-A18Z_120520_SN590_0158_AC0J99ACXX_s_1_rg.sorted.bam,65.65,NA,0.18,58cfa831e4b0c9d6adf6cad4,TCGA-DA-A1I2-06A-21D-A18Z_120520_SN590_0158_AC0J99ACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1I2-06A,01AD975D-C2ED-4E4D-BD3B-C9512FC9073C,Metastatic,Illumina HiSeq,01864b7d-181e-4599-9dd4-31fca5173ddd,Skin,45,1E373C9C-DDB0-4C77-87AF-468EE586F998,FFBDE34F-A8F9-458A-9022-EC29D8EC6277,TCGA-DA-A1I2-06A-21D-A18Z-02,HG19_Broad_variant,TCGA-DA-A1I2,TCGA-SKCM,NA,s7328,Harvard Medical School,Yale,United States,NO,T4b,N2b,Not available,Stage III
13722.58cfa831e4b0c9d6adf6c459,58cfa831e4b0c9d6adf6c459,TCGA-CN-4727-10A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CN-4727-10A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_8_rg.sorted,TCGA-CN-4727-10A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_8_rg.sorted.bam,1116.4,1.9,0.15,58cfa831e4b0c9d6adf6c459,TCGA-CN-4727-10A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4727-10A,12D05E8F-8D13-47C1-B713-2250F6ABCEF9,Blood Derived Normal,Illumina HiSeq,03edf3dd-9b2f-4ef6-8846-5a0154eacc1e,Head and Neck,56,CC2D6CFA-7640-44DD-A200-68FD9F9EE69C,28CF8227-EDE2-470C-81C1-A11462070E9A,TCGA-CN-4727-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4727,TCGA-HNSC,NA,s15494,Harvard Medical School,University of Pittsburgh,United States,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c5eb,58cfa831e4b0c9d6adf6c5eb,TCGA-CG-4300-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_3_rg.sorted.filtered.,WGS,TCGA-CG-4300-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_3_rg.sorted,TCGA-CG-4300-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_3_rg.sorted.bam,203.9,1.9,0.15,58cfa831e4b0c9d6adf6c5eb,TCGA-CG-4300-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_3_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4300-01A,8ED901F6-D1BC-48B1-8514-6E8C066DC160,Primary Tumor,Illumina HiSeq,56ae4dc6-1cf2-431b-a266-c26d18e12827,Stomach,79,95D00401-E891-414F-B748-BC746B233BCE,B4092131-14B4-474E-8129-A385D3ABAED6,TCGA-CG-4300-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4300,TCGA-STAD,609,s14754,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIB
13722.58cfa831e4b0c9d6adf6cc03,58cfa831e4b0c9d6adf6cc03,TCGA-DU-7010-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DU-7010-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_3_rg.sorted,TCGA-DU-7010-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_3_rg.sorted.bam,193,NA,0.16,58cfa831e4b0c9d6adf6cc03,TCGA-DU-7010-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_3_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7010-01A,834E560A-A506-456D-BAF2-A206CA058153,Primary Tumor,Illumina HiSeq,61859b0d-b4a7-4c67-bf02-21422618f2f2,Brain,58,A6DA348E-A70C-4620-BFCB-2AFBE893284B,3EF3E4F1-9B47-4F11-9024-85242ECEE397,TCGA-DU-7010-01A-11D-2022-02,HG19_Broad_variant,TCGA-DU-7010,TCGA-LGG,456,s8355,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa832e4b0c9d6adf6d1da,58cfa832e4b0c9d6adf6d1da,TCGA-HI-7169-01A-11D-2111_130607_SN590_0232_BD26R5ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-HI-7169-01A-11D-2111_130607_SN590_0232_BD26R5ACXX_s_3_rg.sorted,TCGA-HI-7169-01A-11D-2111_130607_SN590_0232_BD26R5ACXX_s_3_rg.sorted.bam,54.6,NA,0.13,58cfa832e4b0c9d6adf6d1da,TCGA-HI-7169-01A-11D-2111_130607_SN590_0232_BD26R5ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HI-7169-01A,11FB5853-8EEB-4AD8-825D-3EAAF3FA08D6,Primary Tumor,Illumina HiSeq,9537d469-d484-46ee-a6e8-6bb3461148c5,Prostate,55,AEEF0836-305C-465C-A9CA-6C1825353AE7,58543208-CB10-466F-A0FC-6C5202B8F13D,TCGA-HI-7169-01A-11D-2111-02,HG19_Broad_variant,TCGA-HI-7169,TCGA-PRAD,NA,s4155,Harvard Medical School,Fox Chase,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c401,58cfa831e4b0c9d6adf6c401,TCGA-CH-5791-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CH-5791-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_1_rg.sorted,TCGA-CH-5791-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_1_rg.sorted.bam,145.7,2,0.17,58cfa831e4b0c9d6adf6c401,TCGA-CH-5791-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5791-01A,829BED0C-C40D-44FD-AEE8-6C7589DB60F9,Primary Tumor,Illumina HiSeq,e2778c71-6feb-40df-8b1e-8d8f0e889beb,Prostate,72,C14B5C15-994B-4739-870B-A50984D274A1,500F071A-6697-4880-BBD0-9054CCAE108A,TCGA-CH-5791-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5791,TCGA-PRAD,NA,s3417,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6be68,58cfa830e4b0c9d6adf6be68,TCGA-BJ-A28Z-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BJ-A28Z-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_2_rg.sorted,TCGA-BJ-A28Z-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_2_rg.sorted.bam,46.06,1.81,0.15,58cfa830e4b0c9d6adf6be68,TCGA-BJ-A28Z-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A28Z-01A,6BA76174-620E-4851-857A-D0ADBFD6F3E6,Primary Tumor,Illumina HiSeq,3d2be877-3825-44b4-99b1-b3c314e68c0c,Thyroid,46,D9689254-AFE2-4544-AF54-E02670BD5EBD,F353E9F5-A869-4BE1-ACC4-A832D77285D4,TCGA-BJ-A28Z-01A-11D-A16N-02,HG19_Broad_variant,TCGA-BJ-A28Z,TCGA-THCA,NA,s12508,Harvard Medical School,University of Pittsburgh,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa832e4b0c9d6adf6cf96,58cfa832e4b0c9d6adf6cf96,TCGA-G9-6351-01A-21D-1957_130405_SN590_0222_BD21LGACXX_s_2_rg.sorted.filtered.,WGS,TCGA-G9-6351-01A-21D-1957_130405_SN590_0222_BD21LGACXX_s_2_rg.sorted,TCGA-G9-6351-01A-21D-1957_130405_SN590_0222_BD21LGACXX_s_2_rg.sorted.bam,149.7,1.9,0.15,58cfa832e4b0c9d6adf6cf96,TCGA-G9-6351-01A-21D-1957_130405_SN590_0222_BD21LGACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6351-01A,F59B9C65-46E8-4CC3-AA71-8844F6C2273C,Primary Tumor,Illumina HiSeq,ddf40c8c-cec5-4f4b-853a-1541566f51b5,Prostate,51,92436584-12D6-4CF2-9AB1-CDF98E4E8260,DE6145E0-8D30-4CA1-A169-0BDC7E5BC57A,TCGA-G9-6351-01A-21D-1957-02,HG19_Broad_variant,TCGA-G9-6351,TCGA-PRAD,NA,s3618,Harvard Medical School,Roswell Park,United States,NO,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c9f1,58cfa831e4b0c9d6adf6c9f1,TCGA-DA-A1HY-10A-01D-A18Z_120612_SN590_0162_BC0VNGACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DA-A1HY-10A-01D-A18Z_120612_SN590_0162_BC0VNGACXX_s_2_rg.sorted,TCGA-DA-A1HY-10A-01D-A18Z_120612_SN590_0162_BC0VNGACXX_s_2_rg.sorted.bam,27.75,NA,0.15,58cfa831e4b0c9d6adf6c9f1,TCGA-DA-A1HY-10A-01D-A18Z_120612_SN590_0162_BC0VNGACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1HY-10A,40E17BF8-6C19-4E5E-B60D-AD54F504A970,Blood Derived Normal,Illumina HiSeq,cd19c1ed-65ae-412e-8d09-572a87a53517,Skin,42,06A02194-D705-401A-B6E4-FA2DF9958CF1,60ADADDE-D83B-4427-9AE8-AEA0544B4B34,TCGA-DA-A1HY-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-DA-A1HY,TCGA-SKCM,NA,s7507,Harvard Medical School,Yale,United States,NO,T2b,N1,Not available,Stage III
13722.58cfa82fe4b0c9d6adf6b82d,58cfa82fe4b0c9d6adf6b82d,TCGA-44-6779-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_8_rg.sorted.filtered.,WGS,TCGA-44-6779-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_8_rg.sorted,TCGA-44-6779-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_8_rg.sorted.bam,62.7,1.9,0.15,58cfa82fe4b0c9d6adf6b82d,TCGA-44-6779-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-44-6779-01A,CBBEA9F1-396A-4BF3-B67C-2CAC3394DCEB,Primary Tumor,Illumina HiSeq,ab458a7b-afac-4c72-8db7-45994af6ceb8,Lung,50,5E04D394-7A40-4E89-BA20-892774DCB469,DB5F07FE-8DC0-4259-A6B1-E75B6F1188C5,TCGA-44-6779-01A-11D-1853-02,HG19_Broad_variant,TCGA-44-6779,TCGA-LUAD,500,s11344,Harvard Medical School,Christiana Healthcare,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa830e4b0c9d6adf6c16e,58cfa830e4b0c9d6adf6c16e,TCGA-BJ-A0Z9-10A-01D-A10R_120616_SN1120_0153_AC0WMJACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BJ-A0Z9-10A-01D-A10R_120616_SN1120_0153_AC0WMJACXX_s_8_rg.sorted,TCGA-BJ-A0Z9-10A-01D-A10R_120616_SN1120_0153_AC0WMJACXX_s_8_rg.sorted.bam,15.3,1.98,0.17,58cfa830e4b0c9d6adf6c16e,TCGA-BJ-A0Z9-10A-01D-A10R_120616_SN1120_0153_AC0WMJACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0Z9-10A,86F9ECA0-D1EA-4375-A6BC-055E44B3198A,Blood Derived Normal,Illumina HiSeq,3336e590-f910-4bf5-935b-509f5f84d860,Thyroid,57,C42D7353-3155-4F95-8557-1F0DD786B1C1,5FBB0F62-94C8-4F0F-BAB6-5F9DD79C3D43,TCGA-BJ-A0Z9-10A-01D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0Z9,TCGA-THCA,NA,s12233,Harvard Medical School,University of Pittsburgh,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage III
13722.58cfa831e4b0c9d6adf6c390,58cfa831e4b0c9d6adf6c390,TCGA-C5-A2LZ-10B-01D-A20X_140106_SN590_0244_BC384EACXX_s_6_rg.sorted.filtered.,WGS,TCGA-C5-A2LZ-10B-01D-A20X_140106_SN590_0244_BC384EACXX_s_6_rg.sorted,TCGA-C5-A2LZ-10B-01D-A20X_140106_SN590_0244_BC384EACXX_s_6_rg.sorted.bam,15.83,NA,0.16,58cfa831e4b0c9d6adf6c390,TCGA-C5-A2LZ-10B-01D-A20X_140106_SN590_0244_BC384EACXX_s_6_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A2LZ-10B,BE8FA67D-C2D3-4FFF-82FE-A46BA1FA8DF0,Blood Derived Normal,Illumina HiSeq,a618c67d-3bd4-49aa-a5e3-8bd38024e5ae,Cervix,65,337C81CA-C85E-4C54-9DD6-9F80043CE62F,4E6A2EE8-6D74-495D-BCE9-5D8F846262A5,TCGA-C5-A2LZ-10B-01D-A20X-26,HG19_Broad_variant,TCGA-C5-A2LZ,TCGA-CESC,3046,s1176,MD Anderson - Institute for Applied Cancer Science,Medical College of Wisconsin,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c6c8,58cfa831e4b0c9d6adf6c6c8,TCGA-CU-A3KJ-01A-11D-A21C_120914_SN590_0179_AD13PPACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CU-A3KJ-01A-11D-A21C_120914_SN590_0179_AD13PPACXX_s_7_rg.sorted,TCGA-CU-A3KJ-01A-11D-A21C_120914_SN590_0179_AD13PPACXX_s_7_rg.sorted.bam,49.18,NA,0.15,58cfa831e4b0c9d6adf6c6c8,TCGA-CU-A3KJ-01A-11D-A21C_120914_SN590_0179_AD13PPACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CU-A3KJ-01A,A75584BC-BEF7-48F6-B4B3-C1472A3AF768,Primary Tumor,Illumina HiSeq,6b7a9ee7-ee89-4473-9170-7372313595f7,Bladder,75,3D92F5A6-949A-4176-9309-4294CCA6FC25,25847D62-9932-4A04-9B00-378794D2CE72,TCGA-CU-A3KJ-01A-11D-A21C-26,HG19_Broad_variant,TCGA-CU-A3KJ,TCGA-BLCA,NA,s3098,MD Anderson - Institute for Applied Cancer Science,UNC,United States,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82fe4b0c9d6adf6b6dc,58cfa82fe4b0c9d6adf6b6dc,TCGA-50-5935-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_8_rg.sorted.filtered.,WGS,TCGA-50-5935-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_8_rg.sorted,TCGA-50-5935-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_8_rg.sorted.bam,190.4,1.9,0.15,58cfa82fe4b0c9d6adf6b6dc,TCGA-50-5935-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5935-01A,100430C8-1446-45C8-AF36-B6DBB3DDD0C1,Primary Tumor,Illumina HiSeq,f4ad5c7d-a36e-4d9a-9c36-444e4b443953,Lung,86,98687ADB-F8E9-4E6E-BC1B-396A3DDFAC96,6F0D56B0-E246-4566-AFFB-B8DD5E88B5BA,TCGA-50-5935-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-5935,TCGA-LUAD,653,s10908,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6cc96,58cfa831e4b0c9d6adf6cc96,TCGA-FD-A3SM-10A-01D-A233_120830_SN208_0423_AC190AACXX_s_6_rg.sorted.filtered.,WGS,TCGA-FD-A3SM-10A-01D-A233_120830_SN208_0423_AC190AACXX_s_6_rg.sorted,TCGA-FD-A3SM-10A-01D-A233_120830_SN208_0423_AC190AACXX_s_6_rg.sorted.bam,56.87,NA,0.15,58cfa831e4b0c9d6adf6cc96,TCGA-FD-A3SM-10A-01D-A233_120830_SN208_0423_AC190AACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3SM-10A,474582F2-8DEC-4FBC-803F-4FD9BA2E0957,Blood Derived Normal,Illumina HiSeq,63dc4922-4d08-42bf-bb9a-10a25d19c59b,Bladder,70,B6B39C54-C867-4E52-87C0-F1182C84554F,CAA3C709-1C50-4E7E-82D6-3CB12DC5D1BB,TCGA-FD-A3SM-10A-01D-A233-26,HG19_Broad_variant,TCGA-FD-A3SM,TCGA-BLCA,NA,s3110,MD Anderson - RPPA Core Facility (Proteomics),BLN - University Of Chicago,United States,NO,T3a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c976,58cfa831e4b0c9d6adf6c976,TCGA-DK-A1A6-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DK-A1A6-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_7_rg.sorted,TCGA-DK-A1A6-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_7_rg.sorted.bam,85.12,1.95,0.15,58cfa831e4b0c9d6adf6c976,TCGA-DK-A1A6-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,Not available,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A6-01A,9C274536-3CA1-4F0E-93A8-1688074D862F,Primary Tumor,Illumina HiSeq,66e30a9a-052c-40b8-ac7c-a241a6b87d6e,Bladder,53,7AD1CD01-0EA2-4FA4-9B05-C280BD256546,CACE3242-E727-4E1F-9427-B952E10C9B12,TCGA-DK-A1A6-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DK-A1A6,TCGA-BLCA,NA,s2892,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2a,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa830e4b0c9d6adf6c256,58cfa830e4b0c9d6adf6c256,TCGA-BH-A0HK-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BH-A0HK-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_2_rg.sorted,TCGA-BH-A0HK-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_2_rg.sorted.bam,20.06,2.07,0.17,58cfa830e4b0c9d6adf6c256,TCGA-BH-A0HK-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0HK-10A,24334AC1-28A3-4B61-B590-3F51E375B247,Blood Derived Normal,Illumina HiSeq,c9ee059e-f157-47b4-a76b-64e57c14f01d,Breast,81,A67DC9C2-6D31-4B7D-99AD-C25CE2672E8C,AACC0421-E331-49E8-BA8F-AA7B091336C5,TCGA-BH-A0HK-10A-01D-A060-02,HG19_Broad_variant,TCGA-BH-A0HK,TCGA-BRCA,NA,s6124,Harvard Medical School,University of Pittsburgh,None,NO,T2,N1,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa831e4b0c9d6adf6c6aa,58cfa831e4b0c9d6adf6c6aa,TCGA-CV-5966-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CV-5966-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_6_rg.sorted,TCGA-CV-5966-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_6_rg.sorted.bam,31,1.9,0.14,58cfa831e4b0c9d6adf6c6aa,TCGA-CV-5966-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_6_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5966-11A,0D0731E2-8D82-4B6D-9258-2896A770A868,Solid Tissue Normal,Illumina HiSeq,41d152b5-0e3b-4db4-a2b0-0f2a5276d6e8,Head and Neck,63,53D3B388-6F20-40E1-BA4B-B969F3E52E09,32059756-2F60-4B75-BDBC-72BE2CEE7259,TCGA-CV-5966-11A-01D-1681-02,HG19_Broad_variant,TCGA-CV-5966,TCGA-HNSC,545,s16045,Harvard Medical School,MD Anderson Cancer Center,None,NO,T4a,N1,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c59a,58cfa831e4b0c9d6adf6c59a,TCGA-CN-4737-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CN-4737-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_4_rg.sorted,TCGA-CN-4737-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_4_rg.sorted.bam,142,1.9,0.15,58cfa831e4b0c9d6adf6c59a,TCGA-CN-4737-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4737-01A,1F744ADA-6DE1-446D-B62C-76A7FC8B40AF,Primary Tumor,Illumina HiSeq,db7d0f46-b4eb-4cad-8324-08d0a5781624,Head and Neck,19,BA5D40F5-56A2-438B-92B8-6EB7DB6D6AFA,43003723-9C58-4B5E-8F47-56B4BDA476A0,TCGA-CN-4737-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4737,TCGA-HNSC,NA,s15754,Harvard Medical School,University of Pittsburgh,None,NO,T2,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c65f,58cfa831e4b0c9d6adf6c65f,TCGA-CQ-5325-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CQ-5325-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_5_rg.sorted,TCGA-CQ-5325-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_5_rg.sorted.bam,35.7,1.9,0.14,58cfa831e4b0c9d6adf6c65f,TCGA-CQ-5325-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-5325-10A,408C5D54-7888-4955-8386-BF8819B48A6C,Blood Derived Normal,Illumina HiSeq,3fe557f8-8ca8-4e87-b083-a50b0c942824,Head and Neck,65,4F23D06D-E97A-44A6-A485-635E64FDFAB0,FDF04252-7092-4C2A-937F-A7ED2E15CED7,TCGA-CQ-5325-10A-01D-1681-02,HG19_Broad_variant,TCGA-CQ-5325,TCGA-HNSC,654,s16329,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6cf84,58cfa832e4b0c9d6adf6cf84,TCGA-FS-A1ZM-06A-12D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FS-A1ZM-06A-12D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_3_rg.sorted,TCGA-FS-A1ZM-06A-12D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_3_rg.sorted.bam,50.9,NA,0.15,58cfa832e4b0c9d6adf6cf84,TCGA-FS-A1ZM-06A-12D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZM-06A,9937259A-9D47-483C-8773-B3C60E02A653,Metastatic,Illumina HiSeq,3f7ff4ec-1e07-4f3c-a649-4819d0db712c,Skin,74,838AB0DA-14FA-481D-8EE9-B15463EBB62D,BF915DAD-C627-4A13-84AB-4BFD5DFF76BE,TCGA-FS-A1ZM-06A-12D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZM,TCGA-SKCM,NA,s8032,Harvard Medical School,Essen,Germany,NO,T2,N2c,Not available,Stage III
13722.58cfa830e4b0c9d6adf6bdb3,58cfa830e4b0c9d6adf6bdb3,TCGA-BG-A0MG-01A-21D-A101_120330_SN1120_0129_BD0UCLACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BG-A0MG-01A-21D-A101_120330_SN1120_0129_BD0UCLACXX_s_5_rg.sorted,TCGA-BG-A0MG-01A-21D-A101_120330_SN1120_0129_BD0UCLACXX_s_5_rg.sorted.bam,57.94,1.87,0.14,58cfa830e4b0c9d6adf6bdb3,TCGA-BG-A0MG-01A-21D-A101_120330_SN1120_0129_BD0UCLACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0MG-01A,9CDE90C8-2BE0-4328-A032-FF1DC19E66FD,Primary Tumor,Illumina HiSeq,30b3e5f5-4066-401d-9cf3-5ee64b9014ef,Uterus,73,96B6826D-8A4C-45F5-8CD3-B5988AA5FD0E,755BD772-9331-402B-832B-2933AAECFC71,TCGA-BG-A0MG-01A-21D-A101-02,HG19_Broad_variant,TCGA-BG-A0MG,TCGA-UCEC,NA,s4248,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c916,58cfa831e4b0c9d6adf6c916,TCGA-D3-A1Q7-10A-01D-A18Z_120516_SN1222_0107_BD12HYACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D3-A1Q7-10A-01D-A18Z_120516_SN1222_0107_BD12HYACXX_s_3_rg.sorted,TCGA-D3-A1Q7-10A-01D-A18Z_120516_SN1222_0107_BD12HYACXX_s_3_rg.sorted.bam,16.63,NA,0.17,58cfa831e4b0c9d6adf6c916,TCGA-D3-A1Q7-10A-01D-A18Z_120516_SN1222_0107_BD12HYACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A1Q7-10A,DF6303CD-FFB5-422F-9865-B09029A6D54F,Blood Derived Normal,Illumina HiSeq,e3e0036b-8e9b-4e50-87ac-5b77b6295bd6,Skin,42,D1621C19-7370-49B7-B5B8-A97A98874857,B4F4D3D6-D548-40B8-A155-44D9E4A3E655,TCGA-D3-A1Q7-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-D3-A1Q7,TCGA-SKCM,NA,s7496,Harvard Medical School,MD Anderson,United States,NO,T1b,N0,Not available,Stage IB
13722.58cfa832e4b0c9d6adf6cf7b,58cfa832e4b0c9d6adf6cf7b,TCGA-FS-A1ZZ-10A-01D-A190_120602_SN1120_0146_AC0WLVACXX_s_7_rg.sorted.filtered.,WGS,TCGA-FS-A1ZZ-10A-01D-A190_120602_SN1120_0146_AC0WLVACXX_s_7_rg.sorted,TCGA-FS-A1ZZ-10A-01D-A190_120602_SN1120_0146_AC0WLVACXX_s_7_rg.sorted.bam,45.06,NA,0.16,58cfa832e4b0c9d6adf6cf7b,TCGA-FS-A1ZZ-10A-01D-A190_120602_SN1120_0146_AC0WLVACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZZ-10A,F6FF5E77-60D8-4987-9A92-654FD4DB81F1,Blood Derived Normal,Illumina HiSeq,23022644-31a1-40a0-b7eb-97e14bec2d3f,Skin,54,16756720-FA90-435C-94CD-6D68458BF096,17A12A35-5A02-4F8D-BC01-C5FAA35A2790,TCGA-FS-A1ZZ-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZZ,TCGA-SKCM,822,s7540,Harvard Medical School,Essen,Germany,NO,T3b,N0,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6d4e5,58cfa832e4b0c9d6adf6d4e5,TCGA-V4-A9F1-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-V4-A9F1-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_1_rg.sorted,TCGA-V4-A9F1-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_1_rg.sorted.bam,51.84,NA,0.17,58cfa832e4b0c9d6adf6d4e5,TCGA-V4-A9F1-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9F1-01A,94F3D9B0-0EE4-4F6A-A8FF-CE7A4D8FAB76,Primary Tumor,Illumina HiSeq,83f97de6-ac60-4cc0-bcff-bdecfe40f951,Eye,46,6C6A3062-B453-434B-9168-7837CAABC4EF,706721D2-3759-4664-BFB7-8FF7273C2786,TCGA-V4-A9F1-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9F1,TCGA-UVM,NA,s226,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3a,N0,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6c4da,58cfa831e4b0c9d6adf6c4da,TCGA-CG-4477-01A-01D-1154_121029_SN208_0438_AC18NJACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CG-4477-01A-01D-1154_121029_SN208_0438_AC18NJACXX_s_2_rg.sorted,TCGA-CG-4477-01A-01D-1154_121029_SN208_0438_AC18NJACXX_s_2_rg.sorted.bam,281.2,1.9,0.14,58cfa831e4b0c9d6adf6c4da,TCGA-CG-4477-01A-01D-1154_121029_SN208_0438_AC18NJACXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4477-01A,18D0AAE7-9694-4252-B8FE-16E62DADAB07,Primary Tumor,Illumina HiSeq,a2b4b066-6bb7-401c-9ff9-e88bee42884b,Stomach,58,6D7C7B4E-6913-487D-9DC3-DDA901434192,3AE56504-30EE-4C03-9F69-C5B415DE6738,TCGA-CG-4477-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4477,TCGA-STAD,NA,s14764,Harvard Medical School,Indivumed,Germany,NO,T2a,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6ccb2,58cfa831e4b0c9d6adf6ccb2,TCGA-EE-A2MH-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EE-A2MH-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_1_rg.sorted,TCGA-EE-A2MH-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_1_rg.sorted.bam,67.86,NA,0.16,58cfa831e4b0c9d6adf6ccb2,TCGA-EE-A2MH-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MH-06A,BD2345ED-33B8-4010-8479-4D6C67E29561,Metastatic,Illumina HiSeq,559cf449-1385-4c18-ae67-8723edf24857,Skin,66,BB992A35-5C82-4B27-99B6-A39B5C6501FF,F0C1AB78-7825-4CF4-B4D7-E7A1A8A17C0F,TCGA-EE-A2MH-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2MH,TCGA-SKCM,516,s7691,Harvard Medical School,University of Sydney,Australia,NO,T4a,N0,Not available,Stage III
13722.58cfa82fe4b0c9d6adf6b9e8,58cfa82fe4b0c9d6adf6b9e8,TCGA-A5-A0G9-01A-11D-A043_120318_SN590_0146_AC0KH7ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-A5-A0G9-01A-11D-A043_120318_SN590_0146_AC0KH7ACXX_s_3_rg.sorted,TCGA-A5-A0G9-01A-11D-A043_120318_SN590_0146_AC0KH7ACXX_s_3_rg.sorted.bam,54.22,1.93,0.16,58cfa82fe4b0c9d6adf6b9e8,TCGA-A5-A0G9-01A-11D-A043_120318_SN590_0146_AC0KH7ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0G9-01A,45D58088-D3F4-4EB0-B75C-BCB98C0981DC,Primary Tumor,Illumina HiSeq,daffebdf-d935-425e-8576-3401ef583860,Uterus,79,117A5B33-42C5-4A52-BABE-D9712F3E7472,0DE57B60-95AF-48E2-85CA-58135A314355,TCGA-A5-A0G9-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0G9,TCGA-UCEC,NA,s4778,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d1fc,58cfa832e4b0c9d6adf6d1fc,TCGA-GV-A3JV-10B-01D-A221_120830_SN590_0178_AD143RACXX_s_2_rg.sorted.filtered.,WGS,TCGA-GV-A3JV-10B-01D-A221_120830_SN590_0178_AD143RACXX_s_2_rg.sorted,TCGA-GV-A3JV-10B-01D-A221_120830_SN590_0178_AD143RACXX_s_2_rg.sorted.bam,9.45,NA,0.14,58cfa832e4b0c9d6adf6d1fc,TCGA-GV-A3JV-10B-01D-A221_120830_SN590_0178_AD143RACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GV-A3JV-10B,01EE41EF-1894-4408-9E96-A22A1F068190,Blood Derived Normal,Illumina HiSeq,a8f1ba67-bcef-45d1-b508-d4ce580d4362,Bladder,66,9E7277EA-1A1C-4644-9A26-AA1E8A70B20E,01EA14EC-3F5A-4AFE-BA6B-AB86945E39AA,TCGA-GV-A3JV-10B-01D-A221-26,HG19_Broad_variant,TCGA-GV-A3JV,TCGA-BLCA,NA,s2934,MD Anderson - Institute for Applied Cancer Science,BLN - Cleveland Clinic,United States,NO,T3b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6cd3e,58cfa831e4b0c9d6adf6cd3e,TCGA-ER-A19D-06A-11D-A18Y_120723_SN1120_0177_AC11GTACXX_s_3_rg.sorted.filtered.,WGS,TCGA-ER-A19D-06A-11D-A18Y_120723_SN1120_0177_AC11GTACXX_s_3_rg.sorted,TCGA-ER-A19D-06A-11D-A18Y_120723_SN1120_0177_AC11GTACXX_s_3_rg.sorted.bam,60.84,NA,0.16,58cfa831e4b0c9d6adf6cd3e,TCGA-ER-A19D-06A-11D-A18Y_120723_SN1120_0177_AC11GTACXX_s_3_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19D-06A,3409F118-1798-48D6-9556-12A5C77EBEFB,Metastatic,Illumina HiSeq,051dd55e-0c45-4fb7-a1c0-4da4438e9078,Skin,46,ECCBE1D5-33F3-443B-8C12-57276C552238,6778B87E-33A9-4382-9493-07215A7F4447,TCGA-ER-A19D-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-ER-A19D,TCGA-SKCM,383,s8019,Harvard Medical School,University of Pittsburgh,United States,NO,T2a,N0,Not available,Stage IB
13722.58cfa831e4b0c9d6adf6c688,58cfa831e4b0c9d6adf6c688,TCGA-CU-A0YO-01A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CU-A0YO-01A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_5_rg.sorted,TCGA-CU-A0YO-01A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_5_rg.sorted.bam,30.08,1.91,0.16,58cfa831e4b0c9d6adf6c688,TCGA-CU-A0YO-01A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CU-A0YO-01A,4A9EF220-922C-49CF-BBED-D173B214ED31,Primary Tumor,Illumina HiSeq,98d555c2-93ae-4db5-9b19-43655d10609d,Bladder,84,9E190462-39FC-41B2-B1D6-2DA150412FCF,A407711E-26FF-4C0C-9391-326A51614BB7,TCGA-CU-A0YO-01A-11D-A10R-02,HG19_Broad_variant,TCGA-CU-A0YO,TCGA-BLCA,149,s3097,Harvard Medical School,UNC,United States,NO,T3a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c53e,58cfa831e4b0c9d6adf6c53e,TCGA-CH-5794-10A-01D-1573_130125_SN208_0451_BD1RB1ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CH-5794-10A-01D-1573_130125_SN208_0451_BD1RB1ACXX_s_6_rg.sorted,TCGA-CH-5794-10A-01D-1573_130125_SN208_0451_BD1RB1ACXX_s_6_rg.sorted.bam,79.4,1.9,0.13,58cfa831e4b0c9d6adf6c53e,TCGA-CH-5794-10A-01D-1573_130125_SN208_0451_BD1RB1ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5794-10A,A80D3EE7-60DD-49BB-B049-9335AFC035F5,Blood Derived Normal,Illumina HiSeq,3c58e5e5-3f65-4e72-8ec0-9975b3385833,Prostate,65,9BB98558-26D3-4887-8788-00518181BC3C,153DE8A8-5009-4408-BE9C-CAA1BF15A042,TCGA-CH-5794-10A-01D-1573-02,HG19_Broad_variant,TCGA-CH-5794,TCGA-PRAD,NA,s3935,Harvard Medical School,Indivumed,Germany,NO,T2b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bf3d,58cfa830e4b0c9d6adf6bf3d,TCGA-BR-4187-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BR-4187-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_5_rg.sorted,TCGA-BR-4187-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_5_rg.sorted.bam,138.9,1.9,0.15,58cfa830e4b0c9d6adf6bf3d,TCGA-BR-4187-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4187-01A,12071070-D06B-4C7B-A7B1-77C84963ABE6,Primary Tumor,Illumina HiSeq,1da3a244-39ae-4b4d-baed-e4d9b312f777,Stomach,56,144FB4ED-63BB-4908-B678-6026E09566A3,57CF858D-FF3F-4528-96DB-5A820C9B78DE,TCGA-BR-4187-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4187,TCGA-STAD,NA,s15046,Harvard Medical School,Asterand,Russia,NO,TX,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa830e4b0c9d6adf6bd9a,58cfa830e4b0c9d6adf6bd9a,TCGA-BG-A0M6-01A-31D-A101_120330_SN1120_0129_BD0UCLACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BG-A0M6-01A-31D-A101_120330_SN1120_0129_BD0UCLACXX_s_2_rg.sorted,TCGA-BG-A0M6-01A-31D-A101_120330_SN1120_0129_BD0UCLACXX_s_2_rg.sorted.bam,71.62,1.94,0.14,58cfa830e4b0c9d6adf6bd9a,TCGA-BG-A0M6-01A-31D-A101_120330_SN1120_0129_BD0UCLACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0M6-01A,002724FA-7051-49FA-9C58-4BCB7EBA4AC6,Primary Tumor,Illumina HiSeq,0db41cb8-f118-4d04-a002-22df953a0dec,Uterus,73,66E4B080-E6EF-4531-9B69-1B27F15C5669,61C058D9-E5DC-4D74-B378-28B8F0A2BF78,TCGA-BG-A0M6-01A-31D-A101-02,HG19_Broad_variant,TCGA-BG-A0M6,TCGA-UCEC,NA,s4249,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c502,58cfa831e4b0c9d6adf6c502,TCGA-CG-5730-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CG-5730-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_4_rg.sorted,TCGA-CG-5730-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_4_rg.sorted.bam,82.3,1.9,0.15,58cfa831e4b0c9d6adf6c502,TCGA-CG-5730-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5730-11A,09587F1C-5C99-4102-BC49-84D50FA8D0CE,Solid Tissue Normal,Illumina HiSeq,bbd5bdf5-6935-4c46-ac56-be3e2c238528,Stomach,80,16225D9E-2074-42AE-91E5-4D0352916465,2CC66884-8812-464E-A232-6B90A028BD26,TCGA-CG-5730-11A-01D-1598-02,HG19_Broad_variant,TCGA-CG-5730,TCGA-STAD,NA,s15328,Harvard Medical School,Indivumed,Germany,NO,T2,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa82fe4b0c9d6adf6b9a8,58cfa82fe4b0c9d6adf6b9a8,TCGA-67-6215-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_7.rg.sorted.filtered.,WGS,TCGA-67-6215-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_7.rg.sorted,TCGA-67-6215-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_7.rg.sorted.bam,292.4,1.9,0.14,58cfa82fe4b0c9d6adf6b9a8,TCGA-67-6215-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_7.rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-67-6215-01A,DBD5B0DE-94C9-45DD-AFB3-6820A7ECACA2,Primary Tumor,Illumina HiSeq,502bd59b-5e8d-4170-9a24-b18fa50a5dc1,Lung,52,3BA5F6B9-6458-44E2-A0AA-B5C7E5FCD632,483EF1DC-150E-4623-BA11-772ADE84E4E4,TCGA-67-6215-01A-11D-1751-02,HG19_Broad_variant,TCGA-67-6215,TCGA-LUAD,NA,s11555,Harvard Medical School,St Joseph's Medical Center (MD),United States,NO,T2a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa832e4b0c9d6adf6ce71,58cfa832e4b0c9d6adf6ce71,TCGA-FS-A1ZK-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FS-A1ZK-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_8_rg.sorted,TCGA-FS-A1ZK-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_8_rg.sorted.bam,50.13,NA,0.16,58cfa832e4b0c9d6adf6ce71,TCGA-FS-A1ZK-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZK-10A,1404791B-86BF-4DFD-85B4-C8FF356F109C,Blood Derived Normal,Illumina HiSeq,2e15541d-4e6a-4d69-aace-9b16fdce059f,Skin,68,9F006B7F-4BE8-423E-86C6-36EF71215C9F,A5BA51BF-D226-4FB9-A0E2-D154461F4858,TCGA-FS-A1ZK-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZK,TCGA-SKCM,728,s7870,Harvard Medical School,Essen,Germany,NO,T4,N0,Not available,Stage II
13722.58cfa832e4b0c9d6adf6d1e5,58cfa832e4b0c9d6adf6d1e5,TCGA-FG-6690-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FG-6690-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_5_rg.sorted,TCGA-FG-6690-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_5_rg.sorted.bam,113,1.9,0.14,58cfa832e4b0c9d6adf6d1e5,TCGA-FG-6690-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-6690-10A,AD202887-88B3-4E0F-A4C3-7E135D4CB258,Blood Derived Normal,Illumina HiSeq,a570edf3-b9eb-4c0f-b0d3-cb958f070979,Brain,70,8CBF4DDC-A8CF-4AA2-ABB2-E793853E28EF,FEE715CF-4D4E-49B0-A8DC-DAD81F1C0117,TCGA-FG-6690-10A-01D-1891-02,HG19_Broad_variant,TCGA-FG-6690,TCGA-LGG,NA,s8365,Harvard Medical School,Case Western,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6c5f5,58cfa831e4b0c9d6adf6c5f5,TCGA-CN-5355-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CN-5355-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_7_rg.sorted,TCGA-CN-5355-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_7_rg.sorted.bam,322.7,1.9,0.16,58cfa831e4b0c9d6adf6c5f5,TCGA-CN-5355-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_7_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5355-01A,45A10908-19E6-421A-8903-1440BFA57C9D,Primary Tumor,Illumina HiSeq,083daa5f-0e79-4402-94b2-48a892a5a4f1,Head and Neck,64,63535469-D402-4BA2-9AB5-986E6ED80F55,180BC055-9C10-4B84-80C4-3DF00742719D,TCGA-CN-5355-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5355,TCGA-HNSC,NA,s15501,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6bf26,58cfa830e4b0c9d6adf6bf26,TCGA-BR-4201-11A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BR-4201-11A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_4_rg.sorted,TCGA-BR-4201-11A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_4_rg.sorted.bam,293.3,1.9,0.13,58cfa830e4b0c9d6adf6bf26,TCGA-BR-4201-11A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4201-11A,8520654B-2192-46CF-9D72-1DDB885A7C55,Solid Tissue Normal,Illumina HiSeq,a6dc7c10-d45e-4f8a-a8fd-bd928d8f554c,Stomach,66,76438A23-27DF-4C9A-8ED9-3FA6CD0CE817,D4E9F0DD-A50B-47E8-97EC-C61EE7799884,TCGA-BR-4201-11A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4201,TCGA-STAD,NA,s14964,Harvard Medical School,Asterand,Russia,NO,T2a,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa831e4b0c9d6adf6ca90,58cfa831e4b0c9d6adf6ca90,TCGA-DU-5872-01A-11D-1703_130808_SN208_0488_BC294YACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DU-5872-01A-11D-1703_130808_SN208_0488_BC294YACXX_s_6_rg.sorted,TCGA-DU-5872-01A-11D-1703_130808_SN208_0488_BC294YACXX_s_6_rg.sorted.bam,31.7,1.8,0.17,58cfa831e4b0c9d6adf6ca90,TCGA-DU-5872-01A-11D-1703_130808_SN208_0488_BC294YACXX_s_6_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-5872-01A,48607130-C09A-491D-882F-7D2591D13182,Primary Tumor,Illumina HiSeq,ed7bb33a-0d4e-4215-b4c5-2dc1250d882b,Brain,43,048550EE-189D-483D-B07F-B77F10278420,CF245938-DD0C-42FE-9A39-09F29FF12F23,TCGA-DU-5872-01A-11D-1703-02,HG19_Broad_variant,TCGA-DU-5872,TCGA-LGG,NA,s8350,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa831e4b0c9d6adf6c914,58cfa831e4b0c9d6adf6c914,TCGA-DK-A1AA-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DK-A1AA-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_3_rg.sorted,TCGA-DK-A1AA-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_3_rg.sorted.bam,72.54,1.95,0.16,58cfa831e4b0c9d6adf6c914,TCGA-DK-A1AA-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AA-01A,56D8A1B8-1268-4362-A7F1-77B76FBF1B59,Primary Tumor,Illumina HiSeq,006c1498-f327-4fff-8936-7d7cb06639f4,Bladder,57,577700D1-C366-41EF-8A0D-E50DEEFB5E3C,6482BD80-A3F1-4169-A9F2-B45A9445035C,TCGA-DK-A1AA-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DK-A1AA,TCGA-BLCA,NA,s3107,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c63e,58cfa831e4b0c9d6adf6c63e,TCGA-CN-4733-10A-01D-1868_120530_SN1222_0110_AC0VLAACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CN-4733-10A-01D-1868_120530_SN1222_0110_AC0VLAACXX_s_6_rg.sorted,TCGA-CN-4733-10A-01D-1868_120530_SN1222_0110_AC0VLAACXX_s_6_rg.sorted.bam,195,1.9,0.16,58cfa831e4b0c9d6adf6c63e,TCGA-CN-4733-10A-01D-1868_120530_SN1222_0110_AC0VLAACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4733-10A,DEDD71B4-8537-4947-839E-90ACEDDD0893,Blood Derived Normal,Illumina HiSeq,42c2db46-32f6-476f-8c0a-eef25c7b64db,Head and Neck,61,7554FBBB-837F-4F9E-B7FE-B05AA1D76831,C4E4D614-B608-435A-B715-F2115D20AB3A,TCGA-CN-4733-10A-01D-1868-02,HG19_Broad_variant,TCGA-CN-4733,TCGA-HNSC,NA,s15757,Harvard Medical School,University of Pittsburgh,None,NO,T1,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6cce7,58cfa831e4b0c9d6adf6cce7,TCGA-EK-A3GJ-01A-21D-A20X_140106_SN590_0243_AC371BACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EK-A3GJ-01A-21D-A20X_140106_SN590_0243_AC371BACXX_s_1_rg.sorted,TCGA-EK-A3GJ-01A-21D-A20X_140106_SN590_0243_AC371BACXX_s_1_rg.sorted.bam,68.37,NA,0.16,58cfa831e4b0c9d6adf6cce7,TCGA-EK-A3GJ-01A-21D-A20X_140106_SN590_0243_AC371BACXX_s_1_rg.sorted.bam,Alive,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A3GJ-01A,DEDA68DD-E9AD-45CC-9DBB-1C5836EF6519,Primary Tumor,Illumina HiSeq,dde88a3f-8602-42a1-9b43-037c49cb3d34,Cervix,51,93AB0265-4851-4A8E-BEE3-496EA8DE56F7,1DE48F6B-49E4-4FE8-9D1B-0C7773DD7671,TCGA-EK-A3GJ-01A-21D-A20X-26,HG19_Broad_variant,TCGA-EK-A3GJ,TCGA-CESC,NA,s1192,MD Anderson - Institute for Applied Cancer Science,Gynecologic Oncology Group,United States,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c410,58cfa831e4b0c9d6adf6c410,TCGA-C5-A3HL-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_1_rg.sorted.filtered.,WGS,TCGA-C5-A3HL-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_1_rg.sorted,TCGA-C5-A3HL-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_1_rg.sorted.bam,10.96,NA,0.14,58cfa831e4b0c9d6adf6c410,TCGA-C5-A3HL-10A-01D-A20X_140131_SN590_0247_AC3FDBACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A3HL-10A,09329A53-D58D-4480-95D8-32043E40DE6E,Blood Derived Normal,Illumina HiSeq,9b5f1439-6b4f-4a02-857c-75dd4c6d298e,Cervix,76,794BB890-8431-4860-A6D9-B310918E0B1D,5704F39D-FA66-4E36-B752-45908D9D83A0,TCGA-C5-A3HL-10A-01D-A20X-26,HG19_Broad_variant,TCGA-C5-A3HL,TCGA-CESC,NA,s1515,MD Anderson - Institute for Applied Cancer Science,Medical College of Wisconsin,United States,NO,T1b2,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6cc5e,58cfa831e4b0c9d6adf6cc5e,TCGA-EM-A3OB-10A-01D-A221_120610_SN1120_0152_BD13TDACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EM-A3OB-10A-01D-A221_120610_SN1120_0152_BD13TDACXX_s_8_rg.sorted,TCGA-EM-A3OB-10A-01D-A221_120610_SN1120_0152_BD13TDACXX_s_8_rg.sorted.bam,15.79,NA,0.14,58cfa831e4b0c9d6adf6cc5e,TCGA-EM-A3OB-10A-01D-A221_120610_SN1120_0152_BD13TDACXX_s_8_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3OB-10A,8CFC2589-B0AD-4FE6-8420-8F6FE0178BCC,Blood Derived Normal,Illumina HiSeq,e5f58c71-f76c-48a0-bd0a-2c3e9bccad0d,Thyroid,33,F0F1F5C2-35E9-4F9C-922D-35D4B3828BCD,A4A1B381-CA4E-451A-94AB-EA9D7AB4009B,TCGA-EM-A3OB-10A-01D-A221-26,HG19_Broad_variant,TCGA-EM-A3OB,TCGA-THCA,NA,s12112,MD Anderson - Institute for Applied Cancer Science,University Health Network,Canada,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa831e4b0c9d6adf6ca84,58cfa831e4b0c9d6adf6ca84,TCGA-DU-5872-10A-01D-1703_130813_SN1440_0160_AD2B87ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DU-5872-10A-01D-1703_130813_SN1440_0160_AD2B87ACXX_s_1_rg.sorted,TCGA-DU-5872-10A-01D-1703_130813_SN1440_0160_AD2B87ACXX_s_1_rg.sorted.bam,168.4,1.9,0.14,58cfa831e4b0c9d6adf6ca84,TCGA-DU-5872-10A-01D-1703_130813_SN1440_0160_AD2B87ACXX_s_1_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-5872-10A,48607130-C09A-491D-882F-7D2591D13182,Blood Derived Normal,Illumina HiSeq,31f28101-11ef-411d-baa5-15d1a1618d2d,Brain,43,274BE2B2-3354-4E96-B871-F2722D7DE04D,25EC883D-0C94-4A6E-8F94-E865111831B1,TCGA-DU-5872-10A-01D-1703-02,HG19_Broad_variant,TCGA-DU-5872,TCGA-LGG,NA,s8345,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa831e4b0c9d6adf6cb12,58cfa831e4b0c9d6adf6cb12,TCGA-EA-A3HS-01A-11D-A20X_140106_SN590_0243_AC371BACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EA-A3HS-01A-11D-A20X_140106_SN590_0243_AC371BACXX_s_3_rg.sorted,TCGA-EA-A3HS-01A-11D-A20X_140106_SN590_0243_AC371BACXX_s_3_rg.sorted.bam,76.91,NA,0.16,58cfa831e4b0c9d6adf6cb12,TCGA-EA-A3HS-01A-11D-A20X_140106_SN590_0243_AC371BACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EA-A3HS-01A,753EE373-FBCF-4349-B9B2-5A41936E27E9,Primary Tumor,Illumina HiSeq,684e83c6-0894-4bfd-a2ee-6b1877c74f82,Cervix,35,0835FA38-9870-472E-B9A0-2A2652807BC5,E87CC37B-FD44-4DD9-9D14-455B89C6D4C2,TCGA-EA-A3HS-01A-11D-A20X-26,HG19_Broad_variant,TCGA-EA-A3HS,TCGA-CESC,NA,s1522,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T1b,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b6a2,58cfa82fe4b0c9d6adf6b6a2,TCGA-44-6776-11A-01D-1853_120123_SN590_0134_AC0DJKACXX_s_1_rg.sorted.filtered.,WGS,TCGA-44-6776-11A-01D-1853_120123_SN590_0134_AC0DJKACXX_s_1_rg.sorted,TCGA-44-6776-11A-01D-1853_120123_SN590_0134_AC0DJKACXX_s_1_rg.sorted.bam,195.7,1.9,0.15,58cfa82fe4b0c9d6adf6b6a2,TCGA-44-6776-11A-01D-1853_120123_SN590_0134_AC0DJKACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-44-6776-11A,C2A1DE2E-6451-4C95-8CE6-263F2B7E6EFF,Solid Tissue Normal,Illumina HiSeq,b7a6be76-449b-46fc-863f-1e1cb9498eae,Lung,60,DA9934B1-92AA-4A5F-B12D-EFE510FD7499,CD224998-3A69-4ECC-9EDE-893F793E7761,TCGA-44-6776-11A-01D-1853-02,HG19_Broad_variant,TCGA-44-6776,TCGA-LUAD,NA,s10657,Harvard Medical School,Christiana Healthcare,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6c47a,58cfa831e4b0c9d6adf6c47a,TCGA-BT-A3PK-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BT-A3PK-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_3_rg.sorted,TCGA-BT-A3PK-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_3_rg.sorted.bam,57.66,NA,0.17,58cfa831e4b0c9d6adf6c47a,TCGA-BT-A3PK-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A3PK-01A,73041FCF-F3B6-4851-B34D-1D62A1FCF6FE,Primary Tumor,Illumina HiSeq,637e8bd5-61ee-4d45-8cc5-e3b89950d020,Bladder,80,F09E1EEB-BCD5-4DBA-92F0-7D4B34B81CE7,EE975BE9-76BF-4B5A-BF4C-155750C168CD,TCGA-BT-A3PK-01A-21D-A221-26,HG19_Broad_variant,TCGA-BT-A3PK,TCGA-BLCA,NA,s2858,MD Anderson - Institute for Applied Cancer Science,University of Pittsburgh,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa82fe4b0c9d6adf6b780,58cfa82fe4b0c9d6adf6b780,TCGA-50-5045-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_1_rg.sorted.filtered.,WGS,TCGA-50-5045-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_1_rg.sorted,TCGA-50-5045-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_1_rg.sorted.bam,1032.7,1.9,0.17,58cfa82fe4b0c9d6adf6b780,TCGA-50-5045-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_1_rg.sorted.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5045-01A,9EE20C0D-A1C3-47F3-ABDA-131B3F190F52,Primary Tumor,Illumina HiSeq,e3bc7a3f-c296-412c-8974-8c21cf01dbfb,Lung,57,BDD75BCA-6224-4743-A367-CB1FF01E8121,42839A7D-81DB-428A-AB3B-072ACD26CA91,TCGA-50-5045-01A-01D-1623-02,HG19_Broad_variant,TCGA-50-5045,TCGA-LUAD,2174,s11004,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa832e4b0c9d6adf6ce63,58cfa832e4b0c9d6adf6ce63,TCGA-GV-A3QH-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_5_rg.sorted.filtered.,WGS,TCGA-GV-A3QH-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_5_rg.sorted,TCGA-GV-A3QH-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_5_rg.sorted.bam,38.38,NA,0.14,58cfa832e4b0c9d6adf6ce63,TCGA-GV-A3QH-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GV-A3QH-01A,33BC6A7C-9844-41E3-96B3-1E34BB3FEDD5,Primary Tumor,Illumina HiSeq,5672aee8-638c-45c6-af4f-0ccc5e2a1b45,Bladder,67,DEB7311F-E747-44EC-92C3-1E56CD5CACF2,B14D2F40-53F3-4A3A-8FA8-1BE7F102CA25,TCGA-GV-A3QH-01A-11D-A221-26,HG19_Broad_variant,TCGA-GV-A3QH,TCGA-BLCA,NA,s3129,MD Anderson - Institute for Applied Cancer Science,BLN - Cleveland Clinic,United States,NO,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6ca7f,58cfa831e4b0c9d6adf6ca7f,TCGA-DK-A1A5-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DK-A1A5-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_1_rg.sorted,TCGA-DK-A1A5-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_1_rg.sorted.bam,59.04,1.91,0.16,58cfa831e4b0c9d6adf6ca7f,TCGA-DK-A1A5-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A5-01A,904A8757-E0C5-41EF-B583-C8F170CAAAC1,Primary Tumor,Illumina HiSeq,3aa26bad-446a-4391-a584-27b78fc638e8,Bladder,79,A9EF3EC5-B1C1-481F-89CF-1729FAB50173,C4A751AF-E8CC-452A-9B5B-99D4B0AC585D,TCGA-DK-A1A5-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DK-A1A5,TCGA-BLCA,65,s2889,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6cac0,58cfa831e4b0c9d6adf6cac0,TCGA-DK-A3IQ-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DK-A3IQ-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_4_rg.sorted,TCGA-DK-A3IQ-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_4_rg.sorted.bam,37.23,NA,0.15,58cfa831e4b0c9d6adf6cac0,TCGA-DK-A3IQ-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3IQ-10A,E44F60EC-66C4-45A2-A003-0A1FAF1D6E03,Blood Derived Normal,Illumina HiSeq,0cfcdefd-603d-4cc2-a651-88d3e5f5c56c,Bladder,74,DE282A5B-70C9-4E37-B665-5B185C91FE14,0ED2BFE5-2AAE-43C4-96E9-67ADEA33CD9B,TCGA-DK-A3IQ-10A-01D-A210-26,HG19_Broad_variant,TCGA-DK-A3IQ,TCGA-BLCA,NA,s2896,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c4be,58cfa831e4b0c9d6adf6c4be,TCGA-BR-4367-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_3_rg.sorted.filtered.,WGS,TCGA-BR-4367-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_3_rg.sorted,TCGA-BR-4367-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_3_rg.sorted.bam,65.9,1.9,0.14,58cfa831e4b0c9d6adf6c4be,TCGA-BR-4367-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4367-01A,D139BD0C-2EEB-44EC-856B-E77CB03D294E,Primary Tumor,Illumina HiSeq,98785371-4af3-4d04-acc8-5c53c8076618,Stomach,78,1506E790-C21C-4419-B11B-14250C947FB5,174658D3-1933-47FD-A883-5F4AFA169778,TCGA-BR-4367-01A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4367,TCGA-STAD,NA,s14611,Harvard Medical School,Asterand,Russia,NO,TX,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa831e4b0c9d6adf6c7b5,58cfa831e4b0c9d6adf6c7b5,TCGA-CV-5973-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CV-5973-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_5_rg.sorted,TCGA-CV-5973-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_5_rg.sorted.bam,17,1.8,0.14,58cfa831e4b0c9d6adf6c7b5,TCGA-CV-5973-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5973-11A,8FC1F1BE-D2D5-4B3A-9973-F4D964018BEB,Solid Tissue Normal,Illumina HiSeq,195bab19-b8a4-467b-b019-332843975246,Head and Neck,62,8ED1F8FB-095A-4E76-88A3-15CEE4B5B4BB,FE312A26-D94E-4AE0-962A-2372E061EECC,TCGA-CV-5973-11A-01D-1681-02,HG19_Broad_variant,TCGA-CV-5973,TCGA-HNSC,NA,s15898,Harvard Medical School,MD Anderson Cancer Center,None,NO,T3,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6cbf1,58cfa831e4b0c9d6adf6cbf1,TCGA-EM-A3O3-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EM-A3O3-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_5_rg.sorted,TCGA-EM-A3O3-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_5_rg.sorted.bam,48.3,NA,0.16,58cfa831e4b0c9d6adf6cbf1,TCGA-EM-A3O3-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_5_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3O3-01A,2A398AF1-AEA5-4AAE-AB00-A2DC152F965A,Primary Tumor,Illumina HiSeq,52b6fd69-3b74-441b-a40b-77c172dd0979,Thyroid,83,60C1BA59-C04E-4237-A8B9-FA0D894BBAFA,EEBDC565-A071-4356-8CBF-1560A8BB034D,TCGA-EM-A3O3-01A-11D-A221-26,HG19_Broad_variant,TCGA-EM-A3O3,TCGA-THCA,NA,s12111,MD Anderson - Institute for Applied Cancer Science,University Health Network,Canada,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa830e4b0c9d6adf6bfb6,58cfa830e4b0c9d6adf6bfb6,TCGA-B5-A0K0-10A-01D-A043_120209_SN1120_0114_BC0DFVACXX_s_8_rg.sorted.filtered.,WGS,TCGA-B5-A0K0-10A-01D-A043_120209_SN1120_0114_BC0DFVACXX_s_8_rg.sorted,TCGA-B5-A0K0-10A-01D-A043_120209_SN1120_0114_BC0DFVACXX_s_8_rg.sorted.bam,43.36,1.97,0.15,58cfa830e4b0c9d6adf6bfb6,TCGA-B5-A0K0-10A-01D-A043_120209_SN1120_0114_BC0DFVACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0K0-10A,29C8F468-5AC1-4D6C-8376-E36E6D246926,Blood Derived Normal,Illumina HiSeq,967c5a49-ca2a-4d26-bd4a-840a16998e01,Uterus,48,1DF69E2E-F392-465F-8E61-4671BA2FCD35,3CB411F8-9308-4CED-822B-C94FE602AB73,TCGA-B5-A0K0-10A-01D-A043-02,HG19_Broad_variant,TCGA-B5-A0K0,TCGA-UCEC,NA,s5001,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6be55,58cfa830e4b0c9d6adf6be55,TCGA-AP-A0LT-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-AP-A0LT-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_1_rg.sorted,TCGA-AP-A0LT-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_1_rg.sorted.bam,118.49,2.07,0.17,58cfa830e4b0c9d6adf6be55,TCGA-AP-A0LT-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LT-01A,43714E9A-E9C4-4206-AF92-1D00D2A8AE35,Primary Tumor,Illumina HiSeq,42ca121f-f3b0-4b47-acb4-f1294f88eb39,Uterus,57,C94DD7A5-DD58-4702-A7D1-8199D3F8C9CC,B057AD28-5D99-48BC-B642-7E548914F1B1,TCGA-AP-A0LT-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A0LT,TCGA-UCEC,NA,s4242,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6cf35,58cfa832e4b0c9d6adf6cf35,TCGA-G9-6356-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_2_rg.sorted.filtered.,WGS,TCGA-G9-6356-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_2_rg.sorted,TCGA-G9-6356-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_2_rg.sorted.bam,39.7,1.8,0.14,58cfa832e4b0c9d6adf6cf35,TCGA-G9-6356-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6356-10A,1D7FFBE7-6139-412B-8739-8082A63A2B33,Blood Derived Normal,Illumina HiSeq,c966ad1f-2ded-40de-950e-0b9ee42a5923,Prostate,60,6E069287-0274-4F2E-A996-0C27F81C9329,FA765A2B-44EA-4964-8135-3648FE153E05,TCGA-G9-6356-10A-01D-1784-02,HG19_Broad_variant,TCGA-G9-6356,TCGA-PRAD,NA,s3971,Harvard Medical School,Roswell Park,United States,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cc24,58cfa831e4b0c9d6adf6cc24,TCGA-DU-7292-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DU-7292-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_1_rg.sorted,TCGA-DU-7292-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_1_rg.sorted.bam,28,NA,0.14,58cfa831e4b0c9d6adf6cc24,TCGA-DU-7292-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7292-01A,145F87A3-5E86-4A87-8E49-B166A2271D02,Primary Tumor,Illumina HiSeq,06fe9cf9-6572-4026-9990-7ec39cd21278,Brain,69,BD3011C5-FCF0-4B28-8D82-1175F69B118B,A3B00BDD-7250-4E6F-8F83-6CC01D672EF4,TCGA-DU-7292-01A-11D-2022-02,HG19_Broad_variant,TCGA-DU-7292,TCGA-LGG,242,s8361,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6c94f,58cfa831e4b0c9d6adf6c94f,TCGA-D7-5578-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_2_rg.sorted.filtered.,WGS,TCGA-D7-5578-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_2_rg.sorted,TCGA-D7-5578-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_2_rg.sorted.bam,331,1.88,0.15,58cfa831e4b0c9d6adf6c94f,TCGA-D7-5578-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-5578-01A,A3C1F9A2-9174-48CF-81DC-2AFCFDC4BA9C,Primary Tumor,Illumina HiSeq,306aee2b-5fac-4825-952b-d838746530a5,Stomach,80,E88D8673-C0BE-4549-8DAF-100187608F17,A00E8607-F965-421B-B0ED-57C09488F514,TCGA-D7-5578-01A-01D-1598-02,HG19_Broad_variant,TCGA-D7-5578,TCGA-STAD,NA,s15401,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T3,N2,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIIA
13722.58cfa832e4b0c9d6adf6cf22,58cfa832e4b0c9d6adf6cf22,TCGA-G9-6364-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_7_rg.sorted.filtered.,WGS,TCGA-G9-6364-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_7_rg.sorted,TCGA-G9-6364-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_7_rg.sorted.bam,79.4,1.9,0.13,58cfa832e4b0c9d6adf6cf22,TCGA-G9-6364-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6364-01A,F8D8B417-5945-42A5-850A-FBC04B4F0E61,Primary Tumor,Illumina HiSeq,01dfbaf5-2c53-4f89-97c0-f845932cfde5,Prostate,72,242C8BCB-F8D3-4D3A-ABB1-0AB5D74D3BCB,6E0AAA4D-9ACC-4E63-AC7E-5B478D6406B5,TCGA-G9-6364-01A-21D-1784-02,HG19_Broad_variant,TCGA-G9-6364,TCGA-PRAD,NA,s4147,Harvard Medical School,Roswell Park,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c426,58cfa831e4b0c9d6adf6c426,TCGA-CN-4727-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CN-4727-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_7_rg.sorted,TCGA-CN-4727-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_7_rg.sorted.bam,81.7,1.9,0.14,58cfa831e4b0c9d6adf6c426,TCGA-CN-4727-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4727-01A,12D05E8F-8D13-47C1-B713-2250F6ABCEF9,Primary Tumor,Illumina HiSeq,f26c4909-b285-4ca0-ac40-fe65ad4a6a1a,Head and Neck,56,F102AEF0-94B8-4D26-8055-35B76DA9DD5F,E42C764C-98DB-4E55-A625-B1443E6C4B3A,TCGA-CN-4727-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4727,TCGA-HNSC,NA,s15495,Harvard Medical School,University of Pittsburgh,United States,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c684,58cfa831e4b0c9d6adf6c684,TCGA-CN-4738-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CN-4738-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_7_rg.sorted,TCGA-CN-4738-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_7_rg.sorted.bam,122.7,1.9,0.15,58cfa831e4b0c9d6adf6c684,TCGA-CN-4738-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4738-01A,97640EF0-0259-4244-95BA-48D28C60B372,Primary Tumor,Illumina HiSeq,142fc981-c09b-4d94-96d3-b0d48b4d59f2,Head and Neck,53,8277E744-0508-47D5-9CEA-11DCF7F56D35,0EABE3ED-367B-4055-8700-0036E6A0FB1D,TCGA-CN-4738-01A-02D-1509-02,HG19_Broad_variant,TCGA-CN-4738,TCGA-HNSC,436,s16176,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6cb95,58cfa831e4b0c9d6adf6cb95,TCGA-EE-A2GT-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EE-A2GT-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_5_rg.sorted,TCGA-EE-A2GT-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_5_rg.sorted.bam,20.12,NA,0.17,58cfa831e4b0c9d6adf6cb95,TCGA-EE-A2GT-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2GT-10A,97D9DFC9-C937-48B4-B453-DF081950419F,Blood Derived Normal,Illumina HiSeq,4798cb67-a102-4a3f-b036-caa4d5ff6bb1,Skin,77,0A095191-727B-45FF-9E30-E6CC490326A4,90DBCC2C-71AB-4ABF-8A1D-7587305E9435,TCGA-EE-A2GT-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2GT,TCGA-SKCM,NA,s7509,Harvard Medical School,University of Sydney,Australia,NO,T3a,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6c756,58cfa831e4b0c9d6adf6c756,TCGA-D3-A1QB-10A-01D-A18Z_120626_SN590_0164_BC0VMVACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D3-A1QB-10A-01D-A18Z_120626_SN590_0164_BC0VMVACXX_s_4_rg.sorted,TCGA-D3-A1QB-10A-01D-A18Z_120626_SN590_0164_BC0VMVACXX_s_4_rg.sorted.bam,21.07,NA,0.16,58cfa831e4b0c9d6adf6c756,TCGA-D3-A1QB-10A-01D-A18Z_120626_SN590_0164_BC0VMVACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A1QB-10A,C59A5615-2DD1-4902-A62B-0E312EAB5484,Blood Derived Normal,Illumina HiSeq,3d27f6db-c1af-4fa8-87c5-3784e31cc9ca,Skin,75,EAE60575-D043-4D1A-9A51-FC785D9F75C4,863B524B-4438-4133-98C0-C03BACC092A2,TCGA-D3-A1QB-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-D3-A1QB,TCGA-SKCM,NA,s7497,Harvard Medical School,MD Anderson,United States,NO,T0,N2c,Not available,Stage III
13722.58cfa831e4b0c9d6adf6cc80,58cfa831e4b0c9d6adf6cc80,TCGA-EL-A3T6-01A-11D-A221_120523_SN1222_0108_AC0VL4ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EL-A3T6-01A-11D-A221_120523_SN1222_0108_AC0VL4ACXX_s_7_rg.sorted,TCGA-EL-A3T6-01A-11D-A221_120523_SN1222_0108_AC0VL4ACXX_s_7_rg.sorted.bam,40.31,NA,0.15,58cfa831e4b0c9d6adf6cc80,TCGA-EL-A3T6-01A-11D-A221_120523_SN1222_0108_AC0VL4ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EL-A3T6-01A,90507BAA-B716-4BCF-A18E-9D8AE97D809A,Primary Tumor,Illumina HiSeq,fb31d05f-8a2e-416d-92b9-fd333e80561f,Thyroid,34,61367375-8317-4CAE-86CF-2FD65AB8ABC8,C1FE07E8-83AC-47A7-B8E5-FA62DE03BB17,TCGA-EL-A3T6-01A-11D-A221-26,HG19_Broad_variant,TCGA-EL-A3T6,TCGA-THCA,NA,s12518,MD Anderson - Institute for Applied Cancer Science,MD Anderson,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82ee4b0c9d6adf6afa6,58cfa82ee4b0c9d6adf6afa6,TCGA-05-4422-10A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-05-4422-10A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_6_rg.sorted,TCGA-05-4422-10A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_6_rg.sorted.bam,61.23,1.8,0.15,58cfa82ee4b0c9d6adf6afa6,TCGA-05-4422-10A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_6_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4422-10A,44DEC838-B653-42A7-A58B-A1FD232CD68C,Blood Derived Normal,Illumina HiSeq,8563e108-6248-4f9c-81ef-2c8118956385,Lung,68,FCE6E4CC-207C-4B2C-8387-6166D47565BB,6214FC0C-5B64-4611-B8F3-213A879615E7,TCGA-05-4422-10A-01D-1203-02,HG19_Broad_variant,TCGA-05-4422,TCGA-LUAD,NA,s11329,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa832e4b0c9d6adf6d0dd,58cfa832e4b0c9d6adf6d0dd,TCGA-HW-7495-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_3_rg.sorted.filtered.,WGS,TCGA-HW-7495-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_3_rg.sorted,TCGA-HW-7495-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_3_rg.sorted.bam,107,NA,0.15,58cfa832e4b0c9d6adf6d0dd,TCGA-HW-7495-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HW-7495-01A,49967A57-7C12-46BB-8D71-CEBBB17C9935,Primary Tumor,Illumina HiSeq,10d85d7f-6926-453a-bfef-d1b9d129d9d1,Brain,45,1CCC7965-99A5-420A-B5AB-F9853B50E3B1,07DDE76E-E126-4D66-BA85-059F076B7D04,TCGA-HW-7495-01A-11D-2022-02,HG19_Broad_variant,TCGA-HW-7495,TCGA-LGG,NA,s8577,Harvard Medical School,MSKCC,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa830e4b0c9d6adf6c25d,58cfa830e4b0c9d6adf6c25d,TCGA-BJ-A0Z3-10A-01D-A13U_120706_SN1120_0170_BD1422ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BJ-A0Z3-10A-01D-A13U_120706_SN1120_0170_BD1422ACXX_s_8_rg.sorted,TCGA-BJ-A0Z3-10A-01D-A13U_120706_SN1120_0170_BD1422ACXX_s_8_rg.sorted.bam,24.48,1.95,0.16,58cfa830e4b0c9d6adf6c25d,TCGA-BJ-A0Z3-10A-01D-A13U_120706_SN1120_0170_BD1422ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0Z3-10A,331CAE6E-2868-4C58-9302-709A9FF7D025,Blood Derived Normal,Illumina HiSeq,9033bf3e-9c80-4f03-9bcf-a63c9794ccff,Thyroid,33,CE23632D-EA12-422B-AA3A-78874E665E4D,A1FFA620-F821-4652-AF2E-0C629067F9A5,TCGA-BJ-A0Z3-10A-01D-A13U-02,HG19_Broad_variant,TCGA-BJ-A0Z3,TCGA-THCA,NA,s12746,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c634,58cfa831e4b0c9d6adf6c634,TCGA-CN-5361-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CN-5361-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_2_rg.sorted,TCGA-CN-5361-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_2_rg.sorted.bam,225.7,1.9,0.15,58cfa831e4b0c9d6adf6c634,TCGA-CN-5361-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5361-01A,044579EF-16A6-4F00-B951-EDC423D8A14F,Primary Tumor,Illumina HiSeq,490cddf8-816a-45f5-acbf-3fd898eb3479,Head and Neck,80,C807171A-4433-4246-A454-C5CF768DA8AA,A4E6D494-865F-4F60-B9C6-13C9C0CEA6AB,TCGA-CN-5361-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5361,TCGA-HNSC,NA,s16184,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N2a,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c6c2,58cfa831e4b0c9d6adf6c6c2,TCGA-CN-4740-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CN-4740-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_5_rg.sorted,TCGA-CN-4740-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_5_rg.sorted.bam,78.7,1.9,0.14,58cfa831e4b0c9d6adf6c6c2,TCGA-CN-4740-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4740-01A,E37C83DC-C2C4-4E5F-A57B-39FFCF9AA3CF,Primary Tumor,Illumina HiSeq,c1580763-a5d9-4753-b80c-f8d5498a7494,Head and Neck,79,2311DEEC-8DBC-4449-BE09-FCD4E3BAFD87,9DD678DF-BCE7-46C2-8454-3DE815FB85ED,TCGA-CN-4740-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4740,TCGA-HNSC,NA,s15884,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82ee4b0c9d6adf6b00e,58cfa82ee4b0c9d6adf6b00e,TCGA-05-4422-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-05-4422-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_5_rg.sorted,TCGA-05-4422-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_5_rg.sorted.bam,631.63,1.9,0.15,58cfa82ee4b0c9d6adf6b00e,TCGA-05-4422-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_5_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4422-01A,44DEC838-B653-42A7-A58B-A1FD232CD68C,Primary Tumor,Illumina HiSeq,9fcb53c6-7d0c-4468-8a77-40e6ea3d43d8,Lung,68,DACBC55D-25C6-4E86-BD1B-38345B4DF7A7,09DD9098-5702-44A6-B9EA-F148ECE1E264,TCGA-05-4422-01A-01D-1203-02,HG19_Broad_variant,TCGA-05-4422,TCGA-LUAD,NA,s11223,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa830e4b0c9d6adf6be78,58cfa830e4b0c9d6adf6be78,TCGA-BL-A3JM-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BL-A3JM-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_3_rg.sorted,TCGA-BL-A3JM-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_3_rg.sorted.bam,24.07,NA,0.16,58cfa830e4b0c9d6adf6be78,TCGA-BL-A3JM-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BL-A3JM-01A,0F4FB205-B13C-4A85-97B3-779429E6CCDD,Primary Tumor,Illumina HiSeq,5cd881b7-caa0-43ad-9ba8-f9696fdf7403,Bladder,62,110ACEE1-915F-43A2-B382-5D0AF1FC167F,6ABBBA00-C322-4EDE-91A4-85D0D3E886F9,TCGA-BL-A3JM-01A-12D-A21C-26,HG19_Broad_variant,TCGA-BL-A3JM,TCGA-BLCA,205,s2691,MD Anderson - Institute for Applied Cancer Science,Christiana Healthcare,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6d44e,58cfa832e4b0c9d6adf6d44e,TCGA-VD-A8KG-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-VD-A8KG-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_4_rg.sorted,TCGA-VD-A8KG-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_4_rg.sorted.bam,43.78,NA,0.17,58cfa832e4b0c9d6adf6d44e,TCGA-VD-A8KG-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KG-01A,9F57834A-4DC4-45ED-97DE-ED4DA9D0598D,Primary Tumor,Illumina HiSeq,4a7b8d85-7b0f-4e37-b941-e61363166648,Eye,47,75A06E1E-CF06-418C-BFB7-3B9147D19078,376A6943-6FCC-406B-B543-4C0C385D2E22,TCGA-VD-A8KG-01A-11D-A40D-26,HG19_Broad_variant,TCGA-VD-A8KG,TCGA-UVM,NA,s272,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T2a,NX,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6cb6c,58cfa831e4b0c9d6adf6cb6c,TCGA-EE-A2MG-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EE-A2MG-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_6_rg.sorted,TCGA-EE-A2MG-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_6_rg.sorted.bam,32.01,NA,0.15,58cfa831e4b0c9d6adf6cb6c,TCGA-EE-A2MG-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MG-10A,E653F888-37CF-41D5-A1CF-45397C90B31D,Blood Derived Normal,Illumina HiSeq,0bf941ea-fb16-4935-9af6-a05d078fdf99,Skin,23,457F41A3-E268-4CF9-9585-FD2A87B9F683,20D8F05B-2BC0-4CB7-9476-0EA90E69C965,TCGA-EE-A2MG-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2MG,TCGA-SKCM,3139,s7515,Harvard Medical School,University of Sydney,Australia,NO,T2,N0,Not available,Stage I
13722.58cfa831e4b0c9d6adf6c87c,58cfa831e4b0c9d6adf6c87c,TCGA-CV-7414-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CV-7414-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_8_rg.sorted,TCGA-CV-7414-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_8_rg.sorted.bam,79.73,NA,0.16,58cfa831e4b0c9d6adf6c87c,TCGA-CV-7414-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7414-01A,C3B2C38D-81A3-42FD-A41E-6F6DE3934007,Primary Tumor,Illumina HiSeq,d2264558-e25d-4169-9e22-8f3c23b50ad9,Head and Neck,78,7BE274D5-D5A0-4EF9-A65A-4127ED864F0C,A78CD28C-EDAF-4439-905B-44B4616DF078,TCGA-CV-7414-01A-11D-2317-26,HG19_Broad_variant,TCGA-CV-7414,TCGA-HNSC,14,s15523,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82fe4b0c9d6adf6b878,58cfa82fe4b0c9d6adf6b878,TCGA-75-6205-10A-01D-1751_120301_SN208_0270_AD0KLRACXX_s_7_rg.sorted.filtered.,WGS,TCGA-75-6205-10A-01D-1751_120301_SN208_0270_AD0KLRACXX_s_7_rg.sorted,TCGA-75-6205-10A-01D-1751_120301_SN208_0270_AD0KLRACXX_s_7_rg.sorted.bam,202.7,1.9,0.15,58cfa82fe4b0c9d6adf6b878,TCGA-75-6205-10A-01D-1751_120301_SN208_0270_AD0KLRACXX_s_7_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-6205-10A,9A63F744-4ED4-4B4D-AAC6-F9BDA66AA563,Blood Derived Normal,Illumina HiSeq,247f390f-cb78-4845-a99b-65b33f838887,Lung,NA,2E7C5E7E-EA36-42BE-A7E5-994D8B348789,67364D7F-58EB-4954-828A-5D31DC75AF20,TCGA-75-6205-10A-01D-1751-02,HG19_Broad_variant,TCGA-75-6205,TCGA-LUAD,NA,s11011,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,T2a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa830e4b0c9d6adf6bdc8,58cfa830e4b0c9d6adf6bdc8,TCGA-BH-A0BM-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BH-A0BM-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_4_rg.sorted,TCGA-BH-A0BM-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_4_rg.sorted.bam,10.8,1.92,0.15,58cfa830e4b0c9d6adf6bdc8,TCGA-BH-A0BM-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0BM-10A,C2AEEE6C-BA10-4CF9-B560-C739580F7BF3,Blood Derived Normal,Illumina HiSeq,dfd425ac-1f68-4ee1-b9cb-983f4bc32371,Breast,54,3F8B9139-A283-42B3-ACCB-AB8CF047B8AA,D770733C-EE28-4D36-845F-FD51C1F72666,TCGA-BH-A0BM-10A-01D-A060-02,HG19_Broad_variant,TCGA-BH-A0BM,TCGA-BRCA,NA,s5492,Harvard Medical School,University of Pittsburgh,None,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa831e4b0c9d6adf6ca2d,58cfa831e4b0c9d6adf6ca2d,TCGA-DO-A1K0-10A-01D-A13U_120706_SN1222_0123_BD1488ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DO-A1K0-10A-01D-A13U_120706_SN1222_0123_BD1488ACXX_s_4_rg.sorted,TCGA-DO-A1K0-10A-01D-A13U_120706_SN1222_0123_BD1488ACXX_s_4_rg.sorted.bam,8.25,1.97,0.15,58cfa831e4b0c9d6adf6ca2d,TCGA-DO-A1K0-10A-01D-A13U_120706_SN1222_0123_BD1488ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DO-A1K0-10A,B7A01148-5BAB-4268-986A-A9CF7BCA967F,Blood Derived Normal,Illumina HiSeq,36a669c2-5641-40b8-9b53-d660e0636162,Thyroid,30,D654C724-9C1F-41F9-BE78-FD14A148CDCF,3C802666-0D28-49A9-8F6F-69ACEE0E7AEE,TCGA-DO-A1K0-10A-01D-A13U-02,HG19_Broad_variant,TCGA-DO-A1K0,TCGA-THCA,NA,s12642,Harvard Medical School,Medical College of Georgia,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82fe4b0c9d6adf6b7b8,58cfa82fe4b0c9d6adf6b7b8,TCGA-44-5645-11A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_8_rg.sorted.filtered.,WGS,TCGA-44-5645-11A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_8_rg.sorted,TCGA-44-5645-11A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_8_rg.sorted.bam,207.7,1.9,0.13,58cfa82fe4b0c9d6adf6b7b8,TCGA-44-5645-11A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_8_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-5645-11A,DDEACCCF-0953-4952-8A4E-C2617F2E7BCC,Solid Tissue Normal,Illumina HiSeq,046d2d90-c237-4a78-9661-79758711edfe,Lung,61,FEAF6024-F488-4636-BD99-7FD770CC3D15,27717C6D-D53D-490A-8065-620B7CFE302E,TCGA-44-5645-11A-01D-1623-02,HG19_Broad_variant,TCGA-44-5645,TCGA-LUAD,NA,s10991,Harvard Medical School,Christiana Healthcare,United States,NO,T1,NX,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6cbd0,58cfa831e4b0c9d6adf6cbd0,TCGA-EJ-7125-01A-11D-1957_130221_SN1120_0239_BD1V59ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EJ-7125-01A-11D-1957_130221_SN1120_0239_BD1V59ACXX_s_7_rg.sorted,TCGA-EJ-7125-01A-11D-1957_130221_SN1120_0239_BD1V59ACXX_s_7_rg.sorted.bam,118.7,NA,0.15,58cfa831e4b0c9d6adf6cbd0,TCGA-EJ-7125-01A-11D-1957_130221_SN1120_0239_BD1V59ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7125-01A,ACA312AB-6DBD-4183-8B22-8F37834F3426,Primary Tumor,Illumina HiSeq,c476525e-5147-4afb-bed0-f9ad34226240,Prostate,44,08E17DE6-FE0D-4FF0-B588-1CF1AB03F594,4BAD4379-B8AB-4D28-968E-5729602757EB,TCGA-EJ-7125-01A-11D-1957-02,HG19_Broad_variant,TCGA-EJ-7125,TCGA-PRAD,NA,s3442,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d27e,58cfa832e4b0c9d6adf6d27e,TCGA-IR-A3LA-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_6_rg.sorted.filtered.,WGS,TCGA-IR-A3LA-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_6_rg.sorted,TCGA-IR-A3LA-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_6_rg.sorted.bam,21.13,NA,0.17,58cfa832e4b0c9d6adf6d27e,TCGA-IR-A3LA-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-IR-A3LA-10A,7B8C04D7-824D-493D-8F2C-9ED87A907192,Blood Derived Normal,Illumina HiSeq,5b0c885d-73d4-4af1-9c47-a5d59d6a0664,Cervix,60,D0EBB92C-01A5-4486-A39F-6C89187AC640,95138E7D-C1D7-410C-8A64-F28B128A4F24,TCGA-IR-A3LA-10A-01D-A232-26,HG19_Broad_variant,TCGA-IR-A3LA,TCGA-CESC,NA,s1215,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T1b1,N0,Endometrioid Adenocarcinoma of Endocervix,Not available
13722.58cfa830e4b0c9d6adf6c1db,58cfa830e4b0c9d6adf6c1db,TCGA-BB-4224-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BB-4224-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_1_rg.sorted,TCGA-BB-4224-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_1_rg.sorted.bam,16.7,1.9,0.13,58cfa830e4b0c9d6adf6c1db,TCGA-BB-4224-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BB-4224-01A,58574E35-8A30-4207-B127-59FFF7C87A43,Primary Tumor,Illumina HiSeq,44a7ef3f-57df-49e2-80b9-1f0dca51067f,Head and Neck,52,077ACD68-8C30-41A6-BB7E-5B014866B807,E2FF93EB-AE22-4C6B-B4D5-181B9393BC64,TCGA-BB-4224-01A-01D-1431-02,HG19_Broad_variant,TCGA-BB-4224,TCGA-HNSC,NA,s15876,Harvard Medical School,Johns Hopkins,United States,NO,T2,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6c16c,58cfa830e4b0c9d6adf6c16c,TCGA-BA-5557-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BA-5557-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_4_rg.sorted,TCGA-BA-5557-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_4_rg.sorted.bam,52.7,1.9,0.16,58cfa830e4b0c9d6adf6c16c,TCGA-BA-5557-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5557-01A,7E0575CE-670B-4035-8A90-4D35279707B2,Primary Tumor,Illumina HiSeq,bb531fb4-064f-47dd-8231-bd6131866968,Head and Neck,41,67D75889-E868-41F2-8255-5D5D1AA0A854,0DDC26B3-2D83-4539-A934-4B0FEF8D1F69,TCGA-BA-5557-01A-01D-1509-02,HG19_Broad_variant,TCGA-BA-5557,TCGA-HNSC,NA,s15617,Harvard Medical School,UNC,None,NO,T1,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6cdda,58cfa831e4b0c9d6adf6cdda,TCGA-FG-6691-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-FG-6691-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_6_rg.sorted,TCGA-FG-6691-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_6_rg.sorted.bam,41,1.9,0.14,58cfa831e4b0c9d6adf6cdda,TCGA-FG-6691-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-6691-10A,E4D9B696-3311-44E7-9191-FDE56C080A00,Blood Derived Normal,Illumina HiSeq,87f5566b-671c-48b4-8170-bef9aa55eb6b,Brain,23,EB350E44-4AF0-46FA-B329-30F599B9A953,5261C079-4E84-44DB-8E0C-B097344AE1E7,TCGA-FG-6691-10A-01D-1891-02,HG19_Broad_variant,TCGA-FG-6691,TCGA-LGG,NA,s8572,Harvard Medical School,Case Western,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa832e4b0c9d6adf6ce5a,58cfa832e4b0c9d6adf6ce5a,TCGA-GV-A3QG-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_3_rg.sorted.filtered.,WGS,TCGA-GV-A3QG-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_3_rg.sorted,TCGA-GV-A3QG-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_3_rg.sorted.bam,32.14,NA,0.15,58cfa832e4b0c9d6adf6ce5a,TCGA-GV-A3QG-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GV-A3QG-01A,79F23A0E-5AAE-4618-8191-7DD7C0552408,Primary Tumor,Illumina HiSeq,2102b9a0-6afe-47a9-89ae-9778452a6dcd,Bladder,65,FB9B1639-242F-4019-937F-DD13C40D9C2B,27EDCB5C-D1E4-4683-A967-A436E22D1958,TCGA-GV-A3QG-01A-11D-A221-26,HG19_Broad_variant,TCGA-GV-A3QG,TCGA-BLCA,NA,s3309,MD Anderson - Institute for Applied Cancer Science,BLN - Cleveland Clinic,United States,NO,T3a,N3,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82ee4b0c9d6adf6afa8,58cfa82ee4b0c9d6adf6afa8,TCGA-05-4420-10A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-05-4420-10A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_4_rg.sorted,TCGA-05-4420-10A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_4_rg.sorted.bam,98.23,1.9,0.14,58cfa82ee4b0c9d6adf6afa8,TCGA-05-4420-10A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_4_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4420-10A,3D2AA654-1B5F-4EB4-A1C2-AF31F5760069,Blood Derived Normal,Illumina HiSeq,13949a21-5d65-4769-8f90-de657bddf4e6,Lung,41,79586ED4-9D42-46D1-B318-70C5E1C471F2,0BAC6387-9717-41BF-B886-7D1636EACF43,TCGA-05-4420-10A-01D-1203-02,HG19_Broad_variant,TCGA-05-4420,TCGA-LUAD,NA,s11222,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa831e4b0c9d6adf6c988,58cfa831e4b0c9d6adf6c988,TCGA-DJ-A1QE-01A-21D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DJ-A1QE-01A-21D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_2_rg.sorted,TCGA-DJ-A1QE-01A-21D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_2_rg.sorted.bam,36.64,2.05,0.17,58cfa831e4b0c9d6adf6c988,TCGA-DJ-A1QE-01A-21D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QE-01A,DCCBA97D-4E81-42FB-93B3-90BE68A034FB,Primary Tumor,Illumina HiSeq,b2380599-45dd-48d5-840c-f6e358db7169,Thyroid,62,E8BF40C4-8F4D-4032-B18B-D61A87A2DD1A,FB93D33F-510B-45BD-8E70-8FD3A0EA5DBE,TCGA-DJ-A1QE-01A-21D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QE,TCGA-THCA,NA,s12635,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa832e4b0c9d6adf6d242,58cfa832e4b0c9d6adf6d242,TCGA-HG-A2PA-10B-01D-A20X_140106_SN590_0244_BC384EACXX_s_8_rg.sorted.filtered.,WGS,TCGA-HG-A2PA-10B-01D-A20X_140106_SN590_0244_BC384EACXX_s_8_rg.sorted,TCGA-HG-A2PA-10B-01D-A20X_140106_SN590_0244_BC384EACXX_s_8_rg.sorted.bam,16.82,NA,0.17,58cfa832e4b0c9d6adf6d242,TCGA-HG-A2PA-10B-01D-A20X_140106_SN590_0244_BC384EACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-HG-A2PA-10A,E2FF7CFD-A101-45B9-895F-26F403E7BDFB,Blood Derived Normal,Illumina HiSeq,cd34db28-8cb3-4000-9b95-22210dde4e3f,Cervix,38,6BF28F80-8EB4-48E6-B63C-6FD68F41F42F,EF4B310C-6080-4ABC-832D-F963D4E58920,TCGA-HG-A2PA-10B-01D-A20X-26,HG19_Broad_variant,TCGA-HG-A2PA,TCGA-CESC,NA,s1373,MD Anderson - Institute for Applied Cancer Science,Roswell Park,United States,NO,T1b2,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d12a,58cfa832e4b0c9d6adf6d12a,TCGA-FY-A3R8-10A-01D-A221_120524_SN1120_0144_AC0VNCACXX_s_6_rg.sorted.filtered.,WGS,TCGA-FY-A3R8-10A-01D-A221_120524_SN1120_0144_AC0VNCACXX_s_6_rg.sorted,TCGA-FY-A3R8-10A-01D-A221_120524_SN1120_0144_AC0VNCACXX_s_6_rg.sorted.bam,24.18,NA,0.14,58cfa832e4b0c9d6adf6d12a,TCGA-FY-A3R8-10A-01D-A221_120524_SN1120_0144_AC0VNCACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FY-A3R8-10A,C77976B6-35EA-4623-A92A-6D9440A978E6,Blood Derived Normal,Illumina HiSeq,9651771f-3b39-4442-95d4-c1c7915d54cf,Thyroid,62,0BB3305B-7846-4EF8-956E-4A0EA66E1B6E,0A84D3EF-6AD7-4FA4-88FB-B342E4B0245F,TCGA-FY-A3R8-10A-01D-A221-26,HG19_Broad_variant,TCGA-FY-A3R8,TCGA-THCA,NA,s12118,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T3,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa832e4b0c9d6adf6cfec,58cfa832e4b0c9d6adf6cfec,TCGA-G9-6361-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_7_rg.sorted.filtered.,WGS,TCGA-G9-6361-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_7_rg.sorted,TCGA-G9-6361-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_7_rg.sorted.bam,39,1.9,0.16,58cfa832e4b0c9d6adf6cfec,TCGA-G9-6361-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6361-10A,71D14304-CCB0-4A4C-B935-8C014CA75FD0,Blood Derived Normal,Illumina HiSeq,ae16cf88-3acd-4765-9960-e47c371159d7,Prostate,61,3AE1F56D-81A7-4201-8935-9A6D465043F5,F29AA876-D30B-4B4A-A279-B7590CE789A9,TCGA-G9-6361-10A-01D-1957-02,HG19_Broad_variant,TCGA-G9-6361,TCGA-PRAD,NA,s3615,Harvard Medical School,Roswell Park,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cd64,58cfa831e4b0c9d6adf6cd64,TCGA-FD-A3SS-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FD-A3SS-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_1_rg.sorted,TCGA-FD-A3SS-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_1_rg.sorted.bam,37.16,NA,0.15,58cfa831e4b0c9d6adf6cd64,TCGA-FD-A3SS-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3SS-01A,7B98B829-FDC7-4719-BEE9-C83F6154019C,Primary Tumor,Illumina HiSeq,23aab0ed-a2ae-43db-9050-527db1729aa5,Bladder,66,015E6B08-AB3C-4D1D-99E4-77B5E10BD7FC,315B09D3-D014-4EF1-9CAC-AD5F63F6024A,TCGA-FD-A3SS-01A-12D-A233-26,HG19_Broad_variant,TCGA-FD-A3SS,TCGA-BLCA,NA,s3302,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T4,N3,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6d2c1,58cfa832e4b0c9d6adf6d2c1,TCGA-HT-7476-10A-01D-2022_130913_SN1440_0168_BD2B0UACXX_s_4_rg.sorted.filtered.,WGS,TCGA-HT-7476-10A-01D-2022_130913_SN1440_0168_BD2B0UACXX_s_4_rg.sorted,TCGA-HT-7476-10A-01D-2022_130913_SN1440_0168_BD2B0UACXX_s_4_rg.sorted.bam,118,NA,0.13,58cfa832e4b0c9d6adf6d2c1,TCGA-HT-7476-10A-01D-2022_130913_SN1440_0168_BD2B0UACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7476-10A,27D0D3CB-16C0-4BA8-9662-95917F665004,Blood Derived Normal,Illumina HiSeq,79fd9f03-72a7-4dca-8389-9855dd6660ae,Brain,26,0DDB502C-B171-4221-8D42-84C1F81574D8,C177E222-B7E4-464C-878B-31497E2794F6,TCGA-HT-7476-10A-01D-2022-02,HG19_Broad_variant,TCGA-HT-7476,TCGA-LGG,NA,s8761,Harvard Medical School,Case Western - St Joes,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6cb1a,58cfa831e4b0c9d6adf6cb1a,TCGA-E7-A3X6-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_5_rg.sorted.filtered.,WGS,TCGA-E7-A3X6-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_5_rg.sorted,TCGA-E7-A3X6-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_5_rg.sorted.bam,39.5,NA,0.15,58cfa831e4b0c9d6adf6cb1a,TCGA-E7-A3X6-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-E7-A3X6-01A,C871EA6B-FBD2-4E6F-AB29-F43F6E3DDCBB,Primary Tumor,Illumina HiSeq,548e206a-eaec-49d3-a405-664cf76d0e16,Bladder,70,554AE735-9991-4CB3-AFE8-4951490BD709,AE6DC0A6-7405-44C2-886F-E10BAD336295,TCGA-E7-A3X6-01A-12D-A233-26,HG19_Broad_variant,TCGA-E7-A3X6,TCGA-BLCA,NA,s3291,MD Anderson - Institute for Applied Cancer Science,Asterand,Ukraine,NO,T2,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa830e4b0c9d6adf6bed3,58cfa830e4b0c9d6adf6bed3,TCGA-AX-A0IW-10A-01D-A043_120327_SN590_0149_AD0U12ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-AX-A0IW-10A-01D-A043_120327_SN590_0149_AD0U12ACXX_s_4_rg.sorted,TCGA-AX-A0IW-10A-01D-A043_120327_SN590_0149_AD0U12ACXX_s_4_rg.sorted.bam,11.25,1.88,0.15,58cfa830e4b0c9d6adf6bed3,TCGA-AX-A0IW-10A-01D-A043_120327_SN590_0149_AD0U12ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A0IW-10A,DB21FCCF-40CB-4235-A34D-336A03B8C8F4,Blood Derived Normal,Illumina HiSeq,a874be45-7770-40b7-b171-8acea42f3b9a,Uterus,67,750AC41E-C9D6-4425-82B0-E3609D42B194,E739607D-DEB1-41CA-9D33-B38168645123,TCGA-AX-A0IW-10A-01D-A043-02,HG19_Broad_variant,TCGA-AX-A0IW,TCGA-UCEC,NA,s4427,Harvard Medical School,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c522,58cfa831e4b0c9d6adf6c522,TCGA-CN-4731-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CN-4731-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_7_rg.sorted,TCGA-CN-4731-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_7_rg.sorted.bam,31.7,1.9,0.14,58cfa831e4b0c9d6adf6c522,TCGA-CN-4731-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4731-01A,50E25A4B-2EB2-4770-9A2D-8922A1E0AB56,Primary Tumor,Illumina HiSeq,50e66965-d2d5-49dd-a113-8b1751d6f7b7,Head and Neck,63,CD4E9D8C-B1F9-486A-ADCD-BD4B77A50326,981D992B-B92F-4E42-AA43-FC48068648A8,TCGA-CN-4731-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4731,TCGA-HNSC,NA,s15753,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c686,58cfa831e4b0c9d6adf6c686,TCGA-CN-4737-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CN-4737-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_4_rg.sorted,TCGA-CN-4737-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_4_rg.sorted.bam,702.7,1.9,0.16,58cfa831e4b0c9d6adf6c686,TCGA-CN-4737-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4737-10A,1F744ADA-6DE1-446D-B62C-76A7FC8B40AF,Blood Derived Normal,Illumina HiSeq,fdf0a7f2-3007-49fa-b8f8-88f75e9f9396,Head and Neck,19,E0D710B0-E301-4441-BF1C-44AE39CB3239,76742CF6-8394-4B19-A4A8-59C305F21DC4,TCGA-CN-4737-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4737,TCGA-HNSC,NA,s16031,Harvard Medical School,University of Pittsburgh,None,NO,T2,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82fe4b0c9d6adf6b80c,58cfa82fe4b0c9d6adf6b80c,TCGA-44-4112-01A-01D-1103_120318_SN1120_0124_AC0HNPACXX_s_1_rg.sorted.filtered.,WGS,TCGA-44-4112-01A-01D-1103_120318_SN1120_0124_AC0HNPACXX_s_1_rg.sorted,TCGA-44-4112-01A-01D-1103_120318_SN1120_0124_AC0HNPACXX_s_1_rg.sorted.bam,452.63,1.9,0.15,58cfa82fe4b0c9d6adf6b80c,TCGA-44-4112-01A-01D-1103_120318_SN1120_0124_AC0HNPACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-4112-01A,68B86559-38B2-41F2-B66E-C3C2B628B14D,Primary Tumor,Illumina HiSeq,7c0e7b16-7643-4891-96de-63f2106bfb1a,Lung,60,6C206676-E511-4281-91F5-BFE91B3279A4,68185A4B-CC12-494D-99F5-84F5888A24F9,TCGA-44-4112-01A-01D-1103-02,HG19_Broad_variant,TCGA-44-4112,TCGA-LUAD,NA,s10651,Harvard Medical School,Christiana Healthcare,None,NO,T2a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6cb4e,58cfa831e4b0c9d6adf6cb4e,TCGA-EE-A2M6-10A-01D-A190_120724_SN208_0417_AC117BACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EE-A2M6-10A-01D-A190_120724_SN208_0417_AC117BACXX_s_8_rg.sorted,TCGA-EE-A2M6-10A-01D-A190_120724_SN208_0417_AC117BACXX_s_8_rg.sorted.bam,28.18,NA,0.15,58cfa831e4b0c9d6adf6cb4e,TCGA-EE-A2M6-10A-01D-A190_120724_SN208_0417_AC117BACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2M6-10A,58F0AE89-E277-4DFF-BB73-777CDF602DC7,Blood Derived Normal,Illumina HiSeq,5d31b027-a845-46a7-94e8-1a9dcd01370a,Skin,61,CDE8691F-3F84-47CD-8565-824CCA801BEC,F8C1E946-924D-4EB3-A2B4-04756B782F2C,TCGA-EE-A2M6-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2M6,TCGA-SKCM,NA,s7511,Harvard Medical School,University of Sydney,Australia,NO,T1,N0,Not available,Stage I
13722.58cfa831e4b0c9d6adf6c458,58cfa831e4b0c9d6adf6c458,TCGA-CG-5734-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CG-5734-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_8_rg.sorted,TCGA-CG-5734-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_8_rg.sorted.bam,46,1.9,0.16,58cfa831e4b0c9d6adf6c458,TCGA-CG-5734-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_8_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5734-11A,2A227292-C73D-45FC-AB68-CDFAF7AEF9E7,Solid Tissue Normal,Illumina HiSeq,a90934d5-13a4-4673-80b4-25d0755eb14c,Stomach,68,09D2C310-03CB-4AD8-8285-BB896EC1C1CC,91B72A4B-A301-46F5-8704-B4327804B307,TCGA-CG-5734-11A-01D-1598-02,HG19_Broad_variant,TCGA-CG-5734,TCGA-STAD,243,s15195,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa832e4b0c9d6adf6d0e0,58cfa832e4b0c9d6adf6d0e0,TCGA-FS-A1ZD-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FS-A1ZD-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_2_rg.sorted,TCGA-FS-A1ZD-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_2_rg.sorted.bam,66.27,NA,0.17,58cfa832e4b0c9d6adf6d0e0,TCGA-FS-A1ZD-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZD-06A,C2948FE9-5798-43BC-A743-511E94E417F8,Metastatic,Illumina HiSeq,50f957e6-39df-4b6e-bd03-6b3ba6622543,Skin,63,3B63CB75-EC13-4CAB-B11D-EB6E7FAA8641,F550E879-225E-46BD-9A2C-8AD3ED801DF4,TCGA-FS-A1ZD-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZD,TCGA-SKCM,1628,s7530,Harvard Medical School,Essen,Germany,NO,T2b,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6c3cb,58cfa831e4b0c9d6adf6c3cb,TCGA-C5-A3HD-01B-11D-A20X_140117_SN590_0245_AC371LACXX_s_1_rg.sorted.filtered.,WGS,TCGA-C5-A3HD-01B-11D-A20X_140117_SN590_0245_AC371LACXX_s_1_rg.sorted,TCGA-C5-A3HD-01B-11D-A20X_140117_SN590_0245_AC371LACXX_s_1_rg.sorted.bam,60.19,NA,0.16,58cfa831e4b0c9d6adf6c3cb,TCGA-C5-A3HD-01B-11D-A20X_140117_SN590_0245_AC371LACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A3HD-01B,12427B02-6E3F-461C-B271-6AB230F628E7,Primary Tumor,Illumina HiSeq,475d850b-49e8-4f15-9f59-8d65bf9cf22d,Cervix,51,56AA88C8-AF6D-42BE-8672-074476F6575A,03576AE9-4222-48C3-A428-D85AEC400BD6,TCGA-C5-A3HD-01B-11D-A20X-26,HG19_Broad_variant,TCGA-C5-A3HD,TCGA-CESC,NA,s1171,MD Anderson - Institute for Applied Cancer Science,Medical College of Wisconsin,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6be01,58cfa830e4b0c9d6adf6be01,TCGA-BG-A0M8-01A-12D-A101_120330_SN1120_0129_BD0UCLACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BG-A0M8-01A-12D-A101_120330_SN1120_0129_BD0UCLACXX_s_3_rg.sorted,TCGA-BG-A0M8-01A-12D-A101_120330_SN1120_0129_BD0UCLACXX_s_3_rg.sorted.bam,67.61,2,0.15,58cfa830e4b0c9d6adf6be01,TCGA-BG-A0M8-01A-12D-A101_120330_SN1120_0129_BD0UCLACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0M8-01A,E055DB71-F3DA-43D3-A9B2-2F65DFB23D3E,Primary Tumor,Illumina HiSeq,f354958c-ea56-472d-b145-a7e2895af8e2,Uterus,50,9CFB7290-EF60-4FDA-ABD7-9552AE11E4E7,D45D62ED-7BC6-4682-BB4B-2CA6EBBCE717,TCGA-BG-A0M8-01A-12D-A101-02,HG19_Broad_variant,TCGA-BG-A0M8,TCGA-UCEC,NA,s4434,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c973,58cfa831e4b0c9d6adf6c973,TCGA-DA-A1HW-10A-01D-A18Z_120612_SN590_0162_BC0VNGACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DA-A1HW-10A-01D-A18Z_120612_SN590_0162_BC0VNGACXX_s_8_rg.sorted,TCGA-DA-A1HW-10A-01D-A18Z_120612_SN590_0162_BC0VNGACXX_s_8_rg.sorted.bam,18.18,NA,0.16,58cfa831e4b0c9d6adf6c973,TCGA-DA-A1HW-10A-01D-A18Z_120612_SN590_0162_BC0VNGACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1HW-10A,800D3A17-269F-4D97-94FF-8585F20038D8,Blood Derived Normal,Illumina HiSeq,19d8b19f-ad7f-4a2e-8a4b-e1cac0212f82,Skin,37,8A27E6E0-A444-4701-B052-041F90267A69,8BD5C911-3AFB-4541-86E6-1330E7C9A5ED,TCGA-DA-A1HW-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-DA-A1HW,TCGA-SKCM,NA,s7838,Harvard Medical School,Yale,United States,NO,T1a,N1b,Not available,Stage IIIB
13722.58cfa832e4b0c9d6adf6d3f4,58cfa832e4b0c9d6adf6d3f4,TCGA-V4-A9EI-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_6_rg.sorted.filtered.,WGS,TCGA-V4-A9EI-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_6_rg.sorted,TCGA-V4-A9EI-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_6_rg.sorted.bam,15.66,NA,0.16,58cfa832e4b0c9d6adf6d3f4,TCGA-V4-A9EI-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EI-10A,B533E555-90CF-4657-80C6-15B67DA8AD26,Blood Derived Normal,Illumina HiSeq,d50a954a-7e7e-4b83-9420-74815f643545,Eye,78,F7908425-85C4-4473-8F3C-CF90F8C34191,20C2ABA6-0A2D-4960-AA0B-E2F8F6553E70,TCGA-V4-A9EI-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9EI,TCGA-UVM,389,s217,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4c,N0,Not available,Stage IIIB
13722.58cfa832e4b0c9d6adf6d020,58cfa832e4b0c9d6adf6d020,TCGA-GV-A3JZ-01A-11D-A21C_120830_SN590_0178_AD143RACXX_s_7_rg.sorted.filtered.,WGS,TCGA-GV-A3JZ-01A-11D-A21C_120830_SN590_0178_AD143RACXX_s_7_rg.sorted,TCGA-GV-A3JZ-01A-11D-A21C_120830_SN590_0178_AD143RACXX_s_7_rg.sorted.bam,63.92,NA,0.14,58cfa832e4b0c9d6adf6d020,TCGA-GV-A3JZ-01A-11D-A21C_120830_SN590_0178_AD143RACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GV-A3JZ-01A,9CC92795-7A24-4875-87F0-3EFCCBFCC970,Primary Tumor,Illumina HiSeq,d4d5d34c-9665-4291-a3d6-14bc9b48f2fa,Bladder,55,449E18FB-CBC0-4365-AEEC-EDC6A6B276BD,5A651606-6D92-445B-AA0B-B73CC9329402,TCGA-GV-A3JZ-01A-11D-A21C-26,HG19_Broad_variant,TCGA-GV-A3JZ,TCGA-BLCA,NA,s2738,MD Anderson - Institute for Applied Cancer Science,BLN - Cleveland Clinic,United States,NO,T4a,N3,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c69a,58cfa831e4b0c9d6adf6c69a,TCGA-CQ-5329-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CQ-5329-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_7_rg.sorted,TCGA-CQ-5329-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_7_rg.sorted.bam,77.7,1.9,0.14,58cfa831e4b0c9d6adf6c69a,TCGA-CQ-5329-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-5329-10A,02DCC11F-4F0E-4C9E-8D96-D22D47BEEF5D,Blood Derived Normal,Illumina HiSeq,9f0c3cb3-500d-46d1-8abc-1b4492354050,Head and Neck,46,03BF8F50-0D93-4656-A625-4D4BBF3A876F,E3943EA3-6B2E-402E-BB8D-B226FADF1038,TCGA-CQ-5329-10A-01D-1681-02,HG19_Broad_variant,TCGA-CQ-5329,TCGA-HNSC,NA,s16327,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6ca97,58cfa831e4b0c9d6adf6ca97,TCGA-D1-A17K-10A-01D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-D1-A17K-10A-01D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_5_rg.sorted,TCGA-D1-A17K-10A-01D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_5_rg.sorted.bam,29.91,1.96,0.17,58cfa831e4b0c9d6adf6ca97,TCGA-D1-A17K-10A-01D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A17K-10A,5C22C8D6-5805-455C-8E1C-E6B8006738E4,Blood Derived Normal,Illumina HiSeq,3aa41447-e70b-41dc-9ca0-cac568fa8e39,Uterus,74,72719D9E-F802-4E2B-8979-0A080EE83E09,BE759333-002C-4763-8F1A-4A1CF5EDC33B,TCGA-D1-A17K-10A-01D-A12F-02,HG19_Broad_variant,TCGA-D1-A17K,TCGA-UCEC,NA,s4615,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6c242,58cfa830e4b0c9d6adf6c242,TCGA-BB-4223-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BB-4223-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_8_rg.sorted,TCGA-BB-4223-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_8_rg.sorted.bam,341.4,1.6,0.15,58cfa830e4b0c9d6adf6c242,TCGA-BB-4223-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BB-4223-10A,05F01280-BF77-4682-A7A8-20DD0EAC77BD,Blood Derived Normal,Illumina HiSeq,a8c97047-ef56-4439-be7b-19e789bde2bf,Head and Neck,48,75430612-09BB-4D6F-9304-62A5B517D424,139A8577-EC63-4AAF-9796-200173B6DE91,TCGA-BB-4223-10A-01D-1431-02,HG19_Broad_variant,TCGA-BB-4223,TCGA-HNSC,NA,s16172,Harvard Medical School,Johns Hopkins,United States,NO,T2,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c5fc,58cfa831e4b0c9d6adf6c5fc,TCGA-CN-5369-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CN-5369-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_3_rg.sorted,TCGA-CN-5369-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_3_rg.sorted.bam,345.7,1.9,0.15,58cfa831e4b0c9d6adf6c5fc,TCGA-CN-5369-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_3_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5369-01A,B98867D7-7D5A-4C58-8878-37BEE6F2F4FA,Primary Tumor,Illumina HiSeq,bd85b141-d240-412f-9b74-379c4e3797d2,Head and Neck,90,B4C02606-0F86-46E4-9DAF-DC7DBCD60D78,1A532CA9-E72F-4906-867B-272A18CFEC79,TCGA-CN-5369-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5369,TCGA-HNSC,380,s16323,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c698,58cfa831e4b0c9d6adf6c698,TCGA-CN-5366-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CN-5366-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_1_rg.sorted,TCGA-CN-5366-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_1_rg.sorted.bam,313.7,1.9,0.16,58cfa831e4b0c9d6adf6c698,TCGA-CN-5366-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5366-01A,30EB06A5-8E88-4C46-BEBB-FB93CA07F108,Primary Tumor,Illumina HiSeq,0a7fb0ab-3302-4187-a567-58bc19979dc5,Head and Neck,51,62FDF8F3-A028-453F-B27C-C2506BE68CBE,AE791AB1-78E2-4E8B-AB05-4435D9C67AA3,TCGA-CN-5366-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5366,TCGA-HNSC,360,s15497,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6d40a,58cfa832e4b0c9d6adf6d40a,TCGA-V4-A9F3-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-V4-A9F3-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_3_rg.sorted,TCGA-V4-A9F3-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_3_rg.sorted.bam,49.28,NA,0.16,58cfa832e4b0c9d6adf6d40a,TCGA-V4-A9F3-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9F3-01A,E21D8018-8FE9-4C92-8B36-28D7D3F7DF2B,Primary Tumor,Illumina HiSeq,cae118e4-484b-45f4-b225-3d7297583648,Eye,49,6805D6DB-775C-4817-9F1B-5BE44AE2DA45,395ECE1C-9831-48BF-A933-A4A94566CD9D,TCGA-V4-A9F3-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9F3,TCGA-UVM,NA,s229,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa831e4b0c9d6adf6c95e,58cfa831e4b0c9d6adf6c95e,TCGA-DJ-A1QN-10A-01D-A14U_120629_SN1120_0168_BD1454ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DJ-A1QN-10A-01D-A14U_120629_SN1120_0168_BD1454ACXX_s_3_rg.sorted,TCGA-DJ-A1QN-10A-01D-A14U_120629_SN1120_0168_BD1454ACXX_s_3_rg.sorted.bam,18.72,2,0.16,58cfa831e4b0c9d6adf6c95e,TCGA-DJ-A1QN-10A-01D-A14U_120629_SN1120_0168_BD1454ACXX_s_3_rg.sorted.bam,Alive,FEMALE,Not available,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QN-10A,2012869D-C169-4CEA-AA09-C892FB79BBAA,Blood Derived Normal,Illumina HiSeq,d00042e4-f3b6-449e-be48-584604e5d67c,Thyroid,42,4D578AF6-98D7-4F4E-8379-63040529E147,4DE0299A-E33E-4ABF-863C-8656B5CF904C,TCGA-DJ-A1QN-10A-01D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QN,TCGA-THCA,NA,s12515,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa830e4b0c9d6adf6bd2e,58cfa830e4b0c9d6adf6bd2e,TCGA-AA-A01P-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A01P-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A01P-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,76.48,1.86,0.16,58cfa830e4b0c9d6adf6bd2e,TCGA-AA-A01P-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01P-01A,13AE9D83-A22F-451F-88BB-686051725CF3,Primary Tumor,Illumina HiSeq,bd44a9e2-a1a2-43a2-bfca-3a7d028fd86c,Colorectal,80,133C13DE-6C6B-45E2-A611-A5C5A4AEBAA6,7788130D-F341-4900-B7E0-95EAD3063A9F,TCGA-AA-A01P-01A-21D-A079-02,HG18,TCGA-AA-A01P,TCGA-COAD,1158,s13527,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage III
13722.58cfa832e4b0c9d6adf6d648,58cfa832e4b0c9d6adf6d648,TCGA-LN-A49Y-10A-01D-A267_131120_SN1222_0229_AD2FDGACXX_s_6_rg.sorted.filtered.,WGS,TCGA-LN-A49Y-10A-01D-A267_131120_SN1222_0229_AD2FDGACXX_s_6_rg.sorted,TCGA-LN-A49Y-10A-01D-A267_131120_SN1222_0229_AD2FDGACXX_s_6_rg.sorted.bam,70.65,NA,0.15,58cfa832e4b0c9d6adf6d648,TCGA-LN-A49Y-10A-01D-A267_131120_SN1222_0229_AD2FDGACXX_s_6_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49Y-10A,87FABA0E-28E7-4A7E-A7E1-12582EC68FAC,Blood Derived Normal,Illumina HiSeq,90238e0b-cf44-4a8a-bb0e-2f034e197c58,Esophagus,77,DD3C843E-95D4-43F7-93FF-052777F0E65E,2911715B-5518-44A7-B7D7-54B4C413EB54,TCGA-LN-A49Y-10A-01D-A267-26,HG19_Broad_variant,TCGA-LN-A49Y,TCGA-ESCA,NA,s1872,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6c39c,58cfa831e4b0c9d6adf6c39c,TCGA-BG-A0MO-10A-01D-A043_120327_SN590_0148_BC0LM8ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BG-A0MO-10A-01D-A043_120327_SN590_0148_BC0LM8ACXX_s_2_rg.sorted,TCGA-BG-A0MO-10A-01D-A043_120327_SN590_0148_BC0LM8ACXX_s_2_rg.sorted.bam,7.1,1.95,0.15,58cfa831e4b0c9d6adf6c39c,TCGA-BG-A0MO-10A-01D-A043_120327_SN590_0148_BC0LM8ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0MO-10A,734EF97F-807C-480E-8DF9-FEAF041032D2,Blood Derived Normal,Illumina HiSeq,1d255a62-a9f0-4075-b7cf-b09d3e044a24,Uterus,63,CA5DBD05-F91F-440B-B947-D0A060272E78,2B37CA7F-E0EF-4D91-ABD8-81E6468BF3AF,TCGA-BG-A0MO-10A-01D-A043-02,HG19_Broad_variant,TCGA-BG-A0MO,TCGA-UCEC,NA,s4252,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d1cf,58cfa832e4b0c9d6adf6d1cf,TCGA-HR-A2OH-10A-01D-A190_120602_SN1120_0146_AC0WLVACXX_s_3_rg.sorted.filtered.,WGS,TCGA-HR-A2OH-10A-01D-A190_120602_SN1120_0146_AC0WLVACXX_s_3_rg.sorted,TCGA-HR-A2OH-10A-01D-A190_120602_SN1120_0146_AC0WLVACXX_s_3_rg.sorted.bam,81.58,NA,0.17,58cfa832e4b0c9d6adf6d1cf,TCGA-HR-A2OH-10A-01D-A190_120602_SN1120_0146_AC0WLVACXX_s_3_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Skin Cutaneous Melanoma,Aligned reads,TCGA-HR-A2OH-10A,6668ACFE-1594-42C0-B839-8A592702675F,Blood Derived Normal,Illumina HiSeq,2a69954c-008f-4a79-a1eb-0e0307cac08a,Skin,46,6F582EE2-246D-4985-9903-7CAFDDE5273C,1F0B2C4C-7A6E-462E-B67D-A81771F77FE0,TCGA-HR-A2OH-10A-01D-A190-02,HG19_Broad_variant,TCGA-HR-A2OH,TCGA-SKCM,2004,s7543,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,T3b,N2a,Not available,Stage IIIB
13722.58cfa832e4b0c9d6adf6cf38,58cfa832e4b0c9d6adf6cf38,TCGA-FS-A1ZS-06A-12D-A18Y_120602_SN1120_0147_BD13TBACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FS-A1ZS-06A-12D-A18Y_120602_SN1120_0147_BD13TBACXX_s_5_rg.sorted,TCGA-FS-A1ZS-06A-12D-A18Y_120602_SN1120_0147_BD13TBACXX_s_5_rg.sorted.bam,43.28,NA,0.15,58cfa832e4b0c9d6adf6cf38,TCGA-FS-A1ZS-06A-12D-A18Y_120602_SN1120_0147_BD13TBACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZS-06A,31E94518-F6DD-4458-94D8-DDA3CC7A0831,Metastatic,Illumina HiSeq,38f5da25-1002-4a1a-b654-e111be27a91b,Skin,54,4B61F2EB-276C-4EC8-BCE0-E6E3AC0DD1F6,FA2EE471-5348-4ED3-A421-F188D6FA00C0,TCGA-FS-A1ZS-06A-12D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZS,TCGA-SKCM,NA,s7872,Harvard Medical School,Essen,Germany,NO,T2,N0,Not available,Stage I
13722.58cfa82fe4b0c9d6adf6b94e,58cfa82fe4b0c9d6adf6b94e,TCGA-A5-A0GB-10A-01D-A043_120530_SN1222_0110_AC0VLAACXX_s_3_rg.sorted.filtered.,WGS,TCGA-A5-A0GB-10A-01D-A043_120530_SN1222_0110_AC0VLAACXX_s_3_rg.sorted,TCGA-A5-A0GB-10A-01D-A043_120530_SN1222_0110_AC0VLAACXX_s_3_rg.sorted.bam,20.06,2.26,0.17,58cfa82fe4b0c9d6adf6b94e,TCGA-A5-A0GB-10A-01D-A043_120530_SN1222_0110_AC0VLAACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GB-10A,2F4458B6-3CAF-4E33-890E-A04722BADD1B,Blood Derived Normal,Illumina HiSeq,f8c18acc-2985-4620-aef4-9655b0d9e9c0,Uterus,65,BD040510-4425-4F67-836F-AD1523E2E035,4AD0F5C3-2433-4A60-A155-349039DB5C59,TCGA-A5-A0GB-10A-01D-A043-02,HG19_Broad_variant,TCGA-A5-A0GB,TCGA-UCEC,NA,s5383,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bb7e,58cfa830e4b0c9d6adf6bb7e,TCGA-A5-A0GB-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-A5-A0GB-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_2_rg.sorted,TCGA-A5-A0GB-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_2_rg.sorted.bam,52.54,2,0.16,58cfa830e4b0c9d6adf6bb7e,TCGA-A5-A0GB-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GB-01A,2F4458B6-3CAF-4E33-890E-A04722BADD1B,Primary Tumor,Illumina HiSeq,c4dd9407-812c-41b2-9953-baec8808ddbd,Uterus,65,130744CA-A9A2-4C99-8ABB-20FE76E0A955,A025733C-E300-4C47-B2EF-D9C978B58BFD,TCGA-A5-A0GB-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0GB,TCGA-UCEC,NA,s4585,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d14f,58cfa832e4b0c9d6adf6d14f,TCGA-GD-A3OP-10A-01D-A221_120902_SN1222_0147_AC195DACXX_s_3_rg.sorted.filtered.,WGS,TCGA-GD-A3OP-10A-01D-A221_120902_SN1222_0147_AC195DACXX_s_3_rg.sorted,TCGA-GD-A3OP-10A-01D-A221_120902_SN1222_0147_AC195DACXX_s_3_rg.sorted.bam,21.8,NA,0.15,58cfa832e4b0c9d6adf6d14f,TCGA-GD-A3OP-10A-01D-A221_120902_SN1222_0147_AC195DACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GD-A3OP-10A,31DA07BB-6752-49A3-A7EA-5427C04A9458,Blood Derived Normal,Illumina HiSeq,d3a22355-fa13-43ee-89ab-330f81b78673,Bladder,84,F7CEF7A7-8615-493D-887F-7C9CD056680F,D36D661B-7132-4DCA-8B38-62D8877DC624,TCGA-GD-A3OP-10A-01D-A221-26,HG19_Broad_variant,TCGA-GD-A3OP,TCGA-BLCA,NA,s2729,MD Anderson - Institute for Applied Cancer Science,ABS - IUPUI,United States,NO,T4a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6ce36,58cfa832e4b0c9d6adf6ce36,TCGA-EM-A1CV-11A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EM-A1CV-11A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_3_rg.sorted,TCGA-EM-A1CV-11A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_3_rg.sorted.bam,28.58,1.95,0.15,58cfa832e4b0c9d6adf6ce36,TCGA-EM-A1CV-11A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_3_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1CV-11A,762EDDB5-1B47-4B79-B20A-1EDFB07C0705,Solid Tissue Normal,Illumina HiSeq,9f594300-3be6-48b9-8eaa-b71fd52d4222,Thyroid,32,B8989340-7811-4E27-A879-EC0D193715E7,ABDD39C6-E88D-4B87-BE62-CD8A39435EFE,TCGA-EM-A1CV-11A-11D-A13U-02,HG19_Broad_variant,TCGA-EM-A1CV,TCGA-THCA,NA,s12753,Harvard Medical School,University Health Network,Canada,NO,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c375,58cfa831e4b0c9d6adf6c375,TCGA-CG-4477-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CG-4477-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_2_rg.sorted,TCGA-CG-4477-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_2_rg.sorted.bam,281.2,1.9,0.14,58cfa831e4b0c9d6adf6c375,TCGA-CG-4477-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4477-01A,18D0AAE7-9694-4252-B8FE-16E62DADAB07,Primary Tumor,Illumina HiSeq,854ac518-e119-4ce6-97c4-b123e75a99ee,Stomach,58,6D7C7B4E-6913-487D-9DC3-DDA901434192,3AE56504-30EE-4C03-9F69-C5B415DE6738,TCGA-CG-4477-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4477,TCGA-STAD,NA,s14907,Harvard Medical School,Indivumed,Germany,NO,T2a,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6ca6a,58cfa831e4b0c9d6adf6ca6a,TCGA-DJ-A13S-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DJ-A13S-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_8_rg.sorted,TCGA-DJ-A13S-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_8_rg.sorted.bam,37.77,1.92,0.14,58cfa831e4b0c9d6adf6ca6a,TCGA-DJ-A13S-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13S-10A,8AA99F35-C644-4F91-9EFF-A5D3FAE758B0,Blood Derived Normal,Illumina HiSeq,bce12e97-f376-4f4e-b605-757fdaa9c477,Thyroid,19,932EB8E5-FEAF-4C8C-8037-2D4D3B56D677,CC298C32-42CE-4BDF-8363-2AC6A214B9AA,TCGA-DJ-A13S-10A-01D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13S,TCGA-THCA,NA,s12370,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa830e4b0c9d6adf6bc0a,58cfa830e4b0c9d6adf6bc0a,TCGA-A5-A0GV-01A-31D-A043_120214_SN590_0139_BC0DYEACXX_s_3_rg.sorted.filtered.,WGS,TCGA-A5-A0GV-01A-31D-A043_120214_SN590_0139_BC0DYEACXX_s_3_rg.sorted,TCGA-A5-A0GV-01A-31D-A043_120214_SN590_0139_BC0DYEACXX_s_3_rg.sorted.bam,42.49,2.13,0.16,58cfa830e4b0c9d6adf6bc0a,TCGA-A5-A0GV-01A-31D-A043_120214_SN590_0139_BC0DYEACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GV-01A,5E3B981E-73FE-4CC9-8C89-B420E8E2F426,Primary Tumor,Illumina HiSeq,c99f6cb7-44cc-4045-a0f6-4fec580e964c,Uterus,67,339926E1-61E6-4256-A808-F931AA2C17D2,721D7961-15F0-4A52-8D2C-885278D3B579,TCGA-A5-A0GV-01A-31D-A043-02,HG19_Broad_variant,TCGA-A5-A0GV,TCGA-UCEC,NA,s4987,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d244,58cfa832e4b0c9d6adf6d244,TCGA-IR-A3LK-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_6_rg.sorted.filtered.,WGS,TCGA-IR-A3LK-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_6_rg.sorted,TCGA-IR-A3LK-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_6_rg.sorted.bam,24.72,NA,0.16,58cfa832e4b0c9d6adf6d244,TCGA-IR-A3LK-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-IR-A3LK-10A,B79558C5-1DB2-4B1E-A7B8-EFBD19AA855E,Blood Derived Normal,Illumina HiSeq,0f01b47f-e0cb-4246-b65b-317c03f5930c,Cervix,69,DD471C07-B1BC-441E-8FEE-8DF228EBA7B3,DED6849A-2A0F-4151-9A2D-1900B222C838,TCGA-IR-A3LK-10A-01D-A20X-26,HG19_Broad_variant,TCGA-IR-A3LK,TCGA-CESC,NA,s1213,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T1b2,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c9a8,58cfa831e4b0c9d6adf6c9a8,TCGA-DK-A1AG-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DK-A1AG-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_7_rg.sorted,TCGA-DK-A1AG-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_7_rg.sorted.bam,70.38,1.89,0.17,58cfa831e4b0c9d6adf6c9a8,TCGA-DK-A1AG-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AG-01A,F8C0A69C-DF53-4A0A-A30E-4424C0CE3DD5,Primary Tumor,Illumina HiSeq,4043eef2-fcc6-411c-a6a3-ddd71f3852d8,Bladder,65,64668AA0-DDE5-4534-8CD0-378881E4A4E4,69A3B1DB-3463-456C-B3D1-6BE1FD7EE1D9,TCGA-DK-A1AG-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DK-A1AG,TCGA-BLCA,NA,s2885,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6cf50,58cfa832e4b0c9d6adf6cf50,TCGA-FS-A1ZY-10A-01D-A190_120602_SN1120_0146_AC0WLVACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FS-A1ZY-10A-01D-A190_120602_SN1120_0146_AC0WLVACXX_s_8_rg.sorted,TCGA-FS-A1ZY-10A-01D-A190_120602_SN1120_0146_AC0WLVACXX_s_8_rg.sorted.bam,51.2,NA,0.16,58cfa832e4b0c9d6adf6cf50,TCGA-FS-A1ZY-10A-01D-A190_120602_SN1120_0146_AC0WLVACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZY-10A,A3DF4BA6-538E-4B53-A356-EB1EF743B2AB,Blood Derived Normal,Illumina HiSeq,38a9b4ea-ffdd-466d-a579-e92170d3b596,Skin,71,ED3DFADC-B57A-47F8-BC24-A4EDD2F19D2F,4839ACFD-CE38-47AF-AAFB-B423AAC76BF4,TCGA-FS-A1ZY-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZY,TCGA-SKCM,824,s7873,Harvard Medical School,Essen,Germany,NO,T3b,N0,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6c8fa,58cfa831e4b0c9d6adf6c8fa,TCGA-CU-A0YO-10A-01D-A10R_120926_SN590_0182_BD1EAGACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CU-A0YO-10A-01D-A10R_120926_SN590_0182_BD1EAGACXX_s_6_rg.sorted,TCGA-CU-A0YO-10A-01D-A10R_120926_SN590_0182_BD1EAGACXX_s_6_rg.sorted.bam,20.75,1.95,0.16,58cfa831e4b0c9d6adf6c8fa,TCGA-CU-A0YO-10A-01D-A10R_120926_SN590_0182_BD1EAGACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CU-A0YO-10A,4A9EF220-922C-49CF-BBED-D173B214ED31,Blood Derived Normal,Illumina HiSeq,d9b681f1-ebb5-4f97-8585-796e6ae8fb6d,Bladder,84,ABD9CFE7-EF6B-4A64-8733-0637581A0FC4,16A7AF6E-660A-49F8-8291-BACDA29FB3E1,TCGA-CU-A0YO-10A-01D-A10R-02,HG19_Broad_variant,TCGA-CU-A0YO,TCGA-BLCA,149,s3275,Harvard Medical School,UNC,United States,NO,T3a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6cf02,58cfa832e4b0c9d6adf6cf02,TCGA-FS-A1YY-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_6_rg.sorted.filtered.,WGS,TCGA-FS-A1YY-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_6_rg.sorted,TCGA-FS-A1YY-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_6_rg.sorted.bam,36.8,NA,0.16,58cfa832e4b0c9d6adf6cf02,TCGA-FS-A1YY-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_6_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1YY-10A,C3A8881B-70F8-402C-AC75-1CC49FCA4E87,Blood Derived Normal,Illumina HiSeq,80ab908d-d526-4748-b549-a33d238a0ddd,Skin,55,33C8D0DE-B147-4027-A599-90ED0F46B095,64FBFA57-CFF3-4193-A826-415DE8F91396,TCGA-FS-A1YY-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1YY,TCGA-SKCM,6953,s7364,Harvard Medical School,Essen,Germany,NO,T3a,N0,Not available,Stage IIA
13722.58cfa82fe4b0c9d6adf6b687,58cfa82fe4b0c9d6adf6b687,TCGA-44-6148-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_6_rg.sorted.filtered.,WGS,TCGA-44-6148-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_6_rg.sorted,TCGA-44-6148-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_6_rg.sorted.bam,164.4,1.9,0.16,58cfa82fe4b0c9d6adf6b687,TCGA-44-6148-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-6148-01A,8994C8C4-9EA0-46CB-B4A5-0055D7DA5BFA,Primary Tumor,Illumina HiSeq,e3f95d46-09ce-43a0-a2c7-581cb9fe8da9,Lung,60,C0FE5FFE-C0A3-4E62-AA55-2BC18788E505,F8A1C395-E730-48F9-BF82-E8931E4AF154,TCGA-44-6148-01A-11D-1751-02,HG19_Broad_variant,TCGA-44-6148,TCGA-LUAD,NA,s10995,Harvard Medical School,Christiana Healthcare,United States,NO,T1b,N0,Lung Mucinous Adenocarcinoma,Stage IA
13722.58cfa831e4b0c9d6adf6c4a2,58cfa831e4b0c9d6adf6c4a2,TCGA-CG-5732-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CG-5732-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_2_rg.sorted,TCGA-CG-5732-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_2_rg.sorted.bam,180,1.9,0.16,58cfa831e4b0c9d6adf6c4a2,TCGA-CG-5732-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_2_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5732-01A,E62D5F3C-0A99-4932-A589-BFF4FA02B1D3,Primary Tumor,Illumina HiSeq,3bc07391-1ef5-4bbf-9614-e3f31b8448c9,Stomach,66,5295412B-3D28-4774-85D8-3D38C682C343,E09E88E6-7697-4A1F-BF79-6DE9BE6E0960,TCGA-CG-5732-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5732,TCGA-STAD,NA,s14491,Harvard Medical School,Indivumed,Germany,NO,T2,N3,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa82fe4b0c9d6adf6b6d4,58cfa82fe4b0c9d6adf6b6d4,TCGA-75-6206-10A-01D-1751_120301_SN208_0270_AD0KLRACXX_s_8_rg.sorted.filtered.,WGS,TCGA-75-6206-10A-01D-1751_120301_SN208_0270_AD0KLRACXX_s_8_rg.sorted,TCGA-75-6206-10A-01D-1751_120301_SN208_0270_AD0KLRACXX_s_8_rg.sorted.bam,687.7,1.9,0.15,58cfa82fe4b0c9d6adf6b6d4,TCGA-75-6206-10A-01D-1751_120301_SN208_0270_AD0KLRACXX_s_8_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-6206-10A,C4C1469D-752F-42B6-8686-714AD4A8AC97,Blood Derived Normal,Illumina HiSeq,56ce7501-9487-4758-8a1c-0068f71b89b2,Lung,NA,27BF26D9-15F2-4A21-A62A-2C1AE8FA5CE4,E97EC9A4-9230-46B9-A0BC-06C14CE59235,TCGA-75-6206-10A-01D-1751-02,HG19_Broad_variant,TCGA-75-6206,TCGA-LUAD,NA,s10667,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c774,58cfa831e4b0c9d6adf6c774,TCGA-D1-A174-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D1-A174-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_3_rg.sorted,TCGA-D1-A174-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_3_rg.sorted.bam,124.95,1.37,0.15,58cfa831e4b0c9d6adf6c774,TCGA-D1-A174-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A174-01A,FC7315B0-9F48-4206-B197-2268C0518EB4,Primary Tumor,Illumina HiSeq,6ec3f35d-55a7-439a-b179-8a4aebcab751,Uterus,51,AD5A9CB6-B3F9-4651-B6D1-13C78010BD88,D661CFB9-248A-49E6-B0DB-865CA257E8DC,TCGA-D1-A174-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A174,TCGA-UCEC,NA,s4614,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d262,58cfa832e4b0c9d6adf6d262,TCGA-JX-A3Q8-10A-01D-A245_140206_SN1222_0239_BC2RAKACXX_s_4_rg.sorted.filtered.,WGS,TCGA-JX-A3Q8-10A-01D-A245_140206_SN1222_0239_BC2RAKACXX_s_4_rg.sorted,TCGA-JX-A3Q8-10A-01D-A245_140206_SN1222_0239_BC2RAKACXX_s_4_rg.sorted.bam,73.18,NA,0.14,58cfa832e4b0c9d6adf6d262,TCGA-JX-A3Q8-10A-01D-A245_140206_SN1222_0239_BC2RAKACXX_s_4_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-JX-A3Q8-10A,34629EB8-0C5E-4910-8E13-BF7D6A1E337F,Blood Derived Normal,Illumina HiSeq,638ee124-3225-4587-944a-aff7c7759987,Cervix,40,A5162279-45AE-4031-B119-71A8C934918F,DFEDE0BA-0E85-4D22-9A70-88E798CD267A,TCGA-JX-A3Q8-10A-01D-A245-26,HG19_Broad_variant,TCGA-JX-A3Q8,TCGA-CESC,NA,s1219,MD Anderson - Institute for Applied Cancer Science,Washington University,United States,NO,T1b1,N0,Endocervical Type of Adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d3f9,58cfa832e4b0c9d6adf6d3f9,TCGA-V4-A9EC-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_1_rg.sorted.filtered.,WGS,TCGA-V4-A9EC-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_1_rg.sorted,TCGA-V4-A9EC-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_1_rg.sorted.bam,13.73,NA,0.17,58cfa832e4b0c9d6adf6d3f9,TCGA-V4-A9EC-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EC-10A,EEAB0529-31E6-4EDB-BD2C-A21F2A169381,Blood Derived Normal,Illumina HiSeq,9dd842e1-2901-4410-9e77-232c609f0a25,Eye,75,DBD5162B-09FB-4909-8F38-6E0E94FCFD62,568769F5-B952-442E-B656-5CE4757E1095,TCGA-V4-A9EC-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9EC,TCGA-UVM,NA,s198,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3a,N0,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6c60e,58cfa831e4b0c9d6adf6c60e,TCGA-CQ-6219-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CQ-6219-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_7_rg.sorted,TCGA-CQ-6219-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_7_rg.sorted.bam,187.7,1.9,0.16,58cfa831e4b0c9d6adf6c60e,TCGA-CQ-6219-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-6219-01A,0CA3D25A-22E9-4E40-834B-65F402535005,Primary Tumor,Illumina HiSeq,e1a5a3ec-64d9-4348-8104-4f08021e914e,Head and Neck,50,2AAD293C-B3ED-4BD7-971D-EA8A5EFC66AD,215B7B8C-E4D0-4CD2-B2B8-9CDC222EBF25,TCGA-CQ-6219-01A-11D-1911-02,HG19_Broad_variant,TCGA-CQ-6219,TCGA-HNSC,479,s15632,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T3,N2a,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6c17e,58cfa830e4b0c9d6adf6c17e,TCGA-BA-4074-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BA-4074-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_1_rg.sorted,TCGA-BA-4074-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_1_rg.sorted.bam,598.33,1.9,0.16,58cfa830e4b0c9d6adf6c17e,TCGA-BA-4074-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-4074-01A,A63CA97D-EF31-4118-9547-A6730967290F,Primary Tumor,Illumina HiSeq,da78e5e3-ea94-4ac2-8b21-69809cabb0c7,Head and Neck,69,7BC6B159-19B4-4711-961D-830BC9E56493,4786A24C-D127-43FB-9D9C-FF59622B7B24,TCGA-BA-4074-01A-01D-1431-02,HG19_Broad_variant,TCGA-BA-4074,TCGA-HNSC,462,s16168,Harvard Medical School,UNC,None,NO,T2,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82ee4b0c9d6adf6affc,58cfa82ee4b0c9d6adf6affc,TCGA-05-4424-10A-01D-1853_120312_SN1120_0120_AD0PYGACXX_s_2_rg.sorted.filtered.,WGS,TCGA-05-4424-10A-01D-1853_120312_SN1120_0120_AD0PYGACXX_s_2_rg.sorted,TCGA-05-4424-10A-01D-1853_120312_SN1120_0120_AD0PYGACXX_s_2_rg.sorted.bam,129,1.9,0.14,58cfa82ee4b0c9d6adf6affc,TCGA-05-4424-10A-01D-1853_120312_SN1120_0120_AD0PYGACXX_s_2_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4424-10A,66763A0C-6CDA-4832-A0CC-E7B496D78EAA,Blood Derived Normal,Illumina HiSeq,d10fa246-b319-4797-ba50-e80f1686b364,Lung,70,83108C37-2C1C-4B3E-BAA1-E2DF6C56F32B,704B4714-B522-4AE3-AFFA-733FD095049C,TCGA-05-4424-10A-01D-1853-02,HG19_Broad_variant,TCGA-05-4424,TCGA-LUAD,NA,s10984,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Lung Adenocarcinoma Mixed Subtype,Stage IIB
13722.58cfa832e4b0c9d6adf6cefe,58cfa832e4b0c9d6adf6cefe,TCGA-H2-A3RI-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_2_rg.sorted.filtered.,WGS,TCGA-H2-A3RI-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_2_rg.sorted,TCGA-H2-A3RI-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_2_rg.sorted.bam,58.31,NA,0.15,58cfa832e4b0c9d6adf6cefe,TCGA-H2-A3RI-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-H2-A3RI-01A,BF193C4F-FBAC-41BC-B1AF-19B6CE856F0F,Primary Tumor,Illumina HiSeq,24a690e4-62f0-4e09-bbb1-ec78dafcf3cd,Thyroid,29,EAAE1A05-7D7E-406A-A02B-282A8B66F95C,5E15CB1B-B0D3-4FB9-9B30-3AEBE4DFC96B,TCGA-H2-A3RI-01A-11D-A221-26,HG19_Broad_variant,TCGA-H2-A3RI,TCGA-THCA,NA,s12259,MD Anderson - Institute for Applied Cancer Science,Christiana Healthcare,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c8b0,58cfa831e4b0c9d6adf6c8b0,TCGA-CV-7432-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CV-7432-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_1_rg.sorted,TCGA-CV-7432-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_1_rg.sorted.bam,222.73,NA,0.15,58cfa831e4b0c9d6adf6c8b0,TCGA-CV-7432-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7432-01A,EAF674DD-9909-4879-B9A3-74253169EDDD,Primary Tumor,Illumina HiSeq,d1f8d81a-4553-4c26-9d59-534aa2475dca,Head and Neck,79,9213AB13-AFC6-40B9-B278-98DD05C92934,541FB07A-7568-4CFC-9FCD-C5B403C619BA,TCGA-CV-7432-01A-11D-2317-26,HG19_Broad_variant,TCGA-CV-7432,TCGA-HNSC,2570,s15783,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6ccfe,58cfa831e4b0c9d6adf6ccfe,TCGA-EK-A3GN-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EK-A3GN-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_7_rg.sorted,TCGA-EK-A3GN-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_7_rg.sorted.bam,133.46,NA,0.15,58cfa831e4b0c9d6adf6ccfe,TCGA-EK-A3GN-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A3GN-10A,F727FCB9-E457-4643-9468-F739133B7E9C,Blood Derived Normal,Illumina HiSeq,6fbb1b79-abc3-4cfd-a0a6-c476836ed488,Cervix,47,7150E9B7-9E22-482F-923B-2203C07BD589,48654B33-F0D3-4C3D-B6A7-AC109940B7B7,TCGA-EK-A3GN-10A-01D-A20X-26,HG19_Broad_variant,TCGA-EK-A3GN,TCGA-CESC,NA,s1191,MD Anderson - Institute for Applied Cancer Science,Gynecologic Oncology Group,United States,NO,TX,NX,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d124,58cfa832e4b0c9d6adf6d124,TCGA-GV-A3QH-10A-01D-A221_120830_SN590_0178_AD143RACXX_s_6_rg.sorted.filtered.,WGS,TCGA-GV-A3QH-10A-01D-A221_120830_SN590_0178_AD143RACXX_s_6_rg.sorted,TCGA-GV-A3QH-10A-01D-A221_120830_SN590_0178_AD143RACXX_s_6_rg.sorted.bam,49.77,NA,0.16,58cfa832e4b0c9d6adf6d124,TCGA-GV-A3QH-10A-01D-A221_120830_SN590_0178_AD143RACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GV-A3QH-10A,33BC6A7C-9844-41E3-96B3-1E34BB3FEDD5,Blood Derived Normal,Illumina HiSeq,f84af011-24a9-4fbb-b801-5d6062f0b896,Bladder,67,A5354509-A8C7-4AF4-B545-B1024B6553C1,E9F742A2-417D-4C42-A7D8-7CD91B81EA1B,TCGA-GV-A3QH-10A-01D-A221-26,HG19_Broad_variant,TCGA-GV-A3QH,TCGA-BLCA,NA,s2933,MD Anderson - Institute for Applied Cancer Science,BLN - Cleveland Clinic,United States,NO,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa82fe4b0c9d6adf6b950,58cfa82fe4b0c9d6adf6b950,TCGA-A5-A0GJ-10A-01D-A043_120318_SN590_0146_AC0KH7ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-A5-A0GJ-10A-01D-A043_120318_SN590_0146_AC0KH7ACXX_s_8_rg.sorted,TCGA-A5-A0GJ-10A-01D-A043_120318_SN590_0146_AC0KH7ACXX_s_8_rg.sorted.bam,35.22,2,0.15,58cfa82fe4b0c9d6adf6b950,TCGA-A5-A0GJ-10A-01D-A043_120318_SN590_0146_AC0KH7ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GJ-10A,94817E78-78F5-4556-9394-610DF65605E2,Blood Derived Normal,Illumina HiSeq,19ffb6c4-bc21-4995-b962-527122ff1061,Uterus,44,81C5B859-DB07-4FA5-90D8-B0C36E913743,51A30A94-7D94-47D0-AABE-F0600572255A,TCGA-A5-A0GJ-10A-01D-A043-02,HG19_Broad_variant,TCGA-A5-A0GJ,TCGA-UCEC,NA,s4774,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b5fa,58cfa82fe4b0c9d6adf6b5fa,TCGA-50-5933-11A-01D-1751_110928_SN590_0108_BB01CWACXX_s_7_rg.sorted.filtered.,WGS,TCGA-50-5933-11A-01D-1751_110928_SN590_0108_BB01CWACXX_s_7_rg.sorted,TCGA-50-5933-11A-01D-1751_110928_SN590_0108_BB01CWACXX_s_7_rg.sorted.bam,200.4,1.9,0.14,58cfa82fe4b0c9d6adf6b5fa,TCGA-50-5933-11A-01D-1751_110928_SN590_0108_BB01CWACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5933-11A,7A0EA814-F0DE-4BC4-A81A-DAA000559369,Solid Tissue Normal,Illumina HiSeq,0cb84810-ecf1-4b3a-99d2-525d6d78e81a,Lung,72,E535FB19-2411-4E71-A3CD-08AEC4F0FD4C,DCD4C5C5-650B-4125-89F5-5C3A123EC954,TCGA-50-5933-11A-01D-1751-02,HG19_Broad_variant,TCGA-50-5933,TCGA-LUAD,2393,s10792,Harvard Medical School,University of Pittsburgh,United States,NO,T4,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIB
13722.58cfa831e4b0c9d6adf6c5b9,58cfa831e4b0c9d6adf6c5b9,TCGA-CG-4460-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CG-4460-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_4_rg.sorted,TCGA-CG-4460-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_4_rg.sorted.bam,1646.64,1.9,0.15,58cfa831e4b0c9d6adf6c5b9,TCGA-CG-4460-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_4_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4460-10A,3C3D4EF0-019A-423E-89B2-4AC5A7B567AB,Blood Derived Normal,Illumina HiSeq,88366088-e644-4828-abfa-01a45fdb23d3,Stomach,66,5567BCD4-E089-4E6E-9D4C-3B2696A0D696,3AF16C09-89EA-4CAE-9182-11A223BF6293,TCGA-CG-4460-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4460,TCGA-STAD,669,s14901,Harvard Medical School,Indivumed,Germany,NO,T4,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa830e4b0c9d6adf6c0f8,58cfa830e4b0c9d6adf6c0f8,TCGA-B6-A0RI-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_4_rg.sorted.filtered.,WGS,TCGA-B6-A0RI-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_4_rg.sorted,TCGA-B6-A0RI-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_4_rg.sorted.bam,46.43,1.78,0.15,58cfa830e4b0c9d6adf6c0f8,TCGA-B6-A0RI-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0RI-10A,BFD55808-DDDD-44C3-97D7-41600497B992,Blood Derived Normal,Illumina HiSeq,a498f419-7468-4a58-8a82-6692d63a46df,Breast,44,4E128A37-BE58-477A-A01F-448179360B7C,C9478F7D-BFE3-4E80-8161-39B3D440FA16,TCGA-B6-A0RI-10A-01D-A060-02,HG19_Broad_variant,TCGA-B6-A0RI,TCGA-BRCA,NA,s6463,Harvard Medical School,Duke,United States,NO,T4b,N1b,Infiltrating Ductal Carcinoma,Stage IIIB
13722.58cfa832e4b0c9d6adf6d4e9,58cfa832e4b0c9d6adf6d4e9,TCGA-V4-A9EJ-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_7_rg.sorted.filtered.,WGS,TCGA-V4-A9EJ-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_7_rg.sorted,TCGA-V4-A9EJ-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_7_rg.sorted.bam,15.97,NA,0.16,58cfa832e4b0c9d6adf6d4e9,TCGA-V4-A9EJ-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EJ-10A,D9CCBA9B-6BF0-44D9-8097-A97AB747F0BD,Blood Derived Normal,Illumina HiSeq,98c97d86-5953-4ec8-889d-858269e7a3de,Eye,38,CEF70E8E-DA78-4EEC-AB47-63A8D2BE2CC4,2D56C517-0383-4CD6-9CC1-1E15753465A0,TCGA-V4-A9EJ-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9EJ,TCGA-UVM,NA,s230,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3a,N0,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6c47e,58cfa831e4b0c9d6adf6c47e,TCGA-CG-5727-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CG-5727-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_7_rg.sorted,TCGA-CG-5727-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_7_rg.sorted.bam,151,1.9,0.15,58cfa831e4b0c9d6adf6c47e,TCGA-CG-5727-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_7_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5727-11A,B75EB694-8E9D-4DBB-B536-7D278C728CBB,Solid Tissue Normal,Illumina HiSeq,5ce3b760-487e-4111-9fdd-b0a32df72ed9,Stomach,66,B83A6E11-739B-4B4A-9B13-BB189E8FED70,A5D43809-AF5D-417E-94AD-EB03D681F951,TCGA-CG-5727-11A-01D-1598-02,HG19_Broad_variant,TCGA-CG-5727,TCGA-STAD,NA,s14993,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa831e4b0c9d6adf6c3d2,58cfa831e4b0c9d6adf6c3d2,TCGA-CG-5721-11A-01D-1598_121011_SN208_0434_AC18MYACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CG-5721-11A-01D-1598_121011_SN208_0434_AC18MYACXX_s_4_rg.sorted,TCGA-CG-5721-11A-01D-1598_121011_SN208_0434_AC18MYACXX_s_4_rg.sorted.bam,141,1.9,0.15,58cfa831e4b0c9d6adf6c3d2,TCGA-CG-5721-11A-01D-1598_121011_SN208_0434_AC18MYACXX_s_4_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5721-11A,588ABAEA-AB16-42F4-9457-5901EE791B5F,Solid Tissue Normal,Illumina HiSeq,259d4033-0c05-4f3b-ab2a-b0c7018bad33,Stomach,58,700FCA23-4807-4ED5-9745-87C6BCD51FBF,87FDC6BA-3120-4F7F-94FC-B5E0E6B5306C,TCGA-CG-5721-11A-01D-1598-02,HG19_Broad_variant,TCGA-CG-5721,TCGA-STAD,NA,s14989,Harvard Medical School,Indivumed,Germany,NO,T4,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa830e4b0c9d6adf6bed9,58cfa830e4b0c9d6adf6bed9,TCGA-BJ-A192-10A-01D-A13U_120706_SN1120_0170_BD1422ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BJ-A192-10A-01D-A13U_120706_SN1120_0170_BD1422ACXX_s_6_rg.sorted,TCGA-BJ-A192-10A-01D-A13U_120706_SN1120_0170_BD1422ACXX_s_6_rg.sorted.bam,18.86,1.82,0.16,58cfa830e4b0c9d6adf6bed9,TCGA-BJ-A192-10A-01D-A13U_120706_SN1120_0170_BD1422ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A192-10A,B55375C3-9EF2-4D2F-9C29-224E746931C4,Blood Derived Normal,Illumina HiSeq,eac8c42e-b403-4215-9111-4183ad1dbf57,Thyroid,54,4E667DBC-AED4-46CF-B7E9-5F380B5FF07F,5A78F9CD-834D-4561-AC79-836C2598C942,TCGA-BJ-A192-10A-01D-A13U-02,HG19_Broad_variant,TCGA-BJ-A192,TCGA-THCA,NA,s11988,Harvard Medical School,University of Pittsburgh,United States,NO,T3,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa830e4b0c9d6adf6c1ce,58cfa830e4b0c9d6adf6c1ce,TCGA-BB-4224-10A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BB-4224-10A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_2_rg.sorted,TCGA-BB-4224-10A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_2_rg.sorted.bam,100.4,1.9,0.13,58cfa830e4b0c9d6adf6c1ce,TCGA-BB-4224-10A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BB-4224-10A,58574E35-8A30-4207-B127-59FFF7C87A43,Blood Derived Normal,Illumina HiSeq,5fadfb17-7c88-4357-a519-b6c61ea4dc49,Head and Neck,52,2C21CAA5-DD9B-43E1-807A-4A145D3AA192,A4ECE80F-3F1F-4930-817D-6F8F1606DE5B,TCGA-BB-4224-10A-01D-1431-02,HG19_Broad_variant,TCGA-BB-4224,TCGA-HNSC,NA,s15613,Harvard Medical School,Johns Hopkins,United States,NO,T2,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c71e,58cfa831e4b0c9d6adf6c71e,TCGA-D7-6518-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D7-6518-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_3_rg.sorted,TCGA-D7-6518-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_3_rg.sorted.bam,59.4,1.8,0.16,58cfa831e4b0c9d6adf6c71e,TCGA-D7-6518-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6518-01A,40E507FB-E285-424B-A98B-362E47A53E4A,Primary Tumor,Illumina HiSeq,d4c1a136-c2f2-4cac-9b15-79669253b6e8,Stomach,75,B6B986E2-6770-4C59-9D0F-AEA3F3BA26E9,2BAFD8B4-962F-411F-89C6-BB5C7E2A1E78,TCGA-D7-6518-01A-11D-1798-02,HG19_Broad_variant,TCGA-D7-6518,TCGA-STAD,NA,s14994,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA
13722.58cfa832e4b0c9d6adf6cef7,58cfa832e4b0c9d6adf6cef7,TCGA-IG-A5B8-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_3_rg.sorted.filtered.,WGS,TCGA-IG-A5B8-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_3_rg.sorted,TCGA-IG-A5B8-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_3_rg.sorted.bam,23.16,NA,0.14,58cfa832e4b0c9d6adf6cef7,TCGA-IG-A5B8-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A5B8-01A,A4D36E09-5D8E-4006-855C-E466682B6813,Primary Tumor,Illumina HiSeq,948983f4-15f3-4b59-983e-18a248b1f4d9,Esophagus,72,C7E7425E-1F33-42B3-A2A2-ADDAAE6365E9,09D7FAFF-2E10-4C45-BB7E-E58B50911EFE,TCGA-IG-A5B8-01A-11D-A28P-26,HG19_Broad_variant,TCGA-IG-A5B8,TCGA-ESCA,24,s1817,MD Anderson - Institute for Applied Cancer Science,Asterand,Ukraine,NO,T3,N0,Not available,Stage IB
13722.58cfa831e4b0c9d6adf6cb59,58cfa831e4b0c9d6adf6cb59,TCGA-EE-A2MG-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EE-A2MG-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_2_rg.sorted,TCGA-EE-A2MG-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_2_rg.sorted.bam,51.09,NA,0.15,58cfa831e4b0c9d6adf6cb59,TCGA-EE-A2MG-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MG-06A,E653F888-37CF-41D5-A1CF-45397C90B31D,Metastatic,Illumina HiSeq,e2184793-28bf-4bf1-b685-2958c8c0b8a3,Skin,23,F68D55B0-001D-460D-9EB8-81B2AA26A909,8EAACD8C-A326-45BF-97C3-E1F300E1A1AA,TCGA-EE-A2MG-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2MG,TCGA-SKCM,3139,s7348,Harvard Medical School,University of Sydney,Australia,NO,T2,N0,Not available,Stage I
13722.58cfa831e4b0c9d6adf6cb02,58cfa831e4b0c9d6adf6cb02,TCGA-EB-A24C-10A-01D-A190_120730_SN208_0420_BC12YJACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EB-A24C-10A-01D-A190_120730_SN208_0420_BC12YJACXX_s_6_rg.sorted,TCGA-EB-A24C-10A-01D-A190_120730_SN208_0420_BC12YJACXX_s_6_rg.sorted.bam,51.27,NA,0.17,58cfa831e4b0c9d6adf6cb02,TCGA-EB-A24C-10A-01D-A190_120730_SN208_0420_BC12YJACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EB-A24C-10A,2F1BBE96-49D9-417B-BC9C-A09992489340,Blood Derived Normal,Illumina HiSeq,cf91e71a-52c1-41bf-9864-33faccf6ec54,Skin,56,9B492DF2-8520-48E3-825A-F5519B511969,38A1ABF6-EF0C-43D2-AEA6-B00431957213,TCGA-EB-A24C-10A-01D-A190-02,HG19_Broad_variant,TCGA-EB-A24C,TCGA-SKCM,NA,s8006,Harvard Medical School,Asterand,Ukraine,NO,T4b,NX,Not available,Not available
13722.58cfa831e4b0c9d6adf6cad2,58cfa831e4b0c9d6adf6cad2,TCGA-DI-A1BU-01A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DI-A1BU-01A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_7_rg.sorted,TCGA-DI-A1BU-01A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_7_rg.sorted.bam,88.64,1.98,0.17,58cfa831e4b0c9d6adf6cad2,TCGA-DI-A1BU-01A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-DI-A1BU-01A,53245616-E095-4616-89BB-6062669122DA,Primary Tumor,Illumina HiSeq,1a6e5cca-d65a-40c4-b8ce-b7b282493459,Uterus,55,241BFB1F-5CF8-458D-B335-18BABF507E85,085C72D3-C295-4D9B-A5CC-08F76CFF2284,TCGA-DI-A1BU-01A-11D-A133-02,HG19_Broad_variant,TCGA-DI-A1BU,TCGA-UCEC,NA,s4805,Harvard Medical School,MD Anderson,United States,NO,Not available,Not available,Mixed serous and endometrioid,Not available
13722.58cfa832e4b0c9d6adf6d576,58cfa832e4b0c9d6adf6d576,TCGA-V4-A9EZ-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_3_rg.sorted.filtered.,WGS,TCGA-V4-A9EZ-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_3_rg.sorted,TCGA-V4-A9EZ-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_3_rg.sorted.bam,34.26,NA,0.16,58cfa832e4b0c9d6adf6d576,TCGA-V4-A9EZ-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EZ-01A,39E494BC-7710-4F9F-98B0-0F509F7AEF1A,Primary Tumor,Illumina HiSeq,5c8725d3-7d4e-4fa4-9626-127c91f5ea5c,Eye,78,9FEE606B-30E8-4BD6-B4C3-E21EFE64870C,6C22A928-CD61-4D62-B401-A4BE19418177,TCGA-V4-A9EZ-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9EZ,TCGA-UVM,NA,s225,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3a,N0,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6ce1e,58cfa832e4b0c9d6adf6ce1e,TCGA-FG-5963-11A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FG-5963-11A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_8_rg.sorted,TCGA-FG-5963-11A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_8_rg.sorted.bam,157.3,1.9,0.13,58cfa832e4b0c9d6adf6ce1e,TCGA-FG-5963-11A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-5963-10A,68F550CA-3A33-45E4-B1C9-14F99E543263,Blood Derived Normal,Illumina HiSeq,58b865f4-5c4e-4736-b667-a649145bb764,Brain,23,41C11D33-7790-4033-99B4-087F0E87474A,6F920119-C9AD-4EBF-BBC8-7724FEAE7B7B,TCGA-FG-5963-10A-01D-1703-02,HG19_Broad_variant,TCGA-FG-5963,TCGA-LGG,NA,s8145,Harvard Medical School,Case Western,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa832e4b0c9d6adf6d004,58cfa832e4b0c9d6adf6d004,TCGA-HC-7230-10A-01D-2111_130517_SN590_0231_BC24V6ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-HC-7230-10A-01D-2111_130517_SN590_0231_BC24V6ACXX_s_1_rg.sorted,TCGA-HC-7230-10A-01D-2111_130517_SN590_0231_BC24V6ACXX_s_1_rg.sorted.bam,208.7,NA,0.15,58cfa832e4b0c9d6adf6d004,TCGA-HC-7230-10A-01D-2111_130517_SN590_0231_BC24V6ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7230-10A,03C66CF8-BC68-4EE1-A322-689A29B72262,Blood Derived Normal,Illumina HiSeq,0f575782-1639-413a-a7d0-e25ba87f997f,Prostate,50,E3D2EE1D-EDA1-4D28-AC3F-91F1579ABCF3,2AEFE035-4A89-4CF4-8F3D-5DF94AD636CC,TCGA-HC-7230-10A-01D-2111-02,HG19_Broad_variant,TCGA-HC-7230,TCGA-PRAD,NA,s3980,Harvard Medical School,International Genomics Consortium,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6ca74,58cfa831e4b0c9d6adf6ca74,TCGA-D3-A2J6-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_7_rg.sorted.filtered.,WGS,TCGA-D3-A2J6-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_7_rg.sorted,TCGA-D3-A2J6-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_7_rg.sorted.bam,16.83,NA,0.17,58cfa831e4b0c9d6adf6ca74,TCGA-D3-A2J6-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A2J6-10A,6F5157B8-D43A-4FBC-B7DA-23629F5B53DA,Blood Derived Normal,Illumina HiSeq,097403a5-4887-4f69-9102-7bad4016d96d,Skin,65,3EBFE354-A4CC-46EE-BD2A-ED7D84F3D76D,E5DB58D8-8AE1-47B3-AA3F-CDD7A8FFCF97,TCGA-D3-A2J6-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-D3-A2J6,TCGA-SKCM,1321,s7997,Harvard Medical School,MD Anderson,United States,NO,T3b,N0,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6c62e,58cfa831e4b0c9d6adf6c62e,TCGA-CN-5361-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CN-5361-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_6_rg.sorted,TCGA-CN-5361-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_6_rg.sorted.bam,112.4,1.9,0.13,58cfa831e4b0c9d6adf6c62e,TCGA-CN-5361-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5361-10A,044579EF-16A6-4F00-B951-EDC423D8A14F,Blood Derived Normal,Illumina HiSeq,34ee605a-e704-413f-91ff-81dbaef22fb7,Head and Neck,80,5B2581D8-C087-4CAA-B9CE-BC0168FBFEFA,2B747573-FEA7-4404-937E-5D7D74772776,TCGA-CN-5361-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5361,TCGA-HNSC,NA,s15624,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N2a,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6c05c,58cfa830e4b0c9d6adf6c05c,TCGA-BJ-A0ZB-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BJ-A0ZB-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_7_rg.sorted,TCGA-BJ-A0ZB-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_7_rg.sorted.bam,16.66,2.02,0.17,58cfa830e4b0c9d6adf6c05c,TCGA-BJ-A0ZB-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0ZB-10A,DC4D8468-6F34-40CB-A826-8D582CD86FDE,Blood Derived Normal,Illumina HiSeq,ba7ddca6-c0da-4789-8a9c-7c30729af0a7,Thyroid,66,C2F1F7A8-2633-4166-95AB-501FB192AF39,65D9DF75-E244-4631-8065-BFB90CD80172,TCGA-BJ-A0ZB-10A-01D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZB,TCGA-THCA,NA,s12627,Harvard Medical School,University of Pittsburgh,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA
13722.58cfa831e4b0c9d6adf6cb16,58cfa831e4b0c9d6adf6cb16,TCGA-E7-A3X6-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_6_rg.sorted.filtered.,WGS,TCGA-E7-A3X6-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_6_rg.sorted,TCGA-E7-A3X6-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_6_rg.sorted.bam,35.52,NA,0.15,58cfa831e4b0c9d6adf6cb16,TCGA-E7-A3X6-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-E7-A3X6-10A,C871EA6B-FBD2-4E6F-AB29-F43F6E3DDCBB,Blood Derived Normal,Illumina HiSeq,2068d801-01a5-4304-a51d-95555d328e12,Bladder,70,5C6A6AD1-2ECC-45BB-80E1-558EEB03DED9,DF3F7510-F340-4FDB-84BE-E020675F58A5,TCGA-E7-A3X6-10A-01D-A233-26,HG19_Broad_variant,TCGA-E7-A3X6,TCGA-BLCA,NA,s3290,MD Anderson - Institute for Applied Cancer Science,Asterand,Ukraine,NO,T2,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa830e4b0c9d6adf6bfbc,58cfa830e4b0c9d6adf6bfbc,TCGA-BR-6565-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BR-6565-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_8_rg.sorted,TCGA-BR-6565-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_8_rg.sorted.bam,320.7,1.9,0.16,58cfa830e4b0c9d6adf6bfbc,TCGA-BR-6565-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6565-10A,DAECEA36-B379-46CE-8AE9-A38D22556CE2,Blood Derived Normal,Illumina HiSeq,99084bc3-84ee-4ccc-9c54-1b5a74af410b,Stomach,67,612F7812-9ED4-40AD-AD6C-4C80C1E19F35,E58458DC-B614-466B-863D-428B18FD3A64,TCGA-BR-6565-10A-01D-1798-02,HG19_Broad_variant,TCGA-BR-6565,TCGA-STAD,NA,s14531,Harvard Medical School,Asterand,Russia,NO,T4a,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB
13722.58cfa831e4b0c9d6adf6c7b8,58cfa831e4b0c9d6adf6c7b8,TCGA-D1-A16B-10A-01D-A12F_120511_SN208_0299_BD12J9ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-D1-A16B-10A-01D-A12F_120511_SN208_0299_BD12J9ACXX_s_2_rg.sorted,TCGA-D1-A16B-10A-01D-A12F_120511_SN208_0299_BD12J9ACXX_s_2_rg.sorted.bam,7.5,1.92,0.15,58cfa831e4b0c9d6adf6c7b8,TCGA-D1-A16B-10A-01D-A12F_120511_SN208_0299_BD12J9ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A16B-10A,BCA1057A-1E96-404D-8A37-5A8DC1944EE7,Blood Derived Normal,Illumina HiSeq,ee24ca3f-bf5f-4dd3-8f41-15d8fcecf487,Uterus,64,AECBCF95-6D7A-401D-999E-D2169479D50B,CD46E08E-0A38-4B73-ACED-468468511434,TCGA-D1-A16B-10A-01D-A12F-02,HG19_Broad_variant,TCGA-D1-A16B,TCGA-UCEC,NA,s5223,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c808,58cfa831e4b0c9d6adf6c808,TCGA-CV-7095-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CV-7095-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_5_rg.sorted,TCGA-CV-7095-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_5_rg.sorted.bam,7.43,NA,0.16,58cfa831e4b0c9d6adf6c808,TCGA-CV-7095-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_5_rg.sorted.bam,Dead,FEMALE,Not available,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7095-10A,D7D49895-032F-4385-8B68-AE16F8675CA7,Blood Derived Normal,Illumina HiSeq,362b9d7a-e5e5-45ad-b441-a3e549093fc5,Head and Neck,87,32E597C3-7C52-4DBA-898C-2340F518DA38,717FA6A7-2887-4147-8BC3-EEEEF6CFEF5A,TCGA-CV-7095-10A-01D-2317-26,HG19_Broad_variant,TCGA-CV-7095,TCGA-HNSC,572,s15651,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c55a,58cfa831e4b0c9d6adf6c55a,TCGA-CG-5733-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CG-5733-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_6_rg.sorted,TCGA-CG-5733-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_6_rg.sorted.bam,129,1.9,0.16,58cfa831e4b0c9d6adf6c55a,TCGA-CG-5733-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_6_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5733-11A,8A9AFA5E-63CE-41EB-AAFB-B0B03653DA5A,Solid Tissue Normal,Illumina HiSeq,f72098d0-5e3e-49e7-a5e9-5bf9f620f2c0,Stomach,83,C7134D34-299D-440B-94C5-1A4D59978F01,6521DCC6-77A9-4DBC-A27A-6AF8194CB45A,TCGA-CG-5733-11A-01D-1598-02,HG19_Broad_variant,TCGA-CG-5733,TCGA-STAD,641,s14992,Harvard Medical School,Indivumed,Germany,NO,T2,N2,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6cd29,58cfa831e4b0c9d6adf6cd29,TCGA-ER-A2NF-06A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_2_rg.sorted.filtered.,WGS,TCGA-ER-A2NF-06A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_2_rg.sorted,TCGA-ER-A2NF-06A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_2_rg.sorted.bam,70.24,NA,0.15,58cfa831e4b0c9d6adf6cd29,TCGA-ER-A2NF-06A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A2NF-06A,D32A4219-4CCA-470F-B6B3-11447D9F5E0B,Metastatic,Illumina HiSeq,5edfca3e-18b8-45be-9168-c232a12a27eb,Skin,53,20ECF8D6-2CA9-4C8A-B6CE-8B2A3BA51AE3,B86BEFC7-9B14-40C8-82FB-8ED70C8B36C0,TCGA-ER-A2NF-06A-11D-A18Z-02,HG19_Broad_variant,TCGA-ER-A2NF,TCGA-SKCM,NA,s7356,Harvard Medical School,University of Pittsburgh,None,NO,T4b,N3,Not available,Stage IIIC
13722.58cfa832e4b0c9d6adf6d186,58cfa832e4b0c9d6adf6d186,TCGA-IR-A3L7-01A-21D-A20X_140117_SN590_0245_AC371LACXX_s_3_rg.sorted.filtered.,WGS,TCGA-IR-A3L7-01A-21D-A20X_140117_SN590_0245_AC371LACXX_s_3_rg.sorted,TCGA-IR-A3L7-01A-21D-A20X_140117_SN590_0245_AC371LACXX_s_3_rg.sorted.bam,59.39,NA,0.15,58cfa832e4b0c9d6adf6d186,TCGA-IR-A3L7-01A-21D-A20X_140117_SN590_0245_AC371LACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-IR-A3L7-01A,66229DD6-C771-4455-A90C-C66FB40CF7FE,Primary Tumor,Illumina HiSeq,c50ab1fa-015d-4420-a67f-b023a5377b16,Cervix,37,F571523C-758C-4F34-A44B-F8E6A3EEBE0F,27168C7B-D67E-4B11-B5BA-A79FB523400B,TCGA-IR-A3L7-01A-21D-A20X-26,HG19_Broad_variant,TCGA-IR-A3L7,TCGA-CESC,NA,s1211,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c956,58cfa831e4b0c9d6adf6c956,TCGA-DJ-A1QQ-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DJ-A1QQ-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_7_rg.sorted,TCGA-DJ-A1QQ-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_7_rg.sorted.bam,25.11,0.18,0.16,58cfa831e4b0c9d6adf6c956,TCGA-DJ-A1QQ-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_7_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QQ-10A,99EF2FEC-5A3C-4E42-8F78-7EAF9877E26D,Blood Derived Normal,Illumina HiSeq,90c167bf-1373-46c1-bb08-0bdd5f44a2a4,Thyroid,43,3BBBC8D3-799A-4D4E-A43C-E7A8B449492A,C8A4F7A1-2E2F-4485-8201-9CB104D276E8,TCGA-DJ-A1QQ-10A-01D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QQ,TCGA-THCA,NA,s12516,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c60c,58cfa831e4b0c9d6adf6c60c,TCGA-CN-5360-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CN-5360-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_1_rg.sorted,TCGA-CN-5360-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_1_rg.sorted.bam,449.7,1.9,0.15,58cfa831e4b0c9d6adf6c60c,TCGA-CN-5360-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5360-01A,5793879B-F663-4A10-9BD9-1ACD2E189650,Primary Tumor,Illumina HiSeq,56414402-7420-42b7-a93d-3d1f88308155,Head and Neck,68,0C00768E-8B13-4B8E-80FC-B344740845F1,7EE362C2-86AD-462C-B478-21255D96ED90,TCGA-CN-5360-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5360,TCGA-HNSC,NA,s15883,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c998,58cfa831e4b0c9d6adf6c998,TCGA-DK-A1A7-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DK-A1A7-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_1_rg.sorted,TCGA-DK-A1A7-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_1_rg.sorted.bam,35.04,2,0.15,58cfa831e4b0c9d6adf6c998,TCGA-DK-A1A7-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A7-01A,3ED614E7-F356-4D87-985B-D3BBBAE3BB40,Primary Tumor,Illumina HiSeq,4c14028a-f15d-42f9-ad5f-19f0dca3984e,Bladder,67,D68D16F7-6117-4D3D-8347-CF5CD3F23AE4,2DDD46A0-5304-4CA3-9AE3-AC3787D3C86A,TCGA-DK-A1A7-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DK-A1A7,TCGA-BLCA,NA,s3280,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6d4da,58cfa832e4b0c9d6adf6d4da,TCGA-VD-A8KE-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-VD-A8KE-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_2_rg.sorted,TCGA-VD-A8KE-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_2_rg.sorted.bam,35.8,NA,0.15,58cfa832e4b0c9d6adf6d4da,TCGA-VD-A8KE-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KE-01A,C9BFC2A7-0914-4080-A0A3-1C6A4E58E1AB,Primary Tumor,Illumina HiSeq,54db22ce-0562-4448-825c-d4e883f4aca6,Eye,74,35DFEB9D-1F64-4D51-B27A-24AD8AA3327B,119B486A-77DF-49A2-80A0-19555DEB7573,TCGA-VD-A8KE-01A-11D-A40D-26,HG19_Broad_variant,TCGA-VD-A8KE,TCGA-UVM,NA,s279,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T2a,NX,Not available,Stage IIA
13722.58cfa82fe4b0c9d6adf6b684,58cfa82fe4b0c9d6adf6b684,TCGA-55-6712-10A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_6_rg.sorted.filtered.,WGS,TCGA-55-6712-10A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_6_rg.sorted,TCGA-55-6712-10A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_6_rg.sorted.bam,192,1.9,0.14,58cfa82fe4b0c9d6adf6b684,TCGA-55-6712-10A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-55-6712-10A,F17D3463-AF6C-42C2-A8E9-FAE45F69286F,Blood Derived Normal,Illumina HiSeq,88cd05e2-cda3-4c5c-b350-f06a08f7be13,Lung,71,EB5FE1FB-E720-4E84-9F21-B2D6261EFA86,04630E6E-9636-47E2-B66D-D65844AFCF58,TCGA-55-6712-10A-01D-1853-02,HG19_Broad_variant,TCGA-55-6712,TCGA-LUAD,NA,s11351,Harvard Medical School,International Genomics Consortium,United States,NO,T2a,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa831e4b0c9d6adf6cd39,58cfa831e4b0c9d6adf6cd39,TCGA-ET-A25L-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-ET-A25L-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_6_rg.sorted,TCGA-ET-A25L-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_6_rg.sorted.bam,63.41,1.93,0.17,58cfa831e4b0c9d6adf6cd39,TCGA-ET-A25L-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-ET-A25L-01A,4481D84D-109E-44A0-BCB4-E6E61BDCE796,Primary Tumor,Illumina HiSeq,bd558097-490f-4ee3-af4a-093fd4aebaf1,Thyroid,52,7D90939F-BAB7-4A39-8D57-79540142BB63,3490DBDC-8BFC-476F-BC1F-2D142365D9A2,TCGA-ET-A25L-01A-11D-A16N-02,HG19_Broad_variant,TCGA-ET-A25L,TCGA-THCA,NA,s12524,Harvard Medical School,Johns Hopkins,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage IVA
13722.58cfa830e4b0c9d6adf6c16a,58cfa830e4b0c9d6adf6c16a,TCGA-BH-A0HK-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BH-A0HK-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_1_rg.sorted,TCGA-BH-A0HK-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_1_rg.sorted.bam,22.97,1.94,0.13,58cfa830e4b0c9d6adf6c16a,TCGA-BH-A0HK-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0HK-01A,24334AC1-28A3-4B61-B590-3F51E375B247,Primary Tumor,Illumina HiSeq,c4f3a9e0-4b45-4e06-9320-171c27d9e28d,Breast,81,8835B20E-9343-4266-A356-E0343C657130,B96AE5EC-0139-4B8D-8136-B5BFA7AF8987,TCGA-BH-A0HK-01A-11D-A060-02,HG19_Broad_variant,TCGA-BH-A0HK,TCGA-BRCA,NA,s5642,Harvard Medical School,University of Pittsburgh,None,NO,T2,N1,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa830e4b0c9d6adf6bd8f,58cfa830e4b0c9d6adf6bd8f,TCGA-BB-4223-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BB-4223-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_7_rg.sorted,TCGA-BB-4223-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_7_rg.sorted.bam,11.7,2,0.14,58cfa830e4b0c9d6adf6bd8f,TCGA-BB-4223-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BB-4223-01A,05F01280-BF77-4682-A7A8-20DD0EAC77BD,Primary Tumor,Illumina HiSeq,e8bc6546-004a-4702-9289-b5c90582298e,Head and Neck,48,82DB742D-885D-4788-B509-474715AE183B,007F0F41-C370-45F9-8053-2C774ADDED49,TCGA-BB-4223-01A-01D-1431-02,HG19_Broad_variant,TCGA-BB-4223,TCGA-HNSC,NA,s15490,Harvard Medical School,Johns Hopkins,United States,NO,T2,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6cd54,58cfa831e4b0c9d6adf6cd54,TCGA-ET-A25N-11A-01D-A16N_120718_SN590_0170_BD141RACXX_s_3_rg.sorted.filtered.,WGS,TCGA-ET-A25N-11A-01D-A16N_120718_SN590_0170_BD141RACXX_s_3_rg.sorted,TCGA-ET-A25N-11A-01D-A16N_120718_SN590_0170_BD141RACXX_s_3_rg.sorted.bam,21.32,1.91,0.16,58cfa831e4b0c9d6adf6cd54,TCGA-ET-A25N-11A-01D-A16N_120718_SN590_0170_BD141RACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-ET-A25N-11A,EBCCFB5F-C0A8-4263-AAFF-B5DD83585191,Solid Tissue Normal,Illumina HiSeq,dd7d0489-9e8f-4905-887d-8946943c9729,Thyroid,28,57DB2F77-C805-4328-8B19-A1BF2C996C1D,2BAECDF9-667C-434C-8F8D-49232854778F,TCGA-ET-A25N-11A-01D-A16N-02,HG19_Broad_variant,TCGA-ET-A25N,TCGA-THCA,NA,s12386,Harvard Medical School,Johns Hopkins,United States,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6ca96,58cfa831e4b0c9d6adf6ca96,TCGA-DI-A1BU-10A-01D-A133_120511_SN1120_0141_BC0VK9ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DI-A1BU-10A-01D-A133_120511_SN1120_0141_BC0VK9ACXX_s_8_rg.sorted,TCGA-DI-A1BU-10A-01D-A133_120511_SN1120_0141_BC0VK9ACXX_s_8_rg.sorted.bam,21.28,2.05,0.15,58cfa831e4b0c9d6adf6ca96,TCGA-DI-A1BU-10A-01D-A133_120511_SN1120_0141_BC0VK9ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-DI-A1BU-10A,53245616-E095-4616-89BB-6062669122DA,Blood Derived Normal,Illumina HiSeq,57bcc650-8415-4b37-b825-c09512d4993b,Uterus,55,565621D6-BB5C-42DE-85BF-3137AE9D22E2,7E5AB7AE-E070-44B2-A15C-63848C8002E9,TCGA-DI-A1BU-10A-01D-A133-02,HG19_Broad_variant,TCGA-DI-A1BU,TCGA-UCEC,NA,s4448,Harvard Medical School,MD Anderson,United States,NO,Not available,Not available,Mixed serous and endometrioid,Not available
13722.58cfa831e4b0c9d6adf6cc87,58cfa831e4b0c9d6adf6cc87,TCGA-EM-A3O6-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EM-A3O6-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_1_rg.sorted,TCGA-EM-A3O6-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_1_rg.sorted.bam,44.88,NA,0.15,58cfa831e4b0c9d6adf6cc87,TCGA-EM-A3O6-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_1_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3O6-01A,398D5C2E-F877-4BBF-A10C-486B8523C9CE,Primary Tumor,Illumina HiSeq,efd1fae6-df5c-4d7d-9579-296f0077b186,Thyroid,54,B3E6F726-256B-450B-B3F5-A1BB9AAB9C15,FA63C656-1DD5-4A92-9AE8-36B3408E00C7,TCGA-EM-A3O6-01A-11D-A221-26,HG19_Broad_variant,TCGA-EM-A3O6,TCGA-THCA,NA,s12114,MD Anderson - Institute for Applied Cancer Science,University Health Network,Canada,NO,T2,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa831e4b0c9d6adf6c66d,58cfa831e4b0c9d6adf6c66d,TCGA-CU-A0YN-01A-21D-A10R_120926_SN590_0182_BD1EAGACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CU-A0YN-01A-21D-A10R_120926_SN590_0182_BD1EAGACXX_s_3_rg.sorted,TCGA-CU-A0YN-01A-21D-A10R_120926_SN590_0182_BD1EAGACXX_s_3_rg.sorted.bam,82.02,2,0.16,58cfa831e4b0c9d6adf6c66d,TCGA-CU-A0YN-01A-21D-A10R_120926_SN590_0182_BD1EAGACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CU-A0YN-01A,679A6869-2CE9-4472-8DB1-8869E2C1A440,Primary Tumor,Illumina HiSeq,89fcc222-6a37-406f-a641-b3d857104f9f,Bladder,60,DBCC2FCB-A103-46DA-9893-6EC689D2F98E,98E994A3-9823-472B-AED1-38876DEA7F24,TCGA-CU-A0YN-01A-21D-A10R-02,HG19_Broad_variant,TCGA-CU-A0YN,TCGA-BLCA,393,s3276,Harvard Medical School,UNC,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c356,58cfa831e4b0c9d6adf6c356,TCGA-CG-4477-01A-01D-1154_130815_VM001_0007_VMR0007CXX_s_2_rg.sorted.filtered.,WGS,TCGA-CG-4477-01A-01D-1154_130815_VM001_0007_VMR0007CXX_s_2_rg.sorted,TCGA-CG-4477-01A-01D-1154_130815_VM001_0007_VMR0007CXX_s_2_rg.sorted.bam,281.2,1.9,0.14,58cfa831e4b0c9d6adf6c356,TCGA-CG-4477-01A-01D-1154_130815_VM001_0007_VMR0007CXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4477-01A,18D0AAE7-9694-4252-B8FE-16E62DADAB07,Primary Tumor,Illumina HiSeq,6fb461b5-4d42-4cba-bc62-bb8f68c3deed,Stomach,58,6D7C7B4E-6913-487D-9DC3-DDA901434192,3AE56504-30EE-4C03-9F69-C5B415DE6738,TCGA-CG-4477-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4477,TCGA-STAD,NA,s14637,Harvard Medical School,Indivumed,Germany,NO,T2a,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa830e4b0c9d6adf6babc,58cfa830e4b0c9d6adf6babc,TCGA-AA-A01T-01A-21D-A079-02_110402_SN208_0200_BB02BTABXX_s_5.rg.sorted.filtered.,WGS,TCGA-AA-A01T-01A-21D-A079-02_110402_SN208_0200_BB02BTABXX_s_5.rg.sorted,TCGA-AA-A01T-01A-21D-A079-02_110402_SN208_0200_BB02BTABXX_s_5.rg.sorted.bam,80.04,2.03,0.14,58cfa830e4b0c9d6adf6babc,TCGA-AA-A01T-01A-21D-A079-02_110402_SN208_0200_BB02BTABXX_s_5.rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01T-01A,F87C6DCC-1A9E-4DF5-962C-1F946E2611F8,Primary Tumor,Illumina HiSeq,0dd44906-041d-4af2-8f42-a1bed185e1c6,Colorectal,63,BFC99C6D-7791-4037-9C74-A74BE68E616A,8F61B113-0E19-403E-9637-48E9D9733692,TCGA-AA-A01T-01A-21D-A079-02,HG18_Broad_variant,TCGA-AA-A01T,TCGA-COAD,NA,s13839,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage III
13722.58cfa830e4b0c9d6adf6c2e0,58cfa830e4b0c9d6adf6c2e0,TCGA-BT-A20P-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BT-A20P-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_3_rg.sorted,TCGA-BT-A20P-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_3_rg.sorted.bam,75.72,2.03,0.15,58cfa830e4b0c9d6adf6c2e0,TCGA-BT-A20P-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_3_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20P-01A,F48937ED-E294-41F0-8872-7010391167A9,Primary Tumor,Illumina HiSeq,814688fe-5071-40b6-bb89-643389543580,Bladder,81,6B43EEEC-4FEB-4062-827A-E63ED8CE3820,022AEFEC-CBAC-46C1-9F17-AC087BD7164E,TCGA-BT-A20P-01A-11D-A14U-02,HG19_Broad_variant,TCGA-BT-A20P,TCGA-BLCA,544,s3272,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c778,58cfa831e4b0c9d6adf6c778,TCGA-D1-A17D-01A-12D-A12F_120522_SN208_0301_BC0VNWACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D1-A17D-01A-12D-A12F_120522_SN208_0301_BC0VNWACXX_s_4_rg.sorted,TCGA-D1-A17D-01A-12D-A12F_120522_SN208_0301_BC0VNWACXX_s_4_rg.sorted.bam,99.41,2,0.15,58cfa831e4b0c9d6adf6c778,TCGA-D1-A17D-01A-12D-A12F_120522_SN208_0301_BC0VNWACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A17D-01A,7DDEDDD1-B2AD-425F-94A2-9C476B959F2A,Primary Tumor,Illumina HiSeq,9d6f1593-568e-447d-b4f7-10048102ce8f,Uterus,58,9EC5A25B-9CE1-4FDE-9341-13DA39BC74B0,0F6ECDCA-5659-426A-8DAC-3211183597BD,TCGA-D1-A17D-01A-12D-A12F-02,HG19_Broad_variant,TCGA-D1-A17D,TCGA-UCEC,NA,s4443,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b5cc,58cfa82fe4b0c9d6adf6b5cc,TCGA-38-4628-01A-01D-1203_110804_SN208_0217_BC03EKABXX_s_8_rg.sorted.filtered.,WGS,TCGA-38-4628-01A-01D-1203_110804_SN208_0217_BC03EKABXX_s_8_rg.sorted,TCGA-38-4628-01A-01D-1203_110804_SN208_0217_BC03EKABXX_s_8_rg.sorted.bam,32.52,1.9,0.13,58cfa82fe4b0c9d6adf6b5cc,TCGA-38-4628-01A-01D-1203_110804_SN208_0217_BC03EKABXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-38-4628-01A,CC4BD56A-25C5-4C48-B583-AC3AEB778CA6,Primary Tumor,Illumina HiSeq,f215f323-8551-4bdc-bce7-17bc9bd45bf4,Lung,65,A74F6423-B5D3-4AE2-B61F-3EE04B1073BF,606E6830-C9FB-4107-8BD4-253C193D56B6,TCGA-38-4628-01A-01D-1203-02,HG19_Broad_variant,TCGA-38-4628,TCGA-LUAD,1492,s10652,Harvard Medical School,UNC,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa830e4b0c9d6adf6c146,58cfa830e4b0c9d6adf6c146,TCGA-BA-4074-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BA-4074-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_2_rg.sorted,TCGA-BA-4074-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_2_rg.sorted.bam,61.03,1.9,0.14,58cfa830e4b0c9d6adf6c146,TCGA-BA-4074-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-4074-10A,A63CA97D-EF31-4118-9547-A6730967290F,Blood Derived Normal,Illumina HiSeq,669ebf5f-7222-410b-b76e-2551f11e014f,Head and Neck,69,BCB3B1E4-AD0E-44B7-9143-E6B642BC7F72,9DAE3CA2-1F5A-458E-98EF-7451D5F41EBC,TCGA-BA-4074-10A-01D-1431-02,HG19_Broad_variant,TCGA-BA-4074,TCGA-HNSC,462,s15608,Harvard Medical School,UNC,None,NO,T2,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6cbb2,58cfa831e4b0c9d6adf6cbb2,TCGA-EK-A2RD-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EK-A2RD-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_6_rg.sorted,TCGA-EK-A2RD-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_6_rg.sorted.bam,11.5,NA,0.16,58cfa831e4b0c9d6adf6cbb2,TCGA-EK-A2RD-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_6_rg.sorted.bam,Alive,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2RD-10A,16363EF7-899D-4927-A74B-E7C03B3D8AF1,Blood Derived Normal,Illumina HiSeq,38640bc1-87b3-4a78-9b34-d7ffce7d0cd0,Cervix,47,0262E6F4-0B87-4A9F-AF4B-8E1657CAB3C5,F22E0E0E-40F1-46AA-80C7-BBF3310F5413,TCGA-EK-A2RD-10A-01D-A20X-26,HG19_Broad_variant,TCGA-EK-A2RD,TCGA-CESC,NA,s1194,MD Anderson - Institute for Applied Cancer Science,Gynecologic Oncology Group,United States,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6cd7e,58cfa831e4b0c9d6adf6cd7e,TCGA-FE-A3PD-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_7_rg.sorted.filtered.,WGS,TCGA-FE-A3PD-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_7_rg.sorted,TCGA-FE-A3PD-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_7_rg.sorted.bam,59.24,NA,0.15,58cfa831e4b0c9d6adf6cd7e,TCGA-FE-A3PD-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A3PD-01A,39D90499-8549-4DA5-B391-C421F18FACF1,Primary Tumor,Illumina HiSeq,66155739-2eb1-4230-8b24-645dca4e0c0d,Thyroid,17,A6C23CA9-E6F4-4A2C-BB86-25EF76076381,3F63EB17-5F71-4EEC-AEF5-1D4FF328043C,TCGA-FE-A3PD-01A-11D-A221-26,HG19_Broad_variant,TCGA-FE-A3PD,TCGA-THCA,NA,s12390,MD Anderson - Institute for Applied Cancer Science,Ohio State University,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa832e4b0c9d6adf6d478,58cfa832e4b0c9d6adf6d478,TCGA-VD-A8KD-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-VD-A8KD-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_1_rg.sorted,TCGA-VD-A8KD-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_1_rg.sorted.bam,49.59,NA,0.17,58cfa832e4b0c9d6adf6d478,TCGA-VD-A8KD-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_1_rg.sorted.bam,Dead,MALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KD-01A,73B3E4DD-C53D-4FE3-8607-EE462C9CBBD1,Primary Tumor,Illumina HiSeq,32e66b83-1d91-4ed8-b672-cc125bbe3b57,Eye,72,4F0319B2-722C-48E1-A5E1-798463E9EA02,347DBA4E-7CA8-4432-A0F7-90F9009F8AA3,TCGA-VD-A8KD-01A-11D-A40D-26,HG19_Broad_variant,TCGA-VD-A8KD,TCGA-UVM,114,s270,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T4a,NX,Not available,Stage IV
13722.58cfa831e4b0c9d6adf6cc16,58cfa831e4b0c9d6adf6cc16,TCGA-DU-7294-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DU-7294-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_3_rg.sorted,TCGA-DU-7294-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_3_rg.sorted.bam,62.7,NA,0.17,58cfa831e4b0c9d6adf6cc16,TCGA-DU-7294-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7294-01A,3F6FFB08-32A9-4555-BFD1-243B7F526105,Primary Tumor,Illumina HiSeq,2df0ab9f-8d32-40e9-883d-f5afad653272,Brain,53,C2D0A3C8-2354-475C-9027-5DF9523391CE,E6552DAE-BDEA-4945-9BA9-9C88D34CEBBC,TCGA-DU-7294-01A-11D-2022-02,HG19_Broad_variant,TCGA-DU-7294,TCGA-LGG,NA,s8362,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa830e4b0c9d6adf6bf61,58cfa830e4b0c9d6adf6bf61,TCGA-BR-4366-11A-01D-1154_130815_VM001_0002_VMR0002CXX_s_2_rg.sorted.filtered.,WGS,TCGA-BR-4366-11A-01D-1154_130815_VM001_0002_VMR0002CXX_s_2_rg.sorted,TCGA-BR-4366-11A-01D-1154_130815_VM001_0002_VMR0002CXX_s_2_rg.sorted.bam,42.3,1.9,0.14,58cfa830e4b0c9d6adf6bf61,TCGA-BR-4366-11A-01D-1154_130815_VM001_0002_VMR0002CXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4366-11A,525A6978-2D7B-4F3A-AC68-13FE8CBBBDCC,Solid Tissue Normal,Illumina HiSeq,9179774b-7bf8-4aa0-886f-2917234201eb,Stomach,87,EFB4B208-B314-4B12-87DF-C8F776515842,009F6A4A-9D83-44DF-A83C-B707B74E37D1,TCGA-BR-4366-11A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4366,TCGA-STAD,NA,s15303,Harvard Medical School,Asterand,Russia,NO,TX,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa830e4b0c9d6adf6c1c9,58cfa830e4b0c9d6adf6c1c9,TCGA-BG-A0MQ-10A-02D-A101_120406_SN208_0281_AC0KDBACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BG-A0MQ-10A-02D-A101_120406_SN208_0281_AC0KDBACXX_s_7_rg.sorted,TCGA-BG-A0MQ-10A-02D-A101_120406_SN208_0281_AC0KDBACXX_s_7_rg.sorted.bam,6.94,1.79,0.14,58cfa830e4b0c9d6adf6c1c9,TCGA-BG-A0MQ-10A-02D-A101_120406_SN208_0281_AC0KDBACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0MQ-10A,12D36A1D-9922-4311-BBDA-71F32AC2C03B,Blood Derived Normal,Illumina HiSeq,64f40fd7-7cbd-4f15-8f79-c145111f31bd,Uterus,71,0B751781-2FFF-44E0-B8C3-110EB62FCEE7,AB49DF17-7A69-4655-B35F-8B4FF56DFCF8,TCGA-BG-A0MQ-10A-02D-A101-02,HG19_Broad_variant,TCGA-BG-A0MQ,TCGA-UCEC,NA,s4432,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cda6,58cfa831e4b0c9d6adf6cda6,TCGA-FE-A231-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FE-A231-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_2_rg.sorted,TCGA-FE-A231-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_2_rg.sorted.bam,19.94,2,0.16,58cfa831e4b0c9d6adf6cda6,TCGA-FE-A231-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A231-10A,7044DEE0-FD6C-4E75-B731-DC60A386A1AB,Blood Derived Normal,Illumina HiSeq,d2802fde-7e81-4964-915a-9469258cc84a,Thyroid,70,2F9DB370-79E8-4656-82CE-1EF4D477B46A,C42AD034-4E5B-44A0-B4E8-977CDE011C8B,TCGA-FE-A231-10A-01D-A14U-02,HG19_Broad_variant,TCGA-FE-A231,TCGA-THCA,NA,s12759,Harvard Medical School,Ohio State University,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA
13722.58cfa832e4b0c9d6adf6cf94,58cfa832e4b0c9d6adf6cf94,TCGA-FU-A3NI-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FU-A3NI-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_8_rg.sorted,TCGA-FU-A3NI-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_8_rg.sorted.bam,36.82,NA,0.16,58cfa832e4b0c9d6adf6cf94,TCGA-FU-A3NI-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-FU-A3NI-01A,DAC27C24-CDBF-4527-9214-178FDE3D098A,Primary Tumor,Illumina HiSeq,e3d152ec-0ab5-4fb6-b2ca-ecdb79e43095,Cervix,45,C75C6FD3-79EF-48B8-B3BD-D097EF2A73AD,90DC57B8-74B7-4FB0-9EE7-52A4264D395F,TCGA-FU-A3NI-01A-11D-A245-26,HG19_Broad_variant,TCGA-FU-A3NI,TCGA-CESC,NA,s1204,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T1b1,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c4d0,58cfa831e4b0c9d6adf6c4d0,TCGA-BT-A3PJ-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BT-A3PJ-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_1_rg.sorted,TCGA-BT-A3PJ-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_1_rg.sorted.bam,55.89,NA,0.15,58cfa831e4b0c9d6adf6c4d0,TCGA-BT-A3PJ-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A3PJ-01A,CB664EEF-BE6F-44EF-AA90-6F6DA0E6440A,Primary Tumor,Illumina HiSeq,cac436d2-b3cb-4351-953e-084c7a431f0f,Bladder,76,29D79B83-FA80-490E-A8A1-C51C9AD061FE,4BAD319F-9A5F-4257-863A-BCD8ED983EFE,TCGA-BT-A3PJ-01A-21D-A221-26,HG19_Broad_variant,TCGA-BT-A3PJ,TCGA-BLCA,NA,s2698,MD Anderson - Institute for Applied Cancer Science,University of Pittsburgh,United States,NO,T3a,N3,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6cde6,58cfa831e4b0c9d6adf6cde6,TCGA-FS-A1YX-06A-11D-A18Y_120724_SN208_0417_AC117BACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FS-A1YX-06A-11D-A18Y_120724_SN208_0417_AC117BACXX_s_1_rg.sorted,TCGA-FS-A1YX-06A-11D-A18Y_120724_SN208_0417_AC117BACXX_s_1_rg.sorted.bam,36.84,NA,0.16,58cfa831e4b0c9d6adf6cde6,TCGA-FS-A1YX-06A-11D-A18Y_120724_SN208_0417_AC117BACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1YX-06A,4537C0E1-B2BD-425F-A6F4-27F4733DC25A,Metastatic,Illumina HiSeq,6126185a-3723-4e2e-8299-9b572802970a,Skin,39,15D812E2-2BB0-47F0-80D2-5F72697BA71B,F487FF4F-86E2-4F0B-A166-39A39670A9F9,TCGA-FS-A1YX-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1YX,TCGA-SKCM,1478,s7365,Harvard Medical School,Essen,Germany,NO,T2,N0,Not available,Stage I
13722.58cfa832e4b0c9d6adf6cf28,58cfa832e4b0c9d6adf6cf28,TCGA-H2-A3RI-11A-11D-A221_120611_SN1222_0115_BD141KACXX_s_4_rg.sorted.filtered.,WGS,TCGA-H2-A3RI-11A-11D-A221_120611_SN1222_0115_BD141KACXX_s_4_rg.sorted,TCGA-H2-A3RI-11A-11D-A221_120611_SN1222_0115_BD141KACXX_s_4_rg.sorted.bam,30.6,NA,0.16,58cfa832e4b0c9d6adf6cf28,TCGA-H2-A3RI-11A-11D-A221_120611_SN1222_0115_BD141KACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-H2-A3RI-11A,BF193C4F-FBAC-41BC-B1AF-19B6CE856F0F,Solid Tissue Normal,Illumina HiSeq,4eb6cb87-95fa-472d-8586-3243852bee0d,Thyroid,29,44098BAB-EF64-4695-918C-501874BEC9E4,82A3F4E9-87A9-411E-B3C0-CA8D497432F5,TCGA-H2-A3RI-11A-11D-A221-26,HG19_Broad_variant,TCGA-H2-A3RI,TCGA-THCA,NA,s12534,MD Anderson - Institute for Applied Cancer Science,Christiana Healthcare,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82fe4b0c9d6adf6b6bb,58cfa82fe4b0c9d6adf6b6bb,TCGA-64-5774-10A-01D-1623_110826_SN590_0103_AC005WACXX_s_2_rg.sorted.filtered.,WGS,TCGA-64-5774-10A-01D-1623_110826_SN590_0103_AC005WACXX_s_2_rg.sorted,TCGA-64-5774-10A-01D-1623_110826_SN590_0103_AC005WACXX_s_2_rg.sorted.bam,147.4,1.9,0.14,58cfa82fe4b0c9d6adf6b6bb,TCGA-64-5774-10A-01D-1623_110826_SN590_0103_AC005WACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-64-5774-10A,FD3FC273-C035-40EA-A459-FF4806F5D592,Blood Derived Normal,Illumina HiSeq,fee3375f-0641-4334-a876-7570f40bb0c0,Lung,60,C10D6419-C120-49BA-B2CD-BBB636B7A3F8,B40329F6-ABA0-4030-9F14-40CC2C20475A,TCGA-64-5774-10A-01D-1623-02,HG19_Broad_variant,TCGA-64-5774,TCGA-LUAD,NA,s11462,Harvard Medical School,Fox Chase,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa832e4b0c9d6adf6d23c,58cfa832e4b0c9d6adf6d23c,TCGA-IR-A3LK-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_8_rg.sorted.filtered.,WGS,TCGA-IR-A3LK-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_8_rg.sorted,TCGA-IR-A3LK-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_8_rg.sorted.bam,24.72,NA,0.16,58cfa832e4b0c9d6adf6d23c,TCGA-IR-A3LK-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-IR-A3LK-10A,B79558C5-1DB2-4B1E-A7B8-EFBD19AA855E,Blood Derived Normal,Illumina HiSeq,a4df291b-d7e9-452c-ab2b-52ff1db1051d,Cervix,69,DD471C07-B1BC-441E-8FEE-8DF228EBA7B3,DED6849A-2A0F-4151-9A2D-1900B222C838,TCGA-IR-A3LK-10A-01D-A20X-26,HG19_Broad_variant,TCGA-IR-A3LK,TCGA-CESC,NA,s1538,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T1b2,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6bd32,58cfa830e4b0c9d6adf6bd32,TCGA-AA-A01P-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.,WGS,TCGA-AA-A01P-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole,TCGA-AA-A01P-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,53.07,1.95,0.15,58cfa830e4b0c9d6adf6bd32,TCGA-AA-A01P-11A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,Dead,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01P-11A,13AE9D83-A22F-451F-88BB-686051725CF3,Solid Tissue Normal,Illumina HiSeq,3608d4d3-d6e8-4b8d-a3bd-b921d4f9ae0e,Colorectal,80,16F6C3FC-3001-4FC4-81A5-9D24DFBCC087,C65B8095-F2F8-42AD-BDA6-6C4F2738BF54,TCGA-AA-A01P-11A-11D-A079-02,HG18,TCGA-AA-A01P,TCGA-COAD,1158,s13531,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage III
13722.58cfa832e4b0c9d6adf6cf97,58cfa832e4b0c9d6adf6cf97,TCGA-G9-6362-01A-11D-1784_130215_SN590_0211_AC1UJWACXX_s_3_rg.sorted.filtered.,WGS,TCGA-G9-6362-01A-11D-1784_130215_SN590_0211_AC1UJWACXX_s_3_rg.sorted,TCGA-G9-6362-01A-11D-1784_130215_SN590_0211_AC1UJWACXX_s_3_rg.sorted.bam,385.4,1.8,0.13,58cfa832e4b0c9d6adf6cf97,TCGA-G9-6362-01A-11D-1784_130215_SN590_0211_AC1UJWACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6362-01A,F228EF91-ECFB-4D1E-8E6A-B43D2185270E,Primary Tumor,Illumina HiSeq,04834dec-1ae4-4a26-956a-f51c69d6c324,Prostate,57,1A626C6C-3DD9-4D87-BB93-CB2FEB82FBE8,A9B195C5-0441-4C98-8314-C50ECA082994,TCGA-G9-6362-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6362,TCGA-PRAD,NA,s4149,Harvard Medical School,Roswell Park,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c24a,58cfa830e4b0c9d6adf6c24a,TCGA-BT-A3PH-10A-01D-A221_120902_SN1222_0147_AC195DACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BT-A3PH-10A-01D-A221_120902_SN1222_0147_AC195DACXX_s_8_rg.sorted,TCGA-BT-A3PH-10A-01D-A221_120902_SN1222_0147_AC195DACXX_s_8_rg.sorted.bam,18.65,NA,0.14,58cfa830e4b0c9d6adf6c24a,TCGA-BT-A3PH-10A-01D-A221_120902_SN1222_0147_AC195DACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A3PH-10A,932BCDD4-5145-49E8-9A95-8A546396F572,Blood Derived Normal,Illumina HiSeq,11b9a43d-0732-4a19-8b6c-cc1a568f3553,Bladder,76,59AC02BD-BB4F-42F4-BC5E-8679D7D80D33,B46B881B-0AEB-4265-81FA-1982E9C9534D,TCGA-BT-A3PH-10A-01D-A221-26,HG19_Broad_variant,TCGA-BT-A3PH,TCGA-BLCA,142,s3268,MD Anderson - Institute for Applied Cancer Science,University of Pittsburgh,United States,NO,T3b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6cf72,58cfa832e4b0c9d6adf6cf72,TCGA-G9-6370-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-G9-6370-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_6_rg.sorted,TCGA-G9-6370-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_6_rg.sorted.bam,43.7,1.8,0.15,58cfa832e4b0c9d6adf6cf72,TCGA-G9-6370-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6370-10A,F947B0BC-BDAC-44E8-B5B9-FFAE4147740A,Blood Derived Normal,Illumina HiSeq,843714e6-d7a1-47d1-b3e1-9bc71c2e21ca,Prostate,52,8FF4EEBE-420C-442E-A41D-4C1F050B0EED,1BFB79D5-D5EE-47A3-AD7D-07F41AD4BA47,TCGA-G9-6370-10A-01D-1784-02,HG19_Broad_variant,TCGA-G9-6370,TCGA-PRAD,NA,s4148,Harvard Medical School,Roswell Park,United States,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c4e7,58cfa831e4b0c9d6adf6c4e7,TCGA-BR-4367-11A-01D-1154_130815_VM001_0002_VMR0002CXX_s_4_rg.sorted.filtered.,WGS,TCGA-BR-4367-11A-01D-1154_130815_VM001_0002_VMR0002CXX_s_4_rg.sorted,TCGA-BR-4367-11A-01D-1154_130815_VM001_0002_VMR0002CXX_s_4_rg.sorted.bam,200,1.9,0.14,58cfa831e4b0c9d6adf6c4e7,TCGA-BR-4367-11A-01D-1154_130815_VM001_0002_VMR0002CXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4367-11A,D139BD0C-2EEB-44EC-856B-E77CB03D294E,Solid Tissue Normal,Illumina HiSeq,ea05becd-5829-4f1f-8dd3-56dedaa95846,Stomach,78,437E0DC0-CF92-43A0-B6AC-405A7B22B56D,3219D0B6-A19B-4359-A682-84B2E06B2201,TCGA-BR-4367-11A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4367,TCGA-STAD,NA,s15236,Harvard Medical School,Asterand,Russia,NO,TX,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa831e4b0c9d6adf6c967,58cfa831e4b0c9d6adf6c967,TCGA-DJ-A13V-10A-01D-A10R_120616_SN1120_0154_BD142VACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DJ-A13V-10A-01D-A10R_120616_SN1120_0154_BD142VACXX_s_4_rg.sorted,TCGA-DJ-A13V-10A-01D-A10R_120616_SN1120_0154_BD142VACXX_s_4_rg.sorted.bam,35.32,1.93,0.16,58cfa831e4b0c9d6adf6c967,TCGA-DJ-A13V-10A-01D-A10R_120616_SN1120_0154_BD142VACXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13V-10A,99AC4F2E-2E63-4F1E-AF0F-8F23A2CAF999,Blood Derived Normal,Illumina HiSeq,e3b798f9-04a4-4365-a60b-37a5b6893d1a,Thyroid,21,727FF1F4-06E5-4B68-BCE4-EC16DCF4893F,EA9BCF86-E3C9-480C-AF3D-1C8C8A4D83A1,TCGA-DJ-A13V-10A-01D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13V,TCGA-THCA,NA,s11994,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa830e4b0c9d6adf6ba54,58cfa830e4b0c9d6adf6ba54,TCGA-AA-A01Q-01A-01D-A077_110402_SN208_0200_BB02BTABXX_s_4_rg.sorted.filtered.,WGS,TCGA-AA-A01Q-01A-01D-A077_110402_SN208_0200_BB02BTABXX_s_4_rg.sorted,TCGA-AA-A01Q-01A-01D-A077_110402_SN208_0200_BB02BTABXX_s_4_rg.sorted.bam,237.45,1.73,0.15,58cfa830e4b0c9d6adf6ba54,TCGA-AA-A01Q-01A-01D-A077_110402_SN208_0200_BB02BTABXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01Q-01A,4BE66108-E72A-406B-BB4B-F58FF2877336,Primary Tumor,Illumina HiSeq,f50b391c-a832-4938-86aa-0ae2e8261a9e,Colorectal,48,5D1D7C40-F636-46C6-9540-4DF11A466B15,D84E59D4-7777-4922-990F-622BD246A9F1,TCGA-AA-A01Q-01A-01D-A077-02,HG18_Broad_variant,TCGA-AA-A01Q,TCGA-COAD,NA,s13032,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa832e4b0c9d6adf6d298,58cfa832e4b0c9d6adf6d298,TCGA-HT-7481-10A-01D-2022_130913_SN1440_0168_BD2B0UACXX_s_5_rg.sorted.filtered.,WGS,TCGA-HT-7481-10A-01D-2022_130913_SN1440_0168_BD2B0UACXX_s_5_rg.sorted,TCGA-HT-7481-10A-01D-2022_130913_SN1440_0168_BD2B0UACXX_s_5_rg.sorted.bam,315,NA,0.13,58cfa832e4b0c9d6adf6d298,TCGA-HT-7481-10A-01D-2022_130913_SN1440_0168_BD2B0UACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7481-10A,BFF37DE3-DC68-4E69-BDFC-8B524DD7774F,Blood Derived Normal,Illumina HiSeq,7b00539d-b389-4e45-b200-b742550d68d3,Brain,39,F44899E6-7FA9-439E-8D5E-2AE0E6299CF0,5CA4D8F5-2CA5-44F2-8A2C-C4458B6C2B8D,TCGA-HT-7481-10A-01D-2022-02,HG19_Broad_variant,TCGA-HT-7481,TCGA-LGG,NA,s8373,Harvard Medical School,Case Western - St Joes,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82fe4b0c9d6adf6b7b4,58cfa82fe4b0c9d6adf6b7b4,TCGA-50-5930-01A-11D-1751_111007_SN590_0110_C003AACXX_s_1_rg.sorted.filtered.,WGS,TCGA-50-5930-01A-11D-1751_111007_SN590_0110_C003AACXX_s_1_rg.sorted,TCGA-50-5930-01A-11D-1751_111007_SN590_0110_C003AACXX_s_1_rg.sorted.bam,181.4,2,0.16,58cfa82fe4b0c9d6adf6b7b4,TCGA-50-5930-01A-11D-1751_111007_SN590_0110_C003AACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5930-01A,368E23F0-E573-4547-BF5A-14080BAF737B,Primary Tumor,Illumina HiSeq,09c8fefe-47f0-44eb-b4f4-160944e2991a,Lung,47,3E30DBD1-10BF-4450-8D19-6F44D3284E02,31047F3B-8F9D-47D9-87D3-BB2F8CF7E1EF,TCGA-50-5930-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-5930,TCGA-LUAD,282,s11347,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIA
13722.58cfa831e4b0c9d6adf6c9b4,58cfa831e4b0c9d6adf6c9b4,TCGA-DJ-A13S-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DJ-A13S-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_6_rg.sorted,TCGA-DJ-A13S-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_6_rg.sorted.bam,58.89,1.97,0.13,58cfa831e4b0c9d6adf6c9b4,TCGA-DJ-A13S-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13S-01A,8AA99F35-C644-4F91-9EFF-A5D3FAE758B0,Primary Tumor,Illumina HiSeq,a19c2149-887d-4a36-992f-2a0ebb46072c,Thyroid,19,17952842-3447-4A38-90F4-D25B90C3233A,3C630C3D-343D-4F9F-8067-43B66466D382,TCGA-DJ-A13S-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13S,TCGA-THCA,NA,s12239,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa830e4b0c9d6adf6c30a,58cfa830e4b0c9d6adf6c30a,TCGA-BR-6457-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BR-6457-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_4_rg.sorted,TCGA-BR-6457-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_4_rg.sorted.bam,147.7,1.9,0.15,58cfa830e4b0c9d6adf6c30a,TCGA-BR-6457-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6457-10A,05CE16D4-A999-491A-91AD-9449A57228FF,Blood Derived Normal,Illumina HiSeq,c937c321-5e90-4ec8-925e-e1cd02e6d5e5,Stomach,69,1D6C8FEB-3DD6-4B8F-8403-7B67B759E66B,A54F167D-F10B-4511-A956-AF502B5F3874,TCGA-BR-6457-10A-01D-1798-02,HG19_Broad_variant,TCGA-BR-6457,TCGA-STAD,NA,s14617,Harvard Medical School,Asterand,Ukraine,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA
13722.58cfa831e4b0c9d6adf6c75e,58cfa831e4b0c9d6adf6c75e,TCGA-D1-A1O0-10A-01D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D1-A1O0-10A-01D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_4_rg.sorted,TCGA-D1-A1O0-10A-01D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_4_rg.sorted.bam,19.49,1.98,0.17,58cfa831e4b0c9d6adf6c75e,TCGA-D1-A1O0-10A-01D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A1O0-10A,A98BBE29-8817-4380-A738-3C1BF9F8E0CC,Blood Derived Normal,Illumina HiSeq,28a1d78c-cec8-4067-8f4b-201ef9b7fe9d,Uterus,77,24C73392-0F24-418E-B89F-1C3D4613DDF3,BC47D6F0-E345-43D0-950B-89D6BFC019AE,TCGA-D1-A1O0-10A-01D-A17E-02,HG19_Broad_variant,TCGA-D1-A1O0,TCGA-UCEC,NA,s5025,Harvard Medical School,Mayo Clinic,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c516,58cfa831e4b0c9d6adf6c516,TCGA-BT-A3PJ-10A-01D-A221_120906_SN208_0426_BC194HACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BT-A3PJ-10A-01D-A221_120906_SN208_0426_BC194HACXX_s_2_rg.sorted,TCGA-BT-A3PJ-10A-01D-A221_120906_SN208_0426_BC194HACXX_s_2_rg.sorted.bam,24.23,NA,0.16,58cfa831e4b0c9d6adf6c516,TCGA-BT-A3PJ-10A-01D-A221_120906_SN208_0426_BC194HACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A3PJ-10A,CB664EEF-BE6F-44EF-AA90-6F6DA0E6440A,Blood Derived Normal,Illumina HiSeq,717b2eb2-3d5e-4477-95da-1f30739ece0b,Bladder,76,34AC9B44-6A13-4D4F-BDEB-ECBF30ED9B08,CBC9B726-452B-4D31-8A24-CB770F3B5AD0,TCGA-BT-A3PJ-10A-01D-A221-26,HG19_Broad_variant,TCGA-BT-A3PJ,TCGA-BLCA,NA,s3271,MD Anderson - Institute for Applied Cancer Science,University of Pittsburgh,United States,NO,T3a,N3,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6ccc8,58cfa831e4b0c9d6adf6ccc8,TCGA-EK-A2RD-01A-12D-A20X_140117_SN590_0245_AC371LACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EK-A2RD-01A-12D-A20X_140117_SN590_0245_AC371LACXX_s_2_rg.sorted,TCGA-EK-A2RD-01A-12D-A20X_140117_SN590_0245_AC371LACXX_s_2_rg.sorted.bam,50.11,NA,0.15,58cfa831e4b0c9d6adf6ccc8,TCGA-EK-A2RD-01A-12D-A20X_140117_SN590_0245_AC371LACXX_s_2_rg.sorted.bam,Alive,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2RD-01A,16363EF7-899D-4927-A74B-E7C03B3D8AF1,Primary Tumor,Illumina HiSeq,2f14caa1-7594-45db-b8dc-69e3659c129d,Cervix,47,5690A425-BA49-4BCA-B5EC-461BD5660BE0,D14F932D-58AF-4648-93DD-75F8F8A539BC,TCGA-EK-A2RD-01A-12D-A20X-26,HG19_Broad_variant,TCGA-EK-A2RD,TCGA-CESC,NA,s1366,MD Anderson - Institute for Applied Cancer Science,Gynecologic Oncology Group,United States,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c8be,58cfa831e4b0c9d6adf6c8be,TCGA-DK-A1A5-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DK-A1A5-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_2_rg.sorted,TCGA-DK-A1A5-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_2_rg.sorted.bam,56.09,1.95,0.15,58cfa831e4b0c9d6adf6c8be,TCGA-DK-A1A5-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A5-10A,904A8757-E0C5-41EF-B583-C8F170CAAAC1,Blood Derived Normal,Illumina HiSeq,43d7b3d5-6a0c-49f1-a63c-d49c8fdb8c86,Bladder,79,608EEC1D-33BC-48DD-A928-49B09E87CCC8,BCB12F76-2D37-4B56-B1FC-62CA41B39703,TCGA-DK-A1A5-10A-01D-A13U-02,HG19_Broad_variant,TCGA-DK-A1A5,TCGA-BLCA,65,s2891,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c7e5,58cfa831e4b0c9d6adf6c7e5,TCGA-D1-A169-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_1_rg.sorted.filtered.,WGS,TCGA-D1-A169-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_1_rg.sorted,TCGA-D1-A169-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_1_rg.sorted.bam,68.97,1.95,0.15,58cfa831e4b0c9d6adf6c7e5,TCGA-D1-A169-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A169-01A,9A599F57-0E8D-4E1F-A181-791F5FDEADB7,Primary Tumor,Illumina HiSeq,43a5a914-7913-4e5e-9d2f-42fcec7bab2f,Uterus,63,9B36F264-55C3-4E08-A151-4B356871520C,B3A7C237-92C3-448A-A87E-8C8B1061A79F,TCGA-D1-A169-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A169,TCGA-UCEC,NA,s4796,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c5a4,58cfa831e4b0c9d6adf6c5a4,TCGA-CN-4739-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CN-4739-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_3_rg.sorted,TCGA-CN-4739-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_3_rg.sorted.bam,10.4,1.9,0.15,58cfa831e4b0c9d6adf6c5a4,TCGA-CN-4739-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4739-10A,7E3B90C1-8772-4E12-8050-A156558BEB82,Blood Derived Normal,Illumina HiSeq,1f5e9479-345d-4dc7-a9c5-24dbf2e32405,Head and Neck,71,B916FA4A-1D15-4619-9D6C-1000E96B7E0D,86D66FCC-56C5-491A-95A9-B57E40F6C380,TCGA-CN-4739-10A-01D-1509-02,HG19_Broad_variant,TCGA-CN-4739,TCGA-HNSC,NA,s15628,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6bad4,58cfa830e4b0c9d6adf6bad4,TCGA-AA-A01V-01A-23D-A079-02_110402_SN208_0200_BB02BTABXX_s_7.rg.sorted.filtered.,WGS,TCGA-AA-A01V-01A-23D-A079-02_110402_SN208_0200_BB02BTABXX_s_7.rg.sorted,TCGA-AA-A01V-01A-23D-A079-02_110402_SN208_0200_BB02BTABXX_s_7.rg.sorted.bam,86.94,2,0.15,58cfa830e4b0c9d6adf6bad4,TCGA-AA-A01V-01A-23D-A079-02_110402_SN208_0200_BB02BTABXX_s_7.rg.sorted.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01V-01A,0CB0DAC8-4CE2-444A-B1AE-1550E065B4D9,Primary Tumor,Illumina HiSeq,f9fde040-dea2-4d98-8a28-05cb13efa1c2,Colorectal,59,8816F14D-9FBB-4033-9CA4-6CA0DB66161A,D13F4522-90DC-41C8-A274-FBD9C0CD2E60,TCGA-AA-A01V-01A-23D-A079-02,HG18_Broad_variant,TCGA-AA-A01V,TCGA-COAD,NA,s13683,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa832e4b0c9d6adf6cfa8,58cfa832e4b0c9d6adf6cfa8,TCGA-GV-A3JV-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_1_rg.sorted.filtered.,WGS,TCGA-GV-A3JV-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_1_rg.sorted,TCGA-GV-A3JV-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_1_rg.sorted.bam,63.27,NA,0.14,58cfa832e4b0c9d6adf6cfa8,TCGA-GV-A3JV-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GV-A3JV-01A,01EE41EF-1894-4408-9E96-A22A1F068190,Primary Tumor,Illumina HiSeq,8f626567-33e0-4b6a-974f-6b41b341c60e,Bladder,66,55072935-CD20-4355-897B-F60F77A18847,E5863D29-E61D-4EE2-B04E-FE61C9B9CA5E,TCGA-GV-A3JV-01A-11D-A221-26,HG19_Broad_variant,TCGA-GV-A3JV,TCGA-BLCA,NA,s3308,MD Anderson - Institute for Applied Cancer Science,BLN - Cleveland Clinic,United States,NO,T3b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c3c2,58cfa831e4b0c9d6adf6c3c2,TCGA-BT-A20Q-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BT-A20Q-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_5_rg.sorted,TCGA-BT-A20Q-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_5_rg.sorted.bam,56.34,2.11,0.15,58cfa831e4b0c9d6adf6c3c2,TCGA-BT-A20Q-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20Q-01A,419DEAAC-EA45-4BDD-9FA0-B5CD8429B44F,Primary Tumor,Illumina HiSeq,9d2dc2d3-8995-42b8-9bee-010c8bce06e0,Bladder,73,F3906CD4-31C7-48A8-935B-5B7FAFEC1AE7,72AF980B-98A8-4572-8AF9-EFD4294700F9,TCGA-BT-A20Q-01A-11D-A14U-02,HG19_Broad_variant,TCGA-BT-A20Q,TCGA-BLCA,593,s3083,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6cd1c,58cfa831e4b0c9d6adf6cd1c,TCGA-EY-A1GC-10A-01D-A13M_120516_SN1222_0107_BD12HYACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EY-A1GC-10A-01D-A13M_120516_SN1222_0107_BD12HYACXX_s_6_rg.sorted,TCGA-EY-A1GC-10A-01D-A13M_120516_SN1222_0107_BD12HYACXX_s_6_rg.sorted.bam,20.75,1.73,0.16,58cfa831e4b0c9d6adf6cd1c,TCGA-EY-A1GC-10A-01D-A13M_120516_SN1222_0107_BD12HYACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-EY-A1GC-10A,EBC25A41-BECB-4395-AE33-483A304B07D8,Blood Derived Normal,Illumina HiSeq,09d75c63-a601-4014-87e9-b0ee743619ad,Uterus,62,4FB947E9-0D41-4002-850C-771D676AAA4F,62203496-84AA-4653-8578-EC9DCDD53F8F,TCGA-EY-A1GC-10A-01D-A13M-02,HG19_Broad_variant,TCGA-EY-A1GC,TCGA-UCEC,NA,s4266,Harvard Medical School,University of North Carolina,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c996,58cfa831e4b0c9d6adf6c996,TCGA-DK-A1AC-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DK-A1AC-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_6_rg.sorted,TCGA-DK-A1AC-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_6_rg.sorted.bam,64.42,1.91,0.16,58cfa831e4b0c9d6adf6c996,TCGA-DK-A1AC-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,Not available,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AC-10A,36C14E9D-1863-4C55-BBBB-F8C9DD418932,Blood Derived Normal,Illumina HiSeq,7b5dbb5a-bca2-4772-8f0f-af7cdca1713e,Bladder,72,00D99D48-F628-4533-8DDA-539ADD87CEDD,10182859-0BC3-434E-8773-007F65394926,TCGA-DK-A1AC-10A-01D-A13U-02,HG19_Broad_variant,TCGA-DK-A1AC,TCGA-BLCA,NA,s2706,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6ccc6,58cfa831e4b0c9d6adf6ccc6,TCGA-EM-A1CS-01A-11D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EM-A1CS-01A-11D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_5_rg.sorted,TCGA-EM-A1CS-01A-11D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_5_rg.sorted.bam,69.84,1.88,0.18,58cfa831e4b0c9d6adf6ccc6,TCGA-EM-A1CS-01A-11D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_5_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1CS-01A,E92BDB0D-969A-4D98-ADA8-5DFEC68119B5,Primary Tumor,Illumina HiSeq,b6cf1366-a645-4bd9-ac5f-0e8c5d18a4ca,Thyroid,55,C1DAF740-06E2-4509-86BE-5BFCC52B508A,67082C81-DE62-42A4-82B7-CB6BE2C961D3,TCGA-EM-A1CS-01A-11D-A13U-02,HG19_Broad_variant,TCGA-EM-A1CS,TCGA-THCA,NA,s12251,Harvard Medical School,University Health Network,Canada,NO,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6d148,58cfa832e4b0c9d6adf6d148,TCGA-IG-A4QT-10A-02D-A267_131120_SN1222_0229_AD2FDGACXX_s_4_rg.sorted.filtered.,WGS,TCGA-IG-A4QT-10A-02D-A267_131120_SN1222_0229_AD2FDGACXX_s_4_rg.sorted,TCGA-IG-A4QT-10A-02D-A267_131120_SN1222_0229_AD2FDGACXX_s_4_rg.sorted.bam,38.95,NA,0.16,58cfa832e4b0c9d6adf6d148,TCGA-IG-A4QT-10A-02D-A267_131120_SN1222_0229_AD2FDGACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A4QT-10A,3F7B600B-282E-4F35-9FD8-567B3FCA8273,Blood Derived Normal,Illumina HiSeq,55542698-bbd2-4f39-958a-cffe77756e94,Esophagus,56,79CBA036-B919-4480-8253-9786E072FC73,74A32DE8-E1BF-4923-BD9C-3F7890ABF0CA,TCGA-IG-A4QT-10A-02D-A267-26,HG19_Broad_variant,TCGA-IG-A4QT,TCGA-ESCA,NA,s1726,MD Anderson - Institute for Applied Cancer Science,Asterand,Ukraine,NO,T3,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6cd12,58cfa831e4b0c9d6adf6cd12,TCGA-FD-A3SJ-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FD-A3SJ-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_1_rg.sorted,TCGA-FD-A3SJ-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_1_rg.sorted.bam,30.78,NA,0.17,58cfa831e4b0c9d6adf6cd12,TCGA-FD-A3SJ-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3SJ-01A,6D8D8169-0C1A-4CDB-BE6F-9761C981A369,Primary Tumor,Illumina HiSeq,2635ae0a-878a-4237-ad5c-5f0092134ee3,Bladder,59,491A8898-7CC5-45D9-9502-FD24399C239D,E9F8EE08-E951-41A8-88AB-E7A98618EECC,TCGA-FD-A3SJ-01A-12D-A233-26,HG19_Broad_variant,TCGA-FD-A3SJ,TCGA-BLCA,739,s2909,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T2b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6cff5,58cfa832e4b0c9d6adf6cff5,TCGA-G9-6370-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-G9-6370-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_5_rg.sorted,TCGA-G9-6370-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_5_rg.sorted.bam,59.4,2,0.14,58cfa832e4b0c9d6adf6cff5,TCGA-G9-6370-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6370-01A,F947B0BC-BDAC-44E8-B5B9-FFAE4147740A,Primary Tumor,Illumina HiSeq,7b80e96d-c20b-4080-9382-26a778397c15,Prostate,52,644E1E7D-DFD1-4F83-82DC-AE0C7E010F6F,D97C0E4A-EB95-49BC-B430-EE0122726442,TCGA-G9-6370-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6370,TCGA-PRAD,NA,s3449,Harvard Medical School,Roswell Park,United States,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bdab,58cfa830e4b0c9d6adf6bdab,TCGA-BG-A0MC-10A-01D-A043_120530_SN1222_0110_AC0VLAACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BG-A0MC-10A-01D-A043_120530_SN1222_0110_AC0VLAACXX_s_2_rg.sorted,TCGA-BG-A0MC-10A-01D-A043_120530_SN1222_0110_AC0VLAACXX_s_2_rg.sorted.bam,8.06,1.95,0.17,58cfa830e4b0c9d6adf6bdab,TCGA-BG-A0MC-10A-01D-A043_120530_SN1222_0110_AC0VLAACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0MC-10A,884FD57D-BD8E-40E7-82F6-0BA1C71101A9,Blood Derived Normal,Illumina HiSeq,653d9980-8bbe-49a2-804c-6684090ddf62,Uterus,74,E9B69826-4669-4C37-BD74-1192C9660A22,41BAB218-A348-4E18-8E9C-6B345DDB22B9,TCGA-BG-A0MC-10A-01D-A043-02,HG19_Broad_variant,TCGA-BG-A0MC,TCGA-UCEC,NA,s4793,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d031,58cfa832e4b0c9d6adf6d031,TCGA-G9-6364-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_8_rg.sorted.filtered.,WGS,TCGA-G9-6364-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_8_rg.sorted,TCGA-G9-6364-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_8_rg.sorted.bam,29.7,1.8,0.14,58cfa832e4b0c9d6adf6d031,TCGA-G9-6364-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6364-10A,F8D8B417-5945-42A5-850A-FBC04B4F0E61,Blood Derived Normal,Illumina HiSeq,fe1be0ad-62e6-4e97-b330-8f32afa551a0,Prostate,72,6D96E479-CB4A-4837-9580-AF1CE22EF0E5,EEA967FC-CB06-4F96-89EC-AAAA0B2C79A2,TCGA-G9-6364-10A-01D-1784-02,HG19_Broad_variant,TCGA-G9-6364,TCGA-PRAD,NA,s4151,Harvard Medical School,Roswell Park,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d3fc,58cfa832e4b0c9d6adf6d3fc,TCGA-V4-A9ES-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_4_rg.sorted.filtered.,WGS,TCGA-V4-A9ES-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_4_rg.sorted,TCGA-V4-A9ES-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_4_rg.sorted.bam,11.87,NA,0.15,58cfa832e4b0c9d6adf6d3fc,TCGA-V4-A9ES-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9ES-10A,C510A423-6AB1-431E-9248-D2AC91FDEDBA,Blood Derived Normal,Illumina HiSeq,cd93524c-a4d1-441b-901b-c88bef32470c,Eye,54,0C868425-BB23-45C7-B665-289585923FAF,4CF18CA6-9715-49C9-8E0C-4F1110064808,TCGA-V4-A9ES-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9ES,TCGA-UVM,NA,s202,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T3b,N0,Not available,Stage IIIA
13722.58cfa831e4b0c9d6adf6c89c,58cfa831e4b0c9d6adf6c89c,TCGA-DJ-A1QD-10A-01D-A14U_120717_SN1120_0175_AC1179ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DJ-A1QD-10A-01D-A14U_120717_SN1120_0175_AC1179ACXX_s_8_rg.sorted,TCGA-DJ-A1QD-10A-01D-A14U_120717_SN1120_0175_AC1179ACXX_s_8_rg.sorted.bam,30.45,1.91,0.18,58cfa831e4b0c9d6adf6c89c,TCGA-DJ-A1QD-10A-01D-A14U_120717_SN1120_0175_AC1179ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QD-10A,DA201150-748E-4B74-BB35-10C995E26079,Blood Derived Normal,Illumina HiSeq,9988a265-d995-48ca-b130-de90744c22b8,Thyroid,20,BE3A9226-DDA7-491F-910B-8BC614635DB5,F2A6B68F-6A10-4D99-AF4D-17309A015112,TCGA-DJ-A1QD-10A-01D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QD,TCGA-THCA,NA,s12238,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa830e4b0c9d6adf6c160,58cfa830e4b0c9d6adf6c160,TCGA-BA-5149-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BA-5149-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_4_rg.sorted,TCGA-BA-5149-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_4_rg.sorted.bam,65.4,1.9,0.15,58cfa830e4b0c9d6adf6c160,TCGA-BA-5149-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5149-10A,CB99FB14-641C-4FB3-BF1D-17EFB8CD982A,Blood Derived Normal,Illumina HiSeq,4b0f007d-eb09-44cc-be19-114f76f43c09,Head and Neck,47,C991BC28-AB65-4D05-931A-676BE035B94C,9668CD24-0B23-4749-8C84-B12203236DA4,TCGA-BA-5149-10A-01D-1509-02,HG19_Broad_variant,TCGA-BA-5149,TCGA-HNSC,NA,s16027,Harvard Medical School,UNC,None,NO,T3,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6ca26,58cfa831e4b0c9d6adf6ca26,TCGA-DJ-A13O-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DJ-A13O-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_8_rg.sorted,TCGA-DJ-A13O-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_8_rg.sorted.bam,34.01,1.9,0.15,58cfa831e4b0c9d6adf6ca26,TCGA-DJ-A13O-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13O-10A,77D5B246-33BA-4A96-9D73-06ACA797653E,Blood Derived Normal,Illumina HiSeq,811c4997-02a6-42c1-9075-e970fb42fbb5,Thyroid,56,A79EC95F-6285-4F6B-A9A1-4957F4F29172,C27C265E-8EB0-4808-A639-6F62C7E7BF4B,TCGA-DJ-A13O-10A-01D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13O,TCGA-THCA,NA,s12638,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6cc8b,58cfa831e4b0c9d6adf6cc8b,TCGA-ER-A19N-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_7_rg.sorted.filtered.,WGS,TCGA-ER-A19N-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_7_rg.sorted,TCGA-ER-A19N-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_7_rg.sorted.bam,45.46,NA,0.16,58cfa831e4b0c9d6adf6cc8b,TCGA-ER-A19N-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19N-10A,9EE83669-D7A4-476E-8857-304600B4917A,Blood Derived Normal,Illumina HiSeq,0b049bb6-7ac6-4ef2-b258-988bafaf88e0,Skin,47,7872967C-2ADD-4157-9CC0-FD87C2F32AEE,708F03DF-83EE-47F7-99F4-AD2E7E0DB63B,TCGA-ER-A19N-10A-01D-A190-02,HG19_Broad_variant,TCGA-ER-A19N,TCGA-SKCM,NA,s7694,Harvard Medical School,University of Pittsburgh,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6c2b4,58cfa830e4b0c9d6adf6c2b4,TCGA-BT-A2LB-11A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BT-A2LB-11A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_8_rg.sorted,TCGA-BT-A2LB-11A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_8_rg.sorted.bam,7.56,NA,0.18,58cfa830e4b0c9d6adf6c2b4,TCGA-BT-A2LB-11A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A2LB-11A,D17A5AB1-3789-4652-AFF5-D8F4F2291F9C,Solid Tissue Normal,Illumina HiSeq,c3d22884-08fb-4b8d-a589-f0ba4184d031,Bladder,73,085DA7A1-E01D-4273-B5F2-7AAB5D4D942A,00BA084F-E60A-41ED-BA1A-E1A07C85478E,TCGA-BT-A2LB-11A-11D-A18D-02,HG19_Broad_variant,TCGA-BT-A2LB,TCGA-BLCA,NA,s2868,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82ee4b0c9d6adf6ae64,58cfa82ee4b0c9d6adf6ae64,TCGA-05-4396-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-05-4396-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_1_rg.sorted,TCGA-05-4396-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_1_rg.sorted.bam,301.7,1.9,0.16,58cfa82ee4b0c9d6adf6ae64,TCGA-05-4396-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_1_rg.sorted.bam,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4396-01A,9F81C602-8AFA-4588-B0B6-6E5A1A128D5A,Primary Tumor,Illumina HiSeq,61bb72a1-5c87-411d-af04-3e058c2beab2,Lung,76,4D85772B-287E-4790-B1E8-CD1C0E88AD48,1F0C98A3-3EED-45E0-BF81-78632C02D375,TCGA-05-4396-01A-21D-1853-02,HG19_Broad_variant,TCGA-05-4396,TCGA-LUAD,303,s10640,Harvard Medical School,Indivumed,Germany,NO,T4,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIIB
13722.58cfa830e4b0c9d6adf6be06,58cfa830e4b0c9d6adf6be06,TCGA-BG-A0MQ-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BG-A0MQ-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_6_rg.sorted,TCGA-BG-A0MQ-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_6_rg.sorted.bam,87.16,2,0.14,58cfa830e4b0c9d6adf6be06,TCGA-BG-A0MQ-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0MQ-01A,12D36A1D-9922-4311-BBDA-71F32AC2C03B,Primary Tumor,Illumina HiSeq,d1e9cdb8-f8a6-43da-9afb-28a6e6d72b6a,Uterus,71,3D1FA321-D2E8-4460-AE87-356AB1CA6281,08F01B17-0386-4C7E-B926-1736CEC043D2,TCGA-BG-A0MQ-01A-11D-A101-02,HG19_Broad_variant,TCGA-BG-A0MQ,TCGA-UCEC,NA,s4253,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b926,58cfa82fe4b0c9d6adf6b926,TCGA-49-6742-11A-01D-1853_111218_SN208_0258_C054RACXX_s_2_rg.sorted.filtered.,WGS,TCGA-49-6742-11A-01D-1853_111218_SN208_0258_C054RACXX_s_2_rg.sorted,TCGA-49-6742-11A-01D-1853_111218_SN208_0258_C054RACXX_s_2_rg.sorted.bam,62.7,1.9,0.13,58cfa82fe4b0c9d6adf6b926,TCGA-49-6742-11A-01D-1853_111218_SN208_0258_C054RACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-6742-11A,21FB46F9-4BBB-441C-AF19-A687E9138344,Solid Tissue Normal,Illumina HiSeq,b6826f9b-2630-48c0-a9e5-6046874af7d5,Lung,70,D9548FE4-5631-473A-82CD-1B089B638963,C87686FB-5CF8-4843-AD58-9DABFAA871AD,TCGA-49-6742-11A-01D-1853-02,HG19_Broad_variant,TCGA-49-6742,TCGA-LUAD,NA,s10782,Harvard Medical School,Johns Hopkins,United States,NO,T2a,N1,Mucinous (Colloid) Carcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6c661,58cfa831e4b0c9d6adf6c661,TCGA-CG-4443-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_3_rg.sorted.filtered.,WGS,TCGA-CG-4443-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_3_rg.sorted,TCGA-CG-4443-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_3_rg.sorted.bam,261.2,1.9,0.15,58cfa831e4b0c9d6adf6c661,TCGA-CG-4443-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_3_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4443-01A,8CB0144B-BE6B-40A1-86A2-708F96D9B615,Primary Tumor,Illumina HiSeq,d15f98aa-3849-4230-aea5-46a959ece810,Stomach,68,F4FB736A-42C9-4367-A327-D0D1C4CBA359,0FCF9057-D05B-480B-A17F-5FE35BFEB0CA,TCGA-CG-4443-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4443,TCGA-STAD,NA,s15245,Harvard Medical School,Indivumed,Germany,NO,T1,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6c40c,58cfa831e4b0c9d6adf6c40c,TCGA-C5-A3HD-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_5_rg.sorted.filtered.,WGS,TCGA-C5-A3HD-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_5_rg.sorted,TCGA-C5-A3HD-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_5_rg.sorted.bam,10.42,NA,0.14,58cfa831e4b0c9d6adf6c40c,TCGA-C5-A3HD-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A3HD-10A,12427B02-6E3F-461C-B271-6AB230F628E7,Blood Derived Normal,Illumina HiSeq,a955b684-6a8f-4334-8362-a5d192f147be,Cervix,51,BA733B4B-CB5F-4AB7-BAA9-3A30605E5EF9,777AD9F3-653C-451B-8422-3A8A4E02D3DA,TCGA-C5-A3HD-10A-01D-A20X-26,HG19_Broad_variant,TCGA-C5-A3HD,TCGA-CESC,NA,s1174,MD Anderson - Institute for Applied Cancer Science,Medical College of Wisconsin,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6bd90,58cfa830e4b0c9d6adf6bd90,TCGA-BF-A1PZ-10A-01D-A18Z_120612_SN590_0162_BC0VNGACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BF-A1PZ-10A-01D-A18Z_120612_SN590_0162_BC0VNGACXX_s_6_rg.sorted,TCGA-BF-A1PZ-10A-01D-A18Z_120612_SN590_0162_BC0VNGACXX_s_6_rg.sorted.bam,38.45,NA,0.17,58cfa830e4b0c9d6adf6bd90,TCGA-BF-A1PZ-10A-01D-A18Z_120612_SN590_0162_BC0VNGACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-BF-A1PZ-10A,455F982C-A067-46AC-BF89-3E535D0FFCA0,Blood Derived Normal,Illumina HiSeq,a56b528f-a7b0-4561-bfbd-279eb0517d9a,Skin,71,E4831A1B-FCF4-4249-AF6F-B851A021A4DE,D10573D8-10B1-4B7B-B4DE-E3946C95E9B0,TCGA-BF-A1PZ-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-BF-A1PZ,TCGA-SKCM,NA,s7827,Harvard Medical School,Cureline,Russia,NO,T4a,N0,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6d258,58cfa832e4b0c9d6adf6d258,TCGA-K4-A3WV-11A-21D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_8_rg.sorted.filtered.,WGS,TCGA-K4-A3WV-11A-21D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_8_rg.sorted,TCGA-K4-A3WV-11A-21D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_8_rg.sorted.bam,14.71,NA,0.15,58cfa832e4b0c9d6adf6d258,TCGA-K4-A3WV-11A-21D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-K4-A3WV-11A,D53EADE8-A845-4252-AECE-92F3573486A7,Solid Tissue Normal,Illumina HiSeq,3dc4b7a1-75cf-4f52-b921-7d6dcb7d1046,Bladder,77,C8B4ED6D-69C0-4052-BEC2-9FE6A3CFC481,30325C24-68C0-40DD-987B-DF84C4B5FBEA,TCGA-K4-A3WV-11A-21D-A23Q-26,HG19_Broad_variant,TCGA-K4-A3WV,TCGA-BLCA,NA,s2938,MD Anderson - Institute for Applied Cancer Science,ABS - Lahey Clinic,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa832e4b0c9d6adf6d422,58cfa832e4b0c9d6adf6d422,TCGA-VD-AA8M-10A-01D-A40E_140807_SN1440_0194_AC5B5RACXX_s_2_rg.sorted.filtered.,WGS,TCGA-VD-AA8M-10A-01D-A40E_140807_SN1440_0194_AC5B5RACXX_s_2_rg.sorted,TCGA-VD-AA8M-10A-01D-A40E_140807_SN1440_0194_AC5B5RACXX_s_2_rg.sorted.bam,9.04,NA,0.15,58cfa832e4b0c9d6adf6d422,TCGA-VD-AA8M-10A-01D-A40E_140807_SN1440_0194_AC5B5RACXX_s_2_rg.sorted.bam,Alive,MALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-AA8M-10A,9DC5CC23-C903-4FE2-8354-64F8316FF0D4,Blood Derived Normal,Illumina HiSeq,351608b2-545c-499d-994e-ef14265e37e9,Eye,64,09175EE2-1543-4A0D-94CB-3FE6F48F74CF,4728EFB8-39E2-49C2-A060-66EDB562A396,TCGA-VD-AA8M-10A-01D-A40E-26,HG19_Broad_variant,TCGA-VD-AA8M,TCGA-UVM,NA,s268,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T2a,N0,Not available,Stage IIA
13722.58cfa830e4b0c9d6adf6bef6,58cfa830e4b0c9d6adf6bef6,TCGA-BJ-A28Z-10A-01D-A16N_120718_SN590_0169_AC0WL7ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BJ-A28Z-10A-01D-A16N_120718_SN590_0169_AC0WL7ACXX_s_4_rg.sorted,TCGA-BJ-A28Z-10A-01D-A16N_120718_SN590_0169_AC0WL7ACXX_s_4_rg.sorted.bam,68.68,1.83,0.15,58cfa830e4b0c9d6adf6bef6,TCGA-BJ-A28Z-10A-01D-A16N_120718_SN590_0169_AC0WL7ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A28Z-10A,6BA76174-620E-4851-857A-D0ADBFD6F3E6,Blood Derived Normal,Illumina HiSeq,55bc34ed-0652-4e21-bc91-8a8301ae8813,Thyroid,46,D186595F-2F60-4DA1-9E19-EF9866667CBC,525DE278-22C8-4601-A667-19DF54F0ADAD,TCGA-BJ-A28Z-10A-01D-A16N-02,HG19_Broad_variant,TCGA-BJ-A28Z,TCGA-THCA,NA,s12103,Harvard Medical School,University of Pittsburgh,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa82ee4b0c9d6adf6b0a5,58cfa82ee4b0c9d6adf6b0a5,TCGA-05-4249-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_1_rg.sorted.filtered.,WGS,TCGA-05-4249-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_1_rg.sorted,TCGA-05-4249-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_1_rg.sorted.bam,64.93,1.9,0.15,58cfa82ee4b0c9d6adf6b0a5,TCGA-05-4249-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_1_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4249-01A,4ADDF05F-3668-4B3F-A17F-C0227329CA52,Primary Tumor,Illumina HiSeq,94e6a5cd-7ba5-4f3e-bf83-7d07522963b4,Lung,67,80F196FE-1EAF-40CB-AB58-C84795ACC5C7,E3F50937-D6CF-423B-9DD3-31D715892FC7,TCGA-05-4249-01A-01D-1103-02,HG19_Broad_variant,TCGA-05-4249,TCGA-LUAD,NA,s10642,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa832e4b0c9d6adf6ce42,58cfa832e4b0c9d6adf6ce42,TCGA-ET-A25J-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-ET-A25J-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_1_rg.sorted,TCGA-ET-A25J-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_1_rg.sorted.bam,57.24,2,0.17,58cfa832e4b0c9d6adf6ce42,TCGA-ET-A25J-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-ET-A25K-01A,2F9ED09D-2626-4C23-BA47-1850D36F812A,Primary Tumor,Illumina HiSeq,970a6dab-c1e4-4446-968a-4b37d1506eeb,Thyroid,36,343311B1-D586-4F92-9984-32AF1AFB1F62,663173D3-A9EE-4E73-8444-52F01727BE6D,TCGA-ET-A25K-01A-11D-A16N-02,HG19_Broad_variant,TCGA-ET-A25K,TCGA-THCA,NA,s12757,Harvard Medical School,Johns Hopkins,United States,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6d184,58cfa832e4b0c9d6adf6d184,TCGA-HC-7212-10A-01D-2111_130517_SN590_0230_AD24B4ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-HC-7212-10A-01D-2111_130517_SN590_0230_AD24B4ACXX_s_5_rg.sorted,TCGA-HC-7212-10A-01D-2111_130517_SN590_0230_AD24B4ACXX_s_5_rg.sorted.bam,305.6,NA,0.14,58cfa832e4b0c9d6adf6d184,TCGA-HC-7212-10A-01D-2111_130517_SN590_0230_AD24B4ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7212-10A,907B64D6-A26A-4092-A247-AC9AF444D1C7,Blood Derived Normal,Illumina HiSeq,e9912ef2-dbc1-4b69-8688-122162432c0a,Prostate,56,76008F3A-E2BF-47EF-A3C9-9C6EF4961CFA,79707D3F-B93A-48B5-9ECE-C70DE74A833F,TCGA-HC-7212-10A-01D-2111-02,HG19_Broad_variant,TCGA-HC-7212,TCGA-PRAD,NA,s3808,Harvard Medical School,International Genomics Consortium,United States,NO,T2a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d63e,58cfa832e4b0c9d6adf6d63e,TCGA-LN-A49R-10A-01D-A248_121211_SN208_0443_BC1H55ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-LN-A49R-10A-01D-A248_121211_SN208_0443_BC1H55ACXX_s_4_rg.sorted,TCGA-LN-A49R-10A-01D-A248_121211_SN208_0443_BC1H55ACXX_s_4_rg.sorted.bam,114.36,NA,0.16,58cfa832e4b0c9d6adf6d63e,TCGA-LN-A49R-10A-01D-A248_121211_SN208_0443_BC1H55ACXX_s_4_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49R-10A,4C9FB311-0860-4A04-A2F6-79558AC1D98F,Blood Derived Normal,Illumina HiSeq,4273ccc9-68d2-4dd9-814b-49f562ea9c82,Esophagus,46,A48D6F44-6174-4B60-9F8C-D25F27AEEE2B,27251848-E20F-43DF-8D0B-9BA976BF924D,TCGA-LN-A49R-10A-01D-A248-26,HG19_Broad_variant,TCGA-LN-A49R,TCGA-ESCA,NA,s1769,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N1,Not available,Stage III
13722.58cfa830e4b0c9d6adf6be6e,58cfa830e4b0c9d6adf6be6e,TCGA-BJ-A190-01A-11D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BJ-A190-01A-11D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_6_rg.sorted,TCGA-BJ-A190-01A-11D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_6_rg.sorted.bam,53.09,1.95,0.16,58cfa830e4b0c9d6adf6be6e,TCGA-BJ-A190-01A-11D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A190-01A,04FFF86A-B6F5-4900-9E37-C1F0B881B160,Primary Tumor,Illumina HiSeq,a9f1f6de-8f02-48c6-a9e2-6cef21cd8438,Thyroid,55,2EB89D79-861E-41C2-BDD5-6F16D2A84B25,42FE4D84-B54D-42B8-81F8-92191723D057,TCGA-BJ-A190-01A-11D-A13U-02,HG19_Broad_variant,TCGA-BJ-A190,TCGA-THCA,NA,s12234,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage II
13722.58cfa831e4b0c9d6adf6c7eb,58cfa831e4b0c9d6adf6c7eb,TCGA-D1-A17Q-10A-01D-A12F_120418_SN1222_0097_AC0M28ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-D1-A17Q-10A-01D-A12F_120418_SN1222_0097_AC0M28ACXX_s_8_rg.sorted,TCGA-D1-A17Q-10A-01D-A12F_120418_SN1222_0097_AC0M28ACXX_s_8_rg.sorted.bam,26.66,1.96,0.17,58cfa831e4b0c9d6adf6c7eb,TCGA-D1-A17Q-10A-01D-A12F_120418_SN1222_0097_AC0M28ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A17Q-10A,CA8DBBFD-8928-4E25-94C6-B875DE631BBD,Blood Derived Normal,Illumina HiSeq,8534d080-820f-47f9-bb58-a7bad05321ef,Uterus,54,884E1EE9-8CFD-46C6-8414-8316F41C986E,206EE62B-D698-44F5-A177-7950EAA0D849,TCGA-D1-A17Q-10A-01D-A12F-02,HG19_Broad_variant,TCGA-D1-A17Q,TCGA-UCEC,NA,s4446,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c71c,58cfa831e4b0c9d6adf6c71c,TCGA-CV-7414-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CV-7414-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_7_rg.sorted,TCGA-CV-7414-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_7_rg.sorted.bam,4.33,NA,0.15,58cfa831e4b0c9d6adf6c71c,TCGA-CV-7414-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7414-10A,C3B2C38D-81A3-42FD-A41E-6F6DE3934007,Blood Derived Normal,Illumina HiSeq,2f7acc14-13c2-4d7a-8ba8-6f6e9d6e12b6,Head and Neck,78,328F4499-00A9-410A-A458-F18BA8CE3AC8,3D6C1E58-7D9C-436C-8CF8-BD98C9821255,TCGA-CV-7414-10A-01D-2317-26,HG19_Broad_variant,TCGA-CV-7414,TCGA-HNSC,14,s15910,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6d01a,58cfa832e4b0c9d6adf6d01a,TCGA-G9-6353-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_4_rg.sorted.filtered.,WGS,TCGA-G9-6353-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_4_rg.sorted,TCGA-G9-6353-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_4_rg.sorted.bam,144.7,1.9,0.15,58cfa832e4b0c9d6adf6d01a,TCGA-G9-6353-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6353-01A,BCC94953-CE79-428E-99C1-632E42C1B9BC,Primary Tumor,Illumina HiSeq,86ec03a4-f08e-474e-b887-c5e06822b414,Prostate,58,4CBA0BA5-58C3-455C-9CD5-7D9428D27F8C,758712E3-95F1-4BB5-A83A-D01C4844122D,TCGA-G9-6353-01A-11D-1957-02,HG19_Broad_variant,TCGA-G9-6353,TCGA-PRAD,NA,s3970,Harvard Medical School,Roswell Park,United States,NO,T3a,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c75a,58cfa831e4b0c9d6adf6c75a,TCGA-D6-6515-01A-21D-1868_120530_SN1222_0110_AC0VLAACXX_s_7_rg.sorted.filtered.,WGS,TCGA-D6-6515-01A-21D-1868_120530_SN1222_0110_AC0VLAACXX_s_7_rg.sorted,TCGA-D6-6515-01A-21D-1868_120530_SN1222_0110_AC0VLAACXX_s_7_rg.sorted.bam,127.7,1.9,0.15,58cfa831e4b0c9d6adf6c75a,TCGA-D6-6515-01A-21D-1868_120530_SN1222_0110_AC0VLAACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-D6-6515-01A,8E0E456E-85EE-4DE5-8F0B-72393D6ACDE0,Primary Tumor,Illumina HiSeq,5a79073a-b6a0-41df-b26b-247649784d4d,Head and Neck,82,4453D224-F846-4CEE-972F-8438C964913B,D6E287D9-D7C4-496C-829F-F7D7980D77A2,TCGA-D6-6515-01A-21D-1868-02,HG19_Broad_variant,TCGA-D6-6515,TCGA-HNSC,403,s15914,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa830e4b0c9d6adf6bfb2,58cfa830e4b0c9d6adf6bfb2,TCGA-BR-6455-10A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BR-6455-10A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_1_rg.sorted,TCGA-BR-6455-10A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_1_rg.sorted.bam,105.7,1.9,0.14,58cfa830e4b0c9d6adf6bfb2,TCGA-BR-6455-10A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6455-10A,75A29059-4705-4A55-BC3D-F5923B24B358,Blood Derived Normal,Illumina HiSeq,63bba89b-b557-47c5-9c7e-894a64d517e2,Stomach,59,322DD934-877A-4185-9ADF-B537C79CE640,A4E758A7-5BBF-46AF-A02C-CF9BEF16185B,TCGA-BR-6455-10A-01D-1798-02,HG19_Broad_variant,TCGA-BR-6455,TCGA-STAD,NA,s14610,Harvard Medical School,Asterand,Russia,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB
13722.58cfa830e4b0c9d6adf6c263,58cfa830e4b0c9d6adf6c263,TCGA-BH-A0HX-10A-02D-A060_130807_SN590_0236_BC291KACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BH-A0HX-10A-02D-A060_130807_SN590_0236_BC291KACXX_s_8_rg.sorted,TCGA-BH-A0HX-10A-02D-A060_130807_SN590_0236_BC291KACXX_s_8_rg.sorted.bam,7.54,2.03,0.13,58cfa830e4b0c9d6adf6c263,TCGA-BH-A0HX-10A-02D-A060_130807_SN590_0236_BC291KACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0HX-10A,3B01D064-8C00-4972-9F07-407EAC8E7534,Blood Derived Normal,Illumina HiSeq,f43d0ad4-4ad4-4388-833e-94faf1db1598,Breast,54,B17B1EEF-04FD-4D51-B4AE-6E071AFBED16,39C48C76-B9AC-4485-A7C3-4729A56F830C,TCGA-BH-A0HX-10A-02D-A060-02,HG19_Broad_variant,TCGA-BH-A0HX,TCGA-BRCA,NA,s6466,Harvard Medical School,University of Pittsburgh,None,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa832e4b0c9d6adf6d25a,58cfa832e4b0c9d6adf6d25a,TCGA-IQ-7632-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_2_rg.sorted.filtered.,WGS,TCGA-IQ-7632-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_2_rg.sorted,TCGA-IQ-7632-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_2_rg.sorted.bam,9.33,NA,0.14,58cfa832e4b0c9d6adf6d25a,TCGA-IQ-7632-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-IQ-7632-01A,601A4146-8093-4F20-9A0A-A97916C9E7F6,Primary Tumor,Illumina HiSeq,9f8feb9c-6c20-4997-afcf-24177e9a7829,Head and Neck,68,CD989471-A9CF-4FAD-A321-C01764BB85D7,614C0F1F-C677-44ED-B3E1-0FA9DE03F591,TCGA-IQ-7632-01A-11D-2317-26,HG19_Broad_variant,TCGA-IQ-7632,TCGA-HNSC,NA,s16062,MD Anderson - RPPA Core Facility (Proteomics),University of Miami,United States,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c718,58cfa831e4b0c9d6adf6c718,TCGA-D7-6528-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-D7-6528-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_5_rg.sorted,TCGA-D7-6528-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_5_rg.sorted.bam,303.4,1.9,0.15,58cfa831e4b0c9d6adf6c718,TCGA-D7-6528-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6528-01A,35496E4E-598F-4FFC-B11E-8EDAEB676079,Primary Tumor,Illumina HiSeq,478ea84f-df8f-4d1b-a7da-ab1ac7751e97,Stomach,70,DF817250-9A2C-42E8-AD90-0D9E13FE37B3,7DA37A25-E2DE-4193-AD71-2182B6DA5C26,TCGA-D7-6528-01A-11D-1798-02,HG19_Broad_variant,TCGA-D7-6528,TCGA-STAD,NA,s14562,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N0,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IB
13722.58cfa831e4b0c9d6adf6cd0c,58cfa831e4b0c9d6adf6cd0c,TCGA-ET-A25L-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_2_rg.sorted.filtered.,WGS,TCGA-ET-A25L-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_2_rg.sorted,TCGA-ET-A25L-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_2_rg.sorted.bam,22.88,2.2,0.18,58cfa831e4b0c9d6adf6cd0c,TCGA-ET-A25L-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-ET-A25L-10A,4481D84D-109E-44A0-BCB4-E6E61BDCE796,Blood Derived Normal,Illumina HiSeq,887ff57f-346c-4a44-a195-c4c113c48c23,Thyroid,52,517CF62F-A089-4BBE-B398-1913DEE1514F,14D6E945-1A5F-4EA7-B418-B8463BAAD0CF,TCGA-ET-A25L-10A-01D-A16N-02,HG19_Broad_variant,TCGA-ET-A25L,TCGA-THCA,NA,s12645,Harvard Medical School,Johns Hopkins,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage IVA
13722.58cfa831e4b0c9d6adf6cd16,58cfa831e4b0c9d6adf6cd16,TCGA-FD-A3SL-01A-21D-A233_120830_SN208_0423_AC190AACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FD-A3SL-01A-21D-A233_120830_SN208_0423_AC190AACXX_s_3_rg.sorted,TCGA-FD-A3SL-01A-21D-A233_120830_SN208_0423_AC190AACXX_s_3_rg.sorted.bam,18.6,NA,0.16,58cfa831e4b0c9d6adf6cd16,TCGA-FD-A3SL-01A-21D-A233_120830_SN208_0423_AC190AACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3SL-01A,4570B6E2-D430-41CA-AAB1-CE4D14C36463,Primary Tumor,Illumina HiSeq,764ae567-a7b6-4d13-bef1-8cc55afb4524,Bladder,60,0A1E88E0-3593-40BA-86E5-751074885578,2BF89FED-C215-4893-BA35-2FE0C7DD5DD0,TCGA-FD-A3SL-01A-21D-A233-26,HG19_Broad_variant,TCGA-FD-A3SL,TCGA-BLCA,NA,s2720,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T4a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6ca18,58cfa831e4b0c9d6adf6ca18,TCGA-DJ-A1QE-10A-01D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DJ-A1QE-10A-01D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_4_rg.sorted,TCGA-DJ-A1QE-10A-01D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_4_rg.sorted.bam,36.43,1.96,0.18,58cfa831e4b0c9d6adf6ca18,TCGA-DJ-A1QE-10A-01D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QE-10A,DCCBA97D-4E81-42FB-93B3-90BE68A034FB,Blood Derived Normal,Illumina HiSeq,fca4c4c6-e34c-4af8-a27e-debac8a5f0e3,Thyroid,62,144A8435-0F16-44A6-9651-71FB483AE5B7,6E01EA1F-B400-4FAC-A143-2DE218C224D9,TCGA-DJ-A1QE-10A-01D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QE,TCGA-THCA,NA,s12366,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa831e4b0c9d6adf6c72c,58cfa831e4b0c9d6adf6c72c,TCGA-CV-7434-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CV-7434-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_8_rg.sorted,TCGA-CV-7434-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_8_rg.sorted.bam,28.03,NA,0.14,58cfa831e4b0c9d6adf6c72c,TCGA-CV-7434-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7434-10A,63B50E1C-7948-464F-BFF1-8E0E5DAAFCC5,Blood Derived Normal,Illumina HiSeq,61309435-9e3d-4fc8-989e-63773d630677,Head and Neck,64,B59039EF-7711-40AE-B87F-D8B566365F1F,615AE823-25D8-4409-91DD-78E14339312B,TCGA-CV-7434-10A-01D-2317-26,HG19_Broad_variant,TCGA-CV-7434,TCGA-HNSC,218,s16054,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T4a,N1,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6bf2a,58cfa830e4b0c9d6adf6bf2a,TCGA-AP-A0LD-10A-01D-A043_120330_SN1120_0128_AC0L52ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-AP-A0LD-10A-01D-A043_120330_SN1120_0128_AC0L52ACXX_s_3_rg.sorted,TCGA-AP-A0LD-10A-01D-A043_120330_SN1120_0128_AC0L52ACXX_s_3_rg.sorted.bam,32.44,1.88,0.16,58cfa830e4b0c9d6adf6bf2a,TCGA-AP-A0LD-10A-01D-A043_120330_SN1120_0128_AC0L52ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LD-10A,1200C8B7-A058-4C01-BBE2-04EC09A65245,Blood Derived Normal,Illumina HiSeq,4fd3b516-8908-4161-8c02-d293169c11c0,Uterus,63,9D49BB1E-896D-4545-8CAC-E85405093B83,28DE6452-C37F-4B68-AFE5-2FA37E42198C,TCGA-AP-A0LD-10A-01D-A043-02,HG19_Broad_variant,TCGA-AP-A0LD,TCGA-UCEC,NA,s4782,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6ceba,58cfa832e4b0c9d6adf6ceba,TCGA-FD-A3B4-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FD-A3B4-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_3_rg.sorted,TCGA-FD-A3B4-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_3_rg.sorted.bam,41.92,NA,0.16,58cfa832e4b0c9d6adf6ceba,TCGA-FD-A3B4-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_3_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3B4-01A,899F8D52-4C3A-4371-90EB-1F106001EDDC,Primary Tumor,Illumina HiSeq,54b70ff2-6c53-438c-934a-97fe2837620e,Bladder,55,6895A68F-0EFD-4B0E-8CF2-9195833DBBA1,7E975842-6EB5-4D66-A2F1-7EA7E8E989FC,TCGA-FD-A3B4-01A-12D-A204-02,HG19_Broad_variant,TCGA-FD-A3B4,TCGA-BLCA,NA,s3111,Harvard Medical School,BLN - University Of Chicago,United States,NO,T4a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c7a7,58cfa831e4b0c9d6adf6c7a7,TCGA-D1-A17C-10A-01D-A12F_120418_SN1222_0097_AC0M28ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-D1-A17C-10A-01D-A12F_120418_SN1222_0097_AC0M28ACXX_s_7_rg.sorted,TCGA-D1-A17C-10A-01D-A12F_120418_SN1222_0097_AC0M28ACXX_s_7_rg.sorted.bam,25.1,1.94,0.18,58cfa831e4b0c9d6adf6c7a7,TCGA-D1-A17C-10A-01D-A12F_120418_SN1222_0097_AC0M28ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A17C-10A,6F4F0CDD-8387-45D0-A9E8-EFCE6260159D,Blood Derived Normal,Illumina HiSeq,365415a3-ae32-4590-8f15-d95fc3622cb1,Uterus,78,1227DA0C-73A9-47A9-8BC2-C93D363B5AAD,B16483E2-968A-4BD5-B8AC-9B132DE1D050,TCGA-D1-A17C-10A-01D-A12F-02,HG19_Broad_variant,TCGA-D1-A17C,TCGA-UCEC,NA,s4444,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6be04,58cfa830e4b0c9d6adf6be04,TCGA-BG-A0M9-01A-21D-A101_120330_SN1120_0129_BD0UCLACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BG-A0M9-01A-21D-A101_120330_SN1120_0129_BD0UCLACXX_s_4_rg.sorted,TCGA-BG-A0M9-01A-21D-A101_120330_SN1120_0129_BD0UCLACXX_s_4_rg.sorted.bam,133.79,2,0.17,58cfa830e4b0c9d6adf6be04,TCGA-BG-A0M9-01A-21D-A101_120330_SN1120_0129_BD0UCLACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0M9-01A,4FD1CB59-6C50-4355-9D37-A341E1F4FAD9,Primary Tumor,Illumina HiSeq,633f3cff-14c3-45f7-b568-caa86760d863,Uterus,73,DC487BBF-555B-423B-B7C0-3E92DEFA5A79,3D712314-6FDC-41C7-9CE1-5F9BB85929EE,TCGA-BG-A0M9-01A-21D-A101-02,HG19_Broad_variant,TCGA-BG-A0M9,TCGA-UCEC,NA,s4603,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6ba42,58cfa82fe4b0c9d6adf6ba42,TCGA-AA-A01R-01A-21D-A079-02_110402_SN208_0200_BB02BTABXX_s_3.rg.sorted.filtered.,WGS,TCGA-AA-A01R-01A-21D-A079-02_110402_SN208_0200_BB02BTABXX_s_3.rg.sorted,TCGA-AA-A01R-01A-21D-A079-02_110402_SN208_0200_BB02BTABXX_s_3.rg.sorted.bam,75.21,1.8,0.14,58cfa82fe4b0c9d6adf6ba42,TCGA-AA-A01R-01A-21D-A079-02_110402_SN208_0200_BB02BTABXX_s_3.rg.sorted.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01R-01A,97F6C8D3-09A0-4128-8F10-41E736648A5F,Primary Tumor,Illumina HiSeq,dc5cfaa9-514c-4e4d-b882-21df489668aa,Colorectal,47,73EE34E8-422D-4AB1-B0F0-DA8A5A2DD9AB,F8021A03-B35B-4E6C-B196-2948789AFCF3,TCGA-AA-A01R-01A-21D-A079-02,HG18_Broad_variant,TCGA-AA-A01R,TCGA-COAD,NA,s12876,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage III
13722.58cfa82fe4b0c9d6adf6b88f,58cfa82fe4b0c9d6adf6b88f,TCGA-73-4676-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_7_rg.sorted.filtered.,WGS,TCGA-73-4676-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_7_rg.sorted,TCGA-73-4676-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_7_rg.sorted.bam,216,1.9,0.15,58cfa82fe4b0c9d6adf6b88f,TCGA-73-4676-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4676-01A,195A5AFB-B79F-44D2-9D12-884487630C2B,Primary Tumor,Illumina HiSeq,a2b68d59-a4d4-4793-9e6c-72ccaf7c242b,Lung,45,22434A49-EB8A-43AC-8C08-AE6DCBE6FBB8,A79111BF-CB9D-4790-AE9F-6CB13C9334E2,TCGA-73-4676-01A-01D-1751-02,HG19_Broad_variant,TCGA-73-4676,TCGA-LUAD,NA,s11465,Harvard Medical School,Roswell Park,United States,NO,T2a,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa831e4b0c9d6adf6c749,58cfa831e4b0c9d6adf6c749,TCGA-CV-7407-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CV-7407-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_2_rg.sorted,TCGA-CV-7407-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_2_rg.sorted.bam,8.33,NA,0.14,58cfa831e4b0c9d6adf6c749,TCGA-CV-7407-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7407-10A,8B63BE59-9CE6-45A0-80D9-4D20F4918CB9,Blood Derived Normal,Illumina HiSeq,324e0ca4-45b2-4348-bcc6-969674ada4bc,Head and Neck,67,2B996D86-64A5-4721-85F2-C75DBBAD5B81,7C8D7D6B-52A3-4766-AE2E-B70E938E0F6B,TCGA-CV-7407-10A-01D-2317-26,HG19_Broad_variant,TCGA-CV-7407,TCGA-HNSC,1081,s16055,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c3ce,58cfa831e4b0c9d6adf6c3ce,TCGA-CG-5722-11A-02D-1598_121011_SN208_0434_AC18MYACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CG-5722-11A-02D-1598_121011_SN208_0434_AC18MYACXX_s_5_rg.sorted,TCGA-CG-5722-11A-02D-1598_121011_SN208_0434_AC18MYACXX_s_5_rg.sorted.bam,56,1.9,0.15,58cfa831e4b0c9d6adf6c3ce,TCGA-CG-5722-11A-02D-1598_121011_SN208_0434_AC18MYACXX_s_5_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5722-11A,F35E8FEF-F61D-4614-B73F-F7E1D0F21F52,Solid Tissue Normal,Illumina HiSeq,53d1fe8c-b529-4f7f-a9d7-672085ce2fab,Stomach,67,756AEB10-195E-409D-A8AC-8B3A048FC51A,8B4B06BF-79BA-47C9-BCFD-A5E54BEF972E,TCGA-CG-5722-11A-02D-1598-02,HG19_Broad_variant,TCGA-CG-5722,TCGA-STAD,NA,s15462,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa831e4b0c9d6adf6c9a0,58cfa831e4b0c9d6adf6c9a0,TCGA-DO-A1K0-01A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DO-A1K0-01A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_3_rg.sorted,TCGA-DO-A1K0-01A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_3_rg.sorted.bam,80.19,1.78,0.16,58cfa831e4b0c9d6adf6c9a0,TCGA-DO-A1K0-01A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DO-A1K0-01A,B7A01148-5BAB-4268-986A-A9CF7BCA967F,Primary Tumor,Illumina HiSeq,52d6a725-e64a-4e5b-88cb-c4845dc97057,Thyroid,30,C25AED9B-A1B7-48A9-8587-8D218F6A9562,7BC99883-45C3-4ADF-8761-40B4836552F2,TCGA-DO-A1K0-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DO-A1K0,TCGA-THCA,NA,s12245,Harvard Medical School,Medical College of Georgia,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82fe4b0c9d6adf6b916,58cfa82fe4b0c9d6adf6b916,TCGA-A5-A0GE-10A-01D-A043_120214_SN590_0139_BC0DYEACXX_s_2_rg.sorted.filtered.,WGS,TCGA-A5-A0GE-10A-01D-A043_120214_SN590_0139_BC0DYEACXX_s_2_rg.sorted,TCGA-A5-A0GE-10A-01D-A043_120214_SN590_0139_BC0DYEACXX_s_2_rg.sorted.bam,7.16,1.93,0.15,58cfa82fe4b0c9d6adf6b916,TCGA-A5-A0GE-10A-01D-A043_120214_SN590_0139_BC0DYEACXX_s_2_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GE-10A,A587E62E-430E-4F1B-82B7-6FBE856FDAF1,Blood Derived Normal,Illumina HiSeq,e1f06289-6848-4ad1-835f-3f14509605cb,Uterus,38,FC6580A8-FFE8-4F16-A19D-DB65F2789369,C6F8AA30-A713-414E-9D09-B75367426478,TCGA-A5-A0GE-10A-01D-A043-02,HG19_Broad_variant,TCGA-A5-A0GE,TCGA-UCEC,NA,s4993,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6c308,58cfa830e4b0c9d6adf6c308,TCGA-BR-6458-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BR-6458-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_6_rg.sorted,TCGA-BR-6458-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_6_rg.sorted.bam,250.7,1.9,0.16,58cfa830e4b0c9d6adf6c308,TCGA-BR-6458-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6458-10A,E516880B-C4E5-43CD-A358-BE0DB88564D7,Blood Derived Normal,Illumina HiSeq,0fb3d589-66c9-49b8-9263-a04b09abcdd4,Stomach,57,ECBEC910-E4E1-4899-9547-0F649528E162,B787599F-7B73-4249-A813-19B87FFA98A2,TCGA-BR-6458-10A-01D-1798-02,HG19_Broad_variant,TCGA-BR-6458,TCGA-STAD,NA,s15380,Harvard Medical School,Asterand,Ukraine,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB
13722.58cfa831e4b0c9d6adf6c946,58cfa831e4b0c9d6adf6c946,TCGA-CV-7432-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CV-7432-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_2_rg.sorted,TCGA-CV-7432-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_2_rg.sorted.bam,95.03,NA,0.14,58cfa831e4b0c9d6adf6c946,TCGA-CV-7432-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7432-10A,EAF674DD-9909-4879-B9A3-74253169EDDD,Blood Derived Normal,Illumina HiSeq,7698153d-ef10-4787-a1d6-4b0022b02236,Head and Neck,79,53470D1A-5DF1-40C4-9758-DDB52A50099F,F1189AE7-3633-4FCD-8659-FA9E8BCCA663,TCGA-CV-7432-10A-01D-2317-26,HG19_Broad_variant,TCGA-CV-7432,TCGA-HNSC,2570,s15527,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa830e4b0c9d6adf6bb3e,58cfa830e4b0c9d6adf6bb3e,TCGA-AA-A01S-01A-21D-A079_110402_SN208_0200_BB02BTABXX_s_6_rg.sorted.filtered.,WGS,TCGA-AA-A01S-01A-21D-A079_110402_SN208_0200_BB02BTABXX_s_6_rg.sorted,TCGA-AA-A01S-01A-21D-A079_110402_SN208_0200_BB02BTABXX_s_6_rg.sorted.bam,89.57,1.8,0.13,58cfa830e4b0c9d6adf6bb3e,TCGA-AA-A01S-01A-21D-A079_110402_SN208_0200_BB02BTABXX_s_6_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01S-01A,84E34CF2-B3BB-4A1A-8FB7-6C2C604C4008,Primary Tumor,Illumina HiSeq,fe7c227a-1329-4956-b9bf-08bbb6fe161d,Colorectal,47,5743700C-CBD3-4F87-8109-6349A96EB605,DC9E606A-12D6-4AA6-9780-1D999EB72C5A,TCGA-AA-A01S-01A-21D-A079-02,HG18_Broad_variant,TCGA-AA-A01S,TCGA-COAD,NA,s13206,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage III
13722.58cfa831e4b0c9d6adf6cb40,58cfa831e4b0c9d6adf6cb40,TCGA-EE-A2GS-06A-12D-A18Y_120724_SN208_0418_BD13N7ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EE-A2GS-06A-12D-A18Y_120724_SN208_0418_BD13N7ACXX_s_3_rg.sorted,TCGA-EE-A2GS-06A-12D-A18Y_120724_SN208_0418_BD13N7ACXX_s_3_rg.sorted.bam,46.23,NA,0.18,58cfa831e4b0c9d6adf6cb40,TCGA-EE-A2GS-06A-12D-A18Y_120724_SN208_0418_BD13N7ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2GS-06A,880BB701-F1D3-4BF2-BFC8-143AD8D07B6A,Metastatic,Illumina HiSeq,effe1a0a-bcd4-4a16-9d4b-62396920b6fb,Skin,28,B9D12203-7D72-4BE3-A1D2-53836EBBD599,D1786636-29E9-478A-A6CD-161FEDB453DA,TCGA-EE-A2GS-06A-12D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2GS,TCGA-SKCM,NA,s8013,Harvard Medical School,University of Sydney,Australia,NO,T2a,N0,Not available,Stage IB
13722.58cfa831e4b0c9d6adf6cad8,58cfa831e4b0c9d6adf6cad8,TCGA-DU-6403-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DU-6403-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_4_rg.sorted,TCGA-DU-6403-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_4_rg.sorted.bam,78,1.9,0.15,58cfa831e4b0c9d6adf6cad8,TCGA-DU-6403-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_4_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6403-10A,8DAA29C0-F652-4130-A004-5183BBE30C63,Blood Derived Normal,Illumina HiSeq,5d588402-a79e-45a9-ba69-9bd3eba3aa6c,Brain,60,696EAE07-1FB0-4F51-B026-28B8684C2F30,56E72F88-2F97-483F-8AD2-359AAE10F380,TCGA-DU-6403-10A-01D-1703-02,HG19_Broad_variant,TCGA-DU-6403,TCGA-LGG,354,s8142,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa832e4b0c9d6adf6d155,58cfa832e4b0c9d6adf6d155,TCGA-G9-6361-01A-21D-1957_130405_SN590_0222_BD21LGACXX_s_6_rg.sorted.filtered.,WGS,TCGA-G9-6361-01A-21D-1957_130405_SN590_0222_BD21LGACXX_s_6_rg.sorted,TCGA-G9-6361-01A-21D-1957_130405_SN590_0222_BD21LGACXX_s_6_rg.sorted.bam,19.7,1.9,0.15,58cfa832e4b0c9d6adf6d155,TCGA-G9-6361-01A-21D-1957_130405_SN590_0222_BD21LGACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6361-01A,71D14304-CCB0-4A4C-B935-8C014CA75FD0,Primary Tumor,Illumina HiSeq,4fc66c05-8bf3-4a56-8bfe-6d20c3195258,Prostate,61,A369C190-964E-471C-878A-D8FADE7CF992,54B8E171-9BCC-469D-9315-114FE2C57DC1,TCGA-G9-6361-01A-21D-1957-02,HG19_Broad_variant,TCGA-G9-6361,TCGA-PRAD,NA,s3795,Harvard Medical School,Roswell Park,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cd1e,58cfa831e4b0c9d6adf6cd1e,TCGA-EX-A1H6-01B-11D-A232_140124_SN208_0506_BC2PD5ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EX-A1H6-01B-11D-A232_140124_SN208_0506_BC2PD5ACXX_s_3_rg.sorted,TCGA-EX-A1H6-01B-11D-A232_140124_SN208_0506_BC2PD5ACXX_s_3_rg.sorted.bam,47.39,NA,0.16,58cfa831e4b0c9d6adf6cd1e,TCGA-EX-A1H6-01B-11D-A232_140124_SN208_0506_BC2PD5ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EX-A1H6-01B,1FE594D9-4240-49EE-8AFD-C7D16A377181,Primary Tumor,Illumina HiSeq,32948425-770d-4a87-8c3d-ade77ab0391d,Cervix,38,FE018D31-EEE8-4335-96A1-95ECEABFADF1,DD730721-CEC0-4034-B18D-588A200D4D76,TCGA-EX-A1H6-01B-11D-A232-26,HG19_Broad_variant,TCGA-EX-A1H6,TCGA-CESC,NA,s1197,MD Anderson - Institute for Applied Cancer Science,University of North Carolina,United States,NO,T1b1,N0,Endocervical Type of Adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cddc,58cfa831e4b0c9d6adf6cddc,TCGA-FS-A1YW-06A-11D-A18Y_120724_SN208_0417_AC117BACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FS-A1YW-06A-11D-A18Y_120724_SN208_0417_AC117BACXX_s_2_rg.sorted,TCGA-FS-A1YW-06A-11D-A18Y_120724_SN208_0417_AC117BACXX_s_2_rg.sorted.bam,56.24,NA,0.17,58cfa831e4b0c9d6adf6cddc,TCGA-FS-A1YW-06A-11D-A18Y_120724_SN208_0417_AC117BACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1YW-06A,57DD4D65-CFAD-4533-92B4-90742289603B,Metastatic,Illumina HiSeq,215f3593-6275-410b-b345-926e04f4c119,Skin,52,1070E0C9-F9D1-434A-ABB7-873756921138,26CD8807-D47B-4D9B-BB4A-4C40745B4C36,TCGA-FS-A1YW-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1YW,TCGA-SKCM,6598,s7522,Harvard Medical School,Essen,Germany,NO,T1b,N0,Not available,Stage IB
13722.58cfa832e4b0c9d6adf6cf44,58cfa832e4b0c9d6adf6cf44,TCGA-G9-6371-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-G9-6371-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_8_rg.sorted,TCGA-G9-6371-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_8_rg.sorted.bam,1.7,1.9,0.15,58cfa832e4b0c9d6adf6cf44,TCGA-G9-6371-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6371-10A,D5C43A14-21AB-4178-AE33-2D8B7BAA256F,Blood Derived Normal,Illumina HiSeq,9e568f08-d30c-467b-a69d-7e89d377c1a7,Prostate,58,48B83AF3-9A1A-4C27-BBB3-DB6FA21F2886,29D36B2A-4434-4F5F-9405-82FF38A8A5D2,TCGA-G9-6371-10A-01D-1784-02,HG19_Broad_variant,TCGA-G9-6371,TCGA-PRAD,NA,s3978,Harvard Medical School,Roswell Park,United States,NO,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c41e,58cfa831e4b0c9d6adf6c41e,TCGA-BT-A2LD-10A-01D-A210_120914_SN590_0180_BC19KDACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BT-A2LD-10A-01D-A210_120914_SN590_0180_BC19KDACXX_s_6_rg.sorted,TCGA-BT-A2LD-10A-01D-A210_120914_SN590_0180_BC19KDACXX_s_6_rg.sorted.bam,27.33,NA,0.16,58cfa831e4b0c9d6adf6c41e,TCGA-BT-A2LD-10A-01D-A210_120914_SN590_0180_BC19KDACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A2LD-10A,9DD97821-7AFD-4982-8B1D-F14F845B79F7,Blood Derived Normal,Illumina HiSeq,81838e98-98aa-4bf3-94e0-1819bd2a4c6b,Bladder,78,A06B15AF-EAC8-482A-90E2-8BD8E6154AD0,AF8D98C7-B75F-4115-8CF2-2B569B1AF6A8,TCGA-BT-A2LD-10A-01D-A210-26,HG19_Broad_variant,TCGA-BT-A2LD,TCGA-BLCA,NA,s2861,MD Anderson - Institute for Applied Cancer Science,University of Pittsburgh,United States,NO,T3a,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa830e4b0c9d6adf6bfd3,58cfa830e4b0c9d6adf6bfd3,TCGA-BR-4357-11A-01D-1154_130815_VM001_0001_VMR0001CXX_s_6_rg.sorted.filtered.,WGS,TCGA-BR-4357-11A-01D-1154_130815_VM001_0001_VMR0001CXX_s_6_rg.sorted,TCGA-BR-4357-11A-01D-1154_130815_VM001_0001_VMR0001CXX_s_6_rg.sorted.bam,142.3,1.9,0.15,58cfa830e4b0c9d6adf6bfd3,TCGA-BR-4357-11A-01D-1154_130815_VM001_0001_VMR0001CXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4357-11A,BEC83DFF-2BBA-4467-92AA-5DC3DB9E0EAF,Solid Tissue Normal,Illumina HiSeq,9c4e7319-08e6-46e0-a33b-68d2dc8a6926,Stomach,58,0B8024D5-1268-49BC-B2F7-7B45701A17F1,5E69772F-6726-4D2A-9BA1-2C8636F3F1D5,TCGA-BR-4357-11A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4357,TCGA-STAD,NA,s15377,Harvard Medical School,Asterand,Russia,NO,T3,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa831e4b0c9d6adf6c6fa,58cfa831e4b0c9d6adf6c6fa,TCGA-CQ-7068-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CQ-7068-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_5_rg.sorted,TCGA-CQ-7068-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_5_rg.sorted.bam,6.83,NA,0.16,58cfa831e4b0c9d6adf6c6fa,TCGA-CQ-7068-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-7068-10A,8EBE8C25-5EF9-42D4-9414-8313227B673F,Blood Derived Normal,Illumina HiSeq,ab245773-e618-4653-9bbd-066158ce2131,Head and Neck,80,B3F3A97A-FE74-4F1B-AB76-64EBD4F6518E,19652FBF-B3BC-4900-9CF5-67BAF165D19F,TCGA-CQ-7068-10A-01D-2317-26,HG19_Broad_variant,TCGA-CQ-7068,TCGA-HNSC,NA,s15895,MD Anderson - Institute for Applied Cancer Science,"University Health Network, Toronto",Canada,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa832e4b0c9d6adf6cf25,58cfa832e4b0c9d6adf6cf25,TCGA-FS-A1Z3-10A-01D-A190_120711_SN208_0414_BD13L5ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FS-A1Z3-10A-01D-A190_120711_SN208_0414_BD13L5ACXX_s_8_rg.sorted,TCGA-FS-A1Z3-10A-01D-A190_120711_SN208_0414_BD13L5ACXX_s_8_rg.sorted.bam,53.95,NA,0.17,58cfa832e4b0c9d6adf6cf25,TCGA-FS-A1Z3-10A-01D-A190_120711_SN208_0414_BD13L5ACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1Z3-10A,29BCB876-5A91-4D56-AF47-7B4C856C151F,Blood Derived Normal,Illumina HiSeq,b12e8334-b794-42ce-97be-51daf06e6962,Skin,72,1AFC2065-A13D-4FD5-B9CA-DA874B15AF71,07583C97-A4DA-4856-AE27-44BF71C9A3D3,TCGA-FS-A1Z3-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1Z3,TCGA-SKCM,636,s7698,Harvard Medical School,Essen,Germany,NO,TX,N0,Not available,Stage IV
13722.58cfa830e4b0c9d6adf6c174,58cfa830e4b0c9d6adf6c174,TCGA-BA-4076-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BA-4076-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_6_rg.sorted,TCGA-BA-4076-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_6_rg.sorted.bam,51.03,1.9,0.14,58cfa830e4b0c9d6adf6c174,TCGA-BA-4076-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-4076-10A,7DE19081-D5FD-468C-AD0D-F6E3E8B2AD70,Blood Derived Normal,Illumina HiSeq,ebc1363c-072a-468d-abba-3a9ac03513bf,Head and Neck,39,D6F48BB2-379A-448D-B13D-2DFC5DA91D0C,01549853-3132-42A7-A2ED-5AD365EAA63F,TCGA-BA-4076-10A-01D-1431-02,HG19_Broad_variant,TCGA-BA-4076,TCGA-HNSC,415,s15612,Harvard Medical School,UNC,None,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b9b1,58cfa82fe4b0c9d6adf6b9b1,TCGA-50-6594-11A-01D-1751_120105_SN1120_0107_AC054PACXX_s_2_rg.sorted.filtered.,WGS,TCGA-50-6594-11A-01D-1751_120105_SN1120_0107_AC054PACXX_s_2_rg.sorted,TCGA-50-6594-11A-01D-1751_120105_SN1120_0107_AC054PACXX_s_2_rg.sorted.bam,76.4,1.9,0.15,58cfa82fe4b0c9d6adf6b9b1,TCGA-50-6594-11A-01D-1751_120105_SN1120_0107_AC054PACXX_s_2_rg.sorted.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-6594-11A,8504FD86-A70A-4CBA-9EC8-25C9E60CA549,Solid Tissue Normal,Illumina HiSeq,29591d1b-39c4-4087-a852-643e35cc55b0,Lung,79,E4E03B13-95A6-4ED1-8DA2-66C517DD1516,78942C9E-D4AE-4D66-B756-AFD76F55ACDA,TCGA-50-6594-11A-01D-1751-02,HG19_Broad_variant,TCGA-50-6594,TCGA-LUAD,370,s11455,Harvard Medical School,University of Pittsburgh,United States,NO,T3,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa830e4b0c9d6adf6bc4e,58cfa830e4b0c9d6adf6bc4e,TCGA-AP-A05P-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_5_rg.sorted.filtered.,WGS,TCGA-AP-A05P-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_5_rg.sorted,TCGA-AP-A05P-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_5_rg.sorted.bam,55.61,2.3,0.14,58cfa830e4b0c9d6adf6bc4e,TCGA-AP-A05P-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_5_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A05P-01A,3CB83517-78A4-47B8-8B1E-57E765DBDD2E,Primary Tumor,Illumina HiSeq,a12cb33f-6f29-4068-a6c8-3e20520bc2e0,Uterus,54,F51F7B0E-3EA6-4232-9DE4-A4DD63B23BB5,E08A6886-B019-4920-ACC3-73A4CAF18E3F,TCGA-AP-A05P-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A05P,TCGA-UCEC,NA,s5385,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d0ea,58cfa832e4b0c9d6adf6d0ea,TCGA-HW-7489-10A-01D-2022_130913_SN1440_0168_BD2B0UACXX_s_6_rg.sorted.filtered.,WGS,TCGA-HW-7489-10A-01D-2022_130913_SN1440_0168_BD2B0UACXX_s_6_rg.sorted,TCGA-HW-7489-10A-01D-2022_130913_SN1440_0168_BD2B0UACXX_s_6_rg.sorted.bam,434.3,NA,0.14,58cfa832e4b0c9d6adf6d0ea,TCGA-HW-7489-10A-01D-2022_130913_SN1440_0168_BD2B0UACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HW-7489-10A,6957D45E-7CCB-457D-800D-C2A2037F4F01,Blood Derived Normal,Illumina HiSeq,bcccd3c8-2eee-44ca-bb10-16e4dc8672d5,Brain,38,DC41823F-6A90-4D03-B8A2-2DF1DCE72687,706FE100-2E22-4CE8-8730-6515C2DB7ACE,TCGA-HW-7489-10A-01D-2022-02,HG19_Broad_variant,TCGA-HW-7489,TCGA-LGG,NA,s8374,Harvard Medical School,MSKCC,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa82ee4b0c9d6adf6ae54,58cfa82ee4b0c9d6adf6ae54,TCGA-05-4250-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_2_rg.sorted.filtered.,WGS,TCGA-05-4250-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_2_rg.sorted,TCGA-05-4250-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_2_rg.sorted.bam,282.93,1.9,0.15,58cfa82ee4b0c9d6adf6ae54,TCGA-05-4250-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_2_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4250-01A,F98ECD8A-B878-4F53-B911-20CD8E17281C,Primary Tumor,Illumina HiSeq,b7bbb240-9e61-41e0-a669-1744d0bda12b,Lung,79,8F274178-7A8E-46B6-8D2C-900338BBB946,A444B1E8-9FE9-492B-A361-93CAAB3681BC,TCGA-05-4250-01A-01D-1103-02,HG19_Broad_variant,TCGA-05-4250,TCGA-LUAD,121,s11441,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6c67d,58cfa831e4b0c9d6adf6c67d,TCGA-CG-4469-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CG-4469-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_3_rg.sorted,TCGA-CG-4469-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_3_rg.sorted.bam,298.2,1.9,0.14,58cfa831e4b0c9d6adf6c67d,TCGA-CG-4469-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_3_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4469-01A,2AC986F6-CD6F-4CA5-90CC-7A105CFE85EA,Primary Tumor,Illumina HiSeq,dcd0352b-a451-4eaa-840e-14884d08bd89,Stomach,70,2A3D7538-D377-4D94-BB61-BF77BA56BE1B,9BAFEA4B-CCC4-4F5D-8BFE-BD13D56741F6,TCGA-CG-4469-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4469,TCGA-STAD,215,s14831,Harvard Medical School,Indivumed,Germany,NO,T3,N3,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa832e4b0c9d6adf6d009,58cfa832e4b0c9d6adf6d009,TCGA-G9-6338-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_6_rg.sorted.filtered.,WGS,TCGA-G9-6338-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_6_rg.sorted,TCGA-G9-6338-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_6_rg.sorted.bam,44,1.9,0.15,58cfa832e4b0c9d6adf6d009,TCGA-G9-6338-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6338-10A,2C48B1BF-4E49-4869-874B-F08787FA04B5,Blood Derived Normal,Illumina HiSeq,618841c7-8398-44d8-bf70-1275e50d01cd,Prostate,61,4E890A54-84A6-4EFD-9F72-43759925B861,95600DE2-AE98-4D3A-9994-0E2ADB114036,TCGA-G9-6338-10A-01D-1957-02,HG19_Broad_variant,TCGA-G9-6338,TCGA-PRAD,NA,s3967,Harvard Medical School,Roswell Park,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d40e,58cfa832e4b0c9d6adf6d40e,TCGA-VD-A8KF-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-VD-A8KF-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_3_rg.sorted,TCGA-VD-A8KF-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_3_rg.sorted.bam,45.75,NA,0.16,58cfa832e4b0c9d6adf6d40e,TCGA-VD-A8KF-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_3_rg.sorted.bam,Dead,MALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KF-01A,78039723-94A9-4903-8BB4-C00852E8E889,Primary Tumor,Illumina HiSeq,29607312-d3fc-46a7-97ec-8515bd642e3a,Eye,68,B48C5179-16E6-47F1-87C7-EE8B71989BF9,8EB5960A-3FDC-4641-AF72-C80755429C8D,TCGA-VD-A8KF-01A-11D-A40D-26,HG19_Broad_variant,TCGA-VD-A8KF,TCGA-UVM,40,s266,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T4b,NX,Not available,Stage IIIB
13722.58cfa832e4b0c9d6adf6cf30,58cfa832e4b0c9d6adf6cf30,TCGA-HC-7075-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_5_rg.sorted.filtered.,WGS,TCGA-HC-7075-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_5_rg.sorted,TCGA-HC-7075-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_5_rg.sorted.bam,310,NA,0.16,58cfa832e4b0c9d6adf6cf30,TCGA-HC-7075-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7075-10A,5DD69C3E-9A3D-450C-9F10-10B4D6DAEEBA,Blood Derived Normal,Illumina HiSeq,a027a038-5142-4ed8-a1ab-1ae31a4dc271,Prostate,63,3EC216B1-4260-45E7-BF41-3F13676F3222,FF9017A8-BB23-47A4-A137-833BD5E6F753,TCGA-HC-7075-10A-01D-1957-02,HG19_Broad_variant,TCGA-HC-7075,TCGA-PRAD,NA,s3623,Harvard Medical School,International Genomics Consortium,United States,NO,T2a,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bdc4,58cfa830e4b0c9d6adf6bdc4,TCGA-BG-A18A-01A-21D-A12F_120626_SN590_0163_AC0VU5ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BG-A18A-01A-21D-A12F_120626_SN590_0163_AC0VU5ACXX_s_7_rg.sorted,TCGA-BG-A18A-01A-21D-A12F_120626_SN590_0163_AC0VU5ACXX_s_7_rg.sorted.bam,21.93,1.96,0.17,58cfa830e4b0c9d6adf6bdc4,TCGA-BG-A18A-01A-21D-A12F_120626_SN590_0163_AC0VU5ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A18A-01A,FEB3E930-3638-44B4-AC0F-A5DCB01FED76,Primary Tumor,Illumina HiSeq,cf06b397-1811-4a38-93b4-05f1457e9882,Uterus,74,8FD0971D-40BA-46C2-B3C4-8E48A3E6C122,518AFA21-9E19-49DE-A2A6-387828A10837,TCGA-BG-A18A-01A-21D-A12F-02,HG19_Broad_variant,TCGA-BG-A18A,TCGA-UCEC,NA,s4789,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6af9e,58cfa82ee4b0c9d6adf6af9e,TCGA-05-4427-01A-21D-1853_111207_SN590_0112_D09CDACXX_s_3_rg.sorted.filtered.,WGS,TCGA-05-4427-01A-21D-1853_111207_SN590_0112_D09CDACXX_s_3_rg.sorted,TCGA-05-4427-01A-21D-1853_111207_SN590_0112_D09CDACXX_s_3_rg.sorted.bam,290.7,1.8,0.17,58cfa82ee4b0c9d6adf6af9e,TCGA-05-4427-01A-21D-1853_111207_SN590_0112_D09CDACXX_s_3_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4427-01A,78A24C56-576C-4245-BB42-6603B3D19897,Primary Tumor,Illumina HiSeq,10c44e9b-d94b-4f27-b275-2dab46a863c6,Lung,65,785B0C56-BED5-4D19-B7B3-D1A0CEB5D648,6B6663FE-F439-4546-B256-0024F66F748D,TCGA-05-4427-01A-21D-1853-02,HG19_Broad_variant,TCGA-05-4427,TCGA-LUAD,NA,s11225,Harvard Medical School,Indivumed,Germany,NO,T2,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIB
13722.58cfa831e4b0c9d6adf6cab4,58cfa831e4b0c9d6adf6cab4,TCGA-DA-A1I8-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DA-A1I8-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_8_rg.sorted,TCGA-DA-A1I8-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_8_rg.sorted.bam,18.67,NA,0.15,58cfa831e4b0c9d6adf6cab4,TCGA-DA-A1I8-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1I8-10A,7B92FCD4-F9BE-4B97-94A2-B2E8348AEABA,Blood Derived Normal,Illumina HiSeq,2fd27dbc-9de2-4741-a087-0aee9dcda991,Skin,63,AAE8BDEA-4787-4144-8A1C-206F756ECDBC,2EA039F3-B715-4EA4-9D71-0509730885E2,TCGA-DA-A1I8-10A-01D-A190-02,HG19_Broad_variant,TCGA-DA-A1I8,TCGA-SKCM,NA,s7836,Harvard Medical School,Yale,United States,NO,T4b,N0,Not available,Stage IIC
13722.58cfa831e4b0c9d6adf6ccc4,58cfa831e4b0c9d6adf6ccc4,TCGA-EJ-7125-10A-01D-1957_130221_SN1120_0239_BD1V59ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EJ-7125-10A-01D-1957_130221_SN1120_0239_BD1V59ACXX_s_8_rg.sorted,TCGA-EJ-7125-10A-01D-1957_130221_SN1120_0239_BD1V59ACXX_s_8_rg.sorted.bam,250,NA,0.14,58cfa831e4b0c9d6adf6ccc4,TCGA-EJ-7125-10A-01D-1957_130221_SN1120_0239_BD1V59ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7125-10A,ACA312AB-6DBD-4183-8B22-8F37834F3426,Blood Derived Normal,Illumina HiSeq,956fdfd4-adc9-438d-8935-bb8a0626167c,Prostate,44,CEE0CE25-5CB8-4C3F-AEAC-D67EA0BA9611,D088E931-4D7E-4A03-8B5F-7A5B6D081B25,TCGA-EJ-7125-10A-01D-1957-02,HG19_Broad_variant,TCGA-EJ-7125,TCGA-PRAD,NA,s3792,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82fe4b0c9d6adf6b8e2,58cfa82fe4b0c9d6adf6b8e2,TCGA-A7-A26F-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_1_rg.sorted.filtered.,WGS,TCGA-A7-A26F-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_1_rg.sorted,TCGA-A7-A26F-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_1_rg.sorted.bam,8.32,NA,0.14,58cfa82fe4b0c9d6adf6b8e2,TCGA-A7-A26F-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A7-A26F-01B,3B7B9C1E-A84C-47ED-983C-9E4B00CBF01A,Primary Tumor,Illumina HiSeq,4925c013-4605-47d0-9c97-2e8a69233aa4,Breast,55,29619D1E-E8B4-411E-BBBA-07F2CFB69E8A,A723DE1E-A9E0-487D-8D86-7AA4A062A1C2,TCGA-A7-A26F-01B-04D-A22S-26,HG19_Broad_variant,TCGA-A7-A26F,TCGA-BRCA,NA,s6916,MD Anderson - Institute for Applied Cancer Science,Christiana Healthcare,United States,YES,T1,N0,Other  specify,Stage IA
13722.58cfa831e4b0c9d6adf6cb68,58cfa831e4b0c9d6adf6cb68,TCGA-EE-A2M5-06A-12D-A18Y_120724_SN208_0418_BD13N7ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EE-A2M5-06A-12D-A18Y_120724_SN208_0418_BD13N7ACXX_s_1_rg.sorted,TCGA-EE-A2M5-06A-12D-A18Y_120724_SN208_0418_BD13N7ACXX_s_1_rg.sorted.bam,77.34,NA,0.16,58cfa831e4b0c9d6adf6cb68,TCGA-EE-A2M5-06A-12D-A18Y_120724_SN208_0418_BD13N7ACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2M5-06A,B5E37B9B-6264-4CC8-9B44-1D8AC0692D6C,Metastatic,Illumina HiSeq,3ee9a207-ca0a-45f4-b364-4a70483214dd,Skin,49,B3189E4F-3B90-4A1E-8FF1-FA2FEDC46C4C,270E8D67-394C-49D7-971C-1C829302C9E9,TCGA-EE-A2M5-06A-12D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2M5,TCGA-SKCM,659,s7857,Harvard Medical School,University of Sydney,Australia,NO,T2,N0,Not available,Stage I
13722.58cfa831e4b0c9d6adf6ca43,58cfa831e4b0c9d6adf6ca43,TCGA-DJ-A1QL-01A-11D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DJ-A1QL-01A-11D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_1_rg.sorted,TCGA-DJ-A1QL-01A-11D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_1_rg.sorted.bam,77.76,1.96,0.18,58cfa831e4b0c9d6adf6ca43,TCGA-DJ-A1QL-01A-11D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_1_rg.sorted.bam,Alive,MALE,Not available,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QL-01A,E4B08E66-0772-4956-8670-E5C6553EECBE,Primary Tumor,Illumina HiSeq,115df95b-61fb-4fef-a23f-df0ade71c646,Thyroid,70,62B6D426-E1E4-48E8-BC8F-6B07C67CC0D0,C5B8FBAE-98B5-437B-A8BD-D695C5E8CB4F,TCGA-DJ-A1QL-01A-11D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QL,TCGA-THCA,NA,s12373,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa831e4b0c9d6adf6c5d8,58cfa831e4b0c9d6adf6c5d8,TCGA-CN-5363-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CN-5363-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_3_rg.sorted,TCGA-CN-5363-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_3_rg.sorted.bam,197.7,1.9,0.15,58cfa831e4b0c9d6adf6c5d8,TCGA-CN-5363-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_3_rg.sorted.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5363-01A,291B069C-9DDE-4E1E-8430-85146BC94338,Primary Tumor,Illumina HiSeq,624b1e50-b5bd-4a3f-98fd-4514bff3244d,Head and Neck,48,5E4E1E21-8016-4E27-8F72-2411714203E8,BEB17091-BD47-4666-8E3A-7A397977EA41,TCGA-CN-5363-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5363,TCGA-HNSC,253,s15891,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N3,Head and Neck Squamous Cell Carcinoma,Stage IVB
13722.58cfa832e4b0c9d6adf6cff8,58cfa832e4b0c9d6adf6cff8,TCGA-GD-A2C5-11A-11D-A17R_120927_SN208_0432_AC188LACXX_s_8_rg.sorted.filtered.,WGS,TCGA-GD-A2C5-11A-11D-A17R_120927_SN208_0432_AC188LACXX_s_8_rg.sorted,TCGA-GD-A2C5-11A-11D-A17R_120927_SN208_0432_AC188LACXX_s_8_rg.sorted.bam,18.62,NA,0.15,58cfa832e4b0c9d6adf6cff8,TCGA-GD-A2C5-11A-11D-A17R_120927_SN208_0432_AC188LACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GD-A2C5-11A,5D54C742-5A8E-4C40-8D62-95E75E210AB8,Solid Tissue Normal,Illumina HiSeq,d56808f7-e6d9-4234-b65c-7ff6bad653f8,Bladder,53,892EB338-9C49-4378-A934-623F4EDACF7D,C0270E61-DE9A-4A93-941F-74A9E15BE419,TCGA-GD-A2C5-11A-11D-A17R-02,HG19_Broad_variant,TCGA-GD-A2C5,TCGA-BLCA,NA,s2926,Harvard Medical School,ABS - IUPUI,United States,NO,T3a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6d010,58cfa832e4b0c9d6adf6d010,TCGA-G9-6338-01A-12D-1957_130222_SN1222_0174_BC1RNEACXX_s_5_rg.sorted.filtered.,WGS,TCGA-G9-6338-01A-12D-1957_130222_SN1222_0174_BC1RNEACXX_s_5_rg.sorted,TCGA-G9-6338-01A-12D-1957_130222_SN1222_0174_BC1RNEACXX_s_5_rg.sorted.bam,218.7,NA,0.16,58cfa832e4b0c9d6adf6d010,TCGA-G9-6338-01A-12D-1957_130222_SN1222_0174_BC1RNEACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6338-01A,2C48B1BF-4E49-4869-874B-F08787FA04B5,Primary Tumor,Illumina HiSeq,3c22fc65-7067-4d13-a148-5e953f3a7097,Prostate,61,21FC7F0F-FCB3-422F-AA73-0E09FD06DA35,BF3CC12E-1835-40C8-B29F-C685B828AB18,TCGA-G9-6338-01A-12D-1957-02,HG19_Broad_variant,TCGA-G9-6338,TCGA-PRAD,NA,s3451,Harvard Medical School,Roswell Park,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c9c6,58cfa831e4b0c9d6adf6c9c6,TCGA-DA-A1I7-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DA-A1I7-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_7_rg.sorted,TCGA-DA-A1I7-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_7_rg.sorted.bam,24.4,NA,0.15,58cfa831e4b0c9d6adf6c9c6,TCGA-DA-A1I7-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1I7-10A,DFE8BAA8-1C2C-4C36-92C9-61548CEBEC19,Blood Derived Normal,Illumina HiSeq,46644fd2-8d67-4fe0-bd0b-2a2d74d08596,Skin,62,3BB3E8C1-DF0C-4635-BF1B-7FFD3E58384C,9DB43937-2095-4F40-86BF-C86840D44150,TCGA-DA-A1I7-10A-01D-A190-02,HG19_Broad_variant,TCGA-DA-A1I7,TCGA-SKCM,NA,s7327,Harvard Medical School,Yale,United States,NO,T0,N2b,Not available,Stage IIIB
13722.58cfa831e4b0c9d6adf6cd90,58cfa831e4b0c9d6adf6cd90,TCGA-FE-A3PA-01A-12D-A221_120611_SN1222_0114_AC0WL3ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FE-A3PA-01A-12D-A221_120611_SN1222_0114_AC0WL3ACXX_s_1_rg.sorted,TCGA-FE-A3PA-01A-12D-A221_120611_SN1222_0114_AC0WL3ACXX_s_1_rg.sorted.bam,44.72,NA,0.15,58cfa831e4b0c9d6adf6cd90,TCGA-FE-A3PA-01A-12D-A221_120611_SN1222_0114_AC0WL3ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A3PA-01A,10BDAFBB-831D-48B5-B9A3-AD374FC50235,Primary Tumor,Illumina HiSeq,0d67cded-ff5a-4b7c-bc1e-2bda8ee44700,Thyroid,16,D37BED2A-BF63-43E0-91D0-6C95E4CA2D45,DBD2621E-9F39-45C6-B9AE-67873AECA03D,TCGA-FE-A3PA-01A-12D-A221-26,HG19_Broad_variant,TCGA-FE-A3PA,TCGA-THCA,NA,s12760,MD Anderson - Institute for Applied Cancer Science,Ohio State University,United States,NO,T4,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa82fe4b0c9d6adf6b991,58cfa82fe4b0c9d6adf6b991,TCGA-50-6597-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_3_rg.sorted.filtered.,WGS,TCGA-50-6597-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_3_rg.sorted,TCGA-50-6597-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_3_rg.sorted.bam,12.7,1.9,0.15,58cfa82fe4b0c9d6adf6b991,TCGA-50-6597-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-6597-01A,0D66BF6C-EED0-4726-BD5B-3BF6D610B4E0,Primary Tumor,Illumina HiSeq,e7110ba5-6000-459a-8128-32b420e21194,Lung,79,C5363830-3DB9-4C0C-AA47-B32FDC888C60,84D15DBA-6689-4A93-B2CA-999BF7F97E96,TCGA-50-6597-01A-11D-1853-02,HG19_Broad_variant,TCGA-50-6597,TCGA-LUAD,NA,s11553,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c972,58cfa831e4b0c9d6adf6c972,TCGA-D7-6528-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-D7-6528-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_6_rg.sorted,TCGA-D7-6528-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_6_rg.sorted.bam,291.7,1.9,0.15,58cfa831e4b0c9d6adf6c972,TCGA-D7-6528-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6528-10A,35496E4E-598F-4FFC-B11E-8EDAEB676079,Blood Derived Normal,Illumina HiSeq,d4ea96e7-6bf3-4ac4-88ad-e0199ddef1b7,Stomach,70,45FE00A2-0D61-4861-8F22-B0D306458CE4,E9E37E3D-03CA-41A1-B725-2768EDFB3017,TCGA-D7-6528-10A-01D-1798-02,HG19_Broad_variant,TCGA-D7-6528,TCGA-STAD,NA,s15407,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N0,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IB
13722.58cfa831e4b0c9d6adf6ca88,58cfa831e4b0c9d6adf6ca88,TCGA-DU-5852-10A-01D-1703_130806_SN1222_0209_AD2AW0ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DU-5852-10A-01D-1703_130806_SN1222_0209_AD2AW0ACXX_s_8_rg.sorted,TCGA-DU-5852-10A-01D-1703_130806_SN1222_0209_AD2AW0ACXX_s_8_rg.sorted.bam,93,1.8,0.14,58cfa831e4b0c9d6adf6ca88,TCGA-DU-5852-10A-01D-1703_130806_SN1222_0209_AD2AW0ACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-5852-10A,9ED5AF0E-C87F-46FF-81E7-9D3041B4034E,Blood Derived Normal,Illumina HiSeq,6d9e6678-64e1-4fa4-b57d-338f163a62a1,Brain,61,5A82BD3E-7E2F-4D14-95F8-B85C684A3B7D,73074E40-BF47-4433-BA0E-FFEBFE1ED4C2,TCGA-DU-5852-10A-01D-1703-02,HG19_Broad_variant,TCGA-DU-5852,TCGA-LGG,205,s8560,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa832e4b0c9d6adf6d040,58cfa832e4b0c9d6adf6d040,TCGA-FU-A3YQ-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FU-A3YQ-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_5_rg.sorted,TCGA-FU-A3YQ-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_5_rg.sorted.bam,104.06,NA,0.15,58cfa832e4b0c9d6adf6d040,TCGA-FU-A3YQ-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-FU-A3YQ-10A,6E01248B-C551-4F52-8066-CB2D26EB6394,Blood Derived Normal,Illumina HiSeq,02661caa-7ed3-483f-b1bb-720e65fef5b3,Cervix,35,F4FBEDEB-D14D-4189-99AF-0F015CFE5AC7,D6A3F40F-4BD5-4173-A695-CD4837267B21,TCGA-FU-A3YQ-10A-01D-A232-26,HG19_Broad_variant,TCGA-FU-A3YQ,TCGA-CESC,NA,s1207,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6cecb,58cfa832e4b0c9d6adf6cecb,TCGA-EM-A3O3-10A-01D-A221_120611_SN1222_0115_BD141KACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EM-A3O3-10A-01D-A221_120611_SN1222_0115_BD141KACXX_s_6_rg.sorted,TCGA-EM-A3O3-10A-01D-A221_120611_SN1222_0115_BD141KACXX_s_6_rg.sorted.bam,74,NA,0.15,58cfa832e4b0c9d6adf6cecb,TCGA-EM-A3O3-10A-01D-A221_120611_SN1222_0115_BD141KACXX_s_6_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3O3-10A,2A398AF1-AEA5-4AAE-AB00-A2DC152F965A,Blood Derived Normal,Illumina HiSeq,3a397284-a4e0-4b4d-bcfc-8a9df5e73588,Thyroid,83,0F899B5B-6290-4C1E-94F2-2C98F06011D1,C9FDBBBB-FC72-494D-98BC-CDB6D98F618A,TCGA-EM-A3O3-10A-01D-A221-26,HG19_Broad_variant,TCGA-EM-A3O3,TCGA-THCA,NA,s11998,MD Anderson - Institute for Applied Cancer Science,University Health Network,Canada,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa832e4b0c9d6adf6d086,58cfa832e4b0c9d6adf6d086,TCGA-HC-7212-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-HC-7212-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_4_rg.sorted,TCGA-HC-7212-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_4_rg.sorted.bam,333.3,NA,0.15,58cfa832e4b0c9d6adf6d086,TCGA-HC-7212-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7212-01A,907B64D6-A26A-4092-A247-AC9AF444D1C7,Primary Tumor,Illumina HiSeq,4ff229a3-6637-4fdc-a3b6-079e28773187,Prostate,56,92888479-B534-432D-8F70-CAE857E0074B,9BF25BFC-4E07-4979-9169-F6CDADDB3A90,TCGA-HC-7212-01A-11D-2111-02,HG19_Broad_variant,TCGA-HC-7212,TCGA-PRAD,NA,s4153,Harvard Medical School,International Genomics Consortium,United States,NO,T2a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cb8e,58cfa831e4b0c9d6adf6cb8e,TCGA-EE-A17X-06A-11D-A18Y_120730_SN1222_0141_BC115GACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EE-A17X-06A-11D-A18Y_120730_SN1222_0141_BC115GACXX_s_6_rg.sorted,TCGA-EE-A17X-06A-11D-A18Y_120730_SN1222_0141_BC115GACXX_s_6_rg.sorted.bam,48.71,NA,0.17,58cfa831e4b0c9d6adf6cb8e,TCGA-EE-A17X-06A-11D-A18Y_120730_SN1222_0141_BC115GACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,Not available,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A17X-06A,5F8CC8D6-8A1C-41D0-BAD6-FEDD2948F40A,Metastatic,Illumina HiSeq,6d053510-47ba-47ff-8349-8711be6a15c7,Skin,54,55AC45ED-8022-4386-8825-90A1A600D40E,F0FF8EF6-85B4-4241-BDF3-E5CA4549583A,TCGA-EE-A17X-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A17X,TCGA-SKCM,907,s8004,Harvard Medical School,University of Sydney,Australia,NO,T1a,N0,Not available,Stage IA
13722.58cfa82fe4b0c9d6adf6b9ad,58cfa82fe4b0c9d6adf6b9ad,TCGA-86-6562-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_8_rg.sorted.filtered.,WGS,TCGA-86-6562-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_8_rg.sorted,TCGA-86-6562-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_8_rg.sorted.bam,316.7,1.9,0.14,58cfa82fe4b0c9d6adf6b9ad,TCGA-86-6562-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-86-6562-10A,DCD066BA-5894-453E-B1DA-82092858C3DB,Blood Derived Normal,Illumina HiSeq,02776cc1-3edd-49d5-b77e-8a9ec2d68f5a,Lung,52,EB924A4A-EC5C-4E4A-856D-F5984B89687C,2DD29997-7D20-4F06-963B-C82274A2FD03,TCGA-86-6562-10A-01D-1751-02,HG19_Broad_variant,TCGA-86-6562,TCGA-LUAD,NA,s11254,Harvard Medical School,Asterand,Russia,NO,T2a,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa831e4b0c9d6adf6c5de,58cfa831e4b0c9d6adf6c5de,TCGA-CN-5364-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CN-5364-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_4_rg.sorted,TCGA-CN-5364-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_4_rg.sorted.bam,172.7,1.9,0.14,58cfa831e4b0c9d6adf6c5de,TCGA-CN-5364-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5364-01A,13F63218-0949-41E6-A661-C844414C45B5,Primary Tumor,Illumina HiSeq,c408c80c-a712-46f0-8945-22511233d2bf,Head and Neck,55,38A4AC42-BE08-4187-98C2-AF861218C3DB,6CE3D597-51F1-4807-A28F-271F25F95ED4,TCGA-CN-5364-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5364,TCGA-HNSC,493,s15767,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c813,58cfa831e4b0c9d6adf6c813,TCGA-CV-7238-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CV-7238-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_6_rg.sorted,TCGA-CV-7238-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_6_rg.sorted.bam,1.83,NA,0.15,58cfa831e4b0c9d6adf6c813,TCGA-CV-7238-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7238-10A,78FCC813-D0A8-44AA-B004-62810DCA9D12,Blood Derived Normal,Illumina HiSeq,70f8bf18-8050-4dad-9029-c90972a9bfb4,Head and Neck,69,CB099E57-06AC-4139-8B3D-45F1E395B3C5,AEEBFA8B-F1A2-41DA-905D-FC10B87E87EC,TCGA-CV-7238-10A-01D-2317-26,HG19_Broad_variant,TCGA-CV-7238,TCGA-HNSC,NA,s16204,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa830e4b0c9d6adf6be2e,58cfa830e4b0c9d6adf6be2e,TCGA-BG-A0MS-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BG-A0MS-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_7_rg.sorted,TCGA-BG-A0MS-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_7_rg.sorted.bam,76.64,1.97,0.15,58cfa830e4b0c9d6adf6be2e,TCGA-BG-A0MS-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0MS-01A,A798A8CC-4E72-4A8C-9E20-74A14DEAFD12,Primary Tumor,Illumina HiSeq,71c1fd79-298f-43fd-82ba-a1a2228aaa51,Uterus,53,EF7F78EB-314B-4CF2-B45B-810C84C6AA7B,463D0533-A168-4F50-8EA9-7812D01B5115,TCGA-BG-A0MS-01A-11D-A101-02,HG19_Broad_variant,TCGA-BG-A0MS,TCGA-UCEC,NA,s5392,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cd0d,58cfa831e4b0c9d6adf6cd0d,TCGA-ER-A19A-06A-21D-A18Y_120723_SN1120_0177_AC11GTACXX_s_4_rg.sorted.filtered.,WGS,TCGA-ER-A19A-06A-21D-A18Y_120723_SN1120_0177_AC11GTACXX_s_4_rg.sorted,TCGA-ER-A19A-06A-21D-A18Y_120723_SN1120_0177_AC11GTACXX_s_4_rg.sorted.bam,37.44,NA,0.16,58cfa831e4b0c9d6adf6cd0d,TCGA-ER-A19A-06A-21D-A18Y_120723_SN1120_0177_AC11GTACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19A-06A,41FCB9D3-9FB0-4625-98F4-1F564095EBC2,Metastatic,Illumina HiSeq,d62acfb8-3c88-47ac-b523-665ad3712081,Skin,79,09EE780C-E3DE-4638-88A7-879DE8017CBA,CFD54992-FD66-4234-9468-90D1A1219520,TCGA-ER-A19A-06A-21D-A18Y-02,HG19_Broad_variant,TCGA-ER-A19A,TCGA-SKCM,NA,s7696,Harvard Medical School,University of Pittsburgh,United States,NO,TX,N0,Not available,Stage IV
13722.58cfa831e4b0c9d6adf6cdd1,58cfa831e4b0c9d6adf6cdd1,TCGA-FD-A3SS-10A-01D-A233_120905_SN1120_0187_AD1E4NACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FD-A3SS-10A-01D-A233_120905_SN1120_0187_AD1E4NACXX_s_2_rg.sorted,TCGA-FD-A3SS-10A-01D-A233_120905_SN1120_0187_AD1E4NACXX_s_2_rg.sorted.bam,53.16,NA,0.17,58cfa831e4b0c9d6adf6cdd1,TCGA-FD-A3SS-10A-01D-A233_120905_SN1120_0187_AD1E4NACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3SS-10A,7B98B829-FDC7-4719-BEE9-C83F6154019C,Blood Derived Normal,Illumina HiSeq,275f5d73-157d-4162-a8da-dec4f5f8c299,Bladder,66,3CC80B9B-B7B5-42BF-83CC-212A828128EE,72276377-845C-4A0B-872A-4FA4FCE12B91,TCGA-FD-A3SS-10A-01D-A233-26,HG19_Broad_variant,TCGA-FD-A3SS,TCGA-BLCA,NA,s2912,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T4,N3,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6d370,58cfa832e4b0c9d6adf6d370,TCGA-L5-A43J-11A-11D-A248_121211_SN208_0443_BC1H55ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-L5-A43J-11A-11D-A248_121211_SN208_0443_BC1H55ACXX_s_6_rg.sorted,TCGA-L5-A43J-11A-11D-A248_121211_SN208_0443_BC1H55ACXX_s_6_rg.sorted.bam,21.77,NA,0.15,58cfa832e4b0c9d6adf6d370,TCGA-L5-A43J-11A-11D-A248_121211_SN208_0443_BC1H55ACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A43J-11A,209E2E16-CB88-4A8F-9CDB-10E152CAA26C,Solid Tissue Normal,Illumina HiSeq,e995d4f3-1a22-44d2-9253-00a5adecf3fb,Esophagus,90,515AF7C4-4CCD-43D6-AABE-1532EC8177CA,109FD024-BD84-4DCF-BD87-E4B4CE8146AB,TCGA-L5-A43J-11A-11D-A248-26,HG19_Broad_variant,TCGA-L5-A43J,TCGA-ESCA,131,s1840,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T3,N0,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6cae2,58cfa831e4b0c9d6adf6cae2,TCGA-DU-5854-10A-01D-1703_130806_SN1440_0159_BC29Y3ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DU-5854-10A-01D-1703_130806_SN1440_0159_BC29Y3ACXX_s_2_rg.sorted,TCGA-DU-5854-10A-01D-1703_130806_SN1440_0159_BC29Y3ACXX_s_2_rg.sorted.bam,85,1.8,0.15,58cfa831e4b0c9d6adf6cae2,TCGA-DU-5854-10A-01D-1703_130806_SN1440_0159_BC29Y3ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-5854-10A,B95AFB1A-A1DF-4D85-AD34-191928E28A77,Blood Derived Normal,Illumina HiSeq,ef916508-4f9f-45d1-b65b-8d69a7895db8,Brain,57,8AC25071-2BC5-437A-AB26-1FEDBC3747CB,E7E00A72-A00D-4D50-A329-620A510A7B6C,TCGA-DU-5854-10A-01D-1703-02,HG19_Broad_variant,TCGA-DU-5854,TCGA-LGG,NA,s8344,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6c576,58cfa831e4b0c9d6adf6c576,TCGA-CN-4725-10A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CN-4725-10A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_4_rg.sorted,TCGA-CN-4725-10A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_4_rg.sorted.bam,274.4,1.9,0.14,58cfa831e4b0c9d6adf6c576,TCGA-CN-4725-10A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4725-10A,3BE2ACE5-1C2A-49E9-8DA9-CEED6119530B,Blood Derived Normal,Illumina HiSeq,bf165379-dbd3-45a0-b736-21fb5757d11a,Head and Neck,60,53B7BCFC-B007-436C-A375-4CBA7DE5BA1E,CCEF4FE6-7FAB-4F31-914D-44F1D42AAE7D,TCGA-CN-4725-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4725,TCGA-HNSC,NA,s15622,Harvard Medical School,University of Pittsburgh,None,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa830e4b0c9d6adf6bdd0,58cfa830e4b0c9d6adf6bdd0,TCGA-BH-A0GY-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BH-A0GY-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_8_rg.sorted,TCGA-BH-A0GY-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_8_rg.sorted.bam,8.18,2.06,0.13,58cfa830e4b0c9d6adf6bdd0,TCGA-BH-A0GY-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0GY-10A,7D9D3522-EC3B-4EFE-8C8E-C0E675276EF5,Blood Derived Normal,Illumina HiSeq,2e13622c-8cd4-44aa-a010-0de1e4dbcbee,Breast,67,CD531C9F-A0E9-498A-9032-42040EC975DE,A9C89A38-C132-4BA7-A2D4-26B3184AA047,TCGA-BH-A0GY-10A-01D-A060-02,HG19_Broad_variant,TCGA-BH-A0GY,TCGA-BRCA,NA,s6918,Harvard Medical School,University of Pittsburgh,None,NO,T2,N1,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6be94,58cfa830e4b0c9d6adf6be94,TCGA-BL-A13I-11A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BL-A13I-11A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_5_rg.sorted,TCGA-BL-A13I-11A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_5_rg.sorted.bam,9.8,1.98,0.16,58cfa830e4b0c9d6adf6be94,TCGA-BL-A13I-11A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BL-A13I-11A,EBC094A6-CDC9-4C02-B8EC-A181B25A364D,Solid Tissue Normal,Illumina HiSeq,18c5e150-2417-4ca7-88c8-d147dfb43853,Bladder,57,DD38F3F6-5A39-41B7-B2EA-8917298E76D2,325DC686-E598-42C6-B2E7-3AE19B1EA4F9,TCGA-BL-A13I-11A-11D-A13U-02,HG19_Broad_variant,TCGA-BL-A13I,TCGA-BLCA,223,s3082,Harvard Medical School,Christiana Healthcare,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa830e4b0c9d6adf6beea,58cfa830e4b0c9d6adf6beea,TCGA-AP-A0LL-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-AP-A0LL-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_3_rg.sorted,TCGA-AP-A0LL-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_3_rg.sorted.bam,106.84,1.77,0.15,58cfa830e4b0c9d6adf6beea,TCGA-AP-A0LL-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LL-01A,D17668C4-5D66-4E16-8B70-B54616581AAE,Primary Tumor,Illumina HiSeq,0ea2fbb0-cc11-44d9-9706-2523b9d268be,Uterus,56,488A7462-8348-422C-91D3-7D9F0C39D25E,0D29C555-7C7C-4BBB-A4C6-E554CC758CA7,TCGA-AP-A0LL-01A-12D-A101-02,HG19_Broad_variant,TCGA-AP-A0LL,TCGA-UCEC,NA,s4595,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6cf82,58cfa832e4b0c9d6adf6cf82,TCGA-G9-6348-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_7_rg.sorted.filtered.,WGS,TCGA-G9-6348-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_7_rg.sorted,TCGA-G9-6348-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_7_rg.sorted.bam,59.4,1.9,0.14,58cfa832e4b0c9d6adf6cf82,TCGA-G9-6348-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6348-01A,8AD78C4F-C84C-4F9E-88C9-42A05EB65498,Primary Tumor,Illumina HiSeq,32ce4cfa-ee58-4c85-8e6b-9e7fd9bb6b8e,Prostate,68,A692E125-CCFC-4376-9CEA-2410511882BF,68D451D5-F3A1-46C9-BD28-05D71D2C94FC,TCGA-G9-6348-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6348,TCGA-PRAD,NA,s3447,Harvard Medical School,Roswell Park,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82fe4b0c9d6adf6b9f0,58cfa82fe4b0c9d6adf6b9f0,TCGA-A5-A0G5-10A-01D-A043_120318_SN590_0146_AC0KH7ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-A5-A0G5-10A-01D-A043_120318_SN590_0146_AC0KH7ACXX_s_2_rg.sorted,TCGA-A5-A0G5-10A-01D-A043_120318_SN590_0146_AC0KH7ACXX_s_2_rg.sorted.bam,16.99,1.85,0.14,58cfa82fe4b0c9d6adf6b9f0,TCGA-A5-A0G5-10A-01D-A043_120318_SN590_0146_AC0KH7ACXX_s_2_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0G5-10A,4806D9A6-E65D-4A82-B422-1B287980A0C6,Blood Derived Normal,Illumina HiSeq,a28c40ec-cbba-4ed8-ace9-208d66dc0e8b,Uterus,73,F15B93DA-B9EF-4DD7-92E9-B6A8926A3A75,3554D67F-1ED4-4F7D-AB2E-83DD0B79F8BC,TCGA-A5-A0G5-10A-01D-A043-02,HG19_Broad_variant,TCGA-A5-A0G5,TCGA-UCEC,NA,s4587,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6c2db,58cfa830e4b0c9d6adf6c2db,TCGA-C4-A0F0-01A-12D-A10R_120926_SN590_0181_AC19HCACXX_s_5_rg.sorted.filtered.,WGS,TCGA-C4-A0F0-01A-12D-A10R_120926_SN590_0181_AC19HCACXX_s_5_rg.sorted,TCGA-C4-A0F0-01A-12D-A10R_120926_SN590_0181_AC19HCACXX_s_5_rg.sorted.bam,13.51,1.77,0.15,58cfa830e4b0c9d6adf6c2db,TCGA-C4-A0F0-01A-12D-A10R_120926_SN590_0181_AC19HCACXX_s_5_rg.sorted.bam,Alive,MALE,Not available,Not available,Bladder Urothelial Carcinoma,Aligned reads,TCGA-C4-A0F0-01A,40398C03-A9CC-476B-9EE9-AECF161BE43F,Primary Tumor,Illumina HiSeq,38f56daa-7d69-4fe0-8895-10e22397ee2a,Bladder,60,54234A11-8674-4B01-B2EF-A4C6D772AA43,5584A4A7-2EA1-46D8-8960-8905689D5720,TCGA-C4-A0F0-01A-12D-A10R-02,HG19_Broad_variant,TCGA-C4-A0F0,TCGA-BLCA,NA,s2862,Harvard Medical School,Indivumed,Germany,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa830e4b0c9d6adf6bf50,58cfa830e4b0c9d6adf6bf50,TCGA-BR-4279-11A-01D-1128_121127_SN208_0441_BC1F8CACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BR-4279-11A-01D-1128_121127_SN208_0441_BC1F8CACXX_s_2_rg.sorted,TCGA-BR-4279-11A-01D-1128_121127_SN208_0441_BC1F8CACXX_s_2_rg.sorted.bam,7.9,1.9,0.16,58cfa830e4b0c9d6adf6bf50,TCGA-BR-4279-11A-01D-1128_121127_SN208_0441_BC1F8CACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4279-11A,117EB38B-0C62-4336-A866-FA5BD013256A,Solid Tissue Normal,Illumina HiSeq,1fc5b32a-8266-4f98-8444-a219ed9631a2,Stomach,43,B87F1A8B-9A6A-44AE-BB89-686186F2FD2D,BB0A8962-7A53-4786-B7E5-ADE753A3D009,TCGA-BR-4279-11A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4279,TCGA-STAD,NA,s15101,Harvard Medical School,Asterand,Russia,NO,T2a,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa832e4b0c9d6adf6cf46,58cfa832e4b0c9d6adf6cf46,TCGA-G9-6371-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-G9-6371-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_7_rg.sorted,TCGA-G9-6371-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_7_rg.sorted.bam,59.4,2,0.17,58cfa832e4b0c9d6adf6cf46,TCGA-G9-6371-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6371-01A,D5C43A14-21AB-4178-AE33-2D8B7BAA256F,Primary Tumor,Illumina HiSeq,46c365e2-d78e-45ed-8356-c9ad57629c34,Prostate,58,2F91086C-ADCD-4A79-96AA-58819AB28A57,570A6B67-7527-4F71-B37F-5D9102648470,TCGA-G9-6371-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6371,TCGA-PRAD,NA,s3798,Harvard Medical School,Roswell Park,United States,NO,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c236,58cfa830e4b0c9d6adf6c236,TCGA-BJ-A0Z3-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BJ-A0Z3-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_7_rg.sorted,TCGA-BJ-A0Z3-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_7_rg.sorted.bam,64.48,1.98,0.16,58cfa830e4b0c9d6adf6c236,TCGA-BJ-A0Z3-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0Z3-01A,331CAE6E-2868-4C58-9302-709A9FF7D025,Primary Tumor,Illumina HiSeq,ddae4f5a-aed4-4466-9434-23f6ed312d19,Thyroid,33,6BF032C1-B7D5-4B1C-BF41-C9BFEAFA5E7A,3D0982B1-944E-4C03-AAA4-F8FD4602D4C9,TCGA-BJ-A0Z3-01A-11D-A13U-02,HG19_Broad_variant,TCGA-BJ-A0Z3,TCGA-THCA,NA,s12628,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6d03c,58cfa832e4b0c9d6adf6d03c,TCGA-G9-6336-10A-01D-1784_130115_SN590_0208_BD1TAGACXX_s_6_rg.sorted.filtered.,WGS,TCGA-G9-6336-10A-01D-1784_130115_SN590_0208_BD1TAGACXX_s_6_rg.sorted,TCGA-G9-6336-10A-01D-1784_130115_SN590_0208_BD1TAGACXX_s_6_rg.sorted.bam,16.7,1.9,0.13,58cfa832e4b0c9d6adf6d03c,TCGA-G9-6336-10A-01D-1784_130115_SN590_0208_BD1TAGACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6336-10A,59207BCD-F127-481F-B576-8716DA7D7D97,Blood Derived Normal,Illumina HiSeq,1b1f382a-4dbf-432b-88ed-e94a3d9a55b3,Prostate,57,71864139-EC05-4BB1-9DF7-27954283261E,C92E8498-68AE-4F04-81C6-1F8B028F2403,TCGA-G9-6336-10A-01D-1784-02,HG19_Broad_variant,TCGA-G9-6336,TCGA-PRAD,NA,s3450,Harvard Medical School,Roswell Park,United States,NO,Not available,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cc08,58cfa831e4b0c9d6adf6cc08,TCGA-EE-A2A1-06A-11D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EE-A2A1-06A-11D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_3_rg.sorted,TCGA-EE-A2A1-06A-11D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_3_rg.sorted.bam,55.01,NA,0.17,58cfa831e4b0c9d6adf6cc08,TCGA-EE-A2A1-06A-11D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2A1-06A,A92E70E1-C57D-45EF-A822-33B361C22291,Metastatic,Illumina HiSeq,d2b1ca54-da4a-4eba-8e02-a1cc07f55639,Skin,46,70BEAF75-9B5D-47F7-AC73-AB7C99984C8B,BD64EE85-341B-4D5A-8DDE-17898F3CDC99,TCGA-EE-A2A1-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2A1,TCGA-SKCM,NA,s7332,Harvard Medical School,University of Sydney,Australia,NO,T2a,N0,Not available,Stage IB
13722.58cfa831e4b0c9d6adf6c8f2,58cfa831e4b0c9d6adf6c8f2,TCGA-CV-5976-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CV-5976-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_2_rg.sorted,TCGA-CV-5976-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_2_rg.sorted.bam,135,1.9,0.15,58cfa831e4b0c9d6adf6c8f2,TCGA-CV-5976-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5976-01A,23062172-7361-4E61-8EE6-B0A613D72A24,Primary Tumor,Illumina HiSeq,ef7745ae-17be-41bc-a3a5-c24eeda89075,Head and Neck,50,EEF68956-D624-4CD0-9C48-28FAF052C5F9,2581BC16-0DEF-40BC-8A97-54A1AE577E26,TCGA-CV-5976-01A-11D-1681-02,HG19_Broad_variant,TCGA-CV-5976,TCGA-HNSC,NA,s16041,Harvard Medical School,MD Anderson Cancer Center,None,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6d006,58cfa832e4b0c9d6adf6d006,TCGA-FS-A1ZF-10A-01D-A190_120605_SN1222_0113_BC0WUCACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FS-A1ZF-10A-01D-A190_120605_SN1222_0113_BC0WUCACXX_s_8_rg.sorted,TCGA-FS-A1ZF-10A-01D-A190_120605_SN1222_0113_BC0WUCACXX_s_8_rg.sorted.bam,48.76,NA,0.17,58cfa832e4b0c9d6adf6d006,TCGA-FS-A1ZF-10A-01D-A190_120605_SN1222_0113_BC0WUCACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZF-10A,E0D36CC0-652C-4224-BB10-09D15C7BD8F1,Blood Derived Normal,Illumina HiSeq,33a85bcf-963a-4790-bd1f-1c7d28f1db24,Skin,78,1F3F382C-3210-48A1-9C02-772321216C5C,3A3F2B88-9E3A-4B69-99E2-D6B98C5F465A,TCGA-FS-A1ZF-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZF,TCGA-SKCM,470,s7369,Harvard Medical School,Essen,Germany,NO,T4b,N0,Not available,Stage IIC
13722.58cfa831e4b0c9d6adf6ccb6,58cfa831e4b0c9d6adf6ccb6,TCGA-EE-A2ML-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EE-A2ML-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_3_rg.sorted,TCGA-EE-A2ML-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_3_rg.sorted.bam,60.49,NA,0.15,58cfa831e4b0c9d6adf6ccb6,TCGA-EE-A2ML-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2ML-06A,01CFBFAE-F344-439D-AEAB-A9E15D636325,Metastatic,Illumina HiSeq,2336ae9f-4b2d-45d1-853f-e0ed0b651e71,Skin,35,0CD2BB77-7E7F-4CA7-8E5F-87BC5B46C550,A77E44A0-C4ED-45C0-B21A-1B6DEE9B1EFB,TCGA-EE-A2ML-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2ML,TCGA-SKCM,NA,s7688,Harvard Medical School,University of Sydney,Australia,NO,T3a,N0,Not available,Stage II
13722.58cfa832e4b0c9d6adf6ce32,58cfa832e4b0c9d6adf6ce32,TCGA-ER-A2NF-10A-01D-A18Z_120516_SN1222_0107_BD12HYACXX_s_4_rg.sorted.filtered.,WGS,TCGA-ER-A2NF-10A-01D-A18Z_120516_SN1222_0107_BD12HYACXX_s_4_rg.sorted,TCGA-ER-A2NF-10A-01D-A18Z_120516_SN1222_0107_BD12HYACXX_s_4_rg.sorted.bam,15.51,NA,0.17,58cfa832e4b0c9d6adf6ce32,TCGA-ER-A2NF-10A-01D-A18Z_120516_SN1222_0107_BD12HYACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A2NF-10A,D32A4219-4CCA-470F-B6B3-11447D9F5E0B,Blood Derived Normal,Illumina HiSeq,d65224cb-bbae-42de-884a-9a237085e215,Skin,53,C3CE1857-971F-4416-9F5A-2AA029C6C75A,F621CC23-047B-4E89-B6D6-B407FF00C7A3,TCGA-ER-A2NF-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-ER-A2NF,TCGA-SKCM,NA,s8020,Harvard Medical School,University of Pittsburgh,None,NO,T4b,N3,Not available,Stage IIIC
13722.58cfa831e4b0c9d6adf6c3b0,58cfa831e4b0c9d6adf6c3b0,TCGA-BH-A0H7-01A-13D-A060_130725_SN590_0233_AD2B3HACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BH-A0H7-01A-13D-A060_130725_SN590_0233_AD2B3HACXX_s_7_rg.sorted,TCGA-BH-A0H7-01A-13D-A060_130725_SN590_0233_AD2B3HACXX_s_7_rg.sorted.bam,20.53,2,0.15,58cfa831e4b0c9d6adf6c3b0,TCGA-BH-A0H7-01A-13D-A060_130725_SN590_0233_AD2B3HACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0H7-01A,2021ED1F-DC75-4701-B8B8-1386466E4802,Primary Tumor,Illumina HiSeq,d5ab471a-88d1-4966-865a-f7fa29214fe4,Breast,65,69BFA6CE-ED46-4321-A107-347C49D68951,E0E60B71-1EFA-4896-B89F-D05974CDCF48,TCGA-BH-A0H7-01A-13D-A060-02,HG19_Broad_variant,TCGA-BH-A0H7,TCGA-BRCA,NA,s5801,Harvard Medical School,University of Pittsburgh,None,NO,T1c,N2a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa831e4b0c9d6adf6c740,58cfa831e4b0c9d6adf6c740,TCGA-D3-A3C8-10A-01D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-D3-A3C8-10A-01D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_6_rg.sorted,TCGA-D3-A3C8-10A-01D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_6_rg.sorted.bam,18.14,NA,0.17,58cfa831e4b0c9d6adf6c740,TCGA-D3-A3C8-10A-01D-A18Z_120626_SN590_0163_AC0VU5ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A3C8-10A,16182443-12A1-4B0F-A6AB-33C2942E2991,Blood Derived Normal,Illumina HiSeq,8cb73a3e-5bb3-4c87-9f23-3c223fc0af0a,Skin,58,5DBB9CC8-5C79-4C61-B414-39C9030AB221,FFE107B9-1019-47D7-90DC-3900385015A8,TCGA-D3-A3C8-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-D3-A3C8,TCGA-SKCM,NA,s8000,Harvard Medical School,MD Anderson,United States,NO,TX,N3,Not available,Stage IIIC
13722.58cfa832e4b0c9d6adf6d396,58cfa832e4b0c9d6adf6d396,TCGA-L5-A43E-11A-11D-A248_130115_SN590_0207_AC1H8PACXX_s_4_rg.sorted.filtered.,WGS,TCGA-L5-A43E-11A-11D-A248_130115_SN590_0207_AC1H8PACXX_s_4_rg.sorted,TCGA-L5-A43E-11A-11D-A248_130115_SN590_0207_AC1H8PACXX_s_4_rg.sorted.bam,14.98,NA,0.16,58cfa832e4b0c9d6adf6d396,TCGA-L5-A43E-11A-11D-A248_130115_SN590_0207_AC1H8PACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A43E-11A,6969FE5A-5993-48E5-95C5-C5C7D3D08205,Solid Tissue Normal,Illumina HiSeq,56fca640-d695-4f90-abab-4a31202952f6,Esophagus,74,02E7E003-B682-4391-9FEC-88E27CF9C858,740A8D74-AC91-4BC8-98AF-973F22410956,TCGA-L5-A43E-11A-11D-A248-26,HG19_Broad_variant,TCGA-L5-A43E,TCGA-ESCA,NA,s1740,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T1,N0,Not available,Stage I
13722.58cfa832e4b0c9d6adf6ceb1,58cfa832e4b0c9d6adf6ceb1,TCGA-EM-A1CW-11A-12D-A13U_120706_SN1222_0122_AC0WPYACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EM-A1CW-11A-12D-A13U_120706_SN1222_0122_AC0WPYACXX_s_6_rg.sorted,TCGA-EM-A1CW-11A-12D-A13U_120706_SN1222_0122_AC0WPYACXX_s_6_rg.sorted.bam,36.84,1.82,0.15,58cfa832e4b0c9d6adf6ceb1,TCGA-EM-A1CW-11A-12D-A13U_120706_SN1222_0122_AC0WPYACXX_s_6_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1CW-11A,22EB9F00-6869-4D8F-B657-DFD64F81E9E9,Solid Tissue Normal,Illumina HiSeq,835978aa-a34d-4803-8f67-b150df22dbb1,Thyroid,39,66990135-F339-4195-855B-A95AB74B4FE4,87592E6E-4EF0-4D83-B2A5-4B52FA10B36A,TCGA-EM-A1CW-11A-12D-A13U-02,HG19_Broad_variant,TCGA-EM-A1CW,TCGA-THCA,NA,s12110,Harvard Medical School,University Health Network,Canada,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa832e4b0c9d6adf6ce66,58cfa832e4b0c9d6adf6ce66,TCGA-GN-A266-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_4_rg.sorted.filtered.,WGS,TCGA-GN-A266-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_4_rg.sorted,TCGA-GN-A266-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_4_rg.sorted.bam,37.9,NA,0.17,58cfa832e4b0c9d6adf6ce66,TCGA-GN-A266-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-GN-A266-10A,3429967F-4F77-4894-BF27-C4A22698CA92,Blood Derived Normal,Illumina HiSeq,59df09f9-be81-41ce-bb63-1a6f3ce58efc,Skin,45,35D85937-9F8A-4DFC-8CE2-FA6E913AF9F3,7F4405F2-9D42-405C-8291-5C332DAD2591,TCGA-GN-A266-10A-01D-A190-02,HG19_Broad_variant,TCGA-GN-A266,TCGA-SKCM,308,s7375,Harvard Medical School,Roswell,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6c136,58cfa830e4b0c9d6adf6c136,TCGA-BS-A0UJ-01A-12D-A101_120407_SN590_0151_BC0KKJACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BS-A0UJ-01A-12D-A101_120407_SN590_0151_BC0KKJACXX_s_3_rg.sorted,TCGA-BS-A0UJ-01A-12D-A101_120407_SN590_0151_BC0KKJACXX_s_3_rg.sorted.bam,125.71,2,0.17,58cfa830e4b0c9d6adf6c136,TCGA-BS-A0UJ-01A-12D-A101_120407_SN590_0151_BC0KKJACXX_s_3_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0UJ-01A,FF82548A-F1BB-4DAA-A8F7-B3831B5843AD,Primary Tumor,Illumina HiSeq,094adbd4-f2af-42bb-9509-0dcfa2c6672f,Uterus,68,2EA1339F-A5EB-4552-AC13-858FA70E606E,15FDA615-0A79-4211-B5DE-F61741E8937A,TCGA-BS-A0UJ-01A-12D-A101-02,HG19_Broad_variant,TCGA-BS-A0UJ,TCGA-UCEC,NA,s5221,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c931,58cfa831e4b0c9d6adf6c931,TCGA-DQ-5624-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DQ-5624-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_6_rg.sorted,TCGA-DQ-5624-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_6_rg.sorted.bam,33,1.9,0.15,58cfa831e4b0c9d6adf6c931,TCGA-DQ-5624-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-DQ-5624-10A,B4A41682-4ACA-4F1D-BACD-66F5E6EC7466,Blood Derived Normal,Illumina HiSeq,72bf54c2-0056-4578-8448-34fb30ed8b3a,Head and Neck,43,A782129D-F444-45AB-AFEC-0F45B369B258,55E14906-C54C-495E-B360-0384B230200D,TCGA-DQ-5624-10A-01D-1868-02,HG19_Broad_variant,TCGA-DQ-5624,TCGA-HNSC,NA,s15786,Harvard Medical School,University of Michigan,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6be64,58cfa830e4b0c9d6adf6be64,TCGA-BJ-A3PR-11A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BJ-A3PR-11A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_7_rg.sorted,TCGA-BJ-A3PR-11A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_7_rg.sorted.bam,32.54,NA,0.15,58cfa830e4b0c9d6adf6be64,TCGA-BJ-A3PR-11A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A3PR-11A,FD036EC5-3FFB-40B1-8002-943BE0E2532E,Solid Tissue Normal,Illumina HiSeq,4e71bc35-c98b-4880-9538-13d5c74139d2,Thyroid,69,3C13C880-E3E3-4C49-B486-C4388F8C33F3,8EE14781-7682-49F7-BD24-B11B095F2BC3,TCGA-BJ-A3PR-11A-11D-A221-26,HG19_Broad_variant,TCGA-BJ-A3PR,TCGA-THCA,NA,s12847,MD Anderson - Institute for Applied Cancer Science,University of Pittsburgh,United States,NO,T1a,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c803,58cfa831e4b0c9d6adf6c803,TCGA-D1-A16N-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_2_rg.sorted.filtered.,WGS,TCGA-D1-A16N-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_2_rg.sorted,TCGA-D1-A16N-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_2_rg.sorted.bam,99.18,1.97,0.15,58cfa831e4b0c9d6adf6c803,TCGA-D1-A16N-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A16N-01A,DBBBDDAE-D711-40F5-BD10-863735885B1F,Primary Tumor,Illumina HiSeq,0cea9a43-7170-4273-879f-084cb6e14196,Uterus,51,6D916A47-DCFF-4C98-9E88-348AAA353F98,133CBA56-19C9-47AE-AB5E-37FF35A7E71E,TCGA-D1-A16N-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A16N,TCGA-UCEC,NA,s4263,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b880,58cfa82fe4b0c9d6adf6b880,TCGA-A5-A0VP-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-A5-A0VP-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_6_rg.sorted,TCGA-A5-A0VP-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_6_rg.sorted.bam,13.28,2,0.16,58cfa82fe4b0c9d6adf6b880,TCGA-A5-A0VP-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0VP-10A,2DB0FB62-64CE-457C-9E22-DD05EF59F684,Blood Derived Normal,Illumina HiSeq,704b6bd0-471d-4b24-8b66-d1e9cba7e424,Uterus,74,75E2A958-78F2-42A7-BEF2-1C2E68DC2BBF,C52324E4-AF6B-478B-BDA8-D0CF8A811C09,TCGA-A5-A0VP-10A-01D-A101-02,HG19_Broad_variant,TCGA-A5-A0VP,TCGA-UCEC,NA,s4776,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6be88,58cfa830e4b0c9d6adf6be88,TCGA-BJ-A291-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BJ-A291-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_8_rg.sorted,TCGA-BJ-A291-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_8_rg.sorted.bam,30.94,1.89,0.15,58cfa830e4b0c9d6adf6be88,TCGA-BJ-A291-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A291-01A,D4C68C1C-A3F3-4E0C-B555-D457378A1D24,Primary Tumor,Illumina HiSeq,bb0bf0e4-e29d-422a-879e-b8dc7f5c720b,Thyroid,56,D1612961-A709-487B-A4D1-CE42F0B9AA54,E28A1E8B-41A3-44C0-ADBC-6A203C92DDF5,TCGA-BJ-A291-01A-11D-A16N-02,HG19_Broad_variant,TCGA-BJ-A291,TCGA-THCA,NA,s11990,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6d288,58cfa832e4b0c9d6adf6d288,TCGA-HT-7476-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_6_rg.sorted.filtered.,WGS,TCGA-HT-7476-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_6_rg.sorted,TCGA-HT-7476-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_6_rg.sorted.bam,31.7,NA,0.15,58cfa832e4b0c9d6adf6d288,TCGA-HT-7476-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7476-01A,27D0D3CB-16C0-4BA8-9662-95917F665004,Primary Tumor,Illumina HiSeq,8eda6747-01ab-4378-b3c9-6f638de37412,Brain,26,50823838-03B8-4CD8-A40D-8439011C9B38,06ABBC57-F759-43B4-AD0A-3CEE74E012B5,TCGA-HT-7476-01A-11D-2022-02,HG19_Broad_variant,TCGA-HT-7476,TCGA-LGG,NA,s8370,Harvard Medical School,Case Western - St Joes,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa82fe4b0c9d6adf6b680,58cfa82fe4b0c9d6adf6b680,TCGA-49-4488-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_1_rg.sorted.filtered.,WGS,TCGA-49-4488-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_1_rg.sorted,TCGA-49-4488-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_1_rg.sorted.bam,195.4,1.9,0.14,58cfa82fe4b0c9d6adf6b680,TCGA-49-4488-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4488-01A,D721BFE0-90E3-415E-B9F3-1A270EFA5FBB,Primary Tumor,Illumina HiSeq,26421230-2518-42aa-85ee-f9c83d47a6ba,Lung,74,1AEA8530-43FD-47EA-A2F1-377267DC9D33,DA0D3199-053B-4789-A217-CA2BFB83D57E,TCGA-49-4488-01A-01D-1751-02,HG19_Broad_variant,TCGA-49-4488,TCGA-LUAD,869,s11236,Harvard Medical School,Johns Hopkins,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6c8eb,58cfa831e4b0c9d6adf6c8eb,TCGA-D7-6524-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_6_rg.sorted.filtered.,WGS,TCGA-D7-6524-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_6_rg.sorted,TCGA-D7-6524-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_6_rg.sorted.bam,156.7,1.9,0.15,58cfa831e4b0c9d6adf6c8eb,TCGA-D7-6524-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6524-10A,7EF3F065-1928-4A58-B5A6-76DDDB8488CF,Blood Derived Normal,Illumina HiSeq,53a3658a-e190-413c-904b-1f8bf1ddf4ee,Stomach,53,87288983-703E-485D-B236-7EBACBFE9086,CD98C312-9C0F-4923-BBCA-7BCF722DE68B,TCGA-D7-6524-10A-01D-1798-02,HG19_Broad_variant,TCGA-D7-6524,TCGA-STAD,NA,s14420,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N1,Stomach  Adenocarcinoma  Diffuse Type,Stage II
13722.58cfa831e4b0c9d6adf6c5da,58cfa831e4b0c9d6adf6c5da,TCGA-CN-5366-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CN-5366-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_5_rg.sorted,TCGA-CN-5366-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_5_rg.sorted.bam,31.4,1.9,0.15,58cfa831e4b0c9d6adf6c5da,TCGA-CN-5366-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5366-10A,30EB06A5-8E88-4C46-BEBB-FB93CA07F108,Blood Derived Normal,Illumina HiSeq,8d6d4c85-46e4-449c-9bc1-f75a4af110a6,Head and Neck,51,111AD944-F78E-4EC6-967B-F05C49B49B1C,1683419A-F9D7-4484-A65B-B5A1DE47D1EB,TCGA-CN-5366-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5366,TCGA-HNSC,360,s16322,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6cfae,58cfa832e4b0c9d6adf6cfae,TCGA-G9-6342-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_8_rg.sorted.filtered.,WGS,TCGA-G9-6342-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_8_rg.sorted,TCGA-G9-6342-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_8_rg.sorted.bam,45,1.8,0.14,58cfa832e4b0c9d6adf6cfae,TCGA-G9-6342-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6342-10A,00E41E6A-9FE7-44F9-978B-7B05B179506A,Blood Derived Normal,Illumina HiSeq,28236670-c301-4b5e-a898-f0d264f00b8a,Prostate,61,B9CBE7E7-9C36-4964-B2CD-085B261F6BC3,D34FDC30-1501-4986-83AB-BD5F2872240E,TCGA-G9-6342-10A-01D-1957-02,HG19_Broad_variant,TCGA-G9-6342,TCGA-PRAD,NA,s4150,Harvard Medical School,Roswell Park,United States,NO,T3a,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c5c8,58cfa831e4b0c9d6adf6c5c8,TCGA-CG-4469-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_7_rg.sorted.filtered.,WGS,TCGA-CG-4469-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_7_rg.sorted,TCGA-CG-4469-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_7_rg.sorted.bam,298.2,1.9,0.14,58cfa831e4b0c9d6adf6c5c8,TCGA-CG-4469-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_7_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4469-01A,2AC986F6-CD6F-4CA5-90CC-7A105CFE85EA,Primary Tumor,Illumina HiSeq,ed99ca3f-0ae6-43ab-a171-dc2774cf52e2,Stomach,70,2A3D7538-D377-4D94-BB61-BF77BA56BE1B,9BAFEA4B-CCC4-4F5D-8BFE-BD13D56741F6,TCGA-CG-4469-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4469,TCGA-STAD,215,s14988,Harvard Medical School,Indivumed,Germany,NO,T3,N3,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa831e4b0c9d6adf6c85a,58cfa831e4b0c9d6adf6c85a,TCGA-D6-6825-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-D6-6825-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_6_rg.sorted,TCGA-D6-6825-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_6_rg.sorted.bam,530,1.9,0.15,58cfa831e4b0c9d6adf6c85a,TCGA-D6-6825-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-D6-6825-10A,42BC2336-2408-441A-83B9-AADC9700F750,Blood Derived Normal,Illumina HiSeq,dac94d31-7c1f-4e4b-98af-a3a585b86fae,Head and Neck,73,2D4DD757-4C4F-49E4-B5BA-84BCAE21C5FD,222663D9-DF98-4A0B-88EB-83FCB81BCB0A,TCGA-D6-6825-10A-01D-1911-02,HG19_Broad_variant,TCGA-D6-6825,TCGA-HNSC,NA,s15656,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6cc7a,58cfa831e4b0c9d6adf6cc7a,TCGA-ER-A19E-06A-11D-A18Y_120723_SN1120_0177_AC11GTACXX_s_2_rg.sorted.filtered.,WGS,TCGA-ER-A19E-06A-11D-A18Y_120723_SN1120_0177_AC11GTACXX_s_2_rg.sorted,TCGA-ER-A19E-06A-11D-A18Y_120723_SN1120_0177_AC11GTACXX_s_2_rg.sorted.bam,30.72,NA,0.16,58cfa831e4b0c9d6adf6cc7a,TCGA-ER-A19E-06A-11D-A18Y_120723_SN1120_0177_AC11GTACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19E-06A,3FEA3F02-2DB3-44E0-984E-C61130D92C9B,Metastatic,Illumina HiSeq,d3874936-da5d-479f-8c3c-1f3d9306dde2,Skin,36,96BB672C-48FB-4AAE-9FA5-7CEAF98E5348,189A39F9-D385-4DBE-9DE6-0CDBB00E0BDA,TCGA-ER-A19E-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-ER-A19E,TCGA-SKCM,396,s7859,Harvard Medical School,University of Pittsburgh,United States,NO,T2a,N0,Not available,Stage IB
13722.58cfa82fe4b0c9d6adf6b6c1,58cfa82fe4b0c9d6adf6b6c1,TCGA-44-6775-10A-01D-1853_111207_SN590_0112_D09CDACXX_s_5_rg.sorted.filtered.,WGS,TCGA-44-6775-10A-01D-1853_111207_SN590_0112_D09CDACXX_s_5_rg.sorted,TCGA-44-6775-10A-01D-1853_111207_SN590_0112_D09CDACXX_s_5_rg.sorted.bam,489.3,1.9,0.16,58cfa82fe4b0c9d6adf6b6c1,TCGA-44-6775-10A-01D-1853_111207_SN590_0112_D09CDACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-6775-10A,3C4FF061-D214-4D1C-8D2E-3034F207C252,Blood Derived Normal,Illumina HiSeq,797b054a-91c8-4360-8f90-8f4aea0d25cd,Lung,72,18129C77-70F2-4DB9-9B5B-39E6D9C429A0,93BC6F55-FDB1-4BCA-B07B-3370CBD8D402,TCGA-44-6775-10A-01D-1853-02,HG19_Broad_variant,TCGA-44-6775,TCGA-LUAD,NA,s10658,Harvard Medical School,Christiana Healthcare,United States,NO,T2a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c5e2,58cfa831e4b0c9d6adf6c5e2,TCGA-CG-4300-10A-01D-1154_130815_VM001_0003_VMR0003CXX_s_4_rg.sorted.filtered.,WGS,TCGA-CG-4300-10A-01D-1154_130815_VM001_0003_VMR0003CXX_s_4_rg.sorted,TCGA-CG-4300-10A-01D-1154_130815_VM001_0003_VMR0003CXX_s_4_rg.sorted.bam,136.6,1.9,0.15,58cfa831e4b0c9d6adf6c5e2,TCGA-CG-4300-10A-01D-1154_130815_VM001_0003_VMR0003CXX_s_4_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4300-10A,8ED901F6-D1BC-48B1-8514-6E8C066DC160,Blood Derived Normal,Illumina HiSeq,059e7973-6498-492c-b3a6-9adc84950f18,Stomach,79,D3396AE2-DF13-47B9-B955-ACBA8C222255,295E29A6-5CA9-4C89-84C4-679AC988A1F6,TCGA-CG-4300-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4300,TCGA-STAD,609,s15393,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIB
13722.58cfa831e4b0c9d6adf6c848,58cfa831e4b0c9d6adf6c848,TCGA-D6-6823-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-D6-6823-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_5_rg.sorted,TCGA-D6-6823-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_5_rg.sorted.bam,658,1.9,0.15,58cfa831e4b0c9d6adf6c848,TCGA-D6-6823-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-D6-6823-10A,FBDAB01C-191C-4AEF-9451-CA3AFEC55FA1,Blood Derived Normal,Illumina HiSeq,60900e52-222a-400c-9981-8ea2dfba4553,Head and Neck,50,3CA51C87-28F6-4269-A387-D9D89E8FBA56,0B3ABCE7-4747-4354-8481-EEB667C705EE,TCGA-D6-6823-10A-01D-1911-02,HG19_Broad_variant,TCGA-D6-6823,TCGA-HNSC,NA,s15654,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa832e4b0c9d6adf6d1d3,58cfa832e4b0c9d6adf6d1d3,TCGA-HI-7168-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-HI-7168-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_2_rg.sorted,TCGA-HI-7168-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_2_rg.sorted.bam,130.6,NA,0.16,58cfa832e4b0c9d6adf6d1d3,TCGA-HI-7168-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HI-7168-10A,25D70934-01A5-45A2-9960-68D3058B6965,Blood Derived Normal,Illumina HiSeq,ab5dab2c-9975-4682-921c-6e013cd929bb,Prostate,62,5C923E40-E32E-4656-8FF6-E3DB3B28CE2D,2B30D8C9-1DBE-4E62-9973-8819115CD82C,TCGA-HI-7168-10A-01D-2111-02,HG19_Broad_variant,TCGA-HI-7168,TCGA-PRAD,NA,s3815,Harvard Medical School,Fox Chase,United States,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bf40,58cfa830e4b0c9d6adf6bf40,TCGA-AX-A1CJ-01A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-AX-A1CJ-01A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_5_rg.sorted,TCGA-AX-A1CJ-01A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_5_rg.sorted.bam,100.97,1.91,0.17,58cfa830e4b0c9d6adf6bf40,TCGA-AX-A1CJ-01A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_5_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A1CJ-01A,ABAF757B-F79F-40BD-96E3-E2C0F63061F0,Primary Tumor,Illumina HiSeq,f42806a5-e473-4ae8-bb1a-aa11fe2dde53,Uterus,59,72D06DDF-9FB2-4577-BFDB-B0E463105B4A,A4EE1BB7-59FF-4034-ABA1-9AF4F62B42B0,TCGA-AX-A1CJ-01A-11D-A133-02,HG19_Broad_variant,TCGA-AX-A1CJ,TCGA-UCEC,NA,s5388,Harvard Medical School,Gynecologic Oncology Group,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cda4,58cfa831e4b0c9d6adf6cda4,TCGA-FE-A3PB-10A-01D-A221_120524_SN1120_0144_AC0VNCACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FE-A3PB-10A-01D-A221_120524_SN1120_0144_AC0VNCACXX_s_5_rg.sorted,TCGA-FE-A3PB-10A-01D-A221_120524_SN1120_0144_AC0VNCACXX_s_5_rg.sorted.bam,17.97,NA,0.15,58cfa831e4b0c9d6adf6cda4,TCGA-FE-A3PB-10A-01D-A221_120524_SN1120_0144_AC0VNCACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A3PB-10A,05A8268A-6B33-429B-8638-8C9BB366EF28,Blood Derived Normal,Illumina HiSeq,272883da-0bff-48ff-8c9e-6010ed548b15,Thyroid,33,094C47B3-D01D-4C2A-A387-59BD13C33A89,741170E7-70D5-4B9A-94EF-B9B9B8453711,TCGA-FE-A3PB-10A-01D-A221-26,HG19_Broad_variant,TCGA-FE-A3PB,TCGA-THCA,NA,s12257,MD Anderson - Institute for Applied Cancer Science,Ohio State University,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6cf8b,58cfa832e4b0c9d6adf6cf8b,TCGA-GC-A3OO-10C-01D-A233_120913_SN208_0429_AC187FACXX_s_5_rg.sorted.filtered.,WGS,TCGA-GC-A3OO-10C-01D-A233_120913_SN208_0429_AC187FACXX_s_5_rg.sorted,TCGA-GC-A3OO-10C-01D-A233_120913_SN208_0429_AC187FACXX_s_5_rg.sorted.bam,17.37,NA,0.14,58cfa832e4b0c9d6adf6cf8b,TCGA-GC-A3OO-10C-01D-A233_120913_SN208_0429_AC187FACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GC-A3OO-10C,1FF60FD9-3CA3-43BE-92A8-8DBA2CD4D4DF,Blood Derived Normal,Illumina HiSeq,288ab04f-61f7-4278-8ac5-e7a12d87a6ae,Bladder,79,F25E0B85-356A-4745-A382-947783E92AE3,C64A9DEF-9353-4781-905A-42F24600F369,TCGA-GC-A3OO-10C-01D-A233-26,HG19_Broad_variant,TCGA-GC-A3OO,TCGA-BLCA,NA,s2925,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c7b1,58cfa831e4b0c9d6adf6c7b1,TCGA-CN-6996-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CN-6996-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_5_rg.sorted,TCGA-CN-6996-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_5_rg.sorted.bam,155.7,NA,0.15,58cfa831e4b0c9d6adf6c7b1,TCGA-CN-6996-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-6996-01A,49B94421-FE82-4F24-8EF2-820674142418,Primary Tumor,Illumina HiSeq,533cea76-ea79-4b37-8e72-5626bc894990,Head and Neck,58,2C3790CE-A54D-431B-B76C-FA25441AA41C,5367CF72-E404-4203-AD7D-CF7663072EA7,TCGA-CN-6996-01A-11D-1911-02,HG19_Broad_variant,TCGA-CN-6996,TCGA-HNSC,NA,s16180,Harvard Medical School,University of Pittsburgh,United States,NO,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6ca71,58cfa831e4b0c9d6adf6ca71,TCGA-DO-A1JZ-01A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DO-A1JZ-01A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_6_rg.sorted,TCGA-DO-A1JZ-01A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_6_rg.sorted.bam,91.81,1.77,0.15,58cfa831e4b0c9d6adf6ca71,TCGA-DO-A1JZ-01A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_6_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DO-A1JZ-01A,169F045F-1739-4B0B-9BDC-028AACA420F8,Primary Tumor,Illumina HiSeq,a349224e-f179-4a21-ae6f-5807917a484d,Thyroid,23,2EEB72CD-8A11-4ED1-87B0-3CF0C1BF1FB5,C69C86EC-D4E4-422B-88F8-AF3CE8B14148,TCGA-DO-A1JZ-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DO-A1JZ,TCGA-THCA,NA,s12377,Harvard Medical School,Medical College of Georgia,United States,NO,T2,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa831e4b0c9d6adf6c82b,58cfa831e4b0c9d6adf6c82b,TCGA-D1-A17Q-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-D1-A17Q-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_2_rg.sorted,TCGA-D1-A17Q-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_2_rg.sorted.bam,77.69,1.86,0.16,58cfa831e4b0c9d6adf6c82b,TCGA-D1-A17Q-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A17Q-01A,CA8DBBFD-8928-4E25-94C6-B875DE631BBD,Primary Tumor,Illumina HiSeq,77e56615-42dd-4c50-a518-cc93c3b80107,Uterus,54,B6ABEB01-B6EA-4AB4-AA00-AE16CFC88B7C,59FB249D-4C77-40B1-A557-98281869AC91,TCGA-D1-A17Q-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A17Q,TCGA-UCEC,NA,s4442,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b67c,58cfa82fe4b0c9d6adf6b67c,TCGA-44-6778-11A-01D-1853_120312_SN1120_0120_AD0PYGACXX_s_7_rg.sorted.filtered.,WGS,TCGA-44-6778-11A-01D-1853_120312_SN1120_0120_AD0PYGACXX_s_7_rg.sorted,TCGA-44-6778-11A-01D-1853_120312_SN1120_0120_AD0PYGACXX_s_7_rg.sorted.bam,84.7,1.9,0.15,58cfa82fe4b0c9d6adf6b67c,TCGA-44-6778-11A-01D-1853_120312_SN1120_0120_AD0PYGACXX_s_7_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-44-6778-11A,5D5CC436-6E57-4D23-A164-7F5153C2E666,Solid Tissue Normal,Illumina HiSeq,8e94334e-a21b-40fb-9b54-bc9af6bcb7c8,Lung,59,2D27ED82-5872-4628-B6B3-A3DEECCEB0DF,9E581E04-C431-49E6-8C70-DC84FBF35F00,TCGA-44-6778-11A-01D-1853-02,HG19_Broad_variant,TCGA-44-6778,TCGA-LUAD,NA,s11339,Harvard Medical School,Christiana Healthcare,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6c836,58cfa831e4b0c9d6adf6c836,TCGA-D7-6521-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_1_rg.sorted.filtered.,WGS,TCGA-D7-6521-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_1_rg.sorted,TCGA-D7-6521-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_1_rg.sorted.bam,131.4,1.9,0.14,58cfa831e4b0c9d6adf6c836,TCGA-D7-6521-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6521-01A,6DE6B8E2-03EB-4F32-B5A3-BEA73FC632B4,Primary Tumor,Illumina HiSeq,72a895e9-b1b0-4b79-a5e6-6bae340e8798,Stomach,65,C3D9FC3B-EF2A-4D02-B7A4-5D1463AD5EF3,0F49F6E2-C6C8-4F3E-8755-BAA962453E71,TCGA-D7-6521-01A-11D-1798-02,HG19_Broad_variant,TCGA-D7-6521,TCGA-STAD,NA,s14838,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2b,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA
13722.58cfa830e4b0c9d6adf6bcc6,58cfa830e4b0c9d6adf6bcc6,TCGA-AP-A0L9-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_3_rg.sorted.filtered.,WGS,TCGA-AP-A0L9-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_3_rg.sorted,TCGA-AP-A0L9-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_3_rg.sorted.bam,93.54,2.18,0.15,58cfa830e4b0c9d6adf6bcc6,TCGA-AP-A0L9-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0L9-01A,7B9947D5-E86B-4006-8890-EA5209584A88,Primary Tumor,Illumina HiSeq,df10c3ed-7978-4d58-b4f6-52a76db0994a,Uterus,71,53D0521F-10D6-4F70-9277-D99025A6B963,DAA573AF-564D-456D-8181-DF4C07B77672,TCGA-AP-A0L9-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A0L9,TCGA-UCEC,NA,s4423,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bdd4,58cfa830e4b0c9d6adf6bdd4,TCGA-BH-A0BM-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BH-A0BM-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_3_rg.sorted,TCGA-BH-A0BM-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_3_rg.sorted.bam,18.62,1.9,0.15,58cfa830e4b0c9d6adf6bdd4,TCGA-BH-A0BM-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0BM-01A,C2AEEE6C-BA10-4CF9-B560-C739580F7BF3,Primary Tumor,Illumina HiSeq,46f039c4-a705-4933-bf85-0e96e80e5024,Breast,54,5423B7F8-D2BB-47C8-9AF8-3D3E1276888C,FA99DD38-37F1-4B24-960E-617F92CDADD0,TCGA-BH-A0BM-01A-11D-A060-02,HG19_Broad_variant,TCGA-BH-A0BM,TCGA-BRCA,NA,s6772,Harvard Medical School,University of Pittsburgh,None,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa832e4b0c9d6adf6d5b4,58cfa832e4b0c9d6adf6d5b4,TCGA-LN-A49P-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-LN-A49P-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_3_rg.sorted,TCGA-LN-A49P-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_3_rg.sorted.bam,26.81,NA,0.16,58cfa832e4b0c9d6adf6d5b4,TCGA-LN-A49P-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_3_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49P-01A,B64A5F5A-5913-432E-9D08-0FF67A8C6B64,Primary Tumor,Illumina HiSeq,bc96d005-85da-45f9-924a-a168644b49c0,Esophagus,71,4B768A42-B383-40A9-9A6F-511974E9E4C8,044EA190-FCC0-41BE-99F7-274A1DDA540B,TCGA-LN-A49P-01A-11D-A248-26,HG19_Broad_variant,TCGA-LN-A49P,TCGA-ESCA,NA,s1760,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa82fe4b0c9d6adf6b62c,58cfa82fe4b0c9d6adf6b62c,TCGA-50-5941-01A-11D-1751_111007_SN590_0110_C003AACXX_s_3_rg.sorted.filtered.,WGS,TCGA-50-5941-01A-11D-1751_111007_SN590_0110_C003AACXX_s_3_rg.sorted,TCGA-50-5941-01A-11D-1751_111007_SN590_0110_C003AACXX_s_3_rg.sorted.bam,237.4,1.9,0.16,58cfa82fe4b0c9d6adf6b62c,TCGA-50-5941-01A-11D-1751_111007_SN590_0110_C003AACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-50-5941-01A,F3F024C2-52F1-400E-946C-398F5B72E6DC,Primary Tumor,Illumina HiSeq,f7c353bf-7be8-42d0-88d0-e89032718c2f,Lung,55,91719392-76CE-479F-BA05-E43BF0201CC4,666720AF-64D9-4A63-BE57-2B8E49E79413,TCGA-50-5941-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-5941,TCGA-LUAD,NA,s11128,Harvard Medical School,University of Pittsburgh,United States,NO,T2a,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa830e4b0c9d6adf6c062,58cfa830e4b0c9d6adf6c062,TCGA-B6-A0RI-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_3_rg.sorted.filtered.,WGS,TCGA-B6-A0RI-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_3_rg.sorted,TCGA-B6-A0RI-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_3_rg.sorted.bam,78.5,1.92,0.14,58cfa830e4b0c9d6adf6c062,TCGA-B6-A0RI-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0RI-01A,BFD55808-DDDD-44C3-97D7-41600497B992,Primary Tumor,Illumina HiSeq,9283f68e-d261-4afd-b0eb-0a29fdda83ca,Breast,44,973EE776-E287-4568-A43D-7B16CC0094A9,71542129-1393-4608-B81C-1767A5051763,TCGA-B6-A0RI-01A-11D-A060-02,HG19_Broad_variant,TCGA-B6-A0RI,TCGA-BRCA,NA,s6273,Harvard Medical School,Duke,United States,NO,T4b,N1b,Infiltrating Ductal Carcinoma,Stage IIIB
13722.58cfa831e4b0c9d6adf6c5dc,58cfa831e4b0c9d6adf6c5dc,TCGA-CN-5364-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CN-5364-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_8_rg.sorted,TCGA-CN-5364-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_8_rg.sorted.bam,38.4,1.9,0.14,58cfa831e4b0c9d6adf6c5dc,TCGA-CN-5364-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5364-10A,13F63218-0949-41E6-A661-C844414C45B5,Blood Derived Normal,Illumina HiSeq,2dc9d158-11f1-4d04-a6e6-8075121def2e,Head and Neck,55,7CFD419C-8485-4080-BDB3-18B33964FBDF,31CB16D7-5896-4895-AE00-46DD28092923,TCGA-CN-5364-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5364,TCGA-HNSC,493,s16185,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6c134,58cfa830e4b0c9d6adf6c134,TCGA-B6-A0RG-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_3_rg.sorted.filtered.,WGS,TCGA-B6-A0RG-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_3_rg.sorted,TCGA-B6-A0RG-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_3_rg.sorted.bam,40.26,2.11,0.15,58cfa830e4b0c9d6adf6c134,TCGA-B6-A0RG-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0RG-01A,9B13927C-7357-44FD-8385-92AE6A656B7D,Primary Tumor,Illumina HiSeq,b38ff19d-a769-4388-81e2-03263bba7985,Breast,26,B98AA84F-5144-4062-BADC-32E89368D684,E71ED8ED-7371-4423-83C8-6075A6FC7C39,TCGA-B6-A0RG-01A-11D-A060-02,HG19_Broad_variant,TCGA-B6-A0RG,TCGA-BRCA,NA,s5640,Harvard Medical School,Duke,United States,NO,T3,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa831e4b0c9d6adf6c4c4,58cfa831e4b0c9d6adf6c4c4,TCGA-CF-A27C-10A-01D-A16N_120920_SN1222_0151_BD1D5CACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CF-A27C-10A-01D-A16N_120920_SN1222_0151_BD1D5CACXX_s_8_rg.sorted,TCGA-CF-A27C-10A-01D-A16N_120920_SN1222_0151_BD1D5CACXX_s_8_rg.sorted.bam,178.36,1.89,0.18,58cfa831e4b0c9d6adf6c4c4,TCGA-CF-A27C-10A-01D-A16N_120920_SN1222_0151_BD1D5CACXX_s_8_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CF-A27C-10A,7FEE9D6F-C0EA-43C2-89C2-66D965A077A8,Blood Derived Normal,Illumina HiSeq,0152aa29-570c-4966-b98d-5b7f4cf31305,Bladder,52,1C4C59DC-B0B3-48B0-9888-42891CF1E8F8,6D4B14CF-5E4E-4DE2-B809-79CBAC40F7B8,TCGA-CF-A27C-10A-01D-A16N-02,HG19_Broad_variant,TCGA-CF-A27C,TCGA-BLCA,NA,s2878,Harvard Medical School,ILSbio,Vietnam,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6d1dc,58cfa832e4b0c9d6adf6d1dc,TCGA-HT-7473-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_4_rg.sorted.filtered.,WGS,TCGA-HT-7473-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_4_rg.sorted,TCGA-HT-7473-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_4_rg.sorted.bam,122.7,NA,0.15,58cfa832e4b0c9d6adf6d1dc,TCGA-HT-7473-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7473-01A,DBFACCB0-E8C0-48E8-9AEF-570267574822,Primary Tumor,Illumina HiSeq,0c3613f1-9a5e-42d1-a1a9-884cf56894f4,Brain,28,D302390B-4B66-48E6-92DE-612504B34FA3,A664FDA7-9BF1-4016-A16A-BCA75C6D139C,TCGA-HT-7473-01A-11D-2022-02,HG19_Broad_variant,TCGA-HT-7473,TCGA-LGG,NA,s8154,Harvard Medical School,Case Western - St Joes,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa831e4b0c9d6adf6c3ca,58cfa831e4b0c9d6adf6c3ca,TCGA-CG-5724-11A-01D-1598_121011_SN208_0434_AC18MYACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CG-5724-11A-01D-1598_121011_SN208_0434_AC18MYACXX_s_8_rg.sorted,TCGA-CG-5724-11A-01D-1598_121011_SN208_0434_AC18MYACXX_s_8_rg.sorted.bam,261,1.9,0.15,58cfa831e4b0c9d6adf6c3ca,TCGA-CG-5724-11A-01D-1598_121011_SN208_0434_AC18MYACXX_s_8_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5724-11A,0B4E8D73-459D-4930-9D1A-ABB8D53E1844,Solid Tissue Normal,Illumina HiSeq,4289e6b1-841a-44f2-adf3-c4729a04518c,Stomach,59,4074EB62-5EBC-4305-A437-7689B76E6F71,5216A2FE-BD9F-47F9-899E-4531A80AF2FC,TCGA-CG-5724-11A-01D-1598-02,HG19_Broad_variant,TCGA-CG-5724,TCGA-STAD,366,s15194,Harvard Medical School,Indivumed,Germany,NO,T3,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IV
13722.58cfa831e4b0c9d6adf6c6f0,58cfa831e4b0c9d6adf6c6f0,TCGA-CV-5439-11B-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CV-5439-11B-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_5_rg.sorted,TCGA-CV-5439-11B-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_5_rg.sorted.bam,32,1.8,0.14,58cfa831e4b0c9d6adf6c6f0,TCGA-CV-5439-11B-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5439-11B,3EE863DA-7991-414F-82D8-2B6502D4C061,Solid Tissue Normal,Illumina HiSeq,f81e667a-9c30-4093-8e59-c8fa7f8b772c,Head and Neck,62,23F2A9BF-D544-407E-A074-AD7CA9614D7D,82E05280-64DC-4926-931F-B24196B966AF,TCGA-CV-5439-11B-01D-1681-02,HG19_Broad_variant,TCGA-CV-5439,TCGA-HNSC,546,s15513,Harvard Medical School,MD Anderson Cancer Center,None,NO,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6c214,58cfa830e4b0c9d6adf6c214,TCGA-BA-4077-01B-01D-1431_120310_SN590_0145_BD0RGYACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BA-4077-01B-01D-1431_120310_SN590_0145_BD0RGYACXX_s_7_rg.sorted,TCGA-BA-4077-01B-01D-1431_120310_SN590_0145_BD0RGYACXX_s_7_rg.sorted.bam,246.33,1.9,0.15,58cfa830e4b0c9d6adf6c214,TCGA-BA-4077-01B-01D-1431_120310_SN590_0145_BD0RGYACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-4077-01B,4BFBCE2B-9D0B-4E8A-950F-FD8E0BA3E05A,Primary Tumor,Illumina HiSeq,4f243210-88ea-4d9f-88fd-faf45b45d38e,Head and Neck,45,327BBCA7-FA25-4A92-BE27-21A4C184C760,8428602A-5EEC-4D09-B187-02B1CFF24EB5,TCGA-BA-4077-01B-01D-1431-02,HG19_Broad_variant,TCGA-BA-4077,TCGA-HNSC,1134,s16314,Harvard Medical School,UNC,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c7cb,58cfa831e4b0c9d6adf6c7cb,TCGA-CX-7085-01A-21D-2317_120710_SN590_0166_AC0VNFACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CX-7085-01A-21D-2317_120710_SN590_0166_AC0VNFACXX_s_3_rg.sorted,TCGA-CX-7085-01A-21D-2317_120710_SN590_0166_AC0VNFACXX_s_3_rg.sorted.bam,262.73,NA,0.15,58cfa831e4b0c9d6adf6c7cb,TCGA-CX-7085-01A-21D-2317_120710_SN590_0166_AC0VNFACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CX-7085-01A,2A7B4613-F908-4E78-98ED-857DCD7ED774,Primary Tumor,Illumina HiSeq,2a118e3e-c8f9-43b4-b1d7-4659e37a96ce,Head and Neck,77,A07E086C-1D2D-4D92-A663-ECD7EA4DBD73,57FA3BBB-D571-475C-95A2-AAEDFF4835FC,TCGA-CX-7085-01A-21D-2317-26,HG19_Broad_variant,TCGA-CX-7085,TCGA-HNSC,NA,s16056,MD Anderson - Institute for Applied Cancer Science,Medical College of Georgia,United States,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6cd7a,58cfa831e4b0c9d6adf6cd7a,TCGA-EY-A1GC-01A-11D-A13I_120516_SN1222_0107_BD12HYACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EY-A1GC-01A-11D-A13I_120516_SN1222_0107_BD12HYACXX_s_5_rg.sorted,TCGA-EY-A1GC-01A-11D-A13I_120516_SN1222_0107_BD12HYACXX_s_5_rg.sorted.bam,63.8,1.81,0.16,58cfa831e4b0c9d6adf6cd7a,TCGA-EY-A1GC-01A-11D-A13I_120516_SN1222_0107_BD12HYACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-EY-A1GC-01A,EBC25A41-BECB-4395-AE33-483A304B07D8,Primary Tumor,Illumina HiSeq,e6c7f95a-f103-4fbc-a123-91eefcfbf4c2,Uterus,62,06BE0E15-E48E-4243-AD8D-86CCA9DA68F9,C8E60958-98D8-4EE6-BAA1-DEEEECFF141F,TCGA-EY-A1GC-01A-11D-A13I-02,HG19_Broad_variant,TCGA-EY-A1GC,TCGA-UCEC,NA,s4620,Harvard Medical School,University of North Carolina,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cd97,58cfa831e4b0c9d6adf6cd97,TCGA-FE-A238-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FE-A238-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_1_rg.sorted,TCGA-FE-A238-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_1_rg.sorted.bam,84.67,2.14,0.16,58cfa831e4b0c9d6adf6cd97,TCGA-FE-A238-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A238-10A,DFFC4F7A-C67A-4AC5-A338-717DFFDE686D,Blood Derived Normal,Illumina HiSeq,b306d369-9c40-4392-866e-ac180ee999fa,Thyroid,36,526E831B-6E71-4816-B132-36B525A351B1,3FBBAA9D-89F1-429B-8FEB-FF4D1AF32980,TCGA-FE-A238-10A-01D-A16N-02,HG19_Broad_variant,TCGA-FE-A238,TCGA-THCA,NA,s12255,Harvard Medical School,Ohio State University,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c39a,58cfa831e4b0c9d6adf6c39a,TCGA-CG-5721-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CG-5721-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_1_rg.sorted,TCGA-CG-5721-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_1_rg.sorted.bam,211,1.9,0.16,58cfa831e4b0c9d6adf6c39a,TCGA-CG-5721-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_1_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5721-01A,588ABAEA-AB16-42F4-9457-5901EE791B5F,Primary Tumor,Illumina HiSeq,450e30b5-bcb4-4169-a48f-bbf3db7feda2,Stomach,58,B79123B9-5094-426D-8267-FD4A1C9F2778,8DE4E4AE-4C98-4D4E-BC77-2C205D817E01,TCGA-CG-5721-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5721,TCGA-STAD,NA,s14555,Harvard Medical School,Indivumed,Germany,NO,T4,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa831e4b0c9d6adf6c3f0,58cfa831e4b0c9d6adf6c3f0,TCGA-C5-A2LX-01A-11D-A18I_140206_SN1222_0239_BC2RAKACXX_s_5_rg.sorted.filtered.,WGS,TCGA-C5-A2LX-01A-11D-A18I_140206_SN1222_0239_BC2RAKACXX_s_5_rg.sorted,TCGA-C5-A2LX-01A-11D-A18I_140206_SN1222_0239_BC2RAKACXX_s_5_rg.sorted.bam,82.12,NA,0.18,58cfa831e4b0c9d6adf6c3f0,TCGA-C5-A2LX-01A-11D-A18I_140206_SN1222_0239_BC2RAKACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A2LX-01A,B82F4C6D-530F-4B0E-8F33-995633CB254A,Primary Tumor,Illumina HiSeq,ef574f7b-2b69-4be8-83f3-cc02df579a0a,Cervix,54,41BEBEA3-11C2-4748-8E60-082CFB8E0251,F4772B1E-699C-4C3D-9E0B-1BD4634A7F36,TCGA-C5-A2LX-01A-11D-A18I-02,HG19_Broad_variant,TCGA-C5-A2LX,TCGA-CESC,NA,s1175,Harvard Medical School,Medical College of Wisconsin,United States,NO,T2,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d1ea,58cfa832e4b0c9d6adf6d1ea,TCGA-ET-A25J-11A-01D-A16N_120718_SN590_0169_AC0WL7ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-ET-A25J-11A-01D-A16N_120718_SN590_0169_AC0WL7ACXX_s_3_rg.sorted,TCGA-ET-A25J-11A-01D-A16N_120718_SN590_0169_AC0WL7ACXX_s_3_rg.sorted.bam,24.02,1.62,0.15,58cfa832e4b0c9d6adf6d1ea,TCGA-ET-A25J-11A-01D-A16N_120718_SN590_0169_AC0WL7ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-ET-A25J-11A,618A1C29-5C26-46DB-83D5-4799F9043CD3,Solid Tissue Normal,Illumina HiSeq,5656cb7c-7e70-4014-b67f-5aedc6553483,Thyroid,40,52B6215E-6DC4-412C-931A-2FFE3E949DA3,93B1148E-E39E-4920-8736-F922C80C59DA,TCGA-ET-A25J-11A-01D-A16N-02,HG19_Broad_variant,TCGA-ET-A25J,TCGA-THCA,NA,s12646,Harvard Medical School,Johns Hopkins,United States,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6cba8,58cfa831e4b0c9d6adf6cba8,TCGA-EJ-5525-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EJ-5525-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_1_rg.sorted,TCGA-EJ-5525-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_1_rg.sorted.bam,333.7,1.9,0.15,58cfa831e4b0c9d6adf6cba8,TCGA-EJ-5525-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5525-01A,554A7381-46FD-4301-B91B-5AF7F173C350,Primary Tumor,Illumina HiSeq,10ab041f-88f9-463c-873d-508073d1672b,Prostate,67,351AF15C-B213-4621-8BCB-3F4DDCF72553,333DDE15-F4B2-4301-A6AC-59C7F4CD6639,TCGA-EJ-5525-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5525,TCGA-PRAD,NA,s3602,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c138,58cfa830e4b0c9d6adf6c138,TCGA-BS-A0UF-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BS-A0UF-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_1_rg.sorted,TCGA-BS-A0UF-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_1_rg.sorted.bam,110.21,1.89,0.17,58cfa830e4b0c9d6adf6c138,TCGA-BS-A0UF-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_1_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0UF-01A,F77D7256-2CCF-42A7-9B30-332AC24CA812,Primary Tumor,Illumina HiSeq,33e84ef1-730b-4f0b-9967-bca62c9f631c,Uterus,65,C805F55A-322F-4A11-AE0C-4BBC365D1BD6,D1F78FB2-7BB7-4BF7-8EC7-E2E08F579A38,TCGA-BS-A0UF-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0UF,TCGA-UCEC,NA,s5220,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cd09,58cfa831e4b0c9d6adf6cd09,TCGA-EX-A3L1-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EX-A3L1-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_6_rg.sorted,TCGA-EX-A3L1-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_6_rg.sorted.bam,44.57,NA,0.14,58cfa831e4b0c9d6adf6cd09,TCGA-EX-A3L1-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EX-A3L1-01A,F5D90810-8C4B-4CED-9360-383E42CB54B3,Primary Tumor,Illumina HiSeq,73141d26-4c6a-46e1-ab5f-b431f2f35c23,Cervix,32,89AD6395-973B-4011-BFBD-6759209406BE,6F24A0BE-76D7-4388-B73A-32BE2E902470,TCGA-EX-A3L1-01A-11D-A245-26,HG19_Broad_variant,TCGA-EX-A3L1,TCGA-CESC,NA,s1530,MD Anderson - Institute for Applied Cancer Science,University of North Carolina,United States,NO,T2a1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b988,58cfa82fe4b0c9d6adf6b988,TCGA-67-6215-10A-01D-1751_120301_SN208_0270_AD0KLRACXX_s_5_rg.sorted.filtered.,WGS,TCGA-67-6215-10A-01D-1751_120301_SN208_0270_AD0KLRACXX_s_5_rg.sorted,TCGA-67-6215-10A-01D-1751_120301_SN208_0270_AD0KLRACXX_s_5_rg.sorted.bam,156.7,1.9,0.15,58cfa82fe4b0c9d6adf6b988,TCGA-67-6215-10A-01D-1751_120301_SN208_0270_AD0KLRACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-67-6215-10A,DBD5B0DE-94C9-45DD-AFB3-6820A7ECACA2,Blood Derived Normal,Illumina HiSeq,30aaa08e-3e7d-4c12-8452-ae8bfb552ef2,Lung,52,BCCA4C61-554E-4521-8F3B-018F28E10559,000520ED-D9C8-496C-84B2-5F483AB271FD,TCGA-67-6215-10A-01D-1751-02,HG19_Broad_variant,TCGA-67-6215,TCGA-LUAD,NA,s10911,Harvard Medical School,St Joseph's Medical Center (MD),United States,NO,T2a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c389,58cfa831e4b0c9d6adf6c389,TCGA-CD-5800-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CD-5800-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_5_rg.sorted,TCGA-CD-5800-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_5_rg.sorted.bam,214.7,1.9,0.15,58cfa831e4b0c9d6adf6c389,TCGA-CD-5800-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_5_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-5800-10A,EEB114EA-ECEE-49EE-A162-B3B7BC0A60CD,Blood Derived Normal,Illumina HiSeq,f7df3714-78fc-460f-8d69-6870f63c1f49,Stomach,51,7FA0B096-DD41-4BD1-B826-00A265F4857D,CE784634-F5A7-4317-A7AD-BF5098E2247C,TCGA-CD-5800-10A-01D-1598-02,HG19_Broad_variant,TCGA-CD-5800,TCGA-STAD,NA,s15318,Harvard Medical School,ILSbio,Vietnam,NO,T3,N0,Stomach Intestinal Adenocarcinoma Papillary Type,Stage II
13722.58cfa830e4b0c9d6adf6c1d4,58cfa830e4b0c9d6adf6c1d4,TCGA-BB-4225-10A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BB-4225-10A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_4_rg.sorted,TCGA-BB-4225-10A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_4_rg.sorted.bam,71.4,1.4,0.13,58cfa830e4b0c9d6adf6c1d4,TCGA-BB-4225-10A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BB-4225-10A,C1F50A22-38DF-41CC-A1F4-F7985504A7AC,Blood Derived Normal,Illumina HiSeq,4d810623-2a13-4ed1-ac3c-9582a8e96048,Head and Neck,73,F50A9185-7AF4-4EB7-8866-AA3FBBBC3BAB,27BEDA53-5C52-4515-9125-702366FE2B4A,TCGA-BB-4225-10A-01D-1431-02,HG19_Broad_variant,TCGA-BB-4225,TCGA-HNSC,NA,s16315,Harvard Medical School,Johns Hopkins,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c4ae,58cfa831e4b0c9d6adf6c4ae,TCGA-BR-6566-10A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BR-6566-10A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_3_rg.sorted,TCGA-BR-6566-10A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_3_rg.sorted.bam,174.7,1.9,0.16,58cfa831e4b0c9d6adf6c4ae,TCGA-BR-6566-10A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6566-10A,43F0421C-6578-4D77-9314-EF0305C7EFBD,Blood Derived Normal,Illumina HiSeq,929fba9b-a5db-4260-beee-93a5f1be80ac,Stomach,64,81E4E4F1-AAF2-494F-A128-9070D2E0DE53,604D30E0-231B-491C-BE4B-7A750BE8CFE5,TCGA-BR-6566-10A-01D-1798-02,HG19_Broad_variant,TCGA-BR-6566,TCGA-STAD,NA,s14472,Harvard Medical School,Asterand,Russia,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA
13722.58cfa831e4b0c9d6adf6c5f4,58cfa831e4b0c9d6adf6c5f4,TCGA-CG-4465-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CG-4465-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_5_rg.sorted,TCGA-CG-4465-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_5_rg.sorted.bam,110.9,1.9,0.14,58cfa831e4b0c9d6adf6c5f4,TCGA-CG-4465-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_5_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4465-10A,C9AB5BF4-092A-420F-9B90-87DEEA58104C,Blood Derived Normal,Illumina HiSeq,fac76410-c449-448e-8f7c-c33a3e3cadc5,Stomach,69,85ED773E-80B5-407A-9B44-E9D333716079,597C92D7-94B4-442C-925D-882BE837B5F6,TCGA-CG-4465-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4465,TCGA-STAD,274,s15126,Harvard Medical School,Indivumed,Germany,NO,T4,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IV
13722.58cfa831e4b0c9d6adf6cd4a,58cfa831e4b0c9d6adf6cd4a,TCGA-FD-A3SN-10A-01D-A233_120830_SN208_0423_AC190AACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FD-A3SN-10A-01D-A233_120830_SN208_0423_AC190AACXX_s_8_rg.sorted,TCGA-FD-A3SN-10A-01D-A233_120830_SN208_0423_AC190AACXX_s_8_rg.sorted.bam,44.17,NA,0.16,58cfa831e4b0c9d6adf6cd4a,TCGA-FD-A3SN-10A-01D-A233_120830_SN208_0423_AC190AACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3SN-10A,0FB043D3-D86B-4CD8-8C01-9E2B3E965BB0,Blood Derived Normal,Illumina HiSeq,6b3838e6-41ba-4745-bd39-cc0d6771fd98,Bladder,79,0D002F09-C85D-47DC-A642-D6127E629110,9367BF1A-A415-42F0-9848-228B8BAB6F94,TCGA-FD-A3SN-10A-01D-A233-26,HG19_Broad_variant,TCGA-FD-A3SN,TCGA-BLCA,NA,s2910,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82fe4b0c9d6adf6b8f4,58cfa82fe4b0c9d6adf6b8f4,TCGA-A7-A0DC-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_2_rg.sorted.filtered.,WGS,TCGA-A7-A0DC-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_2_rg.sorted,TCGA-A7-A0DC-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_2_rg.sorted.bam,6.58,NA,0.15,58cfa82fe4b0c9d6adf6b8f4,TCGA-A7-A0DC-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A7-A0DC-01B,CB9F5E50-F49D-4899-8895-9367AFCC1015,Primary Tumor,Illumina HiSeq,b8f1a569-bcd5-4da4-a1ea-ae76c98a5d91,Breast,63,00B54C99-C26D-423A-9871-2552C1603A9C,A253B105-73B8-4E33-8870-B31CCFB02847,TCGA-A7-A0DC-01B-04D-A22S-26,HG19_Broad_variant,TCGA-A7-A0DC,TCGA-BRCA,NA,s6121,MD Anderson - Institute for Applied Cancer Science,Christiana Healthcare,None,YES,T1c,N0 (i-),Infiltrating Ductal Carcinoma,Stage IA
13722.58cfa82fe4b0c9d6adf6b6fc,58cfa82fe4b0c9d6adf6b6fc,TCGA-55-6712-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_5_rg.sorted.filtered.,WGS,TCGA-55-6712-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_5_rg.sorted,TCGA-55-6712-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_5_rg.sorted.bam,218.7,1.9,0.15,58cfa82fe4b0c9d6adf6b6fc,TCGA-55-6712-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-55-6712-01A,F17D3463-AF6C-42C2-A8E9-FAE45F69286F,Primary Tumor,Illumina HiSeq,fb1682cf-0fca-4bf1-963d-67a3a177fe98,Lung,71,EA75499C-7BF0-47BE-9B09-3C12AAA22F12,61ADB041-60CE-4263-BEB3-33A4DBBA217B,TCGA-55-6712-01A-11D-1853-02,HG19_Broad_variant,TCGA-55-6712,TCGA-LUAD,NA,s11345,Harvard Medical School,International Genomics Consortium,United States,NO,T2a,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa830e4b0c9d6adf6c23a,58cfa830e4b0c9d6adf6c23a,TCGA-BT-A20R-01A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BT-A20R-01A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_3_rg.sorted,TCGA-BT-A20R-01A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_3_rg.sorted.bam,26.04,1.91,0.17,58cfa830e4b0c9d6adf6c23a,TCGA-BT-A20R-01A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_3_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20R-01A,F8780A4B-7F55-41D1-BF92-8513955D150E,Primary Tumor,Illumina HiSeq,e997f623-927f-4dae-8fe9-590eef9a9f59,Bladder,79,20231B7F-CB6A-4CD0-9C46-10D4E959D483,78460059-E3A1-40F1-89B5-2F69C6E2E0F1,TCGA-BT-A20R-01A-12D-A16N-02,HG19_Broad_variant,TCGA-BT-A20R,TCGA-BLCA,154,s2696,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c7de,58cfa831e4b0c9d6adf6c7de,TCGA-D1-A17B-10A-01D-A12F_120413_SN1120_0133_BC0J8UACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D1-A17B-10A-01D-A12F_120413_SN1120_0133_BC0J8UACXX_s_3_rg.sorted,TCGA-D1-A17B-10A-01D-A12F_120413_SN1120_0133_BC0J8UACXX_s_3_rg.sorted.bam,44.38,2,0.15,58cfa831e4b0c9d6adf6c7de,TCGA-D1-A17B-10A-01D-A12F_120413_SN1120_0133_BC0J8UACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A17B-10A,E55DD65A-C75E-4A3C-BB24-8B3AF4D65321,Blood Derived Normal,Illumina HiSeq,1b9457d8-9c16-4247-b276-1ead20efc5dc,Uterus,69,131CB413-EA4A-4DCB-B0F5-8F4BC66D8D08,7520530E-39A1-4666-A534-CCC41B2EF335,TCGA-D1-A17B-10A-01D-A12F-02,HG19_Broad_variant,TCGA-D1-A17B,TCGA-UCEC,NA,s5229,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6cf2b,58cfa832e4b0c9d6adf6cf2b,TCGA-FS-A1ZP-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FS-A1ZP-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_5_rg.sorted,TCGA-FS-A1ZP-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_5_rg.sorted.bam,39.25,NA,0.15,58cfa832e4b0c9d6adf6cf2b,TCGA-FS-A1ZP-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZP-10A,4CDB18F5-47BF-475F-B34C-FA4912515268,Blood Derived Normal,Illumina HiSeq,c45fbf32-91bb-4076-a1d5-62da08774f63,Skin,52,7765773F-AD0D-438F-A5B0-9DF496DA22F7,E5CD2522-30A3-4CA0-B342-942D98E02F97,TCGA-FS-A1ZP-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZP,TCGA-SKCM,2273,s7871,Harvard Medical School,Essen,Germany,NO,T3,N0,Not available,Stage II
13722.58cfa831e4b0c9d6adf6c8ea,58cfa831e4b0c9d6adf6c8ea,TCGA-CV-7411-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CV-7411-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_5_rg.sorted,TCGA-CV-7411-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_5_rg.sorted.bam,80.73,NA,0.16,58cfa831e4b0c9d6adf6c8ea,TCGA-CV-7411-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7411-01A,600FC87B-A177-4BF9-9084-457F7E7E102C,Primary Tumor,Illumina HiSeq,7db9b308-952d-4c12-98c4-9de1f4b9fbd2,Head and Neck,64,24876E1A-E07E-4F74-86BF-3395A88CE4A1,221E7B51-6E05-45A9-99AC-EB705D3B2AD8,TCGA-CV-7411-01A-11D-2317-26,HG19_Broad_variant,TCGA-CV-7411,TCGA-HNSC,2717,s15526,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82ee4b0c9d6adf6af8e,58cfa82ee4b0c9d6adf6af8e,TCGA-05-4405-10A-01D-1853_111204_SN208_0256_C0562ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-05-4405-10A-01D-1853_111204_SN208_0256_C0562ACXX_s_3_rg.sorted,TCGA-05-4405-10A-01D-1853_111204_SN208_0256_C0562ACXX_s_3_rg.sorted.bam,43,1.9,0.14,58cfa82ee4b0c9d6adf6af8e,TCGA-05-4405-10A-01D-1853_111204_SN208_0256_C0562ACXX_s_3_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4405-10A,F587C9AB-2949-4410-80D6-A050865D48AA,Blood Derived Normal,Illumina HiSeq,5ba6a451-8249-4373-b08c-91c603ad51bc,Lung,74,202767FD-8637-4451-A049-568E10E752D2,13562942-715C-494C-A79B-212EA8BCC2D0,TCGA-05-4405-10A-01D-1853-02,HG19_Broad_variant,TCGA-05-4405,TCGA-LUAD,NA,s11221,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa831e4b0c9d6adf6c6fe,58cfa831e4b0c9d6adf6c6fe,TCGA-CV-5970-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CV-5970-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_7_rg.sorted,TCGA-CV-5970-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_7_rg.sorted.bam,37,1.9,0.13,58cfa831e4b0c9d6adf6c6fe,TCGA-CV-5970-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5970-11A,1F6167D9-C99D-4873-8D6E-E62A1C964135,Solid Tissue Normal,Illumina HiSeq,004bd2ad-a03c-45c2-9e51-6051014fe91b,Head and Neck,59,EF1AEFD1-1B8F-4840-9037-282DE48ED7F7,B31C32DB-0966-4A8A-AD18-0F5EDAFBBCCB,TCGA-CV-5970-11A-01D-1681-02,HG19_Broad_variant,TCGA-CV-5970,TCGA-HNSC,406,s16337,Harvard Medical School,MD Anderson Cancer Center,None,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c91d,58cfa831e4b0c9d6adf6c91d,TCGA-DJ-A13R-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DJ-A13R-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_4_rg.sorted,TCGA-DJ-A13R-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_4_rg.sorted.bam,60.3,1.88,0.15,58cfa831e4b0c9d6adf6c91d,TCGA-DJ-A13R-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13R-10A,3E787A0E-B5D2-401E-B1E5-077376090B3A,Blood Derived Normal,Illumina HiSeq,ed7404d8-0429-4aa7-9487-9ed11a162c7a,Thyroid,50,4CD78789-F3CE-423A-A09E-0514C295A475,BCD273B7-C1C8-40BD-85EC-674E75F3F46C,TCGA-DJ-A13R-10A-01D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13R,TCGA-THCA,NA,s12511,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III
13722.58cfa82fe4b0c9d6adf6b748,58cfa82fe4b0c9d6adf6b748,TCGA-44-6776-01A-11D-1853_111207_SN590_0112_D09CDACXX_s_7_rg.sorted.filtered.,WGS,TCGA-44-6776-01A-11D-1853_111207_SN590_0112_D09CDACXX_s_7_rg.sorted,TCGA-44-6776-01A-11D-1853_111207_SN590_0112_D09CDACXX_s_7_rg.sorted.bam,142.7,1.9,0.15,58cfa82fe4b0c9d6adf6b748,TCGA-44-6776-01A-11D-1853_111207_SN590_0112_D09CDACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-44-6776-01A,C2A1DE2E-6451-4C95-8CE6-263F2B7E6EFF,Primary Tumor,Illumina HiSeq,bb5d193c-cc97-466b-9b28-bdbf5cf255e8,Lung,60,64FB8EBA-A055-4128-92CA-695A3A6F8EBD,5BC01EC3-A1C2-41BB-A9C5-95946A066FA6,TCGA-44-6776-01A-11D-1853-02,HG19_Broad_variant,TCGA-44-6776,TCGA-LUAD,NA,s10660,Harvard Medical School,Christiana Healthcare,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6c488,58cfa831e4b0c9d6adf6c488,TCGA-CD-5801-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CD-5801-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_6_rg.sorted,TCGA-CD-5801-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_6_rg.sorted.bam,269.7,1.9,0.16,58cfa831e4b0c9d6adf6c488,TCGA-CD-5801-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_6_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-5801-10A,DF822EA3-E0E6-4AD3-A228-E20E3A737DAC,Blood Derived Normal,Illumina HiSeq,0127bc2c-34be-4051-8211-7ccdc8529b37,Stomach,69,524D40B6-5811-49E4-AF3A-C8C70B2D0F7B,6CD1E3D4-E1D8-42F2-AE17-3DE6CBEC983F,TCGA-CD-5801-10A-01D-1598-02,HG19_Broad_variant,TCGA-CD-5801,TCGA-STAD,NA,s14976,Harvard Medical School,ILSbio,Vietnam,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa832e4b0c9d6adf6d018,58cfa832e4b0c9d6adf6d018,TCGA-FT-A3EE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FT-A3EE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_1_rg.sorted,TCGA-FT-A3EE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_1_rg.sorted.bam,35.79,NA,0.15,58cfa832e4b0c9d6adf6d018,TCGA-FT-A3EE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FT-A3EE-01A,CCE62116-3DCD-400D-ADA0-9839CA02466E,Primary Tumor,Illumina HiSeq,7bd31003-35c9-4165-b964-e3d1e803dbe9,Bladder,80,2356F78C-0653-468F-83DB-6CF6107BD259,0C871E11-F5FB-4B9E-B286-163187A68992,TCGA-FT-A3EE-01A-11D-A204-02,HG19_Broad_variant,TCGA-FT-A3EE,TCGA-BLCA,99,s2913,Harvard Medical School,BLN - University of Miami,United States,NO,T4a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6ceac,58cfa832e4b0c9d6adf6ceac,TCGA-FD-A3NA-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FD-A3NA-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_1_rg.sorted,TCGA-FD-A3NA-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_1_rg.sorted.bam,63.16,NA,0.16,58cfa832e4b0c9d6adf6ceac,TCGA-FD-A3NA-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3NA-01A,14917461-DAE4-44CB-909D-42AC45AEF450,Primary Tumor,Illumina HiSeq,8c4c1672-fea7-4c17-a6d0-d4a0f3c04558,Bladder,60,7BD000AB-6F48-4A9E-98A4-EAF47D6E3C05,37789FCA-0C64-49B7-A704-572A19BD2645,TCGA-FD-A3NA-01A-11D-A21C-26,HG19_Broad_variant,TCGA-FD-A3NA,TCGA-BLCA,NA,s3114,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa830e4b0c9d6adf6c128,58cfa830e4b0c9d6adf6c128,TCGA-B6-A0RE-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_7_rg.sorted.filtered.,WGS,TCGA-B6-A0RE-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_7_rg.sorted,TCGA-B6-A0RE-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_7_rg.sorted.bam,49.61,2.14,0.16,58cfa830e4b0c9d6adf6c128,TCGA-B6-A0RE-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_7_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0RE-01A,08DA7C4C-3067-4BCF-9D7A-78566DF72E69,Primary Tumor,Illumina HiSeq,f7dd44eb-562f-4d27-8c45-5ec7fbf49448,Breast,61,270BE245-2239-4E96-A917-79CCA40868BA,D5CE279A-3A7F-43E7-894C-265E9504C3FD,TCGA-B6-A0RE-01A-11D-A060-02,HG19_Broad_variant,TCGA-B6-A0RE,TCGA-BRCA,NA,s6769,Harvard Medical School,Duke,United States,NO,TX,N0 (i-),Infiltrating Ductal Carcinoma,Stage X
13722.58cfa831e4b0c9d6adf6c366,58cfa831e4b0c9d6adf6c366,TCGA-CG-5720-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CG-5720-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_2_rg.sorted,TCGA-CG-5720-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_2_rg.sorted.bam,135,1.9,0.14,58cfa831e4b0c9d6adf6c366,TCGA-CG-5720-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_2_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5720-01A,7C9EA4FA-4CBC-4941-945A-E531E1D48304,Primary Tumor,Illumina HiSeq,6cf7bbf9-63f5-40e8-b595-c9012a1825ba,Stomach,71,1B2E1B50-8D4E-4E62-9B1B-B484936BD6EB,98CE6D0E-465C-40FA-9408-33AA7A25FBB2,TCGA-CG-5720-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5720,TCGA-STAD,30,s14984,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa830e4b0c9d6adf6bb6a,58cfa830e4b0c9d6adf6bb6a,TCGA-75-6205-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-75-6205-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_4_rg.sorted,TCGA-75-6205-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_4_rg.sorted.bam,267.4,1.9,0.15,58cfa830e4b0c9d6adf6bb6a,TCGA-75-6205-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_4_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-6205-01A,9A63F744-4ED4-4B4D-AAC6-F9BDA66AA563,Primary Tumor,Illumina HiSeq,ccc090ad-afab-4e7d-b71b-dcd39a87e359,Lung,NA,D845174B-1A04-4D22-B34F-C48D7AE35233,A5D194B2-0A92-49A1-9AC3-FC4C1B6ADE92,TCGA-75-6205-01A-11D-1751-02,HG19_Broad_variant,TCGA-75-6205,TCGA-LUAD,NA,s10666,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,T2a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa832e4b0c9d6adf6d578,58cfa832e4b0c9d6adf6d578,TCGA-V4-A9EM-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_2_rg.sorted.filtered.,WGS,TCGA-V4-A9EM-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_2_rg.sorted,TCGA-V4-A9EM-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_2_rg.sorted.bam,31.67,NA,0.15,58cfa832e4b0c9d6adf6d578,TCGA-V4-A9EM-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EM-01A,711EB720-4CB7-48DE-9350-5C729BF9F0DA,Primary Tumor,Illumina HiSeq,f3dd06ee-2d71-4310-b226-e94b83da83f7,Eye,53,79658DC3-F2B6-4C5E-9BF7-2C0E440BA3BF,2A1955C2-F55D-48EF-A013-AA69288C3A0C,TCGA-V4-A9EM-01A-11D-A40D-26,HG19_Broad_variant,TCGA-V4-A9EM,TCGA-UVM,NA,s233,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa832e4b0c9d6adf6ce8a,58cfa832e4b0c9d6adf6ce8a,TCGA-G2-A2EL-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_5_rg.sorted.filtered.,WGS,TCGA-G2-A2EL-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_5_rg.sorted,TCGA-G2-A2EL-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_5_rg.sorted.bam,27.96,NA,0.16,58cfa832e4b0c9d6adf6ce8a,TCGA-G2-A2EL-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-G2-A2EL-01A,30C7445E-D0C4-4A0F-96A4-27E4259EE10B,Primary Tumor,Illumina HiSeq,15128dae-4500-4372-9676-d23d4c116527,Bladder,77,90F1D206-3E97-4C88-922C-FE4773C37CAA,D850DDCD-6E04-4EB4-887C-E1AE410C301C,TCGA-G2-A2EL-01A-12D-A18D-02,HG19_Broad_variant,TCGA-G2-A2EL,TCGA-BLCA,819,s3122,Harvard Medical School,MD Anderson,United States,NO,Not available,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c91f,58cfa831e4b0c9d6adf6c91f,TCGA-DK-A1AB-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DK-A1AB-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_3_rg.sorted,TCGA-DK-A1AB-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_3_rg.sorted.bam,43.47,2,0.18,58cfa831e4b0c9d6adf6c91f,TCGA-DK-A1AB-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AB-01A,F027D254-EC01-4882-A8A7-964AE90B7D49,Primary Tumor,Illumina HiSeq,a5005e15-2ada-4bf4-9a61-0febc81a99ca,Bladder,74,253F84AB-FCE2-4E2D-955B-0B8D13A9E4F0,D1F85B58-EBF8-4A73-A5E0-8DFE62CF1164,TCGA-DK-A1AB-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DK-A1AB,TCGA-BLCA,NA,s2707,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T4a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82fe4b0c9d6adf6b686,58cfa82fe4b0c9d6adf6b686,TCGA-44-6779-11A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_2_rg.sorted.filtered.,WGS,TCGA-44-6779-11A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_2_rg.sorted,TCGA-44-6779-11A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_2_rg.sorted.bam,222.7,1.9,0.15,58cfa82fe4b0c9d6adf6b686,TCGA-44-6779-11A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-44-6779-11A,CBBEA9F1-396A-4BF3-B67C-2CAC3394DCEB,Solid Tissue Normal,Illumina HiSeq,85ba6328-d485-4bdb-8720-4dca67560048,Lung,50,D6833663-C9ED-4BAE-A0F3-A92B18B21577,E4E0BE5A-9D60-4224-B4B6-EEC24899D791,TCGA-44-6779-11A-01D-1853-02,HG19_Broad_variant,TCGA-44-6779,TCGA-LUAD,500,s11124,Harvard Medical School,Christiana Healthcare,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa831e4b0c9d6adf6c61d,58cfa831e4b0c9d6adf6c61d,TCGA-CN-4740-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CN-4740-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_5_rg.sorted,TCGA-CN-4740-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_5_rg.sorted.bam,38.4,1.9,0.13,58cfa831e4b0c9d6adf6c61d,TCGA-CN-4740-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4740-10A,E37C83DC-C2C4-4E5F-A57B-39FFCF9AA3CF,Blood Derived Normal,Illumina HiSeq,d36d8c79-6394-457e-a92f-c582f98097a0,Head and Neck,79,533B0EC7-41DD-405E-A6B5-6E82CB689CDE,A820807E-4D6F-4481-BD39-C29522B3C3FE,TCGA-CN-4740-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4740,TCGA-HNSC,NA,s15886,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6c25a,58cfa830e4b0c9d6adf6c25a,TCGA-C4-A0F0-10A-01D-A10R_120926_SN590_0181_AC19HCACXX_s_6_rg.sorted.filtered.,WGS,TCGA-C4-A0F0-10A-01D-A10R_120926_SN590_0181_AC19HCACXX_s_6_rg.sorted,TCGA-C4-A0F0-10A-01D-A10R_120926_SN590_0181_AC19HCACXX_s_6_rg.sorted.bam,17.76,2.02,0.17,58cfa830e4b0c9d6adf6c25a,TCGA-C4-A0F0-10A-01D-A10R_120926_SN590_0181_AC19HCACXX_s_6_rg.sorted.bam,Alive,MALE,Not available,Not available,Bladder Urothelial Carcinoma,Aligned reads,TCGA-C4-A0F0-10A,40398C03-A9CC-476B-9EE9-AECF161BE43F,Blood Derived Normal,Illumina HiSeq,c5e7b6e1-16a2-46ee-85ed-49e5092c1e70,Bladder,60,2F276A79-5F80-4FEC-842D-F4ADC4163F26,AEB2BBE5-2FD5-4747-B39F-17ECD434B4E8,TCGA-C4-A0F0-10A-01D-A10R-02,HG19_Broad_variant,TCGA-C4-A0F0,TCGA-BLCA,NA,s2857,Harvard Medical School,Indivumed,Germany,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa832e4b0c9d6adf6d1a4,58cfa832e4b0c9d6adf6d1a4,TCGA-IG-A50L-01A-11D-A267_131120_SN1222_0230_BC29YPACXX_s_1_rg.sorted.filtered.,WGS,TCGA-IG-A50L-01A-11D-A267_131120_SN1222_0230_BC29YPACXX_s_1_rg.sorted,TCGA-IG-A50L-01A-11D-A267_131120_SN1222_0230_BC29YPACXX_s_1_rg.sorted.bam,22.45,NA,0.17,58cfa832e4b0c9d6adf6d1a4,TCGA-IG-A50L-01A-11D-A267_131120_SN1222_0230_BC29YPACXX_s_1_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A50L-01A,9E54A27F-D0FA-4A5B-91BC-13E27FED2A3D,Primary Tumor,Illumina HiSeq,3e7102a5-f6cf-4918-83d4-8bc4a36d6eda,Esophagus,58,5B30B4D1-4FC6-4712-92B4-E3BE5131551E,62296F7F-6BE0-41E3-A2AA-27B3D1ACE0C7,TCGA-IG-A50L-01A-11D-A267-26,HG19_Broad_variant,TCGA-IG-A50L,TCGA-ESCA,NA,s1815,MD Anderson - Institute for Applied Cancer Science,Asterand,Vietnam,NO,T3,N1,Not available,Stage IIIA
13722.58cfa830e4b0c9d6adf6bf55,58cfa830e4b0c9d6adf6bf55,TCGA-BR-4255-11A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BR-4255-11A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_8_rg.sorted,TCGA-BR-4255-11A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_8_rg.sorted.bam,70.9,1.9,0.15,58cfa830e4b0c9d6adf6bf55,TCGA-BR-4255-11A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4255-11A,956017BA-5E4B-42C7-B93D-42316874BA93,Solid Tissue Normal,Illumina HiSeq,9a506d86-f850-4a34-a336-6a7ac27b7aad,Stomach,76,14C7AEAF-97D3-48B6-BB08-B38D7D3E12ED,80DCF338-52AA-4563-A7A3-6111C1247354,TCGA-BR-4255-11A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4255,TCGA-STAD,NA,s14816,Harvard Medical School,Asterand,Russia,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa830e4b0c9d6adf6c202,58cfa830e4b0c9d6adf6c202,TCGA-BA-5558-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BA-5558-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_8_rg.sorted,TCGA-BA-5558-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_8_rg.sorted.bam,317.4,1.9,0.15,58cfa830e4b0c9d6adf6c202,TCGA-BA-5558-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5558-10A,6A1AA50C-097C-4E04-8DDD-12D50F8A5AC2,Blood Derived Normal,Illumina HiSeq,da16b0c3-9934-4caa-b4ca-5e4c5d9a4494,Head and Neck,65,160DD4E9-A8C0-42B3-BF9B-747D5AC25922,730EC759-9CC9-4F3A-96D1-C11101CBE3B3,TCGA-BA-5558-10A-01D-1509-02,HG19_Broad_variant,TCGA-BA-5558,TCGA-HNSC,NA,s15611,Harvard Medical School,UNC,None,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6cce2,58cfa831e4b0c9d6adf6cce2,TCGA-EM-A1CS-10A-01D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EM-A1CS-10A-01D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_7_rg.sorted,TCGA-EM-A1CS-10A-01D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_7_rg.sorted.bam,29.7,2.03,0.15,58cfa831e4b0c9d6adf6cce2,TCGA-EM-A1CS-10A-01D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_7_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1CS-10A,E92BDB0D-969A-4D98-ADA8-5DFEC68119B5,Blood Derived Normal,Illumina HiSeq,2a0f4d5d-c751-4c68-9f40-28b07dae7b03,Thyroid,55,3929AAFB-3850-4F1A-A883-CA904D6CBC69,9EA0BB57-C503-4043-BEB0-3939368D70D9,TCGA-EM-A1CS-10A-01D-A13U-02,HG19_Broad_variant,TCGA-EM-A1CS,TCGA-THCA,NA,s11999,Harvard Medical School,University Health Network,Canada,NO,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa830e4b0c9d6adf6c2a8,58cfa830e4b0c9d6adf6c2a8,TCGA-BR-4184-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BR-4184-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_3_rg.sorted,TCGA-BR-4184-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_3_rg.sorted.bam,257.9,1.9,0.15,58cfa830e4b0c9d6adf6c2a8,TCGA-BR-4184-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4184-01A,0D4D23BA-066B-4244-A3A5-922CDCAAA28F,Primary Tumor,Illumina HiSeq,efa9bef0-628c-4883-8eea-34f0690acc42,Stomach,70,5DB02C36-DCF0-4311-AD90-754E4EC579EE,501F74C8-6E77-429C-99BD-739D45A74ED1,TCGA-BR-4184-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4184,TCGA-STAD,NA,s15102,Harvard Medical School,Asterand,Russia,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82fe4b0c9d6adf6b5e0,58cfa82fe4b0c9d6adf6b5e0,TCGA-50-5941-10A-01D-1751_111007_SN590_0110_C003AACXX_s_4_rg.sorted.filtered.,WGS,TCGA-50-5941-10A-01D-1751_111007_SN590_0110_C003AACXX_s_4_rg.sorted,TCGA-50-5941-10A-01D-1751_111007_SN590_0110_C003AACXX_s_4_rg.sorted.bam,30.7,1.9,0.16,58cfa82fe4b0c9d6adf6b5e0,TCGA-50-5941-10A-01D-1751_111007_SN590_0110_C003AACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-50-5941-10A,F3F024C2-52F1-400E-946C-398F5B72E6DC,Blood Derived Normal,Illumina HiSeq,30af8e89-edaf-467e-a92e-6c6387c651dc,Lung,55,F5FA8534-1CE2-4D90-A6EF-9EF5D49F1666,9A9FA257-23B4-4B19-9CF0-26E9E13EB6C5,TCGA-50-5941-10A-01D-1751-02,HG19_Broad_variant,TCGA-50-5941,TCGA-LUAD,NA,s10785,Harvard Medical School,University of Pittsburgh,United States,NO,T2a,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82ee4b0c9d6adf6ae56,58cfa82ee4b0c9d6adf6ae56,TCGA-05-4395-10A-01D-1203_120305_SN1120_0119_BD0REAACXX_s_6_rg.sorted.filtered.,WGS,TCGA-05-4395-10A-01D-1203_120305_SN1120_0119_BD0REAACXX_s_6_rg.sorted,TCGA-05-4395-10A-01D-1203_120305_SN1120_0119_BD0REAACXX_s_6_rg.sorted.bam,146.9,1.8,0.16,58cfa82ee4b0c9d6adf6ae56,TCGA-05-4395-10A-01D-1203_120305_SN1120_0119_BD0REAACXX_s_6_rg.sorted.bam,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4395-10A,762DEA8A-5B41-4058-979A-B7876ED13D7E,Blood Derived Normal,Illumina HiSeq,4e22fe2c-0d95-4a62-9b9b-af0b7b0839c1,Lung,76,440ED729-AF4A-44C2-AF41-AB7CD2D6B796,7F0B8263-9D74-429A-80EB-26F498240727,TCGA-05-4395-10A-01D-1203-02,HG19_Broad_variant,TCGA-05-4395,TCGA-LUAD,0,s10901,Harvard Medical School,Indivumed,Germany,NO,T4,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIB
13722.58cfa831e4b0c9d6adf6c5ed,58cfa831e4b0c9d6adf6c5ed,TCGA-CG-4306-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_3_rg.sorted.filtered.,WGS,TCGA-CG-4306-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_3_rg.sorted,TCGA-CG-4306-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_3_rg.sorted.bam,213.2,1.9,0.14,58cfa831e4b0c9d6adf6c5ed,TCGA-CG-4306-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_3_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4306-01A,73D177F7-8C0A-42F6-A73D-8073C0E6142B,Primary Tumor,Illumina HiSeq,97a524b1-432a-4c20-adcf-5e45ee168834,Stomach,90,78785DB9-C3D5-4C26-BBEF-E741C4AAE429,42E4D7EE-860D-498E-AA00-D2AB42EB4ECA,TCGA-CG-4306-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4306,TCGA-STAD,31,s14827,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa832e4b0c9d6adf6cf54,58cfa832e4b0c9d6adf6cf54,TCGA-IG-A5B8-10A-01D-A28P_131120_SN1222_0230_BC29YPACXX_s_5_rg.sorted.filtered.,WGS,TCGA-IG-A5B8-10A-01D-A28P_131120_SN1222_0230_BC29YPACXX_s_5_rg.sorted,TCGA-IG-A5B8-10A-01D-A28P_131120_SN1222_0230_BC29YPACXX_s_5_rg.sorted.bam,28.98,NA,0.16,58cfa832e4b0c9d6adf6cf54,TCGA-IG-A5B8-10A-01D-A28P_131120_SN1222_0230_BC29YPACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A5B8-10A,A4D36E09-5D8E-4006-855C-E466682B6813,Blood Derived Normal,Illumina HiSeq,bbda63c3-7af9-493b-bce0-37a2ba7311be,Esophagus,72,FDC348D0-9FBB-40E0-9A2A-9147ACAFAB9A,28C9C36B-B94F-4420-8B46-4871E97D2629,TCGA-IG-A5B8-10A-01D-A28P-26,HG19_Broad_variant,TCGA-IG-A5B8,TCGA-ESCA,24,s1635,MD Anderson - Institute for Applied Cancer Science,Asterand,Ukraine,NO,T3,N0,Not available,Stage IB
13722.58cfa832e4b0c9d6adf6cfb8,58cfa832e4b0c9d6adf6cfb8,TCGA-GC-A3I6-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-GC-A3I6-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_5_rg.sorted,TCGA-GC-A3I6-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_5_rg.sorted.bam,65,NA,0.16,58cfa832e4b0c9d6adf6cfb8,TCGA-GC-A3I6-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GC-A3I6-01A,74CBB078-9AAE-422A-A7AF-DD29EBCA949E,Primary Tumor,Illumina HiSeq,ec0a1f1d-c6e7-4b4a-a296-02087e0b6586,Bladder,45,DB9442F6-38F2-4092-9E85-F5EC0C924025,8B23B777-2BF2-422A-8AB3-1DF94EE61690,TCGA-GC-A3I6-01A-11D-A210-26,HG19_Broad_variant,TCGA-GC-A3I6,TCGA-BLCA,NA,s2733,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c3fc,58cfa831e4b0c9d6adf6c3fc,TCGA-CH-5788-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CH-5788-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_3_rg.sorted,TCGA-CH-5788-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_3_rg.sorted.bam,257.7,1.9,0.16,58cfa831e4b0c9d6adf6c3fc,TCGA-CH-5788-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5788-01A,C039014F-821C-43D6-9D3C-914F9C8D98FA,Primary Tumor,Illumina HiSeq,8bd51d54-e1be-4a0a-bad5-3b8013692b90,Prostate,69,144E0265-C04E-4538-A721-94DEF2570486,ADB6611D-7A44-4FFE-A48B-FF8E24696B38,TCGA-CH-5788-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5788,TCGA-PRAD,NA,s3595,Harvard Medical School,Indivumed,Germany,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c670,58cfa831e4b0c9d6adf6c670,TCGA-CS-4944-01A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CS-4944-01A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_3_rg.sorted,TCGA-CS-4944-01A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_3_rg.sorted.bam,18,1.9,0.14,58cfa831e4b0c9d6adf6c670,TCGA-CS-4944-01A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,Not available,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-4944-01A,64CD17EB-C778-45E9-B994-02B68182E51B,Primary Tumor,Illumina HiSeq,c266d33e-c72f-4059-b287-2f1bbd6fd48b,Brain,50,F1AA24E4-BC7F-427F-9CEB-8CAAFABFE535,63B56E68-639B-483B-B777-EAD4BDDC112C,TCGA-CS-4944-01A-01D-1465-02,HG19_Broad_variant,TCGA-CS-4944,TCGA-LGG,NA,s8127,Harvard Medical School,Thomas Jefferson University,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa832e4b0c9d6adf6d1b5,58cfa832e4b0c9d6adf6d1b5,TCGA-HI-7170-01A-11D-2111_130607_SN590_0232_BD26R5ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-HI-7170-01A-11D-2111_130607_SN590_0232_BD26R5ACXX_s_5_rg.sorted,TCGA-HI-7170-01A-11D-2111_130607_SN590_0232_BD26R5ACXX_s_5_rg.sorted.bam,96.3,NA,0.15,58cfa832e4b0c9d6adf6d1b5,TCGA-HI-7170-01A-11D-2111_130607_SN590_0232_BD26R5ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HI-7170-01A,6394E00A-1F6F-4EA2-B885-373BBB59DEF9,Primary Tumor,Illumina HiSeq,4eefa9f0-575b-4039-912a-7c0e58f4e508,Prostate,58,70BF0C3E-0C06-4168-996C-46783752FA37,1C5E0781-5295-427A-B94A-062B2708B62C,TCGA-HI-7170-01A-11D-2111-02,HG19_Broad_variant,TCGA-HI-7170,TCGA-PRAD,NA,s3629,Harvard Medical School,Fox Chase,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c85f,58cfa831e4b0c9d6adf6c85f,TCGA-D6-6517-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D6-6517-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_4_rg.sorted,TCGA-D6-6517-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_4_rg.sorted.bam,367,1.8,0.15,58cfa831e4b0c9d6adf6c85f,TCGA-D6-6517-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-D6-6517-10A,EBE99910-E9F2-43DC-AD57-AC2F610B60C8,Blood Derived Normal,Illumina HiSeq,019b158f-ce54-4f1b-9db2-b82383657121,Head and Neck,59,A2DD87A8-E0D1-47C1-A8D1-70B9730AA4BA,81C11B09-5291-4389-977F-904F11E62597,TCGA-D6-6517-10A-01D-1868-02,HG19_Broad_variant,TCGA-D6-6517,TCGA-HNSC,NA,s15530,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa830e4b0c9d6adf6bf28,58cfa830e4b0c9d6adf6bf28,TCGA-BR-4187-11A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BR-4187-11A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_8_rg.sorted,TCGA-BR-4187-11A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_8_rg.sorted.bam,249.9,1.9,0.16,58cfa830e4b0c9d6adf6bf28,TCGA-BR-4187-11A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4187-11A,12071070-D06B-4C7B-A7B1-77C84963ABE6,Solid Tissue Normal,Illumina HiSeq,6ba29a1c-c406-4572-bb2e-69bb70f46dfa,Stomach,56,5B3D227E-A9B7-4A5D-859B-27065CC14C6A,2E462096-2631-4956-B78C-84460306B288,TCGA-BR-4187-11A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4187,TCGA-STAD,NA,s15376,Harvard Medical School,Asterand,Russia,NO,TX,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa832e4b0c9d6adf6cecd,58cfa832e4b0c9d6adf6cecd,TCGA-EK-A2R7-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EK-A2R7-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_7_rg.sorted,TCGA-EK-A2R7-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_7_rg.sorted.bam,14.04,NA,0.18,58cfa832e4b0c9d6adf6cecd,TCGA-EK-A2R7-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2R7-10A,D7A75BF5-5189-4978-99D9-FCEF91C9FBD2,Blood Derived Normal,Illumina HiSeq,86ab2e15-4d96-4350-b5cb-99b156e7ea61,Cervix,45,6064867B-CA99-4158-9E01-A8A37A0F955C,3FD8793C-06FE-4899-9BCE-87814C4AC594,TCGA-EK-A2R7-10A-01D-A18I-02,HG19_Broad_variant,TCGA-EK-A2R7,TCGA-CESC,NA,s1527,Harvard Medical School,Gynecologic Oncology Group,United States,NO,T1b1,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6cdba,58cfa831e4b0c9d6adf6cdba,TCGA-ER-A19K-01A-21D-A18Y_120723_SN1120_0177_AC11GTACXX_s_1_rg.sorted.filtered.,WGS,TCGA-ER-A19K-01A-21D-A18Y_120723_SN1120_0177_AC11GTACXX_s_1_rg.sorted,TCGA-ER-A19K-01A-21D-A18Y_120723_SN1120_0177_AC11GTACXX_s_1_rg.sorted.bam,38.56,NA,0.15,58cfa831e4b0c9d6adf6cdba,TCGA-ER-A19K-01A-21D-A18Y_120723_SN1120_0177_AC11GTACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19K-01A,F9E36BC2-484F-48E8-82BA-99026957277A,Primary Tumor,Illumina HiSeq,7f909731-9b4e-45a5-b8e0-ae6d67969159,Skin,79,E358B11D-2A35-45AE-8910-AE2DC06D39F4,EB5E15F5-55E7-433C-8DD2-AA3DF568F0CF,TCGA-ER-A19K-01A-21D-A18Y-02,HG19_Broad_variant,TCGA-ER-A19K,TCGA-SKCM,469,s7862,Harvard Medical School,University of Pittsburgh,United States,NO,T4b,N0,Not available,Stage IIC
13722.58cfa832e4b0c9d6adf6cfaa,58cfa832e4b0c9d6adf6cfaa,TCGA-FS-A1ZS-10A-01D-A190_120602_SN1120_0147_BD13TBACXX_s_7_rg.sorted.filtered.,WGS,TCGA-FS-A1ZS-10A-01D-A190_120602_SN1120_0147_BD13TBACXX_s_7_rg.sorted,TCGA-FS-A1ZS-10A-01D-A190_120602_SN1120_0147_BD13TBACXX_s_7_rg.sorted.bam,30.03,NA,0.17,58cfa832e4b0c9d6adf6cfaa,TCGA-FS-A1ZS-10A-01D-A190_120602_SN1120_0147_BD13TBACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZS-10A,31E94518-F6DD-4458-94D8-DDA3CC7A0831,Blood Derived Normal,Illumina HiSeq,d805072e-bd81-4372-8429-4d37de4b4efa,Skin,54,B2F92369-CCF6-4B10-9D8E-5843C15B48B9,2BAB4819-3BC4-4970-AD50-71C1977724CA,TCGA-FS-A1ZS-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZS,TCGA-SKCM,NA,s7699,Harvard Medical School,Essen,Germany,NO,T2,N0,Not available,Stage I
13722.58cfa82fe4b0c9d6adf6b648,58cfa82fe4b0c9d6adf6b648,TCGA-86-6562-01A-11D-1751_120403_SN1222_0094_BD0UKBACXX_s_3_rg.sorted.filtered.,WGS,TCGA-86-6562-01A-11D-1751_120403_SN1222_0094_BD0UKBACXX_s_3_rg.sorted,TCGA-86-6562-01A-11D-1751_120403_SN1222_0094_BD0UKBACXX_s_3_rg.sorted.bam,237.4,1.9,0.13,58cfa82fe4b0c9d6adf6b648,TCGA-86-6562-01A-11D-1751_120403_SN1222_0094_BD0UKBACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-86-6562-01A,DCD066BA-5894-453E-B1DA-82092858C3DB,Primary Tumor,Illumina HiSeq,71d960e2-40e8-4084-bcc1-5ebbefc183af,Lung,52,DE4BB1D0-8BD9-4614-85CA-C39D8C636BCC,3AB9FD95-4329-4DD3-823D-F2E050CBA3C1,TCGA-86-6562-01A-11D-1751-02,HG19_Broad_variant,TCGA-86-6562,TCGA-LUAD,NA,s11014,Harvard Medical School,Asterand,Russia,NO,T2a,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa832e4b0c9d6adf6d1c8,58cfa832e4b0c9d6adf6d1c8,TCGA-HI-7170-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-HI-7170-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_6_rg.sorted,TCGA-HI-7170-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_6_rg.sorted.bam,157.6,NA,0.17,58cfa832e4b0c9d6adf6d1c8,TCGA-HI-7170-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HI-7170-10A,6394E00A-1F6F-4EA2-B885-373BBB59DEF9,Blood Derived Normal,Illumina HiSeq,3469af72-4b83-4fe2-bc08-221168d68d84,Prostate,58,B42AA0FA-0368-4D18-B827-1CCDB894700C,F187CCC7-3C46-4C3E-B97C-A16CDB4B00D3,TCGA-HI-7170-10A-01D-2111-02,HG19_Broad_variant,TCGA-HI-7170,TCGA-PRAD,NA,s3632,Harvard Medical School,Fox Chase,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6cf7a,58cfa832e4b0c9d6adf6cf7a,TCGA-G9-6499-01A-12D-1957_130412_SN590_0224_BC1YMJACXX_s_2_rg.sorted.filtered.,WGS,TCGA-G9-6499-01A-12D-1957_130412_SN590_0224_BC1YMJACXX_s_2_rg.sorted,TCGA-G9-6499-01A-12D-1957_130412_SN590_0224_BC1YMJACXX_s_2_rg.sorted.bam,62.7,2,0.14,58cfa832e4b0c9d6adf6cf7a,TCGA-G9-6499-01A-12D-1957_130412_SN590_0224_BC1YMJACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6499-01A,ACD5CEEF-C5CF-4E95-9394-C50FDBC70C8D,Primary Tumor,Illumina HiSeq,db7d4277-9d52-4996-ab7f-5e6ddc01c234,Prostate,66,424FB9D8-F70E-4A36-B895-A766176EEE7C,24062AD0-10DD-4BFB-B805-CA18C57D1FA0,TCGA-G9-6499-01A-12D-1957-02,HG19_Broad_variant,TCGA-G9-6499,TCGA-PRAD,NA,s3459,Harvard Medical School,Roswell Park,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d3cc,58cfa832e4b0c9d6adf6d3cc,TCGA-L5-A4OM-11A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_2_rg.sorted.filtered.,WGS,TCGA-L5-A4OM-11A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_2_rg.sorted,TCGA-L5-A4OM-11A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_2_rg.sorted.bam,17.52,NA,0.15,58cfa832e4b0c9d6adf6d3cc,TCGA-L5-A4OM-11A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OM-11A,1A578AE7-5C0B-48EF-8BAF-7189DF703A93,Solid Tissue Normal,Illumina HiSeq,6cb9b1dd-1e99-4d78-bf35-297e0dbc9c0e,Esophagus,54,E3410FC5-3053-496E-88CE-10C845B994F1,2ADC9673-BA0A-41D7-8BF1-FDA37B11DA1B,TCGA-L5-A4OM-11A-11D-A267-26,HG19_Broad_variant,TCGA-L5-A4OM,TCGA-ESCA,NA,s1660,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T1,N0,Not available,Stage IA
13722.58cfa831e4b0c9d6adf6c7f7,58cfa831e4b0c9d6adf6c7f7,TCGA-D1-A17C-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-D1-A17C-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_1_rg.sorted,TCGA-D1-A17C-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_1_rg.sorted.bam,46.77,1.95,0.15,58cfa831e4b0c9d6adf6c7f7,TCGA-D1-A17C-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A17C-01A,6F4F0CDD-8387-45D0-A9E8-EFCE6260159D,Primary Tumor,Illumina HiSeq,554e5953-4680-4681-a963-fcc940b3f448,Uterus,78,2D5AC7FC-BED4-4C7F-927D-9B44846324C4,99444E9D-219B-4653-9410-B258D28DEEB7,TCGA-D1-A17C-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A17C,TCGA-UCEC,NA,s4801,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d618,58cfa832e4b0c9d6adf6d618,TCGA-LN-A4MR-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_8_rg.sorted.filtered.,WGS,TCGA-LN-A4MR-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_8_rg.sorted,TCGA-LN-A4MR-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_8_rg.sorted.bam,38.53,NA,0.17,58cfa832e4b0c9d6adf6d618,TCGA-LN-A4MR-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_8_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A4MR-01A,CC14603B-E32C-43F3-8218-B6ED7EE2EC18,Primary Tumor,Illumina HiSeq,6c329173-3100-4df0-ad53-2f0bdffd2143,Esophagus,57,CB5E48F2-2803-4F25-9D6C-4A812722E900,65B1AB3A-A807-44D1-A734-DE9A6821151C,TCGA-LN-A4MR-01A-11D-A28P-26,HG19_Broad_variant,TCGA-LN-A4MR,TCGA-ESCA,NA,s1774,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T2,N0,Not available,Stage IIA
13722.58cfa82fe4b0c9d6adf6b669,58cfa82fe4b0c9d6adf6b669,TCGA-44-6775-11A-01D-1853_111207_SN590_0112_D09CDACXX_s_6_rg.sorted.filtered.,WGS,TCGA-44-6775-11A-01D-1853_111207_SN590_0112_D09CDACXX_s_6_rg.sorted,TCGA-44-6775-11A-01D-1853_111207_SN590_0112_D09CDACXX_s_6_rg.sorted.bam,16.7,1.9,0.14,58cfa82fe4b0c9d6adf6b669,TCGA-44-6775-11A-01D-1853_111207_SN590_0112_D09CDACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-6775-11A,3C4FF061-D214-4D1C-8D2E-3034F207C252,Solid Tissue Normal,Illumina HiSeq,5628940b-6674-4130-b526-a3c2921984c9,Lung,72,3F3669E8-F8AD-4267-99C8-D221774CC859,13D5FBFA-D5A3-4195-9756-91151ECAA5CF,TCGA-44-6775-11A-01D-1853-02,HG19_Broad_variant,TCGA-44-6775,TCGA-LUAD,NA,s11551,Harvard Medical School,Christiana Healthcare,United States,NO,T2a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6cace,58cfa831e4b0c9d6adf6cace,TCGA-DA-A1I5-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DA-A1I5-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_6_rg.sorted,TCGA-DA-A1I5-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_6_rg.sorted.bam,20.69,NA,0.15,58cfa831e4b0c9d6adf6cace,TCGA-DA-A1I5-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1I5-10A,E2271488-1A7D-4733-A1EA-38BBAEB97B4C,Blood Derived Normal,Illumina HiSeq,3112c5a0-bd63-4479-bcb0-203b6585ee22,Skin,27,7D0CBB6F-9BF0-437F-A1C2-47FA839A2DCC,792F1ED6-B16E-4BAF-9013-E91D77B22C89,TCGA-DA-A1I5-10A-01D-A190-02,HG19_Broad_variant,TCGA-DA-A1I5,TCGA-SKCM,NA,s7835,Harvard Medical School,Yale,United States,NO,T1a,N0,Not available,Stage IV
13722.58cfa832e4b0c9d6adf6d0ce,58cfa832e4b0c9d6adf6d0ce,TCGA-G2-A3IB-10A-01D-A210_120912_SN1222_0149_BD1CW3ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-G2-A3IB-10A-01D-A210_120912_SN1222_0149_BD1CW3ACXX_s_2_rg.sorted,TCGA-G2-A3IB-10A-01D-A210_120912_SN1222_0149_BD1CW3ACXX_s_2_rg.sorted.bam,12.31,NA,0.16,58cfa832e4b0c9d6adf6d0ce,TCGA-G2-A3IB-10A-01D-A210_120912_SN1222_0149_BD1CW3ACXX_s_2_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-G2-A3IB-10A,AF53D51E-0B5C-437F-A1C0-EC5F55C49364,Blood Derived Normal,Illumina HiSeq,a8fee664-cc6f-4175-9b23-497bb28d2dd6,Bladder,66,6AD50D2E-6F47-4D09-88E5-6A2B4F99BCFE,9C6A7EC3-E304-4495-915C-F498E23BEBAD,TCGA-G2-A3IB-10A-01D-A210-26,HG19_Broad_variant,TCGA-G2-A3IB,TCGA-BLCA,NA,s3305,MD Anderson - Institute for Applied Cancer Science,MD Anderson,United States,NO,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c614,58cfa831e4b0c9d6adf6c614,TCGA-CQ-6221-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CQ-6221-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_5_rg.sorted,TCGA-CQ-6221-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_5_rg.sorted.bam,9.53,NA,0.14,58cfa831e4b0c9d6adf6c614,TCGA-CQ-6221-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-6221-10A,839B660C-98FE-4468-A2B3-408594350250,Blood Derived Normal,Illumina HiSeq,74dfb1a3-cdd5-4360-923f-2c18cd7e6044,Head and Neck,79,12BACDFA-4252-405C-B49A-361438036A52,573C20DD-4DC1-4404-BE48-6E3AA7E6475A,TCGA-CQ-6221-10A-01D-2317-26,HG19_Broad_variant,TCGA-CQ-6221,TCGA-HNSC,NA,s15893,MD Anderson - Institute for Applied Cancer Science,"University Health Network, Toronto",Canada,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c6f2,58cfa831e4b0c9d6adf6c6f2,TCGA-CV-5976-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CV-5976-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_6_rg.sorted,TCGA-CV-5976-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_6_rg.sorted.bam,37,1.9,0.14,58cfa831e4b0c9d6adf6c6f2,TCGA-CV-5976-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5976-11A,23062172-7361-4E61-8EE6-B0A613D72A24,Solid Tissue Normal,Illumina HiSeq,f5c4e8eb-c5ca-4eb2-b92d-a5a054c4a0c6,Head and Neck,50,B721E292-1D8D-451C-BB08-77BC2A61A1B0,662DE6A8-5889-4EB1-86D6-7C5E4012F914,TCGA-CV-5976-11A-01D-1681-02,HG19_Broad_variant,TCGA-CV-5976,TCGA-HNSC,NA,s15642,Harvard Medical School,MD Anderson Cancer Center,None,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82fe4b0c9d6adf6b8d9,58cfa82fe4b0c9d6adf6b8d9,TCGA-50-5055-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_5_rg.sorted.filtered.,WGS,TCGA-50-5055-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_5_rg.sorted,TCGA-50-5055-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_5_rg.sorted.bam,853.7,1.9,0.17,58cfa82fe4b0c9d6adf6b8d9,TCGA-50-5055-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5055-01A,CC3D9750-7CE0-489F-86D4-8017B7EBED29,Primary Tumor,Illumina HiSeq,97723d64-755b-4f00-b641-95ad083c397e,Lung,79,68D19E88-7FBD-48CC-A09F-55C47BFAF6E7,323E338B-1BA7-49E2-811B-C1FEE673A926,TCGA-50-5055-01A-01D-1623-02,HG19_Broad_variant,TCGA-50-5055,TCGA-LUAD,NA,s11008,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIA
13722.58cfa832e4b0c9d6adf6d0d5,58cfa832e4b0c9d6adf6d0d5,TCGA-FS-A1Z4-10A-01D-A190_120711_SN208_0414_BD13L5ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-FS-A1Z4-10A-01D-A190_120711_SN208_0414_BD13L5ACXX_s_6_rg.sorted,TCGA-FS-A1Z4-10A-01D-A190_120711_SN208_0414_BD13L5ACXX_s_6_rg.sorted.bam,127.26,NA,0.17,58cfa832e4b0c9d6adf6d0d5,TCGA-FS-A1Z4-10A-01D-A190_120711_SN208_0414_BD13L5ACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1Z4-10A,8465257B-7212-44A3-BD9F-1F7D017499AD,Blood Derived Normal,Illumina HiSeq,95ed4f71-803b-44ac-a13b-342354376a61,Skin,62,FC080989-3E83-45CE-A52E-52BD231F2B1A,FDA54930-6F29-4C59-AE0A-721F9BAADB89,TCGA-FS-A1Z4-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1Z4,TCGA-SKCM,854,s7367,Harvard Medical School,Essen,Germany,NO,T1,N0,Not available,Stage I
13722.58cfa830e4b0c9d6adf6bd7e,58cfa830e4b0c9d6adf6bd7e,TCGA-AP-A05P-10A-01D-A043_120214_SN590_0139_BC0DYEACXX_s_6_rg.sorted.filtered.,WGS,TCGA-AP-A05P-10A-01D-A043_120214_SN590_0139_BC0DYEACXX_s_6_rg.sorted,TCGA-AP-A05P-10A-01D-A043_120214_SN590_0139_BC0DYEACXX_s_6_rg.sorted.bam,37.05,2.21,0.15,58cfa830e4b0c9d6adf6bd7e,TCGA-AP-A05P-10A-01D-A043_120214_SN590_0139_BC0DYEACXX_s_6_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A05P-10A,3CB83517-78A4-47B8-8B1E-57E765DBDD2E,Blood Derived Normal,Illumina HiSeq,ecfa17c8-9981-4618-a559-0a1b0b8639a3,Uterus,54,C1E003DF-12D0-4E77-8C6E-C52615CBAB96,EE0D1DC0-B5AC-4558-8EBD-C3A5E721DFEB,TCGA-AP-A05P-10A-01D-A043-02,HG19_Broad_variant,TCGA-AP-A05P,TCGA-UCEC,NA,s5200,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b71e,58cfa82fe4b0c9d6adf6b71e,TCGA-64-5815-10A-01D-1623_110826_SN590_0103_AC005WACXX_s_6_rg.sorted.filtered.,WGS,TCGA-64-5815-10A-01D-1623_110826_SN590_0103_AC005WACXX_s_6_rg.sorted,TCGA-64-5815-10A-01D-1623_110826_SN590_0103_AC005WACXX_s_6_rg.sorted.bam,171.4,1.9,0.14,58cfa82fe4b0c9d6adf6b71e,TCGA-64-5815-10A-01D-1623_110826_SN590_0103_AC005WACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-64-5815-10A,A65700C2-E58C-4FD4-AEB1-5686B8F4D212,Blood Derived Normal,Illumina HiSeq,9ed58ced-f480-42df-be0a-fdc8a5c298f7,Lung,74,E34398CE-FB59-4BB7-919A-AE03489EC54A,F1EC082F-85F1-478A-A2F2-8FD6296977CB,TCGA-64-5815-10A-01D-1623-02,HG19_Broad_variant,TCGA-64-5815,TCGA-LUAD,NA,s10909,Harvard Medical School,Fox Chase,United States,NO,T2,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIB
13722.58cfa831e4b0c9d6adf6cb25,58cfa831e4b0c9d6adf6cb25,TCGA-E8-A242-01A-21D-A16N_121204_SN208_0442_BC1F7YACXX_s_3_rg.sorted.filtered.,WGS,TCGA-E8-A242-01A-21D-A16N_121204_SN208_0442_BC1F7YACXX_s_3_rg.sorted,TCGA-E8-A242-01A-21D-A16N_121204_SN208_0442_BC1F7YACXX_s_3_rg.sorted.bam,17.09,1.94,0.18,58cfa831e4b0c9d6adf6cb25,TCGA-E8-A242-01A-21D-A16N_121204_SN208_0442_BC1F7YACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-E8-A242-01A,4D9DE9A1-7DF1-412E-9F16-15DD51B4C5F5,Primary Tumor,Illumina HiSeq,0e5bb14f-1671-4b8a-9a38-e1d389ecd440,Thyroid,56,225B76AD-DB11-457A-9A77-E1F333895E5C,EA178797-16FB-41AB-B71F-3B397153CE63,TCGA-E8-A242-01A-21D-A16N-02,HG19_Broad_variant,TCGA-E8-A242,TCGA-THCA,NA,s12378,Harvard Medical School,Asterand,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa830e4b0c9d6adf6c1e1,58cfa830e4b0c9d6adf6c1e1,TCGA-BG-A0MT-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BG-A0MT-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_8_rg.sorted,TCGA-BG-A0MT-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_8_rg.sorted.bam,93.28,1.98,0.17,58cfa830e4b0c9d6adf6c1e1,TCGA-BG-A0MT-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0MT-01A,082E32C5-7F82-466A-B52D-A3293A8F8E57,Primary Tumor,Illumina HiSeq,3499ad67-e5ed-4030-9fba-fac9fa52f9c5,Uterus,64,91F629F5-6938-4F5C-BA2E-1F519CE6B255,23FB2C48-BE95-4169-BB10-00EA361C5687,TCGA-BG-A0MT-01A-11D-A101-02,HG19_Broad_variant,TCGA-BG-A0MT,TCGA-UCEC,NA,s5217,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cd96,58cfa831e4b0c9d6adf6cd96,TCGA-FE-A230-10A-01D-A14U_120629_SN1120_0168_BD1454ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FE-A230-10A-01D-A14U_120629_SN1120_0168_BD1454ACXX_s_4_rg.sorted,TCGA-FE-A230-10A-01D-A14U_120629_SN1120_0168_BD1454ACXX_s_4_rg.sorted.bam,53.75,1.88,0.15,58cfa831e4b0c9d6adf6cd96,TCGA-FE-A230-10A-01D-A14U_120629_SN1120_0168_BD1454ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A230-10A,B1D71782-2443-43F3-BD0E-8B7220515CB6,Blood Derived Normal,Illumina HiSeq,95f6440a-f378-4551-859b-3c4c64c419f6,Thyroid,30,33613A27-3E77-4ED8-AB5F-A9DE98431149,D31A8255-C4C9-4512-9333-5B97C8A70936,TCGA-FE-A230-10A-01D-A14U-02,HG19_Broad_variant,TCGA-FE-A230,TCGA-THCA,NA,s12529,Harvard Medical School,Ohio State University,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c7aa,58cfa831e4b0c9d6adf6c7aa,TCGA-D1-A17R-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_1_rg.sorted.filtered.,WGS,TCGA-D1-A17R-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_1_rg.sorted,TCGA-D1-A17R-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_1_rg.sorted.bam,76.31,1.88,0.16,58cfa831e4b0c9d6adf6c7aa,TCGA-D1-A17R-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A17R-01A,73A0DD38-115D-48FB-B683-04AA5D612F2A,Primary Tumor,Illumina HiSeq,5425360b-22c2-480d-aa90-d7b4b67dad49,Uterus,58,205DE3E7-B078-4904-82C3-3D0F757D94A8,DF3E4C9B-67D4-46FF-BFE0-4F55A72CA179,TCGA-D1-A17R-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A17R,TCGA-UCEC,339,s5227,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c6e2,58cfa831e4b0c9d6adf6c6e2,TCGA-CN-5355-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CN-5355-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_7_rg.sorted,TCGA-CN-5355-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_7_rg.sorted.bam,15.4,1.9,0.14,58cfa831e4b0c9d6adf6c6e2,TCGA-CN-5355-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_7_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5355-10A,45A10908-19E6-421A-8903-1440BFA57C9D,Blood Derived Normal,Illumina HiSeq,b41ec820-7463-4bef-84a1-09d5c40fc499,Head and Neck,64,C2EF7833-C2FA-446C-A12E-F353C744B1E4,75ACDB7E-80B8-41DA-B105-F57F4BE1E9F0,TCGA-CN-5355-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5355,TCGA-HNSC,NA,s15764,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c63c,58cfa831e4b0c9d6adf6c63c,TCGA-CN-4741-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CN-4741-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_6_rg.sorted,TCGA-CN-4741-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_6_rg.sorted.bam,84.4,1.9,0.15,58cfa831e4b0c9d6adf6c63c,TCGA-CN-4741-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4741-10A,277B02E9-DED5-4980-845D-AF53690000AC,Blood Derived Normal,Illumina HiSeq,ada75f19-f08c-4bbe-a617-4f070b55e658,Head and Neck,75,8D8DDCA2-6461-4A8B-A696-DA0906661B9E,CAA37FFF-7EA8-4980-A7FF-FF228F2B432A,TCGA-CN-4741-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4741,TCGA-HNSC,NA,s15626,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6d3d0,58cfa832e4b0c9d6adf6d3d0,TCGA-L5-A43J-01A-12D-A248_121211_SN208_0443_BC1H55ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-L5-A43J-01A-12D-A248_121211_SN208_0443_BC1H55ACXX_s_5_rg.sorted,TCGA-L5-A43J-01A-12D-A248_121211_SN208_0443_BC1H55ACXX_s_5_rg.sorted.bam,17.75,NA,0.17,58cfa832e4b0c9d6adf6d3d0,TCGA-L5-A43J-01A-12D-A248_121211_SN208_0443_BC1H55ACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A43J-01A,209E2E16-CB88-4A8F-9CDB-10E152CAA26C,Primary Tumor,Illumina HiSeq,ed639604-bac1-4406-ad55-5a821261a54a,Esophagus,90,EEA7BE16-BAF9-4101-A712-CFAF5349476E,9BDD056B-DEC2-4856-9093-94FD133CF06B,TCGA-L5-A43J-01A-12D-A248-26,HG19_Broad_variant,TCGA-L5-A43J,TCGA-ESCA,131,s1739,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T3,N0,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6c6de,58cfa831e4b0c9d6adf6c6de,TCGA-CG-4443-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_4_rg.sorted.filtered.,WGS,TCGA-CG-4443-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_4_rg.sorted,TCGA-CG-4443-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_4_rg.sorted.bam,80.9,1.9,0.16,58cfa831e4b0c9d6adf6c6de,TCGA-CG-4443-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_4_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4443-10A,8CB0144B-BE6B-40A1-86A2-708F96D9B615,Blood Derived Normal,Illumina HiSeq,d8d4539e-9091-4761-ba28-e83c2f89a9f3,Stomach,68,5F5EB83F-C6C8-409B-A8CE-89AF811FE35E,C3189796-A375-481F-9F34-1013B41FD585,TCGA-CG-4443-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4443,TCGA-STAD,NA,s15191,Harvard Medical School,Indivumed,Germany,NO,T1,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6c822,58cfa831e4b0c9d6adf6c822,TCGA-D1-A2G0-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-D1-A2G0-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_6_rg.sorted,TCGA-D1-A2G0-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_6_rg.sorted.bam,11.63,NA,0.15,58cfa831e4b0c9d6adf6c822,TCGA-D1-A2G0-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A2G0-10A,6F661F0D-F08B-486E-8BD7-4306E1593EB9,Blood Derived Normal,Illumina HiSeq,e49e2287-a4cb-4280-ad97-698435bac987,Uterus,70,87CB512B-1C17-4C8C-93DB-7B7E62880924,330535EC-19A5-4FB7-821E-58A8AD25060B,TCGA-D1-A2G0-10A-01D-A17E-02,HG19_Broad_variant,TCGA-D1-A2G0,TCGA-UCEC,NA,s5228,Harvard Medical School,Mayo Clinic,United States,NO,Not available,Not available,Mixed serous and endometrioid,Not available
13722.58cfa831e4b0c9d6adf6c65d,58cfa831e4b0c9d6adf6c65d,TCGA-CG-4465-10A-01D-1154_130815_VM001_0005_VMR0005CXX_s_2_rg.sorted.filtered.,WGS,TCGA-CG-4465-10A-01D-1154_130815_VM001_0005_VMR0005CXX_s_2_rg.sorted,TCGA-CG-4465-10A-01D-1154_130815_VM001_0005_VMR0005CXX_s_2_rg.sorted.bam,110.9,1.9,0.14,58cfa831e4b0c9d6adf6c65d,TCGA-CG-4465-10A-01D-1154_130815_VM001_0005_VMR0005CXX_s_2_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4465-10A,C9AB5BF4-092A-420F-9B90-87DEEA58104C,Blood Derived Normal,Illumina HiSeq,6109b58f-b3ad-4763-a565-ff5c8665b31a,Stomach,69,85ED773E-80B5-407A-9B44-E9D333716079,597C92D7-94B4-442C-925D-882BE837B5F6,TCGA-CG-4465-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4465,TCGA-STAD,274,s14982,Harvard Medical School,Indivumed,Germany,NO,T4,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IV
13722.58cfa832e4b0c9d6adf6d5b2,58cfa832e4b0c9d6adf6d5b2,TCGA-LN-A49R-01A-11D-A248_121211_SN208_0443_BC1H55ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-LN-A49R-01A-11D-A248_121211_SN208_0443_BC1H55ACXX_s_3_rg.sorted,TCGA-LN-A49R-01A-11D-A248_121211_SN208_0443_BC1H55ACXX_s_3_rg.sorted.bam,25.76,NA,0.16,58cfa832e4b0c9d6adf6d5b2,TCGA-LN-A49R-01A-11D-A248_121211_SN208_0443_BC1H55ACXX_s_3_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49R-01A,4C9FB311-0860-4A04-A2F6-79558AC1D98F,Primary Tumor,Illumina HiSeq,94a0c801-3854-49af-babc-dbd07042752e,Esophagus,46,74585CFD-4536-4EF9-89E6-B2D133BB6A0C,219B22EF-9A05-4BA2-AB14-DD88A395615E,TCGA-LN-A49R-01A-11D-A248-26,HG19_Broad_variant,TCGA-LN-A49R,TCGA-ESCA,NA,s1852,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N1,Not available,Stage III
13722.58cfa830e4b0c9d6adf6c1a0,58cfa830e4b0c9d6adf6c1a0,TCGA-B7-5818-01A-11D-1598_121130_SN1222_0160_AC1F13ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-B7-5818-01A-11D-1598_121130_SN1222_0160_AC1F13ACXX_s_8_rg.sorted,TCGA-B7-5818-01A-11D-1598_121130_SN1222_0160_AC1F13ACXX_s_8_rg.sorted.bam,411,1.9,0.14,58cfa830e4b0c9d6adf6c1a0,TCGA-B7-5818-01A-11D-1598_121130_SN1222_0160_AC1F13ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-B7-5818-01A,6E03B415-84A1-4B91-8717-1A41EDD4A255,Primary Tumor,Illumina HiSeq,9924779b-8261-4ea6-9925-28dd5a0aed8a,Stomach,62,FD97CDF5-0F7F-48A2-B5DA-5C5F56A89166,0EBF1A63-C6E4-49FE-B21B-AE46FF14261D,TCGA-B7-5818-01A-11D-1598-02,HG19_Broad_variant,TCGA-B7-5818,TCGA-STAD,NA,s14963,Harvard Medical School,Cureline,Russia,NO,T2,N0,Stomach  Adenocarcinoma  Diffuse Type,Stage IB
13722.58cfa830e4b0c9d6adf6c2aa,58cfa830e4b0c9d6adf6c2aa,TCGA-BR-4201-01A-01D-1128_120816_SN590_0175_AD16M6ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BR-4201-01A-01D-1128_120816_SN590_0175_AD16M6ACXX_s_5_rg.sorted,TCGA-BR-4201-01A-01D-1128_120816_SN590_0175_AD16M6ACXX_s_5_rg.sorted.bam,204.9,1.9,0.15,58cfa830e4b0c9d6adf6c2aa,TCGA-BR-4201-01A-01D-1128_120816_SN590_0175_AD16M6ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4201-01A,8520654B-2192-46CF-9D72-1DDB885A7C55,Primary Tumor,Illumina HiSeq,359db0d8-a78f-4d9d-9a3e-9f1a04472df0,Stomach,66,B42CC87B-4BB0-433D-8AFB-CB314B8CBA30,FE12C75F-5A26-40A8-BEF0-742FAD4CD0E5,TCGA-BR-4201-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4201,TCGA-STAD,NA,s14529,Harvard Medical School,Asterand,Russia,NO,T2a,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa82fe4b0c9d6adf6b690,58cfa82fe4b0c9d6adf6b690,TCGA-44-6776-10A-01D-1853_111207_SN590_0112_D09CDACXX_s_8_rg.sorted.filtered.,WGS,TCGA-44-6776-10A-01D-1853_111207_SN590_0112_D09CDACXX_s_8_rg.sorted,TCGA-44-6776-10A-01D-1853_111207_SN590_0112_D09CDACXX_s_8_rg.sorted.bam,620,1.9,0.17,58cfa82fe4b0c9d6adf6b690,TCGA-44-6776-10A-01D-1853_111207_SN590_0112_D09CDACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-44-6776-10A,C2A1DE2E-6451-4C95-8CE6-263F2B7E6EFF,Blood Derived Normal,Illumina HiSeq,043a1a5e-6327-41d8-838f-0af474ccf4ce,Lung,60,0DD94B00-F572-4650-B646-6B71685FA36C,9BFD050E-38C6-47A0-8DDE-B6D3D8FEA0C7,TCGA-44-6776-10A-01D-1853-02,HG19_Broad_variant,TCGA-44-6776,TCGA-LUAD,NA,s11341,Harvard Medical School,Christiana Healthcare,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82fe4b0c9d6adf6b6d8,58cfa82fe4b0c9d6adf6b6d8,TCGA-50-5942-01A-21D-1751_111007_SN590_0110_C003AACXX_s_5_rg.sorted.filtered.,WGS,TCGA-50-5942-01A-21D-1751_111007_SN590_0110_C003AACXX_s_5_rg.sorted,TCGA-50-5942-01A-21D-1751_111007_SN590_0110_C003AACXX_s_5_rg.sorted.bam,168.4,1.9,0.14,58cfa82fe4b0c9d6adf6b6d8,TCGA-50-5942-01A-21D-1751_111007_SN590_0110_C003AACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5942-01A,75DD635E-8E0C-4C0B-B21C-20F77770218D,Primary Tumor,Illumina HiSeq,915fe8ed-278a-43fb-90cd-986d5c65e9ad,Lung,67,AED669E8-23B6-4786-9398-6BB048815DFA,8DC8F884-F58B-4EFA-AE96-C87AB7F6D991,TCGA-50-5942-01A-21D-1751-02,HG19_Broad_variant,TCGA-50-5942,TCGA-LUAD,NA,s10794,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6cb00,58cfa831e4b0c9d6adf6cb00,TCGA-EA-A3QE-01A-21D-A245_140124_SN1440_0178_AC2PL6ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EA-A3QE-01A-21D-A245_140124_SN1440_0178_AC2PL6ACXX_s_5_rg.sorted,TCGA-EA-A3QE-01A-21D-A245_140124_SN1440_0178_AC2PL6ACXX_s_5_rg.sorted.bam,67,NA,0.14,58cfa831e4b0c9d6adf6cb00,TCGA-EA-A3QE-01A-21D-A245_140124_SN1440_0178_AC2PL6ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EA-A3QE-01A,A4E444B5-BBCA-4EF0-B92F-908D608CBB91,Primary Tumor,Illumina HiSeq,14055776-9bfb-42c1-a760-39fb0c8dba92,Cervix,45,36FFA53D-1404-49C0-B9C1-A3EB1ECBC6B9,80A263E0-9F91-48FD-B53C-7E2A25710BF3,TCGA-EA-A3QE-01A-21D-A245-26,HG19_Broad_variant,TCGA-EA-A3QE,TCGA-CESC,NA,s1524,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T1b,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c9c1,58cfa831e4b0c9d6adf6c9c1,TCGA-DK-A1A6-10A-01D-A13U_121011_SN590_0184_BC192GACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DK-A1A6-10A-01D-A13U_121011_SN590_0184_BC192GACXX_s_8_rg.sorted,TCGA-DK-A1A6-10A-01D-A13U_121011_SN590_0184_BC192GACXX_s_8_rg.sorted.bam,67.49,1.93,0.17,58cfa831e4b0c9d6adf6c9c1,TCGA-DK-A1A6-10A-01D-A13U_121011_SN590_0184_BC192GACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,Not available,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A6-10A,9C274536-3CA1-4F0E-93A8-1688074D862F,Blood Derived Normal,Illumina HiSeq,bd7ea8ac-238d-4a6d-8a48-5d2ce8a29981,Bladder,53,E1FD80CA-0A44-4604-8B6F-283C56824721,4CC13FCD-6F52-4B4C-AFAB-DC292E41F30A,TCGA-DK-A1A6-10A-01D-A13U-02,HG19_Broad_variant,TCGA-DK-A1A6,TCGA-BLCA,NA,s2888,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2a,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa830e4b0c9d6adf6c31e,58cfa830e4b0c9d6adf6c31e,TCGA-CF-A27C-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CF-A27C-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_7_rg.sorted,TCGA-CF-A27C-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_7_rg.sorted.bam,67.64,2.28,0.18,58cfa830e4b0c9d6adf6c31e,TCGA-CF-A27C-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_7_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CF-A27C-01A,7FEE9D6F-C0EA-43C2-89C2-66D965A077A8,Primary Tumor,Illumina HiSeq,ecc65751-9b59-49c3-a142-7a4c61174649,Bladder,52,EAD6792B-4E52-4C28-891C-6D8696873A13,1E553EB3-8C42-48A1-87A7-BFA8541CE568,TCGA-CF-A27C-01A-11D-A16N-02,HG19_Broad_variant,TCGA-CF-A27C,TCGA-BLCA,NA,s2873,Harvard Medical School,ILSbio,Vietnam,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82fe4b0c9d6adf6b8c0,58cfa82fe4b0c9d6adf6b8c0,TCGA-49-6743-01A-11D-1853_111218_SN208_0258_C054RACXX_s_3_rg.sorted.filtered.,WGS,TCGA-49-6743-01A-11D-1853_111218_SN208_0258_C054RACXX_s_3_rg.sorted,TCGA-49-6743-01A-11D-1853_111218_SN208_0258_C054RACXX_s_3_rg.sorted.bam,219.7,1.9,0.14,58cfa82fe4b0c9d6adf6b8c0,TCGA-49-6743-01A-11D-1853_111218_SN208_0258_C054RACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-49-6743-01A,A391D49F-A822-460B-981C-6FBE1868EE38,Primary Tumor,Illumina HiSeq,8b2cdd00-4024-407a-94a7-dbfe5eaa6cd1,Lung,81,5D7DAE28-FC9F-4160-83AA-122F999668B0,3B48B0C9-B9B9-4926-97CA-7232A360A0EE,TCGA-49-6743-01A-11D-1853-02,HG19_Broad_variant,TCGA-49-6743,TCGA-LUAD,NA,s10998,Harvard Medical School,Johns Hopkins,United States,NO,T1,N2,Lung Clear Cell Adenocarcinoma,Stage IIIA
13722.58cfa82fe4b0c9d6adf6b6f8,58cfa82fe4b0c9d6adf6b6f8,TCGA-50-6593-01A-11D-1751_120105_SN1120_0107_AC054PACXX_s_3_rg.sorted.filtered.,WGS,TCGA-50-6593-01A-11D-1751_120105_SN1120_0107_AC054PACXX_s_3_rg.sorted,TCGA-50-6593-01A-11D-1751_120105_SN1120_0107_AC054PACXX_s_3_rg.sorted.bam,245.4,1.8,0.13,58cfa82fe4b0c9d6adf6b6f8,TCGA-50-6593-01A-11D-1751_120105_SN1120_0107_AC054PACXX_s_3_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-6593-01A,E10568FE-0436-43F2-9F0F-48F9903868C4,Primary Tumor,Illumina HiSeq,f552d49e-eaf1-4d8f-bd11-0f2017c95ba3,Lung,49,3B2ED302-D8F1-4078-95F0-3B5C5B322DEB,BC00F0B2-D91E-444A-91A4-08AC5F09CA1F,TCGA-50-6593-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-6593,TCGA-LUAD,336,s11456,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIA
13722.58cfa831e4b0c9d6adf6cc0f,58cfa831e4b0c9d6adf6cc0f,TCGA-EE-A29E-10A-01D-A190_120730_SN1222_0141_BC115GACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EE-A29E-10A-01D-A190_120730_SN1222_0141_BC115GACXX_s_4_rg.sorted,TCGA-EE-A29E-10A-01D-A190_120730_SN1222_0141_BC115GACXX_s_4_rg.sorted.bam,26.22,NA,0.17,58cfa831e4b0c9d6adf6cc0f,TCGA-EE-A29E-10A-01D-A190_120730_SN1222_0141_BC115GACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29E-10A,83D05B9A-F409-4169-BEF9-E772D2CFBFAF,Blood Derived Normal,Illumina HiSeq,e4cd78aa-d008-4138-ba8e-f9435d69a2ba,Skin,54,D422B04A-2EC6-4769-8546-425772FB812E,93EB9265-C790-4980-B305-4E0240791242,TCGA-EE-A29E-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A29E,TCGA-SKCM,NA,s7683,Harvard Medical School,University of Sydney,Australia,NO,T3a,N1b,Not available,Stage IIIB
13722.58cfa831e4b0c9d6adf6ccdf,58cfa831e4b0c9d6adf6ccdf,TCGA-EM-A3O7-01A-11D-A221_120524_SN1120_0145_BD12MWACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EM-A3O7-01A-11D-A221_120524_SN1120_0145_BD12MWACXX_s_1_rg.sorted,TCGA-EM-A3O7-01A-11D-A221_120524_SN1120_0145_BD12MWACXX_s_1_rg.sorted.bam,34.81,NA,0.15,58cfa831e4b0c9d6adf6ccdf,TCGA-EM-A3O7-01A-11D-A221_120524_SN1120_0145_BD12MWACXX_s_1_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3O7-01A,3A211D5A-085F-4902-86B6-50E4EB36B897,Primary Tumor,Illumina HiSeq,c3515173-4e8f-4198-a9de-0bf2232c3fbd,Thyroid,46,362F0CC2-B884-404B-8DF1-2BFC2A75E9C3,AF35D79C-4F32-4B6E-8FDE-BDA9D715A542,TCGA-EM-A3O7-01A-11D-A221-26,HG19_Broad_variant,TCGA-EM-A3O7,TCGA-THCA,NA,s12383,MD Anderson - Institute for Applied Cancer Science,University Health Network,Canada,NO,T3,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa832e4b0c9d6adf6cf0a,58cfa832e4b0c9d6adf6cf0a,TCGA-FS-A1ZA-06A-11D-A18Y_120712_SN1222_0124_AC11GPACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FS-A1ZA-06A-11D-A18Y_120712_SN1222_0124_AC11GPACXX_s_1_rg.sorted,TCGA-FS-A1ZA-06A-11D-A18Y_120712_SN1222_0124_AC11GPACXX_s_1_rg.sorted.bam,50.34,NA,0.16,58cfa832e4b0c9d6adf6cf0a,TCGA-FS-A1ZA-06A-11D-A18Y_120712_SN1222_0124_AC11GPACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZA-06A,177B515E-BCB9-4A08-9B38-3CCDEC0E293F,Metastatic,Illumina HiSeq,d159fb2a-3b27-4d7c-a951-5d250e812f94,Skin,45,2202923F-63CB-4EDF-BF68-8898E974BEA0,9D3074DC-AEFF-47FC-AF7F-843CE639D00E,TCGA-FS-A1ZA-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZA,TCGA-SKCM,843,s7868,Harvard Medical School,Essen,Germany,NO,T4b,N2c,Not available,Stage IIIB
13722.58cfa832e4b0c9d6adf6ceb4,58cfa832e4b0c9d6adf6ceb4,TCGA-EX-A3L1-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EX-A3L1-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_5_rg.sorted,TCGA-EX-A3L1-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_5_rg.sorted.bam,11.52,NA,0.15,58cfa832e4b0c9d6adf6ceb4,TCGA-EX-A3L1-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EX-A3L1-10A,F5D90810-8C4B-4CED-9360-383E42CB54B3,Blood Derived Normal,Illumina HiSeq,bfcd19d2-9301-411b-856a-ee0acb688dff,Cervix,32,92F592AF-39F4-4772-83BA-83D303BD1D60,2536ACAB-8A96-4ACC-ABE2-30701C9E79D9,TCGA-EX-A3L1-10A-01D-A245-26,HG19_Broad_variant,TCGA-EX-A3L1,TCGA-CESC,NA,s1529,MD Anderson - Institute for Applied Cancer Science,University of North Carolina,United States,NO,T2a1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c784,58cfa831e4b0c9d6adf6c784,TCGA-CN-6013-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CN-6013-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_5_rg.sorted,TCGA-CN-6013-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_5_rg.sorted.bam,492.7,1.9,0.15,58cfa831e4b0c9d6adf6c784,TCGA-CN-6013-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-6013-10A,714496C5-D221-4397-9C5A-CD2D22603E6F,Blood Derived Normal,Illumina HiSeq,6b051d97-36f0-4a18-80f9-60c27c73c081,Head and Neck,56,8B510BC8-7B3C-4861-9A40-C2C30B7099E0,762CA7DA-6D6E-4709-B1AA-13621D962D35,TCGA-CN-6013-10A-01D-1681-02,HG19_Broad_variant,TCGA-CN-6013,TCGA-HNSC,NA,s15889,Harvard Medical School,University of Pittsburgh,United States,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6d22a,58cfa832e4b0c9d6adf6d22a,TCGA-IQ-7632-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-IQ-7632-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_3_rg.sorted,TCGA-IQ-7632-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_3_rg.sorted.bam,197.03,NA,0.13,58cfa832e4b0c9d6adf6d22a,TCGA-IQ-7632-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-IQ-7632-10A,601A4146-8093-4F20-9A0A-A97916C9E7F6,Blood Derived Normal,Illumina HiSeq,dd7b51dc-f3ec-450a-91b7-909ceb81e85e,Head and Neck,68,28D815A5-CAB2-4F9C-A6BD-EE17FCA4488F,25BE07AE-D5E7-4B3C-B855-CC6843F21BFB,TCGA-IQ-7632-10A-01D-2317-26,HG19_Broad_variant,TCGA-IQ-7632,TCGA-HNSC,NA,s15918,MD Anderson - Institute for Applied Cancer Science,University of Miami,United States,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6cb04,58cfa831e4b0c9d6adf6cb04,TCGA-EA-A3HT-01A-61D-A245_140124_SN1440_0178_AC2PL6ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EA-A3HT-01A-61D-A245_140124_SN1440_0178_AC2PL6ACXX_s_2_rg.sorted,TCGA-EA-A3HT-01A-61D-A245_140124_SN1440_0178_AC2PL6ACXX_s_2_rg.sorted.bam,54.34,NA,0.15,58cfa831e4b0c9d6adf6cb04,TCGA-EA-A3HT-01A-61D-A245_140124_SN1440_0178_AC2PL6ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EA-A3HT-01A,3C5B2452-014B-495F-B86A-F522ED84BC3B,Primary Tumor,Illumina HiSeq,e0e70b08-26f3-48d5-80c3-4836e9faa569,Cervix,68,8460C1E5-0029-4D66-AF11-373324347800,CE1A5984-E350-46A3-BF53-B32DEC8F8AF0,TCGA-EA-A3HT-01A-61D-A245-26,HG19_Broad_variant,TCGA-EA-A3HT,TCGA-CESC,NA,s1182,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T1b,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c45c,58cfa831e4b0c9d6adf6c45c,TCGA-BT-A3PK-10A-01D-A221_120906_SN208_0426_BC194HACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BT-A3PK-10A-01D-A221_120906_SN208_0426_BC194HACXX_s_4_rg.sorted,TCGA-BT-A3PK-10A-01D-A221_120906_SN208_0426_BC194HACXX_s_4_rg.sorted.bam,35,NA,0.15,58cfa831e4b0c9d6adf6c45c,TCGA-BT-A3PK-10A-01D-A221_120906_SN208_0426_BC194HACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A3PK-10A,73041FCF-F3B6-4851-B34D-1D62A1FCF6FE,Blood Derived Normal,Illumina HiSeq,17390bf6-09d7-4acf-bf79-b8cc3eded7e1,Bladder,80,4D8FC916-872E-474F-9C66-E9F59D861130,451FC302-4234-4716-AC2E-3DE8BFE627D1,TCGA-BT-A3PK-10A-01D-A221-26,HG19_Broad_variant,TCGA-BT-A3PK,TCGA-BLCA,NA,s3267,MD Anderson - Institute for Applied Cancer Science,University of Pittsburgh,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa830e4b0c9d6adf6bf44,58cfa830e4b0c9d6adf6bf44,TCGA-AX-A2HD-01A-21D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-AX-A2HD-01A-21D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_1_rg.sorted,TCGA-AX-A2HD-01A-21D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_1_rg.sorted.bam,115.02,1.84,0.16,58cfa830e4b0c9d6adf6bf44,TCGA-AX-A2HD-01A-21D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A2HD-01A,A8DEF1A0-A136-47F4-9AD9-60EBCF9B726B,Primary Tumor,Illumina HiSeq,b9d10df5-eb11-4976-b3dd-10e970fc715d,Uterus,69,5A2EDE97-0CF7-44D7-A789-92EE9BDA3D6C,C24E7F27-2155-4727-B6D8-8E5BC16D9197,TCGA-AX-A2HD-01A-21D-A17E-02,HG19_Broad_variant,TCGA-AX-A2HD,TCGA-UCEC,NA,s4428,Harvard Medical School,Gynecologic Oncology Group,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d194,58cfa832e4b0c9d6adf6d194,TCGA-G9-6377-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_8_rg.sorted.filtered.,WGS,TCGA-G9-6377-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_8_rg.sorted,TCGA-G9-6377-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_8_rg.sorted.bam,95.7,1.9,0.15,58cfa832e4b0c9d6adf6d194,TCGA-G9-6377-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6377-01A,007F9081-5093-4323-B4F8-CD510BF20705,Primary Tumor,Illumina HiSeq,126d92ca-d172-491d-9366-11555d88901b,Prostate,61,8F105D0D-0630-46FC-8168-DCBA11A5197F,811D74B4-6F98-4B1F-9ADD-CB949E4B5B20,TCGA-G9-6377-01A-11D-1957-02,HG19_Broad_variant,TCGA-G9-6377,TCGA-PRAD,NA,s3977,Harvard Medical School,Roswell Park,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c57b,58cfa831e4b0c9d6adf6c57b,TCGA-CG-5728-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CG-5728-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_4_rg.sorted,TCGA-CG-5728-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_4_rg.sorted.bam,103,1.9,0.16,58cfa831e4b0c9d6adf6c57b,TCGA-CG-5728-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5728-01A,1286AC33-A466-4F58-900E-F6B13FE9C25A,Primary Tumor,Illumina HiSeq,557597f6-e3e0-4ac2-a626-902dc5b8709f,Stomach,88,CC525529-8511-41B1-B6C9-BF51DF484B7B,CC47C834-085D-407B-8F82-70FCF2402BAF,TCGA-CG-5728-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5728,TCGA-STAD,NA,s14418,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa832e4b0c9d6adf6ce96,58cfa832e4b0c9d6adf6ce96,TCGA-G2-A2EC-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_5_rg.sorted.filtered.,WGS,TCGA-G2-A2EC-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_5_rg.sorted,TCGA-G2-A2EC-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_5_rg.sorted.bam,18.46,NA,0.18,58cfa832e4b0c9d6adf6ce96,TCGA-G2-A2EC-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_5_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-G2-A2EC-01A,28E25FFB-8B0C-4839-A735-ED7B78E3213A,Primary Tumor,Illumina HiSeq,0d4b7559-34dc-4690-a8e9-144698537cdd,Bladder,58,2DA969E6-9A63-4C03-8347-01A51496C224,09ED2111-236D-47C1-A82D-7919C8EEA5B2,TCGA-G2-A2EC-01A-11D-A17R-02,HG19_Broad_variant,TCGA-G2-A2EC,TCGA-BLCA,NA,s3303,Harvard Medical School,MD Anderson,United States,NO,Not available,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa832e4b0c9d6adf6cfa2,58cfa832e4b0c9d6adf6cfa2,TCGA-G9-6333-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_4_rg.sorted.filtered.,WGS,TCGA-G9-6333-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_4_rg.sorted,TCGA-G9-6333-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_4_rg.sorted.bam,14,1.8,0.16,58cfa832e4b0c9d6adf6cfa2,TCGA-G9-6333-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6333-10A,64BF32C9-9466-404A-A147-E7A0B9E91E34,Blood Derived Normal,Illumina HiSeq,ead27538-b8e3-4f26-905e-764c0be3f524,Prostate,66,5AC98B24-4104-40D1-8E73-1CB0EF6D343C,30D073C8-EAF3-464B-8089-007CD94FEECD,TCGA-G9-6333-10A-01D-1957-02,HG19_Broad_variant,TCGA-G9-6333,TCGA-PRAD,NA,s3613,Harvard Medical School,Roswell Park,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d22e,58cfa832e4b0c9d6adf6d22e,TCGA-FY-A3R7-10A-01D-A221_120611_SN1222_0114_AC0WL3ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FY-A3R7-10A-01D-A221_120611_SN1222_0114_AC0WL3ACXX_s_4_rg.sorted,TCGA-FY-A3R7-10A-01D-A221_120611_SN1222_0114_AC0WL3ACXX_s_4_rg.sorted.bam,22.27,NA,0.15,58cfa832e4b0c9d6adf6d22e,TCGA-FY-A3R7-10A-01D-A221_120611_SN1222_0114_AC0WL3ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FY-A3R7-10A,B983A678-B0AE-42C2-8F37-D6ECAF07413B,Blood Derived Normal,Illumina HiSeq,001bd10e-dbe3-4a56-9851-45ccd2286cdb,Thyroid,50,8734208A-0724-4409-847D-496E1CF21B79,CECA5E63-F8BD-4EEB-BF6A-8360E1B340F5,TCGA-FY-A3R7-10A-01D-A221-26,HG19_Broad_variant,TCGA-FY-A3R7,TCGA-THCA,NA,s12008,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa832e4b0c9d6adf6ce22,58cfa832e4b0c9d6adf6ce22,TCGA-EJ-5524-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EJ-5524-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_8_rg.sorted,TCGA-EJ-5524-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_8_rg.sorted.bam,437.4,1.9,0.15,58cfa832e4b0c9d6adf6ce22,TCGA-EJ-5524-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5524-10A,4048C139-1329-4E6A-8D2F-C0AA104A68EE,Blood Derived Normal,Illumina HiSeq,f7ef709a-7e6b-4b7e-9827-28d64d2cedb3,Prostate,57,330555E0-0B47-46B8-BDB6-125675717E3B,6D03C8FA-1441-410F-B980-CABF11F60930,TCGA-EJ-5524-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5524,TCGA-PRAD,NA,s3945,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c885,58cfa831e4b0c9d6adf6c885,TCGA-D7-6521-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_2_rg.sorted.filtered.,WGS,TCGA-D7-6521-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_2_rg.sorted,TCGA-D7-6521-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_2_rg.sorted.bam,415.7,1.9,0.15,58cfa831e4b0c9d6adf6c885,TCGA-D7-6521-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6521-10A,6DE6B8E2-03EB-4F32-B5A3-BEA73FC632B4,Blood Derived Normal,Illumina HiSeq,eb009690-3197-4b8c-9b74-0020480845fb,Stomach,65,F7C9FE46-4828-4C41-A15B-6D6B8BE59DA2,A2ECB6E3-ABF3-46A7-A4C6-505FC39A8CDC,TCGA-D7-6521-10A-01D-1798-02,HG19_Broad_variant,TCGA-D7-6521,TCGA-STAD,NA,s15403,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2b,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA
13722.58cfa832e4b0c9d6adf6d43c,58cfa832e4b0c9d6adf6d43c,TCGA-VD-A8KJ-10A-01D-A40E_140829_SN208_0523_BC5FKTACXX_s_6_rg.sorted.filtered.,WGS,TCGA-VD-A8KJ-10A-01D-A40E_140829_SN208_0523_BC5FKTACXX_s_6_rg.sorted,TCGA-VD-A8KJ-10A-01D-A40E_140829_SN208_0523_BC5FKTACXX_s_6_rg.sorted.bam,8.54,NA,0.14,58cfa832e4b0c9d6adf6d43c,TCGA-VD-A8KJ-10A-01D-A40E_140829_SN208_0523_BC5FKTACXX_s_6_rg.sorted.bam,Alive,MALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KJ-10A,7289BC25-2551-4C6D-B2FA-C7E13859B9B3,Blood Derived Normal,Illumina HiSeq,37a62b71-ae40-4679-9643-b3c405d72caf,Eye,53,F470BBBF-57CB-4D19-9338-9E25ECFC6B96,E82A1AF4-8319-4A81-95A1-7E087BCD9012,TCGA-VD-A8KJ-10A-01D-A40E-26,HG19_Broad_variant,TCGA-VD-A8KJ,TCGA-UVM,NA,s281,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T3a,NX,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6cd19,58cfa831e4b0c9d6adf6cd19,TCGA-FD-A3NA-10A-01D-A21C_120830_SN590_0177_BD141PACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FD-A3NA-10A-01D-A21C_120830_SN590_0177_BD141PACXX_s_2_rg.sorted,TCGA-FD-A3NA-10A-01D-A21C_120830_SN590_0177_BD141PACXX_s_2_rg.sorted.bam,48.19,NA,0.16,58cfa831e4b0c9d6adf6cd19,TCGA-FD-A3NA-10A-01D-A21C_120830_SN590_0177_BD141PACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3NA-10A,14917461-DAE4-44CB-909D-42AC45AEF450,Blood Derived Normal,Illumina HiSeq,6e999ca0-d8a6-4bc2-9630-4637a8193a3b,Bladder,60,0271B8CA-3241-4F99-9CE4-D68B9F3D5084,EBC9A32A-0FB0-4D11-A721-62E6239A892D,TCGA-FD-A3NA-10A-01D-A21C-26,HG19_Broad_variant,TCGA-FD-A3NA,TCGA-BLCA,NA,s2900,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c53a,58cfa831e4b0c9d6adf6c53a,TCGA-CH-5767-11B-01D-1784_130115_SN590_0208_BD1TAGACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CH-5767-11B-01D-1784_130115_SN590_0208_BD1TAGACXX_s_2_rg.sorted,TCGA-CH-5767-11B-01D-1784_130115_SN590_0208_BD1TAGACXX_s_2_rg.sorted.bam,98.4,1.9,0.15,58cfa831e4b0c9d6adf6c53a,TCGA-CH-5767-11B-01D-1784_130115_SN590_0208_BD1TAGACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5767-11B,8DC53431-44AB-485E-B4E6-C3D06509506D,Solid Tissue Normal,Illumina HiSeq,1cbd34c5-4fa8-46ee-b97f-ccbd7b816165,Prostate,66,FCBBC85A-D75B-4280-B6FB-643C8643E2F7,137B56C8-7D2A-4E33-9732-8D1B067F6C1C,TCGA-CH-5767-11B-01D-1784-02,HG19_Broad_variant,TCGA-CH-5767,TCGA-PRAD,NA,s3772,Harvard Medical School,Indivumed,Germany,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82fe4b0c9d6adf6b7ca,58cfa82fe4b0c9d6adf6b7ca,TCGA-50-5930-11A-01D-1751_111007_SN590_0110_C003AACXX_s_2_rg.sorted.filtered.,WGS,TCGA-50-5930-11A-01D-1751_111007_SN590_0110_C003AACXX_s_2_rg.sorted,TCGA-50-5930-11A-01D-1751_111007_SN590_0110_C003AACXX_s_2_rg.sorted.bam,131.4,1.9,0.15,58cfa82fe4b0c9d6adf6b7ca,TCGA-50-5930-11A-01D-1751_111007_SN590_0110_C003AACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5930-11A,368E23F0-E573-4547-BF5A-14080BAF737B,Solid Tissue Normal,Illumina HiSeq,8e682cfc-cf44-4c71-b08e-152f8539f402,Lung,47,4CDDB392-FC4B-4400-A44F-2E92A78B3E97,A3426EEB-C297-4456-B368-6A366350FBF6,TCGA-50-5930-11A-01D-1751-02,HG19_Broad_variant,TCGA-50-5930,TCGA-LUAD,282,s10788,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIA
13722.58cfa830e4b0c9d6adf6bc48,58cfa830e4b0c9d6adf6bc48,TCGA-AO-A0JJ-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_4_rg.sorted.filtered.,WGS,TCGA-AO-A0JJ-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_4_rg.sorted,TCGA-AO-A0JJ-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_4_rg.sorted.bam,96.1,1.71,0.17,58cfa830e4b0c9d6adf6bc48,TCGA-AO-A0JJ-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A0JJ-10A,BEF7B135-A727-45E8-850A-CC4CD56C49AA,Blood Derived Normal,Illumina HiSeq,335753c7-066c-41ad-8616-f9ec5f6b22e8,Breast,54,57F491FB-7CAD-4BC8-B55B-2231AD16A9E3,8A9F1058-6930-4942-879D-6633DB1848E0,TCGA-AO-A0JJ-10A-01D-A060-02,HG19_Broad_variant,TCGA-AO-A0JJ,TCGA-BRCA,NA,s5959,Harvard Medical School,MSKCC,None,NO,T2,N1a,Infiltrating Lobular Carcinoma,Stage IIB
13722.58cfa832e4b0c9d6adf6d204,58cfa832e4b0c9d6adf6d204,TCGA-IG-A50L-10A-01D-A267_131120_SN1222_0230_BC29YPACXX_s_2_rg.sorted.filtered.,WGS,TCGA-IG-A50L-10A-01D-A267_131120_SN1222_0230_BC29YPACXX_s_2_rg.sorted,TCGA-IG-A50L-10A-01D-A267_131120_SN1222_0230_BC29YPACXX_s_2_rg.sorted.bam,29.86,NA,0.16,58cfa832e4b0c9d6adf6d204,TCGA-IG-A50L-10A-01D-A267_131120_SN1222_0230_BC29YPACXX_s_2_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A50L-10A,9E54A27F-D0FA-4A5B-91BC-13E27FED2A3D,Blood Derived Normal,Illumina HiSeq,076f3e42-50cd-41e8-a522-ddb7d596c148,Esophagus,58,45D0F3AE-C269-41B0-89DE-A3CBDB78EE20,82F578C7-E031-48B6-B674-1C428C120E00,TCGA-IG-A50L-10A-01D-A267-26,HG19_Broad_variant,TCGA-IG-A50L,TCGA-ESCA,NA,s1820,MD Anderson - Institute for Applied Cancer Science,Asterand,Vietnam,NO,T3,N1,Not available,Stage IIIA
13722.58cfa831e4b0c9d6adf6c7a2,58cfa831e4b0c9d6adf6c7a2,TCGA-CV-5971-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CV-5971-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_8_rg.sorted,TCGA-CV-5971-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_8_rg.sorted.bam,30,1.9,0.15,58cfa831e4b0c9d6adf6c7a2,TCGA-CV-5971-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5971-11A,1465B7EC-8D2B-47DD-8387-977EED44CC86,Solid Tissue Normal,Illumina HiSeq,1ceeef7f-0aec-40ec-b515-3b369cde02e2,Head and Neck,60,925E85CB-0CEB-44B7-A745-7B7C21427DF8,27495DD9-B50E-4C66-AFF3-C910D0DCC72D,TCGA-CV-5971-11A-01D-1681-02,HG19_Broad_variant,TCGA-CV-5971,TCGA-HNSC,NA,s16046,Harvard Medical School,MD Anderson Cancer Center,None,NO,T4a,N2a,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6d10e,58cfa832e4b0c9d6adf6d10e,TCGA-HW-7489-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_2_rg.sorted.filtered.,WGS,TCGA-HW-7489-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_2_rg.sorted,TCGA-HW-7489-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_2_rg.sorted.bam,56,NA,0.14,58cfa832e4b0c9d6adf6d10e,TCGA-HW-7489-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HW-7489-01A,6957D45E-7CCB-457D-800D-C2A2037F4F01,Primary Tumor,Illumina HiSeq,e81e0ec5-b546-421b-a1ee-5adf17fd07c0,Brain,38,B4E032D1-B12E-4DC0-8978-899760F0A245,BBCC5F2C-08F5-424D-8A66-099084F3C47E,TCGA-HW-7489-01A-11D-2022-02,HG19_Broad_variant,TCGA-HW-7489,TCGA-LGG,NA,s8578,Harvard Medical School,MSKCC,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa832e4b0c9d6adf6d044,58cfa832e4b0c9d6adf6d044,TCGA-GD-A2C5-01A-12D-A17R_120927_SN208_0432_AC188LACXX_s_6_rg.sorted.filtered.,WGS,TCGA-GD-A2C5-01A-12D-A17R_120927_SN208_0432_AC188LACXX_s_6_rg.sorted,TCGA-GD-A2C5-01A-12D-A17R_120927_SN208_0432_AC188LACXX_s_6_rg.sorted.bam,40.79,NA,0.16,58cfa832e4b0c9d6adf6d044,TCGA-GD-A2C5-01A-12D-A17R_120927_SN208_0432_AC188LACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GD-A2C5-01A,5D54C742-5A8E-4C40-8D62-95E75E210AB8,Primary Tumor,Illumina HiSeq,27e88ee3-dcb4-43c4-9653-c55aa1851cb1,Bladder,53,2CD62676-762C-461D-B111-1F81E7CD5877,EEB315EA-D1B6-4F92-91B0-9AAAC7083D68,TCGA-GD-A2C5-01A-12D-A17R-02,HG19_Broad_variant,TCGA-GD-A2C5,TCGA-BLCA,NA,s2920,Harvard Medical School,ABS - IUPUI,United States,NO,T3a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c3fa,58cfa831e4b0c9d6adf6c3fa,TCGA-BT-A2LB-10A-01D-A18D_120904_SN1120_0186_BC1911ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BT-A2LB-10A-01D-A18D_120904_SN1120_0186_BC1911ACXX_s_7_rg.sorted,TCGA-BT-A2LB-10A-01D-A18D_120904_SN1120_0186_BC1911ACXX_s_7_rg.sorted.bam,69.79,NA,0.16,58cfa831e4b0c9d6adf6c3fa,TCGA-BT-A2LB-10A-01D-A18D_120904_SN1120_0186_BC1911ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A2LB-10A,D17A5AB1-3789-4652-AFF5-D8F4F2291F9C,Blood Derived Normal,Illumina HiSeq,832b34b6-3018-44f5-b83b-4b2b9f5f032f,Bladder,73,46DEE0FD-8287-40CA-BE34-7E93A66CC23B,B13D2A50-787D-44AD-9E6A-EF40BC09E23D,TCGA-BT-A2LB-10A-01D-A18D-02,HG19_Broad_variant,TCGA-BT-A2LB,TCGA-BLCA,NA,s3088,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c8c4,58cfa831e4b0c9d6adf6c8c4,TCGA-CN-5373-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CN-5373-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_4_rg.sorted,TCGA-CN-5373-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_4_rg.sorted.bam,165.7,1.9,0.14,58cfa831e4b0c9d6adf6c8c4,TCGA-CN-5373-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5373-01A,546F01D5-AED5-4FB8-91C0-0FD5E0FDE935,Primary Tumor,Illumina HiSeq,22213a76-97e9-4565-8074-c3046269b70a,Head and Neck,55,9D73D061-F1E1-47BA-929D-FEEB6C191279,3FE7F18F-8AA4-4AFE-8AF0-256876F7E86E,TCGA-CN-5373-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5373,TCGA-HNSC,NA,s16035,Harvard Medical School,University of Pittsburgh,None,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c82e,58cfa831e4b0c9d6adf6c82e,TCGA-D6-6826-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-D6-6826-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_7_rg.sorted,TCGA-D6-6826-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_7_rg.sorted.bam,405,1.9,0.16,58cfa831e4b0c9d6adf6c82e,TCGA-D6-6826-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-D6-6826-10A,31243867-8E9F-46E9-A213-B83544EB8028,Blood Derived Normal,Illumina HiSeq,cb6e32f1-cfa4-4387-a53f-e7a562ac45d9,Head and Neck,64,7AA13049-917A-4D7A-BCEB-3C718EC8FB7A,A6B7AC7D-425D-4741-BE71-3E3FA167AEE8,TCGA-D6-6826-10A-01D-1911-02,HG19_Broad_variant,TCGA-D6-6826,TCGA-HNSC,NA,s15913,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6cd76,58cfa831e4b0c9d6adf6cd76,TCGA-FD-A3B3-10A-01D-A204_121002_SN1222_0155_BD1ERHACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FD-A3B3-10A-01D-A204_121002_SN1222_0155_BD1ERHACXX_s_8_rg.sorted,TCGA-FD-A3B3-10A-01D-A204_121002_SN1222_0155_BD1ERHACXX_s_8_rg.sorted.bam,14.2,NA,0.16,58cfa831e4b0c9d6adf6cd76,TCGA-FD-A3B3-10A-01D-A204_121002_SN1222_0155_BD1ERHACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3B3-10A,4B5D873B-BFDA-482E-92A0-BF84C0F9032A,Blood Derived Normal,Illumina HiSeq,675113cf-e818-448a-a767-827cd45c7827,Bladder,74,9E9FD5A9-9BBE-484F-90EE-6E35E49908DF,6FAB5B8D-8E7A-4099-9495-F38CF408E273,TCGA-FD-A3B3-10A-01D-A204-02,HG19_Broad_variant,TCGA-FD-A3B3,TCGA-BLCA,NA,s2722,Harvard Medical School,BLN - University Of Chicago,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c9ac,58cfa831e4b0c9d6adf6c9ac,TCGA-DB-5279-10A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DB-5279-10A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_8_rg.sorted,TCGA-DB-5279-10A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_8_rg.sorted.bam,70.7,1.9,0.15,58cfa831e4b0c9d6adf6c9ac,TCGA-DB-5279-10A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_8_rg.sorted.bam,Alive,MALE,Not available,Not available,Brain Lower Grade Glioma,Aligned reads,TCGA-DB-5279-10A,85F77526-791E-47CD-904D-D1DBB49EAEAB,Blood Derived Normal,Illumina HiSeq,767a0a89-778e-4312-bd3b-123ddca4d6e2,Brain,59,9F564BDC-2E24-4A53-A50B-B23522CD7798,390161FE-0819-43C8-B4DF-C591B46E51F2,TCGA-DB-5279-10A-01D-1465-02,HG19_Broad_variant,TCGA-DB-5279,TCGA-LGG,NA,s8752,Harvard Medical School,Mayo Clinic - Rochester,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa832e4b0c9d6adf6d188,58cfa832e4b0c9d6adf6d188,TCGA-HC-7233-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-HC-7233-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_6_rg.sorted,TCGA-HC-7233-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_6_rg.sorted.bam,207.3,NA,0.14,58cfa832e4b0c9d6adf6d188,TCGA-HC-7233-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,Not available,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7233-01A,E2B33861-2247-413F-B2E5-9BE3B604666C,Primary Tumor,Illumina HiSeq,b16d1760-889f-44f7-a1c1-1dfa3f31efc3,Prostate,73,848C2C7B-918E-4A09-BAD9-3B3D59BBC101,8262CCFE-6E66-412E-A8C8-E4FA91979764,TCGA-HC-7233-01A-11D-2111-02,HG19_Broad_variant,TCGA-HC-7233,TCGA-PRAD,NA,s3813,Harvard Medical School,International Genomics Consortium,Yemen,NO,T2a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6ca01,58cfa831e4b0c9d6adf6ca01,TCGA-DQ-5625-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DQ-5625-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_1_rg.sorted,TCGA-DQ-5625-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_1_rg.sorted.bam,154.7,1.9,0.15,58cfa831e4b0c9d6adf6ca01,TCGA-DQ-5625-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-DQ-5625-01A,53D9A130-4A3A-4491-85CD-9A44415A1632,Primary Tumor,Illumina HiSeq,33b84364-a81e-48fd-89d6-552802c7ff18,Head and Neck,52,74856E66-109F-4A68-A496-8FA66729FE1F,9641D13E-BE95-46BB-8330-6128EE15D47C,TCGA-DQ-5625-01A-01D-1868-02,HG19_Broad_variant,TCGA-DQ-5625,TCGA-HNSC,NA,s16058,Harvard Medical School,University of Michigan,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6cf70,58cfa832e4b0c9d6adf6cf70,TCGA-GD-A3OP-11A-11D-A221_120902_SN1222_0147_AC195DACXX_s_2_rg.sorted.filtered.,WGS,TCGA-GD-A3OP-11A-11D-A221_120902_SN1222_0147_AC195DACXX_s_2_rg.sorted,TCGA-GD-A3OP-11A-11D-A221_120902_SN1222_0147_AC195DACXX_s_2_rg.sorted.bam,8.9,NA,0.14,58cfa832e4b0c9d6adf6cf70,TCGA-GD-A3OP-11A-11D-A221_120902_SN1222_0147_AC195DACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GD-A3OP-11A,31DA07BB-6752-49A3-A7EA-5427C04A9458,Solid Tissue Normal,Illumina HiSeq,cec19b51-29ce-4b48-81a6-7f61054cc053,Bladder,84,22340B82-9219-49C6-B511-FDA79F24F36E,120EE6C1-48C4-42BB-97F2-BFFD79B35FF9,TCGA-GD-A3OP-11A-11D-A221-26,HG19_Broad_variant,TCGA-GD-A3OP,TCGA-BLCA,NA,s2921,MD Anderson - Institute for Applied Cancer Science,ABS - IUPUI,United States,NO,T4a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6ca93,58cfa831e4b0c9d6adf6ca93,TCGA-D1-A16R-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_5_rg.sorted.filtered.,WGS,TCGA-D1-A16R-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_5_rg.sorted,TCGA-D1-A16R-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_5_rg.sorted.bam,93.33,1.39,0.17,58cfa831e4b0c9d6adf6ca93,TCGA-D1-A16R-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A16R-01A,40F43483-B504-4EA7-AD24-40682B10CAAC,Primary Tumor,Illumina HiSeq,3574ade8-f6bc-44dc-94ce-8ea657978707,Uterus,39,F57EB4ED-4393-4DC3-9362-A4757EF8B21D,93FEF054-0782-4A27-A27B-22176874E805,TCGA-D1-A16R-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A16R,TCGA-UCEC,NA,s4618,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cad0,58cfa831e4b0c9d6adf6cad0,TCGA-DU-6402-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DU-6402-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_3_rg.sorted,TCGA-DU-6402-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_3_rg.sorted.bam,41,1.9,0.15,58cfa831e4b0c9d6adf6cad0,TCGA-DU-6402-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6402-10A,152F028E-EE29-40E0-8E75-5CAFFFACBD45,Blood Derived Normal,Illumina HiSeq,3cd68c5a-a87d-41a1-97aa-29c156e57988,Brain,52,3C6F9D48-F638-4D28-80AC-0A6A276ADF87,1383A087-72C2-4BA9-B4E8-EBE3C80206B5,TCGA-DU-6402-10A-01D-1703-02,HG19_Broad_variant,TCGA-DU-6402,TCGA-LGG,214,s8346,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa82fe4b0c9d6adf6ba37,58cfa82fe4b0c9d6adf6ba37,TCGA-A5-A0G2-10A-01D-A043_120301_SN590_0142_AD0LPVACXX_s_2_rg.sorted.filtered.,WGS,TCGA-A5-A0G2-10A-01D-A043_120301_SN590_0142_AD0LPVACXX_s_2_rg.sorted,TCGA-A5-A0G2-10A-01D-A043_120301_SN590_0142_AD0LPVACXX_s_2_rg.sorted.bam,18.79,1.89,0.17,58cfa82fe4b0c9d6adf6ba37,TCGA-A5-A0G2-10A-01D-A043_120301_SN590_0142_AD0LPVACXX_s_2_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0G2-10A,4ABBD258-0F0C-4428-901D-625D47AD363A,Blood Derived Normal,Illumina HiSeq,07955d67-db65-4ccd-a245-1e9981824904,Uterus,57,D6272155-71A9-4B3F-A2E7-4D45E945236C,89A3BA3E-D1A7-4B9F-8F59-CA715A1266BD,TCGA-A5-A0G2-10A-01D-A043-02,HG19_Broad_variant,TCGA-A5-A0G2,TCGA-UCEC,NA,s4586,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cc76,58cfa831e4b0c9d6adf6cc76,TCGA-ER-A194-01A-11D-A18Y_120723_SN1120_0178_BD1887ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-ER-A194-01A-11D-A18Y_120723_SN1120_0178_BD1887ACXX_s_4_rg.sorted,TCGA-ER-A194-01A-11D-A18Y_120723_SN1120_0178_BD1887ACXX_s_4_rg.sorted.bam,30.36,NA,0.17,58cfa831e4b0c9d6adf6cc76,TCGA-ER-A194-01A-11D-A18Y_120723_SN1120_0178_BD1887ACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A194-01A,2BBF00F4-7798-4DAD-9894-96202C9132BE,Primary Tumor,Illumina HiSeq,40a52169-d476-4650-a043-d5fda21a4213,Skin,77,EA15A5B0-8BA7-4114-853F-E3396E81CCEB,411370DC-4C66-484F-AC7E-42A19E486DFC,TCGA-ER-A194-01A-11D-A18Y-02,HG19_Broad_variant,TCGA-ER-A194,TCGA-SKCM,1354,s7693,Harvard Medical School,University of Pittsburgh,United States,NO,Not available,N0,Not available,Not available
13722.58cfa82fe4b0c9d6adf6b8dc,58cfa82fe4b0c9d6adf6b8dc,TCGA-A7-A0D9-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_6_rg.sorted.filtered.,WGS,TCGA-A7-A0D9-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_6_rg.sorted,TCGA-A7-A0D9-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_6_rg.sorted.bam,338.66,1.9,0.15,58cfa82fe4b0c9d6adf6b8dc,TCGA-A7-A0D9-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A7-A0D9-10A,17BAEF7C-D97D-4B98-AB53-503EF856523D,Blood Derived Normal,Illumina HiSeq,4d84158c-282c-48bc-ae3d-55ada9b30f29,Breast,37,70B623D6-E6A5-4BB6-A1BE-62E8EF235FE5,34D29129-A82C-477F-8D08-DC972D08AC45,TCGA-A7-A0D9-10A-01D-A060-02,HG19_Broad_variant,TCGA-A7-A0D9,TCGA-BRCA,NA,s5797,Harvard Medical School,Christiana Healthcare,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82fe4b0c9d6adf6b766,58cfa82fe4b0c9d6adf6b766,TCGA-67-6217-10A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_4_rg.sorted.filtered.,WGS,TCGA-67-6217-10A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_4_rg.sorted,TCGA-67-6217-10A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_4_rg.sorted.bam,124.7,1.9,0.15,58cfa82fe4b0c9d6adf6b766,TCGA-67-6217-10A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-67-6217-10A,108A71CF-B9DB-47CD-AA74-C03EC989B41B,Blood Derived Normal,Illumina HiSeq,868f0059-3a66-4f4c-a285-0b547b522450,Lung,73,EAC9B8A6-1569-4CEC-A266-AD10C42226FD,5E6CB91C-E92E-4605-9CBB-291FF6611FB0,TCGA-67-6217-10A-01D-1751-02,HG19_Broad_variant,TCGA-67-6217,TCGA-LUAD,NA,s11243,Harvard Medical School,St Joseph's Medical Center (MD),United States,NO,T2a,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa830e4b0c9d6adf6c234,58cfa830e4b0c9d6adf6c234,TCGA-BT-A20R-11A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BT-A20R-11A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_4_rg.sorted,TCGA-BT-A20R-11A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_4_rg.sorted.bam,17.44,1.78,0.18,58cfa830e4b0c9d6adf6c234,TCGA-BT-A20R-11A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_4_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20R-11A,F8780A4B-7F55-41D1-BF92-8513955D150E,Solid Tissue Normal,Illumina HiSeq,81815e13-7a11-4252-9fea-8006d97d9a9b,Bladder,79,4F6353E2-FB61-48B7-B784-3C0D391D708B,B2AEED65-1A63-4712-A8E1-22C91A2C690B,TCGA-BT-A20R-11A-11D-A16N-02,HG19_Broad_variant,TCGA-BT-A20R,TCGA-BLCA,154,s2865,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa830e4b0c9d6adf6c1a6,58cfa830e4b0c9d6adf6c1a6,TCGA-BH-A0HB-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BH-A0HB-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_5_rg.sorted,TCGA-BH-A0HB-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_5_rg.sorted.bam,58.9,2,0.14,58cfa830e4b0c9d6adf6c1a6,TCGA-BH-A0HB-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0HB-01A,0C1023C0-D2CE-4940-8047-7642F1DC3965,Primary Tumor,Illumina HiSeq,c9a434dc-8ce3-485f-88aa-a2373f6cdfac,Breast,55,19193B8F-1E1B-448C-B934-93F25E60D45B,49556237-D73F-4DE9-B5D9-7169DB7A53C5,TCGA-BH-A0HB-01A-11D-A060-02,HG19_Broad_variant,TCGA-BH-A0HB,TCGA-BRCA,NA,s6275,Harvard Medical School,University of Pittsburgh,None,NO,T1c,N0 (i-),Infiltrating Ductal Carcinoma,Stage IA
13722.58cfa831e4b0c9d6adf6cc94,58cfa831e4b0c9d6adf6cc94,TCGA-EJ-5502-10A-01D-1573_130223_SN590_0214_BC1UJ3ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EJ-5502-10A-01D-1573_130223_SN590_0214_BC1UJ3ACXX_s_6_rg.sorted,TCGA-EJ-5502-10A-01D-1573_130223_SN590_0214_BC1UJ3ACXX_s_6_rg.sorted.bam,121.4,1.9,0.15,58cfa831e4b0c9d6adf6cc94,TCGA-EJ-5502-10A-01D-1573_130223_SN590_0214_BC1UJ3ACXX_s_6_rg.sorted.bam,Alive,MALE,Not available,Not available,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5502-10A,48E83A4C-C602-494A-80CD-E2F4B4DD701E,Blood Derived Normal,Illumina HiSeq,ba38e3c4-9b7a-47f3-819a-86b4b443cdd3,Prostate,50,E5B3D936-B458-4E11-8CE2-707E2B73233C,27D1AFF1-E0BC-43C5-9C8C-209B685B2A96,TCGA-EJ-5502-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5502,TCGA-PRAD,NA,s3952,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d1ce,58cfa832e4b0c9d6adf6d1ce,TCGA-HT-7473-10A-01D-2022_130913_SN1440_0167_AC2A6PACXX_s_7_rg.sorted.filtered.,WGS,TCGA-HT-7473-10A-01D-2022_130913_SN1440_0167_AC2A6PACXX_s_7_rg.sorted,TCGA-HT-7473-10A-01D-2022_130913_SN1440_0167_AC2A6PACXX_s_7_rg.sorted.bam,246,NA,0.16,58cfa832e4b0c9d6adf6d1ce,TCGA-HT-7473-10A-01D-2022_130913_SN1440_0167_AC2A6PACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7473-10A,DBFACCB0-E8C0-48E8-9AEF-570267574822,Blood Derived Normal,Illumina HiSeq,2b1e29cb-e83c-4e25-a643-1ded3bbcccb6,Brain,28,996FE719-74D2-433B-9E73-76ED2775DDE9,8CDB3395-5562-4FAE-89AF-2980F5F9B09B,TCGA-HT-7473-10A-01D-2022-02,HG19_Broad_variant,TCGA-HT-7473,TCGA-LGG,NA,s8152,Harvard Medical School,Case Western - St Joes,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa831e4b0c9d6adf6cc4c,58cfa831e4b0c9d6adf6cc4c,TCGA-EA-A1QS-01A-61D-A232_140124_SN208_0506_BC2PD5ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EA-A1QS-01A-61D-A232_140124_SN208_0506_BC2PD5ACXX_s_2_rg.sorted,TCGA-EA-A1QS-01A-61D-A232_140124_SN208_0506_BC2PD5ACXX_s_2_rg.sorted.bam,36.95,NA,0.15,58cfa831e4b0c9d6adf6cc4c,TCGA-EA-A1QS-01A-61D-A232_140124_SN208_0506_BC2PD5ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EA-A1QS-01A,6F9D21C0-3B88-450D-A249-3E9BAFBA2DFA,Primary Tumor,Illumina HiSeq,c7f62ea9-e05f-40ea-9e4c-1771bd722b74,Cervix,46,8389C79E-164E-4462-ADCD-364DB3AFB463,109962B4-F4A5-4C72-B902-92516110FE7E,TCGA-EA-A1QS-01A-61D-A232-26,HG19_Broad_variant,TCGA-EA-A1QS,TCGA-CESC,NA,s1361,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d0d4,58cfa832e4b0c9d6adf6d0d4,TCGA-FY-A3I5-01B-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FY-A3I5-01B-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_1_rg.sorted,TCGA-FY-A3I5-01B-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_1_rg.sorted.bam,41.37,NA,0.14,58cfa832e4b0c9d6adf6d0d4,TCGA-FY-A3I5-01B-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FY-A3I5-01B,52203FF5-57B2-4D56-8935-2FF1EB61D7B8,Primary Tumor,Illumina HiSeq,ed0cff3d-a985-40a9-b0df-ec57b3bcdd50,Thyroid,64,7AEC7C70-6A5A-48D5-A863-A8DB40D93097,C32A9B9D-B381-4492-9BBC-8F25B09D18C1,TCGA-FY-A3I5-01B-11D-A221-26,HG19_Broad_variant,TCGA-FY-A3I5,TCGA-THCA,NA,s12119,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III
13722.58cfa831e4b0c9d6adf6c34a,58cfa831e4b0c9d6adf6c34a,TCGA-CG-5718-01A-11D-1598_121029_SN208_0438_AC18NJACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CG-5718-01A-11D-1598_121029_SN208_0438_AC18NJACXX_s_6_rg.sorted,TCGA-CG-5718-01A-11D-1598_121029_SN208_0438_AC18NJACXX_s_6_rg.sorted.bam,563,1.9,0.15,58cfa831e4b0c9d6adf6c34a,TCGA-CG-5718-01A-11D-1598_121029_SN208_0438_AC18NJACXX_s_6_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5718-01A,D5C58161-05ED-4472-81ED-176216F49929,Primary Tumor,Illumina HiSeq,98032563-24e7-466c-9f90-1ba67975f2f9,Stomach,78,5865A287-63C4-44F7-92D5-C4F3C323AF89,1A108108-EEAC-4EE8-AFD7-871AFA69054B,TCGA-CG-5718-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5718,TCGA-STAD,NA,s14903,Harvard Medical School,Indivumed,Germany,NO,T2b,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa831e4b0c9d6adf6c73a,58cfa831e4b0c9d6adf6c73a,TCGA-D7-6524-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_5_rg.sorted.filtered.,WGS,TCGA-D7-6524-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_5_rg.sorted,TCGA-D7-6524-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_5_rg.sorted.bam,274.4,1.9,0.16,58cfa831e4b0c9d6adf6c73a,TCGA-D7-6524-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6524-01A,7EF3F065-1928-4A58-B5A6-76DDDB8488CF,Primary Tumor,Illumina HiSeq,67f702e7-84ad-4d23-90e7-03040d417e4d,Stomach,53,6F14723A-AF83-402D-AB98-B4ED29A93AAF,48540EAA-46FD-4C0A-9893-1FF69D205F79,TCGA-D7-6524-01A-11D-1798-02,HG19_Broad_variant,TCGA-D7-6524,TCGA-STAD,NA,s14557,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N1,Stomach  Adenocarcinoma  Diffuse Type,Stage II
13722.58cfa831e4b0c9d6adf6c37e,58cfa831e4b0c9d6adf6c37e,TCGA-CG-5719-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CG-5719-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_1_rg.sorted,TCGA-CG-5719-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_1_rg.sorted.bam,46,1.9,0.16,58cfa831e4b0c9d6adf6c37e,TCGA-CG-5719-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_1_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5719-01A,263F67E0-0A28-42E6-B3F3-1DDD0D397220,Primary Tumor,Illumina HiSeq,e6237df3-92e8-4e8b-92a4-b09d3515f16f,Stomach,54,606573EE-ED11-4DB5-ABAF-E842EC575EEE,9008E364-B8F3-4923-B0CC-6ED34AA7BAC3,TCGA-CG-5719-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5719,TCGA-STAD,NA,s15247,Harvard Medical School,Indivumed,Germany,NO,T4,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa830e4b0c9d6adf6bdce,58cfa830e4b0c9d6adf6bdce,TCGA-BH-A0H6-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BH-A0H6-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_2_rg.sorted,TCGA-BH-A0H6-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_2_rg.sorted.bam,18.64,2.08,0.16,58cfa830e4b0c9d6adf6bdce,TCGA-BH-A0H6-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0H6-10A,AEB6A3A6-B57A-4C53-90E6-E833777DD2A1,Blood Derived Normal,Illumina HiSeq,f8cb702c-5eff-49df-98b0-e1404066dc8f,Breast,82,9269A6CA-6D25-4815-8BB2-6AB526262266,3DDCCFEC-A269-41AB-B274-31E992F98878,TCGA-BH-A0H6-10A-01D-A060-02,HG19_Broad_variant,TCGA-BH-A0H6,TCGA-BRCA,NA,s6125,Harvard Medical School,University of Pittsburgh,None,NO,T1b,NX,Infiltrating Ductal Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c3d6,58cfa831e4b0c9d6adf6c3d6,TCGA-CG-5734-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CG-5734-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_7_rg.sorted,TCGA-CG-5734-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_7_rg.sorted.bam,206,1.9,0.15,58cfa831e4b0c9d6adf6c3d6,TCGA-CG-5734-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_7_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5734-01A,2A227292-C73D-45FC-AB68-CDFAF7AEF9E7,Primary Tumor,Illumina HiSeq,4cac9679-5c5e-4b51-b7a0-0d82ab2c2237,Stomach,68,A0237637-3859-47D9-A60E-0AF8C6884B4A,12BCC59A-0A89-4087-B976-A22F66D8190C,TCGA-CG-5734-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5734,TCGA-STAD,243,s14990,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6c6be,58cfa831e4b0c9d6adf6c6be,TCGA-CN-4742-01A-02D-1509_120420_SN208_0285_AD0T5JACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CN-4742-01A-02D-1509_120420_SN208_0285_AD0T5JACXX_s_1_rg.sorted,TCGA-CN-4742-01A-02D-1509_120420_SN208_0285_AD0T5JACXX_s_1_rg.sorted.bam,52.7,1.9,0.16,58cfa831e4b0c9d6adf6c6be,TCGA-CN-4742-01A-02D-1509_120420_SN208_0285_AD0T5JACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4742-01A,444E5BFC-D4E5-4B0D-B96D-88ECEA8873E9,Primary Tumor,Illumina HiSeq,e655fe0a-a859-4967-b69c-4c8d36a8a7e0,Head and Neck,48,507B9A1D-BFBF-43F8-86D2-665A488441AF,A9768535-FE1C-4B4F-B709-DED0809BA592,TCGA-CN-4742-01A-02D-1509-02,HG19_Broad_variant,TCGA-CN-4742,TCGA-HNSC,397,s15892,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6cdb6,58cfa831e4b0c9d6adf6cdb6,TCGA-FG-5963-01A-11D-1703_130813_SN1440_0161_BC29ENACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FG-5963-01A-11D-1703_130813_SN1440_0161_BC29ENACXX_s_1_rg.sorted,TCGA-FG-5963-01A-11D-1703_130813_SN1440_0161_BC29ENACXX_s_1_rg.sorted.bam,7.3,2,0.13,58cfa831e4b0c9d6adf6cdb6,TCGA-FG-5963-01A-11D-1703_130813_SN1440_0161_BC29ENACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-5963-01A,68F550CA-3A33-45E4-B1C9-14F99E543263,Primary Tumor,Illumina HiSeq,11f814ba-95e7-4824-ab33-1e14947dcbd5,Brain,23,41C647E8-6A53-464B-9EFC-78547C514519,166F687B-F395-4AC7-A06A-78826A0722E7,TCGA-FG-5963-01A-11D-1703-02,HG19_Broad_variant,TCGA-FG-5963,TCGA-LGG,NA,s8148,Harvard Medical School,Case Western,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa830e4b0c9d6adf6c286,58cfa830e4b0c9d6adf6c286,TCGA-BH-A0HB-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BH-A0HB-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_6_rg.sorted,TCGA-BH-A0HB-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_6_rg.sorted.bam,10.32,1.88,0.16,58cfa830e4b0c9d6adf6c286,TCGA-BH-A0HB-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0HB-10A,0C1023C0-D2CE-4940-8047-7642F1DC3965,Blood Derived Normal,Illumina HiSeq,6c213158-4cff-4e3f-a2fe-79b1eb8349dc,Breast,55,12ED991B-96F2-4A0E-AA8B-8345573A8E57,3F02CEB5-9B6C-453C-8A81-00D2B609B742,TCGA-BH-A0HB-10A-01D-A060-02,HG19_Broad_variant,TCGA-BH-A0HB,TCGA-BRCA,NA,s6917,Harvard Medical School,University of Pittsburgh,None,NO,T1c,N0 (i-),Infiltrating Ductal Carcinoma,Stage IA
13722.58cfa831e4b0c9d6adf6c481,58cfa831e4b0c9d6adf6c481,TCGA-CG-5725-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CG-5725-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_5_rg.sorted,TCGA-CG-5725-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_5_rg.sorted.bam,14.7,1.9,0.13,58cfa831e4b0c9d6adf6c481,TCGA-CG-5725-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_5_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5725-11A,129D95CA-71EF-44AA-A93D-F87803C37C9A,Solid Tissue Normal,Illumina HiSeq,42216242-2d3d-4bb9-9b00-f0d50042790a,Stomach,72,0529F76F-29A6-4640-9DFD-447AA67EF836,9539B3CF-4AB9-468B-A80A-D91F624DD650,TCGA-CG-5725-11A-01D-1598-02,HG19_Broad_variant,TCGA-CG-5725,TCGA-STAD,457,s15067,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa830e4b0c9d6adf6c208,58cfa830e4b0c9d6adf6c208,TCGA-BA-5558-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BA-5558-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_5_rg.sorted,TCGA-BA-5558-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_5_rg.sorted.bam,252.7,1.9,0.15,58cfa830e4b0c9d6adf6c208,TCGA-BA-5558-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5558-01A,6A1AA50C-097C-4E04-8DDD-12D50F8A5AC2,Primary Tumor,Illumina HiSeq,4116c10d-23f4-49f2-bd5a-9b9466f08bfb,Head and Neck,65,EB749281-B3DC-43E4-812E-F5F5004A21ED,41737268-345A-4F87-B2DB-E184247E1396,TCGA-BA-5558-01A-01D-1509-02,HG19_Broad_variant,TCGA-BA-5558,TCGA-HNSC,NA,s15610,Harvard Medical School,UNC,None,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c518,58cfa831e4b0c9d6adf6c518,TCGA-CN-4729-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CN-4729-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_4_rg.sorted,TCGA-CN-4729-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_4_rg.sorted.bam,948.4,1.9,0.14,58cfa831e4b0c9d6adf6c518,TCGA-CN-4729-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4729-10A,2FC960BD-01B0-422D-AD33-34520FA3DF0E,Blood Derived Normal,Illumina HiSeq,a038764a-307f-4a6f-8fd0-5ad2d2e2c05e,Head and Neck,73,818173B3-BD9D-44DD-B1C0-6CBF552C51D7,21E11B04-9295-48DE-A5C2-2796A44698EE,TCGA-CN-4729-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4729,TCGA-HNSC,NA,s15621,Harvard Medical School,University of Pittsburgh,None,NO,T2,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6c702,58cfa831e4b0c9d6adf6c702,TCGA-CV-5966-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CV-5966-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_2_rg.sorted,TCGA-CV-5966-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_2_rg.sorted.bam,99,1.9,0.14,58cfa831e4b0c9d6adf6c702,TCGA-CV-5966-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5966-01A,0D0731E2-8D82-4B6D-9258-2896A770A868,Primary Tumor,Illumina HiSeq,a774b0c6-39f6-4601-9c2a-5a81369b9f87,Head and Neck,63,E71C33E9-1F74-4CF6-B6BF-985D0C96F71E,84D0CA61-132A-4B85-A343-0C55DE088B0C,TCGA-CV-5966-01A-11D-1681-02,HG19_Broad_variant,TCGA-CV-5966,TCGA-HNSC,545,s16335,Harvard Medical School,MD Anderson Cancer Center,None,NO,T4a,N1,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6cec0,58cfa832e4b0c9d6adf6cec0,TCGA-EK-A2R8-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EK-A2R8-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_8_rg.sorted,TCGA-EK-A2R8-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_8_rg.sorted.bam,21,NA,0.16,58cfa832e4b0c9d6adf6cec0,TCGA-EK-A2R8-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2R8-10A,D4510801-8CE4-4F10-8B31-25C0A39B5135,Blood Derived Normal,Illumina HiSeq,8498b73d-be83-4863-bad7-ddd22874d071,Cervix,48,0C67F012-629A-478A-8836-646272637695,F4A6EA47-F2FA-4101-9229-D35ACA3A39B3,TCGA-EK-A2R8-10A-01D-A18I-02,HG19_Broad_variant,TCGA-EK-A2R8,TCGA-CESC,NA,s1528,Harvard Medical School,Gynecologic Oncology Group,United States,NO,T1b2,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6bee4,58cfa830e4b0c9d6adf6bee4,TCGA-AP-A0LJ-10A-01D-A043_120324_SN1120_0127_BC0L80ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-AP-A0LJ-10A-01D-A043_120324_SN1120_0127_BC0L80ACXX_s_8_rg.sorted,TCGA-AP-A0LJ-10A-01D-A043_120324_SN1120_0127_BC0L80ACXX_s_8_rg.sorted.bam,33.9,1.8,0.14,58cfa830e4b0c9d6adf6bee4,TCGA-AP-A0LJ-10A-01D-A043_120324_SN1120_0127_BC0L80ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LJ-10A,B4A520AE-F259-48C8-823E-C10B9B8A133A,Blood Derived Normal,Illumina HiSeq,621545f7-ce7d-481d-95ca-f241098c48d1,Uterus,42,6E436D9F-6DF5-4414-BD68-CF6607D24E28,20DB61A1-BF33-4A14-B10C-2DF57BFC6824,TCGA-AP-A0LJ-10A-01D-A043-02,HG19_Broad_variant,TCGA-AP-A0LJ,TCGA-UCEC,NA,s4426,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c5b3,58cfa831e4b0c9d6adf6c5b3,TCGA-CG-4436-10A-01D-1154_130815_VM001_0003_VMR0003CXX_s_6_rg.sorted.filtered.,WGS,TCGA-CG-4436-10A-01D-1154_130815_VM001_0003_VMR0003CXX_s_6_rg.sorted,TCGA-CG-4436-10A-01D-1154_130815_VM001_0003_VMR0003CXX_s_6_rg.sorted.bam,108.9,1.9,0.16,58cfa831e4b0c9d6adf6c5b3,TCGA-CG-4436-10A-01D-1154_130815_VM001_0003_VMR0003CXX_s_6_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4436-10A,7938CA55-766E-4277-9E7E-603FFA02E570,Blood Derived Normal,Illumina HiSeq,3eeefb8e-1bd7-4739-b4c3-b7695bedf7d3,Stomach,57,5B54776F-F475-4EFC-93A3-D6B54C954F2F,C2FA7041-FFB4-4296-8E12-57045F98BD17,TCGA-CG-4436-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4436,TCGA-STAD,NA,s14758,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c671,58cfa831e4b0c9d6adf6c671,TCGA-CN-5363-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CN-5363-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_7_rg.sorted,TCGA-CN-5363-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_7_rg.sorted.bam,15.4,1.9,0.14,58cfa831e4b0c9d6adf6c671,TCGA-CN-5363-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_7_rg.sorted.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5363-10A,291B069C-9DDE-4E1E-8430-85146BC94338,Blood Derived Normal,Illumina HiSeq,97348237-93c4-44d0-9bb6-3c2ee7ac10a1,Head and Neck,48,591E99EC-46F9-442D-AC20-745DCCC8A52B,559D615C-BE5B-4AD1-8860-B633A0B361B6,TCGA-CN-5363-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5363,TCGA-HNSC,253,s16324,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N3,Head and Neck Squamous Cell Carcinoma,Stage IVB
13722.58cfa831e4b0c9d6adf6cbfc,58cfa831e4b0c9d6adf6cbfc,TCGA-EJ-5506-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EJ-5506-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_5_rg.sorted,TCGA-EJ-5506-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_5_rg.sorted.bam,238.7,1.9,0.15,58cfa831e4b0c9d6adf6cbfc,TCGA-EJ-5506-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5506-01A,E5E4D3B6-8E58-4DCF-8F67-A00E656A8E27,Primary Tumor,Illumina HiSeq,bd66d4a0-aa1a-4bf3-a764-cb7292bc89b1,Prostate,67,9EBDA113-B0FC-4233-87AC-DAD0E7D033DE,CED987BC-B780-487A-A82E-2EB589AD3796,TCGA-EJ-5506-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5506,TCGA-PRAD,NA,s3780,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c02e,58cfa830e4b0c9d6adf6c02e,TCGA-BJ-A0ZC-10A-01D-A13U_120706_SN1222_0123_BD1488ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BJ-A0ZC-10A-01D-A13U_120706_SN1222_0123_BD1488ACXX_s_2_rg.sorted,TCGA-BJ-A0ZC-10A-01D-A13U_120706_SN1222_0123_BD1488ACXX_s_2_rg.sorted.bam,65.57,1.93,0.17,58cfa830e4b0c9d6adf6c02e,TCGA-BJ-A0ZC-10A-01D-A13U_120706_SN1222_0123_BD1488ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0ZC-10A,6675C581-297D-44CD-B80F-AE7E53D48228,Blood Derived Normal,Illumina HiSeq,58e1cb0c-b7b5-4c66-accc-3ad21f51a8a1,Thyroid,55,CF4CE78D-BB15-494E-80E0-6EFBC987D617,E18B064C-F6BD-4625-A065-722412F92FC8,TCGA-BJ-A0ZC-10A-01D-A13U-02,HG19_Broad_variant,TCGA-BJ-A0ZC,TCGA-THCA,NA,s12506,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82fe4b0c9d6adf6b60d,58cfa82fe4b0c9d6adf6b60d,TCGA-38-4631-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_5_rg.sorted.filtered.,WGS,TCGA-38-4631-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_5_rg.sorted,TCGA-38-4631-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_5_rg.sorted.bam,387.4,1.9,0.15,58cfa82fe4b0c9d6adf6b60d,TCGA-38-4631-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-38-4631-01A,2483621A-4DB3-41AB-AA33-B9427EA8A0AF,Primary Tumor,Illumina HiSeq,b1dd06d4-cd7d-4e62-8deb-12fed31731b5,Lung,72,13B0D336-205A-42AC-8A50-DB0EB065013D,B1FA802A-C88E-4B8D-88FF-4545DCF326DE,TCGA-38-4631-01A-01D-1751-02,HG19_Broad_variant,TCGA-38-4631,TCGA-LUAD,354,s11229,Harvard Medical School,UNC,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82fe4b0c9d6adf6b5f1,58cfa82fe4b0c9d6adf6b5f1,TCGA-38-4629-11A-01D-1203_110712_SN590_0096_A80WMCABXX_s_4_rg.sorted.filtered.,WGS,TCGA-38-4629-11A-01D-1203_110712_SN590_0096_A80WMCABXX_s_4_rg.sorted,TCGA-38-4629-11A-01D-1203_110712_SN590_0096_A80WMCABXX_s_4_rg.sorted.bam,113.9,1.9,0.16,58cfa82fe4b0c9d6adf6b5f1,TCGA-38-4629-11A-01D-1203_110712_SN590_0096_A80WMCABXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-38-4629-11A,127BF818-F7E5-46B5-A9DE-39F6D96B8B83,Solid Tissue Normal,Illumina HiSeq,364e81ba-b440-470b-a9e4-8e3795d66795,Lung,68,85C1E746-D2E4-4BCE-BBC3-11FEB9CE4C28,D2150D6C-5E42-49D0-B65F-59A3004B1A17,TCGA-38-4629-11A-01D-1203-02,HG19_Broad_variant,TCGA-38-4629,TCGA-LUAD,864,s11446,Harvard Medical School,UNC,None,NO,T3,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa831e4b0c9d6adf6c5b8,58cfa831e4b0c9d6adf6c5b8,TCGA-CN-5360-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CN-5360-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_5_rg.sorted,TCGA-CN-5360-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_5_rg.sorted.bam,98.4,1.9,0.14,58cfa831e4b0c9d6adf6c5b8,TCGA-CN-5360-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5360-10A,5793879B-F663-4A10-9BD9-1ACD2E189650,Blood Derived Normal,Illumina HiSeq,e5e36209-eb45-4a7f-b70a-547a36daace6,Head and Neck,68,9439BC03-9D26-454A-BA80-A0F5A4585656,E8A06D37-CC48-46E7-B1DA-C9B8A9B2A462,TCGA-CN-5360-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5360,TCGA-HNSC,NA,s15890,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6becf,58cfa830e4b0c9d6adf6becf,TCGA-BL-A13J-11A-13D-A10R_120920_SN1222_0151_BD1D5CACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BL-A13J-11A-13D-A10R_120920_SN1222_0151_BD1D5CACXX_s_2_rg.sorted,TCGA-BL-A13J-11A-13D-A10R_120920_SN1222_0151_BD1D5CACXX_s_2_rg.sorted.bam,13.33,1.94,0.14,58cfa830e4b0c9d6adf6becf,TCGA-BL-A13J-11A-13D-A10R_120920_SN1222_0151_BD1D5CACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BL-A13J-11A,556FCBC8-172A-4AF1-8822-AE036E8D68E8,Solid Tissue Normal,Illumina HiSeq,477877cc-b9b8-4869-b082-7dc505705bcd,Bladder,65,2A834A44-9490-4C60-B587-EBE890C3FB0A,9B4FFD23-8B53-4DFC-A98E-E4C70F7680F0,TCGA-BL-A13J-11A-13D-A10R-02,HG19_Broad_variant,TCGA-BL-A13J,TCGA-BLCA,81,s3081,Harvard Medical School,Christiana Healthcare,United States,NO,T4,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6d208,58cfa832e4b0c9d6adf6d208,TCGA-HC-7232-10A-01D-2111_130517_SN590_0231_BC24V6ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-HC-7232-10A-01D-2111_130517_SN590_0231_BC24V6ACXX_s_5_rg.sorted,TCGA-HC-7232-10A-01D-2111_130517_SN590_0231_BC24V6ACXX_s_5_rg.sorted.bam,170.65,NA,0.16,58cfa832e4b0c9d6adf6d208,TCGA-HC-7232-10A-01D-2111_130517_SN590_0231_BC24V6ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7232-10A,CE3585D3-7388-4D05-84C8-64E0883003B3,Blood Derived Normal,Illumina HiSeq,650b3a4f-0196-40bf-88c0-7b01ad67b377,Prostate,66,28553F1A-F11A-4876-9BEF-B16AFFFFBDA5,E8BDB147-E6DD-4755-B088-684DB3A94E2A,TCGA-HC-7232-10A-01D-2111-02,HG19_Broad_variant,TCGA-HC-7232,TCGA-PRAD,NA,s3628,Harvard Medical School,International Genomics Consortium,United States,NO,T3b,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c61a,58cfa831e4b0c9d6adf6c61a,TCGA-CG-4305-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_1_rg.sorted.filtered.,WGS,TCGA-CG-4305-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_1_rg.sorted,TCGA-CG-4305-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_1_rg.sorted.bam,264.2,1.9,0.13,58cfa831e4b0c9d6adf6c61a,TCGA-CG-4305-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_1_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4305-01A,E0E35051-FBB4-4389-AEDB-87BDE84D21AD,Primary Tumor,Illumina HiSeq,dad3a237-d784-4731-bbef-c4d3dce49fa2,Stomach,69,6B64B4A0-EDC8-4DC3-B527-D320DED81351,A01B1633-2A30-4379-80AC-72799C14B5C7,TCGA-CG-4305-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4305,TCGA-STAD,NA,s14981,Harvard Medical School,Indivumed,Germany,NO,T2a,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa832e4b0c9d6adf6cf7f,58cfa832e4b0c9d6adf6cf7f,TCGA-GD-A3OP-01A-21D-A221_120902_SN1222_0147_AC195DACXX_s_1_rg.sorted.filtered.,WGS,TCGA-GD-A3OP-01A-21D-A221_120902_SN1222_0147_AC195DACXX_s_1_rg.sorted,TCGA-GD-A3OP-01A-21D-A221_120902_SN1222_0147_AC195DACXX_s_1_rg.sorted.bam,15.89,NA,0.17,58cfa832e4b0c9d6adf6cf7f,TCGA-GD-A3OP-01A-21D-A221_120902_SN1222_0147_AC195DACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GD-A3OP-01A,31DA07BB-6752-49A3-A7EA-5427C04A9458,Primary Tumor,Illumina HiSeq,e01f55a8-4fbe-4f9a-8617-ce0e6900f177,Bladder,84,C0773229-5A20-4451-9DB5-F757E34921AE,AB6D114E-DF58-4912-85F4-3C385CAA3749,TCGA-GD-A3OP-01A-21D-A221-26,HG19_Broad_variant,TCGA-GD-A3OP,TCGA-BLCA,NA,s3125,MD Anderson - Institute for Applied Cancer Science,ABS - IUPUI,United States,NO,T4a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82ee4b0c9d6adf6af20,58cfa82ee4b0c9d6adf6af20,TCGA-05-4415-01A-22D-1853_111204_SN208_0256_C0562ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-05-4415-01A-22D-1853_111204_SN208_0256_C0562ACXX_s_5_rg.sorted,TCGA-05-4415-01A-22D-1853_111204_SN208_0256_C0562ACXX_s_5_rg.sorted.bam,143.7,1.9,0.14,58cfa82ee4b0c9d6adf6af20,TCGA-05-4415-01A-22D-1853_111204_SN208_0256_C0562ACXX_s_5_rg.sorted.bam,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4415-01A,D15B7B29-C5C5-41D8-B83B-7CC12FE92820,Primary Tumor,Illumina HiSeq,ae778c61-5e62-4f34-9b62-f28d9acf21b1,Lung,57,57E160F5-45FC-44EF-95C6-54E112E3B7F5,4CD99514-20D0-439F-9B9F-BDDCEE5D950F,TCGA-05-4415-01A-22D-1853-02,HG19_Broad_variant,TCGA-05-4415,TCGA-LUAD,91,s11220,Harvard Medical School,Indivumed,Germany,NO,T4,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIB
13722.58cfa831e4b0c9d6adf6cb94,58cfa831e4b0c9d6adf6cb94,TCGA-EK-A3GN-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EK-A3GN-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_5_rg.sorted,TCGA-EK-A3GN-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_5_rg.sorted.bam,133.46,NA,0.15,58cfa831e4b0c9d6adf6cb94,TCGA-EK-A3GN-10A-01D-A20X_140417_SN590_0248_AC3EUFACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A3GN-10A,F727FCB9-E457-4643-9468-F739133B7E9C,Blood Derived Normal,Illumina HiSeq,9b083a7a-df5d-4937-a89c-341a4622b771,Cervix,47,7150E9B7-9E22-482F-923B-2203C07BD589,48654B33-F0D3-4C3D-B6A7-AC109940B7B7,TCGA-EK-A3GN-10A-01D-A20X-26,HG19_Broad_variant,TCGA-EK-A3GN,TCGA-CESC,NA,s1365,MD Anderson - Institute for Applied Cancer Science,Gynecologic Oncology Group,United States,NO,TX,NX,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d04e,58cfa832e4b0c9d6adf6d04e,TCGA-G9-6329-01A-13D-1957_130222_SN1222_0174_BC1RNEACXX_s_1_rg.sorted.filtered.,WGS,TCGA-G9-6329-01A-13D-1957_130222_SN1222_0174_BC1RNEACXX_s_1_rg.sorted,TCGA-G9-6329-01A-13D-1957_130222_SN1222_0174_BC1RNEACXX_s_1_rg.sorted.bam,41.7,1.9,0.15,58cfa832e4b0c9d6adf6d04e,TCGA-G9-6329-01A-13D-1957_130222_SN1222_0174_BC1RNEACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6329-01A,A08FD0A6-A89A-4ADB-B641-D4C1238ABB71,Primary Tumor,Illumina HiSeq,1971b9d7-8a67-4447-835d-23525622c037,Prostate,67,E004F38D-C874-4E03-830B-4E554EF3E274,46BEFA09-3AF0-415C-994E-330B07586058,TCGA-G9-6329-01A-13D-1957-02,HG19_Broad_variant,TCGA-G9-6329,TCGA-PRAD,NA,s3796,Harvard Medical School,Roswell Park,United States,NO,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d128,58cfa832e4b0c9d6adf6d128,TCGA-G2-A3IE-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-G2-A3IE-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_3_rg.sorted,TCGA-G2-A3IE-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_3_rg.sorted.bam,48.07,NA,0.15,58cfa832e4b0c9d6adf6d128,TCGA-G2-A3IE-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-G2-A3IE-01A,C65BA2B8-E867-42E8-BBD0-C2CDF5130CFB,Primary Tumor,Illumina HiSeq,171a2a97-43d5-41cc-a9ae-2f685c3ed80f,Bladder,51,FC529667-D055-4FC3-806D-C0431D9A6CFF,5C93720D-56AA-4324-8543-9B37351BC9B6,TCGA-G2-A3IE-01A-11D-A210-26,HG19_Broad_variant,TCGA-G2-A3IE,TCGA-BLCA,612,s2917,MD Anderson - Institute for Applied Cancer Science,MD Anderson,United States,NO,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa830e4b0c9d6adf6be66,58cfa830e4b0c9d6adf6be66,TCGA-BJ-A3PT-01A-12D-A221_120530_SN1222_0111_BD12L1ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BJ-A3PT-01A-12D-A221_120530_SN1222_0111_BD12L1ACXX_s_1_rg.sorted,TCGA-BJ-A3PT-01A-12D-A221_120530_SN1222_0111_BD12L1ACXX_s_1_rg.sorted.bam,17.47,NA,0.15,58cfa830e4b0c9d6adf6be66,TCGA-BJ-A3PT-01A-12D-A221_120530_SN1222_0111_BD12L1ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A3PT-01A,29C4319C-3EAD-42B1-810D-418DA8D515C4,Primary Tumor,Illumina HiSeq,0d7263bd-8ffa-4ba1-93c4-0444afd9b56e,Thyroid,51,8C112A5F-AE83-4B13-8E00-802382729344,EC6A8D75-A25A-4179-BAF4-53607841AC09,TCGA-BJ-A3PT-01A-12D-A221-26,HG19_Broad_variant,TCGA-BJ-A3PT,TCGA-THCA,NA,s12747,MD Anderson - Institute for Applied Cancer Science,University of Pittsburgh,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa832e4b0c9d6adf6d57a,58cfa832e4b0c9d6adf6d57a,TCGA-LN-A4MQ-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_4_rg.sorted.filtered.,WGS,TCGA-LN-A4MQ-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_4_rg.sorted,TCGA-LN-A4MQ-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_4_rg.sorted.bam,35.61,NA,0.16,58cfa832e4b0c9d6adf6d57a,TCGA-LN-A4MQ-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_4_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A4MQ-01A,33C0199A-BE0C-46D1-BB1E-889BFAEDF20B,Primary Tumor,Illumina HiSeq,beb51eaa-d60f-4bae-a401-293cb0ff9121,Esophagus,46,23CF07BE-97E6-4F55-A8F2-FF03CDBBA74E,4B6D7228-2E11-44F6-A1F4-DABF2085BB05,TCGA-LN-A4MQ-01A-11D-A28P-26,HG19_Broad_variant,TCGA-LN-A4MQ,TCGA-ESCA,NA,s1868,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N1,Not available,Stage III
13722.58cfa831e4b0c9d6adf6c7fc,58cfa831e4b0c9d6adf6c7fc,TCGA-CV-6959-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CV-6959-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_8_rg.sorted,TCGA-CV-6959-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_8_rg.sorted.bam,79.7,1.9,0.14,58cfa831e4b0c9d6adf6c7fc,TCGA-CV-6959-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6959-11A,EF3CE0E5-D2E8-4616-8B1A-A78C591CF235,Solid Tissue Normal,Illumina HiSeq,e12b73cf-efab-4371-8449-776e46f7949c,Head and Neck,48,C6706A96-631D-43D0-9A08-0BBE9D6295FB,556078E9-11DC-4089-9520-D5D5C49E42E0,TCGA-CV-6959-11A-01D-1911-02,HG19_Broad_variant,TCGA-CV-6959,TCGA-HNSC,256,s16203,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6c7c8,58cfa831e4b0c9d6adf6c7c8,TCGA-D1-A17K-01A-11D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-D1-A17K-01A-11D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_2_rg.sorted,TCGA-D1-A17K-01A-11D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_2_rg.sorted.bam,56.36,1.95,0.15,58cfa831e4b0c9d6adf6c7c8,TCGA-D1-A17K-01A-11D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A17K-01A,5C22C8D6-5805-455C-8E1C-E6B8006738E4,Primary Tumor,Illumina HiSeq,312dd86a-5fc1-4446-bfd6-fe867e3617f2,Uterus,74,CA213835-EFC5-4216-A762-A6B320B516BF,3E67F5BD-C5A6-4CDD-8D71-78038D316447,TCGA-D1-A17K-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A17K,TCGA-UCEC,NA,s4617,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6ceea,58cfa832e4b0c9d6adf6ceea,TCGA-FS-A1Z4-06A-11D-A18Y_120711_SN208_0414_BD13L5ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FS-A1Z4-06A-11D-A18Y_120711_SN208_0414_BD13L5ACXX_s_5_rg.sorted,TCGA-FS-A1Z4-06A-11D-A18Y_120711_SN208_0414_BD13L5ACXX_s_5_rg.sorted.bam,67.34,NA,0.15,58cfa832e4b0c9d6adf6ceea,TCGA-FS-A1Z4-06A-11D-A18Y_120711_SN208_0414_BD13L5ACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1Z4-06A,8465257B-7212-44A3-BD9F-1F7D017499AD,Metastatic,Illumina HiSeq,0161c7e1-fed0-4d34-8c99-afa6e680230c,Skin,62,9AFE3E49-19FE-426F-ADCC-9A017F42DC45,7D7EB9C0-01BF-46E1-8107-F17852714D60,TCGA-FS-A1Z4-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1Z4,TCGA-SKCM,854,s7528,Harvard Medical School,Essen,Germany,NO,T1,N0,Not available,Stage I
13722.58cfa832e4b0c9d6adf6d07a,58cfa832e4b0c9d6adf6d07a,TCGA-HC-7077-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_7_rg.sorted.filtered.,WGS,TCGA-HC-7077-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_7_rg.sorted,TCGA-HC-7077-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_7_rg.sorted.bam,76,NA,0.14,58cfa832e4b0c9d6adf6d07a,TCGA-HC-7077-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_7_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7077-10A,92252560-5984-41F6-A4B5-A3AA8654C0C8,Blood Derived Normal,Illumina HiSeq,dd0dd624-e056-45af-8e61-7badb7a7fe56,Prostate,64,766EEC0B-6346-4A94-9F1A-2AD9364CE165,60A6879B-1737-4351-B658-6283F73F8393,TCGA-HC-7077-10A-01D-1957-02,HG19_Broad_variant,TCGA-HC-7077,TCGA-PRAD,NA,s3982,Harvard Medical School,International Genomics Consortium,United States,NO,T3a,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c594,58cfa831e4b0c9d6adf6c594,TCGA-CG-4469-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CG-4469-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_7_rg.sorted,TCGA-CG-4469-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_7_rg.sorted.bam,23.9,1.9,0.15,58cfa831e4b0c9d6adf6c594,TCGA-CG-4469-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_7_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4469-10A,2AC986F6-CD6F-4CA5-90CC-7A105CFE85EA,Blood Derived Normal,Illumina HiSeq,e07b3b35-5adb-4abd-9750-e316a6f53fff,Stomach,70,0279401D-8BB4-4E90-AB5B-E0BC1F6C1709,725941B2-EABE-486D-B19D-FD215B801A8E,TCGA-CG-4469-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4469,TCGA-STAD,215,s14905,Harvard Medical School,Indivumed,Germany,NO,T3,N3,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa831e4b0c9d6adf6cbf7,58cfa831e4b0c9d6adf6cbf7,TCGA-EK-A2PL-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EK-A2PL-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_1_rg.sorted,TCGA-EK-A2PL-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_1_rg.sorted.bam,72.21,NA,0.16,58cfa831e4b0c9d6adf6cbf7,TCGA-EK-A2PL-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2PL-01A,45CADCF3-EA98-4063-9255-5C18D6A5CBAB,Primary Tumor,Illumina HiSeq,ca898dd4-73fc-4fa3-8d2b-3d4f27be4736,Cervix,36,6EE33187-69A7-4328-9521-173CFCDE7A1B,2AC0C1AB-11A3-4806-82FE-08529AD8BBDD,TCGA-EK-A2PL-01A-11D-A18I-02,HG19_Broad_variant,TCGA-EK-A2PL,TCGA-CESC,NA,s1187,Harvard Medical School,Gynecologic Oncology Group,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6cf7e,58cfa832e4b0c9d6adf6cf7e,TCGA-G9-6363-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_6_rg.sorted.filtered.,WGS,TCGA-G9-6363-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_6_rg.sorted,TCGA-G9-6363-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_6_rg.sorted.bam,8.7,1.9,0.15,58cfa832e4b0c9d6adf6cf7e,TCGA-G9-6363-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6363-10A,B5B3871C-078C-46A7-AC50-EF916D4A6781,Blood Derived Normal,Illumina HiSeq,2a69deb3-9543-4506-b9b1-31593b6cb7d5,Prostate,64,B7119CE5-584D-4696-B5B3-EDD5B6ED5F98,C835BA0A-5D30-4D36-B233-F0212B0322A6,TCGA-G9-6363-10A-01D-1784-02,HG19_Broad_variant,TCGA-G9-6363,TCGA-PRAD,NA,s3454,Harvard Medical School,Roswell Park,United States,NO,T4,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c3b8,58cfa831e4b0c9d6adf6c3b8,TCGA-CG-5724-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CG-5724-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_7_rg.sorted,TCGA-CG-5724-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_7_rg.sorted.bam,362,1.9,0.15,58cfa831e4b0c9d6adf6c3b8,TCGA-CG-5724-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_7_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5724-01A,0B4E8D73-459D-4930-9D1A-ABB8D53E1844,Primary Tumor,Illumina HiSeq,b1cebb86-fe73-4b53-899d-9e6a4caa800b,Stomach,59,4D624B21-5AEE-42B8-B192-8AFECB51434D,8611C0AC-38E4-4BFD-A1C4-56CABFCF6374,TCGA-CG-5724-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5724,TCGA-STAD,366,s15248,Harvard Medical School,Indivumed,Germany,NO,T3,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IV
13722.58cfa831e4b0c9d6adf6cdd0,58cfa831e4b0c9d6adf6cdd0,TCGA-FE-A3PD-10A-01D-A221_120611_SN1222_0115_BD141KACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FE-A3PD-10A-01D-A221_120611_SN1222_0115_BD141KACXX_s_8_rg.sorted,TCGA-FE-A3PD-10A-01D-A221_120611_SN1222_0115_BD141KACXX_s_8_rg.sorted.bam,10.47,NA,0.17,58cfa831e4b0c9d6adf6cdd0,TCGA-FE-A3PD-10A-01D-A221_120611_SN1222_0115_BD141KACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A3PD-10A,39D90499-8549-4DA5-B391-C421F18FACF1,Blood Derived Normal,Illumina HiSeq,15d6d1a8-5bb0-4b4b-9f8a-06c8530be145,Thyroid,17,703333E7-A2BA-4601-8F33-D0CD1F587E76,6CDCC877-A657-49EF-BD45-B51124FAE18E,TCGA-FE-A3PD-10A-01D-A221-26,HG19_Broad_variant,TCGA-FE-A3PD,TCGA-THCA,NA,s12254,MD Anderson - Institute for Applied Cancer Science,Ohio State University,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa830e4b0c9d6adf6c29c,58cfa830e4b0c9d6adf6c29c,TCGA-BS-A0T9-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BS-A0T9-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_3_rg.sorted,TCGA-BS-A0T9-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_3_rg.sorted.bam,66.31,1.98,0.16,58cfa830e4b0c9d6adf6c29c,TCGA-BS-A0T9-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_3_rg.sorted.bam,Dead,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0T9-01A,4EB95566-0E73-4260-853E-F7DF650667A0,Primary Tumor,Illumina HiSeq,2c61f255-688e-4a53-83fd-bea3b66d5a15,Uterus,39,3C9FF865-013F-427A-8D4D-C8E60EA346A1,CB5B905D-7287-41B3-9B49-B2F7FF7D2173,TCGA-BS-A0T9-01A-11D-A12F-02,HG19_Broad_variant,TCGA-BS-A0T9,TCGA-UCEC,1428,s4260,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c78a,58cfa831e4b0c9d6adf6c78a,TCGA-CV-5439-01A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CV-5439-01A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_1_rg.sorted,TCGA-CV-5439-01A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_1_rg.sorted.bam,262,1.9,0.17,58cfa831e4b0c9d6adf6c78a,TCGA-CV-5439-01A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5439-01A,3EE863DA-7991-414F-82D8-2B6502D4C061,Primary Tumor,Illumina HiSeq,e10c02de-cabd-4311-baab-3bb90e13717f,Head and Neck,62,C94D8E61-8A15-4702-90EF-37616F1C015B,A1170138-A1B1-4D13-B66B-0507D3DE897B,TCGA-CV-5439-01A-01D-1681-02,HG19_Broad_variant,TCGA-CV-5439,TCGA-HNSC,546,s16194,Harvard Medical School,MD Anderson Cancer Center,None,NO,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c8e8,58cfa831e4b0c9d6adf6c8e8,TCGA-CV-6441-01A-11D-1681_120427_SN208_0287_AC0J25ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CV-6441-01A-11D-1681_120427_SN208_0287_AC0J25ACXX_s_2_rg.sorted,TCGA-CV-6441-01A-11D-1681_120427_SN208_0287_AC0J25ACXX_s_2_rg.sorted.bam,46,1.9,0.14,58cfa831e4b0c9d6adf6c8e8,TCGA-CV-6441-01A-11D-1681_120427_SN208_0287_AC0J25ACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6441-01A,59398D50-45CF-4812-A24E-0C00C0199971,Primary Tumor,Illumina HiSeq,4df6f8df-9255-4e46-8936-baeab0ed20c2,Head and Neck,60,192C9F36-08EC-4F7F-8137-1A9BD0282D98,FE879D88-4817-4ED8-9FB2-EE92AF1A582F,TCGA-CV-6441-01A-11D-1681-02,HG19_Broad_variant,TCGA-CV-6441,TCGA-HNSC,292,s15779,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6c444,58cfa831e4b0c9d6adf6c444,TCGA-CH-5744-10A-01D-1572_130104_SN1120_0209_BD1KP6ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CH-5744-10A-01D-1572_130104_SN1120_0209_BD1KP6ACXX_s_6_rg.sorted,TCGA-CH-5744-10A-01D-1572_130104_SN1120_0209_BD1KP6ACXX_s_6_rg.sorted.bam,130.4,1.9,0.15,58cfa831e4b0c9d6adf6c444,TCGA-CH-5744-10A-01D-1572_130104_SN1120_0209_BD1KP6ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5744-10A,4E76DE8E-CB0D-4B83-8AB4-53BC67A7A9D3,Blood Derived Normal,Illumina HiSeq,7e3d3253-ca6c-4dbf-97ea-4d9126f9acad,Prostate,64,3F028008-19E4-400C-BADC-5540E6C4A242,AC85C5E7-0716-4375-AC65-56D632C858D1,TCGA-CH-5744-10A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5744,TCGA-PRAD,NA,s3414,Harvard Medical School,Indivumed,Germany,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c3dc,58cfa831e4b0c9d6adf6c3dc,TCGA-CG-5726-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CG-5726-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_2_rg.sorted,TCGA-CG-5726-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_2_rg.sorted.bam,217,1.9,0.16,58cfa831e4b0c9d6adf6c3dc,TCGA-CG-5726-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_2_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5726-01A,863AD936-E2A0-471C-8D95-3A548BB94AFA,Primary Tumor,Illumina HiSeq,87491384-bbcf-4127-8cf0-59e692b8e37b,Stomach,73,C881739A-982C-436F-9BE2-4638DB792C53,D472F361-BC94-44A5-9158-5BD999C96C27,TCGA-CG-5726-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5726,TCGA-STAD,881,s15130,Harvard Medical School,Indivumed,Germany,NO,T1,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6c93f,58cfa831e4b0c9d6adf6c93f,TCGA-DK-A1AC-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DK-A1AC-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_5_rg.sorted,TCGA-DK-A1AC-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_5_rg.sorted.bam,61.12,1.95,0.15,58cfa831e4b0c9d6adf6c93f,TCGA-DK-A1AC-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,Not available,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AC-01A,36C14E9D-1863-4C55-BBBB-F8C9DD418932,Primary Tumor,Illumina HiSeq,befc5d25-55df-4a22-b4e4-25508f3935c9,Bladder,72,CD2FB6B8-5DB9-42B4-A407-A5B6F7B8665F,221E5DDE-BAB0-456C-87BE-DB54998FE197,TCGA-DK-A1AC-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DK-A1AC,TCGA-BLCA,NA,s2884,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6d002,58cfa832e4b0c9d6adf6d002,TCGA-FU-A3TX-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FU-A3TX-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_3_rg.sorted,TCGA-FU-A3TX-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_3_rg.sorted.bam,108.86,NA,0.15,58cfa832e4b0c9d6adf6d002,TCGA-FU-A3TX-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_3_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-FU-A3TX-10A,B75644C2-B515-41CE-9B03-842EF5208A17,Blood Derived Normal,Illumina HiSeq,02fd7716-d363-4d47-81b8-16f0a83a944b,Cervix,78,7B4B0F8F-F929-4BFF-9728-2CBDF071D6E8,3CE97CE7-8F4B-46C6-9EBF-3BC218BA2075,TCGA-FU-A3TX-10A-01D-A232-26,HG19_Broad_variant,TCGA-FU-A3TX,TCGA-CESC,NA,s1372,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T1b2,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6cbd9,58cfa831e4b0c9d6adf6cbd9,TCGA-EJ-5515-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EJ-5515-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_1_rg.sorted,TCGA-EJ-5515-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_1_rg.sorted.bam,150.7,1.9,0.14,58cfa831e4b0c9d6adf6cbd9,TCGA-EJ-5515-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5515-01A,19CF56B2-A85B-43E7-971F-5680B9B1A67A,Primary Tumor,Illumina HiSeq,25dbfef2-277f-4974-a326-2747d9494a2d,Prostate,60,5FBA6E4A-3D7D-478E-AFA6-E66C816E7852,C124D41D-EBD2-4DAE-A344-8518DB3354A4,TCGA-EJ-5515-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5515,TCGA-PRAD,NA,s4132,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cc23,58cfa831e4b0c9d6adf6cc23,TCGA-EJ-5503-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EJ-5503-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_7_rg.sorted,TCGA-EJ-5503-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_7_rg.sorted.bam,172.7,1.9,0.16,58cfa831e4b0c9d6adf6cc23,TCGA-EJ-5503-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5503-01A,AA252F78-EBF3-42F9-86AF-BB6E57345706,Primary Tumor,Illumina HiSeq,4eba210f-0895-487c-9b48-db8a8c629cc4,Prostate,50,627B9FF8-2557-4470-824A-B76A8BCD1E9F,68211C41-2971-4B41-8EEE-75FFB78175BC,TCGA-EJ-5503-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5503,TCGA-PRAD,NA,s3782,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c942,58cfa831e4b0c9d6adf6c942,TCGA-CV-7247-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CV-7247-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_6_rg.sorted,TCGA-CV-7247-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_6_rg.sorted.bam,8.43,NA,0.16,58cfa831e4b0c9d6adf6c942,TCGA-CV-7247-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7247-10A,5E25AB76-A8AB-4779-AA03-8DE658F18DA1,Blood Derived Normal,Illumina HiSeq,eda6d221-38ba-4187-8a10-2c0217d09e31,Head and Neck,55,2E9CDAD5-53EC-4B5E-8A1E-4F8ABEE04149,16906F53-CCD9-4D19-8DBF-8DD6A59D392F,TCGA-CV-7247-10A-01D-2317-26,HG19_Broad_variant,TCGA-CV-7247,TCGA-HNSC,577,s16049,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa832e4b0c9d6adf6ce58,58cfa832e4b0c9d6adf6ce58,TCGA-FU-A3HY-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-FU-A3HY-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_7_rg.sorted,TCGA-FU-A3HY-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_7_rg.sorted.bam,37.56,NA,0.16,58cfa832e4b0c9d6adf6ce58,TCGA-FU-A3HY-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-FU-A3HY-01A,674E010C-7AD4-4DC2-86B0-284CD4560633,Primary Tumor,Illumina HiSeq,30d23ada-985e-43b1-9cc5-9e3931905b07,Cervix,47,A5879A60-AA8B-4DA0-904A-9FFE2968418C,0FD6C08E-8B41-422F-A6BA-1234E6596ADA,TCGA-FU-A3HY-01A-11D-A245-26,HG19_Broad_variant,TCGA-FU-A3HY,TCGA-CESC,NA,s1531,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T1b2,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c867,58cfa831e4b0c9d6adf6c867,TCGA-D6-6827-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-D6-6827-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_8_rg.sorted,TCGA-D6-6827-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_8_rg.sorted.bam,876,1.9,0.14,58cfa831e4b0c9d6adf6c867,TCGA-D6-6827-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-D6-6827-10A,3C5BC678-41E9-46B3-9686-5CD95659AB71,Blood Derived Normal,Illumina HiSeq,aef80235-e93d-436c-8a32-888344249391,Head and Neck,55,2EF80E58-961D-45D6-AC3A-A520BE3728C9,E38F279E-881E-4A80-806E-50B316E0741D,TCGA-D6-6827-10A-01D-1911-02,HG19_Broad_variant,TCGA-D6-6827,TCGA-HNSC,NA,s15653,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c6e7,58cfa831e4b0c9d6adf6c6e7,TCGA-CN-4742-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CN-4742-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_4_rg.sorted,TCGA-CN-4742-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_4_rg.sorted.bam,41.4,1.9,0.16,58cfa831e4b0c9d6adf6c6e7,TCGA-CN-4742-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_4_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4742-10A,444E5BFC-D4E5-4B0D-B96D-88ECEA8873E9,Blood Derived Normal,Illumina HiSeq,2f928254-a183-425a-b4d0-4a9317c432fd,Head and Neck,48,580D4B59-8FB5-49BC-8030-56524652DDC3,80CAB596-28EA-43F4-BFEB-98599A3494CF,TCGA-CN-4742-10A-01D-1509-02,HG19_Broad_variant,TCGA-CN-4742,TCGA-HNSC,397,s16175,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6cfdc,58cfa832e4b0c9d6adf6cfdc,TCGA-HC-7232-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-HC-7232-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_4_rg.sorted,TCGA-HC-7232-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_4_rg.sorted.bam,168.3,NA,0.16,58cfa832e4b0c9d6adf6cfdc,TCGA-HC-7232-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7232-01A,CE3585D3-7388-4D05-84C8-64E0883003B3,Primary Tumor,Illumina HiSeq,26e5268d-e95b-44da-ae7c-dfb6fe50a127,Prostate,66,0F4B7D00-1C4C-4634-A45E-10F8949ABB43,E847C3F1-CE33-494C-8D95-F82314C95F01,TCGA-HC-7232-01A-11D-2111-02,HG19_Broad_variant,TCGA-HC-7232,TCGA-PRAD,NA,s4156,Harvard Medical School,International Genomics Consortium,United States,NO,T3b,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cd9c,58cfa831e4b0c9d6adf6cd9c,TCGA-FD-A3SR-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_7_rg.sorted.filtered.,WGS,TCGA-FD-A3SR-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_7_rg.sorted,TCGA-FD-A3SR-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_7_rg.sorted.bam,39.24,NA,0.14,58cfa831e4b0c9d6adf6cd9c,TCGA-FD-A3SR-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3SR-01A,72D6E9AA-4A99-4FC9-A67B-4631E95FB043,Primary Tumor,Illumina HiSeq,e8c95d25-27f4-4cba-b644-eb39019c6cc0,Bladder,68,8E9683F4-52B4-4646-921E-7BF89F56774A,93A2B3C4-915C-46BE-9D36-C244036B7A0C,TCGA-FD-A3SR-01A-11D-A233-26,HG19_Broad_variant,TCGA-FD-A3SR,TCGA-BLCA,602,s3116,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T4a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa830e4b0c9d6adf6c232,58cfa830e4b0c9d6adf6c232,TCGA-BA-5557-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BA-5557-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_7_rg.sorted,TCGA-BA-5557-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_7_rg.sorted.bam,209.4,1.9,0.15,58cfa830e4b0c9d6adf6c232,TCGA-BA-5557-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_7_rg.sorted.bam,Alive,FEMALE,Not available,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5557-10A,7E0575CE-670B-4035-8A90-4D35279707B2,Blood Derived Normal,Illumina HiSeq,11ddaf7c-cee4-47b6-a167-60967da1bd66,Head and Neck,41,C56044D3-D6D5-41CD-B9A0-62EE45944B88,5F826C70-5AA0-40C4-8ACC-A7C17A74B457,TCGA-BA-5557-10A-01D-1509-02,HG19_Broad_variant,TCGA-BA-5557,TCGA-HNSC,NA,s15878,Harvard Medical School,UNC,None,NO,T1,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa82fe4b0c9d6adf6b904,58cfa82fe4b0c9d6adf6b904,TCGA-49-4512-01A-21D-1853_120123_SN590_0134_AC0DJKACXX_s_6_rg.sorted.filtered.,WGS,TCGA-49-4512-01A-21D-1853_120123_SN590_0134_AC0DJKACXX_s_6_rg.sorted,TCGA-49-4512-01A-21D-1853_120123_SN590_0134_AC0DJKACXX_s_6_rg.sorted.bam,180.7,1.9,0.15,58cfa82fe4b0c9d6adf6b904,TCGA-49-4512-01A-21D-1853_120123_SN590_0134_AC0DJKACXX_s_6_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4512-01A,A1E65587-24C1-4B41-92A7-4E1F15FFFD78,Primary Tumor,Illumina HiSeq,bfba789d-2b84-4c34-89f9-7a38586facf6,Lung,69,D809A778-D1AC-4406-AB09-67CC70F1F0C2,6D2569C8-4E18-423B-852D-315DDC3AE2F7,TCGA-49-4512-01A-21D-1853-02,HG19_Broad_variant,TCGA-49-4512,TCGA-LUAD,905,s10780,Harvard Medical School,Johns Hopkins,United States,NO,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa832e4b0c9d6adf6d48c,58cfa832e4b0c9d6adf6d48c,TCGA-V4-A9EO-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_3_rg.sorted.filtered.,WGS,TCGA-V4-A9EO-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_3_rg.sorted,TCGA-V4-A9EO-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_3_rg.sorted.bam,13.99,NA,0.15,58cfa832e4b0c9d6adf6d48c,TCGA-V4-A9EO-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EO-10A,BCB87378-9F43-45E4-BDF2-F6DFA6AC5B8C,Blood Derived Normal,Illumina HiSeq,56cf5ec2-6fef-42ef-aaad-d51429c3b5f4,Eye,74,DA54B80C-C6DD-42BC-B974-2B71416DD5BF,925E7575-E4C8-420F-85BB-0083A85E06B1,TCGA-V4-A9EO-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9EO,TCGA-UVM,NA,s246,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa831e4b0c9d6adf6c834,58cfa831e4b0c9d6adf6c834,TCGA-D1-A17D-10A-01D-A12F_120522_SN208_0301_BC0VNWACXX_s_8_rg.sorted.filtered.,WGS,TCGA-D1-A17D-10A-01D-A12F_120522_SN208_0301_BC0VNWACXX_s_8_rg.sorted,TCGA-D1-A17D-10A-01D-A12F_120522_SN208_0301_BC0VNWACXX_s_8_rg.sorted.bam,28.05,2.02,0.17,58cfa831e4b0c9d6adf6c834,TCGA-D1-A17D-10A-01D-A12F_120522_SN208_0301_BC0VNWACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A17D-10A,7DDEDDD1-B2AD-425F-94A2-9C476B959F2A,Blood Derived Normal,Illumina HiSeq,4d8ddec6-ce87-4279-80bf-9cbbee45d1e7,Uterus,58,E1C4F986-0667-4B47-9BEE-2C6BF81A45EE,CE8CB6B1-B049-43B7-BDB4-8038DC57CF25,TCGA-D1-A17D-10A-01D-A12F-02,HG19_Broad_variant,TCGA-D1-A17D,TCGA-UCEC,NA,s5225,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d16e,58cfa832e4b0c9d6adf6d16e,TCGA-IG-A5S3-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_7_rg.sorted.filtered.,WGS,TCGA-IG-A5S3-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_7_rg.sorted,TCGA-IG-A5S3-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_7_rg.sorted.bam,45.06,NA,0.15,58cfa832e4b0c9d6adf6d16e,TCGA-IG-A5S3-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A5S3-01A,DF0125B2-5278-4DED-B3B7-9FC829FE9F63,Primary Tumor,Illumina HiSeq,736bee98-6905-4aea-a839-1157081fd524,Esophagus,69,9595654D-B5F8-4571-A80A-BDD179881D91,AC4D24CB-89FC-4744-9227-4F65D8893F90,TCGA-IG-A5S3-01A-11D-A28P-26,HG19_Broad_variant,TCGA-IG-A5S3,TCGA-ESCA,NA,s1827,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T3,N0,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6d407,58cfa832e4b0c9d6adf6d407,TCGA-VD-A8KJ-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-VD-A8KJ-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_6_rg.sorted,TCGA-VD-A8KJ-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_6_rg.sorted.bam,45.14,NA,0.16,58cfa832e4b0c9d6adf6d407,TCGA-VD-A8KJ-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_6_rg.sorted.bam,Alive,MALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KJ-01A,7289BC25-2551-4C6D-B2FA-C7E13859B9B3,Primary Tumor,Illumina HiSeq,fc31e7c7-1135-4bd9-b27a-14853ce2751f,Eye,53,81194B66-EBA6-4AD8-A745-6CABD69218F0,EB63AF0F-8072-47F0-8CC6-02A5B28126C7,TCGA-VD-A8KJ-01A-11D-A40D-26,HG19_Broad_variant,TCGA-VD-A8KJ,TCGA-UVM,NA,s274,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T3a,NX,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6cc74,58cfa831e4b0c9d6adf6cc74,TCGA-ER-A19K-10A-01D-A190_120723_SN1120_0177_AC11GTACXX_s_5_rg.sorted.filtered.,WGS,TCGA-ER-A19K-10A-01D-A190_120723_SN1120_0177_AC11GTACXX_s_5_rg.sorted,TCGA-ER-A19K-10A-01D-A190_120723_SN1120_0177_AC11GTACXX_s_5_rg.sorted.bam,37.33,NA,0.16,58cfa831e4b0c9d6adf6cc74,TCGA-ER-A19K-10A-01D-A190_120723_SN1120_0177_AC11GTACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19K-10A,F9E36BC2-484F-48E8-82BA-99026957277A,Blood Derived Normal,Illumina HiSeq,8818c079-7f53-40c3-b16c-9e9f9fa6bb4e,Skin,79,5F73A302-CD64-4349-AC6D-A92145FBC5CE,A0D8A73C-3415-493E-8250-AA2EA9591590,TCGA-ER-A19K-10A-01D-A190-02,HG19_Broad_variant,TCGA-ER-A19K,TCGA-SKCM,469,s7860,Harvard Medical School,University of Pittsburgh,United States,NO,T4b,N0,Not available,Stage IIC
13722.58cfa831e4b0c9d6adf6cafc,58cfa831e4b0c9d6adf6cafc,TCGA-EA-A3QE-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EA-A3QE-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_4_rg.sorted,TCGA-EA-A3QE-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_4_rg.sorted.bam,52.94,NA,0.15,58cfa831e4b0c9d6adf6cafc,TCGA-EA-A3QE-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EA-A3QE-10A,A4E444B5-BBCA-4EF0-B92F-908D608CBB91,Blood Derived Normal,Illumina HiSeq,dfcbe88f-984f-4e3b-bbe6-02ac2ea58cf6,Cervix,45,1AB52CDC-8A5C-4F21-AEC9-F4BE1691C1CE,D6202D9F-5AFD-4AA6-A4AD-05D1D5EF4147,TCGA-EA-A3QE-10A-01D-A245-26,HG19_Broad_variant,TCGA-EA-A3QE,TCGA-CESC,NA,s1363,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T1b,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b6c4,58cfa82fe4b0c9d6adf6b6c4,TCGA-44-6774-11A-01D-1853_111204_SN208_0256_C0562ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-44-6774-11A-01D-1853_111204_SN208_0256_C0562ACXX_s_8_rg.sorted,TCGA-44-6774-11A-01D-1853_111204_SN208_0256_C0562ACXX_s_8_rg.sorted.bam,115.7,1.9,0.14,58cfa82fe4b0c9d6adf6b6c4,TCGA-44-6774-11A-01D-1853_111204_SN208_0256_C0562ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-6774-11A,33C71EAD-4C2A-476D-85EF-885DBBFC2CBD,Solid Tissue Normal,Illumina HiSeq,b2c21986-7ec8-4686-89b3-45fc5f257b49,Lung,56,09584CAC-EED9-458E-842B-C2FF06DF64E1,43FA0F12-DABE-4C58-BFE0-4ACD6543EBCC,TCGA-44-6774-11A-01D-1853-02,HG19_Broad_variant,TCGA-44-6774,TCGA-LUAD,NA,s11000,Harvard Medical School,Christiana Healthcare,United States,NO,T1,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6ca1b,58cfa831e4b0c9d6adf6ca1b,TCGA-DK-A2I6-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DK-A2I6-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_6_rg.sorted,TCGA-DK-A2I6-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_6_rg.sorted.bam,57.02,NA,0.16,58cfa831e4b0c9d6adf6ca1b,TCGA-DK-A2I6-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A2I6-01A,DE810AF0-4C18-4E8F-9836-F8ABC425E3EB,Primary Tumor,Illumina HiSeq,6567cd2d-a1e5-4226-9239-77c48c09c55e,Bladder,81,A536F8F9-3A68-4792-880D-387D78FD0C66,B791021D-173E-4B08-8769-A9F289818D11,TCGA-DK-A2I6-01A-12D-A18D-02,HG19_Broad_variant,TCGA-DK-A2I6,TCGA-BLCA,NA,s2703,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6cba4,58cfa831e4b0c9d6adf6cba4,TCGA-EJ-5521-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EJ-5521-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_3_rg.sorted,TCGA-EJ-5521-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_3_rg.sorted.bam,72.7,1.9,0.14,58cfa831e4b0c9d6adf6cba4,TCGA-EJ-5521-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5521-01A,D44D4BCB-BEB1-4464-ACD2-9972751F5018,Primary Tumor,Illumina HiSeq,c9a43591-8317-4ff5-a2e9-33c98c6a6012,Prostate,63,9EEBD2EC-AF9D-493C-A006-A436C28D4CD3,83248990-416D-48F0-B6F4-59C4C7CEEBD8,TCGA-EJ-5521-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5521,TCGA-PRAD,NA,s4134,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bdcc,58cfa830e4b0c9d6adf6bdcc,TCGA-BH-A0H6-01A-21D-A060_130725_SN590_0233_AD2B3HACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BH-A0H6-01A-21D-A060_130725_SN590_0233_AD2B3HACXX_s_1_rg.sorted,TCGA-BH-A0H6-01A-21D-A060_130725_SN590_0233_AD2B3HACXX_s_1_rg.sorted.bam,71.16,2.03,0.15,58cfa830e4b0c9d6adf6bdcc,TCGA-BH-A0H6-01A-21D-A060_130725_SN590_0233_AD2B3HACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0H6-01A,AEB6A3A6-B57A-4C53-90E6-E833777DD2A1,Primary Tumor,Illumina HiSeq,9c69c17b-33de-4bb8-be9f-7e0dcde9db0a,Breast,82,B2921C9D-C655-46F3-86E5-2FC2BED1ED33,57D73BC9-950E-42A3-B9FB-6045117112B7,TCGA-BH-A0H6-01A-21D-A060-02,HG19_Broad_variant,TCGA-BH-A0H6,TCGA-BRCA,NA,s5963,Harvard Medical School,University of Pittsburgh,None,NO,T1b,NX,Infiltrating Ductal Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c558,58cfa831e4b0c9d6adf6c558,TCGA-CN-4733-01A-02D-1868_120427_SN208_0287_AC0J25ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CN-4733-01A-02D-1868_120427_SN208_0287_AC0J25ACXX_s_5_rg.sorted,TCGA-CN-4733-01A-02D-1868_120427_SN208_0287_AC0J25ACXX_s_5_rg.sorted.bam,7.7,1.9,0.14,58cfa831e4b0c9d6adf6c558,TCGA-CN-4733-01A-02D-1868_120427_SN208_0287_AC0J25ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4733-01A,DEDD71B4-8537-4947-839E-90ACEDDD0893,Primary Tumor,Illumina HiSeq,c1887d1c-970a-4e8d-80df-a16844daef9f,Head and Neck,61,A1FD1C9D-C763-488A-8649-FF069F56D2BE,1CB41C9B-FB04-438D-A9FB-89D6186E0D37,TCGA-CN-4733-01A-02D-1868-02,HG19_Broad_variant,TCGA-CN-4733,TCGA-HNSC,NA,s15880,Harvard Medical School,University of Pittsburgh,None,NO,T1,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6c814,58cfa831e4b0c9d6adf6c814,TCGA-D1-A16R-10A-01D-A12F_120523_SN1222_0109_BD12MPACXX_s_8_rg.sorted.filtered.,WGS,TCGA-D1-A16R-10A-01D-A12F_120523_SN1222_0109_BD12MPACXX_s_8_rg.sorted,TCGA-D1-A16R-10A-01D-A12F_120523_SN1222_0109_BD12MPACXX_s_8_rg.sorted.bam,13.73,1.9,0.16,58cfa831e4b0c9d6adf6c814,TCGA-D1-A16R-10A-01D-A12F_120523_SN1222_0109_BD12MPACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A16R-10A,40F43483-B504-4EA7-AD24-40682B10CAAC,Blood Derived Normal,Illumina HiSeq,45cdae94-4e58-421e-8995-cd60304a0aa5,Uterus,39,14C95800-0B29-4BF0-BD36-1401A542E859,1073455E-5418-45D4-9D15-08EDE3D0248F,TCGA-D1-A16R-10A-01D-A12F-02,HG19_Broad_variant,TCGA-D1-A16R,TCGA-UCEC,NA,s4265,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c98b,58cfa831e4b0c9d6adf6c98b,TCGA-DJ-A1QL-10A-01D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DJ-A1QL-10A-01D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_3_rg.sorted,TCGA-DJ-A1QL-10A-01D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_3_rg.sorted.bam,21.22,1.98,0.16,58cfa831e4b0c9d6adf6c98b,TCGA-DJ-A1QL-10A-01D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_3_rg.sorted.bam,Alive,MALE,Not available,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QL-10A,E4B08E66-0772-4956-8670-E5C6553EECBE,Blood Derived Normal,Illumina HiSeq,72e4c07c-b432-4b1b-a6d3-b48c1c758af3,Thyroid,70,4A3FF681-4C8C-43DA-BFC7-9CF2598375B4,7160E4B1-ED02-4BB5-A8C9-6DE807D0B976,TCGA-DJ-A1QL-10A-01D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QL,TCGA-THCA,NA,s12242,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa831e4b0c9d6adf6c757,58cfa831e4b0c9d6adf6c757,TCGA-CV-7183-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CV-7183-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_7_rg.sorted,TCGA-CV-7183-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_7_rg.sorted.bam,7.43,NA,0.14,58cfa831e4b0c9d6adf6c757,TCGA-CV-7183-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7183-01A,DE206681-3E27-4D4F-8669-AEFB12B5B1E3,Primary Tumor,Illumina HiSeq,f449ea84-f7cf-4a26-bc43-707ac56f0038,Head and Neck,53,0BFD11FD-B227-41EF-BD54-7BE877BCE5A2,C2030338-EFEF-48CD-B893-BBDB8D85456E,TCGA-CV-7183-01A-11D-2317-26,HG19_Broad_variant,TCGA-CV-7183,TCGA-HNSC,NA,s15652,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa832e4b0c9d6adf6d226,58cfa832e4b0c9d6adf6d226,TCGA-FS-A1ZH-10A-01D-A190_120605_SN1222_0113_BC0WUCACXX_s_6_rg.sorted.filtered.,WGS,TCGA-FS-A1ZH-10A-01D-A190_120605_SN1222_0113_BC0WUCACXX_s_6_rg.sorted,TCGA-FS-A1ZH-10A-01D-A190_120605_SN1222_0113_BC0WUCACXX_s_6_rg.sorted.bam,51.84,NA,0.16,58cfa832e4b0c9d6adf6d226,TCGA-FS-A1ZH-10A-01D-A190_120605_SN1222_0113_BC0WUCACXX_s_6_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZH-10A,9F5BD948-DC3D-4B17-A114-D2F5C46FE10C,Blood Derived Normal,Illumina HiSeq,b643b41e-59b2-4796-99cb-3c40e021942f,Skin,71,56B42C33-3400-40BA-903A-CC359E5689F0,5D27B80E-C27E-47B3-9689-63224B08C95B,TCGA-FS-A1ZH-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZH,TCGA-SKCM,996,s7371,Harvard Medical School,Essen,Germany,NO,T3b,N2c,Not available,Stage IV
13722.58cfa831e4b0c9d6adf6c616,58cfa831e4b0c9d6adf6c616,TCGA-CG-4305-10A-01D-1154_130815_VM001_0001_VMR0001CXX_s_2_rg.sorted.filtered.,WGS,TCGA-CG-4305-10A-01D-1154_130815_VM001_0001_VMR0001CXX_s_2_rg.sorted,TCGA-CG-4305-10A-01D-1154_130815_VM001_0001_VMR0001CXX_s_2_rg.sorted.bam,25.9,1.9,0.15,58cfa831e4b0c9d6adf6c616,TCGA-CG-4305-10A-01D-1154_130815_VM001_0001_VMR0001CXX_s_2_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4305-10A,E0E35051-FBB4-4389-AEDB-87BDE84D21AD,Blood Derived Normal,Illumina HiSeq,a9425aae-9f82-4927-bef0-4b29926935d2,Stomach,69,E585C25B-2247-4E71-B847-3D6D73B77D26,FEA37E9C-C745-4688-96F3-77E8A42137E2,TCGA-CG-4305-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4305,TCGA-STAD,NA,s14756,Harvard Medical School,Indivumed,Germany,NO,T2a,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa832e4b0c9d6adf6ced3,58cfa832e4b0c9d6adf6ced3,TCGA-EJ-5527-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EJ-5527-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_5_rg.sorted,TCGA-EJ-5527-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_5_rg.sorted.bam,188.7,1.9,0.15,58cfa832e4b0c9d6adf6ced3,TCGA-EJ-5527-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5527-01A,BA0C9096-5F35-4F0A-AE98-EE1A695B55F0,Primary Tumor,Illumina HiSeq,62c0aaa3-44c3-4b25-b1cb-8e6196d66189,Prostate,69,15A638FE-4DFD-4280-AD40-5E0D5FDE3812,AE85C536-0580-4A34-B686-161D337E7951,TCGA-EJ-5527-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5527,TCGA-PRAD,NA,s3443,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6ce86,58cfa832e4b0c9d6adf6ce86,TCGA-G2-A3VY-10A-01D-A233_120913_SN208_0428_BC188KACXX_s_7_rg.sorted.filtered.,WGS,TCGA-G2-A3VY-10A-01D-A233_120913_SN208_0428_BC188KACXX_s_7_rg.sorted,TCGA-G2-A3VY-10A-01D-A233_120913_SN208_0428_BC188KACXX_s_7_rg.sorted.bam,9.94,NA,0.17,58cfa832e4b0c9d6adf6ce86,TCGA-G2-A3VY-10A-01D-A233_120913_SN208_0428_BC188KACXX_s_7_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-G2-A3VY-10A,CD50C69F-0F45-4C57-B61A-8C6B41AB4F7E,Blood Derived Normal,Illumina HiSeq,5135b458-af9a-472c-a3b2-0456e678130e,Bladder,66,D108E059-4A2D-41AA-A776-0661AE5D90CA,6048A973-E984-4153-846A-75A9721B3CF3,TCGA-G2-A3VY-10A-01D-A233-26,HG19_Broad_variant,TCGA-G2-A3VY,TCGA-BLCA,NA,s3120,MD Anderson - Institute for Applied Cancer Science,MD Anderson,United States,NO,Not available,Not available,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa82fe4b0c9d6adf6b9ea,58cfa82fe4b0c9d6adf6b9ea,TCGA-91-6835-11A-01D-1853_120310_SN590_0144_AD0PNFACXX_s_6_rg.sorted.filtered.,WGS,TCGA-91-6835-11A-01D-1853_120310_SN590_0144_AD0PNFACXX_s_6_rg.sorted,TCGA-91-6835-11A-01D-1853_120310_SN590_0144_AD0PNFACXX_s_6_rg.sorted.bam,327.7,1.9,0.13,58cfa82fe4b0c9d6adf6b9ea,TCGA-91-6835-11A-01D-1853_120310_SN590_0144_AD0PNFACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-91-6835-11A,2F09479F-87FC-4C34-8E2C-333E970A3681,Solid Tissue Normal,Illumina HiSeq,842df4e9-6924-416b-bf5a-773944b4ba5e,Lung,81,D6EF8F0B-39AD-42BD-B2BD-62B42BBB69E2,2E6A7A9B-AE70-4871-856C-1D139C570919,TCGA-91-6835-11A-01D-1853-02,HG19_Broad_variant,TCGA-91-6835,TCGA-LUAD,NA,s11252,Harvard Medical School,ABS - IUPUI,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa832e4b0c9d6adf6cfe4,58cfa832e4b0c9d6adf6cfe4,TCGA-G9-6333-01A-12D-1957_130222_SN1222_0174_BC1RNEACXX_s_3_rg.sorted.filtered.,WGS,TCGA-G9-6333-01A-12D-1957_130222_SN1222_0174_BC1RNEACXX_s_3_rg.sorted,TCGA-G9-6333-01A-12D-1957_130222_SN1222_0174_BC1RNEACXX_s_3_rg.sorted.bam,157.7,1.9,0.14,58cfa832e4b0c9d6adf6cfe4,TCGA-G9-6333-01A-12D-1957_130222_SN1222_0174_BC1RNEACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6333-01A,64BF32C9-9466-404A-A147-E7A0B9E91E34,Primary Tumor,Illumina HiSeq,0e4674b7-f8ed-422c-909a-b2bfdf58ecf1,Prostate,66,98013499-4FAC-4378-9D7E-B3686003A4FC,F6373E03-914F-44B2-954D-E63DE95F89E8,TCGA-G9-6333-01A-12D-1957-02,HG19_Broad_variant,TCGA-G9-6333,TCGA-PRAD,NA,s3611,Harvard Medical School,Roswell Park,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c33c,58cfa831e4b0c9d6adf6c33c,TCGA-CG-4475-01A-01D-1154_121026_SN1120_0198_BC188JACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CG-4475-01A-01D-1154_121026_SN1120_0198_BC188JACXX_s_7_rg.sorted,TCGA-CG-4475-01A-01D-1154_121026_SN1120_0198_BC188JACXX_s_7_rg.sorted.bam,128.2,1.9,0.14,58cfa831e4b0c9d6adf6c33c,TCGA-CG-4475-01A-01D-1154_121026_SN1120_0198_BC188JACXX_s_7_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4475-01A,CAD2ADC1-0F41-4651-9C80-AE9961E2DC8D,Primary Tumor,Illumina HiSeq,8d322c4d-bfdb-40cc-a222-87ff33a87718,Stomach,76,3E5D09C6-8F98-4701-BD24-FCA581343DE8,86D8A371-57BB-4DC7-9872-0EB4542208DC,TCGA-CG-4475-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4475,TCGA-STAD,NA,s14706,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Not available,Stage IIB
13722.58cfa830e4b0c9d6adf6c122,58cfa830e4b0c9d6adf6c122,TCGA-BS-A0TE-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BS-A0TE-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_3_rg.sorted,TCGA-BS-A0TE-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_3_rg.sorted.bam,18.46,2.12,0.13,58cfa830e4b0c9d6adf6c122,TCGA-BS-A0TE-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_3_rg.sorted.bam,Dead,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TE-10A,09066FBF-6A1D-46C9-A4C5-C53340C3D1BA,Blood Derived Normal,Illumina HiSeq,f8af36b9-66a9-43c7-91f7-de5b728f0d49,Uterus,35,0DBD157F-3CC0-4364-B76D-5E6775BA82BC,63677E1D-5D49-47A1-BF72-32377846EEE8,TCGA-BS-A0TE-10A-01D-A101-02,HG19_Broad_variant,TCGA-BS-A0TE,TCGA-UCEC,146,s4794,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cd84,58cfa831e4b0c9d6adf6cd84,TCGA-FE-A235-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FE-A235-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_1_rg.sorted,TCGA-FE-A235-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_1_rg.sorted.bam,74.82,2,0.17,58cfa831e4b0c9d6adf6cd84,TCGA-FE-A235-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A235-01A,C781B49E-D08F-49E6-B774-7CFE4100E92D,Primary Tumor,Illumina HiSeq,7eafbe04-60be-48a5-8e8a-937b1dde35e8,Thyroid,26,377A0CBF-6A82-43FA-BC95-DADECED8916D,F3F4F8FB-6FAD-46B7-85D0-C591EB926DD7,TCGA-FE-A235-01A-11D-A16N-02,HG19_Broad_variant,TCGA-FE-A235,TCGA-THCA,NA,s12528,Harvard Medical School,Ohio State University,United States,NO,T2,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82fe4b0c9d6adf6b8f0,58cfa82fe4b0c9d6adf6b8f0,TCGA-75-5122-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_2_rg.sorted.filtered.,WGS,TCGA-75-5122-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_2_rg.sorted,TCGA-75-5122-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_2_rg.sorted.bam,194.7,1.9,0.15,58cfa82fe4b0c9d6adf6b8f0,TCGA-75-5122-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_2_rg.sorted.bam,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-5122-10A,78AE716B-0CA5-4C01-A053-D41288385FCD,Blood Derived Normal,Illumina HiSeq,b223fc0a-cce3-4c35-8a1f-fb5fceca402e,Lung,NA,EF7E95DC-5686-417E-AD90-239CA31826C5,99190FE2-C307-4217-A0F0-71F8820D31B9,TCGA-75-5122-10A-01D-1751-02,HG19_Broad_variant,TCGA-75-5122,TCGA-LUAD,NA,s11558,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6cc82,58cfa831e4b0c9d6adf6cc82,TCGA-ER-A19A-10A-01D-A190_120723_SN1120_0177_AC11GTACXX_s_8_rg.sorted.filtered.,WGS,TCGA-ER-A19A-10A-01D-A190_120723_SN1120_0177_AC11GTACXX_s_8_rg.sorted,TCGA-ER-A19A-10A-01D-A190_120723_SN1120_0177_AC11GTACXX_s_8_rg.sorted.bam,40.3,NA,0.16,58cfa831e4b0c9d6adf6cc82,TCGA-ER-A19A-10A-01D-A190_120723_SN1120_0177_AC11GTACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19A-10A,41FCB9D3-9FB0-4625-98F4-1F564095EBC2,Blood Derived Normal,Illumina HiSeq,9bcb5eb0-7146-42d1-bb51-a661b93142ac,Skin,79,24869B25-7ECF-4928-8E78-9B6ACA6A2197,9C635EFB-06D8-4379-B5CD-D93F3F64658A,TCGA-ER-A19A-10A-01D-A190-02,HG19_Broad_variant,TCGA-ER-A19A,TCGA-SKCM,NA,s7360,Harvard Medical School,University of Pittsburgh,United States,NO,TX,N0,Not available,Stage IV
13722.58cfa831e4b0c9d6adf6c912,58cfa831e4b0c9d6adf6c912,TCGA-DK-A2I2-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DK-A2I2-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_3_rg.sorted,TCGA-DK-A2I2-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_3_rg.sorted.bam,49.35,NA,0.16,58cfa831e4b0c9d6adf6c912,TCGA-DK-A2I2-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_3_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A2I2-01A,234086DD-5A74-4FF1-94AB-BAD43EE69D5C,Primary Tumor,Illumina HiSeq,99517da2-f39e-4005-8efc-4487b92c0dcc,Bladder,63,45F8E4B6-5D36-47D7-A77D-E5E4C15848B3,767D7AA5-093D-48AB-BCDA-92729F4B95B7,TCGA-DK-A2I2-01A-11D-A17R-02,HG19_Broad_variant,TCGA-DK-A2I2,TCGA-BLCA,237,s2708,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N3,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6cae8,58cfa831e4b0c9d6adf6cae8,TCGA-D7-6522-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D7-6522-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_3_rg.sorted,TCGA-D7-6522-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_3_rg.sorted.bam,52.7,1.9,0.14,58cfa831e4b0c9d6adf6cae8,TCGA-D7-6522-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6522-01A,8BB3FACB-1933-4350-9F78-74537559E000,Primary Tumor,Illumina HiSeq,ac3cc7c3-e03a-4218-b297-d6c525338753,Stomach,58,825AE87A-69C0-44AC-A1AF-D1FAD7746C05,030D9DF5-48AB-46F4-AC23-F299A069191C,TCGA-D7-6522-01A-11D-1798-02,HG19_Broad_variant,TCGA-D7-6522,TCGA-STAD,NA,s15197,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N0,Stomach  Adenocarcinoma  Diffuse Type,Stage IB
13722.58cfa832e4b0c9d6adf6ce06,58cfa832e4b0c9d6adf6ce06,TCGA-FD-A3B4-10A-01D-A204_121002_SN1222_0155_BD1ERHACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FD-A3B4-10A-01D-A204_121002_SN1222_0155_BD1ERHACXX_s_4_rg.sorted,TCGA-FD-A3B4-10A-01D-A204_121002_SN1222_0155_BD1ERHACXX_s_4_rg.sorted.bam,14.43,NA,0.17,58cfa832e4b0c9d6adf6ce06,TCGA-FD-A3B4-10A-01D-A204_121002_SN1222_0155_BD1ERHACXX_s_4_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3B4-10A,899F8D52-4C3A-4371-90EB-1F106001EDDC,Blood Derived Normal,Illumina HiSeq,c312905a-2708-40b3-9055-264aa217c722,Bladder,55,A6DE65C6-971C-4527-B5DE-2EA7EC56BBDA,EE8151F1-7D38-4804-ABE4-26DD9B220695,TCGA-FD-A3B4-10A-01D-A204-02,HG19_Broad_variant,TCGA-FD-A3B4,TCGA-BLCA,NA,s2908,Harvard Medical School,BLN - University Of Chicago,United States,NO,T4a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c38c,58cfa831e4b0c9d6adf6c38c,TCGA-CD-5803-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CD-5803-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_8_rg.sorted,TCGA-CD-5803-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_8_rg.sorted.bam,493.3,1.9,0.17,58cfa831e4b0c9d6adf6c38c,TCGA-CD-5803-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_8_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-5803-10A,33901C6F-9180-4A19-866C-F4AC6BEC76DA,Blood Derived Normal,Illumina HiSeq,c5245994-d084-4ea6-b869-e4f9a02b9ad8,Stomach,78,903B78B4-31A7-48AD-825F-294F31A91BDA,773B46FD-7ED6-40A1-9434-CA1DCC7B3334,TCGA-CD-5803-10A-01D-1598-02,HG19_Broad_variant,TCGA-CD-5803,TCGA-STAD,NA,s14977,Harvard Medical School,ILSbio,Vietnam,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa831e4b0c9d6adf6c7dd,58cfa831e4b0c9d6adf6c7dd,TCGA-CV-6933-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CV-6933-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_3_rg.sorted,TCGA-CV-6933-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_3_rg.sorted.bam,361.7,1.9,0.15,58cfa831e4b0c9d6adf6c7dd,TCGA-CV-6933-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6933-01A,2A749317-0156-4213-8482-B2C2D6E52E9B,Primary Tumor,Illumina HiSeq,76d94513-c228-445e-91f7-474a75422b69,Head and Neck,53,8C57C9E6-75BD-442C-984D-3709D2AC4CEC,662EA9EC-86E3-46EE-91C9-6972DA5B5CA1,TCGA-CV-6933-01A-11D-1911-02,HG19_Broad_variant,TCGA-CV-6933,TCGA-HNSC,2741,s15516,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T3,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa830e4b0c9d6adf6becb,58cfa830e4b0c9d6adf6becb,TCGA-AO-A0JL-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_2_rg.sorted.filtered.,WGS,TCGA-AO-A0JL-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_2_rg.sorted,TCGA-AO-A0JL-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_2_rg.sorted.bam,42.91,2,0.14,58cfa830e4b0c9d6adf6becb,TCGA-AO-A0JL-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A0JL-10A,D5D8E76E-2F2A-49BC-BA0A-D51283611B16,Blood Derived Normal,Illumina HiSeq,4db7f9bb-a3b8-4b87-b98c-8ba5be69963f,Breast,59,6F0C9CAE-2A0F-4512-9B36-E94917CF2561,5159552D-2BC4-4C78-A5FD-3B34084C6A4E,TCGA-AO-A0JL-10A-01D-A060-02,HG19_Broad_variant,TCGA-AO-A0JL,TCGA-BRCA,NA,s6122,Harvard Medical School,MSKCC,None,NO,T2,N2a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82fe4b0c9d6adf6b8de,58cfa82fe4b0c9d6adf6b8de,TCGA-A7-A0D9-01A-31D-A060_130807_SN590_0235_AC29RAACXX_s_5_rg.sorted.filtered.,WGS,TCGA-A7-A0D9-01A-31D-A060_130807_SN590_0235_AC29RAACXX_s_5_rg.sorted,TCGA-A7-A0D9-01A-31D-A060_130807_SN590_0235_AC29RAACXX_s_5_rg.sorted.bam,59.5,2.02,0.17,58cfa82fe4b0c9d6adf6b8de,TCGA-A7-A0D9-01A-31D-A060_130807_SN590_0235_AC29RAACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A7-A0D9-01A,17BAEF7C-D97D-4B98-AB53-503EF856523D,Primary Tumor,Illumina HiSeq,43dc32db-2202-486d-82f4-388e37224379,Breast,37,C144AE50-ED29-4E27-BBEE-FA81E79AC7DB,7CD9AC40-F6B5-4C68-9D9A-D57845B812DB,TCGA-A7-A0D9-01A-31D-A060-02,HG19_Broad_variant,TCGA-A7-A0D9,TCGA-BRCA,NA,s5638,Harvard Medical School,Christiana Healthcare,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6cb0a,58cfa831e4b0c9d6adf6cb0a,TCGA-DU-6408-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DU-6408-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_7_rg.sorted,TCGA-DU-6408-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_7_rg.sorted.bam,78,1.9,0.15,58cfa831e4b0c9d6adf6cb0a,TCGA-DU-6408-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6408-10A,14375753-A69F-41E0-B910-2BB8E84CC43A,Blood Derived Normal,Illumina HiSeq,8157eb3b-a140-425c-af13-e727b719c9ec,Brain,23,BD47E91E-1D28-4890-8596-6493EA7C8639,72A17A30-A2A6-4077-92FB-FBAEBA75E266,TCGA-DU-6408-10A-01D-1703-02,HG19_Broad_variant,TCGA-DU-6408,TCGA-LGG,3470,s8139,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6c737,58cfa831e4b0c9d6adf6c737,TCGA-CV-7263-01A-11D-2317_120623_SN1222_0118_AD13T1ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CV-7263-01A-11D-2317_120623_SN1222_0118_AD13T1ACXX_s_8_rg.sorted,TCGA-CV-7263-01A-11D-2317_120623_SN1222_0118_AD13T1ACXX_s_8_rg.sorted.bam,170.73,NA,0.14,58cfa831e4b0c9d6adf6c737,TCGA-CV-7263-01A-11D-2317_120623_SN1222_0118_AD13T1ACXX_s_8_rg.sorted.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,Not available,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7263-01A,93B742EB-5FC3-4CE2-B7F6-C89F97E0DCC9,Primary Tumor,Illumina HiSeq,d8d79518-dd53-49b5-850c-3af45043e30c,Head and Neck,64,54DCB9AC-FD35-49C2-A790-B1F016160183,32435F1B-5D36-4335-B25E-43B89202F1B2,TCGA-CV-7263-01A-11D-2317-26,HG19_Broad_variant,TCGA-CV-7263,TCGA-HNSC,560,s15776,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa82fe4b0c9d6adf6b9ce,58cfa82fe4b0c9d6adf6b9ce,TCGA-67-6216-10A-01D-1751_120301_SN208_0270_AD0KLRACXX_s_6_rg.sorted.filtered.,WGS,TCGA-67-6216-10A-01D-1751_120301_SN208_0270_AD0KLRACXX_s_6_rg.sorted,TCGA-67-6216-10A-01D-1751_120301_SN208_0270_AD0KLRACXX_s_6_rg.sorted.bam,261.7,1.9,0.17,58cfa82fe4b0c9d6adf6b9ce,TCGA-67-6216-10A-01D-1751_120301_SN208_0270_AD0KLRACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-67-6216-10A,CCECCE70-DD54-4C5B-BF9F-CA87D290CB00,Blood Derived Normal,Illumina HiSeq,ca8f48ed-992b-4763-ad25-7d8f16528337,Lung,57,E196675A-2C83-4726-9D0A-E633E5D8E9B1,08670F63-D3EA-4C70-B74C-34ECBD0B5205,TCGA-67-6216-10A-01D-1751-02,HG19_Broad_variant,TCGA-67-6216,TCGA-LUAD,NA,s11247,Harvard Medical School,St Joseph's Medical Center (MD),United States,NO,T1a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6c3da,58cfa831e4b0c9d6adf6c3da,TCGA-CG-5726-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CG-5726-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_6_rg.sorted,TCGA-CG-5726-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_6_rg.sorted.bam,291,1.9,0.16,58cfa831e4b0c9d6adf6c3da,TCGA-CG-5726-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_6_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5726-11A,863AD936-E2A0-471C-8D95-3A548BB94AFA,Solid Tissue Normal,Illumina HiSeq,3c2e1753-936d-4794-bf43-9af5aa4b97ce,Stomach,73,EFCE3117-E72E-4E8A-BDD0-3B375C32DC4A,40A968A5-738C-441A-B374-AECE5647A083,TCGA-CG-5726-11A-01D-1598-02,HG19_Broad_variant,TCGA-CG-5726,TCGA-STAD,881,s14836,Harvard Medical School,Indivumed,Germany,NO,T1,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IA
13722.58cfa832e4b0c9d6adf6d4c4,58cfa832e4b0c9d6adf6d4c4,TCGA-VD-A8KN-10B-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-VD-A8KN-10B-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_8_rg.sorted,TCGA-VD-A8KN-10B-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_8_rg.sorted.bam,7.78,NA,0.14,58cfa832e4b0c9d6adf6d4c4,TCGA-VD-A8KN-10B-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_8_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KN-10B,B26CB5F2-4FF0-4476-8D02-7256ACE7D8A3,Blood Derived Normal,Illumina HiSeq,910bc203-3c1f-423f-b9c4-7a89912ed3bc,Eye,60,5F481155-99E3-4986-B9CC-D66B0BAD4509,81027108-022C-40BD-AFEB-0F072AAD1B08,TCGA-VD-A8KN-10B-01D-A40E-26,HG19_Broad_variant,TCGA-VD-A8KN,TCGA-UVM,NA,s248,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T2a,NX,Not available,Stage IIA
13722.58cfa832e4b0c9d6adf6cf39,58cfa832e4b0c9d6adf6cf39,TCGA-G9-6332-10A-01D-1784_130115_SN590_0208_BD1TAGACXX_s_4_rg.sorted.filtered.,WGS,TCGA-G9-6332-10A-01D-1784_130115_SN590_0208_BD1TAGACXX_s_4_rg.sorted,TCGA-G9-6332-10A-01D-1784_130115_SN590_0208_BD1TAGACXX_s_4_rg.sorted.bam,24.7,1.8,0.14,58cfa832e4b0c9d6adf6cf39,TCGA-G9-6332-10A-01D-1784_130115_SN590_0208_BD1TAGACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6332-10A,C46022F8-B122-4367-836B-EC1AE641A87D,Blood Derived Normal,Illumina HiSeq,4e876235-3367-4541-8b5c-432145854a49,Prostate,55,008159C1-3E45-408D-A89C-DBBCDF585F41,6D2BAA7D-0488-4308-B53C-B6E1318EBA6D,TCGA-G9-6332-10A-01D-1784-02,HG19_Broad_variant,TCGA-G9-6332,TCGA-PRAD,NA,s3969,Harvard Medical School,Roswell Park,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bd78,58cfa830e4b0c9d6adf6bd78,TCGA-AO-A0JJ-01A-11D-A060_130725_SN590_0233_AD2B3HACXX_s_3_rg.sorted.filtered.,WGS,TCGA-AO-A0JJ-01A-11D-A060_130725_SN590_0233_AD2B3HACXX_s_3_rg.sorted,TCGA-AO-A0JJ-01A-11D-A060_130725_SN590_0233_AD2B3HACXX_s_3_rg.sorted.bam,29.04,1.87,0.14,58cfa830e4b0c9d6adf6bd78,TCGA-AO-A0JJ-01A-11D-A060_130725_SN590_0233_AD2B3HACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A0JJ-01A,BEF7B135-A727-45E8-850A-CC4CD56C49AA,Primary Tumor,Illumina HiSeq,6d955c96-b34d-4aea-961b-378e856ae8cb,Breast,54,008DAFDD-A3D1-4801-8C0A-8714E2B58E48,ED24B69D-599E-42ED-BBE3-5C4F59FABED4,TCGA-AO-A0JJ-01A-11D-A060-02,HG19_Broad_variant,TCGA-AO-A0JJ,TCGA-BRCA,NA,s6271,Harvard Medical School,MSKCC,None,NO,T2,N1a,Infiltrating Lobular Carcinoma,Stage IIB
13722.58cfa82fe4b0c9d6adf6b9dd,58cfa82fe4b0c9d6adf6b9dd,TCGA-91-6829-11A-01D-1853_120305_SN1120_0119_BD0REAACXX_s_3_rg.sorted.filtered.,WGS,TCGA-91-6829-11A-01D-1853_120305_SN1120_0119_BD0REAACXX_s_3_rg.sorted,TCGA-91-6829-11A-01D-1853_120305_SN1120_0119_BD0REAACXX_s_3_rg.sorted.bam,267.7,1.9,0.16,58cfa82fe4b0c9d6adf6b9dd,TCGA-91-6829-11A-01D-1853_120305_SN1120_0119_BD0REAACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-91-6829-11A,1427CD18-5AD3-491A-9981-908E31AE49DB,Solid Tissue Normal,Illumina HiSeq,a1eb6a43-9ab8-4c52-a1e2-a18576cf662c,Lung,78,EEDF6790-10F7-4C33-A1A6-7857AD23F7E8,33A1760A-4C6A-4B3C-86F2-530E6F3867C2,TCGA-91-6829-11A-01D-1853-02,HG19_Broad_variant,TCGA-91-6829,TCGA-LUAD,1258,s11359,Harvard Medical School,ABS - IUPUI,United States,NO,T2,N0,Lung Bronchioloalveolar Carcinoma Nonmucinous,Stage IB
13722.58cfa830e4b0c9d6adf6bc86,58cfa830e4b0c9d6adf6bc86,TCGA-AX-A2HD-11A-11D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-AX-A2HD-11A-11D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_2_rg.sorted,TCGA-AX-A2HD-11A-11D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_2_rg.sorted.bam,26.63,1.83,0.17,58cfa830e4b0c9d6adf6bc86,TCGA-AX-A2HD-11A-11D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A2HD-11A,A8DEF1A0-A136-47F4-9AD9-60EBCF9B726B,Solid Tissue Normal,Illumina HiSeq,39807b39-505a-406e-a14a-07c227eae42f,Uterus,69,26BC3B4C-B0BC-4D05-9DBF-334F27F1CB89,693C4452-359A-4876-88F6-E99BB600FD4F,TCGA-AX-A2HD-11A-11D-A17E-02,HG19_Broad_variant,TCGA-AX-A2HD,TCGA-UCEC,NA,s4780,Harvard Medical School,Gynecologic Oncology Group,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6c254,58cfa830e4b0c9d6adf6c254,TCGA-C5-A2LX-10A-01D-A18I_140206_SN1222_0239_BC2RAKACXX_s_7_rg.sorted.filtered.,WGS,TCGA-C5-A2LX-10A-01D-A18I_140206_SN1222_0239_BC2RAKACXX_s_7_rg.sorted,TCGA-C5-A2LX-10A-01D-A18I_140206_SN1222_0239_BC2RAKACXX_s_7_rg.sorted.bam,24.64,NA,0.16,58cfa830e4b0c9d6adf6c254,TCGA-C5-A2LX-10A-01D-A18I_140206_SN1222_0239_BC2RAKACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A2LX-10A,B82F4C6D-530F-4B0E-8F33-995633CB254A,Blood Derived Normal,Illumina HiSeq,2ae4bce7-ffc3-4bce-a766-63d284bcab75,Cervix,54,9D41477D-8B08-46BA-ABDD-865BBAAD1F81,A7161C5A-7BA3-4DD8-9403-28B22C2E7147,TCGA-C5-A2LX-10A-01D-A18I-02,HG19_Broad_variant,TCGA-C5-A2LX,TCGA-CESC,NA,s1172,Harvard Medical School,Medical College of Wisconsin,United States,NO,T2,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b896,58cfa82fe4b0c9d6adf6b896,TCGA-49-6742-01A-11D-1853_111218_SN208_0258_C054RACXX_s_1_rg.sorted.filtered.,WGS,TCGA-49-6742-01A-11D-1853_111218_SN208_0258_C054RACXX_s_1_rg.sorted,TCGA-49-6742-01A-11D-1853_111218_SN208_0258_C054RACXX_s_1_rg.sorted.bam,39.7,2,0.13,58cfa82fe4b0c9d6adf6b896,TCGA-49-6742-01A-11D-1853_111218_SN208_0258_C054RACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-6742-01A,21FB46F9-4BBB-441C-AF19-A687E9138344,Primary Tumor,Illumina HiSeq,eeeb9a6f-97a9-4db9-aeb9-c5afaf9d0153,Lung,70,F0A4AE58-D5BC-4AB0-B1CF-0D951EA91FC7,04467FAB-BB2F-4F26-AF9E-39C09D920A63,TCGA-49-6742-01A-11D-1853-02,HG19_Broad_variant,TCGA-49-6742,TCGA-LUAD,NA,s10655,Harvard Medical School,Johns Hopkins,United States,NO,T2a,N1,Mucinous (Colloid) Carcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6be5a,58cfa830e4b0c9d6adf6be5a,TCGA-BJ-A18Y-10A-01D-A13U_120706_SN1222_0122_AC0WPYACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BJ-A18Y-10A-01D-A13U_120706_SN1222_0122_AC0WPYACXX_s_2_rg.sorted,TCGA-BJ-A18Y-10A-01D-A13U_120706_SN1222_0122_AC0WPYACXX_s_2_rg.sorted.bam,40.18,1.88,0.16,58cfa830e4b0c9d6adf6be5a,TCGA-BJ-A18Y-10A-01D-A13U_120706_SN1222_0122_AC0WPYACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A18Y-10A,ACB3B9DB-16E9-40F5-87A9-9DF9D4CEEE54,Blood Derived Normal,Illumina HiSeq,bfbcbb41-3d4e-4ee9-9fe1-af5d464bba4e,Thyroid,29,13867A18-2AA2-426C-A515-69AA1DABE296,6CB890E9-E04E-4FDD-82F4-8B38870D1C30,TCGA-BJ-A18Y-10A-01D-A13U-02,HG19_Broad_variant,TCGA-BJ-A18Y,TCGA-THCA,NA,s11985,Harvard Medical School,University of Pittsburgh,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6d014,58cfa832e4b0c9d6adf6d014,TCGA-G9-6336-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_5_rg.sorted.filtered.,WGS,TCGA-G9-6336-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_5_rg.sorted,TCGA-G9-6336-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_5_rg.sorted.bam,81.4,1.9,0.14,58cfa832e4b0c9d6adf6d014,TCGA-G9-6336-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6336-01A,59207BCD-F127-481F-B576-8716DA7D7D97,Primary Tumor,Illumina HiSeq,35e1082b-0264-4bb6-93d6-1d0e1b133135,Prostate,57,34C8B195-ECAB-492B-AED2-43ACFEDEF708,DB1475AB-0C9E-4D4C-B7F4-88DD8BB2F9B9,TCGA-G9-6336-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6336,TCGA-PRAD,NA,s3799,Harvard Medical School,Roswell Park,United States,NO,Not available,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d210,58cfa832e4b0c9d6adf6d210,TCGA-H2-A26U-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_6_rg.sorted.filtered.,WGS,TCGA-H2-A26U-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_6_rg.sorted,TCGA-H2-A26U-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_6_rg.sorted.bam,169.94,1.69,0.15,58cfa832e4b0c9d6adf6d210,TCGA-H2-A26U-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-H2-A26U-10A,E61FB24B-613A-4B6D-BB2B-00CCEDBD3DBC,Blood Derived Normal,Illumina HiSeq,861454f1-5ad7-4baf-b14f-04dac8c86852,Thyroid,54,272D97A5-448E-4382-AEB3-3CD13A8433B6,83710020-E939-4AB3-A482-D51DCC937377,TCGA-H2-A26U-10A-01D-A16N-02,HG19_Broad_variant,TCGA-H2-A26U,TCGA-THCA,NA,s12533,Harvard Medical School,Christiana Healthcare,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa82ee4b0c9d6adf6b092,58cfa82ee4b0c9d6adf6b092,TCGA-05-4417-01A-22D-1853_111204_SN208_0256_C0562ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-05-4417-01A-22D-1853_111204_SN208_0256_C0562ACXX_s_6_rg.sorted,TCGA-05-4417-01A-22D-1853_111204_SN208_0256_C0562ACXX_s_6_rg.sorted.bam,184.7,1.9,0.16,58cfa82ee4b0c9d6adf6b092,TCGA-05-4417-01A-22D-1853_111204_SN208_0256_C0562ACXX_s_6_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4417-01A,A244A99A-D7CC-4FB1-BC76-B66886481621,Primary Tumor,Illumina HiSeq,f4f3791e-3b72-4f33-986c-dca1cf3ada94,Lung,51,9AB40E48-6979-43CB-9ACF-1D4F474CAD4D,B7C6B0BD-AB9E-4211-8B3A-786B45C43F3D,TCGA-05-4417-01A-22D-1853-02,HG19_Broad_variant,TCGA-05-4417,TCGA-LUAD,NA,s11437,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa832e4b0c9d6adf6cea2,58cfa832e4b0c9d6adf6cea2,TCGA-FY-A3I5-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FY-A3I5-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_3_rg.sorted,TCGA-FY-A3I5-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_3_rg.sorted.bam,16.75,NA,0.15,58cfa832e4b0c9d6adf6cea2,TCGA-FY-A3I5-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FY-A3I5-10A,52203FF5-57B2-4D56-8935-2FF1EB61D7B8,Blood Derived Normal,Illumina HiSeq,dda96f65-0944-4037-9aa6-938793ee65e4,Thyroid,64,A415ACDB-70AC-48AB-B080-293027B45970,3126B13C-DEDE-43F1-A9DF-C444362C8C59,TCGA-FY-A3I5-10A-01D-A221-26,HG19_Broad_variant,TCGA-FY-A3I5,TCGA-THCA,NA,s12761,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III
13722.58cfa830e4b0c9d6adf6c02c,58cfa830e4b0c9d6adf6c02c,TCGA-BJ-A0ZC-01A-12D-A13U_120706_SN1222_0123_BD1488ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BJ-A0ZC-01A-12D-A13U_120706_SN1222_0123_BD1488ACXX_s_1_rg.sorted,TCGA-BJ-A0ZC-01A-12D-A13U_120706_SN1222_0123_BD1488ACXX_s_1_rg.sorted.bam,26.88,1.91,0.16,58cfa830e4b0c9d6adf6c02c,TCGA-BJ-A0ZC-01A-12D-A13U_120706_SN1222_0123_BD1488ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0ZC-01A,6675C581-297D-44CD-B80F-AE7E53D48228,Primary Tumor,Illumina HiSeq,a470b305-96a5-43a8-b1f4-db15c7b0b4d5,Thyroid,55,1F945AFF-7BC2-40F5-87DB-92313E541243,0E4A0528-883D-47A5-B399-57B1B15EC412,TCGA-BJ-A0ZC-01A-12D-A13U-02,HG19_Broad_variant,TCGA-BJ-A0ZC,TCGA-THCA,NA,s12232,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6ce60,58cfa832e4b0c9d6adf6ce60,TCGA-GV-A3QF-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-GV-A3QF-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_4_rg.sorted,TCGA-GV-A3QF-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_4_rg.sorted.bam,21.58,NA,0.16,58cfa832e4b0c9d6adf6ce60,TCGA-GV-A3QF-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GV-A3QF-01A,47990D5E-A0E1-4752-86F5-4F5B84E219DF,Primary Tumor,Illumina HiSeq,bcac19c7-1e8c-40ba-a577-39fce12db063,Bladder,79,6647C98E-7AA1-49E4-A067-D53AEBACFF9C,F7B433D0-F5DA-4E9C-9C32-A614FB4F614C,TCGA-GV-A3QF-01A-31D-A233-26,HG19_Broad_variant,TCGA-GV-A3QF,TCGA-BLCA,NA,s2931,MD Anderson - Institute for Applied Cancer Science,BLN - Cleveland Clinic,United States,NO,T3b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c8a0,58cfa831e4b0c9d6adf6c8a0,TCGA-DJ-A1QH-10A-01D-A14U_120629_SN1222_0121_BD143UACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DJ-A1QH-10A-01D-A14U_120629_SN1222_0121_BD143UACXX_s_8_rg.sorted,TCGA-DJ-A1QH-10A-01D-A14U_120629_SN1222_0121_BD143UACXX_s_8_rg.sorted.bam,61.2,2.13,0.17,58cfa831e4b0c9d6adf6c8a0,TCGA-DJ-A1QH-10A-01D-A14U_120629_SN1222_0121_BD143UACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QH-10A,F3C73DC9-6280-4619-A629-B575FDBDB0CA,Blood Derived Normal,Illumina HiSeq,46267199-5c17-4cc1-bf0e-2637d85dd2b2,Thyroid,58,933EC9D6-5A60-4969-B718-68D1A98B672E,EC86C465-E3B7-44A3-8A2B-D5326717A4E5,TCGA-DJ-A1QH-10A-01D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QH,TCGA-THCA,NA,s12375,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage III
13722.58cfa830e4b0c9d6adf6c210,58cfa830e4b0c9d6adf6c210,TCGA-BA-4077-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BA-4077-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_8_rg.sorted,TCGA-BA-4077-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_8_rg.sorted.bam,58.03,1.9,0.14,58cfa830e4b0c9d6adf6c210,TCGA-BA-4077-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-4077-10A,4BFBCE2B-9D0B-4E8A-950F-FD8E0BA3E05A,Blood Derived Normal,Illumina HiSeq,b95aebf7-d49b-41bd-86d3-66e2ef172c88,Head and Neck,45,8C074534-49B5-4D4A-A9C8-59BFEF52A800,0687CAE5-A756-4B2F-9DA4-FD4E9C4B91B2,TCGA-BA-4077-10A-01D-1431-02,HG19_Broad_variant,TCGA-BA-4077,TCGA-HNSC,1134,s15879,Harvard Medical School,UNC,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c8b6,58cfa831e4b0c9d6adf6c8b6,TCGA-DO-A1JZ-10A-01D-A13U_120706_SN1222_0123_BD1488ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DO-A1JZ-10A-01D-A13U_120706_SN1222_0123_BD1488ACXX_s_7_rg.sorted,TCGA-DO-A1JZ-10A-01D-A13U_120706_SN1222_0123_BD1488ACXX_s_7_rg.sorted.bam,15.3,1.84,0.18,58cfa831e4b0c9d6adf6c8b6,TCGA-DO-A1JZ-10A-01D-A13U_120706_SN1222_0123_BD1488ACXX_s_7_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DO-A1JZ-10A,169F045F-1739-4B0B-9BDC-028AACA420F8,Blood Derived Normal,Illumina HiSeq,b48c4339-fe64-4f48-a8d8-ab17a38fdb94,Thyroid,23,E85615F8-007A-4BF9-BD95-DC75A3D544A7,86EC9DCE-0309-4F8E-8340-6CF31CB6F4E0,TCGA-DO-A1JZ-10A-01D-A13U-02,HG19_Broad_variant,TCGA-DO-A1JZ,TCGA-THCA,NA,s12244,Harvard Medical School,Medical College of Georgia,United States,NO,T2,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa832e4b0c9d6adf6ceb7,58cfa832e4b0c9d6adf6ceb7,TCGA-EJ-5522-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EJ-5522-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_5_rg.sorted,TCGA-EJ-5522-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_5_rg.sorted.bam,414.7,1.9,0.17,58cfa832e4b0c9d6adf6ceb7,TCGA-EJ-5522-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5522-01A,214884EF-A932-4FC3-B6FF-16CE5164DA3E,Primary Tumor,Illumina HiSeq,ee0fc9f9-f7ac-4f93-a066-2751ffaa3959,Prostate,51,8AC1E1E7-8266-48E0-8D4C-D78873111341,2312B3FC-1F68-43D5-8B19-D449089F153C,TCGA-EJ-5522-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5522,TCGA-PRAD,NA,s4133,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bf5c,58cfa830e4b0c9d6adf6bf5c,TCGA-BR-4292-11A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BR-4292-11A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_4_rg.sorted,TCGA-BR-4292-11A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_4_rg.sorted.bam,193.3,1.9,0.15,58cfa830e4b0c9d6adf6bf5c,TCGA-BR-4292-11A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4292-11A,703D3E86-32F4-44AE-BD88-C02378FC2269,Solid Tissue Normal,Illumina HiSeq,763db891-de7a-4a7f-8608-d70ab806e102,Stomach,73,1351C1B9-3E15-4FE6-A8D4-F3376E3561B4,94341BBF-538A-498F-860C-0A5B2F1872AB,TCGA-BR-4292-11A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4292,TCGA-STAD,NA,s14878,Harvard Medical School,Asterand,Russia,NO,T1,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa831e4b0c9d6adf6c680,58cfa831e4b0c9d6adf6c680,TCGA-CG-4455-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CG-4455-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_3_rg.sorted,TCGA-CG-4455-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_3_rg.sorted.bam,67.9,1.9,0.16,58cfa831e4b0c9d6adf6c680,TCGA-CG-4455-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_3_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4455-10A,8A173D98-20A1-4C84-86C1-97818E1C665A,Blood Derived Normal,Illumina HiSeq,b2384b4a-3f8b-482e-baa3-8ce2f162c4fb,Stomach,72,DDD0129D-79B1-497A-BB38-60745BD9DEB4,7E88B22D-C19E-45C9-AD0C-4951B5A361A0,TCGA-CG-4455-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4455,TCGA-STAD,NA,s15244,Harvard Medical School,Indivumed,Germany,NO,T2b,N1,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage II
13722.58cfa832e4b0c9d6adf6d175,58cfa832e4b0c9d6adf6d175,TCGA-FS-A1Z7-10A-01D-A190_120712_SN1222_0124_AC11GPACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FS-A1Z7-10A-01D-A190_120712_SN1222_0124_AC11GPACXX_s_4_rg.sorted,TCGA-FS-A1Z7-10A-01D-A190_120712_SN1222_0124_AC11GPACXX_s_4_rg.sorted.bam,51.14,NA,0.18,58cfa832e4b0c9d6adf6d175,TCGA-FS-A1Z7-10A-01D-A190_120712_SN1222_0124_AC11GPACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1Z7-10A,F3BB6362-6801-4C95-A828-09C0002A8B87,Blood Derived Normal,Illumina HiSeq,affbe8f2-deb0-45e1-a584-9c4d3b4f981b,Skin,19,41F8841F-7164-4E6A-82B9-D2B52FEE61A4,B3CA6E8E-F372-4991-8AC4-989A36947C61,TCGA-FS-A1Z7-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1Z7,TCGA-SKCM,237,s7523,Harvard Medical School,Essen,Germany,NO,T4b,N1b,Not available,Stage IIIC
13722.58cfa831e4b0c9d6adf6c4c0,58cfa831e4b0c9d6adf6c4c0,TCGA-BR-4369-11A-01D-1154_130815_VM001_0002_VMR0002CXX_s_8_rg.sorted.filtered.,WGS,TCGA-BR-4369-11A-01D-1154_130815_VM001_0002_VMR0002CXX_s_8_rg.sorted,TCGA-BR-4369-11A-01D-1154_130815_VM001_0002_VMR0002CXX_s_8_rg.sorted.bam,67.3,1.9,0.14,58cfa831e4b0c9d6adf6c4c0,TCGA-BR-4369-11A-01D-1154_130815_VM001_0002_VMR0002CXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4369-11A,FE9A5FCF-FF99-4DD1-8CC7-ED9F4B9D952B,Solid Tissue Normal,Illumina HiSeq,d5894343-a206-49f1-adce-53c336fec1ee,Stomach,75,08591D7E-0482-494D-A75A-5F5201BEC02F,91E85E65-7D7D-45B1-A0B4-4CE2E1311499,TCGA-BR-4369-11A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4369,TCGA-STAD,NA,s14532,Harvard Medical School,Asterand,Russia,NO,TX,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa830e4b0c9d6adf6c192,58cfa830e4b0c9d6adf6c192,TCGA-BA-5149-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BA-5149-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_1_rg.sorted,TCGA-BA-5149-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_1_rg.sorted.bam,277.7,1.9,0.15,58cfa830e4b0c9d6adf6c192,TCGA-BA-5149-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5149-01A,CB99FB14-641C-4FB3-BF1D-17EFB8CD982A,Primary Tumor,Illumina HiSeq,88e71e4f-d4a5-4136-844d-883107af63b9,Head and Neck,47,E5A9FE30-E292-47DC-8EF5-565894B02A62,0F1EEC01-B772-47F6-8A14-0F651FC2F84E,TCGA-BA-5149-01A-01D-1509-02,HG19_Broad_variant,TCGA-BA-5149,TCGA-HNSC,NA,s15616,Harvard Medical School,UNC,None,NO,T3,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6cff0,58cfa832e4b0c9d6adf6cff0,TCGA-GD-A3OS-01A-12D-A221_120906_SN208_0426_BC194HACXX_s_7_rg.sorted.filtered.,WGS,TCGA-GD-A3OS-01A-12D-A221_120906_SN208_0426_BC194HACXX_s_7_rg.sorted,TCGA-GD-A3OS-01A-12D-A221_120906_SN208_0426_BC194HACXX_s_7_rg.sorted.bam,37.3,NA,0.14,58cfa832e4b0c9d6adf6cff0,TCGA-GD-A3OS-01A-12D-A221_120906_SN208_0426_BC194HACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GD-A3OS-01A,2A41B7D4-132F-4FB6-87B5-487C445379C7,Primary Tumor,Illumina HiSeq,2a801113-8404-4c17-9d60-508761ec1659,Bladder,54,C629CD55-54D7-4E31-AB90-955EBFF0B20A,80DBF776-1B0B-454C-9DA6-9688816A294D,TCGA-GD-A3OS-01A-12D-A221-26,HG19_Broad_variant,TCGA-GD-A3OS,TCGA-BLCA,NA,s2922,MD Anderson - Institute for Applied Cancer Science,ABS - IUPUI,United States,NO,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6cb3e,58cfa831e4b0c9d6adf6cb3e,TCGA-EE-A2GC-10A-01D-A190_120726_SN590_0171_AD13PJACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EE-A2GC-10A-01D-A190_120726_SN590_0171_AD13PJACXX_s_7_rg.sorted,TCGA-EE-A2GC-10A-01D-A190_120726_SN590_0171_AD13PJACXX_s_7_rg.sorted.bam,24.03,NA,0.17,58cfa831e4b0c9d6adf6cb3e,TCGA-EE-A2GC-10A-01D-A190_120726_SN590_0171_AD13PJACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2GC-10A,0A4B780E-8143-4118-AD98-FD2A2A6678C3,Blood Derived Normal,Illumina HiSeq,5949ea6f-17c0-4445-98ef-38a1e483e726,Skin,82,50CBA159-A844-4EBE-B07B-AD9C5F0347EC,E79FDD40-B36B-4C39-B808-39FF4CCE3B6E,TCGA-EE-A2GC-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2GC,TCGA-SKCM,NA,s7684,Harvard Medical School,University of Sydney,Australia,NO,T3b,N0,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6c596,58cfa831e4b0c9d6adf6c596,TCGA-CG-4469-10A-01D-1154_130815_VM001_0005_VMR0005CXX_s_8_rg.sorted.filtered.,WGS,TCGA-CG-4469-10A-01D-1154_130815_VM001_0005_VMR0005CXX_s_8_rg.sorted,TCGA-CG-4469-10A-01D-1154_130815_VM001_0005_VMR0005CXX_s_8_rg.sorted.bam,23.9,1.9,0.15,58cfa831e4b0c9d6adf6c596,TCGA-CG-4469-10A-01D-1154_130815_VM001_0005_VMR0005CXX_s_8_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4469-10A,2AC986F6-CD6F-4CA5-90CC-7A105CFE85EA,Blood Derived Normal,Illumina HiSeq,8c7f32c0-34e4-4aea-8603-cce8acbc1b82,Stomach,70,0279401D-8BB4-4E90-AB5B-E0BC1F6C1709,725941B2-EABE-486D-B19D-FD215B801A8E,TCGA-CG-4469-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4469,TCGA-STAD,215,s14762,Harvard Medical School,Indivumed,Germany,NO,T3,N3,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa832e4b0c9d6adf6cee8,58cfa832e4b0c9d6adf6cee8,TCGA-FD-A3B8-10A-01D-A210_120912_SN1120_0192_AC18ALACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FD-A3B8-10A-01D-A210_120912_SN1120_0192_AC18ALACXX_s_8_rg.sorted,TCGA-FD-A3B8-10A-01D-A210_120912_SN1120_0192_AC18ALACXX_s_8_rg.sorted.bam,41.57,NA,0.17,58cfa832e4b0c9d6adf6cee8,TCGA-FD-A3B8-10A-01D-A210_120912_SN1120_0192_AC18ALACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3B8-10A,537CA5D1-5B26-496F-B7B4-05FEA7B46353,Blood Derived Normal,Illumina HiSeq,cc9d7008-bf77-41cc-b38b-bf5af9413291,Bladder,56,BB3B0C46-8F28-4A6C-8D8F-947730EC1D7C,D6FD38D6-566B-4679-B39D-9F68E2BE4E78,TCGA-FD-A3B8-10A-01D-A210-26,HG19_Broad_variant,TCGA-FD-A3B8,TCGA-BLCA,NA,s3294,MD Anderson - RPPA Core Facility (Proteomics),BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa82fe4b0c9d6adf6b62e,58cfa82fe4b0c9d6adf6b62e,TCGA-75-6206-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-75-6206-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_5_rg.sorted,TCGA-75-6206-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_5_rg.sorted.bam,304.4,1.9,0.16,58cfa82fe4b0c9d6adf6b62e,TCGA-75-6206-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_5_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-6206-01A,C4C1469D-752F-42B6-8686-714AD4A8AC97,Primary Tumor,Illumina HiSeq,2b0c2142-3073-4443-9998-a7e909add85d,Lung,NA,4AFC6152-819B-4E55-817D-DF8A42EB0D36,B6836DCC-F7D7-45BF-AE7C-DE6F2140779E,TCGA-75-6206-01A-11D-1751-02,HG19_Broad_variant,TCGA-75-6206,TCGA-LUAD,NA,s11131,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c420,58cfa831e4b0c9d6adf6c420,TCGA-BT-A20T-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BT-A20T-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_7_rg.sorted,TCGA-BT-A20T-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_7_rg.sorted.bam,59.68,2.07,0.17,58cfa831e4b0c9d6adf6c420,TCGA-BT-A20T-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20T-01A,096B4F32-10C1-4737-A0DD-CAE04C54EE33,Primary Tumor,Illumina HiSeq,e605a62d-c633-415e-bba0-2174fd3ad94e,Bladder,63,52F538EF-B05D-4C76-9976-CE6D49158016,3929BC99-B4FC-4EB9-BDEA-1986EA49AF2A,TCGA-BT-A20T-01A-11D-A14U-02,HG19_Broad_variant,TCGA-BT-A20T,TCGA-BLCA,453,s2871,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c76e,58cfa831e4b0c9d6adf6c76e,TCGA-D7-6518-10A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D7-6518-10A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_4_rg.sorted,TCGA-D7-6518-10A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_4_rg.sorted.bam,192.7,1.9,0.15,58cfa831e4b0c9d6adf6c76e,TCGA-D7-6518-10A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6518-10A,40E507FB-E285-424B-A98B-362E47A53E4A,Blood Derived Normal,Illumina HiSeq,3158223f-89b3-425b-8b91-8b386fd4e604,Stomach,75,5D912F1D-3670-4A62-802F-F0AA3CECC6A9,529E5313-06C5-4F25-91A1-C76C0AA4FBA3,TCGA-D7-6518-10A-01D-1798-02,HG19_Broad_variant,TCGA-D7-6518,TCGA-STAD,NA,s15132,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA
13722.58cfa830e4b0c9d6adf6bc74,58cfa830e4b0c9d6adf6bc74,TCGA-AX-A1CJ-11A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-AX-A1CJ-11A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_6_rg.sorted,TCGA-AX-A1CJ-11A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_6_rg.sorted.bam,73.42,1.95,0.15,58cfa830e4b0c9d6adf6bc74,TCGA-AX-A1CJ-11A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_6_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A1CJ-11A,ABAF757B-F79F-40BD-96E3-E2C0F63061F0,Solid Tissue Normal,Illumina HiSeq,c62b26b6-8926-42d4-8602-bb8462ef7956,Uterus,59,210AE0CA-30CB-48EE-AE34-9228DBB7EE19,B3D0D218-03CC-4922-BB97-CB8415CC7B69,TCGA-AX-A1CJ-11A-11D-A133-02,HG19_Broad_variant,TCGA-AX-A1CJ,TCGA-UCEC,NA,s4998,Harvard Medical School,Gynecologic Oncology Group,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bfd2,58cfa830e4b0c9d6adf6bfd2,TCGA-BG-A0MS-10A-02D-A101_120406_SN208_0281_AC0KDBACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BG-A0MS-10A-02D-A101_120406_SN208_0281_AC0KDBACXX_s_8_rg.sorted,TCGA-BG-A0MS-10A-02D-A101_120406_SN208_0281_AC0KDBACXX_s_8_rg.sorted.bam,6.56,1.86,0.16,58cfa830e4b0c9d6adf6bfd2,TCGA-BG-A0MS-10A-02D-A101_120406_SN208_0281_AC0KDBACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0MS-10A,A798A8CC-4E72-4A8C-9E20-74A14DEAFD12,Blood Derived Normal,Illumina HiSeq,8c7d0948-d0c3-4bd5-bd25-bf8b70f1e346,Uterus,53,13F70704-8617-4547-BD50-A41C1DB3C6B2,F25B6FF4-0207-428C-8FF1-DD40235D0D0C,TCGA-BG-A0MS-10A-02D-A101-02,HG19_Broad_variant,TCGA-BG-A0MS,TCGA-UCEC,NA,s4602,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d630,58cfa832e4b0c9d6adf6d630,TCGA-LN-A49Y-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_5_rg.sorted.filtered.,WGS,TCGA-LN-A49Y-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_5_rg.sorted,TCGA-LN-A49Y-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_5_rg.sorted.bam,41.86,NA,0.16,58cfa832e4b0c9d6adf6d630,TCGA-LN-A49Y-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_5_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49Y-01A,87FABA0E-28E7-4A7E-A7E1-12582EC68FAC,Primary Tumor,Illumina HiSeq,61d40e9e-a5c9-4e35-8e7f-5e08661da9b6,Esophagus,77,E443EA94-586E-4A0B-8330-55336AAE9A15,9AAF77BB-57CB-4073-BA2E-380B80303B0B,TCGA-LN-A49Y-01A-11D-A267-26,HG19_Broad_variant,TCGA-LN-A49Y,TCGA-ESCA,NA,s1870,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6c6ad,58cfa831e4b0c9d6adf6c6ad,TCGA-CV-5970-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CV-5970-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_3_rg.sorted,TCGA-CV-5970-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_3_rg.sorted.bam,115,1.9,0.15,58cfa831e4b0c9d6adf6c6ad,TCGA-CV-5970-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5970-01A,1F6167D9-C99D-4873-8D6E-E62A1C964135,Primary Tumor,Illumina HiSeq,e7fcc1c5-e66d-4024-adb8-45def5252f1a,Head and Neck,59,4DF92618-5E63-46D7-8526-846932BCE3C2,7EBDEF16-0A0E-4DB2-AB6A-7B6115A7B739,TCGA-CV-5970-01A-11D-1681-02,HG19_Broad_variant,TCGA-CV-5970,TCGA-HNSC,406,s15509,Harvard Medical School,MD Anderson Cancer Center,None,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c3ec,58cfa831e4b0c9d6adf6c3ec,TCGA-CH-5748-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CH-5748-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_3_rg.sorted,TCGA-CH-5748-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_3_rg.sorted.bam,196.7,1.9,0.14,58cfa831e4b0c9d6adf6c3ec,TCGA-CH-5748-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5748-01A,0AF98331-9305-41E9-AF55-30390016D65E,Primary Tumor,Illumina HiSeq,02aa8440-93b8-43d7-a58b-6c4421e05321,Prostate,64,A499BF51-B137-4DA9-87A3-D1B1A0F04695,24A0496A-CA69-4AE3-BF8A-92289C738E9F,TCGA-CH-5748-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5748,TCGA-PRAD,NA,s3413,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d080,58cfa832e4b0c9d6adf6d080,TCGA-HC-7210-10A-01D-2111_130517_SN590_0230_AD24B4ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-HC-7210-10A-01D-2111_130517_SN590_0230_AD24B4ACXX_s_1_rg.sorted,TCGA-HC-7210-10A-01D-2111_130517_SN590_0230_AD24B4ACXX_s_1_rg.sorted.bam,143.6,NA,0.14,58cfa832e4b0c9d6adf6d080,TCGA-HC-7210-10A-01D-2111_130517_SN590_0230_AD24B4ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7210-10A,6A5AF80E-07AD-4CD3-AAAB-5DB1090835D9,Blood Derived Normal,Illumina HiSeq,51025f8f-6dc7-4e50-b60b-bbb7bc5cb367,Prostate,74,B119375C-2026-4B94-A619-92A0FBA24235,7FE62AF7-884E-450E-BFD8-AA56F3D3E889,TCGA-HC-7210-10A-01D-2111-02,HG19_Broad_variant,TCGA-HC-7210,TCGA-PRAD,NA,s3809,Harvard Medical School,International Genomics Consortium,United States,NO,T2a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d015,58cfa832e4b0c9d6adf6d015,TCGA-G9-6332-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_3_rg.sorted.filtered.,WGS,TCGA-G9-6332-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_3_rg.sorted,TCGA-G9-6332-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_3_rg.sorted.bam,156.4,1.9,0.15,58cfa832e4b0c9d6adf6d015,TCGA-G9-6332-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6332-01A,C46022F8-B122-4367-836B-EC1AE641A87D,Primary Tumor,Illumina HiSeq,91b58182-30c5-4b45-bf21-ee32128e4ad0,Prostate,55,30558AEB-76B7-4D27-99C0-E3EE21A00BD1,B9FAA261-1FA4-4870-B98F-60153ED7AD8C,TCGA-G9-6332-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6332,TCGA-PRAD,NA,s3974,Harvard Medical School,Roswell Park,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c2e6,58cfa830e4b0c9d6adf6c2e6,TCGA-C5-A2M1-10A-01D-A18I_140206_SN1222_0239_BC2RAKACXX_s_8_rg.sorted.filtered.,WGS,TCGA-C5-A2M1-10A-01D-A18I_140206_SN1222_0239_BC2RAKACXX_s_8_rg.sorted,TCGA-C5-A2M1-10A-01D-A18I_140206_SN1222_0239_BC2RAKACXX_s_8_rg.sorted.bam,14.69,NA,0.15,58cfa830e4b0c9d6adf6c2e6,TCGA-C5-A2M1-10A-01D-A18I_140206_SN1222_0239_BC2RAKACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A2M1-10A,8911C80C-C903-48E4-AF5B-FFEDEF9ABC47,Blood Derived Normal,Illumina HiSeq,78a6a70e-fe67-4b95-a5eb-6bff4842969c,Cervix,37,D54090CA-8F9B-4F5E-BA79-92CADB9BD6A7,106D9368-DD47-43F6-AA1A-A469376469BC,TCGA-C5-A2M1-10A-01D-A18I-02,HG19_Broad_variant,TCGA-C5-A2M1,TCGA-CESC,NA,s1517,Harvard Medical School,Medical College of Wisconsin,United States,NO,T1b1,N0,Endocervical Type of Adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cca9,58cfa831e4b0c9d6adf6cca9,TCGA-ER-A196-01A-11D-A18Y_120723_SN1120_0178_BD1887ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-ER-A196-01A-11D-A18Y_120723_SN1120_0178_BD1887ACXX_s_3_rg.sorted,TCGA-ER-A196-01A-11D-A18Y_120723_SN1120_0178_BD1887ACXX_s_3_rg.sorted.bam,32.16,NA,0.17,58cfa831e4b0c9d6adf6cca9,TCGA-ER-A196-01A-11D-A18Y_120723_SN1120_0178_BD1887ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A196-01A,A9EB1022-FFD3-42DE-A39D-2126FC7EC0CE,Primary Tumor,Illumina HiSeq,ef8b8b6f-6812-446b-b27c-03db8997900d,Skin,64,239F69F7-E78A-4B09-BF00-E521F63A3BB4,77937F29-C94F-4251-A0AB-9D07DED92796,TCGA-ER-A196-01A-11D-A18Y-02,HG19_Broad_variant,TCGA-ER-A196,TCGA-SKCM,NA,s8021,Harvard Medical School,University of Pittsburgh,United States,NO,T4b,N0,Not available,Stage IIC
13722.58cfa82fe4b0c9d6adf6b6a0,58cfa82fe4b0c9d6adf6b6a0,TCGA-44-6778-10A-01D-1853_120312_SN1120_0120_AD0PYGACXX_s_6_rg.sorted.filtered.,WGS,TCGA-44-6778-10A-01D-1853_120312_SN1120_0120_AD0PYGACXX_s_6_rg.sorted,TCGA-44-6778-10A-01D-1853_120312_SN1120_0120_AD0PYGACXX_s_6_rg.sorted.bam,179,1.9,0.15,58cfa82fe4b0c9d6adf6b6a0,TCGA-44-6778-10A-01D-1853_120312_SN1120_0120_AD0PYGACXX_s_6_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-44-6778-10A,5D5CC436-6E57-4D23-A164-7F5153C2E666,Blood Derived Normal,Illumina HiSeq,81a9ac95-7603-496d-a966-9fa6ebf33f49,Lung,59,BEBC6D2B-2535-4ADD-8F65-95C1666A5B1D,014CA609-0E9A-4A43-A9DD-25BBBE06FAE7,TCGA-44-6778-10A-01D-1853-02,HG19_Broad_variant,TCGA-44-6778,TCGA-LUAD,NA,s11343,Harvard Medical School,Christiana Healthcare,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6c792,58cfa831e4b0c9d6adf6c792,TCGA-CV-6003-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CV-6003-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_8_rg.sorted,TCGA-CV-6003-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_8_rg.sorted.bam,35,1.8,0.14,58cfa831e4b0c9d6adf6c792,TCGA-CV-6003-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6003-11A,417B357E-C90E-4B63-AE7A-4B782038FFD3,Solid Tissue Normal,Illumina HiSeq,ee070c27-f11a-4e98-9b45-ccc7d38c8241,Head and Neck,50,2B487266-919F-45DF-B7DD-1E60E063FF80,921977EE-19C0-4DEF-BF18-3493D6054677,TCGA-CV-6003-11A-01D-1681-02,HG19_Broad_variant,TCGA-CV-6003,TCGA-HNSC,NA,s15510,Harvard Medical School,MD Anderson Cancer Center,None,NO,T2,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6cd7c,58cfa831e4b0c9d6adf6cd7c,TCGA-FD-A3B3-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_7_rg.sorted.filtered.,WGS,TCGA-FD-A3B3-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_7_rg.sorted,TCGA-FD-A3B3-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_7_rg.sorted.bam,42.39,NA,0.15,58cfa831e4b0c9d6adf6cd7c,TCGA-FD-A3B3-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3B3-01A,4B5D873B-BFDA-482E-92A0-BF84C0F9032A,Primary Tumor,Illumina HiSeq,6b702a7f-ff83-4ff2-96a8-9da2f015ebcc,Bladder,74,769EE027-5ED7-4EC2-86B5-FE40F9D6FB5A,57731F40-BBEF-4C7B-BFDC-CE75DA6EB1EB,TCGA-FD-A3B3-01A-12D-A204-02,HG19_Broad_variant,TCGA-FD-A3B3,TCGA-BLCA,NA,s2903,Harvard Medical School,BLN - University Of Chicago,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c579,58cfa831e4b0c9d6adf6c579,TCGA-CF-A3MI-10A-01D-A210_120913_SN208_0428_BC188KACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CF-A3MI-10A-01D-A210_120913_SN208_0428_BC188KACXX_s_2_rg.sorted,TCGA-CF-A3MI-10A-01D-A210_120913_SN208_0428_BC188KACXX_s_2_rg.sorted.bam,77.89,NA,0.16,58cfa831e4b0c9d6adf6c579,TCGA-CF-A3MI-10A-01D-A210_120913_SN208_0428_BC188KACXX_s_2_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CF-A3MI-10A,F1EBF96B-8DF9-4E59-ACEF-7AD433E40214,Blood Derived Normal,Illumina HiSeq,b157e6ff-21c1-412a-953b-66770d827a6a,Bladder,62,B43F4063-C931-47DA-B4F7-14B6EB744DAB,3448338D-C923-4F62-896D-C055BABF8FDA,TCGA-CF-A3MI-10A-01D-A210-26,HG19_Broad_variant,TCGA-CF-A3MI,TCGA-BLCA,NA,s2876,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T2,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa832e4b0c9d6adf6ced1,58cfa832e4b0c9d6adf6ced1,TCGA-EJ-5542-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EJ-5542-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_5_rg.sorted,TCGA-EJ-5542-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_5_rg.sorted.bam,214.7,1.9,0.15,58cfa832e4b0c9d6adf6ced1,TCGA-EJ-5542-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5542-01A,5A92EC4C-36EE-4588-ACA2-E3303F29C7AD,Primary Tumor,Illumina HiSeq,45ba9a12-204e-4ab8-b544-61f2519b176f,Prostate,60,DFFC7994-E957-4451-A9DB-56D4560D6547,185234ED-0A19-490C-86D8-19762FB13C1A,TCGA-EJ-5542-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5542,TCGA-PRAD,NA,s3964,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6ca8a,58cfa831e4b0c9d6adf6ca8a,TCGA-DU-6399-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DU-6399-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_2_rg.sorted,TCGA-DU-6399-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_2_rg.sorted.bam,51,1.9,0.14,58cfa831e4b0c9d6adf6ca8a,TCGA-DU-6399-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6399-10A,4EF429BE-C345-4258-9B42-B56E215E1A2C,Blood Derived Normal,Illumina HiSeq,f4761372-b118-4406-97da-d7c39196df5e,Brain,54,A552CE70-38B2-4ED3-9DB8-B61EB91F537E,49C50948-0F65-4CDB-B8F1-A9E0987D775B,TCGA-DU-6399-10A-01D-1703-02,HG19_Broad_variant,TCGA-DU-6399,TCGA-LGG,2000,s8133,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa832e4b0c9d6adf6d0ee,58cfa832e4b0c9d6adf6d0ee,TCGA-FS-A1ZG-10A-01D-A190_120605_SN1222_0113_BC0WUCACXX_s_7_rg.sorted.filtered.,WGS,TCGA-FS-A1ZG-10A-01D-A190_120605_SN1222_0113_BC0WUCACXX_s_7_rg.sorted,TCGA-FS-A1ZG-10A-01D-A190_120605_SN1222_0113_BC0WUCACXX_s_7_rg.sorted.bam,19.14,NA,0.18,58cfa832e4b0c9d6adf6d0ee,TCGA-FS-A1ZG-10A-01D-A190_120605_SN1222_0113_BC0WUCACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZG-10A,F52AE9F4-8A61-4FF2-9C24-23F4048D3DA6,Blood Derived Normal,Illumina HiSeq,0121e582-d1b1-4c5c-a9be-8ef4511b3148,Skin,60,2905286F-8C55-48DC-8B52-D481514EDC09,CFCBC9B2-DD33-484D-829B-4606B4646D32,TCGA-FS-A1ZG-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZG,TCGA-SKCM,295,s7373,Harvard Medical School,Essen,Germany,NO,T4b,N2b,Not available,Stage IIIC
13722.58cfa831e4b0c9d6adf6c870,58cfa831e4b0c9d6adf6c870,TCGA-D1-A16N-10A-01D-A12F_120522_SN208_0301_BC0VNWACXX_s_6_rg.sorted.filtered.,WGS,TCGA-D1-A16N-10A-01D-A12F_120522_SN208_0301_BC0VNWACXX_s_6_rg.sorted,TCGA-D1-A16N-10A-01D-A12F_120522_SN208_0301_BC0VNWACXX_s_6_rg.sorted.bam,29.65,1.35,0.18,58cfa831e4b0c9d6adf6c870,TCGA-D1-A16N-10A-01D-A12F_120522_SN208_0301_BC0VNWACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A16N-10A,DBBBDDAE-D711-40F5-BD10-863735885B1F,Blood Derived Normal,Illumina HiSeq,698a6ab3-cc32-4d8b-b438-d175d822590a,Uterus,51,4FF10030-A754-4B81-A6FD-A78C95B29CA8,2804E329-FB93-4BD5-9DCC-30DD37FA1ED5,TCGA-D1-A16N-10A-01D-A12F-02,HG19_Broad_variant,TCGA-D1-A16N,TCGA-UCEC,NA,s5397,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6ce0a,58cfa832e4b0c9d6adf6ce0a,TCGA-FD-A3B7-10A-01D-A210_120912_SN1120_0192_AC18ALACXX_s_6_rg.sorted.filtered.,WGS,TCGA-FD-A3B7-10A-01D-A210_120912_SN1120_0192_AC18ALACXX_s_6_rg.sorted,TCGA-FD-A3B7-10A-01D-A210_120912_SN1120_0192_AC18ALACXX_s_6_rg.sorted.bam,17.05,NA,0.17,58cfa832e4b0c9d6adf6ce0a,TCGA-FD-A3B7-10A-01D-A210_120912_SN1120_0192_AC18ALACXX_s_6_rg.sorted.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3B7-10A,EF5DD4B3-B77A-444A-B5B0-C999A5A3D129,Blood Derived Normal,Illumina HiSeq,846e6076-8a19-4673-95e6-f23e24f87b29,Bladder,66,D7D42434-85F8-40DC-84D6-D318FFCF791F,130CD76A-F6B7-430D-9F68-A920476EFCD3,TCGA-FD-A3B7-10A-01D-A210-26,HG19_Broad_variant,TCGA-FD-A3B7,TCGA-BLCA,122,s2902,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82fe4b0c9d6adf6b8d4,58cfa82fe4b0c9d6adf6b8d4,TCGA-50-5049-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_3_rg.sorted.filtered.,WGS,TCGA-50-5049-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_3_rg.sorted,TCGA-50-5049-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_3_rg.sorted.bam,743.7,1.9,0.16,58cfa82fe4b0c9d6adf6b8d4,TCGA-50-5049-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5049-01A,9944F46F-9FA8-4E2C-A806-776BEC7F8803,Primary Tumor,Illumina HiSeq,16ea05eb-f830-4b36-83bb-989c8de99568,Lung,70,21B2F32E-CCEA-4B20-86D3-6647E99825CF,26ED24EC-1AD1-492D-B2CB-46314B47919E,TCGA-50-5049-01A-01D-1623-02,HG19_Broad_variant,TCGA-50-5049,TCGA-LUAD,NA,s11457,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82fe4b0c9d6adf6b894,58cfa82fe4b0c9d6adf6b894,TCGA-A5-A0VQ-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-A5-A0VQ-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_7_rg.sorted,TCGA-A5-A0VQ-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_7_rg.sorted.bam,21.48,1.91,0.16,58cfa82fe4b0c9d6adf6b894,TCGA-A5-A0VQ-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_7_rg.sorted.bam,Alive,FEMALE,Not available,HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0VQ-10A,23489245-48D7-4F19-8A42-E23B1181412B,Blood Derived Normal,Illumina HiSeq,454b7f4f-321e-4a19-b484-bdb2279d3b74,Uterus,62,AE0455A3-3C16-4A66-B282-65C8108A9481,06276560-9149-4373-8466-CF72D191E234,TCGA-A5-A0VQ-10A-01D-A101-02,HG19_Broad_variant,TCGA-A5-A0VQ,TCGA-UCEC,NA,s4988,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6be82,58cfa830e4b0c9d6adf6be82,TCGA-BL-A0C8-01A-11D-A10R_120926_SN590_0181_AC19HCACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BL-A0C8-01A-11D-A10R_120926_SN590_0181_AC19HCACXX_s_1_rg.sorted,TCGA-BL-A0C8-01A-11D-A10R_120926_SN590_0181_AC19HCACXX_s_1_rg.sorted.bam,69.7,2,0.17,58cfa830e4b0c9d6adf6be82,TCGA-BL-A0C8-01A-11D-A10R_120926_SN590_0181_AC19HCACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BL-A0C8-01A,A6003B1C-56A9-430A-A5E2-B70AF3F81BDB,Primary Tumor,Illumina HiSeq,19df03d2-75d2-408e-86e2-482ddeed9736,Bladder,73,5FEED572-07C0-4DA0-8649-CA8F8682657A,AB020F79-BA66-457C-9D77-DDD87C799538,TCGA-BL-A0C8-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BL-A0C8,TCGA-BLCA,NA,s2690,Harvard Medical School,Christiana Healthcare,United States,NO,T1,NX,Not available,Stage I
13722.58cfa832e4b0c9d6adf6cfcc,58cfa832e4b0c9d6adf6cfcc,TCGA-G9-6343-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_1_rg.sorted.filtered.,WGS,TCGA-G9-6343-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_1_rg.sorted,TCGA-G9-6343-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_1_rg.sorted.bam,38,1.8,0.15,58cfa832e4b0c9d6adf6cfcc,TCGA-G9-6343-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6343-10A,36B87D12-9F96-460F-A3B5-A4C08CBF5B07,Blood Derived Normal,Illumina HiSeq,f331491f-dba0-4053-b733-d52da4ca549c,Prostate,62,E1A1845B-E19F-4AB0-A286-3175BE9F50D9,06C3E81B-4F68-4FA4-A2F0-B4ED6E7A87FB,TCGA-G9-6343-10A-01D-1957-02,HG19_Broad_variant,TCGA-G9-6343,TCGA-PRAD,NA,s3975,Harvard Medical School,Roswell Park,United States,NO,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6cfc8,58cfa832e4b0c9d6adf6cfc8,TCGA-FS-A1ZN-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_6_rg.sorted.filtered.,WGS,TCGA-FS-A1ZN-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_6_rg.sorted,TCGA-FS-A1ZN-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_6_rg.sorted.bam,23.83,NA,0.16,58cfa832e4b0c9d6adf6cfc8,TCGA-FS-A1ZN-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZN-10A,9D86940D-50FB-4D2F-8B1E-539196885F46,Blood Derived Normal,Illumina HiSeq,27bdfcc3-454a-4619-a5db-13e91e2aff16,Skin,43,24D3D408-8417-4497-814E-31D407886EE0,A5E22F8F-A2D8-4968-B258-BC67282CB9C0,TCGA-FS-A1ZN-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZN,TCGA-SKCM,730,s7536,Harvard Medical School,Essen,Germany,NO,T4b,N1a,Not available,Stage IIIA
13722.58cfa82fe4b0c9d6adf6ba08,58cfa82fe4b0c9d6adf6ba08,TCGA-A5-A0G2-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_1_rg.sorted.filtered.,WGS,TCGA-A5-A0G2-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_1_rg.sorted,TCGA-A5-A0G2-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_1_rg.sorted.bam,104.46,2.03,0.15,58cfa82fe4b0c9d6adf6ba08,TCGA-A5-A0G2-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_1_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0G2-01A,4ABBD258-0F0C-4428-901D-625D47AD363A,Primary Tumor,Illumina HiSeq,f5289cfe-4208-4623-896c-ec78fb5f7dc5,Uterus,57,771811E3-740E-42FE-BE9C-FD485997EAAE,579C21E4-83BD-4DAE-B030-53E0930DEACA,TCGA-A5-A0G2-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0G2,TCGA-UCEC,NA,s4773,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cb14,58cfa831e4b0c9d6adf6cb14,TCGA-DU-6405-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DU-6405-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_5_rg.sorted,TCGA-DU-6405-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_5_rg.sorted.bam,22,2.6,0.15,58cfa831e4b0c9d6adf6cb14,TCGA-DU-6405-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6405-10A,9239A22E-80B1-49A2-B0D5-CBAB7E415254,Blood Derived Normal,Illumina HiSeq,107b4f56-260b-41d1-85fc-a6746e87ca0e,Brain,51,D2389FBB-2FCA-4A1B-8992-3DB9B9BF6FBB,D0282997-6C05-4DF5-B79B-48E0788F2332,TCGA-DU-6405-10A-01D-1703-02,HG19_Broad_variant,TCGA-DU-6405,TCGA-LGG,605,s8138,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6c45f,58cfa831e4b0c9d6adf6c45f,TCGA-CG-5728-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CG-5728-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_8_rg.sorted,TCGA-CG-5728-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_8_rg.sorted.bam,309,1.9,0.15,58cfa831e4b0c9d6adf6c45f,TCGA-CG-5728-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_8_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5728-11A,1286AC33-A466-4F58-900E-F6B13FE9C25A,Solid Tissue Normal,Illumina HiSeq,db35e103-ab69-44f7-b5c2-913ab5032554,Stomach,88,AE411D6A-4E7B-4B8D-B41C-5153FB5D4D25,F3D1F1F3-EECE-45D5-96AC-16FF3D85F025,TCGA-CG-5728-11A-01D-1598-02,HG19_Broad_variant,TCGA-CG-5728,TCGA-STAD,NA,s15461,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c590,58cfa831e4b0c9d6adf6c590,TCGA-CG-4472-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CG-4472-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_4_rg.sorted,TCGA-CG-4472-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_4_rg.sorted.bam,157.9,1.9,0.14,58cfa831e4b0c9d6adf6c590,TCGA-CG-4472-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_4_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4472-01A,306F0222-8734-44CA-9A31-86E4E62B0A1B,Primary Tumor,Illumina HiSeq,f1d39d03-103f-46f0-8fbf-ef9e944d68ad,Stomach,49,A474CFDD-0822-42E8-A478-C0895A409CCD,8363DF43-B859-4A78-8CDE-3E06C6230EB2,TCGA-CG-4472-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4472,TCGA-STAD,NA,s15457,Harvard Medical School,Indivumed,Germany,NO,T4,N1,Not available,Stage IV
13722.58cfa832e4b0c9d6adf6d1a2,58cfa832e4b0c9d6adf6d1a2,TCGA-HI-7168-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-HI-7168-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_8_rg.sorted,TCGA-HI-7168-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_8_rg.sorted.bam,116.3,NA,0.14,58cfa832e4b0c9d6adf6d1a2,TCGA-HI-7168-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HI-7168-01A,25D70934-01A5-45A2-9960-68D3058B6965,Primary Tumor,Illumina HiSeq,97c2b4ae-c671-4cf5-8b44-5c36e7e8fb57,Prostate,62,DD410832-95AA-4FA6-A2B9-3FECA6F70E1D,9FD5990D-22E1-4D64-996D-543BCD447500,TCGA-HI-7168-01A-11D-2111-02,HG19_Broad_variant,TCGA-HI-7168,TCGA-PRAD,NA,s3633,Harvard Medical School,Fox Chase,United States,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6ceed,58cfa832e4b0c9d6adf6ceed,TCGA-FY-A3R7-01A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FY-A3R7-01A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_3_rg.sorted,TCGA-FY-A3R7-01A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_3_rg.sorted.bam,10.86,NA,0.15,58cfa832e4b0c9d6adf6ceed,TCGA-FY-A3R7-01A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FY-A3R7-01A,B983A678-B0AE-42C2-8F37-D6ECAF07413B,Primary Tumor,Illumina HiSeq,8f5f6e5a-6274-4d57-8dbd-2dc9d5bc3544,Thyroid,50,E85B6BC8-C182-4483-8F53-F312D5A545CB,5F86B67F-ECBC-477C-B72A-F41F104E03A2,TCGA-FY-A3R7-01A-11D-A221-26,HG19_Broad_variant,TCGA-FY-A3R7,TCGA-THCA,NA,s12009,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa832e4b0c9d6adf6d279,58cfa832e4b0c9d6adf6d279,TCGA-HT-7475-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_5_rg.sorted.filtered.,WGS,TCGA-HT-7475-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_5_rg.sorted,TCGA-HT-7475-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_5_rg.sorted.bam,79.7,NA,0.15,58cfa832e4b0c9d6adf6d279,TCGA-HT-7475-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7475-01A,41456932-436E-4CDB-BFE8-97D089656786,Primary Tumor,Illumina HiSeq,13942ed5-f37e-4807-b133-369aab923f17,Brain,67,5E11FC94-CCDB-4E53-9A9D-5D7707157674,B59DECE1-1DE9-46D3-B5CD-0EFD8F453F8D,TCGA-HT-7475-01A-11D-2022-02,HG19_Broad_variant,TCGA-HT-7475,TCGA-LGG,NA,s8372,Harvard Medical School,Case Western - St Joes,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa832e4b0c9d6adf6cf00,58cfa832e4b0c9d6adf6cf00,TCGA-FS-A1Z7-06A-11D-A18Y_120712_SN1222_0124_AC11GPACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FS-A1Z7-06A-11D-A18Y_120712_SN1222_0124_AC11GPACXX_s_3_rg.sorted,TCGA-FS-A1Z7-06A-11D-A18Y_120712_SN1222_0124_AC11GPACXX_s_3_rg.sorted.bam,25.78,NA,0.17,58cfa832e4b0c9d6adf6cf00,TCGA-FS-A1Z7-06A-11D-A18Y_120712_SN1222_0124_AC11GPACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1Z7-06A,F3BB6362-6801-4C95-A828-09C0002A8B87,Metastatic,Illumina HiSeq,3e98b38f-dcad-4b32-9291-c9cd6b59c84b,Skin,19,B50324D0-2C8B-42EE-8767-F9900D2068FD,01285377-C51D-46C6-9F23-2639D151AC28,TCGA-FS-A1Z7-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1Z7,TCGA-SKCM,237,s7867,Harvard Medical School,Essen,Germany,NO,T4b,N1b,Not available,Stage IIIC
13722.58cfa832e4b0c9d6adf6d058,58cfa832e4b0c9d6adf6d058,TCGA-IG-A4QT-01A-21D-A267_131120_SN1222_0229_AD2FDGACXX_s_3_rg.sorted.filtered.,WGS,TCGA-IG-A4QT-01A-21D-A267_131120_SN1222_0229_AD2FDGACXX_s_3_rg.sorted,TCGA-IG-A4QT-01A-21D-A267_131120_SN1222_0229_AD2FDGACXX_s_3_rg.sorted.bam,23.35,NA,0.14,58cfa832e4b0c9d6adf6d058,TCGA-IG-A4QT-01A-21D-A267_131120_SN1222_0229_AD2FDGACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A4QT-01A,3F7B600B-282E-4F35-9FD8-567B3FCA8273,Primary Tumor,Illumina HiSeq,4bffb791-ea4d-4a2e-86dd-ac9a6dd727e6,Esophagus,56,49B4F5ED-93E8-41B5-971E-7C6454C8554D,79A37247-ACFA-4DE0-A904-027707CACE87,TCGA-IG-A4QT-01A-21D-A267-26,HG19_Broad_variant,TCGA-IG-A4QT,TCGA-ESCA,NA,s1909,MD Anderson - Institute for Applied Cancer Science,Asterand,Ukraine,NO,T3,N0,Not available,Stage IIA
13722.58cfa832e4b0c9d6adf6d022,58cfa832e4b0c9d6adf6d022,TCGA-GD-A3OS-10A-01D-A221_120906_SN208_0426_BC194HACXX_s_8_rg.sorted.filtered.,WGS,TCGA-GD-A3OS-10A-01D-A221_120906_SN208_0426_BC194HACXX_s_8_rg.sorted,TCGA-GD-A3OS-10A-01D-A221_120906_SN208_0426_BC194HACXX_s_8_rg.sorted.bam,37.86,NA,0.15,58cfa832e4b0c9d6adf6d022,TCGA-GD-A3OS-10A-01D-A221_120906_SN208_0426_BC194HACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GD-A3OS-10A,2A41B7D4-132F-4FB6-87B5-487C445379C7,Blood Derived Normal,Illumina HiSeq,70ba803f-783d-4116-9e3b-0798393f59ac,Bladder,54,491CB6B6-3B4E-46A3-9189-68734398D62E,251BF0E3-4052-495E-BD26-EF2FA8AD953F,TCGA-GD-A3OS-10A-01D-A221-26,HG19_Broad_variant,TCGA-GD-A3OS,TCGA-BLCA,NA,s2928,MD Anderson - Institute for Applied Cancer Science,ABS - IUPUI,United States,NO,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c5e5,58cfa831e4b0c9d6adf6c5e5,TCGA-CG-4306-10A-01D-1154_130815_VM001_0001_VMR0001CXX_s_4_rg.sorted.filtered.,WGS,TCGA-CG-4306-10A-01D-1154_130815_VM001_0001_VMR0001CXX_s_4_rg.sorted,TCGA-CG-4306-10A-01D-1154_130815_VM001_0001_VMR0001CXX_s_4_rg.sorted.bam,97.9,1.9,0.16,58cfa831e4b0c9d6adf6c5e5,TCGA-CG-4306-10A-01D-1154_130815_VM001_0001_VMR0001CXX_s_4_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4306-10A,73D177F7-8C0A-42F6-A73D-8073C0E6142B,Blood Derived Normal,Illumina HiSeq,c0a0bf03-12bc-447d-9f12-b8881dee8f37,Stomach,90,75F42FE8-877E-4A9C-A27D-D89E05A00B5D,8263E2A7-C76D-43CB-9229-4909E8C6BF40,TCGA-CG-4306-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4306,TCGA-STAD,31,s14702,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa831e4b0c9d6adf6cb0e,58cfa831e4b0c9d6adf6cb0e,TCGA-EA-A3Y4-01A-51D-A245_140124_SN1440_0178_AC2PL6ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EA-A3Y4-01A-51D-A245_140124_SN1440_0178_AC2PL6ACXX_s_1_rg.sorted,TCGA-EA-A3Y4-01A-51D-A245_140124_SN1440_0178_AC2PL6ACXX_s_1_rg.sorted.bam,30.33,NA,0.15,58cfa831e4b0c9d6adf6cb0e,TCGA-EA-A3Y4-01A-51D-A245_140124_SN1440_0178_AC2PL6ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EA-A3Y4-01A,3AC62513-B5F4-4063-AABD-DAD08A1F56FB,Primary Tumor,Illumina HiSeq,32cd0b72-100c-4e6c-81f1-6be30738cafb,Cervix,40,FF97C148-76BA-480E-9456-5DD7D7238373,A7529CB6-2386-410F-B09A-62E10BAFF8CB,TCGA-EA-A3Y4-01A-51D-A245-26,HG19_Broad_variant,TCGA-EA-A3Y4,TCGA-CESC,NA,s1362,MD Anderson - Institute for Applied Cancer Science,Asterand,Ukraine,NO,T1b,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6bc7a,58cfa830e4b0c9d6adf6bc7a,TCGA-AO-A0JL-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_1_rg.sorted.filtered.,WGS,TCGA-AO-A0JL-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_1_rg.sorted,TCGA-AO-A0JL-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_1_rg.sorted.bam,48.13,1.89,0.13,58cfa830e4b0c9d6adf6bc7a,TCGA-AO-A0JL-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A0JL-01A,D5D8E76E-2F2A-49BC-BA0A-D51283611B16,Primary Tumor,Illumina HiSeq,b39a31b9-dd85-403d-ac11-d7b6dd2703a6,Breast,59,834D2E25-DA72-413B-BB0E-3BEB24D46472,A34C3F47-AD37-4777-A733-07AE8F4B4BFF,TCGA-AO-A0JL-01A-11D-A060-02,HG19_Broad_variant,TCGA-AO-A0JL,TCGA-BRCA,NA,s5639,Harvard Medical School,MSKCC,None,NO,T2,N2a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa831e4b0c9d6adf6c844,58cfa831e4b0c9d6adf6c844,TCGA-D1-A17U-10A-01D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-D1-A17U-10A-01D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_6_rg.sorted,TCGA-D1-A17U-10A-01D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_6_rg.sorted.bam,26.88,1.95,0.17,58cfa831e4b0c9d6adf6c844,TCGA-D1-A17U-10A-01D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A17U-10A,6397C4A1-0A29-4C2C-B8CB-CE73AF93DD0B,Blood Derived Normal,Illumina HiSeq,02e3a4e4-e14c-48a7-9e6a-b797f4038cd9,Uterus,53,B0D7D8A8-D95E-48C0-A830-2C819403A91D,335F31BC-2F12-4A6D-9E5E-F91338544F54,TCGA-D1-A17U-10A-01D-A12F-02,HG19_Broad_variant,TCGA-D1-A17U,TCGA-UCEC,NA,s4804,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6cfc6,58cfa832e4b0c9d6adf6cfc6,TCGA-G9-6353-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_5_rg.sorted.filtered.,WGS,TCGA-G9-6353-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_5_rg.sorted,TCGA-G9-6353-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_5_rg.sorted.bam,16,1.8,0.15,58cfa832e4b0c9d6adf6cfc6,TCGA-G9-6353-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6353-10A,BCC94953-CE79-428E-99C1-632E42C1B9BC,Blood Derived Normal,Illumina HiSeq,e230f78f-00cc-4bd0-a15c-369e9ceb0adb,Prostate,58,3C7B873C-58A9-4B6B-9072-9951AD168D5E,41E46979-9567-422A-B925-4AA663DC0E76,TCGA-G9-6353-10A-01D-1957-02,HG19_Broad_variant,TCGA-G9-6353,TCGA-PRAD,NA,s3972,Harvard Medical School,Roswell Park,United States,NO,T3a,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c797,58cfa831e4b0c9d6adf6c797,TCGA-CV-7178-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CV-7178-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_3_rg.sorted,TCGA-CV-7178-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_3_rg.sorted.bam,36.03,NA,0.17,58cfa831e4b0c9d6adf6c797,TCGA-CV-7178-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_3_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7178-10A,8F044599-3FBE-4B69-B67D-49AEE9168545,Blood Derived Normal,Illumina HiSeq,428da9ec-1409-4479-843a-6d2ecff5f7b8,Head and Neck,64,16ED7D38-69BB-4D8B-B150-44AC80CE4FCB,CBC1F4A7-5FFD-46D7-835D-40EDB0336C5C,TCGA-CV-7178-10A-01D-2317-26,HG19_Broad_variant,TCGA-CV-7178,TCGA-HNSC,2166,s15522,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T4a,N2,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6bddc,58cfa830e4b0c9d6adf6bddc,TCGA-BG-A0MU-10A-02D-A101_120406_SN1120_0131_BD0UK4ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BG-A0MU-10A-02D-A101_120406_SN1120_0131_BD0UK4ACXX_s_1_rg.sorted,TCGA-BG-A0MU-10A-02D-A101_120406_SN1120_0131_BD0UK4ACXX_s_1_rg.sorted.bam,10.2,2,0.17,58cfa830e4b0c9d6adf6bddc,TCGA-BG-A0MU-10A-02D-A101_120406_SN1120_0131_BD0UK4ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0MU-10A,A7329910-B1C7-4A18-B28E-8FAD79121339,Blood Derived Normal,Illumina HiSeq,56dc6ee6-2816-48fc-b41d-acea5bdb9330,Uterus,78,AE04F86F-3927-4E5E-BC46-997CD6BED18A,37E6CE2A-F097-4D62-B8BE-2C790F76774F,TCGA-BG-A0MU-10A-02D-A101-02,HG19_Broad_variant,TCGA-BG-A0MU,TCGA-UCEC,NA,s4790,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c342,58cfa831e4b0c9d6adf6c342,TCGA-CG-4475-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_5_rg.sorted.filtered.,WGS,TCGA-CG-4475-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_5_rg.sorted,TCGA-CG-4475-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_5_rg.sorted.bam,128.2,1.9,0.14,58cfa831e4b0c9d6adf6c342,TCGA-CG-4475-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_5_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4475-01A,CAD2ADC1-0F41-4651-9C80-AE9961E2DC8D,Primary Tumor,Illumina HiSeq,77dce8cf-5642-43d4-8111-4f72d2ef30ef,Stomach,76,3E5D09C6-8F98-4701-BD24-FCA581343DE8,86D8A371-57BB-4DC7-9872-0EB4542208DC,TCGA-CG-4475-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4475,TCGA-STAD,NA,s14639,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6d0d2,58cfa832e4b0c9d6adf6d0d2,TCGA-IG-A3Y9-01A-12D-A248_121211_SN208_0443_BC1H55ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-IG-A3Y9-01A-12D-A248_121211_SN208_0443_BC1H55ACXX_s_7_rg.sorted,TCGA-IG-A3Y9-01A-12D-A248_121211_SN208_0443_BC1H55ACXX_s_7_rg.sorted.bam,28.44,NA,0.16,58cfa832e4b0c9d6adf6d0d2,TCGA-IG-A3Y9-01A-12D-A248_121211_SN208_0443_BC1H55ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A3Y9-01A,4B8809A6-4AB3-4567-8623-37CE3FAA978C,Primary Tumor,Illumina HiSeq,c2ef3740-4373-4315-812a-aec2bc6fde24,Esophagus,72,ACABEB3D-A6C0-46E8-ABB5-5FA9373D98AB,4320D40E-6CE1-4C13-A260-751281314AED,TCGA-IG-A3Y9-01A-12D-A248-26,HG19_Broad_variant,TCGA-IG-A3Y9,TCGA-ESCA,NA,s1627,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T4,N0,Not available,Stage IIIA
13722.58cfa831e4b0c9d6adf6c710,58cfa831e4b0c9d6adf6c710,TCGA-CV-7428-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CV-7428-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_2_rg.sorted,TCGA-CV-7428-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_2_rg.sorted.bam,325.73,NA,0.16,58cfa831e4b0c9d6adf6c710,TCGA-CV-7428-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7428-01A,90D3C240-5CB6-4601-A852-B5CDFBCD6483,Primary Tumor,Illumina HiSeq,234197c5-8479-49c1-9f04-5e9171364a3d,Head and Neck,47,F3CFC60B-ADA9-4549-8CDB-6CEBABB1E6B3,BA021325-B1CC-4C81-99B7-7B7349CFFFB6,TCGA-CV-7428-01A-11D-2317-26,HG19_Broad_variant,TCGA-CV-7428,TCGA-HNSC,1671,s15784,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c6fc,58cfa831e4b0c9d6adf6c6fc,TCGA-CV-5431-01A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CV-5431-01A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_3_rg.sorted,TCGA-CV-5431-01A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_3_rg.sorted.bam,464.7,1.8,0.15,58cfa831e4b0c9d6adf6c6fc,TCGA-CV-5431-01A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5431-01A,64BB5550-2735-4401-A0DB-58EC1020A32D,Primary Tumor,Illumina HiSeq,0cba1ad9-9899-40b0-9fa7-dc39030c04e7,Head and Neck,73,BE567C0A-3833-45D7-B846-D229A8E16E16,D751368D-5948-42EF-8C61-D24595CAC1E9,TCGA-CV-5431-01A-01D-1509-02,HG19_Broad_variant,TCGA-CV-5431,TCGA-HNSC,522,s16334,Harvard Medical School,MD Anderson Cancer Center,None,NO,T3,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6be20,58cfa830e4b0c9d6adf6be20,TCGA-B6-A0RG-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_4_rg.sorted.filtered.,WGS,TCGA-B6-A0RG-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_4_rg.sorted,TCGA-B6-A0RG-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_4_rg.sorted.bam,7.45,2,0.15,58cfa830e4b0c9d6adf6be20,TCGA-B6-A0RG-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0RG-10A,9B13927C-7357-44FD-8385-92AE6A656B7D,Blood Derived Normal,Illumina HiSeq,5ad51bb7-5bcd-42bc-b3ad-64bb242f91b3,Breast,26,3EBECB70-9957-4BFB-8E69-DC6F157C3F08,6F602AEF-51FE-40AD-9984-0F95D27A4078,TCGA-B6-A0RG-10A-01D-A060-02,HG19_Broad_variant,TCGA-B6-A0RG,TCGA-BRCA,NA,s5962,Harvard Medical School,Duke,United States,NO,T3,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa830e4b0c9d6adf6c218,58cfa830e4b0c9d6adf6c218,TCGA-BT-A20X-11A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BT-A20X-11A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_6_rg.sorted,TCGA-BT-A20X-11A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_6_rg.sorted.bam,9.27,1.77,0.15,58cfa830e4b0c9d6adf6c218,TCGA-BT-A20X-11A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20X-11A,BE8B3F36-AAA1-4302-B28E-DE1996FACEAF,Solid Tissue Normal,Illumina HiSeq,85b68bda-849a-4597-8161-176a8ad06f09,Bladder,56,F949B635-1BF1-457F-B72A-02F59753E467,4200DE6A-AE4E-42DD-8AB5-1B78298A2A22,TCGA-BT-A20X-11A-12D-A16N-02,HG19_Broad_variant,TCGA-BT-A20X,TCGA-BLCA,251,s3091,Harvard Medical School,University of Pittsburgh,United States,NO,T4a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6d1cc,58cfa832e4b0c9d6adf6d1cc,TCGA-HM-A3JK-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_8_rg.sorted.filtered.,WGS,TCGA-HM-A3JK-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_8_rg.sorted,TCGA-HM-A3JK-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_8_rg.sorted.bam,43.15,NA,0.16,58cfa832e4b0c9d6adf6d1cc,TCGA-HM-A3JK-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-HM-A3JK-10A,7C4CD55F-750E-4941-A9F3-0632A75D6531,Blood Derived Normal,Illumina HiSeq,7d7efc4f-e09e-4207-80d4-b6965a70903d,Cervix,64,113328E5-1A07-45F9-97C0-DEC4C28B14DB,7D0C6527-2A32-48CE-97A5-03C73864368A,TCGA-HM-A3JK-10A-01D-A245-26,HG19_Broad_variant,TCGA-HM-A3JK,TCGA-CESC,NA,s1374,MD Anderson - Institute for Applied Cancer Science,Christiana Healthcare,United States,NO,T2b,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c6ea,58cfa831e4b0c9d6adf6c6ea,TCGA-CG-4442-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_1_rg.sorted.filtered.,WGS,TCGA-CG-4442-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_1_rg.sorted,TCGA-CG-4442-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_1_rg.sorted.bam,165.2,1.9,0.14,58cfa831e4b0c9d6adf6c6ea,TCGA-CG-4442-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_1_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4442-01A,8FCCFF71-3710-4CB9-B8AF-61707AEBE5D8,Primary Tumor,Illumina HiSeq,3a08f497-17a4-4b39-87b6-680e2fa13379,Stomach,85,51927F82-2585-465B-92ED-36EF46D44FAB,7597FC80-5A3C-4999-97B2-4DCB55609CC2,TCGA-CG-4442-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4442,TCGA-STAD,NA,s14635,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa830e4b0c9d6adf6be41,58cfa830e4b0c9d6adf6be41,TCGA-BJ-A28R-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BJ-A28R-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_8_rg.sorted,TCGA-BJ-A28R-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_8_rg.sorted.bam,60.26,1.93,0.17,58cfa830e4b0c9d6adf6be41,TCGA-BJ-A28R-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A28R-10A,524A39EE-8FA3-418E-98A2-A6A90E9C8064,Blood Derived Normal,Illumina HiSeq,22696c6b-bf53-4670-9518-1526986414a8,Thyroid,38,576D5B97-6871-4E32-8A11-14ECAE9D490C,90BB8D84-280A-4E9C-8F10-4003DCDCEF31,TCGA-BJ-A28R-10A-01D-A16N-02,HG19_Broad_variant,TCGA-BJ-A28R,TCGA-THCA,NA,s12355,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c79e,58cfa831e4b0c9d6adf6c79e,TCGA-CN-6019-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CN-6019-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_8_rg.sorted,TCGA-CN-6019-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_8_rg.sorted.bam,473.7,1.9,0.17,58cfa831e4b0c9d6adf6c79e,TCGA-CN-6019-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-6019-10A,EE3061EC-273C-4BEF-A325-35E9C469BF01,Blood Derived Normal,Illumina HiSeq,7b49ae2c-674f-4f8f-b99b-fd2884c78a1b,Head and Neck,61,71ABA174-1006-4B0E-96FA-EF1BF171314B,2138A253-33D1-4402-8F65-BBE6F609AB58,TCGA-CN-6019-10A-01D-1681-02,HG19_Broad_variant,TCGA-CN-6019,TCGA-HNSC,NA,s15761,Harvard Medical School,University of Pittsburgh,United States,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6d03a,58cfa832e4b0c9d6adf6d03a,TCGA-GC-A3WC-11A-11D-A233_120904_SN1120_0186_BC1911ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-GC-A3WC-11A-11D-A233_120904_SN1120_0186_BC1911ACXX_s_2_rg.sorted,TCGA-GC-A3WC-11A-11D-A233_120904_SN1120_0186_BC1911ACXX_s_2_rg.sorted.bam,10.9,NA,0.17,58cfa832e4b0c9d6adf6d03a,TCGA-GC-A3WC-11A-11D-A233_120904_SN1120_0186_BC1911ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GC-A3WC-11A,DB52C68A-ED44-4EC4-9381-D75F9BCBC29A,Solid Tissue Normal,Illumina HiSeq,33924502-cf1d-4609-9e24-f717bcd9c439,Bladder,80,67ECDE91-9420-41F4-AE8A-5DA68D3EEABC,2058E8CF-4904-4A24-BCA5-3C5EB4D35A73,TCGA-GC-A3WC-11A-11D-A233-26,HG19_Broad_variant,TCGA-GC-A3WC,TCGA-BLCA,NA,s3126,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c650,58cfa831e4b0c9d6adf6c650,TCGA-CG-4455-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_6_rg.sorted.filtered.,WGS,TCGA-CG-4455-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_6_rg.sorted,TCGA-CG-4455-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_6_rg.sorted.bam,67.9,1.9,0.16,58cfa831e4b0c9d6adf6c650,TCGA-CG-4455-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_6_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4455-10A,8A173D98-20A1-4C84-86C1-97818E1C665A,Blood Derived Normal,Illumina HiSeq,761098d4-2b01-462b-95d1-962819d14226,Stomach,72,DDD0129D-79B1-497A-BB38-60745BD9DEB4,7E88B22D-C19E-45C9-AD0C-4951B5A361A0,TCGA-CG-4455-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4455,TCGA-STAD,NA,s14412,Harvard Medical School,Indivumed,Germany,NO,T2b,N1,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage II
13722.58cfa831e4b0c9d6adf6cba2,58cfa831e4b0c9d6adf6cba2,TCGA-EJ-5519-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EJ-5519-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_2_rg.sorted,TCGA-EJ-5519-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_2_rg.sorted.bam,763.4,1.9,0.17,58cfa831e4b0c9d6adf6cba2,TCGA-EJ-5519-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5519-10A,5313A055-C2D7-4CBD-A8C1-57AC85912D89,Blood Derived Normal,Illumina HiSeq,79a51d91-ec23-4cd1-be9c-59457bbad94a,Prostate,64,0ED92655-C273-4638-98F7-0BEE62811238,8FD697D8-1093-4960-99FD-9F803E59E92A,TCGA-EJ-5519-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5519,TCGA-PRAD,NA,s3951,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6cec2,58cfa832e4b0c9d6adf6cec2,TCGA-HC-7080-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_2_rg.sorted.filtered.,WGS,TCGA-HC-7080-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_2_rg.sorted,TCGA-HC-7080-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_2_rg.sorted.bam,398.7,NA,0.13,58cfa832e4b0c9d6adf6cec2,TCGA-HC-7080-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7080-01A,FD50FF41-EC9D-4DB1-A673-36BA0CA1EAC8,Primary Tumor,Illumina HiSeq,4012de79-f9d8-4ee6-ab04-538482e6a66c,Prostate,66,E30730B8-81F1-49A8-8446-547B5C3CC730,CEF3C431-0329-4619-834B-DC57B33399A5,TCGA-HC-7080-01A-11D-1957-02,HG19_Broad_variant,TCGA-HC-7080,TCGA-PRAD,NA,s3807,Harvard Medical School,International Genomics Consortium,United States,NO,T2a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c90c,58cfa831e4b0c9d6adf6c90c,TCGA-DK-A2HX-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DK-A2HX-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_1_rg.sorted,TCGA-DK-A2HX-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_1_rg.sorted.bam,16.46,NA,0.14,58cfa831e4b0c9d6adf6c90c,TCGA-DK-A2HX-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A2HX-01A,C728FAC9-5452-4759-A4ED-A366E0F757CB,Primary Tumor,Illumina HiSeq,17e4edb9-ac80-43de-a7c1-66edf1201ac0,Bladder,80,537F3FE6-4E8E-4570-827A-0F5CAB193BE0,4BAFEFB4-28D5-4126-B6B7-AE5B0D03F05D,TCGA-DK-A2HX-01A-12D-A18D-02,HG19_Broad_variant,TCGA-DK-A2HX,TCGA-BLCA,NA,s2712,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c33e,58cfa831e4b0c9d6adf6c33e,TCGA-CG-4474-01A-02D-1154_121026_SN1120_0198_BC188JACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CG-4474-01A-02D-1154_121026_SN1120_0198_BC188JACXX_s_1_rg.sorted,TCGA-CG-4474-01A-02D-1154_121026_SN1120_0198_BC188JACXX_s_1_rg.sorted.bam,112.2,1.9,0.14,58cfa831e4b0c9d6adf6c33e,TCGA-CG-4474-01A-02D-1154_121026_SN1120_0198_BC188JACXX_s_1_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4474-01A,39DD61A8-CD17-4DF3-AE17-61E239EB00BD,Primary Tumor,Illumina HiSeq,65c20199-b73c-42b2-b95a-3995b59e5d20,Stomach,67,68D21E75-16AC-48D0-B7CA-ABFDE13DED29,A3D7BAF1-387C-4094-957E-24BD2A78ED8D,TCGA-CG-4474-01A-02D-1154-02,HG19_Broad_variant,TCGA-CG-4474,TCGA-STAD,NA,s15326,Harvard Medical School,Indivumed,Germany,NO,T4a,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IV
13722.58cfa832e4b0c9d6adf6d084,58cfa832e4b0c9d6adf6d084,TCGA-HC-7080-10A-01D-1957_130422_SN590_0225_BD23TLACXX_s_3_rg.sorted.filtered.,WGS,TCGA-HC-7080-10A-01D-1957_130422_SN590_0225_BD23TLACXX_s_3_rg.sorted,TCGA-HC-7080-10A-01D-1957_130422_SN590_0225_BD23TLACXX_s_3_rg.sorted.bam,188,NA,0.16,58cfa832e4b0c9d6adf6d084,TCGA-HC-7080-10A-01D-1957_130422_SN590_0225_BD23TLACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7080-10A,FD50FF41-EC9D-4DB1-A673-36BA0CA1EAC8,Blood Derived Normal,Illumina HiSeq,eec2b211-fe5e-4169-883d-c614c804bdfd,Prostate,66,5E4C42B8-D17B-48D5-A8DE-C841E6313DE8,F31AA1B5-D26C-4178-A609-7A481B45F7AA,TCGA-HC-7080-10A-01D-1957-02,HG19_Broad_variant,TCGA-HC-7080,TCGA-PRAD,NA,s3626,Harvard Medical School,International Genomics Consortium,United States,NO,T2a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c3aa,58cfa831e4b0c9d6adf6c3aa,TCGA-CG-5723-11A-02D-1598_121011_SN208_0434_AC18MYACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CG-5723-11A-02D-1598_121011_SN208_0434_AC18MYACXX_s_6_rg.sorted,TCGA-CG-5723-11A-02D-1598_121011_SN208_0434_AC18MYACXX_s_6_rg.sorted.bam,393.3,1.9,0.14,58cfa831e4b0c9d6adf6c3aa,TCGA-CG-5723-11A-02D-1598_121011_SN208_0434_AC18MYACXX_s_6_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5723-11A,0F00AD32-E4BE-49D4-A02A-D233BFC913C5,Solid Tissue Normal,Illumina HiSeq,6bd76290-af9b-4812-8b89-e9a8f8416fbc,Stomach,83,CDB68733-745A-4DA9-BF49-B0E0E74A3332,E9EA0FC9-4BF4-40E1-9AA8-D3D278CD630E,TCGA-CG-5723-11A-02D-1598-02,HG19_Broad_variant,TCGA-CG-5723,TCGA-STAD,NA,s15329,Harvard Medical School,Indivumed,Germany,NO,T2,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa82fe4b0c9d6adf6b697,58cfa82fe4b0c9d6adf6b697,TCGA-44-5643-01A-01D-1623_120228_SN1120_0116_AD0KRVACXX_s_7_rg.sorted.filtered.,WGS,TCGA-44-5643-01A-01D-1623_120228_SN1120_0116_AD0KRVACXX_s_7_rg.sorted,TCGA-44-5643-01A-01D-1623_120228_SN1120_0116_AD0KRVACXX_s_7_rg.sorted.bam,672.7,1.9,0.15,58cfa82fe4b0c9d6adf6b697,TCGA-44-5643-01A-01D-1623_120228_SN1120_0116_AD0KRVACXX_s_7_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-5643-01A,27FCEEC1-3298-4CDD-A4E6-8F5CF34604F0,Primary Tumor,Illumina HiSeq,d7fc0a17-7a0f-4345-904e-dd40d39ebbc3,Lung,53,ED5B47C1-569F-492B-8D6C-155E3BA79ACB,98EAE374-5F58-4544-BB02-BF605A09AD15,TCGA-44-5643-01A-01D-1623-02,HG19_Broad_variant,TCGA-44-5643,TCGA-LUAD,NA,s10778,Harvard Medical School,Christiana Healthcare,United States,NO,T2b,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa832e4b0c9d6adf6cf34,58cfa832e4b0c9d6adf6cf34,TCGA-G9-6363-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_5_rg.sorted.filtered.,WGS,TCGA-G9-6363-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_5_rg.sorted,TCGA-G9-6363-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_5_rg.sorted.bam,313.4,1.8,0.13,58cfa832e4b0c9d6adf6cf34,TCGA-G9-6363-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6363-01A,B5B3871C-078C-46A7-AC50-EF916D4A6781,Primary Tumor,Illumina HiSeq,a64da28b-c092-4dfb-9503-06c15e566ac3,Prostate,64,65D588FF-58E3-4932-A7F4-25EF23C433D5,DBF42C34-D2E5-4136-83F5-093453913D5B,TCGA-G9-6363-01A-21D-1784-02,HG19_Broad_variant,TCGA-G9-6363,TCGA-PRAD,NA,s3452,Harvard Medical School,Roswell Park,United States,NO,T4,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c4b2,58cfa831e4b0c9d6adf6c4b2,TCGA-BR-6706-10A-01D-1880_121220_SN1222_0163_AC1HA2ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BR-6706-10A-01D-1880_121220_SN1222_0163_AC1HA2ACXX_s_6_rg.sorted,TCGA-BR-6706-10A-01D-1880_121220_SN1222_0163_AC1HA2ACXX_s_6_rg.sorted.bam,471,1.9,0.15,58cfa831e4b0c9d6adf6c4b2,TCGA-BR-6706-10A-01D-1880_121220_SN1222_0163_AC1HA2ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6706-10A,93AEBBD4-19CF-495A-B8CE-3C4A3FEBA152,Blood Derived Normal,Illumina HiSeq,f98df3e1-6bfd-4745-9c3b-412598e8d952,Stomach,63,3F76462F-9485-4382-B825-09570F0AB41F,1428A4F7-A164-4CB4-97CC-F637E6FD4FD4,TCGA-BR-6706-10A-01D-1880-02,HG19_Broad_variant,TCGA-BR-6706,TCGA-STAD,NA,s14689,Harvard Medical School,Asterand,Ukraine,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6c6e6,58cfa831e4b0c9d6adf6c6e6,TCGA-CN-4734-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CN-4734-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_1_rg.sorted,TCGA-CN-4734-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_1_rg.sorted.bam,850.4,1.9,0.15,58cfa831e4b0c9d6adf6c6e6,TCGA-CN-4734-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4734-10A,B80FDC9A-341D-4277-9664-8E8F770D9DDD,Blood Derived Normal,Illumina HiSeq,dc55020c-4480-41b1-ad6f-0295abea2b6c,Head and Neck,70,782C9013-4F6F-461B-AA33-5E60D38BFCCC,67C9A43F-0254-47C0-9AE7-B3328D75CBFA,TCGA-CN-4734-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4734,TCGA-HNSC,NA,s16321,Harvard Medical School,University of Pittsburgh,None,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c39e,58cfa831e4b0c9d6adf6c39e,TCGA-C5-A2M1-01A-11D-A18I_140206_SN1222_0239_BC2RAKACXX_s_6_rg.sorted.filtered.,WGS,TCGA-C5-A2M1-01A-11D-A18I_140206_SN1222_0239_BC2RAKACXX_s_6_rg.sorted,TCGA-C5-A2M1-01A-11D-A18I_140206_SN1222_0239_BC2RAKACXX_s_6_rg.sorted.bam,54.44,NA,0.16,58cfa831e4b0c9d6adf6c39e,TCGA-C5-A2M1-01A-11D-A18I_140206_SN1222_0239_BC2RAKACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A2M1-01A,8911C80C-C903-48E4-AF5B-FFEDEF9ABC47,Primary Tumor,Illumina HiSeq,374c6310-126e-48e8-8b83-145f75714a4b,Cervix,37,065BB06F-5BB7-4F79-B374-97A3011F22AE,E2DAD681-2B26-43A0-804B-0F2DD17B1EFE,TCGA-C5-A2M1-01A-11D-A18I-02,HG19_Broad_variant,TCGA-C5-A2M1,TCGA-CESC,NA,s1518,Harvard Medical School,Medical College of Wisconsin,United States,NO,T1b1,N0,Endocervical Type of Adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6c1be,58cfa830e4b0c9d6adf6c1be,TCGA-BS-A0UT-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BS-A0UT-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_4_rg.sorted,TCGA-BS-A0UT-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_4_rg.sorted.bam,16.38,1.9,0.16,58cfa830e4b0c9d6adf6c1be,TCGA-BS-A0UT-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_4_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0UT-10A,E2B1D0DE-5221-44A1-8FAD-9708A3CADA14,Blood Derived Normal,Illumina HiSeq,ce5e4242-4066-48c3-bae1-a64cba28a927,Uterus,62,452C7150-C00B-4945-9564-92D26805F128,6A617CA5-0762-4337-9B3F-F7BF10416751,TCGA-BS-A0UT-10A-01D-A101-02,HG19_Broad_variant,TCGA-BS-A0UT,TCGA-UCEC,NA,s5016,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d558,58cfa832e4b0c9d6adf6d558,TCGA-L5-A4OM-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_1_rg.sorted.filtered.,WGS,TCGA-L5-A4OM-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_1_rg.sorted,TCGA-L5-A4OM-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_1_rg.sorted.bam,36.8,NA,0.17,58cfa832e4b0c9d6adf6d558,TCGA-L5-A4OM-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OM-01A,1A578AE7-5C0B-48EF-8BAF-7189DF703A93,Primary Tumor,Illumina HiSeq,2069622c-925f-4886-8005-9b8680ecc584,Esophagus,54,01EF1408-F028-4F6C-B09E-9BBB8D738704,081DEE66-D2A2-4FF2-94A1-6E3219D878D7,TCGA-L5-A4OM-01A-11D-A267-26,HG19_Broad_variant,TCGA-L5-A4OM,TCGA-ESCA,NA,s1842,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T1,N0,Not available,Stage IA
13722.58cfa832e4b0c9d6adf6d284,58cfa832e4b0c9d6adf6d284,TCGA-HT-7481-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_1_rg.sorted.filtered.,WGS,TCGA-HT-7481-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_1_rg.sorted,TCGA-HT-7481-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_1_rg.sorted.bam,22,NA,0.13,58cfa832e4b0c9d6adf6d284,TCGA-HT-7481-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7481-01A,BFF37DE3-DC68-4E69-BDFC-8B524DD7774F,Primary Tumor,Illumina HiSeq,fbc2ca18-8dd6-41c3-9ec3-0189f96877ce,Brain,39,712405B3-14C4-4C26-9839-1749763D816B,AF69E75D-03C6-4EB0-A0B8-129BE37E30A2,TCGA-HT-7481-01A-11D-2022-02,HG19_Broad_variant,TCGA-HT-7481,TCGA-LGG,NA,s8762,Harvard Medical School,Case Western - St Joes,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6cba0,58cfa831e4b0c9d6adf6cba0,TCGA-EJ-5519-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EJ-5519-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_1_rg.sorted,TCGA-EJ-5519-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_1_rg.sorted.bam,233.7,1.9,0.15,58cfa831e4b0c9d6adf6cba0,TCGA-EJ-5519-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5519-01A,5313A055-C2D7-4CBD-A8C1-57AC85912D89,Primary Tumor,Illumina HiSeq,75f448c7-b10b-4c15-ae49-4eb217c65391,Prostate,64,EEE1828E-D25F-462B-9735-89CA2ECCC7E1,4C2E88A3-B668-40A8-B625-B6D7A48DEAF5,TCGA-EJ-5519-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5519,TCGA-PRAD,NA,s3949,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c13c,58cfa830e4b0c9d6adf6c13c,TCGA-BS-A0UF-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BS-A0UF-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_1_rg.sorted,TCGA-BS-A0UF-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_1_rg.sorted.bam,16.27,2.03,0.16,58cfa830e4b0c9d6adf6c13c,TCGA-BS-A0UF-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_1_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0UF-10A,F77D7256-2CCF-42A7-9B30-332AC24CA812,Blood Derived Normal,Illumina HiSeq,4901eca0-dc95-4a8a-b119-955bac45c497,Uterus,65,283B4B89-BABC-45E1-AE18-04E258DA434D,4FD6E229-6662-4039-A2EF-225350AC231C,TCGA-BS-A0UF-10A-01D-A101-02,HG19_Broad_variant,TCGA-BS-A0UF,TCGA-UCEC,NA,s4435,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cbba,58cfa831e4b0c9d6adf6cbba,TCGA-EJ-5542-10A-01D-1573_130221_SN1120_0239_BD1V59ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EJ-5542-10A-01D-1573_130221_SN1120_0239_BD1V59ACXX_s_6_rg.sorted,TCGA-EJ-5542-10A-01D-1573_130221_SN1120_0239_BD1V59ACXX_s_6_rg.sorted.bam,389.4,1.9,0.15,58cfa831e4b0c9d6adf6cbba,TCGA-EJ-5542-10A-01D-1573_130221_SN1120_0239_BD1V59ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5542-10A,5A92EC4C-36EE-4588-ACA2-E3303F29C7AD,Blood Derived Normal,Illumina HiSeq,1e52051f-16ba-40b2-bbf3-8cf3fd858f90,Prostate,60,5D13A5E3-AD75-40BA-A3B4-C7BCF53A1E1F,093883AA-B9C6-4416-9B8D-CF280DB8BEF5,TCGA-EJ-5542-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5542,TCGA-PRAD,NA,s3963,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c467,58cfa831e4b0c9d6adf6c467,TCGA-CH-5751-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CH-5751-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_7_rg.sorted,TCGA-CH-5751-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_7_rg.sorted.bam,226.7,1.9,0.15,58cfa831e4b0c9d6adf6c467,TCGA-CH-5751-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5751-01A,721E76D0-4B1D-4E78-ADB8-1344B8030062,Primary Tumor,Illumina HiSeq,c152f07f-eb7f-464d-ba51-ce1b55777952,Prostate,68,6D8CE214-3A06-4F7C-858B-709A40EBBE25,FC06702A-2C27-42FD-A925-D0DB20C358E7,TCGA-CH-5751-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5751,TCGA-PRAD,NA,s3425,Harvard Medical School,Indivumed,Germany,NO,T4,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c7d4,58cfa831e4b0c9d6adf6c7d4,TCGA-D7-6519-10A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_6_rg.sorted.filtered.,WGS,TCGA-D7-6519-10A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_6_rg.sorted,TCGA-D7-6519-10A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_6_rg.sorted.bam,331.7,1.9,0.15,58cfa831e4b0c9d6adf6c7d4,TCGA-D7-6519-10A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6519-10A,E37CAE9E-0656-4B89-B326-739A5CC859E0,Blood Derived Normal,Illumina HiSeq,95e3ee3b-6ed5-4d0d-a7a9-64ae3139dab4,Stomach,64,AC4792AA-4989-43F5-A9D2-B82B25490F38,5820AD02-BC44-4840-A3EC-5749EBC0C719,TCGA-D7-6519-10A-01D-1798-02,HG19_Broad_variant,TCGA-D7-6519,TCGA-STAD,NA,s15330,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N1,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIB
13722.58cfa831e4b0c9d6adf6c476,58cfa831e4b0c9d6adf6c476,TCGA-CG-5727-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CG-5727-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_3_rg.sorted,TCGA-CG-5727-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_3_rg.sorted.bam,269,1.9,0.15,58cfa831e4b0c9d6adf6c476,TCGA-CG-5727-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_3_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5727-01A,B75EB694-8E9D-4DBB-B536-7D278C728CBB,Primary Tumor,Illumina HiSeq,3488abf3-f0fd-4eff-a75b-32457ccff3bd,Stomach,66,CD194D5F-3814-4E5E-88B6-6CF4CF491146,D2CC734B-DEE5-4345-98B0-BCCB42941669,TCGA-CG-5727-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5727,TCGA-STAD,NA,s15327,Harvard Medical School,Indivumed,Germany,NO,T3,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa82fe4b0c9d6adf6b701,58cfa82fe4b0c9d6adf6b701,TCGA-44-6775-01A-11D-1853_111207_SN590_0112_D09CDACXX_s_4_rg.sorted.filtered.,WGS,TCGA-44-6775-01A-11D-1853_111207_SN590_0112_D09CDACXX_s_4_rg.sorted,TCGA-44-6775-01A-11D-1853_111207_SN590_0112_D09CDACXX_s_4_rg.sorted.bam,237.3,1.9,0.16,58cfa82fe4b0c9d6adf6b701,TCGA-44-6775-01A-11D-1853_111207_SN590_0112_D09CDACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-6775-01A,3C4FF061-D214-4D1C-8D2E-3034F207C252,Primary Tumor,Illumina HiSeq,c17b3c9b-e41f-48e2-9cde-facc8537afbc,Lung,72,7C606F64-69A1-465C-9F4E-2EB1EBEDA5D7,8B286297-0077-44ED-9093-6F13E2CA4EBA,TCGA-44-6775-01A-11D-1853-02,HG19_Broad_variant,TCGA-44-6775,TCGA-LUAD,NA,s11454,Harvard Medical School,Christiana Healthcare,United States,NO,T2a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c8c8,58cfa831e4b0c9d6adf6c8c8,TCGA-CV-6952-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CV-6952-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_1_rg.sorted,TCGA-CV-6952-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_1_rg.sorted.bam,111.7,1.9,0.15,58cfa831e4b0c9d6adf6c8c8,TCGA-CV-6952-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6952-01A,7ED006E8-461F-4664-BFFF-55FA6812743C,Primary Tumor,Illumina HiSeq,7145e1a2-e609-45d9-a111-efe59656286d,Head and Neck,65,18E70193-5D78-41DD-9FCA-AF5E54594AD3,EAA6BAF6-1D90-471D-BBFF-2230B87339E4,TCGA-CV-6952-01A-11D-1911-02,HG19_Broad_variant,TCGA-CV-6952,TCGA-HNSC,185,s15647,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6cc40,58cfa831e4b0c9d6adf6cc40,TCGA-EK-A2R7-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EK-A2R7-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_3_rg.sorted,TCGA-EK-A2R7-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_3_rg.sorted.bam,66.58,NA,0.17,58cfa831e4b0c9d6adf6cc40,TCGA-EK-A2R7-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2R7-01A,D7A75BF5-5189-4978-99D9-FCEF91C9FBD2,Primary Tumor,Illumina HiSeq,b998e76d-dff1-4454-abce-bbe7b5a6c398,Cervix,45,EE9A22DF-8612-4B71-AF3A-6B16C73197EA,9C763A04-CC5B-41E1-A5AC-2CB06B9E80C3,TCGA-EK-A2R7-01A-11D-A18I-02,HG19_Broad_variant,TCGA-EK-A2R7,TCGA-CESC,NA,s1526,Harvard Medical School,Gynecologic Oncology Group,United States,NO,T1b1,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c446,58cfa831e4b0c9d6adf6c446,TCGA-CH-5750-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CH-5750-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_5_rg.sorted,TCGA-CH-5750-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_5_rg.sorted.bam,300.7,1.9,0.16,58cfa831e4b0c9d6adf6c446,TCGA-CH-5750-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5750-01A,DC40CF49-B208-4F59-B5F0-CFBDD02970B2,Primary Tumor,Illumina HiSeq,d0338227-feec-4f2e-bcfa-89c723bb89b5,Prostate,72,0386D0E9-7BD8-467F-BA97-A379C1D67A83,E1FEA0C9-E1D6-49C2-9DFF-9DC87F7776E9,TCGA-CH-5750-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5750,TCGA-PRAD,NA,s3591,Harvard Medical School,Indivumed,Germany,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6cfd4,58cfa832e4b0c9d6adf6cfd4,TCGA-FU-A3WB-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FU-A3WB-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_4_rg.sorted,TCGA-FU-A3WB-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_4_rg.sorted.bam,24.48,NA,0.15,58cfa832e4b0c9d6adf6cfd4,TCGA-FU-A3WB-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-FU-A3WB-10A,6868BA1D-B612-454C-8146-74AF2F573D76,Blood Derived Normal,Illumina HiSeq,51850ff3-c031-496e-9989-ba2d764676ca,Cervix,43,E4D37B4A-2B93-48DC-B8E2-20FD88C0A8D1,C248D351-2B56-4924-A4C9-CDB7AF48B34B,TCGA-FU-A3WB-10A-01D-A232-26,HG19_Broad_variant,TCGA-FU-A3WB,TCGA-CESC,NA,s1206,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T2a2,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b66d,58cfa82fe4b0c9d6adf6b66d,TCGA-50-6597-10A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_4_rg.sorted.filtered.,WGS,TCGA-50-6597-10A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_4_rg.sorted,TCGA-50-6597-10A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_4_rg.sorted.bam,14,1.8,0.14,58cfa82fe4b0c9d6adf6b66d,TCGA-50-6597-10A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-6597-10A,0D66BF6C-EED0-4726-BD5B-3BF6D610B4E0,Blood Derived Normal,Illumina HiSeq,cf5182e3-08aa-45af-8c6f-2d6afdf01d08,Lung,79,254F2707-C4FB-41DA-BFC0-2190EB9368D5,6E660AAE-3656-424B-966A-DEC114CCCBCE,TCGA-50-6597-10A-01D-1853-02,HG19_Broad_variant,TCGA-50-6597,TCGA-LUAD,NA,s11129,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa830e4b0c9d6adf6c1a4,58cfa830e4b0c9d6adf6c1a4,TCGA-BA-5559-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BA-5559-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_1_rg.sorted,TCGA-BA-5559-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_1_rg.sorted.bam,94.4,1.9,0.15,58cfa830e4b0c9d6adf6c1a4,TCGA-BA-5559-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5559-10A,17B17D91-C3DF-4B89-9C10-4DB069AFF656,Blood Derived Normal,Illumina HiSeq,e4331399-eb06-4ee0-a375-64ffa929d8e7,Head and Neck,71,43FBB037-8BA4-4BA3-8458-71A027EDA822,673B6C98-3F56-42D2-BFF8-2E68992864F4,TCGA-BA-5559-10A-01D-1509-02,HG19_Broad_variant,TCGA-BA-5559,TCGA-HNSC,NA,s15491,Harvard Medical School,UNC,None,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c354,58cfa831e4b0c9d6adf6c354,TCGA-CG-4476-10A-01D-1154_121029_SN208_0438_AC18NJACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CG-4476-10A-01D-1154_121029_SN208_0438_AC18NJACXX_s_3_rg.sorted,TCGA-CG-4476-10A-01D-1154_121029_SN208_0438_AC18NJACXX_s_3_rg.sorted.bam,67.9,1.9,0.16,58cfa831e4b0c9d6adf6c354,TCGA-CG-4476-10A-01D-1154_121029_SN208_0438_AC18NJACXX_s_3_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4476-10A,442D7415-D095-4962-8296-A14390BAD40A,Blood Derived Normal,Illumina HiSeq,3ed041fd-9dd4-4ac6-8681-f69faacd1552,Stomach,69,15D8F5B3-63C4-400A-83C3-49B0A68CA1EF,E6AEDF0B-5818-444A-A4F0-D374F531BDB5,TCGA-CG-4476-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4476,TCGA-STAD,NA,s14415,Harvard Medical School,Indivumed,Germany,NO,T4b,N3a,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIC
13722.58cfa830e4b0c9d6adf6c240,58cfa830e4b0c9d6adf6c240,TCGA-BS-A0U8-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BS-A0U8-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_8_rg.sorted,TCGA-BS-A0U8-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_8_rg.sorted.bam,17.81,2.05,0.17,58cfa830e4b0c9d6adf6c240,TCGA-BS-A0U8-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0U8-10A,FB7475DF-30CC-4316-B9AC-37CBEEB6BA2B,Blood Derived Normal,Illumina HiSeq,2ab387c8-839e-4435-9f0a-51ea04594026,Uterus,55,5CA13FB8-860E-4126-B510-BBF920500533,B02F987B-C5A1-4724-8B56-3C7EA9240B73,TCGA-BS-A0U8-10A-01D-A101-02,HG19_Broad_variant,TCGA-BS-A0U8,TCGA-UCEC,NA,s4606,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b696,58cfa82fe4b0c9d6adf6b696,TCGA-73-4658-11A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_6_rg.sorted.filtered.,WGS,TCGA-73-4658-11A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_6_rg.sorted,TCGA-73-4658-11A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_6_rg.sorted.bam,21.4,1.9,0.15,58cfa82fe4b0c9d6adf6b696,TCGA-73-4658-11A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_6_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4658-11A,AFB91740-2668-46D7-BA01-BB26153AD1C7,Solid Tissue Normal,Illumina HiSeq,154d1467-8cef-484b-b813-86a414c476d2,Lung,80,0E18E1B8-3E7A-43FF-BB86-F097EB9BABC5,27CFDE2F-DC0C-41BF-B179-411D1A3E025F,TCGA-73-4658-11A-01D-1751-02,HG19_Broad_variant,TCGA-73-4658,TCGA-LUAD,1600,s10912,Harvard Medical School,Roswell Park,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6cc5c,58cfa831e4b0c9d6adf6cc5c,TCGA-EJ-5502-01A-01D-1572_130329_SN590_0221_BD1WHDACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EJ-5502-01A-01D-1572_130329_SN590_0221_BD1WHDACXX_s_5_rg.sorted,TCGA-EJ-5502-01A-01D-1572_130329_SN590_0221_BD1WHDACXX_s_5_rg.sorted.bam,238.7,1.9,0.17,58cfa831e4b0c9d6adf6cc5c,TCGA-EJ-5502-01A-01D-1572_130329_SN590_0221_BD1WHDACXX_s_5_rg.sorted.bam,Alive,MALE,Not available,Not available,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5502-01A,48E83A4C-C602-494A-80CD-E2F4B4DD701E,Primary Tumor,Illumina HiSeq,40f605db-50a6-4ed1-b652-61045959ba2e,Prostate,50,D36A0B54-6E09-4EE2-923B-C1516D78BB03,0432A271-DB73-434C-971A-B3B2C3FD2285,TCGA-EJ-5502-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5502,TCGA-PRAD,NA,s3785,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c10c,58cfa830e4b0c9d6adf6c10c,TCGA-BS-A0TA-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BS-A0TA-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_8_rg.sorted,TCGA-BS-A0TA-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_8_rg.sorted.bam,15.24,1.9,0.15,58cfa830e4b0c9d6adf6c10c,TCGA-BS-A0TA-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_8_rg.sorted.bam,Alive,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TA-10A,AD3D8420-F562-4CBE-AC82-C968BD4F782D,Blood Derived Normal,Illumina HiSeq,eefab396-34cc-4190-9980-99576677cbaa,Uterus,58,435C97F0-2223-46D6-A682-7113C7071D35,BD02B371-649E-449D-B86C-F0B30FDEAADA,TCGA-BS-A0TA-10A-01D-A101-02,HG19_Broad_variant,TCGA-BS-A0TA,TCGA-UCEC,NA,s4262,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6ba48,58cfa82fe4b0c9d6adf6ba48,TCGA-A5-A0G5-01A-11D-A043_120327_SN590_0148_BC0LM8ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-A5-A0G5-01A-11D-A043_120327_SN590_0148_BC0LM8ACXX_s_3_rg.sorted,TCGA-A5-A0G5-01A-11D-A043_120327_SN590_0148_BC0LM8ACXX_s_3_rg.sorted.bam,83.98,2,0.17,58cfa82fe4b0c9d6adf6ba48,TCGA-A5-A0G5-01A-11D-A043_120327_SN590_0148_BC0LM8ACXX_s_3_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0G5-01A,4806D9A6-E65D-4A82-B422-1B287980A0C6,Primary Tumor,Illumina HiSeq,db20abab-2eed-4958-a741-e31199adb617,Uterus,73,FA7392E8-335E-4465-9272-4A19DC99412E,EDFD99A3-38A2-4E43-A3D1-B1D19EA818E5,TCGA-A5-A0G5-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0G5,TCGA-UCEC,NA,s5382,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bbb6,58cfa830e4b0c9d6adf6bbb6,TCGA-A2-A0EU-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_2_rg.sorted.filtered.,WGS,TCGA-A2-A0EU-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_2_rg.sorted,TCGA-A2-A0EU-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_2_rg.sorted.bam,21.31,1.91,0.13,58cfa830e4b0c9d6adf6bbb6,TCGA-A2-A0EU-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A0EU-10A,C0427237-B476-4AF4-B664-7BD479922EA5,Blood Derived Normal,Illumina HiSeq,bbc2932c-4507-4111-a367-ba914dfe257b,Breast,79,7B9319B5-3093-4E22-94B2-E7A956BDC271,11E97514-242B-4CE1-99EA-3830E6902EE3,TCGA-A2-A0EU-10A-01D-A060-02,HG19_Broad_variant,TCGA-A2-A0EU,TCGA-BRCA,NA,s6768,Harvard Medical School,Walter Reed,None,NO,T1c,N0 (i-),Infiltrating Ductal Carcinoma,Stage IA
13722.58cfa832e4b0c9d6adf6d00c,58cfa832e4b0c9d6adf6d00c,TCGA-HC-7230-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-HC-7230-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_8_rg.sorted,TCGA-HC-7230-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_8_rg.sorted.bam,142.3,NA,0.14,58cfa832e4b0c9d6adf6d00c,TCGA-HC-7230-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7230-01A,03C66CF8-BC68-4EE1-A322-689A29B72262,Primary Tumor,Illumina HiSeq,40ad0094-93d2-45aa-a8b1-070359637c85,Prostate,50,B8BAC212-127D-4EEE-8647-3BDDC13C9415,CE9AA8B5-5CDB-42F1-A810-7F48FC241D20,TCGA-HC-7230-01A-11D-2111-02,HG19_Broad_variant,TCGA-HC-7230,TCGA-PRAD,NA,s3804,Harvard Medical School,International Genomics Consortium,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c332,58cfa831e4b0c9d6adf6c332,TCGA-CG-4472-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_1_rg.sorted.filtered.,WGS,TCGA-CG-4472-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_1_rg.sorted,TCGA-CG-4472-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_1_rg.sorted.bam,157.9,1.9,0.14,58cfa831e4b0c9d6adf6c332,TCGA-CG-4472-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_1_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4472-01A,306F0222-8734-44CA-9A31-86E4E62B0A1B,Primary Tumor,Illumina HiSeq,74cc19cf-8ff9-4786-87d9-936dcbb9196e,Stomach,49,A474CFDD-0822-42E8-A478-C0895A409CCD,8363DF43-B859-4A78-8CDE-3E06C6230EB2,TCGA-CG-4472-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4472,TCGA-STAD,NA,s14640,Harvard Medical School,Indivumed,Germany,NO,T4,N1,Not available,Stage IV
13722.58cfa831e4b0c9d6adf6c889,58cfa831e4b0c9d6adf6c889,TCGA-D7-6525-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_7_rg.sorted.filtered.,WGS,TCGA-D7-6525-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_7_rg.sorted,TCGA-D7-6525-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_7_rg.sorted.bam,198.4,1.9,0.15,58cfa831e4b0c9d6adf6c889,TCGA-D7-6525-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6525-01A,82F9A197-040D-4C5E-89D9-D87A7AA0168D,Primary Tumor,Illumina HiSeq,03097d75-d0ad-4e1e-8a9b-5157a768cc05,Stomach,58,C1AC6717-828B-4289-9755-7C56A6FC1392,26A09728-CA75-4E29-A222-0826899E0800,TCGA-D7-6525-01A-11D-1798-02,HG19_Broad_variant,TCGA-D7-6525,TCGA-STAD,NA,s14493,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA
13722.58cfa831e4b0c9d6adf6cb0c,58cfa831e4b0c9d6adf6cb0c,TCGA-EA-A3Y4-10A-01D-A245_140124_SN1440_0178_AC2PL6ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EA-A3Y4-10A-01D-A245_140124_SN1440_0178_AC2PL6ACXX_s_3_rg.sorted,TCGA-EA-A3Y4-10A-01D-A245_140124_SN1440_0178_AC2PL6ACXX_s_3_rg.sorted.bam,102.17,NA,0.15,58cfa831e4b0c9d6adf6cb0c,TCGA-EA-A3Y4-10A-01D-A245_140124_SN1440_0178_AC2PL6ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EA-A3Y4-10A,3AC62513-B5F4-4063-AABD-DAD08A1F56FB,Blood Derived Normal,Illumina HiSeq,6e7276b2-90e0-400f-b317-ce52a58361da,Cervix,40,FD1C17D6-7C6B-4C0E-BB07-BEEE96129208,6761FD61-205D-431A-A767-022E7AEAE939,TCGA-EA-A3Y4-10A-01D-A245-26,HG19_Broad_variant,TCGA-EA-A3Y4,TCGA-CESC,NA,s1184,MD Anderson - Institute for Applied Cancer Science,Asterand,Ukraine,NO,T1b,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d3b6,58cfa832e4b0c9d6adf6d3b6,TCGA-L5-A4ON-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_7_rg.sorted.filtered.,WGS,TCGA-L5-A4ON-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_7_rg.sorted,TCGA-L5-A4ON-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_7_rg.sorted.bam,47.01,NA,0.17,58cfa832e4b0c9d6adf6d3b6,TCGA-L5-A4ON-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4ON-01A,CABA34F2-3877-48CA-9FBC-665C3960F574,Primary Tumor,Illumina HiSeq,9bb22695-702d-410d-98a3-d4adcf022a94,Esophagus,65,B801A0D7-09E8-48D8-9C8E-C6D52767F7C1,469616E0-7C5B-491E-8D25-E71CCDB27D18,TCGA-L5-A4ON-01A-11D-A267-26,HG19_Broad_variant,TCGA-L5-A4ON,TCGA-ESCA,558,s1843,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T1,N1,Not available,Stage IIB
13722.58cfa830e4b0c9d6adf6bbbc,58cfa830e4b0c9d6adf6bbbc,TCGA-A2-A0EU-01A-22D-A060_130807_SN590_0235_AC29RAACXX_s_1_rg.sorted.filtered.,WGS,TCGA-A2-A0EU-01A-22D-A060_130807_SN590_0235_AC29RAACXX_s_1_rg.sorted,TCGA-A2-A0EU-01A-22D-A060_130807_SN590_0235_AC29RAACXX_s_1_rg.sorted.bam,40.68,1.8,0.14,58cfa830e4b0c9d6adf6bbbc,TCGA-A2-A0EU-01A-22D-A060_130807_SN590_0235_AC29RAACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A0EU-01A,C0427237-B476-4AF4-B664-7BD479922EA5,Primary Tumor,Illumina HiSeq,f8f8a691-8930-46b3-9cd7-1b8ac6895baf,Breast,79,69DBB2AE-3F19-4C29-9C24-810AE60312F3,7F0FA628-7A18-4E52-81CC-3E213C431D3E,TCGA-A2-A0EU-01A-22D-A060-02,HG19_Broad_variant,TCGA-A2-A0EU,TCGA-BRCA,NA,s5489,Harvard Medical School,Walter Reed,None,NO,T1c,N0 (i-),Infiltrating Ductal Carcinoma,Stage IA
13722.58cfa832e4b0c9d6adf6cffe,58cfa832e4b0c9d6adf6cffe,TCGA-G9-6377-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_1_rg.sorted.filtered.,WGS,TCGA-G9-6377-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_1_rg.sorted,TCGA-G9-6377-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_1_rg.sorted.bam,27,1.9,0.17,58cfa832e4b0c9d6adf6cffe,TCGA-G9-6377-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6377-10A,007F9081-5093-4323-B4F8-CD510BF20705,Blood Derived Normal,Illumina HiSeq,82468f85-9845-4b13-b10d-4118b20e9e48,Prostate,61,509D8324-81CE-441E-BDC9-CEEECF00B936,C161B052-D60E-4782-878A-D5738B4D030A,TCGA-G9-6377-10A-01D-1957-02,HG19_Broad_variant,TCGA-G9-6377,TCGA-PRAD,NA,s3800,Harvard Medical School,Roswell Park,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c6a2,58cfa831e4b0c9d6adf6c6a2,TCGA-CQ-6223-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CQ-6223-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_3_rg.sorted,TCGA-CQ-6223-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_3_rg.sorted.bam,325.7,1.9,0.15,58cfa831e4b0c9d6adf6c6a2,TCGA-CQ-6223-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-6223-01A,D9E8C707-E61A-4813-8DC0-2472E9CCF12B,Primary Tumor,Illumina HiSeq,d12d744d-5a58-4e30-bcb7-b8c033a8255d,Head and Neck,69,775DB365-3533-41D9-B635-582292B22700,6CE8A7EC-2730-49E4-81F0-47B03A54EA1A,TCGA-CQ-6223-01A-11D-1911-02,HG19_Broad_variant,TCGA-CQ-6223,TCGA-HNSC,NA,s16038,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c720,58cfa831e4b0c9d6adf6c720,TCGA-D7-6527-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D7-6527-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_3_rg.sorted,TCGA-D7-6527-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_3_rg.sorted.bam,84.4,1.9,0.13,58cfa831e4b0c9d6adf6c720,TCGA-D7-6527-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6527-01A,CB622CD6-776D-4681-8A67-4ADDD61C66B8,Primary Tumor,Illumina HiSeq,d1534b7a-a5b2-4083-9736-d1ad62a97ad2,Stomach,62,8461CE68-3A6F-4343-8977-78448123F373,F91DFFCE-5185-4555-92EA-919E94EB9569,TCGA-D7-6527-01A-11D-1798-02,HG19_Broad_variant,TCGA-D7-6527,TCGA-STAD,NA,s14496,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N1,Stomach Intestinal Adenocarcinoma Papillary Type,Stage II
13722.58cfa832e4b0c9d6adf6d602,58cfa832e4b0c9d6adf6d602,TCGA-LN-A49N-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_7_rg.sorted.filtered.,WGS,TCGA-LN-A49N-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_7_rg.sorted,TCGA-LN-A49N-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_7_rg.sorted.bam,23.88,NA,0.15,58cfa832e4b0c9d6adf6d602,TCGA-LN-A49N-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_7_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49N-01A,AE404398-6544-4F3A-8830-44A4A227F8D5,Primary Tumor,Illumina HiSeq,cc2923b6-4e0b-4a1c-ad36-baa7b55f96ac,Esophagus,50,79EDB231-5534-4EB8-9B67-2BF628C19FB4,092A4F76-1526-48FA-932B-5FFA9AC1FAF5,TCGA-LN-A49N-01A-11D-A248-26,HG19_Broad_variant,TCGA-LN-A49N,TCGA-ESCA,NA,s1668,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T2,N1,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6c572,58cfa831e4b0c9d6adf6c572,TCGA-CN-4736-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CN-4736-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_3_rg.sorted,TCGA-CN-4736-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_3_rg.sorted.bam,557.4,1.9,0.14,58cfa831e4b0c9d6adf6c572,TCGA-CN-4736-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_3_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4736-10A,0FB3E5FF-54F0-43C5-9322-541BB7825E7F,Blood Derived Normal,Illumina HiSeq,c96f69ef-daa9-46cf-b34f-d7c328956edd,Head and Neck,70,206FA54C-7FB3-442A-9A50-09C5CEA8A6C7,10D1A9FE-CB75-426B-9D1D-55F21CD1A5F1,TCGA-CN-4736-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4736,TCGA-HNSC,395,s15619,Harvard Medical School,University of Pittsburgh,None,NO,T1,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6ba9b,58cfa830e4b0c9d6adf6ba9b,TCGA-A5-A0GJ-01A-11D-A043_120318_SN590_0146_AC0KH7ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-A5-A0GJ-01A-11D-A043_120318_SN590_0146_AC0KH7ACXX_s_7_rg.sorted,TCGA-A5-A0GJ-01A-11D-A043_120318_SN590_0146_AC0KH7ACXX_s_7_rg.sorted.bam,92.8,2.11,0.16,58cfa830e4b0c9d6adf6ba9b,TCGA-A5-A0GJ-01A-11D-A043_120318_SN590_0146_AC0KH7ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GJ-01A,94817E78-78F5-4556-9394-610DF65605E2,Primary Tumor,Illumina HiSeq,d5b73d0f-c14a-4a54-a8e1-14bc027cfef5,Uterus,44,48FA5B7D-E488-4743-A7CE-ACEB9945F00B,A5D63CC4-892C-4357-B8A1-2BF50CF425DC,TCGA-A5-A0GJ-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0GJ,TCGA-UCEC,NA,s5384,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b67a,58cfa82fe4b0c9d6adf6b67a,TCGA-44-6779-10A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_1_rg.sorted.filtered.,WGS,TCGA-44-6779-10A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_1_rg.sorted,TCGA-44-6779-10A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_1_rg.sorted.bam,330,1.9,0.17,58cfa82fe4b0c9d6adf6b67a,TCGA-44-6779-10A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-44-6779-10A,CBBEA9F1-396A-4BF3-B67C-2CAC3394DCEB,Blood Derived Normal,Illumina HiSeq,f0c8649c-84d2-4fca-a36b-589106e28853,Lung,50,6E64FD37-19C0-442C-A490-3BCCBEB84597,09A8A60E-F929-467D-A666-B61F784A1E74,TCGA-44-6779-10A-01D-1853-02,HG19_Broad_variant,TCGA-44-6779,TCGA-LUAD,500,s10997,Harvard Medical School,Christiana Healthcare,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa830e4b0c9d6adf6c120,58cfa830e4b0c9d6adf6c120,TCGA-BJ-A0ZG-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BJ-A0ZG-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_5_rg.sorted,TCGA-BJ-A0ZG-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_5_rg.sorted.bam,37.3,1.98,0.16,58cfa830e4b0c9d6adf6c120,TCGA-BJ-A0ZG-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0ZG-01A,A3810F36-D2B4-4A45-AD08-A4DBFB9D27AA,Primary Tumor,Illumina HiSeq,44c5a52a-3434-4e05-a510-33799f327c93,Thyroid,80,3AC025C9-FEC6-4997-8630-085750DC84E0,D030DC18-6E50-4679-8BF9-26A1DAEC8F79,TCGA-BJ-A0ZG-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZG,TCGA-THCA,NA,s12101,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa831e4b0c9d6adf6cbab,58cfa831e4b0c9d6adf6cbab,TCGA-EK-A2PL-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EK-A2PL-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_5_rg.sorted,TCGA-EK-A2PL-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_5_rg.sorted.bam,17.04,NA,0.15,58cfa831e4b0c9d6adf6cbab,TCGA-EK-A2PL-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2PL-10A,45CADCF3-EA98-4063-9255-5C18D6A5CBAB,Blood Derived Normal,Illumina HiSeq,b844ef40-47ec-47f7-a517-bb3a171bfc7f,Cervix,36,62FEC159-331A-48EE-A6C4-19DE841FF7CE,EFD4F564-9625-4D10-87CC-F9B6079260EE,TCGA-EK-A2PL-10A-01D-A18I-02,HG19_Broad_variant,TCGA-EK-A2PL,TCGA-CESC,NA,s1369,Harvard Medical School,Gynecologic Oncology Group,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6cc68,58cfa831e4b0c9d6adf6cc68,TCGA-EK-A2R8-01A-21D-A18I_140204_SN208_0508_BC2R1UACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EK-A2R8-01A-21D-A18I_140204_SN208_0508_BC2R1UACXX_s_4_rg.sorted,TCGA-EK-A2R8-01A-21D-A18I_140204_SN208_0508_BC2R1UACXX_s_4_rg.sorted.bam,58.64,NA,0.17,58cfa831e4b0c9d6adf6cc68,TCGA-EK-A2R8-01A-21D-A18I_140204_SN208_0508_BC2R1UACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2R8-01A,D4510801-8CE4-4F10-8B31-25C0A39B5135,Primary Tumor,Illumina HiSeq,d050a7c3-8fe5-472e-bc71-4dff85991e92,Cervix,48,6B8E0AF3-1632-4FED-9A37-879EA013AE24,80B2C20E-8EFB-4105-8A96-A695FCFB73CB,TCGA-EK-A2R8-01A-21D-A18I-02,HG19_Broad_variant,TCGA-EK-A2R8,TCGA-CESC,NA,s1190,Harvard Medical School,Gynecologic Oncology Group,United States,NO,T1b2,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6cffc,58cfa832e4b0c9d6adf6cffc,TCGA-G9-6329-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_2_rg.sorted.filtered.,WGS,TCGA-G9-6329-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_2_rg.sorted,TCGA-G9-6329-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_2_rg.sorted.bam,25,1.8,0.16,58cfa832e4b0c9d6adf6cffc,TCGA-G9-6329-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6329-10A,A08FD0A6-A89A-4ADB-B641-D4C1238ABB71,Blood Derived Normal,Illumina HiSeq,b3789c8a-7d5b-4bac-9ad7-4d8c002c629c,Prostate,67,07C6CFE4-E843-4E47-BB5F-AEC0EF337CEC,1EBB9324-2F1E-4AEA-9669-C29E1F251DF7,TCGA-G9-6329-10A-01D-1957-02,HG19_Broad_variant,TCGA-G9-6329,TCGA-PRAD,NA,s3448,Harvard Medical School,Roswell Park,United States,NO,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cd34,58cfa831e4b0c9d6adf6cd34,TCGA-ER-A196-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-ER-A196-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_7_rg.sorted,TCGA-ER-A196-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_7_rg.sorted.bam,53.46,NA,0.17,58cfa831e4b0c9d6adf6cd34,TCGA-ER-A196-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A196-10A,A9EB1022-FFD3-42DE-A39D-2126FC7EC0CE,Blood Derived Normal,Illumina HiSeq,b5f37fc3-4d8d-4df9-9af7-cb4b59f49dbf,Skin,64,CC5637D5-960B-46F9-BEDB-80773965D67E,46412D85-4008-45C9-A031-B8BF1A8D56CC,TCGA-ER-A196-10A-01D-A190-02,HG19_Broad_variant,TCGA-ER-A196,TCGA-SKCM,NA,s8015,Harvard Medical School,University of Pittsburgh,United States,NO,T4b,N0,Not available,Stage IIC
13722.58cfa831e4b0c9d6adf6cb4f,58cfa831e4b0c9d6adf6cb4f,TCGA-EE-A20H-10A-01D-A190_120805_SN1222_0142_AD16TGACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EE-A20H-10A-01D-A190_120805_SN1222_0142_AD16TGACXX_s_2_rg.sorted,TCGA-EE-A20H-10A-01D-A190_120805_SN1222_0142_AD16TGACXX_s_2_rg.sorted.bam,41.34,NA,0.18,58cfa831e4b0c9d6adf6cb4f,TCGA-EE-A20H-10A-01D-A190_120805_SN1222_0142_AD16TGACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A20H-10A,267B98E7-708F-458A-82D1-5FAA415B9EE7,Blood Derived Normal,Illumina HiSeq,6bf8f988-3d85-4446-9a80-aae5d73a3ca1,Skin,56,FEED8018-70BD-461B-80CF-77AEA0C0D906,E202F603-4E1E-451B-AE65-78F232D7162D,TCGA-EE-A20H-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A20H,TCGA-SKCM,5118,s7338,Harvard Medical School,University of Sydney,Australia,NO,T2,N0,Not available,Stage I
13722.58cfa831e4b0c9d6adf6cb05,58cfa831e4b0c9d6adf6cb05,TCGA-EA-A3HT-10A-01D-A245_140124_SN1440_0178_AC2PL6ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EA-A3HT-10A-01D-A245_140124_SN1440_0178_AC2PL6ACXX_s_4_rg.sorted,TCGA-EA-A3HT-10A-01D-A245_140124_SN1440_0178_AC2PL6ACXX_s_4_rg.sorted.bam,38.74,NA,0.17,58cfa831e4b0c9d6adf6cb05,TCGA-EA-A3HT-10A-01D-A245_140124_SN1440_0178_AC2PL6ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EA-A3HT-10A,3C5B2452-014B-495F-B86A-F522ED84BC3B,Blood Derived Normal,Illumina HiSeq,381a7580-473d-404d-80c8-deb66057b4fb,Cervix,68,89EF7B55-AFE7-4EAC-84E3-B0DF9ECF4B67,7D908322-4AAA-45F2-9B56-6C9214CE92D2,TCGA-EA-A3HT-10A-01D-A245-26,HG19_Broad_variant,TCGA-EA-A3HT,TCGA-CESC,NA,s1183,MD Anderson - RPPA Core Facility (Proteomics),Asterand,Russia,NO,T1b,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b942,58cfa82fe4b0c9d6adf6b942,TCGA-A5-A0GN-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-A5-A0GN-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_3_rg.sorted,TCGA-A5-A0GN-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_3_rg.sorted.bam,65.96,1.81,0.16,58cfa82fe4b0c9d6adf6b942,TCGA-A5-A0GN-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GN-01A,A2A2DBDA-D10C-49C4-86A8-61BAF6160CDA,Primary Tumor,Illumina HiSeq,7270b44f-635f-48bf-b3c4-8042b4557613,Uterus,65,F6F9C40B-1E58-47A3-B518-9694FB5FF2CF,41896FDE-677E-419C-B8B9-0171D6669A4A,TCGA-A5-A0GN-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0GN,TCGA-UCEC,NA,s4589,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d090,58cfa832e4b0c9d6adf6d090,TCGA-IG-A3Y9-10A-01D-A248_121211_SN208_0443_BC1H55ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-IG-A3Y9-10A-01D-A248_121211_SN208_0443_BC1H55ACXX_s_8_rg.sorted,TCGA-IG-A3Y9-10A-01D-A248_121211_SN208_0443_BC1H55ACXX_s_8_rg.sorted.bam,43.69,NA,0.15,58cfa832e4b0c9d6adf6d090,TCGA-IG-A3Y9-10A-01D-A248_121211_SN208_0443_BC1H55ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A3Y9-10A,4B8809A6-4AB3-4567-8623-37CE3FAA978C,Blood Derived Normal,Illumina HiSeq,dbf0257e-441e-492b-84b8-ce0f3da4665c,Esophagus,72,BD0A34F8-7DBD-422A-8DF4-489EB0E80361,2050F33A-ED4D-494C-B37F-D95DC754330B,TCGA-IG-A3Y9-10A-01D-A248-26,HG19_Broad_variant,TCGA-IG-A3Y9,TCGA-ESCA,NA,s1822,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T4,N0,Not available,Stage IIIA
13722.58cfa832e4b0c9d6adf6d116,58cfa832e4b0c9d6adf6d116,TCGA-JX-A3Q0-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_3_rg.sorted.filtered.,WGS,TCGA-JX-A3Q0-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_3_rg.sorted,TCGA-JX-A3Q0-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_3_rg.sorted.bam,42.52,NA,0.14,58cfa832e4b0c9d6adf6d116,TCGA-JX-A3Q0-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_3_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-JX-A3Q0-01A,20280122-A66A-4C83-8F25-0B9D97558DC2,Primary Tumor,Illumina HiSeq,20d5be50-f8a2-406a-9415-bc65cdff0cad,Cervix,63,04FFDFC0-A73F-47AE-9014-73870B69AD91,A7EE4E31-77DF-470B-A748-87BB4DF76FD5,TCGA-JX-A3Q0-01A-11D-A245-26,HG19_Broad_variant,TCGA-JX-A3Q0,TCGA-CESC,NA,s1218,MD Anderson - Institute for Applied Cancer Science,Washington University,United States,NO,T3,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6cac4,58cfa831e4b0c9d6adf6cac4,TCGA-E1-5303-10A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-E1-5303-10A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_4_rg.sorted,TCGA-E1-5303-10A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_4_rg.sorted.bam,24.4,1.9,0.17,58cfa831e4b0c9d6adf6cac4,TCGA-E1-5303-10A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-E1-5303-10A,44A5C3B4-62A7-407B-B492-7069E1A43A26,Blood Derived Normal,Illumina HiSeq,9d733e32-c2c8-481d-a4d1-ff87fd9a342f,Brain,38,3CE7EAD9-20C2-44B3-96F7-8425AE307CD6,4A280202-B193-4C9E-A33F-6272D77A2666,TCGA-E1-5303-10A-01D-1465-02,HG19_Broad_variant,TCGA-E1-5303,TCGA-LGG,2052,s8140,Harvard Medical School,Duke,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6c35c,58cfa831e4b0c9d6adf6c35c,TCGA-CG-4475-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CG-4475-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_8_rg.sorted,TCGA-CG-4475-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_8_rg.sorted.bam,45.9,1.9,0.15,58cfa831e4b0c9d6adf6c35c,TCGA-CG-4475-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_8_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4475-10A,CAD2ADC1-0F41-4651-9C80-AE9961E2DC8D,Blood Derived Normal,Illumina HiSeq,8e28c3d4-9556-49b7-bde1-8f7fe76e98fa,Stomach,76,5CEA6C63-C68C-41ED-B064-9941E60F64BD,0404F559-4DA5-4935-ACB5-D2F2F7730F30,TCGA-CG-4475-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4475,TCGA-STAD,NA,s14705,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Not available,Stage IIB
13722.58cfa830e4b0c9d6adf6c112,58cfa830e4b0c9d6adf6c112,TCGA-B5-A0K9-10A-02D-A101_120406_SN208_0281_AC0KDBACXX_s_2_rg.sorted.filtered.,WGS,TCGA-B5-A0K9-10A-02D-A101_120406_SN208_0281_AC0KDBACXX_s_2_rg.sorted,TCGA-B5-A0K9-10A-02D-A101_120406_SN208_0281_AC0KDBACXX_s_2_rg.sorted.bam,59.37,2.1,0.16,58cfa830e4b0c9d6adf6c112,TCGA-B5-A0K9-10A-02D-A101_120406_SN208_0281_AC0KDBACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0K9-10A,4485CC98-5D58-4EB4-8325-7D1A617B6461,Blood Derived Normal,Illumina HiSeq,285455ac-3652-45e6-9634-9b705defc33c,Uterus,88,23D730B3-A4B4-4FEC-916A-67DC5C79241F,5F225516-70A5-4A2E-8F28-B91932006218,TCGA-B5-A0K9-10A-02D-A101-02,HG19_Broad_variant,TCGA-B5-A0K9,TCGA-UCEC,NA,s4600,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c3ac,58cfa831e4b0c9d6adf6c3ac,TCGA-CG-5722-01A-21D-1598_121011_SN208_0434_AC18MYACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CG-5722-01A-21D-1598_121011_SN208_0434_AC18MYACXX_s_2_rg.sorted,TCGA-CG-5722-01A-21D-1598_121011_SN208_0434_AC18MYACXX_s_2_rg.sorted.bam,195,1.9,0.15,58cfa831e4b0c9d6adf6c3ac,TCGA-CG-5722-01A-21D-1598_121011_SN208_0434_AC18MYACXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5722-01A,F35E8FEF-F61D-4614-B73F-F7E1D0F21F52,Primary Tumor,Illumina HiSeq,05762233-5294-478d-b462-14b931579f63,Stomach,67,30D63C9D-E36A-4654-86B5-5D7A622089C2,F262DDED-846F-4DEB-8FC3-EF0DF814ECA4,TCGA-CG-5722-01A-21D-1598-02,HG19_Broad_variant,TCGA-CG-5722,TCGA-STAD,NA,s14642,Harvard Medical School,Indivumed,Germany,NO,T3,N2,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa831e4b0c9d6adf6c92a,58cfa831e4b0c9d6adf6c92a,TCGA-CN-6017-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CN-6017-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_6_rg.sorted,TCGA-CN-6017-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_6_rg.sorted.bam,384.7,1.9,0.16,58cfa831e4b0c9d6adf6c92a,TCGA-CN-6017-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-6017-10A,23C4E2EB-142B-4FCC-A974-9A248AEC3F37,Blood Derived Normal,Illumina HiSeq,553eeabf-a561-46bd-8f08-ad29986c1766,Head and Neck,55,EE520EE4-84F7-4CA2-B513-67C76368991E,088B8668-613A-4864-8C03-EA150C4E5AAE,TCGA-CN-6017-10A-01D-1681-02,HG19_Broad_variant,TCGA-CN-6017,TCGA-HNSC,NA,s16034,Harvard Medical School,University of Pittsburgh,United States,NO,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6c132,58cfa830e4b0c9d6adf6c132,TCGA-BS-A0UM-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BS-A0UM-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_3_rg.sorted,TCGA-BS-A0UM-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_3_rg.sorted.bam,20.2,1.94,0.13,58cfa830e4b0c9d6adf6c132,TCGA-BS-A0UM-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0UM-10A,A7C565FC-C711-4B63-9549-4CD74D1F57C2,Blood Derived Normal,Illumina HiSeq,e06c3a0d-7216-434e-aea1-0b79cfac3269,Uterus,64,D5EF6EF5-A2E1-49A9-BFCB-C6BB41424676,7E557D99-F492-4067-B0A4-A70485952689,TCGA-BS-A0UM-10A-01D-A101-02,HG19_Broad_variant,TCGA-BS-A0UM,TCGA-UCEC,NA,s5007,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6be6c,58cfa830e4b0c9d6adf6be6c,TCGA-BL-A13J-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BL-A13J-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_8_rg.sorted,TCGA-BL-A13J-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_8_rg.sorted.bam,57.46,1.9,0.15,58cfa830e4b0c9d6adf6be6c,TCGA-BL-A13J-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BL-A13J-01A,556FCBC8-172A-4AF1-8822-AE036E8D68E8,Primary Tumor,Illumina HiSeq,58daf5d5-0c54-4a8c-b756-35565cdc9671,Bladder,65,CF23846D-A7D2-40A9-8B51-49A27967D101,782CEFE1-C28F-40BA-93A2-66279184EEF6,TCGA-BL-A13J-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BL-A13J,TCGA-BLCA,81,s3080,Harvard Medical School,Christiana Healthcare,United States,NO,T4,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c648,58cfa831e4b0c9d6adf6c648,TCGA-CG-4466-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CG-4466-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_6_rg.sorted,TCGA-CG-4466-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_6_rg.sorted.bam,67.9,1.9,0.15,58cfa831e4b0c9d6adf6c648,TCGA-CG-4466-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_6_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4466-10A,2F1B96B2-7031-4F7D-9490-14728D320F3E,Blood Derived Normal,Illumina HiSeq,af58bea8-9aeb-47c8-946e-6b197b06ea79,Stomach,81,2775F741-265C-4B56-9D75-AF665CCBFC8A,45323803-2E2E-4A6F-B8C7-1D74C29E9C84,TCGA-CG-4466-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4466,TCGA-STAD,NA,s14761,Harvard Medical School,Indivumed,Germany,NO,T2a,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa82fe4b0c9d6adf6b8f2,58cfa82fe4b0c9d6adf6b8f2,TCGA-50-5932-01A-11D-1751_111007_SN590_0110_C003AACXX_s_6_rg.sorted.filtered.,WGS,TCGA-50-5932-01A-11D-1751_111007_SN590_0110_C003AACXX_s_6_rg.sorted,TCGA-50-5932-01A-11D-1751_111007_SN590_0110_C003AACXX_s_6_rg.sorted.bam,289.4,1.9,0.15,58cfa82fe4b0c9d6adf6b8f2,TCGA-50-5932-01A-11D-1751_111007_SN590_0110_C003AACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5932-01A,EBCBA7F2-CE13-4BAE-97CD-91A6B1DCD465,Primary Tumor,Illumina HiSeq,a1be116a-f392-49b3-97c6-b674ac8dee93,Lung,75,7ECB9621-7A1F-4876-9DFB-9B77CC4CB7B4,B9ACEF1D-8029-47AB-9830-06B2FF147CDB,TCGA-50-5932-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-5932,TCGA-LUAD,1235,s10661,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa832e4b0c9d6adf6cea8,58cfa832e4b0c9d6adf6cea8,TCGA-G2-A2EK-10A-01D-A18D_120913_SN208_0429_AC187FACXX_s_4_rg.sorted.filtered.,WGS,TCGA-G2-A2EK-10A-01D-A18D_120913_SN208_0429_AC187FACXX_s_4_rg.sorted,TCGA-G2-A2EK-10A-01D-A18D_120913_SN208_0429_AC187FACXX_s_4_rg.sorted.bam,11.06,NA,0.17,58cfa832e4b0c9d6adf6cea8,TCGA-G2-A2EK-10A-01D-A18D_120913_SN208_0429_AC187FACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-G2-A2EK-10A,5DA1CB68-C438-4DDC-999F-90AED0C4BD7A,Blood Derived Normal,Illumina HiSeq,2d89e6fb-9416-4502-9329-ae8eaa2caa9c,Bladder,57,933F10B3-E2F5-472D-8AD1-2B9EC6F4157D,94CDAD33-E2F4-4CE7-B2FF-AF1F42E95155,TCGA-G2-A2EK-10A-01D-A18D-02,HG19_Broad_variant,TCGA-G2-A2EK,TCGA-BLCA,NA,s2916,Harvard Medical School,MD Anderson,United States,NO,Not available,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa82fe4b0c9d6adf6b9c6,58cfa82fe4b0c9d6adf6b9c6,TCGA-73-4658-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_5_rg.sorted.filtered.,WGS,TCGA-73-4658-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_5_rg.sorted,TCGA-73-4658-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_5_rg.sorted.bam,150.4,1.9,0.15,58cfa82fe4b0c9d6adf6b9c6,TCGA-73-4658-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4658-01A,AFB91740-2668-46D7-BA01-BB26153AD1C7,Primary Tumor,Illumina HiSeq,9ee6d96c-98e7-4829-94dc-f41e5f078854,Lung,80,BFDE37F2-AB6F-4426-A33D-EF9D21772F02,6A3AFDA7-56BB-4120-AB92-6EDA217BC214,TCGA-73-4658-01A-01D-1751-02,HG19_Broad_variant,TCGA-73-4658,TCGA-LUAD,1600,s11130,Harvard Medical School,Roswell Park,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c936,58cfa831e4b0c9d6adf6c936,TCGA-D1-A16E-01A-22D-A12F_120523_SN1222_0109_BD12MPACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D1-A16E-01A-22D-A12F_120523_SN1222_0109_BD12MPACXX_s_4_rg.sorted,TCGA-D1-A16E-01A-22D-A12F_120523_SN1222_0109_BD12MPACXX_s_4_rg.sorted.bam,37.7,1.95,0.15,58cfa831e4b0c9d6adf6c936,TCGA-D1-A16E-01A-22D-A12F_120523_SN1222_0109_BD12MPACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A16E-01A,E70465F6-1922-4EB7-B646-8B01AD3CE77B,Primary Tumor,Illumina HiSeq,d5fd8d77-e4f4-4b13-b244-0dbbc2f74021,Uterus,73,58FC1E66-39C4-44D1-BDD3-338E0D833792,0651FC75-DFFC-4271-8832-2DB47C642804,TCGA-D1-A16E-01A-22D-A12F-02,HG19_Broad_variant,TCGA-D1-A16E,TCGA-UCEC,NA,s4439,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c748,58cfa831e4b0c9d6adf6c748,TCGA-CV-6959-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CV-6959-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_4_rg.sorted,TCGA-CV-6959-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_4_rg.sorted.bam,264.7,1.9,0.13,58cfa831e4b0c9d6adf6c748,TCGA-CV-6959-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6959-01A,EF3CE0E5-D2E8-4616-8B1A-A78C591CF235,Primary Tumor,Illumina HiSeq,ff9553cc-07a7-497f-be70-1ad5b8e09130,Head and Neck,48,07FB167A-3F61-4517-A79E-BA2042F10A3A,E1D21CB1-4329-447E-AC5B-EC31BF045495,TCGA-CV-6959-01A-11D-1911-02,HG19_Broad_variant,TCGA-CV-6959,TCGA-HNSC,256,s15903,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6cd48,58cfa831e4b0c9d6adf6cd48,TCGA-EX-A1H6-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EX-A1H6-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_8_rg.sorted,TCGA-EX-A1H6-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_8_rg.sorted.bam,16.29,NA,0.16,58cfa831e4b0c9d6adf6cd48,TCGA-EX-A1H6-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EX-A1H6-10A,1FE594D9-4240-49EE-8AFD-C7D16A377181,Blood Derived Normal,Illumina HiSeq,61682ee7-1d2b-4a08-8b35-9080798410a3,Cervix,38,E7210376-D4FB-4A0A-ACB6-6D07183C8E09,135247AD-B09B-4F45-BFDC-79A5E3F056F4,TCGA-EX-A1H6-10A-01D-A232-26,HG19_Broad_variant,TCGA-EX-A1H6,TCGA-CESC,NA,s1196,MD Anderson - Institute for Applied Cancer Science,University of North Carolina,United States,NO,T1b1,N0,Endocervical Type of Adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6c0fe,58cfa830e4b0c9d6adf6c0fe,TCGA-B5-A0K4-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-B5-A0K4-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_3_rg.sorted,TCGA-B5-A0K4-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_3_rg.sorted.bam,31.24,2.03,0.14,58cfa830e4b0c9d6adf6c0fe,TCGA-B5-A0K4-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_3_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0K4-01A,A8F38E37-978B-4435-B676-E8D4C34DA909,Primary Tumor,Illumina HiSeq,a95ec772-f010-453f-b4a3-20abf1f681e3,Uterus,51,A4AC1F6E-3411-47AE-9592-513B3D32223F,4612DB59-3A8E-4F32-968A-76BCE0D4F042,TCGA-B5-A0K4-01A-11D-A043-02,HG19_Broad_variant,TCGA-B5-A0K4,TCGA-UCEC,NA,s5389,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c83f,58cfa831e4b0c9d6adf6c83f,TCGA-D1-A177-10A-01D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D1-A177-10A-01D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_4_rg.sorted,TCGA-D1-A177-10A-01D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_4_rg.sorted.bam,21.02,1.36,0.17,58cfa831e4b0c9d6adf6c83f,TCGA-D1-A177-10A-01D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A177-10A,E8C58D8B-51D7-4599-AF79-469EE6F269DB,Blood Derived Normal,Illumina HiSeq,ab2de74e-7320-4840-9096-c45534d1108c,Uterus,70,AAD4247B-3621-4856-8A51-46D2BA4EF136,2F3DDA0F-FFD2-4847-B352-83C8708B5B2D,TCGA-D1-A177-10A-01D-A12F-02,HG19_Broad_variant,TCGA-D1-A177,TCGA-UCEC,NA,s4802,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d25c,58cfa832e4b0c9d6adf6d25c,TCGA-JX-A3PZ-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_2_rg.sorted.filtered.,WGS,TCGA-JX-A3PZ-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_2_rg.sorted,TCGA-JX-A3PZ-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_2_rg.sorted.bam,19.49,NA,0.14,58cfa832e4b0c9d6adf6d25c,TCGA-JX-A3PZ-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-JX-A3PZ-01A,3DF6ABE2-2123-4BFA-A4E4-88DF5F940C04,Primary Tumor,Illumina HiSeq,ecad03c2-29cd-48c4-8c37-7eade85970f7,Cervix,25,BD39C4C4-A4DD-4B2D-9F3C-608CA8708958,1B04D621-E036-4D1E-9D57-6CCCD0C020D8,TCGA-JX-A3PZ-01A-11D-A245-26,HG19_Broad_variant,TCGA-JX-A3PZ,TCGA-CESC,642,s1540,MD Anderson - Institute for Applied Cancer Science,Washington University,United States,NO,T1b,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c6e0,58cfa831e4b0c9d6adf6c6e0,TCGA-CG-4442-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_2_rg.sorted.filtered.,WGS,TCGA-CG-4442-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_2_rg.sorted,TCGA-CG-4442-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_2_rg.sorted.bam,57.9,1.9,0.16,58cfa831e4b0c9d6adf6c6e0,TCGA-CG-4442-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_2_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4442-10A,8FCCFF71-3710-4CB9-B8AF-61707AEBE5D8,Blood Derived Normal,Illumina HiSeq,c3e26eec-0792-4737-ad87-9d9a95fa438f,Stomach,85,85F0304A-7ED7-4715-B1B3-655DF4C87FBF,A0B6BE92-8B83-4971-B845-D3A5DAB98106,TCGA-CG-4442-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4442,TCGA-STAD,NA,s15322,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa832e4b0c9d6adf6d07c,58cfa832e4b0c9d6adf6d07c,TCGA-HC-7213-10A-01D-2111_130517_SN590_0230_AD24B4ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-HC-7213-10A-01D-2111_130517_SN590_0230_AD24B4ACXX_s_7_rg.sorted,TCGA-HC-7213-10A-01D-2111_130517_SN590_0230_AD24B4ACXX_s_7_rg.sorted.bam,187.6,NA,0.15,58cfa832e4b0c9d6adf6d07c,TCGA-HC-7213-10A-01D-2111_130517_SN590_0230_AD24B4ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7213-10A,26EEFAA1-1666-4CE1-8CF4-F6FABFF81FD2,Blood Derived Normal,Illumina HiSeq,21be48c5-46c5-48a4-ad57-a4703154b4bf,Prostate,53,FA3DB8B0-1BD6-4C58-918C-8086C383AD5C,3579FC2E-0118-4CE3-A9C2-501C10AD2623,TCGA-HC-7213-10A-01D-2111-02,HG19_Broad_variant,TCGA-HC-7213,TCGA-PRAD,NA,s3627,Harvard Medical School,International Genomics Consortium,United States,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c7fb,58cfa831e4b0c9d6adf6c7fb,TCGA-D7-6526-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-D7-6526-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_1_rg.sorted,TCGA-D7-6526-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_1_rg.sorted.bam,423.4,1.9,0.15,58cfa831e4b0c9d6adf6c7fb,TCGA-D7-6526-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6526-01A,A28E57E2-9071-4558-856A-162F7A837380,Primary Tumor,Illumina HiSeq,0a9e4a52-46b9-4c50-9dd3-9418ed5569e2,Stomach,67,DDCEA84E-3135-445C-BA0D-62F686463797,737041EA-9798-4D2E-9C0B-371F533E058F,TCGA-D7-6526-01A-11D-1798-02,HG19_Broad_variant,TCGA-D7-6526,TCGA-STAD,NA,s15251,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T3,N2,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIIA
13722.58cfa832e4b0c9d6adf6d153,58cfa832e4b0c9d6adf6d153,TCGA-FU-A3YQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_6_rg.sorted.filtered.,WGS,TCGA-FU-A3YQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_6_rg.sorted,TCGA-FU-A3YQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_6_rg.sorted.bam,36.15,NA,0.15,58cfa832e4b0c9d6adf6d153,TCGA-FU-A3YQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-FU-A3YQ-01A,6E01248B-C551-4F52-8066-CB2D26EB6394,Primary Tumor,Illumina HiSeq,104b02af-20c0-4d30-ba14-f5028b3a3ee4,Cervix,35,84A97589-63AE-4151-89F3-40F5AA9DE72E,5C95B361-B203-400F-B18A-8375849F5B84,TCGA-FU-A3YQ-01A-11D-A232-26,HG19_Broad_variant,TCGA-FU-A3YQ,TCGA-CESC,NA,s1205,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b861,58cfa82fe4b0c9d6adf6b861,TCGA-A5-A0R9-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-A5-A0R9-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_5_rg.sorted,TCGA-A5-A0R9-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_5_rg.sorted.bam,17.82,1.84,0.14,58cfa82fe4b0c9d6adf6b861,TCGA-A5-A0R9-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0R9-10A,284174FD-1320-4617-9E99-75BD75DF9BF3,Blood Derived Normal,Illumina HiSeq,7dd18801-cadc-4e38-9c58-382d556d861e,Uterus,51,A1B31C24-B03A-4305-89DE-5E1EE65405E6,53D8A79C-1D94-4E9C-A398-65E638DAE589,TCGA-A5-A0R9-10A-01D-A101-02,HG19_Broad_variant,TCGA-A5-A0R9,TCGA-UCEC,NA,s4986,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d3cd,58cfa832e4b0c9d6adf6d3cd,TCGA-L5-A43H-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_3_rg.sorted.filtered.,WGS,TCGA-L5-A43H-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_3_rg.sorted,TCGA-L5-A43H-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_3_rg.sorted.bam,36.23,NA,0.16,58cfa832e4b0c9d6adf6d3cd,TCGA-L5-A43H-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A43H-01A,06CA7FC4-4AE0-47D5-9E83-F92BA42A957B,Primary Tumor,Illumina HiSeq,f8c7d908-f915-4b1b-9947-4b6eadf4e914,Esophagus,75,C144B311-B50C-4CB1-89B3-0B056871F54B,E2B4C9E3-0346-40A8-A700-4D5DAB592085,TCGA-L5-A43H-01A-11D-A248-26,HG19_Broad_variant,TCGA-L5-A43H,TCGA-ESCA,9,s1915,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T3,N1,Not available,Stage III
13722.58cfa832e4b0c9d6adf6d51a,58cfa832e4b0c9d6adf6d51a,TCGA-L5-A4ON-11A-21D-A267_131120_SN1222_0229_AD2FDGACXX_s_8_rg.sorted.filtered.,WGS,TCGA-L5-A4ON-11A-21D-A267_131120_SN1222_0229_AD2FDGACXX_s_8_rg.sorted,TCGA-L5-A4ON-11A-21D-A267_131120_SN1222_0229_AD2FDGACXX_s_8_rg.sorted.bam,15.69,NA,0.17,58cfa832e4b0c9d6adf6d51a,TCGA-L5-A4ON-11A-21D-A267_131120_SN1222_0229_AD2FDGACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4ON-11A,CABA34F2-3877-48CA-9FBC-665C3960F574,Solid Tissue Normal,Illumina HiSeq,076123dd-cb55-4d5f-86cd-5d7360352c5b,Esophagus,65,A7E0BBB4-1A9E-4EF3-BAC9-6E674CBF133D,026BBF44-1585-415A-90EB-54C2A80AF2EF,TCGA-L5-A4ON-11A-21D-A267-26,HG19_Broad_variant,TCGA-L5-A4ON,TCGA-ESCA,558,s1847,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T1,N1,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6c32f,58cfa831e4b0c9d6adf6c32f,TCGA-CG-4474-01A-02D-1154_130815_VM001_0006_VMR0006CXX_s_3_rg.sorted.filtered.,WGS,TCGA-CG-4474-01A-02D-1154_130815_VM001_0006_VMR0006CXX_s_3_rg.sorted,TCGA-CG-4474-01A-02D-1154_130815_VM001_0006_VMR0006CXX_s_3_rg.sorted.bam,112.2,1.9,0.14,58cfa831e4b0c9d6adf6c32f,TCGA-CG-4474-01A-02D-1154_130815_VM001_0006_VMR0006CXX_s_3_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4474-01A,39DD61A8-CD17-4DF3-AE17-61E239EB00BD,Primary Tumor,Illumina HiSeq,2b986f51-b858-4e25-a6f7-cbc49e180234,Stomach,67,68D21E75-16AC-48D0-B7CA-ABFDE13DED29,A3D7BAF1-387C-4094-957E-24BD2A78ED8D,TCGA-CG-4474-01A-02D-1154-02,HG19_Broad_variant,TCGA-CG-4474,TCGA-STAD,NA,s15399,Harvard Medical School,Indivumed,Germany,NO,T4a,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IV
13722.58cfa831e4b0c9d6adf6c3fe,58cfa831e4b0c9d6adf6c3fe,TCGA-CH-5792-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CH-5792-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_3_rg.sorted,TCGA-CH-5792-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_3_rg.sorted.bam,61.7,1.9,0.17,58cfa831e4b0c9d6adf6c3fe,TCGA-CH-5792-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5792-01A,8A5F2D7F-835C-4726-B238-F82D6A7F25BD,Primary Tumor,Illumina HiSeq,1c4a46f6-fc5f-44b1-b30a-5baaa806e78b,Prostate,57,DA5F8107-7B69-45B5-8BEB-21D17B066CB4,5975F57F-2918-46C2-B59F-38FAA67A49BA,TCGA-CH-5792-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5792,TCGA-PRAD,NA,s3933,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bedb,58cfa830e4b0c9d6adf6bedb,TCGA-AP-A0LP-10A-01D-A101_120406_SN208_0281_AC0KDBACXX_s_5_rg.sorted.filtered.,WGS,TCGA-AP-A0LP-10A-01D-A101_120406_SN208_0281_AC0KDBACXX_s_5_rg.sorted,TCGA-AP-A0LP-10A-01D-A101_120406_SN208_0281_AC0KDBACXX_s_5_rg.sorted.bam,34.3,1.91,0.13,58cfa830e4b0c9d6adf6bedb,TCGA-AP-A0LP-10A-01D-A101_120406_SN208_0281_AC0KDBACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LP-10A,EFAE3940-D3CC-4988-BDB4-FA05D977AFF5,Blood Derived Normal,Illumina HiSeq,2b1e3b74-bf9f-487e-a763-3ceecfb24090,Uterus,76,67F90A95-8C23-45EE-82CD-A0F24058D35A,5A346376-940C-412D-9B0C-E4DE7CA6D733,TCGA-AP-A0LP-10A-01D-A101-02,HG19_Broad_variant,TCGA-AP-A0LP,TCGA-UCEC,NA,s4779,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d1c9,58cfa832e4b0c9d6adf6d1c9,TCGA-HM-A3JK-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_1_rg.sorted.filtered.,WGS,TCGA-HM-A3JK-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_1_rg.sorted,TCGA-HM-A3JK-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_1_rg.sorted.bam,58.55,NA,0.15,58cfa832e4b0c9d6adf6d1c9,TCGA-HM-A3JK-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-HM-A3JK-01A,7C4CD55F-750E-4941-A9F3-0632A75D6531,Primary Tumor,Illumina HiSeq,cc4a29a9-d389-4d17-b8c7-53fcc5731b22,Cervix,64,88C6E5CB-D33E-4042-BE7B-12A081ACDAFB,EDAC7C77-CA42-461B-9006-F65E3EB6B7AB,TCGA-HM-A3JK-01A-11D-A245-26,HG19_Broad_variant,TCGA-HM-A3JK,TCGA-CESC,NA,s1208,MD Anderson - Institute for Applied Cancer Science,Christiana Healthcare,United States,NO,T2b,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d35e,58cfa832e4b0c9d6adf6d35e,TCGA-L5-A43I-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-L5-A43I-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_5_rg.sorted,TCGA-L5-A43I-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_5_rg.sorted.bam,27.04,NA,0.15,58cfa832e4b0c9d6adf6d35e,TCGA-L5-A43I-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A43I-01A,22EE75E0-5D61-41F4-AACD-B4E09C70D2C3,Primary Tumor,Illumina HiSeq,deef8598-1109-476b-b3f7-ca8bd62bf710,Esophagus,77,210B53EB-2664-4E0E-A00B-A24838804726,4E5B2FFE-BCF1-485A-B507-2B332BE6DF98,TCGA-L5-A43I-01A-11D-A248-26,HG19_Broad_variant,TCGA-L5-A43I,TCGA-ESCA,556,s1836,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T3,N1,Not available,Stage IIIA
13722.58cfa831e4b0c9d6adf6cd14,58cfa831e4b0c9d6adf6cd14,TCGA-EE-A2MP-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EE-A2MP-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_1_rg.sorted,TCGA-EE-A2MP-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_1_rg.sorted.bam,40.99,NA,0.16,58cfa831e4b0c9d6adf6cd14,TCGA-EE-A2MP-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MP-06A,54782BD7-79BE-4E3C-BF99-844E7BB0E5D7,Metastatic,Illumina HiSeq,1288fe80-f90b-46ac-a3fa-ac3529fd8e8c,Skin,34,BC9F8071-37F7-44BC-8A3C-F48860C7B5DC,E3BF7C48-9944-48C6-B1A0-26B69C28A49F,TCGA-EE-A2MP-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2MP,TCGA-SKCM,NA,s7853,Harvard Medical School,University of Sydney,Australia,NO,T2,N0,Not available,Stage I
13722.58cfa831e4b0c9d6adf6c388,58cfa831e4b0c9d6adf6c388,TCGA-CG-5723-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CG-5723-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_3_rg.sorted,TCGA-CG-5723-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_3_rg.sorted.bam,224,1.9,0.14,58cfa831e4b0c9d6adf6c388,TCGA-CG-5723-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_3_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5723-01A,0F00AD32-E4BE-49D4-A02A-D233BFC913C5,Primary Tumor,Illumina HiSeq,9e55e0ac-b9dd-42dd-afe7-d6f93c1dcc88,Stomach,83,4CCD9CCB-BF50-44EB-AA55-133D8824C433,9A2DC75A-E7BE-4226-9D8C-940946F75958,TCGA-CG-5723-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5723,TCGA-STAD,NA,s14417,Harvard Medical School,Indivumed,Germany,NO,T2,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa831e4b0c9d6adf6c902,58cfa831e4b0c9d6adf6c902,TCGA-DB-5273-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DB-5273-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_1_rg.sorted,TCGA-DB-5273-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_1_rg.sorted.bam,64,1.9,0.15,58cfa831e4b0c9d6adf6c902,TCGA-DB-5273-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DB-5273-01A,AE2DB022-EB4F-4B65-89B6-9FD4439DDEEF,Primary Tumor,Illumina HiSeq,844bcbca-fe48-4dee-be69-4cef2ac59e27,Brain,33,4BA48810-3915-4567-9D35-615DF00006E4,6F0ACC8E-2A73-4B08-AAA3-A29EBE61E6B7,TCGA-DB-5273-01A-01D-1465-02,HG19_Broad_variant,TCGA-DB-5273,TCGA-LGG,NA,s8751,Harvard Medical School,Mayo Clinic - Rochester,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6ca33,58cfa831e4b0c9d6adf6ca33,TCGA-DK-A2I2-10A-01D-A17R_120927_SN208_0433_BD1D5JACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DK-A2I2-10A-01D-A17R_120927_SN208_0433_BD1D5JACXX_s_4_rg.sorted,TCGA-DK-A2I2-10A-01D-A17R_120927_SN208_0433_BD1D5JACXX_s_4_rg.sorted.bam,15.28,NA,0.16,58cfa831e4b0c9d6adf6ca33,TCGA-DK-A2I2-10A-01D-A17R_120927_SN208_0433_BD1D5JACXX_s_4_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A2I2-10A,234086DD-5A74-4FF1-94AB-BAD43EE69D5C,Blood Derived Normal,Illumina HiSeq,e257ae8b-2d82-4b7d-b7a2-976b611b16b2,Bladder,63,A94F8AE7-CE64-4BB3-9A15-1E65E273A4DA,A709AC1F-F30A-4DEC-9990-F31841CBB3BD,TCGA-DK-A2I2-10A-01D-A17R-02,HG19_Broad_variant,TCGA-DK-A2I2,TCGA-BLCA,237,s3101,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N3,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa830e4b0c9d6adf6c054,58cfa830e4b0c9d6adf6c054,TCGA-B5-A0K4-10A-01D-A043_120504_SN590_0156_BC0H68ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-B5-A0K4-10A-01D-A043_120504_SN590_0156_BC0H68ACXX_s_4_rg.sorted,TCGA-B5-A0K4-10A-01D-A043_120504_SN590_0156_BC0H68ACXX_s_4_rg.sorted.bam,29.97,2.03,0.16,58cfa830e4b0c9d6adf6c054,TCGA-B5-A0K4-10A-01D-A043_120504_SN590_0156_BC0H68ACXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0K4-10A,A8F38E37-978B-4435-B676-E8D4C34DA909,Blood Derived Normal,Illumina HiSeq,36d00246-213f-4c95-a5a4-f558597a08ba,Uterus,51,94FDE18C-1E3B-46CA-88F4-E41566384633,569A4D40-7177-4D9F-BE01-EC38E2277D5C,TCGA-B5-A0K4-10A-01D-A043-02,HG19_Broad_variant,TCGA-B5-A0K4,TCGA-UCEC,NA,s4599,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6cfc4,58cfa832e4b0c9d6adf6cfc4,TCGA-FU-A3TQ-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FU-A3TQ-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_2_rg.sorted,TCGA-FU-A3TQ-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_2_rg.sorted.bam,67.6,NA,0.17,58cfa832e4b0c9d6adf6cfc4,TCGA-FU-A3TQ-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-FU-A3TQ-10A,7218AA6F-3345-484F-A329-A3B6169A67C7,Blood Derived Normal,Illumina HiSeq,ea233e9d-f242-4136-9f61-e20710d8c141,Cervix,55,B76ED8FA-2F4E-489F-AAF7-A69CC535C888,D4E0FFAC-F931-49AE-B959-F40F5E92F290,TCGA-FU-A3TQ-10A-01D-A232-26,HG19_Broad_variant,TCGA-FU-A3TQ,TCGA-CESC,NA,s1370,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T2b,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d545,58cfa832e4b0c9d6adf6d545,TCGA-L5-A43E-01A-11D-A248_130115_SN590_0207_AC1H8PACXX_s_1_rg.sorted.filtered.,WGS,TCGA-L5-A43E-01A-11D-A248_130115_SN590_0207_AC1H8PACXX_s_1_rg.sorted,TCGA-L5-A43E-01A-11D-A248_130115_SN590_0207_AC1H8PACXX_s_1_rg.sorted.bam,40.6,NA,0.15,58cfa832e4b0c9d6adf6d545,TCGA-L5-A43E-01A-11D-A248_130115_SN590_0207_AC1H8PACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A43E-01A,6969FE5A-5993-48E5-95C5-C5C7D3D08205,Primary Tumor,Illumina HiSeq,70d7fe7a-b9ff-4651-94bd-cc39c64b3657,Esophagus,74,5C8F603A-B8D3-407C-8E74-559C5F8C4D0E,2BDCF492-4741-430F-B1C3-ED029AD05FD6,TCGA-L5-A43E-01A-11D-A248-26,HG19_Broad_variant,TCGA-L5-A43E,TCGA-ESCA,NA,s1916,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T1,N0,Not available,Stage I
13722.58cfa831e4b0c9d6adf6c574,58cfa831e4b0c9d6adf6c574,TCGA-CN-4738-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CN-4738-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_2_rg.sorted,TCGA-CN-4738-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_2_rg.sorted.bam,52.4,1.9,0.15,58cfa831e4b0c9d6adf6c574,TCGA-CN-4738-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4738-10A,97640EF0-0259-4244-95BA-48D28C60B372,Blood Derived Normal,Illumina HiSeq,6420a19a-13dc-4a15-9792-d6c02672c4c8,Head and Neck,53,51622170-A903-43CB-BC38-4D40C7EA170F,0487F393-1CF0-4CB4-864F-FA2C895E2E07,TCGA-CN-4738-10A-01D-1509-02,HG19_Broad_variant,TCGA-CN-4738,TCGA-HNSC,436,s16182,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82fe4b0c9d6adf6b885,58cfa82fe4b0c9d6adf6b885,TCGA-A5-A0GX-10A-01D-A043_120327_SN590_0148_BC0LM8ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-A5-A0GX-10A-01D-A043_120327_SN590_0148_BC0LM8ACXX_s_8_rg.sorted,TCGA-A5-A0GX-10A-01D-A043_120327_SN590_0148_BC0LM8ACXX_s_8_rg.sorted.bam,16.78,2.02,0.17,58cfa82fe4b0c9d6adf6b885,TCGA-A5-A0GX-10A-01D-A043_120327_SN590_0148_BC0LM8ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GX-10A,553F0CCD-4E6F-4AE2-9B39-97529EB3D826,Blood Derived Normal,Illumina HiSeq,70c8aa33-5105-415c-b6a3-a247449de2dc,Uterus,53,FF637ADE-4B5A-4A0A-9712-4FF2FC5E5B9D,351BBF18-3B64-4A6D-B8CD-D7C3B97D0539,TCGA-A5-A0GX-10A-01D-A043-02,HG19_Broad_variant,TCGA-A5-A0GX,TCGA-UCEC,NA,s5196,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6ce02,58cfa832e4b0c9d6adf6ce02,TCGA-EJ-5524-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EJ-5524-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_7_rg.sorted,TCGA-EJ-5524-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_7_rg.sorted.bam,248.7,1.9,0.14,58cfa832e4b0c9d6adf6ce02,TCGA-EJ-5524-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5524-01A,4048C139-1329-4E6A-8D2F-C0AA104A68EE,Primary Tumor,Illumina HiSeq,bc7b862d-c88b-41f2-9061-6c4895d6b5be,Prostate,57,C197A81D-2AA5-4285-88E3-761798E2C190,4B173FC3-DBE0-47AA-8ACC-D36466B5522D,TCGA-EJ-5524-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5524,TCGA-PRAD,NA,s3435,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c91b,58cfa831e4b0c9d6adf6c91b,TCGA-DK-A2I1-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DK-A2I1-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_1_rg.sorted,TCGA-DK-A2I1-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_1_rg.sorted.bam,37.09,NA,0.15,58cfa831e4b0c9d6adf6c91b,TCGA-DK-A2I1-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A2I1-01A,036B9681-AB58-4734-A8FD-E0D5D078BF5A,Primary Tumor,Illumina HiSeq,724308ea-3fa9-4762-9800-445a044e94f2,Bladder,73,F9BD70B2-6CDE-48E5-9F0D-55D86CCFEBA8,010259EE-2667-4B8E-BB20-0F75F53A64BA,TCGA-DK-A2I1-01A-11D-A17R-02,HG19_Broad_variant,TCGA-DK-A2I1,TCGA-BLCA,NA,s2704,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c34c,58cfa831e4b0c9d6adf6c34c,TCGA-CG-4476-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_8_rg.sorted.filtered.,WGS,TCGA-CG-4476-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_8_rg.sorted,TCGA-CG-4476-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_8_rg.sorted.bam,67.9,1.9,0.16,58cfa831e4b0c9d6adf6c34c,TCGA-CG-4476-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_8_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4476-10A,442D7415-D095-4962-8296-A14390BAD40A,Blood Derived Normal,Illumina HiSeq,a6ccc4b9-9b2d-4960-900b-4e637c691eee,Stomach,69,15D8F5B3-63C4-400A-83C3-49B0A68CA1EF,E6AEDF0B-5818-444A-A4F0-D374F531BDB5,TCGA-CG-4476-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4476,TCGA-STAD,NA,s14829,Harvard Medical School,Indivumed,Germany,NO,T4b,N3a,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIC
13722.58cfa832e4b0c9d6adf6d06e,58cfa832e4b0c9d6adf6d06e,TCGA-IG-A3I8-11A-11D-A248_130115_SN590_0207_AC1H8PACXX_s_3_rg.sorted.filtered.,WGS,TCGA-IG-A3I8-11A-11D-A248_130115_SN590_0207_AC1H8PACXX_s_3_rg.sorted,TCGA-IG-A3I8-11A-11D-A248_130115_SN590_0207_AC1H8PACXX_s_3_rg.sorted.bam,9.09,NA,0.16,58cfa832e4b0c9d6adf6d06e,TCGA-IG-A3I8-11A-11D-A248_130115_SN590_0207_AC1H8PACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A3I8-11A,7BF3F18B-A013-48D2-A743-26A57FDBE4C4,Solid Tissue Normal,Illumina HiSeq,a07143e4-7233-41d7-ab3a-1cde065914f8,Esophagus,51,E843C89C-0AC4-4F98-A7BF-2D354CDD3A33,CE4B8CDA-D1C8-4653-ADBC-1E450281E3A6,TCGA-IG-A3I8-11A-11D-A248-26,HG19_Broad_variant,TCGA-IG-A3I8,TCGA-ESCA,NA,s1727,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T3,N0,Not available,Stage IIA
13722.58cfa830e4b0c9d6adf6be7a,58cfa830e4b0c9d6adf6be7a,TCGA-BJ-A190-10A-01D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BJ-A190-10A-01D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_8_rg.sorted,TCGA-BJ-A190-10A-01D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_8_rg.sorted.bam,60.56,1.93,0.16,58cfa830e4b0c9d6adf6be7a,TCGA-BJ-A190-10A-01D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A190-10A,04FFF86A-B6F5-4900-9E37-C1F0B881B160,Blood Derived Normal,Illumina HiSeq,e22bc87d-3dff-4873-8313-a7893de7d0c6,Thyroid,55,953F9755-A3DA-446C-980F-1679C19138EC,58A913F6-CD46-45AB-83EF-DE29953A07B3,TCGA-BJ-A190-10A-01D-A13U-02,HG19_Broad_variant,TCGA-BJ-A190,TCGA-THCA,NA,s12236,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage II
13722.58cfa831e4b0c9d6adf6cb4b,58cfa831e4b0c9d6adf6cb4b,TCGA-EE-A2A6-06A-11D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EE-A2A6-06A-11D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_1_rg.sorted,TCGA-EE-A2A6-06A-11D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_1_rg.sorted.bam,65.73,NA,0.16,58cfa831e4b0c9d6adf6cb4b,TCGA-EE-A2A6-06A-11D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2A6-06A,CDCF4D91-98A1-4A65-98DD-C6FC80805A0C,Metastatic,Illumina HiSeq,6d7d5e8e-5581-42f1-9c7f-72f105da496d,Skin,43,5BB8D694-E4C5-4B02-91D6-B152DCDBA345,3C47A989-E13A-436B-8F57-783B8628D6C9,TCGA-EE-A2A6-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2A6,TCGA-SKCM,NA,s7680,Harvard Medical School,University of Sydney,Australia,NO,T1a,N0,Not available,Stage IA
13722.58cfa830e4b0c9d6adf6c12e,58cfa830e4b0c9d6adf6c12e,TCGA-BS-A0UM-01A-11D-A101_120622_SN1120_0155_AC0WVLACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BS-A0UM-01A-11D-A101_120622_SN1120_0155_AC0WVLACXX_s_1_rg.sorted,TCGA-BS-A0UM-01A-11D-A101_120622_SN1120_0155_AC0WVLACXX_s_1_rg.sorted.bam,107.99,2,0.17,58cfa830e4b0c9d6adf6c12e,TCGA-BS-A0UM-01A-11D-A101_120622_SN1120_0155_AC0WVLACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0UM-01A,A7C565FC-C711-4B63-9549-4CD74D1F57C2,Primary Tumor,Illumina HiSeq,942f9e1e-4e57-4325-a7d0-0a464cda140a,Uterus,64,6F70F18E-5C53-4F1F-A63D-62BD27039B8D,6CD1B997-3123-4934-A06C-14A5CF1BEBFC,TCGA-BS-A0UM-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0UM,TCGA-UCEC,NA,s5009,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d12c,58cfa832e4b0c9d6adf6d12c,TCGA-G2-A2EK-01A-22D-A18D_120913_SN208_0429_AC187FACXX_s_3_rg.sorted.filtered.,WGS,TCGA-G2-A2EK-01A-22D-A18D_120913_SN208_0429_AC187FACXX_s_3_rg.sorted,TCGA-G2-A2EK-01A-22D-A18D_120913_SN208_0429_AC187FACXX_s_3_rg.sorted.bam,16.85,NA,0.18,58cfa832e4b0c9d6adf6d12c,TCGA-G2-A2EK-01A-22D-A18D_120913_SN208_0429_AC187FACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-G2-A2EK-01A,5DA1CB68-C438-4DDC-999F-90AED0C4BD7A,Primary Tumor,Illumina HiSeq,f98c8702-90e5-4e7a-ad12-d11a9af57bf5,Bladder,57,FF1691F2-DF11-4068-8D8D-A778F384EC60,8A75CF19-7645-489D-AAEC-5D9AD293C4B1,TCGA-G2-A2EK-01A-22D-A18D-02,HG19_Broad_variant,TCGA-G2-A2EK,TCGA-BLCA,NA,s2725,Harvard Medical School,MD Anderson,United States,NO,Not available,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa832e4b0c9d6adf6d20c,58cfa832e4b0c9d6adf6d20c,TCGA-HC-7233-10A-01D-2111_130517_SN590_0231_BC24V6ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-HC-7233-10A-01D-2111_130517_SN590_0231_BC24V6ACXX_s_7_rg.sorted,TCGA-HC-7233-10A-01D-2111_130517_SN590_0231_BC24V6ACXX_s_7_rg.sorted.bam,326.6,NA,0.15,58cfa832e4b0c9d6adf6d20c,TCGA-HC-7233-10A-01D-2111_130517_SN590_0231_BC24V6ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,Not available,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7233-10A,E2B33861-2247-413F-B2E5-9BE3B604666C,Blood Derived Normal,Illumina HiSeq,5e685d94-c8fe-4fd0-945f-268e1a8d4d77,Prostate,73,E2E7CA1B-2EB0-4DCB-8887-CC9D4F1D9EC1,A1FA2146-4996-4D78-9BFC-B31F884ABD6D,TCGA-HC-7233-10A-01D-2111-02,HG19_Broad_variant,TCGA-HC-7233,TCGA-PRAD,NA,s3631,Harvard Medical School,International Genomics Consortium,Yemen,NO,T2a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d2ce,58cfa832e4b0c9d6adf6d2ce,TCGA-HT-7475-10A-01D-2022_130913_SN1440_0167_AC2A6PACXX_s_8_rg.sorted.filtered.,WGS,TCGA-HT-7475-10A-01D-2022_130913_SN1440_0167_AC2A6PACXX_s_8_rg.sorted,TCGA-HT-7475-10A-01D-2022_130913_SN1440_0167_AC2A6PACXX_s_8_rg.sorted.bam,125,NA,0.16,58cfa832e4b0c9d6adf6d2ce,TCGA-HT-7475-10A-01D-2022_130913_SN1440_0167_AC2A6PACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7475-10A,41456932-436E-4CDB-BFE8-97D089656786,Blood Derived Normal,Illumina HiSeq,688c23ec-5c4c-438c-9553-132c7c3da53b,Brain,67,ACF7770E-26CF-47C0-A0B5-B16E26FC4F13,CCEAE3AB-084B-4EE9-A98D-0DFB6A8C536F,TCGA-HT-7475-10A-01D-2022-02,HG19_Broad_variant,TCGA-HT-7475,TCGA-LGG,NA,s8760,Harvard Medical School,Case Western - St Joes,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa832e4b0c9d6adf6cf74,58cfa832e4b0c9d6adf6cf74,TCGA-G9-6499-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_3_rg.sorted.filtered.,WGS,TCGA-G9-6499-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_3_rg.sorted,TCGA-G9-6499-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_3_rg.sorted.bam,533,1.8,0.15,58cfa832e4b0c9d6adf6cf74,TCGA-G9-6499-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6499-10A,ACD5CEEF-C5CF-4E95-9394-C50FDBC70C8D,Blood Derived Normal,Illumina HiSeq,03cd9985-d047-464a-946a-1992ac4c8c1c,Prostate,66,F10976A2-68E6-4E06-8549-19EB0183E07C,AB941C2B-2FAB-45D6-99A8-551750EE30CA,TCGA-G9-6499-10A-01D-1957-02,HG19_Broad_variant,TCGA-G9-6499,TCGA-PRAD,NA,s3621,Harvard Medical School,Roswell Park,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c90d,58cfa831e4b0c9d6adf6c90d,TCGA-DK-A1A7-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DK-A1A7-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_2_rg.sorted,TCGA-DK-A1A7-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_2_rg.sorted.bam,64.01,1.91,0.17,58cfa831e4b0c9d6adf6c90d,TCGA-DK-A1A7-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A7-10A,3ED614E7-F356-4D87-985B-D3BBBAE3BB40,Blood Derived Normal,Illumina HiSeq,28afea94-fe9b-4212-8f6a-5b75af1905dd,Bladder,67,7C9BD4C3-A3EF-495E-B37C-5CD329D16A18,8781CB17-9E67-45BC-9B5E-2B9B41C297C7,TCGA-DK-A1A7-10A-01D-A13U-02,HG19_Broad_variant,TCGA-DK-A1A7,TCGA-BLCA,NA,s3106,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6d212,58cfa832e4b0c9d6adf6d212,TCGA-FS-A1ZA-10A-01D-A190_120712_SN1222_0124_AC11GPACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FS-A1ZA-10A-01D-A190_120712_SN1222_0124_AC11GPACXX_s_2_rg.sorted,TCGA-FS-A1ZA-10A-01D-A190_120712_SN1222_0124_AC11GPACXX_s_2_rg.sorted.bam,53.21,NA,0.17,58cfa832e4b0c9d6adf6d212,TCGA-FS-A1ZA-10A-01D-A190_120712_SN1222_0124_AC11GPACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZA-10A,177B515E-BCB9-4A08-9B38-3CCDEC0E293F,Blood Derived Normal,Illumina HiSeq,f44a5b70-d708-4509-a3f7-1bedc687a10a,Skin,45,02BF0806-A097-4024-A79C-16F7FD969CF7,F4D999FE-96FE-43F7-BC5D-C39F78938717,TCGA-FS-A1ZA-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZA,TCGA-SKCM,843,s8025,Harvard Medical School,Essen,Germany,NO,T4b,N2c,Not available,Stage IIIB
13722.58cfa832e4b0c9d6adf6cf07,58cfa832e4b0c9d6adf6cf07,TCGA-HC-7079-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_8_rg.sorted.filtered.,WGS,TCGA-HC-7079-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_8_rg.sorted,TCGA-HC-7079-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_8_rg.sorted.bam,133,NA,0.15,58cfa832e4b0c9d6adf6cf07,TCGA-HC-7079-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7079-01A,10FBE481-F111-4F88-AE45-4D67CB265567,Primary Tumor,Illumina HiSeq,5debd428-e42f-459c-8945-f3e0a3053b9e,Prostate,51,190EF71A-5B5D-4009-B707-68F10147CB65,3935531A-0F99-4617-A5B6-6774E74CEE5E,TCGA-HC-7079-01A-11D-1957-02,HG19_Broad_variant,TCGA-HC-7079,TCGA-PRAD,NA,s3624,Harvard Medical School,International Genomics Consortium,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6ccca,58cfa831e4b0c9d6adf6ccca,TCGA-EJ-5497-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EJ-5497-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_6_rg.sorted,TCGA-EJ-5497-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_6_rg.sorted.bam,1203.4,1.9,0.16,58cfa831e4b0c9d6adf6ccca,TCGA-EJ-5497-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5497-10A,DEE02265-D8DD-4379-AE08-72D72B03A570,Blood Derived Normal,Illumina HiSeq,e9e5af5e-fd0b-4048-9b62-94b0e5e932b8,Prostate,47,52A73803-24FD-4723-ADA2-73010373F825,395FCF15-E902-43EF-83CB-3F46C7CA0F19,TCGA-EJ-5497-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5497,TCGA-PRAD,NA,s3606,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c908,58cfa831e4b0c9d6adf6c908,TCGA-DK-A1AA-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DK-A1AA-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_4_rg.sorted,TCGA-DK-A1AA-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_4_rg.sorted.bam,46.88,1.88,0.15,58cfa831e4b0c9d6adf6c908,TCGA-DK-A1AA-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AA-10A,56D8A1B8-1268-4362-A7F1-77B76FBF1B59,Blood Derived Normal,Illumina HiSeq,c6b09f3f-3fe9-4d73-a1d9-c6ce0084ac1e,Bladder,57,C976B658-9A59-4205-93FF-E1AAD1995C49,EB9F2A7C-67B3-4B46-9196-6596C8C5832B,TCGA-DK-A1AA-10A-01D-A13U-02,HG19_Broad_variant,TCGA-DK-A1AA,TCGA-BLCA,NA,s3283,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c5a8,58cfa831e4b0c9d6adf6c5a8,TCGA-CN-4731-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CN-4731-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_8_rg.sorted,TCGA-CN-4731-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_8_rg.sorted.bam,550.4,1.9,0.15,58cfa831e4b0c9d6adf6c5a8,TCGA-CN-4731-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4731-10A,50E25A4B-2EB2-4770-9A2D-8922A1E0AB56,Blood Derived Normal,Illumina HiSeq,bb50f6f4-9a32-49a6-a81f-dca3c16699cd,Head and Neck,63,C01EE9F4-05A4-438A-BA60-0F5A92864398,C54FB259-8BCF-495A-B96B-40266CAD460F,TCGA-CN-4731-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4731,TCGA-HNSC,NA,s15756,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6c193,58cfa830e4b0c9d6adf6c193,TCGA-BA-5555-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BA-5555-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_5_rg.sorted,TCGA-BA-5555-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_5_rg.sorted.bam,64.4,1.9,0.14,58cfa830e4b0c9d6adf6c193,TCGA-BA-5555-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_5_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5555-10A,8970F713-4A7A-4125-892C-6A34139371D8,Blood Derived Normal,Illumina HiSeq,cb082daa-fb68-4836-bd36-abeed40b581c,Head and Neck,54,99CA3C12-0D63-428F-8B1B-03E4A3E8E233,8837A50C-34E3-471D-89FE-D9444255804B,TCGA-BA-5555-10A-01D-1509-02,HG19_Broad_variant,TCGA-BA-5555,TCGA-HNSC,NA,s16317,Harvard Medical School,UNC,None,NO,T3,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c32b,58cfa831e4b0c9d6adf6c32b,TCGA-CG-4474-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CG-4474-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_2_rg.sorted,TCGA-CG-4474-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_2_rg.sorted.bam,15.9,1.8,0.15,58cfa831e4b0c9d6adf6c32b,TCGA-CG-4474-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4474-10A,39DD61A8-CD17-4DF3-AE17-61E239EB00BD,Blood Derived Normal,Illumina HiSeq,a149db78-b4d7-497e-a6a0-de097c1710fc,Stomach,67,A546EC24-E8CE-4B04-B25F-A230A5EA1067,90FBAFC6-E6C2-40D3-A0A3-D1ACD2D19E64,TCGA-CG-4474-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4474,TCGA-STAD,NA,s15128,Harvard Medical School,Indivumed,Germany,NO,T4a,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IV
13722.58cfa832e4b0c9d6adf6d06c,58cfa832e4b0c9d6adf6d06c,TCGA-HC-7211-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-HC-7211-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_2_rg.sorted,TCGA-HC-7211-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_2_rg.sorted.bam,286.3,NA,0.14,58cfa832e4b0c9d6adf6d06c,TCGA-HC-7211-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7211-01A,EC3870C9-4930-4AF7-B2EB-1E16C9EC9F14,Primary Tumor,Illumina HiSeq,c6d8e1f6-600a-4387-a51a-8812fee4f285,Prostate,62,79BF8C2C-470E-4BE8-8144-9C0B366ECADD,226F7F0E-AC30-4F20-87A2-EB8128402BE4,TCGA-HC-7211-01A-11D-2111-02,HG19_Broad_variant,TCGA-HC-7211,TCGA-PRAD,NA,s3622,Harvard Medical School,International Genomics Consortium,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c8a6,58cfa831e4b0c9d6adf6c8a6,TCGA-D7-6519-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_5_rg.sorted.filtered.,WGS,TCGA-D7-6519-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_5_rg.sorted,TCGA-D7-6519-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_5_rg.sorted.bam,266.4,1.9,0.14,58cfa831e4b0c9d6adf6c8a6,TCGA-D7-6519-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6519-01A,E37CAE9E-0656-4B89-B326-739A5CC859E0,Primary Tumor,Illumina HiSeq,66b2b99b-ac75-4068-9d05-34e6dbe9721d,Stomach,64,FA7426E1-FCFB-4B08-AD50-1D9E903A81FB,D7D0FD1C-F540-4BE1-A10B-160F59970FFF,TCGA-D7-6519-01A-11D-1798-02,HG19_Broad_variant,TCGA-D7-6519,TCGA-STAD,NA,s15249,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N1,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIB
13722.58cfa831e4b0c9d6adf6ccf8,58cfa831e4b0c9d6adf6ccf8,TCGA-FD-A3SP-01A-31D-A233_120830_SN208_0424_BD1DKLACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FD-A3SP-01A-31D-A233_120830_SN208_0424_BD1DKLACXX_s_3_rg.sorted,TCGA-FD-A3SP-01A-31D-A233_120830_SN208_0424_BD1DKLACXX_s_3_rg.sorted.bam,26.79,NA,0.15,58cfa831e4b0c9d6adf6ccf8,TCGA-FD-A3SP-01A-31D-A233_120830_SN208_0424_BD1DKLACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3SP-01A,5F99DCFF-D809-4C87-8024-C9B30BD565E9,Primary Tumor,Illumina HiSeq,2da38f98-8b94-404e-99e7-7a8d58aa25c1,Bladder,60,3592A9C5-124E-428F-B1F9-40429C591429,9BE9B27C-A33C-450E-806D-7C791472DAE6,TCGA-FD-A3SP-01A-31D-A233-26,HG19_Broad_variant,TCGA-FD-A3SP,TCGA-BLCA,NA,s3112,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c910,58cfa831e4b0c9d6adf6c910,TCGA-DJ-A13L-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DJ-A13L-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_7_rg.sorted,TCGA-DJ-A13L-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_7_rg.sorted.bam,20.69,NA,0.17,58cfa831e4b0c9d6adf6c910,TCGA-DJ-A13L-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13L-10A,C7A2F394-3E3F-4C90-9F1E-F2BE3E5B0D6B,Blood Derived Normal,Illumina HiSeq,09cd97bb-435c-4d68-bd00-34e98de49b0d,Thyroid,85,1985D930-DCB1-45FA-A706-559F7B77009E,FF8F39F9-2F9A-4C2F-86C5-F3EA1EFF1E98,TCGA-DJ-A13L-10A-01D-A221-26,HG19_Broad_variant,TCGA-DJ-A13L,TCGA-THCA,NA,s12749,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage I
13722.58cfa831e4b0c9d6adf6c8a2,58cfa831e4b0c9d6adf6c8a2,TCGA-DQ-5631-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DQ-5631-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_2_rg.sorted,TCGA-DQ-5631-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_2_rg.sorted.bam,207.7,1.9,0.14,58cfa831e4b0c9d6adf6c8a2,TCGA-DQ-5631-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-DQ-5631-01A,10B3F56A-E61E-486B-8D3C-176668D5DC34,Primary Tumor,Illumina HiSeq,9aae2925-69ec-44f9-bc1d-bfefd16ce242,Head and Neck,52,2E4AA773-6094-46BD-A97F-9694E80C71CF,5B9E894B-444B-4DCF-9E6C-C1F398A52A81,TCGA-DQ-5631-01A-01D-1868-02,HG19_Broad_variant,TCGA-DQ-5631,TCGA-HNSC,548,s15916,Harvard Medical School,University of Michigan,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6c10e,58cfa830e4b0c9d6adf6c10e,TCGA-BS-A0TI-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BS-A0TI-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_5_rg.sorted,TCGA-BS-A0TI-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_5_rg.sorted.bam,6.8,2,0.17,58cfa830e4b0c9d6adf6c10e,TCGA-BS-A0TI-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TI-10A,DF857BC6-FD6A-4713-BEF9-6EE1301E5FB1,Blood Derived Normal,Illumina HiSeq,6c79babf-5d05-4b25-be49-7ca0b6cd759a,Uterus,64,F4052639-340A-488B-810A-8403FC796000,3CB294E3-4240-49DE-BA0E-8F802CF741CF,TCGA-BS-A0TI-10A-01D-A101-02,HG19_Broad_variant,TCGA-BS-A0TI,TCGA-UCEC,NA,s4605,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6c1f0,58cfa830e4b0c9d6adf6c1f0,TCGA-BG-A18A-10A-01D-A12F_120626_SN590_0163_AC0VU5ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BG-A18A-10A-01D-A12F_120626_SN590_0163_AC0VU5ACXX_s_8_rg.sorted,TCGA-BG-A18A-10A-01D-A12F_120626_SN590_0163_AC0VU5ACXX_s_8_rg.sorted.bam,43.15,1.98,0.17,58cfa830e4b0c9d6adf6c1f0,TCGA-BG-A18A-10A-01D-A12F_120626_SN590_0163_AC0VU5ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A18A-10A,FEB3E930-3638-44B4-AC0F-A5DCB01FED76,Blood Derived Normal,Illumina HiSeq,dd3a2d63-837e-4868-bd5b-558c9555fa7b,Uterus,74,4AA1EED0-0890-4FD8-9367-07DBCBC4BF11,50671901-C77B-4E88-8A99-5F1CF123F00C,TCGA-BG-A18A-10A-01D-A12F-02,HG19_Broad_variant,TCGA-BG-A18A,TCGA-UCEC,NA,s4251,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c3dd,58cfa831e4b0c9d6adf6c3dd,TCGA-CH-5744-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CH-5744-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_5_rg.sorted,TCGA-CH-5744-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_5_rg.sorted.bam,249.7,1.9,0.15,58cfa831e4b0c9d6adf6c3dd,TCGA-CH-5744-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5744-01A,4E76DE8E-CB0D-4B83-8AB4-53BC67A7A9D3,Primary Tumor,Illumina HiSeq,b48809ce-93ac-45d2-b127-bf6ee8bd6870,Prostate,64,DCCEAF54-0BCE-4650-9980-9843ABCE0C41,B3198EFA-5613-4B16-BA05-4F0AACCCC00F,TCGA-CH-5744-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5744,TCGA-PRAD,NA,s3771,Harvard Medical School,Indivumed,Germany,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c440,58cfa831e4b0c9d6adf6c440,TCGA-CH-5789-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CH-5789-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_5_rg.sorted,TCGA-CH-5789-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_5_rg.sorted.bam,148.7,1.9,0.15,58cfa831e4b0c9d6adf6c440,TCGA-CH-5789-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5789-01A,BE5411DC-3CAA-4B25-9B94-CE463E8E52B4,Primary Tumor,Illumina HiSeq,fc8da645-2fde-4ef8-9ee7-8b8101580793,Prostate,61,3C42EB4B-DB63-4F81-8D28-A439E932C716,1D569000-EA8E-4D54-A581-AEE36E66688E,TCGA-CH-5789-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5789,TCGA-PRAD,NA,s3779,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c298,58cfa830e4b0c9d6adf6c298,TCGA-BH-A0GY-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BH-A0GY-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_7_rg.sorted,TCGA-BH-A0GY-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_7_rg.sorted.bam,48.65,2.08,0.16,58cfa830e4b0c9d6adf6c298,TCGA-BH-A0GY-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0GY-01A,7D9D3522-EC3B-4EFE-8C8E-C0E675276EF5,Primary Tumor,Illumina HiSeq,bcac7e1b-ddeb-43d6-ba44-db40336bf564,Breast,67,A7E71EAC-1768-4FC2-8EBA-1576D22E0F43,F5C72179-9BDA-4BC6-B006-93EB616804BC,TCGA-BH-A0GY-01A-11D-A060-02,HG19_Broad_variant,TCGA-BH-A0GY,TCGA-BRCA,NA,s6771,Harvard Medical School,University of Pittsburgh,None,NO,T2,N1,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82fe4b0c9d6adf6b8ec,58cfa82fe4b0c9d6adf6b8ec,TCGA-50-5049-10A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_4_rg.sorted.filtered.,WGS,TCGA-50-5049-10A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_4_rg.sorted,TCGA-50-5049-10A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_4_rg.sorted.bam,96.4,1.9,0.15,58cfa82fe4b0c9d6adf6b8ec,TCGA-50-5049-10A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5049-10A,9944F46F-9FA8-4E2C-A806-776BEC7F8803,Blood Derived Normal,Illumina HiSeq,3a6b8979-927a-418d-971c-e268a67a00c1,Lung,70,507A2EAF-BCE2-48EE-8D87-7DCE6D49879F,234C1669-E9DF-4C3A-9BC0-D44365EC4A2C,TCGA-50-5049-10A-01D-1623-02,HG19_Broad_variant,TCGA-50-5049,TCGA-LUAD,NA,s11006,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa830e4b0c9d6adf6c228,58cfa830e4b0c9d6adf6c228,TCGA-BT-A20X-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BT-A20X-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_5_rg.sorted,TCGA-BT-A20X-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_5_rg.sorted.bam,38.54,1.64,0.16,58cfa830e4b0c9d6adf6c228,TCGA-BT-A20X-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20X-01A,BE8B3F36-AAA1-4302-B28E-DE1996FACEAF,Primary Tumor,Illumina HiSeq,256c8b67-1fea-4666-b42c-21e8860946e3,Bladder,56,4D7D3354-6588-4E02-9354-AB5044BA1AB3,B9EE2E33-FF09-41FE-901C-453588041DCE,TCGA-BT-A20X-01A-11D-A16N-02,HG19_Broad_variant,TCGA-BT-A20X,TCGA-BLCA,251,s2692,Harvard Medical School,University of Pittsburgh,United States,NO,T4a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c76c,58cfa831e4b0c9d6adf6c76c,TCGA-CV-7178-01A-21D-2317_120623_SN1222_0118_AD13T1ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CV-7178-01A-21D-2317_120623_SN1222_0118_AD13T1ACXX_s_7_rg.sorted,TCGA-CV-7178-01A-21D-2317_120623_SN1222_0118_AD13T1ACXX_s_7_rg.sorted.bam,199.73,NA,0.16,58cfa831e4b0c9d6adf6c76c,TCGA-CV-7178-01A-21D-2317_120623_SN1222_0118_AD13T1ACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7178-01A,8F044599-3FBE-4B69-B67D-49AEE9168545,Primary Tumor,Illumina HiSeq,f76f830b-a361-4cf5-a60f-69d4d574723f,Head and Neck,64,CAAB8E84-3225-4543-949E-7B7EB11244A2,A139820A-0B76-4A95-A3EE-DDDDF514A9C3,TCGA-CV-7178-01A-21D-2317-26,HG19_Broad_variant,TCGA-CV-7178,TCGA-HNSC,2166,s15900,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T4a,N2,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6cfd6,58cfa832e4b0c9d6adf6cfd6,TCGA-FS-A1ZJ-10A-01D-A190_120605_SN1222_0113_BC0WUCACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FS-A1ZJ-10A-01D-A190_120605_SN1222_0113_BC0WUCACXX_s_5_rg.sorted,TCGA-FS-A1ZJ-10A-01D-A190_120605_SN1222_0113_BC0WUCACXX_s_5_rg.sorted.bam,49.53,NA,0.16,58cfa832e4b0c9d6adf6cfd6,TCGA-FS-A1ZJ-10A-01D-A190_120605_SN1222_0113_BC0WUCACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZJ-10A,2F0661E5-5006-481E-9B40-7B1EC96EAA3C,Blood Derived Normal,Illumina HiSeq,28dcf393-ff38-4302-be63-4a95793c09a0,Skin,75,88179E39-3DEA-471B-BE9B-F22773D67054,09F3648F-5FB8-4677-A458-DA2F6E77BC0E,TCGA-FS-A1ZJ-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZJ,TCGA-SKCM,1441,s7535,Harvard Medical School,Essen,Germany,NO,T2,N0,Not available,Stage I
13722.58cfa831e4b0c9d6adf6c7a6,58cfa831e4b0c9d6adf6c7a6,TCGA-D1-A174-10A-01D-A12F_120522_SN208_0301_BC0VNWACXX_s_7_rg.sorted.filtered.,WGS,TCGA-D1-A174-10A-01D-A12F_120522_SN208_0301_BC0VNWACXX_s_7_rg.sorted,TCGA-D1-A174-10A-01D-A12F_120522_SN208_0301_BC0VNWACXX_s_7_rg.sorted.bam,25.16,1.39,0.17,58cfa831e4b0c9d6adf6c7a6,TCGA-D1-A174-10A-01D-A12F_120522_SN208_0301_BC0VNWACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A174-10A,FC7315B0-9F48-4206-B197-2268C0518EB4,Blood Derived Normal,Illumina HiSeq,7bc53b59-d263-430d-89c8-bd97fad697f4,Uterus,51,DF9A1F44-9B3F-48B2-96AF-54AAABDFD243,0182D4E1-F835-46B5-A8F0-53DECF5868DE,TCGA-D1-A174-10A-01D-A12F-02,HG19_Broad_variant,TCGA-D1-A174,TCGA-UCEC,NA,s4799,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6cfd8,58cfa832e4b0c9d6adf6cfd8,TCGA-FU-A3TQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FU-A3TQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_3_rg.sorted,TCGA-FU-A3TQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_3_rg.sorted.bam,59.29,NA,0.15,58cfa832e4b0c9d6adf6cfd8,TCGA-FU-A3TQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-FU-A3TQ-01A,7218AA6F-3345-484F-A329-A3B6169A67C7,Primary Tumor,Illumina HiSeq,87ede4e6-17e6-4287-8ee3-cde27de3aa7d,Cervix,55,2F3BFFB4-2C85-4B72-9AF5-4DB9DC358AE6,7018744F-49FF-4F47-AEE5-07F0DEA5D7D3,TCGA-FU-A3TQ-01A-11D-A232-26,HG19_Broad_variant,TCGA-FU-A3TQ,TCGA-CESC,NA,s1199,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T2b,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c690,58cfa831e4b0c9d6adf6c690,TCGA-CS-6290-10A-01D-1703_130808_SN208_0487_AC28U7ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CS-6290-10A-01D-1703_130808_SN208_0487_AC28U7ACXX_s_8_rg.sorted,TCGA-CS-6290-10A-01D-1703_130808_SN208_0487_AC28U7ACXX_s_8_rg.sorted.bam,127,1.9,0.14,58cfa831e4b0c9d6adf6c690,TCGA-CS-6290-10A-01D-1703_130808_SN208_0487_AC28U7ACXX_s_8_rg.sorted.bam,Alive,MALE,Not available,Not available,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-6290-10A,42FE260F-520B-4FAC-8C09-D2B31AED59FB,Blood Derived Normal,Illumina HiSeq,5e2f3e2f-546e-4dde-b8c7-ab81ce38c575,Brain,31,51465F70-FF73-4028-90E4-92583EECFB27,48B76CCA-E836-4296-81BB-BE7B2C5AA9F5,TCGA-CS-6290-10A-01D-1703-02,HG19_Broad_variant,TCGA-CS-6290,TCGA-LGG,NA,s8750,Harvard Medical School,Thomas Jefferson University,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6c35e,58cfa831e4b0c9d6adf6c35e,TCGA-CG-4475-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_6_rg.sorted.filtered.,WGS,TCGA-CG-4475-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_6_rg.sorted,TCGA-CG-4475-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_6_rg.sorted.bam,45.9,1.9,0.15,58cfa831e4b0c9d6adf6c35e,TCGA-CG-4475-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_6_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4475-10A,CAD2ADC1-0F41-4651-9C80-AE9961E2DC8D,Blood Derived Normal,Illumina HiSeq,7b3804c3-ac4b-4a32-8dde-9ba52821064c,Stomach,76,5CEA6C63-C68C-41ED-B064-9941E60F64BD,0404F559-4DA5-4935-ACB5-D2F2F7730F30,TCGA-CG-4475-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4475,TCGA-STAD,NA,s14414,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Not available,Stage IIB
13722.58cfa830e4b0c9d6adf6bee8,58cfa830e4b0c9d6adf6bee8,TCGA-AP-A0LL-10A-01D-A101_120406_SN208_0281_AC0KDBACXX_s_4_rg.sorted.filtered.,WGS,TCGA-AP-A0LL-10A-01D-A101_120406_SN208_0281_AC0KDBACXX_s_4_rg.sorted,TCGA-AP-A0LL-10A-01D-A101_120406_SN208_0281_AC0KDBACXX_s_4_rg.sorted.bam,30.29,2.07,0.13,58cfa830e4b0c9d6adf6bee8,TCGA-AP-A0LL-10A-01D-A101_120406_SN208_0281_AC0KDBACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LL-10A,D17668C4-5D66-4E16-8B70-B54616581AAE,Blood Derived Normal,Illumina HiSeq,e415e9ef-bee6-4c78-a8a2-07929e59fbfe,Uterus,56,ACC43C62-1C62-4BA1-ABFA-D8F4872E8D8B,D51C3BF5-BC45-4E48-9B34-6AC5AE6EFAED,TCGA-AP-A0LL-10A-01D-A101-02,HG19_Broad_variant,TCGA-AP-A0LL,TCGA-UCEC,NA,s5386,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d5fc,58cfa832e4b0c9d6adf6d5fc,TCGA-LN-A49N-10A-01D-A248_130101_SN590_0206_AC1H8RACXX_s_8_rg.sorted.filtered.,WGS,TCGA-LN-A49N-10A-01D-A248_130101_SN590_0206_AC1H8RACXX_s_8_rg.sorted,TCGA-LN-A49N-10A-01D-A248_130101_SN590_0206_AC1H8RACXX_s_8_rg.sorted.bam,55.78,NA,0.15,58cfa832e4b0c9d6adf6d5fc,TCGA-LN-A49N-10A-01D-A248_130101_SN590_0206_AC1H8RACXX_s_8_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49N-10A,AE404398-6544-4F3A-8830-44A4A227F8D5,Blood Derived Normal,Illumina HiSeq,aa86a081-bb87-417e-87f5-749a306c5c4e,Esophagus,50,DC16E711-F7E7-4E14-8514-A5C27E5A6301,91E04C4D-5947-4A49-A21D-56E02B9DE417,TCGA-LN-A49N-10A-01D-A248-26,HG19_Broad_variant,TCGA-LN-A49N,TCGA-ESCA,NA,s1854,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T2,N1,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6c9b5,58cfa831e4b0c9d6adf6c9b5,TCGA-DK-A3IU-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DK-A3IU-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_7_rg.sorted,TCGA-DK-A3IU-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_7_rg.sorted.bam,34.01,NA,0.15,58cfa831e4b0c9d6adf6c9b5,TCGA-DK-A3IU-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3IU-01A,F093F043-EFD4-4CBA-A87F-8CBB5C1ACD9E,Primary Tumor,Illumina HiSeq,346b87a3-0c3a-455c-b3c1-0fb96acd0f2f,Bladder,58,B9C39E8B-D689-499A-BC06-CE3BFFC9996C,8E8E8966-582A-45FF-96C2-EC0C1718C4F2,TCGA-DK-A3IU-01A-11D-A210-26,HG19_Broad_variant,TCGA-DK-A3IU,TCGA-BLCA,NA,s3285,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c50c,58cfa831e4b0c9d6adf6c50c,TCGA-CF-A3MI-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CF-A3MI-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_1_rg.sorted,TCGA-CF-A3MI-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_1_rg.sorted.bam,46.48,NA,0.14,58cfa831e4b0c9d6adf6c50c,TCGA-CF-A3MI-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_1_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CF-A3MI-01A,F1EBF96B-8DF9-4E59-ACEF-7AD433E40214,Primary Tumor,Illumina HiSeq,6559c325-d368-4f95-a2c0-df5efa895e3d,Bladder,62,A373568A-BBD3-4D67-92D6-96E8378065CF,86D4A4FB-47BB-4CD4-B481-CE9F815D38E6,TCGA-CF-A3MI-01A-11D-A210-26,HG19_Broad_variant,TCGA-CF-A3MI,TCGA-BLCA,NA,s3273,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T2,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6cafe,58cfa831e4b0c9d6adf6cafe,TCGA-EA-A3QD-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EA-A3QD-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_1_rg.sorted,TCGA-EA-A3QD-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_1_rg.sorted.bam,11.96,NA,0.15,58cfa831e4b0c9d6adf6cafe,TCGA-EA-A3QD-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EA-A3QD-10A,9E2E29E8-D94A-499F-A98A-5B53B2C38F3B,Blood Derived Normal,Illumina HiSeq,c62c9fa4-7e51-4f44-a9e7-66773a034e59,Cervix,59,ECD247FC-70A8-4C1E-BF11-C0DB2FF531A0,98045064-732D-4A16-BAD9-CA11CD012FA6,TCGA-EA-A3QD-10A-01D-A232-26,HG19_Broad_variant,TCGA-EA-A3QD,TCGA-CESC,NA,s1523,MD Anderson - Institute for Applied Cancer Science,Asterand,United States,NO,T1b1,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b674,58cfa82fe4b0c9d6adf6b674,TCGA-71-6725-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_7_rg.sorted.filtered.,WGS,TCGA-71-6725-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_7_rg.sorted,TCGA-71-6725-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_7_rg.sorted.bam,406.7,1.9,0.14,58cfa82fe4b0c9d6adf6b674,TCGA-71-6725-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_7_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-71-6725-01A,4B7CD595-E7F9-45A8-B736-A8C7C42D9539,Primary Tumor,Illumina HiSeq,9c1abbc4-5f6b-486c-a6a3-17a01c8783cb,Lung,48,83973755-FA6A-460A-A042-385B34698C39,1AD7566E-B9DD-43A3-94DC-96F525007EAA,TCGA-71-6725-01A-11D-1853-02,HG19_Broad_variant,TCGA-71-6725,TCGA-LUAD,NA,s11554,Harvard Medical School,ILSbio,Vietnam,NO,T2,N0,Lung Papillary Adenocarcinoma,Stage IB
13722.58cfa832e4b0c9d6adf6cf48,58cfa832e4b0c9d6adf6cf48,TCGA-HC-7075-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_4_rg.sorted.filtered.,WGS,TCGA-HC-7075-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_4_rg.sorted,TCGA-HC-7075-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_4_rg.sorted.bam,242.7,NA,0.15,58cfa832e4b0c9d6adf6cf48,TCGA-HC-7075-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7075-01A,5DD69C3E-9A3D-450C-9F10-10B4D6DAEEBA,Primary Tumor,Illumina HiSeq,7fee8465-32e2-4bef-bd48-102b2534003a,Prostate,63,1FA3E5C2-E415-42FA-AEA3-F6C84959522A,CFC425B3-7570-4FD2-8DB6-611EF4D627DF,TCGA-HC-7075-01A-11D-1957-02,HG19_Broad_variant,TCGA-HC-7075,TCGA-PRAD,NA,s3811,Harvard Medical School,International Genomics Consortium,United States,NO,T2a,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bf32,58cfa830e4b0c9d6adf6bf32,TCGA-BR-4188-01A-01D-1128_120805_SN1222_0143_BD172BACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BR-4188-01A-01D-1128_120805_SN1222_0143_BD172BACXX_s_1_rg.sorted,TCGA-BR-4188-01A-01D-1128_120805_SN1222_0143_BD172BACXX_s_1_rg.sorted.bam,230.9,1.9,0.15,58cfa830e4b0c9d6adf6bf32,TCGA-BR-4188-01A-01D-1128_120805_SN1222_0143_BD172BACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4188-01A,151257D7-BA5B-49A0-94F5-50E28F9F46F1,Primary Tumor,Illumina HiSeq,3f570dc4-5d29-4f95-bcf8-281dd6d25981,Stomach,53,26398996-4EB5-4C24-BA78-3CA9A3B6EBC0,549B1391-8EBF-49D0-BF3A-6CAF92A8DC00,TCGA-BR-4188-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4188,TCGA-STAD,NA,s14811,Harvard Medical School,Asterand,Russia,NO,TX,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa830e4b0c9d6adf6bf52,58cfa830e4b0c9d6adf6bf52,TCGA-BR-4280-01A-01D-1128_121127_SN208_0440_AC1F4LACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BR-4280-01A-01D-1128_121127_SN208_0440_AC1F4LACXX_s_1_rg.sorted,TCGA-BR-4280-01A-01D-1128_121127_SN208_0440_AC1F4LACXX_s_1_rg.sorted.bam,252.9,1.9,0.14,58cfa830e4b0c9d6adf6bf52,TCGA-BR-4280-01A-01D-1128_121127_SN208_0440_AC1F4LACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4280-01A,E0916597-E489-45EF-A8F7-653A3C6591EF,Primary Tumor,Illumina HiSeq,418e722c-d444-43fe-87b1-6d8ce0ce5359,Stomach,78,797D2D3A-F01C-4985-B27C-4E4C2838D34D,7F073E1B-E936-44FF-B3C0-8F4C26ECC3A9,TCGA-BR-4280-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4280,TCGA-STAD,NA,s14880,Harvard Medical School,Asterand,Russia,NO,T2b,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage III
13722.58cfa832e4b0c9d6adf6d0f0,58cfa832e4b0c9d6adf6d0f0,TCGA-HC-7077-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_6_rg.sorted.filtered.,WGS,TCGA-HC-7077-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_6_rg.sorted,TCGA-HC-7077-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_6_rg.sorted.bam,192.7,NA,0.15,58cfa832e4b0c9d6adf6d0f0,TCGA-HC-7077-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_6_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7077-01A,92252560-5984-41F6-A4B5-A3AA8654C0C8,Primary Tumor,Illumina HiSeq,bea10bd4-1049-4162-bb70-0bf5073199c6,Prostate,64,F3E4CC00-D6FE-4291-BB07-8E501E772CE1,EFC4EC34-58ED-40DE-8E0D-BCBA6320BF4C,TCGA-HC-7077-01A-11D-1957-02,HG19_Broad_variant,TCGA-HC-7077,TCGA-PRAD,NA,s4154,Harvard Medical School,International Genomics Consortium,United States,NO,T3a,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82fe4b0c9d6adf6b720,58cfa82fe4b0c9d6adf6b720,TCGA-67-6217-01A-11D-1751_120309_SN208_0274_AD0R6DACXX_s_3_rg.sorted.filtered.,WGS,TCGA-67-6217-01A-11D-1751_120309_SN208_0274_AD0R6DACXX_s_3_rg.sorted,TCGA-67-6217-01A-11D-1751_120309_SN208_0274_AD0R6DACXX_s_3_rg.sorted.bam,282.4,1.9,0.13,58cfa82fe4b0c9d6adf6b720,TCGA-67-6217-01A-11D-1751_120309_SN208_0274_AD0R6DACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-67-6217-01A,108A71CF-B9DB-47CD-AA74-C03EC989B41B,Primary Tumor,Illumina HiSeq,cb2962fe-7f6e-4a68-871a-11d696bb5279,Lung,73,BC0FE45C-3249-46D7-8991-C6888F0B9579,565E717D-310B-4FB1-B79A-5F40FF12BBB8,TCGA-67-6217-01A-11D-1751-02,HG19_Broad_variant,TCGA-67-6217,TCGA-LUAD,NA,s11244,Harvard Medical School,St Joseph's Medical Center (MD),United States,NO,T2a,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa831e4b0c9d6adf6cccc,58cfa831e4b0c9d6adf6cccc,TCGA-EJ-5530-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EJ-5530-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_7_rg.sorted,TCGA-EJ-5530-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_7_rg.sorted.bam,388.7,1.9,0.14,58cfa831e4b0c9d6adf6cccc,TCGA-EJ-5530-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5530-01A,E4A755E3-4938-4321-B5A9-27A445036791,Primary Tumor,Illumina HiSeq,83b4e2b0-670b-441b-9b17-fa5c1da740c5,Prostate,61,27D61473-39D6-478A-A576-427D1AEDA01F,CBA52846-FAD3-4D21-8949-0105BD2AE713,TCGA-EJ-5530-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5530,TCGA-PRAD,NA,s3961,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c826,58cfa831e4b0c9d6adf6c826,TCGA-D1-A17U-01A-21D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D1-A17U-01A-21D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_3_rg.sorted,TCGA-D1-A17U-01A-21D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_3_rg.sorted.bam,73.35,1.96,0.17,58cfa831e4b0c9d6adf6c826,TCGA-D1-A17U-01A-21D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A17U-01A,6397C4A1-0A29-4C2C-B8CB-CE73AF93DD0B,Primary Tumor,Illumina HiSeq,8d00983f-b836-41a9-a4b9-51c75b4452a8,Uterus,53,1F1945EE-4CF3-43A3-9998-1C4528C7A511,1B9EB26F-48E0-4EBF-9094-5013E3DF2FBD,TCGA-D1-A17U-01A-21D-A12F-02,HG19_Broad_variant,TCGA-D1-A17U,TCGA-UCEC,NA,s4616,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6c1de,58cfa830e4b0c9d6adf6c1de,TCGA-BT-A0YX-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BT-A0YX-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_6_rg.sorted,TCGA-BT-A0YX-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_6_rg.sorted.bam,62.34,1.97,0.15,58cfa830e4b0c9d6adf6c1de,TCGA-BT-A0YX-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A0YX-01A,22473AD4-DF39-4716-B558-3C1409D5FA0E,Primary Tumor,Illumina HiSeq,71886c7b-a73b-4c00-9555-5fd61b5e1347,Bladder,70,DA614214-F84C-43AB-983C-D9D76CF2D6AE,DC052DFC-26A8-4393-8849-FA954913C622,TCGA-BT-A0YX-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BT-A0YX,TCGA-BLCA,NA,s2867,Harvard Medical School,University of Pittsburgh,None,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82ee4b0c9d6adf6aee7,58cfa82ee4b0c9d6adf6aee7,TCGA-05-4410-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-05-4410-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_4_rg.sorted,TCGA-05-4410-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_4_rg.sorted.bam,182.7,1.9,0.16,58cfa82ee4b0c9d6adf6aee7,TCGA-05-4410-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_4_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4410-01A,D28E465C-E553-4C53-8BB7-3D8199B9A8A5,Primary Tumor,Illumina HiSeq,bdcc8e9a-8d27-4167-ae6f-3c41b38c6c51,Lung,62,F8961F5C-E28B-44A2-8E4E-B5759FE2D849,51E2038A-2D9D-481D-A3B6-D5D5D6B33E4F,TCGA-05-4410-01A-21D-1853-02,HG19_Broad_variant,TCGA-05-4410,TCGA-LUAD,NA,s10773,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa831e4b0c9d6adf6c69c,58cfa831e4b0c9d6adf6c69c,TCGA-CQ-6229-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CQ-6229-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_2_rg.sorted,TCGA-CQ-6229-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_2_rg.sorted.bam,60.7,1.9,0.17,58cfa831e4b0c9d6adf6c69c,TCGA-CQ-6229-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-6229-01A,A091822C-447A-49A5-8C20-E329DF79599C,Primary Tumor,Illumina HiSeq,c3f7b43b-25d2-4df3-a85c-231a6708bf8c,Head and Neck,61,F01165B0-911A-45B0-BA7D-7CD0E723A2E4,4AF0777A-6FE3-49AE-B3B9-4AB077DDB007,TCGA-CQ-6229-01A-11D-1911-02,HG19_Broad_variant,TCGA-CQ-6229,TCGA-HNSC,NA,s15631,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c5a0,58cfa831e4b0c9d6adf6c5a0,TCGA-CG-4465-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CG-4465-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_1_rg.sorted,TCGA-CG-4465-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_1_rg.sorted.bam,122.2,1.9,0.13,58cfa831e4b0c9d6adf6c5a0,TCGA-CG-4465-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_1_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4465-01A,C9AB5BF4-092A-420F-9B90-87DEEA58104C,Primary Tumor,Illumina HiSeq,cb9d270d-5328-46d7-b7ff-cb564fad9175,Stomach,69,89DAB798-0B26-470C-82AF-1B23C83FE4F5,2CCE681F-F5C6-496E-96C3-21046ECEAA56,TCGA-CG-4465-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4465,TCGA-STAD,274,s14826,Harvard Medical School,Indivumed,Germany,NO,T4,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IV
13722.58cfa832e4b0c9d6adf6d046,58cfa832e4b0c9d6adf6d046,TCGA-FU-A3HY-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_6_rg.sorted.filtered.,WGS,TCGA-FU-A3HY-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_6_rg.sorted,TCGA-FU-A3HY-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_6_rg.sorted.bam,48.84,NA,0.17,58cfa832e4b0c9d6adf6d046,TCGA-FU-A3HY-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-FU-A3HY-10A,674E010C-7AD4-4DC2-86B0-284CD4560633,Blood Derived Normal,Illumina HiSeq,311eb518-2d97-4352-a019-82bbc266a540,Cervix,47,CC602955-FCEC-4357-8B7C-31111CDE9A74,77158E53-321C-4196-A93D-926E1BF3540A,TCGA-FU-A3HY-10A-01D-A245-26,HG19_Broad_variant,TCGA-FU-A3HY,TCGA-CESC,NA,s1200,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T1b2,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c673,58cfa831e4b0c9d6adf6c673,TCGA-CU-A0YR-11A-13D-A10R_120920_SN1222_0150_AC1927ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CU-A0YR-11A-13D-A10R_120920_SN1222_0150_AC1927ACXX_s_5_rg.sorted,TCGA-CU-A0YR-11A-13D-A10R_120920_SN1222_0150_AC1927ACXX_s_5_rg.sorted.bam,21.05,2.03,0.16,58cfa831e4b0c9d6adf6c673,TCGA-CU-A0YR-11A-13D-A10R_120920_SN1222_0150_AC1927ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CU-A0YR-11A,811B3950-36E7-485F-BC48-ACA1EEE2DDEF,Solid Tissue Normal,Illumina HiSeq,1efc9ebb-a445-4460-9053-367c5b4daaf5,Bladder,83,C60912E4-2F70-4C1E-91BD-F2F5548E532B,4A3BA06D-AE96-4194-AC33-2133D7C5074A,TCGA-CU-A0YR-11A-13D-A10R-02,HG19_Broad_variant,TCGA-CU-A0YR,TCGA-BLCA,NA,s2880,Harvard Medical School,UNC,United States,NO,T2,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6cbdd,58cfa831e4b0c9d6adf6cbdd,TCGA-EJ-5532-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EJ-5532-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_3_rg.sorted,TCGA-EJ-5532-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_3_rg.sorted.bam,188.7,1.9,0.15,58cfa831e4b0c9d6adf6cbdd,TCGA-EJ-5532-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5532-01A,AE3A0C92-148D-4F1C-8563-06AC1050F53E,Primary Tumor,Illumina HiSeq,e7c833a1-c77a-4c65-b268-1db73a7028e3,Prostate,57,F32F7738-BAD4-40C9-B49F-084BB098A05A,E5F35020-2A9F-47B3-8271-FEF8E1883567,TCGA-EJ-5532-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5532,TCGA-PRAD,NA,s3956,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c310,58cfa830e4b0c9d6adf6c310,TCGA-BR-6710-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BR-6710-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_3_rg.sorted,TCGA-BR-6710-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_3_rg.sorted.bam,391.7,1.9,0.14,58cfa830e4b0c9d6adf6c310,TCGA-BR-6710-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6710-01A,012E99FE-E3E8-4BB0-BB74-5B0C9992187C,Primary Tumor,Illumina HiSeq,e0e0146e-bf19-42c8-801b-c5a6ed564c5b,Stomach,41,25E9E880-4EA1-40CF-BBB6-0F961C735C97,999D0F8C-6A89-4753-AD18-F44304EA78F9,TCGA-BR-6710-01A-11D-1880-02,HG19_Broad_variant,TCGA-BR-6710,TCGA-STAD,NA,s15383,Harvard Medical School,Asterand,Ukraine,NO,T2,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c51a,58cfa831e4b0c9d6adf6c51a,TCGA-CN-4730-10A-01D-1431_120712_SN1222_0125_BD13TPACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CN-4730-10A-01D-1431_120712_SN1222_0125_BD13TPACXX_s_8_rg.sorted,TCGA-CN-4730-10A-01D-1431_120712_SN1222_0125_BD13TPACXX_s_8_rg.sorted.bam,928.4,1.9,0.16,58cfa831e4b0c9d6adf6c51a,TCGA-CN-4730-10A-01D-1431_120712_SN1222_0125_BD13TPACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4730-10A,35C1F2C6-771C-4533-82DF-F8E2EC7107D7,Blood Derived Normal,Illumina HiSeq,975d6473-5677-45fd-8930-d94f3addfc30,Head and Neck,62,3D7DC830-42C8-4746-AA06-C5A58E6AD510,D7DBCD9B-1AF6-41AE-8C6F-420E6041E346,TCGA-CN-4730-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4730,TCGA-HNSC,NA,s15623,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N1,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c60a,58cfa831e4b0c9d6adf6c60a,TCGA-CQ-6220-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CQ-6220-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_1_rg.sorted,TCGA-CQ-6220-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_1_rg.sorted.bam,342.7,1.9,0.15,58cfa831e4b0c9d6adf6c60a,TCGA-CQ-6220-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-6220-01A,96D0CEFE-7949-4736-A7DC-1E4FA94765EC,Primary Tumor,Illumina HiSeq,d86390d3-24c6-4e56-9b8a-d6b3ec75c989,Head and Neck,69,E0E75203-3982-40B2-A057-FAA8433DFB7A,C7EABDCF-81F2-4C87-946A-B5BA42056B04,TCGA-CQ-6220-01A-11D-1911-02,HG19_Broad_variant,TCGA-CQ-6220,TCGA-HNSC,985,s16037,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa832e4b0c9d6adf6d476,58cfa832e4b0c9d6adf6d476,TCGA-VD-A8KE-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-VD-A8KE-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_2_rg.sorted,TCGA-VD-A8KE-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_2_rg.sorted.bam,7.86,NA,0.14,58cfa832e4b0c9d6adf6d476,TCGA-VD-A8KE-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KE-10A,C9BFC2A7-0914-4080-A0A3-1C6A4E58E1AB,Blood Derived Normal,Illumina HiSeq,039a8bcd-6658-48eb-b3f8-c416c8447636,Eye,74,B4AFD975-296B-4B83-B322-987E3F3212C4,667F5A4B-76E1-4709-B384-78BF22280855,TCGA-VD-A8KE-10A-01D-A40E-26,HG19_Broad_variant,TCGA-VD-A8KE,TCGA-UVM,NA,s259,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T2a,NX,Not available,Stage IIA
13722.58cfa830e4b0c9d6adf6c10a,58cfa830e4b0c9d6adf6c10a,TCGA-BS-A0TG-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BS-A0TG-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_4_rg.sorted,TCGA-BS-A0TG-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_4_rg.sorted.bam,15.46,1.82,0.14,58cfa830e4b0c9d6adf6c10a,TCGA-BS-A0TG-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TG-10A,13F31BCB-BEFD-4ED2-ADC0-DC9E9CE52B75,Blood Derived Normal,Illumina HiSeq,a1ae7935-6ba2-41ab-a964-95b087ce291a,Uterus,60,0762739C-25E9-48FB-BF71-4774FF5A6655,BAA329DB-9ED8-416D-BB51-75711DEF8057,TCGA-BS-A0TG-10A-01D-A101-02,HG19_Broad_variant,TCGA-BS-A0TG,TCGA-UCEC,NA,s4610,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c5ce,58cfa831e4b0c9d6adf6c5ce,TCGA-CG-5725-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CG-5725-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_1_rg.sorted,TCGA-CG-5725-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_1_rg.sorted.bam,333.7,1.9,0.14,58cfa831e4b0c9d6adf6c5ce,TCGA-CG-5725-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_1_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5725-01A,129D95CA-71EF-44AA-A93D-F87803C37C9A,Primary Tumor,Illumina HiSeq,61968fb0-fb5d-48fa-88eb-4cd76a6b4456,Stomach,72,E1DED05A-1BC0-42A7-A560-DD67EB804EB4,5254031E-CF64-4B0C-80D8-3EBB4A2DC70F,TCGA-CG-5725-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5725,TCGA-STAD,457,s15129,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c8bc,58cfa831e4b0c9d6adf6c8bc,TCGA-DK-A3IT-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DK-A3IT-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_5_rg.sorted,TCGA-DK-A3IT-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_5_rg.sorted.bam,24.31,NA,0.16,58cfa831e4b0c9d6adf6c8bc,TCGA-DK-A3IT-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3IT-01A,58520C66-7688-435A-B09F-653B18768C41,Primary Tumor,Illumina HiSeq,276fd52d-8d51-4e03-85a5-a7f02ee03b71,Bladder,62,6B48DAE5-B757-450A-8248-65C2434A7AFC,CDBAE634-52F3-4165-A214-BB60BEC5D6C4,TCGA-DK-A3IT-01A-31D-A210-26,HG19_Broad_variant,TCGA-DK-A3IT,TCGA-BLCA,NA,s2715,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa830e4b0c9d6adf6bd88,58cfa830e4b0c9d6adf6bd88,TCGA-BG-A0LX-10A-01D-A043_120322_SN208_0278_BD0RB0ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BG-A0LX-10A-01D-A043_120322_SN208_0278_BD0RB0ACXX_s_6_rg.sorted,TCGA-BG-A0LX-10A-01D-A043_120322_SN208_0278_BD0RB0ACXX_s_6_rg.sorted.bam,21.13,2,0.15,58cfa830e4b0c9d6adf6bd88,TCGA-BG-A0LX-10A-01D-A043_120322_SN208_0278_BD0RB0ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0LX-10A,AC1D3946-FE6C-4BD8-B02C-638799CB0F67,Blood Derived Normal,Illumina HiSeq,5cefe5f6-99c7-421a-8cac-ecf860ae5139,Uterus,57,BB935FAB-8B12-4FDC-8A49-A03FD67CC014,6BD21A7A-30FC-4BD0-8ED7-F4ABE21ECBA8,TCGA-BG-A0LX-10A-01D-A043-02,HG19_Broad_variant,TCGA-BG-A0LX,TCGA-UCEC,NA,s4791,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c412,58cfa831e4b0c9d6adf6c412,TCGA-CH-5794-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CH-5794-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_5_rg.sorted,TCGA-CH-5794-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_5_rg.sorted.bam,52.7,2,0.15,58cfa831e4b0c9d6adf6c412,TCGA-CH-5794-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5794-01A,A80D3EE7-60DD-49BB-B049-9335AFC035F5,Primary Tumor,Illumina HiSeq,2cf518ee-af91-4cf0-a277-263170f71791,Prostate,65,D1A1CCFE-1215-4B34-94A9-C9765264F617,9D7EACBC-B476-4813-9215-AC0073382A25,TCGA-CH-5794-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5794,TCGA-PRAD,NA,s3775,Harvard Medical School,Indivumed,Germany,NO,T2b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c406,58cfa831e4b0c9d6adf6c406,TCGA-C5-A3HE-01A-21D-A232_140124_SN1120_0292_BD2F1HACXX_s_8_rg.sorted.filtered.,WGS,TCGA-C5-A3HE-01A-21D-A232_140124_SN1120_0292_BD2F1HACXX_s_8_rg.sorted,TCGA-C5-A3HE-01A-21D-A232_140124_SN1120_0292_BD2F1HACXX_s_8_rg.sorted.bam,43.33,NA,0.15,58cfa831e4b0c9d6adf6c406,TCGA-C5-A3HE-01A-21D-A232_140124_SN1120_0292_BD2F1HACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A3HE-01A,BC63DD2A-B8F6-4B30-A8D7-CE193BCD17F1,Primary Tumor,Illumina HiSeq,1d64c1f3-438b-4576-b2bc-74c1a26a2aca,Cervix,44,506D8B22-EE8D-4FB3-BB57-5CA79D6F5637,D0321E82-FF46-450C-AAF2-9FDCA2FF2590,TCGA-C5-A3HE-01A-21D-A232-26,HG19_Broad_variant,TCGA-C5-A3HE,TCGA-CESC,NA,s1514,MD Anderson - Institute for Applied Cancer Science,Medical College of Wisconsin,United States,NO,T1b2,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c819,58cfa831e4b0c9d6adf6c819,TCGA-CN-6998-01A-23D-2317_120623_SN1222_0118_AD13T1ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CN-6998-01A-23D-2317_120623_SN1222_0118_AD13T1ACXX_s_5_rg.sorted,TCGA-CN-6998-01A-23D-2317_120623_SN1222_0118_AD13T1ACXX_s_5_rg.sorted.bam,9.03,NA,0.13,58cfa831e4b0c9d6adf6c819,TCGA-CN-6998-01A-23D-2317_120623_SN1222_0118_AD13T1ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-6998-01A,039788EC-1364-40C7-9E9D-13DC305674E9,Primary Tumor,Illumina HiSeq,d281a462-58dd-4303-9419-617fec3fcf35,Head and Neck,53,64C8DB8B-5D5C-4FBE-8996-4A7CB161D4A0,88B8B48D-51B8-4D46-9C36-E565A2582D94,TCGA-CN-6998-01A-23D-2317-26,HG19_Broad_variant,TCGA-CN-6998,TCGA-HNSC,NA,s16333,MD Anderson - Institute for Applied Cancer Science,University of Pittsburgh,United States,NO,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c768,58cfa831e4b0c9d6adf6c768,TCGA-D1-A1O0-01A-11D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D1-A1O0-01A-11D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_3_rg.sorted,TCGA-D1-A1O0-01A-11D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_3_rg.sorted.bam,86.58,1.84,0.16,58cfa831e4b0c9d6adf6c768,TCGA-D1-A1O0-01A-11D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A1O0-01A,A98BBE29-8817-4380-A738-3C1BF9F8E0CC,Primary Tumor,Illumina HiSeq,30d286e0-9e60-48a1-81f4-b35d81af6da1,Uterus,77,E113E0F0-3AE5-48A3-A226-AD920F41259E,8DF3928E-65CE-4578-96A4-BA3AE51E764C,TCGA-D1-A1O0-01A-11D-A17E-02,HG19_Broad_variant,TCGA-D1-A1O0,TCGA-UCEC,NA,s4619,Harvard Medical School,Mayo Clinic,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d038,58cfa832e4b0c9d6adf6d038,TCGA-FT-A3EE-10A-01D-A204_121002_SN1222_0155_BD1ERHACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FT-A3EE-10A-01D-A204_121002_SN1222_0155_BD1ERHACXX_s_2_rg.sorted,TCGA-FT-A3EE-10A-01D-A204_121002_SN1222_0155_BD1ERHACXX_s_2_rg.sorted.bam,103.3,NA,0.16,58cfa832e4b0c9d6adf6d038,TCGA-FT-A3EE-10A-01D-A204_121002_SN1222_0155_BD1ERHACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FT-A3EE-10A,CCE62116-3DCD-400D-ADA0-9839CA02466E,Blood Derived Normal,Illumina HiSeq,2398ce28-2b46-494f-a9fa-1bc987618a00,Bladder,80,6DFC7EAC-19ED-4BBB-936A-9D4591C7C2B3,AD854667-865A-4C6F-9AF6-1D09642EF5DC,TCGA-FT-A3EE-10A-01D-A204-02,HG19_Broad_variant,TCGA-FT-A3EE,TCGA-BLCA,99,s2724,Harvard Medical School,BLN - University of Miami,United States,NO,T4a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6cf86,58cfa832e4b0c9d6adf6cf86,TCGA-G9-6343-01A-21D-1957_130329_SN590_0221_BD1WHDACXX_s_8_rg.sorted.filtered.,WGS,TCGA-G9-6343-01A-21D-1957_130329_SN590_0221_BD1WHDACXX_s_8_rg.sorted,TCGA-G9-6343-01A-21D-1957_130329_SN590_0221_BD1WHDACXX_s_8_rg.sorted.bam,108.7,1.9,0.14,58cfa832e4b0c9d6adf6cf86,TCGA-G9-6343-01A-21D-1957_130329_SN590_0221_BD1WHDACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6343-01A,36B87D12-9F96-460F-A3B5-A4C08CBF5B07,Primary Tumor,Illumina HiSeq,e413f861-4cba-4bf6-a805-aff9ecf4eb3b,Prostate,62,084C6D1F-047E-4B0E-9034-3B0FC18D510D,CB58EB3E-4769-4050-BB51-AE248D0FABAA,TCGA-G9-6343-01A-21D-1957-02,HG19_Broad_variant,TCGA-G9-6343,TCGA-PRAD,NA,s3453,Harvard Medical School,Roswell Park,United States,NO,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c80f,58cfa831e4b0c9d6adf6c80f,TCGA-CV-6938-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CV-6938-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_4_rg.sorted,TCGA-CV-6938-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_4_rg.sorted.bam,62.7,2,0.16,58cfa831e4b0c9d6adf6c80f,TCGA-CV-6938-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6938-01A,FF9DB03D-F81C-4079-8B05-F5A8C05B8CFE,Primary Tumor,Illumina HiSeq,a328ffc7-c5cd-4726-a75a-e625d33859a8,Head and Neck,87,9EB292E6-AE4D-4613-98EE-0197FD97B633,87E1BCCB-5B03-40AF-A262-0B2B5E6A08D2,TCGA-CV-6938-01A-11D-1911-02,HG19_Broad_variant,TCGA-CV-6938,TCGA-HNSC,144,s16050,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa830e4b0c9d6adf6bee2,58cfa830e4b0c9d6adf6bee2,TCGA-AP-A0LO-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_7_rg.sorted.filtered.,WGS,TCGA-AP-A0LO-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_7_rg.sorted,TCGA-AP-A0LO-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_7_rg.sorted.bam,90.97,2.13,0.17,58cfa830e4b0c9d6adf6bee2,TCGA-AP-A0LO-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LO-01A,A081DA6F-51F3-4555-A6B8-736F8C6CDA39,Primary Tumor,Illumina HiSeq,4726575a-1ad0-471a-8a8e-26eb668681f2,Uterus,45,9846D8F3-5B22-48E9-B972-A0FE9F509FB4,A91FCC79-7AE0-4BD1-BCAE-543E49E2D62E,TCGA-AP-A0LO-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A0LO,TCGA-UCEC,1016,s4243,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c462,58cfa831e4b0c9d6adf6c462,TCGA-CH-5792-10A-01D-1572_130125_SN208_0451_BD1RB1ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CH-5792-10A-01D-1572_130125_SN208_0451_BD1RB1ACXX_s_4_rg.sorted,TCGA-CH-5792-10A-01D-1572_130125_SN208_0451_BD1RB1ACXX_s_4_rg.sorted.bam,195.4,1.9,0.15,58cfa831e4b0c9d6adf6c462,TCGA-CH-5792-10A-01D-1572_130125_SN208_0451_BD1RB1ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5792-10A,8A5F2D7F-835C-4726-B238-F82D6A7F25BD,Blood Derived Normal,Illumina HiSeq,a3ab0225-b534-4b3f-8356-d82c84c70db2,Prostate,57,C33B93D4-DAA9-43B9-AFD4-F3712F9ACCCF,2D818154-C3B0-4272-98F5-4EF38F1EAB41,TCGA-CH-5792-10A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5792,TCGA-PRAD,NA,s3934,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cbee,58cfa831e4b0c9d6adf6cbee,TCGA-EK-A2PM-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EK-A2PM-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_2_rg.sorted,TCGA-EK-A2PM-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_2_rg.sorted.bam,43.27,NA,0.16,58cfa831e4b0c9d6adf6cbee,TCGA-EK-A2PM-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2PM-01A,085FB6D8-6265-484E-9307-8292386714B7,Primary Tumor,Illumina HiSeq,332b29bf-f948-4e2c-bf51-f768f819e9e9,Cervix,81,2E7F29FB-97DE-4EE0-BCA7-6A51C4C3E5CF,C32BE42D-CF78-4F46-B461-748796CEDA4A,TCGA-EK-A2PM-01A-11D-A18I-02,HG19_Broad_variant,TCGA-EK-A2PM,TCGA-CESC,NA,s1195,Harvard Medical School,Gynecologic Oncology Group,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c7e7,58cfa831e4b0c9d6adf6c7e7,TCGA-CV-5977-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CV-5977-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_7_rg.sorted,TCGA-CV-5977-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_7_rg.sorted.bam,22,1.9,0.17,58cfa831e4b0c9d6adf6c7e7,TCGA-CV-5977-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5977-11A,50239D1D-B3A4-4240-AB83-B24BA67B1299,Solid Tissue Normal,Illumina HiSeq,e6770560-36ba-42ca-bdc1-8a715a864c51,Head and Neck,66,7DB4F0EF-5756-42F6-8D3B-68F68BCB7B8B,C4BE77A1-3AE3-4D82-B53B-7FAA22A796BD,TCGA-CV-5977-11A-01D-1681-02,HG19_Broad_variant,TCGA-CV-5977,TCGA-HNSC,NA,s16199,Harvard Medical School,MD Anderson Cancer Center,None,NO,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c340,58cfa831e4b0c9d6adf6c340,TCGA-CG-4474-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_4_rg.sorted.filtered.,WGS,TCGA-CG-4474-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_4_rg.sorted,TCGA-CG-4474-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_4_rg.sorted.bam,15.9,1.8,0.15,58cfa831e4b0c9d6adf6c340,TCGA-CG-4474-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4474-10A,39DD61A8-CD17-4DF3-AE17-61E239EB00BD,Blood Derived Normal,Illumina HiSeq,72d1cbea-ee5c-4c20-9e94-72684fb953df,Stomach,67,A546EC24-E8CE-4B04-B25F-A230A5EA1067,90FBAFC6-E6C2-40D3-A0A3-D1ACD2D19E64,TCGA-CG-4474-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4474,TCGA-STAD,NA,s14490,Harvard Medical School,Indivumed,Germany,NO,T4a,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IV
13722.58cfa830e4b0c9d6adf6c126,58cfa830e4b0c9d6adf6c126,TCGA-BS-A0TJ-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BS-A0TJ-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_6_rg.sorted,TCGA-BS-A0TJ-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_6_rg.sorted.bam,11.22,1.88,0.16,58cfa830e4b0c9d6adf6c126,TCGA-BS-A0TJ-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_6_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TJ-10A,F74DA4C6-4291-46D2-ABD4-7D7F6EF03B00,Blood Derived Normal,Illumina HiSeq,5cdf9afa-86d9-4e53-a76a-8223c971f668,Uterus,59,B3FA5912-FFE9-4CC6-A973-FDF611415B50,E127BE60-BC96-4B16-AADA-98C546F2FE78,TCGA-BS-A0TJ-10A-01D-A101-02,HG19_Broad_variant,TCGA-BS-A0TJ,TCGA-UCEC,NA,s4609,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6ca86,58cfa831e4b0c9d6adf6ca86,TCGA-DJ-A1QI-10A-01D-A14U_120717_SN1120_0175_AC1179ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DJ-A1QI-10A-01D-A14U_120717_SN1120_0175_AC1179ACXX_s_7_rg.sorted,TCGA-DJ-A1QI-10A-01D-A14U_120717_SN1120_0175_AC1179ACXX_s_7_rg.sorted.bam,37.8,1.92,0.15,58cfa831e4b0c9d6adf6ca86,TCGA-DJ-A1QI-10A-01D-A14U_120717_SN1120_0175_AC1179ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QI-10A,3B1E2BD6-3D32-40F7-9B32-0DF32DFCBC72,Blood Derived Normal,Illumina HiSeq,67e8a52c-7619-457e-9e9b-96991cd41e73,Thyroid,63,FF0C61F9-7F90-48B4-BA4E-F9D7B61A8557,D921807B-9289-42D6-A27F-2D17056F12F4,TCGA-DJ-A1QI-10A-01D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QI,TCGA-THCA,NA,s12750,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage II
13722.58cfa830e4b0c9d6adf6c250,58cfa830e4b0c9d6adf6c250,TCGA-BA-4078-10A-01D-1431_120612_SN590_0161_AC0VUTACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BA-4078-10A-01D-1431_120612_SN590_0161_AC0VUTACXX_s_6_rg.sorted,TCGA-BA-4078-10A-01D-1431_120612_SN590_0161_AC0VUTACXX_s_6_rg.sorted.bam,63.03,1.9,0.14,58cfa830e4b0c9d6adf6c250,TCGA-BA-4078-10A-01D-1431_120612_SN590_0161_AC0VUTACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-4078-10A,C7353D6A-82A2-4A0D-8CD4-8C8957943EDB,Blood Derived Normal,Illumina HiSeq,406d17b0-5421-49f4-a66e-227f2076da6f,Head and Neck,83,25B0AE1D-2ADD-49B9-A5AE-99702A5C48F4,FA6F21FF-7667-491C-9A99-31B473C9D683,TCGA-BA-4078-10A-01D-1431-02,HG19_Broad_variant,TCGA-BA-4078,TCGA-HNSC,276,s15489,Harvard Medical School,UNC,None,NO,Not available,Not available,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d0d0,58cfa832e4b0c9d6adf6d0d0,TCGA-IG-A3YA-01A-11D-A248_121211_SN208_0443_BC1H55ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-IG-A3YA-01A-11D-A248_121211_SN208_0443_BC1H55ACXX_s_1_rg.sorted,TCGA-IG-A3YA-01A-11D-A248_121211_SN208_0443_BC1H55ACXX_s_1_rg.sorted.bam,41.16,NA,0.16,58cfa832e4b0c9d6adf6d0d0,TCGA-IG-A3YA-01A-11D-A248_121211_SN208_0443_BC1H55ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A3YA-01A,7AB6DE57-D659-47F1-A70F-1B67650E99D7,Primary Tumor,Illumina HiSeq,d20d3af7-3c79-446f-834f-9be861dc1490,Esophagus,53,AAADB48E-3C60-4AE4-B6EB-7B5F9C9D6544,A389CF30-6460-43E5-A895-6EBFC9555AF2,TCGA-IG-A3YA-01A-11D-A248-26,HG19_Broad_variant,TCGA-IG-A3YA,TCGA-ESCA,NA,s1819,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T4,N0,Not available,Stage IIIA
13722.58cfa831e4b0c9d6adf6c8c6,58cfa831e4b0c9d6adf6c8c6,TCGA-DK-A3IN-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DK-A3IN-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_2_rg.sorted,TCGA-DK-A3IN-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_2_rg.sorted.bam,31.51,NA,0.14,58cfa831e4b0c9d6adf6c8c6,TCGA-DK-A3IN-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3IN-10A,FC0032DB-B6D8-4DA3-BD1B-BEEC4196ABF0,Blood Derived Normal,Illumina HiSeq,7f0ce9af-6471-4dd5-9040-7facfecf821b,Bladder,72,57164A47-FBE9-4D70-9DF4-5E16DBCFDCAE,63B0D67D-B29B-4817-81ED-A79A4E882DE8,TCGA-DK-A3IN-10A-01D-A210-26,HG19_Broad_variant,TCGA-DK-A3IN,TCGA-BLCA,250,s2886,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T4a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c77f,58cfa831e4b0c9d6adf6c77f,TCGA-D7-6815-01A-11D-1880_130111_SN208_0447_AC1JP0ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-D7-6815-01A-11D-1880_130111_SN208_0447_AC1JP0ACXX_s_1_rg.sorted,TCGA-D7-6815-01A-11D-1880_130111_SN208_0447_AC1JP0ACXX_s_1_rg.sorted.bam,457,1.9,0.15,58cfa831e4b0c9d6adf6c77f,TCGA-D7-6815-01A-11D-1880_130111_SN208_0447_AC1JP0ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6815-01A,53086E20-A727-40D6-B42D-8030109B5130,Primary Tumor,Illumina HiSeq,aaa1a66d-814e-403e-bd88-38f4e3ea8c47,Stomach,70,B5F3D9A1-46B5-4A63-8F7D-9C993FE9340D,810C88A8-62F3-42C6-BBFD-A9D65E2A07A4,TCGA-D7-6815-01A-11D-1880-02,HG19_Broad_variant,TCGA-D7-6815,TCGA-STAD,NA,s14497,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N2,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIB
13722.58cfa831e4b0c9d6adf6cbb8,58cfa831e4b0c9d6adf6cbb8,TCGA-EK-A2PM-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EK-A2PM-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_6_rg.sorted,TCGA-EK-A2PM-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_6_rg.sorted.bam,122.14,NA,0.17,58cfa831e4b0c9d6adf6cbb8,TCGA-EK-A2PM-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2PM-10A,085FB6D8-6265-484E-9307-8292386714B7,Blood Derived Normal,Illumina HiSeq,c41a041f-a7af-40aa-b516-42ca0cca7082,Cervix,81,B62127DC-8526-4099-AFC3-BE2E295C7DEE,7A8CDBE5-834A-49F0-88D7-20F0D0E7127F,TCGA-EK-A2PM-10A-01D-A18I-02,HG19_Broad_variant,TCGA-EK-A2PM,TCGA-CESC,NA,s1189,Harvard Medical School,Gynecologic Oncology Group,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6cb9a,58cfa831e4b0c9d6adf6cb9a,TCGA-EJ-7317-01A-31D-2111_130422_SN590_0225_BD23TLACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EJ-7317-01A-31D-2111_130422_SN590_0225_BD23TLACXX_s_6_rg.sorted,TCGA-EJ-7317-01A-31D-2111_130422_SN590_0225_BD23TLACXX_s_6_rg.sorted.bam,61.4,NA,0.16,58cfa831e4b0c9d6adf6cb9a,TCGA-EJ-7317-01A-31D-2111_130422_SN590_0225_BD23TLACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7317-01A,68FC3693-0910-4EE8-8997-99C6333B65F4,Primary Tumor,Illumina HiSeq,7c1cef2b-4606-4c6c-ad6d-b49ca86b9f74,Prostate,71,AEEA2F28-0766-42D7-9E6A-C14BEB03E692,B25F2F78-DB49-49DF-9150-DF43F23589A4,TCGA-EJ-7317-01A-31D-2111-02,HG19_Broad_variant,TCGA-EJ-7317,TCGA-PRAD,NA,s3959,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c0ba,58cfa830e4b0c9d6adf6c0ba,TCGA-BJ-A0ZF-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BJ-A0ZF-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_3_rg.sorted,TCGA-BJ-A0ZF-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_3_rg.sorted.bam,11.62,1.93,0.17,58cfa830e4b0c9d6adf6c0ba,TCGA-BJ-A0ZF-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0ZF-10A,8BEEE000-ECAB-4A49-9C9D-BB8E677AE199,Blood Derived Normal,Illumina HiSeq,16e9c9be-3729-4e42-a182-b0de1f8a25be,Thyroid,54,2A0FC5CD-C936-44E4-852A-8C2797CB8729,E43257E9-B1AC-4DB6-8446-6661D5795ACE,TCGA-BJ-A0ZF-10A-01D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZF,TCGA-THCA,NA,s12745,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Other  specify,Stage II
13722.58cfa830e4b0c9d6adf6bff4,58cfa830e4b0c9d6adf6bff4,TCGA-B5-A0JR-10A-01D-A043_120403_SN1222_0094_BD0UKBACXX_s_7_rg.sorted.filtered.,WGS,TCGA-B5-A0JR-10A-01D-A043_120403_SN1222_0094_BD0UKBACXX_s_7_rg.sorted,TCGA-B5-A0JR-10A-01D-A043_120403_SN1222_0094_BD0UKBACXX_s_7_rg.sorted.bam,8.16,1.98,0.17,58cfa830e4b0c9d6adf6bff4,TCGA-B5-A0JR-10A-01D-A043_120403_SN1222_0094_BD0UKBACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0JR-10A,A766D113-BC3F-4448-A4E5-F391FB0C0E22,Blood Derived Normal,Illumina HiSeq,01608c11-9bd4-4e76-a8cd-b5fdf4fc19f9,Uterus,73,CA5FD93A-6951-451A-B41E-5B2A1C522B5E,311C1165-5FB7-4164-AF09-9C9ADB797544,TCGA-B5-A0JR-10A-01D-A043-02,HG19_Broad_variant,TCGA-B5-A0JR,TCGA-UCEC,NA,s5209,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c610,58cfa831e4b0c9d6adf6c610,TCGA-CQ-6221-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CQ-6221-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_6_rg.sorted,TCGA-CQ-6221-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_6_rg.sorted.bam,12.33,NA,0.15,58cfa831e4b0c9d6adf6c610,TCGA-CQ-6221-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-6221-01A,839B660C-98FE-4468-A2B3-408594350250,Primary Tumor,Illumina HiSeq,16de682b-970e-4857-821f-5a32d6b74f71,Head and Neck,79,65BAAE80-7FD5-40B1-B5FB-BDD013B70931,C90134BD-6F38-45B9-B82D-E84ACEB2E90F,TCGA-CQ-6221-01A-11D-2317-26,HG19_Broad_variant,TCGA-CQ-6221,TCGA-HNSC,NA,s15637,MD Anderson - Institute for Applied Cancer Science,"University Health Network, Toronto",Canada,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6cbcd,58cfa831e4b0c9d6adf6cbcd,TCGA-EJ-5526-10A-01D-1573_130221_SN1120_0238_AC1TDEACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EJ-5526-10A-01D-1573_130221_SN1120_0238_AC1TDEACXX_s_4_rg.sorted,TCGA-EJ-5526-10A-01D-1573_130221_SN1120_0238_AC1TDEACXX_s_4_rg.sorted.bam,713.4,1.9,0.16,58cfa831e4b0c9d6adf6cbcd,TCGA-EJ-5526-10A-01D-1573_130221_SN1120_0238_AC1TDEACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5526-10A,EEC48399-5660-4B25-8D34-191B54315C72,Blood Derived Normal,Illumina HiSeq,7101d4c4-2636-40d7-85dd-c3036f889b7b,Prostate,56,B670084A-5C1B-4F10-9AAE-B0E80E5D0AE6,95D2B91D-833C-47CF-97FD-A4D2D7627D74,TCGA-EJ-5526-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5526,TCGA-PRAD,NA,s4144,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c40e,58cfa831e4b0c9d6adf6c40e,TCGA-CH-5790-10A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CH-5790-10A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_8_rg.sorted,TCGA-CH-5790-10A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_8_rg.sorted.bam,98.4,1.9,0.15,58cfa831e4b0c9d6adf6c40e,TCGA-CH-5790-10A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5790-10A,2B5EF82D-E137-43F6-BFEF-B202F20EE187,Blood Derived Normal,Illumina HiSeq,d44cf3be-e75c-45a3-a47b-d7571c521c1b,Prostate,64,3AF0A188-4B58-4FA5-A620-63B362741284,528D23A1-834C-4350-86C7-68D7EC56B73D,TCGA-CH-5790-10A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5790,TCGA-PRAD,NA,s3422,Harvard Medical School,Indivumed,Germany,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c3e8,58cfa831e4b0c9d6adf6c3e8,TCGA-CD-5798-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CD-5798-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_3_rg.sorted,TCGA-CD-5798-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_3_rg.sorted.bam,214.7,1.9,0.15,58cfa831e4b0c9d6adf6c3e8,TCGA-CD-5798-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_3_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-5798-10A,E42F45C6-FD00-44CF-A210-C8803DA326A1,Blood Derived Normal,Illumina HiSeq,89241089-c1c3-413f-8996-a3f43497f231,Stomach,82,FE945E1F-78EF-49E8-AFFE-40D7768BF07E,B612B3C3-A7C8-492D-934D-34E9BAF71C76,TCGA-CD-5798-10A-01D-1598-02,HG19_Broad_variant,TCGA-CD-5798,TCGA-STAD,NA,s14546,Harvard Medical School,ILSbio,Vietnam,NO,T3,N0,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage II
13722.58cfa830e4b0c9d6adf6c22a,58cfa830e4b0c9d6adf6c22a,TCGA-BS-A0UJ-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BS-A0UJ-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_2_rg.sorted,TCGA-BS-A0UJ-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_2_rg.sorted.bam,15.86,1.93,0.15,58cfa830e4b0c9d6adf6c22a,TCGA-BS-A0UJ-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_2_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0UJ-10A,FF82548A-F1BB-4DAA-A8F7-B3831B5843AD,Blood Derived Normal,Illumina HiSeq,d9b854a2-bbb4-46b4-af22-dc842d971d32,Uterus,68,A672454B-994C-4953-8B33-A77AE28C1BA0,C567555E-FD02-40F8-870C-254E066195AA,TCGA-BS-A0UJ-10A-01D-A101-02,HG19_Broad_variant,TCGA-BS-A0UJ,TCGA-UCEC,NA,s5008,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d12e,58cfa832e4b0c9d6adf6d12e,TCGA-G2-A3IB-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-G2-A3IB-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_1_rg.sorted,TCGA-G2-A3IB-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_1_rg.sorted.bam,39.31,NA,0.15,58cfa832e4b0c9d6adf6d12e,TCGA-G2-A3IB-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_1_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-G2-A3IB-01A,AF53D51E-0B5C-437F-A1C0-EC5F55C49364,Primary Tumor,Illumina HiSeq,f78443a3-8c1b-429a-93c3-fcd93f3c6d55,Bladder,66,791E4058-E872-4AF8-A431-F5782811F02A,80F634F1-C34C-40CD-9F9B-BBFC18E9DE6E,TCGA-G2-A3IB-01A-11D-A210-26,HG19_Broad_variant,TCGA-G2-A3IB,TCGA-BLCA,NA,s2726,MD Anderson - Institute for Applied Cancer Science,MD Anderson,United States,NO,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa82fe4b0c9d6adf6b879,58cfa82fe4b0c9d6adf6b879,TCGA-A5-A0RA-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-A5-A0RA-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_6_rg.sorted,TCGA-A5-A0RA-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_6_rg.sorted.bam,7.22,2.16,0.16,58cfa82fe4b0c9d6adf6b879,TCGA-A5-A0RA-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0RA-10A,AFD710B8-D172-4AC4-9973-E969DB1ED231,Blood Derived Normal,Illumina HiSeq,0299a5c4-cb18-4ec1-bbdc-6305aab55198,Uterus,68,55E3C47B-0A82-4347-98BD-F4F3B6D0C7C7,DCEB13CD-497F-4206-9055-3D034AD58997,TCGA-A5-A0RA-10A-01D-A101-02,HG19_Broad_variant,TCGA-A5-A0RA,TCGA-UCEC,NA,s5197,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6c1e8,58cfa830e4b0c9d6adf6c1e8,TCGA-BT-A0YX-10A-01D-A10R_120920_SN1222_0150_AC1927ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BT-A0YX-10A-01D-A10R_120920_SN1222_0150_AC1927ACXX_s_7_rg.sorted,TCGA-BT-A0YX-10A-01D-A10R_120920_SN1222_0150_AC1927ACXX_s_7_rg.sorted.bam,20.99,1.95,0.16,58cfa830e4b0c9d6adf6c1e8,TCGA-BT-A0YX-10A-01D-A10R_120920_SN1222_0150_AC1927ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A0YX-10A,22473AD4-DF39-4716-B558-3C1409D5FA0E,Blood Derived Normal,Illumina HiSeq,a3d8075a-0e5e-4177-ba61-0f8cf6367170,Bladder,70,FA93053D-5905-4B53-B0E3-826150554E0B,F847285D-43DD-4EB6-8A97-E4224294318F,TCGA-BT-A0YX-10A-01D-A10R-02,HG19_Broad_variant,TCGA-BT-A0YX,TCGA-BLCA,NA,s3266,Harvard Medical School,University of Pittsburgh,None,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c8c2,58cfa831e4b0c9d6adf6c8c2,TCGA-DK-A3IL-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DK-A3IL-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_3_rg.sorted,TCGA-DK-A3IL-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_3_rg.sorted.bam,32.38,NA,0.16,58cfa831e4b0c9d6adf6c8c2,TCGA-DK-A3IL-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3IL-01A,178B28CD-99C3-48DC-8D09-1EF71B4CEE80,Primary Tumor,Illumina HiSeq,56a85daa-804e-4c68-b2be-c58cf3d5153e,Bladder,79,59D6683F-5EB7-493D-8E8E-78B88BE2CD70,F666A681-CA0D-4281-8E8A-156A24BBB63A,TCGA-DK-A3IL-01A-11D-A210-26,HG19_Broad_variant,TCGA-DK-A3IL,TCGA-BLCA,NA,s3282,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82ee4b0c9d6adf6afae,58cfa82ee4b0c9d6adf6afae,TCGA-05-4425-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_3_rg.sorted.filtered.,WGS,TCGA-05-4425-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_3_rg.sorted,TCGA-05-4425-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_3_rg.sorted.bam,357.4,1.9,0.15,58cfa82ee4b0c9d6adf6afae,TCGA-05-4425-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_3_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4425-01A,69B23036-ADD9-42C9-941F-02FB74D9B08C,Primary Tumor,Illumina HiSeq,bf137f71-691f-42f6-a29c-e37a457bad18,Lung,70,98BEE17E-0B07-40D8-A70F-3163DBFD9C79,C0DC5772-8A3E-43BE-9059-FC524A5183C9,TCGA-05-4425-01A-01D-1751-02,HG19_Broad_variant,TCGA-05-4425,TCGA-LUAD,NA,s10775,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IV
13722.58cfa830e4b0c9d6adf6c2bc,58cfa830e4b0c9d6adf6c2bc,TCGA-BJ-A0ZH-10A-01D-A10R_120711_SN208_0414_BD13L5ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BJ-A0ZH-10A-01D-A10R_120711_SN208_0414_BD13L5ACXX_s_4_rg.sorted,TCGA-BJ-A0ZH-10A-01D-A10R_120711_SN208_0414_BD13L5ACXX_s_4_rg.sorted.bam,10.76,1.39,0.16,58cfa830e4b0c9d6adf6c2bc,TCGA-BJ-A0ZH-10A-01D-A10R_120711_SN208_0414_BD13L5ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0ZH-10A,866CA8AD-ADC9-45D4-AD92-9F8F1A161DDF,Blood Derived Normal,Illumina HiSeq,765d1c43-26a7-45f8-9fd4-dff42c8b1d11,Thyroid,52,5B7A0DF5-39FE-4D79-8D47-0F1714872513,07B4F9EF-AF11-4B55-9FF0-1B947D7AC42A,TCGA-BJ-A0ZH-10A-01D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZH,TCGA-THCA,NA,s12100,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N1b,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage IVA
13722.58cfa831e4b0c9d6adf6cca6,58cfa831e4b0c9d6adf6cca6,TCGA-EJ-5497-01A-02D-1572_130125_SN1120_0233_AD1K3HACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EJ-5497-01A-02D-1572_130125_SN1120_0233_AD1K3HACXX_s_5_rg.sorted,TCGA-EJ-5497-01A-02D-1572_130125_SN1120_0233_AD1K3HACXX_s_5_rg.sorted.bam,209.7,1.9,0.16,58cfa831e4b0c9d6adf6cca6,TCGA-EJ-5497-01A-02D-1572_130125_SN1120_0233_AD1K3HACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5497-01A,DEE02265-D8DD-4379-AE08-72D72B03A570,Primary Tumor,Illumina HiSeq,453a9559-644e-46b9-8be3-7e4511448e7e,Prostate,47,317BE3B2-B7C1-4772-9E33-D55EB4B9FAA9,0B2246C7-CE2E-427D-BA10-4A2C942D0986,TCGA-EJ-5497-01A-02D-1572-02,HG19_Broad_variant,TCGA-EJ-5497,TCGA-PRAD,NA,s3944,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6ca8e,58cfa831e4b0c9d6adf6ca8e,TCGA-DK-A1A3-10A-01D-A13U_120921_SN208_0431_BD1D5FACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DK-A1A3-10A-01D-A13U_120921_SN208_0431_BD1D5FACXX_s_8_rg.sorted,TCGA-DK-A1A3-10A-01D-A13U_120921_SN208_0431_BD1D5FACXX_s_8_rg.sorted.bam,58.67,1.93,0.15,58cfa831e4b0c9d6adf6ca8e,TCGA-DK-A1A3-10A-01D-A13U_120921_SN208_0431_BD1D5FACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A3-10A,C5B20CCC-523D-491C-8536-008E05C57212,Blood Derived Normal,Illumina HiSeq,dea57f3e-8079-4c79-9961-51b68eba2dcc,Bladder,60,57DE21D1-0917-49B0-9813-7F4B7A94F6EB,CCBC402E-6FAB-4BB8-84CA-314649D26EF0,TCGA-DK-A1A3-10A-01D-A13U-02,HG19_Broad_variant,TCGA-DK-A1A3,TCGA-BLCA,NA,s2702,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c9c7,58cfa831e4b0c9d6adf6c9c7,TCGA-DQ-5630-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DQ-5630-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_1_rg.sorted,TCGA-DQ-5630-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_1_rg.sorted.bam,374.7,1.9,0.15,58cfa831e4b0c9d6adf6c9c7,TCGA-DQ-5630-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-DQ-5630-01A,91A712B5-A724-48D0-BA06-4F6857683463,Primary Tumor,Illumina HiSeq,865b23ff-32b6-41bf-8316-cde4e80d7873,Head and Neck,73,A0CDB208-E66F-4AD7-86FA-5077145A4A68,4C2960DA-103B-4620-ABCD-0EE586F39E0D,TCGA-DQ-5630-01A-01D-1868-02,HG19_Broad_variant,TCGA-DQ-5630,TCGA-HNSC,NA,s16346,Harvard Medical School,University of Michigan,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d0bd,58cfa832e4b0c9d6adf6d0bd,TCGA-IG-A3YA-10A-01D-A248_121211_SN208_0443_BC1H55ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-IG-A3YA-10A-01D-A248_121211_SN208_0443_BC1H55ACXX_s_2_rg.sorted,TCGA-IG-A3YA-10A-01D-A248_121211_SN208_0443_BC1H55ACXX_s_2_rg.sorted.bam,29.05,NA,0.14,58cfa832e4b0c9d6adf6d0bd,TCGA-IG-A3YA-10A-01D-A248_121211_SN208_0443_BC1H55ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A3YA-10A,7AB6DE57-D659-47F1-A70F-1B67650E99D7,Blood Derived Normal,Illumina HiSeq,30a64ae9-4650-4b8f-bc01-1f3f09a64837,Esophagus,53,D701CFE3-252E-4CC7-9A5E-017F73334E65,E376DDDA-2F21-470E-BAA2-15D1D3C5720B,TCGA-IG-A3YA-10A-01D-A248-26,HG19_Broad_variant,TCGA-IG-A3YA,TCGA-ESCA,NA,s1619,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T4,N0,Not available,Stage IIIA
13722.58cfa830e4b0c9d6adf6c2d8,58cfa830e4b0c9d6adf6c2d8,TCGA-BT-A3PH-01A-11D-A221_120902_SN1222_0147_AC195DACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BT-A3PH-01A-11D-A221_120902_SN1222_0147_AC195DACXX_s_7_rg.sorted,TCGA-BT-A3PH-01A-11D-A221_120902_SN1222_0147_AC195DACXX_s_7_rg.sorted.bam,56.18,NA,0.16,58cfa830e4b0c9d6adf6c2d8,TCGA-BT-A3PH-01A-11D-A221_120902_SN1222_0147_AC195DACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A3PH-01A,932BCDD4-5145-49E8-9A95-8A546396F572,Primary Tumor,Illumina HiSeq,9096dde9-2391-4c22-b816-2057b8adb483,Bladder,76,33A83E54-3BE5-4A68-8AB0-D31D0BCD3B67,4C010558-360B-44AF-A980-A1CCDF3AB9C7,TCGA-BT-A3PH-01A-11D-A221-26,HG19_Broad_variant,TCGA-BT-A3PH,TCGA-BLCA,142,s2699,MD Anderson - Institute for Applied Cancer Science,University of Pittsburgh,United States,NO,T3b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6cfe2,58cfa832e4b0c9d6adf6cfe2,TCGA-GV-A3JW-10A-01D-A210_120912_SN1222_0149_BD1CW3ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-GV-A3JW-10A-01D-A210_120912_SN1222_0149_BD1CW3ACXX_s_8_rg.sorted,TCGA-GV-A3JW-10A-01D-A210_120912_SN1222_0149_BD1CW3ACXX_s_8_rg.sorted.bam,38.54,NA,0.16,58cfa832e4b0c9d6adf6cfe2,TCGA-GV-A3JW-10A-01D-A210_120912_SN1222_0149_BD1CW3ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GV-A3JW-10A,3D644EAF-82FC-4BC7-93B7-3E600E8C6511,Blood Derived Normal,Illumina HiSeq,c147acc0-a739-4bac-a729-755e35fb2783,Bladder,74,0C439003-1B55-486C-B828-1B2BCAE2FD6A,23DC8C03-8CE9-4722-B57D-033CF7BF6BDB,TCGA-GV-A3JW-10A-01D-A210-26,HG19_Broad_variant,TCGA-GV-A3JW,TCGA-BLCA,NA,s2932,MD Anderson - Institute for Applied Cancer Science,BLN - Cleveland Clinic,United States,NO,T2,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c716,58cfa831e4b0c9d6adf6c716,TCGA-CV-7428-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CV-7428-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_1_rg.sorted,TCGA-CV-7428-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_1_rg.sorted.bam,6.13,NA,0.15,58cfa831e4b0c9d6adf6c716,TCGA-CV-7428-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7428-10A,90D3C240-5CB6-4601-A852-B5CDFBCD6483,Blood Derived Normal,Illumina HiSeq,ff322aea-a4fd-4377-81b7-e8cac37aa770,Head and Neck,47,52BAF3E9-1C5A-4DA5-81B9-729F84C2B36B,7E12A56F-C3E7-4AA4-BD55-D6A572587F98,TCGA-CV-7428-10A-01D-2317-26,HG19_Broad_variant,TCGA-CV-7428,TCGA-HNSC,1671,s16206,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6ce56,58cfa832e4b0c9d6adf6ce56,TCGA-GV-A3QF-10A-01D-A233_120904_SN1120_0186_BC1911ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-GV-A3QF-10A-01D-A233_120904_SN1120_0186_BC1911ACXX_s_5_rg.sorted,TCGA-GV-A3QF-10A-01D-A233_120904_SN1120_0186_BC1911ACXX_s_5_rg.sorted.bam,63.5,NA,0.15,58cfa832e4b0c9d6adf6ce56,TCGA-GV-A3QF-10A-01D-A233_120904_SN1120_0186_BC1911ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GV-A3QF-10A,47990D5E-A0E1-4752-86F5-4F5B84E219DF,Blood Derived Normal,Illumina HiSeq,c19d7e07-cd68-4880-a727-0e2717a37461,Bladder,79,96F2F621-E9E7-4E8F-B6B5-58B1DFF50FD1,2167BCA3-246E-492D-AC79-469FC22FFD2E,TCGA-GV-A3QF-10A-01D-A233-26,HG19_Broad_variant,TCGA-GV-A3QF,TCGA-BLCA,NA,s2929,MD Anderson - Institute for Applied Cancer Science,BLN - Cleveland Clinic,United States,NO,T3b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6ca02,58cfa831e4b0c9d6adf6ca02,TCGA-DJ-A1QG-10A-01D-A14U_120629_SN1222_0121_BD143UACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DJ-A1QG-10A-01D-A14U_120629_SN1222_0121_BD143UACXX_s_4_rg.sorted,TCGA-DJ-A1QG-10A-01D-A14U_120629_SN1222_0121_BD143UACXX_s_4_rg.sorted.bam,39.36,1.91,0.16,58cfa831e4b0c9d6adf6ca02,TCGA-DJ-A1QG-10A-01D-A14U_120629_SN1222_0121_BD143UACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QG-10A,CB29E795-7618-4882-A7E0-69D39787B80C,Blood Derived Normal,Illumina HiSeq,c478083a-0e34-4cfb-83ef-b3038b04fce7,Thyroid,62,083FAC8E-F1CF-4870-AB32-1DC6ABE973AA,B5210C9F-CEC7-4109-9447-E7FA1B19FD09,TCGA-DJ-A1QG-10A-01D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QG,TCGA-THCA,NA,s12364,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa832e4b0c9d6adf6cea9,58cfa832e4b0c9d6adf6cea9,TCGA-EJ-5516-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EJ-5516-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_3_rg.sorted,TCGA-EJ-5516-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_3_rg.sorted.bam,197.7,1.9,0.16,58cfa832e4b0c9d6adf6cea9,TCGA-EJ-5516-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5516-01A,1FD06207-54E0-4ABA-819C-C7F671871F39,Primary Tumor,Illumina HiSeq,80ba9751-2e29-4949-a07f-6e3542df8770,Prostate,49,84D2D822-204E-4031-AF83-E188BB72F3AF,7DBAAFC9-A93D-4FFB-9FF0-85FACD567555,TCGA-EJ-5516-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5516,TCGA-PRAD,NA,s4136,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cc46,58cfa831e4b0c9d6adf6cc46,TCGA-EJ-5521-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EJ-5521-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_4_rg.sorted,TCGA-EJ-5521-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_4_rg.sorted.bam,212.4,1.9,0.15,58cfa831e4b0c9d6adf6cc46,TCGA-EJ-5521-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5521-10A,D44D4BCB-BEB1-4464-ACD2-9972751F5018,Blood Derived Normal,Illumina HiSeq,a00f8885-cc89-43c1-bf1a-d15ddf152756,Prostate,63,77E4A2C2-79F8-400E-8231-10D06E4CB32C,4A35BBF6-F6FA-4CD2-B673-8227EC846063,TCGA-EJ-5521-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5521,TCGA-PRAD,NA,s3601,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cbaa,58cfa831e4b0c9d6adf6cbaa,TCGA-EJ-5526-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EJ-5526-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_3_rg.sorted,TCGA-EJ-5526-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_3_rg.sorted.bam,378.7,1.9,0.15,58cfa831e4b0c9d6adf6cbaa,TCGA-EJ-5526-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5526-01A,EEC48399-5660-4B25-8D34-191B54315C72,Primary Tumor,Illumina HiSeq,e57f50b5-06be-4be0-8b02-706bfb439f25,Prostate,56,4DBE4FA2-308F-4D5B-BF33-4C051F7DC537,4AC5F198-9558-42C9-8285-91D3F826E0E9,TCGA-EJ-5526-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5526,TCGA-PRAD,NA,s4143,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c74d,58cfa831e4b0c9d6adf6c74d,TCGA-D1-A177-01A-21D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-D1-A177-01A-21D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_1_rg.sorted,TCGA-D1-A177-01A-21D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_1_rg.sorted.bam,86.4,1.36,0.15,58cfa831e4b0c9d6adf6c74d,TCGA-D1-A177-01A-21D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A177-01A,E8C58D8B-51D7-4599-AF79-469EE6F269DB,Primary Tumor,Illumina HiSeq,cf08e174-408a-4212-8caf-72692bcb55af,Uterus,70,97587FD4-0F6F-4AF5-AC0A-7328ABB40E9C,2F6D7D10-84AA-48A6-9B8E-9CBB257C653D,TCGA-D1-A177-01A-21D-A12F-02,HG19_Broad_variant,TCGA-D1-A177,TCGA-UCEC,NA,s4800,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c9d5,58cfa831e4b0c9d6adf6c9d5,TCGA-DK-A3IQ-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DK-A3IQ-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_3_rg.sorted,TCGA-DK-A3IQ-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_3_rg.sorted.bam,22.29,NA,0.16,58cfa831e4b0c9d6adf6c9d5,TCGA-DK-A3IQ-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3IQ-01A,E44F60EC-66C4-45A2-A003-0A1FAF1D6E03,Primary Tumor,Illumina HiSeq,edc43d06-7118-46e7-894e-d40138b6d69c,Bladder,74,1E375786-DB8F-4A8C-BA1C-C6DD7DE1A9BE,DB940CE0-2357-4E83-AA19-AEA672A121D9,TCGA-DK-A3IQ-01A-31D-A210-26,HG19_Broad_variant,TCGA-DK-A3IQ,TCGA-BLCA,NA,s2894,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6cd10,58cfa831e4b0c9d6adf6cd10,TCGA-EJ-5494-10A-01D-1573_130125_SN208_0451_BD1RB1ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EJ-5494-10A-01D-1573_130125_SN208_0451_BD1RB1ACXX_s_8_rg.sorted,TCGA-EJ-5494-10A-01D-1573_130125_SN208_0451_BD1RB1ACXX_s_8_rg.sorted.bam,1044.4,1.9,0.16,58cfa831e4b0c9d6adf6cd10,TCGA-EJ-5494-10A-01D-1573_130125_SN208_0451_BD1RB1ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5494-10A,E27C50E2-2A41-4F8C-9EF8-2BC51FB0C23E,Blood Derived Normal,Illumina HiSeq,7138c14a-2dab-4b19-b460-da77aa8d9819,Prostate,50,4AF92BBC-2716-4CBC-90F3-F0DB33FE4113,8C1C3F1B-CF15-44A3-9980-E614DE09A5A3,TCGA-EJ-5494-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5494,TCGA-PRAD,NA,s3942,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d036,58cfa832e4b0c9d6adf6d036,TCGA-FU-A3WB-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FU-A3WB-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_5_rg.sorted,TCGA-FU-A3WB-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_5_rg.sorted.bam,44.44,NA,0.16,58cfa832e4b0c9d6adf6d036,TCGA-FU-A3WB-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-FU-A3WB-01A,6868BA1D-B612-454C-8146-74AF2F573D76,Primary Tumor,Illumina HiSeq,39124a1d-9323-40ae-aee5-6fb32cf4a565,Cervix,43,0334B0B7-115E-40A0-960B-6A3365CDA3AD,52C1B6D6-A160-4FFB-945C-6FB3B29EFEF9,TCGA-FU-A3WB-01A-11D-A232-26,HG19_Broad_variant,TCGA-FU-A3WB,TCGA-CESC,NA,s1203,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T2a2,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d655,58cfa832e4b0c9d6adf6d655,TCGA-LN-A49O-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_1_rg.sorted.filtered.,WGS,TCGA-LN-A49O-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_1_rg.sorted,TCGA-LN-A49O-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_1_rg.sorted.bam,20.64,NA,0.16,58cfa832e4b0c9d6adf6d655,TCGA-LN-A49O-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_1_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49O-01A,3DF1B9DB-D900-47D2-839D-3900829CB2A9,Primary Tumor,Illumina HiSeq,e460c5ae-4179-406e-a1fd-fb7b1c7403ae,Esophagus,47,37A1045E-A566-4BC0-88CA-A54C5426A96D,C5253C04-01D3-40D9-85A2-155F9D0360C3,TCGA-LN-A49O-01A-11D-A248-26,HG19_Broad_variant,TCGA-LN-A49O,TCGA-ESCA,NA,s1863,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa832e4b0c9d6adf6d217,58cfa832e4b0c9d6adf6d217,TCGA-IR-A3LF-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-IR-A3LF-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_4_rg.sorted,TCGA-IR-A3LF-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_4_rg.sorted.bam,21.55,NA,0.16,58cfa832e4b0c9d6adf6d217,TCGA-IR-A3LF-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-IR-A3LF-10A,785DDEA1-399D-47D8-B2B0-39E95EAA24B5,Blood Derived Normal,Illumina HiSeq,d1073f97-3ce5-4d38-9ccc-813fee28fb63,Cervix,64,BACC5092-B6AB-4A28-9D55-FA3AD22C3EEF,757BABBC-9A2D-4BF5-B298-48222FEA7BD8,TCGA-IR-A3LF-10A-01D-A232-26,HG19_Broad_variant,TCGA-IR-A3LF,TCGA-CESC,NA,s1209,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T1b1,N0,Endocervical Adenocarcinoma of the Usual Type,Not available
13722.58cfa82fe4b0c9d6adf6b81e,58cfa82fe4b0c9d6adf6b81e,TCGA-A5-A0GE-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_1_rg.sorted.filtered.,WGS,TCGA-A5-A0GE-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_1_rg.sorted,TCGA-A5-A0GE-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_1_rg.sorted.bam,82.92,2,0.17,58cfa82fe4b0c9d6adf6b81e,TCGA-A5-A0GE-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_1_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GE-01A,A587E62E-430E-4F1B-82B7-6FBE856FDAF1,Primary Tumor,Illumina HiSeq,d3918efd-f063-4ea7-b839-9c0c143fd07c,Uterus,38,20C3F64D-ACF6-45B3-9ACE-2F93B3A951C8,3E23FB82-C875-460A-B19D-5EF9DCC58B9A,TCGA-A5-A0GE-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0GE,TCGA-UCEC,NA,s4995,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d658,58cfa832e4b0c9d6adf6d658,TCGA-LN-A4MQ-10A-01D-A28P_131120_SN1222_0230_BC29YPACXX_s_6_rg.sorted.filtered.,WGS,TCGA-LN-A4MQ-10A-01D-A28P_131120_SN1222_0230_BC29YPACXX_s_6_rg.sorted,TCGA-LN-A4MQ-10A-01D-A28P_131120_SN1222_0230_BC29YPACXX_s_6_rg.sorted.bam,86.39,NA,0.16,58cfa832e4b0c9d6adf6d658,TCGA-LN-A4MQ-10A-01D-A28P_131120_SN1222_0230_BC29YPACXX_s_6_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A4MQ-10A,33C0199A-BE0C-46D1-BB1E-889BFAEDF20B,Blood Derived Normal,Illumina HiSeq,51c059e7-2bfb-4c2d-8c4e-fb79084111b8,Esophagus,46,76ED11D7-1BE7-4C86-8708-59AA29079DAE,C7BBECA9-9DF3-4A4A-A08B-D3520BCE94C2,TCGA-LN-A4MQ-10A-01D-A28P-26,HG19_Broad_variant,TCGA-LN-A4MQ,TCGA-ESCA,NA,s1875,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N1,Not available,Stage III
13722.58cfa831e4b0c9d6adf6cb4a,58cfa831e4b0c9d6adf6cb4a,TCGA-EE-A2M7-06A-11D-A18Y_120724_SN208_0417_AC117BACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EE-A2M7-06A-11D-A18Y_120724_SN208_0417_AC117BACXX_s_4_rg.sorted,TCGA-EE-A2M7-06A-11D-A18Y_120724_SN208_0417_AC117BACXX_s_4_rg.sorted.bam,53.73,NA,0.15,58cfa831e4b0c9d6adf6cb4a,TCGA-EE-A2M7-06A-11D-A18Y_120724_SN208_0417_AC117BACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2M7-06A,7B4BCF0E-EC55-489B-870F-A4360A6BEA2F,Metastatic,Illumina HiSeq,7212211c-0722-4a90-a452-49224f4e3e43,Skin,66,F2C3A0AD-8C29-45AA-BB06-C4A6641F136F,936FC6FD-3129-43C2-B102-2CBCD4E31DD2,TCGA-EE-A2M7-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2M7,TCGA-SKCM,877,s7850,Harvard Medical School,University of Sydney,Australia,NO,T3a,N0,Not available,Stage II
13722.58cfa831e4b0c9d6adf6cb92,58cfa831e4b0c9d6adf6cb92,TCGA-EE-A2GR-10A-01D-A190_120726_SN590_0171_AD13PJACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EE-A2GR-10A-01D-A190_120726_SN590_0171_AD13PJACXX_s_5_rg.sorted,TCGA-EE-A2GR-10A-01D-A190_120726_SN590_0171_AD13PJACXX_s_5_rg.sorted.bam,16.7,NA,0.15,58cfa831e4b0c9d6adf6cb92,TCGA-EE-A2GR-10A-01D-A190_120726_SN590_0171_AD13PJACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2GR-10A,919DFC28-6B55-452E-884C-48CB86802AC2,Blood Derived Normal,Illumina HiSeq,48e07f50-8a21-4cbc-a141-7b4b16e333f5,Skin,78,733FB926-7791-46B4-BF47-848ED4B43177,6E77C52C-3C48-4AF0-9F0D-393CE3C268F2,TCGA-EE-A2GR-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2GR,TCGA-SKCM,NA,s7514,Harvard Medical School,University of Sydney,Australia,NO,T4,N0,Not available,Stage II
13722.58cfa832e4b0c9d6adf6d034,58cfa832e4b0c9d6adf6d034,TCGA-GC-A3RD-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_7_rg.sorted.filtered.,WGS,TCGA-GC-A3RD-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_7_rg.sorted,TCGA-GC-A3RD-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_7_rg.sorted.bam,46.83,NA,0.16,58cfa832e4b0c9d6adf6d034,TCGA-GC-A3RD-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GC-A3RD-01A,6A2155B3-915C-41B1-B730-32E55E0C1FBD,Primary Tumor,Illumina HiSeq,27573bf6-b72d-47e6-93f7-38d2887d8b32,Bladder,83,1C60F60E-A3C6-43A1-A56E-BA68801D2D90,C9E9DC46-2917-47BE-92DA-9C40C6F13500,TCGA-GC-A3RD-01A-12D-A233-26,HG19_Broad_variant,TCGA-GC-A3RD,TCGA-BLCA,NA,s2731,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c59e,58cfa831e4b0c9d6adf6c59e,TCGA-CG-4465-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_1_rg.sorted.filtered.,WGS,TCGA-CG-4465-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_1_rg.sorted,TCGA-CG-4465-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_1_rg.sorted.bam,122.2,1.9,0.13,58cfa831e4b0c9d6adf6c59e,TCGA-CG-4465-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_1_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4465-01A,C9AB5BF4-092A-420F-9B90-87DEEA58104C,Primary Tumor,Illumina HiSeq,543d167f-2418-4dea-b387-5baa5dc4309f,Stomach,69,89DAB798-0B26-470C-82AF-1B23C83FE4F5,2CCE681F-F5C6-496E-96C3-21046ECEAA56,TCGA-CG-4465-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4465,TCGA-STAD,274,s14411,Harvard Medical School,Indivumed,Germany,NO,T4,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IV
13722.58cfa82fe4b0c9d6adf6b92a,58cfa82fe4b0c9d6adf6b92a,TCGA-91-6828-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_3_rg.sorted.filtered.,WGS,TCGA-91-6828-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_3_rg.sorted,TCGA-91-6828-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_3_rg.sorted.bam,349.7,1.9,0.14,58cfa82fe4b0c9d6adf6b92a,TCGA-91-6828-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-91-6828-01A,9536E32D-2707-48D2-A36D-08C521665BB9,Primary Tumor,Illumina HiSeq,94e2b6af-1f25-4698-9414-f3d916d26aee,Lung,70,CFE0F0E4-D8BF-40CE-99F1-2BF99CECA18B,2C0D4A9F-857D-4C6F-B616-304AB5922A2F,TCGA-91-6828-01A-11D-1853-02,HG19_Broad_variant,TCGA-91-6828,TCGA-LUAD,NA,s10802,Harvard Medical School,ABS - IUPUI,United States,NO,T1a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82fe4b0c9d6adf6b69c,58cfa82fe4b0c9d6adf6b69c,TCGA-44-6777-11A-01D-1853_120123_SN590_0134_AC0DJKACXX_s_3_rg.sorted.filtered.,WGS,TCGA-44-6777-11A-01D-1853_120123_SN590_0134_AC0DJKACXX_s_3_rg.sorted,TCGA-44-6777-11A-01D-1853_120123_SN590_0134_AC0DJKACXX_s_3_rg.sorted.bam,118.7,1.9,0.14,58cfa82fe4b0c9d6adf6b69c,TCGA-44-6777-11A-01D-1853_120123_SN590_0134_AC0DJKACXX_s_3_rg.sorted.bam,Dead,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-44-6777-11A,349E6F38-2C67-4A69-A777-B9173A2A27CF,Solid Tissue Normal,Illumina HiSeq,e60ccd22-0cc2-4758-8098-0d5f331aceb1,Lung,85,5F42537F-8C2A-48B6-8D9C-1F409711D128,D3991B40-64D4-4B15-8CA9-E4F64F877210,TCGA-44-6777-11A-01D-1853-02,HG19_Broad_variant,TCGA-44-6777,TCGA-LUAD,987,s11452,Harvard Medical School,Christiana Healthcare,United States,NO,T2,NX,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c432,58cfa831e4b0c9d6adf6c432,TCGA-C4-A0F6-10A-01D-A10R_120920_SN1222_0150_AC1927ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-C4-A0F6-10A-01D-A10R_120920_SN1222_0150_AC1927ACXX_s_3_rg.sorted,TCGA-C4-A0F6-10A-01D-A10R_120920_SN1222_0150_AC1927ACXX_s_3_rg.sorted.bam,14.74,2.11,0.15,58cfa831e4b0c9d6adf6c432,TCGA-C4-A0F6-10A-01D-A10R_120920_SN1222_0150_AC1927ACXX_s_3_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Bladder Urothelial Carcinoma,Aligned reads,TCGA-C4-A0F6-10A,4FF9B4F2-6D04-4FED-8796-155902A8BF28,Blood Derived Normal,Illumina HiSeq,b54ac4b7-3c94-4496-bf96-61b3ca3db0c5,Bladder,82,5C24259B-6AFE-4FE2-A030-92659C071362,A44A6075-FCCC-4F8B-B11B-9ECD1B54D5AF,TCGA-C4-A0F6-10A-01D-A10R-02,HG19_Broad_variant,TCGA-C4-A0F6,TCGA-BLCA,NA,s2864,Harvard Medical School,Indivumed,Germany,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6cbca,58cfa831e4b0c9d6adf6cbca,TCGA-EJ-5517-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EJ-5517-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_5_rg.sorted,TCGA-EJ-5517-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_5_rg.sorted.bam,52.7,1.9,0.15,58cfa831e4b0c9d6adf6cbca,TCGA-EJ-5517-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5517-01A,4B9AA301-D2E3-47F3-B724-A34F420B2B6B,Primary Tumor,Illumina HiSeq,add98c6f-07de-48db-b930-82504d0dd976,Prostate,55,B5FE6254-D1C6-4BA2-BD75-5CAF4FB2E2B7,62E5A068-01A5-40EC-8FF9-097D627127A0,TCGA-EJ-5517-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5517,TCGA-PRAD,NA,s3437,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c12a,58cfa830e4b0c9d6adf6c12a,TCGA-BS-A0U7-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BS-A0U7-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_7_rg.sorted,TCGA-BS-A0U7-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_7_rg.sorted.bam,18.15,1.88,0.15,58cfa830e4b0c9d6adf6c12a,TCGA-BS-A0U7-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0U7-10A,282DDC43-922D-4F1F-80C7-6BA2DE23B7BC,Blood Derived Normal,Illumina HiSeq,1d024fe0-273a-4aac-958d-5f2ece359b9b,Uterus,63,9D663867-F946-46AA-B126-959232A2E855,30687D43-CBDD-4557-A792-302873F3F75E,TCGA-BS-A0U7-10A-01D-A101-02,HG19_Broad_variant,TCGA-BS-A0U7,TCGA-UCEC,935,s5014,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6ca92,58cfa831e4b0c9d6adf6ca92,TCGA-DQ-5624-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DQ-5624-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_5_rg.sorted,TCGA-DQ-5624-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_5_rg.sorted.bam,98.7,1.9,0.15,58cfa831e4b0c9d6adf6ca92,TCGA-DQ-5624-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-DQ-5624-01A,B4A41682-4ACA-4F1D-BACD-66F5E6EC7466,Primary Tumor,Illumina HiSeq,72ea153a-e312-4f8e-8fa6-bd705df2b106,Head and Neck,43,39A74037-6C20-4713-A6AA-E972218EFF90,45F819EB-F6B5-4B82-9E47-060B2E111851,TCGA-DQ-5624-01A-01D-1868-02,HG19_Broad_variant,TCGA-DQ-5624,TCGA-HNSC,NA,s15532,Harvard Medical School,University of Michigan,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6c25c,58cfa830e4b0c9d6adf6c25c,TCGA-C5-A2LS-10A-01D-A232_140124_SN1120_0291_AC2PHAACXX_s_8_rg.sorted.filtered.,WGS,TCGA-C5-A2LS-10A-01D-A232_140124_SN1120_0291_AC2PHAACXX_s_8_rg.sorted,TCGA-C5-A2LS-10A-01D-A232_140124_SN1120_0291_AC2PHAACXX_s_8_rg.sorted.bam,19,NA,0.17,58cfa830e4b0c9d6adf6c25c,TCGA-C5-A2LS-10A-01D-A232_140124_SN1120_0291_AC2PHAACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A2LS-10A,185E1520-92EE-4AF5-AF15-FBEEFB352C99,Blood Derived Normal,Illumina HiSeq,2f77e8f5-e810-408a-aa50-caa8f614c77a,Cervix,37,82D8E275-5D14-4CB5-9C88-2D0E3F863A27,0BC2434B-6D84-4338-A55C-284A338A82C5,TCGA-C5-A2LS-10A-01D-A232-26,HG19_Broad_variant,TCGA-C5-A2LS,TCGA-CESC,NA,s1357,MD Anderson - Institute for Applied Cancer Science,Medical College of Wisconsin,United States,NO,T1b2,N0,Endocervical Adenocarcinoma of the Usual Type,Not available
13722.58cfa831e4b0c9d6adf6cd8a,58cfa831e4b0c9d6adf6cd8a,TCGA-FE-A235-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FE-A235-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_2_rg.sorted,TCGA-FE-A235-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_2_rg.sorted.bam,28.74,1.95,0.17,58cfa831e4b0c9d6adf6cd8a,TCGA-FE-A235-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A235-10A,C781B49E-D08F-49E6-B774-7CFE4100E92D,Blood Derived Normal,Illumina HiSeq,008e77b4-0033-406b-9e24-84f55f7caf34,Thyroid,26,58E2000A-E322-43BF-B0DF-9C0757145F55,CB7CC52D-4E2A-4FDE-B45C-7AE89FB188C9,TCGA-FE-A235-10A-01D-A16N-02,HG19_Broad_variant,TCGA-FE-A235,TCGA-THCA,NA,s12649,Harvard Medical School,Ohio State University,United States,NO,T2,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82ee4b0c9d6adf6afa4,58cfa82ee4b0c9d6adf6afa4,TCGA-05-4425-10A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_4_rg.sorted.filtered.,WGS,TCGA-05-4425-10A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_4_rg.sorted,TCGA-05-4425-10A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_4_rg.sorted.bam,294.7,1.9,0.16,58cfa82ee4b0c9d6adf6afa4,TCGA-05-4425-10A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4425-10A,69B23036-ADD9-42C9-941F-02FB74D9B08C,Blood Derived Normal,Illumina HiSeq,bfe20429-49d0-4a72-a8e2-5254fa77bbc1,Lung,70,21FAC452-927C-4827-95B7-50F7026BBE81,5780D4D6-681B-440D-B7A6-31012DED5352,TCGA-05-4425-10A-01D-1751-02,HG19_Broad_variant,TCGA-05-4425,TCGA-LUAD,NA,s11444,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IV
13722.58cfa82fe4b0c9d6adf6b724,58cfa82fe4b0c9d6adf6b724,TCGA-71-6725-10A-01D-1853_120305_SN1120_0119_BD0REAACXX_s_1_rg.sorted.filtered.,WGS,TCGA-71-6725-10A-01D-1853_120305_SN1120_0119_BD0REAACXX_s_1_rg.sorted,TCGA-71-6725-10A-01D-1853_120305_SN1120_0119_BD0REAACXX_s_1_rg.sorted.bam,166,1.9,0.15,58cfa82fe4b0c9d6adf6b724,TCGA-71-6725-10A-01D-1853_120305_SN1120_0119_BD0REAACXX_s_1_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-71-6725-10A,4B7CD595-E7F9-45A8-B736-A8C7C42D9539,Blood Derived Normal,Illumina HiSeq,6ab86bce-d92f-4638-a2d7-4761bcc675d7,Lung,48,9BE42F9A-4AC0-427F-A1BA-45FB541174B7,62E9B0D2-3A69-47EA-BE27-551213D303CC,TCGA-71-6725-10A-01D-1853-02,HG19_Broad_variant,TCGA-71-6725,TCGA-LUAD,NA,s10665,Harvard Medical School,ILSbio,Vietnam,NO,T2,N0,Lung Papillary Adenocarcinoma,Stage IB
13722.58cfa830e4b0c9d6adf6c24e,58cfa830e4b0c9d6adf6c24e,TCGA-BT-A20J-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BT-A20J-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_2_rg.sorted,TCGA-BT-A20J-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_2_rg.sorted.bam,14.88,1.95,0.16,58cfa830e4b0c9d6adf6c24e,TCGA-BT-A20J-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20J-11A,74B1E72D-FDD0-4D84-8858-3BB32D58FF7E,Solid Tissue Normal,Illumina HiSeq,da071b6a-1e54-41d9-86c9-47599382a770,Bladder,75,C53A13EF-44CD-49AF-B69C-82C5C11A3AB4,61898C3F-4C48-4E04-9B67-BE546BC7C662,TCGA-BT-A20J-11A-11D-A14U-02,HG19_Broad_variant,TCGA-BT-A20J,TCGA-BLCA,579,s3265,Harvard Medical School,University of Pittsburgh,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c3e2,58cfa831e4b0c9d6adf6c3e2,TCGA-CH-5743-01A-21D-1572_130104_SN1120_0209_BD1KP6ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CH-5743-01A-21D-1572_130104_SN1120_0209_BD1KP6ACXX_s_3_rg.sorted,TCGA-CH-5743-01A-21D-1572_130104_SN1120_0209_BD1KP6ACXX_s_3_rg.sorted.bam,245.7,1.9,0.15,58cfa831e4b0c9d6adf6c3e2,TCGA-CH-5743-01A-21D-1572_130104_SN1120_0209_BD1KP6ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5743-01A,2DEE4BD8-B00E-4F8A-BFEA-5D8D1A068202,Primary Tumor,Illumina HiSeq,1c58f516-3239-499a-bbcd-f5a8d619d796,Prostate,66,6BD8573D-535F-4F6D-8EAF-60918B5DA578,EE5F51E6-F989-4380-A86F-29CBF50BA03A,TCGA-CH-5743-01A-21D-1572-02,HG19_Broad_variant,TCGA-CH-5743,TCGA-PRAD,NA,s3588,Harvard Medical School,Indivumed,Germany,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cb3c,58cfa831e4b0c9d6adf6cb3c,TCGA-EE-A2GP-10A-01D-A190_120726_SN590_0171_AD13PJACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EE-A2GP-10A-01D-A190_120726_SN590_0171_AD13PJACXX_s_6_rg.sorted,TCGA-EE-A2GP-10A-01D-A190_120726_SN590_0171_AD13PJACXX_s_6_rg.sorted.bam,52.44,NA,0.16,58cfa831e4b0c9d6adf6cb3c,TCGA-EE-A2GP-10A-01D-A190_120726_SN590_0171_AD13PJACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2GP-10A,06F09D1C-BA44-4CF9-A518-762D241A30DB,Blood Derived Normal,Illumina HiSeq,202c00c0-a3f0-4582-a62c-9eea259bd599,Skin,80,AFD87E85-3310-41E5-8F66-9429CBD6DBCD,E4F81123-781A-407A-B922-C6CE48CFF9EC,TCGA-EE-A2GP-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2GP,TCGA-SKCM,423,s7510,Harvard Medical School,University of Sydney,Australia,NO,T4b,N1a,Not available,Stage IIIB
13722.58cfa831e4b0c9d6adf6c602,58cfa831e4b0c9d6adf6c602,TCGA-CQ-6225-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CQ-6225-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_1_rg.sorted,TCGA-CQ-6225-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_1_rg.sorted.bam,191.7,1.9,0.15,58cfa831e4b0c9d6adf6c602,TCGA-CQ-6225-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-6225-01A,90F44998-3C05-44B2-9501-BBD0F43C5147,Primary Tumor,Illumina HiSeq,a96392ab-a0d3-4c22-a2e2-08b58bb3e61b,Head and Neck,65,E907D8D4-C4C6-441F-9F19-FF3746E5D13E,40BFD664-E699-4F0D-9670-30D0F5CC8728,TCGA-CQ-6225-01A-11D-1911-02,HG19_Broad_variant,TCGA-CQ-6225,TCGA-HNSC,403,s16186,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6cbf3,58cfa831e4b0c9d6adf6cbf3,TCGA-EA-A1QS-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EA-A1QS-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_7_rg.sorted,TCGA-EA-A1QS-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_7_rg.sorted.bam,46.7,NA,0.16,58cfa831e4b0c9d6adf6cbf3,TCGA-EA-A1QS-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EA-A1QS-10A,6F9D21C0-3B88-450D-A249-3E9BAFBA2DFA,Blood Derived Normal,Illumina HiSeq,59f4f825-bca8-4cb6-b942-b3af019dd252,Cervix,46,DAC3E9E0-2A56-450B-9F7D-81B57BB8607E,1E24844B-8DEB-4AAB-B837-0CB92CEB33F7,TCGA-EA-A1QS-10A-01D-A232-26,HG19_Broad_variant,TCGA-EA-A1QS,TCGA-CESC,NA,s1521,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6c07c,58cfa830e4b0c9d6adf6c07c,TCGA-BJ-A0ZH-01A-11D-A10R_120711_SN208_0414_BD13L5ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BJ-A0ZH-01A-11D-A10R_120711_SN208_0414_BD13L5ACXX_s_2_rg.sorted,TCGA-BJ-A0ZH-01A-11D-A10R_120711_SN208_0414_BD13L5ACXX_s_2_rg.sorted.bam,57.81,1.95,0.16,58cfa830e4b0c9d6adf6c07c,TCGA-BJ-A0ZH-01A-11D-A10R_120711_SN208_0414_BD13L5ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0ZH-01A,866CA8AD-ADC9-45D4-AD92-9F8F1A161DDF,Primary Tumor,Illumina HiSeq,488591c3-7ba4-421a-9fc0-36d0604c8175,Thyroid,52,01EE736B-F907-465B-9142-C50BE0A3461B,8B8B2852-9D53-4654-A37C-2749C0F264ED,TCGA-BJ-A0ZH-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZH,TCGA-THCA,NA,s12096,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N1b,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage IVA
13722.58cfa831e4b0c9d6adf6c9d4,58cfa831e4b0c9d6adf6c9d4,TCGA-DB-5276-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DB-5276-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_5_rg.sorted,TCGA-DB-5276-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_5_rg.sorted.bam,52.7,1.9,0.15,58cfa831e4b0c9d6adf6c9d4,TCGA-DB-5276-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DB-5276-01A,9D0C1552-00A7-4F0A-A04A-A82E721EE4E3,Primary Tumor,Illumina HiSeq,02206442-a052-4c44-a4b8-1467493df2eb,Brain,32,11CB167F-CD54-409F-BFEA-511E620C96FC,5396382E-9FBC-43DA-9C88-DF17FFDA1E2B,TCGA-DB-5276-01A-01D-1465-02,HG19_Broad_variant,TCGA-DB-5276,TCGA-LGG,NA,s8131,Harvard Medical School,Mayo Clinic - Rochester,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa832e4b0c9d6adf6d078,58cfa832e4b0c9d6adf6d078,TCGA-HC-7081-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_4_rg.sorted.filtered.,WGS,TCGA-HC-7081-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_4_rg.sorted,TCGA-HC-7081-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_4_rg.sorted.bam,130.7,NA,0.14,58cfa832e4b0c9d6adf6d078,TCGA-HC-7081-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,Not available,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7081-01A,3DA2E90E-6450-4286-8C74-08DBECBFD788,Primary Tumor,Illumina HiSeq,f44b51c1-3e9f-49b0-817b-b31a58264c39,Prostate,62,D4EAA3C5-A0F0-4CD7-8B93-73DFB09B359A,AA4E666F-E577-4F00-82A7-EBC3B8739960,TCGA-HC-7081-01A-11D-1957-02,HG19_Broad_variant,TCGA-HC-7081,TCGA-PRAD,NA,s3805,Harvard Medical School,International Genomics Consortium,United States,NO,T3b,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c5cc,58cfa831e4b0c9d6adf6c5cc,TCGA-BR-4368-11A-01D-1154_130815_VM001_0002_VMR0002CXX_s_6_rg.sorted.filtered.,WGS,TCGA-BR-4368-11A-01D-1154_130815_VM001_0002_VMR0002CXX_s_6_rg.sorted,TCGA-BR-4368-11A-01D-1154_130815_VM001_0002_VMR0002CXX_s_6_rg.sorted.bam,192.3,1.9,0.15,58cfa831e4b0c9d6adf6c5cc,TCGA-BR-4368-11A-01D-1154_130815_VM001_0002_VMR0002CXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4368-11A,449BF2BE-B20E-4AD0-9FFB-910D83114018,Solid Tissue Normal,Illumina HiSeq,8d384344-e3de-49fd-b94d-7bf0f0c03920,Stomach,78,F294C5A3-6A15-4B8B-B8B6-BA0940EB2F00,AACEE07D-E09A-4EB7-B320-41F082A241E2,TCGA-BR-4368-11A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4368,TCGA-STAD,NA,s14616,Harvard Medical School,Asterand,Russia,NO,T4,N2,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa830e4b0c9d6adf6bda2,58cfa830e4b0c9d6adf6bda2,TCGA-BF-A1PX-01A-12D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BF-A1PX-01A-12D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_2_rg.sorted,TCGA-BF-A1PX-01A-12D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_2_rg.sorted.bam,42.01,NA,0.16,58cfa830e4b0c9d6adf6bda2,TCGA-BF-A1PX-01A-12D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-BF-A1PX-01A,197AC33E-D5DF-40DE-92F2-6EF7FE2AD6DD,Primary Tumor,Illumina HiSeq,4a62234d-e7fe-4cd1-a319-baafc27c9db8,Skin,56,EE2F9863-0DAE-4830-A780-E7745414BC3D,98B49A52-61EC-4A87-B2DD-EEFD6E0E028F,TCGA-BF-A1PX-01A-12D-A18Z-02,HG19_Broad_variant,TCGA-BF-A1PX,TCGA-SKCM,282,s7825,Harvard Medical School,Cureline,Russia,NO,T4b,N2a,Not available,Stage IIIB
13722.58cfa830e4b0c9d6adf6c30e,58cfa830e4b0c9d6adf6c30e,TCGA-BR-6801-10A-01D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BR-6801-10A-01D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_6_rg.sorted,TCGA-BR-6801-10A-01D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_6_rg.sorted.bam,187,1.9,0.15,58cfa830e4b0c9d6adf6c30e,TCGA-BR-6801-10A-01D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6801-10A,24FED326-BDCF-4C20-A06E-7C1C3D6C9CC5,Blood Derived Normal,Illumina HiSeq,ad1f6971-d904-467d-a98d-2bc17299540c,Stomach,70,CC6EAF22-F6AB-413B-9495-BE715DA438E2,BC80C770-044A-41A1-8D11-171F99950B4C,TCGA-BR-6801-10A-01D-1880-02,HG19_Broad_variant,TCGA-BR-6801,TCGA-STAD,NA,s15449,Harvard Medical School,Asterand,Russia,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA
13722.58cfa832e4b0c9d6adf6cfa4,58cfa832e4b0c9d6adf6cfa4,TCGA-FU-A3NI-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_7_rg.sorted.filtered.,WGS,TCGA-FU-A3NI-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_7_rg.sorted,TCGA-FU-A3NI-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_7_rg.sorted.bam,20.76,NA,0.15,58cfa832e4b0c9d6adf6cfa4,TCGA-FU-A3NI-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-FU-A3NI-10A,DAC27C24-CDBF-4527-9214-178FDE3D098A,Blood Derived Normal,Illumina HiSeq,012f7e0c-b279-426a-9979-aa846fda7c90,Cervix,45,E949DB99-6FE2-48F2-9D45-469A7909BA87,9A07D593-5276-417F-98A8-C8605057CD75,TCGA-FU-A3NI-10A-01D-A245-26,HG19_Broad_variant,TCGA-FU-A3NI,TCGA-CESC,NA,s1532,MD Anderson - RPPA Core Facility (Proteomics),International Genomics Consortium,United States,NO,T1b1,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6be0d,58cfa830e4b0c9d6adf6be0d,TCGA-BG-A0M9-10A-01D-A101_120406_SN208_0281_AC0KDBACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BG-A0M9-10A-01D-A101_120406_SN208_0281_AC0KDBACXX_s_6_rg.sorted,TCGA-BG-A0M9-10A-01D-A101_120406_SN208_0281_AC0KDBACXX_s_6_rg.sorted.bam,7.78,2.03,0.16,58cfa830e4b0c9d6adf6be0d,TCGA-BG-A0M9-10A-01D-A101_120406_SN208_0281_AC0KDBACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0M9-10A,4FD1CB59-6C50-4355-9D37-A341E1F4FAD9,Blood Derived Normal,Illumina HiSeq,2526461b-6bcd-4565-bb28-611a41d4286a,Uterus,73,C87CFE2D-33E1-43EE-9EF9-7DEA955DEBEE,5C73D70A-0685-4062-B760-6BBD60017C75,TCGA-BG-A0M9-10A-01D-A101-02,HG19_Broad_variant,TCGA-BG-A0M9,TCGA-UCEC,NA,s4250,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6ce08,58cfa832e4b0c9d6adf6ce08,TCGA-FD-A3B5-10A-01D-A210_120912_SN1120_0192_AC18ALACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FD-A3B5-10A-01D-A210_120912_SN1120_0192_AC18ALACXX_s_2_rg.sorted,TCGA-FD-A3B5-10A-01D-A210_120912_SN1120_0192_AC18ALACXX_s_2_rg.sorted.bam,19.54,NA,0.16,58cfa832e4b0c9d6adf6ce08,TCGA-FD-A3B5-10A-01D-A210_120912_SN1120_0192_AC18ALACXX_s_2_rg.sorted.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3B5-10A,462D5A6B-9F39-4AAE-A35B-D06A7811D053,Blood Derived Normal,Illumina HiSeq,47bf4c5b-dc12-4d32-bdb4-e95b09f41768,Bladder,86,1E5EB200-7D4C-4A5E-8C1C-1EC04EC3FE0C,139E14E3-B5EA-4ED3-A293-67D9967DE3BB,TCGA-FD-A3B5-10A-01D-A210-26,HG19_Broad_variant,TCGA-FD-A3B5,TCGA-BLCA,272,s3297,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T2b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c6a0,58cfa831e4b0c9d6adf6c6a0,TCGA-CQ-6224-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CQ-6224-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_4_rg.sorted,TCGA-CQ-6224-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_4_rg.sorted.bam,40.7,2,0.16,58cfa831e4b0c9d6adf6c6a0,TCGA-CQ-6224-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-6224-01A,D86FD392-FA5C-4142-A647-440E6C32D478,Primary Tumor,Illumina HiSeq,e8b32a2c-944e-4b3e-a302-ffe9e9f8a3ea,Head and Neck,52,AD242EAC-A5AE-42B7-85CE-3E4D0DD308D6,3FAD44AE-89FC-4BB4-BA86-15A0EF7E2C3A,TCGA-CQ-6224-01A-11D-1911-02,HG19_Broad_variant,TCGA-CQ-6224,TCGA-HNSC,NA,s15633,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T2,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6ca76,58cfa831e4b0c9d6adf6ca76,TCGA-DK-A2HX-10A-01D-A18D_120913_SN208_0429_AC187FACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DK-A2HX-10A-01D-A18D_120913_SN208_0429_AC187FACXX_s_2_rg.sorted,TCGA-DK-A2HX-10A-01D-A18D_120913_SN208_0429_AC187FACXX_s_2_rg.sorted.bam,25.35,NA,0.15,58cfa831e4b0c9d6adf6ca76,TCGA-DK-A2HX-10A-01D-A18D_120913_SN208_0429_AC187FACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A2HX-10A,C728FAC9-5452-4759-A4ED-A366E0F757CB,Blood Derived Normal,Illumina HiSeq,eb041cfc-02dc-491c-a584-db245f5d273a,Bladder,80,1E934A96-C1CE-4427-AFD3-5F311FCD795F,29357D01-F9BA-49B4-AD9F-5789986C092F,TCGA-DK-A2HX-10A-01D-A18D-02,HG19_Broad_variant,TCGA-DK-A2HX,TCGA-BLCA,NA,s2713,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa830e4b0c9d6adf6c206,58cfa830e4b0c9d6adf6c206,TCGA-BT-A20W-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BT-A20W-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_5_rg.sorted,TCGA-BT-A20W-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_5_rg.sorted.bam,77.69,1.98,0.17,58cfa830e4b0c9d6adf6c206,TCGA-BT-A20W-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20W-01A,4DC5CFFE-ED8C-47AB-B5FC-F9615B5414F7,Primary Tumor,Illumina HiSeq,a817f2b5-a06a-422e-869a-694baf6bb127,Bladder,71,CA14F475-1BE4-450C-80C3-7094D23D0B3D,A32E59E0-242F-465D-8277-E0FE26124091,TCGA-BT-A20W-01A-21D-A14U-02,HG19_Broad_variant,TCGA-BT-A20W,TCGA-BLCA,254,s3085,Harvard Medical School,University of Pittsburgh,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c7ec,58cfa831e4b0c9d6adf6c7ec,TCGA-CV-7263-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CV-7263-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_4_rg.sorted,TCGA-CV-7263-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_4_rg.sorted.bam,2.73,NA,0.14,58cfa831e4b0c9d6adf6c7ec,TCGA-CV-7263-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_4_rg.sorted.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,Not available,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7263-10A,93B742EB-5FC3-4CE2-B7F6-C89F97E0DCC9,Blood Derived Normal,Illumina HiSeq,64a6f3f5-8b60-439f-86f8-603118060103,Head and Neck,64,E57B3C9C-5BF5-432C-B7D1-4C1D37F22510,AD8791C4-E40B-46F7-88D8-6E514243F970,TCGA-CV-7263-10A-01D-2317-26,HG19_Broad_variant,TCGA-CV-7263,TCGA-HNSC,560,s16053,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6cca3,58cfa831e4b0c9d6adf6cca3,TCGA-EJ-5499-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EJ-5499-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_1_rg.sorted,TCGA-EJ-5499-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_1_rg.sorted.bam,91.7,1.9,0.15,58cfa831e4b0c9d6adf6cca3,TCGA-EJ-5499-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_1_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5499-01A,FD1AA612-DF86-4D48-892D-2ACEBD76EA96,Primary Tumor,Illumina HiSeq,21f9da4c-83ce-44b4-b002-e18cd232ac6b,Prostate,61,22C4F5C2-1B1E-4212-8110-09DBD5CE10A9,0F4314C9-967C-4EF1-9CF2-A7B206E6129E,TCGA-EJ-5499-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5499,TCGA-PRAD,NA,s3789,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d18a,58cfa832e4b0c9d6adf6d18a,TCGA-HC-7079-10A-01D-1957_130422_SN590_0225_BD23TLACXX_s_1_rg.sorted.filtered.,WGS,TCGA-HC-7079-10A-01D-1957_130422_SN590_0225_BD23TLACXX_s_1_rg.sorted,TCGA-HC-7079-10A-01D-1957_130422_SN590_0225_BD23TLACXX_s_1_rg.sorted.bam,183.3,NA,0.15,58cfa832e4b0c9d6adf6d18a,TCGA-HC-7079-10A-01D-1957_130422_SN590_0225_BD23TLACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7079-10A,10FBE481-F111-4F88-AE45-4D67CB265567,Blood Derived Normal,Illumina HiSeq,105059d4-8eb5-4f7a-a63f-838e9c234d43,Prostate,51,53CD52BA-57F8-4924-9143-9CE98DDB607E,C5549F0E-C3F4-450A-A8DE-4D3AD0155C85,TCGA-HC-7079-10A-01D-1957-02,HG19_Broad_variant,TCGA-HC-7079,TCGA-PRAD,NA,s3460,Harvard Medical School,International Genomics Consortium,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c002,58cfa830e4b0c9d6adf6c002,TCGA-BJ-A0Z2-10A-01D-A10R_120711_SN208_0414_BD13L5ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BJ-A0Z2-10A-01D-A10R_120711_SN208_0414_BD13L5ACXX_s_3_rg.sorted,TCGA-BJ-A0Z2-10A-01D-A10R_120711_SN208_0414_BD13L5ACXX_s_3_rg.sorted.bam,18.36,1.93,0.17,58cfa830e4b0c9d6adf6c002,TCGA-BJ-A0Z2-10A-01D-A10R_120711_SN208_0414_BD13L5ACXX_s_3_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0Z2-10A,F9CEFFC0-D544-418D-B4A9-BD3C84E37026,Blood Derived Normal,Illumina HiSeq,12bc46cb-9018-4c63-8a13-7e1d81aebc12,Thyroid,57,BB9C69C4-22D7-4462-BC55-71341EA4D000,3708A7B8-C70F-4452-9643-C580CB42304A,TCGA-BJ-A0Z2-10A-01D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0Z2,TCGA-THCA,NA,s11986,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage IVC
13722.58cfa830e4b0c9d6adf6ba66,58cfa830e4b0c9d6adf6ba66,TCGA-91-6828-10A-01D-1853_120310_SN590_0144_AD0PNFACXX_s_4_rg.sorted.filtered.,WGS,TCGA-91-6828-10A-01D-1853_120310_SN590_0144_AD0PNFACXX_s_4_rg.sorted,TCGA-91-6828-10A-01D-1853_120310_SN590_0144_AD0PNFACXX_s_4_rg.sorted.bam,442,1.9,0.16,58cfa830e4b0c9d6adf6ba66,TCGA-91-6828-10A-01D-1853_120310_SN590_0144_AD0PNFACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-91-6828-10A,9536E32D-2707-48D2-A36D-08C521665BB9,Blood Derived Normal,Illumina HiSeq,a572c04b-c826-4837-94e8-72ccdc833516,Lung,70,4A3B397B-AD28-4817-A3EC-EF0B80996384,4AF2C139-3D39-4156-B258-841B9E085E98,TCGA-91-6828-10A-01D-1853-02,HG19_Broad_variant,TCGA-91-6828,TCGA-LUAD,NA,s11464,Harvard Medical School,ABS - IUPUI,United States,NO,T1a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6cc72,58cfa831e4b0c9d6adf6cc72,TCGA-ER-A199-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-ER-A199-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_5_rg.sorted,TCGA-ER-A199-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_5_rg.sorted.bam,39.1,NA,0.16,58cfa831e4b0c9d6adf6cc72,TCGA-ER-A199-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A199-10A,E218FC54-1139-4944-82E2-742839E5553A,Blood Derived Normal,Illumina HiSeq,5f956b1c-bc43-469e-8611-72b020b8830c,Skin,86,1BDFB4EA-F6E1-4C77-9FC6-421C246E4A9A,9EC20523-003B-4DE2-B573-82355C08EFEB,TCGA-ER-A199-10A-01D-A190-02,HG19_Broad_variant,TCGA-ER-A199,TCGA-SKCM,279,s7519,Harvard Medical School,University of Pittsburgh,United States,NO,T4b,N3,Not available,Stage IIIC
13722.58cfa831e4b0c9d6adf6c7f0,58cfa831e4b0c9d6adf6c7f0,TCGA-CV-7429-10A-01D-2317_120622_SN1120_0156_BD123WACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CV-7429-10A-01D-2317_120622_SN1120_0156_BD123WACXX_s_7_rg.sorted,TCGA-CV-7429-10A-01D-2317_120622_SN1120_0156_BD123WACXX_s_7_rg.sorted.bam,9.33,NA,0.17,58cfa831e4b0c9d6adf6c7f0,TCGA-CV-7429-10A-01D-2317_120622_SN1120_0156_BD123WACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7429-10A,44D99F11-EF5B-45D7-B7DF-B5C5893D878F,Blood Derived Normal,Illumina HiSeq,6998b65f-568a-4636-a6cb-07fb23e984a7,Head and Neck,55,349E31CA-41F2-4617-A20D-98B2277A4374,38F01A0A-8FF8-44D0-9982-C8281DF02F18,TCGA-CV-7429-10A-01D-2317-26,HG19_Broad_variant,TCGA-CV-7429,TCGA-HNSC,107,s15782,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c400,58cfa831e4b0c9d6adf6c400,TCGA-CH-5789-10A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CH-5789-10A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_6_rg.sorted,TCGA-CH-5789-10A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_6_rg.sorted.bam,79.4,1.9,0.16,58cfa831e4b0c9d6adf6c400,TCGA-CH-5789-10A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5789-10A,BE5411DC-3CAA-4B25-9B94-CE463E8E52B4,Blood Derived Normal,Illumina HiSeq,df814918-8b73-4130-9bee-73bafbe5419b,Prostate,61,A5CDDC99-2677-4876-8070-F0260FC30BCD,C7A1BBF5-830E-47CC-BE4C-361109986056,TCGA-CH-5789-10A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5789,TCGA-PRAD,NA,s3429,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bf8b,58cfa830e4b0c9d6adf6bf8b,TCGA-BR-6564-10A-01D-1880_121220_SN1222_0163_AC1HA2ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BR-6564-10A-01D-1880_121220_SN1222_0163_AC1HA2ACXX_s_2_rg.sorted,TCGA-BR-6564-10A-01D-1880_121220_SN1222_0163_AC1HA2ACXX_s_2_rg.sorted.bam,76,1.9,0.17,58cfa830e4b0c9d6adf6bf8b,TCGA-BR-6564-10A-01D-1880_121220_SN1222_0163_AC1HA2ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6564-10A,AF1086CC-B330-4AD6-AE1C-3B5C7259949A,Blood Derived Normal,Illumina HiSeq,471dc261-17ff-4b2a-9f63-5e47a77d7ae9,Stomach,46,1819FA3B-E55C-4B4D-98C2-F0C4D98C7327,B7B31E77-1472-42A3-903D-63C74F1A84DA,TCGA-BR-6564-10A-01D-1880-02,HG19_Broad_variant,TCGA-BR-6564,TCGA-STAD,NA,s15179,Harvard Medical School,Asterand,Russia,NO,T3,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA
13722.58cfa831e4b0c9d6adf6c531,58cfa831e4b0c9d6adf6c531,TCGA-CH-5768-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CH-5768-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_3_rg.sorted,TCGA-CH-5768-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_3_rg.sorted.bam,131.7,1.9,0.15,58cfa831e4b0c9d6adf6c531,TCGA-CH-5768-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5768-01A,F6C61A22-A711-416D-9E65-6A1B957E5B2E,Primary Tumor,Illumina HiSeq,98aa2eb7-52a4-424c-aa01-a574d0215ee6,Prostate,72,C4FF48C4-E953-4267-AB9C-3A09A97A88C4,9813DF8A-57D6-4D59-8534-3942B7FE672E,TCGA-CH-5768-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5768,TCGA-PRAD,NA,s3420,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c246,58cfa830e4b0c9d6adf6c246,TCGA-BA-4078-01A-01D-1431_120612_SN590_0161_AC0VUTACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BA-4078-01A-01D-1431_120612_SN590_0161_AC0VUTACXX_s_5_rg.sorted,TCGA-BA-4078-01A-01D-1431_120612_SN590_0161_AC0VUTACXX_s_5_rg.sorted.bam,747.33,1.9,0.16,58cfa830e4b0c9d6adf6c246,TCGA-BA-4078-01A-01D-1431_120612_SN590_0161_AC0VUTACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-4078-01A,C7353D6A-82A2-4A0D-8CD4-8C8957943EDB,Primary Tumor,Illumina HiSeq,cf3b040a-b4be-41ce-a172-1a295ebd79b2,Head and Neck,83,2027EDE3-13F5-40F6-BEF6-16704981D676,66A9CFF2-397E-415E-BF54-9A75CCC80BDE,TCGA-BA-4078-01A-01D-1431-02,HG19_Broad_variant,TCGA-BA-4078,TCGA-HNSC,276,s15877,Harvard Medical School,UNC,None,NO,Not available,Not available,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c9d3,58cfa831e4b0c9d6adf6c9d3,TCGA-DK-A1A3-01A-11D-A13U_120921_SN208_0431_BD1D5FACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DK-A1A3-01A-11D-A13U_120921_SN208_0431_BD1D5FACXX_s_7_rg.sorted,TCGA-DK-A1A3-01A-11D-A13U_120921_SN208_0431_BD1D5FACXX_s_7_rg.sorted.bam,16.46,1.91,0.17,58cfa831e4b0c9d6adf6c9d3,TCGA-DK-A1A3-01A-11D-A13U_120921_SN208_0431_BD1D5FACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A3-01A,C5B20CCC-523D-491C-8536-008E05C57212,Primary Tumor,Illumina HiSeq,0e78dec3-7b8b-425e-9cc5-489bf825e0ea,Bladder,60,954E46BA-514F-4708-AD3C-ECBF8CEF005A,DC0A234A-9177-4E2A-B218-212F1278B4A1,TCGA-DK-A1A3-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DK-A1A3,TCGA-BLCA,NA,s3102,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c744,58cfa831e4b0c9d6adf6c744,TCGA-D3-A1Q7-06A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_1_rg.sorted.filtered.,WGS,TCGA-D3-A1Q7-06A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_1_rg.sorted,TCGA-D3-A1Q7-06A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_1_rg.sorted.bam,56.17,NA,0.17,58cfa831e4b0c9d6adf6c744,TCGA-D3-A1Q7-06A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A1Q7-06A,DF6303CD-FFB5-422F-9865-B09029A6D54F,Metastatic,Illumina HiSeq,f9cdbc4b-24de-4377-ac12-2d532ee5fa4f,Skin,42,E9879B40-CE83-49C6-A4D4-12B43CE2A55A,CF12EE87-5C0F-4450-8490-FECE5B88DF0B,TCGA-D3-A1Q7-06A-11D-A18Z-02,HG19_Broad_variant,TCGA-D3-A1Q7,TCGA-SKCM,NA,s7999,Harvard Medical School,MD Anderson,United States,NO,T1b,N0,Not available,Stage IB
13722.58cfa831e4b0c9d6adf6c7f3,58cfa831e4b0c9d6adf6c7f3,TCGA-D7-5577-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_1_rg.sorted.filtered.,WGS,TCGA-D7-5577-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_1_rg.sorted,TCGA-D7-5577-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_1_rg.sorted.bam,414,1.87,0.14,58cfa831e4b0c9d6adf6c7f3,TCGA-D7-5577-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-5577-01A,2DC154AA-C478-404B-A92E-86ABCC8DBDB7,Primary Tumor,Illumina HiSeq,e417c8be-9c96-4e81-a2c9-ac3f23791347,Stomach,53,93BBD9FD-2385-46C3-AF21-E46C72A8A75D,8FCA6D2A-04D8-4A60-AEA3-298853E74752,TCGA-D7-5577-01A-01D-1598-02,HG19_Broad_variant,TCGA-D7-5577,TCGA-STAD,NA,s14908,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N3,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIIA
13722.58cfa831e4b0c9d6adf6cbd4,58cfa831e4b0c9d6adf6cbd4,TCGA-EJ-5527-10A-01D-1573_130221_SN1120_0238_AC1TDEACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EJ-5527-10A-01D-1573_130221_SN1120_0238_AC1TDEACXX_s_6_rg.sorted,TCGA-EJ-5527-10A-01D-1573_130221_SN1120_0238_AC1TDEACXX_s_6_rg.sorted.bam,329.4,1.9,0.16,58cfa831e4b0c9d6adf6cbd4,TCGA-EJ-5527-10A-01D-1573_130221_SN1120_0238_AC1TDEACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5527-10A,BA0C9096-5F35-4F0A-AE98-EE1A695B55F0,Blood Derived Normal,Illumina HiSeq,38e4be78-cef4-4c22-9407-ba48b34614f5,Prostate,69,7373EF74-66D8-47AD-9267-AE41080B694F,68F24DF0-2CA8-4BA2-899C-1364400944CA,TCGA-EJ-5527-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5527,TCGA-PRAD,NA,s3607,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bbf4,58cfa830e4b0c9d6adf6bbf4,TCGA-A5-A0GW-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_5_rg.sorted.filtered.,WGS,TCGA-A5-A0GW-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_5_rg.sorted,TCGA-A5-A0GW-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_5_rg.sorted.bam,88.42,2.12,0.14,58cfa830e4b0c9d6adf6bbf4,TCGA-A5-A0GW-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_5_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GW-01A,5B6B9D0F-787C-4AE9-AFD4-DE7CE6C57A42,Primary Tumor,Illumina HiSeq,84e2e6bd-f438-45e9-9d44-2af82246e341,Uterus,46,E84D0533-E892-4C1E-9415-99F92AA9A360,3DCC9DC1-990D-4053-967E-B8E4EE752C4E,TCGA-A5-A0GW-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0GW,TCGA-UCEC,NA,s4421,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6ccfa,58cfa831e4b0c9d6adf6ccfa,TCGA-FD-A3SP-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FD-A3SP-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_4_rg.sorted,TCGA-FD-A3SP-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_4_rg.sorted.bam,53.29,NA,0.14,58cfa831e4b0c9d6adf6ccfa,TCGA-FD-A3SP-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3SP-10A,5F99DCFF-D809-4C87-8024-C9B30BD565E9,Blood Derived Normal,Illumina HiSeq,0fb6c4ad-36eb-4250-aff4-193b6fe1badc,Bladder,60,7E2B3335-B19A-4532-B0ED-1288D0E4C3A4,5A49A738-8904-49FF-95B7-58D58FAFD372,TCGA-FD-A3SP-10A-01D-A233-26,HG19_Broad_variant,TCGA-FD-A3SP,TCGA-BLCA,NA,s3300,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82fe4b0c9d6adf6b8a8,58cfa82fe4b0c9d6adf6b8a8,TCGA-A5-A0GD-10A-01D-A043_120504_SN208_0297_BC0VJEACXX_s_7_rg.sorted.filtered.,WGS,TCGA-A5-A0GD-10A-01D-A043_120504_SN208_0297_BC0VJEACXX_s_7_rg.sorted,TCGA-A5-A0GD-10A-01D-A043_120504_SN208_0297_BC0VJEACXX_s_7_rg.sorted.bam,14.89,1.93,0.16,58cfa82fe4b0c9d6adf6b8a8,TCGA-A5-A0GD-10A-01D-A043_120504_SN208_0297_BC0VJEACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GD-10A,1486A031-B74D-4976-8B0B-4569E6978F49,Blood Derived Normal,Illumina HiSeq,f57ef0e6-cdbc-412d-b41e-83ae999958b8,Uterus,75,FEA14411-8A57-4794-AD7F-D83C19104636,A43F9FE5-1CD2-44E6-9E11-42432A1702B8,TCGA-A5-A0GD-10A-01D-A043-02,HG19_Broad_variant,TCGA-A5-A0GD,TCGA-UCEC,NA,s4588,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c56b,58cfa831e4b0c9d6adf6c56b,TCGA-CH-5746-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CH-5746-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_1_rg.sorted,TCGA-CH-5746-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_1_rg.sorted.bam,299.7,1.9,0.15,58cfa831e4b0c9d6adf6c56b,TCGA-CH-5746-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5746-01A,618272C0-C2ED-4BFB-BB4B-404F0987F822,Primary Tumor,Illumina HiSeq,c4373feb-ceca-4bb3-9db2-6f9e94d29605,Prostate,57,54AD063E-68D9-4104-856A-2BD3905FA971,ABAFDCA6-6109-4686-A058-BDBEB9ADD1E7,TCGA-CH-5746-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5746,TCGA-PRAD,NA,s3930,Harvard Medical School,Indivumed,Germany,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82fe4b0c9d6adf6b932,58cfa82fe4b0c9d6adf6b932,TCGA-91-6836-01A-21D-1853_120310_SN590_0144_AD0PNFACXX_s_7_rg.sorted.filtered.,WGS,TCGA-91-6836-01A-21D-1853_120310_SN590_0144_AD0PNFACXX_s_7_rg.sorted,TCGA-91-6836-01A-21D-1853_120310_SN590_0144_AD0PNFACXX_s_7_rg.sorted.bam,278.7,1.9,0.14,58cfa82fe4b0c9d6adf6b932,TCGA-91-6836-01A-21D-1853_120310_SN590_0144_AD0PNFACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-91-6836-01A,0B31DBDF-0623-48E4-A0EC-017650DCEDA7,Primary Tumor,Illumina HiSeq,68fe0529-8b54-4c01-83f0-a5dc5097e2cb,Lung,52,49A0AB8A-F379-4394-ACCF-0B4B08D2DCC6,0D6B80DD-76A1-4174-9275-731B4A347213,TCGA-91-6836-01A-21D-1853-02,HG19_Broad_variant,TCGA-91-6836,TCGA-LUAD,NA,s10669,Harvard Medical School,ABS - IUPUI,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa830e4b0c9d6adf6c2af,58cfa830e4b0c9d6adf6c2af,TCGA-AX-A0J1-10A-01D-A043_120403_SN1222_0094_BD0UKBACXX_s_5_rg.sorted.filtered.,WGS,TCGA-AX-A0J1-10A-01D-A043_120403_SN1222_0094_BD0UKBACXX_s_5_rg.sorted,TCGA-AX-A0J1-10A-01D-A043_120403_SN1222_0094_BD0UKBACXX_s_5_rg.sorted.bam,7.14,1.93,0.17,58cfa830e4b0c9d6adf6c2af,TCGA-AX-A0J1-10A-01D-A043_120403_SN1222_0094_BD0UKBACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A0J1-10A,EC7A9D74-8B3F-4747-8926-1739A016AB2B,Blood Derived Normal,Illumina HiSeq,a63b4482-6fb6-4554-a81b-a77003d1b12f,Uterus,80,7249199D-6E4A-4A4A-9F4C-996E9B7E2D20,89FA0B56-B5CD-49DA-8408-8A5ACA30813C,TCGA-AX-A0J1-10A-01D-A043-02,HG19_Broad_variant,TCGA-AX-A0J1,TCGA-UCEC,NA,s4592,Harvard Medical School,Gynecologic Oncology Group,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c44a,58cfa831e4b0c9d6adf6c44a,TCGA-CH-5741-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CH-5741-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_1_rg.sorted,TCGA-CH-5741-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_1_rg.sorted.bam,214.7,1.9,0.15,58cfa831e4b0c9d6adf6c44a,TCGA-CH-5741-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5741-01A,B3BF57D4-E31A-4740-B438-FA826FB79550,Primary Tumor,Illumina HiSeq,ae88c859-e075-4e3a-ba86-e6018e71fa98,Prostate,56,B22CBB75-E6E5-443D-AB4E-1CFD0079C69A,6AC2CA6C-FC79-4E5D-B08F-029A4AC2577B,TCGA-CH-5741-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5741,TCGA-PRAD,NA,s3589,Harvard Medical School,Indivumed,Germany,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82fe4b0c9d6adf6b5ce,58cfa82fe4b0c9d6adf6b5ce,TCGA-44-5643-10A-01D-1623_120228_SN1120_0116_AD0KRVACXX_s_5_rg.sorted.filtered.,WGS,TCGA-44-5643-10A-01D-1623_120228_SN1120_0116_AD0KRVACXX_s_5_rg.sorted,TCGA-44-5643-10A-01D-1623_120228_SN1120_0116_AD0KRVACXX_s_5_rg.sorted.bam,330.4,1.9,0.15,58cfa82fe4b0c9d6adf6b5ce,TCGA-44-5643-10A-01D-1623_120228_SN1120_0116_AD0KRVACXX_s_5_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-5643-10A,27FCEEC1-3298-4CDD-A4E6-8F5CF34604F0,Blood Derived Normal,Illumina HiSeq,e4cbf4f2-ff4e-416e-bc31-0d67f0f9437a,Lung,53,E4463FF5-D83E-4C36-B700-EF17DDB195AB,F663AFD4-EA19-4E60-94D7-B4BC9AA54001,TCGA-44-5643-10A-01D-1623-02,HG19_Broad_variant,TCGA-44-5643,TCGA-LUAD,NA,s10990,Harvard Medical School,Christiana Healthcare,United States,NO,T2b,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa832e4b0c9d6adf6d5f3,58cfa832e4b0c9d6adf6d5f3,TCGA-LN-A49O-10A-01D-A248_130101_SN590_0206_AC1H8RACXX_s_2_rg.sorted.filtered.,WGS,TCGA-LN-A49O-10A-01D-A248_130101_SN590_0206_AC1H8RACXX_s_2_rg.sorted,TCGA-LN-A49O-10A-01D-A248_130101_SN590_0206_AC1H8RACXX_s_2_rg.sorted.bam,27.67,NA,0.14,58cfa832e4b0c9d6adf6d5f3,TCGA-LN-A49O-10A-01D-A248_130101_SN590_0206_AC1H8RACXX_s_2_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49O-10A,3DF1B9DB-D900-47D2-839D-3900829CB2A9,Blood Derived Normal,Illumina HiSeq,0e9f25c2-7d72-4858-a0d6-898ea60249b4,Esophagus,47,8AAEC35B-EFC1-47CD-A82B-C5F9E4DDA9CE,B1558A26-DB94-49A0-B060-337D14644B51,TCGA-LN-A49O-10A-01D-A248-26,HG19_Broad_variant,TCGA-LN-A49O,TCGA-ESCA,NA,s1857,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6cb54,58cfa831e4b0c9d6adf6cb54,TCGA-EE-A2MC-06A-12D-A18Y_120724_SN208_0417_AC117BACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EE-A2MC-06A-12D-A18Y_120724_SN208_0417_AC117BACXX_s_3_rg.sorted,TCGA-EE-A2MC-06A-12D-A18Y_120724_SN208_0417_AC117BACXX_s_3_rg.sorted.bam,38.73,NA,0.18,58cfa831e4b0c9d6adf6cb54,TCGA-EE-A2MC-06A-12D-A18Y_120724_SN208_0417_AC117BACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MC-06A,3791BD88-C61E-46C3-AAA4-942C2169887C,Metastatic,Illumina HiSeq,f0ce1c44-2f33-40d9-842a-55269b546ed4,Skin,73,E51EADC7-1F85-464C-989B-9D464233618D,A536CA41-2718-41D6-9F86-9EA43F51A3A9,TCGA-EE-A2MC-06A-12D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2MC,TCGA-SKCM,1871,s7689,Harvard Medical School,University of Sydney,Australia,NO,T2,N0,Not available,Stage I
13722.58cfa831e4b0c9d6adf6c7a3,58cfa831e4b0c9d6adf6c7a3,TCGA-CV-6954-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CV-6954-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_3_rg.sorted,TCGA-CV-6954-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_3_rg.sorted.bam,62.7,1.9,0.15,58cfa831e4b0c9d6adf6c7a3,TCGA-CV-6954-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_3_rg.sorted.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,Not available,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6954-01A,402FD96C-76D3-4AC2-9F64-77BD34BE0ADB,Primary Tumor,Illumina HiSeq,115469a6-3c3e-4a3b-adf9-ed831266829c,Head and Neck,59,F72D39EA-7DB5-47C6-9428-3E26454C9A9A,7FA6660F-0B18-4F4D-AEA1-17C22A9DBAA6,TCGA-CV-6954-01A-11D-1911-02,HG19_Broad_variant,TCGA-CV-6954,TCGA-HNSC,2002,s16341,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T4a,NX,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c858,58cfa831e4b0c9d6adf6c858,TCGA-D6-6517-01A-11D-1868_120427_SN208_0288_BD0RWBACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D6-6517-01A-11D-1868_120427_SN208_0288_BD0RWBACXX_s_3_rg.sorted,TCGA-D6-6517-01A-11D-1868_120427_SN208_0288_BD0RWBACXX_s_3_rg.sorted.bam,209.7,1.9,0.15,58cfa831e4b0c9d6adf6c858,TCGA-D6-6517-01A-11D-1868_120427_SN208_0288_BD0RWBACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-D6-6517-01A,EBE99910-E9F2-43DC-AD57-AC2F610B60C8,Primary Tumor,Illumina HiSeq,e84f34a5-8df7-4824-92d7-4f53b4bace58,Head and Neck,59,8C099F45-3FD6-4966-8CDB-CA4B9288B1A2,97962F6C-B2FB-4618-A5A4-7B376714EC62,TCGA-D6-6517-01A-11D-1868-02,HG19_Broad_variant,TCGA-D6-6517,TCGA-HNSC,NA,s15655,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa830e4b0c9d6adf6bf08,58cfa830e4b0c9d6adf6bf08,TCGA-BR-4183-01A-02D-1128_120807_SN590_0174_BC11N6ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BR-4183-01A-02D-1128_120807_SN590_0174_BC11N6ACXX_s_7_rg.sorted,TCGA-BR-4183-01A-02D-1128_120807_SN590_0174_BC11N6ACXX_s_7_rg.sorted.bam,196.9,1.9,0.16,58cfa830e4b0c9d6adf6bf08,TCGA-BR-4183-01A-02D-1128_120807_SN590_0174_BC11N6ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4183-01A,33503349-BA7A-43F4-BCB2-AC8D16808432,Primary Tumor,Illumina HiSeq,d0ba8758-affb-40ae-84d2-6c4209a92090,Stomach,55,C17A8996-14C4-4A17-A55B-925172A45211,B5E3A2A5-71FD-4ED8-98DB-0CB725638C26,TCGA-BR-4183-01A-02D-1128-02,HG19_Broad_variant,TCGA-BR-4183,TCGA-STAD,NA,s14527,Harvard Medical School,Asterand,Russia,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6c98e,58cfa831e4b0c9d6adf6c98e,TCGA-D7-6520-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_7_rg.sorted.filtered.,WGS,TCGA-D7-6520-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_7_rg.sorted,TCGA-D7-6520-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_7_rg.sorted.bam,94.4,1.9,0.14,58cfa831e4b0c9d6adf6c98e,TCGA-D7-6520-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6520-01A,3C573AF6-6298-49DE-8DE0-6A7F9CE9B000,Primary Tumor,Illumina HiSeq,46b79d94-56c0-4b23-955d-2395a50ecaf9,Stomach,53,7C162352-903E-4723-AF91-6FDD8E8EAD3B,F1CB7996-BD0E-4123-84E9-D359E5DB7700,TCGA-D7-6520-01A-11D-1798-02,HG19_Broad_variant,TCGA-D7-6520,TCGA-STAD,NA,s14494,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2b,N2,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIIA
13722.58cfa831e4b0c9d6adf6c760,58cfa831e4b0c9d6adf6c760,TCGA-D7-6815-10A-01D-1880_130111_SN208_0447_AC1JP0ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-D7-6815-10A-01D-1880_130111_SN208_0447_AC1JP0ACXX_s_2_rg.sorted,TCGA-D7-6815-10A-01D-1880_130111_SN208_0447_AC1JP0ACXX_s_2_rg.sorted.bam,185,1.9,0.15,58cfa831e4b0c9d6adf6c760,TCGA-D7-6815-10A-01D-1880_130111_SN208_0447_AC1JP0ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6815-10A,53086E20-A727-40D6-B42D-8030109B5130,Blood Derived Normal,Illumina HiSeq,f673f591-e023-4c88-9054-8433fa9d0e2f,Stomach,70,B051617A-8114-4EAF-A0E4-37D69CF65065,787C736A-143C-4BBF-B13F-146594B1C671,TCGA-D7-6815-10A-01D-1880-02,HG19_Broad_variant,TCGA-D7-6815,TCGA-STAD,NA,s14997,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N2,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIB
13722.58cfa831e4b0c9d6adf6cb44,58cfa831e4b0c9d6adf6cb44,TCGA-EE-A17X-10A-01D-A190_120730_SN1222_0141_BC115GACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EE-A17X-10A-01D-A190_120730_SN1222_0141_BC115GACXX_s_7_rg.sorted,TCGA-EE-A17X-10A-01D-A190_120730_SN1222_0141_BC115GACXX_s_7_rg.sorted.bam,33.23,NA,0.17,58cfa831e4b0c9d6adf6cb44,TCGA-EE-A17X-10A-01D-A190_120730_SN1222_0141_BC115GACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,Not available,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A17X-10A,5F8CC8D6-8A1C-41D0-BAD6-FEDD2948F40A,Blood Derived Normal,Illumina HiSeq,f56ec114-dd45-40eb-aeb3-d10b94e3af35,Skin,54,4E9EF0D5-E5B0-4C8A-9C13-C8D088F205D6,3578D9CB-AB85-4041-9777-8A4C3EA3BDEE,TCGA-EE-A17X-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A17X,TCGA-SKCM,907,s7682,Harvard Medical School,University of Sydney,Australia,NO,T1a,N0,Not available,Stage IA
13722.58cfa831e4b0c9d6adf6cd98,58cfa831e4b0c9d6adf6cd98,TCGA-FE-A3PA-10A-01D-A221_120611_SN1222_0114_AC0WL3ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FE-A3PA-10A-01D-A221_120611_SN1222_0114_AC0WL3ACXX_s_2_rg.sorted,TCGA-FE-A3PA-10A-01D-A221_120611_SN1222_0114_AC0WL3ACXX_s_2_rg.sorted.bam,173.47,NA,0.15,58cfa831e4b0c9d6adf6cd98,TCGA-FE-A3PA-10A-01D-A221_120611_SN1222_0114_AC0WL3ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A3PA-10A,10BDAFBB-831D-48B5-B9A3-AD374FC50235,Blood Derived Normal,Illumina HiSeq,dfd0c37b-97f9-41b0-9366-e0d58a3f21bd,Thyroid,16,CCEA50A0-B282-4BFE-8A65-281C8CCA75B9,B646AFC1-670B-4F67-8D0A-7577DAE03C11,TCGA-FE-A3PA-10A-01D-A221-26,HG19_Broad_variant,TCGA-FE-A3PA,TCGA-THCA,NA,s12531,MD Anderson - Institute for Applied Cancer Science,Ohio State University,United States,NO,T4,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa82fe4b0c9d6adf6b8c6,58cfa82fe4b0c9d6adf6b8c6,TCGA-A5-A0GX-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-A5-A0GX-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_2_rg.sorted,TCGA-A5-A0GX-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_2_rg.sorted.bam,89.76,2.06,0.14,58cfa82fe4b0c9d6adf6b8c6,TCGA-A5-A0GX-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GX-01A,553F0CCD-4E6F-4AE2-9B39-97529EB3D826,Primary Tumor,Illumina HiSeq,cae767f1-aaee-4821-aa36-3ceb0b1756e8,Uterus,53,983A35A9-C825-4961-86C0-4C6133B5C9C1,FE0654FE-39AA-4993-8F36-768C7D829092,TCGA-A5-A0GX-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0GX,TCGA-UCEC,NA,s4989,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cdad,58cfa831e4b0c9d6adf6cdad,TCGA-FD-A3SQ-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_6_rg.sorted.filtered.,WGS,TCGA-FD-A3SQ-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_6_rg.sorted,TCGA-FD-A3SQ-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_6_rg.sorted.bam,54.42,NA,0.15,58cfa831e4b0c9d6adf6cdad,TCGA-FD-A3SQ-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3SQ-10A,3071CB51-DCF5-41F7-B047-AFC2DCBF0AAF,Blood Derived Normal,Illumina HiSeq,ccb5242d-6bc3-405b-829a-ed7ff3c509b0,Bladder,62,D6E68B46-7FB2-4AEE-8A99-EF0962049EC5,A98425A7-CDC8-4AEC-89BC-A615B125CAA0,TCGA-FD-A3SQ-10A-01D-A233-26,HG19_Broad_variant,TCGA-FD-A3SQ,TCGA-BLCA,1423,s2905,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T3a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82fe4b0c9d6adf6b7fa,58cfa82fe4b0c9d6adf6b7fa,TCGA-38-4629-01A-02D-1203_120305_SN1120_0119_BD0REAACXX_s_8_rg.sorted.filtered.,WGS,TCGA-38-4629-01A-02D-1203_120305_SN1120_0119_BD0REAACXX_s_8_rg.sorted,TCGA-38-4629-01A-02D-1203_120305_SN1120_0119_BD0REAACXX_s_8_rg.sorted.bam,155.9,1.9,0.14,58cfa82fe4b0c9d6adf6b7fa,TCGA-38-4629-01A-02D-1203_120305_SN1120_0119_BD0REAACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-38-4629-01A,127BF818-F7E5-46B5-A9DE-39F6D96B8B83,Primary Tumor,Illumina HiSeq,ecb1f536-930a-4c20-a11a-c69c6740295f,Lung,68,EB822F95-8B15-4C86-B5E5-B0AFE9C32E0C,51FF3351-1A43-458F-9BD9-99BD39FDDAF3,TCGA-38-4629-01A-02D-1203-02,HG19_Broad_variant,TCGA-38-4629,TCGA-LUAD,864,s11450,Harvard Medical School,UNC,None,NO,T3,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa831e4b0c9d6adf6cb17,58cfa831e4b0c9d6adf6cb17,TCGA-EA-A3QD-01A-32D-A232_140124_SN1120_0291_AC2PHAACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EA-A3QD-01A-32D-A232_140124_SN1120_0291_AC2PHAACXX_s_2_rg.sorted,TCGA-EA-A3QD-01A-32D-A232_140124_SN1120_0291_AC2PHAACXX_s_2_rg.sorted.bam,58.49,NA,0.15,58cfa831e4b0c9d6adf6cb17,TCGA-EA-A3QD-01A-32D-A232_140124_SN1120_0291_AC2PHAACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EA-A3QD-01A,9E2E29E8-D94A-499F-A98A-5B53B2C38F3B,Primary Tumor,Illumina HiSeq,d97f385a-fc08-43a1-9481-35f9ffdfcc05,Cervix,59,987E1913-A506-4A06-B247-9FF778CE552B,677FE002-1736-4263-B2CE-D93983F0BF95,TCGA-EA-A3QD-01A-32D-A232-26,HG19_Broad_variant,TCGA-EA-A3QD,TCGA-CESC,NA,s1185,MD Anderson - Institute for Applied Cancer Science,Asterand,United States,NO,T1b1,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6cb73,58cfa831e4b0c9d6adf6cb73,TCGA-EE-A2GC-06A-11D-A18Y_120726_SN590_0171_AD13PJACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EE-A2GC-06A-11D-A18Y_120726_SN590_0171_AD13PJACXX_s_3_rg.sorted,TCGA-EE-A2GC-06A-11D-A18Y_120726_SN590_0171_AD13PJACXX_s_3_rg.sorted.bam,68.75,NA,0.15,58cfa831e4b0c9d6adf6cb73,TCGA-EE-A2GC-06A-11D-A18Y_120726_SN590_0171_AD13PJACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2GC-06A,0A4B780E-8143-4118-AD98-FD2A2A6678C3,Metastatic,Illumina HiSeq,0c42714c-45d4-4591-bb02-c4f3116a72ea,Skin,82,498B5692-1FF2-4D4E-B96A-9CE977A2F24F,BE14E43C-34E5-4F20-86BA-80226FE02DC8,TCGA-EE-A2GC-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2GC,TCGA-SKCM,NA,s8014,Harvard Medical School,University of Sydney,Australia,NO,T3b,N0,Not available,Stage IIB
13722.58cfa832e4b0c9d6adf6ce6a,58cfa832e4b0c9d6adf6ce6a,TCGA-H2-A26U-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_5_rg.sorted.filtered.,WGS,TCGA-H2-A26U-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_5_rg.sorted,TCGA-H2-A26U-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_5_rg.sorted.bam,65.58,1.91,0.17,58cfa832e4b0c9d6adf6ce6a,TCGA-H2-A26U-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-H2-A26U-01A,E61FB24B-613A-4B6D-BB2B-00CCEDBD3DBC,Primary Tumor,Illumina HiSeq,91b791c7-9ac1-4a55-bb8a-110046b81a61,Thyroid,54,A4240AB1-970E-4A99-989E-8968903E3A25,79850C4D-71D0-4905-946A-F309DCDDA59F,TCGA-H2-A26U-01A-11D-A16N-02,HG19_Broad_variant,TCGA-H2-A26U,TCGA-THCA,NA,s12762,Harvard Medical School,Christiana Healthcare,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa831e4b0c9d6adf6c7d8,58cfa831e4b0c9d6adf6c7d8,TCGA-D1-A169-10A-01D-A12F_120522_SN208_0301_BC0VNWACXX_s_5_rg.sorted.filtered.,WGS,TCGA-D1-A169-10A-01D-A12F_120522_SN208_0301_BC0VNWACXX_s_5_rg.sorted,TCGA-D1-A169-10A-01D-A12F_120522_SN208_0301_BC0VNWACXX_s_5_rg.sorted.bam,10.9,1.88,0.16,58cfa831e4b0c9d6adf6c7d8,TCGA-D1-A169-10A-01D-A12F_120522_SN208_0301_BC0VNWACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A169-10A,9A599F57-0E8D-4E1F-A181-791F5FDEADB7,Blood Derived Normal,Illumina HiSeq,8e7ebc74-1345-499c-82c8-6a3a7f866edc,Uterus,63,602219E4-F146-476B-BC3F-47B6CAEB16C8,67A2DCA1-02DD-4C46-88C6-19C592A96B0F,TCGA-D1-A169-10A-01D-A12F-02,HG19_Broad_variant,TCGA-D1-A169,TCGA-UCEC,NA,s4797,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c47b,58cfa831e4b0c9d6adf6c47b,TCGA-CH-5751-10A-01D-1572_130103_SN1222_0165_AC1FBHACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CH-5751-10A-01D-1572_130103_SN1222_0165_AC1FBHACXX_s_8_rg.sorted,TCGA-CH-5751-10A-01D-1572_130103_SN1222_0165_AC1FBHACXX_s_8_rg.sorted.bam,212.4,1.9,0.15,58cfa831e4b0c9d6adf6c47b,TCGA-CH-5751-10A-01D-1572_130103_SN1222_0165_AC1FBHACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5751-10A,721E76D0-4B1D-4E78-ADB8-1344B8030062,Blood Derived Normal,Illumina HiSeq,31eb5a98-80e8-470f-9e31-765c00c7b655,Prostate,68,A701D962-E9E7-433A-9365-D02160134E04,2CE5E478-A5F2-4832-937F-3F41CDF81810,TCGA-CH-5751-10A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5751,TCGA-PRAD,NA,s3426,Harvard Medical School,Indivumed,Germany,NO,T4,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d4c1,58cfa832e4b0c9d6adf6d4c1,TCGA-VD-A8KF-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-VD-A8KF-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_3_rg.sorted,TCGA-VD-A8KF-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_3_rg.sorted.bam,5.12,NA,0.15,58cfa832e4b0c9d6adf6d4c1,TCGA-VD-A8KF-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_3_rg.sorted.bam,Dead,MALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KF-10A,78039723-94A9-4903-8BB4-C00852E8E889,Blood Derived Normal,Illumina HiSeq,cd56f90a-2df3-4592-818a-92ad4f72de24,Eye,68,015B25B1-3875-41B6-A6CA-E428A76D73CE,C3A48720-B5CF-44D8-9A22-973FD36320ED,TCGA-VD-A8KF-10A-01D-A40E-26,HG19_Broad_variant,TCGA-VD-A8KF,TCGA-UVM,40,s282,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T4b,NX,Not available,Stage IIIB
13722.58cfa831e4b0c9d6adf6c70c,58cfa831e4b0c9d6adf6c70c,TCGA-CV-5973-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CV-5973-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_1_rg.sorted,TCGA-CV-5973-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_1_rg.sorted.bam,115,1.9,0.15,58cfa831e4b0c9d6adf6c70c,TCGA-CV-5973-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5973-01A,8FC1F1BE-D2D5-4B3A-9973-F4D964018BEB,Primary Tumor,Illumina HiSeq,4965236e-7173-4701-bd61-0550f3451b03,Head and Neck,62,5078222F-B257-4286-A29A-BC1E395149BC,55E8AEAC-4C0E-49DF-8F57-605E7C820B89,TCGA-CV-5973-01A-11D-1681-02,HG19_Broad_variant,TCGA-CV-5973,TCGA-HNSC,NA,s16193,Harvard Medical School,MD Anderson Cancer Center,None,NO,T3,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa832e4b0c9d6adf6d0ac,58cfa832e4b0c9d6adf6d0ac,TCGA-IG-A3I8-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_5_rg.sorted.filtered.,WGS,TCGA-IG-A3I8-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_5_rg.sorted,TCGA-IG-A3I8-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_5_rg.sorted.bam,64.11,NA,0.16,58cfa832e4b0c9d6adf6d0ac,TCGA-IG-A3I8-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A3I8-01A,7BF3F18B-A013-48D2-A743-26A57FDBE4C4,Primary Tumor,Illumina HiSeq,d45e0e39-36b5-4628-9dae-7a185f129e6b,Esophagus,51,944A68B7-51D4-4831-88D4-D647BE17BC13,3A1FBCCE-BAB6-466C-AE4C-AADC4E5D357F,TCGA-IG-A3I8-01A-11D-A248-26,HG19_Broad_variant,TCGA-IG-A3I8,TCGA-ESCA,NA,s1621,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T3,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6cd60,58cfa831e4b0c9d6adf6cd60,TCGA-EJ-5498-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EJ-5498-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_8_rg.sorted,TCGA-EJ-5498-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_8_rg.sorted.bam,265.4,1.9,0.16,58cfa831e4b0c9d6adf6cd60,TCGA-EJ-5498-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5498-10A,79EC7468-9AAF-4BB0-94C7-72BE4F497868,Blood Derived Normal,Illumina HiSeq,ed7ab548-eb8d-46b7-ae35-1b081b1ed787,Prostate,56,6C151588-2966-4624-BE3A-8657D36D51DE,67A226F5-7B7C-4A18-854C-EBB688E15FFF,TCGA-EJ-5498-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5498,TCGA-PRAD,NA,s3947,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6ce04,58cfa832e4b0c9d6adf6ce04,TCGA-FD-A3B6-10A-01D-A210_120912_SN1120_0192_AC18ALACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FD-A3B6-10A-01D-A210_120912_SN1120_0192_AC18ALACXX_s_4_rg.sorted,TCGA-FD-A3B6-10A-01D-A210_120912_SN1120_0192_AC18ALACXX_s_4_rg.sorted.bam,10.85,NA,0.16,58cfa832e4b0c9d6adf6ce04,TCGA-FD-A3B6-10A-01D-A210_120912_SN1120_0192_AC18ALACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3B6-10A,36054200-3FA4-4541-A25C-47282E4EF88D,Blood Derived Normal,Illumina HiSeq,e74f45ed-30c8-4516-9011-9146d0451714,Bladder,75,DC51D2C0-BAC0-4A5C-BDE4-EFC727DCA0E9,D87637C7-E61A-43D3-A30E-6EFECB96B1D4,TCGA-FD-A3B6-10A-01D-A210-26,HG19_Broad_variant,TCGA-FD-A3B6,TCGA-BLCA,NA,s3293,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6cb8a,58cfa831e4b0c9d6adf6cb8a,TCGA-EE-A29T-06A-11D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EE-A29T-06A-11D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_5_rg.sorted,TCGA-EE-A29T-06A-11D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_5_rg.sorted.bam,45.93,NA,0.17,58cfa831e4b0c9d6adf6cb8a,TCGA-EE-A29T-06A-11D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29T-06A,9B99FFEE-FE9F-4BE5-A00A-EF86627282A4,Metastatic,Illumina HiSeq,b9efa6bb-7ce3-4b05-9ecb-6d56bedf6e7b,Skin,51,06072B6C-841F-493A-9DB0-6B555E692B2C,1B87EB2D-2F57-4CBD-8A00-57A0EB69AC7C,TCGA-EE-A29T-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A29T,TCGA-SKCM,NA,s7847,Harvard Medical School,University of Sydney,Australia,NO,TX,NX,Not available,Not available
13722.58cfa831e4b0c9d6adf6ca9c,58cfa831e4b0c9d6adf6ca9c,TCGA-D7-6817-10A-01D-1880_130111_SN208_0447_AC1JP0ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D7-6817-10A-01D-1880_130111_SN208_0447_AC1JP0ACXX_s_4_rg.sorted,TCGA-D7-6817-10A-01D-1880_130111_SN208_0447_AC1JP0ACXX_s_4_rg.sorted.bam,419,1.9,0.14,58cfa831e4b0c9d6adf6ca9c,TCGA-D7-6817-10A-01D-1880_130111_SN208_0447_AC1JP0ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6817-10A,6FFEFB3F-3919-4FEF-AB15-5D32D8F51D57,Blood Derived Normal,Illumina HiSeq,3b400a10-191c-44f7-af35-4b9ea1cb192e,Stomach,63,4F4A4499-0E06-4108-9F26-BF7D6A5DAF3F,0BDC98DD-3B4D-4737-8574-28E3F48366F7,TCGA-D7-6817-10A-01D-1880-02,HG19_Broad_variant,TCGA-D7-6817,TCGA-STAD,NA,s14995,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2b,N3,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIIA
13722.58cfa832e4b0c9d6adf6d35a,58cfa832e4b0c9d6adf6d35a,TCGA-L5-A43H-11A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_4_rg.sorted.filtered.,WGS,TCGA-L5-A43H-11A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_4_rg.sorted,TCGA-L5-A43H-11A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_4_rg.sorted.bam,28,NA,0.16,58cfa832e4b0c9d6adf6d35a,TCGA-L5-A43H-11A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A43H-11A,06CA7FC4-4AE0-47D5-9E83-F92BA42A957B,Solid Tissue Normal,Illumina HiSeq,d672a472-fb3f-45d1-bc7e-ae54476d82b1,Esophagus,75,F42F027E-3F16-4814-8807-CF886A9EC28B,DF77EB72-CB34-498C-A3CE-DE1DA1261739,TCGA-L5-A43H-11A-11D-A248-26,HG19_Broad_variant,TCGA-L5-A43H,TCGA-ESCA,9,s1735,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T3,N1,Not available,Stage III
13722.58cfa832e4b0c9d6adf6d392,58cfa832e4b0c9d6adf6d392,TCGA-L5-A43E-10A-01D-A248_130115_SN590_0207_AC1H8PACXX_s_2_rg.sorted.filtered.,WGS,TCGA-L5-A43E-10A-01D-A248_130115_SN590_0207_AC1H8PACXX_s_2_rg.sorted,TCGA-L5-A43E-10A-01D-A248_130115_SN590_0207_AC1H8PACXX_s_2_rg.sorted.bam,12.92,NA,0.15,58cfa832e4b0c9d6adf6d392,TCGA-L5-A43E-10A-01D-A248_130115_SN590_0207_AC1H8PACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A43E-10A,6969FE5A-5993-48E5-95C5-C5C7D3D08205,Blood Derived Normal,Illumina HiSeq,280db512-2841-4ac0-b78d-95d671a67788,Esophagus,74,0EA6822B-8940-422A-BB35-6714B8EE4D6B,E46D6A9A-8AF9-4DA5-A4E2-ED90AC9D1EAD,TCGA-L5-A43E-10A-01D-A248-26,HG19_Broad_variant,TCGA-L5-A43E,TCGA-ESCA,NA,s1647,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T1,N0,Not available,Stage I
13722.58cfa832e4b0c9d6adf6cefc,58cfa832e4b0c9d6adf6cefc,TCGA-H4-A2HQ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_5_rg.sorted.filtered.,WGS,TCGA-H4-A2HQ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_5_rg.sorted,TCGA-H4-A2HQ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_5_rg.sorted.bam,54.46,NA,0.15,58cfa832e4b0c9d6adf6cefc,TCGA-H4-A2HQ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_5_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-H4-A2HQ-01A,CEDE5274-279D-4021-8ACA-5ECC4BF94D66,Primary Tumor,Illumina HiSeq,46adb3c9-ac82-4284-b0d1-f95b10435695,Bladder,64,CBEDC0DB-39FD-4661-9531-CC24D422FAC4,CD60EBC2-EF2A-4B47-8D42-C864AA095B8D,TCGA-H4-A2HQ-01A-11D-A17R-02,HG19_Broad_variant,TCGA-H4-A2HQ,TCGA-BLCA,NA,s2735,Harvard Medical School,Medical College of Georgia,United States,NO,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6d406,58cfa832e4b0c9d6adf6d406,TCGA-VD-A8KH-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-VD-A8KH-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_5_rg.sorted,TCGA-VD-A8KH-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_5_rg.sorted.bam,11.43,NA,0.17,58cfa832e4b0c9d6adf6d406,TCGA-VD-A8KH-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_5_rg.sorted.bam,Alive,MALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KH-10A,39AF6E0F-908C-4B2B-97B8-A4D1966E47E1,Blood Derived Normal,Illumina HiSeq,df0bc11f-91e5-45d1-9ef8-50a3deceb924,Eye,69,CD8EF3DD-F50A-42B3-9D28-355728F2DEDC,5E80CA54-D6F1-4061-BE7C-5583945CFD81,TCGA-VD-A8KH-10A-01D-A40E-26,HG19_Broad_variant,TCGA-VD-A8KH,TCGA-UVM,NA,s280,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T4b,NX,Not available,Stage IIIB
13722.58cfa831e4b0c9d6adf6c6b8,58cfa831e4b0c9d6adf6c6b8,TCGA-CV-5431-11A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CV-5431-11A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_6_rg.sorted,TCGA-CV-5431-11A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_6_rg.sorted.bam,25.7,1.8,0.14,58cfa831e4b0c9d6adf6c6b8,TCGA-CV-5431-11A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5431-11A,64BB5550-2735-4401-A0DB-58EC1020A32D,Solid Tissue Normal,Illumina HiSeq,d7c39448-b5a1-49bb-8ff7-249509a8ffaf,Head and Neck,73,39E3FACF-6D13-4611-BCFA-90EF0350814D,2DD2EAD7-B8E3-4FEB-B03A-C799C73BEF17,TCGA-CV-5431-11A-01D-1509-02,HG19_Broad_variant,TCGA-CV-5431,TCGA-HNSC,522,s16044,Harvard Medical School,MD Anderson Cancer Center,None,NO,T3,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6cbac,58cfa831e4b0c9d6adf6cbac,TCGA-EB-A24D-10A-01D-A190_120730_SN208_0420_BC12YJACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EB-A24D-10A-01D-A190_120730_SN208_0420_BC12YJACXX_s_7_rg.sorted,TCGA-EB-A24D-10A-01D-A190_120730_SN208_0420_BC12YJACXX_s_7_rg.sorted.bam,48.4,NA,0.18,58cfa831e4b0c9d6adf6cbac,TCGA-EB-A24D-10A-01D-A190_120730_SN208_0420_BC12YJACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EB-A24D-10A,D7EE2693-39A8-4E3A-B6F6-E4729800E34E,Blood Derived Normal,Illumina HiSeq,1418a25a-5829-4edd-a545-8bebb544a7e8,Skin,72,D9EE5E38-F7F7-4E9A-8C01-4CDED37DC2EC,9B6A527A-83F8-4B0A-95F4-AF1DD54B3404,TCGA-EB-A24D-10A-01D-A190-02,HG19_Broad_variant,TCGA-EB-A24D,TCGA-SKCM,NA,s7839,Harvard Medical School,Asterand,Ukraine,NO,T4a,N2b,Not available,Stage IIIB
13722.58cfa831e4b0c9d6adf6c3f2,58cfa831e4b0c9d6adf6c3f2,TCGA-CH-5748-10A-01D-1572_130103_SN1222_0165_AC1FBHACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CH-5748-10A-01D-1572_130103_SN1222_0165_AC1FBHACXX_s_4_rg.sorted,TCGA-CH-5748-10A-01D-1572_130103_SN1222_0165_AC1FBHACXX_s_4_rg.sorted.bam,114.4,1.9,0.15,58cfa831e4b0c9d6adf6c3f2,TCGA-CH-5748-10A-01D-1572_130103_SN1222_0165_AC1FBHACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5748-10A,0AF98331-9305-41E9-AF55-30390016D65E,Blood Derived Normal,Illumina HiSeq,c1f919a6-32b6-4134-a118-61ce369b31d2,Prostate,64,17C53B15-D6BF-4E3E-8BE2-7A14FABF33CA,178D7CC1-0C32-4D2F-8CF9-3E2789780A98,TCGA-CH-5748-10A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5748,TCGA-PRAD,NA,s3769,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6cff4,58cfa832e4b0c9d6adf6cff4,TCGA-G2-A2ES-11A-31D-A17R_120921_SN208_0430_AC18CWACXX_s_8_rg.sorted.filtered.,WGS,TCGA-G2-A2ES-11A-31D-A17R_120921_SN208_0430_AC18CWACXX_s_8_rg.sorted,TCGA-G2-A2ES-11A-31D-A17R_120921_SN208_0430_AC18CWACXX_s_8_rg.sorted.bam,8.9,NA,0.16,58cfa832e4b0c9d6adf6cff4,TCGA-G2-A2ES-11A-31D-A17R_120921_SN208_0430_AC18CWACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-G2-A2ES-11A,72D8EAE8-9EFB-45B2-ACBD-82C6B5732E38,Solid Tissue Normal,Illumina HiSeq,f8583339-ea56-43ba-af11-e7b5945ecfb4,Bladder,85,F7D5544F-E86D-410F-995C-86A717742036,F310E6C4-B237-4EA0-A8A1-679B5B49C50D,TCGA-G2-A2ES-11A-31D-A17R-02,HG19_Broad_variant,TCGA-G2-A2ES,TCGA-BLCA,NA,s3119,Harvard Medical School,MD Anderson,United States,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa830e4b0c9d6adf6c0a2,58cfa830e4b0c9d6adf6c0a2,TCGA-BJ-A0ZG-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BJ-A0ZG-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_7_rg.sorted,TCGA-BJ-A0ZG-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_7_rg.sorted.bam,6.76,1.71,0.13,58cfa830e4b0c9d6adf6c0a2,TCGA-BJ-A0ZG-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0ZG-10A,A3810F36-D2B4-4A45-AD08-A4DBFB9D27AA,Blood Derived Normal,Illumina HiSeq,ec575768-5714-4488-a113-a87ae6de34f0,Thyroid,80,CF6D9496-441B-4ED1-90D0-BDE9F2C8FD61,B66FBD46-CC3B-4881-ADA0-2998BAF442DA,TCGA-BJ-A0ZG-10A-01D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZG,TCGA-THCA,NA,s12098,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa82ee4b0c9d6adf6ae6c,58cfa82ee4b0c9d6adf6ae6c,TCGA-05-4405-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_2.rg.sorted.filtered.,WGS,TCGA-05-4405-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_2.rg.sorted,TCGA-05-4405-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_2.rg.sorted.bam,175.7,1.9,0.17,58cfa82ee4b0c9d6adf6ae6c,TCGA-05-4405-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_2.rg.sorted.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4405-01A,F587C9AB-2949-4410-80D6-A050865D48AA,Primary Tumor,Illumina HiSeq,47fe3db4-7a54-4703-b3a4-7ad7def2469c,Lung,74,9CE83CC4-7B9B-4CE7-98F5-5CE8A8D70902,8A9ADFB9-6266-490D-B1B6-F66F43F3F657,TCGA-05-4405-01A-21D-1853-02,HG19_Broad_variant,TCGA-05-4405,TCGA-LUAD,NA,s10768,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa831e4b0c9d6adf6c3e6,58cfa831e4b0c9d6adf6c3e6,TCGA-CH-5745-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CH-5745-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_7_rg.sorted,TCGA-CH-5745-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_7_rg.sorted.bam,146.7,1.9,0.15,58cfa831e4b0c9d6adf6c3e6,TCGA-CH-5745-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5745-01A,AC67D0DF-7DC0-4A1A-8B47-BEEC9B94DE86,Primary Tumor,Illumina HiSeq,c1d27dca-0355-41e5-a53b-0af94a125c6a,Prostate,68,BDA91E83-643B-4FAE-BFE9-B4660F3BDF02,780758FF-58EE-4B4B-AC71-DE15C89C4625,TCGA-CH-5745-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5745,TCGA-PRAD,NA,s3770,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c544,58cfa831e4b0c9d6adf6c544,TCGA-CH-5788-10A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CH-5788-10A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_4_rg.sorted,TCGA-CH-5788-10A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_4_rg.sorted.bam,101.4,1.9,0.15,58cfa831e4b0c9d6adf6c544,TCGA-CH-5788-10A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5788-10A,C039014F-821C-43D6-9D3C-914F9C8D98FA,Blood Derived Normal,Illumina HiSeq,bd062ff6-6f65-449b-8441-b83018519258,Prostate,69,7B15C08B-3DB1-4505-A8A7-21FF56A7DCA6,E642F580-1F27-4773-AF08-2483009C4E7F,TCGA-CH-5788-10A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5788,TCGA-PRAD,NA,s3416,Harvard Medical School,Indivumed,Germany,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cbc7,58cfa831e4b0c9d6adf6cbc7,TCGA-EJ-7327-01A-11D-2111_130422_SN590_0225_BD23TLACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EJ-7327-01A-11D-2111_130422_SN590_0225_BD23TLACXX_s_8_rg.sorted,TCGA-EJ-7327-01A-11D-2111_130422_SN590_0225_BD23TLACXX_s_8_rg.sorted.bam,261.3,NA,0.14,58cfa831e4b0c9d6adf6cbc7,TCGA-EJ-7327-01A-11D-2111_130422_SN590_0225_BD23TLACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7327-01A,E90AB72A-4BBB-4C37-B48A-8A1A85D79D04,Primary Tumor,Illumina HiSeq,fe462cbb-5d52-4a0e-8cb8-a7e6c0f39c7c,Prostate,61,992415EF-53DE-4C52-A538-07931E68182B,0FC53595-F61A-4171-B982-335AEE13CC85,TCGA-EJ-7327-01A-11D-2111-02,HG19_Broad_variant,TCGA-EJ-7327,TCGA-PRAD,NA,s4145,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82fe4b0c9d6adf6b6b3,58cfa82fe4b0c9d6adf6b6b3,TCGA-55-6642-11A-01D-1853_120310_SN590_0144_AD0PNFACXX_s_2_rg.sorted.filtered.,WGS,TCGA-55-6642-11A-01D-1853_120310_SN590_0144_AD0PNFACXX_s_2_rg.sorted,TCGA-55-6642-11A-01D-1853_120310_SN590_0144_AD0PNFACXX_s_2_rg.sorted.bam,202.7,1.9,0.14,58cfa82fe4b0c9d6adf6b6b3,TCGA-55-6642-11A-01D-1853_120310_SN590_0144_AD0PNFACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-55-6642-11A,474B86D9-D897-467D-85D4-51DFA26EA107,Solid Tissue Normal,Illumina HiSeq,ae204af3-603b-4186-b84a-4634f70af495,Lung,63,16813145-731C-4C86-ADE2-3DF32A47D4B0,2F9F7057-AF60-41FA-AB40-0EB76A8455FD,TCGA-55-6642-11A-01D-1853-02,HG19_Broad_variant,TCGA-55-6642,TCGA-LUAD,NA,s10662,Harvard Medical School,International Genomics Consortium,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c68c,58cfa831e4b0c9d6adf6c68c,TCGA-CH-5746-10A-01D-1572_130103_SN1222_0165_AC1FBHACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CH-5746-10A-01D-1572_130103_SN1222_0165_AC1FBHACXX_s_2_rg.sorted,TCGA-CH-5746-10A-01D-1572_130103_SN1222_0165_AC1FBHACXX_s_2_rg.sorted.bam,258.4,1.9,0.16,58cfa831e4b0c9d6adf6c68c,TCGA-CH-5746-10A-01D-1572_130103_SN1222_0165_AC1FBHACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5746-10A,618272C0-C2ED-4BFB-BB4B-404F0987F822,Blood Derived Normal,Illumina HiSeq,f96d7355-1ea6-48c4-8399-14a9bef45847,Prostate,57,317F224F-974F-4CD0-829C-EA777A96D726,2C125199-3BB0-4CF5-BA35-54DDF9EBF94D,TCGA-CH-5746-10A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5746,TCGA-PRAD,NA,s3590,Harvard Medical School,Indivumed,Germany,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d158,58cfa832e4b0c9d6adf6d158,TCGA-IR-A3LF-01A-21D-A232_140124_SN1120_0292_BD2F1HACXX_s_7_rg.sorted.filtered.,WGS,TCGA-IR-A3LF-01A-21D-A232_140124_SN1120_0292_BD2F1HACXX_s_7_rg.sorted,TCGA-IR-A3LF-01A-21D-A232_140124_SN1120_0292_BD2F1HACXX_s_7_rg.sorted.bam,36.63,NA,0.15,58cfa832e4b0c9d6adf6d158,TCGA-IR-A3LF-01A-21D-A232_140124_SN1120_0292_BD2F1HACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-IR-A3LF-01A,785DDEA1-399D-47D8-B2B0-39E95EAA24B5,Primary Tumor,Illumina HiSeq,aba44461-5b2e-40f7-9e8e-262aee825e6c,Cervix,64,B6A74A02-CD3B-4F0A-BB2F-F90C1D3F6D14,02D65CAC-E751-493F-A4FB-3DDB1400EFAC,TCGA-IR-A3LF-01A-21D-A232-26,HG19_Broad_variant,TCGA-IR-A3LF,TCGA-CESC,NA,s1216,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T1b1,N0,Endocervical Adenocarcinoma of the Usual Type,Not available
13722.58cfa831e4b0c9d6adf6c863,58cfa831e4b0c9d6adf6c863,TCGA-CV-6960-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CV-6960-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_2_rg.sorted,TCGA-CV-6960-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_2_rg.sorted.bam,19.03,NA,0.14,58cfa831e4b0c9d6adf6c863,TCGA-CV-6960-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_2_rg.sorted.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,Not available,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6960-10A,2C985B30-0F8F-4C8F-A924-CC6AAD7EBF0D,Blood Derived Normal,Illumina HiSeq,48a5d368-878b-4e4a-9232-501b2c2dfbfe,Head and Neck,49,923CD247-B6A7-4FBA-8867-59BEC8641A05,8865D60E-A053-4471-862D-B1B90BCBC99E,TCGA-CV-6960-10A-01D-2317-26,HG19_Broad_variant,TCGA-CV-6960,TCGA-HNSC,862,s15517,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6c448,58cfa831e4b0c9d6adf6c448,TCGA-CH-5791-10A-01D-1572_130125_SN208_0451_BD1RB1ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CH-5791-10A-01D-1572_130125_SN208_0451_BD1RB1ACXX_s_2_rg.sorted,TCGA-CH-5791-10A-01D-1572_130125_SN208_0451_BD1RB1ACXX_s_2_rg.sorted.bam,161.4,1.9,0.15,58cfa831e4b0c9d6adf6c448,TCGA-CH-5791-10A-01D-1572_130125_SN208_0451_BD1RB1ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5791-10A,829BED0C-C40D-44FD-AEE8-6C7589DB60F9,Blood Derived Normal,Illumina HiSeq,747350b7-a5fa-4e6a-bf4b-72ea53989d5c,Prostate,72,B08C0243-25F7-4D67-AA5F-164D923EFC5C,14DD8BDC-9413-47FA-AB23-15EC575D06E5,TCGA-CH-5791-10A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5791,TCGA-PRAD,NA,s3932,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bd92,58cfa830e4b0c9d6adf6bd92,TCGA-BG-A0LW-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BG-A0LW-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_5_rg.sorted,TCGA-BG-A0LW-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_5_rg.sorted.bam,100.95,1.92,0.15,58cfa830e4b0c9d6adf6bd92,TCGA-BG-A0LW-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0LW-01A,68181BC9-AA8B-44EC-8601-564B30EA0561,Primary Tumor,Illumina HiSeq,89430da6-f21d-4534-8b48-c645836813b5,Uterus,47,6527EC31-1D41-49C2-93FF-11615A6CBA8B,5D88ADF5-468B-4377-B3E3-DF986C613D24,TCGA-BG-A0LW-01A-11D-A043-02,HG19_Broad_variant,TCGA-BG-A0LW,TCGA-UCEC,NA,s5003,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d4ad,58cfa832e4b0c9d6adf6d4ad,TCGA-VD-A8KD-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-VD-A8KD-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_1_rg.sorted,TCGA-VD-A8KD-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_1_rg.sorted.bam,8.59,NA,0.16,58cfa832e4b0c9d6adf6d4ad,TCGA-VD-A8KD-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_1_rg.sorted.bam,Dead,MALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KD-10A,73B3E4DD-C53D-4FE3-8607-EE462C9CBBD1,Blood Derived Normal,Illumina HiSeq,99f8995a-98db-4c2b-9fdc-df94af8f5515,Eye,72,7337009E-7A20-47E3-8DF3-2CBEF6098FDB,65C5261C-A028-4FB0-B117-82F3D6A3CB4C,TCGA-VD-A8KD-10A-01D-A40E-26,HG19_Broad_variant,TCGA-VD-A8KD,TCGA-UVM,114,s267,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T4a,NX,Not available,Stage IV
13722.58cfa831e4b0c9d6adf6c55c,58cfa831e4b0c9d6adf6c55c,TCGA-CH-5750-10A-01D-1572_130103_SN1222_0165_AC1FBHACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CH-5750-10A-01D-1572_130103_SN1222_0165_AC1FBHACXX_s_6_rg.sorted,TCGA-CH-5750-10A-01D-1572_130103_SN1222_0165_AC1FBHACXX_s_6_rg.sorted.bam,289.4,1.9,0.16,58cfa831e4b0c9d6adf6c55c,TCGA-CH-5750-10A-01D-1572_130103_SN1222_0165_AC1FBHACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5750-10A,DC40CF49-B208-4F59-B5F0-CFBDD02970B2,Blood Derived Normal,Illumina HiSeq,54cfd889-407a-47bf-97d6-e938fb0f0f0c,Prostate,72,3877B217-E1C2-4FFA-8956-DCD5EBF4FBBD,05EF9854-9858-4C11-9676-2C71A51F611C,TCGA-CH-5750-10A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5750,TCGA-PRAD,NA,s3774,Harvard Medical School,Indivumed,Germany,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d568,58cfa832e4b0c9d6adf6d568,TCGA-VD-A8KG-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-VD-A8KG-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_4_rg.sorted,TCGA-VD-A8KG-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_4_rg.sorted.bam,12.89,NA,0.14,58cfa832e4b0c9d6adf6d568,TCGA-VD-A8KG-10A-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-A8KG-10A,9F57834A-4DC4-45ED-97DE-ED4DA9D0598D,Blood Derived Normal,Illumina HiSeq,f2f590c6-e0ce-44d9-acd6-1c306cd23171,Eye,47,BAC82025-0457-4837-9E73-277FAEDC15EF,5487E440-F84B-45BF-826E-5BF4CE1CD962,TCGA-VD-A8KG-10A-01D-A40E-26,HG19_Broad_variant,TCGA-VD-A8KG,TCGA-UVM,NA,s255,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T2a,NX,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6c4ef,58cfa831e4b0c9d6adf6c4ef,TCGA-BK-A0CB-10A-05D-A101_120406_SN208_0281_AC0KDBACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BK-A0CB-10A-05D-A101_120406_SN208_0281_AC0KDBACXX_s_1_rg.sorted,TCGA-BK-A0CB-10A-05D-A101_120406_SN208_0281_AC0KDBACXX_s_1_rg.sorted.bam,10.08,1.74,0.16,58cfa831e4b0c9d6adf6c4ef,TCGA-BK-A0CB-10A-05D-A101_120406_SN208_0281_AC0KDBACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BK-A0CB-10A,59E9029A-8DDD-4447-B35A-72BC39F82A30,Blood Derived Normal,Illumina HiSeq,9dd332ef-84c8-4b9d-b5d8-a0284caa04e8,Uterus,60,DBD6C648-E013-4249-9636-A0A2C6A8BFF0,88C92710-D589-4E52-811B-4D5B677C618E,TCGA-BK-A0CB-10A-05D-A101-02,HG19_Broad_variant,TCGA-BK-A0CB,TCGA-UCEC,NA,s4259,Harvard Medical School,Christiana Healthcare,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d178,58cfa832e4b0c9d6adf6d178,TCGA-HC-7081-10A-01D-1958_130422_SN590_0225_BD23TLACXX_s_5_rg.sorted.filtered.,WGS,TCGA-HC-7081-10A-01D-1958_130422_SN590_0225_BD23TLACXX_s_5_rg.sorted,TCGA-HC-7081-10A-01D-1958_130422_SN590_0225_BD23TLACXX_s_5_rg.sorted.bam,193,NA,0.15,58cfa832e4b0c9d6adf6d178,TCGA-HC-7081-10A-01D-1958_130422_SN590_0225_BD23TLACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,Not available,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7081-10A,3DA2E90E-6450-4286-8C74-08DBECBFD788,Blood Derived Normal,Illumina HiSeq,8696b1a7-d544-4806-95c3-83dff3aa5508,Prostate,62,447E7951-2ECB-4646-8E3D-B3DE527F9838,14B57C36-7B01-449F-AB30-579156E08FA7,TCGA-HC-7081-10A-01D-1958-02,HG19_Broad_variant,TCGA-HC-7081,TCGA-PRAD,NA,s3461,Harvard Medical School,International Genomics Consortium,United States,NO,T3b,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cdd8,58cfa831e4b0c9d6adf6cdd8,TCGA-FD-A3SR-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FD-A3SR-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_8_rg.sorted,TCGA-FD-A3SR-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_8_rg.sorted.bam,55.83,NA,0.17,58cfa831e4b0c9d6adf6cdd8,TCGA-FD-A3SR-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3SR-10A,72D6E9AA-4A99-4FC9-A67B-4631E95FB043,Blood Derived Normal,Illumina HiSeq,ea09ef7b-e64d-4515-bd29-48e6bb5e9522,Bladder,68,26A72200-0064-43C2-84B6-BBF18BCACF0F,963EBEDB-0183-4920-8C5A-AE373BE315D5,TCGA-FD-A3SR-10A-01D-A233-26,HG19_Broad_variant,TCGA-FD-A3SR,TCGA-BLCA,602,s3301,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T4a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6d0f2,58cfa832e4b0c9d6adf6d0f2,TCGA-HC-7213-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-HC-7213-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_6_rg.sorted,TCGA-HC-7213-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_6_rg.sorted.bam,408.3,NA,0.15,58cfa832e4b0c9d6adf6d0f2,TCGA-HC-7213-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7213-01A,26EEFAA1-1666-4CE1-8CF4-F6FABFF81FD2,Primary Tumor,Illumina HiSeq,14482ee6-0af5-43ad-bc2b-c9574446f6b9,Prostate,53,0CB3DFFD-1521-4887-B19C-94DCD340D306,6D368C2B-4F13-4006-A487-7DB0ADA55C6A,TCGA-HC-7213-01A-11D-2111-02,HG19_Broad_variant,TCGA-HC-7213,TCGA-PRAD,NA,s3812,Harvard Medical School,International Genomics Consortium,United States,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cac2,58cfa831e4b0c9d6adf6cac2,TCGA-DJ-A13R-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DJ-A13R-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_2_rg.sorted,TCGA-DJ-A13R-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_2_rg.sorted.bam,78.88,1.95,0.16,58cfa831e4b0c9d6adf6cac2,TCGA-DJ-A13R-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13R-01A,3E787A0E-B5D2-401E-B1E5-077376090B3A,Primary Tumor,Illumina HiSeq,84cf379b-0f45-44d0-b5e3-00a439bab300,Thyroid,50,27B0FF79-4213-4B57-B6E0-A393B8983D20,7B0104C8-1264-4580-94D1-C7C39D79C6E6,TCGA-DJ-A13R-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13R,TCGA-THCA,NA,s12368,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III
13722.58cfa831e4b0c9d6adf6c5ca,58cfa831e4b0c9d6adf6c5ca,TCGA-BR-6705-10A-01D-1880_121220_SN1222_0163_AC1HA2ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BR-6705-10A-01D-1880_121220_SN1222_0163_AC1HA2ACXX_s_4_rg.sorted,TCGA-BR-6705-10A-01D-1880_121220_SN1222_0163_AC1HA2ACXX_s_4_rg.sorted.bam,187.3,1.9,0.15,58cfa831e4b0c9d6adf6c5ca,TCGA-BR-6705-10A-01D-1880_121220_SN1222_0163_AC1HA2ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6705-10A,B14F2FCB-E869-475E-BC7C-ADAF6E7E636F,Blood Derived Normal,Illumina HiSeq,7fbe76eb-2522-4271-89b9-61797e2e206d,Stomach,68,EDB50087-0611-46DB-9BE5-C3DACE105CDB,693FA0BF-922B-44B2-827F-93FC366D8812,TCGA-BR-6705-10A-01D-1880-02,HG19_Broad_variant,TCGA-BR-6705,TCGA-STAD,NA,s14691,Harvard Medical School,Asterand,Ukraine,NO,T3,N3a,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIB
13722.58cfa831e4b0c9d6adf6cc6a,58cfa831e4b0c9d6adf6cc6a,TCGA-ER-A197-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-ER-A197-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_6_rg.sorted,TCGA-ER-A197-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_6_rg.sorted.bam,34.03,NA,0.16,58cfa831e4b0c9d6adf6cc6a,TCGA-ER-A197-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_6_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A197-10A,3EBB2374-4518-4E19-9B65-9C3E66252C4C,Blood Derived Normal,Illumina HiSeq,256ef618-0c68-4c1c-b754-2fb29870cf2c,Skin,83,3647C9F3-ADBF-47BD-98C5-DE52E323306B,564616DE-9FEF-436D-B3A0-5AFA65276D94,TCGA-ER-A197-10A-01D-A190-02,HG19_Broad_variant,TCGA-ER-A197,TCGA-SKCM,424,s7354,Harvard Medical School,University of Pittsburgh,United States,NO,T4b,N1a,Not available,Stage IIIB
13722.58cfa832e4b0c9d6adf6d0a0,58cfa832e4b0c9d6adf6d0a0,TCGA-HW-7495-10A-01D-2022_130913_SN1440_0168_BD2B0UACXX_s_7_rg.sorted.filtered.,WGS,TCGA-HW-7495-10A-01D-2022_130913_SN1440_0168_BD2B0UACXX_s_7_rg.sorted,TCGA-HW-7495-10A-01D-2022_130913_SN1440_0168_BD2B0UACXX_s_7_rg.sorted.bam,366,NA,0.14,58cfa832e4b0c9d6adf6d0a0,TCGA-HW-7495-10A-01D-2022_130913_SN1440_0168_BD2B0UACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HW-7495-10A,49967A57-7C12-46BB-8D71-CEBBB17C9935,Blood Derived Normal,Illumina HiSeq,938bedfd-8385-4a31-a739-3d8bb17c8a1d,Brain,45,3DA04A47-7161-4DC0-8F0D-0E439159BC74,48B8B9BE-BBE0-4CAF-B8DD-265BE265D256,TCGA-HW-7495-10A-01D-2022-02,HG19_Broad_variant,TCGA-HW-7495,TCGA-LGG,NA,s8375,Harvard Medical School,MSKCC,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82fe4b0c9d6adf6b83a,58cfa82fe4b0c9d6adf6b83a,TCGA-A5-A0R8-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-A5-A0R8-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_4_rg.sorted,TCGA-A5-A0R8-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_4_rg.sorted.bam,16.35,1.97,0.15,58cfa82fe4b0c9d6adf6b83a,TCGA-A5-A0R8-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0R8-10A,06D16B6B-9CA6-4CEC-A785-F27AA4323CEC,Blood Derived Normal,Illumina HiSeq,aba38e39-8eb7-4475-b9d0-1d8868b47fbd,Uterus,81,2309BBE1-9809-4ABA-9A0E-6AF113447806,DE4B2450-F33C-448E-BC24-38A82B2232A2,TCGA-A5-A0R8-10A-01D-A101-02,HG19_Broad_variant,TCGA-A5-A0R8,TCGA-UCEC,NA,s4990,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c3b2,58cfa831e4b0c9d6adf6c3b2,TCGA-CG-4476-01A-01D-1154_121029_SN208_0438_AC18NJACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CG-4476-01A-01D-1154_121029_SN208_0438_AC18NJACXX_s_1_rg.sorted,TCGA-CG-4476-01A-01D-1154_121029_SN208_0438_AC18NJACXX_s_1_rg.sorted.bam,127.2,1.9,0.14,58cfa831e4b0c9d6adf6c3b2,TCGA-CG-4476-01A-01D-1154_121029_SN208_0438_AC18NJACXX_s_1_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4476-01A,442D7415-D095-4962-8296-A14390BAD40A,Primary Tumor,Illumina HiSeq,fa01457a-1a83-47ed-b744-7494b9756706,Stomach,69,37F5444F-A58D-4899-A11B-9C09ECD357FC,0C5818D8-5C20-4E4B-99CF-6F378CA6EBE7,TCGA-CG-4476-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4476,TCGA-STAD,NA,s14554,Harvard Medical School,Indivumed,Germany,NO,T4b,N3a,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIC
13722.58cfa831e4b0c9d6adf6c667,58cfa831e4b0c9d6adf6c667,TCGA-CG-4466-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CG-4466-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_2_rg.sorted,TCGA-CG-4466-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_2_rg.sorted.bam,143.3,1.9,0.14,58cfa831e4b0c9d6adf6c667,TCGA-CG-4466-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4466-01A,2F1B96B2-7031-4F7D-9490-14728D320F3E,Primary Tumor,Illumina HiSeq,cea9fe91-10d4-464c-80a6-24b7ed98ba9c,Stomach,81,0BC4ABB4-047B-4C8D-9F79-5B9EB32969E9,623D5E6A-A5D3-4580-BEF7-04673D42A1D0,TCGA-CG-4466-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4466,TCGA-STAD,NA,s14757,Harvard Medical School,Indivumed,Germany,NO,T2a,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa82fe4b0c9d6adf6b646,58cfa82fe4b0c9d6adf6b646,TCGA-75-5126-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_6_rg.sorted.filtered.,WGS,TCGA-75-5126-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_6_rg.sorted,TCGA-75-5126-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_6_rg.sorted.bam,72.7,1.9,0.16,58cfa82fe4b0c9d6adf6b646,TCGA-75-5126-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_6_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-5126-10A,93766482-2F20-4C8F-BBD8-BDD203C37D5A,Blood Derived Normal,Illumina HiSeq,c15f5681-638a-4471-a349-56138d68fe62,Lung,NA,9D7D2BB6-7463-4695-AD94-E70C4CE0BAA8,43ACFB6F-D582-4016-BD27-24FA2B22B6E7,TCGA-75-5126-10A-01D-1751-02,HG19_Broad_variant,TCGA-75-5126,TCGA-LUAD,NA,s10801,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,T3,N2,Lung Papillary Adenocarcinoma,Stage IIIA
13722.58cfa832e4b0c9d6adf6d14a,58cfa832e4b0c9d6adf6d14a,TCGA-FS-A1ZM-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_7_rg.sorted.filtered.,WGS,TCGA-FS-A1ZM-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_7_rg.sorted,TCGA-FS-A1ZM-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_7_rg.sorted.bam,46.64,NA,0.17,58cfa832e4b0c9d6adf6d14a,TCGA-FS-A1ZM-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZM-10A,9937259A-9D47-483C-8773-B3C60E02A653,Blood Derived Normal,Illumina HiSeq,802e023c-a4de-478e-8d5a-10bd9d163dec,Skin,74,D2AA13F1-D13B-43CC-95E1-1FA3A611F1CC,99346D7E-B398-4886-BCFB-29876B53964D,TCGA-FS-A1ZM-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZM,TCGA-SKCM,NA,s7539,Harvard Medical School,Essen,Germany,NO,T2,N2c,Not available,Stage III
13722.58cfa831e4b0c9d6adf6c5bf,58cfa831e4b0c9d6adf6c5bf,TCGA-CN-5356-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CN-5356-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_8_rg.sorted,TCGA-CN-5356-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_8_rg.sorted.bam,231.4,1.9,0.16,58cfa831e4b0c9d6adf6c5bf,TCGA-CN-5356-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5356-10A,E1FED7AA-2BCE-45AE-B0C6-7F50EF97E425,Blood Derived Normal,Illumina HiSeq,057502ad-201c-4e2a-967a-1ed9dbf9245b,Head and Neck,56,CF684788-D8E6-49DA-8421-B2DBF040A529,9DCEEF82-8725-48B3-8728-4D48B3033796,TCGA-CN-5356-10A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5356,TCGA-HNSC,NA,s16183,Harvard Medical School,University of Pittsburgh,None,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6cd50,58cfa831e4b0c9d6adf6cd50,TCGA-FD-A3SQ-01A-21D-A233_120830_SN208_0424_BD1DKLACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FD-A3SQ-01A-21D-A233_120830_SN208_0424_BD1DKLACXX_s_5_rg.sorted,TCGA-FD-A3SQ-01A-21D-A233_120830_SN208_0424_BD1DKLACXX_s_5_rg.sorted.bam,35.93,NA,0.14,58cfa831e4b0c9d6adf6cd50,TCGA-FD-A3SQ-01A-21D-A233_120830_SN208_0424_BD1DKLACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3SQ-01A,3071CB51-DCF5-41F7-B047-AFC2DCBF0AAF,Primary Tumor,Illumina HiSeq,104a1ca4-a3b6-42e6-b6ba-1b0916160573,Bladder,62,A78A8C62-06ED-4562-B529-D30A5D1508E7,749C6741-66D9-4BEE-B5D6-7F6C4F9F0F88,TCGA-FD-A3SQ-01A-21D-A233-26,HG19_Broad_variant,TCGA-FD-A3SQ,TCGA-BLCA,1423,s3295,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T3a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6ccc2,58cfa831e4b0c9d6adf6ccc2,TCGA-EJ-5510-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EJ-5510-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_6_rg.sorted,TCGA-EJ-5510-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_6_rg.sorted.bam,635.4,1.9,0.16,58cfa831e4b0c9d6adf6ccc2,TCGA-EJ-5510-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5510-10A,4A3D9EFE-F24E-4135-8A70-E202651E7A81,Blood Derived Normal,Illumina HiSeq,ded2ef5d-8342-4b98-be7e-ca384611f209,Prostate,48,20C35589-0E2B-4A88-80EC-B9E5E0CAEB7D,8F8E5DD8-A750-4DBC-A7EC-FC9AF143F0DD,TCGA-EJ-5510-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5510,TCGA-PRAD,NA,s3599,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cbbd,58cfa831e4b0c9d6adf6cbbd,TCGA-EJ-5522-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EJ-5522-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_6_rg.sorted,TCGA-EJ-5522-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_6_rg.sorted.bam,467.4,1.9,0.17,58cfa831e4b0c9d6adf6cbbd,TCGA-EJ-5522-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5522-10A,214884EF-A932-4FC3-B6FF-16CE5164DA3E,Blood Derived Normal,Illumina HiSeq,63030ee9-29f8-4955-8347-16e12ab169ca,Prostate,51,DD1221A7-825F-4598-82EC-0A069639A36B,40816943-ECAF-4499-BD1A-07206D9328B9,TCGA-EJ-5522-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5522,TCGA-PRAD,NA,s3946,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c404,58cfa831e4b0c9d6adf6c404,TCGA-CH-5790-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CH-5790-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_7_rg.sorted,TCGA-CH-5790-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_7_rg.sorted.bam,285.7,1.9,0.15,58cfa831e4b0c9d6adf6c404,TCGA-CH-5790-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5790-01A,2B5EF82D-E137-43F6-BFEF-B202F20EE187,Primary Tumor,Illumina HiSeq,22e486a4-e20b-4211-b3fd-35f37d14e718,Prostate,64,5C8782C0-0B0D-4AFF-B996-423D214FF5FF,9BA30DBB-2730-48A1-94E5-10CCA134728F,TCGA-CH-5790-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5790,TCGA-PRAD,NA,s3936,Harvard Medical School,Indivumed,Germany,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cb72,58cfa831e4b0c9d6adf6cb72,TCGA-EJ-5516-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EJ-5516-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_4_rg.sorted,TCGA-EJ-5516-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_4_rg.sorted.bam,758.4,1.9,0.16,58cfa831e4b0c9d6adf6cb72,TCGA-EJ-5516-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5516-10A,1FD06207-54E0-4ABA-819C-C7F671871F39,Blood Derived Normal,Illumina HiSeq,62d826e0-8cb6-4568-9f74-02b23a1421df,Prostate,49,C0D9909A-4EED-44DE-AFBA-0D8C0A549DDD,121C2F4C-3B87-4094-8CD4-8ADB3E27859E,TCGA-EJ-5516-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5516,TCGA-PRAD,NA,s3783,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c278,58cfa830e4b0c9d6adf6c278,TCGA-B5-A0K1-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_3_rg.sorted.filtered.,WGS,TCGA-B5-A0K1-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_3_rg.sorted,TCGA-B5-A0K1-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_3_rg.sorted.bam,82.72,2.05,0.16,58cfa830e4b0c9d6adf6c278,TCGA-B5-A0K1-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0K1-01A,40A3ED98-3892-449C-B07E-7B7612BD997E,Primary Tumor,Illumina HiSeq,fb29a0da-eb80-43a5-be71-85cf2d58268c,Uterus,69,B514F636-DEE3-45F3-BB31-197CA6A171F1,D4814366-AEF2-453B-8DC7-A731B5E53FE8,TCGA-B5-A0K1-01A-11D-A043-02,HG19_Broad_variant,TCGA-B5-A0K1,TCGA-UCEC,NA,s5211,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c49a,58cfa831e4b0c9d6adf6c49a,TCGA-BR-4292-01A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BR-4292-01A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_1_rg.sorted,TCGA-BR-4292-01A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_1_rg.sorted.bam,20.9,1.9,0.15,58cfa831e4b0c9d6adf6c49a,TCGA-BR-4292-01A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4292-01A,703D3E86-32F4-44AE-BD88-C02378FC2269,Primary Tumor,Illumina HiSeq,a7dacb77-1a29-40e8-a758-c37b5bc38631,Stomach,73,2E0E0776-6AD0-4118-B27E-C65D6076A3D4,CA45AA53-32C8-4412-B867-E242ED5B101C,TCGA-BR-4292-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4292,TCGA-STAD,NA,s14817,Harvard Medical School,Asterand,Russia,NO,T1,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa830e4b0c9d6adf6bfce,58cfa830e4b0c9d6adf6bfce,TCGA-BR-6710-10A-01D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BR-6710-10A-01D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_4_rg.sorted,TCGA-BR-6710-10A-01D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_4_rg.sorted.bam,294,1.9,0.17,58cfa830e4b0c9d6adf6bfce,TCGA-BR-6710-10A-01D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6710-10A,012E99FE-E3E8-4BB0-BB74-5B0C9992187C,Blood Derived Normal,Illumina HiSeq,a4f4bc0d-7d51-4c01-b0c7-98f206980452,Stomach,41,DDBC1E15-BF90-4A2A-BF72-A5E0F39149C3,2B49E069-0DB8-4574-ACFA-4B9B8A0F86F2,TCGA-BR-6710-10A-01D-1880-02,HG19_Broad_variant,TCGA-BR-6710,TCGA-STAD,NA,s15382,Harvard Medical School,Asterand,Ukraine,NO,T2,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa830e4b0c9d6adf6c0fa,58cfa830e4b0c9d6adf6c0fa,TCGA-BS-A0TD-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BS-A0TD-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_2_rg.sorted,TCGA-BS-A0TD-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_2_rg.sorted.bam,18.7,1.95,0.15,58cfa830e4b0c9d6adf6c0fa,TCGA-BS-A0TD-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_2_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TD-10A,FFAA98A0-2B69-46DC-AEE5-C5C3F2ABBC38,Blood Derived Normal,Illumina HiSeq,74436d29-252b-4a2a-b3b1-42c41efd689f,Uterus,65,2729ED97-F971-4D98-8BAA-F99404DD2B9F,BF739F03-C24E-4FC8-81EE-1BC104FDE973,TCGA-BS-A0TD-10A-01D-A101-02,HG19_Broad_variant,TCGA-BS-A0TD,TCGA-UCEC,NA,s5011,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d01c,58cfa832e4b0c9d6adf6d01c,TCGA-FU-A3TX-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FU-A3TX-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_4_rg.sorted,TCGA-FU-A3TX-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_4_rg.sorted.bam,57.65,NA,0.16,58cfa832e4b0c9d6adf6d01c,TCGA-FU-A3TX-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-FU-A3TX-01A,B75644C2-B515-41CE-9B03-842EF5208A17,Primary Tumor,Illumina HiSeq,3692ce0d-daf2-4076-a86f-4d8e9ea25745,Cervix,78,D9146847-1E6A-4963-9BC2-C2041B36A84C,14CDA56B-E939-4F52-8F22-00F3E5EA0DA6,TCGA-FU-A3TX-01A-11D-A232-26,HG19_Broad_variant,TCGA-FU-A3TX,TCGA-CESC,NA,s1371,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T1b2,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6bc9f,58cfa830e4b0c9d6adf6bc9f,TCGA-AP-A0LO-10A-01D-A043_120327_SN590_0148_BC0LM8ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-AP-A0LO-10A-01D-A043_120327_SN590_0148_BC0LM8ACXX_s_5_rg.sorted,TCGA-AP-A0LO-10A-01D-A043_120327_SN590_0148_BC0LM8ACXX_s_5_rg.sorted.bam,34.1,1.93,0.16,58cfa830e4b0c9d6adf6bc9f,TCGA-AP-A0LO-10A-01D-A043_120327_SN590_0148_BC0LM8ACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LO-10A,A081DA6F-51F3-4555-A6B8-736F8C6CDA39,Blood Derived Normal,Illumina HiSeq,4486708d-e7b7-4dbc-868e-487277d40b95,Uterus,45,FBFCB809-4EE6-4402-9FB8-F435BA7B43A1,F389371A-6695-4E68-8167-F15CF57786EC,TCGA-AP-A0LO-10A-01D-A043-02,HG19_Broad_variant,TCGA-AP-A0LO,TCGA-UCEC,1016,s5201,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c438,58cfa831e4b0c9d6adf6c438,TCGA-CH-5772-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CH-5772-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_1_rg.sorted,TCGA-CH-5772-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_1_rg.sorted.bam,85.7,1.9,0.16,58cfa831e4b0c9d6adf6c438,TCGA-CH-5772-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5772-01A,ECF9F8BE-7830-4626-8617-694C68EF4074,Primary Tumor,Illumina HiSeq,97cf547a-bc4b-4b08-9f8e-c1986b18aa30,Prostate,63,068AC08D-1A9E-4C71-B436-4ED861A9DCF8,5C9AAB80-29D2-4D85-A9FE-99FA22222CA4,TCGA-CH-5772-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5772,TCGA-PRAD,NA,s4128,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cdc5,58cfa831e4b0c9d6adf6cdc5,TCGA-FD-A3SO-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FD-A3SO-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_1_rg.sorted,TCGA-FD-A3SO-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_1_rg.sorted.bam,39.92,NA,0.14,58cfa831e4b0c9d6adf6cdc5,TCGA-FD-A3SO-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3SO-01A,94809FBF-4895-42C0-A7C6-F39EE1A41F1A,Primary Tumor,Illumina HiSeq,6b296020-484a-4cc2-a114-6c8a34ed5712,Bladder,68,869E3D55-CAD8-436E-B6A8-7ED90AD0A535,3D37A593-EFD7-4250-961D-D914E0AB8C13,TCGA-FD-A3SO-01A-11D-A233-26,HG19_Broad_variant,TCGA-FD-A3SO,TCGA-BLCA,168,s2911,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T3a,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6cc2d,58cfa831e4b0c9d6adf6cc2d,TCGA-EE-A2A1-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EE-A2A1-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_6_rg.sorted,TCGA-EE-A2A1-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_6_rg.sorted.bam,28.75,NA,0.15,58cfa831e4b0c9d6adf6cc2d,TCGA-EE-A2A1-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2A1-10A,A92E70E1-C57D-45EF-A822-33B361C22291,Blood Derived Normal,Illumina HiSeq,d20d23e7-eda7-44ca-8c01-958309009ef8,Skin,46,0933084B-90BA-4105-8989-996F00776A8B,4E250771-0ED3-4FD5-A177-90276344D1FD,TCGA-EE-A2A1-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2A1,TCGA-SKCM,NA,s7678,Harvard Medical School,University of Sydney,Australia,NO,T2a,N0,Not available,Stage IB
13722.58cfa82fe4b0c9d6adf6b8ee,58cfa82fe4b0c9d6adf6b8ee,TCGA-49-4512-11A-01D-1853_120123_SN590_0134_AC0DJKACXX_s_7_rg.sorted.filtered.,WGS,TCGA-49-4512-11A-01D-1853_120123_SN590_0134_AC0DJKACXX_s_7_rg.sorted,TCGA-49-4512-11A-01D-1853_120123_SN590_0134_AC0DJKACXX_s_7_rg.sorted.bam,151.7,1.9,0.15,58cfa82fe4b0c9d6adf6b8ee,TCGA-49-4512-11A-01D-1853_120123_SN590_0134_AC0DJKACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4512-11A,A1E65587-24C1-4B41-92A7-4E1F15FFFD78,Solid Tissue Normal,Illumina HiSeq,425e9966-6cdb-4456-8501-ac186279082f,Lung,69,67BF333D-F746-497F-B6B1-F241E93DC467,579F0180-CF2E-4BB4-9367-35131DC7524E,TCGA-49-4512-11A-01D-1853-02,HG19_Broad_variant,TCGA-49-4512,TCGA-LUAD,905,s11232,Harvard Medical School,Johns Hopkins,United States,NO,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa830e4b0c9d6adf6be70,58cfa830e4b0c9d6adf6be70,TCGA-BJ-A28R-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BJ-A28R-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_7_rg.sorted,TCGA-BJ-A28R-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_7_rg.sorted.bam,82.3,2.03,0.16,58cfa830e4b0c9d6adf6be70,TCGA-BJ-A28R-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A28R-01A,524A39EE-8FA3-418E-98A2-A6A90E9C8064,Primary Tumor,Illumina HiSeq,122e0c7e-da24-4121-907e-8b913b4e4147,Thyroid,38,F4906B86-3971-4ED3-AC3C-69635311FB45,A5170F7D-F298-4330-8272-8DACFF7775A1,TCGA-BJ-A28R-01A-11D-A16N-02,HG19_Broad_variant,TCGA-BJ-A28R,TCGA-THCA,NA,s11987,Harvard Medical School,University of Pittsburgh,United States,NO,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c50e,58cfa831e4b0c9d6adf6c50e,TCGA-CH-5771-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CH-5771-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_8_rg.sorted,TCGA-CH-5771-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_8_rg.sorted.bam,129.7,2,0.13,58cfa831e4b0c9d6adf6c50e,TCGA-CH-5771-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5771-11A,3ACD8328-76F7-4F43-9660-394B95748C3D,Solid Tissue Normal,Illumina HiSeq,353ba45f-47db-42c5-bb67-3baf1e0a1733,Prostate,63,3BAC387D-1199-4842-863C-8BCC09EFBF3F,6C19FDB0-3E90-4740-8660-263965F296B2,TCGA-CH-5771-11A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5771,TCGA-PRAD,NA,s3773,Harvard Medical School,Indivumed,Germany,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c35a,58cfa831e4b0c9d6adf6c35a,TCGA-CG-4477-10A-01D-1154_121029_SN208_0438_AC18NJACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CG-4477-10A-01D-1154_121029_SN208_0438_AC18NJACXX_s_4_rg.sorted,TCGA-CG-4477-10A-01D-1154_121029_SN208_0438_AC18NJACXX_s_4_rg.sorted.bam,67.9,1.9,0.16,58cfa831e4b0c9d6adf6c35a,TCGA-CG-4477-10A-01D-1154_121029_SN208_0438_AC18NJACXX_s_4_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4477-10A,18D0AAE7-9694-4252-B8FE-16E62DADAB07,Blood Derived Normal,Illumina HiSeq,e9116b76-5b39-48ec-802b-70e4c7eec731,Stomach,58,02F3A2F6-914C-4201-AB90-A7F2830F5CBA,B851171C-FDED-4A21-8766-A0AFD1B147B2,TCGA-CG-4477-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4477,TCGA-STAD,NA,s14489,Harvard Medical School,Indivumed,Germany,NO,T2a,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c530,58cfa831e4b0c9d6adf6c530,TCGA-CH-5753-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CH-5753-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_3_rg.sorted,TCGA-CH-5753-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_3_rg.sorted.bam,339.7,1.9,0.16,58cfa831e4b0c9d6adf6c530,TCGA-CH-5753-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5753-01A,928C48A0-68EE-4E28-AE83-9832E52850CA,Primary Tumor,Illumina HiSeq,971890ca-4817-4b12-b817-51caf2239fa3,Prostate,70,2BEEEBA8-47FE-4857-8704-E4C63E38C926,302AE7E6-2ADD-4556-8173-21EA12412058,TCGA-CH-5753-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5753,TCGA-PRAD,NA,s3592,Harvard Medical School,Indivumed,Germany,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bfdf,58cfa830e4b0c9d6adf6bfdf,TCGA-BR-6801-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BR-6801-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_5_rg.sorted,TCGA-BR-6801-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_5_rg.sorted.bam,172.7,1.9,0.15,58cfa830e4b0c9d6adf6bfdf,TCGA-BR-6801-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6801-01A,24FED326-BDCF-4C20-A06E-7C1C3D6C9CC5,Primary Tumor,Illumina HiSeq,48843aff-35a1-472b-a298-6489ad1b7de7,Stomach,70,713F11EE-D285-4A3B-B421-1D416E5F8E52,FDD2EE8C-C74B-49B8-A530-8CC171C34804,TCGA-BR-6801-01A-11D-1880-02,HG19_Broad_variant,TCGA-BR-6801,TCGA-STAD,NA,s15450,Harvard Medical School,Asterand,Russia,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA
13722.58cfa831e4b0c9d6adf6cd62,58cfa831e4b0c9d6adf6cd62,TCGA-EJ-5498-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EJ-5498-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_7_rg.sorted,TCGA-EJ-5498-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_7_rg.sorted.bam,52.7,1.9,0.17,58cfa831e4b0c9d6adf6cd62,TCGA-EJ-5498-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5498-01A,79EC7468-9AAF-4BB0-94C7-72BE4F497868,Primary Tumor,Illumina HiSeq,1ea5110e-6493-415f-ae21-019a8d1e2a17,Prostate,56,AAF0AF43-DAE0-4AA7-9D4C-6CAF1F039857,24F583BD-C378-4981-A661-97B8E39CE600,TCGA-EJ-5498-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5498,TCGA-PRAD,NA,s3948,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6af98,58cfa82ee4b0c9d6adf6af98,TCGA-05-4410-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_4_rg.sorted.filtered.,WGS,TCGA-05-4410-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_4_rg.sorted,TCGA-05-4410-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_4_rg.sorted.bam,231,1.9,0.14,58cfa82ee4b0c9d6adf6af98,TCGA-05-4410-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_4_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4410-10A,D28E465C-E553-4C53-8BB7-3D8199B9A8A5,Blood Derived Normal,Illumina HiSeq,53af425f-3279-4968-bc2e-56cc1f8678b3,Lung,62,DBF225D7-8BDD-4C28-B0E9-55EBE7404A4C,ACB50D57-7B1B-416D-9D8A-B097168C04C5,TCGA-05-4410-10A-01D-1853-02,HG19_Broad_variant,TCGA-05-4410,TCGA-LUAD,NA,s11545,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa831e4b0c9d6adf6cc09,58cfa831e4b0c9d6adf6cc09,TCGA-EB-A299-10A-01D-A190_120805_SN1222_0142_AD16TGACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EB-A299-10A-01D-A190_120805_SN1222_0142_AD16TGACXX_s_1_rg.sorted,TCGA-EB-A299-10A-01D-A190_120805_SN1222_0142_AD16TGACXX_s_1_rg.sorted.bam,23.85,NA,0.16,58cfa831e4b0c9d6adf6cc09,TCGA-EB-A299-10A-01D-A190_120805_SN1222_0142_AD16TGACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EB-A299-10A,90402C32-9548-432E-85B8-A4F80E14401E,Blood Derived Normal,Illumina HiSeq,2b13cbc9-eda0-417f-b0a4-a227fa33aac1,Skin,63,7D5C395F-F4BA-49A7-8408-D4CE41A406EF,E2C9FDAC-FF37-421D-B802-38A3471EE9FB,TCGA-EB-A299-10A-01D-A190-02,HG19_Broad_variant,TCGA-EB-A299,TCGA-SKCM,NA,s8003,Harvard Medical School,Asterand,Russia,NO,T2b,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6cd00,58cfa831e4b0c9d6adf6cd00,TCGA-EJ-5531-10A-01D-1573_130221_SN1120_0239_BD1V59ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EJ-5531-10A-01D-1573_130221_SN1120_0239_BD1V59ACXX_s_2_rg.sorted,TCGA-EJ-5531-10A-01D-1573_130221_SN1120_0239_BD1V59ACXX_s_2_rg.sorted.bam,621.4,1.9,0.16,58cfa831e4b0c9d6adf6cd00,TCGA-EJ-5531-10A-01D-1573_130221_SN1120_0239_BD1V59ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5531-10A,ADF3C2F7-D5F9-41C3-BD8C-7F9F1F22FF73,Blood Derived Normal,Illumina HiSeq,4962332e-85c4-4f65-959e-90f2e6169742,Prostate,62,35177C7C-C669-4B3B-9B45-379A40255DF0,87D43596-60A3-42DD-91E1-0C20634B0467,TCGA-EJ-5531-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5531,TCGA-PRAD,NA,s3446,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c0e2,58cfa830e4b0c9d6adf6c0e2,TCGA-BJ-A0ZF-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BJ-A0ZF-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_1_rg.sorted,TCGA-BJ-A0ZF-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_1_rg.sorted.bam,67.32,2.02,0.17,58cfa830e4b0c9d6adf6c0e2,TCGA-BJ-A0ZF-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0ZF-01A,8BEEE000-ECAB-4A49-9C9D-BB8E677AE199,Primary Tumor,Illumina HiSeq,9bd9796f-01f5-45d5-837b-b0bece0995f4,Thyroid,54,83A66A9D-916A-44E8-A7E6-A1385DB504DB,14EE09BE-144A-4461-8F5A-A738CC5D955E,TCGA-BJ-A0ZF-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZF,TCGA-THCA,NA,s12505,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Other  specify,Stage II
13722.58cfa830e4b0c9d6adf6ba86,58cfa830e4b0c9d6adf6ba86,TCGA-91-6836-11A-01D-1853_120310_SN590_0144_AD0PNFACXX_s_8_rg.sorted.filtered.,WGS,TCGA-91-6836-11A-01D-1853_120310_SN590_0144_AD0PNFACXX_s_8_rg.sorted,TCGA-91-6836-11A-01D-1853_120310_SN590_0144_AD0PNFACXX_s_8_rg.sorted.bam,279.7,1.9,0.13,58cfa830e4b0c9d6adf6ba86,TCGA-91-6836-11A-01D-1853_120310_SN590_0144_AD0PNFACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-91-6836-11A,0B31DBDF-0623-48E4-A0EC-017650DCEDA7,Solid Tissue Normal,Illumina HiSeq,76fb7328-b5a3-43dd-b29f-412366ad711a,Lung,52,BAA41644-5248-4838-ACC4-56D35C7A88AE,706F3CC6-7D2F-4342-AB87-02FD79E3B8B4,TCGA-91-6836-11A-01D-1853-02,HG19_Broad_variant,TCGA-91-6836,TCGA-LUAD,NA,s11360,Harvard Medical School,ABS - IUPUI,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6cc50,58cfa831e4b0c9d6adf6cc50,TCGA-EJ-5503-10A-01D-1573_130223_SN590_0214_BC1UJ3ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EJ-5503-10A-01D-1573_130223_SN590_0214_BC1UJ3ACXX_s_8_rg.sorted,TCGA-EJ-5503-10A-01D-1573_130223_SN590_0214_BC1UJ3ACXX_s_8_rg.sorted.bam,248.4,1.9,0.15,58cfa831e4b0c9d6adf6cc50,TCGA-EJ-5503-10A-01D-1573_130223_SN590_0214_BC1UJ3ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5503-10A,AA252F78-EBF3-42F9-86AF-BB6E57345706,Blood Derived Normal,Illumina HiSeq,6f2a0bc7-14c0-431b-ad1a-9ed9cdc21dc4,Prostate,50,84460943-D44C-4B47-9BF1-DEB1C5B5E0BD,165CBB8A-1D84-42E4-BAAA-31F4D0CFA3F1,TCGA-EJ-5503-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5503,TCGA-PRAD,NA,s3438,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6ce18,58cfa832e4b0c9d6adf6ce18,TCGA-FD-A3B5-01A-11D-A210_120912_SN1120_0192_AC18ALACXX_s_1_rg.sorted.filtered.,WGS,TCGA-FD-A3B5-01A-11D-A210_120912_SN1120_0192_AC18ALACXX_s_1_rg.sorted,TCGA-FD-A3B5-01A-11D-A210_120912_SN1120_0192_AC18ALACXX_s_1_rg.sorted.bam,33.2,NA,0.17,58cfa832e4b0c9d6adf6ce18,TCGA-FD-A3B5-01A-11D-A210_120912_SN1120_0192_AC18ALACXX_s_1_rg.sorted.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3B5-01A,462D5A6B-9F39-4AAE-A35B-D06A7811D053,Primary Tumor,Illumina HiSeq,d7af6a65-2c95-4a83-8e6f-756aef5309bd,Bladder,86,F9DEDC8C-327D-456A-9C0B-E1EC58AE3169,0D51FF4C-41D7-4296-BDDC-F9DB7F41276A,TCGA-FD-A3B5-01A-11D-A210-26,HG19_Broad_variant,TCGA-FD-A3B5,TCGA-BLCA,272,s2721,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T2b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6cf1a,58cfa832e4b0c9d6adf6cf1a,TCGA-H7-7774-01A-21D-2317_120623_SN1222_0119_BC0WLLACXX_s_4_rg.sorted.filtered.,WGS,TCGA-H7-7774-01A-21D-2317_120623_SN1222_0119_BC0WLLACXX_s_4_rg.sorted,TCGA-H7-7774-01A-21D-2317_120623_SN1222_0119_BC0WLLACXX_s_4_rg.sorted.bam,52.73,NA,0.15,58cfa832e4b0c9d6adf6cf1a,TCGA-H7-7774-01A-21D-2317_120623_SN1222_0119_BC0WLLACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-H7-7774-01A,EEAE67AC-C9E0-468D-AAD6-052501F7B982,Primary Tumor,Illumina HiSeq,ab347312-e135-4dd6-9be3-fa5fdebbcd68,Head and Neck,75,50F6615A-49CC-4E14-B5DD-54784B66C27B,B9B2B6F5-57EB-4DD6-8FE2-1E8669840DAB,TCGA-H7-7774-01A-21D-2317-26,HG19_Broad_variant,TCGA-H7-7774,TCGA-HNSC,NA,s16209,MD Anderson - Institute for Applied Cancer Science,ABS - IUPUI,United States,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c546,58cfa831e4b0c9d6adf6c546,TCGA-CH-5768-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CH-5768-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_4_rg.sorted,TCGA-CH-5768-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_4_rg.sorted.bam,216.7,1.9,0.15,58cfa831e4b0c9d6adf6c546,TCGA-CH-5768-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5768-11A,F6C61A22-A711-416D-9E65-6A1B957E5B2E,Solid Tissue Normal,Illumina HiSeq,94474228-f50e-43be-ae1f-20104c2b61cc,Prostate,72,4B013862-E655-4A6F-AF4F-0B291C1242B5,8661FD53-3B4D-4AFF-A7BD-6B7654CE8740,TCGA-CH-5768-11A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5768,TCGA-PRAD,NA,s4130,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cc01,58cfa831e4b0c9d6adf6cc01,TCGA-E8-A242-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_4_rg.sorted.filtered.,WGS,TCGA-E8-A242-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_4_rg.sorted,TCGA-E8-A242-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_4_rg.sorted.bam,36.62,1.87,0.17,58cfa831e4b0c9d6adf6cc01,TCGA-E8-A242-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-E8-A242-10A,4D9DE9A1-7DF1-412E-9F16-15DD51B4C5F5,Blood Derived Normal,Illumina HiSeq,3fe95dc7-b12d-4021-b7f7-a5c31038f8ee,Thyroid,56,490FB30A-5455-48ED-95C9-86D044A364B7,ABA2F28E-DD7B-43B5-81F9-83C014DC2EF1,TCGA-E8-A242-10A-01D-A16N-02,HG19_Broad_variant,TCGA-E8-A242,TCGA-THCA,NA,s12517,Harvard Medical School,Asterand,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa830e4b0c9d6adf6c319,58cfa830e4b0c9d6adf6c319,TCGA-BR-6705-01A-12D-1880_121220_SN1222_0163_AC1HA2ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BR-6705-01A-12D-1880_121220_SN1222_0163_AC1HA2ACXX_s_3_rg.sorted,TCGA-BR-6705-01A-12D-1880_121220_SN1222_0163_AC1HA2ACXX_s_3_rg.sorted.bam,27.7,1.9,0.15,58cfa830e4b0c9d6adf6c319,TCGA-BR-6705-01A-12D-1880_121220_SN1222_0163_AC1HA2ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6705-01A,B14F2FCB-E869-475E-BC7C-ADAF6E7E636F,Primary Tumor,Illumina HiSeq,cf5ffdf8-e424-4a51-862f-816cba0c92e0,Stomach,68,DB8D0AC1-23B7-49AB-8BB3-44782156F038,F55A158B-F7DB-4786-9553-65DEBCAE80BA,TCGA-BR-6705-01A-12D-1880-02,HG19_Broad_variant,TCGA-BR-6705,TCGA-STAD,NA,s15239,Harvard Medical School,Asterand,Ukraine,NO,T3,N3a,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIB
13722.58cfa832e4b0c9d6adf6d17b,58cfa832e4b0c9d6adf6d17b,TCGA-HC-7209-10A-01D-2111_130502_SN590_0229_BD2459ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-HC-7209-10A-01D-2111_130502_SN590_0229_BD2459ACXX_s_7_rg.sorted,TCGA-HC-7209-10A-01D-2111_130502_SN590_0229_BD2459ACXX_s_7_rg.sorted.bam,132.6,NA,0.14,58cfa832e4b0c9d6adf6d17b,TCGA-HC-7209-10A-01D-2111_130502_SN590_0229_BD2459ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7209-10A,582D1177-73B0-4A9C-8505-70D6B402BD01,Blood Derived Normal,Illumina HiSeq,2c1969af-caf3-449f-9e39-f2387807413f,Prostate,60,AF82C7AB-99F0-408B-B64F-1CBE4BC57E57,569D456D-3A1F-4C57-A0C8-EBE4CE7B3A9D,TCGA-HC-7209-10A-01D-2111-02,HG19_Broad_variant,TCGA-HC-7209,TCGA-PRAD,NA,s3981,Harvard Medical School,International Genomics Consortium,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c338,58cfa831e4b0c9d6adf6c338,TCGA-CG-4476-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_7_rg.sorted.filtered.,WGS,TCGA-CG-4476-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_7_rg.sorted,TCGA-CG-4476-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_7_rg.sorted.bam,127.2,1.9,0.14,58cfa831e4b0c9d6adf6c338,TCGA-CG-4476-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_7_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4476-01A,442D7415-D095-4962-8296-A14390BAD40A,Primary Tumor,Illumina HiSeq,87a698be-8fb0-4ced-842b-fdc852b98aa8,Stomach,69,37F5444F-A58D-4899-A11B-9C09ECD357FC,0C5818D8-5C20-4E4B-99CF-6F378CA6EBE7,TCGA-CG-4476-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4476,TCGA-STAD,NA,s14983,Harvard Medical School,Indivumed,Germany,NO,T4b,N3a,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIC
13722.58cfa830e4b0c9d6adf6bf66,58cfa830e4b0c9d6adf6bf66,TCGA-BR-4294-11A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BR-4294-11A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_5_rg.sorted,TCGA-BR-4294-11A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_5_rg.sorted.bam,219.9,1.9,0.15,58cfa830e4b0c9d6adf6bf66,TCGA-BR-4294-11A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4294-11A,ACAB1362-C8A0-448B-8533-0CD84D97959C,Solid Tissue Normal,Illumina HiSeq,77aba0c4-8048-441c-89af-698eee7d38aa,Stomach,65,301E4023-CCA5-42D9-B9F3-ECF06DCEED40,18B69220-5BDF-4B08-BE0D-1C99C2943DA5,TCGA-BR-4294-11A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4294,TCGA-STAD,NA,s15300,Harvard Medical School,Asterand,Russia,NO,T2a,NX,Stomach  Intestinal Adenocarcinoma  Tubular Type,Not available
13722.58cfa832e4b0c9d6adf6d170,58cfa832e4b0c9d6adf6d170,TCGA-J8-A3YH-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_3_rg.sorted.filtered.,WGS,TCGA-J8-A3YH-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_3_rg.sorted,TCGA-J8-A3YH-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_3_rg.sorted.bam,48.6,NA,0.15,58cfa832e4b0c9d6adf6d170,TCGA-J8-A3YH-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,Not available,Thyroid Carcinoma,Aligned reads,TCGA-J8-A3YH-01A,A09B20B5-C187-4632-B996-0D5314A9885C,Primary Tumor,Illumina HiSeq,f6ec340c-1c9c-4c8d-9266-4728709a90e6,Thyroid,39,EFDAD0C2-A44D-48F8-A908-E8C9747E78B8,BF118D4C-A2DF-4617-92E2-3475E07D9BE7,TCGA-J8-A3YH-01A-11D-A23Q-26,HG19_Broad_variant,TCGA-J8-A3YH,TCGA-THCA,NA,s12535,MD Anderson - Institute for Applied Cancer Science,Mayo Clinic,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c408,58cfa831e4b0c9d6adf6c408,TCGA-C5-A3HE-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-C5-A3HE-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_5_rg.sorted,TCGA-C5-A3HE-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_5_rg.sorted.bam,13.29,NA,0.15,58cfa831e4b0c9d6adf6c408,TCGA-C5-A3HE-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A3HE-10A,BC63DD2A-B8F6-4B30-A8D7-CE193BCD17F1,Blood Derived Normal,Illumina HiSeq,127e65bb-ad88-449a-a8b7-a3b77a65f010,Cervix,44,58E4B79D-744E-45FE-9836-91D2B2E2C19E,00D7D6B4-0231-4094-9125-194AFC57B28E,TCGA-C5-A3HE-10A-01D-A232-26,HG19_Broad_variant,TCGA-C5-A3HE,TCGA-CESC,NA,s1359,MD Anderson - Institute for Applied Cancer Science,Medical College of Wisconsin,United States,NO,T1b2,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6bf54,58cfa830e4b0c9d6adf6bf54,TCGA-BR-4253-11A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BR-4253-11A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_6_rg.sorted,TCGA-BR-4253-11A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_6_rg.sorted.bam,166.9,1.9,0.13,58cfa830e4b0c9d6adf6bf54,TCGA-BR-4253-11A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4253-11A,411257A4-A148-4606-8C8B-F9F1240E40ED,Solid Tissue Normal,Illumina HiSeq,6237a524-9f83-4bf5-8956-06e3e60438b1,Stomach,80,9A8357DE-8FCE-4126-80FD-DFCEC05FF2F3,BD51E472-AB57-4A4C-B361-46D7A843BE18,TCGA-BR-4253-11A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4253,TCGA-STAD,NA,s15047,Harvard Medical School,Asterand,Russia,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82fe4b0c9d6adf6b9ab,58cfa82fe4b0c9d6adf6b9ab,TCGA-44-6777-01A-11D-1853_120123_SN590_0134_AC0DJKACXX_s_2_rg.sorted.filtered.,WGS,TCGA-44-6777-01A-11D-1853_120123_SN590_0134_AC0DJKACXX_s_2_rg.sorted,TCGA-44-6777-01A-11D-1853_120123_SN590_0134_AC0DJKACXX_s_2_rg.sorted.bam,36.7,1.9,0.15,58cfa82fe4b0c9d6adf6b9ab,TCGA-44-6777-01A-11D-1853_120123_SN590_0134_AC0DJKACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-44-6777-01A,349E6F38-2C67-4A69-A777-B9173A2A27CF,Primary Tumor,Illumina HiSeq,8f0fdfb5-6a7c-4e9a-9a4f-d32f9aca542d,Lung,85,174E4405-4848-4E5E-93CC-0CDF2795C91A,AAAAE42F-88A5-4E99-8057-A92D6759BE19,TCGA-44-6777-01A-11D-1853-02,HG19_Broad_variant,TCGA-44-6777,TCGA-LUAD,987,s11550,Harvard Medical School,Christiana Healthcare,United States,NO,T2,NX,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa832e4b0c9d6adf6d1c2,58cfa832e4b0c9d6adf6d1c2,TCGA-HI-7171-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-HI-7171-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_8_rg.sorted,TCGA-HI-7171-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_8_rg.sorted.bam,206.6,NA,0.16,58cfa832e4b0c9d6adf6d1c2,TCGA-HI-7171-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HI-7171-10A,931FEB14-3F69-41C1-8435-5FD4FB775BDF,Blood Derived Normal,Illumina HiSeq,966d1a07-f599-4c0f-86a7-d4b4616c7bc1,Prostate,56,460D202A-7B89-4959-89F3-9A06A7A495C4,6F928FB8-3939-4628-A901-537528D56DC6,TCGA-HI-7171-10A-01D-2111-02,HG19_Broad_variant,TCGA-HI-7171,TCGA-PRAD,1329,s3984,Harvard Medical School,Fox Chase,United States,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6cf9a,58cfa832e4b0c9d6adf6cf9a,TCGA-GD-A3OQ-10A-01D-A221_120902_SN1222_0147_AC195DACXX_s_6_rg.sorted.filtered.,WGS,TCGA-GD-A3OQ-10A-01D-A221_120902_SN1222_0147_AC195DACXX_s_6_rg.sorted,TCGA-GD-A3OQ-10A-01D-A221_120902_SN1222_0147_AC195DACXX_s_6_rg.sorted.bam,93.37,NA,0.17,58cfa832e4b0c9d6adf6cf9a,TCGA-GD-A3OQ-10A-01D-A221_120902_SN1222_0147_AC195DACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GD-A3OQ-10A,2E85C30C-C4C4-4096-9EEF-4EB2C7D991A3,Blood Derived Normal,Illumina HiSeq,07f6d725-9ddf-438e-b531-b9c37f9b25a8,Bladder,48,76EA53B1-0D5A-469C-839F-D2C23C5DC44E,510F71A5-4A02-40A3-AD30-F6BC6E8FE4BA,TCGA-GD-A3OQ-10A-01D-A221-26,HG19_Broad_variant,TCGA-GD-A3OQ,TCGA-BLCA,NA,s3124,MD Anderson - Institute for Applied Cancer Science,ABS - IUPUI,United States,NO,T4a,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6ce0f,58cfa832e4b0c9d6adf6ce0f,TCGA-FD-A3B8-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_7_rg.sorted.filtered.,WGS,TCGA-FD-A3B8-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_7_rg.sorted,TCGA-FD-A3B8-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_7_rg.sorted.bam,26.04,NA,0.16,58cfa832e4b0c9d6adf6ce0f,TCGA-FD-A3B8-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3B8-01A,537CA5D1-5B26-496F-B7B4-05FEA7B46353,Primary Tumor,Illumina HiSeq,c0aadcb9-2d54-45c7-9585-575ed21ea52f,Bladder,56,9A27AA84-D541-4FA3-A798-D7559A5AE70C,582B2439-02F1-4E2A-9A4E-771603658FB5,TCGA-FD-A3B8-01A-31D-A210-26,HG19_Broad_variant,TCGA-FD-A3B8,TCGA-BLCA,NA,s3296,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa82fe4b0c9d6adf6b5dc,58cfa82fe4b0c9d6adf6b5dc,TCGA-50-5939-01A-11D-1623_120302_SN208_0271_BC0D91ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-50-5939-01A-11D-1623_120302_SN208_0271_BC0D91ACXX_s_3_rg.sorted,TCGA-50-5939-01A-11D-1623_120302_SN208_0271_BC0D91ACXX_s_3_rg.sorted.bam,111.7,1.9,0.15,58cfa82fe4b0c9d6adf6b5dc,TCGA-50-5939-01A-11D-1623_120302_SN208_0271_BC0D91ACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5939-01A,12B79B4F-C28C-418E-A1E7-E622F33FDCC2,Primary Tumor,Illumina HiSeq,7a3d6187-a909-4946-83bf-0d6fc6a753ee,Lung,85,6A27F5F8-F4EE-45C7-B953-DDD7D0291DBB,08D803D0-A294-4F70-9560-563357172BBB,TCGA-50-5939-01A-11D-1623-02,HG19_Broad_variant,TCGA-50-5939,TCGA-LUAD,460,s11007,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa831e4b0c9d6adf6c3a2,58cfa831e4b0c9d6adf6c3a2,TCGA-BS-A0UV-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BS-A0UV-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_5_rg.sorted,TCGA-BS-A0UV-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_5_rg.sorted.bam,11.85,1.97,0.15,58cfa831e4b0c9d6adf6c3a2,TCGA-BS-A0UV-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_5_rg.sorted.bam,Alive,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0UV-10A,B19425AB-A82F-4C2A-BF58-D1BD30511D74,Blood Derived Normal,Illumina HiSeq,262ac8f5-08d6-47ea-9493-ded1af443ae2,Uterus,55,C1DB0188-CBB7-4202-B8CF-65D4DB60F512,B546C8AD-A075-4840-B01B-FE19371815D3,TCGA-BS-A0UV-10A-01D-A101-02,HG19_Broad_variant,TCGA-BS-A0UV,TCGA-UCEC,NA,s4611,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6ce9d,58cfa832e4b0c9d6adf6ce9d,TCGA-FE-A234-10A-01D-A14U_120717_SN1120_0175_AC1179ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-FE-A234-10A-01D-A14U_120717_SN1120_0175_AC1179ACXX_s_4_rg.sorted,TCGA-FE-A234-10A-01D-A14U_120717_SN1120_0175_AC1179ACXX_s_4_rg.sorted.bam,16.68,1.89,0.17,58cfa832e4b0c9d6adf6ce9d,TCGA-FE-A234-10A-01D-A14U_120717_SN1120_0175_AC1179ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A234-10A,E4C85BDD-7B7C-414F-9503-647D9B825915,Blood Derived Normal,Illumina HiSeq,7a6f98a6-b049-415c-bce1-5294405f5eb7,Thyroid,26,2A2331F2-F5F1-42AA-BADE-1365E899CB78,580852B4-DE04-4646-B02E-F5EFAA3316BC,TCGA-FE-A234-10A-01D-A14U-02,HG19_Broad_variant,TCGA-FE-A234,TCGA-THCA,NA,s12387,Harvard Medical School,Ohio State University,United States,NO,T2,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6d174,58cfa832e4b0c9d6adf6d174,TCGA-HC-7231-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-HC-7231-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_2_rg.sorted,TCGA-HC-7231-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_2_rg.sorted.bam,61.3,NA,0.17,58cfa832e4b0c9d6adf6d174,TCGA-HC-7231-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,Not available,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7231-01A,B182BDA9-3D9F-4958-96EB-BD6CC441830C,Primary Tumor,Illumina HiSeq,4b0f4fcc-c7c6-44bc-95d3-e693b0fbc7c7,Prostate,66,6AC7857C-5446-4297-95A9-5F2C11C28220,9826D5D9-D6D3-4216-9CA1-FE010711E13E,TCGA-HC-7231-01A-11D-2111-02,HG19_Broad_variant,TCGA-HC-7231,TCGA-PRAD,NA,s3806,Harvard Medical School,International Genomics Consortium,United States,NO,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6ce92,58cfa832e4b0c9d6adf6ce92,TCGA-G2-A2EJ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_3_rg.sorted.filtered.,WGS,TCGA-G2-A2EJ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_3_rg.sorted,TCGA-G2-A2EJ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_3_rg.sorted.bam,36.89,NA,0.16,58cfa832e4b0c9d6adf6ce92,TCGA-G2-A2EJ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-G2-A2EJ-01A,C6227D39-D9E8-4E28-9E70-D7F720AB25E4,Primary Tumor,Illumina HiSeq,18abb4d7-25d0-477e-bda6-011263e96364,Bladder,56,FBAD20BA-EE08-4D46-825B-870126AAD539,8D99E3A4-DECB-49D7-9727-C5D7606D60DF,TCGA-G2-A2EJ-01A-11D-A17R-02,HG19_Broad_variant,TCGA-G2-A2EJ,TCGA-BLCA,NA,s3304,Harvard Medical School,MD Anderson,United States,NO,Not available,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6cd56,58cfa831e4b0c9d6adf6cd56,TCGA-FD-A3SO-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_2_rg.sorted.filtered.,WGS,TCGA-FD-A3SO-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_2_rg.sorted,TCGA-FD-A3SO-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_2_rg.sorted.bam,52.91,NA,0.15,58cfa831e4b0c9d6adf6cd56,TCGA-FD-A3SO-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3SO-10A,94809FBF-4895-42C0-A7C6-F39EE1A41F1A,Blood Derived Normal,Illumina HiSeq,db8ba963-75f5-4fb2-a6bd-3da7bc62ab16,Bladder,68,7BB8F66E-7D27-4A06-AA65-F1B39F5A73FD,1407FF6C-90E1-4184-ABB3-0E5BCFAC2848,TCGA-FD-A3SO-10A-01D-A233-26,HG19_Broad_variant,TCGA-FD-A3SO,TCGA-BLCA,168,s2906,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T3a,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c676,58cfa831e4b0c9d6adf6c676,TCGA-CS-5396-10A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CS-5396-10A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_6_rg.sorted,TCGA-CS-5396-10A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_6_rg.sorted.bam,18.7,1.9,0.13,58cfa831e4b0c9d6adf6c676,TCGA-CS-5396-10A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-5396-10A,B6C2C9BD-625B-4A98-830C-49C344F6CB5F,Blood Derived Normal,Illumina HiSeq,02bd97c1-a586-4f04-b6e2-16ca05a0ef21,Brain,53,8129E5AC-BE68-40AD-87ED-442DFFE9034A,E51ABE6B-7759-4B50-8919-51778F4BFA01,TCGA-CS-5396-10A-01D-1465-02,HG19_Broad_variant,TCGA-CS-5396,TCGA-LGG,NA,s8557,Harvard Medical School,Thomas Jefferson University,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6c746,58cfa831e4b0c9d6adf6c746,TCGA-D7-6817-01A-11D-1880_130111_SN208_0447_AC1JP0ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D7-6817-01A-11D-1880_130111_SN208_0447_AC1JP0ACXX_s_3_rg.sorted,TCGA-D7-6817-01A-11D-1880_130111_SN208_0447_AC1JP0ACXX_s_3_rg.sorted.bam,435.7,1.9,0.17,58cfa831e4b0c9d6adf6c746,TCGA-D7-6817-01A-11D-1880_130111_SN208_0447_AC1JP0ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6817-01A,6FFEFB3F-3919-4FEF-AB15-5D32D8F51D57,Primary Tumor,Illumina HiSeq,9d6376df-5da8-4903-ac82-a2c69750107a,Stomach,63,9E01F1D4-7BA6-42B7-A43C-833195EF4B49,10358672-8D99-4098-8B0A-71D4960A45FA,TCGA-D7-6817-01A-11D-1880-02,HG19_Broad_variant,TCGA-D7-6817,TCGA-STAD,NA,s14422,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2b,N3,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIIA
13722.58cfa830e4b0c9d6adf6ba81,58cfa830e4b0c9d6adf6ba81,TCGA-91-6831-01A-11D-1853_120305_SN1120_0119_BD0REAACXX_s_4_rg.sorted.filtered.,WGS,TCGA-91-6831-01A-11D-1853_120305_SN1120_0119_BD0REAACXX_s_4_rg.sorted,TCGA-91-6831-01A-11D-1853_120305_SN1120_0119_BD0REAACXX_s_4_rg.sorted.bam,196.7,1.9,0.14,58cfa830e4b0c9d6adf6ba81,TCGA-91-6831-01A-11D-1853_120305_SN1120_0119_BD0REAACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-91-6831-01A,DB0B9E63-4272-4F29-BF0E-1EC0FE79A9D7,Primary Tumor,Illumina HiSeq,319d6c8c-207c-477a-8254-30695b75f9e2,Lung,66,7B1D8B50-F3DF-4AAB-A654-C3810D8D576D,0D0D96AE-A83B-4C09-8ED9-4A568E816EFC,TCGA-91-6831-01A-11D-1853-02,HG19_Broad_variant,TCGA-91-6831,TCGA-LUAD,NA,s10670,Harvard Medical School,ABS - IUPUI,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa832e4b0c9d6adf6d52c,58cfa832e4b0c9d6adf6d52c,TCGA-L5-A43I-11A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-L5-A43I-11A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_6_rg.sorted,TCGA-L5-A43I-11A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_6_rg.sorted.bam,22.84,NA,0.16,58cfa832e4b0c9d6adf6d52c,TCGA-L5-A43I-11A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A43I-11A,22EE75E0-5D61-41F4-AACD-B4E09C70D2C3,Solid Tissue Normal,Illumina HiSeq,293ca156-99a1-4a10-805c-5a09fa0ff255,Esophagus,77,C6347711-A7B8-4195-B25C-9EB58822989B,2C9090C6-C4E1-4C0E-BB0A-E5DA04FBE9E7,TCGA-L5-A43I-11A-11D-A248-26,HG19_Broad_variant,TCGA-L5-A43I,TCGA-ESCA,556,s1736,MD Anderson - Institute for Applied Cancer Science,University of Michigan,United States,NO,T3,N1,Not available,Stage IIIA
13722.58cfa82ee4b0c9d6adf6ae60,58cfa82ee4b0c9d6adf6ae60,TCGA-05-4390-01A-02D-1751_120305_SN1120_0118_AD0L4HACXX_s_1_rg.sorted.filtered.,WGS,TCGA-05-4390-01A-02D-1751_120305_SN1120_0118_AD0L4HACXX_s_1_rg.sorted,TCGA-05-4390-01A-02D-1751_120305_SN1120_0118_AD0L4HACXX_s_1_rg.sorted.bam,827.4,1.9,0.14,58cfa82ee4b0c9d6adf6ae60,TCGA-05-4390-01A-02D-1751_120305_SN1120_0118_AD0L4HACXX_s_1_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4390-01A,B8475929-2D9D-4909-BD62-59684A140BD7,Primary Tumor,Illumina HiSeq,625e3715-ed9e-4946-8c92-f5a93e92e6d4,Lung,58,C7F76210-D0F2-4FB8-80F1-35098DBE03DE,4BC393B5-F924-4D66-BC93-58A3CB2EBBC5,TCGA-05-4390-01A-02D-1751-02,HG19_Broad_variant,TCGA-05-4390,TCGA-LUAD,NA,s11328,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa831e4b0c9d6adf6c40a,58cfa831e4b0c9d6adf6c40a,TCGA-CH-5772-11A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CH-5772-11A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_2_rg.sorted,TCGA-CH-5772-11A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_2_rg.sorted.bam,52.7,2,0.15,58cfa831e4b0c9d6adf6c40a,TCGA-CH-5772-11A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5772-11A,ECF9F8BE-7830-4626-8617-694C68EF4074,Solid Tissue Normal,Illumina HiSeq,4101a708-70fa-42dd-8aae-c5e3d3b12dd5,Prostate,63,222A8CFC-3D32-48C2-BAAB-EBF25D7C8156,26283C5E-0BA5-4B9E-8771-401E1A31A437,TCGA-CH-5772-11A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5772,TCGA-PRAD,NA,s3776,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cac8,58cfa831e4b0c9d6adf6cac8,TCGA-DA-A1IC-10A-01D-A190_120730_SN208_0420_BC12YJACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DA-A1IC-10A-01D-A190_120730_SN208_0420_BC12YJACXX_s_2_rg.sorted,TCGA-DA-A1IC-10A-01D-A190_120730_SN208_0420_BC12YJACXX_s_2_rg.sorted.bam,32.66,NA,0.16,58cfa831e4b0c9d6adf6cac8,TCGA-DA-A1IC-10A-01D-A190_120730_SN208_0420_BC12YJACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1IC-10A,6625CE3F-3A1F-45F9-AA42-AB1931D6DAF4,Blood Derived Normal,Illumina HiSeq,615d39b9-8a2a-4712-87f9-40c1911e199c,Skin,81,564A6108-65B7-49D2-A8B9-02C32EE52CDD,4473278F-ED1D-4391-B15E-498F3F90D5CE,TCGA-DA-A1IC-10A-01D-A190-02,HG19_Broad_variant,TCGA-DA-A1IC,TCGA-SKCM,NA,s7500,Harvard Medical School,Yale,United States,NO,T3a,N2c,Not available,Stage IIIB
13722.58cfa832e4b0c9d6adf6d1d2,58cfa832e4b0c9d6adf6d1d2,TCGA-HQ-A2OE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_5_rg.sorted.filtered.,WGS,TCGA-HQ-A2OE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_5_rg.sorted,TCGA-HQ-A2OE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_5_rg.sorted.bam,71.88,NA,0.16,58cfa832e4b0c9d6adf6d1d2,TCGA-HQ-A2OE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_5_rg.sorted.bam,Alive,MALE,Not available,Not available,Bladder Urothelial Carcinoma,Aligned reads,TCGA-HQ-A2OE-01A,353C5FCC-9C6A-4AC6-99DC-FB4573B2AE6C,Primary Tumor,Illumina HiSeq,21c45d2f-f8bc-45dc-85d2-790ea5506bc4,Bladder,69,65DBBE08-4645-4552-9A1A-E6F79A621013,B04D2557-D084-4445-97BB-10A6CB59DC6B,TCGA-HQ-A2OE-01A-11D-A204-02,HG19_Broad_variant,TCGA-HQ-A2OE,TCGA-BLCA,NA,s2935,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,T2a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Not available
13722.58cfa830e4b0c9d6adf6c312,58cfa830e4b0c9d6adf6c312,TCGA-BR-6706-01A-11D-1880_121220_SN1222_0163_AC1HA2ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BR-6706-01A-11D-1880_121220_SN1222_0163_AC1HA2ACXX_s_5_rg.sorted,TCGA-BR-6706-01A-11D-1880_121220_SN1222_0163_AC1HA2ACXX_s_5_rg.sorted.bam,292.7,1.9,0.16,58cfa830e4b0c9d6adf6c312,TCGA-BR-6706-01A-11D-1880_121220_SN1222_0163_AC1HA2ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6706-01A,93AEBBD4-19CF-495A-B8CE-3C4A3FEBA152,Primary Tumor,Illumina HiSeq,175293ed-2943-410e-8c01-a61c21354054,Stomach,63,C6BC78E9-87F1-4BE1-8EEB-17B2F59093E3,29893248-F981-4565-8754-AC75FB8C2586,TCGA-BR-6706-01A-11D-1880-02,HG19_Broad_variant,TCGA-BR-6706,TCGA-STAD,NA,s15452,Harvard Medical School,Asterand,Ukraine,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa830e4b0c9d6adf6c2e4,58cfa830e4b0c9d6adf6c2e4,TCGA-BR-6802-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BR-6802-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_7_rg.sorted,TCGA-BR-6802-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_7_rg.sorted.bam,487.7,1.9,0.14,58cfa830e4b0c9d6adf6c2e4,TCGA-BR-6802-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6802-01A,7C831A1D-3253-4AF4-A0FF-7FE9FF9AF1CE,Primary Tumor,Illumina HiSeq,73cec875-41a5-40bd-9d13-9e1ed4dd64d0,Stomach,65,E3BF04C2-961F-4511-AF63-5A0E8AE6377B,0B4F4B0B-EF5C-4717-875A-7B8C5342DBC4,TCGA-BR-6802-01A-11D-1880-02,HG19_Broad_variant,TCGA-BR-6802,TCGA-STAD,NA,s14885,Harvard Medical School,Asterand,Russia,NO,T3,N2,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa830e4b0c9d6adf6c224,58cfa830e4b0c9d6adf6c224,TCGA-C5-A2LS-01A-22D-A232_140124_SN1120_0291_AC2PHAACXX_s_1_rg.sorted.filtered.,WGS,TCGA-C5-A2LS-01A-22D-A232_140124_SN1120_0291_AC2PHAACXX_s_1_rg.sorted,TCGA-C5-A2LS-01A-22D-A232_140124_SN1120_0291_AC2PHAACXX_s_1_rg.sorted.bam,49.75,NA,0.15,58cfa830e4b0c9d6adf6c224,TCGA-C5-A2LS-01A-22D-A232_140124_SN1120_0291_AC2PHAACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A2LS-01A,185E1520-92EE-4AF5-AF15-FBEEFB352C99,Primary Tumor,Illumina HiSeq,3c012d75-0d17-4b4d-834f-cd4767f6b023,Cervix,37,79248694-77E1-4FBE-8C94-64A308FC982D,DE7180EF-3E7E-43D5-8ACE-C7ED57992345,TCGA-C5-A2LS-01A-22D-A232-26,HG19_Broad_variant,TCGA-C5-A2LS,TCGA-CESC,NA,s1356,MD Anderson - Institute for Applied Cancer Science,Medical College of Wisconsin,United States,NO,T1b2,N0,Endocervical Adenocarcinoma of the Usual Type,Not available
13722.58cfa831e4b0c9d6adf6cbeb,58cfa831e4b0c9d6adf6cbeb,TCGA-EM-A1CW-01A-21D-A13U_120706_SN1222_0122_AC0WPYACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EM-A1CW-01A-21D-A13U_120706_SN1222_0122_AC0WPYACXX_s_7_rg.sorted,TCGA-EM-A1CW-01A-21D-A13U_120706_SN1222_0122_AC0WPYACXX_s_7_rg.sorted.bam,29.55,2.05,0.18,58cfa831e4b0c9d6adf6cbeb,TCGA-EM-A1CW-01A-21D-A13U_120706_SN1222_0122_AC0WPYACXX_s_7_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A1CW-01A,22EB9F00-6869-4D8F-B657-DFD64F81E9E9,Primary Tumor,Illumina HiSeq,9c39283e-3646-4154-8265-d68a2f7de106,Thyroid,39,7045F3E1-5239-4159-9B38-31E4168853D0,2CC2002C-4F0A-47A6-AA0A-35FE1B545A7A,TCGA-EM-A1CW-01A-21D-A13U-02,HG19_Broad_variant,TCGA-EM-A1CW,TCGA-THCA,NA,s12253,Harvard Medical School,University Health Network,Canada,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa832e4b0c9d6adf6d254,58cfa832e4b0c9d6adf6d254,TCGA-IR-A3LA-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_7_rg.sorted.filtered.,WGS,TCGA-IR-A3LA-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_7_rg.sorted,TCGA-IR-A3LA-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_7_rg.sorted.bam,56.17,NA,0.15,58cfa832e4b0c9d6adf6d254,TCGA-IR-A3LA-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-IR-A3LA-01A,7B8C04D7-824D-493D-8F2C-9ED87A907192,Primary Tumor,Illumina HiSeq,96c944ec-9e55-4b27-aa91-b936b4d7cff5,Cervix,60,7925EA80-8AAE-4D99-AFE2-74AD1AAE6D9D,B541AE4A-279F-49A1-9877-1F2226A51737,TCGA-IR-A3LA-01A-11D-A232-26,HG19_Broad_variant,TCGA-IR-A3LA,TCGA-CESC,NA,s1377,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T1b1,N0,Endometrioid Adenocarcinoma of Endocervix,Not available
13722.58cfa831e4b0c9d6adf6cbc4,58cfa831e4b0c9d6adf6cbc4,TCGA-EJ-5532-10A-01D-1573_130221_SN1120_0239_BD1V59ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EJ-5532-10A-01D-1573_130221_SN1120_0239_BD1V59ACXX_s_4_rg.sorted,TCGA-EJ-5532-10A-01D-1573_130221_SN1120_0239_BD1V59ACXX_s_4_rg.sorted.bam,665.4,1.9,0.16,58cfa831e4b0c9d6adf6cbc4,TCGA-EJ-5532-10A-01D-1573_130221_SN1120_0239_BD1V59ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5532-10A,AE3A0C92-148D-4F1C-8563-06AC1050F53E,Blood Derived Normal,Illumina HiSeq,eb3898c4-6098-4e04-b474-26ff917324b6,Prostate,57,BAAAF843-3E18-49D6-9CCC-21D8A025262C,F3516AED-A847-4F93-8B55-43FEA30563A4,TCGA-EJ-5532-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5532,TCGA-PRAD,NA,s3962,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6ce5c,58cfa832e4b0c9d6adf6ce5c,TCGA-GE-A2C6-10A-01D-A16N_120805_SN208_0422_BD16VPACXX_s_8_rg.sorted.filtered.,WGS,TCGA-GE-A2C6-10A-01D-A16N_120805_SN208_0422_BD16VPACXX_s_8_rg.sorted,TCGA-GE-A2C6-10A-01D-A16N_120805_SN208_0422_BD16VPACXX_s_8_rg.sorted.bam,72.38,2.08,0.15,58cfa832e4b0c9d6adf6ce5c,TCGA-GE-A2C6-10A-01D-A16N_120805_SN208_0422_BD16VPACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-GE-A2C6-10A,7DEEDEBA-F05B-453C-9DF1-EEB20B0EC72E,Blood Derived Normal,Illumina HiSeq,b6bf2fbc-c57f-48cb-8fae-30e409afb4bb,Thyroid,33,DC7837F2-9B14-4E27-A7F8-08FE3CE27761,2E5F216C-704C-4AC0-A666-A164352BD22E,TCGA-GE-A2C6-10A-01D-A16N-02,HG19_Broad_variant,TCGA-GE-A2C6,TCGA-THCA,NA,s12122,Harvard Medical School,ABS - IUPUI,United States,NO,T2,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa830e4b0c9d6adf6c22c,58cfa830e4b0c9d6adf6c22c,TCGA-BT-A0S7-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BT-A0S7-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_4_rg.sorted,TCGA-BT-A0S7-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_4_rg.sorted.bam,12.85,1.87,0.15,58cfa830e4b0c9d6adf6c22c,TCGA-BT-A0S7-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A0S7-01A,68BC786E-07C7-4964-BC88-5E2A8633626A,Primary Tumor,Illumina HiSeq,55a63ec5-a803-44ee-905f-c7bfff9162d6,Bladder,75,A9B73851-4609-4DF7-8EB8-45A56F4B2DD6,F415813D-F975-492B-9E4E-55CE47C967B9,TCGA-BT-A0S7-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BT-A0S7,TCGA-BLCA,200,s3269,Harvard Medical School,University of Pittsburgh,United States,NO,T4a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6cbae,58cfa831e4b0c9d6adf6cbae,TCGA-EJ-5517-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EJ-5517-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_6_rg.sorted,TCGA-EJ-5517-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_6_rg.sorted.bam,610.4,1.9,0.17,58cfa831e4b0c9d6adf6cbae,TCGA-EJ-5517-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5517-10A,4B9AA301-D2E3-47F3-B724-A34F420B2B6B,Blood Derived Normal,Illumina HiSeq,9b9eefbd-747b-48b2-9382-494a8c720a29,Prostate,55,96162A0B-A13A-43F8-8C78-FCE1B5A22938,A42F2DDC-EDDE-486D-BDDF-1A633CA32453,TCGA-EJ-5517-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5517,TCGA-PRAD,NA,s3432,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82fe4b0c9d6adf6b7fc,58cfa82fe4b0c9d6adf6b7fc,TCGA-38-6178-01A-11D-1751_120301_SN208_0270_AD0KLRACXX_s_3_rg.sorted.filtered.,WGS,TCGA-38-6178-01A-11D-1751_120301_SN208_0270_AD0KLRACXX_s_3_rg.sorted,TCGA-38-6178-01A-11D-1751_120301_SN208_0270_AD0KLRACXX_s_3_rg.sorted.bam,240.4,1.9,0.14,58cfa82fe4b0c9d6adf6b7fc,TCGA-38-6178-01A-11D-1751_120301_SN208_0270_AD0KLRACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-38-6178-01A,EDF80622-AEA2-4B50-BB69-691D6708AA83,Primary Tumor,Illumina HiSeq,f309d501-6d91-40ce-839c-bef9a434bae1,Lung,70,81FB5FA9-D901-4FAA-B909-376B8676D2BC,DE9A3263-6ACD-4BBB-9F91-D4E7FCBEFA04,TCGA-38-6178-01A-11D-1751-02,HG19_Broad_variant,TCGA-38-6178,TCGA-LUAD,NA,s11119,Harvard Medical School,UNC,United States,NO,T2b,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6c86a,58cfa831e4b0c9d6adf6c86a,TCGA-CV-6003-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CV-6003-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_4_rg.sorted,TCGA-CV-6003-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_4_rg.sorted.bam,223,1.9,0.14,58cfa831e4b0c9d6adf6c86a,TCGA-CV-6003-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6003-01A,417B357E-C90E-4B63-AE7A-4B782038FFD3,Primary Tumor,Illumina HiSeq,b314312e-2a3f-45dd-a813-870344654395,Head and Neck,50,6892F7E3-630E-45B5-8C30-139161461A85,9DF426C5-E45E-428B-A63C-11D4C1BEB4B2,TCGA-CV-6003-01A-11D-1681-02,HG19_Broad_variant,TCGA-CV-6003,TCGA-HNSC,NA,s16197,Harvard Medical School,MD Anderson Cancer Center,None,NO,T2,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6cbd6,58cfa831e4b0c9d6adf6cbd6,TCGA-EJ-5525-10A-01D-1573_130221_SN1120_0238_AC1TDEACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EJ-5525-10A-01D-1573_130221_SN1120_0238_AC1TDEACXX_s_2_rg.sorted,TCGA-EJ-5525-10A-01D-1573_130221_SN1120_0238_AC1TDEACXX_s_2_rg.sorted.bam,477.4,1.9,0.16,58cfa831e4b0c9d6adf6cbd6,TCGA-EJ-5525-10A-01D-1573_130221_SN1120_0238_AC1TDEACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5525-10A,554A7381-46FD-4301-B91B-5AF7F173C350,Blood Derived Normal,Illumina HiSeq,7a9972fa-ec25-4ba0-bfea-8a15187015dd,Prostate,67,B518D7C3-9F94-45BB-9DA5-F49BE6059853,A5B4A31F-190E-47A2-B1A7-A7D0A463BD66,TCGA-EJ-5525-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5525,TCGA-PRAD,NA,s3793,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bf68,58cfa830e4b0c9d6adf6bf68,TCGA-BR-4370-11A-01D-1154_130815_VM001_0003_VMR0003CXX_s_2_rg.sorted.filtered.,WGS,TCGA-BR-4370-11A-01D-1154_130815_VM001_0003_VMR0003CXX_s_2_rg.sorted,TCGA-BR-4370-11A-01D-1154_130815_VM001_0003_VMR0003CXX_s_2_rg.sorted.bam,93.3,1.9,0.15,58cfa830e4b0c9d6adf6bf68,TCGA-BR-4370-11A-01D-1154_130815_VM001_0003_VMR0003CXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4370-11A,A2A71CB0-9DBD-45CC-8867-DA84500515E7,Solid Tissue Normal,Illumina HiSeq,2d7a67d4-6bea-4ea5-a59c-edfc3adb7ed5,Stomach,74,A070F13B-EABC-4C8B-9587-E8BAA418B627,39E35101-5830-4EE4-88EE-63C559C10798,TCGA-BR-4370-11A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4370,TCGA-STAD,NA,s15107,Harvard Medical School,Asterand,Russia,NO,TX,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa831e4b0c9d6adf6cd5c,58cfa831e4b0c9d6adf6cd5c,TCGA-EJ-5494-01A-01D-1572_130125_SN208_0451_BD1RB1ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EJ-5494-01A-01D-1572_130125_SN208_0451_BD1RB1ACXX_s_7_rg.sorted,TCGA-EJ-5494-01A-01D-1572_130125_SN208_0451_BD1RB1ACXX_s_7_rg.sorted.bam,107.7,1.9,0.15,58cfa831e4b0c9d6adf6cd5c,TCGA-EJ-5494-01A-01D-1572_130125_SN208_0451_BD1RB1ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5494-01A,E27C50E2-2A41-4F8C-9EF8-2BC51FB0C23E,Primary Tumor,Illumina HiSeq,01d186ab-6289-40da-9715-4f766da74b10,Prostate,50,37103479-02BD-45E8-95B3-7A4A78523999,9AA32D54-78ED-4DFC-ACA4-E1A88404F791,TCGA-EJ-5494-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5494,TCGA-PRAD,NA,s4131,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d1ac,58cfa832e4b0c9d6adf6d1ac,TCGA-HC-7211-11A-01D-2111_130517_SN590_0230_AD24B4ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-HC-7211-11A-01D-2111_130517_SN590_0230_AD24B4ACXX_s_3_rg.sorted,TCGA-HC-7211-11A-01D-2111_130517_SN590_0230_AD24B4ACXX_s_3_rg.sorted.bam,347.3,NA,0.16,58cfa832e4b0c9d6adf6d1ac,TCGA-HC-7211-11A-01D-2111_130517_SN590_0230_AD24B4ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7211-11A,EC3870C9-4930-4AF7-B2EB-1E16C9EC9F14,Solid Tissue Normal,Illumina HiSeq,05e04c32-8191-475a-9d50-3fa50aadb8d5,Prostate,62,710AADB2-1976-41F4-8A8A-BBB6B3283018,8C9CDD7B-FF6C-4D47-9306-E6AAF4C00790,TCGA-HC-7211-11A-01D-2111-02,HG19_Broad_variant,TCGA-HC-7211,TCGA-PRAD,NA,s3810,Harvard Medical School,International Genomics Consortium,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c6ce,58cfa831e4b0c9d6adf6c6ce,TCGA-CS-6290-01A-11D-1703_130808_SN208_0487_AC28U7ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CS-6290-01A-11D-1703_130808_SN208_0487_AC28U7ACXX_s_7_rg.sorted,TCGA-CS-6290-01A-11D-1703_130808_SN208_0487_AC28U7ACXX_s_7_rg.sorted.bam,95.3,1.9,0.15,58cfa831e4b0c9d6adf6c6ce,TCGA-CS-6290-01A-11D-1703_130808_SN208_0487_AC28U7ACXX_s_7_rg.sorted.bam,Alive,MALE,Not available,Not available,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-6290-01A,42FE260F-520B-4FAC-8C09-D2B31AED59FB,Primary Tumor,Illumina HiSeq,dd2c0db0-5e68-43b9-a591-4efa9a782af1,Brain,31,6148F31E-CDBA-481B-BCD7-B3AEE05925B1,D31BD4D8-DF61-4B6B-9304-17B22FDD023B,TCGA-CS-6290-01A-11D-1703-02,HG19_Broad_variant,TCGA-CS-6290,TCGA-LGG,NA,s8555,Harvard Medical School,Thomas Jefferson University,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6c37a,58cfa831e4b0c9d6adf6c37a,TCGA-CD-5813-01A-11D-1598_121026_SN1120_0198_BC188JACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CD-5813-01A-11D-1598_121026_SN1120_0198_BC188JACXX_s_5_rg.sorted,TCGA-CD-5813-01A-11D-1598_121026_SN1120_0198_BC188JACXX_s_5_rg.sorted.bam,46,1.9,0.17,58cfa831e4b0c9d6adf6c37a,TCGA-CD-5813-01A-11D-1598_121026_SN1120_0198_BC188JACXX_s_5_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-5813-01A,152B9D8A-19FD-4665-B9E4-4FEDFB1608CD,Primary Tumor,Illumina HiSeq,ccc0d204-3529-43aa-b108-62d12f6465bd,Stomach,60,09E42E33-D2EC-406C-9A42-36D9D2EBD6C6,2118F0C5-3178-40EA-850D-C3F6F8752DD9,TCGA-CD-5813-01A-11D-1598-02,HG19_Broad_variant,TCGA-CD-5813,TCGA-STAD,NA,s14408,Harvard Medical School,ILSbio,Vietnam,NO,T3,N0,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage II
13722.58cfa831e4b0c9d6adf6c4ac,58cfa831e4b0c9d6adf6c4ac,TCGA-CF-A3MH-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CF-A3MH-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_1_rg.sorted,TCGA-CF-A3MH-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_1_rg.sorted.bam,63.16,NA,0.15,58cfa831e4b0c9d6adf6c4ac,TCGA-CF-A3MH-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_1_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CF-A3MH-01A,B8A8D2FC-421B-4393-8D5A-946CF72CB496,Primary Tumor,Illumina HiSeq,f82c1606-fe81-428d-9889-58cafa1f29e4,Bladder,75,8CF68BB1-5966-40CD-A038-E9E91E608766,463978F0-D37A-4035-9D1C-8C0E7B0F721C,TCGA-CF-A3MH-01A-11D-A210-26,HG19_Broad_variant,TCGA-CF-A3MH,TCGA-BLCA,NA,s2874,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T2,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c828,58cfa831e4b0c9d6adf6c828,TCGA-CV-7238-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CV-7238-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_4_rg.sorted,TCGA-CV-7238-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_4_rg.sorted.bam,143.73,NA,0.14,58cfa831e4b0c9d6adf6c828,TCGA-CV-7238-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7238-01A,78FCC813-D0A8-44AA-B004-62810DCA9D12,Primary Tumor,Illumina HiSeq,3eb627a6-bbcf-4699-ad23-e52a26cd4453,Head and Neck,69,831808D5-1883-4F6F-B252-1BB397FBD62A,D051D2CB-F8DE-4E42-B9CF-E7CBE43861A0,TCGA-CV-7238-01A-11D-2317-26,HG19_Broad_variant,TCGA-CV-7238,TCGA-HNSC,NA,s15520,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c534,58cfa831e4b0c9d6adf6c534,TCGA-CH-5766-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CH-5766-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_1_rg.sorted,TCGA-CH-5766-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_1_rg.sorted.bam,273.7,1.9,0.15,58cfa831e4b0c9d6adf6c534,TCGA-CH-5766-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5766-01A,A5C77AB6-6E98-4A3D-81C8-F3D5FABD31D2,Primary Tumor,Illumina HiSeq,f778efd0-d2ed-48bc-ab57-e2bd12130169,Prostate,55,8477DA86-95BD-4B6D-A3E8-C16C9D61EA1F,ACAE8359-C2D0-4EB8-836B-D0BDF815F065,TCGA-CH-5766-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5766,TCGA-PRAD,NA,s3421,Harvard Medical School,Indivumed,Germany,NO,T3a,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c552,58cfa831e4b0c9d6adf6c552,TCGA-CH-5762-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CH-5762-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_1_rg.sorted,TCGA-CH-5762-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_1_rg.sorted.bam,211.7,1.9,0.15,58cfa831e4b0c9d6adf6c552,TCGA-CH-5762-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5762-01A,D4FFAFDC-EE83-43DF-AA3B-7326503C6438,Primary Tumor,Illumina HiSeq,70b297c6-c1f6-4651-93c3-17888cf0b118,Prostate,60,6D1A2D44-72F3-4333-8506-E53CDC4E5185,25189A34-4C05-4D77-9A3B-212A475F66B1,TCGA-CH-5762-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5762,TCGA-PRAD,NA,s3594,Harvard Medical School,Indivumed,Germany,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6be90,58cfa830e4b0c9d6adf6be90,TCGA-BL-A13I-01A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BL-A13I-01A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_4_rg.sorted,TCGA-BL-A13I-01A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_4_rg.sorted.bam,92.87,2,0.15,58cfa830e4b0c9d6adf6be90,TCGA-BL-A13I-01A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_4_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BL-A13I-01A,EBC094A6-CDC9-4C02-B8EC-A181B25A364D,Primary Tumor,Illumina HiSeq,b7cfe609-703a-4750-b9e7-5bda8e948cc4,Bladder,57,62C2BA8F-02E3-4100-86BC-5958038B4983,7C09CFF3-3162-4952-93AD-8A7D89F07266,TCGA-BL-A13I-01A-11D-A13U-02,HG19_Broad_variant,TCGA-BL-A13I,TCGA-BLCA,223,s2689,Harvard Medical School,Christiana Healthcare,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c464,58cfa831e4b0c9d6adf6c464,TCGA-CH-5743-10A-01D-1572_130104_SN1120_0209_BD1KP6ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CH-5743-10A-01D-1572_130104_SN1120_0209_BD1KP6ACXX_s_4_rg.sorted,TCGA-CH-5743-10A-01D-1572_130104_SN1120_0209_BD1KP6ACXX_s_4_rg.sorted.bam,26.4,1.9,0.15,58cfa831e4b0c9d6adf6c464,TCGA-CH-5743-10A-01D-1572_130104_SN1120_0209_BD1KP6ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5743-10A,2DEE4BD8-B00E-4F8A-BFEA-5D8D1A068202,Blood Derived Normal,Illumina HiSeq,9e05f936-10ec-46a8-96d8-efc5c8510e51,Prostate,66,83AE9498-5808-4360-ACAD-E0C5948F27A4,43E22987-804C-496E-8011-BDB9340C4A33,TCGA-CH-5743-10A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5743,TCGA-PRAD,NA,s3587,Harvard Medical School,Indivumed,Germany,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6cf2a,58cfa832e4b0c9d6adf6cf2a,TCGA-H4-A2HQ-10A-01D-A17R_120921_SN208_0430_AC18CWACXX_s_6_rg.sorted.filtered.,WGS,TCGA-H4-A2HQ-10A-01D-A17R_120921_SN208_0430_AC18CWACXX_s_6_rg.sorted,TCGA-H4-A2HQ-10A-01D-A17R_120921_SN208_0430_AC18CWACXX_s_6_rg.sorted.bam,10.51,NA,0.18,58cfa832e4b0c9d6adf6cf2a,TCGA-H4-A2HQ-10A-01D-A17R_120921_SN208_0430_AC18CWACXX_s_6_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-H4-A2HQ-10A,CEDE5274-279D-4021-8ACA-5ECC4BF94D66,Blood Derived Normal,Illumina HiSeq,feb80610-46c5-490f-a029-9c6b401aeb25,Bladder,64,1650C0FB-03FF-45CB-93A6-A7544CEF346E,3A1438D1-7115-47FE-84AC-608C1DF101D5,TCGA-H4-A2HQ-10A-01D-A17R-02,HG19_Broad_variant,TCGA-H4-A2HQ,TCGA-BLCA,NA,s2930,Harvard Medical School,Medical College of Georgia,United States,NO,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa830e4b0c9d6adf6c24c,58cfa830e4b0c9d6adf6c24c,TCGA-BT-A20U-11A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BT-A20U-11A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_8_rg.sorted,TCGA-BT-A20U-11A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_8_rg.sorted.bam,50.51,2.1,0.16,58cfa830e4b0c9d6adf6c24c,TCGA-BT-A20U-11A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20U-11A,83B41D35-69B1-4218-BE1A-8821D8A6899C,Solid Tissue Normal,Illumina HiSeq,62a2b30e-c3e7-4831-8cda-b72f3d30157a,Bladder,70,996EE634-A7F1-4273-80D2-ADBD68D5A1CE,643C646C-1135-4636-9E12-67AED166780E,TCGA-BT-A20U-11A-11D-A14U-02,HG19_Broad_variant,TCGA-BT-A20U,TCGA-BLCA,455,s2863,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa830e4b0c9d6adf6c166,58cfa830e4b0c9d6adf6c166,TCGA-BS-A0TC-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BS-A0TC-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_1_rg.sorted,TCGA-BS-A0TC-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_1_rg.sorted.bam,15.3,1.98,0.17,58cfa830e4b0c9d6adf6c166,TCGA-BS-A0TC-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_1_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TC-10A,7B7D2D2B-ABE6-4F32-ADD0-3715096995D1,Blood Derived Normal,Illumina HiSeq,dcd97c1e-7749-4903-ad55-e117ba95468d,Uterus,69,30B01B06-1614-43CA-86AE-204D55A40892,164DB1B3-6A8C-448E-B17E-0BD444F700B9,TCGA-BS-A0TC-10A-01D-A101-02,HG19_Broad_variant,TCGA-BS-A0TC,TCGA-UCEC,NA,s5013,Harvard Medical School,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c74c,58cfa831e4b0c9d6adf6c74c,TCGA-D7-6526-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-D7-6526-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_2_rg.sorted,TCGA-D7-6526-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_2_rg.sorted.bam,274.7,1.9,0.15,58cfa831e4b0c9d6adf6c74c,TCGA-D7-6526-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6526-10A,A28E57E2-9071-4558-856A-162F7A837380,Blood Derived Normal,Illumina HiSeq,9470ad93-71f4-4d5d-a26b-8cec32d802dc,Stomach,67,79CEFAAA-0ED8-4BB9-BF61-47A835D9AE17,6713B663-75DF-4692-9B14-5B9746C206C1,TCGA-D7-6526-10A-01D-1798-02,HG19_Broad_variant,TCGA-D7-6526,TCGA-STAD,NA,s15408,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T3,N2,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIIA
13722.58cfa831e4b0c9d6adf6cc1a,58cfa831e4b0c9d6adf6cc1a,TCGA-EE-A29V-06A-12D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EE-A29V-06A-12D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_4_rg.sorted,TCGA-EE-A29V-06A-12D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_4_rg.sorted.bam,44.62,NA,0.17,58cfa831e4b0c9d6adf6cc1a,TCGA-EE-A29V-06A-12D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29V-06A,01CB0004-FC1E-4DA5-9D27-F458F8D711EE,Metastatic,Illumina HiSeq,fea260c9-151c-4558-914f-1f9a5a20ef6a,Skin,85,08CD5F21-F1F6-4FFB-8587-2E13F6DED157,A974F839-A24A-4763-8E48-A3777AA7757F,TCGA-EE-A29V-06A-12D-A18Y-02,HG19_Broad_variant,TCGA-EE-A29V,TCGA-SKCM,787,s7339,Harvard Medical School,University of Sydney,Australia,NO,T3b,N1b,Not available,Stage IIIC
13722.58cfa831e4b0c9d6adf6c6b3,58cfa831e4b0c9d6adf6c6b3,TCGA-CV-5966-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CV-5966-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_7_rg.sorted,TCGA-CV-5966-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_7_rg.sorted.bam,62,1.8,0.14,58cfa831e4b0c9d6adf6c6b3,TCGA-CV-5966-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5966-10A,0D0731E2-8D82-4B6D-9258-2896A770A868,Blood Derived Normal,Illumina HiSeq,29536ca9-0a82-43fd-869c-1663c534daee,Head and Neck,63,BAD68BB8-4147-4981-959E-440AFC642F6E,154101FF-F8CF-4D61-BE7E-1DC04317799B,TCGA-CV-5966-10A-01D-1868-02,HG19_Broad_variant,TCGA-CV-5966,TCGA-HNSC,545,s16195,Harvard Medical School,MD Anderson Cancer Center,None,NO,T4a,N1,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c6d0,58cfa831e4b0c9d6adf6c6d0,TCGA-CS-4941-01A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CS-4941-01A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_1_rg.sorted,TCGA-CS-4941-01A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_1_rg.sorted.bam,157,1.9,0.15,58cfa831e4b0c9d6adf6c6d0,TCGA-CS-4941-01A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-4941-01A,FC222F23-B3B2-4AC0-BC61-E8E8FA5CC160,Primary Tumor,Illumina HiSeq,7df56317-1eca-4fb0-af19-36a4bfc5df00,Brain,67,4E5AEE62-DF39-4A74-917C-C3AB154F8D0E,8CA32F59-BA52-49E8-BA72-D2761ED47099,TCGA-CS-4941-01A-01D-1465-02,HG19_Broad_variant,TCGA-CS-4941,TCGA-LGG,234,s8126,Harvard Medical School,Thomas Jefferson University,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6ccc0,58cfa831e4b0c9d6adf6ccc0,TCGA-EJ-5531-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EJ-5531-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_1_rg.sorted,TCGA-EJ-5531-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_1_rg.sorted.bam,81.7,1.9,0.15,58cfa831e4b0c9d6adf6ccc0,TCGA-EJ-5531-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5531-01A,ADF3C2F7-D5F9-41C3-BD8C-7F9F1F22FF73,Primary Tumor,Illumina HiSeq,0993d456-af78-4078-aa16-bd810177c278,Prostate,62,48F3A8B8-110C-49AB-BD85-CE33328C2CF6,90219925-E6E8-40BC-8DD0-BD76F942B48C,TCGA-EJ-5531-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5531,TCGA-PRAD,NA,s3445,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c84c,58cfa831e4b0c9d6adf6c84c,TCGA-D7-6527-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D7-6527-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_4_rg.sorted,TCGA-D7-6527-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_4_rg.sorted.bam,227.7,1.9,0.15,58cfa831e4b0c9d6adf6c84c,TCGA-D7-6527-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6527-10A,CB622CD6-776D-4681-8A67-4ADDD61C66B8,Blood Derived Normal,Illumina HiSeq,7fda4d3c-8153-4107-b896-7b7967fdf926,Stomach,62,1C932E82-DF6F-4CE3-B691-46C0D5E9F893,DBB176B8-D56A-4B76-B4D0-B0763370AEE3,TCGA-D7-6527-10A-01D-1798-02,HG19_Broad_variant,TCGA-D7-6527,TCGA-STAD,NA,s15332,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N1,Stomach Intestinal Adenocarcinoma Papillary Type,Stage II
13722.58cfa832e4b0c9d6adf6d1d8,58cfa832e4b0c9d6adf6d1d8,TCGA-HQ-A2OE-10A-01D-A204_121002_SN1222_0155_BD1ERHACXX_s_6_rg.sorted.filtered.,WGS,TCGA-HQ-A2OE-10A-01D-A204_121002_SN1222_0155_BD1ERHACXX_s_6_rg.sorted,TCGA-HQ-A2OE-10A-01D-A204_121002_SN1222_0155_BD1ERHACXX_s_6_rg.sorted.bam,20.82,NA,0.15,58cfa832e4b0c9d6adf6d1d8,TCGA-HQ-A2OE-10A-01D-A204_121002_SN1222_0155_BD1ERHACXX_s_6_rg.sorted.bam,Alive,MALE,Not available,Not available,Bladder Urothelial Carcinoma,Aligned reads,TCGA-HQ-A2OE-10A,353C5FCC-9C6A-4AC6-99DC-FB4573B2AE6C,Blood Derived Normal,Illumina HiSeq,2ff1fc67-2977-45d1-baca-e4098f7bca8d,Bladder,69,A360CC7F-D30B-48A5-AB63-3754E3A8C709,86227A84-351B-41F4-9915-FDA1049A6DCA,TCGA-HQ-A2OE-10A-01D-A204-02,HG19_Broad_variant,TCGA-HQ-A2OE,TCGA-BLCA,NA,s3310,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,T2a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Not available
13722.58cfa832e4b0c9d6adf6d5ce,58cfa832e4b0c9d6adf6d5ce,TCGA-LN-A49P-10A-01D-A248_121212_SN1120_0205_AC1F18ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-LN-A49P-10A-01D-A248_121212_SN1120_0205_AC1F18ACXX_s_4_rg.sorted,TCGA-LN-A49P-10A-01D-A248_121212_SN1120_0205_AC1F18ACXX_s_4_rg.sorted.bam,69.34,NA,0.15,58cfa832e4b0c9d6adf6d5ce,TCGA-LN-A49P-10A-01D-A248_121212_SN1120_0205_AC1F18ACXX_s_4_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49P-10A,B64A5F5A-5913-432E-9D08-0FF67A8C6B64,Blood Derived Normal,Illumina HiSeq,09ab52cb-87e3-4028-97fd-6ed9d6d28017,Esophagus,71,D948C66C-6764-4610-AC4C-771F01BE793B,C8C2DBA6-8D76-40F5-953E-278FE4469EF6,TCGA-LN-A49P-10A-01D-A248-26,HG19_Broad_variant,TCGA-LN-A49P,TCGA-ESCA,NA,s1861,MD Anderson - Institute for Applied Cancer Science,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa830e4b0c9d6adf6c1fa,58cfa830e4b0c9d6adf6c1fa,TCGA-BA-5559-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BA-5559-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_6_rg.sorted,TCGA-BA-5559-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_6_rg.sorted.bam,476.7,1.9,0.16,58cfa830e4b0c9d6adf6c1fa,TCGA-BA-5559-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5559-01A,17B17D91-C3DF-4B89-9C10-4DB069AFF656,Primary Tumor,Illumina HiSeq,a6749339-8b87-4219-84dd-8045857cbe79,Head and Neck,71,FBEA64F9-B46B-4AF1-BFB2-1791D93977B6,61532C84-EDD9-492D-AF89-99086F87381E,TCGA-BA-5559-01A-01D-1509-02,HG19_Broad_variant,TCGA-BA-5559,TCGA-HNSC,NA,s16320,Harvard Medical School,UNC,None,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6cb22,58cfa831e4b0c9d6adf6cb22,TCGA-E5-A2PC-01A-11D-A204_120926_SN1222_0153_BD1D4MACXX_s_1_rg.sorted.filtered.,WGS,TCGA-E5-A2PC-01A-11D-A204_120926_SN1222_0153_BD1D4MACXX_s_1_rg.sorted,TCGA-E5-A2PC-01A-11D-A204_120926_SN1222_0153_BD1D4MACXX_s_1_rg.sorted.bam,63.68,NA,0.16,58cfa831e4b0c9d6adf6cb22,TCGA-E5-A2PC-01A-11D-A204_120926_SN1222_0153_BD1D4MACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-E5-A2PC-01A,4107AE6F-502C-4BDC-BF14-E4B3711CBA38,Primary Tumor,Illumina HiSeq,496052c5-5ab2-4852-88e1-348116a86746,Bladder,61,2195B75E-157F-4547-9705-1E7E75666CA8,FABA82E6-FF3D-468C-91EC-A88794619697,TCGA-E5-A2PC-01A-11D-A204-02,HG19_Broad_variant,TCGA-E5-A2PC,TCGA-BLCA,NA,s3289,Harvard Medical School,Roswell Park,United States,NO,T2b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c632,58cfa831e4b0c9d6adf6c632,TCGA-CG-4441-01A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CG-4441-01A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_1_rg.sorted,TCGA-CG-4441-01A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_1_rg.sorted.bam,250,1.9,0.15,58cfa831e4b0c9d6adf6c632,TCGA-CG-4441-01A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_1_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4441-01A,37E22429-EFD7-4D6A-B79A-9D8C7BE2170C,Primary Tumor,Illumina HiSeq,d3542e45-2b25-406d-976d-5d4c63e4839e,Stomach,83,60937697-57BA-4D03-9545-B0E321215448,DE856FF9-FEF4-4AA8-9418-F29EB79932B0,TCGA-CG-4441-01A-01D-1798-02,HG19_Broad_variant,TCGA-CG-4441,TCGA-STAD,426,s14699,Harvard Medical School,Indivumed,Germany,NO,T2,N2,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6ccb0,58cfa831e4b0c9d6adf6ccb0,TCGA-ER-A194-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-ER-A194-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_8_rg.sorted,TCGA-ER-A194-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_8_rg.sorted.bam,38.52,NA,0.16,58cfa831e4b0c9d6adf6ccb0,TCGA-ER-A194-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A194-10A,2BBF00F4-7798-4DAD-9894-96202C9132BE,Blood Derived Normal,Illumina HiSeq,ef0fa608-64aa-4fed-b93e-aeab3d012096,Skin,77,A2D0D9EA-35AC-416E-B5C2-768B69DC1372,E478F5FD-9C6D-4169-A023-B78D5F925EBD,TCGA-ER-A194-10A-01D-A190-02,HG19_Broad_variant,TCGA-ER-A194,TCGA-SKCM,1354,s7351,Harvard Medical School,University of Pittsburgh,United States,NO,Not available,N0,Not available,Not available
13722.58cfa831e4b0c9d6adf6c96b,58cfa831e4b0c9d6adf6c96b,TCGA-DU-5849-10A-01D-1703_130806_SN1222_0209_AD2AW0ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DU-5849-10A-01D-1703_130806_SN1222_0209_AD2AW0ACXX_s_6_rg.sorted,TCGA-DU-5849-10A-01D-1703_130806_SN1222_0209_AD2AW0ACXX_s_6_rg.sorted.bam,91,1.9,0.14,58cfa831e4b0c9d6adf6c96b,TCGA-DU-5849-10A-01D-1703_130806_SN1222_0209_AD2AW0ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-5849-10A,5AF8ADA5-86B5-4832-8A8E-E975ECCA5515,Blood Derived Normal,Illumina HiSeq,ce60dc42-d2f9-4eda-b08c-8e71133127b7,Brain,48,4D468A8E-04DA-4C51-AF1A-C0DC10E67F8D,FCEC83BA-6596-472D-9988-71092389A8ED,TCGA-DU-5849-10A-01D-1703-02,HG19_Broad_variant,TCGA-DU-5849,TCGA-LGG,NA,s8755,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6c765,58cfa831e4b0c9d6adf6c765,TCGA-D7-6522-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_4_rg.sorted.filtered.,WGS,TCGA-D7-6522-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_4_rg.sorted,TCGA-D7-6522-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_4_rg.sorted.bam,169.7,1.9,0.15,58cfa831e4b0c9d6adf6c765,TCGA-D7-6522-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6522-10A,8BB3FACB-1933-4350-9F78-74537559E000,Blood Derived Normal,Illumina HiSeq,b268b352-4bb7-4b44-8367-f621ab6d372c,Stomach,58,0A5814D0-90A4-490E-A536-B423FCE6B5AA,0BC76B5E-0E98-4192-9801-2605243F425A,TCGA-D7-6522-10A-01D-1798-02,HG19_Broad_variant,TCGA-D7-6522,TCGA-STAD,NA,s15200,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N0,Stomach  Adenocarcinoma  Diffuse Type,Stage IB
13722.58cfa82fe4b0c9d6adf6b943,58cfa82fe4b0c9d6adf6b943,TCGA-A5-A0GV-10A-01D-A043_120214_SN590_0139_BC0DYEACXX_s_4_rg.sorted.filtered.,WGS,TCGA-A5-A0GV-10A-01D-A043_120214_SN590_0139_BC0DYEACXX_s_4_rg.sorted,TCGA-A5-A0GV-10A-01D-A043_120214_SN590_0139_BC0DYEACXX_s_4_rg.sorted.bam,10.97,1.94,0.17,58cfa82fe4b0c9d6adf6b943,TCGA-A5-A0GV-10A-01D-A043_120214_SN590_0139_BC0DYEACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GV-10A,5E3B981E-73FE-4CC9-8C89-B420E8E2F426,Blood Derived Normal,Illumina HiSeq,640286f9-ba4e-441b-baf8-e2ed40a65578,Uterus,67,4A3E6225-7149-4AC4-B104-C133B00F1B6D,BA20653D-7EF1-40D6-B86D-74C46B6D8BA7,TCGA-A5-A0GV-10A-01D-A043-02,HG19_Broad_variant,TCGA-A5-A0GV,TCGA-UCEC,NA,s4418,Harvard Medical School,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cba5,58cfa831e4b0c9d6adf6cba5,TCGA-EJ-7331-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EJ-7331-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_4_rg.sorted,TCGA-EJ-7331-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_4_rg.sorted.bam,214.3,NA,0.15,58cfa831e4b0c9d6adf6cba5,TCGA-EJ-7331-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7331-01A,B424B73A-2DFA-473F-AB56-AB382CD1CDEF,Primary Tumor,Illumina HiSeq,a85ad241-998c-4d85-a63b-903ddeb62201,Prostate,64,5AA2E382-C8DF-44E3-8802-994188B11D55,F2DA114D-161B-46CD-BAA7-46E63DBC5D5C,TCGA-EJ-7331-01A-11D-2111-02,HG19_Broad_variant,TCGA-EJ-7331,TCGA-PRAD,NA,s4139,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c9d2,58cfa831e4b0c9d6adf6c9d2,TCGA-DQ-5630-10A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DQ-5630-10A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_3_rg.sorted,TCGA-DQ-5630-10A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_3_rg.sorted.bam,134,1.9,0.15,58cfa831e4b0c9d6adf6c9d2,TCGA-DQ-5630-10A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-DQ-5630-10A,91A712B5-A724-48D0-BA06-4F6857683463,Blood Derived Normal,Illumina HiSeq,1c95b304-0beb-462d-bb72-fe1946dfbc5f,Head and Neck,73,06BDB35A-E44C-4D86-AD0E-3BF74F567609,08A5D543-6FF9-402B-B86D-1A5ED0F0D75E,TCGA-DQ-5630-10A-01D-1868-02,HG19_Broad_variant,TCGA-DQ-5630,TCGA-HNSC,NA,s16208,Harvard Medical School,University of Michigan,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ae42,58cfa82ee4b0c9d6adf6ae42,TCGA-05-4250-10A-01D-1103_120228_SN1120_0116_AD0KRVACXX_s_1_rg.sorted.filtered.,WGS,TCGA-05-4250-10A-01D-1103_120228_SN1120_0116_AD0KRVACXX_s_1_rg.sorted,TCGA-05-4250-10A-01D-1103_120228_SN1120_0116_AD0KRVACXX_s_1_rg.sorted.bam,14.63,1.9,0.16,58cfa82ee4b0c9d6adf6ae42,TCGA-05-4250-10A-01D-1103_120228_SN1120_0116_AD0KRVACXX_s_1_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4250-10A,F98ECD8A-B878-4F53-B911-20CD8E17281C,Blood Derived Normal,Illumina HiSeq,e2b88393-7111-4c16-8b98-344fb8aa701f,Lung,79,6AE21FEA-41BE-4CD2-BFCB-EC138D42CFF3,6963DBCE-5E1F-419E-8997-1178CA90D733,TCGA-05-4250-10A-01D-1103-02,HG19_Broad_variant,TCGA-05-4250,TCGA-LUAD,121,s11116,Harvard Medical School,Indivumed,Germany,NO,T3,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6ca62,58cfa831e4b0c9d6adf6ca62,TCGA-DQ-5625-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DQ-5625-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_2_rg.sorted,TCGA-DQ-5625-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_2_rg.sorted.bam,31,1.9,0.16,58cfa831e4b0c9d6adf6ca62,TCGA-DQ-5625-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-DQ-5625-10A,53D9A130-4A3A-4491-85CD-9A44415A1632,Blood Derived Normal,Illumina HiSeq,faef45e3-26d8-4053-a1ff-b62774815392,Head and Neck,52,F3AD5B44-87B1-41AE-8CC1-42E158BC174C,EB9FB8DF-AD96-4EFF-8673-4D3DDB4BD6AB,TCGA-DQ-5625-10A-01D-1868-02,HG19_Broad_variant,TCGA-DQ-5625,TCGA-HNSC,NA,s16344,Harvard Medical School,University of Michigan,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6cbe4,58cfa831e4b0c9d6adf6cbe4,TCGA-EJ-7327-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EJ-7327-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_1_rg.sorted,TCGA-EJ-7327-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_1_rg.sorted.bam,403.6,NA,0.16,58cfa831e4b0c9d6adf6cbe4,TCGA-EJ-7327-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7327-10A,E90AB72A-4BBB-4C37-B48A-8A1A85D79D04,Blood Derived Normal,Illumina HiSeq,27f26a58-df63-4203-aea9-f907fc527c8c,Prostate,61,2B7212E7-C498-4CAA-A42C-78922CB118E4,B8EA6339-5F79-4E87-998F-C06E7799E32A,TCGA-EJ-7327-10A-01D-2111-02,HG19_Broad_variant,TCGA-EJ-7327,TCGA-PRAD,NA,s3608,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d099,58cfa832e4b0c9d6adf6d099,TCGA-IG-A3I8-10A-01D-A248_130101_SN590_0206_AC1H8RACXX_s_6_rg.sorted.filtered.,WGS,TCGA-IG-A3I8-10A-01D-A248_130101_SN590_0206_AC1H8RACXX_s_6_rg.sorted,TCGA-IG-A3I8-10A-01D-A248_130101_SN590_0206_AC1H8RACXX_s_6_rg.sorted.bam,17.93,NA,0.16,58cfa832e4b0c9d6adf6d099,TCGA-IG-A3I8-10A-01D-A248_130101_SN590_0206_AC1H8RACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A3I8-10A,7BF3F18B-A013-48D2-A743-26A57FDBE4C4,Blood Derived Normal,Illumina HiSeq,222a927c-a91a-4ae4-8b41-8756e75a8966,Esophagus,51,5715077C-E499-4CD0-8135-779FE90B9ED6,AC1F885F-C497-4096-A2B4-9DEBB04C01E8,TCGA-IG-A3I8-10A-01D-A248-26,HG19_Broad_variant,TCGA-IG-A3I8,TCGA-ESCA,NA,s1823,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T3,N0,Not available,Stage IIA
13722.58cfa832e4b0c9d6adf6d114,58cfa832e4b0c9d6adf6d114,TCGA-G2-A2ES-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_7_rg.sorted.filtered.,WGS,TCGA-G2-A2ES-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_7_rg.sorted,TCGA-G2-A2ES-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_7_rg.sorted.bam,46.96,NA,0.16,58cfa832e4b0c9d6adf6d114,TCGA-G2-A2ES-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-G2-A2ES-01A,72D8EAE8-9EFB-45B2-ACBD-82C6B5732E38,Primary Tumor,Illumina HiSeq,5922785f-2336-403c-9cb6-0843df3383b5,Bladder,85,C2288290-F17A-435C-90E7-5A4913F0C076,52FA3B0A-B5C7-4A74-A798-0DB359029147,TCGA-G2-A2ES-01A-11D-A17R-02,HG19_Broad_variant,TCGA-G2-A2ES,TCGA-BLCA,NA,s2919,Harvard Medical School,MD Anderson,United States,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6cb84,58cfa831e4b0c9d6adf6cb84,TCGA-EE-A29V-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EE-A29V-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_7_rg.sorted,TCGA-EE-A29V-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_7_rg.sorted.bam,24.23,NA,0.15,58cfa831e4b0c9d6adf6cb84,TCGA-EE-A29V-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29V-10A,01CB0004-FC1E-4DA5-9D27-F458F8D711EE,Blood Derived Normal,Illumina HiSeq,fa59fd22-b903-473f-a799-3a3f6bcb8536,Skin,85,50459715-30F2-49A7-BE1F-9A54D61242A8,8965C2DB-BDE8-4C9B-84AA-6D2B55101415,TCGA-EE-A29V-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A29V,TCGA-SKCM,787,s8005,Harvard Medical School,University of Sydney,Australia,NO,T3b,N1b,Not available,Stage IIIC
13722.58cfa831e4b0c9d6adf6c9e2,58cfa831e4b0c9d6adf6c9e2,TCGA-DQ-5631-10A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DQ-5631-10A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_4_rg.sorted,TCGA-DQ-5631-10A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_4_rg.sorted.bam,135,1.9,0.15,58cfa831e4b0c9d6adf6c9e2,TCGA-DQ-5631-10A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-DQ-5631-10A,10B3F56A-E61E-486B-8D3C-176668D5DC34,Blood Derived Normal,Illumina HiSeq,f614c1a4-6710-4035-bf2b-23679a3c3fd0,Head and Neck,52,730E5BDB-1E07-47A4-B708-3CC08C603017,5833C7BB-9FEE-4244-A533-36712BCF2444,TCGA-DQ-5631-10A-01D-1868-02,HG19_Broad_variant,TCGA-DQ-5631,TCGA-HNSC,548,s15533,Harvard Medical School,University Of Michigan,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6c20a,58cfa830e4b0c9d6adf6c20a,TCGA-BT-A20N-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BT-A20N-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_2_rg.sorted,TCGA-BT-A20N-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_2_rg.sorted.bam,16.18,1.98,0.17,58cfa830e4b0c9d6adf6c20a,TCGA-BT-A20N-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_2_rg.sorted.bam,Dead,MALE,Not available,Not available,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20N-11A,EBEDAB7C-DD7C-448E-8324-78C86F13BE8B,Solid Tissue Normal,Illumina HiSeq,3a98735f-f5b6-4273-ac15-6d6f17971bcf,Bladder,72,753C9421-02BE-4ECD-9F8E-5DBB4FE72C38,0618C478-AD92-4BC0-A3F7-730181708653,TCGA-BT-A20N-11A-11D-A14U-02,HG19_Broad_variant,TCGA-BT-A20N,TCGA-BLCA,795,s2869,Harvard Medical School,University of Pittsburgh,None,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c52e,58cfa831e4b0c9d6adf6c52e,TCGA-CH-5769-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CH-5769-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_5_rg.sorted,TCGA-CH-5769-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_5_rg.sorted.bam,75.7,1.9,0.15,58cfa831e4b0c9d6adf6c52e,TCGA-CH-5769-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5769-01A,A7B76662-8380-4F35-9307-99C0ACACB904,Primary Tumor,Illumina HiSeq,2fe51267-827f-4ffb-8aa8-42352e2352d5,Prostate,48,18606532-21D5-40BF-92CF-A42B027449A1,5488DCD8-EC8B-4E14-8F62-5F9931580B87,TCGA-CH-5769-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5769,TCGA-PRAD,NA,s3424,Harvard Medical School,Indivumed,Germany,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c54c,58cfa831e4b0c9d6adf6c54c,TCGA-CH-5766-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CH-5766-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_2_rg.sorted,TCGA-CH-5766-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_2_rg.sorted.bam,52.7,2,0.14,58cfa831e4b0c9d6adf6c54c,TCGA-CH-5766-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5766-11A,A5C77AB6-6E98-4A3D-81C8-F3D5FABD31D2,Solid Tissue Normal,Illumina HiSeq,3e827e6b-5861-47a6-9904-89cef9f94a0f,Prostate,55,09E15F2E-FC45-4ABA-86D6-2A5DD97AE173,536FED80-5729-4B83-93A0-FCFF2025B722,TCGA-CH-5766-11A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5766,TCGA-PRAD,NA,s4127,Harvard Medical School,Indivumed,Germany,NO,T3a,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cbdf,58cfa831e4b0c9d6adf6cbdf,TCGA-EJ-5515-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EJ-5515-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_2_rg.sorted,TCGA-EJ-5515-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_2_rg.sorted.bam,366.4,1.9,0.16,58cfa831e4b0c9d6adf6cbdf,TCGA-EJ-5515-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5515-10A,19CF56B2-A85B-43E7-971F-5680B9B1A67A,Blood Derived Normal,Illumina HiSeq,d2477eab-8dfa-47b7-9212-c2d294698767,Prostate,60,66E47792-74A2-4F8F-A7E5-602A8EC92DD8,14D2AE51-6008-4DE7-8A69-EA4CE0FC80BE,TCGA-EJ-5515-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5515,TCGA-PRAD,NA,s3955,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c761,58cfa831e4b0c9d6adf6c761,TCGA-CV-6952-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CV-6952-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_5_rg.sorted,TCGA-CV-6952-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_5_rg.sorted.bam,13,1.9,0.14,58cfa831e4b0c9d6adf6c761,TCGA-CV-6952-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_5_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6952-10A,7ED006E8-461F-4664-BFFF-55FA6812743C,Blood Derived Normal,Illumina HiSeq,0e2d0224-15cc-4ffb-b42d-300f4f08688a,Head and Neck,65,AA8A2097-2F73-4176-81C9-782F2C068DB9,B0D99166-225D-4BCA-910F-48754CE443A2,TCGA-CV-6952-10A-01D-1911-02,HG19_Broad_variant,TCGA-CV-6952,TCGA-HNSC,185,s15519,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6bf95,58cfa830e4b0c9d6adf6bf95,TCGA-BR-6564-01A-12D-1880_121220_SN1222_0163_AC1HA2ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BR-6564-01A-12D-1880_121220_SN1222_0163_AC1HA2ACXX_s_1_rg.sorted,TCGA-BR-6564-01A-12D-1880_121220_SN1222_0163_AC1HA2ACXX_s_1_rg.sorted.bam,29.7,1.9,0.13,58cfa830e4b0c9d6adf6bf95,TCGA-BR-6564-01A-12D-1880_121220_SN1222_0163_AC1HA2ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6564-01A,AF1086CC-B330-4AD6-AE1C-3B5C7259949A,Primary Tumor,Illumina HiSeq,6ee5a220-be0b-4909-bd37-5a6d8c53177d,Stomach,46,B8355E52-D7A7-4711-BBA7-BC4D201741F2,62E2C436-03DA-4B32-B43A-DF7AC992DD7C,TCGA-BR-6564-01A-12D-1880-02,HG19_Broad_variant,TCGA-BR-6564,TCGA-STAD,NA,s15051,Harvard Medical School,Asterand,Russia,NO,T3,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA
13722.58cfa831e4b0c9d6adf6c72a,58cfa831e4b0c9d6adf6c72a,TCGA-D1-A17R-10A-01D-A12F_120523_SN1222_0109_BD12MPACXX_s_2_rg.sorted.filtered.,WGS,TCGA-D1-A17R-10A-01D-A12F_120523_SN1222_0109_BD12MPACXX_s_2_rg.sorted,TCGA-D1-A17R-10A-01D-A12F_120523_SN1222_0109_BD12MPACXX_s_2_rg.sorted.bam,27.3,1.96,0.17,58cfa831e4b0c9d6adf6c72a,TCGA-D1-A17R-10A-01D-A12F_120523_SN1222_0109_BD12MPACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A17R-10A,73A0DD38-115D-48FB-B683-04AA5D612F2A,Blood Derived Normal,Illumina HiSeq,c8e63bfe-78b9-440d-bab8-d90db0329891,Uterus,58,3F4549BD-550F-4E11-B0F0-D08C43DB73D9,24FD6EF3-8975-4674-85CF-6593CBFA7129,TCGA-D1-A17R-10A-01D-A12F-02,HG19_Broad_variant,TCGA-D1-A17R,TCGA-UCEC,339,s4447,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6ca52,58cfa831e4b0c9d6adf6ca52,TCGA-DK-A3IM-10A-01D-A210_120913_SN208_0428_BC188KACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DK-A3IM-10A-01D-A210_120913_SN208_0428_BC188KACXX_s_5_rg.sorted,TCGA-DK-A3IM-10A-01D-A210_120913_SN208_0428_BC188KACXX_s_5_rg.sorted.bam,44.11,NA,0.15,58cfa831e4b0c9d6adf6ca52,TCGA-DK-A3IM-10A-01D-A210_120913_SN208_0428_BC188KACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3IM-10A,41B59716-116F-4942-8B63-409870A87E26,Blood Derived Normal,Illumina HiSeq,1f1106b7-eff0-48a4-828a-0a42816b6736,Bladder,76,1C583727-98EE-45B2-A73E-CD2F543EB5C8,C816A9A5-C7B7-455A-A8C1-07E6012B4984,TCGA-DK-A3IM-10A-01D-A210-26,HG19_Broad_variant,TCGA-DK-A3IM,TCGA-BLCA,NA,s3103,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c565,58cfa831e4b0c9d6adf6c565,TCGA-CH-5763-11A-01D-1572_130104_SN208_0445_AC1JWAACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CH-5763-11A-01D-1572_130104_SN208_0445_AC1JWAACXX_s_4_rg.sorted,TCGA-CH-5763-11A-01D-1572_130104_SN208_0445_AC1JWAACXX_s_4_rg.sorted.bam,116.7,1.9,0.13,58cfa831e4b0c9d6adf6c565,TCGA-CH-5763-11A-01D-1572_130104_SN208_0445_AC1JWAACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5763-11A,18E79A01-07A2-4CD5-B700-71D41724E041,Solid Tissue Normal,Illumina HiSeq,51855ca2-0a23-4f4a-8e63-5b34fcb33c98,Prostate,66,20F71991-0257-47C1-AE58-A64C83EAF8FE,913AAA7F-C6B7-47F7-B046-6548F217180D,TCGA-CH-5763-11A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5763,TCGA-PRAD,NA,s3778,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82fe4b0c9d6adf6b800,58cfa82fe4b0c9d6adf6b800,TCGA-38-4632-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_7_rg.sorted.filtered.,WGS,TCGA-38-4632-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_7_rg.sorted,TCGA-38-4632-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_7_rg.sorted.bam,465.4,1.9,0.15,58cfa82fe4b0c9d6adf6b800,TCGA-38-4632-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_7_rg.sorted.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-38-4632-01A,875333AB-9048-462D-AAA2-693AD127E3CC,Primary Tumor,Illumina HiSeq,ee38fc59-2812-43a0-b6c0-ab684daab63d,Lung,42,D994817A-474E-4F92-8A78-7586CAA85D52,77D4D914-9C77-401B-BD71-9CF71A58DCE7,TCGA-38-4632-01A-01D-1751-02,HG19_Broad_variant,TCGA-38-4632,TCGA-LUAD,1357,s11449,Harvard Medical School,UNC,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IV
13722.58cfa830e4b0c9d6adf6bf1c,58cfa830e4b0c9d6adf6bf1c,TCGA-BR-4267-11A-01D-1128_120805_SN1120_0181_AD16WCACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BR-4267-11A-01D-1128_120805_SN1120_0181_AD16WCACXX_s_7_rg.sorted,TCGA-BR-4267-11A-01D-1128_120805_SN1120_0181_AD16WCACXX_s_7_rg.sorted.bam,273.9,1.9,0.15,58cfa830e4b0c9d6adf6bf1c,TCGA-BR-4267-11A-01D-1128_120805_SN1120_0181_AD16WCACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4267-11A,0D0F0200-25B8-483B-B04A-82A7833B4D30,Solid Tissue Normal,Illumina HiSeq,1ec7ecd8-69c7-4a5f-a296-4ebb9e591729,Stomach,51,5BD407C3-D3E1-44C1-8B1D-53951B497CF4,BC752F5C-8AC9-4DA9-A141-6DADD565B2EA,TCGA-BR-4267-11A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4267,TCGA-STAD,NA,s15045,Harvard Medical School,Asterand,None,NO,T2a,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c9c4,58cfa831e4b0c9d6adf6c9c4,TCGA-DK-A1AG-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DK-A1AG-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_8_rg.sorted,TCGA-DK-A1AG-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_8_rg.sorted.bam,49.77,1.93,0.16,58cfa831e4b0c9d6adf6c9c4,TCGA-DK-A1AG-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AG-10A,F8C0A69C-DF53-4A0A-A30E-4424C0CE3DD5,Blood Derived Normal,Illumina HiSeq,90e16c1d-22cd-49d7-a4ff-546778f2adda,Bladder,65,A55072D2-EFF0-4B87-8330-55022E8D6F39,A40FB6BF-8D18-48E3-B5A3-2962C26C64F5,TCGA-DK-A1AG-10A-01D-A13U-02,HG19_Broad_variant,TCGA-DK-A1AG,TCGA-BLCA,NA,s3281,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c3d7,58cfa831e4b0c9d6adf6c3d7,TCGA-CH-5741-10A-01D-1572_130104_SN1120_0209_BD1KP6ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CH-5741-10A-01D-1572_130104_SN1120_0209_BD1KP6ACXX_s_2_rg.sorted,TCGA-CH-5741-10A-01D-1572_130104_SN1120_0209_BD1KP6ACXX_s_2_rg.sorted.bam,170.4,1.9,0.15,58cfa831e4b0c9d6adf6c3d7,TCGA-CH-5741-10A-01D-1572_130104_SN1120_0209_BD1KP6ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5741-10A,B3BF57D4-E31A-4740-B438-FA826FB79550,Blood Derived Normal,Illumina HiSeq,b82ce0ca-281f-43c5-a79e-de66036ebf94,Prostate,56,CA3BC043-4D2E-4C95-88E8-94D61B8C9DA0,849BD756-7D8C-4739-B54E-FAC588C4A9B0,TCGA-CH-5741-10A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5741,TCGA-PRAD,NA,s3928,Harvard Medical School,Indivumed,Germany,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d4ac,58cfa832e4b0c9d6adf6d4ac,TCGA-V4-A9EW-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_8_rg.sorted.filtered.,WGS,TCGA-V4-A9EW-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_8_rg.sorted,TCGA-V4-A9EW-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_8_rg.sorted.bam,12.18,NA,0.16,58cfa832e4b0c9d6adf6d4ac,TCGA-V4-A9EW-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EW-10A,6BE5176C-4980-4663-ADFF-D04F05737DA0,Blood Derived Normal,Illumina HiSeq,064b51f8-ed13-4eb6-a4bd-658d9e9ddc44,Eye,44,8A5E4620-B955-4634-BF3C-16221C2FE97D,28B2A22C-5D33-4906-8217-C94E1B9317E8,TCGA-V4-A9EW-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9EW,TCGA-UVM,NA,s241,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa831e4b0c9d6adf6ccf0,58cfa831e4b0c9d6adf6ccf0,TCGA-EJ-5512-01A-01D-1572_130131_SN1120_0234_AD1PVUACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EJ-5512-01A-01D-1572_130131_SN1120_0234_AD1PVUACXX_s_5_rg.sorted,TCGA-EJ-5512-01A-01D-1572_130131_SN1120_0234_AD1PVUACXX_s_5_rg.sorted.bam,100.7,1.9,0.13,58cfa831e4b0c9d6adf6ccf0,TCGA-EJ-5512-01A-01D-1572_130131_SN1120_0234_AD1PVUACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5512-01A,C28F931F-5AB2-4899-9FE9-54024F082D92,Primary Tumor,Illumina HiSeq,1df8e29c-5be8-4dbf-abb8-f0ded9419a14,Prostate,46,D0B41403-8458-45E1-946E-21054FBA65B8,D5F126D6-7AAF-425A-BBEA-E7587A25529D,TCGA-EJ-5512-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5512,TCGA-PRAD,NA,s3954,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cd06,58cfa831e4b0c9d6adf6cd06,TCGA-EJ-5496-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EJ-5496-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_3_rg.sorted,TCGA-EJ-5496-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_3_rg.sorted.bam,253.7,1.9,0.14,58cfa831e4b0c9d6adf6cd06,TCGA-EJ-5496-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5496-01A,6755C231-355F-4CC3-85F1-6306C7F5D44B,Primary Tumor,Illumina HiSeq,00039222-b24d-4c86-b6ac-ffc00b3b6ece,Prostate,59,D0873929-EAC8-42E2-AF6F-DF3CB9CE698C,0A4FA030-2417-4F6F-8B86-5036FCA48F1E,TCGA-EJ-5496-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5496,TCGA-PRAD,NA,s3598,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d4de,58cfa832e4b0c9d6adf6d4de,TCGA-V4-A9EV-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_7_rg.sorted.filtered.,WGS,TCGA-V4-A9EV-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_7_rg.sorted,TCGA-V4-A9EV-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_7_rg.sorted.bam,12.34,NA,0.17,58cfa832e4b0c9d6adf6d4de,TCGA-V4-A9EV-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EV-10A,DA6F0ED2-A6D5-4D87-823E-122EBD59AABA,Blood Derived Normal,Illumina HiSeq,74880b79-7b56-4029-b604-9f487bf08e07,Eye,59,924E3002-1E9A-4DB2-B7C1-74F0FFCA0425,B145C816-3917-4E1C-A787-D0E92BED09D5,TCGA-V4-A9EV-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9EV,TCGA-UVM,NA,s224,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa830e4b0c9d6adf6bf14,58cfa830e4b0c9d6adf6bf14,TCGA-BR-4267-01A-01D-1128_120805_SN1120_0181_AD16WCACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BR-4267-01A-01D-1128_120805_SN1120_0181_AD16WCACXX_s_3_rg.sorted,TCGA-BR-4267-01A-01D-1128_120805_SN1120_0181_AD16WCACXX_s_3_rg.sorted.bam,265.9,1.9,0.13,58cfa830e4b0c9d6adf6bf14,TCGA-BR-4267-01A-01D-1128_120805_SN1120_0181_AD16WCACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4267-01A,0D0F0200-25B8-483B-B04A-82A7833B4D30,Primary Tumor,Illumina HiSeq,cd48e485-3a3f-4eec-92e7-f1c52c0866f1,Stomach,51,32D28ED3-2E33-4D83-8DE6-82E156B33211,F0DB5AF5-091F-4CDC-9917-BEFD658BF454,TCGA-BR-4267-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4267,TCGA-STAD,NA,s15044,Harvard Medical School,Asterand,None,NO,T2a,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6cb56,58cfa831e4b0c9d6adf6cb56,TCGA-EE-A20H-06A-11D-A18Y_120730_SN1222_0141_BC115GACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EE-A20H-06A-11D-A18Y_120730_SN1222_0141_BC115GACXX_s_8_rg.sorted,TCGA-EE-A20H-06A-11D-A18Y_120730_SN1222_0141_BC115GACXX_s_8_rg.sorted.bam,55.78,NA,0.16,58cfa831e4b0c9d6adf6cb56,TCGA-EE-A20H-06A-11D-A18Y_120730_SN1222_0141_BC115GACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A20H-06A,267B98E7-708F-458A-82D1-5FAA415B9EE7,Metastatic,Illumina HiSeq,8a9e2a3c-228d-41b2-b1f5-a8242675c6e3,Skin,56,79AC8FFC-843B-4F1F-A681-8A507769DB19,609F4177-82C0-4E12-B1E9-291EBB381FF6,TCGA-EE-A20H-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A20H,TCGA-SKCM,5118,s8008,Harvard Medical School,University of Sydney,Australia,NO,T2,N0,Not available,Stage I
13722.58cfa831e4b0c9d6adf6c7d6,58cfa831e4b0c9d6adf6c7d6,TCGA-D1-A168-10A-01D-A12F_120420_SN208_0286_BD0T87ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-D1-A168-10A-01D-A12F_120420_SN208_0286_BD0T87ACXX_s_8_rg.sorted,TCGA-D1-A168-10A-01D-A12F_120420_SN208_0286_BD0T87ACXX_s_8_rg.sorted.bam,13.52,1.97,0.14,58cfa831e4b0c9d6adf6c7d6,TCGA-D1-A168-10A-01D-A12F_120420_SN208_0286_BD0T87ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A168-10A,41893E97-7E90-4B03-B738-260F288ADE4C,Blood Derived Normal,Illumina HiSeq,274b9d8f-b7c4-4462-bea7-dc245a19a39b,Uterus,67,0E52377B-62A1-4B0C-A62C-4C4D2CE3F45E,7AD8CF50-EF3A-4E75-A691-9B10AB5CEF00,TCGA-D1-A168-10A-01D-A12F-02,HG19_Broad_variant,TCGA-D1-A168,TCGA-UCEC,NA,s4612,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c46d,58cfa831e4b0c9d6adf6c46d,TCGA-CD-5799-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CD-5799-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_4_rg.sorted,TCGA-CD-5799-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_4_rg.sorted.bam,79.4,1.9,0.16,58cfa831e4b0c9d6adf6c46d,TCGA-CD-5799-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_4_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-5799-10A,C991697F-77F9-412A-9BD1-0E47F7387CB2,Blood Derived Normal,Illumina HiSeq,da9b3cb3-7284-4196-ae37-470689dcf5bd,Stomach,45,02A57E6D-BFA6-4A57-9C36-1292CAF91EB4,ED920586-15C8-4E14-8EDD-996771D6A569,TCGA-CD-5799-10A-01D-1598-02,HG19_Broad_variant,TCGA-CD-5799,TCGA-STAD,NA,s15117,Harvard Medical School,ILSbio,Vietnam,NO,T2,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa832e4b0c9d6adf6d134,58cfa832e4b0c9d6adf6d134,TCGA-G2-A3VY-01A-11D-A233_120913_SN208_0428_BC188KACXX_s_6_rg.sorted.filtered.,WGS,TCGA-G2-A3VY-01A-11D-A233_120913_SN208_0428_BC188KACXX_s_6_rg.sorted,TCGA-G2-A3VY-01A-11D-A233_120913_SN208_0428_BC188KACXX_s_6_rg.sorted.bam,27.44,NA,0.15,58cfa832e4b0c9d6adf6d134,TCGA-G2-A3VY-01A-11D-A233_120913_SN208_0428_BC188KACXX_s_6_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-G2-A3VY-01A,CD50C69F-0F45-4C57-B61A-8C6B41AB4F7E,Primary Tumor,Illumina HiSeq,fc9767fe-ddfb-4540-b151-0a80300c0a1d,Bladder,66,5A66149F-8FB0-41BC-880C-56D5541E3D94,8263C8A3-7CE5-4487-B8A1-29CE9417D1E3,TCGA-G2-A3VY-01A-11D-A233-26,HG19_Broad_variant,TCGA-G2-A3VY,TCGA-BLCA,NA,s2914,MD Anderson - Institute for Applied Cancer Science,MD Anderson,United States,NO,Not available,Not available,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa832e4b0c9d6adf6d02c,58cfa832e4b0c9d6adf6d02c,TCGA-GD-A2C5-10A-01D-A17R_120927_SN208_0432_AC188LACXX_s_7_rg.sorted.filtered.,WGS,TCGA-GD-A2C5-10A-01D-A17R_120927_SN208_0432_AC188LACXX_s_7_rg.sorted,TCGA-GD-A2C5-10A-01D-A17R_120927_SN208_0432_AC188LACXX_s_7_rg.sorted.bam,30.35,NA,0.11,58cfa832e4b0c9d6adf6d02c,TCGA-GD-A2C5-10A-01D-A17R_120927_SN208_0432_AC188LACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GD-A2C5-10A,5D54C742-5A8E-4C40-8D62-95E75E210AB8,Blood Derived Normal,Illumina HiSeq,e5ea7215-cf70-453d-bf6d-64868d34d584,Bladder,53,68F5998D-53C5-4CC1-9249-2C24AE8579AD,33CF143A-29E5-40C1-8301-7A7A271BF4EF,TCGA-GD-A2C5-10A-01D-A17R-02,HG19_Broad_variant,TCGA-GD-A2C5,TCGA-BLCA,NA,s2732,Harvard Medical School,ABS - IUPUI,United States,NO,T3a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c536,58cfa831e4b0c9d6adf6c536,TCGA-CH-5763-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CH-5763-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_3_rg.sorted,TCGA-CH-5763-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_3_rg.sorted.bam,172.7,1.9,0.17,58cfa831e4b0c9d6adf6c536,TCGA-CH-5763-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5763-01A,18E79A01-07A2-4CD5-B700-71D41724E041,Primary Tumor,Illumina HiSeq,25246d22-8217-4900-8b3c-c63126974b5c,Prostate,66,F4192448-E5B3-4A9F-8354-9FE28503017A,0B812175-D56C-4407-9745-8DA5B8E531B4,TCGA-CH-5763-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5763,TCGA-PRAD,NA,s4126,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c53b,58cfa831e4b0c9d6adf6c53b,TCGA-CH-5761-11A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CH-5761-11A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_8_rg.sorted,TCGA-CH-5761-11A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_8_rg.sorted.bam,215.7,1.9,0.13,58cfa831e4b0c9d6adf6c53b,TCGA-CH-5761-11A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5761-11A,854A481B-71A2-4F23-80AA-E91E9F4069B1,Solid Tissue Normal,Illumina HiSeq,ce8211c1-e866-447d-9c68-847d7d6d07f8,Prostate,61,2FC91628-6898-4D9D-931B-45D793450207,DEA1EF4F-6B51-4310-9E60-A9D9C27C1D41,TCGA-CH-5761-11A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5761,TCGA-PRAD,NA,s3939,Harvard Medical School,Indivumed,Germany,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6ca50,58cfa831e4b0c9d6adf6ca50,TCGA-DK-A1AD-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DK-A1AD-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_6_rg.sorted,TCGA-DK-A1AD-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_6_rg.sorted.bam,50.25,1.92,0.15,58cfa831e4b0c9d6adf6ca50,TCGA-DK-A1AD-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,Not available,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AD-10A,88A521CE-A5E9-4C6F-83D4-EC36A62FEDB6,Blood Derived Normal,Illumina HiSeq,02eda981-844a-4b1d-b9a6-fe1f173053e9,Bladder,69,836350C2-353D-462D-890B-8A471AFF9B4D,FFF392FF-6BD4-4155-9A69-3354F30FA6F4,TCGA-DK-A1AD-10A-01D-A13U-02,HG19_Broad_variant,TCGA-DK-A1AD,TCGA-BLCA,NA,s2709,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c920,58cfa831e4b0c9d6adf6c920,TCGA-CV-7091-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CV-7091-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_7_rg.sorted,TCGA-CV-7091-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_7_rg.sorted.bam,61.03,NA,0.13,58cfa831e4b0c9d6adf6c920,TCGA-CV-7091-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7091-10A,2A192049-6435-49AB-8444-DDEB2B9EE774,Blood Derived Normal,Illumina HiSeq,fd03b019-209c-4744-9f18-0fdd68024ed6,Head and Neck,54,2957E13D-6A6D-40FF-852C-E30690F9D758,28B008FF-7892-4193-B1DF-575D09BD6D7F,TCGA-CV-7091-10A-01D-2317-26,HG19_Broad_variant,TCGA-CV-7091,TCGA-HNSC,NA,s15644,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6cc58,58cfa831e4b0c9d6adf6cc58,TCGA-EJ-5501-10A-01D-1573_130223_SN590_0214_BC1UJ3ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EJ-5501-10A-01D-1573_130223_SN590_0214_BC1UJ3ACXX_s_4_rg.sorted,TCGA-EJ-5501-10A-01D-1573_130223_SN590_0214_BC1UJ3ACXX_s_4_rg.sorted.bam,214.4,1.9,0.15,58cfa831e4b0c9d6adf6cc58,TCGA-EJ-5501-10A-01D-1573_130223_SN590_0214_BC1UJ3ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5501-10A,8DF0C1E8-966C-4F46-AD15-FAE9E745A32E,Blood Derived Normal,Illumina HiSeq,91be46fe-3b96-4d1b-a7f4-229e972c32d1,Prostate,55,6A7ADCA9-9918-462D-8B8C-CB6A6AA8AD2D,1D371948-3DB6-4390-B576-6E4FDDD7C1FC,TCGA-EJ-5501-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5501,TCGA-PRAD,NA,s3604,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cb1e,58cfa831e4b0c9d6adf6cb1e,TCGA-E5-A2PC-10B-01D-A204_120926_SN1222_0153_BD1D4MACXX_s_2_rg.sorted.filtered.,WGS,TCGA-E5-A2PC-10B-01D-A204_120926_SN1222_0153_BD1D4MACXX_s_2_rg.sorted,TCGA-E5-A2PC-10B-01D-A204_120926_SN1222_0153_BD1D4MACXX_s_2_rg.sorted.bam,12.14,NA,0.16,58cfa831e4b0c9d6adf6cb1e,TCGA-E5-A2PC-10B-01D-A204_120926_SN1222_0153_BD1D4MACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-E5-A2PC-10A,4107AE6F-502C-4BDC-BF14-E4B3711CBA38,Blood Derived Normal,Illumina HiSeq,d15f0d2c-94bd-40f7-8589-0087c2ec6339,Bladder,61,6408217A-386D-4B4E-8416-C61B37CA5FEE,11CC13C2-FBB5-43EF-9FBB-AA9468591AF9,TCGA-E5-A2PC-10B-01D-A204-02,HG19_Broad_variant,TCGA-E5-A2PC,TCGA-BLCA,NA,s3288,Harvard Medical School,Roswell Park,United States,NO,T2b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c428,58cfa831e4b0c9d6adf6c428,TCGA-BT-A20W-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BT-A20W-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_6_rg.sorted,TCGA-BT-A20W-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_6_rg.sorted.bam,21.45,2.03,0.15,58cfa831e4b0c9d6adf6c428,TCGA-BT-A20W-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20W-11A,4DC5CFFE-ED8C-47AB-B5FC-F9615B5414F7,Solid Tissue Normal,Illumina HiSeq,f3f37b3b-3755-4102-b654-abea4d035ed1,Bladder,71,5FF660D2-10DE-4D72-BDE0-93840309B5E5,47F326E8-52A3-43C8-BF5E-43358E0D13B9,TCGA-BT-A20W-11A-11D-A14U-02,HG19_Broad_variant,TCGA-BT-A20W,TCGA-BLCA,254,s2695,Harvard Medical School,University of Pittsburgh,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c4b7,58cfa831e4b0c9d6adf6c4b7,TCGA-BR-4253-01A-01D-1128_120816_SN590_0175_AD16M6ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BR-4253-01A-01D-1128_120816_SN590_0175_AD16M6ACXX_s_7_rg.sorted,TCGA-BR-4253-01A-01D-1128_120816_SN590_0175_AD16M6ACXX_s_7_rg.sorted.bam,201.9,1.9,0.14,58cfa831e4b0c9d6adf6c4b7,TCGA-BR-4253-01A-01D-1128_120816_SN590_0175_AD16M6ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4253-01A,411257A4-A148-4606-8C8B-F9F1240E40ED,Primary Tumor,Illumina HiSeq,90590609-4f3e-48b4-98e5-963c1c97f057,Stomach,80,C536B8DF-6FE3-425E-82E8-36299A6BA2B9,B7CE561B-B51B-4C85-822D-58DF663DE8EA,TCGA-BR-4253-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4253,TCGA-STAD,NA,s15104,Harvard Medical School,Asterand,Russia,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6caec,58cfa831e4b0c9d6adf6caec,TCGA-DJ-A1QM-10A-01D-A14U_120629_SN1120_0167_AC0WMBACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DJ-A1QM-10A-01D-A14U_120629_SN1120_0167_AC0WMBACXX_s_5_rg.sorted,TCGA-DJ-A1QM-10A-01D-A14U_120629_SN1120_0167_AC0WMBACXX_s_5_rg.sorted.bam,20.06,2.3,0.15,58cfa831e4b0c9d6adf6caec,TCGA-DJ-A1QM-10A-01D-A14U_120629_SN1120_0167_AC0WMBACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QM-10A,3597AF5E-65FF-40A7-95FC-DACC26CBCA14,Blood Derived Normal,Illumina HiSeq,e2866656-6032-4a62-a4f1-437b4fc38f62,Thyroid,42,03C149F0-A850-421E-B777-73A634A3FC82,C9A6DDA6-A5C6-42A6-B21C-A7E9EF57C238,TCGA-DJ-A1QM-10A-01D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QM,TCGA-THCA,NA,s12108,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T1a,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa830e4b0c9d6adf6c216,58cfa830e4b0c9d6adf6c216,TCGA-BT-A20O-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BT-A20O-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_4_rg.sorted,TCGA-BT-A20O-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_4_rg.sorted.bam,10.13,1.84,0.17,58cfa830e4b0c9d6adf6c216,TCGA-BT-A20O-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20O-11A,C0E7FBE7-B9CB-4E65-941B-CD7D581C54EC,Solid Tissue Normal,Illumina HiSeq,d9764a1d-1e8f-47de-8916-e254751cd477,Bladder,75,F8846751-C6D7-4213-83BC-5A0382CBFFAE,F0DC405B-AFAB-4AE2-8585-295F6BC65243,TCGA-BT-A20O-11A-11D-A14U-02,HG19_Broad_variant,TCGA-BT-A20O,TCGA-BLCA,370,s3086,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6caee,58cfa831e4b0c9d6adf6caee,TCGA-E1-5303-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-E1-5303-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_3_rg.sorted,TCGA-E1-5303-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_3_rg.sorted.bam,46,1.9,0.14,58cfa831e4b0c9d6adf6caee,TCGA-E1-5303-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-E1-5303-01A,44A5C3B4-62A7-407B-B492-7069E1A43A26,Primary Tumor,Illumina HiSeq,e94ddca3-3117-4958-85a6-cde716b710dc,Brain,38,150856F7-77DA-4AA5-A28B-310A505AEA24,287AB664-A970-437E-A7F9-EF6C20D2266E,TCGA-E1-5303-01A-01D-1465-02,HG19_Broad_variant,TCGA-E1-5303,TCGA-LGG,2052,s8137,Harvard Medical School,Duke,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6c6d6,58cfa831e4b0c9d6adf6c6d6,TCGA-CS-4944-10A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CS-4944-10A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_4_rg.sorted,TCGA-CS-4944-10A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_4_rg.sorted.bam,420.7,1.9,0.15,58cfa831e4b0c9d6adf6c6d6,TCGA-CS-4944-10A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,Not available,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-4944-10A,64CD17EB-C778-45E9-B994-02B68182E51B,Blood Derived Normal,Illumina HiSeq,4454284c-2c7d-48f0-8ddb-ee4896355ab4,Brain,50,7A4DC30F-0128-4BAF-B6CC-91773BF41E45,C1CB9060-2D95-4139-8881-6C4BB98AEEAD,TCGA-CS-4944-10A-01D-1465-02,HG19_Broad_variant,TCGA-CS-4944,TCGA-LGG,NA,s8554,Harvard Medical School,Thomas Jefferson University,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa832e4b0c9d6adf6ce83,58cfa832e4b0c9d6adf6ce83,TCGA-G2-A2EJ-10A-01D-A17R_120921_SN208_0430_AC18CWACXX_s_4_rg.sorted.filtered.,WGS,TCGA-G2-A2EJ-10A-01D-A17R_120921_SN208_0430_AC18CWACXX_s_4_rg.sorted,TCGA-G2-A2EJ-10A-01D-A17R_120921_SN208_0430_AC18CWACXX_s_4_rg.sorted.bam,9.62,NA,0.16,58cfa832e4b0c9d6adf6ce83,TCGA-G2-A2EJ-10A-01D-A17R_120921_SN208_0430_AC18CWACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-G2-A2EJ-10A,C6227D39-D9E8-4E28-9E70-D7F720AB25E4,Blood Derived Normal,Illumina HiSeq,5ca74123-b721-4ec8-bade-785975c82891,Bladder,56,B695C910-8DA4-4F65-94E3-BB8463305582,39AE305E-B2CB-406E-B625-9DEDF1191A86,TCGA-G2-A2EJ-10A-01D-A17R-02,HG19_Broad_variant,TCGA-G2-A2EJ,TCGA-BLCA,NA,s2918,Harvard Medical School,MD Anderson,United States,NO,Not available,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c3f8,58cfa831e4b0c9d6adf6c3f8,TCGA-CH-5771-01A-21D-1572_130104_SN208_0446_BD1KR5ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CH-5771-01A-21D-1572_130104_SN208_0446_BD1KR5ACXX_s_7_rg.sorted,TCGA-CH-5771-01A-21D-1572_130104_SN208_0446_BD1KR5ACXX_s_7_rg.sorted.bam,30.7,1.9,0.14,58cfa831e4b0c9d6adf6c3f8,TCGA-CH-5771-01A-21D-1572_130104_SN208_0446_BD1KR5ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5771-01A,3ACD8328-76F7-4F43-9660-394B95748C3D,Primary Tumor,Illumina HiSeq,93b110cf-3f4b-4f72-8025-320b77838b0a,Prostate,63,19C87DE2-7936-4277-8AA8-3942D36E7579,83F4BDB9-ED8B-4472-87BB-74C901B1A350,TCGA-CH-5771-01A-21D-1572-02,HG19_Broad_variant,TCGA-CH-5771,TCGA-PRAD,NA,s3931,Harvard Medical School,Indivumed,Germany,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6ccd6,58cfa831e4b0c9d6adf6ccd6,TCGA-EJ-5506-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EJ-5506-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_6_rg.sorted,TCGA-EJ-5506-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_6_rg.sorted.bam,277.4,1.9,0.15,58cfa831e4b0c9d6adf6ccd6,TCGA-EJ-5506-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5506-10A,E5E4D3B6-8E58-4DCF-8F67-A00E656A8E27,Blood Derived Normal,Illumina HiSeq,299c9fa9-0cc5-4e97-80d8-e0b7c60bd861,Prostate,67,89ABEFF0-3EE1-4E9C-A1F4-D8CC03A26F8A,380366C0-C2C1-4C13-9806-5270B7CF4824,TCGA-EJ-5506-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5506,TCGA-PRAD,NA,s3433,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cc90,58cfa831e4b0c9d6adf6cc90,TCGA-EJ-5518-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EJ-5518-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_7_rg.sorted,TCGA-EJ-5518-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_7_rg.sorted.bam,131.7,1.9,0.15,58cfa831e4b0c9d6adf6cc90,TCGA-EJ-5518-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5518-01A,2B35C119-CDC1-49E2-8229-CA5CDE9E63D0,Primary Tumor,Illumina HiSeq,02ae3fcb-c1fe-400a-8172-0c62a8d4639c,Prostate,66,F12FA61C-FF1B-48E2-BE19-1D52D50DC261,BD026793-2032-4D13-9A6A-A189583A537C,TCGA-EJ-5518-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5518,TCGA-PRAD,NA,s3430,Harvard Medical School,University of Pittsburgh,United States,NO,T4,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cb98,58cfa831e4b0c9d6adf6cb98,TCGA-EJ-5512-10A-01D-1573_130131_SN1120_0234_AD1PVUACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EJ-5512-10A-01D-1573_130131_SN1120_0234_AD1PVUACXX_s_6_rg.sorted,TCGA-EJ-5512-10A-01D-1573_130131_SN1120_0234_AD1PVUACXX_s_6_rg.sorted.bam,544.4,1.9,0.17,58cfa831e4b0c9d6adf6cb98,TCGA-EJ-5512-10A-01D-1573_130131_SN1120_0234_AD1PVUACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5512-10A,C28F931F-5AB2-4899-9FE9-54024F082D92,Blood Derived Normal,Illumina HiSeq,e86e1bf3-6515-4cff-9811-7b19fe9b2d00,Prostate,46,9A0E8F46-D5E6-463C-B643-8CD35632B467,5FEA307B-0809-4D62-969E-0E8FEC5DED9C,TCGA-EJ-5512-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5512,TCGA-PRAD,NA,s4137,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c3f6,58cfa831e4b0c9d6adf6c3f6,TCGA-CH-5769-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CH-5769-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_6_rg.sorted,TCGA-CH-5769-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_6_rg.sorted.bam,175.7,2,0.13,58cfa831e4b0c9d6adf6c3f6,TCGA-CH-5769-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5769-11A,A7B76662-8380-4F35-9307-99C0ACACB904,Solid Tissue Normal,Illumina HiSeq,f2ed1ffa-45fe-4497-9137-3a7270cc913b,Prostate,48,B41D906B-2FEF-45C9-8B3A-C52B5856950E,7E331D74-AD6C-49D7-A9BD-7CFE657B5567,TCGA-CH-5769-11A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5769,TCGA-PRAD,NA,s3937,Harvard Medical School,Indivumed,Germany,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cd08,58cfa831e4b0c9d6adf6cd08,TCGA-EJ-5495-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EJ-5495-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_2_rg.sorted,TCGA-EJ-5495-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_2_rg.sorted.bam,1161.4,1.9,0.16,58cfa831e4b0c9d6adf6cd08,TCGA-EJ-5495-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5495-10A,962DD3D5-8501-4658-8CB9-2424B476124C,Blood Derived Normal,Illumina HiSeq,c1976dc5-9458-46ad-a1a5-1db90aa4eb04,Prostate,68,36329281-238C-492A-B442-70182FFCB017,642519A5-9911-4355-A257-97288162AC53,TCGA-EJ-5495-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5495,TCGA-PRAD,NA,s3941,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6cfe0,58cfa832e4b0c9d6adf6cfe0,TCGA-GC-A3WC-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-GC-A3WC-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_1_rg.sorted,TCGA-GC-A3WC-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_1_rg.sorted.bam,23.27,NA,0.17,58cfa832e4b0c9d6adf6cfe0,TCGA-GC-A3WC-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GC-A3WC-01A,DB52C68A-ED44-4EC4-9381-D75F9BCBC29A,Primary Tumor,Illumina HiSeq,5d982317-5753-41de-85ef-30ee85c56ba9,Bladder,80,24F9D01B-1210-4716-9466-8FE9F3612B8B,50E62704-6262-4426-BDAE-0490DC108B61,TCGA-GC-A3WC-01A-31D-A233-26,HG19_Broad_variant,TCGA-GC-A3WC,TCGA-BLCA,NA,s3307,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82fe4b0c9d6adf6b7de,58cfa82fe4b0c9d6adf6b7de,TCGA-50-5931-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_2_rg.sorted.filtered.,WGS,TCGA-50-5931-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_2_rg.sorted,TCGA-50-5931-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_2_rg.sorted.bam,345.4,1.9,0.15,58cfa82fe4b0c9d6adf6b7de,TCGA-50-5931-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5931-01A,12CCD581-A921-41BC-BCEE-4E9BE54532CC,Primary Tumor,Illumina HiSeq,ba1d7028-7d97-4a0b-917e-b861a8656748,Lung,75,16A2D381-75A0-423B-AAC2-D5710AFB183B,5EA8E18D-2D34-4C6E-A89D-36DE5E91E80C,TCGA-50-5931-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-5931,TCGA-LUAD,434,s11458,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6cb7c,58cfa831e4b0c9d6adf6cb7c,TCGA-EE-A2GB-10A-01D-A190_120726_SN590_0171_AD13PJACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EE-A2GB-10A-01D-A190_120726_SN590_0171_AD13PJACXX_s_8_rg.sorted,TCGA-EE-A2GB-10A-01D-A190_120726_SN590_0171_AD13PJACXX_s_8_rg.sorted.bam,35.83,NA,0.18,58cfa831e4b0c9d6adf6cb7c,TCGA-EE-A2GB-10A-01D-A190_120726_SN590_0171_AD13PJACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2GB-10A,E58BED18-503C-4182-BCF3-5AF6F20E1B8A,Blood Derived Normal,Illumina HiSeq,310b2515-640a-417e-9a35-bee64f90ac1c,Skin,51,ACD1CECE-2851-4851-BB58-7DFD7441B9B6,BDAE7DA4-5F86-471E-8AD9-E5FDE3EBD0ED,TCGA-EE-A2GB-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2GB,TCGA-SKCM,NA,s7347,Harvard Medical School,University of Sydney,Australia,NO,T2b,N1a,Not available,Stage IIIB
13722.58cfa82ee4b0c9d6adf6afec,58cfa82ee4b0c9d6adf6afec,TCGA-05-5715-10A-01D-1623_120228_SN1120_0116_AD0KRVACXX_s_3_rg.sorted.filtered.,WGS,TCGA-05-5715-10A-01D-1623_120228_SN1120_0116_AD0KRVACXX_s_3_rg.sorted,TCGA-05-5715-10A-01D-1623_120228_SN1120_0116_AD0KRVACXX_s_3_rg.sorted.bam,160.4,1.9,0.16,58cfa82ee4b0c9d6adf6afec,TCGA-05-5715-10A-01D-1623_120228_SN1120_0116_AD0KRVACXX_s_3_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-5715-10A,E0A19099-5D25-40DF-AD73-6260DF3A1B32,Blood Derived Normal,Illumina HiSeq,93ca0971-dab1-4845-ad59-48fe54014068,Lung,69,8281B534-7B60-4FC6-BA0A-A711B0A19E64,057028CA-4A69-4003-825D-AAE09E0CE546,TCGA-05-5715-10A-01D-1623-02,HG19_Broad_variant,TCGA-05-5715,TCGA-LUAD,NA,s10776,Harvard Medical School,Indivumed,Germany,NO,T2a,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa831e4b0c9d6adf6c56e,58cfa831e4b0c9d6adf6c56e,TCGA-CH-5764-11A-01D-1572_130104_SN208_0445_AC1JWAACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CH-5764-11A-01D-1572_130104_SN208_0445_AC1JWAACXX_s_6_rg.sorted,TCGA-CH-5764-11A-01D-1572_130104_SN208_0445_AC1JWAACXX_s_6_rg.sorted.bam,52.7,2,0.16,58cfa831e4b0c9d6adf6c56e,TCGA-CH-5764-11A-01D-1572_130104_SN208_0445_AC1JWAACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5764-11A,ED73F136-42E8-4100-B432-D10370D07E8B,Solid Tissue Normal,Illumina HiSeq,2a2319bf-1c6c-4a8d-84e0-a9b256cb0903,Prostate,66,9A252640-7E22-42F9-917B-DD54A0EC8EAD,CDAA0E08-857F-47D2-A11B-196F56C5DE04,TCGA-CH-5764-11A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5764,TCGA-PRAD,NA,s3419,Harvard Medical School,Indivumed,Germany,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6be24,58cfa830e4b0c9d6adf6be24,TCGA-B7-5818-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_2_rg.sorted.filtered.,WGS,TCGA-B7-5818-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_2_rg.sorted,TCGA-B7-5818-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_2_rg.sorted.bam,299.7,1.9,0.16,58cfa830e4b0c9d6adf6be24,TCGA-B7-5818-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-B7-5818-10A,6E03B415-84A1-4B91-8717-1A41EDD4A255,Blood Derived Normal,Illumina HiSeq,144edb0d-1d38-420e-a1b5-ea974935bacf,Stomach,62,B55FF48A-8CD0-4B55-94AE-5537A956BF43,3505EFD5-D2CE-4FCC-9980-5FBF2522AF0D,TCGA-B7-5818-10A-01D-1598-02,HG19_Broad_variant,TCGA-B7-5818,TCGA-STAD,NA,s15447,Harvard Medical School,Cureline,Russia,NO,T2,N0,Stomach  Adenocarcinoma  Diffuse Type,Stage IB
13722.58cfa832e4b0c9d6adf6d01e,58cfa832e4b0c9d6adf6d01e,TCGA-FS-A1ZQ-10A-01D-A190_120602_SN1120_0147_BD13TBACXX_s_8_rg.sorted.filtered.,WGS,TCGA-FS-A1ZQ-10A-01D-A190_120602_SN1120_0147_BD13TBACXX_s_8_rg.sorted,TCGA-FS-A1ZQ-10A-01D-A190_120602_SN1120_0147_BD13TBACXX_s_8_rg.sorted.bam,53.87,NA,0.16,58cfa832e4b0c9d6adf6d01e,TCGA-FS-A1ZQ-10A-01D-A190_120602_SN1120_0147_BD13TBACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZQ-10A,B91AF125-A024-4BA3-A5E8-99955FF9EFC5,Blood Derived Normal,Illumina HiSeq,3789dc51-ce06-41cd-9fe4-a60f3b49303a,Skin,31,567E5BB0-A080-43FD-87A4-94C5CCFF2148,0BFF6798-E967-424F-8B78-2875F6074F18,TCGA-FS-A1ZQ-10A-01D-A190-02,HG19_Broad_variant,TCGA-FS-A1ZQ,TCGA-SKCM,4062,s7534,Harvard Medical School,Essen,Germany,NO,TX,N0,Not available,I or II NOS
13722.58cfa830e4b0c9d6adf6bf8f,58cfa830e4b0c9d6adf6bf8f,TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0113_AC0DKVACXX_s_7_rg.sorted.filtered.,WGS,TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0113_AC0DKVACXX_s_7_rg.sorted,TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0113_AC0DKVACXX_s_7_rg.sorted.bam,106.93,1.95,0.16,58cfa830e4b0c9d6adf6bf8f,TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0113_AC0DKVACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0K0-01A,29C8F468-5AC1-4D6C-8376-E36E6D246926,Primary Tumor,Illumina HiSeq,5de016ca-e694-4ebc-b06f-5d07f7523fda,Uterus,48,11C43948-E7C9-4436-A654-82FA8033B625,3296C785-7C20-487D-BAEC-C66022E77E53,TCGA-B5-A0K0-01A-11D-A043-02,HG19_Broad_variant,TCGA-B5-A0K0,TCGA-UCEC,NA,s5204,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d269,58cfa832e4b0c9d6adf6d269,TCGA-K4-A3WS-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_1_rg.sorted.filtered.,WGS,TCGA-K4-A3WS-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_1_rg.sorted,TCGA-K4-A3WS-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_1_rg.sorted.bam,18.56,NA,0.16,58cfa832e4b0c9d6adf6d269,TCGA-K4-A3WS-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-K4-A3WS-01A,68ADACD1-A16E-4489-9E68-792A6BD8811C,Primary Tumor,Illumina HiSeq,891c215b-20ad-4eb3-9e53-87910b1d06f4,Bladder,66,54070AE0-0C10-4C10-B8BB-A7313B80A45F,F1840542-AEBE-4B4C-BA50-1686740847D4,TCGA-K4-A3WS-01A-11D-A23Q-26,HG19_Broad_variant,TCGA-K4-A3WS,TCGA-BLCA,NA,s3131,MD Anderson - Institute for Applied Cancer Science,ABS - Lahey Clinic,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6cb70,58cfa831e4b0c9d6adf6cb70,TCGA-EE-A29T-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EE-A29T-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_8_rg.sorted,TCGA-EE-A29T-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_8_rg.sorted.bam,20.36,NA,0.15,58cfa831e4b0c9d6adf6cb70,TCGA-EE-A29T-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29T-10A,9B99FFEE-FE9F-4BE5-A00A-EF86627282A4,Blood Derived Normal,Illumina HiSeq,83148501-88fd-4908-bad2-144b603a893c,Skin,51,CBE28A4D-8883-4EC4-B33D-5E7744C7978F,F0195AA4-9E9C-4B23-8FC7-4671385A687D,TCGA-EE-A29T-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A29T,TCGA-SKCM,NA,s7676,Harvard Medical School,University of Sydney,Australia,NO,TX,NX,Not available,Not available
13722.58cfa830e4b0c9d6adf6c2d0,58cfa830e4b0c9d6adf6c2d0,TCGA-CE-A27D-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CE-A27D-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_1_rg.sorted,TCGA-CE-A27D-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_1_rg.sorted.bam,52.72,1.93,0.17,58cfa830e4b0c9d6adf6c2d0,TCGA-CE-A27D-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_1_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-CE-A27D-01A,75A93F0E-CD41-43C6-A303-FF37E31395E9,Primary Tumor,Illumina HiSeq,c2d55126-05aa-44ef-97c3-ae2ac400c1b9,Thyroid,28,1807CEEE-28E1-4E8D-A1C4-6F6AD60EE310,CE991BB3-A63D-40C1-BFAF-3C4498D2C6EE,TCGA-CE-A27D-01A-11D-A16N-02,HG19_Broad_variant,TCGA-CE-A27D,TCGA-THCA,NA,s12362,Harvard Medical School,ILSbio,Vietnam,NO,T2,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6d4d4,58cfa832e4b0c9d6adf6d4d4,TCGA-VD-AA8P-01A-11D-A40D_140829_SN208_0523_BC5FKTACXX_s_7_rg.sorted.filtered.,WGS,TCGA-VD-AA8P-01A-11D-A40D_140829_SN208_0523_BC5FKTACXX_s_7_rg.sorted,TCGA-VD-AA8P-01A-11D-A40D_140829_SN208_0523_BC5FKTACXX_s_7_rg.sorted.bam,65.26,NA,0.16,58cfa832e4b0c9d6adf6d4d4,TCGA-VD-AA8P-01A-11D-A40D_140829_SN208_0523_BC5FKTACXX_s_7_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-AA8P-01A,B224E42D-8B6D-4578-963C-BF528B954900,Primary Tumor,Illumina HiSeq,c3957866-f525-4f68-b483-cf444a24bb38,Eye,64,6029915F-6337-4816-998A-9754C770ED93,6331804A-DC4D-4244-9C0D-A5CEC20E593C,TCGA-VD-AA8P-01A-11D-A40D-26,HG19_Broad_variant,TCGA-VD-AA8P,TCGA-UVM,NA,s261,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T3a,N0,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6c540,58cfa831e4b0c9d6adf6c540,TCGA-CH-5764-01A-21D-1572_130104_SN208_0445_AC1JWAACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CH-5764-01A-21D-1572_130104_SN208_0445_AC1JWAACXX_s_5_rg.sorted,TCGA-CH-5764-01A-21D-1572_130104_SN208_0445_AC1JWAACXX_s_5_rg.sorted.bam,157.7,1.9,0.17,58cfa831e4b0c9d6adf6c540,TCGA-CH-5764-01A-21D-1572_130104_SN208_0445_AC1JWAACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5764-01A,ED73F136-42E8-4100-B432-D10370D07E8B,Primary Tumor,Illumina HiSeq,036937fb-20a8-45df-a234-f7396aefb2d1,Prostate,66,48726D56-93A1-4730-A660-FCEEE0321084,F57D0D07-21B0-4901-9D81-C371C4673D4A,TCGA-CH-5764-01A-21D-1572-02,HG19_Broad_variant,TCGA-CH-5764,TCGA-PRAD,NA,s3777,Harvard Medical School,Indivumed,Germany,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6ca14,58cfa831e4b0c9d6adf6ca14,TCGA-D7-6822-10A-01D-1880_121220_SN1120_0207_BC1JALACXX_s_6_rg.sorted.filtered.,WGS,TCGA-D7-6822-10A-01D-1880_121220_SN1120_0207_BC1JALACXX_s_6_rg.sorted,TCGA-D7-6822-10A-01D-1880_121220_SN1120_0207_BC1JALACXX_s_6_rg.sorted.bam,413.3,1.9,0.15,58cfa831e4b0c9d6adf6ca14,TCGA-D7-6822-10A-01D-1880_121220_SN1120_0207_BC1JALACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6822-10A,E2AAABD9-F4BA-4763-A28A-C14D46A4BC5D,Blood Derived Normal,Illumina HiSeq,32163f63-f4dc-4d1a-bc93-3eff35bd1b5d,Stomach,77,B60B4A59-1064-4349-8942-375F7D0B4337,7D89EBA3-F7DE-43D9-A7BC-94FA4CEAEF67,TCGA-D7-6822-10A-01D-1880-02,HG19_Broad_variant,TCGA-D7-6822,TCGA-STAD,NA,s14710,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N0,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IB
13722.58cfa831e4b0c9d6adf6cb3a,58cfa831e4b0c9d6adf6cb3a,TCGA-EE-A2GR-06A-11D-A18Y_120726_SN590_0171_AD13PJACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EE-A2GR-06A-11D-A18Y_120726_SN590_0171_AD13PJACXX_s_1_rg.sorted,TCGA-EE-A2GR-06A-11D-A18Y_120726_SN590_0171_AD13PJACXX_s_1_rg.sorted.bam,61.93,NA,0.16,58cfa831e4b0c9d6adf6cb3a,TCGA-EE-A2GR-06A-11D-A18Y_120726_SN590_0171_AD13PJACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2GR-06A,919DFC28-6B55-452E-884C-48CB86802AC2,Metastatic,Illumina HiSeq,9dea8dd3-8434-45ef-8b9b-1e397b099652,Skin,78,4F644FC3-191C-4B19-9FFC-D5BE630CEC93,7A5A39D0-F2D6-4158-8ED4-C76E62657738,TCGA-EE-A2GR-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2GR,TCGA-SKCM,NA,s7852,Harvard Medical School,University of Sydney,Australia,NO,T4,N0,Not available,Stage II
13722.58cfa831e4b0c9d6adf6cc60,58cfa831e4b0c9d6adf6cc60,TCGA-EJ-5501-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EJ-5501-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_3_rg.sorted,TCGA-EJ-5501-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_3_rg.sorted.bam,153.7,1.9,0.16,58cfa831e4b0c9d6adf6cc60,TCGA-EJ-5501-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5501-01A,8DF0C1E8-966C-4F46-AD15-FAE9E745A32E,Primary Tumor,Illumina HiSeq,6e2cf9a5-b8c5-4f44-8800-c95ad84bc9a8,Prostate,55,A1E37A0A-67F5-4A19-A540-A45CB89C4203,759BD886-73F1-4DEF-A446-98DAAC2C5B88,TCGA-EJ-5501-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5501,TCGA-PRAD,NA,s3790,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cdaf,58cfa831e4b0c9d6adf6cdaf,TCGA-FE-A22Z-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FE-A22Z-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_3_rg.sorted,TCGA-FE-A22Z-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_3_rg.sorted.bam,78.59,2.03,0.16,58cfa831e4b0c9d6adf6cdaf,TCGA-FE-A22Z-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A22Z-01A,78D14F86-896A-4F98-9274-B2E8E387ADD9,Primary Tumor,Illumina HiSeq,ae24ab9d-6983-466a-a7f4-50da56438303,Thyroid,61,D206D300-E0CE-4A40-AF1F-45A685346A6E,B7A31BAC-FD92-47AF-8C9C-E78E3FC1609A,TCGA-FE-A22Z-01A-11D-A16N-02,HG19_Broad_variant,TCGA-FE-A22Z,TCGA-THCA,NA,s12648,Harvard Medical School,Ohio State University,United States,NO,T4a,N1,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage IVA
13722.58cfa832e4b0c9d6adf6d0f5,58cfa832e4b0c9d6adf6d0f5,TCGA-HC-7209-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-HC-7209-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_6_rg.sorted,TCGA-HC-7209-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_6_rg.sorted.bam,121.3,NA,0.15,58cfa832e4b0c9d6adf6d0f5,TCGA-HC-7209-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7209-01A,582D1177-73B0-4A9C-8505-70D6B402BD01,Primary Tumor,Illumina HiSeq,d228a749-988a-4fcb-9f15-e334295216fb,Prostate,60,AA7850AC-FB78-433B-8D55-A24C05935DB5,3C59E423-E1A6-4C67-8A88-63A0817B856E,TCGA-HC-7209-01A-11D-2111-02,HG19_Broad_variant,TCGA-HC-7209,TCGA-PRAD,NA,s3625,Harvard Medical School,International Genomics Consortium,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c92f,58cfa831e4b0c9d6adf6c92f,TCGA-CQ-6229-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CQ-6229-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_6_rg.sorted,TCGA-CQ-6229-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_6_rg.sorted.bam,57,NA,0.14,58cfa831e4b0c9d6adf6c92f,TCGA-CQ-6229-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-6229-10A,A091822C-447A-49A5-8C20-E329DF79599C,Blood Derived Normal,Illumina HiSeq,16ed6dc6-b3ef-4721-a79d-db228afd20c2,Head and Neck,61,6C33C6D3-A5B8-47D2-8A20-66A54E46E272,7CA9E363-A5A7-4458-8015-6A72FB563F79,TCGA-CQ-6229-10A-01D-1911-02,HG19_Broad_variant,TCGA-CQ-6229,TCGA-HNSC,NA,s16189,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c837,58cfa831e4b0c9d6adf6c837,TCGA-CV-7095-01A-21D-2317_120730_SN1222_0140_AC11GKACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CV-7095-01A-21D-2317_120730_SN1222_0140_AC11GKACXX_s_2_rg.sorted,TCGA-CV-7095-01A-21D-2317_120730_SN1222_0140_AC11GKACXX_s_2_rg.sorted.bam,90.73,NA,0.14,58cfa831e4b0c9d6adf6c837,TCGA-CV-7095-01A-21D-2317_120730_SN1222_0140_AC11GKACXX_s_2_rg.sorted.bam,Dead,FEMALE,Not available,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7095-01A,D7D49895-032F-4385-8B68-AE16F8675CA7,Primary Tumor,Illumina HiSeq,d944910b-a3cf-45e9-84be-5ea0e6cd6f03,Head and Neck,87,E7D35C82-8992-4CC0-AA65-DF5CAB5727EB,F85FA02B-0695-4F2E-957B-FF11F1E6FCE6,TCGA-CV-7095-01A-21D-2317-26,HG19_Broad_variant,TCGA-CV-7095,TCGA-HNSC,572,s16052,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c81c,58cfa831e4b0c9d6adf6c81c,TCGA-CV-6933-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CV-6933-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_7_rg.sorted,TCGA-CV-6933-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_7_rg.sorted.bam,34,1.9,0.16,58cfa831e4b0c9d6adf6c81c,TCGA-CV-6933-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_7_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6933-10A,2A749317-0156-4213-8482-B2C2D6E52E9B,Blood Derived Normal,Illumina HiSeq,983b388d-7527-45b1-bcc8-375b7f38e128,Head and Neck,53,6D7E5088-B49D-4182-90C2-79DF36F96E35,C74C03E1-2876-41E9-950D-6CB081DF559C,TCGA-CV-6933-10A-01D-1911-02,HG19_Broad_variant,TCGA-CV-6933,TCGA-HNSC,2741,s15899,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T3,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa832e4b0c9d6adf6d1bb,58cfa832e4b0c9d6adf6d1bb,TCGA-EJ-5509-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EJ-5509-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_3_rg.sorted,TCGA-EJ-5509-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_3_rg.sorted.bam,116.7,1.9,0.14,58cfa832e4b0c9d6adf6d1bb,TCGA-EJ-5509-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5509-01A,13CE70A8-785C-4B59-B073-41922CB201F9,Primary Tumor,Illumina HiSeq,6fd44a89-a20c-4ecc-bafe-54da9b58cd9d,Prostate,63,99A7115E-046B-488E-95D2-48C35BD29867,4F3831BE-6C1C-4786-B953-2612753C1E5C,TCGA-EJ-5509-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5509,TCGA-PRAD,NA,s3440,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c290,58cfa830e4b0c9d6adf6c290,TCGA-BR-4294-01A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BR-4294-01A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_2_rg.sorted,TCGA-BR-4294-01A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_2_rg.sorted.bam,42.9,1.9,0.14,58cfa830e4b0c9d6adf6c290,TCGA-BR-4294-01A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4294-01A,ACAB1362-C8A0-448B-8533-0CD84D97959C,Primary Tumor,Illumina HiSeq,23c036ca-ac6a-45dc-9100-558b2249f3bc,Stomach,65,CB5D3EDE-205D-43F6-A3E3-DB287FB1783B,97DB8928-FACC-4095-984F-07C52A759DB4,TCGA-BR-4294-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4294,TCGA-STAD,NA,s15374,Harvard Medical School,Asterand,Russia,NO,T2a,NX,Stomach  Intestinal Adenocarcinoma  Tubular Type,Not available
13722.58cfa831e4b0c9d6adf6c786,58cfa831e4b0c9d6adf6c786,TCGA-CV-5970-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CV-5970-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_8_rg.sorted,TCGA-CV-5970-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_8_rg.sorted.bam,4,1.8,0.15,58cfa831e4b0c9d6adf6c786,TCGA-CV-5970-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5970-10A,1F6167D9-C99D-4873-8D6E-E62A1C964135,Blood Derived Normal,Illumina HiSeq,509b8904-dfc6-4184-9e6c-1248a6280d9e,Head and Neck,59,156CC44B-397D-46D0-AF8C-2ECCF6F6CDC2,3222362E-0351-470B-82F3-EDEFBFA5B399,TCGA-CV-5970-10A-01D-1868-02,HG19_Broad_variant,TCGA-CV-5970,TCGA-HNSC,406,s16200,Harvard Medical School,MD Anderson Cancer Center,None,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6cfac,58cfa832e4b0c9d6adf6cfac,TCGA-GE-A2C6-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_5_rg.sorted.filtered.,WGS,TCGA-GE-A2C6-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_5_rg.sorted,TCGA-GE-A2C6-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_5_rg.sorted.bam,75.85,1.8,0.17,58cfa832e4b0c9d6adf6cfac,TCGA-GE-A2C6-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-GE-A2C6-01A,7DEEDEBA-F05B-453C-9DF1-EEB20B0EC72E,Primary Tumor,Illumina HiSeq,4920d08d-433e-4371-8daa-641819a1e53f,Thyroid,33,D717EECF-11DC-4E15-851A-9EA18332A48B,A5FA44A2-8101-4A0C-982C-57337853BACA,TCGA-GE-A2C6-01A-11D-A16N-02,HG19_Broad_variant,TCGA-GE-A2C6,TCGA-THCA,NA,s12123,Harvard Medical School,ABS - IUPUI,United States,NO,T2,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa830e4b0c9d6adf6bc60,58cfa830e4b0c9d6adf6bc60,TCGA-AP-A0LH-10A-01D-A043_120214_SN590_0138_AC0E8HACXX_s_2_rg.sorted.filtered.,WGS,TCGA-AP-A0LH-10A-01D-A043_120214_SN590_0138_AC0E8HACXX_s_2_rg.sorted,TCGA-AP-A0LH-10A-01D-A043_120214_SN590_0138_AC0E8HACXX_s_2_rg.sorted.bam,31.83,1.72,0.15,58cfa830e4b0c9d6adf6bc60,TCGA-AP-A0LH-10A-01D-A043_120214_SN590_0138_AC0E8HACXX_s_2_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LH-10A,7DCE4215-01F6-43E9-9378-9E22C26C23A2,Blood Derived Normal,Illumina HiSeq,265fdf19-e338-42d6-9032-162923c0a164,Uterus,60,6E5515FB-6252-4703-B7F4-B57E38121C5B,F7861538-BDB9-4C6B-820E-8184B2AA793F,TCGA-AP-A0LH-10A-01D-A043-02,HG19_Broad_variant,TCGA-AP-A0LH,TCGA-UCEC,1106,s4425,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Mixed serous and endometrioid,Not available
13722.58cfa832e4b0c9d6adf6d4e8,58cfa832e4b0c9d6adf6d4e8,TCGA-V4-A9EM-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_2_rg.sorted.filtered.,WGS,TCGA-V4-A9EM-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_2_rg.sorted,TCGA-V4-A9EM-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_2_rg.sorted.bam,14.19,NA,0.16,58cfa832e4b0c9d6adf6d4e8,TCGA-V4-A9EM-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EM-10A,711EB720-4CB7-48DE-9350-5C729BF9F0DA,Blood Derived Normal,Illumina HiSeq,df7c3143-4237-4983-960d-157f97ded09a,Eye,53,6BF447C9-1339-47CD-B047-A6CD9CB1C6CE,431CE2C0-57E8-4B1C-B5D2-3A8EA49A3D51,TCGA-V4-A9EM-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9EM,TCGA-UVM,NA,s221,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa82ee4b0c9d6adf6aefb,58cfa82ee4b0c9d6adf6aefb,TCGA-05-4415-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_6_rg.sorted.filtered.,WGS,TCGA-05-4415-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_6_rg.sorted,TCGA-05-4415-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_6_rg.sorted.bam,48,1.8,0.14,58cfa82ee4b0c9d6adf6aefb,TCGA-05-4415-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_6_rg.sorted.bam,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4415-10A,D15B7B29-C5C5-41D8-B83B-7CC12FE92820,Blood Derived Normal,Illumina HiSeq,57cfe098-8cf8-4aab-ba84-1d57f4617af9,Lung,57,DD13F373-F9B3-4263-8E0C-C925B2AE5FD1,6D2948A0-4BB5-4959-971B-B98B8944FB0A,TCGA-05-4415-10A-01D-1853-02,HG19_Broad_variant,TCGA-05-4415,TCGA-LUAD,91,s10771,Harvard Medical School,Indivumed,Germany,NO,T4,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIB
13722.58cfa832e4b0c9d6adf6cf0e,58cfa832e4b0c9d6adf6cf0e,TCGA-FS-A1Z3-06A-11D-A18Y_120711_SN208_0414_BD13L5ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-FS-A1Z3-06A-11D-A18Y_120711_SN208_0414_BD13L5ACXX_s_7_rg.sorted,TCGA-FS-A1Z3-06A-11D-A18Y_120711_SN208_0414_BD13L5ACXX_s_7_rg.sorted.bam,43.25,NA,0.17,58cfa832e4b0c9d6adf6cf0e,TCGA-FS-A1Z3-06A-11D-A18Y_120711_SN208_0414_BD13L5ACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1Z3-06A,29BCB876-5A91-4D56-AF47-7B4C856C151F,Metastatic,Illumina HiSeq,c18e2956-90d4-4a37-8841-e3b090936c2c,Skin,72,851FA9C8-97E5-40EE-8F48-7121F273AADE,9EAE9C8D-45FA-4A49-8F70-1AB43E6598F9,TCGA-FS-A1Z3-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1Z3,TCGA-SKCM,636,s7524,Harvard Medical School,Essen,Germany,NO,TX,N0,Not available,Stage IV
13722.58cfa831e4b0c9d6adf6cb7a,58cfa831e4b0c9d6adf6cb7a,TCGA-EJ-7317-10A-01D-2111_130422_SN590_0225_BD23TLACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EJ-7317-10A-01D-2111_130422_SN590_0225_BD23TLACXX_s_7_rg.sorted,TCGA-EJ-7317-10A-01D-2111_130422_SN590_0225_BD23TLACXX_s_7_rg.sorted.bam,293.6,NA,0.15,58cfa831e4b0c9d6adf6cb7a,TCGA-EJ-7317-10A-01D-2111_130422_SN590_0225_BD23TLACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7317-10A,68FC3693-0910-4EE8-8997-99C6333B65F4,Blood Derived Normal,Illumina HiSeq,15df0c4b-18fc-47ff-a394-3f998afafcbc,Prostate,71,251761C0-C419-4B44-973E-1D2BB89D26E2,DACE52C7-8DFA-4706-9E3C-A1141CC4E68B,TCGA-EJ-7317-10A-01D-2111-02,HG19_Broad_variant,TCGA-EJ-7317,TCGA-PRAD,NA,s3441,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bdd6,58cfa830e4b0c9d6adf6bdd6,TCGA-BG-A0MC-01A-21D-A043_120530_SN1222_0110_AC0VLAACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BG-A0MC-01A-21D-A043_120530_SN1222_0110_AC0VLAACXX_s_1_rg.sorted,TCGA-BG-A0MC-01A-21D-A043_120530_SN1222_0110_AC0VLAACXX_s_1_rg.sorted.bam,84.24,2.08,0.16,58cfa830e4b0c9d6adf6bdd6,TCGA-BG-A0MC-01A-21D-A043_120530_SN1222_0110_AC0VLAACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0MC-01A,884FD57D-BD8E-40E7-82F6-0BA1C71101A9,Primary Tumor,Illumina HiSeq,db9c9c51-2c42-4a56-a87d-9c01038c4e6f,Uterus,74,46B48BF8-346B-4F25-916E-26A3CDDFA00D,9376C8CD-BD9D-4576-BBE3-7D771914AFA3,TCGA-BG-A0MC-01A-21D-A043-02,HG19_Broad_variant,TCGA-BG-A0MC,TCGA-UCEC,NA,s4601,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bd86,58cfa830e4b0c9d6adf6bd86,TCGA-BG-A0LX-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BG-A0LX-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_7_rg.sorted,TCGA-BG-A0LX-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_7_rg.sorted.bam,65.42,2.11,0.15,58cfa830e4b0c9d6adf6bd86,TCGA-BG-A0LX-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0LX-01A,AC1D3946-FE6C-4BD8-B02C-638799CB0F67,Primary Tumor,Illumina HiSeq,182220ca-d437-40a2-adeb-d4cb1ce2f284,Uterus,57,99CDF3A0-90DC-4992-B75A-11DD41928D43,B294F25A-93D9-49A6-8FD3-6D2B0BBEF27C,TCGA-BG-A0LX-01A-11D-A043-02,HG19_Broad_variant,TCGA-BG-A0LX,TCGA-UCEC,NA,s5218,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6cb36,58cfa831e4b0c9d6adf6cb36,TCGA-EE-A2GP-06A-11D-A18Y_120726_SN590_0171_AD13PJACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EE-A2GP-06A-11D-A18Y_120726_SN590_0171_AD13PJACXX_s_2_rg.sorted,TCGA-EE-A2GP-06A-11D-A18Y_120726_SN590_0171_AD13PJACXX_s_2_rg.sorted.bam,43.01,NA,0.15,58cfa831e4b0c9d6adf6cb36,TCGA-EE-A2GP-06A-11D-A18Y_120726_SN590_0171_AD13PJACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2GP-06A,06F09D1C-BA44-4CF9-A518-762D241A30DB,Metastatic,Illumina HiSeq,8b518870-b998-4d74-b43e-91c419614660,Skin,80,8F45D68C-D4D7-426D-87C4-03A74FADBEBB,D23C89BB-28C1-4320-9C82-B990849035E8,TCGA-EE-A2GP-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2GP,TCGA-SKCM,423,s7855,Harvard Medical School,University of Sydney,Australia,NO,T4b,N1a,Not available,Stage IIIB
13722.58cfa830e4b0c9d6adf6c034,58cfa830e4b0c9d6adf6c034,TCGA-BR-6852-10A-01D-1880_130115_SN590_0207_AC1H8PACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BR-6852-10A-01D-1880_130115_SN590_0207_AC1H8PACXX_s_8_rg.sorted,TCGA-BR-6852-10A-01D-1880_130115_SN590_0207_AC1H8PACXX_s_8_rg.sorted.bam,312,1.8,0.16,58cfa830e4b0c9d6adf6c034,TCGA-BR-6852-10A-01D-1880_130115_SN590_0207_AC1H8PACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6852-10A,44799C67-61CD-4F3E-BDBC-423E2E0FD2E8,Blood Derived Normal,Illumina HiSeq,9f843373-3bfd-4a53-ba12-0a753b47d24d,Stomach,64,D97976AE-20EB-499F-ADAB-07CB854F1111,21A1C386-3D1A-40F2-854F-6BAF92BCB3AC,TCGA-BR-6852-10A-01D-1880-02,HG19_Broad_variant,TCGA-BR-6852,TCGA-STAD,NA,s15108,Harvard Medical School,Asterand,Ukraine,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA
13722.58cfa831e4b0c9d6adf6c350,58cfa831e4b0c9d6adf6c350,TCGA-CG-5717-01A-11D-1598_121029_SN208_0438_AC18NJACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CG-5717-01A-11D-1598_121029_SN208_0438_AC18NJACXX_s_5_rg.sorted,TCGA-CG-5717-01A-11D-1598_121029_SN208_0438_AC18NJACXX_s_5_rg.sorted.bam,152,1.9,0.15,58cfa831e4b0c9d6adf6c350,TCGA-CG-5717-01A-11D-1598_121029_SN208_0438_AC18NJACXX_s_5_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5717-01A,BDC3899E-15AE-421F-829B-0E07FBD27C60,Primary Tumor,Illumina HiSeq,34ec4e75-2398-4904-adf0-34500892e1a5,Stomach,58,CEA37BBD-1BCC-4205-BE3D-DAFAC2E30256,64826993-D765-4895-BE39-BE5ECC72807B,TCGA-CG-5717-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5717,TCGA-STAD,212,s14488,Harvard Medical School,Indivumed,Germany,NO,T2b,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa830e4b0c9d6adf6c2d6,58cfa830e4b0c9d6adf6c2d6,TCGA-BR-6707-01A-11D-1880_121220_SN1222_0163_AC1HA2ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BR-6707-01A-11D-1880_121220_SN1222_0163_AC1HA2ACXX_s_7_rg.sorted,TCGA-BR-6707-01A-11D-1880_121220_SN1222_0163_AC1HA2ACXX_s_7_rg.sorted.bam,333.7,1.9,0.15,58cfa830e4b0c9d6adf6c2d6,TCGA-BR-6707-01A-11D-1880_121220_SN1222_0163_AC1HA2ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6707-01A,DF3DF249-86C2-43D4-ABE1-796CD7DF653F,Primary Tumor,Illumina HiSeq,e2babdbd-1849-48ed-8726-1e3788be6064,Stomach,75,36F691AA-B737-4369-AD62-84F987F697A6,AA430360-2BE7-4C92-A10C-52588D8A6061,TCGA-BR-6707-01A-11D-1880-02,HG19_Broad_variant,TCGA-BR-6707,TCGA-STAD,NA,s14890,Harvard Medical School,Asterand,Ukraine,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA
13722.58cfa831e4b0c9d6adf6c3c4,58cfa831e4b0c9d6adf6c3c4,TCGA-BT-A20O-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_3_rg.sorted.filtered.,WGS,TCGA-BT-A20O-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_3_rg.sorted,TCGA-BT-A20O-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_3_rg.sorted.bam,63.78,1.88,0.16,58cfa831e4b0c9d6adf6c3c4,TCGA-BT-A20O-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20O-01A,C0E7FBE7-B9CB-4E65-941B-CD7D581C54EC,Primary Tumor,Illumina HiSeq,c345a912-f3c8-4622-9793-88cf795fc964,Bladder,75,5ECD84AD-44FD-4599-BF3D-AB725E0404EC,13596E86-7CD8-4A07-941F-E936D0004F6B,TCGA-BT-A20O-01A-21D-A14U-02,HG19_Broad_variant,TCGA-BT-A20O,TCGA-BLCA,370,s3090,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6cff2,58cfa832e4b0c9d6adf6cff2,TCGA-GC-A3I6-10A-01D-A210_120912_SN1222_0149_BD1CW3ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-GC-A3I6-10A-01D-A210_120912_SN1222_0149_BD1CW3ACXX_s_6_rg.sorted,TCGA-GC-A3I6-10A-01D-A210_120912_SN1222_0149_BD1CW3ACXX_s_6_rg.sorted.bam,10.57,NA,0.14,58cfa832e4b0c9d6adf6cff2,TCGA-GC-A3I6-10A-01D-A210_120912_SN1222_0149_BD1CW3ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GC-A3I6-10A,74CBB078-9AAE-422A-A7AF-DD29EBCA949E,Blood Derived Normal,Illumina HiSeq,792b4366-c23e-4272-8b38-4ac0acc9ddf8,Bladder,45,8344BA96-586C-43C8-85CD-EBC951243777,408AFEA4-C7A4-478B-848C-B3670739D12A,TCGA-GC-A3I6-10A-01D-A210-26,HG19_Broad_variant,TCGA-GC-A3I6,TCGA-BLCA,NA,s2734,MD Anderson - Institute for Applied Cancer Science,International Genomics Consortium,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa830e4b0c9d6adf6c2ba,58cfa830e4b0c9d6adf6c2ba,TCGA-CE-A27D-10A-01D-A16N_120805_SN208_0422_BD16VPACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CE-A27D-10A-01D-A16N_120805_SN208_0422_BD16VPACXX_s_2_rg.sorted,TCGA-CE-A27D-10A-01D-A16N_120805_SN208_0422_BD16VPACXX_s_2_rg.sorted.bam,138.72,1.98,0.16,58cfa830e4b0c9d6adf6c2ba,TCGA-CE-A27D-10A-01D-A16N_120805_SN208_0422_BD16VPACXX_s_2_rg.sorted.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-CE-A27D-10A,75A93F0E-CD41-43C6-A303-FF37E31395E9,Blood Derived Normal,Illumina HiSeq,3bef8106-13f9-47e1-b775-aed6791c0d10,Thyroid,28,C850C70D-E86D-4F21-A6C3-62976A48033E,515713BB-0323-40A3-B2F0-52CA03F6860E,TCGA-CE-A27D-10A-01D-A16N-02,HG19_Broad_variant,TCGA-CE-A27D,TCGA-THCA,NA,s12510,Harvard Medical School,ILSbio,Vietnam,NO,T2,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c3ea,58cfa831e4b0c9d6adf6c3ea,TCGA-CH-5745-10A-01D-1572_130104_SN1120_0209_BD1KP6ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CH-5745-10A-01D-1572_130104_SN1120_0209_BD1KP6ACXX_s_8_rg.sorted,TCGA-CH-5745-10A-01D-1572_130104_SN1120_0209_BD1KP6ACXX_s_8_rg.sorted.bam,128.4,1.9,0.15,58cfa831e4b0c9d6adf6c3ea,TCGA-CH-5745-10A-01D-1572_130104_SN1120_0209_BD1KP6ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5745-10A,AC67D0DF-7DC0-4A1A-8B47-BEEC9B94DE86,Blood Derived Normal,Illumina HiSeq,9ea9f797-df7f-4211-af54-30bb1c25941b,Prostate,68,690A7FAC-91CD-45C5-8DB7-69D7B9D1DBBF,D2F85EE6-E96F-42E5-86E4-2933E646D193,TCGA-CH-5745-10A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5745,TCGA-PRAD,NA,s3929,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c752,58cfa831e4b0c9d6adf6c752,TCGA-CV-6939-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CV-6939-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_1_rg.sorted,TCGA-CV-6939-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_1_rg.sorted.bam,193.7,1.9,0.14,58cfa831e4b0c9d6adf6c752,TCGA-CV-6939-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,Not available,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6939-01A,E7D1F0DD-EEC0-4670-A2BA-00FFE38C6382,Primary Tumor,Illumina HiSeq,28dc7c63-6d80-4648-a356-07e8f846bc80,Head and Neck,60,1ED822F5-FEA5-46DE-9681-EC484DE734D8,8BB4510A-C148-4A9E-8ECF-6F8C8E9309CA,TCGA-CV-6939-01A-11D-1911-02,HG19_Broad_variant,TCGA-CV-6939,TCGA-HNSC,666,s15515,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6bec7,58cfa830e4b0c9d6adf6bec7,TCGA-AP-A0LJ-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-AP-A0LJ-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_7_rg.sorted,TCGA-AP-A0LJ-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_7_rg.sorted.bam,83.32,2.09,0.15,58cfa830e4b0c9d6adf6bec7,TCGA-AP-A0LJ-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LJ-01A,B4A520AE-F259-48C8-823E-C10B9B8A133A,Primary Tumor,Illumina HiSeq,c3705d55-9194-4d83-9162-41aae551e016,Uterus,42,BE3ED392-4D9F-4EAF-8A56-D251846DF4DA,2A88E054-E64F-4C5F-97F0-53F95D64FC04,TCGA-AP-A0LJ-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A0LJ,TCGA-UCEC,NA,s4996,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d490,58cfa832e4b0c9d6adf6d490,TCGA-VD-AA8M-01A-11D-A40D_140807_SN1440_0194_AC5B5RACXX_s_1_rg.sorted.filtered.,WGS,TCGA-VD-AA8M-01A-11D-A40D_140807_SN1440_0194_AC5B5RACXX_s_1_rg.sorted,TCGA-VD-AA8M-01A-11D-A40D_140807_SN1440_0194_AC5B5RACXX_s_1_rg.sorted.bam,57.94,NA,0.15,58cfa832e4b0c9d6adf6d490,TCGA-VD-AA8M-01A-11D-A40D_140807_SN1440_0194_AC5B5RACXX_s_1_rg.sorted.bam,Alive,MALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-AA8M-01A,9DC5CC23-C903-4FE2-8354-64F8316FF0D4,Primary Tumor,Illumina HiSeq,4a38e73e-520a-4721-a89a-7a2b3b334ee6,Eye,64,DDC9047A-FD34-4874-87B0-72DAB50311E6,ABFED748-0BF8-4E64-8AB1-2A4DA1BB5A62,TCGA-VD-AA8M-01A-11D-A40D-26,HG19_Broad_variant,TCGA-VD-AA8M,TCGA-UVM,NA,s271,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T2a,N0,Not available,Stage IIA
13722.58cfa832e4b0c9d6adf6ce9c,58cfa832e4b0c9d6adf6ce9c,TCGA-FD-A3B7-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_5_rg.sorted.filtered.,WGS,TCGA-FD-A3B7-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_5_rg.sorted,TCGA-FD-A3B7-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_5_rg.sorted.bam,28.25,NA,0.16,58cfa832e4b0c9d6adf6ce9c,TCGA-FD-A3B7-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_5_rg.sorted.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3B7-01A,EF5DD4B3-B77A-444A-B5B0-C999A5A3D129,Primary Tumor,Illumina HiSeq,4a37fdf6-816c-46ca-b703-cf3d58b32149,Bladder,66,A307CA46-3A09-4F0C-84AB-9A9E8954DE38,6014D6A8-5495-4D71-AB6E-622E3E6C4DC6,TCGA-FD-A3B7-01A-31D-A210-26,HG19_Broad_variant,TCGA-FD-A3B7,TCGA-BLCA,122,s2901,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c564,58cfa831e4b0c9d6adf6c564,TCGA-CH-5752-10A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CH-5752-10A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_2_rg.sorted,TCGA-CH-5752-10A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_2_rg.sorted.bam,79.4,1.9,0.14,58cfa831e4b0c9d6adf6c564,TCGA-CH-5752-10A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5752-10A,D8F56D75-51AB-4A86-A502-C86E1DCD1EFF,Blood Derived Normal,Illumina HiSeq,78b4b6a6-b8b1-4499-8d0d-6f183072b505,Prostate,66,29DDF3D3-369B-4340-9B4F-338C23BE538A,5568CB77-E553-43F6-A320-3BF96A3E88B2,TCGA-CH-5752-10A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5752,TCGA-PRAD,NA,s3423,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c1f2,58cfa830e4b0c9d6adf6c1f2,TCGA-BT-A20N-01A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BT-A20N-01A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_1_rg.sorted,TCGA-BT-A20N-01A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_1_rg.sorted.bam,70.31,1.91,0.17,58cfa830e4b0c9d6adf6c1f2,TCGA-BT-A20N-01A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_1_rg.sorted.bam,Dead,MALE,Not available,Not available,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20N-01A,EBEDAB7C-DD7C-448E-8324-78C86F13BE8B,Primary Tumor,Illumina HiSeq,c7de2a6f-d24f-4be6-98af-307070063116,Bladder,72,89EC2DFD-7A0C-4631-958D-D5492BC89F8D,CE801D11-240F-4510-8010-E3D7DA8247FC,TCGA-BT-A20N-01A-11D-A14U-02,HG19_Broad_variant,TCGA-BT-A20N,TCGA-BLCA,795,s2697,Harvard Medical School,University of Pittsburgh,None,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6cd2c,58cfa831e4b0c9d6adf6cd2c,TCGA-EJ-5495-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EJ-5495-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_1_rg.sorted,TCGA-EJ-5495-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_1_rg.sorted.bam,176.7,1.9,0.15,58cfa831e4b0c9d6adf6cd2c,TCGA-EJ-5495-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5495-01A,962DD3D5-8501-4658-8CB9-2424B476124C,Primary Tumor,Illumina HiSeq,a2c14576-771c-460f-a71b-e25651274ca1,Prostate,68,8E53414F-455E-4665-AE0E-9E7405262A96,5644F0E3-3A3B-411A-B28D-C93C3BBD8F86,TCGA-EJ-5495-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5495,TCGA-PRAD,NA,s3597,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d102,58cfa832e4b0c9d6adf6d102,TCGA-HC-7231-10A-01D-2111_130517_SN590_0231_BC24V6ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-HC-7231-10A-01D-2111_130517_SN590_0231_BC24V6ACXX_s_3_rg.sorted,TCGA-HC-7231-10A-01D-2111_130517_SN590_0231_BC24V6ACXX_s_3_rg.sorted.bam,180.6,NA,0.14,58cfa832e4b0c9d6adf6d102,TCGA-HC-7231-10A-01D-2111_130517_SN590_0231_BC24V6ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,Not available,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7231-10A,B182BDA9-3D9F-4958-96EB-BD6CC441830C,Blood Derived Normal,Illumina HiSeq,9ad2873c-4fe1-4a32-9c57-921c2e4c87d2,Prostate,66,29687E3D-5220-42C8-BD92-7D0A85DB6B18,6AAE755F-02B5-4717-97B5-AF8937ACC4E7,TCGA-HC-7231-10A-01D-2111-02,HG19_Broad_variant,TCGA-HC-7231,TCGA-PRAD,NA,s3630,Harvard Medical School,International Genomics Consortium,United States,NO,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6ccbc,58cfa831e4b0c9d6adf6ccbc,TCGA-EJ-7328-10A-01D-2111_130502_SN590_0228_AD24A9ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EJ-7328-10A-01D-2111_130502_SN590_0228_AD24A9ACXX_s_3_rg.sorted,TCGA-EJ-7328-10A-01D-2111_130502_SN590_0228_AD24A9ACXX_s_3_rg.sorted.bam,211.6,NA,0.15,58cfa831e4b0c9d6adf6ccbc,TCGA-EJ-7328-10A-01D-2111_130502_SN590_0228_AD24A9ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7328-10A,42B7D14F-09E5-4D91-BB98-5FE35907A6A9,Blood Derived Normal,Illumina HiSeq,ad1bcbc2-4111-46be-aa25-6f8222612d52,Prostate,70,562FB2D5-34A4-4AB3-A7C2-7FF5EDCAB189,C8679C7C-C1C9-4A07-A82B-AF7F768223E6,TCGA-EJ-7328-10A-01D-2111-02,HG19_Broad_variant,TCGA-EJ-7328,TCGA-PRAD,NA,s3444,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c636,58cfa831e4b0c9d6adf6c636,TCGA-CG-4441-10A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CG-4441-10A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_2_rg.sorted,TCGA-CG-4441-10A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_2_rg.sorted.bam,30,1.9,0.15,58cfa831e4b0c9d6adf6c636,TCGA-CG-4441-10A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_2_rg.sorted.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4441-10A,37E22429-EFD7-4D6A-B79A-9D8C7BE2170C,Blood Derived Normal,Illumina HiSeq,a450bc30-69de-4e0a-a561-2145c316b5f1,Stomach,83,869BA8D0-89C5-4753-8F7A-403EA5A7F20F,9F2622C7-461C-419B-B0F3-2AAAE488592C,TCGA-CG-4441-10A-01D-1798-02,HG19_Broad_variant,TCGA-CG-4441,TCGA-STAD,426,s15395,Harvard Medical School,Indivumed,Germany,NO,T2,N2,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6cd8c,58cfa831e4b0c9d6adf6cd8c,TCGA-EJ-7781-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-EJ-7781-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_6_rg.sorted,TCGA-EJ-7781-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_6_rg.sorted.bam,168.3,NA,0.16,58cfa831e4b0c9d6adf6cd8c,TCGA-EJ-7781-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7781-01A,33283111-9A2F-4D5E-92A5-3435846404F7,Primary Tumor,Illumina HiSeq,bf6c4719-7b88-4975-9591-8bd34c19e3cf,Prostate,65,B5504343-6915-4D15-A81E-641B03C77F24,193083B4-B2E1-486C-A4F5-F62818AEBBC2,TCGA-EJ-7781-01A-11D-2111-02,HG19_Broad_variant,TCGA-EJ-7781,TCGA-PRAD,NA,s4141,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bd8a,58cfa830e4b0c9d6adf6bd8a,TCGA-BG-A0LW-10A-01D-A043_120214_SN590_0138_AC0E8HACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BG-A0LW-10A-01D-A043_120214_SN590_0138_AC0E8HACXX_s_6_rg.sorted,TCGA-BG-A0LW-10A-01D-A043_120214_SN590_0138_AC0E8HACXX_s_6_rg.sorted.bam,13,2.1,0.13,58cfa830e4b0c9d6adf6bd8a,TCGA-BG-A0LW-10A-01D-A043_120214_SN590_0138_AC0E8HACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A0LW-10A,68181BC9-AA8B-44EC-8601-564B30EA0561,Blood Derived Normal,Illumina HiSeq,1eb12505-9633-4851-9fc4-409b41c55970,Uterus,47,ADDF5D6E-5C42-400B-98BC-B44E48336953,D883C522-CED2-4540-9B2C-A3A6C56EDD25,TCGA-BG-A0LW-10A-01D-A043-02,HG19_Broad_variant,TCGA-BG-A0LW,TCGA-UCEC,NA,s4431,Harvard Medical School,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d47a,58cfa832e4b0c9d6adf6d47a,TCGA-V4-A9EU-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_6_rg.sorted.filtered.,WGS,TCGA-V4-A9EU-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_6_rg.sorted,TCGA-V4-A9EU-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_6_rg.sorted.bam,12.25,NA,0.16,58cfa832e4b0c9d6adf6d47a,TCGA-V4-A9EU-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EU-10A,DF685F8C-645A-47AE-A471-63BF1973A0AE,Blood Derived Normal,Illumina HiSeq,3b7b29f5-9121-460f-b3de-49f14373e68e,Eye,83,BB227A1D-921F-4435-8119-81D4F83D28F9,480331C2-14DC-4011-869F-76A13C693F75,TCGA-V4-A9EU-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9EU,TCGA-UVM,NA,s214,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4d,N0,Not available,Stage IIIC
13722.58cfa831e4b0c9d6adf6c69e,58cfa831e4b0c9d6adf6c69e,TCGA-CQ-6220-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CQ-6220-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_5_rg.sorted,TCGA-CQ-6220-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_5_rg.sorted.bam,93,NA,0.14,58cfa831e4b0c9d6adf6c69e,TCGA-CQ-6220-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-6220-10A,96D0CEFE-7949-4736-A7DC-1E4FA94765EC,Blood Derived Normal,Illumina HiSeq,7a4c76f2-7fac-4e3d-8651-0c74feb12abb,Head and Neck,69,67AD295F-426F-4761-90C3-448623D8EF37,59E0535C-BC9C-4584-A559-331C216EF4C9,TCGA-CQ-6220-10A-01D-1911-02,HG19_Broad_variant,TCGA-CQ-6220,TCGA-HNSC,985,s15771,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6cd58,58cfa831e4b0c9d6adf6cd58,TCGA-EJ-5496-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EJ-5496-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_4_rg.sorted,TCGA-EJ-5496-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_4_rg.sorted.bam,1010.4,1.9,0.16,58cfa831e4b0c9d6adf6cd58,TCGA-EJ-5496-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5496-10A,6755C231-355F-4CC3-85F1-6306C7F5D44B,Blood Derived Normal,Illumina HiSeq,e93a13bd-c687-4275-9c7e-75b9b3c024b2,Prostate,59,276AE44F-7531-45B9-9372-5BBCC90B7CF6,7C73B237-4177-4966-8481-81ECC4ECDB61,TCGA-EJ-5496-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5496,TCGA-PRAD,NA,s3788,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c665,58cfa831e4b0c9d6adf6c665,TCGA-CQ-6225-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CQ-6225-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_5_rg.sorted,TCGA-CQ-6225-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_5_rg.sorted.bam,38,NA,0.14,58cfa831e4b0c9d6adf6c665,TCGA-CQ-6225-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-6225-10A,90F44998-3C05-44B2-9501-BBD0F43C5147,Blood Derived Normal,Illumina HiSeq,82431af8-972a-4db7-b424-bac44c375bc2,Head and Neck,65,D30CD5CB-D0DE-446A-8A57-4F8B69AB25FE,7F65174A-1AB8-492D-91B6-0C39F14243AF,TCGA-CQ-6225-10A-01D-1911-02,HG19_Broad_variant,TCGA-CQ-6225,TCGA-HNSC,403,s16326,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6c7dc,58cfa831e4b0c9d6adf6c7dc,TCGA-D1-A16E-10A-01D-A12F_120523_SN1222_0109_BD12MPACXX_s_7_rg.sorted.filtered.,WGS,TCGA-D1-A16E-10A-01D-A12F_120523_SN1222_0109_BD12MPACXX_s_7_rg.sorted,TCGA-D1-A16E-10A-01D-A12F_120523_SN1222_0109_BD12MPACXX_s_7_rg.sorted.bam,11.86,2,0.15,58cfa831e4b0c9d6adf6c7dc,TCGA-D1-A16E-10A-01D-A12F_120523_SN1222_0109_BD12MPACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A16E-10A,E70465F6-1922-4EB7-B646-8B01AD3CE77B,Blood Derived Normal,Illumina HiSeq,8acc5ebb-d186-4dee-8bf1-22525966499f,Uterus,73,F4A2823E-A694-4036-88DC-8C27F7854DB4,43CE6A12-A5CA-479C-B1F8-7955BFCFFB4C,TCGA-D1-A16E-10A-01D-A12F-02,HG19_Broad_variant,TCGA-D1-A16E,TCGA-UCEC,NA,s4440,Harvard Medical School,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c492,58cfa831e4b0c9d6adf6c492,TCGA-CD-5813-10A-01D-1598_121026_SN1120_0198_BC188JACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CD-5813-10A-01D-1598_121026_SN1120_0198_BC188JACXX_s_6_rg.sorted,TCGA-CD-5813-10A-01D-1598_121026_SN1120_0198_BC188JACXX_s_6_rg.sorted.bam,125.7,1.9,0.14,58cfa831e4b0c9d6adf6c492,TCGA-CD-5813-10A-01D-1598_121026_SN1120_0198_BC188JACXX_s_6_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-5813-10A,152B9D8A-19FD-4665-B9E4-4FEDFB1608CD,Blood Derived Normal,Illumina HiSeq,7cbca34e-4195-452d-84af-5ae9596c63af,Stomach,60,BDD59D7A-02EC-49A5-B797-5AC689AA00A5,021DAB66-2CCD-46F4-A889-C7B4D423453E,TCGA-CD-5813-10A-01D-1598-02,HG19_Broad_variant,TCGA-CD-5813,TCGA-STAD,NA,s15319,Harvard Medical School,ILSbio,Vietnam,NO,T3,N0,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage II
13722.58cfa832e4b0c9d6adf6d4bc,58cfa832e4b0c9d6adf6d4bc,TCGA-V4-A9EL-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_1_rg.sorted.filtered.,WGS,TCGA-V4-A9EL-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_1_rg.sorted,TCGA-V4-A9EL-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_1_rg.sorted.bam,15.27,NA,0.16,58cfa832e4b0c9d6adf6d4bc,TCGA-V4-A9EL-10A-01D-A40E_140808_SN590_0254_BC49WNACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Aligned reads,TCGA-V4-A9EL-10A,8DE236F1-C029-44DF-A2A9-319145488BAA,Blood Derived Normal,Illumina HiSeq,202da79d-2064-434a-97c8-e68627064341,Eye,60,11398D15-36C2-46AB-AEA5-288602F19A13,8F6B5477-E2DB-4AD5-A8C3-B84D1CCE03DE,TCGA-V4-A9EL-10A-01D-A40E-26,HG19_Broad_variant,TCGA-V4-A9EL,TCGA-UVM,NA,s231,MD Anderson - Institute for Applied Cancer Science,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA
13722.58cfa830e4b0c9d6adf6c1f8,58cfa830e4b0c9d6adf6c1f8,TCGA-BT-A20T-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BT-A20T-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_8_rg.sorted,TCGA-BT-A20T-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_8_rg.sorted.bam,10.21,1.76,0.18,58cfa830e4b0c9d6adf6c1f8,TCGA-BT-A20T-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20T-11A,096B4F32-10C1-4737-A0DD-CAE04C54EE33,Solid Tissue Normal,Illumina HiSeq,7205e655-2448-4a14-8a14-2a8a6a97c6ee,Bladder,63,27461A27-26EB-4C2C-9C54-E16FBD32C615,FF148CF3-AFB7-42F1-A137-AD7D6CB889C1,TCGA-BT-A20T-11A-11D-A14U-02,HG19_Broad_variant,TCGA-BT-A20T,TCGA-BLCA,453,s2870,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c67c,58cfa831e4b0c9d6adf6c67c,TCGA-CN-4739-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CN-4739-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_8_rg.sorted,TCGA-CN-4739-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_8_rg.sorted.bam,187.7,1.9,0.14,58cfa831e4b0c9d6adf6c67c,TCGA-CN-4739-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4739-01A,7E3B90C1-8772-4E12-8050-A156558BEB82,Primary Tumor,Illumina HiSeq,796943be-2aa7-419f-801f-22c78459cc72,Head and Neck,71,F450DBE6-4972-4C49-AF97-963BCD0D0DA0,3B0BED92-ED76-451D-B605-A79FAE296DDE,TCGA-CN-4739-01A-02D-1509-02,HG19_Broad_variant,TCGA-CN-4739,TCGA-HNSC,NA,s15888,Harvard Medical School,University of Pittsburgh,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6cbc3,58cfa831e4b0c9d6adf6cbc3,TCGA-EJ-7331-10A-01D-2111_130502_SN590_0228_AD24A9ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EJ-7331-10A-01D-2111_130502_SN590_0228_AD24A9ACXX_s_5_rg.sorted,TCGA-EJ-7331-10A-01D-2111_130502_SN590_0228_AD24A9ACXX_s_5_rg.sorted.bam,268.6,NA,0.16,58cfa831e4b0c9d6adf6cbc3,TCGA-EJ-7331-10A-01D-2111_130502_SN590_0228_AD24A9ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7331-10A,B424B73A-2DFA-473F-AB56-AB382CD1CDEF,Blood Derived Normal,Illumina HiSeq,e78549aa-ba12-42c0-b788-639fb85774a8,Prostate,64,219983F4-DA82-4EA0-B9A0-257988E6C0F7,738A7AAD-026B-46B0-B10D-D1899AE297C1,TCGA-EJ-7331-10A-01D-2111-02,HG19_Broad_variant,TCGA-EJ-7331,TCGA-PRAD,NA,s3609,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c305,58cfa830e4b0c9d6adf6c305,TCGA-BR-6802-10A-01D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BR-6802-10A-01D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_8_rg.sorted,TCGA-BR-6802-10A-01D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_8_rg.sorted.bam,249,1.9,0.15,58cfa830e4b0c9d6adf6c305,TCGA-BR-6802-10A-01D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6802-10A,7C831A1D-3253-4AF4-A0FF-7FE9FF9AF1CE,Blood Derived Normal,Illumina HiSeq,2c69e92d-3297-4add-a687-68ad89040c66,Stomach,65,4FD5B38F-5857-4E1F-86DE-BD44D1D80207,DEA0515B-71BD-4B14-9666-446C1E128F8B,TCGA-BR-6802-10A-01D-1880-02,HG19_Broad_variant,TCGA-BR-6802,TCGA-STAD,NA,s15238,Harvard Medical School,Asterand,Russia,NO,T3,N2,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6cc8d,58cfa831e4b0c9d6adf6cc8d,TCGA-ER-A19D-10A-01D-A190_120723_SN1120_0177_AC11GTACXX_s_7_rg.sorted.filtered.,WGS,TCGA-ER-A19D-10A-01D-A190_120723_SN1120_0177_AC11GTACXX_s_7_rg.sorted,TCGA-ER-A19D-10A-01D-A190_120723_SN1120_0177_AC11GTACXX_s_7_rg.sorted.bam,15.61,NA,0.18,58cfa831e4b0c9d6adf6cc8d,TCGA-ER-A19D-10A-01D-A190_120723_SN1120_0177_AC11GTACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19D-10A,3409F118-1798-48D6-9556-12A5C77EBEFB,Blood Derived Normal,Illumina HiSeq,9f8626eb-9474-4d4f-8aaf-7f04869226d4,Skin,46,DF2B6EFB-3439-4A33-B905-47FD40CA30F5,B7AFB900-2269-4585-BE1F-A72F71499520,TCGA-ER-A19D-10A-01D-A190-02,HG19_Broad_variant,TCGA-ER-A19D,TCGA-SKCM,383,s7352,Harvard Medical School,University of Pittsburgh,United States,NO,T2a,N0,Not available,Stage IB
13722.58cfa831e4b0c9d6adf6c55e,58cfa831e4b0c9d6adf6c55e,TCGA-CH-5753-10A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CH-5753-10A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_4_rg.sorted,TCGA-CH-5753-10A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_4_rg.sorted.bam,368.4,1.9,0.16,58cfa831e4b0c9d6adf6c55e,TCGA-CH-5753-10A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5753-10A,928C48A0-68EE-4E28-AE83-9832E52850CA,Blood Derived Normal,Illumina HiSeq,7244700c-38c6-43d7-8edd-8ffe49b8b04c,Prostate,70,075D2A08-79D0-4AA7-91D5-26BB3A1C3AB2,3E161E33-5110-47FF-ADC7-7F56DB149050,TCGA-CH-5753-10A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5753,TCGA-PRAD,NA,s3415,Harvard Medical School,Indivumed,Germany,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c6f4,58cfa831e4b0c9d6adf6c6f4,TCGA-CV-5977-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CV-5977-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_3_rg.sorted,TCGA-CV-5977-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_3_rg.sorted.bam,307,1.9,0.15,58cfa831e4b0c9d6adf6c6f4,TCGA-CV-5977-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5977-01A,50239D1D-B3A4-4240-AB83-B24BA67B1299,Primary Tumor,Illumina HiSeq,ccdab134-2f40-4e7a-8b7c-ac1269321d3e,Head and Neck,66,84756AB5-9CB6-4DBD-848C-A85804F22AA1,140E6B2E-7EDD-417D-B720-58BEAB50AEA5,TCGA-CV-5977-01A-11D-1681-02,HG19_Broad_variant,TCGA-CV-5977,TCGA-HNSC,NA,s15896,Harvard Medical School,MD Anderson Cancer Center,None,NO,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c88c,58cfa831e4b0c9d6adf6c88c,TCGA-D7-6822-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_5_rg.sorted.filtered.,WGS,TCGA-D7-6822-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_5_rg.sorted,TCGA-D7-6822-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_5_rg.sorted.bam,442.7,1.9,0.14,58cfa831e4b0c9d6adf6c88c,TCGA-D7-6822-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6822-01A,E2AAABD9-F4BA-4763-A28A-C14D46A4BC5D,Primary Tumor,Illumina HiSeq,b8f8d06c-7bbf-4d0d-8f5a-e3012379df95,Stomach,77,C30AFDA8-FC63-4228-A9A9-42BCDB562ACE,586B20D4-917E-4344-BFBC-A21B12811C69,TCGA-D7-6822-01A-11D-1880-02,HG19_Broad_variant,TCGA-D7-6822,TCGA-STAD,NA,s14769,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N0,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IB
13722.58cfa82fe4b0c9d6adf6b7f7,58cfa82fe4b0c9d6adf6b7f7,TCGA-38-4631-11A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_6_rg.sorted.filtered.,WGS,TCGA-38-4631-11A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_6_rg.sorted,TCGA-38-4631-11A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_6_rg.sorted.bam,61.4,1.8,0.15,58cfa82fe4b0c9d6adf6b7f7,TCGA-38-4631-11A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_6_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-38-4631-11A,2483621A-4DB3-41AB-AA33-B9427EA8A0AF,Solid Tissue Normal,Illumina HiSeq,5ae01470-ac1e-459f-9598-e44be31e416a,Lung,72,FF565F35-43C7-4694-B7D0-70F440732B1C,C4C0A045-CC32-40F7-9B93-63214C946740,TCGA-38-4631-11A-01D-1751-02,HG19_Broad_variant,TCGA-38-4631,TCGA-LUAD,354,s11227,Harvard Medical School,UNC,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6cd28,58cfa831e4b0c9d6adf6cd28,TCGA-EE-A2MP-10A-01D-A190_120724_SN1222_0138_AC1168ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EE-A2MP-10A-01D-A190_120724_SN1222_0138_AC1168ACXX_s_5_rg.sorted,TCGA-EE-A2MP-10A-01D-A190_120724_SN1222_0138_AC1168ACXX_s_5_rg.sorted.bam,37.32,NA,0.15,58cfa831e4b0c9d6adf6cd28,TCGA-EE-A2MP-10A-01D-A190_120724_SN1222_0138_AC1168ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MP-10A,54782BD7-79BE-4E3C-BF99-844E7BB0E5D7,Blood Derived Normal,Illumina HiSeq,ae55062b-1a3c-407b-827e-7567130bf44e,Skin,34,DC48E514-D167-4252-8621-2D313D4B93CF,98D1F8A0-A931-4BEA-BE45-97C735FC47CD,TCGA-EE-A2MP-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2MP,TCGA-SKCM,NA,s7858,Harvard Medical School,University of Sydney,Australia,NO,T2,N0,Not available,Stage I
13722.58cfa831e4b0c9d6adf6c898,58cfa831e4b0c9d6adf6c898,TCGA-DU-5854-01A-11D-1703_130806_SN1440_0159_BC29Y3ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DU-5854-01A-11D-1703_130806_SN1440_0159_BC29Y3ACXX_s_1_rg.sorted,TCGA-DU-5854-01A-11D-1703_130806_SN1440_0159_BC29Y3ACXX_s_1_rg.sorted.bam,66.3,1.9,0.16,58cfa831e4b0c9d6adf6c898,TCGA-DU-5854-01A-11D-1703_130806_SN1440_0159_BC29Y3ACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-5854-01A,B95AFB1A-A1DF-4D85-AD34-191928E28A77,Primary Tumor,Illumina HiSeq,f499956c-7655-4be7-8a53-44403d30ea04,Brain,57,D5BAA53A-958C-4163-A388-D3C957C891F9,4716DB1C-94F8-40AE-B89B-EA41E6A7E8CE,TCGA-DU-5854-01A-11D-1703-02,HG19_Broad_variant,TCGA-DU-5854,TCGA-LGG,NA,s8562,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6cb60,58cfa831e4b0c9d6adf6cb60,TCGA-EE-A2GB-06A-11D-A18Y_120726_SN590_0171_AD13PJACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EE-A2GB-06A-11D-A18Y_120726_SN590_0171_AD13PJACXX_s_4_rg.sorted,TCGA-EE-A2GB-06A-11D-A18Y_120726_SN590_0171_AD13PJACXX_s_4_rg.sorted.bam,55.16,NA,0.15,58cfa831e4b0c9d6adf6cb60,TCGA-EE-A2GB-06A-11D-A18Y_120726_SN590_0171_AD13PJACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2GB-06A,E58BED18-503C-4182-BCF3-5AF6F20E1B8A,Metastatic,Illumina HiSeq,2dd72796-7cac-418d-a092-523f88e1dd64,Skin,51,EB4904DB-E9F4-4877-A429-A739562A2C86,BEA81FA6-A4BA-478B-9C37-5283A7F6748D,TCGA-EE-A2GB-06A-11D-A18Y-02,HG19_Broad_variant,TCGA-EE-A2GB,TCGA-SKCM,NA,s8007,Harvard Medical School,University of Sydney,Australia,NO,T2b,N1a,Not available,Stage IIIB
13722.58cfa830e4b0c9d6adf6bf23,58cfa830e4b0c9d6adf6bf23,TCGA-B5-A0K1-10A-01D-A043_120214_SN590_0138_AC0E8HACXX_s_4_rg.sorted.filtered.,WGS,TCGA-B5-A0K1-10A-01D-A043_120214_SN590_0138_AC0E8HACXX_s_4_rg.sorted,TCGA-B5-A0K1-10A-01D-A043_120214_SN590_0138_AC0E8HACXX_s_4_rg.sorted.bam,45.13,1.97,0.14,58cfa830e4b0c9d6adf6bf23,TCGA-B5-A0K1-10A-01D-A043_120214_SN590_0138_AC0E8HACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0K1-10A,40A3ED98-3892-449C-B07E-7B7612BD997E,Blood Derived Normal,Illumina HiSeq,39f2c18d-e88e-4bae-a080-e0f971f99f99,Uterus,69,DCD30DE0-1752-4D6B-A20A-5054F63EC7C8,27572436-3466-419E-B630-67DCE18F6C6C,TCGA-B5-A0K1-10A-01D-A043-02,HG19_Broad_variant,TCGA-B5-A0K1,TCGA-UCEC,NA,s4597,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6b087,58cfa82ee4b0c9d6adf6b087,TCGA-05-4417-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_8_rg.sorted.filtered.,WGS,TCGA-05-4417-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_8_rg.sorted,TCGA-05-4417-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_8_rg.sorted.bam,39,1.9,0.15,58cfa82ee4b0c9d6adf6b087,TCGA-05-4417-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_8_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4417-10A,A244A99A-D7CC-4FB1-BC76-B66886481621,Blood Derived Normal,Illumina HiSeq,e22b68ac-9772-4665-b367-38eee8691898,Lung,51,655AD2E6-05FF-4A3F-9947-4F21DA1F4FDF,548CEAF3-3FC3-4A22-8BEB-E218DD47A2DA,TCGA-05-4417-10A-01D-1853-02,HG19_Broad_variant,TCGA-05-4417,TCGA-LUAD,NA,s11331,Harvard Medical School,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa82fe4b0c9d6adf6b97c,58cfa82fe4b0c9d6adf6b97c,TCGA-91-6831-11A-02D-1853_120305_SN1120_0119_BD0REAACXX_s_5_rg.sorted.filtered.,WGS,TCGA-91-6831-11A-02D-1853_120305_SN1120_0119_BD0REAACXX_s_5_rg.sorted,TCGA-91-6831-11A-02D-1853_120305_SN1120_0119_BD0REAACXX_s_5_rg.sorted.bam,184.7,1.9,0.14,58cfa82fe4b0c9d6adf6b97c,TCGA-91-6831-11A-02D-1853_120305_SN1120_0119_BD0REAACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-91-6831-11A,DB0B9E63-4272-4F29-BF0E-1EC0FE79A9D7,Solid Tissue Normal,Illumina HiSeq,668cb7d1-0943-47c0-a4fa-a0b61974412a,Lung,66,41433A93-F941-40D7-BD47-CB6BEF90D289,C31BDC8D-4CA4-48F7-AF96-E9FBD02ABF99,TCGA-91-6831-11A-02D-1853-02,HG19_Broad_variant,TCGA-91-6831,TCGA-LUAD,NA,s10799,Harvard Medical School,ABS - IUPUI,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c85e,58cfa831e4b0c9d6adf6c85e,TCGA-CV-6938-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CV-6938-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_8_rg.sorted,TCGA-CV-6938-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_8_rg.sorted.bam,75,1.8,0.13,58cfa831e4b0c9d6adf6c85e,TCGA-CV-6938-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6938-10A,FF9DB03D-F81C-4079-8B05-F5A8C05B8CFE,Blood Derived Normal,Illumina HiSeq,2bf8f074-cca1-41f9-88b4-32ba64d7990c,Head and Neck,87,1F925F99-1D41-4BDF-99AE-CA7B4D16A567,3A63D568-0924-4D11-BCA0-86DAB2D8C889,TCGA-CV-6938-10A-01D-1911-02,HG19_Broad_variant,TCGA-CV-6938,TCGA-HNSC,144,s15906,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa830e4b0c9d6adf6c306,58cfa830e4b0c9d6adf6c306,TCGA-BR-6803-10A-01D-1880_130115_SN590_0207_AC1H8PACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BR-6803-10A-01D-1880_130115_SN590_0207_AC1H8PACXX_s_6_rg.sorted,TCGA-BR-6803-10A-01D-1880_130115_SN590_0207_AC1H8PACXX_s_6_rg.sorted.bam,188,1.9,0.15,58cfa830e4b0c9d6adf6c306,TCGA-BR-6803-10A-01D-1880_130115_SN590_0207_AC1H8PACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6803-10A,2F90209B-7464-4D7E-83D1-67850C263DED,Blood Derived Normal,Illumina HiSeq,8e0aa4a2-6371-4260-ac1c-249ff5c4f1f9,Stomach,54,68D1CB22-4E71-4187-943A-9984754C98A9,2252B273-50EA-45D3-A87D-F51D0C6547F7,TCGA-BR-6803-10A-01D-1880-02,HG19_Broad_variant,TCGA-BR-6803,TCGA-STAD,NA,s14401,Harvard Medical School,Asterand,Russia,NO,T3,N0,Stomach  Adenocarcinoma  Diffuse Type,Stage IIA
13722.58cfa831e4b0c9d6adf6cae0,58cfa831e4b0c9d6adf6cae0,TCGA-DJ-A13L-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DJ-A13L-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_5_rg.sorted,TCGA-DJ-A13L-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_5_rg.sorted.bam,32.87,NA,0.15,58cfa831e4b0c9d6adf6cae0,TCGA-DJ-A13L-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13L-01A,C7A2F394-3E3F-4C90-9F1E-F2BE3E5B0D6B,Primary Tumor,Illumina HiSeq,9424534d-10ae-4669-9a13-75ab8e7a7432,Thyroid,85,AB13FB1A-8B7F-4D84-84A9-C4F7EE59CAF8,417BD826-C151-459E-AAEA-DFA2CB4182DF,TCGA-DJ-A13L-01A-11D-A221-26,HG19_Broad_variant,TCGA-DJ-A13L,TCGA-THCA,NA,s12105,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage I
13722.58cfa830e4b0c9d6adf6c190,58cfa830e4b0c9d6adf6c190,TCGA-B7-5816-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_1_rg.sorted.filtered.,WGS,TCGA-B7-5816-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_1_rg.sorted,TCGA-B7-5816-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_1_rg.sorted.bam,459.7,1.9,0.16,58cfa830e4b0c9d6adf6c190,TCGA-B7-5816-10A-01D-1598_121107_SN590_0199_AC179PACXX_s_1_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-B7-5816-10A,F07070C0-FD0A-4C19-BA1E-5F06B933CD7C,Blood Derived Normal,Illumina HiSeq,c42706d2-adb2-442e-a7d3-43fc52f02c43,Stomach,51,78BA755E-A4DA-4C45-B09A-250C815A85DB,0EB13C07-2B5D-4832-8BA0-A91D271FB5E6,TCGA-B7-5816-10A-01D-1598-02,HG19_Broad_variant,TCGA-B7-5816,TCGA-STAD,NA,s15178,Harvard Medical School,Cureline,Russia,NO,T4a,N0,Stomach  Adenocarcinoma  Diffuse Type,Stage IIB
13722.58cfa831e4b0c9d6adf6c568,58cfa831e4b0c9d6adf6c568,TCGA-CH-5762-11A-01D-1572_130104_SN208_0445_AC1JWAACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CH-5762-11A-01D-1572_130104_SN208_0445_AC1JWAACXX_s_2_rg.sorted,TCGA-CH-5762-11A-01D-1572_130104_SN208_0445_AC1JWAACXX_s_2_rg.sorted.bam,91.7,2,0.13,58cfa831e4b0c9d6adf6c568,TCGA-CH-5762-11A-01D-1572_130104_SN208_0445_AC1JWAACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5762-11A,D4FFAFDC-EE83-43DF-AA3B-7326503C6438,Solid Tissue Normal,Illumina HiSeq,823dc639-947b-44e0-839b-882ab9437fac,Prostate,60,B95300F1-994C-4DE7-AC5B-964D7EA4E358,8897B262-39F8-492F-99A2-93C4012D6241,TCGA-CH-5762-11A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5762,TCGA-PRAD,NA,s3938,Harvard Medical School,Indivumed,Germany,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6befa,58cfa830e4b0c9d6adf6befa,TCGA-BJ-A28W-10A-01D-A16N_120805_SN208_0421_AC11HPACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BJ-A28W-10A-01D-A16N_120805_SN208_0421_AC11HPACXX_s_4_rg.sorted,TCGA-BJ-A28W-10A-01D-A16N_120805_SN208_0421_AC11HPACXX_s_4_rg.sorted.bam,62.61,1.87,0.17,58cfa830e4b0c9d6adf6befa,TCGA-BJ-A28W-10A-01D-A16N_120805_SN208_0421_AC11HPACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A28W-10A,A6D37F61-BECA-46EA-A59A-62257475AC77,Blood Derived Normal,Illumina HiSeq,341f9656-c88d-4835-910f-e6e4ed9b7ad3,Thyroid,32,5961BC0B-0B25-426E-8318-6E04406630A1,1038A255-2A5F-4804-BCFB-F9E6701B5BFB,TCGA-BJ-A28W-10A-01D-A16N-02,HG19_Broad_variant,TCGA-BJ-A28W,TCGA-THCA,NA,s12631,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6ceb0,58cfa832e4b0c9d6adf6ceb0,TCGA-EJ-5530-10A-01D-1573_130221_SN1120_0238_AC1TDEACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EJ-5530-10A-01D-1573_130221_SN1120_0238_AC1TDEACXX_s_8_rg.sorted,TCGA-EJ-5530-10A-01D-1573_130221_SN1120_0238_AC1TDEACXX_s_8_rg.sorted.bam,696.4,1.9,0.16,58cfa832e4b0c9d6adf6ceb0,TCGA-EJ-5530-10A-01D-1573_130221_SN1120_0238_AC1TDEACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5530-10A,E4A755E3-4938-4321-B5A9-27A445036791,Blood Derived Normal,Illumina HiSeq,9722e61b-009b-4167-927d-68a6e13d0ead,Prostate,61,0D40DA59-0AF0-47ED-A4E3-42229D6F212F,842AF7DF-177C-4B4B-8EBD-7292D06BFC9F,TCGA-EJ-5530-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5530,TCGA-PRAD,NA,s4138,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6beec,58cfa830e4b0c9d6adf6beec,TCGA-BL-A13J-10A-01D-A10R_120920_SN1222_0151_BD1D5CACXX_s_1_rg.sorted.filtered.,WGS,TCGA-BL-A13J-10A-01D-A10R_120920_SN1222_0151_BD1D5CACXX_s_1_rg.sorted,TCGA-BL-A13J-10A-01D-A10R_120920_SN1222_0151_BD1D5CACXX_s_1_rg.sorted.bam,16.09,2.03,0.15,58cfa830e4b0c9d6adf6beec,TCGA-BL-A13J-10A-01D-A10R_120920_SN1222_0151_BD1D5CACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BL-A13J-10A,556FCBC8-172A-4AF1-8822-AE036E8D68E8,Blood Derived Normal,Illumina HiSeq,db6e73ca-87ed-458b-9bd3-e274590e1b37,Bladder,65,C7348A4B-9360-4249-B1E2-CFD8647D3633,BE58C334-8842-4430-B763-D6186D19713C,TCGA-BL-A13J-10A-01D-A10R-02,HG19_Broad_variant,TCGA-BL-A13J,TCGA-BLCA,81,s3264,Harvard Medical School,Christiana Healthcare,United States,NO,T4,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c815,58cfa831e4b0c9d6adf6c815,TCGA-CV-6951-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CV-6951-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_8_rg.sorted,TCGA-CV-6951-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_8_rg.sorted.bam,6,1.9,0.16,58cfa831e4b0c9d6adf6c815,TCGA-CV-6951-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6951-10A,91728CD6-ED91-49DC-9279-FAEDBE211A9D,Blood Derived Normal,Illumina HiSeq,c7e5f6bc-d595-433f-89cc-cfd1cc99ff25,Head and Neck,57,16ECE3C5-7709-481C-A4BD-49ED6E6BDDA6,851E3F8F-6F52-4B1F-A439-7D08B7457276,TCGA-CV-6951-10A-01D-1911-02,HG19_Broad_variant,TCGA-CV-6951,TCGA-HNSC,915,s15518,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T4a,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c8d8,58cfa831e4b0c9d6adf6c8d8,TCGA-CV-6951-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CV-6951-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_4_rg.sorted,TCGA-CV-6951-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_4_rg.sorted.bam,62.7,1.9,0.14,58cfa831e4b0c9d6adf6c8d8,TCGA-CV-6951-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6951-01A,91728CD6-ED91-49DC-9279-FAEDBE211A9D,Primary Tumor,Illumina HiSeq,ec458668-da73-4d3e-8ac6-08a0e974b879,Head and Neck,57,9EE0F161-0976-4697-BF69-7E42E7149FEB,90F9C6C1-B7E9-48E4-9A02-C5FAB56AFD95,TCGA-CV-6951-01A-11D-1911-02,HG19_Broad_variant,TCGA-CV-6951,TCGA-HNSC,915,s15905,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T4a,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6bf38,58cfa830e4b0c9d6adf6bf38,TCGA-AP-A0L8-10A-01D-A043_120324_SN1120_0127_BC0L80ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-AP-A0L8-10A-01D-A043_120324_SN1120_0127_BC0L80ACXX_s_6_rg.sorted,TCGA-AP-A0L8-10A-01D-A043_120324_SN1120_0127_BC0L80ACXX_s_6_rg.sorted.bam,35.69,1.84,0.17,58cfa830e4b0c9d6adf6bf38,TCGA-AP-A0L8-10A-01D-A043_120324_SN1120_0127_BC0L80ACXX_s_6_rg.sorted.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0L8-10A,9AA8C2B4-DB32-4899-BF0C-D578CB175E90,Blood Derived Normal,Illumina HiSeq,fa2fd6aa-d874-4777-b0af-20ce23f744ee,Uterus,70,6FFE937D-CB2E-49EA-9737-D2619A0EBB01,1ABAE462-1F01-44D5-8028-8F968E54FC72,TCGA-AP-A0L8-10A-01D-A043-02,HG19_Broad_variant,TCGA-AP-A0L8,TCGA-UCEC,1484,s4593,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c8dc,58cfa831e4b0c9d6adf6c8dc,TCGA-CV-6945-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CV-6945-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_6_rg.sorted,TCGA-CV-6945-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_6_rg.sorted.bam,14,1.8,0.14,58cfa831e4b0c9d6adf6c8dc,TCGA-CV-6945-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6945-10A,15714E69-E075-4688-8F51-C7102FE4CA07,Blood Derived Normal,Illumina HiSeq,881094bd-54eb-4839-a62c-4abb208130cb,Head and Neck,41,974F0AEE-5BB9-4840-B141-A02B6A2FB65B,4DF4A64E-3543-4FF7-969F-49F5EB5EF877,TCGA-CV-6945-10A-01D-1911-02,HG19_Broad_variant,TCGA-CV-6945,TCGA-HNSC,366,s16047,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T4a,N2,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6cbc9,58cfa831e4b0c9d6adf6cbc9,TCGA-EJ-5514-01A-01D-1572_130131_SN1120_0234_AD1PVUACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EJ-5514-01A-01D-1572_130131_SN1120_0234_AD1PVUACXX_s_7_rg.sorted,TCGA-EJ-5514-01A-01D-1572_130131_SN1120_0234_AD1PVUACXX_s_7_rg.sorted.bam,271.7,1.9,0.15,58cfa831e4b0c9d6adf6cbc9,TCGA-EJ-5514-01A-01D-1572_130131_SN1120_0234_AD1PVUACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5514-01A,F82D53B1-3DF8-4249-A615-464C9F4E0A32,Primary Tumor,Illumina HiSeq,581bee6a-6abe-4b55-8dc4-63bb242df1cf,Prostate,66,29AD80A4-B429-495C-885E-A92CFE2E4501,6F8F8AAC-C0DE-46F6-A7CF-502893CC57CB,TCGA-EJ-5514-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5514,TCGA-PRAD,NA,s3439,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d45c,58cfa832e4b0c9d6adf6d45c,TCGA-VD-AA8P-10A-01D-A40E_140829_SN208_0523_BC5FKTACXX_s_8_rg.sorted.filtered.,WGS,TCGA-VD-AA8P-10A-01D-A40E_140829_SN208_0523_BC5FKTACXX_s_8_rg.sorted,TCGA-VD-AA8P-10A-01D-A40E_140829_SN208_0523_BC5FKTACXX_s_8_rg.sorted.bam,12.64,NA,0.15,58cfa832e4b0c9d6adf6d45c,TCGA-VD-AA8P-10A-01D-A40E_140829_SN208_0523_BC5FKTACXX_s_8_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Aligned reads,TCGA-VD-AA8P-10A,B224E42D-8B6D-4578-963C-BF528B954900,Blood Derived Normal,Illumina HiSeq,7d58eb3a-f560-405b-9fc7-cc1755594217,Eye,64,2BF04DB3-60E2-44FB-86F5-B0160B59AF67,395D9AA0-FD35-4688-86ED-F0DBBF7247EB,TCGA-VD-AA8P-10A-01D-A40E-26,HG19_Broad_variant,TCGA-VD-AA8P,TCGA-UVM,NA,s256,MD Anderson - Institute for Applied Cancer Science,University of Liverpool,United Kingdom,NO,T3a,N0,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6c818,58cfa831e4b0c9d6adf6c818,TCGA-CV-6948-10A-01D-1911_120816_SN1222_0144_AD16PUACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CV-6948-10A-01D-1911_120816_SN1222_0144_AD16PUACXX_s_8_rg.sorted,TCGA-CV-6948-10A-01D-1911_120816_SN1222_0144_AD16PUACXX_s_8_rg.sorted.bam,23,1.8,0.13,58cfa831e4b0c9d6adf6c818,TCGA-CV-6948-10A-01D-1911_120816_SN1222_0144_AD16PUACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6948-10A,FCF0DC48-B889-4593-A15B-AA715AAE7BF5,Blood Derived Normal,Illumina HiSeq,44d87ab1-c19b-4411-8774-2f888600c978,Head and Neck,79,86696AE2-B67D-43B3-929B-C4BAB7417852,4291C3F6-447E-482F-ADB3-304D59F87F82,TCGA-CV-6948-10A-01D-1911-02,HG19_Broad_variant,TCGA-CV-6948,TCGA-HNSC,1289,s15777,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T4a,N3,Head and Neck Squamous Cell Carcinoma,Stage IVB
13722.58cfa832e4b0c9d6adf6ce0c,58cfa832e4b0c9d6adf6ce0c,TCGA-FD-A3B6-01A-21D-A210_120912_SN1120_0192_AC18ALACXX_s_3_rg.sorted.filtered.,WGS,TCGA-FD-A3B6-01A-21D-A210_120912_SN1120_0192_AC18ALACXX_s_3_rg.sorted,TCGA-FD-A3B6-01A-21D-A210_120912_SN1120_0192_AC18ALACXX_s_3_rg.sorted.bam,61.5,NA,0.16,58cfa832e4b0c9d6adf6ce0c,TCGA-FD-A3B6-01A-21D-A210_120912_SN1120_0192_AC18ALACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3B6-01A,36054200-3FA4-4541-A25C-47282E4EF88D,Primary Tumor,Illumina HiSeq,15aeae5e-1ef3-4574-a7af-025ac4d4be89,Bladder,75,D6818C85-5857-44B0-AD64-1EEB53B80606,D8D4A23A-F993-4A8F-9414-AD25149B4CB3,TCGA-FD-A3B6-01A-21D-A210-26,HG19_Broad_variant,TCGA-FD-A3B6,TCGA-BLCA,NA,s3298,MD Anderson - Institute for Applied Cancer Science,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6c3a0,58cfa831e4b0c9d6adf6c3a0,TCGA-BT-A20U-01A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BT-A20U-01A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_7_rg.sorted,TCGA-BT-A20U-01A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_7_rg.sorted.bam,68.38,1.71,0.17,58cfa831e4b0c9d6adf6c3a0,TCGA-BT-A20U-01A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20U-01A,83B41D35-69B1-4218-BE1A-8821D8A6899C,Primary Tumor,Illumina HiSeq,9947c8cb-fa3d-4cc2-942e-b013f7a47faa,Bladder,70,D29E555F-8467-45C8-9124-0E6A757B1ADF,8D4442E9-3312-4607-A59F-49538B19FA71,TCGA-BT-A20U-01A-11D-A14U-02,HG19_Broad_variant,TCGA-BT-A20U,TCGA-BLCA,455,s3270,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6ce46,58cfa832e4b0c9d6adf6ce46,TCGA-EJ-5504-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EJ-5504-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_1_rg.sorted,TCGA-EJ-5504-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_1_rg.sorted.bam,125.7,1.9,0.15,58cfa832e4b0c9d6adf6ce46,TCGA-EJ-5504-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5504-01A,E1C3D1BD-CF8F-4FA4-AC8E-BF9E54F7AAD4,Primary Tumor,Illumina HiSeq,ea018935-4ded-4def-a204-bda7035ba32c,Prostate,65,7D0C0A85-8459-43A3-AC22-F447BB042149,FB332EAD-214E-4D76-BD3C-0774D906F68B,TCGA-EJ-5504-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5504,TCGA-PRAD,NA,s3953,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c562,58cfa831e4b0c9d6adf6c562,TCGA-CH-5761-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CH-5761-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_7_rg.sorted,TCGA-CH-5761-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_7_rg.sorted.bam,197.7,1.9,0.15,58cfa831e4b0c9d6adf6c562,TCGA-CH-5761-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5761-01A,854A481B-71A2-4F23-80AA-E91E9F4069B1,Primary Tumor,Illumina HiSeq,4d316299-7958-45e8-93ab-2150e05d3210,Prostate,61,332A54B1-2DF4-4BAA-84AC-2D95ABEF4064,F2F787DA-691C-4E73-A8B1-8D662781953E,TCGA-CH-5761-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5761,TCGA-PRAD,NA,s3593,Harvard Medical School,Indivumed,Germany,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c7d0,58cfa831e4b0c9d6adf6c7d0,TCGA-CV-6945-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CV-6945-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_2_rg.sorted,TCGA-CV-6945-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_2_rg.sorted.bam,155.7,1.9,0.14,58cfa831e4b0c9d6adf6c7d0,TCGA-CV-6945-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6945-01A,15714E69-E075-4688-8F51-C7102FE4CA07,Primary Tumor,Illumina HiSeq,50a2b9f7-d572-47c4-bf4b-3d6255512094,Head and Neck,41,55849997-67DE-4FC6-B7BF-9D02D15920C9,FC2ACD2E-751C-4252-85A1-6C5A8E980964,TCGA-CV-6945-01A-11D-1911-02,HG19_Broad_variant,TCGA-CV-6945,TCGA-HNSC,366,s15775,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T4a,N2,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c56a,58cfa831e4b0c9d6adf6c56a,TCGA-CH-5765-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CH-5765-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_7_rg.sorted,TCGA-CH-5765-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_7_rg.sorted.bam,256.7,1.9,0.16,58cfa831e4b0c9d6adf6c56a,TCGA-CH-5765-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5765-01A,716EB429-D7AF-4D4F-BD8D-AFCFF1A323EE,Primary Tumor,Illumina HiSeq,265ff01e-199b-4908-acaa-62aa8986967a,Prostate,55,E2359111-B056-4676-A8B6-C5CEA259B478,B7EFFFED-73EC-4139-A359-41B239F2978D,TCGA-CH-5765-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5765,TCGA-PRAD,NA,s3428,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c8c0,58cfa831e4b0c9d6adf6c8c0,TCGA-CV-5971-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_4_rg.sorted.filtered.,WGS,TCGA-CV-5971-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_4_rg.sorted,TCGA-CV-5971-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_4_rg.sorted.bam,22,1.9,0.16,58cfa831e4b0c9d6adf6c8c0,TCGA-CV-5971-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5971-01A,1465B7EC-8D2B-47DD-8387-977EED44CC86,Primary Tumor,Illumina HiSeq,03c22e39-15a9-4b8a-8db1-cf41d618b7fc,Head and Neck,60,82589B3F-BD41-4ABE-9469-7DD48447DDDC,5739D7DE-98D4-4591-B8B1-E0E9AA9B05DF,TCGA-CV-5971-01A-11D-1681-02,HG19_Broad_variant,TCGA-CV-5971,TCGA-HNSC,NA,s16198,Harvard Medical School,MD Anderson Cancer Center,None,NO,T4a,N2a,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6ccd4,58cfa831e4b0c9d6adf6ccd4,TCGA-EJ-5511-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EJ-5511-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_8_rg.sorted,TCGA-EJ-5511-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_8_rg.sorted.bam,599.4,1.9,0.17,58cfa831e4b0c9d6adf6ccd4,TCGA-EJ-5511-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_8_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5511-10A,F8A42FEB-FBC9-4A13-BAD5-1DCEFCA2A9BF,Blood Derived Normal,Illumina HiSeq,22de66f2-6831-4ec8-8ee6-15de1605d466,Prostate,55,5D8C39A9-AC3C-46D2-97DE-DFC1F512EC40,FDDE3ED3-6525-4F34-B6E8-77A171410743,TCGA-EJ-5511-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5511,TCGA-PRAD,NA,s3791,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c849,58cfa831e4b0c9d6adf6c849,TCGA-D7-6525-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_8_rg.sorted.filtered.,WGS,TCGA-D7-6525-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_8_rg.sorted,TCGA-D7-6525-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_8_rg.sorted.bam,270,1.9,0.16,58cfa831e4b0c9d6adf6c849,TCGA-D7-6525-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6525-10A,82F9A197-040D-4C5E-89D9-D87A7AA0168D,Blood Derived Normal,Illumina HiSeq,f95ec729-b7a8-4b1f-9c2c-ef00b3a74a77,Stomach,58,A523DD59-E6A8-4E71-AF54-E8064F3CDE61,11034761-0AB1-435A-A8A9-1F362E312403,TCGA-D7-6525-10A-01D-1798-02,HG19_Broad_variant,TCGA-D7-6525,TCGA-STAD,NA,s14558,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA
13722.58cfa831e4b0c9d6adf6cb9e,58cfa831e4b0c9d6adf6cb9e,TCGA-EJ-7328-01A-31D-2111_130502_SN590_0228_AD24A9ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EJ-7328-01A-31D-2111_130502_SN590_0228_AD24A9ACXX_s_2_rg.sorted,TCGA-EJ-7328-01A-31D-2111_130502_SN590_0228_AD24A9ACXX_s_2_rg.sorted.bam,282.3,NA,0.16,58cfa831e4b0c9d6adf6cb9e,TCGA-EJ-7328-01A-31D-2111_130502_SN590_0228_AD24A9ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7328-01A,42B7D14F-09E5-4D91-BB98-5FE35907A6A9,Primary Tumor,Illumina HiSeq,09a1120f-21a6-48c2-a9e8-3b229a16fc7f,Prostate,70,4539A7C3-CCA2-4ED0-9310-92CD843AA1CD,C4D292D4-D001-4704-94C9-CC1674F6F16E,TCGA-EJ-7328-01A-31D-2111-02,HG19_Broad_variant,TCGA-EJ-7328,TCGA-PRAD,NA,s3960,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c336,58cfa831e4b0c9d6adf6c336,TCGA-CG-4472-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CG-4472-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_8_rg.sorted,TCGA-CG-4472-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_8_rg.sorted.bam,47.6,1.9,0.15,58cfa831e4b0c9d6adf6c336,TCGA-CG-4472-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_8_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4472-10A,306F0222-8734-44CA-9A31-86E4E62B0A1B,Blood Derived Normal,Illumina HiSeq,0f6fc60a-9288-4cc4-9b91-35bb56cbad3f,Stomach,49,37B5833C-2E32-4077-A3E1-48735827FE29,6958B1D6-FCF8-4B38-A669-F0F834B1D02A,TCGA-CG-4472-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4472,TCGA-STAD,NA,s14638,Harvard Medical School,Indivumed,Germany,NO,T4,N1,Not available,Stage IV
13722.58cfa831e4b0c9d6adf6c550,58cfa831e4b0c9d6adf6c550,TCGA-CH-5754-10A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CH-5754-10A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_6_rg.sorted,TCGA-CH-5754-10A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_6_rg.sorted.bam,104.4,1.9,0.14,58cfa831e4b0c9d6adf6c550,TCGA-CH-5754-10A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5754-10A,0AAD0ABD-750A-400D-A34F-491DA996D46C,Blood Derived Normal,Illumina HiSeq,eff5ccea-5f74-449e-a9e6-4eb5a83e71c7,Prostate,65,C424E5E9-8E39-4C4B-A02D-37B6E7F11E38,76512EE5-8E1C-4A61-A662-AD9FF0DA8746,TCGA-CH-5754-10A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5754,TCGA-PRAD,NA,s3940,Harvard Medical School,Indivumed,Germany,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c54e,58cfa831e4b0c9d6adf6c54e,TCGA-CH-5765-11A-01D-1572_130104_SN208_0445_AC1JWAACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CH-5765-11A-01D-1572_130104_SN208_0445_AC1JWAACXX_s_8_rg.sorted,TCGA-CH-5765-11A-01D-1572_130104_SN208_0445_AC1JWAACXX_s_8_rg.sorted.bam,100.7,2,0.14,58cfa831e4b0c9d6adf6c54e,TCGA-CH-5765-11A-01D-1572_130104_SN208_0445_AC1JWAACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5765-11A,716EB429-D7AF-4D4F-BD8D-AFCFF1A323EE,Solid Tissue Normal,Illumina HiSeq,b2118b85-15e8-4468-ac1e-ae5862adf28d,Prostate,55,98DE6EDA-3A96-4CC1-9BF3-643F4BD6E87A,24C79143-DE2A-4834-92B2-C6F2421F7CF9,TCGA-CH-5765-11A-01D-1572-02,HG19_Broad_variant,TCGA-CH-5765,TCGA-PRAD,NA,s3418,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c629,58cfa831e4b0c9d6adf6c629,TCGA-CQ-6219-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CQ-6219-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_8_rg.sorted,TCGA-CQ-6219-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_8_rg.sorted.bam,54,NA,0.16,58cfa831e4b0c9d6adf6c629,TCGA-CQ-6219-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-6219-10A,0CA3D25A-22E9-4E40-834B-65F402535005,Blood Derived Normal,Illumina HiSeq,24f2b999-b137-4cd9-8d46-948ef995485d,Head and Neck,50,A10F3B24-FF67-48FB-9EB3-AFB10B3D36FB,008B9151-B9C9-42D8-AC2A-E2F3C4A62ABC,TCGA-CQ-6219-10A-01D-1911-02,HG19_Broad_variant,TCGA-CQ-6219,TCGA-HNSC,479,s15770,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T3,N2a,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6cb63,58cfa831e4b0c9d6adf6cb63,TCGA-EE-A2A6-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EE-A2A6-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_2_rg.sorted,TCGA-EE-A2A6-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_2_rg.sorted.bam,24.47,NA,0.15,58cfa831e4b0c9d6adf6cb63,TCGA-EE-A2A6-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2A6-10A,CDCF4D91-98A1-4A65-98DD-C6FC80805A0C,Blood Derived Normal,Illumina HiSeq,944c7826-6e83-41b9-8b1a-bd058c415e96,Skin,43,C994DAF7-D84C-43BB-B40B-07AA57737E33,7B8E839F-740B-4BDE-98B8-44EA426D0F52,TCGA-EE-A2A6-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2A6,TCGA-SKCM,NA,s7843,Harvard Medical School,University of Sydney,Australia,NO,T1a,N0,Not available,Stage IA
13722.58cfa831e4b0c9d6adf6c556,58cfa831e4b0c9d6adf6c556,TCGA-CH-5752-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CH-5752-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_1_rg.sorted,TCGA-CH-5752-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_1_rg.sorted.bam,191.7,1.9,0.16,58cfa831e4b0c9d6adf6c556,TCGA-CH-5752-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5752-01A,D8F56D75-51AB-4A86-A502-C86E1DCD1EFF,Primary Tumor,Illumina HiSeq,d1bae4e7-eb79-4ede-abb5-19a328e4ad0c,Prostate,66,94A01526-7771-4A05-A9CE-9694B73DF3A7,490FC467-7E7E-40A1-98D0-ABA46EC71F53,TCGA-CH-5752-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5752,TCGA-PRAD,NA,s3427,Harvard Medical School,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cbf9,58cfa831e4b0c9d6adf6cbf9,TCGA-EJ-7785-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EJ-7785-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_4_rg.sorted,TCGA-EJ-7785-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_4_rg.sorted.bam,160.3,NA,0.15,58cfa831e4b0c9d6adf6cbf9,TCGA-EJ-7785-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7785-01A,2DEF2A53-D2E8-46F0-8B07-F32DBF1833A4,Primary Tumor,Illumina HiSeq,dfbfaf44-ade6-4c48-88fb-a3898d878853,Prostate,54,63EBD9B1-F118-4315-8722-708F47A07063,196C6111-FF69-40F1-A7AA-973C5AC9106E,TCGA-EJ-7785-01A-11D-2111-02,HG19_Broad_variant,TCGA-EJ-7785,TCGA-PRAD,NA,s3966,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82fe4b0c9d6adf6b6fa,58cfa82fe4b0c9d6adf6b6fa,TCGA-50-5939-11A-01D-1623_120302_SN208_0271_BC0D91ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-50-5939-11A-01D-1623_120302_SN208_0271_BC0D91ACXX_s_4_rg.sorted,TCGA-50-5939-11A-01D-1623_120302_SN208_0271_BC0D91ACXX_s_4_rg.sorted.bam,38.7,2,0.14,58cfa82fe4b0c9d6adf6b6fa,TCGA-50-5939-11A-01D-1623_120302_SN208_0271_BC0D91ACXX_s_4_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5939-11A,12B79B4F-C28C-418E-A1E7-E622F33FDCC2,Solid Tissue Normal,Illumina HiSeq,67afa188-5949-4813-8056-994a819a72b5,Lung,85,1A762AC4-B6EF-4EA1-889A-0FDA1DF26765,B6DDA01B-CC15-4491-9623-AC2D9B9E92DC,TCGA-50-5939-11A-01D-1623-02,HG19_Broad_variant,TCGA-50-5939,TCGA-LUAD,460,s11349,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa832e4b0c9d6adf6d082,58cfa832e4b0c9d6adf6d082,TCGA-HC-7210-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-HC-7210-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_8_rg.sorted,TCGA-HC-7210-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_8_rg.sorted.bam,131.3,NA,0.15,58cfa832e4b0c9d6adf6d082,TCGA-HC-7210-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7210-01A,6A5AF80E-07AD-4CD3-AAAB-5DB1090835D9,Primary Tumor,Illumina HiSeq,e6934494-d8e1-44c6-a343-30a6aa2e6cbc,Prostate,74,9069FC65-9BAE-49F3-9329-B78C8CC6CF1E,D414D851-0AF6-4C8F-8E40-CCA9FDF79488,TCGA-HC-7210-01A-11D-2111-02,HG19_Broad_variant,TCGA-HC-7210,TCGA-PRAD,NA,s3983,Harvard Medical School,International Genomics Consortium,United States,NO,T2a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cb81,58cfa831e4b0c9d6adf6cb81,TCGA-EJ-7782-10A-01D-2111_130502_SN590_0229_BD2459ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EJ-7782-10A-01D-2111_130502_SN590_0229_BD2459ACXX_s_1_rg.sorted,TCGA-EJ-7782-10A-01D-2111_130502_SN590_0229_BD2459ACXX_s_1_rg.sorted.bam,74.6,NA,0.16,58cfa831e4b0c9d6adf6cb81,TCGA-EJ-7782-10A-01D-2111_130502_SN590_0229_BD2459ACXX_s_1_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7782-10A,1426B4BF-F4A5-477C-BBBB-E0E656549764,Blood Derived Normal,Illumina HiSeq,978aefd3-3013-45dc-a27f-b3b3a3352296,Prostate,71,71342824-DDD4-4A58-A005-E0D63CD36DA3,F9C1CBBE-F4C6-40B8-90B1-03D69590744A,TCGA-EJ-7782-10A-01D-2111-02,HG19_Broad_variant,TCGA-EJ-7782,TCGA-PRAD,NA,s4140,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6ae48,58cfa82ee4b0c9d6adf6ae48,TCGA-05-4384-01A-01D-1751_120228_SN1120_0117_BC0DKWACXX_s_4_rg.sorted.filtered.,WGS,TCGA-05-4384-01A-01D-1751_120228_SN1120_0117_BC0DKWACXX_s_4_rg.sorted,TCGA-05-4384-01A-01D-1751_120228_SN1120_0117_BC0DKWACXX_s_4_rg.sorted.bam,486.4,1.9,0.15,58cfa82ee4b0c9d6adf6ae48,TCGA-05-4384-01A-01D-1751_120228_SN1120_0117_BC0DKWACXX_s_4_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4384-01A,9A50E7E4-831D-489F-87D2-979E987561CC,Primary Tumor,Illumina HiSeq,985192a3-1403-4393-895a-ca9a4d12268f,Lung,66,E4416303-50B0-4316-BFEE-030C7B29FAC6,5253B1A2-8C57-414A-8E19-6E8390A6C18D,TCGA-05-4384-01A-01D-1751-02,HG19_Broad_variant,TCGA-05-4384,TCGA-LUAD,NA,s10982,Harvard Medical School,Indivumed,Germany,NO,T2,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIA
13722.58cfa831e4b0c9d6adf6c6b6,58cfa831e4b0c9d6adf6c6b6,TCGA-CQ-7065-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CQ-7065-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_1_rg.sorted,TCGA-CQ-7065-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_1_rg.sorted.bam,15.93,NA,0.13,58cfa831e4b0c9d6adf6c6b6,TCGA-CQ-7065-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_1_rg.sorted.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-7065-01A,20ECE2CA-8601-4CCA-AEC5-0A5C0B92594D,Primary Tumor,Illumina HiSeq,a7ab0507-8b7a-45aa-9e07-21bfc50fddd0,Head and Neck,40,65B44EBF-F817-4B29-8FB6-01B07BC2E7D1,DFB72780-B485-403B-997C-6F6FD0EF0E75,TCGA-CQ-7065-01A-11D-2317-26,HG19_Broad_variant,TCGA-CQ-7065,TCGA-HNSC,NA,s16040,MD Anderson - Institute for Applied Cancer Science,"University Health Network, Toronto",Canada,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c7c2,58cfa831e4b0c9d6adf6c7c2,TCGA-D7-5579-10A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_6_rg.sorted.filtered.,WGS,TCGA-D7-5579-10A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_6_rg.sorted,TCGA-D7-5579-10A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_6_rg.sorted.bam,181.4,1.9,0.15,58cfa831e4b0c9d6adf6c7c2,TCGA-D7-5579-10A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-5579-10A,8B5746F9-DBEE-40BD-9141-1081960CF286,Blood Derived Normal,Illumina HiSeq,21ebfb93-aed0-454f-9a92-bd368dad175c,Stomach,74,A6AE07DC-A946-4D82-BF8D-F1837CFF3D1F,0865EF16-5B0E-4260-BE68-7C6B19EF7089,TCGA-D7-5579-10A-01D-1598-02,HG19_Broad_variant,TCGA-D7-5579,TCGA-STAD,NA,s14910,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T3,N2,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage IIIA
13722.58cfa82fe4b0c9d6adf6b99a,58cfa82fe4b0c9d6adf6b99a,TCGA-64-5774-01A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_1_rg.sorted.filtered.,WGS,TCGA-64-5774-01A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_1_rg.sorted,TCGA-64-5774-01A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_1_rg.sorted.bam,877.7,1.9,0.15,58cfa82fe4b0c9d6adf6b99a,TCGA-64-5774-01A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-64-5774-01A,FD3FC273-C035-40EA-A459-FF4806F5D592,Primary Tumor,Illumina HiSeq,b5b4f9c8-7044-4c76-ae48-241c8c4dd953,Lung,60,252C5D60-7033-44C3-8AB5-4604670A80F4,83902D13-5FD4-4640-B20F-3A8110F6D5EC,TCGA-64-5774-01A-01D-1623-02,HG19_Broad_variant,TCGA-64-5774,TCGA-LUAD,NA,s10910,Harvard Medical School,Fox Chase,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa832e4b0c9d6adf6cf14,58cfa832e4b0c9d6adf6cf14,TCGA-FE-A22Z-10A-01D-A16N_120805_SN208_0422_BD16VPACXX_s_6_rg.sorted.filtered.,WGS,TCGA-FE-A22Z-10A-01D-A16N_120805_SN208_0422_BD16VPACXX_s_6_rg.sorted,TCGA-FE-A22Z-10A-01D-A16N_120805_SN208_0422_BD16VPACXX_s_6_rg.sorted.bam,27.97,1.9,0.15,58cfa832e4b0c9d6adf6cf14,TCGA-FE-A22Z-10A-01D-A16N_120805_SN208_0422_BD16VPACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A22Z-10A,78D14F86-896A-4F98-9274-B2E8E387ADD9,Blood Derived Normal,Illumina HiSeq,c548c623-51dc-406f-8ce7-5589f31b53d7,Thyroid,61,7727F473-C83D-4CF2-B779-C4FDB6172AA7,0348769D-7455-4465-9154-45B4E677505B,TCGA-FE-A22Z-10A-01D-A16N-02,HG19_Broad_variant,TCGA-FE-A22Z,TCGA-THCA,NA,s12006,Harvard Medical School,Ohio State University,United States,NO,T4a,N1,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage IVA
13722.58cfa831e4b0c9d6adf6cba6,58cfa831e4b0c9d6adf6cba6,TCGA-EJ-7784-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EJ-7784-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_2_rg.sorted,TCGA-EJ-7784-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_2_rg.sorted.bam,456.3,NA,0.15,58cfa831e4b0c9d6adf6cba6,TCGA-EJ-7784-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7784-01A,4BC71292-60BB-4B63-86C1-0FE021083804,Primary Tumor,Illumina HiSeq,a2c5ffab-f279-44fb-a025-079de410f1c4,Prostate,63,0D3EC78C-3DA8-443F-BAA6-93CAED5B065C,2B122D7B-B5CE-44CE-B1EA-7E39E42B2A63,TCGA-EJ-7784-01A-11D-2111-02,HG19_Broad_variant,TCGA-EJ-7784,TCGA-PRAD,NA,s3958,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c850,58cfa831e4b0c9d6adf6c850,TCGA-CV-6948-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CV-6948-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_3_rg.sorted,TCGA-CV-6948-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_3_rg.sorted.bam,263.7,1.9,0.15,58cfa831e4b0c9d6adf6c850,TCGA-CV-6948-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_3_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6948-01A,FCF0DC48-B889-4593-A15B-AA715AAE7BF5,Primary Tumor,Illumina HiSeq,87c6cf32-e113-471b-86b3-cca360f47616,Head and Neck,79,21844F33-DD12-4940-B42D-2F9FABB2F7BA,8FEEA708-D971-4FD0-8542-1E31A9DFF8EA,TCGA-CV-6948-01A-11D-1911-02,HG19_Broad_variant,TCGA-CV-6948,TCGA-HNSC,1289,s15650,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T4a,N3,Head and Neck Squamous Cell Carcinoma,Stage IVB
13722.58cfa82fe4b0c9d6adf6b9e2,58cfa82fe4b0c9d6adf6b9e2,TCGA-64-5815-01A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_3_rg.sorted.filtered.,WGS,TCGA-64-5815-01A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_3_rg.sorted,TCGA-64-5815-01A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_3_rg.sorted.bam,132.7,1.9,0.14,58cfa82fe4b0c9d6adf6b9e2,TCGA-64-5815-01A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-64-5815-01A,A65700C2-E58C-4FD4-AEB1-5686B8F4D212,Primary Tumor,Illumina HiSeq,d64bfa4e-ae37-494a-aabe-6787ac58054a,Lung,74,4420AAE3-3F44-4852-974D-74F155B99FE4,7DC45930-978E-42B5-8ECB-942F3C6DA727,TCGA-64-5815-01A-01D-1623-02,HG19_Broad_variant,TCGA-64-5815,TCGA-LUAD,NA,s11460,Harvard Medical School,Fox Chase,United States,NO,T2,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIB
13722.58cfa831e4b0c9d6adf6c72e,58cfa831e4b0c9d6adf6c72e,TCGA-D6-6515-10A-01D-1868_120530_SN1222_0110_AC0VLAACXX_s_8_rg.sorted.filtered.,WGS,TCGA-D6-6515-10A-01D-1868_120530_SN1222_0110_AC0VLAACXX_s_8_rg.sorted,TCGA-D6-6515-10A-01D-1868_120530_SN1222_0110_AC0VLAACXX_s_8_rg.sorted.bam,566,1.9,0.14,58cfa831e4b0c9d6adf6c72e,TCGA-D6-6515-10A-01D-1868_120530_SN1222_0110_AC0VLAACXX_s_8_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-D6-6515-10A,8E0E456E-85EE-4DE5-8F0B-72393D6ACDE0,Blood Derived Normal,Illumina HiSeq,9162c3e1-cccb-4dbd-8584-1ed07c67a6ae,Head and Neck,82,30F64CB6-602E-442B-A49C-AD7BA013582F,E0792BA6-84EE-48A7-8965-3EA79DED53A3,TCGA-D6-6515-10A-01D-1868-02,HG19_Broad_variant,TCGA-D6-6515,TCGA-HNSC,403,s15915,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c924,58cfa831e4b0c9d6adf6c924,TCGA-CN-6996-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_6_rg.sorted.filtered.,WGS,TCGA-CN-6996-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_6_rg.sorted,TCGA-CN-6996-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_6_rg.sorted.bam,579,NA,0.15,58cfa831e4b0c9d6adf6c924,TCGA-CN-6996-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_6_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-6996-10A,49B94421-FE82-4F24-8EF2-820674142418,Blood Derived Normal,Illumina HiSeq,ca0120d2-68ba-4605-a647-eb86ed714611,Head and Neck,58,91A53555-ECB3-4FF6-B56F-8AC5021BB5A8,F268F2F5-1BE4-454B-809B-C509F1454D8E,TCGA-CN-6996-10A-01D-1911-02,HG19_Broad_variant,TCGA-CN-6996,TCGA-HNSC,NA,s15505,Harvard Medical School,University of Pittsburgh,United States,NO,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6cf4c,58cfa832e4b0c9d6adf6cf4c,TCGA-H2-A3RH-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-H2-A3RH-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_4_rg.sorted,TCGA-H2-A3RH-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_4_rg.sorted.bam,74.91,NA,0.17,58cfa832e4b0c9d6adf6cf4c,TCGA-H2-A3RH-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-H2-A3RH-10A,0314B145-2F3A-4A90-A580-375B5F0A63A4,Blood Derived Normal,Illumina HiSeq,a07850f9-e3b6-40f0-93f7-2950007d31e2,Thyroid,41,5BDA33B8-52C2-48B6-A557-5C52E91D4679,843CEE28-125A-4E16-81B1-F50C60BABF50,TCGA-H2-A3RH-10A-01D-A221-26,HG19_Broad_variant,TCGA-H2-A3RH,TCGA-THCA,NA,s12652,MD Anderson - Institute for Applied Cancer Science,Christiana Healthcare,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa831e4b0c9d6adf6c950,58cfa831e4b0c9d6adf6c950,TCGA-D7-6818-10A-01D-1880_121220_SN1120_0207_BC1JALACXX_s_2_rg.sorted.filtered.,WGS,TCGA-D7-6818-10A-01D-1880_121220_SN1120_0207_BC1JALACXX_s_2_rg.sorted,TCGA-D7-6818-10A-01D-1880_121220_SN1120_0207_BC1JALACXX_s_2_rg.sorted.bam,529,1.9,0.15,58cfa831e4b0c9d6adf6c950,TCGA-D7-6818-10A-01D-1880_121220_SN1120_0207_BC1JALACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6818-10A,AA2934F9-8783-428E-88A6-1D04B93FA1FD,Blood Derived Normal,Illumina HiSeq,327fce3d-289c-4d30-b812-d43fda314ac6,Stomach,53,5AB5F428-FB43-4C52-8E99-11574504065C,EF7F4439-A466-40B2-AEE2-1A2AEA45BDDD,TCGA-D7-6818-10A-01D-1880-02,HG19_Broad_variant,TCGA-D7-6818,TCGA-STAD,NA,s15463,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA
13722.58cfa831e4b0c9d6adf6c542,58cfa831e4b0c9d6adf6c542,TCGA-CH-5754-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CH-5754-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_5_rg.sorted,TCGA-CH-5754-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_5_rg.sorted.bam,197.7,1.9,0.16,58cfa831e4b0c9d6adf6c542,TCGA-CH-5754-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5754-01A,0AAD0ABD-750A-400D-A34F-491DA996D46C,Primary Tumor,Illumina HiSeq,9b3dfe47-a8c3-4a73-8aa3-66af9d5001a2,Prostate,65,BE645D37-B3E1-4D09-91CB-6231E25ACEB8,2C0EF4A5-DC20-45E7-B8EE-7525D77128B6,TCGA-CH-5754-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5754,TCGA-PRAD,NA,s3596,Harvard Medical School,Indivumed,Germany,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bfba,58cfa830e4b0c9d6adf6bfba,TCGA-BR-6707-10A-01D-1880_121220_SN1222_0163_AC1HA2ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-BR-6707-10A-01D-1880_121220_SN1222_0163_AC1HA2ACXX_s_8_rg.sorted,TCGA-BR-6707-10A-01D-1880_121220_SN1222_0163_AC1HA2ACXX_s_8_rg.sorted.bam,242,1.9,0.15,58cfa830e4b0c9d6adf6bfba,TCGA-BR-6707-10A-01D-1880_121220_SN1222_0163_AC1HA2ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6707-10A,DF3DF249-86C2-43D4-ABE1-796CD7DF653F,Blood Derived Normal,Illumina HiSeq,a99c1ab3-7b20-46dc-b74c-1866a6aaaf62,Stomach,75,40AA2161-2798-4CA5-ACE8-F6115E8BD86A,3957C639-FC9C-44C3-8256-27BA04BEF74E,TCGA-BR-6707-10A-01D-1880-02,HG19_Broad_variant,TCGA-BR-6707,TCGA-STAD,NA,s14621,Harvard Medical School,Asterand,Ukraine,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA
13722.58cfa82fe4b0c9d6adf6b756,58cfa82fe4b0c9d6adf6b756,TCGA-91-6835-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_5_rg.sorted.filtered.,WGS,TCGA-91-6835-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_5_rg.sorted,TCGA-91-6835-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_5_rg.sorted.bam,328.7,1.9,0.14,58cfa82fe4b0c9d6adf6b756,TCGA-91-6835-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-91-6835-01A,2F09479F-87FC-4C34-8E2C-333E970A3681,Primary Tumor,Illumina HiSeq,8c5e1a0f-e9a8-4ce4-b066-97b2040c5327,Lung,81,EFD3F14F-F785-4AEC-9EFD-6DD8E9C41EBA,A4DC40A6-EE0F-4637-937F-406F5FC8579F,TCGA-91-6835-01A-11D-1853-02,HG19_Broad_variant,TCGA-91-6835,TCGA-LUAD,NA,s10913,Harvard Medical School,ABS - IUPUI,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6afbe,58cfa82ee4b0c9d6adf6afbe,TCGA-05-4427-10A-01D-1853_120228_SN1120_0117_BC0DKWACXX_s_2_rg.sorted.filtered.,WGS,TCGA-05-4427-10A-01D-1853_120228_SN1120_0117_BC0DKWACXX_s_2_rg.sorted,TCGA-05-4427-10A-01D-1853_120228_SN1120_0117_BC0DKWACXX_s_2_rg.sorted.bam,112,1.9,0.14,58cfa82ee4b0c9d6adf6afbe,TCGA-05-4427-10A-01D-1853_120228_SN1120_0117_BC0DKWACXX_s_2_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4427-10A,78A24C56-576C-4245-BB42-6603B3D19897,Blood Derived Normal,Illumina HiSeq,9d47bafd-adc4-4120-b715-fe1ecbf86b82,Lung,65,3F3A0974-5AAD-4895-8153-B95D0D46595D,D161ED6B-FA73-4243-BFFD-921D92DB4E13,TCGA-05-4427-10A-01D-1853-02,HG19_Broad_variant,TCGA-05-4427,TCGA-LUAD,NA,s10985,Harvard Medical School,Indivumed,Germany,NO,T2,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIB
13722.58cfa832e4b0c9d6adf6d22c,58cfa832e4b0c9d6adf6d22c,TCGA-IR-A3L7-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_7_rg.sorted.filtered.,WGS,TCGA-IR-A3L7-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_7_rg.sorted,TCGA-IR-A3L7-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_7_rg.sorted.bam,23.81,NA,0.16,58cfa832e4b0c9d6adf6d22c,TCGA-IR-A3L7-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-IR-A3L7-10A,66229DD6-C771-4455-A90C-C66FB40CF7FE,Blood Derived Normal,Illumina HiSeq,15c1faa9-4030-4527-9860-f1846bbb8e9e,Cervix,37,C5375B9E-E0AB-4D77-BDF8-375405A54989,9BA68390-DBBE-4681-BFED-86DD2AC1D6D4,TCGA-IR-A3L7-10A-01D-A20X-26,HG19_Broad_variant,TCGA-IR-A3L7,TCGA-CESC,NA,s1212,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c923,58cfa831e4b0c9d6adf6c923,TCGA-DB-5276-10A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DB-5276-10A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_6_rg.sorted,TCGA-DB-5276-10A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_6_rg.sorted.bam,78.7,1.9,0.14,58cfa831e4b0c9d6adf6c923,TCGA-DB-5276-10A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DB-5276-10A,9D0C1552-00A7-4F0A-A04A-A82E721EE4E3,Blood Derived Normal,Illumina HiSeq,c584cffe-856d-48a8-b1e6-95db5cb5f3de,Brain,32,BC639E06-8F9C-4759-B158-C03EC8E9DBF4,6F18CF36-A52F-4D38-9585-64DF0307BA29,TCGA-DB-5276-10A-01D-1465-02,HG19_Broad_variant,TCGA-DB-5276,TCGA-LGG,NA,s8129,Harvard Medical School,Mayo Clinic - Rochester,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa831e4b0c9d6adf6c8d2,58cfa831e4b0c9d6adf6c8d2,TCGA-CV-6939-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_5_rg.sorted.filtered.,WGS,TCGA-CV-6939-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_5_rg.sorted,TCGA-CV-6939-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_5_rg.sorted.bam,60,1.8,0.13,58cfa831e4b0c9d6adf6c8d2,TCGA-CV-6939-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_5_rg.sorted.bam,Dead,MALE,WHITE,Not available,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6939-10A,E7D1F0DD-EEC0-4670-A2BA-00FFE38C6382,Blood Derived Normal,Illumina HiSeq,309581c5-c366-45cd-8989-49eb97775978,Head and Neck,60,65C69882-7AD5-4EA8-B8F6-CA17A0EA8E73,F5E8B5DB-1814-4D08-9D7D-3AD879EFD522,TCGA-CV-6939-10A-01D-1911-02,HG19_Broad_variant,TCGA-CV-6939,TCGA-HNSC,666,s15901,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6bc5a,58cfa830e4b0c9d6adf6bc5a,TCGA-AP-A0LH-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_1_rg.sorted.filtered.,WGS,TCGA-AP-A0LH-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_1_rg.sorted,TCGA-AP-A0LH-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_1_rg.sorted.bam,94.43,2,0.16,58cfa830e4b0c9d6adf6bc5a,TCGA-AP-A0LH-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_1_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LH-01A,7DCE4215-01F6-43E9-9378-9E22C26C23A2,Primary Tumor,Illumina HiSeq,4334c333-7627-4949-90aa-55897232ec49,Uterus,60,4C657AD4-2C53-4EA9-82B5-52996E74E3FF,FCA1C7F5-E456-4574-9716-79770E6DAE8C,TCGA-AP-A0LH-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A0LH,TCGA-UCEC,1106,s5203,Harvard Medical School,MSKCC,None,NO,Not available,Not available,Mixed serous and endometrioid,Not available
13722.58cfa831e4b0c9d6adf6c324,58cfa831e4b0c9d6adf6c324,TCGA-CG-4472-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_2_rg.sorted.filtered.,WGS,TCGA-CG-4472-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_2_rg.sorted,TCGA-CG-4472-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_2_rg.sorted.bam,47.6,1.9,0.15,58cfa831e4b0c9d6adf6c324,TCGA-CG-4472-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_2_rg.sorted.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4472-10A,306F0222-8734-44CA-9A31-86E4E62B0A1B,Blood Derived Normal,Illumina HiSeq,e9ebc1e2-3bf0-48b2-bfee-bff5a72097dd,Stomach,49,37B5833C-2E32-4077-A3E1-48735827FE29,6958B1D6-FCF8-4B38-A669-F0F834B1D02A,TCGA-CG-4472-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4472,TCGA-STAD,NA,s15193,Harvard Medical School,Indivumed,Germany,NO,T4,N1,Not available,Stage IV
13722.58cfa831e4b0c9d6adf6c465,58cfa831e4b0c9d6adf6c465,TCGA-CG-5733-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_3_rg.sorted.filtered.,WGS,TCGA-CG-5733-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_3_rg.sorted,TCGA-CG-5733-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_3_rg.sorted.bam,332,1.9,0.15,58cfa831e4b0c9d6adf6c465,TCGA-CG-5733-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_3_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5733-01A,8A9AFA5E-63CE-41EB-AAFB-B0B03653DA5A,Primary Tumor,Illumina HiSeq,4b31f837-59fa-48a7-bfbc-475e1251bd07,Stomach,83,315E485B-3069-4ADC-8AB5-BEDCC0642930,73EA65AA-3677-425F-B084-1FC3BEBA2D03,TCGA-CG-5733-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5733,TCGA-STAD,641,s14492,Harvard Medical School,Indivumed,Germany,NO,T2,N2,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82fe4b0c9d6adf6b6d5,58cfa82fe4b0c9d6adf6b6d5,TCGA-55-6543-10A-01D-1751_120228_SN1120_0117_BC0DKWACXX_s_8_rg.sorted.filtered.,WGS,TCGA-55-6543-10A-01D-1751_120228_SN1120_0117_BC0DKWACXX_s_8_rg.sorted,TCGA-55-6543-10A-01D-1751_120228_SN1120_0117_BC0DKWACXX_s_8_rg.sorted.bam,225.7,1.9,0.15,58cfa82fe4b0c9d6adf6b6d5,TCGA-55-6543-10A-01D-1751_120228_SN1120_0117_BC0DKWACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-55-6543-10A,E68219B0-A9C2-49DF-8F0D-DB5EA97FD2DC,Blood Derived Normal,Illumina HiSeq,a66c52d0-6f85-4b19-aa52-97c7fd45d6f1,Lung,60,656A0565-869D-462E-899B-EB5DA57C75C7,DA1D674C-9EC2-4822-8CDE-9E4E655B3098,TCGA-55-6543-10A-01D-1751-02,HG19_Broad_variant,TCGA-55-6543,TCGA-LUAD,NA,s11240,Harvard Medical School,International Genomics Consortium,United States,NO,T1b,N0,Lung Bronchioloalveolar Carcinoma Mucinous,Stage IA
13722.58cfa831e4b0c9d6adf6cd87,58cfa831e4b0c9d6adf6cd87,TCGA-EJ-7781-10A-01D-2111_130502_SN590_0228_AD24A9ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EJ-7781-10A-01D-2111_130502_SN590_0228_AD24A9ACXX_s_7_rg.sorted,TCGA-EJ-7781-10A-01D-2111_130502_SN590_0228_AD24A9ACXX_s_7_rg.sorted.bam,220.6,NA,0.17,58cfa831e4b0c9d6adf6cd87,TCGA-EJ-7781-10A-01D-2111_130502_SN590_0228_AD24A9ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7781-10A,33283111-9A2F-4D5E-92A5-3435846404F7,Blood Derived Normal,Illumina HiSeq,710510b5-d614-4a34-984a-0cb67724df03,Prostate,65,6839F951-8A1F-4023-8778-0EC40A6FF986,0CB2A252-8798-4883-9ADA-7AEEC9C4615C,TCGA-EJ-7781-10A-01D-2111-02,HG19_Broad_variant,TCGA-EJ-7781,TCGA-PRAD,NA,s3965,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d19e,58cfa832e4b0c9d6adf6d19e,TCGA-IR-A3LL-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_8_rg.sorted.filtered.,WGS,TCGA-IR-A3LL-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_8_rg.sorted,TCGA-IR-A3LL-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_8_rg.sorted.bam,32.75,NA,0.16,58cfa832e4b0c9d6adf6d19e,TCGA-IR-A3LL-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_8_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-IR-A3LL-10A,7C4AB1CA-4BDD-4EF7-9A42-F6C0C7136D26,Blood Derived Normal,Illumina HiSeq,4b74b0ed-9434-46b0-bf59-1a357318e495,Cervix,60,C05EAB24-367B-4996-BCE0-6E9B24029287,2DEE547C-55D9-4E7B-9F22-B82B004130C0,TCGA-IR-A3LL-10A-01D-A20X-26,HG19_Broad_variant,TCGA-IR-A3LL,TCGA-CESC,NA,s1539,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6cec6,58cfa832e4b0c9d6adf6cec6,TCGA-G2-A2EC-10A-01D-A17R_120927_SN208_0433_BD1D5JACXX_s_6_rg.sorted.filtered.,WGS,TCGA-G2-A2EC-10A-01D-A17R_120927_SN208_0433_BD1D5JACXX_s_6_rg.sorted,TCGA-G2-A2EC-10A-01D-A17R_120927_SN208_0433_BD1D5JACXX_s_6_rg.sorted.bam,39.61,NA,0.17,58cfa832e4b0c9d6adf6cec6,TCGA-G2-A2EC-10A-01D-A17R_120927_SN208_0433_BD1D5JACXX_s_6_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-G2-A2EC-10A,28E25FFB-8B0C-4839-A735-ED7B78E3213A,Blood Derived Normal,Illumina HiSeq,b2ae08c3-020a-401c-9a25-c937c153c403,Bladder,58,9F4EE11B-298A-4F1A-867A-86BBA1372476,87406693-CC45-41E6-94D2-0D6933577BCA,TCGA-G2-A2EC-10A-01D-A17R-02,HG19_Broad_variant,TCGA-G2-A2EC,TCGA-BLCA,NA,s2727,Harvard Medical School,MD Anderson,United States,NO,Not available,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa831e4b0c9d6adf6cd4e,58cfa831e4b0c9d6adf6cd4e,TCGA-ET-A25R-10A-01D-A16N_120805_SN208_0422_BD16VPACXX_s_7_rg.sorted.filtered.,WGS,TCGA-ET-A25R-10A-01D-A16N_120805_SN208_0422_BD16VPACXX_s_7_rg.sorted,TCGA-ET-A25R-10A-01D-A16N_120805_SN208_0422_BD16VPACXX_s_7_rg.sorted.bam,33.46,1.62,0.18,58cfa831e4b0c9d6adf6cd4e,TCGA-ET-A25R-10A-01D-A16N_120805_SN208_0422_BD16VPACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-ET-A25R-10A,097B9CF1-EC0C-487C-9ADE-2BDAB12EB4CA,Blood Derived Normal,Illumina HiSeq,ff72e312-4484-403b-a19c-43c5dca61c5f,Thyroid,51,18E68337-FFFC-49E9-BAA5-0CA0948FDD5A,4A3F2DC0-834F-4D82-82CD-41BEC8AC61E6,TCGA-ET-A25R-10A-01D-A16N-02,HG19_Broad_variant,TCGA-ET-A25R,TCGA-THCA,NA,s12527,Harvard Medical School,Johns Hopkins,United States,NO,T3,NX,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage III
13722.58cfa830e4b0c9d6adf6bef8,58cfa830e4b0c9d6adf6bef8,TCGA-BJ-A28W-01A-11D-A16N_120805_SN208_0421_AC11HPACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BJ-A28W-01A-11D-A16N_120805_SN208_0421_AC11HPACXX_s_2_rg.sorted,TCGA-BJ-A28W-01A-11D-A16N_120805_SN208_0421_AC11HPACXX_s_2_rg.sorted.bam,59.66,1.88,0.17,58cfa830e4b0c9d6adf6bef8,TCGA-BJ-A28W-01A-11D-A16N_120805_SN208_0421_AC11HPACXX_s_2_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A28W-01A,A6D37F61-BECA-46EA-A59A-62257475AC77,Primary Tumor,Illumina HiSeq,32effbdc-7d3b-4ad8-9245-1a253cbe1ff3,Thyroid,32,32AEF736-82A4-4813-A272-86EF160E7D56,229AD821-4BB0-4046-B5E6-6193005D3C8A,TCGA-BJ-A28W-01A-11D-A16N-02,HG19_Broad_variant,TCGA-BJ-A28W,TCGA-THCA,NA,s12507,Harvard Medical School,University of Pittsburgh,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6cf12,58cfa832e4b0c9d6adf6cf12,TCGA-H7-7774-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_3_rg.sorted.filtered.,WGS,TCGA-H7-7774-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_3_rg.sorted,TCGA-H7-7774-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_3_rg.sorted.bam,85.03,NA,0.15,58cfa832e4b0c9d6adf6cf12,TCGA-H7-7774-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-H7-7774-10A,EEAE67AC-C9E0-468D-AAD6-052501F7B982,Blood Derived Normal,Illumina HiSeq,4b8c5d66-16c6-43b0-8204-3a12b6a6394b,Head and Neck,75,51C3E2E6-E44A-4259-9F28-3DA984FE0664,F7E34DFA-8785-43E9-904B-1C7AFD2AFDC2,TCGA-H7-7774-10A-01D-2317-26,HG19_Broad_variant,TCGA-H7-7774,TCGA-HNSC,NA,s15917,MD Anderson - Institute for Applied Cancer Science,ABS - IUPUI,United States,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c7b0,58cfa831e4b0c9d6adf6c7b0,TCGA-D7-5578-10A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_5_rg.sorted.filtered.,WGS,TCGA-D7-5578-10A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_5_rg.sorted,TCGA-D7-5578-10A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_5_rg.sorted.bam,38.7,1.9,0.16,58cfa831e4b0c9d6adf6c7b0,TCGA-D7-5578-10A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-5578-10A,A3C1F9A2-9174-48CF-81DC-2AFCFDC4BA9C,Blood Derived Normal,Illumina HiSeq,a07d68ed-d63d-42c7-80dc-29e0c8cf5367,Stomach,80,51391BD9-2B63-47FB-888F-36F2F026F342,37CFFDEC-C98B-4657-AF4F-37C07C05EE16,TCGA-D7-5578-10A-01D-1598-02,HG19_Broad_variant,TCGA-D7-5578,TCGA-STAD,NA,s15196,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T3,N2,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIIA
13722.58cfa831e4b0c9d6adf6c9b9,58cfa831e4b0c9d6adf6c9b9,TCGA-DK-A3IL-10A-01D-A210_120913_SN208_0428_BC188KACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DK-A3IL-10A-01D-A210_120913_SN208_0428_BC188KACXX_s_4_rg.sorted,TCGA-DK-A3IL-10A-01D-A210_120913_SN208_0428_BC188KACXX_s_4_rg.sorted.bam,43.72,NA,0.15,58cfa831e4b0c9d6adf6c9b9,TCGA-DK-A3IL-10A-01D-A210_120913_SN208_0428_BC188KACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3IL-10A,178B28CD-99C3-48DC-8D09-1EF71B4CEE80,Blood Derived Normal,Illumina HiSeq,bacc62d8-d2ef-4268-8478-db3af3db5479,Bladder,79,CD3CFB26-E66F-408E-81F6-3B61C247C976,B497E684-A149-4AB1-B224-9EFC28ECE539,TCGA-DK-A3IL-10A-01D-A210-26,HG19_Broad_variant,TCGA-DK-A3IL,TCGA-BLCA,NA,s3279,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c7da,58cfa831e4b0c9d6adf6c7da,TCGA-CV-7091-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CV-7091-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_8_rg.sorted,TCGA-CV-7091-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_8_rg.sorted.bam,289.73,NA,0.15,58cfa831e4b0c9d6adf6c7da,TCGA-CV-7091-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7091-01A,2A192049-6435-49AB-8444-DDEB2B9EE774,Primary Tumor,Illumina HiSeq,8a0170b3-9cda-4426-be4b-9e488f6244c2,Head and Neck,54,3AB78DC4-682E-4B5A-ADDA-223ACF0FBB6A,78998DCE-A468-416B-9F81-D64E43B52883,TCGA-CV-7091-01A-11D-2317-26,HG19_Broad_variant,TCGA-CV-7091,TCGA-HNSC,NA,s16342,MD Anderson - Institute for Applied Cancer Science,MD Anderson Cancer Center,United States,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6cbf4,58cfa831e4b0c9d6adf6cbf4,TCGA-EJ-7782-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EJ-7782-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_8_rg.sorted,TCGA-EJ-7782-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_8_rg.sorted.bam,344.3,NA,0.16,58cfa831e4b0c9d6adf6cbf4,TCGA-EJ-7782-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_8_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7782-01A,1426B4BF-F4A5-477C-BBBB-E0E656549764,Primary Tumor,Illumina HiSeq,f92312ba-ec6b-477e-a08c-12c8af6d1775,Prostate,71,951C894E-9354-45AD-834A-FFC04441A3A9,47FB5E53-DD88-4B25-B6EF-C1ABE55FD5BA,TCGA-EJ-7782-01A-11D-2111-02,HG19_Broad_variant,TCGA-EJ-7782,TCGA-PRAD,NA,s3794,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cd6c,58cfa831e4b0c9d6adf6cd6c,TCGA-ET-A25R-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_4_rg.sorted.filtered.,WGS,TCGA-ET-A25R-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_4_rg.sorted,TCGA-ET-A25R-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_4_rg.sorted.bam,101.84,1.93,0.17,58cfa831e4b0c9d6adf6cd6c,TCGA-ET-A25R-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-ET-A25R-01A,097B9CF1-EC0C-487C-9ADE-2BDAB12EB4CA,Primary Tumor,Illumina HiSeq,442f6193-a979-40e4-89db-2e541d3ebdb7,Thyroid,51,C29162A3-F162-4D32-AB9A-421BE1FEB13C,77A80565-1BC9-4F0A-AFB3-23955FE283EB,TCGA-ET-A25R-01A-11D-A16N-02,HG19_Broad_variant,TCGA-ET-A25R,TCGA-THCA,NA,s12003,Harvard Medical School,Johns Hopkins,United States,NO,T3,NX,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage III
13722.58cfa832e4b0c9d6adf6ce14,58cfa832e4b0c9d6adf6ce14,TCGA-EJ-5511-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EJ-5511-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_7_rg.sorted,TCGA-EJ-5511-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_7_rg.sorted.bam,398.7,1.9,0.15,58cfa832e4b0c9d6adf6ce14,TCGA-EJ-5511-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_7_rg.sorted.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5511-01A,F8A42FEB-FBC9-4A13-BAD5-1DCEFCA2A9BF,Primary Tumor,Illumina HiSeq,dfa7170d-3cc1-43b7-9d24-7be107cf2896,Prostate,55,1DA89009-5DBE-4D62-9406-36330F47B738,5D753860-8965-45E5-A919-C076B53334D4,TCGA-EJ-5511-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5511,TCGA-PRAD,NA,s3600,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6ccbe,58cfa831e4b0c9d6adf6ccbe,TCGA-EJ-5507-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EJ-5507-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_8_rg.sorted,TCGA-EJ-5507-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_8_rg.sorted.bam,138.4,1.8,0.15,58cfa831e4b0c9d6adf6ccbe,TCGA-EJ-5507-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5507-10A,607200F5-DF80-4F5D-90FB-FDC455A7415B,Blood Derived Normal,Illumina HiSeq,f6d132bc-c74a-4472-8e91-6d86e10f785e,Prostate,54,B4886477-D3F2-4C34-8104-0C379C64F38D,69C6307E-B897-4B90-BBA9-14DE96F14864,TCGA-EJ-5507-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5507,TCGA-PRAD,NA,s3431,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82fe4b0c9d6adf6b9c0,58cfa82fe4b0c9d6adf6b9c0,TCGA-75-5147-10A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_7_rg.sorted.filtered.,WGS,TCGA-75-5147-10A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_7_rg.sorted,TCGA-75-5147-10A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_7_rg.sorted.bam,46.4,1.9,0.15,58cfa82fe4b0c9d6adf6b9c0,TCGA-75-5147-10A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_7_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-5147-10A,D2824E6D-3784-45C2-9B0F-52B17356B5DA,Blood Derived Normal,Illumina HiSeq,1bbeacf6-d839-4656-a6ac-354d5ceae738,Lung,NA,C6EB2230-098B-4B50-85F5-1CDDFB1FB9A3,D20B4B63-2D12-4958-9BA8-E8B7538CA472,TCGA-75-5147-10A-01D-1623-02,HG19_Broad_variant,TCGA-75-5147,TCGA-LUAD,NA,s11250,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c938,58cfa831e4b0c9d6adf6c938,TCGA-DH-5143-10A-01D-1465_130806_SN1222_0209_AD2AW0ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-DH-5143-10A-01D-1465_130806_SN1222_0209_AD2AW0ACXX_s_2_rg.sorted,TCGA-DH-5143-10A-01D-1465_130806_SN1222_0209_AD2AW0ACXX_s_2_rg.sorted.bam,749.7,1.9,0.15,58cfa831e4b0c9d6adf6c938,TCGA-DH-5143-10A-01D-1465_130806_SN1222_0209_AD2AW0ACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DH-5143-10A,DCD0856D-423A-40D7-8070-4C0988D61416,Blood Derived Normal,Illumina HiSeq,14764abf-abd2-4bc1-a8ee-79b07761338f,Brain,30,D5E50908-DDB0-4887-B6C3-63038AD511B8,15453F10-46D7-40AC-9B5E-5FB44E05FCE5,TCGA-DH-5143-10A-01D-1465-02,HG19_Broad_variant,TCGA-DH-5143,TCGA-LGG,NA,s8132,Harvard Medical School,University of Florida,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa831e4b0c9d6adf6c90a,58cfa831e4b0c9d6adf6c90a,TCGA-DU-5849-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DU-5849-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_5_rg.sorted,TCGA-DU-5849-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_5_rg.sorted.bam,97.3,1.8,0.14,58cfa831e4b0c9d6adf6c90a,TCGA-DU-5849-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-5849-01A,5AF8ADA5-86B5-4832-8A8E-E975ECCA5515,Primary Tumor,Illumina HiSeq,d4f0a4e9-de7c-498f-89e7-aad71fb01915,Brain,48,9E0E239F-CED4-4CF3-BF3C-5EC8224D760B,7732E26C-3B82-4D03-A331-82D8088CEB44,TCGA-DU-5849-01A-11D-1703-02,HG19_Broad_variant,TCGA-DU-5849,TCGA-LGG,NA,s8349,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6cbb5,58cfa831e4b0c9d6adf6cbb5,TCGA-EJ-5507-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_7_rg.sorted.filtered.,WGS,TCGA-EJ-5507-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_7_rg.sorted,TCGA-EJ-5507-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_7_rg.sorted.bam,347.7,1.9,0.15,58cfa831e4b0c9d6adf6cbb5,TCGA-EJ-5507-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5507-01A,607200F5-DF80-4F5D-90FB-FDC455A7415B,Primary Tumor,Illumina HiSeq,0dbb7308-269c-4ad8-97c7-e7475ae08189,Prostate,54,F93327F7-0290-4915-97BB-E31BAE2697DD,D2336094-05BD-4E89-84A3-91D641DC31D0,TCGA-EJ-5507-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5507,TCGA-PRAD,NA,s3787,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c6e4,58cfa831e4b0c9d6adf6c6e4,TCGA-CS-4941-10A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-CS-4941-10A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_2_rg.sorted,TCGA-CS-4941-10A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_2_rg.sorted.bam,354.7,1.9,0.15,58cfa831e4b0c9d6adf6c6e4,TCGA-CS-4941-10A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-4941-10A,FC222F23-B3B2-4AC0-BC61-E8E8FA5CC160,Blood Derived Normal,Illumina HiSeq,76207c4c-20a5-4a76-aa64-df7b90201a78,Brain,67,FC331AA4-2641-4A1F-9AA2-64C8829438E0,82E2CAEA-0FD6-4C5F-A831-F7387621D603,TCGA-CS-4941-10A-01D-1465-02,HG19_Broad_variant,TCGA-CS-4941,TCGA-LGG,234,s8749,Harvard Medical School,Thomas Jefferson University,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6cce5,58cfa831e4b0c9d6adf6cce5,TCGA-EJ-5505-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EJ-5505-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_4_rg.sorted,TCGA-EJ-5505-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_4_rg.sorted.bam,499.4,1.9,0.16,58cfa831e4b0c9d6adf6cce5,TCGA-EJ-5505-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5505-10A,1EA3B879-5451-49FB-B930-16E9B5627F18,Blood Derived Normal,Illumina HiSeq,b49d48cf-faee-4790-83ab-3920e77326b5,Prostate,57,466BD165-3778-4F22-9F3C-CAE696CDD633,813653EC-4D2B-4B69-B89D-9F6716542CE5,TCGA-EJ-5505-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5505,TCGA-PRAD,NA,s3436,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6be76,58cfa830e4b0c9d6adf6be76,TCGA-BJ-A3PU-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-BJ-A3PU-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_5_rg.sorted,TCGA-BJ-A3PU-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_5_rg.sorted.bam,52.74,NA,0.15,58cfa830e4b0c9d6adf6be76,TCGA-BJ-A3PU-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A3PU-01A,4CCCC34B-DAF6-41CA-9BF8-F1614525EAC9,Primary Tumor,Illumina HiSeq,42209b7e-0b20-42c9-aa80-993445de4b03,Thyroid,52,0BE2571E-3572-4974-95CE-21B9972B24B2,C290C4E6-11FF-49B6-89A1-0332A8D8DD6B,TCGA-BJ-A3PU-01A-11D-A221-26,HG19_Broad_variant,TCGA-BJ-A3PU,TCGA-THCA,NA,s12361,MD Anderson - RPPA Core Facility (Proteomics),University of Pittsburgh,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa831e4b0c9d6adf6c945,58cfa831e4b0c9d6adf6c945,TCGA-D7-6818-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_1_rg.sorted.filtered.,WGS,TCGA-D7-6818-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_1_rg.sorted,TCGA-D7-6818-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_1_rg.sorted.bam,113.7,1.9,0.14,58cfa831e4b0c9d6adf6c945,TCGA-D7-6818-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6818-01A,AA2934F9-8783-428E-88A6-1D04B93FA1FD,Primary Tumor,Illumina HiSeq,5a217dfc-ada8-4dec-8f7c-06be0123b9ef,Stomach,53,953E155F-D9E1-41C8-BA12-351A38195D22,21E75BA4-E4C1-4D8A-BFA2-E4698B4FB46B,TCGA-D7-6818-01A-11D-1880-02,HG19_Broad_variant,TCGA-D7-6818,TCGA-STAD,NA,s15464,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA
13722.58cfa831e4b0c9d6adf6cd23,58cfa831e4b0c9d6adf6cd23,TCGA-F1-6874-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_7_rg.sorted.filtered.,WGS,TCGA-F1-6874-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_7_rg.sorted,TCGA-F1-6874-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_7_rg.sorted.bam,373.7,1.9,0.14,58cfa831e4b0c9d6adf6cd23,TCGA-F1-6874-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-F1-6874-01A,106F3344-F699-4B2C-8F62-4AC6C948DDE4,Primary Tumor,Illumina HiSeq,734d68fe-de19-4aef-8031-8ba255233eba,Stomach,79,C28FEBB9-E845-462F-B6A0-CB565EE6A049,273DDC2E-8E77-4F81-85C2-B9A8583D9E1D,TCGA-F1-6874-01A-11D-1880-02,HG19_Broad_variant,TCGA-F1-6874,TCGA-STAD,NA,s14773,Harvard Medical School,UNC,United States,NO,T2,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa830e4b0c9d6adf6bf60,58cfa830e4b0c9d6adf6bf60,TCGA-BR-4357-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_5_rg.sorted.filtered.,WGS,TCGA-BR-4357-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_5_rg.sorted,TCGA-BR-4357-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_5_rg.sorted.bam,197.2,1.9,0.16,58cfa830e4b0c9d6adf6bf60,TCGA-BR-4357-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4357-01A,BEC83DFF-2BBA-4467-92AA-5DC3DB9E0EAF,Primary Tumor,Illumina HiSeq,4bc9f55b-1edb-49c9-be1a-1d00a108b99b,Stomach,58,81C87C27-47C7-4DC7-BF92-E0037433DF30,93F60FA6-0D34-441E-8F61-80306E10D046,TCGA-BR-4357-01A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4357,TCGA-STAD,NA,s15301,Harvard Medical School,Asterand,Russia,NO,T3,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available
13722.58cfa831e4b0c9d6adf6cbc1,58cfa831e4b0c9d6adf6cbc1,TCGA-EJ-7784-10A-01D-2111_130502_SN590_0229_BD2459ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EJ-7784-10A-01D-2111_130502_SN590_0229_BD2459ACXX_s_3_rg.sorted,TCGA-EJ-7784-10A-01D-2111_130502_SN590_0229_BD2459ACXX_s_3_rg.sorted.bam,304.6,NA,0.16,58cfa831e4b0c9d6adf6cbc1,TCGA-EJ-7784-10A-01D-2111_130502_SN590_0229_BD2459ACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7784-10A,4BC71292-60BB-4B63-86C1-0FE021083804,Blood Derived Normal,Illumina HiSeq,9c78d3ff-5257-47e3-86d4-8c7bbdfc5130,Prostate,63,83FA44AA-DFC8-4A1F-9F87-09B0660C3F21,839085D9-2754-467B-AA09-E9558DCA5D88,TCGA-EJ-7784-10A-01D-2111-02,HG19_Broad_variant,TCGA-EJ-7784,TCGA-PRAD,NA,s3957,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6ceda,58cfa832e4b0c9d6adf6ceda,TCGA-EJ-5505-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_3_rg.sorted.filtered.,WGS,TCGA-EJ-5505-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_3_rg.sorted,TCGA-EJ-5505-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_3_rg.sorted.bam,164.7,1.9,0.14,58cfa832e4b0c9d6adf6ceda,TCGA-EJ-5505-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5505-01A,1EA3B879-5451-49FB-B930-16E9B5627F18,Primary Tumor,Illumina HiSeq,156ad547-dfb8-48c9-88b9-6842c81fead1,Prostate,57,A31147E1-4A52-4233-BC27-B0DFA6708DC6,3AB7712C-40E4-4752-AC1D-0CB9D7345413,TCGA-EJ-5505-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5505,TCGA-PRAD,NA,s3605,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6ca5a,58cfa831e4b0c9d6adf6ca5a,TCGA-DK-A3IN-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DK-A3IN-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_1_rg.sorted,TCGA-DK-A3IN-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_1_rg.sorted.bam,36.12,NA,0.15,58cfa831e4b0c9d6adf6ca5a,TCGA-DK-A3IN-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_1_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3IN-01A,FC0032DB-B6D8-4DA3-BD1B-BEEC4196ABF0,Primary Tumor,Illumina HiSeq,ff3d1235-2aed-4091-a8a2-72340b403e05,Bladder,72,F8C14183-3982-44E5-967E-03967EAA8123,11901B8B-BE4C-4914-8D50-06EA0128EB39,TCGA-DK-A3IN-01A-11D-A210-26,HG19_Broad_variant,TCGA-DK-A3IN,TCGA-BLCA,250,s2890,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T4a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6cedd,58cfa832e4b0c9d6adf6cedd,TCGA-EJ-5508-01A-02D-1572_130308_SN590_0219_BC1UVPACXX_s_1_rg.sorted.filtered.,WGS,TCGA-EJ-5508-01A-02D-1572_130308_SN590_0219_BC1UVPACXX_s_1_rg.sorted,TCGA-EJ-5508-01A-02D-1572_130308_SN590_0219_BC1UVPACXX_s_1_rg.sorted.bam,256.7,1.9,0.15,58cfa832e4b0c9d6adf6cedd,TCGA-EJ-5508-01A-02D-1572_130308_SN590_0219_BC1UVPACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5508-01A,BD18DD01-D894-4BDD-9CE2-E25705A52A57,Primary Tumor,Illumina HiSeq,69098ac9-e4d2-44cd-ae04-e179d90a749e,Prostate,65,E3969BF5-B0CC-49E3-B8CB-3D9E98F1676D,706963B3-03D9-4990-AE75-09F8781D79B7,TCGA-EJ-5508-01A-02D-1572-02,HG19_Broad_variant,TCGA-EJ-5508,TCGA-PRAD,NA,s3784,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cd30,58cfa831e4b0c9d6adf6cd30,TCGA-F1-6874-10A-01D-1880_121220_SN1120_0207_BC1JALACXX_s_8_rg.sorted.filtered.,WGS,TCGA-F1-6874-10A-01D-1880_121220_SN1120_0207_BC1JALACXX_s_8_rg.sorted,TCGA-F1-6874-10A-01D-1880_121220_SN1120_0207_BC1JALACXX_s_8_rg.sorted.bam,82,1.9,0.13,58cfa831e4b0c9d6adf6cd30,TCGA-F1-6874-10A-01D-1880_121220_SN1120_0207_BC1JALACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-F1-6874-10A,106F3344-F699-4B2C-8F62-4AC6C948DDE4,Blood Derived Normal,Illumina HiSeq,478d46a8-c228-4b0d-9d5b-c433514e64d3,Stomach,79,76368D40-D8B0-453A-82B6-F45C61C124D3,A132AFF7-EF8D-4844-B2EF-F3A4CE6BE7B0,TCGA-F1-6874-10A-01D-1880-02,HG19_Broad_variant,TCGA-F1-6874,TCGA-STAD,NA,s14425,Harvard Medical School,UNC,United States,NO,T2,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6ccba,58cfa831e4b0c9d6adf6ccba,TCGA-EJ-7785-10A-01D-2111_130502_SN590_0229_BD2459ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EJ-7785-10A-01D-2111_130502_SN590_0229_BD2459ACXX_s_5_rg.sorted,TCGA-EJ-7785-10A-01D-2111_130502_SN590_0229_BD2459ACXX_s_5_rg.sorted.bam,282.6,NA,0.15,58cfa831e4b0c9d6adf6ccba,TCGA-EJ-7785-10A-01D-2111_130502_SN590_0229_BD2459ACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7785-10A,2DEF2A53-D2E8-46F0-8B07-F32DBF1833A4,Blood Derived Normal,Illumina HiSeq,138e80f6-23a0-459a-9177-6dd8c1ce4b69,Prostate,54,8922B439-8133-4337-B4A3-1B46AE61B8D5,806ADA5A-32C9-43F2-BE24-8A563C07DB1E,TCGA-EJ-7785-10A-01D-2111-02,HG19_Broad_variant,TCGA-EJ-7785,TCGA-PRAD,NA,s4142,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82fe4b0c9d6adf6b61e,58cfa82fe4b0c9d6adf6b61e,TCGA-75-5146-10A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_5_rg.sorted.filtered.,WGS,TCGA-75-5146-10A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_5_rg.sorted,TCGA-75-5146-10A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_5_rg.sorted.bam,300.4,1.9,0.16,58cfa82fe4b0c9d6adf6b61e,TCGA-75-5146-10A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_5_rg.sorted.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-5146-10A,1D276B62-5E64-48FB-B2CE-5192B511FE37,Blood Derived Normal,Illumina HiSeq,22cccb1d-1901-4369-8c11-24895005a4df,Lung,NA,5F68BDF1-1348-483B-8595-A8DB4044BF1F,0FB64824-EACC-4E60-B834-21E990B18FC5,TCGA-75-5146-10A-01D-1623-02,HG19_Broad_variant,TCGA-75-5146,TCGA-LUAD,NA,s10798,Harvard Medical School,Ontario Institute for Cancer Research (OICR),Canada,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6c6ac,58cfa831e4b0c9d6adf6c6ac,TCGA-CQ-6223-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CQ-6223-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_7_rg.sorted,TCGA-CQ-6223-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_7_rg.sorted.bam,55,NA,0.14,58cfa831e4b0c9d6adf6c6ac,TCGA-CQ-6223-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-6223-10A,D9E8C707-E61A-4813-8DC0-2472E9CCF12B,Blood Derived Normal,Illumina HiSeq,e392e96d-65fa-489f-829d-9a222f0ff650,Head and Neck,69,2AE7FBDA-7434-4105-9FED-C5F650BF10DB,4189A43B-649F-4495-B4FB-3B452E53BCFC,TCGA-CQ-6223-10A-01D-1911-02,HG19_Broad_variant,TCGA-CQ-6223,TCGA-HNSC,NA,s15630,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6ca7a,58cfa831e4b0c9d6adf6ca7a,TCGA-DK-A3IT-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_6_rg.sorted.filtered.,WGS,TCGA-DK-A3IT-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_6_rg.sorted,TCGA-DK-A3IT-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_6_rg.sorted.bam,22.32,NA,0.15,58cfa831e4b0c9d6adf6ca7a,TCGA-DK-A3IT-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_6_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3IT-10A,58520C66-7688-435A-B09F-653B18768C41,Blood Derived Normal,Illumina HiSeq,a0fae593-7715-4c62-865f-1a19df61e8c1,Bladder,62,6FEB6861-FDCD-48B4-8B5B-E5B977832E17,9707C724-039B-4347-AFA6-F6668BBEE70D,TCGA-DK-A3IT-10A-01D-A210-26,HG19_Broad_variant,TCGA-DK-A3IT,TCGA-BLCA,NA,s2718,MD Anderson - Institute for Applied Cancer Science,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c7f8,58cfa831e4b0c9d6adf6c7f8,TCGA-CN-6998-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-CN-6998-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_1_rg.sorted,TCGA-CN-6998-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_1_rg.sorted.bam,955.03,NA,0.14,58cfa831e4b0c9d6adf6c7f8,TCGA-CN-6998-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-6998-10A,039788EC-1364-40C7-9E9D-13DC305674E9,Blood Derived Normal,Illumina HiSeq,3bcec620-bcec-4025-afe3-25731e0db2a4,Head and Neck,53,5938BBFB-E390-437D-BC1F-BFC0FD6A9497,81C32657-4CBF-41AA-BFD9-7F4D50D33275,TCGA-CN-6998-10A-01D-2317-26,HG19_Broad_variant,TCGA-CN-6998,TCGA-HNSC,NA,s15508,MD Anderson - Institute for Applied Cancer Science,University of Pittsburgh,United States,NO,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c782,58cfa831e4b0c9d6adf6c782,TCGA-CV-6959-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CV-6959-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_8_rg.sorted,TCGA-CV-6959-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_8_rg.sorted.bam,16,1.9,0.15,58cfa831e4b0c9d6adf6c782,TCGA-CV-6959-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6959-10A,EF3CE0E5-D2E8-4616-8B1A-A78C591CF235,Blood Derived Normal,Illumina HiSeq,4eee28c3-7d03-46c8-99b8-b3b17fce88d8,Head and Neck,48,854B6BC0-3318-4D35-A6F5-6F598E47870C,8862CE4E-8AA5-4542-8750-67B26759B7D1,TCGA-CV-6959-10A-01D-1911-02,HG19_Broad_variant,TCGA-CV-6959,TCGA-HNSC,256,s16340,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa830e4b0c9d6adf6bf7c,58cfa830e4b0c9d6adf6bf7c,TCGA-B5-A0K0-10A-01D-A043_120322_SN208_0278_BD0RB0ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-B5-A0K0-10A-01D-A043_120322_SN208_0278_BD0RB0ACXX_s_5_rg.sorted,TCGA-B5-A0K0-10A-01D-A043_120322_SN208_0278_BD0RB0ACXX_s_5_rg.sorted.bam,43.36,1.97,0.15,58cfa830e4b0c9d6adf6bf7c,TCGA-B5-A0K0-10A-01D-A043_120322_SN208_0278_BD0RB0ACXX_s_5_rg.sorted.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0K0-10A,29C8F468-5AC1-4D6C-8376-E36E6D246926,Blood Derived Normal,Illumina HiSeq,6391c247-10cf-4199-a09a-ff94a9633944,Uterus,48,1DF69E2E-F392-465F-8E61-4671BA2FCD35,3CB411F8-9308-4CED-822B-C94FE602AB73,TCGA-B5-A0K0-10A-01D-A043-02,HG19_Broad_variant,TCGA-B5-A0K0,TCGA-UCEC,NA,s4246,Harvard Medical School,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b668,58cfa82fe4b0c9d6adf6b668,TCGA-55-6642-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_1_rg.sorted.filtered.,WGS,TCGA-55-6642-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_1_rg.sorted,TCGA-55-6642-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_1_rg.sorted.bam,245.7,1.9,0.14,58cfa82fe4b0c9d6adf6b668,TCGA-55-6642-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-55-6642-01A,474B86D9-D897-467D-85D4-51DFA26EA107,Primary Tumor,Illumina HiSeq,9b12800d-6911-4d3f-a25e-4d1b686b63aa,Lung,63,08D8F333-08F9-4268-99B7-61F7B057F542,93AF51CC-26FF-4904-84BC-2DFFB317D86A,TCGA-55-6642-01A-11D-1853-02,HG19_Broad_variant,TCGA-55-6642,TCGA-LUAD,NA,s11552,Harvard Medical School,International Genomics Consortium,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6cc9a,58cfa831e4b0c9d6adf6cc9a,TCGA-EE-A2MI-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EE-A2MI-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_8_rg.sorted,TCGA-EE-A2MI-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_8_rg.sorted.bam,26.57,NA,0.15,58cfa831e4b0c9d6adf6cc9a,TCGA-EE-A2MI-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_8_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MI-10A,C061AE6C-7A02-47C3-AECD-A56487C01603,Blood Derived Normal,Illumina HiSeq,270078f3-9359-471b-99e5-0c398664d8ef,Skin,43,A0DABFDB-1FCF-47E3-B822-7E4B54D9B38E,B1AE52DE-36C5-4F03-9302-B226F153B066,TCGA-EE-A2MI-10A-01D-A190-02,HG19_Broad_variant,TCGA-EE-A2MI,TCGA-SKCM,6225,s7345,Harvard Medical School,University of Sydney,Australia,NO,T4,N0,Not available,Stage IIB
13722.58cfa831e4b0c9d6adf6cb90,58cfa831e4b0c9d6adf6cb90,TCGA-EJ-5508-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EJ-5508-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_2_rg.sorted,TCGA-EJ-5508-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_2_rg.sorted.bam,1081.4,1.9,0.17,58cfa831e4b0c9d6adf6cb90,TCGA-EJ-5508-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5508-10A,BD18DD01-D894-4BDD-9CE2-E25705A52A57,Blood Derived Normal,Illumina HiSeq,0d2993b7-024f-4363-9ff1-9d3ce308eca0,Prostate,65,8E8F4F4E-5BE8-4372-8DC0-19B70A671E24,40F79B17-FF1D-4EF6-A784-2D6B3952C371,TCGA-EJ-5508-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5508,TCGA-PRAD,NA,s3434,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6cc92,58cfa831e4b0c9d6adf6cc92,TCGA-EJ-5510-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_5_rg.sorted.filtered.,WGS,TCGA-EJ-5510-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_5_rg.sorted,TCGA-EJ-5510-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_5_rg.sorted.bam,52.7,1.9,0.15,58cfa831e4b0c9d6adf6cc92,TCGA-EJ-5510-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5510-01A,4A3D9EFE-F24E-4135-8A70-E202651E7A81,Primary Tumor,Illumina HiSeq,95ce00b3-cfc9-4400-ab07-de043b39cccf,Prostate,48,3EAE6B68-D333-4B36-9E70-D2BED19C1DFA,495CB006-3042-4F8A-9AFA-9C10415DBB26,TCGA-EJ-5510-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5510,TCGA-PRAD,NA,s3603,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6ccea,58cfa831e4b0c9d6adf6ccea,TCGA-EJ-5509-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_4_rg.sorted.filtered.,WGS,TCGA-EJ-5509-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_4_rg.sorted,TCGA-EJ-5509-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_4_rg.sorted.bam,132.4,1.9,0.15,58cfa831e4b0c9d6adf6ccea,TCGA-EJ-5509-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_4_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5509-10A,13CE70A8-785C-4B59-B073-41922CB201F9,Blood Derived Normal,Illumina HiSeq,47e80516-5fba-4339-88e2-fbf8f7c524af,Prostate,63,1BD3E76B-3C7D-4143-A4BB-2356B18848B2,FDF3FF32-0919-4AF4-9BA3-E5907B77F134,TCGA-EJ-5509-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5509,TCGA-PRAD,NA,s3781,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6ca3c,58cfa831e4b0c9d6adf6ca3c,TCGA-DH-5143-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DH-5143-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_5_rg.sorted,TCGA-DH-5143-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_5_rg.sorted.bam,48,1.9,0.16,58cfa831e4b0c9d6adf6ca3c,TCGA-DH-5143-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_5_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DH-5143-01A,DCD0856D-423A-40D7-8070-4C0988D61416,Primary Tumor,Illumina HiSeq,9e2bca97-d504-4863-b306-8f559a2cc8a1,Brain,30,570101B6-3670-4D1A-A94D-0DDC8DF42061,55952783-8C2C-4528-A544-B4C962AB634A,TCGA-DH-5143-01A-01D-1465-02,HG19_Broad_variant,TCGA-DH-5143,TCGA-LGG,NA,s8753,Harvard Medical School,University of Florida,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa830e4b0c9d6adf6c238,58cfa830e4b0c9d6adf6c238,TCGA-BT-A20Q-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_6_rg.sorted.filtered.,WGS,TCGA-BT-A20Q-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_6_rg.sorted,TCGA-BT-A20Q-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_6_rg.sorted.bam,7,1.89,0.14,58cfa830e4b0c9d6adf6c238,TCGA-BT-A20Q-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_6_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20Q-11A,419DEAAC-EA45-4BDD-9FA0-B5CD8429B44F,Solid Tissue Normal,Illumina HiSeq,6669a6f9-a976-4716-a57d-7b08ef6afd14,Bladder,73,DF346965-B972-445D-9AAC-35605B908F4D,51F7BC24-EEEB-407E-BCB0-531A5092067A,TCGA-BT-A20Q-11A-11D-A14U-02,HG19_Broad_variant,TCGA-BT-A20Q,TCGA-BLCA,593,s2694,Harvard Medical School,University of Pittsburgh,United States,NO,T3b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6ccda,58cfa831e4b0c9d6adf6ccda,TCGA-EJ-5504-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_2_rg.sorted.filtered.,WGS,TCGA-EJ-5504-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_2_rg.sorted,TCGA-EJ-5504-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_2_rg.sorted.bam,178.4,1.9,0.15,58cfa831e4b0c9d6adf6ccda,TCGA-EJ-5504-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_2_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5504-10A,E1C3D1BD-CF8F-4FA4-AC8E-BF9E54F7AAD4,Blood Derived Normal,Illumina HiSeq,fdf14dea-7dab-403e-9c85-8b16dcf88d2c,Prostate,65,EFA8FC5E-04B7-47D0-8861-A36B500E0764,7EE9D6AF-14EE-4475-9D16-DD8252FE8410,TCGA-EJ-5504-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5504,TCGA-PRAD,NA,s4135,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c032,58cfa830e4b0c9d6adf6c032,TCGA-BR-6852-01A-11D-1880_130115_SN590_0207_AC1H8PACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BR-6852-01A-11D-1880_130115_SN590_0207_AC1H8PACXX_s_7_rg.sorted,TCGA-BR-6852-01A-11D-1880_130115_SN590_0207_AC1H8PACXX_s_7_rg.sorted.bam,385.7,1.9,0.15,58cfa830e4b0c9d6adf6c032,TCGA-BR-6852-01A-11D-1880_130115_SN590_0207_AC1H8PACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6852-01A,44799C67-61CD-4F3E-BDBC-423E2E0FD2E8,Primary Tumor,Illumina HiSeq,bff2f642-516a-4072-95aa-f213a4555f79,Stomach,64,F230ED0B-8D08-4546-9762-923097B4BF02,20F8131D-3F7E-47C5-AE84-A3886A387514,TCGA-BR-6852-01A-11D-1880-02,HG19_Broad_variant,TCGA-BR-6852,TCGA-STAD,NA,s15387,Harvard Medical School,Asterand,Ukraine,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA
13722.58cfa830e4b0c9d6adf6c2f5,58cfa830e4b0c9d6adf6c2f5,TCGA-BR-6803-01A-11D-1880_130329_SN590_0221_BD1WHDACXX_s_7_rg.sorted.filtered.,WGS,TCGA-BR-6803-01A-11D-1880_130329_SN590_0221_BD1WHDACXX_s_7_rg.sorted,TCGA-BR-6803-01A-11D-1880_130329_SN590_0221_BD1WHDACXX_s_7_rg.sorted.bam,91.7,1.9,0.14,58cfa830e4b0c9d6adf6c2f5,TCGA-BR-6803-01A-11D-1880_130329_SN590_0221_BD1WHDACXX_s_7_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6803-01A,2F90209B-7464-4D7E-83D1-67850C263DED,Primary Tumor,Illumina HiSeq,af361f62-8dd0-4336-9fa9-41cdc800b18e,Stomach,54,E56FE72A-760A-4A60-9013-EA611080BA3F,D2F16739-9EAA-465D-95BA-D13C3AEB9A40,TCGA-BR-6803-01A-11D-1880-02,HG19_Broad_variant,TCGA-BR-6803,TCGA-STAD,NA,s15308,Harvard Medical School,Asterand,Russia,NO,T3,N0,Stomach  Adenocarcinoma  Diffuse Type,Stage IIA
13722.58cfa832e4b0c9d6adf6d0cc,58cfa832e4b0c9d6adf6d0cc,TCGA-IG-A3QL-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-IG-A3QL-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_7_rg.sorted,TCGA-IG-A3QL-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_7_rg.sorted.bam,27.52,NA,0.15,58cfa832e4b0c9d6adf6d0cc,TCGA-IG-A3QL-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A3QL-01A,0AC08ECF-4D70-48A4-9DFD-F44032551CB9,Primary Tumor,Illumina HiSeq,da10bdbe-12f7-41ed-b836-1689589d7ba2,Esophagus,54,D571A2B3-892B-46C4-883C-FDED4980492F,A48A75A1-B82B-4F4A-A04F-DFF6B1E801F1,TCGA-IG-A3QL-01A-11D-A248-26,HG19_Broad_variant,TCGA-IG-A3QL,TCGA-ESCA,NA,s1824,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T2,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6ca70,58cfa831e4b0c9d6adf6ca70,TCGA-DK-A1AB-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DK-A1AB-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_4_rg.sorted,TCGA-DK-A1AB-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_4_rg.sorted.bam,31.2,1.94,0.18,58cfa831e4b0c9d6adf6ca70,TCGA-DK-A1AB-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AB-10A,F027D254-EC01-4882-A8A7-964AE90B7D49,Blood Derived Normal,Illumina HiSeq,9eaeaeec-3d40-4c27-8e58-b9aa313a628f,Bladder,74,8A3DABE6-85A3-43E6-9223-654B16A7180B,DD644B8E-4BFF-4511-82CF-251EED30CD3E,TCGA-DK-A1AB-10A-01D-A13U-02,HG19_Broad_variant,TCGA-DK-A1AB,TCGA-BLCA,NA,s2705,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T4a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa831e4b0c9d6adf6c95b,58cfa831e4b0c9d6adf6c95b,TCGA-DU-5847-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-DU-5847-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_3_rg.sorted,TCGA-DU-5847-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_3_rg.sorted.bam,173.3,1.9,0.14,58cfa831e4b0c9d6adf6c95b,TCGA-DU-5847-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_3_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-5847-01A,92A7C445-2217-400A-BDCD-DF41502416B6,Primary Tumor,Illumina HiSeq,a76674c6-34c4-4c06-b7e4-eb602b3bc5fa,Brain,34,C68FC12C-C538-4A89-9F6E-C0800A5A6B53,F83FB674-A46C-47DE-BAD8-36605068D2E2,TCGA-DU-5847-01A-11D-1703-02,HG19_Broad_variant,TCGA-DU-5847,TCGA-LGG,NA,s8136,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6cbdb,58cfa831e4b0c9d6adf6cbdb,TCGA-EJ-5514-10A-01D-1573_130131_SN1120_0234_AD1PVUACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EJ-5514-10A-01D-1573_130131_SN1120_0234_AD1PVUACXX_s_8_rg.sorted,TCGA-EJ-5514-10A-01D-1573_130131_SN1120_0234_AD1PVUACXX_s_8_rg.sorted.bam,484.4,1.9,0.16,58cfa831e4b0c9d6adf6cbdb,TCGA-EJ-5514-10A-01D-1573_130131_SN1120_0234_AD1PVUACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5514-10A,F82D53B1-3DF8-4249-A615-464C9F4E0A32,Blood Derived Normal,Illumina HiSeq,eb55f146-90ca-458a-a1ae-b7e8347c700c,Prostate,66,EC2C8B2F-9FB0-49CB-B42F-ED7F03A3AF56,6EEFB25F-0E21-401F-8D8E-3F4305D40565,TCGA-EJ-5514-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5514,TCGA-PRAD,NA,s3943,Harvard Medical School,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6ca56,58cfa831e4b0c9d6adf6ca56,TCGA-DU-5852-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DU-5852-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_7_rg.sorted,TCGA-DU-5852-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_7_rg.sorted.bam,172.3,1.9,0.16,58cfa831e4b0c9d6adf6ca56,TCGA-DU-5852-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_7_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-5852-01A,9ED5AF0E-C87F-46FF-81E7-9D3041B4034E,Primary Tumor,Illumina HiSeq,9dd03595-2a2f-4fc1-9cd1-52a490696f01,Brain,61,101AAA90-FE0A-42B7-BCC7-4F44E29883EC,E5AF958A-0014-4259-970D-5E0EA3CAE376,TCGA-DU-5852-01A-11D-1703-02,HG19_Broad_variant,TCGA-DU-5852,TCGA-LGG,205,s8347,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa831e4b0c9d6adf6c832,58cfa831e4b0c9d6adf6c832,TCGA-CV-6954-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_7_rg.sorted.filtered.,WGS,TCGA-CV-6954-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_7_rg.sorted,TCGA-CV-6954-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_7_rg.sorted.bam,16,1.8,0.14,58cfa831e4b0c9d6adf6c832,TCGA-CV-6954-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_7_rg.sorted.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,Not available,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6954-10A,402FD96C-76D3-4AC2-9F64-77BD34BE0ADB,Blood Derived Normal,Illumina HiSeq,90995f22-7f27-483b-9410-bfd068cdbc20,Head and Neck,59,EAA7EA4D-7F53-4107-B147-EA87EFA8B954,2B5419A2-9E0E-40AF-9FC7-EA3A56780E87,TCGA-CV-6954-10A-01D-1911-02,HG19_Broad_variant,TCGA-CV-6954,TCGA-HNSC,2002,s16202,Harvard Medical School,MD Anderson Cancer Center,United States,NO,T4a,NX,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82fe4b0c9d6adf6b7ee,58cfa82fe4b0c9d6adf6b7ee,TCGA-91-6829-01A-21D-1853_120305_SN1120_0119_BD0REAACXX_s_2_rg.sorted.filtered.,WGS,TCGA-91-6829-01A-21D-1853_120305_SN1120_0119_BD0REAACXX_s_2_rg.sorted,TCGA-91-6829-01A-21D-1853_120305_SN1120_0119_BD0REAACXX_s_2_rg.sorted.bam,62.7,1.9,0.15,58cfa82fe4b0c9d6adf6b7ee,TCGA-91-6829-01A-21D-1853_120305_SN1120_0119_BD0REAACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-91-6829-01A,1427CD18-5AD3-491A-9981-908E31AE49DB,Primary Tumor,Illumina HiSeq,be9bb40c-b149-4b91-b271-b8881bb90d6f,Lung,78,9B416640-9AEC-4B0D-AA88-B94287375950,E6E4F55E-8C3A-45E9-8F3B-9FDFE9D2965D,TCGA-91-6829-01A-21D-1853-02,HG19_Broad_variant,TCGA-91-6829,TCGA-LUAD,1258,s11361,Harvard Medical School,ABS - IUPUI,United States,NO,T2,N0,Lung Bronchioloalveolar Carcinoma Nonmucinous,Stage IB
13722.58cfa832e4b0c9d6adf6d09e,58cfa832e4b0c9d6adf6d09e,TCGA-IG-A3QL-10A-01D-A248_121212_SN1120_0205_AC1F18ACXX_s_8_rg.sorted.filtered.,WGS,TCGA-IG-A3QL-10A-01D-A248_121212_SN1120_0205_AC1F18ACXX_s_8_rg.sorted,TCGA-IG-A3QL-10A-01D-A248_121212_SN1120_0205_AC1F18ACXX_s_8_rg.sorted.bam,17.26,NA,0.17,58cfa832e4b0c9d6adf6d09e,TCGA-IG-A3QL-10A-01D-A248_121212_SN1120_0205_AC1F18ACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A3QL-10A,0AC08ECF-4D70-48A4-9DFD-F44032551CB9,Blood Derived Normal,Illumina HiSeq,e64424bc-c276-403f-b9fd-fc7d120b74ea,Esophagus,54,2A674E27-A52D-4035-A902-9EBE6CEB3896,B7EFC773-B9C0-45E1-91A9-93BC0A1DAE0C,TCGA-IG-A3QL-10A-01D-A248-26,HG19_Broad_variant,TCGA-IG-A3QL,TCGA-ESCA,NA,s1816,MD Anderson - Institute for Applied Cancer Science,Asterand,Russia,NO,T2,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6c48a,58cfa831e4b0c9d6adf6c48a,TCGA-CG-4462-10A-01D-1154_121023_SN208_0437_BD1H3FACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CG-4462-10A-01D-1154_121023_SN208_0437_BD1H3FACXX_s_8_rg.sorted,TCGA-CG-4462-10A-01D-1154_121023_SN208_0437_BD1H3FACXX_s_8_rg.sorted.bam,112.9,1.8,0.14,58cfa831e4b0c9d6adf6c48a,TCGA-CG-4462-10A-01D-1154_121023_SN208_0437_BD1H3FACXX_s_8_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4462-10A,E9EA3687-0DB3-47F3-8099-B4FC054397F1,Blood Derived Normal,Illumina HiSeq,c1ec8c57-0cf2-4bfe-b6d3-a7ed77f918c4,Stomach,72,1A413F5F-C3C1-4249-A9C9-627798B6483A,F13DC305-E466-4C6E-9E69-F18A26DD2AB8,TCGA-CG-4462-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4462,TCGA-STAD,0,s14703,Harvard Medical School,Indivumed,Germany,NO,T3,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IV
13722.58cfa831e4b0c9d6adf6ca10,58cfa831e4b0c9d6adf6ca10,TCGA-DU-5847-10A-01D-1703_130806_SN1222_0209_AD2AW0ACXX_s_4_rg.sorted.filtered.,WGS,TCGA-DU-5847-10A-01D-1703_130806_SN1222_0209_AD2AW0ACXX_s_4_rg.sorted,TCGA-DU-5847-10A-01D-1703_130806_SN1222_0209_AD2AW0ACXX_s_4_rg.sorted.bam,74,1.9,0.14,58cfa831e4b0c9d6adf6ca10,TCGA-DU-5847-10A-01D-1703_130806_SN1222_0209_AD2AW0ACXX_s_4_rg.sorted.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-5847-10A,92A7C445-2217-400A-BDCD-DF41502416B6,Blood Derived Normal,Illumina HiSeq,d565f96e-c548-46a5-8dd2-341da735c3d8,Brain,34,1047FE18-DF48-4043-9D62-3B0FB0F6A1D0,00321B81-7463-4F1A-AB82-3B74FFF43F44,TCGA-DU-5847-10A-01D-1703-02,HG19_Broad_variant,TCGA-DU-5847,TCGA-LGG,NA,s8348,Harvard Medical School,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6c87d,58cfa831e4b0c9d6adf6c87d,TCGA-D3-A2JD-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D3-A2JD-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_3_rg.sorted,TCGA-D3-A2JD-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_3_rg.sorted.bam,18,NA,0.18,58cfa831e4b0c9d6adf6c87d,TCGA-D3-A2JD-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_3_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A2JD-10A,A5F95C6C-E25A-4AD8-BD5D-FCFD8A31933C,Blood Derived Normal,Illumina HiSeq,28a73c15-1674-4322-94fc-ecf6ca914d51,Skin,58,FC0F052A-C6DE-4AD4-852A-5BF7FE83ABB2,626E455C-5340-4095-8D27-D1D83615D201,TCGA-D3-A2JD-10A-01D-A18Z-02,HG19_Broad_variant,TCGA-D3-A2JD,TCGA-SKCM,361,s7321,Harvard Medical School,MD Anderson,United States,NO,T4b,N1b,Not available,Stage IIIC
13722.58cfa831e4b0c9d6adf6ca0c,58cfa831e4b0c9d6adf6ca0c,TCGA-DK-A1AE-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_7_rg.sorted.filtered.,WGS,TCGA-DK-A1AE-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_7_rg.sorted,TCGA-DK-A1AE-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_7_rg.sorted.bam,76.27,1.91,0.17,58cfa831e4b0c9d6adf6ca0c,TCGA-DK-A1AE-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_7_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AE-01A,493A4FF2-37A5-4B79-928D-83DBFE534556,Primary Tumor,Illumina HiSeq,31314a75-c671-479c-aff0-437d0965f1fc,Bladder,84,67865453-D515-4D63-84E8-CFB2686A211D,885B8E06-182F-437B-9183-B454643A64EC,TCGA-DK-A1AE-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DK-A1AE,TCGA-BLCA,NA,s2710,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c9d0,58cfa831e4b0c9d6adf6c9d0,TCGA-D7-6820-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_3_rg.sorted.filtered.,WGS,TCGA-D7-6820-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_3_rg.sorted,TCGA-D7-6820-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_3_rg.sorted.bam,160.7,1.9,0.14,58cfa831e4b0c9d6adf6c9d0,TCGA-D7-6820-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_3_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6820-01A,1142251C-28EB-48BF-9C54-7126D4557605,Primary Tumor,Illumina HiSeq,8b99bd62-c3d1-40c5-af7c-b1976df9622c,Stomach,64,490660D7-5512-4DBF-893A-B6B8C27CA407,B53083C4-6000-4B71-92CE-B2299D0EA2D3,TCGA-D7-6820-01A-11D-1880-02,HG19_Broad_variant,TCGA-D7-6820,TCGA-STAD,NA,s15331,Harvard Medical School,Greater Poland Cancer Center,Poland,NO,T2,N1,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIB
13722.58cfa831e4b0c9d6adf6ccee,58cfa831e4b0c9d6adf6ccee,TCGA-EJ-5518-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_8_rg.sorted.filtered.,WGS,TCGA-EJ-5518-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_8_rg.sorted,TCGA-EJ-5518-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_8_rg.sorted.bam,610.4,1.9,0.16,58cfa831e4b0c9d6adf6ccee,TCGA-EJ-5518-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5518-10A,2B35C119-CDC1-49E2-8229-CA5CDE9E63D0,Blood Derived Normal,Illumina HiSeq,048d94f9-66cb-4acc-9246-166201f39dab,Prostate,66,DA203181-CD7A-44FD-85D9-9A7E7D8E9778,98CE8C9E-8F01-466B-92B5-EE4FA7E7AFF7,TCGA-EJ-5518-10A-01D-1573-02,HG19_Broad_variant,TCGA-EJ-5518,TCGA-PRAD,NA,s3786,Harvard Medical School,University of Pittsburgh,United States,NO,T4,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6ca3e,58cfa831e4b0c9d6adf6ca3e,TCGA-DK-A1AE-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_8_rg.sorted.filtered.,WGS,TCGA-DK-A1AE-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_8_rg.sorted,TCGA-DK-A1AE-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_8_rg.sorted.bam,43.92,1.98,0.16,58cfa831e4b0c9d6adf6ca3e,TCGA-DK-A1AE-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AE-10A,493A4FF2-37A5-4B79-928D-83DBFE534556,Blood Derived Normal,Illumina HiSeq,bd5c0062-f4b4-40fd-abd7-657e17170eca,Bladder,84,FDE77852-768F-4949-9CCC-4FAA7BDBC6F3,4206AC09-4332-4A08-AAED-36512D313A52,TCGA-DK-A1AE-10A-01D-A13U-02,HG19_Broad_variant,TCGA-DK-A1AE,TCGA-BLCA,NA,s3104,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c348,58cfa831e4b0c9d6adf6c348,TCGA-CG-4462-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_8_rg.sorted.filtered.,WGS,TCGA-CG-4462-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_8_rg.sorted,TCGA-CG-4462-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_8_rg.sorted.bam,112.9,1.8,0.14,58cfa831e4b0c9d6adf6c348,TCGA-CG-4462-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_8_rg.sorted.bam,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4462-10A,E9EA3687-0DB3-47F3-8099-B4FC054397F1,Blood Derived Normal,Illumina HiSeq,5451c12f-c4fc-4e74-93da-2db445659914,Stomach,72,1A413F5F-C3C1-4249-A9C9-627798B6483A,F13DC305-E466-4C6E-9E69-F18A26DD2AB8,TCGA-CG-4462-10A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4462,TCGA-STAD,0,s14482,Harvard Medical School,Indivumed,Germany,NO,T3,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IV
13722.58cfa831e4b0c9d6adf6c9cc,58cfa831e4b0c9d6adf6c9cc,TCGA-DO-A1JZ-11A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_5_rg.sorted.filtered.,WGS,TCGA-DO-A1JZ-11A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_5_rg.sorted,TCGA-DO-A1JZ-11A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_5_rg.sorted.bam,34.85,1.87,0.18,58cfa831e4b0c9d6adf6c9cc,TCGA-DO-A1JZ-11A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_5_rg.sorted.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DO-A1JZ-11A,169F045F-1739-4B0B-9BDC-028AACA420F8,Solid Tissue Normal,Illumina HiSeq,30bf8f15-68fe-456b-b8e4-ea373602a809,Thyroid,23,36232F2E-9DA5-42D2-90F2-3D1589133229,D913E31C-92E9-43C1-B21A-D36F62BB3446,TCGA-DO-A1JZ-11A-11D-A13U-02,HG19_Broad_variant,TCGA-DO-A1JZ,TCGA-THCA,NA,s12109,Harvard Medical School,Medical College of Georgia,United States,NO,T2,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa830e4b0c9d6adf6c21e,58cfa830e4b0c9d6adf6c21e,TCGA-BT-A20P-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_4_rg.sorted.filtered.,WGS,TCGA-BT-A20P-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_4_rg.sorted,TCGA-BT-A20P-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_4_rg.sorted.bam,11.99,2.03,0.16,58cfa830e4b0c9d6adf6c21e,TCGA-BT-A20P-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_4_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20P-11A,F48937ED-E294-41F0-8872-7010391167A9,Solid Tissue Normal,Illumina HiSeq,84bd8301-5869-4245-a3cc-3781508f00c5,Bladder,81,2A07DBF4-D44C-4643-8A37-80E013DBE20B,327826B3-DDC6-4478-A28D-9688B58F279F,TCGA-BT-A20P-11A-11D-A14U-02,HG19_Broad_variant,TCGA-BT-A20P,TCGA-BLCA,544,s2859,Harvard Medical School,University of Pittsburgh,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6ca31,58cfa831e4b0c9d6adf6ca31,TCGA-DK-A2I6-10A-01D-A18D_121005_SN1120_0195_AC13RHACXX_s_1_rg.sorted.filtered.,WGS,TCGA-DK-A2I6-10A-01D-A18D_121005_SN1120_0195_AC13RHACXX_s_1_rg.sorted,TCGA-DK-A2I6-10A-01D-A18D_121005_SN1120_0195_AC13RHACXX_s_1_rg.sorted.bam,11.91,NA,0.15,58cfa831e4b0c9d6adf6ca31,TCGA-DK-A2I6-10A-01D-A18D_121005_SN1120_0195_AC13RHACXX_s_1_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A2I6-10A,DE810AF0-4C18-4E8F-9836-F8ABC425E3EB,Blood Derived Normal,Illumina HiSeq,4456fd98-e15f-406d-a4be-d8e3ec851888,Bladder,81,E68C90DA-B63A-4D90-9D2B-C0FFC796C9CC,6CAB2D7F-8E6A-4F30-9A04-34C29C7417D5,TCGA-DK-A2I6-10A-01D-A18D-02,HG19_Broad_variant,TCGA-DK-A2I6,TCGA-BLCA,NA,s2883,Harvard Medical School,Memorial Sloan Kettering,United States,NO,T2b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa830e4b0c9d6adf6c1e4,58cfa830e4b0c9d6adf6c1e4,TCGA-BT-A0S7-10A-01D-A10R_120920_SN1222_0150_AC1927ACXX_s_2_rg.sorted.filtered.,WGS,TCGA-BT-A0S7-10A-01D-A10R_120920_SN1222_0150_AC1927ACXX_s_2_rg.sorted,TCGA-BT-A0S7-10A-01D-A10R_120920_SN1222_0150_AC1927ACXX_s_2_rg.sorted.bam,22.85,1.94,0.14,58cfa830e4b0c9d6adf6c1e4,TCGA-BT-A0S7-10A-01D-A10R_120920_SN1222_0150_AC1927ACXX_s_2_rg.sorted.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A0S7-10A,68BC786E-07C7-4964-BC88-5E2A8633626A,Blood Derived Normal,Illumina HiSeq,2414eb9d-53e3-403c-87e5-dcb81ae001db,Bladder,75,584B35EF-DECB-4A5D-AA61-C83BCB2D15B2,3D48F5A7-07A3-4283-88A1-05C5E58B4B9B,TCGA-BT-A0S7-10A-01D-A10R-02,HG19_Broad_variant,TCGA-BT-A0S7,TCGA-BLCA,200,s2693,Harvard Medical School,University of Pittsburgh,United States,NO,T4a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa832e4b0c9d6adf6ce50,58cfa832e4b0c9d6adf6ce50,TCGA-ER-A19E-10A-01D-A190_120723_SN1120_0177_AC11GTACXX_s_6_rg.sorted.filtered.,WGS,TCGA-ER-A19E-10A-01D-A190_120723_SN1120_0177_AC11GTACXX_s_6_rg.sorted,TCGA-ER-A19E-10A-01D-A190_120723_SN1120_0177_AC11GTACXX_s_6_rg.sorted.bam,21.01,NA,0.16,58cfa832e4b0c9d6adf6ce50,TCGA-ER-A19E-10A-01D-A190_120723_SN1120_0177_AC11GTACXX_s_6_rg.sorted.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19E-10A,3FEA3F02-2DB3-44E0-984E-C61130D92C9B,Blood Derived Normal,Illumina HiSeq,ddd1871b-91a1-4f2f-acd5-a69ecf18c07e,Skin,36,D88BD93A-7ACE-4247-B36E-D434583D31BC,341315CF-D88D-4153-AC84-7243D4D1BC04,TCGA-ER-A19E-10A-01D-A190-02,HG19_Broad_variant,TCGA-ER-A19E,TCGA-SKCM,396,s7358,Harvard Medical School,University of Pittsburgh,United States,NO,T2a,N0,Not available,Stage IB
13722.58cfa831e4b0c9d6adf6c6c9,58cfa831e4b0c9d6adf6c6c9,TCGA-CQ-6224-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_8_rg.sorted.filtered.,WGS,TCGA-CQ-6224-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_8_rg.sorted,TCGA-CQ-6224-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_8_rg.sorted.bam,67,NA,0.16,58cfa831e4b0c9d6adf6c6c9,TCGA-CQ-6224-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_8_rg.sorted.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-6224-10A,D86FD392-FA5C-4142-A647-440E6C32D478,Blood Derived Normal,Illumina HiSeq,532aa1c3-e7a0-4117-9718-2accf1ab0fd5,Head and Neck,52,737605E7-E6DC-4A82-A244-61B6AEFE392B,DC395D99-027E-4997-B75B-6E17E066FB3E,TCGA-CQ-6224-10A-01D-1911-02,HG19_Broad_variant,TCGA-CQ-6224,TCGA-HNSC,NA,s16190,Harvard Medical School,"University Health Network, Toronto",Canada,NO,T2,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82fe4b0c9d6adf6b7fe,58cfa82fe4b0c9d6adf6b7fe,TCGA-38-4632-11A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_8_rg.sorted.filtered.,WGS,TCGA-38-4632-11A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_8_rg.sorted,TCGA-38-4632-11A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_8_rg.sorted.bam,153.4,1.9,0.16,58cfa82fe4b0c9d6adf6b7fe,TCGA-38-4632-11A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_8_rg.sorted.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-38-4632-11A,875333AB-9048-462D-AAA2-693AD127E3CC,Solid Tissue Normal,Illumina HiSeq,64c992dd-605a-4f70-b4a2-240b669c9e61,Lung,42,84F43782-7249-46C3-9241-51E8933FA720,E25A6DC8-7BE3-4559-BD22-6493E08BAE91,TCGA-38-4632-11A-01D-1751-02,HG19_Broad_variant,TCGA-38-4632,TCGA-LUAD,1357,s11448,Harvard Medical School,UNC,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IV
13722.58cfa831e4b0c9d6adf6c48e,58cfa831e4b0c9d6adf6c48e,TCGA-C4-A0F6-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_1_rg.sorted.filtered.,WGS,TCGA-C4-A0F6-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_1_rg.sorted,TCGA-C4-A0F6-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_1_rg.sorted.bam,74.36,1.93,0.16,58cfa831e4b0c9d6adf6c48e,TCGA-C4-A0F6-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_1_rg.sorted.bam,Alive,FEMALE,Not available,Not available,Bladder Urothelial Carcinoma,Aligned reads,TCGA-C4-A0F6-01A,4FF9B4F2-6D04-4FED-8796-155902A8BF28,Primary Tumor,Illumina HiSeq,2332be3a-c2a5-446a-ae60-b8f873fe1866,Bladder,82,905D2BF1-08CB-4260-8188-00B60D881CF2,1765E178-12BD-4682-AB4A-368C4DCB5AEE,TCGA-C4-A0F6-01A-11D-A10R-02,HG19_Broad_variant,TCGA-C4-A0F6,TCGA-BLCA,NA,s3084,Harvard Medical School,Indivumed,Germany,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82ee4b0c9d6adf6a902,58cfa82ee4b0c9d6adf6a902,G32462.TCGA-DK-A1A7-10A-01D-A13W-08.1.filtered.,WGS,G32462.TCGA-DK-A1A7-10A-01D-A13W-08.1,G32462.TCGA-DK-A1A7-10A-01D-A13W-08.1.bam,64.01,1.91,0.08,58cfa82ee4b0c9d6adf6a902,G32462.TCGA-DK-A1A7-10A-01D-A13W-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A7-10A,3ED614E7-F356-4D87-985B-D3BBBAE3BB40,Blood Derived Normal,Illumina HiSeq,dc182b44-7962-4477-a21a-0ea544b8bb22,Bladder,67,7C9BD4C3-A3EF-495E-B37C-5CD329D16A18,C14E29AA-A979-4452-8019-7EEBFB3D5D04,TCGA-DK-A1A7-10A-01D-A13W-08,HG19_Broad_variant,TCGA-DK-A1A7,TCGA-BLCA,NA,s2685,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82ee4b0c9d6adf6aa51,58cfa82ee4b0c9d6adf6aa51,G35155.TCGA-CR-5243-01A-01D-1512-08.2.filtered.,WGS,G35155.TCGA-CR-5243-01A-01D-1512-08.2,G35155.TCGA-CR-5243-01A-01D-1512-08.2.bam,348.7,1.9,0.05,58cfa82ee4b0c9d6adf6aa51,G35155.TCGA-CR-5243-01A-01D-1512-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-5243-01A,E37F479F-CA05-45E4-AC6D-A974BED6E7F8,Primary Tumor,Illumina HiSeq,9b40a7ed-a315-4294-ade6-8b2194292f0b,Head and Neck,51,D89D46EA-9A7A-4FD8-B11E-9C9CA4780119,297E8B35-5B8B-4D5B-B812-86165F949A20,TCGA-CR-5243-01A-01D-1512-08,HG19_Broad_variant,TCGA-CR-5243,TCGA-HNSC,NA,s15873,Broad Institute of MIT and Harvard,Vanderbilt University,None,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6abe9,58cfa82ee4b0c9d6adf6abe9,G35155.TCGA-CR-6481-01A-11D-1870-08.2.filtered.,WGS,G35155.TCGA-CR-6481-01A-11D-1870-08.2,G35155.TCGA-CR-6481-01A-11D-1870-08.2.bam,88.7,1.9,0.05,58cfa82ee4b0c9d6adf6abe9,G35155.TCGA-CR-6481-01A-11D-1870-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-6481-01A,9A76BD98-1D2B-4D0F-9772-883520FF6210,Primary Tumor,Illumina HiSeq,577ba651-2ad3-4e83-a94c-547efbe03ebe,Head and Neck,47,04652163-A674-446F-9E86-607DE19E4C34,5E7D2531-81C1-48BB-9C0A-1867D1F83F92,TCGA-CR-6481-01A-11D-1870-08,HG19_Broad_variant,TCGA-CR-6481,TCGA-HNSC,NA,s15869,Broad Institute of MIT and Harvard,Vanderbilt University,United States,NO,Not available,Not available,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ab12,58cfa82ee4b0c9d6adf6ab12,G35155.TCGA-CQ-6220-01A-11D-1912-08.2.filtered.,WGS,G35155.TCGA-CQ-6220-01A-11D-1912-08.2,G35155.TCGA-CQ-6220-01A-11D-1912-08.2.bam,342.7,1.9,0.05,58cfa82ee4b0c9d6adf6ab12,G35155.TCGA-CQ-6220-01A-11D-1912-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-6220-01A,96D0CEFE-7949-4736-A7DC-1E4FA94765EC,Primary Tumor,Illumina HiSeq,34bb201c-76f4-432d-b2d3-a46d882b205d,Head and Neck,69,E0E75203-3982-40B2-A057-FAA8433DFB7A,65E67EDA-16A4-4DFD-94A9-546C76D94A02,TCGA-CQ-6220-01A-11D-1912-08,HG19_Broad_variant,TCGA-CQ-6220,TCGA-HNSC,985,s15748,Broad Institute of MIT and Harvard,"University Health Network, Toronto",Canada,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6ab7e,58cfa82ee4b0c9d6adf6ab7e,G35155.TCGA-CQ-5323-01A-01D-1683-08.2.filtered.,WGS,G35155.TCGA-CQ-5323-01A-01D-1683-08.2,G35155.TCGA-CQ-5323-01A-01D-1683-08.2.bam,481,1.9,0.05,58cfa82ee4b0c9d6adf6ab7e,G35155.TCGA-CQ-5323-01A-01D-1683-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-5323-01A,DEEFDD62-4D35-40C9-AD4C-0B593F35CFF7,Primary Tumor,Illumina HiSeq,a8f7b17a-acda-474e-be1c-c3a584542451,Head and Neck,82,3AC5396D-B92F-41D5-A3F0-603AA52AAFA3,892067EF-C465-46EA-8F91-10636DD0081B,TCGA-CQ-5323-01A-01D-1683-08,HG19_Broad_variant,TCGA-CQ-5323,TCGA-HNSC,NA,s15874,Broad Institute of MIT and Harvard,"University Health Network, Toronto",Canada,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ab1c,58cfa82ee4b0c9d6adf6ab1c,G35155.TCGA-CV-7406-01A-11D-2078-08.2.filtered.,WGS,G35155.TCGA-CV-7406-01A-11D-2078-08.2,G35155.TCGA-CV-7406-01A-11D-2078-08.2.bam,161.7,NA,0.05,58cfa82ee4b0c9d6adf6ab1c,G35155.TCGA-CV-7406-01A-11D-2078-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7406-01A,2C6D6C93-FB6D-47F7-A868-5E9A82C75D4C,Primary Tumor,Illumina HiSeq,378f5b8c-a067-4ecf-af73-b546498381c4,Head and Neck,49,39D9F003-89E6-4349-B060-F5A604789FB3,8C9EFFA8-ACB6-4DB0-874A-8F0DF386924C,TCGA-CV-7406-01A-11D-2078-08,HG19_Broad_variant,TCGA-CV-7406,TCGA-HNSC,1748,s15486,Broad Institute of MIT and Harvard,MD Anderson Cancer Center,United States,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6abf5,58cfa82ee4b0c9d6adf6abf5,G35155.TCGA-CR-7368-01A-11D-2129-08.2.filtered.,WGS,G35155.TCGA-CR-7368-01A-11D-2129-08.2,G35155.TCGA-CR-7368-01A-11D-2129-08.2.bam,250.7,NA,0.05,58cfa82ee4b0c9d6adf6abf5,G35155.TCGA-CR-7368-01A-11D-2129-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-7368-01A,27C28C89-F4E7-4AEC-A806-C0DA7756E47F,Primary Tumor,Illumina HiSeq,71be6814-d02e-4639-9836-25de17a1ec0f,Head and Neck,54,0C4C4B41-05AC-48CE-B5C0-A639FFAFC411,4B194AB3-D213-4A7A-BE46-909B4F0C7291,TCGA-CR-7368-01A-11D-2129-08,HG19_Broad_variant,TCGA-CR-7368,TCGA-HNSC,NA,s15875,Broad Institute of MIT and Harvard,Vanderbilt University,United States,NO,T4a,N1,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82ee4b0c9d6adf6aba6,58cfa82ee4b0c9d6adf6aba6,G35155.TCGA-CR-6471-01A-11D-1870-08.2.filtered.,WGS,G35155.TCGA-CR-6471-01A-11D-1870-08.2,G35155.TCGA-CR-6471-01A-11D-1870-08.2.bam,90.7,1.9,0.05,58cfa82ee4b0c9d6adf6aba6,G35155.TCGA-CR-6471-01A-11D-1870-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-6471-01A,EDA29281-E803-4217-8603-D6A388408611,Primary Tumor,Illumina HiSeq,280b365a-3459-4fa2-9daa-644b077065dd,Head and Neck,58,4F845FB4-4724-455F-88F2-09DE7259A484,C087E87F-867C-45DD-8645-5AB774E4827C,TCGA-CR-6471-01A-11D-1870-08,HG19_Broad_variant,TCGA-CR-6471,TCGA-HNSC,1202,s15607,Broad Institute of MIT and Harvard,Vanderbilt University,United States,NO,T4a,N1,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82ee4b0c9d6adf6ac6c,58cfa82ee4b0c9d6adf6ac6c,G35155.TCGA-HD-7754-01A-11D-2078-08.2.filtered.,WGS,G35155.TCGA-HD-7754-01A-11D-2078-08.2,G35155.TCGA-HD-7754-01A-11D-2078-08.2.bam,471.73,NA,0.05,58cfa82ee4b0c9d6adf6ac6c,G35155.TCGA-HD-7754-01A-11D-2078-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-HD-7754-01A,10F53522-9AE7-47B9-80AA-B4B481561465,Primary Tumor,Illumina HiSeq,58f7e425-aa07-404f-afe5-6a47488d4296,Head and Neck,69,ADB496A1-07EB-45B9-8690-00184143300E,233ECDC4-0B42-4533-8908-64AC7D3AC33B,TCGA-HD-7754-01A-11D-2078-08,HG19_Broad_variant,TCGA-HD-7754,TCGA-HNSC,NA,s16167,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82ee4b0c9d6adf6aa64,58cfa82ee4b0c9d6adf6aa64,G35155.TCGA-CN-5373-01A-01D-1434-08.2.filtered.,WGS,G35155.TCGA-CN-5373-01A-01D-1434-08.2,G35155.TCGA-CN-5373-01A-01D-1434-08.2.bam,165.7,1.9,0.05,58cfa82ee4b0c9d6adf6aa64,G35155.TCGA-CN-5373-01A-01D-1434-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5373-01A,546F01D5-AED5-4FB8-91C0-0FD5E0FDE935,Primary Tumor,Illumina HiSeq,25d55985-95b6-4558-b42e-5c32684d89b0,Head and Neck,55,9D73D061-F1E1-47BA-929D-FEEB6C191279,00988676-1E9B-4E00-B4AA-A8F86C21B206,TCGA-CN-5373-01A-01D-1434-08,HG19_Broad_variant,TCGA-CN-5373,TCGA-HNSC,NA,s15872,Broad Institute of MIT and Harvard,University of Pittsburgh,None,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ab8d,58cfa82ee4b0c9d6adf6ab8d,G35155.TCGA-DQ-7591-01A-11D-2078-08.2.filtered.,WGS,G35155.TCGA-DQ-7591-01A-11D-2078-08.2,G35155.TCGA-DQ-7591-01A-11D-2078-08.2.bam,482.7,NA,0.05,58cfa82ee4b0c9d6adf6ab8d,G35155.TCGA-DQ-7591-01A-11D-2078-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-DQ-7591-01A,3EF779CF-772E-445E-93C8-E1094EA8B878,Primary Tumor,Illumina HiSeq,17aee7fb-ed6f-46de-8dc7-ad13153b83a3,Head and Neck,62,FB144A86-0EB9-4754-BD74-8BA4BFFE7666,4068A2FC-452D-4B2C-88D8-72D30097527B,TCGA-DQ-7591-01A-11D-2078-08,HG19_Broad_variant,TCGA-DQ-7591,TCGA-HNSC,NA,s15871,Broad Institute of MIT and Harvard,University of Michigan,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa83ce4b0c9d6adf72f09,58cfa83ce4b0c9d6adf72f09,d52a490452bcea89e4f7a08fecfa888e.filtered.,WGS,d52a490452bcea89e4f7a08fecfa888e,d52a490452bcea89e4f7a08fecfa888e.bam,70.65,NA,0.08,58cfa83ce4b0c9d6adf72f09,d52a490452bcea89e4f7a08fecfa888e.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49Y-10A,87FABA0E-28E7-4A7E-A7E1-12582EC68FAC,Blood Derived Normal,HiSeq X Ten,85988d72-2950-4c0d-946f-b5964a17be87,Esophagus,77,DD3C843E-95D4-43F7-93FF-052777F0E65E,78F201B5-47A9-4FCC-BFF1-A93FA936ED65,TCGA-LN-A49Y-10A-01D-A27G-09,GRCh37-lite_WUGSC_variant_2,TCGA-LN-A49Y,TCGA-ESCA,NA,s1950,Washington University School of Medicine,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa82de4b0c9d6adf6a532,58cfa82de4b0c9d6adf6a532,4e08c52156a4549e3d071bb4bdfe8b21.filtered.,WGS,4e08c52156a4549e3d071bb4bdfe8b21,4e08c52156a4549e3d071bb4bdfe8b21.bam,25.79,NA,0.08,58cfa82de4b0c9d6adf6a532,4e08c52156a4549e3d071bb4bdfe8b21.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A97I-10A,7AA71C68-4205-4745-838B-0D00BD49A501,Blood Derived Normal,HiSeq X Ten,900aefea-4de7-4c48-8f7a-840cf599da65,Esophagus,58,57BC8C81-ACEE-4B77-A170-1371B458656C,FCD83C0F-4889-4682-8CFC-EAC824708060,TCGA-IG-A97I-10A-01D-A38A-09,GRCh37-lite_WUGSC_variant_2,TCGA-IG-A97I,TCGA-ESCA,NA,s1712,Washington University School of Medicine,Asterand,Ukraine,NO,T2,N0,Not available,Stage IIA
13722.58cfa83ce4b0c9d6adf72e3c,58cfa83ce4b0c9d6adf72e3c,a40a6455eacaa0ab5af33298fc105c2e.filtered.,WGS,a40a6455eacaa0ab5af33298fc105c2e,a40a6455eacaa0ab5af33298fc105c2e.bam,35.59,NA,0.07,58cfa83ce4b0c9d6adf72e3c,a40a6455eacaa0ab5af33298fc105c2e.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-K1-A3PN-10A,F519BE07-434E-4EB2-ACF9-318565B83D50,Blood Derived Normal,HiSeq X Ten,01c342ec-b7a7-47ff-9892-35d32e026a64,Mesenchymal,64,F7007628-B5E0-4305-B36D-B58FA9EFFA7A,B24E4A7B-236B-4DBE-9B7A-6C8427F8E423,TCGA-K1-A3PN-10A-01D-A22A-09,GRCh37-lite,TCGA-K1-A3PN,TCGA-SARC,NA,s2457,Washington University School of Medicine,University of Pittsburgh,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a6c2,58cfa82de4b0c9d6adf6a6c2,8e10ae1481b7e4a1cb9b140a9a4191f1.filtered.,WGS,8e10ae1481b7e4a1cb9b140a9a4191f1,8e10ae1481b7e4a1cb9b140a9a4191f1.bam,16.74,NA,0.08,58cfa82de4b0c9d6adf6a6c2,8e10ae1481b7e4a1cb9b140a9a4191f1.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A8NE-11A,67FAE19C-3CE9-4F91-B01E-4B130ABF632E,Solid Tissue Normal,HiSeq X Ten,da6236ac-ec74-4f04-9e28-e072c805f5a0,Esophagus,77,7B6415F2-9424-4B68-9936-BC18C20CDE47,0D8CF159-3AE8-476D-8EED-6DB88565E839,TCGA-L5-A8NE-11A-11D-A37F-09,GRCh37-lite_WUGSC_variant_2,TCGA-L5-A8NE,TCGA-ESCA,NA,s1714,Washington University School of Medicine,University of Michigan,United States,NO,T2,N1,Not available,Stage IIB
13722.58cfa83ce4b0c9d6adf72f41,58cfa83ce4b0c9d6adf72f41,cf76c905472f188e3fb5edbcfd5cfd7e.filtered.,WGS,cf76c905472f188e3fb5edbcfd5cfd7e,cf76c905472f188e3fb5edbcfd5cfd7e.bam,10.34,NA,0.09,58cfa83ce4b0c9d6adf72f41,cf76c905472f188e3fb5edbcfd5cfd7e.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A891-11A,F28F37A0-8E24-4A36-90F0-83CF5A27BE10,Solid Tissue Normal,HiSeq X Ten,9faf002f-2eb2-4b06-9fde-f09bc61b8cc9,Esophagus,51,7110BDAC-0D52-4E69-BFC0-D6094129556D,B224C840-9566-4AA5-9F0D-7386909DA464,TCGA-L5-A891-11A-21D-A36M-09,GRCh37-lite_WUGSC_variant_2,TCGA-L5-A891,TCGA-ESCA,NA,s1704,Washington University School of Medicine,University of Michigan,United States,NO,T3,N1,Not available,Not available
13722.58cfa82ee4b0c9d6adf6b0d2,58cfa82ee4b0c9d6adf6b0d2,TCGA-06-0128-10A-01D-0572-09_whole.filtered.,WGS,TCGA-06-0128-10A-01D-0572-09_whole,NA,NA,NA,NA,58cfa82ee4b0c9d6adf6b0d2,TCGA-06-0128-10A-01D-0572-09_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0128-10A,31E6E6C8-9197-4927-BFE4-8F6836F963DA,Blood Derived Normal,Illumina GA,dc3c6105-9a34-4865-862f-bf56e7e94449,Brain,66,863CEE8C-6AF1-4CEF-AC53-61429E19AE89,CC800350-631C-43AB-8622-692D5A7E5B93,TCGA-06-0128-10A-01D-0572-09,NCBI36_WUGSC_variant,TCGA-06-0128,TCGA-GBM,691,NA,NA,NA,NA,NA,NA,NA,NA,NA
13722.58cfa82de4b0c9d6adf6a566,58cfa82de4b0c9d6adf6a566,2f9586b68a97bc16007845a593828c1e.filtered.,WGS,2f9586b68a97bc16007845a593828c1e,2f9586b68a97bc16007845a593828c1e.bam,20.59,NA,0.08,58cfa82de4b0c9d6adf6a566,2f9586b68a97bc16007845a593828c1e.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OF-11A,0C78B1B5-F480-45AD-A253-19297BC886B4,Solid Tissue Normal,HiSeq X Ten,7985fb15-cbd2-4a77-974c-b2b85d1a136e,Esophagus,63,8941FC42-90AF-46D6-B1EF-E18FCB957BCF,5C706022-8E43-463A-B161-F6687B4BA88A,TCGA-L5-A4OF-11A-12D-A27G-09,GRCh37-lite_WUGSC_variant_2,TCGA-L5-A4OF,TCGA-ESCA,NA,s1810,Washington University School of Medicine,University of Michigan,United States,NO,T1,N1,Not available,Stage IIB
13722.58cfa83ce4b0c9d6adf73124,58cfa83ce4b0c9d6adf73124,dc7aabcd4195783f5757de95ab75bc1a.filtered.,WGS,dc7aabcd4195783f5757de95ab75bc1a,dc7aabcd4195783f5757de95ab75bc1a.bam,20.55,NA,0.07,58cfa83ce4b0c9d6adf73124,dc7aabcd4195783f5757de95ab75bc1a.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A6Z2-11A,1AD65834-8BAC-4B80-8B2E-2588548EA003,Solid Tissue Normal,HiSeq X Ten,9976aca0-66ef-4086-899f-4ee8fcb38219,Mesenchymal,82,87D1B106-FF9C-46D5-B3A2-1086A92339F4,4269113E-908E-4959-B1F2-6CFD8A779D59,TCGA-DX-A6Z2-11A-11D-A36M-09,GRCh37-lite,TCGA-DX-A6Z2,TCGA-SARC,NA,s2469,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a482,58cfa82de4b0c9d6adf6a482,1157c2326f6b88c0267a2aeb305e2759.filtered.,WGS,1157c2326f6b88c0267a2aeb305e2759,1157c2326f6b88c0267a2aeb305e2759.bam,30.81,NA,0.08,58cfa82de4b0c9d6adf6a482,1157c2326f6b88c0267a2aeb305e2759.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A4A1-10A,3C1F8B73-BAD7-4649-B08E-C7AFC647EDF3,Blood Derived Normal,HiSeq X Ten,7741f3b9-466b-4d52-ad8c-142a9d413adc,Esophagus,60,D82B94A8-D310-4A59-AD40-BAF448B75718,BE17983E-AEB5-495E-A39C-6BF4AA0BAF9A,TCGA-LN-A4A1-10A-01D-A27G-09,GRCh37-lite_WUGSC_variant_2,TCGA-LN-A4A1,TCGA-ESCA,NA,s1709,Washington University School of Medicine,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa83ce4b0c9d6adf7320c,58cfa83ce4b0c9d6adf7320c,b80bb37b2c3616374e7c8b2874644977.filtered.,WGS,b80bb37b2c3616374e7c8b2874644977,b80bb37b2c3616374e7c8b2874644977.bam,104,1.92,0.15,58cfa83ce4b0c9d6adf7320c,b80bb37b2c3616374e7c8b2874644977.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0128-10A,31E6E6C8-9197-4927-BFE4-8F6836F963DA,Blood Derived Normal,Illumina GA,af93d4d3-f3b2-462b-8bca-6f3bf42421c5,Brain,66,863CEE8C-6AF1-4CEF-AC53-61429E19AE89,CC800350-631C-43AB-8622-692D5A7E5B93,TCGA-06-0128-10A-01D-0572-09,GRCh37-lite,TCGA-06-0128,TCGA-GBM,691,s13936,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a43c,58cfa82de4b0c9d6adf6a43c,46e9e1b27e516e01f2a836135f5c9bb7.filtered.,WGS,46e9e1b27e516e01f2a836135f5c9bb7,46e9e1b27e516e01f2a836135f5c9bb7.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a43c,46e9e1b27e516e01f2a836135f5c9bb7.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2906-11A,5B5D770E-DB72-4EE8-A89A-DB80FB31D3CD,Solid Tissue Normal,Illumina GA,7f6d68a7-314d-43b9-9ae4-63f729aeeadc,Blood,59,DB63DBD9-697C-4CAF-94AA-1D4070AC834F,B5561C6C-EECE-4AC3-969B-094285B5E3FF,TCGA-AB-2906-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2906,TCGA-LAML,NA,s7164,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a6bd,58cfa82de4b0c9d6adf6a6bd,9662e3a8fb4412b24b2cceba98099747.filtered.,WGS,9662e3a8fb4412b24b2cceba98099747,9662e3a8fb4412b24b2cceba98099747.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a6bd,9662e3a8fb4412b24b2cceba98099747.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2979-11A,CE7E25DC-5DF9-48C5-8F9F-756F6CF765EB,Solid Tissue Normal,Illumina GA,9cfe41a4-e968-444e-874c-95185e9b1be7,Blood,30,F3BC9FB8-E243-48F8-8D40-3FE3BE8439ED,79B57153-6800-44E6-9F71-4E7323B04470,TCGA-AB-2979-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2979,TCGA-LAML,NA,s6981,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf73116,58cfa83ce4b0c9d6adf73116,e1fd0963f179515dbd7a5f7018b66fd9.filtered.,WGS,e1fd0963f179515dbd7a5f7018b66fd9,e1fd0963f179515dbd7a5f7018b66fd9.bam,55.79,2.17,0.08,58cfa83ce4b0c9d6adf73116,e1fd0963f179515dbd7a5f7018b66fd9.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0BW-11A,5D1D00C6-FCAE-479E-AE1E-DE76EFD41D98,Solid Tissue Normal,Illumina HiSeq,190c051d-e6c9-4898-ae78-5946797b28ff,Breast,71,D03B3D7B-3629-4FDE-A47A-3184F67236EB,CA6B4239-5535-4790-A449-4B95E9395ADB,TCGA-BH-A0BW-11A-12D-A314-09,GRCh37-lite,TCGA-BH-A0BW,TCGA-BRCA,NA,s6613,Washington University School of Medicine,University of Pittsburgh,None,NO,T1c,N0,Infiltrating Ductal Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6b1ee,58cfa82ee4b0c9d6adf6b1ee,TCGA-14-1454-10A-01D-0703-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-14-1454-10A-01D-0703-09_IlluminaGA-DNASeq_whole,TCGA-14-1454-10A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,139.6,1.9,0.14,58cfa82ee4b0c9d6adf6b1ee,TCGA-14-1454-10A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1454-10A,C2399F5D-DC29-42E9-81F1-1D164D4CC55D,Blood Derived Normal,Illumina GA,f09ec6e7-64d3-4ccc-8eda-00868849962d,Brain,54,99A026B9-0925-4CCD-9A49-92F936F97679,F047FB20-36D8-43DE-A433-8094B18109B0,TCGA-14-1454-10A-01D-0703-09,NCBI36_WUGSC_variant,TCGA-14-1454,TCGA-GBM,918,s14375,Washington University School of Medicine,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82fe4b0c9d6adf6b56e,58cfa82fe4b0c9d6adf6b56e,TCGA-29-1707-02A-01D-0926-12_Illumina.filtered.,WGS,TCGA-29-1707-02A-01D-0926-12_Illumina,TCGA-29-1707-02A-01D-0926-12_Illumina.bam,400,1.9,0.15,58cfa82fe4b0c9d6adf6b56e,TCGA-29-1707-02A-01D-0926-12_Illumina.bam,Alive,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-29-1707-02A,7FD6AB8A-201E-431D-A886-6AB553B6CA36,Recurrent Tumor,Illumina HiSeq,120c5bcc-8f2d-4f64-864b-63d865be7f72,Ovary,41,F2A14F3D-6181-48D6-8F44-48B36AB1F246,487C7F3A-DBFA-471D-BDD8-6F234AB67852,TCGA-29-1707-02A-01D-0926-12,NCBI36_BCM_variant,TCGA-29-1707,TCGA-OV,NA,s17726,Baylor College of Medicine,Duke,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf72ea4,58cfa83ce4b0c9d6adf72ea4,d2678419dbaa466f87e5ef213dcb40d2.filtered.,WGS,d2678419dbaa466f87e5ef213dcb40d2,d2678419dbaa466f87e5ef213dcb40d2.bam,9.95,NA,0.08,58cfa83ce4b0c9d6adf72ea4,d2678419dbaa466f87e5ef213dcb40d2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A3U7-10A,EA3A524B-6EE3-4904-8924-29FCAA20985C,Blood Derived Normal,Illumina HiSeq,4c7ea8e7-ee17-4784-a9fa-4e9e8068ce6c,Mesenchymal,67,16FAED69-355A-4B47-99AF-B5006FD4D988,D4B86F75-B56F-404F-B88D-20ADF47E17DD,TCGA-DX-A3U7-10A-01D-A29N-09,GRCh37-lite,TCGA-DX-A3U7,TCGA-SARC,NA,s2466,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf73202,58cfa83ce4b0c9d6adf73202,ad786b2cf587eb34483a7966f08a20fd.filtered.,WGS,ad786b2cf587eb34483a7966f08a20fd,ad786b2cf587eb34483a7966f08a20fd.bam,139.6,1.9,0.14,58cfa83ce4b0c9d6adf73202,ad786b2cf587eb34483a7966f08a20fd.bam,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1454-10A,C2399F5D-DC29-42E9-81F1-1D164D4CC55D,Blood Derived Normal,Illumina GA,ea0339ec-ca38-4a61-a011-a8470fbd3dbf,Brain,54,99A026B9-0925-4CCD-9A49-92F936F97679,F047FB20-36D8-43DE-A433-8094B18109B0,TCGA-14-1454-10A-01D-0703-09,GRCh37-lite,TCGA-14-1454,TCGA-GBM,918,s14247,Washington University School of Medicine,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a6e2,58cfa82de4b0c9d6adf6a6e2,8409fbcf595ba489877dfe01d3f3babb.filtered.,WGS,8409fbcf595ba489877dfe01d3f3babb,8409fbcf595ba489877dfe01d3f3babb.bam,59.55,NA,0.08,58cfa82de4b0c9d6adf6a6e2,8409fbcf595ba489877dfe01d3f3babb.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A4A4-10A,E89D7900-915D-4936-B1B2-CAC3670EA2F4,Blood Derived Normal,HiSeq X Ten,c726f794-5f41-4268-a154-e41565ab1e62,Esophagus,36,43AD599A-DF3C-4BBF-9F36-285112CB79F5,50939D6D-DF1D-4F3E-8857-C4D11E46BA5E,TCGA-LN-A4A4-10A-01D-A27G-09,GRCh37-lite_WUGSC_variant_2,TCGA-LN-A4A4,TCGA-ESCA,NA,s1716,Washington University School of Medicine,ILSbio,Vietnam,NO,T3,N1,Not available,Stage III
13722.58cfa82fe4b0c9d6adf6b9f2,58cfa82fe4b0c9d6adf6b9f2,TCGA-AA-3534-10A-01D-1525-10_Illumina.filtered.,WGS,TCGA-AA-3534-10A-01D-1525-10_Illumina,TCGA-AA-3534-10A-01D-1525-10_Illumina.bam,32.5,1.9,0.05,58cfa82fe4b0c9d6adf6b9f2,TCGA-AA-3534-10A-01D-1525-10_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3534-10A,DF228C56-89AC-4122-93B3-6C0740C4EC09,Blood Derived Normal,Illumina HiSeq,f7e9c24b-3c8a-4426-a4ed-0d4953929360,Colorectal,78,4F63B73F-95C5-4515-B3A7-58A4A348368F,F93348B5-6A8B-4734-9D97-8175A81D18F1,TCGA-AA-3534-10A-01D-1525-10,NCBI36_BCM_variant,TCGA-AA-3534,TCGA-COAD,NA,s13668,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82fe4b0c9d6adf6b78e,58cfa82fe4b0c9d6adf6b78e,TCGA-29-2414-02A-01D-0926-12_Illumina.filtered.,WGS,TCGA-29-2414-02A-01D-0926-12_Illumina,TCGA-29-2414-02A-01D-0926-12_Illumina.bam,100,1.9,0.15,58cfa82fe4b0c9d6adf6b78e,TCGA-29-2414-02A-01D-0926-12_Illumina.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-29-2414-02A,A2319490-B85D-4219-A1B0-FA1EC432D5C8,Recurrent Tumor,Illumina HiSeq,ce5a4d2a-7dc1-4690-b71c-1145efc9ef51,Ovary,75,DFFC14AD-F9FC-4D33-B5E2-8C57019816FE,C007C040-2391-4597-BC68-DDB383E2F33D,TCGA-29-2414-02A-01D-0926-12,NCBI36_BCM_variant,TCGA-29-2414,TCGA-OV,2621,s17689,Baylor College of Medicine,Duke,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bb92,58cfa830e4b0c9d6adf6bb92,TCGA-A2-A0D0-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-A2-A0D0-10A-01D-A128-09_IlluminaGA-DNASeq_whole,TCGA-A2-A0D0-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,24.18,1.95,0.08,58cfa830e4b0c9d6adf6bb92,TCGA-A2-A0D0-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A0D0-10A,324BCBA2-F6A4-45A6-807C-215BDFFCCA21,Blood Derived Normal,Illumina HiSeq,d5cf3968-3a25-4d98-9af5-206f96cce6db,Breast,60,8CAB86C8-E392-4387-ACEA-23B02BAF79AA,780A0702-3E17-4768-BD37-77F09E427673,TCGA-A2-A0D0-10A-01D-A128-09,GRCh37-lite,TCGA-A2-A0D0,TCGA-BRCA,NA,s5636,Washington University School of Medicine,Walter Reed,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa83ce4b0c9d6adf72ec0,58cfa83ce4b0c9d6adf72ec0,d820260550ed5924c59f81c3b52d9aef.filtered.,WGS,d820260550ed5924c59f81c3b52d9aef,d820260550ed5924c59f81c3b52d9aef.bam,186.4,2.05,0.09,58cfa83ce4b0c9d6adf72ec0,d820260550ed5924c59f81c3b52d9aef.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0K8-10B,24118B8F-59FE-482A-AED3-7B1BDE1571B7,Blood Derived Normal,Illumina HiSeq,dc6942f5-8f80-4394-9218-09d97da13ef2,Uterus,71,37C227F4-E09F-4996-A757-28C11388434C,87212DDC-290F-4C83-85C7-05625B898F86,TCGA-B5-A0K8-10B-01D-A34H-09,GRCh37-lite,TCGA-B5-A0K8,TCGA-UCEC,NA,s4400,Washington University School of Medicine,Duke,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a492,58cfa82de4b0c9d6adf6a492,243c10f1efa33520bf06a2abbf747e06.filtered.,WGS,243c10f1efa33520bf06a2abbf747e06,243c10f1efa33520bf06a2abbf747e06.bam,29.88,1.72,0.08,58cfa82de4b0c9d6adf6a492,243c10f1efa33520bf06a2abbf747e06.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A054-10A,D77E4DBC-B239-4742-8CB7-EFD427010D13,Blood Derived Normal,Illumina HiSeq,14a2def0-6613-4a7b-a857-655ccfb48cf9,Uterus,64,2A884E50-859A-4269-A604-210562E65E9C,42482DBA-7343-43F6-8E59-185462D53EC6,TCGA-AP-A054-10A-01D-A066-09,GRCh37-lite,TCGA-AP-A054,TCGA-UCEC,709,s4235,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf730f3,58cfa83ce4b0c9d6adf730f3,bfb755eba2cb74f4b267ec11599be1e6.filtered.,WGS,bfb755eba2cb74f4b267ec11599be1e6,bfb755eba2cb74f4b267ec11599be1e6.bam,34.65,1.78,0.08,58cfa83ce4b0c9d6adf730f3,bfb755eba2cb74f4b267ec11599be1e6.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A05D-10A,F7E06A10-74CA-4F52-A944-B3F22C016998,Blood Derived Normal,Illumina HiSeq,e5f25684-823e-40cc-af50-3fe79d356351,Uterus,67,2010755C-C987-427A-B3F0-3DBD4BB1249F,2B203ABC-26AB-49C2-9D47-766366BE3992,TCGA-AP-A05D-10A-01D-A013-09,GRCh37-lite,TCGA-AP-A05D,TCGA-UCEC,NA,s4398,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a704,58cfa82de4b0c9d6adf6a704,994b896532e3794d4f63fb96973b2256.filtered.,WGS,994b896532e3794d4f63fb96973b2256,994b896532e3794d4f63fb96973b2256.bam,19.66,2,0.07,58cfa82de4b0c9d6adf6a704,994b896532e3794d4f63fb96973b2256.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A15K-10A,17C1D42C-CB84-4655-A4CD-B54BAE17ECAF,Blood Derived Normal,Illumina HiSeq,8cdfd720-da4b-4c8d-a277-eca9d8f65307,Breast,58,15A0F69E-6BCB-4680-B4F4-36F03E58012B,6C7D0BEB-A20C-4CF8-8E52-2028A8620BB5,TCGA-E2-A15K-10A-01D-A12Q-09,GRCh37-lite,TCGA-E2-A15K,TCGA-BRCA,NA,s5794,Washington University School of Medicine,Roswell Park,None,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa83ce4b0c9d6adf73102,58cfa83ce4b0c9d6adf73102,e31a435be032cfbe070f85a8cf8be96e.filtered.,WGS,e31a435be032cfbe070f85a8cf8be96e,e31a435be032cfbe070f85a8cf8be96e.bam,21.68,NA,0.08,58cfa83ce4b0c9d6adf73102,e31a435be032cfbe070f85a8cf8be96e.bam,Alive,FEMALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OJ-11A,CB419344-6148-43D4-B549-570BD09B3E05,Solid Tissue Normal,HiSeq X Ten,3de139a7-6240-4f15-b3ab-566f3bdfbf79,Esophagus,70,F73DB16E-FFF9-43A0-A75C-AF0D39812E68,9CFE6810-0D93-48FF-B2D6-2758E2A7D40F,TCGA-L5-A4OJ-11A-12D-A27G-09,GRCh37-lite_WUGSC_variant_2,TCGA-L5-A4OJ,TCGA-ESCA,NA,s1903,Washington University School of Medicine,University of Michigan,United States,NO,T1,N0,Not available,Stage I
13722.58cfa82de4b0c9d6adf6a46c,58cfa82de4b0c9d6adf6a46c,457ee39945c7939772dcc332d62d2032.filtered.,WGS,457ee39945c7939772dcc332d62d2032,457ee39945c7939772dcc332d62d2032.bam,9.57,NA,0.09,58cfa82de4b0c9d6adf6a46c,457ee39945c7939772dcc332d62d2032.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A2J4-10A,F75D2589-FD7B-49A1-A1C8-0B4726B81F3C,Blood Derived Normal,Illumina HiSeq,6ad69af1-1704-4370-89a5-bb8a72af61ae,Mesenchymal,60,BAC433A0-9C1C-4ACF-965F-1612BA341C70,7BEAAFF7-E241-4851-8DBA-FD0B302C53CF,TCGA-DX-A2J4-10A-01D-A21Q-09,GRCh37-lite,TCGA-DX-A2J4,TCGA-SARC,NA,s2337,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a56b,58cfa82de4b0c9d6adf6a56b,23a987f09c4bbfd3db0e42c85c318643.filtered.,WGS,23a987f09c4bbfd3db0e42c85c318643,23a987f09c4bbfd3db0e42c85c318643.bam,41.87,NA,0.08,58cfa82de4b0c9d6adf6a56b,23a987f09c4bbfd3db0e42c85c318643.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A5U5-10A,656E3C14-1FC6-473A-813E-719753E7B408,Blood Derived Normal,HiSeq X Ten,e87aef68-16ab-46b9-b79f-fd72a3f0a8d8,Esophagus,57,36438768-5E31-4D84-ACE3-067F5F044360,6F06991D-86DD-42A1-8EA0-8D832543DDB8,TCGA-LN-A5U5-10A-01D-A28E-09,GRCh37-lite_WUGSC_variant_2,TCGA-LN-A5U5,TCGA-ESCA,NA,s1612,Washington University School of Medicine,ILSbio,Vietnam,NO,T3,N1,Not available,Stage IV
13722.58cfa83ce4b0c9d6adf72eb3,58cfa83ce4b0c9d6adf72eb3,d823e46f8b726a23375599ff06b3ee23.filtered.,WGS,d823e46f8b726a23375599ff06b3ee23,d823e46f8b726a23375599ff06b3ee23.bam,38.27,NA,0.08,58cfa83ce4b0c9d6adf72eb3,d823e46f8b726a23375599ff06b3ee23.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-V5-A7RC-10A,AAC385C1-42F9-4D9E-B9BF-94CA13EBC5AE,Blood Derived Normal,HiSeq X Ten,a0ca6871-1756-40a8-a889-a0fc948e68b9,Esophagus,55,7FAA0EA4-DD78-4B0C-A47E-62A2A4E97C14,028AACF0-76B0-49A8-A1E8-D1D8205DD9F0,TCGA-V5-A7RC-10A-01D-A403-09,GRCh37-lite_WUGSC_variant_2,TCGA-V5-A7RC,TCGA-ESCA,104,s1706,Washington University School of Medicine,Duke University,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a6b2,58cfa82de4b0c9d6adf6a6b2,8f5c8fd28b6c6113bdedd06a58237d53.filtered.,WGS,8f5c8fd28b6c6113bdedd06a58237d53,8f5c8fd28b6c6113bdedd06a58237d53.bam,28.55,2,0.08,58cfa82de4b0c9d6adf6a6b2,8f5c8fd28b6c6113bdedd06a58237d53.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A124-10A,B094E8B2-8ECE-4B36-8025-18073A8B873C,Blood Derived Normal,Illumina HiSeq,df77d00f-d0ce-435b-8776-c9043d199f1c,Breast,38,BD2CF5B3-2981-4DE2-95B6-F7092851D23F,0C4D979C-75F8-49BD-8E65-F980CBEAE267,TCGA-AO-A124-10A-01D-A10M-09,GRCh37-lite,TCGA-AO-A124,TCGA-BRCA,NA,s6117,Washington University School of Medicine,MSKCC,None,NO,T2,N0 (i-),Other  specify,Stage IIA
13722.58cfa82de4b0c9d6adf6a5ba,58cfa82de4b0c9d6adf6a5ba,6011eb0b47e84a64100b4ab1fb7890d4.filtered.,WGS,6011eb0b47e84a64100b4ab1fb7890d4,6011eb0b47e84a64100b4ab1fb7890d4.bam,17.14,1.93,0.08,58cfa82de4b0c9d6adf6a5ba,6011eb0b47e84a64100b4ab1fb7890d4.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AQ-A04J-10A,9938CE5C-E74E-446E-A932-F096F85CC3B1,Blood Derived Normal,Illumina HiSeq,daa58157-819b-4aa9-b5f7-a7db1fb9acba,Breast,45,98EBBB82-4AFB-4BBD-B29C-03ADF2EDA305,5BF42CFB-BFE4-4666-9D7E-7D50500BDEBD,TCGA-AQ-A04J-10A-01D-A128-09,GRCh37-lite,TCGA-AQ-A04J,TCGA-BRCA,NA,s6457,Washington University School of Medicine,Not available,United States,NO,T2,N0 (i+),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a500,58cfa82de4b0c9d6adf6a500,1a412b398e31a45c322e65711a35d52f.filtered.,WGS,1a412b398e31a45c322e65711a35d52f,1a412b398e31a45c322e65711a35d52f.bam,27.3,2.03,0.08,58cfa82de4b0c9d6adf6a500,1a412b398e31a45c322e65711a35d52f.bam,Alive,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0V8-10A,2B76CC9C-C379-43E4-9C3F-56197A3353BE,Blood Derived Normal,Illumina HiSeq,fa9ff5b6-2ff3-4c3b-bb39-b3df34a375d2,Uterus,68,6E63CD30-AE3C-4B5A-8001-26C93F903A10,332A9DF3-3816-4BA2-9C2A-732E0895294E,TCGA-BS-A0V8-10A-01D-A122-09,GRCh37-lite,TCGA-BS-A0V8,TCGA-UCEC,NA,s4406,Washington University School of Medicine,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a634,58cfa82de4b0c9d6adf6a634,63fce88d543c8b969ca3171331e19211.filtered.,WGS,63fce88d543c8b969ca3171331e19211,63fce88d543c8b969ca3171331e19211.bam,14.72,1.91,0.08,58cfa82de4b0c9d6adf6a634,63fce88d543c8b969ca3171331e19211.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A15K-11A,17C1D42C-CB84-4655-A4CD-B54BAE17ECAF,Solid Tissue Normal,Illumina HiSeq,4968e751-3f12-4e99-8228-6a58cbf1bca4,Breast,58,1EB11F10-2ACA-4CA1-B6FC-BBC97CC485FD,26163687-7EDE-43BE-AEB7-21AD33133D45,TCGA-E2-A15K-11A-13D-A12Q-09,GRCh37-lite,TCGA-E2-A15K,TCGA-BRCA,NA,s6113,Washington University School of Medicine,Roswell Park,None,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa82fe4b0c9d6adf6b50c,58cfa82fe4b0c9d6adf6b50c,TCGA-26-1438-10A-01D-0703-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-26-1438-10A-01D-0703-09_IlluminaGA-DNASeq_whole,TCGA-26-1438-10A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,1269.6,1.9,0.14,58cfa82fe4b0c9d6adf6b50c,TCGA-26-1438-10A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-26-1438-10A,17DFFFFC-65D6-4209-9075-18A441001F0F,Blood Derived Normal,Illumina GA,a7d083aa-8e3b-4fa5-b17a-5dd2aff653ed,Brain,36,A7BA7046-B119-4580-A3B4-B4F6F505227F,9F2D2C1D-1B1D-49E3-80FB-8E1A89BE52FE,TCGA-26-1438-10A-01D-0703-09,NCBI36_WUGSC_variant,TCGA-26-1438,TCGA-GBM,NA,s14353,Washington University School of Medicine,University of Florida,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82fe4b0c9d6adf6b771,58cfa82fe4b0c9d6adf6b771,TCGA-61-1916-11A-01D-0926-12_Illumina.filtered.,WGS,TCGA-61-1916-11A-01D-0926-12_Illumina,TCGA-61-1916-11A-01D-0926-12_Illumina.bam,155.3,1.9,0.15,58cfa82fe4b0c9d6adf6b771,TCGA-61-1916-11A-01D-0926-12_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-61-1916-11A,B25B3379-DF8F-4900-9BCE-0F8DF50F549B,Solid Tissue Normal,Illumina HiSeq,c24b9dc8-b105-4e1f-a067-790ef8a8b884,Ovary,53,D52F953E-B8E1-47C1-9D67-F73136E6B763,2754262E-E173-4F9B-BD4B-61E38019BCC3,TCGA-61-1916-11A-01D-0926-12,NCBI36_BCM_variant,TCGA-61-1916,TCGA-OV,475,s17732,Baylor College of Medicine,University of Pittsburgh,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a6d2,58cfa82de4b0c9d6adf6a6d2,91ccea470239ab86aafc536d744daf88.filtered.,WGS,91ccea470239ab86aafc536d744daf88,91ccea470239ab86aafc536d744daf88.bam,1269.6,1.9,0.14,58cfa82de4b0c9d6adf6a6d2,91ccea470239ab86aafc536d744daf88.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-26-1438-10A,17DFFFFC-65D6-4209-9075-18A441001F0F,Blood Derived Normal,Illumina GA,80d00b72-e301-4855-97a8-286f8d3fe406,Brain,36,A7BA7046-B119-4580-A3B4-B4F6F505227F,9F2D2C1D-1B1D-49E3-80FB-8E1A89BE52FE,TCGA-26-1438-10A-01D-0703-09,GRCh37-lite,TCGA-26-1438,TCGA-GBM,NA,s14200,Washington University School of Medicine,University of Florida,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6bd84,58cfa830e4b0c9d6adf6bd84,TCGA-AB-3000-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-3000-03A-01D-0739-09_whole,TCGA-AB-3000-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bd84,TCGA-AB-3000-03A-01D-0739-09_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3000-03A,92C7E4D6-EB53-46C5-9721-5EDCCD60BCC9,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,fa364111-8645-4328-981b-f6a777df46ea,Blood,25,6C2BE933-F491-4EEC-8882-6B35BD4F8EF3,3D9C2B87-CD6B-4A73-B9A7-9BE8A4F37FD3,TCGA-AB-3000-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-3000,TCGA-LAML,NA,s7053,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a5ca,58cfa82de4b0c9d6adf6a5ca,72e59a417c67930a0de99ab36c4df550.filtered.,WGS,72e59a417c67930a0de99ab36c4df550,72e59a417c67930a0de99ab36c4df550.bam,21.47,NA,0.09,58cfa82de4b0c9d6adf6a5ca,72e59a417c67930a0de99ab36c4df550.bam,Dead,MALE,Not available,Not available,Sarcoma,Aligned reads,TCGA-DX-A3U8-10A,D40C99D0-79F6-499D-B7F1-5FC4237CFC57,Blood Derived Normal,Illumina HiSeq,e04a8b1c-4213-48c5-9203-62eaa6ec0003,Mesenchymal,43,9B1631B8-A1A3-4F78-B094-9019234E7DD8,DE98DB7B-81EE-4500-AB0A-80894271D467,TCGA-DX-A3U8-10A-01D-A29N-09,GRCh37-lite,TCGA-DX-A3U8,TCGA-SARC,138,s2342,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a560,58cfa82de4b0c9d6adf6a560,0a1391284ac30b02d85a5885bca3ad6d.filtered.,WGS,0a1391284ac30b02d85a5885bca3ad6d,0a1391284ac30b02d85a5885bca3ad6d.bam,13.48,NA,0.09,58cfa82de4b0c9d6adf6a560,0a1391284ac30b02d85a5885bca3ad6d.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2RE-10A,9AA36AC2-8418-4109-A3C1-63CA8742BAAB,Blood Derived Normal,Illumina HiSeq,e89116c7-baf6-41ea-a3b7-90fbdd692255,Cervix,26,49B39F9A-A7BE-40D3-A3D7-3DF579DAFAAE,A756A6D1-19C0-4C17-A1DA-12A5A23718A0,TCGA-EK-A2RE-10A-01D-A34H-09,GRCh37-lite,TCGA-EK-A2RE,TCGA-CESC,NA,s1345,Washington University School of Medicine,Gynecologic Oncology Group,United States,NO,T2a2,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82de4b0c9d6adf6a646,58cfa82de4b0c9d6adf6a646,7cdc3dce590a37c14215501abc56072b.filtered.,WGS,7cdc3dce590a37c14215501abc56072b,7cdc3dce590a37c14215501abc56072b.bam,11.23,NA,0.07,58cfa82de4b0c9d6adf6a646,7cdc3dce590a37c14215501abc56072b.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-HB-A5W3-10A,C5B0E6BE-48B5-40E5-9D90-F9112050AA88,Blood Derived Normal,Illumina HiSeq,f325a922-a166-48d2-b2bf-f33cd8576feb,Mesenchymal,58,EBD8957C-5F46-48F2-8A39-1D327C3B724F,546CFD48-E472-4186-A83A-09F5AEF53000,TCGA-HB-A5W3-10A-01D-A29N-09,GRCh37-lite,TCGA-HB-A5W3,TCGA-SARC,384,s2343,Washington University School of Medicine,University of North Carolina,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6bde8,58cfa830e4b0c9d6adf6bde8,TCGA-BH-A0B3-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-BH-A0B3-10A-01D-A128-09_IlluminaGA-DNASeq_whole,TCGA-BH-A0B3-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,16.52,1.94,0.07,58cfa830e4b0c9d6adf6bde8,TCGA-BH-A0B3-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0B3-10A,18EB4DFC-556F-4BF3-A411-4780209ED1E0,Blood Derived Normal,Illumina HiSeq,3e0ede40-674b-441b-9bb4-28f65ecb7d8c,Breast,53,156C15D8-5E27-49C1-AB20-77B60B4FC665,67D6596D-D6A8-4D16-A10B-C744B2DB8117,TCGA-BH-A0B3-10A-01D-A128-09,GRCh37-lite,TCGA-BH-A0B3,TCGA-BRCA,NA,s5800,Washington University School of Medicine,University of Pittsburgh,None,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa83ce4b0c9d6adf73090,58cfa83ce4b0c9d6adf73090,f6f0bc109f78a22318fcd55e02cd9e0e.filtered.,WGS,f6f0bc109f78a22318fcd55e02cd9e0e,f6f0bc109f78a22318fcd55e02cd9e0e.bam,54.22,1.93,0.08,58cfa83ce4b0c9d6adf73090,f6f0bc109f78a22318fcd55e02cd9e0e.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0G9-01A,45D58088-D3F4-4EB0-B75C-BCB98C0981DC,Primary Tumor,Illumina HiSeq,5394f784-0e1a-4fe2-82e6-a4ba4d7f95b4,Uterus,79,117A5B33-42C5-4A52-BABE-D9712F3E7472,EAE45FBE-9F7D-4F59-A0A9-1F0F0D69AFC4,TCGA-A5-A0G9-01A-11D-A066-09,GRCh37-lite,TCGA-A5-A0G9,TCGA-UCEC,NA,s4575,Washington University School of Medicine,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6b1a4,58cfa82ee4b0c9d6adf6b1a4,TCGA-14-0786-10A-01D-0703-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-14-0786-10A-01D-0703-09_IlluminaGA-DNASeq_whole,TCGA-14-0786-10A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,91.6,1.9,0.19,58cfa82ee4b0c9d6adf6b1a4,TCGA-14-0786-10A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-0786-10A,12824B2B-9C0A-4DCF-8941-34593A4E93DA,Blood Derived Normal,Illumina GA,4580948d-4987-44cb-b488-4a9b0410a65f,Brain,50,956D0A4E-4485-40BF-ABE2-D7D24F3C4C7A,E8114AE7-E076-44CA-B2BB-B6C3629B53B0,TCGA-14-0786-10A-01D-0703-09,NCBI36_WUGSC_variant,TCGA-14-0786,TCGA-GBM,701,s14103,Washington University School of Medicine,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6bebc,58cfa830e4b0c9d6adf6bebc,TCGA-AB-2981-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2981-03A-01D-0739-09_whole,TCGA-AB-2981-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bebc,TCGA-AB-2981-03A-01D-0739-09_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2981-03A,BE6DD0E8-9966-4961-987D-4D64D15FF9CA,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,2f164e15-1d90-4d0b-bf80-f15a9a3f119f,Blood,35,324EFA3E-4CCA-4748-A895-B40339DE154B,7212BA7B-F637-4F9F-B616-94109BFB8898,TCGA-AB-2981-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2981,TCGA-LAML,NA,s7300,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a4fa,58cfa82de4b0c9d6adf6a4fa,3f3ef84660f7426d20a9c5cb429db8ee.filtered.,WGS,3f3ef84660f7426d20a9c5cb429db8ee,3f3ef84660f7426d20a9c5cb429db8ee.bam,34.85,1.74,0.08,58cfa82de4b0c9d6adf6a4fa,3f3ef84660f7426d20a9c5cb429db8ee.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A051-10A,B045F24B-F822-4DF9-9FFA-47308EDCEC8C,Blood Derived Normal,Illumina HiSeq,8728b3d3-aca8-4f84-a4c2-496d9e18083c,Uterus,69,F75CD7D6-DC83-4636-BB88-C181C0A7834E,A91ABF2C-52DA-4473-8785-496A239AE4D5,TCGA-AP-A051-10A-01D-A013-09,GRCh37-lite,TCGA-AP-A051,TCGA-UCEC,NA,s4767,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bdd2,58cfa830e4b0c9d6adf6bdd2,TCGA-BH-A0E0-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-BH-A0E0-10A-01D-A128-09_IlluminaGA-DNASeq_whole,TCGA-BH-A0E0-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,12.94,2.03,0.08,58cfa830e4b0c9d6adf6bdd2,TCGA-BH-A0E0-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0E0-10A,20E8106B-1290-4735-ABE4-7621E08E3DC8,Blood Derived Normal,Illumina HiSeq,48d26da8-f7ee-4828-890b-be10385c1187,Breast,38,FE4E376B-7C87-4ED1-8994-7C8A8DAF402B,3448B251-9EE2-413B-8A08-F0160CEDEBA0,TCGA-BH-A0E0-10A-01D-A128-09,GRCh37-lite,TCGA-BH-A0E0,TCGA-BRCA,NA,s6774,Washington University School of Medicine,University of Pittsburgh,None,NO,T3,N3a,Infiltrating Ductal Carcinoma,Stage IIIC
13722.58cfa82de4b0c9d6adf6a644,58cfa82de4b0c9d6adf6a644,7cc3dd16015812a7719ba947df5a6072.filtered.,WGS,7cc3dd16015812a7719ba947df5a6072,7cc3dd16015812a7719ba947df5a6072.bam,22.28,NA,0.12,58cfa82de4b0c9d6adf6a644,7cc3dd16015812a7719ba947df5a6072.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-GI-A2C9-11A,9F6BE944-83DE-42AB-8738-F0022F475E61,Solid Tissue Normal,Illumina HiSeq,70c562ea-b1bc-41ac-aa70-e3865fb5f03e,Breast,58,93B78420-ED0E-45D3-93F5-F60CE671A812,E0D54A00-8D0B-4A09-BF35-75183818D3ED,TCGA-GI-A2C9-11A-22D-A21Q-09,GRCh37-lite,TCGA-GI-A2C9,TCGA-BRCA,NA,s5484,Washington University School of Medicine,ABS - IUPUI,United States,NO,T3,N0,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa82de4b0c9d6adf6a650,58cfa82de4b0c9d6adf6a650,7e80bee114f233cb474adf3b85c42f91.filtered.,WGS,7e80bee114f233cb474adf3b85c42f91,7e80bee114f233cb474adf3b85c42f91.bam,91.6,1.9,0.19,58cfa82de4b0c9d6adf6a650,7e80bee114f233cb474adf3b85c42f91.bam,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-0786-10A,12824B2B-9C0A-4DCF-8941-34593A4E93DA,Blood Derived Normal,Illumina GA,3ec0cace-4125-41c1-89bf-8519996cceea,Brain,50,956D0A4E-4485-40BF-ABE2-D7D24F3C4C7A,E8114AE7-E076-44CA-B2BB-B6C3629B53B0,TCGA-14-0786-10A-01D-0703-09,GRCh37-lite,TCGA-14-0786,TCGA-GBM,701,s13871,Washington University School of Medicine,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf72fde,58cfa83ce4b0c9d6adf72fde,bb06d7ab408c6716e20c1e6607182a1c.filtered.,WGS,bb06d7ab408c6716e20c1e6607182a1c,bb06d7ab408c6716e20c1e6607182a1c.bam,26.22,1.73,0.09,58cfa83ce4b0c9d6adf72fde,bb06d7ab408c6716e20c1e6607182a1c.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-AR-A24Z-10A,9FEFBE7C-F66A-4940-843E-285CB7B392C1,Blood Derived Normal,Illumina HiSeq,832184fd-56a4-488a-a361-8fee484a5391,Breast,57,CCA6B801-F735-420C-9BF3-A11FA35E56B5,E7976863-3BBF-42AC-B272-CCD7CA5BF679,TCGA-AR-A24Z-10A-01D-A167-09,GRCh37-lite,TCGA-AR-A24Z,TCGA-BRCA,NA,s6444,Washington University School of Medicine,Mayo,United States,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a64c,58cfa82de4b0c9d6adf6a64c,7d61482fcdb0b3474ce081a341b53dc4.filtered.,WGS,7d61482fcdb0b3474ce081a341b53dc4,7d61482fcdb0b3474ce081a341b53dc4.bam,21.88,NA,0.08,58cfa82de4b0c9d6adf6a64c,7d61482fcdb0b3474ce081a341b53dc4.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A1L0-10A,854E42BC-95B2-4B77-A4B2-FFBD6C28B281,Blood Derived Normal,Illumina HiSeq,3727a1a3-db2c-49ae-87ac-665a9a845e2b,Mesenchymal,58,34CDAAD4-C92F-4BC4-A8DB-09CFF5EFBC99,E64C9084-028A-460D-8EBC-5587C4601EA8,TCGA-DX-A1L0-10A-01D-A24N-09,GRCh37-lite,TCGA-DX-A1L0,TCGA-SARC,564,s2491,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a6f8,58cfa82de4b0c9d6adf6a6f8,99231eb34b1f9fb496429a33945944d6.filtered.,WGS,99231eb34b1f9fb496429a33945944d6,99231eb34b1f9fb496429a33945944d6.bam,18.7,1.82,0.08,58cfa82de4b0c9d6adf6a6f8,99231eb34b1f9fb496429a33945944d6.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A1C8-10A,BAD34C92-1E64-4187-A0B4-061105FD13BA,Blood Derived Normal,Illumina HiSeq,700244b2-fe0e-4242-bc86-6b418aeca931,Uterus,77,B06ABBDA-60D6-4E45-8FF0-11F555D42F14,8313A88B-CAF0-4C11-ADCF-090F26F94B23,TCGA-AX-A1C8-10A-01D-A34H-09,GRCh37-lite,TCGA-AX-A1C8,TCGA-UCEC,NA,s5191,Washington University School of Medicine,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a494,58cfa82de4b0c9d6adf6a494,1164896cd389b0293fc5d942b5da6940.filtered.,WGS,1164896cd389b0293fc5d942b5da6940,1164896cd389b0293fc5d942b5da6940.bam,8.87,NA,0.08,58cfa82de4b0c9d6adf6a494,1164896cd389b0293fc5d942b5da6940.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-MO-A47R-10A,8654C2B5-27D7-43C5-9A39-7FDEFD7A0324,Blood Derived Normal,Illumina HiSeq,c90bd12e-acf7-4188-a172-f5db6045aaa6,Mesenchymal,75,66BEC5B8-228F-4D11-86C6-3076A654B315,40925959-5B66-45A5-A8A2-61EE7E67B084,TCGA-MO-A47R-10A-01D-A24N-09,GRCh37-lite,TCGA-MO-A47R,TCGA-SARC,NA,s2332,Washington University School of Medicine,ILSbio,Vietnam,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72f83,58cfa83ce4b0c9d6adf72f83,ad1cf501bd8ce3f285d74c81648798f2.filtered.,WGS,ad1cf501bd8ce3f285d74c81648798f2,ad1cf501bd8ce3f285d74c81648798f2.bam,16.5,NA,0.09,58cfa83ce4b0c9d6adf72f83,ad1cf501bd8ce3f285d74c81648798f2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-IW-A3M4-10B,0DA5EE6C-D012-4A57-9992-9D74937AAA5F,Blood Derived Normal,Illumina HiSeq,782474f3-3799-4e88-bb9f-ae4014ac2829,Mesenchymal,48,150AE96A-6C41-474A-A434-C0E25B988B3A,8475F0EF-158E-493E-82B5-44E895DFC0A7,TCGA-IW-A3M4-10B-01D-A21Q-09,GRCh37-lite,TCGA-IW-A3M4,TCGA-SARC,NA,s2625,Washington University School of Medicine,Cedars Sinai,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a446,58cfa82de4b0c9d6adf6a446,2fa9bf8f4ca8cc6f8392362de32be09a.filtered.,WGS,2fa9bf8f4ca8cc6f8392362de32be09a,2fa9bf8f4ca8cc6f8392362de32be09a.bam,18.7,1.95,0.08,58cfa82de4b0c9d6adf6a446,2fa9bf8f4ca8cc6f8392362de32be09a.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TD-10A,FFAA98A0-2B69-46DC-AEE5-C5C3F2ABBC38,Blood Derived Normal,Illumina HiSeq,ac4b5c32-2603-41f6-a58b-fa7ba69b5be7,Uterus,65,2729ED97-F971-4D98-8BAA-F99404DD2B9F,47F826A1-96ED-4F4D-94E0-49F4460EF44F,TCGA-BS-A0TD-10A-01D-A10B-09,GRCh37-lite,TCGA-BS-A0TD,TCGA-UCEC,NA,s4580,Washington University School of Medicine,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf72ed6,58cfa83ce4b0c9d6adf72ed6,e3a4928af3288dd832f84bf77fd81898.filtered.,WGS,e3a4928af3288dd832f84bf77fd81898,e3a4928af3288dd832f84bf77fd81898.bam,13.5,2.5,0.08,58cfa83ce4b0c9d6adf72ed6,e3a4928af3288dd832f84bf77fd81898.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A1MQ-10A,EB59CF69-1997-41B9-BF69-69AD7DA292A1,Blood Derived Normal,Illumina HiSeq,a7a5766f-801a-4fd5-b296-42fcb2a30a3d,Cervix,35,45E629A2-EDC8-427A-AD29-05D6DB9B0E04,F186998C-A619-4A53-B514-EF51644EDA21,TCGA-C5-A1MQ-10A-01D-A200-09,GRCh37-lite,TCGA-C5-A1MQ,TCGA-CESC,NA,s1342,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,T2b,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b583,58cfa82fe4b0c9d6adf6b583,TCGA-29-1704-01B-01D-0926-12_Illumina.filtered.,WGS,TCGA-29-1704-01B-01D-0926-12_Illumina,TCGA-29-1704-01B-01D-0926-12_Illumina.bam,100,1.9,0.14,58cfa82fe4b0c9d6adf6b583,TCGA-29-1704-01B-01D-0926-12_Illumina.bam,Alive,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-29-1704-01B,8E7F1C74-7CB3-43C0-B07C-BF69B780053F,Primary Tumor,Illumina HiSeq,900a0414-df0c-4e17-8651-8c01bfce6964,Ovary,61,0B7F454A-33B0-4E5C-9E55-81D7B00D15F4,A73BA735-1C59-47FC-915B-D2603510DC73,TCGA-29-1704-01B-01D-0926-12,NCBI36_BCM_variant,TCGA-29-1704,TCGA-OV,NA,s17389,Baylor College of Medicine,Duke,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a51e,58cfa82de4b0c9d6adf6a51e,1ba3844520b272a8a41adea7119b7add.filtered.,WGS,1ba3844520b272a8a41adea7119b7add,1ba3844520b272a8a41adea7119b7add.bam,5.14,NA,0.08,58cfa82de4b0c9d6adf6a51e,1ba3844520b272a8a41adea7119b7add.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-FX-A2QS-10A,2905CBD1-719B-46D9-B8AF-8FE4927BC473,Blood Derived Normal,Illumina HiSeq,e4683fe1-a255-45d8-ac6f-68d733c7476c,Mesenchymal,61,20030A57-62B7-480B-A43F-4C35CCB4EC6E,306F6BC4-C021-4480-8E72-E3D5CE522EE8,TCGA-FX-A2QS-10A-01D-A21Q-09,GRCh37-lite,TCGA-FX-A2QS,TCGA-SARC,NA,s2478,Washington University School of Medicine,International Genomics Consortium,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6b0e3,58cfa82ee4b0c9d6adf6b0e3,TCGA-13-0791-01A-01D-0926-12_Illumina.filtered.,WGS,TCGA-13-0791-01A-01D-0926-12_Illumina,TCGA-13-0791-01A-01D-0926-12_Illumina.bam,3.34,1.9,0.15,58cfa82ee4b0c9d6adf6b0e3,TCGA-13-0791-01A-01D-0926-12_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0791-01A,90118207-8F11-4784-AC1B-0DEEC2E7AF3A,Primary Tumor,Illumina HiSeq,8aed3c69-0d57-4044-998f-9ce7de86165f,Ovary,58,04C9A370-2813-4104-98C7-4948D27DACB3,602247EA-7B1C-4B43-B9EE-5636CC9087BC,TCGA-13-0791-01A-01D-0926-12,NCBI36_BCM_variant,TCGA-13-0791,TCGA-OV,NA,s17291,Baylor College of Medicine,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b622,58cfa82fe4b0c9d6adf6b622,TCGA-29-1707-10A-01D-0926-12_Illumina.filtered.,WGS,TCGA-29-1707-10A-01D-0926-12_Illumina,TCGA-29-1707-10A-01D-0926-12_Illumina.bam,11.4,1.84,0.14,58cfa82fe4b0c9d6adf6b622,TCGA-29-1707-10A-01D-0926-12_Illumina.bam,Alive,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-29-1707-10A,7FD6AB8A-201E-431D-A886-6AB553B6CA36,Blood Derived Normal,Illumina HiSeq,bf028326-27d2-4fa7-8223-7252c1e25689,Ovary,41,0FDB716D-D203-4AC2-9250-D273715055D3,5AF7ACAC-B437-4F1A-9D27-224D805E4E12,TCGA-29-1707-10A-01D-0926-12,NCBI36_BCM_variant,TCGA-29-1707,TCGA-OV,NA,s17961,Baylor College of Medicine,Duke,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6c143,58cfa830e4b0c9d6adf6c143,TCGA-AB-2967-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2967-11A-01D-0739-09_whole,TCGA-AB-2967-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6c143,TCGA-AB-2967-11A-01D-0739-09_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2967-11A,9C022254-F9F7-4C61-BE48-48C60A92448E,Solid Tissue Normal,Illumina GA,72716dcb-583b-4c55-87af-a6d8b4ae9244,Blood,58,56035ACE-10BA-4BEF-AB7F-38C3CFCA3A64,B5BABADF-7B10-45FC-8C93-5F68A08B07ED,TCGA-AB-2967-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2967,TCGA-LAML,NA,s7043,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82fe4b0c9d6adf6b268,58cfa82fe4b0c9d6adf6b268,TCGA-16-1460-01A-01D-0932-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-16-1460-01A-01D-0932-09_IlluminaGA-DNASeq_whole,TCGA-16-1460-01A-01D-0932-09_IlluminaGA-DNASeq_whole.bam,160.97,1.9,0.15,58cfa82fe4b0c9d6adf6b268,TCGA-16-1460-01A-01D-0932-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-16-1460-01A,827453A9-7388-4336-9AC5-4DEFCB904607,Primary Tumor,Illumina GA,a8394e78-631a-46b8-a117-639d795423f6,Brain,36,143E54AE-A4F2-4BC2-987D-5C5EC01ECAF2,325FCF3F-E3EA-4EF5-B59D-0936350B2D3F,TCGA-16-1460-01A-01D-0932-09,NCBI36_WUGSC_variant,TCGA-16-1460,TCGA-GBM,NA,s14350,Washington University School of Medicine,Toronto Western Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a4a4,58cfa82de4b0c9d6adf6a4a4,1ee077bc38d6f8b5a3c7283664ca525b.filtered.,WGS,1ee077bc38d6f8b5a3c7283664ca525b,1ee077bc38d6f8b5a3c7283664ca525b.bam,19.45,NA,0.07,58cfa82de4b0c9d6adf6a4a4,1ee077bc38d6f8b5a3c7283664ca525b.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A3LT-10A,E7A72F7E-77B1-4D95-8F37-39A6CFFC35DC,Blood Derived Normal,Illumina HiSeq,8bc72181-a2a0-4601-a4c2-cf3407046504,Mesenchymal,62,90F18E9D-9104-4EAE-927F-9C66B45EA843,C7214163-07FC-488C-90F5-A10990EBAA09,TCGA-DX-A3LT-10A-01D-A32V-09,GRCh37-lite,TCGA-DX-A3LT,TCGA-SARC,NA,s2334,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72f25,58cfa83ce4b0c9d6adf72f25,e78122f0f22778f289d6ed382f0c64ee.filtered.,WGS,e78122f0f22778f289d6ed382f0c64ee,e78122f0f22778f289d6ed382f0c64ee.bam,NA,NA,NA,58cfa83ce4b0c9d6adf72f25,e78122f0f22778f289d6ed382f0c64ee.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2991-03A,28BB21F0-2851-4B7E-9F8A-6D0A016318E2,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,49f91ddc-95d8-4158-9c18-1d3b432289f8,Blood,40,2AAB4284-20DB-4702-91D3-DA820141394B,5F3D1F46-26BD-4F17-A748-DBA49DE28019,TCGA-AB-2991-03A-01D-0741-05,GRCh37-lite,TCGA-AB-2991,TCGA-LAML,NA,s7158,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6b040,58cfa82ee4b0c9d6adf6b040,TCGA-06-0155-10A-01D-0703-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-06-0155-10A-01D-0703-09_IlluminaGA-DNASeq_whole,TCGA-06-0155-10A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,100,1.9,0.15,58cfa82ee4b0c9d6adf6b040,TCGA-06-0155-10A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0155-10A,FA1F1CFC-9DA0-488B-93FE-60AAFF99C171,Blood Derived Normal,Illumina GA,98a77ad5-55e9-4312-8014-136a3507c4a9,Brain,61,C0CFC2F4-B828-42C9-9388-4ED05F503B54,7B8AE3A0-2AB4-4710-838D-8353E1FAF310,TCGA-06-0155-10A-01D-0703-09,NCBI36_WUGSC_variant,TCGA-06-0155,TCGA-GBM,318,s14230,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf72fcf,58cfa83ce4b0c9d6adf72fcf,a9e580ab8b8754d2f8461cc919a61258.filtered.,WGS,a9e580ab8b8754d2f8461cc919a61258,a9e580ab8b8754d2f8461cc919a61258.bam,160.97,1.9,0.15,58cfa83ce4b0c9d6adf72fcf,a9e580ab8b8754d2f8461cc919a61258.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-16-1460-01A,827453A9-7388-4336-9AC5-4DEFCB904607,Primary Tumor,Illumina GA,7897ea22-b7ea-4502-9d19-a6827bf7da2d,Brain,36,143E54AE-A4F2-4BC2-987D-5C5EC01ECAF2,325FCF3F-E3EA-4EF5-B59D-0936350B2D3F,TCGA-16-1460-01A-01D-0932-09,GRCh37-lite,TCGA-16-1460,TCGA-GBM,NA,s14325,Washington University School of Medicine,Toronto Western Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf73071,58cfa83ce4b0c9d6adf73071,f31e08129d2203eb95db8f197638efcd.filtered.,WGS,f31e08129d2203eb95db8f197638efcd,f31e08129d2203eb95db8f197638efcd.bam,16.85,NA,0.09,58cfa83ce4b0c9d6adf73071,f31e08129d2203eb95db8f197638efcd.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2R9-10A,00AD0FFE-2105-4829-A495-1C2ACEB5BB31,Blood Derived Normal,Illumina HiSeq,e1a04d71-458b-4484-b2a7-5c5dc63dcba9,Cervix,58,996AD494-90B1-4AC7-9339-DD4ACF5AF472,70FDD61F-C657-4B0E-8370-724FCEE4A6E8,TCGA-EK-A2R9-10A-01D-A34H-09,GRCh37-lite,TCGA-EK-A2R9,TCGA-CESC,NA,s1343,Washington University School of Medicine,Gynecologic Oncology Group,United States,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b524,58cfa82fe4b0c9d6adf6b524,TCGA-29-1705-01A-01D-0926-12_Illumina.filtered.,WGS,TCGA-29-1705-01A-01D-0926-12_Illumina,TCGA-29-1705-01A-01D-0926-12_Illumina.bam,135.7,1.9,0.15,58cfa82fe4b0c9d6adf6b524,TCGA-29-1705-01A-01D-0926-12_Illumina.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-29-1705-01A,F9C835DB-2AB6-4BF5-826F-48723493C0EC,Primary Tumor,Illumina HiSeq,862f409b-92fe-4bea-95cc-97f8beae4add,Ovary,47,FD3E7BA8-21A5-438B-82EE-482ED6905310,6730E18B-CC34-493E-AAE2-54E51D5D9CFF,TCGA-29-1705-01A-01D-0926-12,NCBI36_BCM_variant,TCGA-29-1705,TCGA-OV,555,s17530,Baylor College of Medicine,Duke,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a63c,58cfa82de4b0c9d6adf6a63c,4b97f9383cb7d56fba152986d1042246.filtered.,WGS,4b97f9383cb7d56fba152986d1042246,4b97f9383cb7d56fba152986d1042246.bam,100,1.9,0.15,58cfa82de4b0c9d6adf6a63c,4b97f9383cb7d56fba152986d1042246.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0155-10A,FA1F1CFC-9DA0-488B-93FE-60AAFF99C171,Blood Derived Normal,Illumina GA,bd9e7246-f595-4dc0-a4f1-719faeeef8b6,Brain,61,C0CFC2F4-B828-42C9-9388-4ED05F503B54,7B8AE3A0-2AB4-4710-838D-8353E1FAF310,TCGA-06-0155-10A-01D-0703-09,GRCh37-lite,TCGA-06-0155,TCGA-GBM,318,s13917,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a540,58cfa82de4b0c9d6adf6a540,3673e63534c107f41189cc7b216ed30b.filtered.,WGS,3673e63534c107f41189cc7b216ed30b,3673e63534c107f41189cc7b216ed30b.bam,7.49,2,0.08,58cfa82de4b0c9d6adf6a540,3673e63534c107f41189cc7b216ed30b.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A7-A0CE-10A,9D95A65B-E41D-4F93-92D4-99DCE29FF40D,Blood Derived Normal,Illumina HiSeq,2ff7263f-3be1-441e-a60d-2fb82d7e3478,Breast,57,AAC9A83D-4EE2-49A8-82DE-DEBDF3E6848C,5F750C41-AC61-4246-9224-E077B83D35F2,TCGA-A7-A0CE-10A-01D-A017-09,GRCh37-lite,TCGA-A7-A0CE,TCGA-BRCA,NA,s5478,Washington University School of Medicine,Christiana Healthcare,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6b1e4,58cfa82ee4b0c9d6adf6b1e4,TCGA-16-1063-10A-01D-0703-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-16-1063-10A-01D-0703-09_IlluminaGA-DNASeq_whole,TCGA-16-1063-10A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,13.3,1.9,0.15,58cfa82ee4b0c9d6adf6b1e4,TCGA-16-1063-10A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-16-1063-10A,6E6962D8-34B8-431C-8220-42B0B92A410B,Blood Derived Normal,Illumina GA,3bad06e8-05dc-4dc2-8e2d-04a59ee88fb3,Brain,72,AF8FC3B9-4AC7-4761-A920-AAB7BBDDE08D,064DAC47-BB48-4792-B480-DC9130FBE943,TCGA-16-1063-10A-01D-0703-09,NCBI36_WUGSC_variant,TCGA-16-1063,TCGA-GBM,425,s14351,Washington University School of Medicine,Toronto Western Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a563,58cfa82de4b0c9d6adf6a563,00a016cbe7ea291456bdcbd03dc828b0.filtered.,WGS,00a016cbe7ea291456bdcbd03dc828b0,00a016cbe7ea291456bdcbd03dc828b0.bam,44.19,NA,0.07,58cfa82de4b0c9d6adf6a563,00a016cbe7ea291456bdcbd03dc828b0.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-FX-A3RE-10A,7F9031DA-124A-4A38-83E6-878A50E58C24,Blood Derived Normal,Illumina HiSeq,c9ab74b3-9a97-414a-a208-65134953cbb7,Mesenchymal,65,5007F7B1-7911-4EB8-B679-B8E59025D36E,833EC0AA-F61E-49FC-ACF0-DDD1A0A1F5C4,TCGA-FX-A3RE-10A-01D-A22A-09,GRCh37-lite,TCGA-FX-A3RE,TCGA-SARC,NA,s2329,Washington University School of Medicine,International Genomics Consortium,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a6ce,58cfa82de4b0c9d6adf6a6ce,916494ff91cb6e9c02fd5cad868a9432.filtered.,WGS,916494ff91cb6e9c02fd5cad868a9432,916494ff91cb6e9c02fd5cad868a9432.bam,13.3,1.9,0.15,58cfa82de4b0c9d6adf6a6ce,916494ff91cb6e9c02fd5cad868a9432.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-16-1063-10A,6E6962D8-34B8-431C-8220-42B0B92A410B,Blood Derived Normal,Illumina GA,e8b6db16-1cda-42af-8ee6-e1c81714bdd7,Brain,72,AF8FC3B9-4AC7-4761-A920-AAB7BBDDE08D,064DAC47-BB48-4792-B480-DC9130FBE943,TCGA-16-1063-10A-01D-0703-09,GRCh37-lite,TCGA-16-1063,TCGA-GBM,425,s13872,Washington University School of Medicine,Toronto Western Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a582,58cfa82de4b0c9d6adf6a582,2eaa264efb60b22dbe42a997b35f232e.filtered.,WGS,2eaa264efb60b22dbe42a997b35f232e,2eaa264efb60b22dbe42a997b35f232e.bam,11.64,NA,0.09,58cfa82de4b0c9d6adf6a582,2eaa264efb60b22dbe42a997b35f232e.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A1L3-10A,9517413B-B5B8-4130-8BA1-D86D44ABE2EC,Blood Derived Normal,Illumina HiSeq,365bf63a-85fc-478e-95b0-a77c00530078,Mesenchymal,60,02F4E533-2ED1-45E0-AB63-C55FBF938C4F,7F34C3A1-EFEE-47C6-BD61-502061FEC7E3,TCGA-DX-A1L3-10A-01D-A24N-09,GRCh37-lite,TCGA-DX-A1L3,TCGA-SARC,NA,s2335,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72e9e,58cfa83ce4b0c9d6adf72e9e,ca58002bcf44f1d1e5539693a2d83704.filtered.,WGS,ca58002bcf44f1d1e5539693a2d83704,ca58002bcf44f1d1e5539693a2d83704.bam,20.22,1.96,0.09,58cfa83ce4b0c9d6adf72e9e,ca58002bcf44f1d1e5539693a2d83704.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A1BJ-10A,7941D1C7-5319-4E8D-A15F-60B61CB68A9B,Blood Derived Normal,Illumina HiSeq,5543916b-b5c3-40b9-9614-537c7ad6e235,Cervix,34,7B080A45-A698-4873-B41B-29F4E6E9D5A1,23D0A67E-CC2B-4F7A-8756-537D93E0798A,TCGA-C5-A1BJ-10A-01D-A200-09,GRCh37-lite,TCGA-C5-A1BJ,TCGA-CESC,NA,s1340,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b9d2,58cfa82fe4b0c9d6adf6b9d2,TCGA-AA-3518-10A-01D-1525-10_Illumina.filtered.,WGS,TCGA-AA-3518-10A-01D-1525-10_Illumina,TCGA-AA-3518-10A-01D-1525-10_Illumina.bam,117.86,1.9,0.05,58cfa82fe4b0c9d6adf6b9d2,TCGA-AA-3518-10A-01D-1525-10_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3518-10A,C5C4A0A5-900D-483D-9282-475654D63265,Blood Derived Normal,Illumina HiSeq,20e838c3-2c21-4875-90e0-626174a3c1db,Colorectal,81,DA5D09FA-0582-45EC-BC71-B8461A0FB13D,A8761858-4C07-4277-A857-5A1861A99C52,TCGA-AA-3518-10A-01D-1525-10,NCBI36_BCM_variant,TCGA-AA-3518,TCGA-COAD,NA,s13179,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a612,58cfa82de4b0c9d6adf6a612,4e04a50d4698f562bb4cb2d8a39c7527.filtered.,WGS,4e04a50d4698f562bb4cb2d8a39c7527,4e04a50d4698f562bb4cb2d8a39c7527.bam,5.6,1.78,0.08,58cfa82de4b0c9d6adf6a612,4e04a50d4698f562bb4cb2d8a39c7527.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0JN-10A,B60F22AC-A659-4F33-B01D-820E86A9A5C9,Blood Derived Normal,Illumina HiSeq,2e2b4d8e-a79d-4b01-8ad5-132ca5b96775,Uterus,84,00FD9A99-8E94-4AEF-94FC-4AABC6381BFC,3A13777B-203E-4CD7-8E25-0A8E5D00798A,TCGA-B5-A0JN-10A-01D-A10B-09,GRCh37-lite,TCGA-B5-A0JN,TCGA-UCEC,NA,s4409,Washington University School of Medicine,Duke,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf72ec9,58cfa83ce4b0c9d6adf72ec9,d5295c8befb5a83beac78163cd03987b.filtered.,WGS,d5295c8befb5a83beac78163cd03987b,d5295c8befb5a83beac78163cd03987b.bam,6.04,NA,0.08,58cfa83ce4b0c9d6adf72ec9,d5295c8befb5a83beac78163cd03987b.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A3LY-10B,3505F91D-BC66-4732-84B6-18C5B32CA6B8,Blood Derived Normal,Illumina HiSeq,d7cd8be8-2b1d-47ea-9512-1ddbc3d83cf1,Mesenchymal,66,191F71AF-125B-4541-B4CF-8375FE22F0F6,F1611D3F-A7D1-42AB-B07C-27D0CE090948,TCGA-DX-A3LY-10B-01D-A27P-09,GRCh37-lite,TCGA-DX-A3LY,TCGA-SARC,NA,s2631,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a615,58cfa82de4b0c9d6adf6a615,77c3044fa5dcd9733a29a43fe849d146.filtered.,WGS,77c3044fa5dcd9733a29a43fe849d146,77c3044fa5dcd9733a29a43fe849d146.bam,10.83,NA,0.08,58cfa82de4b0c9d6adf6a615,77c3044fa5dcd9733a29a43fe849d146.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A2IZ-10A,6B189EFF-B919-49D6-8775-DBF32C9CCBBA,Blood Derived Normal,Illumina HiSeq,172226bb-7470-4760-b78d-a7c3f6389d01,Mesenchymal,60,05062141-46FC-4ED0-842F-CFA97FCB1909,9DC2FA01-EF68-44CE-98D0-DDDCB6EF4F46,TCGA-DX-A2IZ-10A-01D-A21Q-09,GRCh37-lite,TCGA-DX-A2IZ,TCGA-SARC,NA,s2344,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72ed4,58cfa83ce4b0c9d6adf72ed4,e44ee6b35a5e590d454a2cbc0c856885.filtered.,WGS,e44ee6b35a5e590d454a2cbc0c856885,e44ee6b35a5e590d454a2cbc0c856885.bam,13.5,NA,0.08,58cfa83ce4b0c9d6adf72ed4,e44ee6b35a5e590d454a2cbc0c856885.bam,Dead,FEMALE,WHITE,Not available,Sarcoma,Aligned reads,TCGA-IW-A3M5-10A,C20682A1-F340-430D-99F9-077FE093ED19,Blood Derived Normal,Illumina HiSeq,1f03dfdc-425a-4419-9d42-1f0bfaf46f58,Mesenchymal,76,4C450699-A2D6-47CE-BC64-623AE4151407,E5ABA172-82CB-406E-9841-D2568D14B2FC,TCGA-IW-A3M5-10A-01D-A21Q-09,GRCh37-lite,TCGA-IW-A3M5,TCGA-SARC,180,s2630,Washington University School of Medicine,Cedars Sinai,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a4aa,58cfa82de4b0c9d6adf6a4aa,138102d5725a67563ee38c7d240bfa5b.filtered.,WGS,138102d5725a67563ee38c7d240bfa5b,138102d5725a67563ee38c7d240bfa5b.bam,97,NA,0.08,58cfa82de4b0c9d6adf6a4aa,138102d5725a67563ee38c7d240bfa5b.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-IE-A4EK-10A,590FDB76-20EF-4F95-9783-7D80E7A25E5A,Blood Derived Normal,Illumina HiSeq,2a713d78-8d5f-44dd-9dc8-539f62109abf,Mesenchymal,54,D7B2E09B-F974-402B-9CB6-B08AEE956ECE,0989420D-2639-41EE-912D-3526312EEB65,TCGA-IE-A4EK-10A-01D-A24N-09,GRCh37-lite,TCGA-IE-A4EK,TCGA-SARC,NA,s2331,Washington University School of Medicine,ABS - IUPUI,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf7310c,58cfa83ce4b0c9d6adf7310c,e197a935bf028894f9cec5ec9a249bf2.filtered.,WGS,e197a935bf028894f9cec5ec9a249bf2,e197a935bf028894f9cec5ec9a249bf2.bam,6,1.59,0.08,58cfa83ce4b0c9d6adf7310c,e197a935bf028894f9cec5ec9a249bf2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0I2-10B,328DFCB0-B5AE-43F2-BC87-DAD0AB3DF9E7,Blood Derived Normal,Illumina HiSeq,32d9eca6-d09e-458e-8564-2f50ca1eb655,Breast,45,99C37035-A40A-458C-868B-B0D3B64720F8,20641853-1373-4304-A795-5C8F45459B27,TCGA-B6-A0I2-10B-01D-A12L-09,GRCh37-lite,TCGA-B6-A0I2,TCGA-BRCA,NA,s6107,Washington University School of Medicine,Duke,United States,NO,T1c,N0 (i-),Infiltrating Ductal Carcinoma,Stage IA
13722.58cfa82ee4b0c9d6adf6afce,58cfa82ee4b0c9d6adf6afce,TCGA-06-1086-10A-01D-0703-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-06-1086-10A-01D-0703-09_IlluminaGA-DNASeq_whole,TCGA-06-1086-10A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,146.6,1.9,0.16,58cfa82ee4b0c9d6adf6afce,TCGA-06-1086-10A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-1086-10A,97686AB2-3B7E-4B21-9BF3-9A5A01709E04,Blood Derived Normal,Illumina GA,bd01cb18-b762-4c43-a9b4-4fcfb75eb413,Brain,42,AE3EE6E9-7108-4208-9B8F-5738B9BFF084,D85192D7-683F-4214-B8DE-AE2E4FF2405C,TCGA-06-1086-10A-01D-0703-09,NCBI36_WUGSC_variant,TCGA-06-1086,TCGA-GBM,208,s14311,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a632,58cfa82de4b0c9d6adf6a632,784368518e3a3c64c915a45ea1a63ef8.filtered.,WGS,784368518e3a3c64c915a45ea1a63ef8,784368518e3a3c64c915a45ea1a63ef8.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a632,784368518e3a3c64c915a45ea1a63ef8.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2993-03A,74D13C8F-6CD4-44E1-9767-A136FA411448,Primary Blood Derived Cancer - Peripheral Blood,Illumina HiSeq,966a4cea-3538-4024-a0c3-cf23ae8b94af,Blood,57,1E58625B-9090-4F92-A19C-F1B8E22F11F8,25C67AC8-226A-4E99-BAFE-A99471596EDF,TCGA-AB-2993-03A-01D-0741-05,NCBI36_WUGSC_variant,TCGA-AB-2993,TCGA-LAML,761,s7016,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a5e8,58cfa82de4b0c9d6adf6a5e8,677ceb59bb28b84c7a5d5e3d3a1332c9.filtered.,WGS,677ceb59bb28b84c7a5d5e3d3a1332c9,677ceb59bb28b84c7a5d5e3d3a1332c9.bam,25.28,1.76,0.09,58cfa82de4b0c9d6adf6a5e8,677ceb59bb28b84c7a5d5e3d3a1332c9.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A1BN-10A,8A4DA4F0-30F2-497E-8A7C-988FD6B813CB,Blood Derived Normal,Illumina HiSeq,85c2015a-844d-46ce-9d10-7eb30a07fb3c,Cervix,26,BFF9E8CC-5194-4CB7-8670-4C0ED526DF15,DAA802FE-3FC4-4473-BE23-731BD01D143C,TCGA-C5-A1BN-10A-01D-A200-09,GRCh37-lite,TCGA-C5-A1BN,TCGA-CESC,166,s1164,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82de4b0c9d6adf6a465,58cfa82de4b0c9d6adf6a465,104b50afc4356e62c33af19b16a20b75.filtered.,WGS,104b50afc4356e62c33af19b16a20b75,104b50afc4356e62c33af19b16a20b75.bam,146.6,1.9,0.16,58cfa82de4b0c9d6adf6a465,104b50afc4356e62c33af19b16a20b75.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-1086-10A,97686AB2-3B7E-4B21-9BF3-9A5A01709E04,Blood Derived Normal,Illumina GA,d00dfa80-94ab-48a6-ab21-3040301d532d,Brain,42,AE3EE6E9-7108-4208-9B8F-5738B9BFF084,D85192D7-683F-4214-B8DE-AE2E4FF2405C,TCGA-06-1086-10A-01D-0703-09,GRCh37-lite,TCGA-06-1086,TCGA-GBM,208,s13916,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6c27c,58cfa830e4b0c9d6adf6c27c,TCGA-AB-2989-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2989-11A-01D-0739-09_whole,TCGA-AB-2989-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6c27c,TCGA-AB-2989-11A-01D-0739-09_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2989-11A,E2E610CE-31C3-4FC0-917D-92D48FEB600A,Solid Tissue Normal,Illumina GA,bdff2244-f81a-4919-a971-aae92afdc39e,Blood,29,FAFB19E2-2C76-4D2B-AAD3-C4FD90AA1135,BAA70711-9504-4EBC-8E86-A870629D4161,TCGA-AB-2989-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2989,TCGA-LAML,365,s7055,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72fb4,58cfa83ce4b0c9d6adf72fb4,a1da51d3bdbea29cb8e06fc29c490e5b.filtered.,WGS,a1da51d3bdbea29cb8e06fc29c490e5b,a1da51d3bdbea29cb8e06fc29c490e5b.bam,NA,NA,NA,58cfa83ce4b0c9d6adf72fb4,a1da51d3bdbea29cb8e06fc29c490e5b.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2976-03A,C0C52E79-813B-45A9-8021-343AAA6663F6,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,df134dc1-7033-4c17-8ed5-eda72828667b,Blood,53,BDCFDA22-DB12-4CAC-B99D-C1FCC4ABB4A3,5BD15984-630F-46A9-A99E-0C24B26F2ED7,TCGA-AB-2976-03A-01D-0739-09,GRCh37-lite,TCGA-AB-2976,TCGA-LAML,915,s7275,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a51a,58cfa82de4b0c9d6adf6a51a,3389b84009a91bfa203a09dbe8bebdc4.filtered.,WGS,3389b84009a91bfa203a09dbe8bebdc4,3389b84009a91bfa203a09dbe8bebdc4.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a51a,3389b84009a91bfa203a09dbe8bebdc4.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2990-11A,D1BF3B65-493E-4249-8CB3-7C9F8CE4DC48,Solid Tissue Normal,Illumina GA,091d42b4-4a69-4f84-bb1a-ebf5a75ad283,Blood,51,8C602759-0EA6-46DC-810F-7A5BE1491DCB,7FF43BE0-1381-4220-A165-9A9E17909534,TCGA-AB-2990-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2990,TCGA-LAML,NA,s6971,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a627,58cfa82de4b0c9d6adf6a627,4feecb3959b1664ecd5ce9cabc6b181d.filtered.,WGS,4feecb3959b1664ecd5ce9cabc6b181d,4feecb3959b1664ecd5ce9cabc6b181d.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a627,4feecb3959b1664ecd5ce9cabc6b181d.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2991-11A,28BB21F0-2851-4B7E-9F8A-6D0A016318E2,Solid Tissue Normal,Illumina GA,080ebb87-5b7a-4842-be66-17a04dfb9ca7,Blood,40,D137AFA1-A0D9-4B75-83A9-22FAF6876C4C,4DE3B1F0-997C-43EC-B5EA-4B5DC4367C3A,TCGA-AB-2991-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2991,TCGA-LAML,NA,s7013,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6bd04,58cfa830e4b0c9d6adf6bd04,TCGA-AB-2975-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2975-03A-01D-0739-09_whole,TCGA-AB-2975-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bd04,TCGA-AB-2975-03A-01D-0739-09_whole.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2975-03A,93FF9379-D1A1-412F-A776-C53397BA0DC3,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,49edd0a4-843e-4f20-8b79-c4862c6958b7,Blood,54,BC1B4410-07A6-4B5D-B8E9-78A6A171905E,46B127F4-A3DE-486C-8B90-D300EE13B182,TCGA-AB-2975-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2975,TCGA-LAML,NA,s7188,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a452,58cfa82de4b0c9d6adf6a452,081ed0887d9f6b02b9d79ba4f9371cd9.filtered.,WGS,081ed0887d9f6b02b9d79ba4f9371cd9,081ed0887d9f6b02b9d79ba4f9371cd9.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a452,081ed0887d9f6b02b9d79ba4f9371cd9.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2967-11A,9C022254-F9F7-4C61-BE48-48C60A92448E,Solid Tissue Normal,Illumina GA,23dfd913-efd5-41bd-9bff-9a042feae29e,Blood,58,56035ACE-10BA-4BEF-AB7F-38C3CFCA3A64,B5BABADF-7B10-45FC-8C93-5F68A08B07ED,TCGA-AB-2967-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2967,TCGA-LAML,NA,s7133,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a4f8,58cfa82de4b0c9d6adf6a4f8,38b3ee1ebcc03f8d994e177b973cd6db.filtered.,WGS,38b3ee1ebcc03f8d994e177b973cd6db,38b3ee1ebcc03f8d994e177b973cd6db.bam,55.93,NA,0.08,58cfa82de4b0c9d6adf6a4f8,38b3ee1ebcc03f8d994e177b973cd6db.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A3U6-10A,6201394F-B70E-4F14-9519-FF9D5F06EB09,Blood Derived Normal,Illumina HiSeq,21c7a6f8-536f-44f1-a8c4-a7e103cf3509,Mesenchymal,63,CCF3805D-68EA-44E5-8EC9-48E39AE9F8AC,7536CF00-AED9-4045-94E7-E562E7EC6B34,TCGA-DX-A3U6-10A-01D-A29N-09,GRCh37-lite,TCGA-DX-A3U6,TCGA-SARC,NA,s2483,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6bfc8,58cfa830e4b0c9d6adf6bfc8,TCGA-AB-2987-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2987-03A-01D-0739-09_whole,TCGA-AB-2987-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bfc8,TCGA-AB-2987-03A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2987-03A,C147D12E-5E96-484E-BBE7-DC2F11F889BF,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,e024ec47-ca00-4d1b-a5e9-a22dab2286f3,Blood,75,401A0850-B8A9-4FC2-9002-9547CBF5E957,372359DC-F250-4F75-A817-01C92FE03688,TCGA-AB-2987-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2987,TCGA-LAML,184,s7006,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6c00a,58cfa830e4b0c9d6adf6c00a,TCGA-AB-2983-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2983-03A-01D-0739-09_whole,TCGA-AB-2983-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6c00a,TCGA-AB-2983-03A-01D-0739-09_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2983-03A,082CA353-A5AE-421F-AE58-098257A1425F,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,aa9fb924-6dd8-4a03-b20b-3393357a4d39,Blood,45,EDCE86C4-62ED-4744-A50B-97ACB4EEE60C,14026827-734D-42A2-8803-03F598FE541E,TCGA-AB-2983-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2983,TCGA-LAML,335,s7146,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a5ac,58cfa82de4b0c9d6adf6a5ac,70e610fa22329c2d1c043073d2a351bd.filtered.,WGS,70e610fa22329c2d1c043073d2a351bd,70e610fa22329c2d1c043073d2a351bd.bam,13.05,NA,0.08,58cfa82de4b0c9d6adf6a5ac,70e610fa22329c2d1c043073d2a351bd.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A1KW-10A,CD73A55F-03C1-4DA0-9FA7-1AE4A263664E,Blood Derived Normal,Illumina HiSeq,fb3f91bc-afab-4bfd-8376-698b204f6069,Mesenchymal,67,458B4CAE-CFF4-4C2D-9840-4CBF2C895A5F,02DE8A64-BD6D-46DA-9FC5-81D2A543E25B,TCGA-DX-A1KW-10A-01D-A24N-09,GRCh37-lite,TCGA-DX-A1KW,TCGA-SARC,NA,s2348,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6be50,58cfa830e4b0c9d6adf6be50,TCGA-AF-2689-10A-01D-1525-10_Illumina.filtered.,WGS,TCGA-AF-2689-10A-01D-1525-10_Illumina,TCGA-AF-2689-10A-01D-1525-10_Illumina.bam,3.21,1.9,0.05,58cfa830e4b0c9d6adf6be50,TCGA-AF-2689-10A-01D-1525-10_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-AF-2689-10A,335D0351-3740-4847-9FF4-BE2F078C70F7,Blood Derived Normal,Illumina HiSeq,26421357-e1b2-4880-9f0b-5c39f0487fe8,Colorectal,41,DC4852E8-3E77-4D45-8E7E-F9B6EFFF01E4,0FDD7673-2A4D-4FA3-B89F-F5FB069EDF63,TCGA-AF-2689-10A-01D-1525-10,NCBI36_BCM_variant,TCGA-AF-2689,TCGA-READ,NA,s2138,Baylor College of Medicine,Christiana Healthcare,None,NO,T3,N2,Rectal Adenocarcinoma,Stage IV
13722.58cfa82ee4b0c9d6adf6b1cf,58cfa82ee4b0c9d6adf6b1cf,TCGA-14-1401-10A-01D-0703-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-14-1401-10A-01D-0703-09_IlluminaGA-DNASeq_whole,TCGA-14-1401-10A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,65.6,1.9,0.15,58cfa82ee4b0c9d6adf6b1cf,TCGA-14-1401-10A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,Dead,MALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1401-10A,6176621D-8534-4FBA-A0E7-74A5A78245A9,Blood Derived Normal,Illumina GA,40d5fd3a-85f3-4e78-a7db-4cbc05ef380b,Brain,54,2052E7CE-50ED-4889-ACC1-567C9F8E2C91,2EF2436E-61A2-4F90-BF16-606BABECABB3,TCGA-14-1401-10A-01D-0703-09,NCBI36_WUGSC_variant,TCGA-14-1401,TCGA-GBM,114,s13954,Washington University School of Medicine,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf72f1d,58cfa83ce4b0c9d6adf72f1d,e80cf73a9a390fc6f37659e80bd3197a.filtered.,WGS,e80cf73a9a390fc6f37659e80bd3197a,e80cf73a9a390fc6f37659e80bd3197a.bam,8.06,1.87,0.07,58cfa83ce4b0c9d6adf72f1d,e80cf73a9a390fc6f37659e80bd3197a.bam,Dead,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A08L-10A,8BD68696-5EEB-46D7-9DC6-C39C849029A4,Blood Derived Normal,Illumina HiSeq,aa5093d9-f4ec-4b1c-8e9b-eabedd7ee5e8,Breast,89,501A3E64-231D-4977-8D75-5A554EADB583,98051587-E722-4FBB-AAF6-2B310F555ED0,TCGA-A8-A08L-10A-01D-A19H-09,GRCh37-lite,TCGA-A8-A08L,TCGA-BRCA,304,s6446,Washington University School of Medicine,Indivumed,Germany,NO,T3,N2a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82fe4b0c9d6adf6b637,58cfa82fe4b0c9d6adf6b637,TCGA-61-1916-01A-01D-0926-12_Illumina.filtered.,WGS,TCGA-61-1916-01A-01D-0926-12_Illumina,TCGA-61-1916-01A-01D-0926-12_Illumina.bam,10,1.9,0.15,58cfa82fe4b0c9d6adf6b637,TCGA-61-1916-01A-01D-0926-12_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-61-1916-01A,B25B3379-DF8F-4900-9BCE-0F8DF50F549B,Primary Tumor,Illumina HiSeq,d71b84ef-ef63-479b-be2b-057676d1d06e,Ovary,53,21B12282-EFAE-494D-9F1F-D2316740238D,CFF6FF00-3B8E-46B4-9266-5C29C3DE8194,TCGA-61-1916-01A-01D-0926-12,NCBI36_BCM_variant,TCGA-61-1916,TCGA-OV,475,s17163,Baylor College of Medicine,University of Pittsburgh,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf72f00,58cfa83ce4b0c9d6adf72f00,c361e63eb25875d77f33d743e30ce37a.filtered.,WGS,c361e63eb25875d77f33d743e30ce37a,c361e63eb25875d77f33d743e30ce37a.bam,NA,NA,NA,58cfa83ce4b0c9d6adf72f00,c361e63eb25875d77f33d743e30ce37a.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3000-03A,92C7E4D6-EB53-46C5-9721-5EDCCD60BCC9,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,57efa0f2-533c-4b19-8167-fa7b8f44c5a4,Blood,25,6C2BE933-F491-4EEC-8882-6B35BD4F8EF3,963672C4-4614-4797-AAE0-742C3C125A25,TCGA-AB-3000-03A-01D-0741-05,GRCh37-lite,TCGA-AB-3000,TCGA-LAML,NA,s7156,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72fe8,58cfa83ce4b0c9d6adf72fe8,f316e3dff60e757701731d0c0cd94c3d.filtered.,WGS,f316e3dff60e757701731d0c0cd94c3d,f316e3dff60e757701731d0c0cd94c3d.bam,24.95,1.71,0.08,58cfa83ce4b0c9d6adf72fe8,f316e3dff60e757701731d0c0cd94c3d.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A04Q-10A,B5FBA77B-1F50-4E71-95B2-566AFBA4BDD7,Blood Derived Normal,Illumina HiSeq,4f762d03-b511-4e74-a7af-6633100d33cd,Breast,48,5DFFF1AD-3046-4E43-8304-A8579A9F203B,BCC3DDC8-33E4-4F7C-81E6-8AD2480C62A7,TCGA-A2-A04Q-10A-01D-A128-09,GRCh37-lite,TCGA-A2-A04Q,TCGA-BRCA,NA,s6256,Washington University School of Medicine,Walter Reed,None,NO,T1,N0 (i-),Infiltrating Ductal Carcinoma,Stage IA
13722.58cfa82de4b0c9d6adf6a44b,58cfa82de4b0c9d6adf6a44b,064d2f15569ea353626d7b59f5bfd25d.filtered.,WGS,064d2f15569ea353626d7b59f5bfd25d,064d2f15569ea353626d7b59f5bfd25d.bam,9.5,NA,0.07,58cfa82de4b0c9d6adf6a44b,064d2f15569ea353626d7b59f5bfd25d.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A3LU-10A,E786DE34-4C21-460F-89AB-008DE4347049,Blood Derived Normal,Illumina HiSeq,44b7172e-b9bd-4e78-a20c-693216b575a9,Mesenchymal,60,A8EE2E8A-DEBD-45DF-99D3-600BB0B236FF,97A68A03-DC99-4BA9-8B81-1B40F2CE32EA,TCGA-DX-A3LU-10A-01D-A21Q-09,GRCh37-lite,TCGA-DX-A3LU,TCGA-SARC,NA,s2328,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72e4f,58cfa83ce4b0c9d6adf72e4f,c38c501c37a6112217e5a6291c94e082.filtered.,WGS,c38c501c37a6112217e5a6291c94e082,c38c501c37a6112217e5a6291c94e082.bam,9.67,NA,0.09,58cfa83ce4b0c9d6adf72e4f,c38c501c37a6112217e5a6291c94e082.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A240-10A,3608BFBB-2A92-4EC2-A330-BF4790A8B65C,Blood Derived Normal,Illumina HiSeq,778dabb2-b6a8-4d35-9088-a7c6b7562855,Mesenchymal,51,BE056C34-EF56-4526-A595-F81DBDE87A3D,2CED1EDD-817A-4E6B-96B5-C192F0A91663,TCGA-DX-A240-10A-01D-A27P-09,GRCh37-lite,TCGA-DX-A240,TCGA-SARC,NA,s2628,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a6ac,58cfa82de4b0c9d6adf6a6ac,8a34a453a51130ed0f395b8cac03fe30.filtered.,WGS,8a34a453a51130ed0f395b8cac03fe30,8a34a453a51130ed0f395b8cac03fe30.bam,9.53,NA,0.09,58cfa82de4b0c9d6adf6a6ac,8a34a453a51130ed0f395b8cac03fe30.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-FX-A48G-11A,12BFD446-2EE5-4664-A492-C023D134F60F,Solid Tissue Normal,Illumina HiSeq,dc5c3bf0-ed04-4a55-9f8a-6e39b8a73798,Mesenchymal,56,B02976CE-24E5-44BA-AF08-5B40B1D03FC2,9FF2246F-8C56-445F-B2D9-AEEFF5CE527A,TCGA-FX-A48G-11A-12D-A24N-09,GRCh37-lite,TCGA-FX-A48G,TCGA-SARC,NA,s2349,Washington University School of Medicine,International Genomics Consortium,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf730bc,58cfa83ce4b0c9d6adf730bc,fc5c85d8f5e38babc01190428928c325.filtered.,WGS,fc5c85d8f5e38babc01190428928c325,fc5c85d8f5e38babc01190428928c325.bam,23.53,2,0.09,58cfa83ce4b0c9d6adf730bc,fc5c85d8f5e38babc01190428928c325.bam,Dead,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-AR-A256-10A,D3D545B3-457F-4389-821F-704CB24AFF7F,Blood Derived Normal,Illumina HiSeq,3c6b93f3-c90a-4e23-9fdb-f7d1d3e89a82,Breast,45,DEC1A314-B7F4-4F86-83CB-A40E0B0994A2,09F34836-FC9A-4FF4-A0C9-FD93259E32F3,TCGA-AR-A256-10A-01D-A167-09,GRCh37-lite,TCGA-AR-A256,TCGA-BRCA,2854,s6614,Washington University School of Medicine,Mayo,United States,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a688,58cfa82de4b0c9d6adf6a688,760071f8e60ef39a6884464df08526f5.filtered.,WGS,760071f8e60ef39a6884464df08526f5,760071f8e60ef39a6884464df08526f5.bam,14.07,1.86,0.07,58cfa82de4b0c9d6adf6a688,760071f8e60ef39a6884464df08526f5.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0BW-10A,5D1D00C6-FCAE-479E-AE1E-DE76EFD41D98,Blood Derived Normal,Illumina HiSeq,b2814a9e-e181-44be-8ac3-cea9313752a8,Breast,71,449E6D54-AD02-45E2-A3D2-A5DCA2C3BA14,ECDAC032-E125-4CD8-BA62-6265ECFFB3D7,TCGA-BH-A0BW-10A-01D-A314-09,GRCh37-lite,TCGA-BH-A0BW,TCGA-BRCA,NA,s6267,Washington University School of Medicine,University of Pittsburgh,None,NO,T1c,N0,Infiltrating Ductal Carcinoma,Stage I
13722.58cfa83ce4b0c9d6adf72eff,58cfa83ce4b0c9d6adf72eff,ba4f987db0390a4708581c710b27ddcb.filtered.,WGS,ba4f987db0390a4708581c710b27ddcb,ba4f987db0390a4708581c710b27ddcb.bam,NA,NA,NA,58cfa83ce4b0c9d6adf72eff,ba4f987db0390a4708581c710b27ddcb.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2975-03A,93FF9379-D1A1-412F-A776-C53397BA0DC3,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,d504ac62-ddde-4e0b-b070-88b97480837e,Blood,54,BC1B4410-07A6-4B5D-B8E9-78A6A171905E,46B127F4-A3DE-486C-8B90-D300EE13B182,TCGA-AB-2975-03A-01D-0739-09,GRCh37-lite,TCGA-AB-2975,TCGA-LAML,NA,s7279,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a5c5,58cfa82de4b0c9d6adf6a5c5,682d86f6440758f0452a9556d9b0d965.filtered.,WGS,682d86f6440758f0452a9556d9b0d965,682d86f6440758f0452a9556d9b0d965.bam,58.08,1.94,0.07,58cfa82de4b0c9d6adf6a5c5,682d86f6440758f0452a9556d9b0d965.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0WX-10A,A482FC4C-FF1D-46A0-A968-7DF06422CC4B,Blood Derived Normal,Illumina HiSeq,5df0fe6c-10bd-4c09-8766-283df19e6760,Breast,40,3D2E8C04-BFBF-471D-88A4-1A12B39A6298,57C92229-F196-429C-8C85-874E2906A3D4,TCGA-B6-A0WX-10A-01D-A10G-09,GRCh37-lite,TCGA-B6-A0WX,TCGA-BRCA,653,s6265,Washington University School of Medicine,Duke,United States,NO,T3,N1b,Other  specify,Stage IIIA
13722.58cfa830e4b0c9d6adf6bc70,58cfa830e4b0c9d6adf6bc70,TCGA-AF-2689-01A-01D-1525-10_Illumina.filtered.,WGS,TCGA-AF-2689-01A-01D-1525-10_Illumina,TCGA-AF-2689-01A-01D-1525-10_Illumina.bam,291.94,1.9,0.05,58cfa830e4b0c9d6adf6bc70,TCGA-AF-2689-01A-01D-1525-10_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-AF-2689-01A,335D0351-3740-4847-9FF4-BE2F078C70F7,Primary Tumor,Illumina HiSeq,de8813ea-30e6-4c81-b8a9-335126d4a854,Colorectal,41,8BEE44CB-3FE4-47A8-BD1B-90A59EA606BE,734D2153-2338-4538-A99B-0DE3E82E50F0,TCGA-AF-2689-01A-01D-1525-10,NCBI36_BCM_variant,TCGA-AF-2689,TCGA-READ,NA,s2306,Baylor College of Medicine,Christiana Healthcare,None,NO,T3,N2,Rectal Adenocarcinoma,Stage IV
13722.58cfa82de4b0c9d6adf6a602,58cfa82de4b0c9d6adf6a602,7205318b126c437ae3a99c9c456bdb71.filtered.,WGS,7205318b126c437ae3a99c9c456bdb71,7205318b126c437ae3a99c9c456bdb71.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a602,7205318b126c437ae3a99c9c456bdb71.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2993-03A,74D13C8F-6CD4-44E1-9767-A136FA411448,Primary Blood Derived Cancer - Peripheral Blood,Illumina HiSeq,b1158474-7efb-435f-8988-2715dc265554,Blood,57,1E58625B-9090-4F92-A19C-F1B8E22F11F8,25C67AC8-226A-4E99-BAFE-A99471596EDF,TCGA-AB-2993-03A-01D-0741-05,GRCh37-lite,TCGA-AB-2993,TCGA-LAML,761,s7102,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a6e4,58cfa82de4b0c9d6adf6a6e4,8d0537e44f3c8b0c56a7decef1236da3.filtered.,WGS,8d0537e44f3c8b0c56a7decef1236da3,8d0537e44f3c8b0c56a7decef1236da3.bam,16.93,NA,0.08,58cfa82de4b0c9d6adf6a6e4,8d0537e44f3c8b0c56a7decef1236da3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-IE-A4EI-10A,C5E23947-253B-40D2-916A-277B2A580BE2,Blood Derived Normal,Illumina HiSeq,5820d6f2-c89a-4b30-86c6-e009311d92c8,Mesenchymal,67,91F3EF06-0D92-460C-9131-5B3B56EC6749,9F3E9EB7-1873-4F33-A9C8-671EAE8CC921,TCGA-IE-A4EI-10A-01D-A24N-09,GRCh37-lite,TCGA-IE-A4EI,TCGA-SARC,NA,s2493,Washington University School of Medicine,ABS - IUPUI,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a488,58cfa82de4b0c9d6adf6a488,13cf3705382d9fa3718c1f9ee909853b.filtered.,WGS,13cf3705382d9fa3718c1f9ee909853b,13cf3705382d9fa3718c1f9ee909853b.bam,32.16,2.06,0.08,58cfa82de4b0c9d6adf6a488,13cf3705382d9fa3718c1f9ee909853b.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E9-A1NH-11A,B2AAC45B-2073-4C7A-ADB9-769A4FDCC111,Solid Tissue Normal,Illumina HiSeq,9ec85678-e1a8-44bd-9676-72b0d1b991d7,Breast,71,A646C533-70B4-43B7-B1B1-0D26509A13CC,0EE95056-A7CC-415C-A487-3AD08604DFC0,TCGA-E9-A1NH-11A-33D-A14G-09,GRCh37-lite,TCGA-E9-A1NH,TCGA-BRCA,NA,s6258,Washington University School of Medicine,Asterand,Russia,NO,T2,N1,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa83ce4b0c9d6adf72ebb,58cfa83ce4b0c9d6adf72ebb,dd2257dc20b7a6b5bba5e609faa08f25.filtered.,WGS,dd2257dc20b7a6b5bba5e609faa08f25,dd2257dc20b7a6b5bba5e609faa08f25.bam,10.7,1.86,0.08,58cfa83ce4b0c9d6adf72ebb,dd2257dc20b7a6b5bba5e609faa08f25.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0EA-10A,1F601832-EEE3-48FB-ACF5-80C4A454F26E,Blood Derived Normal,Illumina HiSeq,9a8c10ef-1524-476d-aede-92a75cf6f28b,Breast,72,9A6C71A6-82CD-42B1-A93F-F569370848D6,CFBD5476-E83A-401D-9F9A-639C73A0E35B,TCGA-BH-A0EA-10A-01D-A110-09,GRCh37-lite,TCGA-BH-A0EA,TCGA-BRCA,991,s5782,Washington University School of Medicine,University of Pittsburgh,None,NO,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa83ce4b0c9d6adf72e92,58cfa83ce4b0c9d6adf72e92,cb6b276f142f61c0948db2f9e3fc1a06.filtered.,WGS,cb6b276f142f61c0948db2f9e3fc1a06,cb6b276f142f61c0948db2f9e3fc1a06.bam,14.21,NA,0.07,58cfa83ce4b0c9d6adf72e92,cb6b276f142f61c0948db2f9e3fc1a06.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A3XX-10A,53886143-C1C6-40E9-88E6-E4E5E0271FC8,Blood Derived Normal,Illumina HiSeq,128df03c-0852-4e14-8f58-1c66046567fb,Breast,49,C6EB6218-AD71-40A6-88B7-A4F1A015B816,E96D5811-4736-40DD-966D-E0E172AEB0AF,TCGA-A2-A3XX-10A-01D-A23C-09,GRCh37-lite,TCGA-A2-A3XX,TCGA-BRCA,NA,s6254,Washington University School of Medicine,Walter Reed,United States,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a55e,58cfa82de4b0c9d6adf6a55e,2ca71b5b408f6ddfc0cfec958f78e540.filtered.,WGS,2ca71b5b408f6ddfc0cfec958f78e540,2ca71b5b408f6ddfc0cfec958f78e540.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a55e,2ca71b5b408f6ddfc0cfec958f78e540.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2976-11A,C0C52E79-813B-45A9-8021-343AAA6663F6,Solid Tissue Normal,Illumina GA,550deec0-7595-4da3-87fe-088ebb3e4791,Blood,53,FBEF78AD-08DA-4A88-9765-0FEDCBC33F4A,FC79912E-0C78-44D9-9951-4B2DFCD349C9,TCGA-AB-2976-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2976,TCGA-LAML,915,s7200,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a50a,58cfa82de4b0c9d6adf6a50a,3ac5940e7260ebdac67fda67f843bb37.filtered.,WGS,3ac5940e7260ebdac67fda67f843bb37,3ac5940e7260ebdac67fda67f843bb37.bam,16.06,NA,0.09,58cfa82de4b0c9d6adf6a50a,3ac5940e7260ebdac67fda67f843bb37.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A2J0-10A,2FF6AEDE-7BCD-440B-99AB-7A023FAF658E,Blood Derived Normal,Illumina HiSeq,112d3432-8361-4b26-a990-963dfe67246f,Mesenchymal,61,415CE513-C8A5-400D-AEBE-05B9D7D60EAE,EADFBA85-5283-41EA-A71A-DC89AC1BAB4C,TCGA-DX-A2J0-10A-01D-A21Q-09,GRCh37-lite,TCGA-DX-A2J0,TCGA-SARC,295,s2482,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a4e4,58cfa82de4b0c9d6adf6a4e4,1e9de602347f4c3b44493a7b389e177b.filtered.,WGS,1e9de602347f4c3b44493a7b389e177b,1e9de602347f4c3b44493a7b389e177b.bam,23.65,1.93,0.09,58cfa82de4b0c9d6adf6a4e4,1e9de602347f4c3b44493a7b389e177b.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A2H5-11A,C88E3901-F3EE-436A-BA80-143C8EAB7D69,Solid Tissue Normal,Illumina HiSeq,35834e9e-f9e6-4df2-a3c8-5220847dda31,Uterus,67,9793E609-348F-4AA6-9705-EC236604F085,AF172F1E-DACE-49E8-B0E6-1123B351AB65,TCGA-AX-A2H5-11A-11D-A17D-09,GRCh37-lite,TCGA-AX-A2H5,TCGA-UCEC,NA,s4578,Washington University School of Medicine,Gynecologic Oncology Group,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bcde,58cfa830e4b0c9d6adf6bcde,TCGA-AB-2977-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2977-03A-01D-0739-09_whole,TCGA-AB-2977-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bcde,TCGA-AB-2977-03A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2977-03A,F95063BC-A640-4980-99A7-84645902DAF4,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,2120160a-fc45-46c9-a64f-bb9967ec366a,Blood,71,87A5E85B-00C3-4EB7-9548-F2B83F6AFAC3,56189E90-E223-4523-B613-10DF5B2EB23D,TCGA-AB-2977-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2977,TCGA-LAML,31,s7118,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf731da,58cfa83ce4b0c9d6adf731da,bfa1e20d9b7b963ef3b548bde1c4cf00.filtered.,WGS,bfa1e20d9b7b963ef3b548bde1c4cf00,bfa1e20d9b7b963ef3b548bde1c4cf00.bam,46.34,1.95,0.08,58cfa83ce4b0c9d6adf731da,bfa1e20d9b7b963ef3b548bde1c4cf00.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A7-A13D-10A,8785012F-F73E-4D68-87CF-1D804AF32782,Blood Derived Normal,Illumina HiSeq,b80530e4-9ddc-40fa-a763-ea5010e21813,Breast,46,82C28BC5-DB37-4400-9A77-9D65F5071CE5,DBC462F5-F723-4CF7-A48D-84001D2D51E9,TCGA-A7-A13D-10A-02D-A12Q-09,GRCh37-lite,TCGA-A7-A13D,TCGA-BRCA,NA,s6445,Washington University School of Medicine,Christiana Healthcare,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa83ce4b0c9d6adf731bc,58cfa83ce4b0c9d6adf731bc,e1ffee232f222a57cec0f119a949e196.filtered.,WGS,e1ffee232f222a57cec0f119a949e196,e1ffee232f222a57cec0f119a949e196.bam,50.69,1.88,0.08,58cfa83ce4b0c9d6adf731bc,e1ffee232f222a57cec0f119a949e196.bam,Dead,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A09X-10A,27B05B15-A44B-45ED-A6E3-E7D1CA488EA9,Blood Derived Normal,Illumina HiSeq,9f917b23-c2a4-434b-87fa-4ea1453473db,Breast,62,EBEE905F-EE0A-47B1-910A-7AAC6CAFDF13,C89CDE14-D56D-4AD6-9CBB-C809DBB7D77C,TCGA-A8-A09X-10A-01D-A19H-09,GRCh37-lite,TCGA-A8-A09X,TCGA-BRCA,426,s6904,Washington University School of Medicine,Indivumed,Germany,NO,T2,N3a,Infiltrating Lobular Carcinoma,Stage IIIC
13722.58cfa82de4b0c9d6adf6a496,58cfa82de4b0c9d6adf6a496,112778209a264064ef4723c2643be148.filtered.,WGS,112778209a264064ef4723c2643be148,112778209a264064ef4723c2643be148.bam,23.1,1.93,0.08,58cfa82de4b0c9d6adf6a496,112778209a264064ef4723c2643be148.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A12H-10A,B5B99291-507E-4B68-A039-9A0F571F55DF,Blood Derived Normal,Illumina HiSeq,3acf783b-164a-4cee-bc63-deedb1ebc450,Breast,69,0B3F2524-3370-43E3-B1E4-07505A043165,15DD92B8-5AB6-4FF7-9244-951120EFF28D,TCGA-AO-A12H-10A-01D-A314-09,GRCh37-lite,TCGA-AO-A12H,TCGA-BRCA,NA,s5472,Washington University School of Medicine,MSKCC,None,NO,T2,N0 (i-),Other  specify,Stage IIA
13722.58cfa82de4b0c9d6adf6a69b,58cfa82de4b0c9d6adf6a69b,8b54b7ddf5689b470daeccb1102a4076.filtered.,WGS,8b54b7ddf5689b470daeccb1102a4076,8b54b7ddf5689b470daeccb1102a4076.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a69b,8b54b7ddf5689b470daeccb1102a4076.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2983-03A,082CA353-A5AE-421F-AE58-098257A1425F,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,059a4661-5fc8-4e14-9e9d-208ab8e28688,Blood,45,EDCE86C4-62ED-4744-A50B-97ACB4EEE60C,C18E3A6E-FCB3-40FC-9D04-02CCA3517A2E,TCGA-AB-2983-03A-01D-0742-05,GRCh37-lite,TCGA-AB-2983,TCGA-LAML,335,s7066,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a520,58cfa82de4b0c9d6adf6a520,333fbe3c434cef7ad15ead3da2957f3d.filtered.,WGS,333fbe3c434cef7ad15ead3da2957f3d,333fbe3c434cef7ad15ead3da2957f3d.bam,50.51,2.08,0.08,58cfa82de4b0c9d6adf6a520,333fbe3c434cef7ad15ead3da2957f3d.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-D8-A27H-10A,0DCA98B0-F43E-45B6-9A02-00092C78678C,Blood Derived Normal,Illumina HiSeq,71bbc4fc-5b27-43d5-8475-9a1d1c744147,Breast,72,2A206224-13A9-44A4-926A-A80E61ADAEBC,0EE10097-FADC-4E57-A304-7A342CB44EDF,TCGA-D8-A27H-10A-01D-A17G-09,GRCh37-lite,TCGA-D8-A27H,TCGA-BRCA,NA,s6261,Washington University School of Medicine,Greater Poland Cancer Center,Poland,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6c01a,58cfa830e4b0c9d6adf6c01a,TCGA-AB-2985-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2985-11A-01D-0739-09_whole,TCGA-AB-2985-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6c01a,TCGA-AB-2985-11A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2985-11A,2CA0C154-C4FB-4B6D-845F-F2A5A4CC2416,Solid Tissue Normal,Illumina GA,43ba410f-7717-489a-b95b-f256fbd89d0c,Blood,81,D648AABF-377C-4F3C-BED5-7CA9BDB70286,139677D5-471A-40B7-89EF-807034101853,TCGA-AB-2985-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2985,TCGA-LAML,273,s7239,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6bbd0,58cfa830e4b0c9d6adf6bbd0,TCGA-AB-2985-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2985-03A-01D-0739-09_whole,TCGA-AB-2985-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bbd0,TCGA-AB-2985-03A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2985-03A,2CA0C154-C4FB-4B6D-845F-F2A5A4CC2416,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,2bd077f6-a55d-41d1-a895-94f584a9cfd1,Blood,81,CED7EF84-17D9-43EC-BB99-98D9D894F9E9,1E7D69A3-F69C-4D3D-98CD-965347B3150C,TCGA-AB-2985-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2985,TCGA-LAML,273,s7047,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82fe4b0c9d6adf6b572,58cfa82fe4b0c9d6adf6b572,TCGA-29-1705-10A-01D-0926-12_Illumina.filtered.,WGS,TCGA-29-1705-10A-01D-0926-12_Illumina,TCGA-29-1705-10A-01D-0926-12_Illumina.bam,12.8,1.88,0.14,58cfa82fe4b0c9d6adf6b572,TCGA-29-1705-10A-01D-0926-12_Illumina.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-29-1705-10A,F9C835DB-2AB6-4BF5-826F-48723493C0EC,Blood Derived Normal,Illumina HiSeq,2b75fbc4-4996-4d68-aee6-c0239d9e03c2,Ovary,47,8DD1B32F-3534-4002-B6A4-600F9A69D234,8B647CC5-2C70-40FB-94BA-EEA6DC275DC6,TCGA-29-1705-10A-01D-0926-12,NCBI36_BCM_variant,TCGA-29-1705,TCGA-OV,555,s18131,Baylor College of Medicine,Duke,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6b06c,58cfa82ee4b0c9d6adf6b06c,TCGA-13-0791-10A-01D-0926-12_Illumina.filtered.,WGS,TCGA-13-0791-10A-01D-0926-12_Illumina,TCGA-13-0791-10A-01D-0926-12_Illumina.bam,6.5,1.9,0.18,58cfa82ee4b0c9d6adf6b06c,TCGA-13-0791-10A-01D-0926-12_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0791-10A,90118207-8F11-4784-AC1B-0DEEC2E7AF3A,Blood Derived Normal,Illumina HiSeq,6c609f74-8d0a-48ae-a832-617ee8c50b88,Ovary,58,C3521FFB-392B-4818-9E6E-D0FC36670795,96F940F6-0ACD-411A-AD14-D559FC76131E,TCGA-13-0791-10A-01D-0926-12,NCBI36_BCM_variant,TCGA-13-0791,TCGA-OV,NA,s17125,Baylor College of Medicine,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a43e,58cfa82de4b0c9d6adf6a43e,055eb8679f8fd643681edea879ed39e5.filtered.,WGS,055eb8679f8fd643681edea879ed39e5,055eb8679f8fd643681edea879ed39e5.bam,80.57,NA,0.07,58cfa82de4b0c9d6adf6a43e,055eb8679f8fd643681edea879ed39e5.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A8I1-10A,83762308-4DBA-4870-B90B-64331EBC9BAA,Blood Derived Normal,HiSeq X Ten,e4b922b0-42ff-4cb2-b076-63446bc73bd8,Esophagus,67,5EFCB700-EAE7-4AE7-AC00-5E3C815AEC01,5B49DFB2-1197-4A77-AFEB-3D827509D4C6,TCGA-LN-A8I1-10A-01D-A36M-09,GRCh37-lite_WUGSC_variant_2,TCGA-LN-A8I1,TCGA-ESCA,NA,s1806,Washington University School of Medicine,ILSbio,Vietnam,NO,T2,N0,Not available,Stage IIA
13722.58cfa82de4b0c9d6adf6a6ee,58cfa82de4b0c9d6adf6a6ee,985dd30689149902a58894d5c2a0c11e.filtered.,WGS,985dd30689149902a58894d5c2a0c11e,985dd30689149902a58894d5c2a0c11e.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a6ee,985dd30689149902a58894d5c2a0c11e.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3012-03A,3997C824-8B85-4E1D-B4B1-D32C26155296,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,ba4506ad-207a-4732-b1fd-89e62a16aa6b,Blood,53,DB8FC9F9-912F-4C9F-935D-34082E6536B2,8075A848-671D-4DE3-9C0E-9A86251A5E93,TCGA-AB-3012-03A-01D-0741-05,GRCh37-lite,TCGA-AB-3012,TCGA-LAML,NA,s7251,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a44d,58cfa82de4b0c9d6adf6a44d,4844004286e9369557674738d9be6d4a.filtered.,WGS,4844004286e9369557674738d9be6d4a,4844004286e9369557674738d9be6d4a.bam,21.91,1.63,0.08,58cfa82de4b0c9d6adf6a44d,4844004286e9369557674738d9be6d4a.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A25B-10A,EADF8482-E60E-4307-ADB7-D5C3B9FA6CAE,Blood Derived Normal,Illumina HiSeq,639ddd7e-f28c-4b27-ae48-82d236b2f872,Breast,39,8A33780A-F820-46A6-8830-E0D32581DBBC,C16CF182-B4B2-42C0-A2B1-CE071638DE2F,TCGA-A2-A25B-10A-01D-A167-09,GRCh37-lite,TCGA-A2-A25B,TCGA-BRCA,NA,s6762,Washington University School of Medicine,Walter Reed,United States,NO,T2,N1,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa82de4b0c9d6adf6a4ee,58cfa82de4b0c9d6adf6a4ee,2548c39fc92627580ce126914f9e541c.filtered.,WGS,2548c39fc92627580ce126914f9e541c,2548c39fc92627580ce126914f9e541c.bam,10.66,1.96,0.09,58cfa82de4b0c9d6adf6a4ee,2548c39fc92627580ce126914f9e541c.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0RU-10B,6956473B-92E5-4069-A26B-B48E280E76F2,Blood Derived Normal,Illumina HiSeq,a29cdc57-52ec-48f1-87d6-5f2a56480a48,Breast,40,53CA1040-ECA4-4ACA-B437-EEDEB89062D3,B7759C1C-44BA-4C57-A975-C98EED1A9C76,TCGA-B6-A0RU-10B-01D-A12L-09,GRCh37-lite,TCGA-B6-A0RU,TCGA-BRCA,NA,s6758,Washington University School of Medicine,Duke,United States,NO,T1c,N0 (i-),Other  specify,Stage IA
13722.58cfa830e4b0c9d6adf6be2c,58cfa830e4b0c9d6adf6be2c,TCGA-BH-A0WA-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-BH-A0WA-10A-01D-A128-09_IlluminaGA-DNASeq_whole,TCGA-BH-A0WA-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,13.39,2.5,0.07,58cfa830e4b0c9d6adf6be2c,TCGA-BH-A0WA-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0WA-10A,786E8DBE-442E-4551-87B3-B4C333B04DD4,Blood Derived Normal,Illumina HiSeq,8ed08a9b-096c-47fc-85fe-61038535e131,Breast,82,081B3B50-1CEE-40B5-8795-2266874673F8,BBA9F20C-543F-4473-86B5-423C6FC22594,TCGA-BH-A0WA-10A-01D-A128-09,GRCh37-lite,TCGA-BH-A0WA,TCGA-BRCA,NA,s6775,Washington University School of Medicine,University of Pittsburgh,None,NO,T1c,N0 (i-),Not available,Stage I
13722.58cfa830e4b0c9d6adf6c2a6,58cfa830e4b0c9d6adf6c2a6,TCGA-AB-2996-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2996-11A-01D-0739-09_whole,TCGA-AB-2996-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6c2a6,TCGA-AB-2996-11A-01D-0739-09_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2996-11A,5D10CA47-ABC6-4953-9620-1C63542354BF,Solid Tissue Normal,Illumina GA,44d9f009-9b7e-41f7-a33c-978d7df5d3bb,Blood,74,F7BEC33A-238F-4A4F-984A-5F05EED6B268,2B2BA0F5-7AB3-4AE0-9828-097CC0E89A15,TCGA-AB-2996-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2996,TCGA-LAML,NA,s7274,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72f80,58cfa83ce4b0c9d6adf72f80,ac88d7f8dd2eeed283a197fa464d16e0.filtered.,WGS,ac88d7f8dd2eeed283a197fa464d16e0,ac88d7f8dd2eeed283a197fa464d16e0.bam,65.6,1.9,0.15,58cfa83ce4b0c9d6adf72f80,ac88d7f8dd2eeed283a197fa464d16e0.bam,Dead,MALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1401-10A,6176621D-8534-4FBA-A0E7-74A5A78245A9,Blood Derived Normal,Illumina GA,da1ad0ff-94c3-4694-ba82-fe8699b74b81,Brain,54,2052E7CE-50ED-4889-ACC1-567C9F8E2C91,2EF2436E-61A2-4F90-BF16-606BABECABB3,TCGA-14-1401-10A-01D-0703-09,GRCh37-lite,TCGA-14-1401,TCGA-GBM,114,s13962,Washington University School of Medicine,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a5dc,58cfa82de4b0c9d6adf6a5dc,5c54cebf17d98a845d11ad5d5185f4a0.filtered.,WGS,5c54cebf17d98a845d11ad5d5185f4a0,5c54cebf17d98a845d11ad5d5185f4a0.bam,37.22,1.8,0.07,58cfa82de4b0c9d6adf6a5dc,5c54cebf17d98a845d11ad5d5185f4a0.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0RU-01A,6956473B-92E5-4069-A26B-B48E280E76F2,Primary Tumor,Illumina HiSeq,2efc5248-9be4-4e98-a400-f2ee744ac29d,Breast,40,C94232F8-2E37-46D0-B12A-B8E920E659D9,97064332-1D4F-4571-93FF-354FFE6D7DF9,TCGA-B6-A0RU-01A-11D-A12L-09,GRCh37-lite,TCGA-B6-A0RU,TCGA-BRCA,NA,s5950,Washington University School of Medicine,Duke,United States,NO,T1c,N0 (i-),Other  specify,Stage IA
13722.58cfa82de4b0c9d6adf6a512,58cfa82de4b0c9d6adf6a512,3272b46f2b0b4ced2d306818a7890234.filtered.,WGS,3272b46f2b0b4ced2d306818a7890234,3272b46f2b0b4ced2d306818a7890234.bam,14.97,NA,0.08,58cfa82de4b0c9d6adf6a512,3272b46f2b0b4ced2d306818a7890234.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A3LS-10A,39F68467-3D37-4B19-AA43-ED7B120C619D,Blood Derived Normal,Illumina HiSeq,e0e17855-f2c6-4b51-a6e0-09f313c6f967,Mesenchymal,78,1896CA69-CC92-479E-855F-A47EE30A1C62,DC2E1F2D-585D-4DAB-9BB2-AEE31EE5B436,TCGA-DX-A3LS-10A-01D-A21Q-09,GRCh37-lite,TCGA-DX-A3LS,TCGA-SARC,275,s2639,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a5d1,58cfa82de4b0c9d6adf6a5d1,5e03deaed4f9d67805b748d70f393b0c.filtered.,WGS,5e03deaed4f9d67805b748d70f393b0c,5e03deaed4f9d67805b748d70f393b0c.bam,80.13,1.91,0.07,58cfa82de4b0c9d6adf6a5d1,5e03deaed4f9d67805b748d70f393b0c.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AN-A0XR-10A,F51AF6DB-2655-47FB-9FFC-83A503A728EA,Blood Derived Normal,Illumina HiSeq,5820a5ab-6b80-4a87-8140-d96b70cd48d4,Breast,55,AD969C08-88A4-4421-8CE9-606F67C4891E,4066FC82-49BA-4A54-A81C-768AE25E2741,TCGA-AN-A0XR-10A-01D-A10G-09,GRCh37-lite,TCGA-AN-A0XR,TCGA-BRCA,NA,s6766,Washington University School of Medicine,Cureline,None,NO,T2,N2,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82de4b0c9d6adf6a638,58cfa82de4b0c9d6adf6a638,4f775502d475a2bb06ef956ee457c09b.filtered.,WGS,4f775502d475a2bb06ef956ee457c09b,4f775502d475a2bb06ef956ee457c09b.bam,66.75,1.91,0.08,58cfa82de4b0c9d6adf6a638,4f775502d475a2bb06ef956ee457c09b.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-EW-A1PH-10A,4DA999A0-EF41-4A0B-B1D1-446B39CC855A,Blood Derived Normal,Illumina HiSeq,9bb03dd1-4a31-4ff3-930f-2ccf230339ae,Breast,52,2EDC0D6D-F928-45EC-AC6B-2CEE7B111A87,8F191915-D076-4C9E-95C7-1DE76EA96CC0,TCGA-EW-A1PH-10A-01D-A17G-09,GRCh37-lite,TCGA-EW-A1PH,TCGA-BRCA,NA,s6456,Washington University School of Medicine,University of Miami,United States,NO,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa83ce4b0c9d6adf7314c,58cfa83ce4b0c9d6adf7314c,ad2e11dd12a22954808bf04bdec0d080.filtered.,WGS,ad2e11dd12a22954808bf04bdec0d080,ad2e11dd12a22954808bf04bdec0d080.bam,8.82,2.06,0.07,58cfa83ce4b0c9d6adf7314c,ad2e11dd12a22954808bf04bdec0d080.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0H0-10A,96457EBF-AE88-41F4-97E5-CDC3163418AA,Blood Derived Normal,Illumina HiSeq,45b4fccd-bfa3-497e-a46a-b39a2b2d1263,Breast,69,3EB88A9F-AEC6-438B-82AD-620D248D9AB9,782B1013-EEB6-47CF-B7F1-536AC6D15F16,TCGA-BH-A0H0-10A-01D-A314-09,GRCh37-lite,TCGA-BH-A0H0,TCGA-BRCA,NA,s5620,Washington University School of Medicine,University of Pittsburgh,None,NO,T1c,N0 (i-),Infiltrating Ductal Carcinoma,Stage IA
13722.58cfa830e4b0c9d6adf6ba6a,58cfa830e4b0c9d6adf6ba6a,TCGA-A2-A04P-01A-31D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-A2-A04P-01A-31D-A128-09_IlluminaGA-DNASeq_whole,TCGA-A2-A04P-01A-31D-A128-09_IlluminaGA-DNASeq_whole.bam,66.09,2.03,0.08,58cfa830e4b0c9d6adf6ba6a,TCGA-A2-A04P-01A-31D-A128-09_IlluminaGA-DNASeq_whole.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A04P-01A,CCD4A24B-D8CC-4686-9DEE-C98B0C5A8D21,Primary Tumor,Illumina HiSeq,680a94d4-95ae-4e50-b380-28f9f3c3be71,Breast,36,E4DEE88B-58D0-4953-AD4A-A2DF876F3C95,A85CF239-FF51-46E7-9B88-4C2CB49C66B9,TCGA-A2-A04P-01A-31D-A128-09,GRCh37-lite,TCGA-A2-A04P,TCGA-BRCA,548,s5958,Washington University School of Medicine,Walter Reed,None,NO,T2,N3c,Infiltrating Ductal Carcinoma,Stage IIIC
13722.58cfa83ce4b0c9d6adf72f12,58cfa83ce4b0c9d6adf72f12,c535b5e8e14454d2fb5975ead8bd9321.filtered.,WGS,c535b5e8e14454d2fb5975ead8bd9321,c535b5e8e14454d2fb5975ead8bd9321.bam,22.35,1.97,0.08,58cfa83ce4b0c9d6adf72f12,c535b5e8e14454d2fb5975ead8bd9321.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A0D4-10A,75113445-D2D6-44A0-866C-C9175E6D214B,Blood Derived Normal,Illumina HiSeq,231cf234-5a6f-486a-805f-8e2f12139cb6,Breast,37,138745F8-F15E-486B-A7DA-B835C1D7A67E,C462D06F-679D-451B-9BB9-0DA8E349A49B,TCGA-A2-A0D4-10A-01D-A314-09,GRCh37-lite,TCGA-A2-A0D4,TCGA-BRCA,NA,s6104,Washington University School of Medicine,Walter Reed,None,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa82fe4b0c9d6adf6b6c0,58cfa82fe4b0c9d6adf6b6c0,TCGA-61-1916-02A-01D-0926-12_Illumina.filtered.,WGS,TCGA-61-1916-02A-01D-0926-12_Illumina,TCGA-61-1916-02A-01D-0926-12_Illumina.bam,700,1.9,0.16,58cfa82fe4b0c9d6adf6b6c0,TCGA-61-1916-02A-01D-0926-12_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-61-1916-02A,B25B3379-DF8F-4900-9BCE-0F8DF50F549B,Recurrent Tumor,Illumina HiSeq,5adbde84-722e-44dd-aba5-d23d9f7cb442,Ovary,53,15FC46D7-5172-4B19-BB69-914F07CF9CE2,672F7350-0D38-44CC-9AE5-A5949E2B0E97,TCGA-61-1916-02A-01D-0926-12,NCBI36_BCM_variant,TCGA-61-1916,TCGA-OV,475,s17544,Baylor College of Medicine,University of Pittsburgh,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bcd8,58cfa830e4b0c9d6adf6bcd8,TCGA-AB-2969-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2969-03A-01D-0739-09_whole,TCGA-AB-2969-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bcd8,TCGA-AB-2969-03A-01D-0739-09_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2969-03A,929DE9A5-3224-4851-8FF0-8A92354C1F16,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,a1b0ecfa-4e82-4b2d-964e-68cf15707fbd,Blood,55,9069B85B-EEBA-49C0-A624-65817CC0E915,C2942501-AEBC-4DC5-B31D-52D624F2F163,TCGA-AB-2969-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2969,TCGA-LAML,NA,s7045,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6bd4b,58cfa830e4b0c9d6adf6bd4b,TCGA-AB-2907-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2907-11A-01D-0739-09_whole,TCGA-AB-2907-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bd4b,TCGA-AB-2907-11A-01D-0739-09_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2907-11A,E843A0EA-45A5-4C11-92A1-08FF12EB4531,Solid Tissue Normal,Illumina GA,e9ba3fd1-93b0-455a-9fad-03bde9653714,Blood,69,0799189E-3ED8-42E0-8771-F9D1797F3184,A29C2D2B-1E78-443F-AAC3-DEF013F368CA,TCGA-AB-2907-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2907,TCGA-LAML,NA,s7143,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6bd80,58cfa830e4b0c9d6adf6bd80,TCGA-AB-3000-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-3000-11A-01D-0739-09_whole,TCGA-AB-3000-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bd80,TCGA-AB-3000-11A-01D-0739-09_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3000-11A,92C7E4D6-EB53-46C5-9721-5EDCCD60BCC9,Solid Tissue Normal,Illumina GA,4b265bf9-23c1-440b-a21b-982ae4da8546,Blood,25,D01A0802-4697-4F66-8E52-325CC4F9CAF2,C9E8FC7E-5BA0-424A-8659-433C2A7470EA,TCGA-AB-3000-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-3000,TCGA-LAML,NA,s7090,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a5bc,58cfa82de4b0c9d6adf6a5bc,7312d5e6ae948c9c6485d394dd643d43.filtered.,WGS,7312d5e6ae948c9c6485d394dd643d43,7312d5e6ae948c9c6485d394dd643d43.bam,71.04,1.87,0.09,58cfa82de4b0c9d6adf6a5bc,7312d5e6ae948c9c6485d394dd643d43.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-EW-A1PB-10A,88DB1340-E4BF-451A-87C0-6E9168296F5E,Blood Derived Normal,Illumina HiSeq,46b06dbe-5f5d-4733-8c98-f4a3fdf451c4,Breast,70,1D1C9067-00BF-4513-9A9D-217CBE35202A,26AA0F07-C813-4659-88FA-FDBAE73A937E,TCGA-EW-A1PB-10A-01D-A142-09,GRCh37-lite,TCGA-EW-A1PB,TCGA-BRCA,NA,s5630,Washington University School of Medicine,University of Miami,United States,NO,T3,N1a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa830e4b0c9d6adf6bdfe,58cfa830e4b0c9d6adf6bdfe,TCGA-AB-2975-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2975-11A-01D-0739-09_whole,TCGA-AB-2975-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bdfe,TCGA-AB-2975-11A-01D-0739-09_whole.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2975-11A,93FF9379-D1A1-412F-A776-C53397BA0DC3,Solid Tissue Normal,Illumina GA,009680e0-23f9-47dd-bbe1-0a3f4bfe5e19,Blood,54,B25F1D82-C885-4E27-8992-8A453C30A50A,07925C7F-550A-4728-908A-1ED34112DA56,TCGA-AB-2975-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2975,TCGA-LAML,NA,s7115,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf73112,58cfa83ce4b0c9d6adf73112,ecbc5c73c20744cd118d00da739ac84b.filtered.,WGS,ecbc5c73c20744cd118d00da739ac84b,ecbc5c73c20744cd118d00da739ac84b.bam,NA,NA,NA,58cfa83ce4b0c9d6adf73112,ecbc5c73c20744cd118d00da739ac84b.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2985-11A,2CA0C154-C4FB-4B6D-845F-F2A5A4CC2416,Solid Tissue Normal,Illumina GA,3dc6b3cb-d03f-463b-bad9-c14d148ba6df,Blood,81,D648AABF-377C-4F3C-BED5-7CA9BDB70286,139677D5-471A-40B7-89EF-807034101853,TCGA-AB-2985-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2985,TCGA-LAML,273,s7245,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a6f4,58cfa82de4b0c9d6adf6a6f4,9a3623ca36e06ee9d500dc34c0a877e8.filtered.,WGS,9a3623ca36e06ee9d500dc34c0a877e8,9a3623ca36e06ee9d500dc34c0a877e8.bam,34.1,1.93,0.08,58cfa82de4b0c9d6adf6a6f4,9a3623ca36e06ee9d500dc34c0a877e8.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LO-10A,A081DA6F-51F3-4555-A6B8-736F8C6CDA39,Blood Derived Normal,Illumina HiSeq,c16c6461-1160-45bf-be24-3e4c6dd25d2e,Uterus,45,FBFCB809-4EE6-4402-9FB8-F435BA7B43A1,13BA2335-AF92-4149-B7F3-2993B70E11CA,TCGA-AP-A0LO-10A-01D-A066-09,GRCh37-lite,TCGA-AP-A0LO,TCGA-UCEC,1016,s4985,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a4bc,58cfa82de4b0c9d6adf6a4bc,11061be66fae71c16788fd9fc1a73afb.filtered.,WGS,11061be66fae71c16788fd9fc1a73afb,11061be66fae71c16788fd9fc1a73afb.bam,22.65,1.95,0.08,58cfa82de4b0c9d6adf6a4bc,11061be66fae71c16788fd9fc1a73afb.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AR-A1AY-10A,5FD9552A-C742-4388-940D-295D1107AE00,Blood Derived Normal,Illumina HiSeq,08e07f8e-1ab8-4039-a26d-4a7e1fcb9d98,Breast,65,1A474269-BC7C-4490-A7AE-30EA51124792,1C6D0926-E635-4F26-97A6-642C012E930D,TCGA-AR-A1AY-10A-01D-A12Q-09,GRCh37-lite,TCGA-AR-A1AY,TCGA-BRCA,NA,s6453,Washington University School of Medicine,Mayo,None,NO,T1,N0,Infiltrating Ductal Carcinoma,Stage I
13722.58cfa83ce4b0c9d6adf72ebd,58cfa83ce4b0c9d6adf72ebd,df14444c99582a25a6c4270c0ec0c57a.filtered.,WGS,df14444c99582a25a6c4270c0ec0c57a,df14444c99582a25a6c4270c0ec0c57a.bam,NA,NA,NA,58cfa83ce4b0c9d6adf72ebd,df14444c99582a25a6c4270c0ec0c57a.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3007-03A,D3988699-70D6-43E1-B84B-9E38B4D2D2B1,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,e1a51d5e-e946-4e89-96a3-26c7881fd5e5,Blood,35,F1FFC6D2-CB72-4139-B1B6-1F37A702B879,BD80821B-408F-43B2-961D-F09BBB12D7F6,TCGA-AB-3007-03A-01D-0741-05,GRCh37-lite,TCGA-AB-3007,TCGA-LAML,NA,s7283,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a54e,58cfa82de4b0c9d6adf6a54e,080d8935160ea0ca83586cf80b722247.filtered.,WGS,080d8935160ea0ca83586cf80b722247,080d8935160ea0ca83586cf80b722247.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a54e,080d8935160ea0ca83586cf80b722247.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2993-11A,74D13C8F-6CD4-44E1-9767-A136FA411448,Solid Tissue Normal,Illumina GA,78205fa6-27dd-4a79-adef-465578b67eba,Blood,57,4EEAD847-4D92-41E0-B238-DF2DBBAEE9B6,C537A524-B89A-4738-8BBE-B00F335D4A75,TCGA-AB-2993-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2993,TCGA-LAML,761,s7134,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a6b0,58cfa82de4b0c9d6adf6a6b0,826a94a33e1850d9f4bb57ed99d013e7.filtered.,WGS,826a94a33e1850d9f4bb57ed99d013e7,826a94a33e1850d9f4bb57ed99d013e7.bam,26.55,NA,0.09,58cfa82de4b0c9d6adf6a6b0,826a94a33e1850d9f4bb57ed99d013e7.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A2LV-10A,00BCA18C-B3D4-45A3-8F19-034CC40449A4,Blood Derived Normal,Illumina HiSeq,5d6ed525-a289-497a-a138-6e7570dc1f9e,Cervix,36,6FEAFB61-D586-4E88-84D1-DFB715AEFDC6,28FA35AE-F144-4EF0-918E-FE72471C8101,TCGA-C5-A2LV-10A-01D-A18J-09,GRCh37-lite,TCGA-C5-A2LV,TCGA-CESC,NA,s1511,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,T1b,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b526,58cfa82fe4b0c9d6adf6b526,TCGA-29-1704-10A-01D-0926-12_Illumina.filtered.,WGS,TCGA-29-1704-10A-01D-0926-12_Illumina,TCGA-29-1704-10A-01D-0926-12_Illumina.bam,200,1.9,0.16,58cfa82fe4b0c9d6adf6b526,TCGA-29-1704-10A-01D-0926-12_Illumina.bam,Alive,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-29-1704-10A,8E7F1C74-7CB3-43C0-B07C-BF69B780053F,Blood Derived Normal,Illumina HiSeq,d3464c79-f85f-4cbc-a4a8-5763274d4772,Ovary,61,DD70BBA5-42D5-4CF8-8360-16B6DE2CEBF2,44E31E9C-8B32-49EF-9E61-40DCD55B5C49,TCGA-29-1704-10A-01D-0926-12,NCBI36_BCM_variant,TCGA-29-1704,TCGA-OV,NA,s17532,Baylor College of Medicine,Duke,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a6f6,58cfa82de4b0c9d6adf6a6f6,985ebcb22e11e01fdcef2ea18860a936.filtered.,WGS,985ebcb22e11e01fdcef2ea18860a936,985ebcb22e11e01fdcef2ea18860a936.bam,7.45,1.92,0.07,58cfa82de4b0c9d6adf6a6f6,985ebcb22e11e01fdcef2ea18860a936.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0AV-10A,790FF5DB-B7F3-4946-AAED-305F66B1DD6A,Blood Derived Normal,Illumina HiSeq,d56f0f11-ae97-4969-a5f2-84945ca2c281,Breast,52,4FE385EA-0135-480C-84E0-4ED9F4B1BB7E,3AB50B2E-8B0C-4CCD-B6BF-D577F5E9FC94,TCGA-BH-A0AV-10A-01D-A110-09,GRCh37-lite,TCGA-BH-A0AV,TCGA-BRCA,NA,s6460,Washington University School of Medicine,University of Pittsburgh,None,NO,T1c,N0,Infiltrating Ductal Carcinoma,Stage I
13722.58cfa82de4b0c9d6adf6a5f0,58cfa82de4b0c9d6adf6a5f0,5c35e2ab0776a05bbc9817c096346b92.filtered.,WGS,5c35e2ab0776a05bbc9817c096346b92,5c35e2ab0776a05bbc9817c096346b92.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a5f0,5c35e2ab0776a05bbc9817c096346b92.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2996-11A,5D10CA47-ABC6-4953-9620-1C63542354BF,Solid Tissue Normal,Illumina GA,1fa7cc53-2c51-42a9-adae-e1bfc94bea98,Blood,74,F7BEC33A-238F-4A4F-984A-5F05EED6B268,2B2BA0F5-7AB3-4AE0-9828-097CC0E89A15,TCGA-AB-2996-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2996,TCGA-LAML,NA,s7165,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a62e,58cfa82de4b0c9d6adf6a62e,5e5b36501f397d1baded6fb8e0d1272a.filtered.,WGS,5e5b36501f397d1baded6fb8e0d1272a,5e5b36501f397d1baded6fb8e0d1272a.bam,14.43,1.39,0.08,58cfa82de4b0c9d6adf6a62e,5e5b36501f397d1baded6fb8e0d1272a.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A16G-10A,16E69011-C295-479F-B521-86E66FBA498D,Blood Derived Normal,Illumina HiSeq,da837283-ab60-47a3-bbd9-5a449b9e409e,Uterus,74,5F56BA05-2FAF-4052-B4C7-1F6E0C349C51,6D3D68E8-21D1-40AF-9B9F-933980A38801,TCGA-D1-A16G-10A-01D-A12J-09,GRCh37-lite,TCGA-D1-A16G,TCGA-UCEC,834,s4239,Washington University School of Medicine,Mayo Clinic,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a478,58cfa82de4b0c9d6adf6a478,30ca9dda6dc901c20e4df461aec63c56.filtered.,WGS,30ca9dda6dc901c20e4df461aec63c56,30ca9dda6dc901c20e4df461aec63c56.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a478,30ca9dda6dc901c20e4df461aec63c56.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2987-03A,C147D12E-5E96-484E-BBE7-DC2F11F889BF,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,5efd36b6-4b88-4c0d-9ab0-078daf12d67f,Blood,75,401A0850-B8A9-4FC2-9002-9547CBF5E957,0ED17783-F51E-43D5-8852-5E2EC3E97620,TCGA-AB-2987-03A-01D-0742-05,GRCh37-lite,TCGA-AB-2987,TCGA-LAML,184,s7247,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a4ba,58cfa82de4b0c9d6adf6a4ba,1e153b1e43ce5444de39e6c20baa20c7.filtered.,WGS,1e153b1e43ce5444de39e6c20baa20c7,1e153b1e43ce5444de39e6c20baa20c7.bam,15.37,1.98,0.08,58cfa82de4b0c9d6adf6a4ba,1e153b1e43ce5444de39e6c20baa20c7.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A1NU-10A,E56491AF-718F-4CA1-B3CD-0E5B3154697B,Blood Derived Normal,Illumina HiSeq,ebdfdf2c-e248-442b-90a6-f5b85951aa9f,Uterus,74,82EACB30-B052-46EB-B69D-8CF7F7D74A8A,8EA99948-820A-45B7-AB96-484FBBC9952A,TCGA-D1-A1NU-10A-01D-A14G-09,GRCh37-lite,TCGA-D1-A1NU,TCGA-UCEC,NA,s4577,Washington University School of Medicine,Mayo Clinic,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf72ee1,58cfa83ce4b0c9d6adf72ee1,e6507c999d39ed773eac1bc8f7ad5afb.filtered.,WGS,e6507c999d39ed773eac1bc8f7ad5afb,e6507c999d39ed773eac1bc8f7ad5afb.bam,79.35,1.93,0.08,58cfa83ce4b0c9d6adf72ee1,e6507c999d39ed773eac1bc8f7ad5afb.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A1M9-10A,A3BE445A-A592-4073-815B-47AE41F9C4A0,Blood Derived Normal,Illumina HiSeq,955cddcd-6ab3-40a9-bb44-8095d3af1446,Cervix,46,AE9477F6-7175-41AD-9090-4E61419D9B91,9FAF0290-1BD2-4873-A232-9084A238179C,TCGA-C5-A1M9-10A-01D-A200-09,GRCh37-lite,TCGA-C5-A1M9,TCGA-CESC,1065,s1341,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,T3b,N1,Endocervical Type of Adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b8fb,58cfa82fe4b0c9d6adf6b8fb,TCGA-AA-3518-01A-02D-1525-10_Illumina.filtered.,WGS,TCGA-AA-3518-01A-02D-1525-10_Illumina,TCGA-AA-3518-01A-02D-1525-10_Illumina.bam,3.86,1.9,0.05,58cfa82fe4b0c9d6adf6b8fb,TCGA-AA-3518-01A-02D-1525-10_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3518-01A,C5C4A0A5-900D-483D-9282-475654D63265,Primary Tumor,Illumina HiSeq,7d2638fc-9574-4f2a-baf2-495e6ba99e93,Colorectal,81,BC08B757-ED0A-44C0-88CD-85496BB72A75,F4B9D98F-7B76-4EAA-9595-10B0973D5FF7,TCGA-AA-3518-01A-02D-1525-10,NCBI36_BCM_variant,TCGA-AA-3518,TCGA-COAD,NA,s13027,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a516,58cfa82de4b0c9d6adf6a516,12cdfd6759ccc47c2476719bbb230bf7.filtered.,WGS,12cdfd6759ccc47c2476719bbb230bf7,12cdfd6759ccc47c2476719bbb230bf7.bam,40.46,NA,0.08,58cfa82de4b0c9d6adf6a516,12cdfd6759ccc47c2476719bbb230bf7.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-FX-A3NJ-10A,7BAB6742-4E3D-4FCF-9B90-D3E0218B4D79,Blood Derived Normal,Illumina HiSeq,0f77f5e1-c366-4210-83fe-2006a8624359,Mesenchymal,54,5A18ED8E-523F-428C-8365-17546F2135D0,5925FF29-AB11-4A35-957F-0E6198757944,TCGA-FX-A3NJ-10A-01D-A21Q-09,GRCh37-lite,TCGA-FX-A3NJ,TCGA-SARC,NA,s2330,Washington University School of Medicine,International Genomics Consortium,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a5cb,58cfa82de4b0c9d6adf6a5cb,6d7e6efd259f6da22588aaacd73c3c0e.filtered.,WGS,6d7e6efd259f6da22588aaacd73c3c0e,6d7e6efd259f6da22588aaacd73c3c0e.bam,46.27,1.72,0.09,58cfa82de4b0c9d6adf6a5cb,6d7e6efd259f6da22588aaacd73c3c0e.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-EW-A1J5-10A,5D8ED961-A012-4B6B-BFFB-9468D3953646,Blood Derived Normal,Illumina HiSeq,ce79ca01-0c22-4e25-a5da-fd9438299f91,Breast,59,75B94F6E-1011-4106-9D9E-3B6E5573C3E8,D0C5457B-7BA5-4482-ACC8-EDC375E0E121,TCGA-EW-A1J5-10A-01D-A13O-09,GRCh37-lite,TCGA-EW-A1J5,TCGA-BRCA,NA,s6627,Washington University School of Medicine,University of Miami,United States,NO,T3,N0 (i-),Infiltrating Lobular Carcinoma,Stage IIB
13722.58cfa83ce4b0c9d6adf730c7,58cfa83ce4b0c9d6adf730c7,fa6bec3d86dc832a801cad28a615155f.filtered.,WGS,fa6bec3d86dc832a801cad28a615155f,fa6bec3d86dc832a801cad28a615155f.bam,17.94,2,0.08,58cfa83ce4b0c9d6adf730c7,fa6bec3d86dc832a801cad28a615155f.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A08S-10A,2779FA01-AC93-4E80-A997-3385F72172C3,Blood Derived Normal,Illumina HiSeq,88281394-1a54-4fd8-8b8c-7c6fd3134331,Breast,71,793BE994-DEDD-4A82-A409-89E0832ABF23,A2C71708-A460-4CEE-AF93-D070BE1E6D2C,TCGA-A8-A08S-10A-01D-A19H-09,GRCh37-lite,TCGA-A8-A08S,TCGA-BRCA,NA,s6752,Washington University School of Medicine,Indivumed,Germany,NO,T1c,N1,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a453,58cfa82de4b0c9d6adf6a453,0e568ec10e5985f96895830ea05ab7ea.filtered.,WGS,0e568ec10e5985f96895830ea05ab7ea,0e568ec10e5985f96895830ea05ab7ea.bam,26.04,1.95,0.08,58cfa82de4b0c9d6adf6a453,0e568ec10e5985f96895830ea05ab7ea.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A0D1-10A,084C6AEC-94F7-4090-8F3F-59FA9E89721A,Blood Derived Normal,Illumina HiSeq,a74be239-af6b-4564-9546-58302824434c,Breast,76,EAE92247-2372-4EC9-A140-57009E1D1BE5,C569741B-DAD3-4042-B1B0-45D62EB6A967,TCGA-A2-A0D1-10A-01D-A19H-09,GRCh37-lite,TCGA-A2-A0D1,TCGA-BRCA,NA,s6257,Washington University School of Medicine,Walter Reed,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6be26,58cfa830e4b0c9d6adf6be26,TCGA-BH-A0WA-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-BH-A0WA-01A-11D-A128-09_IlluminaGA-DNASeq_whole,TCGA-BH-A0WA-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam,63.5,1.95,0.07,58cfa830e4b0c9d6adf6be26,TCGA-BH-A0WA-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0WA-01A,786E8DBE-442E-4551-87B3-B4C333B04DD4,Primary Tumor,Illumina HiSeq,1671f5e8-9bbd-41c1-803e-c518d5ba004f,Breast,82,8EF7AD6F-A6E4-405C-B20E-D547985BD9D6,EDDFBFB9-3AE8-449B-B870-46062A2571C1,TCGA-BH-A0WA-01A-11D-A128-09,GRCh37-lite,TCGA-BH-A0WA,TCGA-BRCA,NA,s6631,Washington University School of Medicine,University of Pittsburgh,None,NO,T1c,N0 (i-),Not available,Stage I
13722.58cfa82de4b0c9d6adf6a567,58cfa82de4b0c9d6adf6a567,05ac8012bd475ab2ce3d45b2e0e5864b.filtered.,WGS,05ac8012bd475ab2ce3d45b2e0e5864b,05ac8012bd475ab2ce3d45b2e0e5864b.bam,28.76,1.93,0.08,58cfa82de4b0c9d6adf6a567,05ac8012bd475ab2ce3d45b2e0e5864b.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A0YG-10A,C0892598-1F7B-4F23-9CD8-731F797753D5,Blood Derived Normal,Illumina HiSeq,0fe624ef-b6b8-45dc-8e70-c51c6a2e31d7,Breast,63,FE03FD53-82B8-4C77-9644-1CB989873811,D1ED4413-2B27-4C4D-B1D0-14CFC39721DB,TCGA-A2-A0YG-10A-01D-A19H-09,GRCh37-lite,TCGA-A2-A0YG,TCGA-BRCA,NA,s6260,Washington University School of Medicine,Walter Reed,None,NO,T2,N3a,Infiltrating Ductal Carcinoma,Stage IIIC
13722.58cfa82de4b0c9d6adf6a4c0,58cfa82de4b0c9d6adf6a4c0,19ada9681b4376a963a9b9e1b4877a12.filtered.,WGS,19ada9681b4376a963a9b9e1b4877a12,19ada9681b4376a963a9b9e1b4877a12.bam,18.03,NA,0.08,58cfa82de4b0c9d6adf6a4c0,19ada9681b4376a963a9b9e1b4877a12.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AR-A2LK-10A,1B703058-E596-45BC-80FE-8B98D545C2E2,Blood Derived Normal,Illumina HiSeq,2c451421-5276-4960-9791-c9d9c5a2b7ff,Breast,62,6EC8CCF0-4292-4ADD-9190-7339FFED7FFA,ADFEFA9C-2E3E-444D-8018-F364999F5F42,TCGA-AR-A2LK-10A-01D-A17W-09,GRCh37-lite,TCGA-AR-A2LK,TCGA-BRCA,NA,s6759,Washington University School of Medicine,Mayo,United States,NO,T3,N2,Infiltrating Lobular Carcinoma,Stage III
13722.58cfa830e4b0c9d6adf6be34,58cfa830e4b0c9d6adf6be34,TCGA-AB-2974-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2974-11A-01D-0739-09_whole,TCGA-AB-2974-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6be34,TCGA-AB-2974-11A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2974-11A,FF7839BB-176E-4483-AC6E-7FAE9F6E2E54,Solid Tissue Normal,Illumina GA,065a01e7-077b-48df-af57-667012a7a761,Blood,67,A4C17541-6F15-4CF2-B204-5770EC91E6C9,D811ED5B-2B58-412C-AA34-2678349BA1F5,TCGA-AB-2974-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2974,TCGA-LAML,92,s7116,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6bc3f,58cfa830e4b0c9d6adf6bc3f,TCGA-AO-A0J4-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-AO-A0J4-10A-01D-A128-09_IlluminaGA-DNASeq_whole,TCGA-AO-A0J4-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,111.5,1.95,0.08,58cfa830e4b0c9d6adf6bc3f,TCGA-AO-A0J4-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A0J4-10A,A9B7D7FE-BE31-4F71-AFEE-C1BFDF511888,Blood Derived Normal,Illumina HiSeq,4d68d5de-7417-49a8-adf6-12b3ccc612c0,Breast,41,82BB4CE9-08E3-4EAE-83B6-268225097575,F146C30D-FCE0-49BC-B684-8AD9CCACA7CF,TCGA-AO-A0J4-10A-01D-A128-09,GRCh37-lite,TCGA-AO-A0J4,TCGA-BRCA,NA,s5961,Washington University School of Medicine,MSKCC,None,NO,T1c,N0 (i-),Infiltrating Ductal Carcinoma,Stage IA
13722.58cfa830e4b0c9d6adf6bd41,58cfa830e4b0c9d6adf6bd41,TCGA-AG-3593-01A-01D-1525-10_Illumina.filtered.,WGS,TCGA-AG-3593-01A-01D-1525-10_Illumina,TCGA-AG-3593-01A-01D-1525-10_Illumina.bam,495.85,1.9,0.05,58cfa830e4b0c9d6adf6bd41,TCGA-AG-3593-01A-01D-1525-10_Illumina.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3593-01A,10290E91-9784-4F94-8DAA-B5D9A8B0EFB9,Primary Tumor,Illumina HiSeq,d2b54a0a-394a-4174-afce-c86c43e4524d,Colorectal,72,EFFCA0F1-E81D-47CD-8287-392A2B6AB786,FAFF4626-615B-416A-B7A6-9D177DCC94A9,TCGA-AG-3593-01A-01D-1525-10,NCBI36_BCM_variant,TCGA-AG-3593,TCGA-READ,NA,s2130,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6afb4,58cfa82ee4b0c9d6adf6afb4,TCGA-06-1086-01A-02D-0932-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-06-1086-01A-02D-0932-09_IlluminaGA-DNASeq_whole,TCGA-06-1086-01A-02D-0932-09_IlluminaGA-DNASeq_whole.bam,383.3,1.9,0.19,58cfa82ee4b0c9d6adf6afb4,TCGA-06-1086-01A-02D-0932-09_IlluminaGA-DNASeq_whole.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-1086-01A,97686AB2-3B7E-4B21-9BF3-9A5A01709E04,Primary Tumor,Illumina GA,e46650d8-974c-4314-9e04-d1c122b1e29e,Brain,42,B70E073A-955C-44E0-8B29-7BF7FDC07CF9,25BEE010-CC99-4AF0-BA2F-FE4DD308BE33,TCGA-06-1086-01A-02D-0932-09,NCBI36_WUGSC_variant,TCGA-06-1086,TCGA-GBM,208,s14178,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6bb32,58cfa830e4b0c9d6adf6bb32,TCGA-AA-A00R-01A-01D-A126-10_Illumina.filtered.,WGS,TCGA-AA-A00R-01A-01D-A126-10_Illumina,TCGA-AA-A00R-01A-01D-A126-10_Illumina.bam,205.35,1.73,0.08,58cfa830e4b0c9d6adf6bb32,TCGA-AA-A00R-01A-01D-A126-10_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A00R-01A,CA22EDD4-EB7C-4677-84AA-6F0354459A19,Primary Tumor,Illumina HiSeq,a3f8272c-4b21-47f7-be7c-d4fc4cbb70b0,Colorectal,64,F72EEAE9-F7F5-4576-A072-5021119117D6,05780D48-80E7-4D70-B00C-081F8A9519F2,TCGA-AA-A00R-01A-01D-A126-10,NCBI36_BCM_variant,TCGA-AA-A00R,TCGA-COAD,NA,s13370,Baylor College of Medicine,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa82de4b0c9d6adf6a58c,58cfa82de4b0c9d6adf6a58c,10878d76d4c0ad80ec41454ae734cdca.filtered.,WGS,10878d76d4c0ad80ec41454ae734cdca,10878d76d4c0ad80ec41454ae734cdca.bam,383.3,1.9,0.19,58cfa82de4b0c9d6adf6a58c,10878d76d4c0ad80ec41454ae734cdca.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-1086-01A,97686AB2-3B7E-4B21-9BF3-9A5A01709E04,Primary Tumor,Illumina GA,795f4cb5-44bd-4bbf-ba7d-68195fc6deed,Brain,42,B70E073A-955C-44E0-8B29-7BF7FDC07CF9,25BEE010-CC99-4AF0-BA2F-FE4DD308BE33,TCGA-06-1086-01A-02D-0932-09,GRCh37-lite,TCGA-06-1086,TCGA-GBM,208,s14157,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a4f0,58cfa82de4b0c9d6adf6a4f0,1ecfd8273a363b01bfe1272097ed576c.filtered.,WGS,1ecfd8273a363b01bfe1272097ed576c,1ecfd8273a363b01bfe1272097ed576c.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a4f0,1ecfd8273a363b01bfe1272097ed576c.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2906-03A,5B5D770E-DB72-4EE8-A89A-DB80FB31D3CD,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,adb926d1-8609-4d10-aa2f-ea31732af0d7,Blood,59,4BF1E9FC-BACF-472A-B40F-AAB6555862CC,0D5A3E47-4CFD-43B3-B593-E895A5DF70F4,TCGA-AB-2906-03A-01D-0742-05,NCBI36_WUGSC_variant,TCGA-AB-2906,TCGA-LAML,NA,s6970,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a6aa,58cfa82de4b0c9d6adf6a6aa,95b879a71f7bf9082e2f29544a9a96e5.filtered.,WGS,95b879a71f7bf9082e2f29544a9a96e5,95b879a71f7bf9082e2f29544a9a96e5.bam,15.75,1.83,0.08,58cfa82de4b0c9d6adf6a6aa,95b879a71f7bf9082e2f29544a9a96e5.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0G9-10A,45D58088-D3F4-4EB0-B75C-BCB98C0981DC,Blood Derived Normal,Illumina HiSeq,3406e946-469e-43a8-98de-9753e240c1a4,Uterus,79,824F35BF-457F-4E24-90FB-4F2934263C69,2DE4A671-05B6-4612-BD15-EC20C4AC22C6,TCGA-A5-A0G9-10A-01D-A066-09,GRCh37-lite,TCGA-A5-A0G9,TCGA-UCEC,NA,s4584,Washington University School of Medicine,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf73114,58cfa83ce4b0c9d6adf73114,afb6f261618cb1962ce8e7d28d2bebd6.filtered.,WGS,afb6f261618cb1962ce8e7d28d2bebd6,afb6f261618cb1962ce8e7d28d2bebd6.bam,14.79,NA,0.08,58cfa83ce4b0c9d6adf73114,afb6f261618cb1962ce8e7d28d2bebd6.bam,Alive,FEMALE,WHITE,Not available,Sarcoma,Aligned reads,TCGA-IS-A3K7-10A,5A64F7E9-3833-4A3C-962B-13EB3E305C69,Blood Derived Normal,Illumina HiSeq,6b6c17c4-6d37-4c4e-95ee-52e279d50bf7,Mesenchymal,63,DC53E339-AC44-429C-845A-50C52D01BF95,71896BE3-FCE7-4266-B6D8-3E20E38337FD,TCGA-IS-A3K7-10A-01D-A21Q-09,GRCh37-lite,TCGA-IS-A3K7,TCGA-SARC,NA,s2627,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf73093,58cfa83ce4b0c9d6adf73093,f49f6910c3804642d41fbdec025ab3e8.filtered.,WGS,f49f6910c3804642d41fbdec025ab3e8,f49f6910c3804642d41fbdec025ab3e8.bam,NA,NA,NA,58cfa83ce4b0c9d6adf73093,f49f6910c3804642d41fbdec025ab3e8.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2981-03A,BE6DD0E8-9966-4961-987D-4D64D15FF9CA,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,4cda291a-7837-481b-b4ab-367453767908,Blood,35,324EFA3E-4CCA-4748-A895-B40339DE154B,35599400-713D-4ED4-A489-96874AB5C9DA,TCGA-AB-2981-03A-01D-0742-05,GRCh37-lite,TCGA-AB-2981,TCGA-LAML,NA,s7198,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6b10c,58cfa82ee4b0c9d6adf6b10c,TCGA-13-0890-10A-01W-0421-09_whole.filtered.,WGS,TCGA-13-0890-10A-01W-0421-09_whole,TCGA-13-0890-10A-01W-0421-09_whole.bam,222,NA,0.5,58cfa82ee4b0c9d6adf6b10c,TCGA-13-0890-10A-01W-0421-09_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0890-10A,EE0A4A13-613E-4C5D-96C3-8083A013702D,Blood Derived Normal,Illumina GA,ef737ede-c220-454e-bb3a-20878d4e0076,Ovary,56,5495F287-C30D-4770-B073-5ABE03ED4FFF,29711D3A-D06A-45E5-A4A1-98527B64431F,TCGA-13-0890-10A-01W-0421-09,NCBI36_WUGSC_variant,TCGA-13-0890,TCGA-OV,NA,s17740,Washington University School of Medicine,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a67c,58cfa82de4b0c9d6adf6a67c,5decd6fc51393068c23c55ac1ad92921.filtered.,WGS,5decd6fc51393068c23c55ac1ad92921,5decd6fc51393068c23c55ac1ad92921.bam,49.05,NA,0.08,58cfa82de4b0c9d6adf6a67c,5decd6fc51393068c23c55ac1ad92921.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-EW-A3U0-10A,D9DC3B59-613D-469E-8B4F-6C5A557EB26A,Blood Derived Normal,Illumina HiSeq,e49f86f3-22dd-40c7-8b86-73ec1d90694b,Breast,61,D04E7090-2988-4E76-AC69-0ADA504AE7ED,8FC3CFB0-E245-4089-A73C-8D93CB8FC5EE,TCGA-EW-A3U0-10A-01D-A22A-09,GRCh37-lite,TCGA-EW-A3U0,TCGA-BRCA,NA,s6765,Washington University School of Medicine,University of Miami,United States,NO,T3,N1a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82de4b0c9d6adf6a5ec,58cfa82de4b0c9d6adf6a5ec,7584b2ea6ab67ca7411a7722eb44d8dd.filtered.,WGS,7584b2ea6ab67ca7411a7722eb44d8dd,7584b2ea6ab67ca7411a7722eb44d8dd.bam,30.18,2.08,0.08,58cfa82de4b0c9d6adf6a5ec,7584b2ea6ab67ca7411a7722eb44d8dd.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0DG-11A,0BC5744C-5FA3-45BB-87D0-70A02068B392,Solid Tissue Normal,Illumina HiSeq,f5b1fe9e-b024-4845-a47a-42964a009d73,Breast,30,A3D00F8E-39C2-4E35-BC2F-DF9184B35670,D0D81468-73F6-4A8A-8F00-B99BD127C228,TCGA-BH-A0DG-11A-43D-A12Q-09,GRCh37-lite,TCGA-BH-A0DG,TCGA-BRCA,NA,s5485,Washington University School of Medicine,University of Pittsburgh,None,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a70a,58cfa82de4b0c9d6adf6a70a,9f6bf8689fcd3380ed50482daacd6d62.filtered.,WGS,9f6bf8689fcd3380ed50482daacd6d62,9f6bf8689fcd3380ed50482daacd6d62.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a70a,9f6bf8689fcd3380ed50482daacd6d62.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2997-03A,5E491CE4-D8DA-495B-A3AA-177E06CD69D0,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,9814f4a5-1eff-4e02-adb9-8eaa96b71605,Blood,25,429967B4-DC06-46C6-AD15-7B841D7B484E,5687E321-0C36-4A38-A4C5-D7A26171AC1C,TCGA-AB-2997-03A-01D-0739-09,GRCh37-lite,TCGA-AB-2997,TCGA-LAML,NA,s7206,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a442,58cfa82de4b0c9d6adf6a442,0edf5c3de83b754d8d9b5ed6ab9e8a94.filtered.,WGS,0edf5c3de83b754d8d9b5ed6ab9e8a94,0edf5c3de83b754d8d9b5ed6ab9e8a94.bam,5.5,NA,0.07,58cfa82de4b0c9d6adf6a442,0edf5c3de83b754d8d9b5ed6ab9e8a94.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A1L2-10A,73D2E8EF-4E10-416A-845B-F48374E48ECB,Blood Derived Normal,Illumina HiSeq,e2f439b3-8ea1-416d-a08f-2ec6159a91ff,Mesenchymal,78,12BDBCDC-65B4-436C-B3CB-1C58C3C765CE,BAB2414E-D20B-4B79-AE79-1223A627736E,TCGA-DX-A1L2-10A-01D-A24N-09,GRCh37-lite,TCGA-DX-A1L2,TCGA-SARC,NA,s2327,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a4fc,58cfa82de4b0c9d6adf6a4fc,143cb9761910d538bdd6adea5e1b8cca.filtered.,WGS,143cb9761910d538bdd6adea5e1b8cca,143cb9761910d538bdd6adea5e1b8cca.bam,15.77,NA,0.08,58cfa82de4b0c9d6adf6a4fc,143cb9761910d538bdd6adea5e1b8cca.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-IS-A3KA-10A,257DC623-41E1-4FA3-859C-C787DB10BD60,Blood Derived Normal,Illumina HiSeq,2763297f-4400-4421-9d0b-5b736d83fb37,Mesenchymal,73,CD52C7E6-A9E5-41CF-A7A0-E4B1C052336B,5F7A0FB0-9477-462C-959E-7FC6F0125FEC,TCGA-IS-A3KA-10A-01D-A21Q-09,GRCh37-lite,TCGA-IS-A3KA,TCGA-SARC,413,s2475,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf73178,58cfa83ce4b0c9d6adf73178,da2b965e21759e1c9f2fd4ff550f335a.filtered.,WGS,da2b965e21759e1c9f2fd4ff550f335a,da2b965e21759e1c9f2fd4ff550f335a.bam,178.6,1.88,0.15,58cfa83ce4b0c9d6adf73178,da2b965e21759e1c9f2fd4ff550f335a.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0128-01A,31E6E6C8-9197-4927-BFE4-8F6836F963DA,Primary Tumor,Illumina GA,f0ac9e75-1b36-4c78-affc-77ce293823d4,Brain,66,FF6B6D81-68C6-4583-8A25-D914428BB23D,54940C29-C592-4621-9553-2021EE8C6CB7,TCGA-06-0128-01A-01D-0572-09,GRCh37-lite,TCGA-06-0128,TCGA-GBM,691,s13964,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf72ebf,58cfa83ce4b0c9d6adf72ebf,dcc179fd39da566d773dd5f70adce225.filtered.,WGS,dcc179fd39da566d773dd5f70adce225,dcc179fd39da566d773dd5f70adce225.bam,34.32,1.95,0.08,58cfa83ce4b0c9d6adf72ebf,dcc179fd39da566d773dd5f70adce225.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AN-A0G0-10A,96312510-C126-485D-8109-ED81844A1DC3,Blood Derived Normal,Illumina HiSeq,31f37360-2e47-4710-b5b5-57fc2b3a88e1,Breast,56,3D611795-3EF6-4F22-B093-4DAB08F11005,82968510-CE27-4819-9788-9637753AC772,TCGA-AN-A0G0-10A-01D-A047-09,GRCh37-lite,TCGA-AN-A0G0,TCGA-BRCA,NA,s6611,Washington University School of Medicine,Cureline,None,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82fe4b0c9d6adf6b5eb,58cfa82fe4b0c9d6adf6b5eb,TCGA-29-2414-10A-01D-0926-12_Illumina.filtered.,WGS,TCGA-29-2414-10A-01D-0926-12_Illumina,TCGA-29-2414-10A-01D-0926-12_Illumina.bam,2,1.9,0.17,58cfa82fe4b0c9d6adf6b5eb,TCGA-29-2414-10A-01D-0926-12_Illumina.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-29-2414-10A,A2319490-B85D-4219-A1B0-FA1EC432D5C8,Blood Derived Normal,Illumina HiSeq,de411f44-d184-49bc-adbb-280b1dc4d3de,Ovary,75,3A79F24C-A6C3-4B31-9551-37D97C6027AD,32D1CC2D-4D42-4471-9833-158883F90274,TCGA-29-2414-10A-01D-0926-12,NCBI36_BCM_variant,TCGA-29-2414,TCGA-OV,2621,s17579,Baylor College of Medicine,Duke,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a69a,58cfa82de4b0c9d6adf6a69a,89f97fb431993848f145375c06801195.filtered.,WGS,89f97fb431993848f145375c06801195,89f97fb431993848f145375c06801195.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a69a,89f97fb431993848f145375c06801195.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2998-11A,BA9A95CF-44CE-4126-BA21-4970DFA12593,Solid Tissue Normal,Illumina GA,c35efc4b-706c-418a-871e-1af40b34d766,Blood,68,55A3EF1A-E2B8-46A4-9164-46A5E194AB6D,86091AFE-5087-48C5-8511-ED4320DF0D01,TCGA-AB-2998-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2998,TCGA-LAML,31,s6979,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a690,58cfa82de4b0c9d6adf6a690,8be090d1b6b3dcd84524b15677209008.filtered.,WGS,8be090d1b6b3dcd84524b15677209008,8be090d1b6b3dcd84524b15677209008.bam,69.44,2,0.08,58cfa82de4b0c9d6adf6a690,8be090d1b6b3dcd84524b15677209008.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A1MY-10A,5D2F1A0F-A01B-48C2-B749-1CA710AA2BB4,Blood Derived Normal,Illumina HiSeq,3d34d28c-39d3-4fea-a6aa-bc5381ac2eab,Uterus,62,DEF3BEF3-FE3D-4DB9-A733-CCB913591555,7E34DF03-DED2-493F-85B2-08289AF95F88,TCGA-B5-A1MY-10A-01D-A34H-09,GRCh37-lite,TCGA-B5-A1MY,TCGA-UCEC,361,s5192,Washington University School of Medicine,Duke,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6c1da,58cfa830e4b0c9d6adf6c1da,TCGA-AB-3002-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-3002-03A-01D-0739-09_whole,TCGA-AB-3002-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6c1da,TCGA-AB-3002-03A-01D-0739-09_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3002-03A,478F29B1-6604-4E75-A492-47C384799F44,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,0379d38a-fc2c-4a6e-a324-da5ec8552776,Blood,68,61C0F3DF-32C8-4BCE-816B-39579F06BC5B,320EBE6F-48BD-40F1-9BE5-1401A3BFF328,TCGA-AB-3002-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-3002,TCGA-LAML,1431,s7273,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72ee8,58cfa83ce4b0c9d6adf72ee8,df2eae4cbef1c0aecdbe1d0f2424edb1.filtered.,WGS,df2eae4cbef1c0aecdbe1d0f2424edb1,df2eae4cbef1c0aecdbe1d0f2424edb1.bam,83.63,NA,0.08,58cfa83ce4b0c9d6adf72ee8,df2eae4cbef1c0aecdbe1d0f2424edb1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A3M1-10A,B85E2156-D5AC-486C-93E1-86525EA41A64,Blood Derived Normal,Illumina HiSeq,ebc81d7c-b0be-4ec8-a158-b82c3477fce8,Mesenchymal,79,02DB6DE3-6DE8-426E-89BA-6BA6F03A6BA3,D732488F-AA89-4EE1-8915-C6BA1C5A5C44,TCGA-DX-A3M1-10A-01D-A22A-09,GRCh37-lite,TCGA-DX-A3M1,TCGA-SARC,NA,s2470,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf731d4,58cfa83ce4b0c9d6adf731d4,b6cc1affd819e34fc6f2f080f75ac2f1.filtered.,WGS,b6cc1affd819e34fc6f2f080f75ac2f1,b6cc1affd819e34fc6f2f080f75ac2f1.bam,3.94,NA,0.07,58cfa83ce4b0c9d6adf731d4,b6cc1affd819e34fc6f2f080f75ac2f1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A1KU-10A,EA0E5AE7-1F15-4504-AEA3-EFD1F6733304,Blood Derived Normal,Illumina HiSeq,3bf3b42e-a2f8-4999-aba4-1ed849dc8bbd,Mesenchymal,82,C97C8405-72E7-427C-9A1B-4077D0B65D43,82655523-70C2-4B8D-83CD-BF3DFA800B4A,TCGA-DX-A1KU-10A-01D-A24N-09,GRCh37-lite,TCGA-DX-A1KU,TCGA-SARC,427,s2463,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a4ae,58cfa82de4b0c9d6adf6a4ae,247da315a50c7fb4598daf792c5086ff.filtered.,WGS,247da315a50c7fb4598daf792c5086ff,247da315a50c7fb4598daf792c5086ff.bam,30.26,1.68,0.09,58cfa82de4b0c9d6adf6a4ae,247da315a50c7fb4598daf792c5086ff.bam,Dead,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A1BF-10A,262311A0-7A10-4934-8FBA-11EE581AD738,Blood Derived Normal,Illumina HiSeq,7a3dd7ed-42f8-4430-94ff-ce66abc93b74,Cervix,46,D7002BAA-1A99-441D-8D83-D146DC49B78F,524328BF-E279-40B1-B028-5868B98D2A4D,TCGA-C5-A1BF-10A-01D-A200-09,GRCh37-lite,TCGA-C5-A1BF,TCGA-CESC,570,s1161,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,TX,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa83ce4b0c9d6adf730e4,58cfa83ce4b0c9d6adf730e4,c1708e13b2a9faaf5f50fc2e1f491bca.filtered.,WGS,c1708e13b2a9faaf5f50fc2e1f491bca,c1708e13b2a9faaf5f50fc2e1f491bca.bam,14.09,NA,0.09,58cfa83ce4b0c9d6adf730e4,c1708e13b2a9faaf5f50fc2e1f491bca.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2RL-10A,61EB08D0-EA01-45E7-884B-AC3D6070172A,Blood Derived Normal,Illumina HiSeq,59e94488-d19c-44a4-9cb9-0a2d4d5836ab,Cervix,32,D4A4CABD-FA00-4DBF-A25B-B3635FC0AD9A,B64F18C1-731E-4988-A079-1306B8D9C14D,TCGA-EK-A2RL-10A-01D-A34H-09,GRCh37-lite,TCGA-EK-A2RL,TCGA-CESC,NA,s1610,Washington University School of Medicine,Gynecologic Oncology Group,United States,NO,T1b1,N1,Endocervical Type of Adenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf73182,58cfa83ce4b0c9d6adf73182,afadeaa36fa98e1d8bb84a2932ffc28f.filtered.,WGS,afadeaa36fa98e1d8bb84a2932ffc28f,afadeaa36fa98e1d8bb84a2932ffc28f.bam,25.12,2.03,0.08,58cfa83ce4b0c9d6adf73182,afadeaa36fa98e1d8bb84a2932ffc28f.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A0CM-10A,EB2DBB4F-66B6-4525-8323-431970F7A64E,Blood Derived Normal,Illumina HiSeq,5aa2407a-3abf-42c8-817f-5de4731a1bc7,Breast,40,FC7033BB-1A9D-488D-AE8D-ECB67F179700,23CE62FF-753C-4A79-ADCC-2C39ED96D012,TCGA-A2-A0CM-10A-01D-A128-09,GRCh37-lite,TCGA-A2-A0CM,TCGA-BRCA,754,s6966,Washington University School of Medicine,Walter Reed,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a57a,58cfa82de4b0c9d6adf6a57a,0c8a429a53075b0031b9c569f8d6ad02.filtered.,WGS,0c8a429a53075b0031b9c569f8d6ad02,0c8a429a53075b0031b9c569f8d6ad02.bam,14.01,NA,0.07,58cfa82de4b0c9d6adf6a57a,0c8a429a53075b0031b9c569f8d6ad02.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A3LW-10A,2CACD9D0-8414-4F17-8259-C9D838597F39,Blood Derived Normal,Illumina HiSeq,a3284a18-fe34-490a-b4f4-14101c4b697e,Mesenchymal,43,58A401D6-9ABB-4E3D-B12E-C29AE301DC45,2D8FB05E-4FB9-4350-B197-A56F40089CB7,TCGA-DX-A3LW-10A-01D-A32V-09,GRCh37-lite,TCGA-DX-A3LW,TCGA-SARC,NA,s2333,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a544,58cfa82de4b0c9d6adf6a544,1f466cc9506aff74d0ecb5f37d454082.filtered.,WGS,1f466cc9506aff74d0ecb5f37d454082,1f466cc9506aff74d0ecb5f37d454082.bam,6.91,NA,0.07,58cfa82de4b0c9d6adf6a544,1f466cc9506aff74d0ecb5f37d454082.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-IF-A4AJ-11A,4E8C570C-3CBE-4878-8B2C-B966868DD60D,Solid Tissue Normal,Illumina HiSeq,b84d55b2-c676-42c4-b996-763d5a11efe2,Mesenchymal,80,9E81666B-55CE-4205-A4A1-C170AD59F63D,E8F6F409-7FF3-4EDA-AD53-419F91052D25,TCGA-IF-A4AJ-11A-12D-A24N-09,GRCh37-lite,TCGA-IF-A4AJ,TCGA-SARC,767,s2476,Washington University School of Medicine,University of Texas MD Anderson Cancer Center,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf73133,58cfa83ce4b0c9d6adf73133,efa92e2f26565e290d296d0bfa15deba.filtered.,WGS,efa92e2f26565e290d296d0bfa15deba,efa92e2f26565e290d296d0bfa15deba.bam,16.05,1.98,0.07,58cfa83ce4b0c9d6adf73133,efa92e2f26565e290d296d0bfa15deba.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A094-10A,993103B1-E5A1-4C33-8629-BE53EBC41D64,Blood Derived Normal,Illumina HiSeq,2cd07b47-50c8-4208-9637-21b2ec86670d,Breast,75,2C4FEBE8-DD9B-4213-85F9-CEAA9594E5AF,E45C007A-E0E6-454C-9804-9D72FF7378FD,TCGA-A8-A094-10A-01D-A19H-09,GRCh37-lite,TCGA-A8-A094,TCGA-BRCA,NA,s6906,Washington University School of Medicine,Indivumed,Germany,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6b0ac,58cfa82ee4b0c9d6adf6b0ac,TCGA-13-0890-01A-01W-0421-09_whole.filtered.,WGS,TCGA-13-0890-01A-01W-0421-09_whole,TCGA-13-0890-01A-01W-0421-09_whole.bam,385,NA,0.5,58cfa82ee4b0c9d6adf6b0ac,TCGA-13-0890-01A-01W-0421-09_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0890-01A,EE0A4A13-613E-4C5D-96C3-8083A013702D,Primary Tumor,Illumina GA,5e23b711-a91b-47ed-a34b-2e91f5627f48,Ovary,56,37981859-BA7A-4F93-8FCB-78615E696149,15B867FB-7A7B-4158-9ABD-91870BA77EB7,TCGA-13-0890-01A-01W-0421-09,NCBI36_WUGSC_variant,TCGA-13-0890,TCGA-OV,NA,s17124,Washington University School of Medicine,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a562,58cfa82de4b0c9d6adf6a562,2d076b319d13bbab7835a04a2d724a18.filtered.,WGS,2d076b319d13bbab7835a04a2d724a18,2d076b319d13bbab7835a04a2d724a18.bam,130.57,1.95,0.08,58cfa82de4b0c9d6adf6a562,2d076b319d13bbab7835a04a2d724a18.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A06B-10A,95E6D327-9AB7-45DE-9527-F5634B3995C3,Blood Derived Normal,Illumina HiSeq,aae209a4-ca40-462b-8d7f-c9715f68a5b6,Uterus,72,EB746A8F-14ED-47E4-8B29-D75F675A4C9D,8FE7CCE2-3CC1-4D9C-9C80-19C2CF54906B,TCGA-AX-A06B-10A-01D-A325-09,GRCh37-lite,TCGA-AX-A06B,TCGA-UCEC,NA,s4579,Washington University School of Medicine,Gynecologic Oncology Group,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf72fc7,58cfa83ce4b0c9d6adf72fc7,a76527914454587759373c0190c7678e.filtered.,WGS,a76527914454587759373c0190c7678e,a76527914454587759373c0190c7678e.bam,58.34,NA,0.08,58cfa83ce4b0c9d6adf72fc7,a76527914454587759373c0190c7678e.bam,Alive,FEMALE,Not available,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-DG-A2KJ-10A,7C93642D-7E05-40F8-B1EF-A014EDCFBA42,Blood Derived Normal,Illumina HiSeq,88d67937-e5d1-4d8c-a4b3-05cf8f2ddfd2,Cervix,50,F51E97A5-4844-47E4-B6E9-96AD043E31B5,8741AF22-0355-4085-9C09-ABEE617690D0,TCGA-DG-A2KJ-10A-01D-A18J-09,GRCh37-lite,TCGA-DG-A2KJ,TCGA-CESC,NA,s1501,Washington University School of Medicine,Ontario Institute for Cancer Research,Canada,NO,T1b,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa83ce4b0c9d6adf730d0,58cfa83ce4b0c9d6adf730d0,fef249d4e459bee0e48abb198d2028ee.filtered.,WGS,fef249d4e459bee0e48abb198d2028ee,fef249d4e459bee0e48abb198d2028ee.bam,38.5,1.64,0.08,58cfa83ce4b0c9d6adf730d0,fef249d4e459bee0e48abb198d2028ee.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A1MI-10A,941F75A1-FEA4-4539-BA69-60BB11608F6D,Blood Derived Normal,Illumina HiSeq,5283bba7-623e-476e-bd42-b147b6b6f394,Cervix,50,B9B8F225-DF87-48BD-BB39-E049F8BB2C0F,C18E858E-2B87-4911-A158-FA6034FFA950,TCGA-C5-A1MI-10A-01D-A200-09,GRCh37-lite,TCGA-C5-A1MI,TCGA-CESC,1083,s1611,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,T1b1,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82de4b0c9d6adf6a476,58cfa82de4b0c9d6adf6a476,1dcd58c318ce7a2f8b12105db1a27c82.filtered.,WGS,1dcd58c318ce7a2f8b12105db1a27c82,1dcd58c318ce7a2f8b12105db1a27c82.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a476,1dcd58c318ce7a2f8b12105db1a27c82.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2906-03A,5B5D770E-DB72-4EE8-A89A-DB80FB31D3CD,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,f3fa3448-fd1c-46a9-bdba-3edee2dd6ae7,Blood,59,4BF1E9FC-BACF-472A-B40F-AAB6555862CC,0D5A3E47-4CFD-43B3-B593-E895A5DF70F4,TCGA-AB-2906-03A-01D-0742-05,GRCh37-lite,TCGA-AB-2906,TCGA-LAML,NA,s6969,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72fe0,58cfa83ce4b0c9d6adf72fe0,aa7fc4b1eb76fad78a3e138ca2f7114b.filtered.,WGS,aa7fc4b1eb76fad78a3e138ca2f7114b,aa7fc4b1eb76fad78a3e138ca2f7114b.bam,14.08,1.96,0.09,58cfa83ce4b0c9d6adf72fe0,aa7fc4b1eb76fad78a3e138ca2f7114b.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A0TN-10B,14C65927-B9DD-4EF6-9917-DB7BC431FF2F,Blood Derived Normal,Illumina HiSeq,f69c19a2-3142-43d4-b62b-2bfb91c76ac3,Cervix,21,CEA46E75-27F2-4349-A4A2-9460CC7EB4D7,463D50B1-583C-4531-92DE-5DF50D8881BF,TCGA-C5-A0TN-10B-01D-A200-09,GRCh37-lite,TCGA-C5-A0TN,TCGA-CESC,348,s1502,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,T1b,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa83ce4b0c9d6adf72e7e,58cfa83ce4b0c9d6adf72e7e,c9aad1e391c4492d152b088de484f646.filtered.,WGS,c9aad1e391c4492d152b088de484f646,c9aad1e391c4492d152b088de484f646.bam,12.67,1.93,0.08,58cfa83ce4b0c9d6adf72e7e,c9aad1e391c4492d152b088de484f646.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EX-A1H5-10A,6B74C07A-9932-4A80-8296-9DB08D0C6964,Blood Derived Normal,Illumina HiSeq,23af8d74-ce98-421c-aa2c-f0cb33494eae,Cervix,58,28B61277-D0AB-419C-BE3F-D1E56A2C20B6,6ECF0C96-9322-4146-891D-89BC5BDB8070,TCGA-EX-A1H5-10A-01D-A200-09,GRCh37-lite,TCGA-EX-A1H5,TCGA-CESC,NA,s1503,Washington University School of Medicine,University of North Carolina,United States,NO,T2b,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6be0c,58cfa830e4b0c9d6adf6be0c,TCGA-AB-2967-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2967-03A-01D-0739-09_whole,TCGA-AB-2967-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6be0c,TCGA-AB-2967-03A-01D-0739-09_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2967-03A,9C022254-F9F7-4C61-BE48-48C60A92448E,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,468b2662-9228-4abc-a54e-b3f919009c73,Blood,58,CCB851A6-72CC-4F0A-9759-7F493CBF488C,60A69167-464F-4DF2-A6F9-ED402ED58F76,TCGA-AB-2967-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2967,TCGA-LAML,NA,s7042,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf7311e,58cfa83ce4b0c9d6adf7311e,daa0950ea36eb03f2ceecd8730fade48.filtered.,WGS,daa0950ea36eb03f2ceecd8730fade48,daa0950ea36eb03f2ceecd8730fade48.bam,82.66,2,0.08,58cfa83ce4b0c9d6adf7311e,daa0950ea36eb03f2ceecd8730fade48.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AN-A0AT-10A,05506F4C-E701-4A9D-AE06-97F066AADE43,Blood Derived Normal,Illumina HiSeq,37554d25-cb93-436e-9379-74d3111e16c7,Breast,62,669A4076-13DE-42DC-895C-85D040422042,591A3934-0614-4C7E-8CD5-B7785B709BAD,TCGA-AN-A0AT-10A-01D-A047-09,GRCh37-lite,TCGA-AN-A0AT,TCGA-BRCA,NA,s6612,Washington University School of Medicine,Cureline,None,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6be19,58cfa830e4b0c9d6adf6be19,TCGA-AB-2977-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2977-11A-01D-0739-09_whole,TCGA-AB-2977-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6be19,TCGA-AB-2977-11A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2977-11A,F95063BC-A640-4980-99A7-84645902DAF4,Solid Tissue Normal,Illumina GA,2123339d-a200-450f-a7ee-80ce07c9b809,Blood,71,404143F6-BCB4-4BE8-A791-6DA7F09190AC,4992751B-33FC-4136-BCBC-564C6854CEF3,TCGA-AB-2977-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2977,TCGA-LAML,31,s7270,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72ef9,58cfa83ce4b0c9d6adf72ef9,ba1be52c7e1ba54b9239744965b4af57.filtered.,WGS,ba1be52c7e1ba54b9239744965b4af57,ba1be52c7e1ba54b9239744965b4af57.bam,27.82,1.95,0.07,58cfa83ce4b0c9d6adf72ef9,ba1be52c7e1ba54b9239744965b4af57.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0IQ-10A,01EEF340-598C-4205-A990-CEC190AC2CA5,Blood Derived Normal,Illumina HiSeq,11ba6141-baa1-4403-beb6-4c5aa4dff23f,Breast,40,459247DB-4FC3-4415-9A9C-ED7B9B2AD95D,22A79ED6-A633-4BB0-9D33-F508ED2F2C69,TCGA-B6-A0IQ-10A-01D-A128-09,GRCh37-lite,TCGA-B6-A0IQ,TCGA-BRCA,NA,s5779,Washington University School of Medicine,Duke,United States,NO,T3,N1b,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa83ce4b0c9d6adf730de,58cfa83ce4b0c9d6adf730de,edf9e88f2d650163ceeb4bb75a04b8a8.filtered.,WGS,edf9e88f2d650163ceeb4bb75a04b8a8,edf9e88f2d650163ceeb4bb75a04b8a8.bam,27.72,2,0.09,58cfa83ce4b0c9d6adf730de,edf9e88f2d650163ceeb4bb75a04b8a8.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-E6-A1LZ-10A,9205C164-7975-421A-90C3-EDFE8DEF595C,Blood Derived Normal,Illumina HiSeq,7a986264-f769-409b-b44b-8cf5cce7b498,Uterus,76,7DABF2C0-BB56-4FB5-AA33-FD37D600096C,782F742D-1251-4F17-B169-68F2969BA478,TCGA-E6-A1LZ-10A-01D-A142-09,GRCh37-lite,TCGA-E6-A1LZ,TCGA-UCEC,NA,s4979,Washington University School of Medicine,Roswell Park,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a62a,58cfa82de4b0c9d6adf6a62a,58d251e38e74fbdfea909ba38fd6b2c4.filtered.,WGS,58d251e38e74fbdfea909ba38fd6b2c4,58d251e38e74fbdfea909ba38fd6b2c4.bam,30.09,1.89,0.09,58cfa82de4b0c9d6adf6a62a,58d251e38e74fbdfea909ba38fd6b2c4.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A1FC-11A,B97BF89A-7A85-4EEF-AE7E-F787AEAD1F0A,Solid Tissue Normal,Illumina HiSeq,689d4e64-e8da-4e5d-8d57-fce960e4285a,Breast,78,A6916373-70F1-434C-910A-407609815556,00B14C77-845C-432E-923C-C2C412F5DF31,TCGA-BH-A1FC-11A-32D-A314-09,GRCh37-lite,TCGA-BH-A1FC,TCGA-BRCA,3472,s6112,Washington University School of Medicine,University of Pittsburgh,None,NO,T1c,N1b,Medullary Carcinoma,Stage IIA
13722.58cfa82fe4b0c9d6adf6b5d0,58cfa82fe4b0c9d6adf6b5d0,TCGA-26-1438-01A-01D-0932-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-26-1438-01A-01D-0932-09_IlluminaGA-DNASeq_whole,TCGA-26-1438-01A-01D-0932-09_IlluminaGA-DNASeq_whole.bam,24.3,1.9,0.15,58cfa82fe4b0c9d6adf6b5d0,TCGA-26-1438-01A-01D-0932-09_IlluminaGA-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-26-1438-01A,17DFFFFC-65D6-4209-9075-18A441001F0F,Primary Tumor,Illumina GA,befb4bf8-d5ba-41fd-953b-e739e7733dcf,Brain,36,9D3C5ABF-8652-4F73-A99D-B3C2C9B7EB54,A6957D15-453C-4F3B-AB8C-C38054DFE548,TCGA-26-1438-01A-01D-0932-09,NCBI36_WUGSC_variant,TCGA-26-1438,TCGA-GBM,NA,s14352,Washington University School of Medicine,University of Florida,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6bc0c,58cfa830e4b0c9d6adf6bc0c,TCGA-AG-3593-10A-01D-1525-10_Illumina.filtered.,WGS,TCGA-AG-3593-10A-01D-1525-10_Illumina,TCGA-AG-3593-10A-01D-1525-10_Illumina.bam,23.15,1.8,0.05,58cfa830e4b0c9d6adf6bc0c,TCGA-AG-3593-10A-01D-1525-10_Illumina.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3593-10A,10290E91-9784-4F94-8DAA-B5D9A8B0EFB9,Blood Derived Normal,Illumina HiSeq,a5af095e-eec0-41e5-8c5e-0ce755e61a3f,Colorectal,72,6AE385A6-F73C-4A62-A9A1-3207E9C4F802,C3AA670C-8595-46E9-9FB3-129CCAE433ED,TCGA-AG-3593-10A-01D-1525-10,NCBI36_BCM_variant,TCGA-AG-3593,TCGA-READ,NA,s2128,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa83ce4b0c9d6adf73164,58cfa83ce4b0c9d6adf73164,c5e3d269b2624b3c34eee5b7aa5c0473.filtered.,WGS,c5e3d269b2624b3c34eee5b7aa5c0473,c5e3d269b2624b3c34eee5b7aa5c0473.bam,NA,NA,NA,58cfa83ce4b0c9d6adf73164,c5e3d269b2624b3c34eee5b7aa5c0473.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2990-03A,D1BF3B65-493E-4249-8CB3-7C9F8CE4DC48,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,3d27c41f-ca77-42a7-8b56-d5f6fcdc52b9,Blood,51,7170E3D6-866F-47BA-9B00-681CF3C09F67,7B5C8C1F-0F5D-4795-B2FF-087B5F9BA7E9,TCGA-AB-2990-03A-01D-0742-05,GRCh37-lite,TCGA-AB-2990,TCGA-LAML,NA,s7095,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6bc2c,58cfa830e4b0c9d6adf6bc2c,TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole,TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam,78.64,1.86,0.08,58cfa830e4b0c9d6adf6bc2c,TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A0J4-01A,A9B7D7FE-BE31-4F71-AFEE-C1BFDF511888,Primary Tumor,Illumina HiSeq,b518df9f-2eae-4c82-92e3-3eb196cdd3a5,Breast,41,CF11642A-EB96-4B37-B914-371C71F8E0CA,110B5F05-DED7-45EC-B0F6-A941C92D77DD,TCGA-AO-A0J4-01A-11D-A128-09,GRCh37-lite,TCGA-AO-A0J4,TCGA-BRCA,NA,s5960,Washington University School of Medicine,MSKCC,None,NO,T1c,N0 (i-),Infiltrating Ductal Carcinoma,Stage IA
13722.58cfa82de4b0c9d6adf6a4a2,58cfa82de4b0c9d6adf6a4a2,153a1891b0e0e5b7072bd3bc59dcdc06.filtered.,WGS,153a1891b0e0e5b7072bd3bc59dcdc06,153a1891b0e0e5b7072bd3bc59dcdc06.bam,24.3,1.9,0.15,58cfa82de4b0c9d6adf6a4a2,153a1891b0e0e5b7072bd3bc59dcdc06.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-26-1438-01A,17DFFFFC-65D6-4209-9075-18A441001F0F,Primary Tumor,Illumina GA,73ca3131-cbc4-45e3-9522-d893f730f388,Brain,36,9D3C5ABF-8652-4F73-A99D-B3C2C9B7EB54,A6957D15-453C-4F3B-AB8C-C38054DFE548,TCGA-26-1438-01A-01D-0932-09,GRCh37-lite,TCGA-26-1438,TCGA-GBM,NA,s14077,Washington University School of Medicine,University of Florida,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf731b4,58cfa83ce4b0c9d6adf731b4,ed08bd5c24283a732e590c6c3fdb0bf2.filtered.,WGS,ed08bd5c24283a732e590c6c3fdb0bf2,ed08bd5c24283a732e590c6c3fdb0bf2.bam,9.4,1.93,0.08,58cfa83ce4b0c9d6adf731b4,ed08bd5c24283a732e590c6c3fdb0bf2.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A11H-10B,DEE43082-4AA7-4650-981C-A779E9FE7B55,Blood Derived Normal,Illumina HiSeq,255125dd-cc6d-4b7e-a042-7662021a54c3,Uterus,67,6F374EE5-E6CA-41EE-A2FD-27768A55C96B,644A1732-FEA5-45AB-BD6C-96CFFC4FC5EA,TCGA-B5-A11H-10B-01D-A122-09,GRCh37-lite,TCGA-B5-A11H,TCGA-UCEC,NA,s4978,Washington University School of Medicine,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf7309c,58cfa83ce4b0c9d6adf7309c,f6471a84a954b9df1c487b9c6a1ca642.filtered.,WGS,f6471a84a954b9df1c487b9c6a1ca642,f6471a84a954b9df1c487b9c6a1ca642.bam,45.05,2.02,0.09,58cfa83ce4b0c9d6adf7309c,f6471a84a954b9df1c487b9c6a1ca642.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0K3-10A,79ECC142-8F6E-4260-A7CE-C8E2A6212C35,Blood Derived Normal,Illumina HiSeq,dba527e0-2ba4-4422-9dd2-45cfd3d0f6fc,Uterus,62,B445099B-5442-43A2-91F4-16B020FC4740,A4FF4936-A38F-43AD-BF5D-8F17C787109E,TCGA-B5-A0K3-10A-01D-A325-09,GRCh37-lite,TCGA-B5-A0K3,TCGA-UCEC,NA,s4402,Washington University School of Medicine,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a648,58cfa82de4b0c9d6adf6a648,7da068ecfc1c9feb10193349c64bd217.filtered.,WGS,7da068ecfc1c9feb10193349c64bd217,7da068ecfc1c9feb10193349c64bd217.bam,53.57,1.96,0.09,58cfa82de4b0c9d6adf6a648,7da068ecfc1c9feb10193349c64bd217.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A23R-10A,B5F27002-4277-418D-90B0-CC5A2742692E,Blood Derived Normal,Illumina HiSeq,48cb46f4-714f-4f82-8ab0-26c0883c0592,Mesenchymal,55,DFDC1D32-D657-4357-94FA-D528DD0B6A5C,DAF47FE1-0C16-4711-A274-DB2C20165C2C,TCGA-DX-A23R-10A-01D-A26G-09,GRCh37-lite,TCGA-DX-A23R,TCGA-SARC,NA,s2345,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82fe4b0c9d6adf6b6ae,58cfa82fe4b0c9d6adf6b6ae,TCGA-29-1705-02A-01D-0926-12_Illumina.filtered.,WGS,TCGA-29-1705-02A-01D-0926-12_Illumina,TCGA-29-1705-02A-01D-0926-12_Illumina.bam,20,1.9,0.14,58cfa82fe4b0c9d6adf6b6ae,TCGA-29-1705-02A-01D-0926-12_Illumina.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-29-1705-02A,F9C835DB-2AB6-4BF5-826F-48723493C0EC,Recurrent Tumor,Illumina HiSeq,09c58620-3616-4c48-81b8-2e6fa34352f6,Ovary,47,B5163587-A94D-4674-9F11-76A5ADC9151D,49596020-9105-4488-B83C-C629CD1C3B83,TCGA-29-1705-02A-01D-0926-12,NCBI36_BCM_variant,TCGA-29-1705,TCGA-OV,555,s17883,Baylor College of Medicine,Duke,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf72eaf,58cfa83ce4b0c9d6adf72eaf,d546c291eab34ae1238698a788e2005c.filtered.,WGS,d546c291eab34ae1238698a788e2005c,d546c291eab34ae1238698a788e2005c.bam,17.4,2,0.07,58cfa83ce4b0c9d6adf72eaf,d546c291eab34ae1238698a788e2005c.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BK-A139-10A,8D9E4917-334B-4C76-AEE1-1E22BE772DB0,Blood Derived Normal,Illumina HiSeq,cca964ae-aded-4085-a219-920becf9df6c,Uterus,74,DC183CCA-CF96-4DF3-87DB-BFCFF58DC273,2AE69CBA-BE7F-46C3-B610-E27A48DAEF9D,TCGA-BK-A139-10A-01D-A122-09,GRCh37-lite,TCGA-BK-A139,TCGA-UCEC,NA,s4973,Washington University School of Medicine,Christiana Healthcare,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a6a8,58cfa82de4b0c9d6adf6a6a8,951b84e6d6a0e3c96960a60e3291e860.filtered.,WGS,951b84e6d6a0e3c96960a60e3291e860,951b84e6d6a0e3c96960a60e3291e860.bam,22.18,1.95,0.07,58cfa82de4b0c9d6adf6a6a8,951b84e6d6a0e3c96960a60e3291e860.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A14X-10A,60DF7543-6DA5-4C75-943B-5800C1E08234,Blood Derived Normal,Illumina HiSeq,0a820852-4686-4bed-8995-35aba8b37368,Breast,55,8328302C-CFF7-46DA-9B14-9C55F6EE531C,6194BBB4-88AE-4DB8-86E1-99D4D2315E89,TCGA-E2-A14X-10A-01D-A314-09,GRCh37-lite,TCGA-E2-A14X,TCGA-BRCA,NA,s6120,Washington University School of Medicine,Roswell Park,None,NO,T2,N2,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82de4b0c9d6adf6a5fa,58cfa82de4b0c9d6adf6a5fa,72077dd82688118a434727543642c7ea.filtered.,WGS,72077dd82688118a434727543642c7ea,72077dd82688118a434727543642c7ea.bam,15.3,1.98,0.09,58cfa82de4b0c9d6adf6a5fa,72077dd82688118a434727543642c7ea.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TC-10A,7B7D2D2B-ABE6-4F32-ADD0-3715096995D1,Blood Derived Normal,Illumina HiSeq,362ee630-5718-4c0b-a6ca-b5351c4afb1c,Uterus,69,30B01B06-1614-43CA-86AE-204D55A40892,0F8FE087-F15B-4F31-8B3D-8DCCE822939E,TCGA-BS-A0TC-10A-01D-A10B-09,GRCh37-lite,TCGA-BS-A0TC,TCGA-UCEC,NA,s4414,Washington University School of Medicine,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a524,58cfa82de4b0c9d6adf6a524,435533d16e831b2d6f6a0dc3bd50df1e.filtered.,WGS,435533d16e831b2d6f6a0dc3bd50df1e,435533d16e831b2d6f6a0dc3bd50df1e.bam,17.94,NA,0.08,58cfa82de4b0c9d6adf6a524,435533d16e831b2d6f6a0dc3bd50df1e.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-EW-A1PC-10A,F45210D3-9E66-4F5E-BEF1-5EE5547CC893,Blood Derived Normal,Illumina HiSeq,bbbfdc86-7d19-4c67-9a3f-c46da84f900d,Breast,66,EDED4CB4-F527-4FF6-A97D-2EC424B37ABE,58DDDDD4-CB14-4081-AC9F-C291DCDDC24D,TCGA-EW-A1PC-10A-01D-A21Q-09,GRCh37-lite,TCGA-EW-A1PC,TCGA-BRCA,NA,s6619,Washington University School of Medicine,University of Miami,United States,NO,T3,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa82de4b0c9d6adf6a5b0,58cfa82de4b0c9d6adf6a5b0,6f190ad98c150955d05310d0057d1f6f.filtered.,WGS,6f190ad98c150955d05310d0057d1f6f,6f190ad98c150955d05310d0057d1f6f.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a5b0,6f190ad98c150955d05310d0057d1f6f.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2975-11A,93FF9379-D1A1-412F-A776-C53397BA0DC3,Solid Tissue Normal,Illumina GA,a121ea24-8e5c-49a5-8bc0-4110f8a6efc5,Blood,54,B25F1D82-C885-4E27-8992-8A453C30A50A,07925C7F-550A-4728-908A-1ED34112DA56,TCGA-AB-2975-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2975,TCGA-LAML,NA,s7063,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72edd,58cfa83ce4b0c9d6adf72edd,e43cb6521def509cf89cee162d20ca68.filtered.,WGS,e43cb6521def509cf89cee162d20ca68,e43cb6521def509cf89cee162d20ca68.bam,29.16,1.98,0.08,58cfa83ce4b0c9d6adf72edd,e43cb6521def509cf89cee162d20ca68.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A0EY-10A,D67CD793-2931-429A-9084-2F3C4C8BE7AD,Blood Derived Normal,Illumina HiSeq,20d69bac-1191-4446-9c05-469bef595edd,Breast,62,724E1354-8CE6-4EE3-8971-2E411E2C7F78,503BAEB5-D5D6-46DF-8695-C5E0F274C49C,TCGA-A2-A0EY-10A-01D-A19H-09,GRCh37-lite,TCGA-A2-A0EY,TCGA-BRCA,NA,s5946,Washington University School of Medicine,Walter Reed,None,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa83ce4b0c9d6adf73098,58cfa83ce4b0c9d6adf73098,f232a415b12a85ec04ceb082509958cc.filtered.,WGS,f232a415b12a85ec04ceb082509958cc,f232a415b12a85ec04ceb082509958cc.bam,9.27,2.06,0.08,58cfa83ce4b0c9d6adf73098,f232a415b12a85ec04ceb082509958cc.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A1LK-11A,1D27253F-B036-44E7-A04D-8DA5BBF57419,Solid Tissue Normal,Illumina HiSeq,32766841-2370-4aad-b93e-8d5e8b002229,Breast,84,FA69FFB2-A9F4-4D89-9C15-43988A9852EF,D21604F4-6D60-4EEA-BD42-F6AB6C19CAB8,TCGA-E2-A1LK-11A-12D-A314-09,GRCh37-lite,TCGA-E2-A1LK,TCGA-BRCA,266,s5783,Washington University School of Medicine,Roswell Park,United States,NO,T4b,N3a,Infiltrating Ductal Carcinoma,Stage IIIC
13722.58cfa83ce4b0c9d6adf72f0b,58cfa83ce4b0c9d6adf72f0b,bd84b1b4e53170c8c0a48eda107e6317.filtered.,WGS,bd84b1b4e53170c8c0a48eda107e6317,bd84b1b4e53170c8c0a48eda107e6317.bam,30.29,2.07,0.07,58cfa83ce4b0c9d6adf72f0b,bd84b1b4e53170c8c0a48eda107e6317.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LL-10A,D17668C4-5D66-4E16-8B70-B54616581AAE,Blood Derived Normal,Illumina HiSeq,f1e0e257-a16b-4a00-b0c1-605ee9458570,Uterus,56,ACC43C62-1C62-4BA1-ABFA-D8F4872E8D8B,EA5EE522-CAB3-4F66-9E55-AE5C1A1A6E0F,TCGA-AP-A0LL-10A-01D-A10B-09,GRCh37-lite,TCGA-AP-A0LL,TCGA-UCEC,NA,s5183,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a4dc,58cfa82de4b0c9d6adf6a4dc,3a01287b5f545395a05cd849b38ca6c4.filtered.,WGS,3a01287b5f545395a05cd849b38ca6c4,3a01287b5f545395a05cd849b38ca6c4.bam,26.78,NA,0.08,58cfa82de4b0c9d6adf6a4dc,3a01287b5f545395a05cd849b38ca6c4.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A3U5-10A,8F3F6F7C-4B50-467E-A6E8-D836735913F6,Blood Derived Normal,Illumina HiSeq,3d868952-9921-4c5f-888f-e248c302900e,Mesenchymal,52,BEE94F53-C054-4CFF-926B-1BF1B749D7CD,D88D98C1-20D6-4351-A37B-39915181BA3F,TCGA-DX-A3U5-10A-01D-A22A-09,GRCh37-lite,TCGA-DX-A3U5,TCGA-SARC,NA,s2484,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a692,58cfa82de4b0c9d6adf6a692,87fe1a78d4d22c8d3ecbf97c42b8c414.filtered.,WGS,87fe1a78d4d22c8d3ecbf97c42b8c414,87fe1a78d4d22c8d3ecbf97c42b8c414.bam,15.44,NA,0.08,58cfa82de4b0c9d6adf6a692,87fe1a78d4d22c8d3ecbf97c42b8c414.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A2LT-10A,FB66B7F5-22CA-4D4D-97C2-30E6EDFFF781,Blood Derived Normal,Illumina HiSeq,d4e12dd5-93a7-4afe-96c4-470639a67f6e,Cervix,38,947484CD-30E0-4941-8F84-DDF8EB70E3B0,AFF606FF-0C62-4ADF-B137-275BF4AAFA5A,TCGA-C5-A2LT-10A-01D-A18J-09,GRCh37-lite,TCGA-C5-A2LT,TCGA-CESC,NA,s1513,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,T1b,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b958,58cfa82fe4b0c9d6adf6b958,TCGA-AA-3534-01A-01D-1525-10_Illumina.filtered.,WGS,TCGA-AA-3534-01A-01D-1525-10_Illumina,TCGA-AA-3534-01A-01D-1525-10_Illumina.bam,84.63,1.9,0.05,58cfa82fe4b0c9d6adf6b958,TCGA-AA-3534-01A-01D-1525-10_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3534-01A,DF228C56-89AC-4122-93B3-6C0740C4EC09,Primary Tumor,Illumina HiSeq,a3cf0d96-684b-4e42-ac5f-e1e6813123de,Colorectal,78,ECADE2C1-9DE2-4B05-B30C-4C8B81C65AE1,66701395-5A53-41BB-866B-3BBF08BC33AB,TCGA-AA-3534-01A-01D-1525-10,NCBI36_BCM_variant,TCGA-AA-3534,TCGA-COAD,NA,s13509,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa83ce4b0c9d6adf72f6e,58cfa83ce4b0c9d6adf72f6e,e8ca1fee02c380bc36915df141c7889a.filtered.,WGS,e8ca1fee02c380bc36915df141c7889a,e8ca1fee02c380bc36915df141c7889a.bam,24.45,2.06,0.08,58cfa83ce4b0c9d6adf72f6e,e8ca1fee02c380bc36915df141c7889a.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A259-10A,3FC3755D-A3F8-4E2C-813F-FF124F2A75C1,Blood Derived Normal,Illumina HiSeq,d2a43dcc-9fe7-4ca8-9f36-dcffd1ac50b3,Breast,70,264CFFAA-EBCB-4FD0-A889-63374AFE7829,30CCA542-BE1F-4A2F-BE4C-D20F26D0F45A,TCGA-A2-A259-10A-01D-A17G-09,GRCh37-lite,TCGA-A2-A259,TCGA-BRCA,NA,s6616,Washington University School of Medicine,Walter Reed,United States,NO,T1c,N0 (i-),Infiltrating Ductal Carcinoma,Stage I
13722.58cfa82de4b0c9d6adf6a552,58cfa82de4b0c9d6adf6a552,57edc9591e1f3a93eb3375923eecc0b3.filtered.,WGS,57edc9591e1f3a93eb3375923eecc0b3,57edc9591e1f3a93eb3375923eecc0b3.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a552,57edc9591e1f3a93eb3375923eecc0b3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2984-11A,810D293B-7DFC-4E91-AB29-042457632399,Solid Tissue Normal,Illumina GA,c039cd89-dab1-4867-bb10-2a5957d4a71b,Blood,38,92AC1300-F0B6-4C19-A592-18931F88D5C5,7E5F93A8-6056-47D1-9C1B-E8628C5699E6,TCGA-AB-2984-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2984,TCGA-LAML,NA,s6974,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a54a,58cfa82de4b0c9d6adf6a54a,141cc2a256a4e0066e43ca564fb958ad.filtered.,WGS,141cc2a256a4e0066e43ca564fb958ad,141cc2a256a4e0066e43ca564fb958ad.bam,19.07,1.94,0.08,58cfa82de4b0c9d6adf6a54a,141cc2a256a4e0066e43ca564fb958ad.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A09I-10A,1557183C-AEDD-4DF6-B98A-3654667F7B69,Blood Derived Normal,Illumina HiSeq,0fdbc528-9b3a-4f41-b5e4-9e0f68b6823e,Breast,84,C8AFFD05-3105-4B90-B569-6EC0AD275D30,1EA3BCBF-242F-40FD-840B-FDDB4F65A63F,TCGA-A8-A09I-10A-01D-A19H-09,GRCh37-lite,TCGA-A8-A09I,TCGA-BRCA,NA,s6452,Washington University School of Medicine,Indivumed,Germany,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a5b6,58cfa82de4b0c9d6adf6a5b6,598b935d795357aee0c7f67c0304dea9.filtered.,WGS,598b935d795357aee0c7f67c0304dea9,598b935d795357aee0c7f67c0304dea9.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a5b6,598b935d795357aee0c7f67c0304dea9.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3007-11A,D3988699-70D6-43E1-B84B-9E38B4D2D2B1,Solid Tissue Normal,Illumina GA,6bdd14ea-2d9a-41d2-9823-4fbce3e774d0,Blood,35,E23A4F5F-4D6C-4866-B5AE-81D47BE952EB,FFF75BD4-E19F-4B6C-841D-12F05E25A817,TCGA-AB-3007-11A-01D-0739-09,GRCh37-lite,TCGA-AB-3007,TCGA-LAML,NA,s7060,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a4ac,58cfa82de4b0c9d6adf6a4ac,384e3a54d13c4da95f4e7a281f456d43.filtered.,WGS,384e3a54d13c4da95f4e7a281f456d43,384e3a54d13c4da95f4e7a281f456d43.bam,7.9,1.9,0.08,58cfa82de4b0c9d6adf6a4ac,384e3a54d13c4da95f4e7a281f456d43.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A1LG-11A,EF4CBD38-BC79-4D60-A715-647EDD2EBE9E,Solid Tissue Normal,Illumina HiSeq,6bd8c3ea-15b6-4d42-b4f1-bbfdacb145f8,Breast,50,54E5A437-3BC0-4D22-880C-926582B86BCB,583D989C-FA07-46F5-B463-6CE5A2744927,TCGA-E2-A1LG-11A-42D-A14K-09,GRCh37-lite,TCGA-E2-A1LG,TCGA-BRCA,NA,s6621,Washington University School of Medicine,Roswell Park,United States,NO,T2,N0,Infiltrating Lobular Carcinoma,Stage IIA
13722.58cfa83ce4b0c9d6adf730e2,58cfa83ce4b0c9d6adf730e2,df5832da41bd52551f7bd168eec917c1.filtered.,WGS,df5832da41bd52551f7bd168eec917c1,df5832da41bd52551f7bd168eec917c1.bam,NA,NA,NA,58cfa83ce4b0c9d6adf730e2,df5832da41bd52551f7bd168eec917c1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2989-11A,E2E610CE-31C3-4FC0-917D-92D48FEB600A,Solid Tissue Normal,Illumina GA,0b5ebb7a-c29f-4c70-9a08-54ef9b84fb11,Blood,29,FAFB19E2-2C76-4D2B-AAD3-C4FD90AA1135,BAA70711-9504-4EBC-8E86-A870629D4161,TCGA-AB-2989-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2989,TCGA-LAML,365,s7097,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a702,58cfa82de4b0c9d6adf6a702,9bc66de4dce9c72e3a48ab48eebc3e7b.filtered.,WGS,9bc66de4dce9c72e3a48ab48eebc3e7b,9bc66de4dce9c72e3a48ab48eebc3e7b.bam,73.3,1.83,0.08,58cfa82de4b0c9d6adf6a702,9bc66de4dce9c72e3a48ab48eebc3e7b.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-EW-A1P8-10A,359F12F9-5C41-48A4-85BC-FD7E307BF7D8,Blood Derived Normal,Illumina HiSeq,ab0a625b-6478-4d76-8b3e-b3e479e4242e,Breast,58,1EE2800D-4897-4990-B292-F7F8A04EEB6B,E52DD335-3B9A-4E3E-BA2E-F125611ECD09,TCGA-EW-A1P8-10A-01D-A314-09,GRCh37-lite,TCGA-EW-A1P8,TCGA-BRCA,239,s5956,Washington University School of Medicine,University of Miami,United States,NO,T2,N3b,Infiltrating Ductal Carcinoma,Stage IIIC
13722.58cfa830e4b0c9d6adf6bd6c,58cfa830e4b0c9d6adf6bd6c,TCGA-AA-A00R-10A-01D-A126-10_Illumina.filtered.,WGS,TCGA-AA-A00R-10A-01D-A126-10_Illumina,TCGA-AA-A00R-10A-01D-A126-10_Illumina.bam,44.4,1.73,0.08,58cfa830e4b0c9d6adf6bd6c,TCGA-AA-A00R-10A-01D-A126-10_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A00R-10A,CA22EDD4-EB7C-4677-84AA-6F0354459A19,Blood Derived Normal,Illumina HiSeq,9a4caa15-bfd6-497d-8a8a-515828a6a3ca,Colorectal,64,610F87EF-BAC9-4B0F-BE44-A61B3FBBCBEF,5E84FC1E-F5D1-4CFA-B23B-8E826F8A9EF5,TCGA-AA-A00R-10A-01D-A126-10,NCBI36_BCM_variant,TCGA-AA-A00R,TCGA-COAD,NA,s13673,Baylor College of Medicine,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa83ce4b0c9d6adf730f8,58cfa83ce4b0c9d6adf730f8,ac09128a46bbc02f6489288f88dbbe55.filtered.,WGS,ac09128a46bbc02f6489288f88dbbe55,ac09128a46bbc02f6489288f88dbbe55.bam,24.02,NA,0.08,58cfa83ce4b0c9d6adf730f8,ac09128a46bbc02f6489288f88dbbe55.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-N1-A6IA-11A,8F4C042C-FBE3-4D0C-B2BD-695BC37483F5,Solid Tissue Normal,HiSeq X Ten,2a76085f-4b9f-4793-8d87-527ddca16ab6,Mesenchymal,41,507C77BC-2F03-46F0-92A7-F2B5B29A2EA3,29F71321-1CE9-42D2-8923-7528A4BFF739,TCGA-N1-A6IA-11A-11D-A32I-09,GRCh37-lite,TCGA-N1-A6IA,TCGA-SARC,NA,s2462,Washington University School of Medicine,Montefiore Medical Center,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6c154,58cfa830e4b0c9d6adf6c154,TCGA-AB-2970-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2970-11A-01D-0739-09_whole,TCGA-AB-2970-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6c154,TCGA-AB-2970-11A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2970-11A,088C2E4E-FC4E-4252-84ED-E3CA2C401958,Solid Tissue Normal,Illumina GA,9732df1c-1297-4584-ab33-65ef514d5452,Blood,34,11AE5258-0D63-47DF-B450-3F7E5ECBB6A6,D0983A5D-CB05-4B25-8053-631D52627B28,TCGA-AB-2970-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2970,TCGA-LAML,305,s7234,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a62c,58cfa82de4b0c9d6adf6a62c,53545c501f1b20afd03278ba918fbcf2.filtered.,WGS,53545c501f1b20afd03278ba918fbcf2,53545c501f1b20afd03278ba918fbcf2.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a62c,53545c501f1b20afd03278ba918fbcf2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2967-03A,9C022254-F9F7-4C61-BE48-48C60A92448E,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,483dd680-2e65-497c-a182-4a51dd4a0544,Blood,58,CCB851A6-72CC-4F0A-9759-7F493CBF488C,39327988-D56B-4085-8796-0445E9387509,TCGA-AB-2967-03A-01D-0742-05,GRCh37-lite,TCGA-AB-2967,TCGA-LAML,NA,s7014,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a4fe,58cfa82de4b0c9d6adf6a4fe,305608c6dd9b31358a9837c9f0da7c16.filtered.,WGS,305608c6dd9b31358a9837c9f0da7c16,305608c6dd9b31358a9837c9f0da7c16.bam,27.31,NA,0.08,58cfa82de4b0c9d6adf6a4fe,305608c6dd9b31358a9837c9f0da7c16.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2PK-10A,0809BA8B-4AB6-4F43-934C-C1CCBC014A7E,Blood Derived Normal,Illumina HiSeq,fb7abe42-2f5a-4290-9765-595b6bc19069,Cervix,43,8AC65E67-E498-4771-B362-A76C57BB5895,607F3F40-63E5-4182-B77B-2A2B11991004,TCGA-EK-A2PK-10A-01D-A18J-09,GRCh37-lite,TCGA-EK-A2PK,TCGA-CESC,NA,s1509,Washington University School of Medicine,Gynecologic Oncology Group,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa83ce4b0c9d6adf7314a,58cfa83ce4b0c9d6adf7314a,b0309a87a1a7399bda55bc2b952f82aa.filtered.,WGS,b0309a87a1a7399bda55bc2b952f82aa,b0309a87a1a7399bda55bc2b952f82aa.bam,38.96,1.89,0.08,58cfa83ce4b0c9d6adf7314a,b0309a87a1a7399bda55bc2b952f82aa.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LF-10A,748E38B1-2EAD-4A0A-8881-D640617B856B,Blood Derived Normal,Illumina HiSeq,13237b6b-b46f-447d-8767-de4a8d0cbf55,Uterus,82,58B87EF2-914A-4F84-A461-E81394821AC4,1D931D9E-37A8-401F-89CF-E621CE8D56A8,TCGA-AP-A0LF-10A-01D-A122-09,GRCh37-lite,TCGA-AP-A0LF,TCGA-UCEC,NA,s4397,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b522,58cfa82fe4b0c9d6adf6b522,TCGA-29-1704-02A-01D-0926-12_Illumina.filtered.,WGS,TCGA-29-1704-02A-01D-0926-12_Illumina,TCGA-29-1704-02A-01D-0926-12_Illumina.bam,100,1.9,0.14,58cfa82fe4b0c9d6adf6b522,TCGA-29-1704-02A-01D-0926-12_Illumina.bam,Alive,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-29-1704-02A,8E7F1C74-7CB3-43C0-B07C-BF69B780053F,Recurrent Tumor,Illumina HiSeq,5096c5f8-0949-4fba-b265-2bb2a87a9cea,Ovary,61,81E2FBF0-5809-4832-A6D5-75AEBA6F0D81,FFCF9262-42AB-4874-9874-D2AF7D33490B,TCGA-29-1704-02A-01D-0926-12,NCBI36_BCM_variant,TCGA-29-1704,TCGA-OV,NA,s17345,Baylor College of Medicine,Duke,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6c158,58cfa830e4b0c9d6adf6c158,TCGA-AB-2970-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2970-03A-01D-0739-09_whole,TCGA-AB-2970-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6c158,TCGA-AB-2970-03A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2970-03A,088C2E4E-FC4E-4252-84ED-E3CA2C401958,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,64bc5114-6e38-4dc7-b54b-47dae02ba515,Blood,34,84D08806-F569-4DED-99AD-A1749DE7018A,8ACE649F-6C0A-47A4-9EBB-081FD6F8A025,TCGA-AB-2970-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2970,TCGA-LAML,305,s7114,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a6f2,58cfa82de4b0c9d6adf6a6f2,99a359d4fd54a84e0a24c48144fdcea0.filtered.,WGS,99a359d4fd54a84e0a24c48144fdcea0,99a359d4fd54a84e0a24c48144fdcea0.bam,2.97,1.9,0.15,58cfa82de4b0c9d6adf6a6f2,99a359d4fd54a84e0a24c48144fdcea0.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0890-10A,EE0A4A13-613E-4C5D-96C3-8083A013702D,Blood Derived Normal,Illumina GA,0c89033c-66bc-491a-b285-5528f579bcd6,Ovary,56,5495F287-C30D-4770-B073-5ABE03ED4FFF,25B82AC7-6882-4187-A7A7-A195E42B0B63,TCGA-13-0890-10A-01D-0447-09,GRCh37-lite,TCGA-13-0890,TCGA-OV,NA,s18017,Washington University School of Medicine,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a4ca,58cfa82de4b0c9d6adf6a4ca,36d3e07abb553dbd01a91e8a1d6e6e6f.filtered.,WGS,36d3e07abb553dbd01a91e8a1d6e6e6f,36d3e07abb553dbd01a91e8a1d6e6e6f.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a4ca,36d3e07abb553dbd01a91e8a1d6e6e6f.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2998-11A,BA9A95CF-44CE-4126-BA21-4970DFA12593,Solid Tissue Normal,Illumina GA,d251898a-fb20-4a77-bcc6-4b0f0a3c588e,Blood,68,55A3EF1A-E2B8-46A4-9164-46A5E194AB6D,86091AFE-5087-48C5-8511-ED4320DF0D01,TCGA-AB-2998-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2998,TCGA-LAML,31,s7058,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72e94,58cfa83ce4b0c9d6adf72e94,ca0a24f17277c17abc77cfba28df3a4a.filtered.,WGS,ca0a24f17277c17abc77cfba28df3a4a,ca0a24f17277c17abc77cfba28df3a4a.bam,4.74,NA,0.07,58cfa83ce4b0c9d6adf72e94,ca0a24f17277c17abc77cfba28df3a4a.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-HB-A43Z-10A,9C9B53E5-CDBE-4510-A839-4A3B5039681B,Blood Derived Normal,Illumina HiSeq,f8f48a00-573e-401b-bad7-110e689a2b1d,Mesenchymal,58,8BD885ED-F857-4990-A246-A3E3FA845C04,33AC805D-038D-4238-8F33-54634F71015E,TCGA-HB-A43Z-10A-01D-A24N-09,GRCh37-lite,TCGA-HB-A43Z,TCGA-SARC,NA,s2467,Washington University School of Medicine,University of North Carolina,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a605,58cfa82de4b0c9d6adf6a605,690abaeb2cb158cb141d3f5315e2ef25.filtered.,WGS,690abaeb2cb158cb141d3f5315e2ef25,690abaeb2cb158cb141d3f5315e2ef25.bam,15.46,1.82,0.07,58cfa82de4b0c9d6adf6a605,690abaeb2cb158cb141d3f5315e2ef25.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TG-10A,13F31BCB-BEFD-4ED2-ADC0-DC9E9CE52B75,Blood Derived Normal,Illumina HiSeq,de8d8e35-070b-47f4-a78d-8d239ff9828f,Uterus,60,0762739C-25E9-48FB-BF71-4774FF5A6655,1770B780-E104-4AC4-8F38-C0E9A5EC6B27,TCGA-BS-A0TG-10A-01D-A10B-09,GRCh37-lite,TCGA-BS-A0TG,TCGA-UCEC,NA,s4984,Washington University School of Medicine,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a4b0,58cfa82de4b0c9d6adf6a4b0,195004977c13d70e1a42ad2ef9b19fa4.filtered.,WGS,195004977c13d70e1a42ad2ef9b19fa4,195004977c13d70e1a42ad2ef9b19fa4.bam,42.36,1.98,0.09,58cfa82de4b0c9d6adf6a4b0,195004977c13d70e1a42ad2ef9b19fa4.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-D8-A27F-10A,1549DC64-3DAB-43FC-96E9-B07D520957E1,Blood Derived Normal,Illumina HiSeq,5e608249-2680-4ecf-ba66-89998d2d6a1d,Breast,40,80585D9D-5A78-450B-8830-551F1B4819C6,A070D518-B1FE-4505-86B5-FC08201A4B61,TCGA-D8-A27F-10A-01D-A16D-09,GRCh37-lite,TCGA-D8-A27F,TCGA-BRCA,NA,s5787,Washington University School of Medicine,Greater Poland Cancer Center,Poland,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6b11c,58cfa82ee4b0c9d6adf6b11c,TCGA-13-0723-10B-01D-0447-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-13-0723-10B-01D-0447-09_IlluminaGA-DNASeq_whole,TCGA-13-0723-10B-01D-0447-09_IlluminaGA-DNASeq_whole.bam,0,1.9,0.19,58cfa82ee4b0c9d6adf6b11c,TCGA-13-0723-10B-01D-0447-09_IlluminaGA-DNASeq_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0723-10B,FF530F28-0EC0-4494-BB54-44BB055BAE1C,Blood Derived Normal,Illumina GA,533225b4-0006-446b-868a-beb80d8a6a84,Ovary,63,59C54866-C3D9-467E-830F-4D6183B005B1,02CB8979-C5FF-4751-9D40-9B2FDBFB8A9B,TCGA-13-0723-10B-01D-0447-09,NCBI36_WUGSC_variant,TCGA-13-0723,TCGA-OV,1204,s18089,Washington University School of Medicine,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf72eea,58cfa83ce4b0c9d6adf72eea,c418efb9913b78e45546dfb361a65778.filtered.,WGS,c418efb9913b78e45546dfb361a65778,c418efb9913b78e45546dfb361a65778.bam,15.02,NA,0.08,58cfa83ce4b0c9d6adf72eea,c418efb9913b78e45546dfb361a65778.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-GM-A2DF-10C,D6F7AFC0-1558-43AD-ACB1-2B5311ED2264,Blood Derived Normal,Illumina HiSeq,26743711-c60e-43a7-899e-28535b3d3c27,Breast,53,66BB20B3-DEBB-4034-8E49-221C75AE7D22,12CA0B20-2F39-43DF-A572-28F4069502DE,TCGA-GM-A2DF-10C-01D-A17W-09,GRCh37-lite,TCGA-GM-A2DF,TCGA-BRCA,NA,s6609,Washington University School of Medicine,MD Anderson,United States,NO,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa83ce4b0c9d6adf72fca,58cfa83ce4b0c9d6adf72fca,a80cc7c2ac01d9fdff7f0a89dfa1c6c7.filtered.,WGS,a80cc7c2ac01d9fdff7f0a89dfa1c6c7,a80cc7c2ac01d9fdff7f0a89dfa1c6c7.bam,73.23,NA,0.08,58cfa83ce4b0c9d6adf72fca,a80cc7c2ac01d9fdff7f0a89dfa1c6c7.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-FX-A48G-10A,12BFD446-2EE5-4664-A492-C023D134F60F,Blood Derived Normal,Illumina HiSeq,9c37fe31-ffd5-407d-922a-eb2db1b55e88,Mesenchymal,56,6CA0E2AD-D357-454E-B059-5288662C4BF8,BF6CBA4A-F118-406F-A167-4D41B9CF209A,TCGA-FX-A48G-10A-01D-A24N-09,GRCh37-lite,TCGA-FX-A48G,TCGA-SARC,NA,s2459,Washington University School of Medicine,International Genomics Consortium,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a630,58cfa82de4b0c9d6adf6a630,75ee291068e5b81083484950ce18b4d8.filtered.,WGS,75ee291068e5b81083484950ce18b4d8,75ee291068e5b81083484950ce18b4d8.bam,21.82,2,0.08,58cfa82de4b0c9d6adf6a630,75ee291068e5b81083484950ce18b4d8.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A18U-11A,233B02F3-C4F0-4A67-9DB5-E68D5CDACCB6,Solid Tissue Normal,Illumina HiSeq,66d1645c-a6d2-4a4f-9150-78bd1f576ae2,Breast,72,0B290880-D67C-42B4-AA57-AFD3C3D09518,CC233ED9-C88F-4845-A458-8BFFC7EAF403,TCGA-BH-A18U-11A-23D-A19H-09,GRCh37-lite,TCGA-BH-A18U,TCGA-BRCA,1563,s5791,Washington University School of Medicine,University of Pittsburgh,None,NO,T2,N2a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82de4b0c9d6adf6a460,58cfa82de4b0c9d6adf6a460,456b3eac20e712d691d7660394a07598.filtered.,WGS,456b3eac20e712d691d7660394a07598,456b3eac20e712d691d7660394a07598.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a460,456b3eac20e712d691d7660394a07598.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2985-03A,2CA0C154-C4FB-4B6D-845F-F2A5A4CC2416,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,17d2f07e-10c4-460c-a21c-43c5bf149927,Blood,81,CED7EF84-17D9-43EC-BB99-98D9D894F9E9,448EB0B1-916C-4A71-A0AF-926C3935405B,TCGA-AB-2985-03A-01D-0742-05,GRCh37-lite,TCGA-AB-2985,TCGA-LAML,273,s7012,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a5da,58cfa82de4b0c9d6adf6a5da,72037429d860f22e2662003e14708cfe.filtered.,WGS,72037429d860f22e2662003e14708cfe,72037429d860f22e2662003e14708cfe.bam,9.19,NA,0.08,58cfa82de4b0c9d6adf6a5da,72037429d860f22e2662003e14708cfe.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0I1-10A,5DD423E8-FEAA-4568-A750-500948C41D6C,Blood Derived Normal,Illumina HiSeq,ad8ec5b0-99a1-493d-bd8d-9bb358f87991,Breast,73,59205671-D3D4-40B2-85C1-D9EABFCA089D,82B4B870-3CC6-429F-BB9A-D53757437517,TCGA-B6-A0I1-10A-01D-A21Q-09,GRCh37-lite,TCGA-B6-A0I1,TCGA-BRCA,2361,s5793,Washington University School of Medicine,Duke,United States,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a593,58cfa82de4b0c9d6adf6a593,5f23a57e0e5180bd231904f1597b6cc5.filtered.,WGS,5f23a57e0e5180bd231904f1597b6cc5,5f23a57e0e5180bd231904f1597b6cc5.bam,29.22,1.75,0.07,58cfa82de4b0c9d6adf6a593,5f23a57e0e5180bd231904f1597b6cc5.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LI-10A,E1E8DC66-467C-48A5-BE56-3DB4F665B9F1,Blood Derived Normal,Illumina HiSeq,9ec49fe2-a8cf-4a03-9c1c-86881673257a,Uterus,67,4B47A13D-1E13-47F0-AD67-6CB0AD02E3B1,6E370331-AED2-4295-B955-2A9E3E146B7F,TCGA-AP-A0LI-10A-01D-A066-09,GRCh37-lite,TCGA-AP-A0LI,TCGA-UCEC,NA,s4237,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a6ea,58cfa82de4b0c9d6adf6a6ea,97d6377295cd0817733cb7c43c4ada7a.filtered.,WGS,97d6377295cd0817733cb7c43c4ada7a,97d6377295cd0817733cb7c43c4ada7a.bam,44.49,1.93,0.08,58cfa82de4b0c9d6adf6a6ea,97d6377295cd0817733cb7c43c4ada7a.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A18R-11A,F6E1EC78-5AD9-4879-9B7E-262D17B166AD,Solid Tissue Normal,Illumina HiSeq,6d0781dd-0e6b-44b9-bdba-469778ae2a04,Breast,50,3196C5F3-9227-4A9D-B87A-3E1F680A768C,2DC03379-AF51-45DE-8EE1-78687DA05313,TCGA-BH-A18R-11A-42D-A19H-09,GRCh37-lite,TCGA-BH-A18R,TCGA-BRCA,1142,s5486,Washington University School of Medicine,University of Pittsburgh,None,NO,T2b,N1,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa83ce4b0c9d6adf73151,58cfa83ce4b0c9d6adf73151,d4504d39c63605431fff1046c6900dda.filtered.,WGS,d4504d39c63605431fff1046c6900dda,d4504d39c63605431fff1046c6900dda.bam,16.86,1.17,0.08,58cfa83ce4b0c9d6adf73151,d4504d39c63605431fff1046c6900dda.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A1M8-10A,110CD100-5730-4873-9FAB-2AE6C8732062,Blood Derived Normal,Illumina HiSeq,f9f50bfe-4bce-47cd-8371-5aa09e5b1977,Cervix,43,D551F7B2-6778-4983-A8BE-D101EB7E5C26,19C1A21B-70EF-4A13-9C82-D4DF73E144E5,TCGA-C5-A1M8-10A-01D-A200-09,GRCh37-lite,TCGA-C5-A1M8,TCGA-CESC,NA,s1505,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,T1b,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b8e0,58cfa82fe4b0c9d6adf6b8e0,TCGA-A7-A0CE-01A-11D-A12L-09_IlluminaGA-DNASeq_whole_1.filtered.,WGS,TCGA-A7-A0CE-01A-11D-A12L-09_IlluminaGA-DNASeq_whole_1,TCGA-A7-A0CE-01A-11D-A12L-09_IlluminaGA-DNASeq_whole_1.bam,40.39,1.89,0.07,58cfa82fe4b0c9d6adf6b8e0,TCGA-A7-A0CE-01A-11D-A12L-09_IlluminaGA-DNASeq_whole_1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A7-A0CE-01A,9D95A65B-E41D-4F93-92D4-99DCE29FF40D,Primary Tumor,Illumina HiSeq,d744c7c6-690c-4f5e-968e-532936b3696a,Breast,57,9DC315CE-3B76-4754-B103-2C2580CDE4AB,7B08E810-F3C9-4155-AC11-F45A3A4F8B41,TCGA-A7-A0CE-01A-11D-A12L-09,GRCh37-lite,TCGA-A7-A0CE,TCGA-BRCA,NA,s5490,Washington University School of Medicine,Christiana Healthcare,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a683,58cfa82de4b0c9d6adf6a683,692c3778a86ca9872957c9a79f3cb1f1.filtered.,WGS,692c3778a86ca9872957c9a79f3cb1f1,692c3778a86ca9872957c9a79f3cb1f1.bam,54.86,1.92,0.09,58cfa82de4b0c9d6adf6a683,692c3778a86ca9872957c9a79f3cb1f1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AN-A04D-10A,49717F75-0F2D-4E1C-9A12-F1CD7877B80A,Blood Derived Normal,Illumina HiSeq,4a1b29e7-a50b-4f6a-a8a5-0e1727c4647e,Breast,58,D3AACCDA-91D8-42D4-A1E6-1720F92214EC,03FE1DF5-EC6A-40E7-B609-A749B1AAFAD9,TCGA-AN-A04D-10A-01D-A314-09,GRCh37-lite,TCGA-AN-A04D,TCGA-BRCA,NA,s5482,Washington University School of Medicine,Cureline,None,NO,T2,N1,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa83ce4b0c9d6adf7306c,58cfa83ce4b0c9d6adf7306c,c1103b8b310e78d73fb7962663f7dc6a.filtered.,WGS,c1103b8b310e78d73fb7962663f7dc6a,c1103b8b310e78d73fb7962663f7dc6a.bam,0,1.9,0.19,58cfa83ce4b0c9d6adf7306c,c1103b8b310e78d73fb7962663f7dc6a.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0723-10B,FF530F28-0EC0-4494-BB54-44BB055BAE1C,Blood Derived Normal,Illumina GA,c96ae68a-3845-4b55-b797-064acafd5b06,Ovary,63,59C54866-C3D9-467E-830F-4D6183B005B1,02CB8979-C5FF-4751-9D40-9B2FDBFB8A9B,TCGA-13-0723-10B-01D-0447-09,GRCh37-lite,TCGA-13-0723,TCGA-OV,1204,s17586,Washington University School of Medicine,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf72f34,58cfa83ce4b0c9d6adf72f34,b25a9036b8fc3d068adceca9887e9a8f.filtered.,WGS,b25a9036b8fc3d068adceca9887e9a8f,b25a9036b8fc3d068adceca9887e9a8f.bam,85.7,1.92,0.09,58cfa83ce4b0c9d6adf72f34,b25a9036b8fc3d068adceca9887e9a8f.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A7-A26G-10A,5ED024E8-D05E-4C65-9441-EDA9930CCC82,Blood Derived Normal,Illumina HiSeq,b1afd1ab-e46c-4616-8f8e-70509f3f1c32,Breast,50,227A21EF-33D5-4981-9F0F-B48C75B090C8,337F54B9-3DC4-47CD-9E63-075EDD482454,TCGA-A7-A26G-10A-01D-A314-09,GRCh37-lite,TCGA-A7-A26G,TCGA-BRCA,NA,s5778,Washington University School of Medicine,Christiana Healthcare,United States,NO,T2,N0 (i+),Other  specify,Stage IIA
13722.58cfa83ce4b0c9d6adf72eee,58cfa83ce4b0c9d6adf72eee,ab46e9105ac4921cb2875cf654f76114.filtered.,WGS,ab46e9105ac4921cb2875cf654f76114,ab46e9105ac4921cb2875cf654f76114.bam,19.93,1.98,0.08,58cfa83ce4b0c9d6adf72eee,ab46e9105ac4921cb2875cf654f76114.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A156-10A,F05D314C-5EC5-4E2A-B785-9A702716F111,Blood Derived Normal,Illumina HiSeq,d87cfc01-42b6-4dc0-9403-d2daee055209,Breast,61,C1010EA5-926A-42AF-8E7A-B22BB368CE1B,F4F71B7E-B3E2-4573-8F78-EC9FC7F2D6E0,TCGA-E2-A156-10A-01D-A314-09,GRCh37-lite,TCGA-E2-A156,TCGA-BRCA,NA,s6748,Washington University School of Medicine,Roswell Park,None,NO,T1c,N0,Infiltrating Ductal Carcinoma,Stage I
13722.58cfa82de4b0c9d6adf6a5f5,58cfa82de4b0c9d6adf6a5f5,51fb402ae50ce6ad975504649caad6ce.filtered.,WGS,51fb402ae50ce6ad975504649caad6ce,51fb402ae50ce6ad975504649caad6ce.bam,14,NA,0.08,58cfa82de4b0c9d6adf6a5f5,51fb402ae50ce6ad975504649caad6ce.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A3KC-10A,2D29A4AC-98E7-4663-9DD6-5681BC32AC2E,Blood Derived Normal,Illumina HiSeq,0dee69dc-a2f3-404c-b1d3-0155e3df4b39,Breast,55,4F91387A-8561-4A68-A814-BE41B4D8E6A2,ABBA0FE4-8C3B-4B8D-9B68-36708BA3A4EF,TCGA-A2-A3KC-10A-01D-A20S-09,GRCh37-lite,TCGA-A2-A3KC,TCGA-BRCA,NA,s5948,Washington University School of Medicine,Walter Reed,United States,NO,T2,N1a,Infiltrating Lobular Carcinoma,Stage IIB
13722.58cfa83ce4b0c9d6adf73100,58cfa83ce4b0c9d6adf73100,e3a0c3d9d276b4fdb43b9746cfe85567.filtered.,WGS,e3a0c3d9d276b4fdb43b9746cfe85567,e3a0c3d9d276b4fdb43b9746cfe85567.bam,18.64,2.08,0.08,58cfa83ce4b0c9d6adf73100,e3a0c3d9d276b4fdb43b9746cfe85567.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0H6-10A,AEB6A3A6-B57A-4C53-90E6-E833777DD2A1,Blood Derived Normal,Illumina HiSeq,9327706b-160e-4773-95f1-a875f0a92f60,Breast,82,9269A6CA-6D25-4815-8BB2-6AB526262266,E38A0342-1A02-478F-B61E-435D11BE797E,TCGA-BH-A0H6-10A-01D-A314-09,GRCh37-lite,TCGA-BH-A0H6,TCGA-BRCA,NA,s5624,Washington University School of Medicine,University of Pittsburgh,None,NO,T1b,NX,Infiltrating Ductal Carcinoma,Stage I
13722.58cfa83ce4b0c9d6adf7316c,58cfa83ce4b0c9d6adf7316c,be716873eee872e58e836ff261891669.filtered.,WGS,be716873eee872e58e836ff261891669,be716873eee872e58e836ff261891669.bam,29,2.13,0.08,58cfa83ce4b0c9d6adf7316c,be716873eee872e58e836ff261891669.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-DS-A0VL-10A,DFD30F94-19E3-4838-95DF-14A3763419AF,Blood Derived Normal,Illumina HiSeq,cd6ccfff-e6b2-4bbe-bcf7-290e0e3f80cf,Cervix,25,A2C63996-6951-47B8-BBB5-A04C8A66EEEC,AF0CBA79-1A57-4EE1-B997-85C0870DE269,TCGA-DS-A0VL-10A-01D-A200-09,GRCh37-lite,TCGA-DS-A0VL,TCGA-CESC,NA,s1504,Washington University School of Medicine,Cedars Sinai,United States,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6c2c2,58cfa830e4b0c9d6adf6c2c2,TCGA-AB-2989-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2989-03A-01D-0739-09_whole,TCGA-AB-2989-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6c2c2,TCGA-AB-2989-03A-01D-0739-09_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2989-03A,E2E610CE-31C3-4FC0-917D-92D48FEB600A,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,9b1c95dd-7c4e-4093-bc88-6220a66c978d,Blood,29,04B6F323-9F46-4DE1-9D8F-BB6853D8C93A,B385B03F-4EE1-4BE9-9291-9B5FDFD66384,TCGA-AB-2989-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2989,TCGA-LAML,365,s7154,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a454,58cfa82de4b0c9d6adf6a454,01aa8d222c93eac50081544889046aeb.filtered.,WGS,01aa8d222c93eac50081544889046aeb,01aa8d222c93eac50081544889046aeb.bam,9.4,1.88,0.08,58cfa82de4b0c9d6adf6a454,01aa8d222c93eac50081544889046aeb.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A075-10B,7861A5F2-8910-4BCB-9C34-F79C5ACD6E21,Blood Derived Normal,Illumina HiSeq,8d13d716-2db8-42e8-9c7a-42fce5c7dfc6,Breast,42,D123AD55-3559-4185-87C1-A16235950BFC,6D1294B5-4FBB-4F31-8D45-E8540BE8452D,TCGA-A8-A075-10B-01D-A19H-09,GRCh37-lite,TCGA-A8-A075,TCGA-BRCA,NA,s6755,Washington University School of Medicine,Indivumed,Germany,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa82de4b0c9d6adf6a5f4,58cfa82de4b0c9d6adf6a5f4,6e6df6d5127aa75119a983f6e9554092.filtered.,WGS,6e6df6d5127aa75119a983f6e9554092,6e6df6d5127aa75119a983f6e9554092.bam,18.08,1.86,0.08,58cfa82de4b0c9d6adf6a5f4,6e6df6d5127aa75119a983f6e9554092.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0RE-10A,08DA7C4C-3067-4BCF-9D7A-78566DF72E69,Blood Derived Normal,Illumina HiSeq,fb69f79f-0d25-4867-8a83-764167ccd5e0,Breast,61,B515904E-B78D-41BB-A960-D8B26A384B16,132C4EC7-509C-43C3-BE90-3A95170E31D5,TCGA-B6-A0RE-10A-01D-A128-09,GRCh37-lite,TCGA-B6-A0RE,TCGA-BRCA,NA,s6266,Washington University School of Medicine,Duke,United States,NO,TX,N0 (i-),Infiltrating Ductal Carcinoma,Stage X
13722.58cfa830e4b0c9d6adf6be00,58cfa830e4b0c9d6adf6be00,TCGA-AB-2966-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2966-03A-01D-0739-09_whole,TCGA-AB-2966-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6be00,TCGA-AB-2966-03A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2966-03A,B1C32911-5CA8-4B77-8063-A97C30A3A348,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,e8fc1fb1-2589-4e3e-8aba-249b2c2d6b72,Blood,57,DCC4F5CD-032E-4129-92A9-D0A47EFD12D5,EA13B395-DADE-4E11-BEDF-A1F36BCCFAB7,TCGA-AB-2966-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2966,TCGA-LAML,854,s7148,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a5aa,58cfa82de4b0c9d6adf6a5aa,45d8009fe017f814c4cd066fa993ed8f.filtered.,WGS,45d8009fe017f814c4cd066fa993ed8f,45d8009fe017f814c4cd066fa993ed8f.bam,7.49,1.95,0.08,58cfa82de4b0c9d6adf6a5aa,45d8009fe017f814c4cd066fa993ed8f.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BK-A0CC-10A,2B865F8C-539F-4CB2-8F08-41709E9511E5,Blood Derived Normal,Illumina HiSeq,ee7e7564-830f-4251-b486-f81a173b9655,Uterus,69,78A39052-8E93-48B6-8BF3-9E0F69FA240F,5A352077-3E2F-45EC-A0D1-A3380D8156C8,TCGA-BK-A0CC-10A-01D-A013-09,GRCh37-lite,TCGA-BK-A0CC,TCGA-UCEC,NA,s4582,Washington University School of Medicine,Christiana Healthcare,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf72e4e,58cfa83ce4b0c9d6adf72e4e,aac500043338d17345f6c88291afc16f.filtered.,WGS,aac500043338d17345f6c88291afc16f,aac500043338d17345f6c88291afc16f.bam,31.83,1.72,0.07,58cfa83ce4b0c9d6adf72e4e,aac500043338d17345f6c88291afc16f.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LH-10A,7DCE4215-01F6-43E9-9378-9E22C26C23A2,Blood Derived Normal,Illumina HiSeq,8cb57b82-ea91-46b2-93fc-5891637a86fd,Uterus,60,6E5515FB-6252-4703-B7F4-B57E38121C5B,31AB7C18-4F67-4852-952A-A7CE8EDE2A30,TCGA-AP-A0LH-10A-01D-A066-09,GRCh37-lite,TCGA-AP-A0LH,TCGA-UCEC,1106,s4396,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Mixed serous and endometrioid,Not available
13722.58cfa83ce4b0c9d6adf7316a,58cfa83ce4b0c9d6adf7316a,d9475b3941b070ab594bf87f35c3bb64.filtered.,WGS,d9475b3941b070ab594bf87f35c3bb64,d9475b3941b070ab594bf87f35c3bb64.bam,13.76,2,0.08,58cfa83ce4b0c9d6adf7316a,d9475b3941b070ab594bf87f35c3bb64.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-DI-A1NN-11A,944A102F-3475-45AA-9E30-4B92D1449F00,Solid Tissue Normal,Illumina HiSeq,bbac625f-8abc-4371-81df-955aac7e6f64,Uterus,63,553FAB81-FDE1-4F15-8900-1FCEF7C5CD63,7ABFC125-0B77-4A32-98E9-350C6C66A770,TCGA-DI-A1NN-11A-21D-A16D-09,GRCh37-lite,TCGA-DI-A1NN,TCGA-UCEC,NA,s4976,Washington University School of Medicine,MD Anderson,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a55c,58cfa82de4b0c9d6adf6a55c,2b3e58fa7d731b844fe92dfbeb9a597e.filtered.,WGS,2b3e58fa7d731b844fe92dfbeb9a597e,2b3e58fa7d731b844fe92dfbeb9a597e.bam,38.4,1.33,0.07,58cfa82de4b0c9d6adf6a55c,2b3e58fa7d731b844fe92dfbeb9a597e.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0DT-11A,74F31744-0AED-4633-BEEC-4E203315F0B7,Solid Tissue Normal,Illumina HiSeq,fafbdaae-4f36-4715-85b5-8cc9be96343c,Breast,41,A9CE148B-AD26-4257-8F5C-295FD2DCB1D7,03C623E2-04D7-43EA-ADE1-5F5A619CD5C8,TCGA-BH-A0DT-11A-12D-A12B-09,GRCh37-lite,TCGA-BH-A0DT,TCGA-BRCA,NA,s5475,Washington University School of Medicine,University of Pittsburgh,None,NO,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa83ce4b0c9d6adf73204,58cfa83ce4b0c9d6adf73204,e1a5abee600fb4b0041613970a420df5.filtered.,WGS,e1a5abee600fb4b0041613970a420df5,e1a5abee600fb4b0041613970a420df5.bam,15.35,1.9,0.07,58cfa83ce4b0c9d6adf73204,e1a5abee600fb4b0041613970a420df5.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GA-10A,71FED998-8FAC-4E6B-B38A-22C83E05E958,Blood Derived Normal,Illumina HiSeq,539ccf4d-b32a-4206-9646-db8e092ecd9b,Uterus,67,FAE7E73A-D9EF-4A6F-807E-A46A46C29179,E2C40A5B-5DE4-415C-87FF-8573B83E8AAC,TCGA-A5-A0GA-10A-01D-A066-09,GRCh37-lite,TCGA-A5-A0GA,TCGA-UCEC,543,s4764,Washington University School of Medicine,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf7311c,58cfa83ce4b0c9d6adf7311c,df21c3f858ffb1310c3ad68d28d70e2b.filtered.,WGS,df21c3f858ffb1310c3ad68d28d70e2b,df21c3f858ffb1310c3ad68d28d70e2b.bam,74.52,1.93,0.08,58cfa83ce4b0c9d6adf7311c,df21c3f858ffb1310c3ad68d28d70e2b.bam,Alive,FEMALE,Not available,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-EO-A1Y8-10A,DE4E13C8-5AD0-46D2-AE54-B9CA22B939D8,Blood Derived Normal,Illumina HiSeq,d6c3a198-7c08-4a97-937e-d3245e8ee900,Uterus,87,AD2CE7DA-C43A-4D39-9710-0C95371E3D7C,B2EDFB0D-D838-4EB1-9C8B-D39F9FFDC4F5,TCGA-EO-A1Y8-10A-01D-A159-09,GRCh37-lite,TCGA-EO-A1Y8,TCGA-UCEC,NA,s5373,Washington University School of Medicine,University Health Network,Canada,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a490,58cfa82de4b0c9d6adf6a490,1df2bf9cb438141bbe76b4a18e708e91.filtered.,WGS,1df2bf9cb438141bbe76b4a18e708e91,1df2bf9cb438141bbe76b4a18e708e91.bam,23.68,2.05,0.08,58cfa82de4b0c9d6adf6a490,1df2bf9cb438141bbe76b4a18e708e91.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A11G-10A,D2AA7D70-A25F-4A9E-9D52-37E372461824,Blood Derived Normal,Illumina HiSeq,92b1160b-6674-4c07-a4bf-560479bf5567,Uterus,71,4AA60E62-A361-4BEE-AC7E-97CC480C9985,BAC2CF85-BE6D-4D68-91BF-83DAAB5EA3A6,TCGA-B5-A11G-10A-01D-A122-09,GRCh37-lite,TCGA-B5-A11G,TCGA-UCEC,NA,s5188,Washington University School of Medicine,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6c2d4,58cfa830e4b0c9d6adf6c2d4,TCGA-AB-2995-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2995-11A-01D-0739-09_whole,TCGA-AB-2995-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6c2d4,TCGA-AB-2995-11A-01D-0739-09_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2995-11A,EB14339D-FEFA-46C3-99A6-55268384361A,Solid Tissue Normal,Illumina GA,d6e0d24e-dbc6-46de-86f5-d07186dc3dad,Blood,63,530165A5-F73B-43DB-BB77-1F630A5105B8,CE73C6C8-40AB-4A3C-ACD6-C22444DA3567,TCGA-AB-2995-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2995,TCGA-LAML,NA,s7194,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72e90,58cfa83ce4b0c9d6adf72e90,cee1724c461492416edf64ee160c4fc2.filtered.,WGS,cee1724c461492416edf64ee160c4fc2,cee1724c461492416edf64ee160c4fc2.bam,13.06,NA,0.09,58cfa83ce4b0c9d6adf72e90,cee1724c461492416edf64ee160c4fc2.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A3Y0-10A,174850B4-5EC2-462B-A890-89BD1716B3C2,Blood Derived Normal,Illumina HiSeq,2a32c16c-432c-401f-9725-63857230380b,Breast,57,7ECBCA0F-2185-4BFF-9B1C-13BCD82D749D,46E1FD58-C2EA-46EF-BFC9-26D61E7BE608,TCGA-A2-A3Y0-10A-01D-A23C-09,GRCh37-lite,TCGA-A2-A3Y0,TCGA-BRCA,NA,s6608,Washington University School of Medicine,Walter Reed,United States,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa83ce4b0c9d6adf730ec,58cfa83ce4b0c9d6adf730ec,ed89b11f6091381cc2a7656e8a4f9854.filtered.,WGS,ed89b11f6091381cc2a7656e8a4f9854,ed89b11f6091381cc2a7656e8a4f9854.bam,10.85,NA,0.07,58cfa83ce4b0c9d6adf730ec,ed89b11f6091381cc2a7656e8a4f9854.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-WP-A9GB-10A,05D4099F-521A-4DF6-ABAC-F86F84B3AF7F,Blood Derived Normal,HiSeq X Ten,5c94ee60-42c9-4084-a535-b0b68eaad886,Mesenchymal,59,F74D3AB7-359F-4827-AC85-E7004147439A,765FA923-05C1-4FBE-A8DC-BA3C987C84D5,TCGA-WP-A9GB-10A-01D-A37F-09,GRCh37-lite,TCGA-WP-A9GB,TCGA-SARC,275,s2635,Washington University School of Medicine,University of Kansas,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a6c6,58cfa82de4b0c9d6adf6a6c6,8171dcfcf0e0d24686c680765f13cb3d.filtered.,WGS,8171dcfcf0e0d24686c680765f13cb3d,8171dcfcf0e0d24686c680765f13cb3d.bam,19.09,1.95,0.07,58cfa82de4b0c9d6adf6a6c6,8171dcfcf0e0d24686c680765f13cb3d.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A092-10A,38A8B734-9ACC-42F9-B5B7-E51B0DFC6504,Blood Derived Normal,Illumina HiSeq,9b123116-1002-41ca-a335-c49ced491c8b,Breast,48,9B7E6427-B290-43DC-8991-EA77384CDF3C,C9FE2D18-B298-46EA-BA31-A87E42E790CD,TCGA-A8-A092-10A-01D-A19H-09,GRCh37-lite,TCGA-A8-A092,TCGA-BRCA,NA,s5953,Washington University School of Medicine,Indivumed,Germany,NO,T2,N2a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa83ce4b0c9d6adf730f2,58cfa83ce4b0c9d6adf730f2,bf115add392ee3d5d397a139cc5a837b.filtered.,WGS,bf115add392ee3d5d397a139cc5a837b,bf115add392ee3d5d397a139cc5a837b.bam,NA,NA,NA,58cfa83ce4b0c9d6adf730f2,bf115add392ee3d5d397a139cc5a837b.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2970-03A,088C2E4E-FC4E-4252-84ED-E3CA2C401958,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,a3067a64-7161-4ba1-80d2-a51a0883bee1,Blood,34,84D08806-F569-4DED-99AD-A1749DE7018A,2CFF92F5-9D23-44B3-8513-DDA5857DC0C1,TCGA-AB-2970-03A-01D-0741-05,GRCh37-lite,TCGA-AB-2970,TCGA-LAML,305,s7096,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a609,58cfa82de4b0c9d6adf6a609,7652d849b685c386a065309525f742d7.filtered.,WGS,7652d849b685c386a065309525f742d7,7652d849b685c386a065309525f742d7.bam,7.14,1.93,0.08,58cfa82de4b0c9d6adf6a609,7652d849b685c386a065309525f742d7.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A0J1-10A,EC7A9D74-8B3F-4747-8926-1739A016AB2B,Blood Derived Normal,Illumina HiSeq,71b29e81-6847-4a7c-9051-48bb0ea4e4b2,Uterus,80,7249199D-6E4A-4A4A-9F4C-996E9B7E2D20,8623A4A0-5AE3-4A17-9263-1F78DADE3832,TCGA-AX-A0J1-10A-01D-A066-09,GRCh37-lite,TCGA-AX-A0J1,TCGA-UCEC,NA,s4583,Washington University School of Medicine,Gynecologic Oncology Group,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6b1de,58cfa82ee4b0c9d6adf6b1de,TCGA-14-1454-01A-01D-0932-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-14-1454-01A-01D-0932-09_IlluminaGA-DNASeq_whole,TCGA-14-1454-01A-01D-0932-09_IlluminaGA-DNASeq_whole.bam,430.3,1.9,0.16,58cfa82ee4b0c9d6adf6b1de,TCGA-14-1454-01A-01D-0932-09_IlluminaGA-DNASeq_whole.bam,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1454-01A,C2399F5D-DC29-42E9-81F1-1D164D4CC55D,Primary Tumor,Illumina GA,c931c29a-283a-4838-93b6-45123b6db713,Brain,54,C84D5666-F3DD-49D9-8D72-7F594EA189D5,BEBFBF9F-FAB3-4F80-920F-A8942D0835B1,TCGA-14-1454-01A-01D-0932-09,NCBI36_WUGSC_variant,TCGA-14-1454,TCGA-GBM,918,s14104,Washington University School of Medicine,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a700,58cfa82de4b0c9d6adf6a700,9bcdd395d21fe21860b2a4e5833d1d6c.filtered.,WGS,9bcdd395d21fe21860b2a4e5833d1d6c,9bcdd395d21fe21860b2a4e5833d1d6c.bam,35.22,2,0.07,58cfa82de4b0c9d6adf6a700,9bcdd395d21fe21860b2a4e5833d1d6c.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GJ-10A,94817E78-78F5-4556-9394-610DF65605E2,Blood Derived Normal,Illumina HiSeq,6164c1be-27d4-49e1-8b8d-3cc04a0cbd5c,Uterus,44,81C5B859-DB07-4FA5-90D8-B0C36E913743,9BD1F3F1-C0CF-47D3-B25F-0E6DD9A43F0D,TCGA-A5-A0GJ-10A-01D-A325-09,GRCh37-lite,TCGA-A5-A0GJ,TCGA-UCEC,NA,s5380,Washington University School of Medicine,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a4b6,58cfa82de4b0c9d6adf6a4b6,0f6f01b874a9ad317f478405d01a7b78.filtered.,WGS,0f6f01b874a9ad317f478405d01a7b78,0f6f01b874a9ad317f478405d01a7b78.bam,29.43,1.9,0.09,58cfa82de4b0c9d6adf6a4b6,0f6f01b874a9ad317f478405d01a7b78.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-EY-A1GW-10A,F8AC5FD2-11F2-4B3A-A3A6-FF1A6D8E1CAE,Blood Derived Normal,Illumina HiSeq,729a4630-2ce5-4af2-9661-d07eb0b0ab37,Uterus,73,BCF2DE1F-4E6A-4CCD-BD41-4D895FD15DEE,B30EC52B-29C0-46DC-BC39-080D3696CBD8,TCGA-EY-A1GW-10A-01D-A13O-09,GRCh37-lite,TCGA-EY-A1GW,TCGA-UCEC,NA,s4405,Washington University School of Medicine,University of North Carolina,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf72ef2,58cfa83ce4b0c9d6adf72ef2,d9c0f56d19bf2cc626bd331ed68e3b0c.filtered.,WGS,d9c0f56d19bf2cc626bd331ed68e3b0c,d9c0f56d19bf2cc626bd331ed68e3b0c.bam,430.3,1.9,0.16,58cfa83ce4b0c9d6adf72ef2,d9c0f56d19bf2cc626bd331ed68e3b0c.bam,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1454-01A,C2399F5D-DC29-42E9-81F1-1D164D4CC55D,Primary Tumor,Illumina GA,82c66e4c-497d-42aa-941e-0ac018ba7cb6,Brain,54,C84D5666-F3DD-49D9-8D72-7F594EA189D5,BEBFBF9F-FAB3-4F80-920F-A8942D0835B1,TCGA-14-1454-01A-01D-0932-09,GRCh37-lite,TCGA-14-1454,TCGA-GBM,918,s14389,Washington University School of Medicine,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf73140,58cfa83ce4b0c9d6adf73140,b7df79de6780ae94d9bdca8965684247.filtered.,WGS,b7df79de6780ae94d9bdca8965684247,b7df79de6780ae94d9bdca8965684247.bam,35.69,1.84,0.08,58cfa83ce4b0c9d6adf73140,b7df79de6780ae94d9bdca8965684247.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0L8-10A,9AA8C2B4-DB32-4899-BF0C-D578CB175E90,Blood Derived Normal,Illumina HiSeq,99658879-5740-48d9-946c-1a8824ee667e,Uterus,70,6FFE937D-CB2E-49EA-9737-D2619A0EBB01,B16149DD-2602-44C5-9C5D-74E34EE58B74,TCGA-AP-A0L8-10A-01D-A066-09,GRCh37-lite,TCGA-AP-A0L8,TCGA-UCEC,1484,s5181,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a4c4,58cfa82de4b0c9d6adf6a4c4,361e7a513afa7609e295faeb67b6c110.filtered.,WGS,361e7a513afa7609e295faeb67b6c110,361e7a513afa7609e295faeb67b6c110.bam,37.98,1.84,0.09,58cfa82de4b0c9d6adf6a4c4,361e7a513afa7609e295faeb67b6c110.bam,Dead,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A1ML-10A,374F614A-BCD1-4283-AC6F-FC27DDC79987,Blood Derived Normal,Illumina HiSeq,89c8b231-ff58-48a3-9017-7ec06043377d,Cervix,49,49DCA437-04B4-4224-AD9E-C81ABFA2DF0E,EEC629E1-E1C3-4A64-9F06-08C0607F8B90,TCGA-C5-A1ML-10A-01D-A200-09,GRCh37-lite,TCGA-C5-A1ML,TCGA-CESC,636,s1349,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6bc30,58cfa830e4b0c9d6adf6bc30,TCGA-AB-2983-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2983-11A-01D-0739-09_whole,TCGA-AB-2983-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bc30,TCGA-AB-2983-11A-01D-0739-09_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2983-11A,082CA353-A5AE-421F-AE58-098257A1425F,Solid Tissue Normal,Illumina GA,e797a0d2-aa22-49ac-bc43-2f75ec65899b,Blood,45,69C09921-B570-489A-95B4-6CD733E89A05,707D05C9-0DF6-4ED0-91A2-5CB30B3B42B8,TCGA-AB-2983-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2983,TCGA-LAML,335,s7082,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6c1ea,58cfa830e4b0c9d6adf6c1ea,TCGA-AO-A0J6-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-AO-A0J6-01A-11D-A128-09_IlluminaGA-DNASeq_whole,TCGA-AO-A0J6-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam,73.05,2,0.08,58cfa830e4b0c9d6adf6c1ea,TCGA-AO-A0J6-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A0J6-01A,E9F4F373-37A5-48AD-A1A0-B0D47820111A,Primary Tumor,Illumina HiSeq,71b1d18c-e0ab-473a-b4ee-55ebb68cfda8,Breast,61,0C12EA89-EEB4-4865-91EB-10CF75884C21,F69E5057-EDA6-4391-BA9A-AEDBF6B572DA,TCGA-AO-A0J6-01A-11D-A128-09,GRCh37-lite,TCGA-AO-A0J6,TCGA-BRCA,NA,s5798,Washington University School of Medicine,MSKCC,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa83ce4b0c9d6adf7319e,58cfa83ce4b0c9d6adf7319e,a9b7a7f4e30cf25f96128ad25efe72ca.filtered.,WGS,a9b7a7f4e30cf25f96128ad25efe72ca,a9b7a7f4e30cf25f96128ad25efe72ca.bam,NA,NA,NA,58cfa83ce4b0c9d6adf7319e,a9b7a7f4e30cf25f96128ad25efe72ca.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2974-11A,FF7839BB-176E-4483-AC6E-7FAE9F6E2E54,Solid Tissue Normal,Illumina GA,74733a75-bd81-4c98-b6f2-bf760046a386,Blood,67,A4C17541-6F15-4CF2-B204-5770EC91E6C9,D811ED5B-2B58-412C-AA34-2678349BA1F5,TCGA-AB-2974-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2974,TCGA-LAML,92,s7093,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a706,58cfa82de4b0c9d6adf6a706,9d8ce2b76d747b3501ea18ad8f1b4bfb.filtered.,WGS,9d8ce2b76d747b3501ea18ad8f1b4bfb,9d8ce2b76d747b3501ea18ad8f1b4bfb.bam,24.29,NA,0.08,58cfa82de4b0c9d6adf6a706,9d8ce2b76d747b3501ea18ad8f1b4bfb.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-FX-A2QS-11A,2905CBD1-719B-46D9-B8AF-8FE4927BC473,Solid Tissue Normal,Illumina HiSeq,f4156c87-d07e-4172-9f4c-b24105ffb5fa,Mesenchymal,61,C69AC5DB-43EA-4F28-A44A-D4C99DBE5E6F,5B25B7DB-9B62-46DA-BB84-314E9186DA96,TCGA-FX-A2QS-11A-11D-A21Q-09,GRCh37-lite,TCGA-FX-A2QS,TCGA-SARC,NA,s2350,Washington University School of Medicine,International Genomics Consortium,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf7304e,58cfa83ce4b0c9d6adf7304e,a7751c8cfdc93f1d8c593044ee32e902.filtered.,WGS,a7751c8cfdc93f1d8c593044ee32e902,a7751c8cfdc93f1d8c593044ee32e902.bam,42.16,1.98,0.09,58cfa83ce4b0c9d6adf7304e,a7751c8cfdc93f1d8c593044ee32e902.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A18C-10A,66E305CA-8A16-44F0-B837-85E529B7AD55,Blood Derived Normal,Illumina HiSeq,b07a0aa4-0418-4460-86c3-8a8c34314113,Uterus,72,9B300C20-4B43-4832-9746-F0401E0E7DDB,312EF8AA-C9EA-41B5-B3E3-5588E8C606A4,TCGA-BG-A18C-10A-01D-A12J-09,GRCh37-lite,TCGA-BG-A18C,TCGA-UCEC,NA,s4761,Washington University School of Medicine,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b948,58cfa82fe4b0c9d6adf6b948,TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole,TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole.bam,91.2,1.92,0.08,58cfa82fe4b0c9d6adf6b948,TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A04T-01A,B58AD350-5140-4FA8-BC2C-24BCA8395F3A,Primary Tumor,Illumina HiSeq,6dd42df3-896f-418a-9f13-468ac66d69bc,Breast,62,6DD4870F-1EC2-484B-8703-6397D8E67DAA,B752B444-F033-4BE4-9D24-E5E80B4181AF,TCGA-A2-A04T-01A-21D-A128-09,GRCh37-lite,TCGA-A2-A04T,TCGA-BRCA,NA,s5637,Washington University School of Medicine,Walter Reed,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a67a,58cfa82de4b0c9d6adf6a67a,5bb7debe47981e59cd82317bf4ef97fa.filtered.,WGS,5bb7debe47981e59cd82317bf4ef97fa,5bb7debe47981e59cd82317bf4ef97fa.bam,12.57,NA,0.08,58cfa82de4b0c9d6adf6a67a,5bb7debe47981e59cd82317bf4ef97fa.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-AC-A2BK-11A,6FA2A667-9C36-4526-8A58-1975E863A806,Solid Tissue Normal,Illumina HiSeq,0cdbbe0e-0c6f-4320-a72f-e80cf5faeb8d,Breast,78,32A1654E-0650-4D90-98EE-B438B4005DF0,8F640FE4-AA25-444A-95B1-CA7A17BAEB52,TCGA-AC-A2BK-11A-13D-A21Q-09,GRCh37-lite,TCGA-AC-A2BK,TCGA-BRCA,NA,s5483,Washington University School of Medicine,International Genomics Consortium,United States,NO,T2,N2a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa83ce4b0c9d6adf7311a,58cfa83ce4b0c9d6adf7311a,adffab3072f2a40a5ab4e59bb4a40b02.filtered.,WGS,adffab3072f2a40a5ab4e59bb4a40b02,adffab3072f2a40a5ab4e59bb4a40b02.bam,29.91,1.96,0.09,58cfa83ce4b0c9d6adf7311a,adffab3072f2a40a5ab4e59bb4a40b02.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A17K-10A,5C22C8D6-5805-455C-8E1C-E6B8006738E4,Blood Derived Normal,Illumina HiSeq,68ad7b2b-089b-43c0-a3b9-b8679859e995,Uterus,74,72719D9E-F802-4E2B-8979-0A080EE83E09,B79AA868-1325-4D9D-A36C-86A7CF79E069,TCGA-D1-A17K-10A-01D-A325-09,GRCh37-lite,TCGA-D1-A17K,TCGA-UCEC,NA,s5469,Washington University School of Medicine,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6c004,58cfa830e4b0c9d6adf6c004,TCGA-AB-2986-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2986-11A-01D-0739-09_whole,TCGA-AB-2986-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6c004,TCGA-AB-2986-11A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2986-11A,233400C5-6A47-40E2-BF2A-8B7FC9DF462B,Solid Tissue Normal,Illumina GA,0899070c-b0c0-4d7a-8c0d-877f32a72142,Blood,31,F169634F-4742-457E-815A-87386C5B0306,D6E1248C-8BB3-4040-A0D2-C010EDC8E56D,TCGA-AB-2986-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2986,TCGA-LAML,212,s7152,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6bd0b,58cfa830e4b0c9d6adf6bd0b,TCGA-AB-2971-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2971-11A-01D-0739-09_whole,TCGA-AB-2971-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bd0b,TCGA-AB-2971-11A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2971-11A,5ECE14FD-3D7F-4ECB-96AA-2C44D8F15CA4,Solid Tissue Normal,Illumina GA,c85319e4-b2e2-4551-b55a-550cbb8679f5,Blood,76,B53E190A-D776-440E-BB83-F412E357F5FC,3B98AB49-9AE4-461A-8E29-BE6E97425D04,TCGA-AB-2971-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2971,TCGA-LAML,792,s7000,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6be08,58cfa830e4b0c9d6adf6be08,TCGA-AB-2965-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2965-11A-01D-0739-09_whole,TCGA-AB-2965-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6be08,TCGA-AB-2965-11A-01D-0739-09_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2965-11A,05924106-07F6-44CA-BA15-7452B8A657E4,Solid Tissue Normal,Illumina GA,700575bc-341d-4635-bef7-3a7918086035,Blood,60,0687049C-7DE6-49DC-A45C-82C9F8C33DE5,882146D8-0B40-490B-B405-7BA28BF8AAA0,TCGA-AB-2965-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2965,TCGA-LAML,335,s7301,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82fe4b0c9d6adf6b58d,58cfa82fe4b0c9d6adf6b58d,TCGA-29-1707-01A-01D-0926-12_Illumina.filtered.,WGS,TCGA-29-1707-01A-01D-0926-12_Illumina,TCGA-29-1707-01A-01D-0926-12_Illumina.bam,162.7,1.9,0.17,58cfa82fe4b0c9d6adf6b58d,TCGA-29-1707-01A-01D-0926-12_Illumina.bam,Alive,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-29-1707-01A,7FD6AB8A-201E-431D-A886-6AB553B6CA36,Primary Tumor,Illumina HiSeq,a4acbdd6-5aa4-4824-bc5b-55b505b69d8d,Ovary,41,64B5EB1A-1D6E-477E-A33B-C9A4546DAEF3,08CD6E0B-DB36-4479-883F-8E3337F7E3A2,TCGA-29-1707-01A-01D-0926-12,NCBI36_BCM_variant,TCGA-29-1707,TCGA-OV,NA,s18004,Baylor College of Medicine,Duke,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bfdd,58cfa830e4b0c9d6adf6bfdd,TCGA-AB-2995-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2995-03A-01D-0739-09_whole,TCGA-AB-2995-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bfdd,TCGA-AB-2995-03A-01D-0739-09_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2995-03A,EB14339D-FEFA-46C3-99A6-55268384361A,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,fffb1142-1235-425f-92ed-bb291a36d971,Blood,63,A9CE5C16-9D28-4211-BAC5-D1F6106F22FA,10A026EC-F343-4B63-B67E-59938E0CFFAC,TCGA-AB-2995-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2995,TCGA-LAML,NA,s7007,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72ea5,58cfa83ce4b0c9d6adf72ea5,c53c5893769e9b84b2482817482783cc.filtered.,WGS,c53c5893769e9b84b2482817482783cc,c53c5893769e9b84b2482817482783cc.bam,23.1,1.69,0.08,58cfa83ce4b0c9d6adf72ea5,c53c5893769e9b84b2482817482783cc.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-EY-A1GS-10A,C10B2885-70EA-4D32-BC48-8B85530DF702,Blood Derived Normal,Illumina HiSeq,f2cfdcfb-e5c8-4936-a7da-54b9fcc0cf61,Uterus,71,D9A0C0DB-DAEB-484B-822F-CE9686094054,AAF43383-6A55-49D1-8131-78C18BC1843B,TCGA-EY-A1GS-10A-01D-A13O-09,GRCh37-lite,TCGA-EY-A1GS,TCGA-UCEC,NA,s4970,Washington University School of Medicine,University of North Carolina,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6b1f8,58cfa82ee4b0c9d6adf6b1f8,TCGA-14-0786-01B-01D-0932-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-14-0786-01B-01D-0932-09_IlluminaGA-DNASeq_whole,TCGA-14-0786-01B-01D-0932-09_IlluminaGA-DNASeq_whole.bam,234.3,1.9,0.14,58cfa82ee4b0c9d6adf6b1f8,TCGA-14-0786-01B-01D-0932-09_IlluminaGA-DNASeq_whole.bam,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-0786-01B,12824B2B-9C0A-4DCF-8941-34593A4E93DA,Primary Tumor,Illumina GA,1206a5fa-76f9-4bc3-b319-b6dba0ffaf8e,Brain,50,597CAEAF-8957-43FE-99DC-43E136881A55,96EF40C3-8D4C-4FE1-A33A-99F5B205A0BB,TCGA-14-0786-01B-01D-0932-09,NCBI36_WUGSC_variant,TCGA-14-0786,TCGA-GBM,701,s13898,Washington University School of Medicine,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a68d,58cfa82de4b0c9d6adf6a68d,9646c21c9ef08fca9f08151b0ff38ee5.filtered.,WGS,9646c21c9ef08fca9f08151b0ff38ee5,9646c21c9ef08fca9f08151b0ff38ee5.bam,21.36,1.95,0.07,58cfa82de4b0c9d6adf6a68d,9646c21c9ef08fca9f08151b0ff38ee5.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A07B-10A,B43E41AF-1D82-4B5F-B8F1-ADD0510E6B86,Blood Derived Normal,Illumina HiSeq,c4935fc4-ed6f-446a-a4cb-b41d1f4b38ef,Breast,69,9A73732B-3BC0-4677-BDA2-78535F08C232,92DC6BB4-B622-4653-B5B1-9FF180221BF3,TCGA-A8-A07B-10A-01D-A19H-09,GRCh37-lite,TCGA-A8-A07B,TCGA-BRCA,NA,s5487,Washington University School of Medicine,Indivumed,Germany,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a6f0,58cfa82de4b0c9d6adf6a6f0,9802f275692b4130ed0848237ee1447e.filtered.,WGS,9802f275692b4130ed0848237ee1447e,9802f275692b4130ed0848237ee1447e.bam,49.14,1.91,0.07,58cfa82de4b0c9d6adf6a6f0,9802f275692b4130ed0848237ee1447e.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0X5-10A,4E6EDFE6-ADCB-4C12-8FF4-38A79F5887E8,Blood Derived Normal,Illumina HiSeq,1859efd4-29c0-48f0-9b0a-533ab337913a,Breast,61,003C8CFF-EC0E-4F7C-B38B-93575FD68A23,3FF1B637-7389-4E74-9E63-01642DF895F4,TCGA-B6-A0X5-10A-01D-A10G-09,GRCh37-lite,TCGA-B6-A0X5,TCGA-BRCA,2097,s6119,Washington University School of Medicine,Duke,United States,NO,T2,N1b,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa82de4b0c9d6adf6a585,58cfa82de4b0c9d6adf6a585,03bef5376c018b6d84c592f87aea1f37.filtered.,WGS,03bef5376c018b6d84c592f87aea1f37,03bef5376c018b6d84c592f87aea1f37.bam,57.24,1.91,0.08,58cfa82de4b0c9d6adf6a585,03bef5376c018b6d84c592f87aea1f37.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AJ-A23M-10A,D39DF936-4BC6-404D-9E1D-F6416CC5A34C,Blood Derived Normal,Illumina HiSeq,393908f7-ff74-42de-9e9d-314eb0119741,Uterus,61,4DF2F60B-CC2C-4F9D-886A-A5F14A42C5D8,F454293A-1AF4-4483-BD92-CE855CB2AD1F,TCGA-AJ-A23M-10A-01D-A159-09,GRCh37-lite,TCGA-AJ-A23M,TCGA-UCEC,NA,s4576,Washington University School of Medicine,International Genomics Conosrtium,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6be5c,58cfa830e4b0c9d6adf6be5c,TCGA-AB-3002-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-3002-11A-01D-0739-09_whole,TCGA-AB-3002-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6be5c,TCGA-AB-3002-11A-01D-0739-09_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3002-11A,478F29B1-6604-4E75-A492-47C384799F44,Solid Tissue Normal,Illumina GA,cd0f3104-6cba-4878-ade4-6b2596c38496,Blood,68,6803AE4E-0176-466A-A05E-E0E75E648AE3,F0B052B2-F9C8-48B4-A333-936B3DA6F164,TCGA-AB-3002-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-3002,TCGA-LAML,1431,s7088,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a4da,58cfa82de4b0c9d6adf6a4da,1401474c9715a75706af4e73d3914782.filtered.,WGS,1401474c9715a75706af4e73d3914782,1401474c9715a75706af4e73d3914782.bam,18.22,1.88,0.08,58cfa82de4b0c9d6adf6a4da,1401474c9715a75706af4e73d3914782.bam,Alive,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0U9-10A,5FFA2EC6-2D94-4B09-8FB9-3591CF38FA4F,Blood Derived Normal,Illumina HiSeq,29b9d657-651c-4718-8e0c-40402608b490,Uterus,59,908C54D1-0BC2-4693-8FCA-C34EC770A96D,6AED3269-FC65-45BE-8E39-732BC3CFFA8B,TCGA-BS-A0U9-10A-01D-A325-09,GRCh37-lite,TCGA-BS-A0U9,TCGA-UCEC,NA,s4404,Washington University School of Medicine,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6b08e,58cfa82ee4b0c9d6adf6b08e,TCGA-13-0791-02A-01D-0926-12_Illumina.filtered.,WGS,TCGA-13-0791-02A-01D-0926-12_Illumina,TCGA-13-0791-02A-01D-0926-12_Illumina.bam,300,1.9,0.15,58cfa82ee4b0c9d6adf6b08e,TCGA-13-0791-02A-01D-0926-12_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0791-02A,90118207-8F11-4784-AC1B-0DEEC2E7AF3A,Recurrent Tumor,Illumina HiSeq,861c03eb-0dfa-4568-ac11-aa0448663c69,Ovary,58,F4083A1A-8D21-4104-AB81-CF60A8363EBA,3AEC4C1C-EDE6-4C33-9280-FC6ADD59A848,TCGA-13-0791-02A-01D-0926-12,NCBI36_BCM_variant,TCGA-13-0791,TCGA-OV,NA,s17175,Baylor College of Medicine,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf731e0,58cfa83ce4b0c9d6adf731e0,daed17a8897c7086f76612720e434425.filtered.,WGS,daed17a8897c7086f76612720e434425,daed17a8897c7086f76612720e434425.bam,NA,NA,NA,58cfa83ce4b0c9d6adf731e0,daed17a8897c7086f76612720e434425.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2984-03A,810D293B-7DFC-4E91-AB29-042457632399,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,f24533b7-61fb-4028-b18c-c923e9e45b57,Blood,38,BD27E567-768F-4A37-B401-4330849B28B6,3C90E4B9-81CD-4033-B233-593C37FBAC1F,TCGA-AB-2984-03A-01D-0739-09,GRCh37-lite,TCGA-AB-2984,TCGA-LAML,NA,s7197,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72f04,58cfa83ce4b0c9d6adf72f04,da60919696928e24aa5fcbb89cc8bfa3.filtered.,WGS,da60919696928e24aa5fcbb89cc8bfa3,da60919696928e24aa5fcbb89cc8bfa3.bam,8.55,1.95,0.08,58cfa83ce4b0c9d6adf72f04,da60919696928e24aa5fcbb89cc8bfa3.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A1LL-11A,2A84997D-CCEE-4F46-BEA2-752534F26416,Solid Tissue Normal,Illumina HiSeq,f2fe81a1-3e80-4b03-9699-eaa8a4652be5,Breast,73,A172AEF1-943F-4423-8EA0-FEEC5EBF1958,63DC530D-0968-45A2-BA97-BFFF1EF2E5CD,TCGA-E2-A1LL-11A-21D-A314-09,GRCh37-lite,TCGA-E2-A1LL,TCGA-BRCA,NA,s6105,Washington University School of Medicine,Roswell Park,United States,NO,T3,N2a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82de4b0c9d6adf6a4d8,58cfa82de4b0c9d6adf6a4d8,440a2f2ecb7e515f50cbe3008fb3e1e5.filtered.,WGS,440a2f2ecb7e515f50cbe3008fb3e1e5,440a2f2ecb7e515f50cbe3008fb3e1e5.bam,234.3,1.9,0.14,58cfa82de4b0c9d6adf6a4d8,440a2f2ecb7e515f50cbe3008fb3e1e5.bam,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-0786-01B,12824B2B-9C0A-4DCF-8941-34593A4E93DA,Primary Tumor,Illumina GA,a0d363f2-2d9d-469b-95ce-39d562751396,Brain,50,597CAEAF-8957-43FE-99DC-43E136881A55,B73CFD2E-044F-4B41-B404-080D9D18E61D,TCGA-14-0786-01B-01D-0703-09,GRCh37-lite,TCGA-14-0786,TCGA-GBM,701,s14199,Washington University School of Medicine,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf7314e,58cfa83ce4b0c9d6adf7314e,b56e328d4f1f38dee893b6e4f51044ba.filtered.,WGS,b56e328d4f1f38dee893b6e4f51044ba,b56e328d4f1f38dee893b6e4f51044ba.bam,56.7,1.92,0.08,58cfa83ce4b0c9d6adf7314e,b56e328d4f1f38dee893b6e4f51044ba.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0RT-10A,4BF50455-9AB7-4521-A791-089F66D3B877,Blood Derived Normal,Illumina HiSeq,75db9c75-640f-4ad6-9d97-a0cb485b35d8,Breast,39,5CFFE233-5B5F-47B3-9DD2-7F80E821E15E,BC3DDD6B-6378-48E3-A676-380C45BF213F,TCGA-B6-A0RT-10A-01D-A128-09,GRCh37-lite,TCGA-B6-A0RT,TCGA-BRCA,NA,s5944,Washington University School of Medicine,Duke,United States,NO,T3,N1,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82de4b0c9d6adf6a443,58cfa82de4b0c9d6adf6a443,0801219a750465be82240c1c6489a7f5.filtered.,WGS,0801219a750465be82240c1c6489a7f5,0801219a750465be82240c1c6489a7f5.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a443,0801219a750465be82240c1c6489a7f5.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2966-03A,B1C32911-5CA8-4B77-8063-A97C30A3A348,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,4301b67a-475e-4317-97a5-694805d11c3e,Blood,57,DCC4F5CD-032E-4129-92A9-D0A47EFD12D5,5D716008-250C-49F9-8026-EEA1ED4D38FB,TCGA-AB-2966-03A-01D-0741-05,GRCh37-lite,TCGA-AB-2966,TCGA-LAML,854,s7011,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72f07,58cfa83ce4b0c9d6adf72f07,b2e1f973fd60e42c83f60e0abfe9717c.filtered.,WGS,b2e1f973fd60e42c83f60e0abfe9717c,b2e1f973fd60e42c83f60e0abfe9717c.bam,NA,NA,NA,58cfa83ce4b0c9d6adf72f07,b2e1f973fd60e42c83f60e0abfe9717c.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2989-03A,E2E610CE-31C3-4FC0-917D-92D48FEB600A,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,3d5e15f2-f014-4798-9e76-80cad8801979,Blood,29,04B6F323-9F46-4DE1-9D8F-BB6853D8C93A,C3446BD7-5059-4D80-A799-543C1D343234,TCGA-AB-2989-03A-01D-0742-05,GRCh37-lite,TCGA-AB-2989,TCGA-LAML,365,s7129,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a5ae,58cfa82de4b0c9d6adf6a5ae,75357fc2d2a78c9d0471722e29ca260b.filtered.,WGS,75357fc2d2a78c9d0471722e29ca260b,75357fc2d2a78c9d0471722e29ca260b.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a5ae,75357fc2d2a78c9d0471722e29ca260b.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2995-11A,EB14339D-FEFA-46C3-99A6-55268384361A,Solid Tissue Normal,Illumina GA,a0a392f6-02b6-46da-9013-0f05fded8a76,Blood,63,530165A5-F73B-43DB-BB77-1F630A5105B8,CE73C6C8-40AB-4A3C-ACD6-C22444DA3567,TCGA-AB-2995-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2995,TCGA-LAML,NA,s7285,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a61c,58cfa82de4b0c9d6adf6a61c,5f651cb67a58c86e824c7bc365100295.filtered.,WGS,5f651cb67a58c86e824c7bc365100295,5f651cb67a58c86e824c7bc365100295.bam,17.77,NA,0.08,58cfa82de4b0c9d6adf6a61c,5f651cb67a58c86e824c7bc365100295.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-GM-A3XL-10A,65CAC997-4D39-4501-85EC-4FCB328A8EB5,Blood Derived Normal,Illumina HiSeq,1c380c75-c405-42a9-8984-c87a63cc94a2,Breast,49,86BDDEDB-0034-4A61-AF7E-F577454C9646,90469BFB-140C-4856-BE28-A9B04C183157,TCGA-GM-A3XL-10A-01D-A22X-09,GRCh37-lite,TCGA-GM-A3XL,TCGA-BRCA,NA,s5790,Washington University School of Medicine,MD Anderson,United States,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a621,58cfa82de4b0c9d6adf6a621,54c87a63e243f1591e2bdfffad550c99.filtered.,WGS,54c87a63e243f1591e2bdfffad550c99,54c87a63e243f1591e2bdfffad550c99.bam,32.44,1.88,0.08,58cfa82de4b0c9d6adf6a621,54c87a63e243f1591e2bdfffad550c99.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LD-10A,1200C8B7-A058-4C01-BBE2-04EC09A65245,Blood Derived Normal,Illumina HiSeq,5b853034-41e8-4872-b613-f9a44a734189,Uterus,63,9D49BB1E-896D-4545-8CAC-E85405093B83,C6A65B03-A24D-406A-8DC5-508D2FB576AD,TCGA-AP-A0LD-10A-01D-A066-09,GRCh37-lite,TCGA-AP-A0LD,TCGA-UCEC,NA,s4983,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a5e4,58cfa82de4b0c9d6adf6a5e4,5d97ddc05d218a76448b199e90a42889.filtered.,WGS,5d97ddc05d218a76448b199e90a42889,5d97ddc05d218a76448b199e90a42889.bam,15.87,NA,0.08,58cfa82de4b0c9d6adf6a5e4,5d97ddc05d218a76448b199e90a42889.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2RM-10A,C13215D9-26A8-4C8B-B4FE-5DA6AA3222AF,Blood Derived Normal,Illumina HiSeq,07d652d2-3b53-4a95-ac74-b1c043089673,Cervix,40,FE891CD9-AE0A-4242-8A56-B5D6D2B85B43,B2A9B6B3-8AE5-4DA7-AE2E-02CB5B0390B2,TCGA-EK-A2RM-10A-01D-A18J-09,GRCh37-lite,TCGA-EK-A2RM,TCGA-CESC,NA,s1166,Washington University School of Medicine,Gynecologic Oncology Group,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa83ce4b0c9d6adf73187,58cfa83ce4b0c9d6adf73187,a40573206785187a19235a673ae4ab01.filtered.,WGS,a40573206785187a19235a673ae4ab01,a40573206785187a19235a673ae4ab01.bam,55.76,1.97,0.08,58cfa83ce4b0c9d6adf73187,a40573206785187a19235a673ae4ab01.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-C8-A12L-10A,441919EB-8C9F-478C-BDA3-8DE4F8295E8A,Blood Derived Normal,Illumina HiSeq,1961adaf-b22b-4091-b508-99f711a4eaf1,Breast,67,C3BA3FE2-7B85-44A0-B0C7-55669601D97A,5C18404D-8918-4A84-B1C2-AE7D7731C213,TCGA-C8-A12L-10A-01D-A19H-09,GRCh37-lite,TCGA-C8-A12L,TCGA-BRCA,NA,s6745,Washington University School of Medicine,ILSbio,Vietnam,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6bfca,58cfa830e4b0c9d6adf6bfca,TCGA-AB-2987-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2987-11A-01D-0739-09_whole,TCGA-AB-2987-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bfca,TCGA-AB-2987-11A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2987-11A,C147D12E-5E96-484E-BBE7-DC2F11F889BF,Solid Tissue Normal,Illumina GA,f90f19bf-8ef3-4bec-b9b8-fcfd1f14b8ed,Blood,75,4EA1FFB5-1804-4EB8-9AC6-DD30B34FE6AC,E0CC389E-0E7C-4E40-885E-4B3427F1CC36,TCGA-AB-2987-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2987,TCGA-LAML,184,s7124,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a670,58cfa82de4b0c9d6adf6a670,584d3eda47ec27e5fcabcd9551aaad55.filtered.,WGS,584d3eda47ec27e5fcabcd9551aaad55,584d3eda47ec27e5fcabcd9551aaad55.bam,24.26,1.79,0.07,58cfa82de4b0c9d6adf6a670,584d3eda47ec27e5fcabcd9551aaad55.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A04X-10A,733A2A0F-B37A-4B81-B49E-3C0F30D1EB37,Blood Derived Normal,Illumina HiSeq,c942bc80-18ce-4573-869b-4fc96677f775,Breast,34,BAB345A6-97F2-4963-A696-2A4393C9C7BF,79ADE75E-AD86-436D-B2E0-0B5100B472C9,TCGA-A2-A04X-10A-01D-A19H-09,GRCh37-lite,TCGA-A2-A04X,TCGA-BRCA,NA,s6625,Washington University School of Medicine,Walter Reed,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a56d,58cfa82de4b0c9d6adf6a56d,2fe7c16235d161d9080b3dea418a515f.filtered.,WGS,2fe7c16235d161d9080b3dea418a515f,2fe7c16235d161d9080b3dea418a515f.bam,154.2,1.89,0.14,58cfa82de4b0c9d6adf6a56d,2fe7c16235d161d9080b3dea418a515f.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0208-10A,E3711A9B-6D4C-44DF-BBAB-0A675046A5DF,Blood Derived Normal,Illumina GA,776681be-9474-4eeb-81b8-d693a2506af5,Brain,52,F56030BE-C047-43CF-82FB-21B21BFB5E8B,A5E9C1B9-AB5A-4F96-919A-7A83C382E0A6,TCGA-06-0208-10A-01D-0512-09,GRCh37-lite,TCGA-06-0208,TCGA-GBM,256,s13870,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6bdc6,58cfa830e4b0c9d6adf6bdc6,TCGA-BH-A0B3-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-BH-A0B3-01A-11D-A128-09_IlluminaGA-DNASeq_whole,TCGA-BH-A0B3-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam,52.29,1.9,0.08,58cfa830e4b0c9d6adf6bdc6,TCGA-BH-A0B3-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0B3-01A,18EB4DFC-556F-4BF3-A411-4780209ED1E0,Primary Tumor,Illumina HiSeq,82535082-739b-4a9b-8609-4724bbdd27ee,Breast,53,FC1F0AD4-8412-4143-8EBF-FA6592F396E9,43F7A2E0-FEC9-4E43-872D-18C6C946FA17,TCGA-BH-A0B3-01A-11D-A128-09,GRCh37-lite,TCGA-BH-A0B3,TCGA-BRCA,NA,s6464,Washington University School of Medicine,University of Pittsburgh,None,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa82de4b0c9d6adf6a608,58cfa82de4b0c9d6adf6a608,59614cc1b7530d11e6c78b04c1b3415d.filtered.,WGS,59614cc1b7530d11e6c78b04c1b3415d,59614cc1b7530d11e6c78b04c1b3415d.bam,26.08,NA,0.08,58cfa82de4b0c9d6adf6a608,59614cc1b7530d11e6c78b04c1b3415d.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A2LY-10A,E733F289-A0EC-478C-AAD9-1378AD26DDFA,Blood Derived Normal,Illumina HiSeq,03ebae4c-d724-4d32-9b91-943abd271d24,Cervix,30,80879749-FD29-4988-A078-CD34D4745453,433B41E8-D79A-4DA0-A700-821CD97CC1B9,TCGA-C5-A2LY-10A-01D-A18J-09,GRCh37-lite,TCGA-C5-A2LY,TCGA-CESC,NA,s1352,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6bc98,58cfa830e4b0c9d6adf6bc98,TCGA-AB-3005-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-3005-03A-01D-0739-09_whole,TCGA-AB-3005-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bc98,TCGA-AB-3005-03A-01D-0739-09_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3005-03A,E49A1768-BF1E-49C0-BCA3-4E076928281C,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,8a6a9ccb-bb91-4e92-9533-1b2eae1ae3a7,Blood,45,D2C577B5-6C67-4A19-ADD7-FB87FA52523C,85335B80-6D61-4344-8AB3-1CF4BE2EE53F,TCGA-AB-3005-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-3005,TCGA-LAML,NA,s7054,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6aaa8,58cfa82ee4b0c9d6adf6aaa8,G32463.TCGA-DK-A1A5-01A-11D-A13W-08.3.filtered.,WGS,G32463.TCGA-DK-A1A5-01A-11D-A13W-08.3,G32463.TCGA-DK-A1A5-01A-11D-A13W-08.3.bam,59.04,1.91,0.08,58cfa82ee4b0c9d6adf6aaa8,G32463.TCGA-DK-A1A5-01A-11D-A13W-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A5-01A,904A8757-E0C5-41EF-B583-C8F170CAAAC1,Primary Tumor,Illumina HiSeq,bc2dfa86-f2b0-4747-beb4-8940c4a6c000,Bladder,79,A9EF3EC5-B1C1-481F-89CF-1729FAB50173,448FE471-3F4E-4DC8-A4E0-6F147DC93ABE,TCGA-DK-A1A5-01A-11D-A13W-08,HG19_Broad_variant,TCGA-DK-A1A5,TCGA-BLCA,65,s3253,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa83ce4b0c9d6adf7320a,58cfa83ce4b0c9d6adf7320a,b4fb6f3c8975390c84c136ba9b277834.filtered.,WGS,b4fb6f3c8975390c84c136ba9b277834,b4fb6f3c8975390c84c136ba9b277834.bam,21.02,1.97,0.07,58cfa83ce4b0c9d6adf7320a,b4fb6f3c8975390c84c136ba9b277834.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A109-10A,F0787165-6F58-4D67-B510-928EEA2C4882,Blood Derived Normal,Illumina HiSeq,bd77a131-48d3-4950-992a-ace47923f7ae,Breast,64,A0549DF7-5945-4355-81F3-58B896BA5B93,7826A2E6-30AE-460B-AB97-2986F1D76D4B,TCGA-E2-A109-10A-01D-A10M-09,GRCh37-lite,TCGA-E2-A109,TCGA-BRCA,NA,s6103,Washington University School of Medicine,Roswell Park,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a58d,58cfa82de4b0c9d6adf6a58d,6892179ad4076c2008c759c6d52f93f9.filtered.,WGS,6892179ad4076c2008c759c6d52f93f9,6892179ad4076c2008c759c6d52f93f9.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a58d,6892179ad4076c2008c759c6d52f93f9.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2963-03A,DC7C0A9B-EF72-4188-A711-69DBF70C744C,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,bede1739-c266-4e53-b85b-b8c54790c7ae,Blood,56,FA7146A0-D6A0-4465-A9E3-662B177EB02C,C71705D0-1095-4683-A2F7-C6051CD1C97C,TCGA-AB-2963-03A-01D-0741-05,GRCh37-lite,TCGA-AB-2963,TCGA-LAML,1642,s7284,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a504,58cfa82de4b0c9d6adf6a504,318aaeefba803b6d0d67f487427a6f42.filtered.,WGS,318aaeefba803b6d0d67f487427a6f42,318aaeefba803b6d0d67f487427a6f42.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a504,318aaeefba803b6d0d67f487427a6f42.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2995-03A,EB14339D-FEFA-46C3-99A6-55268384361A,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,8387ffae-8b51-420d-a4d1-4c131205f1d6,Blood,63,A9CE5C16-9D28-4211-BAC5-D1F6106F22FA,FA40B7EA-63B5-45A7-A434-0D4F50B58D49,TCGA-AB-2995-03A-01D-0741-05,GRCh37-lite,TCGA-AB-2995,TCGA-LAML,NA,s7162,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6bd05,58cfa830e4b0c9d6adf6bd05,TCGA-AB-2974-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2974-03A-01D-0739-09_whole,TCGA-AB-2974-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bd05,TCGA-AB-2974-03A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2974-03A,FF7839BB-176E-4483-AC6E-7FAE9F6E2E54,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,3b62d28e-a675-4845-858b-207f161ceb66,Blood,67,43B83836-5FF0-4239-88FA-7A5B07FDF5E1,CD5C86F1-AA57-4266-B150-C64CBF496A27,TCGA-AB-2974-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2974,TCGA-LAML,92,s6999,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6b1d9,58cfa82ee4b0c9d6adf6b1d9,TCGA-16-1063-01B-01D-0932-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-16-1063-01B-01D-0932-09_IlluminaGA-DNASeq_whole,TCGA-16-1063-01B-01D-0932-09_IlluminaGA-DNASeq_whole.bam,393.3,1.9,0.16,58cfa82ee4b0c9d6adf6b1d9,TCGA-16-1063-01B-01D-0932-09_IlluminaGA-DNASeq_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-16-1063-01B,6E6962D8-34B8-431C-8220-42B0B92A410B,Primary Tumor,Illumina GA,a0326643-cf32-4aea-99e0-ef4b53adb537,Brain,72,3530CC47-0486-4B38-BF9B-1FBA96D5963F,7163A0F7-2C69-40B8-8857-8AB3F46F0ACF,TCGA-16-1063-01B-01D-0932-09,NCBI36_WUGSC_variant,TCGA-16-1063,TCGA-GBM,425,s13991,Washington University School of Medicine,Toronto Western Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a4cc,58cfa82de4b0c9d6adf6a4cc,1e9af460376762c5d489a2b820834e3f.filtered.,WGS,1e9af460376762c5d489a2b820834e3f,1e9af460376762c5d489a2b820834e3f.bam,15.12,1.95,0.08,58cfa82de4b0c9d6adf6a4cc,1e9af460376762c5d489a2b820834e3f.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A15H-10A,5580B21A-2CDB-4777-AD79-6E06654144F5,Blood Derived Normal,Illumina HiSeq,b2b05078-b11f-488e-afc8-2d70b062609e,Breast,38,09644A32-44EA-4FAC-AFB9-448810B90EED,CCC8619F-C4AC-4CD9-9DAB-83FAAA59AFC5,TCGA-E2-A15H-10A-01D-A19H-09,GRCh37-lite,TCGA-E2-A15H,TCGA-BRCA,NA,s6911,Washington University School of Medicine,Roswell Park,None,NO,T1c,N1mi,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6bdd8,58cfa830e4b0c9d6adf6bdd8,TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole,TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam,55.87,1.93,0.08,58cfa830e4b0c9d6adf6bdd8,TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0E0-01A,20E8106B-1290-4735-ABE4-7621E08E3DC8,Primary Tumor,Illumina HiSeq,fc737335-21e7-4997-b267-04d3f91043f5,Breast,38,662CC11C-DA31-4E31-8E77-46011B38EA96,E8392F20-C9E3-4649-B64F-5B266C393A76,TCGA-BH-A0E0-01A-11D-A128-09,GRCh37-lite,TCGA-BH-A0E0,TCGA-BRCA,NA,s5804,Washington University School of Medicine,University of Pittsburgh,None,NO,T3,N3a,Infiltrating Ductal Carcinoma,Stage IIIC
13722.58cfa82de4b0c9d6adf6a550,58cfa82de4b0c9d6adf6a550,49861aebca28da370701b7a96aff70cd.filtered.,WGS,49861aebca28da370701b7a96aff70cd,49861aebca28da370701b7a96aff70cd.bam,144.67,1.9,0.07,58cfa82de4b0c9d6adf6a550,49861aebca28da370701b7a96aff70cd.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A05S-10A,3A4A6AFF-4720-41FC-A114-85F38610EBB1,Blood Derived Normal,Illumina HiSeq,647fc67b-0022-4886-89d0-b73f80f2af8c,Uterus,81,A223F336-672C-436E-8B42-5662E74E2676,1362F2AC-D382-4AE1-A2BF-600C968CA344,TCGA-AX-A05S-10A-01D-A17G-09,GRCh37-lite,TCGA-AX-A05S,TCGA-UCEC,413,s5377,Washington University School of Medicine,Gynecologic Oncology Group,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a6fe,58cfa82de4b0c9d6adf6a6fe,9d896838589c013c3e218549888b0ba2.filtered.,WGS,9d896838589c013c3e218549888b0ba2,9d896838589c013c3e218549888b0ba2.bam,393.3,1.9,0.16,58cfa82de4b0c9d6adf6a6fe,9d896838589c013c3e218549888b0ba2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-16-1063-01B,6E6962D8-34B8-431C-8220-42B0B92A410B,Primary Tumor,Illumina GA,d1547799-b37d-4b85-8bbc-47297d34763d,Brain,72,3530CC47-0486-4B38-BF9B-1FBA96D5963F,7163A0F7-2C69-40B8-8857-8AB3F46F0ACF,TCGA-16-1063-01B-01D-0932-09,GRCh37-lite,TCGA-16-1063,TCGA-GBM,425,s14250,Washington University School of Medicine,Toronto Western Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a474,58cfa82de4b0c9d6adf6a474,2949f0112938473e4dd08599188c3a55.filtered.,WGS,2949f0112938473e4dd08599188c3a55,2949f0112938473e4dd08599188c3a55.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a474,2949f0112938473e4dd08599188c3a55.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3006-03A,C9943335-86A8-4286-891C-C2331D75DC0D,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,3f83b9a4-47d8-4c54-a44f-4c4515936eb5,Blood,61,A7048844-BC20-4F26-A46D-9D2AC2E7BFB5,247CAC37-25C0-44D3-B517-64512126968B,TCGA-AB-3006-03A-01D-0741-05,GRCh37-lite,TCGA-AB-3006,TCGA-LAML,485,s7135,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6bfd0,58cfa830e4b0c9d6adf6bfd0,TCGA-AB-2986-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2986-03A-01D-0739-09_whole,TCGA-AB-2986-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bfd0,TCGA-AB-2986-03A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2986-03A,233400C5-6A47-40E2-BF2A-8B7FC9DF462B,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,611299d4-8cc7-4a90-8ee5-0ebb04f3b5e3,Blood,31,192B8235-8B09-4102-91CE-DDB77A5E0BAD,F389F28B-93C3-460A-9DCF-9F09D253B4BE,TCGA-AB-2986-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2986,TCGA-LAML,212,s7048,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf73117,58cfa83ce4b0c9d6adf73117,ae40259a6e4efa06f86c35b3cb99bb16.filtered.,WGS,ae40259a6e4efa06f86c35b3cb99bb16,ae40259a6e4efa06f86c35b3cb99bb16.bam,NA,NA,NA,58cfa83ce4b0c9d6adf73117,ae40259a6e4efa06f86c35b3cb99bb16.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2998-03A,BA9A95CF-44CE-4126-BA21-4970DFA12593,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,85602a35-6c04-4309-8b76-c0ababd8040f,Blood,68,C87415BF-FED9-4F79-BCD3-DDED3357A9D7,8C7BAC04-9796-4FBF-9340-41E5A993EF09,TCGA-AB-2998-03A-01D-0742-05,GRCh37-lite,TCGA-AB-2998,TCGA-LAML,31,s7277,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6bc76,58cfa830e4b0c9d6adf6bc76,TCGA-AB-3009-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-3009-11A-01D-0739-09_whole,TCGA-AB-3009-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bc76,TCGA-AB-3009-11A-01D-0739-09_whole.bam,Dead,MALE,Not available,Not available,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3009-11A,C9B92F8F-4599-47D1-9D12-31E42166A091,Solid Tissue Normal,Illumina GA,38684811-17f7-497e-af49-ba81330afa07,Blood,23,CA163AC7-6D69-4F4F-8CA1-6A9EB86D8BC6,B77C4CC4-B7BB-45B7-8324-70F96F9A3629,TCGA-AB-3009-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-3009,TCGA-LAML,577,s7051,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf730c2,58cfa83ce4b0c9d6adf730c2,f9602cc18e6f5feadccfac87ff2ff18f.filtered.,WGS,f9602cc18e6f5feadccfac87ff2ff18f,f9602cc18e6f5feadccfac87ff2ff18f.bam,7.16,1.93,0.08,58cfa83ce4b0c9d6adf730c2,f9602cc18e6f5feadccfac87ff2ff18f.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GE-10A,A587E62E-430E-4F1B-82B7-6FBE856FDAF1,Blood Derived Normal,Illumina HiSeq,d8e71e17-f277-47a2-aa07-e6de80367d79,Uterus,38,FC6580A8-FFE8-4F16-A19D-DB65F2789369,64EAA1A9-4F18-4D9F-8B75-34760D4798D9,TCGA-A5-A0GE-10A-01D-A066-09,GRCh37-lite,TCGA-A5-A0GE,TCGA-UCEC,NA,s5471,Washington University School of Medicine,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6c1c4,58cfa830e4b0c9d6adf6c1c4,TCGA-BH-A0B9-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-BH-A0B9-10A-01D-A128-09_IlluminaGA-DNASeq_whole,TCGA-BH-A0B9-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,31.27,1.9,0.08,58cfa830e4b0c9d6adf6c1c4,TCGA-BH-A0B9-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0B9-10A,5A57DC25-D252-4B22-B192-4DE630D7002F,Blood Derived Normal,Illumina HiSeq,9822e8f0-c9dd-4681-a427-46ce76876761,Breast,44,2FD262A9-384B-4C29-9FA3-837C42D84010,544469B8-D513-45DF-9FE8-861FCB3B2EF1,TCGA-BH-A0B9-10A-01D-A128-09,GRCh37-lite,TCGA-BH-A0B9,TCGA-BRCA,NA,s5802,Washington University School of Medicine,University of Pittsburgh,None,NO,T1c,N0 (i-),Infiltrating Ductal Carcinoma,Stage IA
13722.58cfa830e4b0c9d6adf6bcd4,58cfa830e4b0c9d6adf6bcd4,TCGA-AB-2978-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2978-11A-01D-0739-09_whole,TCGA-AB-2978-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bcd4,TCGA-AB-2978-11A-01D-0739-09_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2978-11A,90FC467C-2B0D-461D-A1B8-C2A519354367,Solid Tissue Normal,Illumina GA,a1db1f04-cd5d-434a-9b0a-3e06016cc569,Blood,61,A933E3E0-FE86-42E8-8A59-E399757C5DCC,BE9D0262-D1FA-48C4-BBA6-0D5415FB9B52,TCGA-AB-2978-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2978,TCGA-LAML,NA,s7120,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a576,58cfa82de4b0c9d6adf6a576,4c50874f118c0e39c13326271773b809.filtered.,WGS,4c50874f118c0e39c13326271773b809,4c50874f118c0e39c13326271773b809.bam,18.17,1.97,0.08,58cfa82de4b0c9d6adf6a576,4c50874f118c0e39c13326271773b809.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A07I-10A,566792AE-F853-4A47-856D-F02CDCFCB18A,Blood Derived Normal,Illumina HiSeq,21138e96-7fba-4eca-b82b-98786a6858c3,Breast,69,B7C62DF0-BE41-43B9-B114-C5704CA024FA,EBE37974-093B-488C-8557-1DDA59F6700B,TCGA-A8-A07I-10A-01D-A19H-09,GRCh37-lite,TCGA-A8-A07I,TCGA-BRCA,NA,s6913,Washington University School of Medicine,Indivumed,Germany,NO,T2,N2a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82de4b0c9d6adf6a664,58cfa82de4b0c9d6adf6a664,80cf68d3db27707d203e2bac230d56fd.filtered.,WGS,80cf68d3db27707d203e2bac230d56fd,80cf68d3db27707d203e2bac230d56fd.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a664,80cf68d3db27707d203e2bac230d56fd.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3002-03A,478F29B1-6604-4E75-A492-47C384799F44,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,19b4d8c8-60b2-481f-a9e6-44e09dd8101b,Blood,68,61C0F3DF-32C8-4BCE-816B-39579F06BC5B,320EBE6F-48BD-40F1-9BE5-1401A3BFF328,TCGA-AB-3002-03A-01D-0739-09,GRCh37-lite,TCGA-AB-3002,TCGA-LAML,1431,s7250,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72ef5,58cfa83ce4b0c9d6adf72ef5,b06b8cd86c7ef5c244907175371d34fe.filtered.,WGS,b06b8cd86c7ef5c244907175371d34fe,b06b8cd86c7ef5c244907175371d34fe.bam,18.46,2.12,0.07,58cfa83ce4b0c9d6adf72ef5,b06b8cd86c7ef5c244907175371d34fe.bam,Dead,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TE-10A,09066FBF-6A1D-46C9-A4C5-C53340C3D1BA,Blood Derived Normal,Illumina HiSeq,e66bee8b-c99d-40d8-876b-6fee2148789d,Uterus,35,0DBD157F-3CC0-4364-B76D-5E6775BA82BC,362E74BD-A76C-4303-ACCB-FB77C488CFD9,TCGA-BS-A0TE-10A-01D-A10B-09,GRCh37-lite,TCGA-BS-A0TE,TCGA-UCEC,146,s5184,Washington University School of Medicine,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6be48,58cfa830e4b0c9d6adf6be48,TCGA-AB-2973-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2973-03A-01D-0739-09_whole,TCGA-AB-2973-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6be48,TCGA-AB-2973-03A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2973-03A,B234D53E-CC20-41C0-9F21-31DB53570A37,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,21759ef3-42d4-4fe6-b319-3e3e4b3f895d,Blood,68,F5A6B358-4924-4EE2-8687-363900A008E8,74DFDE23-DEBB-4C0C-80CB-E06928350B5D,TCGA-AB-2973-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2973,TCGA-LAML,609,s7150,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a508,58cfa82de4b0c9d6adf6a508,3ff0f4f5e508ac0ae2c9b8406e4ff866.filtered.,WGS,3ff0f4f5e508ac0ae2c9b8406e4ff866,3ff0f4f5e508ac0ae2c9b8406e4ff866.bam,32.07,1.75,0.07,58cfa82de4b0c9d6adf6a508,3ff0f4f5e508ac0ae2c9b8406e4ff866.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A05A-10A,C350B53B-3C27-4B9E-8B57-D7B6A1205A1F,Blood Derived Normal,Illumina HiSeq,0cc0d677-617d-4b5d-aae8-f65ef03bee67,Uterus,81,723254A1-4F6F-4CD0-A39F-987A211D06CB,C3AF584A-7000-4B6C-BBE9-C27AC5787B0C,TCGA-AP-A05A-10A-01D-A013-09,GRCh37-lite,TCGA-AP-A05A,TCGA-UCEC,NA,s4408,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a604,58cfa82de4b0c9d6adf6a604,58e6c0baa765d066b3f684ce34db256c.filtered.,WGS,58e6c0baa765d066b3f684ce34db256c,58e6c0baa765d066b3f684ce34db256c.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a604,58e6c0baa765d066b3f684ce34db256c.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2979-03A,CE7E25DC-5DF9-48C5-8F9F-756F6CF765EB,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,e491dbf1-cc30-4493-bd32-4f6c09f6d468,Blood,30,0C692014-1ED0-4429-B119-1D962763CADE,CAB2ED1C-B8A3-471C-92B6-0FE54753926C,TCGA-AB-2979-03A-01D-0742-05,GRCh37-lite,TCGA-AB-2979,TCGA-LAML,NA,s7163,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72ed2,58cfa83ce4b0c9d6adf72ed2,e56897f24c88626691bc08634cbc51bb.filtered.,WGS,e56897f24c88626691bc08634cbc51bb,e56897f24c88626691bc08634cbc51bb.bam,NA,NA,NA,58cfa83ce4b0c9d6adf72ed2,e56897f24c88626691bc08634cbc51bb.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2987-11A,C147D12E-5E96-484E-BBE7-DC2F11F889BF,Solid Tissue Normal,Illumina GA,f137b969-aa9b-4f6a-ba66-2c9b21c41562,Blood,75,4EA1FFB5-1804-4EB8-9AC6-DD30B34FE6AC,E0CC389E-0E7C-4E40-885E-4B3427F1CC36,TCGA-AB-2987-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2987,TCGA-LAML,184,s7281,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf731c2,58cfa83ce4b0c9d6adf731c2,e6f20b27cf3971b0bf7f78af02114fc1.filtered.,WGS,e6f20b27cf3971b0bf7f78af02114fc1,e6f20b27cf3971b0bf7f78af02114fc1.bam,20.54,1.98,0.08,58cfa83ce4b0c9d6adf731c2,e6f20b27cf3971b0bf7f78af02114fc1.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GG-10A,A8614C49-C7F1-4DE9-BD2F-4764B094D604,Blood Derived Normal,Illumina HiSeq,06f659a7-850f-4d24-9f9f-b9a7d0a9880a,Uterus,76,92D9F630-53A4-43E6-802B-3453E52C38C0,EE71EF18-E07D-438B-B31F-FBAED2A8A2A8,TCGA-A5-A0GG-10A-01D-A122-09,GRCh37-lite,TCGA-A5-A0GG,TCGA-UCEC,NA,s4975,Washington University School of Medicine,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a686,58cfa82de4b0c9d6adf6a686,666886d606520f78a6620cf9eb2e88cb.filtered.,WGS,666886d606520f78a6620cf9eb2e88cb,666886d606520f78a6620cf9eb2e88cb.bam,84.49,1.9,0.08,58cfa82de4b0c9d6adf6a686,666886d606520f78a6620cf9eb2e88cb.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A0J2-10A,D2F2560C-EC80-4FEA-9474-C47A2E85EA95,Blood Derived Normal,Illumina HiSeq,67104b13-f236-4501-aa7e-6a7eab9ec28e,Breast,41,7664E64F-BB15-4C10-B1C2-E2B85A512D58,5AFDC08C-4860-498E-8E4E-91D148812E62,TCGA-AO-A0J2-10A-01D-A19H-09,GRCh37-lite,TCGA-AO-A0J2,TCGA-BRCA,NA,s6114,Washington University School of Medicine,MSKCC,None,NO,T1c,N0 (i-),Infiltrating Ductal Carcinoma,Stage IA
13722.58cfa830e4b0c9d6adf6bdbc,58cfa830e4b0c9d6adf6bdbc,TCGA-AO-A0J6-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-AO-A0J6-10A-01D-A128-09_IlluminaGA-DNASeq_whole,TCGA-AO-A0J6-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,57.92,1.8,0.08,58cfa830e4b0c9d6adf6bdbc,TCGA-AO-A0J6-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A0J6-10A,E9F4F373-37A5-48AD-A1A0-B0D47820111A,Blood Derived Normal,Illumina HiSeq,6de10403-e69b-4372-a6f5-e74b01a70129,Breast,61,DD87D6FA-B756-4C73-BF7E-FF325D364F30,65EFED79-CE4A-4318-B8CC-B542AF419B26,TCGA-AO-A0J6-10A-01D-A128-09,GRCh37-lite,TCGA-AO-A0J6,TCGA-BRCA,NA,s5799,Washington University School of Medicine,MSKCC,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82fe4b0c9d6adf6b266,58cfa82fe4b0c9d6adf6b266,TCGA-14-1459-10A-01D-0703-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-14-1459-10A-01D-0703-09_IlluminaGA-DNASeq_whole,TCGA-14-1459-10A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,49.9,1.9,0.14,58cfa82fe4b0c9d6adf6b266,TCGA-14-1459-10A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1459-10A,0798DBE2-1914-427C-A2FE-2A865D0D6EDA,Blood Derived Normal,Illumina GA,e4c857f4-8489-4152-b0fb-7532b6d770e2,Brain,63,67D92F3A-1CBE-4E4E-A8C4-27BE346C1781,65F88317-181A-4CAC-B481-747F84D74FCA,TCGA-14-1459-10A-01D-0703-09,NCBI36_WUGSC_variant,TCGA-14-1459,TCGA-GBM,378,s14032,Washington University School of Medicine,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf72f5b,58cfa83ce4b0c9d6adf72f5b,f1e7a5ba6e5ad7aad6338ba55e41b390.filtered.,WGS,f1e7a5ba6e5ad7aad6338ba55e41b390,f1e7a5ba6e5ad7aad6338ba55e41b390.bam,16.05,1.94,0.07,58cfa83ce4b0c9d6adf72f5b,f1e7a5ba6e5ad7aad6338ba55e41b390.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A08B-10A,D8D7A6C2-6427-4F47-968C-6C3AFFBA4617,Blood Derived Normal,Illumina HiSeq,ae70c8e9-45c8-4382-966a-e8787009508e,Breast,52,64DA7621-012A-479E-AEA6-FD5AF093CDCB,8EE200E1-EA79-4AF1-87C4-831A4B590ECB,TCGA-A8-A08B-10A-01D-A19H-09,GRCh37-lite,TCGA-A8-A08B,TCGA-BRCA,NA,s6968,Washington University School of Medicine,Indivumed,Germany,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6abe5,58cfa82ee4b0c9d6adf6abe5,G35154.TCGA-TQ-A8XE-10A-01D-A367-08.3.filtered.,WGS,G35154.TCGA-TQ-A8XE-10A-01D-A367-08.3,G35154.TCGA-TQ-A8XE-10A-01D-A367-08.3.bam,66.62,NA,0.09,58cfa82ee4b0c9d6adf6abe5,G35154.TCGA-TQ-A8XE-10A-01D-A367-08.3.bam,Dead,FEMALE,WHITE,HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-TQ-A8XE-10A,135A149A-D153-465E-AA58-06D47BB18E00,Blood Derived Normal,Illumina HiSeq,4558b98c-62e9-4761-8420-ead31f2035fa,Brain,42,AA9965CE-6A23-4F0B-9374-05192D5E5AA7,722D3DF5-7254-44F0-BBE0-CF39DBD57866,TCGA-TQ-A8XE-10A-01D-A367-08,HG19_Broad_variant,TCGA-TQ-A8XE,TCGA-LGG,954,s8338,Broad Institute of MIT and Harvard,University of Sao Paulo,Brazil,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa830e4b0c9d6adf6bbae,58cfa830e4b0c9d6adf6bbae,TCGA-A2-A0D2-01A-21D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-A2-A0D2-01A-21D-A128-09_IlluminaGA-DNASeq_whole,TCGA-A2-A0D2-01A-21D-A128-09_IlluminaGA-DNASeq_whole.bam,61.59,1.89,0.08,58cfa830e4b0c9d6adf6bbae,TCGA-A2-A0D2-01A-21D-A128-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A0D2-01A,99E32C59-AA73-43FA-88C9-399DDADB2C72,Primary Tumor,Illumina HiSeq,221d4b81-a70e-4647-8a9a-ce4866538392,Breast,45,72439E36-3C17-4A90-B3E1-8F6CCFD3DCD4,51A5A15A-1551-469F-A5B0-09581EC47975,TCGA-A2-A0D2-01A-21D-A128-09,GRCh37-lite,TCGA-A2-A0D2,TCGA-BRCA,NA,s5488,Washington University School of Medicine,Walter Reed,None,NO,T2,N0 (i+),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa83ce4b0c9d6adf73162,58cfa83ce4b0c9d6adf73162,cbb71293874ccb1d6a912a9d7324e86e.filtered.,WGS,cbb71293874ccb1d6a912a9d7324e86e,cbb71293874ccb1d6a912a9d7324e86e.bam,NA,NA,NA,58cfa83ce4b0c9d6adf73162,cbb71293874ccb1d6a912a9d7324e86e.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2986-11A,233400C5-6A47-40E2-BF2A-8B7FC9DF462B,Solid Tissue Normal,Illumina GA,bf8e82cc-bde2-4def-91be-d82650c2c3be,Blood,31,F169634F-4742-457E-815A-87386C5B0306,D6E1248C-8BB3-4040-A0D2-C010EDC8E56D,TCGA-AB-2986-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2986,TCGA-LAML,212,s7008,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf7305c,58cfa83ce4b0c9d6adf7305c,be7865b871df206f1b481d3f6f2e16c4.filtered.,WGS,be7865b871df206f1b481d3f6f2e16c4,be7865b871df206f1b481d3f6f2e16c4.bam,NA,NA,NA,58cfa83ce4b0c9d6adf7305c,be7865b871df206f1b481d3f6f2e16c4.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2983-11A,082CA353-A5AE-421F-AE58-098257A1425F,Solid Tissue Normal,Illumina GA,9cfc4eb7-3c47-4ac3-bea9-869e65cdd0f0,Blood,45,69C09921-B570-489A-95B4-6CD733E89A05,707D05C9-0DF6-4ED0-91A2-5CB30B3B42B8,TCGA-AB-2983-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2983,TCGA-LAML,335,s7244,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6a96c,58cfa82ee4b0c9d6adf6a96c,G35154.TCGA-DU-6404-10A-01D-A461-08.3.filtered.,WGS,G35154.TCGA-DU-6404-10A-01D-A461-08.3,G35154.TCGA-DU-6404-10A-01D-A461-08.3.bam,53.3,1.8,0.07,58cfa82ee4b0c9d6adf6a96c,G35154.TCGA-DU-6404-10A-01D-A461-08.3.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6404-10A,C0D47E0F-4918-4E06-9DB6-201671B1259C,Blood Derived Normal,Illumina HiSeq,83019f18-87de-42c9-b3af-30c0cd151fe0,Brain,24,4035393D-D331-4D0C-95C7-5B00ACD26035,934D95EC-4AE8-48AF-ACC1-87DAD8B41F8C,TCGA-DU-6404-10A-01D-A461-08,HG19_Broad_variant,TCGA-DU-6404,TCGA-LGG,4068,s8547,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82de4b0c9d6adf6a5e2,58cfa82de4b0c9d6adf6a5e2,4ed73476767e3b022a96ccdb6c9375dd.filtered.,WGS,4ed73476767e3b022a96ccdb6c9375dd,4ed73476767e3b022a96ccdb6c9375dd.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a5e2,4ed73476767e3b022a96ccdb6c9375dd.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2974-03A,FF7839BB-176E-4483-AC6E-7FAE9F6E2E54,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,461fc0ef-c918-4054-a57f-693b7153435c,Blood,67,43B83836-5FF0-4239-88FA-7A5B07FDF5E1,95DD5CF4-2A97-4993-A4F4-6D1EAE738B6F,TCGA-AB-2974-03A-01D-0742-05,GRCh37-lite,TCGA-AB-2974,TCGA-LAML,92,s7203,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6ab96,58cfa82ee4b0c9d6adf6ab96,G35154.TCGA-FG-7643-10A-01D-2086-08.2.filtered.,WGS,G35154.TCGA-FG-7643-10A-01D-2086-08.2,G35154.TCGA-FG-7643-10A-01D-2086-08.2.bam,93.3,NA,0.05,58cfa82ee4b0c9d6adf6ab96,G35154.TCGA-FG-7643-10A-01D-2086-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-7643-10A,B6F13250-31B3-46AD-B514-5A684F1094A9,Blood Derived Normal,Illumina HiSeq,74141a93-8537-46c9-b176-28adb5fb5f94,Brain,49,C3C1221B-21B1-4975-B566-E562FE12521B,D0E20B08-CF3B-41E9-A116-5F157DE4A40B,TCGA-FG-7643-10A-01D-2086-08,HG19_Broad_variant,TCGA-FG-7643,TCGA-LGG,NA,s8535,Broad Institute of MIT and Harvard,Case Western,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa830e4b0c9d6adf6be4e,58cfa830e4b0c9d6adf6be4e,TCGA-AB-3009-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-3009-03A-01D-0739-09_whole,TCGA-AB-3009-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6be4e,TCGA-AB-3009-03A-01D-0739-09_whole.bam,Dead,MALE,Not available,Not available,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3009-03A,C9B92F8F-4599-47D1-9D12-31E42166A091,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,db39d6c7-345c-462f-ae6f-fba90d4eefe5,Blood,23,197053E3-848F-4D62-AEFB-A8E0FAA23967,DDA8A1D8-DD5B-4640-8F48-A2EF2F4898DC,TCGA-AB-3009-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-3009,TCGA-LAML,577,s7126,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a6fc,58cfa82de4b0c9d6adf6a6fc,9ca76c5419b7c28caff81be798afdf6d.filtered.,WGS,9ca76c5419b7c28caff81be798afdf6d,9ca76c5419b7c28caff81be798afdf6d.bam,17.89,1.98,0.08,58cfa82de4b0c9d6adf6a6fc,9ca76c5419b7c28caff81be798afdf6d.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A15E-10A,0A2A3529-F645-4967-9A58-89EE20B8BB62,Blood Derived Normal,Illumina HiSeq,9ed4cd7a-c9d6-47d6-8258-def05e151530,Breast,40,0927DA66-1240-460C-96C4-9EA25A71F94A,F99107DC-06E1-495F-83C9-3E17DC858FE5,TCGA-E2-A15E-10A-01D-A19H-09,GRCh37-lite,TCGA-E2-A15E,TCGA-BRCA,NA,s5955,Washington University School of Medicine,Roswell Park,None,NO,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6a8a6,58cfa82ee4b0c9d6adf6a8a6,G35154.TCGA-E1-5319-10A-01D-1893-08.5.filtered.,WGS,G35154.TCGA-E1-5319-10A-01D-1893-08.5,NA,NA,NA,NA,58cfa82ee4b0c9d6adf6a8a6,G35154.TCGA-E1-5319-10A-01D-1893-08.5.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-E1-5319-10A,84569C1A-6BAA-4380-AE3C-707DF1BE4618,Blood Derived Normal,Illumina HiSeq,d36d48eb-6148-40c8-be7d-706f53852d54,Brain,48,B2C67E4F-BA75-4085-A0C4-3732031E976E,1121C5C3-E239-4EDF-AA09-AF5DBFABAAEA,TCGA-E1-5319-10A-01D-1893-08,HG19_Broad_variant,TCGA-E1-5319,TCGA-LGG,2907,NA,NA,NA,NA,NA,NA,NA,NA,NA
13722.58cfa82ee4b0c9d6adf6ab18,58cfa82ee4b0c9d6adf6ab18,G35154.TCGA-TM-A7CF-10A-01D-A329-08.4.filtered.,WGS,G35154.TCGA-TM-A7CF-10A-01D-A329-08.4,G35154.TCGA-TM-A7CF-10A-01D-A329-08.4.bam,8.27,NA,0.08,58cfa82ee4b0c9d6adf6ab18,G35154.TCGA-TM-A7CF-10A-01D-A329-08.4.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-TM-A7CF-10A,033C1F48-9225-4159-B23B-7042272877DA,Blood Derived Normal,Illumina HiSeq,96ad4e5b-aeec-4421-9d5e-120287a57086,Brain,41,251ACE07-1FFA-46BA-869C-5356709635E1,C6066220-B6FD-47D0-8DAF-6ECEB9A01B57,TCGA-TM-A7CF-10A-01D-A329-08,HG19_Broad_variant,TCGA-TM-A7CF,TCGA-LGG,NA,s8121,Broad Institute of MIT and Harvard,The University of New South Wales,Australia,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa82de4b0c9d6adf6a534,58cfa82de4b0c9d6adf6a534,49320cdd49b83c21082251cf7413af62.filtered.,WGS,49320cdd49b83c21082251cf7413af62,49320cdd49b83c21082251cf7413af62.bam,NA,NA,0.08,58cfa82de4b0c9d6adf6a534,49320cdd49b83c21082251cf7413af62.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A051-01A,B045F24B-F822-4DF9-9FFA-47308EDCEC8C,Primary Tumor,Illumina HiSeq,16685246-b33b-4810-9cef-2ec37924f621,Uterus,69,417CFF62-B034-4197-9CFD-E640D55F3094,BCF858FD-CC3B-4FDE-AB10-EB96216F4366,TCGA-AP-A051-01A-21D-A013-09,GRCh37-lite,TCGA-AP-A051,TCGA-UCEC,NA,s5190,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bce1,58cfa830e4b0c9d6adf6bce1,TCGA-AB-2966-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2966-11A-01D-0739-09_whole,TCGA-AB-2966-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bce1,TCGA-AB-2966-11A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2966-11A,B1C32911-5CA8-4B77-8063-A97C30A3A348,Solid Tissue Normal,Illumina GA,1a823c31-c832-43d1-9776-91103885b35a,Blood,57,6CB66BC3-414A-4443-9289-628F2D64012F,8B0F12C9-65DD-4A1E-9BBA-ACE290EDFDDC,TCGA-AB-2966-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2966,TCGA-LAML,854,s7236,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a595,58cfa82de4b0c9d6adf6a595,5d0262da4025c9d30132153329060e06.filtered.,WGS,5d0262da4025c9d30132153329060e06,5d0262da4025c9d30132153329060e06.bam,32.74,2,0.07,58cfa82de4b0c9d6adf6a595,5d0262da4025c9d30132153329060e06.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-C8-A12Q-10A,A824B3BD-34D5-4CC1-A92F-F9D6AC0F1814,Blood Derived Normal,Illumina HiSeq,53c73214-7b73-4c24-9cae-1c11fcb39573,Breast,78,5766227F-4D93-4917-9D26-6A5685443047,C3591328-2299-4C71-976A-064724A24C86,TCGA-C8-A12Q-10A-01D-A19H-09,GRCh37-lite,TCGA-C8-A12Q,TCGA-BRCA,NA,s6263,Washington University School of Medicine,ILSbio,None,NO,T1,N2,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82ee4b0c9d6adf6a940,58cfa82ee4b0c9d6adf6a940,G35154.TCGA-HT-A5R7-10A-01D-A289-08.2.filtered.,WGS,G35154.TCGA-HT-A5R7-10A-01D-A289-08.2,G35154.TCGA-HT-A5R7-10A-01D-A289-08.2.bam,12.44,NA,0.07,58cfa82ee4b0c9d6adf6a940,G35154.TCGA-HT-A5R7-10A-01D-A289-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-A5R7-10A,7E41BABA-7EF6-4030-B595-D95CD96336B5,Blood Derived Normal,Illumina HiSeq,80186405-a532-4ebd-9122-8575deff3ec0,Brain,33,7C8A06FB-B7E5-4E0B-9079-5F2E7798A7E7,45EC553B-1E7A-4B3C-86A1-C3F1547C1B43,TCGA-HT-A5R7-10A-01D-A289-08,HG19_Broad_variant,TCGA-HT-A5R7,TCGA-LGG,NA,s8548,Broad Institute of MIT and Harvard,Case Western - St Joes,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa82de4b0c9d6adf6a68e,58cfa82de4b0c9d6adf6a68e,94a63ac4ef2470897bddaa15760a6e4c.filtered.,WGS,94a63ac4ef2470897bddaa15760a6e4c,94a63ac4ef2470897bddaa15760a6e4c.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a68e,94a63ac4ef2470897bddaa15760a6e4c.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2992-11A,BEC60BDD-34E7-467C-8662-F3A1BB1A4361,Solid Tissue Normal,Illumina GA,25f893a0-7c82-4111-bc7a-43819e613133,Blood,32,0BBBBAD2-C5BC-4665-8827-3D4A6E652115,844D8005-5BA1-4480-B5B2-939B59F155C7,TCGA-AB-2992-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2992,TCGA-LAML,1706,s6980,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6bb9e,58cfa830e4b0c9d6adf6bb9e,TCGA-A2-A04P-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-A2-A04P-10A-01D-A128-09_IlluminaGA-DNASeq_whole,TCGA-A2-A04P-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,24.55,1.83,0.07,58cfa830e4b0c9d6adf6bb9e,TCGA-A2-A04P-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A04P-10A,CCD4A24B-D8CC-4686-9DEE-C98B0C5A8D21,Blood Derived Normal,Illumina HiSeq,38b3f71f-fbf5-46cd-91b9-a6233ac79a89,Breast,36,C8A2B99E-2188-43E4-A7CB-3DD57D4E7662,07F6C203-D1CF-4C40-B181-B717D327DADE,TCGA-A2-A04P-10A-01D-A128-09,GRCh37-lite,TCGA-A2-A04P,TCGA-BRCA,548,s5957,Washington University School of Medicine,Walter Reed,None,NO,T2,N3c,Infiltrating Ductal Carcinoma,Stage IIIC
13722.58cfa83ce4b0c9d6adf730d2,58cfa83ce4b0c9d6adf730d2,fe64a65ffd884efa5c68f02a56f4a1b7.filtered.,WGS,fe64a65ffd884efa5c68f02a56f4a1b7,fe64a65ffd884efa5c68f02a56f4a1b7.bam,NA,NA,NA,58cfa83ce4b0c9d6adf730d2,fe64a65ffd884efa5c68f02a56f4a1b7.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3000-11A,92C7E4D6-EB53-46C5-9721-5EDCCD60BCC9,Solid Tissue Normal,Illumina GA,06b92c0b-4443-4d37-9a22-60bd9d6bb1e7,Blood,25,D01A0802-4697-4F66-8E52-325CC4F9CAF2,C9E8FC7E-5BA0-424A-8659-433C2A7470EA,TCGA-AB-3000-11A-01D-0739-09,GRCh37-lite,TCGA-AB-3000,TCGA-LAML,NA,s7302,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a662,58cfa82de4b0c9d6adf6a662,80be1fa83e4a0219f965195a2ad79e1b.filtered.,WGS,80be1fa83e4a0219f965195a2ad79e1b,80be1fa83e4a0219f965195a2ad79e1b.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a662,80be1fa83e4a0219f965195a2ad79e1b.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2977-03A,F95063BC-A640-4980-99A7-84645902DAF4,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,b26924c1-8cea-45bc-9be6-acd2b870cd47,Blood,71,87A5E85B-00C3-4EB7-9548-F2B83F6AFAC3,DC0E4E36-BDAE-409B-BE53-28846728D145,TCGA-AB-2977-03A-01D-0742-05,GRCh37-lite,TCGA-AB-2977,TCGA-LAML,31,s7249,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf7310a,58cfa83ce4b0c9d6adf7310a,e10d6e76bf02882a7cdce5e0f118999b.filtered.,WGS,e10d6e76bf02882a7cdce5e0f118999b,e10d6e76bf02882a7cdce5e0f118999b.bam,32.1,1.76,0.07,58cfa83ce4b0c9d6adf7310a,e10d6e76bf02882a7cdce5e0f118999b.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A052-10A,BD4284A7-260D-48B3-9B48-A1C578C30D27,Blood Derived Normal,Illumina HiSeq,2844857a-242f-437c-b0bb-49ecd044b5a6,Uterus,59,BBE82112-697D-4494-9D9C-39C702C98759,6083E755-4747-4CBB-BD42-610DFC921197,TCGA-AP-A052-10A-01D-A013-09,GRCh37-lite,TCGA-AP-A052,TCGA-UCEC,669,s4977,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf7318a,58cfa83ce4b0c9d6adf7318a,b9b59f0a3db1c43860323cf55065ceea.filtered.,WGS,b9b59f0a3db1c43860323cf55065ceea,b9b59f0a3db1c43860323cf55065ceea.bam,41.74,NA,0.08,58cfa83ce4b0c9d6adf7318a,b9b59f0a3db1c43860323cf55065ceea.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A8I1-01A,83762308-4DBA-4870-B90B-64331EBC9BAA,Primary Tumor,HiSeq X Ten,70bf5b6f-2768-47aa-a773-848a8d074fc8,Esophagus,67,26EE8DBB-1D32-4E9A-BE19-7C35F490B068,62B389FA-2DB2-4B3A-9168-021BFEA8D00F,TCGA-LN-A8I1-01A-11D-A36J-09,GRCh37-lite_WUGSC_variant_2,TCGA-LN-A8I1,TCGA-ESCA,NA,s1902,Washington University School of Medicine,ILSbio,Vietnam,NO,T2,N0,Not available,Stage IIA
13722.58cfa83ce4b0c9d6adf73150,58cfa83ce4b0c9d6adf73150,b2c5a3ae7ac562e837c4d8d068119dec.filtered.,WGS,b2c5a3ae7ac562e837c4d8d068119dec,b2c5a3ae7ac562e837c4d8d068119dec.bam,39.47,1.77,0.08,58cfa83ce4b0c9d6adf73150,b2c5a3ae7ac562e837c4d8d068119dec.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LE-10A,DCFF8659-ECCA-4798-80A3-DD6E7642BA2B,Blood Derived Normal,Illumina HiSeq,732dc027-ea60-49a0-b044-9af39c83a89e,Uterus,57,764C141D-BE49-41C1-927B-703931B5568C,E37D65E5-FF01-4A16-A3EC-A2331FC26943,TCGA-AP-A0LE-10A-01D-A10B-09,GRCh37-lite,TCGA-AP-A0LE,TCGA-UCEC,NA,s4762,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6b046,58cfa82ee4b0c9d6adf6b046,TCGA-06-0155-01B-01D-0932-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-06-0155-01B-01D-0932-09_IlluminaGA-DNASeq_whole,TCGA-06-0155-01B-01D-0932-09_IlluminaGA-DNASeq_whole.bam,389,1.8,0.18,58cfa82ee4b0c9d6adf6b046,TCGA-06-0155-01B-01D-0932-09_IlluminaGA-DNASeq_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0155-01B,FA1F1CFC-9DA0-488B-93FE-60AAFF99C171,Primary Tumor,Illumina GA,e23ee283-1f56-4bab-bb3e-9827ed7450b4,Brain,61,F035DBEB-9ED9-43CE-8411-6BA26A707254,EAB71331-53D3-4CF5-96C9-5121A3962C27,TCGA-06-0155-01B-01D-0932-09,NCBI36_WUGSC_variant,TCGA-06-0155,TCGA-GBM,318,s13897,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf73108,58cfa83ce4b0c9d6adf73108,b0f4d56d8be7b73ada803e2771e3522a.filtered.,WGS,b0f4d56d8be7b73ada803e2771e3522a,b0f4d56d8be7b73ada803e2771e3522a.bam,35.11,1.93,0.08,58cfa83ce4b0c9d6adf73108,b0f4d56d8be7b73ada803e2771e3522a.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0L9-10A,7B9947D5-E86B-4006-8890-EA5209584A88,Blood Derived Normal,Illumina HiSeq,a9cd0625-86d7-481a-aa20-f4b73233c820,Uterus,71,60EAC6D9-6404-4C11-A30C-3986D1CACAF2,C76F76C4-92B7-4FA5-9CDC-6FF6E553C1D4,TCGA-AP-A0L9-10A-01D-A066-09,GRCh37-lite,TCGA-AP-A0L9,TCGA-UCEC,NA,s5182,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf72efd,58cfa83ce4b0c9d6adf72efd,d0534a788e290a4d7cca07e9833b2ce8.filtered.,WGS,d0534a788e290a4d7cca07e9833b2ce8,d0534a788e290a4d7cca07e9833b2ce8.bam,389,1.8,0.18,58cfa83ce4b0c9d6adf72efd,d0534a788e290a4d7cca07e9833b2ce8.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0155-01B,FA1F1CFC-9DA0-488B-93FE-60AAFF99C171,Primary Tumor,Illumina GA,6cd2923d-8a50-4943-8cbe-f5f3151434e6,Brain,61,F035DBEB-9ED9-43CE-8411-6BA26A707254,EAB71331-53D3-4CF5-96C9-5121A3962C27,TCGA-06-0155-01B-01D-0932-09,GRCh37-lite,TCGA-06-0155,TCGA-GBM,318,s13963,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6afee,58cfa82ee4b0c9d6adf6afee,TCGA-06-0881-10A-01D-0512-09_whole.filtered.,WGS,TCGA-06-0881-10A-01D-0512-09_whole,TCGA-06-0881-10A-01D-0512-09_whole.bam,36.67,1.89,0.15,58cfa82ee4b0c9d6adf6afee,TCGA-06-0881-10A-01D-0512-09_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0881-10A,1B6C184A-5868-4A51-8A82-AA16A7E65126,Blood Derived Normal,Illumina GA,aa6426ef-df52-44f4-9d5d-367de32e1563,Brain,50,0EDD4B97-AFEE-4D69-B2F6-ACBCF13A94EF,6050F994-F394-4C1C-93CE-D36733AA9AE9,TCGA-06-0881-10A-01D-0512-09,NCBI36_WUGSC_variant,TCGA-06-0881,TCGA-GBM,NA,s14226,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf72f16,58cfa83ce4b0c9d6adf72f16,e3cdf5ee3416fcab177764dcc976d554.filtered.,WGS,e3cdf5ee3416fcab177764dcc976d554,e3cdf5ee3416fcab177764dcc976d554.bam,NA,NA,NA,58cfa83ce4b0c9d6adf72f16,e3cdf5ee3416fcab177764dcc976d554.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2971-11A,5ECE14FD-3D7F-4ECB-96AA-2C44D8F15CA4,Solid Tissue Normal,Illumina GA,16fc690a-4a1b-4cc3-8aaa-3e697990c7eb,Blood,76,B53E190A-D776-440E-BB83-F412E357F5FC,3B98AB49-9AE4-461A-8E29-BE6E97425D04,TCGA-AB-2971-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2971,TCGA-LAML,792,s7131,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6a8d0,58cfa82ee4b0c9d6adf6a8d0,G35154.TCGA-CS-6665-10A-01D-1893-08.2.filtered.,WGS,G35154.TCGA-CS-6665-10A-01D-1893-08.2,G35154.TCGA-CS-6665-10A-01D-1893-08.2.bam,237,1.8,0.05,58cfa82ee4b0c9d6adf6a8d0,G35154.TCGA-CS-6665-10A-01D-1893-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-6665-10A,C16D9F69-26F9-4EC7-B2D5-FF9F7DACFE0F,Blood Derived Normal,Illumina HiSeq,63dafea0-a011-4868-ae45-ad0d1524303a,Brain,51,1B98B990-ED6B-4EC9-96AF-9F690CAABCA6,C4574016-BC61-4FB5-92C6-EFCCEC8CDC5D,TCGA-CS-6665-10A-01D-1893-08,HG19_Broad_variant,TCGA-CS-6665,TCGA-LGG,NA,s8525,Broad Institute of MIT and Harvard,Thomas Jefferson University,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa82fe4b0c9d6adf6b306,58cfa82fe4b0c9d6adf6b306,TCGA-24-1103-01A-01D-0515-09_whole.filtered.,WGS,TCGA-24-1103-01A-01D-0515-09_whole,TCGA-24-1103-01A-01D-0515-09_whole.bam,397.67,1.9,0.15,58cfa82fe4b0c9d6adf6b306,TCGA-24-1103-01A-01D-0515-09_whole.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1103-01A,F34AA3B6-E966-49C6-BC55-130545772C53,Primary Tumor,Illumina GA,eaeb6b7d-1e14-46ed-95d2-75c5bbee93af,Ovary,50,6F9A6F73-285D-4A9C-80EB-5F2EBC1787A4,2C9DC04B-E9EC-4CF1-AB2C-A18EDB30DD37,TCGA-24-1103-01A-01D-0515-09,NCBI36_WUGSC_variant,TCGA-24-1103,TCGA-OV,1646,s17715,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf7312e,58cfa83ce4b0c9d6adf7312e,b9774dd35c320f70de8f2b81c15d5a98.filtered.,WGS,b9774dd35c320f70de8f2b81c15d5a98,b9774dd35c320f70de8f2b81c15d5a98.bam,29.12,1.95,0.08,58cfa83ce4b0c9d6adf7312e,b9774dd35c320f70de8f2b81c15d5a98.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A03L-10A,1174F6E4-FFBE-4E59-A000-8D861C968369,Blood Derived Normal,Illumina HiSeq,03cb8dc7-1f67-4e48-a45f-f95f827694cd,Breast,34,B51D49B7-1893-45E0-94FE-BA3D75616063,EA97B47F-1E01-42C0-AE0A-6E961E665C5E,TCGA-AO-A03L-10A-01D-A19H-09,GRCh37-lite,TCGA-AO-A03L,TCGA-BRCA,NA,s6607,Washington University School of Medicine,MSKCC,None,NO,T3,N2,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82de4b0c9d6adf6a5a4,58cfa82de4b0c9d6adf6a5a4,456bfad361a76bbdd2eaad97e85a7997.filtered.,WGS,456bfad361a76bbdd2eaad97e85a7997,456bfad361a76bbdd2eaad97e85a7997.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a5a4,456bfad361a76bbdd2eaad97e85a7997.bam,Alive,FEMALE,Not available,Not available,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2982-03A,AE9BBADA-D987-4757-A081-74F005821C09,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,04c340c1-a92e-42f7-9127-ca462ef38d86,Blood,29,F85C74C6-D7EA-4C0C-9CEA-267E5E65CFF8,8370B0EE-A7E7-4FBB-A04E-B31C1D1C7B3C,TCGA-AB-2982-03A-01D-0739-09,GRCh37-lite,TCGA-AB-2982,TCGA-LAML,NA,s7059,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6c22d,58cfa830e4b0c9d6adf6c22d,TCGA-AB-2971-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2971-03A-01D-0739-09_whole,TCGA-AB-2971-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6c22d,TCGA-AB-2971-03A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2971-03A,5ECE14FD-3D7F-4ECB-96AA-2C44D8F15CA4,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,f780fa08-5d0d-4c0b-92f3-7052b52807b2,Blood,76,3FB0C4AC-78B3-43D6-871B-05D1EB46CA62,62D20B8B-A793-432A-895C-D496CD3FAE2C,TCGA-AB-2971-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2971,TCGA-LAML,792,s7186,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6a970,58cfa82ee4b0c9d6adf6a970,G35154.TCGA-DU-5874-10A-01D-1705-08.2.filtered.,WGS,G35154.TCGA-DU-5874-10A-01D-1705-08.2,G35154.TCGA-DU-5874-10A-01D-1705-08.2.bam,145,1.9,0.05,58cfa82ee4b0c9d6adf6a970,G35154.TCGA-DU-5874-10A-01D-1705-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-5874-10A,1CC53ADE-73C0-492B-A7DC-328269FD0E66,Blood Derived Normal,Illumina HiSeq,8fae1d21-7d63-4949-a484-770f1751d03f,Brain,62,89940AF5-5A63-4B89-8461-A906EC04ED7D,0B75BE09-BDD0-435E-84AD-0624C781A430,TCGA-DU-5874-10A-01D-1705-08,HG19_Broad_variant,TCGA-DU-5874,TCGA-LGG,NA,s8742,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6aaca,58cfa82ee4b0c9d6adf6aaca,G32454.TCGA-CF-A27C-10A-01D-A16O-08.1.filtered.,WGS,G32454.TCGA-CF-A27C-10A-01D-A16O-08.1,G32454.TCGA-CF-A27C-10A-01D-A16O-08.1.bam,178.36,1.89,0.09,58cfa82ee4b0c9d6adf6aaca,G32454.TCGA-CF-A27C-10A-01D-A16O-08.1.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CF-A27C-10A,7FEE9D6F-C0EA-43C2-89C2-66D965A077A8,Blood Derived Normal,Illumina HiSeq,ca3f55a3-b068-4298-8352-e30c4c9affad,Bladder,52,1C4C59DC-B0B3-48B0-9888-42891CF1E8F8,7C729B94-1488-4DEC-B534-5D73530E535C,TCGA-CF-A27C-10A-01D-A16O-08,HG19_Broad_variant,TCGA-CF-A27C,TCGA-BLCA,NA,s3249,Broad Institute of MIT and Harvard,ILSbio,Vietnam,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82de4b0c9d6adf6a5f8,58cfa82de4b0c9d6adf6a5f8,6a1c2669142c1e3fb2c470b53c45feda.filtered.,WGS,6a1c2669142c1e3fb2c470b53c45feda,6a1c2669142c1e3fb2c470b53c45feda.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a5f8,6a1c2669142c1e3fb2c470b53c45feda.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2970-11A,088C2E4E-FC4E-4252-84ED-E3CA2C401958,Solid Tissue Normal,Illumina GA,389167fd-ba64-4daf-8414-ecae11f45482,Blood,34,11AE5258-0D63-47DF-B450-3F7E5ECBB6A6,D0983A5D-CB05-4B25-8053-631D52627B28,TCGA-AB-2970-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2970,TCGA-LAML,305,s6977,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6b102,58cfa82ee4b0c9d6adf6b102,TCGA-06-0208-01A-01D-0512-09_whole.filtered.,WGS,TCGA-06-0208-01A-01D-0512-09_whole,TCGA-06-0208-01A-01D-0512-09_whole.bam,311.7,1.9,0.19,58cfa82ee4b0c9d6adf6b102,TCGA-06-0208-01A-01D-0512-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0208-01A,E3711A9B-6D4C-44DF-BBAB-0A675046A5DF,Primary Tumor,Illumina GA,3e91bf5c-1231-4128-be80-2c16914c1276,Brain,52,F76E7120-75E8-4E94-8217-E659C09AD276,073E20B4-035F-4E44-A2AA-A4723915DA87,TCGA-06-0208-01A-01D-0512-09,NCBI36_WUGSC_variant,TCGA-06-0208,TCGA-GBM,256,s13989,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf72e9a,58cfa83ce4b0c9d6adf72e9a,cac40b41b0788460b2a61ebd89541fff.filtered.,WGS,cac40b41b0788460b2a61ebd89541fff,cac40b41b0788460b2a61ebd89541fff.bam,26.52,1.95,0.08,58cfa83ce4b0c9d6adf72e9a,cac40b41b0788460b2a61ebd89541fff.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A1CI-11A,FBA80122-D8B2-4D8D-A032-9767E8160F9F,Solid Tissue Normal,Illumina HiSeq,c97c7a6c-553f-4d7b-9e17-8994f4047d8e,Uterus,61,CAD6C89D-F722-470B-93BC-E8B24C033F0F,B4AA278E-ADFE-48E3-8A92-F5057F05F941,TCGA-AX-A1CI-11A-11D-A135-09,GRCh37-lite,TCGA-AX-A1CI,TCGA-UCEC,NA,s4573,Washington University School of Medicine,Gynecologic Oncology Group,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf72f85,58cfa83ce4b0c9d6adf72f85,aa376a5704c441fe39ce1a21a53e5eaa.filtered.,WGS,aa376a5704c441fe39ce1a21a53e5eaa,aa376a5704c441fe39ce1a21a53e5eaa.bam,29.16,1.98,0.08,58cfa83ce4b0c9d6adf72f85,aa376a5704c441fe39ce1a21a53e5eaa.bam,Alive,FEMALE,Not available,HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A0JM-10A,44BEC761-B603-49C0-8634-F6BFE0319BB1,Blood Derived Normal,Illumina HiSeq,ef8744a1-5a99-4907-a1ad-fd44bb54635d,Breast,40,0D7F390B-70D7-42EE-879C-B399A3D84A6A,440CC94E-413D-464C-9160-91D4B0F81D18,TCGA-AO-A0JM-10A-01D-A19H-09,GRCh37-lite,TCGA-AO-A0JM,TCGA-BRCA,NA,s5777,Washington University School of Medicine,MSKCC,None,NO,T2,N1,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa83ce4b0c9d6adf731e4,58cfa83ce4b0c9d6adf731e4,bd005f17f054b1b98796b9efd0bfb272.filtered.,WGS,bd005f17f054b1b98796b9efd0bfb272,bd005f17f054b1b98796b9efd0bfb272.bam,37.54,1.75,0.08,58cfa83ce4b0c9d6adf731e4,bd005f17f054b1b98796b9efd0bfb272.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A053-10A,AF37D8F0-FEA0-47F6-BE0A-2FB55A5DA5C4,Blood Derived Normal,Illumina HiSeq,8da3862a-d5b8-478c-b9c0-d34cb7ba05a3,Uterus,90,757841ED-29DF-4180-A650-76D65700680F,5ACE153C-C849-4FFC-88DF-E6F1D07C1539,TCGA-AP-A053-10A-01D-A013-09,GRCh37-lite,TCGA-AP-A053,TCGA-UCEC,NA,s4968,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a671,58cfa82de4b0c9d6adf6a671,96b6b9366fa4a60ddc55e4cf49fa68ce.filtered.,WGS,96b6b9366fa4a60ddc55e4cf49fa68ce,96b6b9366fa4a60ddc55e4cf49fa68ce.bam,10.28,NA,0.09,58cfa82de4b0c9d6adf6a671,96b6b9366fa4a60ddc55e4cf49fa68ce.bam,Dead,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OR-11A,09EACBFD-3F4A-4D2B-B7A7-C021535E2981,Solid Tissue Normal,HiSeq X Ten,44073086-432f-413b-b1ac-3bfe334d9e67,Esophagus,83,29773D2B-78DD-4BB2-B44B-A02653783773,BDF32094-4E16-4CEA-906E-C047BF493E06,TCGA-L5-A4OR-11A-11D-A27G-09,GRCh37-lite_WUGSC_variant_2,TCGA-L5-A4OR,TCGA-ESCA,96,s1717,Washington University School of Medicine,University of Michigan,United States,NO,T1,N0,Not available,Stage IA
13722.58cfa83ce4b0c9d6adf72e68,58cfa83ce4b0c9d6adf72e68,c5ad79a412027632ed8d7cb4a27285d5.filtered.,WGS,c5ad79a412027632ed8d7cb4a27285d5,c5ad79a412027632ed8d7cb4a27285d5.bam,NA,NA,NA,58cfa83ce4b0c9d6adf72e68,c5ad79a412027632ed8d7cb4a27285d5.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3001-03A,66392380-A9FE-45B7-9191-60993F3F77F4,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,810acc51-00f3-42f9-a53d-bac39e3e668b,Blood,31,348A5FF5-F680-43F6-BB5D-0EF46575C832,256C854B-E247-40DC-AA06-C99359A0B310,TCGA-AB-3001-03A-01D-0741-05,GRCh37-lite,TCGA-AB-3001,TCGA-LAML,NA,s7280,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a577,58cfa82de4b0c9d6adf6a577,4d55b306c9f948c74d83dd41705f0440.filtered.,WGS,4d55b306c9f948c74d83dd41705f0440,4d55b306c9f948c74d83dd41705f0440.bam,91.17,1.76,0.08,58cfa82de4b0c9d6adf6a577,4d55b306c9f948c74d83dd41705f0440.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A1MQ-01A,EB59CF69-1997-41B9-BF69-69AD7DA292A1,Primary Tumor,Illumina HiSeq,6eef85cb-d9eb-495a-b69a-6944cbd18483,Cervix,35,F5FC27D9-4949-43E9-B358-78CB69D87A3C,A67F4531-99EF-43DF-82F5-F6ABC4B11826,TCGA-C5-A1MQ-01A-11D-A200-09,GRCh37-lite,TCGA-C5-A1MQ,TCGA-CESC,NA,s1163,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,T2b,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa83ce4b0c9d6adf731e8,58cfa83ce4b0c9d6adf731e8,f5c26e99b5958414aeaf70107fafd713.filtered.,WGS,f5c26e99b5958414aeaf70107fafd713,f5c26e99b5958414aeaf70107fafd713.bam,25.4,2.02,0.08,58cfa83ce4b0c9d6adf731e8,f5c26e99b5958414aeaf70107fafd713.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-AR-A0TX-10A,C364E81C-EB1E-4870-AB37-9C661F5F2E3D,Blood Derived Normal,Illumina HiSeq,b17edad3-432f-495b-8595-03a17d1d0544,Breast,64,6B18F307-B774-48D7-AB1D-D8F0984F801A,00741E84-D5CA-4D90-9B67-328E808705AE,TCGA-AR-A0TX-10A-01D-A19H-09,GRCh37-lite,TCGA-AR-A0TX,TCGA-BRCA,NA,s6754,Washington University School of Medicine,Mayo,None,NO,T1,N1,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6a98a,58cfa82ee4b0c9d6adf6a98a,G35154.TCGA-HT-A61B-10A-01D-A29Q-08.2.filtered.,WGS,G35154.TCGA-HT-A61B-10A-01D-A29Q-08.2,G35154.TCGA-HT-A61B-10A-01D-A29Q-08.2.bam,21.42,NA,0.07,58cfa82ee4b0c9d6adf6a98a,G35154.TCGA-HT-A61B-10A-01D-A29Q-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-A61B-10A,CF2A1B98-5693-4C04-9167-F85E69A88A4A,Blood Derived Normal,Illumina HiSeq,303ebcff-0840-40c9-bba1-2f343a9883a3,Brain,22,9E7CE89C-945E-469B-95B1-1780673CBDFA,B32D8211-D6FB-4FBD-9727-536B1E77A69D,TCGA-HT-A61B-10A-01D-A29Q-08,HG19_Broad_variant,TCGA-HT-A61B,TCGA-LGG,NA,s8341,Broad Institute of MIT and Harvard,Case Western - St Joes,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa83ce4b0c9d6adf73096,58cfa83ce4b0c9d6adf73096,adc64ad722779bc2b72f0e887849b1cb.filtered.,WGS,adc64ad722779bc2b72f0e887849b1cb,adc64ad722779bc2b72f0e887849b1cb.bam,NA,NA,NA,58cfa83ce4b0c9d6adf73096,adc64ad722779bc2b72f0e887849b1cb.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3008-11A,898A092E-89FE-4010-AFEA-14C605F99481,Solid Tissue Normal,Illumina GA,72e1624a-d8fd-4f9f-93df-b723298329b2,Blood,22,DAE4AD8F-FEDD-49B2-9E53-84524D2A3B1A,F4101358-99F4-4E2D-9203-DF902712E354,TCGA-AB-3008-11A-01D-0739-09,GRCh37-lite,TCGA-AB-3008,TCGA-LAML,822,s7276,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a6ca,58cfa82de4b0c9d6adf6a6ca,94b9d45afaea977d7da4fb781016318c.filtered.,WGS,94b9d45afaea977d7da4fb781016318c,94b9d45afaea977d7da4fb781016318c.bam,49.9,1.9,0.14,58cfa82de4b0c9d6adf6a6ca,94b9d45afaea977d7da4fb781016318c.bam,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1459-10A,0798DBE2-1914-427C-A2FE-2A865D0D6EDA,Blood Derived Normal,Illumina GA,be81a5bf-eb3f-45e7-b763-e75b27fbf78c,Brain,63,67D92F3A-1CBE-4E4E-A8C4-27BE346C1781,65F88317-181A-4CAC-B481-747F84D74FCA,TCGA-14-1459-10A-01D-0703-09,GRCh37-lite,TCGA-14-1459,TCGA-GBM,378,s14362,Washington University School of Medicine,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a584,58cfa82de4b0c9d6adf6a584,2ea3d714e132b70377761db557387c05.filtered.,WGS,2ea3d714e132b70377761db557387c05,2ea3d714e132b70377761db557387c05.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a584,2ea3d714e132b70377761db557387c05.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2980-11A,882ECF72-433B-46FA-9BC4-628C2D943CD1,Solid Tissue Normal,Illumina GA,03fcf98d-69fc-4abf-a465-8c834383c1f8,Blood,50,CF64C883-A589-4F3A-B9D4-FE2D75A328A1,3B04B48E-A9FA-4CC9-98A3-E65C1EE56543,TCGA-AB-2980-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2980,TCGA-LAML,NA,s7246,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72ec4,58cfa83ce4b0c9d6adf72ec4,d2da17fcc212df70ecfaf2bfe9dde90e.filtered.,WGS,d2da17fcc212df70ecfaf2bfe9dde90e,d2da17fcc212df70ecfaf2bfe9dde90e.bam,NA,NA,NA,58cfa83ce4b0c9d6adf72ec4,d2da17fcc212df70ecfaf2bfe9dde90e.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3002-11A,478F29B1-6604-4E75-A492-47C384799F44,Solid Tissue Normal,Illumina GA,4ef2b163-987f-4b20-b2c8-22c7105ca4bc,Blood,68,6803AE4E-0176-466A-A05E-E0E75E648AE3,F0B052B2-F9C8-48B4-A333-936B3DA6F164,TCGA-AB-3002-11A-01D-0739-09,GRCh37-lite,TCGA-AB-3002,TCGA-LAML,1431,s7196,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6a8e8,58cfa82ee4b0c9d6adf6a8e8,G35154.TCGA-DH-A669-10A-01D-A31J-08.3.filtered.,WGS,G35154.TCGA-DH-A669-10A-01D-A31J-08.3,G35154.TCGA-DH-A669-10A-01D-A31J-08.3.bam,56.02,NA,0.07,58cfa82ee4b0c9d6adf6a8e8,G35154.TCGA-DH-A669-10A-01D-A31J-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DH-A669-10A,76E54EF6-1799-4FD9-BEC3-0EA960E8461E,Blood Derived Normal,Illumina HiSeq,958ecf79-2dcd-480b-a65f-d208b59fbf57,Brain,70,F61ACBA6-BD08-428B-8D9B-FCCEFE643A36,E849ABEF-B55E-4124-B760-09101A7C4390,TCGA-DH-A669-10A-01D-A31J-08,HG19_Broad_variant,TCGA-DH-A669,TCGA-LGG,919,s8322,Broad Institute of MIT and Harvard,University of Florida,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82de4b0c9d6adf6a696,58cfa82de4b0c9d6adf6a696,8a3283276f7379064644ef8c36430362.filtered.,WGS,8a3283276f7379064644ef8c36430362,8a3283276f7379064644ef8c36430362.bam,20.65,1.74,0.06,58cfa82de4b0c9d6adf6a696,8a3283276f7379064644ef8c36430362.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A03N-10A,9435447E-D65F-408B-863B-6576B1D652DD,Blood Derived Normal,Illumina HiSeq,6299b302-ec55-4baf-a73d-0da84bb6b964,Breast,59,3053710D-5AFE-417C-B57B-C06AFCB5BF02,45671631-68EF-4375-8A47-22796365F9A1,TCGA-AO-A03N-10A-01D-A19H-09,GRCh37-lite,TCGA-AO-A03N,TCGA-BRCA,NA,s6268,Washington University School of Medicine,MSKCC,None,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa83ce4b0c9d6adf72efc,58cfa83ce4b0c9d6adf72efc,bc77bc34a99fd3e3ca9ff72ebb9852f8.filtered.,WGS,bc77bc34a99fd3e3ca9ff72ebb9852f8,bc77bc34a99fd3e3ca9ff72ebb9852f8.bam,21.25,NA,0.08,58cfa83ce4b0c9d6adf72efc,bc77bc34a99fd3e3ca9ff72ebb9852f8.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-HB-A5W3-01A,C5B0E6BE-48B5-40E5-9D90-F9112050AA88,Primary Tumor,Illumina HiSeq,49c1bf65-391c-43e5-97fe-2f34ca184442,Mesenchymal,58,E7E97623-5C8A-42B4-ABC6-E7B424816713,4D4EFF82-EDE0-47F1-B49A-ADA025952114,TCGA-HB-A5W3-01A-11D-A29N-09,GRCh37-lite,TCGA-HB-A5W3,TCGA-SARC,384,s2669,Washington University School of Medicine,University of North Carolina,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a6db,58cfa82de4b0c9d6adf6a6db,8bbc002aaa491cd922d13b724aa2a6b7.filtered.,WGS,8bbc002aaa491cd922d13b724aa2a6b7,8bbc002aaa491cd922d13b724aa2a6b7.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a6db,8bbc002aaa491cd922d13b724aa2a6b7.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2966-11A,B1C32911-5CA8-4B77-8063-A97C30A3A348,Solid Tissue Normal,Illumina GA,a4c40a4e-68b0-4057-a22a-61796302a625,Blood,57,6CB66BC3-414A-4443-9289-628F2D64012F,8B0F12C9-65DD-4A1E-9BBA-ACE290EDFDDC,TCGA-AB-2966-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2966,TCGA-LAML,854,s7103,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a59f,58cfa82de4b0c9d6adf6a59f,4cc480609f127baaadd7eaeae13f96df.filtered.,WGS,4cc480609f127baaadd7eaeae13f96df,4cc480609f127baaadd7eaeae13f96df.bam,22.91,1.97,0.07,58cfa82de4b0c9d6adf6a59f,4cc480609f127baaadd7eaeae13f96df.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A152-10A,A8015490-9740-45C9-8BD2-EB6D1BEEFC2E,Blood Derived Normal,Illumina HiSeq,a5f27034-eded-4286-bf8f-965029909919,Breast,56,A66F19A5-BF40-47D5-99CF-C79283D011D1,236FD25D-CAE3-4ACF-AEF7-7DEF6042F30A,TCGA-E2-A152-10A-01D-A19H-09,GRCh37-lite,TCGA-E2-A152,TCGA-BRCA,NA,s6623,Washington University School of Medicine,Roswell Park,None,NO,T1c,N0,Infiltrating Ductal Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bd0d,58cfa830e4b0c9d6adf6bd0d,TCGA-AB-2972-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2972-11A-01D-0739-09_whole,TCGA-AB-2972-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bd0d,TCGA-AB-2972-11A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2972-11A,A436F4D7-018E-44E3-A615-9C33FCC1167D,Solid Tissue Normal,Illumina GA,17abb513-d5ad-4900-b456-3bb308a2777b,Blood,82,4311CC49-CB84-4442-B750-96477BB33A36,4C00565D-2FD1-4FA8-AD7F-541683ECE1B0,TCGA-AB-2972-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2972,TCGA-LAML,30,s7272,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6ac29,58cfa82ee4b0c9d6adf6ac29,G35154.TCGA-HT-7689-10A-01D-2253-08.5.filtered.,WGS,G35154.TCGA-HT-7689-10A-01D-2253-08.5,G35154.TCGA-HT-7689-10A-01D-2253-08.5.bam,57.3,NA,0.05,58cfa82ee4b0c9d6adf6ac29,G35154.TCGA-HT-7689-10A-01D-2253-08.5.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7689-10A,D58B535A-6C95-43BB-AD88-0600E6447537,Blood Derived Normal,Illumina HiSeq,4e07a7fd-8425-484d-8ef7-d48bd50ff286,Brain,58,35301FDA-120A-493A-BA46-D725730157C9,77467F98-3E82-4CE7-ABBE-8E69E7A77DBE,TCGA-HT-7689-10A-01D-2253-08,HG19_Broad_variant,TCGA-HT-7689,TCGA-LGG,NA,s8332,Broad Institute of MIT and Harvard,Case Western - St Joes,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82de4b0c9d6adf6a6b4,58cfa82de4b0c9d6adf6a6b4,94b51555d1de0d10503b34342b586c3b.filtered.,WGS,94b51555d1de0d10503b34342b586c3b,94b51555d1de0d10503b34342b586c3b.bam,54.48,2,0.08,58cfa82de4b0c9d6adf6a6b4,94b51555d1de0d10503b34342b586c3b.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-C8-A130-10A,8CF54607-01CE-42B0-9BD9-8627EDD9F3B7,Blood Derived Normal,Illumina HiSeq,44978a5f-a9ce-40ac-8b2e-3ade35e32525,Breast,52,4D3B8AD8-94CE-49A7-A7AF-F56AC17891F6,D141E42E-AA3B-46ED-815F-3192B1959BF4,TCGA-C8-A130-10A-01D-A19H-09,GRCh37-lite,TCGA-C8-A130,TCGA-BRCA,NA,s6628,Washington University School of Medicine,ILSbio,Vietnam,NO,T3,N2,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82de4b0c9d6adf6a559,58cfa82de4b0c9d6adf6a559,0ef58c3571ca4c0603becb4c0c2c894a.filtered.,WGS,0ef58c3571ca4c0603becb4c0c2c894a,0ef58c3571ca4c0603becb4c0c2c894a.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a559,0ef58c3571ca4c0603becb4c0c2c894a.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2977-11A,F95063BC-A640-4980-99A7-84645902DAF4,Solid Tissue Normal,Illumina GA,271232ef-c6d5-439a-94c0-e7fa37dc179d,Blood,71,404143F6-BCB4-4BE8-A791-6DA7F09190AC,4992751B-33FC-4136-BCBC-564C6854CEF3,TCGA-AB-2977-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2977,TCGA-LAML,31,s7010,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6a864,58cfa82ee4b0c9d6adf6a864,G35154.TCGA-DU-5870-10A-01D-A461-08.3.filtered.,WGS,G35154.TCGA-DU-5870-10A-01D-A461-08.3,G35154.TCGA-DU-5870-10A-01D-A461-08.3.bam,92.3,1.9,0.07,58cfa82ee4b0c9d6adf6a864,G35154.TCGA-DU-5870-10A-01D-A461-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-5870-10A,EB42625E-FBBB-4BEE-BBE9-315B3CA2138A,Blood Derived Normal,Illumina HiSeq,6f6fd391-7fbf-4f78-b27d-7f29183238a3,Brain,34,F553F849-0EE8-4471-8C9B-9F1982D4288A,5D762EAA-D788-47E4-83F7-E00B7A2D44B4,TCGA-DU-5870-10A-01D-A461-08,HG19_Broad_variant,TCGA-DU-5870,TCGA-LGG,NA,s8316,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa83ce4b0c9d6adf72f35,58cfa83ce4b0c9d6adf72f35,e7bc65ee6ca1e2ef8129b1d6e03ecd4b.filtered.,WGS,e7bc65ee6ca1e2ef8129b1d6e03ecd4b,e7bc65ee6ca1e2ef8129b1d6e03ecd4b.bam,NA,NA,NA,58cfa83ce4b0c9d6adf72f35,e7bc65ee6ca1e2ef8129b1d6e03ecd4b.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2999-03A,646631CE-7A1F-4274-ABB7-780B939E182F,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,e80221de-1dab-4ff7-b8f6-9631f09eabed,Blood,62,B28629D5-7473-4DDD-AFA1-B57DA9E1C50A,1111EDC5-C274-453B-88B4-A992AC879D74,TCGA-AB-2999-03A-01D-0739-09,GRCh37-lite,TCGA-AB-2999,TCGA-LAML,NA,s7057,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6ab36,58cfa82ee4b0c9d6adf6ab36,G32557.TCGA-ER-A19T-01A-11D-A19A-08.3.filtered.,WGS,G32557.TCGA-ER-A19T-01A-11D-A19A-08.3,G32557.TCGA-ER-A19T-01A-11D-A19A-08.3.bam,76.29,NA,0.09,58cfa82ee4b0c9d6adf6ab36,G32557.TCGA-ER-A19T-01A-11D-A19A-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19T-01A,B85B14D7-3B5A-4800-AF12-622EC03B9FE5,Primary Tumor,Illumina HiSeq,7967a744-2db3-4cec-86e2-524388a325e5,Skin,51,11E2F891-251A-4813-AA90-E944F350C54D,D1942D67-3C90-474E-9164-E76DDF9E335A,TCGA-ER-A19T-01A-11D-A19A-08,HG19_Broad_variant,TCGA-ER-A19T,TCGA-SKCM,270,s7307,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T4a,N3,Not available,Stage IV
13722.58cfa82de4b0c9d6adf6a4ec,58cfa82de4b0c9d6adf6a4ec,30effd7fac01c6c9c0251c137ae867e9.filtered.,WGS,30effd7fac01c6c9c0251c137ae867e9,30effd7fac01c6c9c0251c137ae867e9.bam,39.59,NA,0.08,58cfa82de4b0c9d6adf6a4ec,30effd7fac01c6c9c0251c137ae867e9.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A9FQ-10A,37D13493-975C-432C-BD21-65F383FC66C9,Blood Derived Normal,HiSeq X Ten,432f6ad1-5ba9-4662-a0ed-d508e4cc0e23,Esophagus,62,385B53B0-6869-4E26-BF67-D73F88A1561E,CFE2B919-5FEC-4566-81B7-4395C55C003F,TCGA-LN-A9FQ-10A-01D-A38A-09,GRCh37-lite_WUGSC_variant_2,TCGA-LN-A9FQ,TCGA-ESCA,NA,s1613,Washington University School of Medicine,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa83ce4b0c9d6adf72f3f,58cfa83ce4b0c9d6adf72f3f,efb62a0f5f3ade4952a3b0a2e2b6f067.filtered.,WGS,efb62a0f5f3ade4952a3b0a2e2b6f067,efb62a0f5f3ade4952a3b0a2e2b6f067.bam,NA,NA,NA,58cfa83ce4b0c9d6adf72f3f,efb62a0f5f3ade4952a3b0a2e2b6f067.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2973-03A,B234D53E-CC20-41C0-9F21-31DB53570A37,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,12cbb28f-634c-4a40-aa29-c68f5562d67c,Blood,68,F5A6B358-4924-4EE2-8687-363900A008E8,B2A7CDC3-4574-4D50-9DFB-A8A58DB9B2D2,TCGA-AB-2973-03A-01D-0742-05,GRCh37-lite,TCGA-AB-2973,TCGA-LAML,609,s7009,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a5fd,58cfa82de4b0c9d6adf6a5fd,4fbabb185f2c496b01483fe83b718a48.filtered.,WGS,4fbabb185f2c496b01483fe83b718a48,4fbabb185f2c496b01483fe83b718a48.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a5fd,4fbabb185f2c496b01483fe83b718a48.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3005-03A,E49A1768-BF1E-49C0-BCA3-4E076928281C,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,62eeae43-d36d-4f1a-92a8-8a62f53bfd71,Blood,45,D2C577B5-6C67-4A19-ADD7-FB87FA52523C,85335B80-6D61-4344-8AB3-1CF4BE2EE53F,TCGA-AB-3005-03A-01D-0739-09,GRCh37-lite,TCGA-AB-3005,TCGA-LAML,NA,s6976,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf73126,58cfa83ce4b0c9d6adf73126,d5fdb21175ba5ae28b64edc25073140c.filtered.,WGS,d5fdb21175ba5ae28b64edc25073140c,d5fdb21175ba5ae28b64edc25073140c.bam,23.64,NA,0.08,58cfa83ce4b0c9d6adf73126,d5fdb21175ba5ae28b64edc25073140c.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49M-01A,B3E248B5-5D40-495C-BD10-90ECF0ED6A95,Primary Tumor,HiSeq X Ten,daee208b-4d84-43c5-bdda-ee84b37882ba,Esophagus,62,E6BEF2C0-1C6A-4137-A099-920F1F811489,C633253F-7F42-4FA0-BD73-2D24487C0ACD,TCGA-LN-A49M-01A-21D-A27G-09,GRCh37-lite_WUGSC_variant_2,TCGA-LN-A49M,TCGA-ESCA,NA,s1705,Washington University School of Medicine,ILSbio,Vietnam,NO,T2,N0,Not available,Stage IIA
13722.58cfa82ee4b0c9d6adf6aa23,58cfa82ee4b0c9d6adf6aa23,G35154.TCGA-TQ-A7RV-10A-01D-A34A-08.3.filtered.,WGS,G35154.TCGA-TQ-A7RV-10A-01D-A34A-08.3,G35154.TCGA-TQ-A7RV-10A-01D-A34A-08.3.bam,12.04,NA,0.08,58cfa82ee4b0c9d6adf6aa23,G35154.TCGA-TQ-A7RV-10A-01D-A34A-08.3.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-TQ-A7RV-10A,5A3EDEB6-133E-4116-9F80-2485BD70754D,Blood Derived Normal,Illumina HiSeq,95a7f273-e22c-4af9-b245-ca5d839080d2,Brain,27,F4D24E86-719B-430E-841F-DFDB5D218ED6,C08E86A2-B582-4880-B58B-EE7AC9193EC1,TCGA-TQ-A7RV-10A-01D-A34A-08,HG19_Broad_variant,TCGA-TQ-A7RV,TCGA-LGG,NA,s8748,Broad Institute of MIT and Harvard,University of Sao Paulo,Brazil,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa82de4b0c9d6adf6a53e,58cfa82de4b0c9d6adf6a53e,2dbc8fff2a103cadba04d217cee2077d.filtered.,WGS,2dbc8fff2a103cadba04d217cee2077d,2dbc8fff2a103cadba04d217cee2077d.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a53e,2dbc8fff2a103cadba04d217cee2077d.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2972-11A,A436F4D7-018E-44E3-A615-9C33FCC1167D,Solid Tissue Normal,Illumina GA,864f579d-951b-4a07-bf55-de72e9a84188,Blood,82,4311CC49-CB84-4442-B750-96477BB33A36,4C00565D-2FD1-4FA8-AD7F-541683ECE1B0,TCGA-AB-2972-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2972,TCGA-LAML,30,s7201,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72f0f,58cfa83ce4b0c9d6adf72f0f,d70abbce939febed4d88a2f3041db471.filtered.,WGS,d70abbce939febed4d88a2f3041db471,d70abbce939febed4d88a2f3041db471.bam,97.91,1.93,0.08,58cfa83ce4b0c9d6adf72f0f,d70abbce939febed4d88a2f3041db471.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A1NU-01A,E56491AF-718F-4CA1-B3CD-0E5B3154697B,Primary Tumor,Illumina HiSeq,55250c6d-b9fb-4613-8463-59123f4e2065,Uterus,74,7901F084-C220-4865-A034-DA0144D63A28,FD504153-3CF6-44B9-99D5-21961EBAC188,TCGA-D1-A1NU-01A-11D-A34H-09,GRCh37-lite,TCGA-D1-A1NU,TCGA-UCEC,NA,s4399,Washington University School of Medicine,Mayo Clinic,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf7315d,58cfa83ce4b0c9d6adf7315d,f872cd75aa7d2f1722410ff3f0a2f532.filtered.,WGS,f872cd75aa7d2f1722410ff3f0a2f532,f872cd75aa7d2f1722410ff3f0a2f532.bam,44.31,NA,0.08,58cfa83ce4b0c9d6adf7315d,f872cd75aa7d2f1722410ff3f0a2f532.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-WP-A9GB-01A,05D4099F-521A-4DF6-ABAC-F86F84B3AF7F,Primary Tumor,HiSeq X Ten,88d55eac-81b9-4856-bc36-565a3099696e,Mesenchymal,59,4DF7599A-680C-452A-B472-2370B8F190A5,8ABDEB14-FA39-4BBC-8181-7196573B2629,TCGA-WP-A9GB-01A-11D-A37C-09,GRCh37-lite,TCGA-WP-A9GB,TCGA-SARC,275,s2472,Washington University School of Medicine,University of Kansas,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a558,58cfa82de4b0c9d6adf6a558,07a7ba95f41d6c5b8d08b67beab930ad.filtered.,WGS,07a7ba95f41d6c5b8d08b67beab930ad,07a7ba95f41d6c5b8d08b67beab930ad.bam,6.16,NA,0.07,58cfa82de4b0c9d6adf6a558,07a7ba95f41d6c5b8d08b67beab930ad.bam,Alive,FEMALE,WHITE,Not available,Sarcoma,Aligned reads,TCGA-X2-A95T-10A,8372E154-C9C1-4382-8120-7E14DD426367,Blood Derived Normal,HiSeq X Ten,4ebf8f9e-a056-4173-8b7c-7ab725f46bbc,Mesenchymal,49,EAD1D50B-9A88-472D-A2D6-11E397934093,9DE98674-1EC6-4F41-99E7-4628C6BD23F5,TCGA-X2-A95T-10A-01D-A37F-09,GRCh37-lite,TCGA-X2-A95T,TCGA-SARC,NA,s2474,Washington University School of Medicine,University of Washington,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a64e,58cfa82de4b0c9d6adf6a64e,7e5b9de2c0ab13ea5a2ea9db2bda55ce.filtered.,WGS,7e5b9de2c0ab13ea5a2ea9db2bda55ce,7e5b9de2c0ab13ea5a2ea9db2bda55ce.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a64e,7e5b9de2c0ab13ea5a2ea9db2bda55ce.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3006-11A,C9943335-86A8-4286-891C-C2331D75DC0D,Solid Tissue Normal,Illumina GA,133e5abf-67bb-4e4c-be46-780705a4ca5f,Blood,61,F64167D5-89C9-4123-9CE1-DC84ED06A5A2,3ECB6BF3-B4C8-43AD-9928-411550EBC27C,TCGA-AB-3006-11A-01D-0739-09,GRCh37-lite,TCGA-AB-3006,TCGA-LAML,485,s7065,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a654,58cfa82de4b0c9d6adf6a654,7f103e29d07245ee9348897f0528943e.filtered.,WGS,7f103e29d07245ee9348897f0528943e,7f103e29d07245ee9348897f0528943e.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a654,7f103e29d07245ee9348897f0528943e.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2986-03A,233400C5-6A47-40E2-BF2A-8B7FC9DF462B,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,af335368-05db-4839-ac77-7213998a1682,Blood,31,192B8235-8B09-4102-91CE-DDB77A5E0BAD,F389F28B-93C3-460A-9DCF-9F09D253B4BE,TCGA-AB-2986-03A-01D-0739-09,GRCh37-lite,TCGA-AB-2986,TCGA-LAML,212,s7286,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6c2ab,58cfa830e4b0c9d6adf6c2ab,TCGA-AB-2996-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2996-03A-01D-0739-09_whole,TCGA-AB-2996-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6c2ab,TCGA-AB-2996-03A-01D-0739-09_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2996-03A,5D10CA47-ABC6-4953-9620-1C63542354BF,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,4346beb3-9382-494c-ad07-ffdb7ee5919d,Blood,74,1EC304D2-E533-41A8-9244-84E3937DE8FA,625950A0-F786-4158-90B7-89CB96E4A23B,TCGA-AB-2996-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2996,TCGA-LAML,NA,s7240,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a4e0,58cfa82de4b0c9d6adf6a4e0,278303d618267a446ae11f91ab0f9dc5.filtered.,WGS,278303d618267a446ae11f91ab0f9dc5,278303d618267a446ae11f91ab0f9dc5.bam,36.67,1.89,0.15,58cfa82de4b0c9d6adf6a4e0,278303d618267a446ae11f91ab0f9dc5.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0881-10A,1B6C184A-5868-4A51-8A82-AA16A7E65126,Blood Derived Normal,Illumina GA,30810a78-30c8-4192-b924-edf7a78dd7a9,Brain,50,0EDD4B97-AFEE-4D69-B2F6-ACBCF13A94EF,6050F994-F394-4C1C-93CE-D36733AA9AE9,TCGA-06-0881-10A-01D-0512-09,GRCh37-lite,TCGA-06-0881,TCGA-GBM,NA,s14158,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6aa9c,58cfa82ee4b0c9d6adf6aa9c,G32467.TCGA-DK-A1A6-10A-01D-A13W-08.4.filtered.,WGS,G32467.TCGA-DK-A1A6-10A-01D-A13W-08.4,G32467.TCGA-DK-A1A6-10A-01D-A13W-08.4.bam,67.49,1.93,0.09,58cfa82ee4b0c9d6adf6aa9c,G32467.TCGA-DK-A1A6-10A-01D-A13W-08.4.bam,Alive,MALE,WHITE,Not available,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A6-10A,9C274536-3CA1-4F0E-93A8-1688074D862F,Blood Derived Normal,Illumina HiSeq,5d551ec5-acdd-4188-86a5-895de82dfe6e,Bladder,53,E1FD80CA-0A44-4604-8B6F-283C56824721,FCDB086F-6E88-49CE-A202-B611584A080C,TCGA-DK-A1A6-10A-01D-A13W-08,HG19_Broad_variant,TCGA-DK-A1A6,TCGA-BLCA,NA,s3259,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T2a,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82de4b0c9d6adf6a666,58cfa82de4b0c9d6adf6a666,804182419c4c4708dc5058194c29d6d2.filtered.,WGS,804182419c4c4708dc5058194c29d6d2,804182419c4c4708dc5058194c29d6d2.bam,22.3,NA,0.08,58cfa82de4b0c9d6adf6a666,804182419c4c4708dc5058194c29d6d2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A3LT-01A,E7A72F7E-77B1-4D95-8F37-39A6CFFC35DC,Primary Tumor,Illumina HiSeq,3daa0a7d-91d3-4cad-a48a-5a08bdd32529,Mesenchymal,62,32F8354A-7D2F-467B-AFED-E7F91369615F,A2F02FF7-8433-4CB5-9324-34F13EDEACA1,TCGA-DX-A3LT-01A-12D-A21Q-09,GRCh37-lite,TCGA-DX-A3LT,TCGA-SARC,NA,s2490,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a48e,58cfa82de4b0c9d6adf6a48e,32b9da31c452f4a7fdac5c57de9dc5fd.filtered.,WGS,32b9da31c452f4a7fdac5c57de9dc5fd,32b9da31c452f4a7fdac5c57de9dc5fd.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a48e,32b9da31c452f4a7fdac5c57de9dc5fd.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2965-11A,05924106-07F6-44CA-BA15-7452B8A657E4,Solid Tissue Normal,Illumina GA,1748acb6-a5e7-430f-b6a1-4600479c5eee,Blood,60,0687049C-7DE6-49DC-A45C-82C9F8C33DE5,882146D8-0B40-490B-B405-7BA28BF8AAA0,TCGA-AB-2965-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2965,TCGA-LAML,335,s7101,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a5d8,58cfa82de4b0c9d6adf6a5d8,6dd8e018e9951317883c66d21cc1742c.filtered.,WGS,6dd8e018e9951317883c66d21cc1742c,6dd8e018e9951317883c66d21cc1742c.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a5d8,6dd8e018e9951317883c66d21cc1742c.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2994-11A,B5F20EC2-FF5D-4AAC-8DB6-49887506F0B3,Solid Tissue Normal,Illumina GA,66f2cb92-7986-4225-9703-acb61f0c1bc0,Blood,25,03799DD1-CA4D-4ABA-BE46-8DFDFA2F9B14,B4BE30B8-0AB5-4ACC-8259-2AEF68C178BE,TCGA-AB-2994-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2994,TCGA-LAML,NA,s7138,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6a866,58cfa82ee4b0c9d6adf6a866,G35154.TCGA-FG-5965-10A-01D-1893-08.2.filtered.,WGS,G35154.TCGA-FG-5965-10A-01D-1893-08.2,G35154.TCGA-FG-5965-10A-01D-1893-08.2.bam,85,1.8,0.05,58cfa82ee4b0c9d6adf6a866,G35154.TCGA-FG-5965-10A-01D-1893-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-5965-10A,2CFC07F3-A31C-41A2-A9E3-B708D2421A78,Blood Derived Normal,Illumina HiSeq,164a91ab-6bd9-4c7a-a9fd-ddaf83d0aade,Brain,39,1CD7F0E4-4680-470B-B23D-7FF2FF16EA6E,6F6EEB7C-C029-419F-A597-D0F72FD8AE69,TCGA-FG-5965-10A-01D-1893-08,HG19_Broad_variant,TCGA-FG-5965,TCGA-LGG,NA,s8110,Broad Institute of MIT and Harvard,Case Western,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa82ee4b0c9d6adf6abf8,58cfa82ee4b0c9d6adf6abf8,G35154.TCGA-TQ-A7RK-10A-01D-A33W-08.3.filtered.,WGS,G35154.TCGA-TQ-A7RK-10A-01D-A33W-08.3,G35154.TCGA-TQ-A7RK-10A-01D-A33W-08.3.bam,9.57,NA,0.09,58cfa82ee4b0c9d6adf6abf8,G35154.TCGA-TQ-A7RK-10A-01D-A33W-08.3.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-TQ-A7RK-10A,2F8C789E-BBD8-4753-A48B-6894C21162F8,Blood Derived Normal,Illumina HiSeq,2e36e341-bb8b-468c-bec6-a3cac541abf0,Brain,29,B7B08D55-FE27-4261-A8C2-E29DBC658E74,4A8C0837-95D6-428F-AF78-778185C83361,TCGA-TQ-A7RK-10A-01D-A33W-08,HG19_Broad_variant,TCGA-TQ-A7RK,TCGA-LGG,NA,s8123,Broad Institute of MIT and Harvard,University of Sao Paulo,Brazil,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa830e4b0c9d6adf6bdf0,58cfa830e4b0c9d6adf6bdf0,TCGA-BH-A0B3-11B-21D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-BH-A0B3-11B-21D-A128-09_IlluminaGA-DNASeq_whole,TCGA-BH-A0B3-11B-21D-A128-09_IlluminaGA-DNASeq_whole.bam,47.07,2,0.08,58cfa830e4b0c9d6adf6bdf0,TCGA-BH-A0B3-11B-21D-A128-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0B3-11B,18EB4DFC-556F-4BF3-A411-4780209ED1E0,Solid Tissue Normal,Illumina HiSeq,29af0d77-d43d-4e85-9010-c496c956b250,Breast,53,9A81AF95-30F8-45B1-BBDA-CA5C7A91C5C5,CE23B4FB-A727-4CCB-B4D7-C2E8407ABD7E,TCGA-BH-A0B3-11B-21D-A128-09,GRCh37-lite,TCGA-BH-A0B3,TCGA-BRCA,NA,s6274,Washington University School of Medicine,University of Pittsburgh,None,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa82ee4b0c9d6adf6a8fc,58cfa82ee4b0c9d6adf6a8fc,G35154.TCGA-CS-6186-10A-01D-2024-08.2.filtered.,WGS,G35154.TCGA-CS-6186-10A-01D-2024-08.2,G35154.TCGA-CS-6186-10A-01D-2024-08.2.bam,250,1.9,0.05,58cfa82ee4b0c9d6adf6a8fc,G35154.TCGA-CS-6186-10A-01D-2024-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-6186-10A,9EE6E821-3AF2-42D7-9D14-F0CA455F338C,Blood Derived Normal,Illumina HiSeq,c5e543ca-86b9-4d14-b143-fb733c3a8950,Brain,58,8443AA4F-9650-45F4-921B-927C1F00A31C,111CD7BB-0DA5-485D-9B1F-978A60A29B94,TCGA-CS-6186-10A-01D-2024-08,HG19_Broad_variant,TCGA-CS-6186,TCGA-LGG,538,s8102,Broad Institute of MIT and Harvard,Thomas Jefferson University,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa83ce4b0c9d6adf731c4,58cfa83ce4b0c9d6adf731c4,e65badd2243dde49d8bfef148a909415.filtered.,WGS,e65badd2243dde49d8bfef148a909415,e65badd2243dde49d8bfef148a909415.bam,NA,NA,NA,58cfa83ce4b0c9d6adf731c4,e65badd2243dde49d8bfef148a909415.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2963-11A,DC7C0A9B-EF72-4188-A711-69DBF70C744C,Solid Tissue Normal,Illumina GA,19dbf21d-36b6-45f2-98d8-29add148f771,Blood,56,F307793F-B582-4B23-BF07-04C8D0C9360E,21A5533C-8F5D-4047-8DAA-0AD9D86EA2E3,TCGA-AB-2963-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2963,TCGA-LAML,1642,s7282,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6afda,58cfa82ee4b0c9d6adf6afda,TCGA-06-0877-10A-01D-0512-09_whole.filtered.,WGS,TCGA-06-0877-10A-01D-0512-09_whole,TCGA-06-0877-10A-01D-0512-09_whole.bam,36.67,1.88,0.15,58cfa82ee4b0c9d6adf6afda,TCGA-06-0877-10A-01D-0512-09_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0877-10A,32AFDC6C-E899-4795-9E90-C9A192BBC4C1,Blood Derived Normal,Illumina GA,88977091-c444-47f8-a8e5-659aa1130bde,Brain,78,373FC9C5-1D99-467E-8C81-4D6197236258,6FFB29C5-CAF6-448E-B3D6-72556BA86F8F,TCGA-06-0877-10A-01D-0512-09,NCBI36_WUGSC_variant,TCGA-06-0877,TCGA-GBM,NA,s14100,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6a8c8,58cfa82ee4b0c9d6adf6a8c8,G35154.TCGA-DU-7304-10A-01D-2086-08.4.filtered.,WGS,G35154.TCGA-DU-7304-10A-01D-2086-08.4,G35154.TCGA-DU-7304-10A-01D-2086-08.4.bam,43,NA,0.05,58cfa82ee4b0c9d6adf6a8c8,G35154.TCGA-DU-7304-10A-01D-2086-08.4.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7304-10A,D61710C1-8AC3-44E3-B567-66288A6AB731,Blood Derived Normal,Illumina HiSeq,3aef62ad-f4ed-44ff-aaa9-13bad668bb24,Brain,43,6B57FAE7-483F-4B20-97DA-96CD7DD57B2B,B95BB15A-325A-459A-AADC-D4F68CEE6A65,TCGA-DU-7304-10A-01D-2086-08,HG19_Broad_variant,TCGA-DU-7304,TCGA-LGG,709,s8328,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa82ee4b0c9d6adf6a92c,58cfa82ee4b0c9d6adf6a92c,G35154.TCGA-HT-8104-10A-01D-A461-08.2.filtered.,WGS,G35154.TCGA-HT-8104-10A-01D-A461-08.2,G35154.TCGA-HT-8104-10A-01D-A461-08.2.bam,187.6,NA,0.08,58cfa82ee4b0c9d6adf6a92c,G35154.TCGA-HT-8104-10A-01D-A461-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-8104-10A,5DE6FD84-ED02-4C27-9947-DB57F05FAF6D,Blood Derived Normal,Illumina HiSeq,29612660-50bd-442c-9c73-a18e3a340ee8,Brain,51,4BE310FB-B7AC-4759-9A30-3E55C6F5A341,933456D7-BC8C-4136-8B45-035A41C4D6F2,TCGA-HT-8104-10A-01D-A461-08,HG19_Broad_variant,TCGA-HT-8104,TCGA-LGG,NA,s8544,Broad Institute of MIT and Harvard,Case Western - St Joes,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa83ce4b0c9d6adf7306f,58cfa83ce4b0c9d6adf7306f,a54a70310fc8be77f7bfa8d6dfe44f6a.filtered.,WGS,a54a70310fc8be77f7bfa8d6dfe44f6a,a54a70310fc8be77f7bfa8d6dfe44f6a.bam,NA,NA,NA,58cfa83ce4b0c9d6adf7306f,a54a70310fc8be77f7bfa8d6dfe44f6a.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2997-11A,5E491CE4-D8DA-495B-A3AA-177E06CD69D0,Solid Tissue Normal,Illumina GA,1a373b5d-d990-4fab-a986-1c9b21495100,Blood,25,E3600348-0CAC-4731-8EF2-41983573A5C0,D2461E36-F349-4F2B-BA07-92B745C07675,TCGA-AB-2997-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2997,TCGA-LAML,NA,s7094,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72ea0,58cfa83ce4b0c9d6adf72ea0,cab14fc1d7b56274f68e25c36ca1fe72.filtered.,WGS,cab14fc1d7b56274f68e25c36ca1fe72,cab14fc1d7b56274f68e25c36ca1fe72.bam,117.13,2.03,0.08,58cfa83ce4b0c9d6adf72ea0,cab14fc1d7b56274f68e25c36ca1fe72.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A054-01A,D77E4DBC-B239-4742-8CB7-EFD427010D13,Primary Tumor,Illumina HiSeq,ac0e9eff-9bcd-4c94-a329-d07bcc7d5620,Uterus,64,DDFFB9C7-185F-402F-99B8-8058B40086D9,7364A112-61B9-41C6-B85F-18C97C54CEFD,TCGA-AP-A054-01A-11D-A066-09,GRCh37-lite,TCGA-AP-A054,TCGA-UCEC,709,s5371,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6be32,58cfa830e4b0c9d6adf6be32,TCGA-AB-2973-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2973-11A-01D-0739-09_whole,TCGA-AB-2973-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6be32,TCGA-AB-2973-11A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2973-11A,B234D53E-CC20-41C0-9F21-31DB53570A37,Solid Tissue Normal,Illumina GA,316c2901-2b9f-417a-8e0d-78d43e8495fd,Blood,68,2020ABAA-9028-4B22-BB78-6399AF5861EA,CF1F73E2-147B-42F5-8797-004EB789F776,TCGA-AB-2973-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2973,TCGA-LAML,609,s7191,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf7305a,58cfa83ce4b0c9d6adf7305a,f472a73249d16757bc8ffa8cace69db6.filtered.,WGS,f472a73249d16757bc8ffa8cace69db6,f472a73249d16757bc8ffa8cace69db6.bam,20.48,1.95,0.08,58cfa83ce4b0c9d6adf7305a,f472a73249d16757bc8ffa8cace69db6.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0IJ-10A,2C86C3EA-D926-4D39-A5AE-39ECE4774287,Blood Derived Normal,Illumina HiSeq,b5a04a08-cf8c-4237-bb3b-d8fb7674c945,Breast,42,0985C5F5-C459-4AB1-90FA-D6BB6F9B23E6,53CB363B-46B5-49FA-8868-82D5957DA566,TCGA-B6-A0IJ-10A-01D-A128-09,GRCh37-lite,TCGA-B6-A0IJ,TCGA-BRCA,NA,s5625,Washington University School of Medicine,Duke,United States,NO,T3,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa82de4b0c9d6adf6a6de,58cfa82de4b0c9d6adf6a6de,96494da11b3953fa17435019d7e9b926.filtered.,WGS,96494da11b3953fa17435019d7e9b926,96494da11b3953fa17435019d7e9b926.bam,12.32,2,0.07,58cfa82de4b0c9d6adf6a6de,96494da11b3953fa17435019d7e9b926.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A1-A0SM-10A,784DE7AC-8424-42EB-83D4-A1BEBAA42B97,Blood Derived Normal,Illumina HiSeq,96a41a4f-52b2-4699-9a58-6e8e2be5e409,Breast,77,58D5D36A-DAEC-449C-803C-13BDCDE876EE,F80D013A-BC2D-498D-898F-C25EFF8192A1,TCGA-A1-A0SM-10A-02D-A099-09,GRCh37-lite,TCGA-A1-A0SM,TCGA-BRCA,NA,s6118,Washington University School of Medicine,UCSF,United States,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6a86c,58cfa82ee4b0c9d6adf6a86c,G35154.TCGA-FG-A4MT-10A-01D-A38T-08.3.filtered.,WGS,G35154.TCGA-FG-A4MT-10A-01D-A38T-08.3,G35154.TCGA-FG-A4MT-10A-01D-A38T-08.3.bam,19.44,NA,0.07,58cfa82ee4b0c9d6adf6a86c,G35154.TCGA-FG-A4MT-10A-01D-A38T-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-A4MT-10A,E30F1994-3622-43D0-BEC2-6D7E2D9881D2,Blood Derived Normal,Illumina HiSeq,896a3c30-42ec-4bb4-9b26-cb4ce573d73a,Brain,27,5C84DB8B-9F39-4529-9A97-5D71A24CDB5E,808A6E74-103E-4C30-89C8-EFA1C86F417C,TCGA-FG-A4MT-10A-01D-A38T-08,HG19_Broad_variant,TCGA-FG-A4MT,TCGA-LGG,NA,s8111,Broad Institute of MIT and Harvard,Case Western,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa83ce4b0c9d6adf731fc,58cfa83ce4b0c9d6adf731fc,bdf8238446f85fbec9dac99055591b5a.filtered.,WGS,bdf8238446f85fbec9dac99055591b5a,bdf8238446f85fbec9dac99055591b5a.bam,NA,NA,NA,58cfa83ce4b0c9d6adf731fc,bdf8238446f85fbec9dac99055591b5a.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2978-11A,90FC467C-2B0D-461D-A1B8-C2A519354367,Solid Tissue Normal,Illumina GA,39deb96f-2889-44ab-a709-5001eb1a8408,Blood,61,A933E3E0-FE86-42E8-8A59-E399757C5DCC,BE9D0262-D1FA-48C4-BBA6-0D5415FB9B52,TCGA-AB-2978-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2978,TCGA-LAML,NA,s7130,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a455,58cfa82de4b0c9d6adf6a455,47da0ecd5e1e5af22d3143461eb72f7e.filtered.,WGS,47da0ecd5e1e5af22d3143461eb72f7e,47da0ecd5e1e5af22d3143461eb72f7e.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a455,47da0ecd5e1e5af22d3143461eb72f7e.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2996-03A,5D10CA47-ABC6-4953-9620-1C63542354BF,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,ac3e4260-9459-4295-8d4f-ec11b112caf6,Blood,74,1EC304D2-E533-41A8-9244-84E3937DE8FA,5C50334E-218D-4BF2-ADCB-53DCEBF30B57,TCGA-AB-2996-03A-01D-0741-05,GRCh37-lite,TCGA-AB-2996,TCGA-LAML,NA,s7015,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6aa68,58cfa82ee4b0c9d6adf6aa68,G32546.TCGA-ER-A3ES-06A-11D-A20D-08.1.filtered.,WGS,G32546.TCGA-ER-A3ES-06A-11D-A20D-08.1,G32546.TCGA-ER-A3ES-06A-11D-A20D-08.1.bam,63.41,NA,0.08,58cfa82ee4b0c9d6adf6aa68,G32546.TCGA-ER-A3ES-06A-11D-A20D-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A3ES-06A,B93F703E-BE51-4469-AAAC-2D4A87A37639,Metastatic,Illumina HiSeq,9ab2a208-ee2a-469c-8570-615644c6deb2,Skin,25,C6636FC1-35CC-4971-88D1-3DB5364024F9,73914542-306E-4DFB-A6D2-538BAA7344F2,TCGA-ER-A3ES-06A-11D-A20D-08,HG19_Broad_variant,TCGA-ER-A3ES,TCGA-SKCM,7514,s7476,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf730fa,58cfa83ce4b0c9d6adf730fa,c03fa22a7c8629afd7ba660ae443cddc.filtered.,WGS,c03fa22a7c8629afd7ba660ae443cddc,c03fa22a7c8629afd7ba660ae443cddc.bam,74.86,1.88,0.08,58cfa83ce4b0c9d6adf730fa,c03fa22a7c8629afd7ba660ae443cddc.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A04Q-01A,B5FBA77B-1F50-4E71-95B2-566AFBA4BDD7,Primary Tumor,Illumina HiSeq,77a8d1fa-9421-4333-b128-8a4b8fddfc6f,Breast,48,E17E273D-6F53-4419-9F0C-1E4E667C5257,03B8122D-02D9-4AD0-96ED-001C0D100DE0,TCGA-A2-A04Q-01A-21D-A128-09,GRCh37-lite,TCGA-A2-A04Q,TCGA-BRCA,NA,s6903,Washington University School of Medicine,Walter Reed,None,NO,T1,N0 (i-),Infiltrating Ductal Carcinoma,Stage IA
13722.58cfa82de4b0c9d6adf6a468,58cfa82de4b0c9d6adf6a468,44a507bf96c2aff2d2d2f57b197a65cc.filtered.,WGS,44a507bf96c2aff2d2d2f57b197a65cc,44a507bf96c2aff2d2d2f57b197a65cc.bam,24.3,NA,0.08,58cfa82de4b0c9d6adf6a468,44a507bf96c2aff2d2d2f57b197a65cc.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A4A4-01A,E89D7900-915D-4936-B1B2-CAC3670EA2F4,Primary Tumor,HiSeq X Ten,330e34bd-9f86-433f-817c-9acb397ad5ee,Esophagus,36,C7A31A25-A496-4D26-A9D2-C42ADB22BB45,4D617F90-3296-4B9A-B5C0-E717CEBD3F25,TCGA-LN-A4A4-01A-11D-A27G-09,GRCh37-lite_WUGSC_variant_2,TCGA-LN-A4A4,TCGA-ESCA,NA,s1614,Washington University School of Medicine,ILSbio,Vietnam,NO,T3,N1,Not available,Stage III
13722.58cfa830e4b0c9d6adf6be1e,58cfa830e4b0c9d6adf6be1e,TCGA-AB-2978-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2978-03A-01D-0739-09_whole,TCGA-AB-2978-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6be1e,TCGA-AB-2978-03A-01D-0739-09_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2978-03A,90FC467C-2B0D-461D-A1B8-C2A519354367,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,90ed4aa6-62ac-4580-937c-3438ee02ff46,Blood,61,37A5C03C-45C2-4096-8712-370CE5EBFBBD,960EFB3B-7C3B-42EC-8F29-011D13493C69,TCGA-AB-2978-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2978,TCGA-LAML,NA,s7119,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a693,58cfa82de4b0c9d6adf6a693,93ea360c5937eacd6158ad8b9e05acb3.filtered.,WGS,93ea360c5937eacd6158ad8b9e05acb3,93ea360c5937eacd6158ad8b9e05acb3.bam,26.16,NA,0.08,58cfa82de4b0c9d6adf6a693,93ea360c5937eacd6158ad8b9e05acb3.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OF-01A,0C78B1B5-F480-45AD-A253-19297BC886B4,Primary Tumor,HiSeq X Ten,3ee40366-0f7a-4e3b-af4b-e2b72f3df2b8,Esophagus,63,B11F1BF7-3546-4F3C-872F-A4A910D910E7,F932DD2C-EAC3-40B3-9C43-387B8965D65D,TCGA-L5-A4OF-01A-11D-A27G-09,GRCh37-lite_WUGSC_variant_2,TCGA-L5-A4OF,TCGA-ESCA,NA,s1811,Washington University School of Medicine,University of Michigan,United States,NO,T1,N1,Not available,Stage IIB
13722.58cfa83ce4b0c9d6adf72f7f,58cfa83ce4b0c9d6adf72f7f,a94a5ada9a0bb0f8ace6de28512984f7.filtered.,WGS,a94a5ada9a0bb0f8ace6de28512984f7,a94a5ada9a0bb0f8ace6de28512984f7.bam,110.87,2.41,0.08,58cfa83ce4b0c9d6adf72f7f,a94a5ada9a0bb0f8ace6de28512984f7.bam,Alive,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0V8-01A,2B76CC9C-C379-43E4-9C3F-56197A3353BE,Primary Tumor,Illumina HiSeq,9fd5dab8-8c05-4a1c-829e-8e86285bc04f,Uterus,68,CF369A2C-D3C3-4FA3-B004-E4269530CEFF,8D4CB709-C95C-4BDC-844B-C0BFA2A3028E,TCGA-BS-A0V8-01A-11D-A122-09,GRCh37-lite,TCGA-BS-A0V8,TCGA-UCEC,NA,s5178,Washington University School of Medicine,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a982,58cfa82ee4b0c9d6adf6a982,G35154.TCGA-DU-7013-10A-01D-A461-08.1.filtered.,WGS,G35154.TCGA-DU-7013-10A-01D-A461-08.1,G35154.TCGA-DU-7013-10A-01D-A461-08.1.bam,77,NA,0.07,58cfa82ee4b0c9d6adf6a982,G35154.TCGA-DU-7013-10A-01D-A461-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7013-10A,D61B5D20-4D6D-4FDC-AFE8-4B100B686EDA,Blood Derived Normal,Illumina HiSeq,9aa21497-15c7-4c07-a97a-322fac13beae,Brain,59,6893F38B-0210-46FE-9A52-6BC29F32407E,24B51A21-4E11-4133-B027-3FA0C44D97D6,TCGA-DU-7013-10A-01D-A461-08,HG19_Broad_variant,TCGA-DU-7013,TCGA-LGG,269,s8743,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa82de4b0c9d6adf6a4be,58cfa82de4b0c9d6adf6a4be,16c5b03f7a162662f87a6ef4eb8efdb7.filtered.,WGS,16c5b03f7a162662f87a6ef4eb8efdb7,16c5b03f7a162662f87a6ef4eb8efdb7.bam,78.05,1.93,0.08,58cfa82de4b0c9d6adf6a4be,16c5b03f7a162662f87a6ef4eb8efdb7.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A05D-01A,F7E06A10-74CA-4F52-A944-B3F22C016998,Primary Tumor,Illumina HiSeq,4cb18a3e-36df-43cb-ab17-5ba82f2a7949,Uterus,67,5B19AF28-1179-42CB-A474-856EF2048D5B,82D2EA5F-EBDC-4907-A287-FE837FD6B59C,TCGA-AP-A05D-01A-11D-A013-09,GRCh37-lite,TCGA-AP-A05D,TCGA-UCEC,NA,s4981,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a54c,58cfa82de4b0c9d6adf6a54c,16c723fa8318bbf023389c46fc6f8d02.filtered.,WGS,16c723fa8318bbf023389c46fc6f8d02,16c723fa8318bbf023389c46fc6f8d02.bam,14.64,NA,0.08,58cfa82de4b0c9d6adf6a54c,16c723fa8318bbf023389c46fc6f8d02.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-V5-A7RC-01B,AAC385C1-42F9-4D9E-B9BF-94CA13EBC5AE,Primary Tumor,HiSeq X Ten,3ce6962b-28b2-471e-8ca9-8da280b182c3,Esophagus,55,3743944C-21B7-4584-A7A0-01A9753FFE40,B77BA28D-FF74-47A9-A811-7349C5B0214B,TCGA-V5-A7RC-01B-11D-A403-09,GRCh37-lite_WUGSC_variant_2,TCGA-V5-A7RC,TCGA-ESCA,104,s1808,Washington University School of Medicine,Duke University,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a47a,58cfa82de4b0c9d6adf6a47a,36b47238be0497f388623d943762497c.filtered.,WGS,36b47238be0497f388623d943762497c,36b47238be0497f388623d943762497c.bam,64.57,NA,0.08,58cfa82de4b0c9d6adf6a47a,36b47238be0497f388623d943762497c.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2R9-01A,00AD0FFE-2105-4829-A495-1C2ACEB5BB31,Primary Tumor,Illumina HiSeq,d25f9f12-7f03-4bbe-befe-f9250955975c,Cervix,58,7EFD873D-8165-40F8-A07D-69CFD68A491E,9FF21093-58D7-4B69-AADE-C242A383EA56,TCGA-EK-A2R9-01A-11D-A34H-09,GRCh37-lite,TCGA-EK-A2R9,TCGA-CESC,NA,s1347,Washington University School of Medicine,Gynecologic Oncology Group,United States,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6c19c,58cfa830e4b0c9d6adf6c19c,TCGA-AB-2969-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2969-11A-01D-0739-09_whole,TCGA-AB-2969-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6c19c,TCGA-AB-2969-11A-01D-0739-09_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2969-11A,929DE9A5-3224-4851-8FF0-8A92354C1F16,Solid Tissue Normal,Illumina GA,68b6be7e-07be-4264-8c21-820785b9770a,Blood,55,43E38E03-8B58-48A6-BD58-FBC0F1F80B63,9F76EA23-0923-4B22-99BA-791EE8931003,TCGA-AB-2969-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2969,TCGA-LAML,NA,s7149,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72fb2,58cfa83ce4b0c9d6adf72fb2,a71534313dd3551e1b02d0eed8d54add.filtered.,WGS,a71534313dd3551e1b02d0eed8d54add,a71534313dd3551e1b02d0eed8d54add.bam,55.26,NA,0.08,58cfa83ce4b0c9d6adf72fb2,a71534313dd3551e1b02d0eed8d54add.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AR-A2LK-01A,1B703058-E596-45BC-80FE-8B98D545C2E2,Primary Tumor,Illumina HiSeq,452eb1a3-2221-409b-a97e-f3266c5737cd,Breast,62,D6F5C34A-0F5C-4AED-977A-74A1E5D50915,7B0B60C7-5FA0-440E-937F-8D82119330D6,TCGA-AR-A2LK-01A-11D-A17W-09,GRCh37-lite,TCGA-AR-A2LK,TCGA-BRCA,NA,s6746,Washington University School of Medicine,Mayo,United States,NO,T3,N2,Infiltrating Lobular Carcinoma,Stage III
13722.58cfa82fe4b0c9d6adf6b3c6,58cfa82fe4b0c9d6adf6b3c6,TCGA-24-1103-10A-01D-0515-09_whole.filtered.,WGS,TCGA-24-1103-10A-01D-0515-09_whole,TCGA-24-1103-10A-01D-0515-09_whole.bam,26.67,1.9,0.16,58cfa82fe4b0c9d6adf6b3c6,TCGA-24-1103-10A-01D-0515-09_whole.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1103-10A,F34AA3B6-E966-49C6-BC55-130545772C53,Blood Derived Normal,Illumina GA,5b4fc80b-0926-4222-b2be-42cbfd68b35f,Ovary,50,A6AE520E-D19F-4848-9149-ABB90ED1C9A6,DF8C183D-0CD7-44B1-A100-A20BD3371C61,TCGA-24-1103-10A-01D-0515-09,NCBI36_WUGSC_variant,TCGA-24-1103,TCGA-OV,1646,s17745,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6afcc,58cfa82ee4b0c9d6adf6afcc,TCGA-06-0214-10A-01D-0512-09_whole.filtered.,WGS,TCGA-06-0214-10A-01D-0512-09_whole,TCGA-06-0214-10A-01D-0512-09_whole.bam,14.9,1.9,0.23,58cfa82ee4b0c9d6adf6afcc,TCGA-06-0214-10A-01D-0512-09_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0214-10A,9853C6BB-A42C-4698-ABE5-F3C897EBC8F6,Blood Derived Normal,Illumina GA,76fb4663-7def-434c-80a2-2994a1a4b2d1,Brain,66,D067A643-8E8B-4E86-8186-582FC140F744,ABBF3618-7F5A-4471-9096-B16E1435122E,TCGA-06-0214-10A-01D-0512-09,NCBI36_WUGSC_variant,TCGA-06-0214,TCGA-GBM,457,s14101,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6bd16,58cfa830e4b0c9d6adf6bd16,TCGA-AB-2907-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2907-03A-01D-0739-09_whole,TCGA-AB-2907-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bd16,TCGA-AB-2907-03A-01D-0739-09_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2907-03A,E843A0EA-45A5-4C11-92A1-08FF12EB4531,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,f31e9b4d-c339-4c6b-a615-58ecb6d90189,Blood,69,41E0DAC3-A015-4AB8-B10B-C7EA6C744BED,0F0881A0-C9BC-4636-A99F-36551DF20DEB,TCGA-AB-2907-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2907,TCGA-LAML,NA,s7112,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6b1e9,58cfa82ee4b0c9d6adf6b1e9,TCGA-16-1460-10A-01D-0703-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-16-1460-10A-01D-0703-09_IlluminaGA-DNASeq_whole,TCGA-16-1460-10A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,26.27,1.9,0.15,58cfa82ee4b0c9d6adf6b1e9,TCGA-16-1460-10A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-16-1460-10A,827453A9-7388-4336-9AC5-4DEFCB904607,Blood Derived Normal,Illumina GA,01aeee33-0535-4198-bf56-15d2e239692e,Brain,36,195F3484-6479-4964-B428-59CED370DF98,E62633E2-FFB0-453C-9182-96299FD4CD8C,TCGA-16-1460-10A-01D-0703-09,NCBI36_WUGSC_variant,TCGA-16-1460,TCGA-GBM,NA,s14231,Washington University School of Medicine,Toronto Western Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6a97c,58cfa82ee4b0c9d6adf6a97c,G35154.TCGA-DU-6407-10A-01D-1705-08.2.filtered.,WGS,G35154.TCGA-DU-6407-10A-01D-1705-08.2,G35154.TCGA-DU-6407-10A-01D-1705-08.2.bam,58,1.9,0.05,58cfa82ee4b0c9d6adf6a97c,G35154.TCGA-DU-6407-10A-01D-1705-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6407-10A,70939245-41E0-4845-A473-5FEF719B9828,Blood Derived Normal,Illumina HiSeq,cfed9604-e0dd-47be-8aa0-026854f244e2,Brain,35,8469A6EA-9610-4B3D-8CAA-48E503B0FD2E,4A5655BA-0F40-4C74-9534-23EB5DF3AD4D,TCGA-DU-6407-10A-01D-1705-08,HG19_Broad_variant,TCGA-DU-6407,TCGA-LGG,2875,s8330,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6b0b9,58cfa82ee4b0c9d6adf6b0b9,TCGA-06-0877-01A-01D-0512-09_whole.filtered.,WGS,TCGA-06-0877-01A-01D-0512-09_whole,TCGA-06-0877-01A-01D-0512-09_whole.bam,54.77,1.9,0.14,58cfa82ee4b0c9d6adf6b0b9,TCGA-06-0877-01A-01D-0512-09_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0877-01A,32AFDC6C-E899-4795-9E90-C9A192BBC4C1,Primary Tumor,Illumina GA,eb782e75-2836-492c-8eff-ce3df86f283a,Brain,78,A1F1E403-7984-4819-A969-D3A16594FE37,BA2920A9-1BFD-4F6C-80CF-4FD0DDA2118A,TCGA-06-0877-01A-01D-0512-09,NCBI36_WUGSC_variant,TCGA-06-0877,TCGA-GBM,NA,s13895,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a5c0,58cfa82de4b0c9d6adf6a5c0,717e6a4200b362ed025586922fb03e2b.filtered.,WGS,717e6a4200b362ed025586922fb03e2b,717e6a4200b362ed025586922fb03e2b.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a5c0,717e6a4200b362ed025586922fb03e2b.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2969-03A,929DE9A5-3224-4851-8FF0-8A92354C1F16,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,e5a0489c-da6e-4204-9649-5d8eaa3ab611,Blood,55,9069B85B-EEBA-49C0-A624-65817CC0E915,C2942501-AEBC-4DC5-B31D-52D624F2F163,TCGA-AB-2969-03A-01D-0739-09,GRCh37-lite,TCGA-AB-2969,TCGA-LAML,NA,s7062,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a65f,58cfa82de4b0c9d6adf6a65f,5b233e3c073c9b60910bddaec0e5ed79.filtered.,WGS,5b233e3c073c9b60910bddaec0e5ed79,5b233e3c073c9b60910bddaec0e5ed79.bam,71.04,2,0.07,58cfa82de4b0c9d6adf6a65f,5b233e3c073c9b60910bddaec0e5ed79.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A11G-01A,D2AA7D70-A25F-4A9E-9D52-37E372461824,Primary Tumor,Illumina HiSeq,bef94a7d-d7f5-4172-9a0c-5b3dc033ca00,Uterus,71,FE5D8E64-98B1-4EA7-ADDA-F28D12349A7E,42DE1441-6F3C-4B4D-B8B8-AD91E4B1DBE2,TCGA-B5-A11G-01A-13D-A122-09,GRCh37-lite,TCGA-B5-A11G,TCGA-UCEC,NA,s4411,Washington University School of Medicine,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a44a,58cfa82de4b0c9d6adf6a44a,0213310bd5b7d46c710d9b207ba4a429.filtered.,WGS,0213310bd5b7d46c710d9b207ba4a429,0213310bd5b7d46c710d9b207ba4a429.bam,26.27,1.9,0.15,58cfa82de4b0c9d6adf6a44a,0213310bd5b7d46c710d9b207ba4a429.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-16-1460-10A,827453A9-7388-4336-9AC5-4DEFCB904607,Blood Derived Normal,Illumina GA,892ab262-2b27-488d-ad38-503c4b60cd0a,Brain,36,195F3484-6479-4964-B428-59CED370DF98,E62633E2-FFB0-453C-9182-96299FD4CD8C,TCGA-16-1460-10A-01D-0703-09,GRCh37-lite,TCGA-16-1460,TCGA-GBM,NA,s14360,Washington University School of Medicine,Toronto Western Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6bbb0,58cfa830e4b0c9d6adf6bbb0,TCGA-A2-A04T-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-A2-A04T-10A-01D-A128-09_IlluminaGA-DNASeq_whole,TCGA-A2-A04T-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,23.59,1.8,0.07,58cfa830e4b0c9d6adf6bbb0,TCGA-A2-A04T-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A04T-10A,B58AD350-5140-4FA8-BC2C-24BCA8395F3A,Blood Derived Normal,Illumina HiSeq,f9051235-b44d-460e-91f0-71118754ad79,Breast,62,9340E34D-4ADB-4C90-B496-8FA592471340,705B3927-BBA2-4D67-BBE4-61BD1855EFE4,TCGA-A2-A04T-10A-01D-A128-09,GRCh37-lite,TCGA-A2-A04T,TCGA-BRCA,NA,s5796,Washington University School of Medicine,Walter Reed,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6aabc,58cfa82ee4b0c9d6adf6aabc,G32527.TCGA-FE-A3PD-10A-01D-A21Z-08.2.filtered.,WGS,G32527.TCGA-FE-A3PD-10A-01D-A21Z-08.2,G32527.TCGA-FE-A3PD-10A-01D-A21Z-08.2.bam,10.47,NA,0.09,58cfa82ee4b0c9d6adf6aabc,G32527.TCGA-FE-A3PD-10A-01D-A21Z-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A3PD-10A,39D90499-8549-4DA5-B391-C421F18FACF1,Blood Derived Normal,Illumina HiSeq,dafbd7c5-4fa9-48d9-b7d1-5eb33512fddd,Thyroid,17,703333E7-A2BA-4601-8F33-D0CD1F587E76,9EE50075-10F8-4945-8391-66C5E87D3333,TCGA-FE-A3PD-10A-01D-A21Z-08,HG19_Broad_variant,TCGA-FE-A3PD,TCGA-THCA,NA,s11976,Broad Institute of MIT and Harvard,Ohio State University,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa82ee4b0c9d6adf6a94a,58cfa82ee4b0c9d6adf6a94a,G35154.TCGA-DU-6397-10A-01D-A461-08.3.filtered.,WGS,G35154.TCGA-DU-6397-10A-01D-A461-08.3,G35154.TCGA-DU-6397-10A-01D-A461-08.3.bam,57.3,1.9,0.07,58cfa82ee4b0c9d6adf6a94a,G35154.TCGA-DU-6397-10A-01D-A461-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6397-10A,E695B780-17F4-4E71-9120-7C6BCAFAA3A7,Blood Derived Normal,Illumina HiSeq,623cc431-e17c-4b40-97ed-b5178540519c,Brain,45,73D63D98-A050-4194-8430-68C36CE2A381,1A48EBF2-931B-435C-9EFD-021E0568E375,TCGA-DU-6397-10A-01D-A461-08,HG19_Broad_variant,TCGA-DU-6397,TCGA-LGG,1401,s8537,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6b172,58cfa82ee4b0c9d6adf6b172,TCGA-13-0723-01A-02D-0447-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-13-0723-01A-02D-0447-09_IlluminaGA-DNASeq_whole,TCGA-13-0723-01A-02D-0447-09_IlluminaGA-DNASeq_whole.bam,189.64,1.9,0.18,58cfa82ee4b0c9d6adf6b172,TCGA-13-0723-01A-02D-0447-09_IlluminaGA-DNASeq_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0723-01A,FF530F28-0EC0-4494-BB54-44BB055BAE1C,Primary Tumor,Illumina GA,b4cf5903-4d35-4696-a640-d374bcff25e7,Ovary,63,BC90FAA3-383C-4333-B774-580026C7EBD6,17ED8831-A261-42D9-8FF3-CF75A6CB2A24,TCGA-13-0723-01A-02D-0447-09,NCBI36_WUGSC_variant,TCGA-13-0723,TCGA-OV,1204,s17147,Washington University School of Medicine,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a674,58cfa82de4b0c9d6adf6a674,4e9520d4069328bdb2c43937716bc859.filtered.,WGS,4e9520d4069328bdb2c43937716bc859,4e9520d4069328bdb2c43937716bc859.bam,27.88,NA,0.08,58cfa82de4b0c9d6adf6a674,4e9520d4069328bdb2c43937716bc859.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A3U7-01A,EA3A524B-6EE3-4904-8924-29FCAA20985C,Primary Tumor,Illumina HiSeq,0c2d7c45-b582-429b-bf9f-ed279421c8a6,Mesenchymal,67,910CD9B0-5BBE-47E5-8F4C-A6E8AA580281,9E7B51FB-2249-451A-BF23-BB2A3D935928,TCGA-DX-A3U7-01A-11D-A29N-09,GRCh37-lite,TCGA-DX-A3U7,TCGA-SARC,NA,s2487,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6b1e2,58cfa82ee4b0c9d6adf6b1e2,TCGA-14-1459-01A-01D-0932-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-14-1459-01A-01D-0932-09_IlluminaGA-DNASeq_whole,TCGA-14-1459-01A-01D-0932-09_IlluminaGA-DNASeq_whole.bam,415.6,1.9,0.16,58cfa82ee4b0c9d6adf6b1e2,TCGA-14-1459-01A-01D-0932-09_IlluminaGA-DNASeq_whole.bam,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1459-01A,0798DBE2-1914-427C-A2FE-2A865D0D6EDA,Primary Tumor,Illumina GA,fa1a3406-37fa-4743-91b5-714b19981e53,Brain,63,1E89F944-8061-4F2D-85D1-882570020736,1E27CC8A-5394-4958-9AF6-5ECE1FE24516,TCGA-14-1459-01A-01D-0932-09,NCBI36_WUGSC_variant,TCGA-14-1459,TCGA-GBM,378,s14033,Washington University School of Medicine,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf730fd,58cfa83ce4b0c9d6adf730fd,cc5a729145a62615b759d23c6d035d6c.filtered.,WGS,cc5a729145a62615b759d23c6d035d6c,cc5a729145a62615b759d23c6d035d6c.bam,415.6,1.9,0.16,58cfa83ce4b0c9d6adf730fd,cc5a729145a62615b759d23c6d035d6c.bam,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1459-01A,0798DBE2-1914-427C-A2FE-2A865D0D6EDA,Primary Tumor,Illumina GA,fa542abc-981e-490a-b0d3-8e1b36d47281,Brain,63,1E89F944-8061-4F2D-85D1-882570020736,1E27CC8A-5394-4958-9AF6-5ECE1FE24516,TCGA-14-1459-01A-01D-0932-09,GRCh37-lite,TCGA-14-1459,TCGA-GBM,378,s14248,Washington University School of Medicine,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a4e8,58cfa82de4b0c9d6adf6a4e8,25950fd254b351683666306985068fd4.filtered.,WGS,25950fd254b351683666306985068fd4,25950fd254b351683666306985068fd4.bam,189.64,1.9,0.18,58cfa82de4b0c9d6adf6a4e8,25950fd254b351683666306985068fd4.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0723-01A,FF530F28-0EC0-4494-BB54-44BB055BAE1C,Primary Tumor,Illumina GA,a0f8f3b6-b591-47b6-a927-35012519c64a,Ovary,63,BC90FAA3-383C-4333-B774-580026C7EBD6,17ED8831-A261-42D9-8FF3-CF75A6CB2A24,TCGA-13-0723-01A-02D-0447-09,GRCh37-lite,TCGA-13-0723,TCGA-OV,1204,s18081,Washington University School of Medicine,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ab86,58cfa82ee4b0c9d6adf6ab86,G35153.TCGA-BA-A4IH-01A-11D-A25T-08.5.filtered.,WGS,G35153.TCGA-BA-A4IH-01A-11D-A25T-08.5,G35153.TCGA-BA-A4IH-01A-11D-A25T-08.5.bam,39.39,NA,0.07,58cfa82ee4b0c9d6adf6ab86,G35153.TCGA-BA-A4IH-01A-11D-A25T-08.5.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-A4IH-01A,BD75D8EE-916B-4ABC-BF33-BCE6A4217076,Primary Tumor,Illumina HiSeq,dc2ac994-c455-4e1f-9319-2865614853ba,Head and Neck,57,F87EFB5E-24F5-4D2B-B6B3-987BBDA30E03,B537BC07-9998-49F4-BBBE-5B617152BFD9,TCGA-BA-A4IH-01A-11D-A25T-08,HG19_Broad_variant,TCGA-BA-A4IH,TCGA-HNSC,NA,s15747,Broad Institute of MIT and Harvard,UNC,United States,NO,T2,N1,Head and Neck Squamous Cell Carcinoma Basaloid Type,Stage IVA
13722.58cfa82de4b0c9d6adf6a57c,58cfa82de4b0c9d6adf6a57c,46091923f2dd69b5704e3e63aa5dc27e.filtered.,WGS,46091923f2dd69b5704e3e63aa5dc27e,46091923f2dd69b5704e3e63aa5dc27e.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a57c,46091923f2dd69b5704e3e63aa5dc27e.bam,Dead,MALE,Not available,Not available,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3009-11A,C9B92F8F-4599-47D1-9D12-31E42166A091,Solid Tissue Normal,Illumina GA,bb7d9491-b96e-4d8c-bfdc-9b61d8012112,Blood,23,CA163AC7-6D69-4F4F-8CA1-6A9EB86D8BC6,B77C4CC4-B7BB-45B7-8324-70F96F9A3629,TCGA-AB-3009-11A-01D-0739-09,GRCh37-lite,TCGA-AB-3009,TCGA-LAML,577,s7248,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa831e4b0c9d6adf6cc42,58cfa831e4b0c9d6adf6cc42,TCGA-DV-5566-01A-01D-2104-10_wgs_Illumina.filtered.,WGS,TCGA-DV-5566-01A-01D-2104-10_wgs_Illumina,TCGA-DV-5566-01A-01D-2104-10_wgs_Illumina.bam,124.4,1.9,0.16,58cfa831e4b0c9d6adf6cc42,TCGA-DV-5566-01A-01D-2104-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-DV-5566-01A,4B2EC8AA-8460-440E-B75B-6B92AE7A3FFC,Primary Tumor,Illumina HiSeq,67e2d2b4-5d60-46c8-85b0-236331ed66a8,Kidney,67,58578D50-1E0C-4F5E-929A-C969C5346B05,BCF54C96-2B62-4E24-926F-D77576250DD1,TCGA-DV-5566-01A-01D-2104-10,GRCh37-lite,TCGA-DV-5566,TCGA-KIRC,NA,s8844,Baylor College of Medicine,NCI Urologic Oncology Branch,None,NO,T1a,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa83ce4b0c9d6adf72f6c,58cfa83ce4b0c9d6adf72f6c,e869d292dcb3ead5c9128b76af2ac4bb.filtered.,WGS,e869d292dcb3ead5c9128b76af2ac4bb,e869d292dcb3ead5c9128b76af2ac4bb.bam,83.48,1.95,0.08,58cfa83ce4b0c9d6adf72f6c,e869d292dcb3ead5c9128b76af2ac4bb.bam,Dead,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-AR-A256-01A,D3D545B3-457F-4389-821F-704CB24AFF7F,Primary Tumor,Illumina HiSeq,83a38860-cf50-4344-8dbf-97d4cda96864,Breast,45,87676C70-E2AD-4103-8BC0-3D3C1E40A790,EA43434B-197E-48AC-AE2E-46BC7F3776DE,TCGA-AR-A256-01A-11D-A167-09,GRCh37-lite,TCGA-AR-A256,TCGA-BRCA,2854,s6448,Washington University School of Medicine,Mayo,United States,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82fe4b0c9d6adf6b3ae,58cfa82fe4b0c9d6adf6b3ae,TCGA-24-0982-01A-01D-0516-08_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-24-0982-01A-01D-0516-08_IlluminaGA-DNASeq_whole,TCGA-24-0982-01A-01D-0516-08_IlluminaGA-DNASeq_whole.bam,418.87,1.9,0.16,58cfa82fe4b0c9d6adf6b3ae,TCGA-24-0982-01A-01D-0516-08_IlluminaGA-DNASeq_whole.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-0982-01A,206CE0ED-36A4-47AB-AC8E-F6FCA6AC5C18,Primary Tumor,Illumina GA,5d97901c-ebc3-4010-a553-fa6676b63443,Ovary,77,7FEC33CD-6F46-44C7-8204-E0F42B543ABE,1BE8FA2C-8FEA-4E8C-90DB-C04D9FCDBF49,TCGA-24-0982-01A-01D-0516-08,HG18_Broad_variant,TCGA-24-0982,TCGA-OV,679,s17873,Broad Institute of MIT and Harvard,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a972,58cfa82ee4b0c9d6adf6a972,G35154.TCGA-DU-5872-10A-01D-A465-08.1.filtered.,WGS,G35154.TCGA-DU-5872-10A-01D-A465-08.1,G35154.TCGA-DU-5872-10A-01D-A465-08.1.bam,168.4,1.9,0.07,58cfa82ee4b0c9d6adf6a972,G35154.TCGA-DU-5872-10A-01D-A465-08.1.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-5872-10A,48607130-C09A-491D-882F-7D2591D13182,Blood Derived Normal,Illumina HiSeq,c34d058a-bd0a-4020-8c94-21ecd4e31ef9,Brain,43,274BE2B2-3354-4E96-B871-F2722D7DE04D,EF52238C-1FB1-4BA7-A943-76E849F8145F,TCGA-DU-5872-10A-01D-A465-08,HG19_Broad_variant,TCGA-DU-5872,TCGA-LGG,NA,s8526,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa830e4b0c9d6adf6bdf1,58cfa830e4b0c9d6adf6bdf1,TCGA-AK-3428-01A-02D-2096-10_Illumina.filtered.,WGS,TCGA-AK-3428-01A-02D-2096-10_Illumina,TCGA-AK-3428-01A-02D-2096-10_Illumina.bam,23.4,1.9,0.14,58cfa830e4b0c9d6adf6bdf1,TCGA-AK-3428-01A-02D-2096-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-AK-3428-01A,9DA334ED-314C-4445-BA29-FFD9BB42403C,Primary Tumor,Illumina HiSeq,46d21c8f-8493-4886-82f4-91fd488b4364,Kidney,62,0B96A41E-6A0C-4FC6-8F21-8E5F992CE5D1,D01710F9-EFC8-4B5F-9E53-300B30F9219F,TCGA-AK-3428-01A-02D-2096-10,GRCh37-lite,TCGA-AK-3428,TCGA-KIRC,NA,s9303,Baylor College of Medicine,Fox Chase,None,NO,T3b,N0,Kidney Clear Cell Renal Carcinoma,Stage III
13722.58cfa82de4b0c9d6adf6a6d8,58cfa82de4b0c9d6adf6a6d8,909ed3b4185093163397be4875b0e4ee.filtered.,WGS,909ed3b4185093163397be4875b0e4ee,909ed3b4185093163397be4875b0e4ee.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a6d8,909ed3b4185093163397be4875b0e4ee.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2907-11A,E843A0EA-45A5-4C11-92A1-08FF12EB4531,Solid Tissue Normal,Illumina GA,aedead5f-118d-426d-b0cc-c24efb26f076,Blood,69,0799189E-3ED8-42E0-8771-F9D1797F3184,A29C2D2B-1E78-443F-AAC3-DEF013F368CA,TCGA-AB-2907-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2907,TCGA-LAML,NA,s7288,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6a8f4,58cfa82ee4b0c9d6adf6a8f4,G32456.TCGA-CF-A3MF-01A-12D-A21A-08.2.filtered.,WGS,G32456.TCGA-CF-A3MF-01A-12D-A21A-08.2,G32456.TCGA-CF-A3MF-01A-12D-A21A-08.2.bam,55.07,NA,0.08,58cfa82ee4b0c9d6adf6a8f4,G32456.TCGA-CF-A3MF-01A-12D-A21A-08.2.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CF-A3MF-01A,1E308B12-0590-4DAE-94D0-A539FCF25DF7,Primary Tumor,Illumina HiSeq,62e960fb-aaf6-4d7e-b15d-1b5136f6fa37,Bladder,34,E9889071-4C6E-4761-9D65-06C6B5989FB7,C66C92D5-DF65-46E6-861D-D8A98808E6A3,TCGA-CF-A3MF-01A-12D-A21A-08,HG19_Broad_variant,TCGA-CF-A3MF,TCGA-BLCA,NA,s2683,Broad Institute of MIT and Harvard,ILSbio,Vietnam,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82de4b0c9d6adf6a5a2,58cfa82de4b0c9d6adf6a5a2,77900ab864d04c4dbd5e77723793e1b7.filtered.,WGS,77900ab864d04c4dbd5e77723793e1b7,77900ab864d04c4dbd5e77723793e1b7.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a5a2,77900ab864d04c4dbd5e77723793e1b7.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2994-03A,B5F20EC2-FF5D-4AAC-8DB6-49887506F0B3,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,cdc58906-e1f2-4eb6-bf55-3450c8613244,Blood,25,793AFD96-44AC-4C80-80DB-1A072AC7611E,679DCE85-9FDC-4864-876B-189E068C0E2E,TCGA-AB-2994-03A-01D-0739-09,GRCh37-lite,TCGA-AB-2994,TCGA-LAML,NA,s7204,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a6b3,58cfa82de4b0c9d6adf6a6b3,93155e7b8273b1119a23c0d6172ce196.filtered.,WGS,93155e7b8273b1119a23c0d6172ce196,93155e7b8273b1119a23c0d6172ce196.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a6b3,93155e7b8273b1119a23c0d6172ce196.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3001-11A,66392380-A9FE-45B7-9191-60993F3F77F4,Solid Tissue Normal,Illumina GA,88361040-7c46-4509-84d2-9b9f711a3d36,Blood,31,EFF27F69-4C8D-4813-AF99-B4B2AA9FECC4,89734D2A-E63F-4255-8F4A-223187FA0DAF,TCGA-AB-3001-11A-01D-0739-09,GRCh37-lite,TCGA-AB-3001,TCGA-LAML,NA,s7205,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72ed8,58cfa83ce4b0c9d6adf72ed8,e56f2db4726f327debd64334f96bcd04.filtered.,WGS,e56f2db4726f327debd64334f96bcd04,e56f2db4726f327debd64334f96bcd04.bam,45.06,NA,0.08,58cfa83ce4b0c9d6adf72ed8,e56f2db4726f327debd64334f96bcd04.bam,Dead,FEMALE,WHITE,Not available,Sarcoma,Aligned reads,TCGA-IW-A3M5-01A,C20682A1-F340-430D-99F9-077FE093ED19,Primary Tumor,Illumina HiSeq,83802f59-1279-444a-b96b-4bbdf0aa3baa,Mesenchymal,76,34B60937-76B3-401C-A8DD-3F78E2B20A38,03CED0CE-186A-4349-8D98-572C2BC90382,TCGA-IW-A3M5-01A-22D-A21Q-09,GRCh37-lite,TCGA-IW-A3M5,TCGA-SARC,180,s2671,Washington University School of Medicine,Cedars Sinai,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6a8bc,58cfa82ee4b0c9d6adf6a8bc,G35154.TCGA-FG-8182-10A-01D-2253-08.4.filtered.,WGS,G35154.TCGA-FG-8182-10A-01D-2253-08.4,G35154.TCGA-FG-8182-10A-01D-2253-08.4.bam,117.9,NA,0.05,58cfa82ee4b0c9d6adf6a8bc,G35154.TCGA-FG-8182-10A-01D-2253-08.4.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-8182-10A,6A0BCF0C-FA4C-4119-99D2-F722B781D20F,Blood Derived Normal,Illumina HiSeq,cf62b63d-2102-4de2-9286-867afe868a79,Brain,35,558E7FD5-0BB6-4AD5-9644-FD85491398A7,705290FF-C3B5-4E53-956D-05FC3825CCB7,TCGA-FG-8182-10A-01D-2253-08,HG19_Broad_variant,TCGA-FG-8182,TCGA-LGG,NA,s8331,Broad Institute of MIT and Harvard,Case Western,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82de4b0c9d6adf6a4de,58cfa82de4b0c9d6adf6a4de,397f055d63d2bc89cb693623ed5ac2a0.filtered.,WGS,397f055d63d2bc89cb693623ed5ac2a0,397f055d63d2bc89cb693623ed5ac2a0.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a4de,397f055d63d2bc89cb693623ed5ac2a0.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2964-03A,1C9B389C-4740-449C-A10E-A840E8531E7B,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,1eda9412-6d2e-4dc7-8513-b54b7bfa14a9,Blood,58,E4F9F17F-AC3F-4F2F-B05E-60C3E64D7D3D,08C66839-F40C-4E38-8C49-10A963CC350F,TCGA-AB-2964-03A-01D-0741-05,GRCh37-lite,TCGA-AB-2964,TCGA-LAML,NA,s6972,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a5e6,58cfa82de4b0c9d6adf6a5e6,68643203aa5b5cbe3d40a15c06570987.filtered.,WGS,68643203aa5b5cbe3d40a15c06570987,68643203aa5b5cbe3d40a15c06570987.bam,18.94,2.03,0.07,58cfa82de4b0c9d6adf6a5e6,68643203aa5b5cbe3d40a15c06570987.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A14P-10A,E4FC0909-F284-4471-866D-D8967B6ADCBC,Blood Derived Normal,Illumina HiSeq,a639fa8f-f8d6-4d5c-85bf-5a37c02258d4,Breast,79,B41594A0-5892-4AE6-A354-DDF09A7772A0,45561DA8-6073-4F1D-9CFC-B627516D1242,TCGA-E2-A14P-10A-01D-A19H-09,GRCh37-lite,TCGA-E2-A14P,TCGA-BRCA,NA,s6626,Washington University School of Medicine,Roswell Park,None,NO,T2,N3,Infiltrating Ductal Carcinoma,Stage IIIC
13722.58cfa83ce4b0c9d6adf7312a,58cfa83ce4b0c9d6adf7312a,f416b7d3fb5c81d48517212e0e97bccf.filtered.,WGS,f416b7d3fb5c81d48517212e0e97bccf,f416b7d3fb5c81d48517212e0e97bccf.bam,311.7,1.9,0.19,58cfa83ce4b0c9d6adf7312a,f416b7d3fb5c81d48517212e0e97bccf.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0208-01A,E3711A9B-6D4C-44DF-BBAB-0A675046A5DF,Primary Tumor,Illumina GA,2ec6b2c4-2d1e-4c32-9c4d-b9473a4562ae,Brain,52,F76E7120-75E8-4E94-8217-E659C09AD276,073E20B4-035F-4E44-A2AA-A4723915DA87,TCGA-06-0208-01A-01D-0512-09,GRCh37-lite,TCGA-06-0208,TCGA-GBM,256,s14283,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf731f0,58cfa83ce4b0c9d6adf731f0,ac6f4bd5f5cbc54f584b61a15f1ee746.filtered.,WGS,ac6f4bd5f5cbc54f584b61a15f1ee746,ac6f4bd5f5cbc54f584b61a15f1ee746.bam,NA,NA,NA,58cfa83ce4b0c9d6adf731f0,ac6f4bd5f5cbc54f584b61a15f1ee746.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2988-03A,4B8FF65F-B563-4519-B984-C7CF26B3AD73,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,7e3f8199-9ea9-43e6-b392-b26841eaae42,Blood,67,A1A2B655-97D5-490F-8D2A-874D4DA7DABB,22846F9A-C8EB-4CC5-852A-E54C59326511,TCGA-AB-2988-03A-01D-0742-05,GRCh37-lite,TCGA-AB-2988,TCGA-LAML,30,s7155,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72f69,58cfa83ce4b0c9d6adf72f69,e9c2b6db51ea7cf5483dbf35f3e3145d.filtered.,WGS,e9c2b6db51ea7cf5483dbf35f3e3145d,e9c2b6db51ea7cf5483dbf35f3e3145d.bam,NA,NA,NA,58cfa83ce4b0c9d6adf72f69,e9c2b6db51ea7cf5483dbf35f3e3145d.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2971-03A,5ECE14FD-3D7F-4ECB-96AA-2C44D8F15CA4,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,fb30c786-2766-4c25-a753-5713608293d8,Blood,76,3FB0C4AC-78B3-43D6-871B-05D1EB46CA62,02AB737F-5BED-40A5-A057-9FD8109DCC1F,TCGA-AB-2971-03A-01D-0741-05,GRCh37-lite,TCGA-AB-2971,TCGA-LAML,792,s7132,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a682,58cfa82de4b0c9d6adf6a682,590c4032bb8796aa3eee6a93cca35d91.filtered.,WGS,590c4032bb8796aa3eee6a93cca35d91,590c4032bb8796aa3eee6a93cca35d91.bam,36.67,1.88,0.15,58cfa82de4b0c9d6adf6a682,590c4032bb8796aa3eee6a93cca35d91.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0877-10A,32AFDC6C-E899-4795-9E90-C9A192BBC4C1,Blood Derived Normal,Illumina GA,2e5e0ecf-a7d7-425e-9ed6-59c609ea8f34,Brain,78,373FC9C5-1D99-467E-8C81-4D6197236258,6FFB29C5-CAF6-448E-B3D6-72556BA86F8F,TCGA-06-0877-10A-01D-0512-09,GRCh37-lite,TCGA-06-0877,TCGA-GBM,NA,s14159,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a5d6,58cfa82de4b0c9d6adf6a5d6,5271a27f0d1c57058d98a3160eb23cdf.filtered.,WGS,5271a27f0d1c57058d98a3160eb23cdf,5271a27f0d1c57058d98a3160eb23cdf.bam,30.62,2,0.08,58cfa82de4b0c9d6adf6a5d6,5271a27f0d1c57058d98a3160eb23cdf.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A11I-10A,F6D136C7-C250-4361-9FED-50F513959A40,Blood Derived Normal,Illumina HiSeq,1cc4639d-966e-4516-b022-aea8e6454866,Uterus,65,8338C154-FBF6-4A5E-9A89-FA825AB9BD9E,9CE58A61-6090-4486-B294-065E750B064C,TCGA-B5-A11I-10A-01D-A325-09,GRCh37-lite,TCGA-B5-A11I,TCGA-UCEC,NA,s4768,Washington University School of Medicine,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf72ef0,58cfa83ce4b0c9d6adf72ef0,bd4ced3febde5a91af28a7fa3e8eff56.filtered.,WGS,bd4ced3febde5a91af28a7fa3e8eff56,bd4ced3febde5a91af28a7fa3e8eff56.bam,NA,NA,NA,58cfa83ce4b0c9d6adf72ef0,bd4ced3febde5a91af28a7fa3e8eff56.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2905-11A,AE2392A3-B8C2-4DDB-8CEC-A28CB3FCD80B,Solid Tissue Normal,Illumina GA,6bcd196f-fb12-44fc-b69f-be4eef68a9eb,Blood,48,76B55DF7-B108-4392-9AFB-5521BAD9BCE9,D38F4CBF-101A-445D-ADAF-B3803D5DCFC5,TCGA-AB-2905-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2905,TCGA-LAML,NA,s7278,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6a91a,58cfa82ee4b0c9d6adf6a91a,G32524.TCGA-DJ-A1QL-01A-11D-A14W-08.2.filtered.,WGS,G32524.TCGA-DJ-A1QL-01A-11D-A14W-08.2,G32524.TCGA-DJ-A1QL-01A-11D-A14W-08.2.bam,77.76,1.96,0.09,58cfa82ee4b0c9d6adf6a91a,G32524.TCGA-DJ-A1QL-01A-11D-A14W-08.2.bam,Alive,MALE,Not available,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QL-01A,E4B08E66-0772-4956-8670-E5C6553EECBE,Primary Tumor,Illumina HiSeq,c90da8dc-3705-4381-a713-d4a404dd09ce,Thyroid,70,62B6D426-E1E4-48E8-BC8F-6B07C67CC0D0,79169C46-7049-4576-9885-63973DB76AB9,TCGA-DJ-A1QL-01A-11D-A14W-08,HG19_Broad_variant,TCGA-DJ-A1QL,TCGA-THCA,NA,s12217,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa830e4b0c9d6adf6bdf8,58cfa830e4b0c9d6adf6bdf8,TCGA-AK-3454-01A-02D-2096-10_wgs_Illumina.filtered.,WGS,TCGA-AK-3454-01A-02D-2096-10_wgs_Illumina,TCGA-AK-3454-01A-02D-2096-10_wgs_Illumina.bam,28.07,1.9,0.15,58cfa830e4b0c9d6adf6bdf8,TCGA-AK-3454-01A-02D-2096-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-AK-3454-01A,28E9B6F9-AB6A-400B-A6A9-79095A443591,Primary Tumor,Illumina HiSeq,54d1e202-1017-4494-af06-5b5747b7201c,Kidney,84,74741322-3B24-43E6-9CE1-F267B0555F62,FD74DE4D-6973-4597-A541-E8A13D80AD55,TCGA-AK-3454-01A-02D-2096-10,GRCh37-lite,TCGA-AK-3454,TCGA-KIRC,NA,s9731,Baylor College of Medicine,Fox Chase,United States,NO,T1b,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6aafc,58cfa82ee4b0c9d6adf6aafc,G32538.TCGA-EM-A2CU-10A-01D-A17V-08.3.filtered.,WGS,G32538.TCGA-EM-A2CU-10A-01D-A17V-08.3,G32538.TCGA-EM-A2CU-10A-01D-A17V-08.3.bam,83.06,NA,0.09,58cfa82ee4b0c9d6adf6aafc,G32538.TCGA-EM-A2CU-10A-01D-A17V-08.3.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A2CU-10A,667EB7F6-1D36-49BB-9D7B-C9D167B64619,Blood Derived Normal,Illumina HiSeq,1fc6eb5f-dc02-4faf-92e3-dafdc84099c7,Thyroid,47,85CC9D3F-2919-4387-B4A4-469E92EEFDC3,F0C68997-7104-43FB-B949-3EA4B958AAB9,TCGA-EM-A2CU-10A-01D-A17V-08,HG19_Broad_variant,TCGA-EM-A2CU,TCGA-THCA,NA,s12732,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T2,N1a,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III
13722.58cfa82de4b0c9d6adf6a698,58cfa82de4b0c9d6adf6a698,81721a784888164a9ff23f4f4d935a0a.filtered.,WGS,81721a784888164a9ff23f4f4d935a0a,81721a784888164a9ff23f4f4d935a0a.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a698,81721a784888164a9ff23f4f4d935a0a.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2978-03A,90FC467C-2B0D-461D-A1B8-C2A519354367,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,05e5291a-c886-48ac-a0f7-70ed233767bb,Blood,61,37A5C03C-45C2-4096-8712-370CE5EBFBBD,04356A1D-2615-4729-8AAB-C35440F498BB,TCGA-AB-2978-03A-01D-0742-05,GRCh37-lite,TCGA-AB-2978,TCGA-LAML,NA,s7166,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6b0b4,58cfa82ee4b0c9d6adf6b0b4,TCGA-06-0881-01A-02D-0512-09_whole.filtered.,WGS,TCGA-06-0881-01A-02D-0512-09_whole,TCGA-06-0881-01A-02D-0512-09_whole.bam,54.77,1.9,0.14,58cfa82ee4b0c9d6adf6b0b4,TCGA-06-0881-01A-02D-0512-09_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0881-01A,1B6C184A-5868-4A51-8A82-AA16A7E65126,Primary Tumor,Illumina GA,ef2a6ac1-e4f6-43b4-bfae-9ddf32bfaffa,Brain,50,02354610-465F-4E27-9DEA-80410E1D3972,8480DB03-E875-41AC-A259-18698317F45A,TCGA-06-0881-01A-02D-0512-09,NCBI36_WUGSC_variant,TCGA-06-0881,TCGA-GBM,NA,s14229,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6bce9,58cfa830e4b0c9d6adf6bce9,TCGA-AB-2965-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2965-03A-01D-0739-09_whole,TCGA-AB-2965-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bce9,TCGA-AB-2965-03A-01D-0739-09_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2965-03A,05924106-07F6-44CA-BA15-7452B8A657E4,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,71f9c331-2379-4f9d-b40a-232281985b54,Blood,60,D42A66CD-BC74-477F-A924-1B3A303BFA16,3467D556-EA36-46AA-B48F-29896F5B56F3,TCGA-AB-2965-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2965,TCGA-LAML,335,s7046,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf73092,58cfa83ce4b0c9d6adf73092,f76967b22da60338413354d7107e4cd0.filtered.,WGS,f76967b22da60338413354d7107e4cd0,f76967b22da60338413354d7107e4cd0.bam,NA,NA,NA,58cfa83ce4b0c9d6adf73092,f76967b22da60338413354d7107e4cd0.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2999-11A,646631CE-7A1F-4274-ABB7-780B939E182F,Solid Tissue Normal,Illumina GA,20f5e9aa-90cf-4edb-8dbd-efd0ea4e0a91,Blood,62,975B1F0A-0528-438B-A78A-58DEFBB54DD8,3357E03B-0FFD-40AC-ACD4-4806DFF7D769,TCGA-AB-2999-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2999,TCGA-LAML,NA,s7303,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6a986,58cfa82ee4b0c9d6adf6a986,G35154.TCGA-DU-6407-01A-13D-1705-08.1.filtered.,WGS,G35154.TCGA-DU-6407-01A-13D-1705-08.1,G35154.TCGA-DU-6407-01A-13D-1705-08.1.bam,19.3,1.9,0.05,58cfa82ee4b0c9d6adf6a986,G35154.TCGA-DU-6407-01A-13D-1705-08.1.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6407-01A,70939245-41E0-4845-A473-5FEF719B9828,Primary Tumor,Illumina HiSeq,52ae2dd2-f573-41c6-ad1a-18b19c9eea35,Brain,35,29D91F2B-C040-46BC-9B9E-3A41790DC664,F92A34FA-014E-4B41-A6D0-3B46B8C8A3EE,TCGA-DU-6407-01A-13D-1705-08,HG19_Broad_variant,TCGA-DU-6407,TCGA-LGG,2875,s8532,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6aba3,58cfa82ee4b0c9d6adf6aba3,G32532.TCGA-EL-A3H1-01A-11D-A21A-08.3.filtered.,WGS,G32532.TCGA-EL-A3H1-01A-11D-A21A-08.3,G32532.TCGA-EL-A3H1-01A-11D-A21A-08.3.bam,31.88,NA,0.08,58cfa82ee4b0c9d6adf6aba3,G32532.TCGA-EL-A3H1-01A-11D-A21A-08.3.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EL-A3H1-01A,8D54A2ED-03F1-4A23-BDD2-F3395F5D3716,Primary Tumor,Illumina HiSeq,9cc1b2f2-01f5-4ed3-873b-152726b61e55,Thyroid,66,9ED0332E-C846-4091-BF6E-0C5BF55B9F1A,62FCEB56-8C6E-4D20-9D2F-5B7042854D23,TCGA-EL-A3H1-01A-11D-A21A-08,HG19_Broad_variant,TCGA-EL-A3H1,TCGA-THCA,1500,s12733,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82ee4b0c9d6adf6ab8f,58cfa82ee4b0c9d6adf6ab8f,G35154.TCGA-EZ-7264-10A-01D-2024-08.2.filtered.,WGS,G35154.TCGA-EZ-7264-10A-01D-2024-08.2,G35154.TCGA-EZ-7264-10A-01D-2024-08.2.bam,25.3,NA,0.05,58cfa82ee4b0c9d6adf6ab8f,G35154.TCGA-EZ-7264-10A-01D-2024-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-EZ-7264-10A,FC3B7596-F515-446F-81DB-FED0154CA2C5,Blood Derived Normal,Illumina HiSeq,b74ca950-7df4-42c9-ba4c-a7c1599fe56f,Brain,47,314F5F1D-1E33-4883-AB45-DB46B1F8EF41,D5DFAC45-4AFF-481D-9117-807ED47B7B10,TCGA-EZ-7264-10A-01D-2024-08,HG19_Broad_variant,TCGA-EZ-7264,TCGA-LGG,NA,s8115,Broad Institute of MIT and Harvard,UNC,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82de4b0c9d6adf6a47c,58cfa82de4b0c9d6adf6a47c,223998f19116d66a28e06498d3fc3583.filtered.,WGS,223998f19116d66a28e06498d3fc3583,223998f19116d66a28e06498d3fc3583.bam,14.9,1.9,0.23,58cfa82de4b0c9d6adf6a47c,223998f19116d66a28e06498d3fc3583.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0214-10A,9853C6BB-A42C-4698-ABE5-F3C897EBC8F6,Blood Derived Normal,Illumina GA,1f0336e7-4a12-43a2-bf3f-848a574906de,Brain,66,D067A643-8E8B-4E86-8186-582FC140F744,ABBF3618-7F5A-4471-9096-B16E1435122E,TCGA-06-0214-10A-01D-0512-09,GRCh37-lite,TCGA-06-0214,TCGA-GBM,457,s14011,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a6da,58cfa82de4b0c9d6adf6a6da,917393fd54d541ee5bf939911e9e1142.filtered.,WGS,917393fd54d541ee5bf939911e9e1142,917393fd54d541ee5bf939911e9e1142.bam,17.01,NA,0.08,58cfa82de4b0c9d6adf6a6da,917393fd54d541ee5bf939911e9e1142.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-MO-A47R-01A,8654C2B5-27D7-43C5-9A39-7FDEFD7A0324,Primary Tumor,Illumina HiSeq,1e530776-868a-4b43-ac6b-7e692691b675,Mesenchymal,75,3D38F7C9-00DD-47C1-8649-C50574953AAB,7A5D3B6B-BE5A-4E55-9255-32A069B8AF3D,TCGA-MO-A47R-01A-11D-A24N-09,GRCh37-lite,TCGA-MO-A47R,TCGA-SARC,NA,s2492,Washington University School of Medicine,ILSbio,Vietnam,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a469,58cfa82de4b0c9d6adf6a469,027f660be4ab34e02502cee990e67a84.filtered.,WGS,027f660be4ab34e02502cee990e67a84,027f660be4ab34e02502cee990e67a84.bam,9.03,NA,0.08,58cfa82de4b0c9d6adf6a469,027f660be4ab34e02502cee990e67a84.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A4A1-01A,3C1F8B73-BAD7-4649-B08E-C7AFC647EDF3,Primary Tumor,HiSeq X Ten,de6c65e3-e0ae-43e9-ba68-7afe11ac30ad,Esophagus,60,C880F903-2719-4ED6-8A17-7E0EE7716FF4,A03EF5D0-0CF8-4303-941F-4E3045612671,TCGA-LN-A4A1-01A-21D-A27G-09,GRCh37-lite_WUGSC_variant_2,TCGA-LN-A4A1,TCGA-ESCA,NA,s1710,Washington University School of Medicine,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa82de4b0c9d6adf6a6d4,58cfa82de4b0c9d6adf6a6d4,84cabc6d988c220d0be27b3d2d76db69.filtered.,WGS,84cabc6d988c220d0be27b3d2d76db69,84cabc6d988c220d0be27b3d2d76db69.bam,17.19,NA,0.08,58cfa82de4b0c9d6adf6a6d4,84cabc6d988c220d0be27b3d2d76db69.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-IE-A4EK-01A,590FDB76-20EF-4F95-9783-7D80E7A25E5A,Primary Tumor,Illumina HiSeq,01fcfdba-18c9-4abf-84be-b5fbac48d25a,Mesenchymal,54,9963DA13-6EA7-48A3-A3DE-1C6A38F977B9,56681386-D407-4F53-AE4F-6C04437652F7,TCGA-IE-A4EK-01A-11D-A24N-09,GRCh37-lite,TCGA-IE-A4EK,TCGA-SARC,NA,s2494,Washington University School of Medicine,ABS - IUPUI,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6aba5,58cfa82ee4b0c9d6adf6aba5,G32542.TCGA-D9-A148-10A-01D-A19A-08.3.filtered.,WGS,G32542.TCGA-D9-A148-10A-01D-A19A-08.3,G32542.TCGA-D9-A148-10A-01D-A19A-08.3.bam,18.06,NA,0.08,58cfa82ee4b0c9d6adf6aba5,G32542.TCGA-D9-A148-10A-01D-A19A-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D9-A148-10A,FED23055-1600-4128-8D73-E1AA902A9D1D,Blood Derived Normal,Illumina HiSeq,361173b9-ba45-4cf8-b23f-c01cec3bf529,Skin,40,93BEBC8E-9072-407B-AE4F-E763B7193F5C,B036B9BB-F047-427A-BD1F-7BDEC7C15002,TCGA-D9-A148-10A-01D-A19A-08,HG19_Broad_variant,TCGA-D9-A148,TCGA-SKCM,NA,s7808,Broad Institute of MIT and Harvard,Greater Poland Cancer Center,Poland,NO,TX,N3,Not available,Not available
13722.58cfa82ee4b0c9d6adf6aa84,58cfa82ee4b0c9d6adf6aa84,G32450.TCGA-FD-A3N5-10A-01D-A21A-08.2.filtered.,WGS,G32450.TCGA-FD-A3N5-10A-01D-A21A-08.2,G32450.TCGA-FD-A3N5-10A-01D-A21A-08.2.bam,27.72,NA,0.07,58cfa82ee4b0c9d6adf6aa84,G32450.TCGA-FD-A3N5-10A-01D-A21A-08.2.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3N5-10A,A658BECF-3934-49F2-9E74-291DCA61D4BB,Blood Derived Normal,Illumina HiSeq,e328fab9-8dc9-436b-81e9-d1c31762c9dc,Bladder,69,E5E8BC12-FB3C-4404-AEE2-2B90A11384A0,8AEE029E-9DA1-4714-933A-7613313DD998,TCGA-FD-A3N5-10A-01D-A21A-08,HG19_Broad_variant,TCGA-FD-A3N5,TCGA-BLCA,NA,s2675,Broad Institute of MIT and Harvard,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa82ee4b0c9d6adf6af30,58cfa82ee4b0c9d6adf6af30,G37566.TCGA-HC-7740-10A-01D-2115-08.3.filtered.,WGS,G37566.TCGA-HC-7740-10A-01D-2115-08.3,G37566.TCGA-HC-7740-10A-01D-2115-08.3.bam,185.5,NA,0.05,58cfa82ee4b0c9d6adf6af30,G37566.TCGA-HC-7740-10A-01D-2115-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7740-10A,91E249A6-B0B0-487E-9FAD-0E9F5798DCAE,Blood Derived Normal,Illumina HiSeq,d72a0569-8a57-429e-8b29-e42f85c3a252,Prostate,59,EA660383-0A1A-48EE-9448-822B7CA38067,9DB864A0-450D-4EF4-83FF-1A869AB80803,TCGA-HC-7740-10A-01D-2115-08,HG19_Broad_variant,TCGA-HC-7740,TCGA-PRAD,NA,s3763,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6adb8,58cfa82ee4b0c9d6adf6adb8,G39020.TCGA-CG-4442-10A-01D-A290-08.2.filtered.,WGS,G39020.TCGA-CG-4442-10A-01D-A290-08.2,G39020.TCGA-CG-4442-10A-01D-A290-08.2.bam,57.9,1.9,0.08,58cfa82ee4b0c9d6adf6adb8,G39020.TCGA-CG-4442-10A-01D-A290-08.2.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4442-10A,8FCCFF71-3710-4CB9-B8AF-61707AEBE5D8,Blood Derived Normal,Illumina HiSeq,f593a6cb-9401-41cb-8797-9afa48927312,Stomach,85,85F0304A-7ED7-4715-B1B3-655DF4C87FBF,369C44C6-1EFA-44EF-BAF5-E769073C6A87,TCGA-CG-4442-10A-01D-A290-08,HG19_Broad_variant,TCGA-CG-4442,TCGA-STAD,NA,s15296,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6ad59,58cfa82ee4b0c9d6adf6ad59,G39019.TCGA-DA-A1HV-10A-01D-A198-08.3.filtered.,WGS,G39019.TCGA-DA-A1HV-10A-01D-A198-08.3,G39019.TCGA-DA-A1HV-10A-01D-A198-08.3.bam,11.05,NA,0.08,58cfa82ee4b0c9d6adf6ad59,G39019.TCGA-DA-A1HV-10A-01D-A198-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1HV-10A,210726BD-DB19-48AE-9A3D-E6AC44480E85,Blood Derived Normal,Illumina HiSeq,297c288e-8579-4c2f-9eb9-9fbda1269d4c,Skin,75,D0E9ABC5-985A-4A82-B8C3-64C13460DA72,02FB5E42-5DCC-44BA-97C3-1BE1BA423680,TCGA-DA-A1HV-10A-01D-A198-08,HG19_Broad_variant,TCGA-DA-A1HV,TCGA-SKCM,NA,s7661,Broad Institute of MIT and Harvard,Yale,United States,NO,T0,N2b,Not available,Stage IIIB
13722.58cfa82ee4b0c9d6adf6aac4,58cfa82ee4b0c9d6adf6aac4,G32450.TCGA-FD-A3N5-01A-11D-A21A-08.1.filtered.,WGS,G32450.TCGA-FD-A3N5-01A-11D-A21A-08.1,G32450.TCGA-FD-A3N5-01A-11D-A21A-08.1.bam,30.45,NA,0.08,58cfa82ee4b0c9d6adf6aac4,G32450.TCGA-FD-A3N5-01A-11D-A21A-08.1.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3N5-01A,A658BECF-3934-49F2-9E74-291DCA61D4BB,Primary Tumor,Illumina HiSeq,2650b346-1fc6-4664-bfd1-3765e04cf29a,Bladder,69,66559B5F-AB2F-406B-9EDB-0F5085EEC7C5,418A3DEC-96FF-4719-BECB-E1A8260CCE2F,TCGA-FD-A3N5-01A-11D-A21A-08,HG19_Broad_variant,TCGA-FD-A3N5,TCGA-BLCA,NA,s3248,Broad Institute of MIT and Harvard,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa82ee4b0c9d6adf6a8aa,58cfa82ee4b0c9d6adf6a8aa,G35154.TCGA-E1-5319-01A-01D-1893-08.4.filtered.,WGS,G35154.TCGA-E1-5319-01A-01D-1893-08.4,G35154.TCGA-E1-5319-01A-01D-1893-08.4.bam,56,1.9,0.05,58cfa82ee4b0c9d6adf6a8aa,G35154.TCGA-E1-5319-01A-01D-1893-08.4.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-E1-5319-01A,84569C1A-6BAA-4380-AE3C-707DF1BE4618,Primary Tumor,Illumina HiSeq,6b14040f-a3ce-4fe5-a5f9-f311cd1ec11a,Brain,48,1EE9478B-84A5-4FFD-8499-F2E02A3A21D7,D252A54E-0377-4B3E-8228-26108EA704FA,TCGA-E1-5319-01A-01D-1893-08,HG19_Broad_variant,TCGA-E1-5319,TCGA-LGG,2907,s8323,Broad Institute of MIT and Harvard,Duke,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa83ce4b0c9d6adf7308c,58cfa83ce4b0c9d6adf7308c,faba826f62de3e18afab489ceee4b813.filtered.,WGS,faba826f62de3e18afab489ceee4b813,faba826f62de3e18afab489ceee4b813.bam,6.41,NA,0.07,58cfa83ce4b0c9d6adf7308c,faba826f62de3e18afab489ceee4b813.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A1KW-01A,CD73A55F-03C1-4DA0-9FA7-1AE4A263664E,Primary Tumor,Illumina HiSeq,1ac5c6a6-b264-4f58-b9fb-983c540128a7,Mesenchymal,67,4C93C0A4-73C4-48EF-91E0-40B2143833BC,63DB50D6-5EF2-44D0-9906-26EAE74ECF44,TCGA-DX-A1KW-01A-22D-A24N-09,GRCh37-lite,TCGA-DX-A1KW,TCGA-SARC,NA,s2636,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6aca0,58cfa82ee4b0c9d6adf6aca0,G47088.TCGA-77-6843-10A-01D-1945-08.1.filtered.,WGS,G47088.TCGA-77-6843-10A-01D-1945-08.1,G47088.TCGA-77-6843-10A-01D-1945-08.1.bam,189,1.8,0.05,58cfa82ee4b0c9d6adf6aca0,G47088.TCGA-77-6843-10A-01D-1945-08.1.bam,Dead,MALE,WHITE,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-77-6843-10A,C2598334-F866-4CC3-93EC-2D2E8B85D319,Blood Derived Normal,Illumina HiSeq,5a1021ad-8662-46d1-8cfa-7d06f35393bc,Lung,74,FF240243-CF04-4CA9-B829-3BBD459FF8F5,13459B6C-3E94-429F-A9F7-8A796EE13045,TCGA-77-6843-10A-01D-1945-08,HG19_Broad_variant,TCGA-77-6843,TCGA-LUSC,2224,s10501,Broad Institute of MIT and Harvard,Prince Charles Hospital,Australia,NO,T1,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa82de4b0c9d6adf6a470,58cfa82de4b0c9d6adf6a470,0f3abc47187f5c5787e43eec2fdc949c.filtered.,WGS,0f3abc47187f5c5787e43eec2fdc949c,0f3abc47187f5c5787e43eec2fdc949c.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a470,0f3abc47187f5c5787e43eec2fdc949c.bam,Alive,FEMALE,Not available,Not available,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2982-11A,AE9BBADA-D987-4757-A081-74F005821C09,Solid Tissue Normal,Illumina GA,af79274a-6f4b-45af-b3ae-02f3780dcfc0,Blood,29,90495DBC-D405-42BD-B0C7-837E54D6BE6F,FD834A25-F907-4646-8A91-2A1D97DB9AAF,TCGA-AB-2982-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2982,TCGA-LAML,NA,s7199,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6ab3c,58cfa82ee4b0c9d6adf6ab3c,G37566.TCGA-CH-5771-11A-01D-1576-08.2.filtered.,WGS,G37566.TCGA-CH-5771-11A-01D-1576-08.2,G37566.TCGA-CH-5771-11A-01D-1576-08.2.bam,129.7,2,0.05,58cfa82ee4b0c9d6adf6ab3c,G37566.TCGA-CH-5771-11A-01D-1576-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5771-11A,3ACD8328-76F7-4F43-9660-394B95748C3D,Solid Tissue Normal,Illumina HiSeq,8db96075-ac39-478a-b26f-a624d6a83712,Prostate,63,3BAC387D-1199-4842-863C-8BCC09EFBF3F,D75F9A49-DFC3-493B-B9DD-4940D9803CFD,TCGA-CH-5771-11A-01D-1576-08,HG19_Broad_variant,TCGA-CH-5771,TCGA-PRAD,NA,s3403,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bb98,58cfa830e4b0c9d6adf6bb98,TCGA-A2-A0D0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-A2-A0D0-01A-11D-A128-09_IlluminaGA-DNASeq_whole,TCGA-A2-A0D0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam,66.88,1.91,0.08,58cfa830e4b0c9d6adf6bb98,TCGA-A2-A0D0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A0D0-01A,324BCBA2-F6A4-45A6-807C-215BDFFCCA21,Primary Tumor,Illumina HiSeq,25ddf041-bc97-4ced-aa1a-cf0339d8c23b,Breast,60,7FD5702E-2D7B-4B79-B2D8-5CA4CA33CF65,71FDA5A9-7049-406F-9348-2C24F7DDF5F4,TCGA-A2-A0D0-01A-11D-A128-09,GRCh37-lite,TCGA-A2-A0D0,TCGA-BRCA,NA,s6270,Washington University School of Medicine,Walter Reed,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa83ce4b0c9d6adf72fc2,58cfa83ce4b0c9d6adf72fc2,af05720beca535343a2f1dc9d58e1dfe.filtered.,WGS,af05720beca535343a2f1dc9d58e1dfe,af05720beca535343a2f1dc9d58e1dfe.bam,100.28,NA,0.07,58cfa83ce4b0c9d6adf72fc2,af05720beca535343a2f1dc9d58e1dfe.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49L-10A,AD29744C-A09D-463A-84B5-63CFEB7FF786,Blood Derived Normal,HiSeq X Ten,c790786a-d2bb-418c-b333-b2babda271c8,Esophagus,44,DC4443DD-EE35-4D2A-B1BE-8DC494CACA30,EFF182C7-0675-4FAD-85EF-F59A124A8880,TCGA-LN-A49L-10A-01D-A247-09,GRCh37-lite_WUGSC_variant_2,TCGA-LN-A49L,TCGA-ESCA,NA,s1901,Washington University School of Medicine,ILSbio,Vietnam,NO,T2,N0,Not available,Stage IIA
13722.58cfa82ee4b0c9d6adf6aa88,58cfa82ee4b0c9d6adf6aa88,G32469.TCGA-DK-A1AG-01A-11D-A13W-08.2.filtered.,WGS,G32469.TCGA-DK-A1AG-01A-11D-A13W-08.2,G32469.TCGA-DK-A1AG-01A-11D-A13W-08.2.bam,70.38,1.89,0.08,58cfa82ee4b0c9d6adf6aa88,G32469.TCGA-DK-A1AG-01A-11D-A13W-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AG-01A,F8C0A69C-DF53-4A0A-A30E-4424C0CE3DD5,Primary Tumor,Illumina HiSeq,9ef4c333-8532-4ab7-bd4b-ba1161f87a6d,Bladder,65,64668AA0-DDE5-4534-8CD0-378881E4A4E4,7D2A22EB-7344-4CBA-AD7D-94C3F9EF3D7C,TCGA-DK-A1AG-01A-11D-A13W-08,HG19_Broad_variant,TCGA-DK-A1AG,TCGA-BLCA,NA,s2848,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82de4b0c9d6adf6a522,58cfa82de4b0c9d6adf6a522,2e173cba9eef7aec792a9b66d36c62fd.filtered.,WGS,2e173cba9eef7aec792a9b66d36c62fd,2e173cba9eef7aec792a9b66d36c62fd.bam,107.95,1.77,0.09,58cfa82de4b0c9d6adf6a522,2e173cba9eef7aec792a9b66d36c62fd.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A1FC-01A,B97BF89A-7A85-4EEF-AE7E-F787AEAD1F0A,Primary Tumor,Illumina HiSeq,96f6b8e2-d4c6-44db-a8d4-3c7549e04038,Breast,78,3AD0093A-E57A-450A-B0EF-942C9B67A586,84C77098-03D0-4B22-AFB1-797703E85C6C,TCGA-BH-A1FC-01A-11D-A13L-09,GRCh37-lite,TCGA-BH-A1FC,TCGA-BRCA,3472,s6455,Washington University School of Medicine,University of Pittsburgh,None,NO,T1c,N1b,Medullary Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6a97a,58cfa82ee4b0c9d6adf6a97a,G32453.TCGA-DK-A3IL-10A-01D-A20D-08.1.filtered.,WGS,G32453.TCGA-DK-A3IL-10A-01D-A20D-08.1,G32453.TCGA-DK-A3IL-10A-01D-A20D-08.1.bam,43.72,NA,0.07,58cfa82ee4b0c9d6adf6a97a,G32453.TCGA-DK-A3IL-10A-01D-A20D-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3IL-10A,178B28CD-99C3-48DC-8D09-1EF71B4CEE80,Blood Derived Normal,Illumina HiSeq,0c0a70d3-1218-4617-a4cf-3c0359917232,Bladder,79,CD3CFB26-E66F-408E-81F6-3B61C247C976,C1DA8EED-4919-4BA5-A735-3FBA476C18A7,TCGA-DK-A3IL-10A-01D-A20D-08,HG19_Broad_variant,TCGA-DK-A3IL,TCGA-BLCA,NA,s2846,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa830e4b0c9d6adf6bcaa,58cfa830e4b0c9d6adf6bcaa,TCGA-AG-3727-10A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AG-3727-10A-01D-1989-10_wgs_Illumina,TCGA-AG-3727-10A-01D-1989-10_wgs_Illumina.bam,55.31,1.9,0.15,58cfa830e4b0c9d6adf6bcaa,TCGA-AG-3727-10A-01D-1989-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3727-10A,E6827400-0D95-46B0-8874-6CE9E9D5011B,Blood Derived Normal,Illumina HiSeq,07ae68ae-0178-476c-b9ec-f0d898ced469,Colorectal,78,A2FEF5A0-A5B1-4835-B92E-6F1E8C88C510,8AECF7AD-6962-433A-8D76-9A0DAF6C4FDE,TCGA-AG-3727-10A-01D-1989-10,GRCh37-lite,TCGA-AG-3727,TCGA-READ,NA,s2307,Baylor College of Medicine,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage III
13722.58cfa83ce4b0c9d6adf730fb,58cfa83ce4b0c9d6adf730fb,c21b11a5f7bdf2051a241c4a76e9a7ef.filtered.,WGS,c21b11a5f7bdf2051a241c4a76e9a7ef,c21b11a5f7bdf2051a241c4a76e9a7ef.bam,26.94,NA,0.08,58cfa83ce4b0c9d6adf730fb,c21b11a5f7bdf2051a241c4a76e9a7ef.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-K1-A3PN-01A,F519BE07-434E-4EB2-ACF9-318565B83D50,Primary Tumor,HiSeq X Ten,0bcfd127-838e-4670-8d4a-b028dce79774,Mesenchymal,64,3DB0DE29-F0A6-4CEA-BEC5-22164E795A43,0E554430-E3C5-4C9B-9681-3E9C0F4236F1,TCGA-K1-A3PN-01A-11D-A228-09,GRCh37-lite,TCGA-K1-A3PN,TCGA-SARC,NA,s2468,Washington University School of Medicine,University of Pittsburgh,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a5ea,58cfa82de4b0c9d6adf6a5ea,6ba0f207b75dd31d55a433a1e29c6e01.filtered.,WGS,6ba0f207b75dd31d55a433a1e29c6e01,6ba0f207b75dd31d55a433a1e29c6e01.bam,30.67,1.9,0.14,58cfa82de4b0c9d6adf6a5ea,6ba0f207b75dd31d55a433a1e29c6e01.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0890-01A,EE0A4A13-613E-4C5D-96C3-8083A013702D,Primary Tumor,Illumina GA,d6c010a0-4b16-4942-963e-c8f13dbb679e,Ovary,56,37981859-BA7A-4F93-8FCB-78615E696149,8658F4F5-9A50-4195-8EA3-227951977647,TCGA-13-0890-01A-01D-0447-09,GRCh37-lite,TCGA-13-0890,TCGA-OV,NA,s18082,Washington University School of Medicine,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b9d0,58cfa82fe4b0c9d6adf6b9d0,TCGA-AA-3956-10A-01D-1982-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3956-10A-01D-1982-10_wgs_Illumina,TCGA-AA-3956-10A-01D-1982-10_wgs_Illumina.bam,75.56,1.8,0.15,58cfa82fe4b0c9d6adf6b9d0,TCGA-AA-3956-10A-01D-1982-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3956-10A,7B47489F-C3CC-4388-B5D7-C7C02790A5F6,Blood Derived Normal,Illumina HiSeq,613a153b-be57-4183-a033-95d58f6d48b8,Colorectal,65,5C8C7A7D-1677-43B6-9526-52EF9B17D11A,7436A99F-5DE9-496F-AD6E-A0AEB09951F5,TCGA-AA-3956-10A-01D-1982-10,GRCh37-lite,TCGA-AA-3956,TCGA-COAD,NA,s13193,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa83ce4b0c9d6adf730ed,58cfa83ce4b0c9d6adf730ed,b2e10818826b4072c8f92e5b678b4332.filtered.,WGS,b2e10818826b4072c8f92e5b678b4332,b2e10818826b4072c8f92e5b678b4332.bam,76.73,1.92,0.08,58cfa83ce4b0c9d6adf730ed,b2e10818826b4072c8f92e5b678b4332.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0IQ-01A,01EEF340-598C-4205-A990-CEC190AC2CA5,Primary Tumor,Illumina HiSeq,7f45dc68-74e8-4953-8221-00c2ba51dee4,Breast,40,183A47B2-1B00-4A72-ADEB-F35B55692EE1,8956D73D-7E36-4129-8A3E-D4F3B43BAF0B,TCGA-B6-A0IQ-01A-11D-A128-09,GRCh37-lite,TCGA-B6-A0IQ,TCGA-BRCA,NA,s6102,Washington University School of Medicine,Duke,United States,NO,T3,N1b,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82ee4b0c9d6adf6ac3b,58cfa82ee4b0c9d6adf6ac3b,G39020.TCGA-BR-4280-11A-01D-A290-08.1.filtered.,WGS,G39020.TCGA-BR-4280-11A-01D-A290-08.1,G39020.TCGA-BR-4280-11A-01D-A290-08.1.bam,0,1.9,0.07,58cfa82ee4b0c9d6adf6ac3b,G39020.TCGA-BR-4280-11A-01D-A290-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4280-11A,E0916597-E489-45EF-A8F7-653A3C6591EF,Solid Tissue Normal,Illumina HiSeq,d6f3f036-2ddf-4ddb-81e4-3a1c7a977bfd,Stomach,78,4DC8B427-EBDF-40E0-922C-FCB5020C94FC,F522203F-62EC-4624-B323-CF5DEBEEB5AC,TCGA-BR-4280-11A-01D-A290-08,HG19_Broad_variant,TCGA-BR-4280,TCGA-STAD,NA,s14956,Broad Institute of MIT and Harvard,Asterand,Russia,NO,T2b,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage III
13722.58cfa830e4b0c9d6adf6c18c,58cfa830e4b0c9d6adf6c18c,TCGA-AB-2968-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2968-03A-01D-0739-09_whole,TCGA-AB-2968-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6c18c,TCGA-AB-2968-03A-01D-0739-09_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2968-03A,BC93CFF5-A2C9-4FC5-8965-5570574AC1A2,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,5ae7ba9b-ca4f-40b7-8364-be185ffc5387,Blood,79,258135E2-F09F-4D8A-AED1-2F331109FB16,85D9BA67-6BB0-440D-8D9F-1C9582697BA6,TCGA-AB-2968-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2968,TCGA-LAML,458,s7299,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6aa8f,58cfa82ee4b0c9d6adf6aa8f,G32456.TCGA-CF-A3MF-10A-01D-A21A-08.3.filtered.,WGS,G32456.TCGA-CF-A3MF-10A-01D-A21A-08.3,G32456.TCGA-CF-A3MF-10A-01D-A21A-08.3.bam,37.24,NA,0.08,58cfa82ee4b0c9d6adf6aa8f,G32456.TCGA-CF-A3MF-10A-01D-A21A-08.3.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CF-A3MF-10A,1E308B12-0590-4DAE-94D0-A539FCF25DF7,Blood Derived Normal,Illumina HiSeq,10a650d8-0b73-456b-a674-14fe44e158ec,Bladder,34,59B99C9A-D1C0-4CC0-953B-4358BCF9F392,D6E91F4C-38C0-4393-9CB7-BE076663DFF3,TCGA-CF-A3MF-10A-01D-A21A-08,HG19_Broad_variant,TCGA-CF-A3MF,TCGA-BLCA,NA,s3257,Broad Institute of MIT and Harvard,ILSbio,Vietnam,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82ee4b0c9d6adf6aad4,58cfa82ee4b0c9d6adf6aad4,G32539.TCGA-EM-A3AL-01A-11D-A202-08.1.filtered.,WGS,G32539.TCGA-EM-A3AL-01A-11D-A202-08.1,G32539.TCGA-EM-A3AL-01A-11D-A202-08.1.bam,56.44,NA,0.08,58cfa82ee4b0c9d6adf6aad4,G32539.TCGA-EM-A3AL-01A-11D-A202-08.1.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3AL-01A,0C50A2C2-1D4C-45CA-9127-F96D4DB18DAF,Primary Tumor,Illumina HiSeq,6ad47953-e067-450e-9c68-69b531caba51,Thyroid,45,593736E0-1BED-4EAF-BAC9-E90620554F1D,248FD0ED-F14C-40B8-9F14-E9C7ADF16E22,TCGA-EM-A3AL-01A-11D-A202-08,HG19_Broad_variant,TCGA-EM-A3AL,TCGA-THCA,NA,s12613,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa82de4b0c9d6adf6a480,58cfa82de4b0c9d6adf6a480,1e6e9eda1facdcda16b8442c40fec9c7.filtered.,WGS,1e6e9eda1facdcda16b8442c40fec9c7,1e6e9eda1facdcda16b8442c40fec9c7.bam,29.77,1.86,0.08,58cfa82de4b0c9d6adf6a480,1e6e9eda1facdcda16b8442c40fec9c7.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0I6-10A,045C13EF-3DB7-4ADF-B0A3-23338F0479F3,Blood Derived Normal,Illumina HiSeq,92e425cc-f200-440b-a6ad-71e6feae486b,Breast,49,DEB8DCFD-F24A-4CC3-BC21-CDCD50359D13,E582A24D-98BF-40D3-BBC8-E8823A28127F,TCGA-B6-A0I6-10A-01D-A128-09,GRCh37-lite,TCGA-B6-A0I6,TCGA-BRCA,991,s6756,Washington University School of Medicine,Duke,United States,NO,T1c,N1,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a626,58cfa82de4b0c9d6adf6a626,60885461958e7e7362c585f38d8bb16e.filtered.,WGS,60885461958e7e7362c585f38d8bb16e,60885461958e7e7362c585f38d8bb16e.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a626,60885461958e7e7362c585f38d8bb16e.bam,Dead,MALE,Not available,Not available,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3009-03A,C9B92F8F-4599-47D1-9D12-31E42166A091,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,88c72630-3516-4127-a278-8720387fb1f3,Blood,23,197053E3-848F-4D62-AEFB-A8E0FAA23967,DBB6DBF6-0B14-44CA-A784-52D7AD1CE8CE,TCGA-AB-3009-03A-01D-0741-05,GRCh37-lite,TCGA-AB-3009,TCGA-LAML,577,s7061,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a58f,58cfa82de4b0c9d6adf6a58f,5ef6a0389326d4bf5accd20037a358d3.filtered.,WGS,5ef6a0389326d4bf5accd20037a358d3,5ef6a0389326d4bf5accd20037a358d3.bam,42.25,2,0.08,58cfa82de4b0c9d6adf6a58f,5ef6a0389326d4bf5accd20037a358d3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AQ-A04J-01A,9938CE5C-E74E-446E-A932-F096F85CC3B1,Primary Tumor,Illumina HiSeq,c57fe789-7ef3-4dcb-bc21-b7ccb5ff208e,Breast,45,09D6F42C-5E9F-4ADC-BD8C-E5DCA597FC01,467EF778-F481-44F3-9768-B9900252D2BA,TCGA-AQ-A04J-01A-02D-A128-09,GRCh37-lite,TCGA-AQ-A04J,TCGA-BRCA,NA,s6115,Washington University School of Medicine,Not available,United States,NO,T2,N0 (i+),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a6c7,58cfa82de4b0c9d6adf6a6c7,8d56dc94d8f191808c30df1a5b307b32.filtered.,WGS,8d56dc94d8f191808c30df1a5b307b32,8d56dc94d8f191808c30df1a5b307b32.bam,38.99,NA,0.08,58cfa82de4b0c9d6adf6a6c7,8d56dc94d8f191808c30df1a5b307b32.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-L7-A6VZ-01A,DC4062D7-1C81-4B19-AABD-8307A0DF5029,Primary Tumor,HiSeq X Ten,8fa88455-2b2f-4584-bb62-edc9b3be350d,Esophagus,62,11A58EC0-E27E-4FBB-9119-E8109B8B670A,18C1BA92-261A-4755-99AC-E9B0F4A44D0C,TCGA-L7-A6VZ-01A-12D-A33E-09,GRCh37-lite_WUGSC_variant_2,TCGA-L7-A6VZ,TCGA-ESCA,NA,s1812,Washington University School of Medicine,Christiana Care,United States,NO,T3,N3,Not available,Stage IIIC
13722.58cfa83ce4b0c9d6adf72f2c,58cfa83ce4b0c9d6adf72f2c,e886a9905c6ddb08a07cd12351b2978e.filtered.,WGS,e886a9905c6ddb08a07cd12351b2978e,e886a9905c6ddb08a07cd12351b2978e.bam,6.36,NA,0.07,58cfa83ce4b0c9d6adf72f2c,e886a9905c6ddb08a07cd12351b2978e.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A1L2-01A,73D2E8EF-4E10-416A-845B-F48374E48ECB,Primary Tumor,Illumina HiSeq,f6170f04-5598-4fb8-9027-6176921b624d,Mesenchymal,78,901DFD62-799D-4E40-926E-22A5FD859B5A,4C59FB2D-21B6-4B09-8174-6102DE736E4D,TCGA-DX-A1L2-01A-22D-A24N-09,GRCh37-lite,TCGA-DX-A1L2,TCGA-SARC,NA,s2633,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6a94c,58cfa82ee4b0c9d6adf6a94c,G35154.TCGA-CS-5395-01A-01D-1468-08.1.filtered.,WGS,G35154.TCGA-CS-5395-01A-01D-1468-08.1,G35154.TCGA-CS-5395-01A-01D-1468-08.1.bam,44,1.9,0.05,58cfa82ee4b0c9d6adf6a94c,G35154.TCGA-CS-5395-01A-01D-1468-08.1.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,Not available,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-5395-01A,F86FA219-34E9-4812-8EDF-2B66D7219779,Primary Tumor,Illumina HiSeq,409fc6a2-e9df-4391-988e-bcb0d9e990b8,Brain,43,CB40F8BB-879E-496D-AE52-5535B277A952,3D477AC1-3BDF-4410-9594-1A3A1412C6AE,TCGA-CS-5395-01A-01D-1468-08,HG19_Broad_variant,TCGA-CS-5395,TCGA-LGG,639,s8319,Broad Institute of MIT and Harvard,Thomas Jefferson University,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82de4b0c9d6adf6a6b7,58cfa82de4b0c9d6adf6a6b7,88602276b289b7a6a414295ff99cde08.filtered.,WGS,88602276b289b7a6a414295ff99cde08,88602276b289b7a6a414295ff99cde08.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a6b7,88602276b289b7a6a414295ff99cde08.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2992-03A,BEC60BDD-34E7-467C-8662-F3A1BB1A4361,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,1ff3ab37-b951-4cde-996f-2fb38724fba8,Blood,32,619C2343-330E-4DBE-A810-BD70EA4EFF66,4465A0DF-868C-46EE-9087-C39F64FFD3CA,TCGA-AB-2992-03A-01D-0739-09,GRCh37-lite,TCGA-AB-2992,TCGA-LAML,1706,s7018,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6a95c,58cfa82ee4b0c9d6adf6a95c,G35154.TCGA-DU-7301-01A-11D-2086-08.3.filtered.,WGS,G35154.TCGA-DU-7301-01A-11D-2086-08.3,G35154.TCGA-DU-7301-01A-11D-2086-08.3.bam,33,NA,0.05,58cfa82ee4b0c9d6adf6a95c,G35154.TCGA-DU-7301-01A-11D-2086-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7301-01A,84AE73E4-3B39-4444-9BFB-3FC6057EAB32,Primary Tumor,Illumina HiSeq,a788486c-7bba-436f-a31c-a5d294155cc6,Brain,53,D6BFF803-8B4A-44A1-AF59-0F2BABA7895F,BA94C29B-B76E-4D67-BF5A-CE6BC45D85F8,TCGA-DU-7301-01A-11D-2086-08,HG19_Broad_variant,TCGA-DU-7301,TCGA-LGG,788,s8325,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82de4b0c9d6adf6a4d0,58cfa82de4b0c9d6adf6a4d0,1e1e5255ac951174f371788a6c4292e4.filtered.,WGS,1e1e5255ac951174f371788a6c4292e4,1e1e5255ac951174f371788a6c4292e4.bam,18.7,1.91,0.14,58cfa82de4b0c9d6adf6a4d0,1e1e5255ac951174f371788a6c4292e4.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0124-10A,C2651206-36C5-4F3C-A0D6-3FFC07B27A93,Blood Derived Normal,Illumina GA,886d84af-d20b-4847-a1bc-a24c90dc8b49,Brain,67,5176C91C-6464-4C4D-8DEC-F19763AFB002,C10A7880-800E-4ECD-807B-EF2D0EE9C086,TCGA-06-0124-10A-01D-0375-09,GRCh37-lite,TCGA-06-0124,TCGA-GBM,620,s14249,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a65e,58cfa82de4b0c9d6adf6a65e,6dfdd72436bacf6a5f435146137eee03.filtered.,WGS,6dfdd72436bacf6a5f435146137eee03,6dfdd72436bacf6a5f435146137eee03.bam,8.01,NA,0.08,58cfa82de4b0c9d6adf6a65e,6dfdd72436bacf6a5f435146137eee03.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A2J4-01A,F75D2589-FD7B-49A1-A1C8-0B4726B81F3C,Primary Tumor,Illumina HiSeq,ffc58c6a-5a11-4c5f-a5dd-b5082be0dc38,Mesenchymal,60,46E59502-D5DF-428B-BEEF-6AD1439B86C6,968929B0-6BFB-4A2C-BD4D-570BFCDB8A6A,TCGA-DX-A2J4-01A-32D-A21Q-09,GRCh37-lite,TCGA-DX-A2J4,TCGA-SARC,NA,s2340,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6ad73,58cfa82ee4b0c9d6adf6ad73,G32529.TCGA-ET-A3DV-01A-12D-A202-08.3.filtered.,WGS,G32529.TCGA-ET-A3DV-01A-12D-A202-08.3,G32529.TCGA-ET-A3DV-01A-12D-A202-08.3.bam,16.24,NA,0.08,58cfa82ee4b0c9d6adf6ad73,G32529.TCGA-ET-A3DV-01A-12D-A202-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-ET-A3DV-01A,B46D88E9-8477-4900-8DA9-5E7DBDED0653,Primary Tumor,Illumina HiSeq,6319fae0-343d-45e8-a507-cc9f7acf1b38,Thyroid,68,CE24FE0A-5C4D-4FBE-A02C-76345EAA2892,5DEEAA45-4C1B-4AB2-A487-93C548838F68,TCGA-ET-A3DV-01A-12D-A202-08,HG19_Broad_variant,TCGA-ET-A3DV,TCGA-THCA,NA,s12343,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa82de4b0c9d6adf6a652,58cfa82de4b0c9d6adf6a652,7ffce7b012d977533ba086fa6e53b615.filtered.,WGS,7ffce7b012d977533ba086fa6e53b615,7ffce7b012d977533ba086fa6e53b615.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a652,7ffce7b012d977533ba086fa6e53b615.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2965-03A,05924106-07F6-44CA-BA15-7452B8A657E4,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,95ca4aa2-cfaa-401e-aeb9-17abba0d8f70,Blood,60,D42A66CD-BC74-477F-A924-1B3A303BFA16,8BCC8C06-8C33-4409-8A0C-87723323DCCE,TCGA-AB-2965-03A-01D-0741-05,GRCh37-lite,TCGA-AB-2965,TCGA-LAML,335,s7064,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6abd6,58cfa82ee4b0c9d6adf6abd6,G32535.TCGA-FK-A3SE-01A-11D-A22D-08.1.filtered.,WGS,G32535.TCGA-FK-A3SE-01A-11D-A22D-08.1,G32535.TCGA-FK-A3SE-01A-11D-A22D-08.1.bam,31.42,NA,0.08,58cfa82ee4b0c9d6adf6abd6,G32535.TCGA-FK-A3SE-01A-11D-A22D-08.1.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FK-A3SE-01A,AFB00CD4-E5DA-4251-86FB-532C3F65324C,Primary Tumor,Illumina HiSeq,e2561be5-1c52-4774-a3d5-2a7800d87c6a,Thyroid,31,D3CC158D-413D-49E6-8D23-3ED89FDEA94A,90883300-D4B6-45D7-AF9A-4E4CE4104500,TCGA-FK-A3SE-01A-11D-A22D-08,HG19_Broad_variant,TCGA-FK-A3SE,TCGA-THCA,NA,s12216,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82de4b0c9d6adf6a6e8,58cfa82de4b0c9d6adf6a6e8,971beb5a0385773be9d2f7e8050d8284.filtered.,WGS,971beb5a0385773be9d2f7e8050d8284,971beb5a0385773be9d2f7e8050d8284.bam,54.77,1.9,0.14,58cfa82de4b0c9d6adf6a6e8,971beb5a0385773be9d2f7e8050d8284.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0877-01A,32AFDC6C-E899-4795-9E90-C9A192BBC4C1,Primary Tumor,Illumina GA,6a9625a5-cd3e-4d85-a723-9cd6d9511a6c,Brain,78,A1F1E403-7984-4819-A969-D3A16594FE37,BA2920A9-1BFD-4F6C-80CF-4FD0DDA2118A,TCGA-06-0877-01A-01D-0512-09,GRCh37-lite,TCGA-06-0877,TCGA-GBM,NA,s14078,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa831e4b0c9d6adf6c824,58cfa831e4b0c9d6adf6c824,TCGA-CZ-5454-11A-01D-2102-10_Illumina.filtered.,WGS,TCGA-CZ-5454-11A-01D-2102-10_Illumina,TCGA-CZ-5454-11A-01D-2102-10_Illumina.bam,238.4,1.9,0.14,58cfa831e4b0c9d6adf6c824,TCGA-CZ-5454-11A-01D-2102-10_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CZ-5454-11A,F2801B21-5444-4CC3-A642-C60C6D82CD3D,Solid Tissue Normal,Illumina HiSeq,3e38e431-afc3-4cdd-bf9d-fb8767db1ee0,Kidney,63,11F3A626-D02D-4F10-BD0B-08134078C838,FB0D1B15-C009-4C34-868D-081BD60E64E7,TCGA-CZ-5454-11A-01D-2102-10,GRCh37-lite,TCGA-CZ-5454,TCGA-KIRC,722,s8842,Baylor College of Medicine,Harvard,None,NO,T2,N0,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa82ee4b0c9d6adf6ad0a,58cfa82ee4b0c9d6adf6ad0a,G39019.TCGA-EE-A2A0-10A-01D-A198-08.3.filtered.,WGS,G39019.TCGA-EE-A2A0-10A-01D-A198-08.3,G39019.TCGA-EE-A2A0-10A-01D-A198-08.3.bam,26.35,NA,0.07,58cfa82ee4b0c9d6adf6ad0a,G39019.TCGA-EE-A2A0-10A-01D-A198-08.3.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2A0-10A,81CEDB9E-EE43-476B-9ED9-8D0FDB346065,Blood Derived Normal,Illumina HiSeq,810a5fb0-e605-41da-a3d6-123c8347b07c,Skin,77,2E724C44-DECB-4444-8B61-8741DB672900,58098074-341B-4873-895B-257DE49CF264,TCGA-EE-A2A0-10A-01D-A198-08,HG19_Broad_variant,TCGA-EE-A2A0,TCGA-SKCM,1424,s7820,Broad Institute of MIT and Harvard,University of Sydney,Australia,NO,T3a,N0,Not available,Stage IIA
13722.58cfa82de4b0c9d6adf6a5e0,58cfa82de4b0c9d6adf6a5e0,52920fe00a0a17785ed147951554690d.filtered.,WGS,52920fe00a0a17785ed147951554690d,52920fe00a0a17785ed147951554690d.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a5e0,52920fe00a0a17785ed147951554690d.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2980-03A,882ECF72-433B-46FA-9BC4-628C2D943CD1,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,ec05a71f-c3c8-475c-8a2d-a858dfd2a291,Blood,50,FACB0ECE-BFEA-4BFA-AE42-817E3231A1AB,2BCD56A1-1367-4B97-8F35-ECEB3DCE2E4D,TCGA-AB-2980-03A-01D-0739-09,GRCh37-lite,TCGA-AB-2980,TCGA-LAML,NA,s7202,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6a90d,58cfa82ee4b0c9d6adf6a90d,G32560.TCGA-GN-A266-10A-01D-A199-08.1.filtered.,WGS,G32560.TCGA-GN-A266-10A-01D-A199-08.1,G32560.TCGA-GN-A266-10A-01D-A199-08.1.bam,37.9,NA,0.08,58cfa82ee4b0c9d6adf6a90d,G32560.TCGA-GN-A266-10A-01D-A199-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-GN-A266-10A,3429967F-4F77-4894-BF27-C4A22698CA92,Blood Derived Normal,Illumina HiSeq,d2feefd2-d8d5-4c06-84c0-d6811eed1b38,Skin,45,35D85937-9F8A-4DFC-8CE2-FA6E913AF9F3,9FF91018-9D55-43BE-9AE3-945CAECB0CBB,TCGA-GN-A266-10A-01D-A199-08,HG19_Broad_variant,TCGA-GN-A266,TCGA-SKCM,308,s7811,Broad Institute of MIT and Harvard,Roswell,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa831e4b0c9d6adf6c7e8,58cfa831e4b0c9d6adf6c7e8,TCGA-CV-7255-11A-01D-2276-10_Illumina.filtered.,WGS,TCGA-CV-7255-11A-01D-2276-10_Illumina,TCGA-CV-7255-11A-01D-2276-10_Illumina.bam,28.03,NA,0.05,58cfa831e4b0c9d6adf6c7e8,TCGA-CV-7255-11A-01D-2276-10_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7255-11A,534F85F2-B9EB-45BE-87D5-C3DFFD13D541,Solid Tissue Normal,Illumina HiSeq,e24cfdc8-ec05-41ac-aa61-3339c1769152,Head and Neck,32,2B4DBC74-4623-4746-BC29-8F33CE84A05B,1F285865-6A20-42AE-AF55-AAA0E0AB0E8C,TCGA-CV-7255-11A-01D-2276-10,GRCh37-lite,TCGA-CV-7255,TCGA-HNSC,64,s15643,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa83ce4b0c9d6adf730e0,58cfa83ce4b0c9d6adf730e0,ee32938babfe9b6967e9a4c5f49435dd.filtered.,WGS,ee32938babfe9b6967e9a4c5f49435dd,ee32938babfe9b6967e9a4c5f49435dd.bam,84.77,1.86,0.08,58cfa83ce4b0c9d6adf730e0,ee32938babfe9b6967e9a4c5f49435dd.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LD-01A,1200C8B7-A058-4C01-BBE2-04EC09A65245,Primary Tumor,Illumina HiSeq,d3a5aa02-ef8e-4ad1-adca-1c4b867fe524,Uterus,63,649DADDA-5823-4B0D-B5A2-49F501ADC029,9D2671B9-BD30-4E3C-AA74-01E31DD2531E,TCGA-AP-A0LD-01A-11D-A066-09,GRCh37-lite,TCGA-AP-A0LD,TCGA-UCEC,NA,s5185,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ac56,58cfa82ee4b0c9d6adf6ac56,G39020.TCGA-BR-6452-01A-12D-1800-08.1.filtered.,WGS,G39020.TCGA-BR-6452-01A-12D-1800-08.1,G39020.TCGA-BR-6452-01A-12D-1800-08.1.bam,409.4,1.9,0.05,58cfa82ee4b0c9d6adf6ac56,G39020.TCGA-BR-6452-01A-12D-1800-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6452-01A,27988B3E-CDE1-4F4B-82A1-6D8AD08DB8E9,Primary Tumor,Illumina HiSeq,e69add2b-1a4d-44e6-8186-3fb2163afa5f,Stomach,78,76144F2F-2498-430D-B33C-F000394C427E,C8E961B4-E324-40A2-89F6-736EC3845BC9,TCGA-BR-6452-01A-12D-1800-08,HG19_Broad_variant,TCGA-BR-6452,TCGA-STAD,NA,s14524,Broad Institute of MIT and Harvard,Asterand,Russia,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA
13722.58cfa83ce4b0c9d6adf72f73,58cfa83ce4b0c9d6adf72f73,f0f3dfb66995edcb514e1ccebc2c7e4d.filtered.,WGS,f0f3dfb66995edcb514e1ccebc2c7e4d,f0f3dfb66995edcb514e1ccebc2c7e4d.bam,61.2,1.96,0.09,58cfa83ce4b0c9d6adf72f73,f0f3dfb66995edcb514e1ccebc2c7e4d.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-C8-A130-01A,8CF54607-01CE-42B0-9BD9-8627EDD9F3B7,Primary Tumor,Illumina HiSeq,e70e14f9-ea63-4038-8a0e-5526391ea4fe,Breast,52,3BEA8456-DA16-4691-A260-5C94A83E2860,27F87D1E-2C32-4BEB-9677-62F7A286673D,TCGA-C8-A130-01A-31D-A19H-09,GRCh37-lite,TCGA-C8-A130,TCGA-BRCA,NA,s6751,Washington University School of Medicine,ILSbio,Vietnam,NO,T3,N2,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa83ce4b0c9d6adf72fbd,58cfa83ce4b0c9d6adf72fbd,a765afe852088b93b14f4f8d87893494.filtered.,WGS,a765afe852088b93b14f4f8d87893494,a765afe852088b93b14f4f8d87893494.bam,49.61,2.14,0.08,58cfa83ce4b0c9d6adf72fbd,a765afe852088b93b14f4f8d87893494.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0RE-01A,08DA7C4C-3067-4BCF-9D7A-78566DF72E69,Primary Tumor,Illumina HiSeq,6ed22fe1-529a-4ad1-8eb3-f50a383e4df4,Breast,61,270BE245-2239-4E96-A917-79CCA40868BA,1EB62ABC-7928-405B-84CC-F091CA5347B2,TCGA-B6-A0RE-01A-11D-A128-09,GRCh37-lite,TCGA-B6-A0RE,TCGA-BRCA,NA,s6250,Washington University School of Medicine,Duke,United States,NO,TX,N0 (i-),Infiltrating Ductal Carcinoma,Stage X
13722.58cfa83ce4b0c9d6adf72ef4,58cfa83ce4b0c9d6adf72ef4,adc8fcb8e8a780076e27704767013d83.filtered.,WGS,adc8fcb8e8a780076e27704767013d83,adc8fcb8e8a780076e27704767013d83.bam,15.93,NA,0.08,58cfa83ce4b0c9d6adf72ef4,adc8fcb8e8a780076e27704767013d83.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A240-01A,3608BFBB-2A92-4EC2-A330-BF4790A8B65C,Primary Tumor,Illumina HiSeq,d31b896e-0c05-4b82-9143-a039f927b80f,Mesenchymal,51,8ACAF190-5A0D-440C-9C9A-B9EABDF661BE,3DB6E6CC-1A06-49B9-834E-B6611CDE4C4B,TCGA-DX-A240-01A-32D-A27P-09,GRCh37-lite,TCGA-DX-A240,TCGA-SARC,NA,s2670,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a61e,58cfa82de4b0c9d6adf6a61e,67919d6ae2817354d43a764971e0608f.filtered.,WGS,67919d6ae2817354d43a764971e0608f,67919d6ae2817354d43a764971e0608f.bam,59.44,1.73,0.08,58cfa82de4b0c9d6adf6a61e,67919d6ae2817354d43a764971e0608f.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A1BN-01B,8A4DA4F0-30F2-497E-8A7C-988FD6B813CB,Primary Tumor,Illumina HiSeq,df3a48da-646a-4834-969a-131455b7baa9,Cervix,26,DD05713E-6D6D-4876-89DF-69A905D24500,06DAD93A-4B67-49B3-8FA5-F2546E22BAE7,TCGA-C5-A1BN-01B-11D-A200-09,GRCh37-lite,TCGA-C5-A1BN,TCGA-CESC,166,s1510,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa83ce4b0c9d6adf72f7b,58cfa83ce4b0c9d6adf72f7b,ea3e2e897deb676e1aa5ff1ce3ef39eb.filtered.,WGS,ea3e2e897deb676e1aa5ff1ce3ef39eb,ea3e2e897deb676e1aa5ff1ce3ef39eb.bam,18.52,NA,0.08,58cfa83ce4b0c9d6adf72f7b,ea3e2e897deb676e1aa5ff1ce3ef39eb.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-IF-A4AJ-01A,4E8C570C-3CBE-4878-8B2C-B966868DD60D,Primary Tumor,Illumina HiSeq,5773814e-9b28-40f3-9285-0eed8b3ba493,Mesenchymal,80,86AE3E79-5C03-480F-8A5A-35BAC00CB89D,D53C2680-89AC-4F87-A7BA-F4C669546B76,TCGA-IF-A4AJ-01A-11D-A24N-09,GRCh37-lite,TCGA-IF-A4AJ,TCGA-SARC,767,s2634,Washington University School of Medicine,University of Texas MD Anderson Cancer Center,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a4e2,58cfa82de4b0c9d6adf6a4e2,3868e1400ab74a5d31b7f3ace5862177.filtered.,WGS,3868e1400ab74a5d31b7f3ace5862177,3868e1400ab74a5d31b7f3ace5862177.bam,31.37,NA,0.08,58cfa82de4b0c9d6adf6a4e2,3868e1400ab74a5d31b7f3ace5862177.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2RE-01A,9AA36AC2-8418-4109-A3C1-63CA8742BAAB,Primary Tumor,Illumina HiSeq,87fe03fa-225c-4d35-81a3-8b401d985fae,Cervix,26,7BCF54B6-3FFA-4014-92C6-51A7099E6F02,0D31A44F-1FC5-43A2-9633-36C4E650D3D2,TCGA-EK-A2RE-01A-11D-A34H-09,GRCh37-lite,TCGA-EK-A2RE,TCGA-CESC,NA,s1162,Washington University School of Medicine,Gynecologic Oncology Group,United States,NO,T2a2,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a96d,58cfa82ee4b0c9d6adf6a96d,G35154.TCGA-HW-7487-10A-01D-2024-08.5.filtered.,WGS,G35154.TCGA-HW-7487-10A-01D-2024-08.5,G35154.TCGA-HW-7487-10A-01D-2024-08.5.bam,515.3,NA,0.05,58cfa82ee4b0c9d6adf6a96d,G35154.TCGA-HW-7487-10A-01D-2024-08.5.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HW-7487-10A,42251E02-B687-4BF1-A1B6-E3DD978542E4,Blood Derived Normal,Illumina HiSeq,141d09e0-7b88-4ec6-acd5-3e8588633fd3,Brain,39,9E127BDA-ACA0-4F7F-ACD9-860E3B425177,EADCCE99-923F-4B79-8C99-3656D412EA5A,TCGA-HW-7487-10A-01D-2024-08,HG19_Broad_variant,TCGA-HW-7487,TCGA-LGG,NA,s8120,Broad Institute of MIT and Harvard,MSKCC,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82fe4b0c9d6adf6b61f,58cfa82fe4b0c9d6adf6b61f,TCGA-29-1710-10A-01D-0926-12_Illumina.filtered.,WGS,TCGA-29-1710-10A-01D-0926-12_Illumina,TCGA-29-1710-10A-01D-0926-12_Illumina.bam,2,1.89,0.15,58cfa82fe4b0c9d6adf6b61f,TCGA-29-1710-10A-01D-0926-12_Illumina.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-29-1710-10A,4261267C-7042-4C6E-83ED-12FB401003FC,Blood Derived Normal,Illumina HiSeq,7e7b5682-0c72-41af-8d21-0e986214e73e,Ovary,54,441BC411-82F7-4B5C-A2A1-89049F33548A,9D786B11-E96D-45A3-9D7C-D27D4D6FFB00,TCGA-29-1710-10A-01D-0926-12,NCBI36_BCM_variant,TCGA-29-1710,TCGA-OV,951,s18005,Baylor College of Medicine,Duke,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6acfa,58cfa82ee4b0c9d6adf6acfa,G49537.TCGA-EL-A3T9-11A-11D-A22D-08.2.filtered.,WGS,G49537.TCGA-EL-A3T9-11A-11D-A22D-08.2,G49537.TCGA-EL-A3T9-11A-11D-A22D-08.2.bam,26.78,NA,0.07,58cfa82ee4b0c9d6adf6acfa,G49537.TCGA-EL-A3T9-11A-11D-A22D-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EL-A3T9-11A,8A233B01-2959-467F-8950-02BE16309156,Solid Tissue Normal,Illumina HiSeq,5d9b0003-3982-421b-84bc-419bc0af4d04,Thyroid,69,B2B3F5B7-EBD3-48DB-8678-3E105653985F,60ECCA33-9F6A-4C77-A862-6F3D723029C9,TCGA-EL-A3T9-11A-11D-A22D-08,HG19_Broad_variant,TCGA-EL-A3T9,TCGA-THCA,174,s12346,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,T4,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage IV
13722.58cfa82ee4b0c9d6adf6aab4,58cfa82ee4b0c9d6adf6aab4,G32462.TCGA-DK-A1A7-10A-01D-A13W-08.2.filtered.,WGS,G32462.TCGA-DK-A1A7-10A-01D-A13W-08.2,G32462.TCGA-DK-A1A7-10A-01D-A13W-08.2.bam,64.01,1.91,0.08,58cfa82ee4b0c9d6adf6aab4,G32462.TCGA-DK-A1A7-10A-01D-A13W-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A7-10A,3ED614E7-F356-4D87-985B-D3BBBAE3BB40,Blood Derived Normal,Illumina HiSeq,77c6d0de-f590-405b-8d12-084a7ebbace2,Bladder,67,7C9BD4C3-A3EF-495E-B37C-5CD329D16A18,C14E29AA-A979-4452-8019-7EEBFB3D5D04,TCGA-DK-A1A7-10A-01D-A13W-08,HG19_Broad_variant,TCGA-DK-A1A7,TCGA-BLCA,NA,s3069,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82ee4b0c9d6adf6a8f8,58cfa82ee4b0c9d6adf6a8f8,G32536.TCGA-EL-A3T0-11A-12D-A22D-08.3.filtered.,WGS,G32536.TCGA-EL-A3T0-11A-12D-A22D-08.3,G32536.TCGA-EL-A3T0-11A-12D-A22D-08.3.bam,26.09,NA,0.08,58cfa82ee4b0c9d6adf6a8f8,G32536.TCGA-EL-A3T0-11A-12D-A22D-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EL-A3T0-11A,861F94CE-45FF-4588-ADDB-E1EA48878C2E,Solid Tissue Normal,Illumina HiSeq,9b547a73-1653-440a-bf3a-cb6c09d78f28,Thyroid,45,C603DEFF-FE10-4BE5-99D7-182A290201D3,93F3E9BC-7221-4442-AF55-1004BDF61842,TCGA-EL-A3T0-11A-12D-A22D-08,HG19_Broad_variant,TCGA-EL-A3T0,TCGA-THCA,NA,s12734,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,T3,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa82de4b0c9d6adf6a4a0,58cfa82de4b0c9d6adf6a4a0,319cf1a9534695e3e2744c08a1daa9d5.filtered.,WGS,319cf1a9534695e3e2744c08a1daa9d5,319cf1a9534695e3e2744c08a1daa9d5.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a4a0,319cf1a9534695e3e2744c08a1daa9d5.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2968-03A,BC93CFF5-A2C9-4FC5-8965-5570574AC1A2,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,b6bb44ce-782a-49b0-afff-5914c6f8284c,Blood,79,258135E2-F09F-4D8A-AED1-2F331109FB16,A9E89BC0-2E6C-40C9-9B47-6C6FE061DBC9,TCGA-AB-2968-03A-01D-0741-05,GRCh37-lite,TCGA-AB-2968,TCGA-LAML,458,s6973,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf730ac,58cfa83ce4b0c9d6adf730ac,ac2e74d430052ab39f0e2d8a23113736.filtered.,WGS,ac2e74d430052ab39f0e2d8a23113736,ac2e74d430052ab39f0e2d8a23113736.bam,33.01,NA,0.1,58cfa83ce4b0c9d6adf730ac,ac2e74d430052ab39f0e2d8a23113736.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-GI-A2C9-01A,9F6BE944-83DE-42AB-8738-F0022F475E61,Primary Tumor,Illumina HiSeq,5f4a8fdf-00c0-4ab7-8323-d04f23a9e4a8,Breast,58,143FC27D-E119-48FF-A5EA-BD6AAFC0404E,5DBF3203-CE73-41E4-BF9A-32FC856F73F5,TCGA-GI-A2C9-01A-11D-A21Q-09,GRCh37-lite,TCGA-GI-A2C9,TCGA-BRCA,NA,s5943,Washington University School of Medicine,ABS - IUPUI,United States,NO,T3,N0,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa82de4b0c9d6adf6a4e6,58cfa82de4b0c9d6adf6a4e6,114daee2d5db94a8d315a300daafb728.filtered.,WGS,114daee2d5db94a8d315a300daafb728,114daee2d5db94a8d315a300daafb728.bam,20.16,NA,0.08,58cfa82de4b0c9d6adf6a4e6,114daee2d5db94a8d315a300daafb728.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A3U5-01A,8F3F6F7C-4B50-467E-A6E8-D836735913F6,Primary Tumor,Illumina HiSeq,bee06413-ec4c-4545-b54d-d858d6a6e6e3,Mesenchymal,52,FB5C61D6-717E-4798-8306-86EB196D5609,3C963890-6E79-4B16-A4AA-BAC04938B4D7,TCGA-DX-A3U5-01A-11D-A228-09,GRCh37-lite,TCGA-DX-A3U5,TCGA-SARC,NA,s2473,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6bcec,58cfa830e4b0c9d6adf6bcec,TCGA-AB-2968-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2968-11A-01D-0739-09_whole,TCGA-AB-2968-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bcec,TCGA-AB-2968-11A-01D-0739-09_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2968-11A,BC93CFF5-A2C9-4FC5-8965-5570574AC1A2,Solid Tissue Normal,Illumina GA,a6fba0d4-f947-4fc6-ad01-a6b272498fa5,Blood,79,4F22261B-2E99-4B22-A2DA-C1BA3ACFE067,2F3495F2-E136-437C-8C9A-A2E01DB92A3E,TCGA-AB-2968-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2968,TCGA-LAML,458,s7003,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72f87,58cfa83ce4b0c9d6adf72f87,ba092079b8ef8b571c38f751abd035c0.filtered.,WGS,ba092079b8ef8b571c38f751abd035c0,ba092079b8ef8b571c38f751abd035c0.bam,NA,NA,NA,58cfa83ce4b0c9d6adf72f87,ba092079b8ef8b571c38f751abd035c0.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2973-11A,B234D53E-CC20-41C0-9F21-31DB53570A37,Solid Tissue Normal,Illumina GA,e3ee1732-fa04-45e6-83d5-8cba7f3094fa,Blood,68,2020ABAA-9028-4B22-BB78-6399AF5861EA,CF1F73E2-147B-42F5-8797-004EB789F776,TCGA-AB-2973-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2973,TCGA-LAML,609,s7056,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82fe4b0c9d6adf6b858,58cfa82fe4b0c9d6adf6b858,TCGA-29-1710-01A-02D-0926-12_Illumina.filtered.,WGS,TCGA-29-1710-01A-02D-0926-12_Illumina,TCGA-29-1710-01A-02D-0926-12_Illumina.bam,265,1.9,0.15,58cfa82fe4b0c9d6adf6b858,TCGA-29-1710-01A-02D-0926-12_Illumina.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-29-1710-01A,4261267C-7042-4C6E-83ED-12FB401003FC,Primary Tumor,Illumina HiSeq,3d865220-b0b8-4ca4-b4a1-56e05dc83e6f,Ovary,54,61513DA0-4EB3-4CAE-BFFF-7B05F3362488,6BA4DE87-C332-42B8-AF95-EB14A4C7F229,TCGA-29-1710-01A-02D-0926-12,NCBI36_BCM_variant,TCGA-29-1710,TCGA-OV,951,s17882,Baylor College of Medicine,Duke,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a936,58cfa82ee4b0c9d6adf6a936,G35153.TCGA-BA-A4IH-10A-01D-A25T-08.4.filtered.,WGS,G35153.TCGA-BA-A4IH-10A-01D-A25T-08.4,G35153.TCGA-BA-A4IH-10A-01D-A25T-08.4.bam,7.99,NA,0.08,58cfa82ee4b0c9d6adf6a936,G35153.TCGA-BA-A4IH-10A-01D-A25T-08.4.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-A4IH-10A,BD75D8EE-916B-4ABC-BF33-BCE6A4217076,Blood Derived Normal,Illumina HiSeq,e4a8ada8-a509-41eb-87a1-c2bc06960125,Head and Neck,57,EFF60F0D-E3C1-4A93-9026-C0764C70BA9F,F518AD7C-0500-48C4-81D5-8A424B91BD35,TCGA-BA-A4IH-10A-01D-A25T-08,HG19_Broad_variant,TCGA-BA-A4IH,TCGA-HNSC,NA,s15868,Broad Institute of MIT and Harvard,UNC,United States,NO,T2,N1,Head and Neck Squamous Cell Carcinoma Basaloid Type,Stage IVA
13722.58cfa82de4b0c9d6adf6a67e,58cfa82de4b0c9d6adf6a67e,71884ea02317c53425b8a24978a646ba.filtered.,WGS,71884ea02317c53425b8a24978a646ba,71884ea02317c53425b8a24978a646ba.bam,36.08,NA,0.08,58cfa82de4b0c9d6adf6a67e,71884ea02317c53425b8a24978a646ba.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A8NN-01A,90940FF1-C270-44F5-9949-F726838AAA57,Primary Tumor,HiSeq X Ten,d947fa31-bc49-45c0-8b06-bd0884e9b430,Esophagus,81,EB2FB364-415B-4F67-A1D1-B69F20B9445D,7A1853E1-B739-4C77-9B03-CE2E590953E8,TCGA-L5-A8NN-01A-11D-A37C-09,GRCh37-lite_WUGSC_variant_2,TCGA-L5-A8NN,TCGA-ESCA,NA,s1906,Washington University School of Medicine,University of Michigan,United States,NO,T3,N1,Not available,Stage III
13722.58cfa83ce4b0c9d6adf73082,58cfa83ce4b0c9d6adf73082,f56bc74c20a188c53b338d30ab71d4e2.filtered.,WGS,f56bc74c20a188c53b338d30ab71d4e2,f56bc74c20a188c53b338d30ab71d4e2.bam,89.42,1.98,0.08,58cfa83ce4b0c9d6adf73082,f56bc74c20a188c53b338d30ab71d4e2.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A1BJ-01A,7941D1C7-5319-4E8D-A15F-60B61CB68A9B,Primary Tumor,Illumina HiSeq,0990b367-e2b6-4b2a-8ca1-dd9efab1866a,Cervix,34,C7B95D35-7FE9-4C25-94C6-AE6D7416A5C7,43BE43CB-A367-4A74-94E4-973ACAFCF576,TCGA-C5-A1BJ-01A-11D-A200-09,GRCh37-lite,TCGA-C5-A1BJ,TCGA-CESC,NA,s1344,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82de4b0c9d6adf6a53a,58cfa82de4b0c9d6adf6a53a,55d6e765b492c11513427738173a07b8.filtered.,WGS,55d6e765b492c11513427738173a07b8,55d6e765b492c11513427738173a07b8.bam,8.07,NA,0.08,58cfa82de4b0c9d6adf6a53a,55d6e765b492c11513427738173a07b8.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-FX-A3RE-01A,7F9031DA-124A-4A38-83E6-878A50E58C24,Primary Tumor,Illumina HiSeq,41901beb-8e75-49c2-8bc3-a73dcaff36b1,Mesenchymal,65,8FAEDD92-D7FA-452A-8210-741118E516F7,CDBBD701-9C05-4F9E-923D-06039DD8A04D,TCGA-FX-A3RE-01A-11D-A228-09,GRCh37-lite,TCGA-FX-A3RE,TCGA-SARC,NA,s2336,Washington University School of Medicine,International Genomics Consortium,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa831e4b0c9d6adf6c713,58cfa831e4b0c9d6adf6c713,TCGA-CV-7090-10A-01D-2276-10_Illumina.filtered.,WGS,TCGA-CV-7090-10A-01D-2276-10_Illumina,TCGA-CV-7090-10A-01D-2276-10_Illumina.bam,18.33,NA,0.05,58cfa831e4b0c9d6adf6c713,TCGA-CV-7090-10A-01D-2276-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7090-10A,05FBD98C-28BD-41BC-AE60-16AC0C16C723,Blood Derived Normal,Illumina HiSeq,ba2b472d-b185-4c74-8e0f-8ff0e82db9de,Head and Neck,39,1DEC9BE0-AAEA-4CD9-AE2E-7CAD47E112E0,0822164C-236B-48A7-A50A-2C3FD45C3E36,TCGA-CV-7090-10A-01D-2276-10,GRCh37-lite,TCGA-CV-7090,TCGA-HNSC,NA,s15514,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6acda,58cfa82ee4b0c9d6adf6acda,G39020.TCGA-D7-6528-10A-01D-1800-08.2.filtered.,WGS,G39020.TCGA-D7-6528-10A-01D-1800-08.2,G39020.TCGA-D7-6528-10A-01D-1800-08.2.bam,291.7,1.9,0.05,58cfa82ee4b0c9d6adf6acda,G39020.TCGA-D7-6528-10A-01D-1800-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6528-10A,35496E4E-598F-4FFC-B11E-8EDAEB676079,Blood Derived Normal,Illumina HiSeq,4d2bdc7c-cbd5-4f7b-be1c-3a2c08f5fd36,Stomach,70,45FE00A2-0D61-4861-8F22-B0D306458CE4,C7ABC1E5-AA3A-44DF-BFCA-490332206B15,TCGA-D7-6528-10A-01D-1800-08,HG19_Broad_variant,TCGA-D7-6528,TCGA-STAD,NA,s15230,Broad Institute of MIT and Harvard,Greater Poland Cancer Center,Poland,NO,T2,N0,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IB
13722.58cfa82ee4b0c9d6adf6aaba,58cfa82ee4b0c9d6adf6aaba,G32470.TCGA-FT-A3EE-01A-11D-A202-08.2.filtered.,WGS,G32470.TCGA-FT-A3EE-01A-11D-A202-08.2,G32470.TCGA-FT-A3EE-01A-11D-A202-08.2.bam,35.79,NA,0.07,58cfa82ee4b0c9d6adf6aaba,G32470.TCGA-FT-A3EE-01A-11D-A202-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FT-A3EE-01A,CCE62116-3DCD-400D-ADA0-9839CA02466E,Primary Tumor,Illumina HiSeq,cff49411-c565-469a-83c7-9a253f6b129d,Bladder,80,2356F78C-0653-468F-83DB-6CF6107BD259,FFDD4FEB-ACA3-4104-B1E8-954D705A6450,TCGA-FT-A3EE-01A-11D-A202-08,HG19_Broad_variant,TCGA-FT-A3EE,TCGA-BLCA,99,s3067,Broad Institute of MIT and Harvard,BLN - University of Miami,United States,NO,T4a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82ee4b0c9d6adf6aefe,58cfa82ee4b0c9d6adf6aefe,G39020.TCGA-F1-6177-10A-01D-1800-08.3.filtered.,WGS,G39020.TCGA-F1-6177-10A-01D-1800-08.3,G39020.TCGA-F1-6177-10A-01D-1800-08.3.bam,94,1.9,0.05,58cfa82ee4b0c9d6adf6aefe,G39020.TCGA-F1-6177-10A-01D-1800-08.3.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-F1-6177-10A,C3CBA26E-38C2-4569-AFD6-6B045E604808,Blood Derived Normal,Illumina HiSeq,1edb61f1-07b1-4e73-bffb-71fa3fd004cb,Stomach,90,C9EFF55B-D757-4285-9459-A0B15319C24F,D45B2ED4-F736-470E-92C0-B06718A57582,TCGA-F1-6177-10A-01D-1800-08,HG19_Broad_variant,TCGA-F1-6177,TCGA-STAD,NA,s14739,Broad Institute of MIT and Harvard,UNC,United States,NO,T1b,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage I
13722.58cfa82ee4b0c9d6adf6a814,58cfa82ee4b0c9d6adf6a814,G32559.TCGA-ER-A2NF-06A-11D-A19A-08.2.filtered.,WGS,G32559.TCGA-ER-A2NF-06A-11D-A19A-08.2,G32559.TCGA-ER-A2NF-06A-11D-A19A-08.2.bam,70.24,NA,0.08,58cfa82ee4b0c9d6adf6a814,G32559.TCGA-ER-A2NF-06A-11D-A19A-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A2NF-06A,D32A4219-4CCA-470F-B6B3-11447D9F5E0B,Metastatic,Illumina HiSeq,b01dd24c-30f5-4b80-af01-af708a486693,Skin,53,20ECF8D6-2CA9-4C8A-B6CE-8B2A3BA51AE3,15DAADB0-6B24-4248-9225-470DC08F1552,TCGA-ER-A2NF-06A-11D-A19A-08,HG19_Broad_variant,TCGA-ER-A2NF,TCGA-SKCM,NA,s7990,Broad Institute of MIT and Harvard,University of Pittsburgh,None,NO,T4b,N3,Not available,Stage IIIC
13722.58cfa830e4b0c9d6adf6c196,58cfa830e4b0c9d6adf6c196,TCGA-AK-3455-01A-01D-2233-10_wgs_Illumina.filtered.,WGS,TCGA-AK-3455-01A-01D-2233-10_wgs_Illumina,TCGA-AK-3455-01A-01D-2233-10_wgs_Illumina.bam,612.57,1.9,0.05,58cfa830e4b0c9d6adf6c196,TCGA-AK-3455-01A-01D-2233-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-AK-3455-01A,2ED3296A-5B10-40D8-8AF4-90DC031657CD,Primary Tumor,Illumina HiSeq,77412ddb-2013-4e9c-aa60-2ce76f5269a8,Kidney,71,2D970196-BEEE-4783-90A1-E313A789DD92,A56CD282-F6C5-4373-B3D8-676562894598,TCGA-AK-3455-01A-01D-2233-10,GRCh37-lite,TCGA-AK-3455,TCGA-KIRC,683,s9730,Baylor College of Medicine,Fox Chase,United States,NO,T3b,NX,Kidney Clear Cell Renal Carcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6abaa,58cfa82ee4b0c9d6adf6abaa,G32463.TCGA-DK-A1A5-01A-11D-A13W-08.4.filtered.,WGS,G32463.TCGA-DK-A1A5-01A-11D-A13W-08.4,G32463.TCGA-DK-A1A5-01A-11D-A13W-08.4.bam,59.04,1.91,0.08,58cfa82ee4b0c9d6adf6abaa,G32463.TCGA-DK-A1A5-01A-11D-A13W-08.4.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A5-01A,904A8757-E0C5-41EF-B583-C8F170CAAAC1,Primary Tumor,Illumina HiSeq,f0ccddad-f1d5-4cd3-bad7-f9710dba4127,Bladder,79,A9EF3EC5-B1C1-481F-89CF-1729FAB50173,448FE471-3F4E-4DC8-A4E0-6F147DC93ABE,TCGA-DK-A1A5-01A-11D-A13W-08,HG19_Broad_variant,TCGA-DK-A1A5,TCGA-BLCA,65,s3066,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa830e4b0c9d6adf6c220,58cfa830e4b0c9d6adf6c220,TCGA-BA-4076-10A-01D-2266-10_Illumina.filtered.,WGS,TCGA-BA-4076-10A-01D-2266-10_Illumina,TCGA-BA-4076-10A-01D-2266-10_Illumina.bam,51.03,1.9,0.05,58cfa830e4b0c9d6adf6c220,TCGA-BA-4076-10A-01D-2266-10_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-4076-10A,7DE19081-D5FD-468C-AD0D-F6E3E8B2AD70,Blood Derived Normal,Illumina HiSeq,57de9078-5a6a-4185-846e-9c81add66025,Head and Neck,39,D6F48BB2-379A-448D-B13D-2DFC5DA91D0C,9249EB3D-5186-489E-B7FD-5FFF554E4B6E,TCGA-BA-4076-10A-01D-2266-10,GRCh37-lite,TCGA-BA-4076,TCGA-HNSC,415,s16026,Baylor College of Medicine,UNC,None,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa83ce4b0c9d6adf72f45,58cfa83ce4b0c9d6adf72f45,e731bc4a6b242f2c3e68d238e90047f3.filtered.,WGS,e731bc4a6b242f2c3e68d238e90047f3,e731bc4a6b242f2c3e68d238e90047f3.bam,50.54,1.82,0.08,58cfa83ce4b0c9d6adf72f45,e731bc4a6b242f2c3e68d238e90047f3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A23R-01A,B5F27002-4277-418D-90B0-CC5A2742692E,Primary Tumor,Illumina HiSeq,8611bde3-531a-4ac4-a742-255c5bd80352,Mesenchymal,55,05FC5924-07B1-422E-9D7C-7C0051F72368,35C797FD-CA81-4CEF-B6C4-7E3776F661B3,TCGA-DX-A23R-01A-11D-A26G-09,GRCh37-lite,TCGA-DX-A23R,TCGA-SARC,NA,s2632,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82fe4b0c9d6adf6b92c,58cfa82fe4b0c9d6adf6b92c,TCGA-A3-3372-11A-01D-2094-10_Illumina.filtered.,WGS,TCGA-A3-3372-11A-01D-2094-10_Illumina,TCGA-A3-3372-11A-01D-2094-10_Illumina.bam,439.87,1.9,0.16,58cfa82fe4b0c9d6adf6b92c,TCGA-A3-3372-11A-01D-2094-10_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-A3-3372-11A,11AB53C8-6366-4BC9-B60D-23E6ED2D1CAE,Solid Tissue Normal,Illumina HiSeq,ea015b31-71e8-4a07-b9c0-eaad11d036ac,Kidney,64,B0EC0DE0-7B17-4A9F-AFBD-05F6644E504D,A9EE0148-A5D5-42BC-B31F-D3385EC2616B,TCGA-A3-3372-11A-01D-2094-10,GRCh37-lite,TCGA-A3-3372,TCGA-KIRC,NA,s9442,Baylor College of Medicine,International Genomics Consortium,United States,NO,T3,NX,Kidney Clear Cell Renal Carcinoma,Stage III
13722.58cfa82de4b0c9d6adf6a518,58cfa82de4b0c9d6adf6a518,143a9f78e15769fd3d037c291de40599.filtered.,WGS,143a9f78e15769fd3d037c291de40599,143a9f78e15769fd3d037c291de40599.bam,85.82,2.12,0.07,58cfa82de4b0c9d6adf6a518,143a9f78e15769fd3d037c291de40599.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0K3-01A,79ECC142-8F6E-4260-A7CE-C8E2A6212C35,Primary Tumor,Illumina HiSeq,b48383ea-36f6-4edd-ae2e-04b235d472a3,Uterus,62,ED31DDC2-FEDA-496E-A642-0C4B5DCE014D,D12CFD8B-682D-41DF-ACF8-EE7F68A6241C,TCGA-B5-A0K3-01A-11D-A325-09,GRCh37-lite,TCGA-B5-A0K3,TCGA-UCEC,NA,s5375,Washington University School of Medicine,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ab22,58cfa82ee4b0c9d6adf6ab22,G32467.TCGA-DK-A1A6-01A-11D-A13W-08.3.filtered.,WGS,G32467.TCGA-DK-A1A6-01A-11D-A13W-08.3,G32467.TCGA-DK-A1A6-01A-11D-A13W-08.3.bam,85.12,1.95,0.08,58cfa82ee4b0c9d6adf6ab22,G32467.TCGA-DK-A1A6-01A-11D-A13W-08.3.bam,Alive,MALE,WHITE,Not available,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A6-01A,9C274536-3CA1-4F0E-93A8-1688074D862F,Primary Tumor,Illumina HiSeq,694693d8-dc04-4516-bc18-e8a9ccb24d28,Bladder,53,7AD1CD01-0EA2-4FA4-9B05-C280BD256546,DF8A913C-5160-4FC5-950D-7C890E24E820,TCGA-DK-A1A6-01A-11D-A13W-08,HG19_Broad_variant,TCGA-DK-A1A6,TCGA-BLCA,NA,s2847,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T2a,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa830e4b0c9d6adf6bc94,58cfa830e4b0c9d6adf6bc94,TCGA-AB-3005-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-3005-11A-01D-0739-09_whole,TCGA-AB-3005-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bc94,TCGA-AB-3005-11A-01D-0739-09_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3005-11A,E49A1768-BF1E-49C0-BCA3-4E076928281C,Solid Tissue Normal,Illumina GA,c1af86b8-c9b9-4b43-82ec-c27d252e042d,Blood,45,21E9D305-B94A-4978-8097-AF7BCADDB7BD,F02E1039-61D1-460F-A731-91D178483835,TCGA-AB-3005-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-3005,TCGA-LAML,NA,s7192,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72f9a,58cfa83ce4b0c9d6adf72f9a,a246b48a0a312eda5cafb748151a117b.filtered.,WGS,a246b48a0a312eda5cafb748151a117b,a246b48a0a312eda5cafb748151a117b.bam,74.65,1.93,0.09,58cfa83ce4b0c9d6adf72f9a,a246b48a0a312eda5cafb748151a117b.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-AR-A24Z-01A,9FEFBE7C-F66A-4940-843E-285CB7B392C1,Primary Tumor,Illumina HiSeq,1251c29c-8d85-4187-80dd-c459542e3080,Breast,57,5CDD3886-898B-4861-A748-D4164CE14A07,6C65CB6D-8C50-4C7C-BC84-EEEBE09FBE01,TCGA-AR-A24Z-01A-11D-A314-09,GRCh37-lite,TCGA-AR-A24Z,TCGA-BRCA,NA,s5942,Washington University School of Medicine,Mayo,United States,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a570,58cfa82de4b0c9d6adf6a570,2d3ccd84c9564a9f00feb1379762746c.filtered.,WGS,2d3ccd84c9564a9f00feb1379762746c,2d3ccd84c9564a9f00feb1379762746c.bam,78.11,1.95,0.08,58cfa82de4b0c9d6adf6a570,2d3ccd84c9564a9f00feb1379762746c.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A2H5-01A,C88E3901-F3EE-436A-BA80-143C8EAB7D69,Primary Tumor,Illumina HiSeq,6b01cf12-3537-4e5e-857f-de5dd14c85ce,Uterus,67,44EB96B4-5E4F-460B-BC51-ADD38CBC76A1,CC19A480-9C66-4EE8-A0C0-921ACAC02689,TCGA-AX-A2H5-01A-11D-A34H-09,GRCh37-lite,TCGA-AX-A2H5,TCGA-UCEC,NA,s5376,Washington University School of Medicine,Gynecologic Oncology Group,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c56f,58cfa831e4b0c9d6adf6c56f,TCGA-CJ-6033-11A-01D-2104-10_Illumina.filtered.,WGS,TCGA-CJ-6033-11A-01D-2104-10_Illumina,TCGA-CJ-6033-11A-01D-2104-10_Illumina.bam,13.66,1.9,0.13,58cfa831e4b0c9d6adf6c56f,TCGA-CJ-6033-11A-01D-2104-10_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CJ-6033-11A,4EDFF57F-4B0E-4770-BEAC-590DA7D7232C,Solid Tissue Normal,Illumina HiSeq,7ceeb54a-f1a7-4e5d-9225-cc54c8337e53,Kidney,54,D8A6C759-7AA9-4002-ABD8-17C5E6CDB074,AA436363-9D2A-42F4-87C2-55E5DFA9F8D1,TCGA-CJ-6033-11A-01D-2104-10,GRCh37-lite,TCGA-CJ-6033,TCGA-KIRC,224,s8839,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T3a,N0,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa83ce4b0c9d6adf731d0,58cfa83ce4b0c9d6adf731d0,ff361cc3e22a9619323ddbddf3aac564.filtered.,WGS,ff361cc3e22a9619323ddbddf3aac564,ff361cc3e22a9619323ddbddf3aac564.bam,49.41,NA,0.07,58cfa83ce4b0c9d6adf731d0,ff361cc3e22a9619323ddbddf3aac564.bam,Dead,MALE,Not available,Not available,Sarcoma,Aligned reads,TCGA-DX-A3U8-01A,D40C99D0-79F6-499D-B7F1-5FC4237CFC57,Primary Tumor,Illumina HiSeq,d104749e-66ed-4722-98a5-5d59447e5779,Mesenchymal,43,D40B2922-FA6A-4AFA-BDBF-7B517384AF74,729229FE-92B9-439B-ACD2-B49159116A41,TCGA-DX-A3U8-01A-11D-A29N-09,GRCh37-lite,TCGA-DX-A3U8,TCGA-SARC,138,s2638,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6abb8,58cfa82ee4b0c9d6adf6abb8,G32453.TCGA-DK-A3IL-01A-11D-A20D-08.3.filtered.,WGS,G32453.TCGA-DK-A3IL-01A-11D-A20D-08.3,G32453.TCGA-DK-A3IL-01A-11D-A20D-08.3.bam,32.38,NA,0.08,58cfa82ee4b0c9d6adf6abb8,G32453.TCGA-DK-A3IL-01A-11D-A20D-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A3IL-01A,178B28CD-99C3-48DC-8D09-1EF71B4CEE80,Primary Tumor,Illumina HiSeq,092f2192-b2d3-48e8-be2f-f56c1febe40b,Bladder,79,59D6683F-5EB7-493D-8E8E-78B88BE2CD70,4838B5A9-968C-4178-BFFB-3FAFE1F6DC09,TCGA-DK-A3IL-01A-11D-A20D-08,HG19_Broad_variant,TCGA-DK-A3IL,TCGA-BLCA,NA,s2844,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa83ce4b0c9d6adf72eb9,58cfa83ce4b0c9d6adf72eb9,d1a84a804a5e2b25a1e69c04b2656e82.filtered.,WGS,d1a84a804a5e2b25a1e69c04b2656e82,d1a84a804a5e2b25a1e69c04b2656e82.bam,19.11,NA,0.08,58cfa83ce4b0c9d6adf72eb9,d1a84a804a5e2b25a1e69c04b2656e82.bam,Alive,MALE,WHITE,Not available,Sarcoma,Aligned reads,TCGA-DX-A48U-01A,F2FCB8C3-4679-4753-8887-BF4C2781DF3A,Primary Tumor,HiSeq X Ten,e1c881e3-6486-4be1-b06f-bc990c8b466c,Mesenchymal,57,15811E5D-9D25-4562-B902-CCB24A1A97CF,ACB75BDE-21D7-4529-94E5-8C3D57B82A4D,TCGA-DX-A48U-01A-11D-A307-09,GRCh37-lite,TCGA-DX-A48U,TCGA-SARC,NA,s2465,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf73166,58cfa83ce4b0c9d6adf73166,d79ab9e1fbdab9baa35cf4fcd55ea0da.filtered.,WGS,d79ab9e1fbdab9baa35cf4fcd55ea0da,d79ab9e1fbdab9baa35cf4fcd55ea0da.bam,76.81,1.95,0.08,58cfa83ce4b0c9d6adf73166,d79ab9e1fbdab9baa35cf4fcd55ea0da.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A15K-06A,17C1D42C-CB84-4655-A4CD-B54BAE17ECAF,Metastatic,Illumina HiSeq,94369066-1292-427f-a441-6eddcd074492,Breast,58,4FCF4AFE-40BE-40EB-95CB-5B172ED83D11,F39CC911-36A7-4C06-9E91-4AD86281DB3D,TCGA-E2-A15K-06A-11D-A12Q-09,GRCh37-lite,TCGA-E2-A15K,TCGA-BRCA,NA,s6106,Washington University School of Medicine,Roswell Park,None,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa82ee4b0c9d6adf6ab2e,58cfa82ee4b0c9d6adf6ab2e,G32467.TCGA-DK-A1A6-01A-11D-A13W-08.2.filtered.,WGS,G32467.TCGA-DK-A1A6-01A-11D-A13W-08.2,G32467.TCGA-DK-A1A6-01A-11D-A13W-08.2.bam,85.12,1.95,0.08,58cfa82ee4b0c9d6adf6ab2e,G32467.TCGA-DK-A1A6-01A-11D-A13W-08.2.bam,Alive,MALE,WHITE,Not available,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A6-01A,9C274536-3CA1-4F0E-93A8-1688074D862F,Primary Tumor,Illumina HiSeq,99a71c72-13a7-4c05-ae15-ccfd0da321dd,Bladder,53,7AD1CD01-0EA2-4FA4-9B05-C280BD256546,DF8A913C-5160-4FC5-950D-7C890E24E820,TCGA-DK-A1A6-01A-11D-A13W-08,HG19_Broad_variant,TCGA-DK-A1A6,TCGA-BLCA,NA,s3073,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T2a,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82de4b0c9d6adf6a4d2,58cfa82de4b0c9d6adf6a4d2,10731b6615120dca4979fa4a636972c5.filtered.,WGS,10731b6615120dca4979fa4a636972c5,10731b6615120dca4979fa4a636972c5.bam,42.43,NA,0.08,58cfa82de4b0c9d6adf6a4d2,10731b6615120dca4979fa4a636972c5.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A3YB-10A,A1A233EA-5DDA-4EEB-BD92-6667E8B3EF57,Blood Derived Normal,HiSeq X Ten,b660d722-203f-4392-9055-413a85eff28d,Esophagus,61,4EDC7B38-9477-4E2C-A2E2-064E563FA206,3C15C909-6C3B-45CB-96E7-4AAADF93E541,TCGA-IG-A3YB-10A-01D-A247-09,GRCh37-lite_WUGSC_variant_2,TCGA-IG-A3YB,TCGA-ESCA,NA,s1807,Washington University School of Medicine,Asterand,Russia,NO,T3,N1,Not available,Stage IIIA
13722.58cfa830e4b0c9d6adf6bcf8,58cfa830e4b0c9d6adf6bcf8,TCGA-AF-2691-10A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AF-2691-10A-01D-1989-10_wgs_Illumina,TCGA-AF-2691-10A-01D-1989-10_wgs_Illumina.bam,372.21,1.9,0.14,58cfa830e4b0c9d6adf6bcf8,TCGA-AF-2691-10A-01D-1989-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-AF-2691-10A,830FD359-ABD4-4C99-89E4-2D6BB9CE5637,Blood Derived Normal,Illumina HiSeq,57c67c7b-62d8-4f91-9406-dd8ca3cadbeb,Colorectal,48,2902CDFC-CF54-4459-B018-FE50678C284E,557AD360-4292-4461-8A55-AAE3B9D7B3F9,TCGA-AF-2691-10A-01D-1989-10,GRCh37-lite,TCGA-AF-2691,TCGA-READ,NA,s1958,Baylor College of Medicine,Christiana Healthcare,None,NO,T1,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c7f4,58cfa831e4b0c9d6adf6c7f4,TCGA-CZ-5987-01A-11D-2104-10_Illumina.filtered.,WGS,TCGA-CZ-5987-01A-11D-2104-10_Illumina,TCGA-CZ-5987-01A-11D-2104-10_Illumina.bam,57.4,1.9,0.17,58cfa831e4b0c9d6adf6c7f4,TCGA-CZ-5987-01A-11D-2104-10_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CZ-5987-01A,F5759059-C0E3-4F1A-AF96-5C7197D3C33C,Primary Tumor,Illumina HiSeq,86bbaa26-53e2-4aa9-a257-0f86b5d2ca13,Kidney,60,6E67F804-5C82-4750-894A-0E85357F7E3D,FA5E2900-95E7-4700-9707-A329CD0C77FD,TCGA-CZ-5987-01A-11D-2104-10,GRCh37-lite,TCGA-CZ-5987,TCGA-KIRC,445,s9739,Baylor College of Medicine,Harvard,None,NO,T3b,NX,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa82ee4b0c9d6adf6ac60,58cfa82ee4b0c9d6adf6ac60,G39019.TCGA-DA-A1I8-10A-01D-A199-08.3.filtered.,WGS,G39019.TCGA-DA-A1I8-10A-01D-A199-08.3,G39019.TCGA-DA-A1I8-10A-01D-A199-08.3.bam,18.67,NA,0.07,58cfa82ee4b0c9d6adf6ac60,G39019.TCGA-DA-A1I8-10A-01D-A199-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1I8-10A,7B92FCD4-F9BE-4B97-94A2-B2E8348AEABA,Blood Derived Normal,Illumina HiSeq,ca32ac65-75ff-4d01-a3fe-f08416200c96,Skin,63,AAE8BDEA-4787-4144-8A1C-206F756ECDBC,5C001667-5412-4E44-806E-A1040F0F300A,TCGA-DA-A1I8-10A-01D-A199-08,HG19_Broad_variant,TCGA-DA-A1I8,TCGA-SKCM,NA,s7482,Broad Institute of MIT and Harvard,Yale,United States,NO,T4b,N0,Not available,Stage IIC
13722.58cfa82ee4b0c9d6adf6a977,58cfa82ee4b0c9d6adf6a977,G35154.TCGA-IK-7675-10A-01D-2086-08.6.filtered.,WGS,G35154.TCGA-IK-7675-10A-01D-2086-08.6,G35154.TCGA-IK-7675-10A-01D-2086-08.6.bam,648.3,NA,0.05,58cfa82ee4b0c9d6adf6a977,G35154.TCGA-IK-7675-10A-01D-2086-08.6.bam,Dead,MALE,WHITE,HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-IK-7675-10A,A5F851C5-6130-4EA1-9F86-BE59331A92F7,Blood Derived Normal,Illumina HiSeq,41e4eaa9-9947-44d6-8638-6ed9593c9670,Brain,43,A628ADCA-4AEF-4BD6-ADAD-D9435E93C3BC,110272FC-ED7E-4515-84D7-5E7262CFC9A8,TCGA-IK-7675-10A-01D-2086-08,HG19_Broad_variant,TCGA-IK-7675,TCGA-LGG,578,s8340,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa83ce4b0c9d6adf72eb7,58cfa83ce4b0c9d6adf72eb7,d15db997c9753dbcc63a3c57f36f20dd.filtered.,WGS,d15db997c9753dbcc63a3c57f36f20dd,d15db997c9753dbcc63a3c57f36f20dd.bam,NA,NA,NA,58cfa83ce4b0c9d6adf72eb7,d15db997c9753dbcc63a3c57f36f20dd.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2907-03A,E843A0EA-45A5-4C11-92A1-08FF12EB4531,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,53cc1bb1-1cc5-4d4f-971b-ec437d288676,Blood,69,41E0DAC3-A015-4AB8-B10B-C7EA6C744BED,1CC9C6B1-1049-4408-80CF-1FF39C44AC6B,TCGA-AB-2907-03A-01D-0742-05,GRCh37-lite,TCGA-AB-2907,TCGA-LAML,NA,s7157,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6aa6c,58cfa82ee4b0c9d6adf6aa6c,G32540.TCGA-EL-A3CV-10A-01D-A19M-08.3.filtered.,WGS,G32540.TCGA-EL-A3CV-10A-01D-A19M-08.3,G32540.TCGA-EL-A3CV-10A-01D-A19M-08.3.bam,9.58,NA,0.08,58cfa82ee4b0c9d6adf6aa6c,G32540.TCGA-EL-A3CV-10A-01D-A19M-08.3.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EL-A3CV-10A,FB83F7D7-2182-4FB7-8E3E-8AD7F1FEAC72,Blood Derived Normal,Illumina HiSeq,be2d11d9-2d30-48fb-9da4-135d3c6805e6,Thyroid,40,6779D98B-F6DA-4B98-8CCB-98A566F3ED16,48B6E8F8-3784-4F66-892F-5C294E06C306,TCGA-EL-A3CV-10A-01D-A19M-08,HG19_Broad_variant,TCGA-EL-A3CV,TCGA-THCA,NA,s12494,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa83ce4b0c9d6adf7306a,58cfa83ce4b0c9d6adf7306a,bddd564ff19744ab9ef04369b08aa089.filtered.,WGS,bddd564ff19744ab9ef04369b08aa089,bddd564ff19744ab9ef04369b08aa089.bam,22.48,NA,0.08,58cfa83ce4b0c9d6adf7306a,bddd564ff19744ab9ef04369b08aa089.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A97I-01A,7AA71C68-4205-4745-838B-0D00BD49A501,Primary Tumor,HiSeq X Ten,9b8e813c-501c-40a9-911c-a807156c44df,Esophagus,58,B0B554B7-F166-4066-B59F-B04D53174BBA,AA1DED71-E3FE-4AD9-B9DE-AAFA3DA72D71,TCGA-IG-A97I-01A-11D-A387-09,GRCh37-lite_WUGSC_variant_2,TCGA-IG-A97I,TCGA-ESCA,NA,s1805,Washington University School of Medicine,Asterand,Ukraine,NO,T2,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6c5d2,58cfa831e4b0c9d6adf6c5d2,TCGA-CN-5365-10A-01D-2276-10_Illumina.filtered.,WGS,TCGA-CN-5365-10A-01D-2276-10_Illumina,TCGA-CN-5365-10A-01D-2276-10_Illumina.bam,0,1.9,0.05,58cfa831e4b0c9d6adf6c5d2,TCGA-CN-5365-10A-01D-2276-10_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5365-10A,4CFFEA0B-90A7-4C86-A73F-BB8FECA3ADA7,Blood Derived Normal,Illumina HiSeq,65cf1dc0-039b-4fc7-85e5-efe031070b06,Head and Neck,38,665D66AD-54EE-478E-BDD0-85D77980FB3E,D8367C6F-52E6-430F-A9AC-CA6FAB7222F4,TCGA-CN-5365-10A-01D-2276-10,GRCh37-lite,TCGA-CN-5365,TCGA-HNSC,351,s16179,Baylor College of Medicine,University of Pittsburgh,None,NO,T2,N3,Head and Neck Squamous Cell Carcinoma,Stage IVB
13722.58cfa832e4b0c9d6adf6d3b0,58cfa832e4b0c9d6adf6d3b0,TCGA-KO-8417-11A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KO-8417-11A-01D-2311-10_wgs_Illumina,TCGA-KO-8417-11A-01D-2311-10_wgs_Illumina.bam,298.5,NA,0.05,58cfa832e4b0c9d6adf6d3b0,TCGA-KO-8417-11A-01D-2311-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KO-8417-11A,0B77657A-0297-4CEE-B9F2-5DE72E182016,Solid Tissue Normal,Illumina HiSeq,51a08a60-3a45-442e-a684-853ab27bd614,Kidney,30,E4322EA0-D6BA-473D-87C8-183045BC12B3,32E33F58-0399-49BB-BC8C-1EEB122D4DF4,TCGA-KO-8417-11A-01D-2311-10,GRCh37-lite,TCGA-KO-8417,TCGA-KICH,NA,s16490,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T1,N0,Kidney Chromophobe,Stage I
13722.58cfa83ce4b0c9d6adf731a8,58cfa83ce4b0c9d6adf731a8,bbc8973c94bace011ace01bbae7e5119.filtered.,WGS,bbc8973c94bace011ace01bbae7e5119,bbc8973c94bace011ace01bbae7e5119.bam,38.72,NA,0.08,58cfa83ce4b0c9d6adf731a8,bbc8973c94bace011ace01bbae7e5119.bam,Alive,FEMALE,WHITE,Not available,Sarcoma,Aligned reads,TCGA-X2-A95T-01A,8372E154-C9C1-4382-8120-7E14DD426367,Primary Tumor,HiSeq X Ten,0b196cb5-d13f-4128-b9b6-f569fcd3d570,Mesenchymal,49,2DE5878A-85D4-4A26-9E7D-8D0834CB72EC,EAE14DA4-7965-48F3-919D-F1A4D02028A4,TCGA-X2-A95T-01A-11D-A37C-09,GRCh37-lite,TCGA-X2-A95T,TCGA-SARC,NA,s2626,Washington University School of Medicine,University of Washington,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6baa0,58cfa830e4b0c9d6adf6baa0,TCGA-A3-3387-11A-01D-2102-10_Illumina.filtered.,WGS,TCGA-A3-3387-11A-01D-2102-10_Illumina,TCGA-A3-3387-11A-01D-2102-10_Illumina.bam,49.4,1.9,0.14,58cfa830e4b0c9d6adf6baa0,TCGA-A3-3387-11A-01D-2102-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-A3-3387-11A,9DC7812B-C7A2-4DE4-BF6D-4C7261384A62,Solid Tissue Normal,Illumina HiSeq,7e6c82a1-9f43-4ba9-975c-2c76d37b8520,Kidney,49,F2B36CA3-8D5D-453D-B445-82FAA22A8A35,B4A2213C-45BB-4769-8DC6-D4A158425BEC,TCGA-A3-3387-11A-01D-2102-10,GRCh37-lite,TCGA-A3-3387,TCGA-KIRC,NA,s9001,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1a,N0,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ab6a,58cfa82ee4b0c9d6adf6ab6a,G32459.TCGA-BL-A13J-10A-01D-A10S-08.2.filtered.,WGS,G32459.TCGA-BL-A13J-10A-01D-A10S-08.2,G32459.TCGA-BL-A13J-10A-01D-A10S-08.2.bam,16.09,2.03,0.07,58cfa82ee4b0c9d6adf6ab6a,G32459.TCGA-BL-A13J-10A-01D-A10S-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BL-A13J-10A,556FCBC8-172A-4AF1-8822-AE036E8D68E8,Blood Derived Normal,Illumina HiSeq,05303fca-70be-4464-8117-63e19ea2b177,Bladder,65,C7348A4B-9360-4249-B1E2-CFD8647D3633,E34479B8-834F-4747-984B-E77272F1379D,TCGA-BL-A13J-10A-01D-A10S-08,HG19_Broad_variant,TCGA-BL-A13J,TCGA-BLCA,81,s3078,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,T4,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82ee4b0c9d6adf6a924,58cfa82ee4b0c9d6adf6a924,G32545.TCGA-EE-A29B-06A-11D-A197-08.2.filtered.,WGS,G32545.TCGA-EE-A29B-06A-11D-A197-08.2,G32545.TCGA-EE-A29B-06A-11D-A197-08.2.bam,66.45,NA,0.09,58cfa82ee4b0c9d6adf6a924,G32545.TCGA-EE-A29B-06A-11D-A197-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29B-06A,905EA29F-588A-497B-9F06-2EEF3BDC9442,Metastatic,Illumina HiSeq,3f0b2d7b-3c6f-44f8-9509-db7105ce6a9a,Skin,67,73ED3AA7-1AAD-42B6-AC8A-1CA284A75A48,FA4D35E3-FC38-4E26-A9E0-521A648ACEC1,TCGA-EE-A29B-06A-11D-A197-08,HG19_Broad_variant,TCGA-EE-A29B,TCGA-SKCM,NA,s7649,Broad Institute of MIT and Harvard,University of Sydney,Australia,NO,T3b,N0,Not available,Stage IIB
13722.58cfa82ee4b0c9d6adf6adb2,58cfa82ee4b0c9d6adf6adb2,G39020.TCGA-CG-5730-01A-11D-1600-08.1.filtered.,WGS,G39020.TCGA-CG-5730-01A-11D-1600-08.1,G39020.TCGA-CG-5730-01A-11D-1600-08.1.bam,326.3,1.9,0.05,58cfa82ee4b0c9d6adf6adb2,G39020.TCGA-CG-5730-01A-11D-1600-08.1.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5730-01A,09587F1C-5C99-4102-BC49-84D50FA8D0CE,Primary Tumor,Illumina HiSeq,e44c7152-648d-41d1-91c5-7e8d1c29b687,Stomach,80,2986F11F-3C18-4621-8406-D46614537ED4,26ED0DD6-FCF5-4B45-A3A9-6F813D5FBAF7,TCGA-CG-5730-01A-11D-1600-08,HG19_Broad_variant,TCGA-CG-5730,TCGA-STAD,NA,s14959,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa82ee4b0c9d6adf6aa5e,58cfa82ee4b0c9d6adf6aa5e,G32552.TCGA-EE-A2GN-10A-01D-A198-08.3.filtered.,WGS,G32552.TCGA-EE-A2GN-10A-01D-A198-08.3,G32552.TCGA-EE-A2GN-10A-01D-A198-08.3.bam,6.39,NA,0.09,58cfa82ee4b0c9d6adf6aa5e,G32552.TCGA-EE-A2GN-10A-01D-A198-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2GN-10A,BE73FDE2-D843-426B-9306-A02D3F2A754B,Blood Derived Normal,Illumina HiSeq,0ad9fed5-dec5-43cc-896d-b252fc532597,Skin,67,67B969A1-DC86-4E7E-B74C-8EF5F0E5DFD9,65D9054F-653A-4A10-9E25-1FE617481AA2,TCGA-EE-A2GN-10A-01D-A198-08,HG19_Broad_variant,TCGA-EE-A2GN,TCGA-SKCM,NA,s7656,Broad Institute of MIT and Harvard,University of Sydney,Australia,NO,T2b,N0,Not available,Stage IIA
13722.58cfa82de4b0c9d6adf6a599,58cfa82de4b0c9d6adf6a599,6520482bf50a726c446002cb9b06ac69.filtered.,WGS,6520482bf50a726c446002cb9b06ac69,6520482bf50a726c446002cb9b06ac69.bam,27.61,NA,0.08,58cfa82de4b0c9d6adf6a599,6520482bf50a726c446002cb9b06ac69.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-IE-A4EI-01A,C5E23947-253B-40D2-916A-277B2A580BE2,Primary Tumor,Illumina HiSeq,6070f836-ad03-4454-9395-d7c38f0949c9,Mesenchymal,67,1FE30A2F-22A6-4F88-9A3A-7A11359CC151,522DC834-8367-4F49-B93B-FCBA91A2DE7E,TCGA-IE-A4EI-01A-11D-A24N-09,GRCh37-lite,TCGA-IE-A4EI,TCGA-SARC,NA,s2339,Washington University School of Medicine,ABS - IUPUI,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a51c,58cfa82de4b0c9d6adf6a51c,3016434d8255a1fb2b32ae1ae47ef1ec.filtered.,WGS,3016434d8255a1fb2b32ae1ae47ef1ec,3016434d8255a1fb2b32ae1ae47ef1ec.bam,57.13,1.93,0.08,58cfa82de4b0c9d6adf6a51c,3016434d8255a1fb2b32ae1ae47ef1ec.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A18U-01A,233B02F3-C4F0-4A67-9DB5-E68D5CDACCB6,Primary Tumor,Illumina HiSeq,8797ff7d-3b2a-4ac8-b8a3-375982e8413e,Breast,72,79763193-268D-49E7-B94C-5CB95F7271B6,FB9135D9-2ACF-41DD-8552-359E6B8C9470,TCGA-BH-A18U-01A-21D-A19H-09,GRCh37-lite,TCGA-BH-A18U,TCGA-BRCA,1563,s6912,Washington University School of Medicine,University of Pittsburgh,None,NO,T2,N2a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82de4b0c9d6adf6a68a,58cfa82de4b0c9d6adf6a68a,92b17b06dd8c1279647435d6dc17b382.filtered.,WGS,92b17b06dd8c1279647435d6dc17b382,92b17b06dd8c1279647435d6dc17b382.bam,23.61,1.87,0.07,58cfa82de4b0c9d6adf6a68a,92b17b06dd8c1279647435d6dc17b382.bam,Dead,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A09X-01A,27B05B15-A44B-45ED-A6E3-E7D1CA488EA9,Primary Tumor,Illumina HiSeq,8327f8db-6932-4661-a116-5909cd8e4c81,Breast,62,5A9087B1-D001-4FCC-B061-F59E7026E711,6DBC5C31-043B-40E9-BF1A-E7B4EC351B4D,TCGA-A8-A09X-01A-11D-A19H-09,GRCh37-lite,TCGA-A8-A09X,TCGA-BRCA,426,s5633,Washington University School of Medicine,Indivumed,Germany,NO,T2,N3a,Infiltrating Lobular Carcinoma,Stage IIIC
13722.58cfa82de4b0c9d6adf6a514,58cfa82de4b0c9d6adf6a514,39d36a4631a0662e48415735c9e225a7.filtered.,WGS,39d36a4631a0662e48415735c9e225a7,39d36a4631a0662e48415735c9e225a7.bam,41.18,2.26,0.09,58cfa82de4b0c9d6adf6a514,39d36a4631a0662e48415735c9e225a7.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A1MY-01A,5D2F1A0F-A01B-48C2-B749-1CA710AA2BB4,Primary Tumor,Illumina HiSeq,d76a05f0-61cd-42ac-9cbe-0c1fe2a9a85e,Uterus,62,26189CF5-AE49-44CF-842B-35A3063AB93C,493E7008-551C-4C0E-B567-A0F31868629E,TCGA-B5-A1MY-01A-11D-A142-09,GRCh37-lite,TCGA-B5-A1MY,TCGA-UCEC,361,s4766,Washington University School of Medicine,Duke,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a5ce,58cfa82de4b0c9d6adf6a5ce,730dac4f2b9e3f7bc83f758dbd514583.filtered.,WGS,730dac4f2b9e3f7bc83f758dbd514583,730dac4f2b9e3f7bc83f758dbd514583.bam,59.62,2.13,0.08,58cfa82de4b0c9d6adf6a5ce,730dac4f2b9e3f7bc83f758dbd514583.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GG-01A,A8614C49-C7F1-4DE9-BD2F-4764B094D604,Primary Tumor,Illumina HiSeq,c4002956-bdc1-4b16-810a-ccf4b006d29b,Uterus,76,B5B941E3-F828-4091-B9B1-6B38D1493847,F7187888-F261-4A39-99B4-966FD7207117,TCGA-A5-A0GG-01A-11D-A122-09,GRCh37-lite,TCGA-A5-A0GG,TCGA-UCEC,NA,s5379,Washington University School of Medicine,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bbbe,58cfa830e4b0c9d6adf6bbbe,TCGA-A3-3308-11A-01D-2094-10_Illumina.filtered.,WGS,TCGA-A3-3308-11A-01D-2094-10_Illumina,TCGA-A3-3308-11A-01D-2094-10_Illumina.bam,741.9,1.9,0.15,58cfa830e4b0c9d6adf6bbbe,TCGA-A3-3308-11A-01D-2094-10_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-A3-3308-11A,3CBCA837-F5A7-4A87-8F02-C59EAC232D5A,Solid Tissue Normal,Illumina HiSeq,7aaee1fe-0c9c-4964-8241-bba0d4cf812e,Kidney,77,EED5EE07-F84E-4907-B4EA-1AA879D3602C,857BBC5D-C18D-48CD-AE97-4700096ED17D,TCGA-A3-3308-11A-01D-2094-10,GRCh37-lite,TCGA-A3-3308,TCGA-KIRC,NA,s9443,Baylor College of Medicine,International Genomics Consortium,None,NO,T3b,N0,Kidney Clear Cell Renal Carcinoma,Stage III
13722.58cfa82de4b0c9d6adf6a620,58cfa82de4b0c9d6adf6a620,772ba6cf7583e12d3088feb90685bc2f.filtered.,WGS,772ba6cf7583e12d3088feb90685bc2f,772ba6cf7583e12d3088feb90685bc2f.bam,36.43,NA,0.08,58cfa82de4b0c9d6adf6a620,772ba6cf7583e12d3088feb90685bc2f.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A8NE-01A,67FAE19C-3CE9-4F91-B01E-4B130ABF632E,Primary Tumor,HiSeq X Ten,d6fb5299-3624-4c07-b729-fc117968bc7d,Esophagus,77,F733D5FB-4CD4-436E-9427-40BC64B39B15,F6782B67-BA4D-4AD2-BF1D-72D57C81AB9F,TCGA-L5-A8NE-01A-11D-A37C-09,GRCh37-lite_WUGSC_variant_2,TCGA-L5-A8NE,TCGA-ESCA,NA,s1713,Washington University School of Medicine,University of Michigan,United States,NO,T2,N1,Not available,Stage IIB
13722.58cfa82ee4b0c9d6adf6adcc,58cfa82ee4b0c9d6adf6adcc,G39020.TCGA-CG-5723-11A-02D-1600-08.1.filtered.,WGS,G39020.TCGA-CG-5723-11A-02D-1600-08.1,G39020.TCGA-CG-5723-11A-02D-1600-08.1.bam,393.3,1.9,0.05,58cfa82ee4b0c9d6adf6adcc,G39020.TCGA-CG-5723-11A-02D-1600-08.1.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5723-11A,0F00AD32-E4BE-49D4-A02A-D233BFC913C5,Solid Tissue Normal,Illumina HiSeq,2d735056-1f57-47f6-b1b7-3346648f28d1,Stomach,83,CDB68733-745A-4DA9-BF49-B0E0E74A3332,E4834EC5-3085-4675-8D63-23F546B30799,TCGA-CG-5723-11A-02D-1600-08,HG19_Broad_variant,TCGA-CG-5723,TCGA-STAD,NA,s14961,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa82ee4b0c9d6adf6ac66,58cfa82ee4b0c9d6adf6ac66,G39019.TCGA-DA-A1I2-10A-01D-A19A-08.1.filtered.,WGS,G39019.TCGA-DA-A1I2-10A-01D-A19A-08.1,G39019.TCGA-DA-A1I2-10A-01D-A19A-08.1.bam,37.33,NA,0.08,58cfa82ee4b0c9d6adf6ac66,G39019.TCGA-DA-A1I2-10A-01D-A19A-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1I2-10A,01AD975D-C2ED-4E4D-BD3B-C9512FC9073C,Blood Derived Normal,Illumina HiSeq,c7b9a36c-1c11-4c36-b772-dfdca48cfdf5,Skin,45,346BA3E2-73E0-4ACC-961E-13D258A286DA,33941005-40A5-45DA-A497-BD3FCFBBEC30,TCGA-DA-A1I2-10A-01D-A19A-08,HG19_Broad_variant,TCGA-DA-A1I2,TCGA-SKCM,NA,s7486,Broad Institute of MIT and Harvard,Yale,United States,NO,T4b,N2b,Not available,Stage III
13722.58cfa830e4b0c9d6adf6bd60,58cfa830e4b0c9d6adf6bd60,TCGA-AG-4015-10A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AG-4015-10A-01D-1989-10_wgs_Illumina,TCGA-AG-4015-10A-01D-1989-10_wgs_Illumina.bam,44.59,1.9,0.15,58cfa830e4b0c9d6adf6bd60,TCGA-AG-4015-10A-01D-1989-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-4015-10A,1388BBA1-02BA-40DF-93E5-C3D58B7BBAE0,Blood Derived Normal,Illumina HiSeq,0d3661dd-0e73-4e64-8fb7-4c78f1cc6b1c,Colorectal,85,3C5E0211-94A1-4760-AAF4-DE2B80A92DC3,976E0576-C795-48A8-8433-700F9982EC98,TCGA-AG-4015-10A-01D-1989-10,GRCh37-lite,TCGA-AG-4015,TCGA-READ,NA,s2151,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6a999,58cfa82ee4b0c9d6adf6a999,G32459.TCGA-BL-A13J-10A-01D-A10S-08.3.filtered.,WGS,G32459.TCGA-BL-A13J-10A-01D-A10S-08.3,G32459.TCGA-BL-A13J-10A-01D-A10S-08.3.bam,16.09,2.03,0.07,58cfa82ee4b0c9d6adf6a999,G32459.TCGA-BL-A13J-10A-01D-A10S-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BL-A13J-10A,556FCBC8-172A-4AF1-8822-AE036E8D68E8,Blood Derived Normal,Illumina HiSeq,6e36a1bf-75a4-43f2-b7dc-0d143c21b150,Bladder,65,C7348A4B-9360-4249-B1E2-CFD8647D3633,E34479B8-834F-4747-984B-E77272F1379D,TCGA-BL-A13J-10A-01D-A10S-08,HG19_Broad_variant,TCGA-BL-A13J,TCGA-BLCA,81,s3077,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,T4,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82de4b0c9d6adf6a66a,58cfa82de4b0c9d6adf6a66a,66afd02d503cb850b20a92c3c4e46673.filtered.,WGS,66afd02d503cb850b20a92c3c4e46673,66afd02d503cb850b20a92c3c4e46673.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a66a,66afd02d503cb850b20a92c3c4e46673.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3012-11A,3997C824-8B85-4E1D-B4B1-D32C26155296,Solid Tissue Normal,Illumina GA,b9a0ff19-c21c-43ca-b213-3c263b98deb7,Blood,53,251BBEC9-02EB-46DD-9D32-BF6D6D1F0C67,673432D1-FA29-474C-A1F2-B042F2A57CDB,TCGA-AB-3012-11A-01D-0739-09,GRCh37-lite,TCGA-AB-3012,TCGA-LAML,NA,s7137,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa832e4b0c9d6adf6d4ff,58cfa832e4b0c9d6adf6d4ff,TCGA-KO-8416-11A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KO-8416-11A-01D-2311-10_wgs_Illumina,TCGA-KO-8416-11A-01D-2311-10_wgs_Illumina.bam,182.5,NA,0.05,58cfa832e4b0c9d6adf6d4ff,TCGA-KO-8416-11A-01D-2311-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KO-8416-11A,0EC3CAA1-7C51-417B-A89C-18E9FCEB80C4,Solid Tissue Normal,Illumina HiSeq,6ee31586-ba6f-4747-b645-60a93a39e229,Kidney,41,2BF14636-C30D-4D4E-840C-D13643C917B5,539A0194-EA33-4213-B815-B8DBBC07A276,TCGA-KO-8416-11A-01D-2311-10,GRCh37-lite,TCGA-KO-8416,TCGA-KICH,NA,s16573,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T3a,N0,Kidney Chromophobe,Stage III
13722.58cfa83ce4b0c9d6adf730c0,58cfa83ce4b0c9d6adf730c0,fd78ff5c667f21aef8657e218f7021a2.filtered.,WGS,fd78ff5c667f21aef8657e218f7021a2,fd78ff5c667f21aef8657e218f7021a2.bam,24.76,NA,0.08,58cfa83ce4b0c9d6adf730c0,fd78ff5c667f21aef8657e218f7021a2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-FX-A3NJ-01A,7BAB6742-4E3D-4FCF-9B90-D3E0218B4D79,Primary Tumor,Illumina HiSeq,4031a13e-df1e-4608-8d52-01b9b1c04b9d,Mesenchymal,54,29FDA349-D725-4F69-BB11-95D5454400F4,408ED640-75F6-4346-BDD0-3B93C51ADAE5,TCGA-FX-A3NJ-01A-11D-A21Q-09,GRCh37-lite,TCGA-FX-A3NJ,TCGA-SARC,NA,s2672,Washington University School of Medicine,International Genomics Consortium,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6ab6c,58cfa82ee4b0c9d6adf6ab6c,G32462.TCGA-DK-A1A7-01A-11D-A13W-08.2.filtered.,WGS,G32462.TCGA-DK-A1A7-01A-11D-A13W-08.2,G32462.TCGA-DK-A1A7-01A-11D-A13W-08.2.bam,35.04,2,0.07,58cfa82ee4b0c9d6adf6ab6c,G32462.TCGA-DK-A1A7-01A-11D-A13W-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A7-01A,3ED614E7-F356-4D87-985B-D3BBBAE3BB40,Primary Tumor,Illumina HiSeq,4eade8e4-0984-473e-99f5-523fdc631190,Bladder,67,D68D16F7-6117-4D3D-8347-CF5CD3F23AE4,91F458E6-64B7-454D-A542-B0AA23638FD8,TCGA-DK-A1A7-01A-11D-A13W-08,HG19_Broad_variant,TCGA-DK-A1A7,TCGA-BLCA,NA,s3074,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82ee4b0c9d6adf6a8de,58cfa82ee4b0c9d6adf6a8de,G35154.TCGA-CS-6668-10A-01D-1893-08.4.filtered.,WGS,G35154.TCGA-CS-6668-10A-01D-1893-08.4,G35154.TCGA-CS-6668-10A-01D-1893-08.4.bam,112.3,1.8,0.05,58cfa82ee4b0c9d6adf6a8de,G35154.TCGA-CS-6668-10A-01D-1893-08.4.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-6668-10A,A5D3F3FB-6541-419D-B47E-720D438F1BFF,Blood Derived Normal,Illumina HiSeq,51192faa-2766-43bd-83da-486a2f32e8c0,Brain,57,358E6AC9-C2FA-4EC7-9201-FA121A751B3C,7154A36B-C503-43F5-B291-89BD5CE2875F,TCGA-CS-6668-10A-01D-1893-08,HG19_Broad_variant,TCGA-CS-6668,TCGA-LGG,NA,s8100,Broad Institute of MIT and Harvard,Thomas Jefferson University,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6ac43,58cfa82ee4b0c9d6adf6ac43,G37566.TCGA-G9-7522-10A-01D-2260-08.1.filtered.,WGS,G37566.TCGA-G9-7522-10A-01D-2260-08.1,G37566.TCGA-G9-7522-10A-01D-2260-08.1.bam,67,NA,0.05,58cfa82ee4b0c9d6adf6ac43,G37566.TCGA-G9-7522-10A-01D-2260-08.1.bam,Alive,MALE,Not available,Not available,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-7522-10A,87959988-BB25-47EE-AFC1-9AF92592BBE7,Blood Derived Normal,Illumina HiSeq,6544c47e-8718-4c5e-8c3e-94577b766269,Prostate,49,6C09747D-F594-4750-A33E-9D9FEF60AA27,BA7EB48D-9486-45FC-9728-4CEEB9BDCA09,TCGA-G9-7522-10A-01D-2260-08,HG19_Broad_variant,TCGA-G9-7522,TCGA-PRAD,NA,s3768,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c416,58cfa831e4b0c9d6adf6c416,TCGA-CJ-4639-11A-01D-2095-10_Illumina.filtered.,WGS,TCGA-CJ-4639-11A-01D-2095-10_Illumina,TCGA-CJ-4639-11A-01D-2095-10_Illumina.bam,123.64,1.9,0.14,58cfa831e4b0c9d6adf6c416,TCGA-CJ-4639-11A-01D-2095-10_Illumina.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CJ-4639-11A,3E976301-4042-4AC0-8F01-EF2F1A8161A6,Solid Tissue Normal,Illumina HiSeq,a5400e0f-07e7-46c1-becc-228fd12b0ab2,Kidney,49,DA8B5B7F-250C-4F7C-92A3-4658F9F729B8,31936F1C-86B8-489F-883D-2DC8C9824F57,TCGA-CJ-4639-11A-01D-2095-10,GRCh37-lite,TCGA-CJ-4639,TCGA-KIRC,NA,s9736,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T2,N0,Kidney Clear Cell Renal Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6ac0e,58cfa82ee4b0c9d6adf6ac0e,G39019.TCGA-ER-A19J-10A-01D-A198-08.3.filtered.,WGS,G39019.TCGA-ER-A19J-10A-01D-A198-08.3,G39019.TCGA-ER-A19J-10A-01D-A198-08.3.bam,9.46,NA,0.08,58cfa82ee4b0c9d6adf6ac0e,G39019.TCGA-ER-A19J-10A-01D-A198-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19J-10A,CE28F65D-4AE8-4E63-815F-5B8D4389E092,Blood Derived Normal,Illumina HiSeq,40703ad3-e651-4b4a-9d06-11bea7320edc,Skin,54,268C6DA4-C7DE-4DB9-8ACE-B00B8531E06B,E7B47CEC-4001-4426-81A0-86B345A56800,TCGA-ER-A19J-10A-01D-A198-08,HG19_Broad_variant,TCGA-ER-A19J,TCGA-SKCM,196,s7822,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,TX,N3,Not available,Stage IV
13722.58cfa82ee4b0c9d6adf6acdd,58cfa82ee4b0c9d6adf6acdd,G39020.TCGA-D7-6519-10A-01D-1800-08.3.filtered.,WGS,G39020.TCGA-D7-6519-10A-01D-1800-08.3,G39020.TCGA-D7-6519-10A-01D-1800-08.3.bam,331.7,1.9,0.05,58cfa82ee4b0c9d6adf6acdd,G39020.TCGA-D7-6519-10A-01D-1800-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6519-10A,E37CAE9E-0656-4B89-B326-739A5CC859E0,Blood Derived Normal,Illumina HiSeq,b123947e-b1f7-480a-8b74-3962791498e1,Stomach,64,AC4792AA-4989-43F5-A9D2-B82B25490F38,FB2D7620-EF06-4044-A50D-5BB868E8642B,TCGA-D7-6519-10A-01D-1800-08,HG19_Broad_variant,TCGA-D7-6519,TCGA-STAD,NA,s14464,Broad Institute of MIT and Harvard,Greater Poland Cancer Center,Poland,NO,T2,N1,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIB
13722.58cfa82de4b0c9d6adf6a5b2,58cfa82de4b0c9d6adf6a5b2,6822184f0a41bd067261cf1591f0dbf6.filtered.,WGS,6822184f0a41bd067261cf1591f0dbf6,6822184f0a41bd067261cf1591f0dbf6.bam,34.66,1.95,0.08,58cfa82de4b0c9d6adf6a5b2,6822184f0a41bd067261cf1591f0dbf6.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A12H-01A,B5B99291-507E-4B68-A039-9A0F571F55DF,Primary Tumor,Illumina HiSeq,55b85b3a-3eed-4a89-ab63-56b85e180571,Breast,69,D8AFCB32-81D0-43B3-AD5C-E8C735710624,5A535C49-D42E-43C6-9D32-DC76F28D4F0F,TCGA-AO-A12H-01A-11D-A10Y-09,GRCh37-lite,TCGA-AO-A12H,TCGA-BRCA,NA,s5481,Washington University School of Medicine,MSKCC,None,NO,T2,N0 (i-),Other  specify,Stage IIA
13722.58cfa82ee4b0c9d6adf6a974,58cfa82ee4b0c9d6adf6a974,G32462.TCGA-DK-A1A7-01A-11D-A13W-08.1.filtered.,WGS,G32462.TCGA-DK-A1A7-01A-11D-A13W-08.1,G32462.TCGA-DK-A1A7-01A-11D-A13W-08.1.bam,35.04,2,0.07,58cfa82ee4b0c9d6adf6a974,G32462.TCGA-DK-A1A7-01A-11D-A13W-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A7-01A,3ED614E7-F356-4D87-985B-D3BBBAE3BB40,Primary Tumor,Illumina HiSeq,7a0d461d-525e-4b3a-86d1-d6d3306fb405,Bladder,67,D68D16F7-6117-4D3D-8347-CF5CD3F23AE4,91F458E6-64B7-454D-A542-B0AA23638FD8,TCGA-DK-A1A7-01A-11D-A13W-08,HG19_Broad_variant,TCGA-DK-A1A7,TCGA-BLCA,NA,s3070,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa83ce4b0c9d6adf72eb0,58cfa83ce4b0c9d6adf72eb0,cea4bc4275e349522246f3666f7965b5.filtered.,WGS,cea4bc4275e349522246f3666f7965b5,cea4bc4275e349522246f3666f7965b5.bam,46.1,1.75,0.09,58cfa83ce4b0c9d6adf72eb0,cea4bc4275e349522246f3666f7965b5.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-D8-A27F-01A,1549DC64-3DAB-43FC-96E9-B07D520957E1,Primary Tumor,Illumina HiSeq,f4f2c07e-84b7-47d0-88fe-7032564a1ecc,Breast,40,7E9145F7-CCFF-4132-B2B7-9B992EEBEBF4,FC6D77A9-121B-48AB-A899-713C3D1319A2,TCGA-D8-A27F-01A-11D-A16D-09,GRCh37-lite,TCGA-D8-A27F,TCGA-BRCA,NA,s6967,Washington University School of Medicine,Greater Poland Cancer Center,Poland,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6ad0c,58cfa82ee4b0c9d6adf6ad0c,G39019.TCGA-D3-A1Q1-10A-01D-A198-08.2.filtered.,WGS,G39019.TCGA-D3-A1Q1-10A-01D-A198-08.2,G39019.TCGA-D3-A1Q1-10A-01D-A198-08.2.bam,15.12,NA,0.08,58cfa82ee4b0c9d6adf6ad0c,G39019.TCGA-D3-A1Q1-10A-01D-A198-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A1Q1-10A,8C54FCFD-999F-43C5-B31F-26D006F5FFF3,Blood Derived Normal,Illumina HiSeq,ef92a606-f1f0-4fce-b864-ac45d19029b6,Skin,79,50F94172-3F96-483D-82CD-A7806CDF4837,628778F0-A013-498A-938A-BEA1361ADD23,TCGA-D3-A1Q1-10A-01D-A198-08,HG19_Broad_variant,TCGA-D3-A1Q1,TCGA-SKCM,504,s7315,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,T1b,N3,Not available,Stage IIIC
13722.58cfa82ee4b0c9d6adf6b150,58cfa82ee4b0c9d6adf6b150,TCGA-06-0214-01A-02D-0512-09_whole.filtered.,WGS,TCGA-06-0214-01A-02D-0512-09_whole,TCGA-06-0214-01A-02D-0512-09_whole.bam,20,1.89,0.17,58cfa82ee4b0c9d6adf6b150,TCGA-06-0214-01A-02D-0512-09_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0214-01A,9853C6BB-A42C-4698-ABE5-F3C897EBC8F6,Primary Tumor,Illumina GA,c310365f-4a6f-4734-8b9c-a586ea9d8606,Brain,66,A86189C2-BFF1-4DBE-B4AC-C886478E6FFC,DA484194-5996-4456-A465-DE7891D9AAF3,TCGA-06-0214-01A-02D-0512-09,NCBI36_WUGSC_variant,TCGA-06-0214,TCGA-GBM,457,s14031,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a5be,58cfa82de4b0c9d6adf6a5be,51c624158a65f338e6b4e9401dff072d.filtered.,WGS,51c624158a65f338e6b4e9401dff072d,51c624158a65f338e6b4e9401dff072d.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a5be,51c624158a65f338e6b4e9401dff072d.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3005-11A,E49A1768-BF1E-49C0-BCA3-4E076928281C,Solid Tissue Normal,Illumina GA,e5b40042-4030-473d-bd3a-f78f8155447a,Blood,45,21E9D305-B94A-4978-8097-AF7BCADDB7BD,F02E1039-61D1-460F-A731-91D178483835,TCGA-AB-3005-11A-01D-0739-09,GRCh37-lite,TCGA-AB-3005,TCGA-LAML,NA,s7136,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6abc8,58cfa82ee4b0c9d6adf6abc8,G32460.TCGA-BT-A3PH-10A-01D-A21Z-08.2.filtered.,WGS,G32460.TCGA-BT-A3PH-10A-01D-A21Z-08.2,G32460.TCGA-BT-A3PH-10A-01D-A21Z-08.2.bam,18.65,NA,0.07,58cfa82ee4b0c9d6adf6abc8,G32460.TCGA-BT-A3PH-10A-01D-A21Z-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A3PH-10A,932BCDD4-5145-49E8-9A95-8A546396F572,Blood Derived Normal,Illumina HiSeq,b3c44d04-1766-41e1-9f24-464ed682c9a3,Bladder,76,59AC02BD-BB4F-42F4-BC5E-8679D7D80D33,F7FFCCE9-2A24-4ABE-8F8C-B9BA6A770803,TCGA-BT-A3PH-10A-01D-A21Z-08,HG19_Broad_variant,TCGA-BT-A3PH,TCGA-BLCA,142,s3261,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa83ce4b0c9d6adf7313a,58cfa83ce4b0c9d6adf7313a,ff180684131876b77d5fa19e93aaeb1e.filtered.,WGS,ff180684131876b77d5fa19e93aaeb1e,ff180684131876b77d5fa19e93aaeb1e.bam,52.23,NA,0.08,58cfa83ce4b0c9d6adf7313a,ff180684131876b77d5fa19e93aaeb1e.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-IW-A3M4-01A,0DA5EE6C-D012-4A57-9992-9D74937AAA5F,Primary Tumor,Illumina HiSeq,62a7d6f2-3b71-4449-83fe-da6beea65873,Mesenchymal,48,F854DB6B-57CB-4DA7-9252-B2ADE22C2675,6AA00162-6294-4CE7-B6B7-0C3452E24CD6,TCGA-IW-A3M4-01A-11D-A21Q-09,GRCh37-lite,TCGA-IW-A3M4,TCGA-SARC,NA,s2673,Washington University School of Medicine,Cedars Sinai,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a4c6,58cfa82de4b0c9d6adf6a4c6,386a617f0cfdad8b10adf2f288e7f89c.filtered.,WGS,386a617f0cfdad8b10adf2f288e7f89c,386a617f0cfdad8b10adf2f288e7f89c.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a4c6,386a617f0cfdad8b10adf2f288e7f89c.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2968-11A,BC93CFF5-A2C9-4FC5-8965-5570574AC1A2,Solid Tissue Normal,Illumina GA,19ec9773-6437-481c-af0b-b46f9020e9ba,Blood,79,4F22261B-2E99-4B22-A2DA-C1BA3ACFE067,2F3495F2-E136-437C-8C9A-A2E01DB92A3E,TCGA-AB-2968-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2968,TCGA-LAML,458,s7100,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa831e4b0c9d6adf6c80b,58cfa831e4b0c9d6adf6c80b,TCGA-CZ-5454-01A-01D-2102-10_wgs_Illumina.filtered.,WGS,TCGA-CZ-5454-01A-01D-2102-10_wgs_Illumina,TCGA-CZ-5454-01A-01D-2102-10_wgs_Illumina.bam,99.4,1.9,0.15,58cfa831e4b0c9d6adf6c80b,TCGA-CZ-5454-01A-01D-2102-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CZ-5454-01A,F2801B21-5444-4CC3-A642-C60C6D82CD3D,Primary Tumor,Illumina HiSeq,c238e952-da1c-4af6-a799-62e9ff477374,Kidney,63,B8CCB09D-ACEB-4069-A911-89663575AB4B,B51FA117-2C0A-4E1D-8EC4-9F039073A486,TCGA-CZ-5454-01A-01D-2102-10,GRCh37-lite,TCGA-CZ-5454,TCGA-KIRC,722,s8843,Baylor College of Medicine,Harvard,None,NO,T2,N0,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa830e4b0c9d6adf6bdaf,58cfa830e4b0c9d6adf6bdaf,TCGA-AF-2689-10A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AF-2689-10A-01D-1989-10_wgs_Illumina,TCGA-AF-2689-10A-01D-1989-10_wgs_Illumina.bam,3.21,1.9,0.14,58cfa830e4b0c9d6adf6bdaf,TCGA-AF-2689-10A-01D-1989-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-AF-2689-10A,335D0351-3740-4847-9FF4-BE2F078C70F7,Blood Derived Normal,Illumina HiSeq,19d9e6e7-cbbd-4061-8ac7-8136966ea6c3,Colorectal,41,DC4852E8-3E77-4D45-8E7E-F9B6EFFF01E4,08537B52-C844-4C28-B746-DCF3A5B7700B,TCGA-AF-2689-10A-01D-1989-10,GRCh37-lite,TCGA-AF-2689,TCGA-READ,NA,s2140,Baylor College of Medicine,Christiana Healthcare,None,NO,T3,N2,Rectal Adenocarcinoma,Stage IV
13722.58cfa82ee4b0c9d6adf6ac70,58cfa82ee4b0c9d6adf6ac70,G47088.TCGA-21-5782-10A-01D-1632-08.1.filtered.,WGS,G47088.TCGA-21-5782-10A-01D-1632-08.1,G47088.TCGA-21-5782-10A-01D-1632-08.1.bam,156.4,1.9,0.05,58cfa82ee4b0c9d6adf6ac70,G47088.TCGA-21-5782-10A-01D-1632-08.1.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-21-5782-10A,E21964B8-47C7-4A5F-BFA7-7206222883D2,Blood Derived Normal,Illumina HiSeq,85e9b05b-b769-4f61-b459-75ae4a557b8b,Lung,68,FB30DAEF-7A1F-4D1E-AA45-DDE6792CD388,50497294-50A7-42E2-B6F7-F5D379589860,TCGA-21-5782-10A-01D-1632-08,HG19_Broad_variant,TCGA-21-5782,TCGA-LUSC,962,s9976,Broad Institute of MIT and Harvard,Fox Chase Cancer Center,United States,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6ab06,58cfa82ee4b0c9d6adf6ab06,G32452.TCGA-C4-A0F7-10A-01D-A10S-08.2.filtered.,WGS,G32452.TCGA-C4-A0F7-10A-01D-A10S-08.2,G32452.TCGA-C4-A0F7-10A-01D-A10S-08.2.bam,16.76,1.82,0.07,58cfa82ee4b0c9d6adf6ab06,G32452.TCGA-C4-A0F7-10A-01D-A10S-08.2.bam,Dead,MALE,Not available,Not available,Bladder Urothelial Carcinoma,Aligned reads,TCGA-C4-A0F7-10A,CA554128-DA9D-4F37-9560-CA083509E01D,Blood Derived Normal,Illumina HiSeq,f9c05a41-994c-402c-b582-8efe6bdf32bd,Bladder,77,87C075A4-3B9A-4048-B63B-C2DAA44B1F2E,DF7BA0BA-91DD-453C-B60B-699994EC4B3B,TCGA-C4-A0F7-10A-01D-A10S-08,HG19_Broad_variant,TCGA-C4-A0F7,TCGA-BLCA,62,s2676,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T4b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa83ce4b0c9d6adf72edb,58cfa83ce4b0c9d6adf72edb,df4a0a1fa966f237f85dc788514a4f3f.filtered.,WGS,df4a0a1fa966f237f85dc788514a4f3f,df4a0a1fa966f237f85dc788514a4f3f.bam,18.8,NA,0.08,58cfa83ce4b0c9d6adf72edb,df4a0a1fa966f237f85dc788514a4f3f.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-EW-A3U0-01A,D9DC3B59-613D-469E-8B4F-6C5A557EB26A,Primary Tumor,Illumina HiSeq,107557e5-5611-4f30-9544-e8c315cb063d,Breast,61,549F03A5-3F91-4975-9EEB-AA062264A602,0448206F-3ADE-4087-B1A9-4FB2D14E1367,TCGA-EW-A3U0-01A-11D-A228-09,GRCh37-lite,TCGA-EW-A3U0,TCGA-BRCA,NA,s6610,Washington University School of Medicine,University of Miami,United States,NO,T3,N1a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82ee4b0c9d6adf6afd4,58cfa82ee4b0c9d6adf6afd4,TCGA-13-0751-10A-01D-0446-08_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-13-0751-10A-01D-0446-08_IlluminaGA-DNASeq_whole,TCGA-13-0751-10A-01D-0446-08_IlluminaGA-DNASeq_whole.bam,50,1.9,0.18,58cfa82ee4b0c9d6adf6afd4,TCGA-13-0751-10A-01D-0446-08_IlluminaGA-DNASeq_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0751-10A,15C84DA3-16E5-4909-AEA9-CB5894B0F8AF,Blood Derived Normal,Illumina GA,6e825e79-f917-4c59-a71d-0187e84f3b5c,Ovary,44,A6D8E038-D346-4837-8203-8D5A14DF98E0,F7803D4B-8F86-40D9-8000-1D8301440CB3,TCGA-13-0751-10A-01D-0446-08,HG18_Broad_variant,TCGA-13-0751,TCGA-OV,1678,s17711,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ab3a,58cfa82ee4b0c9d6adf6ab3a,G32535.TCGA-FK-A3SE-10A-01D-A22D-08.1.filtered.,WGS,G32535.TCGA-FK-A3SE-10A-01D-A22D-08.1,G32535.TCGA-FK-A3SE-10A-01D-A22D-08.1.bam,13.58,NA,0.07,58cfa82ee4b0c9d6adf6ab3a,G32535.TCGA-FK-A3SE-10A-01D-A22D-08.1.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FK-A3SE-10A,AFB00CD4-E5DA-4251-86FB-532C3F65324C,Blood Derived Normal,Illumina HiSeq,c6809e5e-c82f-42dd-88fc-35cdd85f4fa6,Thyroid,31,825C57B2-2516-45DC-A87A-815559620F1E,3537E160-D1B4-40BE-9152-2DB2D8AC8A73,TCGA-FK-A3SE-10A-01D-A22D-08,HG19_Broad_variant,TCGA-FK-A3SE,TCGA-THCA,NA,s12728,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa83ce4b0c9d6adf73192,58cfa83ce4b0c9d6adf73192,e09d2580d7444b508697245a025285cd.filtered.,WGS,e09d2580d7444b508697245a025285cd,e09d2580d7444b508697245a025285cd.bam,NA,NA,NA,58cfa83ce4b0c9d6adf73192,e09d2580d7444b508697245a025285cd.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2964-11A,1C9B389C-4740-449C-A10E-A840E8531E7B,Solid Tissue Normal,Illumina GA,e631649e-21df-440a-85ae-a99a41de267b,Blood,58,5C6071C8-4CED-453D-A8D2-C190F56FA18F,4F7299EC-0EE1-4EB8-88FA-1A5007BAB63A,TCGA-AB-2964-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2964,TCGA-LAML,NA,s7159,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a44c,58cfa82de4b0c9d6adf6a44c,023c722ed278d2ab1cbbeef1bfee4130.filtered.,WGS,023c722ed278d2ab1cbbeef1bfee4130,023c722ed278d2ab1cbbeef1bfee4130.bam,45.87,1.86,0.08,58cfa82de4b0c9d6adf6a44c,023c722ed278d2ab1cbbeef1bfee4130.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E9-A1NH-01A,B2AAC45B-2073-4C7A-ADB9-769A4FDCC111,Primary Tumor,Illumina HiSeq,f57cf947-b314-4a64-a112-d09cc8045594,Breast,71,FB0B2D84-D982-4D3A-9803-36420F2E7E46,13C312EC-0ADD-4758-AB8D-C193E2E08C6D,TCGA-E9-A1NH-01A-11D-A14G-09,GRCh37-lite,TCGA-E9-A1NH,TCGA-BRCA,NA,s6449,Washington University School of Medicine,Asterand,Russia,NO,T2,N1,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa830e4b0c9d6adf6bdea,58cfa830e4b0c9d6adf6bdea,TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole,TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam,73.41,1.97,0.07,58cfa830e4b0c9d6adf6bdea,TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0B9-01A,5A57DC25-D252-4B22-B192-4DE630D7002F,Primary Tumor,Illumina HiSeq,1a49cb56-547c-4a77-84e6-116bc406ba19,Breast,44,8137FFEE-BB4F-4E5F-B831-ACFC9C5585A8,CF599959-6AAF-48EA-8A15-8EF09163BAD7,TCGA-BH-A0B9-01A-11D-A128-09,GRCh37-lite,TCGA-BH-A0B9,TCGA-BRCA,NA,s6770,Washington University School of Medicine,University of Pittsburgh,None,NO,T1c,N0 (i-),Infiltrating Ductal Carcinoma,Stage IA
13722.58cfa82ee4b0c9d6adf6aadc,58cfa82ee4b0c9d6adf6aadc,G32551.TCGA-EE-A2MI-06A-11D-A197-08.1.filtered.,WGS,G32551.TCGA-EE-A2MI-06A-11D-A197-08.1,G32551.TCGA-EE-A2MI-06A-11D-A197-08.1.bam,23.06,NA,0.08,58cfa82ee4b0c9d6adf6aadc,G32551.TCGA-EE-A2MI-06A-11D-A197-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MI-06A,C061AE6C-7A02-47C3-AECD-A56487C01603,Metastatic,Illumina HiSeq,c36be5d8-3083-4522-8eca-2e3a350a57c8,Skin,43,3C7442C7-5655-4D38-AE50-41D4E531CE12,6507E084-C038-4BA6-A431-FB9A53190D5F,TCGA-EE-A2MI-06A-11D-A197-08,HG19_Broad_variant,TCGA-EE-A2MI,TCGA-SKCM,6225,s7988,Broad Institute of MIT and Harvard,University of Sydney,Australia,NO,T4,N0,Not available,Stage IIB
13722.58cfa82ee4b0c9d6adf6b032,58cfa82ee4b0c9d6adf6b032,G47088.TCGA-22-5492-11A-01D-1632-08.1.filtered.,WGS,G47088.TCGA-22-5492-11A-01D-1632-08.1,G47088.TCGA-22-5492-11A-01D-1632-08.1.bam,162.7,1.9,0.05,58cfa82ee4b0c9d6adf6b032,G47088.TCGA-22-5492-11A-01D-1632-08.1.bam,Dead,FEMALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-22-5492-11A,422A46B2-A67C-4A7E-923F-9B651CED96F8,Solid Tissue Normal,Illumina HiSeq,8ee7f488-7eec-4d8c-8a19-53090aaf9c64,Lung,73,6290720A-78CC-4F1B-B315-5A878E5115CD,D888D563-4AF8-4487-9E42-7A4595D962DF,TCGA-22-5492-11A-01D-1632-08,HG19_Broad_variant,TCGA-22-5492,TCGA-LUSC,506,s10364,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,United States,NO,T2a,N2,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa83ce4b0c9d6adf72f79,58cfa83ce4b0c9d6adf72f79,ee6e58f9243e97c6b7acb861103392cc.filtered.,WGS,ee6e58f9243e97c6b7acb861103392cc,ee6e58f9243e97c6b7acb861103392cc.bam,34.41,NA,0.08,58cfa83ce4b0c9d6adf72f79,ee6e58f9243e97c6b7acb861103392cc.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-IG-A3YB-01A,A1A233EA-5DDA-4EEB-BD92-6667E8B3EF57,Primary Tumor,HiSeq X Ten,aacb012c-83e2-49b5-b5cd-41c6f2e824ca,Esophagus,61,F936DE42-1441-4C4C-882A-DC67D332C125,E9FE8F50-5356-4F40-A351-34EA4F99E438,TCGA-IG-A3YB-01A-11D-A247-09,GRCh37-lite_WUGSC_variant_2,TCGA-IG-A3YB,TCGA-ESCA,NA,s1708,Washington University School of Medicine,Asterand,Russia,NO,T3,N1,Not available,Stage IIIA
13722.58cfa83ce4b0c9d6adf731b8,58cfa83ce4b0c9d6adf731b8,b063d293e0df48fc160fc08c84c39531.filtered.,WGS,b063d293e0df48fc160fc08c84c39531,b063d293e0df48fc160fc08c84c39531.bam,9.71,NA,0.08,58cfa83ce4b0c9d6adf731b8,b063d293e0df48fc160fc08c84c39531.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A3LW-01A,2CACD9D0-8414-4F17-8259-C9D838597F39,Primary Tumor,Illumina HiSeq,0524db0d-7118-4575-ae31-3f7ebbf000c4,Mesenchymal,43,E25B5088-A3D4-4F3C-8335-308C571F6A30,9D691FA3-5C32-4B98-85C4-F6E0FD4C37E0,TCGA-DX-A3LW-01A-21D-A21Q-09,GRCh37-lite,TCGA-DX-A3LW,TCGA-SARC,NA,s2460,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a4f2,58cfa82de4b0c9d6adf6a4f2,445b94f3224dfee84be46e62087a593c.filtered.,WGS,445b94f3224dfee84be46e62087a593c,445b94f3224dfee84be46e62087a593c.bam,38.02,NA,0.08,58cfa82de4b0c9d6adf6a4f2,445b94f3224dfee84be46e62087a593c.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-L7-A6VZ-10A,DC4062D7-1C81-4B19-AABD-8307A0DF5029,Blood Derived Normal,HiSeq X Ten,58c8aeb2-28a7-478b-a5cf-f9db1db36323,Esophagus,62,E4046766-E08C-4F74-8528-EF45CE597C73,B8F11B6F-EB01-4F1C-910E-3B713B5C0AA5,TCGA-L7-A6VZ-10A-01D-A33H-09,GRCh37-lite_WUGSC_variant_2,TCGA-L7-A6VZ,TCGA-ESCA,NA,s1711,Washington University School of Medicine,Christiana Care,United States,NO,T3,N3,Not available,Stage IIIC
13722.58cfa82de4b0c9d6adf6a618,58cfa82de4b0c9d6adf6a618,5c56d50bef568c9257651f615ec606b3.filtered.,WGS,5c56d50bef568c9257651f615ec606b3,5c56d50bef568c9257651f615ec606b3.bam,70.96,1.93,0.08,58cfa82de4b0c9d6adf6a618,5c56d50bef568c9257651f615ec606b3.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-EW-A1PH-01A,4DA999A0-EF41-4A0B-B1D1-446B39CC855A,Primary Tumor,Illumina HiSeq,877bbc2d-444f-44cf-8e0f-3fd2744c3f91,Breast,52,DD38BA60-656A-46F7-B22B-BCEE3B6D2F19,DF291849-4C35-44E1-B013-8F6B7EE36113,TCGA-EW-A1PH-01A-11D-A17G-09,GRCh37-lite,TCGA-EW-A1PH,TCGA-BRCA,NA,s5951,Washington University School of Medicine,University of Miami,United States,NO,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6bcba,58cfa830e4b0c9d6adf6bcba,TCGA-B0-5693-11A-01D-2103-10_wgs_Illumina.filtered.,WGS,TCGA-B0-5693-11A-01D-2103-10_wgs_Illumina,TCGA-B0-5693-11A-01D-2103-10_wgs_Illumina.bam,63.4,1.9,0.15,58cfa830e4b0c9d6adf6bcba,TCGA-B0-5693-11A-01D-2103-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-B0-5693-11A,DB058EB4-9C5E-4226-92D1-DE24AEA83630,Solid Tissue Normal,Illumina HiSeq,b074b823-3ed4-4be0-88a0-c2fa8d7b01f5,Kidney,47,B979834C-CF76-4ED1-854B-667C35891628,63981C0A-83F9-4CB1-B28A-02C60ADAF923,TCGA-B0-5693-11A-01D-2103-10,GRCh37-lite,TCGA-B0-5693,TCGA-KIRC,NA,s8834,Baylor College of Medicine,University of Pittsburgh,None,NO,T1b,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ab58,58cfa82ee4b0c9d6adf6ab58,G37566.TCGA-CH-5789-10A-01D-1576-08.1.filtered.,WGS,G37566.TCGA-CH-5789-10A-01D-1576-08.1,G37566.TCGA-CH-5789-10A-01D-1576-08.1.bam,79.4,1.9,0.05,58cfa82ee4b0c9d6adf6ab58,G37566.TCGA-CH-5789-10A-01D-1576-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5789-10A,BE5411DC-3CAA-4B25-9B94-CE463E8E52B4,Blood Derived Normal,Illumina HiSeq,834487d2-4198-43c2-b567-02b05a6d52f9,Prostate,61,A5CDDC99-2677-4876-8070-F0260FC30BCD,CE3A5AF9-17C9-4195-8DA2-1BEE4BAC3CAC,TCGA-CH-5789-10A-01D-1576-08,HG19_Broad_variant,TCGA-CH-5789,TCGA-PRAD,NA,s4124,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c4a8,58cfa831e4b0c9d6adf6c4a8,TCGA-BP-4327-11A-01D-1995-10_wgs_Illumina.filtered.,WGS,TCGA-BP-4327-11A-01D-1995-10_wgs_Illumina,TCGA-BP-4327-11A-01D-1995-10_wgs_Illumina.bam,50,1.9,0.16,58cfa831e4b0c9d6adf6c4a8,TCGA-BP-4327-11A-01D-1995-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-BP-4327-11A,9B84D013-713B-4571-888C-12863FDD4A52,Solid Tissue Normal,Illumina HiSeq,066f6732-bace-4e90-bce8-ce46b8322ef9,Kidney,75,368FE1ED-B9EB-44DA-AF40-55E065A4B3D2,C17E6D3F-A923-4A87-B220-27D1B0184420,TCGA-BP-4327-11A-01D-1995-10,GRCh37-lite,TCGA-BP-4327,TCGA-KIRC,109,s9448,Baylor College of Medicine,MSKCC,None,NO,T2,N0,Kidney Clear Cell Renal Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6af40,58cfa82ee4b0c9d6adf6af40,G47088.TCGA-85-8052-10A-01D-2244-08.3.filtered.,WGS,G47088.TCGA-85-8052-10A-01D-2244-08.3,G47088.TCGA-85-8052-10A-01D-2244-08.3.bam,453.33,NA,0.05,58cfa82ee4b0c9d6adf6af40,G47088.TCGA-85-8052-10A-01D-2244-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-85-8052-10A,395BABB3-3F5D-4E71-A675-AF4443F23028,Blood Derived Normal,Illumina HiSeq,c14aca9a-a861-446f-99a0-abc907e4516b,Lung,53,0E88DB42-469A-4BDA-9EF0-BF33A0CA5444,B8E72D67-3FC5-499D-ACC8-9F7174989DFE,TCGA-85-8052-10A-01D-2244-08,HG19_Broad_variant,TCGA-85-8052,TCGA-LUSC,NA,s10076,Broad Institute of MIT and Harvard,Asterand,Russia,NO,T3,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6a8fa,58cfa82ee4b0c9d6adf6a8fa,G32555.TCGA-DA-A1IC-06A-11D-A197-08.1.filtered.,WGS,G32555.TCGA-DA-A1IC-06A-11D-A197-08.1,G32555.TCGA-DA-A1IC-06A-11D-A197-08.1.bam,43.33,NA,0.08,58cfa82ee4b0c9d6adf6a8fa,G32555.TCGA-DA-A1IC-06A-11D-A197-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1IC-06A,6625CE3F-3A1F-45F9-AA42-AB1931D6DAF4,Metastatic,Illumina HiSeq,bdd7c2f0-1c47-4c40-bde5-745c17b0824a,Skin,81,B9FDDA29-EBD4-4B0B-A8DA-555BA05D3567,6920FD0A-82BB-43A4-BC78-C29C42961148,TCGA-DA-A1IC-06A-11D-A197-08,HG19_Broad_variant,TCGA-DA-A1IC,TCGA-SKCM,NA,s7655,Broad Institute of MIT and Harvard,Yale,United States,NO,T3a,N2c,Not available,Stage IIIB
13722.58cfa831e4b0c9d6adf6c79b,58cfa831e4b0c9d6adf6c79b,TCGA-CV-6433-11A-01D-2276-10_Illumina.filtered.,WGS,TCGA-CV-6433-11A-01D-2276-10_Illumina,TCGA-CV-6433-11A-01D-2276-10_Illumina.bam,16.33,1.7,0.05,58cfa831e4b0c9d6adf6c79b,TCGA-CV-6433-11A-01D-2276-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6433-11A,D5EEDFB5-4FA3-4A1E-AD0D-EA550B22A5BA,Solid Tissue Normal,Illumina HiSeq,3d294c7d-40cc-48ed-a436-c0a0b44ef8b9,Head and Neck,57,5E2DC8CE-9F72-4AAB-BFDB-C2C09EEE1AEE,EACADA84-BC54-4C03-879B-B290B7F6AA78,TCGA-CV-6433-11A-01D-2276-10,GRCh37-lite,TCGA-CV-6433,TCGA-HNSC,NA,s16191,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6a966,58cfa82ee4b0c9d6adf6a966,G35154.TCGA-HW-7487-01A-11D-2024-08.3.filtered.,WGS,G35154.TCGA-HW-7487-01A-11D-2024-08.3,G35154.TCGA-HW-7487-01A-11D-2024-08.3.bam,85,NA,0.05,58cfa82ee4b0c9d6adf6a966,G35154.TCGA-HW-7487-01A-11D-2024-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HW-7487-01A,42251E02-B687-4BF1-A1B6-E3DD978542E4,Primary Tumor,Illumina HiSeq,efb882b9-fe40-4205-a704-5757740ee898,Brain,39,3040F10C-04E1-4CF8-8EAD-D74C856425C8,C1ABB741-4FCD-4161-B057-C7EFD619CC99,TCGA-HW-7487-01A-11D-2024-08,HG19_Broad_variant,TCGA-HW-7487,TCGA-LGG,NA,s8550,Broad Institute of MIT and Harvard,MSKCC,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa830e4b0c9d6adf6bf06,58cfa830e4b0c9d6adf6bf06,TCGA-BP-4781-11A-01D-2098-10_wgs_Illumina.filtered.,WGS,TCGA-BP-4781-11A-01D-2098-10_wgs_Illumina,TCGA-BP-4781-11A-01D-2098-10_wgs_Illumina.bam,38.07,1.9,0.14,58cfa830e4b0c9d6adf6bf06,TCGA-BP-4781-11A-01D-2098-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-BP-4781-11A,80C4FC5B-DC7D-4308-8C81-6E83625963B5,Solid Tissue Normal,Illumina HiSeq,96708aae-6010-4ac1-9205-6250224f0c17,Kidney,78,8E0FAB88-BC44-4BCF-8EFC-91B5B181205A,0BEE9546-3E35-47AF-8F24-8507FBFB2F07,TCGA-BP-4781-11A-01D-2098-10,GRCh37-lite,TCGA-BP-4781,TCGA-KIRC,NA,s9304,Baylor College of Medicine,MSKCC,None,NO,T1a,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bf0a,58cfa830e4b0c9d6adf6bf0a,TCGA-BP-5168-11A-01D-2099-10_Illumina.filtered.,WGS,TCGA-BP-5168-11A-01D-2099-10_Illumina,TCGA-BP-5168-11A-01D-2099-10_Illumina.bam,124.4,1.9,0.16,58cfa830e4b0c9d6adf6bf0a,TCGA-BP-5168-11A-01D-2099-10_Illumina.bam,Dead,MALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-BP-5168-11A,781ACAFA-A58B-4180-BBCA-C5B675D51B17,Solid Tissue Normal,Illumina HiSeq,c640e03a-6d0b-4ddd-9ed1-43fd1242a49c,Kidney,75,11489782-62C8-4E66-B7BC-8D616BF58776,F70E4AE3-2349-415B-B48D-CB60EF648984,TCGA-BP-5168-11A-01D-2099-10,GRCh37-lite,TCGA-BP-5168,TCGA-KIRC,1463,s9165,Baylor College of Medicine,MSKCC,None,NO,T1a,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82fe4b0c9d6adf6ba3b,58cfa82fe4b0c9d6adf6ba3b,TCGA-A6-3807-10A-01D-1459-10_wgs_Illumina.filtered.,WGS,TCGA-A6-3807-10A-01D-1459-10_wgs_Illumina,TCGA-A6-3807-10A-01D-1459-10_wgs_Illumina.bam,1.2,1.9,0.05,58cfa82fe4b0c9d6adf6ba3b,TCGA-A6-3807-10A-01D-1459-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-3807-10A,5116E3B4-2BAC-40F5-8046-B9C1783FAAA5,Blood Derived Normal,Illumina HiSeq,1555806c-03b9-4392-b3ab-82a34f015b0d,Colorectal,53,F7D79CFA-E8AB-4023-85A3-34C12CA78C7B,C07AB48C-B3ED-405C-9813-5E2B69ABF492,TCGA-A6-3807-10A-01D-1459-10,GRCh37-lite,TCGA-A6-3807,TCGA-COAD,NA,s13170,Baylor College of Medicine,Christiana Healthcare,None,NO,T3,N2,Colon Adenocarcinoma,Stage IIIC
13722.58cfa82de4b0c9d6adf6a60c,58cfa82de4b0c9d6adf6a60c,749ef764c5fcf5ac98cf3e0086566a41.filtered.,WGS,749ef764c5fcf5ac98cf3e0086566a41,749ef764c5fcf5ac98cf3e0086566a41.bam,7.51,NA,0.08,58cfa82de4b0c9d6adf6a60c,749ef764c5fcf5ac98cf3e0086566a41.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A1L3-01A,9517413B-B5B8-4130-8BA1-D86D44ABE2EC,Primary Tumor,Illumina HiSeq,f5fa948e-2119-4b86-8bc3-7ef737ffdffe,Mesenchymal,60,19A45767-ABF7-4D53-B096-B59847FC47A8,18EC066E-8510-4921-9E35-45D85FB01E38,TCGA-DX-A1L3-01A-11D-A24N-09,GRCh37-lite,TCGA-DX-A1L3,TCGA-SARC,NA,s2347,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a640,58cfa82de4b0c9d6adf6a640,7a02be700709d5daf6393100f819a952.filtered.,WGS,7a02be700709d5daf6393100f819a952,7a02be700709d5daf6393100f819a952.bam,51.59,NA,0.08,58cfa82de4b0c9d6adf6a640,7a02be700709d5daf6393100f819a952.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A2J0-01A,2FF6AEDE-7BCD-440B-99AB-7A023FAF658E,Primary Tumor,Illumina HiSeq,99a5bf7b-7b43-4753-ac23-1a777776a1dc,Mesenchymal,61,A8673BA9-EF34-42CA-A73E-1EFB4F186E88,CB783F8B-D092-4104-B809-3F90B19DF7DF,TCGA-DX-A2J0-01A-11D-A21Q-09,GRCh37-lite,TCGA-DX-A2J0,TCGA-SARC,295,s2346,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6ac10,58cfa82ee4b0c9d6adf6ac10,G39019.TCGA-D3-A3MO-10A-01D-A21A-08.2.filtered.,WGS,G39019.TCGA-D3-A3MO-10A-01D-A21A-08.2,G39019.TCGA-D3-A3MO-10A-01D-A21A-08.2.bam,17.01,NA,0.08,58cfa82ee4b0c9d6adf6ac10,G39019.TCGA-D3-A3MO-10A-01D-A21A-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A3MO-10A,85400BF1-23E0-4E0F-8DF7-F0D108641AEE,Blood Derived Normal,Illumina HiSeq,d0823cd7-aa05-4821-b9f7-753bb1af905c,Skin,47,9466E1F0-4649-4CE0-9C1C-2B665ADE3888,46EE8BA7-EF58-4B4C-913C-9507E7A9D7E2,TCGA-D3-A3MO-10A-01D-A21A-08,HG19_Broad_variant,TCGA-D3-A3MO,TCGA-SKCM,284,s7816,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,TX,N2c,Not available,Stage III
13722.58cfa82ee4b0c9d6adf6ab84,58cfa82ee4b0c9d6adf6ab84,G32547.TCGA-EE-A3JI-10A-01D-A21A-08.1.filtered.,WGS,G32547.TCGA-EE-A3JI-10A-01D-A21A-08.1,G32547.TCGA-EE-A3JI-10A-01D-A21A-08.1.bam,13.46,NA,0.08,58cfa82ee4b0c9d6adf6ab84,G32547.TCGA-EE-A3JI-10A-01D-A21A-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A3JI-10A,296F44F9-3ECB-4B40-AE51-C3A06E3FBE00,Blood Derived Normal,Illumina HiSeq,0b8ed608-eb00-446c-86f0-e1839b752838,Skin,48,3E3B6F2F-A188-451C-85DA-7304DB3F5335,0EDF2345-54A0-4961-A497-B6F9837519AA,TCGA-EE-A3JI-10A-01D-A21A-08,HG19_Broad_variant,TCGA-EE-A3JI,TCGA-SKCM,NA,s7809,Broad Institute of MIT and Harvard,University of Sydney,Australia,NO,T2,N0,Not available,Stage I
13722.58cfa82de4b0c9d6adf6a535,58cfa82de4b0c9d6adf6a535,4d34550076e0e5e5f628e1f2d531963f.filtered.,WGS,4d34550076e0e5e5f628e1f2d531963f,4d34550076e0e5e5f628e1f2d531963f.bam,58.16,2,0.07,58cfa82de4b0c9d6adf6a535,4d34550076e0e5e5f628e1f2d531963f.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A0D4-01A,75113445-D2D6-44A0-866C-C9175E6D214B,Primary Tumor,Illumina HiSeq,ac8422e5-dfeb-40c6-ab1f-dddd9f7fb015,Breast,37,ACE39EF3-1B5E-4AD2-A20D-62957E524281,2B000AF3-2C9D-4EAA-AF3F-8101B7425C37,TCGA-A2-A0D4-01A-11D-A314-09,GRCh37-lite,TCGA-A2-A0D4,TCGA-BRCA,NA,s6624,Washington University School of Medicine,Walter Reed,None,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa83ce4b0c9d6adf73142,58cfa83ce4b0c9d6adf73142,e9efaac16efc09098f681fd6fdda9266.filtered.,WGS,e9efaac16efc09098f681fd6fdda9266,e9efaac16efc09098f681fd6fdda9266.bam,31.62,NA,0.08,58cfa83ce4b0c9d6adf73142,e9efaac16efc09098f681fd6fdda9266.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A3LS-01A,39F68467-3D37-4B19-AA43-ED7B120C619D,Primary Tumor,Illumina HiSeq,c94a5ebc-7224-41b0-96e9-6b057d782253,Mesenchymal,78,386455AA-441E-4BD2-A0A7-AD2ED278E5E6,075FC96D-6742-4EF3-9369-482592AD3A2F,TCGA-DX-A3LS-01A-11D-A21Q-09,GRCh37-lite,TCGA-DX-A3LS,TCGA-SARC,275,s2471,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6a8f0,58cfa82ee4b0c9d6adf6a8f0,G32556.TCGA-FS-A1ZU-10A-01D-A198-08.5.filtered.,WGS,G32556.TCGA-FS-A1ZU-10A-01D-A198-08.5,G32556.TCGA-FS-A1ZU-10A-01D-A198-08.5.bam,9.61,NA,0.07,58cfa82ee4b0c9d6adf6a8f0,G32556.TCGA-FS-A1ZU-10A-01D-A198-08.5.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZU-10A,7CE09A09-074E-4F38-BED7-98AB34347FBE,Blood Derived Normal,Illumina HiSeq,4409b987-7d04-4a4b-ba35-707905f5221d,Skin,70,A1C75C9E-F4DC-448A-B19B-15C68CA20355,7A49B1E5-5FB7-4A7E-85BA-F4C357089023,TCGA-FS-A1ZU-10A-01D-A198-08,HG19_Broad_variant,TCGA-FS-A1ZU,TCGA-SKCM,808,s7306,Broad Institute of MIT and Harvard,Essen,Germany,NO,T4b,N0,Not available,Stage IIC
13722.58cfa82de4b0c9d6adf6a5c2,58cfa82de4b0c9d6adf6a5c2,6f7bad1693a63ab40a5814d9e1f48cd1.filtered.,WGS,6f7bad1693a63ab40a5814d9e1f48cd1,6f7bad1693a63ab40a5814d9e1f48cd1.bam,45.64,NA,0.07,58cfa82de4b0c9d6adf6a5c2,6f7bad1693a63ab40a5814d9e1f48cd1.bam,Alive,MALE,ASIAN,Not available,Esophageal Carcinoma,Aligned reads,TCGA-JY-A93C-01A,BCAB5381-C037-4723-904E-D01EA386B61E,Primary Tumor,HiSeq X Ten,f40bd795-e3fd-4b01-8274-cbf71a9edfa6,Esophagus,47,56E9E53A-431A-4CF5-B39E-0C972550BA4E,E330A3A7-6BE8-48B5-BB3C-1E4D1B75A6A6,TCGA-JY-A93C-01A-11D-A387-09,GRCh37-lite_WUGSC_variant_2,TCGA-JY-A93C,TCGA-ESCA,NA,s1905,Washington University School of Medicine,University Health Network,Canada,NO,T3,N2,Not available,Stage IIIB
13722.58cfa830e4b0c9d6adf6bcbd,58cfa830e4b0c9d6adf6bcbd,TCGA-B0-5693-01A-11D-2103-10_Illumina.filtered.,WGS,TCGA-B0-5693-01A-11D-2103-10_Illumina,TCGA-B0-5693-01A-11D-2103-10_Illumina.bam,344.4,1.9,0.14,58cfa830e4b0c9d6adf6bcbd,TCGA-B0-5693-01A-11D-2103-10_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-B0-5693-01A,DB058EB4-9C5E-4226-92D1-DE24AEA83630,Primary Tumor,Illumina HiSeq,4a0c2db0-f10b-41b1-8aca-fcd712b7f672,Kidney,47,20A21A6F-F615-47F7-9935-B330B116D51B,FB194CA3-10AA-4DC5-8D08-619DDBD6D1B6,TCGA-B0-5693-01A-11D-2103-10,GRCh37-lite,TCGA-B0-5693,TCGA-KIRC,NA,s9937,Baylor College of Medicine,University of Pittsburgh,None,NO,T1b,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6abf9,58cfa82ee4b0c9d6adf6abf9,G37566.TCGA-EJ-7791-10A-01D-2115-08.2.filtered.,WGS,G37566.TCGA-EJ-7791-10A-01D-2115-08.2,G37566.TCGA-EJ-7791-10A-01D-2115-08.2.bam,398.6,NA,0.05,58cfa82ee4b0c9d6adf6abf9,G37566.TCGA-EJ-7791-10A-01D-2115-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7791-10A,4FE004E5-49F9-4336-A690-6EBAD512C813,Blood Derived Normal,Illumina HiSeq,3a9a4363-1e8b-44af-ac8d-ca5532f1ed07,Prostate,67,CFC53498-89EF-43C7-B3D3-483DC09C1A58,9AC76378-8EA0-4911-B4F2-043DB4179A44,TCGA-EJ-7791-10A-01D-2115-08,HG19_Broad_variant,TCGA-EJ-7791,TCGA-PRAD,NA,s3926,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa83ce4b0c9d6adf72f0d,58cfa83ce4b0c9d6adf72f0d,b1b5f931c81fbd7859691665e3448ee8.filtered.,WGS,b1b5f931c81fbd7859691665e3448ee8,b1b5f931c81fbd7859691665e3448ee8.bam,7.27,NA,0.08,58cfa83ce4b0c9d6adf72f0d,b1b5f931c81fbd7859691665e3448ee8.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A1L0-01A,854E42BC-95B2-4B77-A4B2-FFBD6C28B281,Primary Tumor,Illumina HiSeq,f7205545-f757-4561-b291-cfe76e7014de,Mesenchymal,58,87E0C11A-CF75-4877-B4C8-23AA36631B4F,1C188BF5-2C99-4EB4-A774-59C75D53E643,TCGA-DX-A1L0-01A-11D-A24N-09,GRCh37-lite,TCGA-DX-A1L0,TCGA-SARC,564,s2461,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6ab32,58cfa82ee4b0c9d6adf6ab32,G32550.TCGA-EE-A3J5-10A-01D-A20D-08.1.filtered.,WGS,G32550.TCGA-EE-A3J5-10A-01D-A20D-08.1,G32550.TCGA-EE-A3J5-10A-01D-A20D-08.1.bam,14.99,NA,0.07,58cfa82ee4b0c9d6adf6ab32,G32550.TCGA-EE-A3J5-10A-01D-A20D-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A3J5-10A,D6283AB0-9019-4AD2-93AA-2E6B39CD9641,Blood Derived Normal,Illumina HiSeq,5c41f54e-d46e-41ba-aa0f-6980664adfc5,Skin,71,19787591-5EDB-4224-A860-85AACAB17B5C,C96762C7-78D0-49B8-A731-23B9158A0F5F,TCGA-EE-A3J5-10A-01D-A20D-08,HG19_Broad_variant,TCGA-EE-A3J5,TCGA-SKCM,1124,s7310,Broad Institute of MIT and Harvard,University of Sydney,Australia,NO,T4a,N1,Not available,Stage III
13722.58cfa82ee4b0c9d6adf6aa80,58cfa82ee4b0c9d6adf6aa80,G32533.TCGA-EM-A3FQ-01A-11D-A21A-08.3.filtered.,WGS,G32533.TCGA-EM-A3FQ-01A-11D-A21A-08.3,G32533.TCGA-EM-A3FQ-01A-11D-A21A-08.3.bam,10.98,NA,0.08,58cfa82ee4b0c9d6adf6aa80,G32533.TCGA-EM-A3FQ-01A-11D-A21A-08.3.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3FQ-01A,FEF9C64F-5959-4DA0-AAA2-66B56FC7B4C3,Primary Tumor,Illumina HiSeq,dbbab09c-382c-48f0-aeca-e5ec1cc0c948,Thyroid,19,4F88157A-572E-4236-B956-206A9E227DEB,79133E29-BA0B-4E2F-A6D9-BF294C5144F0,TCGA-EM-A3FQ-01A-11D-A21A-08,HG19_Broad_variant,TCGA-EM-A3FQ,TCGA-THCA,NA,s12731,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T3,N1b,Other  specify,Stage I
13722.58cfa82de4b0c9d6adf6a49a,58cfa82de4b0c9d6adf6a49a,1d2f2091a246a644d3f997d0edfd860a.filtered.,WGS,1d2f2091a246a644d3f997d0edfd860a,1d2f2091a246a644d3f997d0edfd860a.bam,17.4,1.97,0.08,58cfa82de4b0c9d6adf6a49a,1d2f2091a246a644d3f997d0edfd860a.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A0EY-01A,D67CD793-2931-429A-9084-2F3C4C8BE7AD,Primary Tumor,Illumina HiSeq,79cc669f-41ce-4384-ac00-fe94ad0c8cd5,Breast,62,2A3E4DBB-AAFF-4B14-BBED-F2D7CF0F8FA3,01658141-8398-4585-9F0F-8355DD9B0604,TCGA-A2-A0EY-01A-11D-A19H-09,GRCh37-lite,TCGA-A2-A0EY,TCGA-BRCA,NA,s5947,Washington University School of Medicine,Walter Reed,None,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa830e4b0c9d6adf6bd09,58cfa830e4b0c9d6adf6bd09,TCGA-AB-2972-03A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2972-03A-01D-0739-09_whole,TCGA-AB-2972-03A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bd09,TCGA-AB-2972-03A-01D-0739-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2972-03A,A436F4D7-018E-44E3-A615-9C33FCC1167D,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,b7aa4812-0263-4758-b08c-a043fde9bce1,Blood,82,56F40052-1F82-4E6D-98AB-6E5E132D59A4,6A7DEACE-79DC-4790-A415-07F0E933EB2A,TCGA-AB-2972-03A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2972,TCGA-LAML,30,s7086,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a5b3,58cfa82de4b0c9d6adf6a5b3,551a836dfba4ddbf7b7859a2395b7794.filtered.,WGS,551a836dfba4ddbf7b7859a2395b7794,551a836dfba4ddbf7b7859a2395b7794.bam,30.4,NA,0.09,58cfa82de4b0c9d6adf6a5b3,551a836dfba4ddbf7b7859a2395b7794.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A3M1-01A,B85E2156-D5AC-486C-93E1-86525EA41A64,Primary Tumor,Illumina HiSeq,bb1d2bd3-0664-4d25-a029-9fe225b91c2e,Mesenchymal,79,1AFCDB32-AE26-4747-A131-54E83DD84A46,72F0A49A-AEC8-47E5-846A-956C4DA1507C,TCGA-DX-A3M1-01A-11D-A228-09,GRCh37-lite,TCGA-DX-A3M1,TCGA-SARC,NA,s2338,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72eec,58cfa83ce4b0c9d6adf72eec,c534a6067d905cfcfadc6f4904b00db2.filtered.,WGS,c534a6067d905cfcfadc6f4904b00db2,c534a6067d905cfcfadc6f4904b00db2.bam,66.44,NA,0.08,58cfa83ce4b0c9d6adf72eec,c534a6067d905cfcfadc6f4904b00db2.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A5U5-01A,656E3C14-1FC6-473A-813E-719753E7B408,Primary Tumor,HiSeq X Ten,ee1ac793-ea1f-44e4-b8e4-602c608c3589,Esophagus,57,945DA36D-32AD-4996-9D77-BE6D09B858F9,83E92F18-198E-46BC-B4BE-F3B867579909,TCGA-LN-A5U5-01A-21D-A28B-09,GRCh37-lite_WUGSC_variant_2,TCGA-LN-A5U5,TCGA-ESCA,NA,s1804,Washington University School of Medicine,ILSbio,Vietnam,NO,T3,N1,Not available,Stage IV
13722.58cfa82de4b0c9d6adf6a45e,58cfa82de4b0c9d6adf6a45e,0d0eb9566151eb04d98adcfbb7299d9a.filtered.,WGS,0d0eb9566151eb04d98adcfbb7299d9a,0d0eb9566151eb04d98adcfbb7299d9a.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a45e,0d0eb9566151eb04d98adcfbb7299d9a.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3011-11A,E08F84FE-0013-4734-9966-CD734E6FEDC5,Solid Tissue Normal,Illumina GA,94f9b703-99a4-4113-9ef3-dc03f468025e,Blood,21,73927E31-3D17-4871-A7E6-6D1AE82421E7,53089A3E-4B9F-4C04-AC13-B972213961F1,TCGA-AB-3011-11A-01D-0739-09,GRCh37-lite,TCGA-AB-3011,TCGA-LAML,NA,s7160,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6ac3f,58cfa82ee4b0c9d6adf6ac3f,G39019.TCGA-DA-A1HW-10A-01D-A19A-08.2.filtered.,WGS,G39019.TCGA-DA-A1HW-10A-01D-A19A-08.2,G39019.TCGA-DA-A1HW-10A-01D-A19A-08.2.bam,18.18,NA,0.08,58cfa82ee4b0c9d6adf6ac3f,G39019.TCGA-DA-A1HW-10A-01D-A19A-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1HW-10A,800D3A17-269F-4D97-94FF-8585F20038D8,Blood Derived Normal,Illumina HiSeq,a57e269c-5066-4ba4-aa74-2fc7712fe4f1,Skin,37,8A27E6E0-A444-4701-B052-041F90267A69,33F2B633-1489-4934-A556-19CC41FC0841,TCGA-DA-A1HW-10A-01D-A19A-08,HG19_Broad_variant,TCGA-DA-A1HW,TCGA-SKCM,NA,s7487,Broad Institute of MIT and Harvard,Yale,United States,NO,T1a,N1b,Not available,Stage IIIB
13722.58cfa82de4b0c9d6adf6a45b,58cfa82de4b0c9d6adf6a45b,46558eada33c446ae8c1b02d32740dab.filtered.,WGS,46558eada33c446ae8c1b02d32740dab,46558eada33c446ae8c1b02d32740dab.bam,31.03,NA,0.08,58cfa82de4b0c9d6adf6a45b,46558eada33c446ae8c1b02d32740dab.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-IS-A3KA-01A,257DC623-41E1-4FA3-859C-C787DB10BD60,Primary Tumor,Illumina HiSeq,5c922de0-6304-416e-a0aa-1a0cb42f0938,Mesenchymal,73,F8495459-CAF7-47CA-9B6A-7FE11FF1BA11,D8F0BECD-FDA8-41F4-A424-E082F9EAE22C,TCGA-IS-A3KA-01A-11D-A21Q-09,GRCh37-lite,TCGA-IS-A3KA,TCGA-SARC,413,s2485,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf73055,58cfa83ce4b0c9d6adf73055,a0f11cd660016ab9419ba4f9328b0535.filtered.,WGS,a0f11cd660016ab9419ba4f9328b0535,a0f11cd660016ab9419ba4f9328b0535.bam,397.67,1.9,0.15,58cfa83ce4b0c9d6adf73055,a0f11cd660016ab9419ba4f9328b0535.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1103-01A,F34AA3B6-E966-49C6-BC55-130545772C53,Primary Tumor,Illumina GA,79a16cdc-55f3-47fb-ad24-660a0db20b63,Ovary,50,6F9A6F73-285D-4A9C-80EB-5F2EBC1787A4,2C9DC04B-E9EC-4CF1-AB2C-A18EDB30DD37,TCGA-24-1103-01A-01D-0515-09,GRCh37-lite,TCGA-24-1103,TCGA-OV,1646,s17651,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6beaf,58cfa830e4b0c9d6adf6beaf,TCGA-AG-3901-10A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AG-3901-10A-01D-1989-10_wgs_Illumina,TCGA-AG-3901-10A-01D-1989-10_wgs_Illumina.bam,44.59,1.9,0.16,58cfa830e4b0c9d6adf6beaf,TCGA-AG-3901-10A-01D-1989-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3901-10A,1586CB0A-081A-4364-9470-46F9D0F0167D,Blood Derived Normal,Illumina HiSeq,7d37bd53-74f6-423f-9409-7049f1460546,Colorectal,67,339F4C4C-C973-40F0-85EC-C244987AA9C1,B917E5AE-2CEF-4A65-B187-1A05D77E66A6,TCGA-AG-3901-10A-01D-1989-10,GRCh37-lite,TCGA-AG-3901,TCGA-READ,NA,s2158,Baylor College of Medicine,Indivumed,Germany,NO,T3,N1,Rectal Mucinous Adenocarcinoma,Stage IIIB
13722.58cfa83ce4b0c9d6adf731cc,58cfa83ce4b0c9d6adf731cc,c60fa4aad576f1b3b720d3433a80345f.filtered.,WGS,c60fa4aad576f1b3b720d3433a80345f,c60fa4aad576f1b3b720d3433a80345f.bam,13.75,NA,0.07,58cfa83ce4b0c9d6adf731cc,c60fa4aad576f1b3b720d3433a80345f.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A3LY-01B,3505F91D-BC66-4732-84B6-18C5B32CA6B8,Primary Tumor,Illumina HiSeq,0f2523c6-fd2e-49ae-b8d1-eb4f0fd50867,Mesenchymal,66,A5697D2C-8E1A-42BE-8EBF-E57D6919BA65,DF4366C4-170F-4233-B577-A8EA277B069C,TCGA-DX-A3LY-01B-11D-A27P-09,GRCh37-lite,TCGA-DX-A3LY,TCGA-SARC,NA,s2629,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf73156,58cfa83ce4b0c9d6adf73156,a950fe8710031ec1f4934aa97d1d2437.filtered.,WGS,a950fe8710031ec1f4934aa97d1d2437,a950fe8710031ec1f4934aa97d1d2437.bam,96.72,1.83,0.07,58cfa83ce4b0c9d6adf73156,a950fe8710031ec1f4934aa97d1d2437.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TD-01A,FFAA98A0-2B69-46DC-AEE5-C5C3F2ABBC38,Primary Tumor,Illumina HiSeq,d09c860a-701a-48f3-bace-b479e65e7493,Uterus,65,8BB3A057-8958-4F62-AF81-976DA2E92DF7,712BA532-FB1A-43FA-A356-B446B509CEB7,TCGA-BS-A0TD-01A-11D-A10B-09,GRCh37-lite,TCGA-BS-A0TD,TCGA-UCEC,NA,s5179,Washington University School of Medicine,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6afdc,58cfa82ee4b0c9d6adf6afdc,TCGA-06-0648-01A-01D-0507-08_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-06-0648-01A-01D-0507-08_IlluminaGA-DNASeq_whole,TCGA-06-0648-01A-01D-0507-08_IlluminaGA-DNASeq_whole.bam,39.37,1.9,0.17,58cfa82ee4b0c9d6adf6afdc,TCGA-06-0648-01A-01D-0507-08_IlluminaGA-DNASeq_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0648-01A,EF6F6553-2575-457E-BC07-401215E54759,Primary Tumor,Illumina GA,e74e8bc2-31a9-4e6e-8631-56c570f8bc7b,Brain,77,A622A4B1-4A42-4CF9-A9FE-86FEE854C93D,7678C0F3-0971-4D88-B3EF-841E1C10D671,TCGA-06-0648-01A-01D-0507-08,HG18_Broad_variant,TCGA-06-0648,TCGA-GBM,298,s13896,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6a946,58cfa82ee4b0c9d6adf6a946,G35154.TCGA-DU-6401-10A-01D-1705-08.2.filtered.,WGS,G35154.TCGA-DU-6401-10A-01D-1705-08.2,G35154.TCGA-DU-6401-10A-01D-1705-08.2.bam,46.7,1.8,0.05,58cfa82ee4b0c9d6adf6a946,G35154.TCGA-DU-6401-10A-01D-1705-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6401-10A,97CB8701-7D63-4142-B404-006FBB3ECB0B,Blood Derived Normal,Illumina HiSeq,30e7af75-7d8e-4aa5-b01e-1149dff334ac,Brain,31,24A25702-2C3C-4AB0-B1E7-C47044767E4A,194434ED-46E0-4CE9-9F8F-38593D2D09C7,TCGA-DU-6401-10A-01D-1705-08,HG19_Broad_variant,TCGA-DU-6401,TCGA-LGG,2660,s8744,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa83ce4b0c9d6adf72fec,58cfa83ce4b0c9d6adf72fec,f45b766a6494688451a4e74a68b954b5.filtered.,WGS,f45b766a6494688451a4e74a68b954b5,f45b766a6494688451a4e74a68b954b5.bam,31.78,NA,0.08,58cfa83ce4b0c9d6adf72fec,f45b766a6494688451a4e74a68b954b5.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-HB-A43Z-01A,9C9B53E5-CDBE-4510-A839-4A3B5039681B,Primary Tumor,Illumina HiSeq,209a73b4-3820-4d16-9437-d67356ab9735,Mesenchymal,58,A6BBEE06-44BF-446A-8D21-550AA6E71960,16D33E09-2E21-4DA2-8E57-E78CE28C4408,TCGA-HB-A43Z-01A-11D-A24N-09,GRCh37-lite,TCGA-HB-A43Z,TCGA-SARC,NA,s2637,Washington University School of Medicine,University of North Carolina,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6abae,58cfa82ee4b0c9d6adf6abae,G32528.TCGA-DJ-A2Q8-01A-11D-A18F-08.5.filtered.,WGS,G32528.TCGA-DJ-A2Q8-01A-11D-A18F-08.5,G32528.TCGA-DJ-A2Q8-01A-11D-A18F-08.5.bam,37.93,NA,0.08,58cfa82ee4b0c9d6adf6abae,G32528.TCGA-DJ-A2Q8-01A-11D-A18F-08.5.bam,Alive,FEMALE,Not available,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A2Q8-01A,F9CF605F-F287-4EBA-8E8F-8BA47E14ECC4,Primary Tumor,Illumina HiSeq,304598e8-69da-48fa-a60c-8f025223e258,Thyroid,47,9AF5F9F1-36A3-48EA-A5E1-9B642E609E97,FA837B4D-55A7-4DCF-9FDF-CF9C13644DF7,TCGA-DJ-A2Q8-01A-11D-A18F-08,HG19_Broad_variant,TCGA-DJ-A2Q8,TCGA-THCA,NA,s12213,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T1a,N0,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage I
13722.58cfa82ee4b0c9d6adf6aa9a,58cfa82ee4b0c9d6adf6aa9a,G32461.TCGA-BT-A3PJ-10A-01D-A21Z-08.1.filtered.,WGS,G32461.TCGA-BT-A3PJ-10A-01D-A21Z-08.1,G32461.TCGA-BT-A3PJ-10A-01D-A21Z-08.1.bam,24.23,NA,0.08,58cfa82ee4b0c9d6adf6aa9a,G32461.TCGA-BT-A3PJ-10A-01D-A21Z-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A3PJ-10A,CB664EEF-BE6F-44EF-AA90-6F6DA0E6440A,Blood Derived Normal,Illumina HiSeq,2e9cf7f2-e8b1-4e29-9469-f5d1e3221b04,Bladder,76,34AC9B44-6A13-4D4F-BDEB-ECBF30ED9B08,C79E40D8-3C21-4219-81F8-C448A38F0F18,TCGA-BT-A3PJ-10A-01D-A21Z-08,HG19_Broad_variant,TCGA-BT-A3PJ,TCGA-BLCA,NA,s2680,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3a,N3,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa83ce4b0c9d6adf730d4,58cfa83ce4b0c9d6adf730d4,fe7b56f09624164caf93abc1f8d3bdc7.filtered.,WGS,fe7b56f09624164caf93abc1f8d3bdc7,fe7b56f09624164caf93abc1f8d3bdc7.bam,34.51,1.9,0.08,58cfa83ce4b0c9d6adf730d4,fe7b56f09624164caf93abc1f8d3bdc7.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0WX-01A,A482FC4C-FF1D-46A0-A968-7DF06422CC4B,Primary Tumor,Illumina HiSeq,1d0beca4-681e-4dbe-a6cf-f6c492c370b2,Breast,40,7DAA9124-2878-4708-AE74-28B17EF4898C,47B5D831-5287-4F62-B17A-6E5EFF2E4184,TCGA-B6-A0WX-01A-11D-A10G-09,GRCh37-lite,TCGA-B6-A0WX,TCGA-BRCA,653,s6109,Washington University School of Medicine,Duke,United States,NO,T3,N1b,Other  specify,Stage IIIA
13722.58cfa82ee4b0c9d6adf6aa48,58cfa82ee4b0c9d6adf6aa48,G32533.TCGA-EM-A3FQ-10A-01D-A21A-08.2.filtered.,WGS,G32533.TCGA-EM-A3FQ-10A-01D-A21A-08.2,G32533.TCGA-EM-A3FQ-10A-01D-A21A-08.2.bam,83.84,NA,0.08,58cfa82ee4b0c9d6adf6aa48,G32533.TCGA-EM-A3FQ-10A-01D-A21A-08.2.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3FQ-10A,FEF9C64F-5959-4DA0-AAA2-66B56FC7B4C3,Blood Derived Normal,Illumina HiSeq,66273215-c277-4df0-8f02-be35e5d6fe80,Thyroid,19,038F84C7-0D7A-4F90-9860-86F77B6DBA03,2125F0B1-C6B9-4B65-A6DB-9FD4422E7C7E,TCGA-EM-A3FQ-10A-01D-A21A-08,HG19_Broad_variant,TCGA-EM-A3FQ,TCGA-THCA,NA,s12345,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T3,N1b,Other  specify,Stage I
13722.58cfa82fe4b0c9d6adf6b9fc,58cfa82fe4b0c9d6adf6b9fc,TCGA-AA-3555-10A-01D-0959-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3555-10A-01D-0959-10_wgs_Illumina,TCGA-AA-3555-10A-01D-0959-10_wgs_Illumina.bam,0,1.9,0.14,58cfa82fe4b0c9d6adf6b9fc,TCGA-AA-3555-10A-01D-0959-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3555-10A,36EAF209-C332-4321-B6AA-51A3368ECD79,Blood Derived Normal,Illumina HiSeq,e46a72b9-a8a8-41dd-af2d-3dadc0faf711,Colorectal,81,A08213B9-B852-4C99-9469-8C9DF8A34AD0,A7CA59D7-DF34-4180-9192-754F38596C34,TCGA-AA-3555-10A-01D-0959-10,GRCh37-lite,TCGA-AA-3555,TCGA-COAD,NA,s13359,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Colon Mucinous Adenocarcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6a884,58cfa82ee4b0c9d6adf6a884,G35154.TCGA-HT-7602-10A-01D-2086-08.3.filtered.,WGS,G35154.TCGA-HT-7602-10A-01D-2086-08.3,G35154.TCGA-HT-7602-10A-01D-2086-08.3.bam,307.18,NA,0.05,58cfa82ee4b0c9d6adf6a884,G35154.TCGA-HT-7602-10A-01D-2086-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7602-10A,799E9106-E62E-4681-8861-137F474EE8B8,Blood Derived Normal,Illumina HiSeq,73cb1269-4aff-4f51-a2ac-32f3211af789,Brain,21,DD410E7C-FBE2-4C5F-9806-5A4BD5B1F671,5844876A-D390-4C02-ACB9-F32647CA7375,TCGA-HT-7602-10A-01D-2086-08,HG19_Broad_variant,TCGA-HT-7602,TCGA-LGG,NA,s8545,Broad Institute of MIT and Harvard,Case Western - St Joes,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa83ce4b0c9d6adf72f43,58cfa83ce4b0c9d6adf72f43,cee8053647191b1b4b10e3f58a90b606.filtered.,WGS,cee8053647191b1b4b10e3f58a90b606,cee8053647191b1b4b10e3f58a90b606.bam,83.38,1.91,0.08,58cfa83ce4b0c9d6adf72f43,cee8053647191b1b4b10e3f58a90b606.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A1LG-01A,EF4CBD38-BC79-4D60-A715-647EDD2EBE9E,Primary Tumor,Illumina HiSeq,c24e6791-401c-4b37-bfe6-669f050ea42e,Breast,50,B462982A-4DD0-425E-BCE3-0EB8F5527264,7CDBE0E8-F614-4F54-B864-FD6B39E8EF1C,TCGA-E2-A1LG-01A-21D-A14K-09,GRCh37-lite,TCGA-E2-A1LG,TCGA-BRCA,NA,s5781,Washington University School of Medicine,Roswell Park,United States,NO,T2,N0,Infiltrating Lobular Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6a991,58cfa82ee4b0c9d6adf6a991,G32555.TCGA-DA-A1IC-10A-01D-A199-08.1.filtered.,WGS,G32555.TCGA-DA-A1IC-10A-01D-A199-08.1,G32555.TCGA-DA-A1IC-10A-01D-A199-08.1.bam,32.66,NA,0.08,58cfa82ee4b0c9d6adf6a991,G32555.TCGA-DA-A1IC-10A-01D-A199-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1IC-10A,6625CE3F-3A1F-45F9-AA42-AB1931D6DAF4,Blood Derived Normal,Illumina HiSeq,680feb9d-81fe-470d-801d-bb8bf34b5564,Skin,81,564A6108-65B7-49D2-A8B9-02C32EE52CDD,759EA550-CC56-4F70-BD66-DCEAFFBD4B0D,TCGA-DA-A1IC-10A-01D-A199-08,HG19_Broad_variant,TCGA-DA-A1IC,TCGA-SKCM,NA,s7658,Broad Institute of MIT and Harvard,Yale,United States,NO,T3a,N2c,Not available,Stage IIIB
13722.58cfa83ce4b0c9d6adf73066,58cfa83ce4b0c9d6adf73066,f223ed2729672e3726080378a2e49038.filtered.,WGS,f223ed2729672e3726080378a2e49038,f223ed2729672e3726080378a2e49038.bam,20.28,NA,0.09,58cfa83ce4b0c9d6adf73066,f223ed2729672e3726080378a2e49038.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A8NN-11A,90940FF1-C270-44F5-9949-F726838AAA57,Solid Tissue Normal,HiSeq X Ten,5efa9827-2c06-4b2c-989e-70cb01f8253f,Esophagus,81,8464AFCB-4202-4226-860B-A8D67BF8086E,F47B1DAB-3BC6-4050-917E-5E94D4BB2C7E,TCGA-L5-A8NN-11A-11D-A37F-09,GRCh37-lite_WUGSC_variant_2,TCGA-L5-A8NN,TCGA-ESCA,NA,s1951,Washington University School of Medicine,University of Michigan,United States,NO,T3,N1,Not available,Stage III
13722.58cfa82ee4b0c9d6adf6abb3,58cfa82ee4b0c9d6adf6abb3,G37566.TCGA-EJ-5506-10A-01D-1577-08.1.filtered.,WGS,G37566.TCGA-EJ-5506-10A-01D-1577-08.1,G37566.TCGA-EJ-5506-10A-01D-1577-08.1.bam,277.4,1.9,0.05,58cfa82ee4b0c9d6adf6abb3,G37566.TCGA-EJ-5506-10A-01D-1577-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5506-10A,E5E4D3B6-8E58-4DCF-8F67-A00E656A8E27,Blood Derived Normal,Illumina HiSeq,31093a03-fae8-4bf1-ab4b-b9043ab25036,Prostate,67,89ABEFF0-3EE1-4E9C-A1F4-D8CC03A26F8A,30A0B8D5-11A9-4367-9979-D2C6906F30CC,TCGA-EJ-5506-10A-01D-1577-08,HG19_Broad_variant,TCGA-EJ-5506,TCGA-PRAD,NA,s3766,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c5a6,58cfa831e4b0c9d6adf6c5a6,TCGA-CN-4737-10A-01D-2266-10_Illumina.filtered.,WGS,TCGA-CN-4737-10A-01D-2266-10_Illumina,TCGA-CN-4737-10A-01D-2266-10_Illumina.bam,702.7,1.9,0.05,58cfa831e4b0c9d6adf6c5a6,TCGA-CN-4737-10A-01D-2266-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4737-10A,1F744ADA-6DE1-446D-B62C-76A7FC8B40AF,Blood Derived Normal,Illumina HiSeq,afe2b5ea-bb70-4f3b-a489-38b303667626,Head and Neck,19,E0D710B0-E301-4441-BF1C-44AE39CB3239,97060C75-AD9A-4C28-926A-15354F608FF9,TCGA-CN-4737-10A-01D-2266-10,GRCh37-lite,TCGA-CN-4737,TCGA-HNSC,NA,s15763,Baylor College of Medicine,University of Pittsburgh,None,NO,T2,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c42e,58cfa831e4b0c9d6adf6c42e,TCGA-CJ-4918-11A-01D-2101-10_Illumina.filtered.,WGS,TCGA-CJ-4918-11A-01D-2101-10_Illumina,TCGA-CJ-4918-11A-01D-2101-10_Illumina.bam,148.4,1.9,0.16,58cfa831e4b0c9d6adf6c42e,TCGA-CJ-4918-11A-01D-2101-10_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CJ-4918-11A,267FF78B-BCEB-466E-8582-C560FE227FF0,Solid Tissue Normal,Illumina HiSeq,6cc74b7f-df4b-4de1-a88c-f2f9d163610e,Kidney,64,00C4D8F0-AEED-4C26-B8DB-BB3883DAD965,92971395-C358-4F1F-9FED-F80EDF6315E6,TCGA-CJ-4918-11A-01D-2101-10,GRCh37-lite,TCGA-CJ-4918,TCGA-KIRC,93,s9738,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T3a,N0,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa82ee4b0c9d6adf6aa9e,58cfa82ee4b0c9d6adf6aa9e,G32455.TCGA-BT-A2LA-01A-11D-A18F-08.2.filtered.,WGS,G32455.TCGA-BT-A2LA-01A-11D-A18F-08.2,G32455.TCGA-BT-A2LA-01A-11D-A18F-08.2.bam,80.43,NA,0.07,58cfa82ee4b0c9d6adf6aa9e,G32455.TCGA-BT-A2LA-01A-11D-A18F-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A2LA-01A,797A71EE-372D-41E5-AEEE-5AB3C4661110,Primary Tumor,Illumina HiSeq,baad6267-e92d-4dc7-a751-271da7ad3f53,Bladder,54,6ED52558-8039-4658-A245-78A29968CE2F,45A7949D-E63F-4956-866C-DF51257032DE,TCGA-BT-A2LA-01A-11D-A18F-08,HG19_Broad_variant,TCGA-BT-A2LA,TCGA-BLCA,NA,s2851,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82fe4b0c9d6adf6b741,58cfa82fe4b0c9d6adf6b741,TCGA-61-2095-11A-01D-0926-12_Illumina.filtered.,WGS,TCGA-61-2095-11A-01D-0926-12_Illumina,TCGA-61-2095-11A-01D-0926-12_Illumina.bam,31.27,1.9,0.16,58cfa82fe4b0c9d6adf6b741,TCGA-61-2095-11A-01D-0926-12_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-61-2095-11A,778CE436-A825-4689-81C1-B7C965404163,Solid Tissue Normal,Illumina HiSeq,e6ccaec4-fb19-47b7-94c3-806a2af6a284,Ovary,54,43C556ED-873C-4A2D-9F33-68E2E7790BA1,7E3B5564-99D6-4833-96BA-3A172F104818,TCGA-61-2095-11A-01D-0926-12,NCBI36_BCM_variant,TCGA-61-2095,TCGA-OV,1875,s18015,Baylor College of Medicine,University of Pittsburgh,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf73184,58cfa83ce4b0c9d6adf73184,aa55b92d7a3d9eabf7f8c19d30f85566.filtered.,WGS,aa55b92d7a3d9eabf7f8c19d30f85566,aa55b92d7a3d9eabf7f8c19d30f85566.bam,60.12,1.87,0.07,58cfa83ce4b0c9d6adf73184,aa55b92d7a3d9eabf7f8c19d30f85566.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TC-01A,7B7D2D2B-ABE6-4F32-ADD0-3715096995D1,Primary Tumor,Illumina HiSeq,cfe5ac46-c8e7-4f91-a88f-bbbb286e9551,Uterus,69,C4C99327-B778-4E29-A111-75569AD38696,B0A83DF8-DD2C-4C1B-B238-9081D2C22258,TCGA-BS-A0TC-01A-11D-A10B-09,GRCh37-lite,TCGA-BS-A0TC,TCGA-UCEC,NA,s4395,Washington University School of Medicine,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a5a8,58cfa82de4b0c9d6adf6a5a8,54736890d181e153ed89edbd36cfb815.filtered.,WGS,54736890d181e153ed89edbd36cfb815,54736890d181e153ed89edbd36cfb815.bam,26.67,1.9,0.16,58cfa82de4b0c9d6adf6a5a8,54736890d181e153ed89edbd36cfb815.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1103-10A,F34AA3B6-E966-49C6-BC55-130545772C53,Blood Derived Normal,Illumina GA,ee539b0e-d76e-4ee8-8c1c-df8ae270c857,Ovary,50,A6AE520E-D19F-4848-9149-ABB90ED1C9A6,DF8C183D-0CD7-44B1-A100-A20BD3371C61,TCGA-24-1103-10A-01D-0515-09,GRCh37-lite,TCGA-24-1103,TCGA-OV,1646,s17112,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6afa0,58cfa82ee4b0c9d6adf6afa0,TCGA-13-0751-01A-01D-0446-08_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-13-0751-01A-01D-0446-08_IlluminaGA-DNASeq_whole,TCGA-13-0751-01A-01D-0446-08_IlluminaGA-DNASeq_whole.bam,86.64,1.9,0.16,58cfa82ee4b0c9d6adf6afa0,TCGA-13-0751-01A-01D-0446-08_IlluminaGA-DNASeq_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0751-01A,15C84DA3-16E5-4909-AEA9-CB5894B0F8AF,Primary Tumor,Illumina GA,198d023f-c0b9-4197-b7d9-c2358b6ff71c,Ovary,44,897A5467-5E46-4370-B805-D651DD579DEF,9F335CD1-2736-41BE-A02B-CDBE4017BB3D,TCGA-13-0751-01A-01D-0446-08,HG18_Broad_variant,TCGA-13-0751,TCGA-OV,1678,s17289,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aad6,58cfa82ee4b0c9d6adf6aad6,G32559.TCGA-ER-A2NF-10A-01D-A19A-08.2.filtered.,WGS,G32559.TCGA-ER-A2NF-10A-01D-A19A-08.2,G32559.TCGA-ER-A2NF-10A-01D-A19A-08.2.bam,15.51,NA,0.08,58cfa82ee4b0c9d6adf6aad6,G32559.TCGA-ER-A2NF-10A-01D-A19A-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A2NF-10A,D32A4219-4CCA-470F-B6B3-11447D9F5E0B,Blood Derived Normal,Illumina HiSeq,f2ec87a0-4f1c-40cd-b405-ee2040f752e3,Skin,53,C3CE1857-971F-4416-9F5A-2AA029C6C75A,F0D22E58-5486-47C4-A316-E974E2BCBAE6,TCGA-ER-A2NF-10A-01D-A19A-08,HG19_Broad_variant,TCGA-ER-A2NF,TCGA-SKCM,NA,s7308,Broad Institute of MIT and Harvard,University of Pittsburgh,None,NO,T4b,N3,Not available,Stage IIIC
13722.58cfa82ee4b0c9d6adf6aa66,58cfa82ee4b0c9d6adf6aa66,G32549.TCGA-FS-A1ZP-10A-01D-A199-08.2.filtered.,WGS,G32549.TCGA-FS-A1ZP-10A-01D-A199-08.2,G32549.TCGA-FS-A1ZP-10A-01D-A199-08.2.bam,39.25,NA,0.08,58cfa82ee4b0c9d6adf6aa66,G32549.TCGA-FS-A1ZP-10A-01D-A199-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZP-10A,4CDB18F5-47BF-475F-B34C-FA4912515268,Blood Derived Normal,Illumina HiSeq,8ec8c9f2-af08-48ef-9f7e-bf39feb84233,Skin,52,7765773F-AD0D-438F-A5B0-9DF496DA22F7,46ECBB48-9320-47EC-8BD8-4657E1885627,TCGA-FS-A1ZP-10A-01D-A199-08,HG19_Broad_variant,TCGA-FS-A1ZP,TCGA-SKCM,2273,s7657,Broad Institute of MIT and Harvard,Essen,Germany,NO,T3,N0,Not available,Stage II
13722.58cfa82ee4b0c9d6adf6a8b0,58cfa82ee4b0c9d6adf6a8b0,G35154.TCGA-FG-5964-01A-11D-1705-08.4.filtered.,WGS,G35154.TCGA-FG-5964-01A-11D-1705-08.4,G35154.TCGA-FG-5964-01A-11D-1705-08.4.bam,102.3,1.9,0.05,58cfa82ee4b0c9d6adf6a8b0,G35154.TCGA-FG-5964-01A-11D-1705-08.4.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-5964-01A,648252DA-DD86-48D1-AE75-4257E3142B0B,Primary Tumor,Illumina HiSeq,7c465b99-b3c1-44c6-899f-74975fb3d594,Brain,62,7BBFBDD1-4CB9-479C-8152-924D79E112F2,C6888BE2-4517-41E4-A801-9C915F24E737,TCGA-FG-5964-01A-11D-1705-08,HG19_Broad_variant,TCGA-FG-5964,TCGA-LGG,NA,s8109,Broad Institute of MIT and Harvard,Case Western,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82de4b0c9d6adf6a4a6,58cfa82de4b0c9d6adf6a4a6,3a96e8c557be05593e3dbb1fccbb73d1.filtered.,WGS,3a96e8c557be05593e3dbb1fccbb73d1,3a96e8c557be05593e3dbb1fccbb73d1.bam,74.02,2.18,0.09,58cfa82de4b0c9d6adf6a4a6,3a96e8c557be05593e3dbb1fccbb73d1.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-EW-A1PB-01A,88DB1340-E4BF-451A-87C0-6E9168296F5E,Primary Tumor,Illumina HiSeq,2ba1984b-043e-4cc5-8bc4-10b6c2915f61,Breast,70,DA9DC40B-0350-4B8C-8A7A-15100D5AEB90,9DDF2119-A222-4FA5-A9F3-0BEC7EEEA36B,TCGA-EW-A1PB-01A-11D-A142-09,GRCh37-lite,TCGA-EW-A1PB,TCGA-BRCA,NA,s6454,Washington University School of Medicine,University of Miami,United States,NO,T3,N1a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82de4b0c9d6adf6a63e,58cfa82de4b0c9d6adf6a63e,4904c28d460c5452fabb15e54e66ee71.filtered.,WGS,4904c28d460c5452fabb15e54e66ee71,4904c28d460c5452fabb15e54e66ee71.bam,73.92,NA,0.09,58cfa82de4b0c9d6adf6a63e,4904c28d460c5452fabb15e54e66ee71.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-EW-A1PC-01B,F45210D3-9E66-4F5E-BEF1-5EE5547CC893,Primary Tumor,Illumina HiSeq,4ded0771-e685-45fb-99f1-4dc1212cc9fc,Breast,66,FB635F1D-5EE1-4E58-86EA-B1AADA2DE4BA,1C0E384F-7254-4AFE-93C0-B3FC6C6A7894,TCGA-EW-A1PC-01B-11D-A21Q-09,GRCh37-lite,TCGA-EW-A1PC,TCGA-BRCA,NA,s5789,Washington University School of Medicine,University of Miami,United States,NO,T3,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa82de4b0c9d6adf6a65c,58cfa82de4b0c9d6adf6a65c,4fa7ea559428c6a86aecf3aa8cb8acc0.filtered.,WGS,4fa7ea559428c6a86aecf3aa8cb8acc0,4fa7ea559428c6a86aecf3aa8cb8acc0.bam,44.55,NA,0.08,58cfa82de4b0c9d6adf6a65c,4fa7ea559428c6a86aecf3aa8cb8acc0.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A2IZ-01A,6B189EFF-B919-49D6-8775-DBF32C9CCBBA,Primary Tumor,Illumina HiSeq,a3746833-4b30-4c7f-b95c-b534566de66c,Mesenchymal,60,B68F7194-1F05-4009-8ED2-58C5EBBCABA8,67BB70B2-B6F8-4AA9-80CE-48829F9FEC56,TCGA-DX-A2IZ-01A-11D-A21Q-09,GRCh37-lite,TCGA-DX-A2IZ,TCGA-SARC,NA,s2488,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6b0af,58cfa82ee4b0c9d6adf6b0af,G49537.TCGA-BJ-A0Z2-10A-01D-A10S-08.2.filtered.,WGS,G49537.TCGA-BJ-A0Z2-10A-01D-A10S-08.2,G49537.TCGA-BJ-A0Z2-10A-01D-A10S-08.2.bam,18.36,1.93,0.09,58cfa82ee4b0c9d6adf6b0af,G49537.TCGA-BJ-A0Z2-10A-01D-A10S-08.2.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0Z2-10A,F9CEFFC0-D544-418D-B4A9-BD3C84E37026,Blood Derived Normal,Illumina HiSeq,f4de7f49-7a13-4a64-97fb-01f3d2edad24,Thyroid,57,BB9C69C4-22D7-4462-BC55-71341EA4D000,6F8F241C-648E-42C0-8660-600B58036C3A,TCGA-BJ-A0Z2-10A-01D-A10S-08,HG19_Broad_variant,TCGA-BJ-A0Z2,TCGA-THCA,NA,s12220,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage IVC
13722.58cfa82de4b0c9d6adf6a6cf,58cfa82de4b0c9d6adf6a6cf,943f4d785b943d37fff5ff0c234c4566.filtered.,WGS,943f4d785b943d37fff5ff0c234c4566,943f4d785b943d37fff5ff0c234c4566.bam,87.75,1.92,0.08,58cfa82de4b0c9d6adf6a6cf,943f4d785b943d37fff5ff0c234c4566.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A16G-01A,16E69011-C295-479F-B521-86E66FBA498D,Primary Tumor,Illumina HiSeq,e4699f4c-2332-49b2-83cb-aff2eeb83c5b,Uterus,74,4C34ECB0-9351-4A55-9FF5-2062B7CB391A,65F9A820-F026-4A10-8BB7-1FBC3B38321E,TCGA-D1-A16G-01A-31D-A12J-09,GRCh37-lite,TCGA-D1-A16G,TCGA-UCEC,834,s4770,Washington University School of Medicine,Mayo Clinic,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a471,58cfa82de4b0c9d6adf6a471,1076369c844452a633e3edce84850064.filtered.,WGS,1076369c844452a633e3edce84850064,1076369c844452a633e3edce84850064.bam,59.16,1.89,0.09,58cfa82de4b0c9d6adf6a471,1076369c844452a633e3edce84850064.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A1C8-01A,BAD34C92-1E64-4187-A0B4-061105FD13BA,Primary Tumor,Illumina HiSeq,37d56097-9e5d-4008-bbc9-5bd69910436b,Uterus,77,83E4DFB0-F240-476B-BC25-F9F52C960AF5,00DB4DC2-3EC7-4FF9-9233-D69C8C8A607F,TCGA-AX-A1C8-01A-11D-A135-09,GRCh37-lite,TCGA-AX-A1C8,TCGA-UCEC,NA,s4403,Washington University School of Medicine,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bf02,58cfa830e4b0c9d6adf6bf02,TCGA-BP-4968-01A-01D-2100-10_wgs_Illumina.filtered.,WGS,TCGA-BP-4968-01A-01D-2100-10_wgs_Illumina,TCGA-BP-4968-01A-01D-2100-10_wgs_Illumina.bam,68.77,1.9,0.14,58cfa830e4b0c9d6adf6bf02,TCGA-BP-4968-01A-01D-2100-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-BP-4968-01A,1E417B93-837D-4110-9090-239EB82C3E20,Primary Tumor,Illumina HiSeq,e2ce6973-54d1-4e7b-88f1-cb684419ff11,Kidney,40,8CD2BBCD-3CE9-4B57-99DA-895B82300AF8,AAD8C8D6-D828-4AAC-9CFB-CEE893E36850,TCGA-BP-4968-01A-01D-2100-10,GRCh37-lite,TCGA-BP-4968,TCGA-KIRC,NA,s9162,Baylor College of Medicine,MSKCC,None,NO,T1b,N0,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82fe4b0c9d6adf6b2a6,58cfa82fe4b0c9d6adf6b2a6,TCGA-13-1411-01A-01D-0515-09_whole.filtered.,WGS,TCGA-13-1411-01A-01D-0515-09_whole,TCGA-13-1411-01A-01D-0515-09_whole.bam,254.67,1.9,0.15,58cfa82fe4b0c9d6adf6b2a6,TCGA-13-1411-01A-01D-0515-09_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-1411-01A,A9D3A7B0-FAF8-4E56-8600-D9E6882A4F23,Primary Tumor,Illumina GA,86bafdd5-8170-46b8-a813-f7fa65336119,Ovary,81,157062B7-9451-4A83-9047-294497DF3B28,DA33F277-D0C6-4309-B0A5-DA37FF9CFD66,TCGA-13-1411-01A-01D-0515-09,NCBI36_WUGSC_variant,TCGA-13-1411,TCGA-OV,NA,s17661,Washington University School of Medicine,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bc3e,58cfa830e4b0c9d6adf6bc3e,TCGA-AG-3582-01A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AG-3582-01A-01D-1989-10_wgs_Illumina,TCGA-AG-3582-01A-01D-1989-10_wgs_Illumina.bam,747.21,1.9,0.15,58cfa830e4b0c9d6adf6bc3e,TCGA-AG-3582-01A-01D-1989-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3582-01A,DB1E3104-8BFD-4353-854A-C478BA1F7D07,Primary Tumor,Illumina HiSeq,f968a6d9-8eb8-436a-92a3-b7080bdf5a3e,Colorectal,75,1B1EF856-EA45-4857-8B4B-C4330FA930D8,D452293A-6148-4FCF-9FBC-446815016751,TCGA-AG-3582-01A-01D-1989-10,GRCh37-lite,TCGA-AG-3582,TCGA-READ,NA,s2135,Baylor College of Medicine,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IV
13722.58cfa82de4b0c9d6adf6a64a,58cfa82de4b0c9d6adf6a64a,7e4be797a621ce82629293065b38f858.filtered.,WGS,7e4be797a621ce82629293065b38f858,7e4be797a621ce82629293065b38f858.bam,13.63,NA,0.09,58cfa82de4b0c9d6adf6a64a,7e4be797a621ce82629293065b38f858.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A2LV-01A,00BCA18C-B3D4-45A3-8F19-034CC40449A4,Primary Tumor,Illumina HiSeq,559f9675-671e-41a5-b073-7782ab8b5542,Cervix,36,CBAD0C55-915A-4F65-B040-57111EAD3BDE,3269608C-5DD7-452A-976A-31AC971AAC2F,TCGA-C5-A2LV-01A-11D-A18J-09,GRCh37-lite,TCGA-C5-A2LV,TCGA-CESC,NA,s1354,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,T1b,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6bbe0,58cfa830e4b0c9d6adf6bbe0,TCGA-AG-A002-10A-01D-A183-10_wgs_Illumina.filtered.,WGS,TCGA-AG-A002-10A-01D-A183-10_wgs_Illumina,TCGA-AG-A002-10A-01D-A183-10_wgs_Illumina.bam,17.06,1.74,0.07,58cfa830e4b0c9d6adf6bbe0,TCGA-AG-A002-10A-01D-A183-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A002-10A,CB005C69-7301-41CE-B534-C9751F1436C5,Blood Derived Normal,Illumina HiSeq,d4c491f9-e972-4330-a709-212a4e3e21f0,Colorectal,35,E2660CFD-8FEC-437F-8A0E-4869030DE46E,DD3258A9-9C00-4E25-82B6-7904082CD29F,TCGA-AG-A002-10A-01D-A183-10,GRCh37-lite,TCGA-AG-A002,TCGA-READ,NA,s1976,Baylor College of Medicine,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa82de4b0c9d6adf6a4b4,58cfa82de4b0c9d6adf6a4b4,30e285b326196b3c05f1a202424a5b2f.filtered.,WGS,30e285b326196b3c05f1a202424a5b2f,30e285b326196b3c05f1a202424a5b2f.bam,53.44,1.91,0.08,58cfa82de4b0c9d6adf6a4b4,30e285b326196b3c05f1a202424a5b2f.bam,Dead,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TE-01A,09066FBF-6A1D-46C9-A4C5-C53340C3D1BA,Primary Tumor,Illumina HiSeq,18f27937-fb61-45fa-92f4-eacb3b722603,Uterus,35,2D1226A1-1C88-422B-9A8D-316BEBEB65FD,AF96DB5A-684F-41D1-A910-5A5193393D9C,TCGA-BS-A0TE-01A-11D-A10B-09,GRCh37-lite,TCGA-BS-A0TE,TCGA-UCEC,146,s4581,Washington University School of Medicine,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ac00,58cfa82ee4b0c9d6adf6ac00,G37566.TCGA-HI-7169-10A-01D-2115-08.2.filtered.,WGS,G37566.TCGA-HI-7169-10A-01D-2115-08.2,G37566.TCGA-HI-7169-10A-01D-2115-08.2.bam,162,NA,0.05,58cfa82ee4b0c9d6adf6ac00,G37566.TCGA-HI-7169-10A-01D-2115-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HI-7169-10A,11FB5853-8EEB-4AD8-825D-3EAAF3FA08D6,Blood Derived Normal,Illumina HiSeq,070dd820-fa5a-42a2-8d3f-3a562df06f24,Prostate,55,BC487EB7-6A06-467B-9D26-DE09895879D8,263E1015-1061-4AD2-8F7E-ED430D2D9E80,TCGA-HI-7169-10A-01D-2115-08,HG19_Broad_variant,TCGA-HI-7169,TCGA-PRAD,NA,s3409,Broad Institute of MIT and Harvard,Fox Chase,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82fe4b0c9d6adf6b24c,58cfa82fe4b0c9d6adf6b24c,TCGA-14-1401-01A-01D-0703-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-14-1401-01A-01D-0703-09_IlluminaGA-DNASeq_whole,TCGA-14-1401-01A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,241.3,1.9,0.15,58cfa82fe4b0c9d6adf6b24c,TCGA-14-1401-01A-01D-0703-09_IlluminaGA-DNASeq_whole.bam,Dead,MALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1401-01A,6176621D-8534-4FBA-A0E7-74A5A78245A9,Primary Tumor,Illumina GA,4f0c79b2-519a-4ee3-b253-bd2b2e67a90c,Brain,54,A2DEDF98-1BFC-4E20-A699-852177F3AAB4,36BC0811-ADFE-4F8F-A1D3-B62EAC535263,TCGA-14-1401-01A-01D-0703-09,NCBI36_WUGSC_variant,TCGA-14-1401,TCGA-GBM,114,s13992,Washington University School of Medicine,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6a93c,58cfa82ee4b0c9d6adf6a93c,G32454.TCGA-CF-A27C-10A-01D-A16O-08.4.filtered.,WGS,G32454.TCGA-CF-A27C-10A-01D-A16O-08.4,G32454.TCGA-CF-A27C-10A-01D-A16O-08.4.bam,178.36,1.89,0.09,58cfa82ee4b0c9d6adf6a93c,G32454.TCGA-CF-A27C-10A-01D-A16O-08.4.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CF-A27C-10A,7FEE9D6F-C0EA-43C2-89C2-66D965A077A8,Blood Derived Normal,Illumina HiSeq,1c684efa-c878-42dc-893a-da27ef782036,Bladder,52,1C4C59DC-B0B3-48B0-9888-42891CF1E8F8,7C729B94-1488-4DEC-B534-5D73530E535C,TCGA-CF-A27C-10A-01D-A16O-08,HG19_Broad_variant,TCGA-CF-A27C,TCGA-BLCA,NA,s2681,Broad Institute of MIT and Harvard,ILSbio,Vietnam,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa83ce4b0c9d6adf7307f,58cfa83ce4b0c9d6adf7307f,b58386e952752d807a06a013a922b7ae.filtered.,WGS,b58386e952752d807a06a013a922b7ae,b58386e952752d807a06a013a922b7ae.bam,17.96,1.86,0.07,58cfa83ce4b0c9d6adf7307f,b58386e952752d807a06a013a922b7ae.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A7-A13D-01A,8785012F-F73E-4D68-87CF-1D804AF32782,Primary Tumor,Illumina HiSeq,3c8a206a-59d4-412a-97c1-9dd31cb9b7c0,Breast,46,79FC9ED3-4E96-4C0E-869E-1756CBDABB39,418E916B-7A4E-4FAB-8616-15DCEC4D79F8,TCGA-A7-A13D-01A-13D-A12Q-09,GRCh37-lite,TCGA-A7-A13D,TCGA-BRCA,NA,s6443,Washington University School of Medicine,Christiana Healthcare,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6a9aa,58cfa82ee4b0c9d6adf6a9aa,G32537.TCGA-EL-A3CX-01A-11D-A19J-08.2.filtered.,WGS,G32537.TCGA-EL-A3CX-01A-11D-A19J-08.2,G32537.TCGA-EL-A3CX-01A-11D-A19J-08.2.bam,46.65,NA,0.08,58cfa82ee4b0c9d6adf6a9aa,G32537.TCGA-EL-A3CX-01A-11D-A19J-08.2.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EL-A3CX-01A,934A58AF-0FFC-487E-9E95-FA7643B7D5CB,Primary Tumor,Illumina HiSeq,7466949f-795d-4b2c-99e4-92d507c8772e,Thyroid,22,C65B5941-3E1D-41C6-9458-CDE70425E7C7,D0A33FD2-085C-488B-B843-2CA97C85A5CB,TCGA-EL-A3CX-01A-11D-A19J-08,HG19_Broad_variant,TCGA-EL-A3CX,TCGA-THCA,NA,s12337,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82de4b0c9d6adf6a48c,58cfa82de4b0c9d6adf6a48c,01e2ea9ed2554ea6df56ed963414b511.filtered.,WGS,01e2ea9ed2554ea6df56ed963414b511,01e2ea9ed2554ea6df56ed963414b511.bam,33.83,1.84,0.08,58cfa82de4b0c9d6adf6a48c,01e2ea9ed2554ea6df56ed963414b511.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A7-A26G-01A,5ED024E8-D05E-4C65-9441-EDA9930CCC82,Primary Tumor,Illumina HiSeq,f7140aea-8ed7-4d5d-adfb-bd360e319805,Breast,50,F0CF4ACD-6B09-4538-B58C-E86C623B6C71,36D1A85E-A09B-4537-86E0-EAF1EB03AED8,TCGA-A7-A26G-01A-21D-A167-09,GRCh37-lite,TCGA-A7-A26G,TCGA-BRCA,NA,s6110,Washington University School of Medicine,Christiana Healthcare,United States,NO,T2,N0 (i+),Other  specify,Stage IIA
13722.58cfa82ee4b0c9d6adf6ac24,58cfa82ee4b0c9d6adf6ac24,G37566.TCGA-HC-7075-10A-01D-1961-08.2.filtered.,WGS,G37566.TCGA-HC-7075-10A-01D-1961-08.2,G37566.TCGA-HC-7075-10A-01D-1961-08.2.bam,310,NA,0.05,58cfa82ee4b0c9d6adf6ac24,G37566.TCGA-HC-7075-10A-01D-1961-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7075-10A,5DD69C3E-9A3D-450C-9F10-10B4D6DAEEBA,Blood Derived Normal,Illumina HiSeq,798928e0-e49d-420d-8f4a-d0345f5fe570,Prostate,63,3EC216B1-4260-45E7-BF41-3F13676F3222,F10CBFD4-A508-4061-A2B0-767DB51DC211,TCGA-HC-7075-10A-01D-1961-08,HG19_Broad_variant,TCGA-HC-7075,TCGA-PRAD,NA,s3767,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2a,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa83ce4b0c9d6adf72edf,58cfa83ce4b0c9d6adf72edf,e4a6e1d5b4230f26d94ced982fad1af3.filtered.,WGS,e4a6e1d5b4230f26d94ced982fad1af3,e4a6e1d5b4230f26d94ced982fad1af3.bam,94.6,1.95,0.08,58cfa83ce4b0c9d6adf72edf,e4a6e1d5b4230f26d94ced982fad1af3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A109-01A,F0787165-6F58-4D67-B510-928EEA2C4882,Primary Tumor,Illumina HiSeq,33884ffd-f43a-4cb9-beb0-9c0a7d6f3f31,Breast,64,710EAE35-A21D-4939-8414-D2AF4EA02FDD,3585E133-B3C1-4D90-B5F2-2B867E0AE0EC,TCGA-E2-A109-01A-11D-A10M-09,GRCh37-lite,TCGA-E2-A109,TCGA-BRCA,NA,s5623,Washington University School of Medicine,Roswell Park,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a63a,58cfa82de4b0c9d6adf6a63a,48485457b07d53a6c480b561c6328aba.filtered.,WGS,48485457b07d53a6c480b561c6328aba,48485457b07d53a6c480b561c6328aba.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a63a,48485457b07d53a6c480b561c6328aba.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2972-03A,A436F4D7-018E-44E3-A615-9C33FCC1167D,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,2b0ac0aa-7f5b-4f7c-8e77-36e6b2c7ceb0,Blood,82,56F40052-1F82-4E6D-98AB-6E5E132D59A4,7A27CF8C-6993-4E70-88EB-867073453891,TCGA-AB-2972-03A-01D-0741-05,GRCh37-lite,TCGA-AB-2972,TCGA-LAML,30,s6975,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6ab08,58cfa82ee4b0c9d6adf6ab08,G32522.TCGA-BJ-A191-10A-01D-A13W-08.1.filtered.,WGS,G32522.TCGA-BJ-A191-10A-01D-A13W-08.1,G32522.TCGA-BJ-A191-10A-01D-A13W-08.1.bam,61.82,1.95,0.08,58cfa82ee4b0c9d6adf6ab08,G32522.TCGA-BJ-A191-10A-01D-A13W-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A191-10A,2501EE46-8D38-448B-8765-E9C9706CBBE8,Blood Derived Normal,Illumina HiSeq,90b2f3f6-acab-417a-b71d-99dd529a79e2,Thyroid,49,88A3A560-FB2D-4E5E-B7B5-831CF7F9671C,62C780B8-C3A9-4C61-A1BC-18A80C5CA48D,TCGA-BJ-A191-10A-01D-A13W-08,HG19_Broad_variant,TCGA-BJ-A191,TCGA-THCA,NA,s12725,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T1b,N0,Other  specify,Stage I
13722.58cfa82ee4b0c9d6adf6aae6,58cfa82ee4b0c9d6adf6aae6,G32531.TCGA-FK-A3S3-01A-11D-A22D-08.1.filtered.,WGS,G32531.TCGA-FK-A3S3-01A-11D-A22D-08.1,G32531.TCGA-FK-A3S3-01A-11D-A22D-08.1.bam,22.44,NA,0.09,58cfa82ee4b0c9d6adf6aae6,G32531.TCGA-FK-A3S3-01A-11D-A22D-08.1.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FK-A3S3-01A,785803BB-42A8-4AFB-B7B4-58C114894408,Primary Tumor,Illumina HiSeq,5c7965a4-3e29-4c83-87e5-2e23f356287c,Thyroid,43,F5EBEFBE-50FA-465A-A355-2C099941039D,15ABB2A3-10A2-4E04-8EB9-6EADBD976AF0,TCGA-FK-A3S3-01A-11D-A22D-08,HG19_Broad_variant,TCGA-FK-A3S3,TCGA-THCA,NA,s12344,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa82de4b0c9d6adf6a4b8,58cfa82de4b0c9d6adf6a4b8,0f22f8fd9ef38ba084e8f5d882a18e4d.filtered.,WGS,0f22f8fd9ef38ba084e8f5d882a18e4d,0f22f8fd9ef38ba084e8f5d882a18e4d.bam,39.65,2.05,0.08,58cfa82de4b0c9d6adf6a4b8,0f22f8fd9ef38ba084e8f5d882a18e4d.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A7-A0CE-11A,9D95A65B-E41D-4F93-92D4-99DCE29FF40D,Solid Tissue Normal,Illumina HiSeq,6cc44144-a33a-4a8c-a7a5-6ca9a0d019d4,Breast,57,139C8065-F56A-45F6-BC7E-7841F85A31AE,EFCAB56B-6F30-4443-801D-4BB8E30CCAD5,TCGA-A7-A0CE-11A-21D-A12L-09,GRCh37-lite,TCGA-A7-A0CE,TCGA-BRCA,NA,s5626,Washington University School of Medicine,Christiana Healthcare,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6ad83,58cfa82ee4b0c9d6adf6ad83,G39020.TCGA-BR-7722-01A-31D-2201-08.2.filtered.,WGS,G39020.TCGA-BR-7722-01A-31D-2201-08.2,G39020.TCGA-BR-7722-01A-31D-2201-08.2.bam,454.7,NA,0.05,58cfa82ee4b0c9d6adf6ad83,G39020.TCGA-BR-7722-01A-31D-2201-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-7722-01A,8D3E3D09-BC61-4D5E-B8D6-5AEE6CB488AE,Primary Tumor,Illumina HiSeq,2ca0a03f-9d9d-49da-98e7-b0ade46e5b18,Stomach,62,58038C32-1359-49EB-AAFE-2F44EC697F52,0FA9CFBA-0F49-47D0-AB54-9DD2144E0A73,TCGA-BR-7722-01A-31D-2201-08,HG19_Broad_variant,TCGA-BR-7722,TCGA-STAD,NA,s14806,Broad Institute of MIT and Harvard,Asterand,Ukraine,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6aaa4,58cfa82ee4b0c9d6adf6aaa4,G26386.TCGA-06-0745-01A-01D-1492-08.1.filtered.,WGS,G26386.TCGA-06-0745-01A-01D-1492-08.1,G26386.TCGA-06-0745-01A-01D-1492-08.1.bam,339.57,1.91,0.05,58cfa82ee4b0c9d6adf6aaa4,G26386.TCGA-06-0745-01A-01D-1492-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0745-01A,386B629E-FAB1-4033-B088-45D6EEB4A13E,Primary Tumor,Illumina HiSeq,02ccb42a-947e-4baf-90b2-dbd453844f63,Brain,59,6EB5B7FF-1797-4C31-AB5B-6DB2B2641C5B,41D50A3C-49FC-4D8A-9C25-BBBCD3A5DA6F,TCGA-06-0745-01A-01D-1492-08,HG19_Broad_variant,TCGA-06-0745,TCGA-GBM,239,s14305,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a510,58cfa82de4b0c9d6adf6a510,3ef8e47cf81ea29f26bf77c4c33b453f.filtered.,WGS,3ef8e47cf81ea29f26bf77c4c33b453f,3ef8e47cf81ea29f26bf77c4c33b453f.bam,80.41,NA,0.08,58cfa82de4b0c9d6adf6a510,3ef8e47cf81ea29f26bf77c4c33b453f.bam,Alive,FEMALE,Not available,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-DG-A2KJ-01A,7C93642D-7E05-40F8-B1EF-A014EDCFBA42,Primary Tumor,Illumina HiSeq,4399a247-c12c-480e-bc92-cf902a8a0a69,Cervix,50,4C1108C0-ED8A-4CAF-9417-DDFB6352C61E,8BE2B0F5-7BAD-4720-B13C-E95B32BDB933,TCGA-DG-A2KJ-01A-11D-A18J-09,GRCh37-lite,TCGA-DG-A2KJ,TCGA-CESC,NA,s1348,Washington University School of Medicine,Ontario Institute for Cancer Research,Canada,NO,T1b,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82de4b0c9d6adf6a526,58cfa82de4b0c9d6adf6a526,54edfd331e278de330c2f6fc9d8b6e06.filtered.,WGS,54edfd331e278de330c2f6fc9d8b6e06,54edfd331e278de330c2f6fc9d8b6e06.bam,45.22,2.08,0.08,58cfa82de4b0c9d6adf6a526,54edfd331e278de330c2f6fc9d8b6e06.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A15H-01A,5580B21A-2CDB-4777-AD79-6E06654144F5,Primary Tumor,Illumina HiSeq,f359078d-7930-4e46-a5d4-3978f5434622,Breast,38,7CB99442-005B-4611-94F9-03AF195EC7E3,6D7F44DF-E9F0-4542-A6D8-D14EE7804002,TCGA-E2-A15H-01A-11D-A19H-09,GRCh37-lite,TCGA-E2-A15H,TCGA-BRCA,NA,s5479,Washington University School of Medicine,Roswell Park,None,NO,T1c,N1mi,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82fe4b0c9d6adf6b45e,58cfa82fe4b0c9d6adf6b45e,TCGA-25-1319-01A-01D-0516-08_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-25-1319-01A-01D-0516-08_IlluminaGA-DNASeq_whole,TCGA-25-1319-01A-01D-0516-08_IlluminaGA-DNASeq_whole.bam,292.97,1.9,0.14,58cfa82fe4b0c9d6adf6b45e,TCGA-25-1319-01A-01D-0516-08_IlluminaGA-DNASeq_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-25-1319-01A,914D8613-3C25-4A10-BE50-28B42F4D3A5D,Primary Tumor,Illumina GA,e10837c0-180f-4712-8a8e-81cbcb7be3ab,Ovary,73,C063D066-9073-4F05-8A38-601AA65DC5BF,B1FE75E5-D8EA-42BF-8643-AA519D4BC937,TCGA-25-1319-01A-01D-0516-08,HG18_Broad_variant,TCGA-25-1319,TCGA-OV,1977,s17748,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ada6,58cfa82ee4b0c9d6adf6ada6,G47088.TCGA-34-5240-10A-01D-1441-08.1.filtered.,WGS,G47088.TCGA-34-5240-10A-01D-1441-08.1,G47088.TCGA-34-5240-10A-01D-1441-08.1.bam,465.4,1.9,0.05,58cfa82ee4b0c9d6adf6ada6,G47088.TCGA-34-5240-10A-01D-1441-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-34-5240-10A,E7D1B042-5B1C-4C29-B501-A5EF4810ECD2,Blood Derived Normal,Illumina HiSeq,b74ae64e-741f-4ffe-a9e5-779f121c98e1,Lung,73,091ED3F6-D99A-4A6B-A9E7-84FC968364EE,332AC9EB-64C2-474D-B772-07E504F3655D,TCGA-34-5240-10A-01D-1441-08,HG19_Broad_variant,TCGA-34-5240,TCGA-LUSC,NA,s10366,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2,N1,Lung Basaloid Squamous Cell Carcinoma,Stage IIB
13722.58cfa82ee4b0c9d6adf6aa60,58cfa82ee4b0c9d6adf6aa60,G32464.TCGA-BT-A20P-11A-11D-A14W-08.1.filtered.,WGS,G32464.TCGA-BT-A20P-11A-11D-A14W-08.1,G32464.TCGA-BT-A20P-11A-11D-A14W-08.1.bam,11.99,2.03,0.08,58cfa82ee4b0c9d6adf6aa60,G32464.TCGA-BT-A20P-11A-11D-A14W-08.1.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20P-11A,F48937ED-E294-41F0-8872-7010391167A9,Solid Tissue Normal,Illumina HiSeq,4f4ba732-c57e-421a-a421-532a1ce76f5d,Bladder,81,2A07DBF4-D44C-4643-8A37-80E013DBE20B,DD05D620-285E-4734-924B-C16361749FA4,TCGA-BT-A20P-11A-11D-A14W-08,HG19_Broad_variant,TCGA-BT-A20P,TCGA-BLCA,544,s2853,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82fe4b0c9d6adf6ba1c,58cfa82fe4b0c9d6adf6ba1c,TCGA-AA-3664-01A-01D-1981-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3664-01A-01D-1981-10_wgs_Illumina,TCGA-AA-3664-01A-01D-1981-10_wgs_Illumina.bam,338.96,1.9,0.16,58cfa82fe4b0c9d6adf6ba1c,TCGA-AA-3664-01A-01D-1981-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3664-01A,A06C09A8-0951-49F4-A765-5147BBCAE109,Primary Tumor,Illumina HiSeq,c35bd7d9-ece5-492b-9d5f-dcc047684dc0,Colorectal,74,D448668C-90F3-40FA-9961-88407090DA31,B6B6E1D3-C592-4836-BDAD-D53AF2DBCC9A,TCGA-AA-3664-01A-01D-1981-10,GRCh37-lite,TCGA-AA-3664,TCGA-COAD,NA,s13365,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6afc2,58cfa82ee4b0c9d6adf6afc2,G39020.TCGA-HU-8608-10A-01D-2394-08.2.filtered.,WGS,G39020.TCGA-HU-8608-10A-01D-2394-08.2,G39020.TCGA-HU-8608-10A-01D-2394-08.2.bam,293,NA,0.05,58cfa82ee4b0c9d6adf6afc2,G39020.TCGA-HU-8608-10A-01D-2394-08.2.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-HU-8608-10A,C6316FB5-99A7-4ADF-832F-DCE44DDCD3AA,Blood Derived Normal,Illumina HiSeq,7316c2ec-ff33-4f79-ab93-c88b253a0f5c,Stomach,70,E1E9690E-4BB6-4942-875A-2BFEAE30B68C,0AF3C4B6-0D9F-4630-B919-94BF0EC56529,TCGA-HU-8608-10A-01D-2394-08,HG19_Broad_variant,TCGA-HU-8608,TCGA-STAD,NA,s14960,Broad Institute of MIT and Harvard,National Cancer Center Korea,Korea South,NO,T4a,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIB
13722.58cfa82ee4b0c9d6adf6a8ec,58cfa82ee4b0c9d6adf6a8ec,G35154.TCGA-HT-7695-01A-11D-2253-08.1.filtered.,WGS,G35154.TCGA-HT-7695-01A-11D-2253-08.1,G35154.TCGA-HT-7695-01A-11D-2253-08.1.bam,86,NA,0.05,58cfa82ee4b0c9d6adf6a8ec,G35154.TCGA-HT-7695-01A-11D-2253-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7695-01A,5017C115-39B8-4C5C-8BE6-2CB298D7C641,Primary Tumor,Illumina HiSeq,0e08feb2-0a06-458b-a3ea-797020f9a68f,Brain,29,8B58DBF3-022C-4337-9FAD-5AE43B1B84F2,86386B36-2950-4479-B79F-4B347053C8BC,TCGA-HT-7695-01A-11D-2253-08,HG19_Broad_variant,TCGA-HT-7695,TCGA-LGG,NA,s8538,Broad Institute of MIT and Harvard,Case Western - St Joes,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa830e4b0c9d6adf6bcc0,58cfa830e4b0c9d6adf6bcc0,TCGA-B0-5094-01A-01D-2099-10_wgs_Illumina.filtered.,WGS,TCGA-B0-5094-01A-01D-2099-10_wgs_Illumina,TCGA-B0-5094-01A-01D-2099-10_wgs_Illumina.bam,167.4,1.9,0.15,58cfa830e4b0c9d6adf6bcc0,TCGA-B0-5094-01A-01D-2099-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-B0-5094-01A,8AAA4E25-5C12-4ACE-96DC-91AAA0C4457C,Primary Tumor,Illumina HiSeq,22151e7f-a939-414f-9658-14262a84253f,Kidney,62,B05A7F4B-BC56-4DA6-B810-79E7C3A5395E,D429C27A-5963-42FE-B3A0-7252C20669D8,TCGA-B0-5094-01A-01D-2099-10,GRCh37-lite,TCGA-B0-5094,TCGA-KIRC,333,s9445,Baylor College of Medicine,University of Pittsburgh,None,NO,T3b,N0,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa82de4b0c9d6adf6a554,58cfa82de4b0c9d6adf6a554,197f3fd7e47bd6b5fb644833e973edc1.filtered.,WGS,197f3fd7e47bd6b5fb644833e973edc1,197f3fd7e47bd6b5fb644833e973edc1.bam,6.1,NA,0.07,58cfa82de4b0c9d6adf6a554,197f3fd7e47bd6b5fb644833e973edc1.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-V5-A7RC-06A,AAC385C1-42F9-4D9E-B9BF-94CA13EBC5AE,Metastatic,HiSeq X Ten,050b7f6e-5608-41e2-a38e-85cf9011790a,Esophagus,55,E4FD9FD5-F75F-4B63-9C84-13887BB13682,4999C529-DDF9-43FE-B312-74302917BC0E,TCGA-V5-A7RC-06A-11D-A403-09,GRCh37-lite_WUGSC_variant_2,TCGA-V5-A7RC,TCGA-ESCA,104,s1809,Washington University School of Medicine,Duke University,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6b0f8,58cfa82ee4b0c9d6adf6b0f8,TCGA-13-1411-10A-01D-0515-09_whole.filtered.,WGS,TCGA-13-1411-10A-01D-0515-09_whole,TCGA-13-1411-10A-01D-0515-09_whole.bam,7.67,1.9,0.16,58cfa82ee4b0c9d6adf6b0f8,TCGA-13-1411-10A-01D-0515-09_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-1411-10A,A9D3A7B0-FAF8-4E56-8600-D9E6882A4F23,Blood Derived Normal,Illumina GA,1336f459-a60d-439b-84de-d5e072a99063,Ovary,81,490F7701-C88E-4269-824B-CDEE46ED34EB,5B2F504B-23FD-4C5B-A548-E24E186423F1,TCGA-13-1411-10A-01D-0515-09,NCBI36_WUGSC_variant,TCGA-13-1411,TCGA-OV,NA,s17868,Washington University School of Medicine,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6acc0,58cfa82ee4b0c9d6adf6acc0,G41960.TCGA-55-6984-01A-11D-1945-08.2.filtered.,WGS,G41960.TCGA-55-6984-01A-11D-1945-08.2,G41960.TCGA-55-6984-01A-11D-1945-08.2.bam,138.7,NA,0.05,58cfa82ee4b0c9d6adf6acc0,G41960.TCGA-55-6984-01A-11D-1945-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-55-6984-01A,F063DDBB-1668-40DF-9EC2-B0A23CA2C389,Primary Tumor,Illumina HiSeq,244af712-e56d-4419-bc80-cdbfc0262b92,Lung,71,76C0ADAE-EEF5-459E-A4C9-397D94EBFDCC,309F5324-5608-4F62-B744-5AB268B70927,TCGA-55-6984-01A-11D-1945-08,HG19_Broad_variant,TCGA-55-6984,TCGA-LUAD,760,s11321,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa830e4b0c9d6adf6bc9c,58cfa830e4b0c9d6adf6bc9c,TCGA-AB-2981-11A-01D-0739-09_whole.filtered.,WGS,TCGA-AB-2981-11A-01D-0739-09_whole,TCGA-AB-2981-11A-01D-0739-09_whole.bam,NA,NA,NA,58cfa830e4b0c9d6adf6bc9c,TCGA-AB-2981-11A-01D-0739-09_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2981-11A,BE6DD0E8-9966-4961-987D-4D64D15FF9CA,Solid Tissue Normal,Illumina GA,028aa18d-e3c2-4357-9582-bf225ff59aa5,Blood,35,4095AACF-1C0E-4542-BF01-4A8A9226C4C1,25CB572C-99A3-4FE6-8E7F-87ED37AB2D17,TCGA-AB-2981-11A-01D-0739-09,NCBI36_WUGSC_variant,TCGA-AB-2981,TCGA-LAML,NA,s7044,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6a91e,58cfa82ee4b0c9d6adf6a91e,G35154.TCGA-CS-5390-10A-01D-1468-08.1.filtered.,WGS,G35154.TCGA-CS-5390-10A-01D-1468-08.1,G35154.TCGA-CS-5390-10A-01D-1468-08.1.bam,216.7,1.9,0.05,58cfa82ee4b0c9d6adf6a91e,G35154.TCGA-CS-5390-10A-01D-1468-08.1.bam,Alive,FEMALE,WHITE,Not available,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-5390-10A,C6CF2B8E-40ED-4C9F-8419-D868BD5AFE11,Blood Derived Normal,Illumina HiSeq,4d87e0d2-5aa5-4679-9053-3cb9d44576f0,Brain,47,58E6E983-2372-49B9-893A-7DFAAEF9DDD0,43746417-C404-4B14-8A55-463E79F3A745,TCGA-CS-5390-10A-01D-1468-08,HG19_Broad_variant,TCGA-CS-5390,TCGA-LGG,NA,s8321,Broad Institute of MIT and Harvard,Thomas Jefferson University,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82de4b0c9d6adf6a4c8,58cfa82de4b0c9d6adf6a4c8,38ef66da807c6d6d0e5ff6f0534f5671.filtered.,WGS,38ef66da807c6d6d0e5ff6f0534f5671,38ef66da807c6d6d0e5ff6f0534f5671.bam,23.59,NA,0.08,58cfa82de4b0c9d6adf6a4c8,38ef66da807c6d6d0e5ff6f0534f5671.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-N1-A6IA-01A,8F4C042C-FBE3-4D0C-B2BD-695BC37483F5,Primary Tumor,HiSeq X Ten,c43b2b57-4323-4543-8d5d-4c9ad1d95f8e,Mesenchymal,41,AF8434CF-5C2F-48CC-B3AC-132DFB505DBD,26F94549-F63A-4C0F-8C70-0341EA0F528F,TCGA-N1-A6IA-01A-12D-A32I-09,GRCh37-lite,TCGA-N1-A6IA,TCGA-SARC,NA,s2480,Washington University School of Medicine,Montefiore Medical Center,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf73060,58cfa83ce4b0c9d6adf73060,a3d780740258da56025b3a939d1ea7d5.filtered.,WGS,a3d780740258da56025b3a939d1ea7d5,a3d780740258da56025b3a939d1ea7d5.bam,57.22,2.05,0.08,58cfa83ce4b0c9d6adf73060,a3d780740258da56025b3a939d1ea7d5.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A0YG-01A,C0892598-1F7B-4F23-9CD8-731F797753D5,Primary Tumor,Illumina HiSeq,64d3bdd6-809b-4c4e-bb57-71f60383b777,Breast,63,5006C942-BC9A-41CB-8674-2341B4E66230,4D409156-3A36-4C63-9AD6-B6AF34F27B06,TCGA-A2-A0YG-01A-21D-A19H-09,GRCh37-lite,TCGA-A2-A0YG,TCGA-BRCA,NA,s6747,Washington University School of Medicine,Walter Reed,None,NO,T2,N3a,Infiltrating Ductal Carcinoma,Stage IIIC
13722.58cfa82ee4b0c9d6adf6ab26,58cfa82ee4b0c9d6adf6ab26,G32557.TCGA-ER-A19T-06A-11D-A19A-08.1.filtered.,WGS,G32557.TCGA-ER-A19T-06A-11D-A19A-08.1,G32557.TCGA-ER-A19T-06A-11D-A19A-08.1.bam,21.29,NA,0.08,58cfa82ee4b0c9d6adf6ab26,G32557.TCGA-ER-A19T-06A-11D-A19A-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19T-06A,B85B14D7-3B5A-4800-AF12-622EC03B9FE5,Metastatic,Illumina HiSeq,bfbe7d34-f247-440d-ba07-439c02cdec96,Skin,51,D3EBC18D-E94B-4991-ABB0-5324B67CD8CE,3F98D326-5676-4257-9AF8-0A5F5D3C2527,TCGA-ER-A19T-06A-11D-A19A-08,HG19_Broad_variant,TCGA-ER-A19T,TCGA-SKCM,270,s7660,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T4a,N3,Not available,Stage IV
13722.58cfa82de4b0c9d6adf6a444,58cfa82de4b0c9d6adf6a444,05b05a3f284cf713011e4bd81b09ab5e.filtered.,WGS,05b05a3f284cf713011e4bd81b09ab5e,05b05a3f284cf713011e4bd81b09ab5e.bam,26.91,1.86,0.07,58cfa82de4b0c9d6adf6a444,05b05a3f284cf713011e4bd81b09ab5e.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0AV-01A,790FF5DB-B7F3-4946-AAED-305F66B1DD6A,Primary Tumor,Illumina HiSeq,b2a1b1a3-a780-4be9-9a65-8937ba5df3b0,Breast,52,DCE6CAC3-6C76-4574-B7A8-C7083B12F22E,9032B7FE-E38A-4641-A45E-67041668ADC4,TCGA-BH-A0AV-01A-31D-A10Y-09,GRCh37-lite,TCGA-BH-A0AV,TCGA-BRCA,NA,s6450,Washington University School of Medicine,University of Pittsburgh,None,NO,T1c,N0,Infiltrating Ductal Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6aaf8,58cfa82ee4b0c9d6adf6aaf8,G32539.TCGA-EM-A3AL-10A-01D-A202-08.1.filtered.,WGS,G32539.TCGA-EM-A3AL-10A-01D-A202-08.1,G32539.TCGA-EM-A3AL-10A-01D-A202-08.1.bam,47.56,NA,0.08,58cfa82ee4b0c9d6adf6aaf8,G32539.TCGA-EM-A3AL-10A-01D-A202-08.1.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3AL-10A,0C50A2C2-1D4C-45CA-9127-F96D4DB18DAF,Blood Derived Normal,Illumina HiSeq,000abafb-6f3e-4571-9390-b6aca92b7a12,Thyroid,45,34320DBA-8834-47BB-B42E-C153B954711E,876B9A95-F58F-427B-BFD1-6919ADDA895D,TCGA-EM-A3AL-10A-01D-A202-08,HG19_Broad_variant,TCGA-EM-A3AL,TCGA-THCA,NA,s12495,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa831e4b0c9d6adf6c862,58cfa831e4b0c9d6adf6c862,TCGA-CW-6093-01A-11D-2279-10_wgs_Illumina.filtered.,WGS,TCGA-CW-6093-01A-11D-2279-10_wgs_Illumina,TCGA-CW-6093-01A-11D-2279-10_wgs_Illumina.bam,112.4,1.9,0.05,58cfa831e4b0c9d6adf6c862,TCGA-CW-6093-01A-11D-2279-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CW-6093-01A,3F93D1CF-A307-4E29-9E6F-239E9FFAA179,Primary Tumor,Illumina HiSeq,1e7df335-e096-49e1-8490-8be7151ec2db,Kidney,73,13BA18EB-C94B-4F6C-AB50-2A98A8044CED,51206157-94CC-4702-8247-C98283B487AA,TCGA-CW-6093-01A-11D-2279-10,GRCh37-lite,TCGA-CW-6093,TCGA-KIRC,NA,s9571,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T1a,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6aaee,58cfa82ee4b0c9d6adf6aaee,G32466.TCGA-H4-A2HQ-01A-11D-A17V-08.2.filtered.,WGS,G32466.TCGA-H4-A2HQ-01A-11D-A17V-08.2,G32466.TCGA-H4-A2HQ-01A-11D-A17V-08.2.bam,54.46,NA,0.07,58cfa82ee4b0c9d6adf6aaee,G32466.TCGA-H4-A2HQ-01A-11D-A17V-08.2.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-H4-A2HQ-01A,CEDE5274-279D-4021-8ACA-5ECC4BF94D66,Primary Tumor,Illumina HiSeq,211fa39b-cffd-430e-b28a-b6624e81fb93,Bladder,64,CBEDC0DB-39FD-4661-9531-CC24D422FAC4,94108975-B7A0-40BA-AD39-E44CC62E8CC0,TCGA-H4-A2HQ-01A-11D-A17V-08,HG19_Broad_variant,TCGA-H4-A2HQ,TCGA-BLCA,NA,s3250,Broad Institute of MIT and Harvard,Medical College of Georgia,United States,NO,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa83ce4b0c9d6adf72fc8,58cfa83ce4b0c9d6adf72fc8,b939c2720803667f3b27acd9d4596892.filtered.,WGS,b939c2720803667f3b27acd9d4596892,b939c2720803667f3b27acd9d4596892.bam,36.4,NA,0.07,58cfa83ce4b0c9d6adf72fc8,b939c2720803667f3b27acd9d4596892.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-FX-A48G-01A,12BFD446-2EE5-4664-A492-C023D134F60F,Primary Tumor,Illumina HiSeq,1e67ee27-4af7-4e44-81ba-76ff196f16fb,Mesenchymal,56,CEEBA881-5A1D-4FDC-8C9D-D60B3FACECF2,CB5E1546-CDA6-4991-911C-F3DD9F1A475A,TCGA-FX-A48G-01A-11D-A24N-09,GRCh37-lite,TCGA-FX-A48G,TCGA-SARC,NA,s2464,Washington University School of Medicine,International Genomics Consortium,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6a948,58cfa82ee4b0c9d6adf6a948,G32560.TCGA-GN-A266-06A-11D-A197-08.3.filtered.,WGS,G32560.TCGA-GN-A266-06A-11D-A197-08.3,G32560.TCGA-GN-A266-06A-11D-A197-08.3.bam,47.6,NA,0.07,58cfa82ee4b0c9d6adf6a948,G32560.TCGA-GN-A266-06A-11D-A197-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-GN-A266-06A,3429967F-4F77-4894-BF27-C4A22698CA92,Metastatic,Illumina HiSeq,f4e4d0dd-2e69-4f3f-98ae-bb44eb0fe266,Skin,45,EA59B74A-7456-43DD-B79C-74040176F0CD,04AA6B77-8074-480C-872E-A1A47AFA5314,TCGA-GN-A266-06A-11D-A197-08,HG19_Broad_variant,TCGA-GN-A266,TCGA-SKCM,308,s7480,Broad Institute of MIT and Harvard,Roswell,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6abe3,58cfa82ee4b0c9d6adf6abe3,G35154.TCGA-FG-5964-10A-01D-1705-08.1.filtered.,WGS,G35154.TCGA-FG-5964-10A-01D-1705-08.1,G35154.TCGA-FG-5964-10A-01D-1705-08.1.bam,71.3,1.8,0.05,58cfa82ee4b0c9d6adf6abe3,G35154.TCGA-FG-5964-10A-01D-1705-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-5964-10A,648252DA-DD86-48D1-AE75-4257E3142B0B,Blood Derived Normal,Illumina HiSeq,fc837d52-5e38-4d1d-a953-48c321d60ce5,Brain,62,9BF6FB6A-1873-44C8-8BAF-225FEC4AEB24,96D57C40-FCC5-4DC4-857C-B2D334627206,TCGA-FG-5964-10A-01D-1705-08,HG19_Broad_variant,TCGA-FG-5964,TCGA-LGG,NA,s8333,Broad Institute of MIT and Harvard,Case Western,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6a8d7,58cfa82ee4b0c9d6adf6a8d7,G32459.TCGA-BL-A13J-01A-11D-A10S-08.3.filtered.,WGS,G32459.TCGA-BL-A13J-01A-11D-A10S-08.3,G32459.TCGA-BL-A13J-01A-11D-A10S-08.3.bam,57.46,1.9,0.08,58cfa82ee4b0c9d6adf6a8d7,G32459.TCGA-BL-A13J-01A-11D-A10S-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BL-A13J-01A,556FCBC8-172A-4AF1-8822-AE036E8D68E8,Primary Tumor,Illumina HiSeq,37852645-c37a-4adb-8701-9300e0dcdb65,Bladder,65,CF23846D-A7D2-40A9-8B51-49A27967D101,0C7ACA3F-E006-4DE3-AFC2-20B4F727D4FD,TCGA-BL-A13J-01A-11D-A10S-08,HG19_Broad_variant,TCGA-BL-A13J,TCGA-BLCA,81,s3075,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,T4,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa832e4b0c9d6adf6d151,58cfa832e4b0c9d6adf6d151,TCGA-KL-8325-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8325-11A-01D-2310-10_wgs_Illumina,TCGA-KL-8325-11A-01D-2310-10_wgs_Illumina.bam,141.3,NA,0.05,58cfa832e4b0c9d6adf6d151,TCGA-KL-8325-11A-01D-2310-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8325-11A,6101FFE6-2EF6-4256-9D6B-A7C545836995,Solid Tissue Normal,Illumina HiSeq,73ef775c-bfae-420f-9ad9-f3e65831fe0c,Kidney,56,82628558-89B9-43FB-A34F-55D10D9C1ABB,4FF5A4A6-94F8-4F4C-AE7C-9B1DDB971FB7,TCGA-KL-8325-11A-01D-2310-10,GRCh37-lite,TCGA-KL-8325,TCGA-KICH,725,s16425,Baylor College of Medicine,MSKCC,United States,NO,T2,NX,Kidney Chromophobe,Stage II
13722.58cfa82ee4b0c9d6adf6ab93,58cfa82ee4b0c9d6adf6ab93,G32537.TCGA-EL-A3CX-10A-01D-A19M-08.4.filtered.,WGS,G32537.TCGA-EL-A3CX-10A-01D-A19M-08.4,G32537.TCGA-EL-A3CX-10A-01D-A19M-08.4.bam,8.5,NA,0.08,58cfa82ee4b0c9d6adf6ab93,G32537.TCGA-EL-A3CX-10A-01D-A19M-08.4.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EL-A3CX-10A,934A58AF-0FFC-487E-9E95-FA7643B7D5CB,Blood Derived Normal,Illumina HiSeq,4f422b97-c72e-45b0-896c-22fb87028374,Thyroid,22,34DEE671-DBAA-4D57-BEFF-4CAEBE8B0479,180BBC51-BDE0-4489-AD9D-EC66B632839B,TCGA-EL-A3CX-10A-01D-A19M-08,HG19_Broad_variant,TCGA-EL-A3CX,TCGA-THCA,NA,s12214,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82ee4b0c9d6adf6aa8e,58cfa82ee4b0c9d6adf6aa8e,G32558.TCGA-FS-A1ZD-10A-01D-A199-08.2.filtered.,WGS,G32558.TCGA-FS-A1ZD-10A-01D-A199-08.2,G32558.TCGA-FS-A1ZD-10A-01D-A199-08.2.bam,45.56,NA,0.08,58cfa82ee4b0c9d6adf6aa8e,G32558.TCGA-FS-A1ZD-10A-01D-A199-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZD-10A,C2948FE9-5798-43BC-A743-511E94E417F8,Blood Derived Normal,Illumina HiSeq,fd5d5c75-b383-4b56-ab23-f375d19f0b7c,Skin,63,D502A3A3-2BD2-49FE-92B7-5DF2826B53E9,DE373850-B2CA-457E-A345-C7634A1DD4FA,TCGA-FS-A1ZD-10A-01D-A199-08,HG19_Broad_variant,TCGA-FS-A1ZD,TCGA-SKCM,1628,s7813,Broad Institute of MIT and Harvard,Essen,Germany,NO,T2b,N0,Not available,Stage IIA
13722.58cfa82ee4b0c9d6adf6afb8,58cfa82ee4b0c9d6adf6afb8,G37566.TCGA-HC-8258-10A-01D-2260-08.3.filtered.,WGS,G37566.TCGA-HC-8258-10A-01D-2260-08.3,G37566.TCGA-HC-8258-10A-01D-2260-08.3.bam,254.6,NA,0.05,58cfa82ee4b0c9d6adf6afb8,G37566.TCGA-HC-8258-10A-01D-2260-08.3.bam,Alive,MALE,Not available,Not available,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-8258-10A,DA5B0169-E4F4-4674-B348-220AF03FF4B5,Blood Derived Normal,Illumina HiSeq,9a96b90c-ef2a-4dc8-a554-8c646275ad73,Prostate,56,B4F16F4A-2CDF-4A71-A8AE-F6478C0E6466,BF511245-3F97-49F0-9422-C646FA25DBA0,TCGA-HC-8258-10A-01D-2260-08,HG19_Broad_variant,TCGA-HC-8258,TCGA-PRAD,NA,s3764,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c442,58cfa831e4b0c9d6adf6c442,TCGA-CJ-4885-01A-01D-2098-10_Illumina.filtered.,WGS,TCGA-CJ-4885-01A-01D-2098-10_Illumina,TCGA-CJ-4885-01A-01D-2098-10_Illumina.bam,75.7,1.9,0.15,58cfa831e4b0c9d6adf6c442,TCGA-CJ-4885-01A-01D-2098-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CJ-4885-01A,5338D435-68FB-4F0D-A3E6-C843F703F75F,Primary Tumor,Illumina HiSeq,e9c31511-6628-44c2-a7cf-b25609056ad9,Kidney,64,A30B3254-3963-48D1-9710-7C3CAC0B1993,72C0603B-AD49-4E53-8164-2B69614BB743,TCGA-CJ-4885-01A-01D-2098-10,GRCh37-lite,TCGA-CJ-4885,TCGA-KIRC,NA,s9171,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T3a,NX,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa82ee4b0c9d6adf6ac8e,58cfa82ee4b0c9d6adf6ac8e,G47088.TCGA-66-2793-11A-01D-1267-08.1.filtered.,WGS,G47088.TCGA-66-2793-11A-01D-1267-08.1,G47088.TCGA-66-2793-11A-01D-1267-08.1.bam,513.63,1.9,0.16,58cfa82ee4b0c9d6adf6ac8e,G47088.TCGA-66-2793-11A-01D-1267-08.1.bam,Dead,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-66-2793-11A,9AF6ED4E-8CDC-4F49-84E9-BA1053B5B3CA,Solid Tissue Normal,Illumina HiSeq,d6d1cdbf-2252-48fa-836e-f875c9d26c46,Lung,68,F9F1F4A3-305E-4716-8C00-65B54A805E46,04580E16-1552-442C-ACE6-7557146F72B2,TCGA-66-2793-11A-01D-1267-08,HG19_Broad_variant,TCGA-66-2793,TCGA-LUSC,306,s10079,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T4,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIB
13722.58cfa830e4b0c9d6adf6ba4e,58cfa830e4b0c9d6adf6ba4e,TCGA-A2-A0D2-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-A2-A0D2-10A-01D-A128-09_IlluminaGA-DNASeq_whole,TCGA-A2-A0D2-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,24.52,1.8,0.07,58cfa830e4b0c9d6adf6ba4e,TCGA-A2-A0D2-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A0D2-10A,99E32C59-AA73-43FA-88C9-399DDADB2C72,Blood Derived Normal,Illumina HiSeq,956f0d4d-6f36-47f6-b9b0-f418ba4544c5,Breast,45,4DD51CDC-2A9E-4A67-A506-E7CD39390AFC,1A1589CC-44A9-4C4F-A0AF-EF3FD3C8E1F2,TCGA-A2-A0D2-10A-01D-A128-09,GRCh37-lite,TCGA-A2-A0D2,TCGA-BRCA,NA,s6269,Washington University School of Medicine,Walter Reed,None,NO,T2,N0 (i+),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a50e,58cfa82de4b0c9d6adf6a50e,29084d88d2f33ba899ea13cb6d938384.filtered.,WGS,29084d88d2f33ba899ea13cb6d938384,29084d88d2f33ba899ea13cb6d938384.bam,41.07,1.97,0.07,58cfa82de4b0c9d6adf6a50e,29084d88d2f33ba899ea13cb6d938384.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AN-A0XR-01A,F51AF6DB-2655-47FB-9FFC-83A503A728EA,Primary Tumor,Illumina HiSeq,19e1e7d4-80dd-4107-98b2-6796fe22947f,Breast,55,6EDCDB8A-80E8-42A8-86FF-3950C1F3CB89,E7DC7492-3A84-49C7-8DEA-8F508B53DC40,TCGA-AN-A0XR-01A-11D-A10G-09,GRCh37-lite,TCGA-AN-A0XR,TCGA-BRCA,NA,s5477,Washington University School of Medicine,Cureline,None,NO,T2,N2,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82ee4b0c9d6adf6ab72,58cfa82ee4b0c9d6adf6ab72,G32465.TCGA-BT-A20Q-11A-11D-A14W-08.1.filtered.,WGS,G32465.TCGA-BT-A20Q-11A-11D-A14W-08.1,G32465.TCGA-BT-A20Q-11A-11D-A14W-08.1.bam,7,1.89,0.07,58cfa82ee4b0c9d6adf6ab72,G32465.TCGA-BT-A20Q-11A-11D-A14W-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20Q-11A,419DEAAC-EA45-4BDD-9FA0-B5CD8429B44F,Solid Tissue Normal,Illumina HiSeq,c4e57539-5d0e-43ce-87df-73ae5c8e8738,Bladder,73,DF346965-B972-445D-9AAC-35605B908F4D,21D0907A-AC47-4A72-8F6C-74D25949FE11,TCGA-BT-A20Q-11A-11D-A14W-08,HG19_Broad_variant,TCGA-BT-A20Q,TCGA-BLCA,593,s3072,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa830e4b0c9d6adf6bb04,58cfa830e4b0c9d6adf6bb04,TCGA-61-2095-01A-01D-0926-12_Illumina.filtered.,WGS,TCGA-61-2095-01A-01D-0926-12_Illumina,TCGA-61-2095-01A-01D-0926-12_Illumina.bam,356.07,1.9,0.14,58cfa830e4b0c9d6adf6bb04,TCGA-61-2095-01A-01D-0926-12_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-61-2095-01A,778CE436-A825-4689-81C1-B7C965404163,Primary Tumor,Illumina HiSeq,1012f498-409c-4df9-ba07-d83dfb56914d,Ovary,54,B2CDE517-9404-45B2-BD39-3DEDB4E129FC,561E3061-26E7-4E5D-9853-6AA71F82DC36,TCGA-61-2095-01A-01D-0926-12,NCBI36_BCM_variant,TCGA-61-2095,TCGA-OV,1875,s17472,Baylor College of Medicine,University of Pittsburgh,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b22b,58cfa82fe4b0c9d6adf6b22b,TCGA-04-1371-11A-01D-0516-08_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-04-1371-11A-01D-0516-08_IlluminaGA-DNASeq_whole,TCGA-04-1371-11A-01D-0516-08_IlluminaGA-DNASeq_whole.bam,235.27,1.9,0.14,58cfa82fe4b0c9d6adf6b22b,TCGA-04-1371-11A-01D-0516-08_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-04-1371-11A,BFF84539-7862-45B2-B5FC-E77291FCCA8B,Solid Tissue Normal,Illumina GA,9cab9d2a-244a-421f-a4ea-0762fb9119db,Ovary,58,6FEFB3D5-7FEA-438F-8986-681082BE8819,81B30BC6-2BC4-48BA-AC99-E10786AFDC3A,TCGA-04-1371-11A-01D-0516-08,HG18_Broad_variant,TCGA-04-1371,TCGA-OV,NA,s17710,Broad Institute of MIT and Harvard,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6acb8,58cfa82ee4b0c9d6adf6acb8,G37566.TCGA-HC-7744-10A-01D-2115-08.1.filtered.,WGS,G37566.TCGA-HC-7744-10A-01D-2115-08.1,G37566.TCGA-HC-7744-10A-01D-2115-08.1.bam,84.6,NA,0.05,58cfa82ee4b0c9d6adf6acb8,G37566.TCGA-HC-7744-10A-01D-2115-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7744-10A,F6381367-142C-45D0-92B3-C1727D1813CE,Blood Derived Normal,Illumina HiSeq,d577528b-ba13-4fce-94b9-4222459bab0c,Prostate,46,5DC18FCC-122A-4E8E-80D3-C7E0D3765D93,12E7E0E3-0619-4659-AC66-F999415AD396,TCGA-HC-7744-10A-01D-2115-08,HG19_Broad_variant,TCGA-HC-7744,TCGA-PRAD,NA,s3411,Broad Institute of MIT and Harvard,International Genomics Consortium,None,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6abba,58cfa82ee4b0c9d6adf6abba,G32543.TCGA-GN-A26C-10A-01D-A19A-08.4.filtered.,WGS,G32543.TCGA-GN-A26C-10A-01D-A19A-08.4,G32543.TCGA-GN-A26C-10A-01D-A19A-08.4.bam,12.31,NA,0.07,58cfa82ee4b0c9d6adf6abba,G32543.TCGA-GN-A26C-10A-01D-A19A-08.4.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-GN-A26C-10A,FA099993-EF30-4EFF-A8FB-AA41B5EA671A,Blood Derived Normal,Illumina HiSeq,0d54d837-8333-4404-9a2e-783be88dbe18,Skin,77,D885D3A2-1668-4E28-A137-8ECC22C096FC,CA8BFCEC-4721-46D0-8C5A-7AC30D86E424,TCGA-GN-A26C-10A-01D-A19A-08,HG19_Broad_variant,TCGA-GN-A26C,TCGA-SKCM,821,s7652,Broad Institute of MIT and Harvard,Roswell,United States,NO,T4b,N2b,Not available,Stage IIIC
13722.58cfa82ee4b0c9d6adf6a94d,58cfa82ee4b0c9d6adf6a94d,G35154.TCGA-DU-5874-01A-11D-1705-08.2.filtered.,WGS,G35154.TCGA-DU-5874-01A-11D-1705-08.2,G35154.TCGA-DU-5874-01A-11D-1705-08.2.bam,301.3,1.9,0.05,58cfa82ee4b0c9d6adf6a94d,G35154.TCGA-DU-5874-01A-11D-1705-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-5874-01A,1CC53ADE-73C0-492B-A7DC-328269FD0E66,Primary Tumor,Illumina HiSeq,b0268c63-93dc-4e0b-b29b-217fd6028c92,Brain,62,3C7CE3D5-F9E4-4FAE-B033-2058446ED7F3,85D915B8-0184-4EC7-93AD-E9FFA2F5743B,TCGA-DU-5874-01A-11D-1705-08,HG19_Broad_variant,TCGA-DU-5874,TCGA-LGG,NA,s8546,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82de4b0c9d6adf6a614,58cfa82de4b0c9d6adf6a614,511a3675203dfa8034f97dbe11cc6195.filtered.,WGS,511a3675203dfa8034f97dbe11cc6195,511a3675203dfa8034f97dbe11cc6195.bam,35.64,NA,0.08,58cfa82de4b0c9d6adf6a614,511a3675203dfa8034f97dbe11cc6195.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-GM-A2DF-01A,D6F7AFC0-1558-43AD-ACB1-2B5311ED2264,Primary Tumor,Illumina HiSeq,f577059e-baa8-4030-9baa-5857d30fbfec,Breast,53,66760E17-251D-4981-BB02-82C29B315080,7456ABD5-303E-4E6F-BF4E-47EFEFC7310F,TCGA-GM-A2DF-01A-11D-A17W-09,GRCh37-lite,TCGA-GM-A2DF,TCGA-BRCA,NA,s6763,Washington University School of Medicine,MD Anderson,United States,NO,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6c41c,58cfa831e4b0c9d6adf6c41c,TCGA-CJ-4885-11A-01D-2098-10_Illumina.filtered.,WGS,TCGA-CJ-4885-11A-01D-2098-10_Illumina,TCGA-CJ-4885-11A-01D-2098-10_Illumina.bam,38.07,1.9,0.15,58cfa831e4b0c9d6adf6c41c,TCGA-CJ-4885-11A-01D-2098-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CJ-4885-11A,5338D435-68FB-4F0D-A3E6-C843F703F75F,Solid Tissue Normal,Illumina HiSeq,f8840c44-fa14-4bc4-a108-93f79453b16d,Kidney,64,85E901C7-BF9C-4195-B91B-090396A9992C,642BF783-2E83-4DB0-9D96-7763A4195C10,TCGA-CJ-4885-11A-01D-2098-10,GRCh37-lite,TCGA-CJ-4885,TCGA-KIRC,NA,s9737,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T3a,NX,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa82ee4b0c9d6adf6adbe,58cfa82ee4b0c9d6adf6adbe,G39020.TCGA-CG-5730-11A-01D-1600-08.1.filtered.,WGS,G39020.TCGA-CG-5730-11A-01D-1600-08.1,G39020.TCGA-CG-5730-11A-01D-1600-08.1.bam,82.3,1.9,0.05,58cfa82ee4b0c9d6adf6adbe,G39020.TCGA-CG-5730-11A-01D-1600-08.1.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5730-11A,09587F1C-5C99-4102-BC49-84D50FA8D0CE,Solid Tissue Normal,Illumina HiSeq,7f327ebb-598c-4874-93d0-5f525410a382,Stomach,80,16225D9E-2074-42AE-91E5-4D0352916465,432F25DB-BDBB-4B92-89C0-7F179F3927ED,TCGA-CG-5730-11A-01D-1600-08,HG19_Broad_variant,TCGA-CG-5730,TCGA-STAD,NA,s15176,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa82ee4b0c9d6adf6a952,58cfa82ee4b0c9d6adf6a952,G26382.TCGA-06-2557-01A-01D-1494-08.1.filtered.,WGS,G26382.TCGA-06-2557-01A-01D-1494-08.1,G26382.TCGA-06-2557-01A-01D-1494-08.1.bam,633.7,1.9,0.05,58cfa82ee4b0c9d6adf6a952,G26382.TCGA-06-2557-01A-01D-1494-08.1.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-2557-01A,6C28F086-6A25-40B6-93EB-BBA0014ACDA6,Primary Tumor,Illumina HiSeq,582d62de-97f1-4c69-8559-dd865f368abd,Brain,76,19521291-90A2-4865-9D3F-25973130D22E,C27290E4-6835-448A-ABDC-DF8DDD5F4630,TCGA-06-2557-01A-01D-1494-08,HG19_Broad_variant,TCGA-06-2557,TCGA-GBM,33,s14370,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6bbd6,58cfa830e4b0c9d6adf6bbd6,TCGA-AG-4008-10A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AG-4008-10A-01D-1989-10_wgs_Illumina,TCGA-AG-4008-10A-01D-1989-10_wgs_Illumina.bam,44.59,1.9,0.17,58cfa830e4b0c9d6adf6bbd6,TCGA-AG-4008-10A-01D-1989-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-4008-10A,72802851-9340-4C5F-A90B-23B7AFD7577A,Blood Derived Normal,Illumina HiSeq,2cf15e4e-c16a-4ab3-9e9c-4db6871e0c1f,Colorectal,63,BA57F55A-1ADE-4C91-9B44-ED9DE039CF29,174F2CAF-EC3C-4816-B9D9-B9421C791BA5,TCGA-AG-4008-10A-01D-1989-10,GRCh37-lite,TCGA-AG-4008,TCGA-READ,NA,s1989,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6af24,58cfa82ee4b0c9d6adf6af24,G39020.TCGA-F1-6177-01A-11D-1800-08.2.filtered.,WGS,G39020.TCGA-F1-6177-01A-11D-1800-08.2,G39020.TCGA-F1-6177-01A-11D-1800-08.2.bam,466.4,1.8,0.05,58cfa82ee4b0c9d6adf6af24,G39020.TCGA-F1-6177-01A-11D-1800-08.2.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-F1-6177-01A,C3CBA26E-38C2-4569-AFD6-6B045E604808,Primary Tumor,Illumina HiSeq,347b5bd7-20b6-4635-ae86-d43256011296,Stomach,90,0538EFDE-935D-4571-A200-B181AB622447,1D0617E8-2725-4411-B50F-E46EA1D43242,TCGA-F1-6177-01A-11D-1800-08,HG19_Broad_variant,TCGA-F1-6177,TCGA-STAD,NA,s14962,Broad Institute of MIT and Harvard,UNC,United States,NO,T1b,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage I
13722.58cfa82de4b0c9d6adf6a5fc,58cfa82de4b0c9d6adf6a5fc,5e859f6467c712851a78fd973b655dc1.filtered.,WGS,5e859f6467c712851a78fd973b655dc1,5e859f6467c712851a78fd973b655dc1.bam,106.84,1.77,0.08,58cfa82de4b0c9d6adf6a5fc,5e859f6467c712851a78fd973b655dc1.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LL-01A,D17668C4-5D66-4E16-8B70-B54616581AAE,Primary Tumor,Illumina HiSeq,56b1f38e-7065-46ee-8f41-f17603791f9f,Uterus,56,488A7462-8348-422C-91D3-7D9F0C39D25E,0385961E-EA99-40B2-AD79-6872BC30D8A1,TCGA-AP-A0LL-01A-12D-A127-09,GRCh37-lite,TCGA-AP-A0LL,TCGA-UCEC,NA,s4412,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bfec,58cfa830e4b0c9d6adf6bfec,TCGA-AG-3885-10A-01D-0967-10_wgs_Illumina.filtered.,WGS,TCGA-AG-3885-10A-01D-0967-10_wgs_Illumina,TCGA-AG-3885-10A-01D-0967-10_wgs_Illumina.bam,19.31,1.8,0.15,58cfa830e4b0c9d6adf6bfec,TCGA-AG-3885-10A-01D-0967-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3885-10A,E5E4AA9F-6015-4D62-A088-69920D7F2500,Blood Derived Normal,Illumina HiSeq,74661b7f-2008-4350-8dac-1a414f9e4b35,Colorectal,71,D7D09FF1-A9F4-4E5B-B1C1-854DF4A856C9,D7F5C210-C7B5-4BD6-9F42-7999FC4A2287,TCGA-AG-3885-10A-01D-0967-10,GRCh37-lite,TCGA-AG-3885,TCGA-READ,NA,s1969,Baylor College of Medicine,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIB
13722.58cfa83ce4b0c9d6adf72ea2,58cfa83ce4b0c9d6adf72ea2,c365daeccf937ff8ec5b164169f4beb6.filtered.,WGS,c365daeccf937ff8ec5b164169f4beb6,c365daeccf937ff8ec5b164169f4beb6.bam,32.61,NA,0.08,58cfa83ce4b0c9d6adf72ea2,c365daeccf937ff8ec5b164169f4beb6.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A3XX-01A,53886143-C1C6-40E9-88E6-E4E5E0271FC8,Primary Tumor,Illumina HiSeq,c11a6c92-3f76-42d3-aa9d-e1e4c34f7cf5,Breast,49,0A1F4A81-38C6-407A-A33B-716A0F9A6B4D,C67409B2-AC25-42A0-8543-4636EF132FE4,TCGA-A2-A3XX-01A-21D-A23C-09,GRCh37-lite,TCGA-A2-A3XX,TCGA-BRCA,NA,s5622,Washington University School of Medicine,Walter Reed,United States,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6c056,58cfa830e4b0c9d6adf6c056,TCGA-B2-4102-11A-01D-2095-10_Illumina.filtered.,WGS,TCGA-B2-4102-11A-01D-2095-10_Illumina,TCGA-B2-4102-11A-01D-2095-10_Illumina.bam,368.64,1.9,0.16,58cfa830e4b0c9d6adf6c056,TCGA-B2-4102-11A-01D-2095-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-B2-4102-11A,BBBCE1BA-C739-43BA-B9CF-A4F746491AE3,Solid Tissue Normal,Illumina HiSeq,be0f86e8-20bd-4667-9989-238cb3598409,Kidney,61,F0D45C3A-CE46-4F6B-81E5-E2A0D64D5018,E1AF298A-4B77-495F-A10B-9991A6A2D227,TCGA-B2-4102-11A-01D-2095-10,GRCh37-lite,TCGA-B2-4102,TCGA-KIRC,NA,s9158,Baylor College of Medicine,Christiana Healthcare,None,NO,T1b,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6a900,58cfa82ee4b0c9d6adf6a900,G32553.TCGA-ER-A19E-10A-01D-A199-08.2.filtered.,WGS,G32553.TCGA-ER-A19E-10A-01D-A199-08.2,G32553.TCGA-ER-A19E-10A-01D-A199-08.2.bam,21.01,NA,0.08,58cfa82ee4b0c9d6adf6a900,G32553.TCGA-ER-A19E-10A-01D-A199-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19E-10A,3FEA3F02-2DB3-44E0-984E-C61130D92C9B,Blood Derived Normal,Illumina HiSeq,c599f7bf-a2b9-4792-bf21-feab85ec1f37,Skin,36,D88BD93A-7ACE-4247-B36E-D434583D31BC,1A1A5E25-4A1B-4573-8D3E-25869F434568,TCGA-ER-A19E-10A-01D-A199-08,HG19_Broad_variant,TCGA-ER-A19E,TCGA-SKCM,396,s7654,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2a,N0,Not available,Stage IB
13722.58cfa83ce4b0c9d6adf73128,58cfa83ce4b0c9d6adf73128,c71bbdff2d8e43b1dd7f270bf112e2c4.filtered.,WGS,c71bbdff2d8e43b1dd7f270bf112e2c4,c71bbdff2d8e43b1dd7f270bf112e2c4.bam,87.89,1.88,0.08,58cfa83ce4b0c9d6adf73128,c71bbdff2d8e43b1dd7f270bf112e2c4.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A0J1-01A,EC7A9D74-8B3F-4747-8926-1739A016AB2B,Primary Tumor,Illumina HiSeq,4d43e1fb-f822-45ec-b3db-8b91f598ced3,Uterus,80,AC14E378-2DE1-458A-B8CD-7C60131AA927,950486AD-14F8-480A-B079-9CC3CD842090,TCGA-AX-A0J1-01A-11D-A066-09,GRCh37-lite,TCGA-AX-A0J1,TCGA-UCEC,NA,s5470,Washington University School of Medicine,Gynecologic Oncology Group,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6abeb,58cfa82ee4b0c9d6adf6abeb,G35154.TCGA-HT-7689-01A-11D-2253-08.2.filtered.,WGS,G35154.TCGA-HT-7689-01A-11D-2253-08.2,G35154.TCGA-HT-7689-01A-11D-2253-08.2.bam,66,NA,0.05,58cfa82ee4b0c9d6adf6abeb,G35154.TCGA-HT-7689-01A-11D-2253-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7689-01A,D58B535A-6C95-43BB-AD88-0600E6447537,Primary Tumor,Illumina HiSeq,55583ba3-88d1-4c7c-8bf7-bfe2699d74da,Brain,58,80122820-0D29-4F56-BF14-AC5EEB6F2760,B95CD446-0FED-4DA2-892F-24B39D073AB4,TCGA-HT-7689-01A-11D-2253-08,HG19_Broad_variant,TCGA-HT-7689,TCGA-LGG,NA,s8336,Broad Institute of MIT and Harvard,Case Western - St Joes,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6aa3e,58cfa82ee4b0c9d6adf6aa3e,G26383.TCGA-02-2485-10A-01D-1494-08.1.filtered.,WGS,G26383.TCGA-02-2485-10A-01D-1494-08.1,G26383.TCGA-02-2485-10A-01D-1494-08.1.bam,83,1.9,0.05,58cfa82ee4b0c9d6adf6aa3e,G26383.TCGA-02-2485-10A-01D-1494-08.1.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-02-2485-10A,521EA765-1BD1-423D-A75D-091243DF37A9,Blood Derived Normal,Illumina HiSeq,47eadee3-8b51-492f-bbd2-2ae4e75e124c,Brain,53,1CC3998F-318A-4C25-8CCD-A720059FAFAD,8FAA4B6D-6C64-4C03-BB3D-E2D33DB491B0,TCGA-02-2485-10A-01D-1494-08,HG19_Broad_variant,TCGA-02-2485,TCGA-GBM,NA,s14303,Broad Institute of MIT and Harvard,MD Anderson Cancer Center,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a6cc,58cfa82de4b0c9d6adf6a6cc,823cfa525e9cabec801fa2f385995c7b.filtered.,WGS,823cfa525e9cabec801fa2f385995c7b,823cfa525e9cabec801fa2f385995c7b.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a6cc,823cfa525e9cabec801fa2f385995c7b.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3008-03A,898A092E-89FE-4010-AFEA-14C605F99481,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,19f482df-3ecd-45bf-81e0-dd19cf432ada,Blood,22,8C783E13-D589-4489-B3A6-8D4F4C4D514F,88E6D314-8576-444A-AF19-811F8FA44C90,TCGA-AB-3008-03A-01D-0741-05,GRCh37-lite,TCGA-AB-3008,TCGA-LAML,822,s7017,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82fe4b0c9d6adf6b2ec,58cfa82fe4b0c9d6adf6b2ec,TCGA-24-0980-10A-01D-0515-09_whole.filtered.,WGS,TCGA-24-0980-10A-01D-0515-09_whole,TCGA-24-0980-10A-01D-0515-09_whole.bam,97.37,1.68,0.14,58cfa82fe4b0c9d6adf6b2ec,TCGA-24-0980-10A-01D-0515-09_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-0980-10A,D1EEACA3-52C0-4A0C-916A-FD64CEC911D9,Blood Derived Normal,Illumina GA,b0c04e85-af91-413b-bd8a-ff40c600c0e9,Ovary,53,FF1500F7-8FC1-4ACD-B93D-375BF881B90A,0F5BFE60-BAF3-4142-B8AE-FD2FAE46666F,TCGA-24-0980-10A-01D-0515-09,NCBI36_WUGSC_variant,TCGA-24-0980,TCGA-OV,233,s17614,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a92a,58cfa82ee4b0c9d6adf6a92a,G32545.TCGA-EE-A29B-10A-01D-A199-08.1.filtered.,WGS,G32545.TCGA-EE-A29B-10A-01D-A199-08.1,G32545.TCGA-EE-A29B-10A-01D-A199-08.1.bam,23.54,NA,0.07,58cfa82ee4b0c9d6adf6a92a,G32545.TCGA-EE-A29B-10A-01D-A199-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A29B-10A,905EA29F-588A-497B-9F06-2EEF3BDC9442,Blood Derived Normal,Illumina HiSeq,5bebff06-11a9-4a6a-946c-3d1f4baf8a3d,Skin,67,CDBC7250-CFDB-485B-BD1F-B3D82DCD168D,9A345F68-0A6C-433E-91AF-1BD41491520C,TCGA-EE-A29B-10A-01D-A199-08,HG19_Broad_variant,TCGA-EE-A29B,TCGA-SKCM,NA,s7985,Broad Institute of MIT and Harvard,University of Sydney,Australia,NO,T3b,N0,Not available,Stage IIB
13722.58cfa82ee4b0c9d6adf6ab2c,58cfa82ee4b0c9d6adf6ab2c,G32556.TCGA-FS-A1ZU-06A-12D-A196-08.6.filtered.,WGS,G32556.TCGA-FS-A1ZU-06A-12D-A196-08.6,G32556.TCGA-FS-A1ZU-06A-12D-A196-08.6.bam,47.22,NA,0.09,58cfa82ee4b0c9d6adf6ab2c,G32556.TCGA-FS-A1ZU-06A-12D-A196-08.6.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZU-06A,7CE09A09-074E-4F38-BED7-98AB34347FBE,Metastatic,Illumina HiSeq,1514792f-0d8e-4ccc-9911-5a9d2a736d4b,Skin,70,DF5485BE-2879-448C-B014-D7FD545D8933,FE8C62A6-C113-46E8-AB91-FDB90BB6A59F,TCGA-FS-A1ZU-06A-12D-A196-08,HG19_Broad_variant,TCGA-FS-A1ZU,TCGA-SKCM,808,s7810,Broad Institute of MIT and Harvard,Essen,Germany,NO,T4b,N0,Not available,Stage IIC
13722.58cfa82ee4b0c9d6adf6aa35,58cfa82ee4b0c9d6adf6aa35,G26363.TCGA-19-2624-01A-01D-1495-08.2.filtered.,WGS,G26363.TCGA-19-2624-01A-01D-1495-08.2,G26363.TCGA-19-2624-01A-01D-1495-08.2.bam,164.1,1.9,0.05,58cfa82ee4b0c9d6adf6aa35,G26363.TCGA-19-2624-01A-01D-1495-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-19-2624-01A,2F4A127F-101A-4192-B3E8-F9BE2C8648BC,Primary Tumor,Illumina HiSeq,d4065322-376e-4196-afdd-8e8b7d51e85b,Brain,51,C9E1BE85-0699-48B4-8977-0DB46AF4EC94,A8F86B64-914C-4D89-897B-33BCDD1759F7,TCGA-19-2624-01A-01D-1495-08,HG19_Broad_variant,TCGA-19-2624,TCGA-GBM,5,s14343,Broad Institute of MIT and Harvard,Case Western,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a732,58cfa82de4b0c9d6adf6a732,G14580.TCGA-64-1678-10A-01D-1040-01.2.filtered.,WGS,G14580.TCGA-64-1678-10A-01D-1040-01.2,G14580.TCGA-64-1678-10A-01D-1040-01.2.bam,106.33,2,0.14,58cfa82de4b0c9d6adf6a732,G14580.TCGA-64-1678-10A-01D-1040-01.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-64-1678-10A,F77CF4D3-9829-4FD3-95A1-B29AED9E94B8,Blood Derived Normal,Illumina HiSeq,e6876c57-9b2f-4df9-a630-09281125e6c0,Lung,70,4BE4B413-FF14-4863-BEC6-8878EAF826D0,C705E3CE-3E8C-497A-8091-04FD4D369AFD,TCGA-64-1678-10A-01D-1040-01,HG19_Broad_variant,TCGA-64-1678,TCGA-LUAD,NA,s11208,Broad Institute of MIT and Harvard,Fox Chase,United States,NO,T2b,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa82de4b0c9d6adf6a658,58cfa82de4b0c9d6adf6a658,56ee38b83bbac3302bd71fef66bd52a5.filtered.,WGS,56ee38b83bbac3302bd71fef66bd52a5,56ee38b83bbac3302bd71fef66bd52a5.bam,73.22,2.09,0.07,58cfa82de4b0c9d6adf6a658,56ee38b83bbac3302bd71fef66bd52a5.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0JN-01A,B60F22AC-A659-4F33-B01D-820E86A9A5C9,Primary Tumor,Illumina HiSeq,4a8180de-0459-43a0-9e22-6a115e56912c,Uterus,84,684C6894-FD49-4934-8962-9628ECE734FB,8DD14F0E-8601-4AA1-864C-3C49E768CDD1,TCGA-B5-A0JN-01A-11D-A10B-09,GRCh37-lite,TCGA-B5-A0JN,TCGA-UCEC,NA,s4410,Washington University School of Medicine,Duke,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6acba,58cfa82ee4b0c9d6adf6acba,G37568.TCGA-DK-A1AE-10A-01D-A25T-08.2.filtered.,WGS,G37568.TCGA-DK-A1AE-10A-01D-A25T-08.2,G37568.TCGA-DK-A1AE-10A-01D-A25T-08.2.bam,43.92,1.98,0.08,58cfa82ee4b0c9d6adf6acba,G37568.TCGA-DK-A1AE-10A-01D-A25T-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AE-10A,493A4FF2-37A5-4B79-928D-83DBFE534556,Blood Derived Normal,Illumina HiSeq,d6087f4f-0f74-44c1-8d0e-1d2a7610e775,Bladder,84,FDE77852-768F-4949-9CCC-4FAA7BDBC6F3,B90F11BA-2F30-4D5E-B218-6D86D4FC2F46,TCGA-DK-A1AE-10A-01D-A25T-08,HG19_Broad_variant,TCGA-DK-A1AE,TCGA-BLCA,NA,s3262,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82ee4b0c9d6adf6ac19,58cfa82ee4b0c9d6adf6ac19,G39019.TCGA-ER-A19L-10A-01D-A199-08.2.filtered.,WGS,G39019.TCGA-ER-A19L-10A-01D-A199-08.2,G39019.TCGA-ER-A19L-10A-01D-A199-08.2.bam,12.67,NA,0.07,58cfa82ee4b0c9d6adf6ac19,G39019.TCGA-ER-A19L-10A-01D-A199-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19L-10A,5F6DF69C-4EBF-4811-8B28-AD393DFBE1A3,Blood Derived Normal,Illumina HiSeq,1825343f-5d5e-4230-916f-02477923d92f,Skin,35,A2CADDC2-B60F-42C0-B863-09AE4FC38249,338DF758-F109-4331-8D51-B3EE0EAB4229,TCGA-ER-A19L-10A-01D-A199-08,HG19_Broad_variant,TCGA-ER-A19L,TCGA-SKCM,4000,s7821,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6bde6,58cfa830e4b0c9d6adf6bde6,TCGA-AK-3428-10A-01D-1995-10_Illumina.filtered.,WGS,TCGA-AK-3428-10A-01D-1995-10_Illumina,TCGA-AK-3428-10A-01D-1995-10_Illumina.bam,28.1,2.1,0.14,58cfa830e4b0c9d6adf6bde6,TCGA-AK-3428-10A-01D-1995-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-AK-3428-10A,9DA334ED-314C-4445-BA29-FFD9BB42403C,Blood Derived Normal,Illumina HiSeq,ad128380-550c-45b6-8d11-335f20eb7d6e,Kidney,62,66EFD8C2-8DF6-40D3-A21B-64EB7E4170F5,42806ED5-4845-4251-B274-AD087B6F2D25,TCGA-AK-3428-10A-01D-1995-10,GRCh37-lite,TCGA-AK-3428,TCGA-KIRC,NA,s9444,Baylor College of Medicine,Fox Chase,None,NO,T3b,N0,Kidney Clear Cell Renal Carcinoma,Stage III
13722.58cfa830e4b0c9d6adf6bc31,58cfa830e4b0c9d6adf6bc31,TCGA-AA-3994-01A-01D-1981-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3994-01A-01D-1981-10_wgs_Illumina,TCGA-AA-3994-01A-01D-1981-10_wgs_Illumina.bam,631.89,1.9,0.16,58cfa830e4b0c9d6adf6bc31,TCGA-AA-3994-01A-01D-1981-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3994-01A,750770DB-53CF-4021-A8C2-5E0DDB97FEF5,Primary Tumor,Illumina HiSeq,6cc193d6-40f0-46ba-aa41-4240fe42a46c,Colorectal,69,41933A62-1325-4089-80B5-06E3EBB238DA,D9690A27-BB02-498E-B15C-EE76E31D16EE,TCGA-AA-3994-01A-01D-1981-10,GRCh37-lite,TCGA-AA-3994,TCGA-COAD,NA,s12867,Baylor College of Medicine,Indivumed,Germany,NO,T3,N1,Colon Mucinous Adenocarcinoma,Stage IIIB
13722.58cfa82ee4b0c9d6adf6ab56,58cfa82ee4b0c9d6adf6ab56,G32526.TCGA-EL-A3TB-11A-11D-A22D-08.1.filtered.,WGS,G32526.TCGA-EL-A3TB-11A-11D-A22D-08.1,G32526.TCGA-EL-A3TB-11A-11D-A22D-08.1.bam,16.16,NA,0.08,58cfa82ee4b0c9d6adf6ab56,G32526.TCGA-EL-A3TB-11A-11D-A22D-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EL-A3TB-11A,A09D0BE0-FD41-4B30-B488-9A9F2ABEF8E7,Solid Tissue Normal,Illumina HiSeq,0a011173-8596-4c4a-9393-4737a51d045c,Thyroid,47,0BB0685E-C618-44E0-9F1C-3B5ACF19F58D,9DCF95BF-FB65-4589-90CB-302DA798F00B,TCGA-EL-A3TB-11A-11D-A22D-08,HG19_Broad_variant,TCGA-EL-A3TB,TCGA-THCA,NA,s12342,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa82ee4b0c9d6adf6ac47,58cfa82ee4b0c9d6adf6ac47,G37566.TCGA-CH-5750-10A-01D-1576-08.2.filtered.,WGS,G37566.TCGA-CH-5750-10A-01D-1576-08.2,G37566.TCGA-CH-5750-10A-01D-1576-08.2.bam,289.4,1.9,0.05,58cfa82ee4b0c9d6adf6ac47,G37566.TCGA-CH-5750-10A-01D-1576-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5750-10A,DC40CF49-B208-4F59-B5F0-CFBDD02970B2,Blood Derived Normal,Illumina HiSeq,6173b866-6a9f-4c66-a7d7-4a27a7a974a2,Prostate,72,3877B217-E1C2-4FFA-8956-DCD5EBF4FBBD,69EBE1AB-C416-4473-8D82-91B475B206D4,TCGA-CH-5750-10A-01D-1576-08,HG19_Broad_variant,TCGA-CH-5750,TCGA-PRAD,NA,s4123,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c2d1,58cfa830e4b0c9d6adf6c2d1,TCGA-B2-4099-01A-02D-2095-10_wgs_Illumina.filtered.,WGS,TCGA-B2-4099-01A-02D-2095-10_wgs_Illumina,TCGA-B2-4099-01A-02D-2095-10_wgs_Illumina.bam,660.34,1.9,0.16,58cfa830e4b0c9d6adf6c2d1,TCGA-B2-4099-01A-02D-2095-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-B2-4099-01A,1ADB05D4-E1CA-4EDE-81C7-FF24A243ABAE,Primary Tumor,Illumina HiSeq,5a0ccacd-ed1b-47b2-818a-592a0cf426ad,Kidney,83,E242ADB8-DB67-475E-A0E4-52A622666B12,252A1C43-F954-44D7-8E31-6BCD0157A05C,TCGA-B2-4099-01A-02D-2095-10,GRCh37-lite,TCGA-B2-4099,TCGA-KIRC,NA,s9732,Baylor College of Medicine,Christiana Healthcare,None,NO,T1a,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82de4b0c9d6adf6a574,58cfa82de4b0c9d6adf6a574,2cf824ff67beaee254d0025b0c57ecfb.filtered.,WGS,2cf824ff67beaee254d0025b0c57ecfb,2cf824ff67beaee254d0025b0c57ecfb.bam,23.2,1.82,0.08,58cfa82de4b0c9d6adf6a574,2cf824ff67beaee254d0025b0c57ecfb.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-D8-A27H-01A,0DCA98B0-F43E-45B6-9A02-00092C78678C,Primary Tumor,Illumina HiSeq,bdde252c-e43c-448b-8e22-1ff90c7c957b,Breast,72,B7542984-1410-45E6-B936-8333FF902EB4,6764E0A2-7A78-45C1-9189-6001C6518CE4,TCGA-D8-A27H-01A-11D-A314-09,GRCh37-lite,TCGA-D8-A27H,TCGA-BRCA,NA,s5786,Washington University School of Medicine,Greater Poland Cancer Center,Poland,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6a88f,58cfa82ee4b0c9d6adf6a88f,G32466.TCGA-H4-A2HQ-10A-01D-A17V-08.1.filtered.,WGS,G32466.TCGA-H4-A2HQ-10A-01D-A17V-08.1,G32466.TCGA-H4-A2HQ-10A-01D-A17V-08.1.bam,10.51,NA,0.09,58cfa82ee4b0c9d6adf6a88f,G32466.TCGA-H4-A2HQ-10A-01D-A17V-08.1.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-H4-A2HQ-10A,CEDE5274-279D-4021-8ACA-5ECC4BF94D66,Blood Derived Normal,Illumina HiSeq,d0c006c3-3605-4574-b55d-e5412d46f756,Bladder,64,1650C0FB-03FF-45CB-93A6-A7544CEF346E,2A00D649-7F80-467D-849D-1383CCEEC965,TCGA-H4-A2HQ-10A-01D-A17V-08,HG19_Broad_variant,TCGA-H4-A2HQ,TCGA-BLCA,NA,s2684,Broad Institute of MIT and Harvard,Medical College of Georgia,United States,NO,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82de4b0c9d6adf6a5c6,58cfa82de4b0c9d6adf6a5c6,7abe99091880688658f0fbf83d4b2209.filtered.,WGS,7abe99091880688658f0fbf83d4b2209,7abe99091880688658f0fbf83d4b2209.bam,100.8,1.86,0.09,58cfa82de4b0c9d6adf6a5c6,7abe99091880688658f0fbf83d4b2209.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A1M8-01A,110CD100-5730-4873-9FAB-2AE6C8732062,Primary Tumor,Illumina HiSeq,bcb9d9ed-cd43-4eb0-a3e5-f667a80c20b7,Cervix,43,72FF7605-0905-4829-8B54-B76B45FBB0DF,07D20658-3DB4-47E7-877B-66536266EDFC,TCGA-C5-A1M8-01A-21D-A200-09,GRCh37-lite,TCGA-C5-A1M8,TCGA-CESC,NA,s1167,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,T1b,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d28e,58cfa832e4b0c9d6adf6d28e,TCGA-KL-8342-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8342-11A-01D-2310-10_wgs_Illumina,TCGA-KL-8342-11A-01D-2310-10_wgs_Illumina.bam,235.6,NA,0.05,58cfa832e4b0c9d6adf6d28e,TCGA-KL-8342-11A-01D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8342-11A,C689AE1D-4A6B-45DB-B4D1-6B34C5C61522,Solid Tissue Normal,Illumina HiSeq,930abaed-ab8d-4114-9307-ef261a1962df,Kidney,45,477E5746-8DCF-4FF1-AEA4-45ABF2F8D218,0D9307DB-AEE2-48B3-A11E-D570B626F1A0,TCGA-KL-8342-11A-01D-2310-10,GRCh37-lite,TCGA-KL-8342,TCGA-KICH,NA,s16428,Baylor College of Medicine,MSKCC,United States,NO,T2b,N0,Kidney Chromophobe,Stage II
13722.58cfa83ce4b0c9d6adf72f7d,58cfa83ce4b0c9d6adf72f7d,e82f5efc1a18908b7a00b45b9bfd5e18.filtered.,WGS,e82f5efc1a18908b7a00b45b9bfd5e18,e82f5efc1a18908b7a00b45b9bfd5e18.bam,48.87,1.91,0.08,58cfa83ce4b0c9d6adf72f7d,e82f5efc1a18908b7a00b45b9bfd5e18.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AR-A1AY-01A,5FD9552A-C742-4388-940D-295D1107AE00,Primary Tumor,Illumina HiSeq,45a65b22-252b-4f92-bd7b-16a76d26c165,Breast,65,81FC993E-8F5A-4B3B-BEA3-4C4C2F5E4EF2,15F90EF0-831B-40A3-98BD-EC226A9E8B26,TCGA-AR-A1AY-01A-21D-A12Q-09,GRCh37-lite,TCGA-AR-A1AY,TCGA-BRCA,NA,s6905,Washington University School of Medicine,Mayo,None,NO,T1,N0,Infiltrating Ductal Carcinoma,Stage I
13722.58cfa82de4b0c9d6adf6a588,58cfa82de4b0c9d6adf6a588,1c0d01c9e6e955d9106abd8457d6a436.filtered.,WGS,1c0d01c9e6e955d9106abd8457d6a436,1c0d01c9e6e955d9106abd8457d6a436.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a588,1c0d01c9e6e955d9106abd8457d6a436.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2981-11A,BE6DD0E8-9966-4961-987D-4D64D15FF9CA,Solid Tissue Normal,Illumina GA,4ede7a6b-145b-497c-a908-04207ffddd53,Blood,35,4095AACF-1C0E-4542-BF01-4A8A9226C4C1,25CB572C-99A3-4FE6-8E7F-87ED37AB2D17,TCGA-AB-2981-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2981,TCGA-LAML,NA,s7161,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa83ce4b0c9d6adf72f03,58cfa83ce4b0c9d6adf72f03,b66e82ee0591fe581241dcc082de2e52.filtered.,WGS,b66e82ee0591fe581241dcc082de2e52,b66e82ee0591fe581241dcc082de2e52.bam,56.36,1.95,0.07,58cfa83ce4b0c9d6adf72f03,b66e82ee0591fe581241dcc082de2e52.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-D1-A17K-01A,5C22C8D6-5805-455C-8E1C-E6B8006738E4,Primary Tumor,Illumina HiSeq,03c25260-4914-4b4e-817e-05d0ba7e3ded,Uterus,74,CA213835-EFC5-4216-A762-A6B320B516BF,105A51C4-CC7E-4D0F-9CF8-E4D64A31D14D,TCGA-D1-A17K-01A-11D-A325-09,GRCh37-lite,TCGA-D1-A17K,TCGA-UCEC,NA,s5370,Washington University School of Medicine,Mayo Clinic,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a9e5,58cfa82ee4b0c9d6adf6a9e5,G26360.TCGA-32-1970-01A-01D-1494-08.1.filtered.,WGS,G26360.TCGA-32-1970-01A-01D-1494-08.1,G26360.TCGA-32-1970-01A-01D-1494-08.1.bam,398.7,1.9,0.05,58cfa82ee4b0c9d6adf6a9e5,G26360.TCGA-32-1970-01A-01D-1494-08.1.bam,Dead,MALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-32-1970-01A,6C5154D2-AF36-492F-B520-D925528824E4,Primary Tumor,Illumina HiSeq,ce02c656-69b1-46a5-a120-f424ab059f55,Brain,59,115D06A0-7FFB-4E2F-BC09-59EA55D12894,65723119-BDFE-46F0-B629-C171023ABD71,TCGA-32-1970-01A-01D-1494-08,HG19_Broad_variant,TCGA-32-1970,TCGA-GBM,468,s13979,Broad Institute of MIT and Harvard,St. Joseph's Hospital (AZ),None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a5de,58cfa82de4b0c9d6adf6a5de,6541447d40abf6e8944eb0fde79c5bb3.filtered.,WGS,6541447d40abf6e8944eb0fde79c5bb3,6541447d40abf6e8944eb0fde79c5bb3.bam,42.49,NA,0.08,58cfa82de4b0c9d6adf6a5de,6541447d40abf6e8944eb0fde79c5bb3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A3LU-01A,E786DE34-4C21-460F-89AB-008DE4347049,Primary Tumor,Illumina HiSeq,5f6336e7-c966-4e89-81bd-15a9523a893c,Mesenchymal,60,39BBAA83-8143-4E62-836E-1584B41B073B,7D734D06-F2B1-4924-A201-620AC8084C49,TCGA-DX-A3LU-01A-11D-A21Q-09,GRCh37-lite,TCGA-DX-A3LU,TCGA-SARC,NA,s2489,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a464,58cfa82de4b0c9d6adf6a464,459f50a1a35d272785306ecb71cc5754.filtered.,WGS,459f50a1a35d272785306ecb71cc5754,459f50a1a35d272785306ecb71cc5754.bam,39.58,NA,0.08,58cfa82de4b0c9d6adf6a464,459f50a1a35d272785306ecb71cc5754.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-FX-A2QS-01A,2905CBD1-719B-46D9-B8AF-8FE4927BC473,Primary Tumor,Illumina HiSeq,8906cefc-240d-4590-8d00-1004fa85fd22,Mesenchymal,61,5402D273-3B02-4BF7-A0A4-625A59FED4CC,7D332CB1-BA25-47E4-8BF8-D25E14F40D59,TCGA-FX-A2QS-01A-11D-A21Q-09,GRCh37-lite,TCGA-FX-A2QS,TCGA-SARC,NA,s2486,Washington University School of Medicine,International Genomics Consortium,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82fe4b0c9d6adf6b924,58cfa82fe4b0c9d6adf6b924,TCGA-A6-2680-10A-01D-2188-10_wgs_Illumina.filtered.,WGS,TCGA-A6-2680-10A-01D-2188-10_wgs_Illumina,TCGA-A6-2680-10A-01D-2188-10_wgs_Illumina.bam,161,1.9,0.05,58cfa82fe4b0c9d6adf6b924,TCGA-A6-2680-10A-01D-2188-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2680-10A,FF1407C6-9174-4BAE-A19B-D34CA71B898C,Blood Derived Normal,Illumina HiSeq,918f63e2-8d07-4be2-aace-c4515f9dfd6b,Colorectal,72,9A6C98F6-F3B0-4BB7-9825-ED33C33C33D0,0FC5546F-CBF6-4A56-A0BF-67DCAA99CCF5,TCGA-A6-2680-10A-01D-2188-10,GRCh37-lite,TCGA-A6-2680,TCGA-COAD,NA,s13659,Baylor College of Medicine,Christiana Healthcare,None,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa82de4b0c9d6adf6a58a,58cfa82de4b0c9d6adf6a58a,186d1b12be64c51f2303cdddde357025.filtered.,WGS,186d1b12be64c51f2303cdddde357025,186d1b12be64c51f2303cdddde357025.bam,89.92,1.91,0.08,58cfa82de4b0c9d6adf6a58a,186d1b12be64c51f2303cdddde357025.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A1M9-01A,A3BE445A-A592-4073-815B-47AE41F9C4A0,Primary Tumor,Illumina HiSeq,e9ec290e-cad8-4af0-8b69-cf804598a951,Cervix,46,577057AF-7775-497B-BEE9-E04562648509,B9D1A64E-D445-4174-A5B4-76DD6EA69419,TCGA-C5-A1M9-01A-11D-A200-09,GRCh37-lite,TCGA-C5-A1M9,TCGA-CESC,1065,s1346,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,T3b,N1,Endocervical Type of Adenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf72f19,58cfa83ce4b0c9d6adf72f19,ccd535b1664251ecbc0fb70ec7dee554.filtered.,WGS,ccd535b1664251ecbc0fb70ec7dee554,ccd535b1664251ecbc0fb70ec7dee554.bam,17.51,1.95,0.07,58cfa83ce4b0c9d6adf72f19,ccd535b1664251ecbc0fb70ec7dee554.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A03N-01B,9435447E-D65F-408B-863B-6576B1D652DD,Primary Tumor,Illumina HiSeq,a198d001-d09b-4a43-9704-060db667151f,Breast,59,06B3E3CA-24B9-4E19-9E59-B51CC6D6735B,F8F749B7-547D-49FA-9DA2-44EED962B6FD,TCGA-AO-A03N-01B-11D-A19H-09,GRCh37-lite,TCGA-AO-A03N,TCGA-BRCA,NA,s6749,Washington University School of Medicine,MSKCC,None,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa831e4b0c9d6adf6c44e,58cfa831e4b0c9d6adf6c44e,TCGA-CJ-4899-11A-01D-2100-10_Illumina.filtered.,WGS,TCGA-CJ-4899-11A-01D-2100-10_Illumina,TCGA-CJ-4899-11A-01D-2100-10_Illumina.bam,144.77,1.9,0.14,58cfa831e4b0c9d6adf6c44e,TCGA-CJ-4899-11A-01D-2100-10_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CJ-4899-11A,900B5F21-E8FB-4A3F-B8E3-EF098716E508,Solid Tissue Normal,Illumina HiSeq,8df67578-2f2d-47b9-8d75-28933b228ce8,Kidney,42,CF55A398-69B5-4BE9-B2FE-B58A94D068DB,C0B70937-10C2-44B8-8384-A4F330D40C17,TCGA-CJ-4899-11A-01D-2100-10,GRCh37-lite,TCGA-CJ-4899,TCGA-KIRC,NA,s9569,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T1b,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82de4b0c9d6adf6a69e,58cfa82de4b0c9d6adf6a69e,898a39476e967ce15adbf5f7f4230feb.filtered.,WGS,898a39476e967ce15adbf5f7f4230feb,898a39476e967ce15adbf5f7f4230feb.bam,60.86,NA,0.09,58cfa82de4b0c9d6adf6a69e,898a39476e967ce15adbf5f7f4230feb.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A2LT-01A,FB66B7F5-22CA-4D4D-97C2-30E6EDFFF781,Primary Tumor,Illumina HiSeq,f6c6e1bd-966a-4f96-b8ab-e8219607f960,Cervix,38,EEDE6958-96A5-433D-8823-503B58559ED4,0F6B355E-3898-4BE6-BE97-DA0C3840A4ED,TCGA-C5-A2LT-01A-11D-A18J-09,GRCh37-lite,TCGA-C5-A2LT,TCGA-CESC,NA,s1512,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,T1b,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ac6e,58cfa82ee4b0c9d6adf6ac6e,G39019.TCGA-GN-A26A-10A-01D-A19A-08.3.filtered.,WGS,G39019.TCGA-GN-A26A-10A-01D-A19A-08.3,G39019.TCGA-GN-A26A-10A-01D-A19A-08.3.bam,9.89,NA,0.08,58cfa82ee4b0c9d6adf6ac6e,G39019.TCGA-GN-A26A-10A-01D-A19A-08.3.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-GN-A26A-10A,5BC515C8-7727-4D69-98E9-31BBCB748550,Blood Derived Normal,Illumina HiSeq,d853ff81-e3fc-4daa-87d0-8ef8835d6ff5,Skin,63,42A0B5DE-0878-404A-A809-6CB11E810186,268A11D4-51A7-491C-9060-7DC559DCDB9E,TCGA-GN-A26A-10A-01D-A19A-08,HG19_Broad_variant,TCGA-GN-A26A,TCGA-SKCM,988,s7489,Broad Institute of MIT and Harvard,Roswell,United States,NO,T3a,N1a,Not available,Stage IIIA
13722.58cfa82ee4b0c9d6adf6aaaa,58cfa82ee4b0c9d6adf6aaaa,G32531.TCGA-FK-A3S3-10A-01D-A22D-08.1.filtered.,WGS,G32531.TCGA-FK-A3S3-10A-01D-A22D-08.1,G32531.TCGA-FK-A3S3-10A-01D-A22D-08.1.bam,13.99,NA,0.08,58cfa82ee4b0c9d6adf6aaaa,G32531.TCGA-FK-A3S3-10A-01D-A22D-08.1.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FK-A3S3-10A,785803BB-42A8-4AFB-B7B4-58C114894408,Blood Derived Normal,Illumina HiSeq,db589ab6-d159-4d6f-bef3-ea54e210169e,Thyroid,43,4AF9827A-E13E-4130-B897-C6A3230335E8,1FE18F38-FE1C-4684-B3A5-2985D577536E,TCGA-FK-A3S3-10A-01D-A22D-08,HG19_Broad_variant,TCGA-FK-A3S3,TCGA-THCA,NA,s12340,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa83ce4b0c9d6adf730ba,58cfa83ce4b0c9d6adf730ba,ad205093ac2a964d9f1ac199076155a7.filtered.,WGS,ad205093ac2a964d9f1ac199076155a7,ad205093ac2a964d9f1ac199076155a7.bam,15.08,NA,0.08,58cfa83ce4b0c9d6adf730ba,ad205093ac2a964d9f1ac199076155a7.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A9FQ-01A,37D13493-975C-432C-BD21-65F383FC66C9,Primary Tumor,HiSeq X Ten,a06a1ae9-d145-4cfb-8740-2f8df77a0046,Esophagus,62,CDE405E5-A694-4CCF-B08D-BFA4D6843291,68F76D9C-F426-44B4-A781-81FA01060390,TCGA-LN-A9FQ-01A-31D-A387-09,GRCh37-lite_WUGSC_variant_2,TCGA-LN-A9FQ,TCGA-ESCA,NA,s1703,Washington University School of Medicine,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa83ce4b0c9d6adf72fae,58cfa83ce4b0c9d6adf72fae,a67ab1214f8c6bab30f876560e45768a.filtered.,WGS,a67ab1214f8c6bab30f876560e45768a,a67ab1214f8c6bab30f876560e45768a.bam,61.5,NA,0.08,58cfa83ce4b0c9d6adf72fae,a67ab1214f8c6bab30f876560e45768a.bam,Alive,FEMALE,WHITE,Not available,Sarcoma,Aligned reads,TCGA-IS-A3K7-01A,5A64F7E9-3833-4A3C-962B-13EB3E305C69,Primary Tumor,Illumina HiSeq,244fb4fa-4623-4468-acf2-601bb7f70990,Mesenchymal,63,7254C2AC-D8AC-4D6E-B444-4CB5F8A6EB36,AFEE5B10-3DFF-4E50-9575-BC9FE20C5DEA,TCGA-IS-A3K7-01A-11D-A21Q-09,GRCh37-lite,TCGA-IS-A3K7,TCGA-SARC,NA,s2458,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6be9e,58cfa830e4b0c9d6adf6be9e,TCGA-AG-3896-10A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AG-3896-10A-01D-1989-10_wgs_Illumina,TCGA-AG-3896-10A-01D-1989-10_wgs_Illumina.bam,44.59,1.9,0.14,58cfa830e4b0c9d6adf6be9e,TCGA-AG-3896-10A-01D-1989-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3896-10A,9AF35239-FFB9-4D4F-889E-F743DA271EEF,Blood Derived Normal,Illumina HiSeq,d827df52-1104-4b8b-aa61-026c79003c6a,Colorectal,85,C8B8CE61-200B-4FD8-B315-CA68823CFBCC,B30484D5-6F6E-42EF-804A-FBA39539160E,TCGA-AG-3896-10A-01D-1989-10,GRCh37-lite,TCGA-AG-3896,TCGA-READ,NA,s2149,Baylor College of Medicine,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa83ce4b0c9d6adf72eac,58cfa83ce4b0c9d6adf72eac,cfb494ec82ff531a0bc7eacc26f33717.filtered.,WGS,cfb494ec82ff531a0bc7eacc26f33717,cfb494ec82ff531a0bc7eacc26f33717.bam,83.96,1.98,0.08,58cfa83ce4b0c9d6adf72eac,cfb494ec82ff531a0bc7eacc26f33717.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GA-01A,71FED998-8FAC-4E6B-B38A-22C83E05E958,Primary Tumor,Illumina HiSeq,b68fc7e3-5a98-423d-8f72-b4b5f50435a5,Uterus,67,5A40330F-9307-4584-9557-5D19F2357FCC,577D5C9E-FBDA-41D5-B0B3-CDB733453EA5,TCGA-A5-A0GA-01A-11D-A066-09,GRCh37-lite,TCGA-A5-A0GA,TCGA-UCEC,543,s4763,Washington University School of Medicine,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf7309a,58cfa83ce4b0c9d6adf7309a,be7bcf9d37d9e65a46acadb6e8e3450e.filtered.,WGS,be7bcf9d37d9e65a46acadb6e8e3450e,be7bcf9d37d9e65a46acadb6e8e3450e.bam,58.65,1.91,0.08,58cfa83ce4b0c9d6adf7309a,be7bcf9d37d9e65a46acadb6e8e3450e.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0BW-01A,5D1D00C6-FCAE-479E-AE1E-DE76EFD41D98,Primary Tumor,Illumina HiSeq,d87bcaa2-19f0-4c3b-8f85-8f47ed056ffc,Breast,71,DBEEDDC1-D149-46F7-91FF-D057F8C6BFFB,07B5141F-AC79-439B-883B-B0183BBE7FF5,TCGA-BH-A0BW-01A-11D-A10Y-09,GRCh37-lite,TCGA-BH-A0BW,TCGA-BRCA,NA,s6253,Washington University School of Medicine,University of Pittsburgh,None,NO,T1c,N0,Infiltrating Ductal Carcinoma,Stage I
13722.58cfa83ce4b0c9d6adf72f14,58cfa83ce4b0c9d6adf72f14,e52ff8a7016a0eac7ed93be3b1a7cfa2.filtered.,WGS,e52ff8a7016a0eac7ed93be3b1a7cfa2,e52ff8a7016a0eac7ed93be3b1a7cfa2.bam,90.97,2.13,0.08,58cfa83ce4b0c9d6adf72f14,e52ff8a7016a0eac7ed93be3b1a7cfa2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LO-01A,A081DA6F-51F3-4555-A6B8-736F8C6CDA39,Primary Tumor,Illumina HiSeq,41a58f7b-d910-420e-ae2c-d37cc1f4a220,Uterus,45,9846D8F3-5B22-48E9-B972-A0FE9F509FB4,A0E317B1-3F3B-4D25-B2D9-FCC2211DFDA3,TCGA-AP-A0LO-01A-11D-A066-09,GRCh37-lite,TCGA-AP-A0LO,TCGA-UCEC,1016,s5372,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c483,58cfa831e4b0c9d6adf6c483,TCGA-CJ-5682-11A-01D-2103-10_Illumina.filtered.,WGS,TCGA-CJ-5682-11A-01D-2103-10_Illumina,TCGA-CJ-5682-11A-01D-2103-10_Illumina.bam,66.4,1.9,0.16,58cfa831e4b0c9d6adf6c483,TCGA-CJ-5682-11A-01D-2103-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CJ-5682-11A,4C325EE1-9B8E-45D4-A0A7-E47EC1EAC402,Solid Tissue Normal,Illumina HiSeq,64edb843-382f-4d7f-a494-936fc2688a72,Kidney,60,5F49B532-B1E3-4B18-A366-068AA0D1F935,4ADB1D2B-262D-4179-A526-964A7560C891,TCGA-CJ-5682-11A-01D-2103-10,GRCh37-lite,TCGA-CJ-5682,TCGA-KIRC,NA,s8838,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T3a,NX,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa82ee4b0c9d6adf6a8d2,58cfa82ee4b0c9d6adf6a8d2,G32469.TCGA-DK-A1AG-01A-11D-A13W-08.3.filtered.,WGS,G32469.TCGA-DK-A1AG-01A-11D-A13W-08.3,G32469.TCGA-DK-A1AG-01A-11D-A13W-08.3.bam,70.38,1.89,0.08,58cfa82ee4b0c9d6adf6a8d2,G32469.TCGA-DK-A1AG-01A-11D-A13W-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AG-01A,F8C0A69C-DF53-4A0A-A30E-4424C0CE3DD5,Primary Tumor,Illumina HiSeq,af228568-1064-4709-8bc8-435278c73ca0,Bladder,65,64668AA0-DDE5-4534-8CD0-378881E4A4E4,7D2A22EB-7344-4CBA-AD7D-94C3F9EF3D7C,TCGA-DK-A1AG-01A-11D-A13W-08,HG19_Broad_variant,TCGA-DK-A1AG,TCGA-BLCA,NA,s2687,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6c414,58cfa831e4b0c9d6adf6c414,TCGA-CJ-4639-01A-01D-2095-10_Illumina.filtered.,WGS,TCGA-CJ-4639-01A-01D-2095-10_Illumina,TCGA-CJ-4639-01A-01D-2095-10_Illumina.bam,90.64,1.9,0.15,58cfa831e4b0c9d6adf6c414,TCGA-CJ-4639-01A-01D-2095-10_Illumina.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CJ-4639-01A,3E976301-4042-4AC0-8F01-EF2F1A8161A6,Primary Tumor,Illumina HiSeq,d3739e9e-1149-4ec1-bb8d-f3b495ed1b4d,Kidney,49,11B1DCA7-6FCE-41C0-9580-A28CCF83E55C,063CFACF-9933-4A2D-8921-0AEB76E12779,TCGA-CJ-4639-01A-01D-2095-10,GRCh37-lite,TCGA-CJ-4639,TCGA-KIRC,NA,s9168,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T2,N0,Kidney Clear Cell Renal Carcinoma,Stage II
13722.58cfa83ce4b0c9d6adf73047,58cfa83ce4b0c9d6adf73047,a10f0e9c2d07b53a9b624701a0351175.filtered.,WGS,a10f0e9c2d07b53a9b624701a0351175,a10f0e9c2d07b53a9b624701a0351175.bam,41.26,NA,0.08,58cfa83ce4b0c9d6adf73047,a10f0e9c2d07b53a9b624701a0351175.bam,Dead,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OR-01A,09EACBFD-3F4A-4D2B-B7A7-C021535E2981,Primary Tumor,HiSeq X Ten,8a60803d-07bf-48e9-9a43-02854b1186d0,Esophagus,83,7DA8E467-C347-4C47-9E2D-AA46840B5CD5,7AEAFB55-1CDD-4496-83C4-1A7360EFFC90,TCGA-L5-A4OR-01A-11D-A27G-09,GRCh37-lite_WUGSC_variant_2,TCGA-L5-A4OR,TCGA-ESCA,96,s1900,Washington University School of Medicine,University of Michigan,United States,NO,T1,N0,Not available,Stage IA
13722.58cfa831e4b0c9d6adf6c6f6,58cfa831e4b0c9d6adf6c6f6,TCGA-CR-5250-10A-01D-2276-10_Illumina.filtered.,WGS,TCGA-CR-5250-10A-01D-2276-10_Illumina,TCGA-CR-5250-10A-01D-2276-10_Illumina.bam,23.73,1.9,0.05,58cfa831e4b0c9d6adf6c6f6,TCGA-CR-5250-10A-01D-2276-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-5250-10A,9E178D80-FE90-4998-9DAE-726C4BECEEF7,Blood Derived Normal,Illumina HiSeq,ff59a531-3bb9-4afc-ad7c-dfd839bcfa0e,Head and Neck,71,66C00888-C048-441E-BFFC-13EB0F299D97,D88E8F94-C624-4618-8D2F-DCE4436140BE,TCGA-CR-5250-10A-01D-2276-10,GRCh37-lite,TCGA-CR-5250,TCGA-HNSC,NA,s15636,Baylor College of Medicine,Vanderbilt University,None,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6acb2,58cfa82ee4b0c9d6adf6acb2,G37566.TCGA-HC-7737-11A-02D-2114-08.3.filtered.,WGS,G37566.TCGA-HC-7737-11A-02D-2114-08.3,G37566.TCGA-HC-7737-11A-02D-2114-08.3.bam,113.3,NA,0.05,58cfa82ee4b0c9d6adf6acb2,G37566.TCGA-HC-7737-11A-02D-2114-08.3.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,Not available,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7737-11A,73F875CB-BCFC-43BA-AB97-4E94CAF836D4,Solid Tissue Normal,Illumina HiSeq,0f09b06b-7747-47b8-be3c-4e592ca62c5d,Prostate,55,AA87EF38-E22C-436A-9F2D-CBD291063148,4ADEFA84-9FFB-4EFE-9A7F-BF1E307F6932,TCGA-HC-7737-11A-02D-2114-08,HG19_Broad_variant,TCGA-HC-7737,TCGA-PRAD,NA,s3408,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2c,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa83ce4b0c9d6adf72f9e,58cfa83ce4b0c9d6adf72f9e,a10df74fe68e2f8902de76b1691f26cd.filtered.,WGS,a10df74fe68e2f8902de76b1691f26cd,a10df74fe68e2f8902de76b1691f26cd.bam,69.7,2,0.07,58cfa83ce4b0c9d6adf72f9e,a10df74fe68e2f8902de76b1691f26cd.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BK-A0CC-01A,2B865F8C-539F-4CB2-8F08-41709E9511E5,Primary Tumor,Illumina HiSeq,83ddf098-024c-49f8-80ef-b79b0b8182d5,Uterus,69,ED22CB10-EBDE-4019-9B6D-E19AB573CA94,E7D74D34-3255-4C20-90FD-B105E6E229C8,TCGA-BK-A0CC-01A-21D-A013-09,GRCh37-lite,TCGA-BK-A0CC,TCGA-UCEC,NA,s5180,Washington University School of Medicine,Christiana Healthcare,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a903,58cfa82ee4b0c9d6adf6a903,G32551.TCGA-EE-A2MI-10A-01D-A199-08.1.filtered.,WGS,G32551.TCGA-EE-A2MI-10A-01D-A199-08.1,G32551.TCGA-EE-A2MI-10A-01D-A199-08.1.bam,26.57,NA,0.07,58cfa82ee4b0c9d6adf6a903,G32551.TCGA-EE-A2MI-10A-01D-A199-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2MI-10A,C061AE6C-7A02-47C3-AECD-A56487C01603,Blood Derived Normal,Illumina HiSeq,75c53bb6-eaca-4c38-b870-6d5a0b80ee43,Skin,43,A0DABFDB-1FCF-47E3-B822-7E4B54D9B38E,231598D2-A4CD-4A61-B98A-3F41220659CD,TCGA-EE-A2MI-10A-01D-A199-08,HG19_Broad_variant,TCGA-EE-A2MI,TCGA-SKCM,6225,s7659,Broad Institute of MIT and Harvard,University of Sydney,Australia,NO,T4,N0,Not available,Stage IIB
13722.58cfa82ee4b0c9d6adf6aa38,58cfa82ee4b0c9d6adf6aa38,G23883.TCGA-A3-3324-01A-01D-2229-08.1.filtered.,WGS,G23883.TCGA-A3-3324-01A-01D-2229-08.1,G23883.TCGA-A3-3324-01A-01D-2229-08.1.bam,602.9,1.9,0.05,58cfa82ee4b0c9d6adf6aa38,G23883.TCGA-A3-3324-01A-01D-2229-08.1.bam,Alive,MALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-A3-3324-01A,4FCA10BD-988A-47F9-8ED5-037C0D59D70C,Primary Tumor,Illumina HiSeq,4fa1626a-b369-4e9c-b908-528e1d550be7,Kidney,51,08CE626E-0734-4D54-BA3F-EA5702B886F3,BADA0A2B-88CC-4F38-9BE5-F4B698AE4DB1,TCGA-A3-3324-01A-01D-2229-08,HG19_Broad_variant,TCGA-A3-3324,TCGA-KIRC,NA,s9154,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T1b,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6a934,58cfa82ee4b0c9d6adf6a934,G32544.TCGA-EB-A24D-10A-01D-A199-08.3.filtered.,WGS,G32544.TCGA-EB-A24D-10A-01D-A199-08.3,G32544.TCGA-EB-A24D-10A-01D-A199-08.3.bam,48.4,NA,0.09,58cfa82ee4b0c9d6adf6a934,G32544.TCGA-EB-A24D-10A-01D-A199-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EB-A24D-10A,D7EE2693-39A8-4E3A-B6F6-E4729800E34E,Blood Derived Normal,Illumina HiSeq,313b2278-4c22-4410-a326-a1d9caa33992,Skin,72,D9EE5E38-F7F7-4E9A-8C01-4CDED37DC2EC,9147BFFE-0ECE-4015-BE88-2D7D440060C0,TCGA-EB-A24D-10A-01D-A199-08,HG19_Broad_variant,TCGA-EB-A24D,TCGA-SKCM,NA,s7475,Broad Institute of MIT and Harvard,Asterand,Ukraine,NO,T4a,N2b,Not available,Stage IIIB
13722.58cfa82de4b0c9d6adf6a43d,58cfa82de4b0c9d6adf6a43d,03a92361f5fdb90b2b4d47abc721a301.filtered.,WGS,03a92361f5fdb90b2b4d47abc721a301,03a92361f5fdb90b2b4d47abc721a301.bam,139.7,1.88,0.16,58cfa82de4b0c9d6adf6a43d,03a92361f5fdb90b2b4d47abc721a301.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0124-01A,C2651206-36C5-4F3C-A0D6-3FFC07B27A93,Primary Tumor,Illumina GA,17937fc3-6a26-4b60-ba31-b7857c19392e,Brain,67,82C23E47-9E17-4E18-A28B-438D244FC406,A0091CB7-3B55-4A9F-A909-39AF318D999C,TCGA-06-0124-01A-01D-0375-09,GRCh37-lite,TCGA-06-0124,TCGA-GBM,620,s14361,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf730cb,58cfa83ce4b0c9d6adf730cb,fa894126e254827396a4f68e2b369bc2.filtered.,WGS,fa894126e254827396a4f68e2b369bc2,fa894126e254827396a4f68e2b369bc2.bam,34.01,1.86,0.08,58cfa83ce4b0c9d6adf730cb,fa894126e254827396a4f68e2b369bc2.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0DG-01A,0BC5744C-5FA3-45BB-87D0-70A02068B392,Primary Tumor,Illumina HiSeq,d1c980ac-6070-4a3b-8ff8-208b0f7897cf,Breast,30,3F104CF7-8DE8-4E77-8BAA-BAD1BBB493AC,EC4D4CBC-D5D1-418D-A292-CAD9576624FD,TCGA-BH-A0DG-01A-21D-A12Q-09,GRCh37-lite,TCGA-BH-A0DG,TCGA-BRCA,NA,s6908,Washington University School of Medicine,University of Pittsburgh,None,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a642,58cfa82de4b0c9d6adf6a642,56c4e1fd143ea68f16ed05f49f2cd315.filtered.,WGS,56c4e1fd143ea68f16ed05f49f2cd315,56c4e1fd143ea68f16ed05f49f2cd315.bam,29.64,1.95,0.07,58cfa82de4b0c9d6adf6a642,56c4e1fd143ea68f16ed05f49f2cd315.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A14P-01A,E4FC0909-F284-4471-866D-D8967B6ADCBC,Primary Tumor,Illumina HiSeq,6291117d-64a7-4c35-94bb-8e06275c498e,Breast,79,58BFE278-A80F-4722-B286-4D966214D244,74B57D2C-A83F-4798-B86B-A533975E4CC0,TCGA-E2-A14P-01A-31D-A19H-09,GRCh37-lite,TCGA-E2-A14P,TCGA-BRCA,NA,s5629,Washington University School of Medicine,Roswell Park,None,NO,T2,N3,Infiltrating Ductal Carcinoma,Stage IIIC
13722.58cfa82de4b0c9d6adf6a76e,58cfa82de4b0c9d6adf6a76e,G14581.TCGA-64-1680-01A-02D-1040-01.2.filtered.,WGS,G14581.TCGA-64-1680-01A-02D-1040-01.2,G14581.TCGA-64-1680-01A-02D-1040-01.2.bam,380.53,1.9,0.15,58cfa82de4b0c9d6adf6a76e,G14581.TCGA-64-1680-01A-02D-1040-01.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-64-1680-01A,1AB7AD70-0F80-41D8-8EFA-3BAEBC8223CC,Primary Tumor,Illumina HiSeq,6b9dbd25-b2c7-4ba6-8030-e98c1c8e9991,Lung,63,0BDBE623-CF95-465A-917D-87DFB6A8618E,DD09C7AA-744A-413D-839F-E75E1825F9F9,TCGA-64-1680-01A-02D-1040-01,HG19_Broad_variant,TCGA-64-1680,TCGA-LUAD,NA,s11313,Broad Institute of MIT and Harvard,Fox Chase,None,NO,T2a,N2,Lung Adenocarcinoma Mixed Subtype,Stage IV
13722.58cfa82de4b0c9d6adf6a591,58cfa82de4b0c9d6adf6a591,682471ccf3c736af5187920ac83b2068.filtered.,WGS,682471ccf3c736af5187920ac83b2068,682471ccf3c736af5187920ac83b2068.bam,15.25,2.03,0.08,58cfa82de4b0c9d6adf6a591,682471ccf3c736af5187920ac83b2068.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0EA-01A,1F601832-EEE3-48FB-ACF5-80C4A454F26E,Primary Tumor,Illumina HiSeq,b1ff5cfd-0f6e-4211-a58a-81b120d0eb6d,Breast,72,7F791228-DD77-4AB0-8227-D784A4C7FEA1,EEF9DCE1-6BA6-432B-BBE2-53C7DBE64FE7,TCGA-BH-A0EA-01A-11D-A314-09,GRCh37-lite,TCGA-BH-A0EA,TCGA-BRCA,991,s5949,Washington University School of Medicine,University of Pittsburgh,None,NO,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6aaa0,58cfa82ee4b0c9d6adf6aaa0,G32554.TCGA-FS-A1ZK-06A-11D-A197-08.1.filtered.,WGS,G32554.TCGA-FS-A1ZK-06A-11D-A197-08.1,G32554.TCGA-FS-A1ZK-06A-11D-A197-08.1.bam,33.04,NA,0.08,58cfa82ee4b0c9d6adf6aaa0,G32554.TCGA-FS-A1ZK-06A-11D-A197-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZK-06A,1404791B-86BF-4DFD-85B4-C8FF356F109C,Metastatic,Illumina HiSeq,04965cc3-824b-486b-9698-336c746b5e30,Skin,68,07E2FEA3-4BA5-49B3-AE9B-61FF8492026C,41A7B031-D928-4A1F-891B-82FB3F6D548F,TCGA-FS-A1ZK-06A-11D-A197-08,HG19_Broad_variant,TCGA-FS-A1ZK,TCGA-SKCM,728,s7991,Broad Institute of MIT and Harvard,Essen,Germany,NO,T4,N0,Not available,Stage II
13722.58cfa82ee4b0c9d6adf6a7cb,58cfa82ee4b0c9d6adf6a7cb,G23079.TCGA_CR_6482_10A_01D_2268_08.2.filtered.,WGS,G23079.TCGA_CR_6482_10A_01D_2268_08.2,G23079.TCGA_CR_6482_10A_01D_2268_08.2.bam,88,1.8,0.13,58cfa82ee4b0c9d6adf6a7cb,G23079.TCGA_CR_6482_10A_01D_2268_08.2.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-6482-10A,468649E7-1525-4B8A-8AB5-DDB27DB5F022,Blood Derived Normal,Illumina HiSeq,313a6b3c-974e-4fd2-8f12-6cddbb546254,Head and Neck,62,3A24AAEB-37CE-4508-81D5-E531AAC8A167,1345478B-17B3-46A0-A78B-F4461A6651FF,TCGA-CR-6482-10A-01D-2268-08,HG19_Broad_variant,TCGA-CR-6482,TCGA-HNSC,NA,s16018,Broad Institute of MIT and Harvard,Vanderbilt University,United States,NO,Not available,Not available,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa82de4b0c9d6adf6a678,58cfa82de4b0c9d6adf6a678,5ccefc1bca215bf54bcca30953e25fc3.filtered.,WGS,5ccefc1bca215bf54bcca30953e25fc3,5ccefc1bca215bf54bcca30953e25fc3.bam,87.84,2.05,0.09,58cfa82de4b0c9d6adf6a678,5ccefc1bca215bf54bcca30953e25fc3.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AJ-A23M-01A,D39DF936-4BC6-404D-9E1D-F6416CC5A34C,Primary Tumor,Illumina HiSeq,c45046fe-9086-4f96-bc47-68de65413b58,Uterus,61,ACBBC556-4E4E-4EBC-B408-55D69720A87D,96F337D2-CEC4-4484-87CD-AB2109D2BF50,TCGA-AJ-A23M-01A-11D-A34H-09,GRCh37-lite,TCGA-AJ-A23M,TCGA-UCEC,NA,s4238,Washington University School of Medicine,International Genomics Conosrtium,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aa1c,58cfa82ee4b0c9d6adf6aa1c,G32465.TCGA-BT-A20Q-01A-11D-A14W-08.1.filtered.,WGS,G32465.TCGA-BT-A20Q-01A-11D-A14W-08.1,G32465.TCGA-BT-A20Q-01A-11D-A14W-08.1.bam,56.34,2.11,0.08,58cfa82ee4b0c9d6adf6aa1c,G32465.TCGA-BT-A20Q-01A-11D-A14W-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20Q-01A,419DEAAC-EA45-4BDD-9FA0-B5CD8429B44F,Primary Tumor,Illumina HiSeq,1e07bbf1-7f3c-4472-b21e-f9eaa7b11659,Bladder,73,F3906CD4-31C7-48A8-935B-5B7FAFEC1AE7,8C619CBC-9E91-4716-9711-5236E55D8F46,TCGA-BT-A20Q-01A-11D-A14W-08,HG19_Broad_variant,TCGA-BT-A20Q,TCGA-BLCA,593,s3255,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82ee4b0c9d6adf6af02,58cfa82ee4b0c9d6adf6af02,G39020.TCGA-FP-7998-10A-01D-2201-08.2.filtered.,WGS,G39020.TCGA-FP-7998-10A-01D-2201-08.2,G39020.TCGA-FP-7998-10A-01D-2201-08.2.bam,113,NA,0.05,58cfa82ee4b0c9d6adf6af02,G39020.TCGA-FP-7998-10A-01D-2201-08.2.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-FP-7998-10A,B2E2D35C-7A79-4165-97A5-82D5C37D94F2,Blood Derived Normal,Illumina HiSeq,adb24a00-e8b6-40bc-8a22-3e8559a20903,Stomach,77,C103EA61-3C54-4453-986C-975BAB1AAC16,1C38848B-B948-49D7-8C2F-BFDCBCDDD43F,TCGA-FP-7998-10A-01D-2201-08,HG19_Broad_variant,TCGA-FP-7998,TCGA-STAD,NA,s15177,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T4a,N3a,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIC
13722.58cfa82de4b0c9d6adf6a6e6,58cfa82de4b0c9d6adf6a6e6,96e095aa070f9cedeb94cb9c5ebeeb82.filtered.,WGS,96e095aa070f9cedeb94cb9c5ebeeb82,96e095aa070f9cedeb94cb9c5ebeeb82.bam,54.77,1.9,0.14,58cfa82de4b0c9d6adf6a6e6,96e095aa070f9cedeb94cb9c5ebeeb82.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0881-01A,1B6C184A-5868-4A51-8A82-AA16A7E65126,Primary Tumor,Illumina GA,551bd1be-d240-4190-b8a4-e774a9ff64d3,Brain,50,02354610-465F-4E27-9DEA-80410E1D3972,8480DB03-E875-41AC-A259-18698317F45A,TCGA-06-0881-01A-02D-0512-09,GRCh37-lite,TCGA-06-0881,TCGA-GBM,NA,s13918,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6bb0c,58cfa830e4b0c9d6adf6bb0c,TCGA-AA-A00N-10A-01D-A17O-10_wgs_Illumina.filtered.,WGS,TCGA-AA-A00N-10A-01D-A17O-10_wgs_Illumina,TCGA-AA-A00N-10A-01D-A17O-10_wgs_Illumina.bam,26.63,1.73,0.08,58cfa830e4b0c9d6adf6bb0c,TCGA-AA-A00N-10A-01D-A17O-10_wgs_Illumina.bam,Dead,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A00N-10A,E457344D-76FB-46BF-B362-61A6E811D131,Blood Derived Normal,Illumina HiSeq,524f4dbd-9c3a-4d0b-bbbd-02132d93caa1,Colorectal,75,CE518719-0573-4214-9F1E-4387673A57D8,F4561A74-4A93-459A-B865-8D385F36E0FD,TCGA-AA-A00N-10A-01D-A17O-10,GRCh37-lite,TCGA-AA-A00N,TCGA-COAD,122,s13373,Baylor College of Medicine,Indivumed,Germany,NO,T4,N0,Colon Mucinous Adenocarcinoma,Stage IIB
13722.58cfa830e4b0c9d6adf6c1d8,58cfa830e4b0c9d6adf6c1d8,TCGA-BA-6873-10A-01D-2266-10_Illumina.filtered.,WGS,TCGA-BA-6873-10A-01D-2266-10_Illumina,TCGA-BA-6873-10A-01D-2266-10_Illumina.bam,76,1.9,0.05,58cfa830e4b0c9d6adf6c1d8,TCGA-BA-6873-10A-01D-2266-10_Illumina.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-6873-10A,BF6B931E-CB2E-4CC0-B603-E9FC71FDC509,Blood Derived Normal,Illumina HiSeq,462b2014-7710-44e6-a8da-32e584676737,Head and Neck,28,B2A9D46A-2627-49ED-B82E-8154833A4808,E26A2E12-6203-4F6E-B494-8128BEF26323,TCGA-BA-6873-10A-01D-2266-10,GRCh37-lite,TCGA-BA-6873,TCGA-HNSC,NA,s15614,Baylor College of Medicine,UNC,United States,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82de4b0c9d6adf6a708,58cfa82de4b0c9d6adf6a708,9e0aa323dd137c62bd3ba6626357862a.filtered.,WGS,9e0aa323dd137c62bd3ba6626357862a,9e0aa323dd137c62bd3ba6626357862a.bam,47.34,2,0.09,58cfa82de4b0c9d6adf6a708,9e0aa323dd137c62bd3ba6626357862a.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-E6-A1LZ-01A,9205C164-7975-421A-90C3-EDFE8DEF595C,Primary Tumor,Illumina HiSeq,d8f785e3-7de9-4e09-b830-5033e5eaa2f4,Uterus,76,62BFF77E-4FE6-4A9F-A867-345584608E7D,F7DCC2E4-1FC4-4B39-BC6A-720E66116D68,TCGA-E6-A1LZ-01A-11D-A142-09,GRCh37-lite,TCGA-E6-A1LZ,TCGA-UCEC,NA,s5193,Washington University School of Medicine,Roswell Park,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a52e,58cfa82de4b0c9d6adf6a52e,103f34ff20cea99f215bfb7393f043b8.filtered.,WGS,103f34ff20cea99f215bfb7393f043b8,103f34ff20cea99f215bfb7393f043b8.bam,45.75,2,0.09,58cfa82de4b0c9d6adf6a52e,103f34ff20cea99f215bfb7393f043b8.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A259-01A,3FC3755D-A3F8-4E2C-813F-FF124F2A75C1,Primary Tumor,Illumina HiSeq,767c5435-e3e1-4cdb-92e0-2b0961610118,Breast,70,EB2DE640-6C2A-4C8A-87C3-80F9FBDC3D9B,13D05F7A-E16A-40EF-9A15-21257DA2CF89,TCGA-A2-A259-01A-11D-A314-09,GRCh37-lite,TCGA-A2-A259,TCGA-BRCA,NA,s5785,Washington University School of Medicine,Walter Reed,United States,NO,T1c,N0 (i-),Infiltrating Ductal Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bfea,58cfa830e4b0c9d6adf6bfea,TCGA-AG-3885-01A-01D-0967-10_wgs_Illumina.filtered.,WGS,TCGA-AG-3885-01A-01D-0967-10_wgs_Illumina,TCGA-AG-3885-01A-01D-0967-10_wgs_Illumina.bam,688.31,1.9,0.15,58cfa830e4b0c9d6adf6bfea,TCGA-AG-3885-01A-01D-0967-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3885-01A,E5E4AA9F-6015-4D62-A088-69920D7F2500,Primary Tumor,Illumina HiSeq,f75ec564-baa7-4aeb-8c4e-21e77d60669d,Colorectal,71,7764DB67-5D9E-4421-86C6-7151ACA688D1,BB6150F7-23E4-40F2-B466-6B6EDD19C502,TCGA-AG-3885-01A-01D-0967-10,GRCh37-lite,TCGA-AG-3885,TCGA-READ,NA,s1964,Baylor College of Medicine,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIB
13722.58cfa82ee4b0c9d6adf6a983,58cfa82ee4b0c9d6adf6a983,G35154.TCGA-DU-7009-10A-01D-2024-08.2.filtered.,WGS,G35154.TCGA-DU-7009-10A-01D-2024-08.2,G35154.TCGA-DU-7009-10A-01D-2024-08.2.bam,60.6,NA,0.05,58cfa82ee4b0c9d6adf6a983,G35154.TCGA-DU-7009-10A-01D-2024-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7009-10A,01C4CA12-AC08-41DD-9E4F-BFB0971688A2,Blood Derived Normal,Illumina HiSeq,a5ee0d34-649a-4a5e-8d63-b9d2dc8196e2,Brain,32,94FF1A2A-7299-4E13-B956-EB649075AFC8,EBCDE902-4750-4E90-B94C-A635AA053EA4,TCGA-DU-7009-10A-01D-2024-08,HG19_Broad_variant,TCGA-DU-7009,TCGA-LGG,NA,s8114,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa830e4b0c9d6adf6bef0,58cfa830e4b0c9d6adf6bef0,TCGA-BP-4327-01A-01D-1995-10_Illumina.filtered.,WGS,TCGA-BP-4327-01A-01D-1995-10_Illumina,TCGA-BP-4327-01A-01D-1995-10_Illumina.bam,119,1.9,0.14,58cfa830e4b0c9d6adf6bef0,TCGA-BP-4327-01A-01D-1995-10_Illumina.bam,Dead,FEMALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-BP-4327-01A,9B84D013-713B-4571-888C-12863FDD4A52,Primary Tumor,Illumina HiSeq,02674510-9972-4120-8940-18449f4623e8,Kidney,75,45CC1D31-9B81-4268-B83A-5D4C740BD2B6,85448D11-9F84-44B7-8AE3-A115F24BDB76,TCGA-BP-4327-01A-01D-1995-10,GRCh37-lite,TCGA-BP-4327,TCGA-KIRC,109,s9565,Baylor College of Medicine,MSKCC,None,NO,T2,N0,Kidney Clear Cell Renal Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6ab9d,58cfa82ee4b0c9d6adf6ab9d,G37566.TCGA-EJ-5503-10A-01D-1577-08.2.filtered.,WGS,G37566.TCGA-EJ-5503-10A-01D-1577-08.2,G37566.TCGA-EJ-5503-10A-01D-1577-08.2.bam,248.4,1.9,0.05,58cfa82ee4b0c9d6adf6ab9d,G37566.TCGA-EJ-5503-10A-01D-1577-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5503-10A,AA252F78-EBF3-42F9-86AF-BB6E57345706,Blood Derived Normal,Illumina HiSeq,aa2d4c6b-fca5-4975-9fee-f2013c3563dc,Prostate,50,84460943-D44C-4B47-9BF1-DEB1C5B5E0BD,0799B439-9364-4606-A024-7F100A249F53,TCGA-EJ-5503-10A-01D-1577-08,HG19_Broad_variant,TCGA-EJ-5503,TCGA-PRAD,NA,s3758,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6ac2e,58cfa82ee4b0c9d6adf6ac2e,G37566.TCGA-HC-7079-10A-01D-1961-08.2.filtered.,WGS,G37566.TCGA-HC-7079-10A-01D-1961-08.2,G37566.TCGA-HC-7079-10A-01D-1961-08.2.bam,183.3,NA,0.05,58cfa82ee4b0c9d6adf6ac2e,G37566.TCGA-HC-7079-10A-01D-1961-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7079-10A,10FBE481-F111-4F88-AE45-4D67CB265567,Blood Derived Normal,Illumina HiSeq,2d28bac5-43c1-42ec-ba29-8c2673db5bc1,Prostate,51,53CD52BA-57F8-4924-9143-9CE98DDB607E,C359BEE4-8D3A-4855-A6B6-1E09AEFD2B2E,TCGA-HC-7079-10A-01D-1961-08,HG19_Broad_variant,TCGA-HC-7079,TCGA-PRAD,NA,s4125,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82de4b0c9d6adf6a734,58cfa82de4b0c9d6adf6a734,G14088.TCGA-60-2698-11A-01D-1522-08.1.filtered.,WGS,G14088.TCGA-60-2698-11A-01D-1522-08.1,G14088.TCGA-60-2698-11A-01D-1522-08.1.bam,89.6,1.9,0.05,58cfa82de4b0c9d6adf6a734,G14088.TCGA-60-2698-11A-01D-1522-08.1.bam,Dead,MALE,WHITE,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-60-2698-11A,FD9EE494-65FE-4DE4-ADFF-7952A059B17F,Solid Tissue Normal,Illumina HiSeq,0494eaa8-5ade-423f-881d-272d7ed5d80f,Lung,62,0EE8B6C2-6FAD-4550-98B0-381A49BA48F2,059E5A0F-CA79-4CAC-B2A9-F39BB8D44206,TCGA-60-2698-11A-01D-1522-08,HG19_Broad_variant,TCGA-60-2698,TCGA-LUSC,311,s10493,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T2,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6a9a4,58cfa82ee4b0c9d6adf6a9a4,G32529.TCGA-ET-A3DV-11A-11D-A202-08.4.filtered.,WGS,G32529.TCGA-ET-A3DV-11A-11D-A202-08.4,G32529.TCGA-ET-A3DV-11A-11D-A202-08.4.bam,7.55,NA,0.09,58cfa82ee4b0c9d6adf6a9a4,G32529.TCGA-ET-A3DV-11A-11D-A202-08.4.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-ET-A3DV-11A,B46D88E9-8477-4900-8DA9-5E7DBDED0653,Solid Tissue Normal,Illumina HiSeq,30f6a49c-3503-49d5-902e-750075b22950,Thyroid,68,D2A252B0-5998-436B-B2A5-2BD59D064D80,BBA5AC91-59B6-4CAE-9199-E31D43571F57,TCGA-ET-A3DV-11A-11D-A202-08,HG19_Broad_variant,TCGA-ET-A3DV,TCGA-THCA,NA,s12085,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa83ce4b0c9d6adf72ed9,58cfa83ce4b0c9d6adf72ed9,df89499681d85c1408e9c4a6f2b60d7b.filtered.,WGS,df89499681d85c1408e9c4a6f2b60d7b,df89499681d85c1408e9c4a6f2b60d7b.bam,20,1.89,0.17,58cfa83ce4b0c9d6adf72ed9,df89499681d85c1408e9c4a6f2b60d7b.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0214-01A,9853C6BB-A42C-4698-ABE5-F3C897EBC8F6,Primary Tumor,Illumina GA,ebec1b6c-e72f-4ab3-8496-17e34ad5d3cd,Brain,66,A86189C2-BFF1-4DBE-B4AC-C886478E6FFC,DA484194-5996-4456-A465-DE7891D9AAF3,TCGA-06-0214-01A-02D-0512-09,GRCh37-lite,TCGA-06-0214,TCGA-GBM,457,s14046,Washington University School of Medicine,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf72ef8,58cfa83ce4b0c9d6adf72ef8,d9a4fed4943a3f61117cf771e1db8985.filtered.,WGS,d9a4fed4943a3f61117cf771e1db8985,d9a4fed4943a3f61117cf771e1db8985.bam,57.99,NA,0.08,58cfa83ce4b0c9d6adf72ef8,d9a4fed4943a3f61117cf771e1db8985.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-AC-A2BK-01A,6FA2A667-9C36-4526-8A58-1975E863A806,Primary Tumor,Illumina HiSeq,53c5c882-8386-48e7-b7dd-8815bcf6b316,Breast,78,B85BE663-EDBA-4E1E-A10C-D0297744A0E9,8E03E773-5557-4E78-889B-4710C515378F,TCGA-AC-A2BK-01A-11D-A314-09,GRCh37-lite,TCGA-AC-A2BK,TCGA-BRCA,NA,s6750,Washington University School of Medicine,International Genomics Consortium,United States,NO,T2,N2a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82ee4b0c9d6adf6a980,58cfa82ee4b0c9d6adf6a980,G35154.TCGA-DU-7009-01A-11D-2024-08.2.filtered.,WGS,G35154.TCGA-DU-7009-01A-11D-2024-08.2,G35154.TCGA-DU-7009-01A-11D-2024-08.2.bam,130.3,NA,0.05,58cfa82ee4b0c9d6adf6a980,G35154.TCGA-DU-7009-01A-11D-2024-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7009-01A,01C4CA12-AC08-41DD-9E4F-BFB0971688A2,Primary Tumor,Illumina HiSeq,446ab57b-076e-4f55-b617-050e5f14bfa5,Brain,32,C7CA8FEE-BD73-435B-B351-216E5DC38726,4853FD17-7214-4F0C-984B-1BE0346CA4AB,TCGA-DU-7009-01A-11D-2024-08,HG19_Broad_variant,TCGA-DU-7009,TCGA-LGG,NA,s8105,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6a9a8,58cfa82ee4b0c9d6adf6a9a8,G32468.TCGA-GD-A2C5-01A-12D-A17V-08.1.filtered.,WGS,G32468.TCGA-GD-A2C5-01A-12D-A17V-08.1,G32468.TCGA-GD-A2C5-01A-12D-A17V-08.1.bam,40.79,NA,0.08,58cfa82ee4b0c9d6adf6a9a8,G32468.TCGA-GD-A2C5-01A-12D-A17V-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GD-A2C5-01A,5D54C742-5A8E-4C40-8D62-95E75E210AB8,Primary Tumor,Illumina HiSeq,5f1b4c77-5775-4a38-b100-dc28cb8fb2b3,Bladder,53,2CD62676-762C-461D-B111-1F81E7CD5877,2B142863-B963-4CC9-8F8F-C72503C93390,TCGA-GD-A2C5-01A-12D-A17V-08,HG19_Broad_variant,TCGA-GD-A2C5,TCGA-BLCA,NA,s3260,Broad Institute of MIT and Harvard,ABS - IUPUI,United States,NO,T3a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82de4b0c9d6adf6a57e,58cfa82de4b0c9d6adf6a57e,2a93b8b5cd6a2b63fb20b07a6f50257e.filtered.,WGS,2a93b8b5cd6a2b63fb20b07a6f50257e,2a93b8b5cd6a2b63fb20b07a6f50257e.bam,17.03,NA,0.08,58cfa82de4b0c9d6adf6a57e,2a93b8b5cd6a2b63fb20b07a6f50257e.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A6Z2-01A,1AD65834-8BAC-4B80-8B2E-2588548EA003,Primary Tumor,HiSeq X Ten,1650a9c8-c304-4a0e-8ea0-946da430effa,Mesenchymal,82,1BF5EA0F-6279-4278-A7D6-4B17D479283A,4035EA7D-E77B-4637-AFB9-5BE5411D0A38,TCGA-DX-A6Z2-01A-12D-A36J-09,GRCh37-lite,TCGA-DX-A6Z2,TCGA-SARC,NA,s2479,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6aaf2,58cfa82ee4b0c9d6adf6aaf2,G32468.TCGA-GD-A2C5-10A-01D-A17V-08.2.filtered.,WGS,G32468.TCGA-GD-A2C5-10A-01D-A17V-08.2,G32468.TCGA-GD-A2C5-10A-01D-A17V-08.2.bam,30.35,NA,0.05,58cfa82ee4b0c9d6adf6aaf2,G32468.TCGA-GD-A2C5-10A-01D-A17V-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-GD-A2C5-10A,5D54C742-5A8E-4C40-8D62-95E75E210AB8,Blood Derived Normal,Illumina HiSeq,ebb0168a-3e3f-4f77-bfb6-dba931e87c1a,Bladder,53,68F5998D-53C5-4CC1-9249-2C24AE8579AD,60E4591C-6CE7-4A65-8355-653F5C41CD2E,TCGA-GD-A2C5-10A-01D-A17V-08,HG19_Broad_variant,TCGA-GD-A2C5,TCGA-BLCA,NA,s2679,Broad Institute of MIT and Harvard,ABS - IUPUI,United States,NO,T3a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa830e4b0c9d6adf6bdda,58cfa830e4b0c9d6adf6bdda,TCGA-AK-3455-10A-01D-2233-10_Illumina.filtered.,WGS,TCGA-AK-3455-10A-01D-2233-10_Illumina,TCGA-AK-3455-10A-01D-2233-10_Illumina.bam,152.27,1.9,0.05,58cfa830e4b0c9d6adf6bdda,TCGA-AK-3455-10A-01D-2233-10_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-AK-3455-10A,2ED3296A-5B10-40D8-8AF4-90DC031657CD,Blood Derived Normal,Illumina HiSeq,e10dcee5-6295-4c8f-a617-4cf75ab30d7f,Kidney,71,017E13FE-BAAD-49A6-AB3C-4D0082029F16,DF08A77E-C095-4818-A000-4BDF6E524207,TCGA-AK-3455-10A-01D-2233-10,GRCh37-lite,TCGA-AK-3455,TCGA-KIRC,683,s9157,Baylor College of Medicine,Fox Chase,United States,NO,T3b,NX,Kidney Clear Cell Renal Carcinoma,Stage III
13722.58cfa82de4b0c9d6adf6a596,58cfa82de4b0c9d6adf6a596,5f3d3040681cc587e66a46c6fe973f92.filtered.,WGS,5f3d3040681cc587e66a46c6fe973f92,5f3d3040681cc587e66a46c6fe973f92.bam,97.64,1.84,0.08,58cfa82de4b0c9d6adf6a596,5f3d3040681cc587e66a46c6fe973f92.bam,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-DS-A0VL-01A,DFD30F94-19E3-4838-95DF-14A3763419AF,Primary Tumor,Illumina HiSeq,2c9bc14c-a6d3-4389-8360-024e9c04a5d4,Cervix,25,CDF4AB19-F243-4EFC-A5DC-8253CBE48845,E07991A4-0901-4ED1-8704-AA376565D862,TCGA-DS-A0VL-01A-21D-A200-09,GRCh37-lite,TCGA-DS-A0VL,TCGA-CESC,NA,s1350,Washington University School of Medicine,Cedars Sinai,United States,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aa22,58cfa82ee4b0c9d6adf6aa22,G32541.TCGA-EE-A2GT-10A-01D-A199-08.3.filtered.,WGS,G32541.TCGA-EE-A2GT-10A-01D-A199-08.3,G32541.TCGA-EE-A2GT-10A-01D-A199-08.3.bam,20.12,NA,0.09,58cfa82ee4b0c9d6adf6aa22,G32541.TCGA-EE-A2GT-10A-01D-A199-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2GT-10A,97D9DFC9-C937-48B4-B453-DF081950419F,Blood Derived Normal,Illumina HiSeq,3a9f812b-3888-482d-b06a-275d29ba9725,Skin,77,0A095191-727B-45FF-9E30-E6CC490326A4,69D0BFF4-EEC5-40A7-AB3D-CBA125BC29F7,TCGA-EE-A2GT-10A-01D-A199-08,HG19_Broad_variant,TCGA-EE-A2GT,TCGA-SKCM,NA,s7651,Broad Institute of MIT and Harvard,University of Sydney,Australia,NO,T3a,N0,Not available,Stage IIA
13722.58cfa82ee4b0c9d6adf6aa42,58cfa82ee4b0c9d6adf6aa42,G32450.TCGA-FD-A3N5-10A-01D-A21A-08.4.filtered.,WGS,G32450.TCGA-FD-A3N5-10A-01D-A21A-08.4,G32450.TCGA-FD-A3N5-10A-01D-A21A-08.4.bam,27.72,NA,0.07,58cfa82ee4b0c9d6adf6aa42,G32450.TCGA-FD-A3N5-10A-01D-A21A-08.4.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3N5-10A,A658BECF-3934-49F2-9E74-291DCA61D4BB,Blood Derived Normal,Illumina HiSeq,c85e79ff-7813-4679-9c88-de2565ff4afa,Bladder,69,E5E8BC12-FB3C-4404-AEE2-2B90A11384A0,8AEE029E-9DA1-4714-933A-7613313DD998,TCGA-FD-A3N5-10A-01D-A21A-08,HG19_Broad_variant,TCGA-FD-A3N5,TCGA-BLCA,NA,s2845,Broad Institute of MIT and Harvard,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa83ce4b0c9d6adf72fea,58cfa83ce4b0c9d6adf72fea,f32bb0a94af8c21ac01c1ee17a7056ce.filtered.,WGS,f32bb0a94af8c21ac01c1ee17a7056ce,f32bb0a94af8c21ac01c1ee17a7056ce.bam,79.8,2.05,0.08,58cfa83ce4b0c9d6adf72fea,f32bb0a94af8c21ac01c1ee17a7056ce.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A09I-01A,1557183C-AEDD-4DF6-B98A-3654667F7B69,Primary Tumor,Illumina HiSeq,767c9f80-f27b-4abe-91c6-394a72835d7a,Breast,84,A09A99F9-33E3-45D5-BFC2-F57CE149A527,987D41EE-6BAB-490C-B0F2-BF28C0089DE9,TCGA-A8-A09I-01A-22D-A19H-09,GRCh37-lite,TCGA-A8-A09I,TCGA-BRCA,NA,s6615,Washington University School of Medicine,Indivumed,Germany,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6ac32,58cfa82ee4b0c9d6adf6ac32,G39019.TCGA-EE-A185-10A-01D-A198-08.1.filtered.,WGS,G39019.TCGA-EE-A185-10A-01D-A198-08.1,G39019.TCGA-EE-A185-10A-01D-A198-08.1.bam,39.51,NA,0.08,58cfa82ee4b0c9d6adf6ac32,G39019.TCGA-EE-A185-10A-01D-A198-08.1.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A185-10A,A01A350D-64BE-4AF3-91C3-7D681C3DB11D,Blood Derived Normal,Illumina HiSeq,4275c6be-3855-43f6-aa8e-d26cccb6250d,Skin,55,4C43E7BD-6669-4D0C-BCED-E42205D66F42,86E96814-FE03-47A8-8EB6-CDEAD9FE4F05,TCGA-EE-A185-10A-01D-A198-08,HG19_Broad_variant,TCGA-EE-A185,TCGA-SKCM,151,s7318,Broad Institute of MIT and Harvard,University of Sydney,Australia,NO,T4b,N3,Not available,Stage IIIC
13722.58cfa82ee4b0c9d6adf6aae8,58cfa82ee4b0c9d6adf6aae8,G32454.TCGA-CF-A27C-01A-11D-A16O-08.4.filtered.,WGS,G32454.TCGA-CF-A27C-01A-11D-A16O-08.4,G32454.TCGA-CF-A27C-01A-11D-A16O-08.4.bam,67.64,2.28,0.09,58cfa82ee4b0c9d6adf6aae8,G32454.TCGA-CF-A27C-01A-11D-A16O-08.4.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-CF-A27C-01A,7FEE9D6F-C0EA-43C2-89C2-66D965A077A8,Primary Tumor,Illumina HiSeq,456bc333-4951-4b6e-845e-2af77b0a86d7,Bladder,52,EAD6792B-4E52-4C28-891C-6D8696873A13,ACC629CB-AD03-4CEC-9B21-922E4932EF3E,TCGA-CF-A27C-01A-11D-A16O-08,HG19_Broad_variant,TCGA-CF-A27C,TCGA-BLCA,NA,s2678,Broad Institute of MIT and Harvard,ILSbio,Vietnam,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa830e4b0c9d6adf6c04e,58cfa830e4b0c9d6adf6c04e,TCGA-B2-4101-11A-01D-2096-10_Illumina.filtered.,WGS,TCGA-B2-4101-11A-01D-2096-10_Illumina,TCGA-B2-4101-11A-01D-2096-10_Illumina.bam,411.13,1.9,0.16,58cfa830e4b0c9d6adf6c04e,TCGA-B2-4101-11A-01D-2096-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-B2-4101-11A,CFC999AA-802E-4A0D-8B14-BE2B19FA2A17,Solid Tissue Normal,Illumina HiSeq,d90fd153-c4b0-4fe0-9e0e-15ebb3f7d2b5,Kidney,52,D285EFCA-3117-49D6-AC12-BC2B47F8A144,3F8B646D-DC94-46E4-8EFC-D46742648FC9,TCGA-B2-4101-11A-01D-2096-10,GRCh37-lite,TCGA-B2-4101,TCGA-KIRC,NA,s9159,Baylor College of Medicine,Christiana Healthcare,None,NO,T2a,NX,Kidney Clear Cell Renal Carcinoma,Stage II
13722.58cfa82de4b0c9d6adf6a53c,58cfa82de4b0c9d6adf6a53c,450a0ae734ab89c01b82ea2af8dacc92.filtered.,WGS,450a0ae734ab89c01b82ea2af8dacc92,450a0ae734ab89c01b82ea2af8dacc92.bam,75.68,1.83,0.09,58cfa82de4b0c9d6adf6a53c,450a0ae734ab89c01b82ea2af8dacc92.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A25B-01A,EADF8482-E60E-4307-ADB7-D5C3B9FA6CAE,Primary Tumor,Illumina HiSeq,372d2951-a381-41f0-88d7-72cc9da6b6db,Breast,39,2C619641-7849-4837-AB92-0DA80342B3E9,6E839EAF-1DBB-43F5-8846-C980E05540C7,TCGA-A2-A25B-01A-11D-A167-09,GRCh37-lite,TCGA-A2-A25B,TCGA-BRCA,NA,s6761,Washington University School of Medicine,Walter Reed,United States,NO,T2,N1,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa830e4b0c9d6adf6ba78,58cfa830e4b0c9d6adf6ba78,TCGA-AA-A03F-01A-11D-A17O-10_wgs_Illumina.filtered.,WGS,TCGA-AA-A03F-01A-11D-A17O-10_wgs_Illumina,TCGA-AA-A03F-01A-11D-A17O-10_wgs_Illumina.bam,124.44,1.85,0.09,58cfa830e4b0c9d6adf6ba78,TCGA-AA-A03F-01A-11D-A17O-10_wgs_Illumina.bam,Dead,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A03F-01A,2A971E32-B0E7-4A3F-8C40-62D69C0307D8,Primary Tumor,Illumina HiSeq,d227eb87-8290-4223-b1d2-c241162935c9,Colorectal,90,8ABA8350-B5EE-4CA2-BC99-5C7922A886C4,18DD42D7-2D84-400E-9ADB-A38FAA916A9E,TCGA-AA-A03F-01A-11D-A17O-10,GRCh37-lite,TCGA-AA-A03F,TCGA-COAD,549,s12884,Baylor College of Medicine,Indivumed,Germany,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage III
13722.58cfa832e4b0c9d6adf6d36a,58cfa832e4b0c9d6adf6d36a,TCGA-KN-8434-11A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8434-11A-01D-2311-10_wgs_Illumina,TCGA-KN-8434-11A-01D-2311-10_wgs_Illumina.bam,240.3,NA,0.05,58cfa832e4b0c9d6adf6d36a,TCGA-KN-8434-11A-01D-2311-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KN-8434-11A,E1E15226-9F8E-4035-8F08-EB1FED57080E,Solid Tissue Normal,Illumina HiSeq,c36ae589-6852-4d73-8c78-c4c08d01c634,Kidney,65,91BDE82E-DB06-4EE4-8848-D2183B8B7ABC,2BA9CC49-F11B-48E0-8AF9-90BAD2C7CC92,TCGA-KN-8434-11A-01D-2311-10,GRCh37-lite,TCGA-KN-8434,TCGA-KICH,NA,s16493,Baylor College of Medicine,Harvard,United States,NO,T2,NX,Kidney Chromophobe,Stage II
13722.58cfa82ee4b0c9d6adf6af36,58cfa82ee4b0c9d6adf6af36,G39020.TCGA-IN-7806-10A-01D-2053-08.3.filtered.,WGS,G39020.TCGA-IN-7806-10A-01D-2053-08.3,G39020.TCGA-IN-7806-10A-01D-2053-08.3.bam,232,NA,0.05,58cfa82ee4b0c9d6adf6af36,G39020.TCGA-IN-7806-10A-01D-2053-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-IN-7806-10A,87C217D4-66F4-46CA-8244-7856CE658FD3,Blood Derived Normal,Illumina HiSeq,e74ea4dc-0eb6-4d88-840f-17d1762d2c46,Stomach,50,6F44B130-0206-4F2F-B47B-C587A8C1898B,970C4BAE-8C4F-423F-948B-5DA4A38B8E09,TCGA-IN-7806-10A-01D-2053-08,HG19_Broad_variant,TCGA-IN-7806,TCGA-STAD,NA,s14740,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3,N1,Stomach  Adenocarcinoma  Diffuse Type,Stage IIB
13722.58cfa82ee4b0c9d6adf6ae06,58cfa82ee4b0c9d6adf6ae06,TCGA-04-1371-01A-01D-0516-08_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-04-1371-01A-01D-0516-08_IlluminaGA-DNASeq_whole,TCGA-04-1371-01A-01D-0516-08_IlluminaGA-DNASeq_whole.bam,363.67,1.9,0.15,58cfa82ee4b0c9d6adf6ae06,TCGA-04-1371-01A-01D-0516-08_IlluminaGA-DNASeq_whole.bam,Alive,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-04-1371-01A,BFF84539-7862-45B2-B5FC-E77291FCCA8B,Primary Tumor,Illumina GA,6b346a06-0fce-4aa3-a503-ea82efacd563,Ovary,58,E173653B-F144-4754-B835-DC69AF2E79DA,0AA531B3-34DB-4170-A994-43065B5C5EB6,TCGA-04-1371-01A-01D-0516-08,HG18_Broad_variant,TCGA-04-1371,TCGA-OV,NA,s17978,Broad Institute of MIT and Harvard,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf72e9c,58cfa83ce4b0c9d6adf72e9c,c7d4da3dbfd3dbc673a6cbab28c5999b.filtered.,WGS,c7d4da3dbfd3dbc673a6cbab28c5999b,c7d4da3dbfd3dbc673a6cbab28c5999b.bam,83.75,1.81,0.08,58cfa83ce4b0c9d6adf72e9c,c7d4da3dbfd3dbc673a6cbab28c5999b.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A11I-01A,F6D136C7-C250-4361-9FED-50F513959A40,Primary Tumor,Illumina HiSeq,290cd155-e6e8-450c-89ce-7688b88465e9,Uterus,65,56652DDE-33DA-451E-A1C2-6E9884F9915A,31BC44B9-35FF-43FD-8A01-A834F3B1CE46,TCGA-B5-A11I-01A-11D-A10M-09,GRCh37-lite,TCGA-B5-A11I,TCGA-UCEC,NA,s4972,Washington University School of Medicine,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ab40,58cfa82ee4b0c9d6adf6ab40,G32559.TCGA-ER-A2NF-01A-11D-A19A-08.2.filtered.,WGS,G32559.TCGA-ER-A2NF-01A-11D-A19A-08.2,G32559.TCGA-ER-A2NF-01A-11D-A19A-08.2.bam,52.36,NA,0.08,58cfa82ee4b0c9d6adf6ab40,G32559.TCGA-ER-A2NF-01A-11D-A19A-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A2NF-01A,D32A4219-4CCA-470F-B6B3-11447D9F5E0B,Primary Tumor,Illumina HiSeq,a17559f3-505c-4dc1-855c-178b1740e1ac,Skin,53,52EDD1DB-F1C3-4B87-B959-B5B095E52463,0884FDF3-7A20-43BC-BF57-E71F36E11AB9,TCGA-ER-A2NF-01A-11D-A19A-08,HG19_Broad_variant,TCGA-ER-A2NF,TCGA-SKCM,NA,s7989,Broad Institute of MIT and Harvard,University of Pittsburgh,None,NO,T4b,N3,Not available,Stage IIIC
13722.58cfa82de4b0c9d6adf6a56a,58cfa82de4b0c9d6adf6a56a,2be207283820c51539ebdfde69ab84ca.filtered.,WGS,2be207283820c51539ebdfde69ab84ca,2be207283820c51539ebdfde69ab84ca.bam,58.3,1.95,0.08,58cfa82de4b0c9d6adf6a56a,2be207283820c51539ebdfde69ab84ca.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-EW-A1P8-01A,359F12F9-5C41-48A4-85BC-FD7E307BF7D8,Primary Tumor,Illumina HiSeq,3a2f0cf6-0405-4ef6-be7e-75054acf1343,Breast,58,BF055644-7BCA-43B6-8F5A-E21C42F7CF88,E55F338F-97E2-4394-AE23-C92606069485,TCGA-EW-A1P8-01A-11D-A142-09,GRCh37-lite,TCGA-EW-A1P8,TCGA-BRCA,239,s5627,Washington University School of Medicine,University of Miami,United States,NO,T2,N3b,Infiltrating Ductal Carcinoma,Stage IIIC
13722.58cfa82ee4b0c9d6adf6ab9a,58cfa82ee4b0c9d6adf6ab9a,G35154.TCGA-HT-7695-10A-01D-2253-08.1.filtered.,WGS,G35154.TCGA-HT-7695-10A-01D-2253-08.1,G35154.TCGA-HT-7695-10A-01D-2253-08.1.bam,140.3,NA,0.05,58cfa82ee4b0c9d6adf6ab9a,G35154.TCGA-HT-7695-10A-01D-2253-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7695-10A,5017C115-39B8-4C5C-8BE6-2CB298D7C641,Blood Derived Normal,Illumina HiSeq,bd971aa9-0dc2-4b9f-8d94-b08b15ca0339,Brain,29,9F9AFEE6-3E0E-45C4-947D-2BDBD7A40485,04911942-C9A9-473F-93D5-79C0C14944AC,TCGA-HT-7695-10A-01D-2253-08,HG19_Broad_variant,TCGA-HT-7695,TCGA-LGG,NA,s8541,Broad Institute of MIT and Harvard,Case Western - St Joes,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa830e4b0c9d6adf6bb93,58cfa830e4b0c9d6adf6bb93,TCGA-AA-A02O-11A-11D-A17O-10_wgs_Illumina.filtered.,WGS,TCGA-AA-A02O-11A-11D-A17O-10_wgs_Illumina,TCGA-AA-A02O-11A-11D-A17O-10_wgs_Illumina.bam,47.17,1.97,0.07,58cfa830e4b0c9d6adf6bb93,TCGA-AA-A02O-11A-11D-A17O-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A02O-11A,6FA41234-9077-4D05-A295-6820F3BEDF5B,Solid Tissue Normal,Illumina HiSeq,6b3c88b6-f348-45da-8b09-5950072275f0,Colorectal,82,DD519F88-2D62-425B-9553-8BB374CD054B,44A50ADA-0EAD-4235-89C1-3DD5607974F7,TCGA-AA-A02O-11A-11D-A17O-10,GRCh37-lite,TCGA-AA-A02O,TCGA-COAD,NA,s13033,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa830e4b0c9d6adf6bdad,58cfa830e4b0c9d6adf6bdad,TCGA-AG-3574-01A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AG-3574-01A-01D-1989-10_wgs_Illumina,TCGA-AG-3574-01A-01D-1989-10_wgs_Illumina.bam,750.21,1.9,0.14,58cfa830e4b0c9d6adf6bdad,TCGA-AG-3574-01A-01D-1989-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3574-01A,0EDA7373-8335-455F-B90A-8C3540F28088,Primary Tumor,Illumina HiSeq,b41b6882-7cf8-49c6-aa56-8418d77c24cb,Colorectal,89,DA897A5D-B2CC-419F-ACD7-473B4928C5D5,ECF4E05A-0912-4B93-AD66-323002F0C845,TCGA-AG-3574-01A-01D-1989-10,GRCh37-lite,TCGA-AG-3574,TCGA-READ,NA,s2309,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage II
13722.58cfa83ce4b0c9d6adf72fdc,58cfa83ce4b0c9d6adf72fdc,a90c589688dc21e54e5e0e654a9932f1.filtered.,WGS,a90c589688dc21e54e5e0e654a9932f1,a90c589688dc21e54e5e0e654a9932f1.bam,NA,NA,NA,58cfa83ce4b0c9d6adf72fdc,a90c589688dc21e54e5e0e654a9932f1.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2905-03A,AE2392A3-B8C2-4DDB-8CEC-A28CB3FCD80B,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,810b11e7-9ef0-4043-abc7-4fcc7be3a3e3,Blood,48,9D11EF97-CF7E-4258-8241-682CB0966680,CCDC0B99-43B9-465C-97CC-199FA22B7D06,TCGA-AB-2905-03A-01D-0739-09,GRCh37-lite,TCGA-AB-2905,TCGA-LAML,NA,s7128,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6aaac,58cfa82ee4b0c9d6adf6aaac,G26375.TCGA-27-2528-01A-01D-1494-08.1.filtered.,WGS,G26375.TCGA-27-2528-01A-01D-1494-08.1,G26375.TCGA-27-2528-01A-01D-1494-08.1.bam,202.7,1.9,0.05,58cfa82ee4b0c9d6adf6aaac,G26375.TCGA-27-2528-01A-01D-1494-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-27-2528-01A,BE3A7EF3-34ED-40E1-9D9C-187940596B26,Primary Tumor,Illumina HiSeq,29b9c185-f979-47f1-91dc-9b8ca4759c35,Brain,62,3190BD1A-A83A-45F6-959A-863BBAE58FFE,374CBD87-428E-4509-85C1-B7D3302C30A0,TCGA-27-2528-01A-01D-1494-08,HG19_Broad_variant,TCGA-27-2528,TCGA-GBM,480,s14221,Broad Institute of MIT and Harvard,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a69f,58cfa82de4b0c9d6adf6a69f,824558b943d0281e9fdc0f4e97a69b78.filtered.,WGS,824558b943d0281e9fdc0f4e97a69b78,824558b943d0281e9fdc0f4e97a69b78.bam,71.16,2.03,0.08,58cfa82de4b0c9d6adf6a69f,824558b943d0281e9fdc0f4e97a69b78.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0H6-01A,AEB6A3A6-B57A-4C53-90E6-E833777DD2A1,Primary Tumor,Illumina HiSeq,8df89d9c-2eb9-459a-adf7-48c9867c9462,Breast,82,B2921C9D-C655-46F3-86E5-2FC2BED1ED33,AA58C09A-7799-4675-8310-D270224B163E,TCGA-BH-A0H6-01A-21D-A314-09,GRCh37-lite,TCGA-BH-A0H6,TCGA-BRCA,NA,s5792,Washington University School of Medicine,University of Pittsburgh,None,NO,T1b,NX,Infiltrating Ductal Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6c274,58cfa830e4b0c9d6adf6c274,TCGA-B0-5094-11A-01D-2099-10_wgs_Illumina.filtered.,WGS,TCGA-B0-5094-11A-01D-2099-10_wgs_Illumina,TCGA-B0-5094-11A-01D-2099-10_wgs_Illumina.bam,62.4,1.9,0.15,58cfa830e4b0c9d6adf6c274,TCGA-B0-5094-11A-01D-2099-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-B0-5094-11A,8AAA4E25-5C12-4ACE-96DC-91AAA0C4457C,Solid Tissue Normal,Illumina HiSeq,16f82ca2-add5-47a6-bcf6-b62f21fff50c,Kidney,62,7519D7A8-C3EE-417B-9CFC-111BC5AD0637,A754E81C-9ED4-4B84-A8D3-A857237EF46B,TCGA-B0-5094-11A-01D-2099-10,GRCh37-lite,TCGA-B0-5094,TCGA-KIRC,333,s8835,Baylor College of Medicine,University of Pittsburgh,None,NO,T3b,N0,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa82ee4b0c9d6adf6a8f2,58cfa82ee4b0c9d6adf6a8f2,G35154.TCGA-CS-6669-10A-01D-1893-08.6.filtered.,WGS,G35154.TCGA-CS-6669-10A-01D-1893-08.6,G35154.TCGA-CS-6669-10A-01D-1893-08.6.bam,675,1.8,0.05,58cfa82ee4b0c9d6adf6a8f2,G35154.TCGA-CS-6669-10A-01D-1893-08.6.bam,Alive,FEMALE,WHITE,Not available,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-6669-10A,DC5BDD21-B23F-400E-BBE2-4C98A517FC9E,Blood Derived Normal,Illumina HiSeq,ea003ef8-eae8-4e85-9599-556b0369c165,Brain,26,4F74077F-6F0A-407F-9270-15F88EF3EB7A,4BC99B08-8B67-443E-88A4-03EDEF39D433,TCGA-CS-6669-10A-01D-1893-08,HG19_Broad_variant,TCGA-CS-6669,TCGA-LGG,NA,s8530,Broad Institute of MIT and Harvard,Thomas Jefferson University,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6c736,58cfa831e4b0c9d6adf6c736,TCGA-CW-6087-11A-01D-2279-10_wgs_Illumina.filtered.,WGS,TCGA-CW-6087-11A-01D-2279-10_wgs_Illumina,TCGA-CW-6087-11A-01D-2279-10_wgs_Illumina.bam,105.4,1.9,0.05,58cfa831e4b0c9d6adf6c736,TCGA-CW-6087-11A-01D-2279-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CW-6087-11A,BBDAA931-E922-49BE-BFBF-FA0C2AE27D7A,Solid Tissue Normal,Illumina HiSeq,0829d141-a2a8-4eb0-a839-de5008511e57,Kidney,61,1CA90DCE-8EFC-420E-BE6C-E52FE009E644,BCF7FA37-3E1F-4A7E-A91F-C70220BDFBBA,TCGA-CW-6087-11A-01D-2279-10,GRCh37-lite,TCGA-CW-6087,TCGA-KIRC,41,s9572,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T3a,N1,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa82de4b0c9d6adf6a796,58cfa82de4b0c9d6adf6a796,G16919.TCGA-A3-3308-11A-01D-2048-08.1.filtered.,WGS,G16919.TCGA-A3-3308-11A-01D-2048-08.1,G16919.TCGA-A3-3308-11A-01D-2048-08.1.bam,741.9,1.9,0.15,58cfa82de4b0c9d6adf6a796,G16919.TCGA-A3-3308-11A-01D-2048-08.1.bam,Alive,FEMALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-A3-3308-11A,3CBCA837-F5A7-4A87-8F02-C59EAC232D5A,Solid Tissue Normal,Illumina HiSeq,a7bbb857-9cb1-437e-a49d-2f2dd01ff469,Kidney,77,EED5EE07-F84E-4907-B4EA-1AA879D3602C,0912E45C-8EEF-4896-A491-7E2CDB5B02AE,TCGA-A3-3308-11A-01D-2048-08,HG19_Broad_variant,TCGA-A3-3308,TCGA-KIRC,NA,s8830,Broad Institute of MIT and Harvard,International Genomics Consortium,None,NO,T3b,N0,Kidney Clear Cell Renal Carcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6a8e0,58cfa82ee4b0c9d6adf6a8e0,G35154.TCGA-DB-5278-01A-01D-1468-08.1.filtered.,WGS,G35154.TCGA-DB-5278-01A-01D-1468-08.1,G35154.TCGA-DB-5278-01A-01D-1468-08.1.bam,215.3,1.9,0.05,58cfa82ee4b0c9d6adf6a8e0,G35154.TCGA-DB-5278-01A-01D-1468-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DB-5278-01A,010AAC75-3BFE-4BF2-B866-AF0F2D92F125,Primary Tumor,Illumina HiSeq,6780f08b-966e-4836-9cd8-46b87be05578,Brain,17,11437143-41F5-4005-9124-4D6A4A2F0E2D,6847E993-1414-4E6F-A2AF-39EBE218DD7C,TCGA-DB-5278-01A-01D-1468-08,HG19_Broad_variant,TCGA-DB-5278,TCGA-LGG,NA,s8101,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6ab0a,58cfa82ee4b0c9d6adf6ab0a,G32451.TCGA-BT-A20T-11A-11D-A14W-08.1.filtered.,WGS,G32451.TCGA-BT-A20T-11A-11D-A14W-08.1,G32451.TCGA-BT-A20T-11A-11D-A14W-08.1.bam,10.21,1.76,0.09,58cfa82ee4b0c9d6adf6ab0a,G32451.TCGA-BT-A20T-11A-11D-A14W-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20T-11A,096B4F32-10C1-4737-A0DD-CAE04C54EE33,Solid Tissue Normal,Illumina HiSeq,1f33179c-e661-4003-9bb0-d0f222368c02,Bladder,63,27461A27-26EB-4C2C-9C54-E16FBD32C615,E0FCCAF5-925A-41F9-B87C-CD5EE4AECB59,TCGA-BT-A20T-11A-11D-A14W-08,HG19_Broad_variant,TCGA-BT-A20T,TCGA-BLCA,453,s3065,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82ee4b0c9d6adf6add2,58cfa82ee4b0c9d6adf6add2,G39020.TCGA-BR-8682-10A-01D-2394-08.3.filtered.,WGS,G39020.TCGA-BR-8682-10A-01D-2394-08.3,G39020.TCGA-BR-8682-10A-01D-2394-08.3.bam,253,NA,0.05,58cfa82ee4b0c9d6adf6add2,G39020.TCGA-BR-8682-10A-01D-2394-08.3.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-8682-10A,D5EFCDE2-21E6-4071-9AA4-3C5688A45B3F,Blood Derived Normal,Illumina HiSeq,7b22ed9c-2c20-44ef-9443-e6ad328825ba,Stomach,52,0A0A7DCB-809E-4A15-84DF-29EA4C22717B,E959D24D-AAB8-4A7E-A29C-5E2370DDCAD8,TCGA-BR-8682-10A-01D-2394-08,HG19_Broad_variant,TCGA-BR-8682,TCGA-STAD,NA,s14738,Broad Institute of MIT and Harvard,Asterand,Vietnam,NO,T4a,N0,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage IIB
13722.58cfa82ee4b0c9d6adf6a8ac,58cfa82ee4b0c9d6adf6a8ac,G35154.TCGA-EZ-7264-01A-11D-2024-08.2.filtered.,WGS,G35154.TCGA-EZ-7264-01A-11D-2024-08.2,G35154.TCGA-EZ-7264-01A-11D-2024-08.2.bam,329,NA,0.05,58cfa82ee4b0c9d6adf6a8ac,G35154.TCGA-EZ-7264-01A-11D-2024-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-EZ-7264-01A,FC3B7596-F515-446F-81DB-FED0154CA2C5,Primary Tumor,Illumina HiSeq,e0ea4522-35f1-40c7-92d2-5d1e7ec0cb63,Brain,47,EECBA415-5517-4265-8944-07AACBC679FB,00493087-9D9D-40CA-86D5-936F1B951C93,TCGA-EZ-7264-01A-11D-2024-08,HG19_Broad_variant,TCGA-EZ-7264,TCGA-LGG,NA,s8329,Broad Institute of MIT and Harvard,UNC,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82de4b0c9d6adf6a50c,58cfa82de4b0c9d6adf6a50c,437fd4c58a0c6f406413c5f2b3073d0a.filtered.,WGS,437fd4c58a0c6f406413c5f2b3073d0a,437fd4c58a0c6f406413c5f2b3073d0a.bam,63.5,1.98,0.08,58cfa82de4b0c9d6adf6a50c,437fd4c58a0c6f406413c5f2b3073d0a.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A156-01A,F05D314C-5EC5-4E2A-B785-9A702716F111,Primary Tumor,Illumina HiSeq,3d9a2788-2bc3-4df9-bae7-fef37f6096b8,Breast,61,9D39F2CF-84B5-45BA-8C40-0A42D8F303B7,2DA2B745-068D-408C-9163-3B3A78D4AAED,TCGA-E2-A156-01A-11D-A314-09,GRCh37-lite,TCGA-E2-A156,TCGA-BRCA,NA,s6622,Washington University School of Medicine,Roswell Park,None,NO,T1c,N0,Infiltrating Ductal Carcinoma,Stage I
13722.58cfa82de4b0c9d6adf6a785,58cfa82de4b0c9d6adf6a785,G16921.TCGA-BP-4977-11A-01D-2048-08.1.filtered.,WGS,G16921.TCGA-BP-4977-11A-01D-2048-08.1,G16921.TCGA-BP-4977-11A-01D-2048-08.1.bam,31.1,1.9,0.14,58cfa82de4b0c9d6adf6a785,G16921.TCGA-BP-4977-11A-01D-2048-08.1.bam,Alive,MALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-BP-4977-11A,CC353686-E2B6-46A1-8095-48E2BC44B11F,Solid Tissue Normal,Illumina HiSeq,ccafc8d9-bf2d-402b-8283-aa0e636b7a12,Kidney,57,8AD3B90E-4DA4-419A-8646-63ACFCE7521D,9D4A6140-2003-46BD-80C5-442942954090,TCGA-BP-4977-11A-01D-2048-08,HG19_Broad_variant,TCGA-BP-4977,TCGA-KIRC,NA,s9561,Broad Institute of MIT and Harvard,MSKCC,None,NO,T1b,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ac86,58cfa82ee4b0c9d6adf6ac86,G41960.TCGA-75-7030-01A-11D-1945-08.2.filtered.,WGS,G41960.TCGA-75-7030-01A-11D-1945-08.2,G41960.TCGA-75-7030-01A-11D-1945-08.2.bam,124.7,NA,0.05,58cfa82ee4b0c9d6adf6ac86,G41960.TCGA-75-7030-01A-11D-1945-08.2.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-7030-01A,DF576520-A6B6-4C9B-8D06-3F59CC5342FD,Primary Tumor,Illumina HiSeq,804a0fba-a82e-4501-9b0b-87c34318562d,Lung,NA,56C937B3-B48F-4662-B992-3265DBB6BC7D,0CE6F3ED-BDBC-4B70-9DB4-2E48F4BF644D,TCGA-75-7030-01A-11D-1945-08,HG19_Broad_variant,TCGA-75-7030,TCGA-LUAD,NA,s10636,Broad Institute of MIT and Harvard,Ontario Institute for Cancer Research (OICR),Canada,NO,T3,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6a98e,58cfa82ee4b0c9d6adf6a98e,G26370.TCGA-27-1831-10A-01D-1494-08.1.filtered.,WGS,G26370.TCGA-27-1831-10A-01D-1494-08.1,G26370.TCGA-27-1831-10A-01D-1494-08.1.bam,107,1.9,0.05,58cfa82ee4b0c9d6adf6a98e,G26370.TCGA-27-1831-10A-01D-1494-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-27-1831-10A,F45F4A30-6B4C-4F15-9140-959D6A25A45F,Blood Derived Normal,Illumina HiSeq,72646388-5b6e-44f7-844c-be38399a3410,Brain,66,967C0508-DBDA-44E5-976B-1296DED8EB70,638E5204-4A1A-43A0-BAB5-2D3F1BAC8DEE,TCGA-27-1831-10A-01D-1494-08,HG19_Broad_variant,TCGA-27-1831,TCGA-GBM,505,s13982,Broad Institute of MIT and Harvard,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa832e4b0c9d6adf6d1e8,58cfa832e4b0c9d6adf6d1e8,TCGA-F5-6814-10A-01D-1924-10_wgs_Illumina.filtered.,WGS,TCGA-F5-6814-10A-01D-1924-10_wgs_Illumina,TCGA-F5-6814-10A-01D-1924-10_wgs_Illumina.bam,284,NA,0.05,58cfa832e4b0c9d6adf6d1e8,TCGA-F5-6814-10A-01D-1924-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-F5-6814-10A,8FEB0E8F-D09B-437D-8651-0CDECFE776BF,Blood Derived Normal,Illumina HiSeq,43d2c403-9f31-440c-be9f-88404962cb1d,Colorectal,57,33185550-81FD-43B0-80A9-F14781013155,E7FF9A4A-F491-493A-8F54-A51C92DB0155,TCGA-F5-6814-10A-01D-1924-10,GRCh37-lite,TCGA-F5-6814,TCGA-READ,NA,s2179,Baylor College of Medicine,Asterand,Russia,NO,T2,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a461,58cfa82de4b0c9d6adf6a461,077f179af5b7fe13cbfcc88a10123c85.filtered.,WGS,077f179af5b7fe13cbfcc88a10123c85,077f179af5b7fe13cbfcc88a10123c85.bam,83.7,1.97,0.08,58cfa82de4b0c9d6adf6a461,077f179af5b7fe13cbfcc88a10123c85.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A1MI-01A,941F75A1-FEA4-4539-BA69-60BB11608F6D,Primary Tumor,Illumina HiSeq,e32cf6ef-190c-4456-b8a7-b40b9c9c8036,Cervix,50,A753BCF7-82D6-4FB1-AF0D-641898BBFF9C,14B8BBF2-310B-459B-B52D-A7EF510CE1CF,TCGA-C5-A1MI-01A-11D-A200-09,GRCh37-lite,TCGA-C5-A1MI,TCGA-CESC,1083,s1508,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,T1b1,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82de4b0c9d6adf6a4ea,58cfa82de4b0c9d6adf6a4ea,282e52fc396cb531fa21b3436906608f.filtered.,WGS,282e52fc396cb531fa21b3436906608f,282e52fc396cb531fa21b3436906608f.bam,35.31,NA,0.08,58cfa82de4b0c9d6adf6a4ea,282e52fc396cb531fa21b3436906608f.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A3Y0-01A,174850B4-5EC2-462B-A890-89BD1716B3C2,Primary Tumor,Illumina HiSeq,f1452ca5-f44b-4f35-a5eb-a8b1f9c44ef7,Breast,57,CAA2D510-9024-4D7D-B0EF-80FA4BE1E2EE,D8FBB398-D1DA-4444-984A-22C8523625DA,TCGA-A2-A3Y0-01A-11D-A23C-09,GRCh37-lite,TCGA-A2-A3Y0,TCGA-BRCA,NA,s6910,Washington University School of Medicine,Walter Reed,United States,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa82de4b0c9d6adf6a4b2,58cfa82de4b0c9d6adf6a4b2,1d839fbbdcb1971d9a0ef13b9f7a8b2e.filtered.,WGS,1d839fbbdcb1971d9a0ef13b9f7a8b2e,1d839fbbdcb1971d9a0ef13b9f7a8b2e.bam,69.79,1.98,0.08,58cfa82de4b0c9d6adf6a4b2,1d839fbbdcb1971d9a0ef13b9f7a8b2e.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AN-A0AT-01A,05506F4C-E701-4A9D-AE06-97F066AADE43,Primary Tumor,Illumina HiSeq,5285cd99-09bc-48e5-abcb-11230d5f40f0,Breast,62,B2905A3F-810B-4E74-AF5C-42D513D91746,F848B66F-BD9E-4FBA-AFD4-EB58848D1EF4,TCGA-AN-A0AT-01A-11D-A045-09,GRCh37-lite,TCGA-AN-A0AT,TCGA-BRCA,NA,s6760,Washington University School of Medicine,Cureline,None,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6ae7f,58cfa82ee4b0c9d6adf6ae7f,G49538.TCGA-06-0221-10A-01D-A35R-08.1.filtered.,WGS,G49538.TCGA-06-0221-10A-01D-A35R-08.1,G49538.TCGA-06-0221-10A-01D-A35R-08.1.bam,138.7,1.88,0.08,58cfa82ee4b0c9d6adf6ae7f,G49538.TCGA-06-0221-10A-01D-A35R-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0221-10A,054F472F-98CB-4559-B2E2-B5F800FC8EEF,Blood Derived Normal,Illumina HiSeq,6fd634c2-7dc1-4b21-b2d4-ab2334f8dd9a,Brain,31,0244FAA4-54DF-47C7-B53B-6CCCDEB8AE9F,A4C7209A-8B5A-4A37-9A1B-5502D941F54B,TCGA-06-0221-10A-01D-A35R-08,HG19_Broad_variant,TCGA-06-0221,TCGA-GBM,603,s13983,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a484,58cfa82de4b0c9d6adf6a484,2d65798c16f002af919022459ec3009d.filtered.,WGS,2d65798c16f002af919022459ec3009d,2d65798c16f002af919022459ec3009d.bam,20,NA,0.09,58cfa82de4b0c9d6adf6a484,2d65798c16f002af919022459ec3009d.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A1KU-01A,EA0E5AE7-1F15-4504-AEA3-EFD1F6733304,Primary Tumor,Illumina HiSeq,f73eec26-a9f4-4fb0-bbaa-ca6aa00f1a51,Mesenchymal,82,B09E1197-D6CD-4A76-8E2F-3B8AF97D2390,C556F81B-8A6C-4BBB-876F-2E2CE570C185,TCGA-DX-A1KU-01A-32D-A24N-09,GRCh37-lite,TCGA-DX-A1KU,TCGA-SARC,427,s2481,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a6bc,58cfa82de4b0c9d6adf6a6bc,96931b4ebc549e6fc4857a1d420bb860.filtered.,WGS,96931b4ebc549e6fc4857a1d420bb860,96931b4ebc549e6fc4857a1d420bb860.bam,63.14,2.06,0.07,58cfa82de4b0c9d6adf6a6bc,96931b4ebc549e6fc4857a1d420bb860.bam,Dead,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A08L-01A,8BD68696-5EEB-46D7-9DC6-C39C849029A4,Primary Tumor,Illumina HiSeq,941e2188-e858-40d6-9f12-5faa6425a67f,Breast,89,C385C7FC-0E3E-4FC8-87C1-6DB442E5606F,FE04D042-A4CC-4A14-8197-415EA40951AA,TCGA-A8-A08L-01A-11D-A19H-09,GRCh37-lite,TCGA-A8-A08L,TCGA-BRCA,304,s5634,Washington University School of Medicine,Indivumed,Germany,NO,T3,N2a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82ee4b0c9d6adf6aa96,58cfa82ee4b0c9d6adf6aa96,G32557.TCGA-ER-A19T-10A-01D-A19A-08.1.filtered.,WGS,G32557.TCGA-ER-A19T-10A-01D-A19A-08.1,G32557.TCGA-ER-A19T-10A-01D-A19A-08.1.bam,23.88,NA,0.09,58cfa82ee4b0c9d6adf6aa96,G32557.TCGA-ER-A19T-10A-01D-A19A-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19T-10A,B85B14D7-3B5A-4800-AF12-622EC03B9FE5,Blood Derived Normal,Illumina HiSeq,c17175b6-5b84-4673-8dce-884951bd642b,Skin,51,C070D019-1F19-43D0-8B34-A46DC4C8790E,E694C1A2-86F0-43D0-95CC-4CFAF0B04060,TCGA-ER-A19T-10A-01D-A19A-08,HG19_Broad_variant,TCGA-ER-A19T,TCGA-SKCM,270,s7812,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T4a,N3,Not available,Stage IV
13722.58cfa82de4b0c9d6adf6a5b8,58cfa82de4b0c9d6adf6a5b8,61a02d82b4437f653c127eb3d3e0a78d.filtered.,WGS,61a02d82b4437f653c127eb3d3e0a78d,61a02d82b4437f653c127eb3d3e0a78d.bam,50.85,1.97,0.08,58cfa82de4b0c9d6adf6a5b8,61a02d82b4437f653c127eb3d3e0a78d.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A14X-01A,60DF7543-6DA5-4C75-943B-5800C1E08234,Primary Tumor,Illumina HiSeq,775348e1-91bf-4bf9-93e9-ff9f955b5a79,Breast,55,A7CC9298-D6F1-48EF-A93A-9C75FC0CB800,74039ACD-5ACA-4C65-818C-3B577D295BE0,TCGA-E2-A14X-01A-11D-A10Y-09,GRCh37-lite,TCGA-E2-A14X,TCGA-BRCA,NA,s6116,Washington University School of Medicine,Roswell Park,None,NO,T2,N2,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82ee4b0c9d6adf6a967,58cfa82ee4b0c9d6adf6a967,G32458.TCGA-BT-A20V-01A-11D-A14W-08.2.filtered.,WGS,G32458.TCGA-BT-A20V-01A-11D-A14W-08.2,G32458.TCGA-BT-A20V-01A-11D-A14W-08.2.bam,101.87,2.11,0.08,58cfa82ee4b0c9d6adf6a967,G32458.TCGA-BT-A20V-01A-11D-A14W-08.2.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20V-01A,24F21425-B001-4986-AEDF-5B4DD851C6AD,Primary Tumor,Illumina HiSeq,a193bc83-ec94-46bb-b7ee-60b8b75c8ad8,Bladder,59,967443E3-35C3-4F41-9BB5-DC899D290806,973D0577-8CA4-44A1-817F-1D3C1BADA151,TCGA-BT-A20V-01A-11D-A14W-08,HG19_Broad_variant,TCGA-BT-A20V,TCGA-BLCA,154,s3252,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T4a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82ee4b0c9d6adf6ab38,58cfa82ee4b0c9d6adf6ab38,G32458.TCGA-BT-A20V-11A-11D-A14W-08.2.filtered.,WGS,G32458.TCGA-BT-A20V-11A-11D-A14W-08.2,G32458.TCGA-BT-A20V-11A-11D-A14W-08.2.bam,24.46,1.93,0.08,58cfa82ee4b0c9d6adf6ab38,G32458.TCGA-BT-A20V-11A-11D-A14W-08.2.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20V-11A,24F21425-B001-4986-AEDF-5B4DD851C6AD,Solid Tissue Normal,Illumina HiSeq,cdb0bfa4-f9fb-4cd7-b19a-84f9afc80f69,Bladder,59,1C7630ED-6B1C-4569-A15C-E296772868DE,F88B2F4C-15F1-4808-BCEC-89ABC7466DE6,TCGA-BT-A20V-11A-11D-A14W-08,HG19_Broad_variant,TCGA-BT-A20V,TCGA-BLCA,154,s3258,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T4a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82ee4b0c9d6adf6aba7,58cfa82ee4b0c9d6adf6aba7,G32467.TCGA-DK-A1A6-10A-01D-A13W-08.5.filtered.,WGS,G32467.TCGA-DK-A1A6-10A-01D-A13W-08.5,G32467.TCGA-DK-A1A6-10A-01D-A13W-08.5.bam,67.49,1.93,0.09,58cfa82ee4b0c9d6adf6aba7,G32467.TCGA-DK-A1A6-10A-01D-A13W-08.5.bam,Alive,MALE,WHITE,Not available,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A6-10A,9C274536-3CA1-4F0E-93A8-1688074D862F,Blood Derived Normal,Illumina HiSeq,182b13b1-b615-4fdf-8972-face22902f2c,Bladder,53,E1FD80CA-0A44-4604-8B6F-283C56824721,FCDB086F-6E88-49CE-A202-B611584A080C,TCGA-DK-A1A6-10A-01D-A13W-08,HG19_Broad_variant,TCGA-DK-A1A6,TCGA-BLCA,NA,s2852,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T2a,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82fe4b0c9d6adf6ba23,58cfa82fe4b0c9d6adf6ba23,TCGA-AA-3666-10A-01D-1981-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3666-10A-01D-1981-10_wgs_Illumina,TCGA-AA-3666-10A-01D-1981-10_wgs_Illumina.bam,81.96,1.9,0.15,58cfa82fe4b0c9d6adf6ba23,TCGA-AA-3666-10A-01D-1981-10_wgs_Illumina.bam,Dead,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3666-10A,A512701F-88BB-4B05-8C94-FD285B9DD13E,Blood Derived Normal,Illumina HiSeq,0a04e686-5ab1-416c-8cff-e198c5fd6ce0,Colorectal,68,F181B2C2-6FB2-4B7D-8C6B-A198EEE941FB,93E8EAA1-9FB9-49F2-B562-92065CB66076,TCGA-AA-3666-10A-01D-1981-10,GRCh37-lite,TCGA-AA-3666,TCGA-COAD,61,s13837,Baylor College of Medicine,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage III
13722.58cfa82fe4b0c9d6adf6b909,58cfa82fe4b0c9d6adf6b909,TCGA-A3-3387-01A-01D-2102-10_Illumina.filtered.,WGS,TCGA-A3-3387-01A-01D-2102-10_Illumina,TCGA-A3-3387-01A-01D-2102-10_Illumina.bam,180.4,1.9,0.14,58cfa82fe4b0c9d6adf6b909,TCGA-A3-3387-01A-01D-2102-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-A3-3387-01A,9DC7812B-C7A2-4DE4-BF6D-4C7261384A62,Primary Tumor,Illumina HiSeq,1abe0bf3-83d3-40d9-8e12-5729d760aeed,Kidney,49,413ED4FA-013A-4751-8F74-D54F6CF992C9,00BF0350-8C7C-4B9E-8143-13EA2DC1122F,TCGA-A3-3387-01A-01D-2102-10,GRCh37-lite,TCGA-A3-3387,TCGA-KIRC,NA,s9302,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1a,N0,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82de4b0c9d6adf6a668,58cfa82de4b0c9d6adf6a668,7bb361e97c34cfa7d98b7297a5f65604.filtered.,WGS,7bb361e97c34cfa7d98b7297a5f65604,7bb361e97c34cfa7d98b7297a5f65604.bam,92.8,2.11,0.08,58cfa82de4b0c9d6adf6a668,7bb361e97c34cfa7d98b7297a5f65604.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GJ-01A,94817E78-78F5-4556-9394-610DF65605E2,Primary Tumor,Illumina HiSeq,b55c1811-4356-4978-a0f1-59bda1ab8a8c,Uterus,44,48FA5B7D-E488-4743-A7CE-ACEB9945F00B,B38D0777-4901-48B8-9CDC-33B7F13A424F,TCGA-A5-A0GJ-01A-11D-A325-09,GRCh37-lite,TCGA-A5-A0GJ,TCGA-UCEC,NA,s4240,Washington University School of Medicine,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ad53,58cfa82ee4b0c9d6adf6ad53,G37566.TCGA-CH-5788-10A-01D-1576-08.4.filtered.,WGS,G37566.TCGA-CH-5788-10A-01D-1576-08.4,G37566.TCGA-CH-5788-10A-01D-1576-08.4.bam,101.4,1.9,0.05,58cfa82ee4b0c9d6adf6ad53,G37566.TCGA-CH-5788-10A-01D-1576-08.4.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5788-10A,C039014F-821C-43D6-9D3C-914F9C8D98FA,Blood Derived Normal,Illumina HiSeq,4087c08f-e268-43c8-939a-54a67cf78246,Prostate,69,7B15C08B-3DB1-4505-A8A7-21FF56A7DCA6,EBC70303-3561-4CF6-A274-8C83D1D5F9BD,TCGA-CH-5788-10A-01D-1576-08,HG19_Broad_variant,TCGA-CH-5788,TCGA-PRAD,NA,s3404,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82de4b0c9d6adf6a766,58cfa82de4b0c9d6adf6a766,G14681.TCGA-60-2719-11A-01D-1522-08.1.filtered.,WGS,G14681.TCGA-60-2719-11A-01D-1522-08.1,G14681.TCGA-60-2719-11A-01D-1522-08.1.bam,250,1.9,0.05,58cfa82de4b0c9d6adf6a766,G14681.TCGA-60-2719-11A-01D-1522-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-60-2719-11A,585E6487-B0A3-4828-8A06-46BEE01DFF74,Solid Tissue Normal,Illumina HiSeq,ec50210b-55a5-41cb-a244-48104f5346fe,Lung,83,3744F45B-0871-471A-A9BE-5B0AD0B3A305,7EFD4B88-BEED-4E5E-B434-2BC0103084E6,TCGA-60-2719-11A-01D-1522-08,HG19_Broad_variant,TCGA-60-2719,TCGA-LUSC,NA,s9973,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6abde,58cfa82ee4b0c9d6adf6abde,G37566.TCGA-G9-6336-10A-01D-1786-08.1.filtered.,WGS,G37566.TCGA-G9-6336-10A-01D-1786-08.1,G37566.TCGA-G9-6336-10A-01D-1786-08.1.bam,16.7,1.9,0.05,58cfa82ee4b0c9d6adf6abde,G37566.TCGA-G9-6336-10A-01D-1786-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6336-10A,59207BCD-F127-481F-B576-8716DA7D7D97,Blood Derived Normal,Illumina HiSeq,35212dfd-bbf0-44ba-a0c5-8c4e26f5ca99,Prostate,57,71864139-EC05-4BB1-9DF7-27954283261E,AEFE7099-96E0-481C-BBFE-1566024DF395,TCGA-G9-6336-10A-01D-1786-08,HG19_Broad_variant,TCGA-G9-6336,TCGA-PRAD,NA,s3585,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,Not available,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6b095,58cfa82ee4b0c9d6adf6b095,G48125.TCGA-24-1562-10A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-24-1562-10A-01D-A312-08.2,G48125.TCGA-24-1562-10A-01D-A312-08.2.bam,404.97,1.9,0.08,58cfa82ee4b0c9d6adf6b095,G48125.TCGA-24-1562-10A-01D-A312-08.2.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1562-10A,4C18D9CF-4AF4-4A86-8B1C-F78795FBBD7E,Blood Derived Normal,Illumina HiSeq,7ea8ecc1-0905-408c-a2b7-3d442b28a95e,Ovary,67,4B1FA422-B017-449B-A763-4962F4121569,768972BA-43B6-464A-823A-5F0C7C6ED028,TCGA-24-1562-10A-01D-A312-08,HG19_Broad_variant,TCGA-24-1562,TCGA-OV,1384,s17407,Broad Institute of MIT and Harvard,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a6c4,58cfa82de4b0c9d6adf6a6c4,890d7ec2b62541e2e80696ea62529008.filtered.,WGS,890d7ec2b62541e2e80696ea62529008,890d7ec2b62541e2e80696ea62529008.bam,63.32,NA,0.07,58cfa82de4b0c9d6adf6a6c4,890d7ec2b62541e2e80696ea62529008.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2RM-01A,C13215D9-26A8-4C8B-B4FE-5DA6AA3222AF,Primary Tumor,Illumina HiSeq,4bb49662-4b46-4288-a828-c518e6d697b2,Cervix,40,F0CA60FB-BD45-4F15-A791-0C5B1218D8EF,801E67C8-C506-410A-BDF0-856A66E974F4,TCGA-EK-A2RM-01A-21D-A18J-09,GRCh37-lite,TCGA-EK-A2RM,TCGA-CESC,NA,s1168,Washington University School of Medicine,Gynecologic Oncology Group,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6ba1a,58cfa82fe4b0c9d6adf6ba1a,TCGA-A3-3370-11A-01D-2099-10_Illumina.filtered.,WGS,TCGA-A3-3370-11A-01D-2099-10_Illumina,TCGA-A3-3370-11A-01D-2099-10_Illumina.bam,110,1.9,0.16,58cfa82fe4b0c9d6adf6ba1a,TCGA-A3-3370-11A-01D-2099-10_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-A3-3370-11A,9F632FC3-2241-469A-A14A-CD537350155F,Solid Tissue Normal,Illumina HiSeq,20e9c9ab-d5ad-4cb7-aaaa-2d31e8ae5b47,Kidney,48,8C23898C-2B3E-4A33-A4C0-A81496645297,CA5FD3CB-D784-4B44-93A7-6704FB6103C6,TCGA-A3-3370-11A-01D-2099-10,GRCh37-lite,TCGA-A3-3370,TCGA-KIRC,NA,s9300,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1b,N0,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa83ce4b0c9d6adf730ca,58cfa83ce4b0c9d6adf730ca,fe1ba68c47fad6337f26bbdac35cbb2b.filtered.,WGS,fe1ba68c47fad6337f26bbdac35cbb2b,fe1ba68c47fad6337f26bbdac35cbb2b.bam,43.03,NA,0.08,58cfa83ce4b0c9d6adf730ca,fe1ba68c47fad6337f26bbdac35cbb2b.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2RL-01A,61EB08D0-EA01-45E7-884B-AC3D6070172A,Primary Tumor,Illumina HiSeq,5848efed-18c8-413b-8a2c-9a63deec56ee,Cervix,32,DD3E80D9-0321-40AD-B963-25E2C94C6092,842DF341-D34F-4ED6-928C-EAF15BF7F667,TCGA-EK-A2RL-01A-11D-A34H-09,GRCh37-lite,TCGA-EK-A2RL,TCGA-CESC,NA,s1507,Washington University School of Medicine,Gynecologic Oncology Group,United States,NO,T1b1,N1,Endocervical Type of Adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a816,58cfa82ee4b0c9d6adf6a816,G35154.TCGA-DU-7301-10A-01D-2086-08.2.filtered.,WGS,G35154.TCGA-DU-7301-10A-01D-2086-08.2,G35154.TCGA-DU-7301-10A-01D-2086-08.2.bam,64.3,NA,0.05,58cfa82ee4b0c9d6adf6a816,G35154.TCGA-DU-7301-10A-01D-2086-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7301-10A,84AE73E4-3B39-4444-9BFB-3FC6057EAB32,Blood Derived Normal,Illumina HiSeq,8d315f21-d285-46ed-b707-ff48d1be543d,Brain,53,4F6960E9-BFEB-4287-B8B1-6FCCF3B3F8D8,536CB58B-852C-491A-94F7-FFBEA4C98871,TCGA-DU-7301-10A-01D-2086-08,HG19_Broad_variant,TCGA-DU-7301,TCGA-LGG,788,s8324,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6ab34,58cfa82ee4b0c9d6adf6ab34,G32460.TCGA-BT-A3PH-01A-11D-A21Z-08.2.filtered.,WGS,G32460.TCGA-BT-A3PH-01A-11D-A21Z-08.2,G32460.TCGA-BT-A3PH-01A-11D-A21Z-08.2.bam,56.18,NA,0.08,58cfa82ee4b0c9d6adf6ab34,G32460.TCGA-BT-A3PH-01A-11D-A21Z-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A3PH-01A,932BCDD4-5145-49E8-9A95-8A546396F572,Primary Tumor,Illumina HiSeq,6a3d1aec-7ab7-4703-b3f0-5ba3f396d70d,Bladder,76,33A83E54-3BE5-4A68-8AB0-D31D0BCD3B67,CDA1A403-16B6-487C-A82A-C377D1D0F89D,TCGA-BT-A3PH-01A-11D-A21Z-08,HG19_Broad_variant,TCGA-BT-A3PH,TCGA-BLCA,142,s3254,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa83ce4b0c9d6adf72f72,58cfa83ce4b0c9d6adf72f72,ea57989a2a3017624491e77218b0f326.filtered.,WGS,ea57989a2a3017624491e77218b0f326,ea57989a2a3017624491e77218b0f326.bam,44.27,1.98,0.08,58cfa83ce4b0c9d6adf72f72,ea57989a2a3017624491e77218b0f326.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A15E-01A,0A2A3529-F645-4967-9A58-89EE20B8BB62,Primary Tumor,Illumina HiSeq,3b80e735-e034-4867-be5e-52500f523ab5,Breast,40,9992EEB9-901B-4A32-BADC-E9BE7C9BA4BA,92B515EB-4036-4DAD-9CCA-DFB59C2EF26E,TCGA-E2-A15E-01A-11D-A19H-09,GRCh37-lite,TCGA-E2-A15E,TCGA-BRCA,NA,s6753,Washington University School of Medicine,Roswell Park,None,NO,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a47e,58cfa82de4b0c9d6adf6a47e,2c5b37c2fff4a62ce10d93452de3771f.filtered.,WGS,2c5b37c2fff4a62ce10d93452de3771f,2c5b37c2fff4a62ce10d93452de3771f.bam,52.88,1.88,0.08,58cfa82de4b0c9d6adf6a47e,2c5b37c2fff4a62ce10d93452de3771f.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A0D1-01A,084C6AEC-94F7-4090-8F3F-59FA9E89721A,Primary Tumor,Illumina HiSeq,6d37aa75-54cd-423e-987a-342e9a2def7a,Breast,76,12ECE355-F1D0-446C-84E9-0AED3E6D29F8,E5593865-5F8E-4A4C-B36F-73FBE64D66DA,TCGA-A2-A0D1-01A-11D-A19H-09,GRCh37-lite,TCGA-A2-A0D1,TCGA-BRCA,NA,s5476,Washington University School of Medicine,Walter Reed,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6abc0,58cfa82ee4b0c9d6adf6abc0,G37566.TCGA-CH-5763-11A-01D-1576-08.1.filtered.,WGS,G37566.TCGA-CH-5763-11A-01D-1576-08.1,G37566.TCGA-CH-5763-11A-01D-1576-08.1.bam,116.7,1.9,0.05,58cfa82ee4b0c9d6adf6abc0,G37566.TCGA-CH-5763-11A-01D-1576-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5763-11A,18E79A01-07A2-4CD5-B700-71D41724E041,Solid Tissue Normal,Illumina HiSeq,219139dd-608b-4b64-ba77-974018988c0c,Prostate,66,20F71991-0257-47C1-AE58-A64C83EAF8FE,B3C65FBF-E781-4A0C-B76D-8A6C4535CCEF,TCGA-CH-5763-11A-01D-1576-08,HG19_Broad_variant,TCGA-CH-5763,TCGA-PRAD,NA,s3760,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6aca6,58cfa82ee4b0c9d6adf6aca6,G48125.TCGA-04-1542-10A-01D-A312-08.1.filtered.,WGS,G48125.TCGA-04-1542-10A-01D-A312-08.1,G48125.TCGA-04-1542-10A-01D-A312-08.1.bam,44.97,1.8,0.07,58cfa82ee4b0c9d6adf6aca6,G48125.TCGA-04-1542-10A-01D-A312-08.1.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-04-1542-10A,0C1A2E7D-E7E4-481E-A012-EF214C444497,Blood Derived Normal,Illumina HiSeq,63e77be3-ddf8-466a-983f-89668f506815,Ovary,52,E7585F75-4992-4C50-8C61-6508A2BDA898,C861BA20-C8B2-4D4B-8F93-8B82E77E859A,TCGA-04-1542-10A-01D-A312-08,HG19_Broad_variant,TCGA-04-1542,TCGA-OV,2561,s17548,Broad Institute of MIT and Harvard,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b910,58cfa82fe4b0c9d6adf6b910,TCGA-A6-2681-10A-01D-2188-10_wgs_Illumina.filtered.,WGS,TCGA-A6-2681-10A-01D-2188-10_wgs_Illumina,TCGA-A6-2681-10A-01D-2188-10_wgs_Illumina.bam,466,1.9,0.05,58cfa82fe4b0c9d6adf6b910,TCGA-A6-2681-10A-01D-2188-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2681-10A,7D8EAB0A-E6C8-4449-9EBF-50C41DB94A06,Blood Derived Normal,Illumina HiSeq,ed5b5738-8484-44b0-a476-d5141cbda574,Colorectal,73,EA27374C-3F62-4128-A14A-8418966AFDB3,3DF07171-60E2-4ADA-8AEF-63EEA6D9A2AB,TCGA-A6-2681-10A-01D-2188-10,GRCh37-lite,TCGA-A6-2681,TCGA-COAD,NA,s12853,Baylor College of Medicine,Christiana Healthcare,United States,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a4a8,58cfa82de4b0c9d6adf6a4a8,1460837133c752e48d8ded9f16cc5949.filtered.,WGS,1460837133c752e48d8ded9f16cc5949,1460837133c752e48d8ded9f16cc5949.bam,43.68,1.56,0.08,58cfa82de4b0c9d6adf6a4a8,1460837133c752e48d8ded9f16cc5949.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A1LK-01A,1D27253F-B036-44E7-A04D-8DA5BBF57419,Primary Tumor,Illumina HiSeq,cdbdb1d9-4c6d-4a22-8867-42722b596ae9,Breast,84,CC937913-802F-48CD-A490-E6B90F007C5D,4E84EED6-82A8-4E91-B0FD-61EC6EF69CE9,TCGA-E2-A1LK-01A-21D-A14G-09,GRCh37-lite,TCGA-E2-A1LK,TCGA-BRCA,266,s6757,Washington University School of Medicine,Roswell Park,United States,NO,T4b,N3a,Infiltrating Ductal Carcinoma,Stage IIIC
13722.58cfa82ee4b0c9d6adf6adf6,58cfa82ee4b0c9d6adf6adf6,G39020.TCGA-CG-4442-01A-01D-A290-08.2.filtered.,WGS,G39020.TCGA-CG-4442-01A-01D-A290-08.2,G39020.TCGA-CG-4442-01A-01D-A290-08.2.bam,165.2,1.9,0.07,58cfa82ee4b0c9d6adf6adf6,G39020.TCGA-CG-4442-01A-01D-A290-08.2.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4442-01A,8FCCFF71-3710-4CB9-B8AF-61707AEBE5D8,Primary Tumor,Illumina HiSeq,05a46a94-fa5c-4e76-b887-07ec0fa0af0f,Stomach,85,51927F82-2585-465B-92ED-36EF46D44FAB,7E305F31-FBB0-4BCE-894B-1DD85E303421,TCGA-CG-4442-01A-01D-A290-08,HG19_Broad_variant,TCGA-CG-4442,TCGA-STAD,NA,s15042,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6ae84,58cfa82ee4b0c9d6adf6ae84,G49537.TCGA-FE-A22Z-10A-01D-A35R-08.1.filtered.,WGS,G49537.TCGA-FE-A22Z-10A-01D-A35R-08.1,G49537.TCGA-FE-A22Z-10A-01D-A35R-08.1.bam,27.97,1.9,0.08,58cfa82ee4b0c9d6adf6ae84,G49537.TCGA-FE-A22Z-10A-01D-A35R-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A22Z-10A,78D14F86-896A-4F98-9274-B2E8E387ADD9,Blood Derived Normal,Illumina HiSeq,36b50f79-9237-4b80-ae5d-014b02df659a,Thyroid,61,7727F473-C83D-4CF2-B779-C4FDB6172AA7,E9058FDE-C9DF-49EC-94F3-B918A84C4C2E,TCGA-FE-A22Z-10A-01D-A35R-08,HG19_Broad_variant,TCGA-FE-A22Z,TCGA-THCA,NA,s11978,Broad Institute of MIT and Harvard,Ohio State University,United States,NO,T4a,N1,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage IVA
13722.58cfa831e4b0c9d6adf6c70a,58cfa831e4b0c9d6adf6c70a,TCGA-CV-5442-11A-01D-2266-10_Illumina.filtered.,WGS,TCGA-CV-5442-11A-01D-2266-10_Illumina,TCGA-CV-5442-11A-01D-2266-10_Illumina.bam,36.7,1.8,0.05,58cfa831e4b0c9d6adf6c70a,TCGA-CV-5442-11A-01D-2266-10_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5442-11A,3C975B68-4A6E-4C97-A8D1-B9A427D4957C,Solid Tissue Normal,Illumina HiSeq,40685f5a-d0e0-4f57-be78-25032bb1a9f2,Head and Neck,76,EC885AF4-3513-4790-AB1F-6ECC94B6115D,6527E1BE-0D25-4846-89B7-6C6B407E25E9,TCGA-CV-5442-11A-01D-2266-10,GRCh37-lite,TCGA-CV-5442,TCGA-HNSC,NA,s16338,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6bb68,58cfa830e4b0c9d6adf6bb68,TCGA-AA-A02Y-01A-43D-A17O-10_wgs_Illumina.filtered.,WGS,TCGA-AA-A02Y-01A-43D-A17O-10_wgs_Illumina,TCGA-AA-A02Y-01A-43D-A17O-10_wgs_Illumina.bam,84.8,1.91,0.08,58cfa830e4b0c9d6adf6bb68,TCGA-AA-A02Y-01A-43D-A17O-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A02Y-01A,A435FDF4-A89A-499E-9006-CBB5693EAB26,Primary Tumor,Illumina HiSeq,258e501e-d510-4eda-b9fb-9d4bf0226c16,Colorectal,73,8537633B-6426-4B66-A2A3-FA942EEDF01B,B2AFBCBA-D67D-43F1-BE3B-05F3A5836EC0,TCGA-AA-A02Y-01A-43D-A17O-10,GRCh37-lite,TCGA-AA-A02Y,TCGA-COAD,NA,s13685,Baylor College of Medicine,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa82de4b0c9d6adf6a530,58cfa82de4b0c9d6adf6a530,11e9896c1184c4a8c38f78209b067bcf.filtered.,WGS,11e9896c1184c4a8c38f78209b067bcf,11e9896c1184c4a8c38f78209b067bcf.bam,31.82,1.93,0.08,58cfa82de4b0c9d6adf6a530,11e9896c1184c4a8c38f78209b067bcf.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0TG-01A,13F31BCB-BEFD-4ED2-ADC0-DC9E9CE52B75,Primary Tumor,Illumina HiSeq,8a9ac951-0c3a-4112-8159-d585756fae14,Uterus,60,36E44603-A1EE-4A5B-9506-49A9358BF8D0,19DEF402-FB8D-4B27-90DD-CE9135A3C0A2,TCGA-BS-A0TG-01A-32D-A10B-09,GRCh37-lite,TCGA-BS-A0TG,TCGA-UCEC,NA,s4233,Washington University School of Medicine,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6af0c,58cfa82ee4b0c9d6adf6af0c,G48125.TCGA-10-0938-11A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-10-0938-11A-01D-A312-08.2,G48125.TCGA-10-0938-11A-01D-A312-08.2.bam,449.97,1.8,0.07,58cfa82ee4b0c9d6adf6af0c,G48125.TCGA-10-0938-11A-01D-A312-08.2.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-10-0938-11A,7CA97692-0BF5-4BBD-81CE-10A051D04BD5,Solid Tissue Normal,Illumina HiSeq,4da78c52-e98e-47d7-86ac-b9a26b492ed7,Ovary,80,59FDE5A1-CC2A-4F0D-9557-111275B0D7ED,F166A6C0-D9A1-46F4-86A1-94B71F917212,TCGA-10-0938-11A-01D-A312-08,HG19_Broad_variant,TCGA-10-0938,TCGA-OV,636,s17708,Broad Institute of MIT and Harvard,MD Anderson Cancer Center,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf73168,58cfa83ce4b0c9d6adf73168,f31cfe2ad0117626a14c5b0dea28c02d.filtered.,WGS,f31cfe2ad0117626a14c5b0dea28c02d,f31cfe2ad0117626a14c5b0dea28c02d.bam,91.48,2.08,0.08,58cfa83ce4b0c9d6adf73168,f31cfe2ad0117626a14c5b0dea28c02d.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LF-01A,748E38B1-2EAD-4A0A-8881-D640617B856B,Primary Tumor,Illumina HiSeq,edd786b0-5020-470f-a33f-28c99bef68c0,Uterus,82,902E2DD8-81E5-4949-A57B-92B3EFD86C63,460F7427-EBCF-404B-9E9E-E0278D0BCA95,TCGA-AP-A0LF-01A-11D-A122-09,GRCh37-lite,TCGA-AP-A0LF,TCGA-UCEC,NA,s5374,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c796,58cfa831e4b0c9d6adf6c796,TCGA-CN-5374-10A-01D-2266-10_Illumina.filtered.,WGS,TCGA-CN-5374-10A-01D-2266-10_Illumina,TCGA-CN-5374-10A-01D-2266-10_Illumina.bam,73.4,1.9,0.05,58cfa831e4b0c9d6adf6c796,TCGA-CN-5374-10A-01D-2266-10_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5374-10A,D7641CA1-A062-4DD2-9414-447AF7311A84,Blood Derived Normal,Illumina HiSeq,ed899124-7dec-45d3-a9f2-79402efa65bb,Head and Neck,56,27FB0AE5-D8A1-46AC-AD3E-2464C52D9CFD,F9416343-E559-49FD-80CE-D6E7607B5B58,TCGA-CN-5374-10A-01D-2266-10,GRCh37-lite,TCGA-CN-5374,TCGA-HNSC,NA,s15882,Baylor College of Medicine,University of Pittsburgh,None,NO,T2,N2,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82ee4b0c9d6adf6a8be,58cfa82ee4b0c9d6adf6a8be,G35154.TCGA-E1-5318-10A-01D-1468-08.1.filtered.,WGS,G35154.TCGA-E1-5318-10A-01D-1468-08.1,G35154.TCGA-E1-5318-10A-01D-1468-08.1.bam,89.7,1.9,0.05,58cfa82ee4b0c9d6adf6a8be,G35154.TCGA-E1-5318-10A-01D-1468-08.1.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-E1-5318-10A,400B2FA3-BAF7-4BAA-99B4-88B9F25B5049,Blood Derived Normal,Illumina HiSeq,a572d1ce-26c6-4788-9feb-6f9000207266,Brain,42,A4858873-BB17-406B-A752-1BF230B512C3,0FCE50B4-028D-4B54-AA49-3A8E28A7F7C6,TCGA-E1-5318-10A-01D-1468-08,HG19_Broad_variant,TCGA-E1-5318,TCGA-LGG,2379,s8335,Broad Institute of MIT and Harvard,Duke,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6c480,58cfa831e4b0c9d6adf6c480,TCGA-CJ-5682-01A-11D-2103-10_Illumina.filtered.,WGS,TCGA-CJ-5682-01A-11D-2103-10_Illumina,TCGA-CJ-5682-01A-11D-2103-10_Illumina.bam,155.4,1.9,0.15,58cfa831e4b0c9d6adf6c480,TCGA-CJ-5682-01A-11D-2103-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CJ-5682-01A,4C325EE1-9B8E-45D4-A0A7-E47EC1EAC402,Primary Tumor,Illumina HiSeq,5586870f-0a22-4bd6-b331-defce06a0f46,Kidney,60,3D38F604-E571-422D-B645-BF73A0348243,DACD4CC2-FC2B-4FBD-ADF6-C8A46AE69C91,TCGA-CJ-5682-01A-11D-2103-10,GRCh37-lite,TCGA-CJ-5682,TCGA-KIRC,NA,s9450,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T3a,NX,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa82de4b0c9d6adf6a710,58cfa82de4b0c9d6adf6a710,G12519.TCGA-34-2600-01A-01D-0963-08.5.filtered.,WGS,G12519.TCGA-34-2600-01A-01D-0963-08.5,G12519.TCGA-34-2600-01A-01D-0963-08.5.bam,626,1.9,0.16,58cfa82de4b0c9d6adf6a710,G12519.TCGA-34-2600-01A-01D-0963-08.5.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-34-2600-01A,DA61857A-B00E-4A19-AB02-8FBB2EE56BEA,Primary Tumor,Illumina HiSeq,c9a14cf5-32b5-43f5-991f-26b83b6a7727,Lung,76,B0C827C6-B7EF-420B-9A6F-7E8B79C320CC,E9CB8877-8E83-46C0-93F0-EA20530C9400,TCGA-34-2600-01A-01D-0963-08,HG19_Broad_variant,TCGA-34-2600,TCGA-LUSC,1874,s10072,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6c8d0,58cfa831e4b0c9d6adf6c8d0,TCGA-CW-6093-11A-01D-2279-10_wgs_Illumina.filtered.,WGS,TCGA-CW-6093-11A-01D-2279-10_wgs_Illumina,TCGA-CW-6093-11A-01D-2279-10_wgs_Illumina.bam,157.4,1.9,0.05,58cfa831e4b0c9d6adf6c8d0,TCGA-CW-6093-11A-01D-2279-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CW-6093-11A,3F93D1CF-A307-4E29-9E6F-239E9FFAA179,Solid Tissue Normal,Illumina HiSeq,566f737a-8b74-4027-9a55-46ce8215ae4c,Kidney,73,E6956C4D-8ECD-4FA8-8802-1881406B88A0,AFC82362-19A6-45E3-83E2-A3D001B300B1,TCGA-CW-6093-11A-01D-2279-10,GRCh37-lite,TCGA-CW-6093,TCGA-KIRC,NA,s9002,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T1a,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d2f2,58cfa832e4b0c9d6adf6d2f2,TCGA-KN-8424-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8424-11A-01D-2310-10_wgs_Illumina,TCGA-KN-8424-11A-01D-2310-10_wgs_Illumina.bam,330.6,NA,0.05,58cfa832e4b0c9d6adf6d2f2,TCGA-KN-8424-11A-01D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KN-8424-11A,8C9E1F60-1838-4AA4-A667-C1CEF7DDDBDF,Solid Tissue Normal,Illumina HiSeq,af8a82f1-e961-4b2a-95d0-026d22853c5c,Kidney,42,12FAE79A-BBBE-48CF-A6CD-D2AB745CF176,5E382FF9-B2B7-49EA-9AE5-B1AE7AB5B910,TCGA-KN-8424-11A-01D-2310-10,GRCh37-lite,TCGA-KN-8424,TCGA-KICH,NA,s16437,Baylor College of Medicine,Harvard,United States,NO,T1b,N0,Kidney Chromophobe,Stage I
13722.58cfa83ce4b0c9d6adf72fd0,58cfa83ce4b0c9d6adf72fd0,b2efe67d968c5b6634b971bdef73c05a.filtered.,WGS,b2efe67d968c5b6634b971bdef73c05a,b2efe67d968c5b6634b971bdef73c05a.bam,60.09,1.81,0.07,58cfa83ce4b0c9d6adf72fd0,b2efe67d968c5b6634b971bdef73c05a.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A11H-01A,DEE43082-4AA7-4650-981C-A779E9FE7B55,Primary Tumor,Illumina HiSeq,f7538b9e-e9b1-41fd-b09d-9ef50a3553d5,Uterus,67,D78D2F6B-3EB3-4082-A7EA-F7B6202CDC58,ACCFC45B-EAE0-4991-A488-E217CDB46655,TCGA-B5-A11H-01A-11D-A122-09,GRCh37-lite,TCGA-B5-A11H,TCGA-UCEC,NA,s4571,Washington University School of Medicine,Duke,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ae4e,58cfa82ee4b0c9d6adf6ae4e,G49837.TCGA-68-7755-10A-01D-A320-08.1.filtered.,WGS,G49837.TCGA-68-7755-10A-01D-A320-08.1,G49837.TCGA-68-7755-10A-01D-A320-08.1.bam,414.3,NA,0.08,58cfa82ee4b0c9d6adf6ae4e,G49837.TCGA-68-7755-10A-01D-A320-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-68-7755-10A,3666BC65-8E40-409E-9A1F-41583DD6D978,Blood Derived Normal,Illumina HiSeq,f966aded-29f7-400a-b203-43df545cabd0,Lung,60,06BC9B2B-FE43-46D7-A6FC-4F0F371565FB,3C65BECE-1980-42FF-871E-747E9905D778,TCGA-68-7755-10A-01D-A320-08,HG19_Broad_variant,TCGA-68-7755,TCGA-LUSC,NA,s9984,Broad Institute of MIT and Harvard,Washington University - Cleveland Clinic,United States,NO,T1b,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa82fe4b0c9d6adf6ba46,58cfa82fe4b0c9d6adf6ba46,TCGA-AA-3516-10A-01D-1953-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3516-10A-01D-1953-10_wgs_Illumina,TCGA-AA-3516-10A-01D-1953-10_wgs_Illumina.bam,88.56,1.9,0.15,58cfa82fe4b0c9d6adf6ba46,TCGA-AA-3516-10A-01D-1953-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3516-10A,D9D7F0D4-FA64-48F2-8037-52CBF0B34AD8,Blood Derived Normal,Illumina HiSeq,c5af0ea6-d2e3-4410-88c0-19d66b59324d,Colorectal,74,E0942099-D2A8-4110-99C4-9B968B88C09D,2A872801-703E-462E-BAD5-77721B14B7CE,TCGA-AA-3516-10A-01D-1953-10,GRCh37-lite,TCGA-AA-3516,TCGA-COAD,NA,s13514,Baylor College of Medicine,Indivumed,Germany,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6aba4,58cfa82ee4b0c9d6adf6aba4,G26366.TCGA-06-0686-10A-01D-1492-08.2.filtered.,WGS,G26366.TCGA-06-0686-10A-01D-1492-08.2,G26366.TCGA-06-0686-10A-01D-1492-08.2.bam,62.37,1.9,0.05,58cfa82ee4b0c9d6adf6aba4,G26366.TCGA-06-0686-10A-01D-1492-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0686-10A,C931F3BD-74C5-4EBD-BC0F-C7C6BECD25AB,Blood Derived Normal,Illumina HiSeq,f2207f8d-d1c7-4dbb-93c6-390acb85876f,Brain,53,C0F5DCC8-3D08-45A5-8D12-5FC67C5D5DC3,62EF1446-019C-4251-8585-792CCC40EED2,TCGA-06-0686-10A-01D-1492-08,HG19_Broad_variant,TCGA-06-0686,TCGA-GBM,NA,s13889,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6ab90,58cfa82ee4b0c9d6adf6ab90,G32455.TCGA-BT-A2LA-11A-11D-A18F-08.4.filtered.,WGS,G32455.TCGA-BT-A2LA-11A-11D-A18F-08.4,G32455.TCGA-BT-A2LA-11A-11D-A18F-08.4.bam,9.14,NA,0.08,58cfa82ee4b0c9d6adf6ab90,G32455.TCGA-BT-A2LA-11A-11D-A18F-08.4.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A2LA-11A,797A71EE-372D-41E5-AEEE-5AB3C4661110,Solid Tissue Normal,Illumina HiSeq,c42d3b28-fc0e-4a98-b1ac-cd68c55c2e50,Bladder,54,F12723EF-51A8-4071-B612-B47A14C2B459,A2B2E34B-005F-4803-9BC2-5F16B5CC8534,TCGA-BT-A2LA-11A-11D-A18F-08,HG19_Broad_variant,TCGA-BT-A2LA,TCGA-BLCA,NA,s2682,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82de4b0c9d6adf6a528,58cfa82de4b0c9d6adf6a528,4938937d8ed0bcbcdfaf4fc75cc4f8ec.filtered.,WGS,4938937d8ed0bcbcdfaf4fc75cc4f8ec,4938937d8ed0bcbcdfaf4fc75cc4f8ec.bam,147.87,1.8,0.16,58cfa82de4b0c9d6adf6a528,4938937d8ed0bcbcdfaf4fc75cc4f8ec.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-0980-01A,D1EEACA3-52C0-4A0C-916A-FD64CEC911D9,Primary Tumor,Illumina GA,10baac7c-c7ed-4a6b-b5c4-9acca1006b89,Ovary,53,D2713AE1-4993-415C-8BB3-A69DD31EF6F5,3DF124E9-1D00-46FD-9C9D-C86D2E2C39E5,TCGA-24-0980-01A-01D-0515-09,GRCh37-lite,TCGA-24-0980,TCGA-OV,233,s17861,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf72e98,58cfa83ce4b0c9d6adf72e98,c7785537c59d3349dd69e0f8e87266b7.filtered.,WGS,c7785537c59d3349dd69e0f8e87266b7,c7785537c59d3349dd69e0f8e87266b7.bam,27.86,1.93,0.08,58cfa83ce4b0c9d6adf72e98,c7785537c59d3349dd69e0f8e87266b7.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A1LL-01A,2A84997D-CCEE-4F46-BEA2-752534F26416,Primary Tumor,Illumina HiSeq,85360168-d41d-4201-8416-2cb4b45fca0f,Breast,73,E57574E4-7E01-4E61-BD29-EE4EC63DDDD6,47312F61-5EF4-4F25-9320-8FBB4758790E,TCGA-E2-A1LL-01A-11D-A142-09,GRCh37-lite,TCGA-E2-A1LL,TCGA-BRCA,NA,s5780,Washington University School of Medicine,Roswell Park,United States,NO,T3,N2a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa831e4b0c9d6adf6c7b4,58cfa831e4b0c9d6adf6c7b4,TCGA-CZ-4856-11A-01D-2101-10_Illumina.filtered.,WGS,TCGA-CZ-4856-11A-01D-2101-10_Illumina,TCGA-CZ-4856-11A-01D-2101-10_Illumina.bam,76.73,1.9,0.15,58cfa831e4b0c9d6adf6c7b4,TCGA-CZ-4856-11A-01D-2101-10_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CZ-4856-11A,FCECAFA8-8B8B-4AE6-81BC-73ACF05B211A,Solid Tissue Normal,Illumina HiSeq,5e33c01a-0a73-4886-a358-7d6e29b2aaee,Kidney,62,E815B1F1-E9FA-42D1-BAB6-4BBC59CCEF0A,61884E70-7CC4-4CDE-AE08-287EA6A780A8,TCGA-CZ-4856-11A-01D-2101-10,GRCh37-lite,TCGA-CZ-4856,TCGA-KIRC,NA,s8840,Baylor College of Medicine,Harvard,None,NO,T1b,N0,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6c19e,58cfa830e4b0c9d6adf6c19e,TCGA-AK-3454-10A-01D-2096-10_Illumina.filtered.,WGS,TCGA-AK-3454-10A-01D-2096-10_Illumina,TCGA-AK-3454-10A-01D-2096-10_Illumina.bam,54.77,1.9,0.17,58cfa830e4b0c9d6adf6c19e,TCGA-AK-3454-10A-01D-2096-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-AK-3454-10A,28E9B6F9-AB6A-400B-A6A9-79095A443591,Blood Derived Normal,Illumina HiSeq,d4a7a4bd-c0c8-411c-8449-ccc966e8e4ca,Kidney,84,38C35805-CF4C-4D80-AF30-4790EF57BAD8,2C3CF0B6-88ED-445B-A9DE-B75BA7220378,TCGA-AK-3454-10A-01D-2096-10,GRCh37-lite,TCGA-AK-3454,TCGA-KIRC,NA,s9156,Baylor College of Medicine,Fox Chase,United States,NO,T1b,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6adde,58cfa82ee4b0c9d6adf6adde,G49537.TCGA-BJ-A45K-10A-01D-A23U-08.2.filtered.,WGS,G49537.TCGA-BJ-A45K-10A-01D-A23U-08.2,G49537.TCGA-BJ-A45K-10A-01D-A23U-08.2.bam,23.65,NA,0.07,58cfa82ee4b0c9d6adf6adde,G49537.TCGA-BJ-A45K-10A-01D-A23U-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A45K-10A,8CFB88F6-7B37-4F1E-882B-3A368B604167,Blood Derived Normal,Illumina HiSeq,1a2dbb58-598e-4f7a-8ce0-21e15e572a81,Thyroid,33,A6D2304F-F391-420C-B6E2-EA68BB871058,EB3F3419-5880-410E-8504-1988487DACD1,TCGA-BJ-A45K-10A-01D-A23U-08,HG19_Broad_variant,TCGA-BJ-A45K,TCGA-THCA,NA,s12496,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82ee4b0c9d6adf6adb6,58cfa82ee4b0c9d6adf6adb6,G48125.TCGA-25-1634-10A-01D-A312-08.4.filtered.,WGS,G48125.TCGA-25-1634-10A-01D-A312-08.4,G48125.TCGA-25-1634-10A-01D-A312-08.4.bam,4.27,1.9,0.07,58cfa82ee4b0c9d6adf6adb6,G48125.TCGA-25-1634-10A-01D-A312-08.4.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-25-1634-10A,15556B28-C6BD-455A-87B6-4B7B3E33D0E4,Blood Derived Normal,Illumina HiSeq,707be4bb-8cd1-45b4-961a-f6cb9e120736,Ovary,75,B76CE717-9D8D-48E0-A740-9E26CE542276,0FC2A90E-6E81-485E-917C-A04D154ADD44,TCGA-25-1634-10A-01D-A312-08,HG19_Broad_variant,TCGA-25-1634,TCGA-OV,1091,s17114,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6b056,58cfa82ee4b0c9d6adf6b056,G41960.TCGA-97-8171-01A-11D-2284-08.2.filtered.,WGS,G41960.TCGA-97-8171-01A-11D-2284-08.2,G41960.TCGA-97-8171-01A-11D-2284-08.2.bam,239.3,NA,0.05,58cfa82ee4b0c9d6adf6b056,G41960.TCGA-97-8171-01A-11D-2284-08.2.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-97-8171-01A,397D3F69-1453-4057-B177-8723EEC923D1,Primary Tumor,Illumina HiSeq,e34a02d6-fc08-42eb-af7c-d4b40644bcf3,Lung,81,84CB5264-6158-40EC-8B65-F96A4A7D6CE4,FA2C3620-7E82-4B12-B135-87986F0F2890,TCGA-97-8171-01A-11D-2284-08,HG19_Broad_variant,TCGA-97-8171,TCGA-LUAD,NA,s10766,Broad Institute of MIT and Harvard,Washington University - NYU,United States,NO,T2a,N2,Lung Papillary Adenocarcinoma,Stage IV
13722.58cfa83ce4b0c9d6adf72ea6,58cfa83ce4b0c9d6adf72ea6,d1ee2de36aac63e924ff27efa16ae3dc.filtered.,WGS,d1ee2de36aac63e924ff27efa16ae3dc,d1ee2de36aac63e924ff27efa16ae3dc.bam,94.43,2,0.08,58cfa83ce4b0c9d6adf72ea6,d1ee2de36aac63e924ff27efa16ae3dc.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LH-01A,7DCE4215-01F6-43E9-9378-9E22C26C23A2,Primary Tumor,Illumina HiSeq,35b27702-57f1-4e49-8d49-3efa49e48c34,Uterus,60,4C657AD4-2C53-4EA9-82B5-52996E74E3FF,19C1C97F-A3EC-44A8-8A20-6F97CAED1A4F,TCGA-AP-A0LH-01A-11D-A066-09,GRCh37-lite,TCGA-AP-A0LH,TCGA-UCEC,1106,s4969,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Mixed serous and endometrioid,Not available
13722.58cfa82de4b0c9d6adf6a46d,58cfa82de4b0c9d6adf6a46d,0434f7930c67bd9c412cb31f2ada0466.filtered.,WGS,0434f7930c67bd9c412cb31f2ada0466,0434f7930c67bd9c412cb31f2ada0466.bam,27.89,1.93,0.08,58cfa82de4b0c9d6adf6a46d,0434f7930c67bd9c412cb31f2ada0466.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A18R-01A,F6E1EC78-5AD9-4879-9B7E-262D17B166AD,Primary Tumor,Illumina HiSeq,14062e7f-b11d-44a9-ae98-3383c517bf91,Breast,50,518BE2C7-FBA5-47B1-8C8B-FEF812FA74A4,9C70688D-6E43-4520-9262-EAAE4E4D597D,TCGA-BH-A18R-01A-11D-A19H-09,GRCh37-lite,TCGA-BH-A18R,TCGA-BRCA,1142,s6259,Washington University School of Medicine,University of Pittsburgh,None,NO,T2b,N1,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a6d6,58cfa82de4b0c9d6adf6a6d6,91d578e349e51da30596c416f3e08405.filtered.,WGS,91d578e349e51da30596c416f3e08405,91d578e349e51da30596c416f3e08405.bam,56.8,1.82,0.08,58cfa82de4b0c9d6adf6a6d6,91d578e349e51da30596c416f3e08405.bam,Dead,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A1ML-01A,374F614A-BCD1-4283-AC6F-FC27DDC79987,Primary Tumor,Illumina HiSeq,897d140f-721c-4162-9f3e-e8b883560558,Cervix,49,F5495789-2C61-42F2-B6B6-A14E00D2F985,F658C350-FB89-4268-8A59-A07E365F4221,TCGA-C5-A1ML-01A-11D-A200-09,GRCh37-lite,TCGA-C5-A1ML,TCGA-CESC,636,s1355,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82de4b0c9d6adf6a6c0,58cfa82de4b0c9d6adf6a6c0,869d810ce565d6181a7a0471f851fd20.filtered.,WGS,869d810ce565d6181a7a0471f851fd20,869d810ce565d6181a7a0471f851fd20.bam,107.78,2.13,0.09,58cfa82de4b0c9d6adf6a6c0,869d810ce565d6181a7a0471f851fd20.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-B5-A0K8-01A,24118B8F-59FE-482A-AED3-7B1BDE1571B7,Primary Tumor,Illumina HiSeq,48423c41-27b2-43d8-8358-735f4bcd008a,Uterus,71,66184035-AF3E-4C2B-901A-0709C49DC54E,554B9439-7E11-43EC-8BC3-448C59100B9E,TCGA-B5-A0K8-01A-11D-A14K-09,GRCh37-lite,TCGA-B5-A0K8,TCGA-UCEC,NA,s4415,Washington University School of Medicine,Duke,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b45a,58cfa82fe4b0c9d6adf6b45a,TCGA-25-1319-10A-01D-0516-08_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-25-1319-10A-01D-0516-08_IlluminaGA-DNASeq_whole,TCGA-25-1319-10A-01D-0516-08_IlluminaGA-DNASeq_whole.bam,20,1.9,0.14,58cfa82fe4b0c9d6adf6b45a,TCGA-25-1319-10A-01D-0516-08_IlluminaGA-DNASeq_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-25-1319-10A,914D8613-3C25-4A10-BE50-28B42F4D3A5D,Blood Derived Normal,Illumina GA,db2fd38f-95ee-4500-9614-a8421700fe91,Ovary,73,474DE020-7D56-46FB-A25F-85007E473B57,887579C6-F07F-4FF6-9B5B-972A9EB8D00A,TCGA-25-1319-10A-01D-0516-08,HG18_Broad_variant,TCGA-25-1319,TCGA-OV,1977,s17842,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a4c2,58cfa82de4b0c9d6adf6a4c2,12dd02ea14d0a87df23ce3bef406fe27.filtered.,WGS,12dd02ea14d0a87df23ce3bef406fe27,12dd02ea14d0a87df23ce3bef406fe27.bam,32.75,NA,0.08,58cfa82de4b0c9d6adf6a4c2,12dd02ea14d0a87df23ce3bef406fe27.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0I1-01A,5DD423E8-FEAA-4568-A750-500948C41D6C,Primary Tumor,Illumina HiSeq,30cac8b3-f09f-4eeb-8dff-e77e8b9c13fd,Breast,73,2A5F4696-6E02-4FE9-B66D-8C2AE93B7C2F,2290B078-6A5B-4C83-9DFB-B525BBF14E4E,TCGA-B6-A0I1-01A-11D-A21Q-09,GRCh37-lite,TCGA-B6-A0I1,TCGA-BRCA,2361,s5473,Washington University School of Medicine,Duke,United States,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa83ce4b0c9d6adf72ee6,58cfa83ce4b0c9d6adf72ee6,daf008933258f806fa354a9618f801be.filtered.,WGS,daf008933258f806fa354a9618f801be,daf008933258f806fa354a9618f801be.bam,62.71,NA,0.08,58cfa83ce4b0c9d6adf72ee6,daf008933258f806fa354a9618f801be.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-EK-A2PK-01A,0809BA8B-4AB6-4F43-934C-C1CCBC014A7E,Primary Tumor,Illumina HiSeq,7109053e-8be0-4965-a5eb-a9bbab5ee53f,Cervix,43,5F613800-55DF-497F-A544-5B12CB9446CE,B3B3A27C-EE9A-42AF-A6D1-9AF5970A98B9,TCGA-EK-A2PK-01A-11D-A18J-09,GRCh37-lite,TCGA-EK-A2PK,TCGA-CESC,NA,s1506,Washington University School of Medicine,Gynecologic Oncology Group,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aee0,58cfa82ee4b0c9d6adf6aee0,G39020.TCGA-HF-7136-01A-11D-2053-08.2.filtered.,WGS,G39020.TCGA-HF-7136-01A-11D-2053-08.2,G39020.TCGA-HF-7136-01A-11D-2053-08.2.bam,210.7,NA,0.05,58cfa82ee4b0c9d6adf6aee0,G39020.TCGA-HF-7136-01A-11D-2053-08.2.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-HF-7136-01A,647DC54F-A51B-40EA-9D97-C93598C2AF71,Primary Tumor,Illumina HiSeq,09ada83c-8149-4ed4-8e85-b2c9be12c8d5,Stomach,NA,F6BB75B6-D0C9-49C5-99D0-E658B490C98D,622EAA04-B8F9-471B-98B0-7BEFD119F14C,TCGA-HF-7136-01A-11D-2053-08,HG19_Broad_variant,TCGA-HF-7136,TCGA-STAD,NA,s14603,Broad Institute of MIT and Harvard,Ontario Institute for Cancer Research (OICR),Canada,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82de4b0c9d6adf6a636,58cfa82de4b0c9d6adf6a636,11badd8e527cc2baf928161490064a79.filtered.,WGS,11badd8e527cc2baf928161490064a79,11badd8e527cc2baf928161490064a79.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a636,11badd8e527cc2baf928161490064a79.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2969-11A,929DE9A5-3224-4851-8FF0-8A92354C1F16,Solid Tissue Normal,Illumina GA,621bb448-1878-421c-84a0-6d52ee837fcd,Blood,55,43E38E03-8B58-48A6-BD58-FBC0F1F80B63,9F76EA23-0923-4B22-99BA-791EE8931003,TCGA-AB-2969-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2969,TCGA-LAML,NA,s7098,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a6e0,58cfa82de4b0c9d6adf6a6e0,8acca8432df87fc66fbf834556f68a20.filtered.,WGS,8acca8432df87fc66fbf834556f68a20,8acca8432df87fc66fbf834556f68a20.bam,92.82,1.95,0.08,58cfa82de4b0c9d6adf6a6e0,8acca8432df87fc66fbf834556f68a20.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A04X-01A,733A2A0F-B37A-4B81-B49E-3C0F30D1EB37,Primary Tumor,Illumina HiSeq,055e605f-56b9-4ca6-8856-1f32ab8e34a6,Breast,34,ABFF5667-7EF4-46C1-AD34-CEABC27E7992,41F140B8-72B9-4AE3-8B25-6144D9F94D0F,TCGA-A2-A04X-01A-21D-A19H-09,GRCh37-lite,TCGA-A2-A04X,TCGA-BRCA,NA,s6767,Washington University School of Medicine,Walter Reed,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a6a4,58cfa82de4b0c9d6adf6a6a4,8d9e0153be8bfe0c936ac4e30cbcbecd.filtered.,WGS,8d9e0153be8bfe0c936ac4e30cbcbecd,8d9e0153be8bfe0c936ac4e30cbcbecd.bam,97.37,1.68,0.14,58cfa82de4b0c9d6adf6a6a4,8d9e0153be8bfe0c936ac4e30cbcbecd.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-0980-10A,D1EEACA3-52C0-4A0C-916A-FD64CEC911D9,Blood Derived Normal,Illumina GA,7e97ad5d-c451-4c3f-813f-d115c6852d41,Ovary,53,FF1500F7-8FC1-4ACD-B93D-375BF881B90A,0F5BFE60-BAF3-4142-B8AE-FD2FAE46666F,TCGA-24-0980-10A-01D-0515-09,GRCh37-lite,TCGA-24-0980,TCGA-OV,233,s18147,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a5d4,58cfa82de4b0c9d6adf6a5d4,5b90de51bbfaf67cf060a869713e0324.filtered.,WGS,5b90de51bbfaf67cf060a869713e0324,5b90de51bbfaf67cf060a869713e0324.bam,56.64,1.95,0.08,58cfa82de4b0c9d6adf6a5d4,5b90de51bbfaf67cf060a869713e0324.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A152-01A,A8015490-9740-45C9-8BD2-EB6D1BEEFC2E,Primary Tumor,Illumina HiSeq,fe904377-4375-437b-8774-c80f11c6e0ff,Breast,56,0EF32921-BB7A-4055-A6ED-E8CED5F824E4,8691C87F-2468-44BB-A670-3DCCD6DA33C6,TCGA-E2-A152-01A-11D-A19H-09,GRCh37-lite,TCGA-E2-A152,TCGA-BRCA,NA,s6915,Washington University School of Medicine,Roswell Park,None,NO,T1c,N0,Infiltrating Ductal Carcinoma,Stage I
13722.58cfa83ce4b0c9d6adf7310e,58cfa83ce4b0c9d6adf7310e,c31801ffe0265e1332d28d053c9a4955.filtered.,WGS,c31801ffe0265e1332d28d053c9a4955,c31801ffe0265e1332d28d053c9a4955.bam,64.37,1.97,0.08,58cfa83ce4b0c9d6adf7310e,c31801ffe0265e1332d28d053c9a4955.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-C8-A12L-01A,441919EB-8C9F-478C-BDA3-8DE4F8295E8A,Primary Tumor,Illumina HiSeq,c12fbad8-2c66-4967-9bfe-6837f6d1e5d4,Breast,67,E3CF8F8C-8FE6-45E2-B786-7DB5590C08CB,D5372745-95CF-4572-A6E7-E7F5B796911A,TCGA-C8-A12L-01A-11D-A19H-09,GRCh37-lite,TCGA-C8-A12L,TCGA-BRCA,NA,s5945,Washington University School of Medicine,ILSbio,Vietnam,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6aa58,58cfa82ee4b0c9d6adf6aa58,G32530.TCGA-EM-A3AQ-01A-11D-A20C-08.1.filtered.,WGS,G32530.TCGA-EM-A3AQ-01A-11D-A20C-08.1,G32530.TCGA-EM-A3AQ-01A-11D-A20C-08.1.bam,59.1,NA,0.08,58cfa82ee4b0c9d6adf6aa58,G32530.TCGA-EM-A3AQ-01A-11D-A20C-08.1.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3AQ-01A,E8F56D0F-EEE4-4DEF-A43A-DEC91F4382A1,Primary Tumor,Illumina HiSeq,c13857f7-bb38-4650-9294-ad8287c6c137,Thyroid,85,E13C3F11-913D-4371-9A7D-5E4DF15FB42A,DBACC1AD-C88A-4BCF-A45F-E9C83C762164,TCGA-EM-A3AQ-01A-11D-A20C-08,HG19_Broad_variant,TCGA-EM-A3AQ,TCGA-THCA,NA,s12215,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T1b,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa83ce4b0c9d6adf73120,58cfa83ce4b0c9d6adf73120,c4db7ecd250c14ade136a8948ac7149e.filtered.,WGS,c4db7ecd250c14ade136a8948ac7149e,c4db7ecd250c14ade136a8948ac7149e.bam,46.45,1.84,0.08,58cfa83ce4b0c9d6adf73120,c4db7ecd250c14ade136a8948ac7149e.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-EW-A1J5-01A,5D8ED961-A012-4B6B-BFFB-9468D3953646,Primary Tumor,Illumina HiSeq,17593e20-8cc4-4961-8ff5-871806aeed93,Breast,59,BF42E8CE-CD3E-46C8-92F9-EA5CDA443A6F,98BB3025-0637-4106-8621-12DF7B5D662F,TCGA-EW-A1J5-01A-11D-A13L-09,GRCh37-lite,TCGA-EW-A1J5,TCGA-BRCA,NA,s6251,Washington University School of Medicine,University of Miami,United States,NO,T3,N0 (i-),Infiltrating Lobular Carcinoma,Stage IIB
13722.58cfa82ee4b0c9d6adf6ab94,58cfa82ee4b0c9d6adf6ab94,G32546.TCGA-ER-A3ES-10A-01D-A20D-08.2.filtered.,WGS,G32546.TCGA-ER-A3ES-10A-01D-A20D-08.2,G32546.TCGA-ER-A3ES-10A-01D-A20D-08.2.bam,9.73,NA,0.08,58cfa82ee4b0c9d6adf6ab94,G32546.TCGA-ER-A3ES-10A-01D-A20D-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A3ES-10A,B93F703E-BE51-4469-AAAC-2D4A87A37639,Blood Derived Normal,Illumina HiSeq,e050fd76-1a7c-42be-a88f-05ba96ab2b50,Skin,25,36DD408D-A726-4CFB-8B95-AD79DADD09E3,61178F55-37D8-4C86-B1F3-3480D4F7A494,TCGA-ER-A3ES-10A-01D-A20D-08,HG19_Broad_variant,TCGA-ER-A3ES,TCGA-SKCM,7514,s7984,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa830e4b0c9d6adf6bac4,58cfa830e4b0c9d6adf6bac4,TCGA-AA-A01S-11A-21D-A17O-10_wgs_Illumina.filtered.,WGS,TCGA-AA-A01S-11A-21D-A17O-10_wgs_Illumina,TCGA-AA-A01S-11A-21D-A17O-10_wgs_Illumina.bam,16.83,1.81,0.08,58cfa830e4b0c9d6adf6bac4,TCGA-AA-A01S-11A-21D-A17O-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01S-11A,84E34CF2-B3BB-4A1A-8FB7-6C2C604C4008,Solid Tissue Normal,Illumina HiSeq,9ce2378a-1fd9-466e-9779-79258fe0bbfd,Colorectal,47,1F703295-7062-4692-87CB-1E5204837A60,E8503260-10DE-4414-84BB-906392060D80,TCGA-AA-A01S-11A-21D-A17O-10,GRCh37-lite,TCGA-AA-A01S,TCGA-COAD,NA,s12874,Baylor College of Medicine,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage III
13722.58cfa82de4b0c9d6adf6a66b,58cfa82de4b0c9d6adf6a66b,6f9e6813a75e86e0dd1890966a4457d9.filtered.,WGS,6f9e6813a75e86e0dd1890966a4457d9,6f9e6813a75e86e0dd1890966a4457d9.bam,66.32,1.9,0.07,58cfa82de4b0c9d6adf6a66b,6f9e6813a75e86e0dd1890966a4457d9.bam,Alive,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BS-A0U9-01B,5FFA2EC6-2D94-4B09-8FB9-3591CF38FA4F,Primary Tumor,Illumina HiSeq,47ea3545-65e4-4c78-8780-1377ec259db5,Uterus,59,99D6D536-AF2C-4C9B-9995-5B4032D54479,82BE6087-A491-42D4-9B48-6A10D1BACE18,TCGA-BS-A0U9-01B-21D-A10M-09,GRCh37-lite,TCGA-BS-A0U9,TCGA-UCEC,NA,s4413,Washington University School of Medicine,University of Hawaii,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ad50,58cfa82ee4b0c9d6adf6ad50,G39020.TCGA-BR-8486-10A-01D-2394-08.2.filtered.,WGS,G39020.TCGA-BR-8486-10A-01D-2394-08.2,G39020.TCGA-BR-8486-10A-01D-2394-08.2.bam,225,NA,0.05,58cfa82ee4b0c9d6adf6ad50,G39020.TCGA-BR-8486-10A-01D-2394-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-8486-10A,B8A1C8C7-3945-4D84-8F58-3A1A1EB10730,Blood Derived Normal,Illumina HiSeq,4a10b9ff-71a3-46a4-8cca-d0b4f7dfec66,Stomach,90,AFED9302-CE38-41B4-BF0F-BC583BB6F473,0FA8CEE4-2D26-4CAF-9DA2-96047854F29F,TCGA-BR-8486-10A-01D-2394-08,HG19_Broad_variant,TCGA-BR-8486,TCGA-STAD,NA,s14804,Broad Institute of MIT and Harvard,Asterand,Russia,NO,T1b,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IA
13722.58cfa82de4b0c9d6adf6a5f2,58cfa82de4b0c9d6adf6a5f2,58c9640b867e208cc0db2f7a975b1c51.filtered.,WGS,58c9640b867e208cc0db2f7a975b1c51,58c9640b867e208cc0db2f7a975b1c51.bam,48.69,2.02,0.08,58cfa82de4b0c9d6adf6a5f2,58c9640b867e208cc0db2f7a975b1c51.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0DT-01A,74F31744-0AED-4633-BEEC-4E203315F0B7,Primary Tumor,Illumina HiSeq,4ac2ec89-0e27-40ab-949e-6cb716b4d9e1,Breast,41,EB11D414-2F0E-44A1-843C-ECACC7212E91,30DBE353-86D5-40ED-84C2-DBDDF7BEB17B,TCGA-BH-A0DT-01A-21D-A12B-09,GRCh37-lite,TCGA-BH-A0DT,TCGA-BRCA,NA,s5480,Washington University School of Medicine,University of Pittsburgh,None,NO,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6a926,58cfa82ee4b0c9d6adf6a926,G35154.TCGA-CS-5395-10A-01D-1468-08.1.filtered.,WGS,G35154.TCGA-CS-5395-10A-01D-1468-08.1,G35154.TCGA-CS-5395-10A-01D-1468-08.1.bam,95.7,1.8,0.05,58cfa82ee4b0c9d6adf6a926,G35154.TCGA-CS-5395-10A-01D-1468-08.1.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,Not available,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-5395-10A,F86FA219-34E9-4812-8EDF-2B66D7219779,Blood Derived Normal,Illumina HiSeq,02d0ed8c-9e40-4121-bf2c-8ed56d07fdd0,Brain,43,69663BC6-88FD-4864-A968-FC80AE2AD55B,BAA7B05C-D0B5-4B1C-B4FA-8955ABE5C3DB,TCGA-CS-5395-10A-01D-1468-08,HG19_Broad_variant,TCGA-CS-5395,TCGA-LGG,639,s8103,Broad Institute of MIT and Harvard,Thomas Jefferson University,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82de4b0c9d6adf6a610,58cfa82de4b0c9d6adf6a610,6e5cc39dc99c646350c2188f42625edd.filtered.,WGS,6e5cc39dc99c646350c2188f42625edd,6e5cc39dc99c646350c2188f42625edd.bam,59.06,1.95,0.08,58cfa82de4b0c9d6adf6a610,6e5cc39dc99c646350c2188f42625edd.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A0TN-01A,14C65927-B9DD-4EF6-9917-DB7BC431FF2F,Primary Tumor,Illumina HiSeq,f860da6f-1cec-4913-aa35-b32670a1734f,Cervix,21,59B0B757-7D08-4B3E-9974-FD02747D3665,945E6808-2887-4F32-AC32-8F9E00353BF6,TCGA-C5-A0TN-01A-21D-A200-09,GRCh37-lite,TCGA-C5-A0TN,TCGA-CESC,348,s1165,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,T1b,N1,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aa8c,58cfa82ee4b0c9d6adf6aa8c,G32527.TCGA-FE-A3PD-01A-11D-A21Z-08.1.filtered.,WGS,G32527.TCGA-FE-A3PD-01A-11D-A21Z-08.1,G32527.TCGA-FE-A3PD-01A-11D-A21Z-08.1.bam,59.24,NA,0.08,58cfa82ee4b0c9d6adf6aa8c,G32527.TCGA-FE-A3PD-01A-11D-A21Z-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A3PD-01A,39D90499-8549-4DA5-B391-C421F18FACF1,Primary Tumor,Illumina HiSeq,afcdae7e-5422-4f04-a64d-6bbdf39605aa,Thyroid,17,A6C23CA9-E6F4-4A2C-BB86-25EF76076381,5BDCA282-C671-48FF-B32B-2380996016C0,TCGA-FE-A3PD-01A-11D-A21Z-08,HG19_Broad_variant,TCGA-FE-A3PD,TCGA-THCA,NA,s12339,Broad Institute of MIT and Harvard,Ohio State University,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa830e4b0c9d6adf6be4a,58cfa830e4b0c9d6adf6be4a,TCGA-AG-3574-10A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AG-3574-10A-01D-1989-10_wgs_Illumina,TCGA-AG-3574-10A-01D-1989-10_wgs_Illumina.bam,41.21,1.8,0.14,58cfa830e4b0c9d6adf6be4a,TCGA-AG-3574-10A-01D-1989-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3574-10A,0EDA7373-8335-455F-B90A-8C3540F28088,Blood Derived Normal,Illumina HiSeq,53fd3b43-c46b-4f05-94ad-04be29bd5933,Colorectal,89,FC65E77A-760D-49D6-81B3-CD55899C76AB,C61270AF-C38E-4DEC-8795-94D4B78A65B1,TCGA-AG-3574-10A-01D-1989-10,GRCh37-lite,TCGA-AG-3574,TCGA-READ,NA,s2126,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6ace9,58cfa82ee4b0c9d6adf6ace9,G39020.TCGA-CG-4443-01A-01D-A290-08.2.filtered.,WGS,G39020.TCGA-CG-4443-01A-01D-A290-08.2,G39020.TCGA-CG-4443-01A-01D-A290-08.2.bam,261.2,1.9,0.08,58cfa82ee4b0c9d6adf6ace9,G39020.TCGA-CG-4443-01A-01D-A290-08.2.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4443-01A,8CB0144B-BE6B-40A1-86A2-708F96D9B615,Primary Tumor,Illumina HiSeq,67df24ad-ea00-45a4-b4b5-b494b97f34df,Stomach,68,F4FB736A-42C9-4367-A327-D0D1C4CBA359,D8D5585D-32CD-4AC4-B410-A4122A17A558,TCGA-CG-4443-01A-01D-A290-08,HG19_Broad_variant,TCGA-CG-4443,TCGA-STAD,NA,s14391,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T1,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IA
13722.58cfa82de4b0c9d6adf6a770,58cfa82de4b0c9d6adf6a770,G14852.TCGA-49-4510-11A-01D-1931-08.3.filtered.,WGS,G14852.TCGA-49-4510-11A-01D-1931-08.3,G14852.TCGA-49-4510-11A-01D-1931-08.3.bam,247.53,1.9,0.15,58cfa82de4b0c9d6adf6a770,G14852.TCGA-49-4510-11A-01D-1931-08.3.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4510-11A,F77B6930-A1CE-446E-A15D-C018CBBECFEE,Solid Tissue Normal,Illumina HiSeq,32ab883f-ebf1-4c4d-8042-992bd32c9757,Lung,51,DB4E6EFA-79AA-44D7-AB88-4866B4E94B0D,8631547D-7C88-4B54-AB1F-ED6C6AED3D2E,TCGA-49-4510-11A-01D-1931-08,HG19_Broad_variant,TCGA-49-4510,TCGA-LUAD,896,s10891,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa832e4b0c9d6adf6d2c8,58cfa832e4b0c9d6adf6d2c8,TCGA-KL-8341-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8341-11A-01D-2310-10_wgs_Illumina,TCGA-KL-8341-11A-01D-2310-10_wgs_Illumina.bam,121,NA,0.05,58cfa832e4b0c9d6adf6d2c8,TCGA-KL-8341-11A-01D-2310-10_wgs_Illumina.bam,Dead,MALE,ASIAN,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8341-11A,70E306EE-9584-49D6-81A1-A49D837AB6AA,Solid Tissue Normal,Illumina HiSeq,4e5e4e50-17df-4cc5-bae2-d17a9143ae71,Kidney,41,27632B12-751A-439F-BA7E-27D8D1EEF8D0,9F1B349F-503A-4237-8DA4-9100DE610E1E,TCGA-KL-8341-11A-01D-2310-10,GRCh37-lite,TCGA-KL-8341,TCGA-KICH,754,s16400,Baylor College of Medicine,MSKCC,United States,NO,T3b,N2,Kidney Chromophobe,Stage IV
13722.58cfa82de4b0c9d6adf6a71a,58cfa82de4b0c9d6adf6a71a,G14855.TCGA-05-4389-01A-01D-1931-08.4.filtered.,WGS,G14855.TCGA-05-4389-01A-01D-1931-08.4,G14855.TCGA-05-4389-01A-01D-1931-08.4.bam,372.53,1.9,0.14,58cfa82de4b0c9d6adf6a71a,G14855.TCGA-05-4389-01A-01D-1931-08.4.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4389-01A,A3DE401D-91FE-49A2-BB07-81C1A06506E6,Primary Tumor,Illumina HiSeq,0979871e-d324-4f7e-98da-f65ff17a74d7,Lung,70,ED61AC6A-F21F-4B88-928A-029340D4AEBD,14BF9BFB-14D6-4CAC-A556-828F680E8A15,TCGA-05-4389-01A-01D-1931-08,HG19_Broad_variant,TCGA-05-4389,TCGA-LUAD,NA,s11426,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T1,N0,Lung Adenocarcinoma Mixed Subtype,Stage IA
13722.58cfa82ee4b0c9d6adf6af7a,58cfa82ee4b0c9d6adf6af7a,G39020.TCGA-F1-6875-11A-01D-2053-08.3.filtered.,WGS,G39020.TCGA-F1-6875-11A-01D-2053-08.3,G39020.TCGA-F1-6875-11A-01D-2053-08.3.bam,86,NA,0.05,58cfa82ee4b0c9d6adf6af7a,G39020.TCGA-F1-6875-11A-01D-2053-08.3.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-F1-6875-11A,283776CD-32E8-4A79-BED1-1411C9D3A9E0,Solid Tissue Normal,Illumina HiSeq,6dcad824-de10-458c-a0fe-32974ab948e1,Stomach,79,396945BA-1CD8-472C-95F1-AF55245646AC,F3A4FD8D-1F1C-48AB-854F-6717FD62C46C,TCGA-F1-6875-11A-01D-2053-08,HG19_Broad_variant,TCGA-F1-6875,TCGA-STAD,2197,s14808,Broad Institute of MIT and Harvard,UNC,United States,NO,T2,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6ac76,58cfa82ee4b0c9d6adf6ac76,G41960.TCGA-50-5932-01A-11D-1753-08.2.filtered.,WGS,G41960.TCGA-50-5932-01A-11D-1753-08.2,G41960.TCGA-50-5932-01A-11D-1753-08.2.bam,289.4,1.9,0.05,58cfa82ee4b0c9d6adf6ac76,G41960.TCGA-50-5932-01A-11D-1753-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5932-01A,EBCBA7F2-CE13-4BAE-97CD-91A6B1DCD465,Primary Tumor,Illumina HiSeq,3c2b6b67-de08-43ef-a735-28548120fa66,Lung,75,7ECB9621-7A1F-4876-9DFB-9B77CC4CB7B4,6726C157-F688-491D-8B56-35628645DF89,TCGA-50-5932-01A-11D-1753-08,HG19_Broad_variant,TCGA-50-5932,TCGA-LUAD,1235,s11324,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6a997,58cfa82ee4b0c9d6adf6a997,G25787.TCGA-78-7156-01A-11D-2036-08.1.filtered.,WGS,G25787.TCGA-78-7156-01A-11D-2036-08.1,G25787.TCGA-78-7156-01A-11D-2036-08.1.bam,405.7,NA,0.05,58cfa82ee4b0c9d6adf6a997,G25787.TCGA-78-7156-01A-11D-2036-08.1.bam,Dead,MALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-78-7156-01A,7B0622AB-63EA-483F-AE40-D3EA587BDBBA,Primary Tumor,Illumina HiSeq,f02c1668-47cc-4ebd-a656-5c2a70f1ae9f,Lung,62,FAB452A2-A57A-4D63-80BC-2AD2B5A20F03,D17EDA6C-B986-4BA3-B0E9-BAC7A751C26A,TCGA-78-7156-01A-11D-2036-08,HG19_Broad_variant,TCGA-78-7156,TCGA-LUAD,976,s10761,Broad Institute of MIT and Harvard,Prince Charles Hospital,Australia,NO,T4,N1,Lung Adenocarcinoma Mixed Subtype,Stage IV
13722.58cfa832e4b0c9d6adf6d526,58cfa832e4b0c9d6adf6d526,TCGA-KO-8407-11A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KO-8407-11A-01D-2311-10_wgs_Illumina,TCGA-KO-8407-11A-01D-2311-10_wgs_Illumina.bam,285.2,NA,0.05,58cfa832e4b0c9d6adf6d526,TCGA-KO-8407-11A-01D-2311-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KO-8407-11A,151F07F5-1529-4FCD-912C-E55B2FF8ABEF,Solid Tissue Normal,Illumina HiSeq,a82a9254-4b2f-4ace-96eb-333cb34bd26d,Kidney,42,157539E2-7060-441F-860E-772558F89A2B,60F94151-BBC5-4BEA-A081-B0247BDBABB3,TCGA-KO-8407-11A-01D-2311-10,GRCh37-lite,TCGA-KO-8407,TCGA-KICH,NA,s16439,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa82ee4b0c9d6adf6a91c,58cfa82ee4b0c9d6adf6a91c,G32463.TCGA-DK-A1A5-10A-01D-A13W-08.3.filtered.,WGS,G32463.TCGA-DK-A1A5-10A-01D-A13W-08.3,G32463.TCGA-DK-A1A5-10A-01D-A13W-08.3.bam,56.09,1.95,0.08,58cfa82ee4b0c9d6adf6a91c,G32463.TCGA-DK-A1A5-10A-01D-A13W-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A5-10A,904A8757-E0C5-41EF-B583-C8F170CAAAC1,Blood Derived Normal,Illumina HiSeq,346c096a-4b32-461b-a634-bda70a3e37b3,Bladder,79,608EEC1D-33BC-48DD-A928-49B09E87CCC8,68402877-A578-4BFD-A05E-58C6E06FB6A3,TCGA-DK-A1A5-10A-01D-A13W-08,HG19_Broad_variant,TCGA-DK-A1A5,TCGA-BLCA,65,s2854,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa82ee4b0c9d6adf6a8ea,58cfa82ee4b0c9d6adf6a8ea,G35154.TCGA-DB-5278-10A-01D-1468-08.1.filtered.,WGS,G35154.TCGA-DB-5278-10A-01D-1468-08.1,G35154.TCGA-DB-5278-10A-01D-1468-08.1.bam,78.3,1.9,0.05,58cfa82ee4b0c9d6adf6a8ea,G35154.TCGA-DB-5278-10A-01D-1468-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DB-5278-10A,010AAC75-3BFE-4BF2-B866-AF0F2D92F125,Blood Derived Normal,Illumina HiSeq,fa6a196d-09f3-47ff-a614-66b54fa20d3c,Brain,17,AFDAFC3C-5D20-453E-80CC-AE12494EF693,80B03480-5D28-481E-A447-59140D82F1F8,TCGA-DB-5278-10A-01D-1468-08,HG19_Broad_variant,TCGA-DB-5278,TCGA-LGG,NA,s8097,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82de4b0c9d6adf6a502,58cfa82de4b0c9d6adf6a502,3d9f475186150ea055fddf25af7bb7e3.filtered.,WGS,3d9f475186150ea055fddf25af7bb7e3,3d9f475186150ea055fddf25af7bb7e3.bam,64.35,1.7,0.08,58cfa82de4b0c9d6adf6a502,3d9f475186150ea055fddf25af7bb7e3.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-EY-A1GW-01A,F8AC5FD2-11F2-4B3A-A3A6-FF1A6D8E1CAE,Primary Tumor,Illumina HiSeq,b2829fb0-5912-46cd-a87b-e2dcbb14192d,Uterus,73,22CB3D87-7FAB-419A-B071-1ADC6B810719,EC31E921-0782-4F77-AC23-4190AF1E61EE,TCGA-EY-A1GW-01A-22D-A13L-09,GRCh37-lite,TCGA-EY-A1GW,TCGA-UCEC,NA,s4407,Washington University School of Medicine,University of North Carolina,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ac71,58cfa82ee4b0c9d6adf6ac71,G37568.TCGA-DK-A1AA-10A-01D-A25T-08.3.filtered.,WGS,G37568.TCGA-DK-A1AA-10A-01D-A25T-08.3,G37568.TCGA-DK-A1AA-10A-01D-A25T-08.3.bam,46.88,1.88,0.08,58cfa82ee4b0c9d6adf6ac71,G37568.TCGA-DK-A1AA-10A-01D-A25T-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AA-10A,56D8A1B8-1268-4362-A7F1-77B76FBF1B59,Blood Derived Normal,Illumina HiSeq,91b0ed37-004b-4b39-b531-d3245daf50a5,Bladder,57,C976B658-9A59-4205-93FF-E1AAD1995C49,0AFE697D-20F1-4F51-A0A9-797D01AFD397,TCGA-DK-A1AA-10A-01D-A25T-08,HG19_Broad_variant,TCGA-DK-A1AA,TCGA-BLCA,NA,s3263,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa83ce4b0c9d6adf73074,58cfa83ce4b0c9d6adf73074,f69f0ef802b7feefa79f55fe3e188902.filtered.,WGS,f69f0ef802b7feefa79f55fe3e188902,f69f0ef802b7feefa79f55fe3e188902.bam,35.42,1.97,0.08,58cfa83ce4b0c9d6adf73074,f69f0ef802b7feefa79f55fe3e188902.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-C8-A12Q-01A,A824B3BD-34D5-4CC1-A92F-F9D6AC0F1814,Primary Tumor,Illumina HiSeq,bb80680a-245c-421b-a3ef-198dc78bad1e,Breast,78,8867F07E-0993-4C9A-96DF-18E24801BA80,D8C6D4B8-F279-4EDC-AAA3-A1CC266AEC4D,TCGA-C8-A12Q-01A-11D-A19H-09,GRCh37-lite,TCGA-C8-A12Q,TCGA-BRCA,NA,s6108,Washington University School of Medicine,ILSbio,None,NO,T1,N2,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa83ce4b0c9d6adf72ee4,58cfa83ce4b0c9d6adf72ee4,d8812a052472972b8c4ec509bc9bec1f.filtered.,WGS,d8812a052472972b8c4ec509bc9bec1f,d8812a052472972b8c4ec509bc9bec1f.bam,70.78,1.98,0.08,58cfa83ce4b0c9d6adf72ee4,d8812a052472972b8c4ec509bc9bec1f.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A06B-01A,95E6D327-9AB7-45DE-9527-F5634B3995C3,Primary Tumor,Illumina HiSeq,4f89c64d-ad85-45a6-a62b-e78fcbe761b3,Uterus,72,A43F90B7-4A6C-423C-82DE-AD2C330AE0FB,55ADA396-0878-4724-8EBE-00DA367EED3D,TCGA-AX-A06B-01A-11D-A325-09,GRCh37-lite,TCGA-AX-A06B,TCGA-UCEC,NA,s4974,Washington University School of Medicine,Gynecologic Oncology Group,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6acc4,58cfa82ee4b0c9d6adf6acc4,G48125.TCGA-23-1124-10A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-23-1124-10A-01D-A312-08.2,G48125.TCGA-23-1124-10A-01D-A312-08.2.bam,32.97,1.9,0.08,58cfa82ee4b0c9d6adf6acc4,G48125.TCGA-23-1124-10A-01D-A312-08.2.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-23-1124-10A,8A6D2CE3-CC57-451B-9B07-8263782AA23F,Blood Derived Normal,Illumina HiSeq,2e589c54-2d6d-4401-ba43-dccf69412663,Ovary,62,C0039818-F312-4F7C-B35C-E7D168486890,37244D55-4316-491A-966C-9E2B4372B5B9,TCGA-23-1124-10A-01D-A312-08,HG19_Broad_variant,TCGA-23-1124,TCGA-OV,1768,s17480,Broad Institute of MIT and Harvard,Cedars Sinai,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a49c,58cfa82de4b0c9d6adf6a49c,24fe83a0f87aa4896917377ff9d12c69.filtered.,WGS,24fe83a0f87aa4896917377ff9d12c69,24fe83a0f87aa4896917377ff9d12c69.bam,254.67,1.9,0.15,58cfa82de4b0c9d6adf6a49c,24fe83a0f87aa4896917377ff9d12c69.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-1411-01A,A9D3A7B0-FAF8-4E56-8600-D9E6882A4F23,Primary Tumor,Illumina GA,6d7fd21e-ddca-421d-a923-d506db0d0e90,Ovary,81,157062B7-9451-4A83-9047-294497DF3B28,DA33F277-D0C6-4309-B0A5-DA37FF9CFD66,TCGA-13-1411-01A-01D-0515-09,GRCh37-lite,TCGA-13-1411,TCGA-OV,NA,s17478,Washington University School of Medicine,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a71e,58cfa82de4b0c9d6adf6a71e,G14856.TCGA-05-4432-10A-01D-1931-08.2.filtered.,WGS,G14856.TCGA-05-4432-10A-01D-1931-08.2,G14856.TCGA-05-4432-10A-01D-1931-08.2.bam,97.23,1.9,0.14,58cfa82de4b0c9d6adf6a71e,G14856.TCGA-05-4432-10A-01D-1931-08.2.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4432-10A,E737F650-B72D-44E7-B750-558A56716803,Blood Derived Normal,Illumina HiSeq,1fc8d68c-3938-4719-b23f-d912c14e4263,Lung,66,DF254D50-B666-4512-99E9-F65D94454FDE,9267239F-FFAB-4AB1-A14C-96E7C6A624E7,TCGA-05-4432-10A-01D-1931-08,HG19_Broad_variant,TCGA-05-4432,TCGA-LUAD,NA,s11314,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIB
13722.58cfa82de4b0c9d6adf6a716,58cfa82de4b0c9d6adf6a716,G14849.TCGA-44-2659-10A-01D-1931-08.5.filtered.,WGS,G14849.TCGA-44-2659-10A-01D-1931-08.5,G14849.TCGA-44-2659-10A-01D-1931-08.5.bam,0,1.9,0.15,58cfa82de4b0c9d6adf6a716,G14849.TCGA-44-2659-10A-01D-1931-08.5.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-2659-10A,BF15F7AD-9D92-473B-91D1-F24AA373AB97,Blood Derived Normal,Illumina HiSeq,fb53288f-0723-4e89-a768-e236489cce5b,Lung,65,E5680906-F59E-41E1-B50F-FD94EB06E7DE,FFD01953-5B92-4E5D-A316-A1360EBA0889,TCGA-44-2659-10A-01D-1931-08,HG19_Broad_variant,TCGA-44-2659,TCGA-LUAD,NA,s11211,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,T1,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82de4b0c9d6adf6a542,58cfa82de4b0c9d6adf6a542,161c6ea1a81d271566d819bb40703564.filtered.,WGS,161c6ea1a81d271566d819bb40703564,161c6ea1a81d271566d819bb40703564.bam,71.74,1.98,0.09,58cfa82de4b0c9d6adf6a542,161c6ea1a81d271566d819bb40703564.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-BG-A18C-01A,66E305CA-8A16-44F0-B837-85E529B7AD55,Primary Tumor,Illumina HiSeq,358cf81d-1664-4a81-9bdc-eddc1d95f8f4,Uterus,72,37F209B1-C738-441C-B205-EAEC4E2ADE4E,6E599FCC-D79A-4E0F-B451-C20768C989F9,TCGA-BG-A18C-01A-11D-A325-09,GRCh37-lite,TCGA-BG-A18C,TCGA-UCEC,NA,s5187,Washington University School of Medicine,University of Pittsburgh,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6c03e,58cfa830e4b0c9d6adf6c03e,TCGA-B2-4099-10A-01D-2095-10_Illumina.filtered.,WGS,TCGA-B2-4099-10A-01D-2095-10_Illumina,TCGA-B2-4099-10A-01D-2095-10_Illumina.bam,99.13,1.9,0.15,58cfa830e4b0c9d6adf6c03e,TCGA-B2-4099-10A-01D-2095-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-B2-4099-10A,1ADB05D4-E1CA-4EDE-81C7-FF24A243ABAE,Blood Derived Normal,Illumina HiSeq,82450547-2df2-4c2e-a68f-f4262f28e38b,Kidney,83,A4F480BA-830B-40D9-A4CB-B6B8DF66EAA4,7B9B0E27-01CD-4FE3-A904-9D396D61F646,TCGA-B2-4099-10A-01D-2095-10,GRCh37-lite,TCGA-B2-4099,TCGA-KIRC,NA,s9733,Baylor College of Medicine,Christiana Healthcare,None,NO,T1a,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82de4b0c9d6adf6a70c,58cfa82de4b0c9d6adf6a70c,9fd4a7bb1756a87afb37ac7a45bbe196.filtered.,WGS,9fd4a7bb1756a87afb37ac7a45bbe196,9fd4a7bb1756a87afb37ac7a45bbe196.bam,56.47,1.91,0.09,58cfa82de4b0c9d6adf6a70c,9fd4a7bb1756a87afb37ac7a45bbe196.bam,Dead,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Aligned reads,TCGA-C5-A1BF-01B,262311A0-7A10-4934-8FBA-11EE581AD738,Primary Tumor,Illumina HiSeq,913cddd8-a6ed-4824-8b2c-02f3160028d6,Cervix,46,37670DB3-74D9-4176-BC34-65D2E062D1CB,7DC3E035-C7AE-4164-A62B-9C2460812B05,TCGA-C5-A1BF-01B-11D-A200-09,GRCh37-lite,TCGA-C5-A1BF,TCGA-CESC,570,s1169,Washington University School of Medicine,Medical College of Wisconsin,United States,NO,TX,N0,Cervical Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ab30,58cfa82ee4b0c9d6adf6ab30,G32524.TCGA-DJ-A1QL-10A-01D-A14W-08.3.filtered.,WGS,G32524.TCGA-DJ-A1QL-10A-01D-A14W-08.3,G32524.TCGA-DJ-A1QL-10A-01D-A14W-08.3.bam,21.22,1.98,0.08,58cfa82ee4b0c9d6adf6ab30,G32524.TCGA-DJ-A1QL-10A-01D-A14W-08.3.bam,Alive,MALE,Not available,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A1QL-10A,E4B08E66-0772-4956-8670-E5C6553EECBE,Blood Derived Normal,Illumina HiSeq,a295bd31-1398-433f-a3e3-a73290da72ba,Thyroid,70,4A3FF681-4C8C-43DA-BFC7-9CF2598375B4,D6EA054F-372B-4FC7-A9F4-C61F74F8F1EE,TCGA-DJ-A1QL-10A-01D-A14W-08,HG19_Broad_variant,TCGA-DJ-A1QL,TCGA-THCA,NA,s11974,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa830e4b0c9d6adf6c294,58cfa830e4b0c9d6adf6c294,TCGA-BP-4781-01A-01D-2098-10_Illumina.filtered.,WGS,TCGA-BP-4781-01A-01D-2098-10_Illumina,TCGA-BP-4781-01A-01D-2098-10_Illumina.bam,69.07,1.9,0.16,58cfa830e4b0c9d6adf6c294,TCGA-BP-4781-01A-01D-2098-10_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-BP-4781-01A,80C4FC5B-DC7D-4308-8C81-6E83625963B5,Primary Tumor,Illumina HiSeq,d6c662c6-17e1-4d7c-ab4b-9a002c00648b,Kidney,78,15423D9C-91C3-4FE5-9880-A28840ACB75A,FBF937F1-5F30-470C-8A77-46CD1C41E073,TCGA-BP-4781-01A-01D-2098-10,GRCh37-lite,TCGA-BP-4781,TCGA-KIRC,NA,s8836,Baylor College of Medicine,MSKCC,None,NO,T1a,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6af22,58cfa82ee4b0c9d6adf6af22,G48125.TCGA-24-1466-10A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-24-1466-10A-01D-A312-08.2,G48125.TCGA-24-1466-10A-01D-A312-08.2.bam,520.57,1.9,0.07,58cfa82ee4b0c9d6adf6af22,G48125.TCGA-24-1466-10A-01D-A312-08.2.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1466-10A,098ACB76-0BF5-44E5-BCAE-F919CF5FA5E5,Blood Derived Normal,Illumina HiSeq,cd9e7937-3e9f-4739-865e-d45594dd32a5,Ovary,74,5193A6B9-0705-491B-99B3-DA1EB1713148,6BBFFEA3-AA60-4AAD-AA68-C3D135A6DDFB,TCGA-24-1466-10A-01D-A312-08,HG19_Broad_variant,TCGA-24-1466,TCGA-OV,1373,s17349,Broad Institute of MIT and Harvard,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a730,58cfa82de4b0c9d6adf6a730,G14847.TCGA-05-4397-10A-01D-1931-08.6.filtered.,WGS,G14847.TCGA-05-4397-10A-01D-1931-08.6,G14847.TCGA-05-4397-10A-01D-1931-08.6.bam,256.93,1.9,0.15,58cfa82de4b0c9d6adf6a730,G14847.TCGA-05-4397-10A-01D-1931-08.6.bam,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4397-10A,6DFD47D2-831A-4386-9051-F78199A16BB5,Blood Derived Normal,Illumina HiSeq,952667bd-0130-41d5-8e5e-d419d6ecc6f9,Lung,65,E9F8F56D-E3A6-4F92-807A-99BD857CAD8A,8D2FC21B-E831-44B3-B7BA-90F557303758,TCGA-05-4397-10A-01D-1931-08,HG19_Broad_variant,TCGA-05-4397,TCGA-LUAD,731,s10971,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIB
13722.58cfa831e4b0c9d6adf6c77c,58cfa831e4b0c9d6adf6c77c,TCGA-CZ-5987-11A-01D-2104-10_Illumina.filtered.,WGS,TCGA-CZ-5987-11A-01D-2104-10_Illumina,TCGA-CZ-5987-11A-01D-2104-10_Illumina.bam,33.4,1.93,0.15,58cfa831e4b0c9d6adf6c77c,TCGA-CZ-5987-11A-01D-2104-10_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CZ-5987-11A,F5759059-C0E3-4F1A-AF96-5C7197D3C33C,Solid Tissue Normal,Illumina HiSeq,ee46ed31-88c8-4517-b0e8-cb2ce590fccb,Kidney,60,145E54BA-08E3-4593-BC73-C19094EB8255,B96C8655-E2B4-4F14-A10C-68E90A06ED3F,TCGA-CZ-5987-11A-01D-2104-10,GRCh37-lite,TCGA-CZ-5987,TCGA-KIRC,445,s9454,Baylor College of Medicine,Harvard,None,NO,T3b,NX,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa82ee4b0c9d6adf6ac08,58cfa82ee4b0c9d6adf6ac08,G39019.TCGA-DA-A3F8-10A-01D-A20D-08.3.filtered.,WGS,G39019.TCGA-DA-A3F8-10A-01D-A20D-08.3,G39019.TCGA-DA-A3F8-10A-01D-A20D-08.3.bam,12.11,NA,0.08,58cfa82ee4b0c9d6adf6ac08,G39019.TCGA-DA-A3F8-10A-01D-A20D-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A3F8-10A,B6691E3C-EE3F-49A2-8BD4-2086413E5D8D,Blood Derived Normal,Illumina HiSeq,d29917b4-2d02-4eaa-89e2-5ba8eb0f0297,Skin,39,AA130B28-0388-4CE1-A4E5-EE86BFC6300A,D7B2AEED-1A42-4335-A545-0D284FC5E463,TCGA-DA-A3F8-10A-01D-A20D-08,HG19_Broad_variant,TCGA-DA-A3F8,TCGA-SKCM,NA,s7666,Broad Institute of MIT and Harvard,Yale,United States,NO,T2a,N2b,Not available,Stage IIIB
13722.58cfa830e4b0c9d6adf6bbba,58cfa830e4b0c9d6adf6bbba,TCGA-AA-A01X-11A-11D-A17O-10_wgs_Illumina.filtered.,WGS,TCGA-AA-A01X-11A-11D-A17O-10_wgs_Illumina,TCGA-AA-A01X-11A-11D-A17O-10_wgs_Illumina.bam,47.22,2.09,0.07,58cfa830e4b0c9d6adf6bbba,TCGA-AA-A01X-11A-11D-A17O-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01X-11A,2E386E48-B99B-4806-A3E3-081D72A606E7,Solid Tissue Normal,Illumina HiSeq,3f501377-1ded-4810-b320-714cacc4f71e,Colorectal,80,E3A8174D-358B-4367-BE5D-95FB8A2CE86F,63ED3218-CC53-444A-8291-E04D68EC4148,TCGA-AA-A01X-11A-11D-A17O-10,GRCh37-lite,TCGA-AA-A01X,TCGA-COAD,NA,s13529,Baylor College of Medicine,Indivumed,Germany,NO,T2,N1,Colon Adenocarcinoma,Stage III
13722.58cfa82de4b0c9d6adf6a4d4,58cfa82de4b0c9d6adf6a4d4,406aecbc23505359850e57fbf05d5b67.filtered.,WGS,406aecbc23505359850e57fbf05d5b67,406aecbc23505359850e57fbf05d5b67.bam,85.32,1.85,0.08,58cfa82de4b0c9d6adf6a4d4,406aecbc23505359850e57fbf05d5b67.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LI-01A,E1E8DC66-467C-48A5-BE56-3DB4F665B9F1,Primary Tumor,Illumina HiSeq,626ae092-ba0a-4c13-b860-b407436bc53b,Uterus,67,981D9E3B-63C5-41E9-827F-7F1D268D62F4,DEC775C5-7D9A-4DC5-B399-DC4B7BA49D73,TCGA-AP-A0LI-01A-11D-A066-09,GRCh37-lite,TCGA-AP-A0LI,TCGA-UCEC,NA,s5189,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c472,58cfa831e4b0c9d6adf6c472,TCGA-CA-6718-10A-01D-1835-10_wgs_Illumina.filtered.,WGS,TCGA-CA-6718-10A-01D-1835-10_wgs_Illumina,TCGA-CA-6718-10A-01D-1835-10_wgs_Illumina.bam,310,1.9,0.05,58cfa831e4b0c9d6adf6c472,TCGA-CA-6718-10A-01D-1835-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-CA-6718-10A,DF5AB6CC-6F68-4B6B-95E2-954C6B57BA9C,Blood Derived Normal,Illumina HiSeq,c3a26964-f2a1-4130-9280-3f40b76dd363,Colorectal,46,7A567E2E-3A9B-4631-8DCB-94811AF1F5E8,93BCDFCC-0D6F-469F-B62F-2BB7A3E603D8,TCGA-CA-6718-10A-01D-1835-10,GRCh37-lite,TCGA-CA-6718,TCGA-COAD,NA,s13845,Baylor College of Medicine,ILSbio,Vietnam,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6bda5,58cfa830e4b0c9d6adf6bda5,TCGA-AA-A03F-11A-12D-A17O-10_wgs_Illumina.filtered.,WGS,TCGA-AA-A03F-11A-12D-A17O-10_wgs_Illumina,TCGA-AA-A03F-11A-12D-A17O-10_wgs_Illumina.bam,80.18,1.92,0.07,58cfa830e4b0c9d6adf6bda5,TCGA-AA-A03F-11A-12D-A17O-10_wgs_Illumina.bam,Dead,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A03F-11A,2A971E32-B0E7-4A3F-8C40-62D69C0307D8,Solid Tissue Normal,Illumina HiSeq,6363126b-bc8c-4b4d-9d0f-efe9e48683f9,Colorectal,90,3CED81F6-87AB-49F3-9C9C-0E2A7DA86182,A9B17428-AC84-48B7-A53C-3B302EC258B6,TCGA-AA-A03F-11A-12D-A17O-10,GRCh37-lite,TCGA-AA-A03F,TCGA-COAD,549,s13384,Baylor College of Medicine,Indivumed,Germany,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6adf7,58cfa82ee4b0c9d6adf6adf7,G49537.TCGA-ET-A2N1-10A-01D-A18F-08.2.filtered.,WGS,G49537.TCGA-ET-A2N1-10A-01D-A18F-08.2,G49537.TCGA-ET-A2N1-10A-01D-A18F-08.2.bam,13.16,NA,0.08,58cfa82ee4b0c9d6adf6adf7,G49537.TCGA-ET-A2N1-10A-01D-A18F-08.2.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-ET-A2N1-10A,E74B8474-F74A-498D-8848-6AA97D38D2D8,Blood Derived Normal,Illumina HiSeq,0cbae84f-fd67-4f3c-9d53-d012c4962571,Thyroid,47,38DD287A-2668-457D-9D54-8068A19BD295,7E8E39E1-CE53-49EC-9F65-B0E9AFCDDEB5,TCGA-ET-A2N1-10A-01D-A18F-08,HG19_Broad_variant,TCGA-ET-A2N1,TCGA-THCA,NA,s12349,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa82ee4b0c9d6adf6a9f6,58cfa82ee4b0c9d6adf6a9f6,G32526.TCGA-EL-A3TB-01A-11D-A22D-08.2.filtered.,WGS,G32526.TCGA-EL-A3TB-01A-11D-A22D-08.2,G32526.TCGA-EL-A3TB-01A-11D-A22D-08.2.bam,42.57,NA,0.07,58cfa82ee4b0c9d6adf6a9f6,G32526.TCGA-EL-A3TB-01A-11D-A22D-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EL-A3TB-01A,A09D0BE0-FD41-4B30-B488-9A9F2ABEF8E7,Primary Tumor,Illumina HiSeq,3b8dc42d-2715-4480-a0f4-7595b3520131,Thyroid,47,11671156-4BBF-4A3C-B074-7D6C27EE4FEE,0567D3E6-6278-4D0A-81AE-C084D73C6DD3,TCGA-EL-A3TB-01A-11D-A22D-08,HG19_Broad_variant,TCGA-EL-A3TB,TCGA-THCA,NA,s12084,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa82de4b0c9d6adf6a60e,58cfa82de4b0c9d6adf6a60e,52cd8d256fb4230a57b9973428e5d8a4.filtered.,WGS,52cd8d256fb4230a57b9973428e5d8a4,52cd8d256fb4230a57b9973428e5d8a4.bam,35.28,1.85,0.07,58cfa82de4b0c9d6adf6a60e,52cd8d256fb4230a57b9973428e5d8a4.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A092-01A,38A8B734-9ACC-42F9-B5B7-E51B0DFC6504,Primary Tumor,Illumina HiSeq,3a2d527a-e52b-426a-aad8-0a7691cf835b,Breast,48,8B5C7E4D-A220-4499-9E38-7DEACC1776A2,CC4F9175-A8C8-424A-99D7-8BD11CAE0E52,TCGA-A8-A092-01A-11D-A19H-09,GRCh37-lite,TCGA-A8-A092,TCGA-BRCA,NA,s6262,Washington University School of Medicine,Indivumed,Germany,NO,T2,N2a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82de4b0c9d6adf6a71c,58cfa82de4b0c9d6adf6a71c,G13228.TCGA-43-3920-11B-01D-1553-08.7.filtered.,WGS,G13228.TCGA-43-3920-11B-01D-1553-08.7,G13228.TCGA-43-3920-11B-01D-1553-08.7.bam,386.73,1.9,0.05,58cfa82de4b0c9d6adf6a71c,G13228.TCGA-43-3920-11B-01D-1553-08.7.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-43-3920-11B,9293E197-E38A-4E19-A7D0-1B45D1AD48BD,Solid Tissue Normal,Illumina HiSeq,bf466647-63bc-44e3-8dc1-12e55b364cdd,Lung,71,8B9CCB03-20AC-4F00-9A78-3C89CCC061CC,A500CC1E-2AE9-480D-A30B-9923126C21C5,TCGA-43-3920-11B-01D-1553-08,HG19_Broad_variant,TCGA-43-3920,TCGA-LUSC,NA,s9972,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82de4b0c9d6adf6a676,58cfa82de4b0c9d6adf6a676,6e7789618e7259fb52cad2908f02f68b.filtered.,WGS,6e7789618e7259fb52cad2908f02f68b,6e7789618e7259fb52cad2908f02f68b.bam,43.84,1.95,0.08,58cfa82de4b0c9d6adf6a676,6e7789618e7259fb52cad2908f02f68b.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A052-01A,BD4284A7-260D-48B3-9B48-A1C578C30D27,Primary Tumor,Illumina HiSeq,94e31842-d1e3-47ad-bee2-70890b17580f,Uterus,59,33C21DCA-F3B3-48CD-9FC5-AD316598F23E,C75CC75A-7496-420F-B526-EA63C77E9839,TCGA-AP-A052-01A-11D-A013-09,GRCh37-lite,TCGA-AP-A052,TCGA-UCEC,669,s4769,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a9fa,58cfa82ee4b0c9d6adf6a9fa,G32463.TCGA-DK-A1A5-10A-01D-A13W-08.2.filtered.,WGS,G32463.TCGA-DK-A1A5-10A-01D-A13W-08.2,G32463.TCGA-DK-A1A5-10A-01D-A13W-08.2.bam,56.09,1.95,0.08,58cfa82ee4b0c9d6adf6a9fa,G32463.TCGA-DK-A1A5-10A-01D-A13W-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1A5-10A,904A8757-E0C5-41EF-B583-C8F170CAAAC1,Blood Derived Normal,Illumina HiSeq,d6515433-0b8f-4f8f-ac6b-99a251278065,Bladder,79,608EEC1D-33BC-48DD-A928-49B09E87CCC8,68402877-A578-4BFD-A05E-58C6E06FB6A3,TCGA-DK-A1A5-10A-01D-A13W-08,HG19_Broad_variant,TCGA-DK-A1A5,TCGA-BLCA,65,s2686,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa82de4b0c9d6adf6a61a,58cfa82de4b0c9d6adf6a61a,77181bb00b006255840c66efcab8d16e.filtered.,WGS,77181bb00b006255840c66efcab8d16e,77181bb00b006255840c66efcab8d16e.bam,15.6,1.92,0.08,58cfa82de4b0c9d6adf6a61a,77181bb00b006255840c66efcab8d16e.bam,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-BH-A0E0-11A,20E8106B-1290-4735-ABE4-7621E08E3DC8,Solid Tissue Normal,Illumina HiSeq,ba938f20-4549-47f9-929c-3351cd03e1ce,Breast,38,90FB06A9-35BE-44B0-9F5B-EB270898AABE,8A1636AA-6B9B-42CB-8F0D-C8529ADB2C63,TCGA-BH-A0E0-11A-13D-A128-09,GRCh37-lite,TCGA-BH-A0E0,TCGA-BRCA,NA,s5954,Washington University School of Medicine,University of Pittsburgh,None,NO,T3,N3a,Infiltrating Ductal Carcinoma,Stage IIIC
13722.58cfa82ee4b0c9d6adf6ab00,58cfa82ee4b0c9d6adf6ab00,G26405.TCGA-14-2554-01A-01D-1494-08.1.filtered.,WGS,G26405.TCGA-14-2554-01A-01D-1494-08.1,G26405.TCGA-14-2554-01A-01D-1494-08.1.bam,335.7,1.9,0.05,58cfa82ee4b0c9d6adf6ab00,G26405.TCGA-14-2554-01A-01D-1494-08.1.bam,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-2554-01A,B1C4579C-72FA-4974-830C-B6A81ACE45F4,Primary Tumor,Illumina HiSeq,88f8661f-2c61-4518-94b2-eae9bec254e6,Brain,52,E8013962-7049-4596-AA49-E6403F608D98,53DEC97D-0464-4FFD-8E2E-95B2B9A03AF0,TCGA-14-2554-01A-01D-1494-08,HG19_Broad_variant,TCGA-14-2554,TCGA-GBM,532,s14371,Broad Institute of MIT and Harvard,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a77d,58cfa82de4b0c9d6adf6a77d,G16920.TCGA-CZ-4856-11A-01D-2048-08.1.filtered.,WGS,G16920.TCGA-CZ-4856-11A-01D-2048-08.1,G16920.TCGA-CZ-4856-11A-01D-2048-08.1.bam,76.73,1.9,0.15,58cfa82de4b0c9d6adf6a77d,G16920.TCGA-CZ-4856-11A-01D-2048-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CZ-4856-11A,FCECAFA8-8B8B-4AE6-81BC-73ACF05B211A,Solid Tissue Normal,Illumina HiSeq,8df671b7-f135-47cb-bdbe-f4332ba8dd78,Kidney,62,E815B1F1-E9FA-42D1-BAB6-4BBC59CCEF0A,259E49C4-C81C-4072-B355-10933FFFD717,TCGA-CZ-4856-11A-01D-2048-08,HG19_Broad_variant,TCGA-CZ-4856,TCGA-KIRC,NA,s9936,Broad Institute of MIT and Harvard,Harvard,None,NO,T1b,N0,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa83ce4b0c9d6adf73186,58cfa83ce4b0c9d6adf73186,dfe3e6d0e03ae11e71a75fd2ef82e0e8.filtered.,WGS,dfe3e6d0e03ae11e71a75fd2ef82e0e8,dfe3e6d0e03ae11e71a75fd2ef82e0e8.bam,43.2,NA,0.08,58cfa83ce4b0c9d6adf73186,dfe3e6d0e03ae11e71a75fd2ef82e0e8.bam,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A891-01A,F28F37A0-8E24-4A36-90F0-83CF5A27BE10,Primary Tumor,HiSeq X Ten,6a8df1ad-3349-44bb-8643-725a89c6e83f,Esophagus,51,5A565170-727C-4398-AC9A-2AD3B7688760,207EA57E-655D-4008-81E3-27FA7B2B1FF6,TCGA-L5-A891-01A-11D-A36J-09,GRCh37-lite_WUGSC_variant_2,TCGA-L5-A891,TCGA-ESCA,NA,s1707,Washington University School of Medicine,University of Michigan,United States,NO,T3,N1,Not available,Not available
13722.58cfa82ee4b0c9d6adf6a7cd,58cfa82ee4b0c9d6adf6a7cd,G23078.TCGA_CR_6487_10A_01D_2268_08.1.filtered.,WGS,G23078.TCGA_CR_6487_10A_01D_2268_08.1,G23078.TCGA_CR_6487_10A_01D_2268_08.1.bam,141,1.8,0.13,58cfa82ee4b0c9d6adf6a7cd,G23078.TCGA_CR_6487_10A_01D_2268_08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-6487-10A,9AE5101B-6031-4AB1-BFCA-198C41AF3184,Blood Derived Normal,Illumina HiSeq,8874033e-39fc-438d-96cb-baabcb41a1f7,Head and Neck,50,FF63290D-0644-4387-99BB-697150A7FB6B,BC26BAA4-0F4D-4B8C-95F4-B8F9FB2BD328,TCGA-CR-6487-10A-01D-2268-08,HG19_Broad_variant,TCGA-CR-6487,TCGA-HNSC,NA,s16164,Broad Institute of MIT and Harvard,Vanderbilt University,United States,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6a8c2,58cfa82ee4b0c9d6adf6a8c2,G35154.TCGA-CS-6668-01A-11D-1893-08.2.filtered.,WGS,G35154.TCGA-CS-6668-01A-11D-1893-08.2,G35154.TCGA-CS-6668-01A-11D-1893-08.2.bam,220,1.9,0.05,58cfa82ee4b0c9d6adf6a8c2,G35154.TCGA-CS-6668-01A-11D-1893-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-6668-01A,A5D3F3FB-6541-419D-B47E-720D438F1BFF,Primary Tumor,Illumina HiSeq,698a92bc-1d75-4e94-a533-d41f6a195e9b,Brain,57,C6784C8A-FA04-429D-9290-40BD95F2D94D,D414E076-DCB6-4EDF-ADEF-0ABDC57354EA,TCGA-CS-6668-01A-11D-1893-08,HG19_Broad_variant,TCGA-CS-6668,TCGA-LGG,NA,s8320,Broad Institute of MIT and Harvard,Thomas Jefferson University,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa83ce4b0c9d6adf730f0,58cfa83ce4b0c9d6adf730f0,ed7c0d707af5e0862abe28d9bbea0aec.filtered.,WGS,ed7c0d707af5e0862abe28d9bbea0aec,ed7c0d707af5e0862abe28d9bbea0aec.bam,82.92,2,0.08,58cfa83ce4b0c9d6adf730f0,ed7c0d707af5e0862abe28d9bbea0aec.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-A5-A0GE-01A,A587E62E-430E-4F1B-82B7-6FBE856FDAF1,Primary Tumor,Illumina HiSeq,acd74d29-be09-40a4-b713-578d8469edd7,Uterus,38,20C3F64D-ACF6-45B3-9ACE-2F93B3A951C8,23CC70C4-B744-4FA0-A0DE-B25C0FDF212F,TCGA-A5-A0GE-01A-11D-A066-09,GRCh37-lite,TCGA-A5-A0GE,TCGA-UCEC,NA,s4765,Washington University School of Medicine,Cedars Sinai,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aa85,58cfa82ee4b0c9d6adf6aa85,G26374.TCGA-06-5415-10A-01D-1486-08.1.filtered.,WGS,G26374.TCGA-06-5415-10A-01D-1486-08.1,G26374.TCGA-06-5415-10A-01D-1486-08.1.bam,89.03,1.9,0.05,58cfa82ee4b0c9d6adf6aa85,G26374.TCGA-06-5415-10A-01D-1486-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-5415-10A,713190ED-C6C1-4695-814B-85CA9B95E6A0,Blood Derived Normal,Illumina HiSeq,2bc00d9f-c389-4e3c-a910-48030970a395,Brain,60,4A4F517D-1B44-406D-B057-7274B97E961E,E09E94F5-BD10-4523-BC83-D441A285C37C,TCGA-06-5415-10A-01D-1486-08,HG19_Broad_variant,TCGA-06-5415,TCGA-GBM,NA,s14169,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6befe,58cfa830e4b0c9d6adf6befe,TCGA-BP-4968-11A-01D-2100-10_Illumina.filtered.,WGS,TCGA-BP-4968-11A-01D-2100-10_Illumina,TCGA-BP-4968-11A-01D-2100-10_Illumina.bam,99.77,1.9,0.17,58cfa830e4b0c9d6adf6befe,TCGA-BP-4968-11A-01D-2100-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-BP-4968-11A,1E417B93-837D-4110-9090-239EB82C3E20,Solid Tissue Normal,Illumina HiSeq,596d0c16-2244-423f-889f-11c84dcf439d,Kidney,40,63B52A31-696E-42E4-87B7-9E7D8B5C72AA,9CDE30AA-EE25-4E70-A511-CF78E3FF84F9,TCGA-BP-4968-11A-01D-2100-10,GRCh37-lite,TCGA-BP-4968,TCGA-KIRC,NA,s9160,Baylor College of Medicine,MSKCC,None,NO,T1b,N0,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c6a3,58cfa831e4b0c9d6adf6c6a3,TCGA-CR-6467-10A-01D-2266-10_Illumina.filtered.,WGS,TCGA-CR-6467-10A-01D-2266-10_Illumina,TCGA-CR-6467-10A-01D-2266-10_Illumina.bam,145,1.8,0.05,58cfa831e4b0c9d6adf6c6a3,TCGA-CR-6467-10A-01D-2266-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-6467-10A,89F91E36-FED8-4DA3-8A35-C761D6F65285,Blood Derived Normal,Illumina HiSeq,7bb031ed-5edc-4778-a891-4fe286111566,Head and Neck,59,2D9AD43C-F177-455E-9B63-1B9FFDC672D9,0075C3F3-A8FE-486F-AA97-B05FC8EF9375,TCGA-CR-6467-10A-01D-2266-10,GRCh37-lite,TCGA-CR-6467,TCGA-HNSC,NA,s16188,Baylor College of Medicine,Vanderbilt University,United States,NO,T2,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6a85e,58cfa82ee4b0c9d6adf6a85e,G32528.TCGA-DJ-A2Q8-10A-01D-A18F-08.5.filtered.,WGS,G32528.TCGA-DJ-A2Q8-10A-01D-A18F-08.5,G32528.TCGA-DJ-A2Q8-10A-01D-A18F-08.5.bam,31.65,NA,0.08,58cfa82ee4b0c9d6adf6a85e,G32528.TCGA-DJ-A2Q8-10A-01D-A18F-08.5.bam,Alive,FEMALE,Not available,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A2Q8-10A,F9CF605F-F287-4EBA-8E8F-8BA47E14ECC4,Blood Derived Normal,Illumina HiSeq,bfe70f21-633e-4c43-86c5-82c6414362a0,Thyroid,47,FDE5E0FB-6D0B-4CDC-858F-0FB96E5CD0E6,CF88AECB-DC11-4F6F-9072-BC153C7A62D9,TCGA-DJ-A2Q8-10A-01D-A18F-08,HG19_Broad_variant,TCGA-DJ-A2Q8,TCGA-THCA,NA,s12726,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T1a,N0,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage I
13722.58cfa82ee4b0c9d6adf6ad28,58cfa82ee4b0c9d6adf6ad28,G49837.TCGA-18-3408-11A-01D-A320-08.4.filtered.,WGS,G49837.TCGA-18-3408-11A-01D-A320-08.4,G49837.TCGA-18-3408-11A-01D-A320-08.4.bam,149.94,1.9,0.08,58cfa82ee4b0c9d6adf6ad28,G49837.TCGA-18-3408-11A-01D-A320-08.4.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-18-3408-11A,D4BC755A-2585-4529-AE36-7E1D88BDECFE,Solid Tissue Normal,Illumina HiSeq,addb9e48-ecaa-425d-aa48-060d755484e4,Lung,77,786C2A76-177F-4F22-A317-20FEA7E594BE,C1E8DEAF-DDA4-4D0A-9316-913A1CB736E7,TCGA-18-3408-11A-01D-A320-08,HG19_Broad_variant,TCGA-18-3408,TCGA-LUSC,NA,s10259,Broad Institute of MIT and Harvard,Princess Margaret Hospital (Canada),Canada,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6ac49,58cfa82ee4b0c9d6adf6ac49,G37566.TCGA-G9-6370-10A-01D-1786-08.2.filtered.,WGS,G37566.TCGA-G9-6370-10A-01D-1786-08.2,G37566.TCGA-G9-6370-10A-01D-1786-08.2.bam,43.7,1.8,0.05,58cfa82ee4b0c9d6adf6ac49,G37566.TCGA-G9-6370-10A-01D-1786-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6370-10A,F947B0BC-BDAC-44E8-B5B9-FFAE4147740A,Blood Derived Normal,Illumina HiSeq,9fc2ef6c-ec15-45d8-ac6a-b1ea9c18d59c,Prostate,52,8FF4EEBE-420C-442E-A41D-4C1F050B0EED,8B44F615-8F5D-4C2D-8C8B-8D48DE8DB586,TCGA-G9-6370-10A-01D-1786-08,HG19_Broad_variant,TCGA-G9-6370,TCGA-PRAD,NA,s3921,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6a916,58cfa82ee4b0c9d6adf6a916,G26380.TCGA-06-0744-10A-01D-1492-08.1.filtered.,WGS,G26380.TCGA-06-0744-10A-01D-1492-08.1,G26380.TCGA-06-0744-10A-01D-1492-08.1.bam,39.37,1.88,0.05,58cfa82ee4b0c9d6adf6a916,G26380.TCGA-06-0744-10A-01D-1492-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0744-10A,5613F5F6-086D-470B-8F77-6DCB7F8625B7,Blood Derived Normal,Illumina HiSeq,95eaa467-4f9b-4391-9ac5-140e03db95db,Brain,66,A469D368-66F3-46C9-A95A-9F8497F58996,FC7BB1B6-6B1D-4A79-A634-0B0E28450B26,TCGA-06-0744-10A-01D-1492-08,HG19_Broad_variant,TCGA-06-0744,TCGA-GBM,NA,s14346,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf731a2,58cfa83ce4b0c9d6adf731a2,a8fa89810891a177c65d943664f1e99b.filtered.,WGS,a8fa89810891a177c65d943664f1e99b,a8fa89810891a177c65d943664f1e99b.bam,106.68,1.91,0.08,58cfa83ce4b0c9d6adf731a2,a8fa89810891a177c65d943664f1e99b.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-DI-A1NN-01A,944A102F-3475-45AA-9E30-4B92D1449F00,Primary Tumor,Illumina HiSeq,b518c962-e072-40bd-962b-f0eebac9aa3b,Uterus,63,5FABCE9C-0DFB-4B0D-8478-599FD181A84F,95E8D38A-122E-494C-A304-BEF4275FED7E,TCGA-DI-A1NN-01A-11D-A34H-09,GRCh37-lite,TCGA-DI-A1NN,TCGA-UCEC,NA,s4760,Washington University School of Medicine,MD Anderson,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf72f75,58cfa83ce4b0c9d6adf72f75,f059a2333e0663ef4831e98db4f4c9e5.filtered.,WGS,f059a2333e0663ef4831e98db4f4c9e5,f059a2333e0663ef4831e98db4f4c9e5.bam,69.64,1.86,0.08,58cfa83ce4b0c9d6adf72f75,f059a2333e0663ef4831e98db4f4c9e5.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A08B-01A,D8D7A6C2-6427-4F47-968C-6C3AFFBA4617,Primary Tumor,Illumina HiSeq,f0967810-7b67-40b6-9995-a392153f2fba,Breast,52,1964ADDF-C524-4C72-B596-009235BAD133,F6114C69-71A1-47D5-9B28-B0227B1872F7,TCGA-A8-A08B-01A-11D-A19H-09,GRCh37-lite,TCGA-A8-A08B,TCGA-BRCA,NA,s6447,Washington University School of Medicine,Indivumed,Germany,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6b006,58cfa82ee4b0c9d6adf6b006,TCGA-13-0725-10B-01D-0446-08_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-13-0725-10B-01D-0446-08_IlluminaGA-DNASeq_whole,TCGA-13-0725-10B-01D-0446-08_IlluminaGA-DNASeq_whole.bam,50,1.9,0.16,58cfa82ee4b0c9d6adf6b006,TCGA-13-0725-10B-01D-0446-08_IlluminaGA-DNASeq_whole.bam,Dead,FEMALE,WHITE,HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0725-10B,446CE2A3-D328-443C-A419-3344BAAD0E16,Blood Derived Normal,Illumina GA,b45a893b-0bf5-41d7-a0f5-79d4995950e4,Ovary,44,2C0AE09E-F422-4986-9E45-CFE13C5EE3DE,AFB81FE3-F799-4E7D-BF02-D7735EF9EB23,TCGA-13-0725-10B-01D-0446-08,HG18_Broad_variant,TCGA-13-0725,TCGA-OV,377,s17980,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ac2c,58cfa82ee4b0c9d6adf6ac2c,G37566.TCGA-HC-7233-10A-01D-2115-08.2.filtered.,WGS,G37566.TCGA-HC-7233-10A-01D-2115-08.2,G37566.TCGA-HC-7233-10A-01D-2115-08.2.bam,326.6,NA,0.05,58cfa82ee4b0c9d6adf6ac2c,G37566.TCGA-HC-7233-10A-01D-2115-08.2.bam,Alive,MALE,WHITE,Not available,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7233-10A,E2B33861-2247-413F-B2E5-9BE3B604666C,Blood Derived Normal,Illumina HiSeq,feec4567-def2-4a31-b762-696e39252247,Prostate,73,E2E7CA1B-2EB0-4DCB-8887-CC9D4F1D9EC1,112415C3-8CEA-4608-9F55-C5714AC77390,TCGA-HC-7233-10A-01D-2115-08,HG19_Broad_variant,TCGA-HC-7233,TCGA-PRAD,NA,s3584,Broad Institute of MIT and Harvard,International Genomics Consortium,Yemen,NO,T2a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6af13,58cfa82ee4b0c9d6adf6af13,G48125.TCGA-24-1544-10A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-24-1544-10A-01D-A312-08.2,G48125.TCGA-24-1544-10A-01D-A312-08.2.bam,93.3,1.8,0.08,58cfa82ee4b0c9d6adf6af13,G48125.TCGA-24-1544-10A-01D-A312-08.2.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1544-10A,21F6BF91-DFC6-4A59-8B76-88A0F95C7B47,Blood Derived Normal,Illumina HiSeq,64788c72-67a2-4602-91be-abf114e49bd2,Ovary,71,E2BE3D89-B678-42E8-ACBC-E97E44CAE565,7C759AA6-CC73-4671-ADBF-DDEDF7D2D75F,TCGA-24-1544-10A-01D-A312-08,HG19_Broad_variant,TCGA-24-1544,TCGA-OV,820,s17204,Broad Institute of MIT and Harvard,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa83ce4b0c9d6adf72e96,58cfa83ce4b0c9d6adf72e96,c7084960dc3d5bdf5efebd6a16721e46.filtered.,WGS,c7084960dc3d5bdf5efebd6a16721e46,c7084960dc3d5bdf5efebd6a16721e46.bam,52.3,2.08,0.08,58cfa83ce4b0c9d6adf72e96,c7084960dc3d5bdf5efebd6a16721e46.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A08S-01A,2779FA01-AC93-4E80-A997-3385F72172C3,Primary Tumor,Illumina HiSeq,b026f426-bb3a-4c0e-b90d-6ec93bde0f53,Breast,71,960D194F-FE39-42A0-831D-5C031CF93544,2C6F1862-BB82-4E7E-9CB3-338BDF022FF4,TCGA-A8-A08S-01A-11D-A19H-09,GRCh37-lite,TCGA-A8-A08S,TCGA-BRCA,NA,s6252,Washington University School of Medicine,Indivumed,Germany,NO,T1c,N1,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6adba,58cfa82ee4b0c9d6adf6adba,G39020.TCGA-D7-6822-10A-01D-1882-08.3.filtered.,WGS,G39020.TCGA-D7-6822-10A-01D-1882-08.3,G39020.TCGA-D7-6822-10A-01D-1882-08.3.bam,413.3,1.9,0.05,58cfa82ee4b0c9d6adf6adba,G39020.TCGA-D7-6822-10A-01D-1882-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6822-10A,E2AAABD9-F4BA-4763-A28A-C14D46A4BC5D,Blood Derived Normal,Illumina HiSeq,53456e48-e181-4f75-be35-28167c1fb50b,Stomach,77,B60B4A59-1064-4349-8942-375F7D0B4337,1BBFEAA7-EC73-45FD-8527-771D952AFD70,TCGA-D7-6822-10A-01D-1882-08,HG19_Broad_variant,TCGA-D7-6822,TCGA-STAD,NA,s15096,Broad Institute of MIT and Harvard,Greater Poland Cancer Center,Poland,NO,T2,N0,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IB
13722.58cfa82de4b0c9d6adf6a59b,58cfa82de4b0c9d6adf6a59b,63caf3c72c859d6a05579c2a05cead25.filtered.,WGS,63caf3c72c859d6a05579c2a05cead25,63caf3c72c859d6a05579c2a05cead25.bam,32.95,NA,0.08,58cfa82de4b0c9d6adf6a59b,63caf3c72c859d6a05579c2a05cead25.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-GM-A3XL-01A,65CAC997-4D39-4501-85EC-4FCB328A8EB5,Primary Tumor,Illumina HiSeq,77d3443d-1bf9-4867-89a2-65cc8e10141b,Breast,49,FED3A891-21BE-4196-B9EF-0BF7C8F976AA,B27D75BA-5989-4200-BFE9-F1B7D7CF8008,TCGA-GM-A3XL-01A-11D-A22X-09,GRCh37-lite,TCGA-GM-A3XL,TCGA-BRCA,NA,s6264,Washington University School of Medicine,MD Anderson,United States,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6aa34,58cfa82ee4b0c9d6adf6aa34,G25774.TCGA-05-5429-10A-01D-1625-08.2.filtered.,WGS,G25774.TCGA-05-5429-10A-01D-1625-08.2,G25774.TCGA-05-5429-10A-01D-1625-08.2.bam,136.4,1.9,0.05,58cfa82ee4b0c9d6adf6aa34,G25774.TCGA-05-5429-10A-01D-1625-08.2.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-5429-10A,63BD2175-4B7C-44C9-AEF3-9EFC8F79837B,Blood Derived Normal,Illumina HiSeq,f3d21928-332c-46d7-8a92-bafee2ed961c,Lung,60,CBFF89AF-5FC7-4C9C-B081-5774657967C2,FEAED996-83E7-46AF-9E74-3D70B303EA6A,TCGA-05-5429-10A-01D-1625-08,HG19_Broad_variant,TCGA-05-5429,TCGA-LUAD,NA,s11542,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T3,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa830e4b0c9d6adf6ba4c,58cfa830e4b0c9d6adf6ba4c,TCGA-AA-A01V-11A-11D-A17O-10_wgs_Illumina.filtered.,WGS,TCGA-AA-A01V-11A-11D-A17O-10_wgs_Illumina,TCGA-AA-A01V-11A-11D-A17O-10_wgs_Illumina.bam,40,1.86,0.07,58cfa830e4b0c9d6adf6ba4c,TCGA-AA-A01V-11A-11D-A17O-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01V-11A,0CB0DAC8-4CE2-444A-B1AE-1550E065B4D9,Solid Tissue Normal,Illumina HiSeq,03e01b0c-3134-4b21-87ae-1fd14f5769c0,Colorectal,59,398A605C-0A45-4757-BC28-996816990576,D795461B-8118-40C1-A03C-93C80A17CD41,TCGA-AA-A01V-11A-11D-A17O-10,GRCh37-lite,TCGA-AA-A01V,TCGA-COAD,NA,s12875,Baylor College of Medicine,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6af70,58cfa82ee4b0c9d6adf6af70,G48125.TCGA-13-0912-10A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-13-0912-10A-01D-A312-08.2,G48125.TCGA-13-0912-10A-01D-A312-08.2.bam,34.97,1.9,0.07,58cfa82ee4b0c9d6adf6af70,G48125.TCGA-13-0912-10A-01D-A312-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0912-10A,58D34254-4F5B-40A4-9E9F-7160062FB2A4,Blood Derived Normal,Illumina HiSeq,d46e048d-0d07-4c12-b946-4f1440519bb9,Ovary,58,C24AE833-72A5-4D74-97C1-06409A3D5F11,D77B7BF5-8F58-4E4F-AD5B-FF0F87DF2EC4,TCGA-13-0912-10A-01D-A312-08,HG19_Broad_variant,TCGA-13-0912,TCGA-OV,NA,s18020,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a930,58cfa82ee4b0c9d6adf6a930,G32548.TCGA-EE-A2M5-06A-12D-A197-08.1.filtered.,WGS,G32548.TCGA-EE-A2M5-06A-12D-A197-08.1,G32548.TCGA-EE-A2M5-06A-12D-A197-08.1.bam,77.34,NA,0.08,58cfa82ee4b0c9d6adf6a930,G32548.TCGA-EE-A2M5-06A-12D-A197-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2M5-06A,B5E37B9B-6264-4CC8-9B44-1D8AC0692D6C,Metastatic,Illumina HiSeq,1b05a86b-df84-4691-843d-2cc39486717e,Skin,49,B3189E4F-3B90-4A1E-8FF1-FA2FEDC46C4C,3869FF3F-21B9-4817-8FF4-83C6FC75AB11,TCGA-EE-A2M5-06A-12D-A197-08,HG19_Broad_variant,TCGA-EE-A2M5,TCGA-SKCM,659,s7983,Broad Institute of MIT and Harvard,University of Sydney,Australia,NO,T2,N0,Not available,Stage I
13722.58cfa82ee4b0c9d6adf6ab42,58cfa82ee4b0c9d6adf6ab42,G32525.TCGA-DJ-A13W-01A-11D-A10S-08.3.filtered.,WGS,G32525.TCGA-DJ-A13W-01A-11D-A10S-08.3,G32525.TCGA-DJ-A13W-01A-11D-A10S-08.3.bam,50.62,1.95,0.08,58cfa82ee4b0c9d6adf6ab42,G32525.TCGA-DJ-A13W-01A-11D-A10S-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13W-01A,3B48CC5E-3396-4DD5-893D-54B75B98B016,Primary Tumor,Illumina HiSeq,2a8caa63-ca28-490f-8b5c-13db08afd1c8,Thyroid,45,4DCA97A5-B0E5-4383-8CC5-B6FF07741647,0C18A8B7-BAD1-4AA4-A6DF-472F89D9761C,TCGA-DJ-A13W-01A-11D-A10S-08,HG19_Broad_variant,TCGA-DJ-A13W,TCGA-THCA,NA,s12736,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa832e4b0c9d6adf6d16c,58cfa832e4b0c9d6adf6d16c,TCGA-KL-8323-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8323-11A-01D-2310-10_wgs_Illumina,TCGA-KL-8323-11A-01D-2310-10_wgs_Illumina.bam,261.5,NA,0.05,58cfa832e4b0c9d6adf6d16c,TCGA-KL-8323-11A-01D-2310-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8323-11A,83B3060C-2449-4581-88EF-817D126E4525,Solid Tissue Normal,Illumina HiSeq,e7ab56c7-d9f3-40dc-ab13-808e7b0c8516,Kidney,57,91B89291-398B-4816-8645-FD6205408205,F5C7FB67-5906-4DB0-AD0D-129DF8E065CB,TCGA-KL-8323-11A-01D-2310-10,GRCh37-lite,TCGA-KL-8323,TCGA-KICH,1158,s16426,Baylor College of Medicine,MSKCC,United States,NO,T3b,NX,Kidney Chromophobe,Stage III
13722.58cfa82de4b0c9d6adf6a780,58cfa82de4b0c9d6adf6a780,G16920.TCGA-CZ-4856-01A-02D-2048-08.1.filtered.,WGS,G16920.TCGA-CZ-4856-01A-02D-2048-08.1,G16920.TCGA-CZ-4856-01A-02D-2048-08.1.bam,34.73,1.9,0.15,58cfa82de4b0c9d6adf6a780,G16920.TCGA-CZ-4856-01A-02D-2048-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CZ-4856-01A,FCECAFA8-8B8B-4AE6-81BC-73ACF05B211A,Primary Tumor,Illumina HiSeq,11912043-5f81-4764-94e5-b6a0218a906c,Kidney,62,6F6C9F00-D6E5-452F-BA04-F77B146B780B,A7293FEF-B5D3-4572-A38B-5DC4F8A67C12,TCGA-CZ-4856-01A-02D-2048-08,HG19_Broad_variant,TCGA-CZ-4856,TCGA-KIRC,NA,s9935,Broad Institute of MIT and Harvard,Harvard,None,NO,T1b,N0,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82de4b0c9d6adf6a748,58cfa82de4b0c9d6adf6a748,G14850.TCGA-49-4486-11A-01D-1931-08.3.filtered.,WGS,G14850.TCGA-49-4486-11A-01D-1931-08.3,G14850.TCGA-49-4486-11A-01D-1931-08.3.bam,176.53,1.9,0.16,58cfa82de4b0c9d6adf6a748,G14850.TCGA-49-4486-11A-01D-1931-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4486-11A,61C655EC-52B5-453F-A6CC-B2ABA445B027,Solid Tissue Normal,Illumina HiSeq,83ce2c4a-f55f-47bf-af39-3fe89232672b,Lung,72,5AF4A67E-13EF-41DD-945C-18669C7D2701,3041C54D-431B-4CC6-8AB4-623673BC6CFD,TCGA-49-4486-11A-01D-1931-08,HG19_Broad_variant,TCGA-49-4486,TCGA-LUAD,2318,s11210,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6ac78,58cfa82ee4b0c9d6adf6ac78,G41960.TCGA-55-6984-11A-01D-1945-08.2.filtered.,WGS,G41960.TCGA-55-6984-11A-01D-1945-08.2,G41960.TCGA-55-6984-11A-01D-1945-08.2.bam,62.7,NA,0.05,58cfa82ee4b0c9d6adf6ac78,G41960.TCGA-55-6984-11A-01D-1945-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-55-6984-11A,F063DDBB-1668-40DF-9EC2-B0A23CA2C389,Solid Tissue Normal,Illumina HiSeq,ca4b6c95-902e-453e-8a03-292a01304628,Lung,71,0E0FF02A-DD07-487B-BD81-FA2A001977FB,95BD4570-1588-4464-A301-AA425AF048B8,TCGA-55-6984-11A-01D-1945-08,HG19_Broad_variant,TCGA-55-6984,TCGA-LUAD,760,s10639,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82de4b0c9d6adf6a5a6,58cfa82de4b0c9d6adf6a5a6,5e03098f26dc684c1f21cc0094f04543.filtered.,WGS,5e03098f26dc684c1f21cc0094f04543,5e03098f26dc684c1f21cc0094f04543.bam,27.49,NA,0.08,58cfa82de4b0c9d6adf6a5a6,5e03098f26dc684c1f21cc0094f04543.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-DX-A3U6-01A,6201394F-B70E-4F14-9519-FF9D5F06EB09,Primary Tumor,Illumina HiSeq,d62aa69c-0aa5-4eab-b882-d3aca07cdd27,Mesenchymal,63,ACEA4025-F740-4A60-AD51-EAF61964256B,DB650EFF-4E2C-4CE3-9124-7697B6E03359,TCGA-DX-A3U6-01A-11D-A29N-09,GRCh37-lite,TCGA-DX-A3U6,TCGA-SARC,NA,s2341,Washington University School of Medicine,Memorial Sloan Kettering,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6ab2a,58cfa82ee4b0c9d6adf6ab2a,G32558.TCGA-FS-A1ZD-06A-11D-A197-08.2.filtered.,WGS,G32558.TCGA-FS-A1ZD-06A-11D-A197-08.2,G32558.TCGA-FS-A1ZD-06A-11D-A197-08.2.bam,66.27,NA,0.08,58cfa82ee4b0c9d6adf6ab2a,G32558.TCGA-FS-A1ZD-06A-11D-A197-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZD-06A,C2948FE9-5798-43BC-A743-511E94E417F8,Metastatic,Illumina HiSeq,3de1f925-49e8-4363-b1dd-cc78303f6594,Skin,63,3B63CB75-EC13-4CAB-B11D-EB6E7FAA8641,8EA666B7-2B6E-4DF8-9A9D-B8265B9749B4,TCGA-FS-A1ZD-06A-11D-A197-08,HG19_Broad_variant,TCGA-FS-A1ZD,TCGA-SKCM,1628,s7305,Broad Institute of MIT and Harvard,Essen,Germany,NO,T2b,N0,Not available,Stage IIA
13722.58cfa82ee4b0c9d6adf6acb0,58cfa82ee4b0c9d6adf6acb0,G48125.TCGA-13-0727-10B-01D-A312-08.2.filtered.,WGS,G48125.TCGA-13-0727-10B-01D-A312-08.2,G48125.TCGA-13-0727-10B-01D-A312-08.2.bam,43.3,1.9,0.09,58cfa82ee4b0c9d6adf6acb0,G48125.TCGA-13-0727-10B-01D-A312-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0727-10B,90F4B65C-CFD4-4066-A5B9-842885C172E2,Blood Derived Normal,Illumina HiSeq,53740d76-9b94-4e51-8980-c22f626c8d0e,Ovary,71,C34A0507-6FD2-4792-90ED-84DF9C699016,1B4A88E7-AB45-4584-8824-C008D74BFBF1,TCGA-13-0727-10B-01D-A312-08,HG19_Broad_variant,TCGA-13-0727,TCGA-OV,462,s17348,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bbb2,58cfa830e4b0c9d6adf6bbb2,TCGA-AA-A02O-01A-21D-A17O-10_wgs_Illumina.filtered.,WGS,TCGA-AA-A02O-01A-21D-A17O-10_wgs_Illumina,TCGA-AA-A02O-01A-21D-A17O-10_wgs_Illumina.bam,107.64,2.11,0.08,58cfa830e4b0c9d6adf6bbb2,TCGA-AA-A02O-01A-21D-A17O-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A02O-01A,6FA41234-9077-4D05-A295-6820F3BEDF5B,Primary Tumor,Illumina HiSeq,22eeeeaf-8aa8-45e6-ace6-b84917c3b402,Colorectal,82,2151DC9E-F76A-4CFF-8A20-B7C107D59C27,4019C219-C51E-479F-8A9D-CFA6816ED696,TCGA-AA-A02O-01A-21D-A17O-10,GRCh37-lite,TCGA-AA-A02O,TCGA-COAD,NA,s12872,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6aa94,58cfa82ee4b0c9d6adf6aa94,G32470.TCGA-FT-A3EE-10A-01D-A202-08.3.filtered.,WGS,G32470.TCGA-FT-A3EE-10A-01D-A202-08.3,G32470.TCGA-FT-A3EE-10A-01D-A202-08.3.bam,103.3,NA,0.08,58cfa82ee4b0c9d6adf6aa94,G32470.TCGA-FT-A3EE-10A-01D-A202-08.3.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FT-A3EE-10A,CCE62116-3DCD-400D-ADA0-9839CA02466E,Blood Derived Normal,Illumina HiSeq,406d7842-62f5-48ca-a4a5-297d47daa99d,Bladder,80,6DFC7EAC-19ED-4BBB-936A-9D4591C7C2B3,DB3BB39B-A1A6-49AF-AAE3-7CB489A724E4,TCGA-FT-A3EE-10A-01D-A202-08,HG19_Broad_variant,TCGA-FT-A3EE,TCGA-BLCA,99,s2855,Broad Institute of MIT and Harvard,BLN - University of Miami,United States,NO,T4a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82ee4b0c9d6adf6a7e6,58cfa82ee4b0c9d6adf6a7e6,G25774.TCGA-05-5429-01A-01D-1625-08.2.filtered.,WGS,G25774.TCGA-05-5429-01A-01D-1625-08.2,G25774.TCGA-05-5429-01A-01D-1625-08.2.bam,670.7,1.9,0.05,58cfa82ee4b0c9d6adf6a7e6,G25774.TCGA-05-5429-01A-01D-1625-08.2.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-5429-01A,63BD2175-4B7C-44C9-AEF3-9EFC8F79837B,Primary Tumor,Illumina HiSeq,5860c273-a773-4f6a-b5a1-a2999bc37419,Lung,60,FBC90B42-7D26-456B-A166-41993A1D3F0D,37D0CF1B-1743-4852-8073-372B16B5C17D,TCGA-05-5429-01A-01D-1625-08,HG19_Broad_variant,TCGA-05-5429,TCGA-LUAD,NA,s10632,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T3,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82de4b0c9d6adf6a73a,58cfa82de4b0c9d6adf6a73a,G14847.TCGA-05-4397-01A-01D-1931-08.6.filtered.,WGS,G14847.TCGA-05-4397-01A-01D-1931-08.6,G14847.TCGA-05-4397-01A-01D-1931-08.6.bam,573.23,1.9,0.14,58cfa82de4b0c9d6adf6a73a,G14847.TCGA-05-4397-01A-01D-1931-08.6.bam,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4397-01A,6DFD47D2-831A-4386-9051-F78199A16BB5,Primary Tumor,Illumina HiSeq,48ff480a-fd08-4db2-8ba6-ce90769d4811,Lung,65,C4C061CD-E926-400B-B18C-B47C234337CA,0B19BEE7-5281-4915-9D98-C20EB3E84ECF,TCGA-05-4397-01A-01D-1931-08,HG19_Broad_variant,TCGA-05-4397,TCGA-LUAD,731,s11424,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIB
13722.58cfa82ee4b0c9d6adf6aca4,58cfa82ee4b0c9d6adf6aca4,G41960.TCGA-55-6972-11A-01D-1945-08.1.filtered.,WGS,G41960.TCGA-55-6972-11A-01D-1945-08.1,G41960.TCGA-55-6972-11A-01D-1945-08.1.bam,244.7,NA,0.05,58cfa82ee4b0c9d6adf6aca4,G41960.TCGA-55-6972-11A-01D-1945-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-55-6972-11A,C4D1E105-28B7-48DF-ABEF-FBE09782FDB2,Solid Tissue Normal,Illumina HiSeq,03a2b1be-957a-46f6-afb1-88c725c5b5e6,Lung,72,650E21B6-138D-4B15-9551-A088695EF45F,32FE5A7B-6F0D-4245-86B9-35055CBD71F7,TCGA-55-6972-11A-01D-1945-08,HG19_Broad_variant,TCGA-55-6972,TCGA-LUAD,NA,s11114,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2,N0,Lung Papillary Adenocarcinoma,Stage IB
13722.58cfa82de4b0c9d6adf6a784,58cfa82de4b0c9d6adf6a784,G16922.TCGA-BP-5010-01A-02D-2048-08.1.filtered.,WGS,G16922.TCGA-BP-5010-01A-02D-2048-08.1,G16922.TCGA-BP-5010-01A-02D-2048-08.1.bam,227.73,1.9,0.14,58cfa82de4b0c9d6adf6a784,G16922.TCGA-BP-5010-01A-02D-2048-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-BP-5010-01A,9F5C0A43-D222-484A-9249-D288387DD7A1,Primary Tumor,Illumina HiSeq,5909062c-40ed-4237-b615-c18d204060eb,Kidney,63,4057D69A-52EF-451B-BD74-6436919970C9,A4F8305F-4409-4776-B34D-4878D18C8693,TCGA-BP-5010-01A-02D-2048-08,HG19_Broad_variant,TCGA-BP-5010,TCGA-KIRC,878,s8999,Broad Institute of MIT and Harvard,MSKCC,None,NO,T3a,N0,Kidney Clear Cell Renal Carcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6a818,58cfa82ee4b0c9d6adf6a818,G32547.TCGA-EE-A3JI-06A-11D-A21A-08.1.filtered.,WGS,G32547.TCGA-EE-A3JI-06A-11D-A21A-08.1,G32547.TCGA-EE-A3JI-06A-11D-A21A-08.1.bam,70.34,NA,0.08,58cfa82ee4b0c9d6adf6a818,G32547.TCGA-EE-A3JI-06A-11D-A21A-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A3JI-06A,296F44F9-3ECB-4B40-AE51-C3A06E3FBE00,Metastatic,Illumina HiSeq,08c367ce-bd24-4f82-b251-52ff2c640380,Skin,48,9CCF7218-B364-48A7-B0A4-354CCCAFAD07,0DD0718D-5DDF-4C59-8C47-0F51303DAEB5,TCGA-EE-A3JI-06A-11D-A21A-08,HG19_Broad_variant,TCGA-EE-A3JI,TCGA-SKCM,NA,s7304,Broad Institute of MIT and Harvard,University of Sydney,Australia,NO,T2,N0,Not available,Stage I
13722.58cfa83ce4b0c9d6adf72ec2,58cfa83ce4b0c9d6adf72ec2,cf3a026c76b42c90171b25f03c7b18ad.filtered.,WGS,cf3a026c76b42c90171b25f03c7b18ad,cf3a026c76b42c90171b25f03c7b18ad.bam,68.2,1.89,0.07,58cfa83ce4b0c9d6adf72ec2,cf3a026c76b42c90171b25f03c7b18ad.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A0CM-01A,EB2DBB4F-66B6-4525-8323-431970F7A64E,Primary Tumor,Illumina HiSeq,a6c27294-bf51-4eac-a2b6-885f5757b32b,Breast,40,EA7FB858-C17B-40D4-9A22-CBD9DA614B65,4B9CBBE5-CBD6-4CDE-853A-FA96A176E86D,TCGA-A2-A0CM-01A-31D-A128-09,GRCh37-lite,TCGA-A2-A0CM,TCGA-BRCA,754,s6255,Washington University School of Medicine,Walter Reed,None,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6ad90,58cfa82ee4b0c9d6adf6ad90,G39020.TCGA-BR-6564-10A-01D-1882-08.2.filtered.,WGS,G39020.TCGA-BR-6564-10A-01D-1882-08.2,G39020.TCGA-BR-6564-10A-01D-1882-08.2.bam,76,1.9,0.05,58cfa82ee4b0c9d6adf6ad90,G39020.TCGA-BR-6564-10A-01D-1882-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6564-10A,AF1086CC-B330-4AD6-AE1C-3B5C7259949A,Blood Derived Normal,Illumina HiSeq,8b88ec34-0f0a-4fe3-aa10-42a0ee7e46e5,Stomach,46,1819FA3B-E55C-4B4D-98C2-F0C4D98C7327,32051BBC-4E2D-46F1-8495-B126556AB3BD,TCGA-BR-6564-10A-01D-1882-08,HG19_Broad_variant,TCGA-BR-6564,TCGA-STAD,NA,s14601,Broad Institute of MIT and Harvard,Asterand,Russia,NO,T3,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA
13722.58cfa82ee4b0c9d6adf6affe,58cfa82ee4b0c9d6adf6affe,G49537.TCGA-EM-A3FL-10A-01D-A21A-08.2.filtered.,WGS,G49537.TCGA-EM-A3FL-10A-01D-A21A-08.2,G49537.TCGA-EM-A3FL-10A-01D-A21A-08.2.bam,37.32,NA,0.08,58cfa82ee4b0c9d6adf6affe,G49537.TCGA-EM-A3FL-10A-01D-A21A-08.2.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3FL-10A,CFDD2155-57A9-499C-92E1-FB82B577B050,Blood Derived Normal,Illumina HiSeq,5ceb9f4d-3ac5-4460-85be-9cf59606aea7,Thyroid,63,4DC15844-DF9B-4AA6-8E56-A5B967EF6545,EDBD0EE1-D300-4FBC-A490-29B3648FD480,TCGA-EM-A3FL-10A-01D-A21A-08,HG19_Broad_variant,TCGA-EM-A3FL,TCGA-THCA,NA,s12740,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T1b,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa82ee4b0c9d6adf6a9d8,58cfa82ee4b0c9d6adf6a9d8,G25252.TCGA-CV-7416-01A-11D-2334-08.1.filtered.,WGS,G25252.TCGA-CV-7416-01A-11D-2334-08.1,G25252.TCGA-CV-7416-01A-11D-2334-08.1.bam,242.7,NA,0.05,58cfa82ee4b0c9d6adf6a9d8,G25252.TCGA-CV-7416-01A-11D-2334-08.1.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7416-01A,96415324-6859-41EB-8D07-BE4E6F7D9781,Primary Tumor,Illumina HiSeq,1374c517-8c54-4a22-80e6-0f48eb1d4de6,Head and Neck,29,2E08CFFB-DA11-40A5-81AB-3B1BFFA5E2CE,2738B06F-155B-4CB8-983B-AD61D451E5AE,TCGA-CV-7416-01A-11D-2334-08,HG19_Broad_variant,TCGA-CV-7416,TCGA-HNSC,763,s15604,Broad Institute of MIT and Harvard,MD Anderson Cancer Center,United States,NO,T4a,Not available,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82ee4b0c9d6adf6aa16,58cfa82ee4b0c9d6adf6aa16,G26398.TCGA-06-5411-10A-01D-1696-08.2.filtered.,WGS,G26398.TCGA-06-5411-10A-01D-1696-08.2,G26398.TCGA-06-5411-10A-01D-1696-08.2.bam,75.33,1.9,0.05,58cfa82ee4b0c9d6adf6aa16,G26398.TCGA-06-5411-10A-01D-1696-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-5411-10A,3F960D3B-A58C-43D0-A8A4-F3555B399C9D,Blood Derived Normal,Illumina HiSeq,056c4096-ae33-4fe4-b2b8-770c8f8eb89d,Brain,51,06966748-4F99-4E84-A76F-41E2B181129F,0F88C693-5A30-43B1-BE9E-C96A791D984C,TCGA-06-5411-10A-01D-1696-08,HG19_Broad_variant,TCGA-06-5411,TCGA-GBM,254,s13891,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6ac12,58cfa82ee4b0c9d6adf6ac12,G39019.TCGA-DA-A3F5-10A-01D-A20D-08.2.filtered.,WGS,G39019.TCGA-DA-A3F5-10A-01D-A20D-08.2,G39019.TCGA-DA-A3F5-10A-01D-A20D-08.2.bam,47.46,NA,0.08,58cfa82ee4b0c9d6adf6ac12,G39019.TCGA-DA-A3F5-10A-01D-A20D-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A3F5-10A,D8EAC750-9DAF-4465-B672-9E31FD369057,Blood Derived Normal,Illumina HiSeq,ea9e834a-de7e-4891-b51f-6b0b0e4c362d,Skin,45,47E654E0-B92B-43E4-A784-299551D074EB,665797B6-021D-4CF4-8BE5-138DB70B1211,TCGA-DA-A3F5-10A-01D-A20D-08,HG19_Broad_variant,TCGA-DA-A3F5,TCGA-SKCM,NA,s7490,Broad Institute of MIT and Harvard,Yale,United States,NO,T1a,N0,Not available,Stage I
13722.58cfa830e4b0c9d6adf6ba64,58cfa830e4b0c9d6adf6ba64,TCGA-AA-A01T-11A-11D-A17O-10_wgs_Illumina.filtered.,WGS,TCGA-AA-A01T-11A-11D-A17O-10_wgs_Illumina,TCGA-AA-A01T-11A-11D-A17O-10_wgs_Illumina.bam,40.17,1.97,0.07,58cfa830e4b0c9d6adf6ba64,TCGA-AA-A01T-11A-11D-A17O-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01T-11A,F87C6DCC-1A9E-4DF5-962C-1F946E2611F8,Solid Tissue Normal,Illumina HiSeq,6b68f9db-81b4-46ed-8ace-d3a67c4a9015,Colorectal,63,4B1CA823-0752-4F67-AD05-70BDBCDC73B6,0F0244DA-FF83-480C-A0FF-B7A6557F6311,TCGA-AA-A01T-11A-11D-A17O-10,GRCh37-lite,TCGA-AA-A01T,TCGA-COAD,NA,s13526,Baylor College of Medicine,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6aa18,58cfa82ee4b0c9d6adf6aa18,G26362.TCGA-06-0157-01A-01D-1491-08.1.filtered.,WGS,G26362.TCGA-06-0157-01A-01D-1491-08.1,G26362.TCGA-06-0157-01A-01D-1491-08.1.bam,331.7,1.89,0.05,58cfa82ee4b0c9d6adf6aa18,G26362.TCGA-06-0157-01A-01D-1491-08.1.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0157-01A,EA3B5DA2-6A12-400C-BF0F-E442F5EC1132,Primary Tumor,Illumina HiSeq,a1c991b7-fe00-4252-815c-ac64d737bcff,Brain,63,BD8A1623-5006-4E03-9EB7-0C5A6F9E73D0,B1E62D8E-24D2-4118-8CD0-3142ACEBDD5B,TCGA-06-0157-01A-01D-1491-08,HG19_Broad_variant,TCGA-06-0157,TCGA-GBM,97,s14345,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6adc8,58cfa82ee4b0c9d6adf6adc8,G48125.TCGA-25-1632-10A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-25-1632-10A-01D-A312-08.2,G48125.TCGA-25-1632-10A-01D-A312-08.2.bam,43.3,1.88,0.09,58cfa82ee4b0c9d6adf6adc8,G48125.TCGA-25-1632-10A-01D-A312-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-25-1632-10A,C435627C-159D-4A6D-A819-30ABAC24BF4D,Blood Derived Normal,Illumina HiSeq,106ba200-8717-449b-9661-bdec1871a250,Ovary,68,DAB8EF24-6B31-4E24-A4F6-C43530BA9C95,42875701-4A11-4644-B57A-174BC4274019,TCGA-25-1632-10A-01D-A312-08,HG19_Broad_variant,TCGA-25-1632,TCGA-OV,1799,s17589,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aa40,58cfa82ee4b0c9d6adf6aa40,G26402.TCGA-06-2570-10A-01D-1495-08.1.filtered.,WGS,G26402.TCGA-06-2570-10A-01D-1495-08.1,G26402.TCGA-06-2570-10A-01D-1495-08.1.bam,120,1.9,0.05,58cfa82ee4b0c9d6adf6aa40,G26402.TCGA-06-2570-10A-01D-1495-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-2570-10A,B37D944C-C65C-46D6-BB8B-3EB37CB85B68,Blood Derived Normal,Illumina HiSeq,77f02364-41bf-40bd-b1db-7b5ee0760e38,Brain,21,E36E3BF5-C133-4297-ACCC-80C05C7F0AB3,ABEF86C9-DF6A-477E-99E9-B8D2AC0641D0,TCGA-06-2570-10A-01D-1495-08,HG19_Broad_variant,TCGA-06-2570,TCGA-GBM,NA,s14265,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6ad3f,58cfa82ee4b0c9d6adf6ad3f,G39020.TCGA-BR-8373-10A-01D-2341-08.3.filtered.,WGS,G39020.TCGA-BR-8373-10A-01D-2341-08.3,G39020.TCGA-BR-8373-10A-01D-2341-08.3.bam,446,NA,0.05,58cfa82ee4b0c9d6adf6ad3f,G39020.TCGA-BR-8373-10A-01D-2341-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-8373-10A,60879669-96C2-4710-82E0-0AE9D0E5B242,Blood Derived Normal,Illumina HiSeq,2828f4a2-a0e8-4b53-9320-de0ab5598e09,Stomach,65,3C4B847F-D8E6-4B2F-8856-5C440F040AAF,2C5CC2C4-1C45-478B-9575-8E0206BB7DE3,TCGA-BR-8373-10A-01D-2341-08,HG19_Broad_variant,TCGA-BR-8373,TCGA-STAD,NA,s14677,Broad Institute of MIT and Harvard,Asterand,Ukraine,NO,T4a,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa830e4b0c9d6adf6bdfc,58cfa830e4b0c9d6adf6bdfc,TCGA-AG-3582-10A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AG-3582-10A-01D-1989-10_wgs_Illumina,TCGA-AG-3582-10A-01D-1989-10_wgs_Illumina.bam,20,1.9,0.17,58cfa830e4b0c9d6adf6bdfc,TCGA-AG-3582-10A-01D-1989-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3582-10A,DB1E3104-8BFD-4353-854A-C478BA1F7D07,Blood Derived Normal,Illumina HiSeq,0e0791f1-6e83-4c6d-a329-9d669695606b,Colorectal,75,E948F2D0-E1BF-46FA-A0E0-A733036D3DA3,59765F45-8069-486F-8FAF-2E69EA1B99CD,TCGA-AG-3582-10A-01D-1989-10,GRCh37-lite,TCGA-AG-3582,TCGA-READ,NA,s2125,Baylor College of Medicine,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IV
13722.58cfa82de4b0c9d6adf6a656,58cfa82de4b0c9d6adf6a656,801434f25120f36fe582c7906500e08e.filtered.,WGS,801434f25120f36fe582c7906500e08e,801434f25120f36fe582c7906500e08e.bam,21.21,NA,0.08,58cfa82de4b0c9d6adf6a656,801434f25120f36fe582c7906500e08e.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A2-A3KC-01A,2D29A4AC-98E7-4663-9DD6-5681BC32AC2E,Primary Tumor,Illumina HiSeq,449d2c68-674e-4e86-89ff-574170845aa1,Breast,55,8318A9A4-E78E-4DB8-97C7-2CC733D0C512,F9F04E42-63A2-4EE1-ADE4-9E5BB5C20CDD,TCGA-A2-A3KC-01A-11D-A20S-09,GRCh37-lite,TCGA-A2-A3KC,TCGA-BRCA,NA,s5952,Washington University School of Medicine,Walter Reed,United States,NO,T2,N1a,Infiltrating Lobular Carcinoma,Stage IIB
13722.58cfa82ee4b0c9d6adf6ae43,58cfa82ee4b0c9d6adf6ae43,G49837.TCGA-96-7545-10A-01D-A320-08.2.filtered.,WGS,G49837.TCGA-96-7545-10A-01D-A320-08.2,G49837.TCGA-96-7545-10A-01D-A320-08.2.bam,371.3,NA,0.07,58cfa82ee4b0c9d6adf6ae43,G49837.TCGA-96-7545-10A-01D-A320-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-96-7545-10A,4CA13C92-84B4-4EDF-842A-B20B7E713415,Blood Derived Normal,Illumina HiSeq,83dae7a7-305d-42f1-91c4-6677813d9b51,Lung,73,789D87B2-59BB-49C8-B055-E2A917A4F018,1B32D5DF-080E-42DF-A725-DBB98659E5C1,TCGA-96-7545-10A-01D-A320-08,HG19_Broad_variant,TCGA-96-7545,TCGA-LUSC,NA,s10505,Broad Institute of MIT and Harvard,Washington University - NYU,United States,NO,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6ad45,58cfa82ee4b0c9d6adf6ad45,G49837.TCGA-66-2795-11A-01D-A320-08.4.filtered.,WGS,G49837.TCGA-66-2795-11A-01D-A320-08.4,G49837.TCGA-66-2795-11A-01D-A320-08.4.bam,20.88,1.9,0.07,58cfa82ee4b0c9d6adf6ad45,G49837.TCGA-66-2795-11A-01D-A320-08.4.bam,Alive,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-66-2795-11A,DA93A143-5799-4856-A5F4-3FF3B9284311,Solid Tissue Normal,Illumina HiSeq,0e7e3f2e-59ad-45ad-ab0d-6f8e4e73408b,Lung,68,77C32CCD-922C-4A88-A507-B7758CA9B61A,F4BC7FE0-D597-49AF-912D-30170020E4CF,TCGA-66-2795-11A-01D-A320-08,HG19_Broad_variant,TCGA-66-2795,TCGA-LUSC,NA,s10086,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T4,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIB
13722.58cfa831e4b0c9d6adf6c8f0,58cfa831e4b0c9d6adf6c8f0,TCGA-CV-7180-10A-01D-2266-10_Illumina.filtered.,WGS,TCGA-CV-7180-10A-01D-2266-10_Illumina,TCGA-CV-7180-10A-01D-2266-10_Illumina.bam,36,NA,0.05,58cfa831e4b0c9d6adf6c8f0,TCGA-CV-7180-10A-01D-2266-10_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7180-10A,D2CA9A4D-C14C-40C0-871C-88794A02E4AA,Blood Derived Normal,Illumina HiSeq,7a1bc885-10c7-42e5-9024-c742bde8c9cc,Head and Neck,34,406255B7-F269-4DC2-9EC2-E68809B66787,87255DF3-4E17-4CC4-A3CF-EA121E937D8F,TCGA-CV-7180-10A-01D-2266-10,GRCh37-lite,TCGA-CV-7180,TCGA-HNSC,327,s15649,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6a7ea,58cfa82ee4b0c9d6adf6a7ea,G23065.TCGA_BA_5153_01A_01D_2268_08.1.filtered.,WGS,G23065.TCGA_BA_5153_01A_01D_2268_08.1,G23065.TCGA_BA_5153_01A_01D_2268_08.1.bam,422.7,1.9,0.15,58cfa82ee4b0c9d6adf6a7ea,G23065.TCGA_BA_5153_01A_01D_2268_08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5153-01A,B3631718-9E0A-454C-BEE1-8F36EBC509D8,Primary Tumor,Illumina HiSeq,29740348-2de4-44e6-bdb0-05a2fb2fd9eb,Head and Neck,51,2DC7070A-9C70-4BB1-9634-8C934BB9C8D1,24D2B176-B1AB-4789-B394-616B722E63DF,TCGA-BA-5153-01A-01D-2268-08,HG19_Broad_variant,TCGA-BA-5153,TCGA-HNSC,1762,s15484,Broad Institute of MIT and Harvard,UNC,None,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ac7d,58cfa82ee4b0c9d6adf6ac7d,G41960.TCGA-78-7158-10A-01D-2036-08.2.filtered.,WGS,G41960.TCGA-78-7158-10A-01D-2036-08.2,G41960.TCGA-78-7158-10A-01D-2036-08.2.bam,97,NA,0.05,58cfa82ee4b0c9d6adf6ac7d,G41960.TCGA-78-7158-10A-01D-2036-08.2.bam,Dead,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-78-7158-10A,501C987E-D1EB-48A9-89EB-72A5062C90B4,Blood Derived Normal,Illumina HiSeq,492a4551-71af-44ec-bbaa-f7642fc42054,Lung,59,8D71845F-3C44-4E52-8E28-DDDEAA80E683,3F4BCED4-F89A-43D2-9C5F-6F9683897FA7,TCGA-78-7158-10A-01D-2036-08,HG19_Broad_variant,TCGA-78-7158,TCGA-LUAD,179,s10763,Broad Institute of MIT and Harvard,Prince Charles Hospital,Australia,NO,T4,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIB
13722.58cfa82ee4b0c9d6adf6ab7a,58cfa82ee4b0c9d6adf6ab7a,G37566.TCGA-G9-6365-10A-01D-1786-08.1.filtered.,WGS,G37566.TCGA-G9-6365-10A-01D-1786-08.1,G37566.TCGA-G9-6365-10A-01D-1786-08.1.bam,27.7,1.8,0.05,58cfa82ee4b0c9d6adf6ab7a,G37566.TCGA-G9-6365-10A-01D-1786-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6365-10A,6845076E-E940-4437-8618-81DB4A447544,Blood Derived Normal,Illumina HiSeq,f94671b2-56ab-469a-a7b4-48c721e6d420,Prostate,71,1668E387-F9EB-4301-9E72-9FDBDC521D45,BAB99CE8-A7BC-4637-9322-032EA79B8C23,TCGA-G9-6365-10A-01D-1786-08,HG19_Broad_variant,TCGA-G9-6365,TCGA-PRAD,NA,s3922,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T4,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82de4b0c9d6adf6a66e,58cfa82de4b0c9d6adf6a66e,7b7def1e9078a8087bb1b2791f5c4d57.filtered.,WGS,7b7def1e9078a8087bb1b2791f5c4d57,7b7def1e9078a8087bb1b2791f5c4d57.bam,75.7,2,0.08,58cfa82de4b0c9d6adf6a66e,7b7def1e9078a8087bb1b2791f5c4d57.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-E2-A15E-06A,0A2A3529-F645-4967-9A58-89EE20B8BB62,Metastatic,Illumina HiSeq,40ec35c7-b205-4778-a319-2be1d3eee9be,Breast,40,28462438-FE47-4880-82D9-EE43D534D8A3,DABB5A94-9706-4429-8DB0-C328E2004340,TCGA-E2-A15E-06A-11D-A19H-09,GRCh37-lite,TCGA-E2-A15E,TCGA-BRCA,NA,s5631,Washington University School of Medicine,Roswell Park,None,NO,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6a8ad,58cfa82ee4b0c9d6adf6a8ad,G26376.TCGA-27-2523-10A-01D-1494-08.1.filtered.,WGS,G26376.TCGA-27-2523-10A-01D-1494-08.1,G26376.TCGA-27-2523-10A-01D-1494-08.1.bam,614,1.9,0.05,58cfa82ee4b0c9d6adf6a8ad,G26376.TCGA-27-2523-10A-01D-1494-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-27-2523-10A,737B35E1-D668-4FCE-9B6E-76946C7952B6,Blood Derived Normal,Illumina HiSeq,603d7e33-6642-42f4-acb3-5b6f04a195f6,Brain,63,7D0DB5ED-70BF-4DFE-9357-1501A96ADDC4,28EA912E-E998-458C-879E-38D55938A2FB,TCGA-27-2523-10A-01D-1494-08,HG19_Broad_variant,TCGA-27-2523,TCGA-GBM,489,s13981,Broad Institute of MIT and Harvard,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf730e8,58cfa83ce4b0c9d6adf730e8,e05892d1ff93e157f1df1fbaf7b2de29.filtered.,WGS,e05892d1ff93e157f1df1fbaf7b2de29,e05892d1ff93e157f1df1fbaf7b2de29.bam,65.45,2.08,0.08,58cfa83ce4b0c9d6adf730e8,e05892d1ff93e157f1df1fbaf7b2de29.bam,Alive,FEMALE,Not available,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-EO-A1Y8-01A,DE4E13C8-5AD0-46D2-AE54-B9CA22B939D8,Primary Tumor,Illumina HiSeq,9346f0a9-a615-49bc-997e-3ef137b190b7,Uterus,87,5B0A8519-3FEA-46D6-8F6D-EC85C403B416,EA6EFCD1-11DE-45F0-8BDE-F1C06AD27E79,TCGA-EO-A1Y8-01A-11D-A159-09,GRCh37-lite,TCGA-EO-A1Y8,TCGA-UCEC,NA,s4401,Washington University School of Medicine,University Health Network,Canada,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6adf2,58cfa82ee4b0c9d6adf6adf2,G49837.TCGA-43-5670-10A-01D-A320-08.1.filtered.,WGS,G49837.TCGA-43-5670-10A-01D-A320-08.1,G49837.TCGA-43-5670-10A-01D-A320-08.1.bam,982.3,NA,0.08,58cfa82ee4b0c9d6adf6adf2,G49837.TCGA-43-5670-10A-01D-A320-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-43-5670-10A,7D905F8F-3967-4EA8-96C8-17B1B03FBEC3,Blood Derived Normal,Illumina HiSeq,99c88f94-9499-480c-ba5d-f94e5eb0f0e7,Lung,70,0F621065-6F8F-4F57-8676-4DD855F4B2ED,38F7CBDE-EA29-4DBA-BCA7-738EB868BCB9,TCGA-43-5670-10A-01D-A320-08,HG19_Broad_variant,TCGA-43-5670,TCGA-LUSC,NA,s10502,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,T2b,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa830e4b0c9d6adf6c013,58cfa830e4b0c9d6adf6c013,TCGA-B3-4103-10A-01D-1459-10_wgs_Illumina.filtered.,WGS,TCGA-B3-4103-10A-01D-1459-10_wgs_Illumina,TCGA-B3-4103-10A-01D-1459-10_wgs_Illumina.bam,146.13,1.9,0.05,58cfa830e4b0c9d6adf6c013,TCGA-B3-4103-10A-01D-1459-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B3-4103-10A,1A726069-0B44-42AD-9A20-0EE90B31796B,Blood Derived Normal,Illumina HiSeq,780c4cf8-efca-450d-b146-d3f4bf73ca41,Kidney,56,FC268FC2-BE99-4307-86A5-E090AFEE70EF,76B6C767-1230-46FA-8CFD-C128F0B580E0,TCGA-B3-4103-10A-01D-1459-10,GRCh37-lite,TCGA-B3-4103,TCGA-KIRP,NA,s11646,Baylor College of Medicine,Christiana Healthcare,None,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa82de4b0c9d6adf6a728,58cfa82de4b0c9d6adf6a728,G14857.TCGA-73-4666-01A-01D-1931-08.4.filtered.,WGS,G14857.TCGA-73-4666-01A-01D-1931-08.4,G14857.TCGA-73-4666-01A-01D-1931-08.4.bam,375.23,1.9,0.16,58cfa82de4b0c9d6adf6a728,G14857.TCGA-73-4666-01A-01D-1931-08.4.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4666-01A,4C31127E-D095-4978-9DAC-35153C27F6ED,Primary Tumor,Illumina HiSeq,16906318-0783-402c-9f2c-b8e22348748c,Lung,52,5BAE2E45-6DBC-458C-A66F-702EB1AF7357,9FFCB7FA-424C-4F93-87A7-CE5E9053C613,TCGA-73-4666-01A-01D-1931-08,HG19_Broad_variant,TCGA-73-4666,TCGA-LUAD,NA,s10758,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IV
13722.58cfa82ee4b0c9d6adf6aa70,58cfa82ee4b0c9d6adf6aa70,G25778.TCGA-05-4396-10A-01D-1855-08.2.filtered.,WGS,G25778.TCGA-05-4396-10A-01D-1855-08.2,G25778.TCGA-05-4396-10A-01D-1855-08.2.bam,73,1.9,0.05,58cfa82ee4b0c9d6adf6aa70,G25778.TCGA-05-4396-10A-01D-1855-08.2.bam,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4396-10A,9F81C602-8AFA-4588-B0B6-6E5A1A128D5A,Blood Derived Normal,Illumina HiSeq,09cacbbd-7331-443c-8ac0-78a0778344b5,Lung,76,329954AA-6B53-4356-9429-09DD91CEA2C5,1F8820D1-4A97-41B7-A4D8-BE832C9E0575,TCGA-05-4396-10A-01D-1855-08,HG19_Broad_variant,TCGA-05-4396,TCGA-LUAD,303,s10630,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T4,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIIB
13722.58cfa82ee4b0c9d6adf6aae2,58cfa82ee4b0c9d6adf6aae2,G32534.TCGA-DJ-A3US-10A-01D-A22D-08.2.filtered.,WGS,G32534.TCGA-DJ-A3US-10A-01D-A22D-08.2,G32534.TCGA-DJ-A3US-10A-01D-A22D-08.2.bam,14.21,NA,0.08,58cfa82ee4b0c9d6adf6aae2,G32534.TCGA-DJ-A3US-10A-01D-A22D-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A3US-10A,6EE95DC8-2BAC-4691-AFA2-8222E07506AD,Blood Derived Normal,Illumina HiSeq,9f8905dd-43d5-4299-bd1e-57a1e27e7835,Thyroid,37,D03234D9-E9FC-4B55-B516-00985999A1B3,23AA8B80-6356-479F-BEAE-D06AA7D895DC,TCGA-DJ-A3US-10A-01D-A22D-08,HG19_Broad_variant,TCGA-DJ-A3US,TCGA-THCA,NA,s12338,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82ee4b0c9d6adf6aade,58cfa82ee4b0c9d6adf6aade,G32461.TCGA-BT-A3PJ-01A-21D-A21Z-08.1.filtered.,WGS,G32461.TCGA-BT-A3PJ-01A-21D-A21Z-08.1,G32461.TCGA-BT-A3PJ-01A-21D-A21Z-08.1.bam,55.89,NA,0.07,58cfa82ee4b0c9d6adf6aade,G32461.TCGA-BT-A3PJ-01A-21D-A21Z-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A3PJ-01A,CB664EEF-BE6F-44EF-AA90-6F6DA0E6440A,Primary Tumor,Illumina HiSeq,d7aa3a92-c61a-478e-af73-14d0204cba5d,Bladder,76,29D79B83-FA80-490E-A8A1-C51C9AD061FE,B73523D7-F5A5-4140-8537-4DF4D1ECF465,TCGA-BT-A3PJ-01A-21D-A21Z-08,HG19_Broad_variant,TCGA-BT-A3PJ,TCGA-BLCA,NA,s3071,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3a,N3,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82ee4b0c9d6adf6accd,58cfa82ee4b0c9d6adf6accd,G39020.TCGA-D7-5579-10A-01D-1600-08.2.filtered.,WGS,G39020.TCGA-D7-5579-10A-01D-1600-08.2,G39020.TCGA-D7-5579-10A-01D-1600-08.2.bam,181.4,1.9,0.05,58cfa82ee4b0c9d6adf6accd,G39020.TCGA-D7-5579-10A-01D-1600-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-5579-10A,8B5746F9-DBEE-40BD-9141-1081960CF286,Blood Derived Normal,Illumina HiSeq,8b977c83-d20d-444a-b2a9-4c28ec06597c,Stomach,74,A6AE07DC-A946-4D82-BF8D-F1837CFF3D1F,865F246B-0E3F-46B7-8112-6C1475198B42,TCGA-D7-5579-10A-01D-1600-08,HG19_Broad_variant,TCGA-D7-5579,TCGA-STAD,NA,s15370,Broad Institute of MIT and Harvard,Greater Poland Cancer Center,Poland,NO,T3,N2,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage IIIA
13722.58cfa82ee4b0c9d6adf6aa12,58cfa82ee4b0c9d6adf6aa12,G26396.TCGA-41-5651-01A-01D-1696-08.1.filtered.,WGS,G26396.TCGA-41-5651-01A-01D-1696-08.1,G26396.TCGA-41-5651-01A-01D-1696-08.1.bam,350.03,1.9,0.05,58cfa82ee4b0c9d6adf6aa12,G26396.TCGA-41-5651-01A-01D-1696-08.1.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-41-5651-01A,C184C3CA-7AD3-4202-B108-CB9FD5F5D947,Primary Tumor,Illumina HiSeq,cdec514c-a32f-496a-81c5-cde0ec0a3b5c,Brain,59,90F74516-FB74-4D3F-9D73-5D2BEE2ED381,5FD77BA9-5015-4D8B-86A0-582E5C76BDD6,TCGA-41-5651-01A-01D-1696-08,HG19_Broad_variant,TCGA-41-5651,TCGA-GBM,NA,s14304,Broad Institute of MIT and Harvard,Christiana Healthcare,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6a8c4,58cfa82ee4b0c9d6adf6a8c4,G35154.TCGA-E1-5318-01A-01D-1468-08.1.filtered.,WGS,G35154.TCGA-E1-5318-01A-01D-1468-08.1,G35154.TCGA-E1-5318-01A-01D-1468-08.1.bam,161,1.9,0.05,58cfa82ee4b0c9d6adf6a8c4,G35154.TCGA-E1-5318-01A-01D-1468-08.1.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-E1-5318-01A,400B2FA3-BAF7-4BAA-99B4-88B9F25B5049,Primary Tumor,Illumina HiSeq,0fc8cc9a-c3ea-48d6-8f7d-18ab9b69ffb1,Brain,42,EDC32A96-F912-4348-80D4-72D08129DB53,8C46A1DF-1C10-4188-992A-A55B782494C9,TCGA-E1-5318-01A-01D-1468-08,HG19_Broad_variant,TCGA-E1-5318,TCGA-LGG,2379,s8326,Broad Institute of MIT and Harvard,Duke,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6aca2,58cfa82ee4b0c9d6adf6aca2,G48125.TCGA-13-0906-10A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-13-0906-10A-01D-A312-08.2,G48125.TCGA-13-0906-10A-01D-A312-08.2.bam,41.97,1.8,0.08,58cfa82ee4b0c9d6adf6aca2,G48125.TCGA-13-0906-10A-01D-A312-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0906-10A,E43D3769-E25F-4FB7-9080-EA26DEFAF094,Blood Derived Normal,Illumina HiSeq,a700cfa3-bfbc-488c-8e17-1cbe431267b6,Ovary,50,0A0DE14F-F9EA-44CE-AD92-836F43EF7908,D0E9F796-7D42-470A-A380-9337106A45FC,TCGA-13-0906-10A-01D-A312-08,HG19_Broad_variant,TCGA-13-0906,TCGA-OV,NA,s17410,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a908,58cfa82ee4b0c9d6adf6a908,G32553.TCGA-ER-A19E-06A-11D-A197-08.1.filtered.,WGS,G32553.TCGA-ER-A19E-06A-11D-A197-08.1,G32553.TCGA-ER-A19E-06A-11D-A197-08.1.bam,30.72,NA,0.08,58cfa82ee4b0c9d6adf6a908,G32553.TCGA-ER-A19E-06A-11D-A197-08.1.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19E-06A,3FEA3F02-2DB3-44E0-984E-C61130D92C9B,Metastatic,Illumina HiSeq,9e66241c-200c-49d5-9ea4-bbb6bbd92753,Skin,36,96BB672C-48FB-4AAE-9FA5-7CEAF98E5348,54A77010-2F16-4DA9-8CA0-746A51801A00,TCGA-ER-A19E-06A-11D-A197-08,HG19_Broad_variant,TCGA-ER-A19E,TCGA-SKCM,396,s7987,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2a,N0,Not available,Stage IB
13722.58cfa82ee4b0c9d6adf6a976,58cfa82ee4b0c9d6adf6a976,G32554.TCGA-FS-A1ZK-10A-01D-A199-08.1.filtered.,WGS,G32554.TCGA-FS-A1ZK-10A-01D-A199-08.1,G32554.TCGA-FS-A1ZK-10A-01D-A199-08.1.bam,50.13,NA,0.08,58cfa82ee4b0c9d6adf6a976,G32554.TCGA-FS-A1ZK-10A-01D-A199-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZK-10A,1404791B-86BF-4DFD-85B4-C8FF356F109C,Blood Derived Normal,Illumina HiSeq,99af9f9f-fd5f-41ce-8394-6d9210c013a8,Skin,68,9F006B7F-4BE8-423E-86C6-36EF71215C9F,8BB3517F-9E54-4272-A6C2-A7B8E8CC567D,TCGA-FS-A1ZK-10A-01D-A199-08,HG19_Broad_variant,TCGA-FS-A1ZK,TCGA-SKCM,728,s7986,Broad Institute of MIT and Harvard,Essen,Germany,NO,T4,N0,Not available,Stage II
13722.58cfa82ee4b0c9d6adf6aac0,58cfa82ee4b0c9d6adf6aac0,G25783.TCGA-55-6986-11A-01D-1945-08.2.filtered.,WGS,G25783.TCGA-55-6986-11A-01D-1945-08.2,G25783.TCGA-55-6986-11A-01D-1945-08.2.bam,325,NA,0.05,58cfa82ee4b0c9d6adf6aac0,G25783.TCGA-55-6986-11A-01D-1945-08.2.bam,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-55-6986-11A,028E99E9-5B9A-4954-BB6E-6D4709A3CEA8,Solid Tissue Normal,Illumina HiSeq,f1b91760-f564-4921-a6ff-13403a3c0b19,Lung,74,E8E0E53A-4009-4141-BA6F-EED35FCAAD7B,2D60408F-5A74-4CD1-A27E-168D1D3379E6,TCGA-55-6986-11A-01D-1945-08,HG19_Broad_variant,TCGA-55-6986,TCGA-LUAD,NA,s10631,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2,N0,Lung Bronchioloalveolar Carcinoma Nonmucinous,Stage IB
13722.58cfa82ee4b0c9d6adf6b191,58cfa82ee4b0c9d6adf6b191,TCGA-13-0725-01A-01D-0465-08_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-13-0725-01A-01D-0465-08_IlluminaGA-DNASeq_whole,TCGA-13-0725-01A-01D-0465-08_IlluminaGA-DNASeq_whole.bam,200.64,1.9,0.17,58cfa82ee4b0c9d6adf6b191,TCGA-13-0725-01A-01D-0465-08_IlluminaGA-DNASeq_whole.bam,Dead,FEMALE,WHITE,HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0725-01A,446CE2A3-D328-443C-A419-3344BAAD0E16,Primary Tumor,Illumina GA,f5664f55-2c18-495b-8653-d54bdd67b6d5,Ovary,44,4A52777F-E23F-49F8-B853-BE84B9A74BDA,BEFA4CAE-378E-4502-8C0B-399D8FA083D9,TCGA-13-0725-01A-01D-0465-08,HG18_Broad_variant,TCGA-13-0725,TCGA-OV,377,s17149,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c658,58cfa831e4b0c9d6adf6c658,TCGA-CR-5249-10A-01D-2276-10_Illumina.filtered.,WGS,TCGA-CR-5249-10A-01D-2276-10_Illumina,TCGA-CR-5249-10A-01D-2276-10_Illumina.bam,12.73,1.9,0.05,58cfa831e4b0c9d6adf6c658,TCGA-CR-5249-10A-01D-2276-10_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-5249-10A,C7DF3466-B9A7-4818-883B-D0CD08483570,Blood Derived Normal,Illumina HiSeq,6a1956ba-8f1c-4504-86e4-1395788b83ff,Head and Neck,35,B72390D2-F19E-493D-9A30-CD81DD232188,4070818B-1918-4D2A-BEB7-98B752D51A8D,TCGA-CR-5249-10A-01D-2276-10,GRCh37-lite,TCGA-CR-5249,TCGA-HNSC,NA,s16332,Baylor College of Medicine,Vanderbilt University,None,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6ac34,58cfa82ee4b0c9d6adf6ac34,G39020.TCGA-BR-4280-01A-01D-A290-08.1.filtered.,WGS,G39020.TCGA-BR-4280-01A-01D-A290-08.1,G39020.TCGA-BR-4280-01A-01D-A290-08.1.bam,252.9,1.9,0.07,58cfa82ee4b0c9d6adf6ac34,G39020.TCGA-BR-4280-01A-01D-A290-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4280-01A,E0916597-E489-45EF-A8F7-653A3C6591EF,Primary Tumor,Illumina HiSeq,82a3e711-b833-4607-8007-dd29e00eea85,Stomach,78,797D2D3A-F01C-4985-B27C-4E4C2838D34D,388A8875-C3F5-494E-8456-28BE8D3626E1,TCGA-BR-4280-01A-01D-A290-08,HG19_Broad_variant,TCGA-BR-4280,TCGA-STAD,NA,s14679,Broad Institute of MIT and Harvard,Asterand,Russia,NO,T2b,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage III
13722.58cfa82ee4b0c9d6adf6ab1a,58cfa82ee4b0c9d6adf6ab1a,G32530.TCGA-EM-A3AQ-10A-01D-A20C-08.1.filtered.,WGS,G32530.TCGA-EM-A3AQ-10A-01D-A20C-08.1,G32530.TCGA-EM-A3AQ-10A-01D-A20C-08.1.bam,63.26,NA,0.07,58cfa82ee4b0c9d6adf6ab1a,G32530.TCGA-EM-A3AQ-10A-01D-A20C-08.1.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3AQ-10A,E8F56D0F-EEE4-4DEF-A43A-DEC91F4382A1,Blood Derived Normal,Illumina HiSeq,4b8e7cdf-61d4-47f5-b8dc-ba6b790145c3,Thyroid,85,E84F9FA2-E742-448B-9890-B4692E19CEAE,E20E9F74-04BD-477E-A3F6-4E2CCEB6D41E,TCGA-EM-A3AQ-10A-01D-A20C-08,HG19_Broad_variant,TCGA-EM-A3AQ,TCGA-THCA,NA,s12735,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T1b,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa832e4b0c9d6adf6d330,58cfa832e4b0c9d6adf6d330,TCGA-KN-8418-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8418-11A-01D-2310-10_wgs_Illumina,TCGA-KN-8418-11A-01D-2310-10_wgs_Illumina.bam,246.3,NA,0.05,58cfa832e4b0c9d6adf6d330,TCGA-KN-8418-11A-01D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KN-8418-11A,F3BA1CF8-AC67-4DA8-96F3-8680DC55F247,Solid Tissue Normal,Illumina HiSeq,3ce60fac-c468-43fe-b00d-b10e782ecbaa,Kidney,41,CA13504F-A309-43F4-BF7E-E85FB4E74942,3FD6A085-BD95-4632-AF35-79F1BA65FE96,TCGA-KN-8418-11A-01D-2310-10,GRCh37-lite,TCGA-KN-8418,TCGA-KICH,NA,s16529,Baylor College of Medicine,Harvard,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa82ee4b0c9d6adf6aed6,58cfa82ee4b0c9d6adf6aed6,G49537.TCGA-DE-A0Y3-10A-01D-A10S-08.2.filtered.,WGS,G49537.TCGA-DE-A0Y3-10A-01D-A10S-08.2,G49537.TCGA-DE-A0Y3-10A-01D-A10S-08.2.bam,23.61,1.93,0.08,58cfa82ee4b0c9d6adf6aed6,G49537.TCGA-DE-A0Y3-10A-01D-A10S-08.2.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DE-A0Y3-10A,C31B3ADF-3FC6-4A72-83B0-BBC0F295B5E7,Blood Derived Normal,Illumina HiSeq,c55e8686-42ff-4301-86a3-c529414481e3,Thyroid,60,2B40DE55-0CBB-44D8-A26F-B48448B32354,22898CC2-01F2-4E03-A2A5-A4C6F9F836CE,TCGA-DE-A0Y3-10A-01D-A10S-08,HG19_Broad_variant,TCGA-DE-A0Y3,TCGA-THCA,NA,s12502,Broad Institute of MIT and Harvard,University of North Carolina,United States,NO,T4a,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVC
13722.58cfa82ee4b0c9d6adf6ace4,58cfa82ee4b0c9d6adf6ace4,G39020.TCGA-CG-4443-10A-01D-A290-08.2.filtered.,WGS,G39020.TCGA-CG-4443-10A-01D-A290-08.2,G39020.TCGA-CG-4443-10A-01D-A290-08.2.bam,80.9,1.9,0.08,58cfa82ee4b0c9d6adf6ace4,G39020.TCGA-CG-4443-10A-01D-A290-08.2.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4443-10A,8CB0144B-BE6B-40A1-86A2-708F96D9B615,Blood Derived Normal,Illumina HiSeq,da94bd95-a2f8-436a-8738-831e4e1ba8b7,Stomach,68,5F5EB83F-C6C8-409B-A8CE-89AF811FE35E,55A4A6B2-6CD9-4606-84EC-FCF9A313FA12,TCGA-CG-4443-10A-01D-A290-08,HG19_Broad_variant,TCGA-CG-4443,TCGA-STAD,NA,s15095,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T1,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6aeba,58cfa82ee4b0c9d6adf6aeba,G39020.TCGA-BR-7722-10A-01D-2201-08.1.filtered.,WGS,G39020.TCGA-BR-7722-10A-01D-2201-08.1,G39020.TCGA-BR-7722-10A-01D-2201-08.1.bam,280.3,NA,0.05,58cfa82ee4b0c9d6adf6aeba,G39020.TCGA-BR-7722-10A-01D-2201-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-7722-10A,8D3E3D09-BC61-4D5E-B8D6-5AEE6CB488AE,Blood Derived Normal,Illumina HiSeq,ebf8678a-8dcf-4977-8266-e030e89a984a,Stomach,62,41A47D10-0FE9-4A73-9ECD-435BF8F4DACA,1FD04123-DBAA-4C8C-9C89-B9CB1A30C14C,TCGA-BR-7722-10A-01D-2201-08,HG19_Broad_variant,TCGA-BR-7722,TCGA-STAD,NA,s15294,Broad Institute of MIT and Harvard,Asterand,Ukraine,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6aace,58cfa82ee4b0c9d6adf6aace,G26390.TCGA-06-0214-10A-01D-1491-08.1.filtered.,WGS,G26390.TCGA-06-0214-10A-01D-1491-08.1,G26390.TCGA-06-0214-10A-01D-1491-08.1.bam,14.9,1.9,0.05,58cfa82ee4b0c9d6adf6aace,G26390.TCGA-06-0214-10A-01D-1491-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0214-10A,9853C6BB-A42C-4698-ABE5-F3C897EBC8F6,Blood Derived Normal,Illumina HiSeq,9d943044-5011-4340-8eea-af69168bb22b,Brain,66,D067A643-8E8B-4E86-8186-582FC140F744,FC3F70C0-3E8F-4146-A308-8A71CB1031A0,TCGA-06-0214-10A-01D-1491-08,HG19_Broad_variant,TCGA-06-0214,TCGA-GBM,457,s14372,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6aab6,58cfa82ee4b0c9d6adf6aab6,G32450.TCGA-FD-A3N5-01A-11D-A21A-08.3.filtered.,WGS,G32450.TCGA-FD-A3N5-01A-11D-A21A-08.3,G32450.TCGA-FD-A3N5-01A-11D-A21A-08.3.bam,30.45,NA,0.08,58cfa82ee4b0c9d6adf6aab6,G32450.TCGA-FD-A3N5-01A-11D-A21A-08.3.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3N5-01A,A658BECF-3934-49F2-9E74-291DCA61D4BB,Primary Tumor,Illumina HiSeq,3519f8d9-0eab-45e8-b398-5ddc469243cd,Bladder,69,66559B5F-AB2F-406B-9EDB-0F5085EEC7C5,418A3DEC-96FF-4719-BECB-E1A8260CCE2F,TCGA-FD-A3N5-01A-11D-A21A-08,HG19_Broad_variant,TCGA-FD-A3N5,TCGA-BLCA,NA,s2677,Broad Institute of MIT and Harvard,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa82ee4b0c9d6adf6aad8,58cfa82ee4b0c9d6adf6aad8,G25773.TCGA-75-5147-10A-01D-1625-08.2.filtered.,WGS,G25773.TCGA-75-5147-10A-01D-1625-08.2,G25773.TCGA-75-5147-10A-01D-1625-08.2.bam,46.4,1.9,0.05,58cfa82ee4b0c9d6adf6aad8,G25773.TCGA-75-5147-10A-01D-1625-08.2.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-5147-10A,D2824E6D-3784-45C2-9B0F-52B17356B5DA,Blood Derived Normal,Illumina HiSeq,31e5136c-8e36-4019-8f00-1cab1d4a9303,Lung,NA,C6EB2230-098B-4B50-85F5-1CDDFB1FB9A3,84C16359-C463-43B1-BF74-0C47A4A57BDD,TCGA-75-5147-10A-01D-1625-08,HG19_Broad_variant,TCGA-75-5147,TCGA-LUAD,NA,s11428,Broad Institute of MIT and Harvard,Ontario Institute for Cancer Research (OICR),Canada,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82de4b0c9d6adf6a572,58cfa82de4b0c9d6adf6a572,29d8acadae6e2c6643400b1090ef29f2.filtered.,WGS,29d8acadae6e2c6643400b1090ef29f2,29d8acadae6e2c6643400b1090ef29f2.bam,61.59,1.88,0.08,58cfa82de4b0c9d6adf6a572,29d8acadae6e2c6643400b1090ef29f2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-A1-A0SM-01A,784DE7AC-8424-42EB-83D4-A1BEBAA42B97,Primary Tumor,Illumina HiSeq,d1b482b0-0e66-4620-bc89-bfc93541735d,Breast,77,289F5433-4834-401F-9361-EFC8E883E630,546B982F-60D9-43DF-9761-09369AFBEE2D,TCGA-A1-A0SM-01A-11D-A19H-09,GRCh37-lite,TCGA-A1-A0SM,TCGA-BRCA,NA,s6111,Washington University School of Medicine,UCSF,United States,NO,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6addb,58cfa82ee4b0c9d6adf6addb,G49538.TCGA-19-1389-10D-01D-2364-08.1.filtered.,WGS,G49538.TCGA-19-1389-10D-01D-2364-08.1,G49538.TCGA-19-1389-10D-01D-2364-08.1.bam,5,NA,0.05,58cfa82ee4b0c9d6adf6addb,G49538.TCGA-19-1389-10D-01D-2364-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-19-1389-10D,309005A2-93A8-4566-B8D3-6B9310144266,Blood Derived Normal,Illumina HiSeq,807c7d59-77b4-428a-9c10-7bb7f24b43b6,Brain,51,4B511D1F-F753-4D9B-B47B-FCA98B8D3E03,1AF2E986-70D4-4F60-A52B-134678FE5CEE,TCGA-19-1389-10D-01D-2364-08,HG19_Broad_variant,TCGA-19-1389,TCGA-GBM,141,s14093,Broad Institute of MIT and Harvard,Case Western,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6bb2c,58cfa830e4b0c9d6adf6bb2c,TCGA-AA-A01R-11A-12D-A17O-10_wgs_Illumina.filtered.,WGS,TCGA-AA-A01R-11A-12D-A17O-10_wgs_Illumina,TCGA-AA-A01R-11A-12D-A17O-10_wgs_Illumina.bam,76.75,1.9,0.08,58cfa830e4b0c9d6adf6bb2c,TCGA-AA-A01R-11A-12D-A17O-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01R-11A,97F6C8D3-09A0-4128-8F10-41E736648A5F,Solid Tissue Normal,Illumina HiSeq,1723023a-cdaf-405c-bbf3-0204af2130c8,Colorectal,47,D19B4EE7-CBA4-491B-8764-99AC49304AD5,54523AC8-0DD8-4256-B33E-F0A802FEE3E8,TCGA-AA-A01R-11A-12D-A17O-10,GRCh37-lite,TCGA-AA-A01R,TCGA-COAD,NA,s13383,Baylor College of Medicine,Indivumed,Germany,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage III
13722.58cfa82de4b0c9d6adf6a721,58cfa82de4b0c9d6adf6a721,G14858.TCGA-73-4659-11A-01D-1931-08.2.filtered.,WGS,G14858.TCGA-73-4659-11A-01D-1931-08.2,G14858.TCGA-73-4659-11A-01D-1931-08.2.bam,274.3,1.9,0.16,58cfa82de4b0c9d6adf6a721,G14858.TCGA-73-4659-11A-01D-1931-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4659-11A,CD0DC947-B708-464E-BEB7-954C9D4583E7,Solid Tissue Normal,Illumina HiSeq,f6587098-0071-4ecd-b925-ff4145189b87,Lung,66,C3A0A2B9-B84B-48DF-BE21-1B2D9EBC7955,026E2AC2-AAA9-46BC-864A-37E1361EA3B1,TCGA-73-4659-11A-01D-1931-08,HG19_Broad_variant,TCGA-73-4659,TCGA-LUAD,711,s11103,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82de4b0c9d6adf6a714,58cfa82de4b0c9d6adf6a714,G14854.TCGA-38-4628-11A-01D-1931-08.6.filtered.,WGS,G14854.TCGA-38-4628-11A-01D-1931-08.6,G14854.TCGA-38-4628-11A-01D-1931-08.6.bam,97.53,1.9,0.15,58cfa82de4b0c9d6adf6a714,G14854.TCGA-38-4628-11A-01D-1931-08.6.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-38-4628-11A,CC4BD56A-25C5-4C48-B583-AC3AEB778CA6,Solid Tissue Normal,Illumina HiSeq,eb3c2eef-32ad-4303-bb2d-a79c9e8fe7d5,Lung,65,CB638069-0750-4BA1-BB4E-A2EE25DCA5FF,A2329DED-D2C0-4AFE-A9DA-A9E29C728C15,TCGA-38-4628-11A-01D-1931-08,HG19_Broad_variant,TCGA-38-4628,TCGA-LUAD,1492,s11316,Broad Institute of MIT and Harvard,UNC,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa830e4b0c9d6adf6bfbe,58cfa830e4b0c9d6adf6bfbe,TCGA-B3-3925-10A-01D-1459-10_wgs_Illumina.filtered.,WGS,TCGA-B3-3925-10A-01D-1459-10_wgs_Illumina,TCGA-B3-3925-10A-01D-1459-10_wgs_Illumina.bam,93,1.9,0.05,58cfa830e4b0c9d6adf6bfbe,TCGA-B3-3925-10A-01D-1459-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B3-3925-10A,75A53BFF-BF0F-4AD8-9B8E-14A27914D4F2,Blood Derived Normal,Illumina HiSeq,bb27d7f2-24b0-40ba-89dc-2980c52b76fb,Kidney,52,C9F8164F-F913-40ED-A31A-75A3D0786AF4,480372C8-A5F8-42FF-8F66-75B98634F9B3,TCGA-B3-3925-10A-01D-1459-10,GRCh37-lite,TCGA-B3-3925,TCGA-KIRP,NA,s11583,Baylor College of Medicine,Christiana Healthcare,None,NO,T3a,NX,Kidney Papillary Renal Cell Carcinoma,Stage III
13722.58cfa82de4b0c9d6adf6a59d,58cfa82de4b0c9d6adf6a59d,6507fcb7033a99eba7d09d1768996237.filtered.,WGS,6507fcb7033a99eba7d09d1768996237,6507fcb7033a99eba7d09d1768996237.bam,128.45,2.03,0.08,58cfa82de4b0c9d6adf6a59d,6507fcb7033a99eba7d09d1768996237.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0L8-01A,9AA8C2B4-DB32-4899-BF0C-D578CB175E90,Primary Tumor,Illumina HiSeq,13a692ca-4d87-484b-aec0-1562b201470f,Uterus,70,D1A7A58F-7A35-4A94-A337-051AE56DED00,15D597DE-D26C-4CE1-B0CB-077E39B55F30,TCGA-AP-A0L8-01A-11D-A066-09,GRCh37-lite,TCGA-AP-A0L8,TCGA-UCEC,1484,s5378,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aa74,58cfa82ee4b0c9d6adf6aa74,G32550.TCGA-EE-A3J5-06A-11D-A20D-08.2.filtered.,WGS,G32550.TCGA-EE-A3J5-06A-11D-A20D-08.2,G32550.TCGA-EE-A3J5-06A-11D-A20D-08.2.bam,42.57,NA,0.08,58cfa82ee4b0c9d6adf6aa74,G32550.TCGA-EE-A3J5-06A-11D-A20D-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A3J5-06A,D6283AB0-9019-4AD2-93AA-2E6B39CD9641,Metastatic,Illumina HiSeq,5cbf3199-cbc6-4578-9d34-210fbc92a3f1,Skin,71,5F915D13-4C74-43A6-BCDD-D0B1596E817F,B07BAD52-D44C-4B27-900A-960985BFADEC,TCGA-EE-A3J5-06A-11D-A20D-08,HG19_Broad_variant,TCGA-EE-A3J5,TCGA-SKCM,1124,s7478,Broad Institute of MIT and Harvard,University of Sydney,Australia,NO,T4a,N1,Not available,Stage III
13722.58cfa82ee4b0c9d6adf6aeec,58cfa82ee4b0c9d6adf6aeec,G48125.TCGA-13-1491-10A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-13-1491-10A-01D-A312-08.2,G48125.TCGA-13-1491-10A-01D-A312-08.2.bam,48.27,1.8,0.08,58cfa82ee4b0c9d6adf6aeec,G48125.TCGA-13-1491-10A-01D-A312-08.2.bam,Dead,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-1491-10A,C8FEBEEF-8E7E-459E-88CB-8086692DC559,Blood Derived Normal,Illumina HiSeq,ae80f37b-1bd5-4f4b-af65-a233fc3c2686,Ovary,55,4E49DEA2-0C46-4431-843C-25A706869CDA,52DD48D5-5EA8-4FC7-B11C-8C3BA30379B9,TCGA-13-1491-10A-01D-A312-08,HG19_Broad_variant,TCGA-13-1491,TCGA-OV,1595,s17115,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6af38,58cfa82ee4b0c9d6adf6af38,G48125.TCGA-09-2050-10A-01D-A312-08.1.filtered.,WGS,G48125.TCGA-09-2050-10A-01D-A312-08.1,G48125.TCGA-09-2050-10A-01D-A312-08.1.bam,52.27,1.8,0.08,58cfa82ee4b0c9d6adf6af38,G48125.TCGA-09-2050-10A-01D-A312-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-09-2050-10A,3C037ACF-F453-4513-A6DD-129163DDDE2A,Blood Derived Normal,Illumina HiSeq,f1580a69-43db-42d6-a2d0-260c67584092,Ovary,65,A52263B0-156F-49D8-8BB9-7E07F2665E64,8EBCAFA8-59FE-4BBD-8D36-C7DC65C13376,TCGA-09-2050-10A-01D-A312-08,HG19_Broad_variant,TCGA-09-2050,TCGA-OV,NA,s17483,Broad Institute of MIT and Harvard,UCSF,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a546,58cfa82de4b0c9d6adf6a546,0efe658adac35f9288ebc6e59891a34b.filtered.,WGS,0efe658adac35f9288ebc6e59891a34b,0efe658adac35f9288ebc6e59891a34b.bam,66.38,2,0.08,58cfa82de4b0c9d6adf6a546,0efe658adac35f9288ebc6e59891a34b.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A05A-01A,C350B53B-3C27-4B9E-8B57-D7B6A1205A1F,Primary Tumor,Illumina HiSeq,1e8db39a-fb8e-4aa5-8cce-962a219e02e7,Uterus,81,482153FB-E69D-4748-9CF4-E281EC141518,99696731-C88F-427B-975B-1D90013E63FF,TCGA-AP-A05A-01A-11D-A013-09,GRCh37-lite,TCGA-AP-A05A,TCGA-UCEC,NA,s4980,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a6ec,58cfa82de4b0c9d6adf6a6ec,9730009cb05430035cc9988462351cef.filtered.,WGS,9730009cb05430035cc9988462351cef,9730009cb05430035cc9988462351cef.bam,38.58,2.02,0.08,58cfa82de4b0c9d6adf6a6ec,9730009cb05430035cc9988462351cef.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-AR-A0TX-01A,C364E81C-EB1E-4870-AB37-9C661F5F2E3D,Primary Tumor,Illumina HiSeq,e9fddd42-1948-4df8-ac61-4db49de8123f,Breast,64,D5ADAF35-04B1-4198-B308-F4720B3D6417,DDC7377D-82C3-480A-BE3C-3D1DA52C77D4,TCGA-AR-A0TX-01A-11D-A19H-09,GRCh37-lite,TCGA-AR-A0TX,TCGA-BRCA,NA,s5632,Washington University School of Medicine,Mayo,None,NO,T1,N1,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a4ce,58cfa82de4b0c9d6adf6a4ce,2258e57e8e0af9db6969a1da86177ca7.filtered.,WGS,2258e57e8e0af9db6969a1da86177ca7,2258e57e8e0af9db6969a1da86177ca7.bam,62.02,2.08,0.08,58cfa82de4b0c9d6adf6a4ce,2258e57e8e0af9db6969a1da86177ca7.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A03L-01A,1174F6E4-FFBE-4E59-A000-8D861C968369,Primary Tumor,Illumina HiSeq,e374014a-934d-4eee-b1e3-53ec285ea08e,Breast,34,00F81E98-E5C3-43B2-9757-F769EC17F3F8,8F558713-F32B-403B-AEDF-C79EFEB41C67,TCGA-AO-A03L-01A-41D-A19H-09,GRCh37-lite,TCGA-AO-A03L,TCGA-BRCA,NA,s6617,Washington University School of Medicine,MSKCC,None,NO,T3,N2,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa83ce4b0c9d6adf730c6,58cfa83ce4b0c9d6adf730c6,fc8da8f3ea309f1c3af2dfbe4fb28b67.filtered.,WGS,fc8da8f3ea309f1c3af2dfbe4fb28b67,fc8da8f3ea309f1c3af2dfbe4fb28b67.bam,7.67,1.9,0.16,58cfa83ce4b0c9d6adf730c6,fc8da8f3ea309f1c3af2dfbe4fb28b67.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-1411-10A,A9D3A7B0-FAF8-4E56-8600-D9E6882A4F23,Blood Derived Normal,Illumina GA,e6490bb6-5bdd-4cf1-aee2-3705fd7c99c8,Ovary,81,490F7701-C88E-4269-824B-CDEE46ED34EB,5B2F504B-23FD-4C5B-A548-E24E186423F1,TCGA-13-1411-10A-01D-0515-09,GRCh37-lite,TCGA-13-1411,TCGA-OV,NA,s18150,Washington University School of Medicine,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a953,58cfa82ee4b0c9d6adf6a953,G32549.TCGA-FS-A1ZP-06A-11D-A197-08.3.filtered.,WGS,G32549.TCGA-FS-A1ZP-06A-11D-A197-08.3,G32549.TCGA-FS-A1ZP-06A-11D-A197-08.3.bam,66.69,NA,0.08,58cfa82ee4b0c9d6adf6a953,G32549.TCGA-FS-A1ZP-06A-11D-A197-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-FS-A1ZP-06A,4CDB18F5-47BF-475F-B34C-FA4912515268,Metastatic,Illumina HiSeq,fd8a5acd-6e84-400c-a43a-e6589cec6b82,Skin,52,3FC2F92E-E55E-4484-B306-4303A9A0CBF5,66D312FC-809D-428B-98E3-A29D211DB35C,TCGA-FS-A1ZP-06A-11D-A197-08,HG19_Broad_variant,TCGA-FS-A1ZP,TCGA-SKCM,2273,s7309,Broad Institute of MIT and Harvard,Essen,Germany,NO,T3,N0,Not available,Stage II
13722.58cfa82ee4b0c9d6adf6a7ec,58cfa82ee4b0c9d6adf6a7ec,G26374.TCGA-06-5415-01A-01D-1486-08.1.filtered.,WGS,G26374.TCGA-06-5415-01A-01D-1486-08.1,G26374.TCGA-06-5415-01A-01D-1486-08.1.bam,1043.73,1.9,0.05,58cfa82ee4b0c9d6adf6a7ec,G26374.TCGA-06-5415-01A-01D-1486-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-5415-01A,713190ED-C6C1-4695-814B-85CA9B95E6A0,Primary Tumor,Illumina HiSeq,ed52d6d6-fd9a-42a4-a02b-6b3a443b576e,Brain,60,E0601D4F-A1DF-4F29-BABA-F8A67556A822,FCA08EE9-B480-4DC7-BE56-F1EB03B56F7C,TCGA-06-5415-01A-01D-1486-08,HG19_Broad_variant,TCGA-06-5415,TCGA-GBM,NA,s14059,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6ac3d,58cfa82ee4b0c9d6adf6ac3d,G39019.TCGA-GN-A264-10A-01D-A198-08.1.filtered.,WGS,G39019.TCGA-GN-A264-10A-01D-A198-08.1,G39019.TCGA-GN-A264-10A-01D-A198-08.1.bam,10.25,NA,0.08,58cfa82ee4b0c9d6adf6ac3d,G39019.TCGA-GN-A264-10A-01D-A198-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-GN-A264-10A,76CC1D42-ACEC-46B3-9663-5E4DE2550353,Blood Derived Normal,Illumina HiSeq,ee630afd-acae-4b74-8ebc-ed5e124fd230,Skin,60,58070D67-F716-475E-8D03-8930BE87A7B8,BEE27BC1-98F6-4819-B8AF-AD2D0AAA3DCE,TCGA-GN-A264-10A-01D-A198-08,HG19_Broad_variant,TCGA-GN-A264,TCGA-SKCM,3587,s7994,Broad Institute of MIT and Harvard,Roswell,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6ad75,58cfa82ee4b0c9d6adf6ad75,G39020.TCGA-BR-8381-10A-01D-2394-08.2.filtered.,WGS,G39020.TCGA-BR-8381-10A-01D-2394-08.2,G39020.TCGA-BR-8381-10A-01D-2394-08.2.bam,348,NA,0.05,58cfa82ee4b0c9d6adf6ad75,G39020.TCGA-BR-8381-10A-01D-2394-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-8381-10A,AEF8D98F-7A1C-47F3-B5A7-A3CB299C70DE,Blood Derived Normal,Illumina HiSeq,061589aa-8b3c-465e-a354-c6d9ba618e35,Stomach,51,652F134C-2A0E-4F48-A285-66476A91B933,69E6CF8A-EB68-478C-A849-51FB2F8736AC,TCGA-BR-8381-10A-01D-2394-08,HG19_Broad_variant,TCGA-BR-8381,TCGA-STAD,NA,s14875,Broad Institute of MIT and Harvard,Asterand,Ukraine,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB
13722.58cfa830e4b0c9d6adf6bf00,58cfa830e4b0c9d6adf6bf00,TCGA-BP-5168-01A-01D-2099-10_Illumina.filtered.,WGS,TCGA-BP-5168-01A-01D-2099-10_Illumina,TCGA-BP-5168-01A-01D-2099-10_Illumina.bam,129.4,1.9,0.15,58cfa830e4b0c9d6adf6bf00,TCGA-BP-5168-01A-01D-2099-10_Illumina.bam,Dead,MALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-BP-5168-01A,781ACAFA-A58B-4180-BBCA-C5B675D51B17,Primary Tumor,Illumina HiSeq,a353f21b-796e-4d66-a273-83755c9b0525,Kidney,75,233C6672-A850-48E0-99FD-024CF1A76B4C,D991F23A-DC1B-427A-B798-BD4187D3AA02,TCGA-BP-5168-01A-01D-2099-10,GRCh37-lite,TCGA-BP-5168,TCGA-KIRC,1463,s8837,Baylor College of Medicine,MSKCC,None,NO,T1a,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6a950,58cfa82ee4b0c9d6adf6a950,G32522.TCGA-BJ-A191-01A-11D-A13W-08.1.filtered.,WGS,G32522.TCGA-BJ-A191-01A-11D-A13W-08.1,G32522.TCGA-BJ-A191-01A-11D-A13W-08.1.bam,110.16,1.93,0.09,58cfa82ee4b0c9d6adf6a950,G32522.TCGA-BJ-A191-01A-11D-A13W-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A191-01A,2501EE46-8D38-448B-8765-E9C9706CBBE8,Primary Tumor,Illumina HiSeq,fe7c5f35-ecea-4165-8fa8-7a178959b096,Thyroid,49,C92FC4E3-7A96-4000-A969-AA894CA58A33,64C2E6A0-2341-49C4-A6DD-656E7BB505DD,TCGA-BJ-A191-01A-11D-A13W-08,HG19_Broad_variant,TCGA-BJ-A191,TCGA-THCA,NA,s11973,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T1b,N0,Other  specify,Stage I
13722.58cfa82ee4b0c9d6adf6aede,58cfa82ee4b0c9d6adf6aede,G49537.TCGA-DE-A3KN-10A-01D-A20C-08.2.filtered.,WGS,G49537.TCGA-DE-A3KN-10A-01D-A20C-08.2,G49537.TCGA-DE-A3KN-10A-01D-A20C-08.2.bam,9.44,NA,0.08,58cfa82ee4b0c9d6adf6aede,G49537.TCGA-DE-A3KN-10A-01D-A20C-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DE-A3KN-10A,085FFCDC-8600-42E2-852A-506465F716A2,Blood Derived Normal,Illumina HiSeq,e22540f9-be48-4373-a224-8a8d3b79a6c6,Thyroid,49,FDFC1873-3D5E-46CB-A929-8C9F4B1697D6,1C6ABCC3-1A61-441A-921D-6D06F762C1A3,TCGA-DE-A3KN-10A-01D-A20C-08,HG19_Broad_variant,TCGA-DE-A3KN,TCGA-THCA,NA,s12086,Broad Institute of MIT and Harvard,University of North Carolina,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA
13722.58cfa82ee4b0c9d6adf6a927,58cfa82ee4b0c9d6adf6a927,G26387.TCGA-19-2620-10A-01D-1495-08.2.filtered.,WGS,G26387.TCGA-19-2620-10A-01D-1495-08.2,G26387.TCGA-19-2620-10A-01D-1495-08.2.bam,123.4,1.9,0.05,58cfa82ee4b0c9d6adf6a927,G26387.TCGA-19-2620-10A-01D-1495-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-19-2620-10A,352768F9-3CE1-419C-BEEF-6515C78F5D7A,Blood Derived Normal,Illumina HiSeq,0ff3404e-df40-4aff-8e66-fa8a76963985,Brain,70,94C13ADC-D315-44A8-836E-800C98106B7D,EDE6D42C-895A-46F7-A0E3-11B152970581,TCGA-19-2620-10A-01D-1495-08,HG19_Broad_variant,TCGA-19-2620,TCGA-GBM,148,s14172,Broad Institute of MIT and Harvard,Case Western,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6af50,58cfa82ee4b0c9d6adf6af50,G49537.TCGA-FY-A2QD-10A-01D-A19M-08.1.filtered.,WGS,G49537.TCGA-FY-A2QD-10A-01D-A19M-08.1,G49537.TCGA-FY-A2QD-10A-01D-A19M-08.1.bam,76.53,NA,0.08,58cfa82ee4b0c9d6adf6af50,G49537.TCGA-FY-A2QD-10A-01D-A19M-08.1.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FY-A2QD-10A,B0CB6ED7-3D9F-4D5E-8DF5-EDCC921C43B4,Blood Derived Normal,Illumina HiSeq,e74d2517-5fda-4dcd-8672-c4ab223c8a7e,Thyroid,61,79C2D43D-39E0-46A4-9CAD-F0088EA5F4A0,7AEB39CD-79B5-4B8B-B801-9EA170D402C5,TCGA-FY-A2QD-10A-01D-A19M-08,HG19_Broad_variant,TCGA-FY-A2QD,TCGA-THCA,NA,s12742,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Not available
13722.58cfa82ee4b0c9d6adf6b140,58cfa82ee4b0c9d6adf6b140,G49538.TCGA-06-0190-10B-01D-A32W-08.1.filtered.,WGS,G49538.TCGA-06-0190-10B-01D-A32W-08.1,G49538.TCGA-06-0190-10B-01D-A32W-08.1.bam,128.7,1.91,0.09,58cfa82ee4b0c9d6adf6b140,G49538.TCGA-06-0190-10B-01D-A32W-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0190-10B,74139255-A635-4C87-814D-3DD04ED630A8,Blood Derived Normal,Illumina HiSeq,f04aa2a8-0893-4143-9c55-621b2bcc01d5,Brain,62,5E4F6C38-9B1F-4406-8BF3-8B3FA6D3399F,EF89DA1C-E378-418D-B3E8-E15D3BBB309E,TCGA-06-0190-10B-01D-A32W-08,HG19_Broad_variant,TCGA-06-0190,TCGA-GBM,317,s14266,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6aa6e,58cfa82ee4b0c9d6adf6aa6e,G32523.TCGA-DJ-A2Q2-10A-01D-A19M-08.2.filtered.,WGS,G32523.TCGA-DJ-A2Q2-10A-01D-A19M-08.2,G32523.TCGA-DJ-A2Q2-10A-01D-A19M-08.2.bam,91.75,NA,0.09,58cfa82ee4b0c9d6adf6aa6e,G32523.TCGA-DJ-A2Q2-10A-01D-A19M-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A2Q2-10A,A00DA907-E527-45F9-9AFB-2FAD2C7B0940,Blood Derived Normal,Illumina HiSeq,795a8bdf-4587-42b2-a974-d0651e0e972e,Thyroid,57,33167ED2-2095-4ADA-A7E6-246A3E312ED9,A78604A5-9AA0-4D49-B007-24C54F34EA21,TCGA-DJ-A2Q2-10A-01D-A19M-08,HG19_Broad_variant,TCGA-DJ-A2Q2,TCGA-THCA,NA,s12083,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III
13722.58cfa82de4b0c9d6adf6a724,58cfa82de4b0c9d6adf6a724,G14857.TCGA-73-4666-11A-01D-1931-08.3.filtered.,WGS,G14857.TCGA-73-4666-11A-01D-1931-08.3,G14857.TCGA-73-4666-11A-01D-1931-08.3.bam,160,1.9,0.15,58cfa82de4b0c9d6adf6a724,G14857.TCGA-73-4666-11A-01D-1931-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4666-11A,4C31127E-D095-4978-9DAC-35153C27F6ED,Solid Tissue Normal,Illumina HiSeq,5f8289fa-f285-4b82-92f2-2968802291ec,Lung,52,D07AC871-EAE1-4892-9E0B-CEEA122D3A64,A0E7ABCC-38C2-4EF0-93D5-AE215759E06C,TCGA-73-4666-11A-01D-1931-08,HG19_Broad_variant,TCGA-73-4666,TCGA-LUAD,NA,s10757,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IV
13722.58cfa82ee4b0c9d6adf6ac3a,58cfa82ee4b0c9d6adf6ac3a,G39019.TCGA-ER-A19D-10A-01D-A199-08.3.filtered.,WGS,G39019.TCGA-ER-A19D-10A-01D-A199-08.3,G39019.TCGA-ER-A19D-10A-01D-A199-08.3.bam,15.61,NA,0.09,58cfa82ee4b0c9d6adf6ac3a,G39019.TCGA-ER-A19D-10A-01D-A199-08.3.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19D-10A,3409F118-1798-48D6-9556-12A5C77EBEFB,Blood Derived Normal,Illumina HiSeq,f9881fbb-b5f4-49cf-adbf-3cb6ec639f0e,Skin,46,DF2B6EFB-3439-4A33-B905-47FD40CA30F5,36E999EE-96C4-47CC-865C-4EB8C9306C57,TCGA-ER-A19D-10A-01D-A199-08,HG19_Broad_variant,TCGA-ER-A19D,TCGA-SKCM,383,s7995,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2a,N0,Not available,Stage IB
13722.58cfa82de4b0c9d6adf6a529,58cfa82de4b0c9d6adf6a529,4aa512860ab86fb3f56ebdc8fcd69ce1.filtered.,WGS,4aa512860ab86fb3f56ebdc8fcd69ce1,4aa512860ab86fb3f56ebdc8fcd69ce1.bam,116.74,2,0.08,58cfa82de4b0c9d6adf6a529,4aa512860ab86fb3f56ebdc8fcd69ce1.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0LE-01A,DCFF8659-ECCA-4798-80A3-DD6E7642BA2B,Primary Tumor,Illumina HiSeq,b5fe9da4-e8c6-4c5a-ae7f-b1227dcafe8f,Uterus,57,9C4A32CF-DE40-4996-91A9-56F1C18D69A4,638E80C7-9A6E-4A32-A621-FC4168E72343,TCGA-AP-A0LE-01A-11D-A127-09,GRCh37-lite,TCGA-AP-A0LE,TCGA-UCEC,NA,s4982,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a740,58cfa82de4b0c9d6adf6a740,G14850.TCGA-49-4486-01A-01D-1931-08.3.filtered.,WGS,G14850.TCGA-49-4486-01A-01D-1931-08.3,G14850.TCGA-49-4486-01A-01D-1931-08.3.bam,142.53,1.9,0.14,58cfa82de4b0c9d6adf6a740,G14850.TCGA-49-4486-01A-01D-1931-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4486-01A,61C655EC-52B5-453F-A6CC-B2ABA445B027,Primary Tumor,Illumina HiSeq,53a1d9af-aa10-4382-bfad-f13af3c6cab9,Lung,72,5AE9B10F-347C-48C3-90CD-9290055CFE4B,23D86395-9E20-4CF9-BF7E-F76544A1F772,TCGA-49-4486-01A-01D-1931-08,HG19_Broad_variant,TCGA-49-4486,TCGA-LUAD,2318,s10628,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6af00,58cfa82ee4b0c9d6adf6af00,G39020.TCGA-D7-8570-10A-01D-2341-08.2.filtered.,WGS,G39020.TCGA-D7-8570-10A-01D-2341-08.2,G39020.TCGA-D7-8570-10A-01D-2341-08.2.bam,373,NA,0.05,58cfa82ee4b0c9d6adf6af00,G39020.TCGA-D7-8570-10A-01D-2341-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-8570-10A,1E1CDF72-820F-48A4-8FB6-89575D07CDE9,Blood Derived Normal,Illumina HiSeq,17649637-fcdf-4c26-add7-6820145afb75,Stomach,44,A5AF7231-AFCE-4F49-B903-632CA9D17CF9,37B5CB53-CFFF-47AE-9769-B5DF2C72F1E5,TCGA-D7-8570-10A-01D-2341-08,HG19_Broad_variant,TCGA-D7-8570,TCGA-STAD,NA,s15231,Broad Institute of MIT and Harvard,Greater Poland Cancer Center,Poland,NO,T3,N3a,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIIB
13722.58cfa82ee4b0c9d6adf6a7e4,58cfa82ee4b0c9d6adf6a7e4,G25771.TCGA-05-4395-10A-01D-2364-08.1.filtered.,WGS,G25771.TCGA-05-4395-10A-01D-2364-08.1,G25771.TCGA-05-4395-10A-01D-2364-08.1.bam,146.9,1.8,0.05,58cfa82ee4b0c9d6adf6a7e4,G25771.TCGA-05-4395-10A-01D-2364-08.1.bam,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4395-10A,762DEA8A-5B41-4058-979A-B7876ED13D7E,Blood Derived Normal,Illumina HiSeq,d5aa2e5d-fa48-4406-863a-198ae4f25c52,Lung,76,440ED729-AF4A-44C2-AF41-AB7CD2D6B796,3499550D-BA28-4636-B895-4E92059CCF23,TCGA-05-4395-10A-01D-2364-08,HG19_Broad_variant,TCGA-05-4395,TCGA-LUAD,0,s11319,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T4,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIB
13722.58cfa82ee4b0c9d6adf6aa0c,58cfa82ee4b0c9d6adf6aa0c,G26375.TCGA-27-2528-10A-01D-1494-08.1.filtered.,WGS,G26375.TCGA-27-2528-10A-01D-1494-08.1,G26375.TCGA-27-2528-10A-01D-1494-08.1.bam,462,1.9,0.05,58cfa82ee4b0c9d6adf6aa0c,G26375.TCGA-27-2528-10A-01D-1494-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-27-2528-10A,BE3A7EF3-34ED-40E1-9D9C-187940596B26,Blood Derived Normal,Illumina HiSeq,af26dcda-af0f-4c5e-bfde-bb635997c8e5,Brain,62,7C23926C-217D-4923-B313-AD51E0306889,BA315999-BDEF-4B98-8207-7653987BC717,TCGA-27-2528-10A-01D-1494-08,HG19_Broad_variant,TCGA-27-2528,TCGA-GBM,480,s14025,Broad Institute of MIT and Harvard,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a5d0,58cfa82de4b0c9d6adf6a5d0,67e9266c5c766d2aa96eaeb76ec9d0b0.filtered.,WGS,67e9266c5c766d2aa96eaeb76ec9d0b0,67e9266c5c766d2aa96eaeb76ec9d0b0.bam,39.52,1.9,0.07,58cfa82de4b0c9d6adf6a5d0,67e9266c5c766d2aa96eaeb76ec9d0b0.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A07B-01A,B43E41AF-1D82-4B5F-B8F1-ADD0510E6B86,Primary Tumor,Illumina MiSeq,88226ae1-28e5-4dc7-abbb-f55d7b64937d,Breast,69,685FA2EA-3DFF-450A-8EA6-E97DFE9000A4,5B7D5767-2037-4175-AEC9-886776343181,TCGA-A8-A07B-01A-11D-A19H-09,GRCh37-lite,TCGA-A8-A07B,TCGA-BRCA,NA,s6458,Washington University School of Medicine,Indivumed,Germany,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6a7d5,58cfa82ee4b0c9d6adf6a7d5,G23062.TCGA_BA_4077_10A_01D_2268_08.2.filtered.,WGS,G23062.TCGA_BA_4077_10A_01D_2268_08.2,G23062.TCGA_BA_4077_10A_01D_2268_08.2.bam,58.03,1.9,0.14,58cfa82ee4b0c9d6adf6a7d5,G23062.TCGA_BA_4077_10A_01D_2268_08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-4077-10A,4BFBCE2B-9D0B-4E8A-950F-FD8E0BA3E05A,Blood Derived Normal,Illumina HiSeq,82ff50a2-3252-4ce5-a0ad-979cce2ec4cb,Head and Neck,45,8C074534-49B5-4D4A-A9C8-59BFEF52A800,C955ACC5-3717-4CCA-A394-004E3C8A0686,TCGA-BA-4077-10A-01D-2268-08,HG19_Broad_variant,TCGA-BA-4077,TCGA-HNSC,1134,s15483,Broad Institute of MIT and Harvard,UNC,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa83ce4b0c9d6adf72fd8,58cfa83ce4b0c9d6adf72fd8,bcbfebca137feee918342e841c0bb404.filtered.,WGS,bcbfebca137feee918342e841c0bb404,bcbfebca137feee918342e841c0bb404.bam,93.85,1.93,0.08,58cfa83ce4b0c9d6adf72fd8,bcbfebca137feee918342e841c0bb404.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A1CI-01A,FBA80122-D8B2-4D8D-A032-9767E8160F9F,Primary Tumor,Illumina HiSeq,47f4dbcb-cbdc-4e4e-a4b2-5080f3e683cf,Uterus,61,DDD2F9E0-0AA3-425B-9D74-74FCC638CB08,92126163-00C3-41F2-9CE6-7AAD5F621407,TCGA-AX-A1CI-01A-11D-A135-09,GRCh37-lite,TCGA-AX-A1CI,TCGA-UCEC,NA,s4572,Washington University School of Medicine,Gynecologic Oncology Group,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a556,58cfa82de4b0c9d6adf6a556,063d6bdd81ba674cf8ce55970b76bc7d.filtered.,WGS,063d6bdd81ba674cf8ce55970b76bc7d,063d6bdd81ba674cf8ce55970b76bc7d.bam,NA,NA,0.08,58cfa82de4b0c9d6adf6a556,063d6bdd81ba674cf8ce55970b76bc7d.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AX-A05S-01A,3A4A6AFF-4720-41FC-A114-85F38610EBB1,Primary Tumor,Illumina HiSeq,982e6db1-dd32-43ea-821b-612393624334,Uterus,81,3D8F263F-6866-4B92-AAEE-743EC5514865,C082DC34-457E-40EC-8258-E11E8ED362C2,TCGA-AX-A05S-01A-11D-A013-09,GRCh37-lite,TCGA-AX-A05S,TCGA-UCEC,413,s5186,Washington University School of Medicine,Gynecologic Oncology Group,United States,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a7d9,58cfa82ee4b0c9d6adf6a7d9,G25249.TCGA-CR-7391-10A-01D-2334-08.1.filtered.,WGS,G25249.TCGA-CR-7391-10A-01D-2334-08.1,G25249.TCGA-CR-7391-10A-01D-2334-08.1.bam,82,NA,0.05,58cfa82ee4b0c9d6adf6a7d9,G25249.TCGA-CR-7391-10A-01D-2334-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-7391-10A,832316EE-08AB-412B-9E4D-8A57FF84BC11,Blood Derived Normal,Illumina HiSeq,1013b4f5-cc60-41aa-9ed4-32c66ca645b8,Head and Neck,36,EFCF402C-AD35-433A-B285-DB8C8CBD9552,EEBC2429-9186-49DE-9911-35FEAA58187B,TCGA-CR-7391-10A-01D-2334-08,HG19_Broad_variant,TCGA-CR-7391,TCGA-HNSC,NA,s15864,Broad Institute of MIT and Harvard,Vanderbilt University,United States,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa82de4b0c9d6adf6a4f6,58cfa82de4b0c9d6adf6a4f6,40885d556f0a4ec2155d1bea9b08f557.filtered.,WGS,40885d556f0a4ec2155d1bea9b08f557,40885d556f0a4ec2155d1bea9b08f557.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a4f6,40885d556f0a4ec2155d1bea9b08f557.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2988-11A,4B8FF65F-B563-4519-B984-C7CF26B3AD73,Solid Tissue Normal,Illumina GA,4beb8dec-0fd9-437e-ae5d-50f8e5cfb7c2,Blood,67,279D7677-B7C1-468B-A9FB-65E7F08248E7,FE6BEA4D-E433-4977-AB67-B7AA610DE359,TCGA-AB-2988-11A-01D-0739-09,GRCh37-lite,TCGA-AB-2988,TCGA-LAML,30,s7099,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82de4b0c9d6adf6a6ad,58cfa82de4b0c9d6adf6a6ad,8f57c53bd900545eb503f173c2fc9b57.filtered.,WGS,8f57c53bd900545eb503f173c2fc9b57,8f57c53bd900545eb503f173c2fc9b57.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a6ad,8f57c53bd900545eb503f173c2fc9b57.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-3011-03A,E08F84FE-0013-4734-9966-CD734E6FEDC5,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,beceffbc-24e5-4c31-853f-66b75d98889b,Blood,21,10740F2A-D9AA-46F6-B7CB-22719FB9B0E1,FC2D6C31-DADB-45CB-9053-C87F535A77A5,TCGA-AB-3011-03A-01D-0739-09,GRCh37-lite,TCGA-AB-3011,TCGA-LAML,NA,s7287,Washington University School of Medicine,Washington University,None,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6ab28,58cfa82ee4b0c9d6adf6ab28,G26381.TCGA-14-1823-01A-01D-1494-08.1.filtered.,WGS,G26381.TCGA-14-1823-01A-01D-1494-08.1,G26381.TCGA-14-1823-01A-01D-1494-08.1.bam,365.37,1.91,0.05,58cfa82ee4b0c9d6adf6ab28,G26381.TCGA-14-1823-01A-01D-1494-08.1.bam,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1823-01A,A515CF2D-E918-4958-9BF6-E611B425A97E,Primary Tumor,Illumina HiSeq,38fe2fc2-ccf1-494b-89f0-54ed8a5a213c,Brain,58,7EAD0574-478A-4FE1-AABE-34965101B05D,4A1AD661-F6AE-44E8-B50B-72FF658FF22B,TCGA-14-1823-01A-01D-1494-08,HG19_Broad_variant,TCGA-14-1823,TCGA-GBM,543,s13928,Broad Institute of MIT and Harvard,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a755,58cfa82de4b0c9d6adf6a755,G14082.TCGA-21-1076-11A-01D-1521-08.2.filtered.,WGS,G14082.TCGA-21-1076-11A-01D-1521-08.2,G14082.TCGA-21-1076-11A-01D-1521-08.2.bam,7,1.8,0.05,58cfa82de4b0c9d6adf6a755,G14082.TCGA-21-1076-11A-01D-1521-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-21-1076-11A,220BE009-8F1E-4A77-AB04-3220B5F87EA6,Solid Tissue Normal,Illumina HiSeq,a5561a9b-57ef-42b7-b1e7-6f208060564c,Lung,54,706EA9BD-2216-444B-8173-3A3E022B622B,578A4A76-B3A4-4C8E-9E54-B7AE27AC482F,TCGA-21-1076-11A-01D-1521-08,HG19_Broad_variant,TCGA-21-1076,TCGA-LUSC,NA,s9975,Broad Institute of MIT and Harvard,Fox Chase Cancer Center,United States,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6a7e1,58cfa82ee4b0c9d6adf6a7e1,G25784.TCGA-91-6840-01A-11D-1945-08.3.filtered.,WGS,G25784.TCGA-91-6840-01A-11D-1945-08.3,G25784.TCGA-91-6840-01A-11D-1945-08.3.bam,315.7,1.9,0.05,58cfa82ee4b0c9d6adf6a7e1,G25784.TCGA-91-6840-01A-11D-1945-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-91-6840-01A,D5326429-9805-47F9-97B0-FBDA658E3F01,Primary Tumor,Illumina HiSeq,27c919e7-a635-4c6d-a12d-31d1ee814e12,Lung,59,AF744755-51EB-4DAF-9029-5CF88730B1DC,09BC8542-4EA1-4599-91B3-D606425B37E2,TCGA-91-6840-01A-11D-1945-08,HG19_Broad_variant,TCGA-91-6840,TCGA-LUAD,NA,s11430,Broad Institute of MIT and Harvard,ABS - IUPUI,United States,NO,T1b,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6a9f4,58cfa82ee4b0c9d6adf6a9f4,G32525.TCGA-DJ-A13W-10A-01D-A10S-08.4.filtered.,WGS,G32525.TCGA-DJ-A13W-10A-01D-A10S-08.4,G32525.TCGA-DJ-A13W-10A-01D-A10S-08.4.bam,38.59,1.95,0.07,58cfa82ee4b0c9d6adf6a9f4,G32525.TCGA-DJ-A13W-10A-01D-A10S-08.4.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13W-10A,3B48CC5E-3396-4DD5-893D-54B75B98B016,Blood Derived Normal,Illumina HiSeq,21e97625-96c6-4091-b0b8-2a3f6d5dead3,Thyroid,45,C6EAF3F8-DD7D-4B38-BF42-8A53AAFAB259,AF0CF9AA-5510-4AF9-9BB4-A7E25E446245,TCGA-DJ-A13W-10A-01D-A10S-08,HG19_Broad_variant,TCGA-DJ-A13W,TCGA-THCA,NA,s12729,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa82de4b0c9d6adf6a624,58cfa82de4b0c9d6adf6a624,52a567ba68a991f7946cfbf0a1803a67.filtered.,WGS,52a567ba68a991f7946cfbf0a1803a67,52a567ba68a991f7946cfbf0a1803a67.bam,71.56,1.94,0.09,58cfa82de4b0c9d6adf6a624,52a567ba68a991f7946cfbf0a1803a67.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-EY-A1GS-01A,C10B2885-70EA-4D32-BC48-8B85530DF702,Primary Tumor,Illumina HiSeq,e36825eb-c127-473a-a3d0-8c56a941a1a6,Uterus,71,99540910-61A1-434B-9937-216DFAC5F719,0C39C03A-EC84-42C6-BE69-8E98BC7A9F5A,TCGA-EY-A1GS-01A-11D-A13L-09,GRCh37-lite,TCGA-EY-A1GS,TCGA-UCEC,NA,s4236,Washington University School of Medicine,University of North Carolina,United States,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a52c,58cfa82de4b0c9d6adf6a52c,08f5ca11eae517c5ad7ce14a801eaf99.filtered.,WGS,08f5ca11eae517c5ad7ce14a801eaf99,08f5ca11eae517c5ad7ce14a801eaf99.bam,46.2,1.89,0.07,58cfa82de4b0c9d6adf6a52c,08f5ca11eae517c5ad7ce14a801eaf99.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A07I-01A,566792AE-F853-4A47-856D-F02CDCFCB18A,Primary Tumor,Illumina HiSeq,6453f2d2-c0d0-46ee-a131-4a59788bb4c3,Breast,69,0D2E50FA-DAEF-45A3-97B2-5D71AB03CFBF,A6C14EBC-81A2-44F7-AF87-2B7EC85E5696,TCGA-A8-A07I-01A-11D-A19H-09,GRCh37-lite,TCGA-A8-A07I,TCGA-BRCA,NA,s5784,Washington University School of Medicine,Indivumed,Germany,NO,T2,N2a,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82ee4b0c9d6adf6ade9,58cfa82ee4b0c9d6adf6ade9,G49538.TCGA-06-0210-10A-01D-1491-08.1.filtered.,WGS,G49538.TCGA-06-0210-10A-01D-1491-08.1,G49538.TCGA-06-0210-10A-01D-1491-08.1.bam,41.7,1.85,0.05,58cfa82ee4b0c9d6adf6ade9,G49538.TCGA-06-0210-10A-01D-1491-08.1.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0210-10A,DE7B7CAC-F094-4D59-8651-E991E34EA093,Blood Derived Normal,Illumina HiSeq,0ed1dc06-a73c-49cc-bfc5-99496a9fc3d1,Brain,72,074A1516-3ADC-41D0-84CB-2A5B13C44469,4E2A4226-999F-4CCA-BF37-17D54B7F8A96,TCGA-06-0210-10A-01D-1491-08,HG19_Broad_variant,TCGA-06-0210,TCGA-GBM,225,s14348,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6ab62,58cfa82ee4b0c9d6adf6ab62,G26402.TCGA-06-2570-01A-01D-1495-08.1.filtered.,WGS,G26402.TCGA-06-2570-01A-01D-1495-08.1,G26402.TCGA-06-2570-01A-01D-1495-08.1.bam,502.7,1.9,0.05,58cfa82ee4b0c9d6adf6ab62,G26402.TCGA-06-2570-01A-01D-1495-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-2570-01A,B37D944C-C65C-46D6-BB8B-3EB37CB85B68,Primary Tumor,Illumina HiSeq,c73a5a07-9d52-4d32-a3bc-1c70f3116562,Brain,21,42200DBC-8248-461D-BF90-5386360213A9,04339769-517C-448D-A7CA-951F83608C60,TCGA-06-2570-01A-01D-1495-08,HG19_Broad_variant,TCGA-06-2570,TCGA-GBM,NA,s13893,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6bdec,58cfa830e4b0c9d6adf6bdec,TCGA-AG-A032-10A-01D-A183-10_wgs_Illumina.filtered.,WGS,TCGA-AG-A032-10A-01D-A183-10_wgs_Illumina,TCGA-AG-A032-10A-01D-A183-10_wgs_Illumina.bam,17.49,1.84,0.07,58cfa830e4b0c9d6adf6bdec,TCGA-AG-A032-10A-01D-A183-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A032-10A,0BB786EE-07CF-4853-9B49-EC95CD14E282,Blood Derived Normal,Illumina HiSeq,ce5133d0-9c6c-45d9-9cfa-a2e3dce76fd7,Colorectal,68,02E756EF-31BD-4E2F-AC81-2476368DBD96,17B3BB66-B895-4331-836D-FDD2F4D5DC6F,TCGA-AG-A032-10A-01D-A183-10,GRCh37-lite,TCGA-AG-A032,TCGA-READ,NA,s2010,Baylor College of Medicine,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIB
13722.58cfa82de4b0c9d6adf6a72c,58cfa82de4b0c9d6adf6a72c,G14858.TCGA-73-4659-01A-01D-1931-08.3.filtered.,WGS,G14858.TCGA-73-4659-01A-01D-1931-08.3,G14858.TCGA-73-4659-01A-01D-1931-08.3.bam,665.52,1.9,0.15,58cfa82de4b0c9d6adf6a72c,G14858.TCGA-73-4659-01A-01D-1931-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-73-4659-01A,CD0DC947-B708-464E-BEB7-954C9D4583E7,Primary Tumor,Illumina HiSeq,967b7c80-0ec2-4e5f-81fd-07bffeeeaa7f,Lung,66,C35A5ED1-1821-4077-BA1E-B972DFA3233B,53D32D8B-5649-42B0-8C52-2C39AF2A961B,TCGA-73-4659-01A-01D-1931-08,HG19_Broad_variant,TCGA-73-4659,TCGA-LUAD,711,s10973,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82ee4b0c9d6adf6b05a,58cfa82ee4b0c9d6adf6b05a,G41960.TCGA-91-6847-11A-01D-1945-08.1.filtered.,WGS,G41960.TCGA-91-6847-11A-01D-1945-08.1,G41960.TCGA-91-6847-11A-01D-1945-08.1.bam,62.7,1.9,0.05,58cfa82ee4b0c9d6adf6b05a,G41960.TCGA-91-6847-11A-01D-1945-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-91-6847-11A,97831D28-AB41-4C18-BFC2-C4C6BC757D13,Solid Tissue Normal,Illumina HiSeq,251ee127-d60e-475f-8ea0-8724fa15c60b,Lung,62,599C32BD-7967-4CED-A571-8836135510A9,B9542378-B8C6-4C0A-A0DB-456396A45554,TCGA-91-6847-11A-01D-1945-08,HG19_Broad_variant,TCGA-91-6847,TCGA-LUAD,NA,s11322,Broad Institute of MIT and Harvard,ABS - IUPUI,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6ae40,58cfa82ee4b0c9d6adf6ae40,G7166.TCGA-55-1594-11A-01D-0969-08.12.filtered.,WGS,G7166.TCGA-55-1594-11A-01D-0969-08.12,G7166.TCGA-55-1594-11A-01D-0969-08.12.bam,133.3,1.9,0.15,58cfa82ee4b0c9d6adf6ae40,G7166.TCGA-55-1594-11A-01D-0969-08.12.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-55-1594-11A,6D72DE06-232A-4983-A06C-EBA6D82CB3F1,Solid Tissue Normal,Illumina GA,74601a5c-3f0c-4a39-9025-4ee7f3cf35dc,Lung,68,99DC64D5-E61D-4E34-9972-F17D292AEC3D,ABF949D3-FDC4-4669-B26D-623F01A500CB,TCGA-55-1594-11A-01D-0969-08,HG19_Broad_variant,TCGA-55-1594,TCGA-LUAD,NA,s11218,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82ee4b0c9d6adf6ae18,58cfa82ee4b0c9d6adf6ae18,G49837.TCGA-56-7582-10A-01D-A320-08.4.filtered.,WGS,G49837.TCGA-56-7582-10A-01D-A320-08.4,G49837.TCGA-56-7582-10A-01D-A320-08.4.bam,436.3,NA,0.09,58cfa82ee4b0c9d6adf6ae18,G49837.TCGA-56-7582-10A-01D-A320-08.4.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-56-7582-10A,B5E2CBDA-BBFA-4EF8-A9C4-CB978BEF9B23,Blood Derived Normal,Illumina HiSeq,6e7bd4aa-f60b-4cbf-af74-c9b127ba048c,Lung,83,C20D4F53-4D3F-4062-A01E-C3CF2D23DE31,E4958EFD-9A84-42AB-A89A-75EBA0A16D63,TCGA-56-7582-10A-01D-A320-08,HG19_Broad_variant,TCGA-56-7582,TCGA-LUSC,NA,s10371,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2a,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6a9f8,58cfa82ee4b0c9d6adf6a9f8,G26378.TCGA-02-2483-10A-01D-1494-08.1.filtered.,WGS,G26378.TCGA-02-2483-10A-01D-1494-08.1,G26378.TCGA-02-2483-10A-01D-1494-08.1.bam,4,1.9,0.05,58cfa82ee4b0c9d6adf6a9f8,G26378.TCGA-02-2483-10A-01D-1494-08.1.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-02-2483-10A,A2AC9937-F351-4D78-9261-264BF6C21E0C,Blood Derived Normal,Illumina HiSeq,934948e1-5e16-4a37-bc5f-5a77d134b1e7,Brain,43,87C346E0-1365-4C41-BF6B-D93B8DAAA2F3,F191BB9C-1937-40E5-8491-76DEDE722CDD,TCGA-02-2483-10A-01D-1494-08,HG19_Broad_variant,TCGA-02-2483,TCGA-GBM,NA,s14139,Broad Institute of MIT and Harvard,MD Anderson Cancer Center,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6aae4,58cfa82ee4b0c9d6adf6aae4,G32464.TCGA-BT-A20P-01A-11D-A14W-08.1.filtered.,WGS,G32464.TCGA-BT-A20P-01A-11D-A14W-08.1,G32464.TCGA-BT-A20P-01A-11D-A14W-08.1.bam,75.72,2.03,0.08,58cfa82ee4b0c9d6adf6aae4,G32464.TCGA-BT-A20P-01A-11D-A14W-08.1.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20P-01A,F48937ED-E294-41F0-8872-7010391167A9,Primary Tumor,Illumina HiSeq,d714be1b-c30c-4f13-8a00-4bf93507bb1c,Bladder,81,6B43EEEC-4FEB-4062-827A-E63ED8CE3820,E6C78A98-F45B-482B-A551-4F11B8C1FF8B,TCGA-BT-A20P-01A-11D-A14W-08,HG19_Broad_variant,TCGA-BT-A20P,TCGA-BLCA,544,s3394,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82ee4b0c9d6adf6aba2,58cfa82ee4b0c9d6adf6aba2,G26376.TCGA-27-2523-01A-01D-1494-08.1.filtered.,WGS,G26376.TCGA-27-2523-01A-01D-1494-08.1,G26376.TCGA-27-2523-01A-01D-1494-08.1.bam,742.7,1.9,0.05,58cfa82ee4b0c9d6adf6aba2,G26376.TCGA-27-2523-01A-01D-1494-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-27-2523-01A,737B35E1-D668-4FCE-9B6E-76946C7952B6,Primary Tumor,Illumina HiSeq,6359c1e1-c29c-4c79-a8ae-237f7a11a242,Brain,63,96881D37-7A3E-4910-B897-19453118FE7C,D60F54F5-B154-42C4-99FB-CEA4E7A33DC7,TCGA-27-2523-01A-01D-1494-08,HG19_Broad_variant,TCGA-27-2523,TCGA-GBM,489,s13892,Broad Institute of MIT and Harvard,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6a95a,58cfa82ee4b0c9d6adf6a95a,G23063.TCGA_CR_7385_01A_11D_2268_08.1.filtered.,WGS,G23063.TCGA_CR_7385_01A_11D_2268_08.1,G23063.TCGA_CR_7385_01A_11D_2268_08.1.bam,289.7,NA,0.15,58cfa82ee4b0c9d6adf6a95a,G23063.TCGA_CR_7385_01A_11D_2268_08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-7385-01A,9F89510C-ED07-471F-B35E-7C87C237B9FE,Primary Tumor,Illumina HiSeq,0d321573-5651-4eb3-9f8c-a11f802e5e92,Head and Neck,42,4C4A6867-BABE-4032-A639-A9B31CDDDC6C,6BBD66DD-EFEE-4D6E-B02F-F88E98526B82,TCGA-CR-7385-01A-11D-2268-08,HG19_Broad_variant,TCGA-CR-7385,TCGA-HNSC,NA,s15605,Broad Institute of MIT and Harvard,Vanderbilt University,United States,NO,T1,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa82de4b0c9d6adf6a548,58cfa82de4b0c9d6adf6a548,0d9ef8b814476b334be08fe7ee6ea88c.filtered.,WGS,0d9ef8b814476b334be08fe7ee6ea88c,0d9ef8b814476b334be08fe7ee6ea88c.bam,66.73,2.23,0.07,58cfa82de4b0c9d6adf6a548,0d9ef8b814476b334be08fe7ee6ea88c.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A075-01A,7861A5F2-8910-4BCB-9C34-F79C5ACD6E21,Primary Tumor,Illumina HiSeq,4d604b9e-e0ae-4c4e-b844-4c1d7924d75b,Breast,42,D3263082-946D-4420-8A63-8D67EEEE09C5,6C8E9197-FD16-4FED-BFDA-E349CAB26314,TCGA-A8-A075-01A-11D-A19H-09,GRCh37-lite,TCGA-A8-A075,TCGA-BRCA,NA,s6451,Washington University School of Medicine,Indivumed,Germany,NO,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa82fe4b0c9d6adf6b976,58cfa82fe4b0c9d6adf6b976,TCGA-AA-3666-01A-02D-1981-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3666-01A-02D-1981-10_wgs_Illumina,TCGA-AA-3666-01A-02D-1981-10_wgs_Illumina.bam,554.96,1.9,0.17,58cfa82fe4b0c9d6adf6b976,TCGA-AA-3666-01A-02D-1981-10_wgs_Illumina.bam,Dead,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3666-01A,A512701F-88BB-4B05-8C94-FD285B9DD13E,Primary Tumor,Illumina HiSeq,6788c172-0c9d-4042-a664-c53d8e8a5cf9,Colorectal,68,F1064663-1462-4901-8BF7-9F50DA5EE7B1,6051F40A-99E5-4461-9255-0E70D757B4D5,TCGA-AA-3666-01A-02D-1981-10,GRCh37-lite,TCGA-AA-3666,TCGA-COAD,61,s13025,Baylor College of Medicine,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6acca,58cfa82ee4b0c9d6adf6acca,G39020.TCGA-EQ-5647-10A-01D-1600-08.2.filtered.,WGS,G39020.TCGA-EQ-5647-10A-01D-1600-08.2,G39020.TCGA-EQ-5647-10A-01D-1600-08.2.bam,716.4,1.9,0.05,58cfa82ee4b0c9d6adf6acca,G39020.TCGA-EQ-5647-10A-01D-1600-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-EQ-5647-10A,2D291FA3-F0FD-4BC1-91A6-783863714190,Blood Derived Normal,Illumina HiSeq,866a460c-f7b2-43cb-9165-664d5c7cdd0f,Stomach,86,7E8AA1C7-AA0E-4205-914C-A2A48DC11844,96DA0697-64A5-4EC6-89BE-40DBAAFC65BC,TCGA-EQ-5647-10A-01D-1600-08,HG19_Broad_variant,TCGA-EQ-5647,TCGA-STAD,19,s14463,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,T4,N3,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa82ee4b0c9d6adf6ada4,58cfa82ee4b0c9d6adf6ada4,G39020.TCGA-BR-A4J4-10A-01D-A25E-08.3.filtered.,WGS,G39020.TCGA-BR-A4J4-10A-01D-A25E-08.3,G39020.TCGA-BR-A4J4-10A-01D-A25E-08.3.bam,57.54,NA,0.07,58cfa82ee4b0c9d6adf6ada4,G39020.TCGA-BR-A4J4-10A-01D-A25E-08.3.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-A4J4-10A,8A24F1A3-4BAB-4591-9676-7BEE01D096C1,Blood Derived Normal,Illumina HiSeq,183879a3-1761-4b9d-a0d2-fd2b2322599c,Stomach,39,2990E70A-887D-4307-9A44-CAAD524EB8CD,CF5A2A68-639D-4623-AD6C-71D061DB302E,TCGA-BR-A4J4-10A-01D-A25E-08,HG19_Broad_variant,TCGA-BR-A4J4,TCGA-STAD,NA,s15169,Broad Institute of MIT and Harvard,Asterand,Vietnam,NO,T4a,N2,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIB
13722.58cfa82ee4b0c9d6adf6a7ee,58cfa82ee4b0c9d6adf6a7ee,G26378.TCGA-02-2483-01A-01D-1494-08.1.filtered.,WGS,G26378.TCGA-02-2483-01A-01D-1494-08.1,G26378.TCGA-02-2483-01A-01D-1494-08.1.bam,264.7,1.9,0.05,58cfa82ee4b0c9d6adf6a7ee,G26378.TCGA-02-2483-01A-01D-1494-08.1.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-02-2483-01A,A2AC9937-F351-4D78-9261-264BF6C21E0C,Primary Tumor,Illumina HiSeq,8f0bfbe1-af94-4579-bcd2-696056315c1e,Brain,43,724D75C1-7F82-4208-8510-3E89F3679BDE,4D7F2C74-862B-4AAD-98E1-FA831F14A905,TCGA-02-2483-01A-01D-1494-08,HG19_Broad_variant,TCGA-02-2483,TCGA-GBM,NA,s14171,Broad Institute of MIT and Harvard,MD Anderson Cancer Center,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6af48,58cfa82ee4b0c9d6adf6af48,G41960.TCGA-78-7158-01A-11D-2036-08.2.filtered.,WGS,G41960.TCGA-78-7158-01A-11D-2036-08.2,G41960.TCGA-78-7158-01A-11D-2036-08.2.bam,575.7,NA,0.05,58cfa82ee4b0c9d6adf6af48,G41960.TCGA-78-7158-01A-11D-2036-08.2.bam,Dead,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-78-7158-01A,501C987E-D1EB-48A9-89EB-72A5062C90B4,Primary Tumor,Illumina HiSeq,a905fe2c-571c-4769-9c35-b107679cad76,Lung,59,EE0D4640-5609-430E-8B80-3058A3F313A8,199BBB0F-996C-40C1-B06D-2066F04BE778,TCGA-78-7158-01A-11D-2036-08,HG19_Broad_variant,TCGA-78-7158,TCGA-LUAD,179,s11325,Broad Institute of MIT and Harvard,Prince Charles Hospital,Australia,NO,T4,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIB
13722.58cfa82ee4b0c9d6adf6acc5,58cfa82ee4b0c9d6adf6acc5,G47088.TCGA-68-8250-10A-01D-2293-08.1.filtered.,WGS,G47088.TCGA-68-8250-10A-01D-2293-08.1,G47088.TCGA-68-8250-10A-01D-2293-08.1.bam,129.6,NA,0.05,58cfa82ee4b0c9d6adf6acc5,G47088.TCGA-68-8250-10A-01D-2293-08.1.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-68-8250-10A,7B982D5E-3A7D-40AC-BD25-6044C62879B6,Blood Derived Normal,Illumina HiSeq,aa4394b9-7fe0-4938-872a-fb718479a1af,Lung,66,69891F97-F793-439B-8805-6274650A6E66,F267353C-6734-4D87-9A84-264D54FC9BDA,TCGA-68-8250-10A-01D-2293-08,HG19_Broad_variant,TCGA-68-8250,TCGA-LUSC,NA,s10255,Broad Institute of MIT and Harvard,Washington University - Cleveland Clinic,United States,NO,T1a,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6ad65,58cfa82ee4b0c9d6adf6ad65,G48125.TCGA-24-1614-10A-01D-A312-08.3.filtered.,WGS,G48125.TCGA-24-1614-10A-01D-A312-08.3,G48125.TCGA-24-1614-10A-01D-A312-08.3.bam,220.97,1.9,0.08,58cfa82ee4b0c9d6adf6ad65,G48125.TCGA-24-1614-10A-01D-A312-08.3.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1614-10A,D3164236-C14A-4230-B527-ECD1A3992F02,Blood Derived Normal,Illumina HiSeq,ad94af5f-c91b-40c8-aa08-da6a66155269,Ovary,57,9EA0F939-3671-42E4-A2C0-92D83296E796,2DC54045-16B1-498B-B1A8-9F1CA34A3A7E,TCGA-24-1614-10A-01D-A312-08,HG19_Broad_variant,TCGA-24-1614,TCGA-OV,1470,s17482,Broad Institute of MIT and Harvard,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ab5a,58cfa82ee4b0c9d6adf6ab5a,G23071.TCGA_CV_7100_10A_01D_2268_08.1.filtered.,WGS,G23071.TCGA_CV_7100_10A_01D_2268_08.1,G23071.TCGA_CV_7100_10A_01D_2268_08.1.bam,21,NA,0.14,58cfa82ee4b0c9d6adf6ab5a,G23071.TCGA_CV_7100_10A_01D_2268_08.1.bam,Dead,MALE,WHITE,Not available,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7100-10A,90A8D2CB-1F31-45F9-8575-EED3CB9A7798,Blood Derived Normal,Illumina HiSeq,1a0d4aab-84fc-453c-a92a-e4af5474a74a,Head and Neck,66,82FF7CAA-BC9B-408E-9106-D76BCEC69665,AC85E832-92B2-45A2-8A0B-3FC4A9E83661,TCGA-CV-7100-10A-01D-2268-08,HG19_Broad_variant,TCGA-CV-7100,TCGA-HNSC,274,s15485,Broad Institute of MIT and Harvard,MD Anderson Cancer Center,United States,NO,T2,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa82de4b0c9d6adf6a580,58cfa82de4b0c9d6adf6a580,2db39072c0d1914dea2d317877070812.filtered.,WGS,2db39072c0d1914dea2d317877070812,2db39072c0d1914dea2d317877070812.bam,81.48,1.85,0.08,58cfa82de4b0c9d6adf6a580,2db39072c0d1914dea2d317877070812.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0I2-01A,328DFCB0-B5AE-43F2-BC87-DAD0AB3DF9E7,Primary Tumor,Illumina HiSeq,1f31bdc1-69ef-49bf-8200-d73661b23c67,Breast,45,47436CE0-438F-475B-AC0D-1972D0C5285E,A2D9325E-DA9D-42F1-A360-328D17ED492B,TCGA-B6-A0I2-01A-11D-A12L-09,GRCh37-lite,TCGA-B6-A0I2,TCGA-BRCA,NA,s5788,Washington University School of Medicine,Duke,United States,NO,T1c,N0 (i-),Infiltrating Ductal Carcinoma,Stage IA
13722.58cfa82ee4b0c9d6adf6ad96,58cfa82ee4b0c9d6adf6ad96,G7166.TCGA-55-1594-01A-01D-0969-08.11.filtered.,WGS,G7166.TCGA-55-1594-01A-01D-0969-08.11,G7166.TCGA-55-1594-01A-01D-0969-08.11.bam,618.6,1.9,0.14,58cfa82ee4b0c9d6adf6ad96,G7166.TCGA-55-1594-01A-01D-0969-08.11.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-55-1594-01A,6D72DE06-232A-4983-A06C-EBA6D82CB3F1,Primary Tumor,Illumina GA,692f523c-9fa5-429d-ae27-3c0b2d1af53d,Lung,68,2885D4B3-34A6-421D-B20C-EEDAD721D10A,1BC7A463-2E66-4C8B-A34F-05F7CCA3B319,TCGA-55-1594-01A-01D-0969-08,HG19_Broad_variant,TCGA-55-1594,TCGA-LUAD,NA,s11433,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82ee4b0c9d6adf6aae0,58cfa82ee4b0c9d6adf6aae0,G25790.TCGA-50-5066-10A-01D-1625-08.2.filtered.,WGS,G25790.TCGA-50-5066-10A-01D-1625-08.2,G25790.TCGA-50-5066-10A-01D-1625-08.2.bam,128.4,1.9,0.05,58cfa82ee4b0c9d6adf6aae0,G25790.TCGA-50-5066-10A-01D-1625-08.2.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5066-10A,3199CFE5-3BE3-43CD-A36B-5CF2C7A9929F,Blood Derived Normal,Illumina HiSeq,f1c099bc-5e67-4c0b-a6d3-7386e4fa7ef1,Lung,72,93ECDE6B-7F85-48C0-B96B-9D2B6A4DCE46,F64D6DF7-FCD5-498A-96B3-854297069BAC,TCGA-50-5066-10A-01D-1625-08,HG19_Broad_variant,TCGA-50-5066,TCGA-LUAD,NA,s11111,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa82ee4b0c9d6adf6ac0a,58cfa82ee4b0c9d6adf6ac0a,G39019.TCGA-DA-A3F3-10A-01D-A20D-08.2.filtered.,WGS,G39019.TCGA-DA-A3F3-10A-01D-A20D-08.2,G39019.TCGA-DA-A3F3-10A-01D-A20D-08.2.bam,30.28,NA,0.08,58cfa82ee4b0c9d6adf6ac0a,G39019.TCGA-DA-A3F3-10A-01D-A20D-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A3F3-10A,3582FB74-F43D-4FCD-8F22-BB1506FCFF1C,Blood Derived Normal,Illumina HiSeq,01f1d9e1-0bec-49f2-8dec-55f3f6c3b9f6,Skin,52,C28D5222-BE73-4956-9F95-607C443D5406,A2815430-61E0-48A8-8E07-AE14019AA8E3,TCGA-DA-A3F3-10A-01D-A20D-08,HG19_Broad_variant,TCGA-DA-A3F3,TCGA-SKCM,NA,s7316,Broad Institute of MIT and Harvard,Yale,United States,NO,T0,N2b,Not available,Stage IIIB
13722.58cfa82ee4b0c9d6adf6ab14,58cfa82ee4b0c9d6adf6ab14,G26381.TCGA-14-1823-10A-01D-1494-08.1.filtered.,WGS,G26381.TCGA-14-1823-10A-01D-1494-08.1,G26381.TCGA-14-1823-10A-01D-1494-08.1.bam,12.67,1.9,0.05,58cfa82ee4b0c9d6adf6ab14,G26381.TCGA-14-1823-10A-01D-1494-08.1.bam,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1823-10A,A515CF2D-E918-4958-9BF6-E611B425A97E,Blood Derived Normal,Illumina HiSeq,a9678a4f-d7d0-42d2-adc2-d6f7c0f7cb92,Brain,58,6308E006-D201-446E-86ED-30890C6C4826,6D188F81-F062-4903-BB99-A634FDD47FB5,TCGA-14-1823-10A-01D-1494-08,HG19_Broad_variant,TCGA-14-1823,TCGA-GBM,543,s14140,Broad Institute of MIT and Harvard,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6baba,58cfa830e4b0c9d6adf6baba,TCGA-AA-A01S-01A-21D-A17O-10_wgs_Illumina.filtered.,WGS,TCGA-AA-A01S-01A-21D-A17O-10_wgs_Illumina,TCGA-AA-A01S-01A-21D-A17O-10_wgs_Illumina.bam,89.57,1.8,0.07,58cfa830e4b0c9d6adf6baba,TCGA-AA-A01S-01A-21D-A17O-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01S-01A,84E34CF2-B3BB-4A1A-8FB7-6C2C604C4008,Primary Tumor,Illumina HiSeq,02f49f2b-40ad-427b-bb81-6ef0c6efc46d,Colorectal,47,5743700C-CBD3-4F87-8109-6349A96EB605,A64000DF-16E5-4B88-865F-5C680ADF60EB,TCGA-AA-A01S-01A-21D-A17O-10,GRCh37-lite,TCGA-AA-A01S,TCGA-COAD,NA,s12877,Baylor College of Medicine,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6acd1,58cfa82ee4b0c9d6adf6acd1,G39020.TCGA-D7-A4YX-10A-01D-A25E-08.2.filtered.,WGS,G39020.TCGA-D7-A4YX-10A-01D-A25E-08.2,G39020.TCGA-D7-A4YX-10A-01D-A25E-08.2.bam,59.28,NA,0.08,58cfa82ee4b0c9d6adf6acd1,G39020.TCGA-D7-A4YX-10A-01D-A25E-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-A4YX-10A,2B4F014F-74E9-4DDA-A1AD-ABCBD124FC44,Blood Derived Normal,Illumina HiSeq,730adaf7-bfb4-437b-af0e-a94fb4379e88,Stomach,63,2DC37982-5BBC-483F-986E-034B4F9E6E08,D03406DC-FAFB-4B9D-B8F0-B3D683E67273,TCGA-D7-A4YX-10A-01D-A25E-08,HG19_Broad_variant,TCGA-D7-A4YX,TCGA-STAD,NA,s14807,Broad Institute of MIT and Harvard,Greater Poland Cancer Center,Poland,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82de4b0c9d6adf6a48a,58cfa82de4b0c9d6adf6a48a,142ba22e796cab1075278cd533a287c8.filtered.,WGS,142ba22e796cab1075278cd533a287c8,142ba22e796cab1075278cd533a287c8.bam,93.54,2.18,0.07,58cfa82de4b0c9d6adf6a48a,142ba22e796cab1075278cd533a287c8.bam,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A0L9-01A,7B9947D5-E86B-4006-8890-EA5209584A88,Primary Tumor,Illumina HiSeq,56ea48ea-3024-42a8-9753-85711f00712f,Uterus,71,53D0521F-10D6-4F70-9277-D99025A6B963,2B78DE4E-4C8B-4ADF-A058-3DAE797E7881,TCGA-AP-A0L9-01A-11D-A066-09,GRCh37-lite,TCGA-AP-A0L9,TCGA-UCEC,NA,s4234,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Serous endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a894,58cfa82ee4b0c9d6adf6a894,G26383.TCGA-02-2485-01A-01D-1494-08.1.filtered.,WGS,G26383.TCGA-02-2485-01A-01D-1494-08.1,G26383.TCGA-02-2485-01A-01D-1494-08.1.bam,521.7,1.9,0.05,58cfa82ee4b0c9d6adf6a894,G26383.TCGA-02-2485-01A-01D-1494-08.1.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-02-2485-01A,521EA765-1BD1-423D-A75D-091243DF37A9,Primary Tumor,Illumina HiSeq,fd79ff6d-c0aa-4d12-8e39-1e3f1aab26a2,Brain,53,5B5F7C1D-8F3D-4F35-8295-58BC3EEFEAB0,0332B017-17D5-4083-8FC4-9D6F8FDBBBDE,TCGA-02-2485-01A-01D-1494-08,HG19_Broad_variant,TCGA-02-2485,TCGA-GBM,NA,s14220,Broad Institute of MIT and Harvard,MD Anderson Cancer Center,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6a7cc,58cfa82ee4b0c9d6adf6a7cc,G23883.TCGA-A3-3324-11A-01D-2229-08.1.filtered.,WGS,G23883.TCGA-A3-3324-11A-01D-2229-08.1,G23883.TCGA-A3-3324-11A-01D-2229-08.1.bam,308.9,1.9,0.05,58cfa82ee4b0c9d6adf6a7cc,G23883.TCGA-A3-3324-11A-01D-2229-08.1.bam,Alive,MALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-A3-3324-11A,4FCA10BD-988A-47F9-8ED5-037C0D59D70C,Solid Tissue Normal,Illumina HiSeq,fcf4ce9b-1a16-4a5b-877e-0d35638d26c7,Kidney,51,E8F91E49-D1FD-430F-A578-5C98300667B4,19AE5A02-0F02-49BD-9F3B-36D4C15AA64C,TCGA-A3-3324-11A-01D-2229-08,HG19_Broad_variant,TCGA-A3-3324,TCGA-KIRC,NA,s9562,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T1b,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ac84,58cfa82ee4b0c9d6adf6ac84,G48125.TCGA-10-0934-11A-01D-A312-08.3.filtered.,WGS,G48125.TCGA-10-0934-11A-01D-A312-08.3,G48125.TCGA-10-0934-11A-01D-A312-08.3.bam,344.64,1.8,0.07,58cfa82ee4b0c9d6adf6ac84,G48125.TCGA-10-0934-11A-01D-A312-08.3.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-10-0934-11A,65DDCCD2-70A7-48B3-88E1-9D6FD1DCD11B,Solid Tissue Normal,Illumina HiSeq,789d93f9-93ef-41b8-97ac-639d85c95ffb,Ovary,50,982B928B-7B07-4465-B173-BA28527F3ED0,71E80BFC-36A5-4910-9CC6-008931B110BA,TCGA-10-0934-11A-01D-A312-08,HG19_Broad_variant,TCGA-10-0934,TCGA-OV,204,s17323,Broad Institute of MIT and Harvard,MD Anderson Cancer Center,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6af84,58cfa82ee4b0c9d6adf6af84,G7167.TCGA-55-1596-01A-01D-0969-08.12.filtered.,WGS,G7167.TCGA-55-1596-01A-01D-0969-08.12,G7167.TCGA-55-1596-01A-01D-0969-08.12.bam,611.3,1.9,0.13,58cfa82ee4b0c9d6adf6af84,G7167.TCGA-55-1596-01A-01D-0969-08.12.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-55-1596-01A,199386C2-BB53-4FAD-A1B6-59AB216A4A50,Primary Tumor,Illumina GA,bfb2ff32-a7a8-4df0-b8fd-ddcfec0fae22,Lung,55,9A7A1B22-9DF6-438F-AD00-54755C7DBC7C,794F7C54-B879-49AE-B31E-1ED67A504BAB,TCGA-55-1596-01A-01D-0969-08,HG19_Broad_variant,TCGA-55-1596,TCGA-LUAD,NA,s11326,Broad Institute of MIT and Harvard,International Genomics Consortium,None,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6a98f,58cfa82ee4b0c9d6adf6a98f,G26405.TCGA-14-2554-10A-01D-1494-08.1.filtered.,WGS,G26405.TCGA-14-2554-10A-01D-1494-08.1,G26405.TCGA-14-2554-10A-01D-1494-08.1.bam,28,1.9,0.05,58cfa82ee4b0c9d6adf6a98f,G26405.TCGA-14-2554-10A-01D-1494-08.1.bam,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-2554-10A,B1C4579C-72FA-4974-830C-B6A81ACE45F4,Blood Derived Normal,Illumina HiSeq,977d792e-0107-4b27-b209-601a99b280ba,Brain,52,A52481AB-009D-4A66-9530-7A0ED5E09420,EA96115E-F5C4-4F9B-A1DC-EC2C4F591B2B,TCGA-14-2554-10A-01D-1494-08,HG19_Broad_variant,TCGA-14-2554,TCGA-GBM,532,s14306,Broad Institute of MIT and Harvard,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6a9ee,58cfa82ee4b0c9d6adf6a9ee,G26398.TCGA-06-5411-01A-01D-1696-08.2.filtered.,WGS,G26398.TCGA-06-5411-01A-01D-1696-08.2,G26398.TCGA-06-5411-01A-01D-1696-08.2.bam,407.03,1.9,0.05,58cfa82ee4b0c9d6adf6a9ee,G26398.TCGA-06-5411-01A-01D-1696-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-5411-01A,3F960D3B-A58C-43D0-A8A4-F3555B399C9D,Primary Tumor,Illumina HiSeq,a5235cf1-9584-4e39-be51-b383765f3fec,Brain,51,7790FA3D-C06F-4C74-B180-CA6D4F53DC7D,2FDAB641-D73B-4F9A-AA4C-C1944F131A69,TCGA-06-5411-01A-01D-1696-08,HG19_Broad_variant,TCGA-06-5411,TCGA-GBM,254,s14170,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf72f94,58cfa83ce4b0c9d6adf72f94,f45f02f7da5f0692a3a5e6f53061ff05.filtered.,WGS,f45f02f7da5f0692a3a5e6f53061ff05,f45f02f7da5f0692a3a5e6f53061ff05.bam,103.95,1.98,0.08,58cfa83ce4b0c9d6adf72f94,f45f02f7da5f0692a3a5e6f53061ff05.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Aligned reads,TCGA-AP-A053-01A,AF37D8F0-FEA0-47F6-BE0A-2FB55A5DA5C4,Primary Tumor,Illumina HiSeq,f5bf0f66-e1e7-424f-90df-9ec48601cece,Uterus,90,E1121A9E-BC27-44EB-A1AD-EB0AB10B7C3A,B77084AB-8148-49E0-B3F9-90F7D9EA1862,TCGA-AP-A053-01A-21D-A013-09,GRCh37-lite,TCGA-AP-A053,TCGA-UCEC,NA,s4574,Washington University School of Medicine,MSKCC,None,NO,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ad6f,58cfa82ee4b0c9d6adf6ad6f,G7165.TCGA-44-2666-01A-01D-0969-08.12.filtered.,WGS,G7165.TCGA-44-2666-01A-01D-0969-08.12,G7165.TCGA-44-2666-01A-01D-0969-08.12.bam,569.9,1.9,0.15,58cfa82ee4b0c9d6adf6ad6f,G7165.TCGA-44-2666-01A-01D-0969-08.12.bam,Dead,MALE,WHITE,HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-2666-01A,E16CA88F-488B-40F0-9169-E5A62482A2FF,Primary Tumor,Illumina GA,9d582e65-3ad6-4679-a554-5713cc921076,Lung,43,27A64F32-69C5-4C49-86B4-C8FC923CAE08,251C7CF7-EABB-4349-8E25-FC156D84314A,TCGA-44-2666-01A-01D-0969-08,HG19_Broad_variant,TCGA-44-2666,TCGA-LUAD,97,s11217,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6af32,58cfa82ee4b0c9d6adf6af32,G41960.TCGA-97-8171-10A-01D-2284-08.2.filtered.,WGS,G41960.TCGA-97-8171-10A-01D-2284-08.2,G41960.TCGA-97-8171-10A-01D-2284-08.2.bam,220.6,NA,0.05,58cfa82ee4b0c9d6adf6af32,G41960.TCGA-97-8171-10A-01D-2284-08.2.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-97-8171-10A,397D3F69-1453-4057-B177-8723EEC923D1,Blood Derived Normal,Illumina HiSeq,ee38fa28-8a23-4ff5-ab4b-bda6fc6a60ce,Lung,81,C8ECAB9D-F4BC-4DD4-AD69-BDDE1CD5E7AE,843A882C-C77B-4931-B48E-31307CA89B80,TCGA-97-8171-10A-01D-2284-08,HG19_Broad_variant,TCGA-97-8171,TCGA-LUAD,NA,s11543,Broad Institute of MIT and Harvard,Washington University - NYU,United States,NO,T2a,N2,Lung Papillary Adenocarcinoma,Stage IV
13722.58cfa82fe4b0c9d6adf6b8e6,58cfa82fe4b0c9d6adf6b8e6,TCGA-A6-6141-10A-01D-1771-10_wgs_Illumina.filtered.,WGS,TCGA-A6-6141-10A-01D-1771-10_wgs_Illumina,TCGA-A6-6141-10A-01D-1771-10_wgs_Illumina.bam,178.7,1.8,0.05,58cfa82fe4b0c9d6adf6b8e6,TCGA-A6-6141-10A-01D-1771-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-6141-10A,58FACEDB-FCB8-4ECF-8338-2BFA4947ACEF,Blood Derived Normal,Illumina HiSeq,a191bf4a-e494-4741-963f-04125c2a7d25,Colorectal,31,E88FE135-97D0-4C2A-8988-0E26C727C64B,DDFE45B0-0C9B-4B7F-9FB3-17715D85A63D,TCGA-A6-6141-10A-01D-1771-10,GRCh37-lite,TCGA-A6-6141,TCGA-COAD,NA,s13654,Baylor College of Medicine,Christiana Healthcare,United States,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82de4b0c9d6adf6a6fa,58cfa82de4b0c9d6adf6a6fa,9ae1429cc5f7f8e4692281baf49e4ff5.filtered.,WGS,9ae1429cc5f7f8e4692281baf49e4ff5,9ae1429cc5f7f8e4692281baf49e4ff5.bam,55.4,1.9,0.08,58cfa82de4b0c9d6adf6a6fa,9ae1429cc5f7f8e4692281baf49e4ff5.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0RT-01A,4BF50455-9AB7-4521-A791-089F66D3B877,Primary Tumor,Illumina HiSeq,0058348e-638c-426a-9fba-b26a3143c45b,Breast,39,C2300B5B-43A7-43B8-8CD1-22FF7E89A21A,1BB3A1C7-4D7B-4FB6-B54D-E94CBD0E32AA,TCGA-B6-A0RT-01A-21D-A128-09,GRCh37-lite,TCGA-B6-A0RT,TCGA-BRCA,NA,s5635,Washington University School of Medicine,Duke,United States,NO,T3,N1,Infiltrating Ductal Carcinoma,Stage IIIA
13722.58cfa82ee4b0c9d6adf6aa26,58cfa82ee4b0c9d6adf6aa26,G25772.TCGA-38-4630-11A-01D-2364-08.3.filtered.,WGS,G25772.TCGA-38-4630-11A-01D-2364-08.3,G25772.TCGA-38-4630-11A-01D-2364-08.3.bam,35.9,1.9,0.05,58cfa82ee4b0c9d6adf6aa26,G25772.TCGA-38-4630-11A-01D-2364-08.3.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-38-4630-11A,F1985735-A188-4567-A88A-530F9B80291B,Solid Tissue Normal,Illumina HiSeq,fc60deae-7143-44b2-82d5-4a904a986c32,Lung,75,B7124920-82CB-4B1C-B694-3430C2D70331,91AFBD6A-1E04-4AFF-8751-4C7A97196E07,TCGA-38-4630-11A-01D-2364-08,HG19_Broad_variant,TCGA-38-4630,TCGA-LUAD,1073,s11541,Broad Institute of MIT and Harvard,UNC,United States,NO,T2,N0,Lung Papillary Adenocarcinoma,Stage IB
13722.58cfa82ee4b0c9d6adf6aaea,58cfa82ee4b0c9d6adf6aaea,G26362.TCGA-06-0157-10A-01D-1491-08.1.filtered.,WGS,G26362.TCGA-06-0157-10A-01D-1491-08.1,G26362.TCGA-06-0157-10A-01D-1491-08.1.bam,241.7,1.9,0.05,58cfa82ee4b0c9d6adf6aaea,G26362.TCGA-06-0157-10A-01D-1491-08.1.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0157-10A,EA3B5DA2-6A12-400C-BF0F-E442F5EC1132,Blood Derived Normal,Illumina HiSeq,1f51c6b2-084c-4359-9453-15013c15ea02,Brain,63,BED2F325-B640-48E3-9F67-B63C914D2A20,E3C99625-890C-48A0-8926-713CC7BFDDF2,TCGA-06-0157-10A-01D-1491-08,HG19_Broad_variant,TCGA-06-0157,TCGA-GBM,97,s14090,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6a8fd,58cfa82ee4b0c9d6adf6a8fd,G26370.TCGA-27-1831-01A-01D-1494-08.1.filtered.,WGS,G26370.TCGA-27-1831-01A-01D-1494-08.1,G26370.TCGA-27-1831-01A-01D-1494-08.1.bam,564.7,1.93,0.05,58cfa82ee4b0c9d6adf6a8fd,G26370.TCGA-27-1831-01A-01D-1494-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-27-1831-01A,F45F4A30-6B4C-4F15-9140-959D6A25A45F,Primary Tumor,Illumina HiSeq,c2dc8176-a9d4-4f93-877b-c6d55f074569,Brain,66,9BB49615-6F5E-471C-B68B-866E6199CEB7,9880C3C9-5685-42A7-8FE9-7585EA1A1D37,TCGA-27-1831-01A-01D-1494-08,HG19_Broad_variant,TCGA-27-1831,TCGA-GBM,505,s14091,Broad Institute of MIT and Harvard,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6bb4c,58cfa830e4b0c9d6adf6bb4c,TCGA-AA-A01T-01A-21D-A17O-10_wgs_Illumina.filtered.,WGS,TCGA-AA-A01T-01A-21D-A17O-10_wgs_Illumina,TCGA-AA-A01T-01A-21D-A17O-10_wgs_Illumina.bam,80.04,2.03,0.07,58cfa830e4b0c9d6adf6bb4c,TCGA-AA-A01T-01A-21D-A17O-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01T-01A,F87C6DCC-1A9E-4DF5-962C-1F946E2611F8,Primary Tumor,Illumina HiSeq,abefb6f0-6456-48a1-b9d2-3789849aaea6,Colorectal,63,BFC99C6D-7791-4037-9C74-A74BE68E616A,75AD15B9-8F9C-40C1-9CA6-1E8454FBD310,TCGA-AA-A01T-01A-21D-A17O-10,GRCh37-lite,TCGA-AA-A01T,TCGA-COAD,NA,s13681,Baylor College of Medicine,Indivumed,Germany,NO,T3,N1,Colon Adenocarcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6accb,58cfa82ee4b0c9d6adf6accb,G39020.TCGA-D7-6815-01A-11D-1882-08.1.filtered.,WGS,G39020.TCGA-D7-6815-01A-11D-1882-08.1,G39020.TCGA-D7-6815-01A-11D-1882-08.1.bam,457,1.9,0.05,58cfa82ee4b0c9d6adf6accb,G39020.TCGA-D7-6815-01A-11D-1882-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6815-01A,53086E20-A727-40D6-B42D-8030109B5130,Primary Tumor,Illumina HiSeq,6265f1bc-c42b-4073-b83d-4f13fbe9da6c,Stomach,70,B5F3D9A1-46B5-4A63-8F7D-9C993FE9340D,9536F736-63BC-4099-BD54-740F5910F4A8,TCGA-D7-6815-01A-11D-1882-08,HG19_Broad_variant,TCGA-D7-6815,TCGA-STAD,NA,s14682,Broad Institute of MIT and Harvard,Greater Poland Cancer Center,Poland,NO,T2,N2,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIB
13722.58cfa82de4b0c9d6adf6a49e,58cfa82de4b0c9d6adf6a49e,3d2308f4fcb270a0468e663dc68d9a50.filtered.,WGS,3d2308f4fcb270a0468e663dc68d9a50,3d2308f4fcb270a0468e663dc68d9a50.bam,60.36,1.92,0.07,58cfa82de4b0c9d6adf6a49e,3d2308f4fcb270a0468e663dc68d9a50.bam,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Aligned reads,TCGA-A8-A094-01A,993103B1-E5A1-4C33-8629-BE53EBC41D64,Primary Tumor,Illumina HiSeq,d706598d-75e8-4df1-94b7-da37b3361303,Breast,75,A36231AA-F304-4BBF-AA86-B9547916C097,DB45D81F-695C-4F99-BEEA-6DBEC1FF47FC,TCGA-A8-A094-01A-11D-A19H-09,GRCh37-lite,TCGA-A8-A094,TCGA-BRCA,NA,s6618,Washington University School of Medicine,Indivumed,Germany,NO,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6afe3,58cfa82ee4b0c9d6adf6afe3,TCGA-04-1331-10A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-04-1331-10A-01D-A324-10_wgs_Illumina,TCGA-04-1331-10A-01D-A324-10_wgs_Illumina.bam,351.97,1.9,0.07,58cfa82ee4b0c9d6adf6afe3,TCGA-04-1331-10A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-04-1331-10A,6D10D4EE-6331-4BBA-93BC-A7B64CC0B22A,Blood Derived Normal,Illumina HiSeq,d7b9a611-8068-467c-a092-ce952a64effc,Ovary,78,D2959EA3-AB1D-4F28-AE54-F6C0232F5E43,2D0FD5E1-9284-445D-B1F6-E0FB200B7175,TCGA-04-1331-10A-01D-A324-10,GRCh37-lite,TCGA-04-1331,TCGA-OV,1336,s17549,Baylor College of Medicine,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6ba89,58cfa830e4b0c9d6adf6ba89,TCGA-AA-A02Y-10A-01D-A17O-10_wgs_Illumina.filtered.,WGS,TCGA-AA-A02Y-10A-01D-A17O-10_wgs_Illumina,TCGA-AA-A02Y-10A-01D-A17O-10_wgs_Illumina.bam,42.84,1.95,0.07,58cfa830e4b0c9d6adf6ba89,TCGA-AA-A02Y-10A-01D-A17O-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A02Y-10A,A435FDF4-A89A-499E-9006-CBB5693EAB26,Blood Derived Normal,Illumina HiSeq,50ef042d-a98b-44e3-b1d9-85c89deaa267,Colorectal,73,DDA1BA9D-36A4-45EA-A100-8B9B8204A3EF,6FDC4C38-13E7-4B41-8F02-4F31381B1686,TCGA-AA-A02Y-10A-01D-A17O-10,GRCh37-lite,TCGA-AA-A02Y,TCGA-COAD,NA,s13534,Baylor College of Medicine,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6a958,58cfa82ee4b0c9d6adf6a958,G26396.TCGA-41-5651-10A-01D-1696-08.1.filtered.,WGS,G26396.TCGA-41-5651-10A-01D-1696-08.1,G26396.TCGA-41-5651-10A-01D-1696-08.1.bam,251.33,1.9,0.05,58cfa82ee4b0c9d6adf6a958,G26396.TCGA-41-5651-10A-01D-1696-08.1.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-41-5651-10A,C184C3CA-7AD3-4202-B108-CB9FD5F5D947,Blood Derived Normal,Illumina HiSeq,b9800373-e5d2-4730-943d-c76afe37c948,Brain,59,1AA635E0-959F-49DD-B8D1-EB294648830E,54C65BDD-AC2E-466A-80CB-6F534095F56B,TCGA-41-5651-10A-01D-1696-08,HG19_Broad_variant,TCGA-41-5651,TCGA-GBM,NA,s14060,Broad Institute of MIT and Harvard,Christiana Healthcare,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa83ce4b0c9d6adf730f6,58cfa83ce4b0c9d6adf730f6,b71610723dc5331eaa33b8d71c0ef584.filtered.,WGS,b71610723dc5331eaa33b8d71c0ef584,b71610723dc5331eaa33b8d71c0ef584.bam,241.3,1.9,0.15,58cfa83ce4b0c9d6adf730f6,b71610723dc5331eaa33b8d71c0ef584.bam,Dead,MALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1401-01A,6176621D-8534-4FBA-A0E7-74A5A78245A9,Primary Tumor,Illumina GA,1e7c3fa8-690b-47fe-a9e7-93244c0df967,Brain,54,A2DEDF98-1BFC-4E20-A699-852177F3AAB4,36BC0811-ADFE-4F8F-A1D3-B62EAC535263,TCGA-14-1401-01A-01D-0703-09,GRCh37-lite,TCGA-14-1401,TCGA-GBM,114,s14076,Washington University School of Medicine,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6abb0,58cfa82ee4b0c9d6adf6abb0,G26366.TCGA-06-0686-01A-01D-1492-08.2.filtered.,WGS,G26366.TCGA-06-0686-01A-01D-1492-08.2,G26366.TCGA-06-0686-01A-01D-1492-08.2.bam,420.57,1.91,0.05,58cfa82ee4b0c9d6adf6abb0,G26366.TCGA-06-0686-01A-01D-1492-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0686-01A,C931F3BD-74C5-4EBD-BC0F-C7C6BECD25AB,Primary Tumor,Illumina HiSeq,4d80b67a-08f2-45cf-84b2-9aabce938c2f,Brain,53,7AF6D7A5-B550-42D9-983A-241EC76FD7F4,2C71D542-1653-4D97-8752-F2FD05C7E75D,TCGA-06-0686-01A-01D-1492-08,HG19_Broad_variant,TCGA-06-0686,TCGA-GBM,NA,s14344,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82fe4b0c9d6adf6b8a5,58cfa82fe4b0c9d6adf6b8a5,TCGA-A6-2683-01A-01D-1554-10_wgs_Illumina.filtered.,WGS,TCGA-A6-2683-01A-01D-1554-10_wgs_Illumina,TCGA-A6-2683-01A-01D-1554-10_wgs_Illumina.bam,467.29,1.9,0.05,58cfa82fe4b0c9d6adf6b8a5,TCGA-A6-2683-01A-01D-1554-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2683-01A,FAFD4576-0709-49E1-926F-AD1EE09907EC,Primary Tumor,Illumina HiSeq,9e91b702-c4fb-4c6e-9060-987e5ff14421,Colorectal,57,C24759F8-566B-42DA-A26D-BB0BF51EE15F,FC453F67-6623-4E8C-B519-0BD79E4D4651,TCGA-A6-2683-01A-01D-1554-10,GRCh37-lite,TCGA-A6-2683,TCGA-COAD,NA,s13015,Baylor College of Medicine,Christiana Healthcare,None,NO,T4,N0,Colon Adenocarcinoma,Stage IV
13722.58cfa82ee4b0c9d6adf6af66,58cfa82ee4b0c9d6adf6af66,G47088.TCGA-22-5485-11A-01D-1632-08.2.filtered.,WGS,G47088.TCGA-22-5485-11A-01D-1632-08.2,G47088.TCGA-22-5485-11A-01D-1632-08.2.bam,22.7,1.9,0.05,58cfa82ee4b0c9d6adf6af66,G47088.TCGA-22-5485-11A-01D-1632-08.2.bam,Dead,FEMALE,WHITE,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-22-5485-11A,305F72A8-069B-410B-BBE4-4ECB761C748D,Solid Tissue Normal,Illumina HiSeq,3b795763-258b-4d9c-be7c-356c7504a463,Lung,58,AB2B1EC0-6B7F-4C17-A1A4-EBB14F64BADE,95779034-450C-4511-91A7-40BACF8E2F78,TCGA-22-5485-11A-01D-1632-08,HG19_Broad_variant,TCGA-22-5485,TCGA-LUSC,916,s9977,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,United States,NO,T1a,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6aa04,58cfa82ee4b0c9d6adf6aa04,G25250.TCGA-CR-6470-01A-11D-2334-08.1.filtered.,WGS,G25250.TCGA-CR-6470-01A-11D-2334-08.1,G25250.TCGA-CR-6470-01A-11D-2334-08.1.bam,137.7,1.9,0.05,58cfa82ee4b0c9d6adf6aa04,G25250.TCGA-CR-6470-01A-11D-2334-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-6470-01A,CD032DDB-55F2-4C77-8DCF-E4E630F7DE6F,Primary Tumor,Illumina HiSeq,1a71c849-3daa-48f9-b309-4c340a01def2,Head and Neck,38,AFB7EA63-2959-4E53-95EA-7A032DCB5A8B,02C6A893-49C5-49D1-8EB1-195021E70D52,TCGA-CR-6470-01A-11D-2334-08,HG19_Broad_variant,TCGA-CR-6470,TCGA-HNSC,NA,s16019,Broad Institute of MIT and Harvard,Vanderbilt University,United States,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6ab52,58cfa82ee4b0c9d6adf6ab52,G26401.TCGA-15-1444-10A-01D-1696-08.1.filtered.,WGS,G26401.TCGA-15-1444-10A-01D-1696-08.1,G26401.TCGA-15-1444-10A-01D-1696-08.1.bam,2,1.9,0.05,58cfa82ee4b0c9d6adf6ab52,G26401.TCGA-15-1444-10A-01D-1696-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-15-1444-10A,4C42DC4E-66B7-40BF-9FBE-B92543248198,Blood Derived Normal,Illumina HiSeq,89ad7385-8faa-47ff-8b2a-1cf30fa598d6,Brain,21,F64D61AC-B8B7-44A8-A5C4-ADFFF2940FF3,41190F35-E3AF-46E3-9B2D-41BC41D5891B,TCGA-15-1444-10A-01D-1696-08,HG19_Broad_variant,TCGA-15-1444,TCGA-GBM,1537,s14264,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,None,NO,Not available,Not available,Glioblastoma Multiforme (GBM),Not available
13722.58cfa82ee4b0c9d6adf6a8a2,58cfa82ee4b0c9d6adf6a8a2,G32457.TCGA-FD-A3N6-10A-01D-A21A-08.3.filtered.,WGS,G32457.TCGA-FD-A3N6-10A-01D-A21A-08.3,G32457.TCGA-FD-A3N6-10A-01D-A21A-08.3.bam,41.98,NA,0.08,58cfa82ee4b0c9d6adf6a8a2,G32457.TCGA-FD-A3N6-10A-01D-A21A-08.3.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3N6-10A,8C1DD7F7-B74A-4FA2-B6A7-86F0348D2567,Blood Derived Normal,Illumina HiSeq,65a2ebc7-7a90-4db7-9eb2-7123085b6ba0,Bladder,43,B14ED321-47EF-43C9-BA7E-8F36E576FDFB,C648AD3A-6DB3-4079-95C0-66010A038A91,TCGA-FD-A3N6-10A-01D-A21A-08,HG19_Broad_variant,TCGA-FD-A3N6,TCGA-BLCA,NA,s3076,Broad Institute of MIT and Harvard,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa830e4b0c9d6adf6baa2,58cfa830e4b0c9d6adf6baa2,TCGA-AA-3514-01A-02D-1554-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3514-01A-02D-1554-10_wgs_Illumina,TCGA-AA-3514-01A-02D-1554-10_wgs_Illumina.bam,263.29,1.9,0.05,58cfa830e4b0c9d6adf6baa2,TCGA-AA-3514-01A-02D-1554-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3514-01A,DDF69ED9-4C53-48B8-9F01-495BD60C3425,Primary Tumor,Illumina HiSeq,2c81df5f-0948-463a-a303-3beb5bd5205b,Colorectal,81,A657AFDB-5322-454F-8DD7-8397291401C5,A0F94565-9169-49EE-8E6A-21BDC43D9DE6,TCGA-AA-3514-01A-02D-1554-10,GRCh37-lite,TCGA-AA-3514,TCGA-COAD,NA,s13667,Baylor College of Medicine,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c775,58cfa831e4b0c9d6adf6c775,TCGA-D5-6540-10A-01D-1719-10_wgs_Illumina.filtered.,WGS,TCGA-D5-6540-10A-01D-1719-10_wgs_Illumina,TCGA-D5-6540-10A-01D-1719-10_wgs_Illumina.bam,415.7,1.9,0.05,58cfa831e4b0c9d6adf6c775,TCGA-D5-6540-10A-01D-1719-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-D5-6540-10A,B08B5F49-9434-4653-9772-097EC29B2CA3,Blood Derived Normal,Illumina HiSeq,1f5b0f69-5647-47cd-9e0f-48e2bc982525,Colorectal,66,AB08F634-968A-4369-9055-E119A300A1AC,3C79D4CA-E62C-4526-95E9-729BC6BAA978,TCGA-D5-6540-10A-01D-1719-10,GRCh37-lite,TCGA-D5-6540,TCGA-COAD,NA,s13691,Baylor College of Medicine,Greater Poland Cancer Center,Poland,NO,T2,N0,Colon Mucinous Adenocarcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6a8ee,58cfa82ee4b0c9d6adf6a8ee,G26397.TCGA-19-5960-10A-01D-1696-08.1.filtered.,WGS,G26397.TCGA-19-5960-10A-01D-1696-08.1,G26397.TCGA-19-5960-10A-01D-1696-08.1.bam,25.33,1.9,0.05,58cfa82ee4b0c9d6adf6a8ee,G26397.TCGA-19-5960-10A-01D-1696-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-19-5960-10A,93ED7A2B-B0CB-4A84-871F-5C34A0B6A640,Blood Derived Normal,Illumina HiSeq,d727c1bb-a81b-4fec-a46b-ab96e054dc69,Brain,56,CECA084D-EDE6-467C-B0B6-A3224DCDA5E5,6550B1A6-606E-478B-8332-3836C47A6B84,TCGA-19-5960-10A-01D-1696-08,HG19_Broad_variant,TCGA-19-5960,TCGA-GBM,NA,s13927,Broad Institute of MIT and Harvard,Case Western,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6acdb,58cfa82ee4b0c9d6adf6acdb,G39020.TCGA-D7-6519-01A-11D-1800-08.2.filtered.,WGS,G39020.TCGA-D7-6519-01A-11D-1800-08.2,G39020.TCGA-D7-6519-01A-11D-1800-08.2.bam,266.4,1.9,0.05,58cfa82ee4b0c9d6adf6acdb,G39020.TCGA-D7-6519-01A-11D-1800-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6519-01A,E37CAE9E-0656-4B89-B326-739A5CC859E0,Primary Tumor,Illumina HiSeq,8f8b5fc2-7fb8-4a30-968b-375bf038514e,Stomach,64,FA7426E1-FCFB-4B08-AD50-1D9E903A81FB,A2E67393-50D7-4BCC-9BBD-C695086A936A,TCGA-D7-6519-01A-11D-1800-08,HG19_Broad_variant,TCGA-D7-6519,TCGA-STAD,NA,s14683,Broad Institute of MIT and Harvard,Greater Poland Cancer Center,Poland,NO,T2,N1,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIB
13722.58cfa82ee4b0c9d6adf6af1e,58cfa82ee4b0c9d6adf6af1e,G7164.TCGA-44-2665-01A-01D-0969-08.12.filtered.,WGS,G7164.TCGA-44-2665-01A-01D-0969-08.12,G7164.TCGA-44-2665-01A-01D-0969-08.12.bam,579.96,1.9,0.15,58cfa82ee4b0c9d6adf6af1e,G7164.TCGA-44-2665-01A-01D-0969-08.12.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-2665-01A,FB79C491-7B01-42AE-8369-8364E442E31B,Primary Tumor,Illumina GA,e8d44df6-c3ec-4eb3-b4aa-621dbc3c6cb6,Lung,55,A0863FA6-515C-44FA-825F-F9E243F945F1,11F505FA-9306-468A-BBCD-D278892DA83F,TCGA-44-2665-01A-01D-0969-08,HG19_Broad_variant,TCGA-44-2665,TCGA-LUAD,NA,s11327,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82de4b0c9d6adf6a6a2,58cfa82de4b0c9d6adf6a6a2,8f2c8e6bf56e22fe6e78a3ba7ca4e259.filtered.,WGS,8f2c8e6bf56e22fe6e78a3ba7ca4e259,8f2c8e6bf56e22fe6e78a3ba7ca4e259.bam,100.9,NA,0.09,58cfa82de4b0c9d6adf6a6a2,8f2c8e6bf56e22fe6e78a3ba7ca4e259.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49M-10A,B3E248B5-5D40-495C-BD10-90ECF0ED6A95,Blood Derived Normal,HiSeq X Ten,d6f6a616-58b5-49ae-9b9d-8161f2077302,Esophagus,62,A0AE2D0B-40EF-4D6A-8324-D70740FAF2B1,4145A8EE-5E08-48AA-861B-6A8A6BFE3FB2,TCGA-LN-A49M-10A-01D-A27G-09,GRCh37-lite_WUGSC_variant_2,TCGA-LN-A49M,TCGA-ESCA,NA,s1715,Washington University School of Medicine,ILSbio,Vietnam,NO,T2,N0,Not available,Stage IIA
13722.58cfa82ee4b0c9d6adf6af2e,58cfa82ee4b0c9d6adf6af2e,G39020.TCGA-HU-8245-10A-01D-2341-08.4.filtered.,WGS,G39020.TCGA-HU-8245-10A-01D-2341-08.4,G39020.TCGA-HU-8245-10A-01D-2341-08.4.bam,116,NA,0.05,58cfa82ee4b0c9d6adf6af2e,G39020.TCGA-HU-8245-10A-01D-2341-08.4.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-HU-8245-10A,4E9D13DA-438D-4B5E-8E86-67432B5E9471,Blood Derived Normal,Illumina HiSeq,560b1964-381a-4c9d-9cc2-1a16eff727d3,Stomach,72,73473F73-6873-4DBB-9913-99F73719B4F9,143533C9-E5DE-40A3-967C-A410D9E18E0F,TCGA-HU-8245-10A-01D-2341-08,HG19_Broad_variant,TCGA-HU-8245,TCGA-STAD,NA,s14605,Broad Institute of MIT and Harvard,National Cancer Center Korea,Korea South,NO,T3,N0,Stomach Intestinal Adenocarcinoma Papillary Type,Stage IIA
13722.58cfa82ee4b0c9d6adf6acd3,58cfa82ee4b0c9d6adf6acd3,G39020.TCGA-D7-6528-01A-11D-1800-08.2.filtered.,WGS,G39020.TCGA-D7-6528-01A-11D-1800-08.2,G39020.TCGA-D7-6528-01A-11D-1800-08.2.bam,303.4,1.9,0.05,58cfa82ee4b0c9d6adf6acd3,G39020.TCGA-D7-6528-01A-11D-1800-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6528-01A,35496E4E-598F-4FFC-B11E-8EDAEB676079,Primary Tumor,Illumina HiSeq,afbd806d-5a24-4b55-ba74-c8fef8aba22c,Stomach,70,DF817250-9A2C-42E8-AD90-0D9E13FE37B3,153A64EE-6322-4F2E-B3DF-77EF7D3A4CF0,TCGA-D7-6528-01A-11D-1800-08,HG19_Broad_variant,TCGA-D7-6528,TCGA-STAD,NA,s15232,Broad Institute of MIT and Harvard,Greater Poland Cancer Center,Poland,NO,T2,N0,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IB
13722.58cfa82ee4b0c9d6adf6ac5c,58cfa82ee4b0c9d6adf6ac5c,G39019.TCGA-DA-A1I0-10B-01D-A20D-08.3.filtered.,WGS,G39019.TCGA-DA-A1I0-10B-01D-A20D-08.3,G39019.TCGA-DA-A1I0-10B-01D-A20D-08.3.bam,144.4,NA,0.08,58cfa82ee4b0c9d6adf6ac5c,G39019.TCGA-DA-A1I0-10B-01D-A20D-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1I0-10B,68F75AB5-9D77-40C5-A8CE-F56016BBE9E4,Blood Derived Normal,Illumina HiSeq,2bc72654-62f3-4a1b-bb0e-f9fcf6b38eb9,Skin,63,9AB158CD-56A3-4855-9937-56B7B1B99BAB,74F05E46-0AEB-4A0E-924F-546B009BF0A3,TCGA-DA-A1I0-10B-01D-A20D-08,HG19_Broad_variant,TCGA-DA-A1I0,TCGA-SKCM,NA,s7817,Broad Institute of MIT and Harvard,Yale,United States,NO,T4b,N3,Not available,Stage IV
13722.58cfa83ce4b0c9d6adf730b4,58cfa83ce4b0c9d6adf730b4,fae749c6bcfc193aa1b9126628a2cf23.filtered.,WGS,fae749c6bcfc193aa1b9126628a2cf23,fae749c6bcfc193aa1b9126628a2cf23.bam,116.59,1.95,0.07,58cfa83ce4b0c9d6adf730b4,fae749c6bcfc193aa1b9126628a2cf23.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0IJ-01A,2C86C3EA-D926-4D39-A5AE-39ECE4774287,Primary Tumor,Illumina HiSeq,b665cc0b-5952-419e-87a4-d97d3298f607,Breast,42,9EF8142A-8627-4DCF-8C87-15B1BC2BFEA2,B7FAC67C-EB7A-485C-A9B3-3E36388D02B1,TCGA-B6-A0IJ-01A-11D-A128-09,GRCh37-lite,TCGA-B6-A0IJ,TCGA-BRCA,NA,s6907,Washington University School of Medicine,Duke,United States,NO,T3,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa82fe4b0c9d6adf6b848,58cfa82fe4b0c9d6adf6b848,TCGA-36-1574-10A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-36-1574-10A-01D-A324-10_wgs_Illumina,TCGA-36-1574-10A-01D-A324-10_wgs_Illumina.bam,70.27,1.9,0.08,58cfa82fe4b0c9d6adf6b848,TCGA-36-1574-10A-01D-A324-10_wgs_Illumina.bam,Alive,FEMALE,ASIAN,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-36-1574-10A,EEB9D147-608D-4692-8ADF-2F601D23A8FF,Blood Derived Normal,Illumina HiSeq,ccbb810b-2b8b-4c12-8bd7-58ca5fd56b62,Ovary,48,BEC8DC7B-A66E-485E-B7E2-0CA00E2FF9AE,F52F32F7-FB2F-47C1-814B-0202E12B49E0,TCGA-36-1574-10A-01D-A324-10,GRCh37-lite,TCGA-36-1574,TCGA-OV,NA,s17852,Baylor College of Medicine,BC Cancer Agency,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a89c,58cfa82ee4b0c9d6adf6a89c,G25775.TCGA-44-6148-01A-11D-1753-08.1.filtered.,WGS,G25775.TCGA-44-6148-01A-11D-1753-08.1,G25775.TCGA-44-6148-01A-11D-1753-08.1.bam,164.4,1.9,0.05,58cfa82ee4b0c9d6adf6a89c,G25775.TCGA-44-6148-01A-11D-1753-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-6148-01A,8994C8C4-9EA0-46CB-B4A5-0055D7DA5BFA,Primary Tumor,Illumina HiSeq,85617ab0-26a0-468d-b153-3e62d6b86c64,Lung,60,C0FE5FFE-C0A3-4E62-AA55-2BC18788E505,9C7B3AC8-1352-49CD-8A8C-DF6B19F6FD64,TCGA-44-6148-01A-11D-1753-08,HG19_Broad_variant,TCGA-44-6148,TCGA-LUAD,NA,s11320,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,T1b,N0,Lung Mucinous Adenocarcinoma,Stage IA
13722.58cfa82ee4b0c9d6adf6a911,58cfa82ee4b0c9d6adf6a911,G16921.TCGA-BP-4977-01A-01D-2048-08.1.filtered.,WGS,G16921.TCGA-BP-4977-01A-01D-2048-08.1,G16921.TCGA-BP-4977-01A-01D-2048-08.1.bam,26.1,1.9,0.16,58cfa82ee4b0c9d6adf6a911,G16921.TCGA-BP-4977-01A-01D-2048-08.1.bam,Alive,MALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-BP-4977-01A,CC353686-E2B6-46A1-8095-48E2BC44B11F,Primary Tumor,Illumina HiSeq,eb47b3fe-95b7-490e-99d4-9e326b44d448,Kidney,57,35C747C0-38BB-4D2E-A428-8E24106ADFAB,1E046AB9-FA4C-4C15-8D78-ED0048C80EBF,TCGA-BP-4977-01A-01D-2048-08,HG19_Broad_variant,TCGA-BP-4977,TCGA-KIRC,NA,s8831,Broad Institute of MIT and Harvard,MSKCC,None,NO,T1b,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d1fe,58cfa832e4b0c9d6adf6d1fe,TCGA-HE-A5NL-10A-01D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-HE-A5NL-10A-01D-A26P-10_wgs_Illumina,TCGA-HE-A5NL-10A-01D-A26P-10_wgs_Illumina.bam,48.63,NA,0.08,58cfa832e4b0c9d6adf6d1fe,TCGA-HE-A5NL-10A-01D-A26P-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-HE-A5NL-10A,E4245FFF-1281-40E5-87B4-4E42A18A3A63,Blood Derived Normal,Illumina HiSeq,7f1aae21-a79b-474c-b2ae-6a482e3466b7,Kidney,51,B45EC544-6007-4830-8949-4FACAC477986,49CD5084-C2B5-47D4-B921-2F2316AFE33A,TCGA-HE-A5NL-10A-01D-A26P-10,GRCh37-lite,TCGA-HE-A5NL,TCGA-KIRP,NA,s11653,Baylor College of Medicine,Ontario Institute for Cancer Research (OICR),Canada,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6aa7e,58cfa82ee4b0c9d6adf6aa7e,G26368.TCGA-19-2629-10A-01D-1495-08.1.filtered.,WGS,G26368.TCGA-19-2629-10A-01D-1495-08.1,G26368.TCGA-19-2629-10A-01D-1495-08.1.bam,426.4,1.9,0.05,58cfa82ee4b0c9d6adf6aa7e,G26368.TCGA-19-2629-10A-01D-1495-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-19-2629-10A,E17A6048-7A72-42C0-AD3F-97CBFF02BC9F,Blood Derived Normal,Illumina HiSeq,8444fc18-5031-42cc-a853-f4a7c13e9de1,Brain,60,2E71F2FC-5DBC-4D21-935B-C1A0E9294F5F,99337AC4-6BCF-4258-81AA-23C5F807AC5F,TCGA-19-2629-10A-01D-1495-08,HG19_Broad_variant,TCGA-19-2629,TCGA-GBM,737,s14058,Broad Institute of MIT and Harvard,Case Western,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a718,58cfa82de4b0c9d6adf6a718,G12518.TCGA-34-2596-11A-01D-0963-08.1.filtered.,WGS,G12518.TCGA-34-2596-11A-01D-0963-08.1,G12518.TCGA-34-2596-11A-01D-0963-08.1.bam,136.6,1.9,0.15,58cfa82de4b0c9d6adf6a718,G12518.TCGA-34-2596-11A-01D-0963-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-34-2596-11A,7D3E77CC-9603-4722-8E39-1912B678871B,Solid Tissue Normal,Illumina HiSeq,b2b3f403-cadd-461e-aa9e-78a1cb6d9269,Lung,70,6DB2DF95-C7E7-4538-B6B4-A79819FBB97B,2C19C734-0571-43A5-8ABF-78C32AB9AA3F,TCGA-34-2596-11A-01D-0963-08,HG19_Broad_variant,TCGA-34-2596,TCGA-LUSC,80,s10491,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82de4b0c9d6adf6a5ee,58cfa82de4b0c9d6adf6a5ee,6979f0583ba67718dda7c5ddb907abd8.filtered.,WGS,6979f0583ba67718dda7c5ddb907abd8,6979f0583ba67718dda7c5ddb907abd8.bam,77.7,2.03,0.08,58cfa82de4b0c9d6adf6a5ee,6979f0583ba67718dda7c5ddb907abd8.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A0J2-01A,D2F2560C-EC80-4FEA-9474-C47A2E85EA95,Primary Tumor,Illumina HiSeq,46cbf954-a4fb-4060-818c-a60666ae41d3,Breast,41,4F5E142F-D936-469D-ABAA-37BAF6F045AF,207F8A42-5B05-4876-B0AE-EBFAEEA27844,TCGA-AO-A0J2-01A-11D-A19H-09,GRCh37-lite,TCGA-AO-A0J2,TCGA-BRCA,NA,s6459,Washington University School of Medicine,MSKCC,None,NO,T1c,N0 (i-),Infiltrating Ductal Carcinoma,Stage IA
13722.58cfa82ee4b0c9d6adf6a820,58cfa82ee4b0c9d6adf6a820,G14084.TCGA-22-1016-11A-01D-1521-08.3.filtered.,WGS,G14084.TCGA-22-1016-11A-01D-1521-08.3,G14084.TCGA-22-1016-11A-01D-1521-08.3.bam,114.3,1.9,0.05,58cfa82ee4b0c9d6adf6a820,G14084.TCGA-22-1016-11A-01D-1521-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-22-1016-11A,037C57D1-B4A5-45DC-BDA4-0550461D321B,Solid Tissue Normal,Illumina HiSeq,e6c18f56-c0ed-44c7-88d3-3af511cc7509,Lung,65,D06BC0A9-6053-454A-BDB9-BBDFDAA7C4E4,1845BC27-C3D3-4254-909C-2DC91F9E296B,TCGA-22-1016-11A-01D-1521-08,HG19_Broad_variant,TCGA-22-1016,TCGA-LUSC,822,s10249,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,United States,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6a8dc,58cfa82ee4b0c9d6adf6a8dc,G26386.TCGA-06-0745-10A-01D-1492-08.1.filtered.,WGS,G26386.TCGA-06-0745-10A-01D-1492-08.1,G26386.TCGA-06-0745-10A-01D-1492-08.1.bam,126.37,1.9,0.05,58cfa82ee4b0c9d6adf6a8dc,G26386.TCGA-06-0745-10A-01D-1492-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0745-10A,386B629E-FAB1-4033-B088-45D6EEB4A13E,Blood Derived Normal,Illumina HiSeq,71b638af-09a1-4ce2-b3b0-054bbe6e1230,Brain,59,988F196C-121D-44CA-8749-1B8D66B28EF0,8E127A6B-B083-4907-95FF-899FB664E36B,TCGA-06-0745-10A-01D-1492-08,HG19_Broad_variant,TCGA-06-0745,TCGA-GBM,239,s14369,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82de4b0c9d6adf6a4d6,58cfa82de4b0c9d6adf6a4d6,4042a719096f3096b3cbb539a45e6492.filtered.,WGS,4042a719096f3096b3cbb539a45e6492,4042a719096f3096b3cbb539a45e6492.bam,47.52,2,0.07,58cfa82de4b0c9d6adf6a4d6,4042a719096f3096b3cbb539a45e6492.bam,Alive,FEMALE,Not available,HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-AO-A0JM-01A,44BEC761-B603-49C0-8634-F6BFE0319BB1,Primary Tumor,Illumina HiSeq,456682bf-18d1-4383-96ba-6e06fe7dd669,Breast,40,7EC2C455-D90F-4CD5-9BBB-AEDBF21ECA00,AACABA97-ECDE-440B-AAE0-0E9C608C4B24,TCGA-AO-A0JM-01A-21D-A19H-09,GRCh37-lite,TCGA-AO-A0JM,TCGA-BRCA,NA,s5628,Washington University School of Medicine,MSKCC,None,NO,T2,N1,Infiltrating Ductal Carcinoma,Stage IIB
13722.58cfa82ee4b0c9d6adf6ae4c,58cfa82ee4b0c9d6adf6ae4c,G49837.TCGA-37-4135-10A-01D-A320-08.2.filtered.,WGS,G49837.TCGA-37-4135-10A-01D-A320-08.2,G49837.TCGA-37-4135-10A-01D-A320-08.2.bam,287.9,1.9,0.08,58cfa82ee4b0c9d6adf6ae4c,G49837.TCGA-37-4135-10A-01D-A320-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-37-4135-10A,1F6B2ACA-7357-40D1-BA7A-99227D9900A2,Blood Derived Normal,Illumina HiSeq,eb881cc1-8710-4cdc-9c55-61d5ea05b373,Lung,68,A3A8DF4E-06EE-4BAF-B53A-8A9396298D13,F056D7BA-D5C7-436B-8F20-8B57C9693982,TCGA-37-4135-10A-01D-A320-08,HG19_Broad_variant,TCGA-37-4135,TCGA-LUSC,NA,s10083,Broad Institute of MIT and Harvard,Cureline,Russia,NO,T2a,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6ab8a,58cfa82ee4b0c9d6adf6ab8a,G26372.TCGA-26-5132-01A-01D-1486-08.2.filtered.,WGS,G26372.TCGA-26-5132-01A-01D-1486-08.2,G26372.TCGA-26-5132-01A-01D-1486-08.2.bam,568.73,1.9,0.05,58cfa82ee4b0c9d6adf6ab8a,G26372.TCGA-26-5132-01A-01D-1486-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-26-5132-01A,2C5FA2D4-8E35-42E4-8BCA-9FB3371A19C8,Primary Tumor,Illumina HiSeq,68345c45-66a1-48a6-a6a5-ed29b8525b04,Brain,74,AC7EA2F0-A526-4B9A-8E81-2736EA38F53B,D1132127-1250-43AF-9C16-425798A3D1A7,TCGA-26-5132-01A-01D-1486-08,HG19_Broad_variant,TCGA-26-5132,TCGA-GBM,NA,s13890,Broad Institute of MIT and Harvard,University of Florida,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6a8c5,58cfa82ee4b0c9d6adf6a8c5,G26391.TCGA-26-5135-10A-01D-1486-08.1.filtered.,WGS,G26391.TCGA-26-5135-10A-01D-1486-08.1,G26391.TCGA-26-5135-10A-01D-1486-08.1.bam,1134.03,1.9,0.05,58cfa82ee4b0c9d6adf6a8c5,G26391.TCGA-26-5135-10A-01D-1486-08.1.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-26-5135-10A,69D56F2D-6924-409B-9D1E-C8D69B400270,Blood Derived Normal,Illumina HiSeq,8e72e896-81dd-423e-9281-48ba03a34a81,Brain,72,CD1E6F91-F07B-4804-B8C9-A03DB048C1B1,8F36AD24-C425-4474-9D03-A5198E2E4901,TCGA-26-5135-10A-01D-1486-08,HG19_Broad_variant,TCGA-26-5135,TCGA-GBM,270,s13980,Broad Institute of MIT and Harvard,University of Florida,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82fe4b0c9d6adf6b40a,58cfa82fe4b0c9d6adf6b40a,TCGA-24-1548-10A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-24-1548-10A-01D-A324-10_wgs_Illumina,TCGA-24-1548-10A-01D-A324-10_wgs_Illumina.bam,446.27,1.8,0.07,58cfa82fe4b0c9d6adf6b40a,TCGA-24-1548-10A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1548-10A,66C92B9E-DE3C-4D1A-BB69-46FFBC6CAF33,Blood Derived Normal,Illumina HiSeq,0a967210-59cb-4e43-9d66-c3d5b0a049a4,Ovary,57,96F72B40-4178-4522-B754-A01EB2D7FEBA,8946FFC5-50DF-4EC8-99A5-84C80176C8D0,TCGA-24-1548-10A-01D-A324-10,GRCh37-lite,TCGA-24-1548,TCGA-OV,493,s17673,Baylor College of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ada8,58cfa82ee4b0c9d6adf6ada8,G48125.TCGA-25-2400-10A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-25-2400-10A-01D-A312-08.2,G48125.TCGA-25-2400-10A-01D-A312-08.2.bam,147.27,1.9,0.08,58cfa82ee4b0c9d6adf6ada8,G48125.TCGA-25-2400-10A-01D-A312-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-25-2400-10A,5C127332-5CA0-45F1-A5AC-4876AD94E491,Blood Derived Normal,Illumina HiSeq,8985a7c0-08ee-4d1d-92fc-eedf204add84,Ovary,76,9C899D76-6517-4A18-B444-8AA5A2DE9E2B,B38DE3A7-DFA7-45C6-8667-AD6BEF18A442,TCGA-25-2400-10A-01D-A312-08,HG19_Broad_variant,TCGA-25-2400,TCGA-OV,1278,s17203,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a81c,58cfa82ee4b0c9d6adf6a81c,G32552.TCGA-EE-A2GN-06A-11D-A196-08.2.filtered.,WGS,G32552.TCGA-EE-A2GN-06A-11D-A196-08.2,G32552.TCGA-EE-A2GN-06A-11D-A196-08.2.bam,57.21,NA,0.08,58cfa82ee4b0c9d6adf6a81c,G32552.TCGA-EE-A2GN-06A-11D-A196-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2GN-06A,BE73FDE2-D843-426B-9306-A02D3F2A754B,Metastatic,Illumina HiSeq,5742f760-4f41-4dea-b4b3-c3a421d561f8,Skin,67,C496DD26-D412-4651-B2F0-5E868B80873E,10BB1A92-901E-4A14-80F4-5E88F997754B,TCGA-EE-A2GN-06A-11D-A196-08,HG19_Broad_variant,TCGA-EE-A2GN,TCGA-SKCM,NA,s7479,Broad Institute of MIT and Harvard,University of Sydney,Australia,NO,T2b,N0,Not available,Stage IIA
13722.58cfa82ee4b0c9d6adf6a7df,58cfa82ee4b0c9d6adf6a7df,G25782.TCGA-55-6982-11A-01D-1945-08.2.filtered.,WGS,G25782.TCGA-55-6982-11A-01D-1945-08.2,G25782.TCGA-55-6982-11A-01D-1945-08.2.bam,477.7,NA,0.05,58cfa82ee4b0c9d6adf6a7df,G25782.TCGA-55-6982-11A-01D-1945-08.2.bam,Dead,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-55-6982-11A,35CB7841-9B09-465A-90C5-E3B8A9FAAD49,Solid Tissue Normal,Illumina HiSeq,30195f83-7677-450a-83b9-06eeeda2a008,Lung,79,FFB185AA-75AC-4696-936B-52F35A345A2D,48A02A49-E77F-4A18-A2A2-3E28F13B25DA,TCGA-55-6982-11A-01D-1945-08,HG19_Broad_variant,TCGA-55-6982,TCGA-LUAD,995,s10634,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6a9c4,58cfa82ee4b0c9d6adf6a9c4,G23076.TCGA_CV_5443_01A_01D_2268_08.1.filtered.,WGS,G23076.TCGA_CV_5443_01A_01D_2268_08.1,G23076.TCGA_CV_5443_01A_01D_2268_08.1.bam,385,1.9,0.15,58cfa82ee4b0c9d6adf6a9c4,G23076.TCGA_CV_5443_01A_01D_2268_08.1.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5443-01A,180036A2-3B56-405E-A1FE-D5932517B6C7,Primary Tumor,Illumina HiSeq,9e76f187-2863-42f5-9540-da82b815d6c0,Head and Neck,63,746322C7-FE75-4B9F-9309-93E9CFA4CB5A,D4B80307-ABBD-48BB-B52C-6DCD409699A2,TCGA-CV-5443-01A-01D-2268-08,HG19_Broad_variant,TCGA-CV-5443,TCGA-HNSC,NA,s15742,Broad Institute of MIT and Harvard,MD Anderson Cancer Center,None,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6adc4,58cfa82ee4b0c9d6adf6adc4,G49837.TCGA-33-4586-11A-01D-A320-08.2.filtered.,WGS,G49837.TCGA-33-4586-11A-01D-A320-08.2,G49837.TCGA-33-4586-11A-01D-A320-08.2.bam,202,1.9,0.08,58cfa82ee4b0c9d6adf6adc4,G49837.TCGA-33-4586-11A-01D-A320-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-33-4586-11A,376DFD27-68E8-4A1A-9C4F-5064279B2A9E,Solid Tissue Normal,Illumina HiSeq,b0808e9e-a9c8-494d-a9ac-4216b64a3354,Lung,57,69CB1538-12D7-4C0A-97F4-0CD616504DBF,F0BDFACC-5435-42D2-9A09-FEED38AAA569,TCGA-33-4586-11A-01D-A320-08,HG19_Broad_variant,TCGA-33-4586,TCGA-LUSC,428,s9980,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T2,N2,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82ee4b0c9d6adf6aa7c,58cfa82ee4b0c9d6adf6aa7c,G26372.TCGA-26-5132-10A-01D-1486-08.2.filtered.,WGS,G26372.TCGA-26-5132-10A-01D-1486-08.2,G26372.TCGA-26-5132-10A-01D-1486-08.2.bam,1015.03,1.9,0.05,58cfa82ee4b0c9d6adf6aa7c,G26372.TCGA-26-5132-10A-01D-1486-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-26-5132-10A,2C5FA2D4-8E35-42E4-8BCA-9FB3371A19C8,Blood Derived Normal,Illumina HiSeq,d35abd2a-0380-439d-bdd4-c53e9119ac66,Brain,74,E13162B5-A8D3-434C-919F-D81309E29C89,D3B73B4C-8CAD-4FA2-B329-27B3F62F0748,TCGA-26-5132-10A-01D-1486-08,HG19_Broad_variant,TCGA-26-5132,TCGA-GBM,NA,s13946,Broad Institute of MIT and Harvard,University of Florida,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6aa72,58cfa82ee4b0c9d6adf6aa72,G26387.TCGA-19-2620-01A-01D-1495-08.2.filtered.,WGS,G26387.TCGA-19-2620-01A-01D-1495-08.2,G26387.TCGA-19-2620-01A-01D-1495-08.2.bam,648.1,1.9,0.05,58cfa82ee4b0c9d6adf6aa72,G26387.TCGA-19-2620-01A-01D-1495-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-19-2620-01A,352768F9-3CE1-419C-BEEF-6515C78F5D7A,Primary Tumor,Illumina HiSeq,57c2175a-25d3-4859-9eab-ecf3563510e9,Brain,70,2ED6BBB4-C2FB-42BF-A0B6-8687A73B3B7B,6DE41AC1-229B-40B9-A494-5588C284351D,TCGA-19-2620-01A-01D-1495-08,HG19_Broad_variant,TCGA-19-2620,TCGA-GBM,148,s14368,Broad Institute of MIT and Harvard,Case Western,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6aad0,58cfa82ee4b0c9d6adf6aad0,G25251.TCGA-CR-7404-10A-01D-2334-08.1.filtered.,WGS,G25251.TCGA-CR-7404-10A-01D-2334-08.1,G25251.TCGA-CR-7404-10A-01D-2334-08.1.bam,210,NA,0.05,58cfa82ee4b0c9d6adf6aad0,G25251.TCGA-CR-7404-10A-01D-2334-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-7404-10A,D189A6C6-210F-4957-B500-457D5CE3F867,Blood Derived Normal,Illumina HiSeq,ee383040-a4f3-4618-8286-715b2d1fa381,Head and Neck,53,A0723862-62F9-4770-B415-E8F52C447E7A,8BEF3E1F-1C5D-4770-9FDE-25B760B4C235,TCGA-CR-7404-10A-01D-2334-08,HG19_Broad_variant,TCGA-CR-7404,TCGA-HNSC,NA,s16311,Broad Institute of MIT and Harvard,Vanderbilt University,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ab64,58cfa82ee4b0c9d6adf6ab64,G32469.TCGA-DK-A1AG-10A-01D-A13W-08.1.filtered.,WGS,G32469.TCGA-DK-A1AG-10A-01D-A13W-08.1,G32469.TCGA-DK-A1AG-10A-01D-A13W-08.1.bam,49.77,1.93,0.08,58cfa82ee4b0c9d6adf6ab64,G32469.TCGA-DK-A1AG-10A-01D-A13W-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AG-10A,F8C0A69C-DF53-4A0A-A30E-4424C0CE3DD5,Blood Derived Normal,Illumina HiSeq,61d6a720-87af-44e2-9d20-b63f90902707,Bladder,65,A55072D2-EFF0-4B87-8330-55022E8D6F39,709C4655-20E7-46E3-B4C1-920C180ABD6F,TCGA-DK-A1AG-10A-01D-A13W-08,HG19_Broad_variant,TCGA-DK-A1AG,TCGA-BLCA,NA,s3068,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa83ce4b0c9d6adf73104,58cfa83ce4b0c9d6adf73104,bbb8b1b82e376eb4e8ac399b06def113.filtered.,WGS,bbb8b1b82e376eb4e8ac399b06def113,bbb8b1b82e376eb4e8ac399b06def113.bam,64.8,2.03,0.08,58cfa83ce4b0c9d6adf73104,bbb8b1b82e376eb4e8ac399b06def113.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Aligned reads,TCGA-B6-A0I6-01A,045C13EF-3DB7-4ADF-B0A3-23338F0479F3,Primary Tumor,Illumina HiSeq,aea89793-bb38-432a-ab2c-b5b9e7e93b1c,Breast,49,14423610-4958-43F4-9A75-1A61C1293024,A876398C-5B1D-444F-A360-5FE2DB697480,TCGA-B6-A0I6-01A-11D-A128-09,GRCh37-lite,TCGA-B6-A0I6,TCGA-BRCA,991,s5621,Washington University School of Medicine,Duke,United States,NO,T1c,N1,Infiltrating Ductal Carcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6aeb2,58cfa82ee4b0c9d6adf6aeb2,G49537.TCGA-FK-A3SD-10A-01D-A33C-08.1.filtered.,WGS,G49537.TCGA-FK-A3SD-10A-01D-A33C-08.1,G49537.TCGA-FK-A3SD-10A-01D-A33C-08.1.bam,16.39,NA,0.08,58cfa82ee4b0c9d6adf6aeb2,G49537.TCGA-FK-A3SD-10A-01D-A33C-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FK-A3SD-10A,63B01B43-A68A-4046-89B0-736BA4D08504,Blood Derived Normal,Illumina HiSeq,6cd08051-c648-4319-bd44-0a79ea528e26,Thyroid,61,EB001D98-07C7-42BA-BDCA-8CBADB4B926A,FFA84A31-0507-4EFA-856A-7A3C74BA1AC5,TCGA-FK-A3SD-10A-01D-A33C-08,HG19_Broad_variant,TCGA-FK-A3SD,TCGA-THCA,NA,s12091,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82ee4b0c9d6adf6ab71,58cfa82ee4b0c9d6adf6ab71,G25785.TCGA-78-7143-10A-01D-2036-08.1.filtered.,WGS,G25785.TCGA-78-7143-10A-01D-2036-08.1,G25785.TCGA-78-7143-10A-01D-2036-08.1.bam,32.67,NA,0.05,58cfa82ee4b0c9d6adf6ab71,G25785.TCGA-78-7143-10A-01D-2036-08.1.bam,Dead,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-78-7143-10A,54254F5A-50E8-4150-A9B7-56A0470D2A56,Blood Derived Normal,Illumina HiSeq,06f9a2a0-93e4-4d22-a956-91e3d6a212ab,Lung,62,395CFDE3-B76F-4358-BD47-ACF9CD673AB6,11E7F779-F338-41D4-914D-19F50CC524C3,TCGA-78-7143-10A-01D-2036-08,HG19_Broad_variant,TCGA-78-7143,TCGA-LUAD,4961,s11427,Broad Institute of MIT and Harvard,Prince Charles Hospital,Australia,NO,T2,N0,Lung Bronchioloalveolar Carcinoma Nonmucinous,Stage IB
13722.58cfa82ee4b0c9d6adf6aa46,58cfa82ee4b0c9d6adf6aa46,G32469.TCGA-DK-A1AG-10A-01D-A13W-08.2.filtered.,WGS,G32469.TCGA-DK-A1AG-10A-01D-A13W-08.2,G32469.TCGA-DK-A1AG-10A-01D-A13W-08.2.bam,49.77,1.93,0.08,58cfa82ee4b0c9d6adf6aa46,G32469.TCGA-DK-A1AG-10A-01D-A13W-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AG-10A,F8C0A69C-DF53-4A0A-A30E-4424C0CE3DD5,Blood Derived Normal,Illumina HiSeq,bac01409-fa33-40a5-a528-0677d2966f4f,Bladder,65,A55072D2-EFF0-4B87-8330-55022E8D6F39,709C4655-20E7-46E3-B4C1-920C180ABD6F,TCGA-DK-A1AG-10A-01D-A13W-08,HG19_Broad_variant,TCGA-DK-A1AG,TCGA-BLCA,NA,s3256,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82ee4b0c9d6adf6aa69,58cfa82ee4b0c9d6adf6aa69,G25779.TCGA-49-4512-11A-01D-1855-08.4.filtered.,WGS,G25779.TCGA-49-4512-11A-01D-1855-08.4,G25779.TCGA-49-4512-11A-01D-1855-08.4.bam,151.7,1.9,0.05,58cfa82ee4b0c9d6adf6aa69,G25779.TCGA-49-4512-11A-01D-1855-08.4.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4512-11A,A1E65587-24C1-4B41-92A7-4E1F15FFFD78,Solid Tissue Normal,Illumina HiSeq,a9aa7e90-edbc-423c-a549-7345a7767b59,Lung,69,67BF333D-F746-497F-B6B1-F241E93DC467,F76EF845-8A03-4B61-B1B2-3F0B4AE5A759,TCGA-49-4512-11A-01D-1855-08,HG19_Broad_variant,TCGA-49-4512,TCGA-LUAD,905,s11429,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82ee4b0c9d6adf6aa78,58cfa82ee4b0c9d6adf6aa78,G32451.TCGA-BT-A20T-01A-11D-A14W-08.1.filtered.,WGS,G32451.TCGA-BT-A20T-01A-11D-A14W-08.1,G32451.TCGA-BT-A20T-01A-11D-A14W-08.1.bam,59.68,2.07,0.09,58cfa82ee4b0c9d6adf6aa78,G32451.TCGA-BT-A20T-01A-11D-A14W-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-BT-A20T-01A,096B4F32-10C1-4737-A0DD-CAE04C54EE33,Primary Tumor,Illumina HiSeq,7d40d139-a746-424d-9f90-d5d3da5e98cb,Bladder,63,52F538EF-B05D-4C76-9976-CE6D49158016,301D6CE3-4099-4C1D-8E50-C04B7CE91450,TCGA-BT-A20T-01A-11D-A14W-08,HG19_Broad_variant,TCGA-BT-A20T,TCGA-BLCA,453,s2674,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV
13722.58cfa82ee4b0c9d6adf6a995,58cfa82ee4b0c9d6adf6a995,G23063.TCGA_CR_7385_10A_01D_2268_08.1.filtered.,WGS,G23063.TCGA_CR_7385_10A_01D_2268_08.1,G23063.TCGA_CR_7385_10A_01D_2268_08.1.bam,25,NA,0.13,58cfa82ee4b0c9d6adf6a995,G23063.TCGA_CR_7385_10A_01D_2268_08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-7385-10A,9F89510C-ED07-471F-B35E-7C87C237B9FE,Blood Derived Normal,Illumina HiSeq,c5913c28-c0b8-4239-a121-017446bde4c3,Head and Neck,42,D1553B1A-BC1E-4DCF-A273-B3EFFABE380B,3A27A8C3-E060-4251-A0D5-D4AF2032391D,TCGA-CR-7385-10A-01D-2268-08,HG19_Broad_variant,TCGA-CR-7385,TCGA-HNSC,NA,s15865,Broad Institute of MIT and Harvard,Vanderbilt University,United States,NO,T1,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6adfe,58cfa82ee4b0c9d6adf6adfe,G7169.TCGA-67-3772-01A-01D-0969-08.11.filtered.,WGS,G7169.TCGA-67-3772-01A-01D-0969-08.11,G7169.TCGA-67-3772-01A-01D-0969-08.11.bam,0,1.9,0.13,58cfa82ee4b0c9d6adf6adfe,G7169.TCGA-67-3772-01A-01D-0969-08.11.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-67-3772-01A,673493F6-975C-49E8-934C-001E9A0FFF90,Primary Tumor,Illumina GA,71899006-7e86-49e1-9d51-c2bd90b4d74e,Lung,82,F65C895F-CFEA-46A3-B3A0-7C8A98D7522A,FE0F7D12-BC3B-4465-A0C8-D54F1CD2032A,TCGA-67-3772-01A-01D-0969-08,HG19_Broad_variant,TCGA-67-3772,TCGA-LUAD,NA,s10978,Broad Institute of MIT and Harvard,St Joseph's Medical Center (MD),United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6abac,58cfa82ee4b0c9d6adf6abac,G25250.TCGA-CR-6470-10A-01D-2334-08.1.filtered.,WGS,G25250.TCGA-CR-6470-10A-01D-2334-08.1,G25250.TCGA-CR-6470-10A-01D-2334-08.1.bam,142,1.9,0.05,58cfa82ee4b0c9d6adf6abac,G25250.TCGA-CR-6470-10A-01D-2334-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-6470-10A,CD032DDB-55F2-4C77-8DCF-E4E630F7DE6F,Blood Derived Normal,Illumina HiSeq,08705672-13bb-497c-8d31-11c561bfe1a4,Head and Neck,38,AA121605-A2C9-43FC-A836-8EC6C42B99DE,6CCAA1AA-3906-41B8-AC89-C35ADC6DFDCC,TCGA-CR-6470-10A-01D-2334-08,HG19_Broad_variant,TCGA-CR-6470,TCGA-HNSC,NA,s16021,Broad Institute of MIT and Harvard,Vanderbilt University,United States,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6aa13,58cfa82ee4b0c9d6adf6aa13,G25787.TCGA-78-7156-10A-01D-2036-08.1.filtered.,WGS,G25787.TCGA-78-7156-10A-01D-2036-08.1,G25787.TCGA-78-7156-10A-01D-2036-08.1.bam,63,NA,0.05,58cfa82ee4b0c9d6adf6aa13,G25787.TCGA-78-7156-10A-01D-2036-08.1.bam,Dead,MALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-78-7156-10A,7B0622AB-63EA-483F-AE40-D3EA587BDBBA,Blood Derived Normal,Illumina HiSeq,93ab8b16-f10e-47da-af99-cc812181135b,Lung,62,8EFB4F70-FC31-42D6-8E99-B95069C771A4,9E3E8148-B609-4B1D-9AC9-AC8F730B14EF,TCGA-78-7156-10A-01D-2036-08,HG19_Broad_variant,TCGA-78-7156,TCGA-LUAD,976,s11112,Broad Institute of MIT and Harvard,Prince Charles Hospital,Australia,NO,T4,N1,Lung Adenocarcinoma Mixed Subtype,Stage IV
13722.58cfa82ee4b0c9d6adf6af17,58cfa82ee4b0c9d6adf6af17,TCGA-04-1347-11A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-04-1347-11A-01D-A324-10_wgs_Illumina,TCGA-04-1347-11A-01D-A324-10_wgs_Illumina.bam,60.97,1.9,0.08,58cfa82ee4b0c9d6adf6af17,TCGA-04-1347-11A-01D-A324-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-04-1347-11A,F0C353FD-947C-41E2-B643-3ECC0D69796C,Solid Tissue Normal,Illumina HiSeq,545030a3-4183-4f19-820b-c9b91d6ab6cc,Ovary,81,54A8FDB2-D9D9-4A89-987A-DA9BED69D145,B1B27DCF-4015-4DFA-ACF5-0A47E93E3F0D,TCGA-04-1347-11A-01D-A324-10,GRCh37-lite,TCGA-04-1347,TCGA-OV,NA,s17205,Baylor College of Medicine,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a922,58cfa82ee4b0c9d6adf6a922,G26380.TCGA-06-0744-01A-01D-1492-08.1.filtered.,WGS,G26380.TCGA-06-0744-01A-01D-1492-08.1,G26380.TCGA-06-0744-01A-01D-1492-08.1.bam,108.57,1.91,0.05,58cfa82ee4b0c9d6adf6a922,G26380.TCGA-06-0744-01A-01D-1492-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0744-01A,5613F5F6-086D-470B-8F77-6DCB7F8625B7,Primary Tumor,Illumina HiSeq,fec78208-6a76-43eb-9c8c-a3d7c5d55fed,Brain,66,C01952D4-AE81-48E2-8818-0E438E66B516,914421D2-898E-433E-BB66-B1710EAAE2C7,TCGA-06-0744-01A-01D-1492-08,HG19_Broad_variant,TCGA-06-0744,TCGA-GBM,NA,s14138,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6a9e7,58cfa82ee4b0c9d6adf6a9e7,G25771.TCGA-05-4395-01A-01D-2364-08.1.filtered.,WGS,G25771.TCGA-05-4395-01A-01D-2364-08.1,G25771.TCGA-05-4395-01A-01D-2364-08.1.bam,385.2,1.9,0.05,58cfa82ee4b0c9d6adf6a9e7,G25771.TCGA-05-4395-01A-01D-2364-08.1.bam,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4395-01A,762DEA8A-5B41-4058-979A-B7876ED13D7E,Primary Tumor,Illumina HiSeq,e32c5a48-a697-44eb-8628-35528945fdf2,Lung,76,9DED6605-39A3-4C0F-AD2E-7F6863960DBE,BCE88385-4A1B-4A8C-920C-060F6A2675D4,TCGA-05-4395-01A-01D-2364-08,HG19_Broad_variant,TCGA-05-4395,TCGA-LUAD,0,s11216,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T4,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIB
13722.58cfa82ee4b0c9d6adf6a8da,58cfa82ee4b0c9d6adf6a8da,G25786.TCGA-78-7146-01A-11D-2036-08.2.filtered.,WGS,G25786.TCGA-78-7146-01A-11D-2036-08.2,G25786.TCGA-78-7146-01A-11D-2036-08.2.bam,113.7,NA,0.05,58cfa82ee4b0c9d6adf6a8da,G25786.TCGA-78-7146-01A-11D-2036-08.2.bam,Dead,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-78-7146-01A,FF9DEF3D-17E5-4EF6-B74E-933F11ED6F00,Primary Tumor,Illumina HiSeq,17e2078c-ad94-4ecc-ba36-9a8e9e4e237e,Lung,71,98A8D751-4EFD-442E-A242-0FE399C2586F,7692E684-4AF2-4892-80AD-1F417B6B38FA,TCGA-78-7146-01A-11D-2036-08,HG19_Broad_variant,TCGA-78-7146,TCGA-LUAD,173,s11108,Broad Institute of MIT and Harvard,Prince Charles Hospital,Australia,NO,T2,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIA
13722.58cfa82ee4b0c9d6adf6af44,58cfa82ee4b0c9d6adf6af44,G47088.TCGA-22-5477-11A-11D-1632-08.1.filtered.,WGS,G47088.TCGA-22-5477-11A-11D-1632-08.1,G47088.TCGA-22-5477-11A-11D-1632-08.1.bam,102.7,1.9,0.05,58cfa82ee4b0c9d6adf6af44,G47088.TCGA-22-5477-11A-11D-1632-08.1.bam,Dead,MALE,WHITE,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-22-5477-11A,BD15F523-45C4-4D7C-A3CC-4FB56ABB0E54,Solid Tissue Normal,Illumina HiSeq,d06f08f9-42b9-4a99-acaa-98fdc8f159ab,Lung,65,F83937DB-9C5A-4E27-9627-C92D90610C6A,186FABC6-490C-4D90-AD23-CE9AD326FC1B,TCGA-22-5477-11A-11D-1632-08,HG19_Broad_variant,TCGA-22-5477,TCGA-LUSC,1346,s10365,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,United States,NO,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6ab78,58cfa82ee4b0c9d6adf6ab78,G23065.TCGA_BA_5153_10A_01D_2268_08.1.filtered.,WGS,G23065.TCGA_BA_5153_10A_01D_2268_08.1,G23065.TCGA_BA_5153_10A_01D_2268_08.1.bam,61.4,1.9,0.14,58cfa82ee4b0c9d6adf6ab78,G23065.TCGA_BA_5153_10A_01D_2268_08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5153-10A,B3631718-9E0A-454C-BEE1-8F36EBC509D8,Blood Derived Normal,Illumina HiSeq,2908ea28-7831-4ed0-9a9e-fab525fefab6,Head and Neck,51,F079E825-160A-40D5-97CC-1931F11C4E2E,FF47B947-C437-4692-AB18-733411C22ABF,TCGA-BA-5153-10A-01D-2268-08,HG19_Broad_variant,TCGA-BA-5153,TCGA-HNSC,1762,s16020,Broad Institute of MIT and Harvard,UNC,None,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aeae,58cfa82ee4b0c9d6adf6aeae,G48125.TCGA-23-1118-10A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-23-1118-10A-01D-A312-08.2,G48125.TCGA-23-1118-10A-01D-A312-08.2.bam,52.97,1.9,0.07,58cfa82ee4b0c9d6adf6aeae,G48125.TCGA-23-1118-10A-01D-A312-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-23-1118-10A,700E91BB-D675-41B2-BBBD-935767C7B447,Blood Derived Normal,Illumina HiSeq,411c7429-f7ea-439a-8768-7a2d1b1d7860,Ovary,45,857BC101-F2A9-4B08-BE06-0BE2FF0A0EB7,8DAA040B-E9B4-4229-8683-D9DE3F555BC4,TCGA-23-1118-10A-01D-A312-08,HG19_Broad_variant,TCGA-23-1118,TCGA-OV,NA,s17707,Broad Institute of MIT and Harvard,Cedars Sinai,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a76c,58cfa82de4b0c9d6adf6a76c,G14853.TCGA-05-4420-10A-01D-1931-08.1.filtered.,WGS,G14853.TCGA-05-4420-10A-01D-1931-08.1,G14853.TCGA-05-4420-10A-01D-1931-08.1.bam,98.23,1.9,0.14,58cfa82de4b0c9d6adf6a76c,G14853.TCGA-05-4420-10A-01D-1931-08.1.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4420-10A,3D2AA654-1B5F-4EB4-A1C2-AF31F5760069,Blood Derived Normal,Illumina HiSeq,803b9ff0-11e8-413f-8486-c9ad1ea350bc,Lung,41,79586ED4-9D42-46D1-B318-70C5E1C471F2,8645FF43-07EB-4E62-A3A0-1DA7D29781B7,TCGA-05-4420-10A-01D-1931-08,HG19_Broad_variant,TCGA-05-4420,TCGA-LUAD,NA,s10756,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa82ee4b0c9d6adf6ab48,58cfa82ee4b0c9d6adf6ab48,G26360.TCGA-32-1970-10A-01D-1494-08.1.filtered.,WGS,G26360.TCGA-32-1970-10A-01D-1494-08.1,G26360.TCGA-32-1970-10A-01D-1494-08.1.bam,113,1.9,0.05,58cfa82ee4b0c9d6adf6ab48,G26360.TCGA-32-1970-10A-01D-1494-08.1.bam,Dead,MALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-32-1970-10A,6C5154D2-AF36-492F-B520-D925528824E4,Blood Derived Normal,Illumina HiSeq,f792ee4f-eb81-4856-97d1-10351392d58c,Brain,59,CF12C642-B9F8-4EF0-BD54-509536FE001D,5B9D2DB6-F2B7-47B8-8105-BA44FF3274B7,TCGA-32-1970-10A-01D-1494-08,HG19_Broad_variant,TCGA-32-1970,TCGA-GBM,468,s14302,Broad Institute of MIT and Harvard,St. Joseph's Hospital (AZ),None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6ac04,58cfa82ee4b0c9d6adf6ac04,G39019.TCGA-DA-A1HY-10A-01D-A19A-08.2.filtered.,WGS,G39019.TCGA-DA-A1HY-10A-01D-A19A-08.2,G39019.TCGA-DA-A1HY-10A-01D-A19A-08.2.bam,27.75,NA,0.08,58cfa82ee4b0c9d6adf6ac04,G39019.TCGA-DA-A1HY-10A-01D-A19A-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1HY-10A,40E17BF8-6C19-4E5E-B60D-AD54F504A970,Blood Derived Normal,Illumina HiSeq,d6ae3f65-80d4-4412-84c8-b58e260a40f5,Skin,42,06A02194-D705-401A-B6E4-FA2DF9958CF1,567A575C-97B9-475C-8954-5F4E868F0A83,TCGA-DA-A1HY-10A-01D-A19A-08,HG19_Broad_variant,TCGA-DA-A1HY,TCGA-SKCM,NA,s7662,Broad Institute of MIT and Harvard,Yale,United States,NO,T2b,N1,Not available,Stage III
13722.58cfa830e4b0c9d6adf6bca4,58cfa830e4b0c9d6adf6bca4,TCGA-AZ-4315-10A-01W-1461-10_wgs_Illumina.filtered.,WGS,TCGA-AZ-4315-10A-01W-1461-10_wgs_Illumina,TCGA-AZ-4315-10A-01W-1461-10_wgs_Illumina.bam,189,NA,0.5,58cfa830e4b0c9d6adf6bca4,TCGA-AZ-4315-10A-01W-1461-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-4315-10A,DE287A25-981D-49F8-81AF-FE0300E4CD31,Blood Derived Normal,Illumina HiSeq,a2d29ce0-a0f2-46e4-84f3-32d821147f5a,Colorectal,61,8D10297B-DEF9-4F00-B231-B1448967FA7A,A5BBB799-34EE-417D-9602-99A4C558E2FD,TCGA-AZ-4315-10A-01W-1461-10,GRCh37-lite,TCGA-AZ-4315,TCGA-COAD,NA,s13387,Baylor College of Medicine,University of Pittsburgh,None,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6ad7c,58cfa82ee4b0c9d6adf6ad7c,G26401.TCGA-15-1444-01A-02D-1696-08.1.filtered.,WGS,G26401.TCGA-15-1444-01A-02D-1696-08.1,G26401.TCGA-15-1444-01A-02D-1696-08.1.bam,294.03,1.9,0.05,58cfa82ee4b0c9d6adf6ad7c,G26401.TCGA-15-1444-01A-02D-1696-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-15-1444-01A,4C42DC4E-66B7-40BF-9FBE-B92543248198,Primary Tumor,Illumina HiSeq,15eb38d5-3d01-48d9-bea4-3b6868b9dee9,Brain,21,07DA260D-EF04-4A23-BDAD-5CEB98A673CA,CBD4D4E7-F1C4-446C-8DBC-CE06C872EC14,TCGA-15-1444-01A-02D-1696-08,HG19_Broad_variant,TCGA-15-1444,TCGA-GBM,1537,s14141,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,None,NO,Not available,Not available,Glioblastoma Multiforme (GBM),Not available
13722.58cfa82ee4b0c9d6adf6af5a,58cfa82ee4b0c9d6adf6af5a,G41960.TCGA-50-5930-11A-01D-1753-08.3.filtered.,WGS,G41960.TCGA-50-5930-11A-01D-1753-08.3,G41960.TCGA-50-5930-11A-01D-1753-08.3.bam,131.4,1.9,0.05,58cfa82ee4b0c9d6adf6af5a,G41960.TCGA-50-5930-11A-01D-1753-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5930-11A,368E23F0-E573-4547-BF5A-14080BAF737B,Solid Tissue Normal,Illumina HiSeq,be3e5d3c-f4d1-4fbc-8bff-6e5cce5261d4,Lung,47,4CDDB392-FC4B-4400-A44F-2E92A78B3E97,99A809F8-C87D-4D0A-A5D5-29918228B48F,TCGA-50-5930-11A-01D-1753-08,HG19_Broad_variant,TCGA-50-5930,TCGA-LUAD,282,s10977,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIA
13722.58cfa82de4b0c9d6adf6a75e,58cfa82de4b0c9d6adf6a75e,G13229.TCGA-56-1622-11A-01D-1521-08.3.filtered.,WGS,G13229.TCGA-56-1622-11A-01D-1521-08.3,G13229.TCGA-56-1622-11A-01D-1521-08.3.bam,153,1.8,0.05,58cfa82de4b0c9d6adf6a75e,G13229.TCGA-56-1622-11A-01D-1521-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-56-1622-11A,3EDF933A-BE1A-46E8-BFB0-ACDFF30E64A0,Solid Tissue Normal,Illumina HiSeq,690e5ae5-4979-4abf-a16d-d839ec9fd2d2,Lung,58,CEAD55B5-08A0-4CC6-8F20-166ACB63E623,AFD79911-90AC-42A9-BFBA-578D52679CB0,TCGA-56-1622-11A-01D-1521-08,HG19_Broad_variant,TCGA-56-1622,TCGA-LUSC,881,s10497,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82de4b0c9d6adf6a68b,58cfa82de4b0c9d6adf6a68b,82e26e89e7487830771a53d538b65c76.filtered.,WGS,82e26e89e7487830771a53d538b65c76,82e26e89e7487830771a53d538b65c76.bam,44.72,NA,0.09,58cfa82de4b0c9d6adf6a68b,82e26e89e7487830771a53d538b65c76.bam,Alive,FEMALE,WHITE,Not available,Esophageal Carcinoma,Aligned reads,TCGA-L5-A4OJ-01A,CB419344-6148-43D4-B549-570BD09B3E05,Primary Tumor,HiSeq X Ten,6c173e9f-fbc8-4a1d-a24b-742a769f2bbc,Esophagus,70,4F03824A-79D6-40E8-A9E0-4079B1209F38,240AE3A5-496B-4240-86EF-C9E428345A77,TCGA-L5-A4OJ-01A-11D-A27G-09,GRCh37-lite_WUGSC_variant_2,TCGA-L5-A4OJ,TCGA-ESCA,NA,s1615,Washington University School of Medicine,University of Michigan,United States,NO,T1,N0,Not available,Stage I
13722.58cfa82ee4b0c9d6adf6afb6,58cfa82ee4b0c9d6adf6afb6,G41960.TCGA-50-5932-11A-01D-1753-08.2.filtered.,WGS,G41960.TCGA-50-5932-11A-01D-1753-08.2,G41960.TCGA-50-5932-11A-01D-1753-08.2.bam,147.4,1.9,0.05,58cfa82ee4b0c9d6adf6afb6,G41960.TCGA-50-5932-11A-01D-1753-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5932-11A,EBCBA7F2-CE13-4BAE-97CD-91A6B1DCD465,Solid Tissue Normal,Illumina HiSeq,ec0e95d7-b66b-415c-9d7e-c47759b2411f,Lung,75,0E7847D9-D1D0-4980-8F44-C428F36B83F0,5C91A9D6-124C-4FFE-ACF5-CE43A4C2C742,TCGA-50-5932-11A-01D-1753-08,HG19_Broad_variant,TCGA-50-5932,TCGA-LUAD,1235,s11431,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6ac95,58cfa82ee4b0c9d6adf6ac95,G47088.TCGA-18-4721-11A-01D-1441-08.2.filtered.,WGS,G47088.TCGA-18-4721-11A-01D-1441-08.2,G47088.TCGA-18-4721-11A-01D-1441-08.2.bam,144.7,1.9,0.05,58cfa82ee4b0c9d6adf6ac95,G47088.TCGA-18-4721-11A-01D-1441-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-18-4721-11A,19F0CB8C-2E57-4310-967F-A9890F1605DB,Solid Tissue Normal,Illumina HiSeq,0dc44bb3-0eb4-40f7-bf0c-3b90375a71a3,Lung,74,1A50CB47-4A02-40BE-AA02-4CEF765DBA3D,F7B631AE-EE98-499B-9D26-DC945E7AC3B8,TCGA-18-4721-11A-01D-1441-08,HG19_Broad_variant,TCGA-18-4721,TCGA-LUSC,NA,s10368,Broad Institute of MIT and Harvard,Princess Margaret Hospital (Canada),Canada,NO,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6ae0e,58cfa82ee4b0c9d6adf6ae0e,TCGA-04-1514-10A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-04-1514-10A-01D-A324-10_wgs_Illumina,TCGA-04-1514-10A-01D-A324-10_wgs_Illumina.bam,186.97,1.9,0.07,58cfa82ee4b0c9d6adf6ae0e,TCGA-04-1514-10A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-04-1514-10A,E9483296-CB91-497A-B955-39A3C3289DAC,Blood Derived Normal,Illumina HiSeq,0ac0cfa4-e0e9-4251-b4fa-7d81e87dc0c1,Ovary,45,A776A204-BB2F-492F-8934-D91681E28719,22CFF4A9-9E40-48A6-8E61-AAEAE538BCF3,TCGA-04-1514-10A-01D-A324-10,GRCh37-lite,TCGA-04-1514,TCGA-OV,1720,s18086,Baylor College of Medicine,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6adf4,58cfa82ee4b0c9d6adf6adf4,G49537.TCGA-BJ-A28V-10A-01D-A19M-08.1.filtered.,WGS,G49537.TCGA-BJ-A28V-10A-01D-A19M-08.1,G49537.TCGA-BJ-A28V-10A-01D-A19M-08.1.bam,37.2,1.83,0.08,58cfa82ee4b0c9d6adf6adf4,G49537.TCGA-BJ-A28V-10A-01D-A19M-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A28V-10A,BED1FB3C-4459-460E-8190-29211857FA73,Blood Derived Normal,Illumina HiSeq,f5aebf5e-4274-463e-8698-47672f4b86bb,Thyroid,80,CFCC903C-DBD6-4CC5-ACFF-0630033CB493,DEB47EC0-3300-4E16-867E-CC3FE8CC3E57,TCGA-BJ-A28V-10A-01D-A19M-08,HG19_Broad_variant,TCGA-BJ-A28V,TCGA-THCA,NA,s12614,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa82fe4b0c9d6adf6b3c0,58cfa82fe4b0c9d6adf6b3c0,TCGA-24-1558-10A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-24-1558-10A-01D-A324-10_wgs_Illumina,TCGA-24-1558-10A-01D-A324-10_wgs_Illumina.bam,280.27,1.9,0.07,58cfa82fe4b0c9d6adf6b3c0,TCGA-24-1558-10A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1558-10A,BA68F2CF-9271-41FD-9655-1FAC7681F588,Blood Derived Normal,Illumina HiSeq,40db651c-2e1d-469d-8e29-a8f1ef202e04,Ovary,73,6CF18D9D-2A3B-4F22-89FD-801956564218,8A8BA44D-E172-4276-A10E-EFDCD7505F3D,TCGA-24-1558-10A-01D-A324-10,GRCh37-lite,TCGA-24-1558,TCGA-OV,594,s17783,Baylor College of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a9e0,58cfa82ee4b0c9d6adf6a9e0,G25777.TCGA-67-6215-10A-01D-1753-08.1.filtered.,WGS,G25777.TCGA-67-6215-10A-01D-1753-08.1,G25777.TCGA-67-6215-10A-01D-1753-08.1.bam,156.7,1.9,0.05,58cfa82ee4b0c9d6adf6a9e0,G25777.TCGA-67-6215-10A-01D-1753-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-67-6215-10A,DBD5B0DE-94C9-45DD-AFB3-6820A7ECACA2,Blood Derived Normal,Illumina HiSeq,9956c905-329c-4a82-b20c-210106732dcc,Lung,52,BCCA4C61-554E-4521-8F3B-018F28E10559,1D5B64BD-F901-4F03-95C8-DB234CD459FD,TCGA-67-6215-10A-01D-1753-08,HG19_Broad_variant,TCGA-67-6215,TCGA-LUAD,NA,s11105,Broad Institute of MIT and Harvard,St Joseph's Medical Center (MD),United States,NO,T2a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6aafa,58cfa82ee4b0c9d6adf6aafa,G26382.TCGA-06-2557-10A-01D-1494-08.1.filtered.,WGS,G26382.TCGA-06-2557-10A-01D-1494-08.1,G26382.TCGA-06-2557-10A-01D-1494-08.1.bam,79,1.9,0.05,58cfa82ee4b0c9d6adf6aafa,G26382.TCGA-06-2557-10A-01D-1494-08.1.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-2557-10A,6C28F086-6A25-40B6-93EB-BBA0014ACDA6,Blood Derived Normal,Illumina HiSeq,f266fe52-8138-457f-a795-43ae11a433b4,Brain,76,50452B8A-DC52-4F25-A9AA-BB1BC0BBEB75,7113EB4C-EA48-40A8-B75F-ED5DF7B04FF0,TCGA-06-2557-10A-01D-1494-08,HG19_Broad_variant,TCGA-06-2557,TCGA-GBM,33,s14219,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6af5f,58cfa82ee4b0c9d6adf6af5f,G48125.TCGA-13-1477-10A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-13-1477-10A-01D-A312-08.2,G48125.TCGA-13-1477-10A-01D-A312-08.2.bam,41.27,1.8,0.07,58cfa82ee4b0c9d6adf6af5f,G48125.TCGA-13-1477-10A-01D-A312-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-1477-10A,13F5814C-1F99-4FFA-84A4-3BBD8979FAAE,Blood Derived Normal,Illumina HiSeq,bc631924-38a7-4613-83f4-0a467fa94b45,Ovary,49,D5DF4F4C-43DD-4208-BAD3-05F109FC0346,CD30E96A-F8EB-45A5-91D9-182DD76AA6F1,TCGA-13-1477-10A-01D-A312-08,HG19_Broad_variant,TCGA-13-1477,TCGA-OV,1662,s17166,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aa2c,58cfa82ee4b0c9d6adf6aa2c,G26363.TCGA-19-2624-10A-01D-1495-08.2.filtered.,WGS,G26363.TCGA-19-2624-10A-01D-1495-08.2,G26363.TCGA-19-2624-10A-01D-1495-08.2.bam,19.4,1.9,0.05,58cfa82ee4b0c9d6adf6aa2c,G26363.TCGA-19-2624-10A-01D-1495-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-19-2624-10A,2F4A127F-101A-4192-B3E8-F9BE2C8648BC,Blood Derived Normal,Illumina HiSeq,64785886-d0ac-4d98-aa1e-77ceabff67f6,Brain,51,3686CA82-A154-45C9-B616-91E22CCA1453,F9B76B10-6585-4724-A373-3C7915D15BFF,TCGA-19-2624-10A-01D-1495-08,HG19_Broad_variant,TCGA-19-2624,TCGA-GBM,5,s14263,Broad Institute of MIT and Harvard,Case Western,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6a876,58cfa82ee4b0c9d6adf6a876,G26391.TCGA-26-5135-01A-01D-1486-08.1.filtered.,WGS,G26391.TCGA-26-5135-01A-01D-1486-08.1,G26391.TCGA-26-5135-01A-01D-1486-08.1.bam,443.73,1.9,0.05,58cfa82ee4b0c9d6adf6a876,G26391.TCGA-26-5135-01A-01D-1486-08.1.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-26-5135-01A,69D56F2D-6924-409B-9D1E-C8D69B400270,Primary Tumor,Illumina HiSeq,1fec68bf-4fbd-4cbf-bf2e-e540dd2bc143,Brain,72,8CFB4C3F-B25F-412C-91C7-997C64EA2D75,2CE48F01-2F61-49D9-A56A-7438BF4A37D7,TCGA-26-5135-01A-01D-1486-08,HG19_Broad_variant,TCGA-26-5135,TCGA-GBM,270,s14173,Broad Institute of MIT and Harvard,University of Florida,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6ab16,58cfa82ee4b0c9d6adf6ab16,G25783.TCGA-55-6986-01A-11D-1945-08.2.filtered.,WGS,G25783.TCGA-55-6986-01A-11D-1945-08.2,G25783.TCGA-55-6986-01A-11D-1945-08.2.bam,62,NA,0.05,58cfa82ee4b0c9d6adf6ab16,G25783.TCGA-55-6986-01A-11D-1945-08.2.bam,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-55-6986-01A,028E99E9-5B9A-4954-BB6E-6D4709A3CEA8,Primary Tumor,Illumina HiSeq,ee88a53a-b82b-4bd8-b13b-da8f5da9e39c,Lung,74,9622C370-68D0-48DA-A7E0-5EB4765B6F27,5A7F3C88-EF02-4E97-8009-5622245B6A09,TCGA-55-6986-01A-11D-1945-08,HG19_Broad_variant,TCGA-55-6986,TCGA-LUAD,NA,s11106,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2,N0,Lung Bronchioloalveolar Carcinoma Nonmucinous,Stage IB
13722.58cfa82ee4b0c9d6adf6ab02,58cfa82ee4b0c9d6adf6ab02,G23071.TCGA_CV_7100_01A_11D_2268_08.1.filtered.,WGS,G23071.TCGA_CV_7100_01A_11D_2268_08.1,G23071.TCGA_CV_7100_01A_11D_2268_08.1.bam,335.7,NA,0.14,58cfa82ee4b0c9d6adf6ab02,G23071.TCGA_CV_7100_01A_11D_2268_08.1.bam,Dead,MALE,WHITE,Not available,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7100-01A,90A8D2CB-1F31-45F9-8575-EED3CB9A7798,Primary Tumor,Illumina HiSeq,4e9d6eec-9af8-4de3-b449-1d56dd8ba30f,Head and Neck,66,08C3093D-4100-4BFC-92FC-A11F1393868F,FECCC27E-5C2E-4339-8746-0945FEE93C1E,TCGA-CV-7100-01A-11D-2268-08,HG19_Broad_variant,TCGA-CV-7100,TCGA-HNSC,274,s16312,Broad Institute of MIT and Harvard,MD Anderson Cancer Center,United States,NO,T2,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6b0c8,58cfa82ee4b0c9d6adf6b0c8,TCGA-10-0937-11A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-10-0937-11A-01D-A324-10_wgs_Illumina,TCGA-10-0937-11A-01D-A324-10_wgs_Illumina.bam,277.64,1.8,0.07,58cfa82ee4b0c9d6adf6b0c8,TCGA-10-0937-11A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-10-0937-11A,A5030259-CF9C-4A58-8710-B9DA8EE59320,Solid Tissue Normal,Illumina HiSeq,f22e0e1b-84d5-4710-9bbf-647a1f02499e,Ovary,44,ADE72C60-8420-4F9C-8F5B-FF44EA1FA398,2E8CB34E-C31B-4915-B1B0-87A66045C5D9,TCGA-10-0937-11A-01D-A324-10,GRCh37-lite,TCGA-10-0937,TCGA-OV,608,s17600,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ab99,58cfa82ee4b0c9d6adf6ab99,G26397.TCGA-19-5960-01A-11D-1696-08.2.filtered.,WGS,G26397.TCGA-19-5960-01A-11D-1696-08.2,G26397.TCGA-19-5960-01A-11D-1696-08.2.bam,513.03,1.9,0.05,58cfa82ee4b0c9d6adf6ab99,G26397.TCGA-19-5960-01A-11D-1696-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-19-5960-01A,93ED7A2B-B0CB-4A84-871F-5C34A0B6A640,Primary Tumor,Illumina HiSeq,264b0e2f-a66b-477b-90af-7dd319a8d4b8,Brain,56,86C6A232-F5AB-47CD-B91B-4CAD6AA1D0F1,B8151614-B08F-49A3-AB6F-2E780F765A17,TCGA-19-5960-01A-11D-1696-08,HG19_Broad_variant,TCGA-19-5960,TCGA-GBM,NA,s14347,Broad Institute of MIT and Harvard,Case Western,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6ad10,58cfa82ee4b0c9d6adf6ad10,G49537.TCGA-EM-A2OV-10A-01D-A202-08.1.filtered.,WGS,G49537.TCGA-EM-A2OV-10A-01D-A202-08.1,G49537.TCGA-EM-A2OV-10A-01D-A202-08.1.bam,43.08,NA,0.08,58cfa82ee4b0c9d6adf6ad10,G49537.TCGA-EM-A2OV-10A-01D-A202-08.1.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EM-A2OV-10A,55E03FFC-F006-4EC8-8E5D-A738FF091F8A,Blood Derived Normal,Illumina HiSeq,d818dc31-fb0f-4c02-9561-d7dd05298d81,Thyroid,64,D814C22E-D964-4A92-AE43-194970962342,F1F40EF8-E5BC-440D-915F-048BB283A01C,TCGA-EM-A2OV-10A-01D-A202-08,HG19_Broad_variant,TCGA-EM-A2OV,TCGA-THCA,NA,s12090,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa82ee4b0c9d6adf6aef6,58cfa82ee4b0c9d6adf6aef6,G49537.TCGA-EM-A2OW-10A-01D-A202-08.1.filtered.,WGS,G49537.TCGA-EM-A2OW-10A-01D-A202-08.1,G49537.TCGA-EM-A2OW-10A-01D-A202-08.1.bam,154.19,NA,0.09,58cfa82ee4b0c9d6adf6aef6,G49537.TCGA-EM-A2OW-10A-01D-A202-08.1.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A2OW-10A,A65EC434-9AE0-453F-B440-08BF25558FD1,Blood Derived Normal,Illumina HiSeq,e128b925-e123-44ca-8ab7-e1db285ad360,Thyroid,37,2C8CCB7D-349E-4D05-80DA-D5CF10ADEF2A,A4765371-2387-4002-9887-2615E5136F7B,TCGA-EM-A2OW-10A-01D-A202-08,HG19_Broad_variant,TCGA-EM-A2OW,TCGA-THCA,NA,s12620,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T1b,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa82ee4b0c9d6adf6ac68,58cfa82ee4b0c9d6adf6ac68,G39019.TCGA-GN-A262-10A-01D-A198-08.1.filtered.,WGS,G39019.TCGA-GN-A262-10A-01D-A198-08.1,G39019.TCGA-GN-A262-10A-01D-A198-08.1.bam,10.25,NA,0.07,58cfa82ee4b0c9d6adf6ac68,G39019.TCGA-GN-A262-10A-01D-A198-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-GN-A262-10A,E36C9411-773B-4A8E-9B43-895B3CB044C7,Blood Derived Normal,Illumina HiSeq,a59783ac-70a4-44f6-92ac-c5d6fdb3a8ee,Skin,47,B11ABD08-A151-4CB4-AD7B-143BDAF5AE57,EB8C867E-D2DA-48C7-BAE7-5AEA6D9AAF1D,TCGA-GN-A262-10A-01D-A198-08,HG19_Broad_variant,TCGA-GN-A262,TCGA-SKCM,NA,s7824,Broad Institute of MIT and Harvard,Roswell,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82fe4b0c9d6adf6ba34,58cfa82fe4b0c9d6adf6ba34,TCGA-A6-2683-11A-01D-1554-10_wgs_Illumina.filtered.,WGS,TCGA-A6-2683-11A-01D-1554-10_wgs_Illumina,TCGA-A6-2683-11A-01D-1554-10_wgs_Illumina.bam,252.73,1.9,0.05,58cfa82fe4b0c9d6adf6ba34,TCGA-A6-2683-11A-01D-1554-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2683-11A,FAFD4576-0709-49E1-926F-AD1EE09907EC,Solid Tissue Normal,Illumina HiSeq,14a92e85-0fea-4740-8dfe-d8d7f2ba8f7d,Colorectal,57,5C7DE7C6-7A72-4185-A72C-1D25D4AB07FE,70D7C76F-0480-444B-8390-2AF62DBD8665,TCGA-A6-2683-11A-01D-1554-10,GRCh37-lite,TCGA-A6-2683,TCGA-COAD,NA,s13017,Baylor College of Medicine,Christiana Healthcare,None,NO,T4,N0,Colon Adenocarcinoma,Stage IV
13722.58cfa82ee4b0c9d6adf6af42,58cfa82ee4b0c9d6adf6af42,G41960.TCGA-75-7030-10A-01D-1946-08.2.filtered.,WGS,G41960.TCGA-75-7030-10A-01D-1946-08.2,G41960.TCGA-75-7030-10A-01D-1946-08.2.bam,187,NA,0.05,58cfa82ee4b0c9d6adf6af42,G41960.TCGA-75-7030-10A-01D-1946-08.2.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-7030-10A,DF576520-A6B6-4C9B-8D06-3F59CC5342FD,Blood Derived Normal,Illumina HiSeq,d5a3ce22-1fc8-401a-ac7b-fa7bc6fad8f7,Lung,NA,09990635-9BE0-4DA6-BFE3-17D393AE8B96,9659D703-504E-4B47-A4F4-B376DBBBFBAC,TCGA-75-7030-10A-01D-1946-08,HG19_Broad_variant,TCGA-75-7030,TCGA-LUAD,NA,s10764,Broad Institute of MIT and Harvard,Ontario Institute for Cancer Research (OICR),Canada,NO,T3,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6aebc,58cfa82ee4b0c9d6adf6aebc,G49537.TCGA-E8-A418-10A-01D-A23K-08.1.filtered.,WGS,G49537.TCGA-E8-A418-10A-01D-A23K-08.1,G49537.TCGA-E8-A418-10A-01D-A23K-08.1.bam,15.22,NA,0.08,58cfa82ee4b0c9d6adf6aebc,G49537.TCGA-E8-A418-10A-01D-A23K-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-E8-A418-10A,EBBD54AD-7B97-4081-AD11-7F7F3CE74EEF,Blood Derived Normal,Illumina HiSeq,4c0664e1-3ab0-4896-876b-46e21c8d58b6,Thyroid,75,F5800A35-2545-4423-89D4-FE70545ED76F,E20B80FD-0AC9-4507-B307-3915E218603E,TCGA-E8-A418-10A-01D-A23K-08,HG19_Broad_variant,TCGA-E8-A418,TCGA-THCA,NA,s12348,Broad Institute of MIT and Harvard,Asterand,Russia,NO,T4a,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA
13722.58cfa82ee4b0c9d6adf6ad6d,58cfa82ee4b0c9d6adf6ad6d,G7164.TCGA-44-2665-10A-01D-0969-08.11.filtered.,WGS,G7164.TCGA-44-2665-10A-01D-0969-08.11,G7164.TCGA-44-2665-10A-01D-0969-08.11.bam,384.93,1.9,0.17,58cfa82ee4b0c9d6adf6ad6d,G7164.TCGA-44-2665-10A-01D-0969-08.11.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-2665-10A,FB79C491-7B01-42AE-8369-8364E442E31B,Blood Derived Normal,Illumina GA,7b1ce680-03d0-4279-871c-e96c91a60a8e,Lung,55,EAE0C6D0-9DFC-4A0F-918E-4B028BB8D4D1,6FF6419E-6677-4FB8-93E9-57DBD8F44974,TCGA-44-2665-10A-01D-0969-08,HG19_Broad_variant,TCGA-44-2665,TCGA-LUAD,NA,s11432,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6ac13,58cfa82ee4b0c9d6adf6ac13,G39019.TCGA-GN-A26A-06A-11D-A19A-08.4.filtered.,WGS,G39019.TCGA-GN-A26A-06A-11D-A19A-08.4,G39019.TCGA-GN-A26A-06A-11D-A19A-08.4.bam,46.66,NA,0.07,58cfa82ee4b0c9d6adf6ac13,G39019.TCGA-GN-A26A-06A-11D-A19A-08.4.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-GN-A26A-06A,5BC515C8-7727-4D69-98E9-31BBCB748550,Metastatic,Illumina HiSeq,258f871c-7b41-4dbb-99d2-0f10f373f70f,Skin,63,CD2C64DC-8FAA-469C-84DC-F701E17917C5,22EDD867-DCD6-42B5-92BB-025CEB84B106,TCGA-GN-A26A-06A-11D-A19A-08,HG19_Broad_variant,TCGA-GN-A26A,TCGA-SKCM,988,s7992,Broad Institute of MIT and Harvard,Roswell,United States,NO,T3a,N1a,Not available,Stage IIIA
13722.58cfa82ee4b0c9d6adf6ac7c,58cfa82ee4b0c9d6adf6ac7c,G41960.TCGA-50-6591-01A-11D-1753-08.3.filtered.,WGS,G41960.TCGA-50-6591-01A-11D-1753-08.3,G41960.TCGA-50-6591-01A-11D-1753-08.3.bam,351.4,1.8,0.05,58cfa82ee4b0c9d6adf6ac7c,G41960.TCGA-50-6591-01A-11D-1753-08.3.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-6591-01A,9B132E4F-7E35-4CC5-8711-43AD62B906D0,Primary Tumor,Illumina HiSeq,3d4858b4-9af4-47f2-84d2-6618c7a21581,Lung,63,0791E7AA-E97C-4DD0-9615-09EC7090F684,BF7462A2-394F-4838-BCB6-4D0126FA48B1,TCGA-50-6591-01A-11D-1753-08,HG19_Broad_variant,TCGA-50-6591,TCGA-LUAD,119,s10637,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IV
13722.58cfa82ee4b0c9d6adf6aa4d,58cfa82ee4b0c9d6adf6aa4d,G26368.TCGA-19-2629-01A-01D-1495-08.1.filtered.,WGS,G26368.TCGA-19-2629-01A-01D-1495-08.1,G26368.TCGA-19-2629-01A-01D-1495-08.1.bam,169.1,1.9,0.05,58cfa82ee4b0c9d6adf6aa4d,G26368.TCGA-19-2629-01A-01D-1495-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-19-2629-01A,E17A6048-7A72-42C0-AD3F-97CBFF02BC9F,Primary Tumor,Illumina HiSeq,f54e5ef9-adae-4612-98af-8247a3499567,Brain,60,B89A4D5D-EE24-4052-B454-B67169328737,56FFAA35-814C-4C0B-B3C6-D4514D34FEC2,TCGA-19-2629-01A-01D-1495-08,HG19_Broad_variant,TCGA-19-2629,TCGA-GBM,737,s14367,Broad Institute of MIT and Harvard,Case Western,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6a7f2,58cfa82ee4b0c9d6adf6a7f2,G25776.TCGA-75-6203-10A-01D-1753-08.1.filtered.,WGS,G25776.TCGA-75-6203-10A-01D-1753-08.1,G25776.TCGA-75-6203-10A-01D-1753-08.1.bam,28.7,1.9,0.05,58cfa82ee4b0c9d6adf6a7f2,G25776.TCGA-75-6203-10A-01D-1753-08.1.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-6203-10A,A8D6694C-A213-4544-AC0B-63BCE16D8F4E,Blood Derived Normal,Illumina HiSeq,279e57e9-744f-4530-a856-cf989245b8ef,Lung,NA,C9C3BFFA-9F10-4681-BDBD-FDACCBA1031C,FDF9B270-14FF-4961-978E-5DFF14D77FEB,TCGA-75-6203-10A-01D-1753-08,HG19_Broad_variant,TCGA-75-6203,TCGA-LUAD,NA,s11317,Broad Institute of MIT and Harvard,Ontario Institute for Cancer Research (OICR),Canada,NO,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82ee4b0c9d6adf6af6a,58cfa82ee4b0c9d6adf6af6a,G41960.TCGA-55-6972-01A-11D-1945-08.1.filtered.,WGS,G41960.TCGA-55-6972-01A-11D-1945-08.1,G41960.TCGA-55-6972-01A-11D-1945-08.1.bam,520.7,NA,0.05,58cfa82ee4b0c9d6adf6af6a,G41960.TCGA-55-6972-01A-11D-1945-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-55-6972-01A,C4D1E105-28B7-48DF-ABEF-FBE09782FDB2,Primary Tumor,Illumina HiSeq,30f0b521-90e2-41a2-9dcc-97b6702a46fc,Lung,72,38C83B40-FBA4-48D4-AD6E-93768CB6139F,46693A2B-5105-4770-A9E1-031DFEDEB694,TCGA-55-6972-01A-11D-1945-08,HG19_Broad_variant,TCGA-55-6972,TCGA-LUAD,NA,s11113,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2,N0,Lung Papillary Adenocarcinoma,Stage IB
13722.58cfa82ee4b0c9d6adf6af92,58cfa82ee4b0c9d6adf6af92,TCGA-04-1367-10A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-04-1367-10A-01D-A324-10_wgs_Illumina,TCGA-04-1367-10A-01D-A324-10_wgs_Illumina.bam,673.97,1.9,0.07,58cfa82ee4b0c9d6adf6af92,TCGA-04-1367-10A-01D-A324-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-04-1367-10A,30B8F4CD-9245-4496-A8A8-C3E59093BC0A,Blood Derived Normal,Illumina HiSeq,f49ebc21-8fdb-4881-8c66-51e2acc29fe0,Ovary,50,3B27CAB3-81F8-4918-B472-57BD5EBD943D,4E1CCB7D-E262-4E93-B08B-8B84E98F8784,TCGA-04-1367-10A-01D-A324-10,GRCh37-lite,TCGA-04-1367,TCGA-OV,NA,s17709,Baylor College of Medicine,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a7f0,58cfa82ee4b0c9d6adf6a7f0,G32548.TCGA-EE-A2M5-10A-01D-A199-08.1.filtered.,WGS,G32548.TCGA-EE-A2M5-10A-01D-A199-08.1,G32548.TCGA-EE-A2M5-10A-01D-A199-08.1.bam,52.28,NA,0.09,58cfa82ee4b0c9d6adf6a7f0,G32548.TCGA-EE-A2M5-10A-01D-A199-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2M5-10A,B5E37B9B-6264-4CC8-9B44-1D8AC0692D6C,Blood Derived Normal,Illumina HiSeq,48f84ddd-5849-4a0a-9f65-2f22c76c3943,Skin,49,0F5E478D-C3FA-44B6-8A17-BA0991516D60,3BF67116-BE87-4C02-B931-352EBB7F3B48,TCGA-EE-A2M5-10A-01D-A199-08,HG19_Broad_variant,TCGA-EE-A2M5,TCGA-SKCM,659,s7650,Broad Institute of MIT and Harvard,University of Sydney,Australia,NO,T2,N0,Not available,Stage I
13722.58cfa82ee4b0c9d6adf6a9d5,58cfa82ee4b0c9d6adf6a9d5,G25788.TCGA-55-7281-01A-11D-2036-08.1.filtered.,WGS,G25788.TCGA-55-7281-01A-11D-2036-08.1,G25788.TCGA-55-7281-01A-11D-2036-08.1.bam,196.7,NA,0.05,58cfa82ee4b0c9d6adf6a9d5,G25788.TCGA-55-7281-01A-11D-2036-08.1.bam,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-55-7281-01A,659668E8-F0D9-4FF2-BBC8-9246F2EF49AB,Primary Tumor,Illumina HiSeq,19c6ac35-62fd-4db0-8641-22abc19d0b52,Lung,70,AFEC3B25-C3F7-4E48-8FB0-6FB4DD581081,D5443922-FEA5-4FF0-BD6E-8CE04E1951D8,TCGA-55-7281-01A-11D-2036-08,HG19_Broad_variant,TCGA-55-7281,TCGA-LUAD,NA,s11213,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T1b,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82de4b0c9d6adf6a790,58cfa82de4b0c9d6adf6a790,G16922.TCGA-BP-5010-11A-01D-2048-08.1.filtered.,WGS,G16922.TCGA-BP-5010-11A-01D-2048-08.1,G16922.TCGA-BP-5010-11A-01D-2048-08.1.bam,80.73,1.9,0.15,58cfa82de4b0c9d6adf6a790,G16922.TCGA-BP-5010-11A-01D-2048-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-BP-5010-11A,9F5C0A43-D222-484A-9249-D288387DD7A1,Solid Tissue Normal,Illumina HiSeq,137c64b0-d3bc-49f8-a502-2c4fb7d61b06,Kidney,63,CEAF58BB-FCAD-4411-84B9-8AF7B8BDD7A1,221F3906-71B2-4EF3-981F-0AFDC393363D,TCGA-BP-5010-11A-01D-2048-08,HG19_Broad_variant,TCGA-BP-5010,TCGA-KIRC,878,s9299,Broad Institute of MIT and Harvard,MSKCC,None,NO,T3a,N0,Kidney Clear Cell Renal Carcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6aefa,58cfa82ee4b0c9d6adf6aefa,G49537.TCGA-DJ-A13R-10A-01D-A10S-08.1.filtered.,WGS,G49537.TCGA-DJ-A13R-10A-01D-A10S-08.1,G49537.TCGA-DJ-A13R-10A-01D-A10S-08.1.bam,60.3,1.88,0.08,58cfa82ee4b0c9d6adf6aefa,G49537.TCGA-DJ-A13R-10A-01D-A10S-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13R-10A,3E787A0E-B5D2-401E-B1E5-077376090B3A,Blood Derived Normal,Illumina HiSeq,b4d95ae2-708c-48db-80c9-15abba0835c3,Thyroid,50,4CD78789-F3CE-423A-A09E-0514C295A475,97808F8D-720C-41C2-BA0D-59922E48A182,TCGA-DJ-A13R-10A-01D-A10S-08,HG19_Broad_variant,TCGA-DJ-A13R,TCGA-THCA,NA,s12227,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III
13722.58cfa82ee4b0c9d6adf6a90c,58cfa82ee4b0c9d6adf6a90c,G23064.TCGA_CR_6472_10A_01D_2268_08.1.filtered.,WGS,G23064.TCGA_CR_6472_10A_01D_2268_08.1,G23064.TCGA_CR_6472_10A_01D_2268_08.1.bam,222.3,1.8,0.16,58cfa82ee4b0c9d6adf6a90c,G23064.TCGA_CR_6472_10A_01D_2268_08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-6472-10A,0956BC67-DD55-4C54-A56A-F22F2856662A,Blood Derived Normal,Illumina HiSeq,d2f9239e-7f1c-4f81-9d85-3690f7dd3412,Head and Neck,59,212A8E4C-31AB-4A72-9E78-D8076FEF8FFF,C2CD77C0-44D7-47DB-84D0-E9B030C2F9D4,TCGA-CR-6472-10A-01D-2268-08,HG19_Broad_variant,TCGA-CR-6472,TCGA-HNSC,NA,s15863,Broad Institute of MIT and Harvard,Vanderbilt University,United States,NO,Not available,Not available,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6acf6,58cfa82ee4b0c9d6adf6acf6,G49537.TCGA-EL-A3MY-11A-12D-A21A-08.1.filtered.,WGS,G49537.TCGA-EL-A3MY-11A-12D-A21A-08.1,G49537.TCGA-EL-A3MY-11A-12D-A21A-08.1.bam,13.89,NA,0.08,58cfa82ee4b0c9d6adf6acf6,G49537.TCGA-EL-A3MY-11A-12D-A21A-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EL-A3MY-11A,7746BE87-7AD0-48A7-84FB-08A81B220BDB,Solid Tissue Normal,Illumina HiSeq,8119eea4-2f17-4a89-8294-9e578a95bc5e,Thyroid,81,B9413CBC-F373-4424-B112-E5AF63F4B070,8B4E9B9D-C2D3-4B38-B7A1-3642E56555D3,TCGA-EL-A3MY-11A-12D-A21A-08,HG19_Broad_variant,TCGA-EL-A3MY,TCGA-THCA,533,s12092,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,T4,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage IVC
13722.58cfa82ee4b0c9d6adf6ae47,58cfa82ee4b0c9d6adf6ae47,G49837.TCGA-94-7943-10A-01D-A320-08.1.filtered.,WGS,G49837.TCGA-94-7943-10A-01D-A320-08.1,G49837.TCGA-94-7943-10A-01D-A320-08.1.bam,225.3,NA,0.08,58cfa82ee4b0c9d6adf6ae47,G49837.TCGA-94-7943-10A-01D-A320-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-94-7943-10A,AECF85CC-058C-46F3-9CDC-3573AC3B8438,Blood Derived Normal,Illumina HiSeq,c55d59ef-3423-418f-b5b0-c2296ca81787,Lung,80,BB4FD47C-7F4F-4EC0-A70D-32B64DC0CE59,6A3884DD-BEAA-43A9-8C40-6367496EB5E0,TCGA-94-7943-10A-01D-A320-08,HG19_Broad_variant,TCGA-94-7943,TCGA-LUSC,NA,s10085,Broad Institute of MIT and Harvard,Washington University - Emory,United States,NO,T1b,NX,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6ac9a,58cfa82ee4b0c9d6adf6ac9a,G41960.TCGA-91-6847-01A-11D-1945-08.1.filtered.,WGS,G41960.TCGA-91-6847-01A-11D-1945-08.1,G41960.TCGA-91-6847-01A-11D-1945-08.1.bam,528.7,1.9,0.05,58cfa82ee4b0c9d6adf6ac9a,G41960.TCGA-91-6847-01A-11D-1945-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-91-6847-01A,97831D28-AB41-4C18-BFC2-C4C6BC757D13,Primary Tumor,Illumina HiSeq,7d8d3882-a579-44c1-b63d-eabff64671d1,Lung,62,96A05D4B-3731-4B98-B38F-A6B33CD6ED96,020FAB36-C7DE-4933-B2BF-DC7B019A1326,TCGA-91-6847-01A-11D-1945-08,HG19_Broad_variant,TCGA-91-6847,TCGA-LUAD,NA,s10635,Broad Institute of MIT and Harvard,ABS - IUPUI,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6af0e,58cfa82ee4b0c9d6adf6af0e,G39020.TCGA-HU-A4G6-10A-01D-A24F-08.3.filtered.,WGS,G39020.TCGA-HU-A4G6-10A-01D-A24F-08.3,G39020.TCGA-HU-A4G6-10A-01D-A24F-08.3.bam,14.4,NA,0.08,58cfa82ee4b0c9d6adf6af0e,G39020.TCGA-HU-A4G6-10A-01D-A24F-08.3.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-HU-A4G6-10A,30A82E9F-2A2D-4A66-BDB1-26B881C21D01,Blood Derived Normal,Illumina HiSeq,6a591fcf-0fe6-406e-b57a-76dc16219647,Stomach,74,E383DEAB-4DE2-4E2A-944C-56F9027F845D,E3E2739F-5F19-4924-8505-3BABFD62F636,TCGA-HU-A4G6-10A-01D-A24F-08,HG19_Broad_variant,TCGA-HU-A4G6,TCGA-STAD,NA,s14684,Broad Institute of MIT and Harvard,National Cancer Center Korea,Korea South,NO,T1b,N0,Stomach Intestinal Adenocarcinoma Papillary Type,Stage IA
13722.58cfa82ee4b0c9d6adf6ad14,58cfa82ee4b0c9d6adf6ad14,G39020.TCGA-BR-6452-10A-01D-1800-08.1.filtered.,WGS,G39020.TCGA-BR-6452-10A-01D-1800-08.1,G39020.TCGA-BR-6452-10A-01D-1800-08.1.bam,34.7,1.9,0.05,58cfa82ee4b0c9d6adf6ad14,G39020.TCGA-BR-6452-10A-01D-1800-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6452-10A,27988B3E-CDE1-4F4B-82A1-6D8AD08DB8E9,Blood Derived Normal,Illumina HiSeq,cefa3484-0227-4faf-b929-3155b670b720,Stomach,78,14F163DB-E740-48B9-8126-AC2A5A691288,0F603726-FDAE-4738-9E1C-F387A61D8E84,TCGA-BR-6452-10A-01D-1800-08,HG19_Broad_variant,TCGA-BR-6452,TCGA-STAD,NA,s15228,Broad Institute of MIT and Harvard,Asterand,Russia,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA
13722.58cfa832e4b0c9d6adf6d1ae,58cfa832e4b0c9d6adf6d1ae,TCGA-HE-A5NJ-10A-01D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-HE-A5NJ-10A-01D-A26P-10_wgs_Illumina,TCGA-HE-A5NJ-10A-01D-A26P-10_wgs_Illumina.bam,37.57,NA,0.08,58cfa832e4b0c9d6adf6d1ae,TCGA-HE-A5NJ-10A-01D-A26P-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-HE-A5NJ-10A,8D28F586-3DE5-4033-A9FD-4F67BE406FB4,Blood Derived Normal,Illumina HiSeq,82e60838-10da-4943-b50c-1638e4dfd68b,Kidney,58,340BA342-B9F1-4A7B-A540-EEDECFF1C5A1,DE0653AD-A848-4F4B-B675-6CB625CB5167,TCGA-HE-A5NJ-10A-01D-A26P-10,GRCh37-lite,TCGA-HE-A5NJ,TCGA-KIRP,NA,s11861,Baylor College of Medicine,Ontario Institute for Cancer Research (OICR),Canada,NO,T1b,NX,Kidney Papillary Renal Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ad36,58cfa82ee4b0c9d6adf6ad36,G49837.TCGA-18-3415-11A-01D-A320-08.2.filtered.,WGS,G49837.TCGA-18-3415-11A-01D-A320-08.2,G49837.TCGA-18-3415-11A-01D-A320-08.2.bam,45.94,1.9,0.08,58cfa82ee4b0c9d6adf6ad36,G49837.TCGA-18-3415-11A-01D-A320-08.2.bam,Alive,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-18-3415-11A,9A874B64-D0D6-416E-97BC-E9071ED0B16B,Solid Tissue Normal,Illumina HiSeq,d744b6bf-d7a7-45f4-bbf7-84b25f7b4a7a,Lung,77,92069F9F-20CA-4922-B802-2562448EBC65,97E65421-89B2-4BEA-A9B2-E6294B28EB3C,TCGA-18-3415-11A-01D-A320-08,HG19_Broad_variant,TCGA-18-3415,TCGA-LUSC,NA,s9979,Broad Institute of MIT and Harvard,Princess Margaret Hospital (Canada),Canada,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82de4b0c9d6adf6a772,58cfa82de4b0c9d6adf6a772,G14855.TCGA-05-4389-10A-01D-1931-08.4.filtered.,WGS,G14855.TCGA-05-4389-10A-01D-1931-08.4,G14855.TCGA-05-4389-10A-01D-1931-08.4.bam,61.23,1.8,0.15,58cfa82de4b0c9d6adf6a772,G14855.TCGA-05-4389-10A-01D-1931-08.4.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4389-10A,A3DE401D-91FE-49A2-BB07-81C1A06506E6,Blood Derived Normal,Illumina HiSeq,8bba0a8e-5113-4344-9cdd-3abfa2e10d55,Lung,70,BDCAC214-BA95-4DDD-8C84-9B60C14109BB,76E90095-8965-4E75-B49D-F6AD71080439,TCGA-05-4389-10A-01D-1931-08,HG19_Broad_variant,TCGA-05-4389,TCGA-LUAD,NA,s10629,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T1,N0,Lung Adenocarcinoma Mixed Subtype,Stage IA
13722.58cfa82ee4b0c9d6adf6af16,58cfa82ee4b0c9d6adf6af16,G39020.TCGA-HF-7136-10A-01D-2053-08.1.filtered.,WGS,G39020.TCGA-HF-7136-10A-01D-2053-08.1,G39020.TCGA-HF-7136-10A-01D-2053-08.1.bam,283,NA,0.05,58cfa82ee4b0c9d6adf6af16,G39020.TCGA-HF-7136-10A-01D-2053-08.1.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-HF-7136-10A,647DC54F-A51B-40EA-9D97-C93598C2AF71,Blood Derived Normal,Illumina HiSeq,c768ee2b-bcfc-442a-9697-6fd379b74814,Stomach,NA,2D397789-DF8B-4051-8DF0-6B388084D835,8417A72F-A578-450F-8E74-17FAEF5B8F67,TCGA-HF-7136-10A-01D-2053-08,HG19_Broad_variant,TCGA-HF-7136,TCGA-STAD,NA,s14685,Broad Institute of MIT and Harvard,Ontario Institute for Cancer Research (OICR),Canada,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82de4b0c9d6adf6a76a,58cfa82de4b0c9d6adf6a76a,G13226.TCGA-21-1078-11A-01D-1521-08.1.filtered.,WGS,G13226.TCGA-21-1078-11A-01D-1521-08.1,G13226.TCGA-21-1078-11A-01D-1521-08.1.bam,4,1.7,0.05,58cfa82de4b0c9d6adf6a76a,G13226.TCGA-21-1078-11A-01D-1521-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-21-1078-11A,0AB8D063-62B4-4D47-82AA-E3351A60029D,Solid Tissue Normal,Illumina HiSeq,7d076ed5-6dbc-411b-a180-a1eaf2d19bd9,Lung,77,FCE0A00E-A958-48EA-8CB3-59880E09F748,59ED3755-0B09-4A75-81BF-0994E7A2D11A,TCGA-21-1078-11A-01D-1521-08,HG19_Broad_variant,TCGA-21-1078,TCGA-LUSC,474,s10492,Broad Institute of MIT and Harvard,Fox Chase Cancer Center,United States,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6ac38,58cfa82ee4b0c9d6adf6ac38,G39020.TCGA-BR-4255-11A-01D-A290-08.2.filtered.,WGS,G39020.TCGA-BR-4255-11A-01D-A290-08.2,G39020.TCGA-BR-4255-11A-01D-A290-08.2.bam,70.9,1.9,0.08,58cfa82ee4b0c9d6adf6ac38,G39020.TCGA-BR-4255-11A-01D-A290-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4255-11A,956017BA-5E4B-42C7-B93D-42316874BA93,Solid Tissue Normal,Illumina HiSeq,e7981f49-1074-4ce6-820c-3630abd6e8d7,Stomach,76,14C7AEAF-97D3-48B6-BB08-B38D7D3E12ED,0D2E9158-0F62-46D9-8F47-AD2D0666DA8F,TCGA-BR-4255-11A-01D-A290-08,HG19_Broad_variant,TCGA-BR-4255,TCGA-STAD,NA,s15295,Broad Institute of MIT and Harvard,Asterand,Russia,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82ee4b0c9d6adf6b0c4,58cfa82ee4b0c9d6adf6b0c4,G8891.TCGA-66-2756-01A-01D-1180-08.1.filtered.,WGS,G8891.TCGA-66-2756-01A-01D-1180-08.1,G8891.TCGA-66-2756-01A-01D-1180-08.1.bam,184.3,1.9,0.15,58cfa82ee4b0c9d6adf6b0c4,G8891.TCGA-66-2756-01A-01D-1180-08.1.bam,Alive,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-66-2756-01A,43ABE847-4BA7-466E-8283-5D7B80B999A7,Primary Tumor,Illumina HiSeq,2cc59bf0-d2ce-42b3-a587-574633628139,Lung,68,D80486CD-F054-4527-A886-CF9446381B9F,25224AA0-CFDD-48EC-92E5-8F3992A3E574,TCGA-66-2756-01A-01D-1180-08,HG19_Broad_variant,TCGA-66-2756,TCGA-LUSC,NA,s10261,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T4,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIB
13722.58cfa82ee4b0c9d6adf6aa44,58cfa82ee4b0c9d6adf6aa44,G25251.TCGA-CR-7404-01A-11D-2334-08.1.filtered.,WGS,G25251.TCGA-CR-7404-01A-11D-2334-08.1,G25251.TCGA-CR-7404-01A-11D-2334-08.1.bam,181.7,NA,0.05,58cfa82ee4b0c9d6adf6aa44,G25251.TCGA-CR-7404-01A-11D-2334-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-7404-01A,D189A6C6-210F-4957-B500-457D5CE3F867,Primary Tumor,Illumina HiSeq,f8742c2f-2e32-467e-9347-f0dd0959da6b,Head and Neck,53,A39131B9-E7C7-4385-A1B9-D8A0A0950337,83ECA7B5-45BB-44C0-8AFE-36F8988D0078,TCGA-CR-7404-01A-11D-2334-08,HG19_Broad_variant,TCGA-CR-7404,TCGA-HNSC,NA,s15602,Broad Institute of MIT and Harvard,Vanderbilt University,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6af76,58cfa82ee4b0c9d6adf6af76,G41960.TCGA-50-5930-01A-11D-1753-08.3.filtered.,WGS,G41960.TCGA-50-5930-01A-11D-1753-08.3,G41960.TCGA-50-5930-01A-11D-1753-08.3.bam,181.4,2,0.05,58cfa82ee4b0c9d6adf6af76,G41960.TCGA-50-5930-01A-11D-1753-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5930-01A,368E23F0-E573-4547-BF5A-14080BAF737B,Primary Tumor,Illumina HiSeq,7ef1f666-79cc-4c94-90b9-49c32631ba72,Lung,47,3E30DBD1-10BF-4450-8D19-6F44D3284E02,BD3E88B3-B37C-4641-85FA-D8125BA324CA,TCGA-50-5930-01A-11D-1753-08,HG19_Broad_variant,TCGA-50-5930,TCGA-LUAD,282,s10638,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIA
13722.58cfa82ee4b0c9d6adf6a7be,58cfa82ee4b0c9d6adf6a7be,G23076.TCGA_CV_5443_11A_01D_2268_08.1.filtered.,WGS,G23076.TCGA_CV_5443_11A_01D_2268_08.1,G23076.TCGA_CV_5443_11A_01D_2268_08.1.bam,62,1.9,0.15,58cfa82ee4b0c9d6adf6a7be,G23076.TCGA_CV_5443_11A_01D_2268_08.1.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5443-11A,180036A2-3B56-405E-A1FE-D5932517B6C7,Solid Tissue Normal,Illumina HiSeq,f744f137-822a-4f3c-960b-aa2f4ab9ebb8,Head and Neck,63,4863312A-043E-418E-812D-2AE2A1F66F29,1CE3915A-B077-41AF-9AD0-B8A81CD1199B,TCGA-CV-5443-11A-01D-2268-08,HG19_Broad_variant,TCGA-CV-5443,TCGA-HNSC,NA,s15743,Broad Institute of MIT and Harvard,MD Anderson Cancer Center,None,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa82fe4b0c9d6adf6b2e0,58cfa82fe4b0c9d6adf6b2e0,TCGA-09-2045-11A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-09-2045-11A-01D-A324-10_wgs_Illumina,TCGA-09-2045-11A-01D-A324-10_wgs_Illumina.bam,132.27,1.9,0.07,58cfa82fe4b0c9d6adf6b2e0,TCGA-09-2045-11A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-09-2045-11A,3768D34F-1527-40DB-B116-CD80CEE5EC3A,Solid Tissue Normal,Illumina HiSeq,bb45bc7f-13ad-4447-bc68-fd56481f2946,Ovary,50,705CECF8-E3FA-4025-8AAF-21C6F91D91C0,96F132C4-8189-45B0-B538-A4FD47A8577F,TCGA-09-2045-11A-01D-A324-10,GRCh37-lite,TCGA-09-2045,TCGA-OV,1069,s17899,Baylor College of Medicine,UCSF,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6ba4a,58cfa830e4b0c9d6adf6ba4a,TCGA-A6-3807-01A-01D-1459-10_wgs_Illumina.filtered.,WGS,TCGA-A6-3807-01A-01D-1459-10_wgs_Illumina,TCGA-A6-3807-01A-01D-1459-10_wgs_Illumina.bam,380,1.9,0.05,58cfa830e4b0c9d6adf6ba4a,TCGA-A6-3807-01A-01D-1459-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-3807-01A,5116E3B4-2BAC-40F5-8046-B9C1783FAAA5,Primary Tumor,Illumina HiSeq,b5897ed2-6c9b-4c6e-b131-41b62e60ecb9,Colorectal,53,1EB2A255-6EDD-4ADB-B52D-99DCEC590C5D,F38B5D2E-5CAB-45C7-BB0A-38B2EFC5C156,TCGA-A6-3807-01A-01D-1459-10,GRCh37-lite,TCGA-A6-3807,TCGA-COAD,NA,s13652,Baylor College of Medicine,Christiana Healthcare,None,NO,T3,N2,Colon Adenocarcinoma,Stage IIIC
13722.58cfa82ee4b0c9d6adf6acd5,58cfa82ee4b0c9d6adf6acd5,G39020.TCGA-D7-6527-10A-01D-1800-08.2.filtered.,WGS,G39020.TCGA-D7-6527-10A-01D-1800-08.2,G39020.TCGA-D7-6527-10A-01D-1800-08.2.bam,227.7,1.9,0.05,58cfa82ee4b0c9d6adf6acd5,G39020.TCGA-D7-6527-10A-01D-1800-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6527-10A,CB622CD6-776D-4681-8A67-4ADDD61C66B8,Blood Derived Normal,Illumina HiSeq,0c16032f-bf10-4293-b1be-a0f6fe286885,Stomach,62,1C932E82-DF6F-4CE3-B691-46C0D5E9F893,3729B122-72FA-41F5-95BA-FCEF586C479D,TCGA-D7-6527-10A-01D-1800-08,HG19_Broad_variant,TCGA-D7-6527,TCGA-STAD,NA,s14681,Broad Institute of MIT and Harvard,Greater Poland Cancer Center,Poland,NO,T2,N1,Stomach Intestinal Adenocarcinoma Papillary Type,Stage II
13722.58cfa82fe4b0c9d6adf6b454,58cfa82fe4b0c9d6adf6b454,TCGA-24-2290-10A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-24-2290-10A-01D-A324-10_wgs_Illumina,TCGA-24-2290-10A-01D-A324-10_wgs_Illumina.bam,228.27,1.9,0.08,58cfa82fe4b0c9d6adf6b454,TCGA-24-2290-10A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-2290-10A,2B14123B-8FCD-402C-9399-4E7C47F20252,Blood Derived Normal,Illumina HiSeq,21beb4a5-39c2-40b8-9675-288c44901592,Ovary,56,D876903D-84EB-456A-B5C1-22207F0A7811,9578D5C5-3517-4123-8989-DF009F7E3407,TCGA-24-2290-10A-01D-A324-10,GRCh37-lite,TCGA-24-2290,TCGA-OV,1102,s17950,Baylor College of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aac9,58cfa82ee4b0c9d6adf6aac9,G25778.TCGA-05-4396-01A-21D-1855-08.2.filtered.,WGS,G25778.TCGA-05-4396-01A-21D-1855-08.2,G25778.TCGA-05-4396-01A-21D-1855-08.2.bam,301.7,1.9,0.05,58cfa82ee4b0c9d6adf6aac9,G25778.TCGA-05-4396-01A-21D-1855-08.2.bam,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4396-01A,9F81C602-8AFA-4588-B0B6-6E5A1A128D5A,Primary Tumor,Illumina HiSeq,80ae7a4a-81b6-4887-b708-cbff2cae5d94,Lung,76,4D85772B-287E-4790-B1E8-CD1C0E88AD48,0176CF1D-0760-4769-A493-277F4BB7585E,TCGA-05-4396-01A-21D-1855-08,HG19_Broad_variant,TCGA-05-4396,TCGA-LUAD,303,s11215,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T4,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIIB
13722.58cfa82ee4b0c9d6adf6ade6,58cfa82ee4b0c9d6adf6ade6,G49837.TCGA-66-2789-11A-01D-A320-08.1.filtered.,WGS,G49837.TCGA-66-2789-11A-01D-A320-08.1,G49837.TCGA-66-2789-11A-01D-A320-08.1.bam,36.88,1.9,0.08,58cfa82ee4b0c9d6adf6ade6,G49837.TCGA-66-2789-11A-01D-A320-08.1.bam,Dead,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-66-2789-11A,87AC0AD4-8C9D-409E-9A86-1D201D01769D,Solid Tissue Normal,Illumina HiSeq,33d19a1f-bda4-4657-8365-e27543cb2c30,Lung,73,FD45B4EE-5BD7-4182-B37F-DF17E5783455,A5145237-1828-4CF9-9646-16F4908EB4DF,TCGA-66-2789-11A-01D-A320-08,HG19_Broad_variant,TCGA-66-2789,TCGA-LUSC,123,s10370,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T1,N3,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIB
13722.58cfa82de4b0c9d6adf6a77a,58cfa82de4b0c9d6adf6a77a,G12520.TCGA-60-2711-01A-01D-0963-08.1.filtered.,WGS,G12520.TCGA-60-2711-01A-01D-0963-08.1,G12520.TCGA-60-2711-01A-01D-0963-08.1.bam,620.3,1.9,0.15,58cfa82de4b0c9d6adf6a77a,G12520.TCGA-60-2711-01A-01D-0963-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-60-2711-01A,1F11DE87-A5FE-49FD-80C1-E279B2BC69DE,Primary Tumor,Illumina HiSeq,53773d17-2e17-4544-845d-b784120af48d,Lung,64,8A3A376A-A4DB-4D4F-85CE-A894A2AA60BB,D54CA81C-1BCC-41EA-B17A-9F7249EBE9C1,TCGA-60-2711-01A-01D-0963-08,HG19_Broad_variant,TCGA-60-2711,TCGA-LUSC,NA,s10496,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6aa7a,58cfa82ee4b0c9d6adf6aa7a,G26390.TCGA-06-0214-01A-02D-1491-08.1.filtered.,WGS,G26390.TCGA-06-0214-01A-02D-1491-08.1,G26390.TCGA-06-0214-01A-02D-1491-08.1.bam,20,1.89,0.05,58cfa82ee4b0c9d6adf6aa7a,G26390.TCGA-06-0214-01A-02D-1491-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0214-01A,9853C6BB-A42C-4698-ABE5-F3C897EBC8F6,Primary Tumor,Illumina HiSeq,b4e7ab91-7a2f-4f62-baa3-1ade0467836e,Brain,66,A86189C2-BFF1-4DBE-B4AC-C886478E6FFC,08AC57EC-0036-4134-A9BB-F22EAA27AB0D,TCGA-06-0214-01A-02D-1491-08,HG19_Broad_variant,TCGA-06-0214,TCGA-GBM,457,s13926,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6ac6a,58cfa82ee4b0c9d6adf6ac6a,G39019.TCGA-GN-A262-06A-11D-A196-08.2.filtered.,WGS,G39019.TCGA-GN-A262-06A-11D-A196-08.2,G39019.TCGA-GN-A262-06A-11D-A196-08.2.bam,77,NA,0.09,58cfa82ee4b0c9d6adf6ac6a,G39019.TCGA-GN-A262-06A-11D-A196-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-GN-A262-06A,E36C9411-773B-4A8E-9B43-895B3CB044C7,Metastatic,Illumina HiSeq,c7719432-272b-496c-9ca1-743d2a8c08ef,Skin,47,B9996930-4DBB-482A-BE2E-81C0D499ADA9,2399AB13-ABFA-480E-9FDA-7947EDC420BE,TCGA-GN-A262-06A-11D-A196-08,HG19_Broad_variant,TCGA-GN-A262,TCGA-SKCM,NA,s7317,Broad Institute of MIT and Harvard,Roswell,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82fe4b0c9d6adf6ba06,58cfa82fe4b0c9d6adf6ba06,TCGA-AA-3956-01A-02D-1981-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3956-01A-02D-1981-10_wgs_Illumina,TCGA-AA-3956-01A-02D-1981-10_wgs_Illumina.bam,282.86,1.9,0.14,58cfa82fe4b0c9d6adf6ba06,TCGA-AA-3956-01A-02D-1981-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3956-01A,7B47489F-C3CC-4388-B5D7-C7C02790A5F6,Primary Tumor,Illumina HiSeq,72141594-ac11-437d-896e-d1ae66162764,Colorectal,65,DC1FFDA5-5B8F-4227-BE04-321643F73731,3C019B2F-52EC-40A8-99B5-98C1423CE627,TCGA-AA-3956-01A-02D-1981-10,GRCh37-lite,TCGA-AA-3956,TCGA-COAD,NA,s12870,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6aed8,58cfa82ee4b0c9d6adf6aed8,G7168.TCGA-67-3771-10A-01D-0969-08.15.filtered.,WGS,G7168.TCGA-67-3771-10A-01D-0969-08.15,G7168.TCGA-67-3771-10A-01D-0969-08.15.bam,368.63,1.9,0.14,58cfa82ee4b0c9d6adf6aed8,G7168.TCGA-67-3771-10A-01D-0969-08.15.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-67-3771-10A,0DF573EE-28F0-4244-B434-09E6CA59FBF0,Blood Derived Normal,Illumina GA,f8c0eb87-e277-443d-9ae0-6a8890763e83,Lung,77,D028A23A-877E-4939-8465-F18944F5886F,B8DF34F3-D151-417A-A542-68259E1006E5,TCGA-67-3771-10A-01D-0969-08,HG19_Broad_variant,TCGA-67-3771,TCGA-LUAD,NA,s10897,Broad Institute of MIT and Harvard,St Joseph's Medical Center (MD),United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa830e4b0c9d6adf6bbdd,58cfa830e4b0c9d6adf6bbdd,TCGA-AG-4015-01A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AG-4015-01A-01D-1989-10_wgs_Illumina,TCGA-AG-4015-01A-01D-1989-10_wgs_Illumina.bam,610.89,1.9,0.14,58cfa830e4b0c9d6adf6bbdd,TCGA-AG-4015-01A-01D-1989-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-4015-01A,1388BBA1-02BA-40DF-93E5-C3D58B7BBAE0,Primary Tumor,Illumina HiSeq,ba539625-e278-4166-9667-ec8f68d0b5a0,Colorectal,85,3C910093-DF83-485B-86EF-26A0991D9A0B,AA06AE46-2336-4666-A3AF-FC790DAF8DA4,TCGA-AG-4015-01A-01D-1989-10,GRCh37-lite,TCGA-AG-4015,TCGA-READ,NA,s2169,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6aa2e,58cfa82ee4b0c9d6adf6aa2e,G25252.TCGA-CV-7416-11A-01D-2334-08.1.filtered.,WGS,G25252.TCGA-CV-7416-11A-01D-2334-08.1,G25252.TCGA-CV-7416-11A-01D-2334-08.1.bam,208,NA,0.05,58cfa82ee4b0c9d6adf6aa2e,G25252.TCGA-CV-7416-11A-01D-2334-08.1.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7416-11A,96415324-6859-41EB-8D07-BE4E6F7D9781,Solid Tissue Normal,Illumina HiSeq,6650adf8-2533-476f-a2ae-1471135763a3,Head and Neck,29,D390D3E6-9516-4485-AF75-955B1A1B76CA,BC890854-512D-4118-B5A5-954F774D0C36,TCGA-CV-7416-11A-01D-2334-08,HG19_Broad_variant,TCGA-CV-7416,TCGA-HNSC,763,s15746,Broad Institute of MIT and Harvard,MD Anderson Cancer Center,United States,NO,T4a,Not available,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82ee4b0c9d6adf6ae30,58cfa82ee4b0c9d6adf6ae30,G7167.TCGA-55-1596-11A-01D-0969-08.15.filtered.,WGS,G7167.TCGA-55-1596-11A-01D-0969-08.15,G7167.TCGA-55-1596-11A-01D-0969-08.15.bam,358.3,1.9,0.17,58cfa82ee4b0c9d6adf6ae30,G7167.TCGA-55-1596-11A-01D-0969-08.15.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-55-1596-11A,199386C2-BB53-4FAD-A1B6-59AB216A4A50,Solid Tissue Normal,Illumina GA,2a257d09-8210-45fd-920a-efb7008724bd,Lung,55,7BD574DA-43AA-40F4-9B95-E50682AED48F,7CFF0DF9-5E90-4692-A24A-C3D87D02CBA6,TCGA-55-1596-11A-01D-0969-08,HG19_Broad_variant,TCGA-55-1596,TCGA-LUAD,NA,s11544,Broad Institute of MIT and Harvard,International Genomics Consortium,None,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82fe4b0c9d6adf6b3ee,58cfa82fe4b0c9d6adf6b3ee,TCGA-24-1552-10A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-24-1552-10A-01D-A324-10_wgs_Illumina,TCGA-24-1552-10A-01D-A324-10_wgs_Illumina.bam,408.97,1.8,0.09,58cfa82fe4b0c9d6adf6b3ee,TCGA-24-1552-10A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1552-10A,62379BE5-13F0-474B-94D3-6F944EC4EE96,Blood Derived Normal,Illumina HiSeq,bd42ac3a-fbfc-4ba1-a233-4d0d48544f4a,Ovary,77,56AB98BE-19EB-46B8-9A20-BEA4D694F06C,F7BFA218-E9BD-4F6D-B9E6-C38F3AD9E9ED,TCGA-24-1552-10A-01D-A324-10,GRCh37-lite,TCGA-24-1552,TCGA-OV,1259,s18116,Baylor College of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ae11,58cfa82ee4b0c9d6adf6ae11,G7168.TCGA-67-3771-01A-01D-0969-08.13.filtered.,WGS,G7168.TCGA-67-3771-01A-01D-0969-08.13,G7168.TCGA-67-3771-01A-01D-0969-08.13.bam,316.63,1.9,0.16,58cfa82ee4b0c9d6adf6ae11,G7168.TCGA-67-3771-01A-01D-0969-08.13.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-67-3771-01A,0DF573EE-28F0-4244-B434-09E6CA59FBF0,Primary Tumor,Illumina GA,0ebe8891-f3c8-405a-ad50-93850699da24,Lung,77,B0410CD6-693D-41D6-9DAD-D1B1C30BF5CB,3B20D548-2A7D-4031-85A1-425CA7201D7A,TCGA-67-3771-01A-01D-0969-08,HG19_Broad_variant,TCGA-67-3771,TCGA-LUAD,NA,s10767,Broad Institute of MIT and Harvard,St Joseph's Medical Center (MD),United States,NO,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6aeb8,58cfa82ee4b0c9d6adf6aeb8,G49538.TCGA-06-0125-10A-01D-1490-08.2.filtered.,WGS,G49538.TCGA-06-0125-10A-01D-1490-08.2,G49538.TCGA-06-0125-10A-01D-1490-08.2.bam,70,1.89,0.05,58cfa82ee4b0c9d6adf6aeb8,G49538.TCGA-06-0125-10A-01D-1490-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0125-10A,8DA3103E-3E6C-4176-A583-D5FE5E60601E,Blood Derived Normal,Illumina HiSeq,d6a1530a-9e80-42a3-9636-6eebb618780a,Brain,63,0B38C4DA-016A-499C-8BD2-2A22C912B74C,EAE82A82-AA9F-4FEA-B1DA-E973E1982DC6,TCGA-06-0125-10A-01D-1490-08,HG19_Broad_variant,TCGA-06-0125,TCGA-GBM,1448,s13950,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6ae87,58cfa82ee4b0c9d6adf6ae87,G49537.TCGA-L6-A4ET-10A-01D-A25A-08.2.filtered.,WGS,G49537.TCGA-L6-A4ET-10A-01D-A25A-08.2,G49537.TCGA-L6-A4ET-10A-01D-A25A-08.2.bam,11.79,NA,0.08,58cfa82ee4b0c9d6adf6ae87,G49537.TCGA-L6-A4ET-10A-01D-A25A-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-L6-A4ET-10A,E1FF7694-64E1-47ED-B0D8-34ACFB4FFEF1,Blood Derived Normal,Illumina HiSeq,b20af8b7-bf6a-4ad9-99f9-63c6f3207233,Thyroid,49,702D6DD2-8F98-48F1-8F34-DE812D5B717A,EA509942-FCAC-486F-AC3D-37457BAB29DB,TCGA-L6-A4ET-10A-01D-A25A-08,HG19_Broad_variant,TCGA-L6-A4ET,TCGA-THCA,NA,s12228,Broad Institute of MIT and Harvard,National Institutes of Health,United States,NO,T3,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage IVC
13722.58cfa82ee4b0c9d6adf6a81a,58cfa82ee4b0c9d6adf6a81a,G23062.TCGA_BA_4077_01B_01D_2268_08.2.filtered.,WGS,G23062.TCGA_BA_4077_01B_01D_2268_08.2,G23062.TCGA_BA_4077_01B_01D_2268_08.2.bam,246.33,1.9,0.15,58cfa82ee4b0c9d6adf6a81a,G23062.TCGA_BA_4077_01B_01D_2268_08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-4077-01B,4BFBCE2B-9D0B-4E8A-950F-FD8E0BA3E05A,Primary Tumor,Illumina HiSeq,6533e56c-b5b8-4c85-862b-a5526c5c2e0a,Head and Neck,45,327BBCA7-FA25-4A92-BE27-21A4C184C760,268D9CDB-CCCF-491A-A9BB-2E3D6B85951F,TCGA-BA-4077-01B-01D-2268-08,HG19_Broad_variant,TCGA-BA-4077,TCGA-HNSC,1134,s16017,Broad Institute of MIT and Harvard,UNC,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82ee4b0c9d6adf6ab9c,58cfa82ee4b0c9d6adf6ab9c,G25777.TCGA-67-6215-01A-11D-1753-08.1.filtered.,WGS,G25777.TCGA-67-6215-01A-11D-1753-08.1,G25777.TCGA-67-6215-01A-11D-1753-08.1.bam,292.4,1.9,0.05,58cfa82ee4b0c9d6adf6ab9c,G25777.TCGA-67-6215-01A-11D-1753-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-67-6215-01A,DBD5B0DE-94C9-45DD-AFB3-6820A7ECACA2,Primary Tumor,Illumina HiSeq,70835707-2b01-4434-88b9-57b2c434b88e,Lung,52,3BA5F6B9-6458-44E2-A0AA-B5C7E5FCD632,68C2A355-862C-4657-B296-5776ED8447B0,TCGA-67-6215-01A-11D-1753-08,HG19_Broad_variant,TCGA-67-6215,TCGA-LUAD,NA,s10633,Broad Institute of MIT and Harvard,St Joseph's Medical Center (MD),United States,NO,T2a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82de4b0c9d6adf6a72a,58cfa82de4b0c9d6adf6a72a,G14581.TCGA-64-1680-10A-01D-1040-01.2.filtered.,WGS,G14581.TCGA-64-1680-10A-01D-1040-01.2,G14581.TCGA-64-1680-10A-01D-1040-01.2.bam,43.93,2,0.15,58cfa82de4b0c9d6adf6a72a,G14581.TCGA-64-1680-10A-01D-1040-01.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-64-1680-10A,1AB7AD70-0F80-41D8-8EFA-3BAEBC8223CC,Blood Derived Normal,Illumina HiSeq,0e182f6d-70c5-46a2-a737-29990f3c472f,Lung,63,B98E2DDC-D065-4E90-B240-A0B37793245F,F4B8B2D5-ACC7-4FD6-B852-C80FD79BE99E,TCGA-64-1680-10A-01D-1040-01,HG19_Broad_variant,TCGA-64-1680,TCGA-LUAD,NA,s10890,Broad Institute of MIT and Harvard,Fox Chase,None,NO,T2a,N2,Lung Adenocarcinoma Mixed Subtype,Stage IV
13722.58cfa82ee4b0c9d6adf6aec6,58cfa82ee4b0c9d6adf6aec6,G49537.TCGA-DE-A2OL-10A-01D-A18F-08.2.filtered.,WGS,G49537.TCGA-DE-A2OL-10A-01D-A18F-08.2,G49537.TCGA-DE-A2OL-10A-01D-A18F-08.2.bam,12.19,NA,0.08,58cfa82ee4b0c9d6adf6aec6,G49537.TCGA-DE-A2OL-10A-01D-A18F-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DE-A2OL-10A,77BB90F0-E923-4E28-BB88-4D6B420E0B5C,Blood Derived Normal,Illumina HiSeq,c1ca0415-c1fb-4cc9-b0d8-3bbbbdcb92f8,Thyroid,44,FB72A12C-0E58-4EC1-9505-EF76891551EC,385B3242-E4B2-4574-9289-48B8826AE644,TCGA-DE-A2OL-10A-01D-A18F-08,HG19_Broad_variant,TCGA-DE-A2OL,TCGA-THCA,NA,s12500,Broad Institute of MIT and Harvard,University of North Carolina,United States,NO,T2,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa82ee4b0c9d6adf6aec0,58cfa82ee4b0c9d6adf6aec0,G49537.TCGA-EM-A2CN-10B-01D-A19M-08.2.filtered.,WGS,G49537.TCGA-EM-A2CN-10B-01D-A19M-08.2,G49537.TCGA-EM-A2CN-10B-01D-A19M-08.2.bam,31.78,NA,0.08,58cfa82ee4b0c9d6adf6aec0,G49537.TCGA-EM-A2CN-10B-01D-A19M-08.2.bam,Alive,MALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A2CN-10B,4AED5116-D27B-4911-B310-05C2248B861F,Blood Derived Normal,Illumina HiSeq,e590d3d8-14d7-4334-b3eb-1daaf338e677,Thyroid,62,1580ADDD-2378-4CA5-A1E6-D6C02C1EC053,06DFC16A-CA37-46CA-8ABB-20C1295E8F3A,TCGA-EM-A2CN-10B-01D-A19M-08,HG19_Broad_variant,TCGA-EM-A2CN,TCGA-THCA,NA,s12497,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage IVC
13722.58cfa82fe4b0c9d6adf6ba14,58cfa82fe4b0c9d6adf6ba14,TCGA-AA-3529-11A-01D-1554-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3529-11A-01D-1554-10_wgs_Illumina,TCGA-AA-3529-11A-01D-1554-10_wgs_Illumina.bam,446.7,1.9,0.05,58cfa82fe4b0c9d6adf6ba14,TCGA-AA-3529-11A-01D-1554-10_wgs_Illumina.bam,Dead,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3529-11A,BFB07784-693B-4C25-874E-4AD6E04A5D46,Solid Tissue Normal,Illumina HiSeq,f8e7f553-29a1-4b6f-96a4-a63ad48a62d9,Colorectal,78,B73F0D09-2505-4F94-9E8B-02B6E2B0FB92,0633601D-2A33-438F-982F-0EE316BD7B7F,TCGA-AA-3529-11A-01D-1554-10,GRCh37-lite,TCGA-AA-3529,TCGA-COAD,0,s13180,Baylor College of Medicine,Indivumed,Germany,NO,T3,N2,Colon Adenocarcinoma,Stage IIIC
13722.58cfa830e4b0c9d6adf6bd0f,58cfa830e4b0c9d6adf6bd0f,TCGA-AA-3685-10A-01D-1981-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3685-10A-01D-1981-10_wgs_Illumina,TCGA-AA-3685-10A-01D-1981-10_wgs_Illumina.bam,110.96,1.9,0.15,58cfa830e4b0c9d6adf6bd0f,TCGA-AA-3685-10A-01D-1981-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3685-10A,DCA004BF-9C14-45A1-B186-AB3759F6C7FE,Blood Derived Normal,Illumina HiSeq,5997dc8e-b2ff-409c-ae44-75c132609542,Colorectal,69,EAB2CE78-F983-46D1-BCA1-643049B73934,826C6475-2C86-4E91-A28A-2B6C4F6F270B,TCGA-AA-3685-10A-01D-1981-10,GRCh37-lite,TCGA-AA-3685,TCGA-COAD,NA,s12871,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa82fe4b0c9d6adf6b4c4,58cfa82fe4b0c9d6adf6b4c4,TCGA-25-2391-10A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-25-2391-10A-01D-A324-10_wgs_Illumina,TCGA-25-2391-10A-01D-A324-10_wgs_Illumina.bam,158.27,1.9,0.07,58cfa82fe4b0c9d6adf6b4c4,TCGA-25-2391-10A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-25-2391-10A,F5033D52-EC36-4E67-88D8-B6D898B81B2F,Blood Derived Normal,Illumina HiSeq,fbeaf042-3331-49be-9336-ac194218ed9a,Ovary,57,59001597-3894-47FB-B926-B6AC5DA947D6,9C0BCB41-71F9-47DA-B80B-91D18084BA4E,TCGA-25-2391-10A-01D-A324-10,GRCh37-lite,TCGA-25-2391,TCGA-OV,1492,s18055,Baylor College of Medicine,Mayo Clinic - Rochester,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aef0,58cfa82ee4b0c9d6adf6aef0,G39020.TCGA-D7-6815-10A-01D-1882-08.1.filtered.,WGS,G39020.TCGA-D7-6815-10A-01D-1882-08.1,G39020.TCGA-D7-6815-10A-01D-1882-08.1.bam,185,1.9,0.05,58cfa82ee4b0c9d6adf6aef0,G39020.TCGA-D7-6815-10A-01D-1882-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6815-10A,53086E20-A727-40D6-B42D-8030109B5130,Blood Derived Normal,Illumina HiSeq,48e964d1-7020-48a9-945c-f3409790f8ea,Stomach,70,B051617A-8114-4EAF-A0E4-37D69CF65065,033F45F0-C6FD-496E-8BF4-214102BE013F,TCGA-D7-6815-10A-01D-1882-08,HG19_Broad_variant,TCGA-D7-6815,TCGA-STAD,NA,s15173,Broad Institute of MIT and Harvard,Greater Poland Cancer Center,Poland,NO,T2,N2,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIB
13722.58cfa82de4b0c9d6adf6a74e,58cfa82de4b0c9d6adf6a74e,G13229.TCGA-56-1622-01A-01D-1521-08.1.filtered.,WGS,G13229.TCGA-56-1622-01A-01D-1521-08.1,G13229.TCGA-56-1622-01A-01D-1521-08.1.bam,338.7,1.9,0.05,58cfa82de4b0c9d6adf6a74e,G13229.TCGA-56-1622-01A-01D-1521-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-56-1622-01A,3EDF933A-BE1A-46E8-BFB0-ACDFF30E64A0,Primary Tumor,Illumina HiSeq,7fdda717-3cf6-4e4d-a2c7-8b7691ce09b2,Lung,58,4083DE2F-3FF5-487B-A27B-783D51C4F853,0BBC7EDE-5022-4084-925C-D65BAAF7ABC2,TCGA-56-1622-01A-01D-1521-08,HG19_Broad_variant,TCGA-56-1622,TCGA-LUSC,881,s10071,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa832e4b0c9d6adf6d10a,58cfa832e4b0c9d6adf6d10a,TCGA-HE-A5NH-10A-01D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-HE-A5NH-10A-01D-A26P-10_wgs_Illumina,TCGA-HE-A5NH-10A-01D-A26P-10_wgs_Illumina.bam,45.1,NA,0.08,58cfa832e4b0c9d6adf6d10a,TCGA-HE-A5NH-10A-01D-A26P-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-HE-A5NH-10A,98A639C2-D615-4DC1-98F0-298752B69B09,Blood Derived Normal,Illumina HiSeq,ea842f77-1b78-4b89-82cc-5bc20e5ac928,Kidney,62,93CA0CEE-52DD-4144-A80D-64C873B28052,10FB6A4B-3CB8-484E-ABFD-0987CDECB32E,TCGA-HE-A5NH-10A-01D-A26P-10,GRCh37-lite,TCGA-HE-A5NH,TCGA-KIRP,NA,s11650,Baylor College of Medicine,Ontario Institute for Cancer Research (OICR),Canada,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6acf3,58cfa82ee4b0c9d6adf6acf3,G49537.TCGA-DJ-A2Q1-10A-01D-A19M-08.1.filtered.,WGS,G49537.TCGA-DJ-A2Q1-10A-01D-A19M-08.1,G49537.TCGA-DJ-A2Q1-10A-01D-A19M-08.1.bam,28.34,NA,0.08,58cfa82ee4b0c9d6adf6acf3,G49537.TCGA-DJ-A2Q1-10A-01D-A19M-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A2Q1-10A,E35B2928-8784-45D0-A71A-A2DF161542FA,Blood Derived Normal,Illumina HiSeq,da7c4856-942e-4ca5-a3f6-30e1d7351c4b,Thyroid,44,3D2DE63E-6D83-4F34-97EF-4D85FE55590E,AE3BDD94-C5B3-4D12-9B54-00AD13BDD3A2,TCGA-DJ-A2Q1-10A-01D-A19M-08,HG19_Broad_variant,TCGA-DJ-A2Q1,TCGA-THCA,NA,s12738,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T1b,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82de4b0c9d6adf6a77c,58cfa82de4b0c9d6adf6a77c,G14852.TCGA-49-4510-01A-01D-1931-08.3.filtered.,WGS,G14852.TCGA-49-4510-01A-01D-1931-08.3,G14852.TCGA-49-4510-01A-01D-1931-08.3.bam,177.53,1.9,0.14,58cfa82de4b0c9d6adf6a77c,G14852.TCGA-49-4510-01A-01D-1931-08.3.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4510-01A,F77B6930-A1CE-446E-A15D-C018CBBECFEE,Primary Tumor,Illumina HiSeq,25c363b3-3a56-4365-8fec-10ccb8618909,Lung,51,9A479D32-13A4-46C2-B26D-34CB6051A891,3E680217-92C1-4C6F-BF67-CA64E469B4A4,TCGA-49-4510-01A-01D-1931-08,HG19_Broad_variant,TCGA-49-4510,TCGA-LUAD,896,s11212,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6af88,58cfa82ee4b0c9d6adf6af88,TCGA-04-1349-11A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-04-1349-11A-01D-A324-10_wgs_Illumina,TCGA-04-1349-11A-01D-A324-10_wgs_Illumina.bam,204.97,1.9,0.08,58cfa82ee4b0c9d6adf6af88,TCGA-04-1349-11A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-04-1349-11A,4B930A10-4B12-4428-84F9-3255B4A3BC4F,Solid Tissue Normal,Illumina HiSeq,37e80689-57fd-4c47-8b1f-c89bc5971310,Ovary,69,F371CD02-F137-4F8A-A21B-76696DFAD79D,99C13D03-AAF5-4DDA-A594-5C82679BB0DB,TCGA-04-1349-11A-01D-A324-10,GRCh37-lite,TCGA-04-1349,TCGA-OV,656,s17207,Baylor College of Medicine,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a778,58cfa82de4b0c9d6adf6a778,G14849.TCGA-44-2659-01A-01D-1931-08.5.filtered.,WGS,G14849.TCGA-44-2659-01A-01D-1931-08.5,G14849.TCGA-44-2659-01A-01D-1931-08.5.bam,82.96,1.9,0.15,58cfa82de4b0c9d6adf6a778,G14849.TCGA-44-2659-01A-01D-1931-08.5.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-2659-01A,BF15F7AD-9D92-473B-91D1-F24AA373AB97,Primary Tumor,Illumina HiSeq,bcdd7201-d7f2-45f5-bbaf-e0ca63b987c4,Lung,65,42208BA8-F465-4D62-9ED9-5DBFAA525913,2BDE43E2-FD4E-413E-ADC7-C50BCA75D358,TCGA-44-2659-01A-01D-1931-08,HG19_Broad_variant,TCGA-44-2659,TCGA-LUAD,NA,s10626,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,T1,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82fe4b0c9d6adf6b810,58cfa82fe4b0c9d6adf6b810,TCGA-36-1570-10A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-36-1570-10A-01D-A324-10_wgs_Illumina,TCGA-36-1570-10A-01D-A324-10_wgs_Illumina.bam,336.27,1.9,0.08,58cfa82fe4b0c9d6adf6b810,TCGA-36-1570-10A-01D-A324-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-36-1570-10A,0F530B3E-5B6D-4892-9EBD-9138D76FDCA7,Blood Derived Normal,Illumina HiSeq,970cda70-6d4c-4427-a50d-bb1a5ee7019b,Ovary,49,49931772-EA7F-4644-955F-086BD55089D2,AC358B78-0D1C-415D-9CA5-B877A3363390,TCGA-36-1570-10A-01D-A324-10,GRCh37-lite,TCGA-36-1570,TCGA-OV,NA,s17395,Baylor College of Medicine,BC Cancer Agency,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bc84,58cfa830e4b0c9d6adf6bc84,TCGA-AG-A032-01A-01D-A183-10_wgs_Illumina.filtered.,WGS,TCGA-AG-A032-01A-01D-A183-10_wgs_Illumina,TCGA-AG-A032-01A-01D-A183-10_wgs_Illumina.bam,237.12,1.85,0.08,58cfa830e4b0c9d6adf6bc84,TCGA-AG-A032-01A-01D-A183-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A032-01A,0BB786EE-07CF-4853-9B49-EC95CD14E282,Primary Tumor,Illumina HiSeq,3d3bf209-70e8-4882-99c7-6e20c03cccea,Colorectal,68,AE3C8931-C06F-466A-B6BF-440007E13387,CD3D7559-B583-4474-81DF-4BF9232DE3C2,TCGA-AG-A032-01A-01D-A183-10,GRCh37-lite,TCGA-AG-A032,TCGA-READ,NA,s2170,Baylor College of Medicine,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIB
13722.58cfa82fe4b0c9d6adf6b2fc,58cfa82fe4b0c9d6adf6b2fc,TCGA-24-1419-10A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-24-1419-10A-01D-A324-10_wgs_Illumina,TCGA-24-1419-10A-01D-A324-10_wgs_Illumina.bam,61.27,1.9,0.08,58cfa82fe4b0c9d6adf6b2fc,TCGA-24-1419-10A-01D-A324-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1419-10A,5E18B17D-4626-4B6D-8AC6-E560CEE0376C,Blood Derived Normal,Illumina HiSeq,0db83578-1dcc-40c4-8934-76d2201eea69,Ovary,62,CF7561B2-7D31-41FD-A0D1-FB5BAE41F2C7,3867B293-9A47-44AD-BDBC-CA9D1448CB6F,TCGA-24-1419-10A-01D-A324-10,GRCh37-lite,TCGA-24-1419,TCGA-OV,NA,s17510,Baylor College of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aa3a,58cfa82ee4b0c9d6adf6aa3a,G23069.TCGA_CR_6480_10A_01D_2268_08.1.filtered.,WGS,G23069.TCGA_CR_6480_10A_01D_2268_08.1,G23069.TCGA_CR_6480_10A_01D_2268_08.1.bam,144,1.9,0.14,58cfa82ee4b0c9d6adf6aa3a,G23069.TCGA_CR_6480_10A_01D_2268_08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-6480-10A,BA9D4568-71A8-41FC-A2BE-0BF784E36D6A,Blood Derived Normal,Illumina HiSeq,745de1a1-46c6-45d4-b70a-c06d2a9cef3e,Head and Neck,53,E49031DD-14F3-4F2C-8457-D0249C491AE9,BFB164E0-33C8-4163-A60D-11742A922E52,TCGA-CR-6480-10A-01D-2268-08,HG19_Broad_variant,TCGA-CR-6480,TCGA-HNSC,NA,s15861,Broad Institute of MIT and Harvard,Vanderbilt University,United States,NO,Not available,Not available,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6adc1,58cfa82ee4b0c9d6adf6adc1,G39020.TCGA-CD-5802-10A-01D-1600-08.1.filtered.,WGS,G39020.TCGA-CD-5802-10A-01D-1600-08.1,G39020.TCGA-CD-5802-10A-01D-1600-08.1.bam,617.7,1.9,0.05,58cfa82ee4b0c9d6adf6adc1,G39020.TCGA-CD-5802-10A-01D-1600-08.1.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-5802-10A,0AECAC64-5982-4D76-8F31-958F6A00951D,Blood Derived Normal,Illumina HiSeq,c1da67a6-2bf9-4bdf-9e88-6f4c4634df79,Stomach,58,602943B6-8FFC-4667-BE39-2E6A9FB3661A,AF722E36-4912-45C4-B431-A2CEFF596BAC,TCGA-CD-5802-10A-01D-1600-08,HG19_Broad_variant,TCGA-CD-5802,TCGA-STAD,NA,s15368,Broad Institute of MIT and Harvard,ILSbio,Vietnam,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa82fe4b0c9d6adf6b7a8,58cfa82fe4b0c9d6adf6b7a8,TCGA-61-2000-11A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-61-2000-11A-01D-A324-10_wgs_Illumina,TCGA-61-2000-11A-01D-A324-10_wgs_Illumina.bam,246.27,2,0.08,58cfa82fe4b0c9d6adf6b7a8,TCGA-61-2000-11A-01D-A324-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-61-2000-11A,29949B65-2913-4C86-BBD7-B85C5DF6F15E,Solid Tissue Normal,Illumina HiSeq,5a752b74-9068-4290-96f5-28cef6542078,Ovary,67,433DD0C4-E3A8-4175-8CD9-A57D221AAB46,501C785E-AA57-44D4-A38E-187BE13546D7,TCGA-61-2000-11A-01D-A324-10,GRCh37-lite,TCGA-61-2000,TCGA-OV,NA,s17143,Baylor College of Medicine,University of Pittsburgh,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ae90,58cfa82ee4b0c9d6adf6ae90,G49538.TCGA-06-0171-10A-01D-A33C-08.2.filtered.,WGS,G49538.TCGA-06-0171-10A-01D-A33C-08.2,G49538.TCGA-06-0171-10A-01D-A33C-08.2.bam,434.7,1.9,0.07,58cfa82ee4b0c9d6adf6ae90,G49538.TCGA-06-0171-10A-01D-A33C-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0171-10A,01A92062-967A-4900-8DC7-A5ECD3B3F8E2,Blood Derived Normal,Illumina HiSeq,dae9460c-3434-40e6-96d1-34b458464c4d,Brain,65,651BF40B-94B9-4DE6-A31F-BF21EE76F5B6,E318EB81-3D79-473E-B4CB-9325E76F91E1,TCGA-06-0171-10A-01D-A33C-08,HG19_Broad_variant,TCGA-06-0171,TCGA-GBM,399,s14027,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6af0a,58cfa82ee4b0c9d6adf6af0a,G48125.TCGA-13-1487-10A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-13-1487-10A-01D-A312-08.2,G48125.TCGA-13-1487-10A-01D-A312-08.2.bam,43.27,1.9,0.07,58cfa82ee4b0c9d6adf6af0a,G48125.TCGA-13-1487-10A-01D-A312-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-1487-10A,C9E28934-8379-4511-817C-D787F2C4CA3A,Blood Derived Normal,Illumina HiSeq,608f88c8-b235-4686-a27f-8917130ace91,Ovary,74,D520E8B9-3742-4A18-B11E-36A20FFCCA3C,8583DBBA-AAE2-41B9-9D07-6740B2655D72,TCGA-13-1487-10A-01D-A312-08,HG19_Broad_variant,TCGA-13-1487,TCGA-OV,681,s17408,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a90a,58cfa82ee4b0c9d6adf6a90a,G32457.TCGA-FD-A3N6-01A-11D-A21A-08.1.filtered.,WGS,G32457.TCGA-FD-A3N6-01A-11D-A21A-08.1,G32457.TCGA-FD-A3N6-01A-11D-A21A-08.1.bam,47.84,NA,0.08,58cfa82ee4b0c9d6adf6a90a,G32457.TCGA-FD-A3N6-01A-11D-A21A-08.1.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-FD-A3N6-01A,8C1DD7F7-B74A-4FA2-B6A7-86F0348D2567,Primary Tumor,Illumina HiSeq,d881868c-a616-4a4c-bbb7-4fbda95e1323,Bladder,43,6CD6D1F4-D8E4-47F9-812F-EB7FEC925F8D,D4615CA0-B5C7-4A5C-8593-BD50034A78AE,TCGA-FD-A3N6-01A-11D-A21A-08,HG19_Broad_variant,TCGA-FD-A3N6,TCGA-BLCA,NA,s2849,Broad Institute of MIT and Harvard,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II
13722.58cfa832e4b0c9d6adf6d4ec,58cfa832e4b0c9d6adf6d4ec,TCGA-QG-A5Z1-10A-01D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-QG-A5Z1-10A-01D-A28G-10_wgs_Illumina,TCGA-QG-A5Z1-10A-01D-A28G-10_wgs_Illumina.bam,11.22,NA,0.07,58cfa832e4b0c9d6adf6d4ec,TCGA-QG-A5Z1-10A-01D-A28G-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-QG-A5Z1-10A,9C45EAEC-D854-4F51-80A3-2D80D6B4AEBC,Blood Derived Normal,Illumina HiSeq,62c3e1f9-6214-4f67-82cc-424f37f29d79,Colorectal,71,5E6DA456-BDE7-419D-BD20-0578573342AB,A37995BF-5CF9-45DA-A480-E21C1C98C4D1,TCGA-QG-A5Z1-10A-01D-A28G-10,GRCh37-lite,TCGA-QG-A5Z1,TCGA-COAD,NA,s13398,Baylor College of Medicine,BLN - Baylor,United States,NO,T3,N1b,Colon Adenocarcinoma,Stage IIIB
13722.58cfa82ee4b0c9d6adf6a98c,58cfa82ee4b0c9d6adf6a98c,G25786.TCGA-78-7146-10A-01D-2036-08.2.filtered.,WGS,G25786.TCGA-78-7146-10A-01D-2036-08.2,G25786.TCGA-78-7146-10A-01D-2036-08.2.bam,75,NA,0.05,58cfa82ee4b0c9d6adf6a98c,G25786.TCGA-78-7146-10A-01D-2036-08.2.bam,Dead,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-78-7146-10A,FF9DEF3D-17E5-4EF6-B74E-933F11ED6F00,Blood Derived Normal,Illumina HiSeq,e3e01e40-c359-4dc8-90ae-a703361e2439,Lung,71,E5E34EF5-842C-4849-9476-54E415D3C3BF,1B679D8A-CA71-43EE-BDFA-5B0DD9FE7F80,TCGA-78-7146-10A-01D-2036-08,HG19_Broad_variant,TCGA-78-7146,TCGA-LUAD,173,s10762,Broad Institute of MIT and Harvard,Prince Charles Hospital,Australia,NO,T2,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIA
13722.58cfa82ee4b0c9d6adf6aa5c,58cfa82ee4b0c9d6adf6aa5c,G23074.TCGA_CN_4741_10A_01D_2268_08.3.filtered.,WGS,G23074.TCGA_CN_4741_10A_01D_2268_08.3,G23074.TCGA_CN_4741_10A_01D_2268_08.3.bam,84.4,1.9,0.15,58cfa82ee4b0c9d6adf6aa5c,G23074.TCGA_CN_4741_10A_01D_2268_08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4741-10A,277B02E9-DED5-4980-845D-AF53690000AC,Blood Derived Normal,Illumina HiSeq,19da4d3c-e43b-4310-9e3b-2fa09a8049c6,Head and Neck,75,8D8DDCA2-6461-4A8B-A696-DA0906661B9E,1C444414-1DFA-4FCD-AA31-68D17A35F898,TCGA-CN-4741-10A-01D-2268-08,HG19_Broad_variant,TCGA-CN-4741,TCGA-HNSC,NA,s16165,Broad Institute of MIT and Harvard,University of Pittsburgh,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82fe4b0c9d6adf6b9e6,58cfa82fe4b0c9d6adf6b9e6,TCGA-AA-3664-10A-01D-1981-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3664-10A-01D-1981-10_wgs_Illumina,TCGA-AA-3664-10A-01D-1981-10_wgs_Illumina.bam,76.96,1.9,0.15,58cfa82fe4b0c9d6adf6b9e6,TCGA-AA-3664-10A-01D-1981-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3664-10A,A06C09A8-0951-49F4-A765-5147BBCAE109,Blood Derived Normal,Illumina HiSeq,83404444-ee83-418a-a273-62ce5bea05c8,Colorectal,74,B4FFAC44-CCEF-458F-80CC-2D230D78012A,040D9ABC-937B-407C-9285-BA3598FF781B,TCGA-AA-3664-10A-01D-1981-10,GRCh37-lite,TCGA-AA-3664,TCGA-COAD,NA,s13665,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6ae7b,58cfa82ee4b0c9d6adf6ae7b,G49537.TCGA-FE-A233-10A-01D-A14W-08.1.filtered.,WGS,G49537.TCGA-FE-A233-10A-01D-A14W-08.1,G49537.TCGA-FE-A233-10A-01D-A14W-08.1.bam,21.67,2,0.09,58cfa82ee4b0c9d6adf6ae7b,G49537.TCGA-FE-A233-10A-01D-A14W-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A233-10A,E70FEAFD-1390-4F4C-A635-DA65C1A7DAEB,Blood Derived Normal,Illumina HiSeq,ebf0fa86-af7b-4163-8475-c1e634821353,Thyroid,18,B9FD4BE0-F412-494D-8837-BEB45B0A3B03,C978BBEE-66B4-4C0C-AA14-7667A1765DBB,TCGA-FE-A233-10A-01D-A14W-08,HG19_Broad_variant,TCGA-FE-A233,TCGA-THCA,NA,s12222,Broad Institute of MIT and Harvard,Ohio State University,United States,NO,T2,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82ee4b0c9d6adf6ad4d,58cfa82ee4b0c9d6adf6ad4d,G48125.TCGA-24-1557-10A-01D-A312-08.1.filtered.,WGS,G48125.TCGA-24-1557-10A-01D-A312-08.1,G48125.TCGA-24-1557-10A-01D-A312-08.1.bam,111.27,1.9,0.08,58cfa82ee4b0c9d6adf6ad4d,G48125.TCGA-24-1557-10A-01D-A312-08.1.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1557-10A,7DCC809B-E33A-4453-B92A-C00786F48CB0,Blood Derived Normal,Illumina HiSeq,c40714fc-62ff-4b73-a45f-b7d160a98b30,Ovary,49,B2FA92CD-8208-48CE-8CE9-30CBE7621B53,ABC055AD-7E73-4E6A-B3E5-524433CFB91E,TCGA-24-1557-10A-01D-A312-08,HG19_Broad_variant,TCGA-24-1557,TCGA-OV,1213,s17652,Broad Institute of MIT and Harvard,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ac4f,58cfa82ee4b0c9d6adf6ac4f,G39019.TCGA-DA-A3F5-06A-11D-A20D-08.2.filtered.,WGS,G39019.TCGA-DA-A3F5-06A-11D-A20D-08.2,G39019.TCGA-DA-A3F5-06A-11D-A20D-08.2.bam,44.17,NA,0.08,58cfa82ee4b0c9d6adf6ac4f,G39019.TCGA-DA-A3F5-06A-11D-A20D-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A3F5-06A,D8EAC750-9DAF-4465-B672-9E31FD369057,Metastatic,Illumina HiSeq,a8b342c2-9bdd-4e3f-a1b0-0f1796f5f603,Skin,45,2BB3C2AB-E9B9-4A12-916A-A9D3105A4D60,14630C19-9EE0-4AB3-9D8B-8C3309D1E7D0,TCGA-DA-A3F5-06A-11D-A20D-08,HG19_Broad_variant,TCGA-DA-A3F5,TCGA-SKCM,NA,s7488,Broad Institute of MIT and Harvard,Yale,United States,NO,T1a,N0,Not available,Stage I
13722.58cfa831e4b0c9d6adf6cb7e,58cfa831e4b0c9d6adf6cb7e,TCGA-DV-5566-10A-01D-2104-10_Illumina.filtered.,WGS,TCGA-DV-5566-10A-01D-2104-10_Illumina,TCGA-DV-5566-10A-01D-2104-10_Illumina.bam,23.1,1.9,0.16,58cfa831e4b0c9d6adf6cb7e,TCGA-DV-5566-10A-01D-2104-10_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-DV-5566-10A,4B2EC8AA-8460-440E-B75B-6B92AE7A3FFC,Blood Derived Normal,Illumina HiSeq,56edc0b6-3991-484d-aa30-184dfc37d393,Kidney,67,55456A36-6827-4419-B1B7-741D732DA4C1,164FE14F-A723-4549-A4C4-561C032E7D34,TCGA-DV-5566-10A-01D-2104-10,GRCh37-lite,TCGA-DV-5566,TCGA-KIRC,NA,s9740,Baylor College of Medicine,NCI Urologic Oncology Branch,None,NO,T1a,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ad2c,58cfa82ee4b0c9d6adf6ad2c,G49538.TCGA-14-1402-10A-01D-1493-08.3.filtered.,WGS,G49538.TCGA-14-1402-10A-01D-1493-08.3,G49538.TCGA-14-1402-10A-01D-1493-08.3.bam,133.3,1.9,0.05,58cfa82ee4b0c9d6adf6ad2c,G49538.TCGA-14-1402-10A-01D-1493-08.3.bam,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1402-10A,BF339349-062F-4EA9-A0B2-D87D3A21099E,Blood Derived Normal,Illumina HiSeq,b83634d5-24f0-480f-8719-3fa10ee45090,Brain,58,5FDA351B-DFA5-4DBB-825A-8A7EC84ECAED,0D9BBE68-41A0-488A-B5EE-8EDBB6DCFD63,TCGA-14-1402-10A-01D-1493-08,HG19_Broad_variant,TCGA-14-1402,TCGA-GBM,975,s14174,Broad Institute of MIT and Harvard,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6ab88,58cfa82ee4b0c9d6adf6ab88,G37566.TCGA-CH-5750-01A-11D-1576-08.2.filtered.,WGS,G37566.TCGA-CH-5750-01A-11D-1576-08.2,G37566.TCGA-CH-5750-01A-11D-1576-08.2.bam,300.7,1.9,0.05,58cfa82ee4b0c9d6adf6ab88,G37566.TCGA-CH-5750-01A-11D-1576-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5750-01A,DC40CF49-B208-4F59-B5F0-CFBDD02970B2,Primary Tumor,Illumina HiSeq,84c3a2f5-0cac-4bc2-8734-3269860bd2c0,Prostate,72,0386D0E9-7BD8-467F-BA97-A379C1D67A83,E1B169C3-44E0-43E5-9EE3-2DF7A678A5EA,TCGA-CH-5750-01A-11D-1576-08,HG19_Broad_variant,TCGA-CH-5750,TCGA-PRAD,NA,s3580,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6abc4,58cfa82ee4b0c9d6adf6abc4,G37566.TCGA-EJ-5506-01A-01D-1576-08.1.filtered.,WGS,G37566.TCGA-EJ-5506-01A-01D-1576-08.1,G37566.TCGA-EJ-5506-01A-01D-1576-08.1.bam,238.7,1.9,0.05,58cfa82ee4b0c9d6adf6abc4,G37566.TCGA-EJ-5506-01A-01D-1576-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5506-01A,E5E4D3B6-8E58-4DCF-8F67-A00E656A8E27,Primary Tumor,Illumina HiSeq,b7db243f-ae86-4f3d-b5f1-38ba6363bd78,Prostate,67,9EBDA113-B0FC-4233-87AC-DAD0E7D033DE,9F5E6063-D19E-4F56-B3F9-5C2260D3BFC9,TCGA-EJ-5506-01A-01D-1576-08,HG19_Broad_variant,TCGA-EJ-5506,TCGA-PRAD,NA,s3757,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6a7cf,58cfa82ee4b0c9d6adf6a7cf,G25249.TCGA-CR-7391-01A-11D-2334-08.1.filtered.,WGS,G25249.TCGA-CR-7391-01A-11D-2334-08.1,G25249.TCGA-CR-7391-01A-11D-2334-08.1.bam,85.7,NA,0.05,58cfa82ee4b0c9d6adf6a7cf,G25249.TCGA-CR-7391-01A-11D-2334-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-7391-01A,832316EE-08AB-412B-9E4D-8A57FF84BC11,Primary Tumor,Illumina HiSeq,ef4db578-e4b8-4047-b761-df26ecf7a41e,Head and Neck,36,54B7DB2E-F0DD-469D-81BB-4E2A86EBEA9D,C121DE15-78F7-4698-91BF-FD0485C466C2,TCGA-CR-7391-01A-11D-2334-08,HG19_Broad_variant,TCGA-CR-7391,TCGA-HNSC,NA,s15862,Broad Institute of MIT and Harvard,Vanderbilt University,United States,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6acac,58cfa82ee4b0c9d6adf6acac,G37566.TCGA-HC-7740-01A-11D-2114-08.2.filtered.,WGS,G37566.TCGA-HC-7740-01A-11D-2114-08.2,G37566.TCGA-HC-7740-01A-11D-2114-08.2.bam,31.3,NA,0.05,58cfa82ee4b0c9d6adf6acac,G37566.TCGA-HC-7740-01A-11D-2114-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7740-01A,91E249A6-B0B0-487E-9FAD-0E9F5798DCAE,Primary Tumor,Illumina HiSeq,dd2df8bb-8035-4f08-b3d4-d9ee910fd0ea,Prostate,59,54D1CF0E-5D54-486C-A863-733B5EDC5986,7303F9FE-88BB-48BA-B9B4-EBF9E4770C1C,TCGA-HC-7740-01A-11D-2114-08,HG19_Broad_variant,TCGA-HC-7740,TCGA-PRAD,NA,s3762,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6abfe,58cfa82ee4b0c9d6adf6abfe,G39019.TCGA-D3-A1Q5-06A-11D-A196-08.2.filtered.,WGS,G39019.TCGA-D3-A1Q5-06A-11D-A196-08.2,G39019.TCGA-D3-A1Q5-06A-11D-A196-08.2.bam,60.48,NA,0.08,58cfa82ee4b0c9d6adf6abfe,G39019.TCGA-D3-A1Q5-06A-11D-A196-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A1Q5-06A,238111F9-A08B-49B4-9035-CC43026330E7,Metastatic,Illumina HiSeq,fde49f52-05cf-488c-8ac4-45a538a6b006,Skin,60,64143381-C9EA-4244-8BEF-3F5127B9E22D,04C09376-8756-41D9-BBCA-F464170A8CFB,TCGA-D3-A1Q5-06A-11D-A196-08,HG19_Broad_variant,TCGA-D3-A1Q5,TCGA-SKCM,3424,s7313,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,TX,N0,Not available,I or II NOS
13722.58cfa82ee4b0c9d6adf6ac44,58cfa82ee4b0c9d6adf6ac44,G39019.TCGA-ER-A19D-06A-11D-A197-08.3.filtered.,WGS,G39019.TCGA-ER-A19D-06A-11D-A197-08.3,G39019.TCGA-ER-A19D-06A-11D-A197-08.3.bam,60.84,NA,0.08,58cfa82ee4b0c9d6adf6ac44,G39019.TCGA-ER-A19D-06A-11D-A197-08.3.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19D-06A,3409F118-1798-48D6-9556-12A5C77EBEFB,Metastatic,Illumina HiSeq,4e093322-8e85-4661-843c-d65319b3669e,Skin,46,ECCBE1D5-33F3-443B-8C12-57276C552238,C21A5D55-9790-429F-A4E6-420293C07B53,TCGA-ER-A19D-06A-11D-A197-08,HG19_Broad_variant,TCGA-ER-A19D,TCGA-SKCM,383,s7819,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2a,N0,Not available,Stage IB
13722.58cfa82de4b0c9d6adf6a742,58cfa82de4b0c9d6adf6a742,G14580.TCGA-64-1678-01A-01D-1040-01.2.filtered.,WGS,G14580.TCGA-64-1678-01A-01D-1040-01.2,G14580.TCGA-64-1678-01A-01D-1040-01.2.bam,482.23,1.9,0.15,58cfa82de4b0c9d6adf6a742,G14580.TCGA-64-1678-01A-01D-1040-01.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-64-1678-01A,F77CF4D3-9829-4FD3-95A1-B29AED9E94B8,Primary Tumor,Illumina HiSeq,3abe422b-51c0-4fb1-932d-f9e07cdb2150,Lung,70,0A2D9FAD-C5DF-46C1-BF96-529C7C92DFBA,53BB7112-3E38-45FE-A9C4-1B0871BABF4A,TCGA-64-1678-01A-01D-1040-01,HG19_Broad_variant,TCGA-64-1678,TCGA-LUAD,NA,s11207,Broad Institute of MIT and Harvard,Fox Chase,United States,NO,T2b,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa82ee4b0c9d6adf6a8e2,58cfa82ee4b0c9d6adf6a8e2,G35154.TCGA-DU-5870-01A-11D-A461-08.3.filtered.,WGS,G35154.TCGA-DU-5870-01A-11D-A461-08.3,G35154.TCGA-DU-5870-01A-11D-A461-08.3.bam,55.6,1.9,0.08,58cfa82ee4b0c9d6adf6a8e2,G35154.TCGA-DU-5870-01A-11D-A461-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-5870-01A,EB42625E-FBBB-4BEE-BBE9-315B3CA2138A,Primary Tumor,Illumina HiSeq,781639a0-ea42-4e90-8e48-2dd0de69143f,Brain,34,25E75875-4A84-4C29-9030-0E0922BD6567,8EFA4E9E-F222-4CCB-BF34-32443183BD7F,TCGA-DU-5870-01A-11D-A461-08,HG19_Broad_variant,TCGA-DU-5870,TCGA-LGG,NA,s8318,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6b1f2,58cfa82ee4b0c9d6adf6b1f2,TCGA-09-1666-10A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-09-1666-10A-01D-A324-10_wgs_Illumina,TCGA-09-1666-10A-01D-A324-10_wgs_Illumina.bam,274.27,1.9,0.08,58cfa82ee4b0c9d6adf6b1f2,TCGA-09-1666-10A-01D-A324-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-09-1666-10A,4EAC2C98-86D2-4EE6-A1D3-157D013C78DC,Blood Derived Normal,Illumina HiSeq,5391ca9b-f632-4854-bb32-74517979563e,Ovary,57,AD831878-2791-490D-A38B-9BDC000CF40E,E8F33F0F-3281-4620-9F3A-96CEE3501A21,TCGA-09-1666-10A-01D-A324-10,GRCh37-lite,TCGA-09-1666,TCGA-OV,NA,s17551,Baylor College of Medicine,UCSF,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b35e,58cfa82fe4b0c9d6adf6b35e,TCGA-24-2024-11A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-24-2024-11A-01D-A324-10_wgs_Illumina,TCGA-24-2024-11A-01D-A324-10_wgs_Illumina.bam,338.57,1.9,0.09,58cfa82fe4b0c9d6adf6b35e,TCGA-24-2024-11A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-2024-11A,0A48873A-092A-4B25-822B-B0B3C18C08A8,Solid Tissue Normal,Illumina HiSeq,a181d053-2e80-4998-bcd6-b49bc17f8a77,Ovary,72,3F3EBCC5-149D-4AC5-9E87-1D2422860AC8,51E4AA65-D472-4844-9525-779A207954E3,TCGA-24-2024-11A-01D-A324-10,GRCh37-lite,TCGA-24-2024,TCGA-OV,1769,s17721,Baylor College of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a9c8,58cfa82ee4b0c9d6adf6a9c8,G23072.TCGA_BB_4225_10A_01D_2268_08.1.filtered.,WGS,G23072.TCGA_BB_4225_10A_01D_2268_08.1,G23072.TCGA_BB_4225_10A_01D_2268_08.1.bam,71.4,1.4,0.13,58cfa82ee4b0c9d6adf6a9c8,G23072.TCGA_BB_4225_10A_01D_2268_08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BB-4225-10A,C1F50A22-38DF-41CC-A1F4-F7985504A7AC,Blood Derived Normal,Illumina HiSeq,ed3a6fa5-eed2-4b41-836b-658c39d33602,Head and Neck,73,F50A9185-7AF4-4EB7-8866-AA3FBBBC3BAB,7E57A5CF-3D3E-4CDF-BDE5-7C030944DBDD,TCGA-BB-4225-10A-01D-2268-08,HG19_Broad_variant,TCGA-BB-4225,TCGA-HNSC,NA,s15867,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a8b8,58cfa82ee4b0c9d6adf6a8b8,G35154.TCGA-DU-7304-01A-12D-A461-08.4.filtered.,WGS,G35154.TCGA-DU-7304-01A-12D-A461-08.4,G35154.TCGA-DU-7304-01A-12D-A461-08.4.bam,97.7,NA,0.08,58cfa82ee4b0c9d6adf6a8b8,G35154.TCGA-DU-7304-01A-12D-A461-08.4.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7304-01A,D61710C1-8AC3-44E3-B567-66288A6AB731,Primary Tumor,Illumina HiSeq,7b4cd316-b4cc-4a73-a4ad-767a6c64ac4d,Brain,43,12B638EF-AEB6-43C4-B9B8-C8A6F077D579,8340C88F-B6DB-4CB7-8E44-A9CDF5E167EE,TCGA-DU-7304-01A-12D-A461-08,HG19_Broad_variant,TCGA-DU-7304,TCGA-LGG,709,s8534,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa82de4b0c9d6adf6a506,58cfa82de4b0c9d6adf6a506,3a58ecfeaab4f45ce0981b7725491b8e.filtered.,WGS,3a58ecfeaab4f45ce0981b7725491b8e,3a58ecfeaab4f45ce0981b7725491b8e.bam,41.86,NA,0.08,58cfa82de4b0c9d6adf6a506,3a58ecfeaab4f45ce0981b7725491b8e.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Aligned reads,TCGA-LN-A49Y-01A,87FABA0E-28E7-4A7E-A7E1-12582EC68FAC,Primary Tumor,HiSeq X Ten,a4679678-809f-4df0-8278-02dbcd5480ba,Esophagus,77,E443EA94-586E-4A0B-8330-55336AAE9A15,554D5940-81B2-4D30-8F95-CA4680D23B18,TCGA-LN-A49Y-01A-11D-A27G-09,GRCh37-lite_WUGSC_variant_2,TCGA-LN-A49Y,TCGA-ESCA,NA,s1904,Washington University School of Medicine,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA
13722.58cfa830e4b0c9d6adf6bb72,58cfa830e4b0c9d6adf6bb72,TCGA-AA-A01V-01A-23D-A17O-10_wgs_Illumina.filtered.,WGS,TCGA-AA-A01V-01A-23D-A17O-10_wgs_Illumina,TCGA-AA-A01V-01A-23D-A17O-10_wgs_Illumina.bam,86.94,2,0.08,58cfa830e4b0c9d6adf6bb72,TCGA-AA-A01V-01A-23D-A17O-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01V-01A,0CB0DAC8-4CE2-444A-B1AE-1550E065B4D9,Primary Tumor,Illumina HiSeq,12678e03-e8e4-4074-91b0-68bb57767c2d,Colorectal,59,8816F14D-9FBB-4033-9CA4-6CA0DB66161A,31F02F48-44A4-445E-AC3D-E9BF3D8D25A2,TCGA-AA-A01V-01A-23D-A17O-10,GRCh37-lite,TCGA-AA-A01V,TCGA-COAD,NA,s13379,Baylor College of Medicine,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa82fe4b0c9d6adf6b8c8,58cfa82fe4b0c9d6adf6b8c8,TCGA-A6-2681-01A-01D-1554-10_wgs_Illumina.filtered.,WGS,TCGA-A6-2681-01A-01D-1554-10_wgs_Illumina,TCGA-A6-2681-01A-01D-1554-10_wgs_Illumina.bam,308,1.9,0.05,58cfa82fe4b0c9d6adf6b8c8,TCGA-A6-2681-01A-01D-1554-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2681-01A,7D8EAB0A-E6C8-4449-9EBF-50C41DB94A06,Primary Tumor,Illumina HiSeq,11d59d80-a10a-4e78-b8a8-64a9569a9e32,Colorectal,73,0537BAD8-0E85-4B05-91B3-FD965E96D0D7,D3DAF373-1485-455E-A0A1-8E33D215D623,TCGA-A6-2681-01A-01D-1554-10,GRCh37-lite,TCGA-A6-2681,TCGA-COAD,NA,s13650,Baylor College of Medicine,Christiana Healthcare,United States,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6ac88,58cfa82ee4b0c9d6adf6ac88,G47088.TCGA-34-5240-01A-01D-1441-08.1.filtered.,WGS,G47088.TCGA-34-5240-01A-01D-1441-08.1,G47088.TCGA-34-5240-01A-01D-1441-08.1.bam,715.7,1.9,0.05,58cfa82ee4b0c9d6adf6ac88,G47088.TCGA-34-5240-01A-01D-1441-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-34-5240-01A,E7D1B042-5B1C-4C29-B501-A5EF4810ECD2,Primary Tumor,Illumina HiSeq,8c136698-e283-46dc-83d9-44916f08fe6b,Lung,73,49395D22-CD07-4AB7-BDF3-CFA56687BA43,4C3840DF-9824-40DB-879E-6D24ADC8C155,TCGA-34-5240-01A-01D-1441-08,HG19_Broad_variant,TCGA-34-5240,TCGA-LUSC,NA,s10361,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2,N1,Lung Basaloid Squamous Cell Carcinoma,Stage IIB
13722.58cfa832e4b0c9d6adf6d482,58cfa832e4b0c9d6adf6d482,TCGA-QG-A5Z2-10A-01D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-QG-A5Z2-10A-01D-A28G-10_wgs_Illumina,TCGA-QG-A5Z2-10A-01D-A28G-10_wgs_Illumina.bam,14.33,NA,0.08,58cfa832e4b0c9d6adf6d482,TCGA-QG-A5Z2-10A-01D-A28G-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-QG-A5Z2-10A,84959E50-17F5-4F2B-8E0C-5EBB139D2C3A,Blood Derived Normal,Illumina HiSeq,85b2ff62-069c-484b-b1cd-6bcde3e9c7a6,Colorectal,61,19A8EB0F-13A7-44D7-B13A-08A080586329,8B9AEC1C-1EC0-4C8E-A64D-D7CDEAB19971,TCGA-QG-A5Z2-10A-01D-A28G-10,GRCh37-lite,TCGA-QG-A5Z2,TCGA-COAD,NA,s12893,Baylor College of Medicine,BLN - Baylor,United States,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ada2,58cfa82ee4b0c9d6adf6ada2,G39020.TCGA-BR-8690-10A-01D-2394-08.4.filtered.,WGS,G39020.TCGA-BR-8690-10A-01D-2394-08.4,G39020.TCGA-BR-8690-10A-01D-2394-08.4.bam,420,NA,0.05,58cfa82ee4b0c9d6adf6ada2,G39020.TCGA-BR-8690-10A-01D-2394-08.4.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-8690-10A,337819D2-5281-4B41-9583-A476924BC837,Blood Derived Normal,Illumina HiSeq,faf51861-5df1-4d45-845e-598709a60996,Stomach,54,F29DE83F-FE29-4CD9-909D-61C66457348B,3E7926EB-67FF-43C6-A3BE-7A3CC78D03C2,TCGA-BR-8690-10A-01D-2394-08,HG19_Broad_variant,TCGA-BR-8690,TCGA-STAD,NA,s14805,Broad Institute of MIT and Harvard,Asterand,Ukraine,NO,T3,N3a,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIB
13722.58cfa82ee4b0c9d6adf6a9a6,58cfa82ee4b0c9d6adf6a9a6,G25789.TCGA-78-7535-01A-11D-2063-08.1.filtered.,WGS,G25789.TCGA-78-7535-01A-11D-2063-08.1,G25789.TCGA-78-7535-01A-11D-2063-08.1.bam,314.3,NA,0.05,58cfa82ee4b0c9d6adf6a9a6,G25789.TCGA-78-7535-01A-11D-2063-08.1.bam,Dead,MALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-78-7535-01A,46592B7B-6968-42A6-83AF-0917C9F4A9A5,Primary Tumor,Illumina HiSeq,c7601721-da6e-403a-9b43-7971f6513153,Lung,45,C0A8C73C-35BA-4724-B13A-9A9986AF36C0,FA8844F8-C4B6-487A-8187-E30C12A7A453,TCGA-78-7535-01A-11D-2063-08,HG19_Broad_variant,TCGA-78-7535,TCGA-LUAD,949,s10759,Broad Institute of MIT and Harvard,Prince Charles Hospital,Australia,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6adee,58cfa82ee4b0c9d6adf6adee,G39020.TCGA-HU-A4H0-11A-11D-A25E-08.1.filtered.,WGS,G39020.TCGA-HU-A4H0-11A-11D-A25E-08.1,G39020.TCGA-HU-A4H0-11A-11D-A25E-08.1.bam,22.2,NA,0.08,58cfa82ee4b0c9d6adf6adee,G39020.TCGA-HU-A4H0-11A-11D-A25E-08.1.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-HU-A4H0-11A,FE45EAEE-FF0C-4D52-B18C-04DC2D64D3B4,Solid Tissue Normal,Illumina HiSeq,f597333e-382e-430c-b763-7d725833e28f,Stomach,72,D10298D1-AA01-4911-B21E-95090F4599AC,DCDF6E0B-30AC-405B-A44E-6086296E70E1,TCGA-HU-A4H0-11A-11D-A25E-08,HG19_Broad_variant,TCGA-HU-A4H0,TCGA-STAD,NA,s14809,Broad Institute of MIT and Harvard,National Cancer Center Korea,Korea South,NO,T4a,N3b,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIC
13722.58cfa82ee4b0c9d6adf6aea1,58cfa82ee4b0c9d6adf6aea1,G49537.TCGA-ET-A4KN-10A-01D-A25A-08.1.filtered.,WGS,G49537.TCGA-ET-A4KN-10A-01D-A25A-08.1,G49537.TCGA-ET-A4KN-10A-01D-A25A-08.1.bam,9.21,NA,0.09,58cfa82ee4b0c9d6adf6aea1,G49537.TCGA-ET-A4KN-10A-01D-A25A-08.1.bam,Alive,FEMALE,WHITE,Not available,Thyroid Carcinoma,Aligned reads,TCGA-ET-A4KN-10A,7629F864-A009-4AA9-BF7E-2D99E00D294E,Blood Derived Normal,Illumina HiSeq,af495898-5404-48dc-8a94-cbcf9469b3a8,Thyroid,51,D107589C-B718-49C9-93B5-DC208C75993A,E3D4072C-07EF-4978-A687-43828578A9B3,TCGA-ET-A4KN-10A-01D-A25A-08,HG19_Broad_variant,TCGA-ET-A4KN,TCGA-THCA,NA,s12223,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage III
13722.58cfa82de4b0c9d6adf6a776,58cfa82de4b0c9d6adf6a776,G14853.TCGA-05-4420-01A-01D-1931-08.1.filtered.,WGS,G14853.TCGA-05-4420-01A-01D-1931-08.1,G14853.TCGA-05-4420-01A-01D-1931-08.1.bam,651.3,1.9,0.16,58cfa82de4b0c9d6adf6a776,G14853.TCGA-05-4420-01A-01D-1931-08.1.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4420-01A,3D2AA654-1B5F-4EB4-A1C2-AF31F5760069,Primary Tumor,Illumina HiSeq,aa05f7cb-814c-4ddf-a639-50291fa19a95,Lung,41,4B202550-9744-4C6C-AD17-97F764EA3F18,DE614A3E-1C0D-49C7-A2F1-28BC58E6E5C7,TCGA-05-4420-01A-01D-1931-08,HG19_Broad_variant,TCGA-05-4420,TCGA-LUAD,NA,s11315,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa82ee4b0c9d6adf6ad3c,58cfa82ee4b0c9d6adf6ad3c,G49537.TCGA-BJ-A28T-10A-01D-A33C-08.2.filtered.,WGS,G49537.TCGA-BJ-A28T-10A-01D-A33C-08.2,G49537.TCGA-BJ-A28T-10A-01D-A33C-08.2.bam,93.81,1.94,0.09,58cfa82ee4b0c9d6adf6ad3c,G49537.TCGA-BJ-A28T-10A-01D-A33C-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A28T-10A,A9D8F797-8A53-4BE5-B957-0F1F6D080390,Blood Derived Normal,Illumina HiSeq,861f954c-0f60-4433-a1bb-faa88b86750e,Thyroid,34,A54F31C9-626E-4869-969D-65A61DB2C932,B939AE95-590A-427B-A9C4-51B165347CF8,TCGA-BJ-A28T-10A-01D-A33C-08,HG19_Broad_variant,TCGA-BJ-A28T,TCGA-THCA,NA,s12616,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T1,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82fe4b0c9d6adf6b9fa,58cfa82fe4b0c9d6adf6b9fa,TCGA-AA-3994-10A-01D-1982-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3994-10A-01D-1982-10_wgs_Illumina,TCGA-AA-3994-10A-01D-1982-10_wgs_Illumina.bam,9.59,1.9,0.13,58cfa82fe4b0c9d6adf6b9fa,TCGA-AA-3994-10A-01D-1982-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3994-10A,750770DB-53CF-4021-A8C2-5E0DDB97FEF5,Blood Derived Normal,Illumina HiSeq,c85ac97b-13a0-489a-a944-f30e12864ad8,Colorectal,69,775698AF-8ABC-408B-A47A-C00430B1224B,ACA7C0B0-E792-4530-91C4-C8F357B63C2A,TCGA-AA-3994-10A-01D-1982-10,GRCh37-lite,TCGA-AA-3994,TCGA-COAD,NA,s13366,Baylor College of Medicine,Indivumed,Germany,NO,T3,N1,Colon Mucinous Adenocarcinoma,Stage IIIB
13722.58cfa82de4b0c9d6adf6a72e,58cfa82de4b0c9d6adf6a72e,G13226.TCGA-21-1078-01A-01D-1521-08.1.filtered.,WGS,G13226.TCGA-21-1078-01A-01D-1521-08.1,G13226.TCGA-21-1078-01A-01D-1521-08.1.bam,586.7,1.8,0.05,58cfa82de4b0c9d6adf6a72e,G13226.TCGA-21-1078-01A-01D-1521-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-21-1078-01A,0AB8D063-62B4-4D47-82AA-E3351A60029D,Primary Tumor,Illumina HiSeq,646caf62-8b1b-43c0-a9c6-471110de099c,Lung,77,EFACAC80-9428-4482-9AEA-6B57FD172D49,8CF9B32D-3D6F-4898-8C7A-89511B754021,TCGA-21-1078-01A-01D-1521-08,HG19_Broad_variant,TCGA-21-1078,TCGA-LUSC,474,s10248,Broad Institute of MIT and Harvard,Fox Chase Cancer Center,United States,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82de4b0c9d6adf6a759,58cfa82de4b0c9d6adf6a759,G13230.TCGA-60-2713-01A-01D-1522-08.3.filtered.,WGS,G13230.TCGA-60-2713-01A-01D-1522-08.3,G13230.TCGA-60-2713-01A-01D-1522-08.3.bam,661.3,1.9,0.05,58cfa82de4b0c9d6adf6a759,G13230.TCGA-60-2713-01A-01D-1522-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-60-2713-01A,E58E8850-154F-4695-BEE0-005C76410327,Primary Tumor,Illumina HiSeq,34149172-2cd5-402b-a1c6-c4fd3919f717,Lung,64,88A9B60F-89DD-4C2B-B13B-5EF5E10B94AB,79EB7BBA-F0D8-462C-ADD7-20A2FB7843E1,TCGA-60-2713-01A-01D-1522-08,HG19_Broad_variant,TCGA-60-2713,TCGA-LUSC,NA,s10074,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82fe4b0c9d6adf6b2ca,58cfa82fe4b0c9d6adf6b2ca,TCGA-23-1110-10A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-23-1110-10A-01D-A324-10_wgs_Illumina,TCGA-23-1110-10A-01D-A324-10_wgs_Illumina.bam,64.97,1.9,0.07,58cfa82fe4b0c9d6adf6b2ca,TCGA-23-1110-10A-01D-A324-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-23-1110-10A,9FB1BA57-2007-4477-B000-2D36F163EFD2,Blood Derived Normal,Illumina HiSeq,8483e431-b465-4a82-9fae-5c7d7cfbfddc,Ovary,42,8E9CEC35-D37F-4434-84BD-E682B00BF4C6,18358095-4684-49D7-A0C8-D86C7B10D1F7,TCGA-23-1110-10A-01D-A324-10,GRCh37-lite,TCGA-23-1110,TCGA-OV,NA,s17508,Baylor College of Medicine,Cedars Sinai,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ad66,58cfa82ee4b0c9d6adf6ad66,G35154.TCGA-HT-A5R7-01A-11D-A461-08.2.filtered.,WGS,G35154.TCGA-HT-A5R7-01A-11D-A461-08.2,G35154.TCGA-HT-A5R7-01A-11D-A461-08.2.bam,17.75,NA,0.08,58cfa82ee4b0c9d6adf6ad66,G35154.TCGA-HT-A5R7-01A-11D-A461-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-A5R7-01A,7E41BABA-7EF6-4030-B595-D95CD96336B5,Primary Tumor,Illumina HiSeq,c239bee2-d22d-4390-be44-ed4be0395f57,Brain,33,7BA53D9A-FE20-487A-B4BB-84451E207755,C71F8C39-653F-42F2-AD3E-439CF86A0738,TCGA-HT-A5R7-01A-11D-A461-08,HG19_Broad_variant,TCGA-HT-A5R7,TCGA-LGG,NA,s8119,Broad Institute of MIT and Harvard,Case Western - St Joes,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa82ee4b0c9d6adf6ad0e,58cfa82ee4b0c9d6adf6ad0e,G37568.TCGA-DK-A1AE-01A-11D-A13W-08.2.filtered.,WGS,G37568.TCGA-DK-A1AE-01A-11D-A13W-08.2,G37568.TCGA-DK-A1AE-01A-11D-A13W-08.2.bam,76.27,1.91,0.08,58cfa82ee4b0c9d6adf6ad0e,G37568.TCGA-DK-A1AE-01A-11D-A13W-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AE-01A,493A4FF2-37A5-4B79-928D-83DBFE534556,Primary Tumor,Illumina HiSeq,2722f260-d3b4-4088-860d-7a5070921255,Bladder,84,67865453-D515-4D63-84E8-CFB2686A211D,ABD2D959-D5ED-4EB3-9759-67EB1AA23325,TCGA-DK-A1AE-01A-11D-A13W-08,HG19_Broad_variant,TCGA-DK-A1AE,TCGA-BLCA,NA,s2688,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa82de4b0c9d6adf6a754,58cfa82de4b0c9d6adf6a754,G13227.TCGA-43-3394-11A-01D-1553-08.1.filtered.,WGS,G13227.TCGA-43-3394-11A-01D-1553-08.1,G13227.TCGA-43-3394-11A-01D-1553-08.1.bam,89.73,1.9,0.05,58cfa82de4b0c9d6adf6a754,G13227.TCGA-43-3394-11A-01D-1553-08.1.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-43-3394-11A,CE8612AB-3149-4A6A-B424-29C0C21C9B8B,Solid Tissue Normal,Illumina HiSeq,812b8f87-8cc8-422b-b8ce-5834ddeaed21,Lung,52,2EEC798F-3161-403E-937F-B340A6A3C865,C3CF63AD-F15B-439F-BE78-0A3C158D6381,TCGA-43-3394-11A-01D-1553-08,HG19_Broad_variant,TCGA-43-3394,TCGA-LUSC,NA,s10357,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,T2a,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6ac54,58cfa82ee4b0c9d6adf6ac54,G35154.TCGA-HW-7486-10A-01D-2024-08.7.filtered.,WGS,G35154.TCGA-HW-7486-10A-01D-2024-08.7,G35154.TCGA-HW-7486-10A-01D-2024-08.7.bam,365.3,NA,0.05,58cfa82ee4b0c9d6adf6ac54,G35154.TCGA-HW-7486-10A-01D-2024-08.7.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HW-7486-10A,55A67639-ED05-4143-AF96-A377BC5489EE,Blood Derived Normal,Illumina HiSeq,78f274f8-ffb8-467e-8f6b-7d6fd1852127,Brain,37,D05EF82A-9523-430E-BC5D-B1B66FC463AB,41E3896B-9B23-4A4D-B3B1-61C60C2638B0,TCGA-HW-7486-10A-01D-2024-08,HG19_Broad_variant,TCGA-HW-7486,TCGA-LGG,NA,s8117,Broad Institute of MIT and Harvard,MSKCC,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6a960,58cfa82ee4b0c9d6adf6a960,G35154.TCGA-DU-6404-01A-11D-A461-08.3.filtered.,WGS,G35154.TCGA-DU-6404-01A-11D-A461-08.3,G35154.TCGA-DU-6404-01A-11D-A461-08.3.bam,202.6,1.9,0.07,58cfa82ee4b0c9d6adf6a960,G35154.TCGA-DU-6404-01A-11D-A461-08.3.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6404-01A,C0D47E0F-4918-4E06-9DB6-201671B1259C,Primary Tumor,Illumina HiSeq,e8c73506-ba8e-44dc-87cd-4305bdb6b7f9,Brain,24,1F5A0C14-D1C1-4E88-BC19-ABFAFFF97445,E24BC524-4F82-4FC8-AA20-0B64C9B74762,TCGA-DU-6404-01A-11D-A461-08,HG19_Broad_variant,TCGA-DU-6404,TCGA-LGG,4068,s8104,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6ac1c,58cfa82ee4b0c9d6adf6ac1c,G37566.TCGA-HC-7079-01A-11D-1961-08.2.filtered.,WGS,G37566.TCGA-HC-7079-01A-11D-1961-08.2,G37566.TCGA-HC-7079-01A-11D-1961-08.2.bam,133,NA,0.05,58cfa82ee4b0c9d6adf6ac1c,G37566.TCGA-HC-7079-01A-11D-1961-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7079-01A,10FBE481-F111-4F88-AE45-4D67CB265567,Primary Tumor,Illumina HiSeq,75a8bf78-150a-4c1f-99fa-41db038cf5a5,Prostate,51,190EF71A-5B5D-4009-B707-68F10147CB65,7F1CA00A-84BA-4B26-A1A5-4D83C363AC69,TCGA-HC-7079-01A-11D-1961-08,HG19_Broad_variant,TCGA-HC-7079,TCGA-PRAD,NA,s3924,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82fe4b0c9d6adf6ba18,58cfa82fe4b0c9d6adf6ba18,TCGA-AA-3534-10A-01D-1525-10_hg19_wgs_Illumina.filtered.,WGS,TCGA-AA-3534-10A-01D-1525-10_hg19_wgs_Illumina,TCGA-AA-3534-10A-01D-1525-10_hg19_wgs_Illumina.bam,32.5,1.9,0.05,58cfa82fe4b0c9d6adf6ba18,TCGA-AA-3534-10A-01D-1525-10_hg19_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3534-10A,DF228C56-89AC-4122-93B3-6C0740C4EC09,Blood Derived Normal,Illumina HiSeq,6005aa4b-25dd-4a9e-9837-cb87da406ec0,Colorectal,78,4F63B73F-95C5-4515-B3A7-58A4A348368F,F93348B5-6A8B-4734-9D97-8175A81D18F1,TCGA-AA-3534-10A-01D-1525-10,GRCh37-lite,TCGA-AA-3534,TCGA-COAD,NA,s12862,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6aa50,58cfa82ee4b0c9d6adf6aa50,G23069.TCGA_CR_6480_01A_11D_2268_08.2.filtered.,WGS,G23069.TCGA_CR_6480_01A_11D_2268_08.2,G23069.TCGA_CR_6480_01A_11D_2268_08.2.bam,158.7,1.9,0.15,58cfa82ee4b0c9d6adf6aa50,G23069.TCGA_CR_6480_01A_11D_2268_08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-6480-01A,BA9D4568-71A8-41FC-A2BE-0BF784E36D6A,Primary Tumor,Illumina HiSeq,cf0a07e0-8d0a-4c16-8d48-7efb9bf38f8a,Head and Neck,53,0C6B4631-381E-4B73-AC9E-62BBC1849FF4,EF673D3D-2031-4036-BA25-4BC7EF04075B,TCGA-CR-6480-01A-11D-2268-08,HG19_Broad_variant,TCGA-CR-6480,TCGA-HNSC,NA,s16166,Broad Institute of MIT and Harvard,Vanderbilt University,United States,NO,Not available,Not available,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ace2,58cfa82ee4b0c9d6adf6ace2,G39020.TCGA-CG-4474-10A-01D-A290-08.1.filtered.,WGS,G39020.TCGA-CG-4474-10A-01D-A290-08.1,G39020.TCGA-CG-4474-10A-01D-A290-08.1.bam,15.9,1.8,0.08,58cfa82ee4b0c9d6adf6ace2,G39020.TCGA-CG-4474-10A-01D-A290-08.1.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4474-10A,39DD61A8-CD17-4DF3-AE17-61E239EB00BD,Blood Derived Normal,Illumina HiSeq,af9433c7-f0e8-4b30-ba69-0ffec543d03a,Stomach,67,A546EC24-E8CE-4B04-B25F-A230A5EA1067,7D3B75DB-B73D-4AD9-AAA9-3075CA5F025A,TCGA-CG-4474-10A-01D-A290-08,HG19_Broad_variant,TCGA-CG-4474,TCGA-STAD,NA,s14460,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T4a,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IV
13722.58cfa82ee4b0c9d6adf6a7d6,58cfa82ee4b0c9d6adf6a7d6,G23064.TCGA_CR_6472_01A_11D_2268_08.1.filtered.,WGS,G23064.TCGA_CR_6472_01A_11D_2268_08.1,G23064.TCGA_CR_6472_01A_11D_2268_08.1.bam,118,1.9,0.15,58cfa82ee4b0c9d6adf6a7d6,G23064.TCGA_CR_6472_01A_11D_2268_08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-6472-01A,0956BC67-DD55-4C54-A56A-F22F2856662A,Primary Tumor,Illumina HiSeq,8bf4b442-c0d0-4794-b87d-990df38dfce7,Head and Neck,59,76095F05-CD2B-4973-800A-10FE58EE1609,5193A482-6ED9-4504-BD7C-C8B9E4103577,TCGA-CR-6472-01A-11D-2268-08,HG19_Broad_variant,TCGA-CR-6472,TCGA-HNSC,NA,s15603,Broad Institute of MIT and Harvard,Vanderbilt University,United States,NO,Not available,Not available,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a7c8,58cfa82ee4b0c9d6adf6a7c8,G25775.TCGA-44-6148-10A-01D-1753-08.1.filtered.,WGS,G25775.TCGA-44-6148-10A-01D-1753-08.1,G25775.TCGA-44-6148-10A-01D-1753-08.1.bam,315.7,1.9,0.05,58cfa82ee4b0c9d6adf6a7c8,G25775.TCGA-44-6148-10A-01D-1753-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-6148-10A,8994C8C4-9EA0-46CB-B4A5-0055D7DA5BFA,Blood Derived Normal,Illumina HiSeq,7713e797-fc02-4096-8f27-9a4d1260df7d,Lung,60,E221C1C3-71D5-424D-8D88-AC09C3140220,E956874C-3969-4986-9B7F-7D8C1B3F2160,TCGA-44-6148-10A-01D-1753-08,HG19_Broad_variant,TCGA-44-6148,TCGA-LUAD,NA,s10976,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,T1b,N0,Lung Mucinous Adenocarcinoma,Stage IA
13722.58cfa82ee4b0c9d6adf6aa06,58cfa82ee4b0c9d6adf6aa06,G23074.TCGA_CN_4741_01A_01D_2268_08.1.filtered.,WGS,G23074.TCGA_CN_4741_01A_01D_2268_08.1,G23074.TCGA_CN_4741_01A_01D_2268_08.1.bam,215.7,1.9,0.14,58cfa82ee4b0c9d6adf6aa06,G23074.TCGA_CN_4741_01A_01D_2268_08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4741-01A,277B02E9-DED5-4980-845D-AF53690000AC,Primary Tumor,Illumina HiSeq,b508fa53-d86f-4e56-9703-6cdb7095ed0b,Head and Neck,75,03C9108A-5139-4BAC-9641-C7DBBEDEF420,F652367A-D6C9-4A0A-AADE-1AB988BE3BE6,TCGA-CN-4741-01A-01D-2268-08,HG19_Broad_variant,TCGA-CN-4741,TCGA-HNSC,NA,s15745,Broad Institute of MIT and Harvard,University of Pittsburgh,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82ee4b0c9d6adf6adce,58cfa82ee4b0c9d6adf6adce,G39020.TCGA-CD-5799-10A-01D-1600-08.1.filtered.,WGS,G39020.TCGA-CD-5799-10A-01D-1600-08.1,G39020.TCGA-CD-5799-10A-01D-1600-08.1.bam,79.4,1.9,0.05,58cfa82ee4b0c9d6adf6adce,G39020.TCGA-CD-5799-10A-01D-1600-08.1.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-5799-10A,C991697F-77F9-412A-9BD1-0E47F7387CB2,Blood Derived Normal,Illumina HiSeq,7e1aa13f-6fd6-404d-a5e4-faad11b606fa,Stomach,45,02A57E6D-BFA6-4A57-9C36-1292CAF91EB4,14228088-EADD-469E-890D-586176DAF99F,TCGA-CD-5799-10A-01D-1600-08,HG19_Broad_variant,TCGA-CD-5799,TCGA-STAD,NA,s14957,Broad Institute of MIT and Harvard,ILSbio,Vietnam,NO,T2,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa830e4b0c9d6adf6be46,58cfa830e4b0c9d6adf6be46,TCGA-AF-2691-01A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AF-2691-01A-01D-1989-10_wgs_Illumina,TCGA-AF-2691-01A-01D-1989-10_wgs_Illumina.bam,406.94,1.9,0.15,58cfa830e4b0c9d6adf6be46,TCGA-AF-2691-01A-01D-1989-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-AF-2691-01A,830FD359-ABD4-4C99-89E4-2D6BB9CE5637,Primary Tumor,Illumina HiSeq,51fe9202-95ee-418b-a143-fe84f4b20380,Colorectal,48,CE252C3D-5CF3-46BC-A181-3714D1C65E4E,81B1E78C-6032-4FF4-B52A-83456B9450EA,TCGA-AF-2691-01A-01D-1989-10,GRCh37-lite,TCGA-AF-2691,TCGA-READ,NA,s1956,Baylor College of Medicine,Christiana Healthcare,None,NO,T1,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa82de4b0c9d6adf6a74a,58cfa82de4b0c9d6adf6a74a,G13227.TCGA-43-3394-01A-01D-1553-08.1.filtered.,WGS,G13227.TCGA-43-3394-01A-01D-1553-08.1,G13227.TCGA-43-3394-01A-01D-1553-08.1.bam,532.37,1.9,0.05,58cfa82de4b0c9d6adf6a74a,G13227.TCGA-43-3394-01A-01D-1553-08.1.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-43-3394-01A,CE8612AB-3149-4A6A-B424-29C0C21C9B8B,Primary Tumor,Illumina HiSeq,bc49e74a-6128-4677-93fa-776314b3caef,Lung,52,D8F165AF-1DF5-4876-ABF8-7596E52A3BC3,EFE4D5DD-FFFB-41DF-AB86-BE06CC16646F,TCGA-43-3394-01A-01D-1553-08,HG19_Broad_variant,TCGA-43-3394,TCGA-LUSC,NA,s10073,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,T2a,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa830e4b0c9d6adf6be58,58cfa830e4b0c9d6adf6be58,TCGA-AF-3913-11A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AF-3913-11A-01D-1989-10_wgs_Illumina,TCGA-AF-3913-11A-01D-1989-10_wgs_Illumina.bam,448.89,1.9,0.15,58cfa830e4b0c9d6adf6be58,TCGA-AF-3913-11A-01D-1989-10_wgs_Illumina.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-AF-3913-11A,03A9DD9D-62AE-4ACD-9272-389274858F3D,Solid Tissue Normal,Illumina HiSeq,458ddbf3-b9e3-496d-910b-85ef509d4ba5,Colorectal,60,4A702DED-02FC-40BA-A4F8-A9C4FE7007F9,41D452BF-7340-4177-9BD7-A2FEA5D13C99,TCGA-AF-3913-11A-01D-1989-10,GRCh37-lite,TCGA-AF-3913,TCGA-READ,316,s2129,Baylor College of Medicine,Christiana Healthcare,None,NO,T3,N1,Rectal Adenocarcinoma,Stage IV
13722.58cfa82de4b0c9d6adf6a486,58cfa82de4b0c9d6adf6a486,19c58d9096b606185c9e666c8a383bca.filtered.,WGS,19c58d9096b606185c9e666c8a383bca,19c58d9096b606185c9e666c8a383bca.bam,29.08,NA,0.07,58cfa82de4b0c9d6adf6a486,19c58d9096b606185c9e666c8a383bca.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Aligned reads,TCGA-K1-A3PN-02A,F519BE07-434E-4EB2-ACF9-318565B83D50,Recurrent Tumor,HiSeq X Ten,e6bd6240-68a5-4f89-b7a0-f86353725bfa,Mesenchymal,64,359FEC0B-7BC1-4BB4-A9D9-11EEA9366AC6,D7EADEB5-54D2-4F18-9821-21D272EE52B5,TCGA-K1-A3PN-02A-11D-A228-09,GRCh37-lite,TCGA-K1-A3PN,TCGA-SARC,NA,s2477,Washington University School of Medicine,University of Pittsburgh,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82fe4b0c9d6adf6b83d,58cfa82fe4b0c9d6adf6b83d,TCGA-36-1571-10A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-36-1571-10A-01D-A324-10_wgs_Illumina,TCGA-36-1571-10A-01D-A324-10_wgs_Illumina.bam,128.27,1.9,0.08,58cfa82fe4b0c9d6adf6b83d,TCGA-36-1571-10A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-36-1571-10A,12581634-EEBB-4841-8498-71DC9D78C546,Blood Derived Normal,Illumina HiSeq,df2be9c4-08ff-400f-98fe-4c742b4c9f59,Ovary,53,D9F3D1E4-7FB3-483E-97C9-4D3FC44BC114,45E4699D-9766-4545-A6E1-2BD585C9EC31,TCGA-36-1571-10A-01D-A324-10,GRCh37-lite,TCGA-36-1571,TCGA-OV,695,s17139,Baylor College of Medicine,BC Cancer Agency,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a9ae,58cfa82ee4b0c9d6adf6a9ae,G16919.TCGA-A3-3308-01A-01D-2048-08.1.filtered.,WGS,G16919.TCGA-A3-3308-01A-01D-2048-08.1,G16919.TCGA-A3-3308-01A-01D-2048-08.1.bam,591.9,1.9,0.17,58cfa82ee4b0c9d6adf6a9ae,G16919.TCGA-A3-3308-01A-01D-2048-08.1.bam,Alive,FEMALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-A3-3308-01A,3CBCA837-F5A7-4A87-8F02-C59EAC232D5A,Primary Tumor,Illumina HiSeq,6208ef74-033a-4d92-ad2e-96de84ea4784,Kidney,77,0B935ADB-0E19-4FCC-9BB0-B9D95872BCEF,EFD9E8D3-7803-4996-85D3-8A9449B3C1AC,TCGA-A3-3308-01A-01D-2048-08,HG19_Broad_variant,TCGA-A3-3308,TCGA-KIRC,NA,s9441,Broad Institute of MIT and Harvard,International Genomics Consortium,None,NO,T3b,N0,Kidney Clear Cell Renal Carcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6ac27,58cfa82ee4b0c9d6adf6ac27,G37566.TCGA-HC-7737-01A-11D-2114-08.3.filtered.,WGS,G37566.TCGA-HC-7737-01A-11D-2114-08.3,G37566.TCGA-HC-7737-01A-11D-2114-08.3.bam,205.3,NA,0.05,58cfa82ee4b0c9d6adf6ac27,G37566.TCGA-HC-7737-01A-11D-2114-08.3.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,Not available,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7737-01A,73F875CB-BCFC-43BA-AB97-4E94CAF836D4,Primary Tumor,Illumina HiSeq,855b7ac8-18b6-4ec4-9471-8d12a802bf46,Prostate,55,47B6E89A-EA86-475A-9F1D-02001069C895,DCF98ACC-736B-4AF6-BDCA-A320A413165A,TCGA-HC-7737-01A-11D-2114-08,HG19_Broad_variant,TCGA-HC-7737,TCGA-PRAD,NA,s3407,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2c,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6aa4a,58cfa82ee4b0c9d6adf6aa4a,G35154.TCGA-HT-A61B-01A-11D-A461-08.2.filtered.,WGS,G35154.TCGA-HT-A61B-01A-11D-A461-08.2,G35154.TCGA-HT-A61B-01A-11D-A461-08.2.bam,20.91,NA,0.08,58cfa82ee4b0c9d6adf6aa4a,G35154.TCGA-HT-A61B-01A-11D-A461-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-A61B-01A,CF2A1B98-5693-4C04-9167-F85E69A88A4A,Primary Tumor,Illumina HiSeq,95493209-d334-4fbe-aeef-683bf27cdf09,Brain,22,32C901F6-B277-4870-B3F4-7A7CE53F124E,46C0DD13-2F72-4396-9F7A-07ACB44D1D57,TCGA-HT-A61B-01A-11D-A461-08,HG19_Broad_variant,TCGA-HT-A61B,TCGA-LGG,NA,s8747,Broad Institute of MIT and Harvard,Case Western - St Joes,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa82ee4b0c9d6adf6b08a,58cfa82ee4b0c9d6adf6b08a,G49837.TCGA-90-7767-10A-01D-A320-08.3.filtered.,WGS,G49837.TCGA-90-7767-10A-01D-A320-08.3,G49837.TCGA-90-7767-10A-01D-A320-08.3.bam,130.3,NA,0.07,58cfa82ee4b0c9d6adf6b08a,G49837.TCGA-90-7767-10A-01D-A320-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-90-7767-10A,9DFF11CD-0784-4A60-9C77-43F8957D3DFA,Blood Derived Normal,Illumina HiSeq,897b33ac-6e52-43d6-856d-e7adcc83770c,Lung,56,338EBCB0-4EB5-4094-89C5-3AF9023067DF,E1601870-C2B6-48AF-9697-41B62D967E10,TCGA-90-7767-10A-01D-A320-08,HG19_Broad_variant,TCGA-90-7767,TCGA-LUSC,NA,s10508,Broad Institute of MIT and Harvard,ABS - IUPUI,United States,NO,T2b,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6ad9e,58cfa82ee4b0c9d6adf6ad9e,G39020.TCGA-CG-5724-11A-01D-1600-08.3.filtered.,WGS,G39020.TCGA-CG-5724-11A-01D-1600-08.3,G39020.TCGA-CG-5724-11A-01D-1600-08.3.bam,261,1.9,0.05,58cfa82ee4b0c9d6adf6ad9e,G39020.TCGA-CG-5724-11A-01D-1600-08.3.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5724-11A,0B4E8D73-459D-4930-9D1A-ABB8D53E1844,Solid Tissue Normal,Illumina HiSeq,ae26ff46-1bed-4f41-92ca-b21924966143,Stomach,59,4074EB62-5EBC-4305-A437-7689B76E6F71,8C55D79F-356A-4589-8403-CDFED8311550,TCGA-CG-5724-11A-01D-1600-08,HG19_Broad_variant,TCGA-CG-5724,TCGA-STAD,366,s14604,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T3,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IV
13722.58cfa82ee4b0c9d6adf6ad9c,58cfa82ee4b0c9d6adf6ad9c,G39020.TCGA-D7-6518-10A-01D-1800-08.5.filtered.,WGS,G39020.TCGA-D7-6518-10A-01D-1800-08.5,G39020.TCGA-D7-6518-10A-01D-1800-08.5.bam,192.7,1.9,0.05,58cfa82ee4b0c9d6adf6ad9c,G39020.TCGA-D7-6518-10A-01D-1800-08.5.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6518-10A,40E507FB-E285-424B-A98B-362E47A53E4A,Blood Derived Normal,Illumina HiSeq,0b761b96-25cd-415f-9d89-55a738a3cedb,Stomach,75,5D912F1D-3670-4A62-802F-F0AA3CECC6A9,8A32DD74-FA56-4328-917E-37C29E44CB47,TCGA-D7-6518-10A-01D-1800-08,HG19_Broad_variant,TCGA-D7-6518,TCGA-STAD,NA,s15175,Broad Institute of MIT and Harvard,Greater Poland Cancer Center,Poland,NO,T2,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA
13722.58cfa82ee4b0c9d6adf6a910,58cfa82ee4b0c9d6adf6a910,G35154.TCGA-CS-6186-01A-12D-A461-08.2.filtered.,WGS,G35154.TCGA-CS-6186-01A-12D-A461-08.2,G35154.TCGA-CS-6186-01A-12D-A461-08.2.bam,324.7,NA,0.08,58cfa82ee4b0c9d6adf6a910,G35154.TCGA-CS-6186-01A-12D-A461-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-6186-01A,9EE6E821-3AF2-42D7-9D14-F0CA455F338C,Primary Tumor,Illumina HiSeq,946c11c5-c3b6-4bd4-a20f-dbf1f726c1fa,Brain,58,5F73FA4E-FC7D-4FC0-8436-2241E57B9B69,A3CA8731-C86A-498D-B3FB-3923AD286BA3,TCGA-CS-6186-01A-12D-A461-08,HG19_Broad_variant,TCGA-CS-6186,TCGA-LGG,538,s8098,Broad Institute of MIT and Harvard,Thomas Jefferson University,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa82de4b0c9d6adf6a774,58cfa82de4b0c9d6adf6a774,G12520.TCGA-60-2711-11A-01D-0963-08.1.filtered.,WGS,G12520.TCGA-60-2711-11A-01D-0963-08.1,G12520.TCGA-60-2711-11A-01D-0963-08.1.bam,431.6,1.9,0.16,58cfa82de4b0c9d6adf6a774,G12520.TCGA-60-2711-11A-01D-0963-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-60-2711-11A,1F11DE87-A5FE-49FD-80C1-E279B2BC69DE,Solid Tissue Normal,Illumina HiSeq,8550fe4b-7259-4609-9904-5a41e1620f96,Lung,64,0784A6F1-FB91-48D6-8CBA-619C655E5D5B,018CC51D-F458-4BA8-A20A-E61337B8D303,TCGA-60-2711-11A-01D-0963-08,HG19_Broad_variant,TCGA-60-2711,TCGA-LUSC,NA,s10154,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6b00c,58cfa82ee4b0c9d6adf6b00c,G41960.TCGA-55-8299-10B-01D-2323-08.1.filtered.,WGS,G41960.TCGA-55-8299-10B-01D-2323-08.1,G41960.TCGA-55-8299-10B-01D-2323-08.1.bam,216.6,NA,0.05,58cfa82ee4b0c9d6adf6b00c,G41960.TCGA-55-8299-10B-01D-2323-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-55-8299-10B,2CD8EA73-CB3F-4B17-9B97-FA12EB03B85B,Blood Derived Normal,Illumina HiSeq,cd560db1-53a9-4e91-88f1-abe2efc405a1,Lung,61,6C6FF27D-C55F-4EDF-A3C0-908FE56604F3,F193EA02-8FB1-460D-902B-5A1EE31A4EAD,TCGA-55-8299-10B-01D-2323-08,HG19_Broad_variant,TCGA-55-8299,TCGA-LUAD,NA,s11323,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T1b,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6ccb8,58cfa831e4b0c9d6adf6ccb8,TCGA-EI-6917-10A-01D-1924-10_wgs_Illumina.filtered.,WGS,TCGA-EI-6917-10A-01D-1924-10_wgs_Illumina,TCGA-EI-6917-10A-01D-1924-10_wgs_Illumina.bam,463.3,1.9,0.05,58cfa831e4b0c9d6adf6ccb8,TCGA-EI-6917-10A-01D-1924-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-EI-6917-10A,0CB21FB0-520F-4105-99EC-697A335115B5,Blood Derived Normal,Illumina HiSeq,313e0092-0686-4ac0-a58e-d5ad607f2850,Colorectal,33,1402B955-BA35-4609-B1F3-079A90718C47,1D30C6B6-8486-4A8B-9025-50B1559FFE28,TCGA-EI-6917-10A-01D-1924-10,GRCh37-lite,TCGA-EI-6917,TCGA-READ,NA,s2178,Baylor College of Medicine,Greater Poland Cancer Center,Poland,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIA
13722.58cfa832e4b0c9d6adf6d344,58cfa832e4b0c9d6adf6d344,TCGA-KO-8406-11A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KO-8406-11A-01D-2311-10_wgs_Illumina,TCGA-KO-8406-11A-01D-2311-10_wgs_Illumina.bam,241.2,NA,0.05,58cfa832e4b0c9d6adf6d344,TCGA-KO-8406-11A-01D-2311-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KO-8406-11A,9AA02D46-294B-4E99-B9EE-56EDCBFB5275,Solid Tissue Normal,Illumina HiSeq,850288bf-04d0-4724-b6bc-d37a18987e2c,Kidney,17,280A4DB9-AE8D-4E51-9B9A-E2576E39DA96,20A022AA-6B2C-4B4D-9A10-9DAD1867A342,TCGA-KO-8406-11A-01D-2311-10,GRCh37-lite,TCGA-KO-8406,TCGA-KICH,NA,s16486,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T1,N0,Kidney Chromophobe,Stage I
13722.58cfa82ee4b0c9d6adf6ac20,58cfa82ee4b0c9d6adf6ac20,G37566.TCGA-CH-5789-01A-11D-1576-08.1.filtered.,WGS,G37566.TCGA-CH-5789-01A-11D-1576-08.1,G37566.TCGA-CH-5789-01A-11D-1576-08.1.bam,148.7,1.9,0.05,58cfa82ee4b0c9d6adf6ac20,G37566.TCGA-CH-5789-01A-11D-1576-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5789-01A,BE5411DC-3CAA-4B25-9B94-CE463E8E52B4,Primary Tumor,Illumina HiSeq,93287c07-09e0-4643-b170-08b49803c218,Prostate,61,3C42EB4B-DB63-4F81-8D28-A439E932C716,B68C5EC2-0875-4D77-B4B7-738D2B2F313C,TCGA-CH-5789-01A-11D-1576-08,HG19_Broad_variant,TCGA-CH-5789,TCGA-PRAD,NA,s3761,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6a7d8,58cfa82ee4b0c9d6adf6a7d8,G25788.TCGA-55-7281-10A-01D-2036-08.1.filtered.,WGS,G25788.TCGA-55-7281-10A-01D-2036-08.1,G25788.TCGA-55-7281-10A-01D-2036-08.1.bam,344,NA,0.05,58cfa82ee4b0c9d6adf6a7d8,G25788.TCGA-55-7281-10A-01D-2036-08.1.bam,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-55-7281-10A,659668E8-F0D9-4FF2-BBC8-9246F2EF49AB,Blood Derived Normal,Illumina HiSeq,38a96bd4-b9ef-4b20-a45f-e1b0fcd37962,Lung,70,DC438040-DBAD-462C-BE85-9741144A2465,7BA2ADA7-2353-4035-B73C-9B2A3880A72C,TCGA-55-7281-10A-01D-2036-08,HG19_Broad_variant,TCGA-55-7281,TCGA-LUAD,NA,s11540,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T1b,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6a858,58cfa82ee4b0c9d6adf6a858,G35154.TCGA-DU-5872-02A-21D-A36O-08.1.filtered.,WGS,G35154.TCGA-DU-5872-02A-21D-A36O-08.1,G35154.TCGA-DU-5872-02A-21D-A36O-08.1.bam,10.08,NA,0.09,58cfa82ee4b0c9d6adf6a858,G35154.TCGA-DU-5872-02A-21D-A36O-08.1.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-5872-02A,48607130-C09A-491D-882F-7D2591D13182,Recurrent Tumor,Illumina HiSeq,83a061e8-88d1-4f4e-8568-8eda2807ad1a,Brain,43,2288D604-4B72-4BD1-B024-62405DDAED1C,50014300-FF2E-49F6-857D-DD3E1F22A588,TCGA-DU-5872-02A-21D-A36O-08,HG19_Broad_variant,TCGA-DU-5872,TCGA-LGG,NA,s8529,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa830e4b0c9d6adf6bc96,58cfa830e4b0c9d6adf6bc96,TCGA-AG-3890-10A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AG-3890-10A-01D-1989-10_wgs_Illumina,TCGA-AG-3890-10A-01D-1989-10_wgs_Illumina.bam,8.59,1.9,0.17,58cfa830e4b0c9d6adf6bc96,TCGA-AG-3890-10A-01D-1989-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3890-10A,E2D395F8-BF13-4FE4-8031-683B0EEDD875,Blood Derived Normal,Illumina HiSeq,3cf659fc-f676-4fd6-8a0a-a2d44ece3c03,Colorectal,62,C5DC7F19-74F0-4053-A405-42EF3E6049B4,7431A18D-9E99-4865-9D57-B330D6B44026,TCGA-AG-3890-10A-01D-1989-10,GRCh37-lite,TCGA-AG-3890,TCGA-READ,NA,s2308,Baylor College of Medicine,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa832e4b0c9d6adf6ce80,58cfa832e4b0c9d6adf6ce80,TCGA-G3-A25V-10A-01D-A16V-10_wgs_Illumina.filtered.,WGS,TCGA-G3-A25V-10A-01D-A16V-10_wgs_Illumina,TCGA-G3-A25V-10A-01D-A16V-10_wgs_Illumina.bam,87.21,1.93,0.09,58cfa832e4b0c9d6adf6ce80,TCGA-G3-A25V-10A-01D-A16V-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-G3-A25V-10A,F435EC00-0DB8-46B4-96BF-890A9D931DF3,Blood Derived Normal,Illumina HiSeq,5393d3bd-71d2-4d08-b8a4-f97bcaddf85f,Liver,68,20579506-71F9-46D5-BA22-FB39AC373592,EAC002F0-7695-4DF1-8FF0-2C5C976279DF,TCGA-G3-A25V-10A-01D-A16V-10,GRCh37-lite,TCGA-G3-A25V,TCGA-LIHC,NA,s16594,Baylor College of Medicine,Alberta Health Services,Canada,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6aa3c,58cfa82ee4b0c9d6adf6aa3c,G23081.TCGA_CV_6961_01A_21D_2268_08.2.filtered.,WGS,G23081.TCGA_CV_6961_01A_21D_2268_08.2,G23081.TCGA_CV_6961_01A_21D_2268_08.2.bam,52.7,1.9,0.14,58cfa82ee4b0c9d6adf6aa3c,G23081.TCGA_CV_6961_01A_21D_2268_08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6961-01A,4075717B-2240-4842-A00A-0C4DBCB910C4,Primary Tumor,Illumina HiSeq,4b9344a0-a7c6-453a-b184-87e94c97920a,Head and Neck,61,BE0A6A2B-A306-4AC6-8BF8-EA6AF16EAA5A,DFA20D2D-1BA3-476A-B4B9-21D21470BEE2,TCGA-CV-6961-01A-21D-2268-08,HG19_Broad_variant,TCGA-CV-6961,TCGA-HNSC,76,s15744,Broad Institute of MIT and Harvard,MD Anderson Cancer Center,United States,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6af51,58cfa82ee4b0c9d6adf6af51,G49538.TCGA-14-1034-10A-01D-1492-08.3.filtered.,WGS,G49538.TCGA-14-1034-10A-01D-1492-08.3,G49538.TCGA-14-1034-10A-01D-1492-08.3.bam,96,1.9,0.05,58cfa82ee4b0c9d6adf6af51,G49538.TCGA-14-1034-10A-01D-1492-08.3.bam,Dead,FEMALE,Not available,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1034-10A,0078B0C4-68A9-483B-9AAB-61156D263213,Blood Derived Normal,Illumina HiSeq,b9fce6a3-6b9f-4ac6-9201-ca3a07c24adc,Brain,60,39F42F29-D669-446A-83C1-79591C3E11AB,BFB563CB-42CD-417A-8E69-96C23C514170,TCGA-14-1034-10A-01D-1492-08,HG19_Broad_variant,TCGA-14-1034,TCGA-GBM,485,s14223,Broad Institute of MIT and Harvard,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6a95e,58cfa82ee4b0c9d6adf6a95e,G35154.TCGA-DU-6397-01A-11D-A461-08.3.filtered.,WGS,G35154.TCGA-DU-6397-01A-11D-A461-08.3,G35154.TCGA-DU-6397-01A-11D-A461-08.3.bam,140.6,1.9,0.07,58cfa82ee4b0c9d6adf6a95e,G35154.TCGA-DU-6397-01A-11D-A461-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6397-01A,E695B780-17F4-4E71-9120-7C6BCAFAA3A7,Primary Tumor,Illumina HiSeq,24c6f54a-e7a2-4148-8335-045e3c74096e,Brain,45,AEB67AEA-F2AA-4181-8E25-7653341A0B61,77909413-9323-4916-BB9F-A8E578342333,TCGA-DU-6397-01A-11D-A461-08,HG19_Broad_variant,TCGA-DU-6397,TCGA-LGG,1401,s8113,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa830e4b0c9d6adf6bc11,58cfa830e4b0c9d6adf6bc11,TCGA-AG-3727-01A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AG-3727-01A-01D-1989-10_wgs_Illumina,TCGA-AG-3727-01A-01D-1989-10_wgs_Illumina.bam,489.31,1.9,0.15,58cfa830e4b0c9d6adf6bc11,TCGA-AG-3727-01A-01D-1989-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3727-01A,E6827400-0D95-46B0-8874-6CE9E9D5011B,Primary Tumor,Illumina HiSeq,70d6fce9-139d-448e-8f5f-14b10832d66b,Colorectal,78,DA1CA84F-6C55-4536-9449-3C87E51EF85A,786FC3E4-E2BF-4914-9251-41C800EBB2FA,TCGA-AG-3727-01A-01D-1989-10,GRCh37-lite,TCGA-AG-3727,TCGA-READ,NA,s2142,Baylor College of Medicine,Indivumed,Germany,NO,T3,N1,Rectal Adenocarcinoma,Stage III
13722.58cfa830e4b0c9d6adf6baf0,58cfa830e4b0c9d6adf6baf0,TCGA-A4-A48D-10A-01D-A25F-10_wgs_Illumina.filtered.,WGS,TCGA-A4-A48D-10A-01D-A25F-10_wgs_Illumina,TCGA-A4-A48D-10A-01D-A25F-10_wgs_Illumina.bam,23.67,NA,0.08,58cfa830e4b0c9d6adf6baf0,TCGA-A4-A48D-10A-01D-A25F-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-A4-A48D-10A,925AE8FF-3200-4564-BE76-94DB0984B027,Blood Derived Normal,Illumina HiSeq,4c9b7554-d2c0-498a-975e-cb6a71cab645,Kidney,84,612D71E8-08C2-4C2C-B1B3-BFD0228FB2E2,B87BA993-24FC-4472-BBBC-D4B8AF979060,TCGA-A4-A48D-10A-01D-A25F-10,GRCh37-lite,TCGA-A4-A48D,TCGA-KIRP,NA,s11636,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1b,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6a89a,58cfa82ee4b0c9d6adf6a89a,G35154.TCGA-HT-8104-01A-11D-A461-08.2.filtered.,WGS,G35154.TCGA-HT-8104-01A-11D-A461-08.2,G35154.TCGA-HT-8104-01A-11D-A461-08.2.bam,129.6,NA,0.08,58cfa82ee4b0c9d6adf6a89a,G35154.TCGA-HT-8104-01A-11D-A461-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-8104-01A,5DE6FD84-ED02-4C27-9947-DB57F05FAF6D,Primary Tumor,Illumina HiSeq,85f4a2b5-246f-41da-9777-57d2ceaf1b70,Brain,51,13845BA9-5FC0-408A-8CA9-AC32511765B7,3139DEFD-0311-4F2A-9AD4-A9903F481832,TCGA-HT-8104-01A-11D-A461-08,HG19_Broad_variant,TCGA-HT-8104,TCGA-LGG,NA,s8334,Broad Institute of MIT and Harvard,Case Western - St Joes,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa832e4b0c9d6adf6d505,58cfa832e4b0c9d6adf6d505,TCGA-KN-8435-11A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8435-11A-01D-2311-10_wgs_Illumina,TCGA-KN-8435-11A-01D-2311-10_wgs_Illumina.bam,211.3,NA,0.05,58cfa832e4b0c9d6adf6d505,TCGA-KN-8435-11A-01D-2311-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KN-8435-11A,F2B58595-DEC0-4194-AB33-7C7DC6C058A6,Solid Tissue Normal,Illumina HiSeq,c425d530-be6a-4c7d-a4e3-375183b321e0,Kidney,59,F1F4235A-7AA4-4DF7-8A9F-F1037CA7957A,9CF36C04-1D2A-4E2F-902D-857033D208D3,TCGA-KN-8435-11A-01D-2311-10,GRCh37-lite,TCGA-KN-8435,TCGA-KICH,NA,s16487,Baylor College of Medicine,Harvard,United States,NO,T2,NX,Kidney Chromophobe,Stage II
13722.58cfa82ee4b0c9d6adf6ac36,58cfa82ee4b0c9d6adf6ac36,G39019.TCGA-DA-A3F3-06A-11D-A20D-08.2.filtered.,WGS,G39019.TCGA-DA-A3F3-06A-11D-A20D-08.2,G39019.TCGA-DA-A3F3-06A-11D-A20D-08.2.bam,79.12,NA,0.09,58cfa82ee4b0c9d6adf6ac36,G39019.TCGA-DA-A3F3-06A-11D-A20D-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A3F3-06A,3582FB74-F43D-4FCD-8F22-BB1506FCFF1C,Metastatic,Illumina HiSeq,7899dc05-8772-49e2-895c-202ffb731c6f,Skin,52,F818321C-6356-4C43-9109-6D873AA6B417,507620EF-F0FC-4AC3-A7C0-EA2E36C40F77,TCGA-DA-A3F3-06A-11D-A20D-08,HG19_Broad_variant,TCGA-DA-A3F3,TCGA-SKCM,NA,s7314,Broad Institute of MIT and Harvard,Yale,United States,NO,T0,N2b,Not available,Stage IIIB
13722.58cfa831e4b0c9d6adf6c433,58cfa831e4b0c9d6adf6c433,TCGA-CJ-4878-11A-01D-2098-10_wgs_Illumina.filtered.,WGS,TCGA-CJ-4878-11A-01D-2098-10_wgs_Illumina,TCGA-CJ-4878-11A-01D-2098-10_wgs_Illumina.bam,38.07,1.9,0.15,58cfa831e4b0c9d6adf6c433,TCGA-CJ-4878-11A-01D-2098-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CJ-4878-11A,7CA06DBE-F073-4AEE-86FF-A545FAD5EA93,Solid Tissue Normal,Illumina HiSeq,b8dfd1a2-5181-4f4f-9758-561ed23be404,Kidney,71,20B35F8D-026C-42D0-B1CE-83D6EE549ABE,E1605CC4-E06B-40A4-A2C9-BC7181F5B551,TCGA-CJ-4878-11A-01D-2098-10,GRCh37-lite,TCGA-CJ-4878,TCGA-KIRC,NA,s9166,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T3a,NX,Kidney Clear Cell Renal Carcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6aa32,58cfa82ee4b0c9d6adf6aa32,G23081.TCGA_CV_6961_11A_01D_2268_08.2.filtered.,WGS,G23081.TCGA_CV_6961_11A_01D_2268_08.2,G23081.TCGA_CV_6961_11A_01D_2268_08.2.bam,52.7,1.9,0.16,58cfa82ee4b0c9d6adf6aa32,G23081.TCGA_CV_6961_11A_01D_2268_08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6961-11A,4075717B-2240-4842-A00A-0C4DBCB910C4,Solid Tissue Normal,Illumina HiSeq,f4233ca2-6eae-497e-8d71-234f85182d06,Head and Neck,61,2F64AB02-D9B5-4EF3-9CBA-7534DC0735D5,26F6321F-F079-430F-8B87-5F06B92C07AF,TCGA-CV-6961-11A-01D-2268-08,HG19_Broad_variant,TCGA-CV-6961,TCGA-HNSC,76,s15482,Broad Institute of MIT and Harvard,MD Anderson Cancer Center,United States,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6aa4c,58cfa82ee4b0c9d6adf6aa4c,G35154.TCGA-TQ-A8XE-01A-11D-A36O-08.2.filtered.,WGS,G35154.TCGA-TQ-A8XE-01A-11D-A36O-08.2,G35154.TCGA-TQ-A8XE-01A-11D-A36O-08.2.bam,12.75,NA,0.07,58cfa82ee4b0c9d6adf6aa4c,G35154.TCGA-TQ-A8XE-01A-11D-A36O-08.2.bam,Dead,FEMALE,WHITE,HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-TQ-A8XE-01A,135A149A-D153-465E-AA58-06D47BB18E00,Primary Tumor,Illumina HiSeq,3bc46ccf-d9f8-41bd-a003-42e547c7d758,Brain,42,7C60D0DE-B913-4454-BF9F-C554810911B5,4AAEBADF-13D2-4865-8AB5-CC989D80A261,TCGA-TQ-A8XE-01A-11D-A36O-08,HG19_Broad_variant,TCGA-TQ-A8XE,TCGA-LGG,954,s8339,Broad Institute of MIT and Harvard,University of Sao Paulo,Brazil,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6ade8,58cfa82ee4b0c9d6adf6ade8,G39019.TCGA-D3-A1Q5-10A-01D-A198-08.2.filtered.,WGS,G39019.TCGA-D3-A1Q5-10A-01D-A198-08.2,G39019.TCGA-D3-A1Q5-10A-01D-A198-08.2.bam,13.85,NA,0.08,58cfa82ee4b0c9d6adf6ade8,G39019.TCGA-D3-A1Q5-10A-01D-A198-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A1Q5-10A,238111F9-A08B-49B4-9035-CC43026330E7,Blood Derived Normal,Illumina HiSeq,55b34f20-71ee-4c4d-abba-4d2024a125c3,Skin,60,71E3E4EA-1112-4D87-BDC7-AA55F4017F04,CD4C0E51-04D2-4D6B-9E83-093A61EAA34C,TCGA-D3-A1Q5-10A-01D-A198-08,HG19_Broad_variant,TCGA-D3-A1Q5,TCGA-SKCM,3424,s7481,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,TX,N0,Not available,I or II NOS
13722.58cfa82ee4b0c9d6adf6add0,58cfa82ee4b0c9d6adf6add0,G39019.TCGA-DA-A1HV-06A-21D-A196-08.3.filtered.,WGS,G39019.TCGA-DA-A1HV-06A-21D-A196-08.3,G39019.TCGA-DA-A1HV-06A-21D-A196-08.3.bam,60.98,NA,0.07,58cfa82ee4b0c9d6adf6add0,G39019.TCGA-DA-A1HV-06A-21D-A196-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1HV-06A,210726BD-DB19-48AE-9A3D-E6AC44480E85,Metastatic,Illumina HiSeq,7fd85690-df2e-4017-8f0b-6cedaf47bd3d,Skin,75,A6344B9C-EDBD-4CA7-9226-2452BF4C1E85,75BA6722-1148-4A52-A9ED-68D890238205,TCGA-DA-A1HV-06A-21D-A196-08,HG19_Broad_variant,TCGA-DA-A1HV,TCGA-SKCM,NA,s7312,Broad Institute of MIT and Harvard,Yale,United States,NO,T0,N2b,Not available,Stage IIIB
13722.58cfa82ee4b0c9d6adf6aef4,58cfa82ee4b0c9d6adf6aef4,G49537.TCGA-EM-A3FR-10A-01D-A21Z-08.1.filtered.,WGS,G49537.TCGA-EM-A3FR-10A-01D-A21Z-08.1,G49537.TCGA-EM-A3FR-10A-01D-A21Z-08.1.bam,35.15,NA,0.08,58cfa82ee4b0c9d6adf6aef4,G49537.TCGA-EM-A3FR-10A-01D-A21Z-08.1.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3FR-10A,2B84CFBC-7CF6-4CB1-A1E3-BA85DAFB89F4,Blood Derived Normal,Illumina HiSeq,f36d945f-fc3a-4ebe-83eb-4ba920a70396,Thyroid,55,6B610B46-F51C-47AE-B5D1-CAF366E9B2AC,D2F5C569-964A-4CB4-A77E-A3DF7BFBE36A,TCGA-EM-A3FR-10A-01D-A21Z-08,HG19_Broad_variant,TCGA-EM-A3FR,TCGA-THCA,NA,s11979,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa82ee4b0c9d6adf6ac1e,58cfa82ee4b0c9d6adf6ac1e,G37566.TCGA-G9-7522-01A-11D-2260-08.1.filtered.,WGS,G37566.TCGA-G9-7522-01A-11D-2260-08.1,G37566.TCGA-G9-7522-01A-11D-2260-08.1.bam,146.7,NA,0.05,58cfa82ee4b0c9d6adf6ac1e,G37566.TCGA-G9-7522-01A-11D-2260-08.1.bam,Alive,MALE,Not available,Not available,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-7522-01A,87959988-BB25-47EE-AFC1-9AF92592BBE7,Primary Tumor,Illumina HiSeq,07b2c012-7fce-49d8-a6b8-6d5eb4907508,Prostate,49,10BFE256-C4A2-4D88-B907-56F86EF63DE9,F54442D1-80FA-4678-AC94-C3AD03BC37FB,TCGA-G9-7522-01A-11D-2260-08,HG19_Broad_variant,TCGA-G9-7522,TCGA-PRAD,NA,s3923,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bbca,58cfa830e4b0c9d6adf6bbca,TCGA-AG-4007-10A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AG-4007-10A-01D-1989-10_wgs_Illumina,TCGA-AG-4007-10A-01D-1989-10_wgs_Illumina.bam,3.59,1.9,0.16,58cfa830e4b0c9d6adf6bbca,TCGA-AG-4007-10A-01D-1989-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-4007-10A,8E00E7E7-FFAF-44F0-91A7-172671F18E08,Blood Derived Normal,Illumina HiSeq,bf5bf305-cd19-4e22-8e98-6671a1196153,Colorectal,87,EB3A1A59-B2C5-4436-A971-FCFE5C643820,3003C9F9-5637-4BD3-9377-1EB25C1D9AA5,TCGA-AG-4007-10A-01D-1989-10,GRCh37-lite,TCGA-AG-4007,TCGA-READ,NA,s2154,Baylor College of Medicine,Indivumed,Germany,NO,T4,N2,Rectal Adenocarcinoma,Stage IV
13722.58cfa830e4b0c9d6adf6c04a,58cfa830e4b0c9d6adf6c04a,TCGA-B1-A47M-11A-11D-A25F-10_wgs_Illumina.filtered.,WGS,TCGA-B1-A47M-11A-11D-A25F-10_wgs_Illumina,TCGA-B1-A47M-11A-11D-A25F-10_wgs_Illumina.bam,21.69,NA,0.08,58cfa830e4b0c9d6adf6c04a,TCGA-B1-A47M-11A-11D-A25F-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B1-A47M-11A,072507CF-1249-4B28-86D4-3AB97822A74C,Solid Tissue Normal,Illumina HiSeq,08b6c4cd-121d-4026-8c69-aaf9266d4f94,Kidney,79,FFC06C44-09CF-4888-9B8B-B78E2CCCC4A9,A154CE02-1879-432F-8B26-2EAE5672904E,TCGA-B1-A47M-11A-11D-A25F-10,GRCh37-lite,TCGA-B1-A47M,TCGA-KIRP,NA,s11854,Baylor College of Medicine,University of Pittsburgh,United States,NO,T3a,NX,Kidney Papillary Renal Cell Carcinoma,Stage III
13722.58cfa830e4b0c9d6adf6c040,58cfa830e4b0c9d6adf6c040,TCGA-B1-A47O-10A-01D-A25F-10_wgs_Illumina.filtered.,WGS,TCGA-B1-A47O-10A-01D-A25F-10_wgs_Illumina,TCGA-B1-A47O-10A-01D-A25F-10_wgs_Illumina.bam,7.61,NA,0.08,58cfa830e4b0c9d6adf6c040,TCGA-B1-A47O-10A-01D-A25F-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B1-A47O-10A,6A6C1569-1045-4ED3-ACDB-5C45E47614CA,Blood Derived Normal,Illumina HiSeq,4ccdd976-871c-4252-a834-d59f524b87d3,Kidney,54,CB7D8EC2-ABD0-44BE-8567-E23FAF81C089,C023A62C-E498-4E1E-BE91-99CF6D7B0708,TCGA-B1-A47O-10A-01D-A25F-10,GRCh37-lite,TCGA-B1-A47O,TCGA-KIRP,NA,s11769,Baylor College of Medicine,University of Pittsburgh,United States,NO,T1b,N0,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ad6b,58cfa82ee4b0c9d6adf6ad6b,G7169.TCGA-67-3772-10A-01D-0969-08.12.filtered.,WGS,G7169.TCGA-67-3772-10A-01D-0969-08.12,G7169.TCGA-67-3772-10A-01D-0969-08.12.bam,143.6,1.9,0.14,58cfa82ee4b0c9d6adf6ad6b,G7169.TCGA-67-3772-10A-01D-0969-08.12.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-67-3772-10A,673493F6-975C-49E8-934C-001E9A0FFF90,Blood Derived Normal,Illumina GA,45ff8274-fe76-4b92-9398-f2f9434295e7,Lung,82,8F6B7EC8-1E40-4851-A570-97CFBDC0B990,6843DB6E-8F8C-459F-9BA7-BB4575C68198,TCGA-67-3772-10A-01D-0969-08,HG19_Broad_variant,TCGA-67-3772,TCGA-LUAD,NA,s10979,Broad Institute of MIT and Harvard,St Joseph's Medical Center (MD),United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6acf2,58cfa82ee4b0c9d6adf6acf2,G49537.TCGA-DJ-A13L-10A-01D-A21Z-08.1.filtered.,WGS,G49537.TCGA-DJ-A13L-10A-01D-A21Z-08.1,G49537.TCGA-DJ-A13L-10A-01D-A21Z-08.1.bam,20.69,NA,0.08,58cfa82ee4b0c9d6adf6acf2,G49537.TCGA-DJ-A13L-10A-01D-A21Z-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13L-10A,C7A2F394-3E3F-4C90-9F1E-F2BE3E5B0D6B,Blood Derived Normal,Illumina HiSeq,77b317e4-8f61-4e49-8b6a-a07af3f7cf98,Thyroid,85,1985D930-DCB1-45FA-A706-559F7B77009E,D2657B4B-D086-43DD-A2F5-0BD9C7D4E4BA,TCGA-DJ-A13L-10A-01D-A21Z-08,HG19_Broad_variant,TCGA-DJ-A13L,TCGA-THCA,NA,s12741,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage I
13722.58cfa832e4b0c9d6adf6d436,58cfa832e4b0c9d6adf6d436,TCGA-QG-A5YX-10A-01D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-QG-A5YX-10A-01D-A28G-10_wgs_Illumina,TCGA-QG-A5YX-10A-01D-A28G-10_wgs_Illumina.bam,8.02,NA,0.07,58cfa832e4b0c9d6adf6d436,TCGA-QG-A5YX-10A-01D-A28G-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-QG-A5YX-10A,300FFF5A-0F61-402D-B845-3938BA7B1294,Blood Derived Normal,Illumina HiSeq,1c42d042-124a-40c6-842a-08d4cdca842a,Colorectal,61,3875579A-7BFB-48A5-8829-233D2C69CDBA,95134C87-66C1-4C65-BFD5-883E2004E20A,TCGA-QG-A5YX-10A-01D-A28G-10,GRCh37-lite,TCGA-QG-A5YX,TCGA-COAD,NA,s13546,Baylor College of Medicine,BLN - Baylor,United States,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6ac26,58cfa82ee4b0c9d6adf6ac26,G37566.TCGA-G9-6365-01A-11D-1786-08.1.filtered.,WGS,G37566.TCGA-G9-6365-01A-11D-1786-08.1,G37566.TCGA-G9-6365-01A-11D-1786-08.1.bam,59.4,1.9,0.05,58cfa82ee4b0c9d6adf6ac26,G37566.TCGA-G9-6365-01A-11D-1786-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6365-01A,6845076E-E940-4437-8618-81DB4A447544,Primary Tumor,Illumina HiSeq,9cc69179-2c77-45b6-b3b1-0b1042756f81,Prostate,71,95D6E1D3-91C1-40E5-986D-1C5ABB33A03F,769E2AC9-A121-4B2A-A0FD-5F755B579811,TCGA-G9-6365-01A-11D-1786-08,HG19_Broad_variant,TCGA-G9-6365,TCGA-PRAD,NA,s3412,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T4,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82de4b0c9d6adf6a762,58cfa82de4b0c9d6adf6a762,G14856.TCGA-05-4432-01A-01D-1931-08.2.filtered.,WGS,G14856.TCGA-05-4432-01A-01D-1931-08.2,G14856.TCGA-05-4432-01A-01D-1931-08.2.bam,306.53,1.9,0.14,58cfa82de4b0c9d6adf6a762,G14856.TCGA-05-4432-01A-01D-1931-08.2.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4432-01A,E737F650-B72D-44E7-B750-558A56716803,Primary Tumor,Illumina HiSeq,612f40cd-a773-4962-b831-73dc8d9fb669,Lung,66,2A675528-1ABC-4220-A61A-25109850CE0D,3FBF4DA2-16C9-49AF-A5B3-3DC6C928E75C,TCGA-05-4432-01A-01D-1931-08,HG19_Broad_variant,TCGA-05-4432,TCGA-LUAD,NA,s11425,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIB
13722.58cfa82ee4b0c9d6adf6ad61,58cfa82ee4b0c9d6adf6ad61,G8892.TCGA-66-2757-01A-01D-1180-08.1.filtered.,WGS,G8892.TCGA-66-2757-01A-01D-1180-08.1,G8892.TCGA-66-2757-01A-01D-1180-08.1.bam,161.3,1.9,0.15,58cfa82ee4b0c9d6adf6ad61,G8892.TCGA-66-2757-01A-01D-1180-08.1.bam,Alive,FEMALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-66-2757-01A,A02932F3-5606-42A5-AEE4-E5B9F5AA1AAA,Primary Tumor,Illumina HiSeq,994d5f87-3d5a-4efb-badb-127ee3dd9480,Lung,65,7C727433-A8A8-44EB-AC11-DCB5EBD9250C,0E2DD8AA-7B45-4E26-BA3C-1A202FCB6BE3,TCGA-66-2757-01A-01D-1180-08,HG19_Broad_variant,TCGA-66-2757,TCGA-LUSC,NA,s10087,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6ab7c,58cfa82ee4b0c9d6adf6ab7c,G37566.TCGA-G9-6336-01A-11D-1786-08.1.filtered.,WGS,G37566.TCGA-G9-6336-01A-11D-1786-08.1,G37566.TCGA-G9-6336-01A-11D-1786-08.1.bam,81.4,1.9,0.05,58cfa82ee4b0c9d6adf6ab7c,G37566.TCGA-G9-6336-01A-11D-1786-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6336-01A,59207BCD-F127-481F-B576-8716DA7D7D97,Primary Tumor,Illumina HiSeq,69760af4-102b-4920-92f4-1424ac8db32a,Prostate,57,34C8B195-ECAB-492B-AED2-43ACFEDEF708,AB318624-DB9D-41D8-B7B8-34712434F28F,TCGA-G9-6336-01A-11D-1786-08,HG19_Broad_variant,TCGA-G9-6336,TCGA-PRAD,NA,s3410,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,Not available,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6b168,58cfa82ee4b0c9d6adf6b168,G49537.TCGA-DJ-A4UT-10A-01D-A25A-08.1.filtered.,WGS,G49537.TCGA-DJ-A4UT-10A-01D-A25A-08.1,G49537.TCGA-DJ-A4UT-10A-01D-A25A-08.1.bam,32.48,NA,0.08,58cfa82ee4b0c9d6adf6b168,G49537.TCGA-DJ-A4UT-10A-01D-A25A-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A4UT-10A,ACB80B76-2394-4250-8687-60E40E16E83B,Blood Derived Normal,Illumina HiSeq,eb065ce4-7b78-4de2-80ff-12ff3a22b63b,Thyroid,32,DCBC8E4A-3E82-45F3-BCB7-B55F12C0183D,9D555B5F-01C2-4422-B5C0-76B0146BBFF8,TCGA-DJ-A4UT-10A-01D-A25A-08,HG19_Broad_variant,TCGA-DJ-A4UT,TCGA-THCA,NA,s12624,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T1a,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa830e4b0c9d6adf6be4c,58cfa830e4b0c9d6adf6be4c,TCGA-AG-3890-01A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AG-3890-01A-01D-1989-10_wgs_Illumina,TCGA-AG-3890-01A-01D-1989-10_wgs_Illumina.bam,614.89,1.9,0.15,58cfa830e4b0c9d6adf6be4c,TCGA-AG-3890-01A-01D-1989-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3890-01A,E2D395F8-BF13-4FE4-8031-683B0EEDD875,Primary Tumor,Illumina HiSeq,8df564e5-cdec-4714-b522-5f7356be8d5d,Colorectal,62,DB70A6DD-DE09-4ED7-916C-708B21734500,03CFF38D-7E29-4409-A508-749BDDB1B3DF,TCGA-AG-3890-01A-01D-1989-10,GRCh37-lite,TCGA-AG-3890,TCGA-READ,NA,s1975,Baylor College of Medicine,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6a8b3,58cfa82ee4b0c9d6adf6a8b3,G35154.TCGA-FG-A4MT-01A-11D-A461-08.3.filtered.,WGS,G35154.TCGA-FG-A4MT-01A-11D-A461-08.3,G35154.TCGA-FG-A4MT-01A-11D-A461-08.3.bam,24.05,NA,0.08,58cfa82ee4b0c9d6adf6a8b3,G35154.TCGA-FG-A4MT-01A-11D-A461-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-A4MT-01A,E30F1994-3622-43D0-BEC2-6D7E2D9881D2,Primary Tumor,Illumina HiSeq,19c19563-8424-46b9-b88c-72e6dcc4ec23,Brain,27,18C49A42-5EB4-4A3F-9233-C2557EA684BF,1120B01A-0819-4C90-A1B4-C2B85108E786,TCGA-FG-A4MT-01A-11D-A461-08,HG19_Broad_variant,TCGA-FG-A4MT,TCGA-LGG,NA,s8740,Broad Institute of MIT and Harvard,Case Western,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6aea9,58cfa82ee4b0c9d6adf6aea9,G49537.TCGA-E8-A416-10A-01D-A23K-08.2.filtered.,WGS,G49537.TCGA-E8-A416-10A-01D-A23K-08.2,G49537.TCGA-E8-A416-10A-01D-A23K-08.2.bam,18.28,NA,0.07,58cfa82ee4b0c9d6adf6aea9,G49537.TCGA-E8-A416-10A-01D-A23K-08.2.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-E8-A416-10A,86B82345-6F4D-44FD-A9DB-6F107DE62F53,Blood Derived Normal,Illumina HiSeq,2bd0dd86-01ff-49f4-a80c-beacb213d4ae,Thyroid,51,0EBC6051-5035-43F6-AF5F-EACF32A4BF92,D60FC127-2B47-4CE1-A120-F43ADC2AE776,TCGA-E8-A416-10A-01D-A23K-08,HG19_Broad_variant,TCGA-E8-A416,TCGA-THCA,NA,s12622,Broad Institute of MIT and Harvard,Asterand,Vietnam,NO,T1b,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82ee4b0c9d6adf6adaf,58cfa82ee4b0c9d6adf6adaf,G7165.TCGA-44-2666-10A-01D-0969-08.14.filtered.,WGS,G7165.TCGA-44-2666-10A-01D-0969-08.14,G7165.TCGA-44-2666-10A-01D-0969-08.14.bam,498.6,1.9,0.15,58cfa82ee4b0c9d6adf6adaf,G7165.TCGA-44-2666-10A-01D-0969-08.14.bam,Dead,MALE,WHITE,HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-44-2666-10A,E16CA88F-488B-40F0-9169-E5A62482A2FF,Blood Derived Normal,Illumina GA,a877dc4f-3962-4731-bed4-cae4fdfd7fde,Lung,43,EB394344-96B4-4F36-B639-0B4B4728EAA9,E8291A63-47BE-48A8-8C42-D41F3E4DD6A4,TCGA-44-2666-10A-01D-0969-08,HG19_Broad_variant,TCGA-44-2666,TCGA-LUAD,97,s10898,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6aff4,58cfa82ee4b0c9d6adf6aff4,G49537.TCGA-BJ-A0ZB-10A-01D-A10S-08.1.filtered.,WGS,G49537.TCGA-BJ-A0ZB-10A-01D-A10S-08.1,G49537.TCGA-BJ-A0ZB-10A-01D-A10S-08.1.bam,16.66,2.02,0.09,58cfa82ee4b0c9d6adf6aff4,G49537.TCGA-BJ-A0ZB-10A-01D-A10S-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0ZB-10A,DC4D8468-6F34-40CB-A826-8D582CD86FDE,Blood Derived Normal,Illumina HiSeq,dd4ff5be-4086-4852-b20e-16803d80f8ba,Thyroid,66,C2F1F7A8-2633-4166-95AB-501FB192AF39,D078CBF9-7E5F-47CB-9F33-725A33F31C1B,TCGA-BJ-A0ZB-10A-01D-A10S-08,HG19_Broad_variant,TCGA-BJ-A0ZB,TCGA-THCA,NA,s11977,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA
13722.58cfa82ee4b0c9d6adf6ad08,58cfa82ee4b0c9d6adf6ad08,G39019.TCGA-D3-A1Q1-06A-21D-A196-08.2.filtered.,WGS,G39019.TCGA-D3-A1Q1-06A-21D-A196-08.2,G39019.TCGA-D3-A1Q1-06A-21D-A196-08.2.bam,45.8,NA,0.09,58cfa82ee4b0c9d6adf6ad08,G39019.TCGA-D3-A1Q1-06A-21D-A196-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A1Q1-06A,8C54FCFD-999F-43C5-B31F-26D006F5FFF3,Metastatic,Illumina HiSeq,6ea97d1a-9ee3-4afb-9ce1-ba48e4f7599b,Skin,79,80E29A9A-98C5-4058-914B-1CD86640527A,A0583407-712D-46F3-8C4E-4EEAA0149087,TCGA-D3-A1Q1-06A-21D-A196-08,HG19_Broad_variant,TCGA-D3-A1Q1,TCGA-SKCM,504,s7815,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,T1b,N3,Not available,Stage IIIC
13722.58cfa82ee4b0c9d6adf6a7e8,58cfa82ee4b0c9d6adf6a7e8,G25773.TCGA-75-5147-01A-01D-1625-08.2.filtered.,WGS,G25773.TCGA-75-5147-01A-01D-1625-08.2,G25773.TCGA-75-5147-01A-01D-1625-08.2.bam,817.7,1.9,0.05,58cfa82ee4b0c9d6adf6a7e8,G25773.TCGA-75-5147-01A-01D-1625-08.2.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-5147-01A,D2824E6D-3784-45C2-9B0F-52B17356B5DA,Primary Tumor,Illumina HiSeq,6ec725e2-6d00-4866-8473-fd1b02309066,Lung,NA,F9F9C1DD-8462-4560-82B8-AEA4309854C9,52910A60-BB15-4BA5-9D09-50D8EE6A445B,TCGA-75-5147-01A-01D-1625-08,HG19_Broad_variant,TCGA-75-5147,TCGA-LUAD,NA,s10974,Broad Institute of MIT and Harvard,Ontario Institute for Cancer Research (OICR),Canada,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6ace8,58cfa82ee4b0c9d6adf6ace8,G39020.TCGA-CD-8529-10A-01D-2341-08.2.filtered.,WGS,G39020.TCGA-CD-8529-10A-01D-2341-08.2,G39020.TCGA-CD-8529-10A-01D-2341-08.2.bam,197,NA,0.05,58cfa82ee4b0c9d6adf6ace8,G39020.TCGA-CD-8529-10A-01D-2341-08.2.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-8529-10A,5B7E557A-6AEE-4077-B3CD-C96179E643AE,Blood Derived Normal,Illumina HiSeq,244c2dc3-6a22-4851-9e9d-ab106781e439,Stomach,65,FE9E7270-E4A8-41AF-90F2-48A17823DFF9,5FAA05C2-24B8-4AF2-8552-4D60486C0BCD,TCGA-CD-8529-10A-01D-2341-08,HG19_Broad_variant,TCGA-CD-8529,TCGA-STAD,NA,s15041,Broad Institute of MIT and Harvard,ILSbio,Vietnam,NO,T4,N0,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage IV
13722.58cfa82fe4b0c9d6adf6b86a,58cfa82fe4b0c9d6adf6b86a,TCGA-A6-2680-01A-01D-1554-10_wgs_Illumina.filtered.,WGS,TCGA-A6-2680-01A-01D-1554-10_wgs_Illumina,TCGA-A6-2680-01A-01D-1554-10_wgs_Illumina.bam,38,1.9,0.05,58cfa82fe4b0c9d6adf6b86a,TCGA-A6-2680-01A-01D-1554-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-2680-01A,FF1407C6-9174-4BAE-A19B-D34CA71B898C,Primary Tumor,Illumina HiSeq,d43e0ed3-ab1d-486a-bbf5-91dabacf8220,Colorectal,72,D664F620-CFEE-4700-B00E-68B65387883C,2CDC4CCE-0877-4EC1-85F5-20C909912E65,TCGA-A6-2680-01A-01D-1554-10,GRCh37-lite,TCGA-A6-2680,TCGA-COAD,NA,s13172,Baylor College of Medicine,Christiana Healthcare,None,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa832e4b0c9d6adf6d32c,58cfa832e4b0c9d6adf6d32c,TCGA-KN-8429-11A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8429-11A-01D-2311-10_wgs_Illumina,TCGA-KN-8429-11A-01D-2311-10_wgs_Illumina.bam,298.3,NA,0.05,58cfa832e4b0c9d6adf6d32c,TCGA-KN-8429-11A-01D-2311-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KN-8429-11A,366219B9-FDE3-4D2D-82D3-15FE6245AA98,Solid Tissue Normal,Illumina HiSeq,8009019c-2ba8-483b-9a77-38c124a731d5,Kidney,38,F69DE2AF-C874-4667-B028-D1ED4FF5A11B,8A9AADE0-01C0-49A8-9A47-1498341EDFF7,TCGA-KN-8429-11A-01D-2311-10,GRCh37-lite,TCGA-KN-8429,TCGA-KICH,NA,s16443,Baylor College of Medicine,Harvard,United States,NO,T3a,N0,Kidney Chromophobe,Stage III
13722.58cfa82fe4b0c9d6adf6b94c,58cfa82fe4b0c9d6adf6b94c,TCGA-AA-3518-10A-01D-1525-10_hg19_wgs_Illumina.filtered.,WGS,TCGA-AA-3518-10A-01D-1525-10_hg19_wgs_Illumina,TCGA-AA-3518-10A-01D-1525-10_hg19_wgs_Illumina.bam,117.86,1.9,0.05,58cfa82fe4b0c9d6adf6b94c,TCGA-AA-3518-10A-01D-1525-10_hg19_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3518-10A,C5C4A0A5-900D-483D-9282-475654D63265,Blood Derived Normal,Illumina HiSeq,de1036e1-ef2b-4b1e-a47f-556789ce4266,Colorectal,81,DA5D09FA-0582-45EC-BC71-B8461A0FB13D,A8761858-4C07-4277-A857-5A1861A99C52,TCGA-AA-3518-10A-01D-1525-10,GRCh37-lite,TCGA-AA-3518,TCGA-COAD,NA,s13662,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6a912,58cfa82ee4b0c9d6adf6a912,G32532.TCGA-EL-A3H1-11A-11D-A21A-08.2.filtered.,WGS,G32532.TCGA-EL-A3H1-11A-11D-A21A-08.2,G32532.TCGA-EL-A3H1-11A-11D-A21A-08.2.bam,31.37,NA,0.08,58cfa82ee4b0c9d6adf6a912,G32532.TCGA-EL-A3H1-11A-11D-A21A-08.2.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EL-A3H1-11A,8D54A2ED-03F1-4A23-BDD2-F3395F5D3716,Solid Tissue Normal,Illumina HiSeq,ce053b0b-5bdf-41c1-a9b0-f2ee2b194af6,Thyroid,66,8A84F2A6-D968-433B-AB28-C7892A869D38,0569A3FC-932D-4ACC-8C2D-3BF9999C3138,TCGA-EL-A3H1-11A-11D-A21A-08,HG19_Broad_variant,TCGA-EL-A3H1,TCGA-THCA,1500,s12493,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82ee4b0c9d6adf6ad2f,58cfa82ee4b0c9d6adf6ad2f,G49837.TCGA-52-7812-10A-01D-A320-08.3.filtered.,WGS,G49837.TCGA-52-7812-10A-01D-A320-08.3,G49837.TCGA-52-7812-10A-01D-A320-08.3.bam,742.3,NA,0.07,58cfa82ee4b0c9d6adf6ad2f,G49837.TCGA-52-7812-10A-01D-A320-08.3.bam,Dead,MALE,WHITE,HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-52-7812-10A,81B7CBC1-C037-426F-95B0-D729A30697DA,Blood Derived Normal,Illumina HiSeq,e045dce8-14ac-43d5-9b40-ce7d20c0a4d7,Lung,68,DCB8DEB8-E798-45B7-9F69-C56577CDA4CA,295AFD6A-AD31-494F-A8BC-4FD64CD4B0BD,TCGA-52-7812-10A-01D-A320-08,HG19_Broad_variant,TCGA-52-7812,TCGA-LUSC,835,s10503,Broad Institute of MIT and Harvard,University of Miami,United States,NO,T2,N2,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa832e4b0c9d6adf6d33c,58cfa832e4b0c9d6adf6d33c,TCGA-KO-8411-11A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KO-8411-11A-01D-2311-10_wgs_Illumina,TCGA-KO-8411-11A-01D-2311-10_wgs_Illumina.bam,242.2,NA,0.05,58cfa832e4b0c9d6adf6d33c,TCGA-KO-8411-11A-01D-2311-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KO-8411-11A,EE8C1919-17A9-4DF1-8AA5-79546621B23C,Solid Tissue Normal,Illumina HiSeq,53f01757-4138-44fb-aca6-9b42beca71ed,Kidney,58,EA285591-3257-4231-9ACD-4EBB95D5B4D4,7F8F088D-0CAB-4301-8A5D-9E780D18439B,TCGA-KO-8411-11A-01D-2311-10,GRCh37-lite,TCGA-KO-8411,TCGA-KICH,NA,s16536,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T1b,NX,Kidney Chromophobe,Stage I
13722.58cfa82ee4b0c9d6adf6acbe,58cfa82ee4b0c9d6adf6acbe,G37566.TCGA-HI-7169-01A-11D-2114-08.2.filtered.,WGS,G37566.TCGA-HI-7169-01A-11D-2114-08.2,G37566.TCGA-HI-7169-01A-11D-2114-08.2.bam,54.6,NA,0.05,58cfa82ee4b0c9d6adf6acbe,G37566.TCGA-HI-7169-01A-11D-2114-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HI-7169-01A,11FB5853-8EEB-4AD8-825D-3EAAF3FA08D6,Primary Tumor,Illumina HiSeq,4ec05d23-3f9f-473a-b292-63ddb0e7d37f,Prostate,55,AEEF0836-305C-465C-A9CA-6C1825353AE7,E1FC4226-40CE-43B7-B92E-AA7CECD0CF4D,TCGA-HI-7169-01A-11D-2114-08,HG19_Broad_variant,TCGA-HI-7169,TCGA-PRAD,NA,s3586,Broad Institute of MIT and Harvard,Fox Chase,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6acb4,58cfa82ee4b0c9d6adf6acb4,G47088.TCGA-77-6843-01A-11D-1945-08.1.filtered.,WGS,G47088.TCGA-77-6843-01A-11D-1945-08.1,G47088.TCGA-77-6843-01A-11D-1945-08.1.bam,285.7,1.9,0.05,58cfa82ee4b0c9d6adf6acb4,G47088.TCGA-77-6843-01A-11D-1945-08.1.bam,Dead,MALE,WHITE,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-77-6843-01A,C2598334-F866-4CC3-93EC-2D2E8B85D319,Primary Tumor,Illumina HiSeq,8cc492fe-df3d-4eb2-a46e-ef531153cf54,Lung,74,8712518A-FE08-43FD-B497-620ECC0AA0AC,FAB3D6F4-DE1C-4D6C-BDEA-AC39A7884657,TCGA-77-6843-01A-11D-1945-08,HG19_Broad_variant,TCGA-77-6843,TCGA-LUSC,2224,s10363,Broad Institute of MIT and Harvard,Prince Charles Hospital,Australia,NO,T1,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa82de4b0c9d6adf6a70e,58cfa82de4b0c9d6adf6a70e,G12518.TCGA-34-2596-01A-01D-0963-08.1.filtered.,WGS,G12518.TCGA-34-2596-01A-01D-0963-08.1,G12518.TCGA-34-2596-01A-01D-0963-08.1.bam,77.3,1.9,0.14,58cfa82de4b0c9d6adf6a70e,G12518.TCGA-34-2596-01A-01D-0963-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-34-2596-01A,7D3E77CC-9603-4722-8E39-1912B678871B,Primary Tumor,Illumina HiSeq,1fb42274-b17f-4050-9559-5d39557227d6,Lung,70,C07C8C94-150B-40A2-8830-5BE34DD99554,692DFA4F-45E5-4183-B5DA-6650A1FBCABD,TCGA-34-2596-01A-01D-0963-08,HG19_Broad_variant,TCGA-34-2596,TCGA-LUSC,80,s10356,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6ace0,58cfa82ee4b0c9d6adf6ace0,G39020.TCGA-CG-5723-01A-11D-1600-08.1.filtered.,WGS,G39020.TCGA-CG-5723-01A-11D-1600-08.1,G39020.TCGA-CG-5723-01A-11D-1600-08.1.bam,224,1.9,0.05,58cfa82ee4b0c9d6adf6ace0,G39020.TCGA-CG-5723-01A-11D-1600-08.1.bam,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5723-01A,0F00AD32-E4BE-49D4-A02A-D233BFC913C5,Primary Tumor,Illumina HiSeq,2a8e56af-ea0b-4304-805e-db8a07ae73dc,Stomach,83,4CCD9CCB-BF50-44EB-AA55-133D8824C433,FFB4F42B-58E9-40C3-8963-11804F041375,TCGA-CG-5723-01A-11D-1600-08,HG19_Broad_variant,TCGA-CG-5723,TCGA-STAD,NA,s14810,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa830e4b0c9d6adf6c15a,58cfa830e4b0c9d6adf6c15a,TCGA-B9-A44B-10A-01D-A25F-10_wgs_Illumina.filtered.,WGS,TCGA-B9-A44B-10A-01D-A25F-10_wgs_Illumina,TCGA-B9-A44B-10A-01D-A25F-10_wgs_Illumina.bam,11.07,NA,0.08,58cfa830e4b0c9d6adf6c15a,TCGA-B9-A44B-10A-01D-A25F-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B9-A44B-10A,B809C2F2-185C-496A-A1D4-589294443A1D,Blood Derived Normal,Illumina HiSeq,a960f893-9b73-4c6d-94ac-b3353c7a73ca,Kidney,70,28A04267-2F50-458C-A3D2-5F18A025C8B6,5D028C99-A58C-419A-B566-610DCBA9CD5C,TCGA-B9-A44B-10A-01D-A25F-10,GRCh37-lite,TCGA-B9-A44B,TCGA-KIRP,NA,s11856,Baylor College of Medicine,UNC,United States,NO,T3b,NX,Kidney Papillary Renal Cell Carcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6af94,58cfa82ee4b0c9d6adf6af94,G49537.TCGA-EM-A2CP-10A-01D-A17V-08.1.filtered.,WGS,G49537.TCGA-EM-A2CP-10A-01D-A17V-08.1,G49537.TCGA-EM-A2CP-10A-01D-A17V-08.1.bam,97.81,NA,0.08,58cfa82ee4b0c9d6adf6af94,G49537.TCGA-EM-A2CP-10A-01D-A17V-08.1.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A2CP-10A,2F59F12D-CA0C-4AC6-9718-98A6D455AF46,Blood Derived Normal,Illumina HiSeq,7b5aeed0-bf1e-4832-93c3-4f30a37d1eb4,Thyroid,26,16933321-36C6-43B3-A0C9-511646391466,E6101D92-5616-476E-8B38-8B6847AE3D48,TCGA-EM-A2CP-10A-01D-A17V-08,HG19_Broad_variant,TCGA-EM-A2CP,TCGA-THCA,NA,s12093,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa82ee4b0c9d6adf6ad5d,58cfa82ee4b0c9d6adf6ad5d,G8891.TCGA-66-2756-11A-01D-1180-08.1.filtered.,WGS,G8891.TCGA-66-2756-11A-01D-1180-08.1,G8891.TCGA-66-2756-11A-01D-1180-08.1.bam,386.6,1.9,0.14,58cfa82ee4b0c9d6adf6ad5d,G8891.TCGA-66-2756-11A-01D-1180-08.1.bam,Alive,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-66-2756-11A,43ABE847-4BA7-466E-8283-5D7B80B999A7,Solid Tissue Normal,Illumina HiSeq,ed3fa380-2bbd-47e8-a9a5-8cbf0d4e91ab,Lung,68,2C9885EA-EA3F-499C-8EFC-557ECB083AAA,9C52F252-FC91-4D59-A85F-804DBA93C9C4,TCGA-66-2756-11A-01D-1180-08,HG19_Broad_variant,TCGA-66-2756,TCGA-LUSC,NA,s9983,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T4,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIB
13722.58cfa82ee4b0c9d6adf6ad4a,58cfa82ee4b0c9d6adf6ad4a,G49837.TCGA-66-2744-11A-01D-A320-08.3.filtered.,WGS,G49837.TCGA-66-2744-11A-01D-A320-08.3,G49837.TCGA-66-2744-11A-01D-A320-08.3.bam,30.94,1.9,0.08,58cfa82ee4b0c9d6adf6ad4a,G49837.TCGA-66-2744-11A-01D-A320-08.3.bam,Alive,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-66-2744-11A,1EE543D5-B8C0-4F79-8373-6BB6319F2EE2,Solid Tissue Normal,Illumina HiSeq,d1c8a770-5306-41d7-be76-d4c7ec68fca4,Lung,71,B6BDE1F3-AE17-4E83-8E74-D4269E5AF31E,F3E59C9D-A856-42E3-B45E-3D291FB66402,TCGA-66-2744-11A-01D-A320-08,HG19_Broad_variant,TCGA-66-2744,TCGA-LUSC,NA,s10081,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82de4b0c9d6adf6a758,58cfa82de4b0c9d6adf6a758,G13231.TCGA-60-2724-11A-01D-1522-08.2.filtered.,WGS,G13231.TCGA-60-2724-11A-01D-1522-08.2,G13231.TCGA-60-2724-11A-01D-1522-08.2.bam,391.6,1.9,0.05,58cfa82de4b0c9d6adf6a758,G13231.TCGA-60-2724-11A-01D-1522-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-60-2724-11A,A3E1AC67-A1F2-44FB-8343-A7E8239FC24A,Solid Tissue Normal,Illumina HiSeq,935ba288-e46d-42be-90ed-e92cd542f105,Lung,47,10F7D78C-3D61-40CA-89C3-80F0E0664343,E54D3ECF-0E9E-4718-9038-3C5B78B0FD8C,TCGA-60-2724-11A-01D-1522-08,HG19_Broad_variant,TCGA-60-2724,TCGA-LUSC,NA,s10156,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T3,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82ee4b0c9d6adf6abd2,58cfa82ee4b0c9d6adf6abd2,G37566.TCGA-CH-5763-01A-11D-1576-08.1.filtered.,WGS,G37566.TCGA-CH-5763-01A-11D-1576-08.1,G37566.TCGA-CH-5763-01A-11D-1576-08.1.bam,172.7,1.9,0.05,58cfa82ee4b0c9d6adf6abd2,G37566.TCGA-CH-5763-01A-11D-1576-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5763-01A,18E79A01-07A2-4CD5-B700-71D41724E041,Primary Tumor,Illumina HiSeq,ba68ecb8-6421-467d-b680-850c82a0b95d,Prostate,66,F4192448-E5B3-4A9F-8354-9FE28503017A,581BE6CF-9778-49C3-9C77-1316EAA78929,TCGA-CH-5763-01A-11D-1576-08,HG19_Broad_variant,TCGA-CH-5763,TCGA-PRAD,NA,s3405,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6ac5e,58cfa82ee4b0c9d6adf6ac5e,G39019.TCGA-DA-A1I2-06A-21D-A19A-08.1.filtered.,WGS,G39019.TCGA-DA-A1I2-06A-21D-A19A-08.1,G39019.TCGA-DA-A1I2-06A-21D-A19A-08.1.bam,65.65,NA,0.09,58cfa82ee4b0c9d6adf6ac5e,G39019.TCGA-DA-A1I2-06A-21D-A19A-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1I2-06A,01AD975D-C2ED-4E4D-BD3B-C9512FC9073C,Metastatic,Illumina HiSeq,def664f3-25fc-4633-96bd-8ebf1a179021,Skin,45,1E373C9C-DDB0-4C77-87AF-468EE586F998,D432E99A-67FB-4609-B90F-99438EEE7CAE,TCGA-DA-A1I2-06A-21D-A19A-08,HG19_Broad_variant,TCGA-DA-A1I2,TCGA-SKCM,NA,s7814,Broad Institute of MIT and Harvard,Yale,United States,NO,T4b,N2b,Not available,Stage III
13722.58cfa82de4b0c9d6adf6a768,58cfa82de4b0c9d6adf6a768,G14083.TCGA-21-1082-10B-01D-1521-08.4.filtered.,WGS,G14083.TCGA-21-1082-10B-01D-1521-08.4,G14083.TCGA-21-1082-10B-01D-1521-08.4.bam,43,1.7,0.05,58cfa82de4b0c9d6adf6a768,G14083.TCGA-21-1082-10B-01D-1521-08.4.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-21-1082-10B,0E2EE54A-51C9-4868-842D-A2A1C1CFB016,Blood Derived Normal,Illumina HiSeq,f2658746-4c87-46e2-94a3-858678ea496e,Lung,61,34E0475D-75C4-43C1-9715-027C19FA25F8,654AE6B0-65DA-4B11-B2FE-E7DD9C44E260,TCGA-21-1082-10B-01D-1521-08,HG19_Broad_variant,TCGA-21-1082,TCGA-LUSC,NA,s10251,Broad Institute of MIT and Harvard,Fox Chase Cancer Center,United States,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6a826,58cfa82ee4b0c9d6adf6a826,G35154.TCGA-DU-5872-01A-11D-A465-08.1.filtered.,WGS,G35154.TCGA-DU-5872-01A-11D-A465-08.1,G35154.TCGA-DU-5872-01A-11D-A465-08.1.bam,31.7,1.8,0.09,58cfa82ee4b0c9d6adf6a826,G35154.TCGA-DU-5872-01A-11D-A465-08.1.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-5872-01A,48607130-C09A-491D-882F-7D2591D13182,Primary Tumor,Illumina HiSeq,359efa91-062f-491e-805a-0130efb943eb,Brain,43,048550EE-189D-483D-B07F-B77F10278420,0BCE913F-C4A0-4CC6-9A8B-A223F00CBA11,TCGA-DU-5872-01A-11D-A465-08,HG19_Broad_variant,TCGA-DU-5872,TCGA-LGG,NA,s8528,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa82de4b0c9d6adf6a736,58cfa82de4b0c9d6adf6a736,G14851.TCGA-05-4422-10A-01D-1931-08.3.filtered.,WGS,G14851.TCGA-05-4422-10A-01D-1931-08.3,G14851.TCGA-05-4422-10A-01D-1931-08.3.bam,61.23,1.8,0.15,58cfa82de4b0c9d6adf6a736,G14851.TCGA-05-4422-10A-01D-1931-08.3.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4422-10A,44DEC838-B653-42A7-A58B-A1FD232CD68C,Blood Derived Normal,Illumina HiSeq,735fb0c2-720d-444e-a61b-218fc42c9a1f,Lung,68,FCE6E4CC-207C-4B2C-8387-6166D47565BB,5DBBA493-1E13-4427-A4E5-C5E240571D09,TCGA-05-4422-10A-01D-1931-08,HG19_Broad_variant,TCGA-05-4422,TCGA-LUAD,NA,s10972,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa82de4b0c9d6adf6a73e,58cfa82de4b0c9d6adf6a73e,G14851.TCGA-05-4422-01A-01D-1931-08.2.filtered.,WGS,G14851.TCGA-05-4422-01A-01D-1931-08.2,G14851.TCGA-05-4422-01A-01D-1931-08.2.bam,631.63,1.9,0.15,58cfa82de4b0c9d6adf6a73e,G14851.TCGA-05-4422-01A-01D-1931-08.2.bam,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4422-01A,44DEC838-B653-42A7-A58B-A1FD232CD68C,Primary Tumor,Illumina HiSeq,b70e3630-efee-4b99-b77b-c3000baf9819,Lung,68,DACBC55D-25C6-4E86-BD1B-38345B4DF7A7,6D2B0633-5BE4-4026-920C-427D3AA7C763,TCGA-05-4422-01A-01D-1931-08,HG19_Broad_variant,TCGA-05-4422,TCGA-LUAD,NA,s11104,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa831e4b0c9d6adf6c6a8,58cfa831e4b0c9d6adf6c6a8,TCGA-CV-5432-10A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CV-5432-10A-01D-A32X-10_wgs_Illumina,TCGA-CV-5432-10A-01D-A32X-10_wgs_Illumina.bam,46,1.8,0.07,58cfa831e4b0c9d6adf6c6a8,TCGA-CV-5432-10A-01D-A32X-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5432-10A,D89B1FD6-BEF4-4803-8ED3-3B442BE600B6,Blood Derived Normal,Illumina HiSeq,39f4a08d-69ba-4e67-b8a9-4983f17e14f6,Head and Neck,68,3A13692E-CB77-464A-8ACE-CBA47F99247F,3205A312-3259-4E13-8B12-3E612E7A2400,TCGA-CV-5432-10A-01D-A32X-10,GRCh37-lite,TCGA-CV-5432,TCGA-HNSC,NA,s16043,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6a85a,58cfa82ee4b0c9d6adf6a85a,G35154.TCGA-HT-7602-01A-21D-2086-08.4.filtered.,WGS,G35154.TCGA-HT-7602-01A-21D-2086-08.4,G35154.TCGA-HT-7602-01A-21D-2086-08.4.bam,15.13,NA,0.05,58cfa82ee4b0c9d6adf6a85a,G35154.TCGA-HT-7602-01A-21D-2086-08.4.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HT-7602-01A,799E9106-E62E-4681-8861-137F474EE8B8,Primary Tumor,Illumina HiSeq,fdc7bab5-c807-4791-be95-6a588e86a4b8,Brain,21,0997BB1A-F0A4-4CB8-9714-5BAF9C391CE8,88395C0E-4AFE-434D-8B20-5A3EEF8B7F00,TCGA-HT-7602-01A-21D-2086-08,HG19_Broad_variant,TCGA-HT-7602,TCGA-LGG,NA,s8531,Broad Institute of MIT and Harvard,Case Western - St Joes,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6a9b2,58cfa82ee4b0c9d6adf6a9b2,G2146.TCGA-06-0185-01A-01D.9.filtered.,WGS,G2146.TCGA-06-0185-01A-01D.9,G2146.TCGA-06-0185-01A-01D.9.bam,194.47,1.89,0.17,58cfa82ee4b0c9d6adf6a9b2,G2146.TCGA-06-0185-01A-01D.9.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0185-01A,8F3ACBBD-B2CA-4E66-8FE5-DBB49277F35B,Primary Tumor,Illumina GA,225007db-7839-42fb-9cdc-bf50718b3079,Brain,54,08737D76-27B8-4472-86F4-C25F99D98439,B6CDB961-42B2-489F-A59E-8C8B892CCA04,TCGA-06-0185-01A-01D-0507-08,HG19_Broad_variant,TCGA-06-0185,TCGA-GBM,NA,s14342,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6c008,58cfa830e4b0c9d6adf6c008,TCGA-B1-A47N-10A-01D-A25F-10_wgs_Illumina.filtered.,WGS,TCGA-B1-A47N-10A-01D-A25F-10_wgs_Illumina,TCGA-B1-A47N-10A-01D-A25F-10_wgs_Illumina.bam,11.32,NA,0.08,58cfa830e4b0c9d6adf6c008,TCGA-B1-A47N-10A-01D-A25F-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B1-A47N-10A,F1EC5A7B-0973-4C38-9908-862196DF9541,Blood Derived Normal,Illumina HiSeq,16422775-cd61-4861-a238-c15d08b99e1e,Kidney,62,3F3227F3-1345-4568-BEC5-2D287EA84A75,2041C373-06A2-4BA8-B9F8-3C11C313E0DB,TCGA-B1-A47N-10A-01D-A25F-10,GRCh37-lite,TCGA-B1-A47N,TCGA-KIRP,NA,s11584,Baylor College of Medicine,University of Pittsburgh,United States,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bf04,58cfa830e4b0c9d6adf6bf04,TCGA-BP-4807-11A-01D-2098-10_wgs_Illumina.filtered.,WGS,TCGA-BP-4807-11A-01D-2098-10_wgs_Illumina,TCGA-BP-4807-11A-01D-2098-10_wgs_Illumina.bam,198.7,1.9,0.15,58cfa830e4b0c9d6adf6bf04,TCGA-BP-4807-11A-01D-2098-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-BP-4807-11A,33CF0893-0411-4758-AA90-602BFEDF0850,Solid Tissue Normal,Illumina HiSeq,b1310112-22ca-40b1-9754-d93cec283294,Kidney,42,6A8AD307-FADA-432D-A223-8D9780C4ECCC,EE755D38-9449-422A-9036-51EC0EAB50FB,TCGA-BP-4807-11A-01D-2098-10,GRCh37-lite,TCGA-BP-4807,TCGA-KIRC,NA,s9161,Baylor College of Medicine,MSKCC,None,NO,T1a,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6b044,58cfa82ee4b0c9d6adf6b044,TCGA-06-0152-10A-01D-0507-08_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-06-0152-10A-01D-0507-08_IlluminaGA-DNASeq_whole,TCGA-06-0152-10A-01D-0507-08_IlluminaGA-DNASeq_whole.bam,32.87,1.9,0.18,58cfa82ee4b0c9d6adf6b044,TCGA-06-0152-10A-01D-0507-08_IlluminaGA-DNASeq_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0152-10A,F5BC5D97-E054-4E53-992D-71B896BD97D5,Blood Derived Normal,Illumina GA,1ddd24e8-d3b2-4654-9eee-721adba54088,Brain,68,0861E08B-9AA1-41B6-8EB7-30FCEC264249,A7DB8F47-1BCD-4041-9219-862D92B8A58E,TCGA-06-0152-10A-01D-0507-08,HG18_Broad_variant,TCGA-06-0152,TCGA-GBM,375,s14064,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6adf9,58cfa82ee4b0c9d6adf6adf9,G49837.TCGA-77-7139-10A-01D-A320-08.3.filtered.,WGS,G49837.TCGA-77-7139-10A-01D-A320-08.3,G49837.TCGA-77-7139-10A-01D-A320-08.3.bam,88.3,NA,0.08,58cfa82ee4b0c9d6adf6adf9,G49837.TCGA-77-7139-10A-01D-A320-08.3.bam,Alive,MALE,WHITE,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-77-7139-10A,EE850103-6314-41A3-9734-8B520DE95B40,Blood Derived Normal,Illumina HiSeq,a87795cf-51a0-468f-bc46-142e6bf5d1c1,Lung,56,13CE75EA-0190-4FC3-8276-FB1DA412C1FA,C765A6F5-18F4-4D57-BAB3-719BBC3DA28A,TCGA-77-7139-10A-01D-A320-08,HG19_Broad_variant,TCGA-77-7139,TCGA-LUSC,NA,s10507,Broad Institute of MIT and Harvard,Prince Charles Hospital,Australia,NO,T2,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6aeb0,58cfa82ee4b0c9d6adf6aeb0,G39020.TCGA-BR-6456-10A-01D-1800-08.3.filtered.,WGS,G39020.TCGA-BR-6456-10A-01D-1800-08.3,G39020.TCGA-BR-6456-10A-01D-1800-08.3.bam,66,1.9,0.05,58cfa82ee4b0c9d6adf6aeb0,G39020.TCGA-BR-6456-10A-01D-1800-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6456-10A,1CA3C5E0-32B0-4467-8EC0-CA212E35D2B3,Blood Derived Normal,Illumina HiSeq,5d2012c9-0bd2-4779-81a0-8dc85e2cb6b2,Stomach,74,3A8917B9-B3FC-4221-AB95-84927E1DEC28,0ADF6445-5470-4B30-923F-5028BDD471B3,TCGA-BR-6456-10A-01D-1800-08,HG19_Broad_variant,TCGA-BR-6456,TCGA-STAD,NA,s15039,Broad Institute of MIT and Harvard,Asterand,Russia,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6aecd,58cfa82ee4b0c9d6adf6aecd,G37566.TCGA-HC-7744-01A-11D-2114-08.1.filtered.,WGS,G37566.TCGA-HC-7744-01A-11D-2114-08.1,G37566.TCGA-HC-7744-01A-11D-2114-08.1.bam,170.3,NA,0.05,58cfa82ee4b0c9d6adf6aecd,G37566.TCGA-HC-7744-01A-11D-2114-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7744-01A,F6381367-142C-45D0-92B3-C1727D1813CE,Primary Tumor,Illumina HiSeq,8589d977-d1ca-42ea-975f-c3e664d57eba,Prostate,46,41E0D8F7-E104-43C4-B3BB-FD0B5CB3C7B2,0192D529-7340-45D8-A5F0-249CBB11CA19,TCGA-HC-7744-01A-11D-2114-08,HG19_Broad_variant,TCGA-HC-7744,TCGA-PRAD,NA,s3925,Broad Institute of MIT and Harvard,International Genomics Consortium,None,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6ac91,58cfa82ee4b0c9d6adf6ac91,G47088.TCGA-22-5477-01A-01D-1632-08.1.filtered.,WGS,G47088.TCGA-22-5477-01A-01D-1632-08.1,G47088.TCGA-22-5477-01A-01D-1632-08.1.bam,859.7,1.9,0.05,58cfa82ee4b0c9d6adf6ac91,G47088.TCGA-22-5477-01A-01D-1632-08.1.bam,Dead,MALE,WHITE,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-22-5477-01A,BD15F523-45C4-4D7C-A3CC-4FB56ABB0E54,Primary Tumor,Illumina HiSeq,198a167a-3034-46af-a58f-46712ddf3eb0,Lung,65,F9D568B1-6951-4EAF-8867-4C86BDAEAA04,E7EBC6FB-0926-4C8A-A67B-0C6B9C1FFABA,TCGA-22-5477-01A-01D-1632-08,HG19_Broad_variant,TCGA-22-5477,TCGA-LUSC,1346,s10500,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,United States,NO,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa830e4b0c9d6adf6be92,58cfa830e4b0c9d6adf6be92,TCGA-AG-4007-01A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AG-4007-01A-01D-1989-10_wgs_Illumina,TCGA-AG-4007-01A-01D-1989-10_wgs_Illumina.bam,915.89,1.9,0.16,58cfa830e4b0c9d6adf6be92,TCGA-AG-4007-01A-01D-1989-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-4007-01A,8E00E7E7-FFAF-44F0-91A7-172671F18E08,Primary Tumor,Illumina HiSeq,16ef1919-094b-44db-a49b-966c6bf84f33,Colorectal,87,E6FC3F28-1DE1-4587-9E0E-0861323E6772,8DA641E4-9B12-4163-BD1E-9D5AF91E5186,TCGA-AG-4007-01A-01D-1989-10,GRCh37-lite,TCGA-AG-4007,TCGA-READ,NA,s1981,Baylor College of Medicine,Indivumed,Germany,NO,T4,N2,Rectal Adenocarcinoma,Stage IV
13722.58cfa82ee4b0c9d6adf6af34,58cfa82ee4b0c9d6adf6af34,G37566.TCGA-G9-6370-01A-11D-1786-08.2.filtered.,WGS,G37566.TCGA-G9-6370-01A-11D-1786-08.2,G37566.TCGA-G9-6370-01A-11D-1786-08.2.bam,59.4,2,0.05,58cfa82ee4b0c9d6adf6af34,G37566.TCGA-G9-6370-01A-11D-1786-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-G9-6370-01A,F947B0BC-BDAC-44E8-B5B9-FFAE4147740A,Primary Tumor,Illumina HiSeq,48541dbc-810e-4dad-a90a-5d33e6df1766,Prostate,52,644E1E7D-DFD1-4F83-82DC-AE0C7E010F6F,9689CB33-8AC9-4EE5-800D-3900769988AF,TCGA-G9-6370-01A-11D-1786-08,HG19_Broad_variant,TCGA-G9-6370,TCGA-PRAD,NA,s3582,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6ab6e,58cfa82ee4b0c9d6adf6ab6e,G37566.TCGA-EJ-7791-01A-11D-2114-08.2.filtered.,WGS,G37566.TCGA-EJ-7791-01A-11D-2114-08.2,G37566.TCGA-EJ-7791-01A-11D-2114-08.2.bam,97.3,NA,0.05,58cfa82ee4b0c9d6adf6ab6e,G37566.TCGA-EJ-7791-01A-11D-2114-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-7791-01A,4FE004E5-49F9-4336-A690-6EBAD512C813,Primary Tumor,Illumina HiSeq,60424977-6a58-4b53-9607-4cf61abb2c55,Prostate,67,57ED8A64-46F9-4E1F-8550-CEF121A6BBC6,D32F41FB-0744-4A62-81F6-0260C4920049,TCGA-EJ-7791-01A-11D-2114-08,HG19_Broad_variant,TCGA-EJ-7791,TCGA-PRAD,NA,s3927,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6c0f4,58cfa830e4b0c9d6adf6c0f4,TCGA-B9-4113-11A-01D-1253-10_wgs_Illumina.filtered.,WGS,TCGA-B9-4113-11A-01D-1253-10_wgs_Illumina,TCGA-B9-4113-11A-01D-1253-10_wgs_Illumina.bam,493,1.9,0.15,58cfa830e4b0c9d6adf6c0f4,TCGA-B9-4113-11A-01D-1253-10_wgs_Illumina.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B9-4113-11A,5C9A6C40-982E-45C7-98D3-AEB6CAD16986,Solid Tissue Normal,Illumina HiSeq,2d22c4bf-127e-4416-ae63-3dbb16346203,Kidney,64,4AFB859D-76D4-4333-8157-800CC9D7F3ED,2F25EBB7-1015-45C2-9351-D343559FD613,TCGA-B9-4113-11A-01D-1253-10,GRCh37-lite,TCGA-B9-4113,TCGA-KIRP,1536,s11775,Baylor College of Medicine,UNC,None,NO,T1,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6a7c0,58cfa82ee4b0c9d6adf6a7c0,G2146.TCGA-06-0185-10B-01D.8.filtered.,WGS,G2146.TCGA-06-0185-10B-01D.8,G2146.TCGA-06-0185-10B-01D.8.bam,50,1.91,0.17,58cfa82ee4b0c9d6adf6a7c0,G2146.TCGA-06-0185-10B-01D.8.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0185-10B,8F3ACBBD-B2CA-4E66-8FE5-DBB49277F35B,Blood Derived Normal,Illumina GA,40b76a98-8865-4410-b390-105e085a225b,Brain,54,FDE1B781-B420-4F32-B5B3-17E93AE401E9,FD23F636-0953-4828-8272-1385405CE62A,TCGA-06-0185-10B-01D-0507-08,HG19_Broad_variant,TCGA-06-0185,TCGA-GBM,NA,s14024,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6ac5a,58cfa82ee4b0c9d6adf6ac5a,G39019.TCGA-DA-A3F8-06A-11D-A20D-08.3.filtered.,WGS,G39019.TCGA-DA-A3F8-06A-11D-A20D-08.3,G39019.TCGA-DA-A3F8-06A-11D-A20D-08.3.bam,69.6,NA,0.09,58cfa82ee4b0c9d6adf6ac5a,G39019.TCGA-DA-A3F8-06A-11D-A20D-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A3F8-06A,B6691E3C-EE3F-49A2-8BD4-2086413E5D8D,Metastatic,Illumina HiSeq,23dfbb4d-5e87-4609-9aae-32da30eff982,Skin,39,018CF360-90D7-4695-BB9E-EA22D4BF8EDA,978AE91E-6EBE-4EFA-97FF-CFAD511AE7B3,TCGA-DA-A3F8-06A-11D-A20D-08,HG19_Broad_variant,TCGA-DA-A3F8,TCGA-SKCM,NA,s7993,Broad Institute of MIT and Harvard,Yale,United States,NO,T2a,N2b,Not available,Stage IIIB
13722.58cfa82ee4b0c9d6adf6ac30,58cfa82ee4b0c9d6adf6ac30,G37566.TCGA-HC-7233-01A-11D-2114-08.2.filtered.,WGS,G37566.TCGA-HC-7233-01A-11D-2114-08.2,G37566.TCGA-HC-7233-01A-11D-2114-08.2.bam,207.3,NA,0.05,58cfa82ee4b0c9d6adf6ac30,G37566.TCGA-HC-7233-01A-11D-2114-08.2.bam,Alive,MALE,WHITE,Not available,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7233-01A,E2B33861-2247-413F-B2E5-9BE3B604666C,Primary Tumor,Illumina HiSeq,4e0a9ee2-a019-4269-90e4-b6c02d5b0091,Prostate,73,848C2C7B-918E-4A09-BAD9-3B3D59BBC101,0C9A5DBC-F7F3-43E7-83D1-77B9FB4B8B54,TCGA-HC-7233-01A-11D-2114-08,HG19_Broad_variant,TCGA-HC-7233,TCGA-PRAD,NA,s3765,Broad Institute of MIT and Harvard,International Genomics Consortium,Yemen,NO,T2a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa82ee4b0c9d6adf6ac64,58cfa82ee4b0c9d6adf6ac64,G39019.TCGA-DA-A1HY-06A-11D-A19A-08.2.filtered.,WGS,G39019.TCGA-DA-A1HY-06A-11D-A19A-08.2,G39019.TCGA-DA-A1HY-06A-11D-A19A-08.2.bam,38.32,NA,0.09,58cfa82ee4b0c9d6adf6ac64,G39019.TCGA-DA-A1HY-06A-11D-A19A-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1HY-06A,40E17BF8-6C19-4E5E-B60D-AD54F504A970,Metastatic,Illumina HiSeq,4067ff38-29aa-4cbb-98e3-14283e4a270b,Skin,42,12590302-AB64-4652-88DD-CBBF5091E1C1,88F2C496-3EB4-4C03-B3A5-8D5A55803AAF,TCGA-DA-A1HY-06A-11D-A19A-08,HG19_Broad_variant,TCGA-DA-A1HY,TCGA-SKCM,NA,s7485,Broad Institute of MIT and Harvard,Yale,United States,NO,T2b,N1,Not available,Stage III
13722.58cfa82de4b0c9d6adf6a746,58cfa82de4b0c9d6adf6a746,G14848.TCGA-05-4398-01A-01D-1931-08.3.filtered.,WGS,G14848.TCGA-05-4398-01A-01D-1931-08.3,G14848.TCGA-05-4398-01A-01D-1931-08.3.bam,403.53,1.9,0.15,58cfa82de4b0c9d6adf6a746,G14848.TCGA-05-4398-01A-01D-1931-08.3.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4398-01A,31C96E35-5E2F-429C-B12A-7BC5A497A300,Primary Tumor,Illumina HiSeq,fc9ee166-a6ea-4c5a-9978-b63277aec83e,Lung,47,DA010683-C537-478F-8F95-E606B05DBC5C,23D77176-DFED-4BEE-AC96-9934377D8D81,TCGA-05-4398-01A-01D-1931-08,HG19_Broad_variant,TCGA-05-4398,TCGA-LUAD,NA,s10625,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T4,N3,Lung Adenocarcinoma Mixed Subtype,Stage IIIB
13722.58cfa82ee4b0c9d6adf6af5d,58cfa82ee4b0c9d6adf6af5d,G41960.TCGA-50-6591-11A-01D-1753-08.3.filtered.,WGS,G41960.TCGA-50-6591-11A-01D-1753-08.3,G41960.TCGA-50-6591-11A-01D-1753-08.3.bam,59.4,1.9,0.05,58cfa82ee4b0c9d6adf6af5d,G41960.TCGA-50-6591-11A-01D-1753-08.3.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-6591-11A,9B132E4F-7E35-4CC5-8711-43AD62B906D0,Solid Tissue Normal,Illumina HiSeq,3cf01f5f-1d8b-46a3-85da-9d9a16ff694d,Lung,63,76A1F269-62CE-4AE1-A08B-8AF43F853E5A,CD2253B4-6C44-45FC-8300-61FB5D23A3BD,TCGA-50-6591-11A-01D-1753-08,HG19_Broad_variant,TCGA-50-6591,TCGA-LUAD,119,s10896,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IV
13722.58cfa82ee4b0c9d6adf6acfe,58cfa82ee4b0c9d6adf6acfe,G49537.TCGA-EL-A4K6-11A-11D-A25A-08.2.filtered.,WGS,G49537.TCGA-EL-A4K6-11A-11D-A25A-08.2,G49537.TCGA-EL-A4K6-11A-11D-A25A-08.2.bam,19.35,NA,0.08,58cfa82ee4b0c9d6adf6acfe,G49537.TCGA-EL-A4K6-11A-11D-A25A-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EL-A4K6-11A,4FC8E011-4433-4537-B03F-457A3A70240F,Solid Tissue Normal,Illumina HiSeq,5042b61b-3252-4a2d-8d92-e89d9b59db07,Thyroid,75,01FD30BD-38CD-4796-9976-C60A85C374F1,1C4C0193-231E-4559-B362-94C10BBD7F67,TCGA-EL-A4K6-11A-11D-A25A-08,HG19_Broad_variant,TCGA-EL-A4K6,TCGA-THCA,NA,s12094,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,T4,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage IV
13722.58cfa82ee4b0c9d6adf6a9ea,58cfa82ee4b0c9d6adf6a9ea,G25772.TCGA-38-4630-01A-01D-2364-08.3.filtered.,WGS,G25772.TCGA-38-4630-01A-01D-2364-08.3,G25772.TCGA-38-4630-01A-01D-2364-08.3.bam,339.9,1.9,0.05,58cfa82ee4b0c9d6adf6a9ea,G25772.TCGA-38-4630-01A-01D-2364-08.3.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-38-4630-01A,F1985735-A188-4567-A88A-530F9B80291B,Primary Tumor,Illumina HiSeq,1ece9db5-148a-413e-9dc4-bf65d88ecc5f,Lung,75,83D01FF9-D0A9-4606-80ED-9A417A980EF7,2282CF06-9C70-47F0-958C-C9E5697AC2C8,TCGA-38-4630-01A-01D-2364-08,HG19_Broad_variant,TCGA-38-4630,TCGA-LUAD,1073,s10975,Broad Institute of MIT and Harvard,UNC,United States,NO,T2,N0,Lung Papillary Adenocarcinoma,Stage IB
13722.58cfa82de4b0c9d6adf6a760,58cfa82de4b0c9d6adf6a760,G13230.TCGA-60-2713-11A-01D-1522-08.7.filtered.,WGS,G13230.TCGA-60-2713-11A-01D-1522-08.7,G13230.TCGA-60-2713-11A-01D-1522-08.7.bam,322.6,1.9,0.05,58cfa82de4b0c9d6adf6a760,G13230.TCGA-60-2713-11A-01D-1522-08.7.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-60-2713-11A,E58E8850-154F-4695-BEE0-005C76410327,Solid Tissue Normal,Illumina HiSeq,f8b163d5-ad95-4ca8-9797-e97cf9b83283,Lung,64,45558BE4-91E0-42A9-AA05-8234B08CCF6C,9EBA89E5-0EB9-413A-AE43-30A1D30A7EEB,TCGA-60-2713-11A-01D-1522-08,HG19_Broad_variant,TCGA-60-2713,TCGA-LUSC,NA,s10359,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6acee,58cfa82ee4b0c9d6adf6acee,G39020.TCGA-CG-4474-01A-02D-A290-08.2.filtered.,WGS,G39020.TCGA-CG-4474-01A-02D-A290-08.2,G39020.TCGA-CG-4474-01A-02D-A290-08.2.bam,112.2,1.9,0.07,58cfa82ee4b0c9d6adf6acee,G39020.TCGA-CG-4474-01A-02D-A290-08.2.bam,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-4474-01A,39DD61A8-CD17-4DF3-AE17-61E239EB00BD,Primary Tumor,Illumina HiSeq,fce67618-325e-4007-bf20-bd524f4bd049,Stomach,67,68D21E75-16AC-48D0-B7CA-ABFDE13DED29,5C4B369C-51A3-4CA7-8B9D-2A8E49C0DDE7,TCGA-CG-4474-01A-02D-A290-08,HG19_Broad_variant,TCGA-CG-4474,TCGA-STAD,NA,s14525,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T4a,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IV
13722.58cfa82ee4b0c9d6adf6ac0c,58cfa82ee4b0c9d6adf6ac0c,G39019.TCGA-EE-A2A0-06A-11D-A196-08.3.filtered.,WGS,G39019.TCGA-EE-A2A0-06A-11D-A196-08.3,G39019.TCGA-EE-A2A0-06A-11D-A196-08.3.bam,28.14,NA,0.08,58cfa82ee4b0c9d6adf6ac0c,G39019.TCGA-EE-A2A0-06A-11D-A196-08.3.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2A0-06A,81CEDB9E-EE43-476B-9ED9-8D0FDB346065,Metastatic,Illumina HiSeq,05a87fb7-c560-47a1-a7c2-5e477231453f,Skin,77,FDE25BEE-ED13-4128-A67C-23463D25A7C1,3F2ECBCD-5C9E-4D57-8AA5-962E2E86A83C,TCGA-EE-A2A0-06A-11D-A196-08,HG19_Broad_variant,TCGA-EE-A2A0,TCGA-SKCM,1424,s7823,Broad Institute of MIT and Harvard,University of Sydney,Australia,NO,T3a,N0,Not available,Stage IIA
13722.58cfa82ee4b0c9d6adf6ab0e,58cfa82ee4b0c9d6adf6ab0e,G35154.TCGA-HW-7486-01A-11D-2024-08.6.filtered.,WGS,G35154.TCGA-HW-7486-01A-11D-2024-08.6,G35154.TCGA-HW-7486-01A-11D-2024-08.6.bam,21,NA,0.05,58cfa82ee4b0c9d6adf6ab0e,G35154.TCGA-HW-7486-01A-11D-2024-08.6.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-HW-7486-01A,55A67639-ED05-4143-AF96-A377BC5489EE,Primary Tumor,Illumina HiSeq,77a6b9b7-4a25-4784-95e5-98346720dcef,Brain,37,F0C5DF7C-53AA-4D90-8189-44A2BB55A696,67F88CD9-AB77-4227-A8D7-5512246F9772,TCGA-HW-7486-01A-11D-2024-08,HG19_Broad_variant,TCGA-HW-7486,TCGA-LGG,NA,s8551,Broad Institute of MIT and Harvard,MSKCC,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6a956,58cfa82ee4b0c9d6adf6a956,G35154.TCGA-DU-6401-01A-11D-1705-08.2.filtered.,WGS,G35154.TCGA-DU-6401-01A-11D-1705-08.2,G35154.TCGA-DU-6401-01A-11D-1705-08.2.bam,124.3,1.9,0.05,58cfa82ee4b0c9d6adf6a956,G35154.TCGA-DU-6401-01A-11D-1705-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6401-01A,97CB8701-7D63-4142-B404-006FBB3ECB0B,Primary Tumor,Illumina HiSeq,f0537710-8458-4890-8a52-3f4457eb308f,Brain,31,680DBC4E-5CEC-4E76-848F-72BC0A2407C6,3A81F733-B3A3-4578-B925-A663612BC92C,TCGA-DU-6401-01A-11D-1705-08,HG19_Broad_variant,TCGA-DU-6401,TCGA-LGG,2660,s8536,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa830e4b0c9d6adf6bd5c,58cfa830e4b0c9d6adf6bd5c,TCGA-AA-3516-01A-02D-1554-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3516-01A-02D-1554-10_wgs_Illumina,TCGA-AA-3516-01A-02D-1554-10_wgs_Illumina.bam,47.29,1.9,0.05,58cfa830e4b0c9d6adf6bd5c,TCGA-AA-3516-01A-02D-1554-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3516-01A,D9D7F0D4-FA64-48F2-8037-52CBF0B34AD8,Primary Tumor,Illumina HiSeq,f25d539d-8289-4400-8da7-ddce46918578,Colorectal,74,4E4F7BEC-56AF-4888-B40B-A33218B010E8,EE25E9EF-5200-40F8-A16D-559D98BFC5EA,TCGA-AA-3516-01A-02D-1554-10,GRCh37-lite,TCGA-AA-3516,TCGA-COAD,NA,s13185,Baylor College of Medicine,Indivumed,Germany,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage III
13722.58cfa832e4b0c9d6adf6d432,58cfa832e4b0c9d6adf6d432,TCGA-MR-A520-10A-01D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-MR-A520-10A-01D-A25V-10_wgs_Illumina,TCGA-MR-A520-10A-01D-A25V-10_wgs_Illumina.bam,9.27,NA,0.07,58cfa832e4b0c9d6adf6d432,TCGA-MR-A520-10A-01D-A25V-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-MR-A520-10A,25E893AD-A0FD-45AE-9AA9-9BCD7C2EC8E5,Blood Derived Normal,Illumina HiSeq,4f1cee03-dc73-4448-8b65-caac81bfcdd1,Liver,58,36FD208D-27BD-4B79-9595-970317DAE647,64B28729-B106-4B33-994D-F1710478466C,TCGA-MR-A520-10A-01D-A25V-10,GRCh37-lite,TCGA-MR-A520,TCGA-LIHC,NA,s17065,Baylor College of Medicine,University of Minnesota,United States,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6be9f,58cfa830e4b0c9d6adf6be9f,TCGA-AG-3896-01A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AG-3896-01A-01D-1989-10_wgs_Illumina,TCGA-AG-3896-01A-01D-1989-10_wgs_Illumina.bam,913.89,1.9,0.15,58cfa830e4b0c9d6adf6be9f,TCGA-AG-3896-01A-01D-1989-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3896-01A,9AF35239-FFB9-4D4F-889E-F743DA271EEF,Primary Tumor,Illumina HiSeq,a9406c81-5dd3-4c50-8984-c81a85f67723,Colorectal,85,03B40342-3CCE-4A45-B2EC-8855AEB85100,14334AEA-2DAE-428C-9D4A-1A37878DFC3F,TCGA-AG-3896-01A-01D-1989-10,GRCh37-lite,TCGA-AG-3896,TCGA-READ,NA,s1992,Baylor College of Medicine,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bb7c,58cfa830e4b0c9d6adf6bb7c,TCGA-AA-A01R-01A-21D-A17O-10_wgs_Illumina.filtered.,WGS,TCGA-AA-A01R-01A-21D-A17O-10_wgs_Illumina,TCGA-AA-A01R-01A-21D-A17O-10_wgs_Illumina.bam,75.21,1.8,0.07,58cfa830e4b0c9d6adf6bb7c,TCGA-AA-A01R-01A-21D-A17O-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01R-01A,97F6C8D3-09A0-4128-8F10-41E736648A5F,Primary Tumor,Illumina HiSeq,5b6c9797-7cfe-4bd0-a656-74dd069d72d9,Colorectal,47,73EE34E8-422D-4AB1-B0F0-DA8A5A2DD9AB,303ABBE5-4155-4A0D-BC3B-F8995261CA52,TCGA-AA-A01R-01A-21D-A17O-10,GRCh37-lite,TCGA-AA-A01R,TCGA-COAD,NA,s13194,Baylor College of Medicine,Indivumed,Germany,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage III
13722.58cfa830e4b0c9d6adf6bc66,58cfa830e4b0c9d6adf6bc66,TCGA-AL-3466-10A-01D-A31Z-10_wgs_Illumina.filtered.,WGS,TCGA-AL-3466-10A-01D-A31Z-10_wgs_Illumina,TCGA-AL-3466-10A-01D-A31Z-10_wgs_Illumina.bam,86.3,2.1,0.08,58cfa830e4b0c9d6adf6bc66,TCGA-AL-3466-10A-01D-A31Z-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-AL-3466-10A,9FC40B03-0B56-4B1F-93ED-DBC455AE3FD9,Blood Derived Normal,Illumina HiSeq,eef3935d-14c2-4c4d-b283-57e2bee37b1b,Kidney,41,B2B7B6A5-883D-4353-8608-981B669584F8,D0CBD054-7FAD-4226-A829-C53F34531FDF,TCGA-AL-3466-10A-01D-A31Z-10,GRCh37-lite,TCGA-AL-3466,TCGA-KIRP,293,s11577,Baylor College of Medicine,Fox Chase,None,NO,T3b,N1,Kidney Papillary Renal Cell Carcinoma,Stage IV
13722.58cfa82de4b0c9d6adf6a750,58cfa82de4b0c9d6adf6a750,G14082.TCGA-21-1076-01A-02D-1521-08.2.filtered.,WGS,G14082.TCGA-21-1076-01A-02D-1521-08.2,G14082.TCGA-21-1076-01A-02D-1521-08.2.bam,423.7,1.9,0.05,58cfa82de4b0c9d6adf6a750,G14082.TCGA-21-1076-01A-02D-1521-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-21-1076-01A,220BE009-8F1E-4A77-AB04-3220B5F87EA6,Primary Tumor,Illumina HiSeq,f960f40f-32d5-4ab1-a88c-0e199b9d1969,Lung,54,22BE9844-4D9E-4372-A46A-B5C64480E5AA,504D4CB0-D2DD-420D-82E6-9EC14434A0FC,TCGA-21-1076-01A-02D-1521-08,HG19_Broad_variant,TCGA-21-1076,TCGA-LUSC,NA,s10358,Broad Institute of MIT and Harvard,Fox Chase Cancer Center,United States,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa831e4b0c9d6adf6cc3a,58cfa831e4b0c9d6adf6cc3a,TCGA-EP-A2KA-10A-01D-A183-10_wgs_Illumina.filtered.,WGS,TCGA-EP-A2KA-10A-01D-A183-10_wgs_Illumina,TCGA-EP-A2KA-10A-01D-A183-10_wgs_Illumina.bam,28.51,NA,0.08,58cfa831e4b0c9d6adf6cc3a,TCGA-EP-A2KA-10A-01D-A183-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-EP-A2KA-10A,440375D7-CDCD-418A-8992-0A8CA42D290D,Blood Derived Normal,Illumina HiSeq,67a513da-3e37-4a1f-9f61-4cc8962897da,Liver,52,96080E33-92A4-4B10-8957-8E2D27501470,A9D75099-91A1-40AA-A8F1-E6035ACD821D,TCGA-EP-A2KA-10A-01D-A183-10,GRCh37-lite,TCGA-EP-A2KA,TCGA-LIHC,NA,s16590,Baylor College of Medicine,Christiana Healthcare,United States,NO,T3a,NX,Hepatocellular Carcinoma,Stage IIIA
13722.58cfa830e4b0c9d6adf6bef4,58cfa830e4b0c9d6adf6bef4,TCGA-B1-A47M-10A-01D-A25F-10_wgs_Illumina.filtered.,WGS,TCGA-B1-A47M-10A-01D-A25F-10_wgs_Illumina,TCGA-B1-A47M-10A-01D-A25F-10_wgs_Illumina.bam,37.23,NA,0.08,58cfa830e4b0c9d6adf6bef4,TCGA-B1-A47M-10A-01D-A25F-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B1-A47M-10A,072507CF-1249-4B28-86D4-3AB97822A74C,Blood Derived Normal,Illumina HiSeq,1a50190e-4988-4b82-b421-8b828bb37d26,Kidney,79,9626CDB5-155B-468F-A487-6304193F3F48,68D9E30C-356A-4FD1-A9E9-6E535A0A963D,TCGA-B1-A47M-10A-01D-A25F-10,GRCh37-lite,TCGA-B1-A47M,TCGA-KIRP,NA,s11644,Baylor College of Medicine,University of Pittsburgh,United States,NO,T3a,NX,Kidney Papillary Renal Cell Carcinoma,Stage III
13722.58cfa82fe4b0c9d6adf6ba12,58cfa82fe4b0c9d6adf6ba12,TCGA-AA-3977-10A-01D-1024-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3977-10A-01D-1024-10_wgs_Illumina,TCGA-AA-3977-10A-01D-1024-10_wgs_Illumina.bam,17.86,1.8,0.15,58cfa82fe4b0c9d6adf6ba12,TCGA-AA-3977-10A-01D-1024-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3977-10A,33E989B9-FAC4-47D8-B429-269044AC772A,Blood Derived Normal,Illumina HiSeq,f511ad35-378f-4391-a60b-6df71d8d62ab,Colorectal,65,9553ED85-E80F-4AA3-9064-0AF8B04F7CFA,71807B57-89D9-40AB-BBBB-D63E2C86040C,TCGA-AA-3977-10A-01D-1024-10,GRCh37-lite,TCGA-AA-3977,TCGA-COAD,NA,s13367,Baylor College of Medicine,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ad57,58cfa82ee4b0c9d6adf6ad57,G8893.TCGA-66-2766-01A-01D-1180-08.4.filtered.,WGS,G8893.TCGA-66-2766-01A-01D-1180-08.4,G8893.TCGA-66-2766-01A-01D-1180-08.4.bam,564.3,1.9,0.14,58cfa82ee4b0c9d6adf6ad57,G8893.TCGA-66-2766-01A-01D-1180-08.4.bam,Alive,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-66-2766-01A,B913D254-8307-4B8A-8313-D978E32BB38F,Primary Tumor,Illumina HiSeq,cba17a86-671f-4744-a52b-a93f56b8ee16,Lung,54,09215E83-EDAC-472D-B849-9225C532358C,45E16B70-C3EC-493E-86D1-505FFDF5056C,TCGA-66-2766-01A-01D-1180-08,HG19_Broad_variant,TCGA-66-2766,TCGA-LUSC,NA,s10262,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N2,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82ee4b0c9d6adf6ac02,58cfa82ee4b0c9d6adf6ac02,G39019.TCGA-DA-A1HW-06A-11D-A19A-08.2.filtered.,WGS,G39019.TCGA-DA-A1HW-06A-11D-A19A-08.2,G39019.TCGA-DA-A1HW-06A-11D-A19A-08.2.bam,44.61,NA,0.08,58cfa82ee4b0c9d6adf6ac02,G39019.TCGA-DA-A1HW-06A-11D-A19A-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1HW-06A,800D3A17-269F-4D97-94FF-8585F20038D8,Metastatic,Illumina HiSeq,2ebf409b-961e-4948-ba57-3e2cbf64f8e5,Skin,37,0CB9BC8F-475B-4FED-9CC0-D1B29E9F178B,FC249113-83D4-4ABE-8C80-A4F7305DCD91,TCGA-DA-A1HW-06A-11D-A19A-08,HG19_Broad_variant,TCGA-DA-A1HW,TCGA-SKCM,NA,s7484,Broad Institute of MIT and Harvard,Yale,United States,NO,T1a,N1b,Not available,Stage IIIB
13722.58cfa832e4b0c9d6adf6ce76,58cfa832e4b0c9d6adf6ce76,TCGA-FV-A496-10A-01D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-FV-A496-10A-01D-A25V-10_wgs_Illumina,TCGA-FV-A496-10A-01D-A25V-10_wgs_Illumina.bam,104.34,NA,0.07,58cfa832e4b0c9d6adf6ce76,TCGA-FV-A496-10A-01D-A25V-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-FV-A496-10A,8AFA3140-DCBD-44C0-AB13-4ADA6A0444D4,Blood Derived Normal,Illumina HiSeq,36411133-c902-48e9-bad1-9a5c7f215769,Liver,84,F47202C2-A5BB-44E3-B209-24AAF42457BB,B736880F-AB1F-41FA-8776-38421620F821,TCGA-FV-A496-10A-01D-A25V-10,GRCh37-lite,TCGA-FV-A496,TCGA-LIHC,NA,s16860,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6cabe,58cfa831e4b0c9d6adf6cabe,TCGA-DD-A1EJ-10A-01D-A152-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A1EJ-10A-01D-A152-10_wgs_Illumina,TCGA-DD-A1EJ-10A-01D-A152-10_wgs_Illumina.bam,19.89,1.85,0.09,58cfa831e4b0c9d6adf6cabe,TCGA-DD-A1EJ-10A-01D-A152-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A1EJ-10A,52292FFC-0902-4D97-B461-20723987A177,Blood Derived Normal,Illumina HiSeq,843cbcea-c1a4-46c4-8c45-27a565867027,Liver,71,FBC4E1F2-60F3-4B3D-90F5-FCAD79CFF7FF,FF037E6B-C763-416F-91EF-BF0EC01A4225,TCGA-DD-A1EJ-10A-01D-A152-10,GRCh37-lite,TCGA-DD-A1EJ,TCGA-LIHC,NA,s16677,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T1,N1,Hepatocellular Carcinoma,Stage IIIC
13722.58cfa831e4b0c9d6adf6cb24,58cfa831e4b0c9d6adf6cb24,TCGA-ED-A4XI-10A-01D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-ED-A4XI-10A-01D-A25V-10_wgs_Illumina,TCGA-ED-A4XI-10A-01D-A25V-10_wgs_Illumina.bam,114.45,NA,0.07,58cfa831e4b0c9d6adf6cb24,TCGA-ED-A4XI-10A-01D-A25V-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-ED-A4XI-10A,C52ABAC9-07DA-4B3D-BF8A-2161CACF9682,Blood Derived Normal,Illumina HiSeq,ab48e1e5-a430-43b9-b55a-01fd7d27cfa7,Liver,58,03B9FCC8-4CF6-4A81-B1D7-382CB1570AB4,72F5179F-1C32-4E78-8F77-027A5400E7FD,TCGA-ED-A4XI-10A-01D-A25V-10,GRCh37-lite,TCGA-ED-A4XI,TCGA-LIHC,NA,s16681,Baylor College of Medicine,Asterand,Vietnam,NO,T2,N0,Hepatocellular Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6ab9f,58cfa82ee4b0c9d6adf6ab9f,G35154.TCGA-TM-A7CF-02A-11D-A32B-08.4.filtered.,WGS,G35154.TCGA-TM-A7CF-02A-11D-A32B-08.4,G35154.TCGA-TM-A7CF-02A-11D-A32B-08.4.bam,7.09,NA,0.07,58cfa82ee4b0c9d6adf6ab9f,G35154.TCGA-TM-A7CF-02A-11D-A32B-08.4.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-TM-A7CF-02A,033C1F48-9225-4159-B23B-7042272877DA,Recurrent Tumor,Illumina HiSeq,1ab4fe08-6067-42db-94b9-7cf6729b1dba,Brain,41,204F56B8-2A07-461B-B4FB-51399AA93BEC,21BF981D-32C6-4973-9C13-124087076E74,TCGA-TM-A7CF-02A-11D-A32B-08,HG19_Broad_variant,TCGA-TM-A7CF,TCGA-LGG,NA,s8549,Broad Institute of MIT and Harvard,The University of New South Wales,Australia,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6ca27,58cfa831e4b0c9d6adf6ca27,TCGA-DD-A3A7-11A-11D-A22F-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A3A7-11A-11D-A22F-10_wgs_Illumina,TCGA-DD-A3A7-11A-11D-A22F-10_wgs_Illumina.bam,24.42,NA,0.07,58cfa831e4b0c9d6adf6ca27,TCGA-DD-A3A7-11A-11D-A22F-10_wgs_Illumina.bam,Dead,MALE,Not available,Not available,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A3A7-11A,614C0ECF-6A84-4C86-8706-79BE5BB00991,Solid Tissue Normal,Illumina HiSeq,d01b6805-cae5-4fc3-92ad-8c80ce192bff,Liver,67,2D7D198B-5689-4373-8ECF-107553B6E32E,134E6BF3-534E-4A0E-94E0-37C93F47F72B,TCGA-DD-A3A7-11A-11D-A22F-10,GRCh37-lite,TCGA-DD-A3A7,TCGA-LIHC,419,s16673,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T3b,N0,Hepatocellular Carcinoma,Stage IIIB
13722.58cfa82ee4b0c9d6adf6addf,58cfa82ee4b0c9d6adf6addf,G49538.TCGA-06-0211-10A-01D-1491-08.1.filtered.,WGS,G49538.TCGA-06-0211-10A-01D-1491-08.1,G49538.TCGA-06-0211-10A-01D-1491-08.1.bam,12.7,1.84,0.05,58cfa82ee4b0c9d6adf6addf,G49538.TCGA-06-0211-10A-01D-1491-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0211-10A,5C984433-33CF-42FC-B3BA-511EFCDCAB19,Blood Derived Normal,Illumina HiSeq,f3799eb9-aa31-4892-b2e6-b278c1e3f2e8,Brain,47,5C4BA77D-D7F4-4D66-B9A9-875167A063AE,EBF97220-6D4D-4016-BAE3-EC279144C19D,TCGA-06-0211-10A-01D-1491-08,HG19_Broad_variant,TCGA-06-0211,TCGA-GBM,360,s13985,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6bc8e,58cfa830e4b0c9d6adf6bc8e,TCGA-AG-3901-01A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AG-3901-01A-01D-1989-10_wgs_Illumina,TCGA-AG-3901-01A-01D-1989-10_wgs_Illumina.bam,510.89,1.9,0.15,58cfa830e4b0c9d6adf6bc8e,TCGA-AG-3901-01A-01D-1989-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3901-01A,1586CB0A-081A-4364-9470-46F9D0F0167D,Primary Tumor,Illumina HiSeq,51acbe73-78d9-48e4-b937-42a159dfb5a5,Colorectal,67,93B755E6-5D6E-4542-8BAE-2121F44F590C,7D59205A-65EC-4341-9748-28639D82ED29,TCGA-AG-3901-01A-01D-1989-10,GRCh37-lite,TCGA-AG-3901,TCGA-READ,NA,s2160,Baylor College of Medicine,Indivumed,Germany,NO,T3,N1,Rectal Mucinous Adenocarcinoma,Stage IIIB
13722.58cfa82ee4b0c9d6adf6ad30,58cfa82ee4b0c9d6adf6ad30,G49837.TCGA-43-5670-01A-21D-A320-08.1.filtered.,WGS,G49837.TCGA-43-5670-01A-21D-A320-08.1,G49837.TCGA-43-5670-01A-21D-A320-08.1.bam,559,NA,0.07,58cfa82ee4b0c9d6adf6ad30,G49837.TCGA-43-5670-01A-21D-A320-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-43-5670-01A,7D905F8F-3967-4EA8-96C8-17B1B03FBEC3,Primary Tumor,Illumina HiSeq,118f7a8c-af7e-4f0d-a235-99c5487eee74,Lung,70,6B829F48-BA74-40D7-B92F-41A2A2B7D136,369C06F2-8904-49CB-99D1-DD297ED0CD0C,TCGA-43-5670-01A-21D-A320-08,HG19_Broad_variant,TCGA-43-5670,TCGA-LUSC,NA,s10369,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,T2b,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa832e4b0c9d6adf6d302,58cfa832e4b0c9d6adf6d302,TCGA-KM-8438-10A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KM-8438-10A-01D-2311-10_wgs_Illumina,TCGA-KM-8438-10A-01D-2311-10_wgs_Illumina.bam,180.6,NA,0.05,58cfa832e4b0c9d6adf6d302,TCGA-KM-8438-10A-01D-2311-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KM-8438-10A,23656226-2D99-4548-959F-5C2EED803E33,Blood Derived Normal,Illumina HiSeq,35a30f37-afc9-4879-9f70-c5bf6d29e882,Kidney,45,9626717B-D569-48F3-93DB-772355A4B5CD,503F8648-A261-4FAD-9062-769D85F140DF,TCGA-KM-8438-10A-01D-2311-10,GRCh37-lite,TCGA-KM-8438,TCGA-KICH,NA,s16530,Baylor College of Medicine,NCI Urologic Oncology Branch,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa830e4b0c9d6adf6c149,58cfa830e4b0c9d6adf6c149,TCGA-BA-4076-01A-01D-2266-10_Illumina.filtered.,WGS,TCGA-BA-4076-01A-01D-2266-10_Illumina,TCGA-BA-4076-01A-01D-2266-10_Illumina.bam,333.33,1.9,0.05,58cfa830e4b0c9d6adf6c149,TCGA-BA-4076-01A-01D-2266-10_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-4076-01A,7DE19081-D5FD-468C-AD0D-F6E3E8B2AD70,Primary Tumor,Illumina HiSeq,62857418-5247-4ae1-8064-d900ef856428,Head and Neck,39,FD99FD83-4040-4738-8A5A-E42D36ECFE0E,E2B5C926-491D-430D-8D9C-5C73D7752D1B,TCGA-BA-4076-01A-01D-2266-10,GRCh37-lite,TCGA-BA-4076,TCGA-HNSC,415,s16171,Baylor College of Medicine,UNC,None,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c3a4,58cfa831e4b0c9d6adf6c3a4,TCGA-CC-5262-10B-01D-A21X-10_wgs_Illumina.filtered.,WGS,TCGA-CC-5262-10B-01D-A21X-10_wgs_Illumina,TCGA-CC-5262-10B-01D-A21X-10_wgs_Illumina.bam,12.67,1.95,0.07,58cfa831e4b0c9d6adf6c3a4,TCGA-CC-5262-10B-01D-A21X-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-CC-5262-10B,1B428ADA-EB3F-40C2-B4BF-1BBF6B61729D,Blood Derived Normal,Illumina HiSeq,c6fa734f-1823-4aa4-88d1-070d427a01a3,Liver,67,40A3AA34-562F-443E-9E4F-37F83EF3436E,AEE5EB7C-536E-47C3-8F02-F362BFC72609,TCGA-CC-5262-10B-01D-A21X-10,GRCh37-lite,TCGA-CC-5262,TCGA-LIHC,NA,s16773,Baylor College of Medicine,ILSbio,None,NO,T4,N0,Hepatocellular Carcinoma,Stage IIIC
13722.58cfa82ee4b0c9d6adf6ad87,58cfa82ee4b0c9d6adf6ad87,G8893.TCGA-66-2766-11A-01D-1180-08.1.filtered.,WGS,G8893.TCGA-66-2766-11A-01D-1180-08.1,G8893.TCGA-66-2766-11A-01D-1180-08.1.bam,212.6,1.9,0.15,58cfa82ee4b0c9d6adf6ad87,G8893.TCGA-66-2766-11A-01D-1180-08.1.bam,Alive,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-66-2766-11A,B913D254-8307-4B8A-8313-D978E32BB38F,Solid Tissue Normal,Illumina HiSeq,6534830b-4f14-47e3-a25a-3f4b99446eee,Lung,54,9FCD7C3D-B3B4-4DDD-8298-411B7A27833A,1D6DFC28-8A39-4976-868E-C78F96551048,TCGA-66-2766-11A-01D-1180-08,HG19_Broad_variant,TCGA-66-2766,TCGA-LUSC,NA,s9985,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N2,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82ee4b0c9d6adf6a9be,58cfa82ee4b0c9d6adf6a9be,G2186.TCGA-24-0982-01A-01D.5.filtered.,WGS,G2186.TCGA-24-0982-01A-01D.5,G2186.TCGA-24-0982-01A-01D.5.bam,418.87,1.9,0.16,58cfa82ee4b0c9d6adf6a9be,G2186.TCGA-24-0982-01A-01D.5.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-0982-01A,206CE0ED-36A4-47AB-AC8E-F6FCA6AC5C18,Primary Tumor,Illumina GA,742e3313-2df4-4757-af69-eb1b20503155,Ovary,77,7FEC33CD-6F46-44C7-8204-E0F42B543ABE,1BE8FA2C-8FEA-4E8C-90DB-C04D9FCDBF49,TCGA-24-0982-01A-01D-0516-08,HG19_Broad_variant,TCGA-24-0982,TCGA-OV,679,s17706,Broad Institute of MIT and Harvard,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c436,58cfa831e4b0c9d6adf6c436,TCGA-CJ-4870-11A-01D-2098-10_wgs_Illumina.filtered.,WGS,TCGA-CJ-4870-11A-01D-2098-10_wgs_Illumina,TCGA-CJ-4870-11A-01D-2098-10_wgs_Illumina.bam,79.07,1.9,0.15,58cfa831e4b0c9d6adf6c436,TCGA-CJ-4870-11A-01D-2098-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CJ-4870-11A,78048432-2DE1-498C-9CF1-9C5BD43DAA39,Solid Tissue Normal,Illumina HiSeq,e9961b9b-48ad-43c1-9e27-a9438ed497f3,Kidney,58,14B6F5F6-87E6-4DA5-BBC9-13E97299EAB8,745368F9-27B8-4E11-ADA9-7DDF99ACD180,TCGA-CJ-4870-11A-01D-2098-10,GRCh37-lite,TCGA-CJ-4870,TCGA-KIRC,NA,s9167,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T3a,NX,Kidney Clear Cell Renal Carcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6a8a4,58cfa82ee4b0c9d6adf6a8a4,G35154.TCGA-CS-6669-01A-11D-1893-08.5.filtered.,WGS,G35154.TCGA-CS-6669-01A-11D-1893-08.5,G35154.TCGA-CS-6669-01A-11D-1893-08.5.bam,11.7,1.9,0.05,58cfa82ee4b0c9d6adf6a8a4,G35154.TCGA-CS-6669-01A-11D-1893-08.5.bam,Alive,FEMALE,WHITE,Not available,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-6669-01A,DC5BDD21-B23F-400E-BBE2-4C98A517FC9E,Primary Tumor,Illumina HiSeq,7069c071-1fef-4c6f-b741-c67ee56619bb,Brain,26,57FAE3BD-B822-4855-A4A1-AFDCC20F6071,218A9531-9264-43BC-8535-858D4CB0919E,TCGA-CS-6669-01A-11D-1893-08,HG19_Broad_variant,TCGA-CS-6669,TCGA-LGG,NA,s8523,Broad Institute of MIT and Harvard,Thomas Jefferson University,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6af86,58cfa82ee4b0c9d6adf6af86,G41960.TCGA-55-8299-01A-11D-2284-08.1.filtered.,WGS,G41960.TCGA-55-8299-01A-11D-2284-08.1,G41960.TCGA-55-8299-01A-11D-2284-08.1.bam,255.7,NA,0.05,58cfa82ee4b0c9d6adf6af86,G41960.TCGA-55-8299-01A-11D-2284-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-55-8299-01A,2CD8EA73-CB3F-4B17-9B97-FA12EB03B85B,Primary Tumor,Illumina HiSeq,0900edf4-dd21-4cc0-a6cb-6de863318729,Lung,61,5D0ED8D1-6E84-4F6C-8E0E-0317AA8B0E3F,15E097E3-E468-466C-8E57-B59FBA90BBF2,TCGA-55-8299-01A-11D-2284-08,HG19_Broad_variant,TCGA-55-8299,TCGA-LUAD,NA,s10765,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T1b,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6c960,58cfa831e4b0c9d6adf6c960,TCGA-DD-A1EL-10A-01D-A152-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A1EL-10A-01D-A152-10_wgs_Illumina,TCGA-DD-A1EL-10A-01D-A152-10_wgs_Illumina.bam,18.76,2.02,0.08,58cfa831e4b0c9d6adf6c960,TCGA-DD-A1EL-10A-01D-A152-10_wgs_Illumina.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A1EL-10A,2854FFE8-1F77-497A-BF49-11E0189FEE35,Blood Derived Normal,Illumina HiSeq,85213cae-e904-49b3-a724-a209aeff99d2,Liver,23,EDF1C491-2B4B-47B3-BCC4-1A4A8458E7D7,B43D641D-F1B1-474E-9475-A1F2E81835B8,TCGA-DD-A1EL-10A-01D-A152-10,GRCh37-lite,TCGA-DD-A1EL,TCGA-LIHC,415,s16853,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T2,N0,Hepatocellular Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6adca,58cfa82ee4b0c9d6adf6adca,G39020.TCGA-BR-A4J4-01A-12D-A25D-08.3.filtered.,WGS,G39020.TCGA-BR-A4J4-01A-12D-A25D-08.3,G39020.TCGA-BR-A4J4-01A-12D-A25D-08.3.bam,25.07,NA,0.08,58cfa82ee4b0c9d6adf6adca,G39020.TCGA-BR-A4J4-01A-12D-A25D-08.3.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-A4J4-01A,8A24F1A3-4BAB-4591-9676-7BEE01D096C1,Primary Tumor,Illumina HiSeq,2cdabae0-c924-481e-ad7e-bbe3f72f5c79,Stomach,39,5A5C4538-D75D-4DA5-8E8C-DD92766FEE50,2C316B7E-6A82-4BA1-9F34-D8BFCF82D41E,TCGA-BR-A4J4-01A-12D-A25D-08,HG19_Broad_variant,TCGA-BR-A4J4,TCGA-STAD,NA,s14459,Broad Institute of MIT and Harvard,Asterand,Vietnam,NO,T4a,N2,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIB
13722.58cfa831e4b0c9d6adf6ca6e,58cfa831e4b0c9d6adf6ca6e,TCGA-DD-A1E9-11A-11D-A152-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A1E9-11A-11D-A152-10_wgs_Illumina,TCGA-DD-A1E9-11A-11D-A152-10_wgs_Illumina.bam,36.54,1.8,0.09,58cfa831e4b0c9d6adf6ca6e,TCGA-DD-A1E9-11A-11D-A152-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A1E9-11A,8153A862-0790-4A33-80DB-ED47FEDCD4EF,Solid Tissue Normal,Illumina HiSeq,5c1d19a1-5035-41ff-b0fa-ada7e4a59dee,Liver,70,786C9B43-92D7-4D5E-8C86-E96F5759FD34,F37FE995-4AF3-489F-988E-CA04430E4E57,TCGA-DD-A1E9-11A-11D-A152-10,GRCh37-lite,TCGA-DD-A1E9,TCGA-LIHC,2759,s16775,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bbfc,58cfa830e4b0c9d6adf6bbfc,TCGA-AG-3593-10A-01D-1525-10_hg19_wgs_Illumina.filtered.,WGS,TCGA-AG-3593-10A-01D-1525-10_hg19_wgs_Illumina,TCGA-AG-3593-10A-01D-1525-10_hg19_wgs_Illumina.bam,23.15,1.8,0.05,58cfa830e4b0c9d6adf6bbfc,TCGA-AG-3593-10A-01D-1525-10_hg19_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3593-10A,10290E91-9784-4F94-8DAA-B5D9A8B0EFB9,Blood Derived Normal,Illumina HiSeq,97d50708-f0d6-4eb9-9915-c8d0d9018521,Colorectal,72,6AE385A6-F73C-4A62-A9A1-3207E9C4F802,C3AA670C-8595-46E9-9FB3-129CCAE433ED,TCGA-AG-3593-10A-01D-1525-10,GRCh37-lite,TCGA-AG-3593,TCGA-READ,NA,s1954,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6afd8,58cfa82ee4b0c9d6adf6afd8,G48125.TCGA-10-0938-01A-02D-A312-08.2.filtered.,WGS,G48125.TCGA-10-0938-01A-02D-A312-08.2,G48125.TCGA-10-0938-01A-02D-A312-08.2.bam,115.67,1.9,0.07,58cfa82ee4b0c9d6adf6afd8,G48125.TCGA-10-0938-01A-02D-A312-08.2.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-10-0938-01A,7CA97692-0BF5-4BBD-81CE-10A051D04BD5,Primary Tumor,Illumina HiSeq,6df8b7aa-5a5e-4a7c-bd82-de0c3fff4dda,Ovary,80,C11664E8-8883-4A0F-87C3-6FDC903860D5,8093649A-74D6-4832-9154-8CC0182FA381,TCGA-10-0938-01A-02D-A312-08,HG19_Broad_variant,TCGA-10-0938,TCGA-OV,636,s17481,Broad Institute of MIT and Harvard,MD Anderson Cancer Center,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6adb4,58cfa82ee4b0c9d6adf6adb4,G47088.TCGA-92-8064-01A-11D-2244-08.2.filtered.,WGS,G47088.TCGA-92-8064-01A-11D-2244-08.2,G47088.TCGA-92-8064-01A-11D-2244-08.2.bam,406.33,NA,0.05,58cfa82ee4b0c9d6adf6adb4,G47088.TCGA-92-8064-01A-11D-2244-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-92-8064-01A,DC6CEECE-EFAA-4B9D-9E12-D35863D7A902,Primary Tumor,Illumina HiSeq,8a33c586-703c-4354-9bde-caab929fcc59,Lung,58,014AD75E-86D2-423F-B9D3-84657D459A28,0E6654C9-CD5E-4F94-A6D4-54F2BB16DE1F,TCGA-92-8064-01A-11D-2244-08,HG19_Broad_variant,TCGA-92-8064,TCGA-LUSC,NA,s10077,Broad Institute of MIT and Harvard,Washington University - St. Louis,United States,NO,T2b,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82fe4b0c9d6adf6b8b6,58cfa82fe4b0c9d6adf6b8b6,TCGA-A6-6781-10A-01D-1924-10_wgs_Illumina.filtered.,WGS,TCGA-A6-6781-10A-01D-1924-10_wgs_Illumina,TCGA-A6-6781-10A-01D-1924-10_wgs_Illumina.bam,319.3,1.9,0.05,58cfa82fe4b0c9d6adf6b8b6,TCGA-A6-6781-10A-01D-1924-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-6781-10A,B54865B6-824E-4163-B759-21A6EACC98CE,Blood Derived Normal,Illumina HiSeq,a27b491f-dfce-4f7b-a18c-8ada5309959c,Colorectal,43,A1FCB039-9FD7-4582-B99A-E4D302CBC6F6,95872778-01C0-48C8-8986-605CB8BC5B40,TCGA-A6-6781-10A-01D-1924-10,GRCh37-lite,TCGA-A6-6781,TCGA-COAD,NA,s12858,Baylor College of Medicine,Christiana Healthcare,United States,NO,T4b,N1b,Colon Mucinous Adenocarcinoma,Stage IIIC
13722.58cfa82ee4b0c9d6adf6a8d6,58cfa82ee4b0c9d6adf6a8d6,G23072.TCGA_BB_4225_01A_01D_2268_08.1.filtered.,WGS,G23072.TCGA_BB_4225_01A_01D_2268_08.1,G23072.TCGA_BB_4225_01A_01D_2268_08.1.bam,56.7,1.9,0.15,58cfa82ee4b0c9d6adf6a8d6,G23072.TCGA_BB_4225_01A_01D_2268_08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BB-4225-01A,C1F50A22-38DF-41CC-A1F4-F7985504A7AC,Primary Tumor,Illumina HiSeq,e43130ec-f2f3-4984-8ba9-8f0e641acce9,Head and Neck,73,AC42070B-F4D6-47BE-96AA-A713D66A0072,81598359-24D5-4A8B-A6E6-7A6F94289119,TCGA-BB-4225-01A-01D-2268-08,HG19_Broad_variant,TCGA-BB-4225,TCGA-HNSC,NA,s16163,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6ba72,58cfa830e4b0c9d6adf6ba72,TCGA-AA-3514-10A-01D-1953-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3514-10A-01D-1953-10_wgs_Illumina,TCGA-AA-3514-10A-01D-1953-10_wgs_Illumina.bam,20,1.9,0.14,58cfa830e4b0c9d6adf6ba72,TCGA-AA-3514-10A-01D-1953-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3514-10A,DDF69ED9-4C53-48B8-9F01-495BD60C3425,Blood Derived Normal,Illumina HiSeq,878b531a-852c-4466-8dcd-2f1ec7299ef6,Colorectal,81,8ED957C3-4D09-4D1C-AD6D-D7E7B7FCC517,49F65CE5-0AF1-43B9-A942-64607A230D7B,TCGA-AA-3514-10A-01D-1953-10,GRCh37-lite,TCGA-AA-3514,TCGA-COAD,NA,s13664,Baylor College of Medicine,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ac62,58cfa82ee4b0c9d6adf6ac62,G39019.TCGA-DA-A1I8-06A-11D-A197-08.3.filtered.,WGS,G39019.TCGA-DA-A1I8-06A-11D-A197-08.3,G39019.TCGA-DA-A1I8-06A-11D-A197-08.3.bam,29.72,NA,0.08,58cfa82ee4b0c9d6adf6ac62,G39019.TCGA-DA-A1I8-06A-11D-A197-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1I8-06A,7B92FCD4-F9BE-4B97-94A2-B2E8348AEABA,Metastatic,Illumina HiSeq,5c90604b-8e38-45e3-99f2-7153d275217b,Skin,63,53F3FC7C-3B45-4516-9749-776E039318AA,64DD81E1-35FA-4579-8A4C-F7486ADBB949,TCGA-DA-A1I8-06A-11D-A197-08,HG19_Broad_variant,TCGA-DA-A1I8,TCGA-SKCM,NA,s7818,Broad Institute of MIT and Harvard,Yale,United States,NO,T4b,N0,Not available,Stage IIC
13722.58cfa82ee4b0c9d6adf6ab1d,58cfa82ee4b0c9d6adf6ab1d,G35154.TCGA-TQ-A8XE-02A-11D-A36O-08.4.filtered.,WGS,G35154.TCGA-TQ-A8XE-02A-11D-A36O-08.4,G35154.TCGA-TQ-A8XE-02A-11D-A36O-08.4.bam,35.06,NA,0.08,58cfa82ee4b0c9d6adf6ab1d,G35154.TCGA-TQ-A8XE-02A-11D-A36O-08.4.bam,Dead,FEMALE,WHITE,HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-TQ-A8XE-02A,135A149A-D153-465E-AA58-06D47BB18E00,Recurrent Tumor,Illumina HiSeq,8a20d221-bfb2-4832-afd6-dcab1e100a82,Brain,42,4B1C1AE5-7723-4A3A-A551-72E1ED5836AA,A82AA836-CACE-4FE9-B49E-09B19A245B03,TCGA-TQ-A8XE-02A-11D-A36O-08,HG19_Broad_variant,TCGA-TQ-A8XE,TCGA-LGG,954,s8746,Broad Institute of MIT and Harvard,University of Sao Paulo,Brazil,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6aa56,58cfa82ee4b0c9d6adf6aa56,G2145.TCGA-06-0152-10A-01D.13.filtered.,WGS,G2145.TCGA-06-0152-10A-01D.13,G2145.TCGA-06-0152-10A-01D.13.bam,32.87,1.9,0.18,58cfa82ee4b0c9d6adf6aa56,G2145.TCGA-06-0152-10A-01D.13.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0152-10A,F5BC5D97-E054-4E53-992D-71B896BD97D5,Blood Derived Normal,Illumina GA,779d993e-79ff-4d76-8f90-ea4f76aa1be3,Brain,68,0861E08B-9AA1-41B6-8EB7-30FCEC264249,A7DB8F47-1BCD-4041-9219-862D92B8A58E,TCGA-06-0152-10A-01D-0507-08,HG19_Broad_variant,TCGA-06-0152,TCGA-GBM,375,s14167,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa832e4b0c9d6adf6d2ba,58cfa832e4b0c9d6adf6d2ba,TCGA-KL-8333-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8333-11A-01D-2310-10_wgs_Illumina,TCGA-KL-8333-11A-01D-2310-10_wgs_Illumina.bam,115.3,NA,0.05,58cfa832e4b0c9d6adf6d2ba,TCGA-KL-8333-11A-01D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8333-11A,02EC7A3A-2812-4A65-93CD-07BF655CC91B,Solid Tissue Normal,Illumina HiSeq,fb409ada-99b5-4fcd-84cb-ab8b46e02999,Kidney,69,DC041EC8-D19C-4066-AA97-719683AA5F83,422375BA-7C98-42A5-B8CC-F88084A938F6,TCGA-KL-8333-11A-01D-2310-10,GRCh37-lite,TCGA-KL-8333,TCGA-KICH,NA,s16569,Baylor College of Medicine,MSKCC,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa830e4b0c9d6adf6bb8a,58cfa830e4b0c9d6adf6bb8a,TCGA-AA-A00R-10A-01D-A126-10_hg19_wgs_Illumina.filtered.,WGS,TCGA-AA-A00R-10A-01D-A126-10_hg19_wgs_Illumina,TCGA-AA-A00R-10A-01D-A126-10_hg19_wgs_Illumina.bam,44.4,1.73,0.08,58cfa830e4b0c9d6adf6bb8a,TCGA-AA-A00R-10A-01D-A126-10_hg19_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A00R-10A,CA22EDD4-EB7C-4677-84AA-6F0354459A19,Blood Derived Normal,Illumina HiSeq,42955a5e-a807-4ee3-82db-e48b37ae1db5,Colorectal,64,610F87EF-BAC9-4B0F-BE44-A61B3FBBCBEF,5E84FC1E-F5D1-4CFA-B23B-8E826F8A9EF5,TCGA-AA-A00R-10A-01D-A126-10,GRCh37-lite,TCGA-AA-A00R,TCGA-COAD,NA,s12868,Baylor College of Medicine,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa832e4b0c9d6adf6ce48,58cfa832e4b0c9d6adf6ce48,TCGA-G3-A25T-10A-01D-A16V-10_wgs_Illumina.filtered.,WGS,TCGA-G3-A25T-10A-01D-A16V-10_wgs_Illumina,TCGA-G3-A25T-10A-01D-A16V-10_wgs_Illumina.bam,105.79,1.89,0.09,58cfa832e4b0c9d6adf6ce48,TCGA-G3-A25T-10A-01D-A16V-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-G3-A25T-10A,F6E5979D-D6A9-4408-BD1B-1B37D1064E83,Blood Derived Normal,Illumina HiSeq,5e7f1da0-0f2c-4b98-9926-ca4241c8025e,Liver,45,21CE6A9C-3E26-4A6F-B7D6-C63796C1A761,AD831284-A522-4712-B7B4-134B92BE8125,TCGA-G3-A25T-10A-01D-A16V-10,GRCh37-lite,TCGA-G3-A25T,TCGA-LIHC,NA,s16863,Baylor College of Medicine,Alberta Health Services,Canada,NO,T3,N0,Hepatocellular Carcinoma,Stage IIIA
13722.58cfa831e4b0c9d6adf6cdbc,58cfa831e4b0c9d6adf6cdbc,TCGA-FF-8062-10A-01D-2210-10_wgs_Illumina.filtered.,WGS,TCGA-FF-8062-10A-01D-2210-10_wgs_Illumina,TCGA-FF-8062-10A-01D-2210-10_wgs_Illumina.bam,223,NA,0.05,58cfa831e4b0c9d6adf6cdbc,TCGA-FF-8062-10A-01D-2210-10_wgs_Illumina.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Aligned reads,TCGA-FF-8062-10A,0E9FCCCC-0630-408D-A121-2C6413824CB7,Blood Derived Normal,Illumina HiSeq,7bcd5576-94f6-428d-b0c6-30226e96c547,Lymph Nodes,60,303B29CB-6CE3-4FD8-891C-6AA8D8B5F1A2,1EDEE53E-5B0F-44C1-93E4-AD0778E1E147,TCGA-FF-8062-10A-01D-2210-10,GRCh37-lite,TCGA-FF-8062,TCGA-DLBC,NA,s1111,Baylor College of Medicine,SingHealth,Singapore,NO,Not available,Not available,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),Not available
13722.58cfa82ee4b0c9d6adf6af06,58cfa82ee4b0c9d6adf6af06,G39020.TCGA-HU-A4G6-01A-11D-A24D-08.3.filtered.,WGS,G39020.TCGA-HU-A4G6-01A-11D-A24D-08.3,G39020.TCGA-HU-A4G6-01A-11D-A24D-08.3.bam,18.13,NA,0.08,58cfa82ee4b0c9d6adf6af06,G39020.TCGA-HU-A4G6-01A-11D-A24D-08.3.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-HU-A4G6-01A,30A82E9F-2A2D-4A66-BDB1-26B881C21D01,Primary Tumor,Illumina HiSeq,01564622-cd3b-4f99-885f-ac2d8ca424c3,Stomach,74,41D015E0-E20E-45B7-98F1-3A010F78A8B4,C79CE3D3-4758-4F52-9DA1-38F994C99F4E,TCGA-HU-A4G6-01A-11D-A24D-08,HG19_Broad_variant,TCGA-HU-A4G6,TCGA-STAD,NA,s14393,Broad Institute of MIT and Harvard,National Cancer Center Korea,Korea South,NO,T1b,N0,Stomach Intestinal Adenocarcinoma Papillary Type,Stage IA
13722.58cfa831e4b0c9d6adf6c43e,58cfa831e4b0c9d6adf6c43e,TCGA-CC-5260-10B-01D-A12Z-10_wgs_Illumina.filtered.,WGS,TCGA-CC-5260-10B-01D-A12Z-10_wgs_Illumina,TCGA-CC-5260-10B-01D-A12Z-10_wgs_Illumina.bam,64.79,1.95,0.07,58cfa831e4b0c9d6adf6c43e,TCGA-CC-5260-10B-01D-A12Z-10_wgs_Illumina.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-CC-5260-10B,CA8AFB2C-BE3D-41E8-8DBC-19FE7AB6154B,Blood Derived Normal,Illumina HiSeq,b6fb9887-45fe-43c2-a3ca-183d6ee57eb1,Liver,61,1CE4828E-5EEE-4793-80F8-097671D0DB7B,BF471C04-91B1-4CCC-9CD2-101B7F008EDC,TCGA-CC-5260-10B-01D-A12Z-10,GRCh37-lite,TCGA-CC-5260,TCGA-LIHC,NA,s16849,Baylor College of Medicine,ILSbio,None,NO,T4,N0,Hepatocellular Carcinoma,Stage IIIC
13722.58cfa82ee4b0c9d6adf6ac40,58cfa82ee4b0c9d6adf6ac40,G39020.TCGA-BR-4255-01A-01D-A290-08.4.filtered.,WGS,G39020.TCGA-BR-4255-01A-01D-A290-08.4,G39020.TCGA-BR-4255-01A-01D-A290-08.4.bam,0,1.9,0.07,58cfa82ee4b0c9d6adf6ac40,G39020.TCGA-BR-4255-01A-01D-A290-08.4.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-4255-01A,956017BA-5E4B-42C7-B93D-42316874BA93,Primary Tumor,Illumina HiSeq,5085f26e-d490-4a13-a172-4cac0f68a682,Stomach,76,A64A7CB8-BA30-45A3-B1DC-2A62D6B1919F,0CD60B96-EB2D-4687-9709-D1455EC45DE7,TCGA-BR-4255-01A-01D-A290-08,HG19_Broad_variant,TCGA-BR-4255,TCGA-STAD,NA,s15172,Broad Institute of MIT and Harvard,Asterand,Russia,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa832e4b0c9d6adf6ce73,58cfa832e4b0c9d6adf6ce73,TCGA-FV-A3I0-11A-11D-A22F-10_wgs_Illumina.filtered.,WGS,TCGA-FV-A3I0-11A-11D-A22F-10_wgs_Illumina,TCGA-FV-A3I0-11A-11D-A22F-10_wgs_Illumina.bam,23.52,NA,0.08,58cfa832e4b0c9d6adf6ce73,TCGA-FV-A3I0-11A-11D-A22F-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-FV-A3I0-11A,A8C2AA08-9156-4845-AD77-5E060858C757,Solid Tissue Normal,Illumina HiSeq,ab740f6f-aa21-4323-b5ef-e49cd057c11d,Liver,76,52BCA35C-ECF3-4E3C-8E98-596622B4ADFD,741183D6-2363-4CBF-B5F9-4548E1CAB32B,TCGA-FV-A3I0-11A-11D-A22F-10,GRCh37-lite,TCGA-FV-A3I0,TCGA-LIHC,NA,s16785,Baylor College of Medicine,International Genomics Consortium,United States,NO,T2,NX,Hepatocholangiocarcinoma (Mixed),Stage II
13722.58cfa82ee4b0c9d6adf6ac16,58cfa82ee4b0c9d6adf6ac16,G39019.TCGA-GN-A264-06A-11D-A196-08.1.filtered.,WGS,G39019.TCGA-GN-A264-06A-11D-A196-08.1,G39019.TCGA-GN-A264-06A-11D-A196-08.1.bam,47.7,NA,0.09,58cfa82ee4b0c9d6adf6ac16,G39019.TCGA-GN-A264-06A-11D-A196-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-GN-A264-06A,76CC1D42-ACEC-46B3-9663-5E4DE2550353,Metastatic,Illumina HiSeq,c2a3d9c8-b29b-4246-be90-70b59cdcc922,Skin,60,E6B93BA0-FC9C-40C0-B82F-F7E71319EE0A,450E8EBA-A3A9-4DCB-B423-E33DFCD5C34E,TCGA-GN-A264-06A-11D-A196-08,HG19_Broad_variant,TCGA-GN-A264,TCGA-SKCM,3587,s7663,Broad Institute of MIT and Harvard,Roswell,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa832e4b0c9d6adf6ce28,58cfa832e4b0c9d6adf6ce28,TCGA-G3-A25S-10A-01D-A16V-10_wgs_Illumina.filtered.,WGS,TCGA-G3-A25S-10A-01D-A16V-10_wgs_Illumina,TCGA-G3-A25S-10A-01D-A16V-10_wgs_Illumina.bam,208.42,2.05,0.08,58cfa832e4b0c9d6adf6ce28,TCGA-G3-A25S-10A-01D-A16V-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-G3-A25S-10A,B865DEC4-F051-4FBE-9405-F832FF2010D7,Blood Derived Normal,Illumina HiSeq,98d4ee80-9d90-450a-9fa3-e267110f6d11,Liver,64,4477A197-1C3C-44A0-ACD5-473395D3F3D0,084D16C3-F0E8-4CC5-B2A9-CB055FD6EBE5,TCGA-G3-A25S-10A-01D-A16V-10,GRCh37-lite,TCGA-G3-A25S,TCGA-LIHC,NA,s16595,Baylor College of Medicine,Alberta Health Services,Canada,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d2ca,58cfa832e4b0c9d6adf6d2ca,TCGA-KL-8332-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8332-11A-01D-2310-10_wgs_Illumina,TCGA-KL-8332-11A-01D-2310-10_wgs_Illumina.bam,220.3,NA,0.05,58cfa832e4b0c9d6adf6d2ca,TCGA-KL-8332-11A-01D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8332-11A,3EC3BCB3-492C-4942-BE02-76A67F57E38F,Solid Tissue Normal,Illumina HiSeq,b9597b47-d425-461c-8123-ce46cef3fe8d,Kidney,55,60BBC00F-DF46-4DDF-9D01-4F66F5B2B26A,1F3AF48C-BA6B-4DB5-BA11-75B7F50FAE1E,TCGA-KL-8332-11A-01D-2310-10,GRCh37-lite,TCGA-KL-8332,TCGA-KICH,NA,s16433,Baylor College of Medicine,MSKCC,United States,NO,T1b,N0,Kidney Chromophobe,Stage I
13722.58cfa830e4b0c9d6adf6c07e,58cfa830e4b0c9d6adf6c07e,TCGA-B1-A47M-01A-11D-A25F-10_wgs_Illumina.filtered.,WGS,TCGA-B1-A47M-01A-11D-A25F-10_wgs_Illumina,TCGA-B1-A47M-01A-11D-A25F-10_wgs_Illumina.bam,27.53,NA,0.08,58cfa830e4b0c9d6adf6c07e,TCGA-B1-A47M-01A-11D-A25F-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B1-A47M-01A,072507CF-1249-4B28-86D4-3AB97822A74C,Primary Tumor,Illumina HiSeq,aa347261-ddce-4395-b3f2-84e8210d4d8a,Kidney,79,75658EDD-12F1-4BB3-BEA2-01C154CB6AE9,8FB7FCAC-6C1D-40C2-9309-B53821CBEF30,TCGA-B1-A47M-01A-11D-A25F-10,GRCh37-lite,TCGA-B1-A47M,TCGA-KIRP,NA,s11581,Baylor College of Medicine,University of Pittsburgh,United States,NO,T3a,NX,Kidney Papillary Renal Cell Carcinoma,Stage III
13722.58cfa832e4b0c9d6adf6ced4,58cfa832e4b0c9d6adf6ced4,TCGA-FV-A495-10A-01D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-FV-A495-10A-01D-A25V-10_wgs_Illumina,TCGA-FV-A495-10A-01D-A25V-10_wgs_Illumina.bam,69.44,NA,0.08,58cfa832e4b0c9d6adf6ced4,TCGA-FV-A495-10A-01D-A25V-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-FV-A495-10A,BD48FA5E-0152-46F0-A4FA-8CF723FF2DCD,Blood Derived Normal,Illumina HiSeq,5fcb27fa-0faa-4474-9df8-33b05001f145,Liver,51,A6F9CD7E-5906-47C7-A344-7CCD199F28C9,88A0F90D-E075-45DA-B4BF-8DFC9FD6B6A8,TCGA-FV-A495-10A-01D-A25V-10,GRCh37-lite,TCGA-FV-A495,TCGA-LIHC,NA,s16987,Baylor College of Medicine,International Genomics Consortium,United States,NO,T2,NX,Hepatocellular Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6acae,58cfa82ee4b0c9d6adf6acae,G37568.TCGA-DK-A1AA-01A-11D-A13W-08.3.filtered.,WGS,G37568.TCGA-DK-A1AA-01A-11D-A13W-08.3,G37568.TCGA-DK-A1AA-01A-11D-A13W-08.3.bam,72.54,1.95,0.08,58cfa82ee4b0c9d6adf6acae,G37568.TCGA-DK-A1AA-01A-11D-A13W-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Aligned reads,TCGA-DK-A1AA-01A,56D8A1B8-1268-4362-A7F1-77B76FBF1B59,Primary Tumor,Illumina HiSeq,0ff07006-7458-42f5-b1fd-d84db4c2f25d,Bladder,57,577700D1-C366-41EF-8A0D-E50DEEFB5E3C,804FFA2E-158B-447D-945C-707684134C87,TCGA-DK-A1AA-01A-11D-A13W-08,HG19_Broad_variant,TCGA-DK-A1AA,TCGA-BLCA,NA,s3079,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III
13722.58cfa831e4b0c9d6adf6cb2e,58cfa831e4b0c9d6adf6cb2e,TCGA-ED-A459-10A-01D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-ED-A459-10A-01D-A25V-10_wgs_Illumina,TCGA-ED-A459-10A-01D-A25V-10_wgs_Illumina.bam,50.92,NA,0.08,58cfa831e4b0c9d6adf6cb2e,TCGA-ED-A459-10A-01D-A25V-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-ED-A459-10A,56403463-1727-4C23-A709-DE5F168C4073,Blood Derived Normal,Illumina HiSeq,dab487ab-05da-4fae-9a5a-4db134619e68,Liver,47,18D38F43-E55F-4DA7-919A-DF1D329E457E,BA12FEC9-E575-4FFF-9119-8989B3CF1D18,TCGA-ED-A459-10A-01D-A25V-10,GRCh37-lite,TCGA-ED-A459,TCGA-LIHC,NA,s16981,Baylor College of Medicine,Asterand,Vietnam,NO,T2,N0,Hepatocellular Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6ae5d,58cfa82ee4b0c9d6adf6ae5d,G49837.TCGA-37-4135-01A-01D-A320-08.2.filtered.,WGS,G49837.TCGA-37-4135-01A-01D-A320-08.2,G49837.TCGA-37-4135-01A-01D-A320-08.2.bam,968.93,1.9,0.07,58cfa82ee4b0c9d6adf6ae5d,G49837.TCGA-37-4135-01A-01D-A320-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-37-4135-01A,1F6B2ACA-7357-40D1-BA7A-99227D9900A2,Primary Tumor,Illumina HiSeq,00a52da3-1aca-4f65-b9ab-15fe28578557,Lung,68,5294476F-A200-453E-9D11-9C50F3C3FA5D,C48D7F4A-E98A-4077-A749-EB9F56F05B84,TCGA-37-4135-01A-01D-A320-08,HG19_Broad_variant,TCGA-37-4135,TCGA-LUSC,NA,s10504,Broad Institute of MIT and Harvard,Cureline,Russia,NO,T2a,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6ad16,58cfa82ee4b0c9d6adf6ad16,G39019.TCGA-D3-A3MO-06A-11D-A21A-08.2.filtered.,WGS,G39019.TCGA-D3-A3MO-06A-11D-A21A-08.2,G39019.TCGA-D3-A3MO-06A-11D-A21A-08.2.bam,37.51,NA,0.08,58cfa82ee4b0c9d6adf6ad16,G39019.TCGA-D3-A3MO-06A-11D-A21A-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D3-A3MO-06A,85400BF1-23E0-4E0F-8DF7-F0D108641AEE,Metastatic,Illumina HiSeq,19fedecf-c071-4e64-99b6-78f3aa9f182a,Skin,47,AEEB9878-C590-45A6-9D8E-38C1FEA54EFA,AFFA4EF4-02EC-40F1-B6A2-739F8BF2AFA9,TCGA-D3-A3MO-06A-11D-A21A-08,HG19_Broad_variant,TCGA-D3-A3MO,TCGA-SKCM,284,s7483,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,TX,N2c,Not available,Stage III
13722.58cfa82de4b0c9d6adf6a75c,58cfa82de4b0c9d6adf6a75c,G14083.TCGA-21-1082-01A-01D-1521-08.3.filtered.,WGS,G14083.TCGA-21-1082-01A-01D-1521-08.3,G14083.TCGA-21-1082-01A-01D-1521-08.3.bam,233.7,1.9,0.05,58cfa82de4b0c9d6adf6a75c,G14083.TCGA-21-1082-01A-01D-1521-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-21-1082-01A,0E2EE54A-51C9-4868-842D-A2A1C1CFB016,Primary Tumor,Illumina HiSeq,94c61492-d5ca-462e-84cf-6d6d690fe431,Lung,61,F091C76E-5D01-4F4B-8F6F-463C9F302930,1C3DF485-8E75-4378-87F6-C6463A520624,TCGA-21-1082-01A-01D-1521-08,HG19_Broad_variant,TCGA-21-1082,TCGA-LUSC,NA,s10247,Broad Institute of MIT and Harvard,Fox Chase Cancer Center,United States,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82fe4b0c9d6adf6b8fa,58cfa82fe4b0c9d6adf6b8fa,TCGA-AA-3518-01A-02D-1525-10_hg19_wgs_Illumina.filtered.,WGS,TCGA-AA-3518-01A-02D-1525-10_hg19_wgs_Illumina,TCGA-AA-3518-01A-02D-1525-10_hg19_wgs_Illumina.bam,3.86,1.9,0.05,58cfa82fe4b0c9d6adf6b8fa,TCGA-AA-3518-01A-02D-1525-10_hg19_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3518-01A,C5C4A0A5-900D-483D-9282-475654D63265,Primary Tumor,Illumina HiSeq,e3929c47-b19b-4c57-9990-6448eb979647,Colorectal,81,BC08B757-ED0A-44C0-88CD-85496BB72A75,F4B9D98F-7B76-4EAA-9595-10B0973D5FF7,TCGA-AA-3518-01A-02D-1525-10,GRCh37-lite,TCGA-AA-3518,TCGA-COAD,NA,s13663,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6abf6,58cfa82ee4b0c9d6adf6abf6,G35154.TCGA-FG-8182-01A-11D-2253-08.3.filtered.,WGS,G35154.TCGA-FG-8182-01A-11D-2253-08.3,G35154.TCGA-FG-8182-01A-11D-2253-08.3.bam,58.6,NA,0.05,58cfa82ee4b0c9d6adf6abf6,G35154.TCGA-FG-8182-01A-11D-2253-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-8182-01A,6A0BCF0C-FA4C-4119-99D2-F722B781D20F,Primary Tumor,Illumina HiSeq,de01f2de-931f-4b79-9abc-966eaee7ca0a,Brain,35,0CF6BE14-2F25-4361-ADE5-7E5B6CA1063E,2AEAAB9F-4459-4BE8-91E7-E0746CBD671C,TCGA-FG-8182-01A-11D-2253-08,HG19_Broad_variant,TCGA-FG-8182,TCGA-LGG,NA,s8112,Broad Institute of MIT and Harvard,Case Western,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6a99c,58cfa82ee4b0c9d6adf6a99c,G35154.TCGA-IK-7675-01A-11D-2086-08.6.filtered.,WGS,G35154.TCGA-IK-7675-01A-11D-2086-08.6,G35154.TCGA-IK-7675-01A-11D-2086-08.6.bam,224,NA,0.05,58cfa82ee4b0c9d6adf6a99c,G35154.TCGA-IK-7675-01A-11D-2086-08.6.bam,Dead,MALE,WHITE,HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-IK-7675-01A,A5F851C5-6130-4EA1-9F86-BE59331A92F7,Primary Tumor,Illumina HiSeq,19191a31-9d4e-43a8-a88e-aff919fd0f95,Brain,43,661F567E-3E63-4692-8EF8-B80A83E6C8DE,A78544D7-65C6-4778-AF62-CEEC24C14056,TCGA-IK-7675-01A-11D-2086-08,HG19_Broad_variant,TCGA-IK-7675,TCGA-LGG,578,s8552,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa830e4b0c9d6adf6c1d2,58cfa830e4b0c9d6adf6c1d2,TCGA-BC-A217-10A-01D-A152-10_wgs_Illumina.filtered.,WGS,TCGA-BC-A217-10A-01D-A152-10_wgs_Illumina,TCGA-BC-A217-10A-01D-A152-10_wgs_Illumina.bam,24.49,2.17,0.08,58cfa830e4b0c9d6adf6c1d2,TCGA-BC-A217-10A-01D-A152-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-BC-A217-10A,6DCFC418-AB28-4365-95EA-C1AE254F2341,Blood Derived Normal,Illumina HiSeq,dc5fdc95-f7e4-4441-9b56-ec43b66412f3,Liver,75,DFFD87C4-9A13-428E-9078-7781E1C92895,B12F2A60-B900-4C83-9B9E-D1F6BBD469F9,TCGA-BC-A217-10A-01D-A152-10,GRCh37-lite,TCGA-BC-A217,TCGA-LIHC,NA,s16671,Baylor College of Medicine,UNC,United States,NO,T2,NX,Hepatocellular Carcinoma,Stage II
13722.58cfa830e4b0c9d6adf6bb7b,58cfa830e4b0c9d6adf6bb7b,TCGA-A3-3363-11A-01D-2094-10_wgs_Illumina.filtered.,WGS,TCGA-A3-3363-11A-01D-2094-10_wgs_Illumina,TCGA-A3-3363-11A-01D-2094-10_wgs_Illumina.bam,199.57,1.9,0.14,58cfa830e4b0c9d6adf6bb7b,TCGA-A3-3363-11A-01D-2094-10_wgs_Illumina.bam,Alive,MALE,ASIAN,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-A3-3363-11A,659294B9-DED9-498A-BC00-C1D4D456AA4A,Solid Tissue Normal,Illumina HiSeq,87eed682-cf5d-4795-886d-a2a65871ddf5,Kidney,50,8BC4AAC8-1E5A-41FE-8142-95CD1768D629,0E62DD52-07DE-44D9-8992-85F636691B3E,TCGA-A3-3363-11A-01D-2094-10,GRCh37-lite,TCGA-A3-3363,TCGA-KIRC,NA,s8832,Baylor College of Medicine,International Genomics Consortium,None,NO,T2,N0,Kidney Clear Cell Renal Carcinoma,Stage II
13722.58cfa830e4b0c9d6adf6bcb9,58cfa830e4b0c9d6adf6bcb9,TCGA-AZ-6601-11A-01D-1771-10_wgs_Illumina.filtered.,WGS,TCGA-AZ-6601-11A-01D-1771-10_wgs_Illumina,TCGA-AZ-6601-11A-01D-1771-10_wgs_Illumina.bam,81.4,1.9,0.05,58cfa830e4b0c9d6adf6bcb9,TCGA-AZ-6601-11A-01D-1771-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-6601-11A,7AD0617E-BC4A-4869-8419-744F04D9B7A3,Solid Tissue Normal,Illumina HiSeq,4db18c79-d142-4670-82f6-5d52be5fb5c9,Colorectal,68,3D8A2EC0-3D65-46E1-8B87-FA7E318D249E,0A0F49D2-35BF-4150-AE2D-FC77E91C5143,TCGA-AZ-6601-11A-01D-1771-10,GRCh37-lite,TCGA-AZ-6601,TCGA-COAD,3042,s13687,Baylor College of Medicine,University of Pittsburgh,United States,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6ab66,58cfa82ee4b0c9d6adf6ab66,G25779.TCGA-49-4512-01A-21D-1855-08.4.filtered.,WGS,G25779.TCGA-49-4512-01A-21D-1855-08.4,G25779.TCGA-49-4512-01A-21D-1855-08.4.bam,180.7,1.9,0.05,58cfa82ee4b0c9d6adf6ab66,G25779.TCGA-49-4512-01A-21D-1855-08.4.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-4512-01A,A1E65587-24C1-4B41-92A7-4E1F15FFFD78,Primary Tumor,Illumina HiSeq,5f8b200d-759a-4368-b604-2b51822122d3,Lung,69,D809A778-D1AC-4406-AB09-67CC70F1F0C2,FA6A60F5-8949-4E01-9435-D3117601627F,TCGA-49-4512-01A-21D-1855-08,HG19_Broad_variant,TCGA-49-4512,TCGA-LUAD,905,s10893,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa832e4b0c9d6adf6cf77,58cfa832e4b0c9d6adf6cf77,TCGA-FV-A23B-11A-11D-A16V-10_wgs_Illumina.filtered.,WGS,TCGA-FV-A23B-11A-11D-A16V-10_wgs_Illumina,TCGA-FV-A23B-11A-11D-A16V-10_wgs_Illumina.bam,59.54,1.84,0.08,58cfa832e4b0c9d6adf6cf77,TCGA-FV-A23B-11A-11D-A16V-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-FV-A23B-11A,C95ED407-BCC2-44AA-BC59-BF7549F2D665,Solid Tissue Normal,Illumina HiSeq,21726edb-b580-4d98-92c8-f4311975c3c8,Liver,70,CF3E04FE-9FC4-4293-A7C0-B46510F590E9,6C3072B0-3EB6-4A43-8A18-74E5A5869D4C,TCGA-FV-A23B-11A-11D-A16V-10,GRCh37-lite,TCGA-FV-A23B,TCGA-LIHC,NA,s17062,Baylor College of Medicine,International Genomics Consortium,United States,NO,T2,N0,Hepatocellular Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6aba8,58cfa82ee4b0c9d6adf6aba8,G35154.TCGA-TQ-A7RK-01A-11D-A33T-08.3.filtered.,WGS,G35154.TCGA-TQ-A7RK-01A-11D-A33T-08.3,G35154.TCGA-TQ-A7RK-01A-11D-A33T-08.3.bam,15.56,NA,0.08,58cfa82ee4b0c9d6adf6aba8,G35154.TCGA-TQ-A7RK-01A-11D-A33T-08.3.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-TQ-A7RK-01A,2F8C789E-BBD8-4753-A48B-6894C21162F8,Primary Tumor,Illumina HiSeq,4b48a880-f86b-4e8b-9d21-65c14ba90284,Brain,29,5793003F-E131-4259-91CB-BE9B65B0E523,EE20C616-5CA0-4B81-81A0-FE1551E6F760,TCGA-TQ-A7RK-01A-11D-A33T-08,HG19_Broad_variant,TCGA-TQ-A7RK,TCGA-LGG,NA,s8745,Broad Institute of MIT and Harvard,University of Sao Paulo,Brazil,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa82ee4b0c9d6adf6ac4b,58cfa82ee4b0c9d6adf6ac4b,G39019.TCGA-EE-A185-06A-11D-A196-08.1.filtered.,WGS,G39019.TCGA-EE-A185-06A-11D-A196-08.1,G39019.TCGA-EE-A185-06A-11D-A196-08.1.bam,41.59,NA,0.08,58cfa82ee4b0c9d6adf6ac4b,G39019.TCGA-EE-A185-06A-11D-A196-08.1.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A185-06A,A01A350D-64BE-4AF3-91C3-7D681C3DB11D,Metastatic,Illumina HiSeq,7ecc3f01-9ffe-470a-9a7b-16ce2f95c98d,Skin,55,B46942E1-2879-4B83-93CD-A12186FE07C9,D056645F-4DD3-49F3-B0A4-2293E2B4D82C,TCGA-EE-A185-06A-11D-A196-08,HG19_Broad_variant,TCGA-EE-A185,TCGA-SKCM,151,s7664,Broad Institute of MIT and Harvard,University of Sydney,Australia,NO,T4b,N3,Not available,Stage IIIC
13722.58cfa82ee4b0c9d6adf6af08,58cfa82ee4b0c9d6adf6af08,G39020.TCGA-D7-A4YX-01A-11D-A25D-08.2.filtered.,WGS,G39020.TCGA-D7-A4YX-01A-11D-A25D-08.2,G39020.TCGA-D7-A4YX-01A-11D-A25D-08.2.bam,42.47,NA,0.08,58cfa82ee4b0c9d6adf6af08,G39020.TCGA-D7-A4YX-01A-11D-A25D-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-A4YX-01A,2B4F014F-74E9-4DDA-A1AD-ABCBD124FC44,Primary Tumor,Illumina HiSeq,004a24e0-0e6d-4811-aac1-344ce1d54320,Stomach,63,DCFF683D-629E-4E67-9E9F-CE5752A2B276,A4C838DF-6AC4-455A-8096-8EC680064374,TCGA-D7-A4YX-01A-11D-A25D-08,HG19_Broad_variant,TCGA-D7-A4YX,TCGA-STAD,NA,s14462,Broad Institute of MIT and Harvard,Greater Poland Cancer Center,Poland,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6adec,58cfa82ee4b0c9d6adf6adec,G49837.TCGA-66-2759-11A-01D-A320-08.2.filtered.,WGS,G49837.TCGA-66-2759-11A-01D-A320-08.2,G49837.TCGA-66-2759-11A-01D-A320-08.2.bam,146.9,1.9,0.08,58cfa82ee4b0c9d6adf6adec,G49837.TCGA-66-2759-11A-01D-A320-08.2.bam,Alive,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-66-2759-11A,E6B72C24-1607-43B9-8B8A-7BF83EEA5895,Solid Tissue Normal,Illumina HiSeq,6270f5a4-d05e-48ba-9751-fb2715752b67,Lung,66,A0A0E151-8E1C-41AC-A2DB-097172F6DB75,268DEC9A-F776-408E-9B63-FA86E8E87C33,TCGA-66-2759-11A-01D-A320-08,HG19_Broad_variant,TCGA-66-2759,TCGA-LUSC,NA,s10161,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N2,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82ee4b0c9d6adf6add4,58cfa82ee4b0c9d6adf6add4,G39020.TCGA-CG-5724-01A-11D-1600-08.3.filtered.,WGS,G39020.TCGA-CG-5724-01A-11D-1600-08.3,G39020.TCGA-CG-5724-01A-11D-1600-08.3.bam,362,1.9,0.05,58cfa82ee4b0c9d6adf6add4,G39020.TCGA-CG-5724-01A-11D-1600-08.3.bam,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,Aligned reads,TCGA-CG-5724-01A,0B4E8D73-459D-4930-9D1A-ABB8D53E1844,Primary Tumor,Illumina HiSeq,f2f2a0e8-364c-4603-8030-6f0f803fe21c,Stomach,59,4D624B21-5AEE-42B8-B192-8AFECB51434D,6DAC8CA0-F776-4EA2-85C4-AEFBA4966BE7,TCGA-CG-5724-01A-11D-1600-08,HG19_Broad_variant,TCGA-CG-5724,TCGA-STAD,366,s15174,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T3,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IV
13722.58cfa831e4b0c9d6adf6cd94,58cfa831e4b0c9d6adf6cd94,TCGA-EP-A26S-10A-01D-A16V-10_wgs_Illumina.filtered.,WGS,TCGA-EP-A26S-10A-01D-A16V-10_wgs_Illumina,TCGA-EP-A26S-10A-01D-A16V-10_wgs_Illumina.bam,123.99,NA,0.07,58cfa831e4b0c9d6adf6cd94,TCGA-EP-A26S-10A-01D-A16V-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-EP-A26S-10A,B7D6621C-8BCE-4A01-8588-9D7761D9372B,Blood Derived Normal,Illumina HiSeq,52cdfc8a-6b31-4b2f-b3a0-6a636562ff5a,Liver,70,4E405FCB-872E-4845-9D90-BC5837E301A1,B2075602-828F-4788-9C30-978A3CA744BD,TCGA-EP-A26S-10A-01D-A16V-10,GRCh37-lite,TCGA-EP-A26S,TCGA-LIHC,NA,s17060,Baylor College of Medicine,Christiana Healthcare,United States,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d2b0,58cfa832e4b0c9d6adf6d2b0,TCGA-KL-8331-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8331-11A-01D-2310-10_wgs_Illumina,TCGA-KL-8331-11A-01D-2310-10_wgs_Illumina.bam,358.3,NA,0.05,58cfa832e4b0c9d6adf6d2b0,TCGA-KL-8331-11A-01D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8331-11A,8AC7F218-BD7B-4DDA-8879-2CEC49748E42,Solid Tissue Normal,Illumina HiSeq,261432cc-0caa-4d25-9058-e57fdc77a6b4,Kidney,48,A1F2C760-BCD5-41DB-886D-2D9BFCBD0DB3,2CA67854-9FEF-4B3E-A4E0-0432DF5A5800,TCGA-KL-8331-11A-01D-2310-10,GRCh37-lite,TCGA-KL-8331,TCGA-KICH,NA,s16424,Baylor College of Medicine,MSKCC,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa832e4b0c9d6adf6cea4,58cfa832e4b0c9d6adf6cea4,TCGA-FV-A4ZQ-10A-01D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-FV-A4ZQ-10A-01D-A25V-10_wgs_Illumina,TCGA-FV-A4ZQ-10A-01D-A25V-10_wgs_Illumina.bam,88.04,NA,0.08,58cfa832e4b0c9d6adf6cea4,TCGA-FV-A4ZQ-10A-01D-A25V-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-FV-A4ZQ-10A,65E430E1-0C9A-4045-83A9-653B7CFF811D,Blood Derived Normal,Illumina HiSeq,9b3ce96b-b3d7-43ed-babc-eee3cabcec50,Liver,52,1E0D5F40-A9C4-44D6-9FF0-1F2A17AFE174,813EF938-CBE3-456A-BA15-01BCA99C2880,TCGA-FV-A4ZQ-10A-01D-A25V-10,GRCh37-lite,TCGA-FV-A4ZQ,TCGA-LIHC,NA,s16683,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c9fb,58cfa831e4b0c9d6adf6c9fb,TCGA-DD-A3A9-11A-11D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A3A9-11A-11D-A25V-10_wgs_Illumina,TCGA-DD-A3A9-11A-11D-A25V-10_wgs_Illumina.bam,36.3,NA,0.08,58cfa831e4b0c9d6adf6c9fb,TCGA-DD-A3A9-11A-11D-A25V-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A3A9-11A,457CCA7C-A8B4-414E-A3C0-7FCCF0EE2034,Solid Tissue Normal,Illumina HiSeq,de8a5902-d3a4-44f1-9f62-bdb08237698b,Liver,64,F0BC5984-F3DA-41FC-8D4E-162562423F01,790941E2-4315-4425-9EEB-9B3AE2377BCB,TCGA-DD-A3A9-11A-11D-A25V-10,GRCh37-lite,TCGA-DD-A3A9,TCGA-LIHC,931,s16780,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T4,N0,Hepatocellular Carcinoma,Stage IVB
13722.58cfa82ee4b0c9d6adf6abd0,58cfa82ee4b0c9d6adf6abd0,G35154.TCGA-TQ-A7RV-01A-21D-A34A-08.3.filtered.,WGS,G35154.TCGA-TQ-A7RV-01A-21D-A34A-08.3,G35154.TCGA-TQ-A7RV-01A-21D-A34A-08.3.bam,8.31,NA,0.08,58cfa82ee4b0c9d6adf6abd0,G35154.TCGA-TQ-A7RV-01A-21D-A34A-08.3.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-TQ-A7RV-01A,5A3EDEB6-133E-4116-9F80-2485BD70754D,Primary Tumor,Illumina HiSeq,90057127-5744-4f65-853a-66561166dcbc,Brain,27,06D89076-34D4-496D-A412-F8C3B46A3A4B,33B54500-B50B-4368-8406-71015C43B929,TCGA-TQ-A7RV-01A-21D-A34A-08,HG19_Broad_variant,TCGA-TQ-A7RV,TCGA-LGG,NA,s8124,Broad Institute of MIT and Harvard,University of Sao Paulo,Brazil,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6caea,58cfa831e4b0c9d6adf6caea,TCGA-DD-A1ED-10A-01D-A152-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A1ED-10A-01D-A152-10_wgs_Illumina,TCGA-DD-A1ED-10A-01D-A152-10_wgs_Illumina.bam,22.56,1.86,0.08,58cfa831e4b0c9d6adf6caea,TCGA-DD-A1ED-10A-01D-A152-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A1ED-10A,0FF6364A-E6F4-47CA-A7E7-14705BF0A8DF,Blood Derived Normal,Illumina HiSeq,80ff36bd-f432-4a8a-9d54-1ee37d61e9b7,Liver,68,115A96B3-2DE6-4D41-8FE9-78DE18C49EF4,09455F77-1BC1-4F4B-9B75-DD79FD3237C3,TCGA-DD-A1ED-10A-01D-A152-10,GRCh37-lite,TCGA-DD-A1ED,TCGA-LIHC,NA,s16974,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ac22,58cfa82ee4b0c9d6adf6ac22,G37566.TCGA-HC-7075-01A-11D-1961-08.2.filtered.,WGS,G37566.TCGA-HC-7075-01A-11D-1961-08.2,G37566.TCGA-HC-7075-01A-11D-1961-08.2.bam,242.7,NA,0.05,58cfa82ee4b0c9d6adf6ac22,G37566.TCGA-HC-7075-01A-11D-1961-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-7075-01A,5DD69C3E-9A3D-450C-9F10-10B4D6DAEEBA,Primary Tumor,Illumina HiSeq,8f4cf0ab-38b1-49e1-8c15-82f9d02b5f9f,Prostate,63,1FA3E5C2-E415-42FA-AEA3-F6C84959522A,DDC422E4-87E2-4FC0-B56B-DDC2D6A92F58,TCGA-HC-7075-01A-11D-1961-08,HG19_Broad_variant,TCGA-HC-7075,TCGA-PRAD,NA,s3406,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2a,Not available,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bcb7,58cfa830e4b0c9d6adf6bcb7,TCGA-B0-5695-11A-01D-2103-10_wgs_Illumina.filtered.,WGS,TCGA-B0-5695-11A-01D-2103-10_wgs_Illumina,TCGA-B0-5695-11A-01D-2103-10_wgs_Illumina.bam,217.39,1.9,0.14,58cfa830e4b0c9d6adf6bcb7,TCGA-B0-5695-11A-01D-2103-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-B0-5695-11A,FB9BAFA5-7133-4955-8156-4EB6763DC8E1,Solid Tissue Normal,Illumina HiSeq,ea381ad1-7777-4408-9233-b13d6862e07e,Kidney,61,1CC1276D-0275-4B9A-8723-695CADE1B8E7,142F5162-1481-4C43-8CE4-52528EEDC283,TCGA-B0-5695-11A-01D-2103-10,GRCh37-lite,TCGA-B0-5695,TCGA-KIRC,NA,s9446,Baylor College of Medicine,University of Pittsburgh,None,NO,T1b,N0,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6a99a,58cfa82ee4b0c9d6adf6a99a,G35154.TCGA-TQ-A7RK-02A-11D-A36O-08.3.filtered.,WGS,G35154.TCGA-TQ-A7RK-02A-11D-A36O-08.3,G35154.TCGA-TQ-A7RK-02A-11D-A36O-08.3.bam,18.74,NA,0.07,58cfa82ee4b0c9d6adf6a99a,G35154.TCGA-TQ-A7RK-02A-11D-A36O-08.3.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-TQ-A7RK-02A,2F8C789E-BBD8-4753-A48B-6894C21162F8,Recurrent Tumor,Illumina HiSeq,a68e5cb4-4fb0-4196-971a-3078fcf7bbc3,Brain,29,5F9FEEE1-F472-4660-B40B-4BFDC5C59678,1C7F2092-DCAE-460D-A4F6-CE80CFC07567,TCGA-TQ-A7RK-02A-11D-A36O-08,HG19_Broad_variant,TCGA-TQ-A7RK,TCGA-LGG,NA,s8122,Broad Institute of MIT and Harvard,University of Sao Paulo,Brazil,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa830e4b0c9d6adf6bee0,58cfa830e4b0c9d6adf6bee0,TCGA-BP-4326-11A-01D-2097-10_wgs_Illumina.filtered.,WGS,TCGA-BP-4326-11A-01D-2097-10_wgs_Illumina,TCGA-BP-4326-11A-01D-2097-10_wgs_Illumina.bam,102,1.9,0.15,58cfa830e4b0c9d6adf6bee0,TCGA-BP-4326-11A-01D-2097-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-BP-4326-11A,7664C241-B369-4D76-9CD1-7F2BDC1D267F,Solid Tissue Normal,Illumina HiSeq,09e413fb-1e33-4076-9f66-ebc969fcc6a2,Kidney,53,B2DEA58E-527E-46E2-BA14-3070115C9A28,1AD7677C-68E0-490E-B1F9-B061155807EA,TCGA-BP-4326-11A-01D-2097-10,GRCh37-lite,TCGA-BP-4326,TCGA-KIRC,NA,s9449,Baylor College of Medicine,MSKCC,None,NO,T1b,N0,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d2dc,58cfa832e4b0c9d6adf6d2dc,TCGA-KL-8342-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8342-01A-11D-2310-10_wgs_Illumina,TCGA-KL-8342-01A-11D-2310-10_wgs_Illumina.bam,71.3,NA,0.05,58cfa832e4b0c9d6adf6d2dc,TCGA-KL-8342-01A-11D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8342-01A,C689AE1D-4A6B-45DB-B4D1-6B34C5C61522,Primary Tumor,Illumina HiSeq,1f1d17e4-280b-4955-97a5-75180878dc8e,Kidney,45,BC04E860-2CB8-4D90-BC17-F3A4D6A09881,F38FC6AC-2AF8-4D89-A514-4E2C5FDF08DE,TCGA-KL-8342-01A-11D-2310-10,GRCh37-lite,TCGA-KL-8342,TCGA-KICH,NA,s16483,Baylor College of Medicine,MSKCC,United States,NO,T2b,N0,Kidney Chromophobe,Stage II
13722.58cfa831e4b0c9d6adf6c490,58cfa831e4b0c9d6adf6c490,TCGA-CJ-6033-01A-11D-2104-10_Illumina.filtered.,WGS,TCGA-CJ-6033-01A-11D-2104-10_Illumina,TCGA-CJ-6033-01A-11D-2104-10_Illumina.bam,13.66,1.9,0.17,58cfa831e4b0c9d6adf6c490,TCGA-CJ-6033-01A-11D-2104-10_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CJ-6033-01A,4EDFF57F-4B0E-4770-BEAC-590DA7D7232C,Primary Tumor,Illumina HiSeq,42a6262a-a044-4cac-b1dd-a97139e7859b,Kidney,54,840633A2-9565-4096-AA67-584952FBD6AB,10D15B7A-16D1-4953-AAEF-F193FFA97F42,TCGA-CJ-6033-01A-11D-2104-10,GRCh37-lite,TCGA-CJ-6033,TCGA-KIRC,224,s9169,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T3a,N0,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa830e4b0c9d6adf6bf0c,58cfa830e4b0c9d6adf6bf0c,TCGA-BP-4756-11A-01D-2097-10_wgs_Illumina.filtered.,WGS,TCGA-BP-4756-11A-01D-2097-10_wgs_Illumina,TCGA-BP-4756-11A-01D-2097-10_wgs_Illumina.bam,67.7,1.9,0.15,58cfa830e4b0c9d6adf6bf0c,TCGA-BP-4756-11A-01D-2097-10_wgs_Illumina.bam,Alive,FEMALE,ASIAN,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-BP-4756-11A,9ECDDE9C-2179-4830-BD10-C4FA40F26066,Solid Tissue Normal,Illumina HiSeq,abac5878-19cf-4559-9c9d-e5772414637a,Kidney,62,514EB21F-86C3-49DF-AF96-1A793F0F5AB5,2442681A-1489-43A1-BAED-B853DFA6CA2A,TCGA-BP-4756-11A-01D-2097-10,GRCh37-lite,TCGA-BP-4756,TCGA-KIRC,NA,s9735,Baylor College of Medicine,MSKCC,None,NO,T1b,N0,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d328,58cfa832e4b0c9d6adf6d328,TCGA-KN-8432-11A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8432-11A-01D-2311-10_wgs_Illumina,TCGA-KN-8432-11A-01D-2311-10_wgs_Illumina.bam,211.3,NA,0.05,58cfa832e4b0c9d6adf6d328,TCGA-KN-8432-11A-01D-2311-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KN-8432-11A,AF1111AF-9384-4E37-9B16-227D38007EBD,Solid Tissue Normal,Illumina HiSeq,0044f889-53c7-47d9-815d-84ea35acee63,Kidney,86,6A5BAAC8-C270-45F7-8911-592D987E3FBE,7D556F90-8997-4E2F-9F30-23814AA3C222,TCGA-KN-8432-11A-01D-2311-10,GRCh37-lite,TCGA-KN-8432,TCGA-KICH,NA,s16407,Baylor College of Medicine,Harvard,United States,NO,T2b,NX,Kidney Chromophobe,Stage II
13722.58cfa830e4b0c9d6adf6ba5d,58cfa830e4b0c9d6adf6ba5d,TCGA-AA-A00R-01A-01D-A126-10_hg19_wgs_Illumina.filtered.,WGS,TCGA-AA-A00R-01A-01D-A126-10_hg19_wgs_Illumina,TCGA-AA-A00R-01A-01D-A126-10_hg19_wgs_Illumina.bam,205.35,1.73,0.08,58cfa830e4b0c9d6adf6ba5d,TCGA-AA-A00R-01A-01D-A126-10_hg19_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A00R-01A,CA22EDD4-EB7C-4677-84AA-6F0354459A19,Primary Tumor,Illumina HiSeq,6182870d-a572-4538-aaa5-06b4adad7bbe,Colorectal,64,F72EEAE9-F7F5-4576-A072-5021119117D6,05780D48-80E7-4D70-B00C-081F8A9519F2,TCGA-AA-A00R-01A-01D-A126-10,GRCh37-lite,TCGA-AA-A00R,TCGA-COAD,NA,s13677,Baylor College of Medicine,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c3ba,58cfa831e4b0c9d6adf6c3ba,TCGA-CC-5261-10A-01D-A12Z-10_wgs_Illumina.filtered.,WGS,TCGA-CC-5261-10A-01D-A12Z-10_wgs_Illumina,TCGA-CC-5261-10A-01D-A12Z-10_wgs_Illumina.bam,77.6,1.95,0.08,58cfa831e4b0c9d6adf6c3ba,TCGA-CC-5261-10A-01D-A12Z-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-CC-5261-10A,1AD7F17E-B3B8-40E9-AAB8-5A17E0AEC408,Blood Derived Normal,Illumina HiSeq,59883362-cc79-4771-8824-7cc42fa91622,Liver,44,6FA15D13-FA7E-4974-843A-982C934047A9,5AD24CF2-DB35-428A-A10F-50B2DECBE482,TCGA-CC-5261-10A-01D-A12Z-10,GRCh37-lite,TCGA-CC-5261,TCGA-LIHC,NA,s16583,Baylor College of Medicine,ILSbio,None,NO,T2,N0,Hepatocellular Carcinoma,Stage II
13722.58cfa832e4b0c9d6adf6d2b4,58cfa832e4b0c9d6adf6d2b4,TCGA-KL-8330-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8330-11A-01D-2310-10_wgs_Illumina,TCGA-KL-8330-11A-01D-2310-10_wgs_Illumina.bam,215.3,NA,0.05,58cfa832e4b0c9d6adf6d2b4,TCGA-KL-8330-11A-01D-2310-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KL-8330-11A,0F3C4F8F-0766-46B0-81B4-18CA4F6EA20A,Solid Tissue Normal,Illumina HiSeq,57bc280a-8867-4db4-b616-91d204974479,Kidney,44,BB830545-A8CE-4EDC-93D5-9C444EA1D952,1D82038A-3A67-4B82-8E8D-5BA2C855B563,TCGA-KL-8330-11A-01D-2310-10,GRCh37-lite,TCGA-KL-8330,TCGA-KICH,NA,s16427,Baylor College of Medicine,MSKCC,United States,NO,T2b,N0,Kidney Chromophobe,Stage II
13722.58cfa82ee4b0c9d6adf6b079,58cfa82ee4b0c9d6adf6b079,TCGA-06-0152-01A-02D-0507-08_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-06-0152-01A-02D-0507-08_IlluminaGA-DNASeq_whole,TCGA-06-0152-01A-02D-0507-08_IlluminaGA-DNASeq_whole.bam,446.47,1.9,0.17,58cfa82ee4b0c9d6adf6b079,TCGA-06-0152-01A-02D-0507-08_IlluminaGA-DNASeq_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0152-01A,F5BC5D97-E054-4E53-992D-71B896BD97D5,Primary Tumor,Illumina GA,4308cab4-6625-42a7-9ef1-e16956b76d9f,Brain,68,1B8EFA87-5057-48D9-BE73-CFB1955A16BB,A99749A3-18E0-4869-842D-B225F39CFD07,TCGA-06-0152-01A-02D-0507-08,HG18_Broad_variant,TCGA-06-0152,TCGA-GBM,375,s14143,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa831e4b0c9d6adf6c3bc,58cfa831e4b0c9d6adf6c3bc,TCGA-CC-A1HT-10A-01D-A12Z-10_wgs_Illumina.filtered.,WGS,TCGA-CC-A1HT-10A-01D-A12Z-10_wgs_Illumina,TCGA-CC-A1HT-10A-01D-A12Z-10_wgs_Illumina.bam,67.88,1.93,0.08,58cfa831e4b0c9d6adf6c3bc,TCGA-CC-A1HT-10A-01D-A12Z-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-CC-A1HT-10A,670C1CBC-4494-45F1-BB8B-18DB82D4F7E0,Blood Derived Normal,Illumina HiSeq,70827008-a0e9-4677-9a4d-ace22fc78191,Liver,50,1E5FF690-F65D-4D2F-9F81-07E87562F515,0255F601-3BE9-4059-9D36-7F666977EFF0,TCGA-CC-A1HT-10A-01D-A12Z-10,GRCh37-lite,TCGA-CC-A1HT,TCGA-LIHC,NA,s16973,Baylor College of Medicine,ILSbio,Vietnam,NO,T3,N0,Hepatocellular Carcinoma,Stage IIIA
13722.58cfa830e4b0c9d6adf6c1cf,58cfa830e4b0c9d6adf6c1cf,TCGA-BC-A216-11A-11D-A152-10_wgs_Illumina.filtered.,WGS,TCGA-BC-A216-11A-11D-A152-10_wgs_Illumina,TCGA-BC-A216-11A-11D-A152-10_wgs_Illumina.bam,43.85,1.91,0.08,58cfa830e4b0c9d6adf6c1cf,TCGA-BC-A216-11A-11D-A152-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-BC-A216-11A,4BBDBE77-F3CB-4B64-9826-72DEBB734784,Solid Tissue Normal,Illumina HiSeq,2e5d5ce6-619a-41ad-a2c7-9f136bb8614e,Liver,62,B3DDEE9B-04D5-4FA3-94C1-754BCC2A0F5D,BAF0C971-0005-4E18-BFDF-A2D71A3AFF12,TCGA-BC-A216-11A-11D-A152-10,GRCh37-lite,TCGA-BC-A216,TCGA-LIHC,NA,s17056,Baylor College of Medicine,UNC,United States,NO,T3,NX,Hepatocellular Carcinoma,Stage IIIA
13722.58cfa832e4b0c9d6adf6cfff,58cfa832e4b0c9d6adf6cfff,TCGA-G3-A25W-11A-12D-A16V-10_wgs_Illumina.filtered.,WGS,TCGA-G3-A25W-11A-12D-A16V-10_wgs_Illumina,TCGA-G3-A25W-11A-12D-A16V-10_wgs_Illumina.bam,46.92,1.81,0.09,58cfa832e4b0c9d6adf6cfff,TCGA-G3-A25W-11A-12D-A16V-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-G3-A25W-11A,06AC44E9-1226-4202-828B-6F224766D7AC,Solid Tissue Normal,Illumina HiSeq,56292a1a-0d0d-48e0-b27b-27a059f5cd34,Liver,79,1467D6A9-E66E-49DC-A1EF-161BA83C4432,FDC8E770-343E-4C4E-BC1D-99375EA94DE4,TCGA-G3-A25W-11A-12D-A16V-10,GRCh37-lite,TCGA-G3-A25W,TCGA-LIHC,NA,s16596,Baylor College of Medicine,Alberta Health Services,Canada,NO,T3b,N0,Hepatocellular Carcinoma,Stage IIIB
13722.58cfa82ee4b0c9d6adf6a8ca,58cfa82ee4b0c9d6adf6a8ca,G35154.TCGA-DH-A669-01A-12D-A31L-08.3.filtered.,WGS,G35154.TCGA-DH-A669-01A-12D-A31L-08.3,G35154.TCGA-DH-A669-01A-12D-A31L-08.3.bam,53.17,NA,0.07,58cfa82ee4b0c9d6adf6a8ca,G35154.TCGA-DH-A669-01A-12D-A31L-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DH-A669-01A,76E54EF6-1799-4FD9-BEC3-0EA960E8461E,Primary Tumor,Illumina HiSeq,5ce3eb80-b2f7-4ebe-bcda-690bfbf4a5ba,Brain,70,78A57936-140F-4593-9BF4-30B850247FAB,425BF16E-AEB2-453A-932B-B3F59016B041,TCGA-DH-A669-01A-12D-A31L-08,HG19_Broad_variant,TCGA-DH-A669,TCGA-LGG,919,s8099,Broad Institute of MIT and Harvard,University of Florida,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6c904,58cfa831e4b0c9d6adf6c904,TCGA-DD-A4NA-11A-11D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A4NA-11A-11D-A25V-10_wgs_Illumina,TCGA-DD-A4NA-11A-11D-A25V-10_wgs_Illumina.bam,23.9,NA,0.08,58cfa831e4b0c9d6adf6c904,TCGA-DD-A4NA-11A-11D-A25V-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A4NA-11A,BEE9D6C8-948F-4B76-97CA-B985064249EF,Solid Tissue Normal,Illumina HiSeq,1d28c87c-de75-4b26-9f67-14d1cf638d90,Liver,67,58D8F5F1-4AA7-412C-83FC-744183FE5421,85FA6EFB-2977-466F-B260-4E95585F2E37,TCGA-DD-A4NA-11A-11D-A25V-10,GRCh37-lite,TCGA-DD-A4NA,TCGA-LIHC,NA,s16680,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T2,N1,Hepatocellular Carcinoma,Stage IIIC
13722.58cfa832e4b0c9d6adf6d326,58cfa832e4b0c9d6adf6d326,TCGA-KO-8407-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KO-8407-01A-11D-2310-10_wgs_Illumina,TCGA-KO-8407-01A-11D-2310-10_wgs_Illumina.bam,150.2,NA,0.05,58cfa832e4b0c9d6adf6d326,TCGA-KO-8407-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KO-8407-01A,151F07F5-1529-4FCD-912C-E55B2FF8ABEF,Primary Tumor,Illumina HiSeq,33c518fb-d4b6-4ec8-8125-6fd6c0032563,Kidney,42,24992BE3-78D6-4193-ACF3-F0A5AC959BB6,64F696A6-58B2-40A8-B848-FD775CD52529,TCGA-KO-8407-01A-11D-2310-10,GRCh37-lite,TCGA-KO-8407,TCGA-KICH,NA,s16438,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa82ee4b0c9d6adf6aba0,58cfa82ee4b0c9d6adf6aba0,G37566.TCGA-EJ-5503-01A-01D-1576-08.2.filtered.,WGS,G37566.TCGA-EJ-5503-01A-01D-1576-08.2,G37566.TCGA-EJ-5503-01A-01D-1576-08.2.bam,172.7,1.9,0.05,58cfa82ee4b0c9d6adf6aba0,G37566.TCGA-EJ-5503-01A-01D-1576-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-EJ-5503-01A,AA252F78-EBF3-42F9-86AF-BB6E57345706,Primary Tumor,Illumina HiSeq,b6f47487-689c-45fe-9716-1aa948f2b2c4,Prostate,50,627B9FF8-2557-4470-824A-B76A8BCD1E9F,25C002F7-E972-421A-B32D-7DD675D81931,TCGA-EJ-5503-01A-01D-1576-08,HG19_Broad_variant,TCGA-EJ-5503,TCGA-PRAD,NA,s3581,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa831e4b0c9d6adf6c474,58cfa831e4b0c9d6adf6c474,TCGA-CA-6717-10A-01D-1835-10_wgs_Illumina.filtered.,WGS,TCGA-CA-6717-10A-01D-1835-10_wgs_Illumina,TCGA-CA-6717-10A-01D-1835-10_wgs_Illumina.bam,420.3,1.9,0.05,58cfa831e4b0c9d6adf6c474,TCGA-CA-6717-10A-01D-1835-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-CA-6717-10A,268C01B3-D2CE-44C0-A2FE-EA846A1253CC,Blood Derived Normal,Illumina HiSeq,6896d05c-37ef-4347-bb21-6d3651e63b21,Colorectal,57,B424F6A7-2D2A-4DAB-832D-3288FEEFF3C7,73FA41A5-CD47-4C3E-B57F-3C40E57ECFA3,TCGA-CA-6717-10A-01D-1835-10,GRCh37-lite,TCGA-CA-6717,TCGA-COAD,NA,s13039,Baylor College of Medicine,ILSbio,Vietnam,NO,T3,N0,Colon Mucinous Adenocarcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6cdbe,58cfa831e4b0c9d6adf6cdbe,TCGA-FF-8061-10A-01D-2210-10_wgs_Illumina.filtered.,WGS,TCGA-FF-8061-10A-01D-2210-10_wgs_Illumina,TCGA-FF-8061-10A-01D-2210-10_wgs_Illumina.bam,70,NA,0.05,58cfa831e4b0c9d6adf6cdbe,TCGA-FF-8061-10A-01D-2210-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Aligned reads,TCGA-FF-8061-10A,C8CDE9EA-89E9-4EE8-8A46-417A48F6D3AB,Blood Derived Normal,Illumina HiSeq,f6b205c0-0cbf-47f8-9e84-d7d5b4028025,Lymph Nodes,42,B866F081-9610-417B-B2C1-0E18BA93D158,08470796-8FF6-4E18-98D5-F9EE0D079517,TCGA-FF-8061-10A-01D-2210-10,GRCh37-lite,TCGA-FF-8061,TCGA-DLBC,NA,s1099,Baylor College of Medicine,SingHealth,Singapore,NO,Not available,Not available,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),Not available
13722.58cfa82ee4b0c9d6adf6a824,58cfa82ee4b0c9d6adf6a824,G35154.TCGA-FG-5965-02B-11D-A29Q-08.2.filtered.,WGS,G35154.TCGA-FG-5965-02B-11D-A29Q-08.2,G35154.TCGA-FG-5965-02B-11D-A29Q-08.2.bam,20.46,NA,0.08,58cfa82ee4b0c9d6adf6a824,G35154.TCGA-FG-5965-02B-11D-A29Q-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-5965-02B,2CFC07F3-A31C-41A2-A9E3-B708D2421A78,Recurrent Tumor,Illumina HiSeq,68fdf201-9dfe-443b-8933-554f011fc87c,Brain,39,FB8EE996-D991-43D2-87DB-FC23D153A3DC,010CBBC1-CACB-4509-9A37-1D62CFF09E49,TCGA-FG-5965-02B-11D-A29Q-08,HG19_Broad_variant,TCGA-FG-5965,TCGA-LGG,NA,s8539,Broad Institute of MIT and Harvard,Case Western,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa831e4b0c9d6adf6cd46,58cfa831e4b0c9d6adf6cd46,TCGA-EP-A3RK-10A-01D-A22F-10_wgs_Illumina.filtered.,WGS,TCGA-EP-A3RK-10A-01D-A22F-10_wgs_Illumina,TCGA-EP-A3RK-10A-01D-A22F-10_wgs_Illumina.bam,79.75,NA,0.08,58cfa831e4b0c9d6adf6cd46,TCGA-EP-A3RK-10A-01D-A22F-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-EP-A3RK-10A,F15279DD-5D12-460B-9BD1-B4F95681CA65,Blood Derived Normal,Illumina HiSeq,8d2f2b76-0b7a-4963-8bc2-dd72bed43ab9,Liver,73,A6FFC817-F4BE-49C1-AA99-3546778CB91F,F4EBCDB4-5FCB-4FBC-BB8C-D961EF98312B,TCGA-EP-A3RK-10A-01D-A22F-10,GRCh37-lite,TCGA-EP-A3RK,TCGA-LIHC,NA,s16858,Baylor College of Medicine,Christiana Healthcare,United States,NO,T3a,NX,Hepatocellular Carcinoma,Stage IIIA
13722.58cfa82ee4b0c9d6adf6b070,58cfa82ee4b0c9d6adf6b070,G8890.TCGA-60-2722-01A-01D-1180-08.2.filtered.,WGS,G8890.TCGA-60-2722-01A-01D-1180-08.2,G8890.TCGA-60-2722-01A-01D-1180-08.2.bam,179,1.9,0.15,58cfa82ee4b0c9d6adf6b070,G8890.TCGA-60-2722-01A-01D-1180-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-60-2722-01A,6FD72426-F6C8-47CA-A500-D5D3600B9B15,Primary Tumor,Illumina HiSeq,417178a5-e706-47ee-92d7-de1eb647b4fc,Lung,66,060717AD-F034-46FA-8E9B-94A9422E4666,96DC785C-8417-4813-8D15-C32B22D78B74,TCGA-60-2722-01A-01D-1180-08,HG19_Broad_variant,TCGA-60-2722,TCGA-LUSC,NA,s9982,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T2,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa832e4b0c9d6adf6cf31,58cfa832e4b0c9d6adf6cf31,TCGA-FV-A3I1-10A-01D-A22F-10_wgs_Illumina.filtered.,WGS,TCGA-FV-A3I1-10A-01D-A22F-10_wgs_Illumina,TCGA-FV-A3I1-10A-01D-A22F-10_wgs_Illumina.bam,34.94,NA,0.07,58cfa832e4b0c9d6adf6cf31,TCGA-FV-A3I1-10A-01D-A22F-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-FV-A3I1-10A,BFD20D71-18A5-4F01-8D56-84378AD92359,Blood Derived Normal,Illumina HiSeq,0b0c6501-1aab-4520-ba60-4922a1241d6a,Liver,81,5F93B853-A6FB-4339-B1E7-0A5CFB51FF8C,5CCE4752-30C6-4BC7-8C28-90617E8DCD3B,TCGA-FV-A3I1-10A-01D-A22F-10,GRCh37-lite,TCGA-FV-A3I1,TCGA-LIHC,NA,s16687,Baylor College of Medicine,International Genomics Consortium,United States,NO,T2,N0,Hepatocellular Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6ca82,58cfa831e4b0c9d6adf6ca82,TCGA-DD-A1EH-11A-11D-A12Z-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A1EH-11A-11D-A12Z-10_wgs_Illumina,TCGA-DD-A1EH-11A-11D-A12Z-10_wgs_Illumina.bam,34.95,1.92,0.08,58cfa831e4b0c9d6adf6ca82,TCGA-DD-A1EH-11A-11D-A12Z-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A1EH-11A,CAB5B264-ABAB-4BDB-816E-9D2C0AC30629,Solid Tissue Normal,Illumina HiSeq,bbef94ab-fc58-467f-8597-4226604d2853,Liver,23,DB3D6662-EEBB-4396-93E3-B5F1022C90D2,81482A77-5ED0-469A-8FF4-04B5ABF752E1,TCGA-DD-A1EH-11A-11D-A12Z-10,GRCh37-lite,TCGA-DD-A1EH,TCGA-LIHC,NA,s16777,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T3,N0,Hepatocellular Carcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6a96a,58cfa82ee4b0c9d6adf6a96a,G35154.TCGA-DU-6404-02A-21D-A36O-08.3.filtered.,WGS,G35154.TCGA-DU-6404-02A-21D-A36O-08.3,G35154.TCGA-DU-6404-02A-21D-A36O-08.3.bam,20.03,NA,0.08,58cfa82ee4b0c9d6adf6a96a,G35154.TCGA-DU-6404-02A-21D-A36O-08.3.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6404-02A,C0D47E0F-4918-4E06-9DB6-201671B1259C,Recurrent Tumor,Illumina HiSeq,065e1f84-f913-4932-b59f-0700a5d0a239,Brain,24,27E52320-BC07-4714-AA09-98FB2C851522,1E938B4C-FCB0-429E-88E9-CED190DCF6D1,TCGA-DU-6404-02A-21D-A36O-08,HG19_Broad_variant,TCGA-DU-6404,TCGA-LGG,4068,s8739,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa832e4b0c9d6adf6ce2e,58cfa832e4b0c9d6adf6ce2e,TCGA-ES-A2HT-11A-11D-A183-10_wgs_Illumina.filtered.,WGS,TCGA-ES-A2HT-11A-11D-A183-10_wgs_Illumina,TCGA-ES-A2HT-11A-11D-A183-10_wgs_Illumina.bam,26.57,NA,0.08,58cfa832e4b0c9d6adf6ce2e,TCGA-ES-A2HT-11A-11D-A183-10_wgs_Illumina.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-ES-A2HT-11A,7DD3BDA9-3A0A-46FA-B052-A6D24B847804,Solid Tissue Normal,Illumina HiSeq,931609b6-b02c-447c-9dae-d1c3456508ee,Liver,54,723A470F-6855-409A-AAD4-D6B933313239,1A9DD052-17C3-4A9D-A566-AD9F88B85428,TCGA-ES-A2HT-11A-11D-A183-10,GRCh37-lite,TCGA-ES-A2HT,TCGA-LIHC,438,s16985,Baylor College of Medicine,University of Florida,United States,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6a9a0,58cfa82ee4b0c9d6adf6a9a0,G35154.TCGA-TM-A7CF-01A-11D-A32B-08.4.filtered.,WGS,G35154.TCGA-TM-A7CF-01A-11D-A32B-08.4,G35154.TCGA-TM-A7CF-01A-11D-A32B-08.4.bam,11.46,NA,0.08,58cfa82ee4b0c9d6adf6a9a0,G35154.TCGA-TM-A7CF-01A-11D-A32B-08.4.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-TM-A7CF-01A,033C1F48-9225-4159-B23B-7042272877DA,Primary Tumor,Illumina HiSeq,41c3ad23-569a-452e-8577-85a783c2a020,Brain,41,ABE68BC0-FE69-409E-851E-3CCF10C8AC94,979F7FD8-AB07-40A0-869A-D08FB8E598FF,TCGA-TM-A7CF-01A-11D-A32B-08,HG19_Broad_variant,TCGA-TM-A7CF,TCGA-LGG,NA,s8116,Broad Institute of MIT and Harvard,The University of New South Wales,Australia,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa831e4b0c9d6adf6c9a9,58cfa831e4b0c9d6adf6c9a9,TCGA-DD-A4ND-11A-11D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A4ND-11A-11D-A25V-10_wgs_Illumina,TCGA-DD-A4ND-11A-11D-A25V-10_wgs_Illumina.bam,23.78,NA,0.08,58cfa831e4b0c9d6adf6c9a9,TCGA-DD-A4ND-11A-11D-A25V-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A4ND-11A,C0BF9278-9CBB-4361-B4D8-AB172B67E276,Solid Tissue Normal,Illumina HiSeq,a34b0961-67cd-4ac4-ab9e-09d98e780605,Liver,56,391F4D5E-0240-40EE-8D3F-70F39C698E1E,40381948-7DFF-4254-8B81-BB6F34579EBF,TCGA-DD-A4ND-11A-11D-A25V-10,GRCh37-lite,TCGA-DD-A4ND,TCGA-LIHC,NA,s16678,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6ba60,58cfa830e4b0c9d6adf6ba60,TCGA-A3-3372-01A-01D-2094-10_Illumina.filtered.,WGS,TCGA-A3-3372-01A-01D-2094-10_Illumina,TCGA-A3-3372-01A-01D-2094-10_Illumina.bam,595.87,1.9,0.15,58cfa830e4b0c9d6adf6ba60,TCGA-A3-3372-01A-01D-2094-10_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-A3-3372-01A,11AB53C8-6366-4BC9-B60D-23E6ED2D1CAE,Primary Tumor,Illumina HiSeq,0dc73f18-4553-49e0-b22e-8bc863c7b907,Kidney,64,D3280297-5674-4AE6-AB57-8D820543901E,F64E9609-D75D-400C-A92D-D77FD54D6C29,TCGA-A3-3372-01A-01D-2094-10,GRCh37-lite,TCGA-A3-3372,TCGA-KIRC,NA,s9155,Baylor College of Medicine,International Genomics Consortium,United States,NO,T3,NX,Kidney Clear Cell Renal Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6cc44,58cfa831e4b0c9d6adf6cc44,TCGA-EP-A2KB-10A-01D-A183-10_wgs_Illumina.filtered.,WGS,TCGA-EP-A2KB-10A-01D-A183-10_wgs_Illumina,TCGA-EP-A2KB-10A-01D-A183-10_wgs_Illumina.bam,25.96,NA,0.08,58cfa831e4b0c9d6adf6cc44,TCGA-EP-A2KB-10A-01D-A183-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-EP-A2KB-10A,18C08546-BED3-4ED9-B223-479AFE633C8E,Blood Derived Normal,Illumina HiSeq,2b9add62-e72e-4122-b972-cad65de0d4ab,Liver,46,75C47A43-A189-4000-868A-8AED3A41E3EF,87DF7481-7DA6-412B-9452-D7CE62844EF4,TCGA-EP-A2KB-10A-01D-A183-10,GRCh37-lite,TCGA-EP-A2KB,TCGA-LIHC,NA,s16782,Baylor College of Medicine,Christiana Healthcare,United States,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ac17,58cfa82ee4b0c9d6adf6ac17,G39019.TCGA-ER-A19J-06A-11D-A196-08.3.filtered.,WGS,G39019.TCGA-ER-A19J-06A-11D-A196-08.3,G39019.TCGA-ER-A19J-06A-11D-A196-08.3.bam,43.66,NA,0.08,58cfa82ee4b0c9d6adf6ac17,G39019.TCGA-ER-A19J-06A-11D-A196-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19J-06A,CE28F65D-4AE8-4E63-815F-5B8D4389E092,Metastatic,Illumina HiSeq,0f4f6522-3560-49e7-afd0-9907e3a80559,Skin,54,13E26CCD-BEDD-468B-94AD-EB1C56AD5FFE,D053F88F-09E6-472E-A691-BB293C461399,TCGA-ER-A19J-06A-11D-A196-08,HG19_Broad_variant,TCGA-ER-A19J,TCGA-SKCM,196,s7996,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,TX,N3,Not available,Stage IV
13722.58cfa82ee4b0c9d6adf6a82c,58cfa82ee4b0c9d6adf6a82c,G35154.TCGA-FG-7643-01A-11D-A461-08.2.filtered.,WGS,G35154.TCGA-FG-7643-01A-11D-A461-08.2,G35154.TCGA-FG-7643-01A-11D-A461-08.2.bam,9.7,NA,0.09,58cfa82ee4b0c9d6adf6a82c,G35154.TCGA-FG-7643-01A-11D-A461-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-7643-01A,B6F13250-31B3-46AD-B514-5A684F1094A9,Primary Tumor,Illumina HiSeq,ad52b277-d592-4ece-a72f-4d48f9394453,Brain,49,71F68BC7-2612-4D84-8948-5A06D30AF488,025B53E6-9687-4085-B5CC-3585CE87625D,TCGA-FG-7643-01A-11D-A461-08,HG19_Broad_variant,TCGA-FG-7643,TCGA-LGG,NA,s8327,Broad Institute of MIT and Harvard,Case Western,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa832e4b0c9d6adf6d2f0,58cfa832e4b0c9d6adf6d2f0,TCGA-KN-8431-11A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8431-11A-01D-2311-10_wgs_Illumina,TCGA-KN-8431-11A-01D-2311-10_wgs_Illumina.bam,219.3,NA,0.05,58cfa832e4b0c9d6adf6d2f0,TCGA-KN-8431-11A-01D-2311-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Kidney Chromophobe,Aligned reads,TCGA-KN-8431-11A,04E9A63A-D742-488C-8564-BF9D79AA2091,Solid Tissue Normal,Illumina HiSeq,8dc5c8bc-edb1-4b71-b884-8ea7778c21b4,Kidney,35,3DE64FB3-0C57-44C5-AC95-EDE3B706830B,3E1C3B30-DC01-472E-B1C3-B81A850659D3,TCGA-KN-8431-11A-01D-2311-10,GRCh37-lite,TCGA-KN-8431,TCGA-KICH,NA,s16404,Baylor College of Medicine,Harvard,United States,NO,T2,NX,Kidney Chromophobe,Stage II
13722.58cfa830e4b0c9d6adf6c052,58cfa830e4b0c9d6adf6c052,TCGA-B2-4101-01A-02D-2096-10_Illumina.filtered.,WGS,TCGA-B2-4101-01A-02D-2096-10_Illumina,TCGA-B2-4101-01A-02D-2096-10_Illumina.bam,138.47,1.9,0.15,58cfa830e4b0c9d6adf6c052,TCGA-B2-4101-01A-02D-2096-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-B2-4101-01A,CFC999AA-802E-4A0D-8B14-BE2B19FA2A17,Primary Tumor,Illumina HiSeq,06203d35-b4db-4e6b-9c54-14edb4129481,Kidney,52,A9947B6C-DBC7-4BA5-AF61-7647E11E2973,F3C1A125-06E9-41C4-9558-275A3E346CC5,TCGA-B2-4101-01A-02D-2096-10,GRCh37-lite,TCGA-B2-4101,TCGA-KIRC,NA,s9564,Baylor College of Medicine,Christiana Healthcare,None,NO,T2a,NX,Kidney Clear Cell Renal Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6ae36,58cfa82ee4b0c9d6adf6ae36,G49837.TCGA-90-7767-01A-11D-A320-08.3.filtered.,WGS,G49837.TCGA-90-7767-01A-11D-A320-08.3,G49837.TCGA-90-7767-01A-11D-A320-08.3.bam,263,NA,0.08,58cfa82ee4b0c9d6adf6ae36,G49837.TCGA-90-7767-01A-11D-A320-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-90-7767-01A,9DFF11CD-0784-4A60-9C77-43F8957D3DFA,Primary Tumor,Illumina HiSeq,667b4d6b-e888-4912-a5fd-74910e9b2f8e,Lung,56,609D3070-4B64-42EE-B071-42BE33DF7600,48F68F73-3AC0-44AC-BA12-B8889FCB7F38,TCGA-90-7767-01A-11D-A320-08,HG19_Broad_variant,TCGA-90-7767,TCGA-LUSC,NA,s9981,Broad Institute of MIT and Harvard,ABS - IUPUI,United States,NO,T2b,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6ad5b,58cfa82ee4b0c9d6adf6ad5b,G8892.TCGA-66-2757-11A-01D-1180-08.1.filtered.,WGS,G8892.TCGA-66-2757-11A-01D-1180-08.1,G8892.TCGA-66-2757-11A-01D-1180-08.1.bam,31.6,1.9,0.15,58cfa82ee4b0c9d6adf6ad5b,G8892.TCGA-66-2757-11A-01D-1180-08.1.bam,Alive,FEMALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-66-2757-11A,A02932F3-5606-42A5-AEE4-E5B9F5AA1AAA,Solid Tissue Normal,Illumina HiSeq,bc24ba97-ddc3-473e-b44e-eeeb9e01b489,Lung,65,E483F506-F9D3-43E3-87B6-9DE36CCC68D6,E597CDB1-F99E-4FC8-B349-B0D296DEA086,TCGA-66-2757-11A-01D-1180-08,HG19_Broad_variant,TCGA-66-2757,TCGA-LUSC,NA,s10166,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6a8e4,58cfa82ee4b0c9d6adf6a8e4,G35154.TCGA-DH-A669-02A-11D-A31L-08.3.filtered.,WGS,G35154.TCGA-DH-A669-02A-11D-A31L-08.3,G35154.TCGA-DH-A669-02A-11D-A31L-08.3.bam,35.84,NA,0.08,58cfa82ee4b0c9d6adf6a8e4,G35154.TCGA-DH-A669-02A-11D-A31L-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DH-A669-02A,76E54EF6-1799-4FD9-BEC3-0EA960E8461E,Recurrent Tumor,Illumina HiSeq,bc4e3b89-3a13-471f-8769-7d711cfbad8e,Brain,70,DFC7F355-5480-4F67-A6B5-1F2945D15A36,B020B62A-8ACF-40D2-97AB-AA870AC61E96,TCGA-DH-A669-02A-11D-A31L-08,HG19_Broad_variant,TCGA-DH-A669,TCGA-LGG,919,s8527,Broad Institute of MIT and Harvard,University of Florida,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6ca5c,58cfa831e4b0c9d6adf6ca5c,TCGA-DD-A4NB-11A-11D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A4NB-11A-11D-A25V-10_wgs_Illumina,TCGA-DD-A4NB-11A-11D-A25V-10_wgs_Illumina.bam,28.44,NA,0.08,58cfa831e4b0c9d6adf6ca5c,TCGA-DD-A4NB-11A-11D-A25V-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A4NB-11A,1983FADE-44F1-41E0-8983-F2CE8D649655,Solid Tissue Normal,Illumina HiSeq,9737f868-16f5-48a2-86db-b0e3b7b46d7b,Liver,25,A0092F01-6E42-4BC7-AB3E-E953D5A50038,861EA9B6-F62F-4D03-9672-DC9F8CE2695B,TCGA-DD-A4NB-11A-11D-A25V-10,GRCh37-lite,TCGA-DD-A4NB,TCGA-LIHC,NA,s16779,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T1,N0,Fibrolamellar Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c97f,58cfa831e4b0c9d6adf6c97f,TCGA-DD-A3A6-11A-11D-A22F-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A3A6-11A-11D-A22F-10_wgs_Illumina,TCGA-DD-A3A6-11A-11D-A22F-10_wgs_Illumina.bam,8.79,NA,0.08,58cfa831e4b0c9d6adf6c97f,TCGA-DD-A3A6-11A-11D-A22F-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A3A6-11A,C4C4820B-6F4C-4CDD-B233-4D22F5933FD9,Solid Tissue Normal,Illumina HiSeq,7f1ee04e-04ea-40a5-8116-06072263adfc,Liver,72,88AF1E79-AA6C-46FB-B087-BB4CE8AEB1AD,A63E3270-347F-4DE0-B8F5-494E9B555A9D,TCGA-DD-A3A6-11A-11D-A22F-10,GRCh37-lite,TCGA-DD-A3A6,TCGA-LIHC,3258,s16778,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T2,N0,Hepatocellular Carcinoma,Stage II
13722.58cfa832e4b0c9d6adf6ce7a,58cfa832e4b0c9d6adf6ce7a,TCGA-G3-A25Y-10A-01D-A16V-10_wgs_Illumina.filtered.,WGS,TCGA-G3-A25Y-10A-01D-A16V-10_wgs_Illumina,TCGA-G3-A25Y-10A-01D-A16V-10_wgs_Illumina.bam,166.26,1.85,0.09,58cfa832e4b0c9d6adf6ce7a,TCGA-G3-A25Y-10A-01D-A16V-10_wgs_Illumina.bam,Dead,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-G3-A25Y-10A,239B4298-B090-480A-A19F-9758A827AA30,Blood Derived Normal,Illumina HiSeq,8dbbb564-d7b7-489d-a37f-e9db39f15430,Liver,52,0FC499E8-F6A5-44C0-9C99-AFE097B15BEF,9CFC4ADF-3FD0-4F1F-B9E1-5F7A6E1469DF,TCGA-G3-A25Y-10A-01D-A16V-10,GRCh37-lite,TCGA-G3-A25Y,TCGA-LIHC,452,s17063,Baylor College of Medicine,Alberta Health Services,Canada,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6a8e6,58cfa82ee4b0c9d6adf6a8e6,G35154.TCGA-DU-5870-02A-12D-A36O-08.3.filtered.,WGS,G35154.TCGA-DU-5870-02A-12D-A36O-08.3,G35154.TCGA-DU-5870-02A-12D-A36O-08.3.bam,11.16,NA,0.08,58cfa82ee4b0c9d6adf6a8e6,G35154.TCGA-DU-5870-02A-12D-A36O-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-5870-02A,EB42625E-FBBB-4BEE-BBE9-315B3CA2138A,Recurrent Tumor,Illumina HiSeq,074b6b1f-4846-42c9-a6dd-ea94aabfb270,Brain,34,97132594-2F4F-4E47-B301-F9895301632D,6C817E3C-A1EE-48A2-A8A9-85B0CF894B1B,TCGA-DU-5870-02A-12D-A36O-08,HG19_Broad_variant,TCGA-DU-5870,TCGA-LGG,NA,s8524,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa830e4b0c9d6adf6bc58,58cfa830e4b0c9d6adf6bc58,TCGA-AL-3467-10A-01D-A31Z-10_wgs_Illumina.filtered.,WGS,TCGA-AL-3467-10A-01D-A31Z-10_wgs_Illumina,TCGA-AL-3467-10A-01D-A31Z-10_wgs_Illumina.bam,136.3,1.9,0.08,58cfa830e4b0c9d6adf6bc58,TCGA-AL-3467-10A-01D-A31Z-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-AL-3467-10A,4D02010E-9E69-40D3-9BF0-3D4510AA0614,Blood Derived Normal,Illumina HiSeq,9f354f07-626b-41a6-9940-8d4866f396ea,Kidney,54,CD38F640-1B37-4E81-BDAC-5500E5CD7CDF,360C4921-8397-4CFB-8327-F400E9F02E57,TCGA-AL-3467-10A-01D-A31Z-10,GRCh37-lite,TCGA-AL-3467,TCGA-KIRP,NA,s11640,Baylor College of Medicine,Fox Chase,None,NO,T1b,NX,Kidney Papillary Renal Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6cd86,58cfa831e4b0c9d6adf6cd86,TCGA-FF-8047-10A-01D-2210-10_wgs_Illumina.filtered.,WGS,TCGA-FF-8047-10A-01D-2210-10_wgs_Illumina,TCGA-FF-8047-10A-01D-2210-10_wgs_Illumina.bam,350,NA,0.05,58cfa831e4b0c9d6adf6cd86,TCGA-FF-8047-10A-01D-2210-10_wgs_Illumina.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Aligned reads,TCGA-FF-8047-10A,F978CB0F-D319-4C01-B4C5-23AE1403A106,Blood Derived Normal,Illumina HiSeq,6d520454-1d05-4c76-9211-4afd506f63a6,Lymph Nodes,38,17861270-0DF8-4EE2-BAA8-F61801A4C87F,07C3103C-94ED-4FEE-968D-318721AA84A9,TCGA-FF-8047-10A-01D-2210-10,GRCh37-lite,TCGA-FF-8047,TCGA-DLBC,NA,s1102,Baylor College of Medicine,SingHealth,Singapore,NO,Not available,Not available,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),Not available
13722.58cfa831e4b0c9d6adf6c9ee,58cfa831e4b0c9d6adf6c9ee,TCGA-DD-A3A8-11A-11D-A22F-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A3A8-11A-11D-A22F-10_wgs_Illumina,TCGA-DD-A3A8-11A-11D-A22F-10_wgs_Illumina.bam,29.6,NA,0.08,58cfa831e4b0c9d6adf6c9ee,TCGA-DD-A3A8-11A-11D-A22F-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A3A8-11A,69D6881B-9E9A-407B-8B02-BAD5FC2455BF,Solid Tissue Normal,Illumina HiSeq,45ebbc1e-08d7-483c-b473-676199924458,Liver,75,F070E7DB-1215-4864-9293-C778F161AE68,20E24E02-0CAA-4E55-812B-B081B3BB03D8,TCGA-DD-A3A8-11A-11D-A22F-10,GRCh37-lite,TCGA-DD-A3A8,TCGA-LIHC,11,s17058,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T2,N0,Hepatocellular Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6af74,58cfa82ee4b0c9d6adf6af74,G8890.TCGA-60-2722-11A-01D-1180-08.1.filtered.,WGS,G8890.TCGA-60-2722-11A-01D-1180-08.1,G8890.TCGA-60-2722-11A-01D-1180-08.1.bam,247.3,1.9,0.15,58cfa82ee4b0c9d6adf6af74,G8890.TCGA-60-2722-11A-01D-1180-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-60-2722-11A,6FD72426-F6C8-47CA-A500-D5D3600B9B15,Solid Tissue Normal,Illumina HiSeq,20f0135c-5de7-4648-8704-b13964e911c5,Lung,66,5A2365B6-F9A1-480D-937D-06D2F254F8DC,4279E604-CC93-4B2E-A5AD-CA95C738A272,TCGA-60-2722-11A-01D-1180-08,HG19_Broad_variant,TCGA-60-2722,TCGA-LUSC,NA,s10167,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T2,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6adaa,58cfa82ee4b0c9d6adf6adaa,G25784.TCGA-91-6840-10A-01D-1946-08.3.filtered.,WGS,G25784.TCGA-91-6840-10A-01D-1946-08.3,G25784.TCGA-91-6840-10A-01D-1946-08.3.bam,277,NA,0.05,58cfa82ee4b0c9d6adf6adaa,G25784.TCGA-91-6840-10A-01D-1946-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-91-6840-10A,D5326429-9805-47F9-97B0-FBDA658E3F01,Blood Derived Normal,Illumina HiSeq,ecb2ce47-ebd7-406d-9b76-31a08bc2531c,Lung,59,939E41BA-B671-4B7A-8B40-8EC680F5327C,087D5121-0E86-4BE5-9E53-11EFD5184752,TCGA-91-6840-10A-01D-1946-08,HG19_Broad_variant,TCGA-91-6840,TCGA-LUAD,NA,s10760,Broad Institute of MIT and Harvard,ABS - IUPUI,United States,NO,T1b,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa830e4b0c9d6adf6c288,58cfa830e4b0c9d6adf6c288,TCGA-AD-6964-10A-01D-1924-10_wgs_Illumina.filtered.,WGS,TCGA-AD-6964-10A-01D-1924-10_wgs_Illumina,TCGA-AD-6964-10A-01D-1924-10_wgs_Illumina.bam,209,NA,0.05,58cfa830e4b0c9d6adf6c288,TCGA-AD-6964-10A-01D-1924-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AD-6964-10A,5E7074A6-5011-4DC5-950C-41365DBC6D09,Blood Derived Normal,Illumina HiSeq,0378ffd0-fa85-4cc3-8efb-c0b12364d74c,Colorectal,58,489A0EE9-B8BE-49AC-8CD0-F174A00B0990,52D6EBB2-5E01-409B-BBF9-389D5086BF05,TCGA-AD-6964-10A-01D-1924-10,GRCh37-lite,TCGA-AD-6964,TCGA-COAD,NA,s13386,Baylor College of Medicine,International Genomics Consortium,United States,NO,T4a,N2b,Colon Adenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6ce4e,58cfa832e4b0c9d6adf6ce4e,TCGA-G3-A3CK-10A-01D-A20W-10_wgs_Illumina.filtered.,WGS,TCGA-G3-A3CK-10A-01D-A20W-10_wgs_Illumina,TCGA-G3-A3CK-10A-01D-A20W-10_wgs_Illumina.bam,87.2,NA,0.09,58cfa832e4b0c9d6adf6ce4e,TCGA-G3-A3CK-10A-01D-A20W-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-G3-A3CK-10A,39EB1DB0-2722-4AF4-8254-D0E10256C64D,Blood Derived Normal,Illumina HiSeq,7c07566d-d70a-4116-96b3-2a8bf44831b6,Liver,61,B7C99BE3-110D-4595-BA37-0ED246883E5C,B9244BA4-A36A-415F-8975-7E933DD7D8A4,TCGA-G3-A3CK-10A-01D-A20W-10,GRCh37-lite,TCGA-G3-A3CK,TCGA-LIHC,NA,s16597,Baylor College of Medicine,Alberta Health Services,Canada,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d2ea,58cfa832e4b0c9d6adf6d2ea,TCGA-KM-8477-10A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KM-8477-10A-01D-2311-10_wgs_Illumina,TCGA-KM-8477-10A-01D-2311-10_wgs_Illumina.bam,191.6,NA,0.05,58cfa832e4b0c9d6adf6d2ea,TCGA-KM-8477-10A-01D-2311-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KM-8477-10A,9680B5FF-1882-434F-9981-E8AC33764B93,Blood Derived Normal,Illumina HiSeq,9798e143-15e6-4599-b88c-301b60ff7802,Kidney,56,F298DA5D-1657-4E77-AFE5-17452BC7425A,685B8712-1FE3-49FC-8F73-A1D25A089282,TCGA-KM-8477-10A-01D-2311-10,GRCh37-lite,TCGA-KM-8477,TCGA-KICH,NA,s16430,Baylor College of Medicine,NCI Urologic Oncology Branch,United States,NO,T1a,NX,Kidney Chromophobe,Stage I
13722.58cfa82ee4b0c9d6adf6a93a,58cfa82ee4b0c9d6adf6a93a,G35154.TCGA-DU-6407-02B-11D-A36O-08.2.filtered.,WGS,G35154.TCGA-DU-6407-02B-11D-A36O-08.2,G35154.TCGA-DU-6407-02B-11D-A36O-08.2.bam,8.48,NA,0.08,58cfa82ee4b0c9d6adf6a93a,G35154.TCGA-DU-6407-02B-11D-A36O-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6407-02B,70939245-41E0-4845-A473-5FEF719B9828,Recurrent Tumor,Illumina HiSeq,841fb551-ccd2-4f66-87f1-32acf8af2e33,Brain,35,2CD2F7DC-6D09-4593-AFF6-89C3A8500EC9,41DA1753-DCFF-4E99-8F41-8FCDE82EFA53,TCGA-DU-6407-02B-11D-A36O-08,HG19_Broad_variant,TCGA-DU-6407,TCGA-LGG,2875,s8542,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6c712,58cfa831e4b0c9d6adf6c712,TCGA-CW-5585-11A-01D-2103-10_wgs_Illumina.filtered.,WGS,TCGA-CW-5585-11A-01D-2103-10_wgs_Illumina,TCGA-CW-5585-11A-01D-2103-10_wgs_Illumina.bam,39.4,1.9,0.14,58cfa831e4b0c9d6adf6c712,TCGA-CW-5585-11A-01D-2103-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CW-5585-11A,0487FC41-386C-4D76-9084-DAF959BF5E98,Solid Tissue Normal,Illumina HiSeq,a7895f58-d78c-4e4b-8499-be0b7238081e,Kidney,51,3EBDB6A2-509D-421B-A186-989ABA538664,ADE59498-FBB4-4680-8CCD-B8D739E5AB50,TCGA-CW-5585-11A-01D-2103-10,GRCh37-lite,TCGA-CW-5585,TCGA-KIRC,NA,s9451,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T3b,N0,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa82ee4b0c9d6adf6ab5f,58cfa82ee4b0c9d6adf6ab5f,G37566.TCGA-CH-5771-01A-21D-1576-08.1.filtered.,WGS,G37566.TCGA-CH-5771-01A-21D-1576-08.1,G37566.TCGA-CH-5771-01A-21D-1576-08.1.bam,30.7,1.9,0.05,58cfa82ee4b0c9d6adf6ab5f,G37566.TCGA-CH-5771-01A-21D-1576-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5771-01A,3ACD8328-76F7-4F43-9660-394B95748C3D,Primary Tumor,Illumina HiSeq,e5382b76-d2ee-4eab-b245-b0d58fda770e,Prostate,63,19C87DE2-7936-4277-8AA8-3942D36E7579,87E1FFEE-A8CD-4D75-937E-ED415CF43546,TCGA-CH-5771-01A-21D-1576-08,HG19_Broad_variant,TCGA-CH-5771,TCGA-PRAD,NA,s3759,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bc5c,58cfa830e4b0c9d6adf6bc5c,TCGA-AL-3468-10A-01D-A31Z-10_wgs_Illumina.filtered.,WGS,TCGA-AL-3468-10A-01D-A31Z-10_wgs_Illumina,TCGA-AL-3468-10A-01D-A31Z-10_wgs_Illumina.bam,118.3,1.9,0.09,58cfa830e4b0c9d6adf6bc5c,TCGA-AL-3468-10A-01D-A31Z-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-AL-3468-10A,2272C592-B9B6-4483-9F7F-6E185699B900,Blood Derived Normal,Illumina HiSeq,e65a51e6-42d3-4d65-9aa5-6df410345b6c,Kidney,74,4B8C2FA0-B8A4-4762-9873-BF29C15272F0,51E58F22-5B5B-4BB8-A879-1D7E3F51CCD0,TCGA-AL-3468-10A-01D-A31Z-10,GRCh37-lite,TCGA-AL-3468,TCGA-KIRP,NA,s11641,Baylor College of Medicine,Fox Chase,United States,NO,T2,NX,Kidney Papillary Renal Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c6ee,58cfa831e4b0c9d6adf6c6ee,TCGA-CR-6467-01A-11D-2266-10_Illumina.filtered.,WGS,TCGA-CR-6467-01A-11D-2266-10_Illumina,TCGA-CR-6467-01A-11D-2266-10_Illumina.bam,319.7,1.9,0.05,58cfa831e4b0c9d6adf6c6ee,TCGA-CR-6467-01A-11D-2266-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-6467-01A,89F91E36-FED8-4DA3-8A35-C761D6F65285,Primary Tumor,Illumina HiSeq,27f00d9e-af52-4af4-b29b-a75a506754a8,Head and Neck,59,5EF4D047-5A84-4E03-ACF5-02029D8A4CF2,EE963667-56B1-49BD-8896-E07B536D3014,TCGA-CR-6467-01A-11D-2266-10,GRCh37-lite,TCGA-CR-6467,TCGA-HNSC,NA,s15769,Baylor College of Medicine,Vanderbilt University,United States,NO,T2,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa832e4b0c9d6adf6d052,58cfa832e4b0c9d6adf6d052,TCGA-FV-A3R2-11A-11D-A22F-10_wgs_Illumina.filtered.,WGS,TCGA-FV-A3R2-11A-11D-A22F-10_wgs_Illumina,TCGA-FV-A3R2-11A-11D-A22F-10_wgs_Illumina.bam,47.49,NA,0.08,58cfa832e4b0c9d6adf6d052,TCGA-FV-A3R2-11A-11D-A22F-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-FV-A3R2-11A,17833039-0D7E-47F0-90E6-8CABAE94C124,Solid Tissue Normal,Illumina HiSeq,a8c77a4c-d263-4383-99d2-ef693740ad3f,Liver,75,50D807B1-A8CB-4299-A597-0D3F8DD98692,3600DB40-C4E6-463B-89F9-A95454C88E2B,TCGA-FV-A3R2-11A-11D-A22F-10,GRCh37-lite,TCGA-FV-A3R2,TCGA-LIHC,194,s16862,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6aa54,58cfa82ee4b0c9d6adf6aa54,G2186.TCGA-24-0982-10C-01D.4.filtered.,WGS,G2186.TCGA-24-0982-10C-01D.4,G2186.TCGA-24-0982-10C-01D.4.bam,209.54,1.9,0.17,58cfa82ee4b0c9d6adf6aa54,G2186.TCGA-24-0982-10C-01D.4.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-0982-10C,206CE0ED-36A4-47AB-AC8E-F6FCA6AC5C18,Blood Derived Normal,Illumina GA,87fdbcaf-d814-492c-be5e-e35cb03f12f9,Ovary,77,51142764-B0DB-474B-B243-F10AF94E7E37,3118A429-7C6D-4F3F-92DB-8062BE3042AB,TCGA-24-0982-10C-01D-0516-08,HG19_Broad_variant,TCGA-24-0982,TCGA-OV,679,s17547,Broad Institute of MIT and Harvard,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d166,58cfa832e4b0c9d6adf6d166,TCGA-KL-8327-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8327-11A-01D-2310-10_wgs_Illumina,TCGA-KL-8327-11A-01D-2310-10_wgs_Illumina.bam,159.3,NA,0.05,58cfa832e4b0c9d6adf6d166,TCGA-KL-8327-11A-01D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8327-11A,02979422-5149-4750-AD5F-483E0BEC6AC5,Solid Tissue Normal,Illumina HiSeq,d8f616fa-a1fb-472f-88be-268ed7ea12b3,Kidney,46,D2F008F2-2A30-4B37-ABC7-9597E2080D85,15D4FBCE-AE77-4500-AB53-A29AB6C75019,TCGA-KL-8327-11A-01D-2310-10,GRCh37-lite,TCGA-KL-8327,TCGA-KICH,NA,s16472,Baylor College of Medicine,MSKCC,United States,NO,T1b,N0,Kidney Chromophobe,Stage I
13722.58cfa832e4b0c9d6adf6d306,58cfa832e4b0c9d6adf6d306,TCGA-KM-8476-10A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KM-8476-10A-01D-2311-10_wgs_Illumina,TCGA-KM-8476-10A-01D-2311-10_wgs_Illumina.bam,238.6,NA,0.05,58cfa832e4b0c9d6adf6d306,TCGA-KM-8476-10A-01D-2311-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KM-8476-10A,4E4FAF51-2CBF-4910-A093-186660E4A19B,Blood Derived Normal,Illumina HiSeq,5e9b7934-aad1-4b4b-8b2d-d06d15b533a6,Kidney,47,6C4DC1C0-8974-4B32-A8B8-011CD683F468,69F24CD1-4EC4-4EF0-876F-4EDA31A72245,TCGA-KM-8476-10A-01D-2311-10,GRCh37-lite,TCGA-KM-8476,TCGA-KICH,NA,s16432,Baylor College of Medicine,NCI Urologic Oncology Branch,United States,NO,T1,NX,Kidney Chromophobe,Stage I
13722.58cfa832e4b0c9d6adf6d31b,58cfa832e4b0c9d6adf6d31b,TCGA-KO-8405-11A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KO-8405-11A-01D-2311-10_wgs_Illumina,TCGA-KO-8405-11A-01D-2311-10_wgs_Illumina.bam,225.2,NA,0.05,58cfa832e4b0c9d6adf6d31b,TCGA-KO-8405-11A-01D-2311-10_wgs_Illumina.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KO-8405-11A,D52C3CB6-921E-4F26-B49C-E6E4F11F9C06,Solid Tissue Normal,Illumina HiSeq,a4dcdf3c-fd95-4407-bcf4-66b5efe5b534,Kidney,29,1B80091E-DB96-4684-A864-4126A54CBD00,43634C4D-E2ED-4B39-BAC2-474388AF50E5,TCGA-KO-8405-11A-01D-2311-10,GRCh37-lite,TCGA-KO-8405,TCGA-KICH,NA,s16537,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T3a,N0,Kidney Chromophobe,Stage III
13722.58cfa82ee4b0c9d6adf6a963,58cfa82ee4b0c9d6adf6a963,G35154.TCGA-DU-6404-02B-11D-A36O-08.3.filtered.,WGS,G35154.TCGA-DU-6404-02B-11D-A36O-08.3,G35154.TCGA-DU-6404-02B-11D-A36O-08.3.bam,38.82,NA,0.07,58cfa82ee4b0c9d6adf6a963,G35154.TCGA-DU-6404-02B-11D-A36O-08.3.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6404-02B,C0D47E0F-4918-4E06-9DB6-201671B1259C,Recurrent Tumor,Illumina HiSeq,444d6791-2bcb-4356-9ce9-5e8bd11c186f,Brain,24,30466DE1-8963-4208-B4B6-3F635992B970,AB87D134-4F50-4591-8693-FBB929E2F332,TCGA-DU-6404-02B-11D-A36O-08,HG19_Broad_variant,TCGA-DU-6404,TCGA-LGG,4068,s8108,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6cde2,58cfa831e4b0c9d6adf6cde2,TCGA-ES-A2HS-11A-11D-A183-10_wgs_Illumina.filtered.,WGS,TCGA-ES-A2HS-11A-11D-A183-10_wgs_Illumina,TCGA-ES-A2HS-11A-11D-A183-10_wgs_Illumina.bam,28.34,NA,0.08,58cfa831e4b0c9d6adf6cde2,TCGA-ES-A2HS-11A-11D-A183-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-ES-A2HS-11A,728AEDB3-551A-4C16-9BE3-7733A9539E9E,Solid Tissue Normal,Illumina HiSeq,13461eac-7c4c-45f7-9511-c0041b7934d4,Liver,80,D263D674-CCE4-4A57-B379-671FA9E5416E,A9C45810-B691-4963-B215-977E8F93D1C2,TCGA-ES-A2HS-11A-11D-A183-10,GRCh37-lite,TCGA-ES-A2HS,TCGA-LIHC,695,s16859,Baylor College of Medicine,University of Florida,United States,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6a906,58cfa82ee4b0c9d6adf6a906,G35154.TCGA-CS-6665-01A-11D-1893-08.2.filtered.,WGS,G35154.TCGA-CS-6665-01A-11D-1893-08.2,G35154.TCGA-CS-6665-01A-11D-1893-08.2.bam,98.7,1.9,0.05,58cfa82ee4b0c9d6adf6a906,G35154.TCGA-CS-6665-01A-11D-1893-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-CS-6665-01A,C16D9F69-26F9-4EC7-B2D5-FF9F7DACFE0F,Primary Tumor,Illumina HiSeq,9d827820-042a-412f-ae10-1f97190c446d,Brain,51,ABDDB338-559A-4386-872B-D1A57C460113,682D5B5E-3569-403C-B31C-887BD0AA26A5,TCGA-CS-6665-01A-11D-1893-08,HG19_Broad_variant,TCGA-CS-6665,TCGA-LGG,NA,s8317,Broad Institute of MIT and Harvard,Thomas Jefferson University,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa82ee4b0c9d6adf6a8ce,58cfa82ee4b0c9d6adf6a8ce,G35154.TCGA-FG-A4MT-02A-11D-A29Q-08.3.filtered.,WGS,G35154.TCGA-FG-A4MT-02A-11D-A29Q-08.3,G35154.TCGA-FG-A4MT-02A-11D-A29Q-08.3.bam,16.2,NA,0.09,58cfa82ee4b0c9d6adf6a8ce,G35154.TCGA-FG-A4MT-02A-11D-A29Q-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-A4MT-02A,E30F1994-3622-43D0-BEC2-6D7E2D9881D2,Recurrent Tumor,Illumina HiSeq,c0b259dd-e27a-46af-a639-f80a0e1e7fff,Brain,27,C83C991F-442C-471B-9019-318F6DA5D97F,185A3A5D-AF6B-4001-8B41-708E61B46CDA,TCGA-FG-A4MT-02A-11D-A29Q-08,HG19_Broad_variant,TCGA-FG-A4MT,TCGA-LGG,NA,s8543,Broad Institute of MIT and Harvard,Case Western,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa831e4b0c9d6adf6c78c,58cfa831e4b0c9d6adf6c78c,TCGA-CZ-5453-11A-01D-2102-10_wgs_Illumina.filtered.,WGS,TCGA-CZ-5453-11A-01D-2102-10_wgs_Illumina,TCGA-CZ-5453-11A-01D-2102-10_wgs_Illumina.bam,87.4,1.9,0.14,58cfa831e4b0c9d6adf6c78c,TCGA-CZ-5453-11A-01D-2102-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CZ-5453-11A,577847B9-F9B6-4954-868F-3D5AB2B4F694,Solid Tissue Normal,Illumina HiSeq,cabd58e7-62b7-4dee-aeb2-88576b747d22,Kidney,67,55ECC463-2410-491D-B052-C1CDE828E3FC,1187935B-396F-4E6E-8ABE-A95031D059AA,TCGA-CZ-5453-11A-01D-2102-10,GRCh37-lite,TCGA-CZ-5453,TCGA-KIRC,NA,s8841,Baylor College of Medicine,Harvard,None,NO,T2,NX,Kidney Clear Cell Renal Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6cd6a,58cfa831e4b0c9d6adf6cd6a,TCGA-FF-8043-10A-01D-2210-10_wgs_Illumina.filtered.,WGS,TCGA-FF-8043-10A-01D-2210-10_wgs_Illumina,TCGA-FF-8043-10A-01D-2210-10_wgs_Illumina.bam,281,NA,0.05,58cfa831e4b0c9d6adf6cd6a,TCGA-FF-8043-10A-01D-2210-10_wgs_Illumina.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Aligned reads,TCGA-FF-8043-10A,A8E2DF1E-4042-42AF-9231-3A00E83489F0,Blood Derived Normal,Illumina HiSeq,26415948-39c0-4fae-8a41-d024d7b1888a,Lymph Nodes,70,27BE14BB-D286-4663-ACD3-28B78459DF7E,DFA74511-2A52-4BD5-88F2-DAD8C7450BE4,TCGA-FF-8043-10A-01D-2210-10,GRCh37-lite,TCGA-FF-8043,TCGA-DLBC,NA,s1104,Baylor College of Medicine,SingHealth,Singapore,NO,Not available,Not available,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),Not available
13722.58cfa82ee4b0c9d6adf6b047,58cfa82ee4b0c9d6adf6b047,TCGA-06-0185-01A-01D-0507-08_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-06-0185-01A-01D-0507-08_IlluminaGA-DNASeq_whole,TCGA-06-0185-01A-01D-0507-08_IlluminaGA-DNASeq_whole.bam,194.47,1.89,0.17,58cfa82ee4b0c9d6adf6b047,TCGA-06-0185-01A-01D-0507-08_IlluminaGA-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0185-01A,8F3ACBBD-B2CA-4E66-8FE5-DBB49277F35B,Primary Tumor,Illumina GA,3079c9ec-0eb1-45ff-81d1-52cac14a6b6b,Brain,54,08737D76-27B8-4472-86F4-C25F99D98439,B6CDB961-42B2-489F-A59E-8C8B892CCA04,TCGA-06-0185-01A-01D-0507-08,HG18_Broad_variant,TCGA-06-0185,TCGA-GBM,NA,s14349,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa831e4b0c9d6adf6c99d,58cfa831e4b0c9d6adf6c99d,TCGA-DD-A1EG-11A-11D-A20W-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A1EG-11A-11D-A20W-10_wgs_Illumina,TCGA-DD-A1EG-11A-11D-A20W-10_wgs_Illumina.bam,21.95,NA,0.08,58cfa831e4b0c9d6adf6c99d,TCGA-DD-A1EG-11A-11D-A20W-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A1EG-11A,6C79F64B-63FE-46F5-BF7B-77208231B0F2,Solid Tissue Normal,Illumina HiSeq,94988a9d-9553-4e0b-a250-39d1540de001,Liver,76,47E4251C-0035-411A-B2DC-DDBAE8EE757A,8EF53597-A429-4BE9-9A3C-F74778AD9A92,TCGA-DD-A1EG-11A-11D-A20W-10,GRCh37-lite,TCGA-DD-A1EG,TCGA-LIHC,1372,s16584,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ac8a,58cfa82ee4b0c9d6adf6ac8a,G47088.TCGA-85-8277-10A-01D-2293-08.1.filtered.,WGS,G47088.TCGA-85-8277-10A-01D-2293-08.1,G47088.TCGA-85-8277-10A-01D-2293-08.1.bam,325.6,NA,0.05,58cfa82ee4b0c9d6adf6ac8a,G47088.TCGA-85-8277-10A-01D-2293-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-85-8277-10A,8E6020A1-68DF-4D57-AD4E-33ACC0861FB3,Blood Derived Normal,Illumina HiSeq,e9c73962-7720-4aad-86d7-519b0f9a3850,Lung,70,0A7903BC-2D51-4A5C-8D31-E9242025B1E3,D4EDCDDF-414F-42AC-AA5E-6D4EF4B4C3C6,TCGA-85-8277-10A-01D-2293-08,HG19_Broad_variant,TCGA-85-8277,TCGA-LUSC,NA,s10254,Broad Institute of MIT and Harvard,Asterand,Russia,NO,T3,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82ee4b0c9d6adf6acc2,58cfa82ee4b0c9d6adf6acc2,G48125.TCGA-23-1124-01A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-23-1124-01A-01D-A312-08.2,G48125.TCGA-23-1124-01A-01D-A312-08.2.bam,307.67,1.9,0.08,58cfa82ee4b0c9d6adf6acc2,G48125.TCGA-23-1124-01A-01D-A312-08.2.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-23-1124-01A,8A6D2CE3-CC57-451B-9B07-8263782AA23F,Primary Tumor,Illumina HiSeq,65f9302b-3490-40e3-926a-d77a313fe760,Ovary,62,D8246FDA-3072-4470-8A7C-DE05BAC409C2,9A5BB831-8CB8-4DE0-B94B-088CB38DEF1A,TCGA-23-1124-01A-01D-A312-08,HG19_Broad_variant,TCGA-23-1124,TCGA-OV,1768,s17409,Broad Institute of MIT and Harvard,Cedars Sinai,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6b050,58cfa82ee4b0c9d6adf6b050,TCGA-06-0185-10B-01D-0507-08_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-06-0185-10B-01D-0507-08_IlluminaGA-DNASeq_whole,TCGA-06-0185-10B-01D-0507-08_IlluminaGA-DNASeq_whole.bam,50,1.91,0.17,58cfa82ee4b0c9d6adf6b050,TCGA-06-0185-10B-01D-0507-08_IlluminaGA-DNASeq_whole.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0185-10B,8F3ACBBD-B2CA-4E66-8FE5-DBB49277F35B,Blood Derived Normal,Illumina GA,4a0826f7-1549-4c51-86ef-049b31559ef5,Brain,54,FDE1B781-B420-4F32-B5B3-17E93AE401E9,FD23F636-0953-4828-8272-1385405CE62A,TCGA-06-0185-10B-01D-0507-08,HG18_Broad_variant,TCGA-06-0185,TCGA-GBM,NA,s14102,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa832e4b0c9d6adf6d2c0,58cfa832e4b0c9d6adf6d2c0,TCGA-KL-8337-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8337-11A-01D-2310-10_wgs_Illumina,TCGA-KL-8337-11A-01D-2310-10_wgs_Illumina.bam,252.3,NA,0.05,58cfa832e4b0c9d6adf6d2c0,TCGA-KL-8337-11A-01D-2310-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8337-11A,5F633C79-FCF8-47DA-B349-ADA3FB794819,Solid Tissue Normal,Illumina HiSeq,699f5906-fec2-45de-804c-219cfc25c729,Kidney,26,73DCEEAF-C362-438F-B267-9A1497664BAD,48A0412D-0D33-43A8-9079-CCD5B28BEF22,TCGA-KL-8337-11A-01D-2310-10,GRCh37-lite,TCGA-KL-8337,TCGA-KICH,NA,s16523,Baylor College of Medicine,MSKCC,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa832e4b0c9d6adf6d39a,58cfa832e4b0c9d6adf6d39a,TCGA-KN-8437-11A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8437-11A-01D-2311-10_wgs_Illumina,TCGA-KN-8437-11A-01D-2311-10_wgs_Illumina.bam,200.3,NA,0.05,58cfa832e4b0c9d6adf6d39a,TCGA-KN-8437-11A-01D-2311-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KN-8437-11A,F1C1502E-1BD6-425A-B651-454363809668,Solid Tissue Normal,Illumina HiSeq,bb8a689c-6268-4ac9-ae71-f2b6ea0a522b,Kidney,42,C2FC0883-9F0B-4F89-B93A-4CBA2684742C,A1283C7D-6305-46D3-B518-47CB8B37BA18,TCGA-KN-8437-11A-01D-2311-10,GRCh37-lite,TCGA-KN-8437,TCGA-KICH,NA,s16440,Baylor College of Medicine,Harvard,United States,NO,T1a,NX,Kidney Chromophobe,Stage I
13722.58cfa831e4b0c9d6adf6cdea,58cfa831e4b0c9d6adf6cdea,TCGA-FF-8041-10A-01D-2210-10_wgs_Illumina.filtered.,WGS,TCGA-FF-8041-10A-01D-2210-10_wgs_Illumina,TCGA-FF-8041-10A-01D-2210-10_wgs_Illumina.bam,312,NA,0.05,58cfa831e4b0c9d6adf6cdea,TCGA-FF-8041-10A-01D-2210-10_wgs_Illumina.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Aligned reads,TCGA-FF-8041-10A,1F971AF1-6772-4FE6-8D35-BBE527A037FE,Blood Derived Normal,Illumina HiSeq,3546bd7f-86e7-4ca1-b760-08ddd46693b8,Lymph Nodes,28,D76966C6-72D5-4749-9013-BBA90CDA2415,D3EF8780-62A6-4DBB-AB8F-3E7122632EFC,TCGA-FF-8041-10A-01D-2210-10,GRCh37-lite,TCGA-FF-8041,TCGA-DLBC,NA,s1105,Baylor College of Medicine,SingHealth,Singapore,NO,Not available,Not available,Primary mediastinal (thymic) DLBCL,Not available
13722.58cfa830e4b0c9d6adf6bbfa,58cfa830e4b0c9d6adf6bbfa,TCGA-AG-3593-01A-01D-1525-10_hg19_wgs_Illumina.filtered.,WGS,TCGA-AG-3593-01A-01D-1525-10_hg19_wgs_Illumina,TCGA-AG-3593-01A-01D-1525-10_hg19_wgs_Illumina.bam,495.85,1.9,0.05,58cfa830e4b0c9d6adf6bbfa,TCGA-AG-3593-01A-01D-1525-10_hg19_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-3593-01A,10290E91-9784-4F94-8DAA-B5D9A8B0EFB9,Primary Tumor,Illumina HiSeq,9275573a-23ac-40aa-b792-cff9ee5bca8c,Colorectal,72,EFFCA0F1-E81D-47CD-8287-392A2B6AB786,FAFF4626-615B-416A-B7A6-9D177DCC94A9,TCGA-AG-3593-01A-01D-1525-10,GRCh37-lite,TCGA-AG-3593,TCGA-READ,NA,s1953,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa832e4b0c9d6adf6d3b8,58cfa832e4b0c9d6adf6d3b8,TCGA-KO-8409-11A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KO-8409-11A-01D-2311-10_wgs_Illumina,TCGA-KO-8409-11A-01D-2311-10_wgs_Illumina.bam,192.2,NA,0.05,58cfa832e4b0c9d6adf6d3b8,TCGA-KO-8409-11A-01D-2311-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KO-8409-11A,08A96DEC-E658-493A-9308-83F7ACE3B3B6,Solid Tissue Normal,Illumina HiSeq,2832fcef-af94-4b00-a9bc-1c317b512393,Kidney,69,E7BE5810-DA66-45CA-BF89-4D84D6F980C2,AB217C1C-6141-4391-85A8-CACD3C7B1989,TCGA-KO-8409-11A-01D-2311-10,GRCh37-lite,TCGA-KO-8409,TCGA-KICH,NA,s16575,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T2b,N0,Kidney Chromophobe,Stage II
13722.58cfa82ee4b0c9d6adf6af46,58cfa82ee4b0c9d6adf6af46,G48125.TCGA-10-0934-01A-02D-A312-08.3.filtered.,WGS,G48125.TCGA-10-0934-01A-02D-A312-08.3,G48125.TCGA-10-0934-01A-02D-A312-08.3.bam,91.67,1.8,0.07,58cfa82ee4b0c9d6adf6af46,G48125.TCGA-10-0934-01A-02D-A312-08.3.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-10-0934-01A,65DDCCD2-70A7-48B3-88E1-9D6FD1DCD11B,Primary Tumor,Illumina HiSeq,91697160-9785-41b6-a697-589c82cd7017,Ovary,50,27A33C2D-6704-4164-AA5B-894665DEA55F,0664753B-7566-41E0-8006-7009C6735406,TCGA-10-0934-01A-02D-A312-08,HG19_Broad_variant,TCGA-10-0934,TCGA-OV,204,s17165,Broad Institute of MIT and Harvard,MD Anderson Cancer Center,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6abb6,58cfa82ee4b0c9d6adf6abb6,G35154.TCGA-TQ-A7RK-02B-11D-A401-08.3.filtered.,WGS,G35154.TCGA-TQ-A7RK-02B-11D-A401-08.3,G35154.TCGA-TQ-A7RK-02B-11D-A401-08.3.bam,30.57,NA,0.08,58cfa82ee4b0c9d6adf6abb6,G35154.TCGA-TQ-A7RK-02B-11D-A401-08.3.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-TQ-A7RK-02B,2F8C789E-BBD8-4753-A48B-6894C21162F8,Recurrent Tumor,Illumina HiSeq,18937bf6-6756-4b8b-8728-e1cabbc746c3,Brain,29,63C9B565-4509-4B86-95C6-AC3ADCB40F3C,50F03B20-B605-4A6E-A55A-558B38BFF7F0,TCGA-TQ-A7RK-02B-11D-A401-08,HG19_Broad_variant,TCGA-TQ-A7RK,TCGA-LGG,NA,s8118,Broad Institute of MIT and Harvard,University of Sao Paulo,Brazil,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa832e4b0c9d6adf6d307,58cfa832e4b0c9d6adf6d307,TCGA-KN-8422-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8422-11A-01D-2310-10_wgs_Illumina,TCGA-KN-8422-11A-01D-2310-10_wgs_Illumina.bam,262.3,NA,0.05,58cfa832e4b0c9d6adf6d307,TCGA-KN-8422-11A-01D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KN-8422-11A,4A88BC85-4C6E-4FAC-8DBB-D3FC5F36B35E,Solid Tissue Normal,Illumina HiSeq,74f6d255-bbc0-4931-8cce-c48d9a3b13f9,Kidney,28,BBE0EF99-A144-4EA4-9A06-5C58326B1F62,E13915DF-0BA2-4242-B4F7-27733B6A01C1,TCGA-KN-8422-11A-01D-2310-10,GRCh37-lite,TCGA-KN-8422,TCGA-KICH,NA,s16395,Baylor College of Medicine,Harvard,United States,NO,T1a,N0,Kidney Chromophobe,Stage I
13722.58cfa82ee4b0c9d6adf6a9f1,58cfa82ee4b0c9d6adf6a9f1,G2147.TCGA-06-0648-01A-01D.7.filtered.,WGS,G2147.TCGA-06-0648-01A-01D.7,G2147.TCGA-06-0648-01A-01D.7.bam,39.37,1.9,0.17,58cfa82ee4b0c9d6adf6a9f1,G2147.TCGA-06-0648-01A-01D.7.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0648-01A,EF6F6553-2575-457E-BC07-401215E54759,Primary Tumor,Illumina GA,66b4cdf4-5d74-4514-8c3f-cae0a74357c0,Brain,77,A622A4B1-4A42-4CF9-A9FE-86FEE854C93D,7678C0F3-0971-4D88-B3EF-841E1C10D671,TCGA-06-0648-01A-01D-0507-08,HG19_Broad_variant,TCGA-06-0648,TCGA-GBM,298,s13978,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa832e4b0c9d6adf6d1e0,58cfa832e4b0c9d6adf6d1e0,TCGA-KL-8323-01A-21D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8323-01A-21D-2310-10_wgs_Illumina,TCGA-KL-8323-01A-21D-2310-10_wgs_Illumina.bam,4.8,NA,0.05,58cfa832e4b0c9d6adf6d1e0,TCGA-KL-8323-01A-21D-2310-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8323-01A,83B3060C-2449-4581-88EF-817D126E4525,Primary Tumor,Illumina HiSeq,8854b195-7eb9-4554-8702-96ed5dd9029f,Kidney,57,8AA1A5F6-3548-494A-857B-E08124AEB9A9,FAE88D21-171C-4DF4-B258-3C5948A1034B,TCGA-KL-8323-01A-21D-2310-10,GRCh37-lite,TCGA-KL-8323,TCGA-KICH,1158,s16471,Baylor College of Medicine,MSKCC,United States,NO,T3b,NX,Kidney Chromophobe,Stage III
13722.58cfa832e4b0c9d6adf6d2f4,58cfa832e4b0c9d6adf6d2f4,TCGA-KN-8427-11A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8427-11A-01D-2311-10_wgs_Illumina,TCGA-KN-8427-11A-01D-2311-10_wgs_Illumina.bam,225.3,NA,0.05,58cfa832e4b0c9d6adf6d2f4,TCGA-KN-8427-11A-01D-2311-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KN-8427-11A,955D428C-8FE8-456B-B86D-65EA6C2A1B18,Solid Tissue Normal,Illumina HiSeq,3139eae4-abc0-479d-a53a-ca1675a6a77c,Kidney,54,4D704013-A663-4756-8A1F-C6043097A68B,8C9E2CE1-0C90-49E7-A0EA-0AC0EFCB7F6B,TCGA-KN-8427-11A-01D-2311-10,GRCh37-lite,TCGA-KN-8427,TCGA-KICH,NA,s16441,Baylor College of Medicine,Harvard,United States,NO,T4,N1,Kidney Chromophobe,Stage IV
13722.58cfa832e4b0c9d6adf6d2f7,58cfa832e4b0c9d6adf6d2f7,TCGA-KN-8428-11A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8428-11A-01D-2311-10_wgs_Illumina,TCGA-KN-8428-11A-01D-2311-10_wgs_Illumina.bam,230.3,NA,0.05,58cfa832e4b0c9d6adf6d2f7,TCGA-KN-8428-11A-01D-2311-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KN-8428-11A,455FD7D4-5FF4-423F-83CE-4630AEF89BB7,Solid Tissue Normal,Illumina HiSeq,b8f344b6-d91d-4212-bc9e-7839cb29aca0,Kidney,71,63BEB494-E581-44E7-800B-5F0FC1EDD6AF,7A9405F5-81BF-4879-ABFE-2688B8F3CA93,TCGA-KN-8428-11A-01D-2311-10,GRCh37-lite,TCGA-KN-8428,TCGA-KICH,1590,s16491,Baylor College of Medicine,Harvard,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa82ee4b0c9d6adf6ab54,58cfa82ee4b0c9d6adf6ab54,G37566.TCGA-CH-5788-01A-11D-1576-08.4.filtered.,WGS,G37566.TCGA-CH-5788-01A-11D-1576-08.4,G37566.TCGA-CH-5788-01A-11D-1576-08.4.bam,257.7,1.9,0.05,58cfa82ee4b0c9d6adf6ab54,G37566.TCGA-CH-5788-01A-11D-1576-08.4.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,Aligned reads,TCGA-CH-5788-01A,C039014F-821C-43D6-9D3C-914F9C8D98FA,Primary Tumor,Illumina HiSeq,fc337685-dcbd-4e7f-9b5b-369121193a7a,Prostate,69,144E0265-C04E-4538-A721-94DEF2570486,9E272BEA-9193-4C10-A802-F7E18B2937A3,TCGA-CH-5788-01A-11D-1576-08,HG19_Broad_variant,TCGA-CH-5788,TCGA-PRAD,NA,s3579,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa830e4b0c9d6adf6bd76,58cfa830e4b0c9d6adf6bd76,TCGA-AL-A5DJ-10A-01D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-AL-A5DJ-10A-01D-A26P-10_wgs_Illumina,TCGA-AL-A5DJ-10A-01D-A26P-10_wgs_Illumina.bam,36.37,NA,0.08,58cfa830e4b0c9d6adf6bd76,TCGA-AL-A5DJ-10A-01D-A26P-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-AL-A5DJ-10A,B06CDF61-61C9-4035-A55D-1EF21DC21069,Blood Derived Normal,Illumina HiSeq,5040e957-e2a5-450d-9823-a492b4466715,Kidney,54,550329F8-7EEA-4C5B-BA79-10D616A50609,7C64233C-871D-4DF4-8C4D-D60713A4AC1E,TCGA-AL-A5DJ-10A-01D-A26P-10,GRCh37-lite,TCGA-AL-A5DJ,TCGA-KIRP,NA,s11767,Baylor College of Medicine,Fox Chase,United States,NO,T3a,NX,Kidney Papillary Renal Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6c44c,58cfa831e4b0c9d6adf6c44c,TCGA-CJ-5681-11A-01D-1535-10_wgs_Illumina.filtered.,WGS,TCGA-CJ-5681-11A-01D-1535-10_wgs_Illumina,TCGA-CJ-5681-11A-01D-1535-10_wgs_Illumina.bam,85.4,1.9,0.05,58cfa831e4b0c9d6adf6c44c,TCGA-CJ-5681-11A-01D-1535-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CJ-5681-11A,2939C03A-6F3F-4F7B-B246-34361BAADEB9,Solid Tissue Normal,Illumina HiSeq,1648741e-e86b-4dad-9a4e-c0bb46e17b88,Kidney,44,D7BBC19B-5690-47FC-94EF-25DBADE69A47,18405E90-5663-4BF6-A93E-EB84613A8D4C,TCGA-CJ-5681-11A-01D-1535-10,GRCh37-lite,TCGA-CJ-5681,TCGA-KIRC,552,s9570,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T3a,NX,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa831e4b0c9d6adf6c845,58cfa831e4b0c9d6adf6c845,TCGA-CV-5442-01A-01D-2266-10_Illumina.filtered.,WGS,TCGA-CV-5442-01A-01D-2266-10_Illumina,TCGA-CV-5442-01A-01D-2266-10_Illumina.bam,323.7,1.9,0.05,58cfa831e4b0c9d6adf6c845,TCGA-CV-5442-01A-01D-2266-10_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5442-01A,3C975B68-4A6E-4C97-A8D1-B9A427D4957C,Primary Tumor,Illumina HiSeq,53f0ce53-95fe-4d6c-930d-f8427c0c46ec,Head and Neck,76,698208BB-7272-4AD5-9CC0-909CB669BDAF,46D35B82-E1B7-4D35-BE5E-3A70FD47E421,TCGA-CV-5442-01A-01D-2266-10,GRCh37-lite,TCGA-CV-5442,TCGA-HNSC,NA,s16336,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6cda2,58cfa831e4b0c9d6adf6cda2,TCGA-FF-8042-10A-01D-2210-10_wgs_Illumina.filtered.,WGS,TCGA-FF-8042-10A-01D-2210-10_wgs_Illumina,TCGA-FF-8042-10A-01D-2210-10_wgs_Illumina.bam,219,NA,0.05,58cfa831e4b0c9d6adf6cda2,TCGA-FF-8042-10A-01D-2210-10_wgs_Illumina.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Aligned reads,TCGA-FF-8042-10A,F0A326D2-1F3E-4A5D-BCA8-32AACCC52338,Blood Derived Normal,Illumina HiSeq,9c403866-10bb-4832-8285-5a615541053b,Lymph Nodes,57,ED98350E-E546-4EFD-805D-225F52EB29BF,92BD05D0-5CB1-4E14-9C66-C3B020B1D9C2,TCGA-FF-8042-10A-01D-2210-10,GRCh37-lite,TCGA-FF-8042,TCGA-DLBC,NA,s1107,Baylor College of Medicine,SingHealth,Singapore,NO,Not available,Not available,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),Not available
13722.58cfa832e4b0c9d6adf6d30f,58cfa832e4b0c9d6adf6d30f,TCGA-KN-8426-11A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8426-11A-01D-2311-10_wgs_Illumina,TCGA-KN-8426-11A-01D-2311-10_wgs_Illumina.bam,247.3,NA,0.05,58cfa832e4b0c9d6adf6d30f,TCGA-KN-8426-11A-01D-2311-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KN-8426-11A,B08DFBA8-6AFB-4217-9259-72BE6F1F3363,Solid Tissue Normal,Illumina HiSeq,5463c070-5310-4b18-bd1e-1a75d1dfc029,Kidney,50,14FDD7A2-B544-491A-8689-F321DBC929E6,FB5C34CE-5B82-4BD7-A195-5F0C2DAB07D4,TCGA-KN-8426-11A-01D-2311-10,GRCh37-lite,TCGA-KN-8426,TCGA-KICH,NA,s16405,Baylor College of Medicine,Harvard,United States,NO,T3a,NX,Kidney Chromophobe,Stage IV
13722.58cfa832e4b0c9d6adf6d2de,58cfa832e4b0c9d6adf6d2de,TCGA-KL-8340-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8340-11A-01D-2310-10_wgs_Illumina,TCGA-KL-8340-11A-01D-2310-10_wgs_Illumina.bam,209.3,NA,0.05,58cfa832e4b0c9d6adf6d2de,TCGA-KL-8340-11A-01D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8340-11A,3129E869-BB2F-423A-BD20-D0DAAE33B11A,Solid Tissue Normal,Illumina HiSeq,2ea28763-5451-41c6-831e-6e763250abe6,Kidney,34,502BEE65-1050-4753-9304-F677AB2EB00D,44123123-63E3-46BD-85EE-C66A37C942A3,TCGA-KL-8340-11A-01D-2310-10,GRCh37-lite,TCGA-KL-8340,TCGA-KICH,NA,s16398,Baylor College of Medicine,MSKCC,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa82fe4b0c9d6adf6b832,58cfa82fe4b0c9d6adf6b832,TCGA-A4-A4ZT-10A-01D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-A4-A4ZT-10A-01D-A26P-10_wgs_Illumina,TCGA-A4-A4ZT-10A-01D-A26P-10_wgs_Illumina.bam,11.48,NA,0.08,58cfa82fe4b0c9d6adf6b832,TCGA-A4-A4ZT-10A-01D-A26P-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-A4-A4ZT-10A,8B3C068D-5090-4030-8E7E-39DA005DEE79,Blood Derived Normal,Illumina HiSeq,a334d198-62ac-4caa-a10f-e769d5012355,Kidney,71,402DC221-B949-4C8F-8A8C-36F40E5CEF0B,3C59A740-98EB-4A0D-8694-AC30AB89B553,TCGA-A4-A4ZT-10A-01D-A26P-10,GRCh37-lite,TCGA-A4-A4ZT,TCGA-KIRP,NA,s11851,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1b,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6a9fd,58cfa82ee4b0c9d6adf6a9fd,G32534.TCGA-DJ-A3US-01A-11D-A22D-08.3.filtered.,WGS,G32534.TCGA-DJ-A3US-01A-11D-A22D-08.3,G32534.TCGA-DJ-A3US-01A-11D-A22D-08.3.bam,47.65,NA,0.08,58cfa82ee4b0c9d6adf6a9fd,G32534.TCGA-DJ-A3US-01A-11D-A22D-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A3US-01A,6EE95DC8-2BAC-4691-AFA2-8222E07506AD,Primary Tumor,Illumina HiSeq,dbbfcd8f-5283-4bf9-98f1-9211808bfed9,Thyroid,37,9F63C13D-6008-416E-9E6B-D4ED4210E569,AD874249-9964-4E48-AA3F-7E828EA28F3F,TCGA-DJ-A3US-01A-11D-A22D-08,HG19_Broad_variant,TCGA-DJ-A3US,TCGA-THCA,NA,s12730,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82ee4b0c9d6adf6ac92,58cfa82ee4b0c9d6adf6ac92,G47088.TCGA-92-8064-10A-01D-2244-08.2.filtered.,WGS,G47088.TCGA-92-8064-10A-01D-2244-08.2,G47088.TCGA-92-8064-10A-01D-2244-08.2.bam,245.63,NA,0.05,58cfa82ee4b0c9d6adf6ac92,G47088.TCGA-92-8064-10A-01D-2244-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-92-8064-10A,DC6CEECE-EFAA-4B9D-9E12-D35863D7A902,Blood Derived Normal,Illumina HiSeq,143f231d-b564-4812-95c2-872fd49155c7,Lung,58,B380D9B9-5562-400E-9A14-E7817D7C5AE4,3F377ED6-ADF8-4874-8DC1-0A52DF72F6D0,TCGA-92-8064-10A-01D-2244-08,HG19_Broad_variant,TCGA-92-8064,TCGA-LUSC,NA,s10159,Broad Institute of MIT and Harvard,Washington University - St. Louis,United States,NO,T2b,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6af82,58cfa82ee4b0c9d6adf6af82,G39020.TCGA-D7-6822-01A-11D-1882-08.3.filtered.,WGS,G39020.TCGA-D7-6822-01A-11D-1882-08.3,G39020.TCGA-D7-6822-01A-11D-1882-08.3.bam,442.7,1.9,0.05,58cfa82ee4b0c9d6adf6af82,G39020.TCGA-D7-6822-01A-11D-1882-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6822-01A,E2AAABD9-F4BA-4763-A28A-C14D46A4BC5D,Primary Tumor,Illumina HiSeq,6bbb2709-a3ca-451a-82c8-996e619878b9,Stomach,77,C30AFDA8-FC63-4228-A9A9-42BCDB562ACE,1021B60D-F7B2-43B0-B2CC-F282D619D533,TCGA-D7-6822-01A-11D-1882-08,HG19_Broad_variant,TCGA-D7-6822,TCGA-STAD,NA,s15097,Broad Institute of MIT and Harvard,Greater Poland Cancer Center,Poland,NO,T2,N0,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IB
13722.58cfa832e4b0c9d6adf6ce82,58cfa832e4b0c9d6adf6ce82,TCGA-FV-A3R3-10A-01D-A22F-10_wgs_Illumina.filtered.,WGS,TCGA-FV-A3R3-10A-01D-A22F-10_wgs_Illumina,TCGA-FV-A3R3-10A-01D-A22F-10_wgs_Illumina.bam,31.27,NA,0.08,58cfa832e4b0c9d6adf6ce82,TCGA-FV-A3R3-10A-01D-A22F-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-FV-A3R3-10A,3DD7C93D-8194-44EE-8014-10DD81EF6441,Blood Derived Normal,Illumina HiSeq,faf36a41-75ac-4cb2-8766-8a6f549a3d28,Liver,38,ACFD9A5E-4AC4-47F0-BD62-AED70AD2BF9F,64EDDDFD-F366-4D51-A8B4-A357B2C68E6C,TCGA-FV-A3R3-10A-01D-A22F-10,GRCh37-lite,TCGA-FV-A3R3,TCGA-LIHC,NA,s16684,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6af96,58cfa82ee4b0c9d6adf6af96,G49538.TCGA-06-0221-02A-11D-2280-08.1.filtered.,WGS,G49538.TCGA-06-0221-02A-11D-2280-08.1,G49538.TCGA-06-0221-02A-11D-2280-08.1.bam,135.06,1.9,0.05,58cfa82ee4b0c9d6adf6af96,G49538.TCGA-06-0221-02A-11D-2280-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0221-02A,054F472F-98CB-4559-B2E2-B5F800FC8EEF,Recurrent Tumor,Illumina HiSeq,6619b98a-9891-4fe3-976c-63cc7ce714e9,Brain,31,A1A8520B-8AAD-4CFC-A1AC-9BA874BA348A,B2D17671-D2E1-4C97-8B01-A976D5ABE1D6,TCGA-06-0221-02A-11D-2280-08,HG19_Broad_variant,TCGA-06-0221,TCGA-GBM,603,s14310,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa831e4b0c9d6adf6c9a3,58cfa831e4b0c9d6adf6c9a3,TCGA-DD-A1EI-11A-11D-A12Z-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A1EI-11A-11D-A12Z-10_wgs_Illumina,TCGA-DD-A1EI-11A-11D-A12Z-10_wgs_Illumina.bam,31.11,1.93,0.08,58cfa831e4b0c9d6adf6c9a3,TCGA-DD-A1EI-11A-11D-A12Z-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A1EI-11A,3ACF7438-FD65-442C-8A30-68B6714537F3,Solid Tissue Normal,Illumina HiSeq,7fc26219-b7be-4009-9daa-f8dc2c2883bc,Liver,46,48F02D39-0821-4A45-87A1-11349283E105,F48E484A-7373-4FFB-BBD7-41C3D2F91D5F,TCGA-DD-A1EI-11A-11D-A12Z-10,GRCh37-lite,TCGA-DD-A1EI,TCGA-LIHC,NA,s16774,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6cd92,58cfa831e4b0c9d6adf6cd92,TCGA-FF-8046-10A-01D-2210-10_wgs_Illumina.filtered.,WGS,TCGA-FF-8046-10A-01D-2210-10_wgs_Illumina,TCGA-FF-8046-10A-01D-2210-10_wgs_Illumina.bam,597,NA,0.05,58cfa831e4b0c9d6adf6cd92,TCGA-FF-8046-10A-01D-2210-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Aligned reads,TCGA-FF-8046-10A,67325322-483F-443F-9FFA-2A20D108A2FB,Blood Derived Normal,Illumina HiSeq,17765332-d068-46ac-b6da-e1ab8b25bd73,Lymph Nodes,51,97997154-8089-4619-B290-9CEE16160D45,35736B32-0A2A-45C0-AEF9-5E7F3D2733AA,TCGA-FF-8046-10A-01D-2210-10,GRCh37-lite,TCGA-FF-8046,TCGA-DLBC,NA,s1106,Baylor College of Medicine,SingHealth,Singapore,NO,Not available,Not available,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),Not available
13722.58cfa832e4b0c9d6adf6d2d2,58cfa832e4b0c9d6adf6d2d2,TCGA-KL-8346-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8346-11A-01D-2310-10_wgs_Illumina,TCGA-KL-8346-11A-01D-2310-10_wgs_Illumina.bam,187.8,NA,0.05,58cfa832e4b0c9d6adf6d2d2,TCGA-KL-8346-11A-01D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8346-11A,A122D361-835E-4CF2-850F-AF7864AA112C,Solid Tissue Normal,Illumina HiSeq,7912daa1-e634-487d-ad82-43698738c0b0,Kidney,62,9D387257-A798-4CAB-9EAB-1FA285D618A8,684B307D-9053-47DC-B223-A5B491327703,TCGA-KL-8346-11A-01D-2310-10,GRCh37-lite,TCGA-KL-8346,TCGA-KICH,NA,s16482,Baylor College of Medicine,MSKCC,United States,NO,T2b,N0,Kidney Chromophobe,Stage II
13722.58cfa82fe4b0c9d6adf6b952,58cfa82fe4b0c9d6adf6b952,TCGA-AA-3534-01A-01D-1525-10_hg19_wgs_Illumina.filtered.,WGS,TCGA-AA-3534-01A-01D-1525-10_hg19_wgs_Illumina,TCGA-AA-3534-01A-01D-1525-10_hg19_wgs_Illumina.bam,84.63,1.9,0.05,58cfa82fe4b0c9d6adf6b952,TCGA-AA-3534-01A-01D-1525-10_hg19_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3534-01A,DF228C56-89AC-4122-93B3-6C0740C4EC09,Primary Tumor,Illumina HiSeq,6e533853-5822-49cf-95a8-d75c517521cc,Colorectal,78,ECADE2C1-9DE2-4B05-B30C-4C8B81C65AE1,66701395-5A53-41BB-866B-3BBF08BC33AB,TCGA-AA-3534-01A-01D-1525-10,GRCh37-lite,TCGA-AA-3534,TCGA-COAD,NA,s12861,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa832e4b0c9d6adf6d2ec,58cfa832e4b0c9d6adf6d2ec,TCGA-KN-8430-11A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8430-11A-01D-2311-10_wgs_Illumina,TCGA-KN-8430-11A-01D-2311-10_wgs_Illumina.bam,179.3,NA,0.05,58cfa832e4b0c9d6adf6d2ec,TCGA-KN-8430-11A-01D-2311-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KN-8430-11A,9F8AA332-E625-46F7-B77B-1FCB3CA99EE2,Solid Tissue Normal,Illumina HiSeq,4e787aeb-1a2f-493f-98ed-4ef7410d3420,Kidney,75,09752CAC-5A29-4C5B-822F-0F66C784ACAE,0E26AD23-4697-4346-BB99-8CDDD8D612C7,TCGA-KN-8430-11A-01D-2311-10,GRCh37-lite,TCGA-KN-8430,TCGA-KICH,NA,s16444,Baylor College of Medicine,Harvard,United States,NO,T1b,N0,Kidney Chromophobe,Stage I
13722.58cfa832e4b0c9d6adf6d2ee,58cfa832e4b0c9d6adf6d2ee,TCGA-KM-8639-10A-01D-2397-10_wgs_Illumina.filtered.,WGS,TCGA-KM-8639-10A-01D-2397-10_wgs_Illumina,TCGA-KM-8639-10A-01D-2397-10_wgs_Illumina.bam,231,NA,0.05,58cfa832e4b0c9d6adf6d2ee,TCGA-KM-8639-10A-01D-2397-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KM-8639-10A,2EA84E23-6A0A-4C5D-9C70-D5355A85DF35,Blood Derived Normal,Illumina HiSeq,bb4da06c-6a47-4afa-8979-7d84d37b1cfb,Kidney,67,D3830F71-78A0-4CE5-954C-A22D13E2680B,04E0D4A3-5826-41D0-9E72-19C5D4CE08FF,TCGA-KM-8639-10A-01D-2397-10,GRCh37-lite,TCGA-KM-8639,TCGA-KICH,NA,s16571,Baylor College of Medicine,NCI Urologic Oncology Branch,United States,NO,T1a,NX,Kidney Chromophobe,Stage I
13722.58cfa82ee4b0c9d6adf6a988,58cfa82ee4b0c9d6adf6a988,G35154.TCGA-DU-6407-02A-12D-A36O-08.2.filtered.,WGS,G35154.TCGA-DU-6407-02A-12D-A36O-08.2,G35154.TCGA-DU-6407-02A-12D-A36O-08.2.bam,8.83,NA,0.09,58cfa82ee4b0c9d6adf6a988,G35154.TCGA-DU-6407-02A-12D-A36O-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6407-02A,70939245-41E0-4845-A473-5FEF719B9828,Recurrent Tumor,Illumina HiSeq,5c3c83f3-c65b-4c23-99d4-64183122fe2c,Brain,35,C6DF9292-94A9-4804-B1D7-A471AFA1DADE,1C4E4BCA-3C01-4651-9F8B-509196553AEB,TCGA-DU-6407-02A-12D-A36O-08,HG19_Broad_variant,TCGA-DU-6407,TCGA-LGG,2875,s8540,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6af5b,58cfa82ee4b0c9d6adf6af5b,G48125.TCGA-09-2050-01A-01D-A312-08.1.filtered.,WGS,G48125.TCGA-09-2050-01A-01D-A312-08.1,G48125.TCGA-09-2050-01A-01D-A312-08.1.bam,724.97,1.9,0.08,58cfa82ee4b0c9d6adf6af5b,G48125.TCGA-09-2050-01A-01D-A312-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-09-2050-01A,3C037ACF-F453-4513-A6DD-129163DDDE2A,Primary Tumor,Illumina HiSeq,221bef91-5df9-4516-81ee-79e1ffc01030,Ovary,65,239E7813-BA65-4F3C-B7DE-77E166707C75,7A921087-8E62-4A93-A757-FD8CDBE1EB8F,TCGA-09-2050-01A-01D-A312-08,HG19_Broad_variant,TCGA-09-2050,TCGA-OV,NA,s17351,Broad Institute of MIT and Harvard,UCSF,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6acfc,58cfa82ee4b0c9d6adf6acfc,G49537.TCGA-EM-A22O-10A-01D-A17V-08.1.filtered.,WGS,G49537.TCGA-EM-A22O-10A-01D-A17V-08.1,G49537.TCGA-EM-A22O-10A-01D-A17V-08.1.bam,18.09,NA,0.08,58cfa82ee4b0c9d6adf6acfc,G49537.TCGA-EM-A22O-10A-01D-A17V-08.1.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EM-A22O-10A,6ABC861A-376D-446B-ACEE-FB0F03A82C09,Blood Derived Normal,Illumina HiSeq,c18338b5-a4c5-444b-8e99-fa6cf1c953b8,Thyroid,75,5A8265D8-F0CC-4198-885C-464C671D9C9E,EA378B05-B95E-468D-B026-5A3B783795DC,TCGA-EM-A22O-10A-01D-A17V-08,HG19_Broad_variant,TCGA-EM-A22O,TCGA-THCA,NA,s11982,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T4a,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA
13722.58cfa832e4b0c9d6adf6ce52,58cfa832e4b0c9d6adf6ce52,TCGA-FV-A2QQ-10B-01D-A22F-10_wgs_Illumina.filtered.,WGS,TCGA-FV-A2QQ-10B-01D-A22F-10_wgs_Illumina,TCGA-FV-A2QQ-10B-01D-A22F-10_wgs_Illumina.bam,10.86,NA,0.07,58cfa832e4b0c9d6adf6ce52,TCGA-FV-A2QQ-10B-01D-A22F-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-FV-A2QQ-10B,D680DF09-368E-42B5-B540-45C41ED31042,Blood Derived Normal,Illumina HiSeq,39ba7aa8-e6e5-4bf2-8c75-54d836634c3a,Liver,80,C4265FC1-0DE8-4BFF-976E-4E1E91D28303,E31C3B51-9A28-4191-B67F-21AC68E47C1E,TCGA-FV-A2QQ-10B-01D-A22F-10,GRCh37-lite,TCGA-FV-A2QQ,TCGA-LIHC,NA,s17061,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1,N1,Hepatocellular Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c6b2,58cfa831e4b0c9d6adf6c6b2,TCGA-CR-5249-01A-01D-2276-10_wgs_Illumina.filtered.,WGS,TCGA-CR-5249-01A-01D-2276-10_wgs_Illumina,TCGA-CR-5249-01A-01D-2276-10_wgs_Illumina.bam,213.73,1.9,0.05,58cfa831e4b0c9d6adf6c6b2,TCGA-CR-5249-01A-01D-2276-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-5249-01A,C7DF3466-B9A7-4818-883B-D0CD08483570,Primary Tumor,Illumina HiSeq,cef48339-6b24-4da9-b25d-55a64c71d0dc,Head and Neck,35,6697DD71-5A58-4862-B26E-EA16DCC383F2,C0812962-A345-48B7-AEC0-01336C2D1EED,TCGA-CR-5249-01A-01D-2276-10,GRCh37-lite,TCGA-CR-5249,TCGA-HNSC,NA,s15894,Baylor College of Medicine,Vanderbilt University,None,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa830e4b0c9d6adf6c212,58cfa830e4b0c9d6adf6c212,TCGA-BC-A10Q-11A-11D-A12Z-10_wgs_Illumina.filtered.,WGS,TCGA-BC-A10Q-11A-11D-A12Z-10_wgs_Illumina,TCGA-BC-A10Q-11A-11D-A12Z-10_wgs_Illumina.bam,33.15,1.95,0.08,58cfa830e4b0c9d6adf6c212,TCGA-BC-A10Q-11A-11D-A12Z-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-BC-A10Q-11A,DFA15FBE-BB14-40CE-AFC6-70694112E3E2,Solid Tissue Normal,Illumina HiSeq,50a904b6-ea19-40eb-adc0-a1d8cd4bf6a8,Liver,72,5D3BF988-3331-4412-BC17-B8F4650A8623,454F62CA-7688-48E6-8A59-0149D11F1FE3,TCGA-BC-A10Q-11A-11D-A12Z-10,GRCh37-lite,TCGA-BC-A10Q,TCGA-LIHC,1135,s16970,Baylor College of Medicine,UNC,United States,NO,T2,NX,Hepatocellular Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ae3b,58cfa82ee4b0c9d6adf6ae3b,G49837.TCGA-77-7139-01A-11D-A320-08.3.filtered.,WGS,G49837.TCGA-77-7139-01A-11D-A320-08.3,G49837.TCGA-77-7139-01A-11D-A320-08.3.bam,403,NA,0.08,58cfa82ee4b0c9d6adf6ae3b,G49837.TCGA-77-7139-01A-11D-A320-08.3.bam,Alive,MALE,WHITE,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-77-7139-01A,EE850103-6314-41A3-9734-8B520DE95B40,Primary Tumor,Illumina HiSeq,af2dee93-083d-492d-87c8-73cb962d49a2,Lung,56,48F646FE-03C6-4E7B-ACF1-9869E379443E,AD41F1F3-E38E-4418-9C16-52BCA5719F39,TCGA-77-7139-01A-11D-A320-08,HG19_Broad_variant,TCGA-77-7139,TCGA-LUSC,NA,s10260,Broad Institute of MIT and Harvard,Prince Charles Hospital,Australia,NO,T2,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6ad33,58cfa82ee4b0c9d6adf6ad33,G49837.TCGA-66-2759-01A-01D-A320-08.2.filtered.,WGS,G49837.TCGA-66-2759-01A-01D-A320-08.2,G49837.TCGA-66-2759-01A-01D-A320-08.2.bam,604.93,1.9,0.08,58cfa82ee4b0c9d6adf6ad33,G49837.TCGA-66-2759-01A-01D-A320-08.2.bam,Alive,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-66-2759-01A,E6B72C24-1607-43B9-8B8A-7BF83EEA5895,Primary Tumor,Illumina HiSeq,38482025-33d2-4b12-a2f0-2654d26fe714,Lung,66,33918A59-C2B0-435E-BA63-8A39DA191712,7AC0B303-D685-4FA5-BFEC-34D2BA1DBC8E,TCGA-66-2759-01A-01D-A320-08,HG19_Broad_variant,TCGA-66-2759,TCGA-LUSC,NA,s10165,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N2,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82ee4b0c9d6adf6a9b8,58cfa82ee4b0c9d6adf6a9b8,G2145.TCGA-06-0152-01A-02D.12.filtered.,WGS,G2145.TCGA-06-0152-01A-02D.12,G2145.TCGA-06-0152-01A-02D.12.bam,446.47,1.9,0.17,58cfa82ee4b0c9d6adf6a9b8,G2145.TCGA-06-0152-01A-02D.12.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0152-01A,F5BC5D97-E054-4E53-992D-71B896BD97D5,Primary Tumor,Illumina GA,2b8f90c5-4947-485a-bae1-932e1c4cd57c,Brain,68,1B8EFA87-5057-48D9-BE73-CFB1955A16BB,A99749A3-18E0-4869-842D-B225F39CFD07,TCGA-06-0152-01A-02D-0507-08,HG19_Broad_variant,TCGA-06-0152,TCGA-GBM,375,s14301,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6a97e,58cfa82ee4b0c9d6adf6a97e,G35154.TCGA-DU-7013-01A-11D-A461-08.1.filtered.,WGS,G35154.TCGA-DU-7013-01A-11D-A461-08.1,G35154.TCGA-DU-7013-01A-11D-A461-08.1.bam,277.7,NA,0.08,58cfa82ee4b0c9d6adf6a97e,G35154.TCGA-DU-7013-01A-11D-A461-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7013-01A,D61B5D20-4D6D-4FDC-AFE8-4B100B686EDA,Primary Tumor,Illumina HiSeq,06158eca-e4b3-400e-806c-5342049e40aa,Brain,59,0F43B42C-EE65-4DF3-BDFF-2101E15B7C9B,344F8786-3383-446B-8662-DEA1FA3B6FF5,TCGA-DU-7013-01A-11D-A461-08,HG19_Broad_variant,TCGA-DU-7013,TCGA-LGG,269,s8533,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa82ee4b0c9d6adf6acc8,58cfa82ee4b0c9d6adf6acc8,G39020.TCGA-D7-8570-01A-11D-2340-08.2.filtered.,WGS,G39020.TCGA-D7-8570-01A-11D-2340-08.2,G39020.TCGA-D7-8570-01A-11D-2340-08.2.bam,318.7,NA,0.05,58cfa82ee4b0c9d6adf6acc8,G39020.TCGA-D7-8570-01A-11D-2340-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-8570-01A,1E1CDF72-820F-48A4-8FB6-89575D07CDE9,Primary Tumor,Illumina HiSeq,4b984072-ec9c-4924-a922-f7c4f5c2eacc,Stomach,44,E23E2A9C-5080-4276-8982-9CF078027A48,429AAD6F-816D-4739-BAA3-B0EBF2FCD501,TCGA-D7-8570-01A-11D-2340-08,HG19_Broad_variant,TCGA-D7-8570,TCGA-STAD,NA,s14877,Broad Institute of MIT and Harvard,Greater Poland Cancer Center,Poland,NO,T3,N3a,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIIB
13722.58cfa832e4b0c9d6adf6d31d,58cfa832e4b0c9d6adf6d31d,TCGA-KN-8434-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8434-01A-11D-2310-10_wgs_Illumina,TCGA-KN-8434-01A-11D-2310-10_wgs_Illumina.bam,71.3,NA,0.05,58cfa832e4b0c9d6adf6d31d,TCGA-KN-8434-01A-11D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KN-8434-01A,E1E15226-9F8E-4035-8F08-EB1FED57080E,Primary Tumor,Illumina HiSeq,46dd26b0-c7e3-4280-b67c-5141df9048cf,Kidney,65,F75DE9FC-5DE8-4CAE-B1E1-8C37D1915C17,24F887E1-CE82-40F3-9674-11102BD076C0,TCGA-KN-8434-01A-11D-2310-10,GRCh37-lite,TCGA-KN-8434,TCGA-KICH,NA,s16488,Baylor College of Medicine,Harvard,United States,NO,T2,NX,Kidney Chromophobe,Stage II
13722.58cfa830e4b0c9d6adf6c162,58cfa830e4b0c9d6adf6c162,TCGA-BA-5149-10A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-BA-5149-10A-01D-A32X-10_wgs_Illumina,TCGA-BA-5149-10A-01D-A32X-10_wgs_Illumina.bam,65.4,1.9,0.08,58cfa830e4b0c9d6adf6c162,TCGA-BA-5149-10A-01D-A32X-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5149-10A,CB99FB14-641C-4FB3-BF1D-17EFB8CD982A,Blood Derived Normal,Illumina HiSeq,8626b587-5c7a-4a53-8c31-903465f3ce40,Head and Neck,47,C991BC28-AB65-4D05-931A-676BE035B94C,B39B682A-56FE-4EAC-87DC-8A13411C1976,TCGA-BA-5149-10A-01D-A32X-10,GRCh37-lite,TCGA-BA-5149,TCGA-HNSC,NA,s16318,Baylor College of Medicine,UNC,None,NO,T3,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6d304,58cfa832e4b0c9d6adf6d304,TCGA-KM-8443-10A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KM-8443-10A-01D-2311-10_wgs_Illumina,TCGA-KM-8443-10A-01D-2311-10_wgs_Illumina.bam,126.6,NA,0.05,58cfa832e4b0c9d6adf6d304,TCGA-KM-8443-10A-01D-2311-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KM-8443-10A,2F1C4DB6-88A7-4A5D-A5FE-94D85F569440,Blood Derived Normal,Illumina HiSeq,9d5dbe83-f6f5-453a-b475-b59155c2110b,Kidney,57,8B524689-0730-4061-BD05-9A497249EF81,982DBBF8-FDF8-4653-91ED-2E857E1A7708,TCGA-KM-8443-10A-01D-2311-10,GRCh37-lite,TCGA-KM-8443,TCGA-KICH,NA,s16534,Baylor College of Medicine,NCI Urologic Oncology Branch,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa832e4b0c9d6adf6d2e8,58cfa832e4b0c9d6adf6d2e8,TCGA-KM-8442-10A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KM-8442-10A-01D-2311-10_wgs_Illumina,TCGA-KM-8442-10A-01D-2311-10_wgs_Illumina.bam,212.6,NA,0.05,58cfa832e4b0c9d6adf6d2e8,TCGA-KM-8442-10A-01D-2311-10_wgs_Illumina.bam,Alive,MALE,Not available,HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KM-8442-10A,40F79CFE-A51F-497B-B06E-7A4F9004F092,Blood Derived Normal,Illumina HiSeq,0273c55a-a89a-432e-a324-b90e1b28ced0,Kidney,38,312454D3-0FA5-43D4-9DB5-8D79473A1419,6FC570C7-DCA7-4892-BBF8-94AFD186A057,TCGA-KM-8442-10A-01D-2311-10,GRCh37-lite,TCGA-KM-8442,TCGA-KICH,NA,s16480,Baylor College of Medicine,NCI Urologic Oncology Branch,United States,NO,T2,NX,Kidney Chromophobe,Stage II
13722.58cfa832e4b0c9d6adf6d1d6,58cfa832e4b0c9d6adf6d1d6,TCGA-HP-A5MZ-10A-01D-A27I-10_wgs_Illumina.filtered.,WGS,TCGA-HP-A5MZ-10A-01D-A27I-10_wgs_Illumina,TCGA-HP-A5MZ-10A-01D-A27I-10_wgs_Illumina.bam,40.87,NA,0.08,58cfa832e4b0c9d6adf6d1d6,TCGA-HP-A5MZ-10A-01D-A27I-10_wgs_Illumina.bam,Dead,MALE,Not available,Not available,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-HP-A5MZ-10A,2D00F09F-0074-46C8-B357-B5F33567762A,Blood Derived Normal,Illumina HiSeq,c787147b-e202-470a-8d32-5b7652919e9e,Liver,78,0CE05134-2B7A-4B7C-AFCA-BBDDE5210CEF,09EA881B-E60D-4CBE-9C35-D556DA8BF86C,TCGA-HP-A5MZ-10A-01D-A27I-10,GRCh37-lite,TCGA-HP-A5MZ,TCGA-LIHC,91,s16598,Baylor College of Medicine,Ontario Institute for Cancer Research (OICR),Canada,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ab20,58cfa82ee4b0c9d6adf6ab20,G32543.TCGA-GN-A26C-01A-11D-A19A-08.5.filtered.,WGS,G32543.TCGA-GN-A26C-01A-11D-A19A-08.5,G32543.TCGA-GN-A26C-01A-11D-A19A-08.5.bam,55.8,NA,0.08,58cfa82ee4b0c9d6adf6ab20,G32543.TCGA-GN-A26C-01A-11D-A19A-08.5.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-GN-A26C-01A,FA099993-EF30-4EFF-A8FB-AA41B5EA671A,Primary Tumor,Illumina HiSeq,da9e3264-de3a-4fca-bfda-59022f9417d2,Skin,77,8288B632-9E64-401C-8F45-F268367F40E4,E2774050-1257-4C29-B201-D79CE70FE17E,TCGA-GN-A26C-01A-11D-A19A-08,HG19_Broad_variant,TCGA-GN-A26C,TCGA-SKCM,821,s7477,Broad Institute of MIT and Harvard,Roswell,United States,NO,T4b,N2b,Not available,Stage IIIC
13722.58cfa831e4b0c9d6adf6c9ad,58cfa831e4b0c9d6adf6c9ad,TCGA-DD-A1EB-11A-11D-A12Z-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A1EB-11A-11D-A12Z-10_wgs_Illumina,TCGA-DD-A1EB-11A-11D-A12Z-10_wgs_Illumina.bam,26.34,1.94,0.09,58cfa831e4b0c9d6adf6c9ad,TCGA-DD-A1EB-11A-11D-A12Z-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A1EB-11A,68015CC7-D3A1-4C90-B8FB-5D14143D9960,Solid Tissue Normal,Illumina HiSeq,f3436b2b-3ab9-4f33-a04b-6ce44ab84d87,Liver,72,759A494F-C699-4DD6-9553-45265C667DAE,BAFFF26D-7343-4A8A-9451-28F3FBA86A9E,TCGA-DD-A1EB-11A-11D-A12Z-10,GRCh37-lite,TCGA-DD-A1EB,TCGA-LIHC,NA,s16674,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ada0,58cfa82ee4b0c9d6adf6ada0,G39020.TCGA-CD-5799-01A-11D-1600-08.1.filtered.,WGS,G39020.TCGA-CD-5799-01A-11D-1600-08.1,G39020.TCGA-CD-5799-01A-11D-1600-08.1.bam,177.7,2,0.05,58cfa82ee4b0c9d6adf6ada0,G39020.TCGA-CD-5799-01A-11D-1600-08.1.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-5799-01A,C991697F-77F9-412A-9BD1-0E47F7387CB2,Primary Tumor,Illumina HiSeq,4086df7e-765b-48a9-bece-369629691ae0,Stomach,45,A3180E0E-EB99-49DD-8252-5FEA05A9885F,EB59B79F-BD36-4BF4-83E3-2AF73BD1D30A,TCGA-CD-5799-01A-11D-1600-08,HG19_Broad_variant,TCGA-CD-5799,TCGA-STAD,NA,s14602,Broad Institute of MIT and Harvard,ILSBIO,Vietnam,NO,T2,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa832e4b0c9d6adf6d30a,58cfa832e4b0c9d6adf6d30a,TCGA-KL-8344-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8344-11A-01D-2310-10_wgs_Illumina,TCGA-KL-8344-11A-01D-2310-10_wgs_Illumina.bam,310.3,NA,0.05,58cfa832e4b0c9d6adf6d30a,TCGA-KL-8344-11A-01D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8344-11A,A5AF1391-89D3-4F41-930E-7E8272AFEC98,Solid Tissue Normal,Illumina HiSeq,f98e6928-d314-4070-ac82-6f0e7e2c0312,Kidney,51,640557C4-626D-484F-9F7C-81CD7631D3EE,D0764FEC-581B-4BD3-AFE8-ADCDF685562A,TCGA-KL-8344-11A-01D-2310-10,GRCh37-lite,TCGA-KL-8344,TCGA-KICH,NA,s16531,Baylor College of Medicine,MSKCC,United States,NO,T3a,N0,Kidney Chromophobe,Stage III
13722.58cfa82ee4b0c9d6adf6ad1b,58cfa82ee4b0c9d6adf6ad1b,G49538.TCGA-06-0221-01A-01D-A32W-08.1.filtered.,WGS,G49538.TCGA-06-0221-01A-01D-A32W-08.1,G49538.TCGA-06-0221-01A-01D-A32W-08.1.bam,381.7,1.89,0.08,58cfa82ee4b0c9d6adf6ad1b,G49538.TCGA-06-0221-01A-01D-A32W-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0221-01A,054F472F-98CB-4559-B2E2-B5F800FC8EEF,Primary Tumor,Illumina HiSeq,684acac7-d7c1-4383-b72f-66e303b0d0e7,Brain,31,6E8D83F2-70BF-44F0-BD64-64D9DFE26F02,96CBA715-CEF0-4E39-92D5-4DEC27E83F1A,TCGA-06-0221-01A-01D-A32W-08,HG19_Broad_variant,TCGA-06-0221,TCGA-GBM,603,s14092,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6c1ac,58cfa830e4b0c9d6adf6c1ac,TCGA-B9-4117-10A-01D-A31Z-10_wgs_Illumina.filtered.,WGS,TCGA-B9-4117-10A-01D-A31Z-10_wgs_Illumina,TCGA-B9-4117-10A-01D-A31Z-10_wgs_Illumina.bam,16.3,1.9,0.08,58cfa830e4b0c9d6adf6c1ac,TCGA-B9-4117-10A-01D-A31Z-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B9-4117-10A,71B35CD8-ECEE-4599-BB24-B1EF78118423,Blood Derived Normal,Illumina HiSeq,956fec6a-7f2c-4aa6-828d-13daa0531b2b,Kidney,48,17F0D728-39F0-46F2-AB7A-71E9694DEF67,9C5114C7-31E5-4AD6-BC6A-A2BC27B0C5C2,TCGA-B9-4117-10A-01D-A31Z-10,GRCh37-lite,TCGA-B9-4117,TCGA-KIRP,NA,s11859,Baylor College of Medicine,UNC,None,NO,T2,NX,Kidney Papillary Renal Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6cfb4,58cfa832e4b0c9d6adf6cfb4,TCGA-GL-A4EM-10A-01D-A25F-10_wgs_Illumina.filtered.,WGS,TCGA-GL-A4EM-10A-01D-A25F-10_wgs_Illumina,TCGA-GL-A4EM-10A-01D-A25F-10_wgs_Illumina.bam,11.7,NA,0.07,58cfa832e4b0c9d6adf6cfb4,TCGA-GL-A4EM-10A-01D-A25F-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-GL-A4EM-10A,2C084454-18E9-4837-9BBA-7E91A73A48E0,Blood Derived Normal,Illumina HiSeq,f2ec678c-432d-4354-bf1e-9e3991a0b7c3,Kidney,61,6BC1FFCC-55B4-4359-9EBD-2A01782B524D,4BC53B4E-8334-46FF-AAAB-4E5A0F30177B,TCGA-GL-A4EM-10A-01D-A25F-10,GRCh37-lite,TCGA-GL-A4EM,TCGA-KIRP,NA,s11588,Baylor College of Medicine,ABS - IUPUI,United States,NO,T1b,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d030,58cfa832e4b0c9d6adf6d030,TCGA-HE-A5NK-10A-01D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-HE-A5NK-10A-01D-A26P-10_wgs_Illumina,TCGA-HE-A5NK-10A-01D-A26P-10_wgs_Illumina.bam,58.3,NA,0.08,58cfa832e4b0c9d6adf6d030,TCGA-HE-A5NK-10A-01D-A26P-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-HE-A5NK-10A,F9306CB1-C4E4-42EB-8AA9-EE906C408E10,Blood Derived Normal,Illumina HiSeq,432d0f97-570c-477f-941a-918314a235eb,Kidney,82,4565FFEA-5110-4CF6-81D9-81DDAFB7232C,254BAF21-7011-4EB9-84CF-45364C96CCB7,TCGA-HE-A5NK-10A-01D-A26P-10,GRCh37-lite,TCGA-HE-A5NK,TCGA-KIRP,NA,s11590,Baylor College of Medicine,Ontario Institute for Cancer Research (OICR),Canada,NO,T1b,NX,Kidney Papillary Renal Cell Carcinoma,Not available
13722.58cfa82de4b0c9d6adf6a726,58cfa82de4b0c9d6adf6a726,G12519.TCGA-34-2600-11A-01D-0963-08.4.filtered.,WGS,G12519.TCGA-34-2600-11A-01D-0963-08.4,G12519.TCGA-34-2600-11A-01D-0963-08.4.bam,5,1.9,0.14,58cfa82de4b0c9d6adf6a726,G12519.TCGA-34-2600-11A-01D-0963-08.4.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-34-2600-11A,DA61857A-B00E-4A19-AB02-8FBB2EE56BEA,Solid Tissue Normal,Illumina HiSeq,1a5d3062-30a2-40f7-b39c-c4d0fd43a813,Lung,76,6686E50A-931D-40B3-95E9-13E182E65610,F95E048C-75EC-4832-8510-C8C593635239,TCGA-34-2600-11A-01D-0963-08,HG19_Broad_variant,TCGA-34-2600,TCGA-LUSC,1874,s10153,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6b084,58cfa82ee4b0c9d6adf6b084,G47088.TCGA-21-1083-11A-01D-1521-08.3.filtered.,WGS,G47088.TCGA-21-1083-11A-01D-1521-08.3,G47088.TCGA-21-1083-11A-01D-1521-08.3.bam,33.3,1.9,0.05,58cfa82ee4b0c9d6adf6b084,G47088.TCGA-21-1083-11A-01D-1521-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-21-1083-11A,0398EAE1-7216-4595-80A5-6B117D96E070,Solid Tissue Normal,Illumina HiSeq,3f48a7d3-51c4-4450-a4bc-f5ff64407542,Lung,75,11BDAA8B-86A1-4F0A-B300-ED70C54791D6,D4F7EBDB-C060-4184-8E85-7AB614619E16,TCGA-21-1083-11A-01D-1521-08,HG19_Broad_variant,TCGA-21-1083,TCGA-LUSC,1315,s10367,Broad Institute of MIT and Harvard,Fox Chase Cancer Center,United States,NO,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa832e4b0c9d6adf6d313,58cfa832e4b0c9d6adf6d313,TCGA-KN-8421-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8421-11A-01D-2310-10_wgs_Illumina,TCGA-KN-8421-11A-01D-2310-10_wgs_Illumina.bam,205.3,NA,0.05,58cfa832e4b0c9d6adf6d313,TCGA-KN-8421-11A-01D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KN-8421-11A,2FC175D1-9D95-44FD-A53E-820F6F404551,Solid Tissue Normal,Illumina HiSeq,96b70d36-07a5-45f3-af9f-7d1e2349e68b,Kidney,47,F408717F-9421-4A00-B177-EA74CA6EAB18,9D5EE3F8-490F-4865-BB90-FE0A1BBF3643,TCGA-KN-8421-11A-01D-2310-10,GRCh37-lite,TCGA-KN-8421,TCGA-KICH,NA,s16532,Baylor College of Medicine,Harvard,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa831e4b0c9d6adf6c933,58cfa831e4b0c9d6adf6c933,TCGA-CN-6989-10A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CN-6989-10A-01D-A32X-10_wgs_Illumina,TCGA-CN-6989-10A-01D-A32X-10_wgs_Illumina.bam,845,NA,0.08,58cfa831e4b0c9d6adf6c933,TCGA-CN-6989-10A-01D-A32X-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-6989-10A,F33AA93F-B32D-4C4F-9A71-1E5AB69C6899,Blood Derived Normal,Illumina HiSeq,a59dd8f5-b54d-4460-ac1e-f3f5831ec920,Head and Neck,64,3570AC4B-B585-4262-B54B-137A2515C689,07B97B7C-C88E-4769-B302-F50D1176BD2D,TCGA-CN-6989-10A-01D-A32X-10,GRCh37-lite,TCGA-CN-6989,TCGA-HNSC,NA,s15766,Baylor College of Medicine,University of Pittsburgh,United States,NO,T3,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82ee4b0c9d6adf6ac06,58cfa82ee4b0c9d6adf6ac06,G39019.TCGA-DA-A1I0-06A-11D-A20D-08.3.filtered.,WGS,G39019.TCGA-DA-A1I0-06A-11D-A20D-08.3,G39019.TCGA-DA-A1I0-06A-11D-A20D-08.3.bam,17.16,NA,0.09,58cfa82ee4b0c9d6adf6ac06,G39019.TCGA-DA-A1I0-06A-11D-A20D-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-DA-A1I0-06A,68F75AB5-9D77-40C5-A8CE-F56016BBE9E4,Metastatic,Illumina HiSeq,66bdb1db-88a0-4989-9f84-06291d75ac65,Skin,63,A9D95B44-6CC8-44E2-8144-DF57AC0AA742,D0E033BC-8E97-4322-B3B1-8626F1E2449B,TCGA-DA-A1I0-06A-11D-A20D-08,HG19_Broad_variant,TCGA-DA-A1I0,TCGA-SKCM,NA,s7311,Broad Institute of MIT and Harvard,Yale,United States,NO,T4b,N3,Not available,Stage IV
13722.58cfa82ee4b0c9d6adf6ae1a,58cfa82ee4b0c9d6adf6ae1a,G49837.TCGA-66-2795-01A-02D-A320-08.4.filtered.,WGS,G49837.TCGA-66-2795-01A-02D-A320-08.4,G49837.TCGA-66-2795-01A-02D-A320-08.4.bam,612.94,1.9,0.08,58cfa82ee4b0c9d6adf6ae1a,G49837.TCGA-66-2795-01A-02D-A320-08.4.bam,Alive,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-66-2795-01A,DA93A143-5799-4856-A5F4-3FF3B9284311,Primary Tumor,Illumina HiSeq,ad1129fe-92b3-4515-b91f-4b415f4e371f,Lung,68,9DC330BF-ACBD-4419-B533-35CF59ACEC71,D18C6E64-9598-488A-8AB3-3652072F9277,TCGA-66-2795-01A-02D-A320-08,HG19_Broad_variant,TCGA-66-2795,TCGA-LUSC,NA,s10256,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T4,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIB
13722.58cfa830e4b0c9d6adf6c1b4,58cfa830e4b0c9d6adf6c1b4,TCGA-BA-6872-10A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-BA-6872-10A-01D-A32X-10_wgs_Illumina,TCGA-BA-6872-10A-01D-A32X-10_wgs_Illumina.bam,64,1.9,0.07,58cfa830e4b0c9d6adf6c1b4,TCGA-BA-6872-10A-01D-A32X-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-6872-10A,3E5F451A-5882-4914-AE1A-95C898C2BCCA,Blood Derived Normal,Illumina HiSeq,71a05657-fd70-495f-9249-703bffe96173,Head and Neck,47,96307963-4A11-45A6-8886-954848E309E5,3BC3B470-DDE6-4A89-A9D5-B2051BB13793,TCGA-BA-6872-10A-01D-A32X-10,GRCh37-lite,TCGA-BA-6872,TCGA-HNSC,384,s16025,Baylor College of Medicine,UNC,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6af4c,58cfa82ee4b0c9d6adf6af4c,G47088.TCGA-18-4721-01A-01D-1441-08.2.filtered.,WGS,G47088.TCGA-18-4721-01A-01D-1441-08.2,G47088.TCGA-18-4721-01A-01D-1441-08.2.bam,305.7,1.9,0.05,58cfa82ee4b0c9d6adf6af4c,G47088.TCGA-18-4721-01A-01D-1441-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-18-4721-01A,19F0CB8C-2E57-4310-967F-A9890F1605DB,Primary Tumor,Illumina HiSeq,cc99a2ed-feab-46b5-86eb-27fa81408f7c,Lung,74,1BAC4FF6-E35B-40F6-BBE4-705AB672D102,D2AB2555-7288-47A4-A80C-BF62D65B67B8,TCGA-18-4721-01A-01D-1441-08,HG19_Broad_variant,TCGA-18-4721,TCGA-LUSC,NA,s10078,Broad Institute of MIT and Harvard,Princess Margaret Hospital (Canada),Canada,NO,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6ae9e,58cfa82ee4b0c9d6adf6ae9e,G49538.TCGA-06-0210-02A-01D-2280-08.1.filtered.,WGS,G49538.TCGA-06-0210-02A-01D-2280-08.1,G49538.TCGA-06-0210-02A-01D-2280-08.1.bam,400,1.9,0.05,58cfa82ee4b0c9d6adf6ae9e,G49538.TCGA-06-0210-02A-01D-2280-08.1.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0210-02A,DE7B7CAC-F094-4D59-8651-E991E34EA093,Recurrent Tumor,Illumina HiSeq,6d80ca64-3d9f-46dc-96ba-e249adaaf2f6,Brain,72,15E8851A-EA08-4CF5-84A3-86FD47B60258,B60392FB-43D9-4C9C-B91B-DED40492E61C,TCGA-06-0210-02A-01D-2280-08,HG19_Broad_variant,TCGA-06-0210,TCGA-GBM,225,s13949,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa830e4b0c9d6adf6c180,58cfa830e4b0c9d6adf6c180,TCGA-B9-4617-10A-01D-A31Z-10_wgs_Illumina.filtered.,WGS,TCGA-B9-4617-10A-01D-A31Z-10_wgs_Illumina,TCGA-B9-4617-10A-01D-A31Z-10_wgs_Illumina.bam,39.24,1.9,0.07,58cfa830e4b0c9d6adf6c180,TCGA-B9-4617-10A-01D-A31Z-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B9-4617-10A,A6E960AF-3CA5-42FB-B546-451C2583282D,Blood Derived Normal,Illumina HiSeq,6649f403-910a-4853-9742-836e5d9f0b90,Kidney,41,82F6D39A-278C-423B-9EB5-928E7C21BCC6,EA210528-6F32-4B2F-B0F1-58886E89F227,TCGA-B9-4617-10A-01D-A31Z-10,GRCh37-lite,TCGA-B9-4617,TCGA-KIRP,NA,s11587,Baylor College of Medicine,UNC,None,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d2d6,58cfa832e4b0c9d6adf6d2d6,TCGA-KL-8343-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8343-11A-01D-2310-10_wgs_Illumina,TCGA-KL-8343-11A-01D-2310-10_wgs_Illumina.bam,210.3,NA,0.05,58cfa832e4b0c9d6adf6d2d6,TCGA-KL-8343-11A-01D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KL-8343-11A,B4A0BF74-1381-4C17-B97D-206810D9E59A,Solid Tissue Normal,Illumina HiSeq,3350a5e6-24f6-4db6-852c-e282f2b10ea9,Kidney,72,E125D7CB-2931-4B91-82CB-2E408285F0E6,25275F7F-A079-4C74-BEC8-33B107316D1B,TCGA-KL-8343-11A-01D-2310-10,GRCh37-lite,TCGA-KL-8343,TCGA-KICH,NA,s16525,Baylor College of Medicine,MSKCC,United States,NO,T3,N0,Kidney Chromophobe,Stage III
13722.58cfa832e4b0c9d6adf6d3c2,58cfa832e4b0c9d6adf6d3c2,TCGA-KO-8406-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KO-8406-01A-11D-2310-10_wgs_Illumina,TCGA-KO-8406-01A-11D-2310-10_wgs_Illumina.bam,131.2,NA,0.05,58cfa832e4b0c9d6adf6d3c2,TCGA-KO-8406-01A-11D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KO-8406-01A,9AA02D46-294B-4E99-B9EE-56EDCBFB5275,Primary Tumor,Illumina HiSeq,1980f1bf-6afb-4a53-97a5-f069b4200e14,Kidney,17,2141972F-8CA9-4E82-B410-B1E3BBB2934A,C29F6ED6-880D-4F03-977E-1087738E5E60,TCGA-KO-8406-01A-11D-2310-10,GRCh37-lite,TCGA-KO-8406,TCGA-KICH,NA,s16408,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T1,N0,Kidney Chromophobe,Stage I
13722.58cfa82ee4b0c9d6adf6ae79,58cfa82ee4b0c9d6adf6ae79,G49538.TCGA-14-1402-01A-01D-1493-08.3.filtered.,WGS,G49538.TCGA-14-1402-01A-01D-1493-08.3,G49538.TCGA-14-1402-01A-01D-1493-08.3.bam,484,1.9,0.05,58cfa82ee4b0c9d6adf6ae79,G49538.TCGA-14-1402-01A-01D-1493-08.3.bam,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1402-01A,BF339349-062F-4EA9-A0B2-D87D3A21099E,Primary Tumor,Illumina HiSeq,16d26bf2-f6a6-472e-b26a-fcd17cf66832,Brain,58,90A6DB9D-669E-4507-A0B9-B1C5D8F5BF4D,6FEE80F8-11CB-4DE7-ADED-E586708D2368,TCGA-14-1402-01A-01D-1493-08,HG19_Broad_variant,TCGA-14-1402,TCGA-GBM,975,s14028,Broad Institute of MIT and Harvard,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa832e4b0c9d6adf6d2e4,58cfa832e4b0c9d6adf6d2e4,TCGA-KM-8440-10A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KM-8440-10A-01D-2311-10_wgs_Illumina,TCGA-KM-8440-10A-01D-2311-10_wgs_Illumina.bam,201.9,NA,0.05,58cfa832e4b0c9d6adf6d2e4,TCGA-KM-8440-10A-01D-2311-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KM-8440-10A,872092B3-D31E-44D7-BD03-E29F52F8AB5A,Blood Derived Normal,Illumina HiSeq,9911d10f-fba5-4d3f-ae28-d23e60c10a25,Kidney,37,163E4A49-551F-4D22-ADE7-0151196DA102,F6D8BF61-9DA3-4CE4-B6CC-E1391C0C0186,TCGA-KM-8440-10A-01D-2311-10,GRCh37-lite,TCGA-KM-8440,TCGA-KICH,NA,s16431,Baylor College of Medicine,NCI Urologic Oncology Branch,United States,NO,T3a,NX,Kidney Chromophobe,Stage III
13722.58cfa831e4b0c9d6adf6c78f,58cfa831e4b0c9d6adf6c78f,TCGA-CZ-4856-01A-02D-2101-10_Illumina.filtered.,WGS,TCGA-CZ-4856-01A-02D-2101-10_Illumina,TCGA-CZ-4856-01A-02D-2101-10_Illumina.bam,34.73,1.9,0.15,58cfa831e4b0c9d6adf6c78f,TCGA-CZ-4856-01A-02D-2101-10_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CZ-4856-01A,FCECAFA8-8B8B-4AE6-81BC-73ACF05B211A,Primary Tumor,Illumina HiSeq,5cf38428-0ee7-4a06-8f49-c41a19ad6f74,Kidney,62,6F6C9F00-D6E5-452F-BA04-F77B146B780B,9FB40473-74CB-43CB-9A54-C990B8BBDE17,TCGA-CZ-4856-01A-02D-2101-10,GRCh37-lite,TCGA-CZ-4856,TCGA-KIRC,NA,s9453,Baylor College of Medicine,Harvard,None,NO,T1b,N0,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ace6,58cfa82ee4b0c9d6adf6ace6,G39020.TCGA-CD-5802-01A-11D-1600-08.1.filtered.,WGS,G39020.TCGA-CD-5802-01A-11D-1600-08.1,G39020.TCGA-CD-5802-01A-11D-1600-08.1.bam,199,2,0.05,58cfa82ee4b0c9d6adf6ace6,G39020.TCGA-CD-5802-01A-11D-1600-08.1.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-5802-01A,0AECAC64-5982-4D76-8F31-958F6A00951D,Primary Tumor,Illumina HiSeq,314d6a95-e101-4389-b923-7b28a44e27c9,Stomach,58,93C38FFB-27AC-4C91-939D-7102EE72F404,C1B44966-0F72-4C4F-8783-AB3FFE7F17B2,TCGA-CD-5802-01A-11D-1600-08,HG19_Broad_variant,TCGA-CD-5802,TCGA-STAD,NA,s15171,Broad Institute of MIT and Harvard,ILSbio,Vietnam,NO,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II
13722.58cfa82ee4b0c9d6adf6af04,58cfa82ee4b0c9d6adf6af04,G39020.TCGA-HU-8245-01A-11D-2340-08.4.filtered.,WGS,G39020.TCGA-HU-8245-01A-11D-2340-08.4,G39020.TCGA-HU-8245-01A-11D-2340-08.4.bam,209.7,NA,0.05,58cfa82ee4b0c9d6adf6af04,G39020.TCGA-HU-8245-01A-11D-2340-08.4.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-HU-8245-01A,4E9D13DA-438D-4B5E-8E86-67432B5E9471,Primary Tumor,Illumina HiSeq,6acf61a8-ac0b-43fa-8b56-db959ad7b3f5,Stomach,72,5CD8D6FC-F68E-4C14-93B0-BABE544C7A63,61CAD26A-CBC6-4977-83B9-DC61E49F2861,TCGA-HU-8245-01A-11D-2340-08,HG19_Broad_variant,TCGA-HU-8245,TCGA-STAD,NA,s14680,Broad Institute of MIT and Harvard,National Cancer Center Korea,Korea South,NO,T3,N0,Stomach Intestinal Adenocarcinoma Papillary Type,Stage IIA
13722.58cfa82fe4b0c9d6adf6b9e0,58cfa82fe4b0c9d6adf6b9e0,TCGA-AA-3977-01A-01D-1024-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3977-01A-01D-1024-10_wgs_Illumina,TCGA-AA-3977-01A-01D-1024-10_wgs_Illumina.bam,540,1.9,0.15,58cfa82fe4b0c9d6adf6b9e0,TCGA-AA-3977-01A-01D-1024-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3977-01A,33E989B9-FAC4-47D8-B429-269044AC772A,Primary Tumor,Illumina HiSeq,34a6b8b6-5a24-4e03-9f20-8b51e27033c5,Colorectal,65,56DD63CB-CF0A-48C3-BCCC-C5094F8D8AC0,93FF786E-0165-4B02-8D27-806D422E93FC,TCGA-AA-3977-01A-01D-1024-10,GRCh37-lite,TCGA-AA-3977,TCGA-COAD,NA,s13028,Baylor College of Medicine,Indivumed,Germany,NO,T2,N0,Colon Adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6acb6,58cfa82ee4b0c9d6adf6acb6,G48125.TCGA-23-1118-01A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-23-1118-01A-01D-A312-08.2,G48125.TCGA-23-1118-01A-01D-A312-08.2.bam,362.67,1.9,0.08,58cfa82ee4b0c9d6adf6acb6,G48125.TCGA-23-1118-01A-01D-A312-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-23-1118-01A,700E91BB-D675-41B2-BBBD-935767C7B447,Primary Tumor,Illumina HiSeq,be8b86e7-e6da-45ca-a286-471e3ef37950,Ovary,45,E1BE8AD9-1A52-4677-8436-3DA22AD12E9A,33EA81F2-DB2C-4567-BD7B-4CB9AADFEF88,TCGA-23-1118-01A-01D-A312-08,HG19_Broad_variant,TCGA-23-1118,TCGA-OV,NA,s18021,Broad Institute of MIT and Harvard,Cedars Sinai,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d342,58cfa832e4b0c9d6adf6d342,TCGA-KO-8410-11A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KO-8410-11A-01D-2311-10_wgs_Illumina,TCGA-KO-8410-11A-01D-2311-10_wgs_Illumina.bam,224.2,NA,0.05,58cfa832e4b0c9d6adf6d342,TCGA-KO-8410-11A-01D-2311-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KO-8410-11A,B5F6A0E3-F9AC-475F-9A34-B8B8834F1779,Solid Tissue Normal,Illumina HiSeq,7580e946-7803-43c2-9629-dc5d808f515c,Kidney,74,C5EA38BF-F297-45A4-82AA-68DAF5D5EF1B,01229ABB-7ADE-4AB4-BE30-3406270B8E6D,TCGA-KO-8410-11A-01D-2311-10,GRCh37-lite,TCGA-KO-8410,TCGA-KICH,NA,s16446,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T1b,N0,Kidney Chromophobe,Stage I
13722.58cfa832e4b0c9d6adf6d324,58cfa832e4b0c9d6adf6d324,TCGA-KN-8425-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8425-11A-01D-2310-10_wgs_Illumina,TCGA-KN-8425-11A-01D-2310-10_wgs_Illumina.bam,244.3,NA,0.05,58cfa832e4b0c9d6adf6d324,TCGA-KN-8425-11A-01D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KN-8425-11A,CC316FAF-DCB1-4DEA-B8B0-A17D000FF40F,Solid Tissue Normal,Illumina HiSeq,f9155e58-91fb-445c-b26c-009756891ff5,Kidney,53,FFC74D53-1FBA-4387-A313-834174B6095F,D0260F96-F7BD-41B1-B929-9451954CB3B4,TCGA-KN-8425-11A-01D-2310-10,GRCh37-lite,TCGA-KN-8425,TCGA-KICH,NA,s16435,Baylor College of Medicine,Harvard,United States,NO,T1b,N0,Kidney Chromophobe,Stage I
13722.58cfa82ee4b0c9d6adf6ac73,58cfa82ee4b0c9d6adf6ac73,G47088.TCGA-85-8277-01A-11D-2293-08.1.filtered.,WGS,G47088.TCGA-85-8277-01A-11D-2293-08.1,G47088.TCGA-85-8277-01A-11D-2293-08.1.bam,270.3,NA,0.05,58cfa82ee4b0c9d6adf6ac73,G47088.TCGA-85-8277-01A-11D-2293-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-85-8277-01A,8E6020A1-68DF-4D57-AD4E-33ACC0861FB3,Primary Tumor,Illumina HiSeq,b6b09fc0-6713-4047-8081-3b8224052fec,Lung,70,5600CB1A-D0F4-468E-B8D2-E431B77496BF,649F2C20-5B50-40A8-A6FD-9A51F3D5B9DF,TCGA-85-8277-01A-11D-2293-08,HG19_Broad_variant,TCGA-85-8277,TCGA-LUSC,NA,s10075,Broad Institute of MIT and Harvard,Asterand,Russia,NO,T3,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa830e4b0c9d6adf6c17a,58cfa830e4b0c9d6adf6c17a,TCGA-B9-4116-10A-01D-A31Z-10_wgs_Illumina.filtered.,WGS,TCGA-B9-4116-10A-01D-A31Z-10_wgs_Illumina,TCGA-B9-4116-10A-01D-A31Z-10_wgs_Illumina.bam,6.3,1.9,0.08,58cfa830e4b0c9d6adf6c17a,TCGA-B9-4116-10A-01D-A31Z-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B9-4116-10A,4EDD92E1-5DA5-49A3-80E4-FA456AA425B8,Blood Derived Normal,Illumina HiSeq,6a8a62a1-b312-426a-a3dc-7e173a832f5c,Kidney,75,59B98DD7-037D-4B28-B744-276A2B25C08D,CD53468B-9164-4A91-B4DC-D9A678AFEFDE,TCGA-B9-4116-10A-01D-A31Z-10,GRCh37-lite,TCGA-B9-4116,TCGA-KIRP,NA,s11857,Baylor College of Medicine,UNC,None,NO,T2a,NX,Kidney Papillary Renal Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6af61,58cfa82ee4b0c9d6adf6af61,G47088.TCGA-98-8022-10A-01D-2244-08.2.filtered.,WGS,G47088.TCGA-98-8022-10A-01D-2244-08.2,G47088.TCGA-98-8022-10A-01D-2244-08.2.bam,195.33,NA,0.05,58cfa82ee4b0c9d6adf6af61,G47088.TCGA-98-8022-10A-01D-2244-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-98-8022-10A,ADC853B1-B8BF-488C-A1E2-E95603459B55,Blood Derived Normal,Illumina HiSeq,8d0ddb26-6b8a-44ee-bfdf-88ffc74c969e,Lung,61,9008AD7B-1F1B-4E23-9B53-321D7EC63ED7,CB63D740-4040-4D71-81E9-1211736B0E5C,TCGA-98-8022-10A-01D-2244-08,HG19_Broad_variant,TCGA-98-8022,TCGA-LUSC,NA,s10160,Broad Institute of MIT and Harvard,Washington University - Alabama,United States,NO,T1a,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6c7c6,58cfa831e4b0c9d6adf6c7c6,TCGA-CW-6087-01A-11D-2279-10_wgs_Illumina.filtered.,WGS,TCGA-CW-6087-01A-11D-2279-10_wgs_Illumina,TCGA-CW-6087-01A-11D-2279-10_wgs_Illumina.bam,47.4,1.9,0.05,58cfa831e4b0c9d6adf6c7c6,TCGA-CW-6087-01A-11D-2279-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CW-6087-01A,BBDAA931-E922-49BE-BFBF-FA0C2AE27D7A,Primary Tumor,Illumina HiSeq,efcf45d7-17bb-4653-908f-773b5045531c,Kidney,61,B4F9B73B-94DB-4E0F-AF55-CF0583318A4A,2C581A74-7716-4C20-B366-A8E1D9A901F6,TCGA-CW-6087-01A-11D-2279-10,GRCh37-lite,TCGA-CW-6087,TCGA-KIRC,41,s9452,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T3a,N1,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa82de4b0c9d6adf6a794,58cfa82de4b0c9d6adf6a794,G14088.TCGA-60-2698-01A-01D-1522-08.1.filtered.,WGS,G14088.TCGA-60-2698-01A-01D-1522-08.1,G14088.TCGA-60-2698-01A-01D-1522-08.1.bam,258.3,1.9,0.05,58cfa82de4b0c9d6adf6a794,G14088.TCGA-60-2698-01A-01D-1522-08.1.bam,Dead,MALE,WHITE,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-60-2698-01A,FD9EE494-65FE-4DE4-ADFF-7952A059B17F,Primary Tumor,Illumina HiSeq,31535197-5bd8-4176-8b52-4bd012f6cb0b,Lung,62,A908CE38-12E6-4EC6-BAAB-9D79221AB6EB,2045C788-9EA8-4EA5-A5E3-65FC16A62ADB,TCGA-60-2698-01A-01D-1522-08,HG19_Broad_variant,TCGA-60-2698,TCGA-LUSC,311,s10494,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T2,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa831e4b0c9d6adf6c79f,58cfa831e4b0c9d6adf6c79f,TCGA-CX-7086-10D-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CX-7086-10D-01D-A32X-10_wgs_Illumina,TCGA-CX-7086-10D-01D-A32X-10_wgs_Illumina.bam,76,NA,0.09,58cfa831e4b0c9d6adf6c79f,TCGA-CX-7086-10D-01D-A32X-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CX-7086-10D,AD6C9D09-2C03-4786-A72D-DD2AA5F603D4,Blood Derived Normal,Illumina HiSeq,62f53214-e1e5-42fe-821b-a2a656206e1f,Head and Neck,53,E94BDE7C-1A9E-4D1C-B681-C996E5BC01C5,4568C503-4D0D-4B5A-84ED-CF7984B3A722,TCGA-CX-7086-10D-01D-A32X-10,GRCh37-lite,TCGA-CX-7086,TCGA-HNSC,NA,s15524,Baylor College of Medicine,Medical College of Georgia,United States,NO,T3,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa830e4b0c9d6adf6c186,58cfa830e4b0c9d6adf6c186,TCGA-B9-4115-10A-01D-A31Z-10_wgs_Illumina.filtered.,WGS,TCGA-B9-4115-10A-01D-A31Z-10_wgs_Illumina,TCGA-B9-4115-10A-01D-A31Z-10_wgs_Illumina.bam,6.3,1.9,0.08,58cfa830e4b0c9d6adf6c186,TCGA-B9-4115-10A-01D-A31Z-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B9-4115-10A,A121406A-30B2-4717-AE96-EDCB17D911E2,Blood Derived Normal,Illumina HiSeq,41c355f5-b0cd-42d7-b7bd-7fcead0915ed,Kidney,53,9EBB4C36-71D5-45FC-A1A4-5B74A6A75449,DA74D129-AE81-417B-A58B-27BFE9AF627F,TCGA-B9-4115-10A-01D-A31Z-10,GRCh37-lite,TCGA-B9-4115,TCGA-KIRP,NA,s11774,Baylor College of Medicine,UNC,None,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6a944,58cfa82ee4b0c9d6adf6a944,G35154.TCGA-DU-6397-02A-12D-A36O-08.3.filtered.,WGS,G35154.TCGA-DU-6397-02A-12D-A36O-08.3,G35154.TCGA-DU-6397-02A-12D-A36O-08.3.bam,8.27,NA,0.08,58cfa82ee4b0c9d6adf6a944,G35154.TCGA-DU-6397-02A-12D-A36O-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-6397-02A,E695B780-17F4-4E71-9120-7C6BCAFAA3A7,Recurrent Tumor,Illumina HiSeq,d184ed85-cb21-43cc-95f6-0619f9283b29,Brain,45,3193FBF0-C5F7-4501-89B1-1A67A64CEAF7,35B2C623-356D-4319-871F-CCD5C349FDEE,TCGA-DU-6397-02A-12D-A36O-08,HG19_Broad_variant,TCGA-DU-6397,TCGA-LGG,1401,s8107,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligodendroglioma,Not available
13722.58cfa82ee4b0c9d6adf6ac8f,58cfa82ee4b0c9d6adf6ac8f,G48125.TCGA-13-1477-01A-01D-A312-08.3.filtered.,WGS,G48125.TCGA-13-1477-01A-01D-A312-08.3,G48125.TCGA-13-1477-01A-01D-A312-08.3.bam,173.97,1.9,0.08,58cfa82ee4b0c9d6adf6ac8f,G48125.TCGA-13-1477-01A-01D-A312-08.3.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-1477-01A,13F5814C-1F99-4FFA-84A4-3BBD8979FAAE,Primary Tumor,Illumina HiSeq,20a1de59-1aa6-4045-a699-63a91e441931,Ovary,49,79908395-D442-44A3-8E91-97C3AE97DDD5,0AE2193F-0D68-485A-B8C2-7568CBCCE33E,TCGA-13-1477-01A-01D-A312-08,HG19_Broad_variant,TCGA-13-1477,TCGA-OV,1662,s18023,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6cfee,58cfa832e4b0c9d6adf6cfee,TCGA-GL-A59R-10A-01D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-GL-A59R-10A-01D-A26P-10_wgs_Illumina,TCGA-GL-A59R-10A-01D-A26P-10_wgs_Illumina.bam,21.55,NA,0.07,58cfa832e4b0c9d6adf6cfee,TCGA-GL-A59R-10A-01D-A26P-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-GL-A59R-10A,78412F82-CC55-43D5-96CA-1D02CF957725,Blood Derived Normal,Illumina HiSeq,b4247c72-34c4-45fb-9377-160a0f6814ef,Kidney,79,7D7DF326-8AA3-4131-8359-8AE7C227F866,B95FF063-202C-47AD-A9FA-D2F922585AE7,TCGA-GL-A59R-10A-01D-A26P-10,GRCh37-lite,TCGA-GL-A59R,TCGA-KIRP,NA,s11778,Baylor College of Medicine,ABS - IUPUI,United States,NO,T3c,N0,Kidney Papillary Renal Cell Carcinoma,Stage III
13722.58cfa830e4b0c9d6adf6bb82,58cfa830e4b0c9d6adf6bb82,TCGA-A3-3308-01A-01D-2094-10_Illumina.filtered.,WGS,TCGA-A3-3308-01A-01D-2094-10_Illumina,TCGA-A3-3308-01A-01D-2094-10_Illumina.bam,591.9,1.9,0.17,58cfa830e4b0c9d6adf6bb82,TCGA-A3-3308-01A-01D-2094-10_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-A3-3308-01A,3CBCA837-F5A7-4A87-8F02-C59EAC232D5A,Primary Tumor,Illumina HiSeq,ff863b55-b221-4580-b322-d2f1c9137279,Kidney,77,0B935ADB-0E19-4FCC-9BB0-B9D95872BCEF,68B7FDB1-22B5-4152-9E69-A41151640CD8,TCGA-A3-3308-01A-01D-2094-10,GRCh37-lite,TCGA-A3-3308,TCGA-KIRC,NA,s9000,Baylor College of Medicine,International Genomics Consortium,None,NO,T3b,N0,Kidney Clear Cell Renal Carcinoma,Stage III
13722.58cfa82de4b0c9d6adf6a763,58cfa82de4b0c9d6adf6a763,G13231.TCGA-60-2724-01A-01D-1522-08.3.filtered.,WGS,G13231.TCGA-60-2724-01A-01D-1522-08.3,G13231.TCGA-60-2724-01A-01D-1522-08.3.bam,508.3,1.9,0.05,58cfa82de4b0c9d6adf6a763,G13231.TCGA-60-2724-01A-01D-1522-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-60-2724-01A,A3E1AC67-A1F2-44FB-8343-A7E8239FC24A,Primary Tumor,Illumina HiSeq,fe7af73f-7704-440b-85f1-35dc1b30dea2,Lung,47,048E7EB0-57A4-4EED-A999-4E46D9FEF885,387C6519-6529-4074-A5AB-00F8052A5732,TCGA-60-2724-01A-01D-1522-08,HG19_Broad_variant,TCGA-60-2724,TCGA-LUSC,NA,s10155,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T3,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82ee4b0c9d6adf6ae81,58cfa82ee4b0c9d6adf6ae81,G49538.TCGA-06-0210-01A-01D-1491-08.1.filtered.,WGS,G49538.TCGA-06-0210-01A-01D-1491-08.1,G49538.TCGA-06-0210-01A-01D-1491-08.1.bam,195.7,1.89,0.05,58cfa82ee4b0c9d6adf6ae81,G49538.TCGA-06-0210-01A-01D-1491-08.1.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0210-01A,DE7B7CAC-F094-4D59-8651-E991E34EA093,Primary Tumor,Illumina HiSeq,47e69676-3a06-4711-ab31-5c65c734e472,Brain,72,D56A1EB8-D47B-41C3-B5D0-F5632DF77B3F,E362F533-5394-4E4A-9E4A-375FFC5F427B,TCGA-06-0210-01A-01D-1491-08,HG19_Broad_variant,TCGA-06-0210,TCGA-GBM,225,s13986,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6af7e,58cfa82ee4b0c9d6adf6af7e,G48125.TCGA-25-1632-01A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-25-1632-01A-01D-A312-08.2,G48125.TCGA-25-1632-01A-01D-A312-08.2.bam,432.97,1.9,0.08,58cfa82ee4b0c9d6adf6af7e,G48125.TCGA-25-1632-01A-01D-A312-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-25-1632-01A,C435627C-159D-4A6D-A819-30ABAC24BF4D,Primary Tumor,Illumina HiSeq,541a0820-9b52-430b-9fca-5eaaeb06eb4a,Ovary,68,ED9C97D8-4DF2-4ED3-B455-4955D72901A8,FF3FE4A3-7D19-4D4D-81B6-AAA41BA5BF39,TCGA-25-1632-01A-01D-A312-08,HG19_Broad_variant,TCGA-25-1632,TCGA-OV,1799,s17406,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d144,58cfa832e4b0c9d6adf6d144,TCGA-KL-8325-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8325-01A-11D-2310-10_wgs_Illumina,TCGA-KL-8325-01A-11D-2310-10_wgs_Illumina.bam,258.3,NA,0.05,58cfa832e4b0c9d6adf6d144,TCGA-KL-8325-01A-11D-2310-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8325-01A,6101FFE6-2EF6-4256-9D6B-A7C545836995,Primary Tumor,Illumina HiSeq,61d8317e-d85d-4447-8c11-18c8f719fbdd,Kidney,56,79C48BEA-33E0-49E6-84F7-6103DA654642,9FC0E0E8-1B0F-400C-B4CF-126193283695,TCGA-KL-8325-01A-11D-2310-10,GRCh37-lite,TCGA-KL-8325,TCGA-KICH,725,s16423,Baylor College of Medicine,MSKCC,United States,NO,T2,NX,Kidney Chromophobe,Stage II
13722.58cfa830e4b0c9d6adf6bd38,58cfa830e4b0c9d6adf6bd38,TCGA-AA-A00N-01A-02D-A17O-10_wgs_Illumina.filtered.,WGS,TCGA-AA-A00N-01A-02D-A17O-10_wgs_Illumina,TCGA-AA-A00N-01A-02D-A17O-10_wgs_Illumina.bam,149.57,1.79,0.08,58cfa830e4b0c9d6adf6bd38,TCGA-AA-A00N-01A-02D-A17O-10_wgs_Illumina.bam,Dead,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A00N-01A,E457344D-76FB-46BF-B362-61A6E811D131,Primary Tumor,Illumina HiSeq,d83f0731-9567-4d26-83ed-42e1c4e01ef0,Colorectal,75,D52F3D05-1850-473E-8E1E-AB2B4F88AF2A,6CA5C1BB-275B-4D05-948A-3C6C7D03FAB9,TCGA-AA-A00N-01A-02D-A17O-10,GRCh37-lite,TCGA-AA-A00N,TCGA-COAD,122,s13516,Baylor College of Medicine,Indivumed,Germany,NO,T4,N0,Colon Mucinous Adenocarcinoma,Stage IIB
13722.58cfa82ee4b0c9d6adf6ae8b,58cfa82ee4b0c9d6adf6ae8b,G49537.TCGA-EM-A22O-01A-11D-A17V-08.1.filtered.,WGS,G49537.TCGA-EM-A22O-01A-11D-A17V-08.1,G49537.TCGA-EM-A22O-01A-11D-A17V-08.1.bam,89.61,1.91,0.09,58cfa82ee4b0c9d6adf6ae8b,G49537.TCGA-EM-A22O-01A-11D-A17V-08.1.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EM-A22O-01A,6ABC861A-376D-446B-ACEE-FB0F03A82C09,Primary Tumor,Illumina HiSeq,93872277-a7c8-4d30-999d-afa2db9d4986,Thyroid,75,AACF33BD-95CE-40FD-9828-1E78CBBB0E1B,13642CF8-9840-4A7D-A26A-95F65B2C70C3,TCGA-EM-A22O-01A-11D-A17V-08,HG19_Broad_variant,TCGA-EM-A22O,TCGA-THCA,NA,s12087,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T4a,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA
13722.58cfa832e4b0c9d6adf6d5ba,58cfa832e4b0c9d6adf6d5ba,TCGA-QG-A5YV-10A-01D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-QG-A5YV-10A-01D-A28G-10_wgs_Illumina,TCGA-QG-A5YV-10A-01D-A28G-10_wgs_Illumina.bam,11.42,NA,0.08,58cfa832e4b0c9d6adf6d5ba,TCGA-QG-A5YV-10A-01D-A28G-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-QG-A5YV-10A,C83D38FC-E011-4F75-A100-96513611F3E9,Blood Derived Normal,Illumina HiSeq,3b0443a1-23bb-40f0-bad1-f1fbc593e673,Colorectal,64,375C0CF9-9BAD-4D07-9FA6-017B0258D5A5,4BC33DA3-558D-434A-9B70-5EF170928451,TCGA-QG-A5YV-10A-01D-A28G-10,GRCh37-lite,TCGA-QG-A5YV,TCGA-COAD,NA,s13397,Baylor College of Medicine,BLN - Baylor,United States,NO,T4b,N1a,Colon Adenocarcinoma,Stage IIIC
13722.58cfa82ee4b0c9d6adf6a8b5,58cfa82ee4b0c9d6adf6a8b5,G35154.TCGA-DU-7304-02A-12D-A36O-08.4.filtered.,WGS,G35154.TCGA-DU-7304-02A-12D-A36O-08.4,G35154.TCGA-DU-7304-02A-12D-A36O-08.4.bam,18.11,NA,0.08,58cfa82ee4b0c9d6adf6a8b5,G35154.TCGA-DU-7304-02A-12D-A36O-08.4.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-DU-7304-02A,D61710C1-8AC3-44E3-B567-66288A6AB731,Recurrent Tumor,Illumina HiSeq,7f2ad00f-02aa-4094-9662-9e8092d240e1,Brain,43,66E2BB27-CA87-468C-A71D-E140F0BCA8DA,02318FD9-CF91-48E2-9402-E2C00BFA919D,TCGA-DU-7304-02A-12D-A36O-08,HG19_Broad_variant,TCGA-DU-7304,TCGA-LGG,709,s8741,Broad Institute of MIT and Harvard,Henry Ford Hospital,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa830e4b0c9d6adf6c2fb,58cfa830e4b0c9d6adf6c2fb,TCGA-BW-A5NO-10A-01D-A27I-10_wgs_Illumina.filtered.,WGS,TCGA-BW-A5NO-10A-01D-A27I-10_wgs_Illumina,TCGA-BW-A5NO-10A-01D-A27I-10_wgs_Illumina.bam,13.85,NA,0.08,58cfa830e4b0c9d6adf6c2fb,TCGA-BW-A5NO-10A-01D-A27I-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-BW-A5NO-10A,EE63C44B-91F4-4004-8DEA-192EAB527036,Blood Derived Normal,Illumina HiSeq,d7ae4a89-f883-434d-ba48-7559047f4aed,Liver,50,6CB5CE01-84FE-45BC-84D3-C26AB190503D,3033AE06-EBB4-4DBB-9F60-B9B9D5C72805,TCGA-BW-A5NO-10A-01D-A27I-10,GRCh37-lite,TCGA-BW-A5NO,TCGA-LIHC,NA,s16971,Baylor College of Medicine,St Joseph's Medical Center (MD),United States,NO,T3a,NX,Hepatocellular Carcinoma,Stage IIIA
13722.58cfa82ee4b0c9d6adf6ad51,58cfa82ee4b0c9d6adf6ad51,G48125.TCGA-24-1614-01A-01D-A312-08.3.filtered.,WGS,G48125.TCGA-24-1614-01A-01D-A312-08.3,G48125.TCGA-24-1614-01A-01D-A312-08.3.bam,51.67,1.9,0.08,58cfa82ee4b0c9d6adf6ad51,G48125.TCGA-24-1614-01A-01D-A312-08.3.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1614-01A,D3164236-C14A-4230-B527-ECD1A3992F02,Primary Tumor,Illumina HiSeq,c60278e1-2516-4bfa-8d8e-236a0501a227,Ovary,57,C36E2D42-0759-46F2-8032-B92E555400C9,5CC7C966-499E-49E3-B509-4EEB00EE03D4,TCGA-24-1614-01A-01D-A312-08,HG19_Broad_variant,TCGA-24-1614,TCGA-OV,1470,s17350,Broad Institute of MIT and Harvard,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ae86,58cfa82ee4b0c9d6adf6ae86,G49538.TCGA-14-1034-01A-01D-1492-08.3.filtered.,WGS,G49538.TCGA-14-1034-01A-01D-1492-08.3,G49538.TCGA-14-1034-01A-01D-1492-08.3.bam,15,1.9,0.05,58cfa82ee4b0c9d6adf6ae86,G49538.TCGA-14-1034-01A-01D-1492-08.3.bam,Dead,FEMALE,Not available,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1034-01A,0078B0C4-68A9-483B-9AAB-61156D263213,Primary Tumor,Illumina HiSeq,08541db8-2e7a-44e8-af91-65a951e09952,Brain,60,F2FFA9FF-86D6-41EF-92E7-7F87E981985B,86CD18AE-6390-4669-A707-4E0E334C690A,TCGA-14-1034-01A-01D-1492-08,HG19_Broad_variant,TCGA-14-1034,TCGA-GBM,485,s13984,Broad Institute of MIT and Harvard,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6aa8a,58cfa82ee4b0c9d6adf6aa8a,G32523.TCGA-DJ-A2Q2-01A-11D-A19J-08.4.filtered.,WGS,G32523.TCGA-DJ-A2Q2-01A-11D-A19J-08.4,G32523.TCGA-DJ-A2Q2-01A-11D-A19J-08.4.bam,41.27,NA,0.08,58cfa82ee4b0c9d6adf6aa8a,G32523.TCGA-DJ-A2Q2-01A-11D-A19J-08.4.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A2Q2-01A,A00DA907-E527-45F9-9AFB-2FAD2C7B0940,Primary Tumor,Illumina HiSeq,a59111e2-1f5e-429d-bb7f-4e413ed0baeb,Thyroid,57,A2E3CA88-9FF0-44AD-8C5A-CA4C7B404DE6,565E656C-D5E3-4FE4-A10C-2E9CA1E498B5,TCGA-DJ-A2Q2-01A-11D-A19J-08,HG19_Broad_variant,TCGA-DJ-A2Q2,TCGA-THCA,NA,s11972,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III
13722.58cfa831e4b0c9d6adf6ca66,58cfa831e4b0c9d6adf6ca66,TCGA-DQ-5629-10A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-DQ-5629-10A-01D-A32X-10_wgs_Illumina,TCGA-DQ-5629-10A-01D-A32X-10_wgs_Illumina.bam,130,1.9,0.08,58cfa831e4b0c9d6adf6ca66,TCGA-DQ-5629-10A-01D-A32X-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-DQ-5629-10A,E95E9E7D-A1ED-46EB-9CF8-1D355BF0577F,Blood Derived Normal,Illumina HiSeq,a61bf907-f580-4de5-8210-8c01ede3d802,Head and Neck,64,769F3C1C-323E-4F04-9AE7-E41F484A964C,1DBB8816-5B42-4A9F-A8DA-960281C93AE4,TCGA-DQ-5629-10A-01D-A32X-10,GRCh37-lite,TCGA-DQ-5629,TCGA-HNSC,NA,s16060,Baylor College of Medicine,University of Michigan,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6c00c,58cfa830e4b0c9d6adf6c00c,TCGA-B3-3926-11A-01D-1253-10_wgs_Illumina.filtered.,WGS,TCGA-B3-3926-11A-01D-1253-10_wgs_Illumina,TCGA-B3-3926-11A-01D-1253-10_wgs_Illumina.bam,3,1.9,0.15,58cfa830e4b0c9d6adf6c00c,TCGA-B3-3926-11A-01D-1253-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B3-3926-11A,2666AB3E-F2B9-4B3D-BFCE-AAC2A4BAFE62,Solid Tissue Normal,Illumina HiSeq,a6e49571-e92b-416a-b4ec-a025f2d229ff,Kidney,59,04BA9DAF-FB69-4CA9-8E63-222F2E667C9D,CDDAC18A-CC7C-48F5-8F2B-690E5FF0B88B,TCGA-B3-3926-11A-01D-1253-10,GRCh37-lite,TCGA-B3-3926,TCGA-KIRP,NA,s11645,Baylor College of Medicine,Christiana Healthcare,None,NO,T1,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6aab8,58cfa82ee4b0c9d6adf6aab8,G23079.TCGA_CR_6482_01A_11D_2268_08.2.filtered.,WGS,G23079.TCGA_CR_6482_01A_11D_2268_08.2,G23079.TCGA_CR_6482_01A_11D_2268_08.2.bam,68.7,1.9,0.14,58cfa82ee4b0c9d6adf6aab8,G23079.TCGA_CR_6482_01A_11D_2268_08.2.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-6482-01A,468649E7-1525-4B8A-8AB5-DDB27DB5F022,Primary Tumor,Illumina HiSeq,47cd6984-3399-4fc7-a843-09a97b33bf4b,Head and Neck,62,92173F97-B46A-4950-8CD8-6729AB9522C5,7158C9FD-A633-4FEF-AA23-BD285F2A87A8,TCGA-CR-6482-01A-11D-2268-08,HG19_Broad_variant,TCGA-CR-6482,TCGA-HNSC,NA,s15866,Broad Institute of MIT and Harvard,Vanderbilt University,United States,NO,Not available,Not available,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6c17c,58cfa830e4b0c9d6adf6c17c,TCGA-B9-4114-10A-01D-A31Z-10_wgs_Illumina.filtered.,WGS,TCGA-B9-4114-10A-01D-A31Z-10_wgs_Illumina,TCGA-B9-4114-10A-01D-A31Z-10_wgs_Illumina.bam,16.3,1.9,0.08,58cfa830e4b0c9d6adf6c17c,TCGA-B9-4114-10A-01D-A31Z-10_wgs_Illumina.bam,,Not available,,,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B9-4114-10A,DF135722-B98D-4DEC-906D-77DA13DF39B9,Blood Derived Normal,Illumina HiSeq,3eff7ac8-7d80-494d-9ea8-ee0dc879c236,Kidney,NA,B2023FC8-A160-4B10-997E-412901C1ACBA,F1D6CBB8-575F-443E-88F7-CEC77E80D27D,TCGA-B9-4114-10A-01D-A31Z-10,GRCh37-lite,TCGA-B9-4114,TCGA-KIRP,NA,s11773,Baylor College of Medicine,UNC,None,NO,NA,NA,NA,NA
13722.58cfa832e4b0c9d6adf6d510,58cfa832e4b0c9d6adf6d510,TCGA-NH-A50V-10A-01D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-NH-A50V-10A-01D-A28G-10_wgs_Illumina,TCGA-NH-A50V-10A-01D-A28G-10_wgs_Illumina.bam,18.27,NA,0.08,58cfa832e4b0c9d6adf6d510,TCGA-NH-A50V-10A-01D-A28G-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-NH-A50V-10A,D3B7ADA6-5395-4212-A921-8E97C92B605D,Blood Derived Normal,Illumina HiSeq,b51c024f-b89d-4306-9e04-9720e3301d0a,Colorectal,69,12B34821-908B-46A3-85AE-E8A5C3045566,4FC333A5-DF4C-45EF-84B3-56D83B9019B4,TCGA-NH-A50V-10A-01D-A28G-10,GRCh37-lite,TCGA-NH-A50V,TCGA-COAD,NA,s13545,Baylor College of Medicine,Candler,United States,NO,T3,N2a,Colon Adenocarcinoma,Stage IIIB
13722.58cfa82ee4b0c9d6adf6af3a,58cfa82ee4b0c9d6adf6af3a,G48125.TCGA-13-0912-01A-01D-A312-08.3.filtered.,WGS,G48125.TCGA-13-0912-01A-01D-A312-08.3,G48125.TCGA-13-0912-01A-01D-A312-08.3.bam,120.67,1.9,0.08,58cfa82ee4b0c9d6adf6af3a,G48125.TCGA-13-0912-01A-01D-A312-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0912-01A,58D34254-4F5B-40A4-9E9F-7160062FB2A4,Primary Tumor,Illumina HiSeq,5e598e0f-da1d-4e41-9a69-4ab15597c460,Ovary,58,BFC06061-2299-4785-9943-67F5EC9EBE3F,95FC38AC-2B36-4C46-ABBF-8D2D52FF9626,TCGA-13-0912-01A-01D-A312-08,HG19_Broad_variant,TCGA-13-0912,TCGA-OV,NA,s17801,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aa01,58cfa82ee4b0c9d6adf6aa01,G23078.TCGA_CR_6487_01A_11D_2268_08.2.filtered.,WGS,G23078.TCGA_CR_6487_01A_11D_2268_08.2,G23078.TCGA_CR_6487_01A_11D_2268_08.2.bam,287.7,1.9,0.14,58cfa82ee4b0c9d6adf6aa01,G23078.TCGA_CR_6487_01A_11D_2268_08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-6487-01A,9AE5101B-6031-4AB1-BFCA-198C41AF3184,Primary Tumor,Illumina HiSeq,5efcbe11-0d48-4b66-abce-d78199fe8fd8,Head and Neck,50,027DEDD3-BD53-420E-B7F2-EB5B8C26BCDC,1DB83E80-BDF7-4D8D-8008-BD8406D641FC,TCGA-CR-6487-01A-11D-2268-08,HG19_Broad_variant,TCGA-CR-6487,TCGA-HNSC,NA,s15606,Broad Institute of MIT and Harvard,Vanderbilt University,United States,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d594,58cfa832e4b0c9d6adf6d594,TCGA-MH-A561-10A-01D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-MH-A561-10A-01D-A26P-10_wgs_Illumina,TCGA-MH-A561-10A-01D-A26P-10_wgs_Illumina.bam,15.21,NA,0.08,58cfa832e4b0c9d6adf6d594,TCGA-MH-A561-10A-01D-A26P-10_wgs_Illumina.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-MH-A561-10A,E6E6A773-B155-45A9-989F-75C12CE1702A,Blood Derived Normal,Illumina HiSeq,31ebd3e6-0042-434d-b07e-bb3deec6e478,Kidney,66,3EAF17CF-C3FA-461E-A233-75E06FDCE379,EBF9EE83-790D-43A8-AE04-E32E2F61BFA6,TCGA-MH-A561-10A-01D-A26P-10,GRCh37-lite,TCGA-MH-A561,TCGA-KIRP,NA,s11783,Baylor College of Medicine,BLN - Baylor,United States,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ae98,58cfa82ee4b0c9d6adf6ae98,G49538.TCGA-06-0190-02A-01D-2280-08.1.filtered.,WGS,G49538.TCGA-06-0190-02A-01D-2280-08.1,G49538.TCGA-06-0190-02A-01D-2280-08.1.bam,500,1.9,0.05,58cfa82ee4b0c9d6adf6ae98,G49538.TCGA-06-0190-02A-01D-2280-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0190-02A,74139255-A635-4C87-814D-3DD04ED630A8,Recurrent Tumor,Illumina HiSeq,5059c072-64dc-47ec-8569-5de233557ab4,Brain,62,0F0D0C43-9987-4B4C-8686-9B4C89A27C57,C065761D-F775-457F-BDA0-4C7C257A701E,TCGA-06-0190-02A-01D-2280-08,HG19_Broad_variant,TCGA-06-0190,TCGA-GBM,317,s14029,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa832e4b0c9d6adf6d161,58cfa832e4b0c9d6adf6d161,TCGA-KL-8328-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8328-11A-01D-2310-10_wgs_Illumina,TCGA-KL-8328-11A-01D-2310-10_wgs_Illumina.bam,222.3,NA,0.05,58cfa832e4b0c9d6adf6d161,TCGA-KL-8328-11A-01D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8328-11A,452135F2-6DE6-4593-A091-DDF6344EE431,Solid Tissue Normal,Illumina HiSeq,936f3049-f3bd-47c0-9ee1-60297c7f1914,Kidney,60,7B840972-4C0F-4A8C-A834-4AA2FAABE074,F468E484-9121-46A5-90CF-ABE4CF4E7335,TCGA-KL-8328-11A-01D-2310-10,GRCh37-lite,TCGA-KL-8328,TCGA-KICH,NA,s16389,Baylor College of Medicine,MSKCC,United States,NO,T2b,N0,Kidney Chromophobe,Stage II
13722.58cfa82ee4b0c9d6adf6ad38,58cfa82ee4b0c9d6adf6ad38,G49537.TCGA-BJ-A28V-01A-11D-A19J-08.1.filtered.,WGS,G49537.TCGA-BJ-A28V-01A-11D-A19J-08.1,G49537.TCGA-BJ-A28V-01A-11D-A19J-08.1.bam,78.4,2,0.08,58cfa82ee4b0c9d6adf6ad38,G49537.TCGA-BJ-A28V-01A-11D-A19J-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A28V-01A,BED1FB3C-4459-460E-8190-29211857FA73,Primary Tumor,Illumina HiSeq,68b5668a-a719-42b2-99bb-d26c59c19b2f,Thyroid,80,4862B699-580D-4F2E-97A0-BD8918537067,19233FD1-5229-466E-ACF3-5882165758E0,TCGA-BJ-A28V-01A-11D-A19J-08,HG19_Broad_variant,TCGA-BJ-A28V,TCGA-THCA,NA,s12617,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa832e4b0c9d6adf6d0b5,58cfa832e4b0c9d6adf6d0b5,TCGA-IA-A40Y-10A-01D-A25F-10_wgs_Illumina.filtered.,WGS,TCGA-IA-A40Y-10A-01D-A25F-10_wgs_Illumina,TCGA-IA-A40Y-10A-01D-A25F-10_wgs_Illumina.bam,26.49,NA,0.07,58cfa832e4b0c9d6adf6d0b5,TCGA-IA-A40Y-10A-01D-A25F-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-IA-A40Y-10A,1DB41963-A520-47F0-828C-ED5C626507B1,Blood Derived Normal,Illumina HiSeq,7423e40c-b8cf-49d7-8e8c-2e35991600b0,Kidney,60,1A3982A0-DBE3-4144-A80C-6B40AEE5DEB6,AAB4115C-FDFE-45AE-9A51-91EE50250623,TCGA-IA-A40Y-10A-01D-A25F-10,GRCh37-lite,TCGA-IA-A40Y,TCGA-KIRP,NA,s11654,Baylor College of Medicine,Cleveland Clinic,United States,NO,T3a,N1,Kidney Papillary Renal Cell Carcinoma,Stage III
13722.58cfa832e4b0c9d6adf6d32a,58cfa832e4b0c9d6adf6d32a,TCGA-KN-8419-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8419-11A-01D-2310-10_wgs_Illumina,TCGA-KN-8419-11A-01D-2310-10_wgs_Illumina.bam,270.3,NA,0.05,58cfa832e4b0c9d6adf6d32a,TCGA-KN-8419-11A-01D-2310-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KN-8419-11A,DC04B82C-E1E8-4917-BA19-C2FEA4A1B69A,Solid Tissue Normal,Illumina HiSeq,0396fd65-803d-4cbd-8446-aae1b47dcc18,Kidney,43,04AB90CD-4030-46BC-8A3B-279B9DFAA24C,04ADCED3-96C5-4EC2-8E06-293544F0C3D7,TCGA-KN-8419-11A-01D-2310-10,GRCh37-lite,TCGA-KN-8419,TCGA-KICH,NA,s16393,Baylor College of Medicine,Harvard,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa831e4b0c9d6adf6c6ec,58cfa831e4b0c9d6adf6c6ec,TCGA-CQ-6228-10A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CQ-6228-10A-01D-A32X-10_wgs_Illumina,TCGA-CQ-6228-10A-01D-A32X-10_wgs_Illumina.bam,67,NA,0.07,58cfa831e4b0c9d6adf6c6ec,TCGA-CQ-6228-10A-01D-A32X-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-6228-10A,E303B8C4-6428-4134-BB9D-A95DC1D8E35E,Blood Derived Normal,Illumina HiSeq,5d6324c4-f5bf-4a4f-bc7b-c12e4c489709,Head and Neck,71,E7D92B6E-9717-43C9-AD7D-0BFFE48C4C1A,07C948F4-4BEF-47D8-87D6-990DF62B541B,TCGA-CQ-6228-10A-01D-A32X-10,GRCh37-lite,TCGA-CQ-6228,TCGA-HNSC,456,s15507,Baylor College of Medicine,"University Health Network, Toronto",Canada,NO,T1,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6c7e3,58cfa831e4b0c9d6adf6c7e3,TCGA-CV-5973-11A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CV-5973-11A-01D-A32X-10_wgs_Illumina,TCGA-CV-5973-11A-01D-A32X-10_wgs_Illumina.bam,17,1.8,0.07,58cfa831e4b0c9d6adf6c7e3,TCGA-CV-5973-11A-01D-A32X-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5973-11A,8FC1F1BE-D2D5-4B3A-9973-F4D964018BEB,Solid Tissue Normal,Illumina HiSeq,f0e1f7a9-618e-4dfa-91db-019ab3386912,Head and Neck,62,8ED1F8FB-095A-4E76-88A3-15CEE4B5B4BB,038BDC6A-3A8D-41D8-855B-35C8EDCC97B6,TCGA-CV-5973-11A-01D-A32X-10,GRCh37-lite,TCGA-CV-5973,TCGA-HNSC,NA,s15897,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T3,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6c917,58cfa831e4b0c9d6adf6c917,TCGA-CN-6011-10A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CN-6011-10A-01D-A32X-10_wgs_Illumina,TCGA-CN-6011-10A-01D-A32X-10_wgs_Illumina.bam,396.7,1.9,0.08,58cfa831e4b0c9d6adf6c917,TCGA-CN-6011-10A-01D-A32X-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-6011-10A,E7D49212-E9CB-4CD7-923A-BDFC82A4A150,Blood Derived Normal,Illumina HiSeq,76964677-277a-41bf-8cd5-1d52cbc10e60,Head and Neck,57,4D620A8E-517E-43B2-AD44-D9A8467E73A7,E2F90B88-0469-4CE8-846F-90FAB387903E,TCGA-CN-6011-10A-01D-A32X-10,GRCh37-lite,TCGA-CN-6011,TCGA-HNSC,NA,s15627,Baylor College of Medicine,University of Pittsburgh,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6d2f5,58cfa832e4b0c9d6adf6d2f5,TCGA-KN-8424-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8424-01A-11D-2310-10_wgs_Illumina,TCGA-KN-8424-01A-11D-2310-10_wgs_Illumina.bam,71.3,NA,0.05,58cfa832e4b0c9d6adf6d2f5,TCGA-KN-8424-01A-11D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KN-8424-01A,8C9E1F60-1838-4AA4-A667-C1CEF7DDDBDF,Primary Tumor,Illumina HiSeq,5c114c89-2e86-497d-a02e-e309eee59dc0,Kidney,42,93B1AE00-43E1-466C-BBC1-8755CB1A1A0C,1E8AE8DD-74C1-44D5-A74E-BFDCE801C736,TCGA-KN-8424-01A-11D-2310-10,GRCh37-lite,TCGA-KN-8424,TCGA-KICH,NA,s16524,Baylor College of Medicine,Harvard,United States,NO,T1b,N0,Kidney Chromophobe,Stage I
13722.58cfa830e4b0c9d6adf6c252,58cfa830e4b0c9d6adf6c252,TCGA-BW-A5NP-10A-01D-A27I-10_wgs_Illumina.filtered.,WGS,TCGA-BW-A5NP-10A-01D-A27I-10_wgs_Illumina,TCGA-BW-A5NP-10A-01D-A27I-10_wgs_Illumina.bam,30.04,NA,0.07,58cfa830e4b0c9d6adf6c252,TCGA-BW-A5NP-10A-01D-A27I-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-BW-A5NP-10A,56A82A56-0241-4D3D-9DE2-696B0C36DF91,Blood Derived Normal,Illumina HiSeq,04c9cdd8-9dcd-467f-ab86-10a648aa2593,Liver,26,2D6271F8-B751-47FF-B01F-E6A88F46D5A6,600BA105-B0F1-4FBA-B1EC-0BBFE622E6CF,TCGA-BW-A5NP-10A-01D-A27I-10,GRCh37-lite,TCGA-BW-A5NP,TCGA-LIHC,NA,s16847,Baylor College of Medicine,St Joseph's Medical Center (MD),United States,NO,T2,N0,Hepatocellular Carcinoma,Stage IV
13722.58cfa82ee4b0c9d6adf6aa1f,58cfa82ee4b0c9d6adf6aa1f,G2185.TCGA-04-1371-11A-01D.7.filtered.,WGS,G2185.TCGA-04-1371-11A-01D.7,G2185.TCGA-04-1371-11A-01D.7.bam,235.27,1.9,0.14,58cfa82ee4b0c9d6adf6aa1f,G2185.TCGA-04-1371-11A-01D.7.bam,Alive,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-04-1371-11A,BFF84539-7862-45B2-B5FC-E77291FCCA8B,Solid Tissue Normal,Illumina GA,0da780af-352f-45c2-ad38-5052e09f6ce9,Ovary,58,6FEFB3D5-7FEA-438F-8986-681082BE8819,81B30BC6-2BC4-48BA-AC99-E10786AFDC3A,TCGA-04-1371-11A-01D-0516-08,HG19_Broad_variant,TCGA-04-1371,TCGA-OV,NA,s17588,Broad Institute of MIT and Harvard,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa830e4b0c9d6adf6bc08,58cfa830e4b0c9d6adf6bc08,TCGA-A6-A5ZU-10A-01D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-A6-A5ZU-10A-01D-A28G-10_wgs_Illumina,TCGA-A6-A5ZU-10A-01D-A28G-10_wgs_Illumina.bam,41.62,NA,0.07,58cfa830e4b0c9d6adf6bc08,TCGA-A6-A5ZU-10A-01D-A28G-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-A5ZU-10A,4881A390-C4E4-48B4-AE66-140C64A87614,Blood Derived Normal,Illumina HiSeq,591559cb-fa56-4f88-b265-c9b1011ddab3,Colorectal,59,9D17F4B1-D7C9-4068-B2D6-20B15741237E,83A4A2EC-E79F-4D04-B3CE-BCD7B9B14819,TCGA-A6-A5ZU-10A-01D-A28G-10,GRCh37-lite,TCGA-A6-A5ZU,TCGA-COAD,NA,s13656,Baylor College of Medicine,Christiana Healthcare,United States,NO,T3,N1,Colon Adenocarcinoma,Stage IIIB
13722.58cfa832e4b0c9d6adf6d319,58cfa832e4b0c9d6adf6d319,TCGA-KN-8429-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8429-01A-11D-2310-10_wgs_Illumina,TCGA-KN-8429-01A-11D-2310-10_wgs_Illumina.bam,71.3,NA,0.05,58cfa832e4b0c9d6adf6d319,TCGA-KN-8429-01A-11D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KN-8429-01A,366219B9-FDE3-4D2D-82D3-15FE6245AA98,Primary Tumor,Illumina HiSeq,a527b958-1e44-4a4f-99e9-ba45c80bd326,Kidney,38,B802658C-4715-4878-97CA-99576F08AF6A,58C7E9C3-1345-48C0-A758-0887358B8696,TCGA-KN-8429-01A-11D-2310-10,GRCh37-lite,TCGA-KN-8429,TCGA-KICH,NA,s16492,Baylor College of Medicine,Harvard,United States,NO,T3a,N0,Kidney Chromophobe,Stage III
13722.58cfa82ee4b0c9d6adf6ad63,58cfa82ee4b0c9d6adf6ad63,G49537.TCGA-BJ-A0Z2-01A-11D-A10S-08.2.filtered.,WGS,G49537.TCGA-BJ-A0Z2-01A-11D-A10S-08.2,G49537.TCGA-BJ-A0Z2-01A-11D-A10S-08.2.bam,89.84,1.92,0.07,58cfa82ee4b0c9d6adf6ad63,G49537.TCGA-BJ-A0Z2-01A-11D-A10S-08.2.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0Z2-01A,F9CEFFC0-D544-418D-B4A9-BD3C84E37026,Primary Tumor,Illumina HiSeq,b84e6415-1014-4d91-a469-879b108fa3bb,Thyroid,57,B06B7493-F38A-493F-8B47-61E0FA4D111F,2DD5EEA1-42A1-4E8B-99AC-20399CC7E15C,TCGA-BJ-A0Z2-01A-11D-A10S-08,HG19_Broad_variant,TCGA-BJ-A0Z2,TCGA-THCA,NA,s12618,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage IVC
13722.58cfa831e4b0c9d6adf6c992,58cfa831e4b0c9d6adf6c992,TCGA-DD-A4NE-11A-11D-A27I-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A4NE-11A-11D-A27I-10_wgs_Illumina,TCGA-DD-A4NE-11A-11D-A27I-10_wgs_Illumina.bam,16.58,NA,0.07,58cfa831e4b0c9d6adf6c992,TCGA-DD-A4NE-11A-11D-A27I-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A4NE-11A,BCE25281-502E-4599-9679-32DC8462FFB1,Solid Tissue Normal,Illumina HiSeq,dd125101-70fd-408a-89f3-ab37dd477c3a,Liver,75,F290F824-C884-4297-B7B8-BAB328CB14AD,2F595B57-7CF4-4499-BEC6-497A4E241E01,TCGA-DD-A4NE-11A-11D-A27I-10,GRCh37-lite,TCGA-DD-A4NE,TCGA-LIHC,660,s16979,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T3a,N0,Hepatocellular Carcinoma,Stage IIIA
13722.58cfa832e4b0c9d6adf6d2d8,58cfa832e4b0c9d6adf6d2d8,TCGA-KL-8334-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8334-11A-01D-2310-10_wgs_Illumina,TCGA-KL-8334-11A-01D-2310-10_wgs_Illumina.bam,231.3,NA,0.05,58cfa832e4b0c9d6adf6d2d8,TCGA-KL-8334-11A-01D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8334-11A,9AABCBD7-A26A-49B1-ABF1-02C0DC3ADCF2,Solid Tissue Normal,Illumina HiSeq,cd0c2fbc-4848-4db5-862a-327eddbd961f,Kidney,37,A918F46A-1DEA-42DF-B46C-AD92CBC4D934,DD7BFE59-20EE-4F8C-8A95-8EB1D0846091,TCGA-KL-8334-11A-01D-2310-10,GRCh37-lite,TCGA-KL-8334,TCGA-KICH,NA,s16436,Baylor College of Medicine,MSKCC,United States,NO,T3a,N0,Kidney Chromophobe,Stage III
13722.58cfa82ee4b0c9d6adf6aea8,58cfa82ee4b0c9d6adf6aea8,G39020.TCGA-BR-8373-01A-11D-2340-08.3.filtered.,WGS,G39020.TCGA-BR-8373-01A-11D-2340-08.3,G39020.TCGA-BR-8373-01A-11D-2340-08.3.bam,188.7,NA,0.05,58cfa82ee4b0c9d6adf6aea8,G39020.TCGA-BR-8373-01A-11D-2340-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-8373-01A,60879669-96C2-4710-82E0-0AE9D0E5B242,Primary Tumor,Illumina HiSeq,cbbdb4e0-d400-45ef-bb4f-790b2cc9cb87,Stomach,65,4370B4F3-4FD7-4558-BF59-DAAE486BADC3,1F2A8889-4374-4037-BB56-0F20733380E3,TCGA-BR-8373-01A-11D-2340-08,HG19_Broad_variant,TCGA-BR-8373,TCGA-STAD,NA,s15094,Broad Institute of MIT and Harvard,Asterand,Ukraine,NO,T4a,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82ee4b0c9d6adf6ad69,58cfa82ee4b0c9d6adf6ad69,G48125.TCGA-25-2400-01A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-25-2400-01A-01D-A312-08.2,G48125.TCGA-25-2400-01A-01D-A312-08.2.bam,26.97,1.9,0.08,58cfa82ee4b0c9d6adf6ad69,G48125.TCGA-25-2400-01A-01D-A312-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-25-2400-01A,5C127332-5CA0-45F1-A5AC-4876AD94E491,Primary Tumor,Illumina HiSeq,8cee9d85-d13a-49d0-a53e-c44c00ed4e36,Ovary,76,B5E8849B-9002-4B65-A2EA-6A46C04ABA4A,D67CAD13-E849-48B0-926C-10B6046BA0B9,TCGA-25-2400-01A-01D-A312-08,HG19_Broad_variant,TCGA-25-2400,TCGA-OV,1278,s17800,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c6f8,58cfa831e4b0c9d6adf6c6f8,TCGA-CR-6491-10A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CR-6491-10A-01D-A32X-10_wgs_Illumina,TCGA-CR-6491-10A-01D-A32X-10_wgs_Illumina.bam,237,1.8,0.08,58cfa831e4b0c9d6adf6c6f8,TCGA-CR-6491-10A-01D-A32X-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-6491-10A,5FCE954C-11B9-41F4-9471-4B5BDC0EFA7F,Blood Derived Normal,Illumina HiSeq,1ff34fd0-0329-461b-a74f-409c6590c6a7,Head and Neck,60,7F539E65-6E3A-4EB3-8711-33A7F2DED0E8,A5449995-33F9-43CB-A439-9284E4F2EFD7,TCGA-CR-6491-10A-01D-A32X-10,GRCh37-lite,TCGA-CR-6491,TCGA-HNSC,NA,s15639,Baylor College of Medicine,Vanderbilt University,United States,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82ee4b0c9d6adf6a7f6,58cfa82ee4b0c9d6adf6a7f6,G2187.TCGA-25-1319-01A-01D.4.filtered.,WGS,G2187.TCGA-25-1319-01A-01D.4,G2187.TCGA-25-1319-01A-01D.4.bam,292.97,1.9,0.14,58cfa82ee4b0c9d6adf6a7f6,G2187.TCGA-25-1319-01A-01D.4.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-25-1319-01A,914D8613-3C25-4A10-BE50-28B42F4D3A5D,Primary Tumor,Illumina GA,e5546364-fc34-41ba-b682-67579744998e,Ovary,73,C063D066-9073-4F05-8A38-601AA65DC5BF,B1FE75E5-D8EA-42BF-8643-AA519D4BC937,TCGA-25-1319-01A-01D-0516-08,HG19_Broad_variant,TCGA-25-1319,TCGA-OV,1977,s17587,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aca8,58cfa82ee4b0c9d6adf6aca8,G39020.TCGA-HU-A4H0-01A-11D-A25D-08.1.filtered.,WGS,G39020.TCGA-HU-A4H0-01A-11D-A25D-08.1,G39020.TCGA-HU-A4H0-01A-11D-A25D-08.1.bam,42.83,NA,0.08,58cfa82ee4b0c9d6adf6aca8,G39020.TCGA-HU-A4H0-01A-11D-A25D-08.1.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-HU-A4H0-01A,FE45EAEE-FF0C-4D52-B18C-04DC2D64D3B4,Primary Tumor,Illumina HiSeq,787fd694-c915-406f-a8a1-0ca998d01d93,Stomach,72,568CBF5F-86DA-4420-9C70-324D11B8E481,7116CC90-F465-4E7E-AA27-48A83ED258E9,TCGA-HU-A4H0-01A-11D-A25D-08,HG19_Broad_variant,TCGA-HU-A4H0,TCGA-STAD,NA,s14394,Broad Institute of MIT and Harvard,National Cancer Center Korea,Korea South,NO,T4a,N3b,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIC
13722.58cfa832e4b0c9d6adf6d472,58cfa832e4b0c9d6adf6d472,TCGA-QG-A5YW-10A-01D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-QG-A5YW-10A-01D-A28G-10_wgs_Illumina,TCGA-QG-A5YW-10A-01D-A28G-10_wgs_Illumina.bam,5.12,NA,0.08,58cfa832e4b0c9d6adf6d472,TCGA-QG-A5YW-10A-01D-A28G-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-QG-A5YW-10A,9F45A227-1FD5-478C-A194-4A5C61B68CC3,Blood Derived Normal,Illumina HiSeq,809c20cb-03fe-4d13-9715-d6cafb4bd36c,Colorectal,55,DD4B861C-0119-43D4-8312-1D61A17C23C5,B8F43F58-F4DC-456E-BB75-10C5BDF28F06,TCGA-QG-A5YW-10A-01D-A28G-10,GRCh37-lite,TCGA-QG-A5YW,TCGA-COAD,NA,s13692,Baylor College of Medicine,BLN - Baylor,United States,NO,T3,N2b,Colon Mucinous Adenocarcinoma,Stage IIIC
13722.58cfa82ee4b0c9d6adf6ac9e,58cfa82ee4b0c9d6adf6ac9e,G48125.TCGA-04-1542-01A-01D-A312-08.1.filtered.,WGS,G48125.TCGA-04-1542-01A-01D-A312-08.1,G48125.TCGA-04-1542-01A-01D-A312-08.1.bam,136.34,1.9,0.08,58cfa82ee4b0c9d6adf6ac9e,G48125.TCGA-04-1542-01A-01D-A312-08.1.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-04-1542-01A,0C1A2E7D-E7E4-481E-A012-EF214C444497,Primary Tumor,Illumina HiSeq,b959ed10-2767-48bb-8031-f7a331c04f91,Ovary,52,D33FD264-13DB-4642-AFCA-37125751CC28,A0BBB3B1-E774-4C75-9301-BA43FB803F20,TCGA-04-1542-01A-01D-A312-08,HG19_Broad_variant,TCGA-04-1542,TCGA-OV,2561,s18019,Broad Institute of MIT and Harvard,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d356,58cfa832e4b0c9d6adf6d356,TCGA-KO-8416-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KO-8416-01A-11D-2310-10_wgs_Illumina,TCGA-KO-8416-01A-11D-2310-10_wgs_Illumina.bam,74.8,NA,0.05,58cfa832e4b0c9d6adf6d356,TCGA-KO-8416-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KO-8416-01A,0EC3CAA1-7C51-417B-A89C-18E9FCEB80C4,Primary Tumor,Illumina HiSeq,3f5f5abf-4e3b-409e-9e2b-c8543d51100b,Kidney,41,545486B9-EF3E-45AD-810A-F4594A2DB883,9D29543E-8601-4FD0-8E76-3DF3DE465CAB,TCGA-KO-8416-01A-11D-2310-10,GRCh37-lite,TCGA-KO-8416,TCGA-KICH,NA,s16576,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T3a,N0,Kidney Chromophobe,Stage III
13722.58cfa832e4b0c9d6adf6d2bd,58cfa832e4b0c9d6adf6d2bd,TCGA-KL-8341-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8341-01A-11D-2310-10_wgs_Illumina,TCGA-KL-8341-01A-11D-2310-10_wgs_Illumina.bam,167,NA,0.05,58cfa832e4b0c9d6adf6d2bd,TCGA-KL-8341-01A-11D-2310-10_wgs_Illumina.bam,Dead,MALE,ASIAN,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8341-01A,70E306EE-9584-49D6-81A1-A49D837AB6AA,Primary Tumor,Illumina HiSeq,507c9643-76a6-4c30-9802-a174ce2a0c8f,Kidney,41,EDF08A41-2AD2-4D1A-B567-5BE518A33469,E9032DF3-8692-4146-A867-B9B64C9B310A,TCGA-KL-8341-01A-11D-2310-10,GRCh37-lite,TCGA-KL-8341,TCGA-KICH,754,s16481,Baylor College of Medicine,MSKCC,United States,NO,T3b,N2,Kidney Chromophobe,Stage IV
13722.58cfa82ee4b0c9d6adf6ad8e,58cfa82ee4b0c9d6adf6ad8e,G2187.TCGA-25-1319-10A-01D.4.filtered.,WGS,G2187.TCGA-25-1319-10A-01D.4,G2187.TCGA-25-1319-10A-01D.4.bam,20,1.9,0.14,58cfa82ee4b0c9d6adf6ad8e,G2187.TCGA-25-1319-10A-01D.4.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-25-1319-10A,914D8613-3C25-4A10-BE50-28B42F4D3A5D,Blood Derived Normal,Illumina GA,dbb6d3a4-35c0-402b-bbe0-a0d42c1f6b53,Ovary,73,474DE020-7D56-46FB-A25F-85007E473B57,887579C6-F07F-4FF6-9B5B-972A9EB8D00A,TCGA-25-1319-10A-01D-0516-08,HG19_Broad_variant,TCGA-25-1319,TCGA-OV,1977,s18018,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ad22,58cfa82ee4b0c9d6adf6ad22,G49537.TCGA-BJ-A28T-01A-11D-A33C-08.2.filtered.,WGS,G49537.TCGA-BJ-A28T-01A-11D-A33C-08.2,G49537.TCGA-BJ-A28T-01A-11D-A33C-08.2.bam,61.44,2,0.08,58cfa82ee4b0c9d6adf6ad22,G49537.TCGA-BJ-A28T-01A-11D-A33C-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A28T-01A,A9D8F797-8A53-4BE5-B957-0F1F6D080390,Primary Tumor,Illumina HiSeq,e27094ec-2670-4ef1-a358-d36554e52da1,Thyroid,34,4CA4149A-E952-4A25-9163-8D4C15B09A62,1D97BA51-D981-4986-9F71-C2B6CB9961C3,TCGA-BJ-A28T-01A-11D-A33C-08,HG19_Broad_variant,TCGA-BJ-A28T,TCGA-THCA,NA,s12218,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T1,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82ee4b0c9d6adf6aed0,58cfa82ee4b0c9d6adf6aed0,G48125.TCGA-13-1491-01A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-13-1491-01A-01D-A312-08.2,G48125.TCGA-13-1491-01A-01D-A312-08.2.bam,295.97,1.9,0.07,58cfa82ee4b0c9d6adf6aed0,G48125.TCGA-13-1491-01A-01D-A312-08.2.bam,Dead,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-1491-01A,C8FEBEEF-8E7E-459E-88CB-8086692DC559,Primary Tumor,Illumina HiSeq,f59b5a81-22df-4a33-86dd-2e648ee08701,Ovary,55,A082B848-0867-4BB4-96BA-008645D9053C,129DE5B2-D9B0-4762-9EF8-72D98231FB50,TCGA-13-1491-01A-01D-A312-08,HG19_Broad_variant,TCGA-13-1491,TCGA-OV,1595,s17167,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d59b,58cfa832e4b0c9d6adf6d59b,TCGA-MH-A55Z-10A-01D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-MH-A55Z-10A-01D-A26P-10_wgs_Illumina,TCGA-MH-A55Z-10A-01D-A26P-10_wgs_Illumina.bam,19.12,NA,0.09,58cfa832e4b0c9d6adf6d59b,TCGA-MH-A55Z-10A-01D-A26P-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-MH-A55Z-10A,F0F7E57F-1E9D-4F24-A685-A0811AACBBED,Blood Derived Normal,Illumina HiSeq,5aebfd80-db09-4239-a549-bb5d5dee7626,Kidney,65,46EDD1C1-E9F4-4D0E-9FBB-9065DCFA2228,3D292F02-EBB2-457B-B5A3-1590B60833A6,TCGA-MH-A55Z-10A-01D-A26P-10,GRCh37-lite,TCGA-MH-A55Z,TCGA-KIRP,NA,s11655,Baylor College of Medicine,BLN - Baylor,United States,NO,T1b,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ae76,58cfa82ee4b0c9d6adf6ae76,G49537.TCGA-FE-A22Z-01A-11D-A35R-08.1.filtered.,WGS,G49537.TCGA-FE-A22Z-01A-11D-A35R-08.1,G49537.TCGA-FE-A22Z-01A-11D-A35R-08.1.bam,78.59,2.03,0.08,58cfa82ee4b0c9d6adf6ae76,G49537.TCGA-FE-A22Z-01A-11D-A35R-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A22Z-01A,78D14F86-896A-4F98-9274-B2E8E387ADD9,Primary Tumor,Illumina HiSeq,d881881c-7108-46ea-92a8-1b1d9c915d5b,Thyroid,61,D206D300-E0CE-4A40-AF1F-45A685346A6E,8845FCE6-E2B4-4929-942B-57096B0BBAFC,TCGA-FE-A22Z-01A-11D-A35R-08,HG19_Broad_variant,TCGA-FE-A22Z,TCGA-THCA,NA,s12737,Broad Institute of MIT and Harvard,Ohio State University,United States,NO,T4a,N1,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage IVA
13722.58cfa82ee4b0c9d6adf6aaec,58cfa82ee4b0c9d6adf6aaec,G32536.TCGA-EL-A3T0-01A-22D-A22D-08.4.filtered.,WGS,G32536.TCGA-EL-A3T0-01A-22D-A22D-08.4,G32536.TCGA-EL-A3T0-01A-22D-A22D-08.4.bam,25.01,NA,0.08,58cfa82ee4b0c9d6adf6aaec,G32536.TCGA-EL-A3T0-01A-22D-A22D-08.4.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EL-A3T0-01A,861F94CE-45FF-4588-ADDB-E1EA48878C2E,Primary Tumor,Illumina HiSeq,5c6477ae-68e1-4407-8f81-53f64006df76,Thyroid,45,913D384C-657A-4AE0-9E8E-E9BDB77D140E,54426B1A-E0D3-4D8E-9E81-2D8E6B153B22,TCGA-EL-A3T0-01A-22D-A22D-08,HG19_Broad_variant,TCGA-EL-A3T0,TCGA-THCA,NA,s11975,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,T3,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa82ee4b0c9d6adf6affa,58cfa82ee4b0c9d6adf6affa,G48125.TCGA-13-0727-01A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-13-0727-01A-01D-A312-08.2,G48125.TCGA-13-0727-01A-01D-A312-08.2.bam,36.64,1.9,0.08,58cfa82ee4b0c9d6adf6affa,G48125.TCGA-13-0727-01A-01D-A312-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0727-01A,90F4B65C-CFD4-4066-A5B9-842885C172E2,Primary Tumor,Illumina HiSeq,e58e09a0-fb52-490e-baf9-19502ff4232d,Ovary,71,6FCD7BB8-6CB0-4797-A5B5-D3EC4911A279,16DF7888-2480-4394-8856-D57A6EF371D2,TCGA-13-0727-01A-01D-A312-08,HG19_Broad_variant,TCGA-13-0727,TCGA-OV,462,s17116,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6a8f6,58cfa82ee4b0c9d6adf6a8f6,G35154.TCGA-FG-5965-01B-11D-1893-08.2.filtered.,WGS,G35154.TCGA-FG-5965-01B-11D-1893-08.2,G35154.TCGA-FG-5965-01B-11D-1893-08.2.bam,86.7,1.9,0.05,58cfa82ee4b0c9d6adf6a8f6,G35154.TCGA-FG-5965-01B-11D-1893-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-FG-5965-01B,2CFC07F3-A31C-41A2-A9E3-B708D2421A78,Primary Tumor,Illumina HiSeq,8e6db5b3-96e4-4a80-9604-99a9433a1bb5,Brain,39,93FBE6D3-2091-4151-9075-0ED2DD4B886F,0730868D-1FE9-4964-A0CC-A12A74D161E6,TCGA-FG-5965-01B-11D-1893-08,HG19_Broad_variant,TCGA-FG-5965,TCGA-LGG,NA,s8106,Broad Institute of MIT and Harvard,Case Western,United States,NO,Not available,Not available,Oligoastrocytoma,Not available
13722.58cfa832e4b0c9d6adf6d33e,58cfa832e4b0c9d6adf6d33e,TCGA-KN-8435-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8435-01A-11D-2310-10_wgs_Illumina,TCGA-KN-8435-01A-11D-2310-10_wgs_Illumina.bam,134,NA,0.05,58cfa832e4b0c9d6adf6d33e,TCGA-KN-8435-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KN-8435-01A,F2B58595-DEC0-4194-AB33-7C7DC6C058A6,Primary Tumor,Illumina HiSeq,28eaaad9-76f1-4c47-9af6-d8dc853ae96c,Kidney,59,B2D2BE13-C233-409A-A793-21D9CD3CFCE7,715F59DD-A80F-422D-988C-F73F4B987BAF,TCGA-KN-8435-01A-11D-2310-10,GRCh37-lite,TCGA-KN-8435,TCGA-KICH,NA,s16489,Baylor College of Medicine,Harvard,United States,NO,T2,NX,Kidney Chromophobe,Stage II
13722.58cfa832e4b0c9d6adf6d30c,58cfa832e4b0c9d6adf6d30c,TCGA-KM-8439-10A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KM-8439-10A-01D-2311-10_wgs_Illumina,TCGA-KM-8439-10A-01D-2311-10_wgs_Illumina.bam,135.6,NA,0.05,58cfa832e4b0c9d6adf6d30c,TCGA-KM-8439-10A-01D-2311-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KM-8439-10A,739DEED4-D1DC-458F-BD0F-1E24D2BFD305,Blood Derived Normal,Illumina HiSeq,b770ae8b-0248-4e7d-9ac3-130654950d0d,Kidney,30,F25CC5D3-5005-41A4-93AB-B70FDF1F0913,1F433AC7-B321-46A9-87AC-C72AD5B1B4E5,TCGA-KM-8439-10A-01D-2311-10,GRCh37-lite,TCGA-KM-8439,TCGA-KICH,NA,s16475,Baylor College of Medicine,NCI Urologic Oncology Branch,United States,NO,T1b,NX,Kidney Chromophobe,Stage I
13722.58cfa82ee4b0c9d6adf6aee2,58cfa82ee4b0c9d6adf6aee2,G49537.TCGA-ET-A2N1-01A-11D-A18F-08.2.filtered.,WGS,G49537.TCGA-ET-A2N1-01A-11D-A18F-08.2,G49537.TCGA-ET-A2N1-01A-11D-A18F-08.2.bam,49.49,NA,0.08,58cfa82ee4b0c9d6adf6aee2,G49537.TCGA-ET-A2N1-01A-11D-A18F-08.2.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-ET-A2N1-01A,E74B8474-F74A-498D-8848-6AA97D38D2D8,Primary Tumor,Illumina HiSeq,f2cf3084-f780-42f8-b97c-c1d5483a1dd9,Thyroid,47,1EFC40AF-FEDF-4BC3-BE59-1E31A87BAA15,7ED3E66E-F784-483F-AC37-1300736584A4,TCGA-ET-A2N1-01A-11D-A18F-08,HG19_Broad_variant,TCGA-ET-A2N1,TCGA-THCA,NA,s12625,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa831e4b0c9d6adf6c807,58cfa831e4b0c9d6adf6c807,TCGA-CV-7432-10A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CV-7432-10A-01D-A32X-10_wgs_Illumina,TCGA-CV-7432-10A-01D-A32X-10_wgs_Illumina.bam,95.03,NA,0.07,58cfa831e4b0c9d6adf6c807,TCGA-CV-7432-10A-01D-A32X-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7432-10A,EAF674DD-9909-4879-B9A3-74253169EDDD,Blood Derived Normal,Illumina HiSeq,c7df3c71-767b-466e-a301-731b8071e632,Head and Neck,79,53470D1A-5DF1-40C4-9758-DDB52A50099F,DBF50D0D-D4E6-46EA-B1A6-90CDA6969C2B,TCGA-CV-7432-10A-01D-A32X-10,GRCh37-lite,TCGA-CV-7432,TCGA-HNSC,2570,s15525,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa830e4b0c9d6adf6bc50,58cfa830e4b0c9d6adf6bc50,TCGA-AL-3472-10A-01D-A31Z-10_wgs_Illumina.filtered.,WGS,TCGA-AL-3472-10A-01D-A31Z-10_wgs_Illumina,TCGA-AL-3472-10A-01D-A31Z-10_wgs_Illumina.bam,136.3,1.7,0.08,58cfa830e4b0c9d6adf6bc50,TCGA-AL-3472-10A-01D-A31Z-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-AL-3472-10A,42D044AE-1416-477D-AC80-779C49BC8D35,Blood Derived Normal,Illumina HiSeq,b025c6cc-9d02-40ff-89d4-a9bbeb2225d5,Kidney,57,9975B6AE-F877-4E66-9076-494BF91A53FE,E2CA76FB-069A-4D7B-9DCD-9D2547B0EBE5,TCGA-AL-3472-10A-01D-A31Z-10,GRCh37-lite,TCGA-AL-3472,TCGA-KIRP,NA,s11639,Baylor College of Medicine,Fox Chase,None,NO,T2,N0,Kidney Papillary Renal Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ad7a,58cfa82ee4b0c9d6adf6ad7a,G39020.TCGA-BR-8381-01A-11D-2394-08.2.filtered.,WGS,G39020.TCGA-BR-8381-01A-11D-2394-08.2,G39020.TCGA-BR-8381-01A-11D-2394-08.2.bam,329,NA,0.05,58cfa82ee4b0c9d6adf6ad7a,G39020.TCGA-BR-8381-01A-11D-2394-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-8381-01A,AEF8D98F-7A1C-47F3-B5A7-A3CB299C70DE,Primary Tumor,Illumina HiSeq,8d5cdec5-779b-4ca8-a709-f2fbc527642b,Stomach,51,1DDC7F73-D793-4AE6-8A6A-851069892FAD,D6738C83-7B52-4224-846A-67BD085AAAB8,TCGA-BR-8381-01A-11D-2394-08,HG19_Broad_variant,TCGA-BR-8381,TCGA-STAD,NA,s15170,Broad Institute of MIT and Harvard,Asterand,Ukraine,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB
13722.58cfa831e4b0c9d6adf6c966,58cfa831e4b0c9d6adf6c966,TCGA-CN-5374-01A-01D-2266-10_Illumina.filtered.,WGS,TCGA-CN-5374-01A-01D-2266-10_Illumina,TCGA-CN-5374-01A-01D-2266-10_Illumina.bam,384.7,1.9,0.05,58cfa831e4b0c9d6adf6c966,TCGA-CN-5374-01A-01D-2266-10_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5374-01A,D7641CA1-A062-4DD2-9414-447AF7311A84,Primary Tumor,Illumina HiSeq,3713f8c9-23d7-490a-bec2-99cb7ab55eac,Head and Neck,56,617DF1E0-B075-4610-B6D5-8850786FEA70,AB923DB7-54E8-4A50-B7FD-C2B4B300041E,TCGA-CN-5374-01A-01D-2266-10,GRCh37-lite,TCGA-CN-5374,TCGA-HNSC,NA,s15768,Baylor College of Medicine,University of Pittsburgh,None,NO,T2,N2,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6d100,58cfa832e4b0c9d6adf6d100,TCGA-HE-A5NF-10A-01D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-HE-A5NF-10A-01D-A26P-10_wgs_Illumina,TCGA-HE-A5NF-10A-01D-A26P-10_wgs_Illumina.bam,57,NA,0.08,58cfa832e4b0c9d6adf6d100,TCGA-HE-A5NF-10A-01D-A26P-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-HE-A5NF-10A,36B46540-472F-4A4D-A801-B8B6AE660DC9,Blood Derived Normal,Illumina HiSeq,15024aea-5d7e-4446-8e81-23aff148daf3,Kidney,58,82E8A2F8-D697-459B-8517-4E2642E459DC,FCFC53C2-52B3-44D1-AE32-76375E3A0836,TCGA-HE-A5NF-10A-01D-A26P-10,GRCh37-lite,TCGA-HE-A5NF,TCGA-KIRP,NA,s11648,Baylor College of Medicine,Ontario Institute for Cancer Research (OICR),Canada,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6c2e2,58cfa830e4b0c9d6adf6c2e2,TCGA-AD-A5EK-10A-01D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-AD-A5EK-10A-01D-A28G-10_wgs_Illumina,TCGA-AD-A5EK-10A-01D-A28G-10_wgs_Illumina.bam,39.53,NA,0.08,58cfa830e4b0c9d6adf6c2e2,TCGA-AD-A5EK-10A-01D-A28G-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AD-A5EK-10A,E8EC26BD-C88D-42B9-AC8A-AB121B8140F8,Blood Derived Normal,Illumina HiSeq,3f5d539e-383b-419e-8904-03f97fd7ffb0,Colorectal,51,114D22E0-DDE4-4AF3-8BBC-1A1BC6AF3A06,0BAAE245-5034-4A34-A076-E831DC38355E,TCGA-AD-A5EK-10A-01D-A28G-10,GRCh37-lite,TCGA-AD-A5EK,TCGA-COAD,NA,s13209,Baylor College of Medicine,International Genomics Consortium,United States,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c41a,58cfa831e4b0c9d6adf6c41a,TCGA-CJ-4899-01A-01D-2100-10_Illumina.filtered.,WGS,TCGA-CJ-4899-01A-01D-2100-10_Illumina,TCGA-CJ-4899-01A-01D-2100-10_Illumina.bam,109.4,1.9,0.16,58cfa831e4b0c9d6adf6c41a,TCGA-CJ-4899-01A-01D-2100-10_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CJ-4899-01A,900B5F21-E8FB-4A3F-B8E3-EF098716E508,Primary Tumor,Illumina HiSeq,ad992cd4-c4d5-4f87-b721-a2cbdf70f57d,Kidney,42,E2D40747-F751-4CCB-A45C-A60B06046DB1,9C181313-5B4C-41C5-9AD5-A5A86FE609AA,TCGA-CJ-4899-01A-01D-2100-10,GRCh37-lite,TCGA-CJ-4899,TCGA-KIRC,NA,s9568,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T1b,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d26a,58cfa832e4b0c9d6adf6d26a,TCGA-KL-8326-11A-01D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8326-11A-01D-2310-10_wgs_Illumina,TCGA-KL-8326-11A-01D-2310-10_wgs_Illumina.bam,280.3,NA,0.05,58cfa832e4b0c9d6adf6d26a,TCGA-KL-8326-11A-01D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8326-11A,03F3DD32-E1D1-485B-A968-3F55798F4D46,Solid Tissue Normal,Illumina HiSeq,4ad06c9b-8c29-4b0e-bc96-97e2322c580a,Kidney,69,7413DDDE-761F-43EB-82FE-EC2A63F963D0,5D6A5BA0-8213-4F89-85E0-021E4B4CC894,TCGA-KL-8326-11A-01D-2310-10,GRCh37-lite,TCGA-KL-8326,TCGA-KICH,NA,s16422,Baylor College of Medicine,MSKCC,United States,NO,T3a,N0,Kidney Chromophobe,Stage III
13722.58cfa830e4b0c9d6adf6bf51,58cfa830e4b0c9d6adf6bf51,TCGA-AY-A54L-10A-01D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-AY-A54L-10A-01D-A28G-10_wgs_Illumina,TCGA-AY-A54L-10A-01D-A28G-10_wgs_Illumina.bam,9.64,NA,0.08,58cfa830e4b0c9d6adf6bf51,TCGA-AY-A54L-10A-01D-A28G-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AY-A54L-10A,D8E9EA52-FF28-4626-BAA3-71350FD53DDF,Blood Derived Normal,Illumina HiSeq,0340d7ef-28c3-4691-a960-3a6f706f776a,Colorectal,74,E41882DE-45D6-48E4-AF74-24AE2B50CEA8,249C512B-8E49-42F0-839A-C2B3D4813F66,TCGA-AY-A54L-10A-01D-A28G-10,GRCh37-lite,TCGA-AY-A54L,TCGA-COAD,NA,s13034,Baylor College of Medicine,UNC,United States,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ac4d,58cfa82ee4b0c9d6adf6ac4d,G39019.TCGA-ER-A19L-06A-12D-A197-08.2.filtered.,WGS,G39019.TCGA-ER-A19L-06A-12D-A197-08.2,G39019.TCGA-ER-A19L-06A-12D-A197-08.2.bam,49.69,NA,0.08,58cfa82ee4b0c9d6adf6ac4d,G39019.TCGA-ER-A19L-06A-12D-A197-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-ER-A19L-06A,5F6DF69C-4EBF-4811-8B28-AD393DFBE1A3,Metastatic,Illumina HiSeq,52a722fd-05d8-46a9-8a35-d4f1d1020666,Skin,35,83679B9D-34F4-487B-93E3-08F1B8060120,8D5FFE62-6DD9-4764-B0B7-5E3010EEFE6D,TCGA-ER-A19L-06A-12D-A197-08,HG19_Broad_variant,TCGA-ER-A19L,TCGA-SKCM,4000,s7665,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,Not available,Not available,Not available,Not available
13722.58cfa82ee4b0c9d6adf6ae96,58cfa82ee4b0c9d6adf6ae96,G49538.TCGA-06-0152-02A-01D-2280-08.1.filtered.,WGS,G49538.TCGA-06-0152-02A-01D-2280-08.1,G49538.TCGA-06-0152-02A-01D-2280-08.1.bam,600,1.9,0.05,58cfa82ee4b0c9d6adf6ae96,G49538.TCGA-06-0152-02A-01D-2280-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0152-02A,F5BC5D97-E054-4E53-992D-71B896BD97D5,Recurrent Tumor,Illumina HiSeq,1d482a80-dbcc-48ae-8e59-ad77dc2d332c,Brain,68,1BF99D0E-EE8B-40A8-B279-DB2F06A9B188,841EB82B-347D-4D7F-805F-3F3701A2983D,TCGA-06-0152-02A-01D-2280-08,HG19_Broad_variant,TCGA-06-0152,TCGA-GBM,375,s13929,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6af26,58cfa82ee4b0c9d6adf6af26,G48125.TCGA-24-1562-01A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-24-1562-01A-01D-A312-08.2,G48125.TCGA-24-1562-01A-01D-A312-08.2.bam,222.67,1.9,0.07,58cfa82ee4b0c9d6adf6af26,G48125.TCGA-24-1562-01A-01D-A312-08.2.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1562-01A,4C18D9CF-4AF4-4A86-8B1C-F78795FBBD7E,Primary Tumor,Illumina HiSeq,b0fd1893-f409-4444-b014-3667fdc22720,Ovary,67,A323F2F5-B250-40A6-A318-084A3933E829,E9D98643-01EE-40C3-A617-E004559625CD,TCGA-24-1562-01A-01D-A312-08,HG19_Broad_variant,TCGA-24-1562,TCGA-OV,1384,s18022,Broad Institute of MIT and Harvard,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d0c1,58cfa832e4b0c9d6adf6d0c1,TCGA-IA-A40X-10A-01D-A25F-10_wgs_Illumina.filtered.,WGS,TCGA-IA-A40X-10A-01D-A25F-10_wgs_Illumina,TCGA-IA-A40X-10A-01D-A25F-10_wgs_Illumina.bam,105.71,NA,0.08,58cfa832e4b0c9d6adf6d0c1,TCGA-IA-A40X-10A-01D-A25F-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-IA-A40X-10A,0C151271-2CF9-43F4-9E9B-FE927DE43131,Blood Derived Normal,Illumina HiSeq,4463f007-73a0-4915-ab70-47ad7b4d8def,Kidney,49,0CB6D915-3533-499F-8D5C-6127076F18C4,611A2445-8DF1-4ABD-BB6B-4954EE1DC47D,TCGA-IA-A40X-10A-01D-A25F-10,GRCh37-lite,TCGA-IA-A40X,TCGA-KIRP,NA,s11781,Baylor College of Medicine,Cleveland Clinic,United States,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6acbc,58cfa82ee4b0c9d6adf6acbc,G37566.TCGA-HC-8258-01A-11D-2260-08.3.filtered.,WGS,G37566.TCGA-HC-8258-01A-11D-2260-08.3,G37566.TCGA-HC-8258-01A-11D-2260-08.3.bam,103.3,NA,0.05,58cfa82ee4b0c9d6adf6acbc,G37566.TCGA-HC-8258-01A-11D-2260-08.3.bam,Alive,MALE,Not available,Not available,Prostate Adenocarcinoma,Aligned reads,TCGA-HC-8258-01A,DA5B0169-E4F4-4674-B348-220AF03FF4B5,Primary Tumor,Illumina HiSeq,696d5596-7630-4286-a1c4-8a3ea96ddf16,Prostate,56,B8881603-9353-4F63-93D7-E14EFED64AA6,597E4011-EA99-4356-B1D9-8CFE35DB7C3B,TCGA-HC-8258-01A-11D-2260-08,HG19_Broad_variant,TCGA-HC-8258,TCGA-PRAD,NA,s3583,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available
13722.58cfa832e4b0c9d6adf6d595,58cfa832e4b0c9d6adf6d595,TCGA-MH-A562-10A-01D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-MH-A562-10A-01D-A26P-10_wgs_Illumina,TCGA-MH-A562-10A-01D-A26P-10_wgs_Illumina.bam,7.05,NA,0.08,58cfa832e4b0c9d6adf6d595,TCGA-MH-A562-10A-01D-A26P-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-MH-A562-10A,45BDCFD6-1E3F-4BE8-B843-AE949E8E43EB,Blood Derived Normal,Illumina HiSeq,234039f3-b051-4986-bdf3-1c35af33ade4,Kidney,57,01150206-F6DA-48B8-BDDA-9F0A732C9FB9,BD8AEC5F-0589-436D-9C8E-EAF4E60046E2,TCGA-MH-A562-10A-01D-A26P-10,GRCh37-lite,TCGA-MH-A562,TCGA-KIRP,NA,s11864,Baylor College of Medicine,BLN - Baylor,United States,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6abce,58cfa82ee4b0c9d6adf6abce,G35154.TCGA-TQ-A7RV-02A-11D-A36O-08.3.filtered.,WGS,G35154.TCGA-TQ-A7RV-02A-11D-A36O-08.3,G35154.TCGA-TQ-A7RV-02A-11D-A36O-08.3.bam,16.28,NA,0.08,58cfa82ee4b0c9d6adf6abce,G35154.TCGA-TQ-A7RV-02A-11D-A36O-08.3.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Brain Lower Grade Glioma,Aligned reads,TCGA-TQ-A7RV-02A,5A3EDEB6-133E-4116-9F80-2485BD70754D,Recurrent Tumor,Illumina HiSeq,de819dc3-dbde-4a92-b859-86e1e2bcd3c4,Brain,27,AEB14C9B-7752-47E5-AEF9-C84E3F4B2849,FEEE6C8A-5011-4B94-8AF6-5525449FAC12,TCGA-TQ-A7RV-02A-11D-A36O-08,HG19_Broad_variant,TCGA-TQ-A7RV,TCGA-LGG,NA,s8337,Broad Institute of MIT and Harvard,University of Sao Paulo,Brazil,NO,Not available,Not available,Astrocytoma,Not available
13722.58cfa82ee4b0c9d6adf6aa61,58cfa82ee4b0c9d6adf6aa61,G32541.TCGA-EE-A2GT-06A-12D-A197-08.6.filtered.,WGS,G32541.TCGA-EE-A2GT-06A-12D-A197-08.6,G32541.TCGA-EE-A2GT-06A-12D-A197-08.6.bam,81.94,NA,0.08,58cfa82ee4b0c9d6adf6aa61,G32541.TCGA-EE-A2GT-06A-12D-A197-08.6.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EE-A2GT-06A,97D9DFC9-C937-48B4-B453-DF081950419F,Metastatic,Illumina HiSeq,566f30f8-0acb-406c-9085-845c0b4cbd94,Skin,77,549F66DB-E789-4BBA-897A-297DD6A0EE8E,5310F698-D31A-4628-84B4-DC9AC29722A5,TCGA-EE-A2GT-06A-12D-A197-08,HG19_Broad_variant,TCGA-EE-A2GT,TCGA-SKCM,NA,s7648,Broad Institute of MIT and Harvard,University of Sydney,Australia,NO,T3a,N0,Not available,Stage IIA
13722.58cfa831e4b0c9d6adf6c8f6,58cfa831e4b0c9d6adf6c8f6,TCGA-CN-6994-10A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CN-6994-10A-01D-A32X-10_wgs_Illumina,TCGA-CN-6994-10A-01D-A32X-10_wgs_Illumina.bam,893,NA,0.09,58cfa831e4b0c9d6adf6c8f6,TCGA-CN-6994-10A-01D-A32X-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-6994-10A,6909302D-358A-46CD-8052-EEDB09C83C83,Blood Derived Normal,Illumina HiSeq,48292910-3d60-4328-adc3-59a101b81ce8,Head and Neck,67,18FBC6DE-9DF1-4D95-9619-EF92C3BF4C91,62D512B9-D138-4C6B-90AF-D29634F0084E,TCGA-CN-6994-10A-01D-A32X-10,GRCh37-lite,TCGA-CN-6994,TCGA-HNSC,NA,s15499,Baylor College of Medicine,University of Pittsburgh,United States,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82ee4b0c9d6adf6aafe,58cfa82ee4b0c9d6adf6aafe,G25781.TCGA-50-6597-10A-01D-1855-08.4.filtered.,WGS,G25781.TCGA-50-6597-10A-01D-1855-08.4,G25781.TCGA-50-6597-10A-01D-1855-08.4.bam,14,1.8,0.05,58cfa82ee4b0c9d6adf6aafe,G25781.TCGA-50-6597-10A-01D-1855-08.4.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-6597-10A,0D66BF6C-EED0-4726-BD5B-3BF6D610B4E0,Blood Derived Normal,Illumina HiSeq,d3037817-9843-4d60-b64f-af284081d989,Lung,79,254F2707-C4FB-41DA-BFC0-2190EB9368D5,32788069-6806-4112-AFE3-28E731A6D8DB,TCGA-50-6597-10A-01D-1855-08,HG19_Broad_variant,TCGA-50-6597,TCGA-LUAD,NA,s11214,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82de4b0c9d6adf6a738,58cfa82de4b0c9d6adf6a738,G14681.TCGA-60-2719-01A-01D-1522-08.1.filtered.,WGS,G14681.TCGA-60-2719-01A-01D-1522-08.1,G14681.TCGA-60-2719-01A-01D-1522-08.1.bam,604.3,1.9,0.05,58cfa82de4b0c9d6adf6a738,G14681.TCGA-60-2719-01A-01D-1522-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-60-2719-01A,585E6487-B0A3-4828-8A06-46BEE01DFF74,Primary Tumor,Illumina HiSeq,f600dac8-9a96-4214-a398-c9e40ed580ec,Lung,83,DD32EF9A-246B-47C9-A0E3-60A110E9047C,EE6CC68E-8D2A-41EE-82C6-0FECDF7E6259,TCGA-60-2719-01A-01D-1522-08,HG19_Broad_variant,TCGA-60-2719,TCGA-LUSC,NA,s10495,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6ad8a,58cfa82ee4b0c9d6adf6ad8a,G39020.TCGA-BR-6564-01A-12D-1882-08.2.filtered.,WGS,G39020.TCGA-BR-6564-01A-12D-1882-08.2,G39020.TCGA-BR-6564-01A-12D-1882-08.2.bam,29.7,1.9,0.05,58cfa82ee4b0c9d6adf6ad8a,G39020.TCGA-BR-6564-01A-12D-1882-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6564-01A,AF1086CC-B330-4AD6-AE1C-3B5C7259949A,Primary Tumor,Illumina HiSeq,69520aa9-d9e7-49e5-a7a9-0b1e402a69c4,Stomach,46,B8355E52-D7A7-4711-BBA7-BC4D201741F2,2E66EB75-097C-4AD8-B2B3-9F5849DFD02F,TCGA-BR-6564-01A-12D-1882-08,HG19_Broad_variant,TCGA-BR-6564,TCGA-STAD,NA,s15037,Broad Institute of MIT and Harvard,Asterand,Russia,NO,T3,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA
13722.58cfa82ee4b0c9d6adf6adfc,58cfa82ee4b0c9d6adf6adfc,G49538.TCGA-06-0211-01A-01D-1491-08.1.filtered.,WGS,G49538.TCGA-06-0211-01A-01D-1491-08.1,G49538.TCGA-06-0211-01A-01D-1491-08.1.bam,0,1.88,0.05,58cfa82ee4b0c9d6adf6adfc,G49538.TCGA-06-0211-01A-01D-1491-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0211-01A,5C984433-33CF-42FC-B3BA-511EFCDCAB19,Primary Tumor,Illumina HiSeq,c68adb10-306f-4541-92b1-c6b5baa25d00,Brain,47,83177103-6AE2-444E-8AE7-E1BF76B1351D,CAEF21A2-190E-456D-95C9-3927A0B250AC,TCGA-06-0211-01A-01D-1491-08,HG19_Broad_variant,TCGA-06-0211,TCGA-GBM,360,s13948,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6ab4e,58cfa82ee4b0c9d6adf6ab4e,G32544.TCGA-EB-A24D-01A-11D-A197-08.3.filtered.,WGS,G32544.TCGA-EB-A24D-01A-11D-A197-08.3,NA,NA,NA,NA,58cfa82ee4b0c9d6adf6ab4e,G32544.TCGA-EB-A24D-01A-11D-A197-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-EB-A24D-01A,D7EE2693-39A8-4E3A-B6F6-E4729800E34E,Primary Tumor,Illumina HiSeq,06f2fd7d-e709-41e6-96ad-8e40c7ff72d8,Skin,72,A74E2FEC-291C-4967-AFE3-101955578225,6C884037-49F9-41C3-B0E5-9CBCD545AEB7,TCGA-EB-A24D-01A-11D-A197-08,HG19_Broad_variant,TCGA-EB-A24D,TCGA-SKCM,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
13722.58cfa82de4b0c9d6adf6a744,58cfa82de4b0c9d6adf6a744,G14848.TCGA-05-4398-10A-01D-1931-08.3.filtered.,WGS,G14848.TCGA-05-4398-10A-01D-1931-08.3,G14848.TCGA-05-4398-10A-01D-1931-08.3.bam,168.23,1.9,0.14,58cfa82de4b0c9d6adf6a744,G14848.TCGA-05-4398-10A-01D-1931-08.3.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-05-4398-10A,31C96E35-5E2F-429C-B12A-7BC5A497A300,Blood Derived Normal,Illumina HiSeq,e903a10f-69c9-4b0a-8863-da0771240120,Lung,47,A65C5573-B230-4CA0-8BE3-8BCCE6BE385E,E249DD46-1025-43D4-AD35-82A353842BAE,TCGA-05-4398-10A-01D-1931-08,HG19_Broad_variant,TCGA-05-4398,TCGA-LUAD,NA,s11209,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T4,N3,Lung Adenocarcinoma Mixed Subtype,Stage IIIB
13722.58cfa82ee4b0c9d6adf6ab24,58cfa82ee4b0c9d6adf6ab24,G32542.TCGA-D9-A148-06A-11D-A19A-08.3.filtered.,WGS,G32542.TCGA-D9-A148-06A-11D-A19A-08.3,G32542.TCGA-D9-A148-06A-11D-A19A-08.3.bam,54.12,NA,0.08,58cfa82ee4b0c9d6adf6ab24,G32542.TCGA-D9-A148-06A-11D-A19A-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,Aligned reads,TCGA-D9-A148-06A,FED23055-1600-4128-8D73-E1AA902A9D1D,Metastatic,Illumina HiSeq,50cb8b67-86b3-430b-8857-7afc5387e07f,Skin,40,8F476CE5-CCCE-4CF6-8374-69F447F17008,D7E884B1-AB8A-4225-9FC9-A2A6FD8F4660,TCGA-D9-A148-06A-11D-A19A-08,HG19_Broad_variant,TCGA-D9-A148,TCGA-SKCM,NA,s7653,Broad Institute of MIT and Harvard,Greater Poland Cancer Center,Poland,NO,TX,N3,Not available,Not available
13722.58cfa82ee4b0c9d6adf6ad04,58cfa82ee4b0c9d6adf6ad04,G49537.TCGA-EL-A3MY-01A-11D-A21A-08.1.filtered.,WGS,G49537.TCGA-EL-A3MY-01A-11D-A21A-08.1,G49537.TCGA-EL-A3MY-01A-11D-A21A-08.1.bam,37.42,NA,0.08,58cfa82ee4b0c9d6adf6ad04,G49537.TCGA-EL-A3MY-01A-11D-A21A-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EL-A3MY-01A,7746BE87-7AD0-48A7-84FB-08A81B220BDB,Primary Tumor,Illumina HiSeq,961c7c05-824f-48c1-aed0-956b03c74c9f,Thyroid,81,E1C4D037-D70F-4AB1-BB34-554538C934CD,A9C29EDD-2EF1-46EF-93C6-796CF0332A2B,TCGA-EL-A3MY-01A-11D-A21A-08,HG19_Broad_variant,TCGA-EL-A3MY,TCGA-THCA,533,s12621,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,T4,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage IVC
13722.58cfa82fe4b0c9d6adf6ba26,58cfa82fe4b0c9d6adf6ba26,TCGA-A3-3370-01A-02D-2099-10_Illumina.filtered.,WGS,TCGA-A3-3370-01A-02D-2099-10_Illumina,TCGA-A3-3370-01A-02D-2099-10_Illumina.bam,152.4,1.9,0.14,58cfa82fe4b0c9d6adf6ba26,TCGA-A3-3370-01A-02D-2099-10_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-A3-3370-01A,9F632FC3-2241-469A-A14A-CD537350155F,Primary Tumor,Illumina HiSeq,2bf569a0-5698-4304-b006-f61284e72aef,Kidney,48,1B2DF3FD-183C-4099-A387-5908C8B44F57,D7F1DB09-8BA0-4B76-BCD2-01C14165F0D5,TCGA-A3-3370-01A-02D-2099-10,GRCh37-lite,TCGA-A3-3370,TCGA-KIRC,NA,s9563,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1b,N0,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6c282,58cfa830e4b0c9d6adf6c282,TCGA-AD-A5EJ-10A-01D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-AD-A5EJ-10A-01D-A28G-10_wgs_Illumina,TCGA-AD-A5EJ-10A-01D-A28G-10_wgs_Illumina.bam,78.39,NA,0.08,58cfa830e4b0c9d6adf6c282,TCGA-AD-A5EJ-10A-01D-A28G-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AD-A5EJ-10A,613AA3E8-A70B-45A9-9C08-0C2346C8BF00,Blood Derived Normal,Illumina HiSeq,42598f0e-7e52-4cd0-ab8d-06a385849f82,Colorectal,74,615A3BD2-2411-4C69-8187-77ECADAFF971,C3CBF9FF-4A5D-4CA7-B456-D4CAE5418330,TCGA-AD-A5EJ-10A-01D-A28G-10,GRCh37-lite,TCGA-AD-A5EJ,TCGA-COAD,NA,s12886,Baylor College of Medicine,International Genomics Consortium,United States,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6bdbe,58cfa830e4b0c9d6adf6bdbe,TCGA-AL-3473-10A-01D-A31Z-10_wgs_Illumina.filtered.,WGS,TCGA-AL-3473-10A-01D-A31Z-10_wgs_Illumina,TCGA-AL-3473-10A-01D-A31Z-10_wgs_Illumina.bam,186.3,1.9,0.07,58cfa830e4b0c9d6adf6bdbe,TCGA-AL-3473-10A-01D-A31Z-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-AL-3473-10A,A7BF785F-0539-4899-AC21-47D1FC347EE8,Blood Derived Normal,Illumina HiSeq,c4c12fbe-51dc-478b-9d4f-cc873c1c533f,Kidney,55,B2B36613-2641-4119-A20D-3F0C62A19986,89A817FB-1BCF-420A-997D-6787644F2CDA,TCGA-AL-3473-10A-01D-A31Z-10,GRCh37-lite,TCGA-AL-3473,TCGA-KIRP,NA,s11576,Baylor College of Medicine,Fox Chase,None,NO,T2,N0,Kidney Papillary Renal Cell Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6ad43,58cfa82ee4b0c9d6adf6ad43,G49837.TCGA-66-2744-01A-01D-A320-08.3.filtered.,WGS,G49837.TCGA-66-2744-01A-01D-A320-08.3,G49837.TCGA-66-2744-01A-01D-A320-08.3.bam,87.27,1.9,0.07,58cfa82ee4b0c9d6adf6ad43,G49837.TCGA-66-2744-01A-01D-A320-08.3.bam,Alive,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-66-2744-01A,1EE543D5-B8C0-4F79-8373-6BB6319F2EE2,Primary Tumor,Illumina HiSeq,8188fa37-2482-4c3a-bc2d-c8ead7d2171c,Lung,71,75E00DD8-0AD9-4447-9407-0AB6AC0A7173,706868B5-4920-433A-BEA3-92E9BF83059B,TCGA-66-2744-01A-01D-A320-08,HG19_Broad_variant,TCGA-66-2744,TCGA-LUSC,NA,s10082,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T2,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa830e4b0c9d6adf6c1b0,58cfa830e4b0c9d6adf6c1b0,TCGA-BA-5556-10A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-BA-5556-10A-01D-A32X-10_wgs_Illumina,TCGA-BA-5556-10A-01D-A32X-10_wgs_Illumina.bam,385.4,1.9,0.08,58cfa830e4b0c9d6adf6c1b0,TCGA-BA-5556-10A-01D-A32X-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5556-10A,70741B73-9683-42BD-87FC-6A021A70103B,Blood Derived Normal,Illumina HiSeq,a2799f35-a768-4cac-a6e3-80c77052b7f9,Head and Neck,58,F57EB501-88BB-446B-9F7E-85FCCD0A828F,31220135-1318-4D47-8D69-49CABF4D087F,TCGA-BA-5556-10A-01D-A32X-10,GRCh37-lite,TCGA-BA-5556,TCGA-HNSC,NA,s15492,Baylor College of Medicine,UNC,None,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c608,58cfa831e4b0c9d6adf6c608,TCGA-CN-5365-01A-01D-2276-10_Illumina.filtered.,WGS,TCGA-CN-5365-01A-01D-2276-10_Illumina,TCGA-CN-5365-01A-01D-2276-10_Illumina.bam,305.73,1.9,0.05,58cfa831e4b0c9d6adf6c608,TCGA-CN-5365-01A-01D-2276-10_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-5365-01A,4CFFEA0B-90A7-4C86-A73F-BB8FECA3ADA7,Primary Tumor,Illumina HiSeq,84352351-1bc3-4c62-93be-29c899ff9811,Head and Neck,38,665D4BFF-603C-497B-816F-C98784665D0F,A0FE80E0-E3AC-485B-8A1A-4C80C101B874,TCGA-CN-5365-01A-01D-2276-10,GRCh37-lite,TCGA-CN-5365,TCGA-HNSC,351,s16033,Baylor College of Medicine,University of Pittsburgh,None,NO,T2,N3,Head and Neck Squamous Cell Carcinoma,Stage IVB
13722.58cfa832e4b0c9d6adf6ce4a,58cfa832e4b0c9d6adf6ce4a,TCGA-G3-A5SL-10A-01D-A27I-10_wgs_Illumina.filtered.,WGS,TCGA-G3-A5SL-10A-01D-A27I-10_wgs_Illumina,TCGA-G3-A5SL-10A-01D-A27I-10_wgs_Illumina.bam,12.74,NA,0.08,58cfa832e4b0c9d6adf6ce4a,TCGA-G3-A5SL-10A-01D-A27I-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-G3-A5SL-10A,9A56D8A8-DADD-442E-BC09-732CD619AEF7,Blood Derived Normal,Illumina HiSeq,432186c9-d268-4a51-8ea8-c28dee78dcb1,Liver,70,E4303024-EACB-4E9F-AE89-0023DEDD117A,A38D4467-C3E5-4639-AD4F-88BCD7AB9F26,TCGA-G3-A5SL-10A-01D-A27I-10,GRCh37-lite,TCGA-G3-A5SL,TCGA-LIHC,NA,s16689,Baylor College of Medicine,Alberta Health Services,Canada,NO,T2,NX,Hepatocellular Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6ad3e,58cfa82ee4b0c9d6adf6ad3e,G39020.TCGA-D7-5579-01A-01D-1600-08.2.filtered.,WGS,G39020.TCGA-D7-5579-01A-01D-1600-08.2,G39020.TCGA-D7-5579-01A-01D-1600-08.2.bam,84.7,1.89,0.05,58cfa82ee4b0c9d6adf6ad3e,G39020.TCGA-D7-5579-01A-01D-1600-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-5579-01A,8B5746F9-DBEE-40BD-9141-1081960CF286,Primary Tumor,Illumina HiSeq,9296203d-9b4e-42bc-b596-e5d928afb7fc,Stomach,74,633DCE5B-7A88-46DC-AD06-8897A609675B,3DB3B7B1-DA1D-4B9C-A92A-C60FECF4328C,TCGA-D7-5579-01A-01D-1600-08,HG19_Broad_variant,TCGA-D7-5579,TCGA-STAD,NA,s15098,Broad Institute of MIT and Harvard,Greater Poland Cancer Center,Poland,NO,T3,N2,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage IIIA
13722.58cfa830e4b0c9d6adf6bb79,58cfa830e4b0c9d6adf6bb79,TCGA-AA-3685-01A-02D-1981-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3685-01A-02D-1981-10_wgs_Illumina,TCGA-AA-3685-01A-02D-1981-10_wgs_Illumina.bam,417.96,1.9,0.15,58cfa830e4b0c9d6adf6bb79,TCGA-AA-3685-01A-02D-1981-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3685-01A,DCA004BF-9C14-45A1-B186-AB3759F6C7FE,Primary Tumor,Illumina HiSeq,e8516b3d-fcff-4f10-94a4-993b059ac4aa,Colorectal,69,A2DD99BF-3A02-42CD-9AA8-80A018584EE6,85E29049-A5E8-49FA-A576-E113C7B2C2E3,TCGA-AA-3685-01A-02D-1981-10,GRCh37-lite,TCGA-AA-3685,TCGA-COAD,NA,s13515,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6acaa,58cfa82ee4b0c9d6adf6acaa,G47088.TCGA-68-8250-01A-11D-2293-08.1.filtered.,WGS,G47088.TCGA-68-8250-01A-11D-2293-08.1,G47088.TCGA-68-8250-01A-11D-2293-08.1.bam,242.3,NA,0.05,58cfa82ee4b0c9d6adf6acaa,G47088.TCGA-68-8250-01A-11D-2293-08.1.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-68-8250-01A,7B982D5E-3A7D-40AC-BD25-6044C62879B6,Primary Tumor,Illumina HiSeq,c923eeaa-1b36-49b3-97b7-f64875389d5f,Lung,66,A6A1A05E-9126-45CD-B7BE-C1C342FAF5AF,71A2B4A2-88DD-4911-A67E-70B3309C4A12,TCGA-68-8250-01A-11D-2293-08,HG19_Broad_variant,TCGA-68-8250,TCGA-LUSC,NA,s10252,Broad Institute of MIT and Harvard,Washington University - Cleveland Clinic,United States,NO,T1a,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6a918,58cfa82ee4b0c9d6adf6a918,G25776.TCGA-75-6203-01A-11D-1753-08.1.filtered.,WGS,G25776.TCGA-75-6203-01A-11D-1753-08.1,G25776.TCGA-75-6203-01A-11D-1753-08.1.bam,49.4,1.9,0.05,58cfa82ee4b0c9d6adf6a918,G25776.TCGA-75-6203-01A-11D-1753-08.1.bam,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-75-6203-01A,A8D6694C-A213-4544-AC0B-63BCE16D8F4E,Primary Tumor,Illumina HiSeq,976f4757-1570-44bb-9a05-7680fc9d30b6,Lung,NA,336EB991-5705-4BC0-A167-6D7F82F81697,D9CD7F95-07D3-4B87-BE83-87340B08D249,TCGA-75-6203-01A-11D-1753-08,HG19_Broad_variant,TCGA-75-6203,TCGA-LUAD,NA,s10892,Broad Institute of MIT and Harvard,Ontario Institute for Cancer Research (OICR),Canada,NO,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa830e4b0c9d6adf6bc64,58cfa830e4b0c9d6adf6bc64,TCGA-AF-3913-01A-02D-1459-10_wgs_Illumina.filtered.,WGS,TCGA-AF-3913-01A-02D-1459-10_wgs_Illumina,TCGA-AF-3913-01A-02D-1459-10_wgs_Illumina.bam,452.29,1.8,0.05,58cfa830e4b0c9d6adf6bc64,TCGA-AF-3913-01A-02D-1459-10_wgs_Illumina.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-AF-3913-01A,03A9DD9D-62AE-4ACD-9272-389274858F3D,Primary Tumor,Illumina HiSeq,13fc1d5a-7c67-4646-953d-ad0f22571017,Colorectal,60,B01C6CD1-68DA-437F-90E4-9A645E8F3470,2B2C1A0B-EAC3-4A6A-9C19-7141CBD573A7,TCGA-AF-3913-01A-02D-1459-10,GRCh37-lite,TCGA-AF-3913,TCGA-READ,316,s2134,Baylor College of Medicine,Christiana Healthcare,None,NO,T3,N1,Rectal Adenocarcinoma,Stage IV
13722.58cfa82fe4b0c9d6adf6b907,58cfa82fe4b0c9d6adf6b907,TCGA-A6-A565-10A-01D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-A6-A565-10A-01D-A28G-10_wgs_Illumina,TCGA-A6-A565-10A-01D-A28G-10_wgs_Illumina.bam,50.98,NA,0.08,58cfa82fe4b0c9d6adf6b907,TCGA-A6-A565-10A-01D-A28G-10_wgs_Illumina.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-A6-A565-10A,DD7A53EE-CB08-40C4-9935-51D1CA17E9E8,Blood Derived Normal,Illumina HiSeq,1a964232-376f-4359-a91e-ba7dd9d9c03a,Colorectal,34,33B05D64-7194-4A95-839A-99B33640242D,D2AC0FE8-17D5-4032-BE6D-543CCA1F7D5A,TCGA-A6-A565-10A-01D-A28G-10,GRCh37-lite,TCGA-A6-A565,TCGA-COAD,494,s13018,Baylor College of Medicine,Christiana Healthcare,United States,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage IIIC
13722.58cfa832e4b0c9d6adf6d485,58cfa832e4b0c9d6adf6d485,TCGA-NH-A50T-10A-01D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-NH-A50T-10A-01D-A28G-10_wgs_Illumina,TCGA-NH-A50T-10A-01D-A28G-10_wgs_Illumina.bam,58,NA,0.08,58cfa832e4b0c9d6adf6d485,TCGA-NH-A50T-10A-01D-A28G-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-NH-A50T-10A,490EABCA-4575-4BD6-9604-6B6E23D069CE,Blood Derived Normal,Illumina HiSeq,80c16860-8c0f-4bf8-9d4e-58680115459c,Colorectal,68,58C00FFA-0FED-45A2-B928-47524DF3E6D2,553F5FCE-25AD-4BD8-A0F4-1CBF70A227B7,TCGA-NH-A50T-10A-01D-A28G-10,GRCh37-lite,TCGA-NH-A50T,TCGA-COAD,NA,s13221,Baylor College of Medicine,Candler,United States,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6c430,58cfa831e4b0c9d6adf6c430,TCGA-CJ-4918-01A-01D-2101-10_Illumina.filtered.,WGS,TCGA-CJ-4918-01A-01D-2101-10_Illumina,TCGA-CJ-4918-01A-01D-2101-10_Illumina.bam,41.4,1.9,0.16,58cfa831e4b0c9d6adf6c430,TCGA-CJ-4918-01A-01D-2101-10_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CJ-4918-01A,267FF78B-BCEB-466E-8582-C560FE227FF0,Primary Tumor,Illumina HiSeq,6b97d11a-5289-440f-a2df-5c10c9cb91fc,Kidney,64,8262BF2A-F944-4101-8E43-51658B580747,81D0D6BB-7319-4B67-BCF7-36DF24E76B43,TCGA-CJ-4918-01A-01D-2101-10,GRCh37-lite,TCGA-CJ-4918,TCGA-KIRC,93,s9305,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T3a,N0,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa82fe4b0c9d6adf6b8b1,58cfa82fe4b0c9d6adf6b8b1,TCGA-A6-A567-10A-01D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-A6-A567-10A-01D-A28G-10_wgs_Illumina,TCGA-A6-A567-10A-01D-A28G-10_wgs_Illumina.bam,50.98,NA,0.08,58cfa82fe4b0c9d6adf6b8b1,TCGA-A6-A567-10A-01D-A28G-10_wgs_Illumina.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-A6-A567-10A,857A5889-19E7-4208-8362-F1377C408037,Blood Derived Normal,Illumina HiSeq,c11fb256-ad9d-4750-ac63-bce5056c770b,Colorectal,56,778356CA-554D-418B-A73B-C8EB39CA0B17,8F8A8062-1FEE-4B53-97AA-A3FDF6B3562F,TCGA-A6-A567-10A-01D-A28G-10,GRCh37-lite,TCGA-A6-A567,TCGA-COAD,1881,s13502,Baylor College of Medicine,Christiana Healthcare,United States,NO,T3,N1,Colon Adenocarcinoma,Stage IV
13722.58cfa832e4b0c9d6adf6d2a3,58cfa832e4b0c9d6adf6d2a3,TCGA-KM-8441-10A-01D-2311-10_wgs_Illumina.filtered.,WGS,TCGA-KM-8441-10A-01D-2311-10_wgs_Illumina,TCGA-KM-8441-10A-01D-2311-10_wgs_Illumina.bam,178.6,NA,0.05,58cfa832e4b0c9d6adf6d2a3,TCGA-KM-8441-10A-01D-2311-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KM-8441-10A,F31BA8EC-A3DD-4DD8-8D15-F6C5975EBE44,Blood Derived Normal,Illumina HiSeq,a45f0dc7-fb06-4a10-94e7-efba5e277de8,Kidney,61,8200ED77-D4BC-4D3D-B00B-156713C7A08D,EA82C301-A5BE-463A-9549-B493CD5C95D8,TCGA-KM-8441-10A-01D-2311-10,GRCh37-lite,TCGA-KM-8441,TCGA-KICH,NA,s16526,Baylor College of Medicine,NCI Urologic Oncology Branch,United States,NO,T1b,NX,Kidney Chromophobe,Stage I
13722.58cfa82ee4b0c9d6adf6a9d9,58cfa82ee4b0c9d6adf6a9d9,G2185.TCGA-04-1371-01A-01D.6.filtered.,WGS,G2185.TCGA-04-1371-01A-01D.6,G2185.TCGA-04-1371-01A-01D.6.bam,363.67,1.9,0.15,58cfa82ee4b0c9d6adf6a9d9,G2185.TCGA-04-1371-01A-01D.6.bam,Alive,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-04-1371-01A,BFF84539-7862-45B2-B5FC-E77291FCCA8B,Primary Tumor,Illumina GA,00f2f460-1e3f-48c3-a328-14b8e1ec4eb8,Ovary,58,E173653B-F144-4754-B835-DC69AF2E79DA,0AA531B3-34DB-4170-A994-43065B5C5EB6,TCGA-04-1371-01A-01D-0516-08,HG19_Broad_variant,TCGA-04-1371,TCGA-OV,NA,s17164,Broad Institute of MIT and Harvard,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b8d8,58cfa82fe4b0c9d6adf6b8d8,TCGA-A6-6781-01A-22D-1924-10_wgs_Illumina.filtered.,WGS,TCGA-A6-6781-01A-22D-1924-10_wgs_Illumina,TCGA-A6-6781-01A-22D-1924-10_wgs_Illumina.bam,190.3,1.9,0.05,58cfa82fe4b0c9d6adf6b8d8,TCGA-A6-6781-01A-22D-1924-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-6781-01A,B54865B6-824E-4163-B759-21A6EACC98CE,Primary Tumor,Illumina HiSeq,bee0f5f3-5654-4349-b3dd-afe0b89cc488,Colorectal,43,F1B2CA40-F20A-42DE-ABA2-4F730D7CCC09,2182CE2C-5941-4B65-9419-FC7966D5E6D5,TCGA-A6-6781-01A-22D-1924-10,GRCh37-lite,TCGA-A6-6781,TCGA-COAD,NA,s13354,Baylor College of Medicine,Christiana Healthcare,United States,NO,T4b,N1b,Colon Mucinous Adenocarcinoma,Stage IIIC
13722.58cfa830e4b0c9d6adf6bbc0,58cfa830e4b0c9d6adf6bbc0,TCGA-AG-A002-01A-01D-A183-10_wgs_Illumina.filtered.,WGS,TCGA-AG-A002-01A-01D-A183-10_wgs_Illumina,TCGA-AG-A002-01A-01D-A183-10_wgs_Illumina.bam,228.5,1.72,0.08,58cfa830e4b0c9d6adf6bbc0,TCGA-AG-A002-01A-01D-A183-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-A002-01A,CB005C69-7301-41CE-B534-C9751F1436C5,Primary Tumor,Illumina HiSeq,23b2dbcf-d83f-448a-8e6a-e3395344bc03,Colorectal,35,B918B56C-5C78-4CEE-85A7-7C88501E88AD,567C8810-DAEF-4FE7-AA45-E70DB20B9F01,TCGA-AG-A002-01A-01D-A183-10,GRCh37-lite,TCGA-AG-A002,TCGA-READ,NA,s2313,Baylor College of Medicine,Indivumed,Germany,NO,T2,N0,Rectal Adenocarcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d55c,58cfa832e4b0c9d6adf6d55c,TCGA-PD-A5DF-10A-01D-A27I-10_wgs_Illumina.filtered.,WGS,TCGA-PD-A5DF-10A-01D-A27I-10_wgs_Illumina,TCGA-PD-A5DF-10A-01D-A27I-10_wgs_Illumina.bam,39.46,NA,0.08,58cfa832e4b0c9d6adf6d55c,TCGA-PD-A5DF-10A-01D-A27I-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-PD-A5DF-10A,1987B453-F97D-45C7-9C89-B9A33313D645,Blood Derived Normal,Illumina HiSeq,650467d1-b257-46dd-9990-25e96f3b2dd8,Liver,58,8938CC2A-D3FD-4253-9BDD-B672A42721E0,CE137C9C-43DF-49E8-82F8-3530D13EECFD,TCGA-PD-A5DF-10A-01D-A27I-10,GRCh37-lite,TCGA-PD-A5DF,TCGA-LIHC,639,s16791,Baylor College of Medicine,Fox Chase,United States,NO,T4,N0,Hepatocellular Carcinoma,Stage IIIB
13722.58cfa830e4b0c9d6adf6c046,58cfa830e4b0c9d6adf6c046,TCGA-B2-4102-01A-02D-2095-10_wgs_Illumina.filtered.,WGS,TCGA-B2-4102-01A-02D-2095-10_wgs_Illumina,TCGA-B2-4102-01A-02D-2095-10_wgs_Illumina.bam,142.77,1.9,0.16,58cfa830e4b0c9d6adf6c046,TCGA-B2-4102-01A-02D-2095-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-B2-4102-01A,BBBCE1BA-C739-43BA-B9CF-A4F746491AE3,Primary Tumor,Illumina HiSeq,08200438-3da7-446b-99d7-c23e7cbfb2b5,Kidney,61,0A187E9E-FAE3-4B9F-B6ED-23CF0FFCB39E,39C55051-E1BC-4081-962A-17205645DE45,TCGA-B2-4102-01A-02D-2095-10,GRCh37-lite,TCGA-B2-4102,TCGA-KIRC,NA,s9734,Baylor College of Medicine,Christiana Healthcare,None,NO,T1b,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bed7,58cfa830e4b0c9d6adf6bed7,TCGA-B3-4104-11A-01D-1253-10_wgs_Illumina.filtered.,WGS,TCGA-B3-4104-11A-01D-1253-10_wgs_Illumina,TCGA-B3-4104-11A-01D-1253-10_wgs_Illumina.bam,422.94,1.9,0.16,58cfa830e4b0c9d6adf6bed7,TCGA-B3-4104-11A-01D-1253-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B3-4104-11A,E15A108E-0B32-426F-926A-3FB1AF0A82D3,Solid Tissue Normal,Illumina HiSeq,481f034b-553d-4240-b733-83c3d008050c,Kidney,75,88D9FC64-AA05-40DE-A445-2CA369A3743E,A540DA82-D1A3-485A-9137-B513E2D8A766,TCGA-B3-4104-11A-01D-1253-10,GRCh37-lite,TCGA-B3-4104,TCGA-KIRP,NA,s11643,Baylor College of Medicine,Christiana Healthcare,None,NO,T2,NX,Kidney Papillary Renal Cell Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6aea4,58cfa82ee4b0c9d6adf6aea4,G49538.TCGA-14-1402-02A-01D-2280-08.3.filtered.,WGS,G49538.TCGA-14-1402-02A-01D-2280-08.3,G49538.TCGA-14-1402-02A-01D-2280-08.3.bam,300,1.9,0.05,58cfa82ee4b0c9d6adf6aea4,G49538.TCGA-14-1402-02A-01D-2280-08.3.bam,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1402-02A,BF339349-062F-4EA9-A0B2-D87D3A21099E,Recurrent Tumor,Illumina HiSeq,d2cd022c-b609-4f21-9be9-f01c78e24321,Brain,58,6D24954C-83BD-4CB3-A771-41025EEA0999,F98DE26B-C7D6-435D-81FA-1F1869DA9087,TCGA-14-1402-02A-01D-2280-08,HG19_Broad_variant,TCGA-14-1402,TCGA-GBM,975,s14308,Broad Institute of MIT and Harvard,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa832e4b0c9d6adf6d36c,58cfa832e4b0c9d6adf6d36c,TCGA-KN-8418-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8418-01A-11D-2310-10_wgs_Illumina,TCGA-KN-8418-01A-11D-2310-10_wgs_Illumina.bam,106.3,NA,0.05,58cfa832e4b0c9d6adf6d36c,TCGA-KN-8418-01A-11D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KN-8418-01A,F3BA1CF8-AC67-4DA8-96F3-8680DC55F247,Primary Tumor,Illumina HiSeq,29118d80-8a70-4ed3-8742-d2c69bbeffb7,Kidney,41,D6F68966-D6A2-4B24-B1D5-15CB8F4ACB8F,9A90F951-AD96-4883-B97F-AC43395DAE5D,TCGA-KN-8418-01A-11D-2310-10,GRCh37-lite,TCGA-KN-8418,TCGA-KICH,NA,s16396,Baylor College of Medicine,Harvard,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa831e4b0c9d6adf6c682,58cfa831e4b0c9d6adf6c682,TCGA-CR-5250-01A-01D-2276-10_Illumina.filtered.,WGS,TCGA-CR-5250-01A-01D-2276-10_Illumina,TCGA-CR-5250-01A-01D-2276-10_Illumina.bam,261.73,1.9,0.05,58cfa831e4b0c9d6adf6c682,TCGA-CR-5250-01A-01D-2276-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-5250-01A,9E178D80-FE90-4998-9DAE-726C4BECEEF7,Primary Tumor,Illumina HiSeq,486d7653-48d6-47cc-b04b-362d1b0e485b,Head and Neck,71,13AE9411-E63F-4093-A80E-8B64837C001D,29FC38AA-F367-46A3-A14D-A5F657AD0CAA,TCGA-CR-5250-01A-01D-2276-10,GRCh37-lite,TCGA-CR-5250,TCGA-HNSC,NA,s16039,Baylor College of Medicine,Vanderbilt University,None,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6c241,58cfa830e4b0c9d6adf6c241,TCGA-BW-A5NQ-10A-01D-A27I-10_wgs_Illumina.filtered.,WGS,TCGA-BW-A5NQ-10A-01D-A27I-10_wgs_Illumina,TCGA-BW-A5NQ-10A-01D-A27I-10_wgs_Illumina.bam,19.04,NA,0.07,58cfa830e4b0c9d6adf6c241,TCGA-BW-A5NQ-10A-01D-A27I-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-BW-A5NQ-10A,C7F1B389-AEC7-4993-8AFB-B7A56064F8FC,Blood Derived Normal,Illumina HiSeq,e39bc75a-24c7-4672-b370-db0f70e35fe9,Liver,63,A867D372-7710-45D5-83AB-F6CF18631D73,62616ABE-8EBE-46FC-B24E-32D8CCA79E40,TCGA-BW-A5NQ-10A-01D-A27I-10,GRCh37-lite,TCGA-BW-A5NQ,TCGA-LIHC,NA,s16772,Baylor College of Medicine,St Joseph's Medical Center (MD),United States,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d3d3,58cfa832e4b0c9d6adf6d3d3,TCGA-KO-8417-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KO-8417-01A-11D-2310-10_wgs_Illumina,TCGA-KO-8417-01A-11D-2310-10_wgs_Illumina.bam,186.5,NA,0.05,58cfa832e4b0c9d6adf6d3d3,TCGA-KO-8417-01A-11D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KO-8417-01A,0B77657A-0297-4CEE-B9F2-5DE72E182016,Primary Tumor,Illumina HiSeq,c1d96592-c2a1-4638-8ee3-0515f3a8c96a,Kidney,30,C6D5A991-4018-4D78-BF0C-4D240E7987B5,0C7AF04B-E171-47C4-8BE5-5DB33F20148E,TCGA-KO-8417-01A-11D-2310-10,GRCh37-lite,TCGA-KO-8417,TCGA-KICH,NA,s16574,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T1,N0,Kidney Chromophobe,Stage I
13722.58cfa82ee4b0c9d6adf6a9ac,58cfa82ee4b0c9d6adf6a9ac,G2043.TCGA-13-0751-10A-01D.4.filtered.,WGS,G2043.TCGA-13-0751-10A-01D.4,G2043.TCGA-13-0751-10A-01D.4.bam,50,1.9,0.18,58cfa82ee4b0c9d6adf6a9ac,G2043.TCGA-13-0751-10A-01D.4.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0751-10A,15C84DA3-16E5-4909-AEA9-CB5894B0F8AF,Blood Derived Normal,Illumina GA,fa48a8b3-73d8-4df1-9f24-e4af35eba56e,Ovary,44,A6D8E038-D346-4837-8203-8D5A14DF98E0,F7803D4B-8F86-40D9-8000-1D8301440CB3,TCGA-13-0751-10A-01D-0446-08,HG19_Broad_variant,TCGA-13-0751,TCGA-OV,1678,s18083,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c81d,58cfa831e4b0c9d6adf6c81d,TCGA-CV-6433-01A-11D-2276-10_Illumina.filtered.,WGS,TCGA-CV-6433-01A-11D-2276-10_Illumina,TCGA-CV-6433-01A-11D-2276-10_Illumina.bam,207.03,1.9,0.05,58cfa831e4b0c9d6adf6c81d,TCGA-CV-6433-01A-11D-2276-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6433-01A,D5EEDFB5-4FA3-4A1E-AD0D-EA550B22A5BA,Primary Tumor,Illumina HiSeq,0fc542ae-619e-45f5-9496-dcf6f31f4c32,Head and Neck,57,47EC5010-4353-493B-AB28-C95BC2CB026C,0E6CA8DC-0F31-4675-95B1-5920576DAEFF,TCGA-CV-6433-01A-11D-2276-10,GRCh37-lite,TCGA-CV-6433,TCGA-HNSC,NA,s15511,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c964,58cfa831e4b0c9d6adf6c964,TCGA-DD-A4NG-11A-11D-A27I-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A4NG-11A-11D-A27I-10_wgs_Illumina,TCGA-DD-A4NG-11A-11D-A27I-10_wgs_Illumina.bam,20.97,NA,0.08,58cfa831e4b0c9d6adf6c964,TCGA-DD-A4NG-11A-11D-A27I-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A4NG-11A,89791F8F-DC06-4A04-B166-AFBFD6CF53DE,Solid Tissue Normal,Illumina HiSeq,1401b2c9-af29-434f-a071-77b3c1f4a25f,Liver,77,DED5062C-1F0D-4191-9570-680587079181,46098E4F-4359-4235-A7E5-4ECC46FAEF8F,TCGA-DD-A4NG-11A-11D-A27I-10,GRCh37-lite,TCGA-DD-A4NG,TCGA-LIHC,NA,s16679,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T3a,NX,Hepatocellular Carcinoma,Stage IIIA
13722.58cfa832e4b0c9d6adf6d5a1,58cfa832e4b0c9d6adf6d5a1,TCGA-MH-A55W-10A-01D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-MH-A55W-10A-01D-A26P-10_wgs_Illumina,TCGA-MH-A55W-10A-01D-A26P-10_wgs_Illumina.bam,11.1,NA,0.08,58cfa832e4b0c9d6adf6d5a1,TCGA-MH-A55W-10A-01D-A26P-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-MH-A55W-10A,2030E10B-A4C2-460F-9E29-90C8A76EA05E,Blood Derived Normal,Illumina HiSeq,38891747-9e6a-4d41-b08c-2e270a5b9f0d,Kidney,50,0519678A-3E12-4868-A09D-EC65C0724B31,38FA8B8F-1A31-4331-9ACC-15E845C9A9B8,TCGA-MH-A55W-10A-01D-A26P-10,GRCh37-lite,TCGA-MH-A55W,TCGA-KIRP,NA,s11656,Baylor College of Medicine,BLN - Baylor,United States,NO,T1b,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6ba74,58cfa830e4b0c9d6adf6ba74,TCGA-AA-3555-01A-01D-0959-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3555-01A-01D-0959-10_wgs_Illumina,TCGA-AA-3555-01A-01D-0959-10_wgs_Illumina.bam,949.56,1.9,0.13,58cfa830e4b0c9d6adf6ba74,TCGA-AA-3555-01A-01D-0959-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3555-01A,36EAF209-C332-4321-B6AA-51A3368ECD79,Primary Tumor,Illumina HiSeq,6843fb20-8f01-4121-9e2c-823e5ce9da98,Colorectal,81,9F9961F0-4EE2-4471-AE4A-A0122D630A28,154F80BD-984C-4792-BB89-20C4DA0C08E0,TCGA-AA-3555-01A-01D-0959-10,GRCh37-lite,TCGA-AA-3555,TCGA-COAD,NA,s13182,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Colon Mucinous Adenocarcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6ae91,58cfa82ee4b0c9d6adf6ae91,G49538.TCGA-06-0125-01A-01D-1490-08.2.filtered.,WGS,G49538.TCGA-06-0125-01A-01D-1490-08.2,G49538.TCGA-06-0125-01A-01D-1490-08.2.bam,43.8,1.87,0.05,58cfa82ee4b0c9d6adf6ae91,G49538.TCGA-06-0125-01A-01D-1490-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0125-01A,8DA3103E-3E6C-4176-A583-D5FE5E60601E,Primary Tumor,Illumina HiSeq,759af811-403e-4320-a598-d3291f429679,Brain,63,3A30326B-7523-4565-9A7E-0F7B5536B1CA,0D2A3D87-8ED4-4B27-82EB-FDE852EDE1D7,TCGA-06-0125-01A-01D-1490-08,HG19_Broad_variant,TCGA-06-0125,TCGA-GBM,1448,s14373,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6add8,58cfa82ee4b0c9d6adf6add8,G48125.TCGA-25-1634-01A-01D-A312-08.4.filtered.,WGS,G48125.TCGA-25-1634-01A-01D-A312-08.4,G48125.TCGA-25-1634-01A-01D-A312-08.4.bam,303.97,1.9,0.08,58cfa82ee4b0c9d6adf6add8,G48125.TCGA-25-1634-01A-01D-A312-08.4.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-25-1634-01A,15556B28-C6BD-455A-87B6-4B7B3E33D0E4,Primary Tumor,Illumina HiSeq,ed70494d-da6d-45b7-ad0f-59cd3afa7d46,Ovary,75,C0091BB4-1079-4254-AD42-42AC1DDD7F1E,3A5EAED6-FCFD-437A-B61C-FD3725C64717,TCGA-25-1634-01A-01D-A312-08,HG19_Broad_variant,TCGA-25-1634,TCGA-OV,1091,s17863,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ae9c,58cfa82ee4b0c9d6adf6ae9c,G49538.TCGA-14-1034-02B-01D-2280-08.3.filtered.,WGS,G49538.TCGA-14-1034-02B-01D-2280-08.3,G49538.TCGA-14-1034-02B-01D-2280-08.3.bam,500,1.9,0.05,58cfa82ee4b0c9d6adf6ae9c,G49538.TCGA-14-1034-02B-01D-2280-08.3.bam,Dead,FEMALE,Not available,Not available,Glioblastoma Multiforme,Aligned reads,TCGA-14-1034-02B,0078B0C4-68A9-483B-9AAB-61156D263213,Recurrent Tumor,Illumina HiSeq,45652a31-3dd4-4c94-989c-b34086cbcc9c,Brain,60,AFD6ABEE-DD83-4B1A-B66F-8FD50190287B,7CAE6C0B-36FE-411B-BBBA-093A4C846D84,TCGA-14-1034-02B-01D-2280-08,HG19_Broad_variant,TCGA-14-1034,TCGA-GBM,485,s14307,Broad Institute of MIT and Harvard,Emory University,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6afb0,58cfa82ee4b0c9d6adf6afb0,G48125.TCGA-24-1544-01A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-24-1544-01A-01D-A312-08.2,G48125.TCGA-24-1544-01A-01D-A312-08.2.bam,141.97,1.9,0.08,58cfa82ee4b0c9d6adf6afb0,G48125.TCGA-24-1544-01A-01D-A312-08.2.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1544-01A,21F6BF91-DFC6-4A59-8B76-88A0F95C7B47,Primary Tumor,Illumina HiSeq,d293d826-e945-45a9-8e15-cc375fcf4063,Ovary,71,CF7B9151-6479-41AF-986C-D9DB10E33CA6,052665D1-AB75-4F40-BE5A-B88154C8BEED,TCGA-24-1544-01A-01D-A312-08,HG19_Broad_variant,TCGA-24-1544,TCGA-OV,820,s17761,Broad Institute of MIT and Harvard,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aebf,58cfa82ee4b0c9d6adf6aebf,G49537.TCGA-DE-A0Y3-01B-11D-A10S-08.2.filtered.,WGS,G49537.TCGA-DE-A0Y3-01B-11D-A10S-08.2,G49537.TCGA-DE-A0Y3-01B-11D-A10S-08.2.bam,60.48,2.03,0.07,58cfa82ee4b0c9d6adf6aebf,G49537.TCGA-DE-A0Y3-01B-11D-A10S-08.2.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DE-A0Y3-01B,C31B3ADF-3FC6-4A72-83B0-BBC0F295B5E7,Primary Tumor,Illumina HiSeq,3c0140ae-22a1-4eff-8981-313aa5dd5315,Thyroid,60,3AE03B86-1473-409C-8118-A91A73A36F60,7DFCFE29-3900-4D7B-8067-60C51584B0B1,TCGA-DE-A0Y3-01B-11D-A10S-08,HG19_Broad_variant,TCGA-DE-A0Y3,TCGA-THCA,NA,s12219,Broad Institute of MIT and Harvard,University of North Carolina,United States,NO,T4a,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVC
13722.58cfa82ee4b0c9d6adf6aeee,58cfa82ee4b0c9d6adf6aeee,G49537.TCGA-FE-A233-01A-11D-A33C-08.1.filtered.,WGS,G49537.TCGA-FE-A233-01A-11D-A33C-08.1,G49537.TCGA-FE-A233-01A-11D-A33C-08.1.bam,92.7,2.05,0.09,58cfa82ee4b0c9d6adf6aeee,G49537.TCGA-FE-A233-01A-11D-A33C-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FE-A233-01A,E70FEAFD-1390-4F4C-A635-DA65C1A7DAEB,Primary Tumor,Illumina HiSeq,d7f3aea8-ea8e-4400-b8b3-cc40582e70cd,Thyroid,18,76A6F76D-F33E-4B4A-B0EE-FB863345F194,473FE833-FCC6-485E-93D2-95E662C3EF53,TCGA-FE-A233-01A-11D-A33C-08,HG19_Broad_variant,TCGA-FE-A233,TCGA-THCA,NA,s12224,Broad Institute of MIT and Harvard,Ohio State University,United States,NO,T2,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82fe4b0c9d6adf6b961,58cfa82fe4b0c9d6adf6b961,TCGA-AA-3529-01A-02D-1554-10_wgs_Illumina.filtered.,WGS,TCGA-AA-3529-01A-02D-1554-10_wgs_Illumina,TCGA-AA-3529-01A-02D-1554-10_wgs_Illumina.bam,109.29,1.9,0.05,58cfa82fe4b0c9d6adf6b961,TCGA-AA-3529-01A-02D-1554-10_wgs_Illumina.bam,Dead,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-3529-01A,BFB07784-693B-4C25-874E-4AD6E04A5D46,Primary Tumor,Illumina HiSeq,510f1886-9023-432a-bc19-46aee37ea8a4,Colorectal,78,B083E3CB-0AF1-44EA-854D-85FD99B75AD5,9E5F0A23-E184-4611-B42B-E882DCF23ACD,TCGA-AA-3529-01A-02D-1554-10,GRCh37-lite,TCGA-AA-3529,TCGA-COAD,0,s12863,Baylor College of Medicine,Indivumed,Germany,NO,T3,N2,Colon Adenocarcinoma,Stage IIIC
13722.58cfa82fe4b0c9d6adf6b8a0,58cfa82fe4b0c9d6adf6b8a0,TCGA-A6-A566-10A-01D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-A6-A566-10A-01D-A28G-10_wgs_Illumina,TCGA-A6-A566-10A-01D-A28G-10_wgs_Illumina.bam,31.48,NA,0.07,58cfa82fe4b0c9d6adf6b8a0,TCGA-A6-A566-10A-01D-A28G-10_wgs_Illumina.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-A566-10A,790266BC-C252-43F4-85D1-1B06EE529CF8,Blood Derived Normal,Illumina HiSeq,0edbadde-12aa-44e7-a08e-3b7504787818,Colorectal,55,A97918E7-3EC8-49E2-814E-F0216471CCF1,53057387-7374-4B37-B76B-0A47903BAA5E,TCGA-A6-A566-10A-01D-A28G-10,GRCh37-lite,TCGA-A6-A566,TCGA-COAD,758,s12857,Baylor College of Medicine,Christiana Healthcare,United States,NO,T4,N1,Colon Mucinous Adenocarcinoma,Stage IIIB
13722.58cfa82ee4b0c9d6adf6aa30,58cfa82ee4b0c9d6adf6aa30,G2042.TCGA-13-0751-01A-01D.4.filtered.,WGS,G2042.TCGA-13-0751-01A-01D.4,G2042.TCGA-13-0751-01A-01D.4.bam,86.64,1.9,0.16,58cfa82ee4b0c9d6adf6aa30,G2042.TCGA-13-0751-01A-01D.4.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0751-01A,15C84DA3-16E5-4909-AEA9-CB5894B0F8AF,Primary Tumor,Illumina GA,ee836636-e175-45b8-8de3-f3da7a1d10f9,Ovary,44,897A5467-5E46-4370-B805-D651DD579DEF,9F335CD1-2736-41BE-A02B-CDBE4017BB3D,TCGA-13-0751-01A-01D-0446-08,HG19_Broad_variant,TCGA-13-0751,TCGA-OV,1678,s17405,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c6dc,58cfa831e4b0c9d6adf6c6dc,TCGA-CR-7382-10A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CR-7382-10A-01D-A32X-10_wgs_Illumina,TCGA-CR-7382-10A-01D-A32X-10_wgs_Illumina.bam,60,NA,0.07,58cfa831e4b0c9d6adf6c6dc,TCGA-CR-7382-10A-01D-A32X-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-7382-10A,F030E410-2585-461E-AD23-9FDF026AC06C,Blood Derived Normal,Illumina HiSeq,eac78b10-617e-41af-8cf9-dd55919bc5c7,Head and Neck,49,27DB87BD-FF36-4ADC-AD1C-066C6AE80122,CEC794FA-BD1E-4502-AC47-6D94059B33EB,TCGA-CR-7382-10A-01D-A32X-10,GRCh37-lite,TCGA-CR-7382,TCGA-HNSC,NA,s15635,Baylor College of Medicine,Vanderbilt University,United States,NO,T2,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6c18e,58cfa830e4b0c9d6adf6c18e,TCGA-BA-6869-10A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-BA-6869-10A-01D-A32X-10_wgs_Illumina,TCGA-BA-6869-10A-01D-A32X-10_wgs_Illumina.bam,48,1.9,0.07,58cfa830e4b0c9d6adf6c18e,TCGA-BA-6869-10A-01D-A32X-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-6869-10A,FAFD6F5B-1D76-4537-BD1C-E0BD7B4E2166,Blood Derived Normal,Illumina HiSeq,609c293a-3273-47e0-b4d1-9fd98e1163db,Head and Neck,62,0AAA8BBA-F4A5-4158-B9B4-A02244B5F6F7,C051B998-1CEC-4FFB-A1AA-32A3C05DD30A,TCGA-BA-6869-10A-01D-A32X-10,GRCh37-lite,TCGA-BA-6869,TCGA-HNSC,NA,s15751,Baylor College of Medicine,UNC,United States,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6a8cc,58cfa82ee4b0c9d6adf6a8cc,G25780.TCGA-49-6742-11A-01D-1855-08.4.filtered.,WGS,G25780.TCGA-49-6742-11A-01D-1855-08.4,G25780.TCGA-49-6742-11A-01D-1855-08.4.bam,62.7,1.9,0.05,58cfa82ee4b0c9d6adf6a8cc,G25780.TCGA-49-6742-11A-01D-1855-08.4.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-6742-11A,21FB46F9-4BBB-441C-AF19-A687E9138344,Solid Tissue Normal,Illumina HiSeq,55cf964d-5dc3-457c-a7c3-0ec44617951b,Lung,70,D9548FE4-5631-473A-82CD-1B089B638963,F09F9865-726D-41BD-B206-B8FAE7D4A81B,TCGA-49-6742-11A-01D-1855-08,HG19_Broad_variant,TCGA-49-6742,TCGA-LUAD,NA,s11318,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T2a,N1,Mucinous (Colloid) Carcinoma,Stage IIA
13722.58cfa832e4b0c9d6adf6cf40,58cfa832e4b0c9d6adf6cf40,TCGA-HE-A5NI-10A-01D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-HE-A5NI-10A-01D-A26P-10_wgs_Illumina,TCGA-HE-A5NI-10A-01D-A26P-10_wgs_Illumina.bam,52.89,NA,0.08,58cfa832e4b0c9d6adf6cf40,TCGA-HE-A5NI-10A-01D-A26P-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-HE-A5NI-10A,D61E22D8-C3CE-4237-83D7-DA188B9FD456,Blood Derived Normal,Illumina HiSeq,0722e0a3-a7b8-4d97-95f1-dcdb17ccaf58,Kidney,73,596721DE-F561-4240-8C9C-57683E4FA942,A08286B5-7084-40D6-BBFE-9601634344BC,TCGA-HE-A5NI-10A-01D-A26P-10,GRCh37-lite,TCGA-HE-A5NI,TCGA-KIRP,NA,s11649,Baylor College of Medicine,Ontario Institute for Cancer Research (OICR),Canada,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ad24,58cfa82ee4b0c9d6adf6ad24,G49837.TCGA-18-3408-01A-01D-A320-08.4.filtered.,WGS,G49837.TCGA-18-3408-01A-01D-A320-08.4,G49837.TCGA-18-3408-01A-01D-A320-08.4.bam,385.94,1.9,0.08,58cfa82ee4b0c9d6adf6ad24,G49837.TCGA-18-3408-01A-01D-A320-08.4.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-18-3408-01A,D4BC755A-2585-4529-AE36-7E1D88BDECFE,Primary Tumor,Illumina HiSeq,cea31b4d-7d33-4497-ae63-50688d12b045,Lung,77,EEFFADF9-2CCB-4937-AE1E-1D50ABA41C4D,24BADF07-8615-48A3-8D6E-45C3D783F18D,TCGA-18-3408-01A-01D-A320-08,HG19_Broad_variant,TCGA-18-3408,TCGA-LUSC,NA,s10257,Broad Institute of MIT and Harvard,Princess Margaret Hospital (Canada),Canada,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa832e4b0c9d6adf6d20a,58cfa832e4b0c9d6adf6d20a,TCGA-HD-7753-10A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-HD-7753-10A-01D-A32X-10_wgs_Illumina,TCGA-HD-7753-10A-01D-A32X-10_wgs_Illumina.bam,115,NA,0.07,58cfa832e4b0c9d6adf6d20a,TCGA-HD-7753-10A-01D-A32X-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-HD-7753-10A,E8AC39E6-377A-412C-B18D-F6C4FC654EC6,Blood Derived Normal,Illumina HiSeq,ddb75587-4d2e-4c11-bd83-f7a0accb8120,Head and Neck,62,7FB56F25-873D-475C-9DB6-F0BE3945D926,60D15C0C-A12E-4FE5-8D76-CAD096F2C248,TCGA-HD-7753-10A-01D-A32X-10,GRCh37-lite,TCGA-HD-7753,TCGA-HNSC,NA,s15657,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bcd6,58cfa830e4b0c9d6adf6bcd6,TCGA-AF-2689-01A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AF-2689-01A-01D-1989-10_wgs_Illumina,NA,NA,NA,NA,58cfa830e4b0c9d6adf6bcd6,TCGA-AF-2689-01A-01D-1989-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-AF-2689-01A,335D0351-3740-4847-9FF4-BE2F078C70F7,Primary Tumor,Illumina HiSeq,5f4b068c-b942-45c3-ab7f-7258bb46e0e6,Colorectal,41,8BEE44CB-3FE4-47A8-BD1B-90A59EA606BE,5B180356-CF58-4FAD-A3D4-00FC12B43FCC,TCGA-AF-2689-01A-01D-1989-10,GRCh37-lite,TCGA-AF-2689,TCGA-READ,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
13722.58cfa832e4b0c9d6adf6d592,58cfa832e4b0c9d6adf6d592,TCGA-MH-A560-10A-01D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-MH-A560-10A-01D-A26P-10_wgs_Illumina,TCGA-MH-A560-10A-01D-A26P-10_wgs_Illumina.bam,14.42,NA,0.08,58cfa832e4b0c9d6adf6d592,TCGA-MH-A560-10A-01D-A26P-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-MH-A560-10A,A40BEABE-496E-4324-A1D1-5A7D8B002AAB,Blood Derived Normal,Illumina HiSeq,9ec31c4d-1993-41db-a1fd-4515bc3befd8,Kidney,62,F953B445-1417-4842-BB2F-DBEF5FEC2446,8FA7C1A8-E64C-4EE8-9012-187AA9DA1210,TCGA-MH-A560-10A-01D-A26P-10,GRCh37-lite,TCGA-MH-A560,TCGA-KIRP,NA,s11865,Baylor College of Medicine,BLN - Baylor,United States,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ae46,58cfa82ee4b0c9d6adf6ae46,G49837.TCGA-33-4586-01A-01D-A320-08.2.filtered.,WGS,G49837.TCGA-33-4586-01A-01D-A320-08.2,G49837.TCGA-33-4586-01A-01D-A320-08.2.bam,362,1.9,0.07,58cfa82ee4b0c9d6adf6ae46,G49837.TCGA-33-4586-01A-01D-A320-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-33-4586-01A,376DFD27-68E8-4A1A-9C4F-5064279B2A9E,Primary Tumor,Illumina HiSeq,e894d311-bbc3-468a-bed1-2c6328ae7bda,Lung,57,A41992A4-D0F9-4D5B-8D05-0E3025D9C8FF,B88F014E-BC0F-4775-8228-39E0B471C3B0,TCGA-33-4586-01A-01D-A320-08,HG19_Broad_variant,TCGA-33-4586,TCGA-LUSC,428,s10162,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T2,N2,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa831e4b0c9d6adf6c78e,58cfa831e4b0c9d6adf6c78e,TCGA-CV-6956-10A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CV-6956-10A-01D-A32X-10_wgs_Illumina,TCGA-CV-6956-10A-01D-A32X-10_wgs_Illumina.bam,22.03,1.8,0.07,58cfa831e4b0c9d6adf6c78e,TCGA-CV-6956-10A-01D-A32X-10_wgs_Illumina.bam,Dead,MALE,WHITE,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6956-10A,8C238D30-DF8E-4E6B-98FC-21696269A294,Blood Derived Normal,Illumina HiSeq,c03352c8-542b-4ea8-b982-ff61e0723b16,Head and Neck,67,BA086EB2-DE97-4D74-9F92-05874932C25E,F6CA8BBE-25BF-4557-A4F6-8DAC8AC3B47E,TCGA-CV-6956-10A-01D-A32X-10,GRCh37-lite,TCGA-CV-6956,TCGA-HNSC,217,s16048,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T3,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa82fe4b0c9d6adf6b89e,58cfa82fe4b0c9d6adf6b89e,TCGA-A6-A56B-10A-01D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-A6-A56B-10A-01D-A28G-10_wgs_Illumina,TCGA-A6-A56B-10A-01D-A28G-10_wgs_Illumina.bam,42.54,NA,0.08,58cfa82fe4b0c9d6adf6b89e,TCGA-A6-A56B-10A-01D-A28G-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-A56B-10A,74A0264D-1D31-430D-9A88-E7334C8AA96C,Blood Derived Normal,Illumina HiSeq,ee77fab1-ee89-43e8-b46f-8f15ee0ea73c,Colorectal,57,CE20A5FF-88F9-43B4-8C8A-62FB9CFFF9E6,3CC05A56-3108-4912-8C0E-2438F2AC203B,TCGA-A6-A56B-10A-01D-A28G-10,GRCh37-lite,TCGA-A6-A56B,TCGA-COAD,NA,s13019,Baylor College of Medicine,Christiana Healthcare,United States,NO,T3,N1,Colon Adenocarcinoma,Stage IIIB
13722.58cfa831e4b0c9d6adf6c68e,58cfa831e4b0c9d6adf6c68e,TCGA-CQ-6225-10A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CQ-6225-10A-01D-A32X-10_wgs_Illumina,TCGA-CQ-6225-10A-01D-A32X-10_wgs_Illumina.bam,38,NA,0.07,58cfa831e4b0c9d6adf6c68e,TCGA-CQ-6225-10A-01D-A32X-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-6225-10A,90F44998-3C05-44B2-9501-BBD0F43C5147,Blood Derived Normal,Illumina HiSeq,16279dce-4563-4617-8c4e-0d1aca77f910,Head and Neck,65,D30CD5CB-D0DE-446A-8A57-4F8B69AB25FE,5B19CDD0-20C5-4FBD-ABF3-B88B95085A11,TCGA-CQ-6225-10A-01D-A32X-10,GRCh37-lite,TCGA-CQ-6225,TCGA-HNSC,403,s16187,Baylor College of Medicine,"University Health Network, Toronto",Canada,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6a7fa,58cfa82ee4b0c9d6adf6a7fa,G25780.TCGA-49-6742-01A-11D-1855-08.4.filtered.,WGS,G25780.TCGA-49-6742-01A-11D-1855-08.4,G25780.TCGA-49-6742-01A-11D-1855-08.4.bam,39.7,2,0.05,58cfa82ee4b0c9d6adf6a7fa,G25780.TCGA-49-6742-01A-11D-1855-08.4.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-49-6742-01A,21FB46F9-4BBB-441C-AF19-A687E9138344,Primary Tumor,Illumina HiSeq,2fdfd442-4aa3-49d0-82e8-7b21b059e7e3,Lung,70,F0A4AE58-D5BC-4AB0-B1CF-0D951EA91FC7,49DEC0C2-8E75-4F44-A253-82B2EA605890,TCGA-49-6742-01A-11D-1855-08,HG19_Broad_variant,TCGA-49-6742,TCGA-LUAD,NA,s10895,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T2a,N1,Mucinous (Colloid) Carcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6c7e1,58cfa831e4b0c9d6adf6c7e1,TCGA-CV-7090-01A-11D-2276-10_Illumina.filtered.,WGS,TCGA-CV-7090-01A-11D-2276-10_Illumina,TCGA-CV-7090-01A-11D-2276-10_Illumina.bam,158.73,NA,0.05,58cfa831e4b0c9d6adf6c7e1,TCGA-CV-7090-01A-11D-2276-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7090-01A,05FBD98C-28BD-41BC-AE60-16AC0C16C723,Primary Tumor,Illumina HiSeq,30e23a3f-f6eb-45e4-9d14-bddafc4fab6d,Head and Neck,39,E8BD9DCB-A9C7-4361-9724-24922A5E613B,A8041E86-071E-46CD-8FB5-7ECDC1AB0553,TCGA-CV-7090-01A-11D-2276-10,GRCh37-lite,TCGA-CV-7090,TCGA-HNSC,NA,s15646,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6af1c,58cfa82ee4b0c9d6adf6af1c,G39020.TCGA-FP-7998-01A-11D-2201-08.2.filtered.,WGS,G39020.TCGA-FP-7998-01A-11D-2201-08.2,G39020.TCGA-FP-7998-01A-11D-2201-08.2.bam,278.7,NA,0.05,58cfa82ee4b0c9d6adf6af1c,G39020.TCGA-FP-7998-01A-11D-2201-08.2.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-FP-7998-01A,B2E2D35C-7A79-4165-97A5-82D5C37D94F2,Primary Tumor,Illumina HiSeq,d124dc46-96b0-4101-b8a6-3e4ebf4862c9,Stomach,77,0A95BD32-539E-43F3-9694-A7D033A6FA84,172C9864-C26D-4E9B-947A-E8CE761E996D,TCGA-FP-7998-01A-11D-2201-08,HG19_Broad_variant,TCGA-FP-7998,TCGA-STAD,NA,s15369,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T4a,N3a,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIC
13722.58cfa830e4b0c9d6adf6bcb5,58cfa830e4b0c9d6adf6bcb5,TCGA-AZ-6601-01A-11D-1771-10_wgs_Illumina.filtered.,WGS,TCGA-AZ-6601-01A-11D-1771-10_wgs_Illumina,TCGA-AZ-6601-01A-11D-1771-10_wgs_Illumina.bam,286.4,1.9,0.05,58cfa830e4b0c9d6adf6bcb5,TCGA-AZ-6601-01A-11D-1771-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-6601-01A,7AD0617E-BC4A-4869-8419-744F04D9B7A3,Primary Tumor,Illumina HiSeq,ae0bedfc-1ef9-4999-8ff2-c0eb8e421ef3,Colorectal,68,DC23BAFB-2CFB-4C1B-9E66-B9CAB22AE855,34348062-073E-40AA-9CA0-4B0CDAAF7177,TCGA-AZ-6601-01A-11D-1771-10,GRCh37-lite,TCGA-AZ-6601,TCGA-COAD,3042,s13215,Baylor College of Medicine,University of Pittsburgh,United States,NO,T3,N0,Colon Adenocarcinoma,Stage II
13722.58cfa831e4b0c9d6adf6cd6e,58cfa831e4b0c9d6adf6cd6e,TCGA-F5-6814-01A-31D-1924-10_wgs_Illumina.filtered.,WGS,TCGA-F5-6814-01A-31D-1924-10_wgs_Illumina,TCGA-F5-6814-01A-31D-1924-10_wgs_Illumina.bam,336.7,NA,0.05,58cfa831e4b0c9d6adf6cd6e,TCGA-F5-6814-01A-31D-1924-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-F5-6814-01A,8FEB0E8F-D09B-437D-8651-0CDECFE776BF,Primary Tumor,Illumina HiSeq,4980286e-15f8-4cb0-b7f7-8e68f04c699f,Colorectal,57,81AB66E0-6470-409B-AA27-846C869D2C8F,14C5B81D-DA49-4DB1-9834-77711C2B1D38,TCGA-F5-6814-01A-31D-1924-10,GRCh37-lite,TCGA-F5-6814,TCGA-READ,NA,s2012,Baylor College of Medicine,Asterand,Russia,NO,T2,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6ad2e,58cfa82ee4b0c9d6adf6ad2e,G49837.TCGA-56-7582-01A-11D-A320-08.4.filtered.,WGS,G49837.TCGA-56-7582-01A-11D-A320-08.4,G49837.TCGA-56-7582-01A-11D-A320-08.4.bam,60,NA,0.08,58cfa82ee4b0c9d6adf6ad2e,G49837.TCGA-56-7582-01A-11D-A320-08.4.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-56-7582-01A,B5E2CBDA-BBFA-4EF8-A9C4-CB978BEF9B23,Primary Tumor,Illumina HiSeq,0a8f41dd-07fb-47be-b963-8d807c40760c,Lung,83,1220E8B3-E16E-454E-BC49-60F49F9FE090,89C48E53-C8A9-4518-B3B8-509CDCAFF52B,TCGA-56-7582-01A-11D-A320-08,HG19_Broad_variant,TCGA-56-7582,TCGA-LUSC,NA,s10163,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2a,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6ac51,58cfa82ee4b0c9d6adf6ac51,G39020.TCGA-BR-6456-01A-11D-1800-08.3.filtered.,WGS,G39020.TCGA-BR-6456-01A-11D-1800-08.3,G39020.TCGA-BR-6456-01A-11D-1800-08.3.bam,282.7,1.9,0.05,58cfa82ee4b0c9d6adf6ac51,G39020.TCGA-BR-6456-01A-11D-1800-08.3.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-6456-01A,1CA3C5E0-32B0-4467-8EC0-CA212E35D2B3,Primary Tumor,Illumina HiSeq,9830e4a0-d8b1-4166-8375-49851288cf1f,Stomach,74,53369A25-3BC4-48CB-9004-DA3507C4D478,C612570A-881D-421F-98B9-0E4563133744,TCGA-BR-6456-01A-11D-1800-08,HG19_Broad_variant,TCGA-BR-6456,TCGA-STAD,NA,s14876,Broad Institute of MIT and Harvard,Asterand,Russia,NO,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6accf,58cfa82ee4b0c9d6adf6accf,G48125.TCGA-24-1557-01A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-24-1557-01A-01D-A312-08.2,G48125.TCGA-24-1557-01A-01D-A312-08.2.bam,115.97,1.9,0.08,58cfa82ee4b0c9d6adf6accf,G48125.TCGA-24-1557-01A-01D-A312-08.2.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1557-01A,7DCC809B-E33A-4453-B92A-C00786F48CB0,Primary Tumor,Illumina HiSeq,07bba28c-8d1a-4228-bd9e-1b27066ba518,Ovary,49,FA79B363-380E-48AE-BB82-DB395085353C,BFF518FB-6DA7-4DFC-AE4C-BD3F641028E2,TCGA-24-1557-01A-01D-A312-08,HG19_Broad_variant,TCGA-24-1557,TCGA-OV,1213,s17862,Broad Institute of MIT and Harvard,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a73c,58cfa82de4b0c9d6adf6a73c,G13228.TCGA-43-3920-01A-01D-1553-08.4.filtered.,WGS,G13228.TCGA-43-3920-01A-01D-1553-08.4,G13228.TCGA-43-3920-01A-01D-1553-08.4.bam,835.37,1.9,0.05,58cfa82de4b0c9d6adf6a73c,G13228.TCGA-43-3920-01A-01D-1553-08.4.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-43-3920-01A,9293E197-E38A-4E19-A7D0-1B45D1AD48BD,Primary Tumor,Illumina HiSeq,3281e662-29ac-4441-86e2-07a71d47196c,Lung,71,BBC07C89-5540-4217-AA56-3608539983C2,A762DD44-A8AC-4269-8163-BBF6D0F8D4B3,TCGA-43-3920-01A-01D-1553-08,HG19_Broad_variant,TCGA-43-3920,TCGA-LUSC,NA,s10157,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6ae9a,58cfa82ee4b0c9d6adf6ae9a,G49537.TCGA-FK-A3SD-01A-11D-A22D-08.1.filtered.,WGS,G49537.TCGA-FK-A3SD-01A-11D-A22D-08.1,G49537.TCGA-FK-A3SD-01A-11D-A22D-08.1.bam,32.19,NA,0.07,58cfa82ee4b0c9d6adf6ae9a,G49537.TCGA-FK-A3SD-01A-11D-A22D-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FK-A3SD-01A,63B01B43-A68A-4046-89B0-736BA4D08504,Primary Tumor,Illumina HiSeq,f713e001-9c18-4a72-a093-90bd147d414f,Thyroid,61,B48D226E-610A-40DC-B62A-6DB863A7366C,29578759-9CCB-4A24-B5B8-C45EBD4339D9,TCGA-FK-A3SD-01A-11D-A22D-08,HG19_Broad_variant,TCGA-FK-A3SD,TCGA-THCA,NA,s12739,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c88e,58cfa831e4b0c9d6adf6c88e,TCGA-D5-6540-01A-11D-1719-10_wgs_Illumina.filtered.,WGS,TCGA-D5-6540-01A-11D-1719-10_wgs_Illumina,TCGA-D5-6540-01A-11D-1719-10_wgs_Illumina.bam,473,1.9,0.05,58cfa831e4b0c9d6adf6c88e,TCGA-D5-6540-01A-11D-1719-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-D5-6540-01A,B08B5F49-9434-4653-9772-097EC29B2CA3,Primary Tumor,Illumina HiSeq,ea4fb044-493b-4e48-ac28-28ba39b8be21,Colorectal,66,201B6B48-418F-48A3-A568-6E851F85C25E,EC43C4B5-FB72-4A4A-AF03-10C2D05FF159,TCGA-D5-6540-01A-11D-1719-10,GRCh37-lite,TCGA-D5-6540,TCGA-COAD,NA,s13396,Baylor College of Medicine,Greater Poland Cancer Center,Poland,NO,T2,N0,Colon Mucinous Adenocarcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c97e,58cfa831e4b0c9d6adf6c97e,TCGA-DQ-5625-10A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-DQ-5625-10A-01D-A32X-10_wgs_Illumina,TCGA-DQ-5625-10A-01D-A32X-10_wgs_Illumina.bam,31,1.9,0.08,58cfa831e4b0c9d6adf6c97e,TCGA-DQ-5625-10A-01D-A32X-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-DQ-5625-10A,53D9A130-4A3A-4491-85CD-9A44415A1632,Blood Derived Normal,Illumina HiSeq,8525b9e2-c05e-4524-ba11-f1673ffc575e,Head and Neck,52,F3AD5B44-87B1-41AE-8CC1-42E158BC174C,FDE15753-1874-45DB-9CCF-7C1BD4238D59,TCGA-DQ-5625-10A-01D-A32X-10,GRCh37-lite,TCGA-DQ-5625,TCGA-HNSC,NA,s16059,Baylor College of Medicine,University of Michigan,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c6a6,58cfa831e4b0c9d6adf6c6a6,TCGA-CV-5431-11A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CV-5431-11A-01D-A32X-10_wgs_Illumina,TCGA-CV-5431-11A-01D-A32X-10_wgs_Illumina.bam,25.7,1.8,0.07,58cfa831e4b0c9d6adf6c6a6,TCGA-CV-5431-11A-01D-A32X-10_wgs_Illumina.bam,Dead,MALE,WHITE,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5431-11A,64BB5550-2735-4401-A0DB-58EC1020A32D,Solid Tissue Normal,Illumina HiSeq,878f4d9b-a3fb-4517-9331-fe3b4590447e,Head and Neck,73,39E3FACF-6D13-4611-BCFA-90EF0350814D,A909F28C-EE65-4859-BB65-B07D77F0BA75,TCGA-CV-5431-11A-01D-A32X-10,GRCh37-lite,TCGA-CV-5431,TCGA-HNSC,522,s15774,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T3,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82ee4b0c9d6adf6aebe,58cfa82ee4b0c9d6adf6aebe,G49538.TCGA-06-0190-01A-01D-1491-08.1.filtered.,WGS,G49538.TCGA-06-0190-01A-01D-1491-08.1,G49538.TCGA-06-0190-01A-01D-1491-08.1.bam,73.7,1.9,0.05,58cfa82ee4b0c9d6adf6aebe,G49538.TCGA-06-0190-01A-01D-1491-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0190-01A,74139255-A635-4C87-814D-3DD04ED630A8,Primary Tumor,Illumina HiSeq,e496b84b-9adf-462a-8d8f-7b336fa12626,Brain,62,5E92A5D5-77A4-401A-ADE3-E01C95302EC0,640AFBF7-7886-4A29-9505-DCF36B611A05,TCGA-06-0190-01A-01D-1491-08,HG19_Broad_variant,TCGA-06-0190,TCGA-GBM,317,s14094,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6ad1a,58cfa82ee4b0c9d6adf6ad1a,G48125.TCGA-24-1466-01A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-24-1466-01A-01D-A312-08.2,G48125.TCGA-24-1466-01A-01D-A312-08.2.bam,110.27,1.9,0.08,58cfa82ee4b0c9d6adf6ad1a,G48125.TCGA-24-1466-01A-01D-A312-08.2.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1466-01A,098ACB76-0BF5-44E5-BCAE-F919CF5FA5E5,Primary Tumor,Illumina HiSeq,13f5418c-eee9-41bd-bcaa-1ecf0416e01f,Ovary,74,3BF6EC5D-E075-41A7-BF32-470EC1F09E98,84CA6AB0-9EDC-4636-9D27-55CDBA334D7D,TCGA-24-1466-01A-01D-A312-08,HG19_Broad_variant,TCGA-24-1466,TCGA-OV,1373,s17889,Broad Institute of MIT and Harvard,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa832e4b0c9d6adf6d300,58cfa832e4b0c9d6adf6d300,TCGA-KM-8440-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KM-8440-01A-11D-2310-10_wgs_Illumina,TCGA-KM-8440-01A-11D-2310-10_wgs_Illumina.bam,38.6,NA,0.05,58cfa832e4b0c9d6adf6d300,TCGA-KM-8440-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KM-8440-01A,872092B3-D31E-44D7-BD03-E29F52F8AB5A,Primary Tumor,Illumina HiSeq,e0e06c60-542a-4e20-928f-7fed440fcd2a,Kidney,37,614E4163-7DA8-4F77-A58D-405B004BE3E0,CDF313C8-59F9-41C6-9BD2-F47CB4287DA5,TCGA-KM-8440-01A-11D-2310-10,GRCh37-lite,TCGA-KM-8440,TCGA-KICH,NA,s16478,Baylor College of Medicine,NCI Urologic Oncology Branch,United States,NO,T3a,NX,Kidney Chromophobe,Stage III
13722.58cfa830e4b0c9d6adf6ba9e,58cfa830e4b0c9d6adf6ba9e,TCGA-AA-A01X-01A-21D-A17O-10_wgs_Illumina.filtered.,WGS,TCGA-AA-A01X-01A-21D-A17O-10_wgs_Illumina,TCGA-AA-A01X-01A-21D-A17O-10_wgs_Illumina.bam,71,1.92,0.07,58cfa830e4b0c9d6adf6ba9e,TCGA-AA-A01X-01A-21D-A17O-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AA-A01X-01A,2E386E48-B99B-4806-A3E3-081D72A606E7,Primary Tumor,Illumina HiSeq,4b96a6ce-adbd-45b8-9c53-ea1850f0731c,Colorectal,80,0225A318-9BB2-4340-A34A-99FCBC563E0A,B7F2E85A-3C6A-48B7-8A4F-2DEC1D85359D,TCGA-AA-A01X-01A-21D-A17O-10,GRCh37-lite,TCGA-AA-A01X,TCGA-COAD,NA,s12880,Baylor College of Medicine,Indivumed,Germany,NO,T2,N1,Colon Adenocarcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6ac8b,58cfa82ee4b0c9d6adf6ac8b,G47088.TCGA-98-8022-01A-11D-2244-08.2.filtered.,WGS,G47088.TCGA-98-8022-01A-11D-2244-08.2,G47088.TCGA-98-8022-01A-11D-2244-08.2.bam,276.03,NA,0.05,58cfa82ee4b0c9d6adf6ac8b,G47088.TCGA-98-8022-01A-11D-2244-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-98-8022-01A,ADC853B1-B8BF-488C-A1E2-E95603459B55,Primary Tumor,Illumina HiSeq,490e3546-83cd-4a44-a792-f1c2e1530f4a,Lung,61,95933B01-06CA-4F3E-8995-EB2AB01A2C4C,6962BC97-FBB8-4220-A600-E3C251E245CB,TCGA-98-8022-01A-11D-2244-08,HG19_Broad_variant,TCGA-98-8022,TCGA-LUSC,NA,s10499,Broad Institute of MIT and Harvard,Washington University - Alabama,United States,NO,T1a,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6af4a,58cfa82ee4b0c9d6adf6af4a,G47088.TCGA-66-2793-01A-01D-1267-08.1.filtered.,WGS,G47088.TCGA-66-2793-01A-01D-1267-08.1,G47088.TCGA-66-2793-01A-01D-1267-08.1.bam,195.33,1.9,0.16,58cfa82ee4b0c9d6adf6af4a,G47088.TCGA-66-2793-01A-01D-1267-08.1.bam,Dead,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-66-2793-01A,9AF6ED4E-8CDC-4F49-84E9-BA1053B5B3CA,Primary Tumor,Illumina HiSeq,ca861e94-4779-4f5f-b97c-4310ed2d7702,Lung,68,DAA128EB-BF5A-4C2C-A7DC-E6E06B6AEB85,7DC5F8BA-0080-43D3-8426-BD527A970761,TCGA-66-2793-01A-01D-1267-08,HG19_Broad_variant,TCGA-66-2793,TCGA-LUSC,306,s10158,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T4,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIB
13722.58cfa832e4b0c9d6adf6d394,58cfa832e4b0c9d6adf6d394,TCGA-KO-8411-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KO-8411-01A-11D-2310-10_wgs_Illumina,TCGA-KO-8411-01A-11D-2310-10_wgs_Illumina.bam,133.2,NA,0.05,58cfa832e4b0c9d6adf6d394,TCGA-KO-8411-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KO-8411-01A,EE8C1919-17A9-4DF1-8AA5-79546621B23C,Primary Tumor,Illumina HiSeq,bcee9ae3-609f-4f6c-bf6e-9bf33233592d,Kidney,58,9E2CDD77-110D-498A-83E8-DF2E044303D6,9DFCBABF-2BC0-43A2-BDDE-D0B2AACA3F6B,TCGA-KO-8411-01A-11D-2310-10,GRCh37-lite,TCGA-KO-8411,TCGA-KICH,NA,s16402,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T1b,NX,Kidney Chromophobe,Stage I
13722.58cfa82ee4b0c9d6adf6adf0,58cfa82ee4b0c9d6adf6adf0,G49538.TCGA-06-0211-02A-02D-2280-08.1.filtered.,WGS,G49538.TCGA-06-0211-02A-02D-2280-08.1,G49538.TCGA-06-0211-02A-02D-2280-08.1.bam,600,1.9,0.05,58cfa82ee4b0c9d6adf6adf0,G49538.TCGA-06-0211-02A-02D-2280-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0211-02A,5C984433-33CF-42FC-B3BA-511EFCDCAB19,Recurrent Tumor,Illumina HiSeq,631bce1e-fa7a-4ec3-9545-15630ca0c249,Brain,47,2E7EEC3F-C9C4-42C2-8B3D-296D916A2842,3914C02E-44AD-4C96-8464-61AA95B42C49,TCGA-06-0211-02A-02D-2280-08,HG19_Broad_variant,TCGA-06-0211,TCGA-GBM,360,s14026,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa831e4b0c9d6adf6c83b,58cfa831e4b0c9d6adf6c83b,TCGA-CV-7180-01A-11D-2266-10_Illumina.filtered.,WGS,TCGA-CV-7180-01A-11D-2266-10_Illumina,TCGA-CV-7180-01A-11D-2266-10_Illumina.bam,52.7,NA,0.05,58cfa831e4b0c9d6adf6c83b,TCGA-CV-7180-01A-11D-2266-10_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7180-01A,D2CA9A4D-C14C-40C0-871C-88794A02E4AA,Primary Tumor,Illumina HiSeq,b66083b7-e0ae-4f6e-ab6a-76caf55a13bc,Head and Neck,34,551B5AC7-41E8-42BC-B64D-20E7E156DBBC,1727E88B-DF0A-4AF2-9191-8C6061D98AD0,TCGA-CV-7180-01A-11D-2266-10,GRCh37-lite,TCGA-CV-7180,TCGA-HNSC,327,s15648,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa82ee4b0c9d6adf6abc6,58cfa82ee4b0c9d6adf6abc6,G32540.TCGA-EL-A3CV-01A-11D-A19J-08.2.filtered.,WGS,G32540.TCGA-EL-A3CV-01A-11D-A19J-08.2,G32540.TCGA-EL-A3CV-01A-11D-A19J-08.2.bam,15.76,NA,0.08,58cfa82ee4b0c9d6adf6abc6,G32540.TCGA-EL-A3CV-01A-11D-A19J-08.2.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EL-A3CV-01A,FB83F7D7-2182-4FB7-8E3E-8AD7F1FEAC72,Primary Tumor,Illumina HiSeq,bd9e1da9-58f5-49d6-b838-2acffb8ee860,Thyroid,40,7BC433ED-7908-4297-AA5A-E033924BCED1,B1753E9C-29D0-4955-89D2-949CDABD1211,TCGA-EL-A3CV-01A-11D-A19J-08,HG19_Broad_variant,TCGA-EL-A3CV,TCGA-THCA,NA,s12727,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82ee4b0c9d6adf6aea6,58cfa82ee4b0c9d6adf6aea6,G49537.TCGA-EM-A2OW-01A-11D-A202-08.1.filtered.,WGS,G49537.TCGA-EM-A2OW-01A-11D-A202-08.1,G49537.TCGA-EM-A2OW-01A-11D-A202-08.1.bam,36.94,NA,0.08,58cfa82ee4b0c9d6adf6aea6,G49537.TCGA-EM-A2OW-01A-11D-A202-08.1.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A2OW-01A,A65EC434-9AE0-453F-B440-08BF25558FD1,Primary Tumor,Illumina HiSeq,c5097aad-061c-40d4-aa81-a97fe09d13f6,Thyroid,37,4D6A2D9E-EC25-4040-A696-2D8D5D5C392E,17A66D24-DE77-4F2A-A8AD-D2C6A69E7671,TCGA-EM-A2OW-01A-11D-A202-08,HG19_Broad_variant,TCGA-EM-A2OW,TCGA-THCA,NA,s12504,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T1b,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa830e4b0c9d6adf6c2a3,58cfa830e4b0c9d6adf6c2a3,TCGA-B1-A47N-01A-11D-A25F-10_wgs_Illumina.filtered.,WGS,TCGA-B1-A47N-01A-11D-A25F-10_wgs_Illumina,TCGA-B1-A47N-01A-11D-A25F-10_wgs_Illumina.bam,32.02,NA,0.08,58cfa830e4b0c9d6adf6c2a3,TCGA-B1-A47N-01A-11D-A25F-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B1-A47N-01A,F1EC5A7B-0973-4C38-9908-862196DF9541,Primary Tumor,Illumina HiSeq,57987e56-d118-4f55-98c4-340866fcf3e8,Kidney,62,C5EDE5F5-35D2-4059-9F0C-6736ABC6F899,BD2CC59D-F5CE-46ED-BEB0-4C80B24CBE71,TCGA-B1-A47N-01A-11D-A25F-10,GRCh37-lite,TCGA-B1-A47N,TCGA-KIRP,NA,s11855,Baylor College of Medicine,University of Pittsburgh,United States,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa82fe4b0c9d6adf6b9e4,58cfa82fe4b0c9d6adf6b9e4,TCGA-A4-A57E-10A-01D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-A4-A57E-10A-01D-A26P-10_wgs_Illumina,TCGA-A4-A57E-10A-01D-A26P-10_wgs_Illumina.bam,17,NA,0.07,58cfa82fe4b0c9d6adf6b9e4,TCGA-A4-A57E-10A-01D-A26P-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-A4-A57E-10A,D80F601B-1064-4FF0-9C51-7F6AFB22D1F5,Blood Derived Normal,Illumina HiSeq,37ba01c7-fb53-47b4-a6c4-9316573e26ac,Kidney,59,F14C9EE4-CF2B-481F-8D1E-998509FDA820,C57AD711-A7D0-472F-ADF1-7AB186DA971B,TCGA-A4-A57E-10A-01D-A26P-10,GRCh37-lite,TCGA-A4-A57E,TCGA-KIRP,NA,s11765,Baylor College of Medicine,International Genomics Consortium,United States,NO,T2a,N0,Kidney Papillary Renal Cell Carcinoma,Stage IV
13722.58cfa82ee4b0c9d6adf6ab92,58cfa82ee4b0c9d6adf6ab92,G25790.TCGA-50-5066-01A-01D-1625-08.2.filtered.,WGS,G25790.TCGA-50-5066-01A-01D-1625-08.2,G25790.TCGA-50-5066-01A-01D-1625-08.2.bam,1182.7,1.9,0.05,58cfa82ee4b0c9d6adf6ab92,G25790.TCGA-50-5066-01A-01D-1625-08.2.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-5066-01A,3199CFE5-3BE3-43CD-A36B-5CF2C7A9929F,Primary Tumor,Illumina HiSeq,a9a4ae39-4e53-45e6-b9c0-2df2afca64ee,Lung,72,478CC306-6AEE-4597-8834-1E5CF8B05A59,F5A97315-1906-4774-980E-0879C6AD368E,TCGA-50-5066-01A-01D-1625-08,HG19_Broad_variant,TCGA-50-5066,TCGA-LUAD,NA,s10894,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB
13722.58cfa830e4b0c9d6adf6c020,58cfa830e4b0c9d6adf6c020,TCGA-B1-A47O-01A-11D-A25F-10_wgs_Illumina.filtered.,WGS,TCGA-B1-A47O-01A-11D-A25F-10_wgs_Illumina,TCGA-B1-A47O-01A-11D-A25F-10_wgs_Illumina.bam,16.46,NA,0.09,58cfa830e4b0c9d6adf6c020,TCGA-B1-A47O-01A-11D-A25F-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B1-A47O-01A,6A6C1569-1045-4ED3-ACDB-5C45E47614CA,Primary Tumor,Illumina HiSeq,3b1d3bea-7b97-415b-ad61-4c84d3bd88e2,Kidney,54,EBADE9FD-DCE5-4EC9-A483-9F165823D9B6,CA2B9FE2-97E0-4D4F-AFD7-A5ACF638800F,TCGA-B1-A47O-01A-11D-A25F-10,GRCh37-lite,TCGA-B1-A47O,TCGA-KIRP,NA,s11768,Baylor College of Medicine,University of Pittsburgh,United States,NO,T1b,N0,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6c13e,58cfa830e4b0c9d6adf6c13e,TCGA-B9-A44B-01A-11D-A25F-10_wgs_Illumina.filtered.,WGS,TCGA-B9-A44B-01A-11D-A25F-10_wgs_Illumina,TCGA-B9-A44B-01A-11D-A25F-10_wgs_Illumina.bam,19.16,NA,0.08,58cfa830e4b0c9d6adf6c13e,TCGA-B9-A44B-01A-11D-A25F-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B9-A44B-01A,B809C2F2-185C-496A-A1D4-589294443A1D,Primary Tumor,Illumina HiSeq,148c4a68-bab6-4ff6-bcd7-fc69c33bea94,Kidney,70,07C08E8F-4DCA-42E4-9954-C62C32FED225,88E35D25-D98D-4576-8EBE-1CD74010ECD8,TCGA-B9-A44B-01A-11D-A25F-10,GRCh37-lite,TCGA-B9-A44B,TCGA-KIRP,NA,s11860,Baylor College of Medicine,UNC,United States,NO,T3b,NX,Kidney Papillary Renal Cell Carcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6aa82,58cfa82ee4b0c9d6adf6aa82,G25781.TCGA-50-6597-01A-11D-1855-08.4.filtered.,WGS,G25781.TCGA-50-6597-01A-11D-1855-08.4,G25781.TCGA-50-6597-01A-11D-1855-08.4.bam,12.7,1.9,0.05,58cfa82ee4b0c9d6adf6aa82,G25781.TCGA-50-6597-01A-11D-1855-08.4.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-50-6597-01A,0D66BF6C-EED0-4726-BD5B-3BF6D610B4E0,Primary Tumor,Illumina HiSeq,0e48684b-e0b4-4625-9f32-7e0331dfcefe,Lung,79,C5363830-3DB9-4C0C-AA47-B32FDC888C60,CD0AEED5-93A1-4287-8A88-FE6B7B5E3983,TCGA-50-6597-01A-11D-1855-08,HG19_Broad_variant,TCGA-50-6597,TCGA-LUAD,NA,s11110,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa830e4b0c9d6adf6bc0e,58cfa830e4b0c9d6adf6bc0e,TCGA-AG-4008-01A-01D-1989-10_wgs_Illumina.filtered.,WGS,TCGA-AG-4008-01A-01D-1989-10_wgs_Illumina,TCGA-AG-4008-01A-01D-1989-10_wgs_Illumina.bam,624.89,1.9,0.14,58cfa830e4b0c9d6adf6bc0e,TCGA-AG-4008-01A-01D-1989-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,Aligned reads,TCGA-AG-4008-01A,72802851-9340-4C5F-A90B-23B7AFD7577A,Primary Tumor,Illumina HiSeq,673cc168-5c3a-4eec-b299-8de319725cc6,Colorectal,63,D803F092-3340-485D-9964-D6554D210E2E,428C100F-D7D0-4860-A8FC-2BAE6A4BBA95,TCGA-AG-4008-01A-01D-1989-10,GRCh37-lite,TCGA-AG-4008,TCGA-READ,NA,s1990,Baylor College of Medicine,Indivumed,Germany,NO,T3,N0,Rectal Adenocarcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6c79a,58cfa831e4b0c9d6adf6c79a,TCGA-CV-7255-01A-11D-2276-10_Illumina.filtered.,WGS,TCGA-CV-7255-01A-11D-2276-10_Illumina,TCGA-CV-7255-01A-11D-2276-10_Illumina.bam,143.73,NA,0.05,58cfa831e4b0c9d6adf6c79a,TCGA-CV-7255-01A-11D-2276-10_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7255-01A,534F85F2-B9EB-45BE-87D5-C3DFFD13D541,Primary Tumor,Illumina HiSeq,7f307e2b-3164-4bb0-aa04-90c538b8bb46,Head and Neck,32,45A42060-1F1C-45FF-9717-9BE2F7FDF3F7,1AFF91A6-1B0F-4575-8F4B-4E064A50B886,TCGA-CV-7255-01A-11D-2276-10,GRCh37-lite,TCGA-CV-7255,TCGA-HNSC,64,s16051,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa831e4b0c9d6adf6ccb4,58cfa831e4b0c9d6adf6ccb4,TCGA-EI-6917-01A-11D-1924-10_wgs_Illumina.filtered.,WGS,TCGA-EI-6917-01A-11D-1924-10_wgs_Illumina,TCGA-EI-6917-01A-11D-1924-10_wgs_Illumina.bam,325,1.9,0.05,58cfa831e4b0c9d6adf6ccb4,TCGA-EI-6917-01A-11D-1924-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,Aligned reads,TCGA-EI-6917-01A,0CB21FB0-520F-4105-99EC-697A335115B5,Primary Tumor,Illumina HiSeq,e00d5548-a577-4019-9f7c-5bad23811d4e,Colorectal,33,37BB8CE7-6C55-4237-A7AD-ADC42E6FF6A8,8853CBEE-7931-49A6-B063-A806943A10AD,TCGA-EI-6917-01A-11D-1924-10,GRCh37-lite,TCGA-EI-6917,TCGA-READ,NA,s2011,Baylor College of Medicine,Greater Poland Cancer Center,Poland,NO,T3,N1,Rectal Adenocarcinoma,Stage IIIA
13722.58cfa82ee4b0c9d6adf6ab5e,58cfa82ee4b0c9d6adf6ab5e,G25785.TCGA-78-7143-01A-11D-2036-08.1.filtered.,WGS,G25785.TCGA-78-7143-01A-11D-2036-08.1,G25785.TCGA-78-7143-01A-11D-2036-08.1.bam,405.7,NA,0.05,58cfa82ee4b0c9d6adf6ab5e,G25785.TCGA-78-7143-01A-11D-2036-08.1.bam,Dead,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-78-7143-01A,54254F5A-50E8-4150-A9B7-56A0470D2A56,Primary Tumor,Illumina HiSeq,d0505bbf-c663-484b-93b6-a129883be59b,Lung,62,EE72F78D-E5DB-4C99-9034-0B5BBF6DF849,B710996C-8D35-4A2C-BC51-389B3E35B0F3,TCGA-78-7143-01A-11D-2036-08,HG19_Broad_variant,TCGA-78-7143,TCGA-LUAD,4961,s11107,Broad Institute of MIT and Harvard,Prince Charles Hospital,Australia,NO,T2,N0,Lung Bronchioloalveolar Carcinoma Nonmucinous,Stage IB
13722.58cfa82ee4b0c9d6adf6a7bc,58cfa82ee4b0c9d6adf6a7bc,G2046.TCGA-13-0725-01A-01D.6.filtered.,WGS,G2046.TCGA-13-0725-01A-01D.6,G2046.TCGA-13-0725-01A-01D.6.bam,200.64,1.9,0.17,58cfa82ee4b0c9d6adf6a7bc,G2046.TCGA-13-0725-01A-01D.6.bam,Dead,FEMALE,WHITE,HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0725-01A,446CE2A3-D328-443C-A419-3344BAAD0E16,Primary Tumor,Illumina GA,1488e278-25b8-47aa-99ec-71a851744b5c,Ovary,44,4A52777F-E23F-49F8-B853-BE84B9A74BDA,BEFA4CAE-378E-4502-8C0B-399D8FA083D9,TCGA-13-0725-01A-01D-0465-08,HG19_Broad_variant,TCGA-13-0725,TCGA-OV,377,s17113,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ad41,58cfa82ee4b0c9d6adf6ad41,G49837.TCGA-52-7812-01A-11D-A320-08.3.filtered.,WGS,G49837.TCGA-52-7812-01A-11D-A320-08.3,G49837.TCGA-52-7812-01A-11D-A320-08.3.bam,402,NA,0.08,58cfa82ee4b0c9d6adf6ad41,G49837.TCGA-52-7812-01A-11D-A320-08.3.bam,Dead,MALE,WHITE,HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-52-7812-01A,81B7CBC1-C037-426F-95B0-D729A30697DA,Primary Tumor,Illumina HiSeq,7beb10bf-82e5-4496-80a3-2e212fece28a,Lung,68,75384E41-370E-4972-870C-2845FB4DED2F,2FE2433B-9A55-431F-A869-2B5A63E8E8FC,TCGA-52-7812-01A-11D-A320-08,HG19_Broad_variant,TCGA-52-7812,TCGA-LUSC,835,s10258,Broad Institute of MIT and Harvard,University of Miami,United States,NO,T2,N2,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa82ee4b0c9d6adf6ae94,58cfa82ee4b0c9d6adf6ae94,G49538.TCGA-06-0125-02A-11D-2280-08.2.filtered.,WGS,G49538.TCGA-06-0125-02A-11D-2280-08.2,G49538.TCGA-06-0125-02A-11D-2280-08.2.bam,3.06,1.9,0.05,58cfa82ee4b0c9d6adf6ae94,G49538.TCGA-06-0125-02A-11D-2280-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0125-02A,8DA3103E-3E6C-4176-A583-D5FE5E60601E,Recurrent Tumor,Illumina HiSeq,2ff37906-c3cc-463a-90dc-10485903705d,Brain,63,2452D88C-350B-4F54-96B8-B273A0706741,96E3DB14-2BB1-4F68-AED6-5E794750C96E,TCGA-06-0125-02A-11D-2280-08,HG19_Broad_variant,TCGA-06-0125,TCGA-GBM,1448,s14061,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6af6c,58cfa82ee4b0c9d6adf6af6c,G48125.TCGA-13-0906-01A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-13-0906-01A-01D-A312-08.2,G48125.TCGA-13-0906-01A-01D-A312-08.2.bam,35.67,1.9,0.08,58cfa82ee4b0c9d6adf6af6c,G48125.TCGA-13-0906-01A-01D-A312-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0906-01A,E43D3769-E25F-4FB7-9080-EA26DEFAF094,Primary Tumor,Illumina HiSeq,aee22c2b-6ab3-4982-b343-b10b89c4b98b,Ovary,50,A0C48680-3CAF-49BD-B495-C9FD3A9CBE76,42AF8F74-FD4B-486D-BC11-DB53CC471D62,TCGA-13-0906-01A-01D-A312-08,HG19_Broad_variant,TCGA-13-0906,TCGA-OV,NA,s17760,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ad3a,58cfa82ee4b0c9d6adf6ad3a,G49537.TCGA-BJ-A0ZB-01A-11D-A10S-08.1.filtered.,WGS,G49537.TCGA-BJ-A0ZB-01A-11D-A10S-08.1,G49537.TCGA-BJ-A0ZB-01A-11D-A10S-08.1.bam,79.63,2,0.08,58cfa82ee4b0c9d6adf6ad3a,G49537.TCGA-BJ-A0ZB-01A-11D-A10S-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A0ZB-01A,DC4D8468-6F34-40CB-A826-8D582CD86FDE,Primary Tumor,Illumina HiSeq,da7e540d-041b-4d8e-9158-52775a1aad5f,Thyroid,66,145A474E-D262-468A-8DB7-EE9F1B7CE0A7,ADD0B0F6-B4A8-4B73-B634-C3600DC567D5,TCGA-BJ-A0ZB-01A-11D-A10S-08,HG19_Broad_variant,TCGA-BJ-A0ZB,TCGA-THCA,NA,s12221,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA
13722.58cfa82ee4b0c9d6adf6ac97,58cfa82ee4b0c9d6adf6ac97,G48125.TCGA-13-1487-01A-01D-A312-08.2.filtered.,WGS,G48125.TCGA-13-1487-01A-01D-A312-08.2,G48125.TCGA-13-1487-01A-01D-A312-08.2.bam,298.97,1.9,0.07,58cfa82ee4b0c9d6adf6ac97,G48125.TCGA-13-1487-01A-01D-A312-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-1487-01A,C9E28934-8379-4511-817C-D787F2C4CA3A,Primary Tumor,Illumina HiSeq,3ce95963-7650-4fe7-9cbc-554ee9d56aa7,Ovary,74,BFF12F06-DABC-4424-AC53-65CA01D0A406,44EEBC04-C027-45AE-BECA-C4012B494F29,TCGA-13-1487-01A-01D-A312-08,HG19_Broad_variant,TCGA-13-1487,TCGA-OV,681,s17280,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b5fe,58cfa82fe4b0c9d6adf6b5fe,TCGA-36-1574-01A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-36-1574-01A-01D-A324-10_wgs_Illumina,TCGA-36-1574-01A-01D-A324-10_wgs_Illumina.bam,475.97,1.9,0.08,58cfa82fe4b0c9d6adf6b5fe,TCGA-36-1574-01A-01D-A324-10_wgs_Illumina.bam,Alive,FEMALE,ASIAN,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-36-1574-01A,EEB9D147-608D-4692-8ADF-2F601D23A8FF,Primary Tumor,Illumina HiSeq,e3ba53fc-a70c-4bd4-8dc4-60969af737fa,Ovary,48,353B6C00-EBFE-4650-8379-F46C8FE3E9CF,80F02AEC-C07A-4BCB-B547-E60F8C33A7B1,TCGA-36-1574-01A-01D-A324-10,GRCh37-lite,TCGA-36-1574,TCGA-OV,NA,s17538,Baylor College of Medicine,BC Cancer Agency,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ad47,58cfa82ee4b0c9d6adf6ad47,G49837.TCGA-68-7755-01A-11D-A320-08.2.filtered.,WGS,G49837.TCGA-68-7755-01A-11D-A320-08.2,G49837.TCGA-68-7755-01A-11D-A320-08.2.bam,35,NA,0.08,58cfa82ee4b0c9d6adf6ad47,G49837.TCGA-68-7755-01A-11D-A320-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-68-7755-01A,3666BC65-8E40-409E-9A1F-41583DD6D978,Primary Tumor,Illumina HiSeq,2a201b20-3b01-4291-9e87-443bfb483c69,Lung,60,87D21E55-7F4A-4652-B7F7-1E64CB300FAE,84E601B7-DFA5-4CD5-9FEF-07F03967A0D4,TCGA-68-7755-01A-11D-A320-08,HG19_Broad_variant,TCGA-68-7755,TCGA-LUSC,NA,s10372,Broad Institute of MIT and Harvard,Washington University - Cleveland Clinic,United States,NO,T1b,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa82ee4b0c9d6adf6aeea,58cfa82ee4b0c9d6adf6aeea,G49537.TCGA-EM-A3FR-01A-11D-A21Z-08.1.filtered.,WGS,G49537.TCGA-EM-A3FR-01A-11D-A21Z-08.1,G49537.TCGA-EM-A3FR-01A-11D-A21Z-08.1.bam,45.93,NA,0.08,58cfa82ee4b0c9d6adf6aeea,G49537.TCGA-EM-A3FR-01A-11D-A21Z-08.1.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3FR-01A,2B84CFBC-7CF6-4CB1-A1E3-BA85DAFB89F4,Primary Tumor,Illumina HiSeq,edb95f67-9483-47e8-9b1f-0aad36f1a1ac,Thyroid,55,319E3498-D5FB-4142-A09F-ABA779DBC094,4BAE2F08-DA75-4991-ACB8-5BA9912F9131,TCGA-EM-A3FR-01A-11D-A21Z-08,HG19_Broad_variant,TCGA-EM-A3FR,TCGA-THCA,NA,s11983,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III
13722.58cfa82ee4b0c9d6adf6ae8a,58cfa82ee4b0c9d6adf6ae8a,G49537.TCGA-L6-A4ET-01A-11D-A257-08.2.filtered.,WGS,G49537.TCGA-L6-A4ET-01A-11D-A257-08.2,G49537.TCGA-L6-A4ET-01A-11D-A257-08.2.bam,42.4,NA,0.08,58cfa82ee4b0c9d6adf6ae8a,G49537.TCGA-L6-A4ET-01A-11D-A257-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-L6-A4ET-01A,E1FF7694-64E1-47ED-B0D8-34ACFB4FFEF1,Primary Tumor,Illumina HiSeq,1e492402-4405-430b-a336-e8043ef159c8,Thyroid,49,D6183BCA-9A4D-41AC-940D-0EAA23DECF56,546B97B0-AB82-42A1-BBD2-241523278EC3,TCGA-L6-A4ET-01A-11D-A257-08,HG19_Broad_variant,TCGA-L6-A4ET,TCGA-THCA,NA,s12743,Broad Institute of MIT and Harvard,National Institutes of Health,United States,NO,T3,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage IVC
13722.58cfa82ee4b0c9d6adf6a9de,58cfa82ee4b0c9d6adf6a9de,G25782.TCGA-55-6982-01A-11D-1945-08.2.filtered.,WGS,G25782.TCGA-55-6982-01A-11D-1945-08.2,G25782.TCGA-55-6982-01A-11D-1945-08.2.bam,86.7,NA,0.05,58cfa82ee4b0c9d6adf6a9de,G25782.TCGA-55-6982-01A-11D-1945-08.2.bam,Dead,FEMALE,WHITE,Not available,Lung Adenocarcinoma,Aligned reads,TCGA-55-6982-01A,35CB7841-9B09-465A-90C5-E3B8A9FAAD49,Primary Tumor,Illumina HiSeq,c6027d22-f05d-42e4-a467-de21b4606751,Lung,79,3B284FC6-7DC4-46C2-8EC9-1121EF0B4308,B7F11036-7AC4-41BC-A9A4-64162725FDFC,TCGA-55-6982-01A-11D-1945-08,HG19_Broad_variant,TCGA-55-6982,TCGA-LUAD,995,s11109,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82de4b0c9d6adf6a74c,58cfa82de4b0c9d6adf6a74c,G14084.TCGA-22-1016-01A-01D-1521-08.3.filtered.,WGS,G14084.TCGA-22-1016-01A-01D-1521-08.3,G14084.TCGA-22-1016-01A-01D-1521-08.3.bam,313,1.9,0.05,58cfa82de4b0c9d6adf6a74c,G14084.TCGA-22-1016-01A-01D-1521-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-22-1016-01A,037C57D1-B4A5-45DC-BDA4-0550461D321B,Primary Tumor,Illumina HiSeq,ec4da199-1467-4435-944a-7558f9ffd8ea,Lung,65,DDB395E5-4B12-4610-9755-01E444B35C2E,935B113E-F5ED-4A07-8E1D-1603DABA7F40,TCGA-22-1016-01A-01D-1521-08,HG19_Broad_variant,TCGA-22-1016,TCGA-LUSC,822,s9974,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,United States,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa830e4b0c9d6adf6bcfc,58cfa830e4b0c9d6adf6bcfc,TCGA-AD-6964-01A-11D-1924-10_wgs_Illumina.filtered.,WGS,TCGA-AD-6964-01A-11D-1924-10_wgs_Illumina,TCGA-AD-6964-01A-11D-1924-10_wgs_Illumina.bam,177.7,NA,0.05,58cfa830e4b0c9d6adf6bcfc,TCGA-AD-6964-01A-11D-1924-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AD-6964-01A,5E7074A6-5011-4DC5-950C-41365DBC6D09,Primary Tumor,Illumina HiSeq,67abf892-45e8-4468-a1fd-8446401b3f55,Colorectal,58,4D16E41A-B100-4080-A759-1F62E54C1C91,42D20028-0DDC-4DAC-9F05-D674F8915F21,TCGA-AD-6964-01A-11D-1924-10,GRCh37-lite,TCGA-AD-6964,TCGA-COAD,NA,s13536,Baylor College of Medicine,International Genomics Consortium,United States,NO,T4a,N2b,Colon Adenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ac75,58cfa82ee4b0c9d6adf6ac75,G47088.TCGA-21-5782-01A-01D-1632-08.1.filtered.,WGS,G47088.TCGA-21-5782-01A-01D-1632-08.1,G47088.TCGA-21-5782-01A-01D-1632-08.1.bam,384.7,1.9,0.05,58cfa82ee4b0c9d6adf6ac75,G47088.TCGA-21-5782-01A-01D-1632-08.1.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-21-5782-01A,E21964B8-47C7-4A5F-BFA7-7206222883D2,Primary Tumor,Illumina HiSeq,80a5fd2e-393b-43b1-9bbd-0e02bd6053a2,Lung,68,9ABF3A20-B34D-429B-9C13-0468DFC20700,4C2AD4A0-5D57-4E27-9F35-058B2F205F50,TCGA-21-5782-01A-01D-1632-08,HG19_Broad_variant,TCGA-21-5782,TCGA-LUSC,962,s10362,Broad Institute of MIT and Harvard,Fox Chase Cancer Center,United States,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6ad2a,58cfa82ee4b0c9d6adf6ad2a,G49538.TCGA-19-1389-02A-21D-A32W-08.1.filtered.,WGS,G49538.TCGA-19-1389-02A-21D-A32W-08.1,G49538.TCGA-19-1389-02A-21D-A32W-08.1.bam,7.36,NA,0.08,58cfa82ee4b0c9d6adf6ad2a,G49538.TCGA-19-1389-02A-21D-A32W-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-19-1389-02A,309005A2-93A8-4566-B8D3-6B9310144266,Recurrent Tumor,Illumina HiSeq,5120b191-e1bb-49c6-9f87-858a75e3a730,Brain,51,2FFC8824-9340-4D4A-B9DA-9EA56D766CDE,82D7FA2D-19CD-41B7-8ED1-EA9FB9A544C6,TCGA-19-1389-02A-21D-A32W-08,HG19_Broad_variant,TCGA-19-1389,TCGA-GBM,141,s14222,Broad Institute of MIT and Harvard,Case Western,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6ad9a,58cfa82ee4b0c9d6adf6ad9a,G49837.TCGA-96-7545-01A-21D-A320-08.2.filtered.,WGS,G49837.TCGA-96-7545-01A-21D-A320-08.2,G49837.TCGA-96-7545-01A-21D-A320-08.2.bam,100,NA,0.08,58cfa82ee4b0c9d6adf6ad9a,G49837.TCGA-96-7545-01A-21D-A320-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-96-7545-01A,4CA13C92-84B4-4EDF-842A-B20B7E713415,Primary Tumor,Illumina HiSeq,dadefdff-15a7-4c69-8436-344e649bc017,Lung,73,59F2654E-7F41-480B-B59C-F0DB373B7160,B7A7D93B-38A7-4FC3-A433-3BB0A8CB7C42,TCGA-96-7545-01A-21D-A320-08,HG19_Broad_variant,TCGA-96-7545,TCGA-LUSC,NA,s10084,Broad Institute of MIT and Harvard,Washington University - NYU,United States,NO,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6aa28,58cfa82ee4b0c9d6adf6aa28,G2144.TCGA-06-0145-01A-01D.13.filtered.,WGS,G2144.TCGA-06-0145-01A-01D.13,G2144.TCGA-06-0145-01A-01D.13.bam,386.67,1.89,0.15,58cfa82ee4b0c9d6adf6aa28,G2144.TCGA-06-0145-01A-01D.13.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0145-01A,3258CB3B-F63B-463C-B2E4-D638149157C5,Primary Tumor,Illumina GA,e271b72c-97e8-44bd-b046-b7ff84eaa806,Brain,53,24ABC0F5-F40F-4A74-8968-88CA574E3F03,ECE0F3A4-A204-4C52-BB1F-88D44A875B2E,TCGA-06-0145-01A-01D-0507-08,HG19_Broad_variant,TCGA-06-0145,TCGA-GBM,71,s14137,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6a812,58cfa82ee4b0c9d6adf6a812,G2144.TCGA-06-0145-10A-01D.12.filtered.,WGS,G2144.TCGA-06-0145-10A-01D.12,G2144.TCGA-06-0145-10A-01D.12.bam,259.67,1.9,0.15,58cfa82ee4b0c9d6adf6a812,G2144.TCGA-06-0145-10A-01D.12.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0145-10A,3258CB3B-F63B-463C-B2E4-D638149157C5,Blood Derived Normal,Illumina GA,f914936d-6a0e-409c-b8e2-fee674db0986,Brain,53,2DE505D9-5BAF-43C5-A541-496A6BE40FAE,0C700657-B0B8-4361-9F89-B89A6C7B262D,TCGA-06-0145-10A-01D-0507-08,HG19_Broad_variant,TCGA-06-0145,TCGA-GBM,71,s14057,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6adda,58cfa82ee4b0c9d6adf6adda,G49837.TCGA-18-3415-01A-01D-A320-08.2.filtered.,WGS,G49837.TCGA-18-3415-01A-01D-A320-08.2,G49837.TCGA-18-3415-01A-01D-A320-08.2.bam,369.94,1.9,0.08,58cfa82ee4b0c9d6adf6adda,G49837.TCGA-18-3415-01A-01D-A320-08.2.bam,Alive,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-18-3415-01A,9A874B64-D0D6-416E-97BC-E9071ED0B16B,Primary Tumor,Illumina HiSeq,c83a2887-3d9e-4a59-9e29-39e05ea6378b,Lung,77,23327C39-2E21-4604-9EBA-15884AE356FC,34881C6B-F59F-42C0-9F29-9C5C47262AE6,TCGA-18-3415-01A-01D-A320-08,HG19_Broad_variant,TCGA-18-3415,TCGA-LUSC,NA,s10080,Broad Institute of MIT and Harvard,Princess Margaret Hospital (Canada),Canada,NO,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB
13722.58cfa82ee4b0c9d6adf6a7c7,58cfa82ee4b0c9d6adf6a7c7,G2046.TCGA-13-0725-10B-01D.6.filtered.,WGS,G2046.TCGA-13-0725-10B-01D.6,G2046.TCGA-13-0725-10B-01D.6.bam,50,1.9,0.16,58cfa82ee4b0c9d6adf6a7c7,G2046.TCGA-13-0725-10B-01D.6.bam,Dead,FEMALE,WHITE,HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-13-0725-10B,446CE2A3-D328-443C-A419-3344BAAD0E16,Blood Derived Normal,Illumina GA,85bbed46-b4aa-4239-973c-d40dd5e678de,Ovary,44,2C0AE09E-F422-4986-9E45-CFE13C5EE3DE,AFB81FE3-F799-4E7D-BF02-D7735EF9EB23,TCGA-13-0725-10B-01D-0446-08,HG19_Broad_variant,TCGA-13-0725,TCGA-OV,377,s17479,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6af2a,58cfa82ee4b0c9d6adf6af2a,G39020.TCGA-HU-8608-01A-11D-2394-08.2.filtered.,WGS,G39020.TCGA-HU-8608-01A-11D-2394-08.2,G39020.TCGA-HU-8608-01A-11D-2394-08.2.bam,200,NA,0.05,58cfa82ee4b0c9d6adf6af2a,G39020.TCGA-HU-8608-01A-11D-2394-08.2.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-HU-8608-01A,C6316FB5-99A7-4ADF-832F-DCE44DDCD3AA,Primary Tumor,Illumina HiSeq,58876087-e158-4469-af68-c91fe264ca8e,Stomach,70,E70FE3AD-F9FA-4097-B472-86606C241D26,A2EE5DDE-4342-4E78-88C5-3C9A8E10CBF5,TCGA-HU-8608-01A-11D-2394-08,HG19_Broad_variant,TCGA-HU-8608,TCGA-STAD,NA,s15298,Broad Institute of MIT and Harvard,National Cancer Center Korea,Korea South,NO,T4a,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIB
13722.58cfa830e4b0c9d6adf6bad6,58cfa830e4b0c9d6adf6bad6,TCGA-A6-6141-01A-11D-1771-10_wgs_Illumina.filtered.,WGS,TCGA-A6-6141-01A-11D-1771-10_wgs_Illumina,TCGA-A6-6141-01A-11D-1771-10_wgs_Illumina.bam,315.4,1.9,0.05,58cfa830e4b0c9d6adf6bad6,TCGA-A6-6141-01A-11D-1771-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-6141-01A,58FACEDB-FCB8-4ECF-8338-2BFA4947ACEF,Primary Tumor,Illumina HiSeq,6fd83764-dbd4-43ec-bab9-c2950c46cf59,Colorectal,31,D67FC406-7974-433E-896D-57197ECED52B,00AA769D-622C-433E-8A8A-63FB5C41EA42,TCGA-A6-6141-01A-11D-1771-10,GRCh37-lite,TCGA-A6-6141,TCGA-COAD,NA,s13355,Baylor College of Medicine,Christiana Healthcare,United States,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6c456,58cfa831e4b0c9d6adf6c456,TCGA-CA-6717-01A-11D-1835-10_wgs_Illumina.filtered.,WGS,TCGA-CA-6717-01A-11D-1835-10_wgs_Illumina,TCGA-CA-6717-01A-11D-1835-10_wgs_Illumina.bam,201,1.9,0.05,58cfa831e4b0c9d6adf6c456,TCGA-CA-6717-01A-11D-1835-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-CA-6717-01A,268C01B3-D2CE-44C0-A2FE-EA846A1253CC,Primary Tumor,Illumina HiSeq,da552d40-23e1-469c-9fe7-ff2904a35ebe,Colorectal,57,D412011F-061C-43D6-8FA7-F917DA658AFF,2DF02F2B-9F1C-4249-B3B4-B03079CD97D9,TCGA-CA-6717-01A-11D-1835-10,GRCh37-lite,TCGA-CA-6717,TCGA-COAD,NA,s13038,Baylor College of Medicine,ILSbio,Vietnam,NO,T3,N0,Colon Mucinous Adenocarcinoma,Stage IIA
13722.58cfa82fe4b0c9d6adf6b920,58cfa82fe4b0c9d6adf6b920,TCGA-A4-A48D-01A-11D-A25F-10_wgs_Illumina.filtered.,WGS,TCGA-A4-A48D-01A-11D-A25F-10_wgs_Illumina,TCGA-A4-A48D-01A-11D-A25F-10_wgs_Illumina.bam,21,NA,0.08,58cfa82fe4b0c9d6adf6b920,TCGA-A4-A48D-01A-11D-A25F-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-A4-A48D-01A,925AE8FF-3200-4564-BE76-94DB0984B027,Primary Tumor,Illumina HiSeq,ca65f407-1de9-4171-8ae5-67e4d85f5beb,Kidney,84,4DDC37D4-35B8-4A5D-BBF1-6DBF0548852B,5ECC88F7-8391-4168-AF11-07A6BF9B3652,TCGA-A4-A48D-01A-11D-A25F-10,GRCh37-lite,TCGA-A4-A48D,TCGA-KIRP,NA,s11850,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1b,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ae8d,58cfa82ee4b0c9d6adf6ae8d,G49538.TCGA-06-0171-02A-11D-2280-08.2.filtered.,WGS,G49538.TCGA-06-0171-02A-11D-2280-08.2,G49538.TCGA-06-0171-02A-11D-2280-08.2.bam,46.06,1.9,0.05,58cfa82ee4b0c9d6adf6ae8d,G49538.TCGA-06-0171-02A-11D-2280-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0171-02A,01A92062-967A-4900-8DC7-A5ECD3B3F8E2,Recurrent Tumor,Illumina HiSeq,8e403d99-1eb2-445f-9ebd-af4dde907b49,Brain,65,87F7C7D4-533A-401D-ACA4-5E36EE815109,39520BE3-A2AF-4189-ACF4-9D239363333A,TCGA-06-0171-02A-11D-2280-08,HG19_Broad_variant,TCGA-06-0171,TCGA-GBM,399,s14309,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6aed4,58cfa82ee4b0c9d6adf6aed4,G49537.TCGA-EM-A2CP-01A-11D-A17V-08.1.filtered.,WGS,G49537.TCGA-EM-A2CP-01A-11D-A17V-08.1,G49537.TCGA-EM-A2CP-01A-11D-A17V-08.1.bam,53.65,NA,0.07,58cfa82ee4b0c9d6adf6aed4,G49537.TCGA-EM-A2CP-01A-11D-A17V-08.1.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A2CP-01A,2F59F12D-CA0C-4AC6-9718-98A6D455AF46,Primary Tumor,Illumina HiSeq,3bca46e2-dbce-4b1c-8aec-37cc8615d471,Thyroid,26,043765F1-FFBD-4AC9-B0AE-733C3643083D,B8CD6882-BE27-4742-BC63-3227D31BF704,TCGA-EM-A2CP-01A-11D-A17V-08,HG19_Broad_variant,TCGA-EM-A2CP,TCGA-THCA,NA,s12095,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa82ee4b0c9d6adf6af68,58cfa82ee4b0c9d6adf6af68,G47088.TCGA-22-5492-01A-01D-1632-08.1.filtered.,WGS,G47088.TCGA-22-5492-01A-01D-1632-08.1,G47088.TCGA-22-5492-01A-01D-1632-08.1.bam,871.7,1.9,0.05,58cfa82ee4b0c9d6adf6af68,G47088.TCGA-22-5492-01A-01D-1632-08.1.bam,Dead,FEMALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-22-5492-01A,422A46B2-A67C-4A7E-923F-9B651CED96F8,Primary Tumor,Illumina HiSeq,ee7c69ad-64c9-44bd-8856-35ef192a2b61,Lung,73,8A0B8A54-D4F7-4911-A692-6731D089EBA2,ABC94013-71F5-4AC6-88A4-01B4EF9F9D2F,TCGA-22-5492-01A-01D-1632-08,HG19_Broad_variant,TCGA-22-5492,TCGA-LUSC,506,s10253,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,United States,NO,T2a,N2,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIA
13722.58cfa82ee4b0c9d6adf6af78,58cfa82ee4b0c9d6adf6af78,G39020.TCGA-EQ-5647-01A-01D-1600-08.2.filtered.,WGS,G39020.TCGA-EQ-5647-01A-01D-1600-08.2,G39020.TCGA-EQ-5647-01A-01D-1600-08.2.bam,255.7,1.87,0.05,58cfa82ee4b0c9d6adf6af78,G39020.TCGA-EQ-5647-01A-01D-1600-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-EQ-5647-01A,2D291FA3-F0FD-4BC1-91A6-783863714190,Primary Tumor,Illumina HiSeq,c688688d-4440-4ff2-b58b-0b2fcf8591f7,Stomach,86,400FED84-FE61-4F7A-9DCC-6C32131106CD,FECCEE20-A62D-4152-B832-B9FDACA87A61,TCGA-EQ-5647-01A-01D-1600-08,HG19_Broad_variant,TCGA-EQ-5647,TCGA-STAD,19,s15040,Broad Institute of MIT and Harvard,Christiana Healthcare,United States,NO,T4,N3,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV
13722.58cfa82ee4b0c9d6adf6ad00,58cfa82ee4b0c9d6adf6ad00,G49537.TCGA-E8-A418-01A-11D-A23M-08.1.filtered.,WGS,G49537.TCGA-E8-A418-01A-11D-A23M-08.1,G49537.TCGA-E8-A418-01A-11D-A23M-08.1.bam,30.97,NA,0.08,58cfa82ee4b0c9d6adf6ad00,G49537.TCGA-E8-A418-01A-11D-A23M-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-E8-A418-01A,EBBD54AD-7B97-4081-AD11-7F7F3CE74EEF,Primary Tumor,Illumina HiSeq,dcbb2120-b24f-4bc5-a07f-706d58345c05,Thyroid,75,979CBB75-28D9-4D33-8083-077C25BDDFD6,63EA274B-D42B-4787-9C54-8EE95EA376EC,TCGA-E8-A418-01A-11D-A23M-08,HG19_Broad_variant,TCGA-E8-A418,TCGA-THCA,NA,s12088,Broad Institute of MIT and Harvard,Asterand,Russia,NO,T4a,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA
13722.58cfa82ee4b0c9d6adf6ae16,58cfa82ee4b0c9d6adf6ae16,G49837.TCGA-94-7943-01A-11D-A320-08.2.filtered.,WGS,G49837.TCGA-94-7943-01A-11D-A320-08.2,G49837.TCGA-94-7943-01A-11D-A320-08.2.bam,203,NA,0.08,58cfa82ee4b0c9d6adf6ae16,G49837.TCGA-94-7943-01A-11D-A320-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-94-7943-01A,AECF85CC-058C-46F3-9CDC-3573AC3B8438,Primary Tumor,Illumina HiSeq,f0eef218-f0af-4e9d-8f67-cdfc840480bc,Lung,80,E447DA47-227D-4956-9F46-AD1F81B73EBA,7731EF7F-25BD-42F5-9A20-BE249306A711,TCGA-94-7943-01A-11D-A320-08,HG19_Broad_variant,TCGA-94-7943,TCGA-LUSC,NA,s10509,Broad Institute of MIT and Harvard,Washington University - Emory,United States,NO,T1b,NX,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa831e4b0c9d6adf6c630,58cfa831e4b0c9d6adf6c630,TCGA-CN-4737-01A-01D-2266-10_Illumina.filtered.,WGS,TCGA-CN-4737-01A-01D-2266-10_Illumina,TCGA-CN-4737-01A-01D-2266-10_Illumina.bam,142,1.9,0.05,58cfa831e4b0c9d6adf6c630,TCGA-CN-4737-01A-01D-2266-10_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-4737-01A,1F744ADA-6DE1-446D-B62C-76A7FC8B40AF,Primary Tumor,Illumina HiSeq,cd1138ab-45a7-4da9-a78d-142e2e75f255,Head and Neck,19,BA5D40F5-56A2-438B-92B8-6EB7DB6D6AFA,878A7FE7-20FF-4651-9587-B4D6FD42E929,TCGA-CN-4737-01A-01D-2266-10,GRCh37-lite,TCGA-CN-4737,TCGA-HNSC,NA,s16030,Baylor College of Medicine,University of Pittsburgh,None,NO,T2,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82ee4b0c9d6adf6ad18,58cfa82ee4b0c9d6adf6ad18,G49537.TCGA-EM-A2OV-01A-11D-A202-08.1.filtered.,WGS,G49537.TCGA-EM-A2OV-01A-11D-A202-08.1,G49537.TCGA-EM-A2OV-01A-11D-A202-08.1.bam,24.95,NA,0.08,58cfa82ee4b0c9d6adf6ad18,G49537.TCGA-EM-A2OV-01A-11D-A202-08.1.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EM-A2OV-01A,55E03FFC-F006-4EC8-8E5D-A738FF091F8A,Primary Tumor,Illumina HiSeq,6c8370c6-102f-4bde-84ce-bf930800ac6a,Thyroid,64,1183BCB5-50A7-4CC0-A94C-732636B7EE7D,2DFE70FD-2650-49C0-B6EB-67DF585D063B,TCGA-EM-A2OV-01A-11D-A202-08,HG19_Broad_variant,TCGA-EM-A2OV,TCGA-THCA,NA,s12347,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II
13722.58cfa82fe4b0c9d6adf6b691,58cfa82fe4b0c9d6adf6b691,TCGA-36-1570-01A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-36-1570-01A-01D-A324-10_wgs_Illumina,TCGA-36-1570-01A-01D-A324-10_wgs_Illumina.bam,286.97,1.9,0.09,58cfa82fe4b0c9d6adf6b691,TCGA-36-1570-01A-01D-A324-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-36-1570-01A,0F530B3E-5B6D-4892-9EBD-9138D76FDCA7,Primary Tumor,Illumina HiSeq,7bd2e9c4-4e02-4a02-83d2-c1da3a047b3a,Ovary,49,22B7E0E2-334C-419C-A243-358BA22E479A,A2F38E9E-48B2-4463-B2E3-61CC8475257F,TCGA-36-1570-01A-01D-A324-10,GRCh37-lite,TCGA-36-1570,TCGA-OV,NA,s18070,Baylor College of Medicine,BC Cancer Agency,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ade1,58cfa82ee4b0c9d6adf6ade1,G39020.TCGA-BR-8682-01A-11D-2394-08.3.filtered.,WGS,G39020.TCGA-BR-8682-01A-11D-2394-08.3,G39020.TCGA-BR-8682-01A-11D-2394-08.3.bam,231,NA,0.05,58cfa82ee4b0c9d6adf6ade1,G39020.TCGA-BR-8682-01A-11D-2394-08.3.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-8682-01A,D5EFCDE2-21E6-4071-9AA4-3C5688A45B3F,Primary Tumor,Illumina HiSeq,36f56254-f585-4353-89b4-00cb5cfa20eb,Stomach,52,4E6BBC3C-BB9E-46C0-8B22-60F9725DB516,EA2055D1-7B8B-4AAF-9A70-8802F4DEEF9B,TCGA-BR-8682-01A-11D-2394-08,HG19_Broad_variant,TCGA-BR-8682,TCGA-STAD,NA,s15038,Broad Institute of MIT and Harvard,Asterand,Vietnam,NO,T4a,N0,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage IIB
13722.58cfa831e4b0c9d6adf6c470,58cfa831e4b0c9d6adf6c470,TCGA-CA-6718-01A-11D-1835-10_wgs_Illumina.filtered.,WGS,TCGA-CA-6718-01A-11D-1835-10_wgs_Illumina,TCGA-CA-6718-01A-11D-1835-10_wgs_Illumina.bam,376.7,1.9,0.05,58cfa831e4b0c9d6adf6c470,TCGA-CA-6718-01A-11D-1835-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-CA-6718-01A,DF5AB6CC-6F68-4B6B-95E2-954C6B57BA9C,Primary Tumor,Illumina HiSeq,3f12f1a7-45cc-4500-b7e1-8ac12465fbfe,Colorectal,46,F235AFBB-DC2A-41DD-B373-77C0AACEFB37,0980E7FD-051D-45E9-9CA6-2BAF073DA4E8,TCGA-CA-6718-01A-11D-1835-10,GRCh37-lite,TCGA-CA-6718,TCGA-COAD,NA,s13037,Baylor College of Medicine,ILSbio,Vietnam,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa82ee4b0c9d6adf6b0f2,58cfa82ee4b0c9d6adf6b0f2,TCGA-06-0145-10A-01D-0507-08_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-06-0145-10A-01D-0507-08_IlluminaGA-DNASeq_whole,TCGA-06-0145-10A-01D-0507-08_IlluminaGA-DNASeq_whole.bam,259.67,1.9,0.15,58cfa82ee4b0c9d6adf6b0f2,TCGA-06-0145-10A-01D-0507-08_IlluminaGA-DNASeq_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0145-10A,3258CB3B-F63B-463C-B2E4-D638149157C5,Blood Derived Normal,Illumina GA,4b1cadd4-8145-4ee1-9cf0-adbab0fa453e,Brain,53,2DE505D9-5BAF-43C5-A541-496A6BE40FAE,0C700657-B0B8-4361-9F89-B89A6C7B262D,TCGA-06-0145-10A-01D-0507-08,HG18_Broad_variant,TCGA-06-0145,TCGA-GBM,71,s13952,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6ad92,58cfa82ee4b0c9d6adf6ad92,G39020.TCGA-D7-6527-01A-11D-1800-08.2.filtered.,WGS,G39020.TCGA-D7-6527-01A-11D-1800-08.2,G39020.TCGA-D7-6527-01A-11D-1800-08.2.bam,84.4,1.9,0.05,58cfa82ee4b0c9d6adf6ad92,G39020.TCGA-D7-6527-01A-11D-1800-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-D7-6527-01A,CB622CD6-776D-4681-8A67-4ADDD61C66B8,Primary Tumor,Illumina HiSeq,869f3603-32f9-4e4d-a862-211f1bb624b8,Stomach,62,8461CE68-3A6F-4343-8977-78448123F373,DC537FCF-D910-4C4B-8AF9-E7DA429F2633,TCGA-D7-6527-01A-11D-1800-08,HG19_Broad_variant,TCGA-D7-6527,TCGA-STAD,NA,s15229,Broad Institute of MIT and Harvard,Greater Poland Cancer Center,Poland,NO,T2,N1,Stomach Intestinal Adenocarcinoma Papillary Type,Stage II
13722.58cfa82fe4b0c9d6adf6b440,58cfa82fe4b0c9d6adf6b440,TCGA-24-2290-01A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-24-2290-01A-01D-A324-10_wgs_Illumina,TCGA-24-2290-01A-01D-A324-10_wgs_Illumina.bam,683.97,1.9,0.08,58cfa82fe4b0c9d6adf6b440,TCGA-24-2290-01A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-2290-01A,2B14123B-8FCD-402C-9399-4E7C47F20252,Primary Tumor,Illumina HiSeq,f1ffb755-85ec-4449-b604-8e9cd194d527,Ovary,56,BBFED693-79E1-4DC7-896E-15B98FC7DBAC,FEA5827B-251D-474B-8713-FC76DB995FE7,TCGA-24-2290-01A-01D-A324-10,GRCh37-lite,TCGA-24-2290,TCGA-OV,1102,s17878,Baylor College of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aeaa,58cfa82ee4b0c9d6adf6aeaa,G49537.TCGA-ET-A4KN-01A-11D-A257-08.1.filtered.,WGS,G49537.TCGA-ET-A4KN-01A-11D-A257-08.1,G49537.TCGA-ET-A4KN-01A-11D-A257-08.1.bam,32.52,NA,0.07,58cfa82ee4b0c9d6adf6aeaa,G49537.TCGA-ET-A4KN-01A-11D-A257-08.1.bam,Alive,FEMALE,WHITE,Not available,Thyroid Carcinoma,Aligned reads,TCGA-ET-A4KN-01A,7629F864-A009-4AA9-BF7E-2D99E00D294E,Primary Tumor,Illumina HiSeq,82a795da-f726-45af-a15f-a778695d466a,Thyroid,51,E01D507C-8E8E-45C6-B4EF-193177A382C4,178D0486-CB0D-4979-8BDF-BB3FE99149BD,TCGA-ET-A4KN-01A-11D-A257-08,HG19_Broad_variant,TCGA-ET-A4KN,TCGA-THCA,NA,s12619,Broad Institute of MIT and Harvard,Johns Hopkins,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage III
13722.58cfa82ee4b0c9d6adf6aea0,58cfa82ee4b0c9d6adf6aea0,G49537.TCGA-FY-A2QD-01A-11D-A19J-08.1.filtered.,WGS,G49537.TCGA-FY-A2QD-01A-11D-A19J-08.1,G49537.TCGA-FY-A2QD-01A-11D-A19J-08.1.bam,37.07,NA,0.08,58cfa82ee4b0c9d6adf6aea0,G49537.TCGA-FY-A2QD-01A-11D-A19J-08.1.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-FY-A2QD-01A,B0CB6ED7-3D9F-4D5E-8DF5-EDCC921C43B4,Primary Tumor,Illumina HiSeq,102342da-d9ce-4eb4-8c20-dda6ce072830,Thyroid,61,08D3CB3B-9A80-4034-B06D-B37DD38C8B9B,E7335A24-E5FC-4558-9EBA-511C5A802320,TCGA-FY-A2QD-01A-11D-A19J-08,HG19_Broad_variant,TCGA-FY-A2QD,TCGA-THCA,NA,s12226,Broad Institute of MIT and Harvard,International Genomics Consortium,United States,NO,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Not available
13722.58cfa82ee4b0c9d6adf6b071,58cfa82ee4b0c9d6adf6b071,TCGA-06-0145-01A-01D-0507-08_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-06-0145-01A-01D-0507-08_IlluminaGA-DNASeq_whole,TCGA-06-0145-01A-01D-0507-08_IlluminaGA-DNASeq_whole.bam,386.67,1.89,0.15,58cfa82ee4b0c9d6adf6b071,TCGA-06-0145-01A-01D-0507-08_IlluminaGA-DNASeq_whole.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0145-01A,3258CB3B-F63B-463C-B2E4-D638149157C5,Primary Tumor,Illumina GA,2b476879-3ae6-47e3-b0f0-4761a4d3f5d9,Brain,53,24ABC0F5-F40F-4A74-8968-88CA574E3F03,ECE0F3A4-A204-4C52-BB1F-88D44A875B2E,TCGA-06-0145-01A-01D-0507-08,HG18_Broad_variant,TCGA-06-0145,TCGA-GBM,71,s13953,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6ac7a,58cfa82ee4b0c9d6adf6ac7a,G39020.TCGA-IN-7806-01A-11D-2053-08.3.filtered.,WGS,G39020.TCGA-IN-7806-01A-11D-2053-08.3,G39020.TCGA-IN-7806-01A-11D-2053-08.3.bam,341.7,NA,0.05,58cfa82ee4b0c9d6adf6ac7a,G39020.TCGA-IN-7806-01A-11D-2053-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-IN-7806-01A,87C217D4-66F4-46CA-8244-7856CE658FD3,Primary Tumor,Illumina HiSeq,65b3a7db-195a-47e8-804b-a1d4a5df79aa,Stomach,50,9B864C79-BF5C-4430-86E8-D8479ED90D25,576A1741-8C65-40DA-9F0F-B2CA805D70F3,TCGA-IN-7806-01A-11D-2053-08,HG19_Broad_variant,TCGA-IN-7806,TCGA-STAD,NA,s15297,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T3,N1,Stomach  Adenocarcinoma  Diffuse Type,Stage IIB
13722.58cfa830e4b0c9d6adf6bc5e,58cfa830e4b0c9d6adf6bc5e,TCGA-AL-3472-01A-01D-1253-10_wgs_Illumina.filtered.,WGS,TCGA-AL-3472-01A-01D-1253-10_wgs_Illumina,TCGA-AL-3472-01A-01D-1253-10_wgs_Illumina.bam,543,1.9,0.13,58cfa830e4b0c9d6adf6bc5e,TCGA-AL-3472-01A-01D-1253-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-AL-3472-01A,42D044AE-1416-477D-AC80-779C49BC8D35,Primary Tumor,Illumina HiSeq,8f19974d-a670-4221-82fc-60d3918c19e0,Kidney,57,7EEA5C2A-F1A2-432E-88A2-E96B809E15D9,63D0C49D-918D-41FB-808A-1F8001981917,TCGA-AL-3472-01A-01D-1253-10,GRCh37-lite,TCGA-AL-3472,TCGA-KIRP,NA,s11852,Baylor College of Medicine,Fox Chase,None,NO,T2,N0,Kidney Papillary Renal Cell Carcinoma,Not available
13722.58cfa82ee4b0c9d6adf6af90,58cfa82ee4b0c9d6adf6af90,TCGA-04-1367-01A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-04-1367-01A-01D-A324-10_wgs_Illumina,TCGA-04-1367-01A-01D-A324-10_wgs_Illumina.bam,540.67,1.9,0.07,58cfa82ee4b0c9d6adf6af90,TCGA-04-1367-01A-01D-A324-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-04-1367-01A,30B8F4CD-9245-4496-A8A8-C3E59093BC0A,Primary Tumor,Illumina HiSeq,6361290f-011b-4284-9230-5b766b2d2b54,Ovary,50,52EC58BA-3228-466A-A5EF-64A6567921D3,35CEBA07-0759-4FBE-B076-AF821A528CF0,TCGA-04-1367-01A-01D-A324-10,GRCh37-lite,TCGA-04-1367,TCGA-OV,NA,s17590,Baylor College of Medicine,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aeb6,58cfa82ee4b0c9d6adf6aeb6,G49537.TCGA-EM-A2CN-01A-11D-A19J-08.2.filtered.,WGS,G49537.TCGA-EM-A2CN-01A-11D-A19J-08.2,G49537.TCGA-EM-A2CN-01A-11D-A19J-08.2.bam,65.79,NA,0.09,58cfa82ee4b0c9d6adf6aeb6,G49537.TCGA-EM-A2CN-01A-11D-A19J-08.2.bam,Alive,MALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A2CN-01A,4AED5116-D27B-4911-B310-05C2248B861F,Primary Tumor,Illumina HiSeq,2dc0d4bf-c927-40fc-bc8e-fbdc5e1da355,Thyroid,62,4548D9EE-668F-495B-845F-8B9FC798EA38,5C02D399-07AF-4573-A568-BC1B256BC8F8,TCGA-EM-A2CN-01A-11D-A19J-08,HG19_Broad_variant,TCGA-EM-A2CN,TCGA-THCA,NA,s12089,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage IVC
13722.58cfa82ee4b0c9d6adf6af6e,58cfa82ee4b0c9d6adf6af6e,G39020.TCGA-F1-6875-01A-11D-2053-08.3.filtered.,WGS,G39020.TCGA-F1-6875-01A-11D-2053-08.3,G39020.TCGA-F1-6875-01A-11D-2053-08.3.bam,583.7,NA,0.05,58cfa82ee4b0c9d6adf6af6e,G39020.TCGA-F1-6875-01A-11D-2053-08.3.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-F1-6875-01A,283776CD-32E8-4A79-BED1-1411C9D3A9E0,Primary Tumor,Illumina HiSeq,b6dcf3d5-80e4-40e1-a164-4697d1de7670,Stomach,79,4E5FDD56-C807-4493-A331-359577C31514,EA1CAC20-88C1-4257-9CDB-D2890EB2E123,TCGA-F1-6875-01A-11D-2053-08,HG19_Broad_variant,TCGA-F1-6875,TCGA-STAD,2197,s14461,Broad Institute of MIT and Harvard,UNC,United States,NO,T2,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IA
13722.58cfa82fe4b0c9d6adf6b384,58cfa82fe4b0c9d6adf6b384,TCGA-24-2024-01A-02D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-24-2024-01A-02D-A324-10_wgs_Illumina,TCGA-24-2024-01A-02D-A324-10_wgs_Illumina.bam,798.27,1.8,0.07,58cfa82fe4b0c9d6adf6b384,TCGA-24-2024-01A-02D-A324-10_wgs_Illumina.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-2024-01A,0A48873A-092A-4B25-822B-B0B3C18C08A8,Primary Tumor,Illumina HiSeq,03e36495-9e80-442c-bc07-456ee80a47ca,Ovary,72,A3F8DCAD-C42A-4070-80C4-782627BBACA2,46F19B5C-3EBA-4B23-A1AB-9748090CA4E5,TCGA-24-2024-01A-02D-A324-10,GRCh37-lite,TCGA-24-2024,TCGA-OV,1769,s17944,Baylor College of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82de4b0c9d6adf6a752,58cfa82de4b0c9d6adf6a752,G13232.TCGA-60-2726-11A-01D-1522-08.2.filtered.,WGS,G13232.TCGA-60-2726-11A-01D-1522-08.2,G13232.TCGA-60-2726-11A-01D-1522-08.2.bam,469.6,1.9,0.05,58cfa82de4b0c9d6adf6a752,G13232.TCGA-60-2726-11A-01D-1522-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-60-2726-11A,3D1F4059-2220-45B4-A4D2-B14F76CEC96A,Solid Tissue Normal,Illumina HiSeq,90672374-114d-4a7f-b7b5-94ebc4299aa7,Lung,56,3C66F293-9BDB-4EDA-899D-886BA05F3FB7,F318C548-D5F1-41A6-80F3-DB1A98AD8530,TCGA-60-2726-11A-01D-1522-08,HG19_Broad_variant,TCGA-60-2726,TCGA-LUSC,358,s10360,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T2,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa82ee4b0c9d6adf6ade4,58cfa82ee4b0c9d6adf6ade4,G49837.TCGA-66-2789-01A-01D-A320-08.2.filtered.,WGS,G49837.TCGA-66-2789-01A-01D-A320-08.2,G49837.TCGA-66-2789-01A-01D-A320-08.2.bam,379.94,1.8,0.07,58cfa82ee4b0c9d6adf6ade4,G49837.TCGA-66-2789-01A-01D-A320-08.2.bam,Dead,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-66-2789-01A,87AC0AD4-8C9D-409E-9A86-1D201D01769D,Primary Tumor,Illumina HiSeq,52b8139f-9275-441d-b6ee-e7d29d66fc68,Lung,73,A633A5CA-C207-45BE-8903-93527DE31C22,9623D295-C23D-4F2F-827C-69F767A26F1F,TCGA-66-2789-01A-01D-A320-08,HG19_Broad_variant,TCGA-66-2789,TCGA-LUSC,123,s10164,Broad Institute of MIT and Harvard,Indivumed,Germany,NO,T1,N3,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIB
13722.58cfa82ee4b0c9d6adf6b028,58cfa82ee4b0c9d6adf6b028,TCGA-04-1347-01A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-04-1347-01A-01D-A324-10_wgs_Illumina,TCGA-04-1347-01A-01D-A324-10_wgs_Illumina.bam,602.67,1.9,0.07,58cfa82ee4b0c9d6adf6b028,TCGA-04-1347-01A-01D-A324-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-04-1347-01A,F0C353FD-947C-41E2-B643-3ECC0D69796C,Primary Tumor,Illumina HiSeq,bbcc4096-ca91-49bb-b631-a4db1ca7ab8b,Ovary,81,4C4747D9-C0BC-486E-B88C-5C1B8214D4DE,1DC9E7FD-FC62-4B32-9619-4E02A266A385,TCGA-04-1347-01A-01D-A324-10,GRCh37-lite,TCGA-04-1347,TCGA-OV,NA,s18085,Baylor College of Medicine,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b8d2,58cfa82fe4b0c9d6adf6b8d2,TCGA-61-2000-01A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-61-2000-01A-01D-A324-10_wgs_Illumina,TCGA-61-2000-01A-01D-A324-10_wgs_Illumina.bam,730.97,1.9,0.08,58cfa82fe4b0c9d6adf6b8d2,TCGA-61-2000-01A-01D-A324-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-61-2000-01A,29949B65-2913-4C86-BBD7-B85C5DF6F15E,Primary Tumor,Illumina HiSeq,19381aa5-278b-49eb-87b8-c53fac7ee2e4,Ovary,67,FDB8966D-55C9-49BE-80DD-369246604AAD,B243ADB4-B3E7-4E0E-BC0D-625AA8DBB1BE,TCGA-61-2000-01A-01D-A324-10,GRCh37-lite,TCGA-61-2000,TCGA-OV,NA,s17798,Baylor College of Medicine,University of Pittsburgh,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b541,58cfa82fe4b0c9d6adf6b541,TCGA-25-2391-01A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-25-2391-01A-01D-A324-10_wgs_Illumina,TCGA-25-2391-01A-01D-A324-10_wgs_Illumina.bam,896.97,1.9,0.07,58cfa82fe4b0c9d6adf6b541,TCGA-25-2391-01A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-25-2391-01A,F5033D52-EC36-4E67-88D8-B6D898B81B2F,Primary Tumor,Illumina HiSeq,4c0ed657-169e-4ee1-b8b9-4544a43ed2ee,Ovary,57,2179798C-4FD4-4434-B1D5-1453F6054FA2,58FAF969-BF37-4180-8807-2F44F2CC8EDA,TCGA-25-2391-01A-01D-A324-10,GRCh37-lite,TCGA-25-2391,TCGA-OV,1492,s17137,Baylor College of Medicine,Mayo Clinic - Rochester,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b80a,58cfa82fe4b0c9d6adf6b80a,TCGA-36-1571-01A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-36-1571-01A-01D-A324-10_wgs_Illumina,TCGA-36-1571-01A-01D-A324-10_wgs_Illumina.bam,740.97,1.9,0.07,58cfa82fe4b0c9d6adf6b80a,TCGA-36-1571-01A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-36-1571-01A,12581634-EEBB-4841-8498-71DC9D78C546,Primary Tumor,Illumina HiSeq,9c491361-7721-46fe-ae77-f268796b5b9a,Ovary,53,A1D026C2-4D7A-4454-A8E3-30E5C243ABA0,BA577913-356C-4488-8F9D-C45778E7B9E1,TCGA-36-1571-01A-01D-A324-10,GRCh37-lite,TCGA-36-1571,TCGA-OV,695,s17463,Baylor College of Medicine,BC Cancer Agency,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ae5a,58cfa82ee4b0c9d6adf6ae5a,TCGA-04-1514-01A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-04-1514-01A-01D-A324-10_wgs_Illumina,TCGA-04-1514-01A-01D-A324-10_wgs_Illumina.bam,279.67,1.9,0.07,58cfa82ee4b0c9d6adf6ae5a,TCGA-04-1514-01A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-04-1514-01A,E9483296-CB91-497A-B955-39A3C3289DAC,Primary Tumor,Illumina HiSeq,07a37a5e-5fa5-415b-9814-363bf0a7bc48,Ovary,45,18E0F4ED-43E2-451F-82BD-102260A30AAA,C691D6B3-8E70-4951-8551-2EE4E4D0D10B,TCGA-04-1514-01A-01D-A324-10,GRCh37-lite,TCGA-04-1514,TCGA-OV,1720,s17412,Baylor College of Medicine,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6b004,58cfa82ee4b0c9d6adf6b004,G49537.TCGA-EM-A3FL-01A-11D-A21A-08.2.filtered.,WGS,G49537.TCGA-EM-A3FL-01A-11D-A21A-08.2,G49537.TCGA-EM-A3FL-01A-11D-A21A-08.2.bam,8.35,NA,0.08,58cfa82ee4b0c9d6adf6b004,G49537.TCGA-EM-A3FL-01A-11D-A21A-08.2.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A3FL-01A,CFDD2155-57A9-499C-92E1-FB82B577B050,Primary Tumor,Illumina HiSeq,477abd20-1834-4af2-8091-7566a4d68578,Thyroid,63,56E31332-09FB-4305-8EE8-ADC568B393F3,1BBB522D-E224-4B3F-9E10-3A47D06B2B05,TCGA-EM-A3FL-01A-11D-A21A-08,HG19_Broad_variant,TCGA-EM-A3FL,TCGA-THCA,NA,s12225,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T1b,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa82ee4b0c9d6adf6b197,58cfa82ee4b0c9d6adf6b197,TCGA-09-1666-01A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-09-1666-01A-01D-A324-10_wgs_Illumina,TCGA-09-1666-01A-01D-A324-10_wgs_Illumina.bam,788.97,1.9,0.08,58cfa82ee4b0c9d6adf6b197,TCGA-09-1666-01A-01D-A324-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-09-1666-01A,4EAC2C98-86D2-4EE6-A1D3-157D013C78DC,Primary Tumor,Illumina HiSeq,6d2f46e9-b19b-431a-aa4e-c409eb1787dc,Ovary,57,77AB9685-021C-4D99-8980-79BEC534828E,127B0F7D-D24E-48B7-AC25-D3F14A43952D,TCGA-09-1666-01A-01D-A324-10,GRCh37-lite,TCGA-09-1666,TCGA-OV,NA,s17490,Baylor College of Medicine,UCSF,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa831e4b0c9d6adf6c450,58cfa831e4b0c9d6adf6c450,TCGA-BW-A5NO-01A-11D-A27I-10_wgs_Illumina.filtered.,WGS,TCGA-BW-A5NO-01A-11D-A27I-10_wgs_Illumina,TCGA-BW-A5NO-01A-11D-A27I-10_wgs_Illumina.bam,61.1,NA,0.08,58cfa831e4b0c9d6adf6c450,TCGA-BW-A5NO-01A-11D-A27I-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-BW-A5NO-01A,EE63C44B-91F4-4004-8DEA-192EAB527036,Primary Tumor,Illumina HiSeq,b36db6ae-5ff9-4608-9db1-8dd5dc62fd82,Liver,50,3CBD785D-CAD5-4299-8FE8-695CA8DB726D,81A8B064-E735-455F-B2DB-AF7AE11DAAC4,TCGA-BW-A5NO-01A-11D-A27I-10,GRCh37-lite,TCGA-BW-A5NO,TCGA-LIHC,NA,s16580,Baylor College of Medicine,St Joseph's Medical Center (MD),United States,NO,T3a,NX,Hepatocellular Carcinoma,Stage IIIA
13722.58cfa82fe4b0c9d6adf6b3a2,58cfa82fe4b0c9d6adf6b3a2,TCGA-24-1419-01A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-24-1419-01A-01D-A324-10_wgs_Illumina,TCGA-24-1419-01A-01D-A324-10_wgs_Illumina.bam,589.97,1.9,0.09,58cfa82fe4b0c9d6adf6b3a2,TCGA-24-1419-01A-01D-A324-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1419-01A,5E18B17D-4626-4B6D-8AC6-E560CEE0376C,Primary Tumor,Illumina HiSeq,915b863a-f427-4e28-8809-4e9f244f9f4d,Ovary,62,92D562DF-4A58-43DA-8811-843D3D3C9438,2F2EAECC-6509-423F-B63A-8C3BEA1BA4A4,TCGA-24-1419-01A-01D-A324-10,GRCh37-lite,TCGA-24-1419,TCGA-OV,NA,s17620,Baylor College of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6afcf,58cfa82ee4b0c9d6adf6afcf,TCGA-06-0648-10A-01D-0507-08_IlluminaGA-DNASeq_whole.filtered.,WGS,TCGA-06-0648-10A-01D-0507-08_IlluminaGA-DNASeq_whole,TCGA-06-0648-10A-01D-0507-08_IlluminaGA-DNASeq_whole.bam,20,1.9,0.16,58cfa82ee4b0c9d6adf6afcf,TCGA-06-0648-10A-01D-0507-08_IlluminaGA-DNASeq_whole.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0648-10A,EF6F6553-2575-457E-BC07-401215E54759,Blood Derived Normal,Illumina GA,919cb7d8-9d21-4fcf-9a4c-c2c3f48c0566,Brain,77,19CF72B4-3B97-4CF5-9806-5A659AA12CB8,0105BC7D-A1CD-44D1-B533-B47A9781C0A5,TCGA-06-0648-10A-01D-0507-08,HG18_Broad_variant,TCGA-06-0648,TCGA-GBM,298,s14268,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82ee4b0c9d6adf6acef,58cfa82ee4b0c9d6adf6acef,G49537.TCGA-DJ-A4UT-01A-11D-A257-08.1.filtered.,WGS,G49537.TCGA-DJ-A4UT-01A-11D-A257-08.1,G49537.TCGA-DJ-A4UT-01A-11D-A257-08.1.bam,37.91,NA,0.08,58cfa82ee4b0c9d6adf6acef,G49537.TCGA-DJ-A4UT-01A-11D-A257-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A4UT-01A,ACB80B76-2394-4250-8687-60E40E16E83B,Primary Tumor,Illumina HiSeq,3f6de736-5ec7-4e27-85a6-a39f216ce0bf,Thyroid,32,4D6855A8-076D-4F95-B6CE-2B250CE3087D,64A17D5B-8F40-4CCF-8F2F-E68C5FE6B1FF,TCGA-DJ-A4UT-01A-11D-A257-08,HG19_Broad_variant,TCGA-DJ-A4UT,TCGA-THCA,NA,s11980,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T1a,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82ee4b0c9d6adf6adac,58cfa82ee4b0c9d6adf6adac,G39020.TCGA-CD-8529-01A-11D-2340-08.2.filtered.,WGS,G39020.TCGA-CD-8529-01A-11D-2340-08.2,G39020.TCGA-CD-8529-01A-11D-2340-08.2.bam,200.7,NA,0.05,58cfa82ee4b0c9d6adf6adac,G39020.TCGA-CD-8529-01A-11D-2340-08.2.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-CD-8529-01A,5B7E557A-6AEE-4077-B3CD-C96179E643AE,Primary Tumor,Illumina HiSeq,65281f4c-9277-4d03-8566-75feb73c114d,Stomach,65,EB18C784-32F7-4570-A661-E4DF8F55378C,931B24DA-5D6D-4C2D-8DE9-EF32D6EB8565,TCGA-CD-8529-01A-11D-2340-08,HG19_Broad_variant,TCGA-CD-8529,TCGA-STAD,NA,s14958,Broad Institute of MIT and Harvard,ILSbio,Vietnam,NO,T4,N0,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage IV
13722.58cfa82ee4b0c9d6adf6ae7c,58cfa82ee4b0c9d6adf6ae7c,G49538.TCGA-06-0171-01A-02D-A33C-08.2.filtered.,WGS,G49538.TCGA-06-0171-01A-02D-A33C-08.2,G49538.TCGA-06-0171-01A-02D-A33C-08.2.bam,117.7,1.92,0.07,58cfa82ee4b0c9d6adf6ae7c,G49538.TCGA-06-0171-01A-02D-A33C-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0171-01A,01A92062-967A-4900-8DC7-A5ECD3B3F8E2,Primary Tumor,Illumina HiSeq,9b5a849c-703d-4d9c-81f4-6bd061fd21a8,Brain,65,6081351A-7D07-41FB-A99E-43587223BFCC,18901F76-660B-4CC6-AF1B-1B6F5D62204D,TCGA-06-0171-01A-02D-A33C-08,HG19_Broad_variant,TCGA-06-0171,TCGA-GBM,399,s13947,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82fe4b0c9d6adf6b290,58cfa82fe4b0c9d6adf6b290,TCGA-09-2045-01A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-09-2045-01A-01D-A324-10_wgs_Illumina,TCGA-09-2045-01A-01D-A324-10_wgs_Illumina.bam,598.97,1.9,0.08,58cfa82fe4b0c9d6adf6b290,TCGA-09-2045-01A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-09-2045-01A,3768D34F-1527-40DB-B116-CD80CEE5EC3A,Primary Tumor,Illumina HiSeq,51ef343e-2d9c-48c4-9a6f-6c4f0dcac50d,Ovary,50,4D5AAF12-A500-4709-9C99-5B9FEF2C79B1,6797443C-EB4A-4654-B957-C0056E5A4206,TCGA-09-2045-01A-01D-A324-10,GRCh37-lite,TCGA-09-2045,TCGA-OV,1069,s17170,Baylor College of Medicine,UCSF,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6af1a,58cfa82ee4b0c9d6adf6af1a,TCGA-04-1349-01A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-04-1349-01A-01D-A324-10_wgs_Illumina,TCGA-04-1349-01A-01D-A324-10_wgs_Illumina.bam,647.67,1.9,0.07,58cfa82ee4b0c9d6adf6af1a,TCGA-04-1349-01A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-04-1349-01A,4B930A10-4B12-4428-84F9-3255B4A3BC4F,Primary Tumor,Illumina HiSeq,38b29598-b696-41ed-a699-9aa027050404,Ovary,69,C7280560-2561-4C23-9C53-C5EB6CEB99B3,5533240D-8FED-440D-B781-6092785A77CE,TCGA-04-1349-01A-01D-A324-10,GRCh37-lite,TCGA-04-1349,TCGA-OV,656,s17763,Baylor College of Medicine,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aff6,58cfa82ee4b0c9d6adf6aff6,TCGA-10-0937-01A-02D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-10-0937-01A-02D-A324-10_wgs_Illumina,TCGA-10-0937-01A-02D-A324-10_wgs_Illumina.bam,272.34,1.9,0.07,58cfa82ee4b0c9d6adf6aff6,TCGA-10-0937-01A-02D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-10-0937-01A,A5030259-CF9C-4A58-8710-B9DA8EE59320,Primary Tumor,Illumina HiSeq,ba32f721-1816-4462-b3f7-f496ee3d8c84,Ovary,44,8585D596-4D6B-4F6C-BB46-A2661F9CA05A,8A69F3CA-4E17-4DAA-8722-A36316E345BA,TCGA-10-0937-01A-02D-A324-10,GRCh37-lite,TCGA-10-0937,TCGA-OV,608,s17910,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ad25,58cfa82ee4b0c9d6adf6ad25,G49538.TCGA-19-1389-01A-01D-2319-08.1.filtered.,WGS,G49538.TCGA-19-1389-01A-01D-2319-08.1,G49538.TCGA-19-1389-01A-01D-2319-08.1.bam,233.3,1.9,0.05,58cfa82ee4b0c9d6adf6ad25,G49538.TCGA-19-1389-01A-01D-2319-08.1.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-19-1389-01A,309005A2-93A8-4566-B8D3-6B9310144266,Primary Tumor,Illumina HiSeq,4af17e02-7d17-41c3-9ee7-32c7c1d5e163,Brain,51,A20EB141-2F2C-44E4-BBC2-5BC9F58F5644,359452A5-29CD-4D2B-BB78-E60FD790A35E,TCGA-19-1389-01A-01D-2319-08,HG19_Broad_variant,TCGA-19-1389,TCGA-GBM,141,s14062,Broad Institute of MIT and Harvard,Case Western,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa82fe4b0c9d6adf6b3fa,58cfa82fe4b0c9d6adf6b3fa,TCGA-24-1552-01A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-24-1552-01A-01D-A324-10_wgs_Illumina,TCGA-24-1552-01A-01D-A324-10_wgs_Illumina.bam,719.67,1.9,0.08,58cfa82fe4b0c9d6adf6b3fa,TCGA-24-1552-01A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1552-01A,62379BE5-13F0-474B-94D3-6F944EC4EE96,Primary Tumor,Illumina HiSeq,5549fe8c-2ced-4cb8-826b-b212f6ba24d5,Ovary,77,411B4C26-FCC4-438A-8731-D0CF5DD6C74F,14ED7388-41ED-43D4-AFB2-04CD6410D5D2,TCGA-24-1552-01A-01D-A324-10,GRCh37-lite,TCGA-24-1552,TCGA-OV,1259,s17300,Baylor College of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ad02,58cfa82ee4b0c9d6adf6ad02,G49537.TCGA-E8-A416-01A-11D-A23M-08.2.filtered.,WGS,G49537.TCGA-E8-A416-01A-11D-A23M-08.2,G49537.TCGA-E8-A416-01A-11D-A23M-08.2.bam,16.01,NA,0.08,58cfa82ee4b0c9d6adf6ad02,G49537.TCGA-E8-A416-01A-11D-A23M-08.2.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-E8-A416-01A,86B82345-6F4D-44FD-A9DB-6F107DE62F53,Primary Tumor,Illumina HiSeq,d49de1af-8dd9-4fdb-8a60-87bd8894395b,Thyroid,51,AF7B5868-2C11-4C74-8033-E914C987ECE6,C8381701-31CB-465A-BDF2-1B8132BE7A14,TCGA-E8-A416-01A-11D-A23M-08,HG19_Broad_variant,TCGA-E8-A416,TCGA-THCA,NA,s12623,Broad Institute of MIT and Harvard,Asterand,Vietnam,NO,T1b,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82fe4b0c9d6adf6b2be,58cfa82fe4b0c9d6adf6b2be,TCGA-23-1110-01A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-23-1110-01A-01D-A324-10_wgs_Illumina,TCGA-23-1110-01A-01D-A324-10_wgs_Illumina.bam,572.67,1.9,0.08,58cfa82fe4b0c9d6adf6b2be,TCGA-23-1110-01A-01D-A324-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-23-1110-01A,9FB1BA57-2007-4477-B000-2D36F163EFD2,Primary Tumor,Illumina HiSeq,1a385700-67e4-4e15-95ac-102406f8fe18,Ovary,42,5ADCA90E-F8AE-4A74-9C7F-A2B64FDA2B31,1292E13B-D7C6-447B-A227-9A8113215580,TCGA-23-1110-01A-01D-A324-10,GRCh37-lite,TCGA-23-1110,TCGA-OV,NA,s17716,Baylor College of Medicine,Cedars Sinai,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6ad1f,58cfa82ee4b0c9d6adf6ad1f,G39020.TCGA-BR-8486-01A-31D-2394-08.2.filtered.,WGS,G39020.TCGA-BR-8486-01A-31D-2394-08.2,G39020.TCGA-BR-8486-01A-31D-2394-08.2.bam,280,NA,0.05,58cfa82ee4b0c9d6adf6ad1f,G39020.TCGA-BR-8486-01A-31D-2394-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-8486-01A,B8A1C8C7-3945-4D84-8F58-3A1A1EB10730,Primary Tumor,Illumina HiSeq,09ea179f-e2fc-479c-9b04-7c3ae8034874,Stomach,90,65FA5F32-8747-41B7-8287-061587DC22DE,6A7CDAF6-211E-4EB8-A70E-1153D69C45E4,TCGA-BR-8486-01A-31D-2394-08,HG19_Broad_variant,TCGA-BR-8486,TCGA-STAD,NA,s14678,Broad Institute of MIT and Harvard,Asterand,Russia,NO,T1b,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IA
13722.58cfa82fe4b0c9d6adf6b408,58cfa82fe4b0c9d6adf6b408,TCGA-24-1558-01A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-24-1558-01A-01D-A324-10_wgs_Illumina,TCGA-24-1558-01A-01D-A324-10_wgs_Illumina.bam,326.97,1.9,0.08,58cfa82fe4b0c9d6adf6b408,TCGA-24-1558-01A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1558-01A,BA68F2CF-9271-41FD-9655-1FAC7681F588,Primary Tumor,Illumina HiSeq,ff5c5c7d-21a4-4a46-b611-efb7750a4316,Ovary,73,3E8BD387-4FDA-4623-924E-314267C55EEA,9020B6A5-8325-4B0D-84D9-04371C857910,TCGA-24-1558-01A-01D-A324-10,GRCh37-lite,TCGA-24-1558,TCGA-OV,594,s18117,Baylor College of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6af7c,58cfa82ee4b0c9d6adf6af7c,TCGA-04-1331-01A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-04-1331-01A-01D-A324-10_wgs_Illumina,TCGA-04-1331-01A-01D-A324-10_wgs_Illumina.bam,417.67,1.9,0.08,58cfa82ee4b0c9d6adf6af7c,TCGA-04-1331-01A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-04-1331-01A,6D10D4EE-6331-4BBA-93BC-A7B64CC0B22A,Primary Tumor,Illumina HiSeq,d7ce51ee-6050-45ea-ad60-5209ad11625a,Ovary,78,A1EC9279-C1A6-4E58-97ED-9EC1F36187C5,C9959F68-C385-4C1F-9188-8203844D288E,TCGA-04-1331-01A-01D-A324-10,GRCh37-lite,TCGA-04-1331,TCGA-OV,1336,s17654,Baylor College of Medicine,Gynecologic Oncology Group,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6aec4,58cfa82ee4b0c9d6adf6aec4,G49537.TCGA-DJ-A13R-01A-11D-A10S-08.1.filtered.,WGS,G49537.TCGA-DJ-A13R-01A-11D-A10S-08.1,G49537.TCGA-DJ-A13R-01A-11D-A10S-08.1.bam,78.88,1.95,0.08,58cfa82ee4b0c9d6adf6aec4,G49537.TCGA-DJ-A13R-01A-11D-A10S-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13R-01A,3E787A0E-B5D2-401E-B1E5-077376090B3A,Primary Tumor,Illumina HiSeq,af5f8467-77af-435f-b962-db1a207085e3,Thyroid,50,27B0FF79-4213-4B57-B6E0-A393B8983D20,3F039593-91D1-43CB-A06B-41E92F7E8D20,TCGA-DJ-A13R-01A-11D-A10S-08,HG19_Broad_variant,TCGA-DJ-A13R,TCGA-THCA,NA,s12503,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III
13722.58cfa83ce4b0c9d6adf73153,58cfa83ce4b0c9d6adf73153,a143c1197455bdf6b5c37a8ffa0549d2.filtered.,WGS,a143c1197455bdf6b5c37a8ffa0549d2,a143c1197455bdf6b5c37a8ffa0549d2.bam,11.77,NA,0.08,58cfa83ce4b0c9d6adf73153,a143c1197455bdf6b5c37a8ffa0549d2.bam,Alive,MALE,ASIAN,Not available,Esophageal Carcinoma,Aligned reads,TCGA-JY-A93C-10A,BCAB5381-C037-4723-904E-D01EA386B61E,Blood Derived Normal,HiSeq X Ten,23a3851f-c993-420b-9d28-c2c80a238ae0,Esophagus,47,B0849F2C-BF53-482E-97C1-0579FB1282D8,4966DBE0-8508-4888-8D41-4909E3A71C98,TCGA-JY-A93C-10A-01D-A38A-09,GRCh37-lite_WUGSC_variant_2,TCGA-JY-A93C,TCGA-ESCA,NA,s1899,Washington University School of Medicine,University Health Network,Canada,NO,T3,N2,Not available,Stage IIIB
13722.58cfa82de4b0c9d6adf6a712,58cfa82de4b0c9d6adf6a712,G14854.TCGA-38-4628-01A-01D-1931-08.5.filtered.,WGS,G14854.TCGA-38-4628-01A-01D-1931-08.5,G14854.TCGA-38-4628-01A-01D-1931-08.5.bam,32.52,1.9,0.13,58cfa82de4b0c9d6adf6a712,G14854.TCGA-38-4628-01A-01D-1931-08.5.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,Aligned reads,TCGA-38-4628-01A,CC4BD56A-25C5-4C48-B583-AC3AEB778CA6,Primary Tumor,Illumina HiSeq,2fb6e0f6-487d-4404-9958-6ca019a21395,Lung,65,A74F6423-B5D3-4AE2-B61F-3EE04B1073BF,C437535B-2ACC-4236-BEAE-94E2C1336830,TCGA-38-4628-01A-01D-1931-08,HG19_Broad_variant,TCGA-38-4628,TCGA-LUAD,1492,s10627,Broad Institute of MIT and Harvard,UNC,United States,NO,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa82ee4b0c9d6adf6ad1c,58cfa82ee4b0c9d6adf6ad1c,G49537.TCGA-BJ-A45K-01A-11D-A23U-08.3.filtered.,WGS,G49537.TCGA-BJ-A45K-01A-11D-A23U-08.3,G49537.TCGA-BJ-A45K-01A-11D-A23U-08.3.bam,27.47,NA,0.08,58cfa82ee4b0c9d6adf6ad1c,G49537.TCGA-BJ-A45K-01A-11D-A23U-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-BJ-A45K-01A,8CFB88F6-7B37-4F1E-882B-3A368B604167,Primary Tumor,Illumina HiSeq,9a38b46c-3b59-40ad-9d22-d0d153c211a1,Thyroid,33,29B4816D-4CFB-45F0-BCD2-6B948245F3A4,77EBE6D2-6537-49D3-849D-FE93E2CF52AF,TCGA-BJ-A45K-01A-11D-A23U-08,HG19_Broad_variant,TCGA-BJ-A45K,TCGA-THCA,NA,s12615,Broad Institute of MIT and Harvard,University of Pittsburgh,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa831e4b0c9d6adf6c8b8,58cfa831e4b0c9d6adf6c8b8,TCGA-DD-A4NG-01A-11D-A27I-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A4NG-01A-11D-A27I-10_wgs_Illumina,TCGA-DD-A4NG-01A-11D-A27I-10_wgs_Illumina.bam,15.95,NA,0.07,58cfa831e4b0c9d6adf6c8b8,TCGA-DD-A4NG-01A-11D-A27I-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A4NG-01A,89791F8F-DC06-4A04-B166-AFBFD6CF53DE,Primary Tumor,Illumina HiSeq,ef6dfbd5-d562-4452-9843-9c3db280717c,Liver,77,38507EDD-DFB4-4931-9895-2C0482BD4555,03C88506-D72E-4A44-A34E-A7F0564F1799,TCGA-DD-A4NG-01A-11D-A27I-10,GRCh37-lite,TCGA-DD-A4NG,TCGA-LIHC,NA,s16856,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T3a,NX,Hepatocellular Carcinoma,Stage IIIA
13722.58cfa82ee4b0c9d6adf6afc7,58cfa82ee4b0c9d6adf6afc7,G49537.TCGA-DJ-A13L-01A-11D-A21Z-08.1.filtered.,WGS,G49537.TCGA-DJ-A13L-01A-11D-A21Z-08.1,G49537.TCGA-DJ-A13L-01A-11D-A21Z-08.1.bam,32.87,NA,0.08,58cfa82ee4b0c9d6adf6afc7,G49537.TCGA-DJ-A13L-01A-11D-A21Z-08.1.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A13L-01A,C7A2F394-3E3F-4C90-9F1E-F2BE3E5B0D6B,Primary Tumor,Illumina HiSeq,56cad7af-d64e-4a7f-9d2e-206cbb921c3f,Thyroid,85,AB13FB1A-8B7F-4D84-84A9-C4F7EE59CAF8,1924D200-6929-4EEF-8A7F-317F8FBAB915,TCGA-DJ-A13L-01A-11D-A21Z-08,HG19_Broad_variant,TCGA-DJ-A13L,TCGA-THCA,NA,s12501,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage I
13722.58cfa82ee4b0c9d6adf6ac9c,58cfa82ee4b0c9d6adf6ac9c,G47088.TCGA-21-1083-01A-01D-1521-08.3.filtered.,WGS,G47088.TCGA-21-1083-01A-01D-1521-08.3,G47088.TCGA-21-1083-01A-01D-1521-08.3.bam,532,1.9,0.05,58cfa82ee4b0c9d6adf6ac9c,G47088.TCGA-21-1083-01A-01D-1521-08.3.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-21-1083-01A,0398EAE1-7216-4595-80A5-6B117D96E070,Primary Tumor,Illumina HiSeq,365def90-a1fd-45b6-a3ab-749e13d4833d,Lung,75,300CB22F-ACB4-4ACD-8D64-FE8DCDF64801,FB0C6353-A90C-45E2-9355-7CD16CF756FF,TCGA-21-1083-01A-01D-1521-08,HG19_Broad_variant,TCGA-21-1083,TCGA-LUSC,1315,s9978,Broad Institute of MIT and Harvard,Fox Chase Cancer Center,United States,NO,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6ad12,58cfa82ee4b0c9d6adf6ad12,G49537.TCGA-DE-A2OL-01A-11D-A18F-08.2.filtered.,WGS,G49537.TCGA-DE-A2OL-01A-11D-A18F-08.2,G49537.TCGA-DE-A2OL-01A-11D-A18F-08.2.bam,71.37,NA,0.08,58cfa82ee4b0c9d6adf6ad12,G49537.TCGA-DE-A2OL-01A-11D-A18F-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DE-A2OL-01A,77BB90F0-E923-4E28-BB88-4D6B420E0B5C,Primary Tumor,Illumina HiSeq,60e1b538-0f36-45ea-892a-a8b64734f42b,Thyroid,44,6CBA95AD-2702-4F50-8B1E-BECDAF014B83,FC812906-D3B6-4210-A842-96F095280CBF,TCGA-DE-A2OL-01A-11D-A18F-08,HG19_Broad_variant,TCGA-DE-A2OL,TCGA-THCA,NA,s12350,Broad Institute of MIT and Harvard,University of North Carolina,United States,NO,T2,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I
13722.58cfa82ee4b0c9d6adf6af3e,58cfa82ee4b0c9d6adf6af3e,G47088.TCGA-22-5485-01A-01D-1632-08.2.filtered.,WGS,G47088.TCGA-22-5485-01A-01D-1632-08.2,G47088.TCGA-22-5485-01A-01D-1632-08.2.bam,342.7,1.9,0.05,58cfa82ee4b0c9d6adf6af3e,G47088.TCGA-22-5485-01A-01D-1632-08.2.bam,Dead,FEMALE,WHITE,Not available,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-22-5485-01A,305F72A8-069B-410B-BBE4-4ECB761C748D,Primary Tumor,Illumina HiSeq,c56332b3-4ccb-4b34-80c3-ffa0b28c5690,Lung,58,ABC3A25F-D5BC-469E-8C3E-8E6F5B129E8F,448AF8B4-E071-48B0-A65B-B4AD17AFDC0C,TCGA-22-5485-01A-01D-1632-08,HG19_Broad_variant,TCGA-22-5485,TCGA-LUSC,916,s10593,Broad Institute of MIT and Harvard,Mayo Clinic - Rochester,United States,NO,T1a,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA
13722.58cfa82ee4b0c9d6adf6aedb,58cfa82ee4b0c9d6adf6aedb,G49537.TCGA-DJ-A2Q1-01A-22D-A19J-08.1.filtered.,WGS,G49537.TCGA-DJ-A2Q1-01A-22D-A19J-08.1,G49537.TCGA-DJ-A2Q1-01A-22D-A19J-08.1.bam,27.76,NA,0.09,58cfa82ee4b0c9d6adf6aedb,G49537.TCGA-DJ-A2Q1-01A-22D-A19J-08.1.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DJ-A2Q1-01A,E35B2928-8784-45D0-A71A-A2DF161542FA,Primary Tumor,Illumina HiSeq,0cac59ec-55cb-4769-ba6d-92c08a076186,Thyroid,44,D1361CB2-6758-4A8C-AE97-8AD5192572FC,007AAB66-2F07-459D-8952-3041D6EA24A8,TCGA-DJ-A2Q1-01A-22D-A19J-08,HG19_Broad_variant,TCGA-DJ-A2Q1,TCGA-THCA,NA,s11981,Broad Institute of MIT and Harvard,Memorial Sloan Kettering,United States,NO,T1b,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage I
13722.58cfa82ee4b0c9d6adf6a7c5,58cfa82ee4b0c9d6adf6a7c5,G2147.TCGA-06-0648-10A-01D.9.filtered.,WGS,G2147.TCGA-06-0648-10A-01D.9,G2147.TCGA-06-0648-10A-01D.9.bam,20,1.9,0.16,58cfa82ee4b0c9d6adf6a7c5,G2147.TCGA-06-0648-10A-01D.9.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0648-10A,EF6F6553-2575-457E-BC07-401215E54759,Blood Derived Normal,Illumina GA,06f9237f-6dc2-4d16-a8cd-34a74bbcefc5,Brain,77,19CF72B4-3B97-4CF5-9806-5A659AA12CB8,0105BC7D-A1CD-44D1-B533-B47A9781C0A5,TCGA-06-0648-10A-01D-0507-08,HG19_Broad_variant,TCGA-06-0648,TCGA-GBM,298,s14168,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa832e4b0c9d6adf6d2f9,58cfa832e4b0c9d6adf6d2f9,TCGA-KN-8426-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8426-01A-11D-2310-10_wgs_Illumina,TCGA-KN-8426-01A-11D-2310-10_wgs_Illumina.bam,110.3,NA,0.05,58cfa832e4b0c9d6adf6d2f9,TCGA-KN-8426-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KN-8426-01A,B08DFBA8-6AFB-4217-9259-72BE6F1F3363,Primary Tumor,Illumina HiSeq,d5461fca-308e-41be-a207-bdb698350564,Kidney,50,8A7FAD85-8756-4411-BE2B-A87159B843A5,A3DEAFCB-B54F-4B7E-89AC-C92C16FB919F,TCGA-KN-8426-01A-11D-2310-10,GRCh37-lite,TCGA-KN-8426,TCGA-KICH,NA,s16473,Baylor College of Medicine,Harvard,United States,NO,T3a,NX,Kidney Chromophobe,Stage IV
13722.58cfa82ee4b0c9d6adf6acf8,58cfa82ee4b0c9d6adf6acf8,G49537.TCGA-EL-A3T9-01A-21D-A22D-08.2.filtered.,WGS,G49537.TCGA-EL-A3T9-01A-21D-A22D-08.2,G49537.TCGA-EL-A3T9-01A-21D-A22D-08.2.bam,33.29,NA,0.08,58cfa82ee4b0c9d6adf6acf8,G49537.TCGA-EL-A3T9-01A-21D-A22D-08.2.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EL-A3T9-01A,8A233B01-2959-467F-8950-02BE16309156,Primary Tumor,Illumina HiSeq,2ef29dae-4708-441b-ab7f-4f8ef4462a47,Thyroid,69,5297F55C-3A46-47ED-8ACC-03333AC26473,D692ECD0-2433-426B-9AF2-A30C44A80F7C,TCGA-EL-A3T9-01A-21D-A22D-08,HG19_Broad_variant,TCGA-EL-A3T9,TCGA-THCA,174,s12499,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,T4,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage IV
13722.58cfa830e4b0c9d6adf6c1e6,58cfa830e4b0c9d6adf6c1e6,TCGA-AL-3466-01A-02D-1402-10_wgs_Illumina.filtered.,WGS,TCGA-AL-3466-01A-02D-1402-10_wgs_Illumina,TCGA-AL-3466-01A-02D-1402-10_wgs_Illumina.bam,151.07,1.9,0.05,58cfa830e4b0c9d6adf6c1e6,TCGA-AL-3466-01A-02D-1402-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-AL-3466-01A,9FC40B03-0B56-4B1F-93ED-DBC455AE3FD9,Primary Tumor,Illumina HiSeq,e3c3f7d5-b1b3-4a59-be19-a675fd939ad5,Kidney,41,D74C7152-798F-4913-95D3-67AC834204F0,642E1379-1061-40BC-9A4C-F7C191E84D9D,TCGA-AL-3466-01A-02D-1402-10,GRCh37-lite,TCGA-AL-3466,TCGA-KIRP,293,s11766,Baylor College of Medicine,Fox Chase,None,NO,T3b,N1,Kidney Papillary Renal Cell Carcinoma,Stage IV
13722.58cfa832e4b0c9d6adf6d1b9,58cfa832e4b0c9d6adf6d1b9,TCGA-HE-A5NL-01A-11D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-HE-A5NL-01A-11D-A26P-10_wgs_Illumina,TCGA-HE-A5NL-01A-11D-A26P-10_wgs_Illumina.bam,35.01,NA,0.07,58cfa832e4b0c9d6adf6d1b9,TCGA-HE-A5NL-01A-11D-A26P-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-HE-A5NL-01A,E4245FFF-1281-40E5-87B4-4E42A18A3A63,Primary Tumor,Illumina HiSeq,14b775e3-8ff9-4815-bb25-ebfc6c526e2f,Kidney,51,21B630BE-466D-46A3-801A-7EB593BDDDB6,A441697C-4CA0-4EAB-9B01-B9CB50223CE2,TCGA-HE-A5NL-01A-11D-A26P-10,GRCh37-lite,TCGA-HE-A5NL,TCGA-KIRP,NA,s11589,Baylor College of Medicine,Ontario Institute for Cancer Research (OICR),Canada,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c8fe,58cfa831e4b0c9d6adf6c8fe,TCGA-CN-6994-01A-11D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CN-6994-01A-11D-A32X-10_wgs_Illumina,TCGA-CN-6994-01A-11D-A32X-10_wgs_Illumina.bam,267.7,NA,0.07,58cfa831e4b0c9d6adf6c8fe,TCGA-CN-6994-01A-11D-A32X-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-6994-01A,6909302D-358A-46CD-8052-EEDB09C83C83,Primary Tumor,Illumina HiSeq,165171a0-a11e-4c82-b718-897ca9741478,Head and Neck,67,1A5AF8E2-61B4-4A04-B4B6-EA41FC34C89A,190EB791-383D-4E27-870D-E470630843E7,TCGA-CN-6994-01A-11D-A32X-10,GRCh37-lite,TCGA-CN-6994,TCGA-HNSC,NA,s16325,Baylor College of Medicine,University of Pittsburgh,United States,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82fe4b0c9d6adf6b3de,58cfa82fe4b0c9d6adf6b3de,TCGA-24-1548-01A-01D-A324-10_wgs_Illumina.filtered.,WGS,TCGA-24-1548-01A-01D-A324-10_wgs_Illumina,TCGA-24-1548-01A-01D-A324-10_wgs_Illumina.bam,329.97,1.9,0.08,58cfa82fe4b0c9d6adf6b3de,TCGA-24-1548-01A-01D-A324-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,Aligned reads,TCGA-24-1548-01A,66C92B9E-DE3C-4D1A-BB69-46FFBC6CAF33,Primary Tumor,Illumina HiSeq,fdbe2c95-c130-4b34-b97f-39aa05a1f35e,Ovary,57,5D4E65AA-D7D0-43EC-B395-DF2F01B1A203,A1FC7064-ABF5-477D-983E-576A784E1D40,TCGA-24-1548-01A-01D-A324-10,GRCh37-lite,TCGA-24-1548,TCGA-OV,493,s17672,Baylor College of Medicine,Washington University,None,NO,Not available,Not available,Serous Cystadenocarcinoma,Not available
13722.58cfa82ee4b0c9d6adf6add6,58cfa82ee4b0c9d6adf6add6,G39020.TCGA-BR-8690-01A-11D-2394-08.4.filtered.,WGS,G39020.TCGA-BR-8690-01A-11D-2394-08.4,G39020.TCGA-BR-8690-01A-11D-2394-08.4.bam,390,NA,0.05,58cfa82ee4b0c9d6adf6add6,G39020.TCGA-BR-8690-01A-11D-2394-08.4.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,Aligned reads,TCGA-BR-8690-01A,337819D2-5281-4B41-9583-A476924BC837,Primary Tumor,Illumina HiSeq,4a0c62bb-6857-41e2-8933-37b5cb32f6b7,Stomach,54,0F7EBFFA-D119-45D6-8AF1-2048ECA173E7,EDC8839F-FA6B-41E0-AD49-F688073730BD,TCGA-BR-8690-01A-11D-2394-08,HG19_Broad_variant,TCGA-BR-8690,TCGA-STAD,NA,s14390,Broad Institute of MIT and Harvard,Asterand,Ukraine,NO,T3,N3a,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIB
13722.58cfa82ee4b0c9d6adf6af4e,58cfa82ee4b0c9d6adf6af4e,G49537.TCGA-EL-A4K6-01A-12D-A257-08.2.filtered.,WGS,G49537.TCGA-EL-A4K6-01A-12D-A257-08.2,G49537.TCGA-EL-A4K6-01A-12D-A257-08.2.bam,55.8,NA,0.08,58cfa82ee4b0c9d6adf6af4e,G49537.TCGA-EL-A4K6-01A-12D-A257-08.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-EL-A4K6-01A,4FC8E011-4433-4537-B03F-457A3A70240F,Primary Tumor,Illumina HiSeq,3fa6f792-4048-42a5-990b-a50e3e20fa7a,Thyroid,75,BB98FF62-4CD8-46D6-9A85-8439265BE40B,66EB4833-1B87-4FD9-A53D-26DC7AD6DE29,TCGA-EL-A4K6-01A-12D-A257-08,HG19_Broad_variant,TCGA-EL-A4K6,TCGA-THCA,NA,s12498,Broad Institute of MIT and Harvard,MD Anderson,United States,NO,T4,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage IV
13722.58cfa830e4b0c9d6adf6c048,58cfa830e4b0c9d6adf6c048,TCGA-B3-3925-01A-02D-1402-10_wgs_Illumina.filtered.,WGS,TCGA-B3-3925-01A-02D-1402-10_wgs_Illumina,TCGA-B3-3925-01A-02D-1402-10_wgs_Illumina.bam,241.07,1.9,0.05,58cfa830e4b0c9d6adf6c048,TCGA-B3-3925-01A-02D-1402-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B3-3925-01A,75A53BFF-BF0F-4AD8-9B8E-14A27914D4F2,Primary Tumor,Illumina HiSeq,9130f58c-9250-4f4f-a60d-028366b76852,Kidney,52,16223531-33C3-4D2C-8715-FA9899CEE168,42F88B95-FA12-47C7-93F1-CF72F207291C,TCGA-B3-3925-01A-02D-1402-10,GRCh37-lite,TCGA-B3-3925,TCGA-KIRP,NA,s11770,Baylor College of Medicine,Christiana Healthcare,None,NO,T3a,NX,Kidney Papillary Renal Cell Carcinoma,Stage III
13722.58cfa830e4b0c9d6adf6bc36,58cfa830e4b0c9d6adf6bc36,TCGA-AL-3467-01A-02D-1402-10_wgs_Illumina.filtered.,WGS,TCGA-AL-3467-01A-02D-1402-10_wgs_Illumina,TCGA-AL-3467-01A-02D-1402-10_wgs_Illumina.bam,305.07,1.9,0.05,58cfa830e4b0c9d6adf6bc36,TCGA-AL-3467-01A-02D-1402-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-AL-3467-01A,4D02010E-9E69-40D3-9BF0-3D4510AA0614,Primary Tumor,Illumina HiSeq,23233f91-10b3-48ca-9864-1ed41832b031,Kidney,54,70E32971-74E6-4C92-8424-D10541D39360,74C4C45F-818F-43A6-82A0-8E3E4EFDA26B,TCGA-AL-3467-01A-02D-1402-10,GRCh37-lite,TCGA-AL-3467,TCGA-KIRP,NA,s11580,Baylor College of Medicine,Fox Chase,None,NO,T1b,NX,Kidney Papillary Renal Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6c005,58cfa830e4b0c9d6adf6c005,TCGA-B3-4103-01A-02D-1402-10_wgs_Illumina.filtered.,WGS,TCGA-B3-4103-01A-02D-1402-10_wgs_Illumina,TCGA-B3-4103-01A-02D-1402-10_wgs_Illumina.bam,216.07,1.9,0.05,58cfa830e4b0c9d6adf6c005,TCGA-B3-4103-01A-02D-1402-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B3-4103-01A,1A726069-0B44-42AD-9A20-0EE90B31796B,Primary Tumor,Illumina HiSeq,e00b0cfe-8b23-4f21-998f-957efbc26955,Kidney,56,3829FA12-FDD5-4829-8F00-BDFBB057F23E,1DA96C26-20A5-435A-8CA3-9F698B8652A2,TCGA-B3-4103-01A-02D-1402-10,GRCh37-lite,TCGA-B3-4103,TCGA-KIRP,NA,s11853,Baylor College of Medicine,Christiana Healthcare,None,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bc4a,58cfa830e4b0c9d6adf6bc4a,TCGA-AL-3468-01A-02D-1402-10_wgs_Illumina.filtered.,WGS,TCGA-AL-3468-01A-02D-1402-10_wgs_Illumina,TCGA-AL-3468-01A-02D-1402-10_wgs_Illumina.bam,171.07,1.9,0.05,58cfa830e4b0c9d6adf6bc4a,TCGA-AL-3468-01A-02D-1402-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-AL-3468-01A,2272C592-B9B6-4483-9F7F-6E185699B900,Primary Tumor,Illumina HiSeq,2cdb23d3-23d0-4aef-9ab9-0f01c712eafa,Kidney,74,2E825CE0-8121-4D0F-B876-905A1DF66D46,19D6CF34-1CD7-4242-A4D1-5D3E11F428AA,TCGA-AL-3468-01A-02D-1402-10,GRCh37-lite,TCGA-AL-3468,TCGA-KIRP,NA,s11578,Baylor College of Medicine,Fox Chase,United States,NO,T2,NX,Kidney Papillary Renal Cell Carcinoma,Stage II
13722.58cfa830e4b0c9d6adf6c178,58cfa830e4b0c9d6adf6c178,TCGA-B9-4115-01A-01D-1554-10_wgs_Illumina.filtered.,WGS,TCGA-B9-4115-01A-01D-1554-10_wgs_Illumina,TCGA-B9-4115-01A-01D-1554-10_wgs_Illumina.bam,374.67,1.9,0.05,58cfa830e4b0c9d6adf6c178,TCGA-B9-4115-01A-01D-1554-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B9-4115-01A,A121406A-30B2-4717-AE96-EDCB17D911E2,Primary Tumor,Illumina HiSeq,4971043f-212e-4a2c-a9db-7e10c9203ce1,Kidney,53,31769C98-8882-44E9-B61B-417903B3E4F5,0ED63D84-D3FE-4289-9255-35F4A03B703B,TCGA-B9-4115-01A-01D-1554-10,GRCh37-lite,TCGA-B9-4115,TCGA-KIRP,NA,s11858,Baylor College of Medicine,UNC,None,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa82ee4b0c9d6adf6ac7e,58cfa82ee4b0c9d6adf6ac7e,G47088.TCGA-85-8052-01A-11D-2244-08.3.filtered.,WGS,G47088.TCGA-85-8052-01A-11D-2244-08.3,G47088.TCGA-85-8052-01A-11D-2244-08.3.bam,56.03,NA,0.05,58cfa82ee4b0c9d6adf6ac7e,G47088.TCGA-85-8052-01A-11D-2244-08.3.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-85-8052-01A,395BABB3-3F5D-4E71-A675-AF4443F23028,Primary Tumor,Illumina HiSeq,541bd2eb-5c99-4a8c-a9d3-c05c470d15f8,Lung,53,9248B38E-EC7B-4C7C-BCB0-E942CE3C4847,43AA4123-0FE2-4071-8A81-CBDD0410B917,TCGA-85-8052-01A-11D-2244-08,HG19_Broad_variant,TCGA-85-8052,TCGA-LUSC,NA,s10498,Broad Institute of MIT and Harvard,Asterand,Russia,NO,T3,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIB
13722.58cfa832e4b0c9d6adf6d168,58cfa832e4b0c9d6adf6d168,TCGA-KL-8328-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8328-01A-11D-2310-10_wgs_Illumina,TCGA-KL-8328-01A-11D-2310-10_wgs_Illumina.bam,110.3,NA,0.05,58cfa832e4b0c9d6adf6d168,TCGA-KL-8328-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8328-01A,452135F2-6DE6-4593-A091-DDF6344EE431,Primary Tumor,Illumina HiSeq,c5c55965-aec9-4c64-9d09-4dbba956669c,Kidney,60,BBCD6B07-862B-4DA1-8880-9D98B643898C,2CCD028D-E7E0-4F77-A512-F658A31819A4,TCGA-KL-8328-01A-11D-2310-10,GRCh37-lite,TCGA-KL-8328,TCGA-KICH,NA,s16518,Baylor College of Medicine,MSKCC,United States,NO,T2b,N0,Kidney Chromophobe,Stage II
13722.58cfa82ee4b0c9d6adf6acec,58cfa82ee4b0c9d6adf6acec,G49537.TCGA-DE-A3KN-01A-11D-A20C-08.2.filtered.,WGS,G49537.TCGA-DE-A3KN-01A-11D-A20C-08.2,G49537.TCGA-DE-A3KN-01A-11D-A20C-08.2.bam,47.57,NA,0.08,58cfa82ee4b0c9d6adf6acec,G49537.TCGA-DE-A3KN-01A-11D-A20C-08.2.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Aligned reads,TCGA-DE-A3KN-01A,085FFCDC-8600-42E2-852A-506465F716A2,Primary Tumor,Illumina HiSeq,62705306-2ad4-4287-ac8d-ca27cf525430,Thyroid,49,620B21C9-AC06-4154-A941-2532C775C6D8,07A7C634-BD9A-4FC2-B9FE-87B060EC3D1F,TCGA-DE-A3KN-01A-11D-A20C-08,HG19_Broad_variant,TCGA-DE-A3KN,TCGA-THCA,NA,s11984,Broad Institute of MIT and Harvard,University of North Carolina,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA
13722.58cfa831e4b0c9d6adf6c3a6,58cfa831e4b0c9d6adf6c3a6,TCGA-CC-A1HT-01A-11D-A12Z-10_wgs_Illumina.filtered.,WGS,TCGA-CC-A1HT-01A-11D-A12Z-10_wgs_Illumina,TCGA-CC-A1HT-01A-11D-A12Z-10_wgs_Illumina.bam,75.65,1.95,0.08,58cfa831e4b0c9d6adf6c3a6,TCGA-CC-A1HT-01A-11D-A12Z-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-CC-A1HT-01A,670C1CBC-4494-45F1-BB8B-18DB82D4F7E0,Primary Tumor,Illumina HiSeq,f7c13bc4-5edc-4964-8267-e7956bf2fdd0,Liver,50,96F911ED-2064-4745-AD07-6C47B0A0C7CD,6B25A78F-20DC-4CCC-B4C0-F9885D16725D,TCGA-CC-A1HT-01A-11D-A12Z-10,GRCh37-lite,TCGA-CC-A1HT,TCGA-LIHC,NA,s16850,Baylor College of Medicine,ILSbio,Vietnam,NO,T3,N0,Hepatocellular Carcinoma,Stage IIIA
13722.58cfa832e4b0c9d6adf6d2d4,58cfa832e4b0c9d6adf6d2d4,TCGA-KL-8346-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8346-01A-11D-2310-10_wgs_Illumina,TCGA-KL-8346-01A-11D-2310-10_wgs_Illumina.bam,69.8,NA,0.05,58cfa832e4b0c9d6adf6d2d4,TCGA-KL-8346-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8346-01A,A122D361-835E-4CF2-850F-AF7864AA112C,Primary Tumor,Illumina HiSeq,bed80d0d-f127-4c4f-9a1f-2c032aa9b498,Kidney,62,ABCF54FE-D93E-4C3B-ACD0-757CDD6A3D3B,BD2EC47B-A120-4B3B-B10D-AEE09805AB33,TCGA-KL-8346-01A-11D-2310-10,GRCh37-lite,TCGA-KL-8346,TCGA-KICH,NA,s16429,Baylor College of Medicine,MSKCC,United States,NO,T2b,N0,Kidney Chromophobe,Stage II
13722.58cfa82de4b0c9d6adf6a720,58cfa82de4b0c9d6adf6a720,G13232.TCGA-60-2726-01A-01D-1522-08.2.filtered.,WGS,G13232.TCGA-60-2726-01A-01D-1522-08.2,G13232.TCGA-60-2726-01A-01D-1522-08.2.bam,741.3,1.9,0.05,58cfa82de4b0c9d6adf6a720,G13232.TCGA-60-2726-01A-01D-1522-08.2.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,Aligned reads,TCGA-60-2726-01A,3D1F4059-2220-45B4-A4D2-B14F76CEC96A,Primary Tumor,Illumina HiSeq,f4213e44-6813-4ccc-a6aa-9213ff594b0b,Lung,56,91A60807-2D0F-474E-B02F-18FEA788B319,A96EDDFC-3AFB-4BF8-A440-C91778113FBD,TCGA-60-2726-01A-01D-1522-08,HG19_Broad_variant,TCGA-60-2726,TCGA-LUSC,358,s10250,Broad Institute of MIT and Harvard,Roswell Park,United States,NO,T2,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIA
13722.58cfa832e4b0c9d6adf6d320,58cfa832e4b0c9d6adf6d320,TCGA-KN-8425-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8425-01A-11D-2310-10_wgs_Illumina,TCGA-KN-8425-01A-11D-2310-10_wgs_Illumina.bam,71.3,NA,0.05,58cfa832e4b0c9d6adf6d320,TCGA-KN-8425-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KN-8425-01A,CC316FAF-DCB1-4DEA-B8B0-A17D000FF40F,Primary Tumor,Illumina HiSeq,60135711-8234-4e49-8d15-e9a5a0726f68,Kidney,53,84ED1792-CEC8-4F98-9988-74B3F5F6F516,81BB13FC-F082-4C0B-8066-1729F11EF617,TCGA-KN-8425-01A-11D-2310-10,GRCh37-lite,TCGA-KN-8425,TCGA-KICH,NA,s16527,Baylor College of Medicine,Harvard,United States,NO,T1b,N0,Kidney Chromophobe,Stage I
13722.58cfa831e4b0c9d6adf6cae4,58cfa831e4b0c9d6adf6cae4,TCGA-DQ-5625-01A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-DQ-5625-01A-01D-A32X-10_wgs_Illumina,TCGA-DQ-5625-01A-01D-A32X-10_wgs_Illumina.bam,154.7,1.9,0.08,58cfa831e4b0c9d6adf6cae4,TCGA-DQ-5625-01A-01D-A32X-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-DQ-5625-01A,53D9A130-4A3A-4491-85CD-9A44415A1632,Primary Tumor,Illumina HiSeq,cb931cae-83da-428c-86f1-59df36c9af80,Head and Neck,52,74856E66-109F-4A68-A496-8FA66729FE1F,D3709EEA-CA2A-49AC-B79C-871A5473D450,TCGA-DQ-5625-01A-01D-A32X-10,GRCh37-lite,TCGA-DQ-5625,TCGA-HNSC,NA,s16061,Baylor College of Medicine,University of Michigan,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d2e2,58cfa832e4b0c9d6adf6d2e2,TCGA-KL-8344-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8344-01A-11D-2310-10_wgs_Illumina,TCGA-KL-8344-01A-11D-2310-10_wgs_Illumina.bam,156.3,NA,0.05,58cfa832e4b0c9d6adf6d2e2,TCGA-KL-8344-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8344-01A,A5AF1391-89D3-4F41-930E-7E8272AFEC98,Primary Tumor,Illumina HiSeq,85c6bd93-8e9d-43f8-ad70-a8d080e1c284,Kidney,51,4CEA843F-80AE-4284-B70F-8989717EEE7C,3ACE181A-23BD-424E-A87E-E0C01A2A2CB8,TCGA-KL-8344-01A-11D-2310-10,GRCh37-lite,TCGA-KL-8344,TCGA-KICH,NA,s16474,Baylor College of Medicine,MSKCC,United States,NO,T3a,N0,Kidney Chromophobe,Stage III
13722.58cfa832e4b0c9d6adf6d029,58cfa832e4b0c9d6adf6d029,TCGA-HE-A5NI-01A-11D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-HE-A5NI-01A-11D-A26P-10_wgs_Illumina,TCGA-HE-A5NI-01A-11D-A26P-10_wgs_Illumina.bam,27.28,NA,0.08,58cfa832e4b0c9d6adf6d029,TCGA-HE-A5NI-01A-11D-A26P-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-HE-A5NI-01A,D61E22D8-C3CE-4237-83D7-DA188B9FD456,Primary Tumor,Illumina HiSeq,b85a3000-296d-44e9-8c6b-9a5db0104583,Kidney,73,520E4C08-E7C6-407F-94CD-A07681BC24A8,40A609BB-2C8F-4146-83C4-E7B0D1B23619,TCGA-HE-A5NI-01A-11D-A26P-10,GRCh37-lite,TCGA-HE-A5NI,TCGA-KIRP,NA,s11651,Baylor College of Medicine,Ontario Institute for Cancer Research (OICR),Canada,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6c198,58cfa830e4b0c9d6adf6c198,TCGA-B9-4116-01A-02D-1402-10_wgs_Illumina.filtered.,WGS,TCGA-B9-4116-01A-02D-1402-10_wgs_Illumina,TCGA-B9-4116-01A-02D-1402-10_wgs_Illumina.bam,149.07,1.8,0.05,58cfa830e4b0c9d6adf6c198,TCGA-B9-4116-01A-02D-1402-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B9-4116-01A,4EDD92E1-5DA5-49A3-80E4-FA456AA425B8,Primary Tumor,Illumina HiSeq,23059106-498b-44b7-a1a9-72b42dcd751c,Kidney,75,DAC245C0-39A0-40D3-8FE1-E33F97B95D27,E6801359-D1D7-4871-B2FB-180674A2E469,TCGA-B9-4116-01A-02D-1402-10,GRCh37-lite,TCGA-B9-4116,TCGA-KIRP,NA,s11772,Baylor College of Medicine,UNC,None,NO,T2a,NX,Kidney Papillary Renal Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d2fe,58cfa832e4b0c9d6adf6d2fe,TCGA-KM-8441-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KM-8441-01A-11D-2310-10_wgs_Illumina,TCGA-KM-8441-01A-11D-2310-10_wgs_Illumina.bam,28.3,NA,0.05,58cfa832e4b0c9d6adf6d2fe,TCGA-KM-8441-01A-11D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KM-8441-01A,F31BA8EC-A3DD-4DD8-8D15-F6C5975EBE44,Primary Tumor,Illumina HiSeq,a15ce5fc-4e2f-4fe0-b799-1be690aa31b9,Kidney,61,566A0F2C-743C-4F18-B14E-1667A8666008,97C1A300-978D-4DF1-9E97-CE2F92B9EFF1,TCGA-KM-8441-01A-11D-2310-10,GRCh37-lite,TCGA-KM-8441,TCGA-KICH,NA,s16570,Baylor College of Medicine,NCI Urologic Oncology Branch,United States,NO,T1b,NX,Kidney Chromophobe,Stage I
13722.58cfa830e4b0c9d6adf6c1d6,58cfa830e4b0c9d6adf6c1d6,TCGA-BC-A216-01A-11D-A152-10_wgs_Illumina.filtered.,WGS,TCGA-BC-A216-01A-11D-A152-10_wgs_Illumina,TCGA-BC-A216-01A-11D-A152-10_wgs_Illumina.bam,85.26,1.85,0.09,58cfa830e4b0c9d6adf6c1d6,TCGA-BC-A216-01A-11D-A152-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-BC-A216-01A,4BBDBE77-F3CB-4B64-9826-72DEBB734784,Primary Tumor,Illumina HiSeq,b808f3c9-f5be-4c4d-af62-4389365badbb,Liver,62,F8B5247F-5276-4189-9041-2D914482D539,C1D9ED06-7498-4C6C-A0DE-DBF28E868109,TCGA-BC-A216-01A-11D-A152-10,GRCh37-lite,TCGA-BC-A216,TCGA-LIHC,NA,s16672,Baylor College of Medicine,UNC,United States,NO,T3,NX,Hepatocellular Carcinoma,Stage IIIA
13722.58cfa832e4b0c9d6adf6d30e,58cfa832e4b0c9d6adf6d30e,TCGA-KN-8431-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8431-01A-11D-2310-10_wgs_Illumina,TCGA-KN-8431-01A-11D-2310-10_wgs_Illumina.bam,71.3,NA,0.05,58cfa832e4b0c9d6adf6d30e,TCGA-KN-8431-01A-11D-2310-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Kidney Chromophobe,Aligned reads,TCGA-KN-8431-01A,04E9A63A-D742-488C-8564-BF9D79AA2091,Primary Tumor,Illumina HiSeq,335b2e98-ed12-462c-8a68-11724a840ad0,Kidney,35,2BBA3FAA-8D55-4AEC-863D-AAE1CEA6FEAB,93B51C61-6EEA-4228-A102-840A2E118522,TCGA-KN-8431-01A-11D-2310-10,GRCh37-lite,TCGA-KN-8431,TCGA-KICH,NA,s16403,Baylor College of Medicine,Harvard,United States,NO,T2,NX,Kidney Chromophobe,Stage II
13722.58cfa830e4b0c9d6adf6c14b,58cfa830e4b0c9d6adf6c14b,TCGA-B9-4114-01A-01D-1253-10_wgs_Illumina.filtered.,WGS,TCGA-B9-4114-01A-01D-1253-10_wgs_Illumina,TCGA-B9-4114-01A-01D-1253-10_wgs_Illumina.bam,712.94,1.9,0.16,58cfa830e4b0c9d6adf6c14b,TCGA-B9-4114-01A-01D-1253-10_wgs_Illumina.bam,,Not available,,,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B9-4114-01A,DF135722-B98D-4DEC-906D-77DA13DF39B9,Primary Tumor,Illumina HiSeq,ed50ed46-d48f-439f-9686-0e9d42b7b9ba,Kidney,NA,A780530F-AB0B-45C8-AB7D-29BF2DD19C9F,D8415CF6-8E4D-4C54-811E-199DA14237F1,TCGA-B9-4114-01A-01D-1253-10,GRCh37-lite,TCGA-B9-4114,TCGA-KIRP,NA,s11771,Baylor College of Medicine,UNC,None,NO,NA,NA,NA,NA
13722.58cfa832e4b0c9d6adf6d2fc,58cfa832e4b0c9d6adf6d2fc,TCGA-KM-8442-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KM-8442-01A-11D-2310-10_wgs_Illumina,TCGA-KM-8442-01A-11D-2310-10_wgs_Illumina.bam,71.3,NA,0.05,58cfa832e4b0c9d6adf6d2fc,TCGA-KM-8442-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,Not available,HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KM-8442-01A,40F79CFE-A51F-497B-B06E-7A4F9004F092,Primary Tumor,Illumina HiSeq,7555ac98-9d69-49ff-a604-7ee15dbf1190,Kidney,38,839592BE-2687-4996-ACF8-0BFDE2B2BE22,9FB73D89-F7C4-47B2-810B-3CE37CD8A3C9,TCGA-KM-8442-01A-11D-2310-10,GRCh37-lite,TCGA-KM-8442,TCGA-KICH,NA,s16392,Baylor College of Medicine,NCI Urologic Oncology Branch,United States,NO,T2,NX,Kidney Chromophobe,Stage II
13722.58cfa832e4b0c9d6adf6d296,58cfa832e4b0c9d6adf6d296,TCGA-KM-8439-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KM-8439-01A-11D-2310-10_wgs_Illumina,TCGA-KM-8439-01A-11D-2310-10_wgs_Illumina.bam,96.3,NA,0.05,58cfa832e4b0c9d6adf6d296,TCGA-KM-8439-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KM-8439-01A,739DEED4-D1DC-458F-BD0F-1E24D2BFD305,Primary Tumor,Illumina HiSeq,1da1e41d-ec72-4c5f-9c1f-50f9606970e1,Kidney,30,A59051E9-5155-4073-A4D6-C9A8C54AD118,9D3B0B87-5FC5-4D09-9C63-4D5FC4BC46D0,TCGA-KM-8439-01A-11D-2310-10,GRCh37-lite,TCGA-KM-8439,TCGA-KICH,NA,s16484,Baylor College of Medicine,NCI Urologic Oncology Branch,United States,NO,T1b,NX,Kidney Chromophobe,Stage I
13722.58cfa832e4b0c9d6adf6d354,58cfa832e4b0c9d6adf6d354,TCGA-KO-8409-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KO-8409-01A-11D-2310-10_wgs_Illumina,TCGA-KO-8409-01A-11D-2310-10_wgs_Illumina.bam,151.2,NA,0.05,58cfa832e4b0c9d6adf6d354,TCGA-KO-8409-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KO-8409-01A,08A96DEC-E658-493A-9308-83F7ACE3B3B6,Primary Tumor,Illumina HiSeq,a6a7348b-80db-4f3a-b7eb-77e0575ab072,Kidney,69,56B3AC6B-BD6E-4960-8610-292CF154A705,8DF1EEB4-DFC9-4A0A-8F93-98460C3AB489,TCGA-KO-8409-01A-11D-2310-10,GRCh37-lite,TCGA-KO-8409,TCGA-KICH,NA,s16445,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T2b,N0,Kidney Chromophobe,Stage II
13722.58cfa832e4b0c9d6adf6d332,58cfa832e4b0c9d6adf6d332,TCGA-KN-8432-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8432-01A-11D-2310-10_wgs_Illumina,TCGA-KN-8432-01A-11D-2310-10_wgs_Illumina.bam,205.3,NA,0.05,58cfa832e4b0c9d6adf6d332,TCGA-KN-8432-01A-11D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KN-8432-01A,AF1111AF-9384-4E37-9B16-227D38007EBD,Primary Tumor,Illumina HiSeq,be9bfce6-c244-4dcb-b5df-36fab219e0f6,Kidney,86,F27E987E-DA76-40C2-B7B8-5DEE724D7EB7,85ED2434-DA94-4333-90CA-6CA4691CBDD3,TCGA-KN-8432-01A-11D-2310-10,GRCh37-lite,TCGA-KN-8432,TCGA-KICH,NA,s16406,Baylor College of Medicine,Harvard,United States,NO,T2b,NX,Kidney Chromophobe,Stage II
13722.58cfa832e4b0c9d6adf6d17e,58cfa832e4b0c9d6adf6d17e,TCGA-HD-7753-01A-11D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-HD-7753-01A-11D-A32X-10_wgs_Illumina,TCGA-HD-7753-01A-11D-A32X-10_wgs_Illumina.bam,103.73,NA,0.07,58cfa832e4b0c9d6adf6d17e,TCGA-HD-7753-01A-11D-A32X-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-HD-7753-01A,E8AC39E6-377A-412C-B18D-F6C4FC654EC6,Primary Tumor,Illumina HiSeq,393b4af8-b44d-4c3f-b5ca-f7032b687a16,Head and Neck,62,E723F1BB-73A3-4D65-BD25-DE76138515E9,54E78DE0-D357-4125-A904-AB35E461572B,TCGA-HD-7753-01A-11D-A32X-10,GRCh37-lite,TCGA-HD-7753,TCGA-HNSC,NA,s15534,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c43a,58cfa831e4b0c9d6adf6c43a,TCGA-CJ-4870-01A-01D-2098-10_wgs_Illumina.filtered.,WGS,TCGA-CJ-4870-01A-01D-2098-10_wgs_Illumina,TCGA-CJ-4870-01A-01D-2098-10_wgs_Illumina.bam,85.7,1.9,0.15,58cfa831e4b0c9d6adf6c43a,TCGA-CJ-4870-01A-01D-2098-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CJ-4870-01A,78048432-2DE1-498C-9CF1-9C5BD43DAA39,Primary Tumor,Illumina HiSeq,22d3d6f1-5686-493f-b205-6ecc2602d2b8,Kidney,58,F7D03CD3-2D55-400A-BB29-F86CCAE475EC,267A9862-17BD-4056-BA4A-1F373736FFBB,TCGA-CJ-4870-01A-01D-2098-10,GRCh37-lite,TCGA-CJ-4870,TCGA-KIRC,NA,s9566,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T3a,NX,Kidney Clear Cell Renal Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6c8f4,58cfa831e4b0c9d6adf6c8f4,TCGA-CV-7432-01A-11D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CV-7432-01A-11D-A32X-10_wgs_Illumina,TCGA-CV-7432-01A-11D-A32X-10_wgs_Illumina.bam,222.73,NA,0.08,58cfa831e4b0c9d6adf6c8f4,TCGA-CV-7432-01A-11D-A32X-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-7432-01A,EAF674DD-9909-4879-B9A3-74253169EDDD,Primary Tumor,Illumina HiSeq,b0ae59a2-ff3b-4c06-a046-3138e659d051,Head and Neck,79,9213AB13-AFC6-40B9-B278-98DD05C92934,D25A4C65-9CB4-4611-909E-E68F93408D84,TCGA-CV-7432-01A-11D-A32X-10,GRCh37-lite,TCGA-CV-7432,TCGA-HNSC,2570,s15785,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c418,58cfa831e4b0c9d6adf6c418,TCGA-CJ-4878-01A-01D-2098-10_wgs_Illumina.filtered.,WGS,TCGA-CJ-4878-01A-01D-2098-10_wgs_Illumina,TCGA-CJ-4878-01A-01D-2098-10_wgs_Illumina.bam,215.7,1.9,0.15,58cfa831e4b0c9d6adf6c418,TCGA-CJ-4878-01A-01D-2098-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CJ-4878-01A,7CA06DBE-F073-4AEE-86FF-A545FAD5EA93,Primary Tumor,Illumina HiSeq,cb7f204c-4503-4691-b1c7-fe363b44f4de,Kidney,71,24814EED-FDDB-475A-822E-EFFF92202954,DE4C3F91-D164-47DF-9971-FEBA840D247C,TCGA-CJ-4878-01A-01D-2098-10,GRCh37-lite,TCGA-CJ-4878,TCGA-KIRC,NA,s9567,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T3a,NX,Kidney Clear Cell Renal Carcinoma,Stage III
13722.58cfa82ee4b0c9d6adf6abe7,58cfa82ee4b0c9d6adf6abe7,G32538.TCGA-EM-A2CU-01A-12D-A17V-08.4.filtered.,WGS,G32538.TCGA-EM-A2CU-01A-12D-A17V-08.4,G32538.TCGA-EM-A2CU-01A-12D-A17V-08.4.bam,27.26,NA,0.08,58cfa82ee4b0c9d6adf6abe7,G32538.TCGA-EM-A2CU-01A-12D-A17V-08.4.bam,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Aligned reads,TCGA-EM-A2CU-01A,667EB7F6-1D36-49BB-9D7B-C9D167B64619,Primary Tumor,Illumina HiSeq,ef836a6f-dd3c-40ed-af7d-87b77a209877,Thyroid,47,5F75F169-6835-4B42-AF77-AB64CBFB5EF3,788FBFAA-51BF-42A4-AFA6-5B87ED04C2D5,TCGA-EM-A2CU-01A-12D-A17V-08,HG19_Broad_variant,TCGA-EM-A2CU,TCGA-THCA,NA,s12341,Broad Institute of MIT and Harvard,University Health Network,Canada,NO,T2,N1a,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III
13722.58cfa82fe4b0c9d6adf6ba25,58cfa82fe4b0c9d6adf6ba25,TCGA-A3-3363-01A-01D-2094-10_wgs_Illumina.filtered.,WGS,TCGA-A3-3363-01A-01D-2094-10_wgs_Illumina,TCGA-A3-3363-01A-01D-2094-10_wgs_Illumina.bam,864.57,1.9,0.14,58cfa82fe4b0c9d6adf6ba25,TCGA-A3-3363-01A-01D-2094-10_wgs_Illumina.bam,Alive,MALE,ASIAN,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-A3-3363-01A,659294B9-DED9-498A-BC00-C1D4D456AA4A,Primary Tumor,Illumina HiSeq,cbce285a-a226-46dc-9f92-dfe98700c750,Kidney,50,605E86AC-58F6-47D4-8BDE-15EB23C857CC,0F53E757-1823-409F-A0EA-249270728E15,TCGA-A3-3363-01A-01D-2094-10,GRCh37-lite,TCGA-A3-3363,TCGA-KIRC,NA,s9301,Baylor College of Medicine,International Genomics Consortium,None,NO,T2,N0,Kidney Clear Cell Renal Carcinoma,Stage II
13722.58cfa832e4b0c9d6adf6d33a,58cfa832e4b0c9d6adf6d33a,TCGA-KN-8430-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8430-01A-11D-2310-10_wgs_Illumina,TCGA-KN-8430-01A-11D-2310-10_wgs_Illumina.bam,155.3,NA,0.05,58cfa832e4b0c9d6adf6d33a,TCGA-KN-8430-01A-11D-2310-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KN-8430-01A,9F8AA332-E625-46F7-B77B-1FCB3CA99EE2,Primary Tumor,Illumina HiSeq,1722dad6-e2ed-4881-9193-2569f9b36201,Kidney,75,85339F51-85C1-4C2E-966E-CDE3D0CFAC91,70FD4434-02C9-4016-BB89-86BEC4317489,TCGA-KN-8430-01A-11D-2310-10,GRCh37-lite,TCGA-KN-8430,TCGA-KICH,NA,s16401,Baylor College of Medicine,Harvard,United States,NO,T1b,N0,Kidney Chromophobe,Stage I
13722.58cfa832e4b0c9d6adf6d5a2,58cfa832e4b0c9d6adf6d5a2,TCGA-MH-A560-01A-11D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-MH-A560-01A-11D-A26P-10_wgs_Illumina,TCGA-MH-A560-01A-11D-A26P-10_wgs_Illumina.bam,8.04,NA,0.07,58cfa832e4b0c9d6adf6d5a2,TCGA-MH-A560-01A-11D-A26P-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-MH-A560-01A,A40BEABE-496E-4324-A1D1-5A7D8B002AAB,Primary Tumor,Illumina HiSeq,b1efdb03-f6ae-443f-85cc-d545d7710c21,Kidney,62,2697D1DE-3D7E-4BD6-9EDE-7516BD10A701,CF5DEB22-F7EB-409D-A0E4-882716199C39,TCGA-MH-A560-01A-11D-A26P-10,GRCh37-lite,TCGA-MH-A560,TCGA-KIRP,NA,s11594,Baylor College of Medicine,BLN - Baylor,United States,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d523,58cfa832e4b0c9d6adf6d523,TCGA-KN-8419-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8419-01A-11D-2310-10_wgs_Illumina,TCGA-KN-8419-01A-11D-2310-10_wgs_Illumina.bam,17.3,NA,0.05,58cfa832e4b0c9d6adf6d523,TCGA-KN-8419-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KN-8419-01A,DC04B82C-E1E8-4917-BA19-C2FEA4A1B69A,Primary Tumor,Illumina HiSeq,14e44071-dc94-49f8-a105-4012aa8e1767,Kidney,43,65256F5D-63A8-49D3-9D76-A3D7E3DDC0E6,A592E80A-3B1A-46AA-BE30-BCD87D6BCA6F,TCGA-KN-8419-01A-11D-2310-10,GRCh37-lite,TCGA-KN-8419,TCGA-KICH,NA,s16533,Baylor College of Medicine,Harvard,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa832e4b0c9d6adf6d07e,58cfa832e4b0c9d6adf6d07e,TCGA-HE-A5NF-01A-11D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-HE-A5NF-01A-11D-A26P-10_wgs_Illumina,TCGA-HE-A5NF-01A-11D-A26P-10_wgs_Illumina.bam,17.39,NA,0.08,58cfa832e4b0c9d6adf6d07e,TCGA-HE-A5NF-01A-11D-A26P-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-HE-A5NF-01A,36B46540-472F-4A4D-A801-B8B6AE660DC9,Primary Tumor,Illumina HiSeq,ccad1f55-76d4-41fc-abf9-9409c743d7e8,Kidney,58,7C6B9F49-9EA0-4532-BDCE-F8987786BF5A,C14407AD-670E-4D1E-9417-2B76F4810FFF,TCGA-HE-A5NF-01A-11D-A26P-10,GRCh37-lite,TCGA-HE-A5NF,TCGA-KIRP,NA,s11779,Baylor College of Medicine,Ontario Institute for Cancer Research (OICR),Canada,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d32e,58cfa832e4b0c9d6adf6d32e,TCGA-KN-8421-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8421-01A-11D-2310-10_wgs_Illumina,TCGA-KN-8421-01A-11D-2310-10_wgs_Illumina.bam,112.3,NA,0.05,58cfa832e4b0c9d6adf6d32e,TCGA-KN-8421-01A-11D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KN-8421-01A,2FC175D1-9D95-44FD-A53E-820F6F404551,Primary Tumor,Illumina HiSeq,2b4a72cf-171d-4cea-ac2a-528687128d7c,Kidney,47,D4694662-8330-4F19-A25D-9A12751C1B57,BA686386-8113-4885-B20F-6AD09A295604,TCGA-KN-8421-01A-11D-2310-10,GRCh37-lite,TCGA-KN-8421,TCGA-KICH,NA,s16476,Baylor College of Medicine,Harvard,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa832e4b0c9d6adf6d2a0,58cfa832e4b0c9d6adf6d2a0,TCGA-KM-8477-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KM-8477-01A-11D-2310-10_wgs_Illumina,TCGA-KM-8477-01A-11D-2310-10_wgs_Illumina.bam,26.3,NA,0.05,58cfa832e4b0c9d6adf6d2a0,TCGA-KM-8477-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KM-8477-01A,9680B5FF-1882-434F-9981-E8AC33764B93,Primary Tumor,Illumina HiSeq,af92bfa8-a70f-4436-b545-46899487c859,Kidney,56,50DA0237-8E9D-4C08-AE44-F32103E8F095,4ECBFD89-393F-4126-AA1C-951A2C23EF89,TCGA-KM-8477-01A-11D-2310-10,GRCh37-lite,TCGA-KM-8477,TCGA-KICH,NA,s16397,Baylor College of Medicine,NCI Urologic Oncology Branch,United States,NO,T1a,NX,Kidney Chromophobe,Stage I
13722.58cfa831e4b0c9d6adf6c6b9,58cfa831e4b0c9d6adf6c6b9,TCGA-CQ-6225-01A-11D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CQ-6225-01A-11D-A32X-10_wgs_Illumina,TCGA-CQ-6225-01A-11D-A32X-10_wgs_Illumina.bam,191.7,1.9,0.08,58cfa831e4b0c9d6adf6c6b9,TCGA-CQ-6225-01A-11D-A32X-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-6225-01A,90F44998-3C05-44B2-9501-BBD0F43C5147,Primary Tumor,Illumina HiSeq,4bedf81d-7024-4c95-8d97-32aa6de7578e,Head and Neck,65,E907D8D4-C4C6-441F-9F19-FF3746E5D13E,AFA4344E-2252-4EF9-8B8A-14AAE14ACC9C,TCGA-CQ-6225-01A-11D-A32X-10,GRCh37-lite,TCGA-CQ-6225,TCGA-HNSC,403,s15503,Baylor College of Medicine,"University Health Network, Toronto",Canada,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6c8e1,58cfa831e4b0c9d6adf6c8e1,TCGA-CW-5585-01A-01D-2103-10_wgs_Illumina.filtered.,WGS,TCGA-CW-5585-01A-01D-2103-10_wgs_Illumina,TCGA-CW-5585-01A-01D-2103-10_wgs_Illumina.bam,288.4,1.88,0.15,58cfa831e4b0c9d6adf6c8e1,TCGA-CW-5585-01A-01D-2103-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CW-5585-01A,0487FC41-386C-4D76-9084-DAF959BF5E98,Primary Tumor,Illumina HiSeq,ff078c8b-f861-46f7-ac62-eb5ff21a805c,Kidney,51,B5040DA2-0D96-422A-9760-98A95C136FE8,3FEAC02A-C99F-4DD9-9EFF-E4F5E87F7DC5,TCGA-CW-5585-01A-01D-2103-10,GRCh37-lite,TCGA-CW-5585,TCGA-KIRC,NA,s9306,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T3b,N0,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa831e4b0c9d6adf6c7be,58cfa831e4b0c9d6adf6c7be,TCGA-CV-6956-01A-21D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CV-6956-01A-21D-A32X-10_wgs_Illumina,TCGA-CV-6956-01A-21D-A32X-10_wgs_Illumina.bam,124.43,NA,0.07,58cfa831e4b0c9d6adf6c7be,TCGA-CV-6956-01A-21D-A32X-10_wgs_Illumina.bam,Dead,MALE,WHITE,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-6956-01A,8C238D30-DF8E-4E6B-98FC-21696269A294,Primary Tumor,Illumina HiSeq,f9762350-aee5-49d2-a5de-165317ff2bd3,Head and Neck,67,8B9F33FA-04EF-4767-93D1-98F6E420D037,5046F1B4-9D95-4841-BA30-691FA44719A2,TCGA-CV-6956-01A-21D-A32X-10,GRCh37-lite,TCGA-CV-6956,TCGA-HNSC,217,s16201,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T3,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa830e4b0c9d6adf6c00e,58cfa830e4b0c9d6adf6c00e,TCGA-B3-3926-01A-02D-1402-10_wgs_Illumina.filtered.,WGS,TCGA-B3-3926-01A-02D-1402-10_wgs_Illumina,TCGA-B3-3926-01A-02D-1402-10_wgs_Illumina.bam,191.07,1.9,0.05,58cfa830e4b0c9d6adf6c00e,TCGA-B3-3926-01A-02D-1402-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B3-3926-01A,2666AB3E-F2B9-4B3D-BFCE-AAC2A4BAFE62,Primary Tumor,Illumina HiSeq,7825c6ac-6e33-4e1d-82cc-35cf60c16253,Kidney,59,3BB75DF9-E710-4F3D-B1B1-A4D459EB376F,72293A70-9DC8-4E4A-ACDC-C74587A90420,TCGA-B3-3926-01A-02D-1402-10,GRCh37-lite,TCGA-B3-3926,TCGA-KIRP,NA,s11582,Baylor College of Medicine,Christiana Healthcare,None,NO,T1,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d338,58cfa832e4b0c9d6adf6d338,TCGA-KN-8427-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8427-01A-11D-2310-10_wgs_Illumina,TCGA-KN-8427-01A-11D-2310-10_wgs_Illumina.bam,198.3,NA,0.05,58cfa832e4b0c9d6adf6d338,TCGA-KN-8427-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KN-8427-01A,955D428C-8FE8-456B-B86D-65EA6C2A1B18,Primary Tumor,Illumina HiSeq,1ab3dc9e-2973-4b02-bf13-e2f1f27c0f05,Kidney,54,8719FECD-7AB5-4468-A978-5C6BF1D4A1D7,07E0E938-F61F-477A-92A2-5B7E74B78943,TCGA-KN-8427-01A-11D-2310-10,GRCh37-lite,TCGA-KN-8427,TCGA-KICH,NA,s16442,Baylor College of Medicine,Harvard,United States,NO,T4,N1,Kidney Chromophobe,Stage IV
13722.58cfa830e4b0c9d6adf6bcb3,58cfa830e4b0c9d6adf6bcb3,TCGA-B0-5695-01A-11D-2103-10_wgs_Illumina.filtered.,WGS,TCGA-B0-5695-01A-11D-2103-10_wgs_Illumina,TCGA-B0-5695-01A-11D-2103-10_wgs_Illumina.bam,239.4,1.9,0.15,58cfa830e4b0c9d6adf6bcb3,TCGA-B0-5695-01A-11D-2103-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-B0-5695-01A,FB9BAFA5-7133-4955-8156-4EB6763DC8E1,Primary Tumor,Illumina HiSeq,a8ffeac5-01c4-4dac-92b8-413f4009f4fa,Kidney,61,86E4862C-7405-40B5-B73F-BE0C6C52EA6D,B6365BDB-E6D5-4615-95B3-DB12A0C2F3D9,TCGA-B0-5695-01A-11D-2103-10,GRCh37-lite,TCGA-B0-5695,TCGA-KIRC,NA,s8833,Baylor College of Medicine,University of Pittsburgh,None,NO,T1b,N0,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bc4c,58cfa830e4b0c9d6adf6bc4c,TCGA-AL-3473-01A-01D-1253-10_wgs_Illumina.filtered.,WGS,TCGA-AL-3473-01A-01D-1253-10_wgs_Illumina,TCGA-AL-3473-01A-01D-1253-10_wgs_Illumina.bam,543,1.9,0.14,58cfa830e4b0c9d6adf6bc4c,TCGA-AL-3473-01A-01D-1253-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-AL-3473-01A,A7BF785F-0539-4899-AC21-47D1FC347EE8,Primary Tumor,Illumina HiSeq,7f8267f9-4d48-48c6-aebb-a596aaf7755c,Kidney,55,DE88A41B-8A32-40D6-9C0B-1FE2303D8AD2,14DD86C1-DFB3-4124-A453-4D64223BC048,TCGA-AL-3473-01A-01D-1253-10,GRCh37-lite,TCGA-AL-3473,TCGA-KIRP,NA,s11638,Baylor College of Medicine,Fox Chase,None,NO,T2,N0,Kidney Papillary Renal Cell Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c6b0,58cfa831e4b0c9d6adf6c6b0,TCGA-CR-6491-01A-11D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CR-6491-01A-11D-A32X-10_wgs_Illumina,TCGA-CR-6491-01A-11D-A32X-10_wgs_Illumina.bam,78.7,1.9,0.08,58cfa831e4b0c9d6adf6c6b0,TCGA-CR-6491-01A-11D-A32X-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-6491-01A,5FCE954C-11B9-41F4-9471-4B5BDC0EFA7F,Primary Tumor,Illumina HiSeq,85a87fce-1144-4d78-8495-597c211a5312,Head and Neck,60,E23D2F8B-ACA4-43C2-876E-F8C6E1CA2D93,A315B798-F037-48D5-91ED-E733E3BBD6EE,TCGA-CR-6491-01A-11D-A32X-10,GRCh37-lite,TCGA-CR-6491,TCGA-HNSC,NA,s15504,Baylor College of Medicine,Vanderbilt University,United States,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6d2e6,58cfa832e4b0c9d6adf6d2e6,TCGA-KM-8476-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KM-8476-01A-11D-2310-10_wgs_Illumina,TCGA-KM-8476-01A-11D-2310-10_wgs_Illumina.bam,50.3,NA,0.05,58cfa832e4b0c9d6adf6d2e6,TCGA-KM-8476-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KM-8476-01A,4E4FAF51-2CBF-4910-A093-186660E4A19B,Primary Tumor,Illumina HiSeq,bcb52a60-30eb-4af3-8ec1-512d6157e6be,Kidney,47,450DFCB0-F059-4427-9A72-EA51DC48956E,5BEBC389-DE0D-45B8-9D2F-6476988C358A,TCGA-KM-8476-01A-11D-2310-10,GRCh37-lite,TCGA-KM-8476,TCGA-KICH,NA,s16391,Baylor College of Medicine,NCI Urologic Oncology Branch,United States,NO,T1,NX,Kidney Chromophobe,Stage I
13722.58cfa830e4b0c9d6adf6c2a2,58cfa830e4b0c9d6adf6c2a2,TCGA-BP-4807-01A-01D-2098-10_wgs_Illumina.filtered.,WGS,TCGA-BP-4807-01A-01D-2098-10_wgs_Illumina,TCGA-BP-4807-01A-01D-2098-10_wgs_Illumina.bam,91.4,1.9,0.16,58cfa830e4b0c9d6adf6c2a2,TCGA-BP-4807-01A-01D-2098-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-BP-4807-01A,33CF0893-0411-4758-AA90-602BFEDF0850,Primary Tumor,Illumina HiSeq,929b4e29-102f-48e2-a919-ff967127437e,Kidney,42,26307437-2F30-4647-81AC-F6BAE5BE6113,A54AAC0E-4108-49CF-BF50-687031C7CDA6,TCGA-BP-4807-01A-01D-2098-10,GRCh37-lite,TCGA-BP-4807,TCGA-KIRC,NA,s9447,Baylor College of Medicine,MSKCC,None,NO,T1a,NX,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c706,58cfa831e4b0c9d6adf6c706,TCGA-CV-5431-01A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CV-5431-01A-01D-A32X-10_wgs_Illumina,TCGA-CV-5431-01A-01D-A32X-10_wgs_Illumina.bam,464.7,1.8,0.08,58cfa831e4b0c9d6adf6c706,TCGA-CV-5431-01A-01D-A32X-10_wgs_Illumina.bam,Dead,MALE,WHITE,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5431-01A,64BB5550-2735-4401-A0DB-58EC1020A32D,Primary Tumor,Illumina HiSeq,cbfa9144-8087-42ab-9497-71bfeddc55ae,Head and Neck,73,BE567C0A-3833-45D7-B846-D229A8E16E16,DE8EF60B-4DBE-4AA8-ADEF-6F58CDFADA29,TCGA-CV-5431-01A-01D-A32X-10,GRCh37-lite,TCGA-CV-5431,TCGA-HNSC,522,s16192,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T3,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6bed5,58cfa830e4b0c9d6adf6bed5,TCGA-BP-4756-01A-01D-2097-10_wgs_Illumina.filtered.,WGS,TCGA-BP-4756-01A-01D-2097-10_wgs_Illumina,TCGA-BP-4756-01A-01D-2097-10_wgs_Illumina.bam,133,1.9,0.14,58cfa830e4b0c9d6adf6bed5,TCGA-BP-4756-01A-01D-2097-10_wgs_Illumina.bam,Alive,FEMALE,ASIAN,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-BP-4756-01A,9ECDDE9C-2179-4830-BD10-C4FA40F26066,Primary Tumor,Illumina HiSeq,21f5c572-343f-4923-af48-99ee2a4ccbdf,Kidney,62,98D425BE-4D70-4260-8C4F-B0EB89E0E4A6,DB4592FB-13C2-4D61-9DC3-A5D43DEF8D4B,TCGA-BP-4756-01A-01D-2097-10,GRCh37-lite,TCGA-BP-4756,TCGA-KIRC,NA,s9164,Baylor College of Medicine,MSKCC,None,NO,T1b,N0,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c66a,58cfa831e4b0c9d6adf6c66a,TCGA-CR-7382-01A-11D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CR-7382-01A-11D-A32X-10_wgs_Illumina,TCGA-CR-7382-01A-11D-A32X-10_wgs_Illumina.bam,170.7,NA,0.08,58cfa831e4b0c9d6adf6c66a,TCGA-CR-7382-01A-11D-A32X-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CR-7382-01A,F030E410-2585-461E-AD23-9FDF026AC06C,Primary Tumor,Illumina HiSeq,ab5f1c0e-d07d-49b4-9fc2-b74f3c4928a6,Head and Neck,49,A8D8886B-B422-4C66-B0B4-4C9F0546B1B3,B86E88E7-0D5F-4B32-A35F-DC97251AB990,TCGA-CR-7382-01A-11D-A32X-10,GRCh37-lite,TCGA-CR-7382,TCGA-HNSC,NA,s16328,Baylor College of Medicine,Vanderbilt University,United States,NO,T2,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa82ee4b0c9d6adf6abab,58cfa82ee4b0c9d6adf6abab,G1744.TCGA-06-0188-10B-01D.2.filtered.,WGS,G1744.TCGA-06-0188-10B-01D.2,G1744.TCGA-06-0188-10B-01D.2.bam,681.37,1.9,0.14,58cfa82ee4b0c9d6adf6abab,G1744.TCGA-06-0188-10B-01D.2.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,Aligned reads,TCGA-06-0188-10B,6573378A-AD14-4654-8810-9F3BD3597BC2,Blood Derived Normal,Illumina GA,a85039dd-0e37-4f9f-a24e-a95f45d95653,Brain,71,4828D56E-DDFF-424C-8660-967EB06D138C,9B23926E-50E1-4208-91C6-00FBC059CC20,TCGA-06-0188-10B-01D-0373-08,HG18_Broad_variant,TCGA-06-0188,TCGA-GBM,NA,s13921,Broad Institute of MIT and Harvard,Henry Ford Hospital,None,NO,Not available,Not available,Untreated primary (de novo) GBM,Not available
13722.58cfa832e4b0c9d6adf6d29d,58cfa832e4b0c9d6adf6d29d,TCGA-KM-8438-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KM-8438-01A-11D-2310-10_wgs_Illumina,TCGA-KM-8438-01A-11D-2310-10_wgs_Illumina.bam,40.3,NA,0.05,58cfa832e4b0c9d6adf6d29d,TCGA-KM-8438-01A-11D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KM-8438-01A,23656226-2D99-4548-959F-5C2EED803E33,Primary Tumor,Illumina HiSeq,171af111-4e87-4e89-af1b-ee3fbed93db6,Kidney,45,3CBDEE56-19F7-4A7A-850E-A7664E67C919,148536CE-EE2A-4952-A19D-10D6F44146B9,TCGA-KM-8438-01A-11D-2310-10,GRCh37-lite,TCGA-KM-8438,TCGA-KICH,NA,s16399,Baylor College of Medicine,NCI Urologic Oncology Branch,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa831e4b0c9d6adf6c8a8,58cfa831e4b0c9d6adf6c8a8,TCGA-CZ-5453-01A-01D-2102-10_wgs_Illumina.filtered.,WGS,TCGA-CZ-5453-01A-01D-2102-10_wgs_Illumina,TCGA-CZ-5453-01A-01D-2102-10_wgs_Illumina.bam,156.4,1.9,0.15,58cfa831e4b0c9d6adf6c8a8,TCGA-CZ-5453-01A-01D-2102-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CZ-5453-01A,577847B9-F9B6-4954-868F-3D5AB2B4F694,Primary Tumor,Illumina HiSeq,28e40615-1ae0-420f-b7c0-ca99eaa91361,Kidney,67,5C1B955D-9D60-4975-A1E6-C4D531E79190,64446AEC-C125-4C81-B9CC-62482CB1AAED,TCGA-CZ-5453-01A-01D-2102-10,GRCh37-lite,TCGA-CZ-5453,TCGA-KIRC,NA,s9307,Baylor College of Medicine,Harvard,None,NO,T2,NX,Kidney Clear Cell Renal Carcinoma,Stage II
13722.58cfa832e4b0c9d6adf6cef0,58cfa832e4b0c9d6adf6cef0,TCGA-FF-8043-01A-11D-2210-10_wgs_Illumina.filtered.,WGS,TCGA-FF-8043-01A-11D-2210-10_wgs_Illumina,TCGA-FF-8043-01A-11D-2210-10_wgs_Illumina.bam,464.7,NA,0.05,58cfa832e4b0c9d6adf6cef0,TCGA-FF-8043-01A-11D-2210-10_wgs_Illumina.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Aligned reads,TCGA-FF-8043-01A,A8E2DF1E-4042-42AF-9231-3A00E83489F0,Primary Tumor,Illumina HiSeq,a5e8328e-363d-44ee-b7f7-43594627c249,Lymph Nodes,70,DEC7125D-7E6C-4D05-9911-C3FF2A8E2B73,E89E9C69-FFCD-4A4C-818D-1DEE43DDC76A,TCGA-FF-8043-01A-11D-2210-10,GRCh37-lite,TCGA-FF-8043,TCGA-DLBC,NA,s1110,Baylor College of Medicine,SingHealth,Singapore,NO,Not available,Not available,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),Not available
13722.58cfa831e4b0c9d6adf6c954,58cfa831e4b0c9d6adf6c954,TCGA-DQ-5629-01A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-DQ-5629-01A-01D-A32X-10_wgs_Illumina,TCGA-DQ-5629-01A-01D-A32X-10_wgs_Illumina.bam,233.7,1.9,0.08,58cfa831e4b0c9d6adf6c954,TCGA-DQ-5629-01A-01D-A32X-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-DQ-5629-01A,E95E9E7D-A1ED-46EB-9CF8-1D355BF0577F,Primary Tumor,Illumina HiSeq,3fb0505f-e847-4658-93f1-0af7d8617e66,Head and Neck,64,57EA3EED-F8E2-4310-90C0-50D89F818A12,2AFB198A-D4AA-4544-BDCE-85695E185869,TCGA-DQ-5629-01A-01D-A32X-10,GRCh37-lite,TCGA-DQ-5629,TCGA-HNSC,NA,s16345,Baylor College of Medicine,University of Michigan,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c977,58cfa831e4b0c9d6adf6c977,TCGA-DD-A1EL-01A-11D-A152-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A1EL-01A-11D-A152-10_wgs_Illumina,TCGA-DD-A1EL-01A-11D-A152-10_wgs_Illumina.bam,63.8,1.71,0.08,58cfa831e4b0c9d6adf6c977,TCGA-DD-A1EL-01A-11D-A152-10_wgs_Illumina.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A1EL-01A,2854FFE8-1F77-497A-BF49-11E0189FEE35,Primary Tumor,Illumina HiSeq,a4594690-fa54-40f6-bd78-08ffa730aa84,Liver,23,5A756B40-6C08-47E8-9B25-9B3FFFF39606,D252F328-4583-4E97-9A71-BB2885F06F73,TCGA-DD-A1EL-01A-11D-A152-10,GRCh37-lite,TCGA-DD-A1EL,TCGA-LIHC,415,s16676,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T2,N0,Hepatocellular Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6c45e,58cfa831e4b0c9d6adf6c45e,TCGA-CJ-5681-01A-11D-1534-10_wgs_Illumina.filtered.,WGS,TCGA-CJ-5681-01A-11D-1534-10_wgs_Illumina,TCGA-CJ-5681-01A-11D-1534-10_wgs_Illumina.bam,253.4,1.9,0.05,58cfa831e4b0c9d6adf6c45e,TCGA-CJ-5681-01A-11D-1534-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-CJ-5681-01A,2939C03A-6F3F-4F7B-B246-34361BAADEB9,Primary Tumor,Illumina HiSeq,7efcb420-d7ac-41f1-847f-17a9ec6d10d5,Kidney,44,252836BE-AFF6-4967-8887-D93B178A4FF9,9AE0744A-9BC1-4CD7-B7CF-C6569ED9E4AA,TCGA-CJ-5681-01A-11D-1534-10,GRCh37-lite,TCGA-CJ-5681,TCGA-KIRC,552,s9170,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T3a,NX,Kidney Clear Cell Renal Carcinoma,Stage IV
13722.58cfa832e4b0c9d6adf6d027,58cfa832e4b0c9d6adf6d027,TCGA-HE-A5NJ-01A-11D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-HE-A5NJ-01A-11D-A26P-10_wgs_Illumina,TCGA-HE-A5NJ-01A-11D-A26P-10_wgs_Illumina.bam,54.68,NA,0.07,58cfa832e4b0c9d6adf6d027,TCGA-HE-A5NJ-01A-11D-A26P-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-HE-A5NJ-01A,8D28F586-3DE5-4033-A9FD-4F67BE406FB4,Primary Tumor,Illumina HiSeq,ac395d4f-83c9-44e8-af57-fc5266ebef92,Kidney,58,DDB72D04-48F5-4AD5-95A7-8D2614BA0AE0,A9DBD55C-5DCC-48DB-8785-6BAEF3FDD7DB,TCGA-HE-A5NJ-01A-11D-A26P-10,GRCh37-lite,TCGA-HE-A5NJ,TCGA-KIRP,NA,s11652,Baylor College of Medicine,Ontario Institute for Cancer Research (OICR),Canada,NO,T1b,NX,Kidney Papillary Renal Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6c22e,58cfa830e4b0c9d6adf6c22e,TCGA-BA-5149-01A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-BA-5149-01A-01D-A32X-10_wgs_Illumina,TCGA-BA-5149-01A-01D-A32X-10_wgs_Illumina.bam,277.7,1.9,0.08,58cfa830e4b0c9d6adf6c22e,TCGA-BA-5149-01A-01D-A32X-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5149-01A,CB99FB14-641C-4FB3-BF1D-17EFB8CD982A,Primary Tumor,Illumina HiSeq,e69377da-ccc2-447e-9c7f-b7a7743575d8,Head and Neck,47,E5A9FE30-E292-47DC-8EF5-565894B02A62,1FFF8B62-534B-4D71-A65F-E5F93B8B50ED,TCGA-BA-5149-01A-01D-A32X-10,GRCh37-lite,TCGA-BA-5149,TCGA-HNSC,NA,s15752,Baylor College of Medicine,UNC,None,NO,T3,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6d2c4,58cfa832e4b0c9d6adf6d2c4,TCGA-KL-8337-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8337-01A-11D-2310-10_wgs_Illumina,TCGA-KL-8337-01A-11D-2310-10_wgs_Illumina.bam,168.3,NA,0.05,58cfa832e4b0c9d6adf6d2c4,TCGA-KL-8337-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8337-01A,5F633C79-FCF8-47DA-B349-ADA3FB794819,Primary Tumor,Illumina HiSeq,283efb4c-4edf-48c2-975a-9578517c0270,Kidney,26,988D64CE-EE26-4837-8161-86C4831BE203,A3FD2EE0-3DD0-4992-9A9F-75E487B43441,TCGA-KL-8337-01A-11D-2310-10,GRCh37-lite,TCGA-KL-8337,TCGA-KICH,NA,s16390,Baylor College of Medicine,MSKCC,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa832e4b0c9d6adf6d311,58cfa832e4b0c9d6adf6d311,TCGA-KN-8422-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8422-01A-11D-2310-10_wgs_Illumina,TCGA-KN-8422-01A-11D-2310-10_wgs_Illumina.bam,156.3,NA,0.05,58cfa832e4b0c9d6adf6d311,TCGA-KN-8422-01A-11D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KN-8422-01A,4A88BC85-4C6E-4FAC-8DBB-D3FC5F36B35E,Primary Tumor,Illumina HiSeq,29066349-24f2-49ee-bf7e-8094129d4525,Kidney,28,8AC713B0-3781-4964-92F1-DEA763B046DE,D648C804-4EAF-4252-8B6F-13378158A07D,TCGA-KN-8422-01A-11D-2310-10,GRCh37-lite,TCGA-KN-8422,TCGA-KICH,NA,s16479,Baylor College of Medicine,Harvard,United States,NO,T1a,N0,Kidney Chromophobe,Stage I
13722.58cfa831e4b0c9d6adf6c6c6,58cfa831e4b0c9d6adf6c6c6,TCGA-CV-5432-01A-02D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CV-5432-01A-02D-A32X-10_wgs_Illumina,TCGA-CV-5432-01A-02D-A32X-10_wgs_Illumina.bam,341,1.9,0.08,58cfa831e4b0c9d6adf6c6c6,TCGA-CV-5432-01A-02D-A32X-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5432-01A,D89B1FD6-BEF4-4803-8ED3-3B442BE600B6,Primary Tumor,Illumina HiSeq,6d564719-34a3-4b79-bf57-a5c8f73d7436,Head and Neck,68,B4A36114-80D3-4F28-B85A-077DC31EB485,9988EB07-01F6-4F83-8699-BB63E0525F08,TCGA-CV-5432-01A-02D-A32X-10,GRCh37-lite,TCGA-CV-5432,TCGA-HNSC,NA,s16196,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa832e4b0c9d6adf6d29a,58cfa832e4b0c9d6adf6d29a,TCGA-KL-8343-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8343-01A-11D-2310-10_wgs_Illumina,TCGA-KL-8343-01A-11D-2310-10_wgs_Illumina.bam,71.3,NA,0.05,58cfa832e4b0c9d6adf6d29a,TCGA-KL-8343-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KL-8343-01A,B4A0BF74-1381-4C17-B97D-206810D9E59A,Primary Tumor,Illumina HiSeq,a7a4a6a6-4a0b-4611-9bd4-1d86b0ddf49c,Kidney,72,FFE4DFE1-B2FE-448E-8664-8299484FC809,34739BD6-B3BE-441D-8CDB-E4233BF14080,TCGA-KL-8343-01A-11D-2310-10,GRCh37-lite,TCGA-KL-8343,TCGA-KICH,NA,s16394,Baylor College of Medicine,MSKCC,United States,NO,T3,N0,Kidney Chromophobe,Stage III
13722.58cfa830e4b0c9d6adf6c15e,58cfa830e4b0c9d6adf6c15e,TCGA-BA-6869-01A-11D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-BA-6869-01A-11D-A32X-10_wgs_Illumina,TCGA-BA-6869-01A-11D-A32X-10_wgs_Illumina.bam,379.7,1.9,0.07,58cfa830e4b0c9d6adf6c15e,TCGA-BA-6869-01A-11D-A32X-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-6869-01A,FAFD6F5B-1D76-4537-BD1C-E0BD7B4E2166,Primary Tumor,Illumina HiSeq,e35c380b-a1ee-47e3-b382-139ed8640d98,Head and Neck,62,F4ED2C84-39F8-4AB3-8762-A9920ACC2432,3E604A1C-B95F-44FF-9723-E2FAC845DA3B,TCGA-BA-6869-01A-11D-A32X-10,GRCh37-lite,TCGA-BA-6869,TCGA-HNSC,NA,s15615,Baylor College of Medicine,UNC,United States,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa830e4b0c9d6adf6be22,58cfa830e4b0c9d6adf6be22,TCGA-B9-4113-01A-01D-1253-10_wgs_Illumina.filtered.,WGS,TCGA-B9-4113-01A-01D-1253-10_wgs_Illumina,TCGA-B9-4113-01A-01D-1253-10_wgs_Illumina.bam,0,1.9,0.15,58cfa830e4b0c9d6adf6be22,TCGA-B9-4113-01A-01D-1253-10_wgs_Illumina.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B9-4113-01A,5C9A6C40-982E-45C7-98D3-AEB6CAD16986,Primary Tumor,Illumina HiSeq,946b3469-d936-4438-8fc4-3075da99cd4d,Kidney,64,DDDC5575-D88F-4F4E-B591-96F11403184B,F03330DD-C616-4AD5-ABC3-6D6B0445E9E9,TCGA-B9-4113-01A-01D-1253-10,GRCh37-lite,TCGA-B9-4113,TCGA-KIRP,1536,s11585,Baylor College of Medicine,UNC,None,NO,T1,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d011,58cfa832e4b0c9d6adf6d011,TCGA-G3-A25Y-01A-11D-A16V-10_wgs_Illumina.filtered.,WGS,TCGA-G3-A25Y-01A-11D-A16V-10_wgs_Illumina,TCGA-G3-A25Y-01A-11D-A16V-10_wgs_Illumina.bam,84.29,1.88,0.08,58cfa832e4b0c9d6adf6d011,TCGA-G3-A25Y-01A-11D-A16V-10_wgs_Illumina.bam,Dead,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-G3-A25Y-01A,239B4298-B090-480A-A19F-9758A827AA30,Primary Tumor,Illumina HiSeq,e3c5b76f-1e3c-4536-92be-2851b2d6f589,Liver,52,433DF923-691A-41F8-8718-6F9783F59873,6B50391F-D890-4CA0-B942-BEAB0F8BF1C9,TCGA-G3-A25Y-01A-11D-A16V-10,GRCh37-lite,TCGA-G3-A25Y,TCGA-LIHC,452,s16864,Baylor College of Medicine,Alberta Health Services,Canada,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d5ad,58cfa832e4b0c9d6adf6d5ad,TCGA-MH-A55Z-01A-11D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-MH-A55Z-01A-11D-A26P-10_wgs_Illumina,TCGA-MH-A55Z-01A-11D-A26P-10_wgs_Illumina.bam,53.89,NA,0.07,58cfa832e4b0c9d6adf6d5ad,TCGA-MH-A55Z-01A-11D-A26P-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-MH-A55Z-01A,F0F7E57F-1E9D-4F24-A685-A0811AACBBED,Primary Tumor,Illumina HiSeq,44cc1ed1-021d-4a1e-9a42-c6cb01ad7781,Kidney,65,1FC5BF90-235F-411C-AC1D-AEDC4DF1746F,B19EC4CD-2876-4A2B-BCB9-B3C8DB54FC15,TCGA-MH-A55Z-01A-11D-A26P-10,GRCh37-lite,TCGA-MH-A55Z,TCGA-KIRP,NA,s11866,Baylor College of Medicine,BLN - Baylor,United States,NO,T1b,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c8ca,58cfa831e4b0c9d6adf6c8ca,TCGA-CV-5973-01A-11D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CV-5973-01A-11D-A32X-10_wgs_Illumina,TCGA-CV-5973-01A-11D-A32X-10_wgs_Illumina.bam,115,1.9,0.08,58cfa831e4b0c9d6adf6c8ca,TCGA-CV-5973-01A-11D-A32X-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CV-5973-01A,8FC1F1BE-D2D5-4B3A-9973-F4D964018BEB,Primary Tumor,Illumina HiSeq,91b47661-f43d-4fb8-a616-e40ed72329d3,Head and Neck,62,5078222F-B257-4286-A29A-BC1E395149BC,7E584FF6-0B81-4F85-81DA-B8117AFEE326,TCGA-CV-5973-01A-11D-A32X-10,GRCh37-lite,TCGA-CV-5973,TCGA-HNSC,NA,s16042,Baylor College of Medicine,MD Anderson Cancer Center,None,NO,T3,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa832e4b0c9d6adf6d59a,58cfa832e4b0c9d6adf6d59a,TCGA-MH-A55W-01A-11D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-MH-A55W-01A-11D-A26P-10_wgs_Illumina,TCGA-MH-A55W-01A-11D-A26P-10_wgs_Illumina.bam,41.46,NA,0.07,58cfa832e4b0c9d6adf6d59a,TCGA-MH-A55W-01A-11D-A26P-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-MH-A55W-01A,2030E10B-A4C2-460F-9E29-90C8A76EA05E,Primary Tumor,Illumina HiSeq,02bc7316-2306-488a-9d16-c7a439636912,Kidney,50,7846E991-0D5F-4E97-ABE1-945C3BE9C9F9,2425A532-F562-423A-88F5-228642F53875,TCGA-MH-A55W-01A-11D-A26P-10,GRCh37-lite,TCGA-MH-A55W,TCGA-KIRP,NA,s11593,Baylor College of Medicine,BLN - Baylor,United States,NO,T1b,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6ca63,58cfa831e4b0c9d6adf6ca63,TCGA-CN-6989-01A-11D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CN-6989-01A-11D-A32X-10_wgs_Illumina,TCGA-CN-6989-01A-11D-A32X-10_wgs_Illumina.bam,182.7,NA,0.08,58cfa831e4b0c9d6adf6ca63,TCGA-CN-6989-01A-11D-A32X-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-6989-01A,F33AA93F-B32D-4C4F-9A71-1E5AB69C6899,Primary Tumor,Illumina HiSeq,190e57a0-694b-46ca-a944-0bf0e9d732c2,Head and Neck,64,7AC8FB22-0A09-4B16-AF8C-B5C2E90A968A,08227616-02A5-46E8-9DB1-F2D1D691AB23,TCGA-CN-6989-01A-11D-A32X-10,GRCh37-lite,TCGA-CN-6989,TCGA-HNSC,NA,s16177,Baylor College of Medicine,University of Pittsburgh,United States,NO,T3,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6ce3a,58cfa832e4b0c9d6adf6ce3a,TCGA-ES-A2HT-01A-12D-A183-10_wgs_Illumina.filtered.,WGS,TCGA-ES-A2HT-01A-12D-A183-10_wgs_Illumina,TCGA-ES-A2HT-01A-12D-A183-10_wgs_Illumina.bam,11.86,NA,0.08,58cfa832e4b0c9d6adf6ce3a,TCGA-ES-A2HT-01A-12D-A183-10_wgs_Illumina.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-ES-A2HT-01A,7DD3BDA9-3A0A-46FA-B052-A6D24B847804,Primary Tumor,Illumina HiSeq,f5b5c206-8657-4209-bc75-e3f064cecdd0,Liver,54,9B68C72D-30D4-4A7A-ADE7-A2BDE50A84F2,D6CCFD6F-2EA9-499D-A25D-4BA9D4A9258E,TCGA-ES-A2HT-01A-12D-A183-10,GRCh37-lite,TCGA-ES-A2HT,TCGA-LIHC,438,s16783,Baylor College of Medicine,University of Florida,United States,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c7ba,58cfa831e4b0c9d6adf6c7ba,TCGA-CN-6011-01A-11D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CN-6011-01A-11D-A32X-10_wgs_Illumina,TCGA-CN-6011-01A-11D-A32X-10_wgs_Illumina.bam,193,1.9,0.08,58cfa831e4b0c9d6adf6c7ba,TCGA-CN-6011-01A-11D-A32X-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CN-6011-01A,E7D49212-E9CB-4CD7-923A-BDFC82A4A150,Primary Tumor,Illumina HiSeq,33680362-5ef1-477f-9dbc-64dc2ed0d5a8,Head and Neck,57,AFBF3020-1715-4E74-8224-05E316796999,21205681-A0C7-48D0-81D4-0B7EF31158CF,TCGA-CN-6011-01A-11D-A32X-10,GRCh37-lite,TCGA-CN-6011,TCGA-HNSC,NA,s15500,Baylor College of Medicine,University of Pittsburgh,None,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa830e4b0c9d6adf6be71,58cfa830e4b0c9d6adf6be71,TCGA-BP-4326-01A-01D-2097-10_wgs_Illumina.filtered.,WGS,TCGA-BP-4326-01A-01D-2097-10_wgs_Illumina,TCGA-BP-4326-01A-01D-2097-10_wgs_Illumina.bam,109,1.9,0.14,58cfa830e4b0c9d6adf6be71,TCGA-BP-4326-01A-01D-2097-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,Aligned reads,TCGA-BP-4326-01A,7664C241-B369-4D76-9CD1-7F2BDC1D267F,Primary Tumor,Illumina HiSeq,8d64ee9c-1973-46e9-8ad7-1d9c3a96a47c,Kidney,53,068BFE4D-341C-49F7-B7A9-5D070DE00AB3,54842328-9432-4820-8976-7964BF9BF147,TCGA-BP-4326-01A-01D-2097-10,GRCh37-lite,TCGA-BP-4326,TCGA-KIRC,NA,s9163,Baylor College of Medicine,MSKCC,None,NO,T1b,N0,Kidney Clear Cell Renal Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d317,58cfa832e4b0c9d6adf6d317,TCGA-KN-8428-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8428-01A-11D-2310-10_wgs_Illumina,TCGA-KN-8428-01A-11D-2310-10_wgs_Illumina.bam,260.3,NA,0.05,58cfa832e4b0c9d6adf6d317,TCGA-KN-8428-01A-11D-2310-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KN-8428-01A,455FD7D4-5FF4-423F-83CE-4630AEF89BB7,Primary Tumor,Illumina HiSeq,1b52b2f7-d6a9-41f9-870c-f1456fda197e,Kidney,71,FFE3D692-7B81-45D9-BE76-2C580A091539,322F0B01-2118-4DBE-ABA1-3875A54EE71B,TCGA-KN-8428-01A-11D-2310-10,GRCh37-lite,TCGA-KN-8428,TCGA-KICH,1590,s16538,Baylor College of Medicine,Harvard,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa831e4b0c9d6adf6c8e4,58cfa831e4b0c9d6adf6c8e4,TCGA-CX-7086-01A-11D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CX-7086-01A-11D-A32X-10_wgs_Illumina,TCGA-CX-7086-01A-11D-A32X-10_wgs_Illumina.bam,464.7,NA,0.08,58cfa831e4b0c9d6adf6c8e4,TCGA-CX-7086-01A-11D-A32X-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CX-7086-01A,AD6C9D09-2C03-4786-A72D-DD2AA5F603D4,Primary Tumor,Illumina HiSeq,2c64cb1b-6ae4-4191-9b2c-e5c13e267e83,Head and Neck,53,B293A736-9A82-4AD9-BF7E-9E2CEA09DDBC,E52FFA79-557A-4024-81F3-F3826C227EC5,TCGA-CX-7086-01A-11D-A32X-10,GRCh37-lite,TCGA-CX-7086,TCGA-HNSC,NA,s16343,Baylor College of Medicine,Medical College of Georgia,United States,NO,T3,N1,Head and Neck Squamous Cell Carcinoma,Stage III
13722.58cfa830e4b0c9d6adf6c14d,58cfa830e4b0c9d6adf6c14d,TCGA-BA-5556-01A-01D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-BA-5556-01A-01D-A32X-10_wgs_Illumina,TCGA-BA-5556-01A-01D-A32X-10_wgs_Illumina.bam,116.7,1.9,0.08,58cfa830e4b0c9d6adf6c14d,TCGA-BA-5556-01A-01D-A32X-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-5556-01A,70741B73-9683-42BD-87FC-6A021A70103B,Primary Tumor,Illumina HiSeq,e855f092-899d-469a-981c-5094b07c31ac,Head and Neck,58,C00EEDDB-6AE2-48BA-8677-C174E579A724,8294A969-59A1-4D3B-895B-F07E96BF9F7A,TCGA-BA-5556-01A-01D-A32X-10,GRCh37-lite,TCGA-BA-5556,TCGA-HNSC,NA,s16319,Baylor College of Medicine,UNC,None,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II
13722.58cfa832e4b0c9d6adf6d43a,58cfa832e4b0c9d6adf6d43a,TCGA-QG-A5YV-01A-11D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-QG-A5YV-01A-11D-A28G-10_wgs_Illumina,TCGA-QG-A5YV-01A-11D-A28G-10_wgs_Illumina.bam,62.92,NA,0.07,58cfa832e4b0c9d6adf6d43a,TCGA-QG-A5YV-01A-11D-A28G-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-QG-A5YV-01A,C83D38FC-E011-4F75-A100-96513611F3E9,Primary Tumor,Illumina HiSeq,fc951188-ba57-4cd7-a209-28726710bb92,Colorectal,64,69EF3E70-5D7A-4E30-ABDE-0F9F76EA3141,E3EF5CAD-4D6E-4F04-BABB-A908EE02644B,TCGA-QG-A5YV-01A-11D-A28G-10,GRCh37-lite,TCGA-QG-A5YV,TCGA-COAD,NA,s13220,Baylor College of Medicine,BLN - Baylor,United States,NO,T4b,N1a,Colon Adenocarcinoma,Stage IIIC
13722.58cfa830e4b0c9d6adf6c000,58cfa830e4b0c9d6adf6c000,TCGA-B3-4104-01A-02D-1402-10_wgs_Illumina.filtered.,WGS,TCGA-B3-4104-01A-02D-1402-10_wgs_Illumina,TCGA-B3-4104-01A-02D-1402-10_wgs_Illumina.bam,198.07,1.9,0.05,58cfa830e4b0c9d6adf6c000,TCGA-B3-4104-01A-02D-1402-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B3-4104-01A,E15A108E-0B32-426F-926A-3FB1AF0A82D3,Primary Tumor,Illumina HiSeq,bf671eff-6fe3-4498-b767-06041f20c7e5,Kidney,75,BB0EFB98-DB70-499D-BC72-56AF138C419C,8E0F02B3-2BC5-4E1B-BA7E-809CB7FDB58C,TCGA-B3-4104-01A-02D-1402-10,GRCh37-lite,TCGA-B3-4104,TCGA-KIRP,NA,s11642,Baylor College of Medicine,Christiana Healthcare,None,NO,T2,NX,Kidney Papillary Renal Cell Carcinoma,Stage II
13722.58cfa832e4b0c9d6adf6d2fa,58cfa832e4b0c9d6adf6d2fa,TCGA-KM-8443-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KM-8443-01A-11D-2310-10_wgs_Illumina,TCGA-KM-8443-01A-11D-2310-10_wgs_Illumina.bam,71.3,NA,0.05,58cfa832e4b0c9d6adf6d2fa,TCGA-KM-8443-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KM-8443-01A,2F1C4DB6-88A7-4A5D-A5FE-94D85F569440,Primary Tumor,Illumina HiSeq,eecb2ae5-92c3-432e-be0c-d7463b8efbb1,Kidney,57,F606FE9C-7D9F-4615-AB16-0BB4C796ADEA,C00DE7A0-0B09-4E07-988C-EF2A7F8E932A,TCGA-KM-8443-01A-11D-2310-10,GRCh37-lite,TCGA-KM-8443,TCGA-KICH,NA,s16528,Baylor College of Medicine,NCI Urologic Oncology Branch,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa831e4b0c9d6adf6c3b6,58cfa831e4b0c9d6adf6c3b6,TCGA-CC-5262-01A-01D-A21X-10_wgs_Illumina.filtered.,WGS,TCGA-CC-5262-01A-01D-A21X-10_wgs_Illumina,TCGA-CC-5262-01A-01D-A21X-10_wgs_Illumina.bam,73.73,1.92,0.07,58cfa831e4b0c9d6adf6c3b6,TCGA-CC-5262-01A-01D-A21X-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-CC-5262-01A,1B428ADA-EB3F-40C2-B4BF-1BBF6B61729D,Primary Tumor,Illumina HiSeq,c98a5543-b4b7-42ad-807e-73cdbbf77345,Liver,67,DC595EED-D459-40FD-8417-6A1C56759EC8,47E5FF56-9534-4FCF-A593-33027E877F93,TCGA-CC-5262-01A-01D-A21X-10,GRCh37-lite,TCGA-CC-5262,TCGA-LIHC,NA,s16851,Baylor College of Medicine,ILSbio,None,NO,T4,N0,Hepatocellular Carcinoma,Stage IIIC
13722.58cfa832e4b0c9d6adf6d5af,58cfa832e4b0c9d6adf6d5af,TCGA-MH-A561-01A-11D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-MH-A561-01A-11D-A26P-10_wgs_Illumina,TCGA-MH-A561-01A-11D-A26P-10_wgs_Illumina.bam,42.2,NA,0.08,58cfa832e4b0c9d6adf6d5af,TCGA-MH-A561-01A-11D-A26P-10_wgs_Illumina.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-MH-A561-01A,E6E6A773-B155-45A9-989F-75C12CE1702A,Primary Tumor,Illumina HiSeq,49516926-9793-4b88-bfa8-c631918a9b7a,Kidney,66,9E93686E-D150-404A-BD88-1DD4D2999ED3,2E8AD1CD-D5D5-4BB4-8BBD-E9BEF45088DA,TCGA-MH-A561-01A-11D-A26P-10,GRCh37-lite,TCGA-MH-A561,TCGA-KIRP,NA,s11592,Baylor College of Medicine,BLN - Baylor,United States,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d246,58cfa832e4b0c9d6adf6d246,TCGA-IA-A40Y-01A-11D-A25F-10_wgs_Illumina.filtered.,WGS,TCGA-IA-A40Y-01A-11D-A25F-10_wgs_Illumina,TCGA-IA-A40Y-01A-11D-A25F-10_wgs_Illumina.bam,22.07,NA,0.08,58cfa832e4b0c9d6adf6d246,TCGA-IA-A40Y-01A-11D-A25F-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-IA-A40Y-01A,1DB41963-A520-47F0-828C-ED5C626507B1,Primary Tumor,Illumina HiSeq,2157f13c-f876-4b2f-91eb-f3ada3c0b2e7,Kidney,60,05ACDAC8-480B-43B6-82F5-B0DDC4A1C36F,AD9455E9-7147-489E-9B1F-3540C457C260,TCGA-IA-A40Y-01A-11D-A25F-10,GRCh37-lite,TCGA-IA-A40Y,TCGA-KIRP,NA,s11863,Baylor College of Medicine,Cleveland Clinic,United States,NO,T3a,N1,Kidney Papillary Renal Cell Carcinoma,Stage III
13722.58cfa832e4b0c9d6adf6d59c,58cfa832e4b0c9d6adf6d59c,TCGA-MH-A562-01A-11D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-MH-A562-01A-11D-A26P-10_wgs_Illumina,TCGA-MH-A562-01A-11D-A26P-10_wgs_Illumina.bam,34.1,NA,0.08,58cfa832e4b0c9d6adf6d59c,TCGA-MH-A562-01A-11D-A26P-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-MH-A562-01A,45BDCFD6-1E3F-4BE8-B843-AE949E8E43EB,Primary Tumor,Illumina HiSeq,6eae65c7-1a89-44c9-a3c5-b7af6d633f1b,Kidney,57,4306E07D-6FC1-4C69-ACB8-00A1DC78CAD8,DDDEA2E4-B8C3-4157-9D92-6DE472E8375A,TCGA-MH-A562-01A-11D-A26P-10,GRCh37-lite,TCGA-MH-A562,TCGA-KIRP,NA,s11782,Baylor College of Medicine,BLN - Baylor,United States,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c612,58cfa831e4b0c9d6adf6c612,TCGA-CQ-6228-01A-11D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-CQ-6228-01A-11D-A32X-10_wgs_Illumina,TCGA-CQ-6228-01A-11D-A32X-10_wgs_Illumina.bam,338.7,1.9,0.07,58cfa831e4b0c9d6adf6c612,TCGA-CQ-6228-01A-11D-A32X-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-CQ-6228-01A,E303B8C4-6428-4134-BB9D-A95DC1D8E35E,Primary Tumor,Illumina HiSeq,c8e6d97c-8cc3-45f6-99a2-d20b8bc3b2d6,Head and Neck,71,62E8F535-CF5E-4F90-AFCD-1E0136066820,C2124BB2-30E1-4093-9A8A-3A188A6DC0A9,TCGA-CQ-6228-01A-11D-A32X-10,GRCh37-lite,TCGA-CQ-6228,TCGA-HNSC,456,s15634,Baylor College of Medicine,"University Health Network, Toronto",Canada,NO,T1,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6d0a2,58cfa832e4b0c9d6adf6d0a2,TCGA-IA-A40X-01A-11D-A25F-10_wgs_Illumina.filtered.,WGS,TCGA-IA-A40X-01A-11D-A25F-10_wgs_Illumina,TCGA-IA-A40X-01A-11D-A25F-10_wgs_Illumina.bam,35.98,NA,0.08,58cfa832e4b0c9d6adf6d0a2,TCGA-IA-A40X-01A-11D-A25F-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-IA-A40X-01A,0C151271-2CF9-43F4-9E9B-FE927DE43131,Primary Tumor,Illumina HiSeq,0d27ff83-40ce-4ea3-8368-b9f9f3b4fe26,Kidney,49,863393ED-42BB-4232-93F4-2B5759D9822C,E1217EBE-1826-41A9-B6C4-702100A66F5E,TCGA-IA-A40X-01A-11D-A25F-10,GRCh37-lite,TCGA-IA-A40X,TCGA-KIRP,NA,s11862,Baylor College of Medicine,Cleveland Clinic,United States,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d04c,58cfa832e4b0c9d6adf6d04c,TCGA-HE-A5NK-01A-11D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-HE-A5NK-01A-11D-A26P-10_wgs_Illumina,TCGA-HE-A5NK-01A-11D-A26P-10_wgs_Illumina.bam,18.38,NA,0.07,58cfa832e4b0c9d6adf6d04c,TCGA-HE-A5NK-01A-11D-A26P-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-HE-A5NK-01A,F9306CB1-C4E4-42EB-8AA9-EE906C408E10,Primary Tumor,Illumina HiSeq,5f1b89ba-b8f2-47c1-962e-8ae688b53555,Kidney,82,A3EDB023-35B4-4FB5-98A0-FF51C0348187,73F57B92-A6E6-4472-940B-579C22D208BF,TCGA-HE-A5NK-01A-11D-A26P-10,GRCh37-lite,TCGA-HE-A5NK,TCGA-KIRP,NA,s11780,Baylor College of Medicine,Ontario Institute for Cancer Research (OICR),Canada,NO,T1b,NX,Kidney Papillary Renal Cell Carcinoma,Not available
13722.58cfa82fe4b0c9d6adf6b8ca,58cfa82fe4b0c9d6adf6b8ca,TCGA-A4-A4ZT-01A-11D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-A4-A4ZT-01A-11D-A26P-10_wgs_Illumina,TCGA-A4-A4ZT-01A-11D-A26P-10_wgs_Illumina.bam,55.16,NA,0.09,58cfa82fe4b0c9d6adf6b8ca,TCGA-A4-A4ZT-01A-11D-A26P-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-A4-A4ZT-01A,8B3C068D-5090-4030-8E7E-39DA005DEE79,Primary Tumor,Illumina HiSeq,90b348f5-ec38-4672-a60b-2bf4add19464,Kidney,71,460188E7-2A1E-4C3F-9C96-48C59A3FA9A0,483BB781-0179-42E1-BF9C-487B240769B8,TCGA-A4-A4ZT-01A-11D-A26P-10,GRCh37-lite,TCGA-A4-A4ZT,TCGA-KIRP,NA,s11635,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1b,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6c1c8,58cfa830e4b0c9d6adf6c1c8,TCGA-BC-A217-01A-11D-A152-10_wgs_Illumina.filtered.,WGS,TCGA-BC-A217-01A-11D-A152-10_wgs_Illumina,TCGA-BC-A217-01A-11D-A152-10_wgs_Illumina.bam,102.31,1.74,0.09,58cfa830e4b0c9d6adf6c1c8,TCGA-BC-A217-01A-11D-A152-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-BC-A217-01A,6DCFC418-AB28-4365-95EA-C1AE254F2341,Primary Tumor,Illumina HiSeq,a8b86f30-113b-4e02-98d3-b1dae29380d3,Liver,75,C827A8B9-359C-4A6F-B950-839B3FB0C097,2BFF30D5-BE79-4686-8164-7A7D9619D3C0,TCGA-BC-A217-01A-11D-A152-10,GRCh37-lite,TCGA-BC-A217,TCGA-LIHC,NA,s17057,Baylor College of Medicine,UNC,United States,NO,T2,NX,Hepatocellular Carcinoma,Stage II
13722.58cfa832e4b0c9d6adf6ce6f,58cfa832e4b0c9d6adf6ce6f,TCGA-GL-A4EM-01A-11D-A25F-10_wgs_Illumina.filtered.,WGS,TCGA-GL-A4EM-01A-11D-A25F-10_wgs_Illumina,TCGA-GL-A4EM-01A-11D-A25F-10_wgs_Illumina.bam,11.47,NA,0.08,58cfa832e4b0c9d6adf6ce6f,TCGA-GL-A4EM-01A-11D-A25F-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-GL-A4EM-01A,2C084454-18E9-4837-9BBA-7E91A73A48E0,Primary Tumor,Illumina HiSeq,39550a3d-400e-427e-871c-7749ae5dc2f3,Kidney,61,353CDF9B-F87E-45ED-8263-B1720FAE4EEA,7815397B-AA39-4B79-BCAA-6859A3F115F8,TCGA-GL-A4EM-01A-11D-A25F-10,GRCh37-lite,TCGA-GL-A4EM,TCGA-KIRP,NA,s11777,Baylor College of Medicine,ABS - IUPUI,United States,NO,T1b,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6c140,58cfa830e4b0c9d6adf6c140,TCGA-BA-6872-01A-11D-A32X-10_wgs_Illumina.filtered.,WGS,TCGA-BA-6872-01A-11D-A32X-10_wgs_Illumina,TCGA-BA-6872-01A-11D-A32X-10_wgs_Illumina.bam,89.7,1.9,0.07,58cfa830e4b0c9d6adf6c140,TCGA-BA-6872-01A-11D-A32X-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Aligned reads,TCGA-BA-6872-01A,3E5F451A-5882-4914-AE1A-95C898C2BCCA,Primary Tumor,Illumina HiSeq,28a6e3a3-207f-4df1-bdb3-c63373ce9ba2,Head and Neck,47,04107A58-667D-4712-B972-61837EFF6029,C76F7FCC-2748-4B6D-805E-D21652DD5E3A,TCGA-BA-6872-01A-11D-A32X-10,GRCh37-lite,TCGA-BA-6872,TCGA-HNSC,384,s16028,Baylor College of Medicine,UNC,United States,NO,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6d1c1,58cfa832e4b0c9d6adf6d1c1,TCGA-FF-8061-01A-11D-2210-10_wgs_Illumina.filtered.,WGS,TCGA-FF-8061-01A-11D-2210-10_wgs_Illumina,TCGA-FF-8061-01A-11D-2210-10_wgs_Illumina.bam,443.7,NA,0.05,58cfa832e4b0c9d6adf6d1c1,TCGA-FF-8061-01A-11D-2210-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Aligned reads,TCGA-FF-8061-01A,C8CDE9EA-89E9-4EE8-8A46-417A48F6D3AB,Primary Tumor,Illumina HiSeq,649ff853-287a-4f0d-94db-0842347bf98c,Lymph Nodes,42,047CAECB-6829-4943-BBC5-F45EED3979B6,A29278AF-7ECF-403E-B6A9-623EA7879D05,TCGA-FF-8061-01A-11D-2210-10,GRCh37-lite,TCGA-FF-8061,TCGA-DLBC,NA,s1103,Baylor College of Medicine,SingHealth,Singapore,NO,Not available,Not available,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),Not available
13722.58cfa832e4b0c9d6adf6d1f2,58cfa832e4b0c9d6adf6d1f2,TCGA-FF-8047-01A-11D-2210-10_wgs_Illumina.filtered.,WGS,TCGA-FF-8047-01A-11D-2210-10_wgs_Illumina,TCGA-FF-8047-01A-11D-2210-10_wgs_Illumina.bam,361.7,NA,0.05,58cfa832e4b0c9d6adf6d1f2,TCGA-FF-8047-01A-11D-2210-10_wgs_Illumina.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Aligned reads,TCGA-FF-8047-01A,F978CB0F-D319-4C01-B4C5-23AE1403A106,Primary Tumor,Illumina HiSeq,59fecb70-aec2-4deb-b598-543c4dd843e1,Lymph Nodes,38,A592550C-97B4-4A82-A088-14A5AC6BF084,1B1780D5-06DA-40EE-9E15-02631A68027B,TCGA-FF-8047-01A-11D-2210-10,GRCh37-lite,TCGA-FF-8047,TCGA-DLBC,NA,s1100,Baylor College of Medicine,SingHealth,Singapore,NO,Not available,Not available,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),Not available
13722.58cfa832e4b0c9d6adf6d58e,58cfa832e4b0c9d6adf6d58e,TCGA-MR-A520-01A-11D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-MR-A520-01A-11D-A25V-10_wgs_Illumina,TCGA-MR-A520-01A-11D-A25V-10_wgs_Illumina.bam,24.04,NA,0.08,58cfa832e4b0c9d6adf6d58e,TCGA-MR-A520-01A-11D-A25V-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-MR-A520-01A,25E893AD-A0FD-45AE-9AA9-9BCD7C2EC8E5,Primary Tumor,Illumina HiSeq,aa52c229-8251-4890-a772-fac2f7c1b7ca,Liver,58,D7F0E432-C20B-4B2B-8D73-2A235F339BE7,352FBBB4-88A5-4354-B1FA-3A01DA3FBFA7,TCGA-MR-A520-01A-11D-A25V-10,GRCh37-lite,TCGA-MR-A520,TCGA-LIHC,NA,s16790,Baylor College of Medicine,University of Minnesota,United States,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6ca58,58cfa831e4b0c9d6adf6ca58,TCGA-DD-A4NA-01A-11D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A4NA-01A-11D-A25V-10_wgs_Illumina,TCGA-DD-A4NA-01A-11D-A25V-10_wgs_Illumina.bam,38.33,NA,0.08,58cfa831e4b0c9d6adf6ca58,TCGA-DD-A4NA-01A-11D-A25V-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A4NA-01A,BEE9D6C8-948F-4B76-97CA-B985064249EF,Primary Tumor,Illumina HiSeq,9011fbab-0082-4675-98d0-33225253f93c,Liver,67,1E7C53F1-DFB6-4A50-BD83-F8062B1306F2,5EAD73FE-1C34-48ED-B20D-89FC3C82DBD6,TCGA-DD-A4NA-01A-11D-A25V-10,GRCh37-lite,TCGA-DD-A4NA,TCGA-LIHC,NA,s17059,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T2,N1,Hepatocellular Carcinoma,Stage IIIC
13722.58cfa832e4b0c9d6adf6d1ee,58cfa832e4b0c9d6adf6d1ee,TCGA-FF-8046-01A-11D-2210-10_wgs_Illumina.filtered.,WGS,TCGA-FF-8046-01A-11D-2210-10_wgs_Illumina,TCGA-FF-8046-01A-11D-2210-10_wgs_Illumina.bam,445.7,NA,0.05,58cfa832e4b0c9d6adf6d1ee,TCGA-FF-8046-01A-11D-2210-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Aligned reads,TCGA-FF-8046-01A,67325322-483F-443F-9FFA-2A20D108A2FB,Primary Tumor,Illumina HiSeq,872155f2-6470-47b1-af0b-1a04950e187e,Lymph Nodes,51,6C8A582B-70B0-4C94-98C8-E800A95AE112,AA847C3D-D3A7-46AA-A81B-DB5099A458FB,TCGA-FF-8046-01A-11D-2210-10,GRCh37-lite,TCGA-FF-8046,TCGA-DLBC,NA,s1101,Baylor College of Medicine,SingHealth,Singapore,NO,Not available,Not available,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),Not available
13722.58cfa831e4b0c9d6adf6c9db,58cfa831e4b0c9d6adf6c9db,TCGA-DD-A3A9-01A-11D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A3A9-01A-11D-A25V-10_wgs_Illumina,TCGA-DD-A3A9-01A-11D-A25V-10_wgs_Illumina.bam,36.73,NA,0.08,58cfa831e4b0c9d6adf6c9db,TCGA-DD-A3A9-01A-11D-A25V-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A3A9-01A,457CCA7C-A8B4-414E-A3C0-7FCCF0EE2034,Primary Tumor,Illumina HiSeq,f40faf20-3443-4f29-85be-0107c0d838aa,Liver,64,9BFBC85E-86E0-4AC5-9304-84B1EB32B9CC,96517058-18D2-4847-8085-768CA8AA1565,TCGA-DD-A3A9-01A-11D-A25V-10,GRCh37-lite,TCGA-DD-A3A9,TCGA-LIHC,931,s16587,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T4,N0,Hepatocellular Carcinoma,Stage IVB
13722.58cfa832e4b0c9d6adf6d0d8,58cfa832e4b0c9d6adf6d0d8,TCGA-G3-A25S-01A-11D-A16V-10_wgs_Illumina.filtered.,WGS,TCGA-G3-A25S-01A-11D-A16V-10_wgs_Illumina,TCGA-G3-A25S-01A-11D-A16V-10_wgs_Illumina.bam,82.14,1.93,0.08,58cfa832e4b0c9d6adf6d0d8,TCGA-G3-A25S-01A-11D-A16V-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-G3-A25S-01A,B865DEC4-F051-4FBE-9405-F832FF2010D7,Primary Tumor,Illumina HiSeq,95c222bc-3817-42a2-b237-911c68ec0cf0,Liver,64,D12BE3F6-68BC-4583-9478-FC01A0EB9387,C05ADC19-2E01-4712-A35A-69EEE4D40998,TCGA-G3-A25S-01A-11D-A16V-10,GRCh37-lite,TCGA-G3-A25S,TCGA-LIHC,NA,s16686,Baylor College of Medicine,Alberta Health Services,Canada,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6cc3c,58cfa831e4b0c9d6adf6cc3c,TCGA-EP-A2KB-01A-11D-A183-10_wgs_Illumina.filtered.,WGS,TCGA-EP-A2KB-01A-11D-A183-10_wgs_Illumina,TCGA-EP-A2KB-01A-11D-A183-10_wgs_Illumina.bam,51.77,NA,0.08,58cfa831e4b0c9d6adf6cc3c,TCGA-EP-A2KB-01A-11D-A183-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-EP-A2KB-01A,18C08546-BED3-4ED9-B223-479AFE633C8E,Primary Tumor,Illumina HiSeq,41e9afd1-d090-475a-ba8a-48976ddc9d52,Liver,46,E2895132-DA4F-4DB5-B417-510E99FCE776,305A5074-5384-45A0-985D-289B178D09F6,TCGA-EP-A2KB-01A-11D-A183-10,GRCh37-lite,TCGA-EP-A2KB,TCGA-LIHC,NA,s16781,Baylor College of Medicine,Christiana Healthcare,United States,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa82fe4b0c9d6adf6b92e,58cfa82fe4b0c9d6adf6b92e,TCGA-A4-A57E-01A-11D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-A4-A57E-01A-11D-A26P-10_wgs_Illumina,TCGA-A4-A57E-01A-11D-A26P-10_wgs_Illumina.bam,37.08,NA,0.08,58cfa82fe4b0c9d6adf6b92e,TCGA-A4-A57E-01A-11D-A26P-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-A4-A57E-01A,D80F601B-1064-4FF0-9C51-7F6AFB22D1F5,Primary Tumor,Illumina HiSeq,8e29468f-f3dd-48a6-9c1a-3bd0083bae2d,Kidney,59,341EA198-C8A2-4675-8077-2C450E9925E1,2DEB8F9A-9E0A-46D1-BCB5-902DB3B5C8AC,TCGA-A4-A57E-01A-11D-A26P-10,GRCh37-lite,TCGA-A4-A57E,TCGA-KIRP,NA,s11637,Baylor College of Medicine,International Genomics Consortium,United States,NO,T2a,N0,Kidney Papillary Renal Cell Carcinoma,Stage IV
13722.58cfa830e4b0c9d6adf6c1ae,58cfa830e4b0c9d6adf6c1ae,TCGA-B9-4617-01A-01D-1253-10_wgs_Illumina.filtered.,WGS,TCGA-B9-4617-01A-01D-1253-10_wgs_Illumina,TCGA-B9-4617-01A-01D-1253-10_wgs_Illumina.bam,45.94,1.9,0.15,58cfa830e4b0c9d6adf6c1ae,TCGA-B9-4617-01A-01D-1253-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B9-4617-01A,A6E960AF-3CA5-42FB-B546-451C2583282D,Primary Tumor,Illumina HiSeq,dbbf365c-a7c9-4093-8ffb-acf0b6eabf20,Kidney,41,605B6DD3-552B-403C-98D9-C8B441B37A90,BEF23192-57CD-4301-B7A7-5E82CA62482D,TCGA-B9-4617-01A-01D-1253-10,GRCh37-lite,TCGA-B9-4617,TCGA-KIRP,NA,s11586,Baylor College of Medicine,UNC,None,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Not available
13722.58cfa830e4b0c9d6adf6c28c,58cfa830e4b0c9d6adf6c28c,TCGA-AD-A5EJ-01A-11D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-AD-A5EJ-01A-11D-A28G-10_wgs_Illumina,TCGA-AD-A5EJ-01A-11D-A28G-10_wgs_Illumina.bam,40.09,NA,0.07,58cfa830e4b0c9d6adf6c28c,TCGA-AD-A5EJ-01A-11D-A28G-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AD-A5EJ-01A,613AA3E8-A70B-45A9-9C08-0C2346C8BF00,Primary Tumor,Illumina HiSeq,ce0bf9ea-efa0-4c54-8970-a703051d667e,Colorectal,74,F675116A-BFEC-47AE-AC24-9B61DD3CC6C1,711C8A16-3CF8-42D8-B29E-FD1E9EF1C82B,TCGA-AD-A5EJ-01A-11D-A28G-10,GRCh37-lite,TCGA-AD-A5EJ,TCGA-COAD,NA,s13538,Baylor College of Medicine,International Genomics Consortium,United States,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa831e4b0c9d6adf6c89a,58cfa831e4b0c9d6adf6c89a,TCGA-DD-A1EH-01A-11D-A12Z-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A1EH-01A-11D-A12Z-10_wgs_Illumina,TCGA-DD-A1EH-01A-11D-A12Z-10_wgs_Illumina.bam,38.71,1.93,0.08,58cfa831e4b0c9d6adf6c89a,TCGA-DD-A1EH-01A-11D-A12Z-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A1EH-01A,CAB5B264-ABAB-4BDB-816E-9D2C0AC30629,Primary Tumor,Illumina HiSeq,6126a7f9-c6d2-4361-9420-37af4bfafb5f,Liver,23,44C98B82-ADCB-4597-A9DB-83E7D2A0E2F9,B9F03936-1DE5-4330-8B0F-6D0AB533876E,TCGA-DD-A1EH-01A-11D-A12Z-10,GRCh37-lite,TCGA-DD-A1EH,TCGA-LIHC,NA,s16776,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T3,N0,Hepatocellular Carcinoma,Stage III
13722.58cfa831e4b0c9d6adf6c9ca,58cfa831e4b0c9d6adf6c9ca,TCGA-DD-A1EB-01A-11D-A12Z-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A1EB-01A-11D-A12Z-10_wgs_Illumina,TCGA-DD-A1EB-01A-11D-A12Z-10_wgs_Illumina.bam,45.15,1.98,0.08,58cfa831e4b0c9d6adf6c9ca,TCGA-DD-A1EB-01A-11D-A12Z-10_wgs_Illumina.bam,Alive,FEMALE,Not available,Not available,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A1EB-01A,68015CC7-D3A1-4C90-B8FB-5D14143D9960,Primary Tumor,Illumina HiSeq,df20c59b-843a-4f42-babb-7205e75d0a32,Liver,72,FEE48A64-CF2F-4AE9-B3CF-315410D8E8AE,90611290-E44C-438E-91AA-F3B83DAE3B71,TCGA-DD-A1EB-01A-11D-A12Z-10,GRCh37-lite,TCGA-DD-A1EB,TCGA-LIHC,NA,s16675,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c8b2,58cfa831e4b0c9d6adf6c8b2,TCGA-DD-A3A7-01A-11D-A22F-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A3A7-01A-11D-A22F-10_wgs_Illumina,TCGA-DD-A3A7-01A-11D-A22F-10_wgs_Illumina.bam,41.76,NA,0.08,58cfa831e4b0c9d6adf6c8b2,TCGA-DD-A3A7-01A-11D-A22F-10_wgs_Illumina.bam,Dead,MALE,Not available,Not available,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A3A7-01A,614C0ECF-6A84-4C86-8706-79BE5BB00991,Primary Tumor,Illumina HiSeq,48ae1497-c89f-4b1e-a0c4-1c6bd49c39b7,Liver,67,1EF290A3-D054-4E3A-9683-8F99A2010E3E,29B92B51-7BA3-42A9-97D3-6A9B5E43F928,TCGA-DD-A3A7-01A-11D-A22F-10,GRCh37-lite,TCGA-DD-A3A7,TCGA-LIHC,419,s16852,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T3b,N0,Hepatocellular Carcinoma,Stage IIIB
13722.58cfa832e4b0c9d6adf6d1b2,58cfa832e4b0c9d6adf6d1b2,TCGA-FF-8041-01A-11D-2210-10_wgs_Illumina.filtered.,WGS,TCGA-FF-8041-01A-11D-2210-10_wgs_Illumina,TCGA-FF-8041-01A-11D-2210-10_wgs_Illumina.bam,454.7,NA,0.05,58cfa832e4b0c9d6adf6d1b2,TCGA-FF-8041-01A-11D-2210-10_wgs_Illumina.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Aligned reads,TCGA-FF-8041-01A,1F971AF1-6772-4FE6-8D35-BBE527A037FE,Primary Tumor,Illumina HiSeq,90920dc3-b0bd-48f3-a446-87f757968eab,Lymph Nodes,28,738A6FD7-D8E1-4FC3-9F73-AD6C9B67DA2A,FA676301-902F-473F-8313-5BFF34AE549A,TCGA-FF-8041-01A-11D-2210-10,GRCh37-lite,TCGA-FF-8041,TCGA-DLBC,NA,s1109,Baylor College of Medicine,SingHealth,Singapore,NO,Not available,Not available,Primary mediastinal (thymic) DLBCL,Not available
13722.58cfa831e4b0c9d6adf6c9a2,58cfa831e4b0c9d6adf6c9a2,TCGA-DD-A3A8-01A-11D-A22F-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A3A8-01A-11D-A22F-10_wgs_Illumina,TCGA-DD-A3A8-01A-11D-A22F-10_wgs_Illumina.bam,34.18,NA,0.07,58cfa831e4b0c9d6adf6c9a2,TCGA-DD-A3A8-01A-11D-A22F-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A3A8-01A,69D6881B-9E9A-407B-8B02-BAD5FC2455BF,Primary Tumor,Illumina HiSeq,772bc588-a4c5-4f9a-a1d8-be943b521c76,Liver,75,93D007F8-84D9-427D-A1E9-54919605F7B3,4CFF8590-559E-4204-8635-96E11BFEDA68,TCGA-DD-A3A8-01A-11D-A22F-10,GRCh37-lite,TCGA-DD-A3A8,TCGA-LIHC,11,s16976,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T2,N0,Hepatocellular Carcinoma,Stage II
13722.58cfa832e4b0c9d6adf6d062,58cfa832e4b0c9d6adf6d062,TCGA-G3-A25T-01A-11D-A16V-10_wgs_Illumina.filtered.,WGS,TCGA-G3-A25T-01A-11D-A16V-10_wgs_Illumina,TCGA-G3-A25T-01A-11D-A16V-10_wgs_Illumina.bam,80.84,2.02,0.08,58cfa832e4b0c9d6adf6d062,TCGA-G3-A25T-01A-11D-A16V-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-G3-A25T-01A,F6E5979D-D6A9-4408-BD1B-1B37D1064E83,Primary Tumor,Illumina HiSeq,97875fbb-c05a-4e3b-89e6-28f20a7eb82f,Liver,45,D42D6E07-8E0E-4345-B1B9-1B8B4574D042,41840DC1-5EA2-4F01-A0D4-8B65ADD641C8,TCGA-G3-A25T-01A-11D-A16V-10,GRCh37-lite,TCGA-G3-A25T,TCGA-LIHC,NA,s16690,Baylor College of Medicine,Alberta Health Services,Canada,NO,T3,N0,Hepatocellular Carcinoma,Stage IIIA
13722.58cfa831e4b0c9d6adf6cc38,58cfa831e4b0c9d6adf6cc38,TCGA-EP-A26S-01A-11D-A16V-10_wgs_Illumina.filtered.,WGS,TCGA-EP-A26S-01A-11D-A16V-10_wgs_Illumina,TCGA-EP-A26S-01A-11D-A16V-10_wgs_Illumina.bam,64,NA,0.07,58cfa831e4b0c9d6adf6cc38,TCGA-EP-A26S-01A-11D-A16V-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-EP-A26S-01A,B7D6621C-8BCE-4A01-8588-9D7761D9372B,Primary Tumor,Illumina HiSeq,e3122147-a994-4b8f-aa05-ddb36413802a,Liver,70,A0B2FF38-E6BF-4F27-98AB-5CF924B0E236,463BF060-8BA6-4A73-8173-172025F7B527,TCGA-EP-A26S-01A-11D-A16V-10,GRCh37-lite,TCGA-EP-A26S,TCGA-LIHC,NA,s16982,Baylor College of Medicine,Christiana Healthcare,United States,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6cf76,58cfa832e4b0c9d6adf6cf76,TCGA-FV-A23B-01A-11D-A16V-10_wgs_Illumina.filtered.,WGS,TCGA-FV-A23B-01A-11D-A16V-10_wgs_Illumina,TCGA-FV-A23B-01A-11D-A16V-10_wgs_Illumina.bam,76.29,1.85,0.08,58cfa832e4b0c9d6adf6cf76,TCGA-FV-A23B-01A-11D-A16V-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-FV-A23B-01A,C95ED407-BCC2-44AA-BC59-BF7549F2D665,Primary Tumor,Illumina HiSeq,1727600d-b6d6-4ab4-9eb1-03b214f5be2c,Liver,70,D056433D-C3E2-467A-8151-DDF2A6D8683A,63ADC09C-E1B1-40DD-9C35-2F8276B656FC,TCGA-FV-A23B-01A-11D-A16V-10,GRCh37-lite,TCGA-FV-A23B,TCGA-LIHC,NA,s16786,Baylor College of Medicine,International Genomics Consortium,United States,NO,T2,N0,Hepatocellular Carcinoma,Stage II
13722.58cfa830e4b0c9d6adf6c156,58cfa830e4b0c9d6adf6c156,TCGA-B9-4117-01A-02D-1402-10_wgs_Illumina.filtered.,WGS,TCGA-B9-4117-01A-02D-1402-10_wgs_Illumina,TCGA-B9-4117-01A-02D-1402-10_wgs_Illumina.bam,155.07,1.9,0.05,58cfa830e4b0c9d6adf6c156,TCGA-B9-4117-01A-02D-1402-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-B9-4117-01A,71B35CD8-ECEE-4599-BB24-B1EF78118423,Primary Tumor,Illumina HiSeq,4d9a1f84-a989-4caa-84d2-36d42c950675,Kidney,48,F3871637-192D-4324-9C59-CECFFF436356,6BA5F81A-B7A0-4C18-A112-2E11094EEC85,TCGA-B9-4117-01A-02D-1402-10,GRCh37-lite,TCGA-B9-4117,TCGA-KIRP,NA,s11776,Baylor College of Medicine,UNC,None,NO,T2,NX,Kidney Papillary Renal Cell Carcinoma,Not available
13722.58cfa832e4b0c9d6adf6ce70,58cfa832e4b0c9d6adf6ce70,TCGA-FV-A496-01A-11D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-FV-A496-01A-11D-A25V-10_wgs_Illumina,TCGA-FV-A496-01A-11D-A25V-10_wgs_Illumina.bam,36.61,NA,0.07,58cfa832e4b0c9d6adf6ce70,TCGA-FV-A496-01A-11D-A25V-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-FV-A496-01A,8AFA3140-DCBD-44C0-AB13-4ADA6A0444D4,Primary Tumor,Illumina HiSeq,62727522-1644-478e-a555-06a870b68bab,Liver,84,FD1E3B28-C143-4EF6-A699-3A61CB20A5ED,6E6AD1A2-F1EB-44D1-9852-F5752AFCF5EB,TCGA-FV-A496-01A-11D-A25V-10,GRCh37-lite,TCGA-FV-A496,TCGA-LIHC,NA,s16787,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d11e,58cfa832e4b0c9d6adf6d11e,TCGA-FV-A4ZQ-01A-11D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-FV-A4ZQ-01A-11D-A25V-10_wgs_Illumina,TCGA-FV-A4ZQ-01A-11D-A25V-10_wgs_Illumina.bam,41.34,NA,0.08,58cfa832e4b0c9d6adf6d11e,TCGA-FV-A4ZQ-01A-11D-A25V-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-FV-A4ZQ-01A,65E430E1-0C9A-4045-83A9-653B7CFF811D,Primary Tumor,Illumina HiSeq,34884ff9-c16b-4800-9b84-dd3ec001b261,Liver,52,56DAAD30-A336-4311-9FEB-26CF3E48C734,D02597F8-3AC7-4165-A65F-0E134E5D215B,TCGA-FV-A4ZQ-01A-11D-A25V-10,GRCh37-lite,TCGA-FV-A4ZQ,TCGA-LIHC,NA,s16592,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6ce6c,58cfa832e4b0c9d6adf6ce6c,TCGA-G3-A3CK-01A-11D-A20W-10_wgs_Illumina.filtered.,WGS,TCGA-G3-A3CK-01A-11D-A20W-10_wgs_Illumina,TCGA-G3-A3CK-01A-11D-A20W-10_wgs_Illumina.bam,43.11,NA,0.08,58cfa832e4b0c9d6adf6ce6c,TCGA-G3-A3CK-01A-11D-A20W-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-G3-A3CK-01A,39EB1DB0-2722-4AF4-8254-D0E10256C64D,Primary Tumor,Illumina HiSeq,210fd1fb-0012-410b-bfc8-bf53607bfe12,Liver,61,2F38C711-639F-4611-9076-DC99A1DB8239,1127B561-EA40-4D5E-95DF-DAA0A5EBC1E4,TCGA-G3-A3CK-01A-11D-A20W-10,GRCh37-lite,TCGA-G3-A3CK,TCGA-LIHC,NA,s16988,Baylor College of Medicine,Alberta Health Services,Canada,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6cfd2,58cfa832e4b0c9d6adf6cfd2,TCGA-GL-A59R-01A-11D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-GL-A59R-01A-11D-A26P-10_wgs_Illumina,TCGA-GL-A59R-01A-11D-A26P-10_wgs_Illumina.bam,21.08,NA,0.08,58cfa832e4b0c9d6adf6cfd2,TCGA-GL-A59R-01A-11D-A26P-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-GL-A59R-01A,78412F82-CC55-43D5-96CA-1D02CF957725,Primary Tumor,Illumina HiSeq,78730e13-6aeb-4c56-8ac4-4a73dcd37bbd,Kidney,79,6F084D86-6CE0-431A-87D7-0E543392EA15,C504D5A9-29B0-4B7E-AC7B-5E543449A0F4,TCGA-GL-A59R-01A-11D-A26P-10,GRCh37-lite,TCGA-GL-A59R,TCGA-KIRP,NA,s11647,Baylor College of Medicine,ABS - IUPUI,United States,NO,T3c,N0,Kidney Papillary Renal Cell Carcinoma,Stage III
13722.58cfa82fe4b0c9d6adf6b8e1,58cfa82fe4b0c9d6adf6b8e1,TCGA-A6-A56B-01A-31D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-A6-A56B-01A-31D-A28G-10_wgs_Illumina,TCGA-A6-A56B-01A-31D-A28G-10_wgs_Illumina.bam,38.26,NA,0.08,58cfa82fe4b0c9d6adf6b8e1,TCGA-A6-A56B-01A-31D-A28G-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-A56B-01A,74A0264D-1D31-430D-9A88-E7334C8AA96C,Primary Tumor,Illumina HiSeq,319d9aec-3e76-4b48-b4a8-9ffcb0f3acc4,Colorectal,57,4425892C-8C35-4F6C-B531-1EC510AD19D2,D3D65DB3-36F9-41C7-8E5E-1683CE94DFCB,TCGA-A6-A56B-01A-31D-A28G-10,GRCh37-lite,TCGA-A6-A56B,TCGA-COAD,NA,s13353,Baylor College of Medicine,Christiana Healthcare,United States,NO,T3,N1,Colon Adenocarcinoma,Stage IIIB
13722.58cfa832e4b0c9d6adf6d51c,58cfa832e4b0c9d6adf6d51c,TCGA-KO-8405-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KO-8405-01A-11D-2310-10_wgs_Illumina,TCGA-KO-8405-01A-11D-2310-10_wgs_Illumina.bam,91.2,NA,0.05,58cfa832e4b0c9d6adf6d51c,TCGA-KO-8405-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KO-8405-01A,D52C3CB6-921E-4F26-B49C-E6E4F11F9C06,Primary Tumor,Illumina HiSeq,f0e77d93-bf81-460d-b8ea-9f6189208a33,Kidney,29,415C8373-535F-4CDD-883B-C7BD7CEB426E,6400C324-2C94-477D-ACB9-669D4EA46F1E,TCGA-KO-8405-01A-11D-2310-10,GRCh37-lite,TCGA-KO-8405,TCGA-KICH,NA,s16535,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T3a,N0,Kidney Chromophobe,Stage III
13722.58cfa832e4b0c9d6adf6d448,58cfa832e4b0c9d6adf6d448,TCGA-QG-A5YW-01A-11D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-QG-A5YW-01A-11D-A28G-10_wgs_Illumina,TCGA-QG-A5YW-01A-11D-A28G-10_wgs_Illumina.bam,63.92,NA,0.08,58cfa832e4b0c9d6adf6d448,TCGA-QG-A5YW-01A-11D-A28G-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-QG-A5YW-01A,9F45A227-1FD5-478C-A194-4A5C61B68CC3,Primary Tumor,Illumina HiSeq,32a205bb-36f6-42a4-8bc1-42318eeccd0f,Colorectal,55,D8DCE266-1073-4BF2-A714-748E7E942635,4CFB0AEE-6661-478A-8694-9D8BA15E46B7,TCGA-QG-A5YW-01A-11D-A28G-10,GRCh37-lite,TCGA-QG-A5YW,TCGA-COAD,NA,s12894,Baylor College of Medicine,BLN - Baylor,United States,NO,T3,N2b,Colon Mucinous Adenocarcinoma,Stage IIIC
13722.58cfa831e4b0c9d6adf6c903,58cfa831e4b0c9d6adf6c903,TCGA-DD-A3A6-01A-11D-A22F-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A3A6-01A-11D-A22F-10_wgs_Illumina,TCGA-DD-A3A6-01A-11D-A22F-10_wgs_Illumina.bam,38.07,NA,0.08,58cfa831e4b0c9d6adf6c903,TCGA-DD-A3A6-01A-11D-A22F-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A3A6-01A,C4C4820B-6F4C-4CDD-B233-4D22F5933FD9,Primary Tumor,Illumina HiSeq,e78847a6-5647-480c-8eb3-a41842fa2139,Liver,72,8BBFEEAB-FF99-4BD0-B407-E1E532BD04FC,7F03CB4B-60B1-460C-B761-402E7CA09B0D,TCGA-DD-A3A6-01A-11D-A22F-10,GRCh37-lite,TCGA-DD-A3A6,TCGA-LIHC,3258,s16854,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T2,N0,Hepatocellular Carcinoma,Stage II
13722.58cfa832e4b0c9d6adf6d3ad,58cfa832e4b0c9d6adf6d3ad,TCGA-NH-A50V-01A-11D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-NH-A50V-01A-11D-A28G-10_wgs_Illumina,TCGA-NH-A50V-01A-11D-A28G-10_wgs_Illumina.bam,33.86,NA,0.08,58cfa832e4b0c9d6adf6d3ad,TCGA-NH-A50V-01A-11D-A28G-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-NH-A50V-01A,D3B7ADA6-5395-4212-A921-8E97C92B605D,Primary Tumor,Illumina HiSeq,80f9989d-1696-49b8-a893-f045bc8615ea,Colorectal,69,A7A71B11-5E34-49A4-8D54-BE27D9C8DAF0,55345803-83D4-4FDB-B0EE-328753801DA1,TCGA-NH-A50V-01A-11D-A28G-10,GRCh37-lite,TCGA-NH-A50V,TCGA-COAD,NA,s13043,Baylor College of Medicine,Candler,United States,NO,T3,N2a,Colon Adenocarcinoma,Stage IIIB
13722.58cfa830e4b0c9d6adf6bb02,58cfa830e4b0c9d6adf6bb02,TCGA-A6-A567-01A-31D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-A6-A567-01A-31D-A28G-10_wgs_Illumina,TCGA-A6-A567-01A-31D-A28G-10_wgs_Illumina.bam,29.22,NA,0.08,58cfa830e4b0c9d6adf6bb02,TCGA-A6-A567-01A-31D-A28G-10_wgs_Illumina.bam,Dead,MALE,BLACK OR AFRICAN AMERICAN,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-A6-A567-01A,857A5889-19E7-4208-8362-F1377C408037,Primary Tumor,Illumina HiSeq,062aa65c-624a-4bc6-97bc-6c35e7dc0ba3,Colorectal,56,ED37A5C0-341C-4ECC-8FB8-4B705E76E2AF,05486349-24A4-4931-BF5F-C9FEFE369AF2,TCGA-A6-A567-01A-31D-A28G-10,GRCh37-lite,TCGA-A6-A567,TCGA-COAD,1881,s12854,Baylor College of Medicine,Christiana Healthcare,United States,NO,T3,N1,Colon Adenocarcinoma,Stage IV
13722.58cfa82fe4b0c9d6adf6b89b,58cfa82fe4b0c9d6adf6b89b,TCGA-A6-A566-01A-11D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-A6-A566-01A-11D-A28G-10_wgs_Illumina,TCGA-A6-A566-01A-11D-A28G-10_wgs_Illumina.bam,17.81,NA,0.08,58cfa82fe4b0c9d6adf6b89b,TCGA-A6-A566-01A-11D-A28G-10_wgs_Illumina.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-A6-A566-01A,790266BC-C252-43F4-85D1-1B06EE529CF8,Primary Tumor,Illumina HiSeq,dd970455-c925-43f6-b58d-24982c846bdd,Colorectal,55,615FDEE9-637E-45C6-8909-36B9201A8EB7,492B4E58-12E2-47B2-BD47-28F8607072FA,TCGA-A6-A566-01A-11D-A28G-10,GRCh37-lite,TCGA-A6-A566,TCGA-COAD,758,s13351,Baylor College of Medicine,Christiana Healthcare,United States,NO,T4,N1,Colon Mucinous Adenocarcinoma,Stage IIIB
13722.58cfa831e4b0c9d6adf6c3e3,58cfa831e4b0c9d6adf6c3e3,TCGA-CC-5260-01A-01D-A12Z-10_wgs_Illumina.filtered.,WGS,TCGA-CC-5260-01A-01D-A12Z-10_wgs_Illumina,TCGA-CC-5260-01A-01D-A12Z-10_wgs_Illumina.bam,91.26,1.95,0.08,58cfa831e4b0c9d6adf6c3e3,TCGA-CC-5260-01A-01D-A12Z-10_wgs_Illumina.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-CC-5260-01A,CA8AFB2C-BE3D-41E8-8DBC-19FE7AB6154B,Primary Tumor,Illumina HiSeq,94aaf939-2195-4c49-b867-778f3670e7ff,Liver,61,7F347680-CD4D-4289-8F8F-3B0541381A42,3BACC189-01B8-46CC-A442-F393C0F428C6,TCGA-CC-5260-01A-01D-A12Z-10,GRCh37-lite,TCGA-CC-5260,TCGA-LIHC,NA,s16581,Baylor College of Medicine,ILSbio,None,NO,T4,N0,Hepatocellular Carcinoma,Stage IIIC
13722.58cfa831e4b0c9d6adf6c9a4,58cfa831e4b0c9d6adf6c9a4,TCGA-DD-A1ED-01A-11D-A152-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A1ED-01A-11D-A152-10_wgs_Illumina,TCGA-DD-A1ED-01A-11D-A152-10_wgs_Illumina.bam,38.22,1.7,0.08,58cfa831e4b0c9d6adf6c9a4,TCGA-DD-A1ED-01A-11D-A152-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A1ED-01A,0FF6364A-E6F4-47CA-A7E7-14705BF0A8DF,Primary Tumor,Illumina HiSeq,baa8f20c-66ac-448e-9ca3-b1302905fa30,Liver,68,1CF84C3E-E7E2-43A6-B9AF-E0042312F02F,4C3EDA94-56F4-46D3-8C88-50D476E773F6,TCGA-DD-A1ED-01A-11D-A152-10,GRCh37-lite,TCGA-DD-A1ED,TCGA-LIHC,NA,s16977,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d5b8,58cfa832e4b0c9d6adf6d5b8,TCGA-KO-8410-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KO-8410-01A-11D-2310-10_wgs_Illumina,TCGA-KO-8410-01A-11D-2310-10_wgs_Illumina.bam,71.2,NA,0.05,58cfa832e4b0c9d6adf6d5b8,TCGA-KO-8410-01A-11D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KO-8410-01A,B5F6A0E3-F9AC-475F-9A34-B8B8834F1779,Primary Tumor,Illumina HiSeq,ccebf6d6-dff4-4e8b-b33c-391cf464f5ab,Kidney,74,3751E3F9-C61F-4D5A-8054-B08590539820,798BD17B-69B7-40D7-92FF-7C2389EDCCCF,TCGA-KO-8410-01A-11D-2310-10,GRCh37-lite,TCGA-KO-8410,TCGA-KICH,NA,s16409,Baylor College of Medicine,MD Anderson Cancer Center,United States,NO,T1b,N0,Kidney Chromophobe,Stage I
13722.58cfa831e4b0c9d6adf6cbe9,58cfa831e4b0c9d6adf6cbe9,TCGA-ED-A459-01A-11D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-ED-A459-01A-11D-A25V-10_wgs_Illumina,TCGA-ED-A459-01A-11D-A25V-10_wgs_Illumina.bam,19.74,NA,0.08,58cfa831e4b0c9d6adf6cbe9,TCGA-ED-A459-01A-11D-A25V-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-ED-A459-01A,56403463-1727-4C23-A709-DE5F168C4073,Primary Tumor,Illumina HiSeq,eefae457-c645-4b48-b599-b479b7be4414,Liver,47,97FA4D8B-1C05-41A6-97C4-0B27DC70EB4C,7FC7B316-F3D3-4E71-9417-423FE334E6BC,TCGA-ED-A459-01A-11D-A25V-10,GRCh37-lite,TCGA-ED-A459,TCGA-LIHC,NA,s16980,Baylor College of Medicine,Asterand,Vietnam,NO,T2,N0,Hepatocellular Carcinoma,Stage II
13722.58cfa832e4b0c9d6adf6ce62,58cfa832e4b0c9d6adf6ce62,TCGA-FV-A2QQ-01A-11D-A22F-10_wgs_Illumina.filtered.,WGS,TCGA-FV-A2QQ-01A-11D-A22F-10_wgs_Illumina,TCGA-FV-A2QQ-01A-11D-A22F-10_wgs_Illumina.bam,36.18,NA,0.08,58cfa832e4b0c9d6adf6ce62,TCGA-FV-A2QQ-01A-11D-A22F-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-FV-A2QQ-01A,D680DF09-368E-42B5-B540-45C41ED31042,Primary Tumor,Illumina HiSeq,5e2beb4b-957f-4d8e-956f-798a63355329,Liver,80,A0096AF4-ABD3-4F6E-A6AC-2CF2E57C7BD9,4904D56F-0FE7-4482-8F6D-9E54D261F399,TCGA-FV-A2QQ-01A-11D-A22F-10,GRCh37-lite,TCGA-FV-A2QQ,TCGA-LIHC,NA,s16861,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1,N1,Hepatocellular Carcinoma,Stage IVA
13722.58cfa832e4b0c9d6adf6d437,58cfa832e4b0c9d6adf6d437,TCGA-QG-A5Z1-01A-11D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-QG-A5Z1-01A-11D-A28G-10_wgs_Illumina,TCGA-QG-A5Z1-01A-11D-A28G-10_wgs_Illumina.bam,39.63,NA,0.08,58cfa832e4b0c9d6adf6d437,TCGA-QG-A5Z1-01A-11D-A28G-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-QG-A5Z1-01A,9C45EAEC-D854-4F51-80A3-2D80D6B4AEBC,Primary Tumor,Illumina HiSeq,cc89a29c-287c-4a64-87c1-40ea6c90f58a,Colorectal,71,95601410-9608-4DDA-BA3F-462BE0E8C35F,D3AFF5D3-23C0-43AE-9C01-8DDD776B530B,TCGA-QG-A5Z1-01A-11D-A28G-10,GRCh37-lite,TCGA-QG-A5Z1,TCGA-COAD,NA,s13041,Baylor College of Medicine,BLN - Baylor,United States,NO,T3,N1b,Colon Adenocarcinoma,Stage IIIB
13722.58cfa831e4b0c9d6adf6c9f6,58cfa831e4b0c9d6adf6c9f6,TCGA-DD-A4NB-01A-12D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A4NB-01A-12D-A25V-10_wgs_Illumina,TCGA-DD-A4NB-01A-12D-A25V-10_wgs_Illumina.bam,9.12,NA,0.07,58cfa831e4b0c9d6adf6c9f6,TCGA-DD-A4NB-01A-12D-A25V-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A4NB-01A,1983FADE-44F1-41E0-8983-F2CE8D649655,Primary Tumor,Illumina HiSeq,a3509f59-4d19-4a9b-afd1-dc57f8f871dd,Liver,25,0A79C3EE-9DD0-4FF7-B079-C9A0AEB08E1F,5D58B984-E0B8-4237-A576-0E9D4079599E,TCGA-DD-A4NB-01A-12D-A25V-10,GRCh37-lite,TCGA-DD-A4NB,TCGA-LIHC,NA,s16855,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T1,N0,Fibrolamellar Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c9bf,58cfa831e4b0c9d6adf6c9bf,TCGA-DD-A1EJ-01A-11D-A152-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A1EJ-01A-11D-A152-10_wgs_Illumina,TCGA-DD-A1EJ-01A-11D-A152-10_wgs_Illumina.bam,51.74,1.45,0.08,58cfa831e4b0c9d6adf6c9bf,TCGA-DD-A1EJ-01A-11D-A152-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A1EJ-01A,52292FFC-0902-4D97-B461-20723987A177,Primary Tumor,Illumina HiSeq,65b1f0b7-fec9-4ee4-8634-583e00af7202,Liver,71,2D549BB0-9E98-40C7-8B33-545C481DD105,9C681CD9-25FB-42AC-AA6B-BB962882FA22,TCGA-DD-A1EJ-01A-11D-A152-10,GRCh37-lite,TCGA-DD-A1EJ,TCGA-LIHC,NA,s16586,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T1,N1,Hepatocellular Carcinoma,Stage IIIC
13722.58cfa832e4b0c9d6adf6ce87,58cfa832e4b0c9d6adf6ce87,TCGA-FV-A3R3-01A-11D-A22F-10_wgs_Illumina.filtered.,WGS,TCGA-FV-A3R3-01A-11D-A22F-10_wgs_Illumina,TCGA-FV-A3R3-01A-11D-A22F-10_wgs_Illumina.bam,16.97,NA,0.08,58cfa832e4b0c9d6adf6ce87,TCGA-FV-A3R3-01A-11D-A22F-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-FV-A3R3-01A,3DD7C93D-8194-44EE-8014-10DD81EF6441,Primary Tumor,Illumina HiSeq,0f95ee88-7930-46cd-a565-bf3d91f5f505,Liver,38,8ABDA02F-AEDF-4599-9407-E253207D5D4C,C285C2FA-24B4-47A1-874D-86E74B002B05,TCGA-FV-A3R3-01A-11D-A22F-10,GRCh37-lite,TCGA-FV-A3R3,TCGA-LIHC,NA,s16685,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6cc59,58cfa831e4b0c9d6adf6cc59,TCGA-EP-A3RK-01A-11D-A22F-10_wgs_Illumina.filtered.,WGS,TCGA-EP-A3RK-01A-11D-A22F-10_wgs_Illumina,TCGA-EP-A3RK-01A-11D-A22F-10_wgs_Illumina.bam,46.15,NA,0.08,58cfa831e4b0c9d6adf6cc59,TCGA-EP-A3RK-01A-11D-A22F-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-EP-A3RK-01A,F15279DD-5D12-460B-9BD1-B4F95681CA65,Primary Tumor,Illumina HiSeq,3b2093f5-b5ba-4e57-b4a1-47a180f9bb81,Liver,73,253DA6EE-8786-4A20-A0DC-58816A8A9C39,0D259AC2-03D1-4814-9B0B-D05E3A6029B7,TCGA-EP-A3RK-01A-11D-A22F-10,GRCh37-lite,TCGA-EP-A3RK,TCGA-LIHC,NA,s16682,Baylor College of Medicine,Christiana Healthcare,United States,NO,T3a,NX,Hepatocellular Carcinoma,Stage IIIA
13722.58cfa832e4b0c9d6adf6d48a,58cfa832e4b0c9d6adf6d48a,TCGA-NH-A50T-01A-11D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-NH-A50T-01A-11D-A28G-10_wgs_Illumina,TCGA-NH-A50T-01A-11D-A28G-10_wgs_Illumina.bam,43.71,NA,0.08,58cfa832e4b0c9d6adf6d48a,TCGA-NH-A50T-01A-11D-A28G-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-NH-A50T-01A,490EABCA-4575-4BD6-9604-6B6E23D069CE,Primary Tumor,Illumina HiSeq,2893d404-6a2e-482b-86f7-eb3ae051faf4,Colorectal,68,9F5AD422-C94D-4914-B6F0-071596ECB589,8A929C55-35A6-4645-BB70-4B85D281B139,TCGA-NH-A50T-01A-11D-A28G-10,GRCh37-lite,TCGA-NH-A50T,TCGA-COAD,NA,s13547,Baylor College of Medicine,Candler,United States,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa830e4b0c9d6adf6bf19,58cfa830e4b0c9d6adf6bf19,TCGA-AY-A54L-01A-11D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-AY-A54L-01A-11D-A28G-10_wgs_Illumina,TCGA-AY-A54L-01A-11D-A28G-10_wgs_Illumina.bam,62.42,NA,0.07,58cfa830e4b0c9d6adf6bf19,TCGA-AY-A54L-01A-11D-A28G-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-AY-A54L-01A,D8E9EA52-FF28-4626-BAA3-71350FD53DDF,Primary Tumor,Illumina HiSeq,709d8bea-f505-4558-b12a-7bd4322e75ea,Colorectal,74,52EFBEB4-7B23-4C49-92F9-931A3EB99055,080ECC31-756A-4A1B-A51E-D632AC8219F7,TCGA-AY-A54L-01A-11D-A28G-10,GRCh37-lite,TCGA-AY-A54L,TCGA-COAD,NA,s13542,Baylor College of Medicine,UNC,United States,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa831e4b0c9d6adf6c3be,58cfa831e4b0c9d6adf6c3be,TCGA-CC-5261-01A-01D-A12Z-10_wgs_Illumina.filtered.,WGS,TCGA-CC-5261-01A-01D-A12Z-10_wgs_Illumina,TCGA-CC-5261-01A-01D-A12Z-10_wgs_Illumina.bam,125.45,1.93,0.08,58cfa831e4b0c9d6adf6c3be,TCGA-CC-5261-01A-01D-A12Z-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-CC-5261-01A,1AD7F17E-B3B8-40E9-AAB8-5A17E0AEC408,Primary Tumor,Illumina HiSeq,43047cdb-fea6-4e20-9248-30ae5624c5a7,Liver,44,538998F3-5230-4963-8B67-D34DE695E97D,A2F143D6-BA07-4FF0-960D-B29C3C716665,TCGA-CC-5261-01A-01D-A12Z-10,GRCh37-lite,TCGA-CC-5261,TCGA-LIHC,NA,s16582,Baylor College of Medicine,ILSbio,None,NO,T2,N0,Hepatocellular Carcinoma,Stage II
13722.58cfa832e4b0c9d6adf6d1f0,58cfa832e4b0c9d6adf6d1f0,TCGA-FF-8042-01A-11D-2210-10_wgs_Illumina.filtered.,WGS,TCGA-FF-8042-01A-11D-2210-10_wgs_Illumina,TCGA-FF-8042-01A-11D-2210-10_wgs_Illumina.bam,439.7,NA,0.05,58cfa832e4b0c9d6adf6d1f0,TCGA-FF-8042-01A-11D-2210-10_wgs_Illumina.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Aligned reads,TCGA-FF-8042-01A,F0A326D2-1F3E-4A5D-BCA8-32AACCC52338,Primary Tumor,Illumina HiSeq,fbeb4f92-2f36-4ebf-8684-0327679f0a2f,Lymph Nodes,57,562F76EB-CD16-4EEC-9B31-3E5DEEE3497C,897A4500-6FB8-4E81-AA07-021A26D632FB,TCGA-FF-8042-01A-11D-2210-10,GRCh37-lite,TCGA-FF-8042,TCGA-DLBC,NA,s1108,Baylor College of Medicine,SingHealth,Singapore,NO,Not available,Not available,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),Not available
13722.58cfa831e4b0c9d6adf6cde4,58cfa831e4b0c9d6adf6cde4,TCGA-ES-A2HS-01A-11D-A183-10_wgs_Illumina.filtered.,WGS,TCGA-ES-A2HS-01A-11D-A183-10_wgs_Illumina,TCGA-ES-A2HS-01A-11D-A183-10_wgs_Illumina.bam,48.99,NA,0.09,58cfa831e4b0c9d6adf6cde4,TCGA-ES-A2HS-01A-11D-A183-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-ES-A2HS-01A,728AEDB3-551A-4C16-9BE3-7733A9539E9E,Primary Tumor,Illumina HiSeq,a3182ffa-89ac-4c42-a051-93cb3aa08207,Liver,80,A06FE860-8D5F-4ED0-B7FC-72F74567FB7E,DCF45005-7E6D-4C26-9994-F973DA7E814F,TCGA-ES-A2HS-01A-11D-A183-10,GRCh37-lite,TCGA-ES-A2HS,TCGA-LIHC,695,s16984,Baylor College of Medicine,University of Florida,United States,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d2b8,58cfa832e4b0c9d6adf6d2b8,TCGA-KL-8331-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8331-01A-11D-2310-10_wgs_Illumina,TCGA-KL-8331-01A-11D-2310-10_wgs_Illumina.bam,125.3,NA,0.05,58cfa832e4b0c9d6adf6d2b8,TCGA-KL-8331-01A-11D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8331-01A,8AC7F218-BD7B-4DDA-8879-2CEC49748E42,Primary Tumor,Illumina HiSeq,30f11cbf-417b-4a4a-b440-1c22bfc3b225,Kidney,48,EEA84BEB-0F41-4120-A350-6F31EC8712BB,7087A2B6-7FC4-45B0-8C48-248864F03DEB,TCGA-KL-8331-01A-11D-2310-10,GRCh37-lite,TCGA-KL-8331,TCGA-KICH,NA,s16421,Baylor College of Medicine,MSKCC,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa831e4b0c9d6adf6c89e,58cfa831e4b0c9d6adf6c89e,TCGA-DD-A1EG-01A-11D-A20W-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A1EG-01A-11D-A20W-10_wgs_Illumina,TCGA-DD-A1EG-01A-11D-A20W-10_wgs_Illumina.bam,24.35,NA,0.08,58cfa831e4b0c9d6adf6c89e,TCGA-DD-A1EG-01A-11D-A20W-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A1EG-01A,6C79F64B-63FE-46F5-BF7B-77208231B0F2,Primary Tumor,Illumina HiSeq,cf962035-7148-470e-a820-f252e162e9ef,Liver,76,E8B59658-06C6-46B7-B51F-ED52DE0C403E,50EE360C-E3DF-4888-9999-EBB88E271D08,TCGA-DD-A1EG-01A-11D-A20W-10,GRCh37-lite,TCGA-DD-A1EG,TCGA-LIHC,1372,s16585,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6bb0d,58cfa830e4b0c9d6adf6bb0d,TCGA-A6-A565-01A-31D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-A6-A565-01A-31D-A28G-10_wgs_Illumina,TCGA-A6-A565-01A-31D-A28G-10_wgs_Illumina.bam,27.34,NA,0.08,58cfa830e4b0c9d6adf6bb0d,TCGA-A6-A565-01A-31D-A28G-10_wgs_Illumina.bam,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Colon Adenocarcinoma,Aligned reads,TCGA-A6-A565-01A,DD7A53EE-CB08-40C4-9935-51D1CA17E9E8,Primary Tumor,Illumina HiSeq,94ddbe0f-9753-4acc-abe8-2bfda86dd8b2,Colorectal,34,87A57810-8B62-4AF1-ADB9-4715A71ED632,63BC376E-5A3D-44FD-8D77-686DFC41E458,TCGA-A6-A565-01A-31D-A28G-10,GRCh37-lite,TCGA-A6-A565,TCGA-COAD,494,s13657,Baylor College of Medicine,Christiana Healthcare,United States,NO,T3,N2,Colon Mucinous Adenocarcinoma,Stage IIIC
13722.58cfa832e4b0c9d6adf6cefa,58cfa832e4b0c9d6adf6cefa,TCGA-HE-A5NH-01A-11D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-HE-A5NH-01A-11D-A26P-10_wgs_Illumina,TCGA-HE-A5NH-01A-11D-A26P-10_wgs_Illumina.bam,20.02,NA,0.08,58cfa832e4b0c9d6adf6cefa,TCGA-HE-A5NH-01A-11D-A26P-10_wgs_Illumina.bam,Alive,MALE,Not available,Not available,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-HE-A5NH-01A,98A639C2-D615-4DC1-98F0-298752B69B09,Primary Tumor,Illumina HiSeq,7d7c81dd-4888-4bac-a7d7-0859f946423b,Kidney,62,E8CD0D5D-2AF6-444F-B8B9-05B1874EDAE2,33B7E799-AD10-498F-9948-8CE433311539,TCGA-HE-A5NH-01A-11D-A26P-10,GRCh37-lite,TCGA-HE-A5NH,TCGA-KIRP,NA,s11591,Baylor College of Medicine,Ontario Institute for Cancer Research (OICR),Canada,NO,T1a,NX,Kidney Papillary Renal Cell Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6cb2c,58cfa831e4b0c9d6adf6cb2c,TCGA-ED-A4XI-01A-11D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-ED-A4XI-01A-11D-A25V-10_wgs_Illumina,TCGA-ED-A4XI-01A-11D-A25V-10_wgs_Illumina.bam,23.36,NA,0.08,58cfa831e4b0c9d6adf6cb2c,TCGA-ED-A4XI-01A-11D-A25V-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-ED-A4XI-01A,C52ABAC9-07DA-4B3D-BF8A-2161CACF9682,Primary Tumor,Illumina HiSeq,a2c23e6e-f1ad-454f-999a-c07f31a63536,Liver,58,25EB5AFD-E7A6-4F3C-82B4-A3DE1F8F9BE1,670F971F-A525-4EF8-91BA-610CFBAEB914,TCGA-ED-A4XI-01A-11D-A25V-10,GRCh37-lite,TCGA-ED-A4XI,TCGA-LIHC,NA,s16589,Baylor College of Medicine,Asterand,Vietnam,NO,T2,N0,Hepatocellular Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6ca2b,58cfa831e4b0c9d6adf6ca2b,TCGA-DD-A1E9-01A-21D-A152-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A1E9-01A-21D-A152-10_wgs_Illumina,TCGA-DD-A1E9-01A-21D-A152-10_wgs_Illumina.bam,41.55,2.03,0.08,58cfa831e4b0c9d6adf6ca2b,TCGA-DD-A1E9-01A-21D-A152-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A1E9-01A,8153A862-0790-4A33-80DB-ED47FEDCD4EF,Primary Tumor,Illumina HiSeq,85774f15-e638-438b-8515-92f3e9a8fa8e,Liver,70,966C4541-84D4-4A4F-9BB9-209431B620C7,84A0BC36-9F29-4B23-AEE1-BF5FF71F697B,TCGA-DD-A1E9-01A-21D-A152-10,GRCh37-lite,TCGA-DD-A1E9,TCGA-LIHC,2759,s16978,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d334,58cfa832e4b0c9d6adf6d334,TCGA-KM-8639-01A-11D-2397-10_wgs_Illumina.filtered.,WGS,TCGA-KM-8639-01A-11D-2397-10_wgs_Illumina,TCGA-KM-8639-01A-11D-2397-10_wgs_Illumina.bam,157,NA,0.05,58cfa832e4b0c9d6adf6d334,TCGA-KM-8639-01A-11D-2397-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KM-8639-01A,2EA84E23-6A0A-4C5D-9C70-D5355A85DF35,Primary Tumor,Illumina HiSeq,f1dafc21-d5b0-48e6-ab3e-2fffa2d599e4,Kidney,67,E1D3EE37-402B-4727-8E27-B797D42F46BA,0B811C6A-8F05-44BD-AC33-FB720D189E71,TCGA-KM-8639-01A-11D-2397-10,GRCh37-lite,TCGA-KM-8639,TCGA-KICH,NA,s16572,Baylor College of Medicine,NCI Urologic Oncology Branch,United States,NO,T1a,NX,Kidney Chromophobe,Stage I
13722.58cfa832e4b0c9d6adf6d112,58cfa832e4b0c9d6adf6d112,TCGA-FV-A3I0-01A-11D-A22F-10_wgs_Illumina.filtered.,WGS,TCGA-FV-A3I0-01A-11D-A22F-10_wgs_Illumina,TCGA-FV-A3I0-01A-11D-A22F-10_wgs_Illumina.bam,32.65,NA,0.07,58cfa832e4b0c9d6adf6d112,TCGA-FV-A3I0-01A-11D-A22F-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-FV-A3I0-01A,A8C2AA08-9156-4845-AD77-5E060858C757,Primary Tumor,Illumina HiSeq,63861662-f89c-47c7-80f6-165f38ed4253,Liver,76,810D65B3-59D9-4815-AA41-0C21A0D17AC2,5DF489BC-6178-49E4-8A42-506F70300DFF,TCGA-FV-A3I0-01A-11D-A22F-10,GRCh37-lite,TCGA-FV-A3I0,TCGA-LIHC,NA,s16593,Baylor College of Medicine,International Genomics Consortium,United States,NO,T2,NX,Hepatocholangiocarcinoma (Mixed),Stage II
13722.58cfa832e4b0c9d6adf6d4fc,58cfa832e4b0c9d6adf6d4fc,TCGA-KN-8437-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KN-8437-01A-11D-2310-10_wgs_Illumina,TCGA-KN-8437-01A-11D-2310-10_wgs_Illumina.bam,88.3,NA,0.05,58cfa832e4b0c9d6adf6d4fc,TCGA-KN-8437-01A-11D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KN-8437-01A,F1C1502E-1BD6-425A-B651-454363809668,Primary Tumor,Illumina HiSeq,b4d37e4e-5f70-4f9f-8577-67d22eef75a4,Kidney,42,05CC0766-7ED0-458E-B1D7-732B632C05A4,345A06D6-FA5C-4674-A847-88A6B537CF3C,TCGA-KN-8437-01A-11D-2310-10,GRCh37-lite,TCGA-KN-8437,TCGA-KICH,NA,s16410,Baylor College of Medicine,Harvard,United States,NO,T1a,NX,Kidney Chromophobe,Stage I
13722.58cfa830e4b0c9d6adf6bdba,58cfa830e4b0c9d6adf6bdba,TCGA-BC-A10Q-01A-11D-A12Z-10_wgs_Illumina.filtered.,WGS,TCGA-BC-A10Q-01A-11D-A12Z-10_wgs_Illumina,TCGA-BC-A10Q-01A-11D-A12Z-10_wgs_Illumina.bam,43.79,1.91,0.08,58cfa830e4b0c9d6adf6bdba,TCGA-BC-A10Q-01A-11D-A12Z-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-BC-A10Q-01A,DFA15FBE-BB14-40CE-AFC6-70694112E3E2,Primary Tumor,Illumina HiSeq,64b40e86-f174-43b5-8a08-7ad687b13815,Liver,72,BF225DC1-4309-4304-849E-CBCC23C8442C,F7E9EED5-7A0B-4B2D-BEA3-FD8C42A3B90E,TCGA-BC-A10Q-01A-11D-A12Z-10,GRCh37-lite,TCGA-BC-A10Q,TCGA-LIHC,1135,s16670,Baylor College of Medicine,UNC,United States,NO,T2,NX,Hepatocellular Carcinoma,Not available
13722.58cfa831e4b0c9d6adf6c934,58cfa831e4b0c9d6adf6c934,TCGA-DD-A4ND-01A-11D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A4ND-01A-11D-A25V-10_wgs_Illumina,TCGA-DD-A4ND-01A-11D-A25V-10_wgs_Illumina.bam,24.52,NA,0.07,58cfa831e4b0c9d6adf6c934,TCGA-DD-A4ND-01A-11D-A25V-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A4ND-01A,C0BF9278-9CBB-4361-B4D8-AB172B67E276,Primary Tumor,Illumina HiSeq,7b8d29e8-a5ac-4b38-9ac0-77398a23286f,Liver,56,4282039E-396B-44D8-B4EC-AC14C46DDEF6,D9C5493E-F969-4C04-A646-9A3134011021,TCGA-DD-A4ND-01A-11D-A25V-10,GRCh37-lite,TCGA-DD-A4ND,TCGA-LIHC,NA,s16857,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6c2c4,58cfa830e4b0c9d6adf6c2c4,TCGA-AD-A5EK-01A-11D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-AD-A5EK-01A-11D-A28G-10_wgs_Illumina,TCGA-AD-A5EK-01A-11D-A28G-10_wgs_Illumina.bam,58.87,NA,0.08,58cfa830e4b0c9d6adf6c2c4,TCGA-AD-A5EK-01A-11D-A28G-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AD-A5EK-01A,E8EC26BD-C88D-42B9-AC8A-AB121B8140F8,Primary Tumor,Illumina HiSeq,e84aec8b-4304-43e0-96c7-d605fc64dd11,Colorectal,51,C48314EE-C778-4B82-8E5A-4923DF4C8413,D0A0D845-32E2-4590-B909-29BD27B92900,TCGA-AD-A5EK-01A-11D-A28G-10,GRCh37-lite,TCGA-AD-A5EK,TCGA-COAD,NA,s13537,Baylor College of Medicine,International Genomics Consortium,United States,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa832e4b0c9d6adf6ce7e,58cfa832e4b0c9d6adf6ce7e,TCGA-FV-A495-01A-11D-A25V-10_wgs_Illumina.filtered.,WGS,TCGA-FV-A495-01A-11D-A25V-10_wgs_Illumina,TCGA-FV-A495-01A-11D-A25V-10_wgs_Illumina.bam,17.43,NA,0.08,58cfa832e4b0c9d6adf6ce7e,TCGA-FV-A495-01A-11D-A25V-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-FV-A495-01A,BD48FA5E-0152-46F0-A4FA-8CF723FF2DCD,Primary Tumor,Illumina HiSeq,bd95350e-cf5e-48c9-929a-3e397b36cd21,Liver,51,B7FC877D-6055-4A28-BBDF-50CE7236B7BF,84FE77B4-F6CC-49BF-A6B9-1621EC9394F8,TCGA-FV-A495-01A-11D-A25V-10,GRCh37-lite,TCGA-FV-A495,TCGA-LIHC,NA,s16591,Baylor College of Medicine,International Genomics Consortium,United States,NO,T2,NX,Hepatocellular Carcinoma,Stage II
13722.58cfa832e4b0c9d6adf6ce7c,58cfa832e4b0c9d6adf6ce7c,TCGA-G3-A5SL-01A-11D-A27I-10_wgs_Illumina.filtered.,WGS,TCGA-G3-A5SL-01A-11D-A27I-10_wgs_Illumina,TCGA-G3-A5SL-01A-11D-A27I-10_wgs_Illumina.bam,50.54,NA,0.07,58cfa832e4b0c9d6adf6ce7c,TCGA-G3-A5SL-01A-11D-A27I-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-G3-A5SL-01A,9A56D8A8-DADD-442E-BC09-732CD619AEF7,Primary Tumor,Illumina HiSeq,f55def89-845d-40d8-a532-eb471f2c04d3,Liver,70,5AF5519D-73EE-481B-A47C-06F54DBD372F,70422E6D-CB1F-4284-8BE9-1D4517FFAD60,TCGA-G3-A5SL-01A-11D-A27I-10,GRCh37-lite,TCGA-G3-A5SL,TCGA-LIHC,NA,s17064,Baylor College of Medicine,Alberta Health Services,Canada,NO,T2,NX,Hepatocellular Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6cd8d,58cfa831e4b0c9d6adf6cd8d,TCGA-FF-8062-01A-11D-2210-10_wgs_Illumina.filtered.,WGS,TCGA-FF-8062-01A-11D-2210-10_wgs_Illumina,TCGA-FF-8062-01A-11D-2210-10_wgs_Illumina.bam,612.7,NA,0.05,58cfa831e4b0c9d6adf6cd8d,TCGA-FF-8062-01A-11D-2210-10_wgs_Illumina.bam,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Aligned reads,TCGA-FF-8062-01A,0E9FCCCC-0630-408D-A121-2C6413824CB7,Primary Tumor,Illumina HiSeq,6b814375-f839-4dc0-a4a2-d495b55c5f64,Lymph Nodes,60,A1DACFBB-042B-496E-94A4-046DC04E27B5,BD403458-5154-488B-931A-A7E737A6BF8C,TCGA-FF-8062-01A-11D-2210-10,GRCh37-lite,TCGA-FF-8062,TCGA-DLBC,NA,s1112,Baylor College of Medicine,SingHealth,Singapore,NO,Not available,Not available,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),Not available
13722.58cfa832e4b0c9d6adf6ce00,58cfa832e4b0c9d6adf6ce00,TCGA-G3-A25W-01A-11D-A16V-10_wgs_Illumina.filtered.,WGS,TCGA-G3-A25W-01A-11D-A16V-10_wgs_Illumina,TCGA-G3-A25W-01A-11D-A16V-10_wgs_Illumina.bam,16.34,1.85,0.09,58cfa832e4b0c9d6adf6ce00,TCGA-G3-A25W-01A-11D-A16V-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-G3-A25W-01A,06AC44E9-1226-4202-828B-6F224766D7AC,Primary Tumor,Illumina HiSeq,8e1a9b98-38eb-4a80-8ceb-050f57ca4d78,Liver,79,859CDE68-B3BB-4867-BCED-C016BFAFFDE9,36E1D9CC-32EC-4A0A-8FB1-C46F058A6FB8,TCGA-G3-A25W-01A-11D-A16V-10,GRCh37-lite,TCGA-G3-A25W,TCGA-LIHC,NA,s16788,Baylor College of Medicine,Alberta Health Services,Canada,NO,T3b,N0,Hepatocellular Carcinoma,Stage IIIB
13722.58cfa830e4b0c9d6adf6bca2,58cfa830e4b0c9d6adf6bca2,TCGA-AZ-4315-01A-01W-1461-10_wgs_Illumina.filtered.,WGS,TCGA-AZ-4315-01A-01W-1461-10_wgs_Illumina,TCGA-AZ-4315-01A-01W-1461-10_wgs_Illumina.bam,171,NA,0.5,58cfa830e4b0c9d6adf6bca2,TCGA-AZ-4315-01A-01W-1461-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-AZ-4315-01A,DE287A25-981D-49F8-81AF-FE0300E4CD31,Primary Tumor,Illumina HiSeq,707a2d43-0ea1-4012-8f29-4202690c6608,Colorectal,61,BA9E5603-BB1D-4AA8-93E4-40043164F143,A9D1B074-7F36-4A04-B270-A2061249FF20,TCGA-AZ-4315-01A-01W-1461-10,GRCh37-lite,TCGA-AZ-4315,TCGA-COAD,NA,s13211,Baylor College of Medicine,University of Pittsburgh,None,NO,T3,N0,Colon Adenocarcinoma,Stage IIA
13722.58cfa832e4b0c9d6adf6d291,58cfa832e4b0c9d6adf6d291,TCGA-KL-8340-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8340-01A-11D-2310-10_wgs_Illumina,TCGA-KL-8340-01A-11D-2310-10_wgs_Illumina.bam,71.3,NA,0.05,58cfa832e4b0c9d6adf6d291,TCGA-KL-8340-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8340-01A,3129E869-BB2F-423A-BD20-D0DAAE33B11A,Primary Tumor,Illumina HiSeq,24326cad-efd9-4017-90e3-2ae8ac037b99,Kidney,34,07C3C6E6-D297-4D80-9C28-974FA470A132,D113CE88-04AB-4675-B363-92F80C28DE34,TCGA-KL-8340-01A-11D-2310-10,GRCh37-lite,TCGA-KL-8340,TCGA-KICH,NA,s16477,Baylor College of Medicine,MSKCC,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa831e4b0c9d6adf6ca23,58cfa831e4b0c9d6adf6ca23,TCGA-DD-A1EI-01A-11D-A12Z-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A1EI-01A-11D-A12Z-10_wgs_Illumina,TCGA-DD-A1EI-01A-11D-A12Z-10_wgs_Illumina.bam,51.84,1.86,0.08,58cfa831e4b0c9d6adf6ca23,TCGA-DD-A1EI-01A-11D-A12Z-10_wgs_Illumina.bam,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A1EI-01A,3ACF7438-FD65-442C-8A30-68B6714537F3,Primary Tumor,Illumina HiSeq,3578b4d9-a65f-4096-bb30-1b3509f8a918,Liver,46,65FB618A-9296-47AD-BBA9-A93FC3F88E68,C016D025-3C92-41C5-B846-493B1FCCE79E,TCGA-DD-A1EI-01A-11D-A12Z-10,GRCh37-lite,TCGA-DD-A1EI,TCGA-LIHC,NA,s16975,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6c23e,58cfa830e4b0c9d6adf6c23e,TCGA-BW-A5NQ-01A-11D-A27I-10_wgs_Illumina.filtered.,WGS,TCGA-BW-A5NQ-01A-11D-A27I-10_wgs_Illumina,TCGA-BW-A5NQ-01A-11D-A27I-10_wgs_Illumina.bam,66.53,NA,0.07,58cfa830e4b0c9d6adf6c23e,TCGA-BW-A5NQ-01A-11D-A27I-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-BW-A5NQ-01A,C7F1B389-AEC7-4993-8AFB-B7A56064F8FC,Primary Tumor,Illumina HiSeq,4bbd34a1-0024-44aa-9e51-9ac4c51c7f1d,Liver,63,C8FFE03A-62C3-4B47-9DEA-CB3377F59ABB,E30C64D5-E796-4CFC-8DC8-6E62BF97822F,TCGA-BW-A5NQ-01A-11D-A27I-10,GRCh37-lite,TCGA-BW-A5NQ,TCGA-LIHC,NA,s16848,Baylor College of Medicine,St Joseph's Medical Center (MD),United States,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa830e4b0c9d6adf6becd,58cfa830e4b0c9d6adf6becd,TCGA-AL-A5DJ-01A-11D-A26P-10_wgs_Illumina.filtered.,WGS,TCGA-AL-A5DJ-01A-11D-A26P-10_wgs_Illumina,TCGA-AL-A5DJ-01A-11D-A26P-10_wgs_Illumina.bam,26.68,NA,0.07,58cfa830e4b0c9d6adf6becd,TCGA-AL-A5DJ-01A-11D-A26P-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Papillary Cell Carcinoma,Aligned reads,TCGA-AL-A5DJ-01A,B06CDF61-61C9-4035-A55D-1EF21DC21069,Primary Tumor,Illumina HiSeq,0fd919c5-b847-49f4-b928-4dd15a94c3a0,Kidney,54,BD6B7CBE-57B6-45B9-96F6-4D39B8303407,B4F515CE-5BEE-4E40-A66A-01F41E92181E,TCGA-AL-A5DJ-01A-11D-A26P-10,GRCh37-lite,TCGA-AL-A5DJ,TCGA-KIRP,NA,s11579,Baylor College of Medicine,Fox Chase,United States,NO,T3a,NX,Kidney Papillary Renal Cell Carcinoma,Stage III
13722.58cfa832e4b0c9d6adf6d130,58cfa832e4b0c9d6adf6d130,TCGA-FV-A3I1-01A-11D-A22F-10_wgs_Illumina.filtered.,WGS,TCGA-FV-A3I1-01A-11D-A22F-10_wgs_Illumina,TCGA-FV-A3I1-01A-11D-A22F-10_wgs_Illumina.bam,39.14,NA,0.08,58cfa832e4b0c9d6adf6d130,TCGA-FV-A3I1-01A-11D-A22F-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-FV-A3I1-01A,BFD20D71-18A5-4F01-8D56-84378AD92359,Primary Tumor,Illumina HiSeq,137dd060-0c76-4ad8-b447-bcf55d593f0c,Liver,81,A744BE68-D008-4847-A11D-89918A419A5F,992D9566-B1DA-421A-BF36-D23382B115FA,TCGA-FV-A3I1-01A-11D-A22F-10,GRCh37-lite,TCGA-FV-A3I1,TCGA-LIHC,NA,s16986,Baylor College of Medicine,International Genomics Consortium,United States,NO,T2,N0,Hepatocellular Carcinoma,Stage II
13722.58cfa831e4b0c9d6adf6cc1c,58cfa831e4b0c9d6adf6cc1c,TCGA-EP-A2KA-01A-11D-A183-10_wgs_Illumina.filtered.,WGS,TCGA-EP-A2KA-01A-11D-A183-10_wgs_Illumina,TCGA-EP-A2KA-01A-11D-A183-10_wgs_Illumina.bam,69.11,NA,0.07,58cfa831e4b0c9d6adf6cc1c,TCGA-EP-A2KA-01A-11D-A183-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-EP-A2KA-01A,440375D7-CDCD-418A-8992-0A8CA42D290D,Primary Tumor,Illumina HiSeq,e0364f92-b574-4946-8ba1-2504614f0845,Liver,52,E6E1BF11-DA29-4052-85A1-584401F0FA3D,484A41C8-FCAF-488D-97DC-BFE6A4B88A95,TCGA-EP-A2KA-01A-11D-A183-10,GRCh37-lite,TCGA-EP-A2KA,TCGA-LIHC,NA,s16983,Baylor College of Medicine,Christiana Healthcare,United States,NO,T3a,NX,Hepatocellular Carcinoma,Stage IIIA
13722.58cfa832e4b0c9d6adf6d470,58cfa832e4b0c9d6adf6d470,TCGA-QG-A5Z2-01A-11D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-QG-A5Z2-01A-11D-A28G-10_wgs_Illumina,TCGA-QG-A5Z2-01A-11D-A28G-10_wgs_Illumina.bam,58.77,NA,0.07,58cfa832e4b0c9d6adf6d470,TCGA-QG-A5Z2-01A-11D-A28G-10_wgs_Illumina.bam,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-QG-A5Z2-01A,84959E50-17F5-4F2B-8E0C-5EBB139D2C3A,Primary Tumor,Illumina HiSeq,2113677f-10e1-4987-bde0-35d29025de2e,Colorectal,61,3D753B5B-8E33-4307-9321-E4AD4821F3BF,31E63F89-A6A9-40FB-823D-F41587BD73D8,TCGA-QG-A5Z2-01A-11D-A28G-10,GRCh37-lite,TCGA-QG-A5Z2,TCGA-COAD,NA,s13042,Baylor College of Medicine,BLN - Baylor,United States,NO,T2,N0,Colon Adenocarcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d433,58cfa832e4b0c9d6adf6d433,TCGA-QG-A5YX-01A-11D-A28G-10_wgs_Illumina.filtered.,WGS,TCGA-QG-A5YX-01A-11D-A28G-10_wgs_Illumina,NA,NA,NA,NA,58cfa832e4b0c9d6adf6d433,TCGA-QG-A5YX-01A-11D-A28G-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,Aligned reads,TCGA-QG-A5YX-01A,300FFF5A-0F61-402D-B845-3938BA7B1294,Primary Tumor,Illumina HiSeq,aba79b86-0583-4858-8c09-d179c8a3b77e,Colorectal,61,346253C0-8E8B-459B-A6D5-03DA9586578F,10AD692B-4C3D-42DE-9B5E-4968441388B3,TCGA-QG-A5YX-01A-11D-A28G-10,GRCh37-lite,TCGA-QG-A5YX,TCGA-COAD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
13722.58cfa832e4b0c9d6adf6d164,58cfa832e4b0c9d6adf6d164,TCGA-KL-8327-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8327-01A-11D-2310-10_wgs_Illumina,TCGA-KL-8327-01A-11D-2310-10_wgs_Illumina.bam,112.3,NA,0.05,58cfa832e4b0c9d6adf6d164,TCGA-KL-8327-01A-11D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8327-01A,02979422-5149-4750-AD5F-483E0BEC6AC5,Primary Tumor,Illumina HiSeq,791eea87-33dd-4932-9e4e-d31487fc9a39,Kidney,46,F35E66EC-7AA5-477C-ABF7-07C35C90F7DE,D72A7338-C144-4C62-A70E-2177A3B4B77E,TCGA-KL-8327-01A-11D-2310-10,GRCh37-lite,TCGA-KL-8327,TCGA-KICH,NA,s16521,Baylor College of Medicine,MSKCC,United States,NO,T1b,N0,Kidney Chromophobe,Stage I
13722.58cfa831e4b0c9d6adf6c422,58cfa831e4b0c9d6adf6c422,TCGA-BW-A5NP-01A-11D-A27I-10_wgs_Illumina.filtered.,WGS,TCGA-BW-A5NP-01A-11D-A27I-10_wgs_Illumina,TCGA-BW-A5NP-01A-11D-A27I-10_wgs_Illumina.bam,62.92,NA,0.08,58cfa831e4b0c9d6adf6c422,TCGA-BW-A5NP-01A-11D-A27I-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-BW-A5NP-01A,56A82A56-0241-4D3D-9DE2-696B0C36DF91,Primary Tumor,Illumina HiSeq,ce91806d-fb1a-452a-ad2e-51c7bdfbeb15,Liver,26,C13884B6-EAEF-4E1C-8FA7-5FE76548D32F,1C00925B-7328-4DB0-B930-04AAB2D80719,TCGA-BW-A5NP-01A-11D-A27I-10,GRCh37-lite,TCGA-BW-A5NP,TCGA-LIHC,NA,s16972,Baylor College of Medicine,St Joseph's Medical Center (MD),United States,NO,T2,N0,Hepatocellular Carcinoma,Stage IV
13722.58cfa832e4b0c9d6adf6ce68,58cfa832e4b0c9d6adf6ce68,TCGA-G3-A25V-01A-11D-A16V-10_wgs_Illumina.filtered.,WGS,TCGA-G3-A25V-01A-11D-A16V-10_wgs_Illumina,TCGA-G3-A25V-01A-11D-A16V-10_wgs_Illumina.bam,62.02,1.79,0.08,58cfa832e4b0c9d6adf6ce68,TCGA-G3-A25V-01A-11D-A16V-10_wgs_Illumina.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-G3-A25V-01A,F435EC00-0DB8-46B4-96BF-890A9D931DF3,Primary Tumor,Illumina HiSeq,ddbeb5de-c37a-4565-8b8d-8965c09eb657,Liver,68,634AB666-0845-4B62-A2A1-ABD408D8B829,4624FD20-E2AD-4826-B606-A694B04E1076,TCGA-G3-A25V-01A-11D-A16V-10,GRCh37-lite,TCGA-G3-A25V,TCGA-LIHC,NA,s16688,Baylor College of Medicine,Alberta Health Services,Canada,NO,T1,N0,Hepatocellular Carcinoma,Stage I
13722.58cfa831e4b0c9d6adf6ca17,58cfa831e4b0c9d6adf6ca17,TCGA-DD-A4NE-01A-11D-A27I-10_wgs_Illumina.filtered.,WGS,TCGA-DD-A4NE-01A-11D-A27I-10_wgs_Illumina,TCGA-DD-A4NE-01A-11D-A27I-10_wgs_Illumina.bam,36.93,NA,0.07,58cfa831e4b0c9d6adf6ca17,TCGA-DD-A4NE-01A-11D-A27I-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-DD-A4NE-01A,BCE25281-502E-4599-9679-32DC8462FFB1,Primary Tumor,Illumina HiSeq,fde02df3-c43e-4d99-bb67-57c883818892,Liver,75,C8CB1326-7AB9-4E3D-BDC9-9CE42715DAC7,343FCBC2-F30C-4FFA-A0B3-F5BB21E5E70B,TCGA-DD-A4NE-01A-11D-A27I-10,GRCh37-lite,TCGA-DD-A4NE,TCGA-LIHC,660,s16588,Baylor College of Medicine,Mayo Clinic - Rochester,United States,NO,T3a,N0,Hepatocellular Carcinoma,Stage IIIA
13722.58cfa832e4b0c9d6adf6ce6e,58cfa832e4b0c9d6adf6ce6e,TCGA-FV-A3R2-01A-11D-A22F-10_wgs_Illumina.filtered.,WGS,TCGA-FV-A3R2-01A-11D-A22F-10_wgs_Illumina,TCGA-FV-A3R2-01A-11D-A22F-10_wgs_Illumina.bam,43.8,NA,0.07,58cfa832e4b0c9d6adf6ce6e,TCGA-FV-A3R2-01A-11D-A22F-10_wgs_Illumina.bam,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-FV-A3R2-01A,17833039-0D7E-47F0-90E6-8CABAE94C124,Primary Tumor,Illumina HiSeq,b20c4bf4-6780-4ba0-ae12-ae33d48a60d2,Liver,75,04BECA9F-830C-4CA8-A947-1BF2D7DF1B26,B9098B7C-EAB0-4EF5-B968-8D3024BF32F7,TCGA-FV-A3R2-01A-11D-A22F-10,GRCh37-lite,TCGA-FV-A3R2,TCGA-LIHC,194,s16784,Baylor College of Medicine,International Genomics Consortium,United States,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d2aa,58cfa832e4b0c9d6adf6d2aa,TCGA-KL-8326-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8326-01A-11D-2310-10_wgs_Illumina,TCGA-KL-8326-01A-11D-2310-10_wgs_Illumina.bam,71.3,NA,0.05,58cfa832e4b0c9d6adf6d2aa,TCGA-KL-8326-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8326-01A,03F3DD32-E1D1-485B-A968-3F55798F4D46,Primary Tumor,Illumina HiSeq,b96eaa8e-2627-4ac2-a3fb-1140269babf6,Kidney,69,59703768-8BE1-47A7-8C7D-D794C0936019,4729FE4B-C1AC-489B-A67E-91E5C5E3FF8C,TCGA-KL-8326-01A-11D-2310-10,GRCh37-lite,TCGA-KL-8326,TCGA-KICH,NA,s16519,Baylor College of Medicine,MSKCC,United States,NO,T3a,N0,Kidney Chromophobe,Stage III
13722.58cfa832e4b0c9d6adf6d2da,58cfa832e4b0c9d6adf6d2da,TCGA-KL-8334-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8334-01A-11D-2310-10_wgs_Illumina,TCGA-KL-8334-01A-11D-2310-10_wgs_Illumina.bam,71.3,NA,0.05,58cfa832e4b0c9d6adf6d2da,TCGA-KL-8334-01A-11D-2310-10_wgs_Illumina.bam,Alive,FEMALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8334-01A,9AABCBD7-A26A-49B1-ABF1-02C0DC3ADCF2,Primary Tumor,Illumina HiSeq,8f7d6dce-86ff-4bee-b2df-12b2ff95f653,Kidney,37,E9938C51-8FC6-4ED0-9201-E51C0E943D1F,94434272-4CBD-4B4D-BD98-44F18526DD69,TCGA-KL-8334-01A-11D-2310-10,GRCh37-lite,TCGA-KL-8334,TCGA-KICH,NA,s16485,Baylor College of Medicine,MSKCC,United States,NO,T3a,N0,Kidney Chromophobe,Stage III
13722.58cfa832e4b0c9d6adf6d2e0,58cfa832e4b0c9d6adf6d2e0,TCGA-KL-8330-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8330-01A-11D-2310-10_wgs_Illumina,TCGA-KL-8330-01A-11D-2310-10_wgs_Illumina.bam,210.3,NA,0.05,58cfa832e4b0c9d6adf6d2e0,TCGA-KL-8330-01A-11D-2310-10_wgs_Illumina.bam,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Kidney Chromophobe,Aligned reads,TCGA-KL-8330-01A,0F3C4F8F-0766-46B0-81B4-18CA4F6EA20A,Primary Tumor,Illumina HiSeq,ee57fec3-c6dc-4fef-9340-d24a48421fe8,Kidney,44,81431ED0-D762-4131-895B-852B2F78786D,09537DCE-C797-4B60-962A-D4C3CD6AB00A,TCGA-KL-8330-01A-11D-2310-10,GRCh37-lite,TCGA-KL-8330,TCGA-KICH,NA,s16522,Baylor College of Medicine,MSKCC,United States,NO,T2b,N0,Kidney Chromophobe,Stage II
13722.58cfa832e4b0c9d6adf6d2b6,58cfa832e4b0c9d6adf6d2b6,TCGA-KL-8332-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8332-01A-11D-2310-10_wgs_Illumina,TCGA-KL-8332-01A-11D-2310-10_wgs_Illumina.bam,71.3,NA,0.05,58cfa832e4b0c9d6adf6d2b6,TCGA-KL-8332-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8332-01A,3EC3BCB3-492C-4942-BE02-76A67F57E38F,Primary Tumor,Illumina HiSeq,b51b4316-5d7e-4f98-96f9-01d644b87e6d,Kidney,55,CD734D15-92C6-4B43-A5D3-EC823F6B9DC2,C6D6F49E-6E95-4E41-8388-71F6FE017D80,TCGA-KL-8332-01A-11D-2310-10,GRCh37-lite,TCGA-KL-8332,TCGA-KICH,NA,s16520,Baylor College of Medicine,MSKCC,United States,NO,T1b,N0,Kidney Chromophobe,Stage I
13722.58cfa832e4b0c9d6adf6d2d0,58cfa832e4b0c9d6adf6d2d0,TCGA-KL-8333-01A-11D-2310-10_wgs_Illumina.filtered.,WGS,TCGA-KL-8333-01A-11D-2310-10_wgs_Illumina,TCGA-KL-8333-01A-11D-2310-10_wgs_Illumina.bam,46.3,NA,0.05,58cfa832e4b0c9d6adf6d2d0,TCGA-KL-8333-01A-11D-2310-10_wgs_Illumina.bam,Alive,MALE,WHITE,Not available,Kidney Chromophobe,Aligned reads,TCGA-KL-8333-01A,02EC7A3A-2812-4A65-93CD-07BF655CC91B,Primary Tumor,Illumina HiSeq,824e5509-79ee-455a-8650-3c757cdf6fbf,Kidney,69,77186D62-B354-49A4-8A2A-12F5F6B938F6,C56505CB-E150-408D-9DF6-3AF4E608C376,TCGA-KL-8333-01A-11D-2310-10,GRCh37-lite,TCGA-KL-8333,TCGA-KICH,NA,s16434,Baylor College of Medicine,MSKCC,United States,NO,T2,N0,Kidney Chromophobe,Stage II
13722.58cfa832e4b0c9d6adf6d1bf,58cfa832e4b0c9d6adf6d1bf,TCGA-HP-A5MZ-01A-21D-A27I-10_wgs_Illumina.filtered.,WGS,TCGA-HP-A5MZ-01A-21D-A27I-10_wgs_Illumina,TCGA-HP-A5MZ-01A-21D-A27I-10_wgs_Illumina.bam,32.76,NA,0.08,58cfa832e4b0c9d6adf6d1bf,TCGA-HP-A5MZ-01A-21D-A27I-10_wgs_Illumina.bam,Dead,MALE,Not available,Not available,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-HP-A5MZ-01A,2D00F09F-0074-46C8-B357-B5F33567762A,Primary Tumor,Illumina HiSeq,bb9234a0-b13c-43f2-8d45-2ec940f73d34,Liver,78,9EC5013E-AABB-487A-87D7-49B4B6BD0F6A,C36213E4-C057-46F5-ADA5-F1F921855BB4,TCGA-HP-A5MZ-01A-21D-A27I-10,GRCh37-lite,TCGA-HP-A5MZ,TCGA-LIHC,91,s16789,Baylor College of Medicine,Ontario Institute for Cancer Research (OICR),Canada,NO,T1,NX,Hepatocellular Carcinoma,Stage I
13722.58cfa832e4b0c9d6adf6d517,58cfa832e4b0c9d6adf6d517,TCGA-PD-A5DF-01A-11D-A27I-10_wgs_Illumina.filtered.,WGS,TCGA-PD-A5DF-01A-11D-A27I-10_wgs_Illumina,TCGA-PD-A5DF-01A-11D-A27I-10_wgs_Illumina.bam,28.25,NA,0.08,58cfa832e4b0c9d6adf6d517,TCGA-PD-A5DF-01A-11D-A27I-10_wgs_Illumina.bam,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Liver Hepatocellular Carcinoma,Aligned reads,TCGA-PD-A5DF-01A,1987B453-F97D-45C7-9C89-B9A33313D645,Primary Tumor,Illumina HiSeq,b1a68eac-e070-4718-a0a6-095bb77bfeea,Liver,58,0B88D087-50FB-4893-AE37-2FC5990A5B15,F1A4F60A-5228-47CD-883F-FF8D2DFE1633,TCGA-PD-A5DF-01A-11D-A27I-10,GRCh37-lite,TCGA-PD-A5DF,TCGA-LIHC,639,s16865,Baylor College of Medicine,Fox Chase,United States,NO,T4,N0,Hepatocellular Carcinoma,Stage IIIB
13722.58cfa82de4b0c9d6adf6a600,58cfa82de4b0c9d6adf6a600,759366461d2bf8bb0583d5b9566ce947.filtered.,WGS,759366461d2bf8bb0583d5b9566ce947,759366461d2bf8bb0583d5b9566ce947.bam,NA,NA,NA,58cfa82de4b0c9d6adf6a600,759366461d2bf8bb0583d5b9566ce947.bam,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Acute Myeloid Leukemia,Aligned reads,TCGA-AB-2969-03A,929DE9A5-3224-4851-8FF0-8A92354C1F16,Primary Blood Derived Cancer - Peripheral Blood,Illumina GA,d991ead7-f6ea-4bb1-aee6-4bc4ee04c507,Blood,55,9069B85B-EEBA-49C0-A624-65817CC0E915,1A533036-36FC-4602-901D-EA17857327FB,TCGA-AB-2969-03A-01D-0741-05,GRCh37-lite,TCGA-AB-2969,TCGA-LAML,NA,s6978,Johns Hopkins / University of Southern California,Washington University,None,NO,Not available,Not available,Not available,Not available